id|nct_id|result_group_id|ctgov_group_code|period|reason|count
4689790|NCT02554929|7599323|FG000|Overall Study|Lost to Follow-up|4
4689791|NCT02554929|7599324|FG001|Overall Study|Lost to Follow-up|4
4689792|NCT02554929|7599323|FG000|Overall Study|Withdrawal by Subject|2
4689793|NCT02554929|7599324|FG001|Overall Study|Withdrawal by Subject|8
4689794|NCT02554981|7599330|FG000|Overall Study|Adverse Event|1
4689795|NCT02554981|7599330|FG000|Overall Study|Administrative Reasons|1
4689796|NCT02554981|7599330|FG000|Overall Study|Other Miscellaneous Reasons|3
4689797|NCT02555215|7599345|FG000|Overall Study|Other|1
4689798|NCT02555215|7599345|FG000|Overall Study|Investigator Decision|2
4689799|NCT02555371|7599375|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1
4689800|NCT02555371|7599376|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0
4689801|NCT02555371|7599377|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0
4689802|NCT02555371|7599378|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0
4689803|NCT02555371|7599379|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0
4689804|NCT02555371|7599375|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2
4689805|NCT02555371|7599376|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0
4689806|NCT02555371|7599377|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0
4689807|NCT02555371|7599378|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0
4689808|NCT02555371|7599379|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0
4689809|NCT02555371|7599375|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5
4689810|NCT02555371|7599376|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0
4689811|NCT02555371|7599377|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0
4689812|NCT02555371|7599378|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0
4689813|NCT02555371|7599379|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0
4689814|NCT02555371|7599375|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1
4689815|NCT02555371|7599376|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0
4689816|NCT02555371|7599377|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0
4689817|NCT02555371|7599378|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0
4448815|NCT00501085|7234513|FG000|Overall Study|Lost to Follow-up|195
4448816|NCT00501085|7234513|FG000|Overall Study|Withdrawal by Subject|34
4448817|NCT00501085|7234513|FG000|Overall Study|Subject Decision|1
4448818|NCT00501085|7234513|FG000|Overall Study|Revision Surgery|7
4448819|NCT00501085|7234513|FG000|Overall Study|Explantation Surgery|26
4448820|NCT00501085|7234513|FG000|Overall Study|Adverse Event|4
4448821|NCT00501085|7234513|FG000|Overall Study|Non-Compliance|24
4448822|NCT00501085|7234513|FG000|Overall Study|Study closed by sponsor|109
4448823|NCT00501085|7234513|FG000|Overall Study|Other loss to follow-up|32
4448824|NCT00501293|7234519|FG000|Optimization Period|Enrolled in error|1
4448825|NCT00501293|7234520|FG001|Optimization Period|Enrolled in error|0
4448826|NCT00501293|7234519|FG000|Maintenance Period|Withdrawal by Subject|14
4448827|NCT00501293|7234520|FG001|Maintenance Period|Withdrawal by Subject|13
4448828|NCT00501293|7234519|FG000|Maintenance Period|Lost to Follow-up|12
4448829|NCT00501293|7234520|FG001|Maintenance Period|Lost to Follow-up|7
4529224|NCT01055028|7347433|FG000|Screening|Screen Failure|1
4529225|NCT01055028|7347434|FG001|Screening|Screen Failure|1
4448830|NCT00501293|7234519|FG000|Maintenance Period|Adverse Event|6
4448831|NCT00501293|7234520|FG001|Maintenance Period|Adverse Event|6
4448832|NCT00501293|7234519|FG000|Maintenance Period|Protocol Violation|2
4447592|NCT00490971|7232838|FG001|Maintenance|Adverse Event|0
4447593|NCT00490971|7232839|FG002|Maintenance|Adverse Event|4
4447594|NCT00490971|7232840|FG003|Maintenance|Adverse Event|5
4447595|NCT00490971|7232841|FG004|Maintenance|Adverse Event|7
4447596|NCT00490971|7232837|FG000|Maintenance|Death|0
4447597|NCT00490971|7232838|FG001|Maintenance|Death|0
4447598|NCT00490971|7232839|FG002|Maintenance|Death|0
4447599|NCT00490971|7232840|FG003|Maintenance|Death|2
4447600|NCT00490971|7232841|FG004|Maintenance|Death|0
4448833|NCT00501293|7234520|FG001|Maintenance Period|Protocol Violation|1
4448834|NCT00501293|7234519|FG000|Maintenance Period|Lack of Efficacy|4
4448835|NCT00501293|7234520|FG001|Maintenance Period|Lack of Efficacy|1
4448836|NCT00501293|7234519|FG000|Maintenance Period|Noncompliant with study medication|5
4448837|NCT00501293|7234520|FG001|Maintenance Period|Noncompliant with study medication|0
4448838|NCT00501293|7234519|FG000|Maintenance Period|Went into rehabilitation|1
4448839|NCT00501293|7234520|FG001|Maintenance Period|Went into rehabilitation|0
4448840|NCT00501293|7234519|FG000|Maintenance Period|Would not wear patch|1
4448841|NCT00501293|7234520|FG001|Maintenance Period|Would not wear patch|0
4448842|NCT00501293|7234519|FG000|Maintenance Period|Application site reaction|1
4448843|NCT00501293|7234520|FG001|Maintenance Period|Application site reaction|0
4448844|NCT00501540|7234527|FG000|Overall Study|Death|5
4448845|NCT00501644|7234553|FG000|Overall Study|Adverse Event|4
4448846|NCT00501644|7234553|FG000|Overall Study|Withdrawal by Subject|1
4448847|NCT00501852|7234557|FG000|Overall Study|Adverse Event|3
4448848|NCT00501852|7234557|FG000|Overall Study|Withdrawal by Subject|2
4448849|NCT00501969|7234587|FG000|Overall Study|Major Protocol Violation|4
4448850|NCT00501969|7234587|FG000|Overall Study|Lack of Efficacy|29
4448851|NCT00501969|7234587|FG000|Overall Study|Adverse Event|76
4448852|NCT00501969|7234587|FG000|Overall Study|Unsatisfactory compliance of subject|7
4448853|NCT00501969|7234587|FG000|Overall Study|Subject withdrew consent|51
4448854|NCT00501969|7234587|FG000|Overall Study|Lost to Follow-up|4
4448855|NCT00501969|7234587|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1
4448856|NCT00501969|7234587|FG000|Overall Study|Other: Sponsors Request|10
4448857|NCT00501969|7234587|FG000|Overall Study|Other: Sponsor Termination at Site|1
4448858|NCT00501969|7234587|FG000|Overall Study|Other: Sponsor Stopped Study|12
4448859|NCT00501969|7234587|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1
4448860|NCT00501969|7234587|FG000|Overall Study|Other: Patients + Investigator Agreement|1
4448861|NCT00501969|7234587|FG000|Overall Study|Other: Patient is Going to Have DBS|1
4448862|NCT00501969|7234587|FG000|Overall Study|Other: Pat Pending Surgery for PD|1
4448863|NCT00501969|7234587|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1
4448864|NCT00501969|7234587|FG000|Overall Study|Other: As Required by Local EC|2
4448865|NCT00501969|7234587|FG000|Overall Study|Other: Admin Request from the Sponsor|3
4448866|NCT00501969|7234587|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1
4448867|NCT00502203|7234595|FG000|Overall Study|Inevaluable|1
4448868|NCT00502242|7234610|FG000|Overall Study|Lack of Efficacy|1
4448869|NCT00502242|7234611|FG001|Overall Study|Lack of Efficacy|11
4448870|NCT00502242|7234610|FG000|Overall Study|Adverse Event|31
4448871|NCT00502242|7234611|FG001|Overall Study|Adverse Event|20
4448872|NCT00502242|7234610|FG000|Overall Study|Physician Decision|2
4448873|NCT00502242|7234611|FG001|Overall Study|Physician Decision|3
4448874|NCT00502242|7234610|FG000|Overall Study|Other - Unspecified|8
4448875|NCT00502242|7234611|FG001|Overall Study|Other - Unspecified|14
4448876|NCT00502242|7234610|FG000|Overall Study|Protocol Violation|3
4448877|NCT00502242|7234611|FG001|Overall Study|Protocol Violation|1
4448878|NCT00502242|7234610|FG000|Overall Study|Withdrawal by Subject|6
4448879|NCT00502242|7234611|FG001|Overall Study|Withdrawal by Subject|7
4448880|NCT00502307|7234617|FG000|Open Label Period (16 Weeks)|Progressive disease|50
4448881|NCT00502307|7234618|FG001|Open Label Period (16 Weeks)|Progressive disease|0
4447601|NCT00490971|7232837|FG000|Maintenance|Lost to Follow-up|0
4447602|NCT00490971|7232838|FG001|Maintenance|Lost to Follow-up|0
4447603|NCT00490971|7232839|FG002|Maintenance|Lost to Follow-up|5
4447604|NCT00490971|7232840|FG003|Maintenance|Lost to Follow-up|8
4447605|NCT00490971|7232841|FG004|Maintenance|Lost to Follow-up|10
4448882|NCT00502307|7234619|FG002|Open Label Period (16 Weeks)|Progressive disease|0
4448883|NCT00502307|7234617|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26
4448884|NCT00502307|7234618|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0
4448885|NCT00502307|7234619|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0
4448886|NCT00502307|7234617|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0
4448887|NCT00502307|7234618|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23
4448888|NCT00502307|7234619|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2
4448889|NCT00502307|7234617|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0
4448890|NCT00502307|7234618|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3
4448891|NCT00502307|7234619|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7
4448892|NCT00502307|7234617|FG000|Maintenance Period|Progressive disease|80
4448893|NCT00502307|7234618|FG001|Maintenance Period|Progressive disease|0
4448894|NCT00502307|7234619|FG002|Maintenance Period|Progressive disease|0
4448895|NCT00502307|7234617|FG000|Maintenance Period|Discontinued due to other reasons|68
4448896|NCT00502307|7234618|FG001|Maintenance Period|Discontinued due to other reasons|0
4448897|NCT00502307|7234619|FG002|Maintenance Period|Discontinued due to other reasons|0
4448898|NCT00502320|7234638|FG000|Overall Study|Lost to Follow-up|1
4448899|NCT00502320|7234639|FG001|Overall Study|Lost to Follow-up|1
4448900|NCT00502320|7234638|FG000|Overall Study|Withdrew Consent|1
4448901|NCT00502320|7234639|FG001|Overall Study|Withdrew Consent|0
4448902|NCT00502320|7234638|FG000|Overall Study|No longer met criteria|1
4448903|NCT00502320|7234639|FG001|Overall Study|No longer met criteria|0
4448904|NCT00502320|7234638|FG000|Overall Study|Screen Failure|0
4448905|NCT00502320|7234639|FG001|Overall Study|Screen Failure|1
4448906|NCT00502320|7234638|FG000|Overall Study|Adverse Event|3
4448907|NCT00502320|7234639|FG001|Overall Study|Adverse Event|5
4515680|NCT00955357|7326681|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0
4515681|NCT00955357|7326682|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1
4515682|NCT00955357|7326681|FG000|Titration Phase|Study medication not tolerated|0
4515683|NCT00955357|7326682|FG001|Titration Phase|Study medication not tolerated|1
4515684|NCT00955357|7326681|FG000|Titration Phase|Non compliance to study procedures|0
4515685|NCT00955357|7326682|FG001|Titration Phase|Non compliance to study procedures|1
4515686|NCT00955357|7326681|FG000|Maintenance Phase|Adverse Event|3
4515687|NCT00955357|7326682|FG001|Maintenance Phase|Adverse Event|23
4515688|NCT00955357|7326681|FG000|Maintenance Phase|Lack of Efficacy|0
4515689|NCT00955357|7326682|FG001|Maintenance Phase|Lack of Efficacy|4
4515690|NCT00955357|7326681|FG000|Maintenance Phase|Protocol Violation|2
4515691|NCT00955357|7326682|FG001|Maintenance Phase|Protocol Violation|6
4515692|NCT00955357|7326681|FG000|Maintenance Phase|Lost to Follow-up|2
4515693|NCT00955357|7326682|FG001|Maintenance Phase|Lost to Follow-up|7
4515694|NCT00955357|7326681|FG000|Maintenance Phase|Withdrawal by Subject|4
4515695|NCT00955357|7326682|FG001|Maintenance Phase|Withdrawal by Subject|4
4515696|NCT00955357|7326681|FG000|Maintenance Phase|Patient moving out of area|0
4515697|NCT00955357|7326682|FG001|Maintenance Phase|Patient moving out of area|1
4515698|NCT00955357|7326681|FG000|Maintenance Phase|Non compliance to study procedures|1
4515699|NCT00955357|7326682|FG001|Maintenance Phase|Non compliance to study procedures|0
4515700|NCT00955409|7326698|FG000|Overall Study|Lack of Efficacy|1
4515701|NCT00955409|7326699|FG001|Overall Study|Lack of Efficacy|0
4515702|NCT00955409|7326700|FG002|Overall Study|Lack of Efficacy|0
4515703|NCT00955409|7326701|FG003|Overall Study|Lack of Efficacy|0
4515704|NCT00955409|7326702|FG004|Overall Study|Lack of Efficacy|0
4515705|NCT00955409|7326703|FG005|Overall Study|Lack of Efficacy|0
4515706|NCT00955409|7326704|FG006|Overall Study|Lack of Efficacy|0
4515707|NCT00955409|7326705|FG007|Overall Study|Lack of Efficacy|0
4515708|NCT00955409|7326706|FG008|Overall Study|Lack of Efficacy|0
4515709|NCT00955409|7326707|FG009|Overall Study|Lack of Efficacy|0
4515710|NCT00955409|7326698|FG000|Overall Study|Withdrawal by Subject|1
4515711|NCT00955409|7326699|FG001|Overall Study|Withdrawal by Subject|0
4515712|NCT00955409|7326700|FG002|Overall Study|Withdrawal by Subject|5
4515713|NCT00955409|7326701|FG003|Overall Study|Withdrawal by Subject|2
4515714|NCT00955409|7326702|FG004|Overall Study|Withdrawal by Subject|0
4515715|NCT00955409|7326703|FG005|Overall Study|Withdrawal by Subject|0
4515716|NCT00955409|7326704|FG006|Overall Study|Withdrawal by Subject|2
4515717|NCT00955409|7326705|FG007|Overall Study|Withdrawal by Subject|0
4515718|NCT00955409|7326706|FG008|Overall Study|Withdrawal by Subject|1
4515719|NCT00955409|7326707|FG009|Overall Study|Withdrawal by Subject|0
4515720|NCT00955409|7326698|FG000|Overall Study|Caregiver Request|2
4515721|NCT00955409|7326699|FG001|Overall Study|Caregiver Request|0
4515722|NCT00955409|7326700|FG002|Overall Study|Caregiver Request|6
4515723|NCT00955409|7326701|FG003|Overall Study|Caregiver Request|5
4515724|NCT00955409|7326702|FG004|Overall Study|Caregiver Request|0
4515725|NCT00955409|7326703|FG005|Overall Study|Caregiver Request|2
4515726|NCT00955409|7326704|FG006|Overall Study|Caregiver Request|3
4515727|NCT00955409|7326705|FG007|Overall Study|Caregiver Request|1
4515728|NCT00955409|7326706|FG008|Overall Study|Caregiver Request|3
4515729|NCT00955409|7326707|FG009|Overall Study|Caregiver Request|0
4515730|NCT00955409|7326698|FG000|Overall Study|Investigator Request|0
4515731|NCT00955409|7326699|FG001|Overall Study|Investigator Request|0
4515732|NCT00955409|7326700|FG002|Overall Study|Investigator Request|1
4515733|NCT00955409|7326701|FG003|Overall Study|Investigator Request|0
4515734|NCT00955409|7326702|FG004|Overall Study|Investigator Request|0
4515735|NCT00955409|7326703|FG005|Overall Study|Investigator Request|0
4515736|NCT00955409|7326704|FG006|Overall Study|Investigator Request|0
4448908|NCT00502593|7234657|FG000|Overall Study|Withdrawn unspecified reason|1
4448909|NCT00502593|7234658|FG001|Overall Study|Withdrawn unspecified reason|1
4448910|NCT00502593|7234659|FG002|Overall Study|Withdrawn unspecified reason|3
4448911|NCT00502593|7234660|FG003|Overall Study|Withdrawn unspecified reason|1
4448912|NCT00502593|7234661|FG004|Overall Study|Withdrawn unspecified reason|2
4448913|NCT00502593|7234662|FG005|Overall Study|Withdrawn unspecified reason|0
4448914|NCT00502593|7234663|FG006|Overall Study|Withdrawn unspecified reason|2
4448915|NCT00502593|7234664|FG007|Overall Study|Withdrawn unspecified reason|0
4448916|NCT00502593|7234665|FG008|Overall Study|Withdrawn unspecified reason|0
4448917|NCT00502593|7234666|FG009|Overall Study|Withdrawn unspecified reason|0
4448918|NCT00502593|7234667|FG010|Overall Study|Withdrawn unspecified reason|0
4448919|NCT00502593|7234668|FG011|Overall Study|Withdrawn unspecified reason|0
4448920|NCT00502593|7234657|FG000|Overall Study|Withdrawal by Subject|0
4448921|NCT00502593|7234658|FG001|Overall Study|Withdrawal by Subject|0
4448922|NCT00502593|7234659|FG002|Overall Study|Withdrawal by Subject|6
4448923|NCT00502593|7234660|FG003|Overall Study|Withdrawal by Subject|2
4448924|NCT00502593|7234661|FG004|Overall Study|Withdrawal by Subject|2
4448925|NCT00502593|7234662|FG005|Overall Study|Withdrawal by Subject|0
4448926|NCT00502593|7234663|FG006|Overall Study|Withdrawal by Subject|3
4448927|NCT00502593|7234664|FG007|Overall Study|Withdrawal by Subject|0
4448928|NCT00502593|7234665|FG008|Overall Study|Withdrawal by Subject|3
4448929|NCT00502593|7234666|FG009|Overall Study|Withdrawal by Subject|0
4448930|NCT00502593|7234667|FG010|Overall Study|Withdrawal by Subject|1
4448931|NCT00502593|7234668|FG011|Overall Study|Withdrawal by Subject|0
4448932|NCT00502593|7234657|FG000|Overall Study|Lost to Follow-up|2
4448933|NCT00502593|7234658|FG001|Overall Study|Lost to Follow-up|1
4448934|NCT00502593|7234659|FG002|Overall Study|Lost to Follow-up|1
4448935|NCT00502593|7234660|FG003|Overall Study|Lost to Follow-up|1
4448936|NCT00502593|7234661|FG004|Overall Study|Lost to Follow-up|0
4448937|NCT00502593|7234662|FG005|Overall Study|Lost to Follow-up|0
4448938|NCT00502593|7234663|FG006|Overall Study|Lost to Follow-up|0
4448939|NCT00502593|7234664|FG007|Overall Study|Lost to Follow-up|0
4448940|NCT00502593|7234665|FG008|Overall Study|Lost to Follow-up|3
4448941|NCT00502593|7234666|FG009|Overall Study|Lost to Follow-up|0
4448942|NCT00502593|7234667|FG010|Overall Study|Lost to Follow-up|1
4448943|NCT00502593|7234668|FG011|Overall Study|Lost to Follow-up|0
4448944|NCT00502671|7234717|FG000|Overall Study|Disease Progression|13
4448945|NCT00502671|7234717|FG000|Overall Study|Personal Reasons|22
4448946|NCT00502671|7234717|FG000|Overall Study|Lost to Follow-up|7
4448947|NCT00502671|7234717|FG000|Overall Study|Protocol Violation|16
4448948|NCT00502671|7234717|FG000|Overall Study|Adverse Event|19
4448949|NCT00502697|7234723|FG000|Overall Study|Withdrawal by Subject|3
4448950|NCT00502697|7234724|FG001|Overall Study|Withdrawal by Subject|1
4448951|NCT00502697|7234723|FG000|Overall Study|disenrolled due to pregnancy loss|3
4448952|NCT00502697|7234724|FG001|Overall Study|disenrolled due to pregnancy loss|5
4448953|NCT00502697|7234723|FG000|Overall Study|found not to meet eligibility criteria|3
4448954|NCT00502697|7234724|FG001|Overall Study|found not to meet eligibility criteria|4
4448955|NCT00502697|7234723|FG000|Overall Study|did not meet assignment criteria|4
4448956|NCT00502697|7234724|FG001|Overall Study|did not meet assignment criteria|2
4448957|NCT00502775|7234733|FG000|Overall Study|Adverse Event|1
4448958|NCT00502775|7234734|FG001|Overall Study|Adverse Event|2
4448959|NCT00502775|7234735|FG002|Overall Study|Adverse Event|1
4448960|NCT00502775|7234733|FG000|Overall Study|Protocol Violation|1
4448961|NCT00502775|7234734|FG001|Overall Study|Protocol Violation|5
4448962|NCT00502775|7234735|FG002|Overall Study|Protocol Violation|2
4448963|NCT00502775|7234733|FG000|Overall Study|Withdrawal by Subject|1
4448964|NCT00502775|7234734|FG001|Overall Study|Withdrawal by Subject|1
4448965|NCT00502775|7234735|FG002|Overall Study|Withdrawal by Subject|2
4448966|NCT00502775|7234733|FG000|Overall Study|Sponsor Terminated Study|1
4448967|NCT00502775|7234734|FG001|Overall Study|Sponsor Terminated Study|0
4448968|NCT00502775|7234735|FG002|Overall Study|Sponsor Terminated Study|1
4448969|NCT00502775|7234733|FG000|Overall Study|Non-compliance with eDiary|4
4448970|NCT00502775|7234734|FG001|Overall Study|Non-compliance with eDiary|1
4448971|NCT00502775|7234735|FG002|Overall Study|Non-compliance with eDiary|1
4448972|NCT00502775|7234733|FG000|Overall Study|Subject unable to swallow capsule|1
4448973|NCT00502775|7234734|FG001|Overall Study|Subject unable to swallow capsule|0
4448974|NCT00502775|7234735|FG002|Overall Study|Subject unable to swallow capsule|1
4448975|NCT00502775|7234733|FG000|Overall Study|Logpad compliance <80%|1
4448976|NCT00502775|7234734|FG001|Overall Study|Logpad compliance <80%|0
4448977|NCT00502775|7234735|FG002|Overall Study|Logpad compliance <80%|0
4448978|NCT00502775|7234733|FG000|Overall Study|Randomized in error|0
4448979|NCT00502775|7234734|FG001|Overall Study|Randomized in error|1
4448980|NCT00502775|7234735|FG002|Overall Study|Randomized in error|1
4448981|NCT00502775|7234733|FG000|Overall Study|Non-compliance|0
4448982|NCT00502775|7234734|FG001|Overall Study|Non-compliance|2
4448983|NCT00502775|7234735|FG002|Overall Study|Non-compliance|2
4448984|NCT00502775|7234733|FG000|Overall Study|Outside pollen area more than 48 hours|0
4448985|NCT00502775|7234734|FG001|Overall Study|Outside pollen area more than 48 hours|1
4448986|NCT00502775|7234735|FG002|Overall Study|Outside pollen area more than 48 hours|0
4448987|NCT00502775|7234733|FG000|Overall Study|Declining pollen counts|0
4448988|NCT00502775|7234734|FG001|Overall Study|Declining pollen counts|1
4448989|NCT00502775|7234735|FG002|Overall Study|Declining pollen counts|1
4448990|NCT00502775|7234733|FG000|Overall Study|Subject in jail|0
4448991|NCT00502775|7234734|FG001|Overall Study|Subject in jail|1
4448992|NCT00502775|7234735|FG002|Overall Study|Subject in jail|0
4448993|NCT00502775|7234733|FG000|Overall Study|Subject took disallowed drug|0
4448994|NCT00502775|7234734|FG001|Overall Study|Subject took disallowed drug|0
4448995|NCT00502775|7234735|FG002|Overall Study|Subject took disallowed drug|1
4448996|NCT00502801|7234743|FG000|Treatment Period|Withdrawal by Subject|3
4448997|NCT00502801|7234743|FG000|Treatment Period|Adverse Event|7
4448998|NCT00502801|7234743|FG000|Treatment Period|Death|14
4448999|NCT00502801|7234743|FG000|Treatment Period|OTHER|30
4449000|NCT00502801|7234743|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1
4449001|NCT00502801|7234743|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2
4449002|NCT00502801|7234743|FG000|End of Therapy to Test of Cure|Death|3
4449003|NCT00502801|7234743|FG000|End of Therapy to Test of Cure|OTHER|2
4449004|NCT00502840|7234747|FG000|Overall Study|Adverse Event|5
4449005|NCT00502840|7234747|FG000|Overall Study|Additional or changed therapy|48
4449006|NCT00502840|7234747|FG000|Overall Study|Lack of Efficacy|11
4449007|NCT00502840|7234747|FG000|Overall Study|Protocol Violation|4
4449008|NCT00502840|7234747|FG000|Overall Study|Withdrawal by Subject|5
4449009|NCT00502840|7234747|FG000|Overall Study|Lost to Follow-up|6
4449010|NCT00502840|7234747|FG000|Overall Study|Administrative problems|1
4449011|NCT00502840|7234747|FG000|Overall Study|Other|20
4449012|NCT00502996|7234770|FG000|Overall Study|Lost to Follow-up|9
4449013|NCT00502996|7234770|FG000|Overall Study|Protocol Violation|2
4449014|NCT00502996|7234770|FG000|Overall Study|Treatment failure|25
4449015|NCT00502996|7234770|FG000|Overall Study|Withdrawal Informed Consent|6
4449016|NCT00502996|7234770|FG000|Overall Study|Adverse Event|2
4449017|NCT00503139|7234787|FG000|Overall Study|Case Report Forms were not collected|4
4449018|NCT00503139|7234787|FG000|Overall Study|Protocol Violation|4
4449019|NCT00503308|7234793|FG000|Overall Study|Protocol Violation|2
4449020|NCT00503308|7234794|FG001|Overall Study|Protocol Violation|1
4449021|NCT00503399|7234802|FG000|Overall Study|Death|2
4449022|NCT00503399|7234803|FG001|Overall Study|Death|1
4449023|NCT00503399|7234802|FG000|Overall Study|Protocol Violation|1
4449024|NCT00503399|7234803|FG001|Overall Study|Protocol Violation|0
4449025|NCT00503399|7234802|FG000|Overall Study|Withdrawal by Subject|4
4449026|NCT00503399|7234803|FG001|Overall Study|Withdrawal by Subject|2
4449027|NCT00503399|7234802|FG000|Overall Study|Adverse Event|0
4449028|NCT00503399|7234803|FG001|Overall Study|Adverse Event|3
4449029|NCT00503399|7234802|FG000|Overall Study|Lost to Follow-up|0
4449030|NCT00503399|7234803|FG001|Overall Study|Lost to Follow-up|2
4449031|NCT00503425|7234809|FG000|Overall Study|Participant files lost|6
4449032|NCT00503425|7234809|FG000|Overall Study|Adverse Event|5
4449033|NCT00503425|7234809|FG000|Overall Study|Lack of Efficacy|25
4449034|NCT00503425|7234809|FG000|Overall Study|Withdrawal by Subject|8
4449035|NCT00503425|7234809|FG000|Overall Study|Lost to Follow-up|3
4449036|NCT00503425|7234809|FG000|Overall Study|Death|3
4449037|NCT00503425|7234809|FG000|Overall Study|Missing Data/Unknown|4
4449038|NCT00503685|7234817|FG000|Overall Study|Adverse Event|0
4449039|NCT00503685|7234818|FG001|Overall Study|Adverse Event|0
4449040|NCT00503685|7234819|FG002|Overall Study|Adverse Event|2
4449041|NCT00503685|7234817|FG000|Overall Study|Withdrawal by Subject|0
4449042|NCT00503685|7234818|FG001|Overall Study|Withdrawal by Subject|1
4449043|NCT00503685|7234819|FG002|Overall Study|Withdrawal by Subject|0
4449044|NCT00503685|7234817|FG000|Overall Study|Protocol Violation|0
4449045|NCT00503685|7234818|FG001|Overall Study|Protocol Violation|1
4449046|NCT00503685|7234819|FG002|Overall Study|Protocol Violation|0
4449047|NCT00503685|7234817|FG000|Overall Study|Eligibility Criteria Not Met|0
4449048|NCT00503685|7234818|FG001|Overall Study|Eligibility Criteria Not Met|1
4449049|NCT00503685|7234819|FG002|Overall Study|Eligibility Criteria Not Met|0
4449050|NCT00503698|7234830|FG000|Overall Study|Protocol Violation|5
4449051|NCT00503698|7234831|FG001|Overall Study|Protocol Violation|6
4449052|NCT00503698|7234830|FG000|Overall Study|Adverse Event|52
4449053|NCT00503698|7234831|FG001|Overall Study|Adverse Event|41
4449054|NCT00503698|7234830|FG000|Overall Study|Death|1
4449055|NCT00503698|7234831|FG001|Overall Study|Death|0
4449056|NCT00503698|7234830|FG000|Overall Study|Lack of Efficacy|3
4449057|NCT00503698|7234831|FG001|Overall Study|Lack of Efficacy|4
4449058|NCT00503698|7234830|FG000|Overall Study|Trial terminated|216
4449059|NCT00503698|7234831|FG001|Overall Study|Trial terminated|253
4449060|NCT00503698|7234830|FG000|Overall Study|End hemodialysis due to renal transplant|10
4449061|NCT00503698|7234831|FG001|Overall Study|End hemodialysis due to renal transplant|4
4449062|NCT00503698|7234830|FG000|Overall Study|Pregnancy/intention to become pregnant|1
4449063|NCT00503698|7234831|FG001|Overall Study|Pregnancy/intention to become pregnant|0
4449064|NCT00503698|7234830|FG000|Overall Study|Any condition in exclusion criteria|4
4449065|NCT00503698|7234831|FG001|Overall Study|Any condition in exclusion criteria|6
4449066|NCT00503698|7234830|FG000|Overall Study|Switch to peritoneal or home dialysis|2
4449067|NCT00503698|7234831|FG001|Overall Study|Switch to peritoneal or home dialysis|2
4449068|NCT00503698|7234830|FG000|Overall Study|Move to nonparticipating dialysis center|2
4449069|NCT00503698|7234831|FG001|Overall Study|Move to nonparticipating dialysis center|1
4449070|NCT00503698|7234830|FG000|Overall Study|Critically ill|2
4449071|NCT00503698|7234831|FG001|Overall Study|Critically ill|0
4449072|NCT00503698|7234830|FG000|Overall Study|Unclassified|48
4449073|NCT00503698|7234831|FG001|Overall Study|Unclassified|32
4449074|NCT00503698|7234830|FG000|Overall Study|Not exposed to trial drug|11
4449075|NCT00503698|7234831|FG001|Overall Study|Not exposed to trial drug|6
4449076|NCT00503776|7234845|FG000|Overall Study|Withdrawal by Subject|1
4449077|NCT00503776|7234846|FG001|Overall Study|Withdrawal by Subject|0
4449078|NCT00503776|7234847|FG002|Overall Study|Withdrawal by Subject|1
4449079|NCT00503776|7234848|FG003|Overall Study|Withdrawal by Subject|1
4449080|NCT00503776|7234845|FG000|Overall Study|Physician Decision|0
4449081|NCT00503776|7234846|FG001|Overall Study|Physician Decision|0
4449082|NCT00503776|7234847|FG002|Overall Study|Physician Decision|1
4449083|NCT00503776|7234848|FG003|Overall Study|Physician Decision|1
4449084|NCT00503867|7234863|FG000|Overall Study|Lost to Follow-up|1
4449085|NCT00503867|7234863|FG000|Overall Study|Adverse Event|1
4449086|NCT00503906|7234867|FG000|Overall Study|Withdrawal by Subject|1
4449087|NCT00503984|7234874|FG000|Overall Study|Protocol Violation|0
4449088|NCT00503984|7234875|FG001|Overall Study|Protocol Violation|1
4449089|NCT00503984|7234876|FG002|Overall Study|Protocol Violation|0
4449090|NCT00503984|7234877|FG003|Overall Study|Protocol Violation|0
4449091|NCT00503984|7234878|FG004|Overall Study|Protocol Violation|0
4449092|NCT00503984|7234879|FG005|Overall Study|Protocol Violation|0
4449093|NCT00503984|7234874|FG000|Overall Study|Adverse Event|0
4449094|NCT00503984|7234875|FG001|Overall Study|Adverse Event|1
4449095|NCT00503984|7234876|FG002|Overall Study|Adverse Event|0
4449096|NCT00503984|7234877|FG003|Overall Study|Adverse Event|0
4449097|NCT00503984|7234878|FG004|Overall Study|Adverse Event|0
4449098|NCT00503984|7234879|FG005|Overall Study|Adverse Event|0
4449099|NCT00503984|7234874|FG000|Overall Study|Death|0
4449100|NCT00503984|7234875|FG001|Overall Study|Death|0
4449101|NCT00503984|7234876|FG002|Overall Study|Death|0
4449102|NCT00503984|7234877|FG003|Overall Study|Death|0
4449103|NCT00503984|7234878|FG004|Overall Study|Death|1
4449104|NCT00503984|7234879|FG005|Overall Study|Death|0
4449105|NCT00503997|7234903|FG000|Overall Study|disease progression|1
4449106|NCT00503997|7234903|FG000|Overall Study|Adverse Event|5
4449107|NCT00503997|7234903|FG000|Overall Study|Death|1
4449108|NCT00503997|7234903|FG000|Overall Study|Withdrawal by Subject|1
4449109|NCT00504075|7234911|FG000|Overall Study|Adverse Event|1
4449110|NCT00504075|7234911|FG000|Overall Study|Lost to Follow-up|5
4449111|NCT00504075|7234911|FG000|Overall Study|Withdrawal by Subject|1
4449112|NCT00504075|7234911|FG000|Overall Study|Required other therapeutic intervention|1
4449113|NCT00504153|7234916|FG000|Overall Study|Withdrawal by Subject|1
4449114|NCT00504153|7234916|FG000|Overall Study|Adverse Event|4
4449115|NCT00504153|7234916|FG000|Overall Study|Death|1
4449116|NCT00504166|7234922|FG000|Overall Study|Adverse Event|1
4449117|NCT00504166|7234923|FG001|Overall Study|Adverse Event|4
4449118|NCT00504166|7234922|FG000|Overall Study|Withdrawal by Subject|3
4449119|NCT00504166|7234923|FG001|Overall Study|Withdrawal by Subject|6
4449120|NCT00504166|7234922|FG000|Overall Study|Physician Decision|1
4449121|NCT00504166|7234923|FG001|Overall Study|Physician Decision|1
4449122|NCT00504166|7234922|FG000|Overall Study|Lost to Follow-up|1
4449123|NCT00504166|7234923|FG001|Overall Study|Lost to Follow-up|3
4449124|NCT00504231|7234933|FG000|Overall Study|Discrepant chart documentation re route|0
4449125|NCT00504231|7234934|FG001|Overall Study|Discrepant chart documentation re route|0
4449126|NCT00504231|7234935|FG002|Overall Study|Discrepant chart documentation re route|1
4449127|NCT00504231|7234936|FG003|Overall Study|Discrepant chart documentation re route|0
4449128|NCT00504257|7234950|FG000|Overall Study|Withdrawal by Subject|2
4449129|NCT00504257|7234950|FG000|Overall Study|ineligible histology|2
4449130|NCT00504309|7234960|FG000|Overall Study|Death|0
4449131|NCT00504309|7234961|FG001|Overall Study|Death|0
4449132|NCT00504309|7234962|FG002|Overall Study|Death|0
4449133|NCT00504309|7234963|FG003|Overall Study|Death|0
4449134|NCT00504309|7234964|FG004|Overall Study|Death|1
4449135|NCT00504309|7234965|FG005|Overall Study|Death|0
4449136|NCT00504309|7234960|FG000|Overall Study|Withdrawal by Subject|0
4449137|NCT00504309|7234961|FG001|Overall Study|Withdrawal by Subject|0
4449138|NCT00504309|7234962|FG002|Overall Study|Withdrawal by Subject|1
4449139|NCT00504309|7234963|FG003|Overall Study|Withdrawal by Subject|0
4449140|NCT00504309|7234964|FG004|Overall Study|Withdrawal by Subject|0
4449141|NCT00504309|7234965|FG005|Overall Study|Withdrawal by Subject|0
4449142|NCT00504348|7234977|FG000|Overall Study|Adverse Event|3
4449143|NCT00504348|7234977|FG000|Overall Study|Lack of Efficacy|4
4449144|NCT00504348|7234977|FG000|Overall Study|Physician Decision|1
4449145|NCT00504426|7234985|FG000|Overall Study|Adverse Event|0
4449146|NCT00504426|7234986|FG001|Overall Study|Adverse Event|0
4449147|NCT00504426|7234987|FG002|Overall Study|Adverse Event|2
4449148|NCT00504426|7234988|FG003|Overall Study|Adverse Event|0
4449149|NCT00504426|7234985|FG000|Overall Study|Protocol Violation|1
4449150|NCT00504426|7234986|FG001|Overall Study|Protocol Violation|1
4449151|NCT00504426|7234987|FG002|Overall Study|Protocol Violation|2
4449152|NCT00504426|7234988|FG003|Overall Study|Protocol Violation|0
4449153|NCT00504426|7234985|FG000|Overall Study|Withdrawal by Subject|2
4449154|NCT00504426|7234986|FG001|Overall Study|Withdrawal by Subject|0
4449155|NCT00504426|7234987|FG002|Overall Study|Withdrawal by Subject|0
4449156|NCT00504426|7234988|FG003|Overall Study|Withdrawal by Subject|0
4449157|NCT00504556|7235010|FG000|Overall Study|Adverse Event|11
4449158|NCT00504556|7235011|FG001|Overall Study|Adverse Event|11
4529226|NCT01055028|7347433|FG000|Treatment Cycles 1 to 3|Adverse Event|0
4529227|NCT01055028|7347434|FG001|Treatment Cycles 1 to 3|Adverse Event|1
4529228|NCT01055028|7347433|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2
4529229|NCT01055028|7347434|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2
4529230|NCT01055028|7347433|FG000|Inter-treatment Period|Did not start Cycle 4|0
4529231|NCT01055028|7347434|FG001|Inter-treatment Period|Did not start Cycle 4|3
4529232|NCT01055132|7347450|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1
4529233|NCT01055132|7347451|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0
4529234|NCT01055132|7347450|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0
4529235|NCT01055132|7347451|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1
4529236|NCT01055197|7347476|FG000|Overall Study|Protocol Violation|7
4529237|NCT01055197|7347477|FG001|Overall Study|Protocol Violation|2
4529238|NCT01055197|7347476|FG000|Overall Study|Withdrawal by Subject|2
4529239|NCT01055197|7347477|FG001|Overall Study|Withdrawal by Subject|0
4529240|NCT01055262|7347496|FG000|Overall Study|Adverse Event|5
4529241|NCT01055262|7347496|FG000|Overall Study|Protocol Violation|3
4529242|NCT01055262|7347496|FG000|Overall Study|Uncooperativeness|1
4529243|NCT01055314|7347502|FG000|Overall Study|Adverse Event|7
4529244|NCT01055314|7347503|FG001|Overall Study|Adverse Event|4
4529245|NCT01055314|7347502|FG000|Overall Study|Death|2
4529246|NCT01055314|7347503|FG001|Overall Study|Death|1
4529247|NCT01055314|7347502|FG000|Overall Study|Lack of Efficacy|11
4529248|NCT01055314|7347503|FG001|Overall Study|Lack of Efficacy|19
4529249|NCT01055314|7347502|FG000|Overall Study|Physician Decision|10
4529250|NCT01055314|7347503|FG001|Overall Study|Physician Decision|5
4529251|NCT01055314|7347502|FG000|Overall Study|Withdrawal by Subject|1
4529252|NCT01055314|7347503|FG001|Overall Study|Withdrawal by Subject|0
4529253|NCT01055314|7347502|FG000|Overall Study|Ineligible|3
4529254|NCT01055314|7347503|FG001|Overall Study|Ineligible|5
4529255|NCT01055314|7347502|FG000|Overall Study|Refusal of further protocol therapy|10
4529256|NCT01055314|7347503|FG001|Overall Study|Refusal of further protocol therapy|4
4529257|NCT01055314|7347502|FG000|Overall Study|No treatment|1
4529258|NCT01055314|7347503|FG001|Overall Study|No treatment|0
4529259|NCT01055457|7347520|FG000|Overall Study|Lost to Follow-up|0
4529260|NCT01055457|7347521|FG001|Overall Study|Lost to Follow-up|1
4529261|NCT01055457|7347522|FG002|Overall Study|Lost to Follow-up|0
4529262|NCT01055457|7347523|FG003|Overall Study|Lost to Follow-up|0
4529263|NCT01055457|7347524|FG004|Overall Study|Lost to Follow-up|0
4529264|NCT01055457|7347525|FG005|Overall Study|Lost to Follow-up|1
4529265|NCT01055457|7347526|FG006|Overall Study|Lost to Follow-up|0
4529266|NCT01055457|7347527|FG007|Overall Study|Lost to Follow-up|0
4529267|NCT01055457|7347528|FG008|Overall Study|Lost to Follow-up|0
4529268|NCT01055457|7347529|FG009|Overall Study|Lost to Follow-up|0
4529269|NCT01055457|7347520|FG000|Overall Study|Protocol Violation|0
4529270|NCT01055457|7347521|FG001|Overall Study|Protocol Violation|0
4529271|NCT01055457|7347522|FG002|Overall Study|Protocol Violation|1
4529272|NCT01055457|7347523|FG003|Overall Study|Protocol Violation|1
4529273|NCT01055457|7347524|FG004|Overall Study|Protocol Violation|1
4529274|NCT01055457|7347525|FG005|Overall Study|Protocol Violation|2
4529275|NCT01055457|7347526|FG006|Overall Study|Protocol Violation|1
4529276|NCT01055457|7347527|FG007|Overall Study|Protocol Violation|0
4529277|NCT01055457|7347528|FG008|Overall Study|Protocol Violation|0
4529278|NCT01055457|7347529|FG009|Overall Study|Protocol Violation|1
4529279|NCT01055457|7347520|FG000|Overall Study|Subject Disinterest|0
4529280|NCT01055457|7347521|FG001|Overall Study|Subject Disinterest|0
4529281|NCT01055457|7347522|FG002|Overall Study|Subject Disinterest|0
4529282|NCT01055457|7347523|FG003|Overall Study|Subject Disinterest|0
4529283|NCT01055457|7347524|FG004|Overall Study|Subject Disinterest|0
4529284|NCT01055457|7347525|FG005|Overall Study|Subject Disinterest|0
4529285|NCT01055457|7347526|FG006|Overall Study|Subject Disinterest|0
4529286|NCT01055457|7347527|FG007|Overall Study|Subject Disinterest|1
4529287|NCT01055457|7347528|FG008|Overall Study|Subject Disinterest|0
4529288|NCT01055457|7347529|FG009|Overall Study|Subject Disinterest|0
4529289|NCT01055457|7347520|FG000|Overall Study|Subject Ineligible|1
4529290|NCT01055457|7347521|FG001|Overall Study|Subject Ineligible|0
4529291|NCT01055457|7347522|FG002|Overall Study|Subject Ineligible|1
4529292|NCT01055457|7347523|FG003|Overall Study|Subject Ineligible|0
4529293|NCT01055457|7347524|FG004|Overall Study|Subject Ineligible|1
4529294|NCT01055457|7347525|FG005|Overall Study|Subject Ineligible|0
4529295|NCT01055457|7347526|FG006|Overall Study|Subject Ineligible|0
4529296|NCT01055457|7347527|FG007|Overall Study|Subject Ineligible|0
4529297|NCT01055457|7347528|FG008|Overall Study|Subject Ineligible|0
4529298|NCT01055457|7347529|FG009|Overall Study|Subject Ineligible|0
4529299|NCT01055457|7347520|FG000|Overall Study|Discomfort|0
4529300|NCT01055457|7347521|FG001|Overall Study|Discomfort|0
4529301|NCT01055457|7347522|FG002|Overall Study|Discomfort|0
4529302|NCT01055457|7347523|FG003|Overall Study|Discomfort|0
4529303|NCT01055457|7347524|FG004|Overall Study|Discomfort|1
4529304|NCT01055457|7347525|FG005|Overall Study|Discomfort|0
4529305|NCT01055457|7347526|FG006|Overall Study|Discomfort|0
4529306|NCT01055457|7347527|FG007|Overall Study|Discomfort|0
4529307|NCT01055457|7347528|FG008|Overall Study|Discomfort|0
4529308|NCT01055457|7347529|FG009|Overall Study|Discomfort|0
4529309|NCT01055457|7347520|FG000|Overall Study|Pregnancy|0
4529310|NCT01055457|7347521|FG001|Overall Study|Pregnancy|0
4449159|NCT00504556|7235012|FG002|Overall Study|Adverse Event|14
4449160|NCT00504556|7235013|FG003|Overall Study|Adverse Event|13
4449161|NCT00504556|7235014|FG004|Overall Study|Adverse Event|5
4449162|NCT00504556|7235010|FG000|Overall Study|Death|3
4449163|NCT00504556|7235011|FG001|Overall Study|Death|3
4449164|NCT00504556|7235012|FG002|Overall Study|Death|1
4449165|NCT00504556|7235013|FG003|Overall Study|Death|0
4449166|NCT00504556|7235014|FG004|Overall Study|Death|2
4449167|NCT00504556|7235010|FG000|Overall Study|Protocol Violation|1
4449168|NCT00504556|7235011|FG001|Overall Study|Protocol Violation|3
4449169|NCT00504556|7235012|FG002|Overall Study|Protocol Violation|2
4449170|NCT00504556|7235013|FG003|Overall Study|Protocol Violation|1
4449171|NCT00504556|7235014|FG004|Overall Study|Protocol Violation|2
4449172|NCT00504556|7235010|FG000|Overall Study|Lost to Follow-up|0
4449173|NCT00504556|7235011|FG001|Overall Study|Lost to Follow-up|0
4449174|NCT00504556|7235012|FG002|Overall Study|Lost to Follow-up|1
4449175|NCT00504556|7235013|FG003|Overall Study|Lost to Follow-up|1
4449176|NCT00504556|7235014|FG004|Overall Study|Lost to Follow-up|1
4449177|NCT00504556|7235010|FG000|Overall Study|Withdrawal by Subject|16
4449178|NCT00504556|7235011|FG001|Overall Study|Withdrawal by Subject|16
4449179|NCT00504556|7235012|FG002|Overall Study|Withdrawal by Subject|7
4449180|NCT00504556|7235013|FG003|Overall Study|Withdrawal by Subject|8
4449181|NCT00504556|7235014|FG004|Overall Study|Withdrawal by Subject|12
4449182|NCT00504556|7235010|FG000|Overall Study|administrative reasons|0
4449183|NCT00504556|7235011|FG001|Overall Study|administrative reasons|2
4449184|NCT00504556|7235012|FG002|Overall Study|administrative reasons|2
4449185|NCT00504556|7235013|FG003|Overall Study|administrative reasons|1
4449186|NCT00504556|7235014|FG004|Overall Study|administrative reasons|2
4449187|NCT00504556|7235010|FG000|Overall Study|did not meet entry criteria|2
4449188|NCT00504556|7235011|FG001|Overall Study|did not meet entry criteria|0
4449189|NCT00504556|7235012|FG002|Overall Study|did not meet entry criteria|1
4449190|NCT00504556|7235013|FG003|Overall Study|did not meet entry criteria|1
4449191|NCT00504556|7235014|FG004|Overall Study|did not meet entry criteria|0
4449192|NCT00504556|7235010|FG000|Overall Study|data monitor committee decision|0
4449193|NCT00504556|7235011|FG001|Overall Study|data monitor committee decision|0
4449194|NCT00504556|7235012|FG002|Overall Study|data monitor committee decision|0
4449195|NCT00504556|7235013|FG003|Overall Study|data monitor committee decision|100
4449196|NCT00504556|7235014|FG004|Overall Study|data monitor committee decision|0
4449197|NCT00504556|7235010|FG000|Overall Study|Other|2
4449198|NCT00504556|7235011|FG001|Overall Study|Other|2
4449199|NCT00504556|7235012|FG002|Overall Study|Other|2
4449200|NCT00504556|7235013|FG003|Overall Study|Other|3
4449201|NCT00504556|7235014|FG004|Overall Study|Other|0
4449202|NCT00504556|7235010|FG000|Overall Study|not in safety analysis set|0
4449203|NCT00504556|7235011|FG001|Overall Study|not in safety analysis set|1
4449204|NCT00504556|7235012|FG002|Overall Study|not in safety analysis set|1
4449205|NCT00504556|7235013|FG003|Overall Study|not in safety analysis set|0
4449206|NCT00504556|7235014|FG004|Overall Study|not in safety analysis set|1
4770341|NCT03922321|7746682|FG000|Overall Study|Participant Moved|1
4770342|NCT03922321|7746682|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1
4770343|NCT03911713|7746691|FG000|Overall Study|Lost to Follow-up|0
4449210|NCT00504595|7235043|FG000|Overall Study|Lack of Efficacy|1
4449211|NCT00504595|7235044|FG001|Overall Study|Lack of Efficacy|0
4449212|NCT00504595|7235045|FG002|Overall Study|Lack of Efficacy|0
4449213|NCT00504595|7235046|FG003|Overall Study|Lack of Efficacy|0
4449214|NCT00504595|7235043|FG000|Overall Study|Other|0
4449215|NCT00504595|7235044|FG001|Overall Study|Other|0
4449216|NCT00504595|7235045|FG002|Overall Study|Other|2
4449217|NCT00504595|7235046|FG003|Overall Study|Other|0
4449218|NCT00504725|7235067|FG000|Overall Study|Protocol Violation|1
4449219|NCT00504725|7235068|FG001|Overall Study|Protocol Violation|0
4449220|NCT00504777|7235078|FG000|Overall Study|Adverse Event|1
4449221|NCT00504829|7235085|FG000|Overall Study|Protocol Violation|6
4449222|NCT00504829|7235086|FG001|Overall Study|Protocol Violation|4
4449223|NCT00504829|7235087|FG002|Overall Study|Protocol Violation|10
4449224|NCT00504881|7235097|FG000|Overall Study|Lack of Efficacy|1
4449225|NCT00504881|7235098|FG001|Overall Study|Lack of Efficacy|5
4449226|NCT00504881|7235097|FG000|Overall Study|Lost to Follow-up|0
4449227|NCT00504881|7235098|FG001|Overall Study|Lost to Follow-up|2
4449228|NCT00504881|7235097|FG000|Overall Study|Withdrawal by Subject|1
4449229|NCT00504881|7235098|FG001|Overall Study|Withdrawal by Subject|4
4449230|NCT00504881|7235097|FG000|Overall Study|Non-Compliance|1
4449231|NCT00504881|7235098|FG001|Overall Study|Non-Compliance|0
4449232|NCT00504881|7235097|FG000|Overall Study|No Birth Control|0
4449233|NCT00504881|7235098|FG001|Overall Study|No Birth Control|1
4449234|NCT00504881|7235097|FG000|Overall Study|Safety Visit not performed|0
4449235|NCT00504881|7235098|FG001|Overall Study|Safety Visit not performed|1
4529311|NCT01055457|7347522|FG002|Overall Study|Pregnancy|0
4449236|NCT00504881|7235097|FG000|Overall Study|AE, serious fatal|0
4449237|NCT00504881|7235098|FG001|Overall Study|AE, serious fatal|1
4449238|NCT00504881|7235097|FG000|Overall Study|SAE, non-fatal|2
4449239|NCT00504881|7235098|FG001|Overall Study|SAE, non-fatal|6
4449240|NCT00504881|7235097|FG000|Overall Study|AE, non-serious non-fatal|4
4449241|NCT00504881|7235098|FG001|Overall Study|AE, non-serious non-fatal|14
4449242|NCT00504881|7235097|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
4449243|NCT00504881|7235098|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2
4529312|NCT01055457|7347523|FG003|Overall Study|Pregnancy|1
4529313|NCT01055457|7347524|FG004|Overall Study|Pregnancy|0
4529314|NCT01055457|7347525|FG005|Overall Study|Pregnancy|0
4529315|NCT01055457|7347526|FG006|Overall Study|Pregnancy|0
4529316|NCT01055457|7347527|FG007|Overall Study|Pregnancy|0
4529317|NCT01055457|7347528|FG008|Overall Study|Pregnancy|0
4529318|NCT01055457|7347529|FG009|Overall Study|Pregnancy|0
4529319|NCT01055457|7347520|FG000|Overall Study|Adverse Event|0
4529320|NCT01055457|7347521|FG001|Overall Study|Adverse Event|0
4529321|NCT01055457|7347522|FG002|Overall Study|Adverse Event|0
4529322|NCT01055457|7347523|FG003|Overall Study|Adverse Event|1
4529323|NCT01055457|7347524|FG004|Overall Study|Adverse Event|0
4529324|NCT01055457|7347525|FG005|Overall Study|Adverse Event|0
4529325|NCT01055457|7347526|FG006|Overall Study|Adverse Event|0
4529326|NCT01055457|7347527|FG007|Overall Study|Adverse Event|0
4529327|NCT01055457|7347528|FG008|Overall Study|Adverse Event|0
4529328|NCT01055457|7347529|FG009|Overall Study|Adverse Event|0
4529329|NCT01055496|7347553|FG000|Overall Study|Withdrawal by Subject|2
4529330|NCT01055496|7347554|FG001|Overall Study|Withdrawal by Subject|4
4529331|NCT01055496|7347553|FG000|Overall Study|Death|13
4529332|NCT01055496|7347554|FG001|Overall Study|Death|23
4529333|NCT01055496|7347553|FG000|Overall Study|Lost to Follow-up|0
4529334|NCT01055496|7347554|FG001|Overall Study|Lost to Follow-up|2
4529335|NCT01055496|7347553|FG000|Overall Study|Other - Unspecified|0
4529336|NCT01055496|7347554|FG001|Overall Study|Other - Unspecified|1
4529337|NCT01055613|7347583|FG000|Overall Study|No Longer Meets Eligibility Criteria|3
4529338|NCT01055613|7347584|FG001|Overall Study|No Longer Meets Eligibility Criteria|0
4529339|NCT01055613|7347583|FG000|Overall Study|Unacceptable lens fit|1
4529340|NCT01055613|7347584|FG001|Overall Study|Unacceptable lens fit|0
4529341|NCT01055613|7347583|FG000|Overall Study|Discomfort|2
4529342|NCT01055613|7347584|FG001|Overall Study|Discomfort|1
4529343|NCT01055613|7347583|FG000|Overall Study|Lost to Follow-up|1
4529344|NCT01055613|7347584|FG001|Overall Study|Lost to Follow-up|1
4529345|NCT01055613|7347583|FG000|Overall Study|Protocol Violation|1
4529346|NCT01055613|7347584|FG001|Overall Study|Protocol Violation|1
4529347|NCT01055613|7347583|FG000|Overall Study|Subject Disinterest|1
4529348|NCT01055613|7347584|FG001|Overall Study|Subject Disinterest|1
4529349|NCT01055639|7347592|FG000|Overall Study|Adverse Event|0
4529350|NCT01055639|7347593|FG001|Overall Study|Adverse Event|1
4529351|NCT01055639|7347592|FG000|Overall Study|Lack of Efficacy|0
4529352|NCT01055639|7347593|FG001|Overall Study|Lack of Efficacy|1
4529353|NCT01055639|7347592|FG000|Overall Study|Lost to Follow-up|8
4529354|NCT01055639|7347593|FG001|Overall Study|Lost to Follow-up|11
4529355|NCT01055639|7347592|FG000|Overall Study|Protocol Violation|5
4449244|NCT00504881|7235097|FG000|Overall Study|AE of unknown type|1
4449245|NCT00504881|7235098|FG001|Overall Study|AE of unknown type|0
4449246|NCT00504894|7235109|FG000|Overall Study|fMRI technical problems|1
4449247|NCT00504894|7235110|FG001|Overall Study|fMRI technical problems|1
4449248|NCT00504894|7235111|FG002|Overall Study|fMRI technical problems|0
4449249|NCT00504894|7235109|FG000|Overall Study|Withdrawal by Subject|0
4449250|NCT00504894|7235110|FG001|Overall Study|Withdrawal by Subject|1
4449251|NCT00504894|7235111|FG002|Overall Study|Withdrawal by Subject|0
4449252|NCT00504894|7235109|FG000|Overall Study|Infusion technical problems|0
4449253|NCT00504894|7235110|FG001|Overall Study|Infusion technical problems|1
4449254|NCT00504894|7235111|FG002|Overall Study|Infusion technical problems|0
4449255|NCT00504894|7235109|FG000|Overall Study|poor subject data|2
4449256|NCT00504894|7235110|FG001|Overall Study|poor subject data|0
4449257|NCT00504894|7235111|FG002|Overall Study|poor subject data|0
4449258|NCT00505076|7235122|FG000|Overall Study|Adverse Event|1
4449259|NCT00505076|7235123|FG001|Overall Study|Adverse Event|0
4449260|NCT00505076|7235124|FG002|Overall Study|Adverse Event|1
4449261|NCT00505076|7235122|FG000|Overall Study|Protocol Violation|2
4449262|NCT00505076|7235123|FG001|Overall Study|Protocol Violation|1
4449263|NCT00505076|7235124|FG002|Overall Study|Protocol Violation|2
4449264|NCT00505076|7235122|FG000|Overall Study|Withdrawal by Subject|0
4449265|NCT00505076|7235123|FG001|Overall Study|Withdrawal by Subject|1
4449266|NCT00505076|7235124|FG002|Overall Study|Withdrawal by Subject|2
4449267|NCT00505284|7235137|FG000|Overall Study|Adverse Event|3
4449268|NCT00505284|7235138|FG001|Overall Study|Adverse Event|7
4449269|NCT00505284|7235139|FG002|Overall Study|Adverse Event|9
4449270|NCT00505284|7235140|FG003|Overall Study|Adverse Event|14
4449271|NCT00505284|7235141|FG004|Overall Study|Adverse Event|22
4449272|NCT00505284|7235137|FG000|Overall Study|Protocol Violation|0
4449273|NCT00505284|7235138|FG001|Overall Study|Protocol Violation|1
4449274|NCT00505284|7235139|FG002|Overall Study|Protocol Violation|1
4449275|NCT00505284|7235140|FG003|Overall Study|Protocol Violation|0
4449276|NCT00505284|7235141|FG004|Overall Study|Protocol Violation|0
4449277|NCT00505284|7235137|FG000|Overall Study|Withdrawal by Subject|2
4449278|NCT00505284|7235138|FG001|Overall Study|Withdrawal by Subject|6
4449279|NCT00505284|7235139|FG002|Overall Study|Withdrawal by Subject|1
4449280|NCT00505284|7235140|FG003|Overall Study|Withdrawal by Subject|0
4449281|NCT00505284|7235141|FG004|Overall Study|Withdrawal by Subject|6
4449282|NCT00505284|7235137|FG000|Overall Study|Lack of Efficacy|0
4449283|NCT00505284|7235138|FG001|Overall Study|Lack of Efficacy|1
4449284|NCT00505284|7235139|FG002|Overall Study|Lack of Efficacy|1
4529356|NCT01055639|7347593|FG001|Overall Study|Protocol Violation|5
4529357|NCT01055639|7347592|FG000|Overall Study|Withdrawal by Subject|8
4449285|NCT00505284|7235140|FG003|Overall Study|Lack of Efficacy|1
4449286|NCT00505284|7235141|FG004|Overall Study|Lack of Efficacy|1
4449287|NCT00505284|7235137|FG000|Overall Study|Physician Decision|0
4449288|NCT00505284|7235138|FG001|Overall Study|Physician Decision|1
4449289|NCT00505284|7235139|FG002|Overall Study|Physician Decision|0
4449290|NCT00505284|7235140|FG003|Overall Study|Physician Decision|0
4449291|NCT00505284|7235141|FG004|Overall Study|Physician Decision|0
4449292|NCT00505284|7235137|FG000|Overall Study|Other|5
4449293|NCT00505284|7235138|FG001|Overall Study|Other|0
4449294|NCT00505284|7235139|FG002|Overall Study|Other|0
4449295|NCT00505284|7235140|FG003|Overall Study|Other|4
4449296|NCT00505284|7235141|FG004|Overall Study|Other|4
4449297|NCT00505375|7235164|FG000|Overall Study|Death|1
4449298|NCT00505375|7235165|FG001|Overall Study|Death|0
4449299|NCT00505375|7235164|FG000|Overall Study|Withdrawal by Subject|2
4449300|NCT00505375|7235165|FG001|Overall Study|Withdrawal by Subject|2
4449301|NCT00505375|7235164|FG000|Overall Study|Lost to Follow-up|0
4449302|NCT00505375|7235165|FG001|Overall Study|Lost to Follow-up|2
4449303|NCT00505375|7235164|FG000|Overall Study|Pregnancy|1
4449304|NCT00505375|7235165|FG001|Overall Study|Pregnancy|0
4449305|NCT00505375|7235164|FG000|Overall Study|Travel issues|0
4449306|NCT00505375|7235165|FG001|Overall Study|Travel issues|1
4449307|NCT00505414|7235173|FG000|Titration Phase|Adverse Event|0
4449308|NCT00505414|7235174|FG001|Titration Phase|Adverse Event|0
4449309|NCT00505414|7235175|FG002|Titration Phase|Adverse Event|0
4449310|NCT00505414|7235176|FG003|Titration Phase|Adverse Event|8
4449311|NCT00505414|7235177|FG004|Titration Phase|Adverse Event|3
4449312|NCT00505414|7235173|FG000|Titration Phase|Death|0
4449313|NCT00505414|7235174|FG001|Titration Phase|Death|0
4449314|NCT00505414|7235175|FG002|Titration Phase|Death|0
4449315|NCT00505414|7235176|FG003|Titration Phase|Death|2
4449316|NCT00505414|7235177|FG004|Titration Phase|Death|0
4449317|NCT00505414|7235173|FG000|Titration Phase|Lack of Efficacy|0
4449318|NCT00505414|7235174|FG001|Titration Phase|Lack of Efficacy|0
4449319|NCT00505414|7235175|FG002|Titration Phase|Lack of Efficacy|0
4449320|NCT00505414|7235176|FG003|Titration Phase|Lack of Efficacy|10
4449321|NCT00505414|7235177|FG004|Titration Phase|Lack of Efficacy|1
4449322|NCT00505414|7235173|FG000|Titration Phase|Protocol Violation|0
4449323|NCT00505414|7235174|FG001|Titration Phase|Protocol Violation|0
4449324|NCT00505414|7235175|FG002|Titration Phase|Protocol Violation|0
4449325|NCT00505414|7235176|FG003|Titration Phase|Protocol Violation|0
4449326|NCT00505414|7235177|FG004|Titration Phase|Protocol Violation|1
4449327|NCT00505414|7235173|FG000|Titration Phase|Withdrawal by Subject|0
4449328|NCT00505414|7235174|FG001|Titration Phase|Withdrawal by Subject|0
4449329|NCT00505414|7235175|FG002|Titration Phase|Withdrawal by Subject|0
4449330|NCT00505414|7235176|FG003|Titration Phase|Withdrawal by Subject|3
4449331|NCT00505414|7235177|FG004|Titration Phase|Withdrawal by Subject|4
4449332|NCT00505414|7235173|FG000|Titration Phase|Underlying disease and therapy required|0
4449333|NCT00505414|7235174|FG001|Titration Phase|Underlying disease and therapy required|0
4449334|NCT00505414|7235175|FG002|Titration Phase|Underlying disease and therapy required|0
4449335|NCT00505414|7235176|FG003|Titration Phase|Underlying disease and therapy required|7
4449336|NCT00505414|7235177|FG004|Titration Phase|Underlying disease and therapy required|3
4449337|NCT00505414|7235173|FG000|Maintenance Phase|Adverse Event|2
4449338|NCT00505414|7235174|FG001|Maintenance Phase|Adverse Event|2
4449339|NCT00505414|7235175|FG002|Maintenance Phase|Adverse Event|3
4449340|NCT00505414|7235176|FG003|Maintenance Phase|Adverse Event|0
4449341|NCT00505414|7235177|FG004|Maintenance Phase|Adverse Event|0
4449342|NCT00505414|7235173|FG000|Maintenance Phase|Death|2
4609292|NCT01685073|7464944|FG000|Overall Study|Lost to Follow-up|6
4609293|NCT01685073|7464945|FG001|Overall Study|Lost to Follow-up|8
4609294|NCT01685073|7464944|FG000|Overall Study|Withdrawal by Subject|24
4609295|NCT01685073|7464945|FG001|Overall Study|Withdrawal by Subject|24
4632588|NCT01903252|7502286|FG002|Maintenance, Open-Label|Withdrawal by Subject|0
4632589|NCT01903252|7502287|FG003|Maintenance, Open-Label|Withdrawal by Subject|1
4632590|NCT01903252|7502288|FG004|Maintenance, Open-Label|Withdrawal by Subject|6
4632591|NCT01903252|7502289|FG005|Maintenance, Open-Label|Withdrawal by Subject|2
4737563|NCT03614078|7687791|FG001|Overall Study|Withdrawal by Subject|2
4449343|NCT00505414|7235174|FG001|Maintenance Phase|Death|0
4449344|NCT00505414|7235175|FG002|Maintenance Phase|Death|1
4449345|NCT00505414|7235176|FG003|Maintenance Phase|Death|0
4449346|NCT00505414|7235177|FG004|Maintenance Phase|Death|0
4449347|NCT00505414|7235173|FG000|Maintenance Phase|Lack of Efficacy|2
4449348|NCT00505414|7235174|FG001|Maintenance Phase|Lack of Efficacy|1
4449349|NCT00505414|7235175|FG002|Maintenance Phase|Lack of Efficacy|1
4449350|NCT00505414|7235176|FG003|Maintenance Phase|Lack of Efficacy|0
4449351|NCT00505414|7235177|FG004|Maintenance Phase|Lack of Efficacy|0
4449352|NCT00505414|7235173|FG000|Maintenance Phase|Withdrawal by Subject|0
4529358|NCT01055639|7347593|FG001|Overall Study|Withdrawal by Subject|11
4529359|NCT01055834|7347637|FG000|Treatment Period I|Adverse Event|1
4529360|NCT01055834|7347638|FG001|Treatment Period I|Adverse Event|0
4529361|NCT01055886|7347649|FG000|Overall Study|Withdrawal by Subject|4
4529362|NCT01055886|7347650|FG001|Overall Study|Withdrawal by Subject|9
4529363|NCT01055886|7347649|FG000|Overall Study|Lost to Follow-up|1
4529364|NCT01055886|7347650|FG001|Overall Study|Lost to Follow-up|1
4449353|NCT00505414|7235174|FG001|Maintenance Phase|Withdrawal by Subject|0
4449354|NCT00505414|7235175|FG002|Maintenance Phase|Withdrawal by Subject|1
4449355|NCT00505414|7235176|FG003|Maintenance Phase|Withdrawal by Subject|0
4449356|NCT00505414|7235177|FG004|Maintenance Phase|Withdrawal by Subject|0
4449357|NCT00505414|7235173|FG000|Maintenance Phase|underlying disease and therapy required|0
4449358|NCT00505414|7235174|FG001|Maintenance Phase|underlying disease and therapy required|2
4449359|NCT00505414|7235175|FG002|Maintenance Phase|underlying disease and therapy required|2
4449360|NCT00505414|7235176|FG003|Maintenance Phase|underlying disease and therapy required|0
4449361|NCT00505414|7235177|FG004|Maintenance Phase|underlying disease and therapy required|0
4449362|NCT00505622|7235196|FG000|Overall Study|Adverse Event|5
4449363|NCT00505622|7235197|FG001|Overall Study|Adverse Event|6
4449364|NCT00505622|7235198|FG002|Overall Study|Adverse Event|4
4449365|NCT00505622|7235196|FG000|Overall Study|Protocol Violation|1
4449366|NCT00505622|7235197|FG001|Overall Study|Protocol Violation|1
4449367|NCT00505622|7235198|FG002|Overall Study|Protocol Violation|0
4449368|NCT00505622|7235196|FG000|Overall Study|Withdrawal by Subject|0
4449369|NCT00505622|7235197|FG001|Overall Study|Withdrawal by Subject|3
4449370|NCT00505622|7235198|FG002|Overall Study|Withdrawal by Subject|2
4449371|NCT00505622|7235196|FG000|Overall Study|Study termination by sponsor|115
4449372|NCT00505622|7235197|FG001|Overall Study|Study termination by sponsor|98
4449373|NCT00505622|7235198|FG002|Overall Study|Study termination by sponsor|90
4449374|NCT00505661|7235210|FG000|Overall Study|Not Eligible|4
4449375|NCT00505687|7235214|FG000|Overall Study|Important protocol violation|2
4449376|NCT00505687|7235214|FG000|Overall Study|Lack of Efficacy|15
4449377|NCT00505687|7235214|FG000|Overall Study|Adverse Event|48
4449378|NCT00505687|7235214|FG000|Overall Study|Subject withdrew consent|15
4449379|NCT00505687|7235214|FG000|Overall Study|Lost to Follow-up|1
4449380|NCT00505687|7235214|FG000|Overall Study|Other: Underwent Implantation Of DBS|1
4449381|NCT00505687|7235214|FG000|Overall Study|Other: Scheduled DBS Surgery|1
4449382|NCT00505687|7235214|FG000|Overall Study|Other: Prolonged Hospitalization|1
4449383|NCT00505687|7235214|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1
4449384|NCT00505687|7235214|FG000|Overall Study|Other: Neupro Given In Hospital|1
4449385|NCT00505687|7235214|FG000|Overall Study|Other: Disease Progression|1
4449386|NCT00505687|7235214|FG000|Overall Study|Other: As Per Sponsor|8
4449387|NCT00505752|7235222|FG000|Overall Study|Adverse Event|1
4449388|NCT00505752|7235223|FG001|Overall Study|Adverse Event|0
4449389|NCT00505752|7235224|FG002|Overall Study|Adverse Event|1
4449390|NCT00505752|7235225|FG003|Overall Study|Adverse Event|0
4449391|NCT00505752|7235222|FG000|Overall Study|Lost to Follow-up|1
4449392|NCT00505752|7235223|FG001|Overall Study|Lost to Follow-up|0
4449393|NCT00505752|7235224|FG002|Overall Study|Lost to Follow-up|0
4449394|NCT00505752|7235225|FG003|Overall Study|Lost to Follow-up|0
4449395|NCT00505752|7235222|FG000|Overall Study|Lack of ovarian response|1
4449396|NCT00505752|7235223|FG001|Overall Study|Lack of ovarian response|3
4449397|NCT00505752|7235224|FG002|Overall Study|Lack of ovarian response|0
4449398|NCT00505752|7235225|FG003|Overall Study|Lack of ovarian response|0
4449399|NCT00505752|7235222|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1
4449400|NCT00505752|7235223|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1
4449401|NCT00505752|7235224|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3
4449402|NCT00505752|7235225|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1
4449403|NCT00505752|7235222|FG000|Overall Study|No oocytes retrieved|0
4449404|NCT00505752|7235223|FG001|Overall Study|No oocytes retrieved|2
4449405|NCT00505752|7235224|FG002|Overall Study|No oocytes retrieved|0
4449406|NCT00505752|7235225|FG003|Overall Study|No oocytes retrieved|1
4449407|NCT00505752|7235222|FG000|Overall Study|No Fertilization|1
4449408|NCT00505752|7235223|FG001|Overall Study|No Fertilization|1
4449409|NCT00505752|7235224|FG002|Overall Study|No Fertilization|2
4449410|NCT00505752|7235225|FG003|Overall Study|No Fertilization|1
4449411|NCT00505752|7235222|FG000|Overall Study|All embryos/blastocysts discarded|0
4449412|NCT00505752|7235223|FG001|Overall Study|All embryos/blastocysts discarded|0
4449413|NCT00505752|7235224|FG002|Overall Study|All embryos/blastocysts discarded|1
4449414|NCT00505752|7235225|FG003|Overall Study|All embryos/blastocysts discarded|1
4449415|NCT00505752|7235222|FG000|Overall Study|Other|1
4449416|NCT00505752|7235223|FG001|Overall Study|Other|2
4449417|NCT00505752|7235224|FG002|Overall Study|Other|1
4449418|NCT00505752|7235225|FG003|Overall Study|Other|2
4449419|NCT00505765|7235238|FG000|Overall Study|Withdrawal by Subject|1
4449420|NCT00505765|7235239|FG001|Overall Study|Withdrawal by Subject|0
4449421|NCT00505765|7235240|FG002|Overall Study|Withdrawal by Subject|0
4449422|NCT00505765|7235238|FG000|Overall Study|Adverse Event|1
4449423|NCT00505765|7235239|FG001|Overall Study|Adverse Event|2
4449424|NCT00505765|7235240|FG002|Overall Study|Adverse Event|0
4449425|NCT00505765|7235238|FG000|Overall Study|Noncompliance|0
4449426|NCT00505765|7235239|FG001|Overall Study|Noncompliance|1
4449427|NCT00505765|7235240|FG002|Overall Study|Noncompliance|3
4449428|NCT00505778|7235250|FG000|Overall Study|Adverse Event|2
4449429|NCT00505778|7235251|FG001|Overall Study|Adverse Event|7
4449430|NCT00505778|7235250|FG000|Overall Study|Physician Decision|8
4449431|NCT00505778|7235251|FG001|Overall Study|Physician Decision|14
4449432|NCT00505778|7235250|FG000|Overall Study|Lost to Follow-up|17
4449433|NCT00505778|7235251|FG001|Overall Study|Lost to Follow-up|23
4449434|NCT00505778|7235250|FG000|Overall Study|Unable to Meet Protocol Criteria|4
4449435|NCT00505778|7235251|FG001|Overall Study|Unable to Meet Protocol Criteria|1
4449436|NCT00505778|7235250|FG000|Overall Study|Protocol Violation|7
4449437|NCT00505778|7235251|FG001|Overall Study|Protocol Violation|9
4449438|NCT00505778|7235250|FG000|Overall Study|Withdrawal by Subject|29
4449439|NCT00505778|7235251|FG001|Overall Study|Withdrawal by Subject|14
4449440|NCT00505778|7235250|FG000|Overall Study|Relapse|65
4449441|NCT00505778|7235251|FG001|Overall Study|Relapse|65
4449442|NCT00505778|7235250|FG000|Overall Study|Took No Study Drug|2
4449443|NCT00505778|7235251|FG001|Overall Study|Took No Study Drug|2
4449444|NCT00505921|7235266|FG000|Overall Study|Ineligible|1
4449445|NCT00505921|7235266|FG000|Overall Study|Failed to Mobilize|8
4449446|NCT00505934|7235270|FG000|Overall Study|Adverse Event|1
4449447|NCT00505934|7235270|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1
4449448|NCT00505934|7235270|FG000|Overall Study|Other: IV dose needed to be changed|1
4449449|NCT00506077|7235289|FG000|Treatment Period 1|Adverse Event|2
4449450|NCT00506077|7235290|FG001|Treatment Period 1|Adverse Event|1
4449451|NCT00506077|7235289|FG000|Treatment Period 1|Lost to Follow-up|0
4449452|NCT00506077|7235290|FG001|Treatment Period 1|Lost to Follow-up|2
4449453|NCT00506077|7235289|FG000|Treatment Period 1|Withdrawal by Subject|2
4449454|NCT00506077|7235290|FG001|Treatment Period 1|Withdrawal by Subject|0
4449455|NCT00506077|7235289|FG000|Treatment Period 2|Adverse Event|0
4449456|NCT00506077|7235290|FG001|Treatment Period 2|Adverse Event|1
4449457|NCT00506077|7235289|FG000|Treatment Period 2|Withdrawal by Subject|1
4449458|NCT00506077|7235290|FG001|Treatment Period 2|Withdrawal by Subject|0
4449459|NCT00506129|7235296|FG000|Overall Study|Disease Progression/Relapse|15
4449460|NCT00506129|7235296|FG000|Overall Study|Death|7
4449461|NCT00506142|7235302|FG000|Overall Study|Adverse Event|8
4449462|NCT00506142|7235303|FG001|Overall Study|Adverse Event|7
4449463|NCT00506142|7235302|FG000|Overall Study|Lack of Efficacy|21
4449464|NCT00506142|7235303|FG001|Overall Study|Lack of Efficacy|7
4449465|NCT00506142|7235302|FG000|Overall Study|Withdrawal by Subject|4
4449466|NCT00506142|7235303|FG001|Overall Study|Withdrawal by Subject|5
4449467|NCT00506142|7235302|FG000|Overall Study|Physician Decision|1
4449468|NCT00506142|7235303|FG001|Overall Study|Physician Decision|0
4449469|NCT00506142|7235302|FG000|Overall Study|New health condition|1
4449470|NCT00506142|7235303|FG001|Overall Study|New health condition|0
4449471|NCT00506285|7235315|FG000|3 Week Screening Phase|Withdrawal by Subject|17
4449472|NCT00506285|7235316|FG001|3 Week Screening Phase|Withdrawal by Subject|10
4449473|NCT00506285|7235315|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4
4449474|NCT00506285|7235316|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3
4449475|NCT00506285|7235315|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5
4449476|NCT00506285|7235316|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2
4449477|NCT00506285|7235315|FG000|6-month Open Label Phase|Lost to Follow-up|1
4449478|NCT00506285|7235316|FG001|6-month Open Label Phase|Lost to Follow-up|7
4449479|NCT00506285|7235315|FG000|6-month Open Label Phase|Withdrawal by Subject|9
4449480|NCT00506285|7235316|FG001|6-month Open Label Phase|Withdrawal by Subject|5
4449481|NCT00506350|7235333|FG000|Overall Study|Serious Adverse Event|1
4449482|NCT00506350|7235334|FG001|Overall Study|Serious Adverse Event|0
4449483|NCT00506350|7235335|FG002|Overall Study|Serious Adverse Event|0
4449484|NCT00506350|7235336|FG003|Overall Study|Serious Adverse Event|0
4449485|NCT00506350|7235337|FG004|Overall Study|Serious Adverse Event|0
4449486|NCT00506350|7235338|FG005|Overall Study|Serious Adverse Event|0
4449487|NCT00506350|7235339|FG006|Overall Study|Serious Adverse Event|0
4449488|NCT00506350|7235340|FG007|Overall Study|Serious Adverse Event|0
4449489|NCT00506350|7235341|FG008|Overall Study|Serious Adverse Event|0
4449490|NCT00506350|7235333|FG000|Overall Study|Adverse Event|0
4449491|NCT00506350|7235334|FG001|Overall Study|Adverse Event|0
4449492|NCT00506350|7235335|FG002|Overall Study|Adverse Event|0
4449493|NCT00506350|7235336|FG003|Overall Study|Adverse Event|0
4449494|NCT00506350|7235337|FG004|Overall Study|Adverse Event|0
4449495|NCT00506350|7235338|FG005|Overall Study|Adverse Event|0
4449496|NCT00506350|7235339|FG006|Overall Study|Adverse Event|0
4449497|NCT00506350|7235340|FG007|Overall Study|Adverse Event|1
4449498|NCT00506350|7235341|FG008|Overall Study|Adverse Event|1
4449499|NCT00506350|7235333|FG000|Overall Study|Protocol Violation|0
4449500|NCT00506350|7235334|FG001|Overall Study|Protocol Violation|0
4449501|NCT00506350|7235335|FG002|Overall Study|Protocol Violation|1
4449502|NCT00506350|7235336|FG003|Overall Study|Protocol Violation|0
4449503|NCT00506350|7235337|FG004|Overall Study|Protocol Violation|0
4449504|NCT00506350|7235338|FG005|Overall Study|Protocol Violation|0
4449505|NCT00506350|7235339|FG006|Overall Study|Protocol Violation|1
4449506|NCT00506350|7235340|FG007|Overall Study|Protocol Violation|0
4449507|NCT00506350|7235341|FG008|Overall Study|Protocol Violation|0
4449508|NCT00506350|7235333|FG000|Overall Study|Withdrawal by Subject|0
4449509|NCT00506350|7235334|FG001|Overall Study|Withdrawal by Subject|1
4449510|NCT00506350|7235335|FG002|Overall Study|Withdrawal by Subject|1
4449511|NCT00506350|7235336|FG003|Overall Study|Withdrawal by Subject|1
4449512|NCT00506350|7235337|FG004|Overall Study|Withdrawal by Subject|4
4449513|NCT00506350|7235338|FG005|Overall Study|Withdrawal by Subject|1
4449514|NCT00506350|7235339|FG006|Overall Study|Withdrawal by Subject|1
4449515|NCT00506350|7235340|FG007|Overall Study|Withdrawal by Subject|2
4449516|NCT00506350|7235341|FG008|Overall Study|Withdrawal by Subject|0
4449517|NCT00506350|7235333|FG000|Overall Study|Lost to Follow-up|1
4449518|NCT00506350|7235334|FG001|Overall Study|Lost to Follow-up|1
4449519|NCT00506350|7235335|FG002|Overall Study|Lost to Follow-up|1
4449520|NCT00506350|7235336|FG003|Overall Study|Lost to Follow-up|1
4449521|NCT00506350|7235337|FG004|Overall Study|Lost to Follow-up|2
4449522|NCT00506350|7235338|FG005|Overall Study|Lost to Follow-up|1
4449523|NCT00506350|7235339|FG006|Overall Study|Lost to Follow-up|0
4449524|NCT00506350|7235340|FG007|Overall Study|Lost to Follow-up|0
4449525|NCT00506350|7235341|FG008|Overall Study|Lost to Follow-up|2
4449526|NCT00506350|7235333|FG000|Overall Study|Medical Reason|0
4449527|NCT00506350|7235334|FG001|Overall Study|Medical Reason|0
4449528|NCT00506350|7235335|FG002|Overall Study|Medical Reason|0
4449529|NCT00506350|7235336|FG003|Overall Study|Medical Reason|0
4449530|NCT00506350|7235337|FG004|Overall Study|Medical Reason|1
4449531|NCT00506350|7235338|FG005|Overall Study|Medical Reason|0
4449532|NCT00506350|7235339|FG006|Overall Study|Medical Reason|0
4449533|NCT00506350|7235340|FG007|Overall Study|Medical Reason|0
4449534|NCT00506350|7235341|FG008|Overall Study|Medical Reason|0
4449535|NCT00506350|7235333|FG000|Overall Study|Other|1
4449536|NCT00506350|7235334|FG001|Overall Study|Other|1
4449537|NCT00506350|7235335|FG002|Overall Study|Other|3
4449538|NCT00506350|7235336|FG003|Overall Study|Other|0
4449539|NCT00506350|7235337|FG004|Overall Study|Other|3
4449540|NCT00506350|7235338|FG005|Overall Study|Other|0
4449541|NCT00506350|7235339|FG006|Overall Study|Other|0
4449542|NCT00506350|7235340|FG007|Overall Study|Other|2
4449543|NCT00506350|7235341|FG008|Overall Study|Other|2
4449544|NCT00506389|7235371|FG000|In-treatment Period|Other|3
4449545|NCT00506389|7235372|FG001|In-treatment Period|Other|3
4449546|NCT00506389|7235373|FG002|In-treatment Period|Other|4
4449547|NCT00506389|7235371|FG000|In-treatment Period|Lost to Follow-up|0
4449548|NCT00506389|7235372|FG001|In-treatment Period|Lost to Follow-up|0
4449549|NCT00506389|7235373|FG002|In-treatment Period|Lost to Follow-up|1
4449550|NCT00506389|7235371|FG000|In-treatment Period|Lack of compliance|1
4449551|NCT00506389|7235372|FG001|In-treatment Period|Lack of compliance|0
4449552|NCT00506389|7235373|FG002|In-treatment Period|Lack of compliance|0
4449553|NCT00506389|7235371|FG000|In-treatment Period|Reasons not related to trial|4
4449554|NCT00506389|7235372|FG001|In-treatment Period|Reasons not related to trial|1
4449555|NCT00506389|7235373|FG002|In-treatment Period|Reasons not related to trial|0
4449556|NCT00506389|7235371|FG000|In-treatment Period|Withdrawal by Subject|3
4449557|NCT00506389|7235372|FG001|In-treatment Period|Withdrawal by Subject|3
4449558|NCT00506389|7235373|FG002|In-treatment Period|Withdrawal by Subject|4
4449559|NCT00506389|7235371|FG000|In-treatment Period|Lack of Efficacy|0
4449560|NCT00506389|7235372|FG001|In-treatment Period|Lack of Efficacy|2
4449561|NCT00506389|7235373|FG002|In-treatment Period|Lack of Efficacy|0
4449562|NCT00506389|7235371|FG000|In-treatment Period|Adverse Event|11
4449563|NCT00506389|7235372|FG001|In-treatment Period|Adverse Event|5
4449564|NCT00506389|7235373|FG002|In-treatment Period|Adverse Event|2
4449565|NCT00506389|7235371|FG000|In-treatment Period|Randomized but not treated|4
4449566|NCT00506389|7235372|FG001|In-treatment Period|Randomized but not treated|1
4449567|NCT00506389|7235373|FG002|In-treatment Period|Randomized but not treated|1
4449568|NCT00506415|7235384|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272
4449569|NCT00506415|7235385|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
4449570|NCT00506415|7235386|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
4449571|NCT00506415|7235387|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
4449572|NCT00506415|7235384|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1
4449573|NCT00506415|7235385|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
4449574|NCT00506415|7235386|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
4449575|NCT00506415|7235387|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
4449576|NCT00506415|7235384|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1
4449577|NCT00506415|7235385|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
4449578|NCT00506415|7235386|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
4449579|NCT00506415|7235387|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
4449580|NCT00506415|7235384|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58
4449581|NCT00506415|7235385|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
4449582|NCT00506415|7235386|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
4449583|NCT00506415|7235387|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
4449584|NCT00506415|7235384|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88
4449585|NCT00506415|7235385|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
4449586|NCT00506415|7235386|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
4449587|NCT00506415|7235387|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
4449588|NCT00506415|7235384|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22
4449589|NCT00506415|7235385|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
4449590|NCT00506415|7235386|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
4449591|NCT00506415|7235387|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
4449592|NCT00506415|7235384|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7
4449593|NCT00506415|7235385|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
4449594|NCT00506415|7235386|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
4449595|NCT00506415|7235387|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
4449596|NCT00506415|7235384|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22
4449597|NCT00506415|7235385|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0
4449598|NCT00506415|7235386|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0
4449599|NCT00506415|7235387|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0
4449600|NCT00506415|7235384|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28
4449601|NCT00506415|7235385|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
4449602|NCT00506415|7235386|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
4449603|NCT00506415|7235387|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
4449604|NCT00506415|7235384|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0
4449605|NCT00506415|7235385|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33
4449606|NCT00506415|7235386|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28
4449607|NCT00506415|7235387|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0
4449608|NCT00506415|7235384|FG000|Double Blind (Maximum 48 Weeks )|Death|0
4449609|NCT00506415|7235385|FG001|Double Blind (Maximum 48 Weeks )|Death|5
4449610|NCT00506415|7235386|FG002|Double Blind (Maximum 48 Weeks )|Death|3
4449611|NCT00506415|7235387|FG003|Double Blind (Maximum 48 Weeks )|Death|0
4449612|NCT00506415|7235384|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0
4449613|NCT00506415|7235385|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13
4449614|NCT00506415|7235386|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13
4449615|NCT00506415|7235387|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0
4449616|NCT00506415|7235384|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0
4449617|NCT00506415|7235385|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5
4449618|NCT00506415|7235386|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3
4449619|NCT00506415|7235387|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0
4449620|NCT00506415|7235384|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0
4449621|NCT00506415|7235385|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4
4449622|NCT00506415|7235386|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6
4449623|NCT00506415|7235387|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0
4449624|NCT00506415|7235384|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0
4449625|NCT00506415|7235385|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20
4449626|NCT00506415|7235386|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17
4449627|NCT00506415|7235387|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0
4449628|NCT00506415|7235384|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0
4449629|NCT00506415|7235385|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3
4449630|NCT00506415|7235386|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2
4449631|NCT00506415|7235387|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0
4449632|NCT00506415|7235384|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
4449633|NCT00506415|7235385|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
4449634|NCT00506415|7235386|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1
4449635|NCT00506415|7235387|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
4449636|NCT00506415|7235384|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
4449637|NCT00506415|7235385|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
4449638|NCT00506415|7235386|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
4449639|NCT00506415|7235387|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4
4449640|NCT00506415|7235384|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
4449641|NCT00506415|7235385|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
4449642|NCT00506415|7235386|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
4449643|NCT00506415|7235387|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18
4449644|NCT00506415|7235384|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
4449645|NCT00506415|7235385|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
4449646|NCT00506415|7235386|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
4449647|NCT00506415|7235387|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8
4449648|NCT00506415|7235384|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
4449649|NCT00506415|7235385|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
4449650|NCT00506415|7235386|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
4449651|NCT00506415|7235387|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14
4449652|NCT00506415|7235384|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
4449653|NCT00506415|7235385|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
4449654|NCT00506415|7235386|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
4449655|NCT00506415|7235387|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5
4449656|NCT00506415|7235384|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
4449657|NCT00506415|7235385|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
4449658|NCT00506415|7235386|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
4449659|NCT00506415|7235387|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6
4449660|NCT00506415|7235384|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0
4449661|NCT00506415|7235385|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0
4449662|NCT00506415|7235386|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0
4449663|NCT00506415|7235387|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7
4515737|NCT00955409|7326705|FG007|Overall Study|Investigator Request|0
4515738|NCT00955409|7326706|FG008|Overall Study|Investigator Request|0
4449664|NCT00506441|7235400|FG000|Period 1; Open-label Period|Adverse Event|21
4449665|NCT00506441|7235401|FG001|Period 1; Open-label Period|Adverse Event|0
4449666|NCT00506441|7235400|FG000|Period 1; Open-label Period|Lack of Efficacy|13
4449667|NCT00506441|7235401|FG001|Period 1; Open-label Period|Lack of Efficacy|0
4449668|NCT00506441|7235400|FG000|Period 1; Open-label Period|Lost to Follow-up|2
4449669|NCT00506441|7235401|FG001|Period 1; Open-label Period|Lost to Follow-up|0
4449670|NCT00506441|7235400|FG000|Period 1; Open-label Period|Physician Decision|5
4449671|NCT00506441|7235401|FG001|Period 1; Open-label Period|Physician Decision|0
4449672|NCT00506441|7235400|FG000|Period 1; Open-label Period|Protocol Violation|9
4449673|NCT00506441|7235401|FG001|Period 1; Open-label Period|Protocol Violation|0
4449674|NCT00506441|7235400|FG000|Period 1; Open-label Period|Withdrawal by Subject|13
4449675|NCT00506441|7235401|FG001|Period 1; Open-label Period|Withdrawal by Subject|0
4449676|NCT00506441|7235400|FG000|Period 1; Open-label Period|Other Reasons|13
4449677|NCT00506441|7235401|FG001|Period 1; Open-label Period|Other Reasons|0
4449678|NCT00506441|7235400|FG000|Period 2; Double-blind Period|Adverse Event|0
4449679|NCT00506441|7235401|FG001|Period 2; Double-blind Period|Adverse Event|1
4449680|NCT00506441|7235400|FG000|Period 2; Double-blind Period|Lack of Efficacy|0
4449681|NCT00506441|7235401|FG001|Period 2; Double-blind Period|Lack of Efficacy|2
4449682|NCT00506441|7235400|FG000|Period 2; Double-blind Period|Physician Decision|1
4449683|NCT00506441|7235401|FG001|Period 2; Double-blind Period|Physician Decision|1
4449684|NCT00506441|7235400|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1
4449685|NCT00506441|7235401|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0
4449686|NCT00506441|7235400|FG000|Period 2; Double-blind Period|Other Reason|1
4449687|NCT00506441|7235401|FG001|Period 2; Double-blind Period|Other Reason|1
4449688|NCT00506454|7235411|FG000|Overall Study|Withdrawal by Subject|1
4449689|NCT00506454|7235412|FG001|Overall Study|Withdrawal by Subject|1
4449690|NCT00506493|7235418|FG000|Overall Study|Death|6
4449691|NCT00506493|7235418|FG000|Overall Study|Withdrawal by Subject|5
4449692|NCT00506519|7235427|FG000|Overall Study|Death|4
4449693|NCT00506519|7235428|FG001|Overall Study|Death|6
4449694|NCT00506519|7235429|FG002|Overall Study|Death|0
4449695|NCT00506519|7235427|FG000|Overall Study|Adverse Event|1
4449696|NCT00506519|7235428|FG001|Overall Study|Adverse Event|0
4449697|NCT00506519|7235429|FG002|Overall Study|Adverse Event|0
4449698|NCT00506662|7235446|FG000|Overall Study|Adverse Event|0
4449699|NCT00506662|7235447|FG001|Overall Study|Adverse Event|2
4449700|NCT00506662|7235446|FG000|Overall Study|Lack of Efficacy|1
4449701|NCT00506662|7235447|FG001|Overall Study|Lack of Efficacy|0
4449702|NCT00506662|7235446|FG000|Overall Study|Protocol Violation|2
4449703|NCT00506662|7235447|FG001|Overall Study|Protocol Violation|4
4449704|NCT00506662|7235446|FG000|Overall Study|Trial terminated|10
4449705|NCT00506662|7235447|FG001|Overall Study|Trial terminated|16
4449706|NCT00506662|7235446|FG000|Overall Study|Not recorded|4
4449707|NCT00506662|7235447|FG001|Overall Study|Not recorded|6
4449708|NCT00506753|7235475|FG000|Overall Study|Lost to Follow-up|21
4449709|NCT00506753|7235476|FG001|Overall Study|Lost to Follow-up|15
4449710|NCT00506779|7235484|FG000|Overall Study|Withdrawal by Subject|1
4449711|NCT00506779|7235485|FG001|Overall Study|Withdrawal by Subject|0
4449712|NCT00506779|7235486|FG002|Overall Study|Withdrawal by Subject|1
4449713|NCT00506779|7235487|FG003|Overall Study|Withdrawal by Subject|0
4449714|NCT00506779|7235484|FG000|Overall Study|Adverse Event|0
4449715|NCT00506779|7235485|FG001|Overall Study|Adverse Event|1
4449716|NCT00506779|7235486|FG002|Overall Study|Adverse Event|1
4449717|NCT00506779|7235487|FG003|Overall Study|Adverse Event|1
4449718|NCT00506831|7235498|FG000|Overall Study|Death|1
4449719|NCT00506831|7235498|FG000|Overall Study|Withdrawal by Subject|1
4449720|NCT00506883|7235510|FG000|Overall Study|Lost to Follow-up|1
4449721|NCT00506883|7235511|FG001|Overall Study|Lost to Follow-up|1
4449722|NCT00506883|7235512|FG002|Overall Study|Lost to Follow-up|1
4449723|NCT00506883|7235510|FG000|Overall Study|Withdrawal by Subject|1
4449724|NCT00506883|7235511|FG001|Overall Study|Withdrawal by Subject|0
4449725|NCT00506883|7235512|FG002|Overall Study|Withdrawal by Subject|1
4449726|NCT00506883|7235510|FG000|Overall Study|Lack of Efficacy|0
4449727|NCT00506883|7235511|FG001|Overall Study|Lack of Efficacy|1
4449728|NCT00506883|7235512|FG002|Overall Study|Lack of Efficacy|1
4449729|NCT00506883|7235510|FG000|Overall Study|Other|5
4449730|NCT00506883|7235511|FG001|Overall Study|Other|1
4449731|NCT00506883|7235512|FG002|Overall Study|Other|1
4449732|NCT00506922|7235525|FG000|Overall Study|Physician Decision|0
4449733|NCT00506922|7235526|FG001|Overall Study|Physician Decision|0
4449734|NCT00506922|7235527|FG002|Overall Study|Physician Decision|0
4449735|NCT00506922|7235528|FG003|Overall Study|Physician Decision|2
4449736|NCT00506922|7235529|FG004|Overall Study|Physician Decision|0
4449737|NCT00506922|7235525|FG000|Overall Study|Withdrawal by Subject|0
4449738|NCT00506922|7235526|FG001|Overall Study|Withdrawal by Subject|0
4609296|NCT01685138|7464951|FG000|Overall Study|Lost to Follow-up|1
4449739|NCT00506922|7235527|FG002|Overall Study|Withdrawal by Subject|0
4449740|NCT00506922|7235528|FG003|Overall Study|Withdrawal by Subject|0
4449741|NCT00506922|7235529|FG004|Overall Study|Withdrawal by Subject|1
4449742|NCT00506948|7235537|FG000|Overall Study|Death|4
4449743|NCT00506948|7235537|FG000|Overall Study|Adverse Event|5
4449744|NCT00506948|7235537|FG000|Overall Study|Physician Decision|1
4449745|NCT00507026|7235544|FG000|Overall Study|Lack of Efficacy|6
4609297|NCT01685138|7464951|FG000|Overall Study|Protocol Violation|1
4449746|NCT00507026|7235545|FG001|Overall Study|Lack of Efficacy|4
4449747|NCT00507026|7235546|FG002|Overall Study|Lack of Efficacy|21
4449748|NCT00507026|7235544|FG000|Overall Study|Withdrawal by Subject|2
4449749|NCT00507026|7235545|FG001|Overall Study|Withdrawal by Subject|0
4449750|NCT00507026|7235546|FG002|Overall Study|Withdrawal by Subject|0
4449751|NCT00507026|7235544|FG000|Overall Study|Investigator Decision|1
4449752|NCT00507026|7235545|FG001|Overall Study|Investigator Decision|0
4449753|NCT00507026|7235546|FG002|Overall Study|Investigator Decision|0
4449754|NCT00507026|7235544|FG000|Overall Study|Adverse Event|2
4449755|NCT00507026|7235545|FG001|Overall Study|Adverse Event|0
4449756|NCT00507026|7235546|FG002|Overall Study|Adverse Event|0
4449757|NCT00507026|7235544|FG000|Overall Study|Protocol Violation|1
4449758|NCT00507026|7235545|FG001|Overall Study|Protocol Violation|0
4449759|NCT00507026|7235546|FG002|Overall Study|Protocol Violation|0
4449760|NCT00507026|7235544|FG000|Overall Study|Other|1
4449761|NCT00507026|7235545|FG001|Overall Study|Other|0
4449762|NCT00507026|7235546|FG002|Overall Study|Other|0
4449763|NCT00507130|7235558|FG000|Overall Study|Lost to Follow-up|0
4449764|NCT00507130|7235559|FG001|Overall Study|Lost to Follow-up|0
4449765|NCT00507130|7235560|FG002|Overall Study|Lost to Follow-up|1
4449766|NCT00507130|7235561|FG003|Overall Study|Lost to Follow-up|1
4449767|NCT00507130|7235558|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1
4449768|NCT00507130|7235559|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
4449769|NCT00507130|7235560|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
4449770|NCT00507130|7235561|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
4449771|NCT00507416|7235583|FG000|Overall Study|Adverse Event|58
4449772|NCT00507416|7235584|FG001|Overall Study|Adverse Event|67
4449773|NCT00507416|7235585|FG002|Overall Study|Adverse Event|65
4449774|NCT00507416|7235583|FG000|Overall Study|Protocol Violation|1
4449775|NCT00507416|7235584|FG001|Overall Study|Protocol Violation|2
4449776|NCT00507416|7235585|FG002|Overall Study|Protocol Violation|0
4449777|NCT00507416|7235583|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7
4449778|NCT00507416|7235584|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7
4449779|NCT00507416|7235585|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8
4449780|NCT00507416|7235583|FG000|Overall Study|Progressive Disease|20
4449781|NCT00507416|7235584|FG001|Overall Study|Progressive Disease|10
4449782|NCT00507416|7235585|FG002|Overall Study|Progressive Disease|13
4449783|NCT00507416|7235583|FG000|Overall Study|Patient declined further treatment|18
4449784|NCT00507416|7235584|FG001|Overall Study|Patient declined further treatment|14
4449785|NCT00507416|7235585|FG002|Overall Study|Patient declined further treatment|11
4449786|NCT00507416|7235583|FG000|Overall Study|Other|11
4449787|NCT00507416|7235584|FG001|Overall Study|Other|16
4449788|NCT00507416|7235585|FG002|Overall Study|Other|13
4449789|NCT00507416|7235583|FG000|Overall Study|Did not Receive Study Treatment|3
4449790|NCT00507416|7235584|FG001|Overall Study|Did not Receive Study Treatment|9
4449791|NCT00507416|7235585|FG002|Overall Study|Did not Receive Study Treatment|4
4449792|NCT00507429|7235595|FG000|Treatment Phase|Disease Progression|12
4449793|NCT00507429|7235596|FG001|Treatment Phase|Disease Progression|5
4449794|NCT00507429|7235595|FG000|Treatment Phase|Adverse Event|12
4449795|NCT00507429|7235596|FG001|Treatment Phase|Adverse Event|5
4449796|NCT00507429|7235595|FG000|Treatment Phase|Withdrawal by Subject|3
4449797|NCT00507429|7235596|FG001|Treatment Phase|Withdrawal by Subject|3
4449798|NCT00507429|7235595|FG000|Treatment Phase|Physician Decision|4
4449799|NCT00507429|7235596|FG001|Treatment Phase|Physician Decision|2
4449800|NCT00507429|7235595|FG000|Treatment Phase|Other|6
4609298|NCT01685138|7464951|FG000|Overall Study|No longer requires treatment|1
4609299|NCT01685138|7464951|FG000|Overall Study|Subject/guardian decision|2
4609300|NCT01685138|7464951|FG000|Overall Study|Physician Decision|6
4609301|NCT01685138|7464951|FG000|Overall Study|Death|10
4609302|NCT01685138|7464951|FG000|Overall Study|Adverse Event|18
4609303|NCT01685138|7464951|FG000|Overall Study|Progressive disease|53
4609304|NCT01685203|7464962|FG000|Overall Study|Lost to Follow-up|3
4609305|NCT01685203|7464963|FG001|Overall Study|Lost to Follow-up|3
4449801|NCT00507429|7235596|FG001|Treatment Phase|Other|3
4449802|NCT00507429|7235595|FG000|Maintenance Phase|Progressive Disease|14
4449803|NCT00507429|7235596|FG001|Maintenance Phase|Progressive Disease|0
4449804|NCT00507442|7235608|FG000|Overall Study|Adverse Event|8
4449805|NCT00507442|7235609|FG001|Overall Study|Adverse Event|11
4449806|NCT00507442|7235610|FG002|Overall Study|Adverse Event|4
4449807|NCT00507442|7235611|FG003|Overall Study|Adverse Event|1
4449808|NCT00507442|7235608|FG000|Overall Study|Protocol Violation|0
4449809|NCT00507442|7235609|FG001|Overall Study|Protocol Violation|1
4449810|NCT00507442|7235610|FG002|Overall Study|Protocol Violation|0
4449811|NCT00507442|7235611|FG003|Overall Study|Protocol Violation|0
4449812|NCT00507442|7235608|FG000|Overall Study|Lost to Follow-up|0
4449813|NCT00507442|7235609|FG001|Overall Study|Lost to Follow-up|0
4449814|NCT00507442|7235610|FG002|Overall Study|Lost to Follow-up|1
4449815|NCT00507442|7235611|FG003|Overall Study|Lost to Follow-up|0
4449816|NCT00507442|7235608|FG000|Overall Study|Physician Decision|0
4449817|NCT00507442|7235609|FG001|Overall Study|Physician Decision|2
4449818|NCT00507442|7235610|FG002|Overall Study|Physician Decision|4
4449819|NCT00507442|7235611|FG003|Overall Study|Physician Decision|1
4449820|NCT00507442|7235608|FG000|Overall Study|Progressive Disease|2
4609306|NCT01685203|7464964|FG002|Overall Study|Lost to Follow-up|0
4609307|NCT01685203|7464965|FG003|Overall Study|Lost to Follow-up|1
4449821|NCT00507442|7235609|FG001|Overall Study|Progressive Disease|4
4449822|NCT00507442|7235610|FG002|Overall Study|Progressive Disease|2
4449823|NCT00507442|7235611|FG003|Overall Study|Progressive Disease|0
4449824|NCT00507442|7235608|FG000|Overall Study|Withdrawal by Subject|4
4449825|NCT00507442|7235609|FG001|Overall Study|Withdrawal by Subject|4
4449826|NCT00507442|7235610|FG002|Overall Study|Withdrawal by Subject|2
4449827|NCT00507442|7235611|FG003|Overall Study|Withdrawal by Subject|1
4449828|NCT00507442|7235608|FG000|Overall Study|Other|2
4449829|NCT00507442|7235609|FG001|Overall Study|Other|5
4449830|NCT00507442|7235610|FG002|Overall Study|Other|2
4449831|NCT00507442|7235611|FG003|Overall Study|Other|2
4449832|NCT00507455|7235628|FG000|Overall Study|Adverse Event|3
4449833|NCT00507455|7235629|FG001|Overall Study|Adverse Event|3
4449834|NCT00507455|7235630|FG002|Overall Study|Adverse Event|6
4449835|NCT00507455|7235628|FG000|Overall Study|Withdrawal by Subject|2
4449836|NCT00507455|7235629|FG001|Overall Study|Withdrawal by Subject|1
4449837|NCT00507455|7235630|FG002|Overall Study|Withdrawal by Subject|2
4449838|NCT00507455|7235628|FG000|Overall Study|Protocol Violation|4
4449839|NCT00507455|7235629|FG001|Overall Study|Protocol Violation|1
4449840|NCT00507455|7235630|FG002|Overall Study|Protocol Violation|1
4449841|NCT00507455|7235628|FG000|Overall Study|Lost to Follow-up|2
4449842|NCT00507455|7235629|FG001|Overall Study|Lost to Follow-up|0
4449843|NCT00507455|7235630|FG002|Overall Study|Lost to Follow-up|2
4449844|NCT00507455|7235628|FG000|Overall Study|Lack of Efficacy|0
4449845|NCT00507455|7235629|FG001|Overall Study|Lack of Efficacy|1
4449846|NCT00507455|7235630|FG002|Overall Study|Lack of Efficacy|0
4449847|NCT00507455|7235628|FG000|Overall Study|Other - miscellaneous reason|1
4449848|NCT00507455|7235629|FG001|Overall Study|Other - miscellaneous reason|0
4449849|NCT00507455|7235630|FG002|Overall Study|Other - miscellaneous reason|1
4449850|NCT00507507|7235640|FG000|Treatment Period|Lost to Follow-up|0
4449851|NCT00507507|7235641|FG001|Treatment Period|Lost to Follow-up|2
4449852|NCT00507507|7235640|FG000|Treatment Period|Physician Decision|4
4449853|NCT00507507|7235641|FG001|Treatment Period|Physician Decision|1
4449854|NCT00507507|7235640|FG000|Treatment Period|Protocol Violation|1
4449855|NCT00507507|7235641|FG001|Treatment Period|Protocol Violation|2
4449856|NCT00507507|7235640|FG000|Treatment Period|Adverse Event|1
4449857|NCT00507507|7235641|FG001|Treatment Period|Adverse Event|1
4449858|NCT00507507|7235640|FG000|Treatment Period|Withdrawal by Subject|46
4449859|NCT00507507|7235641|FG001|Treatment Period|Withdrawal by Subject|47
4449860|NCT00507507|7235640|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1
4449861|NCT00507507|7235641|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0
4449862|NCT00507507|7235640|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0
4449863|NCT00507507|7235641|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1
4449864|NCT00507507|7235640|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9
4449865|NCT00507507|7235641|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16
4449866|NCT00507546|7235651|FG000|Overall Study|Withdrawal by Subject|1
4449867|NCT00507546|7235652|FG001|Overall Study|Withdrawal by Subject|0
4449868|NCT00507546|7235651|FG000|Overall Study|Protocol Violation|1
4449869|NCT00507546|7235652|FG001|Overall Study|Protocol Violation|0
4449870|NCT00507546|7235651|FG000|Overall Study|Physician Decision|0
4449871|NCT00507546|7235652|FG001|Overall Study|Physician Decision|1
4449872|NCT00507689|7235667|FG000|Pre-Randomization Period|Adverse Event|1
4449873|NCT00507689|7235668|FG001|Pre-Randomization Period|Adverse Event|0
4449874|NCT00507689|7235667|FG000|Pre-Randomization Period|Physician Decision|1
4449875|NCT00507689|7235668|FG001|Pre-Randomization Period|Physician Decision|0
4449876|NCT00507689|7235667|FG000|Pre-Randomization Period|Withdrawal by Subject|1
4449877|NCT00507689|7235668|FG001|Pre-Randomization Period|Withdrawal by Subject|0
4449878|NCT00507689|7235667|FG000|Randomized Period|Adverse Event|1
4449879|NCT00507689|7235668|FG001|Randomized Period|Adverse Event|1
4449880|NCT00507689|7235667|FG000|Randomized Period|Withdrawal by Subject|0
4449881|NCT00507689|7235668|FG001|Randomized Period|Withdrawal by Subject|1
4449882|NCT00507728|7235678|FG000|Randomization to Month 3|Lost to Follow-up|15
4449883|NCT00507728|7235679|FG001|Randomization to Month 3|Lost to Follow-up|14
4449884|NCT00507728|7235680|FG002|Randomization to Month 3|Lost to Follow-up|20
4449885|NCT00507728|7235678|FG000|From 3 Months to 6 Months|Lost to Follow-up|6
4449886|NCT00507728|7235679|FG001|From 3 Months to 6 Months|Lost to Follow-up|10
4449887|NCT00507728|7235680|FG002|From 3 Months to 6 Months|Lost to Follow-up|9
4449888|NCT00507819|7235698|FG000|Washout (6 Weeks)|Withdrawal by Subject|1
4449889|NCT00507819|7235699|FG001|Washout (6 Weeks)|Withdrawal by Subject|0
4449890|NCT00508001|7235708|FG000|Overall Study|Adverse Event|2
4449891|NCT00508001|7235709|FG001|Overall Study|Adverse Event|0
4449892|NCT00508001|7235710|FG002|Overall Study|Adverse Event|4
4449893|NCT00508001|7235708|FG000|Overall Study|condition under investigation worsened|13
4449894|NCT00508001|7235709|FG001|Overall Study|condition under investigation worsened|7
4449895|NCT00508001|7235710|FG002|Overall Study|condition under investigation worsened|1
4449896|NCT00508001|7235708|FG000|Overall Study|Death|0
4449897|NCT00508001|7235709|FG001|Overall Study|Death|1
4449898|NCT00508001|7235710|FG002|Overall Study|Death|1
4449899|NCT00508001|7235708|FG000|Overall Study|Withdrawal by Subject|4
4449900|NCT00508001|7235709|FG001|Overall Study|Withdrawal by Subject|4
4449901|NCT00508001|7235710|FG002|Overall Study|Withdrawal by Subject|1
4449902|NCT00508027|7235718|FG000|Dose Level 1|Lost to Follow-up|4
4449903|NCT00508027|7235718|FG000|Dose Level 1|Withdrawal by Subject|2
4449904|NCT00508027|7235718|FG000|Dose Level 1|Physician Decision|2
4449905|NCT00508027|7235718|FG000|Dose Level 2|Lost to Follow-up|2
4449906|NCT00508027|7235718|FG000|Dose Level 2|Withdrawal by Subject|2
4449907|NCT00508144|7235751|FG000|Overall Study|Not eligible|6
4449908|NCT00508144|7235751|FG000|Overall Study|Death|5
4449909|NCT00508157|7235757|FG000|Overall Study|Adverse Event|0
4449910|NCT00508157|7235758|FG001|Overall Study|Adverse Event|1
4449911|NCT00508157|7235757|FG000|Overall Study|Subject Withdrew Consent|1
4449912|NCT00508157|7235758|FG001|Overall Study|Subject Withdrew Consent|0
4449913|NCT00508157|7235757|FG000|Overall Study|Lost to Follow-up|1
4449914|NCT00508157|7235758|FG001|Overall Study|Lost to Follow-up|0
4449915|NCT00508157|7235757|FG000|Overall Study|Subject no longer met study criteria|0
4449916|NCT00508157|7235758|FG001|Overall Study|Subject no longer met study criteria|1
4449917|NCT00508157|7235757|FG000|Overall Study|Other known cause|0
4449918|NCT00508157|7235758|FG001|Overall Study|Other known cause|1
4449919|NCT00508261|7235784|FG000|Overall Study|Other|0
4449920|NCT00508261|7235785|FG001|Overall Study|Other|1
4449921|NCT00508261|7235786|FG002|Overall Study|Other|1
4449922|NCT00508261|7235787|FG003|Overall Study|Other|0
4449923|NCT00508261|7235784|FG000|Overall Study|Serious Adverse Event|0
4449924|NCT00508261|7235785|FG001|Overall Study|Serious Adverse Event|1
4449925|NCT00508261|7235786|FG002|Overall Study|Serious Adverse Event|0
4449926|NCT00508261|7235787|FG003|Overall Study|Serious Adverse Event|0
4449927|NCT00508261|7235784|FG000|Overall Study|Withdrawal by Subject|3
4449928|NCT00508261|7235785|FG001|Overall Study|Withdrawal by Subject|4
4449929|NCT00508261|7235786|FG002|Overall Study|Withdrawal by Subject|4
4449930|NCT00508261|7235787|FG003|Overall Study|Withdrawal by Subject|0
4449931|NCT00508261|7235784|FG000|Overall Study|Migrated/ moved from study area|0
4449932|NCT00508261|7235785|FG001|Overall Study|Migrated/ moved from study area|1
4449933|NCT00508261|7235786|FG002|Overall Study|Migrated/ moved from study area|0
4449934|NCT00508261|7235787|FG003|Overall Study|Migrated/ moved from study area|0
4449935|NCT00508261|7235784|FG000|Overall Study|Lost to Follow-up|0
4449936|NCT00508261|7235785|FG001|Overall Study|Lost to Follow-up|1
4449937|NCT00508261|7235786|FG002|Overall Study|Lost to Follow-up|1
4449938|NCT00508261|7235787|FG003|Overall Study|Lost to Follow-up|1
4449939|NCT00508274|7235801|FG000|Overall Study|Adverse Event|5
4449940|NCT00508274|7235801|FG000|Overall Study|Death|7
4449941|NCT00508274|7235801|FG000|Overall Study|Disease progression|32
4449942|NCT00508274|7235801|FG000|Overall Study|Withdrawal by Subject|1
4449943|NCT00508274|7235801|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2
4449944|NCT00508274|7235801|FG000|Overall Study|Missing|3
4449945|NCT00508391|7235816|FG000|First Treatment|Withdrawal by Subject|6
4449946|NCT00508391|7235817|FG001|First Treatment|Withdrawal by Subject|3
4449947|NCT00508391|7235816|FG000|Second Treatment|Withdrawal by Subject|2
4449948|NCT00508391|7235817|FG001|Second Treatment|Withdrawal by Subject|0
4449949|NCT00508404|7235825|FG000|Overall Study|Ongoing at Data Cut-off|12
4449950|NCT00508404|7235825|FG000|Overall Study|Adverse Event|2
4449951|NCT00508404|7235825|FG000|Overall Study|Death|16
4449952|NCT00508404|7235825|FG000|Overall Study|Physician Decision|2
4449953|NCT00508404|7235825|FG000|Overall Study|Withdrawal by Subject|3
4449954|NCT00508404|7235825|FG000|Overall Study|Protocol-specified Criteria|2
4449955|NCT00508404|7235825|FG000|Overall Study|Lost to Follow-up|2
4449956|NCT00508404|7235825|FG000|Overall Study|Other - Not Specified|3
4449957|NCT00508482|7235842|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9
4449958|NCT00508482|7235843|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7
4449959|NCT00508482|7235844|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4
4449960|NCT00508482|7235842|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12
4449961|NCT00508482|7235843|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10
4449962|NCT00508482|7235844|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16
4449963|NCT00508482|7235842|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20
4449964|NCT00508482|7235843|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6
4449965|NCT00508482|7235844|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1
4449966|NCT00508651|7235859|FG000|Overall Study|Lost to Follow-up|3
4449967|NCT00508651|7235860|FG001|Overall Study|Lost to Follow-up|1
4449968|NCT00508651|7235859|FG000|Overall Study|Withdrawal by Subject|1
4449969|NCT00508651|7235860|FG001|Overall Study|Withdrawal by Subject|1
4449970|NCT00508742|7235877|FG000|Period 1: Infant Series|Adverse Event|5
4449971|NCT00508742|7235878|FG001|Period 1: Infant Series|Adverse Event|4
4449972|NCT00508742|7235877|FG000|Period 1: Infant Series|Protocol Violation|1
4449973|NCT00508742|7235878|FG001|Period 1: Infant Series|Protocol Violation|0
4449974|NCT00508742|7235877|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31
4449975|NCT00508742|7235878|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40
4449976|NCT00508742|7235877|FG000|Period 1: Infant Series|Physician Decision|1
4449977|NCT00508742|7235878|FG001|Period 1: Infant Series|Physician Decision|0
4449978|NCT00508742|7235877|FG000|Period 1: Infant Series|Other|4
4449979|NCT00508742|7235878|FG001|Period 1: Infant Series|Other|1
4449980|NCT00508742|7235877|FG000|Period 2: After Infant Series|Adverse Event|2
4449981|NCT00508742|7235878|FG001|Period 2: After Infant Series|Adverse Event|6
4449982|NCT00508742|7235877|FG000|Period 2: After Infant Series|Lost to Follow-up|1
4449983|NCT00508742|7235878|FG001|Period 2: After Infant Series|Lost to Follow-up|1
4449984|NCT00508742|7235877|FG000|Period 2: After Infant Series|Protocol Violation|1
4449985|NCT00508742|7235878|FG001|Period 2: After Infant Series|Protocol Violation|0
4449986|NCT00508742|7235877|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0
4449987|NCT00508742|7235878|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3
4449988|NCT00508742|7235877|FG000|Period 2: After Infant Series|Failed to Return|1
4449989|NCT00508742|7235878|FG001|Period 2: After Infant Series|Failed to Return|0
4449990|NCT00508742|7235877|FG000|Period 2: After Infant Series|Other|2
4449991|NCT00508742|7235878|FG001|Period 2: After Infant Series|Other|1
4449992|NCT00508742|7235877|FG000|Period 3: Toddler Dose|Adverse Event|1
4449993|NCT00508742|7235878|FG001|Period 3: Toddler Dose|Adverse Event|0
4449994|NCT00508742|7235877|FG000|Period 3: Toddler Dose|Lost to Follow-up|2
4449995|NCT00508742|7235878|FG001|Period 3: Toddler Dose|Lost to Follow-up|3
4449996|NCT00508742|7235877|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17
4449997|NCT00508742|7235878|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8
4449998|NCT00508742|7235877|FG000|Period 3: Toddler Dose|Other|5
4449999|NCT00508742|7235878|FG001|Period 3: Toddler Dose|Other|4
4450000|NCT00508755|7235890|FG000|Overall Study|Withdrawal by Subject|1
4450001|NCT00508820|7235898|FG000|Overall Study|Adverse Event|6
4450002|NCT00508820|7235899|FG001|Overall Study|Adverse Event|10
4450003|NCT00508820|7235898|FG000|Overall Study|Death|6
4450004|NCT00508820|7235899|FG001|Overall Study|Death|8
4450005|NCT00508820|7235898|FG000|Overall Study|Lost to Follow-up|1
4450006|NCT00508820|7235899|FG001|Overall Study|Lost to Follow-up|1
4450007|NCT00508820|7235898|FG000|Overall Study|Physician Decision|8
4450008|NCT00508820|7235899|FG001|Overall Study|Physician Decision|2
4450009|NCT00508820|7235898|FG000|Overall Study|Pregnancy|0
4450010|NCT00508820|7235899|FG001|Overall Study|Pregnancy|2
4450011|NCT00508820|7235898|FG000|Overall Study|Protocol Violation|2
4450012|NCT00508820|7235899|FG001|Overall Study|Protocol Violation|0
4450013|NCT00508820|7235898|FG000|Overall Study|Withdrawal by Subject|10
4450014|NCT00508820|7235899|FG001|Overall Study|Withdrawal by Subject|12
4450015|NCT00508820|7235898|FG000|Overall Study|Other|11
4450016|NCT00508820|7235899|FG001|Overall Study|Other|2
4450017|NCT00508820|7235898|FG000|Overall Study|Noncompliance|1
4450018|NCT00508820|7235899|FG001|Overall Study|Noncompliance|0
4450019|NCT00508820|7235898|FG000|Overall Study|Requirement for alternative therapy|7
4450020|NCT00508820|7235899|FG001|Overall Study|Requirement for alternative therapy|15
4450021|NCT00508820|7235898|FG000|Overall Study|Protocol-specified Criteria|3
4450022|NCT00508820|7235899|FG001|Overall Study|Protocol-specified Criteria|12
4450023|NCT00508924|7235909|FG000|Overall Study|Protocol Violation|0
4450024|NCT00508924|7235910|FG001|Overall Study|Protocol Violation|0
4450025|NCT00508924|7235911|FG002|Overall Study|Protocol Violation|1
4450026|NCT00508924|7235912|FG003|Overall Study|Protocol Violation|1
4450027|NCT00509028|7235928|FG000|Overall Study|Adverse Event|2
4450028|NCT00509028|7235929|FG001|Overall Study|Adverse Event|0
4450029|NCT00509028|7235928|FG000|Overall Study|Withdrawal by Subject|4
4450030|NCT00509028|7235929|FG001|Overall Study|Withdrawal by Subject|3
4450031|NCT00509028|7235928|FG000|Overall Study|Lost to Follow-up|0
4450032|NCT00509028|7235929|FG001|Overall Study|Lost to Follow-up|1
4450033|NCT00509028|7235928|FG000|Overall Study|Protocol Violation|4
4450034|NCT00509028|7235929|FG001|Overall Study|Protocol Violation|2
4450035|NCT00509028|7235928|FG000|Overall Study|Non-compliance|2
4450036|NCT00509028|7235929|FG001|Overall Study|Non-compliance|1
4450037|NCT00509067|7235941|FG000|Overall Study|Lost to Follow-up|1
4450038|NCT00509067|7235942|FG001|Overall Study|Lost to Follow-up|1
4450039|NCT00509067|7235941|FG000|Overall Study|Adverse Event|3
4450040|NCT00509067|7235942|FG001|Overall Study|Adverse Event|1
4450041|NCT00509067|7235941|FG000|Overall Study|Protocol Violation|0
4450042|NCT00509067|7235942|FG001|Overall Study|Protocol Violation|3
4450043|NCT00509093|7235952|FG000|Overall Study|Adverse Event|10
4450044|NCT00509093|7235952|FG000|Overall Study|Disease Progression|9
4450045|NCT00509093|7235952|FG000|Overall Study|Transformed into MDS|1
4450046|NCT00509093|7235952|FG000|Overall Study|Withdrawal by Subject|3
4450047|NCT00509093|7235952|FG000|Overall Study|Physician Decision|1
4450048|NCT00509106|7235958|FG000|Overall Study|Adverse Event|3
4450049|NCT00509106|7235959|FG001|Overall Study|Adverse Event|2
4450050|NCT00509106|7235958|FG000|Overall Study|Noncompliance|0
4450051|NCT00509106|7235959|FG001|Overall Study|Noncompliance|1
4450052|NCT00509106|7235958|FG000|Overall Study|At the request of sponsor/investigator|1
4450053|NCT00509106|7235959|FG001|Overall Study|At the request of sponsor/investigator|2
4450054|NCT00509106|7235958|FG000|Overall Study|Withdrew consent|4
4450055|NCT00509106|7235959|FG001|Overall Study|Withdrew consent|8
4450056|NCT00509106|7235958|FG000|Overall Study|Lost to Follow-up|16
4529365|NCT01055886|7347649|FG000|Overall Study|Withdrawal by PI|0
4529366|NCT01055886|7347650|FG001|Overall Study|Withdrawal by PI|1
4529367|NCT01056107|7347669|FG000|Overall Study|Withdrawal by Subject|0
4529368|NCT01056107|7347670|FG001|Overall Study|Withdrawal by Subject|1
4529369|NCT01056107|7347671|FG002|Overall Study|Withdrawal by Subject|3
4529370|NCT01056107|7347672|FG003|Overall Study|Withdrawal by Subject|0
4529371|NCT01056263|7347693|FG000|Overall Study|Adverse Event|12
4529372|NCT01056263|7347693|FG000|Overall Study|Death|1
4529373|NCT01056263|7347693|FG000|Overall Study|Withdrawal by Subject|1
4529374|NCT01056263|7347693|FG000|Overall Study|Lack of Efficacy|29
4450057|NCT00509106|7235959|FG001|Overall Study|Lost to Follow-up|10
4450058|NCT00509106|7235958|FG000|Overall Study|Other|1
4450059|NCT00509106|7235959|FG001|Overall Study|Other|0
4450060|NCT00509106|7235958|FG000|Overall Study|Death|6
4450061|NCT00509106|7235959|FG001|Overall Study|Death|6
4450062|NCT00509145|7235967|FG000|Overall Study|Death|0
4450063|NCT00509145|7235968|FG001|Overall Study|Death|2
4450064|NCT00509145|7235967|FG000|Overall Study|Adverse Event|42
4450065|NCT00509145|7235968|FG001|Overall Study|Adverse Event|28
4450066|NCT00509145|7235967|FG000|Overall Study|Withdrawal by Subject|32
4450067|NCT00509145|7235968|FG001|Overall Study|Withdrawal by Subject|38
4450068|NCT00509145|7235967|FG000|Overall Study|Physician Decision|11
4450069|NCT00509145|7235968|FG001|Overall Study|Physician Decision|14
4450070|NCT00509145|7235967|FG000|Overall Study|Protocol Violation|1
4450071|NCT00509145|7235968|FG001|Overall Study|Protocol Violation|6
4450072|NCT00509145|7235967|FG000|Overall Study|Pregnancy|3
4450073|NCT00509145|7235968|FG001|Overall Study|Pregnancy|8
4450074|NCT00509145|7235967|FG000|Overall Study|Lost to Follow-up|6
4450075|NCT00509145|7235968|FG001|Overall Study|Lost to Follow-up|5
4450076|NCT00509145|7235967|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12
4450077|NCT00509145|7235968|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22
4450078|NCT00509145|7235967|FG000|Overall Study|Other|6
4450079|NCT00509145|7235968|FG001|Overall Study|Other|6
4450080|NCT00509223|7235996|FG000|Overall Study|Lost to Follow-up|1
4450081|NCT00509223|7235997|FG001|Overall Study|Lost to Follow-up|1
4450082|NCT00509223|7235996|FG000|Overall Study|Adverse Event|1
4450083|NCT00509223|7235997|FG001|Overall Study|Adverse Event|1
4450084|NCT00509223|7235996|FG000|Overall Study|Withdrawal by Subject|25
4450085|NCT00509223|7235997|FG001|Overall Study|Withdrawal by Subject|6
4450086|NCT00509223|7235996|FG000|Overall Study|Including: subject change of address|5
4450087|NCT00509223|7235997|FG001|Overall Study|Including: subject change of address|2
4450088|NCT00509223|7235996|FG000|Overall Study|Did not meet revised inclusion criteria|56
4450089|NCT00509223|7235997|FG001|Overall Study|Did not meet revised inclusion criteria|62
4450090|NCT00509236|7236005|FG000|Overall Study|Adverse Event|7
4450091|NCT00509236|7236006|FG001|Overall Study|Adverse Event|9
4450092|NCT00509236|7236005|FG000|Overall Study|Withdrawal by Subject|5
4450093|NCT00509236|7236006|FG001|Overall Study|Withdrawal by Subject|10
4450094|NCT00509236|7236005|FG000|Overall Study|Protocol Violation|3
4450095|NCT00509236|7236006|FG001|Overall Study|Protocol Violation|0
4450096|NCT00509236|7236005|FG000|Overall Study|Excluded Medication|1
4450097|NCT00509236|7236006|FG001|Overall Study|Excluded Medication|1
4450098|NCT00509236|7236005|FG000|Overall Study|Scheduled Kidney Transplant|1
4450099|NCT00509236|7236006|FG001|Overall Study|Scheduled Kidney Transplant|0
4450100|NCT00509262|7236018|FG000|Overall Study|Adverse Event|16
4450101|NCT00509262|7236019|FG001|Overall Study|Adverse Event|18
4450102|NCT00509262|7236018|FG000|Overall Study|Other|2
4450103|NCT00509262|7236019|FG001|Overall Study|Other|2
4450104|NCT00509262|7236018|FG000|Overall Study|Lack of Efficacy|1
4450105|NCT00509262|7236019|FG001|Overall Study|Lack of Efficacy|0
4450106|NCT00509262|7236018|FG000|Overall Study|Lost to Follow-up|1
4450107|NCT00509262|7236019|FG001|Overall Study|Lost to Follow-up|6
4450108|NCT00509262|7236018|FG000|Overall Study|Physician Decision|1
4450109|NCT00509262|7236019|FG001|Overall Study|Physician Decision|3
4450110|NCT00509262|7236018|FG000|Overall Study|Protocol Violation|2
4450111|NCT00509262|7236019|FG001|Overall Study|Protocol Violation|2
4450112|NCT00509262|7236018|FG000|Overall Study|Withdrawal by Subject|24
4450113|NCT00509262|7236019|FG001|Overall Study|Withdrawal by Subject|11
4450114|NCT00509366|7236039|FG000|Overall Study|Not Treated (Screen Failure)|1
4450115|NCT00509366|7236040|FG001|Overall Study|Not Treated (Screen Failure)|1
4450116|NCT00509366|7236041|FG002|Overall Study|Not Treated (Screen Failure)|1
4450117|NCT00509366|7236042|FG003|Overall Study|Not Treated (Screen Failure)|0
4450118|NCT00509366|7236043|FG004|Overall Study|Not Treated (Screen Failure)|0
4450119|NCT00509769|7236080|FG000|Overall Study|Progressive disease|77
4450120|NCT00509769|7236080|FG000|Overall Study|Adverse Event|4
4450121|NCT00509769|7236080|FG000|Overall Study|Patient's decision|1
4450122|NCT00509769|7236080|FG000|Overall Study|Physician Decision|8
4450123|NCT00509769|7236080|FG000|Overall Study|Use of prohibited therapies during study|1
4450124|NCT00509795|7236088|FG000|Overall Study|Adverse Event|4
4450125|NCT00509795|7236089|FG001|Overall Study|Adverse Event|3
4450126|NCT00509795|7236090|FG002|Overall Study|Adverse Event|5
4450127|NCT00509795|7236091|FG003|Overall Study|Adverse Event|4
4450128|NCT00509795|7236088|FG000|Overall Study|Death|3
4450129|NCT00509795|7236089|FG001|Overall Study|Death|1
4450130|NCT00509795|7236090|FG002|Overall Study|Death|2
4450131|NCT00509795|7236091|FG003|Overall Study|Death|7
4450132|NCT00509795|7236088|FG000|Overall Study|Lack of Efficacy|0
4450133|NCT00509795|7236089|FG001|Overall Study|Lack of Efficacy|0
4450134|NCT00509795|7236090|FG002|Overall Study|Lack of Efficacy|2
4450135|NCT00509795|7236091|FG003|Overall Study|Lack of Efficacy|2
4450136|NCT00509795|7236088|FG000|Overall Study|Lost to Follow-up|1
4450137|NCT00509795|7236089|FG001|Overall Study|Lost to Follow-up|2
4450138|NCT00509795|7236090|FG002|Overall Study|Lost to Follow-up|4
4450139|NCT00509795|7236091|FG003|Overall Study|Lost to Follow-up|4
4450140|NCT00509795|7236088|FG000|Overall Study|OTHER|1
4450141|NCT00509795|7236089|FG001|Overall Study|OTHER|0
4450142|NCT00509795|7236090|FG002|Overall Study|OTHER|4
4450143|NCT00509795|7236091|FG003|Overall Study|OTHER|1
4450144|NCT00509795|7236088|FG000|Overall Study|Protocol Violation|3
4450145|NCT00509795|7236089|FG001|Overall Study|Protocol Violation|0
4450146|NCT00509795|7236090|FG002|Overall Study|Protocol Violation|3
4450147|NCT00509795|7236091|FG003|Overall Study|Protocol Violation|1
4450148|NCT00509795|7236088|FG000|Overall Study|Withdrawal by Subject|10
4450149|NCT00509795|7236089|FG001|Overall Study|Withdrawal by Subject|5
4450150|NCT00509795|7236090|FG002|Overall Study|Withdrawal by Subject|7
4450151|NCT00509795|7236091|FG003|Overall Study|Withdrawal by Subject|8
4450152|NCT00509821|7236104|FG000|Study Period 1 (Induction)|Death|0
4450153|NCT00509821|7236105|FG001|Study Period 1 (Induction)|Death|1
4450154|NCT00509821|7236104|FG000|Study Period 1 (Induction)|Adverse Event|0
4450155|NCT00509821|7236105|FG001|Study Period 1 (Induction)|Adverse Event|2
4450156|NCT00509821|7236104|FG000|Study Period 1 (Induction)|Progressive Disease|0
4450157|NCT00509821|7236105|FG001|Study Period 1 (Induction)|Progressive Disease|1
4450158|NCT00509899|7236133|FG000|Overall Study|Progressive disease|1
4450159|NCT00509899|7236134|FG001|Overall Study|Progressive disease|3
4450160|NCT00509899|7236135|FG002|Overall Study|Progressive disease|5
4450161|NCT00509899|7236136|FG003|Overall Study|Progressive disease|1
4450162|NCT00509899|7236137|FG004|Overall Study|Progressive disease|0
4450163|NCT00509899|7236138|FG005|Overall Study|Progressive disease|1
4450164|NCT00509899|7236139|FG006|Overall Study|Progressive disease|0
4450165|NCT00509899|7236140|FG007|Overall Study|Progressive disease|0
4450166|NCT00509899|7236133|FG000|Overall Study|Unacceptable Toxicity|1
4450167|NCT00509899|7236134|FG001|Overall Study|Unacceptable Toxicity|0
4450168|NCT00509899|7236135|FG002|Overall Study|Unacceptable Toxicity|0
4450169|NCT00509899|7236136|FG003|Overall Study|Unacceptable Toxicity|2
4450170|NCT00509899|7236137|FG004|Overall Study|Unacceptable Toxicity|0
4450171|NCT00509899|7236138|FG005|Overall Study|Unacceptable Toxicity|0
4450172|NCT00509899|7236139|FG006|Overall Study|Unacceptable Toxicity|0
4450173|NCT00509899|7236140|FG007|Overall Study|Unacceptable Toxicity|0
4450174|NCT00509899|7236133|FG000|Overall Study|Withdrawal by Subject|6
4450175|NCT00509899|7236134|FG001|Overall Study|Withdrawal by Subject|2
4450176|NCT00509899|7236135|FG002|Overall Study|Withdrawal by Subject|3
4450177|NCT00509899|7236136|FG003|Overall Study|Withdrawal by Subject|0
4450178|NCT00509899|7236137|FG004|Overall Study|Withdrawal by Subject|3
4450179|NCT00509899|7236138|FG005|Overall Study|Withdrawal by Subject|2
4450180|NCT00509899|7236139|FG006|Overall Study|Withdrawal by Subject|0
4450181|NCT00509899|7236140|FG007|Overall Study|Withdrawal by Subject|0
4450182|NCT00509899|7236133|FG000|Overall Study|Physician Decision|4
4450183|NCT00509899|7236134|FG001|Overall Study|Physician Decision|2
4450184|NCT00509899|7236135|FG002|Overall Study|Physician Decision|7
4450185|NCT00509899|7236136|FG003|Overall Study|Physician Decision|0
4450186|NCT00509899|7236137|FG004|Overall Study|Physician Decision|1
4450187|NCT00509899|7236138|FG005|Overall Study|Physician Decision|4
4450188|NCT00509899|7236139|FG006|Overall Study|Physician Decision|0
4450189|NCT00509899|7236140|FG007|Overall Study|Physician Decision|0
4450190|NCT00509899|7236133|FG000|Overall Study|Intercurrent Illness|1
4450191|NCT00509899|7236134|FG001|Overall Study|Intercurrent Illness|0
4450192|NCT00509899|7236135|FG002|Overall Study|Intercurrent Illness|0
4450193|NCT00509899|7236136|FG003|Overall Study|Intercurrent Illness|1
4450194|NCT00509899|7236137|FG004|Overall Study|Intercurrent Illness|0
4450195|NCT00509899|7236138|FG005|Overall Study|Intercurrent Illness|1
4450196|NCT00509899|7236139|FG006|Overall Study|Intercurrent Illness|0
4450197|NCT00509899|7236140|FG007|Overall Study|Intercurrent Illness|0
4450198|NCT00509899|7236133|FG000|Overall Study|Death|2
4450199|NCT00509899|7236134|FG001|Overall Study|Death|2
4450200|NCT00509899|7236135|FG002|Overall Study|Death|3
4450201|NCT00509899|7236136|FG003|Overall Study|Death|0
4450202|NCT00509899|7236137|FG004|Overall Study|Death|1
4450203|NCT00509899|7236138|FG005|Overall Study|Death|1
4450204|NCT00509899|7236139|FG006|Overall Study|Death|1
4450205|NCT00509899|7236140|FG007|Overall Study|Death|1
4450206|NCT00509899|7236133|FG000|Overall Study|Lack of Efficacy|1
4450207|NCT00509899|7236134|FG001|Overall Study|Lack of Efficacy|0
4450208|NCT00509899|7236135|FG002|Overall Study|Lack of Efficacy|2
4450209|NCT00509899|7236136|FG003|Overall Study|Lack of Efficacy|0
4450210|NCT00509899|7236137|FG004|Overall Study|Lack of Efficacy|0
4450211|NCT00509899|7236138|FG005|Overall Study|Lack of Efficacy|1
4450212|NCT00509899|7236139|FG006|Overall Study|Lack of Efficacy|0
4450213|NCT00509899|7236140|FG007|Overall Study|Lack of Efficacy|0
4450214|NCT00509925|7236154|FG000|Overall Study|Personal reasons|0
4450215|NCT00509925|7236155|FG001|Overall Study|Personal reasons|1
4450216|NCT00510068|7236165|FG000|Double-blind Period|Disease progression|98
4450217|NCT00510068|7236166|FG001|Double-blind Period|Disease progression|169
4450218|NCT00510068|7236165|FG000|Double-blind Period|Final primary analysis|52
4450219|NCT00510068|7236166|FG001|Double-blind Period|Final primary analysis|18
4450220|NCT00510068|7236165|FG000|Double-blind Period|Adverse Event|37
4450221|NCT00510068|7236166|FG001|Double-blind Period|Adverse Event|7
4450222|NCT00510068|7236165|FG000|Double-blind Period|Withdrawal by Subject|8
4450223|NCT00510068|7236166|FG001|Double-blind Period|Withdrawal by Subject|6
4450224|NCT00510068|7236165|FG000|Double-blind Period|Death|4
4450225|NCT00510068|7236166|FG001|Double-blind Period|Death|3
4450226|NCT00510068|7236165|FG000|Double-blind Period|Abnormal test result (s)|1
4450227|NCT00510068|7236166|FG001|Double-blind Period|Abnormal test result (s)|0
4450228|NCT00510068|7236165|FG000|Double-blind Period|Lost to Follow-up|1
4450229|NCT00510068|7236166|FG001|Double-blind Period|Lost to Follow-up|0
4450230|NCT00510068|7236165|FG000|Double-blind Period|Protocol Violation|6
4450231|NCT00510068|7236166|FG001|Double-blind Period|Protocol Violation|0
4450232|NCT00510068|7236165|FG000|Open-label Period|Disease Progression|124
4450233|NCT00510068|7236166|FG001|Open-label Period|Disease Progression|0
4450234|NCT00510068|7236165|FG000|Open-label Period|Adverse Event|46
4450235|NCT00510068|7236166|FG001|Open-label Period|Adverse Event|0
4450236|NCT00510068|7236165|FG000|Open-label Period|Withdrawal by Subject|21
4450237|NCT00510068|7236166|FG001|Open-label Period|Withdrawal by Subject|0
4450238|NCT00510068|7236165|FG000|Open-label Period|Administrative problems|17
4450239|NCT00510068|7236166|FG001|Open-label Period|Administrative problems|0
4450240|NCT00510068|7236165|FG000|Open-label Period|Death|7
4450241|NCT00510068|7236166|FG001|Open-label Period|Death|0
4450242|NCT00510068|7236165|FG000|Open-label Period|New cancer therapy|7
4450243|NCT00510068|7236166|FG001|Open-label Period|New cancer therapy|0
4450244|NCT00510068|7236165|FG000|Open-label Period|Protocol Violation|2
4450245|NCT00510068|7236166|FG001|Open-label Period|Protocol Violation|0
4450246|NCT00510068|7236165|FG000|Open-label Period|Abnormal laboratory value (s)|1
4450247|NCT00510068|7236166|FG001|Open-label Period|Abnormal laboratory value (s)|0
4450248|NCT00510146|7236176|FG000|Double-Blind Treatment|Adverse Event|30
4450249|NCT00510146|7236177|FG001|Double-Blind Treatment|Adverse Event|13
4450250|NCT00510146|7236176|FG000|Double-Blind Treatment|Lack of Efficacy|6
4450251|NCT00510146|7236177|FG001|Double-Blind Treatment|Lack of Efficacy|13
4450252|NCT00510146|7236176|FG000|Double-Blind Treatment|Lost to Follow-up|3
4450253|NCT00510146|7236177|FG001|Double-Blind Treatment|Lost to Follow-up|7
4450254|NCT00510146|7236176|FG000|Double-Blind Treatment|Physician Decision|6
4450255|NCT00510146|7236177|FG001|Double-Blind Treatment|Physician Decision|0
4450256|NCT00510146|7236176|FG000|Double-Blind Treatment|Protocol Violation|1
4450257|NCT00510146|7236177|FG001|Double-Blind Treatment|Protocol Violation|2
4450258|NCT00510146|7236176|FG000|Double-Blind Treatment|Withdrawal by Subject|27
4450259|NCT00510146|7236177|FG001|Double-Blind Treatment|Withdrawal by Subject|13
4450260|NCT00510146|7236176|FG000|Double-Blind Treatment|Clinical Relapse|0
4450261|NCT00510146|7236177|FG001|Double-Blind Treatment|Clinical Relapse|1
4450262|NCT00510146|7236176|FG000|Double-Blind Treatment|Entry Criteria Not Met|3
4450263|NCT00510146|7236177|FG001|Double-Blind Treatment|Entry Criteria Not Met|0
4450264|NCT00510146|7236176|FG000|Open-Label Treatment|Adverse Event|22
4450265|NCT00510146|7236177|FG001|Open-Label Treatment|Adverse Event|8
4450266|NCT00510146|7236176|FG000|Open-Label Treatment|Death|1
4450267|NCT00510146|7236177|FG001|Open-Label Treatment|Death|1
4450268|NCT00510146|7236176|FG000|Open-Label Treatment|Lack of Efficacy|4
4450269|NCT00510146|7236177|FG001|Open-Label Treatment|Lack of Efficacy|0
4450270|NCT00510146|7236176|FG000|Open-Label Treatment|Lost to Follow-up|10
4450271|NCT00510146|7236177|FG001|Open-Label Treatment|Lost to Follow-up|1
4450272|NCT00510146|7236176|FG000|Open-Label Treatment|Physician Decision|3
4450273|NCT00510146|7236177|FG001|Open-Label Treatment|Physician Decision|1
4450274|NCT00510146|7236176|FG000|Open-Label Treatment|Protocol Violation|4
4450275|NCT00510146|7236177|FG001|Open-Label Treatment|Protocol Violation|2
4450276|NCT00510146|7236176|FG000|Open-Label Treatment|Withdrawal by Subject|24
4450277|NCT00510146|7236177|FG001|Open-Label Treatment|Withdrawal by Subject|12
4450278|NCT00510146|7236176|FG000|Open-Label Treatment|Clinical Relapse|1
4450279|NCT00510146|7236177|FG001|Open-Label Treatment|Clinical Relapse|1
4450280|NCT00510146|7236176|FG000|Open-Label Treatment|Sponsor Decision|2
4450281|NCT00510146|7236177|FG001|Open-Label Treatment|Sponsor Decision|0
4450282|NCT00510198|7236187|FG000|Overall Study|Withdrawal by Subject|5
4450283|NCT00510198|7236188|FG001|Overall Study|Withdrawal by Subject|4
4450284|NCT00510276|7236202|FG000|Acute Double-Blind Phase|Adverse Event|21
4450285|NCT00510276|7236203|FG001|Acute Double-Blind Phase|Adverse Event|6
4450286|NCT00510276|7236202|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1
4450287|NCT00510276|7236203|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1
4450288|NCT00510276|7236202|FG000|Acute Double-Blind Phase|Lack of Efficacy|3
4450289|NCT00510276|7236203|FG001|Acute Double-Blind Phase|Lack of Efficacy|4
4450290|NCT00510276|7236202|FG000|Acute Double-Blind Phase|Lost to Follow-up|48
4450291|NCT00510276|7236203|FG001|Acute Double-Blind Phase|Lost to Follow-up|49
4450292|NCT00510276|7236202|FG000|Acute Double-Blind Phase|Physician Decision|0
4450293|NCT00510276|7236203|FG001|Acute Double-Blind Phase|Physician Decision|3
4450294|NCT00510276|7236202|FG000|Acute Double-Blind Phase|Protocol Violation|4
4450295|NCT00510276|7236203|FG001|Acute Double-Blind Phase|Protocol Violation|3
4450296|NCT00510276|7236202|FG000|Acute Double-Blind Phase|Sponsor Decision|2
4450297|NCT00510276|7236203|FG001|Acute Double-Blind Phase|Sponsor Decision|1
4450298|NCT00510276|7236202|FG000|Acute Double-Blind Phase|Subject Decision|26
4450299|NCT00510276|7236203|FG001|Acute Double-Blind Phase|Subject Decision|28
4450300|NCT00510276|7236202|FG000|Extension Open-Label Phase|Adverse Event|9
4450301|NCT00510276|7236203|FG001|Extension Open-Label Phase|Adverse Event|18
4450302|NCT00510276|7236202|FG000|Extension Open-Label Phase|Lack of Efficacy|2
4450303|NCT00510276|7236203|FG001|Extension Open-Label Phase|Lack of Efficacy|7
4450304|NCT00510276|7236202|FG000|Extension Open-Label Phase|Lost to Follow-up|12
4450305|NCT00510276|7236203|FG001|Extension Open-Label Phase|Lost to Follow-up|10
4450306|NCT00510276|7236202|FG000|Extension Open-Label Phase|Physician Decision|2
4450307|NCT00510276|7236203|FG001|Extension Open-Label Phase|Physician Decision|3
4450308|NCT00510276|7236202|FG000|Extension Open-Label Phase|Protocol Violation|0
4450309|NCT00510276|7236203|FG001|Extension Open-Label Phase|Protocol Violation|1
4450310|NCT00510276|7236202|FG000|Extension Open-Label Phase|Sponsor Decision|1
4450311|NCT00510276|7236203|FG001|Extension Open-Label Phase|Sponsor Decision|0
4450312|NCT00510276|7236202|FG000|Extension Open-Label Phase|Subject Decision|7
4450313|NCT00510276|7236203|FG001|Extension Open-Label Phase|Subject Decision|9
4450314|NCT00510289|7236216|FG000|Overall Study|Withdrawal by Subject|7
4450315|NCT00510289|7236216|FG000|Overall Study|Refused bone marrow biopsy|2
4450316|NCT00510289|7236216|FG000|Overall Study|Lost to Follow-up|1
4450317|NCT00510289|7236216|FG000|Overall Study|Progressed prior to starting drug|2
4450318|NCT00510458|7236221|FG000|Overall Study|5 year not evaluable/missed|21
4450319|NCT00510458|7236221|FG000|Overall Study|Death|1
4450320|NCT00510458|7236221|FG000|Overall Study|Terminated|14
4450321|NCT00510458|7236221|FG000|Overall Study|Lost to Follow-up|6
4450322|NCT00510458|7236221|FG000|Overall Study|Withdrawal by Subject|3
4450323|NCT00510458|7236221|FG000|Overall Study|Revision|2
4450324|NCT00510484|7236228|FG000|Wash-out Period|Adverse Event|0
4450325|NCT00510484|7236229|FG001|Wash-out Period|Adverse Event|1
4450326|NCT00510510|7236242|FG000|Overall Study|Adverse Event|4
4450327|NCT00510510|7236243|FG001|Overall Study|Adverse Event|3
4450328|NCT00510510|7236244|FG002|Overall Study|Adverse Event|6
4450329|NCT00510510|7236242|FG000|Overall Study|Lack of Efficacy|0
4450330|NCT00510510|7236243|FG001|Overall Study|Lack of Efficacy|1
4450331|NCT00510510|7236244|FG002|Overall Study|Lack of Efficacy|1
4450332|NCT00510510|7236242|FG000|Overall Study|Subjects no longer requires study drug|0
4450333|NCT00510510|7236243|FG001|Overall Study|Subjects no longer requires study drug|0
4450334|NCT00510510|7236244|FG002|Overall Study|Subjects no longer requires study drug|2
4450335|NCT00510510|7236242|FG000|Overall Study|Withdrawal by Subject|1
4450336|NCT00510510|7236243|FG001|Overall Study|Withdrawal by Subject|2
4450337|NCT00510510|7236244|FG002|Overall Study|Withdrawal by Subject|3
4450338|NCT00510510|7236242|FG000|Overall Study|Lost to Follow-up|0
4450339|NCT00510510|7236243|FG001|Overall Study|Lost to Follow-up|0
4450340|NCT00510510|7236244|FG002|Overall Study|Lost to Follow-up|1
4450341|NCT00510510|7236242|FG000|Overall Study|Protocol Violation|0
4450342|NCT00510510|7236243|FG001|Overall Study|Protocol Violation|3
4450343|NCT00510510|7236244|FG002|Overall Study|Protocol Violation|4
4450344|NCT00510653|7236252|FG000|Overall Study|Withdrawal by Subject|8
4450345|NCT00510653|7236252|FG000|Overall Study|Monetary|3
4450346|NCT00510692|7236258|FG000|Overall Study|Adverse Event|1
4450347|NCT00510692|7236259|FG001|Overall Study|Adverse Event|3
4450348|NCT00510692|7236258|FG000|Overall Study|Withdrawal by Subject|1
4450349|NCT00510692|7236259|FG001|Overall Study|Withdrawal by Subject|0
4450350|NCT00510718|7236274|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1
4450351|NCT00510718|7236275|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8
4450352|NCT00510718|7236274|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3
4450353|NCT00510718|7236275|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6
4450354|NCT00510718|7236274|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8
4450355|NCT00510718|7236275|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11
4450356|NCT00510718|7236274|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1
4450357|NCT00510718|7236275|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3
4450358|NCT00510718|7236274|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1
4450359|NCT00510718|7236275|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3
4450360|NCT00510718|7236274|FG000|Multiple Dose Period: 12 Weeks|Other|1
4450361|NCT00510718|7236275|FG001|Multiple Dose Period: 12 Weeks|Other|1
4450362|NCT00510783|7236300|FG000|Overall Study|Lost to Follow-up|29
4450363|NCT00510783|7236301|FG001|Overall Study|Lost to Follow-up|25
4450364|NCT00510783|7236300|FG000|Overall Study|Withdrawal by Subject|2
4450365|NCT00510783|7236301|FG001|Overall Study|Withdrawal by Subject|3
4450366|NCT00510783|7236300|FG000|Overall Study|Protocol Violation|0
4450367|NCT00510783|7236301|FG001|Overall Study|Protocol Violation|1
4450368|NCT00510835|7236323|FG000|Overall Study|Withdrawal by Subject|6
4450369|NCT00510835|7236324|FG001|Overall Study|Withdrawal by Subject|2
4450370|NCT00510835|7236325|FG002|Overall Study|Withdrawal by Subject|2
4450371|NCT00510874|7236340|FG000|Overall Study|Withdrawal by Subject|1
4450372|NCT00510874|7236341|FG001|Overall Study|Withdrawal by Subject|1
4450373|NCT00510874|7236342|FG002|Overall Study|Withdrawal by Subject|0
4450374|NCT00510874|7236343|FG003|Overall Study|Withdrawal by Subject|0
4450375|NCT00510874|7236344|FG004|Overall Study|Withdrawal by Subject|3
4450376|NCT00510874|7236345|FG005|Overall Study|Withdrawal by Subject|0
4450377|NCT00510874|7236346|FG006|Overall Study|Withdrawal by Subject|0
4450378|NCT00510874|7236340|FG000|Overall Study|Lost to Follow-up|2
4450379|NCT00510874|7236341|FG001|Overall Study|Lost to Follow-up|3
4450380|NCT00510874|7236342|FG002|Overall Study|Lost to Follow-up|1
4450381|NCT00510874|7236343|FG003|Overall Study|Lost to Follow-up|3
4450382|NCT00510874|7236344|FG004|Overall Study|Lost to Follow-up|4
4450383|NCT00510874|7236345|FG005|Overall Study|Lost to Follow-up|0
4450384|NCT00510874|7236346|FG006|Overall Study|Lost to Follow-up|1
4450385|NCT00510887|7236363|FG000|Overall Study|Lost to Follow-up|1
4450386|NCT00510952|7236369|FG000|Overall Study|Adverse Event|1
4450387|NCT00510952|7236370|FG001|Overall Study|Adverse Event|0
4450388|NCT00510952|7236369|FG000|Overall Study|Entry Criteria Not Met|3
4450389|NCT00510952|7236370|FG001|Overall Study|Entry Criteria Not Met|1
4450390|NCT00510952|7236369|FG000|Overall Study|Lost to Follow-up|5
4450391|NCT00510952|7236370|FG001|Overall Study|Lost to Follow-up|3
4450392|NCT00510952|7236369|FG000|Overall Study|Physician Decision|1
4450393|NCT00510952|7236370|FG001|Overall Study|Physician Decision|1
4450394|NCT00510952|7236369|FG000|Overall Study|Protocol Violation|7
4450395|NCT00510952|7236370|FG001|Overall Study|Protocol Violation|4
4450396|NCT00510952|7236369|FG000|Overall Study|Sponsor Decision|1
4450397|NCT00510952|7236370|FG001|Overall Study|Sponsor Decision|0
4450398|NCT00510952|7236369|FG000|Overall Study|Withdrawal by Subject|6
4450399|NCT00510952|7236370|FG001|Overall Study|Withdrawal by Subject|7
4450400|NCT00510952|7236369|FG000|Overall Study|Did Not Receive Study Drug|2
4450401|NCT00510952|7236370|FG001|Overall Study|Did Not Receive Study Drug|0
4450402|NCT00511004|7236379|FG000|Overall Study|Lost to Follow-up|0
4450403|NCT00511004|7236380|FG001|Overall Study|Lost to Follow-up|0
4450404|NCT00511004|7236381|FG002|Overall Study|Lost to Follow-up|4
4450405|NCT00511108|7236406|FG000|Overall Study|Adverse Event|2
4450406|NCT00511108|7236407|FG001|Overall Study|Adverse Event|0
4450407|NCT00511108|7236408|FG002|Overall Study|Adverse Event|1
4450408|NCT00511108|7236409|FG003|Overall Study|Adverse Event|2
4450409|NCT00511108|7236406|FG000|Overall Study|Lost to Follow-up|0
4450410|NCT00511108|7236407|FG001|Overall Study|Lost to Follow-up|2
4450411|NCT00511108|7236408|FG002|Overall Study|Lost to Follow-up|1
4450412|NCT00511108|7236409|FG003|Overall Study|Lost to Follow-up|0
4450413|NCT00511108|7236406|FG000|Overall Study|Physician Decision|0
4450414|NCT00511108|7236407|FG001|Overall Study|Physician Decision|0
4450415|NCT00511108|7236408|FG002|Overall Study|Physician Decision|0
4450416|NCT00511108|7236409|FG003|Overall Study|Physician Decision|1
4450417|NCT00511108|7236406|FG000|Overall Study|Withdrawal by Subject|4
4450418|NCT00511108|7236407|FG001|Overall Study|Withdrawal by Subject|0
4450419|NCT00511108|7236408|FG002|Overall Study|Withdrawal by Subject|3
4450420|NCT00511108|7236409|FG003|Overall Study|Withdrawal by Subject|2
4450421|NCT00511134|7236421|FG000|Overall Study|Withdrawal by Subject|0
4450422|NCT00511134|7236422|FG001|Overall Study|Withdrawal by Subject|2
4515739|NCT00955409|7326707|FG009|Overall Study|Investigator Request|0
4515740|NCT00955409|7326698|FG000|Overall Study|Discontinuation of Study by Sponsor|0
4515741|NCT00955409|7326699|FG001|Overall Study|Discontinuation of Study by Sponsor|0
4515742|NCT00955409|7326700|FG002|Overall Study|Discontinuation of Study by Sponsor|0
4515743|NCT00955409|7326701|FG003|Overall Study|Discontinuation of Study by Sponsor|0
4515744|NCT00955409|7326702|FG004|Overall Study|Discontinuation of Study by Sponsor|0
4515745|NCT00955409|7326703|FG005|Overall Study|Discontinuation of Study by Sponsor|0
4515746|NCT00955409|7326704|FG006|Overall Study|Discontinuation of Study by Sponsor|0
4515747|NCT00955409|7326705|FG007|Overall Study|Discontinuation of Study by Sponsor|1
4515748|NCT00955409|7326706|FG008|Overall Study|Discontinuation of Study by Sponsor|0
4515749|NCT00955409|7326707|FG009|Overall Study|Discontinuation of Study by Sponsor|0
4515750|NCT00955409|7326698|FG000|Overall Study|Lost to Follow-up|0
4515751|NCT00955409|7326699|FG001|Overall Study|Lost to Follow-up|0
4515752|NCT00955409|7326700|FG002|Overall Study|Lost to Follow-up|1
4515753|NCT00955409|7326701|FG003|Overall Study|Lost to Follow-up|0
4515754|NCT00955409|7326702|FG004|Overall Study|Lost to Follow-up|0
4515755|NCT00955409|7326703|FG005|Overall Study|Lost to Follow-up|0
4515756|NCT00955409|7326704|FG006|Overall Study|Lost to Follow-up|1
4515757|NCT00955409|7326705|FG007|Overall Study|Lost to Follow-up|0
4515758|NCT00955409|7326706|FG008|Overall Study|Lost to Follow-up|0
4515759|NCT00955409|7326707|FG009|Overall Study|Lost to Follow-up|0
4515760|NCT00955409|7326698|FG000|Overall Study|Failed to Return|2
4515761|NCT00955409|7326699|FG001|Overall Study|Failed to Return|0
4515762|NCT00955409|7326700|FG002|Overall Study|Failed to Return|0
4515763|NCT00955409|7326701|FG003|Overall Study|Failed to Return|0
4515764|NCT00955409|7326702|FG004|Overall Study|Failed to Return|0
4515765|NCT00955409|7326703|FG005|Overall Study|Failed to Return|0
4515766|NCT00955409|7326704|FG006|Overall Study|Failed to Return|0
4515767|NCT00955409|7326705|FG007|Overall Study|Failed to Return|2
4515768|NCT00955409|7326706|FG008|Overall Study|Failed to Return|0
4515769|NCT00955409|7326707|FG009|Overall Study|Failed to Return|0
4515770|NCT00955409|7326698|FG000|Overall Study|Adverse Event (AE)|2
4515771|NCT00955409|7326699|FG001|Overall Study|Adverse Event (AE)|0
4515772|NCT00955409|7326700|FG002|Overall Study|Adverse Event (AE)|0
4515773|NCT00955409|7326701|FG003|Overall Study|Adverse Event (AE)|0
4515774|NCT00955409|7326702|FG004|Overall Study|Adverse Event (AE)|0
4515775|NCT00955409|7326703|FG005|Overall Study|Adverse Event (AE)|1
4515776|NCT00955409|7326704|FG006|Overall Study|Adverse Event (AE)|2
4515777|NCT00955409|7326705|FG007|Overall Study|Adverse Event (AE)|0
4515778|NCT00955409|7326706|FG008|Overall Study|Adverse Event (AE)|2
4515779|NCT00955409|7326707|FG009|Overall Study|Adverse Event (AE)|0
4515780|NCT00955409|7326698|FG000|Overall Study|Reason not Specified|2
4515781|NCT00955409|7326699|FG001|Overall Study|Reason not Specified|1
4515782|NCT00955409|7326700|FG002|Overall Study|Reason not Specified|13
4515783|NCT00955409|7326701|FG003|Overall Study|Reason not Specified|1
4515784|NCT00955409|7326702|FG004|Overall Study|Reason not Specified|2
4515785|NCT00955409|7326703|FG005|Overall Study|Reason not Specified|0
4515786|NCT00955409|7326704|FG006|Overall Study|Reason not Specified|16
4515787|NCT00955409|7326705|FG007|Overall Study|Reason not Specified|0
4515788|NCT00955409|7326706|FG008|Overall Study|Reason not Specified|8
4515789|NCT00955409|7326707|FG009|Overall Study|Reason not Specified|1
4450423|NCT00511147|7236428|FG000|Overall Study|Withdrawal by Subject|1
4450424|NCT00511147|7236428|FG000|Overall Study|Disease progression|5
4450425|NCT00511147|7236428|FG000|Overall Study|Required platelet transfusion|1
4450426|NCT00511238|7236439|FG000|Overall Study|Adverse Event|13
4450427|NCT00511238|7236440|FG001|Overall Study|Adverse Event|33
4450428|NCT00511238|7236439|FG000|Overall Study|Withdrawal by Subject|2
4450429|NCT00511238|7236440|FG001|Overall Study|Withdrawal by Subject|22
4450430|NCT00511238|7236439|FG000|Overall Study|Progressive Disease|23
4450431|NCT00511238|7236440|FG001|Overall Study|Progressive Disease|157
4450432|NCT00511238|7236439|FG000|Overall Study|various reasons|4
4450433|NCT00511238|7236440|FG001|Overall Study|various reasons|14
4450434|NCT00511472|7236458|FG000|Overall Study|Clinical Adverse Event|1
4450435|NCT00511472|7236459|FG001|Overall Study|Clinical Adverse Event|2
4450436|NCT00511472|7236458|FG000|Overall Study|Laboratory Adverse Event|0
4450437|NCT00511472|7236459|FG001|Overall Study|Laboratory Adverse Event|2
4450438|NCT00511472|7236458|FG000|Overall Study|Not reported|2
4450439|NCT00511472|7236459|FG001|Overall Study|Not reported|2
4450440|NCT00511667|7236476|FG000|Overall Study|Adverse Event|1
4450441|NCT00511667|7236477|FG001|Overall Study|Adverse Event|0
4450442|NCT00511667|7236476|FG000|Overall Study|Protocol Violation|1
4450443|NCT00511667|7236477|FG001|Overall Study|Protocol Violation|1
4450444|NCT00511667|7236476|FG000|Overall Study|Withdrawal by Subject|2
4450445|NCT00511667|7236477|FG001|Overall Study|Withdrawal by Subject|0
4450446|NCT00511667|7236476|FG000|Overall Study|Site terminated|6
4450447|NCT00511667|7236477|FG001|Overall Study|Site terminated|1
4450448|NCT00511667|7236476|FG000|Overall Study|Other|2
4450449|NCT00511667|7236477|FG001|Overall Study|Other|1
4450450|NCT00511797|7236502|FG000|Overall Study|Adverse Event|1
4450451|NCT00511797|7236503|FG001|Overall Study|Adverse Event|2
4450452|NCT00511797|7236504|FG002|Overall Study|Adverse Event|2
4450453|NCT00511797|7236505|FG003|Overall Study|Adverse Event|2
4450454|NCT00511797|7236502|FG000|Overall Study|Lost to Follow-up|1
4450455|NCT00511797|7236503|FG001|Overall Study|Lost to Follow-up|0
4450456|NCT00511797|7236504|FG002|Overall Study|Lost to Follow-up|0
4450457|NCT00511797|7236505|FG003|Overall Study|Lost to Follow-up|1
4450458|NCT00511797|7236502|FG000|Overall Study|Pregnancy|0
4450459|NCT00511797|7236503|FG001|Overall Study|Pregnancy|0
4450460|NCT00511797|7236504|FG002|Overall Study|Pregnancy|0
4450461|NCT00511797|7236505|FG003|Overall Study|Pregnancy|1
4450462|NCT00511797|7236502|FG000|Overall Study|Protocol Violation|0
4609308|NCT01685203|7464966|FG004|Overall Study|Lost to Follow-up|0
4450463|NCT00511797|7236503|FG001|Overall Study|Protocol Violation|2
4450464|NCT00511797|7236504|FG002|Overall Study|Protocol Violation|2
4450465|NCT00511797|7236505|FG003|Overall Study|Protocol Violation|3
4450466|NCT00511797|7236502|FG000|Overall Study|Withdrawal by Subject|3
4450467|NCT00511797|7236503|FG001|Overall Study|Withdrawal by Subject|3
4450468|NCT00511797|7236504|FG002|Overall Study|Withdrawal by Subject|4
4450469|NCT00511797|7236505|FG003|Overall Study|Withdrawal by Subject|2
4450470|NCT00511797|7236502|FG000|Overall Study|Never dispensed|1
4450471|NCT00511797|7236503|FG001|Overall Study|Never dispensed|0
4450472|NCT00511797|7236504|FG002|Overall Study|Never dispensed|1
4450473|NCT00511797|7236505|FG003|Overall Study|Never dispensed|3
4450474|NCT00511797|7236502|FG000|Overall Study|Study drug not taken|0
4450475|NCT00511797|7236503|FG001|Overall Study|Study drug not taken|1
4450476|NCT00511797|7236504|FG002|Overall Study|Study drug not taken|0
4450477|NCT00511797|7236505|FG003|Overall Study|Study drug not taken|1
4450478|NCT00511797|7236502|FG000|Overall Study|Partially missing diary|0
4450479|NCT00511797|7236503|FG001|Overall Study|Partially missing diary|0
4450480|NCT00511797|7236504|FG002|Overall Study|Partially missing diary|1
4450481|NCT00511797|7236505|FG003|Overall Study|Partially missing diary|0
4450482|NCT00511797|7236502|FG000|Overall Study|Other (moving etc)|1
4450483|NCT00511797|7236503|FG001|Overall Study|Other (moving etc)|0
4450484|NCT00511797|7236504|FG002|Overall Study|Other (moving etc)|1
4450485|NCT00511797|7236505|FG003|Overall Study|Other (moving etc)|2
4450486|NCT00511810|7236517|FG000|Overall Study|Lost to Follow-up|1
4450487|NCT00511810|7236518|FG001|Overall Study|Lost to Follow-up|2
4529375|NCT01056263|7347693|FG000|Overall Study|Progressive disease|2
4529376|NCT01056263|7347693|FG000|Overall Study|Neoplasm progression|1
4529377|NCT01056263|7347693|FG000|Overall Study|Objective progression or relapse|1
4529378|NCT01056263|7347693|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5
4529379|NCT01056276|7347699|FG000|Treatment Period-Cycles 1-8|Toxicity|2
4529380|NCT01056276|7347700|FG001|Treatment Period-Cycles 1-8|Toxicity|1
4529381|NCT01056276|7347699|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1
4529382|NCT01056276|7347700|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2
4529383|NCT01056276|7347699|FG000|Treatment Period-Cycles 1-8|Disease Progression|2
4529384|NCT01056276|7347700|FG001|Treatment Period-Cycles 1-8|Disease Progression|2
4529385|NCT01056276|7347699|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1
4529386|NCT01056276|7347700|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2
4450488|NCT00511810|7236517|FG000|Overall Study|Lack of Efficacy|0
4450489|NCT00511810|7236518|FG001|Overall Study|Lack of Efficacy|2
4450490|NCT00511810|7236517|FG000|Overall Study|Refused second scn|0
4450491|NCT00511810|7236518|FG001|Overall Study|Refused second scn|1
4450492|NCT00511836|7236526|FG000|Double-blind Period|Lost to Follow-up|1
4450493|NCT00511836|7236527|FG001|Double-blind Period|Lost to Follow-up|0
4450494|NCT00511875|7236551|FG000|Overall Study|Lost to Follow-up|4
4450495|NCT00511875|7236552|FG001|Overall Study|Lost to Follow-up|0
4450496|NCT00511875|7236551|FG000|Overall Study|Missing variables|1
4450497|NCT00511875|7236552|FG001|Overall Study|Missing variables|0
4450498|NCT00511901|7236560|FG000|Overall Study|Withdrawal by Subject|1
4450499|NCT00511901|7236561|FG001|Overall Study|Withdrawal by Subject|3
4450500|NCT00512096|7236580|FG000|Overall Study|Adverse Event|2
4450501|NCT00512096|7236580|FG000|Overall Study|Withdrawal by Subject|2
4450502|NCT00512096|7236580|FG000|Overall Study|Lack of Efficacy|3
4450503|NCT00512135|7236584|FG000|Overall Study|Not Treated|5
4450504|NCT00512135|7236584|FG000|Overall Study|Lack of Efficacy|2
4450505|NCT00512135|7236584|FG000|Overall Study|Adverse Event|6
4450506|NCT00512135|7236584|FG000|Overall Study|Withdrawal by Subject|22
4450507|NCT00512135|7236584|FG000|Overall Study|Lost to Follow-up|27
4450508|NCT00512135|7236584|FG000|Overall Study|Other|22
4450509|NCT00512148|7236589|FG000|Primay Study Period|Withdrawal by Subject|1
4450510|NCT00512252|7236598|FG000|Overall Study|Lost to Follow-up|0
4450511|NCT00512252|7236599|FG001|Overall Study|Lost to Follow-up|0
4450512|NCT00512252|7236600|FG002|Overall Study|Lost to Follow-up|1
4450513|NCT00512252|7236598|FG000|Overall Study|Protocol Violation|0
4450514|NCT00512252|7236599|FG001|Overall Study|Protocol Violation|0
4450515|NCT00512252|7236600|FG002|Overall Study|Protocol Violation|1
4450516|NCT00512252|7236598|FG000|Overall Study|Death|0
4450517|NCT00512252|7236599|FG001|Overall Study|Death|0
4450518|NCT00512252|7236600|FG002|Overall Study|Death|1
4450519|NCT00512707|7236628|FG000|Overall Study|Lost to Follow-up|5
4450520|NCT00512707|7236629|FG001|Overall Study|Lost to Follow-up|11
4450521|NCT00512707|7236628|FG000|Overall Study|Developed skin irritation|2
4450522|NCT00512707|7236629|FG001|Overall Study|Developed skin irritation|1
4450523|NCT00512707|7236628|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2
4450524|NCT00512707|7236629|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0
4450525|NCT00512707|7236628|FG000|Overall Study|Unable to tolerate the smell of the gel|1
4450526|NCT00512707|7236629|FG001|Overall Study|Unable to tolerate the smell of the gel|0
4450527|NCT00512798|7236637|FG000|Overall Study|Death|0
4450528|NCT00512798|7236638|FG001|Overall Study|Death|3
4450529|NCT00512798|7236637|FG000|Overall Study|Adverse Event|2
4450530|NCT00512798|7236638|FG001|Overall Study|Adverse Event|4
4450531|NCT00512798|7236637|FG000|Overall Study|Progression of disease|14
4450532|NCT00512798|7236638|FG001|Overall Study|Progression of disease|20
4450533|NCT00512798|7236637|FG000|Overall Study|Withdrawal by Subject|3
4450534|NCT00512798|7236638|FG001|Overall Study|Withdrawal by Subject|0
4450535|NCT00512902|7236649|FG000|Overall Study|Adverse Event|7
4450536|NCT00512902|7236649|FG000|Overall Study|Lost to Follow-up|1
4450537|NCT00513019|7236655|FG000|Overall Study|Adverse Event|1
4450538|NCT00513019|7236656|FG001|Overall Study|Adverse Event|0
4450539|NCT00513019|7236655|FG000|Overall Study|Withdrawal by Subject|4
4450540|NCT00513019|7236656|FG001|Overall Study|Withdrawal by Subject|5
4450541|NCT00513071|7236662|FG000|Overall Study|Adverse Event|1
4450542|NCT00513071|7236662|FG000|Overall Study|Withdrawal by Subject|1
4450543|NCT00513071|7236662|FG000|Overall Study|Physician Decision|3
4450544|NCT00513240|7236668|FG000|Overall Study|Did not have intended surgery|3
4450545|NCT00513240|7236669|FG001|Overall Study|Did not have intended surgery|0
4450546|NCT00513240|7236668|FG000|Overall Study|Death|3
4450547|NCT00513240|7236669|FG001|Overall Study|Death|3
4450548|NCT00513240|7236668|FG000|Overall Study|Withdrawal by Subject|7
4450549|NCT00513240|7236669|FG001|Overall Study|Withdrawal by Subject|4
4450550|NCT00513305|7236689|FG000|Overall Study|Adverse Event|6
4450551|NCT00513305|7236690|FG001|Overall Study|Adverse Event|2
4450552|NCT00513305|7236689|FG000|Overall Study|Death (through Consolidation Treatment)|2
4450553|NCT00513305|7236690|FG001|Overall Study|Death (through Consolidation Treatment)|2
4450554|NCT00513305|7236689|FG000|Overall Study|Lack of Efficacy|8
4450555|NCT00513305|7236690|FG001|Overall Study|Lack of Efficacy|13
4450556|NCT00513305|7236689|FG000|Overall Study|Withdrawal by Subject|1
4450557|NCT00513305|7236690|FG001|Overall Study|Withdrawal by Subject|2
4450558|NCT00513305|7236689|FG000|Overall Study|Disease progression|8
4450559|NCT00513305|7236690|FG001|Overall Study|Disease progression|5
4450560|NCT00513305|7236689|FG000|Overall Study|Eligible for stem cell transplant|1
4450561|NCT00513305|7236690|FG001|Overall Study|Eligible for stem cell transplant|0
4450562|NCT00513305|7236689|FG000|Overall Study|Hematologic counts did not recover|1
4450563|NCT00513305|7236690|FG001|Overall Study|Hematologic counts did not recover|0
4450564|NCT00513305|7236689|FG000|Overall Study|Physician Decision|1
4450565|NCT00513305|7236690|FG001|Overall Study|Physician Decision|0
4450566|NCT00513305|7236689|FG000|Overall Study|Persistent hypocellularity|0
4450567|NCT00513305|7236690|FG001|Overall Study|Persistent hypocellularity|1
4450568|NCT00513305|7236689|FG000|Overall Study|Sponsor Decision|0
4450569|NCT00513305|7236690|FG001|Overall Study|Sponsor Decision|2
4450570|NCT00513357|7236706|FG000|Overall Study|did not receive allocated placebo|2
4450571|NCT00513357|7236707|FG001|Overall Study|did not receive allocated placebo|3
4450572|NCT00513357|7236706|FG000|Overall Study|Adverse Event|4
4450573|NCT00513357|7236707|FG001|Overall Study|Adverse Event|2
4450574|NCT00513357|7236706|FG000|Overall Study|Death|2
4450575|NCT00513357|7236707|FG001|Overall Study|Death|0
4450576|NCT00513357|7236706|FG000|Overall Study|Withdrawal by Subject|5
4450577|NCT00513357|7236707|FG001|Overall Study|Withdrawal by Subject|4
4450578|NCT00513357|7236706|FG000|Overall Study|Disease Progression|2
4450579|NCT00513357|7236707|FG001|Overall Study|Disease Progression|1
4450580|NCT00513409|7236721|FG000|Overall Study|Adverse Event|0
4450581|NCT00513409|7236722|FG001|Overall Study|Adverse Event|1
4450582|NCT00513409|7236721|FG000|Overall Study|Withdrawal by Subject|0
4450583|NCT00513409|7236722|FG001|Overall Study|Withdrawal by Subject|2
4450584|NCT00513409|7236721|FG000|Overall Study|Lost to Follow-up|0
4450585|NCT00513409|7236722|FG001|Overall Study|Lost to Follow-up|1
4450586|NCT00513409|7236721|FG000|Overall Study|Physician Decision|1
4450587|NCT00513409|7236722|FG001|Overall Study|Physician Decision|0
4450588|NCT00513409|7236721|FG000|Overall Study|Visit 3 not done|1
4450589|NCT00513409|7236722|FG001|Overall Study|Visit 3 not done|2
4450590|NCT00513474|7236743|FG000|Overall Study|Death|6
4450591|NCT00513474|7236744|FG001|Overall Study|Death|9
4450592|NCT00513474|7236743|FG000|Overall Study|Participant Withdrew Consent|1
4450593|NCT00513474|7236744|FG001|Overall Study|Participant Withdrew Consent|0
4450594|NCT00513500|7236752|FG000|Overall Study|Lost to Follow-up|35
4450595|NCT00513500|7236753|FG001|Overall Study|Lost to Follow-up|39
4450596|NCT00513500|7236752|FG000|Overall Study|Death|2
4450597|NCT00513500|7236753|FG001|Overall Study|Death|1
4450598|NCT00513500|7236752|FG000|Overall Study|Hospitalized|4
4450599|NCT00513500|7236753|FG001|Overall Study|Hospitalized|14
4450600|NCT00513604|7236770|FG000|Overall Study|Not treated|2
4450601|NCT00513604|7236771|FG001|Overall Study|Not treated|0
4450602|NCT00513604|7236772|FG002|Overall Study|Not treated|1
4450603|NCT00513604|7236773|FG003|Overall Study|Not treated|0
4450604|NCT00513604|7236774|FG004|Overall Study|Not treated|0
4450605|NCT00513604|7236770|FG000|Overall Study|Death during treatment|0
4450606|NCT00513604|7236771|FG001|Overall Study|Death during treatment|3
4450607|NCT00513604|7236772|FG002|Overall Study|Death during treatment|2
4450608|NCT00513604|7236773|FG003|Overall Study|Death during treatment|0
4450609|NCT00513604|7236774|FG004|Overall Study|Death during treatment|0
4450610|NCT00513682|7236786|FG000|Washout Phase|Adverse Event|2
4450611|NCT00513695|7236793|FG000|Overall Study|Discontinued therapy|2
4450612|NCT00513695|7236793|FG000|Overall Study|Progression prior to surgery|3
4450613|NCT00513708|7236800|FG000|Overall Study|Lost to Follow-up|4
4450614|NCT00513708|7236801|FG001|Overall Study|Lost to Follow-up|4
4450615|NCT00513708|7236802|FG002|Overall Study|Lost to Follow-up|4
4450616|NCT00514020|7236846|FG000|Overall Study|Adverse Event|6
4450617|NCT00514020|7236846|FG000|Overall Study|Withdrawal by Subject|3
4450618|NCT00514020|7236846|FG000|Overall Study|Physician Decision|1
4450619|NCT00514020|7236846|FG000|Overall Study|disease progression|9
4450620|NCT00514020|7236846|FG000|Overall Study|other complicating disease|2
4450621|NCT00514020|7236846|FG000|Overall Study|patient went to radiation treatment|1
4450622|NCT00514020|7236846|FG000|Overall Study|"patients moved to the no tx group"|6
4450623|NCT00514046|7236859|FG000|Overall Study|transferred to another protocol|2
4450624|NCT00514046|7236860|FG001|Overall Study|transferred to another protocol|1
4450625|NCT00514046|7236861|FG002|Overall Study|transferred to another protocol|3
4450626|NCT00514046|7236862|FG003|Overall Study|transferred to another protocol|0
4450627|NCT00514046|7236863|FG004|Overall Study|transferred to another protocol|1
4450628|NCT00514046|7236864|FG005|Overall Study|transferred to another protocol|0
4450629|NCT00514046|7236865|FG006|Overall Study|transferred to another protocol|0
4450630|NCT00514046|7236866|FG007|Overall Study|transferred to another protocol|0
4450631|NCT00514046|7236867|FG008|Overall Study|transferred to another protocol|0
4450632|NCT00514046|7236859|FG000|Overall Study|Getting vandetanib via the REMS program|1
4450633|NCT00514046|7236860|FG001|Overall Study|Getting vandetanib via the REMS program|0
4450634|NCT00514046|7236861|FG002|Overall Study|Getting vandetanib via the REMS program|0
4450635|NCT00514046|7236862|FG003|Overall Study|Getting vandetanib via the REMS program|0
4450636|NCT00514046|7236863|FG004|Overall Study|Getting vandetanib via the REMS program|0
4450637|NCT00514046|7236864|FG005|Overall Study|Getting vandetanib via the REMS program|0
4450638|NCT00514046|7236865|FG006|Overall Study|Getting vandetanib via the REMS program|0
4450639|NCT00514046|7236866|FG007|Overall Study|Getting vandetanib via the REMS program|1
4450640|NCT00514046|7236867|FG008|Overall Study|Getting vandetanib via the REMS program|1
4450641|NCT00514046|7236859|FG000|Overall Study|Disease progression on study|0
4450642|NCT00514046|7236860|FG001|Overall Study|Disease progression on study|0
4450643|NCT00514046|7236861|FG002|Overall Study|Disease progression on study|2
4450644|NCT00514046|7236862|FG003|Overall Study|Disease progression on study|0
4450645|NCT00514046|7236863|FG004|Overall Study|Disease progression on study|0
4450646|NCT00514046|7236864|FG005|Overall Study|Disease progression on study|1
4450647|NCT00514046|7236865|FG006|Overall Study|Disease progression on study|0
4450648|NCT00514046|7236866|FG007|Overall Study|Disease progression on study|0
4450649|NCT00514046|7236867|FG008|Overall Study|Disease progression on study|0
4450650|NCT00514449|7236899|FG000|Overall Study|Withdrawal by Subject|1
4450651|NCT00514449|7236900|FG001|Overall Study|Withdrawal by Subject|2
4450652|NCT00514449|7236899|FG000|Overall Study|Protocol Violation|1
4450653|NCT00514449|7236900|FG001|Overall Study|Protocol Violation|2
4450654|NCT00514449|7236899|FG000|Overall Study|Lost to Follow-up|1
4450655|NCT00514449|7236900|FG001|Overall Study|Lost to Follow-up|0
4450656|NCT00514514|7236916|FG000|Pre-phase|Death|10
4450657|NCT00514514|7236917|FG001|Pre-phase|Death|0
4450658|NCT00514514|7236918|FG002|Pre-phase|Death|0
4590722|NCT01524627|7437005|FG001|Overall Study|Physician Decision|1
4450659|NCT00514514|7236916|FG000|Pre-phase|administrative problems|2
4450660|NCT00514514|7236917|FG001|Pre-phase|administrative problems|0
4450661|NCT00514514|7236918|FG002|Pre-phase|administrative problems|0
4450662|NCT00514514|7236916|FG000|Pre-phase|Protocol Violation|6
4450663|NCT00514514|7236917|FG001|Pre-phase|Protocol Violation|0
4450664|NCT00514514|7236918|FG002|Pre-phase|Protocol Violation|0
4450665|NCT00514514|7236916|FG000|Pre-phase|condition no longer requires study drug|7
4450666|NCT00514514|7236917|FG001|Pre-phase|condition no longer requires study drug|0
4450667|NCT00514514|7236918|FG002|Pre-phase|condition no longer requires study drug|0
4450668|NCT00514514|7236916|FG000|Pre-phase|abnormal test procedure results|15
4450669|NCT00514514|7236917|FG001|Pre-phase|abnormal test procedure results|0
4450670|NCT00514514|7236918|FG002|Pre-phase|abnormal test procedure results|0
4450671|NCT00514514|7236916|FG000|Pre-phase|Lost to Follow-up|2
4450672|NCT00514514|7236917|FG001|Pre-phase|Lost to Follow-up|0
4450673|NCT00514514|7236918|FG002|Pre-phase|Lost to Follow-up|0
4450674|NCT00514514|7236916|FG000|Pre-phase|abnormal lab values|23
4450675|NCT00514514|7236917|FG001|Pre-phase|abnormal lab values|0
4450676|NCT00514514|7236918|FG002|Pre-phase|abnormal lab values|0
4450677|NCT00514514|7236916|FG000|Pre-phase|Lack of Efficacy|35
4450678|NCT00514514|7236917|FG001|Pre-phase|Lack of Efficacy|0
4450679|NCT00514514|7236918|FG002|Pre-phase|Lack of Efficacy|0
4450680|NCT00514514|7236916|FG000|Pre-phase|Adverse Event|137
4450681|NCT00514514|7236917|FG001|Pre-phase|Adverse Event|0
4450682|NCT00514514|7236918|FG002|Pre-phase|Adverse Event|0
4450683|NCT00514514|7236916|FG000|Pre-phase|Withdrawal by Subject|66
4450684|NCT00514514|7236917|FG001|Pre-phase|Withdrawal by Subject|0
4450685|NCT00514514|7236918|FG002|Pre-phase|Withdrawal by Subject|0
4450686|NCT00514514|7236916|FG000|Randomized - 9 Month|Death|3
4450687|NCT00514514|7236917|FG001|Randomized - 9 Month|Death|2
4450688|NCT00514514|7236918|FG002|Randomized - 9 Month|Death|2
4450689|NCT00514514|7236916|FG000|Randomized - 9 Month|Administrative problems|1
4450690|NCT00514514|7236917|FG001|Randomized - 9 Month|Administrative problems|1
4450691|NCT00514514|7236918|FG002|Randomized - 9 Month|Administrative problems|2
4450692|NCT00514514|7236916|FG000|Randomized - 9 Month|Withdrawal by Subject|7
4450693|NCT00514514|7236917|FG001|Randomized - 9 Month|Withdrawal by Subject|7
4450694|NCT00514514|7236918|FG002|Randomized - 9 Month|Withdrawal by Subject|5
4450695|NCT00514514|7236916|FG000|Randomized - 9 Month|Protocol Violation|1
4450696|NCT00514514|7236917|FG001|Randomized - 9 Month|Protocol Violation|1
4450697|NCT00514514|7236918|FG002|Randomized - 9 Month|Protocol Violation|0
4450698|NCT00514514|7236916|FG000|Randomized - 9 Month|Lack of Efficacy|2
4450699|NCT00514514|7236917|FG001|Randomized - 9 Month|Lack of Efficacy|3
4450700|NCT00514514|7236918|FG002|Randomized - 9 Month|Lack of Efficacy|1
4450701|NCT00514514|7236916|FG000|Randomized - 9 Month|Abnormal laboratory values|0
4450702|NCT00514514|7236917|FG001|Randomized - 9 Month|Abnormal laboratory values|3
4450703|NCT00514514|7236918|FG002|Randomized - 9 Month|Abnormal laboratory values|1
4450704|NCT00514514|7236916|FG000|Randomized - 9 Month|Adverse Event|25
4450705|NCT00514514|7236917|FG001|Randomized - 9 Month|Adverse Event|44
4450706|NCT00514514|7236918|FG002|Randomized - 9 Month|Adverse Event|27
4450707|NCT00514514|7236916|FG000|Extension - 4 Years|Withdrawal by Subject|5
4450708|NCT00514514|7236917|FG001|Extension - 4 Years|Withdrawal by Subject|2
4450709|NCT00514514|7236918|FG002|Extension - 4 Years|Withdrawal by Subject|2
4450710|NCT00514514|7236916|FG000|Extension - 4 Years|Lost to Follow-up|12
4450711|NCT00514514|7236917|FG001|Extension - 4 Years|Lost to Follow-up|10
4450712|NCT00514514|7236918|FG002|Extension - 4 Years|Lost to Follow-up|9
4450713|NCT00514514|7236916|FG000|Extension - 4 Years|Administrative problems|3
4450714|NCT00514514|7236917|FG001|Extension - 4 Years|Administrative problems|1
4450715|NCT00514514|7236918|FG002|Extension - 4 Years|Administrative problems|1
4450716|NCT00514514|7236916|FG000|Extension - 4 Years|Death|8
4450717|NCT00514514|7236917|FG001|Extension - 4 Years|Death|3
4450718|NCT00514514|7236918|FG002|Extension - 4 Years|Death|6
4450719|NCT00514514|7236916|FG000|Extension - 4 Years|Adverse Event|9
4450720|NCT00514514|7236917|FG001|Extension - 4 Years|Adverse Event|6
4450721|NCT00514514|7236918|FG002|Extension - 4 Years|Adverse Event|3
4450722|NCT00514540|7236926|FG000|First-Line Chemo|Withdrawal by Subject|1
4450723|NCT00514540|7236926|FG000|First-Line Chemo|Protocol Violation|7
4450724|NCT00514540|7236926|FG000|Second-Line|Physician/Patient Decision|31
4450725|NCT00514683|7236943|FG000|Overall Study|Not treated|2
4450726|NCT00514683|7236944|FG001|Overall Study|Not treated|1
4450727|NCT00514683|7236945|FG002|Overall Study|Not treated|0
4450728|NCT00514683|7236946|FG003|Overall Study|Not treated|0
4450729|NCT00514683|7236947|FG004|Overall Study|Not treated|1
4450730|NCT00514683|7236943|FG000|Overall Study|Adverse Event|21
4450731|NCT00514683|7236944|FG001|Overall Study|Adverse Event|20
4450732|NCT00514683|7236945|FG002|Overall Study|Adverse Event|15
4450733|NCT00514683|7236946|FG003|Overall Study|Adverse Event|13
4450734|NCT00514683|7236947|FG004|Overall Study|Adverse Event|27
4450735|NCT00514683|7236943|FG000|Overall Study|Protocol Violation|1
4450736|NCT00514683|7236944|FG001|Overall Study|Protocol Violation|1
4450737|NCT00514683|7236945|FG002|Overall Study|Protocol Violation|0
4450738|NCT00514683|7236946|FG003|Overall Study|Protocol Violation|1
4450739|NCT00514683|7236947|FG004|Overall Study|Protocol Violation|0
4450740|NCT00514683|7236943|FG000|Overall Study|Withdrawal by Subject|2
4450741|NCT00514683|7236944|FG001|Overall Study|Withdrawal by Subject|2
4450742|NCT00514683|7236945|FG002|Overall Study|Withdrawal by Subject|1
4450743|NCT00514683|7236946|FG003|Overall Study|Withdrawal by Subject|0
4450744|NCT00514683|7236947|FG004|Overall Study|Withdrawal by Subject|4
4450745|NCT00514683|7236943|FG000|Overall Study|Reason other than listed above|0
4450746|NCT00514683|7236944|FG001|Overall Study|Reason other than listed above|1
4450747|NCT00514683|7236945|FG002|Overall Study|Reason other than listed above|2
4450748|NCT00514683|7236946|FG003|Overall Study|Reason other than listed above|0
4450749|NCT00514683|7236947|FG004|Overall Study|Reason other than listed above|1
4450750|NCT00514735|7236976|FG000|Overall Study|Withdrawal by Subject|13
4450751|NCT00514735|7236977|FG001|Overall Study|Withdrawal by Subject|5
4450752|NCT00514735|7236976|FG000|Overall Study|Death|1
4450753|NCT00514735|7236977|FG001|Overall Study|Death|0
4450754|NCT00514735|7236976|FG000|Overall Study|Lost to Follow-up|0
4450755|NCT00514735|7236977|FG001|Overall Study|Lost to Follow-up|1
4450756|NCT00514904|7236996|FG000|Overall Study|Withdrawal by Subject|3
4450757|NCT00514904|7236997|FG001|Overall Study|Withdrawal by Subject|2
4450758|NCT00514904|7236996|FG000|Overall Study|Lost to Follow-up|21
4450759|NCT00514904|7236997|FG001|Overall Study|Lost to Follow-up|3
4450760|NCT00514917|7237005|FG000|Overall Study|Death|4
4450761|NCT00514917|7237006|FG001|Overall Study|Death|10
4450762|NCT00514917|7237005|FG000|Overall Study|Protocol Violation|1
4450763|NCT00514917|7237006|FG001|Overall Study|Protocol Violation|0
4450764|NCT00514917|7237005|FG000|Overall Study|Lost to Follow-up|4
4450765|NCT00514917|7237006|FG001|Overall Study|Lost to Follow-up|3
4450766|NCT00514917|7237005|FG000|Overall Study|Withdrawal by Subject|18
4450767|NCT00514917|7237006|FG001|Overall Study|Withdrawal by Subject|16
4450768|NCT00514917|7237005|FG000|Overall Study|Discontinued due to study closure|88
4450769|NCT00514917|7237006|FG001|Overall Study|Discontinued due to study closure|81
4450770|NCT00514917|7237005|FG000|Overall Study|Undefined|11
4450771|NCT00514917|7237006|FG001|Overall Study|Undefined|5
4450772|NCT00514943|7237016|FG000|Stage 1|Progressive disease|4
4450773|NCT00514943|7237017|FG001|Stage 1|Progressive disease|8
4450774|NCT00514943|7237016|FG000|Stage 1|Other Adverse Event|16
4450775|NCT00514943|7237017|FG001|Stage 1|Other Adverse Event|6
4450776|NCT00514943|7237016|FG000|Stage 1|Not treated|1
4450777|NCT00514943|7237017|FG001|Stage 1|Not treated|2
4450778|NCT00514943|7237016|FG000|Stage 1|Patient refused to continue study meds|8
4450779|NCT00514943|7237017|FG001|Stage 1|Patient refused to continue study meds|3
4450780|NCT00514943|7237016|FG000|Stage 1|Other than stated above|1
4450781|NCT00514943|7237017|FG001|Stage 1|Other than stated above|7
4450782|NCT00514943|7237016|FG000|Stage 2|Progressive disease|27
4450783|NCT00514943|7237017|FG001|Stage 2|Progressive disease|24
4450784|NCT00514943|7237016|FG000|Stage 2|Other Adverse Event|3
4450785|NCT00514943|7237017|FG001|Stage 2|Other Adverse Event|10
4450786|NCT00514943|7237016|FG000|Stage 2|Patient refused to continue study meds|2
4450787|NCT00514943|7237017|FG001|Stage 2|Patient refused to continue study meds|0
4450788|NCT00514943|7237016|FG000|Stage 2|Other than stated above|0
4450789|NCT00514943|7237017|FG001|Stage 2|Other than stated above|2
4450790|NCT00515008|7237040|FG000|Overall Study|Lost to Follow-up|1
4450791|NCT00515008|7237041|FG001|Overall Study|Lost to Follow-up|0
4450792|NCT00515008|7237040|FG000|Overall Study|Declined|0
4450793|NCT00515008|7237041|FG001|Overall Study|Declined|3
4450794|NCT00515008|7237040|FG000|Overall Study|Left the Boston Area|1
4450795|NCT00515008|7237041|FG001|Overall Study|Left the Boston Area|1
4450796|NCT00515008|7237040|FG000|Overall Study|Scheduling conflict|1
4450797|NCT00515008|7237041|FG001|Overall Study|Scheduling conflict|0
4450798|NCT00515034|7237065|FG000|Overall Study|Adverse Event|2
4450799|NCT00515034|7237066|FG001|Overall Study|Adverse Event|0
4450800|NCT00515034|7237067|FG002|Overall Study|Adverse Event|1
4450801|NCT00515034|7237068|FG003|Overall Study|Adverse Event|0
4450802|NCT00515034|7237065|FG000|Overall Study|Death|4
4450803|NCT00515034|7237066|FG001|Overall Study|Death|2
4450804|NCT00515034|7237067|FG002|Overall Study|Death|1
4450805|NCT00515034|7237068|FG003|Overall Study|Death|3
4450806|NCT00515034|7237065|FG000|Overall Study|Withdrawal by Subject|1
4450807|NCT00515034|7237066|FG001|Overall Study|Withdrawal by Subject|0
4450808|NCT00515034|7237067|FG002|Overall Study|Withdrawal by Subject|3
4450809|NCT00515034|7237068|FG003|Overall Study|Withdrawal by Subject|0
4450810|NCT00515034|7237065|FG000|Overall Study|Physician Decision|0
4450811|NCT00515034|7237066|FG001|Overall Study|Physician Decision|0
4450812|NCT00515034|7237067|FG002|Overall Study|Physician Decision|1
4450813|NCT00515034|7237068|FG003|Overall Study|Physician Decision|1
4450814|NCT00515034|7237065|FG000|Overall Study|Other|1
4450815|NCT00515034|7237066|FG001|Overall Study|Other|0
4450816|NCT00515034|7237067|FG002|Overall Study|Other|2
4450817|NCT00515034|7237068|FG003|Overall Study|Other|1
4450818|NCT00515073|7237078|FG000|Overall Study|Withdrawal by Subject|1
4450819|NCT00515073|7237078|FG000|Overall Study|Physician Decision|1
4450820|NCT00515086|7237086|FG000|Overall Study|Adverse Event|1
4450821|NCT00515086|7237087|FG001|Overall Study|Adverse Event|1
4450822|NCT00515086|7237088|FG002|Overall Study|Adverse Event|2
4450823|NCT00515086|7237089|FG003|Overall Study|Adverse Event|3
4450824|NCT00515086|7237086|FG000|Overall Study|Administrative|1
4450825|NCT00515086|7237087|FG001|Overall Study|Administrative|1
4450826|NCT00515086|7237088|FG002|Overall Study|Administrative|0
4450827|NCT00515086|7237089|FG003|Overall Study|Administrative|0
4450828|NCT00515086|7237086|FG000|Overall Study|Withdrawal by Subject|1
4450829|NCT00515086|7237087|FG001|Overall Study|Withdrawal by Subject|0
4450830|NCT00515086|7237088|FG002|Overall Study|Withdrawal by Subject|0
4450831|NCT00515086|7237089|FG003|Overall Study|Withdrawal by Subject|1
4450832|NCT00515086|7237086|FG000|Overall Study|Unsatisfactory therapeutic effect|18
4450833|NCT00515086|7237087|FG001|Overall Study|Unsatisfactory therapeutic effect|3
4450834|NCT00515086|7237088|FG002|Overall Study|Unsatisfactory therapeutic effect|3
4450835|NCT00515086|7237089|FG003|Overall Study|Unsatisfactory therapeutic effect|2
4450836|NCT00515086|7237086|FG000|Overall Study|Lost to Follow-up|1
4450837|NCT00515086|7237087|FG001|Overall Study|Lost to Follow-up|0
4450838|NCT00515086|7237088|FG002|Overall Study|Lost to Follow-up|0
4450839|NCT00515086|7237089|FG003|Overall Study|Lost to Follow-up|0
4450840|NCT00515086|7237086|FG000|Overall Study|Study drug no longer required|0
4450841|NCT00515086|7237087|FG001|Overall Study|Study drug no longer required|1
4450842|NCT00515086|7237088|FG002|Overall Study|Study drug no longer required|0
4450843|NCT00515086|7237089|FG003|Overall Study|Study drug no longer required|0
4450844|NCT00515086|7237086|FG000|Overall Study|Death|2
4450845|NCT00515086|7237087|FG001|Overall Study|Death|0
4450846|NCT00515086|7237088|FG002|Overall Study|Death|0
4450847|NCT00515086|7237089|FG003|Overall Study|Death|0
4450848|NCT00515099|7237107|FG000|Overall Study|Lost to Follow-up|0
4450849|NCT00515099|7237108|FG001|Overall Study|Lost to Follow-up|4
4450850|NCT00515099|7237107|FG000|Overall Study|Withdrawal by Subject|2
4450851|NCT00515099|7237108|FG001|Overall Study|Withdrawal by Subject|0
4450852|NCT00515099|7237107|FG000|Overall Study|IRB Recommendation|1
4450853|NCT00515099|7237108|FG001|Overall Study|IRB Recommendation|0
4450854|NCT00515216|7237133|FG000|Overall Study|Withdrawal by Subject|1
4450855|NCT00515294|7237142|FG000|Overall Study|Lost to Follow-up|3
4450856|NCT00515294|7237143|FG001|Overall Study|Lost to Follow-up|2
4450857|NCT00515294|7237144|FG002|Overall Study|Lost to Follow-up|3
4450858|NCT00515294|7237145|FG003|Overall Study|Lost to Follow-up|1
4450859|NCT00515294|7237142|FG000|Overall Study|Driver simulator problems|1
4450860|NCT00515294|7237143|FG001|Overall Study|Driver simulator problems|1
4450861|NCT00515294|7237144|FG002|Overall Study|Driver simulator problems|1
4450862|NCT00515294|7237145|FG003|Overall Study|Driver simulator problems|3
4450863|NCT00515294|7237142|FG000|Overall Study|Caffeine amount inaccurate|5
4450864|NCT00515294|7237143|FG001|Overall Study|Caffeine amount inaccurate|0
4450865|NCT00515294|7237144|FG002|Overall Study|Caffeine amount inaccurate|7
4450866|NCT00515294|7237145|FG003|Overall Study|Caffeine amount inaccurate|0
4450867|NCT00515463|7237187|FG000|Overall Study|Physician Decision|4
4450868|NCT00515463|7237188|FG001|Overall Study|Physician Decision|2
4450869|NCT00515463|7237187|FG000|Overall Study|Adverse Event|1
4450870|NCT00515463|7237188|FG001|Overall Study|Adverse Event|2
4450871|NCT00515463|7237187|FG000|Overall Study|Withdrawal by Subject|3
4450872|NCT00515463|7237188|FG001|Overall Study|Withdrawal by Subject|4
4450873|NCT00515463|7237187|FG000|Overall Study|Lost to Follow-up|6
4450874|NCT00515463|7237188|FG001|Overall Study|Lost to Follow-up|5
4450875|NCT00515463|7237187|FG000|Overall Study|Other|0
4450876|NCT00515463|7237188|FG001|Overall Study|Other|1
4450877|NCT00515502|7237195|FG000|Treatment Period 1|Adverse Event|0
4450878|NCT00515502|7237196|FG001|Treatment Period 1|Adverse Event|0
4450879|NCT00515502|7237197|FG002|Treatment Period 1|Adverse Event|0
4450880|NCT00515502|7237198|FG003|Treatment Period 1|Adverse Event|0
4450881|NCT00515502|7237199|FG004|Treatment Period 1|Adverse Event|0
4450882|NCT00515502|7237200|FG005|Treatment Period 1|Adverse Event|0
4450883|NCT00515502|7237201|FG006|Treatment Period 1|Adverse Event|1
4450884|NCT00515502|7237202|FG007|Treatment Period 1|Adverse Event|0
4450885|NCT00515502|7237203|FG008|Treatment Period 1|Adverse Event|1
4450886|NCT00515502|7237204|FG009|Treatment Period 1|Adverse Event|0
4450887|NCT00515502|7237205|FG010|Treatment Period 1|Adverse Event|0
4450888|NCT00515502|7237206|FG011|Treatment Period 1|Adverse Event|1
4450889|NCT00515502|7237195|FG000|Treatment Period 2|Adverse Event|0
4529387|NCT01056276|7347699|FG000|Treatment Period-Cycles 1-8|Physician Decision|3
4529388|NCT01056276|7347700|FG001|Treatment Period-Cycles 1-8|Physician Decision|0
4529389|NCT01056276|7347699|FG000|Treatment Period-Cycles 1-8|Death|3
4529390|NCT01056276|7347700|FG001|Treatment Period-Cycles 1-8|Death|1
4529391|NCT01056276|7347699|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1
4529392|NCT01056276|7347700|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0
4529393|NCT01056276|7347699|FG000|Maintenance Therapy|Toxicity|0
4529394|NCT01056276|7347700|FG001|Maintenance Therapy|Toxicity|2
4529395|NCT01056276|7347699|FG000|Maintenance Therapy|Progressive Disease|0
4529396|NCT01056276|7347700|FG001|Maintenance Therapy|Progressive Disease|9
4529397|NCT01056276|7347699|FG000|Maintenance Therapy|Physician Decision|0
4529398|NCT01056276|7347700|FG001|Maintenance Therapy|Physician Decision|1
4529399|NCT01056276|7347699|FG000|Maintenance Therapy|Withdrawal by Subject|0
4529400|NCT01056276|7347700|FG001|Maintenance Therapy|Withdrawal by Subject|1
4529401|NCT01056276|7347699|FG000|Maintenance Therapy|Intercurrent Illness|0
4529402|NCT01056276|7347700|FG001|Maintenance Therapy|Intercurrent Illness|1
4529403|NCT01056276|7347699|FG000|Maintenance Therapy|Continuing maintenance therapy|0
4529404|NCT01056276|7347700|FG001|Maintenance Therapy|Continuing maintenance therapy|14
4529405|NCT01056289|7347711|FG000|Open-label Phase|Adverse Event|29
4529406|NCT01056289|7347712|FG001|Open-label Phase|Adverse Event|0
4529407|NCT01056289|7347713|FG002|Open-label Phase|Adverse Event|0
4450890|NCT00515502|7237196|FG001|Treatment Period 2|Adverse Event|1
4450891|NCT00515502|7237197|FG002|Treatment Period 2|Adverse Event|0
4450892|NCT00515502|7237198|FG003|Treatment Period 2|Adverse Event|0
4450893|NCT00515502|7237199|FG004|Treatment Period 2|Adverse Event|0
4450894|NCT00515502|7237200|FG005|Treatment Period 2|Adverse Event|0
4450895|NCT00515502|7237201|FG006|Treatment Period 2|Adverse Event|0
4450896|NCT00515502|7237202|FG007|Treatment Period 2|Adverse Event|0
4450897|NCT00515502|7237203|FG008|Treatment Period 2|Adverse Event|0
4450898|NCT00515502|7237204|FG009|Treatment Period 2|Adverse Event|0
4450899|NCT00515502|7237205|FG010|Treatment Period 2|Adverse Event|0
4450900|NCT00515502|7237206|FG011|Treatment Period 2|Adverse Event|0
4450901|NCT00515541|7237236|FG000|Overall Study|Physician Decision|0
4450902|NCT00515541|7237237|FG001|Overall Study|Physician Decision|2
4450903|NCT00515541|7237238|FG002|Overall Study|Physician Decision|0
4450904|NCT00515541|7237239|FG003|Overall Study|Physician Decision|1
4450905|NCT00515541|7237236|FG000|Overall Study|No show for appointments|0
4450906|NCT00515541|7237237|FG001|Overall Study|No show for appointments|1
4450907|NCT00515541|7237238|FG002|Overall Study|No show for appointments|0
4450908|NCT00515541|7237239|FG003|Overall Study|No show for appointments|2
4450909|NCT00515541|7237236|FG000|Overall Study|Withdrawal by Subject|0
4450910|NCT00515541|7237237|FG001|Overall Study|Withdrawal by Subject|2
4450911|NCT00515541|7237238|FG002|Overall Study|Withdrawal by Subject|0
4450912|NCT00515541|7237239|FG003|Overall Study|Withdrawal by Subject|2
4450913|NCT00515619|7237249|FG000|Overall Study|Adverse Event|34
4450914|NCT00515619|7237249|FG000|Overall Study|Lack of Efficacy|92
4450915|NCT00515619|7237249|FG000|Overall Study|Withdrawal by Subject|66
4450916|NCT00515619|7237249|FG000|Overall Study|Protocol Violation|3
4450917|NCT00515619|7237249|FG000|Overall Study|Lost to Follow-up|4
4450918|NCT00515619|7237249|FG000|Overall Study|Unsatisfactory compliance|6
4450919|NCT00515619|7237249|FG000|Overall Study|Other: Site discontinuing trials|2
4450920|NCT00515619|7237249|FG000|Overall Study|Other: Subject cannot attend visits|2
4450921|NCT00515619|7237249|FG000|Overall Study|Other: Subject required surgery|1
4450922|NCT00515619|7237249|FG000|Overall Study|Other: Subject moved to another country|1
4450923|NCT00515619|7237249|FG000|Overall Study|Other: Investigator decision|1
4450924|NCT00515619|7237249|FG000|Overall Study|Other: Subject became pregnant|1
4450925|NCT00515619|7237249|FG000|Overall Study|Other: Request from sponsor|1
4450926|NCT00515619|7237249|FG000|Overall Study|Other: Drug available on license|1
4450927|NCT00515619|7237249|FG000|Overall Study|Other: Subject interested in other AED|1
4450928|NCT00515827|7237277|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1
4450929|NCT00515827|7237278|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1
4450930|NCT00515827|7237277|FG000|Second Intervention (12 Weeks)|Consent withdraw|1
4450931|NCT00515827|7237278|FG001|Second Intervention (12 Weeks)|Consent withdraw|0
4450932|NCT00516048|7237299|FG000|Overall Study|Death|0
4450933|NCT00516048|7237300|FG001|Overall Study|Death|0
4450934|NCT00516048|7237301|FG002|Overall Study|Death|1
4450935|NCT00516048|7237299|FG000|Overall Study|Subject Decision|0
4450936|NCT00516048|7237300|FG001|Overall Study|Subject Decision|2
4450937|NCT00516048|7237301|FG002|Overall Study|Subject Decision|0
4450938|NCT00516074|7237311|FG000|Overall Study|Adverse Event|0
4450939|NCT00516074|7237312|FG001|Overall Study|Adverse Event|1
4450940|NCT00516074|7237311|FG000|Overall Study|Subject Decision|4
4450941|NCT00516074|7237312|FG001|Overall Study|Subject Decision|2
4450942|NCT00516074|7237311|FG000|Overall Study|Loss of Glucose Control|2
4450943|NCT00516074|7237312|FG001|Overall Study|Loss of Glucose Control|0
4450944|NCT00516139|7237318|FG000|Overall Study|Adverse Event|27
4450945|NCT00516139|7237318|FG000|Overall Study|Lost to Follow-up|1
4450946|NCT00516139|7237318|FG000|Overall Study|Protocol Violation|1
4450947|NCT00516139|7237318|FG000|Overall Study|Withdrawal by Subject|8
4450948|NCT00516139|7237318|FG000|Overall Study|Lack of Efficacy|1
4450949|NCT00516269|7237336|FG000|Overall Study|Adverse Event|2
4450950|NCT00516269|7237337|FG001|Overall Study|Adverse Event|1
4450951|NCT00516269|7237336|FG000|Overall Study|Lost to Follow-up|0
4450952|NCT00516269|7237337|FG001|Overall Study|Lost to Follow-up|1
4450953|NCT00516269|7237336|FG000|Overall Study|Protocol Violation|0
4450954|NCT00516269|7237337|FG001|Overall Study|Protocol Violation|1
4450955|NCT00516295|7237346|FG000|Overall Study|Lack of Efficacy|2
4450956|NCT00516295|7237347|FG001|Overall Study|Lack of Efficacy|0
4450957|NCT00516295|7237348|FG002|Overall Study|Lack of Efficacy|0
4450958|NCT00516295|7237346|FG000|Overall Study|Ineligible|1
4450959|NCT00516295|7237347|FG001|Overall Study|Ineligible|0
4450960|NCT00516295|7237348|FG002|Overall Study|Ineligible|0
4450961|NCT00516321|7237358|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11
4450962|NCT00516321|7237359|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0
4450963|NCT00516321|7237360|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0
4450964|NCT00516321|7237358|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9
4450965|NCT00516321|7237359|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0
4450966|NCT00516321|7237360|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0
4450967|NCT00516321|7237358|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1
4450968|NCT00516321|7237359|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0
4450969|NCT00516321|7237360|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0
4450970|NCT00516321|7237358|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2
4450971|NCT00516321|7237359|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0
4450972|NCT00516321|7237360|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0
4450973|NCT00516321|7237358|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7
4450974|NCT00516321|7237359|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0
4450975|NCT00516321|7237360|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0
4450976|NCT00516321|7237358|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3
4450977|NCT00516321|7237359|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0
4450978|NCT00516321|7237360|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0
4450979|NCT00516321|7237358|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0
4450980|NCT00516321|7237359|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12
4450981|NCT00516321|7237360|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22
4450982|NCT00516321|7237358|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0
4450983|NCT00516321|7237359|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13
4450984|NCT00516321|7237360|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18
4450985|NCT00516321|7237358|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0
4450986|NCT00516321|7237359|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8
4450987|NCT00516321|7237360|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13
4450988|NCT00516321|7237358|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0
4450989|NCT00516321|7237359|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0
4450990|NCT00516321|7237360|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1
4450991|NCT00516321|7237358|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0
4450992|NCT00516321|7237359|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2
4450993|NCT00516321|7237360|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0
4450994|NCT00516386|7237368|FG000|Overall Study|not interested in the study|4
4450995|NCT00516386|7237368|FG000|Overall Study|Lost to Follow-up|2
4450996|NCT00516893|7237381|FG000|Overall Study|Lost to Follow-up|4
4450997|NCT00516893|7237381|FG000|Overall Study|Adverse Event|3
4450998|NCT00516893|7237381|FG000|Overall Study|Withdrawal by Subject|2
4450999|NCT00516893|7237381|FG000|Overall Study|Noncompliance|2
4451000|NCT00516893|7237381|FG000|Overall Study|Death|1
4451001|NCT00516893|7237381|FG000|Overall Study|Persistent Antibodies per Protocol|6
4451002|NCT00516893|7237381|FG000|Overall Study|Relocated|1
4451003|NCT00516893|7237381|FG000|Overall Study|Pregnancy|1
4451004|NCT00516893|7237381|FG000|Overall Study|Received Medication From Another Study|1
4451005|NCT00516906|7237387|FG000|Overall Study|Final Dressing Removal Data not captured|6
4451006|NCT00516906|7237388|FG001|Overall Study|Final Dressing Removal Data not captured|2
4451007|NCT00517296|7237407|FG000|Overall Study|Withdrawal by Subject|1
4451008|NCT00517296|7237408|FG001|Overall Study|Withdrawal by Subject|0
4451009|NCT00517413|7237414|FG000|Overall Study|Adverse Event|7
4451010|NCT00517413|7237414|FG000|Overall Study|Death|13
4451011|NCT00517413|7237414|FG000|Overall Study|Protocol Violation|15
4451012|NCT00517413|7237414|FG000|Overall Study|Withdrawal by Subject|2
4451013|NCT00517413|7237414|FG000|Overall Study|Failure to return|1
4451014|NCT00517413|7237414|FG000|Overall Study|Other-Reasons|23
4451015|NCT00517634|7237475|FG000|Second Treatment Period|Withdrawal by Subject|0
4451016|NCT00517634|7237476|FG001|Second Treatment Period|Withdrawal by Subject|0
4451017|NCT00517634|7237477|FG002|Second Treatment Period|Withdrawal by Subject|0
4451018|NCT00517634|7237478|FG003|Second Treatment Period|Withdrawal by Subject|0
4451019|NCT00517634|7237479|FG004|Second Treatment Period|Withdrawal by Subject|1
4451020|NCT00517634|7237480|FG005|Second Treatment Period|Withdrawal by Subject|0
4515790|NCT00955474|7326735|FG000|Overall Study|Physician Decision|7
4515791|NCT00955474|7326736|FG001|Overall Study|Physician Decision|5
4515792|NCT00955617|7326776|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2
4515793|NCT00955617|7326777|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1
4515794|NCT00955617|7326776|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0
4515795|NCT00955617|7326777|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1
4515796|NCT00955617|7326776|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0
4515797|NCT00955617|7326777|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1
4515798|NCT00955617|7326776|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1
4515799|NCT00955617|7326777|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0
4529408|NCT01056289|7347714|FG003|Open-label Phase|Adverse Event|0
4529409|NCT01056289|7347711|FG000|Open-label Phase|Lost to Follow-up|30
4529410|NCT01056289|7347712|FG001|Open-label Phase|Lost to Follow-up|0
4529411|NCT01056289|7347713|FG002|Open-label Phase|Lost to Follow-up|0
4529412|NCT01056289|7347714|FG003|Open-label Phase|Lost to Follow-up|0
4529413|NCT01056289|7347711|FG000|Open-label Phase|Other|9
4529414|NCT01056289|7347712|FG001|Open-label Phase|Other|0
4529415|NCT01056289|7347713|FG002|Open-label Phase|Other|0
4529416|NCT01056289|7347714|FG003|Open-label Phase|Other|0
4529417|NCT01056289|7347711|FG000|Open-label Phase|Protocol Violation|6
4529418|NCT01056289|7347712|FG001|Open-label Phase|Protocol Violation|0
4529419|NCT01056289|7347713|FG002|Open-label Phase|Protocol Violation|0
4529420|NCT01056289|7347714|FG003|Open-label Phase|Protocol Violation|0
4529421|NCT01056289|7347711|FG000|Open-label Phase|Withdrawal by Subject|26
4529422|NCT01056289|7347712|FG001|Open-label Phase|Withdrawal by Subject|0
4529423|NCT01056289|7347713|FG002|Open-label Phase|Withdrawal by Subject|0
4529424|NCT01056289|7347714|FG003|Open-label Phase|Withdrawal by Subject|0
4529425|NCT01056289|7347711|FG000|Open-label Phase|Lack of Efficacy|18
4451021|NCT00517751|7237488|FG000|Overall Study|Death|3
4451022|NCT00517751|7237488|FG000|Overall Study|Withdrawal by Subject|37
4451023|NCT00517751|7237488|FG000|Overall Study|Lost to Follow-up|4
4451024|NCT00517751|7237488|FG000|Overall Study|patient not over due|6
4451025|NCT00517751|7237488|FG000|Overall Study|Patient not due for visit|76
4451026|NCT00517751|7237488|FG000|Overall Study|Missing|3
4451027|NCT00517829|7237494|FG000|Overall Study|Adverse Event|22
4451028|NCT00517829|7237495|FG001|Overall Study|Adverse Event|34
4451029|NCT00517829|7237494|FG000|Overall Study|Disease Progression|39
4451030|NCT00517829|7237495|FG001|Overall Study|Disease Progression|32
4451031|NCT00517829|7237494|FG000|Overall Study|Patient Request|6
4451032|NCT00517829|7237495|FG001|Overall Study|Patient Request|5
4451033|NCT00517829|7237494|FG000|Overall Study|Investigator Request|5
4451034|NCT00517829|7237495|FG001|Overall Study|Investigator Request|3
4451035|NCT00517829|7237494|FG000|Overall Study|Other|3
4451036|NCT00517829|7237495|FG001|Overall Study|Other|1
4451037|NCT00517881|7237501|FG000|Overall Study|Protocol Violation|2
4451038|NCT00517881|7237501|FG000|Overall Study|Adverse Event|1
4451039|NCT00517881|7237501|FG000|Overall Study|Renal transplantation|2
4451040|NCT00517933|7237507|FG000|Period 1|Death|2
4451041|NCT00517933|7237508|FG001|Period 1|Death|1
4451042|NCT00517933|7237507|FG000|Period 1|Adverse Event|4
4451043|NCT00517933|7237508|FG001|Period 1|Adverse Event|4
4451044|NCT00517933|7237507|FG000|Period 1|Lost to Follow-up|2
4451045|NCT00517933|7237508|FG001|Period 1|Lost to Follow-up|0
4451046|NCT00517933|7237507|FG000|Period 1|Underwent lung transplant|0
4451047|NCT00517933|7237508|FG001|Period 1|Underwent lung transplant|1
4451048|NCT00517933|7237507|FG000|Period 2|Death|2
4451049|NCT00517933|7237508|FG001|Period 2|Death|4
4451050|NCT00517933|7237507|FG000|Period 2|Adverse Event|2
4451051|NCT00517933|7237508|FG001|Period 2|Adverse Event|4
4451052|NCT00517933|7237507|FG000|Period 2|Physician Decision|1
4451053|NCT00517933|7237508|FG001|Period 2|Physician Decision|0
4451054|NCT00517933|7237507|FG000|Period 2|Withdrawal by Subject|1
4451055|NCT00517933|7237508|FG001|Period 2|Withdrawal by Subject|3
4451056|NCT00517933|7237507|FG000|Period 2|Underwent lung transplant|0
4451057|NCT00517933|7237508|FG001|Period 2|Underwent lung transplant|2
4451058|NCT00518011|7237519|FG000|Overall Study|Death|1
4451059|NCT00518011|7237520|FG001|Overall Study|Death|1
4451060|NCT00518011|7237519|FG000|Overall Study|Adverse Event|2
4451061|NCT00518011|7237520|FG001|Overall Study|Adverse Event|3
4451062|NCT00518011|7237519|FG000|Overall Study|Disease Progression|2
4451063|NCT00518011|7237520|FG001|Overall Study|Disease Progression|2
4451064|NCT00518011|7237519|FG000|Overall Study|Other Reasons|3
4451065|NCT00518011|7237520|FG001|Overall Study|Other Reasons|2
4451066|NCT00518011|7237519|FG000|Overall Study|Withdrawal by Subject|1
4451067|NCT00518011|7237520|FG001|Overall Study|Withdrawal by Subject|0
4451068|NCT00518115|7237546|FG000|Overall Study|Adverse Event|6
4451069|NCT00518115|7237547|FG001|Overall Study|Adverse Event|1
4451070|NCT00518115|7237548|FG002|Overall Study|Adverse Event|5
4451071|NCT00518115|7237549|FG003|Overall Study|Adverse Event|6
4451072|NCT00518115|7237550|FG004|Overall Study|Adverse Event|5
4451073|NCT00518115|7237551|FG005|Overall Study|Adverse Event|5
4451074|NCT00518115|7237552|FG006|Overall Study|Adverse Event|5
4451075|NCT00518115|7237553|FG007|Overall Study|Adverse Event|10
4451076|NCT00518115|7237554|FG008|Overall Study|Adverse Event|2
4451077|NCT00518115|7237555|FG009|Overall Study|Adverse Event|9
4451078|NCT00518115|7237546|FG000|Overall Study|Lost to Follow-up|0
4451079|NCT00518115|7237547|FG001|Overall Study|Lost to Follow-up|0
4451080|NCT00518115|7237548|FG002|Overall Study|Lost to Follow-up|2
4451081|NCT00518115|7237549|FG003|Overall Study|Lost to Follow-up|3
4451082|NCT00518115|7237550|FG004|Overall Study|Lost to Follow-up|1
4451083|NCT00518115|7237551|FG005|Overall Study|Lost to Follow-up|3
4451084|NCT00518115|7237552|FG006|Overall Study|Lost to Follow-up|0
4451085|NCT00518115|7237553|FG007|Overall Study|Lost to Follow-up|1
4451086|NCT00518115|7237554|FG008|Overall Study|Lost to Follow-up|1
4451087|NCT00518115|7237555|FG009|Overall Study|Lost to Follow-up|1
4451088|NCT00518115|7237546|FG000|Overall Study|Protocol Violation|1
4451089|NCT00518115|7237547|FG001|Overall Study|Protocol Violation|3
4451090|NCT00518115|7237548|FG002|Overall Study|Protocol Violation|1
4451091|NCT00518115|7237549|FG003|Overall Study|Protocol Violation|0
4451092|NCT00518115|7237550|FG004|Overall Study|Protocol Violation|0
4451093|NCT00518115|7237551|FG005|Overall Study|Protocol Violation|0
4451094|NCT00518115|7237552|FG006|Overall Study|Protocol Violation|0
4451095|NCT00518115|7237553|FG007|Overall Study|Protocol Violation|0
4451096|NCT00518115|7237554|FG008|Overall Study|Protocol Violation|0
4451097|NCT00518115|7237555|FG009|Overall Study|Protocol Violation|0
4451098|NCT00518115|7237546|FG000|Overall Study|Withdrawal by Subject|1
4451099|NCT00518115|7237547|FG001|Overall Study|Withdrawal by Subject|1
4451100|NCT00518115|7237548|FG002|Overall Study|Withdrawal by Subject|5
4451101|NCT00518115|7237549|FG003|Overall Study|Withdrawal by Subject|0
4451102|NCT00518115|7237550|FG004|Overall Study|Withdrawal by Subject|2
4451103|NCT00518115|7237551|FG005|Overall Study|Withdrawal by Subject|1
4451104|NCT00518115|7237552|FG006|Overall Study|Withdrawal by Subject|0
4451105|NCT00518115|7237553|FG007|Overall Study|Withdrawal by Subject|2
4451106|NCT00518115|7237554|FG008|Overall Study|Withdrawal by Subject|1
4451107|NCT00518115|7237555|FG009|Overall Study|Withdrawal by Subject|3
4451108|NCT00518115|7237546|FG000|Overall Study|Lack of Efficacy|1
4451109|NCT00518115|7237547|FG001|Overall Study|Lack of Efficacy|0
4451110|NCT00518115|7237548|FG002|Overall Study|Lack of Efficacy|1
4451111|NCT00518115|7237549|FG003|Overall Study|Lack of Efficacy|1
4451112|NCT00518115|7237550|FG004|Overall Study|Lack of Efficacy|0
4451113|NCT00518115|7237551|FG005|Overall Study|Lack of Efficacy|0
4451114|NCT00518115|7237552|FG006|Overall Study|Lack of Efficacy|0
4451115|NCT00518115|7237553|FG007|Overall Study|Lack of Efficacy|1
4451116|NCT00518115|7237554|FG008|Overall Study|Lack of Efficacy|0
4451117|NCT00518115|7237555|FG009|Overall Study|Lack of Efficacy|0
4451118|NCT00518115|7237546|FG000|Overall Study|Non-Compliance|1
4451119|NCT00518115|7237547|FG001|Overall Study|Non-Compliance|0
4451120|NCT00518115|7237548|FG002|Overall Study|Non-Compliance|1
4451121|NCT00518115|7237549|FG003|Overall Study|Non-Compliance|0
4451122|NCT00518115|7237550|FG004|Overall Study|Non-Compliance|1
4451123|NCT00518115|7237551|FG005|Overall Study|Non-Compliance|1
4451124|NCT00518115|7237552|FG006|Overall Study|Non-Compliance|1
4451125|NCT00518115|7237553|FG007|Overall Study|Non-Compliance|1
4529426|NCT01056289|7347712|FG001|Open-label Phase|Lack of Efficacy|0
4529427|NCT01056289|7347713|FG002|Open-label Phase|Lack of Efficacy|0
4529428|NCT01056289|7347714|FG003|Open-label Phase|Lack of Efficacy|0
4529429|NCT01056289|7347711|FG000|Open-label Phase|Not randomized to Double-blind phase|1
4529430|NCT01056289|7347712|FG001|Open-label Phase|Not randomized to Double-blind phase|0
4529431|NCT01056289|7347713|FG002|Open-label Phase|Not randomized to Double-blind phase|0
4529432|NCT01056289|7347714|FG003|Open-label Phase|Not randomized to Double-blind phase|0
4529433|NCT01056289|7347711|FG000|Double-blind Phase|Adverse Event|0
4529434|NCT01056289|7347712|FG001|Double-blind Phase|Adverse Event|1
4529435|NCT01056289|7347713|FG002|Double-blind Phase|Adverse Event|2
4529436|NCT01056289|7347714|FG003|Double-blind Phase|Adverse Event|1
4529437|NCT01056289|7347711|FG000|Double-blind Phase|Lost to Follow-up|0
4529438|NCT01056289|7347712|FG001|Double-blind Phase|Lost to Follow-up|2
4529439|NCT01056289|7347713|FG002|Double-blind Phase|Lost to Follow-up|2
4529440|NCT01056289|7347714|FG003|Double-blind Phase|Lost to Follow-up|2
4529441|NCT01056289|7347711|FG000|Double-blind Phase|Other|0
4529442|NCT01056289|7347712|FG001|Double-blind Phase|Other|0
4529443|NCT01056289|7347713|FG002|Double-blind Phase|Other|1
4529444|NCT01056289|7347714|FG003|Double-blind Phase|Other|2
4609309|NCT01685203|7464967|FG005|Overall Study|Lost to Follow-up|0
4609310|NCT01685203|7464968|FG006|Overall Study|Lost to Follow-up|0
4609311|NCT01685203|7464962|FG000|Overall Study|Adverse Event|0
4609312|NCT01685203|7464963|FG001|Overall Study|Adverse Event|0
4609313|NCT01685203|7464964|FG002|Overall Study|Adverse Event|0
4609314|NCT01685203|7464965|FG003|Overall Study|Adverse Event|0
4609315|NCT01685203|7464966|FG004|Overall Study|Adverse Event|0
4609316|NCT01685203|7464967|FG005|Overall Study|Adverse Event|2
4609317|NCT01685203|7464968|FG006|Overall Study|Adverse Event|0
4609318|NCT01685203|7464962|FG000|Overall Study|Adverse event and withdrew consent|1
4609319|NCT01685203|7464963|FG001|Overall Study|Adverse event and withdrew consent|0
4609320|NCT01685203|7464964|FG002|Overall Study|Adverse event and withdrew consent|0
4609321|NCT01685203|7464965|FG003|Overall Study|Adverse event and withdrew consent|0
4609322|NCT01685203|7464966|FG004|Overall Study|Adverse event and withdrew consent|0
4609323|NCT01685203|7464967|FG005|Overall Study|Adverse event and withdrew consent|0
4609324|NCT01685203|7464968|FG006|Overall Study|Adverse event and withdrew consent|0
4609325|NCT01685203|7464962|FG000|Overall Study|Patient's decision|0
4609326|NCT01685203|7464963|FG001|Overall Study|Patient's decision|0
4609327|NCT01685203|7464964|FG002|Overall Study|Patient's decision|0
4609328|NCT01685203|7464965|FG003|Overall Study|Patient's decision|0
4609329|NCT01685203|7464966|FG004|Overall Study|Patient's decision|0
4609330|NCT01685203|7464967|FG005|Overall Study|Patient's decision|1
4609331|NCT01685203|7464968|FG006|Overall Study|Patient's decision|0
4609332|NCT01685216|7464984|FG000|Overall Study|Did not receive study drug|1
4609333|NCT01685229|7464990|FG000|Overall Study|Subjects missing Study Exit form|3
4609334|NCT01685229|7464991|FG001|Overall Study|Subjects missing Study Exit form|1
4609335|NCT01685229|7464990|FG000|Overall Study|Lost to Follow-up|16
4609336|NCT01685229|7464991|FG001|Overall Study|Lost to Follow-up|10
4609337|NCT01685229|7464990|FG000|Overall Study|Withdrawal by Subject|6
4609338|NCT01685229|7464991|FG001|Overall Study|Withdrawal by Subject|5
4609339|NCT01685229|7464990|FG000|Overall Study|Death|1
4609340|NCT01685229|7464991|FG001|Overall Study|Death|0
4609341|NCT01685372|7465020|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3
4609342|NCT01685372|7465021|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4
4609343|NCT01685437|7465031|FG000|Overall Study|Withdrawal by Subject|22
4609344|NCT01685437|7465031|FG000|Overall Study|Lost to Follow-up|3
4609345|NCT01685437|7465031|FG000|Overall Study|Adverse Event|1
4609346|NCT01685437|7465031|FG000|Overall Study|Protocol Violation|4
4609347|NCT01685437|7465031|FG000|Overall Study|Unable to make visits due to work|1
4609348|NCT01685697|7465062|FG000|Overall Study|Protocol Violation|3
4609349|NCT01685697|7465063|FG001|Overall Study|Protocol Violation|3
4609350|NCT01685801|7465073|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
4609351|NCT01685801|7465074|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
4609352|NCT01685801|7465075|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
4609353|NCT01685801|7465076|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1
4609354|NCT01685801|7465073|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0
4609355|NCT01685801|7465074|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1
4451126|NCT00518115|7237554|FG008|Overall Study|Non-Compliance|0
4451127|NCT00518115|7237555|FG009|Overall Study|Non-Compliance|1
4451128|NCT00518115|7237546|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1
4451129|NCT00518115|7237547|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1
4451130|NCT00518115|7237548|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0
4451131|NCT00518115|7237549|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0
4451132|NCT00518115|7237550|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0
4451133|NCT00518115|7237551|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4
4451134|NCT00518115|7237552|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0
4451135|NCT00518115|7237553|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0
4451136|NCT00518115|7237554|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0
4451137|NCT00518115|7237555|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0
4451138|NCT00518115|7237546|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1
4451139|NCT00518115|7237547|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0
4451140|NCT00518115|7237548|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0
4451141|NCT00518115|7237549|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0
4451142|NCT00518115|7237550|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0
4451143|NCT00518115|7237551|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0
4451144|NCT00518115|7237552|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0
4451145|NCT00518115|7237553|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0
4451146|NCT00518115|7237554|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0
4451147|NCT00518115|7237555|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0
4451148|NCT00518115|7237546|FG000|Overall Study|Different Monotherapy Diabetic Drug|0
4451149|NCT00518115|7237547|FG001|Overall Study|Different Monotherapy Diabetic Drug|0
4451150|NCT00518115|7237548|FG002|Overall Study|Different Monotherapy Diabetic Drug|1
4451151|NCT00518115|7237549|FG003|Overall Study|Different Monotherapy Diabetic Drug|0
4451152|NCT00518115|7237550|FG004|Overall Study|Different Monotherapy Diabetic Drug|0
4451153|NCT00518115|7237551|FG005|Overall Study|Different Monotherapy Diabetic Drug|0
4451154|NCT00518115|7237552|FG006|Overall Study|Different Monotherapy Diabetic Drug|0
4451155|NCT00518115|7237553|FG007|Overall Study|Different Monotherapy Diabetic Drug|0
4451156|NCT00518115|7237554|FG008|Overall Study|Different Monotherapy Diabetic Drug|1
4451157|NCT00518115|7237555|FG009|Overall Study|Different Monotherapy Diabetic Drug|0
4451158|NCT00518115|7237546|FG000|Overall Study|Wrong Monotherapy Administered|0
4451159|NCT00518115|7237547|FG001|Overall Study|Wrong Monotherapy Administered|0
4451160|NCT00518115|7237548|FG002|Overall Study|Wrong Monotherapy Administered|1
4451161|NCT00518115|7237549|FG003|Overall Study|Wrong Monotherapy Administered|0
4451162|NCT00518115|7237550|FG004|Overall Study|Wrong Monotherapy Administered|0
4451163|NCT00518115|7237551|FG005|Overall Study|Wrong Monotherapy Administered|0
4451164|NCT00518115|7237552|FG006|Overall Study|Wrong Monotherapy Administered|1
4451165|NCT00518115|7237553|FG007|Overall Study|Wrong Monotherapy Administered|0
4451166|NCT00518115|7237554|FG008|Overall Study|Wrong Monotherapy Administered|0
4451167|NCT00518115|7237555|FG009|Overall Study|Wrong Monotherapy Administered|0
4451168|NCT00518115|7237546|FG000|Overall Study|Violation of Exclusion Criteria|0
4451169|NCT00518115|7237547|FG001|Overall Study|Violation of Exclusion Criteria|0
4451170|NCT00518115|7237548|FG002|Overall Study|Violation of Exclusion Criteria|0
4451171|NCT00518115|7237549|FG003|Overall Study|Violation of Exclusion Criteria|1
4451172|NCT00518115|7237550|FG004|Overall Study|Violation of Exclusion Criteria|0
4451173|NCT00518115|7237551|FG005|Overall Study|Violation of Exclusion Criteria|0
4451174|NCT00518115|7237552|FG006|Overall Study|Violation of Exclusion Criteria|1
4451175|NCT00518115|7237553|FG007|Overall Study|Violation of Exclusion Criteria|0
4451176|NCT00518115|7237554|FG008|Overall Study|Violation of Exclusion Criteria|0
4451177|NCT00518115|7237555|FG009|Overall Study|Violation of Exclusion Criteria|0
4451178|NCT00518115|7237546|FG000|Overall Study|Family Emergency; Had to Go to England|0
4451179|NCT00518115|7237547|FG001|Overall Study|Family Emergency; Had to Go to England|0
4451180|NCT00518115|7237548|FG002|Overall Study|Family Emergency; Had to Go to England|0
4451181|NCT00518115|7237549|FG003|Overall Study|Family Emergency; Had to Go to England|0
4451182|NCT00518115|7237550|FG004|Overall Study|Family Emergency; Had to Go to England|1
4451183|NCT00518115|7237551|FG005|Overall Study|Family Emergency; Had to Go to England|0
4451184|NCT00518115|7237552|FG006|Overall Study|Family Emergency; Had to Go to England|0
4451185|NCT00518115|7237553|FG007|Overall Study|Family Emergency; Had to Go to England|0
4451186|NCT00518115|7237554|FG008|Overall Study|Family Emergency; Had to Go to England|0
4451187|NCT00518115|7237555|FG009|Overall Study|Family Emergency; Had to Go to England|0
4451188|NCT00518115|7237546|FG000|Overall Study|Withdrew Consent|0
4451189|NCT00518115|7237547|FG001|Overall Study|Withdrew Consent|0
4451190|NCT00518115|7237548|FG002|Overall Study|Withdrew Consent|0
4451191|NCT00518115|7237549|FG003|Overall Study|Withdrew Consent|0
4451192|NCT00518115|7237550|FG004|Overall Study|Withdrew Consent|0
4451193|NCT00518115|7237551|FG005|Overall Study|Withdrew Consent|1
4451194|NCT00518115|7237552|FG006|Overall Study|Withdrew Consent|0
4451195|NCT00518115|7237553|FG007|Overall Study|Withdrew Consent|0
4451196|NCT00518115|7237554|FG008|Overall Study|Withdrew Consent|0
4451197|NCT00518115|7237555|FG009|Overall Study|Withdrew Consent|0
4451198|NCT00518115|7237546|FG000|Overall Study|Moved Out of State|0
4451199|NCT00518115|7237547|FG001|Overall Study|Moved Out of State|0
4451200|NCT00518115|7237548|FG002|Overall Study|Moved Out of State|0
4451201|NCT00518115|7237549|FG003|Overall Study|Moved Out of State|0
4451202|NCT00518115|7237550|FG004|Overall Study|Moved Out of State|0
4451203|NCT00518115|7237551|FG005|Overall Study|Moved Out of State|0
4451204|NCT00518115|7237552|FG006|Overall Study|Moved Out of State|0
4451205|NCT00518115|7237553|FG007|Overall Study|Moved Out of State|0
4451206|NCT00518115|7237554|FG008|Overall Study|Moved Out of State|0
4451207|NCT00518115|7237555|FG009|Overall Study|Moved Out of State|1
4451208|NCT00518180|7237585|FG000|Overall Study|Withdrawal by Subject|29
4451209|NCT00518180|7237586|FG001|Overall Study|Withdrawal by Subject|30
4451210|NCT00518180|7237587|FG002|Overall Study|Withdrawal by Subject|42
4451211|NCT00518180|7237585|FG000|Overall Study|Lost to Follow-up|30
4451212|NCT00518180|7237586|FG001|Overall Study|Lost to Follow-up|28
4451213|NCT00518180|7237587|FG002|Overall Study|Lost to Follow-up|34
4451214|NCT00518180|7237585|FG000|Overall Study|Administrative reason|0
4451215|NCT00518180|7237586|FG001|Overall Study|Administrative reason|2
4451216|NCT00518180|7237587|FG002|Overall Study|Administrative reason|2
4451217|NCT00518180|7237585|FG000|Overall Study|Protocol Violation|5
4451218|NCT00518180|7237586|FG001|Overall Study|Protocol Violation|7
4451219|NCT00518180|7237587|FG002|Overall Study|Protocol Violation|4
4451220|NCT00518180|7237585|FG000|Overall Study|Unable to classify|0
4451221|NCT00518180|7237586|FG001|Overall Study|Unable to classify|2
4451222|NCT00518180|7237587|FG002|Overall Study|Unable to classify|0
4451223|NCT00518180|7237585|FG000|Overall Study|Adverse Event|1
4451224|NCT00518180|7237586|FG001|Overall Study|Adverse Event|0
4451225|NCT00518180|7237587|FG002|Overall Study|Adverse Event|0
4451226|NCT00518206|7237606|FG000|Overall Study|Disease Progression Requiring Therapy|6
4451227|NCT00518206|7237607|FG001|Overall Study|Disease Progression Requiring Therapy|6
4451228|NCT00518206|7237606|FG000|Overall Study|Withdrawal by Subject|2
4451229|NCT00518206|7237607|FG001|Overall Study|Withdrawal by Subject|0
4451230|NCT00518206|7237606|FG000|Overall Study|Drug Supply Issue|1
4451231|NCT00518206|7237607|FG001|Overall Study|Drug Supply Issue|0
4451232|NCT00518206|7237606|FG000|Overall Study|Reason Unknown|1
4451233|NCT00518206|7237607|FG001|Overall Study|Reason Unknown|0
4451234|NCT00518206|7237606|FG000|Overall Study|Completion Status Unknown|1
4451235|NCT00518206|7237607|FG001|Overall Study|Completion Status Unknown|0
4451236|NCT00518284|7237617|FG000|Overall Study|Adverse Event|0
4451237|NCT00518284|7237618|FG001|Overall Study|Adverse Event|1
4451238|NCT00518284|7237619|FG002|Overall Study|Adverse Event|0
4451239|NCT00518284|7237620|FG003|Overall Study|Adverse Event|0
4451240|NCT00518284|7237617|FG000|Overall Study|Study Termination|0
4451241|NCT00518284|7237618|FG001|Overall Study|Study Termination|2
4451242|NCT00518284|7237619|FG002|Overall Study|Study Termination|1
4451243|NCT00518284|7237620|FG003|Overall Study|Study Termination|2
4451244|NCT00518323|7237634|FG000|Overall Study|Lack of Efficacy|14
4451245|NCT00518323|7237635|FG001|Overall Study|Lack of Efficacy|2
4451246|NCT00518323|7237636|FG002|Overall Study|Lack of Efficacy|4
4451247|NCT00518323|7237637|FG003|Overall Study|Lack of Efficacy|20
4451248|NCT00518323|7237634|FG000|Overall Study|Withdrawal by Subject|1
4451249|NCT00518323|7237635|FG001|Overall Study|Withdrawal by Subject|2
4451250|NCT00518323|7237636|FG002|Overall Study|Withdrawal by Subject|4
4451251|NCT00518323|7237637|FG003|Overall Study|Withdrawal by Subject|2
4451252|NCT00518323|7237634|FG000|Overall Study|Lost to Follow-up|0
4451253|NCT00518323|7237635|FG001|Overall Study|Lost to Follow-up|2
4451254|NCT00518323|7237636|FG002|Overall Study|Lost to Follow-up|1
4451255|NCT00518323|7237637|FG003|Overall Study|Lost to Follow-up|3
4451256|NCT00518323|7237634|FG000|Overall Study|Adverse Event|1
4451257|NCT00518323|7237635|FG001|Overall Study|Adverse Event|1
4451258|NCT00518323|7237636|FG002|Overall Study|Adverse Event|1
4451259|NCT00518323|7237637|FG003|Overall Study|Adverse Event|0
4451260|NCT00518323|7237634|FG000|Overall Study|Prohibited medication and others|3
4451261|NCT00518323|7237635|FG001|Overall Study|Prohibited medication and others|1
4451262|NCT00518323|7237636|FG002|Overall Study|Prohibited medication and others|1
4451263|NCT00518323|7237637|FG003|Overall Study|Prohibited medication and others|0
4451264|NCT00518336|7237649|FG000|Year 7|Lost to Follow-up|2
4451265|NCT00518336|7237650|FG001|Year 7|Lost to Follow-up|0
4451266|NCT00518336|7237649|FG000|Year 7|Could not attend in time|0
4451267|NCT00518336|7237650|FG001|Year 7|Could not attend in time|3
4451268|NCT00518336|7237649|FG000|Year 8|Lost to Follow-up|1
4451269|NCT00518336|7237650|FG001|Year 8|Lost to Follow-up|1
4451270|NCT00518336|7237649|FG000|Year 8|Could not attend in time|0
4451271|NCT00518336|7237650|FG001|Year 8|Could not attend in time|1
4451272|NCT00518336|7237649|FG000|Year 9|Migrated/moved from study area|1
4451273|NCT00518336|7237650|FG001|Year 9|Migrated/moved from study area|1
4451274|NCT00518336|7237649|FG000|Year 9|Lost to Follow-up|3
4451275|NCT00518336|7237650|FG001|Year 9|Lost to Follow-up|0
4451276|NCT00518336|7237649|FG000|Year 9|Personal reasons|1
4451277|NCT00518336|7237650|FG001|Year 9|Personal reasons|0
4451278|NCT00518531|7237667|FG000|Treatment Period 1|Adverse Event|5
4451279|NCT00518531|7237668|FG001|Treatment Period 1|Adverse Event|0
4451280|NCT00518531|7237667|FG000|Treatment Period 1|Lost to Follow-up|5
4451281|NCT00518531|7237668|FG001|Treatment Period 1|Lost to Follow-up|3
4451282|NCT00518531|7237667|FG000|Treatment Period 1|Physician Decision|1
4451283|NCT00518531|7237668|FG001|Treatment Period 1|Physician Decision|0
4451284|NCT00518531|7237667|FG000|Treatment Period 1|Protocol Violation|2
4451285|NCT00518531|7237668|FG001|Treatment Period 1|Protocol Violation|0
4451286|NCT00518531|7237667|FG000|Treatment Period 1|Withdrawal by Subject|4
4451287|NCT00518531|7237668|FG001|Treatment Period 1|Withdrawal by Subject|6
4451288|NCT00518531|7237667|FG000|Treatment Period 1|Early crossover|1
4451289|NCT00518531|7237668|FG001|Treatment Period 1|Early crossover|3
4451290|NCT00518531|7237667|FG000|Treatment Period 2|Withdrawal by Subject|0
4451291|NCT00518531|7237668|FG001|Treatment Period 2|Withdrawal by Subject|8
4451292|NCT00518531|7237667|FG000|Treatment Period 2|Complete out of scheduled visit window|1
4451293|NCT00518531|7237668|FG001|Treatment Period 2|Complete out of scheduled visit window|2
4451294|NCT00518531|7237667|FG000|Treatment Period 2|Adverse Event|1
4451295|NCT00518531|7237668|FG001|Treatment Period 2|Adverse Event|7
4451296|NCT00518531|7237667|FG000|Treatment Period 2|Protocol-specified criteria|0
4451297|NCT00518531|7237668|FG001|Treatment Period 2|Protocol-specified criteria|1
4451298|NCT00518531|7237667|FG000|Treatment Period 2|Non-compliance|1
4451299|NCT00518531|7237668|FG001|Treatment Period 2|Non-compliance|2
4451300|NCT00518622|7237684|FG000|Overall Study|Lost to Follow-up|0
4451301|NCT00518622|7237685|FG001|Overall Study|Lost to Follow-up|0
4451302|NCT00518622|7237686|FG002|Overall Study|Lost to Follow-up|1
4451303|NCT00518622|7237687|FG003|Overall Study|Lost to Follow-up|0
4451304|NCT00518622|7237688|FG004|Overall Study|Lost to Follow-up|0
4451305|NCT00518622|7237689|FG005|Overall Study|Lost to Follow-up|0
4451306|NCT00518622|7237690|FG006|Overall Study|Lost to Follow-up|0
4451307|NCT00518622|7237691|FG007|Overall Study|Lost to Follow-up|0
4451308|NCT00518622|7237684|FG000|Overall Study|Study medication taken incorrectly|0
4451309|NCT00518622|7237685|FG001|Overall Study|Study medication taken incorrectly|1
4451310|NCT00518622|7237686|FG002|Overall Study|Study medication taken incorrectly|0
4451311|NCT00518622|7237687|FG003|Overall Study|Study medication taken incorrectly|0
4451312|NCT00518622|7237688|FG004|Overall Study|Study medication taken incorrectly|0
4451313|NCT00518622|7237689|FG005|Overall Study|Study medication taken incorrectly|0
4451314|NCT00518622|7237690|FG006|Overall Study|Study medication taken incorrectly|0
4451315|NCT00518622|7237691|FG007|Overall Study|Study medication taken incorrectly|0
4451316|NCT00518687|7237711|FG000|Overall Study|Adverse Event|201
4451317|NCT00518687|7237712|FG001|Overall Study|Adverse Event|177
4451318|NCT00518687|7237711|FG000|Overall Study|Lost to Follow-up|144
4451319|NCT00518687|7237712|FG001|Overall Study|Lost to Follow-up|155
4451320|NCT00518687|7237711|FG000|Overall Study|Physician Decision|42
4451321|NCT00518687|7237712|FG001|Overall Study|Physician Decision|48
4451322|NCT00518687|7237711|FG000|Overall Study|Progressive disease|2
4451323|NCT00518687|7237712|FG001|Overall Study|Progressive disease|2
4451324|NCT00518687|7237711|FG000|Overall Study|Protocol Violation|8
4451325|NCT00518687|7237712|FG001|Overall Study|Protocol Violation|10
4451326|NCT00518687|7237711|FG000|Overall Study|Study terminated by sponsor|930
4451327|NCT00518687|7237712|FG001|Overall Study|Study terminated by sponsor|918
4451328|NCT00518687|7237711|FG000|Overall Study|Withdrawal by Subject|110
4451329|NCT00518687|7237712|FG001|Overall Study|Withdrawal by Subject|110
4451330|NCT00518882|7237737|FG000|Double-Blind, Week 0-26|Adverse Event|23
4451331|NCT00518882|7237738|FG001|Double-Blind, Week 0-26|Adverse Event|31
4451332|NCT00518882|7237737|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1
4451333|NCT00518882|7237738|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0
4451334|NCT00518882|7237737|FG000|Double-Blind, Week 0-26|Protocol Violation|4
4451335|NCT00518882|7237738|FG001|Double-Blind, Week 0-26|Protocol Violation|3
4451336|NCT00518882|7237737|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1
4451337|NCT00518882|7237738|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1
4451338|NCT00518882|7237737|FG000|Double-Blind, Week 0-26|Lost to follow up|2
4451339|NCT00518882|7237738|FG001|Double-Blind, Week 0-26|Lost to follow up|1
4451340|NCT00518882|7237737|FG000|Double-Blind, Week 0-26|Subject decision|1
4451341|NCT00518882|7237738|FG001|Double-Blind, Week 0-26|Subject decision|1
4451342|NCT00518882|7237737|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1
4451343|NCT00518882|7237738|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3
4451344|NCT00518882|7237737|FG000|Double-Blind, Week 0-26|Loss of trust|0
4451345|NCT00518882|7237738|FG001|Double-Blind, Week 0-26|Loss of trust|1
4451346|NCT00518882|7237737|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0
4451347|NCT00518882|7237738|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1
4451348|NCT00518882|7237737|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0
4451349|NCT00518882|7237738|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2
4451350|NCT00518882|7237737|FG000|Double-Blind, Week 0-26|Mutual consent|0
4451351|NCT00518882|7237738|FG001|Double-Blind, Week 0-26|Mutual consent|1
4451352|NCT00518882|7237737|FG000|Open-Label Extension, Week 26-78|Adverse Event|3
4451353|NCT00518882|7237738|FG001|Open-Label Extension, Week 26-78|Adverse Event|9
4451354|NCT00518882|7237737|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6
4451355|NCT00518882|7237738|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5
4451356|NCT00518882|7237737|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3
4451357|NCT00518882|7237738|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4
4451358|NCT00518882|7237737|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1
4451359|NCT00518882|7237738|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2
4451360|NCT00518882|7237737|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0
4451361|NCT00518882|7237738|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1
4451362|NCT00518882|7237737|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1
4451363|NCT00518882|7237738|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1
4451364|NCT00518882|7237737|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2
4451365|NCT00518882|7237738|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1
4451366|NCT00518882|7237737|FG000|Open-Label Extension, Week 26-78|Change in treatment|1
4451367|NCT00518882|7237738|FG001|Open-Label Extension, Week 26-78|Change in treatment|1
4451368|NCT00518882|7237737|FG000|Open-Label Extension, Week 26-78|Creatine increased|1
4451369|NCT00518882|7237738|FG001|Open-Label Extension, Week 26-78|Creatine increased|0
4451370|NCT00518882|7237737|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1
4451371|NCT00518882|7237738|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0
4451372|NCT00518882|7237737|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2
4451373|NCT00518882|7237738|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0
4451374|NCT00518882|7237737|FG000|Open-Label Extension, Week 26-78|Subject decision|2
4451375|NCT00518882|7237738|FG001|Open-Label Extension, Week 26-78|Subject decision|0
4451376|NCT00518882|7237737|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18
4451377|NCT00518882|7237738|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25
4451378|NCT00518973|7237746|FG000|Overall Study|Withdrawal by Subject|3
4451379|NCT00518973|7237747|FG001|Overall Study|Withdrawal by Subject|2
4451380|NCT00518986|7237755|FG000|Overall Study|Adverse Event|12
4451381|NCT00518986|7237756|FG001|Overall Study|Adverse Event|7
4451382|NCT00518986|7237755|FG000|Overall Study|Lack of Efficacy|0
4451383|NCT00518986|7237756|FG001|Overall Study|Lack of Efficacy|2
4451384|NCT00518986|7237755|FG000|Overall Study|Lost to Follow-up|3
4451385|NCT00518986|7237756|FG001|Overall Study|Lost to Follow-up|2
4451386|NCT00518986|7237755|FG000|Overall Study|Physician Decision|0
4451387|NCT00518986|7237756|FG001|Overall Study|Physician Decision|3
4451388|NCT00518986|7237755|FG000|Overall Study|Protocol Violation|5
4451389|NCT00518986|7237756|FG001|Overall Study|Protocol Violation|7
4451390|NCT00518986|7237755|FG000|Overall Study|Withdrawal by Subject|4
4451391|NCT00518986|7237756|FG001|Overall Study|Withdrawal by Subject|4
4451392|NCT00518986|7237755|FG000|Overall Study|Non-Specific|2
4451393|NCT00518986|7237756|FG001|Overall Study|Non-Specific|1
4451394|NCT00519077|7237762|FG000|Overall Study|Death|6
4451395|NCT00519077|7237762|FG000|Overall Study|Other|2
4451396|NCT00519194|7237766|FG000|Overall Study|Withdrawal by Subject|9
4451397|NCT00519194|7237766|FG000|Overall Study|Death|9
4451398|NCT00519194|7237766|FG000|Overall Study|Lost to Follow-up|3
4451399|NCT00519285|7237772|FG000|Overall Study|Adverse Event|127
4451400|NCT00519285|7237773|FG001|Overall Study|Adverse Event|266
4451401|NCT00519285|7237772|FG000|Overall Study|Disease progression|334
4451402|NCT00519285|7237773|FG001|Overall Study|Disease progression|186
4451403|NCT00519285|7237772|FG000|Overall Study|Physician Decision|75
4451404|NCT00519285|7237773|FG001|Overall Study|Physician Decision|47
4451405|NCT00519285|7237772|FG000|Overall Study|Participant's request|53
4451406|NCT00519285|7237773|FG001|Overall Study|Participant's request|84
4451407|NCT00519285|7237772|FG000|Overall Study|Consent withdrawn|4
4451408|NCT00519285|7237773|FG001|Overall Study|Consent withdrawn|5
4451409|NCT00519285|7237772|FG000|Overall Study|Poor compliance to protocol|5
4451410|NCT00519285|7237773|FG001|Overall Study|Poor compliance to protocol|7
4451411|NCT00519285|7237772|FG000|Overall Study|Reason unspecified|5
4451412|NCT00519285|7237773|FG001|Overall Study|Reason unspecified|8
4451413|NCT00519285|7237772|FG000|Overall Study|Not treated|8
4451414|NCT00519285|7237773|FG001|Overall Study|Not treated|7
4451415|NCT00519285|7237772|FG000|Overall Study|Treatment ongoing|1
4451416|NCT00519285|7237773|FG001|Overall Study|Treatment ongoing|2
4451417|NCT00519376|7237779|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
4451418|NCT00519376|7237780|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
4451419|NCT00519376|7237781|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
4451420|NCT00519376|7237782|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
4451421|NCT00519376|7237783|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
4451422|NCT00519376|7237784|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
4451423|NCT00519376|7237785|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
4451424|NCT00519376|7237786|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
4451425|NCT00519376|7237787|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
4451426|NCT00519376|7237788|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
4451427|NCT00519376|7237789|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
4451428|NCT00519376|7237790|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
4451429|NCT00519376|7237791|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1
4451430|NCT00519376|7237792|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
4451431|NCT00519376|7237793|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
4451432|NCT00519376|7237794|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
4451433|NCT00519376|7237779|FG000|Treatment Period 4|Lost to Follow-up|0
4451434|NCT00519376|7237780|FG001|Treatment Period 4|Lost to Follow-up|0
4451435|NCT00519376|7237781|FG002|Treatment Period 4|Lost to Follow-up|1
4451436|NCT00519376|7237782|FG003|Treatment Period 4|Lost to Follow-up|0
4451437|NCT00519376|7237783|FG004|Treatment Period 4|Lost to Follow-up|0
4451438|NCT00519376|7237784|FG005|Treatment Period 4|Lost to Follow-up|0
4529445|NCT01056289|7347711|FG000|Double-blind Phase|Protocol Violation|0
4529446|NCT01056289|7347712|FG001|Double-blind Phase|Protocol Violation|0
4529447|NCT01056289|7347713|FG002|Double-blind Phase|Protocol Violation|1
4529448|NCT01056289|7347714|FG003|Double-blind Phase|Protocol Violation|1
4529449|NCT01056289|7347711|FG000|Double-blind Phase|Withdrawal by Subject|0
4451439|NCT00519376|7237785|FG006|Treatment Period 4|Lost to Follow-up|0
4451440|NCT00519376|7237786|FG007|Treatment Period 4|Lost to Follow-up|0
4451441|NCT00519376|7237787|FG008|Treatment Period 4|Lost to Follow-up|0
4451442|NCT00519376|7237788|FG009|Treatment Period 4|Lost to Follow-up|0
4451443|NCT00519376|7237789|FG010|Treatment Period 4|Lost to Follow-up|0
4451444|NCT00519376|7237790|FG011|Treatment Period 4|Lost to Follow-up|0
4451445|NCT00519376|7237791|FG012|Treatment Period 4|Lost to Follow-up|0
4451446|NCT00519376|7237792|FG013|Treatment Period 4|Lost to Follow-up|0
4451447|NCT00519376|7237793|FG014|Treatment Period 4|Lost to Follow-up|0
4451448|NCT00519376|7237794|FG015|Treatment Period 4|Lost to Follow-up|0
4451449|NCT00519428|7237809|FG000|Overall Study|Adverse Event|5
4451450|NCT00519428|7237810|FG001|Overall Study|Adverse Event|2
4451451|NCT00519428|7237811|FG002|Overall Study|Adverse Event|10
4451452|NCT00519428|7237809|FG000|Overall Study|Lost to Follow-up|7
4451453|NCT00519428|7237810|FG001|Overall Study|Lost to Follow-up|7
4451454|NCT00519428|7237811|FG002|Overall Study|Lost to Follow-up|6
4451455|NCT00519428|7237809|FG000|Overall Study|Withdrawal by Subject|8
4451456|NCT00519428|7237810|FG001|Overall Study|Withdrawal by Subject|3
4451457|NCT00519428|7237811|FG002|Overall Study|Withdrawal by Subject|7
4451458|NCT00519428|7237809|FG000|Overall Study|unstated|1
4451459|NCT00519428|7237810|FG001|Overall Study|unstated|3
4451460|NCT00519428|7237811|FG002|Overall Study|unstated|2
4451461|NCT00519532|7237822|FG000|Overall Study|Adverse Event|11
4451462|NCT00519532|7237822|FG000|Overall Study|Withdrawal by Subject|5
4451463|NCT00519532|7237822|FG000|Overall Study|Lost to Follow-up|2
4451464|NCT00519623|7237843|FG000|Overall Study|Adverse Event|1
4451465|NCT00519636|7237851|FG000|Treatment Period 1|Adverse Event|1
4451466|NCT00519636|7237852|FG001|Treatment Period 1|Adverse Event|0
4451467|NCT00519636|7237853|FG002|Treatment Period 1|Adverse Event|1
4451468|NCT00519636|7237854|FG003|Treatment Period 1|Adverse Event|0
4451469|NCT00519636|7237851|FG000|Treatment Period 1|Sponsor request due to missed visit|1
4451470|NCT00519636|7237852|FG001|Treatment Period 1|Sponsor request due to missed visit|0
4451471|NCT00519636|7237853|FG002|Treatment Period 1|Sponsor request due to missed visit|0
4451472|NCT00519636|7237854|FG003|Treatment Period 1|Sponsor request due to missed visit|0
4451473|NCT00519636|7237851|FG000|Washout Period|Adverse Event|2
4451474|NCT00519636|7237852|FG001|Washout Period|Adverse Event|1
4451475|NCT00519636|7237853|FG002|Washout Period|Adverse Event|1
4451476|NCT00519636|7237854|FG003|Washout Period|Adverse Event|0
4451477|NCT00519636|7237851|FG000|Washout Period|Lost to Follow-up|1
4451478|NCT00519636|7237852|FG001|Washout Period|Lost to Follow-up|0
4451479|NCT00519636|7237853|FG002|Washout Period|Lost to Follow-up|0
4451480|NCT00519636|7237854|FG003|Washout Period|Lost to Follow-up|0
4451481|NCT00519636|7237851|FG000|Washout Period|Protocol Violation|0
4451482|NCT00519636|7237852|FG001|Washout Period|Protocol Violation|0
4451483|NCT00519636|7237853|FG002|Washout Period|Protocol Violation|1
4451484|NCT00519636|7237854|FG003|Washout Period|Protocol Violation|2
4451485|NCT00519636|7237851|FG000|Washout Period|Withdrawal by Subject|1
4451486|NCT00519636|7237852|FG001|Washout Period|Withdrawal by Subject|0
4451487|NCT00519636|7237853|FG002|Washout Period|Withdrawal by Subject|1
4451488|NCT00519636|7237854|FG003|Washout Period|Withdrawal by Subject|0
4451489|NCT00519636|7237851|FG000|Washout Period|Failed to meet continuation criteria|14
4451490|NCT00519636|7237852|FG001|Washout Period|Failed to meet continuation criteria|11
4451491|NCT00519636|7237853|FG002|Washout Period|Failed to meet continuation criteria|9
4451492|NCT00519636|7237854|FG003|Washout Period|Failed to meet continuation criteria|3
4451493|NCT00519636|7237851|FG000|Washout Period|Out of pollen area > 48 hours|1
4451494|NCT00519636|7237852|FG001|Washout Period|Out of pollen area > 48 hours|0
4451495|NCT00519636|7237853|FG002|Washout Period|Out of pollen area > 48 hours|0
4451496|NCT00519636|7237854|FG003|Washout Period|Out of pollen area > 48 hours|0
4451497|NCT00519636|7237851|FG000|Washout Period|Participating in study at another site|1
4451498|NCT00519636|7237852|FG001|Washout Period|Participating in study at another site|0
4451499|NCT00519636|7237853|FG002|Washout Period|Participating in study at another site|0
4451500|NCT00519636|7237854|FG003|Washout Period|Participating in study at another site|0
4451501|NCT00519636|7237851|FG000|Washout Period|Non-compliant|0
4451502|NCT00519636|7237852|FG001|Washout Period|Non-compliant|1
4451503|NCT00519636|7237853|FG002|Washout Period|Non-compliant|0
4451504|NCT00519636|7237854|FG003|Washout Period|Non-compliant|0
4451505|NCT00519636|7237851|FG000|Washout Period|Per doctors request|0
4451506|NCT00519636|7237852|FG001|Washout Period|Per doctors request|1
4451507|NCT00519636|7237853|FG002|Washout Period|Per doctors request|0
4451508|NCT00519636|7237854|FG003|Washout Period|Per doctors request|0
4451509|NCT00519636|7237851|FG000|Washout Period|Subject randomized in error|0
4451510|NCT00519636|7237852|FG001|Washout Period|Subject randomized in error|0
4451511|NCT00519636|7237853|FG002|Washout Period|Subject randomized in error|1
4451512|NCT00519636|7237854|FG003|Washout Period|Subject randomized in error|0
4451513|NCT00519636|7237851|FG000|Washout Period|Prohibited medications|0
4451514|NCT00519636|7237852|FG001|Washout Period|Prohibited medications|0
4451515|NCT00519636|7237853|FG002|Washout Period|Prohibited medications|1
4451516|NCT00519636|7237854|FG003|Washout Period|Prohibited medications|0
4451517|NCT00519636|7237851|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0
4451518|NCT00519636|7237852|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0
4451519|NCT00519636|7237853|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0
4518736|NCT00976027|7331007|FG001|Overall Study|Adverse Event|2
4451520|NCT00519636|7237854|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1
4451521|NCT00519636|7237851|FG000|Treatment Period 2|Subject randomized in error|0
4451522|NCT00519636|7237852|FG001|Treatment Period 2|Subject randomized in error|1
4451523|NCT00519636|7237853|FG002|Treatment Period 2|Subject randomized in error|0
4451524|NCT00519636|7237854|FG003|Treatment Period 2|Subject randomized in error|0
4451525|NCT00519636|7237851|FG000|Treatment Period 2|Per doctors request|0
4451526|NCT00519636|7237852|FG001|Treatment Period 2|Per doctors request|0
4451527|NCT00519636|7237853|FG002|Treatment Period 2|Per doctors request|1
4451528|NCT00519636|7237854|FG003|Treatment Period 2|Per doctors request|0
4451529|NCT00519636|7237851|FG000|Treatment Period 2|Subject misrandomized|0
4451530|NCT00519636|7237852|FG001|Treatment Period 2|Subject misrandomized|0
4451531|NCT00519636|7237853|FG002|Treatment Period 2|Subject misrandomized|0
4451532|NCT00519636|7237854|FG003|Treatment Period 2|Subject misrandomized|1
4451533|NCT00519636|7237851|FG000|Post Study Period|Subject randomized in error|0
4451534|NCT00519636|7237852|FG001|Post Study Period|Subject randomized in error|0
4451535|NCT00519636|7237853|FG002|Post Study Period|Subject randomized in error|0
4529450|NCT01056289|7347712|FG001|Double-blind Phase|Withdrawal by Subject|0
4529451|NCT01056289|7347713|FG002|Double-blind Phase|Withdrawal by Subject|4
4529452|NCT01056289|7347714|FG003|Double-blind Phase|Withdrawal by Subject|2
4529453|NCT01056289|7347711|FG000|Double-blind Phase|Discontinuation symptom|0
4529454|NCT01056289|7347712|FG001|Double-blind Phase|Discontinuation symptom|1
4529455|NCT01056289|7347713|FG002|Double-blind Phase|Discontinuation symptom|2
4529456|NCT01056289|7347714|FG003|Double-blind Phase|Discontinuation symptom|2
4529457|NCT01056289|7347711|FG000|Double-blind Phase|Physician Decision|0
4529458|NCT01056289|7347712|FG001|Double-blind Phase|Physician Decision|0
4529459|NCT01056289|7347713|FG002|Double-blind Phase|Physician Decision|1
4529460|NCT01056289|7347714|FG003|Double-blind Phase|Physician Decision|0
4529461|NCT01056341|7347746|FG000|Overall Study|Treatment Intolerance|0
4529462|NCT01056341|7347747|FG001|Overall Study|Treatment Intolerance|2
4529463|NCT01056341|7347748|FG002|Overall Study|Treatment Intolerance|0
4529464|NCT01056341|7347749|FG003|Overall Study|Treatment Intolerance|2
4529465|NCT01056341|7347750|FG004|Overall Study|Treatment Intolerance|0
4529466|NCT01056341|7347746|FG000|Overall Study|Lack of Efficacy|32
4529467|NCT01056341|7347747|FG001|Overall Study|Lack of Efficacy|30
4529468|NCT01056341|7347748|FG002|Overall Study|Lack of Efficacy|7
4529469|NCT01056341|7347749|FG003|Overall Study|Lack of Efficacy|25
4529470|NCT01056341|7347750|FG004|Overall Study|Lack of Efficacy|9
4529471|NCT01056341|7347746|FG000|Overall Study|Other reasons|4
4529472|NCT01056341|7347747|FG001|Overall Study|Other reasons|4
4529473|NCT01056341|7347748|FG002|Overall Study|Other reasons|8
4529474|NCT01056341|7347749|FG003|Overall Study|Other reasons|9
4529475|NCT01056341|7347750|FG004|Overall Study|Other reasons|5
4529476|NCT01056380|7347770|FG000|Overall Study|Lost to Follow-up|2
4529477|NCT01056380|7347771|FG001|Overall Study|Lost to Follow-up|3
4529478|NCT01056484|7347781|FG000|Randomized Controlled Trial|Withdrawal by Subject|6
4529479|NCT01056484|7347782|FG001|Randomized Controlled Trial|Withdrawal by Subject|1
4529480|NCT01056484|7347781|FG000|Randomized Controlled Trial|Physician Decision|1
4529481|NCT01056484|7347782|FG001|Randomized Controlled Trial|Physician Decision|0
4529482|NCT01056484|7347781|FG000|Follow up - Non-randomized|Withdrawal by Subject|0
4529483|NCT01056484|7347782|FG001|Follow up - Non-randomized|Withdrawal by Subject|2
4590723|NCT01524627|7437004|FG000|Overall Study|Lost to Follow-up|1
4590724|NCT01524627|7437005|FG001|Overall Study|Lost to Follow-up|1
4590725|NCT01524679|7437013|FG000|Overall Study|Lost to Follow-up|1
4590726|NCT01524679|7437014|FG001|Overall Study|Lost to Follow-up|4
4590727|NCT01524679|7437013|FG000|Overall Study|Withdrawal by Subject|4
4590728|NCT01524679|7437014|FG001|Overall Study|Withdrawal by Subject|4
4590729|NCT01524679|7437013|FG000|Overall Study|Adverse Event|9
4590730|NCT01524679|7437014|FG001|Overall Study|Adverse Event|0
4590731|NCT01524679|7437013|FG000|Overall Study|Protocol Violation|1
4590732|NCT01524679|7437014|FG001|Overall Study|Protocol Violation|0
4590733|NCT01524679|7437013|FG000|Overall Study|Lack of Efficacy|2
4590734|NCT01524679|7437014|FG001|Overall Study|Lack of Efficacy|0
4590735|NCT01524679|7437013|FG000|Overall Study|e.g.wish for children, relocation|6
4590736|NCT01524679|7437014|FG001|Overall Study|e.g.wish for children, relocation|1
4590737|NCT01524692|7437020|FG000|Overall Study|Withdrawal by Subject|3
4590738|NCT01524770|7437025|FG000|First Intervention|Withdrawal by Subject|1
4590739|NCT01524770|7437026|FG001|First Intervention|Withdrawal by Subject|0
4590740|NCT01524770|7437025|FG000|First Intervention|Adverse Event|1
4590741|NCT01524770|7437026|FG001|First Intervention|Adverse Event|1
4590742|NCT01524770|7437025|FG000|First Intervention|Protocol Violation|1
4590743|NCT01524770|7437026|FG001|First Intervention|Protocol Violation|0
4590744|NCT01524783|7437034|FG000|Blinded Period|Adverse Event|64
4451536|NCT00519636|7237854|FG003|Post Study Period|Subject randomized in error|1
4590745|NCT01524783|7437035|FG001|Blinded Period|Adverse Event|7
4590746|NCT01524783|7437036|FG002|Blinded Period|Adverse Event|0
4590747|NCT01524783|7437034|FG000|Blinded Period|Disease Progression|89
4590748|NCT01524783|7437035|FG001|Blinded Period|Disease Progression|75
4590749|NCT01524783|7437036|FG002|Blinded Period|Disease Progression|0
4590750|NCT01524783|7437034|FG000|Blinded Period|Withdrawal by Subject|19
4590751|NCT01524783|7437035|FG001|Blinded Period|Withdrawal by Subject|6
4590752|NCT01524783|7437036|FG002|Blinded Period|Withdrawal by Subject|0
4451537|NCT00519649|7237868|FG000|Overall Study|Withdrawal by Subject|1
4451538|NCT00519779|7237874|FG000|Overall Study|Withdrawal by Subject|0
4451539|NCT00519779|7237875|FG001|Overall Study|Withdrawal by Subject|1
4451540|NCT00519831|7237881|FG000|Overall Study|Adverse Event|3
4451541|NCT00519896|7237885|FG000|Overall Study|Protocol Violation|1
4451542|NCT00519896|7237885|FG000|Overall Study|Adverse Event|1
4451543|NCT00520013|7237892|FG000|Overall Study|Withdrawal by Subject|0
4451544|NCT00520013|7237893|FG001|Overall Study|Withdrawal by Subject|0
4451545|NCT00520013|7237894|FG002|Overall Study|Withdrawal by Subject|1
4451546|NCT00520013|7237892|FG000|Overall Study|Adverse Event|2
4451547|NCT00520013|7237893|FG001|Overall Study|Adverse Event|10
4451548|NCT00520013|7237894|FG002|Overall Study|Adverse Event|7
4451549|NCT00520013|7237892|FG000|Overall Study|Progressive Disease|7
4451550|NCT00520013|7237893|FG001|Overall Study|Progressive Disease|3
4451551|NCT00520013|7237894|FG002|Overall Study|Progressive Disease|0
4451552|NCT00520013|7237892|FG000|Overall Study|Clinical Progression|3
4451553|NCT00520013|7237893|FG001|Overall Study|Clinical Progression|1
4451554|NCT00520013|7237894|FG002|Overall Study|Clinical Progression|0
4451555|NCT00520013|7237892|FG000|Overall Study|Death|0
4451556|NCT00520013|7237893|FG001|Overall Study|Death|1
4451557|NCT00520013|7237894|FG002|Overall Study|Death|0
4451558|NCT00520013|7237892|FG000|Overall Study|Physician Decision|0
4451559|NCT00520013|7237893|FG001|Overall Study|Physician Decision|0
4451560|NCT00520013|7237894|FG002|Overall Study|Physician Decision|3
4451561|NCT00520039|7237902|FG000|Overall Study|Exclusion criteria met at first visit|7
4451562|NCT00520039|7237903|FG001|Overall Study|Exclusion criteria met at first visit|5
4451563|NCT00520130|7237913|FG000|Overall Study|Disease progression on study|4
4451564|NCT00520130|7237914|FG001|Overall Study|Disease progression on study|0
4451565|NCT00520130|7237913|FG000|Overall Study|Physician Decision|1
4451566|NCT00520130|7237914|FG001|Overall Study|Physician Decision|1
4451567|NCT00520299|7237946|FG000|Overall Study|Withdrawal by Subject|0
4451568|NCT00520299|7237947|FG001|Overall Study|Withdrawal by Subject|0
4451569|NCT00520299|7237948|FG002|Overall Study|Withdrawal by Subject|2
4451570|NCT00520299|7237946|FG000|Overall Study|Progressive disease|0
4451571|NCT00520299|7237947|FG001|Overall Study|Progressive disease|3
4451572|NCT00520299|7237948|FG002|Overall Study|Progressive disease|4
4451573|NCT00520351|7237958|FG000|First Intervention|Withdrawal by Subject|1
4451574|NCT00520351|7237959|FG001|First Intervention|Withdrawal by Subject|1
4451575|NCT00520403|7237965|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6
4451576|NCT00520403|7237965|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4
4451577|NCT00520403|7237965|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4
4451578|NCT00520403|7237965|FG000|Bevacizumab + IFN/Vinblastine|Death|2
4451579|NCT00520403|7237965|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1
4451580|NCT00520403|7237965|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1
4451581|NCT00520403|7237965|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1
4451582|NCT00520403|7237965|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1
4451583|NCT00520481|7237975|FG000|Overall Study|Adverse Event|4
4451584|NCT00520481|7237976|FG001|Overall Study|Adverse Event|1
4451585|NCT00520481|7237975|FG000|Overall Study|Withdrawal by Subject|3
4451586|NCT00520481|7237976|FG001|Overall Study|Withdrawal by Subject|0
4451587|NCT00520494|7237984|FG000|Overall Study|Withdrawal by Subject|1
4451588|NCT00520533|7237988|FG000|Overall Study|Death|1
4451589|NCT00520533|7237988|FG000|Overall Study|Suspension of the study for safety reasons|1
4451590|NCT00520533|7237988|FG000|Overall Study|Withdrawal by Subject|1
4451591|NCT00520533|7237988|FG000|Overall Study|Physician Decision|1
4451592|NCT00520546|7237993|FG000|Overall Study|Withdrawal by Subject|1
4451593|NCT00520546|7237993|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5
4451594|NCT00520572|7238008|FG000|Overall Study|Adverse Event|9
4451595|NCT00520572|7238009|FG001|Overall Study|Adverse Event|3
4451596|NCT00520572|7238010|FG002|Overall Study|Adverse Event|6
4451597|NCT00520572|7238011|FG003|Overall Study|Adverse Event|9
4451598|NCT00520572|7238012|FG004|Overall Study|Adverse Event|7
4451599|NCT00520572|7238013|FG005|Overall Study|Adverse Event|2
4451600|NCT00520572|7238008|FG000|Overall Study|Withdrawal by Subject|0
4451601|NCT00520572|7238009|FG001|Overall Study|Withdrawal by Subject|9
4451602|NCT00520572|7238010|FG002|Overall Study|Withdrawal by Subject|5
4451603|NCT00520572|7238011|FG003|Overall Study|Withdrawal by Subject|2
4451604|NCT00520572|7238012|FG004|Overall Study|Withdrawal by Subject|2
4451605|NCT00520572|7238013|FG005|Overall Study|Withdrawal by Subject|0
4451606|NCT00520572|7238008|FG000|Overall Study|Protocol Violation|0
4451607|NCT00520572|7238009|FG001|Overall Study|Protocol Violation|0
4451608|NCT00520572|7238010|FG002|Overall Study|Protocol Violation|1
4451609|NCT00520572|7238011|FG003|Overall Study|Protocol Violation|0
4451610|NCT00520572|7238012|FG004|Overall Study|Protocol Violation|0
4451611|NCT00520572|7238013|FG005|Overall Study|Protocol Violation|0
4451612|NCT00520572|7238008|FG000|Overall Study|Lack of Efficacy|1
4451613|NCT00520572|7238009|FG001|Overall Study|Lack of Efficacy|1
4451614|NCT00520572|7238010|FG002|Overall Study|Lack of Efficacy|1
4451615|NCT00520572|7238011|FG003|Overall Study|Lack of Efficacy|2
4451616|NCT00520572|7238012|FG004|Overall Study|Lack of Efficacy|1
4451617|NCT00520572|7238013|FG005|Overall Study|Lack of Efficacy|0
4451618|NCT00520572|7238008|FG000|Overall Study|Lost to Follow-up|0
4451619|NCT00520572|7238009|FG001|Overall Study|Lost to Follow-up|0
4451620|NCT00520572|7238010|FG002|Overall Study|Lost to Follow-up|0
4451621|NCT00520572|7238011|FG003|Overall Study|Lost to Follow-up|0
4451622|NCT00520572|7238012|FG004|Overall Study|Lost to Follow-up|1
4451623|NCT00520572|7238013|FG005|Overall Study|Lost to Follow-up|0
4451624|NCT00520572|7238008|FG000|Overall Study|Incorrect enrollment|1
4451625|NCT00520572|7238009|FG001|Overall Study|Incorrect enrollment|0
4451626|NCT00520572|7238010|FG002|Overall Study|Incorrect enrollment|1
4451627|NCT00520572|7238011|FG003|Overall Study|Incorrect enrollment|0
4451628|NCT00520572|7238012|FG004|Overall Study|Incorrect enrollment|1
4451629|NCT00520572|7238013|FG005|Overall Study|Incorrect enrollment|0
4451630|NCT00520572|7238008|FG000|Overall Study|Oral corticotherapy for acute urticaria|0
4451631|NCT00520572|7238009|FG001|Overall Study|Oral corticotherapy for acute urticaria|1
4451632|NCT00520572|7238010|FG002|Overall Study|Oral corticotherapy for acute urticaria|0
4451633|NCT00520572|7238011|FG003|Overall Study|Oral corticotherapy for acute urticaria|0
4451634|NCT00520572|7238012|FG004|Overall Study|Oral corticotherapy for acute urticaria|0
4451635|NCT00520572|7238013|FG005|Overall Study|Oral corticotherapy for acute urticaria|0
4451636|NCT00520572|7238008|FG000|Overall Study|Long break in taking Medication|0
4451637|NCT00520572|7238009|FG001|Overall Study|Long break in taking Medication|0
4451638|NCT00520572|7238010|FG002|Overall Study|Long break in taking Medication|0
4451639|NCT00520572|7238011|FG003|Overall Study|Long break in taking Medication|1
4451640|NCT00520572|7238012|FG004|Overall Study|Long break in taking Medication|0
4451641|NCT00520572|7238013|FG005|Overall Study|Long break in taking Medication|0
4451642|NCT00520572|7238008|FG000|Overall Study|Did not receive Treatment|1
4451643|NCT00520572|7238009|FG001|Overall Study|Did not receive Treatment|0
4451644|NCT00520572|7238010|FG002|Overall Study|Did not receive Treatment|1
4451645|NCT00520572|7238011|FG003|Overall Study|Did not receive Treatment|0
4451646|NCT00520572|7238012|FG004|Overall Study|Did not receive Treatment|0
4451647|NCT00520572|7238013|FG005|Overall Study|Did not receive Treatment|0
4451648|NCT00520676|7238029|FG000|Overall Study|Death|84
4451649|NCT00520676|7238030|FG001|Overall Study|Death|81
4451650|NCT00520676|7238029|FG000|Overall Study|Lost to Follow-up|6
4451651|NCT00520676|7238030|FG001|Overall Study|Lost to Follow-up|10
4451652|NCT00520676|7238029|FG000|Overall Study|Physician Decision|4
4451653|NCT00520676|7238030|FG001|Overall Study|Physician Decision|1
4451654|NCT00520676|7238029|FG000|Overall Study|Withdrawal by Subject|7
4451655|NCT00520676|7238030|FG001|Overall Study|Withdrawal by Subject|11
4451656|NCT00520741|7238038|FG000|Overall Study|Adverse Event|16
4451657|NCT00520741|7238039|FG001|Overall Study|Adverse Event|56
4451658|NCT00520741|7238038|FG000|Overall Study|Lack of Efficacy|11
4451659|NCT00520741|7238039|FG001|Overall Study|Lack of Efficacy|30
4451660|NCT00520741|7238038|FG000|Overall Study|Withdrawal by Subject|0
4451661|NCT00520741|7238039|FG001|Overall Study|Withdrawal by Subject|11
4451662|NCT00520741|7238038|FG000|Overall Study|Protocol Violation|2
4451663|NCT00520741|7238039|FG001|Overall Study|Protocol Violation|15
4451664|NCT00520741|7238038|FG000|Overall Study|Unsatisfactory compliance of subject|4
4451665|NCT00520741|7238039|FG001|Overall Study|Unsatisfactory compliance of subject|3
4451666|NCT00520741|7238038|FG000|Overall Study|Lost to Follow-up|4
4451667|NCT00520741|7238039|FG001|Overall Study|Lost to Follow-up|4
4451668|NCT00520741|7238038|FG000|Overall Study|Other reasons for premature termination|0
4451669|NCT00520741|7238039|FG001|Overall Study|Other reasons for premature termination|6
4451670|NCT00520767|7238047|FG000|Overall Study|Death|2
4451671|NCT00520845|7238051|FG000|Overall Study|Death|3
4451672|NCT00520845|7238051|FG000|Overall Study|Adverse Event|4
4529484|NCT01056510|7347791|FG000|Overall Study|Dropout Before Start of Treatment|1
4529485|NCT01056510|7347792|FG001|Overall Study|Dropout Before Start of Treatment|1
4529486|NCT01056510|7347791|FG000|Overall Study|Withdrawal by Subject|4
4529487|NCT01056510|7347792|FG001|Overall Study|Withdrawal by Subject|2
4529488|NCT01056510|7347791|FG000|Overall Study|Death|29
4529489|NCT01056510|7347792|FG001|Overall Study|Death|34
4529490|NCT01056510|7347791|FG000|Overall Study|Noncompliance|1
4529491|NCT01056510|7347792|FG001|Overall Study|Noncompliance|3
4529492|NCT01056510|7347791|FG000|Overall Study|Physician Decision|4
4529493|NCT01056510|7347792|FG001|Overall Study|Physician Decision|5
4529494|NCT01056510|7347791|FG000|Overall Study|Lost to Follow-up|5
4529495|NCT01056510|7347792|FG001|Overall Study|Lost to Follow-up|6
4529496|NCT01056510|7347791|FG000|Overall Study|Other|10
4529497|NCT01056510|7347792|FG001|Overall Study|Other|12
4529498|NCT01056510|7347791|FG000|Overall Study|Missing|0
4529499|NCT01056510|7347792|FG001|Overall Study|Missing|1
4529500|NCT01056523|7347798|FG000|Overall Study|Death|1
4529501|NCT01056523|7347799|FG001|Overall Study|Death|0
4529502|NCT01056523|7347800|FG002|Overall Study|Death|2
4529503|NCT01056523|7347801|FG003|Overall Study|Death|3
4529504|NCT01056523|7347802|FG004|Overall Study|Death|0
4529505|NCT01056523|7347803|FG005|Overall Study|Death|0
4529506|NCT01056523|7347804|FG006|Overall Study|Death|1
4529507|NCT01056536|7347812|FG000|Overall Study|Lost to Follow-up|202
4529508|NCT01056536|7347813|FG001|Overall Study|Lost to Follow-up|116
4529509|NCT01056536|7347814|FG002|Overall Study|Lost to Follow-up|248
4529510|NCT01056640|7347828|FG000|Overall Study|Withdrawal by Subject|11
4451673|NCT00520845|7238051|FG000|Overall Study|Disease Progression, relapse|13
4451674|NCT00520845|7238051|FG000|Overall Study|Withdrawal by Subject|1
4529511|NCT01056640|7347829|FG001|Overall Study|Withdrawal by Subject|8
4529512|NCT01056640|7347828|FG000|Overall Study|Death|15
4529513|NCT01056640|7347829|FG001|Overall Study|Death|4
4529514|NCT01056653|7347838|FG000|Overall Study|Lost to Follow-up|0
4529515|NCT01056653|7347839|FG001|Overall Study|Lost to Follow-up|0
4529516|NCT01056653|7347840|FG002|Overall Study|Lost to Follow-up|2
4529517|NCT01056718|7347849|FG000|Overall Study|Withdrawal by Subject|2
4529518|NCT01056718|7347849|FG000|Overall Study|Ischemia on baseline stress test|1
4529519|NCT01056822|7347856|FG000|Overall Study|Adverse Event|0
4529520|NCT01056822|7347857|FG001|Overall Study|Adverse Event|1
4529521|NCT01056822|7347856|FG000|Overall Study|Protocol Violation|6
4529522|NCT01056822|7347857|FG001|Overall Study|Protocol Violation|5
4529523|NCT01056822|7347856|FG000|Overall Study|Withdrawal by Subject|1
4529524|NCT01056822|7347857|FG001|Overall Study|Withdrawal by Subject|1
4529525|NCT01056822|7347856|FG000|Overall Study|Lost to Follow-up|1
4529526|NCT01056822|7347857|FG001|Overall Study|Lost to Follow-up|0
4529527|NCT01057251|7347892|FG000|Overall Study|Did not meet InclusionExclusion criteria|4
4529528|NCT01057251|7347893|FG001|Overall Study|Did not meet InclusionExclusion criteria|2
4529529|NCT01057251|7347892|FG000|Overall Study|Adverse Event|4
4529530|NCT01057251|7347893|FG001|Overall Study|Adverse Event|2
4529531|NCT01057251|7347892|FG000|Overall Study|Lack of Efficacy|2
4529532|NCT01057251|7347893|FG001|Overall Study|Lack of Efficacy|11
4529533|NCT01057251|7347892|FG000|Overall Study|Protocol Violation|6
4529534|NCT01057251|7347893|FG001|Overall Study|Protocol Violation|2
4529535|NCT01057251|7347892|FG000|Overall Study|Withdrawal by Subject|4
4529536|NCT01057251|7347893|FG001|Overall Study|Withdrawal by Subject|5
4529537|NCT01057251|7347892|FG000|Overall Study|Lost to Follow-up|7
4529538|NCT01057251|7347893|FG001|Overall Study|Lost to Follow-up|6
4529539|NCT01057251|7347892|FG000|Overall Study|Other Reason|1
4529540|NCT01057251|7347893|FG001|Overall Study|Other Reason|1
4529541|NCT01057394|7347920|FG000|Overall Study|Not eligible|0
4529542|NCT01057394|7347921|FG001|Overall Study|Not eligible|2
4529543|NCT01057433|7347925|FG000|Overall Study|Adverse Event|1
4529544|NCT01057589|7347929|FG000|Overall Study|Disease Progression|35
4529545|NCT01057589|7347929|FG000|Overall Study|Adverse Event|10
4529546|NCT01057589|7347929|FG000|Overall Study|Physician Decision|8
4529547|NCT01057589|7347929|FG000|Overall Study|Withdrawal by Subject|3
4529548|NCT01057589|7347929|FG000|Overall Study|Sponsor Decision|1
4529549|NCT01057589|7347929|FG000|Overall Study|Death|8
4529550|NCT01057589|7347929|FG000|Overall Study|Lost to Follow-up|1
4529551|NCT01057693|7347933|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45
4529552|NCT01057693|7347934|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0
4529553|NCT01057693|7347935|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0
4529554|NCT01057693|7347933|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7
4529555|NCT01057693|7347934|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0
4529556|NCT01057693|7347935|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0
4529557|NCT01057693|7347933|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14
4529558|NCT01057693|7347934|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0
4529559|NCT01057693|7347935|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0
4529560|NCT01057693|7347933|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9
4529561|NCT01057693|7347934|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0
4529562|NCT01057693|7347935|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0
4529563|NCT01057693|7347933|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22
4529564|NCT01057693|7347934|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0
4529565|NCT01057693|7347935|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0
4529566|NCT01057693|7347933|FG000|Single-Blind Phase (Up to Week 6)|Other|2
4529567|NCT01057693|7347934|FG001|Single-Blind Phase (Up to Week 6)|Other|0
4529568|NCT01057693|7347935|FG002|Single-Blind Phase (Up to Week 6)|Other|0
4529569|NCT01057693|7347933|FG000|Between Single-Blind and Double-Blind|Adverse Event|5
4529570|NCT01057693|7347934|FG001|Between Single-Blind and Double-Blind|Adverse Event|0
4529571|NCT01057693|7347935|FG002|Between Single-Blind and Double-Blind|Adverse Event|0
4529572|NCT01057693|7347933|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247
4529573|NCT01057693|7347934|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0
4529574|NCT01057693|7347935|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0
4529575|NCT01057693|7347933|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1
4529576|NCT01057693|7347934|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0
4529577|NCT01057693|7347935|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0
4529578|NCT01057693|7347933|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7
4529579|NCT01057693|7347934|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0
4529580|NCT01057693|7347935|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0
4529581|NCT01057693|7347933|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4
4529582|NCT01057693|7347934|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0
4529583|NCT01057693|7347935|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0
4529584|NCT01057693|7347933|FG000|Between Single-Blind and Double-Blind|Other|6
4529585|NCT01057693|7347934|FG001|Between Single-Blind and Double-Blind|Other|0
4529586|NCT01057693|7347935|FG002|Between Single-Blind and Double-Blind|Other|0
4529587|NCT01057693|7347933|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0
4529588|NCT01057693|7347934|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8
4529589|NCT01057693|7347935|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11
4529590|NCT01057693|7347933|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0
4529591|NCT01057693|7347934|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3
4529592|NCT01057693|7347935|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8
4529593|NCT01057693|7347933|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0
4529594|NCT01057693|7347934|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2
4529595|NCT01057693|7347935|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5
4529596|NCT01057693|7347933|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0
4529597|NCT01057693|7347934|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0
4529598|NCT01057693|7347935|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4
4529599|NCT01057693|7347933|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0
4529600|NCT01057693|7347934|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8
4529601|NCT01057693|7347935|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6
4529602|NCT01057693|7347933|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0
4529603|NCT01057693|7347934|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1
4529604|NCT01057693|7347935|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0
4529605|NCT01057693|7347933|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0
4529606|NCT01057693|7347934|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0
4529607|NCT01057693|7347935|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2
4529608|NCT01057810|7347945|FG000|Overall Study|Disease progression|156
4529609|NCT01057810|7347946|FG001|Overall Study|Disease progression|197
4529610|NCT01057810|7347945|FG000|Overall Study|Study drug toxicity|5
4529611|NCT01057810|7347946|FG001|Overall Study|Study drug toxicity|114
4529612|NCT01057810|7347945|FG000|Overall Study|Adverse event unrelated to study drug|13
4529613|NCT01057810|7347946|FG001|Overall Study|Adverse event unrelated to study drug|29
4529614|NCT01057810|7347945|FG000|Overall Study|Withdrawal by Subject|10
4529615|NCT01057810|7347946|FG001|Overall Study|Withdrawal by Subject|25
4529616|NCT01057810|7347945|FG000|Overall Study|Death|2
4529617|NCT01057810|7347946|FG001|Overall Study|Death|12
4529618|NCT01057810|7347945|FG000|Overall Study|Maximum clinical benefit|5
4529619|NCT01057810|7347946|FG001|Overall Study|Maximum clinical benefit|5
4529620|NCT01057810|7347945|FG000|Overall Study|Poor/non-compliance|0
4529621|NCT01057810|7347946|FG001|Overall Study|Poor/non-compliance|1
4529622|NCT01057810|7347945|FG000|Overall Study|No longer met study criteria|0
4529623|NCT01057810|7347946|FG001|Overall Study|No longer met study criteria|1
4529624|NCT01057810|7347945|FG000|Overall Study|Other|7
4529625|NCT01057810|7347946|FG001|Overall Study|Other|14
4529626|NCT01057862|7347954|FG000|Overall Study|Withdrawal by Subject|1
4529627|NCT01057862|7347955|FG001|Overall Study|Withdrawal by Subject|2
4529628|NCT01058005|7347984|FG000|Overall Study|Adverse Event|0
4529629|NCT01058005|7347985|FG001|Overall Study|Adverse Event|2
4529630|NCT01058005|7347986|FG002|Overall Study|Adverse Event|1
4529631|NCT01058005|7347984|FG000|Overall Study|Physician Decision|2
4529632|NCT01058005|7347985|FG001|Overall Study|Physician Decision|2
4529633|NCT01058005|7347986|FG002|Overall Study|Physician Decision|0
4529634|NCT01058005|7347984|FG000|Overall Study|Withdrawal by Subject|4
4529635|NCT01058005|7347985|FG001|Overall Study|Withdrawal by Subject|5
4529636|NCT01058005|7347986|FG002|Overall Study|Withdrawal by Subject|11
4529637|NCT01058005|7347984|FG000|Overall Study|Withdrawn Due to Study Termination|27
4529638|NCT01058005|7347985|FG001|Overall Study|Withdrawn Due to Study Termination|13
4529639|NCT01058005|7347986|FG002|Overall Study|Withdrawn Due to Study Termination|7
4529640|NCT01058005|7347984|FG000|Overall Study|Reason Missing|5
4529641|NCT01058005|7347985|FG001|Overall Study|Reason Missing|3
4529642|NCT01058005|7347986|FG002|Overall Study|Reason Missing|1
4529643|NCT01058096|7348001|FG000|Double-blind Treatment Phase|Adverse Event|11
4529644|NCT01058096|7348002|FG001|Double-blind Treatment Phase|Adverse Event|15
4529645|NCT01058096|7348001|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16
4529646|NCT01058096|7348002|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7
4529647|NCT01058096|7348001|FG000|Double-blind Treatment Phase|Protocol Violation|2
4529648|NCT01058096|7348002|FG001|Double-blind Treatment Phase|Protocol Violation|1
4529649|NCT01058096|7348001|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17
4529650|NCT01058096|7348002|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26
4529651|NCT01058096|7348001|FG000|Double-blind Treatment Phase|Lost to Follow-up|0
4529652|NCT01058096|7348002|FG001|Double-blind Treatment Phase|Lost to Follow-up|1
4529653|NCT01058096|7348001|FG000|Double-blind Treatment Phase|Other Unspecified|2
4529654|NCT01058096|7348002|FG001|Double-blind Treatment Phase|Other Unspecified|0
4529655|NCT01058265|7348014|FG000|Overall Study|Lost to Follow-up|11
4529656|NCT01058265|7348015|FG001|Overall Study|Lost to Follow-up|12
4529657|NCT01058304|7348023|FG000|Overall Study|Withdrawal by Subject|8
4529658|NCT01058304|7348024|FG001|Overall Study|Withdrawal by Subject|5
4529659|NCT01058304|7348023|FG000|Overall Study|Lost to Follow-up|13
4529660|NCT01058304|7348024|FG001|Overall Study|Lost to Follow-up|16
4529661|NCT01058304|7348023|FG000|Overall Study|Developed exclusion criterion|6
4529662|NCT01058304|7348024|FG001|Overall Study|Developed exclusion criterion|12
4529663|NCT01058356|7348030|FG000|Overall Study|Adverse Event|5
4529664|NCT01058356|7348030|FG000|Overall Study|Administration of contraindicated drugs|12
4529665|NCT01058356|7348030|FG000|Overall Study|Withdrawal by Subject|21
4529666|NCT01058356|7348030|FG000|Overall Study|Lost to Follow-up|4
4529667|NCT01058395|7348036|FG000|Overall Study|Death|2
4529668|NCT01058395|7348037|FG001|Overall Study|Death|1
4529669|NCT01058395|7348036|FG000|Overall Study|Lost to Follow-up|1
4529670|NCT01058395|7348037|FG001|Overall Study|Lost to Follow-up|0
4529671|NCT01058421|7348045|FG000|1 Month Outcomes|Death|10
4529672|NCT01058421|7348046|FG001|1 Month Outcomes|Death|6
4529673|NCT01058421|7348045|FG000|1 Month Outcomes|Lost to Follow-up|8
4529674|NCT01058421|7348046|FG001|1 Month Outcomes|Lost to Follow-up|7
4529675|NCT01058421|7348045|FG000|1 Month Outcomes|Remained in Hospital|5
4529676|NCT01058421|7348046|FG001|1 Month Outcomes|Remained in Hospital|12
4529677|NCT01058421|7348045|FG000|1 Month Outcomes|Remained in Other Facility|16
4529678|NCT01058421|7348046|FG001|1 Month Outcomes|Remained in Other Facility|17
4529679|NCT01058421|7348045|FG000|3 Month Outcomes|Death|3
4529680|NCT01058421|7348046|FG001|3 Month Outcomes|Death|5
4529681|NCT01058421|7348045|FG000|3 Month Outcomes|Lost to Follow-up|12
4529682|NCT01058421|7348046|FG001|3 Month Outcomes|Lost to Follow-up|11
4529683|NCT01058421|7348045|FG000|3 Month Outcomes|Remained in Hospital|0
4529684|NCT01058421|7348046|FG001|3 Month Outcomes|Remained in Hospital|2
4529685|NCT01058421|7348045|FG000|3 Month Outcomes|Remained in Other Facility|5
4529686|NCT01058421|7348046|FG001|3 Month Outcomes|Remained in Other Facility|8
4529687|NCT01058421|7348045|FG000|6 Month Outcomes|Death|2
4529688|NCT01058421|7348046|FG001|6 Month Outcomes|Death|2
4529689|NCT01058421|7348045|FG000|6 Month Outcomes|Lost to Follow-up|16
4529690|NCT01058421|7348046|FG001|6 Month Outcomes|Lost to Follow-up|21
4529691|NCT01058421|7348045|FG000|6 Month Outcomes|Remained in Other Facility|1
4529692|NCT01058421|7348046|FG001|6 Month Outcomes|Remained in Other Facility|3
4529693|NCT01058655|7348056|FG000|Overall Study|Withdrawal by Subject|1
4529694|NCT01058655|7348057|FG001|Overall Study|Withdrawal by Subject|0
4529695|NCT01058655|7348058|FG002|Overall Study|Withdrawal by Subject|3
4529696|NCT01058655|7348059|FG003|Overall Study|Withdrawal by Subject|4
4529697|NCT01058655|7348056|FG000|Overall Study|Prolonged Treatment Delay|0
4529698|NCT01058655|7348057|FG001|Overall Study|Prolonged Treatment Delay|0
4529699|NCT01058655|7348058|FG002|Overall Study|Prolonged Treatment Delay|0
4529700|NCT01058655|7348059|FG003|Overall Study|Prolonged Treatment Delay|2
4529701|NCT01058655|7348056|FG000|Overall Study|Symptomatic Deterioration|0
4529702|NCT01058655|7348057|FG001|Overall Study|Symptomatic Deterioration|0
4529703|NCT01058655|7348058|FG002|Overall Study|Symptomatic Deterioration|0
4529704|NCT01058655|7348059|FG003|Overall Study|Symptomatic Deterioration|1
4529705|NCT01058655|7348056|FG000|Overall Study|Clinical Progression (non-RECIST)|1
4529706|NCT01058655|7348057|FG001|Overall Study|Clinical Progression (non-RECIST)|0
4529707|NCT01058655|7348058|FG002|Overall Study|Clinical Progression (non-RECIST)|0
4529708|NCT01058655|7348059|FG003|Overall Study|Clinical Progression (non-RECIST)|7
4529709|NCT01058655|7348056|FG000|Overall Study|Death|0
4529710|NCT01058655|7348057|FG001|Overall Study|Death|1
4529711|NCT01058655|7348058|FG002|Overall Study|Death|1
4529712|NCT01058655|7348059|FG003|Overall Study|Death|0
4529713|NCT01058655|7348056|FG000|Overall Study|Disease Progression|1
4529714|NCT01058655|7348057|FG001|Overall Study|Disease Progression|2
4529715|NCT01058655|7348058|FG002|Overall Study|Disease Progression|4
4529716|NCT01058655|7348059|FG003|Overall Study|Disease Progression|24
4529717|NCT01058655|7348056|FG000|Overall Study|Other|0
4529718|NCT01058655|7348057|FG001|Overall Study|Other|0
4529719|NCT01058655|7348058|FG002|Overall Study|Other|0
4529720|NCT01058655|7348059|FG003|Overall Study|Other|4
4529721|NCT01058668|7348073|FG000|Double-blind Treatment Phase|Adverse Event|8
4529722|NCT01058668|7348074|FG001|Double-blind Treatment Phase|Adverse Event|15
4529723|NCT01058668|7348075|FG002|Double-blind Treatment Phase|Adverse Event|25
4529724|NCT01058668|7348073|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15
4529725|NCT01058668|7348074|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2
4529726|NCT01058668|7348075|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5
4529727|NCT01058668|7348073|FG000|Double-blind Treatment Phase|Protocol Violation|1
4529728|NCT01058668|7348074|FG001|Double-blind Treatment Phase|Protocol Violation|1
4529729|NCT01058668|7348075|FG002|Double-blind Treatment Phase|Protocol Violation|2
4529730|NCT01058668|7348073|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14
4529731|NCT01058668|7348074|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18
4529732|NCT01058668|7348075|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17
4529733|NCT01058668|7348073|FG000|Double-blind Treatment Phase|Lost to Follow-up|0
4529734|NCT01058668|7348074|FG001|Double-blind Treatment Phase|Lost to Follow-up|1
4529735|NCT01058668|7348075|FG002|Double-blind Treatment Phase|Lost to Follow-up|1
4529736|NCT01058668|7348073|FG000|Double-blind Treatment Phase|Other Unspecified|1
4529737|NCT01058668|7348074|FG001|Double-blind Treatment Phase|Other Unspecified|1
4529738|NCT01058668|7348075|FG002|Double-blind Treatment Phase|Other Unspecified|0
4529739|NCT01058707|7348090|FG000|Overall Study|Disease Progression|15
4529740|NCT01058707|7348091|FG001|Overall Study|Disease Progression|20
4529741|NCT01058707|7348092|FG002|Overall Study|Disease Progression|20
4529742|NCT01058707|7348093|FG003|Overall Study|Disease Progression|15
4529743|NCT01058707|7348094|FG004|Overall Study|Disease Progression|23
4529744|NCT01058707|7348095|FG005|Overall Study|Disease Progression|10
4529745|NCT01058707|7348096|FG006|Overall Study|Disease Progression|12
4529746|NCT01058707|7348090|FG000|Overall Study|Adverse Event|11
4529747|NCT01058707|7348091|FG001|Overall Study|Adverse Event|4
4529748|NCT01058707|7348092|FG002|Overall Study|Adverse Event|7
4529749|NCT01058707|7348093|FG003|Overall Study|Adverse Event|6
4529750|NCT01058707|7348094|FG004|Overall Study|Adverse Event|7
4529751|NCT01058707|7348095|FG005|Overall Study|Adverse Event|3
4529752|NCT01058707|7348096|FG006|Overall Study|Adverse Event|1
4529753|NCT01058707|7348090|FG000|Overall Study|Subject Decision|5
4529754|NCT01058707|7348091|FG001|Overall Study|Subject Decision|3
4529755|NCT01058707|7348092|FG002|Overall Study|Subject Decision|3
4529756|NCT01058707|7348093|FG003|Overall Study|Subject Decision|1
4529757|NCT01058707|7348094|FG004|Overall Study|Subject Decision|2
4529758|NCT01058707|7348095|FG005|Overall Study|Subject Decision|3
4529759|NCT01058707|7348096|FG006|Overall Study|Subject Decision|6
4529760|NCT01058707|7348090|FG000|Overall Study|Lost to Follow-up|0
4529761|NCT01058707|7348091|FG001|Overall Study|Lost to Follow-up|0
4529762|NCT01058707|7348092|FG002|Overall Study|Lost to Follow-up|1
4529763|NCT01058707|7348093|FG003|Overall Study|Lost to Follow-up|0
4529764|NCT01058707|7348094|FG004|Overall Study|Lost to Follow-up|0
4529765|NCT01058707|7348095|FG005|Overall Study|Lost to Follow-up|0
4529766|NCT01058707|7348096|FG006|Overall Study|Lost to Follow-up|0
4529767|NCT01058707|7348090|FG000|Overall Study|Reason Not Specified|0
4529768|NCT01058707|7348091|FG001|Overall Study|Reason Not Specified|3
4529769|NCT01058707|7348092|FG002|Overall Study|Reason Not Specified|2
4529770|NCT01058707|7348093|FG003|Overall Study|Reason Not Specified|0
4529771|NCT01058707|7348094|FG004|Overall Study|Reason Not Specified|7
4529772|NCT01058707|7348095|FG005|Overall Study|Reason Not Specified|1
4529773|NCT01058707|7348096|FG006|Overall Study|Reason Not Specified|7
4529774|NCT01058863|7348134|FG000|Overall Study|Lost to Follow-up|1
4529775|NCT01058863|7348134|FG000|Overall Study|Withdrawal by Subject|1
4529776|NCT01058863|7348134|FG000|Overall Study|Sponsor requested withdrawal|1
4529777|NCT01058863|7348134|FG000|Overall Study|Randomized in error|1
4529778|NCT01059175|7348162|FG000|Overall Study|Death|17
4529779|NCT01059175|7348163|FG001|Overall Study|Death|17
4529780|NCT01059175|7348162|FG000|Overall Study|Adverse Event|4
4529781|NCT01059175|7348163|FG001|Overall Study|Adverse Event|2
4529782|NCT01059175|7348162|FG000|Overall Study|Lost to Follow-up|0
4529783|NCT01059175|7348163|FG001|Overall Study|Lost to Follow-up|1
4529784|NCT01059318|7348173|FG000|Core Study (26 Week)|Adverse Event|3
4529785|NCT01059318|7348173|FG000|Core Study (26 Week)|Withdrawal by Subject|1
4529786|NCT01059318|7348173|FG000|Extension (36 Week)|Adverse Event|3
4529787|NCT01059344|7348182|FG000|Overall Study|Adverse Event|12
4529788|NCT01059344|7348183|FG001|Overall Study|Adverse Event|30
4529789|NCT01059344|7348182|FG000|Overall Study|Withdrawal by Subject|6
4529790|NCT01059344|7348183|FG001|Overall Study|Withdrawal by Subject|9
4529791|NCT01059344|7348182|FG000|Overall Study|Lost to Follow-up|1
4529792|NCT01059344|7348183|FG001|Overall Study|Lost to Follow-up|1
4529793|NCT01059344|7348182|FG000|Overall Study|Other|3
4529794|NCT01059344|7348183|FG001|Overall Study|Other|6
4590753|NCT01524783|7437034|FG000|Blinded Period|Protocol deviation|2
4590754|NCT01524783|7437035|FG001|Blinded Period|Protocol deviation|1
4590755|NCT01524783|7437036|FG002|Blinded Period|Protocol deviation|0
4590756|NCT01524783|7437034|FG000|Blinded Period|Death|5
4590757|NCT01524783|7437035|FG001|Blinded Period|Death|2
4590758|NCT01524783|7437036|FG002|Blinded Period|Death|0
4590759|NCT01524783|7437034|FG000|Open-label Period|Disease progression|13
4590760|NCT01524783|7437035|FG001|Open-label Period|Disease progression|0
4590761|NCT01524783|7437036|FG002|Open-label Period|Disease progression|2
4590762|NCT01524783|7437034|FG000|Open-label Period|Administrative problems|5
4590763|NCT01524783|7437035|FG001|Open-label Period|Administrative problems|0
4590764|NCT01524783|7437036|FG002|Open-label Period|Administrative problems|2
4590765|NCT01524783|7437034|FG000|Open-label Period|Adverse Event|5
4590766|NCT01524783|7437035|FG001|Open-label Period|Adverse Event|0
4590767|NCT01524783|7437036|FG002|Open-label Period|Adverse Event|1
4590768|NCT01524783|7437034|FG000|Open-label Period|Withdrawal by Subject|2
4590769|NCT01524783|7437035|FG001|Open-label Period|Withdrawal by Subject|0
4590770|NCT01524783|7437036|FG002|Open-label Period|Withdrawal by Subject|1
4590771|NCT01524783|7437034|FG000|Open-label Period|Protocol deviation|1
4590772|NCT01524783|7437035|FG001|Open-label Period|Protocol deviation|0
4590773|NCT01524783|7437036|FG002|Open-label Period|Protocol deviation|0
4590774|NCT01524796|7437048|FG000|Overall Study|Adverse Event|13
4590775|NCT01524796|7437048|FG000|Overall Study|Lack of Efficacy|3
4590776|NCT01524796|7437048|FG000|Overall Study|Lost to Follow-up|1
4590777|NCT01524796|7437048|FG000|Overall Study|The price|1
4590778|NCT01524796|7437048|FG000|Overall Study|Withdrawal by Subject|4
4590779|NCT01524796|7437048|FG000|Overall Study|Move|1
4590780|NCT01524796|7437048|FG000|Overall Study|Deterioration of pains|1
4590781|NCT01524796|7437048|FG000|Overall Study|Gall stone surgery|1
4590782|NCT01524796|7437048|FG000|Overall Study|Nervous about confidentiality|1
4590783|NCT01524796|7437048|FG000|Overall Study|Switch to carbamazapine|1
4590784|NCT01524796|7437048|FG000|Overall Study|Adverse Event and Lack of Efficacy|1
4590785|NCT01524887|7437055|FG000|Overall Study|Withdrawal by Subject|6
4590786|NCT01524887|7437056|FG001|Overall Study|Withdrawal by Subject|2
4590787|NCT01524887|7437057|FG002|Overall Study|Withdrawal by Subject|3
4590788|NCT01524887|7437055|FG000|Overall Study|Adverse Event|5
4590789|NCT01524887|7437056|FG001|Overall Study|Adverse Event|1
4590790|NCT01524887|7437057|FG002|Overall Study|Adverse Event|1
4590791|NCT01524887|7437055|FG000|Overall Study|Protocol Violation|0
4590792|NCT01524887|7437056|FG001|Overall Study|Protocol Violation|0
4590793|NCT01524887|7437057|FG002|Overall Study|Protocol Violation|1
4529795|NCT01059526|7348248|FG000|Overall Study|Patient enrolled but not treated|20
4529796|NCT01059526|7348249|FG001|Overall Study|Patient enrolled but not treated|17
4529797|NCT01059526|7348248|FG000|Overall Study|Adverse Event|2
4529798|NCT01059526|7348249|FG001|Overall Study|Adverse Event|2
4529799|NCT01059526|7348248|FG000|Overall Study|Protocol Violation|0
4529800|NCT01059526|7348249|FG001|Overall Study|Protocol Violation|1
4529801|NCT01059526|7348248|FG000|Overall Study|Withdrawal by Subject|3
4529802|NCT01059526|7348249|FG001|Overall Study|Withdrawal by Subject|1
4529803|NCT01059526|7348248|FG000|Overall Study|Lost to Follow-up|4
4529804|NCT01059526|7348249|FG001|Overall Study|Lost to Follow-up|1
4529805|NCT01059526|7348248|FG000|Overall Study|Patient found to be dermatographic|1
4529806|NCT01059526|7348249|FG001|Overall Study|Patient found to be dermatographic|0
4529807|NCT01059539|7348255|FG000|Overall Study|Adverse Event|66
4529808|NCT01059539|7348255|FG000|Overall Study|Insufficient Therapeutic Response|26
4529809|NCT01059539|7348255|FG000|Overall Study|Protocol Violation|55
4529810|NCT01059539|7348255|FG000|Overall Study|Withdrawal of Consent|80
4529811|NCT01059539|7348255|FG000|Overall Study|Lost to Follow-up|42
4529812|NCT01059539|7348255|FG000|Overall Study|Reason Not Specified|2
4529813|NCT01059565|7348261|FG000|24-Week Randomized Phase|Randomized but not treated|1
4529814|NCT01059565|7348262|FG001|24-Week Randomized Phase|Randomized but not treated|0
4529815|NCT01059565|7348261|FG000|24-Week Randomized Phase|Adverse Event|5
4529816|NCT01059565|7348262|FG001|24-Week Randomized Phase|Adverse Event|0
4529817|NCT01059565|7348261|FG000|24-Week Randomized Phase|Withdrawal by Subject|3
4529818|NCT01059565|7348262|FG001|24-Week Randomized Phase|Withdrawal by Subject|1
4529819|NCT01059565|7348261|FG000|24-Week Randomized Phase|Lost to Follow-up|0
4529820|NCT01059565|7348262|FG001|24-Week Randomized Phase|Lost to Follow-up|1
4529821|NCT01059565|7348261|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1
4529822|NCT01059565|7348262|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5
4529823|NCT01059565|7348261|FG000|24-Week Open-Label Phase|Adverse Event|2
4529824|NCT01059565|7348262|FG001|24-Week Open-Label Phase|Adverse Event|0
4529825|NCT01059565|7348261|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1
4529826|NCT01059565|7348262|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1
4529827|NCT01059565|7348261|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1
4529828|NCT01059565|7348262|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0
4529829|NCT01059565|7348261|FG000|24-Week Open-Label Phase|Subject noncompliance|1
4529830|NCT01059565|7348262|FG001|24-Week Open-Label Phase|Subject noncompliance|0
4529831|NCT01059565|7348261|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0
4529832|NCT01059565|7348262|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1
4529833|NCT01059565|7348261|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0
4529834|NCT01059565|7348262|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1
4529835|NCT01059617|7348274|FG000|Overall Study|Other|7
4529836|NCT01059617|7348275|FG001|Overall Study|Other|1
4529837|NCT01059617|7348276|FG002|Overall Study|Other|8
4529838|NCT01059617|7348277|FG003|Overall Study|Other|6
4529839|NCT01059630|7348297|FG000|Overall Study|Death|100
4529840|NCT01059630|7348298|FG001|Overall Study|Death|84
4529841|NCT01059630|7348297|FG000|Overall Study|Lost to Follow-up|4
4529842|NCT01059630|7348298|FG001|Overall Study|Lost to Follow-up|1
4529843|NCT01059630|7348297|FG000|Overall Study|Physician Decision|2
4529844|NCT01059630|7348298|FG001|Overall Study|Physician Decision|4
4529845|NCT01059630|7348297|FG000|Overall Study|Withdrawal by Subject|21
4529846|NCT01059630|7348298|FG001|Overall Study|Withdrawal by Subject|14
4529847|NCT01059643|7348304|FG000|Overall Study|Adverse Event|3
4529848|NCT01059643|7348304|FG000|Overall Study|Withdrawal by Subject|2
4529849|NCT01059643|7348304|FG000|Overall Study|Physician Decision|1
4529850|NCT01059773|7348332|FG000|Overall Study|Adverse Event|2
4529851|NCT01059773|7348333|FG001|Overall Study|Adverse Event|2
4529852|NCT01059773|7348332|FG000|Overall Study|Withdrawal by Subject|1
4529853|NCT01059773|7348333|FG001|Overall Study|Withdrawal by Subject|5
4529854|NCT01059773|7348332|FG000|Overall Study|Lost to Follow-up|1
4529855|NCT01059773|7348333|FG001|Overall Study|Lost to Follow-up|1
4529856|NCT01059773|7348332|FG000|Overall Study|Pregnancy|1
4529857|NCT01059773|7348333|FG001|Overall Study|Pregnancy|1
4529858|NCT01059773|7348332|FG000|Overall Study|Protocol Violation|6
4529859|NCT01059773|7348333|FG001|Overall Study|Protocol Violation|2
4529860|NCT01059773|7348332|FG000|Overall Study|Physician Decision|5
4689818|NCT02555371|7599379|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0
4689819|NCT02555371|7599375|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2
4529861|NCT01059773|7348333|FG001|Overall Study|Physician Decision|4
4529862|NCT01059773|7348332|FG000|Overall Study|Lack of Efficacy|3
4529863|NCT01059773|7348333|FG001|Overall Study|Lack of Efficacy|3
4689820|NCT02555371|7599376|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0
4689821|NCT02555371|7599377|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0
4689822|NCT02555371|7599378|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0
4689823|NCT02555371|7599379|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0
4689824|NCT02555371|7599375|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0
4689825|NCT02555371|7599376|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84
4689826|NCT02555371|7599377|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45
4689827|NCT02555371|7599378|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0
4689828|NCT02555371|7599379|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0
4689829|NCT02555371|7599375|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0
4529864|NCT01059773|7348332|FG000|Overall Study|Death|0
4529865|NCT01059773|7348333|FG001|Overall Study|Death|1
4529866|NCT01059773|7348332|FG000|Overall Study|Malignancy including squamous cell skin|0
4529867|NCT01059773|7348333|FG001|Overall Study|Malignancy including squamous cell skin|1
4529868|NCT01059773|7348332|FG000|Overall Study|Ineligible follow TB screening criteria|0
4529869|NCT01059773|7348333|FG001|Overall Study|Ineligible follow TB screening criteria|1
4529870|NCT01059773|7348332|FG000|Overall Study|Other|1
4529871|NCT01059773|7348333|FG001|Overall Study|Other|3
4529872|NCT01059799|7348346|FG000|Overall Study|Adverse Event|2
4529873|NCT01059799|7348347|FG001|Overall Study|Adverse Event|3
4529874|NCT01059799|7348346|FG000|Overall Study|Lack of Efficacy|1
4529875|NCT01059799|7348347|FG001|Overall Study|Lack of Efficacy|0
4529876|NCT01059799|7348346|FG000|Overall Study|Protocol Violation|3
4529877|NCT01059799|7348347|FG001|Overall Study|Protocol Violation|2
4529878|NCT01059799|7348346|FG000|Overall Study|Withdrawal criteria|13
4529879|NCT01059799|7348347|FG001|Overall Study|Withdrawal criteria|2
4529880|NCT01059799|7348346|FG000|Overall Study|Other|12
4529881|NCT01059799|7348347|FG001|Overall Study|Other|3
4529882|NCT01059812|7348355|FG000|Overall Study|Adverse Event|9
4529883|NCT01059812|7348356|FG001|Overall Study|Adverse Event|5
4529884|NCT01059812|7348355|FG000|Overall Study|Lack of Efficacy|2
4529885|NCT01059812|7348356|FG001|Overall Study|Lack of Efficacy|2
4529886|NCT01059812|7348355|FG000|Overall Study|Protocol Violation|3
4529887|NCT01059812|7348356|FG001|Overall Study|Protocol Violation|1
4529888|NCT01059812|7348355|FG000|Overall Study|Withdrawal Criteria|9
4529889|NCT01059812|7348356|FG001|Overall Study|Withdrawal Criteria|4
4529890|NCT01059812|7348355|FG000|Overall Study|Unclassified|14
4529891|NCT01059812|7348356|FG001|Overall Study|Unclassified|4
4529892|NCT01059825|7348368|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0
4529893|NCT01059825|7348369|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0
4529894|NCT01059825|7348370|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0
4529895|NCT01059825|7348371|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0
4529896|NCT01059825|7348372|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0
4529897|NCT01059825|7348373|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0
4529898|NCT01059825|7348374|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3
4529899|NCT01059825|7348368|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0
4529900|NCT01059825|7348369|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0
4529901|NCT01059825|7348370|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0
4529902|NCT01059825|7348371|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0
4529903|NCT01059825|7348372|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0
4529904|NCT01059825|7348373|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0
4529905|NCT01059825|7348374|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14
4529906|NCT01059825|7348368|FG000|Enrolled, Run-in Period|Lost to Follow-up|0
4529907|NCT01059825|7348369|FG001|Enrolled, Run-in Period|Lost to Follow-up|0
4529908|NCT01059825|7348370|FG002|Enrolled, Run-in Period|Lost to Follow-up|0
4529909|NCT01059825|7348371|FG003|Enrolled, Run-in Period|Lost to Follow-up|0
4529910|NCT01059825|7348372|FG004|Enrolled, Run-in Period|Lost to Follow-up|0
4529911|NCT01059825|7348373|FG005|Enrolled, Run-in Period|Lost to Follow-up|0
4529912|NCT01059825|7348374|FG006|Enrolled, Run-in Period|Lost to Follow-up|5
4529913|NCT01059825|7348368|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0
4529914|NCT01059825|7348369|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0
4529915|NCT01059825|7348370|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0
4529916|NCT01059825|7348371|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0
4529917|NCT01059825|7348372|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0
4529918|NCT01059825|7348373|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0
4529919|NCT01059825|7348374|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13
4529920|NCT01059825|7348368|FG000|Enrolled, Run-in Period|Other reason not specified|0
4529921|NCT01059825|7348369|FG001|Enrolled, Run-in Period|Other reason not specified|0
4529922|NCT01059825|7348370|FG002|Enrolled, Run-in Period|Other reason not specified|0
4529923|NCT01059825|7348371|FG003|Enrolled, Run-in Period|Other reason not specified|0
4529924|NCT01059825|7348372|FG004|Enrolled, Run-in Period|Other reason not specified|0
4529925|NCT01059825|7348373|FG005|Enrolled, Run-in Period|Other reason not specified|0
4529926|NCT01059825|7348374|FG006|Enrolled, Run-in Period|Other reason not specified|7
4529927|NCT01059825|7348368|FG000|Enrolled, Run-in Period|Protocol Violation|0
4529928|NCT01059825|7348369|FG001|Enrolled, Run-in Period|Protocol Violation|0
4529929|NCT01059825|7348370|FG002|Enrolled, Run-in Period|Protocol Violation|0
4529930|NCT01059825|7348371|FG003|Enrolled, Run-in Period|Protocol Violation|0
4529931|NCT01059825|7348372|FG004|Enrolled, Run-in Period|Protocol Violation|0
4529932|NCT01059825|7348373|FG005|Enrolled, Run-in Period|Protocol Violation|0
4529933|NCT01059825|7348374|FG006|Enrolled, Run-in Period|Protocol Violation|5
4529934|NCT01059825|7348368|FG000|Treatment Period|Lost to Follow-up|2
4529935|NCT01059825|7348369|FG001|Treatment Period|Lost to Follow-up|1
4529936|NCT01059825|7348370|FG002|Treatment Period|Lost to Follow-up|0
4529937|NCT01059825|7348371|FG003|Treatment Period|Lost to Follow-up|1
4529938|NCT01059825|7348372|FG004|Treatment Period|Lost to Follow-up|2
4529939|NCT01059825|7348373|FG005|Treatment Period|Lost to Follow-up|0
4529940|NCT01059825|7348374|FG006|Treatment Period|Lost to Follow-up|0
4529941|NCT01059825|7348368|FG000|Treatment Period|Withdrawal by Subject|3
4529942|NCT01059825|7348369|FG001|Treatment Period|Withdrawal by Subject|0
4529943|NCT01059825|7348370|FG002|Treatment Period|Withdrawal by Subject|1
4529944|NCT01059825|7348371|FG003|Treatment Period|Withdrawal by Subject|5
4529945|NCT01059825|7348372|FG004|Treatment Period|Withdrawal by Subject|4
4529946|NCT01059825|7348373|FG005|Treatment Period|Withdrawal by Subject|1
4529947|NCT01059825|7348374|FG006|Treatment Period|Withdrawal by Subject|0
4529948|NCT01059825|7348368|FG000|Treatment Period|Other reason not specified|1
4529949|NCT01059825|7348369|FG001|Treatment Period|Other reason not specified|2
4529950|NCT01059825|7348370|FG002|Treatment Period|Other reason not specified|1
4529951|NCT01059825|7348371|FG003|Treatment Period|Other reason not specified|2
4529952|NCT01059825|7348372|FG004|Treatment Period|Other reason not specified|0
4529953|NCT01059825|7348373|FG005|Treatment Period|Other reason not specified|0
4529954|NCT01059825|7348374|FG006|Treatment Period|Other reason not specified|0
4529955|NCT01059825|7348368|FG000|Treatment Period|Protocol Violation|0
4529956|NCT01059825|7348369|FG001|Treatment Period|Protocol Violation|0
4529957|NCT01059825|7348370|FG002|Treatment Period|Protocol Violation|1
4529958|NCT01059825|7348371|FG003|Treatment Period|Protocol Violation|1
4529959|NCT01059825|7348372|FG004|Treatment Period|Protocol Violation|1
4529960|NCT01059825|7348373|FG005|Treatment Period|Protocol Violation|1
4529961|NCT01059825|7348374|FG006|Treatment Period|Protocol Violation|0
4529962|NCT01059825|7348368|FG000|Treatment Period|Adverse event related to study drug|1
4529963|NCT01059825|7348369|FG001|Treatment Period|Adverse event related to study drug|0
4529964|NCT01059825|7348370|FG002|Treatment Period|Adverse event related to study drug|1
4529965|NCT01059825|7348371|FG003|Treatment Period|Adverse event related to study drug|1
4529966|NCT01059825|7348372|FG004|Treatment Period|Adverse event related to study drug|0
4529967|NCT01059825|7348373|FG005|Treatment Period|Adverse event related to study drug|0
4529968|NCT01059825|7348374|FG006|Treatment Period|Adverse event related to study drug|0
4529969|NCT01059825|7348368|FG000|Treatment Period|Insufficient clinical response|3
4529970|NCT01059825|7348369|FG001|Treatment Period|Insufficient clinical response|0
4529971|NCT01059825|7348370|FG002|Treatment Period|Insufficient clinical response|0
4529972|NCT01059825|7348371|FG003|Treatment Period|Insufficient clinical response|0
4529973|NCT01059825|7348372|FG004|Treatment Period|Insufficient clinical response|0
4529974|NCT01059825|7348373|FG005|Treatment Period|Insufficient clinical response|0
4529975|NCT01059825|7348374|FG006|Treatment Period|Insufficient clinical response|0
4529976|NCT01059825|7348368|FG000|Treatment Period|Adverse event not related to study drug|0
4529977|NCT01059825|7348369|FG001|Treatment Period|Adverse event not related to study drug|1
4529978|NCT01059825|7348370|FG002|Treatment Period|Adverse event not related to study drug|2
4529979|NCT01059825|7348371|FG003|Treatment Period|Adverse event not related to study drug|1
4529980|NCT01059825|7348372|FG004|Treatment Period|Adverse event not related to study drug|1
4529981|NCT01059825|7348373|FG005|Treatment Period|Adverse event not related to study drug|1
4529982|NCT01059825|7348374|FG006|Treatment Period|Adverse event not related to study drug|0
4529983|NCT01059864|7348407|FG000|Open-Label Run-In Phase|Adverse Event|7
4529984|NCT01059864|7348408|FG001|Open-Label Run-In Phase|Adverse Event|0
4529985|NCT01059864|7348409|FG002|Open-Label Run-In Phase|Adverse Event|0
4529986|NCT01059864|7348407|FG000|Open-Label Run-In Phase|Lack of Efficacy|1
4529987|NCT01059864|7348408|FG001|Open-Label Run-In Phase|Lack of Efficacy|0
4529988|NCT01059864|7348409|FG002|Open-Label Run-In Phase|Lack of Efficacy|0
4529989|NCT01059864|7348407|FG000|Open-Label Run-In Phase|Lost to Follow-up|2
4529990|NCT01059864|7348408|FG001|Open-Label Run-In Phase|Lost to Follow-up|0
4529991|NCT01059864|7348409|FG002|Open-Label Run-In Phase|Lost to Follow-up|0
4529992|NCT01059864|7348407|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1
4529993|NCT01059864|7348408|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0
4529994|NCT01059864|7348409|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0
4529995|NCT01059864|7348407|FG000|Open-Label Run-In Phase|Protocol Violation|2
4529996|NCT01059864|7348408|FG001|Open-Label Run-In Phase|Protocol Violation|0
4529997|NCT01059864|7348409|FG002|Open-Label Run-In Phase|Protocol Violation|0
4529998|NCT01059864|7348407|FG000|Double-Blind Treatment Phase|Adverse Event|0
4529999|NCT01059864|7348408|FG001|Double-Blind Treatment Phase|Adverse Event|3
4530000|NCT01059864|7348409|FG002|Double-Blind Treatment Phase|Adverse Event|3
4530001|NCT01059903|7348427|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1
4530002|NCT01059903|7348428|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1
4530003|NCT01060007|7348460|FG000|Overall Study|Withdrawal by Subject|1
4530004|NCT01060007|7348460|FG000|Overall Study|Inevaluable for response at surgery|3
4530005|NCT01060059|7348474|FG000|Overall Study|Adverse Event|1
4530006|NCT01060059|7348475|FG001|Overall Study|Adverse Event|1
4530007|NCT01060059|7348474|FG000|Overall Study|Death|2
4530008|NCT01060059|7348475|FG001|Overall Study|Death|3
4530009|NCT01060059|7348474|FG000|Overall Study|Lost to Follow-up|18
4530010|NCT01060059|7348475|FG001|Overall Study|Lost to Follow-up|34
4530011|NCT01060059|7348474|FG000|Overall Study|entry criteria not met|4
4530012|NCT01060059|7348475|FG001|Overall Study|entry criteria not met|3
4530013|NCT01060059|7348474|FG000|Overall Study|Withdrawal by Subject|35
4530014|NCT01060059|7348475|FG001|Overall Study|Withdrawal by Subject|23
4530015|NCT01060059|7348474|FG000|Overall Study|lack of glycemic control|2
4530016|NCT01060059|7348475|FG001|Overall Study|lack of glycemic control|1
4530017|NCT01060059|7348474|FG000|Overall Study|lack of compliance|5
4530018|NCT01060059|7348475|FG001|Overall Study|lack of compliance|2
4530019|NCT01060072|7348485|FG000|Overall Study|Adverse Event|1
4530020|NCT01060072|7348486|FG001|Overall Study|Adverse Event|1
4530021|NCT01060072|7348485|FG000|Overall Study|Physician Decision|0
4530022|NCT01060072|7348486|FG001|Overall Study|Physician Decision|2
4530023|NCT01060072|7348485|FG000|Overall Study|Protocol Violation|0
4530024|NCT01060072|7348486|FG001|Overall Study|Protocol Violation|1
4530025|NCT01060072|7348485|FG000|Overall Study|Acute cholecystitis|1
4530026|NCT01060072|7348486|FG001|Overall Study|Acute cholecystitis|0
4530027|NCT01060072|7348485|FG000|Overall Study|Excluded Medications|0
4530028|NCT01060072|7348486|FG001|Overall Study|Excluded Medications|1
4530029|NCT01060111|7348508|FG000|Overall Study|Adverse Event|9
4530030|NCT01060111|7348509|FG001|Overall Study|Adverse Event|5
4530031|NCT01060111|7348510|FG002|Overall Study|Adverse Event|18
4530032|NCT01060111|7348508|FG000|Overall Study|Lack of Efficacy|2
4530033|NCT01060111|7348509|FG001|Overall Study|Lack of Efficacy|1
4530034|NCT01060111|7348510|FG002|Overall Study|Lack of Efficacy|0
4530035|NCT01060111|7348508|FG000|Overall Study|Inappropriate participant|5
4530036|NCT01060111|7348509|FG001|Overall Study|Inappropriate participant|4
4530037|NCT01060111|7348510|FG002|Overall Study|Inappropriate participant|5
4530038|NCT01060111|7348508|FG000|Overall Study|Participants' evasion for hospital visit|0
4530039|NCT01060111|7348509|FG001|Overall Study|Participants' evasion for hospital visit|3
4530040|NCT01060111|7348510|FG002|Overall Study|Participants' evasion for hospital visit|2
4530041|NCT01060111|7348508|FG000|Overall Study|Participants' non-cooperation|8
4530042|NCT01060111|7348509|FG001|Overall Study|Participants' non-cooperation|6
4530043|NCT01060111|7348510|FG002|Overall Study|Participants' non-cooperation|6
4530044|NCT01060111|7348508|FG000|Overall Study|Adverse event and insufficient effect|0
4530045|NCT01060111|7348509|FG001|Overall Study|Adverse event and insufficient effect|1
4530046|NCT01060111|7348510|FG002|Overall Study|Adverse event and insufficient effect|0
4530047|NCT01060111|7348508|FG000|Overall Study|Participants' non-cooperation|1
4530048|NCT01060111|7348509|FG001|Overall Study|Participants' non-cooperation|0
4530049|NCT01060111|7348510|FG002|Overall Study|Participants' non-cooperation|0
4609356|NCT01685801|7465075|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0
4609357|NCT01685801|7465076|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1
4609358|NCT01685840|7465095|FG000|Overall Study|Death|77
4609359|NCT01685840|7465096|FG001|Overall Study|Death|66
4609360|NCT01685840|7465095|FG000|Overall Study|Lost to Follow-up|27
4609361|NCT01685840|7465096|FG001|Overall Study|Lost to Follow-up|25
4609362|NCT01685840|7465095|FG000|Overall Study|Physician Decision|3
4609363|NCT01685840|7465096|FG001|Overall Study|Physician Decision|7
4609364|NCT01685840|7465095|FG000|Overall Study|Withdrawal by Subject|14
4609365|NCT01685840|7465096|FG001|Overall Study|Withdrawal by Subject|17
4609366|NCT01685840|7465095|FG000|Overall Study|Futility|197
4609367|NCT01685840|7465096|FG001|Overall Study|Futility|200
4609368|NCT01685840|7465095|FG000|Overall Study|Had VAD, Dialysis or Transplant|11
4609369|NCT01685840|7465096|FG001|Overall Study|Had VAD, Dialysis or Transplant|17
4609370|NCT01685983|7465104|FG000|Overall Study|Adverse Event|7
4609371|NCT01685983|7465104|FG000|Overall Study|Death|1
4609372|NCT01685983|7465104|FG000|Overall Study|Withdrawal by Subject|19
4609373|NCT01685983|7465104|FG000|Overall Study|Protocol Violation|2
4609374|NCT01685983|7465104|FG000|Overall Study|Physician Decision|13
4609375|NCT01685983|7465104|FG000|Overall Study|Other|7
4609376|NCT01685983|7465104|FG000|Overall Study|Progressive Disease|32
4609377|NCT01685983|7465104|FG000|Overall Study|Noncompliance with Study Drug|1
4609378|NCT01686152|7465120|FG000|Overall Study|Withdrawal by Subject|11
4609379|NCT01686152|7465121|FG001|Overall Study|Withdrawal by Subject|11
4609380|NCT01686152|7465122|FG002|Overall Study|Withdrawal by Subject|3
4609381|NCT01686152|7465120|FG000|Overall Study|Drug Code Unblinded|0
4609382|NCT01686152|7465121|FG001|Overall Study|Drug Code Unblinded|1
4609383|NCT01686152|7465122|FG002|Overall Study|Drug Code Unblinded|0
4609384|NCT01686152|7465120|FG000|Overall Study|Protocol Violation|6
4609385|NCT01686152|7465121|FG001|Overall Study|Protocol Violation|1
4609386|NCT01686152|7465122|FG002|Overall Study|Protocol Violation|0
4609387|NCT01686152|7465120|FG000|Overall Study|Adverse Event|12
4609388|NCT01686152|7465121|FG001|Overall Study|Adverse Event|11
4609389|NCT01686152|7465122|FG002|Overall Study|Adverse Event|0
4609390|NCT01686152|7465120|FG000|Overall Study|Lack of Efficacy|0
4609391|NCT01686152|7465121|FG001|Overall Study|Lack of Efficacy|0
4609392|NCT01686152|7465122|FG002|Overall Study|Lack of Efficacy|1
4609393|NCT01686152|7465120|FG000|Overall Study|IP Non-compliance|5
4609394|NCT01686152|7465121|FG001|Overall Study|IP Non-compliance|5
4609395|NCT01686152|7465122|FG002|Overall Study|IP Non-compliance|0
4609396|NCT01686152|7465120|FG000|Overall Study|Lost to Follow-up|7
4609397|NCT01686152|7465121|FG001|Overall Study|Lost to Follow-up|6
4609398|NCT01686152|7465122|FG002|Overall Study|Lost to Follow-up|5
4609399|NCT01686373|7465136|FG000|Overall Study|Lost to Follow-up|3
4609400|NCT01686373|7465137|FG001|Overall Study|Lost to Follow-up|0
4609401|NCT01686373|7465136|FG000|Overall Study|Withdrawal by Subject|0
4530050|NCT01060111|7348508|FG000|Overall Study|Other|2
4530051|NCT01060111|7348509|FG001|Overall Study|Other|3
4530052|NCT01060111|7348510|FG002|Overall Study|Other|4
4530053|NCT01060124|7348521|FG000|Overall Study|Other|16
4530054|NCT01060124|7348521|FG000|Overall Study|Adverse Event|14
4530055|NCT01060124|7348521|FG000|Overall Study|Withdrawal by Subject|7
4530056|NCT01060150|7348525|FG000|Overall Study|Adverse Event|6
4530057|NCT01060150|7348525|FG000|Overall Study|Lost to Follow-up|1
4530058|NCT01060150|7348525|FG000|Overall Study|Protocol Violation|6
4530059|NCT01060150|7348525|FG000|Overall Study|Withdrawal by Subject|8
4530060|NCT01060150|7348525|FG000|Overall Study|Enrolled, but not treated|2
4530061|NCT01060384|7348533|FG000|Overall Study|Withdrawal by Subject|0
4530062|NCT01060384|7348534|FG001|Overall Study|Withdrawal by Subject|1
4530063|NCT01060384|7348535|FG002|Overall Study|Withdrawal by Subject|0
4530064|NCT01060384|7348536|FG003|Overall Study|Withdrawal by Subject|0
4530065|NCT01060384|7348537|FG004|Overall Study|Withdrawal by Subject|0
4530066|NCT01060384|7348533|FG000|Overall Study|Death|0
4530067|NCT01060384|7348534|FG001|Overall Study|Death|0
4530068|NCT01060384|7348535|FG002|Overall Study|Death|0
4530069|NCT01060384|7348536|FG003|Overall Study|Death|0
4530070|NCT01060384|7348537|FG004|Overall Study|Death|1
4530071|NCT01060384|7348533|FG000|Overall Study|Intercurrent illness|0
4530072|NCT01060384|7348534|FG001|Overall Study|Intercurrent illness|0
4530073|NCT01060384|7348535|FG002|Overall Study|Intercurrent illness|0
4530074|NCT01060384|7348536|FG003|Overall Study|Intercurrent illness|0
4530075|NCT01060384|7348537|FG004|Overall Study|Intercurrent illness|1
4530076|NCT01060540|7348548|FG000|Overall Study|Withdrawal by Subject|10
4530077|NCT01060540|7348549|FG001|Overall Study|Withdrawal by Subject|20
4530078|NCT01060540|7348548|FG000|Overall Study|Lost to Follow-up|52
4530079|NCT01060540|7348549|FG001|Overall Study|Lost to Follow-up|43
4530080|NCT01060540|7348548|FG000|Overall Study|Death|2
4530081|NCT01060540|7348549|FG001|Overall Study|Death|1
4530082|NCT01060540|7348548|FG000|Overall Study|Physician Decision|0
4530083|NCT01060540|7348549|FG001|Overall Study|Physician Decision|1
4530084|NCT01060553|7348557|FG000|Overall Study|Lost to Follow-up|3
4530085|NCT01060553|7348558|FG001|Overall Study|Lost to Follow-up|5
4530086|NCT01060553|7348557|FG000|Overall Study|Withdrawal by Subject|5
4530087|NCT01060553|7348558|FG001|Overall Study|Withdrawal by Subject|5
4530088|NCT01060553|7348557|FG000|Overall Study|Lack of Efficacy|1
4530089|NCT01060553|7348558|FG001|Overall Study|Lack of Efficacy|0
4530090|NCT01060670|7348574|FG000|Run In|screen failure|0
4530091|NCT01060670|7348575|FG001|Run In|screen failure|238
4530092|NCT01061008|7348585|FG000|Overall Study|Badiocephalic fistula failed|3
4530093|NCT01061008|7348586|FG001|Overall Study|Badiocephalic fistula failed|2
4530094|NCT01061008|7348585|FG000|Overall Study|Death|1
4530095|NCT01061008|7348586|FG001|Overall Study|Death|0
4530096|NCT01061008|7348585|FG000|Overall Study|Withdrawal by Subject|1
4530097|NCT01061008|7348586|FG001|Overall Study|Withdrawal by Subject|3
4530098|NCT01061008|7348585|FG000|Overall Study|Unable to exercise following surgery|1
4530099|NCT01061008|7348586|FG001|Overall Study|Unable to exercise following surgery|0
4530100|NCT01061008|7348585|FG000|Overall Study|Adverse Event|0
4530101|NCT01061008|7348586|FG001|Overall Study|Adverse Event|1
4530102|NCT01061177|7348596|FG000|Overall Study|Adverse Event|117
4530103|NCT01061177|7348596|FG000|Overall Study|Withdrawal by Subject|27
4530104|NCT01061177|7348596|FG000|Overall Study|Disease progression|17
4530105|NCT01061177|7348596|FG000|Overall Study|Protocol Violation|11
4530106|NCT01061177|7348596|FG000|Overall Study|Lost to Follow-up|9
4530107|NCT01061177|7348596|FG000|Overall Study|New cancer therapy|9
4530108|NCT01061177|7348596|FG000|Overall Study|Abnormal laboratory values|6
4530109|NCT01061177|7348596|FG000|Overall Study|Abnormal test procedure results|4
4530110|NCT01061177|7348596|FG000|Overall Study|Administratie problems|4
4530111|NCT01061177|7348596|FG000|Overall Study|Death|4
4530112|NCT01061333|7348600|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0
4530113|NCT01061333|7348601|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1
4530114|NCT01061359|7348612|FG000|Overall Study|Death|32
4530115|NCT01061359|7348612|FG000|Overall Study|Lost to Follow-up|1072
4530116|NCT01061359|7348612|FG000|Overall Study|Relapse|187
4530117|NCT01061359|7348612|FG000|Overall Study|Secondary neoplasm|11
4530118|NCT01061385|7348618|FG000|Overall Study|Lost to Follow-up|1
4530119|NCT01061385|7348619|FG001|Overall Study|Lost to Follow-up|0
4530120|NCT01061385|7348618|FG000|Overall Study|subject decision not related to AE|0
4530121|NCT01061385|7348619|FG001|Overall Study|subject decision not related to AE|1
4530122|NCT01061567|7348639|FG000|Overall Study|Adverse Event|32
4530123|NCT01061567|7348639|FG000|Overall Study|Death|2
4530124|NCT01061567|7348639|FG000|Overall Study|Lack of Efficacy|3
4530125|NCT01061567|7348639|FG000|Overall Study|Lost to Follow-up|24
4530126|NCT01061567|7348639|FG000|Overall Study|Protocol Violation|1
4530127|NCT01061567|7348639|FG000|Overall Study|Withdrawal by Subject|11
4530128|NCT01061567|7348639|FG000|Overall Study|Other reason than stated above|3
4530129|NCT01061606|7348643|FG000|Overall Study|Adverse Event|1
4530130|NCT01061606|7348643|FG000|Overall Study|Death|1
4530131|NCT01061606|7348643|FG000|Overall Study|Disease Progression|4
4530132|NCT01061606|7348643|FG000|Overall Study|alternative therapy|2
4530133|NCT01061671|7348649|FG000|Overall Study|Withdrawal by Subject|16
4530134|NCT01061671|7348650|FG001|Overall Study|Withdrawal by Subject|20
4530135|NCT01061671|7348649|FG000|Overall Study|Lost to Follow-up|3
4530136|NCT01061671|7348650|FG001|Overall Study|Lost to Follow-up|5
4530137|NCT01061671|7348649|FG000|Overall Study|Death|28
4530138|NCT01061671|7348650|FG001|Overall Study|Death|30
4530139|NCT01061710|7348656|FG000|Overall Study|Protocol Violation|14
4530140|NCT01061723|7348666|FG000|Overall Study|Adverse Event|0
4530141|NCT01061723|7348667|FG001|Overall Study|Adverse Event|2
4530142|NCT01061723|7348668|FG002|Overall Study|Adverse Event|5
4530143|NCT01061723|7348669|FG003|Overall Study|Adverse Event|5
4530144|NCT01061723|7348670|FG004|Overall Study|Adverse Event|2
4530145|NCT01061723|7348671|FG005|Overall Study|Adverse Event|6
4530146|NCT01061723|7348666|FG000|Overall Study|Lack of Efficacy|2
4530147|NCT01061723|7348667|FG001|Overall Study|Lack of Efficacy|3
4530148|NCT01061723|7348668|FG002|Overall Study|Lack of Efficacy|4
4530149|NCT01061723|7348669|FG003|Overall Study|Lack of Efficacy|2
4530150|NCT01061723|7348670|FG004|Overall Study|Lack of Efficacy|1
4530151|NCT01061723|7348671|FG005|Overall Study|Lack of Efficacy|1
4530152|NCT01061723|7348666|FG000|Overall Study|Randomized but not treated|0
4530153|NCT01061723|7348667|FG001|Overall Study|Randomized but not treated|0
4530154|NCT01061723|7348668|FG002|Overall Study|Randomized but not treated|0
4530155|NCT01061723|7348669|FG003|Overall Study|Randomized but not treated|0
4530156|NCT01061723|7348670|FG004|Overall Study|Randomized but not treated|0
4530157|NCT01061723|7348671|FG005|Overall Study|Randomized but not treated|1
4530158|NCT01061723|7348666|FG000|Overall Study|Other than specified above|2
4530159|NCT01061723|7348667|FG001|Overall Study|Other than specified above|1
4530160|NCT01061723|7348668|FG002|Overall Study|Other than specified above|1
4530161|NCT01061723|7348669|FG003|Overall Study|Other than specified above|1
4530162|NCT01061723|7348670|FG004|Overall Study|Other than specified above|0
4530163|NCT01061723|7348671|FG005|Overall Study|Other than specified above|1
4530164|NCT01061736|7348700|FG000|Overall Study|Dose regimen not selected|0
4530165|NCT01061736|7348701|FG001|Overall Study|Dose regimen not selected|0
4530166|NCT01061736|7348702|FG002|Overall Study|Dose regimen not selected|0
4530167|NCT01061736|7348703|FG003|Overall Study|Dose regimen not selected|0
4530168|NCT01061736|7348704|FG004|Overall Study|Dose regimen not selected|0
4530169|NCT01061736|7348705|FG005|Overall Study|Dose regimen not selected|0
4530170|NCT01061736|7348706|FG006|Overall Study|Dose regimen not selected|79
4530171|NCT01061736|7348707|FG007|Overall Study|Dose regimen not selected|0
4530172|NCT01061736|7348708|FG008|Overall Study|Dose regimen not selected|0
4530173|NCT01061736|7348709|FG009|Overall Study|Dose regimen not selected|0
4530174|NCT01061736|7348700|FG000|Overall Study|Adverse Event|13
4530175|NCT01061736|7348701|FG001|Overall Study|Adverse Event|1
4530176|NCT01061736|7348702|FG002|Overall Study|Adverse Event|3
4530177|NCT01061736|7348703|FG003|Overall Study|Adverse Event|2
4530178|NCT01061736|7348704|FG004|Overall Study|Adverse Event|4
4530179|NCT01061736|7348705|FG005|Overall Study|Adverse Event|1
4530180|NCT01061736|7348706|FG006|Overall Study|Adverse Event|4
4530181|NCT01061736|7348707|FG007|Overall Study|Adverse Event|63
4530182|NCT01061736|7348708|FG008|Overall Study|Adverse Event|67
4530183|NCT01061736|7348709|FG009|Overall Study|Adverse Event|34
4530184|NCT01061736|7348700|FG000|Overall Study|Lack of Efficacy|0
4530185|NCT01061736|7348701|FG001|Overall Study|Lack of Efficacy|2
4530186|NCT01061736|7348702|FG002|Overall Study|Lack of Efficacy|1
4530187|NCT01061736|7348703|FG003|Overall Study|Lack of Efficacy|1
4530188|NCT01061736|7348704|FG004|Overall Study|Lack of Efficacy|1
4530189|NCT01061736|7348705|FG005|Overall Study|Lack of Efficacy|2
4530190|NCT01061736|7348706|FG006|Overall Study|Lack of Efficacy|1
4530191|NCT01061736|7348707|FG007|Overall Study|Lack of Efficacy|9
4530192|NCT01061736|7348708|FG008|Overall Study|Lack of Efficacy|9
4530193|NCT01061736|7348709|FG009|Overall Study|Lack of Efficacy|10
4530194|NCT01061736|7348700|FG000|Overall Study|Poor compliance to protocol|0
4530195|NCT01061736|7348701|FG001|Overall Study|Poor compliance to protocol|0
4530196|NCT01061736|7348702|FG002|Overall Study|Poor compliance to protocol|0
4530197|NCT01061736|7348703|FG003|Overall Study|Poor compliance to protocol|0
4530198|NCT01061736|7348704|FG004|Overall Study|Poor compliance to protocol|0
4530199|NCT01061736|7348705|FG005|Overall Study|Poor compliance to protocol|0
4530200|NCT01061736|7348706|FG006|Overall Study|Poor compliance to protocol|0
4530201|NCT01061736|7348707|FG007|Overall Study|Poor compliance to protocol|2
4530202|NCT01061736|7348708|FG008|Overall Study|Poor compliance to protocol|5
4530203|NCT01061736|7348709|FG009|Overall Study|Poor compliance to protocol|9
4530204|NCT01061736|7348700|FG000|Overall Study|Not treated|0
4530205|NCT01061736|7348701|FG001|Overall Study|Not treated|0
4530206|NCT01061736|7348702|FG002|Overall Study|Not treated|0
4530207|NCT01061736|7348703|FG003|Overall Study|Not treated|0
4530208|NCT01061736|7348704|FG004|Overall Study|Not treated|1
4530209|NCT01061736|7348705|FG005|Overall Study|Not treated|0
4530210|NCT01061736|7348706|FG006|Overall Study|Not treated|0
4530211|NCT01061736|7348707|FG007|Overall Study|Not treated|2
4530212|NCT01061736|7348708|FG008|Overall Study|Not treated|1
4530213|NCT01061736|7348709|FG009|Overall Study|Not treated|0
4530214|NCT01061736|7348700|FG000|Overall Study|Other than specified above|0
4530215|NCT01061736|7348701|FG001|Overall Study|Other than specified above|1
4530216|NCT01061736|7348702|FG002|Overall Study|Other than specified above|2
4530217|NCT01061736|7348703|FG003|Overall Study|Other than specified above|0
4530218|NCT01061736|7348704|FG004|Overall Study|Other than specified above|1
4530219|NCT01061736|7348705|FG005|Overall Study|Other than specified above|0
4530220|NCT01061736|7348706|FG006|Overall Study|Other than specified above|0
4530221|NCT01061736|7348707|FG007|Overall Study|Other than specified above|18
4530222|NCT01061736|7348708|FG008|Overall Study|Other than specified above|15
4530223|NCT01061736|7348709|FG009|Overall Study|Other than specified above|21
4530224|NCT01061775|7348734|FG000|Overall Study|Physician Decision|2
4530225|NCT01061775|7348734|FG000|Overall Study|Lost to Follow-up|1
4530226|NCT01061866|7348739|FG000|Overall Study|Adverse Event|2
4530227|NCT01062061|7348760|FG000|Overall Study|Enrolled more than once|2
4530228|NCT01062061|7348760|FG000|Overall Study|Investigated before study start|13
4530229|NCT01062061|7348760|FG000|Overall Study|Outside chief indications|10
4530230|NCT01062061|7348760|FG000|Overall Study|Failed to meet inclusion criteria|2
4530231|NCT01062113|7348775|FG000|Overall Study|Adverse Event|1
4530232|NCT01062113|7348776|FG001|Overall Study|Adverse Event|0
4530233|NCT01062113|7348777|FG002|Overall Study|Adverse Event|0
4530234|NCT01062113|7348775|FG000|Overall Study|Lack of Efficacy|38
4609402|NCT01686373|7465137|FG001|Overall Study|Withdrawal by Subject|1
4609403|NCT01686373|7465136|FG000|Overall Study|Adverse Event|0
4609404|NCT01686373|7465137|FG001|Overall Study|Adverse Event|1
4609405|NCT01686438|7465146|FG000|Overall Study|Lost to Follow-up|8
4609406|NCT01686438|7465147|FG001|Overall Study|Lost to Follow-up|9
4609407|NCT01686438|7465148|FG002|Overall Study|Lost to Follow-up|10
4609408|NCT01686438|7465146|FG000|Overall Study|Adverse Event|0
4609409|NCT01686438|7465147|FG001|Overall Study|Adverse Event|0
4530235|NCT01062113|7348776|FG001|Overall Study|Lack of Efficacy|22
4530236|NCT01062113|7348777|FG002|Overall Study|Lack of Efficacy|31
4530237|NCT01062113|7348775|FG000|Overall Study|Withdrawal by Subject|1
4530238|NCT01062113|7348776|FG001|Overall Study|Withdrawal by Subject|0
4530239|NCT01062113|7348777|FG002|Overall Study|Withdrawal by Subject|0
4530240|NCT01062126|7348785|FG000|Overall Study|Death|209
4530241|NCT01062126|7348785|FG000|Overall Study|All Withdrawals|324
4530242|NCT01062256|7348800|FG000|Overall Study|Adverse Event|1
4530243|NCT01062256|7348801|FG001|Overall Study|Adverse Event|0
4530244|NCT01062256|7348802|FG002|Overall Study|Adverse Event|0
4530245|NCT01062256|7348800|FG000|Overall Study|Withdrawal by Subject|1
4530246|NCT01062256|7348801|FG001|Overall Study|Withdrawal by Subject|1
4530247|NCT01062256|7348802|FG002|Overall Study|Withdrawal by Subject|1
4530248|NCT01062256|7348800|FG000|Overall Study|Ineligible|1
4530249|NCT01062256|7348801|FG001|Overall Study|Ineligible|4
4530250|NCT01062256|7348802|FG002|Overall Study|Ineligible|3
4530251|NCT01062256|7348800|FG000|Overall Study|Administrative|0
4530252|NCT01062256|7348801|FG001|Overall Study|Administrative|2
4530253|NCT01062256|7348802|FG002|Overall Study|Administrative|0
4530254|NCT01062399|7348832|FG000|Overall Study|Protocol Violation|0
4530255|NCT01062399|7348833|FG001|Overall Study|Protocol Violation|1
4530256|NCT01062399|7348834|FG002|Overall Study|Protocol Violation|0
4530257|NCT01062399|7348835|FG003|Overall Study|Protocol Violation|6
4530258|NCT01062399|7348836|FG004|Overall Study|Protocol Violation|4
4530259|NCT01062555|7348850|FG000|Phase 1|Death|10
4530260|NCT01062555|7348851|FG001|Phase 1|Death|17
4530261|NCT01062555|7348852|FG002|Phase 1|Death|0
4530262|NCT01062555|7348853|FG003|Phase 1|Death|0
4530263|NCT01062555|7348850|FG000|Phase 1|Graft Failure|12
4530264|NCT01062555|7348851|FG001|Phase 1|Graft Failure|8
4530265|NCT01062555|7348852|FG002|Phase 1|Graft Failure|0
4530266|NCT01062555|7348853|FG003|Phase 1|Graft Failure|0
4530267|NCT01062555|7348850|FG000|Phase 1|Withdrawal by Subject|1
4530268|NCT01062555|7348851|FG001|Phase 1|Withdrawal by Subject|1
4530269|NCT01062555|7348852|FG002|Phase 1|Withdrawal by Subject|0
4530270|NCT01062555|7348853|FG003|Phase 1|Withdrawal by Subject|0
4530271|NCT01062555|7348850|FG000|Phase 2|Death|0
4530272|NCT01062555|7348851|FG001|Phase 2|Death|0
4530273|NCT01062555|7348852|FG002|Phase 2|Death|8
4530274|NCT01062555|7348853|FG003|Phase 2|Death|3
4530275|NCT01062555|7348850|FG000|Phase 2|Graft failure|0
4530276|NCT01062555|7348851|FG001|Phase 2|Graft failure|0
4530277|NCT01062555|7348852|FG002|Phase 2|Graft failure|7
4530278|NCT01062555|7348853|FG003|Phase 2|Graft failure|4
4530279|NCT01062555|7348850|FG000|Phase 2|Withdrawal by Subject|0
4530280|NCT01062555|7348851|FG001|Phase 2|Withdrawal by Subject|0
4530281|NCT01062555|7348852|FG002|Phase 2|Withdrawal by Subject|0
4530282|NCT01062555|7348853|FG003|Phase 2|Withdrawal by Subject|7
4530283|NCT01062555|7348850|FG000|Phase 2|Protocol Violation|0
4530284|NCT01062555|7348851|FG001|Phase 2|Protocol Violation|0
4530285|NCT01062555|7348852|FG002|Phase 2|Protocol Violation|0
4530286|NCT01062555|7348853|FG003|Phase 2|Protocol Violation|3
4530287|NCT01062555|7348850|FG000|Phase 2|Physician Decision|0
4530288|NCT01062555|7348851|FG001|Phase 2|Physician Decision|0
4530289|NCT01062555|7348852|FG002|Phase 2|Physician Decision|0
4530290|NCT01062555|7348853|FG003|Phase 2|Physician Decision|17
4530291|NCT01062763|7348879|FG000|Overall Study|Adverse Event|3
4530292|NCT01062763|7348880|FG001|Overall Study|Adverse Event|4
4530293|NCT01062841|7348888|FG000|Overall Study|Indwelling Device Removed|41
4530294|NCT01062841|7348889|FG001|Overall Study|Indwelling Device Removed|48
4530295|NCT01062841|7348888|FG000|Overall Study|Death|3
4530296|NCT01062841|7348889|FG001|Overall Study|Death|5
4530297|NCT01062841|7348888|FG000|Overall Study|Withdrawal by Subject|2
4530298|NCT01062841|7348889|FG001|Overall Study|Withdrawal by Subject|0
4530299|NCT01062841|7348888|FG000|Overall Study|Withdrawal by Study|3
4530300|NCT01062841|7348889|FG001|Overall Study|Withdrawal by Study|0
4530301|NCT01062971|7348906|FG000|Overall Study|Protocol Violation|1
4530302|NCT01062971|7348907|FG001|Overall Study|Protocol Violation|3
4609410|NCT01686438|7465148|FG002|Overall Study|Adverse Event|1
4609411|NCT01686438|7465146|FG000|Overall Study|Protocol Violation|0
4530303|NCT01062971|7348906|FG000|Overall Study|Lost to Follow-up|3
4530304|NCT01062971|7348907|FG001|Overall Study|Lost to Follow-up|4
4530305|NCT01063036|7348913|FG000|Participants Treated With Study Drug|Adverse Event|1
4530306|NCT01063036|7348913|FG000|Participants Treated With Study Drug|Protocol Violation|1
4530307|NCT01063036|7348913|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2
4530308|NCT01063036|7348913|FG000|Participants Treated With Study Drug|Lost to Follow-up|1
4530309|NCT01063036|7348913|FG000|Participants Treated With Study Drug|Pregnancy|1
4530310|NCT01063036|7348913|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1
4530311|NCT01063036|7348913|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6
4530312|NCT01063036|7348913|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32
4530313|NCT01063062|7348932|FG000|Overall Study|Patient withdrew consent|0
4530314|NCT01063062|7348933|FG001|Overall Study|Patient withdrew consent|1
4530315|NCT01063062|7348932|FG000|Overall Study|Adverse Event|2
4530316|NCT01063062|7348933|FG001|Overall Study|Adverse Event|4
4530317|NCT01063062|7348932|FG000|Overall Study|Protocol Violation|5
4530318|NCT01063062|7348933|FG001|Overall Study|Protocol Violation|4
4530319|NCT01063062|7348932|FG000|Overall Study|Investigator's request|1
4530320|NCT01063062|7348933|FG001|Overall Study|Investigator's request|0
4530321|NCT01063062|7348932|FG000|Overall Study|Lost to Follow-up|0
4530322|NCT01063062|7348933|FG001|Overall Study|Lost to Follow-up|2
4530323|NCT01063062|7348932|FG000|Overall Study|Miscellaneous reason|0
4530324|NCT01063062|7348933|FG001|Overall Study|Miscellaneous reason|1
4530325|NCT01063153|7348955|FG000|Overall Study|Found Ineligible During Screening|2
4530326|NCT01063153|7348956|FG001|Overall Study|Found Ineligible During Screening|0
4530327|NCT01063153|7348955|FG000|Overall Study|Lost to Follow-up|0
4530328|NCT01063153|7348956|FG001|Overall Study|Lost to Follow-up|7
4530329|NCT01063153|7348955|FG000|Overall Study|Withdrawal by Subject|0
4530330|NCT01063153|7348956|FG001|Overall Study|Withdrawal by Subject|1
4530331|NCT01063153|7348955|FG000|Overall Study|Physician Decision|0
4530332|NCT01063153|7348956|FG001|Overall Study|Physician Decision|4
4530333|NCT01063283|7348968|FG000|Cycle 1|Adverse Event|2
4530334|NCT01063283|7348969|FG001|Cycle 1|Adverse Event|0
4530335|NCT01063283|7348970|FG002|Cycle 1|Adverse Event|0
4530336|NCT01063283|7348968|FG000|Cycle 1|Technical failure in data collection|1
4530337|NCT01063283|7348969|FG001|Cycle 1|Technical failure in data collection|0
4530338|NCT01063283|7348970|FG002|Cycle 1|Technical failure in data collection|0
4530339|NCT01063348|7348978|FG000|Overall Study|Lost to Follow-up|3
4530340|NCT01063348|7348979|FG001|Overall Study|Lost to Follow-up|10
4530341|NCT01063595|7348985|FG000|Enrolled in Study and Randomized|Reason not Specified|1
4530342|NCT01063595|7348986|FG001|Enrolled in Study and Randomized|Reason not Specified|0
4530343|NCT01063595|7348985|FG000|Enrolled in Study and Randomized|Adverse Event|0
4530344|NCT01063595|7348986|FG001|Enrolled in Study and Randomized|Adverse Event|1
4530345|NCT01063595|7348985|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0
4530346|NCT01063595|7348986|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1
4530347|NCT01063595|7348985|FG000|First Intervention|Adverse Event|1
4530348|NCT01063595|7348986|FG001|First Intervention|Adverse Event|4
4530349|NCT01063595|7348985|FG000|First Intervention|Withdrawal by Subject|1
4530350|NCT01063595|7348986|FG001|First Intervention|Withdrawal by Subject|0
4530351|NCT01063595|7348985|FG000|First Intervention|Reason not Specified|0
4530352|NCT01063595|7348986|FG001|First Intervention|Reason not Specified|1
4530353|NCT01063764|7348997|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4
4530354|NCT01063764|7348997|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6
4530355|NCT01063764|7348997|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1
4530356|NCT01063764|7348997|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3
4530357|NCT01063764|7348997|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9
4530358|NCT01063764|7348997|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7
4530359|NCT01063764|7348997|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1
4530360|NCT01063855|7349020|FG000|Overall Study|Adverse Event|4
4530361|NCT01063855|7349021|FG001|Overall Study|Adverse Event|4
4530362|NCT01063855|7349020|FG000|Overall Study|Death|0
4530363|NCT01063855|7349021|FG001|Overall Study|Death|1
4530364|NCT01063855|7349020|FG000|Overall Study|Lost to Follow-up|8
4530365|NCT01063855|7349021|FG001|Overall Study|Lost to Follow-up|4
4530366|NCT01063855|7349020|FG000|Overall Study|Pregnancy|1
4530367|NCT01063855|7349021|FG001|Overall Study|Pregnancy|0
4530368|NCT01063855|7349020|FG000|Overall Study|Lack of Efficacy|0
4530369|NCT01063855|7349021|FG001|Overall Study|Lack of Efficacy|1
4530370|NCT01063855|7349020|FG000|Overall Study|Withdrawal by Subject|11
4530371|NCT01063855|7349021|FG001|Overall Study|Withdrawal by Subject|8
4530372|NCT01063855|7349020|FG000|Overall Study|Reason not specified|13
4530373|NCT01063855|7349021|FG001|Overall Study|Reason not specified|11
4530374|NCT01063868|7349033|FG000|Overall Study|Adverse Event|9
4530375|NCT01063868|7349034|FG001|Overall Study|Adverse Event|7
4530376|NCT01063868|7349033|FG000|Overall Study|Withdrawal by Subject|3
4530377|NCT01063868|7349034|FG001|Overall Study|Withdrawal by Subject|1
4530378|NCT01063868|7349033|FG000|Overall Study|Study Terminated By Sponsor|23
4530379|NCT01063868|7349034|FG001|Overall Study|Study Terminated By Sponsor|4
4530380|NCT01063881|7349043|FG000|Overall Study|Adverse Event|12
4530381|NCT01063881|7349044|FG001|Overall Study|Adverse Event|2
4530382|NCT01063881|7349045|FG002|Overall Study|Adverse Event|0
4530383|NCT01063881|7349043|FG000|Overall Study|Lost to Follow-up|13
4530384|NCT01063881|7349044|FG001|Overall Study|Lost to Follow-up|7
4530385|NCT01063881|7349045|FG002|Overall Study|Lost to Follow-up|1
4530386|NCT01063881|7349043|FG000|Overall Study|Withdrawal by Subject|25
4530387|NCT01063881|7349044|FG001|Overall Study|Withdrawal by Subject|1
4530388|NCT01063881|7349045|FG002|Overall Study|Withdrawal by Subject|0
4530389|NCT01063881|7349043|FG000|Overall Study|Reason for not completed not specified|5
4530390|NCT01063881|7349044|FG001|Overall Study|Reason for not completed not specified|1
4530391|NCT01063881|7349045|FG002|Overall Study|Reason for not completed not specified|0
4530392|NCT01063972|7349085|FG000|Overall Study|Death|12
4530393|NCT01063972|7349086|FG001|Overall Study|Death|11
4530394|NCT01063972|7349085|FG000|Overall Study|Incarcerated|2
4530395|NCT01063972|7349086|FG001|Overall Study|Incarcerated|1
4530396|NCT01064167|7349099|FG000|Overall Study|Protocol Violation|14
4530397|NCT01064167|7349100|FG001|Overall Study|Protocol Violation|15
4530398|NCT01064297|7349119|FG000|Overall Study|Lost to Follow-up|791
4530399|NCT01064297|7349120|FG001|Overall Study|Lost to Follow-up|48
4530400|NCT01064297|7349121|FG002|Overall Study|Lost to Follow-up|133
4530401|NCT01064310|7349138|FG000|Period 1|Adverse Event|7
4530402|NCT01064310|7349139|FG001|Period 1|Adverse Event|10
4530403|NCT01064310|7349140|FG002|Period 1|Adverse Event|0
4530404|NCT01064310|7349138|FG000|Period 1|Physician Decision|1
4530405|NCT01064310|7349139|FG001|Period 1|Physician Decision|0
4530406|NCT01064310|7349140|FG002|Period 1|Physician Decision|0
4530407|NCT01064310|7349138|FG000|Period 1|Withdrawal by Subject|2
4530408|NCT01064310|7349139|FG001|Period 1|Withdrawal by Subject|2
4530409|NCT01064310|7349140|FG002|Period 1|Withdrawal by Subject|0
4530410|NCT01064310|7349138|FG000|Period 1|Lack of Efficacy|3
4530411|NCT01064310|7349139|FG001|Period 1|Lack of Efficacy|5
4530412|NCT01064310|7349140|FG002|Period 1|Lack of Efficacy|0
4530413|NCT01064310|7349138|FG000|Period 1|Entered Open-label Period|1
4530414|NCT01064310|7349139|FG001|Period 1|Entered Open-label Period|1
4530415|NCT01064310|7349140|FG002|Period 1|Entered Open-label Period|0
4530416|NCT01064310|7349138|FG000|Period 2|Adverse Event|2
4530417|NCT01064310|7349139|FG001|Period 2|Adverse Event|1
4530418|NCT01064310|7349140|FG002|Period 2|Adverse Event|0
4530419|NCT01064310|7349138|FG000|Period 2|Physician Decision|0
4530420|NCT01064310|7349139|FG001|Period 2|Physician Decision|1
4530421|NCT01064310|7349140|FG002|Period 2|Physician Decision|0
4530422|NCT01064310|7349138|FG000|Period 2|Entered Open-label Period|1
4530423|NCT01064310|7349139|FG001|Period 2|Entered Open-label Period|0
4530424|NCT01064310|7349140|FG002|Period 2|Entered Open-label Period|0
4530425|NCT01064310|7349138|FG000|Period 2|Lack of Efficacy|1
4530426|NCT01064310|7349139|FG001|Period 2|Lack of Efficacy|4
4530427|NCT01064310|7349140|FG002|Period 2|Lack of Efficacy|0
4530428|NCT01064310|7349138|FG000|Open Label Pazopinib|Withdrawal by Subject|0
4530429|NCT01064310|7349139|FG001|Open Label Pazopinib|Withdrawal by Subject|0
4530430|NCT01064310|7349140|FG002|Open Label Pazopinib|Withdrawal by Subject|1
4530431|NCT01064310|7349138|FG000|Open Label Pazopinib|Adverse Event|0
4530432|NCT01064310|7349139|FG001|Open Label Pazopinib|Adverse Event|0
4530433|NCT01064310|7349140|FG002|Open Label Pazopinib|Adverse Event|12
4530434|NCT01064310|7349138|FG000|Open Label Pazopinib|Lack of Efficacy|0
4530435|NCT01064310|7349139|FG001|Open Label Pazopinib|Lack of Efficacy|0
4530436|NCT01064310|7349140|FG002|Open Label Pazopinib|Lack of Efficacy|51
4530437|NCT01064310|7349138|FG000|Open Label Pazopinib|Physician Decision|0
4530438|NCT01064310|7349139|FG001|Open Label Pazopinib|Physician Decision|0
4530439|NCT01064310|7349140|FG002|Open Label Pazopinib|Physician Decision|20
4530440|NCT01064401|7349164|FG000|Overall Study|Adverse Event|47
4530441|NCT01064401|7349165|FG001|Overall Study|Adverse Event|56
4530442|NCT01064401|7349164|FG000|Overall Study|Lack of Efficacy|46
4530443|NCT01064401|7349165|FG001|Overall Study|Lack of Efficacy|23
4530444|NCT01064401|7349164|FG000|Overall Study|Lost to Follow-up|12
4530445|NCT01064401|7349165|FG001|Overall Study|Lost to Follow-up|9
4530446|NCT01064401|7349164|FG000|Overall Study|Consent Withdrawn|98
4530447|NCT01064401|7349165|FG001|Overall Study|Consent Withdrawn|80
4530448|NCT01064401|7349164|FG000|Overall Study|Investigator Decision|4
4530449|NCT01064401|7349165|FG001|Overall Study|Investigator Decision|6
4530450|NCT01064401|7349164|FG000|Overall Study|Death|4
4530451|NCT01064401|7349165|FG001|Overall Study|Death|0
4530452|NCT01064401|7349164|FG000|Overall Study|Pregnancy|4
4530453|NCT01064401|7349165|FG001|Overall Study|Pregnancy|7
4530454|NCT01064401|7349164|FG000|Overall Study|Noncompliance|7
4530455|NCT01064401|7349165|FG001|Overall Study|Noncompliance|8
4530456|NCT01064401|7349164|FG000|Overall Study|Site Closure|4
4530457|NCT01064401|7349165|FG001|Overall Study|Site Closure|5
4530458|NCT01064401|7349164|FG000|Overall Study|Other|2
4530459|NCT01064401|7349165|FG001|Overall Study|Other|1
4530460|NCT01064414|7349175|FG000|Core Period: Baseline to Week 26|Adverse Event|4
4530461|NCT01064414|7349176|FG001|Core Period: Baseline to Week 26|Adverse Event|4
4530462|NCT01064414|7349177|FG002|Core Period: Baseline to Week 26|Adverse Event|2
4530463|NCT01064414|7349175|FG000|Core Period: Baseline to Week 26|Death|0
4530464|NCT01064414|7349176|FG001|Core Period: Baseline to Week 26|Death|1
4530465|NCT01064414|7349177|FG002|Core Period: Baseline to Week 26|Death|0
4530466|NCT01064414|7349175|FG000|Core Period: Baseline to Week 26|Protocol Violation|1
4530467|NCT01064414|7349176|FG001|Core Period: Baseline to Week 26|Protocol Violation|0
4590794|NCT01524887|7437055|FG000|Overall Study|Study termination|73
4609412|NCT01686438|7465147|FG001|Overall Study|Protocol Violation|0
4530468|NCT01064414|7349177|FG002|Core Period: Baseline to Week 26|Protocol Violation|1
4530469|NCT01064414|7349175|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4
4530470|NCT01064414|7349176|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2
4530471|NCT01064414|7349177|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2
4530472|NCT01064414|7349175|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0
4530473|NCT01064414|7349176|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1
4530474|NCT01064414|7349177|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0
4530475|NCT01064414|7349175|FG000|Core Period: Baseline to Week 26|Other|4
4530476|NCT01064414|7349176|FG001|Core Period: Baseline to Week 26|Other|7
4530477|NCT01064414|7349177|FG002|Core Period: Baseline to Week 26|Other|2
4530478|NCT01064414|7349175|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2
4530479|NCT01064414|7349176|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1
4530480|NCT01064414|7349177|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2
4530481|NCT01064414|7349175|FG000|Extension Period: Week 26 to Week 52|Death|0
4530482|NCT01064414|7349176|FG001|Extension Period: Week 26 to Week 52|Death|1
4530483|NCT01064414|7349177|FG002|Extension Period: Week 26 to Week 52|Death|0
4530484|NCT01064414|7349175|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
4530485|NCT01064414|7349176|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
4530486|NCT01064414|7349177|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
4530487|NCT01064414|7349175|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1
4530488|NCT01064414|7349176|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0
4530489|NCT01064414|7349177|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0
4530490|NCT01064414|7349175|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
4530491|NCT01064414|7349176|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
4530492|NCT01064414|7349177|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
4530493|NCT01064414|7349175|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1
4530494|NCT01064414|7349176|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
4530495|NCT01064414|7349177|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
4530496|NCT01064414|7349175|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1
4530497|NCT01064414|7349176|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1
4530498|NCT01064414|7349177|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1
4530499|NCT01064414|7349175|FG000|Extension Period: Week 26 to Week 52|Other|5
4530500|NCT01064414|7349176|FG001|Extension Period: Week 26 to Week 52|Other|2
4530501|NCT01064414|7349177|FG002|Extension Period: Week 26 to Week 52|Other|1
4530502|NCT01064531|7349190|FG000|Overall Study|Lost to Follow-up|0
4530503|NCT01064531|7349191|FG001|Overall Study|Lost to Follow-up|2
4530504|NCT01064531|7349190|FG000|Overall Study|Physician Decision|0
4530505|NCT01064531|7349191|FG001|Overall Study|Physician Decision|1
4530506|NCT01064531|7349190|FG000|Overall Study|Withdrawal by Subject|2
4530507|NCT01064531|7349191|FG001|Overall Study|Withdrawal by Subject|2
4530508|NCT01064531|7349190|FG000|Overall Study|Revision due to femoral stem loosening|1
4530509|NCT01064531|7349191|FG001|Overall Study|Revision due to femoral stem loosening|0
4530510|NCT01064531|7349190|FG000|Overall Study|Revision due to dislocation|0
4530511|NCT01064531|7349191|FG001|Overall Study|Revision due to dislocation|1
4530512|NCT01064531|7349190|FG000|Overall Study|Death|0
4530513|NCT01064531|7349191|FG001|Overall Study|Death|1
4530514|NCT01064622|7349200|FG000|Randomized Phase II|Withdrawal by Subject|2
4530515|NCT01064622|7349201|FG001|Randomized Phase II|Withdrawal by Subject|2
4530516|NCT01064622|7349200|FG000|Randomized Phase II|Protocol Violation|0
4530517|NCT01064622|7349201|FG001|Randomized Phase II|Protocol Violation|1
4530518|NCT01064687|7349214|FG000|Overall Study|Adverse Event|9
4530519|NCT01064687|7349215|FG001|Overall Study|Adverse Event|4
4530520|NCT01064687|7349216|FG002|Overall Study|Adverse Event|10
4530521|NCT01064687|7349217|FG003|Overall Study|Adverse Event|3
4530522|NCT01064687|7349214|FG000|Overall Study|Death|1
4530523|NCT01064687|7349215|FG001|Overall Study|Death|1
4530524|NCT01064687|7349216|FG002|Overall Study|Death|0
4530525|NCT01064687|7349217|FG003|Overall Study|Death|0
4530526|NCT01064687|7349214|FG000|Overall Study|Entry Criteria Not Met|3
4530527|NCT01064687|7349215|FG001|Overall Study|Entry Criteria Not Met|0
4530528|NCT01064687|7349216|FG002|Overall Study|Entry Criteria Not Met|0
4530529|NCT01064687|7349217|FG003|Overall Study|Entry Criteria Not Met|0
4530530|NCT01064687|7349214|FG000|Overall Study|Lack of Efficacy|1
4530531|NCT01064687|7349215|FG001|Overall Study|Lack of Efficacy|0
4530532|NCT01064687|7349216|FG002|Overall Study|Lack of Efficacy|2
4530533|NCT01064687|7349217|FG003|Overall Study|Lack of Efficacy|3
4530534|NCT01064687|7349214|FG000|Overall Study|Lost to Follow-up|7
4530535|NCT01064687|7349215|FG001|Overall Study|Lost to Follow-up|10
4530536|NCT01064687|7349216|FG002|Overall Study|Lost to Follow-up|13
4530537|NCT01064687|7349217|FG003|Overall Study|Lost to Follow-up|5
4530538|NCT01064687|7349214|FG000|Overall Study|Physician Decision|2
4530539|NCT01064687|7349215|FG001|Overall Study|Physician Decision|2
4530540|NCT01064687|7349216|FG002|Overall Study|Physician Decision|0
4530541|NCT01064687|7349217|FG003|Overall Study|Physician Decision|0
4530542|NCT01064687|7349214|FG000|Overall Study|Protocol Violation|1
4609413|NCT01686438|7465148|FG002|Overall Study|Protocol Violation|1
4530543|NCT01064687|7349215|FG001|Overall Study|Protocol Violation|1
4530544|NCT01064687|7349216|FG002|Overall Study|Protocol Violation|0
4530545|NCT01064687|7349217|FG003|Overall Study|Protocol Violation|1
4530546|NCT01064687|7349214|FG000|Overall Study|Sponsor Decision|0
4530547|NCT01064687|7349215|FG001|Overall Study|Sponsor Decision|0
4530548|NCT01064687|7349216|FG002|Overall Study|Sponsor Decision|3
4530549|NCT01064687|7349217|FG003|Overall Study|Sponsor Decision|0
4530550|NCT01064687|7349214|FG000|Overall Study|Withdrawal by Subject|9
4530551|NCT01064687|7349215|FG001|Overall Study|Withdrawal by Subject|7
4530552|NCT01064687|7349216|FG002|Overall Study|Withdrawal by Subject|12
4530553|NCT01064687|7349217|FG003|Overall Study|Withdrawal by Subject|5
4530554|NCT01064687|7349214|FG000|Overall Study|Treatment Noncompliance|1
4530555|NCT01064687|7349215|FG001|Overall Study|Treatment Noncompliance|1
4530556|NCT01064687|7349216|FG002|Overall Study|Treatment Noncompliance|1
4530557|NCT01064687|7349217|FG003|Overall Study|Treatment Noncompliance|0
4530558|NCT01064739|7349247|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1
4770344|NCT03911713|7746692|FG001|Overall Study|Lost to Follow-up|2
4770345|NCT03911713|7746693|FG002|Overall Study|Lost to Follow-up|0
4770346|NCT03911713|7746694|FG003|Overall Study|Lost to Follow-up|0
4770347|NCT03911713|7746695|FG004|Overall Study|Lost to Follow-up|0
4530563|NCT01064856|7349279|FG000|Double-blind (DB) Period|Adverse Event|1
4530564|NCT01064856|7349280|FG001|Double-blind (DB) Period|Adverse Event|0
4530565|NCT01064856|7349281|FG002|Double-blind (DB) Period|Adverse Event|0
4530566|NCT01064856|7349282|FG003|Double-blind (DB) Period|Adverse Event|0
4530567|NCT01064856|7349279|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1
4530568|NCT01064856|7349280|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0
4530569|NCT01064856|7349281|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0
4530570|NCT01064856|7349282|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0
4530571|NCT01064856|7349279|FG000|Open-label (OL) Period|Adverse Event|0
4530572|NCT01064856|7349280|FG001|Open-label (OL) Period|Adverse Event|0
4530573|NCT01064856|7349281|FG002|Open-label (OL) Period|Adverse Event|12
4530574|NCT01064856|7349282|FG003|Open-label (OL) Period|Adverse Event|6
4530575|NCT01064856|7349279|FG000|Open-label (OL) Period|Consent withdrawn by participant|0
4530576|NCT01064856|7349280|FG001|Open-label (OL) Period|Consent withdrawn by participant|0
4530577|NCT01064856|7349281|FG002|Open-label (OL) Period|Consent withdrawn by participant|5
4530578|NCT01064856|7349282|FG003|Open-label (OL) Period|Consent withdrawn by participant|6
4530579|NCT01064856|7349279|FG000|Open-label (OL) Period|Lost to Follow-up|0
4530580|NCT01064856|7349280|FG001|Open-label (OL) Period|Lost to Follow-up|0
4530581|NCT01064856|7349281|FG002|Open-label (OL) Period|Lost to Follow-up|2
4530582|NCT01064856|7349282|FG003|Open-label (OL) Period|Lost to Follow-up|1
4530583|NCT01064856|7349279|FG000|Open-label (OL) Period|Other|0
4530584|NCT01064856|7349280|FG001|Open-label (OL) Period|Other|0
4530585|NCT01064856|7349281|FG002|Open-label (OL) Period|Other|7
4530586|NCT01064856|7349282|FG003|Open-label (OL) Period|Other|7
4590795|NCT01524887|7437056|FG001|Overall Study|Study termination|87
4590796|NCT01524887|7437057|FG002|Overall Study|Study termination|79
4590797|NCT01524887|7437055|FG000|Overall Study|Withdrawal by Caregiver|0
4590798|NCT01524887|7437056|FG001|Overall Study|Withdrawal by Caregiver|0
4590799|NCT01524887|7437057|FG002|Overall Study|Withdrawal by Caregiver|2
4590800|NCT01524887|7437055|FG000|Overall Study|Use of prohibited medication|1
4590801|NCT01524887|7437056|FG001|Overall Study|Use of prohibited medication|0
4590802|NCT01524887|7437057|FG002|Overall Study|Use of prohibited medication|0
4590803|NCT01524900|7437070|FG000|Overall Study|Lost to Follow-up|3
4590804|NCT01524900|7437071|FG001|Overall Study|Lost to Follow-up|12
4590805|NCT01524900|7437072|FG002|Overall Study|Lost to Follow-up|1
4590806|NCT01524900|7437073|FG003|Overall Study|Lost to Follow-up|0
4590807|NCT01524900|7437074|FG004|Overall Study|Lost to Follow-up|0
4590808|NCT01524900|7437070|FG000|Overall Study|Other reason than stated above|1
4590809|NCT01524900|7437071|FG001|Overall Study|Other reason than stated above|1
4590810|NCT01524900|7437072|FG002|Overall Study|Other reason than stated above|0
4590811|NCT01524900|7437073|FG003|Overall Study|Other reason than stated above|0
4590812|NCT01524900|7437074|FG004|Overall Study|Other reason than stated above|0
4590813|NCT01524900|7437070|FG000|Overall Study|No reason documented|2
4590814|NCT01524900|7437071|FG001|Overall Study|No reason documented|1
4590815|NCT01524900|7437072|FG002|Overall Study|No reason documented|0
4590816|NCT01524900|7437073|FG003|Overall Study|No reason documented|1
4590817|NCT01524900|7437074|FG004|Overall Study|No reason documented|0
4590818|NCT01524913|7437090|FG000|Overall Study|Lost to Follow-up|4
4590819|NCT01524913|7437091|FG001|Overall Study|Lost to Follow-up|0
4590820|NCT01524913|7437092|FG002|Overall Study|Lost to Follow-up|0
4590821|NCT01524978|7437111|FG000|Overall Study|Other|16
4590822|NCT01524978|7437112|FG001|Overall Study|Other|2
4590823|NCT01524978|7437113|FG002|Overall Study|Other|1
4590824|NCT01524978|7437114|FG003|Overall Study|Other|2
4590825|NCT01524978|7437115|FG004|Overall Study|Other|1
4590826|NCT01524978|7437116|FG005|Overall Study|Other|3
4590827|NCT01524978|7437117|FG006|Overall Study|Other|17
4590828|NCT01524978|7437118|FG007|Overall Study|Other|1
4590829|NCT01524978|7437119|FG008|Overall Study|Other|2
4590830|NCT01524978|7437120|FG009|Overall Study|Other|2
4590831|NCT01524978|7437121|FG010|Overall Study|Other|5
4590832|NCT01524978|7437111|FG000|Overall Study|Withdrawal by Subject|12
4590833|NCT01524978|7437112|FG001|Overall Study|Withdrawal by Subject|0
4770348|NCT03911713|7746691|FG000|Overall Study|Other|0
4530587|NCT01064947|7349302|FG000|Overall Study|negative culture|41
4530588|NCT01065350|7349312|FG000|Overall Study|Received incorrect drug allocation|0
4530589|NCT01065350|7349313|FG001|Overall Study|Received incorrect drug allocation|1
4530590|NCT01065597|7349361|FG000|Overall Study|Adverse Event|1
4530591|NCT01065766|7349372|FG000|Overall Study|Assessed before the contracted date|1
4530592|NCT01065766|7349372|FG000|Overall Study|Contraindication to administration|6
4530593|NCT01065766|7349372|FG000|Overall Study|Violated dosage/administration|25
4530594|NCT01065844|7349376|FG000|Overall Study|Adverse Event|5
4530595|NCT01066000|7349380|FG000|Overall Study|Protocol Violation|4
4530596|NCT01066000|7349380|FG000|Overall Study|Death|3
4530597|NCT01066000|7349380|FG000|Overall Study|Withdrawal by Subject|1
4530598|NCT01066000|7349380|FG000|Overall Study|Adverse Event|1
4530599|NCT01066039|7349390|FG000|Overall Study|Adverse Event|6
4530600|NCT01066039|7349390|FG000|Overall Study|Withdrawal by Subject|17
4530601|NCT01066039|7349390|FG000|Overall Study|Protocol Violation|2
4530602|NCT01066039|7349390|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9
4530603|NCT01066039|7349390|FG000|Overall Study|Investigator's Request|1
4530604|NCT01066039|7349390|FG000|Overall Study|Dropout due to Insulin Administration|1
4530605|NCT01066039|7349390|FG000|Overall Study|Additional Antihypertensive Required|4
4530606|NCT01066039|7349390|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2
4530607|NCT01066039|7349390|FG000|Overall Study|Failure to Control Blood Pressure|1
4530608|NCT01066039|7349390|FG000|Overall Study|Drug/Dose Adjustment Required|1
4530609|NCT01066052|7349396|FG000|Overall Study|Enrolled But Not Treated|3
4530610|NCT01066052|7349397|FG001|Overall Study|Enrolled But Not Treated|0
4530611|NCT01066104|7349404|FG000|Overall Study|Adverse Event|1
4530612|NCT01066104|7349405|FG001|Overall Study|Adverse Event|1
4530613|NCT01066104|7349404|FG000|Overall Study|Protocol Violation|1
4530614|NCT01066104|7349405|FG001|Overall Study|Protocol Violation|0
4530615|NCT01066143|7349411|FG000|Overall Study|ineligible for the study|8
4530616|NCT01066156|7349415|FG000|Overall Study|ineligible|2
4530617|NCT01066156|7349415|FG000|Overall Study|Lost to Follow-up|7
4530618|NCT01066156|7349415|FG000|Overall Study|Withdrawal by Subject|1
4530619|NCT01066546|7349441|FG000|Overall Study|Study terminated by sponsor|5
4530620|NCT01066585|7349447|FG000|Overall Study|Protocol Violation|1
4530621|NCT01066585|7349448|FG001|Overall Study|Protocol Violation|0
4530622|NCT01066585|7349447|FG000|Overall Study|Withdrawal by Subject|0
4530623|NCT01066585|7349448|FG001|Overall Study|Withdrawal by Subject|3
4530624|NCT01066780|7349467|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1
4530625|NCT01066780|7349468|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1
4530626|NCT01066793|7349478|FG000|Overall Study|Death|4
4530627|NCT01066793|7349479|FG001|Overall Study|Death|1
4530628|NCT01066793|7349480|FG002|Overall Study|Death|1
4530629|NCT01066793|7349481|FG003|Overall Study|Death|0
4530630|NCT01066793|7349482|FG004|Overall Study|Death|0
4530631|NCT01066793|7349483|FG005|Overall Study|Death|0
4530632|NCT01066793|7349478|FG000|Overall Study|Lack of Efficacy|2
4530633|NCT01066793|7349479|FG001|Overall Study|Lack of Efficacy|1
4530634|NCT01066793|7349480|FG002|Overall Study|Lack of Efficacy|0
4530635|NCT01066793|7349481|FG003|Overall Study|Lack of Efficacy|0
4530636|NCT01066793|7349482|FG004|Overall Study|Lack of Efficacy|0
4530637|NCT01066793|7349483|FG005|Overall Study|Lack of Efficacy|0
4530638|NCT01066793|7349478|FG000|Overall Study|Lost to Follow-up|180
4530639|NCT01066793|7349479|FG001|Overall Study|Lost to Follow-up|39
4530640|NCT01066793|7349480|FG002|Overall Study|Lost to Follow-up|82
4530641|NCT01066793|7349481|FG003|Overall Study|Lost to Follow-up|16
4530642|NCT01066793|7349482|FG004|Overall Study|Lost to Follow-up|0
4530643|NCT01066793|7349483|FG005|Overall Study|Lost to Follow-up|1
4530644|NCT01066793|7349478|FG000|Overall Study|Physician Decision|3
4530645|NCT01066793|7349479|FG001|Overall Study|Physician Decision|0
4530646|NCT01066793|7349480|FG002|Overall Study|Physician Decision|0
4530647|NCT01066793|7349481|FG003|Overall Study|Physician Decision|0
4530648|NCT01066793|7349482|FG004|Overall Study|Physician Decision|0
4530649|NCT01066793|7349483|FG005|Overall Study|Physician Decision|0
4530650|NCT01066793|7349478|FG000|Overall Study|Protocol Violation|3
4530651|NCT01066793|7349479|FG001|Overall Study|Protocol Violation|2
4530652|NCT01066793|7349480|FG002|Overall Study|Protocol Violation|2
4530653|NCT01066793|7349481|FG003|Overall Study|Protocol Violation|0
4530654|NCT01066793|7349482|FG004|Overall Study|Protocol Violation|0
4530655|NCT01066793|7349483|FG005|Overall Study|Protocol Violation|0
4530656|NCT01066793|7349478|FG000|Overall Study|Withdrawal by Subject|7
4530657|NCT01066793|7349479|FG001|Overall Study|Withdrawal by Subject|4
4530658|NCT01066793|7349480|FG002|Overall Study|Withdrawal by Subject|1
4530659|NCT01066793|7349481|FG003|Overall Study|Withdrawal by Subject|0
4530660|NCT01066793|7349482|FG004|Overall Study|Withdrawal by Subject|0
4530661|NCT01066793|7349483|FG005|Overall Study|Withdrawal by Subject|0
4530662|NCT01066793|7349478|FG000|Overall Study|Early Termination|3
4530663|NCT01066793|7349479|FG001|Overall Study|Early Termination|0
4530664|NCT01066793|7349480|FG002|Overall Study|Early Termination|0
4530665|NCT01066793|7349481|FG003|Overall Study|Early Termination|0
4530666|NCT01066793|7349482|FG004|Overall Study|Early Termination|0
4530667|NCT01066793|7349483|FG005|Overall Study|Early Termination|0
4530668|NCT01066793|7349478|FG000|Overall Study|Lab test not done|7
4530669|NCT01066793|7349479|FG001|Overall Study|Lab test not done|0
4530670|NCT01066793|7349480|FG002|Overall Study|Lab test not done|0
4530671|NCT01066793|7349481|FG003|Overall Study|Lab test not done|1
4530672|NCT01066793|7349482|FG004|Overall Study|Lab test not done|0
4530673|NCT01066793|7349483|FG005|Overall Study|Lab test not done|0
4530674|NCT01066793|7349478|FG000|Overall Study|Miscellaneous|4
4530675|NCT01066793|7349479|FG001|Overall Study|Miscellaneous|5
4530676|NCT01066793|7349480|FG002|Overall Study|Miscellaneous|6
4530677|NCT01066793|7349481|FG003|Overall Study|Miscellaneous|0
4530678|NCT01066793|7349482|FG004|Overall Study|Miscellaneous|0
4530679|NCT01066793|7349483|FG005|Overall Study|Miscellaneous|0
4530680|NCT01066793|7349478|FG000|Overall Study|Non-responders|104
4530681|NCT01066793|7349479|FG001|Overall Study|Non-responders|5
4530682|NCT01066793|7349480|FG002|Overall Study|Non-responders|11
4530683|NCT01066793|7349481|FG003|Overall Study|Non-responders|25
4530684|NCT01066793|7349482|FG004|Overall Study|Non-responders|0
4530685|NCT01066793|7349483|FG005|Overall Study|Non-responders|0
4530686|NCT01066793|7349478|FG000|Overall Study|Other|15
4530687|NCT01066793|7349479|FG001|Overall Study|Other|5
4530688|NCT01066793|7349480|FG002|Overall Study|Other|6
4530689|NCT01066793|7349481|FG003|Overall Study|Other|2
4530690|NCT01066793|7349482|FG004|Overall Study|Other|0
4530691|NCT01066793|7349483|FG005|Overall Study|Other|0
4530692|NCT01066793|7349478|FG000|Overall Study|Relapse|20
4530693|NCT01066793|7349479|FG001|Overall Study|Relapse|8
4530694|NCT01066793|7349480|FG002|Overall Study|Relapse|2
4530695|NCT01066793|7349481|FG003|Overall Study|Relapse|3
4530696|NCT01066793|7349482|FG004|Overall Study|Relapse|0
4530697|NCT01066793|7349483|FG005|Overall Study|Relapse|0
4530698|NCT01066793|7349478|FG000|Overall Study|Result Not Available|1
4530699|NCT01066793|7349479|FG001|Overall Study|Result Not Available|0
4530700|NCT01066793|7349480|FG002|Overall Study|Result Not Available|0
4530701|NCT01066793|7349481|FG003|Overall Study|Result Not Available|0
4530702|NCT01066793|7349482|FG004|Overall Study|Result Not Available|0
4530703|NCT01066793|7349483|FG005|Overall Study|Result Not Available|0
4530704|NCT01066793|7349478|FG000|Overall Study|Treatment Interrupted|1
4530705|NCT01066793|7349479|FG001|Overall Study|Treatment Interrupted|1
4530706|NCT01066793|7349480|FG002|Overall Study|Treatment Interrupted|0
4530707|NCT01066793|7349481|FG003|Overall Study|Treatment Interrupted|0
4530708|NCT01066793|7349482|FG004|Overall Study|Treatment Interrupted|0
4530709|NCT01066793|7349483|FG005|Overall Study|Treatment Interrupted|0
4530710|NCT01066793|7349478|FG000|Overall Study|Treatment Never Started|18
4530711|NCT01066793|7349479|FG001|Overall Study|Treatment Never Started|5
4530712|NCT01066793|7349480|FG002|Overall Study|Treatment Never Started|4
4530713|NCT01066793|7349481|FG003|Overall Study|Treatment Never Started|1
4530714|NCT01066793|7349482|FG004|Overall Study|Treatment Never Started|0
4530715|NCT01066793|7349483|FG005|Overall Study|Treatment Never Started|0
4530716|NCT01066793|7349478|FG000|Overall Study|Treatment Stopped|2
4530717|NCT01066793|7349479|FG001|Overall Study|Treatment Stopped|1
4530718|NCT01066793|7349480|FG002|Overall Study|Treatment Stopped|0
4530719|NCT01066793|7349481|FG003|Overall Study|Treatment Stopped|1
4530720|NCT01066793|7349482|FG004|Overall Study|Treatment Stopped|0
4530721|NCT01066793|7349483|FG005|Overall Study|Treatment Stopped|0
4530722|NCT01066819|7349504|FG000|Overall Study|Adverse Event|18
4530723|NCT01066819|7349505|FG001|Overall Study|Adverse Event|1
4530724|NCT01066819|7349506|FG002|Overall Study|Adverse Event|6
4530725|NCT01066819|7349507|FG003|Overall Study|Adverse Event|0
4530726|NCT01066819|7349508|FG004|Overall Study|Adverse Event|0
4530727|NCT01066819|7349509|FG005|Overall Study|Adverse Event|0
4530728|NCT01066819|7349504|FG000|Overall Study|Death|5
4530729|NCT01066819|7349505|FG001|Overall Study|Death|0
4530730|NCT01066819|7349506|FG002|Overall Study|Death|1
4530731|NCT01066819|7349507|FG003|Overall Study|Death|0
4530732|NCT01066819|7349508|FG004|Overall Study|Death|0
4530733|NCT01066819|7349509|FG005|Overall Study|Death|0
4530734|NCT01066819|7349504|FG000|Overall Study|Lack of Efficacy|22
4530735|NCT01066819|7349505|FG001|Overall Study|Lack of Efficacy|1
4530736|NCT01066819|7349506|FG002|Overall Study|Lack of Efficacy|2
4530737|NCT01066819|7349507|FG003|Overall Study|Lack of Efficacy|1
4530738|NCT01066819|7349508|FG004|Overall Study|Lack of Efficacy|0
4530739|NCT01066819|7349509|FG005|Overall Study|Lack of Efficacy|0
4530740|NCT01066819|7349504|FG000|Overall Study|Physician Decision|6
4530741|NCT01066819|7349505|FG001|Overall Study|Physician Decision|2
4530742|NCT01066819|7349506|FG002|Overall Study|Physician Decision|3
4530743|NCT01066819|7349507|FG003|Overall Study|Physician Decision|0
4530744|NCT01066819|7349508|FG004|Overall Study|Physician Decision|0
4530745|NCT01066819|7349509|FG005|Overall Study|Physician Decision|0
4530746|NCT01066819|7349504|FG000|Overall Study|Protocol Violation|12
4530747|NCT01066819|7349505|FG001|Overall Study|Protocol Violation|6
4530748|NCT01066819|7349506|FG002|Overall Study|Protocol Violation|0
4530749|NCT01066819|7349507|FG003|Overall Study|Protocol Violation|0
4530750|NCT01066819|7349508|FG004|Overall Study|Protocol Violation|0
4530751|NCT01066819|7349509|FG005|Overall Study|Protocol Violation|0
4530752|NCT01066819|7349504|FG000|Overall Study|Withdrawal by Subject|29
4530753|NCT01066819|7349505|FG001|Overall Study|Withdrawal by Subject|11
4530754|NCT01066819|7349506|FG002|Overall Study|Withdrawal by Subject|6
4530755|NCT01066819|7349507|FG003|Overall Study|Withdrawal by Subject|0
4530756|NCT01066819|7349508|FG004|Overall Study|Withdrawal by Subject|0
4530757|NCT01066819|7349509|FG005|Overall Study|Withdrawal by Subject|0
4530758|NCT01066819|7349504|FG000|Overall Study|Administrative|6
4530759|NCT01066819|7349505|FG001|Overall Study|Administrative|4
4530760|NCT01066819|7349506|FG002|Overall Study|Administrative|2
4530761|NCT01066819|7349507|FG003|Overall Study|Administrative|0
4530762|NCT01066819|7349508|FG004|Overall Study|Administrative|0
4530763|NCT01066819|7349509|FG005|Overall Study|Administrative|0
4530764|NCT01066819|7349504|FG000|Overall Study|Not met inclusion/exclusion criteria|1
4530765|NCT01066819|7349505|FG001|Overall Study|Not met inclusion/exclusion criteria|0
4530766|NCT01066819|7349506|FG002|Overall Study|Not met inclusion/exclusion criteria|0
4530767|NCT01066819|7349507|FG003|Overall Study|Not met inclusion/exclusion criteria|0
4530768|NCT01066819|7349508|FG004|Overall Study|Not met inclusion/exclusion criteria|0
4530769|NCT01066819|7349509|FG005|Overall Study|Not met inclusion/exclusion criteria|0
4530770|NCT01066819|7349504|FG000|Overall Study|Early termination|2
4530771|NCT01066819|7349505|FG001|Overall Study|Early termination|0
4530772|NCT01066819|7349506|FG002|Overall Study|Early termination|0
4530773|NCT01066819|7349507|FG003|Overall Study|Early termination|0
4530774|NCT01066819|7349508|FG004|Overall Study|Early termination|0
4530775|NCT01066819|7349509|FG005|Overall Study|Early termination|0
4530776|NCT01066819|7349504|FG000|Overall Study|Failed to return|298
4530777|NCT01066819|7349505|FG001|Overall Study|Failed to return|107
4530778|NCT01066819|7349506|FG002|Overall Study|Failed to return|68
4530779|NCT01066819|7349507|FG003|Overall Study|Failed to return|7
4530780|NCT01066819|7349508|FG004|Overall Study|Failed to return|2
4530781|NCT01066819|7349509|FG005|Overall Study|Failed to return|3
4530782|NCT01066819|7349504|FG000|Overall Study|Lab test not done|9
4530783|NCT01066819|7349505|FG001|Overall Study|Lab test not done|0
4530784|NCT01066819|7349506|FG002|Overall Study|Lab test not done|2
4530785|NCT01066819|7349507|FG003|Overall Study|Lab test not done|1
4530786|NCT01066819|7349508|FG004|Overall Study|Lab test not done|0
4530787|NCT01066819|7349509|FG005|Overall Study|Lab test not done|0
4530788|NCT01066819|7349504|FG000|Overall Study|Miscellaneous|28
4530789|NCT01066819|7349505|FG001|Overall Study|Miscellaneous|10
4530790|NCT01066819|7349506|FG002|Overall Study|Miscellaneous|18
4530791|NCT01066819|7349507|FG003|Overall Study|Miscellaneous|1
4530792|NCT01066819|7349508|FG004|Overall Study|Miscellaneous|0
4530793|NCT01066819|7349509|FG005|Overall Study|Miscellaneous|0
4530794|NCT01066819|7349504|FG000|Overall Study|Non responders|123
4530795|NCT01066819|7349505|FG001|Overall Study|Non responders|2
4530796|NCT01066819|7349506|FG002|Overall Study|Non responders|7
4530797|NCT01066819|7349507|FG003|Overall Study|Non responders|2
4530798|NCT01066819|7349508|FG004|Overall Study|Non responders|0
4530799|NCT01066819|7349509|FG005|Overall Study|Non responders|1
4530800|NCT01066819|7349504|FG000|Overall Study|Not categorised|9
4609414|NCT01686438|7465146|FG000|Overall Study|Withdrawal by Subject|0
4609415|NCT01686438|7465147|FG001|Overall Study|Withdrawal by Subject|0
4609416|NCT01686438|7465148|FG002|Overall Study|Withdrawal by Subject|1
4609417|NCT01686568|7465188|FG000|Main Study|Withdrawal by Subject|1
4609418|NCT01686568|7465189|FG001|Main Study|Withdrawal by Subject|3
4609419|NCT01686568|7465188|FG000|Main Study|Noncompliance with protocol|0
4609420|NCT01686568|7465189|FG001|Main Study|Noncompliance with protocol|1
4609421|NCT01686568|7465188|FG000|Main Study|Liver enzymes above range of exclusion|1
4609422|NCT01686568|7465189|FG001|Main Study|Liver enzymes above range of exclusion|0
4609423|NCT01686568|7465188|FG000|Sub-Study|Not consented for sub-study|2
4609424|NCT01686568|7465189|FG001|Sub-Study|Not consented for sub-study|2
4609425|NCT01686581|7465195|FG000|Overall Study|Side-effects or Health Problems|15
4609426|NCT01686581|7465195|FG000|Overall Study|Lack of Efficacy|90
4609427|NCT01686581|7465195|FG000|Overall Study|Participant Concerned about Risks|6
4609428|NCT01686581|7465195|FG000|Overall Study|Thinks Injections Too Painful|8
4609429|NCT01686581|7465195|FG000|Overall Study|Thinks Injections Take Too Much Time|2
4609430|NCT01686581|7465195|FG000|Overall Study|Trying to get Pregnant or Nursing|2
4609431|NCT01686581|7465195|FG000|Overall Study|Thinks it is Inconvenient|17
4609432|NCT01686581|7465195|FG000|Overall Study|Other Miscellaneous Reasons|36
4609433|NCT01686581|7465195|FG000|Overall Study|Reason Missing|1
4609434|NCT01686633|7465202|FG000|Overall Study|Lack of Efficacy|33
4609435|NCT01686633|7465203|FG001|Overall Study|Lack of Efficacy|13
4609436|NCT01686633|7465204|FG002|Overall Study|Lack of Efficacy|11
4609437|NCT01686633|7465202|FG000|Overall Study|Withdrawal by Subject|8
4609438|NCT01686633|7465203|FG001|Overall Study|Withdrawal by Subject|8
4609439|NCT01686633|7465204|FG002|Overall Study|Withdrawal by Subject|5
4609440|NCT01686633|7465202|FG000|Overall Study|Physician Decision|3
4609441|NCT01686633|7465203|FG001|Overall Study|Physician Decision|4
4609442|NCT01686633|7465204|FG002|Overall Study|Physician Decision|4
4609443|NCT01686633|7465202|FG000|Overall Study|Adverse Event|4
4609444|NCT01686633|7465203|FG001|Overall Study|Adverse Event|3
4609445|NCT01686633|7465204|FG002|Overall Study|Adverse Event|3
4609446|NCT01686633|7465202|FG000|Overall Study|Protocol Violation|2
4609447|NCT01686633|7465203|FG001|Overall Study|Protocol Violation|3
4609448|NCT01686633|7465204|FG002|Overall Study|Protocol Violation|0
4609449|NCT01686633|7465202|FG000|Overall Study|Protocol-defined Stopping Criteria|1
4609450|NCT01686633|7465203|FG001|Overall Study|Protocol-defined Stopping Criteria|0
4609451|NCT01686633|7465204|FG002|Overall Study|Protocol-defined Stopping Criteria|1
4609452|NCT01686633|7465202|FG000|Overall Study|Lost to Follow-up|0
4609453|NCT01686633|7465203|FG001|Overall Study|Lost to Follow-up|1
4609454|NCT01686633|7465204|FG002|Overall Study|Lost to Follow-up|1
4609455|NCT01686828|7465244|FG000|Overall Study|Physician Decision|1
4530801|NCT01066819|7349505|FG001|Overall Study|Not categorised|2
4530802|NCT01066819|7349506|FG002|Overall Study|Not categorised|6
4530803|NCT01066819|7349507|FG003|Overall Study|Not categorised|1
4530804|NCT01066819|7349508|FG004|Overall Study|Not categorised|0
4530805|NCT01066819|7349509|FG005|Overall Study|Not categorised|0
4530806|NCT01066819|7349504|FG000|Overall Study|Relapse|16
4530807|NCT01066819|7349505|FG001|Overall Study|Relapse|4
4530808|NCT01066819|7349506|FG002|Overall Study|Relapse|3
4530809|NCT01066819|7349507|FG003|Overall Study|Relapse|0
4530810|NCT01066819|7349508|FG004|Overall Study|Relapse|0
4530811|NCT01066819|7349509|FG005|Overall Study|Relapse|0
4530812|NCT01066819|7349504|FG000|Overall Study|Results not available|1
4530813|NCT01066819|7349505|FG001|Overall Study|Results not available|0
4530814|NCT01066819|7349506|FG002|Overall Study|Results not available|0
4530815|NCT01066819|7349507|FG003|Overall Study|Results not available|0
4530816|NCT01066819|7349508|FG004|Overall Study|Results not available|0
4530817|NCT01066819|7349509|FG005|Overall Study|Results not available|0
4530818|NCT01066819|7349504|FG000|Overall Study|Screen failure|1
4530819|NCT01066819|7349505|FG001|Overall Study|Screen failure|0
4530820|NCT01066819|7349506|FG002|Overall Study|Screen failure|0
4530821|NCT01066819|7349507|FG003|Overall Study|Screen failure|0
4530822|NCT01066819|7349508|FG004|Overall Study|Screen failure|0
4530823|NCT01066819|7349509|FG005|Overall Study|Screen failure|0
4530824|NCT01066819|7349504|FG000|Overall Study|Spontaneous cure|1
4530825|NCT01066819|7349505|FG001|Overall Study|Spontaneous cure|0
4530826|NCT01066819|7349506|FG002|Overall Study|Spontaneous cure|0
4530827|NCT01066819|7349507|FG003|Overall Study|Spontaneous cure|0
4530828|NCT01066819|7349508|FG004|Overall Study|Spontaneous cure|0
4530829|NCT01066819|7349509|FG005|Overall Study|Spontaneous cure|0
4530830|NCT01066819|7349504|FG000|Overall Study|Treatment never started|85
4530831|NCT01066819|7349505|FG001|Overall Study|Treatment never started|19
4530832|NCT01066819|7349506|FG002|Overall Study|Treatment never started|19
4530833|NCT01066819|7349507|FG003|Overall Study|Treatment never started|3
4530834|NCT01066819|7349508|FG004|Overall Study|Treatment never started|2
4530835|NCT01066819|7349509|FG005|Overall Study|Treatment never started|2
4530836|NCT01066819|7349504|FG000|Overall Study|Treatment stopped|12
4530837|NCT01066819|7349505|FG001|Overall Study|Treatment stopped|1
4530838|NCT01066819|7349506|FG002|Overall Study|Treatment stopped|2
4530839|NCT01066819|7349507|FG003|Overall Study|Treatment stopped|1
4530840|NCT01066819|7349508|FG004|Overall Study|Treatment stopped|0
4530841|NCT01066819|7349509|FG005|Overall Study|Treatment stopped|0
4530842|NCT01066819|7349504|FG000|Overall Study|Other|5
4530843|NCT01066819|7349505|FG001|Overall Study|Other|1
4530844|NCT01066819|7349506|FG002|Overall Study|Other|1
4530845|NCT01066819|7349507|FG003|Overall Study|Other|0
4530846|NCT01066819|7349508|FG004|Overall Study|Other|0
4530847|NCT01066819|7349509|FG005|Overall Study|Other|0
4530848|NCT01066871|7349525|FG000|Overall Study|Lost to Follow-up|0
4530849|NCT01066871|7349526|FG001|Overall Study|Lost to Follow-up|2
4530850|NCT01066871|7349527|FG002|Overall Study|Lost to Follow-up|2
4530851|NCT01066871|7349528|FG003|Overall Study|Lost to Follow-up|0
4530852|NCT01066871|7349525|FG000|Overall Study|Protocol Violation|1
4530853|NCT01066871|7349526|FG001|Overall Study|Protocol Violation|0
4530854|NCT01066871|7349527|FG002|Overall Study|Protocol Violation|3
4530855|NCT01066871|7349528|FG003|Overall Study|Protocol Violation|2
4530856|NCT01066871|7349525|FG000|Overall Study|Lack of Efficacy|0
4530857|NCT01066871|7349526|FG001|Overall Study|Lack of Efficacy|0
4530858|NCT01066871|7349527|FG002|Overall Study|Lack of Efficacy|0
4530859|NCT01066871|7349528|FG003|Overall Study|Lack of Efficacy|1
4530860|NCT01066871|7349525|FG000|Overall Study|Withdrawal by Subject|3
4530861|NCT01066871|7349526|FG001|Overall Study|Withdrawal by Subject|1
4530862|NCT01066871|7349527|FG002|Overall Study|Withdrawal by Subject|0
4530863|NCT01066871|7349528|FG003|Overall Study|Withdrawal by Subject|0
4530864|NCT01066871|7349525|FG000|Overall Study|Other|0
4530865|NCT01066871|7349526|FG001|Overall Study|Other|2
4530866|NCT01066871|7349527|FG002|Overall Study|Other|1
4530867|NCT01066871|7349528|FG003|Overall Study|Other|2
4530868|NCT01066897|7349545|FG000|Overall Study|Withdrawal by Subject|1
4530869|NCT01066897|7349546|FG001|Overall Study|Withdrawal by Subject|0
4530870|NCT01066897|7349545|FG000|Overall Study|stopped study after developing the flu.|1
4530871|NCT01066897|7349546|FG001|Overall Study|stopped study after developing the flu.|0
4530872|NCT01066923|7349557|FG000|Overall Study|Withdrawal by Subject|3
4530873|NCT01066923|7349558|FG001|Overall Study|Withdrawal by Subject|3
4530874|NCT01066923|7349559|FG002|Overall Study|Withdrawal by Subject|8
4530875|NCT01066923|7349560|FG003|Overall Study|Withdrawal by Subject|8
4530876|NCT01066936|7349570|FG000|Overall Study|Death|2
4530877|NCT01066936|7349570|FG000|Overall Study|Device revised/removed|1
4530878|NCT01066936|7349570|FG000|Overall Study|Lost to Follow-up|3
4530879|NCT01066936|7349570|FG000|Overall Study|Withdrawal by Subject|4
4530880|NCT01067105|7349576|FG000|Overall Study|Adverse Event|14
4530881|NCT01067105|7349576|FG000|Overall Study|Protocol Violation|48
4530882|NCT01067105|7349576|FG000|Overall Study|Withdrawal by Subject|36
4530883|NCT01067105|7349576|FG000|Overall Study|Lost to Follow-up|6
4530884|NCT01067105|7349576|FG000|Overall Study|Physician Decision|6
4530885|NCT01067105|7349576|FG000|Overall Study|Other|31
4530886|NCT01067144|7349582|FG000|Treatment|Did not receive allocated intervention|4
4530887|NCT01067144|7349583|FG001|Treatment|Did not receive allocated intervention|7
4530888|NCT01067144|7349582|FG000|Follow-up|Lost to Follow-up|22
4530889|NCT01067144|7349583|FG001|Follow-up|Lost to Follow-up|12
4530890|NCT01067144|7349582|FG000|Follow-up|Censored owing to second surgery|19
4530891|NCT01067144|7349583|FG001|Follow-up|Censored owing to second surgery|28
4530892|NCT01067144|7349582|FG000|Follow-up|Withdrawal by Subject|18
4530893|NCT01067144|7349583|FG001|Follow-up|Withdrawal by Subject|14
4530894|NCT01067144|7349582|FG000|Follow-up|Surgery cancelled|0
4530895|NCT01067144|7349583|FG001|Follow-up|Surgery cancelled|1
4530896|NCT01067144|7349582|FG000|Follow-up|Death|0
4530897|NCT01067144|7349583|FG001|Follow-up|Death|1
4530898|NCT01067326|7349591|FG000|Overall Study|Adverse Event|0
4530899|NCT01067326|7349592|FG001|Overall Study|Adverse Event|2
4530900|NCT01067326|7349591|FG000|Overall Study|Withdrawal by Subject|1
4530901|NCT01067326|7349592|FG001|Overall Study|Withdrawal by Subject|0
4530902|NCT01067326|7349591|FG000|Overall Study|Early Study Termination|1
4530903|NCT01067326|7349592|FG001|Overall Study|Early Study Termination|1
4530904|NCT01067339|7349600|FG000|Overall Study|Withdrawal by Subject|6
4530905|NCT01067339|7349601|FG001|Overall Study|Withdrawal by Subject|5
4530906|NCT01067352|7349610|FG000|Overall Study|Withdrawal by Subject|1
4530907|NCT01067352|7349611|FG001|Overall Study|Withdrawal by Subject|2
4530908|NCT01067352|7349612|FG002|Overall Study|Withdrawal by Subject|1
4530909|NCT01067352|7349610|FG000|Overall Study|Physician Decision|0
4530910|NCT01067352|7349611|FG001|Overall Study|Physician Decision|1
4530911|NCT01067352|7349612|FG002|Overall Study|Physician Decision|0
4530912|NCT01067469|7349633|FG000|Overall Study|Withdrawal by Subject|0
4530913|NCT01067469|7349634|FG001|Overall Study|Withdrawal by Subject|1
4530914|NCT01067469|7349633|FG000|Overall Study|Disease Progression|0
4530915|NCT01067469|7349634|FG001|Overall Study|Disease Progression|1
4530916|NCT01067508|7349642|FG000|Overall Study|Physician Decision|0
4530917|NCT01067508|7349643|FG001|Overall Study|Physician Decision|1
4530918|NCT01067508|7349642|FG000|Overall Study|Withdrawal by Subject|0
4530919|NCT01067508|7349643|FG001|Overall Study|Withdrawal by Subject|1
4530920|NCT01067846|7349692|FG000|Overall Study|Lost to Follow-up|17
4530921|NCT01067846|7349693|FG001|Overall Study|Lost to Follow-up|19
4530922|NCT01067846|7349692|FG000|Overall Study|Withdrawal by Subject|1
4530923|NCT01067846|7349693|FG001|Overall Study|Withdrawal by Subject|0
4530924|NCT01067846|7349692|FG000|Overall Study|participation in other tx study|1
4530925|NCT01067846|7349693|FG001|Overall Study|participation in other tx study|0
4530926|NCT01067976|7349699|FG000|Overall Study|Study drug never administered|20
4530927|NCT01067976|7349699|FG000|Overall Study|Study prematurely discontinued|2
4530928|NCT01068158|7349719|FG000|Overall Study|Withdrawal by Subject|1
4530929|NCT01068158|7349720|FG001|Overall Study|Withdrawal by Subject|2
4530930|NCT01068158|7349719|FG000|Overall Study|Lost to Follow-up|7
4530931|NCT01068158|7349720|FG001|Overall Study|Lost to Follow-up|0
4530932|NCT01068158|7349719|FG000|Overall Study|Protocol Violation|0
4530933|NCT01068158|7349720|FG001|Overall Study|Protocol Violation|2
4530934|NCT01068262|7349730|FG000|Overall Study|Adverse Event|2
4530935|NCT01068262|7349731|FG001|Overall Study|Adverse Event|0
4530936|NCT01068262|7349732|FG002|Overall Study|Adverse Event|1
4530937|NCT01068262|7349733|FG003|Overall Study|Adverse Event|0
4530938|NCT01068262|7349730|FG000|Overall Study|Protocol Violation|1
4530939|NCT01068262|7349731|FG001|Overall Study|Protocol Violation|0
4530940|NCT01068262|7349732|FG002|Overall Study|Protocol Violation|0
4530941|NCT01068262|7349733|FG003|Overall Study|Protocol Violation|0
4530942|NCT01068262|7349730|FG000|Overall Study|Withdrawal by Subject|0
4530943|NCT01068262|7349731|FG001|Overall Study|Withdrawal by Subject|1
4530944|NCT01068262|7349732|FG002|Overall Study|Withdrawal by Subject|0
4530945|NCT01068262|7349733|FG003|Overall Study|Withdrawal by Subject|0
4530946|NCT01068418|7349746|FG000|Overall Study|Physician Decision|12
4530947|NCT01068509|7349753|FG000|Overall Study|Death|0
4530948|NCT01068509|7349754|FG001|Overall Study|Death|0
4530949|NCT01068509|7349755|FG002|Overall Study|Death|1
4530950|NCT01068509|7349753|FG000|Overall Study|Disease Progression|5
4530951|NCT01068509|7349754|FG001|Overall Study|Disease Progression|20
4530952|NCT01068509|7349755|FG002|Overall Study|Disease Progression|18
4530953|NCT01068509|7349753|FG000|Overall Study|Lost to Follow-up|1
4530954|NCT01068509|7349754|FG001|Overall Study|Lost to Follow-up|0
4530955|NCT01068509|7349755|FG002|Overall Study|Lost to Follow-up|0
4530956|NCT01068509|7349753|FG000|Overall Study|Withdrew Consent|0
4530957|NCT01068509|7349754|FG001|Overall Study|Withdrew Consent|1
4530958|NCT01068509|7349755|FG002|Overall Study|Withdrew Consent|2
4530959|NCT01068509|7349753|FG000|Overall Study|Reason Not Specified|0
4530960|NCT01068509|7349754|FG001|Overall Study|Reason Not Specified|1
4530961|NCT01068509|7349755|FG002|Overall Study|Reason Not Specified|0
4530962|NCT01068600|7349774|FG000|Overall Study|Withdrawal by Subject|5
4530963|NCT01068600|7349775|FG001|Overall Study|Withdrawal by Subject|6
4530964|NCT01068600|7349774|FG000|Overall Study|Adverse Event|3
4530965|NCT01068600|7349775|FG001|Overall Study|Adverse Event|3
4530966|NCT01068600|7349774|FG000|Overall Study|Abnormal laboratory value(s)|1
4530967|NCT01068600|7349775|FG001|Overall Study|Abnormal laboratory value(s)|0
4530968|NCT01068600|7349774|FG000|Overall Study|Lost to Follow-up|1
4530969|NCT01068600|7349775|FG001|Overall Study|Lost to Follow-up|2
4530970|NCT01068600|7349774|FG000|Overall Study|Protocol deviation|1
4530971|NCT01068600|7349775|FG001|Overall Study|Protocol deviation|1
4530972|NCT01068600|7349774|FG000|Overall Study|Unsatisfactory therapeutic effect|0
4530973|NCT01068600|7349775|FG001|Overall Study|Unsatisfactory therapeutic effect|4
4530974|NCT01068600|7349774|FG000|Overall Study|Administrative problems|0
4530975|NCT01068600|7349775|FG001|Overall Study|Administrative problems|1
4530976|NCT01068626|7349783|FG000|Overall Study|Adverse Event|3
4530977|NCT01068626|7349784|FG001|Overall Study|Adverse Event|0
4530978|NCT01068626|7349783|FG000|Overall Study|Withdrawal by Subject|0
4530979|NCT01068626|7349784|FG001|Overall Study|Withdrawal by Subject|2
4530980|NCT01068652|7349792|FG000|Overall Study|Adverse Event|4
4530981|NCT01068652|7349793|FG001|Overall Study|Adverse Event|0
4530982|NCT01068652|7349792|FG000|Overall Study|Lack of Efficacy|0
4530983|NCT01068652|7349793|FG001|Overall Study|Lack of Efficacy|2
4530984|NCT01068652|7349792|FG000|Overall Study|Lost to Follow-up|2
4530985|NCT01068652|7349793|FG001|Overall Study|Lost to Follow-up|1
4530986|NCT01068652|7349792|FG000|Overall Study|Protocol Violation|3
4530987|NCT01068652|7349793|FG001|Overall Study|Protocol Violation|6
4530988|NCT01068652|7349792|FG000|Overall Study|Withdrawal criteria|1
4530989|NCT01068652|7349793|FG001|Overall Study|Withdrawal criteria|2
4530990|NCT01068652|7349792|FG000|Overall Study|Patient was not eligible|1
4530991|NCT01068652|7349793|FG001|Overall Study|Patient was not eligible|0
4530992|NCT01068652|7349792|FG000|Overall Study|Unclassified|7
4530993|NCT01068652|7349793|FG001|Overall Study|Unclassified|4
4530994|NCT01068665|7349801|FG000|Overall Study|Adverse Event|5
4530995|NCT01068665|7349802|FG001|Overall Study|Adverse Event|4
4530996|NCT01068665|7349801|FG000|Overall Study|Lack of Efficacy|0
4530997|NCT01068665|7349802|FG001|Overall Study|Lack of Efficacy|2
4530998|NCT01068665|7349801|FG000|Overall Study|Protocol Violation|5
4530999|NCT01068665|7349802|FG001|Overall Study|Protocol Violation|2
4531000|NCT01068665|7349801|FG000|Overall Study|Withdrawal Criteria|3
4531001|NCT01068665|7349802|FG001|Overall Study|Withdrawal Criteria|9
4531002|NCT01068665|7349801|FG000|Overall Study|Other|17
4531003|NCT01068665|7349802|FG001|Overall Study|Other|12
4531004|NCT01068678|7349810|FG000|Overall Study|Lack of Efficacy|3
4531005|NCT01068678|7349811|FG001|Overall Study|Lack of Efficacy|2
4531006|NCT01068678|7349810|FG000|Overall Study|Protocol Violation|5
4531007|NCT01068678|7349811|FG001|Overall Study|Protocol Violation|1
4531008|NCT01068678|7349810|FG000|Overall Study|Withdrawal criteria|12
4531009|NCT01068678|7349811|FG001|Overall Study|Withdrawal criteria|6
4531010|NCT01068678|7349810|FG000|Overall Study|Unclassified|18
4531011|NCT01068678|7349811|FG001|Overall Study|Unclassified|15
4531012|NCT01068717|7349817|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1
4531013|NCT01068717|7349818|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
4531014|NCT01068717|7349819|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
4531015|NCT01068717|7349820|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
4531016|NCT01068730|7349834|FG000|Period 3|Personal reason|1
4531017|NCT01068730|7349835|FG001|Period 3|Personal reason|0
4531018|NCT01068730|7349836|FG002|Period 3|Personal reason|0
4531019|NCT01068730|7349837|FG003|Period 3|Personal reason|0
4531020|NCT01068730|7349834|FG000|Period 4|Family emergency|0
4531021|NCT01068730|7349835|FG001|Period 4|Family emergency|1
4531022|NCT01068730|7349836|FG002|Period 4|Family emergency|0
4531023|NCT01068730|7349837|FG003|Period 4|Family emergency|0
4531024|NCT01068743|7349854|FG000|Period 3|Adverse Event|0
4531025|NCT01068743|7349855|FG001|Period 3|Adverse Event|1
4531026|NCT01068743|7349856|FG002|Period 3|Adverse Event|0
4531027|NCT01068743|7349857|FG003|Period 3|Adverse Event|0
4609456|NCT01686828|7465245|FG001|Overall Study|Physician Decision|0
4531028|NCT01068769|7349870|FG000|Overall Study|Ineligible|1
4531029|NCT01068860|7349893|FG000|Overall Study|Withdrawal by Subject|0
4531030|NCT01068860|7349894|FG001|Overall Study|Withdrawal by Subject|0
4531031|NCT01068860|7349895|FG002|Overall Study|Withdrawal by Subject|0
4531032|NCT01068860|7349896|FG003|Overall Study|Withdrawal by Subject|0
4531033|NCT01068860|7349897|FG004|Overall Study|Withdrawal by Subject|0
4531034|NCT01068860|7349898|FG005|Overall Study|Withdrawal by Subject|2
4531035|NCT01068860|7349899|FG006|Overall Study|Withdrawal by Subject|0
4531036|NCT01068860|7349900|FG007|Overall Study|Withdrawal by Subject|0
4531037|NCT01068860|7349901|FG008|Overall Study|Withdrawal by Subject|0
4531038|NCT01068860|7349902|FG009|Overall Study|Withdrawal by Subject|3
4531039|NCT01068860|7349893|FG000|Overall Study|Administrative problems; misrandomized|0
4531040|NCT01068860|7349894|FG001|Overall Study|Administrative problems; misrandomized|0
4531041|NCT01068860|7349895|FG002|Overall Study|Administrative problems; misrandomized|0
4531042|NCT01068860|7349896|FG003|Overall Study|Administrative problems; misrandomized|1
4531043|NCT01068860|7349897|FG004|Overall Study|Administrative problems; misrandomized|0
4531044|NCT01068860|7349898|FG005|Overall Study|Administrative problems; misrandomized|0
4531045|NCT01068860|7349899|FG006|Overall Study|Administrative problems; misrandomized|0
4531046|NCT01068860|7349900|FG007|Overall Study|Administrative problems; misrandomized|0
4609457|NCT01686828|7465246|FG002|Overall Study|Physician Decision|0
4531047|NCT01068860|7349901|FG008|Overall Study|Administrative problems; misrandomized|0
4531048|NCT01068860|7349902|FG009|Overall Study|Administrative problems; misrandomized|1
4531049|NCT01068860|7349893|FG000|Overall Study|Lost to Follow-up|0
4531050|NCT01068860|7349894|FG001|Overall Study|Lost to Follow-up|1
4531051|NCT01068860|7349895|FG002|Overall Study|Lost to Follow-up|0
4531052|NCT01068860|7349896|FG003|Overall Study|Lost to Follow-up|0
4531053|NCT01068860|7349897|FG004|Overall Study|Lost to Follow-up|0
4609458|NCT01686828|7465247|FG003|Overall Study|Physician Decision|0
4531054|NCT01068860|7349898|FG005|Overall Study|Lost to Follow-up|0
4531055|NCT01068860|7349899|FG006|Overall Study|Lost to Follow-up|0
4531056|NCT01068860|7349900|FG007|Overall Study|Lost to Follow-up|0
4531057|NCT01068860|7349901|FG008|Overall Study|Lost to Follow-up|0
4531058|NCT01068860|7349902|FG009|Overall Study|Lost to Follow-up|0
4531059|NCT01068912|7349931|FG000|Overall Study|Adverse Event|2
4531060|NCT01068912|7349932|FG001|Overall Study|Adverse Event|3
4531061|NCT01068912|7349933|FG002|Overall Study|Adverse Event|2
4531062|NCT01068912|7349931|FG000|Overall Study|Withdrawal by Subject|5
4531063|NCT01068912|7349932|FG001|Overall Study|Withdrawal by Subject|6
4531064|NCT01068912|7349933|FG002|Overall Study|Withdrawal by Subject|6
4531065|NCT01068912|7349931|FG000|Overall Study|Lost to Follow-up|3
4531066|NCT01068912|7349932|FG001|Overall Study|Lost to Follow-up|7
4531067|NCT01068912|7349933|FG002|Overall Study|Lost to Follow-up|3
4531068|NCT01068912|7349931|FG000|Overall Study|Protocol Violation|0
4531069|NCT01068912|7349932|FG001|Overall Study|Protocol Violation|2
4531070|NCT01068912|7349933|FG002|Overall Study|Protocol Violation|0
4531071|NCT01068912|7349931|FG000|Overall Study|aggravation influenza|1
4531072|NCT01068912|7349932|FG001|Overall Study|aggravation influenza|1
4531073|NCT01068912|7349933|FG002|Overall Study|aggravation influenza|1
4531074|NCT01068912|7349931|FG000|Overall Study|other underlying illness|0
4531075|NCT01068912|7349932|FG001|Overall Study|other underlying illness|3
4531076|NCT01068912|7349933|FG002|Overall Study|other underlying illness|3
4531077|NCT01069172|7349965|FG000|Overall Study|Withdrawal by Subject|1
4531078|NCT01069172|7349966|FG001|Overall Study|Withdrawal by Subject|0
4531079|NCT01069289|7349984|FG000|Overall Study|Withdrawal by Subject|15
4531080|NCT01069289|7349985|FG001|Overall Study|Withdrawal by Subject|26
4531081|NCT01069289|7349984|FG000|Overall Study|Adverse Event|21
4531082|NCT01069289|7349985|FG001|Overall Study|Adverse Event|28
4531083|NCT01069289|7349984|FG000|Overall Study|Eligibility criteria not fulfilled|2
4531084|NCT01069289|7349985|FG001|Overall Study|Eligibility criteria not fulfilled|0
4531085|NCT01069289|7349984|FG000|Overall Study|Severe non-compliance to protocol|3
4531086|NCT01069289|7349985|FG001|Overall Study|Severe non-compliance to protocol|2
4531087|NCT01069289|7349984|FG000|Overall Study|Due to deteriorating health condition|1
4531088|NCT01069289|7349985|FG001|Overall Study|Due to deteriorating health condition|0
4531089|NCT01069341|7350012|FG000|Overall Study|Lost to Follow-up|1
4531090|NCT01069419|7350024|FG000|Overall Study|Adverse Event|233
4531091|NCT01069419|7350024|FG000|Overall Study|Lack of Efficacy|332
4531092|NCT01069419|7350024|FG000|Overall Study|Lost to Follow-up|49
4531093|NCT01069419|7350024|FG000|Overall Study|Remission of disease|11
4531094|NCT01069419|7350024|FG000|Overall Study|Withdrawal by Subject|34
4531095|NCT01069419|7350024|FG000|Overall Study|Other Reason|43
4531096|NCT01069419|7350024|FG000|Overall Study|Missing termination information|13
4531097|NCT01069484|7350030|FG000|Overall Study|Death-in-near-family|1
4531098|NCT01069484|7350031|FG001|Overall Study|Death-in-near-family|0
4531099|NCT01069484|7350030|FG000|Overall Study|No specific reason|8
4531100|NCT01069484|7350031|FG001|Overall Study|No specific reason|2
4531101|NCT01069484|7350030|FG000|Overall Study|Illness mother or child|3
4531102|NCT01069484|7350031|FG001|Overall Study|Illness mother or child|1
4531103|NCT01069523|7350049|FG000|Overall Study|Withdrawal by Subject|4
4531104|NCT01069523|7350050|FG001|Overall Study|Withdrawal by Subject|7
4531105|NCT01069627|7350067|FG000|Overall Study|Disease progression|7
4531106|NCT01069627|7350067|FG000|Overall Study|Adverse Event|12
4531107|NCT01069627|7350067|FG000|Overall Study|Protocol Violation|1
4531108|NCT01069705|7350071|FG000|Overall Study|Adverse Event|1
4531109|NCT01069705|7350071|FG000|Overall Study|Withdrawal by Subject|2
4531110|NCT01069900|7350077|FG000|Overall Study|Technical problems|0
4531111|NCT01069900|7350078|FG001|Overall Study|Technical problems|1
4531112|NCT01069900|7350077|FG000|Overall Study|Lost to Follow-up|7
4531113|NCT01069900|7350078|FG001|Overall Study|Lost to Follow-up|1
4531114|NCT01069900|7350077|FG000|Overall Study|Withdrawal by Subject|6
4689830|NCT02555371|7599376|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2
4689831|NCT02555371|7599377|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2
4689832|NCT02555371|7599378|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0
4689833|NCT02555371|7599379|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0
4689834|NCT02555371|7599375|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0
4689835|NCT02555371|7599376|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1
4689836|NCT02555371|7599377|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0
4689837|NCT02555371|7599378|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0
4689838|NCT02555371|7599379|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0
4531115|NCT01069900|7350078|FG001|Overall Study|Withdrawal by Subject|1
4531116|NCT01069900|7350077|FG000|Overall Study|Protocol Violation|4
4531117|NCT01069900|7350078|FG001|Overall Study|Protocol Violation|1
4531118|NCT01069900|7350077|FG000|Overall Study|Insufficient Therapeutic effect|1
4531119|NCT01069900|7350078|FG001|Overall Study|Insufficient Therapeutic effect|0
4531120|NCT01069939|7350086|FG000|Randomised and Included in the Analyses|Adverse Event|17
4531121|NCT01069939|7350087|FG001|Randomised and Included in the Analyses|Adverse Event|22
4531122|NCT01069939|7350086|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15
4531123|NCT01069939|7350087|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12
4531124|NCT01069939|7350086|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1
4531125|NCT01069939|7350087|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1
4689839|NCT02555371|7599375|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0
4689840|NCT02555371|7599376|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2
4531126|NCT01069939|7350086|FG000|Randomised and Included in the Analyses|Protocol Violation|0
4531127|NCT01069939|7350087|FG001|Randomised and Included in the Analyses|Protocol Violation|1
4531128|NCT01069939|7350086|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0
4531129|NCT01069939|7350087|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1
4531130|NCT01069939|7350086|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7
4531131|NCT01069939|7350087|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33
4531132|NCT01069939|7350086|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4
4531133|NCT01069939|7350087|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3
4531134|NCT01069939|7350086|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4
4531135|NCT01069939|7350087|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2
4531136|NCT01069939|7350086|FG000|Randomised and Included in the Analyses|Physician Decision|0
4531137|NCT01069939|7350087|FG001|Randomised and Included in the Analyses|Physician Decision|2
4531138|NCT01069939|7350086|FG000|Randomised and Included in the Analyses|Removal|1
4531139|NCT01069939|7350087|FG001|Randomised and Included in the Analyses|Removal|0
4531140|NCT01070043|7350095|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18
4531141|NCT01070043|7350096|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0
4609459|NCT01686828|7465244|FG000|Overall Study|New Job|0
4609460|NCT01686828|7465245|FG001|Overall Study|New Job|1
4609461|NCT01686828|7465246|FG002|Overall Study|New Job|0
4609462|NCT01686828|7465247|FG003|Overall Study|New Job|0
4609463|NCT01686828|7465244|FG000|Overall Study|Weight Loss|0
4609464|NCT01686828|7465245|FG001|Overall Study|Weight Loss|0
4609465|NCT01686828|7465246|FG002|Overall Study|Weight Loss|1
4609466|NCT01686828|7465247|FG003|Overall Study|Weight Loss|0
4609467|NCT01686932|7465263|FG000|Period 1|Adverse Event|1
4609468|NCT01686932|7465264|FG001|Period 1|Adverse Event|1
4609469|NCT01686958|7465270|FG000|Overall Study|Withdrawal by Subject|1
4609470|NCT01687101|7465288|FG000|Overall Study|Lost to Follow-up|7
4609471|NCT01687166|7465300|FG000|Overall Study|Attempt subject|2
4609472|NCT01687166|7465301|FG001|Overall Study|Attempt subject|3
4609473|NCT01687166|7465302|FG002|Overall Study|Attempt subject|2
4609474|NCT01687166|7465303|FG003|Overall Study|Attempt subject|0
4609475|NCT01687166|7465300|FG000|Overall Study|Did not meet eligibility criteria|4
4609476|NCT01687166|7465301|FG001|Overall Study|Did not meet eligibility criteria|6
4609477|NCT01687166|7465302|FG002|Overall Study|Did not meet eligibility criteria|1
4609478|NCT01687166|7465303|FG003|Overall Study|Did not meet eligibility criteria|1
4609479|NCT01687166|7465300|FG000|Overall Study|Adverse Event|2
4609480|NCT01687166|7465301|FG001|Overall Study|Adverse Event|1
4609481|NCT01687166|7465302|FG002|Overall Study|Adverse Event|0
4609482|NCT01687166|7465303|FG003|Overall Study|Adverse Event|0
4609483|NCT01687166|7465300|FG000|Overall Study|Physician Decision|3
4609484|NCT01687166|7465301|FG001|Overall Study|Physician Decision|2
4609485|NCT01687166|7465302|FG002|Overall Study|Physician Decision|1
4609486|NCT01687166|7465303|FG003|Overall Study|Physician Decision|0
4609487|NCT01687166|7465300|FG000|Overall Study|Withdrawal by Subject|11
4609488|NCT01687166|7465301|FG001|Overall Study|Withdrawal by Subject|4
4609489|NCT01687166|7465302|FG002|Overall Study|Withdrawal by Subject|3
4609490|NCT01687166|7465303|FG003|Overall Study|Withdrawal by Subject|0
4609491|NCT01687166|7465300|FG000|Overall Study|Lost to Follow-up|2
4609492|NCT01687166|7465301|FG001|Overall Study|Lost to Follow-up|5
4609493|NCT01687166|7465302|FG002|Overall Study|Lost to Follow-up|1
4609494|NCT01687166|7465303|FG003|Overall Study|Lost to Follow-up|0
4609495|NCT01687166|7465300|FG000|Overall Study|Equipment/Device Availability|0
4609496|NCT01687166|7465301|FG001|Overall Study|Equipment/Device Availability|1
4609497|NCT01687166|7465302|FG002|Overall Study|Equipment/Device Availability|0
4609498|NCT01687166|7465303|FG003|Overall Study|Equipment/Device Availability|0
4609499|NCT01687166|7465300|FG000|Overall Study|Death|1
4609500|NCT01687166|7465301|FG001|Overall Study|Death|1
4609501|NCT01687166|7465302|FG002|Overall Study|Death|0
4609502|NCT01687166|7465303|FG003|Overall Study|Death|0
4609503|NCT01687166|7465300|FG000|Overall Study|Protocol Violation|1
4609504|NCT01687166|7465301|FG001|Overall Study|Protocol Violation|1
4609505|NCT01687166|7465302|FG002|Overall Study|Protocol Violation|1
4609506|NCT01687166|7465303|FG003|Overall Study|Protocol Violation|0
4609507|NCT01687166|7465300|FG000|Overall Study|Subject moved out of state|0
4609508|NCT01687166|7465301|FG001|Overall Study|Subject moved out of state|1
4531142|NCT01070043|7350097|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0
4531143|NCT01070043|7350095|FG000|Double-Blind Treatment|Adverse Event|0
4531144|NCT01070043|7350096|FG001|Double-Blind Treatment|Adverse Event|0
4531145|NCT01070043|7350097|FG002|Double-Blind Treatment|Adverse Event|2
4531146|NCT01070303|7350126|FG000|Overall Study|Adverse Event|39
4531147|NCT01070303|7350126|FG000|Overall Study|Withdrawal by Subject|20
4531148|NCT01070303|7350126|FG000|Overall Study|Lost to Follow-up|9
4609509|NCT01687166|7465302|FG002|Overall Study|Subject moved out of state|0
4609510|NCT01687166|7465303|FG003|Overall Study|Subject moved out of state|0
4609511|NCT01687166|7465300|FG000|Overall Study|Patient unable to be compliant|1
4609512|NCT01687166|7465301|FG001|Overall Study|Patient unable to be compliant|0
4609513|NCT01687166|7465302|FG002|Overall Study|Patient unable to be compliant|0
4531149|NCT01070303|7350126|FG000|Overall Study|Protocol Violation|0
4531150|NCT01070303|7350126|FG000|Overall Study|Lack of Efficacy|2
4531151|NCT01070303|7350126|FG000|Overall Study|Administrative Reason|1
4531152|NCT01070303|7350126|FG000|Overall Study|Other|18
4531153|NCT01070316|7350136|FG000|Extension Phase|Lack of Efficacy|3
4531154|NCT01070316|7350136|FG000|Extension Phase|Withdrawal by Subject|1
4531155|NCT01070329|7350142|FG000|Overall Study|Adverse Event|13
4531156|NCT01070329|7350143|FG001|Overall Study|Adverse Event|10
4531157|NCT01070329|7350142|FG000|Overall Study|Lost to Follow-up|22
4531158|NCT01070329|7350143|FG001|Overall Study|Lost to Follow-up|12
4531159|NCT01070329|7350142|FG000|Overall Study|Withdrawal by Subject|9
4531160|NCT01070329|7350143|FG001|Overall Study|Withdrawal by Subject|11
4531161|NCT01070329|7350142|FG000|Overall Study|Protocol Violation|3
4531162|NCT01070329|7350143|FG001|Overall Study|Protocol Violation|8
4531163|NCT01070329|7350142|FG000|Overall Study|Lack of Efficacy|2
4531164|NCT01070329|7350143|FG001|Overall Study|Lack of Efficacy|6
4531165|NCT01070329|7350142|FG000|Overall Study|Physician Decision|2
4531166|NCT01070329|7350143|FG001|Overall Study|Physician Decision|1
4531167|NCT01070329|7350142|FG000|Overall Study|Entry Criteria Not Met|1
4531168|NCT01070329|7350143|FG001|Overall Study|Entry Criteria Not Met|0
4531169|NCT01070329|7350142|FG000|Overall Study|Sponsor Decision|0
4531170|NCT01070329|7350143|FG001|Overall Study|Sponsor Decision|1
4531171|NCT01070381|7350149|FG000|Period 2, 1 Week of Wear|Handling|0
4531172|NCT01070381|7350150|FG001|Period 2, 1 Week of Wear|Handling|1
4531173|NCT01070381|7350149|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1
4531174|NCT01070381|7350150|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0
4531175|NCT01070394|7350156|FG000|Overall Study|Adverse Event|6
4689841|NCT02555371|7599377|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1
4689842|NCT02555371|7599378|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0
4689843|NCT02555371|7599379|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0
4689844|NCT02555371|7599375|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0
4689845|NCT02555371|7599376|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0
4689846|NCT02555371|7599377|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0
4689847|NCT02555371|7599378|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1
4689848|NCT02555371|7599379|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0
4689849|NCT02555371|7599375|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0
4689850|NCT02555371|7599376|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0
4689851|NCT02555371|7599377|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0
4689852|NCT02555371|7599378|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2
4689853|NCT02555371|7599379|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0
4531176|NCT01070394|7350156|FG000|Overall Study|Withdrawal by Subject|1
4531177|NCT01070550|7350168|FG000|Overall Study|Adverse Event|43
4531178|NCT01070550|7350169|FG001|Overall Study|Adverse Event|1
4531179|NCT01070550|7350170|FG002|Overall Study|Adverse Event|3
4531180|NCT01070550|7350171|FG003|Overall Study|Adverse Event|0
4531181|NCT01070550|7350172|FG004|Overall Study|Adverse Event|0
4531182|NCT01070550|7350173|FG005|Overall Study|Adverse Event|0
4531183|NCT01070550|7350168|FG000|Overall Study|Death|20
4531184|NCT01070550|7350169|FG001|Overall Study|Death|4
4531185|NCT01070550|7350170|FG002|Overall Study|Death|3
4531186|NCT01070550|7350171|FG003|Overall Study|Death|0
4531187|NCT01070550|7350172|FG004|Overall Study|Death|0
4531188|NCT01070550|7350173|FG005|Overall Study|Death|0
4531189|NCT01070550|7350168|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2
4531190|NCT01070550|7350169|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1
4531191|NCT01070550|7350170|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1
4531192|NCT01070550|7350171|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0
4531193|NCT01070550|7350172|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0
4531194|NCT01070550|7350173|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0
4531195|NCT01070550|7350168|FG000|Overall Study|Early termination|3
4531196|NCT01070550|7350169|FG001|Overall Study|Early termination|0
4531197|NCT01070550|7350170|FG002|Overall Study|Early termination|0
4531198|NCT01070550|7350171|FG003|Overall Study|Early termination|0
4531199|NCT01070550|7350172|FG004|Overall Study|Early termination|0
4531200|NCT01070550|7350173|FG005|Overall Study|Early termination|0
4531201|NCT01070550|7350168|FG000|Overall Study|Failed to return|450
4531202|NCT01070550|7350169|FG001|Overall Study|Failed to return|33
4531203|NCT01070550|7350170|FG002|Overall Study|Failed to return|144
4531204|NCT01070550|7350171|FG003|Overall Study|Failed to return|40
4531205|NCT01070550|7350172|FG004|Overall Study|Failed to return|1
4531206|NCT01070550|7350173|FG005|Overall Study|Failed to return|2
4531207|NCT01070550|7350168|FG000|Overall Study|Incomplete treatment|2
4531208|NCT01070550|7350169|FG001|Overall Study|Incomplete treatment|0
4531209|NCT01070550|7350170|FG002|Overall Study|Incomplete treatment|0
4531210|NCT01070550|7350171|FG003|Overall Study|Incomplete treatment|0
4531211|NCT01070550|7350172|FG004|Overall Study|Incomplete treatment|0
4531212|NCT01070550|7350173|FG005|Overall Study|Incomplete treatment|0
4531213|NCT01070550|7350168|FG000|Overall Study|Lab test not done|22
4531214|NCT01070550|7350169|FG001|Overall Study|Lab test not done|3
4531215|NCT01070550|7350170|FG002|Overall Study|Lab test not done|4
4531216|NCT01070550|7350171|FG003|Overall Study|Lab test not done|1
4531217|NCT01070550|7350172|FG004|Overall Study|Lab test not done|0
4531218|NCT01070550|7350173|FG005|Overall Study|Lab test not done|1
4531219|NCT01070550|7350168|FG000|Overall Study|Lack of Efficacy|65
4531220|NCT01070550|7350169|FG001|Overall Study|Lack of Efficacy|1
4531221|NCT01070550|7350170|FG002|Overall Study|Lack of Efficacy|5
4531222|NCT01070550|7350171|FG003|Overall Study|Lack of Efficacy|5
4531223|NCT01070550|7350172|FG004|Overall Study|Lack of Efficacy|0
4531224|NCT01070550|7350173|FG005|Overall Study|Lack of Efficacy|1
4531225|NCT01070550|7350168|FG000|Overall Study|Miscellaneous|12
4531226|NCT01070550|7350169|FG001|Overall Study|Miscellaneous|2
4531227|NCT01070550|7350170|FG002|Overall Study|Miscellaneous|3
4531228|NCT01070550|7350171|FG003|Overall Study|Miscellaneous|1
4531229|NCT01070550|7350172|FG004|Overall Study|Miscellaneous|0
4531230|NCT01070550|7350173|FG005|Overall Study|Miscellaneous|0
4531231|NCT01070550|7350168|FG000|Overall Study|New treatment started|3
4531232|NCT01070550|7350169|FG001|Overall Study|New treatment started|1
4531233|NCT01070550|7350170|FG002|Overall Study|New treatment started|0
4531234|NCT01070550|7350171|FG003|Overall Study|New treatment started|2
4531235|NCT01070550|7350172|FG004|Overall Study|New treatment started|0
4531236|NCT01070550|7350173|FG005|Overall Study|New treatment started|0
4531237|NCT01070550|7350168|FG000|Overall Study|Non-responders|493
4531238|NCT01070550|7350169|FG001|Overall Study|Non-responders|4
4531239|NCT01070550|7350170|FG002|Overall Study|Non-responders|21
4531240|NCT01070550|7350171|FG003|Overall Study|Non-responders|20
4531241|NCT01070550|7350172|FG004|Overall Study|Non-responders|0
4531242|NCT01070550|7350173|FG005|Overall Study|Non-responders|2
4531243|NCT01070550|7350168|FG000|Overall Study|Not categorized|33
4531244|NCT01070550|7350169|FG001|Overall Study|Not categorized|2
4531245|NCT01070550|7350170|FG002|Overall Study|Not categorized|6
4531246|NCT01070550|7350171|FG003|Overall Study|Not categorized|1
4531247|NCT01070550|7350172|FG004|Overall Study|Not categorized|0
4531248|NCT01070550|7350173|FG005|Overall Study|Not categorized|1
4531249|NCT01070550|7350168|FG000|Overall Study|Protocol Violation|15
4531250|NCT01070550|7350169|FG001|Overall Study|Protocol Violation|1
4531251|NCT01070550|7350170|FG002|Overall Study|Protocol Violation|1
4531252|NCT01070550|7350171|FG003|Overall Study|Protocol Violation|1
4531253|NCT01070550|7350172|FG004|Overall Study|Protocol Violation|0
4531254|NCT01070550|7350173|FG005|Overall Study|Protocol Violation|0
4531255|NCT01070550|7350168|FG000|Overall Study|Relapse|44
4531256|NCT01070550|7350169|FG001|Overall Study|Relapse|5
4531257|NCT01070550|7350170|FG002|Overall Study|Relapse|14
4531258|NCT01070550|7350171|FG003|Overall Study|Relapse|4
4531259|NCT01070550|7350172|FG004|Overall Study|Relapse|0
4531260|NCT01070550|7350173|FG005|Overall Study|Relapse|0
4531261|NCT01070550|7350168|FG000|Overall Study|Result not available|3
4531262|NCT01070550|7350169|FG001|Overall Study|Result not available|1
4531263|NCT01070550|7350170|FG002|Overall Study|Result not available|3
4531264|NCT01070550|7350171|FG003|Overall Study|Result not available|0
4531265|NCT01070550|7350172|FG004|Overall Study|Result not available|0
4531266|NCT01070550|7350173|FG005|Overall Study|Result not available|0
4531267|NCT01070550|7350168|FG000|Overall Study|Screen failure|1
4531268|NCT01070550|7350169|FG001|Overall Study|Screen failure|0
4531269|NCT01070550|7350170|FG002|Overall Study|Screen failure|0
4531270|NCT01070550|7350171|FG003|Overall Study|Screen failure|0
4531271|NCT01070550|7350172|FG004|Overall Study|Screen failure|0
4531272|NCT01070550|7350173|FG005|Overall Study|Screen failure|0
4531273|NCT01070550|7350168|FG000|Overall Study|Sponsor decision|1
4531274|NCT01070550|7350169|FG001|Overall Study|Sponsor decision|0
4531275|NCT01070550|7350170|FG002|Overall Study|Sponsor decision|0
4531276|NCT01070550|7350171|FG003|Overall Study|Sponsor decision|0
4531277|NCT01070550|7350172|FG004|Overall Study|Sponsor decision|0
4531278|NCT01070550|7350173|FG005|Overall Study|Sponsor decision|0
4531279|NCT01070550|7350168|FG000|Overall Study|Treatment duration shortened|1
4531280|NCT01070550|7350169|FG001|Overall Study|Treatment duration shortened|0
4531281|NCT01070550|7350170|FG002|Overall Study|Treatment duration shortened|0
4531282|NCT01070550|7350171|FG003|Overall Study|Treatment duration shortened|0
4531283|NCT01070550|7350172|FG004|Overall Study|Treatment duration shortened|0
4531284|NCT01070550|7350173|FG005|Overall Study|Treatment duration shortened|0
4531285|NCT01070550|7350168|FG000|Overall Study|Treatment interrupted|7
4531286|NCT01070550|7350169|FG001|Overall Study|Treatment interrupted|0
4531287|NCT01070550|7350170|FG002|Overall Study|Treatment interrupted|1
4531288|NCT01070550|7350171|FG003|Overall Study|Treatment interrupted|1
4609514|NCT01687166|7465303|FG003|Overall Study|Patient unable to be compliant|0
4609515|NCT01687166|7465300|FG000|Overall Study|Physician choice to use different device|1
4609516|NCT01687166|7465301|FG001|Overall Study|Physician choice to use different device|2
4531289|NCT01070550|7350172|FG004|Overall Study|Treatment interrupted|0
4531290|NCT01070550|7350173|FG005|Overall Study|Treatment interrupted|0
4531291|NCT01070550|7350168|FG000|Overall Study|Treatment not started|14
4531292|NCT01070550|7350169|FG001|Overall Study|Treatment not started|2
4531293|NCT01070550|7350170|FG002|Overall Study|Treatment not started|4
4531294|NCT01070550|7350171|FG003|Overall Study|Treatment not started|0
4531295|NCT01070550|7350172|FG004|Overall Study|Treatment not started|0
4531296|NCT01070550|7350173|FG005|Overall Study|Treatment not started|0
4531297|NCT01070550|7350168|FG000|Overall Study|Treatment restarted|0
4531298|NCT01070550|7350169|FG001|Overall Study|Treatment restarted|1
4531299|NCT01070550|7350170|FG002|Overall Study|Treatment restarted|0
4531300|NCT01070550|7350171|FG003|Overall Study|Treatment restarted|0
4531301|NCT01070550|7350172|FG004|Overall Study|Treatment restarted|0
4531302|NCT01070550|7350173|FG005|Overall Study|Treatment restarted|0
4531303|NCT01070550|7350168|FG000|Overall Study|Treatment stopped|3
4531304|NCT01070550|7350169|FG001|Overall Study|Treatment stopped|0
4531305|NCT01070550|7350170|FG002|Overall Study|Treatment stopped|0
4531306|NCT01070550|7350171|FG003|Overall Study|Treatment stopped|0
4531307|NCT01070550|7350172|FG004|Overall Study|Treatment stopped|0
4531308|NCT01070550|7350173|FG005|Overall Study|Treatment stopped|0
4531309|NCT01070550|7350168|FG000|Overall Study|Treatment unavailable|1
4531310|NCT01070550|7350169|FG001|Overall Study|Treatment unavailable|0
4531311|NCT01070550|7350170|FG002|Overall Study|Treatment unavailable|0
4531312|NCT01070550|7350171|FG003|Overall Study|Treatment unavailable|0
4531313|NCT01070550|7350172|FG004|Overall Study|Treatment unavailable|0
4531314|NCT01070550|7350173|FG005|Overall Study|Treatment unavailable|0
4531315|NCT01070550|7350168|FG000|Overall Study|Treatment was stopped early|7
4531316|NCT01070550|7350169|FG001|Overall Study|Treatment was stopped early|0
4531317|NCT01070550|7350170|FG002|Overall Study|Treatment was stopped early|0
4531318|NCT01070550|7350171|FG003|Overall Study|Treatment was stopped early|0
4531319|NCT01070550|7350172|FG004|Overall Study|Treatment was stopped early|0
4531320|NCT01070550|7350173|FG005|Overall Study|Treatment was stopped early|0
4531321|NCT01070550|7350168|FG000|Overall Study|Other|5
4531322|NCT01070550|7350169|FG001|Overall Study|Other|0
4531323|NCT01070550|7350170|FG002|Overall Study|Other|0
4531324|NCT01070550|7350171|FG003|Overall Study|Other|1
4531325|NCT01070550|7350172|FG004|Overall Study|Other|0
4531326|NCT01070550|7350173|FG005|Overall Study|Other|0
4531327|NCT01070550|7350168|FG000|Overall Study|Withdrawal by Subject|35
4531328|NCT01070550|7350169|FG001|Overall Study|Withdrawal by Subject|0
4531329|NCT01070550|7350170|FG002|Overall Study|Withdrawal by Subject|3
4531330|NCT01070550|7350171|FG003|Overall Study|Withdrawal by Subject|0
4531331|NCT01070550|7350172|FG004|Overall Study|Withdrawal by Subject|0
4531332|NCT01070550|7350173|FG005|Overall Study|Withdrawal by Subject|0
4531333|NCT01070771|7350197|FG000|Overall Study|Adverse Event|2
4531334|NCT01070771|7350197|FG000|Overall Study|Protocol Violation|1
4531335|NCT01070784|7350204|FG000|Overall Study|Withdrawal by Subject|6
4531336|NCT01070784|7350205|FG001|Overall Study|Withdrawal by Subject|9
4531337|NCT01070784|7350204|FG000|Overall Study|Adverse Event|14
4531338|NCT01070784|7350205|FG001|Overall Study|Adverse Event|9
4531339|NCT01070888|7350224|FG000|First Intervention (14 Days)|Adverse Event|0
4531340|NCT01070888|7350225|FG001|First Intervention (14 Days)|Adverse Event|1
4531341|NCT01070888|7350224|FG000|First Intervention (14 Days)|Lost to Follow-up|0
4531342|NCT01070888|7350225|FG001|First Intervention (14 Days)|Lost to Follow-up|1
4531343|NCT01070888|7350224|FG000|Washout (14 Days)|Physician Decision|1
4609517|NCT01687166|7465302|FG002|Overall Study|Physician choice to use different device|4
4609518|NCT01687166|7465303|FG003|Overall Study|Physician choice to use different device|0
4609519|NCT01687166|7465300|FG000|Overall Study|Insurance|0
4609520|NCT01687166|7465301|FG001|Overall Study|Insurance|0
4609521|NCT01687166|7465302|FG002|Overall Study|Insurance|1
4609522|NCT01687166|7465303|FG003|Overall Study|Insurance|1
4609523|NCT01687218|7465324|FG000|Overall Study|Withdrawal by Subject|2
4609524|NCT01687218|7465325|FG001|Overall Study|Withdrawal by Subject|3
4609525|NCT01687218|7465326|FG002|Overall Study|Withdrawal by Subject|0
4609526|NCT01687218|7465327|FG003|Overall Study|Withdrawal by Subject|1
4609527|NCT01687218|7465328|FG004|Overall Study|Withdrawal by Subject|1
4609528|NCT01687218|7465329|FG005|Overall Study|Withdrawal by Subject|0
4609529|NCT01687218|7465324|FG000|Overall Study|Relocated, no follow-up planned|1
4609530|NCT01687218|7465325|FG001|Overall Study|Relocated, no follow-up planned|0
4609531|NCT01687218|7465326|FG002|Overall Study|Relocated, no follow-up planned|1
4609532|NCT01687218|7465327|FG003|Overall Study|Relocated, no follow-up planned|1
4609533|NCT01687218|7465328|FG004|Overall Study|Relocated, no follow-up planned|0
4609534|NCT01687218|7465329|FG005|Overall Study|Relocated, no follow-up planned|0
4609535|NCT01687257|7465356|FG000|Overall Study|Efficacy Failure|6
4609536|NCT01687257|7465357|FG001|Overall Study|Efficacy Failure|0
4609537|NCT01687257|7465358|FG002|Overall Study|Efficacy Failure|5
4609538|NCT01687257|7465356|FG000|Overall Study|Subject Withdrew Consent|1
4609539|NCT01687257|7465357|FG001|Overall Study|Subject Withdrew Consent|1
4609540|NCT01687257|7465358|FG002|Overall Study|Subject Withdrew Consent|1
4609541|NCT01687257|7465356|FG000|Overall Study|Adverse Event|1
4609542|NCT01687257|7465357|FG001|Overall Study|Adverse Event|0
4609543|NCT01687257|7465358|FG002|Overall Study|Adverse Event|0
4609544|NCT01687257|7465356|FG000|Overall Study|Investigator's Discretion|0
4609545|NCT01687257|7465357|FG001|Overall Study|Investigator's Discretion|3
4609546|NCT01687257|7465358|FG002|Overall Study|Investigator's Discretion|0
4609547|NCT01687270|7465372|FG000|Overall Study|Lack of Efficacy|11
4609548|NCT01687270|7465372|FG000|Overall Study|Lost to Follow-up|1
4609549|NCT01687283|7465378|FG000|Overall Study|Adverse Event|11
4531344|NCT01070888|7350225|FG001|Washout (14 Days)|Physician Decision|0
4531345|NCT01070979|7350234|FG000|Overall Study|Adverse Event|2
4531346|NCT01070979|7350235|FG001|Overall Study|Adverse Event|3
4531347|NCT01070979|7350236|FG002|Overall Study|Adverse Event|3
4531348|NCT01070979|7350234|FG000|Overall Study|Lost to Follow-up|2
4531349|NCT01070979|7350235|FG001|Overall Study|Lost to Follow-up|1
4531350|NCT01070979|7350236|FG002|Overall Study|Lost to Follow-up|1
4531351|NCT01070979|7350234|FG000|Overall Study|Protocol Violation|0
4531352|NCT01070979|7350235|FG001|Overall Study|Protocol Violation|2
4531353|NCT01070979|7350236|FG002|Overall Study|Protocol Violation|6
4531354|NCT01070979|7350234|FG000|Overall Study|Surgery, moving, personal, abn. labs|4
4531355|NCT01070979|7350235|FG001|Overall Study|Surgery, moving, personal, abn. labs|4
4531356|NCT01070979|7350236|FG002|Overall Study|Surgery, moving, personal, abn. labs|2
4609550|NCT01687283|7465379|FG001|Overall Study|Adverse Event|4
4609551|NCT01687283|7465378|FG000|Overall Study|Lack of Efficacy|3
4531357|NCT01070979|7350234|FG000|Overall Study|Withdrawal by Subject|3
4531358|NCT01070979|7350235|FG001|Overall Study|Withdrawal by Subject|1
4531359|NCT01070979|7350236|FG002|Overall Study|Withdrawal by Subject|1
4531360|NCT01070979|7350234|FG000|Overall Study|No study drug taken|0
4531361|NCT01070979|7350235|FG001|Overall Study|No study drug taken|1
4531362|NCT01070979|7350236|FG002|Overall Study|No study drug taken|0
4531363|NCT01071070|7350258|FG000|Overall Study|Adverse Event|0
4531364|NCT01071070|7350259|FG001|Overall Study|Adverse Event|3
4531365|NCT01071070|7350258|FG000|Overall Study|Withdrawal by Subject|1
4531366|NCT01071070|7350259|FG001|Overall Study|Withdrawal by Subject|0
4531367|NCT01071070|7350258|FG000|Overall Study|Missed 3 consecutive doses of study drug|2
4531368|NCT01071070|7350259|FG001|Overall Study|Missed 3 consecutive doses of study drug|0
4531369|NCT01071070|7350258|FG000|Overall Study|Hypercalcemia|1
4531370|NCT01071070|7350259|FG001|Overall Study|Hypercalcemia|0
4531371|NCT01071083|7350270|FG000|Overall Study|Adverse Event|1
4531372|NCT01071083|7350271|FG001|Overall Study|Adverse Event|0
4531373|NCT01071083|7350272|FG002|Overall Study|Adverse Event|1
4531374|NCT01071083|7350273|FG003|Overall Study|Adverse Event|0
4531375|NCT01071083|7350274|FG004|Overall Study|Adverse Event|1
4531376|NCT01071083|7350270|FG000|Overall Study|Withdrawal by Subject|3
4531377|NCT01071083|7350271|FG001|Overall Study|Withdrawal by Subject|0
4531378|NCT01071083|7350272|FG002|Overall Study|Withdrawal by Subject|2
4531379|NCT01071083|7350273|FG003|Overall Study|Withdrawal by Subject|0
4531380|NCT01071083|7350274|FG004|Overall Study|Withdrawal by Subject|3
4531381|NCT01071083|7350270|FG000|Overall Study|Physician Decision|1
4531382|NCT01071083|7350271|FG001|Overall Study|Physician Decision|0
4531383|NCT01071083|7350272|FG002|Overall Study|Physician Decision|0
4531384|NCT01071083|7350273|FG003|Overall Study|Physician Decision|1
4531385|NCT01071083|7350274|FG004|Overall Study|Physician Decision|1
4531386|NCT01071083|7350270|FG000|Overall Study|Early Rescue|1
4531387|NCT01071083|7350271|FG001|Overall Study|Early Rescue|0
4531388|NCT01071083|7350272|FG002|Overall Study|Early Rescue|0
4531389|NCT01071083|7350273|FG003|Overall Study|Early Rescue|0
4531390|NCT01071083|7350274|FG004|Overall Study|Early Rescue|1
4531391|NCT01071083|7350270|FG000|Overall Study|Subject Moved|0
4531392|NCT01071083|7350271|FG001|Overall Study|Subject Moved|1
4531393|NCT01071083|7350272|FG002|Overall Study|Subject Moved|0
4531394|NCT01071083|7350273|FG003|Overall Study|Subject Moved|0
4531395|NCT01071083|7350274|FG004|Overall Study|Subject Moved|0
4531396|NCT01071083|7350270|FG000|Overall Study|Images Not Usable (Motion)|0
4531397|NCT01071083|7350271|FG001|Overall Study|Images Not Usable (Motion)|1
4531398|NCT01071083|7350272|FG002|Overall Study|Images Not Usable (Motion)|0
4531399|NCT01071083|7350273|FG003|Overall Study|Images Not Usable (Motion)|0
4531400|NCT01071083|7350274|FG004|Overall Study|Images Not Usable (Motion)|0
4531401|NCT01071083|7350270|FG000|Overall Study|Did Not Meet Eligibility Criteria|0
4531402|NCT01071083|7350271|FG001|Overall Study|Did Not Meet Eligibility Criteria|0
4531403|NCT01071083|7350272|FG002|Overall Study|Did Not Meet Eligibility Criteria|1
4531404|NCT01071083|7350273|FG003|Overall Study|Did Not Meet Eligibility Criteria|1
4531405|NCT01071083|7350274|FG004|Overall Study|Did Not Meet Eligibility Criteria|1
4531406|NCT01071083|7350270|FG000|Overall Study|Did Not Want Per Protocol Treatment|0
4531407|NCT01071083|7350271|FG001|Overall Study|Did Not Want Per Protocol Treatment|0
4531408|NCT01071083|7350272|FG002|Overall Study|Did Not Want Per Protocol Treatment|1
4531409|NCT01071083|7350273|FG003|Overall Study|Did Not Want Per Protocol Treatment|0
4531410|NCT01071083|7350274|FG004|Overall Study|Did Not Want Per Protocol Treatment|1
4531411|NCT01071083|7350270|FG000|Overall Study|Subject Refused to Continue|1
4531412|NCT01071083|7350271|FG001|Overall Study|Subject Refused to Continue|0
4531413|NCT01071083|7350272|FG002|Overall Study|Subject Refused to Continue|0
4531414|NCT01071083|7350273|FG003|Overall Study|Subject Refused to Continue|0
4531415|NCT01071083|7350274|FG004|Overall Study|Subject Refused to Continue|0
4531416|NCT01071096|7350286|FG000|First Intervention (90 Days)|Lost to Follow-up|1
4531417|NCT01071096|7350287|FG001|First Intervention (90 Days)|Lost to Follow-up|0
4531418|NCT01071200|7350306|FG000|Overall Study|Lack of ovarian response|1
4531419|NCT01071200|7350307|FG001|Overall Study|Lack of ovarian response|1
4531420|NCT01071200|7350306|FG000|Overall Study|No fertilization|4
4531421|NCT01071200|7350307|FG001|Overall Study|No fertilization|0
4531422|NCT01071200|7350306|FG000|Overall Study|No oocytes retrieved|1
4531423|NCT01071200|7350307|FG001|Overall Study|No oocytes retrieved|1
4531424|NCT01071200|7350306|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1
4531425|NCT01071200|7350307|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0
4531426|NCT01071200|7350306|FG000|Overall Study|No viable embryos|0
4531427|NCT01071200|7350307|FG001|Overall Study|No viable embryos|1
4531428|NCT01071252|7350318|FG000|Overall Study|unsatisfactory therapeutic effect|4
4531429|NCT01071252|7350319|FG001|Overall Study|unsatisfactory therapeutic effect|6
4609552|NCT01687283|7465379|FG001|Overall Study|Lack of Efficacy|1
4531430|NCT01071252|7350320|FG002|Overall Study|unsatisfactory therapeutic effect|2
4531431|NCT01071252|7350321|FG003|Overall Study|unsatisfactory therapeutic effect|0
4531432|NCT01071252|7350322|FG004|Overall Study|unsatisfactory therapeutic effect|6
4531433|NCT01071252|7350318|FG000|Overall Study|Withdrawal by Subject|8
4531434|NCT01071252|7350319|FG001|Overall Study|Withdrawal by Subject|2
4531435|NCT01071252|7350320|FG002|Overall Study|Withdrawal by Subject|1
4531436|NCT01071252|7350321|FG003|Overall Study|Withdrawal by Subject|2
4531437|NCT01071252|7350322|FG004|Overall Study|Withdrawal by Subject|3
4531438|NCT01071252|7350318|FG000|Overall Study|administrative problems|1
4531439|NCT01071252|7350319|FG001|Overall Study|administrative problems|1
4531440|NCT01071252|7350320|FG002|Overall Study|administrative problems|0
4531441|NCT01071252|7350321|FG003|Overall Study|administrative problems|2
4531442|NCT01071252|7350322|FG004|Overall Study|administrative problems|1
4531443|NCT01071252|7350318|FG000|Overall Study|Lost to Follow-up|1
4531444|NCT01071252|7350319|FG001|Overall Study|Lost to Follow-up|0
4531445|NCT01071252|7350320|FG002|Overall Study|Lost to Follow-up|1
4531446|NCT01071252|7350321|FG003|Overall Study|Lost to Follow-up|2
4531447|NCT01071252|7350322|FG004|Overall Study|Lost to Follow-up|0
4531448|NCT01071252|7350318|FG000|Overall Study|Adverse Event|1
4531449|NCT01071252|7350319|FG001|Overall Study|Adverse Event|1
4531450|NCT01071252|7350320|FG002|Overall Study|Adverse Event|0
4531451|NCT01071252|7350321|FG003|Overall Study|Adverse Event|1
4531452|NCT01071252|7350322|FG004|Overall Study|Adverse Event|0
4531453|NCT01071252|7350318|FG000|Overall Study|Death|0
4531454|NCT01071252|7350319|FG001|Overall Study|Death|0
4531455|NCT01071252|7350320|FG002|Overall Study|Death|0
4531456|NCT01071252|7350321|FG003|Overall Study|Death|0
4531457|NCT01071252|7350322|FG004|Overall Study|Death|1
4590834|NCT01524978|7437113|FG002|Overall Study|Withdrawal by Subject|1
4590835|NCT01524978|7437114|FG003|Overall Study|Withdrawal by Subject|1
4590836|NCT01524978|7437115|FG004|Overall Study|Withdrawal by Subject|3
4590837|NCT01524978|7437116|FG005|Overall Study|Withdrawal by Subject|1
4590838|NCT01524978|7437117|FG006|Overall Study|Withdrawal by Subject|6
4590839|NCT01524978|7437118|FG007|Overall Study|Withdrawal by Subject|2
4590840|NCT01524978|7437119|FG008|Overall Study|Withdrawal by Subject|4
4590841|NCT01524978|7437120|FG009|Overall Study|Withdrawal by Subject|0
4590842|NCT01524978|7437121|FG010|Overall Study|Withdrawal by Subject|5
4590843|NCT01524978|7437111|FG000|Overall Study|Lost to Follow-up|0
4590844|NCT01524978|7437112|FG001|Overall Study|Lost to Follow-up|0
4590845|NCT01524978|7437113|FG002|Overall Study|Lost to Follow-up|3
4590846|NCT01524978|7437114|FG003|Overall Study|Lost to Follow-up|0
4590847|NCT01524978|7437115|FG004|Overall Study|Lost to Follow-up|1
4590848|NCT01524978|7437116|FG005|Overall Study|Lost to Follow-up|1
4590849|NCT01524978|7437117|FG006|Overall Study|Lost to Follow-up|2
4590850|NCT01524978|7437118|FG007|Overall Study|Lost to Follow-up|0
4590851|NCT01524978|7437119|FG008|Overall Study|Lost to Follow-up|1
4590852|NCT01524978|7437120|FG009|Overall Study|Lost to Follow-up|1
4590853|NCT01524978|7437121|FG010|Overall Study|Lost to Follow-up|1
4590854|NCT01524978|7437111|FG000|Overall Study|Death|34
4590855|NCT01524978|7437112|FG001|Overall Study|Death|2
4590856|NCT01524978|7437113|FG002|Overall Study|Death|5
4590857|NCT01524978|7437114|FG003|Overall Study|Death|24
4590858|NCT01524978|7437115|FG004|Overall Study|Death|4
4590859|NCT01524978|7437116|FG005|Overall Study|Death|4
4590860|NCT01524978|7437117|FG006|Overall Study|Death|1
4590861|NCT01524978|7437118|FG007|Overall Study|Death|9
4590862|NCT01524978|7437119|FG008|Overall Study|Death|5
4590863|NCT01524978|7437120|FG009|Overall Study|Death|6
4590864|NCT01524978|7437121|FG010|Overall Study|Death|17
4590865|NCT01524991|7437136|FG000|Overall Study|Adverse Event|12
4590866|NCT01524991|7437136|FG000|Overall Study|Death|1
4590867|NCT01524991|7437136|FG000|Overall Study|Disease ProgressionDu|17
4590868|NCT01524991|7437136|FG000|Overall Study|Other complicating disease|1
4590869|NCT01524991|7437136|FG000|Overall Study|Withdrawal by Subject|2
4590870|NCT01524991|7437136|FG000|Overall Study|Symptomatic Deterioration|1
4590871|NCT01525082|7437140|FG000|Overall Study|Death|1
4590872|NCT01525225|7437156|FG000|Enrollment|No longer met study criteria|1
4590873|NCT01525225|7437156|FG000|Enrollment|Other|1
4590874|NCT01525238|7437163|FG000|Overall Study|Withdrawal by Subject|1
4590875|NCT01525238|7437164|FG001|Overall Study|Withdrawal by Subject|0
4590876|NCT01525238|7437165|FG002|Overall Study|Withdrawal by Subject|0
4590877|NCT01525407|7437175|FG000|Overall Study|Change in recipient treatment plan|2
4590878|NCT01525407|7437176|FG001|Overall Study|Change in recipient treatment plan|2
4590879|NCT01525407|7437175|FG000|Overall Study|Withdrawal by Subject|0
4590880|NCT01525407|7437176|FG001|Overall Study|Withdrawal by Subject|1
4590881|NCT01525407|7437175|FG000|Overall Study|Transplant was delayed|0
4590882|NCT01525407|7437176|FG001|Overall Study|Transplant was delayed|1
4590883|NCT01525407|7437175|FG000|Overall Study|Delay in Transplant|1
4590884|NCT01525407|7437176|FG001|Overall Study|Delay in Transplant|0
4590885|NCT01525550|7437193|FG000|Overall Study|Lost to Follow-up|8
4590886|NCT01525550|7437194|FG001|Overall Study|Lost to Follow-up|2
4590887|NCT01525550|7437193|FG000|Overall Study|Death|19
4590888|NCT01525550|7437194|FG001|Overall Study|Death|28
4590889|NCT01525550|7437193|FG000|Overall Study|Other|0
4590890|NCT01525550|7437194|FG001|Overall Study|Other|4
4590891|NCT01525550|7437193|FG000|Overall Study|Sponsor's Decision|30
4531458|NCT01071278|7350334|FG000|Overall Study|Premature Discontinuation|254
4531459|NCT01071278|7350334|FG000|Overall Study|Completion Status Unknown|459
4531460|NCT01071317|7350342|FG000|Overall Study|Lost to Follow-up|2
4531461|NCT01071317|7350343|FG001|Overall Study|Lost to Follow-up|2
4531462|NCT01071395|7350360|FG000|Overall Study|Withdrawal by Subject|2
4531463|NCT01071395|7350361|FG001|Overall Study|Withdrawal by Subject|1
4531464|NCT01071395|7350360|FG000|Overall Study|Adverse Event|3
4531465|NCT01071395|7350361|FG001|Overall Study|Adverse Event|1
4531466|NCT01071512|7350367|FG000|Overall Study|Adverse Event|1
4531467|NCT01071512|7350367|FG000|Overall Study|Development of antibodies to drug|2
4531468|NCT01071512|7350367|FG000|Overall Study|positive anti-JC virus antibody test|2
4531469|NCT01071798|7350375|FG000|Participants Who Received One Cycle|Lack of Efficacy|18
4531470|NCT01071798|7350375|FG000|Participants Who Received One Cycle|Lack of tolerability|14
4531471|NCT01071798|7350375|FG000|Participants Who Received One Cycle|Patient requirement|20
4531472|NCT01071798|7350375|FG000|Participants Who Received One Cycle|Death|5
4531473|NCT01071798|7350375|FG000|Participants Who Received One Cycle|Change of therapy|6
4531474|NCT01071798|7350375|FG000|Participants Who Received One Cycle|Severe concomitant disease|2
4531475|NCT01071798|7350375|FG000|Subpopulation Who Received Two Cycles|Remission|1
4531476|NCT01071798|7350375|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3
4531477|NCT01071798|7350375|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4
4531478|NCT01071798|7350375|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7
4531479|NCT01071915|7350389|FG000|Overall Study|Adverse Event|3
4531480|NCT01071915|7350389|FG000|Overall Study|Physician Decision|2
4531481|NCT01071915|7350389|FG000|Overall Study|Withdrawal by Subject|2
4531482|NCT01071915|7350389|FG000|Overall Study|Miscellaneous Reasons|2
4531483|NCT01071954|7350393|FG000|Overall Study|Noncompliance|4
4531484|NCT01071954|7350393|FG000|Overall Study|Adverse Event|1
4531485|NCT01071954|7350393|FG000|Overall Study|Withdrawal by Subject|11
4531486|NCT01071954|7350393|FG000|Overall Study|Requirement for Alternative Therapy|5
4531487|NCT01071954|7350393|FG000|Overall Study|Administrative Decision|5
4531488|NCT01071954|7350393|FG000|Overall Study|Protocol Specified Criteria|1
4531489|NCT01072149|7350437|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4531490|NCT01072149|7350438|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4531491|NCT01072149|7350439|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
4531492|NCT01072149|7350440|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4531493|NCT01072149|7350441|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4531494|NCT01072149|7350442|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4531495|NCT01072149|7350443|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4531496|NCT01072149|7350444|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4531497|NCT01072149|7350445|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4531498|NCT01072149|7350446|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4531499|NCT01072149|7350447|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4531500|NCT01072149|7350448|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4531501|NCT01072149|7350449|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4531502|NCT01072149|7350450|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4531503|NCT01072149|7350451|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4531504|NCT01072149|7350452|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4531505|NCT01072149|7350453|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4531506|NCT01072149|7350454|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4531507|NCT01072149|7350437|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0
4531508|NCT01072149|7350438|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0
4531509|NCT01072149|7350439|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0
4531510|NCT01072149|7350440|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0
4531511|NCT01072149|7350441|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0
4531512|NCT01072149|7350442|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0
4531513|NCT01072149|7350443|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0
4531514|NCT01072149|7350444|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0
4531515|NCT01072149|7350445|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0
4531516|NCT01072149|7350446|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0
4531517|NCT01072149|7350447|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0
4531518|NCT01072149|7350448|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0
4531519|NCT01072149|7350449|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0
4531520|NCT01072149|7350450|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0
4531521|NCT01072149|7350451|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0
4531522|NCT01072149|7350452|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0
4531523|NCT01072149|7350453|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0
4531524|NCT01072149|7350454|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1
4531525|NCT01072149|7350437|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0
4531526|NCT01072149|7350438|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0
4531527|NCT01072149|7350439|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0
4531528|NCT01072149|7350440|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0
4531529|NCT01072149|7350441|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0
4531530|NCT01072149|7350442|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0
4531531|NCT01072149|7350443|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0
4531532|NCT01072149|7350444|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0
4531533|NCT01072149|7350445|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0
4531534|NCT01072149|7350446|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0
4531535|NCT01072149|7350447|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1
4531536|NCT01072149|7350448|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0
4531537|NCT01072149|7350449|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0
4531538|NCT01072149|7350450|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0
4531539|NCT01072149|7350451|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0
4531540|NCT01072149|7350452|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0
4531541|NCT01072149|7350453|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0
4531542|NCT01072149|7350454|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0
4531543|NCT01072149|7350437|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0
4531544|NCT01072149|7350438|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1
4531545|NCT01072149|7350439|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0
4531546|NCT01072149|7350440|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0
4531547|NCT01072149|7350441|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0
4531548|NCT01072149|7350442|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0
4531549|NCT01072149|7350443|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0
4531550|NCT01072149|7350444|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0
4531551|NCT01072149|7350445|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0
4531552|NCT01072149|7350446|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0
4531553|NCT01072149|7350447|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0
4531554|NCT01072149|7350448|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0
4531555|NCT01072149|7350449|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0
4531556|NCT01072149|7350450|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0
4531557|NCT01072149|7350451|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0
4531558|NCT01072149|7350452|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0
4531559|NCT01072149|7350453|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0
4531560|NCT01072149|7350454|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0
4531561|NCT01072149|7350437|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
4531562|NCT01072149|7350438|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
4531563|NCT01072149|7350439|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1
4531564|NCT01072149|7350440|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
4531565|NCT01072149|7350441|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
4531566|NCT01072149|7350442|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
4531567|NCT01072149|7350443|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
4531568|NCT01072149|7350444|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
4531569|NCT01072149|7350445|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
4531570|NCT01072149|7350446|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
4531571|NCT01072149|7350447|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
4531572|NCT01072149|7350448|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
4531573|NCT01072149|7350449|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
4531574|NCT01072149|7350450|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
4531575|NCT01072149|7350451|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
4531576|NCT01072149|7350452|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
4531577|NCT01072149|7350453|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
4531578|NCT01072149|7350454|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
4531579|NCT01072149|7350437|FG000|Treatment Period 2 (28 Days)|Physician Decision|0
4531580|NCT01072149|7350438|FG001|Treatment Period 2 (28 Days)|Physician Decision|0
4531581|NCT01072149|7350439|FG002|Treatment Period 2 (28 Days)|Physician Decision|0
4531582|NCT01072149|7350440|FG003|Treatment Period 2 (28 Days)|Physician Decision|0
4531583|NCT01072149|7350441|FG004|Treatment Period 2 (28 Days)|Physician Decision|0
4531584|NCT01072149|7350442|FG005|Treatment Period 2 (28 Days)|Physician Decision|0
4531585|NCT01072149|7350443|FG006|Treatment Period 2 (28 Days)|Physician Decision|0
4531586|NCT01072149|7350444|FG007|Treatment Period 2 (28 Days)|Physician Decision|1
4531587|NCT01072149|7350445|FG008|Treatment Period 2 (28 Days)|Physician Decision|0
4531588|NCT01072149|7350446|FG009|Treatment Period 2 (28 Days)|Physician Decision|0
4531589|NCT01072149|7350447|FG010|Treatment Period 2 (28 Days)|Physician Decision|0
4531590|NCT01072149|7350448|FG011|Treatment Period 2 (28 Days)|Physician Decision|0
4531591|NCT01072149|7350449|FG012|Treatment Period 2 (28 Days)|Physician Decision|0
4531592|NCT01072149|7350450|FG013|Treatment Period 2 (28 Days)|Physician Decision|0
4531593|NCT01072149|7350451|FG014|Treatment Period 2 (28 Days)|Physician Decision|0
4531594|NCT01072149|7350452|FG015|Treatment Period 2 (28 Days)|Physician Decision|0
4531595|NCT01072149|7350453|FG016|Treatment Period 2 (28 Days)|Physician Decision|0
4531596|NCT01072149|7350454|FG017|Treatment Period 2 (28 Days)|Physician Decision|0
4531597|NCT01072149|7350437|FG000|Washout Period 2 (14 Days)|Physician Decision|1
4531598|NCT01072149|7350438|FG001|Washout Period 2 (14 Days)|Physician Decision|0
4531599|NCT01072149|7350439|FG002|Washout Period 2 (14 Days)|Physician Decision|0
4531600|NCT01072149|7350440|FG003|Washout Period 2 (14 Days)|Physician Decision|0
4531601|NCT01072149|7350441|FG004|Washout Period 2 (14 Days)|Physician Decision|0
4531602|NCT01072149|7350442|FG005|Washout Period 2 (14 Days)|Physician Decision|0
4531603|NCT01072149|7350443|FG006|Washout Period 2 (14 Days)|Physician Decision|0
4531604|NCT01072149|7350444|FG007|Washout Period 2 (14 Days)|Physician Decision|0
4531605|NCT01072149|7350445|FG008|Washout Period 2 (14 Days)|Physician Decision|0
4531606|NCT01072149|7350446|FG009|Washout Period 2 (14 Days)|Physician Decision|0
4531607|NCT01072149|7350447|FG010|Washout Period 2 (14 Days)|Physician Decision|0
4531608|NCT01072149|7350448|FG011|Washout Period 2 (14 Days)|Physician Decision|0
4531609|NCT01072149|7350449|FG012|Washout Period 2 (14 Days)|Physician Decision|0
4531610|NCT01072149|7350450|FG013|Washout Period 2 (14 Days)|Physician Decision|0
4531611|NCT01072149|7350451|FG014|Washout Period 2 (14 Days)|Physician Decision|0
4531612|NCT01072149|7350452|FG015|Washout Period 2 (14 Days)|Physician Decision|0
4531613|NCT01072149|7350453|FG016|Washout Period 2 (14 Days)|Physician Decision|0
4531614|NCT01072149|7350454|FG017|Washout Period 2 (14 Days)|Physician Decision|0
4531615|NCT01072149|7350437|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0
4531616|NCT01072149|7350438|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0
4531617|NCT01072149|7350439|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0
4531618|NCT01072149|7350440|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0
4531619|NCT01072149|7350441|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0
4531620|NCT01072149|7350442|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0
4531621|NCT01072149|7350443|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0
4531622|NCT01072149|7350444|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0
4531623|NCT01072149|7350445|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0
4531624|NCT01072149|7350446|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0
4531625|NCT01072149|7350447|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0
4531626|NCT01072149|7350448|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0
4531627|NCT01072149|7350449|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0
4531628|NCT01072149|7350450|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0
4531629|NCT01072149|7350451|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0
4531630|NCT01072149|7350452|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1
4531631|NCT01072149|7350453|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0
4531632|NCT01072149|7350454|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0
4531633|NCT01072149|7350437|FG000|Washout Period 2 (14 Days)|Adverse Event|0
4531634|NCT01072149|7350438|FG001|Washout Period 2 (14 Days)|Adverse Event|0
4531635|NCT01072149|7350439|FG002|Washout Period 2 (14 Days)|Adverse Event|0
4531636|NCT01072149|7350440|FG003|Washout Period 2 (14 Days)|Adverse Event|0
4531637|NCT01072149|7350441|FG004|Washout Period 2 (14 Days)|Adverse Event|0
4531638|NCT01072149|7350442|FG005|Washout Period 2 (14 Days)|Adverse Event|0
4531639|NCT01072149|7350443|FG006|Washout Period 2 (14 Days)|Adverse Event|0
4531640|NCT01072149|7350444|FG007|Washout Period 2 (14 Days)|Adverse Event|0
4531641|NCT01072149|7350445|FG008|Washout Period 2 (14 Days)|Adverse Event|0
4531642|NCT01072149|7350446|FG009|Washout Period 2 (14 Days)|Adverse Event|0
4531643|NCT01072149|7350447|FG010|Washout Period 2 (14 Days)|Adverse Event|0
4531644|NCT01072149|7350448|FG011|Washout Period 2 (14 Days)|Adverse Event|0
4531645|NCT01072149|7350449|FG012|Washout Period 2 (14 Days)|Adverse Event|0
4531646|NCT01072149|7350450|FG013|Washout Period 2 (14 Days)|Adverse Event|0
4531647|NCT01072149|7350451|FG014|Washout Period 2 (14 Days)|Adverse Event|0
4531648|NCT01072149|7350452|FG015|Washout Period 2 (14 Days)|Adverse Event|1
4531649|NCT01072149|7350453|FG016|Washout Period 2 (14 Days)|Adverse Event|0
4531650|NCT01072149|7350454|FG017|Washout Period 2 (14 Days)|Adverse Event|0
4531651|NCT01072149|7350437|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0
4531652|NCT01072149|7350438|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0
4531653|NCT01072149|7350439|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0
4531654|NCT01072149|7350440|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0
4531655|NCT01072149|7350441|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0
4531656|NCT01072149|7350442|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0
4531657|NCT01072149|7350443|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0
4531658|NCT01072149|7350444|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0
4531659|NCT01072149|7350445|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0
4531660|NCT01072149|7350446|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0
4531661|NCT01072149|7350447|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0
4531662|NCT01072149|7350448|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0
4531663|NCT01072149|7350449|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1
4531664|NCT01072149|7350450|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0
4531665|NCT01072149|7350451|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0
4531666|NCT01072149|7350452|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0
4531667|NCT01072149|7350453|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0
4531668|NCT01072149|7350454|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0
4531669|NCT01072149|7350437|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
4531670|NCT01072149|7350438|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
4531671|NCT01072149|7350439|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1
4531672|NCT01072149|7350440|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
4531673|NCT01072149|7350441|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
4531674|NCT01072149|7350442|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
4531675|NCT01072149|7350443|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
4531676|NCT01072149|7350444|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
4531677|NCT01072149|7350445|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
4531678|NCT01072149|7350446|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
4531679|NCT01072149|7350447|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
4531680|NCT01072149|7350448|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
4531681|NCT01072149|7350449|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
4531682|NCT01072149|7350450|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1
4531683|NCT01072149|7350451|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
4531684|NCT01072149|7350452|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
4531685|NCT01072149|7350453|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
4531686|NCT01072149|7350454|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
4531687|NCT01072201|7350475|FG000|Overall Study|Lost to Follow-up|0
4531688|NCT01072201|7350476|FG001|Overall Study|Lost to Follow-up|1
4531689|NCT01072344|7350497|FG000|Overall Study|Relasped-reached end point|7
4531690|NCT01072344|7350498|FG001|Overall Study|Relasped-reached end point|12
4531691|NCT01072344|7350497|FG000|Overall Study|Protocol Violation|1
4531692|NCT01072344|7350498|FG001|Overall Study|Protocol Violation|2
4531693|NCT01072344|7350497|FG000|Overall Study|Lost to Follow-up|3
4531694|NCT01072344|7350498|FG001|Overall Study|Lost to Follow-up|4
4531695|NCT01072357|7350506|FG000|Overall Study|Lost to Follow-up|0
4531696|NCT01072357|7350507|FG001|Overall Study|Lost to Follow-up|1
4531697|NCT01072396|7350515|FG000|Period One|Adverse Event|1
4531698|NCT01072396|7350516|FG001|Period One|Adverse Event|1
4531699|NCT01072396|7350515|FG000|Period One|Protocol Violation|2
4531700|NCT01072396|7350516|FG001|Period One|Protocol Violation|1
4531701|NCT01072396|7350515|FG000|Period One|Withdrawal by Subject|2
4531702|NCT01072396|7350516|FG001|Period One|Withdrawal by Subject|0
4531703|NCT01072396|7350515|FG000|Washout Period|Missing termination information|0
4531704|NCT01072396|7350516|FG001|Washout Period|Missing termination information|1
4531705|NCT01072396|7350515|FG000|Period Two|Adverse Event|0
4531706|NCT01072396|7350516|FG001|Period Two|Adverse Event|3
4531707|NCT01072396|7350515|FG000|Period Two|Lost to Follow-up|1
4531708|NCT01072396|7350516|FG001|Period Two|Lost to Follow-up|0
4531709|NCT01072448|7350528|FG000|Overall Study|Adverse Event|9
4531710|NCT01072448|7350529|FG001|Overall Study|Adverse Event|10
4531711|NCT01072448|7350528|FG000|Overall Study|Subject withdrew consent|4
4531712|NCT01072448|7350529|FG001|Overall Study|Subject withdrew consent|9
4531713|NCT01072448|7350528|FG000|Overall Study|Protocol deviation|3
4531714|NCT01072448|7350529|FG001|Overall Study|Protocol deviation|4
4531715|NCT01072448|7350528|FG000|Overall Study|Abnormal test procedure result(s)|1
4531716|NCT01072448|7350529|FG001|Overall Study|Abnormal test procedure result(s)|0
4531717|NCT01072448|7350528|FG000|Overall Study|Unsatisfactory therapeutic effect|1
4531718|NCT01072448|7350529|FG001|Overall Study|Unsatisfactory therapeutic effect|3
4531719|NCT01072448|7350528|FG000|Overall Study|Lost to Follow-up|1
4531720|NCT01072448|7350529|FG001|Overall Study|Lost to Follow-up|1
4531721|NCT01072448|7350528|FG000|Overall Study|Abnormal laboratory value(s)|0
4531722|NCT01072448|7350529|FG001|Overall Study|Abnormal laboratory value(s)|1
4609553|NCT01687283|7465378|FG000|Overall Study|Protocol Violation|1
4609554|NCT01687283|7465379|FG001|Overall Study|Protocol Violation|3
4609555|NCT01687283|7465378|FG000|Overall Study|protocol defined stopping criteria|8
4609556|NCT01687283|7465379|FG001|Overall Study|protocol defined stopping criteria|10
4609557|NCT01687283|7465378|FG000|Overall Study|Lost to Follow-up|1
4609558|NCT01687283|7465379|FG001|Overall Study|Lost to Follow-up|1
4609559|NCT01687283|7465378|FG000|Overall Study|Investigator discretion|2
4609560|NCT01687283|7465379|FG001|Overall Study|Investigator discretion|0
4609561|NCT01687283|7465378|FG000|Overall Study|Withdrawal by Subject|9
4609562|NCT01687283|7465379|FG001|Overall Study|Withdrawal by Subject|8
4609563|NCT01687296|7465387|FG000|Overall Study|Lack of Efficacy|1
4609564|NCT01687296|7465388|FG001|Overall Study|Lack of Efficacy|1
4609565|NCT01687296|7465387|FG000|Overall Study|Protocol Violation|0
4609566|NCT01687296|7465388|FG001|Overall Study|Protocol Violation|1
4609567|NCT01687296|7465387|FG000|Overall Study|Withdrawal by Subject|6
4609568|NCT01687296|7465388|FG001|Overall Study|Withdrawal by Subject|3
4609569|NCT01687413|7465418|FG000|Overall Study|Withdrawal by Subject|0
4609570|NCT01687413|7465419|FG001|Overall Study|Withdrawal by Subject|2
4609571|NCT01687413|7465418|FG000|Overall Study|Not eligible|0
4609572|NCT01687413|7465419|FG001|Overall Study|Not eligible|2
4609573|NCT01687413|7465418|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1
4609574|NCT01687413|7465419|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0
4609575|NCT01687478|7465445|FG000|Overall Study|Adverse Event|3
4609576|NCT01687478|7465446|FG001|Overall Study|Adverse Event|10
4609577|NCT01687478|7465445|FG000|Overall Study|Lost to Follow-up|1
4609578|NCT01687478|7465446|FG001|Overall Study|Lost to Follow-up|3
4609579|NCT01687478|7465445|FG000|Overall Study|Protocol Violation|0
4609580|NCT01687478|7465446|FG001|Overall Study|Protocol Violation|2
4609581|NCT01687478|7465445|FG000|Overall Study|Withdrawal by Subject|21
4609582|NCT01687478|7465446|FG001|Overall Study|Withdrawal by Subject|19
4609583|NCT01687478|7465445|FG000|Overall Study|Physician Decision|1
4609584|NCT01687478|7465446|FG001|Overall Study|Physician Decision|3
4609585|NCT01687478|7465445|FG000|Overall Study|Entry Criteria Not Met|6
4609586|NCT01687478|7465446|FG001|Overall Study|Entry Criteria Not Met|2
4609587|NCT01687595|7465454|FG000|Overall Study|Withdrawal by Subject|8
4609588|NCT01687595|7465455|FG001|Overall Study|Withdrawal by Subject|0
4609589|NCT01687595|7465454|FG000|Overall Study|Lost to Follow-up|3
4609590|NCT01687595|7465455|FG001|Overall Study|Lost to Follow-up|1
4531723|NCT01072448|7350528|FG000|Overall Study|Death|0
4531724|NCT01072448|7350529|FG001|Overall Study|Death|2
4609591|NCT01687595|7465454|FG000|Overall Study|Investigator's decision|1
4531725|NCT01072500|7350537|FG000|Overall Study|Death|2
4531726|NCT01072500|7350538|FG001|Overall Study|Death|2
4531727|NCT01072500|7350537|FG000|Overall Study|Lost to Follow-up|5
4531728|NCT01072500|7350538|FG001|Overall Study|Lost to Follow-up|2
4531729|NCT01072500|7350537|FG000|Overall Study|Withdrawal by Subject|17
4531730|NCT01072500|7350538|FG001|Overall Study|Withdrawal by Subject|10
4531731|NCT01072539|7350546|FG000|Overall Study|Treated prior to the Site Initiation|1
4531732|NCT01072539|7350546|FG000|Overall Study|Protocol Violation|2
4531733|NCT01072630|7350558|FG000|Overall Study|Adverse Event|11
4531734|NCT01072630|7350559|FG001|Overall Study|Adverse Event|19
4531735|NCT01072630|7350560|FG002|Overall Study|Adverse Event|2
4531736|NCT01072630|7350558|FG000|Overall Study|Lack of Efficacy|10
4531737|NCT01072630|7350559|FG001|Overall Study|Lack of Efficacy|10
4531738|NCT01072630|7350560|FG002|Overall Study|Lack of Efficacy|1
4531739|NCT01072630|7350558|FG000|Overall Study|Withdrawal by Subject|8
4531740|NCT01072630|7350559|FG001|Overall Study|Withdrawal by Subject|7
4531741|NCT01072630|7350560|FG002|Overall Study|Withdrawal by Subject|2
4531742|NCT01072630|7350558|FG000|Overall Study|Protocol Violation|10
4531743|NCT01072630|7350559|FG001|Overall Study|Protocol Violation|8
4531744|NCT01072630|7350560|FG002|Overall Study|Protocol Violation|4
4531745|NCT01072630|7350558|FG000|Overall Study|Lost to Follow-up|11
4531746|NCT01072630|7350559|FG001|Overall Study|Lost to Follow-up|11
4609592|NCT01687595|7465455|FG001|Overall Study|Investigator's decision|0
4609593|NCT01687595|7465454|FG000|Overall Study|Sponsor's decision|1
4609594|NCT01687595|7465455|FG001|Overall Study|Sponsor's decision|0
4609595|NCT01687595|7465454|FG000|Overall Study|Noncompliance|1
4609596|NCT01687595|7465455|FG001|Overall Study|Noncompliance|2
4609597|NCT01687595|7465454|FG000|Overall Study|Other than specified|56
4609598|NCT01687595|7465455|FG001|Overall Study|Other than specified|7
4609599|NCT01687673|7465461|FG000|Overall Study|Physician Decision|1
4609600|NCT01687712|7465467|FG000|Cycle 1|Not Biochemically Pregnant|386
4609601|NCT01687712|7465468|FG001|Cycle 1|Not Biochemically Pregnant|348
4609602|NCT01687712|7465467|FG000|Cycle 1|Early Pregnancy Loss|43
4609603|NCT01687712|7465468|FG001|Cycle 1|Early Pregnancy Loss|60
4689854|NCT02555371|7599375|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0
4689855|NCT02555371|7599376|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0
4689856|NCT02555371|7599377|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0
4689857|NCT02555371|7599378|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0
4689858|NCT02555371|7599379|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2
4689859|NCT02555371|7599375|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0
4689860|NCT02555371|7599376|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0
4689861|NCT02555371|7599377|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0
4689862|NCT02555371|7599378|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0
4689863|NCT02555371|7599379|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1
4689864|NCT02555371|7599375|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0
4689865|NCT02555371|7599376|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0
4689866|NCT02555371|7599377|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0
4689867|NCT02555371|7599378|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1
4689868|NCT02555371|7599379|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0
4689869|NCT02555618|7599394|FG000|Overall Study|Sponsor's Circumstances|1
4689870|NCT02555618|7599395|FG001|Overall Study|Sponsor's Circumstances|0
4689871|NCT02555683|7599408|FG000|Overall Study|Physician Decision|1
4689872|NCT02555683|7599409|FG001|Overall Study|Physician Decision|0
4689873|NCT02555683|7599410|FG002|Overall Study|Physician Decision|2
4531747|NCT01072630|7350560|FG002|Overall Study|Lost to Follow-up|1
4531748|NCT01072630|7350558|FG000|Overall Study|Noncompliance with study medication|1
4531749|NCT01072630|7350559|FG001|Overall Study|Noncompliance with study medication|1
4609604|NCT01687712|7465467|FG000|Cycle 1|Ectopic Pregnancy|5
4609605|NCT01687712|7465468|FG001|Cycle 1|Ectopic Pregnancy|5
4609606|NCT01687712|7465467|FG000|Cycle 1|Heterotropic Pregnancy|1
4609607|NCT01687712|7465468|FG001|Cycle 1|Heterotropic Pregnancy|0
4609608|NCT01687712|7465467|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9
4609609|NCT01687712|7465468|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14
4609610|NCT01687712|7465467|FG000|Cycle 1|Abortion|3
4609611|NCT01687712|7465468|FG001|Cycle 1|Abortion|0
4609612|NCT01687712|7465467|FG000|Cycle 1|Intrauterine Fetal Death|0
4609613|NCT01687712|7465468|FG001|Cycle 1|Intrauterine Fetal Death|1
4609614|NCT01687712|7465467|FG000|Cycle 1|Lost to Follow-up|1
4609615|NCT01687712|7465468|FG001|Cycle 1|Lost to Follow-up|1
4609616|NCT01687712|7465467|FG000|Cycle 2|Not Biochemically Pregnant|74
4609617|NCT01687712|7465468|FG001|Cycle 2|Not Biochemically Pregnant|77
4609618|NCT01687712|7465467|FG000|Cycle 2|Early Pregnancy Loss|18
4609619|NCT01687712|7465468|FG001|Cycle 2|Early Pregnancy Loss|16
4609620|NCT01687712|7465467|FG000|Cycle 2|Ectopic Pregnancy|0
4609621|NCT01687712|7465468|FG001|Cycle 2|Ectopic Pregnancy|1
4609622|NCT01687712|7465467|FG000|Cycle 2|Still Birth|1
4609623|NCT01687712|7465468|FG001|Cycle 2|Still Birth|0
4689874|NCT02555683|7599408|FG000|Overall Study|Lost to Follow-up|2
4531750|NCT01072630|7350560|FG002|Overall Study|Noncompliance with study medication|1
4531751|NCT01072630|7350558|FG000|Overall Study|Noncompliance with study procedures|1
4609624|NCT01687712|7465467|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0
4609625|NCT01687712|7465468|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1
4609626|NCT01687712|7465467|FG000|Cycle 3|Not Biochemically Pregnant|21
4531752|NCT01072630|7350559|FG001|Overall Study|Noncompliance with study procedures|2
4531753|NCT01072630|7350560|FG002|Overall Study|Noncompliance with study procedures|1
4531754|NCT01072630|7350558|FG000|Overall Study|Other|3
4531755|NCT01072630|7350559|FG001|Overall Study|Other|2
4531756|NCT01072630|7350560|FG002|Overall Study|Other|1
4531757|NCT01072877|7350620|FG000|Overall Study|Lost to Follow-up|1
4531758|NCT01072877|7350621|FG001|Overall Study|Lost to Follow-up|1
4531759|NCT01072877|7350622|FG002|Overall Study|Lost to Follow-up|0
4531760|NCT01072877|7350623|FG003|Overall Study|Lost to Follow-up|2
4531761|NCT01072877|7350624|FG004|Overall Study|Lost to Follow-up|0
4531762|NCT01072929|7350641|FG000|Overall Study|Adverse Event|8
4531763|NCT01072929|7350642|FG001|Overall Study|Adverse Event|11
4531764|NCT01072929|7350643|FG002|Overall Study|Adverse Event|2
4531765|NCT01072929|7350641|FG000|Overall Study|Lack of Efficacy|7
4531766|NCT01072929|7350642|FG001|Overall Study|Lack of Efficacy|4
4531767|NCT01072929|7350643|FG002|Overall Study|Lack of Efficacy|0
4531768|NCT01072929|7350641|FG000|Overall Study|Withdrawal by Subject|7
4531769|NCT01072929|7350642|FG001|Overall Study|Withdrawal by Subject|15
4531770|NCT01072929|7350643|FG002|Overall Study|Withdrawal by Subject|3
4531771|NCT01072929|7350641|FG000|Overall Study|Protocol Violation|13
4531772|NCT01072929|7350642|FG001|Overall Study|Protocol Violation|11
4531773|NCT01072929|7350643|FG002|Overall Study|Protocol Violation|2
4531774|NCT01072929|7350641|FG000|Overall Study|Lost to Follow-up|8
4531775|NCT01072929|7350642|FG001|Overall Study|Lost to Follow-up|4
4531776|NCT01072929|7350643|FG002|Overall Study|Lost to Follow-up|1
4531777|NCT01072929|7350641|FG000|Overall Study|Noncompliance with study medication|0
4531778|NCT01072929|7350642|FG001|Overall Study|Noncompliance with study medication|3
4531779|NCT01072929|7350643|FG002|Overall Study|Noncompliance with study medication|0
4531780|NCT01072929|7350641|FG000|Overall Study|Noncompliance with study procedures|1
4531781|NCT01072929|7350642|FG001|Overall Study|Noncompliance with study procedures|0
4531782|NCT01072929|7350643|FG002|Overall Study|Noncompliance with study procedures|1
4531783|NCT01072929|7350641|FG000|Overall Study|Other|0
4531784|NCT01072929|7350642|FG001|Overall Study|Other|3
4531785|NCT01072929|7350643|FG002|Overall Study|Other|0
4531786|NCT01073020|7350656|FG000|Overall Study|Withdrawal by Subject|6
4531787|NCT01073020|7350657|FG001|Overall Study|Withdrawal by Subject|4
4531788|NCT01073020|7350658|FG002|Overall Study|Withdrawal by Subject|1
4531789|NCT01073020|7350659|FG003|Overall Study|Withdrawal by Subject|2
4531790|NCT01073020|7350656|FG000|Overall Study|Physician Decision|1
4531791|NCT01073020|7350657|FG001|Overall Study|Physician Decision|0
4531792|NCT01073020|7350658|FG002|Overall Study|Physician Decision|2
4531793|NCT01073020|7350659|FG003|Overall Study|Physician Decision|0
4531794|NCT01073020|7350656|FG000|Overall Study|Death|0
4531795|NCT01073020|7350657|FG001|Overall Study|Death|1
4531796|NCT01073020|7350658|FG002|Overall Study|Death|0
4531797|NCT01073020|7350659|FG003|Overall Study|Death|0
4531798|NCT01073163|7350669|FG000|Overall Study|Adverse Event|1
4531799|NCT01073163|7350669|FG000|Overall Study|Disease Progression|1
4531800|NCT01073163|7350669|FG000|Overall Study|Early termination|1
4531801|NCT01073267|7350677|FG000|Overall Study|Disease Progression|3
4531802|NCT01073293|7350683|FG000|Overall Study|Lost to Follow-up|0
4531803|NCT01073293|7350684|FG001|Overall Study|Lost to Follow-up|1
4531804|NCT01073293|7350683|FG000|Overall Study|Withdrawal by Subject|5
4531805|NCT01073293|7350684|FG001|Overall Study|Withdrawal by Subject|10
4531806|NCT01073462|7350694|FG000|Overall Study|Death|14
4531807|NCT01073462|7350694|FG000|Overall Study|Kidney transplant|10
4531808|NCT01073462|7350694|FG000|Overall Study|Low parathyroid hormone levels|8
4531809|NCT01073462|7350694|FG000|Overall Study|Serious adverse event|2
4531810|NCT01073462|7350694|FG000|Overall Study|Lost to Follow-up|7
4531811|NCT01073566|7350700|FG000|Period 2 (6 Weeks)|Adverse Event|1
4531812|NCT01073566|7350701|FG001|Period 2 (6 Weeks)|Adverse Event|0
4531813|NCT01073605|7350710|FG000|Overall Study|Ongoing at Cutoff Date|1
4531814|NCT01073605|7350711|FG001|Overall Study|Ongoing at Cutoff Date|1
4531815|NCT01073605|7350712|FG002|Overall Study|Ongoing at Cutoff Date|0
4531816|NCT01073605|7350710|FG000|Overall Study|Adverse Event|2
4531817|NCT01073605|7350711|FG001|Overall Study|Adverse Event|1
4531818|NCT01073605|7350712|FG002|Overall Study|Adverse Event|0
4531819|NCT01073605|7350710|FG000|Overall Study|Lost to Follow-up|3
4531820|NCT01073605|7350711|FG001|Overall Study|Lost to Follow-up|4
4531821|NCT01073605|7350712|FG002|Overall Study|Lost to Follow-up|9
4531822|NCT01073605|7350710|FG000|Overall Study|Other|25
4531823|NCT01073605|7350711|FG001|Overall Study|Other|21
4531824|NCT01073605|7350712|FG002|Overall Study|Other|29
4531825|NCT01073605|7350710|FG000|Overall Study|Withdrawal by Subject|31
4531826|NCT01073605|7350711|FG001|Overall Study|Withdrawal by Subject|39
4531827|NCT01073605|7350712|FG002|Overall Study|Withdrawal by Subject|22
4531828|NCT01073605|7350710|FG000|Overall Study|Randomized But Not Treated|0
4531829|NCT01073605|7350711|FG001|Overall Study|Randomized But Not Treated|1
4531830|NCT01073605|7350712|FG002|Overall Study|Randomized But Not Treated|1
4531831|NCT01073618|7350720|FG000|Overall Study|Death|208
4531832|NCT01073618|7350720|FG000|Overall Study|Adverse Event|19
4531833|NCT01073618|7350720|FG000|Overall Study|Other|80
4531834|NCT01073631|7350724|FG000|Overall Study|Death|82
4531835|NCT01073631|7350724|FG000|Overall Study|Adverse Event|24
4531836|NCT01073631|7350724|FG000|Overall Study|Other|63
4531837|NCT01073865|7350739|FG000|Overall Study|Reasons other than below|19
4531838|NCT01073865|7350740|FG001|Overall Study|Reasons other than below|31
4531839|NCT01073865|7350739|FG000|Overall Study|Lost to Follow-up|1
4531840|NCT01073865|7350740|FG001|Overall Study|Lost to Follow-up|1
4531841|NCT01073865|7350739|FG000|Overall Study|Death|3
4531842|NCT01073865|7350740|FG001|Overall Study|Death|2
4531843|NCT01073865|7350739|FG000|Overall Study|Withdrawal by Subject|5
4531844|NCT01073865|7350740|FG001|Overall Study|Withdrawal by Subject|5
4531845|NCT01073930|7350748|FG000|Overall Study|Withdrawal by Subject|3
4531846|NCT01073930|7350749|FG001|Overall Study|Withdrawal by Subject|2
4531847|NCT01073930|7350748|FG000|Overall Study|Lost to Follow-up|0
4531848|NCT01073930|7350749|FG001|Overall Study|Lost to Follow-up|1
4531849|NCT01073930|7350748|FG000|Overall Study|Adverse Event|0
4531850|NCT01073930|7350749|FG001|Overall Study|Adverse Event|1
4531851|NCT01073930|7350748|FG000|Overall Study|Noncompliance with study drug|0
4531852|NCT01073930|7350749|FG001|Overall Study|Noncompliance with study drug|1
4531853|NCT01073930|7350748|FG000|Overall Study|Inadequate prep; unable to do procedure|0
4531854|NCT01073930|7350749|FG001|Overall Study|Inadequate prep; unable to do procedure|1
4531855|NCT01073943|7350757|FG000|Overall Study|Withdrawal by Subject|8
4531856|NCT01073943|7350758|FG001|Overall Study|Withdrawal by Subject|2
4531857|NCT01073943|7350757|FG000|Overall Study|Protocol Violation|2
4531858|NCT01073943|7350758|FG001|Overall Study|Protocol Violation|1
4531859|NCT01073943|7350757|FG000|Overall Study|Adverse Event|1
4531860|NCT01073943|7350758|FG001|Overall Study|Adverse Event|1
4531861|NCT01073943|7350757|FG000|Overall Study|Lost to Follow-up|0
4531862|NCT01073943|7350758|FG001|Overall Study|Lost to Follow-up|2
4531863|NCT01073943|7350757|FG000|Overall Study|Power outage; colonoscopy not done|1
4531864|NCT01073943|7350758|FG001|Overall Study|Power outage; colonoscopy not done|0
4531865|NCT01073943|7350757|FG000|Overall Study|Subject forgot|0
4531866|NCT01073943|7350758|FG001|Overall Study|Subject forgot|1
4531867|NCT01073943|7350757|FG000|Overall Study|Unable to return for follow-up|0
4531868|NCT01073943|7350758|FG001|Overall Study|Unable to return for follow-up|1
4531869|NCT01073943|7350757|FG000|Overall Study|Could not tolerate prep|1
4531870|NCT01073943|7350758|FG001|Overall Study|Could not tolerate prep|0
4531871|NCT01074008|7350773|FG000|Overall Study|Adverse Event|0
4531872|NCT01074008|7350774|FG001|Overall Study|Adverse Event|1
4531873|NCT01074008|7350775|FG002|Overall Study|Adverse Event|0
4531874|NCT01074008|7350776|FG003|Overall Study|Adverse Event|0
4531875|NCT01074008|7350777|FG004|Overall Study|Adverse Event|0
4531876|NCT01074008|7350778|FG005|Overall Study|Adverse Event|0
4531877|NCT01074008|7350779|FG006|Overall Study|Adverse Event|0
4531878|NCT01074008|7350780|FG007|Overall Study|Adverse Event|0
4531879|NCT01074008|7350781|FG008|Overall Study|Adverse Event|0
4531880|NCT01074008|7350773|FG000|Overall Study|Withdrawal by Subject|1
4531881|NCT01074008|7350774|FG001|Overall Study|Withdrawal by Subject|1
4531882|NCT01074008|7350775|FG002|Overall Study|Withdrawal by Subject|1
4531883|NCT01074008|7350776|FG003|Overall Study|Withdrawal by Subject|0
4531884|NCT01074008|7350777|FG004|Overall Study|Withdrawal by Subject|1
4531885|NCT01074008|7350778|FG005|Overall Study|Withdrawal by Subject|0
4531886|NCT01074008|7350779|FG006|Overall Study|Withdrawal by Subject|0
4531887|NCT01074008|7350780|FG007|Overall Study|Withdrawal by Subject|0
4531888|NCT01074008|7350781|FG008|Overall Study|Withdrawal by Subject|0
4609627|NCT01687712|7465468|FG001|Cycle 3|Not Biochemically Pregnant|22
4609628|NCT01687712|7465467|FG000|Cycle 3|Early Pregnancy Loss|1
4609629|NCT01687712|7465468|FG001|Cycle 3|Early Pregnancy Loss|2
4609630|NCT01687712|7465467|FG000|Cycle 3|Ectopic Pregnancy|1
4609631|NCT01687712|7465468|FG001|Cycle 3|Ectopic Pregnancy|0
4609632|NCT01687712|7465467|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1
4609633|NCT01687712|7465468|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0
4689875|NCT02555683|7599409|FG001|Overall Study|Lost to Follow-up|1
4689876|NCT02555683|7599410|FG002|Overall Study|Lost to Follow-up|2
4689877|NCT02555683|7599408|FG000|Overall Study|Technical Problems|1
4689878|NCT02555683|7599409|FG001|Overall Study|Technical Problems|1
4689879|NCT02555683|7599410|FG002|Overall Study|Technical Problems|0
4689880|NCT02555683|7599408|FG000|Overall Study|Protocol deviation|0
4689881|NCT02555683|7599409|FG001|Overall Study|Protocol deviation|1
4689882|NCT02555683|7599410|FG002|Overall Study|Protocol deviation|0
4689883|NCT02555683|7599408|FG000|Overall Study|Lack of Efficacy|2
4689884|NCT02555683|7599409|FG001|Overall Study|Lack of Efficacy|0
4689885|NCT02555683|7599410|FG002|Overall Study|Lack of Efficacy|0
4689886|NCT02555683|7599408|FG000|Overall Study|Death|0
4689887|NCT02555683|7599409|FG001|Overall Study|Death|1
4531889|NCT01074008|7350773|FG000|Overall Study|Lost to Follow-up|0
4531890|NCT01074008|7350774|FG001|Overall Study|Lost to Follow-up|1
4531891|NCT01074008|7350775|FG002|Overall Study|Lost to Follow-up|1
4531892|NCT01074008|7350776|FG003|Overall Study|Lost to Follow-up|1
4531893|NCT01074008|7350777|FG004|Overall Study|Lost to Follow-up|1
4531894|NCT01074008|7350778|FG005|Overall Study|Lost to Follow-up|0
4531895|NCT01074008|7350779|FG006|Overall Study|Lost to Follow-up|1
4531896|NCT01074008|7350780|FG007|Overall Study|Lost to Follow-up|0
4531897|NCT01074008|7350781|FG008|Overall Study|Lost to Follow-up|4
4531898|NCT01074047|7350817|FG000|Treatment Phase|Adverse Event|89
4531899|NCT01074047|7350818|FG001|Treatment Phase|Adverse Event|66
4609634|NCT01687998|7465494|FG000|Overall Study|Withdrawal by Subject|49
4689888|NCT02555683|7599410|FG002|Overall Study|Death|2
4689889|NCT02555683|7599408|FG000|Overall Study|Adverse Event|1
4531900|NCT01074047|7350817|FG000|Treatment Phase|Disease Progression|16
4531901|NCT01074047|7350818|FG001|Treatment Phase|Disease Progression|21
4531902|NCT01074047|7350817|FG000|Treatment Phase|Withdrawal by Subject|27
4531903|NCT01074047|7350818|FG001|Treatment Phase|Withdrawal by Subject|48
4531904|NCT01074047|7350817|FG000|Treatment Phase|Death|53
4531905|NCT01074047|7350818|FG001|Treatment Phase|Death|58
4531906|NCT01074047|7350817|FG000|Treatment Phase|Lost to Follow-up|0
4531907|NCT01074047|7350818|FG001|Treatment Phase|Lost to Follow-up|1
4531908|NCT01074047|7350817|FG000|Treatment Phase|Protocol Violation|0
4531909|NCT01074047|7350818|FG001|Treatment Phase|Protocol Violation|1
4531910|NCT01074047|7350817|FG000|Treatment Phase|Miscellaneous|32
4531911|NCT01074047|7350818|FG001|Treatment Phase|Miscellaneous|39
4531912|NCT01074047|7350817|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5
4531913|NCT01074047|7350818|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8
4531914|NCT01074047|7350817|FG000|Survival Follow-Up Phase|Lost to Follow-up|2
4531915|NCT01074047|7350818|FG001|Survival Follow-Up Phase|Lost to Follow-up|1
4609635|NCT01687998|7465495|FG001|Overall Study|Withdrawal by Subject|51
4609636|NCT01687998|7465494|FG000|Overall Study|Known to be Alive at Study End|54
4609637|NCT01687998|7465495|FG001|Overall Study|Known to be Alive at Study End|62
4609638|NCT01687998|7465494|FG000|Overall Study|Lost to Follow-up|9
4609639|NCT01687998|7465495|FG001|Overall Study|Lost to Follow-up|7
4609640|NCT01688037|7465504|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1
4609641|NCT01688037|7465505|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0
4609642|NCT01688037|7465506|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1
4609643|NCT01688037|7465504|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1
4609644|NCT01688037|7465505|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2
4609645|NCT01688037|7465506|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3
4609646|NCT01688037|7465504|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4
4609647|NCT01688037|7465505|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0
4609648|NCT01688037|7465506|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1
4609649|NCT01688037|7465504|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
4609650|NCT01688037|7465505|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0
4609651|NCT01688037|7465506|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
4609652|NCT01688037|7465504|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0
4609653|NCT01688037|7465505|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1
4609654|NCT01688037|7465506|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0
4609655|NCT01688037|7465504|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4
4609656|NCT01688037|7465505|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1
4609657|NCT01688037|7465506|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1
4609658|NCT01688037|7465504|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0
4609659|NCT01688037|7465505|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0
4609660|NCT01688037|7465506|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2
4609661|NCT01688037|7465504|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1
4609662|NCT01688037|7465505|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2
4609663|NCT01688037|7465506|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0
4609664|NCT01688037|7465504|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0
4609665|NCT01688037|7465505|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0
4609666|NCT01688037|7465506|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1
4609667|NCT01688037|7465504|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0
4609668|NCT01688037|7465505|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1
4609669|NCT01688037|7465506|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0
4609670|NCT01688050|7465518|FG000|Overall Study|Death|7
4609671|NCT01688050|7465518|FG000|Overall Study|Conversion to open repair|1
4609672|NCT01688050|7465518|FG000|Overall Study|Lost to Follow-up|13
4609673|NCT01688050|7465518|FG000|Overall Study|Withdrawal by Subject|10
4609674|NCT01688466|7465558|FG000|Overall Study|Withdrawal by Subject|2
4609675|NCT01688466|7465559|FG001|Overall Study|Withdrawal by Subject|1
4609676|NCT01688466|7465558|FG000|Overall Study|Death|0
4609677|NCT01688466|7465559|FG001|Overall Study|Death|1
4609678|NCT01688466|7465558|FG000|Overall Study|Adverse Event|0
4609679|NCT01688466|7465559|FG001|Overall Study|Adverse Event|4
4609680|NCT01688466|7465558|FG000|Overall Study|Not evaluable|0
4609681|NCT01688466|7465559|FG001|Overall Study|Not evaluable|1
4609682|NCT01688635|7465578|FG000|Washout 1|Withdrawal by Subject|1
4609683|NCT01688635|7465579|FG001|Washout 1|Withdrawal by Subject|0
4609684|NCT01688635|7465578|FG000|Washout 1|Adverse Event|0
4609685|NCT01688635|7465579|FG001|Washout 1|Adverse Event|1
4609686|NCT01688635|7465578|FG000|Washout 1|Physician Decision|0
4609687|NCT01688635|7465579|FG001|Washout 1|Physician Decision|1
4609688|NCT01688635|7465578|FG000|Washout 2|Physician Decision|1
4609689|NCT01688635|7465579|FG001|Washout 2|Physician Decision|0
4609690|NCT01688635|7465578|FG000|Washout 2|Withdrawal by Subject|1
4609691|NCT01688635|7465579|FG001|Washout 2|Withdrawal by Subject|0
4609692|NCT01688635|7465578|FG000|Washout 2|Sponsor Decision|1
4609693|NCT01688635|7465579|FG001|Washout 2|Sponsor Decision|2
4609694|NCT01688635|7465578|FG000|Washout 3|Withdrawal by Subject|1
4609695|NCT01688635|7465579|FG001|Washout 3|Withdrawal by Subject|0
4609696|NCT01688726|7465588|FG000|Overall Study|Adverse Event|1
4609697|NCT01688726|7465589|FG001|Overall Study|Adverse Event|0
4609698|NCT01688726|7465588|FG000|Overall Study|Relocated abroad|0
4531916|NCT01074047|7350817|FG000|Survival Follow-Up Phase|Death|116
4531917|NCT01074047|7350818|FG001|Survival Follow-Up Phase|Death|124
4531918|NCT01074047|7350817|FG000|Survival Follow-Up Phase|Alive at study closure|1
4531919|NCT01074047|7350818|FG001|Survival Follow-Up Phase|Alive at study closure|3
4531920|NCT01074047|7350817|FG000|Extension Phase|Physician Decision|1
4531921|NCT01074047|7350818|FG001|Extension Phase|Physician Decision|0
4531922|NCT01074047|7350817|FG000|Extension Phase|Adverse Event|5
4531923|NCT01074047|7350818|FG001|Extension Phase|Adverse Event|0
4531924|NCT01074047|7350817|FG000|Extension Phase|Disease Progression|9
4531925|NCT01074047|7350818|FG001|Extension Phase|Disease Progression|0
4531926|NCT01074047|7350817|FG000|Extension Phase|Withdrawal by Subject|2
4531927|NCT01074047|7350818|FG001|Extension Phase|Withdrawal by Subject|0
4531928|NCT01074047|7350817|FG000|Extension Phase|Death|5
4531929|NCT01074047|7350818|FG001|Extension Phase|Death|0
4531930|NCT01074216|7350869|FG000|Overall Study|Physician Decision|1
4531931|NCT01074216|7350869|FG000|Overall Study|Not Treated|12
4531932|NCT01074229|7350876|FG000|Overall Study|Lost to Follow-up|1
4531933|NCT01074229|7350877|FG001|Overall Study|Lost to Follow-up|0
4531934|NCT01074229|7350878|FG002|Overall Study|Lost to Follow-up|0
4531935|NCT01074229|7350876|FG000|Overall Study|Change to open surgical procedure|1
4531936|NCT01074229|7350877|FG001|Overall Study|Change to open surgical procedure|3
4531937|NCT01074229|7350878|FG002|Overall Study|Change to open surgical procedure|4
4531938|NCT01074242|7350888|FG000|Overall Study|Case report before date of contract|40
4531939|NCT01074242|7350888|FG000|Overall Study|Lost to Follow-up|1
4531940|NCT01074242|7350888|FG000|Overall Study|Case report unclear|6
4531941|NCT01074242|7350888|FG000|Overall Study|Violation of vaccine dose or dosage|351
4531942|NCT01074242|7350888|FG000|Overall Study|Duplicate Case Report Form|5
4531943|NCT01074255|7350892|FG000|Overall Study|Did not receive EMEND|2
4531944|NCT01074268|7350898|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3
4531945|NCT01074268|7350899|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1
4531946|NCT01074268|7350898|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0
4531947|NCT01074268|7350899|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2
4531948|NCT01074268|7350898|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3
4531949|NCT01074268|7350899|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4
4531950|NCT01074268|7350898|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6
4531951|NCT01074268|7350899|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3
4531952|NCT01074268|7350898|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8
4531953|NCT01074268|7350899|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5
4531954|NCT01074268|7350898|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1
4531955|NCT01074268|7350899|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1
4531956|NCT01074268|7350898|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0
4531957|NCT01074268|7350899|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2
4531958|NCT01074268|7350898|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2
4531959|NCT01074268|7350899|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2
4531960|NCT01074268|7350898|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3
4531961|NCT01074268|7350899|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2
4531962|NCT01074307|7350907|FG000|Overall Study|No primary endpoint evaluation|14
4531963|NCT01074307|7350908|FG001|Overall Study|No primary endpoint evaluation|6
4531964|NCT01074307|7350907|FG000|Overall Study|Exclusion criterion|0
4531965|NCT01074307|7350908|FG001|Overall Study|Exclusion criterion|1
4531966|NCT01074307|7350907|FG000|Overall Study|Protocol Violation|8
4531967|NCT01074307|7350908|FG001|Overall Study|Protocol Violation|5
4531968|NCT01074450|7350916|FG000|First Intervention|Emesis in Dosing Interval|0
4531969|NCT01074450|7350917|FG001|First Intervention|Emesis in Dosing Interval|2
4531970|NCT01074450|7350916|FG000|Second Intervention|Protocol Violation|1
4531971|NCT01074450|7350917|FG001|Second Intervention|Protocol Violation|0
4531972|NCT01074450|7350916|FG000|Second Intervention|Physician Decision|0
4531973|NCT01074450|7350917|FG001|Second Intervention|Physician Decision|1
4531974|NCT01074554|7350934|FG000|Overall Study|Adverse Event|3
4531975|NCT01074554|7350935|FG001|Overall Study|Adverse Event|3
4531976|NCT01074554|7350934|FG000|Overall Study|Lost to Follow-up|0
4531977|NCT01074554|7350935|FG001|Overall Study|Lost to Follow-up|1
4531978|NCT01074658|7350941|FG000|Overall Study|No implant attempted|19
4531979|NCT01074931|7350945|FG000|Overall Study|Economic reasons|1
4531980|NCT01074931|7350945|FG000|Overall Study|Death|5
4531981|NCT01074944|7350953|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2
4531982|NCT01074944|7350954|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0
4531983|NCT01074944|7350955|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0
4531984|NCT01074944|7350956|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0
4531985|NCT01074944|7350957|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0
4531986|NCT01074944|7350953|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1
4531987|NCT01074944|7350954|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
4531988|NCT01074944|7350955|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
4531989|NCT01074944|7350956|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
4531990|NCT01074944|7350957|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
4531991|NCT01074944|7350953|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4
4531992|NCT01074944|7350954|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0
4531993|NCT01074944|7350955|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0
4531994|NCT01074944|7350956|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0
4531995|NCT01074944|7350957|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0
4531996|NCT01074944|7350953|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6
4531997|NCT01074944|7350954|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
4531998|NCT01074944|7350955|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
4531999|NCT01074944|7350956|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
4532000|NCT01074944|7350957|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
4532001|NCT01074944|7350953|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
4532002|NCT01074944|7350954|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2
4532003|NCT01074944|7350955|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3
4532004|NCT01074944|7350956|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
4532005|NCT01074944|7350957|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
4532006|NCT01074944|7350953|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
4532007|NCT01074944|7350954|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6
4532008|NCT01074944|7350955|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1
4532009|NCT01074944|7350956|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
4532010|NCT01074944|7350957|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
4532011|NCT01074944|7350953|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
4532012|NCT01074944|7350954|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1
4532013|NCT01074944|7350955|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1
4532014|NCT01074944|7350956|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
4532015|NCT01074944|7350957|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
4532016|NCT01074944|7350953|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
4532017|NCT01074944|7350954|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1
4532018|NCT01074944|7350955|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
4532019|NCT01074944|7350956|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
4532020|NCT01074944|7350957|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
4532021|NCT01074944|7350953|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
4532022|NCT01074944|7350954|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1
4532023|NCT01074944|7350955|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1
4532024|NCT01074944|7350956|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
4532025|NCT01074944|7350957|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
4532026|NCT01074944|7350953|FG000|Long Term Treatment|Adverse Event|0
4532027|NCT01074944|7350954|FG001|Long Term Treatment|Adverse Event|0
4532028|NCT01074944|7350955|FG002|Long Term Treatment|Adverse Event|0
4532029|NCT01074944|7350956|FG003|Long Term Treatment|Adverse Event|3
4532030|NCT01074944|7350957|FG004|Long Term Treatment|Adverse Event|0
4532031|NCT01074944|7350953|FG000|Long Term Treatment|Lost to Follow-up|0
4532032|NCT01074944|7350954|FG001|Long Term Treatment|Lost to Follow-up|0
4532033|NCT01074944|7350955|FG002|Long Term Treatment|Lost to Follow-up|0
4532034|NCT01074944|7350956|FG003|Long Term Treatment|Lost to Follow-up|2
4532035|NCT01074944|7350957|FG004|Long Term Treatment|Lost to Follow-up|0
4532036|NCT01074944|7350953|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0
4532037|NCT01074944|7350954|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0
4532038|NCT01074944|7350955|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0
4532039|NCT01074944|7350956|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18
4532040|NCT01074944|7350957|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0
4532041|NCT01074944|7350953|FG000|Long Term Treatment|Entered in Period, But Not Treated|0
4532042|NCT01074944|7350954|FG001|Long Term Treatment|Entered in Period, But Not Treated|0
4532043|NCT01074944|7350955|FG002|Long Term Treatment|Entered in Period, But Not Treated|0
4532044|NCT01074944|7350956|FG003|Long Term Treatment|Entered in Period, But Not Treated|1
4609699|NCT01688726|7465589|FG001|Overall Study|Relocated abroad|1
4609700|NCT01688739|7465609|FG000|Overall Study|Administrative Decision|1
4609701|NCT01688739|7465610|FG001|Overall Study|Administrative Decision|0
4609702|NCT01688739|7465611|FG002|Overall Study|Administrative Decision|0
4609703|NCT01688739|7465612|FG003|Overall Study|Administrative Decision|0
4609704|NCT01688739|7465613|FG004|Overall Study|Administrative Decision|0
4609705|NCT01688739|7465614|FG005|Overall Study|Administrative Decision|0
4609706|NCT01688739|7465615|FG006|Overall Study|Administrative Decision|0
4609707|NCT01688739|7465616|FG007|Overall Study|Administrative Decision|0
4609708|NCT01688739|7465617|FG008|Overall Study|Administrative Decision|0
4609709|NCT01688739|7465618|FG009|Overall Study|Administrative Decision|0
4609710|NCT01688830|7465669|FG000|Overall Study|Lost to Follow-up|0
4609711|NCT01688830|7465670|FG001|Overall Study|Lost to Follow-up|0
4609712|NCT01688830|7465671|FG002|Overall Study|Lost to Follow-up|0
4609713|NCT01688830|7465672|FG003|Overall Study|Lost to Follow-up|0
4609714|NCT01688830|7465673|FG004|Overall Study|Lost to Follow-up|0
4609715|NCT01688830|7465674|FG005|Overall Study|Lost to Follow-up|0
4609716|NCT01688830|7465675|FG006|Overall Study|Lost to Follow-up|0
4609717|NCT01688830|7465676|FG007|Overall Study|Lost to Follow-up|0
4609718|NCT01688830|7465677|FG008|Overall Study|Lost to Follow-up|0
4532045|NCT01074944|7350957|FG004|Long Term Treatment|Entered in Period, But Not Treated|0
4609719|NCT01688830|7465678|FG009|Overall Study|Lost to Follow-up|0
4609720|NCT01688830|7465679|FG010|Overall Study|Lost to Follow-up|1
4532046|NCT01074944|7350953|FG000|Long Term Treatment|Withdrawal by Subject|0
4532047|NCT01074944|7350954|FG001|Long Term Treatment|Withdrawal by Subject|0
4532048|NCT01074944|7350955|FG002|Long Term Treatment|Withdrawal by Subject|0
4532049|NCT01074944|7350956|FG003|Long Term Treatment|Withdrawal by Subject|2
4532050|NCT01074944|7350957|FG004|Long Term Treatment|Withdrawal by Subject|0
4532051|NCT01074944|7350953|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0
4532052|NCT01074944|7350954|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0
4532053|NCT01074944|7350955|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0
4532054|NCT01074944|7350956|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0
4532055|NCT01074944|7350957|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2
4532056|NCT01074944|7350953|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
4532057|NCT01074944|7350954|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
4532058|NCT01074944|7350955|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
4532059|NCT01074944|7350956|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
4532060|NCT01074944|7350957|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3
4532061|NCT01075048|7350968|FG000|Overall Study|Death|4
4532062|NCT01075048|7350969|FG001|Overall Study|Death|17
4532063|NCT01075048|7350970|FG002|Overall Study|Death|12
4532064|NCT01075048|7350968|FG000|Overall Study|Start of other or new therapy|4
4532065|NCT01075048|7350969|FG001|Overall Study|Start of other or new therapy|36
4532066|NCT01075048|7350970|FG002|Overall Study|Start of other or new therapy|46
4532067|NCT01075048|7350968|FG000|Overall Study|Withdrawal by Subject|1
4532068|NCT01075048|7350969|FG001|Overall Study|Withdrawal by Subject|6
4532069|NCT01075048|7350970|FG002|Overall Study|Withdrawal by Subject|3
4532070|NCT01075048|7350968|FG000|Overall Study|Lost to Follow-up|0
4532071|NCT01075048|7350969|FG001|Overall Study|Lost to Follow-up|1
4532072|NCT01075048|7350970|FG002|Overall Study|Lost to Follow-up|1
4532073|NCT01075074|7350984|FG000|Overall Study|Surgeon changed to open incisional case|1
4532074|NCT01075074|7350985|FG001|Overall Study|Surgeon changed to open incisional case|2
4532075|NCT01075074|7350986|FG002|Overall Study|Surgeon changed to open incisional case|2
4532076|NCT01075100|7351009|FG000|Overall Study|Adverse Event|15
4532077|NCT01075100|7351010|FG001|Overall Study|Adverse Event|18
4532078|NCT01075100|7351009|FG000|Overall Study|Patient Request|4
4532079|NCT01075100|7351010|FG001|Overall Study|Patient Request|4
4532080|NCT01075100|7351009|FG000|Overall Study|Investigator Request|2
4532081|NCT01075100|7351010|FG001|Overall Study|Investigator Request|1
4532082|NCT01075100|7351009|FG000|Overall Study|Disease Progression|25
4532083|NCT01075100|7351010|FG001|Overall Study|Disease Progression|29
4532084|NCT01075100|7351009|FG000|Overall Study|Other|3
4532085|NCT01075100|7351010|FG001|Overall Study|Other|1
4532086|NCT01075152|7351020|FG000|Overall Study|Withdrawal by Subject|1
4532087|NCT01075152|7351021|FG001|Overall Study|Withdrawal by Subject|0
4532088|NCT01075178|7351031|FG000|Subject Matching|eligible but not matched|130
4532089|NCT01075178|7351032|FG001|Subject Matching|eligible but not matched|403
4532090|NCT01075178|7351031|FG000|Subject Chart Review|died before chart review period|0
4532091|NCT01075178|7351032|FG001|Subject Chart Review|died before chart review period|2
4532092|NCT01075178|7351031|FG000|Subject Chart Review|no data collected due to site closure|3
4532093|NCT01075178|7351032|FG001|Subject Chart Review|no data collected due to site closure|4
4532094|NCT01075178|7351031|FG000|Subject Chart Review|matched partner excluded (reasons above)|6
4532095|NCT01075178|7351032|FG001|Subject Chart Review|matched partner excluded (reasons above)|3
4532096|NCT01075191|7351038|FG000|Overall Study|Death|1
4532097|NCT01075191|7351038|FG000|Overall Study|Intensification|3
4532098|NCT01075191|7351038|FG000|Overall Study|Co-morbidities|1
4532099|NCT01075191|7351038|FG000|Overall Study|Adverse Event|4
4532100|NCT01075191|7351038|FG000|Overall Study|Noncompliance|3
4532101|NCT01075191|7351038|FG000|Overall Study|Therapy Break|3
4532102|NCT01075191|7351038|FG000|Overall Study|Patient's Wish|2
4532103|NCT01075191|7351038|FG000|Overall Study|Unknown Reasons|1
4532104|NCT01075217|7351048|FG000|Overall Study|Adverse Event|1
4532105|NCT01075217|7351049|FG001|Overall Study|Adverse Event|1
4532106|NCT01075217|7351048|FG000|Overall Study|Physician Decision|1
4532107|NCT01075217|7351049|FG001|Overall Study|Physician Decision|0
4532108|NCT01075243|7351066|FG000|Overall Study|Lost to Follow-up|5
4532109|NCT01075243|7351067|FG001|Overall Study|Lost to Follow-up|2
4532110|NCT01075243|7351068|FG002|Overall Study|Lost to Follow-up|0
4532111|NCT01075243|7351066|FG000|Overall Study|Withdrawal by Subject|1
4532112|NCT01075243|7351067|FG001|Overall Study|Withdrawal by Subject|1
4532113|NCT01075243|7351068|FG002|Overall Study|Withdrawal by Subject|0
4532114|NCT01075256|7351081|FG000|Overall Study|Withdrawal by Subject|1
4532115|NCT01075256|7351082|FG001|Overall Study|Withdrawal by Subject|0
4532116|NCT01075256|7351083|FG002|Overall Study|Withdrawal by Subject|0
4532117|NCT01075282|7351099|FG000|Overall Study|Withdrawal by Subject|11
4532118|NCT01075282|7351100|FG001|Overall Study|Withdrawal by Subject|7
4532119|NCT01075282|7351101|FG002|Overall Study|Withdrawal by Subject|11
4532120|NCT01075282|7351099|FG000|Overall Study|Adverse Event|9
4532121|NCT01075282|7351100|FG001|Overall Study|Adverse Event|8
4532122|NCT01075282|7351101|FG002|Overall Study|Adverse Event|5
4532123|NCT01075282|7351099|FG000|Overall Study|Entry Criteria Not Met|3
4532124|NCT01075282|7351100|FG001|Overall Study|Entry Criteria Not Met|2
4532125|NCT01075282|7351101|FG002|Overall Study|Entry Criteria Not Met|0
4532126|NCT01075282|7351099|FG000|Overall Study|Lost to Follow-up|3
4532127|NCT01075282|7351100|FG001|Overall Study|Lost to Follow-up|3
4532128|NCT01075282|7351101|FG002|Overall Study|Lost to Follow-up|3
4532129|NCT01075282|7351099|FG000|Overall Study|Physician Decision|3
4532130|NCT01075282|7351100|FG001|Overall Study|Physician Decision|3
4532131|NCT01075282|7351101|FG002|Overall Study|Physician Decision|3
4532132|NCT01075282|7351099|FG000|Overall Study|Lack of Efficacy|1
4532133|NCT01075282|7351100|FG001|Overall Study|Lack of Efficacy|1
4532134|NCT01075282|7351101|FG002|Overall Study|Lack of Efficacy|0
4532135|NCT01075282|7351099|FG000|Overall Study|Treatment Non-compliance|1
4532136|NCT01075282|7351100|FG001|Overall Study|Treatment Non-compliance|2
4532137|NCT01075282|7351101|FG002|Overall Study|Treatment Non-compliance|2
4532138|NCT01075282|7351099|FG000|Overall Study|Protocol Violation|0
4532139|NCT01075282|7351100|FG001|Overall Study|Protocol Violation|2
4532140|NCT01075282|7351101|FG002|Overall Study|Protocol Violation|1
4532141|NCT01075282|7351099|FG000|Overall Study|Death|0
4532142|NCT01075282|7351100|FG001|Overall Study|Death|1
4532143|NCT01075282|7351101|FG002|Overall Study|Death|2
4532144|NCT01075321|7351110|FG000|Overall Study|Withdrawal by Subject|0
4532145|NCT01075321|7351111|FG001|Overall Study|Withdrawal by Subject|0
4532146|NCT01075321|7351112|FG002|Overall Study|Withdrawal by Subject|1
4532147|NCT01075321|7351113|FG003|Overall Study|Withdrawal by Subject|1
4609721|NCT01688830|7465680|FG011|Overall Study|Lost to Follow-up|0
4609722|NCT01688830|7465681|FG012|Overall Study|Lost to Follow-up|0
4609723|NCT01688830|7465682|FG013|Overall Study|Lost to Follow-up|0
4609724|NCT01688830|7465683|FG014|Overall Study|Lost to Follow-up|0
4609725|NCT01688830|7465684|FG015|Overall Study|Lost to Follow-up|0
4609726|NCT01688830|7465685|FG016|Overall Study|Lost to Follow-up|0
4609727|NCT01688830|7465686|FG017|Overall Study|Lost to Follow-up|0
4609728|NCT01688830|7465687|FG018|Overall Study|Lost to Follow-up|0
4609729|NCT01688830|7465688|FG019|Overall Study|Lost to Follow-up|0
4609730|NCT01688830|7465689|FG020|Overall Study|Lost to Follow-up|0
4609731|NCT01688882|7465794|FG000|Overall Study|Adverse Event|1
4609732|NCT01688882|7465795|FG001|Overall Study|Adverse Event|0
4609733|NCT01688882|7465794|FG000|Overall Study|Unsatisfactory therapeutic effect|1
4609734|NCT01688882|7465795|FG001|Overall Study|Unsatisfactory therapeutic effect|1
4609735|NCT01688882|7465794|FG000|Overall Study|Administrative problems|1
4609736|NCT01688882|7465795|FG001|Overall Study|Administrative problems|0
4609737|NCT01688921|7465811|FG000|Overall Study|Lost to Follow-up|7
4609738|NCT01688921|7465812|FG001|Overall Study|Lost to Follow-up|13
4609739|NCT01688921|7465811|FG000|Overall Study|Physician Decision|6
4609740|NCT01688921|7465812|FG001|Overall Study|Physician Decision|1
4609741|NCT01688921|7465811|FG000|Overall Study|Protocol Violation|0
4609742|NCT01688921|7465812|FG001|Overall Study|Protocol Violation|1
4609743|NCT01688921|7465811|FG000|Overall Study|informed consent|3
4609744|NCT01688921|7465812|FG001|Overall Study|informed consent|0
4609745|NCT01688973|7465821|FG000|Overall Study|Ineligible|2
4609746|NCT01688973|7465822|FG001|Overall Study|Ineligible|3
4609747|NCT01688999|7465832|FG000|Overall Study|Withdrawal by Subject|5
4609748|NCT01688999|7465833|FG001|Overall Study|Withdrawal by Subject|1
4609749|NCT01688999|7465834|FG002|Overall Study|Withdrawal by Subject|1
4609750|NCT01688999|7465832|FG000|Overall Study|Adverse Event|2
4609751|NCT01688999|7465833|FG001|Overall Study|Adverse Event|0
4609752|NCT01688999|7465834|FG002|Overall Study|Adverse Event|2
4609753|NCT01688999|7465832|FG000|Overall Study|Ineligible/Not treated|1
4609754|NCT01688999|7465833|FG001|Overall Study|Ineligible/Not treated|0
4609755|NCT01688999|7465834|FG002|Overall Study|Ineligible/Not treated|0
4609756|NCT01689207|7465857|FG000|Overall Study|Adverse Event|0
4609757|NCT01689207|7465858|FG001|Overall Study|Adverse Event|1
4609758|NCT01689207|7465859|FG002|Overall Study|Adverse Event|0
4609759|NCT01689207|7465860|FG003|Overall Study|Adverse Event|0
4609760|NCT01689207|7465861|FG004|Overall Study|Adverse Event|2
4609761|NCT01689207|7465862|FG005|Overall Study|Adverse Event|1
4609762|NCT01689207|7465863|FG006|Overall Study|Adverse Event|0
4609763|NCT01689207|7465864|FG007|Overall Study|Adverse Event|0
4609764|NCT01689207|7465865|FG008|Overall Study|Adverse Event|1
4609765|NCT01689207|7465866|FG009|Overall Study|Adverse Event|0
4609766|NCT01689207|7465867|FG010|Overall Study|Adverse Event|0
4609767|NCT01689337|7465901|FG000|Overall Study|Study Discontinuation|1
4609768|NCT01689363|7465916|FG000|Overall Study|Protocol Violation|0
4609769|NCT01689363|7465917|FG001|Overall Study|Protocol Violation|1
4609770|NCT01689363|7465918|FG002|Overall Study|Protocol Violation|0
4609771|NCT01689363|7465919|FG003|Overall Study|Protocol Violation|0
4609772|NCT01689363|7465920|FG004|Overall Study|Protocol Violation|0
4609773|NCT01689363|7465921|FG005|Overall Study|Protocol Violation|0
4609774|NCT01689363|7465922|FG006|Overall Study|Protocol Violation|0
4609775|NCT01689363|7465923|FG007|Overall Study|Protocol Violation|0
4609776|NCT01689519|7465945|FG000|Intent to Treat|Death|157
4609777|NCT01689519|7465946|FG001|Intent to Treat|Death|167
4609778|NCT01689519|7465945|FG000|Intent to Treat|Lost to Follow-up|4
4532148|NCT01075321|7351110|FG000|Overall Study|Protocol Violation|0
4532149|NCT01075321|7351111|FG001|Overall Study|Protocol Violation|0
4609779|NCT01689519|7465946|FG001|Intent to Treat|Lost to Follow-up|8
4609780|NCT01689519|7465945|FG000|Intent to Treat|Other|2
4609781|NCT01689519|7465946|FG001|Intent to Treat|Other|4
4609782|NCT01689519|7465945|FG000|Intent to Treat|Physician Decision|4
4609783|NCT01689519|7465946|FG001|Intent to Treat|Physician Decision|1
4532150|NCT01075321|7351112|FG002|Overall Study|Protocol Violation|1
4532151|NCT01075321|7351113|FG003|Overall Study|Protocol Violation|0
4532152|NCT01075321|7351110|FG000|Overall Study|Treatment Incomplete due to progression|1
4532153|NCT01075321|7351111|FG001|Overall Study|Treatment Incomplete due to progression|0
4532154|NCT01075321|7351112|FG002|Overall Study|Treatment Incomplete due to progression|0
4532155|NCT01075321|7351113|FG003|Overall Study|Treatment Incomplete due to progression|0
4532156|NCT01075321|7351110|FG000|Overall Study|Ineligible (miscalculated lab value)|0
4532157|NCT01075321|7351111|FG001|Overall Study|Ineligible (miscalculated lab value)|0
4532158|NCT01075321|7351112|FG002|Overall Study|Ineligible (miscalculated lab value)|0
4532159|NCT01075321|7351113|FG003|Overall Study|Ineligible (miscalculated lab value)|1
4532160|NCT01075412|7351140|FG000|Overall Study|Withdrawal by Subject|0
4532161|NCT01075412|7351141|FG001|Overall Study|Withdrawal by Subject|1
4532162|NCT01075516|7351148|FG000|Overall Study|Death|5
4532163|NCT01075516|7351149|FG001|Overall Study|Death|9
4532164|NCT01075516|7351148|FG000|Overall Study|Lost to Follow-up|10
4532165|NCT01075516|7351149|FG001|Overall Study|Lost to Follow-up|2
4532166|NCT01075516|7351148|FG000|Overall Study|Withdrawal by Subject|3
4532167|NCT01075516|7351149|FG001|Overall Study|Withdrawal by Subject|5
4532168|NCT01075646|7351159|FG000|Overall Study|Lost to Follow-up|4
4532169|NCT01075646|7351160|FG001|Overall Study|Lost to Follow-up|3
4532170|NCT01075646|7351161|FG002|Overall Study|Lost to Follow-up|1
4532171|NCT01075646|7351162|FG003|Overall Study|Lost to Follow-up|2
4532172|NCT01075685|7351174|FG000|Overall Study|Protocol Violation|9
4532173|NCT01075685|7351175|FG001|Overall Study|Protocol Violation|1
4532174|NCT01075685|7351174|FG000|Overall Study|Withdrawal by Subject|20
4532175|NCT01075685|7351175|FG001|Overall Study|Withdrawal by Subject|5
4532176|NCT01075685|7351174|FG000|Overall Study|Lost to Follow-up|563
4532177|NCT01075685|7351175|FG001|Overall Study|Lost to Follow-up|220
4532178|NCT01075763|7351183|FG000|Overall Study|Lost to Follow-up|2
4532179|NCT01075763|7351184|FG001|Overall Study|Lost to Follow-up|1
4532180|NCT01075763|7351183|FG000|Overall Study|Lack of Efficacy|0
4532181|NCT01075763|7351184|FG001|Overall Study|Lack of Efficacy|1
4532182|NCT01075763|7351183|FG000|Overall Study|Withdrawal by Subject|2
4532183|NCT01075763|7351184|FG001|Overall Study|Withdrawal by Subject|2
4532184|NCT01075815|7351192|FG000|Overall Study|Withdrawal before r-hCG administration|6
4532185|NCT01075815|7351193|FG001|Overall Study|Withdrawal before r-hCG administration|1
4532186|NCT01075815|7351192|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1
4532187|NCT01075815|7351193|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1
4532188|NCT01075815|7351192|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3
4532189|NCT01075815|7351193|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2
4532190|NCT01075958|7351199|FG000|Overall Study|Blood sample could not be obtained|44
4532191|NCT01075984|7351212|FG000|Treatment Phase|Adverse Event|0
4532192|NCT01075984|7351213|FG001|Treatment Phase|Adverse Event|1
4532193|NCT01075984|7351214|FG002|Treatment Phase|Adverse Event|3
4532194|NCT01075984|7351215|FG003|Treatment Phase|Adverse Event|7
4532195|NCT01075984|7351216|FG004|Treatment Phase|Adverse Event|35
4532196|NCT01075984|7351212|FG000|Treatment Phase|Protocol Violation|0
4532197|NCT01075984|7351213|FG001|Treatment Phase|Protocol Violation|0
4532198|NCT01075984|7351214|FG002|Treatment Phase|Protocol Violation|1
4532199|NCT01075984|7351215|FG003|Treatment Phase|Protocol Violation|0
4532200|NCT01075984|7351216|FG004|Treatment Phase|Protocol Violation|3
4532201|NCT01075984|7351212|FG000|Treatment Phase|Withdrawal by Subject|0
4532202|NCT01075984|7351213|FG001|Treatment Phase|Withdrawal by Subject|0
4532203|NCT01075984|7351214|FG002|Treatment Phase|Withdrawal by Subject|2
4532204|NCT01075984|7351215|FG003|Treatment Phase|Withdrawal by Subject|0
4532205|NCT01075984|7351216|FG004|Treatment Phase|Withdrawal by Subject|15
4532206|NCT01075984|7351212|FG000|Treatment Phase|Treatment Failure|0
4532207|NCT01075984|7351213|FG001|Treatment Phase|Treatment Failure|0
4532208|NCT01075984|7351214|FG002|Treatment Phase|Treatment Failure|1
4532209|NCT01075984|7351215|FG003|Treatment Phase|Treatment Failure|0
4532210|NCT01075984|7351216|FG004|Treatment Phase|Treatment Failure|5
4532211|NCT01075984|7351212|FG000|Treatment Phase|Progression of disease|0
4532212|NCT01075984|7351213|FG001|Treatment Phase|Progression of disease|0
4532213|NCT01075984|7351214|FG002|Treatment Phase|Progression of disease|0
4532214|NCT01075984|7351215|FG003|Treatment Phase|Progression of disease|0
4532215|NCT01075984|7351216|FG004|Treatment Phase|Progression of disease|2
4532216|NCT01075984|7351212|FG000|Follow-up Phase|Protocol Violation|0
4532217|NCT01075984|7351213|FG001|Follow-up Phase|Protocol Violation|0
4532218|NCT01075984|7351214|FG002|Follow-up Phase|Protocol Violation|1
4532219|NCT01075984|7351215|FG003|Follow-up Phase|Protocol Violation|0
4532220|NCT01075984|7351216|FG004|Follow-up Phase|Protocol Violation|3
4532221|NCT01075984|7351212|FG000|Follow-up Phase|Adverse Event|0
4532222|NCT01075984|7351213|FG001|Follow-up Phase|Adverse Event|0
4532223|NCT01075984|7351214|FG002|Follow-up Phase|Adverse Event|0
4532224|NCT01075984|7351215|FG003|Follow-up Phase|Adverse Event|2
4532225|NCT01075984|7351216|FG004|Follow-up Phase|Adverse Event|27
4532226|NCT01075984|7351212|FG000|Follow-up Phase|Administrative|0
4532227|NCT01075984|7351213|FG001|Follow-up Phase|Administrative|0
4532228|NCT01075984|7351214|FG002|Follow-up Phase|Administrative|0
4532229|NCT01075984|7351215|FG003|Follow-up Phase|Administrative|0
4532230|NCT01075984|7351216|FG004|Follow-up Phase|Administrative|1
4532231|NCT01075984|7351212|FG000|Follow-up Phase|Withdrawal by Subject|0
4532232|NCT01075984|7351213|FG001|Follow-up Phase|Withdrawal by Subject|0
4532233|NCT01075984|7351214|FG002|Follow-up Phase|Withdrawal by Subject|0
4532234|NCT01075984|7351215|FG003|Follow-up Phase|Withdrawal by Subject|0
4532235|NCT01075984|7351216|FG004|Follow-up Phase|Withdrawal by Subject|10
4532236|NCT01075984|7351212|FG000|Follow-up Phase|Progression of disease|0
4532237|NCT01075984|7351213|FG001|Follow-up Phase|Progression of disease|0
4532238|NCT01075984|7351214|FG002|Follow-up Phase|Progression of disease|0
4532239|NCT01075984|7351215|FG003|Follow-up Phase|Progression of disease|0
4532240|NCT01075984|7351216|FG004|Follow-up Phase|Progression of disease|2
4532241|NCT01075984|7351212|FG000|Follow-up Phase|Treatment failure|0
4532242|NCT01075984|7351213|FG001|Follow-up Phase|Treatment failure|0
4532243|NCT01075984|7351214|FG002|Follow-up Phase|Treatment failure|0
4532244|NCT01075984|7351215|FG003|Follow-up Phase|Treatment failure|0
4532245|NCT01075984|7351216|FG004|Follow-up Phase|Treatment failure|4
4532246|NCT01076010|7351231|FG000|Overall Study|Death|15
4532247|NCT01076010|7351232|FG001|Overall Study|Death|1
4532248|NCT01076010|7351233|FG002|Overall Study|Death|0
4532249|NCT01076010|7351231|FG000|Overall Study|Adverse Event|7
4532250|NCT01076010|7351232|FG001|Overall Study|Adverse Event|2
4532251|NCT01076010|7351233|FG002|Overall Study|Adverse Event|0
4532252|NCT01076010|7351231|FG000|Overall Study|Progressive disease|90
4532253|NCT01076010|7351232|FG001|Overall Study|Progressive disease|30
4532254|NCT01076010|7351233|FG002|Overall Study|Progressive disease|1
4532255|NCT01076010|7351231|FG000|Overall Study|Lack of Efficacy|4
4532256|NCT01076010|7351232|FG001|Overall Study|Lack of Efficacy|0
4532257|NCT01076010|7351233|FG002|Overall Study|Lack of Efficacy|0
4532258|NCT01076010|7351231|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0
4532259|NCT01076010|7351232|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1
4532260|NCT01076010|7351233|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0
4532261|NCT01076010|7351231|FG000|Overall Study|Significant Surgical Procedure|0
4532262|NCT01076010|7351232|FG001|Overall Study|Significant Surgical Procedure|1
4532263|NCT01076010|7351233|FG002|Overall Study|Significant Surgical Procedure|0
4532264|NCT01076010|7351231|FG000|Overall Study|Protocol Violation|0
4532265|NCT01076010|7351232|FG001|Overall Study|Protocol Violation|1
4532266|NCT01076010|7351233|FG002|Overall Study|Protocol Violation|0
4532267|NCT01076010|7351231|FG000|Overall Study|Noncompliance|1
4532268|NCT01076010|7351232|FG001|Overall Study|Noncompliance|1
4532269|NCT01076010|7351233|FG002|Overall Study|Noncompliance|0
4532270|NCT01076010|7351231|FG000|Overall Study|Withdrawal by Subject|3
4532271|NCT01076010|7351232|FG001|Overall Study|Withdrawal by Subject|0
4532272|NCT01076010|7351233|FG002|Overall Study|Withdrawal by Subject|1
4532273|NCT01076010|7351231|FG000|Overall Study|Other|5
4532274|NCT01076010|7351232|FG001|Overall Study|Other|2
4532275|NCT01076010|7351233|FG002|Overall Study|Other|0
4532276|NCT01076036|7351241|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2
4532277|NCT01076075|7351262|FG000|Overall Study|Adverse Event|3
4532278|NCT01076075|7351263|FG001|Overall Study|Adverse Event|9
4532279|NCT01076075|7351262|FG000|Overall Study|Lack of Efficacy|5
4532280|NCT01076075|7351263|FG001|Overall Study|Lack of Efficacy|4
4532281|NCT01076075|7351262|FG000|Overall Study|Lost to Follow-up|6
4532282|NCT01076075|7351263|FG001|Overall Study|Lost to Follow-up|5
4532283|NCT01076075|7351262|FG000|Overall Study|other|19
4532284|NCT01076075|7351263|FG001|Overall Study|other|9
4532285|NCT01076075|7351262|FG000|Overall Study|Protocol Violation|0
4532286|NCT01076075|7351263|FG001|Overall Study|Protocol Violation|1
4532287|NCT01076075|7351262|FG000|Overall Study|Withdrawal by Subject|8
4532288|NCT01076075|7351263|FG001|Overall Study|Withdrawal by Subject|19
4532289|NCT01076088|7351278|FG000|Overall Study|Adverse Event|1
4532290|NCT01076088|7351279|FG001|Overall Study|Adverse Event|6
4532291|NCT01076088|7351280|FG002|Overall Study|Adverse Event|3
4532292|NCT01076088|7351281|FG003|Overall Study|Adverse Event|2
4532293|NCT01076088|7351282|FG004|Overall Study|Adverse Event|3
4532294|NCT01076088|7351283|FG005|Overall Study|Adverse Event|3
4532295|NCT01076088|7351278|FG000|Overall Study|Lost to Follow-up|1
4532296|NCT01076088|7351279|FG001|Overall Study|Lost to Follow-up|1
4532297|NCT01076088|7351280|FG002|Overall Study|Lost to Follow-up|0
4532298|NCT01076088|7351281|FG003|Overall Study|Lost to Follow-up|1
4532299|NCT01076088|7351282|FG004|Overall Study|Lost to Follow-up|1
4532300|NCT01076088|7351283|FG005|Overall Study|Lost to Follow-up|2
4532301|NCT01076088|7351278|FG000|Overall Study|Non-compliance with study drug|0
4532302|NCT01076088|7351279|FG001|Overall Study|Non-compliance with study drug|0
4532303|NCT01076088|7351280|FG002|Overall Study|Non-compliance with study drug|0
4532304|NCT01076088|7351281|FG003|Overall Study|Non-compliance with study drug|1
4532305|NCT01076088|7351282|FG004|Overall Study|Non-compliance with study drug|0
4532306|NCT01076088|7351283|FG005|Overall Study|Non-compliance with study drug|0
4532307|NCT01076088|7351278|FG000|Overall Study|Physician Decision|1
4532308|NCT01076088|7351279|FG001|Overall Study|Physician Decision|3
4532309|NCT01076088|7351280|FG002|Overall Study|Physician Decision|0
4532310|NCT01076088|7351281|FG003|Overall Study|Physician Decision|1
4532311|NCT01076088|7351282|FG004|Overall Study|Physician Decision|1
4532312|NCT01076088|7351283|FG005|Overall Study|Physician Decision|0
4532313|NCT01076088|7351278|FG000|Overall Study|Withdrawal by Subject|8
4532314|NCT01076088|7351279|FG001|Overall Study|Withdrawal by Subject|8
4532315|NCT01076088|7351280|FG002|Overall Study|Withdrawal by Subject|14
4532316|NCT01076088|7351281|FG003|Overall Study|Withdrawal by Subject|10
4532317|NCT01076088|7351282|FG004|Overall Study|Withdrawal by Subject|11
4532318|NCT01076088|7351283|FG005|Overall Study|Withdrawal by Subject|17
4532319|NCT01076088|7351278|FG000|Overall Study|Other protocol specified criteria|0
4532320|NCT01076088|7351279|FG001|Overall Study|Other protocol specified criteria|0
4532321|NCT01076088|7351280|FG002|Overall Study|Other protocol specified criteria|0
4532322|NCT01076088|7351281|FG003|Overall Study|Other protocol specified criteria|0
4532323|NCT01076088|7351282|FG004|Overall Study|Other protocol specified criteria|0
4532324|NCT01076088|7351283|FG005|Overall Study|Other protocol specified criteria|1
4532325|NCT01076153|7351298|FG000|Overall Study|Symptoms improved/resolved|10
4532326|NCT01076153|7351298|FG000|Overall Study|Adverse Event|1
4532327|NCT01076166|7351306|FG000|Overall Study|Adverse Event|3
4532328|NCT01076166|7351306|FG000|Overall Study|Symptoms improved/resolved|6
4532329|NCT01076179|7351313|FG000|Overall Study|Withdrawal by Subject|1
4532330|NCT01076192|7351318|FG000|Overall Study|Other|197
4532331|NCT01076205|7351323|FG000|Overall Study|Adverse Drug Reaction|299
4532332|NCT01076205|7351323|FG000|Overall Study|Lack of Effectiveness|1423
4532333|NCT01076205|7351323|FG000|Overall Study|Other Reason|1075
4532334|NCT01076205|7351323|FG000|Overall Study|Unknown Reason|71
4532335|NCT01076205|7351323|FG000|Overall Study|Lost to Follow-up|3151
4590892|NCT01525550|7437194|FG001|Overall Study|Sponsor's Decision|11
4590893|NCT01525550|7437193|FG000|Overall Study|Withdrawal by Subject|4
4590894|NCT01525550|7437194|FG001|Overall Study|Withdrawal by Subject|0
4590895|NCT01525589|7437207|FG000|Overall Study|Non-treatment-related AE|1
4590896|NCT01525589|7437208|FG001|Overall Study|Non-treatment-related AE|0
4590897|NCT01525589|7437209|FG002|Overall Study|Non-treatment-related AE|0
4590898|NCT01525589|7437207|FG000|Overall Study|Progressive disease|48
4590899|NCT01525589|7437208|FG001|Overall Study|Progressive disease|15
4590900|NCT01525589|7437209|FG002|Overall Study|Progressive disease|29
4590901|NCT01525589|7437207|FG000|Overall Study|Never treated|2
4590902|NCT01525589|7437208|FG001|Overall Study|Never treated|0
4590903|NCT01525589|7437209|FG002|Overall Study|Never treated|0
4590904|NCT01525589|7437207|FG000|Overall Study|Physician Decision|4
4590905|NCT01525589|7437208|FG001|Overall Study|Physician Decision|2
4590906|NCT01525589|7437209|FG002|Overall Study|Physician Decision|2
4590907|NCT01525589|7437207|FG000|Overall Study|Death|0
4590908|NCT01525589|7437208|FG001|Overall Study|Death|0
4590909|NCT01525589|7437209|FG002|Overall Study|Death|2
4590910|NCT01525589|7437207|FG000|Overall Study|Treatment-related AE|1
4590911|NCT01525589|7437208|FG001|Overall Study|Treatment-related AE|1
4590912|NCT01525589|7437209|FG002|Overall Study|Treatment-related AE|2
4590913|NCT01525589|7437207|FG000|Overall Study|Other reasons|0
4590914|NCT01525589|7437208|FG001|Overall Study|Other reasons|1
4590915|NCT01525589|7437209|FG002|Overall Study|Other reasons|0
4590916|NCT01525589|7437207|FG000|Overall Study|Withdrawal by Subject|0
4590917|NCT01525589|7437208|FG001|Overall Study|Withdrawal by Subject|1
4590918|NCT01525589|7437209|FG002|Overall Study|Withdrawal by Subject|0
4590919|NCT01525602|7437225|FG000|Overall Study|Adverse Event|1
4590920|NCT01525602|7437226|FG001|Overall Study|Adverse Event|0
4590921|NCT01525602|7437227|FG002|Overall Study|Adverse Event|1
4590922|NCT01525602|7437228|FG003|Overall Study|Adverse Event|1
4590923|NCT01525602|7437229|FG004|Overall Study|Adverse Event|3
4590924|NCT01525602|7437230|FG005|Overall Study|Adverse Event|3
4590925|NCT01525602|7437231|FG006|Overall Study|Adverse Event|0
4590926|NCT01525602|7437232|FG007|Overall Study|Adverse Event|1
4590927|NCT01525602|7437225|FG000|Overall Study|Disease progression|6
4590928|NCT01525602|7437226|FG001|Overall Study|Disease progression|3
4590929|NCT01525602|7437227|FG002|Overall Study|Disease progression|2
4590930|NCT01525602|7437228|FG003|Overall Study|Disease progression|5
4590931|NCT01525602|7437229|FG004|Overall Study|Disease progression|22
4590932|NCT01525602|7437230|FG005|Overall Study|Disease progression|2
4590933|NCT01525602|7437231|FG006|Overall Study|Disease progression|3
4590934|NCT01525602|7437232|FG007|Overall Study|Disease progression|3
4590935|NCT01525602|7437225|FG000|Overall Study|Clinical progression|2
4590936|NCT01525602|7437226|FG001|Overall Study|Clinical progression|0
4590937|NCT01525602|7437227|FG002|Overall Study|Clinical progression|0
4590938|NCT01525602|7437228|FG003|Overall Study|Clinical progression|0
4590939|NCT01525602|7437229|FG004|Overall Study|Clinical progression|0
4590940|NCT01525602|7437230|FG005|Overall Study|Clinical progression|0
4590941|NCT01525602|7437231|FG006|Overall Study|Clinical progression|1
4590942|NCT01525602|7437232|FG007|Overall Study|Clinical progression|1
4590943|NCT01525602|7437225|FG000|Overall Study|Non-compliance|0
4590944|NCT01525602|7437226|FG001|Overall Study|Non-compliance|0
4590945|NCT01525602|7437227|FG002|Overall Study|Non-compliance|0
4590946|NCT01525602|7437228|FG003|Overall Study|Non-compliance|0
4590947|NCT01525602|7437229|FG004|Overall Study|Non-compliance|1
4609784|NCT01689519|7465945|FG000|Intent to Treat|Study terminated by Spon6sor|59
4590948|NCT01525602|7437230|FG005|Overall Study|Non-compliance|0
4590949|NCT01525602|7437231|FG006|Overall Study|Non-compliance|0
4590950|NCT01525602|7437232|FG007|Overall Study|Non-compliance|0
4632592|NCT01903252|7502284|FG000|Maintenance, Open-Label|Other|0
4590951|NCT01525602|7437225|FG000|Overall Study|Withdrawal by Subject|0
4590952|NCT01525602|7437226|FG001|Overall Study|Withdrawal by Subject|0
4590953|NCT01525602|7437227|FG002|Overall Study|Withdrawal by Subject|0
4590954|NCT01525602|7437228|FG003|Overall Study|Withdrawal by Subject|0
4590955|NCT01525602|7437229|FG004|Overall Study|Withdrawal by Subject|3
4532336|NCT01076335|7351389|FG000|Overall Study|Withdrawal by Subject|3
4532337|NCT01076335|7351389|FG000|Overall Study|Withdrawal without treatment|1
4532338|NCT01076361|7351397|FG000|Overall Study|22 leads were excluded from analysis|21
4532339|NCT01076400|7351401|FG000|Overall Study|Adverse Event|2
4532340|NCT01076400|7351402|FG001|Overall Study|Adverse Event|0
4532341|NCT01076400|7351403|FG002|Overall Study|Adverse Event|0
4532342|NCT01076400|7351401|FG000|Overall Study|Progressive Disease|5
4532343|NCT01076400|7351402|FG001|Overall Study|Progressive Disease|0
4532344|NCT01076400|7351403|FG002|Overall Study|Progressive Disease|0
4532345|NCT01076543|7351426|FG000|Overall Study|Withdrawal by Subject|2
4532346|NCT01076543|7351427|FG001|Overall Study|Withdrawal by Subject|0
4532347|NCT01076543|7351428|FG002|Overall Study|Withdrawal by Subject|0
4532348|NCT01076543|7351429|FG003|Overall Study|Withdrawal by Subject|0
4532349|NCT01076543|7351430|FG004|Overall Study|Withdrawal by Subject|0
4532350|NCT01076543|7351431|FG005|Overall Study|Withdrawal by Subject|0
4532351|NCT01076647|7351448|FG000|Overall Study|Adverse Event|4
4532352|NCT01076647|7351449|FG001|Overall Study|Adverse Event|1
4532353|NCT01076647|7351448|FG000|Overall Study|Lack of Efficacy|0
4532354|NCT01076647|7351449|FG001|Overall Study|Lack of Efficacy|1
4532355|NCT01076647|7351448|FG000|Overall Study|Protocol Violation|7
4532356|NCT01076647|7351449|FG001|Overall Study|Protocol Violation|9
4532357|NCT01076647|7351448|FG000|Overall Study|Withdrawal criteria|2
4532358|NCT01076647|7351449|FG001|Overall Study|Withdrawal criteria|2
4532359|NCT01076647|7351448|FG000|Overall Study|Unclassified|12
4532360|NCT01076647|7351449|FG001|Overall Study|Unclassified|12
4532361|NCT01076959|7351472|FG000|Overall Study|Adverse Event|767
4532362|NCT01076959|7351472|FG000|Overall Study|Lack of Efficacy|849
4532363|NCT01076959|7351472|FG000|Overall Study|Non-compliance|274
4532364|NCT01076959|7351472|FG000|Overall Study|Lost to Follow-up|241
4532365|NCT01076959|7351472|FG000|Overall Study|Other|119
4532366|NCT01077024|7351511|FG000|Overall Study|Lost to Follow-up|20
4532367|NCT01077024|7351512|FG001|Overall Study|Lost to Follow-up|14
4532368|NCT01077024|7351511|FG000|Overall Study|Withdrawal by Subject|0
4532369|NCT01077024|7351512|FG001|Overall Study|Withdrawal by Subject|2
4532370|NCT01077024|7351511|FG000|Overall Study|Incarcerated|7
4532371|NCT01077024|7351512|FG001|Overall Study|Incarcerated|8
4532372|NCT01077024|7351511|FG000|Overall Study|Other|4
4532373|NCT01077024|7351512|FG001|Overall Study|Other|4
4532374|NCT01077050|7351518|FG000|Overall Study|Subjects signed ICF could not be located|1
4532375|NCT01077050|7351518|FG000|Overall Study|Screen failure|8
4532376|NCT01077063|7351524|FG000|Overall Study|Adverse Event|3
4532377|NCT01077063|7351525|FG001|Overall Study|Adverse Event|0
4532378|NCT01077063|7351524|FG000|Overall Study|Death|1
4532379|NCT01077063|7351525|FG001|Overall Study|Death|1
4532380|NCT01077063|7351524|FG000|Overall Study|Withdrawal by Subject|0
4532381|NCT01077063|7351525|FG001|Overall Study|Withdrawal by Subject|2
4532382|NCT01077076|7351531|FG000|First Intervention|Withdrawal by Subject|1
4532383|NCT01077076|7351532|FG001|First Intervention|Withdrawal by Subject|0
4532384|NCT01077076|7351533|FG002|First Intervention|Withdrawal by Subject|0
4532385|NCT01077076|7351534|FG003|First Intervention|Withdrawal by Subject|0
4532386|NCT01077076|7351535|FG004|First Intervention|Withdrawal by Subject|0
4532387|NCT01077076|7351536|FG005|First Intervention|Withdrawal by Subject|0
4532388|NCT01077076|7351531|FG000|Third Intervention|Death in the participant's family|0
4532389|NCT01077076|7351532|FG001|Third Intervention|Death in the participant's family|0
4532390|NCT01077076|7351533|FG002|Third Intervention|Death in the participant's family|0
4532391|NCT01077076|7351534|FG003|Third Intervention|Death in the participant's family|0
4532392|NCT01077076|7351535|FG004|Third Intervention|Death in the participant's family|0
4532393|NCT01077076|7351536|FG005|Third Intervention|Death in the participant's family|1
4532394|NCT01077128|7351544|FG000|Overall Study|Adverse Event|8
4532395|NCT01077128|7351544|FG000|Overall Study|Lack of Efficacy|1
4532396|NCT01077128|7351544|FG000|Overall Study|Disease exacerbation|1
4532397|NCT01077128|7351544|FG000|Overall Study|Adverse event and consent withdrawal|1
4532398|NCT01077128|7351544|FG000|Overall Study|Adverse event and disease exacerbation|1
4532399|NCT01077128|7351544|FG000|Overall Study|Lack of efficacy/disease exacerbation|1
4532400|NCT01077128|7351544|FG000|Overall Study|Other|54
4532401|NCT01077154|7351600|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524
4532402|NCT01077154|7351601|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514
4532403|NCT01077154|7351600|FG000|Overall Study|Withdrawal by Subject|369
4532404|NCT01077154|7351601|FG001|Overall Study|Withdrawal by Subject|385
4532405|NCT01077154|7351600|FG000|Overall Study|Death|215
4532406|NCT01077154|7351601|FG001|Overall Study|Death|214
4532407|NCT01077154|7351600|FG000|Overall Study|Lost to Follow-up|43
4532408|NCT01077154|7351601|FG001|Overall Study|Lost to Follow-up|35
4532409|NCT01077154|7351600|FG000|Overall Study|Noncompliance|22
4532410|NCT01077154|7351601|FG001|Overall Study|Noncompliance|20
4532411|NCT01077154|7351600|FG000|Overall Study|Disease Progression|18
4532412|NCT01077154|7351601|FG001|Overall Study|Disease Progression|20
4532413|NCT01077154|7351600|FG000|Overall Study|Ineligibility Determined|10
4532414|NCT01077154|7351601|FG001|Overall Study|Ineligibility Determined|14
4532415|NCT01077154|7351600|FG000|Overall Study|Other|14
4532416|NCT01077154|7351601|FG001|Overall Study|Other|11
4532417|NCT01077154|7351600|FG000|Overall Study|Adverse Event|9
4532418|NCT01077154|7351601|FG001|Overall Study|Adverse Event|9
4532419|NCT01077154|7351600|FG000|Overall Study|Administrative Decision|1
4532420|NCT01077154|7351601|FG001|Overall Study|Administrative Decision|6
4532421|NCT01077154|7351600|FG000|Overall Study|Protocol Deviation|1
4532422|NCT01077154|7351601|FG001|Overall Study|Protocol Deviation|0
4532423|NCT01077193|7351607|FG000|Overall Study|Lost to Follow-up|1
4532424|NCT01077193|7351607|FG000|Overall Study|Withdrawal by Subject|2
4532425|NCT01077193|7351607|FG000|Overall Study|Lack of Efficacy|1
4532426|NCT01077193|7351607|FG000|Overall Study|Study Terminated by Sponsor|40
4532427|NCT01077258|7351611|FG000|Overall Study|Lost to Follow-up|1390
4532428|NCT01077258|7351611|FG000|Overall Study|Adverse drug reaction|218
4532429|NCT01077258|7351611|FG000|Overall Study|Lack of Efficacy|663
4532430|NCT01077258|7351611|FG000|Overall Study|Clinical remission|37
4532431|NCT01077258|7351611|FG000|Overall Study|Other reasons|260
4532432|NCT01077271|7351628|FG000|Overall Study|Parental desire|8
4532433|NCT01077271|7351628|FG000|Overall Study|Screen failure, did not take palivizumab|4
4532434|NCT01077271|7351628|FG000|Overall Study|Noncompliance|2
4532435|NCT01077271|7351628|FG000|Overall Study|Quota used up (insurance reimb issue)|2
4532436|NCT01077271|7351628|FG000|Overall Study|Changed doctors|2
4532437|NCT01077271|7351628|FG000|Overall Study|Parents thought too many injections|2
4532438|NCT01077271|7351628|FG000|Overall Study|End of RSV season nearly reached|1
4532439|NCT01077271|7351628|FG000|Overall Study|Mother unconvinced of the necessity|1
4532440|NCT01077284|7351643|FG000|Overall Study|Adverse Event|2
4532441|NCT01077284|7351644|FG001|Overall Study|Adverse Event|0
4532442|NCT01077284|7351645|FG002|Overall Study|Adverse Event|1
4689890|NCT02555683|7599409|FG001|Overall Study|Adverse Event|0
4689891|NCT02555683|7599410|FG002|Overall Study|Adverse Event|1
4689892|NCT02555683|7599408|FG000|Overall Study|Subject/guardian decision|12
4689893|NCT02555683|7599409|FG001|Overall Study|Subject/guardian decision|12
4689894|NCT02555683|7599410|FG002|Overall Study|Subject/guardian decision|22
4689895|NCT02555683|7599408|FG000|Overall Study|Death post Treatment/safety period|0
4689896|NCT02555683|7599409|FG001|Overall Study|Death post Treatment/safety period|1
4689897|NCT02555683|7599410|FG002|Overall Study|Death post Treatment/safety period|0
4689898|NCT02555722|7599420|FG000|Week 2|Adverse Event|0
4689899|NCT02555722|7599421|FG001|Week 2|Adverse Event|1
4689900|NCT02555722|7599420|FG000|Week 2|Withdrawal by Subject|1
4532443|NCT01077284|7351643|FG000|Overall Study|Lost to Follow-up|1
4532444|NCT01077284|7351644|FG001|Overall Study|Lost to Follow-up|2
4532445|NCT01077284|7351645|FG002|Overall Study|Lost to Follow-up|0
4532446|NCT01077284|7351643|FG000|Overall Study|Withdrawal by Subject|2
4532447|NCT01077284|7351644|FG001|Overall Study|Withdrawal by Subject|3
4532448|NCT01077284|7351645|FG002|Overall Study|Withdrawal by Subject|1
4532449|NCT01077284|7351643|FG000|Overall Study|Other|0
4532450|NCT01077284|7351644|FG001|Overall Study|Other|0
4532451|NCT01077284|7351645|FG002|Overall Study|Other|1
4532452|NCT01077323|7351670|FG000|Overall Study|<9 months enroll before drug dispensed|11226
4532453|NCT01077323|7351671|FG001|Overall Study|<9 months enroll before drug dispensed|263954
4532454|NCT01077323|7351672|FG002|Overall Study|<9 months enroll before drug dispensed|11655523
4532455|NCT01077323|7351670|FG000|Overall Study|Dispensing of drug in baseline period|0
4532456|NCT01077323|7351671|FG001|Overall Study|Dispensing of drug in baseline period|120229
4532457|NCT01077323|7351672|FG002|Overall Study|Dispensing of drug in baseline period|256446
4532458|NCT01077323|7351670|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152
4532459|NCT01077323|7351671|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080
4532460|NCT01077323|7351672|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120
4532461|NCT01077362|7351683|FG000|Overall Study|Lack of Efficacy|13
4532462|NCT01077362|7351684|FG001|Overall Study|Lack of Efficacy|8
4532463|NCT01077362|7351685|FG002|Overall Study|Lack of Efficacy|10
4532464|NCT01077362|7351683|FG000|Overall Study|Lost to Follow-up|1
4532465|NCT01077362|7351684|FG001|Overall Study|Lost to Follow-up|0
4532466|NCT01077362|7351685|FG002|Overall Study|Lost to Follow-up|3
4532467|NCT01077362|7351683|FG000|Overall Study|Adverse Event|12
4532468|NCT01077362|7351684|FG001|Overall Study|Adverse Event|7
4532469|NCT01077362|7351685|FG002|Overall Study|Adverse Event|4
4532470|NCT01077362|7351683|FG000|Overall Study|Withdrawal by Subject|5
4532471|NCT01077362|7351684|FG001|Overall Study|Withdrawal by Subject|3
4532472|NCT01077362|7351685|FG002|Overall Study|Withdrawal by Subject|5
4609785|NCT01689519|7465946|FG001|Intent to Treat|Study terminated by Spon6sor|48
4609786|NCT01689519|7465945|FG000|Intent to Treat|Withdrawal by Subject|21
4609787|NCT01689519|7465946|FG001|Intent to Treat|Withdrawal by Subject|20
4609788|NCT01689519|7465945|FG000|Safety Population|Death|158
4609789|NCT01689519|7465946|FG001|Safety Population|Death|165
4609790|NCT01689519|7465945|FG000|Safety Population|Lost to Follow-up|4
4609791|NCT01689519|7465946|FG001|Safety Population|Lost to Follow-up|8
4609792|NCT01689519|7465945|FG000|Safety Population|Other|2
4689901|NCT02555722|7599421|FG001|Week 2|Withdrawal by Subject|0
4532473|NCT01077362|7351683|FG000|Overall Study|Other|0
4532474|NCT01077362|7351684|FG001|Overall Study|Other|1
4532475|NCT01077362|7351685|FG002|Overall Study|Other|2
4532476|NCT01077375|7351700|FG000|Overall Study|Adverse Event|2
4532477|NCT01077375|7351701|FG001|Overall Study|Adverse Event|15
4532478|NCT01077375|7351700|FG000|Overall Study|Lack of Efficacy|6
4532479|NCT01077375|7351701|FG001|Overall Study|Lack of Efficacy|8
4532480|NCT01077375|7351700|FG000|Overall Study|Withdrawal by Subject|0
4609793|NCT01689519|7465946|FG001|Safety Population|Other|4
4532481|NCT01077375|7351701|FG001|Overall Study|Withdrawal by Subject|6
4532482|NCT01077375|7351700|FG000|Overall Study|Lost to Follow-up|2
4532483|NCT01077375|7351701|FG001|Overall Study|Lost to Follow-up|5
4532484|NCT01077375|7351700|FG000|Overall Study|Other Reason|0
4532485|NCT01077375|7351701|FG001|Overall Study|Other Reason|1
4532486|NCT01077518|7351720|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8
4532487|NCT01077518|7351721|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4
4532488|NCT01077518|7351722|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0
4532489|NCT01077518|7351720|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10
4532490|NCT01077518|7351721|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11
4532491|NCT01077518|7351722|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0
4532492|NCT01077518|7351720|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28
4532493|NCT01077518|7351721|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22
4532494|NCT01077518|7351722|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0
4532495|NCT01077518|7351720|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32
4532496|NCT01077518|7351721|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28
4532497|NCT01077518|7351722|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0
4532498|NCT01077518|7351720|FG000|Optional Ofa Phase|Physician Decision|0
4532499|NCT01077518|7351721|FG001|Optional Ofa Phase|Physician Decision|0
4609794|NCT01689519|7465945|FG000|Safety Population|Physician Decision|4
4609795|NCT01689519|7465946|FG001|Safety Population|Physician Decision|1
4609796|NCT01689519|7465945|FG000|Safety Population|Study Terminated By Sponsor|60
4609797|NCT01689519|7465946|FG001|Safety Population|Study Terminated By Sponsor|47
4609798|NCT01689519|7465945|FG000|Safety Population|Withdrawal by Subject|20
4609799|NCT01689519|7465946|FG001|Safety Population|Withdrawal by Subject|20
4609800|NCT01689532|7465954|FG000|Overall Study|Adverse Event|9
4609801|NCT01689532|7465955|FG001|Overall Study|Adverse Event|5
4609802|NCT01689532|7465954|FG000|Overall Study|Lack of Efficacy|2
4609803|NCT01689532|7465955|FG001|Overall Study|Lack of Efficacy|2
4609804|NCT01689532|7465954|FG000|Overall Study|Withdrawal by Subject|1
4609805|NCT01689532|7465955|FG001|Overall Study|Withdrawal by Subject|2
4609806|NCT01689532|7465954|FG000|Overall Study|Physician Decision|2
4609807|NCT01689532|7465955|FG001|Overall Study|Physician Decision|0
4609808|NCT01689649|7465961|FG000|Overall Study|Lack of Efficacy|3
4609809|NCT01689649|7465961|FG000|Overall Study|Non-compliance|11
4609810|NCT01689649|7465961|FG000|Overall Study|Protocol Violation|3
4609811|NCT01689649|7465961|FG000|Overall Study|Lost to Follow-up|5
4609812|NCT01689857|7465985|FG000|Overall Study|Lost to Follow-up|5
4609813|NCT01689857|7465986|FG001|Overall Study|Lost to Follow-up|2
4609814|NCT01690052|7466001|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1
4609815|NCT01690052|7466002|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2
4609816|NCT01690130|7466021|FG000|Overall Study|Subject have cancelled visit.|1
4609817|NCT01690130|7466022|FG001|Overall Study|Subject have cancelled visit.|0
4609818|NCT01690143|7466028|FG000|Overall Study|Withdrawal by Subject|1
4609819|NCT01690520|7466052|FG000|Overall Study|Death|25
4609820|NCT01690520|7466053|FG001|Overall Study|Death|21
4609821|NCT01690520|7466052|FG000|Overall Study|Lost to Follow-up|2
4609822|NCT01690520|7466053|FG001|Overall Study|Lost to Follow-up|3
4609823|NCT01690520|7466052|FG000|Overall Study|Withdrawal by Subject|2
4609824|NCT01690520|7466053|FG001|Overall Study|Withdrawal by Subject|0
4609825|NCT01690520|7466052|FG000|Overall Study|Relapse|0
4609826|NCT01690520|7466053|FG001|Overall Study|Relapse|1
4609827|NCT01690520|7466052|FG000|Overall Study|Other|0
4532500|NCT01077518|7351722|FG002|Optional Ofa Phase|Physician Decision|1
4609828|NCT01690520|7466053|FG001|Overall Study|Other|1
4609829|NCT01690520|7466052|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22
4609830|NCT01690520|7466053|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21
4609831|NCT01690988|7466088|FG000|Overall Study|Withdrawal by Subject|2
4609832|NCT01690988|7466089|FG001|Overall Study|Withdrawal by Subject|2
4609833|NCT01690988|7466090|FG002|Overall Study|Withdrawal by Subject|3
4609834|NCT01690988|7466088|FG000|Overall Study|Physician Decision|0
4609835|NCT01690988|7466089|FG001|Overall Study|Physician Decision|0
4609836|NCT01690988|7466090|FG002|Overall Study|Physician Decision|1
4609837|NCT01690988|7466088|FG000|Overall Study|Operation Cancelled|1
4609838|NCT01690988|7466089|FG001|Overall Study|Operation Cancelled|1
4609839|NCT01690988|7466090|FG002|Overall Study|Operation Cancelled|0
4609840|NCT01690988|7466088|FG000|Overall Study|Determined ineligible|1
4609841|NCT01690988|7466089|FG001|Overall Study|Determined ineligible|0
4609842|NCT01690988|7466090|FG002|Overall Study|Determined ineligible|0
4609843|NCT01690988|7466088|FG000|Overall Study|Death|1
4609844|NCT01690988|7466089|FG001|Overall Study|Death|1
4609845|NCT01690988|7466090|FG002|Overall Study|Death|1
4609846|NCT01690988|7466088|FG000|Overall Study|Sedated|1
4609847|NCT01690988|7466089|FG001|Overall Study|Sedated|1
4609848|NCT01690988|7466090|FG002|Overall Study|Sedated|2
4609849|NCT01691014|7466105|FG000|Overall Study|Premature Termination|1
4609850|NCT01691014|7466106|FG001|Overall Study|Premature Termination|6
4609851|NCT01691014|7466107|FG002|Overall Study|Premature Termination|0
4609852|NCT01691014|7466108|FG003|Overall Study|Premature Termination|3
4609853|NCT01691014|7466105|FG000|Overall Study|Other|0
4609854|NCT01691014|7466106|FG001|Overall Study|Other|0
4609855|NCT01691014|7466107|FG002|Overall Study|Other|2
4532501|NCT01077518|7351720|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0
4532502|NCT01077518|7351721|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0
4532503|NCT01077518|7351722|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12
4532504|NCT01077518|7351720|FG000|Optional Ofa Phase|Withdrawal by Subject|0
4532505|NCT01077518|7351721|FG001|Optional Ofa Phase|Withdrawal by Subject|0
4532506|NCT01077518|7351722|FG002|Optional Ofa Phase|Withdrawal by Subject|3
4532507|NCT01077544|7351733|FG000|Overall Study|New Cancer Therapy|3
4532508|NCT01077544|7351734|FG001|Overall Study|New Cancer Therapy|3
4532509|NCT01077544|7351733|FG000|Overall Study|Adverse Event|0
4532510|NCT01077544|7351734|FG001|Overall Study|Adverse Event|1
4532511|NCT01077544|7351733|FG000|Overall Study|Disease Progression|0
4532512|NCT01077544|7351734|FG001|Overall Study|Disease Progression|1
4532513|NCT01077622|7351784|FG000|Overall Study|Physician Decision|2
4532514|NCT01077622|7351784|FG000|Overall Study|Withdrawal by Subject|1
4532515|NCT01077713|7351790|FG000|Overall Study|Withdrawal by Subject|1
4532516|NCT01077713|7351791|FG001|Overall Study|Withdrawal by Subject|2
4532517|NCT01077713|7351790|FG000|Overall Study|Progressive Disease (PD)|0
4532518|NCT01077713|7351791|FG001|Overall Study|Progressive Disease (PD)|1
4532519|NCT01077713|7351790|FG000|Overall Study|Death|28
4532520|NCT01077713|7351791|FG001|Overall Study|Death|29
4532521|NCT01077713|7351790|FG000|Overall Study|Lost to Follow-up|1
4532522|NCT01077713|7351791|FG001|Overall Study|Lost to Follow-up|1
4532523|NCT01077713|7351790|FG000|Overall Study|Adverse Event|2
4532524|NCT01077713|7351791|FG001|Overall Study|Adverse Event|1
4532525|NCT01077713|7351790|FG000|Overall Study|Other|4
4532526|NCT01077713|7351791|FG001|Overall Study|Other|2
4532527|NCT01077739|7351799|FG000|Overall Study|Premature withdrawal|1
4532528|NCT01077739|7351800|FG001|Overall Study|Premature withdrawal|3
4532529|NCT01077739|7351799|FG000|Overall Study|Withdrawal by Subject|1
4532530|NCT01077739|7351800|FG001|Overall Study|Withdrawal by Subject|0
4532531|NCT01077739|7351799|FG000|Overall Study|Death|0
4532532|NCT01077739|7351800|FG001|Overall Study|Death|3
4532533|NCT01077739|7351799|FG000|Overall Study|Unacceptable toxicity|1
4532534|NCT01077739|7351800|FG001|Overall Study|Unacceptable toxicity|2
4532535|NCT01077739|7351799|FG000|Overall Study|Other|2
4532536|NCT01077739|7351800|FG001|Overall Study|Other|2
4532537|NCT01077804|7351806|FG000|Overall Study|Unreachable|102
4532538|NCT01077804|7351806|FG000|Overall Study|Refused to continue|79
4532539|NCT01077804|7351806|FG000|Overall Study|Other|18
4532540|NCT01077960|7351865|FG000|Overall Study|Adverse Event|6
4532541|NCT01077960|7351865|FG000|Overall Study|Protocol Violation|3
4532542|NCT01077960|7351865|FG000|Overall Study|Lost to Follow-up|5
4532543|NCT01077960|7351865|FG000|Overall Study|Subject decision|1
4532544|NCT01077960|7351865|FG000|Overall Study|Reason unspecified|1
4532545|NCT01078090|7351884|FG000|Overall Study|Lost to Follow-up|2363
4532546|NCT01078090|7351884|FG000|Overall Study|Adverse drug reaction (ADR)|453
4532547|NCT01078090|7351884|FG000|Overall Study|Lack of Efficacy|1193
4532548|NCT01078090|7351884|FG000|Overall Study|ADR and lack of efficacy|61
4532549|NCT01078090|7351884|FG000|Overall Study|Other|523
4532550|NCT01078116|7351902|FG000|Overall Study|Lost to Follow-up|17
4532551|NCT01078116|7351902|FG000|Overall Study|Adverse Event|5
4532552|NCT01078116|7351902|FG000|Overall Study|Withdrawal by Subject|8
4532553|NCT01078116|7351902|FG000|Overall Study|Lack of effectiveness|15
4532554|NCT01078116|7351902|FG000|Overall Study|Case report form not completed|3
4532555|NCT01078155|7351906|FG000|Overall Study|Adverse Event|7
4532556|NCT01078155|7351906|FG000|Overall Study|Lack of Efficacy|16
4532557|NCT01078155|7351906|FG000|Overall Study|Participant's Decision|6
4532558|NCT01078155|7351906|FG000|Overall Study|Lost to Follow-up|15
4532559|NCT01078168|7351912|FG000|Overall Study|Physician Decision|0
4532560|NCT01078168|7351913|FG001|Overall Study|Physician Decision|1
4532561|NCT01078298|7351972|FG000|Overall Study|Lost to Follow-up|12
4532562|NCT01078298|7351973|FG001|Overall Study|Lost to Follow-up|13
4532563|NCT01078298|7351972|FG000|Overall Study|Withdrawal by Subject|31
4532564|NCT01078298|7351973|FG001|Overall Study|Withdrawal by Subject|33
4532565|NCT01078298|7351972|FG000|Overall Study|Protocol Violation|6
4532566|NCT01078298|7351973|FG001|Overall Study|Protocol Violation|6
4532567|NCT01078298|7351972|FG000|Overall Study|Adverse Event|6
4532568|NCT01078298|7351973|FG001|Overall Study|Adverse Event|5
4532569|NCT01078298|7351972|FG000|Overall Study|Death|2
4532570|NCT01078298|7351973|FG001|Overall Study|Death|0
4532571|NCT01078298|7351972|FG000|Overall Study|Did not meet entrance criteria|0
4532572|NCT01078298|7351973|FG001|Overall Study|Did not meet entrance criteria|1
4532573|NCT01078298|7351972|FG000|Overall Study|Other|24
4532574|NCT01078298|7351973|FG001|Overall Study|Other|32
4532575|NCT01078389|7352012|FG000|Overall Study|Adverse Event|10
4532576|NCT01078389|7352013|FG001|Overall Study|Adverse Event|6
4532577|NCT01078389|7352012|FG000|Overall Study|Major Protocol Deviation|2
4532578|NCT01078389|7352013|FG001|Overall Study|Major Protocol Deviation|0
4532579|NCT01078389|7352012|FG000|Overall Study|Lost to Follow-up|23
4532580|NCT01078389|7352013|FG001|Overall Study|Lost to Follow-up|23
4532581|NCT01078389|7352012|FG000|Overall Study|Voluntary Withdrawal|20
4532582|NCT01078389|7352013|FG001|Overall Study|Voluntary Withdrawal|36
4532583|NCT01078389|7352012|FG000|Overall Study|Other|9
4532584|NCT01078389|7352013|FG001|Overall Study|Other|2
4532585|NCT01078441|7352036|FG000|Overall Study|Withdrawal by Subject|1
4532586|NCT01078545|7352040|FG000|Overall Study|Lost to Follow-up|13
4532587|NCT01078545|7352040|FG000|Overall Study|Physician Decision|6
4532588|NCT01078545|7352040|FG000|Overall Study|Withdrawal by Subject|3
4532589|NCT01078545|7352040|FG000|Overall Study|Death|3
4532590|NCT01078545|7352040|FG000|Overall Study|Participant moved to another physician|1
4532591|NCT01078571|7352057|FG000|Overall Study|Adverse Event|36
4532592|NCT01078571|7352057|FG000|Overall Study|Lack of effectiveness|36
4532593|NCT01078571|7352057|FG000|Overall Study|Reason not reported|21
4532594|NCT01078571|7352057|FG000|Overall Study|Withdrawal by Subject|12
4532595|NCT01078571|7352057|FG000|Overall Study|Lost to Follow-up|8
4532596|NCT01078571|7352057|FG000|Overall Study|Protocol Violation|2
4532597|NCT01078584|7352066|FG000|Overall Study|Final Status Unknown|1073
4532598|NCT01078584|7352066|FG000|Overall Study|Lost to Follow-up|670
4532599|NCT01078584|7352066|FG000|Overall Study|Non-serious Adverse Event|577
4532600|NCT01078584|7352066|FG000|Overall Study|Withdrawal of Consent|244
4532601|NCT01078584|7352066|FG000|Overall Study|Physician Withdrew from Study|90
4532602|NCT01078584|7352066|FG000|Overall Study|Non-compliance|67
4609856|NCT01691014|7466108|FG003|Overall Study|Other|0
4609857|NCT01691014|7466105|FG000|Overall Study|Withdrawal by Subject|0
4609858|NCT01691014|7466106|FG001|Overall Study|Withdrawal by Subject|1
4609859|NCT01691014|7466107|FG002|Overall Study|Withdrawal by Subject|1
4609860|NCT01691014|7466108|FG003|Overall Study|Withdrawal by Subject|1
4609861|NCT01691014|7466105|FG000|Overall Study|Adverse Event|0
4609862|NCT01691014|7466106|FG001|Overall Study|Adverse Event|5
4609863|NCT01691014|7466107|FG002|Overall Study|Adverse Event|1
4609864|NCT01691014|7466108|FG003|Overall Study|Adverse Event|1
4609865|NCT01691014|7466105|FG000|Overall Study|Lack of Efficacy|2
4609866|NCT01691014|7466106|FG001|Overall Study|Lack of Efficacy|3
4609867|NCT01691014|7466107|FG002|Overall Study|Lack of Efficacy|7
4609868|NCT01691014|7466108|FG003|Overall Study|Lack of Efficacy|0
4609869|NCT01691092|7466123|FG000|Overall Study|Lost to Follow-up|10
4609870|NCT01691092|7466123|FG000|Overall Study|Physician Decision|4
4609871|NCT01691092|7466123|FG000|Overall Study|Withdrawal by Subject|3
4609872|NCT01691092|7466123|FG000|Overall Study|non-compliance|3
4609873|NCT01691092|7466123|FG000|Overall Study|used for different study|2
4609874|NCT01691092|7466123|FG000|Overall Study|screen fail|19
4632593|NCT01903252|7502285|FG001|Maintenance, Open-Label|Other|0
4632594|NCT01903252|7502286|FG002|Maintenance, Open-Label|Other|0
4632595|NCT01903252|7502287|FG003|Maintenance, Open-Label|Other|2
4632596|NCT01903252|7502288|FG004|Maintenance, Open-Label|Other|6
4632597|NCT01903252|7502289|FG005|Maintenance, Open-Label|Other|2
4632598|NCT01903356|7502316|FG000|Overall Study|Lost to Follow-up|7
4632599|NCT01903356|7502316|FG000|Overall Study|Violated inclusion/exclusion criteria|5
4632600|NCT01903356|7502316|FG000|Overall Study|Violated the dosage and administration|3
4632601|NCT01903434|7502320|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1
4632602|NCT01903434|7502321|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0
4632603|NCT01903434|7502320|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0
4632604|NCT01903434|7502321|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2
4632605|NCT01903460|7502331|FG000|Overall Study|Adverse Event|0
4632606|NCT01903460|7502332|FG001|Overall Study|Adverse Event|0
4632607|NCT01903460|7502333|FG002|Overall Study|Adverse Event|0
4632608|NCT01903460|7502334|FG003|Overall Study|Adverse Event|1
4532603|NCT01078584|7352066|FG000|Overall Study|Blood Pressure Controlled|49
4532604|NCT01078584|7352066|FG000|Overall Study|Physician Switched Medication|26
4532605|NCT01078584|7352066|FG000|Overall Study|Physician Discontinued Patient|12
4532606|NCT01078584|7352066|FG000|Overall Study|Lack of Efficacy|98
4532607|NCT01078584|7352066|FG000|Overall Study|Protocol Violation|75
4532608|NCT01078584|7352066|FG000|Overall Study|Serious Adverse Event|27
4532609|NCT01078584|7352066|FG000|Overall Study|Multiple Reasons|2
4532610|NCT01078623|7352083|FG000|Treatment Period 1|Adverse Event|1
4532611|NCT01078623|7352084|FG001|Treatment Period 1|Adverse Event|1
4532612|NCT01078623|7352085|FG002|Treatment Period 1|Adverse Event|1
4532613|NCT01078623|7352086|FG003|Treatment Period 1|Adverse Event|0
4532614|NCT01078623|7352087|FG004|Treatment Period 1|Adverse Event|0
4532615|NCT01078623|7352088|FG005|Treatment Period 1|Adverse Event|0
4532616|NCT01078623|7352089|FG006|Treatment Period 1|Adverse Event|1
4532617|NCT01078623|7352090|FG007|Treatment Period 1|Adverse Event|0
4532618|NCT01078623|7352091|FG008|Treatment Period 1|Adverse Event|1
4532619|NCT01078623|7352092|FG009|Treatment Period 1|Adverse Event|1
4532620|NCT01078623|7352093|FG010|Treatment Period 1|Adverse Event|0
4532621|NCT01078623|7352094|FG011|Treatment Period 1|Adverse Event|0
4532622|NCT01078623|7352095|FG012|Treatment Period 1|Adverse Event|0
4532623|NCT01078623|7352096|FG013|Treatment Period 1|Adverse Event|0
4532624|NCT01078623|7352097|FG014|Treatment Period 1|Adverse Event|0
4532625|NCT01078623|7352098|FG015|Treatment Period 1|Adverse Event|0
4532626|NCT01078623|7352099|FG016|Treatment Period 1|Adverse Event|0
4532627|NCT01078623|7352100|FG017|Treatment Period 1|Adverse Event|0
4532628|NCT01078623|7352101|FG018|Treatment Period 1|Adverse Event|0
4532629|NCT01078623|7352102|FG019|Treatment Period 1|Adverse Event|0
4532630|NCT01078623|7352083|FG000|Treatment Period 1|Withdrawal by Subject|0
4532631|NCT01078623|7352084|FG001|Treatment Period 1|Withdrawal by Subject|0
4532632|NCT01078623|7352085|FG002|Treatment Period 1|Withdrawal by Subject|0
4532633|NCT01078623|7352086|FG003|Treatment Period 1|Withdrawal by Subject|0
4532634|NCT01078623|7352087|FG004|Treatment Period 1|Withdrawal by Subject|0
4632609|NCT01903525|7502345|FG000|Overall Study|Lost to Follow-up|5
4532635|NCT01078623|7352088|FG005|Treatment Period 1|Withdrawal by Subject|0
4532636|NCT01078623|7352089|FG006|Treatment Period 1|Withdrawal by Subject|0
4532637|NCT01078623|7352090|FG007|Treatment Period 1|Withdrawal by Subject|1
4532638|NCT01078623|7352091|FG008|Treatment Period 1|Withdrawal by Subject|0
4532639|NCT01078623|7352092|FG009|Treatment Period 1|Withdrawal by Subject|0
4532640|NCT01078623|7352093|FG010|Treatment Period 1|Withdrawal by Subject|1
4532641|NCT01078623|7352094|FG011|Treatment Period 1|Withdrawal by Subject|0
4532642|NCT01078623|7352095|FG012|Treatment Period 1|Withdrawal by Subject|0
4532643|NCT01078623|7352096|FG013|Treatment Period 1|Withdrawal by Subject|0
4532644|NCT01078623|7352097|FG014|Treatment Period 1|Withdrawal by Subject|0
4532645|NCT01078623|7352098|FG015|Treatment Period 1|Withdrawal by Subject|0
4532646|NCT01078623|7352099|FG016|Treatment Period 1|Withdrawal by Subject|0
4532647|NCT01078623|7352100|FG017|Treatment Period 1|Withdrawal by Subject|0
4532648|NCT01078623|7352101|FG018|Treatment Period 1|Withdrawal by Subject|0
4532649|NCT01078623|7352102|FG019|Treatment Period 1|Withdrawal by Subject|0
4532650|NCT01078623|7352083|FG000|Treatment Period 1|Protocol Violation|0
4532651|NCT01078623|7352084|FG001|Treatment Period 1|Protocol Violation|0
4532652|NCT01078623|7352085|FG002|Treatment Period 1|Protocol Violation|0
4532653|NCT01078623|7352086|FG003|Treatment Period 1|Protocol Violation|0
4532654|NCT01078623|7352087|FG004|Treatment Period 1|Protocol Violation|0
4532655|NCT01078623|7352088|FG005|Treatment Period 1|Protocol Violation|1
4532656|NCT01078623|7352089|FG006|Treatment Period 1|Protocol Violation|0
4532657|NCT01078623|7352090|FG007|Treatment Period 1|Protocol Violation|0
4532658|NCT01078623|7352091|FG008|Treatment Period 1|Protocol Violation|0
4532659|NCT01078623|7352092|FG009|Treatment Period 1|Protocol Violation|0
4532660|NCT01078623|7352093|FG010|Treatment Period 1|Protocol Violation|0
4532661|NCT01078623|7352094|FG011|Treatment Period 1|Protocol Violation|0
4532662|NCT01078623|7352095|FG012|Treatment Period 1|Protocol Violation|0
4532663|NCT01078623|7352096|FG013|Treatment Period 1|Protocol Violation|0
4532664|NCT01078623|7352097|FG014|Treatment Period 1|Protocol Violation|0
4532665|NCT01078623|7352098|FG015|Treatment Period 1|Protocol Violation|0
4532666|NCT01078623|7352099|FG016|Treatment Period 1|Protocol Violation|0
4532667|NCT01078623|7352100|FG017|Treatment Period 1|Protocol Violation|0
4532668|NCT01078623|7352101|FG018|Treatment Period 1|Protocol Violation|0
4532669|NCT01078623|7352102|FG019|Treatment Period 1|Protocol Violation|0
4532670|NCT01078623|7352083|FG000|Treatment Period 2|Adverse Event|0
4532671|NCT01078623|7352084|FG001|Treatment Period 2|Adverse Event|0
4532672|NCT01078623|7352085|FG002|Treatment Period 2|Adverse Event|0
4532673|NCT01078623|7352086|FG003|Treatment Period 2|Adverse Event|0
4532674|NCT01078623|7352087|FG004|Treatment Period 2|Adverse Event|0
4532675|NCT01078623|7352088|FG005|Treatment Period 2|Adverse Event|0
4532676|NCT01078623|7352089|FG006|Treatment Period 2|Adverse Event|1
4532677|NCT01078623|7352090|FG007|Treatment Period 2|Adverse Event|0
4532678|NCT01078623|7352091|FG008|Treatment Period 2|Adverse Event|0
4532679|NCT01078623|7352092|FG009|Treatment Period 2|Adverse Event|0
4532680|NCT01078623|7352093|FG010|Treatment Period 2|Adverse Event|0
4532681|NCT01078623|7352094|FG011|Treatment Period 2|Adverse Event|0
4532682|NCT01078623|7352095|FG012|Treatment Period 2|Adverse Event|0
4532683|NCT01078623|7352096|FG013|Treatment Period 2|Adverse Event|0
4532684|NCT01078623|7352097|FG014|Treatment Period 2|Adverse Event|0
4532685|NCT01078623|7352098|FG015|Treatment Period 2|Adverse Event|0
4532686|NCT01078623|7352099|FG016|Treatment Period 2|Adverse Event|0
4532687|NCT01078623|7352100|FG017|Treatment Period 2|Adverse Event|0
4532688|NCT01078623|7352101|FG018|Treatment Period 2|Adverse Event|1
4532689|NCT01078623|7352102|FG019|Treatment Period 2|Adverse Event|0
4532690|NCT01078623|7352083|FG000|Treatment Period 2|Withdrawal by Subject|0
4532691|NCT01078623|7352084|FG001|Treatment Period 2|Withdrawal by Subject|0
4532692|NCT01078623|7352085|FG002|Treatment Period 2|Withdrawal by Subject|0
4532693|NCT01078623|7352086|FG003|Treatment Period 2|Withdrawal by Subject|0
4532694|NCT01078623|7352087|FG004|Treatment Period 2|Withdrawal by Subject|0
4532695|NCT01078623|7352088|FG005|Treatment Period 2|Withdrawal by Subject|1
4532696|NCT01078623|7352089|FG006|Treatment Period 2|Withdrawal by Subject|0
4532697|NCT01078623|7352090|FG007|Treatment Period 2|Withdrawal by Subject|0
4532698|NCT01078623|7352091|FG008|Treatment Period 2|Withdrawal by Subject|0
4532699|NCT01078623|7352092|FG009|Treatment Period 2|Withdrawal by Subject|0
4689902|NCT02555722|7599420|FG000|Month 1|Lens Discomfort|1
4532700|NCT01078623|7352093|FG010|Treatment Period 2|Withdrawal by Subject|0
4532701|NCT01078623|7352094|FG011|Treatment Period 2|Withdrawal by Subject|0
4532702|NCT01078623|7352095|FG012|Treatment Period 2|Withdrawal by Subject|0
4532703|NCT01078623|7352096|FG013|Treatment Period 2|Withdrawal by Subject|0
4532704|NCT01078623|7352097|FG014|Treatment Period 2|Withdrawal by Subject|0
4532705|NCT01078623|7352098|FG015|Treatment Period 2|Withdrawal by Subject|0
4532706|NCT01078623|7352099|FG016|Treatment Period 2|Withdrawal by Subject|0
4532707|NCT01078623|7352100|FG017|Treatment Period 2|Withdrawal by Subject|0
4532708|NCT01078623|7352101|FG018|Treatment Period 2|Withdrawal by Subject|0
4532709|NCT01078623|7352102|FG019|Treatment Period 2|Withdrawal by Subject|0
4532710|NCT01078623|7352083|FG000|Treatment Period 3|Adverse Event|0
4532711|NCT01078623|7352084|FG001|Treatment Period 3|Adverse Event|0
4532712|NCT01078623|7352085|FG002|Treatment Period 3|Adverse Event|0
4532713|NCT01078623|7352086|FG003|Treatment Period 3|Adverse Event|0
4532714|NCT01078623|7352087|FG004|Treatment Period 3|Adverse Event|1
4532715|NCT01078623|7352088|FG005|Treatment Period 3|Adverse Event|0
4532716|NCT01078623|7352089|FG006|Treatment Period 3|Adverse Event|0
4689903|NCT02555722|7599421|FG001|Month 1|Lens Discomfort|0
4532717|NCT01078623|7352090|FG007|Treatment Period 3|Adverse Event|0
4532718|NCT01078623|7352091|FG008|Treatment Period 3|Adverse Event|0
4532719|NCT01078623|7352092|FG009|Treatment Period 3|Adverse Event|0
4532720|NCT01078623|7352093|FG010|Treatment Period 3|Adverse Event|0
4532721|NCT01078623|7352094|FG011|Treatment Period 3|Adverse Event|0
4532722|NCT01078623|7352095|FG012|Treatment Period 3|Adverse Event|0
4532723|NCT01078623|7352096|FG013|Treatment Period 3|Adverse Event|1
4532724|NCT01078623|7352097|FG014|Treatment Period 3|Adverse Event|0
4532725|NCT01078623|7352098|FG015|Treatment Period 3|Adverse Event|0
4532726|NCT01078623|7352099|FG016|Treatment Period 3|Adverse Event|0
4532727|NCT01078623|7352100|FG017|Treatment Period 3|Adverse Event|0
4532728|NCT01078623|7352101|FG018|Treatment Period 3|Adverse Event|0
4532729|NCT01078623|7352102|FG019|Treatment Period 3|Adverse Event|0
4532730|NCT01078623|7352083|FG000|Treatment Period 4|Adverse Event|0
4532731|NCT01078623|7352084|FG001|Treatment Period 4|Adverse Event|0
4532732|NCT01078623|7352085|FG002|Treatment Period 4|Adverse Event|1
4532733|NCT01078623|7352086|FG003|Treatment Period 4|Adverse Event|0
4532734|NCT01078623|7352087|FG004|Treatment Period 4|Adverse Event|0
4532735|NCT01078623|7352088|FG005|Treatment Period 4|Adverse Event|0
4532736|NCT01078623|7352089|FG006|Treatment Period 4|Adverse Event|0
4532737|NCT01078623|7352090|FG007|Treatment Period 4|Adverse Event|0
4532738|NCT01078623|7352091|FG008|Treatment Period 4|Adverse Event|0
4532739|NCT01078623|7352092|FG009|Treatment Period 4|Adverse Event|0
4532740|NCT01078623|7352093|FG010|Treatment Period 4|Adverse Event|0
4532741|NCT01078623|7352094|FG011|Treatment Period 4|Adverse Event|0
4532742|NCT01078623|7352095|FG012|Treatment Period 4|Adverse Event|0
4532743|NCT01078623|7352096|FG013|Treatment Period 4|Adverse Event|0
4532744|NCT01078623|7352097|FG014|Treatment Period 4|Adverse Event|0
4532745|NCT01078623|7352098|FG015|Treatment Period 4|Adverse Event|0
4532746|NCT01078623|7352099|FG016|Treatment Period 4|Adverse Event|0
4532747|NCT01078623|7352100|FG017|Treatment Period 4|Adverse Event|0
4532748|NCT01078623|7352101|FG018|Treatment Period 4|Adverse Event|0
4532749|NCT01078623|7352102|FG019|Treatment Period 4|Adverse Event|0
4532750|NCT01078623|7352083|FG000|Treatment Period 4|Withdrawal by Subject|0
4532751|NCT01078623|7352084|FG001|Treatment Period 4|Withdrawal by Subject|0
4532752|NCT01078623|7352085|FG002|Treatment Period 4|Withdrawal by Subject|0
4532753|NCT01078623|7352086|FG003|Treatment Period 4|Withdrawal by Subject|0
4532754|NCT01078623|7352087|FG004|Treatment Period 4|Withdrawal by Subject|0
4532755|NCT01078623|7352088|FG005|Treatment Period 4|Withdrawal by Subject|0
4532756|NCT01078623|7352089|FG006|Treatment Period 4|Withdrawal by Subject|0
4532757|NCT01078623|7352090|FG007|Treatment Period 4|Withdrawal by Subject|0
4532758|NCT01078623|7352091|FG008|Treatment Period 4|Withdrawal by Subject|0
4532759|NCT01078623|7352092|FG009|Treatment Period 4|Withdrawal by Subject|0
4532760|NCT01078623|7352093|FG010|Treatment Period 4|Withdrawal by Subject|0
4532761|NCT01078623|7352094|FG011|Treatment Period 4|Withdrawal by Subject|0
4532762|NCT01078623|7352095|FG012|Treatment Period 4|Withdrawal by Subject|0
4532763|NCT01078623|7352096|FG013|Treatment Period 4|Withdrawal by Subject|0
4532764|NCT01078623|7352097|FG014|Treatment Period 4|Withdrawal by Subject|0
4532765|NCT01078623|7352098|FG015|Treatment Period 4|Withdrawal by Subject|1
4532766|NCT01078623|7352099|FG016|Treatment Period 4|Withdrawal by Subject|0
4532767|NCT01078623|7352100|FG017|Treatment Period 4|Withdrawal by Subject|0
4532768|NCT01078623|7352101|FG018|Treatment Period 4|Withdrawal by Subject|0
4532769|NCT01078623|7352102|FG019|Treatment Period 4|Withdrawal by Subject|0
4532770|NCT01078675|7352116|FG000|Overall Study|Withdrawal by Subject|7
4532771|NCT01078675|7352117|FG001|Overall Study|Withdrawal by Subject|3
4532772|NCT01078675|7352116|FG000|Overall Study|Protocol Violation|56
4532773|NCT01078675|7352117|FG001|Overall Study|Protocol Violation|0
4532774|NCT01078675|7352116|FG000|Overall Study|Provided in CRF for specific reasons|2
4532775|NCT01078675|7352117|FG001|Overall Study|Provided in CRF for specific reasons|3
4532776|NCT01078675|7352116|FG000|Overall Study|Adverse Event|3
4532777|NCT01078675|7352117|FG001|Overall Study|Adverse Event|0
4532778|NCT01078805|7352132|FG000|Overall Study|Clinically significant abnormal lab|5
4532779|NCT01078805|7352132|FG000|Overall Study|Death|134
4532780|NCT01078805|7352132|FG000|Overall Study|Lost to Follow-up|676
4532781|NCT01078805|7352132|FG000|Overall Study|Physician Decision|169
4532782|NCT01078805|7352132|FG000|Overall Study|Serious adverse event|26
4532783|NCT01078805|7352132|FG000|Overall Study|Sponsor decision|46
4532784|NCT01078805|7352132|FG000|Overall Study|Withdrawal by Subject|739
4532785|NCT01078805|7352132|FG000|Overall Study|Other|173
4532786|NCT01078805|7352132|FG000|Overall Study|Didn't take study drug|82
4532787|NCT01078922|7352157|FG000|Overall Study|Adverse Event|1
4532788|NCT01078974|7352162|FG000|Overall Study|Adverse Event|3
4532789|NCT01079130|7352172|FG000|Overall Study|Adverse Event|1
4532790|NCT01079130|7352173|FG001|Overall Study|Adverse Event|1
4532791|NCT01079130|7352174|FG002|Overall Study|Adverse Event|0
4532792|NCT01079130|7352175|FG003|Overall Study|Adverse Event|1
4532793|NCT01079130|7352176|FG004|Overall Study|Adverse Event|5
4532794|NCT01079130|7352177|FG005|Overall Study|Adverse Event|1
4532795|NCT01079130|7352172|FG000|Overall Study|Administrative problems|1
4532796|NCT01079130|7352173|FG001|Overall Study|Administrative problems|3
4532797|NCT01079130|7352174|FG002|Overall Study|Administrative problems|0
4532798|NCT01079130|7352175|FG003|Overall Study|Administrative problems|0
4532799|NCT01079130|7352176|FG004|Overall Study|Administrative problems|0
4532800|NCT01079130|7352177|FG005|Overall Study|Administrative problems|1
4532801|NCT01079130|7352172|FG000|Overall Study|Withdrawal by Subject|0
4532802|NCT01079130|7352173|FG001|Overall Study|Withdrawal by Subject|1
4532803|NCT01079130|7352174|FG002|Overall Study|Withdrawal by Subject|0
4532804|NCT01079130|7352175|FG003|Overall Study|Withdrawal by Subject|0
4532805|NCT01079130|7352176|FG004|Overall Study|Withdrawal by Subject|1
4532806|NCT01079130|7352177|FG005|Overall Study|Withdrawal by Subject|3
4532807|NCT01079130|7352172|FG000|Overall Study|Protocol deviation|0
4532808|NCT01079130|7352173|FG001|Overall Study|Protocol deviation|2
4532809|NCT01079130|7352174|FG002|Overall Study|Protocol deviation|1
4532810|NCT01079130|7352175|FG003|Overall Study|Protocol deviation|2
4532811|NCT01079130|7352176|FG004|Overall Study|Protocol deviation|0
4532812|NCT01079130|7352177|FG005|Overall Study|Protocol deviation|0
4532813|NCT01079130|7352172|FG000|Overall Study|Abnormal test procedure result(s)|0
4532814|NCT01079130|7352173|FG001|Overall Study|Abnormal test procedure result(s)|0
4532815|NCT01079130|7352174|FG002|Overall Study|Abnormal test procedure result(s)|0
4532816|NCT01079130|7352175|FG003|Overall Study|Abnormal test procedure result(s)|0
4532817|NCT01079130|7352176|FG004|Overall Study|Abnormal test procedure result(s)|1
4532818|NCT01079130|7352177|FG005|Overall Study|Abnormal test procedure result(s)|0
4532819|NCT01079130|7352172|FG000|Overall Study|Unsatisfactory therapeutic effect|0
4532820|NCT01079130|7352173|FG001|Overall Study|Unsatisfactory therapeutic effect|0
4532821|NCT01079130|7352174|FG002|Overall Study|Unsatisfactory therapeutic effect|0
4532822|NCT01079130|7352175|FG003|Overall Study|Unsatisfactory therapeutic effect|2
4532823|NCT01079130|7352176|FG004|Overall Study|Unsatisfactory therapeutic effect|0
4532824|NCT01079130|7352177|FG005|Overall Study|Unsatisfactory therapeutic effect|0
4532825|NCT01079130|7352172|FG000|Overall Study|Lost to Follow-up|0
4532826|NCT01079130|7352173|FG001|Overall Study|Lost to Follow-up|0
4532827|NCT01079130|7352174|FG002|Overall Study|Lost to Follow-up|0
4532828|NCT01079130|7352175|FG003|Overall Study|Lost to Follow-up|0
4532829|NCT01079130|7352176|FG004|Overall Study|Lost to Follow-up|1
4532830|NCT01079130|7352177|FG005|Overall Study|Lost to Follow-up|0
4532831|NCT01079182|7352212|FG000|Overall Study|Lost to Follow-up|1634
4532832|NCT01079182|7352212|FG000|Overall Study|Adverse Drug Reaction (ADR)|261
4532833|NCT01079182|7352212|FG000|Overall Study|Lack of Efficacy|514
4532834|NCT01079182|7352212|FG000|Overall Study|ADR and Lack of Effectiveness|39
4532835|NCT01079182|7352212|FG000|Overall Study|Reasons not Evaluated|271
4532836|NCT01079195|7352216|FG000|Overall Study|No Documentation of Tarka Therapy|739
4532837|NCT01079195|7352216|FG000|Overall Study|No Documentation Available|437
4532838|NCT01079195|7352216|FG000|Overall Study|Adverse Event|157
4532839|NCT01079195|7352216|FG000|Overall Study|Reason Unknown|39
4532840|NCT01079195|7352216|FG000|Overall Study|Withdrawal by Subject|18
4532841|NCT01079195|7352216|FG000|Overall Study|Financial Reasons|15
4532842|NCT01079195|7352216|FG000|Overall Study|Lack of Effectiveness|12
4532843|NCT01079195|7352216|FG000|Overall Study|Physician Decision|4
4532844|NCT01079195|7352216|FG000|Overall Study|Improved Status of Participant|4
4532845|NCT01079195|7352216|FG000|Overall Study|No Follow-up Documentation Available|4
4532846|NCT01079195|7352216|FG000|Overall Study|Non-compliance|2
4532847|NCT01079234|7352223|FG000|Main: Week 0 to 26|Adverse Event|5
4532848|NCT01079234|7352224|FG001|Main: Week 0 to 26|Adverse Event|4
4532849|NCT01079234|7352225|FG002|Main: Week 0 to 26|Adverse Event|1
4532850|NCT01079234|7352226|FG003|Main: Week 0 to 26|Adverse Event|0
4532851|NCT01079234|7352223|FG000|Main: Week 0 to 26|Lack of Efficacy|2
4532852|NCT01079234|7352224|FG001|Main: Week 0 to 26|Lack of Efficacy|1
4532853|NCT01079234|7352225|FG002|Main: Week 0 to 26|Lack of Efficacy|1
4532854|NCT01079234|7352226|FG003|Main: Week 0 to 26|Lack of Efficacy|0
4532855|NCT01079234|7352223|FG000|Main: Week 0 to 26|Protocol Violation|6
4532856|NCT01079234|7352224|FG001|Main: Week 0 to 26|Protocol Violation|2
4532857|NCT01079234|7352225|FG002|Main: Week 0 to 26|Protocol Violation|4
4532858|NCT01079234|7352226|FG003|Main: Week 0 to 26|Protocol Violation|0
4532859|NCT01079234|7352223|FG000|Main: Week 0 to 26|Withdrawal criteria|6
4532860|NCT01079234|7352224|FG001|Main: Week 0 to 26|Withdrawal criteria|6
4532861|NCT01079234|7352225|FG002|Main: Week 0 to 26|Withdrawal criteria|2
4532862|NCT01079234|7352226|FG003|Main: Week 0 to 26|Withdrawal criteria|0
4532863|NCT01079234|7352223|FG000|Main: Week 0 to 26|Unclassified|7
4532864|NCT01079234|7352224|FG001|Main: Week 0 to 26|Unclassified|13
4532865|NCT01079234|7352225|FG002|Main: Week 0 to 26|Unclassified|4
4532866|NCT01079234|7352226|FG003|Main: Week 0 to 26|Unclassified|0
4532867|NCT01079234|7352223|FG000|Extension: Week 27 to 52|Adverse Event|0
4532868|NCT01079234|7352224|FG001|Extension: Week 27 to 52|Adverse Event|0
4532869|NCT01079234|7352225|FG002|Extension: Week 27 to 52|Adverse Event|1
4532870|NCT01079234|7352226|FG003|Extension: Week 27 to 52|Adverse Event|0
4532871|NCT01079234|7352223|FG000|Extension: Week 27 to 52|Lack of Efficacy|0
4532872|NCT01079234|7352224|FG001|Extension: Week 27 to 52|Lack of Efficacy|0
4532873|NCT01079234|7352225|FG002|Extension: Week 27 to 52|Lack of Efficacy|0
4532874|NCT01079234|7352226|FG003|Extension: Week 27 to 52|Lack of Efficacy|2
4532875|NCT01079234|7352223|FG000|Extension: Week 27 to 52|Protocol Violation|0
4532876|NCT01079234|7352224|FG001|Extension: Week 27 to 52|Protocol Violation|0
4532877|NCT01079234|7352225|FG002|Extension: Week 27 to 52|Protocol Violation|2
4532878|NCT01079234|7352226|FG003|Extension: Week 27 to 52|Protocol Violation|5
4532879|NCT01079234|7352223|FG000|Extension: Week 27 to 52|Withdrawal criteria|0
4532880|NCT01079234|7352224|FG001|Extension: Week 27 to 52|Withdrawal criteria|0
4532881|NCT01079234|7352225|FG002|Extension: Week 27 to 52|Withdrawal criteria|4
4532882|NCT01079234|7352226|FG003|Extension: Week 27 to 52|Withdrawal criteria|2
4532883|NCT01079234|7352223|FG000|Extension: Week 27 to 52|Unclassified|0
4532884|NCT01079234|7352224|FG001|Extension: Week 27 to 52|Unclassified|0
4532885|NCT01079234|7352225|FG002|Extension: Week 27 to 52|Unclassified|4
4532886|NCT01079234|7352226|FG003|Extension: Week 27 to 52|Unclassified|7
4532887|NCT01079663|7352261|FG000|Overall Study|Adverse Event|0
4532888|NCT01079663|7352262|FG001|Overall Study|Adverse Event|2
4532889|NCT01079663|7352261|FG000|Overall Study|Protocol Violation|0
4532890|NCT01079663|7352262|FG001|Overall Study|Protocol Violation|2
4532891|NCT01079741|7352273|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
4532892|NCT01079741|7352274|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1
4532893|NCT01079741|7352275|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
4532894|NCT01079741|7352276|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
4532895|NCT01079741|7352277|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
4532896|NCT01079741|7352273|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
4532897|NCT01079741|7352274|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
4532898|NCT01079741|7352275|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
4532899|NCT01079741|7352276|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
4532900|NCT01079741|7352277|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3
4532901|NCT01079806|7352291|FG000|Day 1 to Week 96|Adverse Event|0
4532902|NCT01079806|7352292|FG001|Day 1 to Week 96|Adverse Event|3
4532903|NCT01079806|7352291|FG000|Day 1 to Week 96|Withdrawal by Subject|3
4532904|NCT01079806|7352292|FG001|Day 1 to Week 96|Withdrawal by Subject|2
4532905|NCT01079806|7352291|FG000|Day 1 to Week 96|Pregnancy|0
4532906|NCT01079806|7352292|FG001|Day 1 to Week 96|Pregnancy|1
4532907|NCT01079806|7352291|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2
4532908|NCT01079806|7352292|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0
4532909|NCT01079806|7352291|FG000|Day 1 to Week 96|Lost to Follow-up|1
4532910|NCT01079806|7352292|FG001|Day 1 to Week 96|Lost to Follow-up|0
4532911|NCT01079806|7352291|FG000|Day 1 to Week 96|Subject request to stop study treatment|1
4532912|NCT01079806|7352292|FG001|Day 1 to Week 96|Subject request to stop study treatment|0
4532913|NCT01079806|7352291|FG000|Day 1 to Week 96|Removal by Medical Monitor|0
4532914|NCT01079806|7352292|FG001|Day 1 to Week 96|Removal by Medical Monitor|1
4532915|NCT01079806|7352291|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13
4609875|NCT01691105|7466129|FG000|1 Month Follow-up|Lost to Follow-up|41
4609876|NCT01691105|7466130|FG001|1 Month Follow-up|Lost to Follow-up|38
4609877|NCT01691105|7466129|FG000|1 Month Follow-up|Death|2
4609878|NCT01691105|7466130|FG001|1 Month Follow-up|Death|3
4609879|NCT01691105|7466129|FG000|6 Month Follow-up|Lost to Follow-up|39
4609880|NCT01691105|7466130|FG001|6 Month Follow-up|Lost to Follow-up|58
4609881|NCT01691105|7466129|FG000|6 Month Follow-up|Death|13
4609882|NCT01691105|7466130|FG001|6 Month Follow-up|Death|13
4609883|NCT01691105|7466129|FG000|12 Month Follow-up|Lost to Follow-up|50
4609884|NCT01691105|7466130|FG001|12 Month Follow-up|Lost to Follow-up|71
4609885|NCT01691105|7466129|FG000|12 Month Follow-up|Death|22
4609886|NCT01691105|7466130|FG001|12 Month Follow-up|Death|30
4609887|NCT01691105|7466129|FG000|12 Month Biochemical Verification|Death|22
4609888|NCT01691105|7466130|FG001|12 Month Biochemical Verification|Death|30
4609889|NCT01691105|7466129|FG000|12 Month Biochemical Verification|Lost to Follow-up|50
4609890|NCT01691105|7466130|FG001|12 Month Biochemical Verification|Lost to Follow-up|71
4609891|NCT01691105|7466129|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352
4609892|NCT01691105|7466130|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401
4609893|NCT01691248|7466138|FG000|Overall Study|Protocol Violation|43
4609894|NCT01691248|7466139|FG001|Overall Study|Protocol Violation|27
4609895|NCT01691248|7466138|FG000|Overall Study|Adverse Event|24
4609896|NCT01691248|7466139|FG001|Overall Study|Adverse Event|22
4609897|NCT01691248|7466138|FG000|Overall Study|Withdrawal by Subject|20
4609898|NCT01691248|7466139|FG001|Overall Study|Withdrawal by Subject|18
4609899|NCT01691248|7466138|FG000|Overall Study|Confirmed CDAD|14
4609900|NCT01691248|7466139|FG001|Overall Study|Confirmed CDAD|31
4609901|NCT01691248|7466138|FG000|Overall Study|Lost to Follow-up|2
4609902|NCT01691248|7466139|FG001|Overall Study|Lost to Follow-up|5
4609903|NCT01691248|7466138|FG000|Overall Study|Reason not provided|4
4609904|NCT01691248|7466139|FG001|Overall Study|Reason not provided|4
4609905|NCT01691248|7466138|FG000|Overall Study|Not Treated|4
4609906|NCT01691248|7466139|FG001|Overall Study|Not Treated|7
4609907|NCT01691378|7466192|FG000|Overall Study|Withdrawal by Subject|2
4609908|NCT01691378|7466193|FG001|Overall Study|Withdrawal by Subject|0
4609909|NCT01691378|7466192|FG000|Overall Study|Lost to Follow-up|5
4609910|NCT01691378|7466193|FG001|Overall Study|Lost to Follow-up|2
4609911|NCT01691430|7466201|FG000|Overall Study|Death|17
4609912|NCT01691430|7466202|FG001|Overall Study|Death|16
4609913|NCT01691430|7466201|FG000|Overall Study|Withdrawal by Subject|5
4609914|NCT01691430|7466202|FG001|Overall Study|Withdrawal by Subject|1
4609915|NCT01691430|7466201|FG000|Overall Study|Lost to Follow-up|0
4532916|NCT01079806|7352292|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8
4590956|NCT01525602|7437230|FG005|Overall Study|Withdrawal by Subject|1
4609916|NCT01691430|7466202|FG001|Overall Study|Lost to Follow-up|3
4609917|NCT01691482|7466208|FG000|Treatment Period 2|Adverse Event|0
4609918|NCT01691482|7466209|FG001|Treatment Period 2|Adverse Event|1
4609919|NCT01691482|7466208|FG000|Treatment Period 2|Protocol Violation|1
4609920|NCT01691482|7466209|FG001|Treatment Period 2|Protocol Violation|1
4532917|NCT01079806|7352291|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0
4532918|NCT01079806|7352292|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1
4532919|NCT01079806|7352291|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6
4532920|NCT01079806|7352292|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6
4532921|NCT01079832|7352300|FG000|Overall Study|Withdrawal by Subject|1
4532922|NCT01079936|7352308|FG000|Phase I: MTD|First Remission Status|2
4532923|NCT01079936|7352309|FG001|Phase I: MTD|First Remission Status|0
4532924|NCT01079936|7352310|FG002|Phase I: MTD|First Remission Status|0
4532925|NCT01079936|7352311|FG003|Phase I: MTD|First Remission Status|0
4532926|NCT01079936|7352312|FG004|Phase I: MTD|First Remission Status|0
4532927|NCT01079936|7352308|FG000|Phase I: MTD|No Stem Cell Transplantation|2
4532928|NCT01079936|7352309|FG001|Phase I: MTD|No Stem Cell Transplantation|0
4532929|NCT01079936|7352310|FG002|Phase I: MTD|No Stem Cell Transplantation|0
4532930|NCT01079936|7352311|FG003|Phase I: MTD|No Stem Cell Transplantation|0
4532931|NCT01079936|7352312|FG004|Phase I: MTD|No Stem Cell Transplantation|0
4532932|NCT01079936|7352308|FG000|Phase II|Adverse Event|0
4532933|NCT01079936|7352309|FG001|Phase II|Adverse Event|0
4532934|NCT01079936|7352310|FG002|Phase II|Adverse Event|1
4532935|NCT01079936|7352311|FG003|Phase II|Adverse Event|0
4532936|NCT01079936|7352312|FG004|Phase II|Adverse Event|0
4532937|NCT01079936|7352308|FG000|Phase II|Insurance Issue|0
4532938|NCT01079936|7352309|FG001|Phase II|Insurance Issue|0
4532939|NCT01079936|7352310|FG002|Phase II|Insurance Issue|0
4532940|NCT01079936|7352311|FG003|Phase II|Insurance Issue|0
4532941|NCT01079936|7352312|FG004|Phase II|Insurance Issue|1
4532942|NCT01079949|7352325|FG000|Overall Study|Withdrawal before r-hCG administration|2
4532943|NCT01079949|7352326|FG001|Overall Study|Withdrawal before r-hCG administration|3
4532944|NCT01079949|7352325|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4
4532945|NCT01079949|7352326|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8
4532946|NCT01079949|7352325|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8
4532947|NCT01079949|7352326|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2
4532948|NCT01079949|7352325|FG000|Overall Study|Randomized but not treated|1
4532949|NCT01079949|7352326|FG001|Overall Study|Randomized but not treated|0
4532950|NCT01079962|7352334|FG000|Overall Study|Adverse Event|2
4532951|NCT01079962|7352335|FG001|Overall Study|Adverse Event|2
4532952|NCT01079962|7352334|FG000|Overall Study|Withdrawal by Subject|5
4532953|NCT01079962|7352335|FG001|Overall Study|Withdrawal by Subject|7
4532954|NCT01079962|7352334|FG000|Overall Study|Protocol Violation|2
4532955|NCT01079962|7352335|FG001|Overall Study|Protocol Violation|2
4532956|NCT01079962|7352334|FG000|Overall Study|No blood pressure (BP) control|3
4532957|NCT01079962|7352335|FG001|Overall Study|No blood pressure (BP) control|0
4532958|NCT01079962|7352334|FG000|Overall Study|Inclusion/exclusion criteria|1
4532959|NCT01079962|7352335|FG001|Overall Study|Inclusion/exclusion criteria|3
4532960|NCT01079962|7352334|FG000|Overall Study|Participant not returning for next visit|1
4532961|NCT01079962|7352335|FG001|Overall Study|Participant not returning for next visit|0
4532962|NCT01079962|7352334|FG000|Overall Study|Due to arrhythmia/bradycardia|1
4532963|NCT01079962|7352335|FG001|Overall Study|Due to arrhythmia/bradycardia|1
4532964|NCT01079988|7352346|FG000|Overall Study|Lost to Follow-up|0
4532965|NCT01079988|7352347|FG001|Overall Study|Lost to Follow-up|0
4532966|NCT01079988|7352348|FG002|Overall Study|Lost to Follow-up|0
4532967|NCT01079988|7352349|FG003|Overall Study|Lost to Follow-up|1
4532968|NCT01079988|7352350|FG004|Overall Study|Lost to Follow-up|0
4532969|NCT01079988|7352346|FG000|Overall Study|Lack of Efficacy|1
4532970|NCT01079988|7352347|FG001|Overall Study|Lack of Efficacy|0
4532971|NCT01079988|7352348|FG002|Overall Study|Lack of Efficacy|0
4532972|NCT01079988|7352349|FG003|Overall Study|Lack of Efficacy|0
4532973|NCT01079988|7352350|FG004|Overall Study|Lack of Efficacy|0
4532974|NCT01079988|7352346|FG000|Overall Study|Other|0
4532975|NCT01079988|7352347|FG001|Overall Study|Other|0
4532976|NCT01079988|7352348|FG002|Overall Study|Other|0
4532977|NCT01079988|7352349|FG003|Overall Study|Other|2
4532978|NCT01079988|7352350|FG004|Overall Study|Other|1
4532979|NCT01080131|7352375|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1
4532980|NCT01080131|7352376|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1
4532981|NCT01080131|7352375|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6
4532982|NCT01080131|7352376|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4
4532983|NCT01080131|7352375|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5
4532984|NCT01080131|7352376|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3
4532985|NCT01080131|7352375|FG000|Core Study (0- 12 Weeks)|Administrative problems|0
4532986|NCT01080131|7352376|FG001|Core Study (0- 12 Weeks)|Administrative problems|1
4532987|NCT01080131|7352375|FG000|Core Study (0- 12 Weeks)|Death|1
4532988|NCT01080131|7352376|FG001|Core Study (0- 12 Weeks)|Death|0
4532989|NCT01080131|7352375|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0
4532990|NCT01080131|7352376|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2
4532991|NCT01080131|7352375|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1
4532992|NCT01080131|7352376|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0
4532993|NCT01080131|7352375|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0
4532994|NCT01080131|7352376|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1
4532995|NCT01080131|7352375|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4
4532996|NCT01080131|7352376|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3
4532997|NCT01080131|7352375|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1
4532998|NCT01080131|7352376|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0
4532999|NCT01080131|7352375|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1
4533000|NCT01080131|7352376|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2
4533001|NCT01080131|7352375|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3
4533002|NCT01080131|7352376|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4
4533003|NCT01080131|7352375|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4
4533004|NCT01080131|7352376|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5
4533005|NCT01080300|7352450|FG000|Overall Study|Adverse Event|49
4533006|NCT01080300|7352451|FG001|Overall Study|Adverse Event|35
4533007|NCT01080300|7352450|FG000|Overall Study|Lack of Efficacy|12
4533008|NCT01080300|7352451|FG001|Overall Study|Lack of Efficacy|15
4533009|NCT01080300|7352450|FG000|Overall Study|Protocol Violation|7
4533010|NCT01080300|7352451|FG001|Overall Study|Protocol Violation|13
4533011|NCT01080300|7352450|FG000|Overall Study|Lost to Follow-up|10
4533012|NCT01080300|7352451|FG001|Overall Study|Lost to Follow-up|6
4533013|NCT01080300|7352450|FG000|Overall Study|Death|0
4533014|NCT01080300|7352451|FG001|Overall Study|Death|1
4533015|NCT01080300|7352450|FG000|Overall Study|Withdrawal by Subject|12
4533016|NCT01080300|7352451|FG001|Overall Study|Withdrawal by Subject|28
4533017|NCT01080300|7352450|FG000|Overall Study|Reasons not specified|4
4533018|NCT01080300|7352451|FG001|Overall Study|Reasons not specified|6
4533019|NCT01080326|7352459|FG000|Overall Study|Patient deterioration prior to procedure|3
4533020|NCT01080326|7352459|FG000|Overall Study|Surgeon decision|1
4533021|NCT01080391|7352465|FG000|Overall Study|Randomized but not treated|7
4533022|NCT01080391|7352466|FG001|Overall Study|Randomized but not treated|4
4533023|NCT01080625|7352475|FG000|Overall Study|Physician Decision|0
4533024|NCT01080625|7352476|FG001|Overall Study|Physician Decision|2
4533025|NCT01080625|7352477|FG002|Overall Study|Physician Decision|1
4533026|NCT01080716|7352502|FG000|Part 1|Physician Decision|1
4533027|NCT01080716|7352503|FG001|Part 1|Physician Decision|0
4533028|NCT01080716|7352504|FG002|Part 1|Physician Decision|0
4533029|NCT01080716|7352505|FG003|Part 1|Physician Decision|0
4533030|NCT01080807|7352538|FG000|Overall Study|Adverse Event|9
4533031|NCT01080807|7352539|FG001|Overall Study|Adverse Event|1
4533032|NCT01080807|7352538|FG000|Overall Study|Lack of Efficacy|0
4533033|NCT01080807|7352539|FG001|Overall Study|Lack of Efficacy|1
4533034|NCT01080807|7352538|FG000|Overall Study|Withdrawal by Subject|7
4533035|NCT01080807|7352539|FG001|Overall Study|Withdrawal by Subject|2
4533036|NCT01080807|7352538|FG000|Overall Study|Protocol Violation|7
4533037|NCT01080807|7352539|FG001|Overall Study|Protocol Violation|6
4533038|NCT01080807|7352538|FG000|Overall Study|Lost to Follow-up|6
4533039|NCT01080807|7352539|FG001|Overall Study|Lost to Follow-up|4
4533040|NCT01080807|7352538|FG000|Overall Study|Noncompliance with drug administration|1
4533041|NCT01080807|7352539|FG001|Overall Study|Noncompliance with drug administration|1
4533042|NCT01080807|7352538|FG000|Overall Study|Noncompliance to study procedures|1
4533043|NCT01080807|7352539|FG001|Overall Study|Noncompliance to study procedures|1
4533044|NCT01080807|7352538|FG000|Overall Study|Began working day shift|0
4533045|NCT01080807|7352539|FG001|Overall Study|Began working day shift|2
4533046|NCT01080807|7352538|FG000|Overall Study|Laid off or terminated from job|1
4533047|NCT01080807|7352539|FG001|Overall Study|Laid off or terminated from job|2
4533048|NCT01080807|7352538|FG000|Overall Study|Stopped working consistent night shifts|0
4533049|NCT01080807|7352539|FG001|Overall Study|Stopped working consistent night shifts|1
4533050|NCT01080807|7352538|FG000|Overall Study|Work schedule changing|1
4533051|NCT01080807|7352539|FG001|Overall Study|Work schedule changing|1
4533052|NCT01080807|7352538|FG000|Overall Study|Work schedule and travel|0
4533053|NCT01080807|7352539|FG001|Overall Study|Work schedule and travel|1
4533054|NCT01080807|7352538|FG000|Overall Study|Switched to first shift|1
4533055|NCT01080807|7352539|FG001|Overall Study|Switched to first shift|0
4533056|NCT01080807|7352538|FG000|Overall Study|Moved away without notifying center|1
4533057|NCT01080807|7352539|FG001|Overall Study|Moved away without notifying center|0
4533058|NCT01081132|7352574|FG000|Overall Study|Lack of Efficacy|25
4533059|NCT01081132|7352575|FG001|Overall Study|Lack of Efficacy|9
4533060|NCT01081132|7352574|FG000|Overall Study|Withdrawal by Subject|13
4533061|NCT01081132|7352575|FG001|Overall Study|Withdrawal by Subject|16
4533062|NCT01081132|7352574|FG000|Overall Study|Lost to Follow-up|4
4451675|NCT00520845|7238051|FG000|Overall Study|Alternative Therapy|1
4533063|NCT01081132|7352575|FG001|Overall Study|Lost to Follow-up|11
4533064|NCT01081132|7352574|FG000|Overall Study|Adverse Event|3
4533065|NCT01081132|7352575|FG001|Overall Study|Adverse Event|9
4533066|NCT01081132|7352574|FG000|Overall Study|Non Compliance|4
4533067|NCT01081132|7352575|FG001|Overall Study|Non Compliance|2
4533068|NCT01081132|7352574|FG000|Overall Study|Lack Of Compliance|0
4533069|NCT01081132|7352575|FG001|Overall Study|Lack Of Compliance|1
4533070|NCT01081132|7352574|FG000|Overall Study|Missed Visits|1
4533071|NCT01081132|7352575|FG001|Overall Study|Missed Visits|1
4533072|NCT01081132|7352574|FG000|Overall Study|Stopped Taking Meds|2
4533073|NCT01081132|7352575|FG001|Overall Study|Stopped Taking Meds|0
4533074|NCT01081132|7352574|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0
4533075|NCT01081132|7352575|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1
4533076|NCT01081132|7352574|FG000|Overall Study|Declined Taper Phase|0
4609921|NCT01691508|7466218|FG000|Overall Study|Adverse Event|3
4533077|NCT01081132|7352575|FG001|Overall Study|Declined Taper Phase|1
4533078|NCT01081132|7352574|FG000|Overall Study|Protocol Violation|3
4533079|NCT01081132|7352575|FG001|Overall Study|Protocol Violation|1
4533080|NCT01081145|7352581|FG000|Open-Label Phase|Lack of Efficacy|56
4533081|NCT01081145|7352582|FG001|Open-Label Phase|Lack of Efficacy|0
4533082|NCT01081145|7352581|FG000|Open-Label Phase|Response criteria not met|46
4533083|NCT01081145|7352582|FG001|Open-Label Phase|Response criteria not met|0
4533084|NCT01081145|7352581|FG000|Open-Label Phase|Adverse Event|42
4533085|NCT01081145|7352582|FG001|Open-Label Phase|Adverse Event|0
4533086|NCT01081145|7352581|FG000|Open-Label Phase|Withdrawal by Subject|41
4533087|NCT01081145|7352582|FG001|Open-Label Phase|Withdrawal by Subject|0
4533088|NCT01081145|7352581|FG000|Open-Label Phase|Other|12
4533089|NCT01081145|7352582|FG001|Open-Label Phase|Other|0
4609922|NCT01691508|7466219|FG001|Overall Study|Adverse Event|3
4609923|NCT01691508|7466218|FG000|Overall Study|Withdrawal by Subject|1
4609924|NCT01691508|7466219|FG001|Overall Study|Withdrawal by Subject|0
4609925|NCT01691521|7466228|FG000|Overall Study|Adverse Event|4
4609926|NCT01691521|7466229|FG001|Overall Study|Adverse Event|0
4609927|NCT01691521|7466230|FG002|Overall Study|Adverse Event|1
4609928|NCT01691521|7466228|FG000|Overall Study|Lack of Efficacy|1
4609929|NCT01691521|7466229|FG001|Overall Study|Lack of Efficacy|1
4609930|NCT01691521|7466230|FG002|Overall Study|Lack of Efficacy|2
4609931|NCT01691521|7466228|FG000|Overall Study|Protocol Violation|0
4609932|NCT01691521|7466229|FG001|Overall Study|Protocol Violation|3
4609933|NCT01691521|7466230|FG002|Overall Study|Protocol Violation|0
4609934|NCT01691521|7466228|FG000|Overall Study|Lost to Follow-up|0
4609935|NCT01691521|7466229|FG001|Overall Study|Lost to Follow-up|2
4609936|NCT01691521|7466230|FG002|Overall Study|Lost to Follow-up|2
4609937|NCT01691521|7466228|FG000|Overall Study|Physician Decision|2
4609938|NCT01691521|7466229|FG001|Overall Study|Physician Decision|1
4609939|NCT01691521|7466230|FG002|Overall Study|Physician Decision|0
4609940|NCT01691521|7466228|FG000|Overall Study|Withdrawal by Subject|5
4609941|NCT01691521|7466229|FG001|Overall Study|Withdrawal by Subject|9
4609942|NCT01691521|7466230|FG002|Overall Study|Withdrawal by Subject|4
4609943|NCT01691612|7466286|FG000|Overall Study|deemed ineligible after 1st visit|6
4609944|NCT01691612|7466286|FG000|Overall Study|Adverse Event|1
4609945|NCT01691768|7466304|FG000|Overall Study|Death|0
4609946|NCT01691768|7466305|FG001|Overall Study|Death|2
4609947|NCT01691768|7466304|FG000|Overall Study|Lost to Follow-up|4
4609948|NCT01691768|7466305|FG001|Overall Study|Lost to Follow-up|3
4609949|NCT01691768|7466304|FG000|Overall Study|Withdrawal by Subject|10
4609950|NCT01691768|7466305|FG001|Overall Study|Withdrawal by Subject|9
4609951|NCT01691768|7466304|FG000|Overall Study|Relocated|0
4609952|NCT01691768|7466305|FG001|Overall Study|Relocated|1
4609953|NCT01691768|7466304|FG000|Overall Study|Investigator decision|1
4609954|NCT01691768|7466305|FG001|Overall Study|Investigator decision|1
4609955|NCT01691781|7466314|FG000|Overall Study|Withdrawal by Subject|4
4609956|NCT01691781|7466315|FG001|Overall Study|Withdrawal by Subject|3
4609957|NCT01691781|7466314|FG000|Overall Study|Physician Decision|1
4609958|NCT01691781|7466315|FG001|Overall Study|Physician Decision|1
4609959|NCT01691781|7466314|FG000|Overall Study|Protocol Violation|2
4609960|NCT01691781|7466315|FG001|Overall Study|Protocol Violation|2
4609961|NCT01691781|7466314|FG000|Overall Study|Adverse Event|0
4609962|NCT01691781|7466315|FG001|Overall Study|Adverse Event|1
4609963|NCT01691794|7466324|FG000|Overall Study|Poor/Non-Compliance|1
4609964|NCT01691794|7466325|FG001|Overall Study|Poor/Non-Compliance|4
4609965|NCT01691794|7466326|FG002|Overall Study|Poor/Non-Compliance|1
4609966|NCT01691794|7466324|FG000|Overall Study|Death|0
4609967|NCT01691794|7466325|FG001|Overall Study|Death|0
4609968|NCT01691794|7466326|FG002|Overall Study|Death|1
4609969|NCT01691794|7466324|FG000|Overall Study|Lack of Efficacy|0
4609970|NCT01691794|7466325|FG001|Overall Study|Lack of Efficacy|7
4609971|NCT01691794|7466326|FG002|Overall Study|Lack of Efficacy|1
4609972|NCT01691794|7466324|FG000|Overall Study|Participant request to discontinue|0
4609973|NCT01691794|7466325|FG001|Overall Study|Participant request to discontinue|1
4609974|NCT01691794|7466326|FG002|Overall Study|Participant request to discontinue|0
4609975|NCT01691794|7466324|FG000|Overall Study|Adverse Event|0
4609976|NCT01691794|7466325|FG001|Overall Study|Adverse Event|1
4609977|NCT01691794|7466326|FG002|Overall Study|Adverse Event|1
4609978|NCT01691794|7466324|FG000|Overall Study|Completed Only first 24 weeks of study|0
4609979|NCT01691794|7466325|FG001|Overall Study|Completed Only first 24 weeks of study|2
4609980|NCT01691794|7466326|FG002|Overall Study|Completed Only first 24 weeks of study|3
4609981|NCT01691794|7466324|FG000|Overall Study|Did not complete first 24 weeks of study|0
4609982|NCT01691794|7466325|FG001|Overall Study|Did not complete first 24 weeks of study|3
4609983|NCT01691794|7466326|FG002|Overall Study|Did not complete first 24 weeks of study|3
4609984|NCT01691820|7466336|FG000|Overall Study|Consent withdrawal (not due to an AE)|9
4609985|NCT01691820|7466337|FG001|Overall Study|Consent withdrawal (not due to an AE)|15
4609986|NCT01691820|7466336|FG000|Overall Study|Migrated/moved from study area|7
4609987|NCT01691820|7466337|FG001|Overall Study|Migrated/moved from study area|4
4609988|NCT01691820|7466336|FG000|Overall Study|Lost to Follow-up|6
4533090|NCT01081145|7352581|FG000|Open-Label Phase|Lost to Follow-up|11
4533091|NCT01081145|7352582|FG001|Open-Label Phase|Lost to Follow-up|0
4533092|NCT01081145|7352581|FG000|Open-Label Phase|Protocol Violation|4
4533093|NCT01081145|7352582|FG001|Open-Label Phase|Protocol Violation|0
4533094|NCT01081145|7352581|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3
4533095|NCT01081145|7352582|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2
4533096|NCT01081145|7352581|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1
4533097|NCT01081145|7352582|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0
4533098|NCT01081145|7352581|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10
4533099|NCT01081145|7352582|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8
4533100|NCT01081145|7352581|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3
4533101|NCT01081145|7352582|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2
4533102|NCT01081145|7352581|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13
4533103|NCT01081145|7352582|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20
4533104|NCT01081145|7352581|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47
4533105|NCT01081145|7352582|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71
4533106|NCT01081145|7352581|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4
4533107|NCT01081145|7352582|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3
4533108|NCT01081249|7352590|FG000|Overall Study|Diagnosed with Bipolar Disorder|0
4533109|NCT01081249|7352591|FG001|Overall Study|Diagnosed with Bipolar Disorder|1
4590957|NCT01525602|7437231|FG006|Overall Study|Withdrawal by Subject|0
4590958|NCT01525602|7437232|FG007|Overall Study|Withdrawal by Subject|1
4590959|NCT01525602|7437225|FG000|Overall Study|Physician Decision|0
4590960|NCT01525602|7437226|FG001|Overall Study|Physician Decision|0
4590961|NCT01525602|7437227|FG002|Overall Study|Physician Decision|0
4590962|NCT01525602|7437228|FG003|Overall Study|Physician Decision|0
4590963|NCT01525602|7437229|FG004|Overall Study|Physician Decision|3
4590964|NCT01525602|7437230|FG005|Overall Study|Physician Decision|0
4590965|NCT01525602|7437231|FG006|Overall Study|Physician Decision|1
4590966|NCT01525602|7437232|FG007|Overall Study|Physician Decision|0
4590967|NCT01525602|7437225|FG000|Overall Study|Death|0
4590968|NCT01525602|7437226|FG001|Overall Study|Death|0
4590969|NCT01525602|7437227|FG002|Overall Study|Death|0
4590970|NCT01525602|7437228|FG003|Overall Study|Death|0
4590971|NCT01525602|7437229|FG004|Overall Study|Death|1
4590972|NCT01525602|7437230|FG005|Overall Study|Death|1
4590973|NCT01525602|7437231|FG006|Overall Study|Death|0
4590974|NCT01525602|7437232|FG007|Overall Study|Death|0
4590975|NCT01525602|7437225|FG000|Overall Study|Unqualified based on biopsy; not dosed|0
4590976|NCT01525602|7437226|FG001|Overall Study|Unqualified based on biopsy; not dosed|0
4590977|NCT01525602|7437227|FG002|Overall Study|Unqualified based on biopsy; not dosed|0
4590978|NCT01525602|7437228|FG003|Overall Study|Unqualified based on biopsy; not dosed|0
4590979|NCT01525602|7437229|FG004|Overall Study|Unqualified based on biopsy; not dosed|0
4590980|NCT01525602|7437230|FG005|Overall Study|Unqualified based on biopsy; not dosed|0
4590981|NCT01525602|7437231|FG006|Overall Study|Unqualified based on biopsy; not dosed|1
4590982|NCT01525602|7437232|FG007|Overall Study|Unqualified based on biopsy; not dosed|1
4590983|NCT01525615|7437260|FG000|Overall Study|Adverse Event|11
4590984|NCT01525615|7437261|FG001|Overall Study|Adverse Event|7
4590985|NCT01525615|7437262|FG002|Overall Study|Adverse Event|5
4590986|NCT01525615|7437260|FG000|Overall Study|Lost to Follow-up|1
4590987|NCT01525615|7437261|FG001|Overall Study|Lost to Follow-up|0
4590988|NCT01525615|7437262|FG002|Overall Study|Lost to Follow-up|0
4590989|NCT01525615|7437260|FG000|Overall Study|Withdrawal by Subject|1
4590990|NCT01525615|7437261|FG001|Overall Study|Withdrawal by Subject|0
4590991|NCT01525615|7437262|FG002|Overall Study|Withdrawal by Subject|0
4590992|NCT01525615|7437260|FG000|Overall Study|Other reason not described above|1
4590993|NCT01525615|7437261|FG001|Overall Study|Other reason not described above|0
4590994|NCT01525615|7437262|FG002|Overall Study|Other reason not described above|1
4590995|NCT01525628|7437275|FG000|Overall Study|Adverse Event|1
4590996|NCT01525628|7437276|FG001|Overall Study|Adverse Event|1
4590997|NCT01525628|7437277|FG002|Overall Study|Adverse Event|2
4590998|NCT01525628|7437278|FG003|Overall Study|Adverse Event|0
4590999|NCT01525628|7437279|FG004|Overall Study|Adverse Event|1
4591000|NCT01525628|7437275|FG000|Overall Study|Lack of Efficacy|0
4591001|NCT01525628|7437276|FG001|Overall Study|Lack of Efficacy|2
4591002|NCT01525628|7437277|FG002|Overall Study|Lack of Efficacy|2
4591003|NCT01525628|7437278|FG003|Overall Study|Lack of Efficacy|1
4591004|NCT01525628|7437279|FG004|Overall Study|Lack of Efficacy|2
4591005|NCT01525628|7437275|FG000|Overall Study|Protocol Violation|0
4591006|NCT01525628|7437276|FG001|Overall Study|Protocol Violation|0
4591007|NCT01525628|7437277|FG002|Overall Study|Protocol Violation|1
4591008|NCT01525628|7437278|FG003|Overall Study|Protocol Violation|0
4591009|NCT01525628|7437279|FG004|Overall Study|Protocol Violation|0
4591010|NCT01525628|7437275|FG000|Overall Study|Lost to Follow-up|1
4591011|NCT01525628|7437276|FG001|Overall Study|Lost to Follow-up|1
4591012|NCT01525628|7437277|FG002|Overall Study|Lost to Follow-up|0
4591013|NCT01525628|7437278|FG003|Overall Study|Lost to Follow-up|0
4591014|NCT01525628|7437279|FG004|Overall Study|Lost to Follow-up|0
4591015|NCT01525628|7437275|FG000|Overall Study|Withdrawal by Subject|0
4591016|NCT01525628|7437276|FG001|Overall Study|Withdrawal by Subject|1
4591017|NCT01525628|7437277|FG002|Overall Study|Withdrawal by Subject|0
4591018|NCT01525628|7437278|FG003|Overall Study|Withdrawal by Subject|0
4591019|NCT01525628|7437279|FG004|Overall Study|Withdrawal by Subject|0
4591020|NCT01525628|7437275|FG000|Overall Study|Other reason not defined above|0
4533110|NCT01081301|7352597|FG000|Overall Study|Bereaved|3
4533111|NCT01081301|7352597|FG000|Overall Study|Too busy|5
4533112|NCT01081301|7352597|FG000|Overall Study|Patient too ill|2
4533113|NCT01081301|7352597|FG000|Overall Study|Lost to Follow-up|4
4533114|NCT01081626|7352620|FG000|Overall Study|Dosing error|1
4533115|NCT01081626|7352621|FG001|Overall Study|Dosing error|1
4533116|NCT01081626|7352620|FG000|Overall Study|Missing Estradiol|25
4533117|NCT01081626|7352621|FG001|Overall Study|Missing Estradiol|28
4533118|NCT01081626|7352620|FG000|Overall Study|Low antral follicle count|1
4533119|NCT01081626|7352621|FG001|Overall Study|Low antral follicle count|0
4533120|NCT01081626|7352620|FG000|Overall Study|Overstimulation|0
4533121|NCT01081626|7352621|FG001|Overall Study|Overstimulation|1
4533122|NCT01081626|7352620|FG000|Overall Study|Lost to Follow-up|0
4533123|NCT01081626|7352621|FG001|Overall Study|Lost to Follow-up|1
4533124|NCT01081626|7352620|FG000|Overall Study|Other|33
4533125|NCT01081626|7352621|FG001|Overall Study|Other|30
4533126|NCT01081665|7352627|FG000|Overall Study|Death|41
4533127|NCT01081665|7352627|FG000|Overall Study|Lost to Follow-up|18
4533128|NCT01081665|7352627|FG000|Overall Study|Withdrawal by Subject|17
4533129|NCT01081665|7352627|FG000|Overall Study|Change of dialysis unit|10
4533130|NCT01081665|7352627|FG000|Overall Study|Regulation of iPTH|5
4689904|NCT02555722|7599420|FG000|Month 2|Withdrawal by Subject|3
4689905|NCT02555722|7599421|FG001|Month 2|Withdrawal by Subject|0
4689906|NCT02555722|7599420|FG000|Month 2|Lost to Follow-up|1
4533131|NCT01081665|7352627|FG000|Overall Study|Change in renal replacement therapy|2
4533132|NCT01081665|7352627|FG000|Overall Study|Adverse Event|1
4533133|NCT01081665|7352627|FG000|Overall Study|Lack of Efficacy|1
4533134|NCT01081678|7352635|FG000|Overall Study|Ineligibility Determined|0
4533135|NCT01081678|7352636|FG001|Overall Study|Ineligibility Determined|0
4533136|NCT01081678|7352637|FG002|Overall Study|Ineligibility Determined|1
4533137|NCT01081678|7352638|FG003|Overall Study|Ineligibility Determined|1
4689907|NCT02555722|7599421|FG001|Month 2|Lost to Follow-up|0
4689908|NCT02555878|7599452|FG000|Overall Study|Lost to Follow-up|2
4689909|NCT02555878|7599453|FG001|Overall Study|Lost to Follow-up|3
4689910|NCT02555878|7599452|FG000|Overall Study|Withdrawal by Subject|48
4689911|NCT02555878|7599453|FG001|Overall Study|Withdrawal by Subject|48
4689912|NCT02555878|7599452|FG000|Overall Study|Adverse Event|12
4689913|NCT02555878|7599453|FG001|Overall Study|Adverse Event|8
4689914|NCT02555878|7599452|FG000|Overall Study|Death|74
4689915|NCT02555878|7599453|FG001|Overall Study|Death|59
4689916|NCT02555878|7599452|FG000|Overall Study|Protocol Violation|1
4689917|NCT02555878|7599453|FG001|Overall Study|Protocol Violation|2
4689918|NCT02555878|7599452|FG000|Overall Study|Physician Decision|12
4689919|NCT02555878|7599453|FG001|Overall Study|Physician Decision|13
4689920|NCT02555878|7599452|FG000|Overall Study|Other|17
4689921|NCT02555878|7599453|FG001|Overall Study|Other|17
4689922|NCT02556138|7599478|FG000|Overall Study|Withdrawal by Subject|1
4689923|NCT02556177|7599484|FG000|Overall Study|Subjects did not complete all 4 visits|283
4689924|NCT02556177|7599485|FG001|Overall Study|Subjects did not complete all 4 visits|61
4533138|NCT01081678|7352635|FG000|Overall Study|Noncompliance|3
4533139|NCT01081678|7352636|FG001|Overall Study|Noncompliance|4
4533140|NCT01081678|7352637|FG002|Overall Study|Noncompliance|5
4533141|NCT01081678|7352638|FG003|Overall Study|Noncompliance|2
4533142|NCT01081678|7352635|FG000|Overall Study|Adverse Event|2
4533143|NCT01081678|7352636|FG001|Overall Study|Adverse Event|1
4533144|NCT01081678|7352637|FG002|Overall Study|Adverse Event|2
4533145|NCT01081678|7352638|FG003|Overall Study|Adverse Event|2
4533146|NCT01081678|7352635|FG000|Overall Study|Withdrawal by Subject|15
4533147|NCT01081678|7352636|FG001|Overall Study|Withdrawal by Subject|7
4533148|NCT01081678|7352637|FG002|Overall Study|Withdrawal by Subject|17
4533149|NCT01081678|7352638|FG003|Overall Study|Withdrawal by Subject|14
4533150|NCT01081678|7352635|FG000|Overall Study|Administrative Decision|1
4533151|NCT01081678|7352636|FG001|Overall Study|Administrative Decision|0
4533152|NCT01081678|7352637|FG002|Overall Study|Administrative Decision|0
4533153|NCT01081678|7352638|FG003|Overall Study|Administrative Decision|1
4533154|NCT01081678|7352635|FG000|Overall Study|Lost to Follow-up|4
4533155|NCT01081678|7352636|FG001|Overall Study|Lost to Follow-up|1
4533156|NCT01081678|7352637|FG002|Overall Study|Lost to Follow-up|4
4533157|NCT01081678|7352638|FG003|Overall Study|Lost to Follow-up|3
4533158|NCT01081678|7352635|FG000|Overall Study|Death|2
4533159|NCT01081678|7352636|FG001|Overall Study|Death|2
4533160|NCT01081678|7352637|FG002|Overall Study|Death|2
4533161|NCT01081678|7352638|FG003|Overall Study|Death|6
4533162|NCT01081678|7352635|FG000|Overall Study|Other|0
4533163|NCT01081678|7352636|FG001|Overall Study|Other|1
4533164|NCT01081678|7352637|FG002|Overall Study|Other|0
4533165|NCT01081678|7352638|FG003|Overall Study|Other|0
4533166|NCT01081769|7352650|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10
4689925|NCT02556203|7599493|FG000|Overall Study|Withdrawal by Subject|21
4689926|NCT02556203|7599494|FG001|Overall Study|Withdrawal by Subject|21
4689927|NCT02556203|7599493|FG000|Overall Study|Lost to Follow-up|5
4689928|NCT02556203|7599494|FG001|Overall Study|Lost to Follow-up|5
4533167|NCT01081769|7352651|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12
4533168|NCT01081769|7352650|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6
4533169|NCT01081769|7352651|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6
4533170|NCT01081769|7352650|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6
4533171|NCT01081769|7352651|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7
4533172|NCT01081769|7352650|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2
4533173|NCT01081769|7352651|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0
4533174|NCT01081769|7352650|FG000|CORE Intent-To-Treat|Adverse Event|14
4533175|NCT01081769|7352651|FG001|CORE Intent-To-Treat|Adverse Event|11
4533176|NCT01081769|7352650|FG000|CORE Intent-To-Treat|Death|1
4533177|NCT01081769|7352651|FG001|CORE Intent-To-Treat|Death|1
4533178|NCT01081769|7352650|FG000|CORE Intent-To-Treat|Lack of Efficacy|2
4533179|NCT01081769|7352651|FG001|CORE Intent-To-Treat|Lack of Efficacy|6
4533180|NCT01081769|7352650|FG000|CORE Intent-To-Treat|Lost to Follow-up|4
4533181|NCT01081769|7352651|FG001|CORE Intent-To-Treat|Lost to Follow-up|5
4533182|NCT01081769|7352650|FG000|CORE Intent-To-Treat|Pregnancy|1
4533183|NCT01081769|7352651|FG001|CORE Intent-To-Treat|Pregnancy|0
4533184|NCT01081769|7352650|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52
4533185|NCT01081769|7352651|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60
4533186|NCT01081769|7352650|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0
4533187|NCT01081769|7352651|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5
4533188|NCT01081769|7352650|FG000|CORE Intent-To-Treat|Other|0
4533189|NCT01081769|7352651|FG001|CORE Intent-To-Treat|Other|1
4533190|NCT01081769|7352650|FG000|CORE Intent-To-Treat|Ineligibility|3
4533191|NCT01081769|7352651|FG001|CORE Intent-To-Treat|Ineligibility|4
4533192|NCT01081769|7352650|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1
4533193|NCT01081769|7352651|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2
4533194|NCT01081769|7352650|FG000|CORE Intent-To-Treat|Patient Moved|2
4533195|NCT01081769|7352651|FG001|CORE Intent-To-Treat|Patient Moved|2
4533196|NCT01081795|7352660|FG000|Overall Study|Adverse Event|18
4533197|NCT01081795|7352661|FG001|Overall Study|Adverse Event|23
4533198|NCT01081795|7352662|FG002|Overall Study|Adverse Event|6
4533199|NCT01081795|7352660|FG000|Overall Study|Lack of Efficacy|7
4533200|NCT01081795|7352661|FG001|Overall Study|Lack of Efficacy|5
4533201|NCT01081795|7352662|FG002|Overall Study|Lack of Efficacy|19
4533202|NCT01081795|7352660|FG000|Overall Study|Subject's schedule|1
4533203|NCT01081795|7352661|FG001|Overall Study|Subject's schedule|1
4533204|NCT01081795|7352662|FG002|Overall Study|Subject's schedule|2
4533205|NCT01081795|7352660|FG000|Overall Study|Revocation of informed consent|2
4533206|NCT01081795|7352661|FG001|Overall Study|Revocation of informed consent|0
4533207|NCT01081795|7352662|FG002|Overall Study|Revocation of informed consent|0
4533208|NCT01081795|7352660|FG000|Overall Study|Ineligible for participation|1
4533209|NCT01081795|7352661|FG001|Overall Study|Ineligible for participation|0
4533210|NCT01081795|7352662|FG002|Overall Study|Ineligible for participation|0
4533211|NCT01081795|7352660|FG000|Overall Study|Use of a prohibited concomitant drug|1
4533212|NCT01081795|7352661|FG001|Overall Study|Use of a prohibited concomitant drug|1
4533213|NCT01081795|7352662|FG002|Overall Study|Use of a prohibited concomitant drug|1
4533214|NCT01081795|7352660|FG000|Overall Study|Using drug with restricted days of use|2
4533215|NCT01081795|7352661|FG001|Overall Study|Using drug with restricted days of use|3
4533216|NCT01081795|7352662|FG002|Overall Study|Using drug with restricted days of use|2
4533217|NCT01081795|7352660|FG000|Overall Study|Other|1
4533218|NCT01081795|7352661|FG001|Overall Study|Other|2
4533219|NCT01081795|7352662|FG002|Overall Study|Other|0
4533220|NCT01081834|7352675|FG000|Core Period: Baseline to Week 26|Pregnancy|1
4533221|NCT01081834|7352676|FG001|Core Period: Baseline to Week 26|Pregnancy|0
4533222|NCT01081834|7352677|FG002|Core Period: Baseline to Week 26|Pregnancy|0
4609989|NCT01691820|7466337|FG001|Overall Study|Lost to Follow-up|17
4533223|NCT01081834|7352678|FG003|Core Period: Baseline to Week 26|Pregnancy|0
4533224|NCT01081834|7352679|FG004|Core Period: Baseline to Week 26|Pregnancy|0
4533225|NCT01081834|7352675|FG000|Core Period: Baseline to Week 26|Adverse Event|2
4533226|NCT01081834|7352676|FG001|Core Period: Baseline to Week 26|Adverse Event|5
4533227|NCT01081834|7352677|FG002|Core Period: Baseline to Week 26|Adverse Event|3
4533228|NCT01081834|7352678|FG003|Core Period: Baseline to Week 26|Adverse Event|1
4533229|NCT01081834|7352679|FG004|Core Period: Baseline to Week 26|Adverse Event|1
4533230|NCT01081834|7352675|FG000|Core Period: Baseline to Week 26|Death|1
4533231|NCT01081834|7352676|FG001|Core Period: Baseline to Week 26|Death|0
4533232|NCT01081834|7352677|FG002|Core Period: Baseline to Week 26|Death|0
4533233|NCT01081834|7352678|FG003|Core Period: Baseline to Week 26|Death|0
4533234|NCT01081834|7352679|FG004|Core Period: Baseline to Week 26|Death|0
4533235|NCT01081834|7352675|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2
4533236|NCT01081834|7352676|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2
4533237|NCT01081834|7352677|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5
4533238|NCT01081834|7352678|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0
4533239|NCT01081834|7352679|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0
4609990|NCT01691820|7466336|FG000|Overall Study|Other (unspecified)|4
4533240|NCT01081834|7352675|FG000|Core Period: Baseline to Week 26|Protocol Violation|0
4533241|NCT01081834|7352676|FG001|Core Period: Baseline to Week 26|Protocol Violation|4
4533242|NCT01081834|7352677|FG002|Core Period: Baseline to Week 26|Protocol Violation|0
4533243|NCT01081834|7352678|FG003|Core Period: Baseline to Week 26|Protocol Violation|0
4533244|NCT01081834|7352679|FG004|Core Period: Baseline to Week 26|Protocol Violation|2
4533245|NCT01081834|7352675|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15
4533246|NCT01081834|7352676|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3
4533247|NCT01081834|7352677|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9
4533248|NCT01081834|7352678|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3
4533249|NCT01081834|7352679|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1
4533250|NCT01081834|7352675|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3
4533251|NCT01081834|7352676|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4
4533252|NCT01081834|7352677|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2
4533253|NCT01081834|7352678|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2
4533254|NCT01081834|7352679|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0
4533255|NCT01081834|7352675|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
4533256|NCT01081834|7352676|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
4533257|NCT01081834|7352677|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
4533258|NCT01081834|7352678|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
4533259|NCT01081834|7352679|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
4533260|NCT01081834|7352675|FG000|Core Period: Baseline to Week 26|Other|4
4533261|NCT01081834|7352676|FG001|Core Period: Baseline to Week 26|Other|4
4533262|NCT01081834|7352677|FG002|Core Period: Baseline to Week 26|Other|3
4533263|NCT01081834|7352678|FG003|Core Period: Baseline to Week 26|Other|1
4533264|NCT01081834|7352679|FG004|Core Period: Baseline to Week 26|Other|0
4533265|NCT01081834|7352675|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3
4533266|NCT01081834|7352676|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1
4533267|NCT01081834|7352677|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
4533268|NCT01081834|7352678|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
4533269|NCT01081834|7352679|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
4533270|NCT01081834|7352675|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1
4533271|NCT01081834|7352676|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0
4533272|NCT01081834|7352677|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0
4533273|NCT01081834|7352678|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0
4533274|NCT01081834|7352679|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0
4533275|NCT01081834|7352675|FG000|Extension Period: Week 26 to Week 52|Death|1
4533276|NCT01081834|7352676|FG001|Extension Period: Week 26 to Week 52|Death|0
4533277|NCT01081834|7352677|FG002|Extension Period: Week 26 to Week 52|Death|0
4533278|NCT01081834|7352678|FG003|Extension Period: Week 26 to Week 52|Death|0
4533279|NCT01081834|7352679|FG004|Extension Period: Week 26 to Week 52|Death|0
4533280|NCT01081834|7352675|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4
4533281|NCT01081834|7352676|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4
4533282|NCT01081834|7352677|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
4533283|NCT01081834|7352678|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
4533284|NCT01081834|7352679|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
4533285|NCT01081834|7352675|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0
4533286|NCT01081834|7352676|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1
4533287|NCT01081834|7352677|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0
4533288|NCT01081834|7352678|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0
4533289|NCT01081834|7352679|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0
4533290|NCT01081834|7352675|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
4533291|NCT01081834|7352676|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2
4533292|NCT01081834|7352677|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
4533293|NCT01081834|7352678|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
4533294|NCT01081834|7352679|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
4533295|NCT01081834|7352675|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
4533296|NCT01081834|7352676|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
4533297|NCT01081834|7352677|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
4533298|NCT01081834|7352678|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
4533299|NCT01081834|7352679|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
4533300|NCT01081834|7352675|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
4533301|NCT01081834|7352676|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4
4533302|NCT01081834|7352677|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
4533303|NCT01081834|7352678|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
4533304|NCT01081834|7352679|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
4689929|NCT02556203|7599493|FG000|Overall Study|Adverse Event|1
4689930|NCT02556203|7599494|FG001|Overall Study|Adverse Event|0
4689931|NCT02556255|7599500|FG000|Overall Study|Lost to Follow-up|4
4689932|NCT02556307|7599504|FG000|Overall Study|Premature treatment interruption|11
4689933|NCT02556307|7599504|FG000|Overall Study|Lost to Follow-up|36
4533305|NCT01081834|7352675|FG000|Extension Period: Week 26 to Week 52|Other|4
4533306|NCT01081834|7352676|FG001|Extension Period: Week 26 to Week 52|Other|5
4533307|NCT01081834|7352677|FG002|Extension Period: Week 26 to Week 52|Other|4
4689934|NCT02556307|7599504|FG000|Overall Study|Change to triple therapy|4
4533308|NCT01081834|7352678|FG003|Extension Period: Week 26 to Week 52|Other|0
4533309|NCT01081834|7352679|FG004|Extension Period: Week 26 to Week 52|Other|0
4533310|NCT01081834|7352675|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7
4533311|NCT01081834|7352676|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1
4533312|NCT01081834|7352677|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
4533313|NCT01081834|7352678|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
4533314|NCT01081834|7352679|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
4533315|NCT01081834|7352675|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0
4533316|NCT01081834|7352676|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1
4533317|NCT01081834|7352677|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0
4533318|NCT01081834|7352678|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0
4533319|NCT01081834|7352679|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0
4533320|NCT01081873|7352698|FG000|Overall Study|Death|86
4533321|NCT01081873|7352698|FG000|Overall Study|Withdrawal by Subject|10
4533322|NCT01081873|7352698|FG000|Overall Study|Lost to Follow-up|142
4533323|NCT01081873|7352698|FG000|Overall Study|Progression of prostate cancer|13
4533324|NCT01081873|7352698|FG000|Overall Study|Other|47
4533325|NCT01081912|7352727|FG000|Conversion/Titration|Adverse Event|47
4533326|NCT01081912|7352728|FG001|Conversion/Titration|Adverse Event|0
4533327|NCT01081912|7352729|FG002|Conversion/Titration|Adverse Event|0
4533328|NCT01081912|7352727|FG000|Conversion/Titration|Lack of Efficacy|17
4533329|NCT01081912|7352728|FG001|Conversion/Titration|Lack of Efficacy|0
4533330|NCT01081912|7352729|FG002|Conversion/Titration|Lack of Efficacy|0
4533331|NCT01081912|7352727|FG000|Conversion/Titration|Lost to Follow-up|5
4533332|NCT01081912|7352728|FG001|Conversion/Titration|Lost to Follow-up|0
4533333|NCT01081912|7352729|FG002|Conversion/Titration|Lost to Follow-up|0
4533334|NCT01081912|7352727|FG000|Conversion/Titration|Physician Decision|2
4533335|NCT01081912|7352728|FG001|Conversion/Titration|Physician Decision|0
4533336|NCT01081912|7352729|FG002|Conversion/Titration|Physician Decision|0
4533337|NCT01081912|7352727|FG000|Conversion/Titration|Protocol Violation|67
4533338|NCT01081912|7352728|FG001|Conversion/Titration|Protocol Violation|0
4533339|NCT01081912|7352729|FG002|Conversion/Titration|Protocol Violation|0
4533340|NCT01081912|7352727|FG000|Conversion/Titration|Withdrawal by Subject|23
4533341|NCT01081912|7352728|FG001|Conversion/Titration|Withdrawal by Subject|0
4533342|NCT01081912|7352729|FG002|Conversion/Titration|Withdrawal by Subject|0
4533343|NCT01081912|7352727|FG000|Conversion/Titration|Non-Compliance|47
4533344|NCT01081912|7352728|FG001|Conversion/Titration|Non-Compliance|0
4533345|NCT01081912|7352729|FG002|Conversion/Titration|Non-Compliance|0
4533346|NCT01081912|7352727|FG000|Maintenance Treatment|Adverse Event|0
4533347|NCT01081912|7352728|FG001|Maintenance Treatment|Adverse Event|2
4533348|NCT01081912|7352729|FG002|Maintenance Treatment|Adverse Event|12
4533349|NCT01081912|7352727|FG000|Maintenance Treatment|Lack of Efficacy|0
4533350|NCT01081912|7352728|FG001|Maintenance Treatment|Lack of Efficacy|14
4533351|NCT01081912|7352729|FG002|Maintenance Treatment|Lack of Efficacy|64
4533352|NCT01081912|7352727|FG000|Maintenance Treatment|Lost to Follow-up|0
4533353|NCT01081912|7352728|FG001|Maintenance Treatment|Lost to Follow-up|1
4533354|NCT01081912|7352729|FG002|Maintenance Treatment|Lost to Follow-up|0
4533355|NCT01081912|7352727|FG000|Maintenance Treatment|Physician Decision|0
4533356|NCT01081912|7352728|FG001|Maintenance Treatment|Physician Decision|0
4533357|NCT01081912|7352729|FG002|Maintenance Treatment|Physician Decision|1
4533358|NCT01081912|7352727|FG000|Maintenance Treatment|Protocol Violation|0
4533359|NCT01081912|7352728|FG001|Maintenance Treatment|Protocol Violation|1
4533360|NCT01081912|7352729|FG002|Maintenance Treatment|Protocol Violation|2
4533361|NCT01081912|7352727|FG000|Maintenance Treatment|Withdrawal by Subject|0
4533362|NCT01081912|7352728|FG001|Maintenance Treatment|Withdrawal by Subject|5
4533363|NCT01081912|7352729|FG002|Maintenance Treatment|Withdrawal by Subject|5
4533364|NCT01081912|7352727|FG000|Maintenance Treatment|Non-Compliance|0
4533365|NCT01081912|7352728|FG001|Maintenance Treatment|Non-Compliance|4
4533366|NCT01081912|7352729|FG002|Maintenance Treatment|Non-Compliance|7
4533367|NCT01081912|7352727|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0
4533368|NCT01081912|7352728|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0
4533369|NCT01081912|7352729|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1
4533370|NCT01082081|7352739|FG000|Overall Study|Lost to Follow-up|0
4533371|NCT01082081|7352740|FG001|Overall Study|Lost to Follow-up|0
4533372|NCT01082081|7352741|FG002|Overall Study|Lost to Follow-up|1
4533373|NCT01082081|7352739|FG000|Overall Study|Withdrawal by Subject|0
4533374|NCT01082081|7352740|FG001|Overall Study|Withdrawal by Subject|0
4533375|NCT01082081|7352741|FG002|Overall Study|Withdrawal by Subject|1
4533376|NCT01082081|7352739|FG000|Overall Study|Other Reason|0
4533377|NCT01082081|7352740|FG001|Overall Study|Other Reason|1
4533378|NCT01082081|7352741|FG002|Overall Study|Other Reason|0
4533379|NCT01082211|7352754|FG000|Overall Study|Protocol Violation|4
4533380|NCT01082211|7352754|FG000|Overall Study|No protocol treatment received|3
4533381|NCT01082328|7352761|FG000|Overall Study|Adverse Event|1
4533382|NCT01082367|7352767|FG000|Double-blind Period|Administrative problems|0
4533383|NCT01082367|7352768|FG001|Double-blind Period|Administrative problems|1
4533384|NCT01082367|7352767|FG000|Double-blind Period|Lack of Efficacy|5
4533385|NCT01082367|7352768|FG001|Double-blind Period|Lack of Efficacy|11
4533386|NCT01082367|7352767|FG000|Double-blind Period|Adverse Event|0
4533387|NCT01082367|7352768|FG001|Double-blind Period|Adverse Event|1
4533388|NCT01082367|7352767|FG000|Follow-up (F-U) Period|Administrative problems|1
4533389|NCT01082367|7352768|FG001|Follow-up (F-U) Period|Administrative problems|0
4533390|NCT01082367|7352767|FG000|Follow-up (F-U) Period|Abnormal lab values|1
4533391|NCT01082367|7352768|FG001|Follow-up (F-U) Period|Abnormal lab values|0
4533392|NCT01082367|7352767|FG000|Follow-up (F-U) Period|Adverse Event|0
4533393|NCT01082367|7352768|FG001|Follow-up (F-U) Period|Adverse Event|1
4533394|NCT01082614|7352797|FG000|Overall Study|Adverse Event|1
4533395|NCT01082614|7352798|FG001|Overall Study|Adverse Event|4
4533396|NCT01082614|7352797|FG000|Overall Study|Equipment Malfunction|0
4533397|NCT01082614|7352798|FG001|Overall Study|Equipment Malfunction|1
4533398|NCT01082614|7352797|FG000|Overall Study|Physician Decision|2
4533399|NCT01082614|7352798|FG001|Overall Study|Physician Decision|0
4533400|NCT01082640|7352807|FG000|Overall Study|Adverse Event|9
4533401|NCT01082640|7352808|FG001|Overall Study|Adverse Event|5
4533402|NCT01082640|7352809|FG002|Overall Study|Adverse Event|3
4533403|NCT01082640|7352807|FG000|Overall Study|Withdrawal by Subject|3
4609991|NCT01691820|7466337|FG001|Overall Study|Other (unspecified)|1
4609992|NCT01691859|7466360|FG000|Overall Study|Adverse Event|19
4609993|NCT01691859|7466360|FG000|Overall Study|Lack of Efficacy|11
4609994|NCT01691859|7466360|FG000|Overall Study|Protocol Violation|4
4609995|NCT01691859|7466360|FG000|Overall Study|Product commercially available|221
4609996|NCT01691859|7466360|FG000|Overall Study|Study closed/terminated|50
4609997|NCT01691859|7466360|FG000|Overall Study|Lost to Follow-up|5
4609998|NCT01691859|7466360|FG000|Overall Study|Physician Decision|6
4609999|NCT01691859|7466360|FG000|Overall Study|Withdrawal by Subject|31
4610000|NCT01691885|7466364|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1
4610001|NCT01691885|7466365|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1
4610002|NCT01691885|7466364|FG000|Washout Period (7-9 Days)|Adverse Event|0
4610003|NCT01691885|7466365|FG001|Washout Period (7-9 Days)|Adverse Event|1
4610004|NCT01691898|7466377|FG000|Overall Study|Death|34
4610005|NCT01691898|7466378|FG001|Overall Study|Death|32
4610006|NCT01691898|7466379|FG002|Overall Study|Death|6
4610007|NCT01691898|7466380|FG003|Overall Study|Death|3
4610008|NCT01691898|7466381|FG004|Overall Study|Death|8
4610009|NCT01691898|7466382|FG005|Overall Study|Death|31
4610010|NCT01691898|7466377|FG000|Overall Study|Adverse Event|0
4610011|NCT01691898|7466378|FG001|Overall Study|Adverse Event|1
4610012|NCT01691898|7466379|FG002|Overall Study|Adverse Event|0
4610013|NCT01691898|7466380|FG003|Overall Study|Adverse Event|1
4610014|NCT01691898|7466381|FG004|Overall Study|Adverse Event|1
4610015|NCT01691898|7466382|FG005|Overall Study|Adverse Event|0
4610016|NCT01691898|7466377|FG000|Overall Study|Progression of Disease|1
4610017|NCT01691898|7466378|FG001|Overall Study|Progression of Disease|2
4610018|NCT01691898|7466379|FG002|Overall Study|Progression of Disease|1
4610019|NCT01691898|7466380|FG003|Overall Study|Progression of Disease|0
4610020|NCT01691898|7466381|FG004|Overall Study|Progression of Disease|0
4610021|NCT01691898|7466382|FG005|Overall Study|Progression of Disease|1
4610022|NCT01691898|7466377|FG000|Overall Study|Lost to Follow-up|3
4610023|NCT01691898|7466378|FG001|Overall Study|Lost to Follow-up|1
4610024|NCT01691898|7466379|FG002|Overall Study|Lost to Follow-up|0
4610025|NCT01691898|7466380|FG003|Overall Study|Lost to Follow-up|0
4610026|NCT01691898|7466381|FG004|Overall Study|Lost to Follow-up|1
4610027|NCT01691898|7466382|FG005|Overall Study|Lost to Follow-up|0
4610028|NCT01691898|7466377|FG000|Overall Study|Withdrawal by Subject|9
4610029|NCT01691898|7466378|FG001|Overall Study|Withdrawal by Subject|8
4610030|NCT01691898|7466379|FG002|Overall Study|Withdrawal by Subject|2
4610031|NCT01691898|7466380|FG003|Overall Study|Withdrawal by Subject|1
4610032|NCT01691898|7466381|FG004|Overall Study|Withdrawal by Subject|3
4610033|NCT01691898|7466382|FG005|Overall Study|Withdrawal by Subject|3
4610034|NCT01691898|7466377|FG000|Overall Study|Non-Compliance|0
4610035|NCT01691898|7466378|FG001|Overall Study|Non-Compliance|0
4610036|NCT01691898|7466379|FG002|Overall Study|Non-Compliance|0
4610037|NCT01691898|7466380|FG003|Overall Study|Non-Compliance|0
4610038|NCT01691898|7466381|FG004|Overall Study|Non-Compliance|1
4610039|NCT01691898|7466382|FG005|Overall Study|Non-Compliance|0
4610040|NCT01692119|7466425|FG000|Overall Study|Protocol Violation|3
4610041|NCT01692119|7466426|FG001|Overall Study|Protocol Violation|1
4610042|NCT01692119|7466425|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17
4610043|NCT01692119|7466426|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0
4610044|NCT01692197|7466432|FG000|Overall Study|Failed Screening|3
4610045|NCT01692275|7466443|FG000|Overall Study|Lost to Follow-up|57
4610046|NCT01692275|7466444|FG001|Overall Study|Lost to Follow-up|48
4610047|NCT01692275|7466443|FG000|Overall Study|Withdrawal by Subject|9
4610048|NCT01692275|7466444|FG001|Overall Study|Withdrawal by Subject|11
4610049|NCT01692301|7466464|FG000|Overall Study|Adverse Event|15
4610050|NCT01692301|7466465|FG001|Overall Study|Adverse Event|12
4610051|NCT01692301|7466464|FG000|Overall Study|Death|1
4610052|NCT01692301|7466465|FG001|Overall Study|Death|2
4610053|NCT01692301|7466464|FG000|Overall Study|Lack of Efficacy|0
4610054|NCT01692301|7466465|FG001|Overall Study|Lack of Efficacy|5
4610055|NCT01692301|7466464|FG000|Overall Study|Non-compliance with study treatment|1
4610056|NCT01692301|7466465|FG001|Overall Study|Non-compliance with study treatment|2
4533404|NCT01082640|7352808|FG001|Overall Study|Withdrawal by Subject|3
4533405|NCT01082640|7352809|FG002|Overall Study|Withdrawal by Subject|2
4533406|NCT01082640|7352807|FG000|Overall Study|Major protocol deviation|3
4533407|NCT01082640|7352808|FG001|Overall Study|Major protocol deviation|3
4533408|NCT01082640|7352809|FG002|Overall Study|Major protocol deviation|0
4533409|NCT01082640|7352807|FG000|Overall Study|Lost to Follow-up|0
4533410|NCT01082640|7352808|FG001|Overall Study|Lost to Follow-up|3
4533411|NCT01082640|7352809|FG002|Overall Study|Lost to Follow-up|0
4533412|NCT01082640|7352807|FG000|Overall Study|Other|2
4533413|NCT01082640|7352808|FG001|Overall Study|Other|1
4533414|NCT01082640|7352809|FG002|Overall Study|Other|3
4533415|NCT01082874|7352824|FG000|Overall Study|Lost to Follow-up|10
4533416|NCT01082874|7352825|FG001|Overall Study|Lost to Follow-up|10
4533417|NCT01082874|7352826|FG002|Overall Study|Lost to Follow-up|6
4533418|NCT01082874|7352827|FG003|Overall Study|Lost to Follow-up|10
4533419|NCT01082874|7352824|FG000|Overall Study|Withdrawal by Subject|1
4533420|NCT01082874|7352825|FG001|Overall Study|Withdrawal by Subject|2
4533421|NCT01082874|7352826|FG002|Overall Study|Withdrawal by Subject|5
4533422|NCT01082874|7352827|FG003|Overall Study|Withdrawal by Subject|3
4533423|NCT01082965|7352852|FG000|Overall Study|Protocol Violation|0
4533424|NCT01082965|7352853|FG001|Overall Study|Protocol Violation|1
4533425|NCT01082965|7352852|FG000|Overall Study|Other|1
4533426|NCT01082965|7352853|FG001|Overall Study|Other|1
4533427|NCT01083121|7352859|FG000|Overall Study|Use of Humira outside the approved label|81
4533428|NCT01083160|7352867|FG000|Overall Study|Adverse Event|1
4533429|NCT01083173|7352871|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14
4533430|NCT01083173|7352872|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0
4533431|NCT01083173|7352871|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1
4533432|NCT01083173|7352872|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0
4533433|NCT01083173|7352871|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201
4533434|NCT01083173|7352872|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0
4533435|NCT01083173|7352871|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168
4533436|NCT01083173|7352872|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0
4533437|NCT01083173|7352871|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13
4533438|NCT01083173|7352872|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0
4533439|NCT01083173|7352871|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0
4533440|NCT01083173|7352872|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14
4533441|NCT01083173|7352871|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0
4533442|NCT01083173|7352872|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1
4533443|NCT01083173|7352871|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0
4533444|NCT01083173|7352872|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101
4533445|NCT01083173|7352871|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0
4533446|NCT01083173|7352872|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195
4533447|NCT01083173|7352871|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0
4533448|NCT01083173|7352872|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136
4533449|NCT01083173|7352871|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0
4533450|NCT01083173|7352872|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46
4533451|NCT01083186|7352881|FG000|Overall Study|Lost to Follow-up|48
4533452|NCT01083186|7352881|FG000|Overall Study|Consent Withdrawal|7
4533453|NCT01083186|7352881|FG000|Overall Study|Death|3
4533454|NCT01083186|7352881|FG000|Overall Study|Adverse Event|3
4533455|NCT01083186|7352881|FG000|Overall Study|Lack of Efficacy|2
4533456|NCT01083186|7352881|FG000|Overall Study|Hemodialysis Initiation|28
4533457|NCT01083186|7352881|FG000|Overall Study|Administrative Reasons|2
4533458|NCT01083186|7352881|FG000|Overall Study|Non-compliance to Study Treatment|1
4533459|NCT01083316|7352910|FG000|Overall Study|Adverse Event|2
4533460|NCT01083316|7352910|FG000|Overall Study|Withdrawal by Subject|1
4533461|NCT01083485|7352930|FG000|Overall Study|Adverse Event|0
4533462|NCT01083485|7352931|FG001|Overall Study|Adverse Event|1
4533463|NCT01083485|7352930|FG000|Overall Study|Protocol Violation|1
4533464|NCT01083485|7352931|FG001|Overall Study|Protocol Violation|0
4533465|NCT01083485|7352930|FG000|Overall Study|Withdrawal by Subject|5
4533466|NCT01083485|7352931|FG001|Overall Study|Withdrawal by Subject|2
4533467|NCT01083485|7352930|FG000|Overall Study|Other|1
4533468|NCT01083485|7352931|FG001|Overall Study|Other|0
4533469|NCT01083576|7352941|FG000|Overall Study|Treatment Failure|6
4533470|NCT01083576|7352942|FG001|Overall Study|Treatment Failure|1
4533471|NCT01083602|7352949|FG000|Overall Study|Adverse Event|11
4533472|NCT01083602|7352949|FG000|Overall Study|New Cancer Therapy|2
4533473|NCT01083602|7352949|FG000|Overall Study|Death|1
4533474|NCT01083602|7352949|FG000|Overall Study|Withdrawal by Subject|5
4533475|NCT01083602|7352949|FG000|Overall Study|Lack of Efficacy|36
4533476|NCT01083641|7352962|FG000|Overall Study|Withdrawal by Subject|2
4533477|NCT01083680|7352979|FG000|Overall Study|Lost to Follow-up|2758
4533478|NCT01083680|7352979|FG000|Overall Study|Withdrawal by Subject|1086
4533479|NCT01083693|7352986|FG000|Overall Study|Adverse Event|1
4533480|NCT01083693|7352987|FG001|Overall Study|Adverse Event|1
4533481|NCT01083693|7352988|FG002|Overall Study|Adverse Event|0
4533482|NCT01083693|7352986|FG000|Overall Study|Lost to Follow-up|2
4533483|NCT01083693|7352987|FG001|Overall Study|Lost to Follow-up|0
4533484|NCT01083693|7352988|FG002|Overall Study|Lost to Follow-up|2
4533485|NCT01083693|7352986|FG000|Overall Study|Lack of effectiveness|13
4533486|NCT01083693|7352987|FG001|Overall Study|Lack of effectiveness|2
4533487|NCT01083693|7352988|FG002|Overall Study|Lack of effectiveness|2
4533488|NCT01083693|7352986|FG000|Overall Study|Patient Moved|0
4533489|NCT01083693|7352987|FG001|Overall Study|Patient Moved|1
4533490|NCT01083693|7352988|FG002|Overall Study|Patient Moved|0
4533491|NCT01083693|7352986|FG000|Overall Study|Complete remission|0
4533492|NCT01083693|7352987|FG001|Overall Study|Complete remission|1
4533493|NCT01083693|7352988|FG002|Overall Study|Complete remission|0
4533494|NCT01083693|7352986|FG000|Overall Study|Other medical condition/surgery|1
4533495|NCT01083693|7352987|FG001|Overall Study|Other medical condition/surgery|1
4533496|NCT01083693|7352988|FG002|Overall Study|Other medical condition/surgery|0
4533497|NCT01083693|7352986|FG000|Overall Study|Withdrawal by Subject|3
4533498|NCT01083693|7352987|FG001|Overall Study|Withdrawal by Subject|0
4533499|NCT01083693|7352988|FG002|Overall Study|Withdrawal by Subject|2
4533500|NCT01083693|7352986|FG000|Overall Study|Reason unknown|0
4533501|NCT01083693|7352987|FG001|Overall Study|Reason unknown|0
4533502|NCT01083693|7352988|FG002|Overall Study|Reason unknown|1
4533503|NCT01083810|7353027|FG000|Overall Study|Lost to Follow-up|23
4533504|NCT01083810|7353028|FG001|Overall Study|Lost to Follow-up|11
4533505|NCT01083810|7353029|FG002|Overall Study|Lost to Follow-up|4
4533506|NCT01083810|7353027|FG000|Overall Study|Adverse Event|15
4533507|NCT01083810|7353028|FG001|Overall Study|Adverse Event|11
4533508|NCT01083810|7353029|FG002|Overall Study|Adverse Event|4
4533509|NCT01083810|7353027|FG000|Overall Study|Withdrawal by Subject|7
4533510|NCT01083810|7353028|FG001|Overall Study|Withdrawal by Subject|2
4533511|NCT01083810|7353029|FG002|Overall Study|Withdrawal by Subject|4
4533512|NCT01083810|7353027|FG000|Overall Study|Reason not reported|6
4533513|NCT01083810|7353028|FG001|Overall Study|Reason not reported|1
4533514|NCT01083810|7353029|FG002|Overall Study|Reason not reported|1
4533515|NCT01083810|7353027|FG000|Overall Study|Non-compliance|4
4533516|NCT01083810|7353028|FG001|Overall Study|Non-compliance|7
4533517|NCT01083810|7353029|FG002|Overall Study|Non-compliance|2
4533518|NCT01083810|7353027|FG000|Overall Study|Simplification|4
4533519|NCT01083810|7353028|FG001|Overall Study|Simplification|1
4533520|NCT01083810|7353029|FG002|Overall Study|Simplification|0
4533521|NCT01083810|7353027|FG000|Overall Study|Death|2
4533522|NCT01083810|7353028|FG001|Overall Study|Death|2
4533523|NCT01083810|7353029|FG002|Overall Study|Death|3
4533524|NCT01083810|7353027|FG000|Overall Study|Co-morbidities|1
4533525|NCT01083810|7353028|FG001|Overall Study|Co-morbidities|0
4533526|NCT01083810|7353029|FG002|Overall Study|Co-morbidities|0
4533527|NCT01083810|7353027|FG000|Overall Study|Participation in study|1
4533528|NCT01083810|7353028|FG001|Overall Study|Participation in study|0
4533529|NCT01083810|7353029|FG002|Overall Study|Participation in study|0
4533530|NCT01083810|7353027|FG000|Overall Study|Therapy break|1
4533531|NCT01083810|7353028|FG001|Overall Study|Therapy break|2
4533532|NCT01083810|7353029|FG002|Overall Study|Therapy break|2
4533533|NCT01083810|7353027|FG000|Overall Study|Virologic failure|1
4533534|NCT01083810|7353028|FG001|Overall Study|Virologic failure|8
4533535|NCT01083810|7353029|FG002|Overall Study|Virologic failure|0
4533536|NCT01084005|7353066|FG000|Overall Study|Adverse Event|1
4533537|NCT01084005|7353067|FG001|Overall Study|Adverse Event|8
4533538|NCT01084005|7353066|FG000|Overall Study|Protocol Violation|3
4533539|NCT01084005|7353067|FG001|Overall Study|Protocol Violation|7
4533540|NCT01084005|7353066|FG000|Overall Study|Withdrawal by Subject|1
4533541|NCT01084005|7353067|FG001|Overall Study|Withdrawal by Subject|1
4533542|NCT01084083|7353073|FG000|Overall Study|Adverse Event|5
4533543|NCT01084083|7353073|FG000|Overall Study|Death|1
4533544|NCT01084083|7353073|FG000|Overall Study|Withdrawal by Subject|2
4533545|NCT01084083|7353073|FG000|Overall Study|Complicating disease|1
4533546|NCT01084083|7353073|FG000|Overall Study|Other|2
4533547|NCT01084083|7353073|FG000|Overall Study|Never started assigned therapy|1
4533548|NCT01084135|7353082|FG000|20 Week|Physician Decision|0
4533549|NCT01084135|7353083|FG001|20 Week|Physician Decision|1
4533550|NCT01084174|7353104|FG000|Overall Study|gastrointestinal symptoms|1
4533551|NCT01084174|7353105|FG001|Overall Study|gastrointestinal symptoms|1
4533552|NCT01084174|7353104|FG000|Overall Study|Eosinophilic esophagitis|0
4533553|NCT01084174|7353105|FG001|Overall Study|Eosinophilic esophagitis|1
4533554|NCT01084174|7353104|FG000|Overall Study|Anaphylaxis|0
4533555|NCT01084174|7353105|FG001|Overall Study|Anaphylaxis|1
4533556|NCT01084174|7353104|FG000|Overall Study|Participant noncompliance|0
4533557|NCT01084174|7353105|FG001|Overall Study|Participant noncompliance|1
4533558|NCT01084239|7353113|FG000|28-Day Follow-up|Lost to Follow-up|4
4533559|NCT01084239|7353114|FG001|28-Day Follow-up|Lost to Follow-up|9
4533560|NCT01084538|7353158|FG000|Overall Study|Drug not available|30
4533561|NCT01084538|7353158|FG000|Overall Study|Adverse Event|9
4533562|NCT01084538|7353158|FG000|Overall Study|Kidney transplant|6
4533563|NCT01084538|7353158|FG000|Overall Study|Serious Adverse Event|3
4533564|NCT01084538|7353158|FG000|Overall Study|Lack of effectiveness|2
4533565|NCT01084538|7353158|FG000|Overall Study|Patient noncompliance|2
4533566|NCT01084538|7353158|FG000|Overall Study|Hyperphosphatemia|2
4533567|NCT01084538|7353158|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2
4533568|NCT01084538|7353158|FG000|Overall Study|Change of residence|2
4533569|NCT01084538|7353158|FG000|Overall Study|Over-suppression of parathyroid gland|2
4533570|NCT01084538|7353158|FG000|Overall Study|Reason unknown|8
4533571|NCT01084551|7353165|FG000|Overall Study|Adverse Event|2
4533572|NCT01084551|7353166|FG001|Overall Study|Adverse Event|9
4533573|NCT01084551|7353167|FG002|Overall Study|Adverse Event|4
4533574|NCT01084551|7353165|FG000|Overall Study|Lack of Efficacy|2
4533575|NCT01084551|7353166|FG001|Overall Study|Lack of Efficacy|0
4533576|NCT01084551|7353167|FG002|Overall Study|Lack of Efficacy|1
4533577|NCT01084551|7353165|FG000|Overall Study|Withdrawal by Subject|2
4533578|NCT01084551|7353166|FG001|Overall Study|Withdrawal by Subject|1
4533579|NCT01084551|7353167|FG002|Overall Study|Withdrawal by Subject|0
4533580|NCT01084551|7353165|FG000|Overall Study|Protocol Violation|2
4533581|NCT01084551|7353166|FG001|Overall Study|Protocol Violation|4
4533582|NCT01084551|7353167|FG002|Overall Study|Protocol Violation|0
4533583|NCT01084551|7353165|FG000|Overall Study|Lost to Follow-up|0
4533584|NCT01084551|7353166|FG001|Overall Study|Lost to Follow-up|0
4533585|NCT01084551|7353167|FG002|Overall Study|Lost to Follow-up|3
4533586|NCT01084551|7353165|FG000|Overall Study|Physician Decision|1
4533587|NCT01084551|7353166|FG001|Overall Study|Physician Decision|0
4533588|NCT01084551|7353167|FG002|Overall Study|Physician Decision|0
4533589|NCT01084603|7353175|FG000|Baseline|Withdrawal by Subject|2
4533590|NCT01084603|7353175|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1
4533591|NCT01084603|7353175|FG000|Nicorette® Gum|Withdrawal by Subject|1
4533592|NCT01084603|7353175|FG000|Oral Nicotine 1|Withdrawal by Subject|1
4533593|NCT01084603|7353175|FG000|Washout Period 4|Adverse Event|1
4533594|NCT01084655|7353191|FG000|Overall Study|Radiographic disease progression|3
4533595|NCT01084655|7353192|FG001|Overall Study|Radiographic disease progression|2
4533596|NCT01084655|7353193|FG002|Overall Study|Radiographic disease progression|8
4533597|NCT01084655|7353191|FG000|Overall Study|Withdrawal by Subject|1
4533598|NCT01084655|7353192|FG001|Overall Study|Withdrawal by Subject|0
4533599|NCT01084655|7353193|FG002|Overall Study|Withdrawal by Subject|4
4533600|NCT01084655|7353191|FG000|Overall Study|Adverse Event|2
4533601|NCT01084655|7353192|FG001|Overall Study|Adverse Event|1
4533602|NCT01084655|7353193|FG002|Overall Study|Adverse Event|2
4533603|NCT01084655|7353191|FG000|Overall Study|Other|0
4533604|NCT01084655|7353192|FG001|Overall Study|Other|3
4533605|NCT01084655|7353193|FG002|Overall Study|Other|2
4533606|NCT01084655|7353191|FG000|Overall Study|Symptomatic deterioration|0
4533607|NCT01084655|7353192|FG001|Overall Study|Symptomatic deterioration|0
4533608|NCT01084655|7353193|FG002|Overall Study|Symptomatic deterioration|2
4533609|NCT01084655|7353191|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0
4533610|NCT01084655|7353192|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0
4533611|NCT01084655|7353193|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1
4533612|NCT01084668|7353205|FG000|Overall Study|Lack of Efficacy|5
4533613|NCT01084668|7353205|FG000|Overall Study|Withdrawal by Subject|2
4533614|NCT01084668|7353205|FG000|Overall Study|Pregnancy|1
4533615|NCT01084668|7353205|FG000|Overall Study|Non-compliance|1
4533616|NCT01084694|7353213|FG000|Overall Study|Withdrawal by Subject|2
4533617|NCT01084694|7353214|FG001|Overall Study|Withdrawal by Subject|1
4533618|NCT01084694|7353213|FG000|Overall Study|Death|2
4533619|NCT01084694|7353214|FG001|Overall Study|Death|12
4533620|NCT01084694|7353213|FG000|Overall Study|eligibility not maintained|2
4533621|NCT01084694|7353214|FG001|Overall Study|eligibility not maintained|7
4533622|NCT01084707|7353228|FG000|Overall Study|Withdrawal by Subject|6
4533623|NCT01084772|7353246|FG000|Baseline|Withdrawal by Subject|7
4533624|NCT01084772|7353247|FG001|Baseline|Withdrawal by Subject|6
4533625|NCT01084772|7353246|FG000|3 Months|Death|1
4533626|NCT01084772|7353247|FG001|3 Months|Death|0
4533627|NCT01084772|7353246|FG000|3 Months|Study Termination|2
4533628|NCT01084772|7353247|FG001|3 Months|Study Termination|2
4533629|NCT01084772|7353246|FG000|1 Year|Withdrawal by Subject|0
4533630|NCT01084772|7353247|FG001|1 Year|Withdrawal by Subject|1
4533631|NCT01084772|7353246|FG000|1 Year|Lost to Follow-up|3
4533632|NCT01084772|7353247|FG001|1 Year|Lost to Follow-up|0
4533633|NCT01084772|7353246|FG000|1 Year|Study Termination|0
4533634|NCT01084772|7353247|FG001|1 Year|Study Termination|7
4533635|NCT01084772|7353246|FG000|2 Years|Withdrawal by Subject|1
4533636|NCT01084772|7353247|FG001|2 Years|Withdrawal by Subject|0
4533637|NCT01084772|7353246|FG000|2 Years|Lost to Follow-up|5
4533638|NCT01084772|7353247|FG001|2 Years|Lost to Follow-up|2
4533639|NCT01084772|7353246|FG000|2 Years|Study Termination|3
4533640|NCT01084772|7353247|FG001|2 Years|Study Termination|2
4533641|NCT01085045|7353262|FG000|Part A|Withdrawal by Subject|4
4533642|NCT01085045|7353262|FG000|Part A|Adverse Event|6
4533643|NCT01085045|7353262|FG000|Part A|Protocol Violation|1
4533644|NCT01085045|7353262|FG000|Part A|Protocol Specified Criteria|7
4533645|NCT01085045|7353262|FG000|Part B|Withdrawal by Subject|2
4533646|NCT01085045|7353262|FG000|Part B|Protocol Specified Criteria|6
4533647|NCT01085045|7353262|FG000|Part B|Lost to Follow-up|1
4533648|NCT01085045|7353262|FG000|Part B|Adverse Event|6
4533649|NCT01085136|7353282|FG000|Part A|Other Adverse event|223
4533650|NCT01085136|7353283|FG001|Part A|Other Adverse event|0
4533651|NCT01085136|7353284|FG002|Part A|Other Adverse event|0
4533652|NCT01085136|7353282|FG000|Part A|Protocol Violation|3
4533653|NCT01085136|7353283|FG001|Part A|Protocol Violation|0
4533654|NCT01085136|7353284|FG002|Part A|Protocol Violation|0
4533655|NCT01085136|7353282|FG000|Part A|Lost to Follow-up|3
4533656|NCT01085136|7353283|FG001|Part A|Lost to Follow-up|0
4533657|NCT01085136|7353284|FG002|Part A|Lost to Follow-up|0
4533658|NCT01085136|7353282|FG000|Part A|Refusal to continue trial medication|64
4533659|NCT01085136|7353283|FG001|Part A|Refusal to continue trial medication|0
4533660|NCT01085136|7353284|FG002|Part A|Refusal to continue trial medication|0
4533661|NCT01085136|7353282|FG000|Part A|Other reason not defined above|30
4533662|NCT01085136|7353283|FG001|Part A|Other reason not defined above|0
4533663|NCT01085136|7353284|FG002|Part A|Other reason not defined above|0
4533664|NCT01085136|7353282|FG000|Part B|Other AE|0
4533665|NCT01085136|7353283|FG001|Part B|Other AE|29
4533666|NCT01085136|7353284|FG002|Part B|Other AE|8
4533667|NCT01085136|7353282|FG000|Part B|Refusal to continue trial medication|0
4533668|NCT01085136|7353283|FG001|Part B|Refusal to continue trial medication|12
4533669|NCT01085136|7353284|FG002|Part B|Refusal to continue trial medication|7
4533670|NCT01085136|7353282|FG000|Part B|Not treated|0
4533671|NCT01085136|7353283|FG001|Part B|Not treated|4
4533672|NCT01085136|7353284|FG002|Part B|Not treated|8
4533673|NCT01085136|7353282|FG000|Part B|Other reason not defined above|0
4533674|NCT01085136|7353283|FG001|Part B|Other reason not defined above|6
4533675|NCT01085136|7353284|FG002|Part B|Other reason not defined above|3
4533676|NCT01085201|7353299|FG000|Overall Study|Scheduling conflict|1
4533677|NCT01085201|7353300|FG001|Overall Study|Scheduling conflict|0
4533678|NCT01085201|7353301|FG002|Overall Study|Scheduling conflict|1
4533679|NCT01085201|7353302|FG003|Overall Study|Scheduling conflict|0
4533680|NCT01085201|7353303|FG004|Overall Study|Scheduling conflict|0
4533681|NCT01085201|7353299|FG000|Overall Study|Unknown- no study drug|2
4533682|NCT01085201|7353300|FG001|Overall Study|Unknown- no study drug|0
4533683|NCT01085201|7353301|FG002|Overall Study|Unknown- no study drug|0
4533684|NCT01085201|7353302|FG003|Overall Study|Unknown- no study drug|0
4533685|NCT01085201|7353303|FG004|Overall Study|Unknown- no study drug|0
4533686|NCT01085201|7353299|FG000|Overall Study|Fond ineligible after consent|0
4533687|NCT01085201|7353300|FG001|Overall Study|Fond ineligible after consent|1
4533688|NCT01085201|7353301|FG002|Overall Study|Fond ineligible after consent|1
4533689|NCT01085201|7353302|FG003|Overall Study|Fond ineligible after consent|0
4533690|NCT01085201|7353303|FG004|Overall Study|Fond ineligible after consent|0
4533691|NCT01085214|7353320|FG000|Overall Study|Alternate treatment required|1
4533692|NCT01085357|7353352|FG000|Overall Study|Adverse Event|1
4533693|NCT01085357|7353353|FG001|Overall Study|Adverse Event|1
4533694|NCT01085357|7353352|FG000|Overall Study|Subject Decision|4
4533695|NCT01085357|7353353|FG001|Overall Study|Subject Decision|3
4533696|NCT01085357|7353352|FG000|Overall Study|Investigator Decision|1
4533697|NCT01085357|7353353|FG001|Overall Study|Investigator Decision|1
4533698|NCT01085357|7353352|FG000|Overall Study|Death|11
4533699|NCT01085357|7353353|FG001|Overall Study|Death|1
4533700|NCT01085357|7353352|FG000|Overall Study|Lost to Follow-up|2
4533701|NCT01085357|7353353|FG001|Overall Study|Lost to Follow-up|0
4533702|NCT01085591|7353384|FG000|Overall Study|Adverse Event|0
4533703|NCT01085591|7353385|FG001|Overall Study|Adverse Event|1
4533704|NCT01085591|7353386|FG002|Overall Study|Adverse Event|3
4533705|NCT01085591|7353384|FG000|Overall Study|Physician Decision|1
4533706|NCT01085591|7353385|FG001|Overall Study|Physician Decision|0
4533707|NCT01085591|7353386|FG002|Overall Study|Physician Decision|1
4533708|NCT01085591|7353384|FG000|Overall Study|Withdrawal by Subject|0
4533709|NCT01085591|7353385|FG001|Overall Study|Withdrawal by Subject|2
4533710|NCT01085591|7353386|FG002|Overall Study|Withdrawal by Subject|1
4533711|NCT01085591|7353384|FG000|Overall Study|Lost to Follow-up|0
4533712|NCT01085591|7353385|FG001|Overall Study|Lost to Follow-up|1
4533713|NCT01085591|7353386|FG002|Overall Study|Lost to Follow-up|1
4533714|NCT01085591|7353384|FG000|Overall Study|Protocol Violation|1
4533715|NCT01085591|7353385|FG001|Overall Study|Protocol Violation|1
4533716|NCT01085591|7353386|FG002|Overall Study|Protocol Violation|1
4533717|NCT01085591|7353384|FG000|Overall Study|Other|0
4533718|NCT01085591|7353385|FG001|Overall Study|Other|1
4533719|NCT01085591|7353386|FG002|Overall Study|Other|0
4533720|NCT01085591|7353384|FG000|Overall Study|Not Properly Consented|1
4533721|NCT01085591|7353385|FG001|Overall Study|Not Properly Consented|0
4533722|NCT01085591|7353386|FG002|Overall Study|Not Properly Consented|0
4533723|NCT01085630|7353397|FG000|Overall Study|Insufficient data|1
4533724|NCT01085630|7353398|FG001|Overall Study|Insufficient data|0
4533725|NCT01085630|7353397|FG000|Overall Study|Ineligible|3
4533726|NCT01085630|7353398|FG001|Overall Study|Ineligible|0
4533727|NCT01085682|7353406|FG000|Overall Study|Withdrawal by Subject|25
4533728|NCT01085682|7353407|FG001|Overall Study|Withdrawal by Subject|25
4533729|NCT01085734|7353415|FG000|Overall Study|Adverse Event|0
4533730|NCT01085734|7353416|FG001|Overall Study|Adverse Event|2
4533731|NCT01085734|7353415|FG000|Overall Study|Death|1
4533732|NCT01085734|7353416|FG001|Overall Study|Death|0
4533733|NCT01085734|7353415|FG000|Overall Study|Lost to Follow-up|0
4533734|NCT01085734|7353416|FG001|Overall Study|Lost to Follow-up|1
4533735|NCT01085734|7353415|FG000|Overall Study|Withdrawal by Subject|0
4533736|NCT01085734|7353416|FG001|Overall Study|Withdrawal by Subject|1
4533737|NCT01085812|7353449|FG000|Open-Label Period|Adverse Event|0
4533738|NCT01085812|7353450|FG001|Open-Label Period|Adverse Event|80
4533739|NCT01085812|7353449|FG000|Open-Label Period|Lack of Efficacy|0
4533740|NCT01085812|7353450|FG001|Open-Label Period|Lack of Efficacy|26
4533741|NCT01085812|7353449|FG000|Open-Label Period|Protocol Violation|0
4533742|NCT01085812|7353450|FG001|Open-Label Period|Protocol Violation|39
4533743|NCT01085812|7353449|FG000|Open-Label Period|Withdrawal by Subject|0
4533744|NCT01085812|7353450|FG001|Open-Label Period|Withdrawal by Subject|53
4533745|NCT01085812|7353449|FG000|Open-Label Period|Lost to Follow-up|0
4533746|NCT01085812|7353450|FG001|Open-Label Period|Lost to Follow-up|42
4533747|NCT01085812|7353449|FG000|Double-Blind Period|Adverse Event|3
4533748|NCT01085812|7353450|FG001|Double-Blind Period|Adverse Event|8
4533749|NCT01085812|7353449|FG000|Double-Blind Period|Protocol Violation|2
4533750|NCT01085812|7353450|FG001|Double-Blind Period|Protocol Violation|7
4533751|NCT01085812|7353449|FG000|Double-Blind Period|Withdrawal by Subject|11
4533752|NCT01085812|7353450|FG001|Double-Blind Period|Withdrawal by Subject|24
4533753|NCT01085812|7353449|FG000|Double-Blind Period|Lost to Follow-up|5
4533754|NCT01085812|7353450|FG001|Double-Blind Period|Lost to Follow-up|17
4533755|NCT01085812|7353449|FG000|Double-Blind Period|Other Reasons|0
4533756|NCT01085812|7353450|FG001|Double-Blind Period|Other Reasons|2
4533757|NCT01085812|7353449|FG000|Double-blind Intent-to-treat Population|Adverse Event|3
4533758|NCT01085812|7353450|FG001|Double-blind Intent-to-treat Population|Adverse Event|8
4533759|NCT01085812|7353449|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2
4533760|NCT01085812|7353450|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7
4533761|NCT01085812|7353449|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11
4533762|NCT01085812|7353450|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22
4533763|NCT01085812|7353449|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4
4533764|NCT01085812|7353450|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17
4533765|NCT01085812|7353449|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0
4533766|NCT01085812|7353450|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2
4533767|NCT01086033|7353498|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86
4533768|NCT01086033|7353498|FG000|Overall Study|Lost to Follow-up|86
4533769|NCT01086033|7353498|FG000|Overall Study|Adverse Event|42
4533770|NCT01086033|7353498|FG000|Overall Study|Withdrawal by Subject|41
4533771|NCT01086033|7353498|FG000|Overall Study|Other|14
4533772|NCT01086033|7353498|FG000|Overall Study|Other|13
4533773|NCT01086033|7353498|FG000|Overall Study|AE and Withdrew Consent|5
4533774|NCT01086033|7353498|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5
4533775|NCT01086033|7353498|FG000|Overall Study|Withdrew consent and Other Reason|4
4533776|NCT01086033|7353498|FG000|Overall Study|AE and Lack of Efficacy|4
4533777|NCT01086033|7353498|FG000|Overall Study|Death|1
4533778|NCT01086033|7353498|FG000|Overall Study|AE and Lost to Follow-up|1
4533779|NCT01086033|7353498|FG000|Overall Study|AE and Other Reason|1
4533780|NCT01086033|7353498|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1
4533781|NCT01086150|7353508|FG000|Overall Study|Withdrawal by Subject|0
4533782|NCT01086150|7353509|FG001|Overall Study|Withdrawal by Subject|4
4533783|NCT01086150|7353510|FG002|Overall Study|Withdrawal by Subject|1
4533784|NCT01086150|7353508|FG000|Overall Study|Lost to Follow-up|0
4533785|NCT01086150|7353509|FG001|Overall Study|Lost to Follow-up|1
4533786|NCT01086150|7353510|FG002|Overall Study|Lost to Follow-up|0
4533787|NCT01086150|7353508|FG000|Overall Study|Screen Failure|0
4533788|NCT01086150|7353509|FG001|Overall Study|Screen Failure|1
4533789|NCT01086150|7353510|FG002|Overall Study|Screen Failure|0
4533790|NCT01086215|7353522|FG000|Overall Study|Death|14
4533791|NCT01086215|7353523|FG001|Overall Study|Death|8
4533792|NCT01086215|7353524|FG002|Overall Study|Death|8
4533793|NCT01086215|7353525|FG003|Overall Study|Death|1
4533794|NCT01086215|7353522|FG000|Overall Study|Lost to Follow-up|22
4533795|NCT01086215|7353523|FG001|Overall Study|Lost to Follow-up|39
4533796|NCT01086215|7353524|FG002|Overall Study|Lost to Follow-up|18
4533797|NCT01086215|7353525|FG003|Overall Study|Lost to Follow-up|2
4533798|NCT01086358|7353539|FG000|First Intervention|Lost to Follow-up|9
4533799|NCT01086358|7353540|FG001|First Intervention|Lost to Follow-up|4
4533800|NCT01086358|7353539|FG000|First Intervention|Withdrawal by Subject|0
4533801|NCT01086358|7353540|FG001|First Intervention|Withdrawal by Subject|1
4533802|NCT01086358|7353539|FG000|Second Intervention|Lost to Follow-up|4
4533803|NCT01086358|7353540|FG001|Second Intervention|Lost to Follow-up|4
4533804|NCT01086384|7353548|FG000|2-week Run-in Period|Adverse Event|1
4533805|NCT01086384|7353549|FG001|2-week Run-in Period|Adverse Event|0
4533806|NCT01086384|7353550|FG002|2-week Run-in Period|Adverse Event|0
4533807|NCT01086384|7353548|FG000|2-week Run-in Period|Protocol Violation|1
4533808|NCT01086384|7353549|FG001|2-week Run-in Period|Protocol Violation|0
4533809|NCT01086384|7353550|FG002|2-week Run-in Period|Protocol Violation|0
4533810|NCT01086384|7353548|FG000|2-week Run-in Period|Lost to Follow-up|1
4533811|NCT01086384|7353549|FG001|2-week Run-in Period|Lost to Follow-up|0
4533812|NCT01086384|7353550|FG002|2-week Run-in Period|Lost to Follow-up|0
4533813|NCT01086384|7353548|FG000|2-week Run-in Period|Physician Decision|6
4533814|NCT01086384|7353549|FG001|2-week Run-in Period|Physician Decision|0
4533815|NCT01086384|7353550|FG002|2-week Run-in Period|Physician Decision|0
4533816|NCT01086384|7353548|FG000|2-week Run-in Period|Withdrawal by Subject|19
4533817|NCT01086384|7353549|FG001|2-week Run-in Period|Withdrawal by Subject|0
4533818|NCT01086384|7353550|FG002|2-week Run-in Period|Withdrawal by Subject|0
4533819|NCT01086384|7353548|FG000|2-week Run-in Period|Study Closed/Terminated|42
4533820|NCT01086384|7353549|FG001|2-week Run-in Period|Study Closed/Terminated|0
4533821|NCT01086384|7353550|FG002|2-week Run-in Period|Study Closed/Terminated|0
4533822|NCT01086384|7353548|FG000|2-week Run-in Period|Continuation Criteria Not Met|92
4533823|NCT01086384|7353549|FG001|2-week Run-in Period|Continuation Criteria Not Met|0
4533824|NCT01086384|7353550|FG002|2-week Run-in Period|Continuation Criteria Not Met|0
4533825|NCT01086384|7353548|FG000|2-week Run-in Period|Randomized in Error|1
4533826|NCT01086384|7353549|FG001|2-week Run-in Period|Randomized in Error|0
4533827|NCT01086384|7353550|FG002|2-week Run-in Period|Randomized in Error|0
4533828|NCT01086384|7353548|FG000|Treatment Period|Withdrawal by Subject|0
4533829|NCT01086384|7353549|FG001|Treatment Period|Withdrawal by Subject|53
4533830|NCT01086384|7353550|FG002|Treatment Period|Withdrawal by Subject|55
4533831|NCT01086384|7353548|FG000|Treatment Period|Protocol Violation|0
4533832|NCT01086384|7353549|FG001|Treatment Period|Protocol Violation|26
4533833|NCT01086384|7353550|FG002|Treatment Period|Protocol Violation|17
4533834|NCT01086384|7353548|FG000|Treatment Period|Lack of Efficacy|0
4533835|NCT01086384|7353549|FG001|Treatment Period|Lack of Efficacy|22
4533836|NCT01086384|7353550|FG002|Treatment Period|Lack of Efficacy|13
4533837|NCT01086384|7353548|FG000|Treatment Period|Adverse Event|0
4533838|NCT01086384|7353549|FG001|Treatment Period|Adverse Event|19
4533839|NCT01086384|7353550|FG002|Treatment Period|Adverse Event|15
4533840|NCT01086384|7353548|FG000|Treatment Period|Lost to Follow-up|0
4533841|NCT01086384|7353549|FG001|Treatment Period|Lost to Follow-up|11
4533842|NCT01086384|7353550|FG002|Treatment Period|Lost to Follow-up|9
4533843|NCT01086384|7353548|FG000|Treatment Period|Physician Decision|0
4533844|NCT01086384|7353549|FG001|Treatment Period|Physician Decision|9
4533845|NCT01086384|7353550|FG002|Treatment Period|Physician Decision|6
4533846|NCT01086384|7353548|FG000|Treatment Period|Study Closed/Terminated|0
4533847|NCT01086384|7353549|FG001|Treatment Period|Study Closed/Terminated|7
4533848|NCT01086384|7353550|FG002|Treatment Period|Study Closed/Terminated|8
4533849|NCT01086384|7353548|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0
4533850|NCT01086384|7353549|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0
4533851|NCT01086384|7353550|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1
4533852|NCT01086384|7353548|FG000|Treatment Period|Received Treatment in Error|0
4533853|NCT01086384|7353549|FG001|Treatment Period|Received Treatment in Error|1
4533854|NCT01086384|7353550|FG002|Treatment Period|Received Treatment in Error|0
4533855|NCT01086410|7353560|FG000|Overall Study|Adverse Event|1
4533856|NCT01086410|7353561|FG001|Overall Study|Adverse Event|0
4533857|NCT01086410|7353562|FG002|Overall Study|Adverse Event|0
4533858|NCT01086410|7353563|FG003|Overall Study|Adverse Event|2
4533859|NCT01086410|7353560|FG000|Overall Study|Lack of Efficacy|1
4533860|NCT01086410|7353561|FG001|Overall Study|Lack of Efficacy|1
4533861|NCT01086410|7353562|FG002|Overall Study|Lack of Efficacy|0
4533862|NCT01086410|7353563|FG003|Overall Study|Lack of Efficacy|0
4533863|NCT01086410|7353560|FG000|Overall Study|Protocol Violation|1
4533864|NCT01086410|7353561|FG001|Overall Study|Protocol Violation|1
4533865|NCT01086410|7353562|FG002|Overall Study|Protocol Violation|0
4533866|NCT01086410|7353563|FG003|Overall Study|Protocol Violation|0
4533867|NCT01086410|7353560|FG000|Overall Study|Lost to Follow-up|0
4533868|NCT01086410|7353561|FG001|Overall Study|Lost to Follow-up|0
4533869|NCT01086410|7353562|FG002|Overall Study|Lost to Follow-up|1
4533870|NCT01086410|7353563|FG003|Overall Study|Lost to Follow-up|0
4533871|NCT01086423|7353576|FG000|Overall Study|Protocol Violation|0
4533872|NCT01086423|7353577|FG001|Overall Study|Protocol Violation|0
4533873|NCT01086423|7353578|FG002|Overall Study|Protocol Violation|1
4533874|NCT01086423|7353576|FG000|Overall Study|Migrated/moved from study area|2
4533875|NCT01086423|7353577|FG001|Overall Study|Migrated/moved from study area|0
4533876|NCT01086423|7353578|FG002|Overall Study|Migrated/moved from study area|4
4533877|NCT01086423|7353576|FG000|Overall Study|Adverse event, fatal|1
4533878|NCT01086423|7353577|FG001|Overall Study|Adverse event, fatal|1
4533879|NCT01086423|7353578|FG002|Overall Study|Adverse event, fatal|0
4533880|NCT01086423|7353576|FG000|Overall Study|Adverse event, non-fatal|2
4533881|NCT01086423|7353577|FG001|Overall Study|Adverse event, non-fatal|1
4533882|NCT01086423|7353578|FG002|Overall Study|Adverse event, non-fatal|0
4533883|NCT01086423|7353576|FG000|Overall Study|Withdrawal by Subject|5
4533884|NCT01086423|7353577|FG001|Overall Study|Withdrawal by Subject|1
4533885|NCT01086423|7353578|FG002|Overall Study|Withdrawal by Subject|3
4533886|NCT01086423|7353576|FG000|Overall Study|Lost to Follow-up|0
4533887|NCT01086423|7353577|FG001|Overall Study|Lost to Follow-up|0
4533888|NCT01086423|7353578|FG002|Overall Study|Lost to Follow-up|1
4533889|NCT01086540|7353597|FG000|Overall Study|Death|3
4533890|NCT01086540|7353598|FG001|Overall Study|Death|1
4533891|NCT01086540|7353597|FG000|Overall Study|Physician Decision|2
4533892|NCT01086540|7353598|FG001|Overall Study|Physician Decision|1
4533893|NCT01086540|7353597|FG000|Overall Study|Addition of new therapy for PAH|1
4533894|NCT01086540|7353598|FG001|Overall Study|Addition of new therapy for PAH|0
4533895|NCT01086969|7353645|FG000|Overall Study|Withdrawal by Subject|1
4533896|NCT01086969|7353646|FG001|Overall Study|Withdrawal by Subject|2
4533897|NCT01086969|7353647|FG002|Overall Study|Withdrawal by Subject|0
4591021|NCT01525628|7437276|FG001|Overall Study|Other reason not defined above|0
4591022|NCT01525628|7437277|FG002|Overall Study|Other reason not defined above|0
4591023|NCT01525628|7437278|FG003|Overall Study|Other reason not defined above|3
4533898|NCT01087489|7353655|FG000|Overall Study|enrolled in another VA study|0
4533899|NCT01087489|7353656|FG001|Overall Study|enrolled in another VA study|1
4533900|NCT01087489|7353655|FG000|Overall Study|Death|0
4533901|NCT01087489|7353656|FG001|Overall Study|Death|1
4533902|NCT01087489|7353655|FG000|Overall Study|unable to survey by telephone|0
4533903|NCT01087489|7353656|FG001|Overall Study|unable to survey by telephone|1
4533904|NCT01087502|7353664|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5
4533905|NCT01087502|7353665|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4
4533906|NCT01087502|7353664|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1
4533907|NCT01087502|7353665|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1
4533908|NCT01087502|7353664|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1
4533909|NCT01087502|7353665|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1
4533910|NCT01087502|7353664|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1
4533911|NCT01087502|7353665|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0
4533912|NCT01087502|7353664|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1
4533913|NCT01087502|7353665|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2
4533914|NCT01087502|7353664|FG000|Up to Final Analysis (Week 52)|Adverse Event|17
4533915|NCT01087502|7353665|FG001|Up to Final Analysis (Week 52)|Adverse Event|10
4533916|NCT01087502|7353664|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1
4533917|NCT01087502|7353665|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2
4533918|NCT01087502|7353664|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4
4533919|NCT01087502|7353665|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0
4533920|NCT01087502|7353664|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2
4533921|NCT01087502|7353665|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0
4533922|NCT01087502|7353664|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3
4533923|NCT01087502|7353665|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2
4533924|NCT01087502|7353664|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1
4533925|NCT01087502|7353665|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5
4533926|NCT01087502|7353664|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5
4533927|NCT01087502|7353665|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4
4533928|NCT01087528|7353673|FG000|Overall Study|Withdrawal by Subject|1
4533929|NCT01087528|7353673|FG000|Overall Study|Incomplete CE procedure|6
4533930|NCT01087723|7353690|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0
4533931|NCT01087723|7353691|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1
4533932|NCT01087723|7353690|FG000|Overall Study|Withdrawal by Subject|10
4533933|NCT01087723|7353691|FG001|Overall Study|Withdrawal by Subject|13
4533934|NCT01087723|7353690|FG000|Overall Study|Physician Decision|2
4533935|NCT01087723|7353691|FG001|Overall Study|Physician Decision|0
4533936|NCT01087723|7353690|FG000|Overall Study|Lost to Follow-up|1
4533937|NCT01087723|7353691|FG001|Overall Study|Lost to Follow-up|4
4533938|NCT01087723|7353690|FG000|Overall Study|Reason Not Specified|1
4533939|NCT01087723|7353691|FG001|Overall Study|Reason Not Specified|2
4533940|NCT01087736|7353699|FG000|Overall Study|Lost to Follow-up|1
4533941|NCT01087736|7353700|FG001|Overall Study|Lost to Follow-up|0
4533942|NCT01087736|7353699|FG000|Overall Study|Death|0
4533943|NCT01087736|7353700|FG001|Overall Study|Death|1
4533944|NCT01087736|7353699|FG000|Overall Study|Withdrawal by Subject|0
4533945|NCT01087736|7353700|FG001|Overall Study|Withdrawal by Subject|1
4533946|NCT01087762|7353709|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2
4533947|NCT01087762|7353710|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
4533948|NCT01087762|7353711|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3
4533949|NCT01087762|7353712|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
4533950|NCT01087762|7353713|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
4533951|NCT01087762|7353709|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6
4533952|NCT01087762|7353710|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0
4533953|NCT01087762|7353711|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1
4533954|NCT01087762|7353712|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0
4533955|NCT01087762|7353713|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0
4533956|NCT01087762|7353709|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1
4533957|NCT01087762|7353710|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2
4533958|NCT01087762|7353711|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1
4533959|NCT01087762|7353712|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0
4533960|NCT01087762|7353713|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0
4533961|NCT01087762|7353709|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1
4533962|NCT01087762|7353710|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2
4533963|NCT01087762|7353711|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1
4533964|NCT01087762|7353712|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0
4533965|NCT01087762|7353713|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0
4533966|NCT01087762|7353709|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2
4533967|NCT01087762|7353710|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2
4533968|NCT01087762|7353711|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3
4533969|NCT01087762|7353712|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0
4533970|NCT01087762|7353713|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0
4533971|NCT01087762|7353709|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
4533972|NCT01087762|7353710|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
4533973|NCT01087762|7353711|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
4533974|NCT01087762|7353712|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4
4533975|NCT01087762|7353713|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14
4533976|NCT01087762|7353709|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0
4533977|NCT01087762|7353710|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0
4533978|NCT01087762|7353711|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0
4610057|NCT01692301|7466464|FG000|Overall Study|Protocol deviation|9
4610058|NCT01692301|7466465|FG001|Overall Study|Protocol deviation|2
4610059|NCT01692301|7466464|FG000|Overall Study|Patient/guardian decision|16
4610060|NCT01692301|7466465|FG001|Overall Study|Patient/guardian decision|15
4610061|NCT01692301|7466464|FG000|Overall Study|Technical problems|0
4610062|NCT01692301|7466465|FG001|Overall Study|Technical problems|1
4610063|NCT01692301|7466464|FG000|Overall Study|Physician Decision|2
4610064|NCT01692301|7466465|FG001|Overall Study|Physician Decision|2
4610065|NCT01692301|7466464|FG000|Overall Study|Lost to Follow-up|1
4610066|NCT01692301|7466465|FG001|Overall Study|Lost to Follow-up|1
4610067|NCT01692626|7466489|FG000|Overall Study|Death|0
4610068|NCT01692626|7466490|FG001|Overall Study|Death|1
4610069|NCT01692626|7466489|FG000|Overall Study|Adverse Event|2
4610070|NCT01692626|7466490|FG001|Overall Study|Adverse Event|3
4610071|NCT01692626|7466489|FG000|Overall Study|Protocol Violation|1
4610072|NCT01692626|7466490|FG001|Overall Study|Protocol Violation|2
4610073|NCT01692626|7466489|FG000|Overall Study|Withdrawal by Subject|1
4610074|NCT01692626|7466490|FG001|Overall Study|Withdrawal by Subject|0
4610075|NCT01692730|7466497|FG000|Overall Study|Lost to Follow-up|225
4610076|NCT01692730|7466498|FG001|Overall Study|Lost to Follow-up|227
4610077|NCT01692782|7466537|FG000|Overall Study|Adverse Event|12
4610078|NCT01692782|7466538|FG001|Overall Study|Adverse Event|32
4610079|NCT01692782|7466539|FG002|Overall Study|Adverse Event|2
4610080|NCT01692782|7466537|FG000|Overall Study|Lack of Efficacy|1
4610081|NCT01692782|7466538|FG001|Overall Study|Lack of Efficacy|2
4610082|NCT01692782|7466539|FG002|Overall Study|Lack of Efficacy|0
4610083|NCT01692782|7466537|FG000|Overall Study|Lost to Follow-up|2
4610084|NCT01692782|7466538|FG001|Overall Study|Lost to Follow-up|7
4610085|NCT01692782|7466539|FG002|Overall Study|Lost to Follow-up|1
4610086|NCT01692782|7466537|FG000|Overall Study|Pregnancy|1
4610087|NCT01692782|7466538|FG001|Overall Study|Pregnancy|0
4610088|NCT01692782|7466539|FG002|Overall Study|Pregnancy|0
4610089|NCT01692782|7466537|FG000|Overall Study|Protocol Violation|1
4610090|NCT01692782|7466538|FG001|Overall Study|Protocol Violation|0
4610091|NCT01692782|7466539|FG002|Overall Study|Protocol Violation|2
4610092|NCT01692782|7466537|FG000|Overall Study|Non-complance with study drug|0
4610093|NCT01692782|7466538|FG001|Overall Study|Non-complance with study drug|4
4610094|NCT01692782|7466539|FG002|Overall Study|Non-complance with study drug|1
4610095|NCT01692782|7466537|FG000|Overall Study|Non-compliant with study visits|0
4610096|NCT01692782|7466538|FG001|Overall Study|Non-compliant with study visits|0
4610097|NCT01692782|7466539|FG002|Overall Study|Non-compliant with study visits|1
4610098|NCT01692782|7466537|FG000|Overall Study|SAE not related to study drug|0
4610099|NCT01692782|7466538|FG001|Overall Study|SAE not related to study drug|1
4610100|NCT01692782|7466539|FG002|Overall Study|SAE not related to study drug|0
4610101|NCT01692782|7466537|FG000|Overall Study|Withdrawal by Subject|3
4610102|NCT01692782|7466538|FG001|Overall Study|Withdrawal by Subject|10
4610103|NCT01692782|7466539|FG002|Overall Study|Withdrawal by Subject|3
4610104|NCT01692938|7466549|FG000|Overall Study|Protocol Deviation|1
4610105|NCT01692938|7466550|FG001|Overall Study|Protocol Deviation|1
4610106|NCT01692938|7466549|FG000|Overall Study|Study completed prior to site completion|3
4610107|NCT01692938|7466550|FG001|Overall Study|Study completed prior to site completion|3
4533979|NCT01087762|7353712|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1
4533980|NCT01087762|7353713|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1
4533981|NCT01087762|7353709|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
4533982|NCT01087762|7353710|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
4533983|NCT01087762|7353711|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
4533984|NCT01087762|7353712|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5
4610108|NCT01693029|7466580|FG000|Overall Study|Withdrawal by Subject|15
4610109|NCT01693029|7466581|FG001|Overall Study|Withdrawal by Subject|22
4610110|NCT01693029|7466580|FG000|Overall Study|Kidney transplantation|7
4610111|NCT01693029|7466581|FG001|Overall Study|Kidney transplantation|7
4610112|NCT01693029|7466580|FG000|Overall Study|Bindinging anti-EPO antibodies|6
4610113|NCT01693029|7466581|FG001|Overall Study|Bindinging anti-EPO antibodies|2
4610114|NCT01693029|7466580|FG000|Overall Study|Protocol Violation|6
4610115|NCT01693029|7466581|FG001|Overall Study|Protocol Violation|7
4610116|NCT01693029|7466580|FG000|Overall Study|Change in dialysis modality|2
4610117|NCT01693029|7466581|FG001|Overall Study|Change in dialysis modality|1
4610118|NCT01693029|7466580|FG000|Overall Study|Physician Decision|0
4610119|NCT01693029|7466581|FG001|Overall Study|Physician Decision|2
4610120|NCT01693029|7466580|FG000|Overall Study|Lost to Follow-up|0
4610121|NCT01693029|7466581|FG001|Overall Study|Lost to Follow-up|1
4610122|NCT01693029|7466580|FG000|Overall Study|Adverse Event|1
4610123|NCT01693029|7466581|FG001|Overall Study|Adverse Event|6
4610124|NCT01693029|7466580|FG000|Overall Study|Death|5
4610125|NCT01693029|7466581|FG001|Overall Study|Death|8
4610126|NCT01693029|7466580|FG000|Overall Study|Non-compliance|2
4533985|NCT01087762|7353713|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2
4533986|NCT01087762|7353709|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
4533987|NCT01087762|7353710|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
4533988|NCT01087762|7353711|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
4533989|NCT01087762|7353712|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22
4533990|NCT01087762|7353713|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15
4533991|NCT01087762|7353709|FG000|Open-Label Period (Weeks 48-204)|Other|0
4533992|NCT01087762|7353710|FG001|Open-Label Period (Weeks 48-204)|Other|0
4533993|NCT01087762|7353711|FG002|Open-Label Period (Weeks 48-204)|Other|0
4533994|NCT01087762|7353712|FG003|Open-Label Period (Weeks 48-204)|Other|2
4533995|NCT01087762|7353713|FG004|Open-Label Period (Weeks 48-204)|Other|4
4533996|NCT01087762|7353709|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
4533997|NCT01087762|7353710|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
4533998|NCT01087762|7353711|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
4533999|NCT01087762|7353712|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7
4534000|NCT01087762|7353713|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4
4534001|NCT01087762|7353709|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
4534002|NCT01087762|7353710|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
4534003|NCT01087762|7353711|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
4534004|NCT01087762|7353712|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16
4534005|NCT01087762|7353713|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13
4534006|NCT01087762|7353709|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
4534007|NCT01087762|7353710|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
4534008|NCT01087762|7353711|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
4534009|NCT01087762|7353712|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2
4534010|NCT01087762|7353713|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4
4534011|NCT01087775|7353723|FG000|Overall Study|failed inclusion criteria|2
4534012|NCT01087788|7353731|FG000|24-weeks Double-blind Period|Lack of Efficacy|2
4534013|NCT01087788|7353732|FG001|24-weeks Double-blind Period|Lack of Efficacy|0
4534014|NCT01087788|7353733|FG002|24-weeks Double-blind Period|Lack of Efficacy|1
4534015|NCT01087788|7353731|FG000|24-weeks Double-blind Period|Protocol Violation|0
4534016|NCT01087788|7353732|FG001|24-weeks Double-blind Period|Protocol Violation|1
4534017|NCT01087788|7353733|FG002|24-weeks Double-blind Period|Protocol Violation|0
4534018|NCT01087788|7353731|FG000|24-weeks Double-blind Period|Lost to Follow-up|4
4534019|NCT01087788|7353732|FG001|24-weeks Double-blind Period|Lost to Follow-up|1
4534020|NCT01087788|7353733|FG002|24-weeks Double-blind Period|Lost to Follow-up|1
4534021|NCT01087788|7353731|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7
4534022|NCT01087788|7353732|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2
4534023|NCT01087788|7353733|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5
4534024|NCT01087788|7353731|FG000|24-weeks Double-blind Period|AE, serious fatal|0
4534025|NCT01087788|7353732|FG001|24-weeks Double-blind Period|AE, serious fatal|1
4534026|NCT01087788|7353733|FG002|24-weeks Double-blind Period|AE, serious fatal|1
4534027|NCT01087788|7353731|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0
4534028|NCT01087788|7353732|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2
4534029|NCT01087788|7353733|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3
4534030|NCT01087788|7353731|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2
4689935|NCT02556307|7599504|FG000|Overall Study|Enrolled but not treated|2
4689936|NCT02556632|7599533|FG000|Overall Study|Lost to Follow-up|1
4689937|NCT02556632|7599534|FG001|Overall Study|Lost to Follow-up|0
4689938|NCT02556632|7599535|FG002|Overall Study|Lost to Follow-up|0
4689939|NCT02556632|7599533|FG000|Overall Study|Disliked Intervention|1
4689940|NCT02556632|7599534|FG001|Overall Study|Disliked Intervention|1
4689941|NCT02556632|7599535|FG002|Overall Study|Disliked Intervention|1
4689942|NCT02556632|7599533|FG000|Overall Study|No Reason|1
4689943|NCT02556632|7599534|FG001|Overall Study|No Reason|0
4689944|NCT02556632|7599535|FG002|Overall Study|No Reason|1
4689945|NCT02556632|7599533|FG000|Overall Study|Personal Issues|0
4689946|NCT02556632|7599534|FG001|Overall Study|Personal Issues|1
4689947|NCT02556632|7599535|FG002|Overall Study|Personal Issues|1
4689948|NCT02556632|7599533|FG000|Overall Study|Changed Mind|0
4689949|NCT02556632|7599534|FG001|Overall Study|Changed Mind|1
4689950|NCT02556632|7599535|FG002|Overall Study|Changed Mind|0
4534031|NCT01087788|7353732|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1
4534032|NCT01087788|7353733|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2
4534033|NCT01087788|7353731|FG000|24-weeks Double-blind Period|AE, unknown type|0
4534034|NCT01087788|7353732|FG001|24-weeks Double-blind Period|AE, unknown type|0
4534035|NCT01087788|7353733|FG002|24-weeks Double-blind Period|AE, unknown type|1
4534036|NCT01087788|7353731|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1
4534037|NCT01087788|7353732|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0
4534038|NCT01087788|7353733|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0
4534039|NCT01087788|7353731|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0
4534040|NCT01087788|7353732|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1
4689951|NCT02556632|7599533|FG000|Overall Study|Withdrew (Unrelated Medical)|1
4737564|NCT03614078|7687792|FG002|Overall Study|Withdrawal by Subject|3
4534041|NCT01087788|7353733|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0
4534042|NCT01087788|7353731|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0
4534043|NCT01087788|7353732|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1
4534044|NCT01087788|7353733|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0
4534045|NCT01087788|7353731|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0
4534046|NCT01087788|7353732|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0
4534047|NCT01087788|7353733|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1
4534048|NCT01087788|7353731|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0
4534049|NCT01087788|7353732|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2
4534050|NCT01087788|7353733|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1
4534051|NCT01087788|7353731|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1
4534052|NCT01087788|7353732|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0
4534053|NCT01087788|7353733|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1
4534054|NCT01087788|7353731|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1
4534055|NCT01087788|7353732|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0
4534056|NCT01087788|7353733|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0
4534057|NCT01087788|7353731|FG000|24-weeks Dose-blind Period|AE, serious fatal|0
4534058|NCT01087788|7353732|FG001|24-weeks Dose-blind Period|AE, serious fatal|1
4534059|NCT01087788|7353733|FG002|24-weeks Dose-blind Period|AE, serious fatal|0
4534060|NCT01087788|7353731|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2
4534061|NCT01087788|7353732|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1
4534062|NCT01087788|7353733|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2
4534063|NCT01087788|7353731|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2
4534064|NCT01087788|7353732|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1
4534065|NCT01087788|7353733|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1
4534066|NCT01087788|7353731|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1
4534067|NCT01087788|7353732|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0
4534068|NCT01087788|7353733|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0
4534069|NCT01087788|7353731|FG000|24-weeks Dose-blind Period|Patient moved|0
4534070|NCT01087788|7353732|FG001|24-weeks Dose-blind Period|Patient moved|0
4534071|NCT01087788|7353733|FG002|24-weeks Dose-blind Period|Patient moved|1
4534072|NCT01087788|7353731|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4
4534073|NCT01087788|7353732|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2
4534074|NCT01087788|7353733|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3
4534075|NCT01087788|7353731|FG000|Open-Label Period (OL-P)|Protocol Violation|2
4534076|NCT01087788|7353732|FG001|Open-Label Period (OL-P)|Protocol Violation|1
4534077|NCT01087788|7353733|FG002|Open-Label Period (OL-P)|Protocol Violation|0
4534078|NCT01087788|7353731|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0
4534079|NCT01087788|7353732|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4
4610127|NCT01693029|7466581|FG001|Overall Study|Non-compliance|1
4610128|NCT01693068|7466589|FG000|Randomization Period|On-study|2
4610129|NCT01693068|7466590|FG001|Randomization Period|On-study|5
4610130|NCT01693068|7466591|FG002|Randomization Period|On-study|0
4610131|NCT01693068|7466589|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0
4610132|NCT01693068|7466590|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0
4610133|NCT01693068|7466591|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1
4610134|NCT01693120|7466599|FG000|Enrollment|Lost to Follow-up|1
4610135|NCT01693120|7466599|FG000|Enrollment|Withdrawal by Subject|10
4610136|NCT01693120|7466599|FG000|Enrollment|Protocol Violation|46
4610137|NCT01693120|7466599|FG000|Enrollment|Physician Decision|3
4610138|NCT01693120|7466599|FG000|Enrollment|Adverse Event|1
4610139|NCT01693120|7466599|FG000|Enrollment|Study closed|8
4610140|NCT01693120|7466599|FG000|Enrollment|Other|1
4610141|NCT01693120|7466599|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1
4610142|NCT01693120|7466599|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5
4610143|NCT01693120|7466599|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3
4610144|NCT01693120|7466599|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1
4610145|NCT01693120|7466599|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7
4610146|NCT01693185|7466605|FG000|Overall Study|diagnostic procedure after colonoscopy|0
4610147|NCT01693185|7466606|FG001|Overall Study|diagnostic procedure after colonoscopy|6
4610148|NCT01693250|7466614|FG000|Overall Study|Lost to Follow-up|2
4610149|NCT01693250|7466615|FG001|Overall Study|Lost to Follow-up|2
4610150|NCT01693523|7466626|FG000|Overall Study|Adverse Event|2
4610151|NCT01693523|7466627|FG001|Overall Study|Adverse Event|1
4610152|NCT01693523|7466628|FG002|Overall Study|Adverse Event|0
4610153|NCT01693523|7466626|FG000|Overall Study|Death|0
4610154|NCT01693523|7466627|FG001|Overall Study|Death|1
4610155|NCT01693523|7466628|FG002|Overall Study|Death|1
4610156|NCT01693523|7466626|FG000|Overall Study|Lost to Follow-up|0
4610157|NCT01693523|7466627|FG001|Overall Study|Lost to Follow-up|0
4610158|NCT01693523|7466628|FG002|Overall Study|Lost to Follow-up|4
4610159|NCT01693523|7466626|FG000|Overall Study|Physician Decision|0
4610160|NCT01693523|7466627|FG001|Overall Study|Physician Decision|0
4610161|NCT01693523|7466628|FG002|Overall Study|Physician Decision|1
4610162|NCT01693523|7466626|FG000|Overall Study|Withdrawal by Subject|1
4610163|NCT01693523|7466627|FG001|Overall Study|Withdrawal by Subject|2
4534080|NCT01087788|7353733|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2
4534081|NCT01087788|7353731|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13
4534082|NCT01087788|7353732|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8
4534083|NCT01087788|7353733|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10
4534084|NCT01087788|7353731|FG000|Open-Label Period (OL-P)|AE, serious fatal|2
4534085|NCT01087788|7353732|FG001|Open-Label Period (OL-P)|AE, serious fatal|0
4534086|NCT01087788|7353733|FG002|Open-Label Period (OL-P)|AE, serious fatal|1
4534087|NCT01087788|7353731|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1
4534088|NCT01087788|7353732|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3
4534089|NCT01087788|7353733|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4
4534090|NCT01087788|7353731|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6
4534091|NCT01087788|7353732|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4
4534092|NCT01087788|7353733|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4
4534093|NCT01087788|7353731|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0
4534094|NCT01087788|7353732|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1
4534095|NCT01087788|7353733|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0
4534096|NCT01087788|7353731|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1
4534097|NCT01087788|7353732|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0
4534098|NCT01087788|7353733|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0
4534099|NCT01087788|7353731|FG000|Open-Label Period (OL-P)|Sponsor request|1
4534100|NCT01087788|7353732|FG001|Open-Label Period (OL-P)|Sponsor request|0
4534101|NCT01087788|7353733|FG002|Open-Label Period (OL-P)|Sponsor request|0
4534102|NCT01087788|7353731|FG000|Open-Label Period (OL-P)|Principal investigator decision|0
4534103|NCT01087788|7353732|FG001|Open-Label Period (OL-P)|Principal investigator decision|1
4534104|NCT01087788|7353733|FG002|Open-Label Period (OL-P)|Principal investigator decision|2
4534105|NCT01087788|7353731|FG000|Open-Label Period (OL-P)|No participation in study extension|0
4534106|NCT01087788|7353732|FG001|Open-Label Period (OL-P)|No participation in study extension|0
4534107|NCT01087788|7353733|FG002|Open-Label Period (OL-P)|No participation in study extension|1
4534108|NCT01087788|7353731|FG000|Open-Label Period (OL-P)|Personal reasons|0
4534109|NCT01087788|7353732|FG001|Open-Label Period (OL-P)|Personal reasons|0
4534110|NCT01087788|7353733|FG002|Open-Label Period (OL-P)|Personal reasons|1
4534111|NCT01087814|7353753|FG000|First Intervention (5 Days)|Withdrawal by Subject|3
4534112|NCT01087814|7353754|FG001|First Intervention (5 Days)|Withdrawal by Subject|1
4534113|NCT01087814|7353753|FG000|Second Intervention (5 Days)|Physician Decision|1
4534114|NCT01087814|7353754|FG001|Second Intervention (5 Days)|Physician Decision|0
4534115|NCT01087905|7353768|FG000|Overall Study|Lost to Follow-up|24
4534116|NCT01087905|7353769|FG001|Overall Study|Lost to Follow-up|28
4534117|NCT01087905|7353770|FG002|Overall Study|Lost to Follow-up|18
4534118|NCT01087905|7353771|FG003|Overall Study|Lost to Follow-up|31
4534119|NCT01087905|7353772|FG004|Overall Study|Lost to Follow-up|27
4534120|NCT01087905|7353773|FG005|Overall Study|Lost to Follow-up|25
4534121|NCT01087905|7353774|FG006|Overall Study|Lost to Follow-up|20
4534122|NCT01087905|7353775|FG007|Overall Study|Lost to Follow-up|24
4534123|NCT01087905|7353768|FG000|Overall Study|Withdrawal by Subject|5
4534124|NCT01087905|7353769|FG001|Overall Study|Withdrawal by Subject|4
4534125|NCT01087905|7353770|FG002|Overall Study|Withdrawal by Subject|4
4534126|NCT01087905|7353771|FG003|Overall Study|Withdrawal by Subject|5
4534127|NCT01087905|7353772|FG004|Overall Study|Withdrawal by Subject|4
4534128|NCT01087905|7353773|FG005|Overall Study|Withdrawal by Subject|3
4534129|NCT01087905|7353774|FG006|Overall Study|Withdrawal by Subject|3
4534130|NCT01087905|7353775|FG007|Overall Study|Withdrawal by Subject|5
4534131|NCT01087944|7353813|FG000|Period 1 (Week 1-3)|Adverse Event|1
4534132|NCT01087944|7353814|FG001|Period 1 (Week 1-3)|Adverse Event|0
4534133|NCT01087944|7353813|FG000|Period 2 (Week 4-6)|Adverse Event|0
4534134|NCT01087944|7353814|FG001|Period 2 (Week 4-6)|Adverse Event|2
4534135|NCT01087957|7353822|FG000|Overall Study|Death|2
4534136|NCT01087957|7353823|FG001|Overall Study|Death|2
4534137|NCT01087957|7353822|FG000|Overall Study|Lost to Follow-up|3
4534138|NCT01087957|7353823|FG001|Overall Study|Lost to Follow-up|4
4534139|NCT01087957|7353822|FG000|Overall Study|Protocol Violation|13
4534140|NCT01087957|7353823|FG001|Overall Study|Protocol Violation|25
4534141|NCT01087957|7353822|FG000|Overall Study|Withdrawal by Subject|18
4534142|NCT01087957|7353823|FG001|Overall Study|Withdrawal by Subject|15
4534143|NCT01087957|7353822|FG000|Overall Study|Physician Decision|5
4534144|NCT01087957|7353823|FG001|Overall Study|Physician Decision|9
4534145|NCT01087970|7353829|FG000|Overall Study|Protocol Violation|2
4534146|NCT01088048|7353853|FG000|Overall Study|Adverse Event|7
4534147|NCT01088048|7353854|FG001|Overall Study|Adverse Event|9
4534148|NCT01088048|7353855|FG002|Overall Study|Adverse Event|7
4534149|NCT01088048|7353856|FG003|Overall Study|Adverse Event|5
4534150|NCT01088048|7353857|FG004|Overall Study|Adverse Event|6
4534151|NCT01088048|7353858|FG005|Overall Study|Adverse Event|3
4534152|NCT01088048|7353859|FG006|Overall Study|Adverse Event|3
4534153|NCT01088048|7353860|FG007|Overall Study|Adverse Event|0
4534154|NCT01088048|7353861|FG008|Overall Study|Adverse Event|2
4534155|NCT01088048|7353862|FG009|Overall Study|Adverse Event|2
4534156|NCT01088048|7353853|FG000|Overall Study|Withdrew Consent|1
4534157|NCT01088048|7353854|FG001|Overall Study|Withdrew Consent|1
4534158|NCT01088048|7353855|FG002|Overall Study|Withdrew Consent|1
4534159|NCT01088048|7353856|FG003|Overall Study|Withdrew Consent|1
4534160|NCT01088048|7353857|FG004|Overall Study|Withdrew Consent|2
4534161|NCT01088048|7353858|FG005|Overall Study|Withdrew Consent|1
4534162|NCT01088048|7353859|FG006|Overall Study|Withdrew Consent|0
4534163|NCT01088048|7353860|FG007|Overall Study|Withdrew Consent|2
4534164|NCT01088048|7353861|FG008|Overall Study|Withdrew Consent|2
4534165|NCT01088048|7353862|FG009|Overall Study|Withdrew Consent|1
4534166|NCT01088048|7353853|FG000|Overall Study|Concomitant Medication Prohibited|1
4534167|NCT01088048|7353854|FG001|Overall Study|Concomitant Medication Prohibited|0
4534168|NCT01088048|7353855|FG002|Overall Study|Concomitant Medication Prohibited|0
4534169|NCT01088048|7353856|FG003|Overall Study|Concomitant Medication Prohibited|0
4534170|NCT01088048|7353857|FG004|Overall Study|Concomitant Medication Prohibited|0
4534171|NCT01088048|7353858|FG005|Overall Study|Concomitant Medication Prohibited|0
4534172|NCT01088048|7353859|FG006|Overall Study|Concomitant Medication Prohibited|0
4534173|NCT01088048|7353860|FG007|Overall Study|Concomitant Medication Prohibited|0
4534174|NCT01088048|7353861|FG008|Overall Study|Concomitant Medication Prohibited|0
4534175|NCT01088048|7353862|FG009|Overall Study|Concomitant Medication Prohibited|0
4534176|NCT01088048|7353853|FG000|Overall Study|Investigator Request|2
4534177|NCT01088048|7353854|FG001|Overall Study|Investigator Request|2
4534178|NCT01088048|7353855|FG002|Overall Study|Investigator Request|0
4534179|NCT01088048|7353856|FG003|Overall Study|Investigator Request|0
4534180|NCT01088048|7353857|FG004|Overall Study|Investigator Request|3
4534181|NCT01088048|7353858|FG005|Overall Study|Investigator Request|1
4534182|NCT01088048|7353859|FG006|Overall Study|Investigator Request|1
4534183|NCT01088048|7353860|FG007|Overall Study|Investigator Request|0
4534184|NCT01088048|7353861|FG008|Overall Study|Investigator Request|0
4534185|NCT01088048|7353862|FG009|Overall Study|Investigator Request|0
4534186|NCT01088048|7353853|FG000|Overall Study|Patient Non-compliance|0
4534187|NCT01088048|7353854|FG001|Overall Study|Patient Non-compliance|1
4534188|NCT01088048|7353855|FG002|Overall Study|Patient Non-compliance|0
4534189|NCT01088048|7353856|FG003|Overall Study|Patient Non-compliance|0
4534190|NCT01088048|7353857|FG004|Overall Study|Patient Non-compliance|0
4534191|NCT01088048|7353858|FG005|Overall Study|Patient Non-compliance|0
4534192|NCT01088048|7353859|FG006|Overall Study|Patient Non-compliance|0
4534193|NCT01088048|7353860|FG007|Overall Study|Patient Non-compliance|0
4534194|NCT01088048|7353861|FG008|Overall Study|Patient Non-compliance|0
4534195|NCT01088048|7353862|FG009|Overall Study|Patient Non-compliance|0
4534196|NCT01088048|7353853|FG000|Overall Study|Disease Progression|7
4534197|NCT01088048|7353854|FG001|Overall Study|Disease Progression|4
4534198|NCT01088048|7353855|FG002|Overall Study|Disease Progression|3
4534199|NCT01088048|7353856|FG003|Overall Study|Disease Progression|5
4534200|NCT01088048|7353857|FG004|Overall Study|Disease Progression|3
4534201|NCT01088048|7353858|FG005|Overall Study|Disease Progression|3
4534202|NCT01088048|7353859|FG006|Overall Study|Disease Progression|2
4534203|NCT01088048|7353860|FG007|Overall Study|Disease Progression|1
4534204|NCT01088048|7353861|FG008|Overall Study|Disease Progression|0
4534205|NCT01088048|7353862|FG009|Overall Study|Disease Progression|0
4534206|NCT01088048|7353853|FG000|Overall Study|Death|1
4534207|NCT01088048|7353854|FG001|Overall Study|Death|5
4534208|NCT01088048|7353855|FG002|Overall Study|Death|3
4534209|NCT01088048|7353856|FG003|Overall Study|Death|3
4534210|NCT01088048|7353857|FG004|Overall Study|Death|1
4534211|NCT01088048|7353858|FG005|Overall Study|Death|3
4534212|NCT01088048|7353859|FG006|Overall Study|Death|0
4534213|NCT01088048|7353860|FG007|Overall Study|Death|0
4534214|NCT01088048|7353861|FG008|Overall Study|Death|3
4534215|NCT01088048|7353862|FG009|Overall Study|Death|1
4534216|NCT01088048|7353853|FG000|Overall Study|Other|3
4534217|NCT01088048|7353854|FG001|Overall Study|Other|5
4534218|NCT01088048|7353855|FG002|Overall Study|Other|0
4534219|NCT01088048|7353856|FG003|Overall Study|Other|0
4534220|NCT01088048|7353857|FG004|Overall Study|Other|2
4534221|NCT01088048|7353858|FG005|Overall Study|Other|0
4534222|NCT01088048|7353859|FG006|Overall Study|Other|0
4534223|NCT01088048|7353860|FG007|Overall Study|Other|2
4534224|NCT01088048|7353861|FG008|Overall Study|Other|0
4534225|NCT01088048|7353862|FG009|Overall Study|Other|0
4534226|NCT01088243|7353897|FG000|Overall Study|Adverse Event|1
4534227|NCT01088243|7353898|FG001|Overall Study|Adverse Event|0
4534228|NCT01088399|7353911|FG000|Overall Study|Adverse Event|211
4534229|NCT01088399|7353912|FG001|Overall Study|Adverse Event|16
4534230|NCT01088399|7353913|FG002|Overall Study|Adverse Event|0
4534231|NCT01088399|7353911|FG000|Overall Study|Death|204
4534232|NCT01088399|7353912|FG001|Overall Study|Death|45
4534233|NCT01088399|7353913|FG002|Overall Study|Death|0
4534234|NCT01088399|7353911|FG000|Overall Study|Lack of Efficacy|298
4534235|NCT01088399|7353912|FG001|Overall Study|Lack of Efficacy|7
4534236|NCT01088399|7353913|FG002|Overall Study|Lack of Efficacy|5
4534237|NCT01088399|7353911|FG000|Overall Study|Lost to Follow-up|1070
4534238|NCT01088399|7353912|FG001|Overall Study|Lost to Follow-up|278
4534239|NCT01088399|7353913|FG002|Overall Study|Lost to Follow-up|58
4534240|NCT01088399|7353911|FG000|Overall Study|Physician Decision|531
4610164|NCT01693523|7466628|FG002|Overall Study|Withdrawal by Subject|2
4534241|NCT01088399|7353912|FG001|Overall Study|Physician Decision|88
4534242|NCT01088399|7353913|FG002|Overall Study|Physician Decision|16
4534243|NCT01088399|7353911|FG000|Overall Study|Withdrawal by Subject|544
4534244|NCT01088399|7353912|FG001|Overall Study|Withdrawal by Subject|195
4534245|NCT01088399|7353913|FG002|Overall Study|Withdrawal by Subject|33
4534246|NCT01088399|7353911|FG000|Overall Study|Change to or start of somatropin therapy|234
4534247|NCT01088399|7353912|FG001|Overall Study|Change to or start of somatropin therapy|17
4534248|NCT01088399|7353913|FG002|Overall Study|Change to or start of somatropin therapy|12
4534249|NCT01088399|7353911|FG000|Overall Study|Sponsor decision|1573
4534250|NCT01088399|7353912|FG001|Overall Study|Sponsor decision|298
4534251|NCT01088399|7353913|FG002|Overall Study|Sponsor decision|7
4534252|NCT01088399|7353911|FG000|Overall Study|Protocol Violation|10
4534253|NCT01088399|7353912|FG001|Overall Study|Protocol Violation|1
4534254|NCT01088399|7353913|FG002|Overall Study|Protocol Violation|0
4534255|NCT01088399|7353911|FG000|Overall Study|Enrollment criteria not met|48
4534256|NCT01088399|7353912|FG001|Overall Study|Enrollment criteria not met|119
4534257|NCT01088399|7353913|FG002|Overall Study|Enrollment criteria not met|70
4534258|NCT01088399|7353911|FG000|Overall Study|Study summary visit not completed|2398
4534259|NCT01088399|7353912|FG001|Overall Study|Study summary visit not completed|283
4534260|NCT01088399|7353913|FG002|Overall Study|Study summary visit not completed|80
4534261|NCT01088412|7353924|FG000|Overall Study|Adverse Event|38
4534262|NCT01088412|7353925|FG001|Overall Study|Adverse Event|0
4534263|NCT01088412|7353926|FG002|Overall Study|Adverse Event|0
4534264|NCT01088412|7353924|FG000|Overall Study|Death|42
4534265|NCT01088412|7353925|FG001|Overall Study|Death|6
4534266|NCT01088412|7353926|FG002|Overall Study|Death|0
4534267|NCT01088412|7353924|FG000|Overall Study|Other Reason per Case Report Form|2089
4534268|NCT01088412|7353925|FG001|Overall Study|Other Reason per Case Report Form|103
4534269|NCT01088412|7353926|FG002|Overall Study|Other Reason per Case Report Form|9
4534270|NCT01088412|7353924|FG000|Overall Study|Withdrawal by Subject|1761
4534271|NCT01088412|7353925|FG001|Overall Study|Withdrawal by Subject|25
4534272|NCT01088412|7353926|FG002|Overall Study|Withdrawal by Subject|1
4534273|NCT01088412|7353924|FG000|Overall Study|Received Another GH Product|79
4534274|NCT01088412|7353925|FG001|Overall Study|Received Another GH Product|0
4534275|NCT01088412|7353926|FG002|Overall Study|Received Another GH Product|0
4534276|NCT01088412|7353924|FG000|Overall Study|Participant Moved|601
4534277|NCT01088412|7353925|FG001|Overall Study|Participant Moved|21
4534278|NCT01088412|7353926|FG002|Overall Study|Participant Moved|2
4534279|NCT01088412|7353924|FG000|Overall Study|Physician Decision|1041
4534280|NCT01088412|7353925|FG001|Overall Study|Physician Decision|8
4534281|NCT01088412|7353926|FG002|Overall Study|Physician Decision|4
4534282|NCT01088412|7353924|FG000|Overall Study|Sponsor Decision|4467
4534283|NCT01088412|7353925|FG001|Overall Study|Sponsor Decision|79
4534284|NCT01088412|7353926|FG002|Overall Study|Sponsor Decision|23
4534285|NCT01088412|7353924|FG000|Overall Study|Third Party Required to Change Brand|487
4534286|NCT01088412|7353925|FG001|Overall Study|Third Party Required to Change Brand|0
4534287|NCT01088412|7353926|FG002|Overall Study|Third Party Required to Change Brand|0
4534288|NCT01088412|7353924|FG000|Overall Study|Lost to Follow-up|3052
4534289|NCT01088412|7353925|FG001|Overall Study|Lost to Follow-up|130
4534290|NCT01088412|7353926|FG002|Overall Study|Lost to Follow-up|11
4534291|NCT01088412|7353924|FG000|Overall Study|Study Summary Not Completed|4360
4534292|NCT01088412|7353925|FG001|Overall Study|Study Summary Not Completed|64
4534293|NCT01088412|7353926|FG002|Overall Study|Study Summary Not Completed|22
4534294|NCT01088438|7353939|FG000|Overall Study|Withdrawal by Subject|11
4534295|NCT01088438|7353940|FG001|Overall Study|Withdrawal by Subject|6
4534296|NCT01088438|7353939|FG000|Overall Study|Lost to Follow-up|18
4534297|NCT01088438|7353940|FG001|Overall Study|Lost to Follow-up|30
4534298|NCT01088503|7353962|FG000|Overall Study|Withdrawal by Subject|118
4534299|NCT01088503|7353963|FG001|Overall Study|Withdrawal by Subject|327
4534300|NCT01088503|7353964|FG002|Overall Study|Withdrawal by Subject|10
4534301|NCT01088503|7353962|FG000|Overall Study|Death|64
4534302|NCT01088503|7353963|FG001|Overall Study|Death|358
4534303|NCT01088503|7353964|FG002|Overall Study|Death|7
4534304|NCT01088529|7353972|FG000|Overall Study|Did not receive study treatment|0
4534305|NCT01088529|7353973|FG001|Overall Study|Did not receive study treatment|1
4534306|NCT01088984|7354009|FG000|Phase 1|Death|2
4534307|NCT01088984|7354010|FG001|Phase 1|Death|1
4534308|NCT01088984|7354009|FG000|Phase 1|Disease Progression|2
4534309|NCT01088984|7354010|FG001|Phase 1|Disease Progression|4
4534310|NCT01088984|7354009|FG000|Phase 1|Other|1
4534311|NCT01088984|7354010|FG001|Phase 1|Other|1
4534312|NCT01088984|7354009|FG000|Phase 2|Death|0
4534313|NCT01088984|7354010|FG001|Phase 2|Death|5
4534314|NCT01088984|7354009|FG000|Phase 2|Withdrawal by Subject|0
4534315|NCT01088984|7354010|FG001|Phase 2|Withdrawal by Subject|1
4534316|NCT01088984|7354009|FG000|Phase 2|DIsease Progression|0
4534317|NCT01088984|7354010|FG001|Phase 2|DIsease Progression|25
4534318|NCT01088984|7354009|FG000|Phase 2|Other|0
4534319|NCT01088984|7354010|FG001|Phase 2|Other|1
4534320|NCT01088997|7354021|FG000|Overall Study|Physician Decision|1
4534321|NCT01088997|7354022|FG001|Overall Study|Physician Decision|1
4534322|NCT01088997|7354021|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1
4534323|NCT01088997|7354022|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1
4534324|NCT01088997|7354021|FG000|Overall Study|Excluded prior to receiving drug|1
4534325|NCT01088997|7354022|FG001|Overall Study|Excluded prior to receiving drug|1
4534326|NCT01089023|7354031|FG000|Overall Study|Lost to Follow-up|3
4534327|NCT01089023|7354031|FG000|Overall Study|Adverse Event|1
4534328|NCT01089023|7354031|FG000|Overall Study|Withdrawal by Subject|1
4534329|NCT01089023|7354031|FG000|Overall Study|Protocol Violation|1
4534330|NCT01089023|7354031|FG000|Overall Study|Lack of Efficacy|1
4534331|NCT01089127|7354061|FG000|Overall Study|Adverse Event|5
4534332|NCT01089127|7354062|FG001|Overall Study|Adverse Event|1
4534333|NCT01089127|7354063|FG002|Overall Study|Adverse Event|1
4534334|NCT01089127|7354064|FG003|Overall Study|Adverse Event|0
4534335|NCT01089127|7354065|FG004|Overall Study|Adverse Event|0
4534336|NCT01089127|7354066|FG005|Overall Study|Adverse Event|1
4534337|NCT01089127|7354061|FG000|Overall Study|Subject withdrew consent|0
4534338|NCT01089127|7354062|FG001|Overall Study|Subject withdrew consent|1
4534339|NCT01089127|7354063|FG002|Overall Study|Subject withdrew consent|1
4534340|NCT01089127|7354064|FG003|Overall Study|Subject withdrew consent|1
4534341|NCT01089127|7354065|FG004|Overall Study|Subject withdrew consent|0
4534342|NCT01089127|7354066|FG005|Overall Study|Subject withdrew consent|2
4534343|NCT01089127|7354061|FG000|Overall Study|Abnormal test procedure result(s)|2
4534344|NCT01089127|7354062|FG001|Overall Study|Abnormal test procedure result(s)|1
4534345|NCT01089127|7354063|FG002|Overall Study|Abnormal test procedure result(s)|0
4534346|NCT01089127|7354064|FG003|Overall Study|Abnormal test procedure result(s)|0
4534347|NCT01089127|7354065|FG004|Overall Study|Abnormal test procedure result(s)|0
4534348|NCT01089127|7354066|FG005|Overall Study|Abnormal test procedure result(s)|0
4534349|NCT01089127|7354061|FG000|Overall Study|Lost to Follow-up|1
4534350|NCT01089127|7354062|FG001|Overall Study|Lost to Follow-up|1
4534351|NCT01089127|7354063|FG002|Overall Study|Lost to Follow-up|0
4534352|NCT01089127|7354064|FG003|Overall Study|Lost to Follow-up|0
4534353|NCT01089127|7354065|FG004|Overall Study|Lost to Follow-up|1
4534354|NCT01089127|7354066|FG005|Overall Study|Lost to Follow-up|0
4534355|NCT01089127|7354061|FG000|Overall Study|Protocol deviation|0
4534356|NCT01089127|7354062|FG001|Overall Study|Protocol deviation|1
4534357|NCT01089127|7354063|FG002|Overall Study|Protocol deviation|0
4534358|NCT01089127|7354064|FG003|Overall Study|Protocol deviation|0
4534359|NCT01089127|7354065|FG004|Overall Study|Protocol deviation|1
4534360|NCT01089127|7354066|FG005|Overall Study|Protocol deviation|0
4534361|NCT01089361|7354099|FG000|Overall Study|Death|1
4534362|NCT01089361|7354100|FG001|Overall Study|Death|0
4534363|NCT01089413|7354111|FG000|Overall Study|Lost to Follow-up|1
4534364|NCT01089413|7354111|FG000|Overall Study|Progressive Disease|93
4534365|NCT01089413|7354111|FG000|Overall Study|Participant Withdrew Consent|1
4534366|NCT01089413|7354111|FG000|Overall Study|Unacceptable Toxicity|12
4534367|NCT01089413|7354111|FG000|Overall Study|Death|10
4534368|NCT01089413|7354111|FG000|Overall Study|Metastasectomy|13
4534369|NCT01089413|7354111|FG000|Overall Study|Other|71
4534370|NCT01089504|7354123|FG000|Overall Study|Lost to Follow-up|1
4534371|NCT01089504|7354124|FG001|Overall Study|Lost to Follow-up|1
4534372|NCT01089504|7354123|FG000|Overall Study|Withdrawal by Subject|2
4534373|NCT01089504|7354124|FG001|Overall Study|Withdrawal by Subject|0
4534374|NCT01089543|7354147|FG000|Overall Study|Withdrawal by Subject|2
4534375|NCT01089543|7354148|FG001|Overall Study|Withdrawal by Subject|3
4534376|NCT01089543|7354149|FG002|Overall Study|Withdrawal by Subject|3
4534377|NCT01089543|7354150|FG003|Overall Study|Withdrawal by Subject|1
4534378|NCT01089543|7354147|FG000|Overall Study|Physician Decision|1
4534379|NCT01089543|7354148|FG001|Overall Study|Physician Decision|0
4534380|NCT01089543|7354149|FG002|Overall Study|Physician Decision|0
4534381|NCT01089543|7354150|FG003|Overall Study|Physician Decision|1
4534382|NCT01089543|7354147|FG000|Overall Study|Adverse Event|0
4534383|NCT01089543|7354148|FG001|Overall Study|Adverse Event|1
4534384|NCT01089543|7354149|FG002|Overall Study|Adverse Event|0
4534385|NCT01089543|7354150|FG003|Overall Study|Adverse Event|0
4534386|NCT01089556|7354162|FG000|Study Period II (Weeks 1-8)|Adverse Event|35
4534387|NCT01089556|7354163|FG001|Study Period II (Weeks 1-8)|Adverse Event|39
4534388|NCT01089556|7354164|FG002|Study Period II (Weeks 1-8)|Adverse Event|0
4534389|NCT01089556|7354165|FG003|Study Period II (Weeks 1-8)|Adverse Event|0
4534390|NCT01089556|7354166|FG004|Study Period II (Weeks 1-8)|Adverse Event|0
4534391|NCT01089556|7354167|FG005|Study Period II (Weeks 1-8)|Adverse Event|0
4534392|NCT01089556|7354162|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12
4534393|NCT01089556|7354163|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8
4534394|NCT01089556|7354164|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
4534395|NCT01089556|7354165|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
4534396|NCT01089556|7354166|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
4534397|NCT01089556|7354167|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
4534398|NCT01089556|7354162|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1
4534399|NCT01089556|7354163|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2
4534400|NCT01089556|7354164|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0
4534401|NCT01089556|7354165|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0
4534402|NCT01089556|7354166|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0
4534403|NCT01089556|7354167|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0
4534404|NCT01089556|7354162|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0
4534405|NCT01089556|7354163|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3
4534406|NCT01089556|7354164|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0
4534407|NCT01089556|7354165|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0
4534408|NCT01089556|7354166|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0
4534409|NCT01089556|7354167|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0
4534410|NCT01089556|7354162|FG000|Study Period II (Weeks 1-8)|Physician Decision|4
4534411|NCT01089556|7354163|FG001|Study Period II (Weeks 1-8)|Physician Decision|0
4534412|NCT01089556|7354164|FG002|Study Period II (Weeks 1-8)|Physician Decision|0
4534413|NCT01089556|7354165|FG003|Study Period II (Weeks 1-8)|Physician Decision|0
4534414|NCT01089556|7354166|FG004|Study Period II (Weeks 1-8)|Physician Decision|0
4534415|NCT01089556|7354167|FG005|Study Period II (Weeks 1-8)|Physician Decision|0
4534416|NCT01089556|7354162|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4
4534417|NCT01089556|7354163|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4
4534418|NCT01089556|7354164|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0
4534419|NCT01089556|7354165|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0
4534420|NCT01089556|7354166|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0
4534421|NCT01089556|7354167|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0
4534422|NCT01089556|7354162|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12
4534423|NCT01089556|7354163|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14
4534424|NCT01089556|7354164|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
4534425|NCT01089556|7354165|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
4534426|NCT01089556|7354166|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
4534427|NCT01089556|7354167|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
4534428|NCT01089556|7354162|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3
4534429|NCT01089556|7354163|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4
4534430|NCT01089556|7354164|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0
4534431|NCT01089556|7354165|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0
4534432|NCT01089556|7354166|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0
4534433|NCT01089556|7354167|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0
4534434|NCT01089556|7354162|FG000|Study Period III (Weeks 9-16)|Adverse Event|0
4534435|NCT01089556|7354163|FG001|Study Period III (Weeks 9-16)|Adverse Event|0
4534436|NCT01089556|7354164|FG002|Study Period III (Weeks 9-16)|Adverse Event|4
4534437|NCT01089556|7354165|FG003|Study Period III (Weeks 9-16)|Adverse Event|2
4534438|NCT01089556|7354166|FG004|Study Period III (Weeks 9-16)|Adverse Event|4
4534439|NCT01089556|7354167|FG005|Study Period III (Weeks 9-16)|Adverse Event|3
4534440|NCT01089556|7354162|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0
4534441|NCT01089556|7354163|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0
4534442|NCT01089556|7354164|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
4534443|NCT01089556|7354165|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
4534444|NCT01089556|7354166|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
4534445|NCT01089556|7354167|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
4534446|NCT01089556|7354162|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0
4534447|NCT01089556|7354163|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0
4534448|NCT01089556|7354164|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0
4534449|NCT01089556|7354165|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2
4534450|NCT01089556|7354166|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1
4534451|NCT01089556|7354167|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0
4534452|NCT01089556|7354162|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0
4534453|NCT01089556|7354163|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0
4534454|NCT01089556|7354164|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1
4534455|NCT01089556|7354165|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0
4534456|NCT01089556|7354166|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0
4534457|NCT01089556|7354167|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0
4534458|NCT01089556|7354162|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0
4534459|NCT01089556|7354163|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0
4534460|NCT01089556|7354164|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1
4534461|NCT01089556|7354165|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1
4534462|NCT01089556|7354166|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1
4534463|NCT01089556|7354167|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0
4534464|NCT01089556|7354162|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0
4534465|NCT01089556|7354163|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0
4534466|NCT01089556|7354164|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4
4534467|NCT01089556|7354165|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3
4534468|NCT01089556|7354166|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4
4534469|NCT01089556|7354167|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1
4534470|NCT01089556|7354162|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
4534471|NCT01089556|7354163|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
4534472|NCT01089556|7354164|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3
4534473|NCT01089556|7354165|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
4534474|NCT01089556|7354166|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1
4534475|NCT01089556|7354167|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2
4534476|NCT01089582|7354192|FG000|Overall Study|Death|2
4534477|NCT01089582|7354192|FG000|Overall Study|Adverse Event|15
4534478|NCT01089582|7354192|FG000|Overall Study|Lost to Follow-up|8
4534479|NCT01089582|7354192|FG000|Overall Study|Other|4
4534480|NCT01089582|7354192|FG000|Overall Study|Withdrawal by Subject|1
4534481|NCT01089608|7354209|FG000|Overall Study|Adverse Event|0
4534482|NCT01089608|7354210|FG001|Overall Study|Adverse Event|4
4534483|NCT01089608|7354209|FG000|Overall Study|Lost to Follow-up|0
4534484|NCT01089608|7354210|FG001|Overall Study|Lost to Follow-up|2
4534485|NCT01089647|7354218|FG000|Overall Study|Lost to Follow-up|2
4534486|NCT01089647|7354219|FG001|Overall Study|Lost to Follow-up|2
4534487|NCT01089647|7354218|FG000|Overall Study|Withdrawal by Subject|2
4534488|NCT01089647|7354219|FG001|Overall Study|Withdrawal by Subject|1
4534489|NCT01089647|7354218|FG000|Overall Study|Adverse Event|0
4534490|NCT01089647|7354219|FG001|Overall Study|Adverse Event|1
4534491|NCT01089725|7354230|FG000|Overall Study|Adverse Event|1
4534492|NCT01089725|7354231|FG001|Overall Study|Adverse Event|1
4534493|NCT01089725|7354232|FG002|Overall Study|Adverse Event|0
4534494|NCT01089725|7354233|FG003|Overall Study|Adverse Event|0
4534495|NCT01089725|7354234|FG004|Overall Study|Adverse Event|2
4534496|NCT01089725|7354230|FG000|Overall Study|Lack of Efficacy|4
4534497|NCT01089725|7354231|FG001|Overall Study|Lack of Efficacy|3
4534498|NCT01089725|7354232|FG002|Overall Study|Lack of Efficacy|1
4534499|NCT01089725|7354233|FG003|Overall Study|Lack of Efficacy|0
4534500|NCT01089725|7354234|FG004|Overall Study|Lack of Efficacy|4
4534501|NCT01089725|7354230|FG000|Overall Study|Lost to Follow-up|2
4534502|NCT01089725|7354231|FG001|Overall Study|Lost to Follow-up|2
4534503|NCT01089725|7354232|FG002|Overall Study|Lost to Follow-up|0
4534504|NCT01089725|7354233|FG003|Overall Study|Lost to Follow-up|3
4534505|NCT01089725|7354234|FG004|Overall Study|Lost to Follow-up|0
4534506|NCT01089725|7354230|FG000|Overall Study|Protocol Violation|0
4534507|NCT01089725|7354231|FG001|Overall Study|Protocol Violation|0
4534508|NCT01089725|7354232|FG002|Overall Study|Protocol Violation|1
4534509|NCT01089725|7354233|FG003|Overall Study|Protocol Violation|1
4534510|NCT01089725|7354234|FG004|Overall Study|Protocol Violation|0
4534511|NCT01089725|7354230|FG000|Overall Study|Withdrawal by Subject|5
4534512|NCT01089725|7354231|FG001|Overall Study|Withdrawal by Subject|5
4534513|NCT01089725|7354232|FG002|Overall Study|Withdrawal by Subject|4
4534514|NCT01089725|7354233|FG003|Overall Study|Withdrawal by Subject|5
4534515|NCT01089725|7354234|FG004|Overall Study|Withdrawal by Subject|4
4534516|NCT01089725|7354230|FG000|Overall Study|Study Terminated by Sponsor|51
4534517|NCT01089725|7354231|FG001|Overall Study|Study Terminated by Sponsor|56
4534518|NCT01089725|7354232|FG002|Overall Study|Study Terminated by Sponsor|53
4534519|NCT01089725|7354233|FG003|Overall Study|Study Terminated by Sponsor|68
4534520|NCT01089725|7354234|FG004|Overall Study|Study Terminated by Sponsor|68
4534521|NCT01089725|7354230|FG000|Overall Study|Randomized, but not treated|0
4534522|NCT01089725|7354231|FG001|Overall Study|Randomized, but not treated|1
4534523|NCT01089725|7354232|FG002|Overall Study|Randomized, but not treated|2
4534524|NCT01089725|7354233|FG003|Overall Study|Randomized, but not treated|1
4534525|NCT01089725|7354234|FG004|Overall Study|Randomized, but not treated|2
4534526|NCT01089725|7354230|FG000|Overall Study|Other|3
4534527|NCT01089725|7354231|FG001|Overall Study|Other|0
4534528|NCT01089725|7354232|FG002|Overall Study|Other|0
4534529|NCT01089725|7354233|FG003|Overall Study|Other|1
4534530|NCT01089725|7354234|FG004|Overall Study|Other|0
4534531|NCT01090011|7354259|FG000|Overall Study|Progressive disease|128
4534532|NCT01090011|7354259|FG000|Overall Study|Adverse Event|32
4534533|NCT01090011|7354259|FG000|Overall Study|Protocol Violation|1
4534534|NCT01090011|7354259|FG000|Overall Study|Refusal to start/continue medication|5
4534535|NCT01090011|7354259|FG000|Overall Study|Other reason not defined above|5
4534536|NCT01090050|7354273|FG000|Overall Study|Lost to Follow-up|0
4534537|NCT01090050|7354274|FG001|Overall Study|Lost to Follow-up|1
4534538|NCT01090050|7354273|FG000|Overall Study|Lack of Efficacy|1
4534539|NCT01090050|7354274|FG001|Overall Study|Lack of Efficacy|5
4534540|NCT01090050|7354273|FG000|Overall Study|Physician Decision|0
4534541|NCT01090050|7354274|FG001|Overall Study|Physician Decision|1
4534542|NCT01090063|7354284|FG000|Screen|Screen Failed|4
4534543|NCT01090063|7354284|FG000|Treatment|Withdrawal by Subject|4
4534544|NCT01090076|7354300|FG000|Overall Study|Death|1
4534545|NCT01090076|7354301|FG001|Overall Study|Death|1
4534546|NCT01090076|7354300|FG000|Overall Study|Withdrawal by Subject|0
4534547|NCT01090076|7354301|FG001|Overall Study|Withdrawal by Subject|1
4534548|NCT01090102|7354311|FG000|First 12 Weeks|Withdrawal by Subject|1
4534549|NCT01090102|7354312|FG001|First 12 Weeks|Withdrawal by Subject|1
4534550|NCT01090102|7354311|FG000|First 12 Weeks|Adverse Event|2
4534551|NCT01090102|7354312|FG001|First 12 Weeks|Adverse Event|0
4534552|NCT01090102|7354311|FG000|First 12 Weeks|Death|1
4534553|NCT01090102|7354312|FG001|First 12 Weeks|Death|1
4534554|NCT01090102|7354311|FG000|Second 12 Weeks|Withdrawal by Subject|0
4534555|NCT01090102|7354312|FG001|Second 12 Weeks|Withdrawal by Subject|1
4534556|NCT01090310|7354331|FG000|Core Study|Adverse Event|2
4534557|NCT01090310|7354332|FG001|Core Study|Adverse Event|2
4534558|NCT01090310|7354333|FG002|Core Study|Adverse Event|1
4534559|NCT01090310|7354334|FG003|Core Study|Adverse Event|1
4534560|NCT01090310|7354331|FG000|Core Study|Subject withdrew consent|0
4534561|NCT01090310|7354332|FG001|Core Study|Subject withdrew consent|3
4534562|NCT01090310|7354333|FG002|Core Study|Subject withdrew consent|1
4534563|NCT01090310|7354334|FG003|Core Study|Subject withdrew consent|1
4534564|NCT01090310|7354331|FG000|Core Study|Abnormal test procedure result|0
4534565|NCT01090310|7354332|FG001|Core Study|Abnormal test procedure result|0
4534566|NCT01090310|7354333|FG002|Core Study|Abnormal test procedure result|1
4534567|NCT01090310|7354334|FG003|Core Study|Abnormal test procedure result|0
4534568|NCT01090310|7354331|FG000|Core Study|Administrative reasons|5
4534569|NCT01090310|7354332|FG001|Core Study|Administrative reasons|6
4534570|NCT01090310|7354333|FG002|Core Study|Administrative reasons|4
4534571|NCT01090310|7354334|FG003|Core Study|Administrative reasons|4
4534572|NCT01090310|7354331|FG000|Core Study|Protocol deviation|1
4534573|NCT01090310|7354332|FG001|Core Study|Protocol deviation|0
4534574|NCT01090310|7354333|FG002|Core Study|Protocol deviation|0
4534575|NCT01090310|7354334|FG003|Core Study|Protocol deviation|1
4534576|NCT01090310|7354331|FG000|Extension Study|Aministrative problems|13
4534577|NCT01090310|7354332|FG001|Extension Study|Aministrative problems|15
4534578|NCT01090310|7354333|FG002|Extension Study|Aministrative problems|14
4534579|NCT01090310|7354334|FG003|Extension Study|Aministrative problems|18
4534580|NCT01090310|7354331|FG000|Extension Study|Adverse Event|0
4534581|NCT01090310|7354332|FG001|Extension Study|Adverse Event|0
4534582|NCT01090310|7354333|FG002|Extension Study|Adverse Event|0
4534583|NCT01090310|7354334|FG003|Extension Study|Adverse Event|1
4534584|NCT01090310|7354331|FG000|Extension Study|Unsatisfactory therapeutic effect|1
4534585|NCT01090310|7354332|FG001|Extension Study|Unsatisfactory therapeutic effect|0
4534586|NCT01090310|7354333|FG002|Extension Study|Unsatisfactory therapeutic effect|1
4534587|NCT01090310|7354334|FG003|Extension Study|Unsatisfactory therapeutic effect|1
4534588|NCT01090310|7354331|FG000|Extension Study|Subject withdrew consent|0
4534589|NCT01090310|7354332|FG001|Extension Study|Subject withdrew consent|1
4534590|NCT01090310|7354333|FG002|Extension Study|Subject withdrew consent|0
4534591|NCT01090310|7354334|FG003|Extension Study|Subject withdrew consent|0
4534592|NCT01090323|7354346|FG000|Overall Study|Adverse Event|12
4534593|NCT01090323|7354347|FG001|Overall Study|Adverse Event|2
4534594|NCT01090323|7354346|FG000|Overall Study|Abnormal Lab Values|3
4534595|NCT01090323|7354347|FG001|Overall Study|Abnormal Lab Values|1
4534596|NCT01090323|7354346|FG000|Overall Study|Abnormal Test Procedure Results|2
4534597|NCT01090323|7354347|FG001|Overall Study|Abnormal Test Procedure Results|0
4534598|NCT01090323|7354346|FG000|Overall Study|Unsatisfactory therapeutic effect|4
4534599|NCT01090323|7354347|FG001|Overall Study|Unsatisfactory therapeutic effect|2
4534600|NCT01090323|7354346|FG000|Overall Study|Condition no longer requires drug|5
4534601|NCT01090323|7354347|FG001|Overall Study|Condition no longer requires drug|4
4534602|NCT01090323|7354346|FG000|Overall Study|Protocol Violation|2
4534603|NCT01090323|7354347|FG001|Overall Study|Protocol Violation|1
4534604|NCT01090323|7354346|FG000|Overall Study|Withdrew consent|33
4534605|NCT01090323|7354347|FG001|Overall Study|Withdrew consent|11
4534606|NCT01090323|7354346|FG000|Overall Study|Lost to Follow-up|11
4534607|NCT01090323|7354347|FG001|Overall Study|Lost to Follow-up|6
4534608|NCT01090323|7354346|FG000|Overall Study|Administrative problems|6
4534609|NCT01090323|7354347|FG001|Overall Study|Administrative problems|4
4534610|NCT01090323|7354346|FG000|Overall Study|Death|1
4534611|NCT01090323|7354347|FG001|Overall Study|Death|2
4534612|NCT01090323|7354346|FG000|Overall Study|Stopped end of core|7
4534613|NCT01090323|7354347|FG001|Overall Study|Stopped end of core|0
4534614|NCT01090323|7354346|FG000|Overall Study|Stopped end of extension 1#|3
4534615|NCT01090323|7354347|FG001|Overall Study|Stopped end of extension 1#|1
4534616|NCT01090414|7354357|FG000|Study 101-99|Progressive Disease|28
4534617|NCT01090414|7354358|FG001|Study 101-99|Progressive Disease|48
4534618|NCT01090414|7354359|FG002|Study 101-99|Progressive Disease|10
4534619|NCT01090414|7354360|FG003|Study 101-99|Progressive Disease|4
4534620|NCT01090414|7354357|FG000|Study 101-99|Adverse Event|10
4534621|NCT01090414|7354358|FG001|Study 101-99|Adverse Event|28
4534622|NCT01090414|7354359|FG002|Study 101-99|Adverse Event|18
4534623|NCT01090414|7354360|FG003|Study 101-99|Adverse Event|0
4534624|NCT01090414|7354357|FG000|Study 101-99|Investigator Request|1
4534625|NCT01090414|7354358|FG001|Study 101-99|Investigator Request|11
4534626|NCT01090414|7354359|FG002|Study 101-99|Investigator Request|4
4534627|NCT01090414|7354360|FG003|Study 101-99|Investigator Request|0
4534628|NCT01090414|7354357|FG000|Study 101-99|Death|3
4534629|NCT01090414|7354358|FG001|Study 101-99|Death|8
4534630|NCT01090414|7354359|FG002|Study 101-99|Death|1
4534631|NCT01090414|7354360|FG003|Study 101-99|Death|0
4534632|NCT01090414|7354357|FG000|Study 101-99|Sponsor Discontinued Study|0
4534633|NCT01090414|7354358|FG001|Study 101-99|Sponsor Discontinued Study|7
4534634|NCT01090414|7354359|FG002|Study 101-99|Sponsor Discontinued Study|5
4534635|NCT01090414|7354360|FG003|Study 101-99|Sponsor Discontinued Study|0
4534636|NCT01090414|7354357|FG000|Study 101-99|Other (Unknown Reasons)|3
4534637|NCT01090414|7354358|FG001|Study 101-99|Other (Unknown Reasons)|3
4534638|NCT01090414|7354359|FG002|Study 101-99|Other (Unknown Reasons)|0
4534639|NCT01090414|7354360|FG003|Study 101-99|Other (Unknown Reasons)|0
4534640|NCT01090414|7354357|FG000|Study 101-99|Withdrew Consent|0
4534641|NCT01090414|7354358|FG001|Study 101-99|Withdrew Consent|2
4534642|NCT01090414|7354359|FG002|Study 101-99|Withdrew Consent|3
4534643|NCT01090414|7354360|FG003|Study 101-99|Withdrew Consent|1
4534644|NCT01090414|7354357|FG000|Study 101-99|Participant Request|3
4534645|NCT01090414|7354358|FG001|Study 101-99|Participant Request|1
4534646|NCT01090414|7354359|FG002|Study 101-99|Participant Request|0
4534647|NCT01090414|7354360|FG003|Study 101-99|Participant Request|0
4534648|NCT01090427|7354385|FG000|After Controlled Period|Death|0
4534649|NCT01090427|7354386|FG001|After Controlled Period|Death|0
4534650|NCT01090427|7354387|FG002|After Controlled Period|Death|0
4534651|NCT01090427|7354388|FG003|After Controlled Period|Death|0
4534652|NCT01090427|7354389|FG004|After Controlled Period|Death|0
4534653|NCT01090427|7354390|FG005|After Controlled Period|Death|1
4534654|NCT01090427|7354391|FG006|After Controlled Period|Death|0
4534655|NCT01090427|7354385|FG000|After Controlled Period|Lack of Efficacy|0
4534656|NCT01090427|7354386|FG001|After Controlled Period|Lack of Efficacy|0
4534657|NCT01090427|7354387|FG002|After Controlled Period|Lack of Efficacy|0
4534658|NCT01090427|7354388|FG003|After Controlled Period|Lack of Efficacy|0
4534659|NCT01090427|7354389|FG004|After Controlled Period|Lack of Efficacy|0
4534660|NCT01090427|7354390|FG005|After Controlled Period|Lack of Efficacy|3
4534661|NCT01090427|7354391|FG006|After Controlled Period|Lack of Efficacy|2
4534662|NCT01090427|7354385|FG000|After Controlled Period|Adverse Event|0
4534663|NCT01090427|7354386|FG001|After Controlled Period|Adverse Event|0
4534664|NCT01090427|7354387|FG002|After Controlled Period|Adverse Event|0
4534665|NCT01090427|7354388|FG003|After Controlled Period|Adverse Event|2
4534666|NCT01090427|7354389|FG004|After Controlled Period|Adverse Event|0
4534667|NCT01090427|7354390|FG005|After Controlled Period|Adverse Event|1
4534668|NCT01090427|7354391|FG006|After Controlled Period|Adverse Event|0
4534669|NCT01090453|7354405|FG000|Overall Study|Withdrawal by Subject|1
4534670|NCT01090453|7354406|FG001|Overall Study|Withdrawal by Subject|2
4534671|NCT01090453|7354405|FG000|Overall Study|Lost to Follow-up|7
4534672|NCT01090453|7354406|FG001|Overall Study|Lost to Follow-up|7
4534673|NCT01090453|7354405|FG000|Overall Study|Non serious AEs|1
4534674|NCT01090453|7354406|FG001|Overall Study|Non serious AEs|0
4534675|NCT01090453|7354405|FG000|Overall Study|Protocol Violation|2
4534676|NCT01090453|7354406|FG001|Overall Study|Protocol Violation|0
4534677|NCT01090453|7354405|FG000|Overall Study|Other|2
4534678|NCT01090453|7354406|FG001|Overall Study|Other|4
4534679|NCT01090453|7354405|FG000|Overall Study|Eligibility Criteria|0
4534680|NCT01090453|7354406|FG001|Overall Study|Eligibility Criteria|1
4534681|NCT01090492|7354429|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1
4534682|NCT01090492|7354430|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1
4534683|NCT01090492|7354431|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1
4534684|NCT01090492|7354432|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2
4534685|NCT01090492|7354433|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0
4534686|NCT01090492|7354434|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0
4534687|NCT01090492|7354435|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1
4534688|NCT01090492|7354436|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0
4534689|NCT01090492|7354429|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
4534690|NCT01090492|7354430|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2
4534691|NCT01090492|7354431|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
4534692|NCT01090492|7354432|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
4534693|NCT01090492|7354433|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
4534694|NCT01090492|7354434|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
4534695|NCT01090492|7354435|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
4534696|NCT01090492|7354436|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1
4534697|NCT01090492|7354429|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0
4534698|NCT01090492|7354430|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0
4534699|NCT01090492|7354431|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1
4534700|NCT01090492|7354432|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0
4534701|NCT01090492|7354433|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0
4534702|NCT01090492|7354434|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0
4534703|NCT01090492|7354435|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0
4534704|NCT01090492|7354436|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0
4534705|NCT01090492|7354429|FG000|First Intervention Period (4 Weeks)|Other|0
4534706|NCT01090492|7354430|FG001|First Intervention Period (4 Weeks)|Other|0
4534707|NCT01090492|7354431|FG002|First Intervention Period (4 Weeks)|Other|1
4534708|NCT01090492|7354432|FG003|First Intervention Period (4 Weeks)|Other|1
4534709|NCT01090492|7354433|FG004|First Intervention Period (4 Weeks)|Other|2
4534710|NCT01090492|7354434|FG005|First Intervention Period (4 Weeks)|Other|0
4534711|NCT01090492|7354435|FG006|First Intervention Period (4 Weeks)|Other|0
4534712|NCT01090492|7354436|FG007|First Intervention Period (4 Weeks)|Other|0
4534713|NCT01090492|7354429|FG000|First Intervention Period (4 Weeks)|Pregnancy|0
4534714|NCT01090492|7354430|FG001|First Intervention Period (4 Weeks)|Pregnancy|0
4534715|NCT01090492|7354431|FG002|First Intervention Period (4 Weeks)|Pregnancy|0
4534716|NCT01090492|7354432|FG003|First Intervention Period (4 Weeks)|Pregnancy|0
4534717|NCT01090492|7354433|FG004|First Intervention Period (4 Weeks)|Pregnancy|1
4610165|NCT01693523|7466626|FG000|Overall Study|Lack of compliance study medication|1
4610166|NCT01693523|7466627|FG001|Overall Study|Lack of compliance study medication|2
4610167|NCT01693523|7466628|FG002|Overall Study|Lack of compliance study medication|0
4610168|NCT01693523|7466626|FG000|Overall Study|Chemotherapy was held|1
4610169|NCT01693523|7466627|FG001|Overall Study|Chemotherapy was held|2
4610170|NCT01693523|7466628|FG002|Overall Study|Chemotherapy was held|0
4610171|NCT01693562|7466658|FG000|Escalation Phase|Withdrawal by Subject|0
4610172|NCT01693562|7466659|FG001|Escalation Phase|Withdrawal by Subject|1
4610173|NCT01693562|7466660|FG002|Escalation Phase|Withdrawal by Subject|0
4610174|NCT01693562|7466661|FG003|Escalation Phase|Withdrawal by Subject|0
4610175|NCT01693562|7466662|FG004|Escalation Phase|Withdrawal by Subject|0
4610176|NCT01693562|7466663|FG005|Escalation Phase|Withdrawal by Subject|2
4610177|NCT01693562|7466664|FG006|Escalation Phase|Withdrawal by Subject|0
4610178|NCT01693562|7466665|FG007|Escalation Phase|Withdrawal by Subject|0
4610179|NCT01693562|7466666|FG008|Escalation Phase|Withdrawal by Subject|0
4610180|NCT01693562|7466667|FG009|Escalation Phase|Withdrawal by Subject|0
4610181|NCT01693562|7466668|FG010|Escalation Phase|Withdrawal by Subject|0
4610182|NCT01693562|7466669|FG011|Escalation Phase|Withdrawal by Subject|0
4610183|NCT01693562|7466670|FG012|Escalation Phase|Withdrawal by Subject|0
4610184|NCT01693562|7466671|FG013|Escalation Phase|Withdrawal by Subject|0
4610185|NCT01693562|7466672|FG014|Escalation Phase|Withdrawal by Subject|0
4610186|NCT01693562|7466673|FG015|Escalation Phase|Withdrawal by Subject|0
4610187|NCT01693562|7466674|FG016|Escalation Phase|Withdrawal by Subject|0
4610188|NCT01693562|7466675|FG017|Escalation Phase|Withdrawal by Subject|0
4610189|NCT01693562|7466676|FG018|Escalation Phase|Withdrawal by Subject|0
4610190|NCT01693562|7466677|FG019|Escalation Phase|Withdrawal by Subject|0
4610191|NCT01693562|7466678|FG020|Escalation Phase|Withdrawal by Subject|0
4610192|NCT01693562|7466679|FG021|Escalation Phase|Withdrawal by Subject|0
4610193|NCT01693562|7466680|FG022|Escalation Phase|Withdrawal by Subject|0
4610194|NCT01693562|7466658|FG000|Escalation Phase|Death|4
4610195|NCT01693562|7466659|FG001|Escalation Phase|Death|2
4610196|NCT01693562|7466660|FG002|Escalation Phase|Death|0
4610197|NCT01693562|7466661|FG003|Escalation Phase|Death|3
4610198|NCT01693562|7466662|FG004|Escalation Phase|Death|6
4610199|NCT01693562|7466663|FG005|Escalation Phase|Death|4
4610200|NCT01693562|7466664|FG006|Escalation Phase|Death|0
4610201|NCT01693562|7466665|FG007|Escalation Phase|Death|0
4610202|NCT01693562|7466666|FG008|Escalation Phase|Death|0
4610203|NCT01693562|7466667|FG009|Escalation Phase|Death|0
4610204|NCT01693562|7466668|FG010|Escalation Phase|Death|0
4610205|NCT01693562|7466669|FG011|Escalation Phase|Death|0
4610206|NCT01693562|7466670|FG012|Escalation Phase|Death|0
4610207|NCT01693562|7466671|FG013|Escalation Phase|Death|0
4534718|NCT01090492|7354434|FG005|First Intervention Period (4 Weeks)|Pregnancy|0
4534719|NCT01090492|7354435|FG006|First Intervention Period (4 Weeks)|Pregnancy|0
4534720|NCT01090492|7354436|FG007|First Intervention Period (4 Weeks)|Pregnancy|0
4534721|NCT01090492|7354429|FG000|First Intervention Period (4 Weeks)|Adverse Event|0
4534722|NCT01090492|7354430|FG001|First Intervention Period (4 Weeks)|Adverse Event|2
4534723|NCT01090492|7354431|FG002|First Intervention Period (4 Weeks)|Adverse Event|0
4534724|NCT01090492|7354432|FG003|First Intervention Period (4 Weeks)|Adverse Event|3
4534725|NCT01090492|7354433|FG004|First Intervention Period (4 Weeks)|Adverse Event|1
4534726|NCT01090492|7354434|FG005|First Intervention Period (4 Weeks)|Adverse Event|2
4534727|NCT01090492|7354435|FG006|First Intervention Period (4 Weeks)|Adverse Event|0
4534728|NCT01090492|7354436|FG007|First Intervention Period (4 Weeks)|Adverse Event|5
4534729|NCT01090492|7354429|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1
4534730|NCT01090492|7354430|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0
4534731|NCT01090492|7354431|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0
4534732|NCT01090492|7354432|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0
4534733|NCT01090492|7354433|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1
4534734|NCT01090492|7354434|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0
4534735|NCT01090492|7354435|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1
4534736|NCT01090492|7354436|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1
4534737|NCT01090492|7354429|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0
4534738|NCT01090492|7354430|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1
4534739|NCT01090492|7354431|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0
4534740|NCT01090492|7354432|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0
4534741|NCT01090492|7354433|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0
4534742|NCT01090492|7354434|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0
4534743|NCT01090492|7354435|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0
4534744|NCT01090492|7354436|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0
4534745|NCT01090492|7354429|FG000|Second Intervention Period (4 Weeks)|Other|0
4534746|NCT01090492|7354430|FG001|Second Intervention Period (4 Weeks)|Other|1
4534747|NCT01090492|7354431|FG002|Second Intervention Period (4 Weeks)|Other|1
4534748|NCT01090492|7354432|FG003|Second Intervention Period (4 Weeks)|Other|0
4534749|NCT01090492|7354433|FG004|Second Intervention Period (4 Weeks)|Other|0
4534750|NCT01090492|7354434|FG005|Second Intervention Period (4 Weeks)|Other|0
4534751|NCT01090492|7354435|FG006|Second Intervention Period (4 Weeks)|Other|0
4534752|NCT01090492|7354436|FG007|Second Intervention Period (4 Weeks)|Other|0
4534753|NCT01090492|7354429|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0
4534754|NCT01090492|7354430|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0
4534755|NCT01090492|7354431|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1
4534756|NCT01090492|7354432|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0
4534757|NCT01090492|7354433|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1
4534758|NCT01090492|7354434|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1
4534759|NCT01090492|7354435|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7
4534760|NCT01090492|7354436|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1
4534761|NCT01090492|7354429|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
4534762|NCT01090492|7354430|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
4534763|NCT01090492|7354431|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
4534764|NCT01090492|7354432|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
4610208|NCT01693562|7466672|FG014|Escalation Phase|Death|0
4610209|NCT01693562|7466673|FG015|Escalation Phase|Death|0
4610210|NCT01693562|7466674|FG016|Escalation Phase|Death|0
4610211|NCT01693562|7466675|FG017|Escalation Phase|Death|0
4534765|NCT01090492|7354433|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
4534766|NCT01090492|7354434|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
4534767|NCT01090492|7354435|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1
4534768|NCT01090492|7354436|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
4534769|NCT01090739|7354455|FG000|Enrollment|Withdrawal by Subject|24
4534770|NCT01090739|7354455|FG000|Enrollment|Protocol Violation|14
4534771|NCT01090739|7354455|FG000|Enrollment|Lost to Follow-up|5
4534772|NCT01090739|7354455|FG000|Enrollment|Physician Decision|5
4534773|NCT01090739|7354455|FG000|Enrollment|Sponsor termination of site|4
4534774|NCT01090739|7354455|FG000|Enrollment|Study implant limit reached|2
4534775|NCT01090739|7354455|FG000|Enrollment|Adverse Event|1
4534776|NCT01090739|7354455|FG000|12 Month Follow-up|Withdrawal by Subject|2
4534777|NCT01090739|7354455|FG000|12 Month Follow-up|Lost to Follow-up|1
4534778|NCT01090739|7354455|FG000|12 Month Follow-up|Physician Decision|1
4534779|NCT01090739|7354455|FG000|12 Month Follow-up|Death|1
4534780|NCT01090739|7354455|FG000|24 Month Follow-up|Withdrawal by Subject|7
4534781|NCT01090739|7354455|FG000|24 Month Follow-up|Lost to Follow-up|1
4534782|NCT01090739|7354455|FG000|24 Month Follow-up|Death|1
4534783|NCT01090739|7354455|FG000|36 Month Follow-up|Withdrawal by Subject|6
4534784|NCT01090739|7354455|FG000|36 Month Follow-up|Visit still pending|17
4534785|NCT01090765|7354475|FG000|Overall Study|Patient withdrew consent|0
4534786|NCT01090765|7354476|FG001|Overall Study|Patient withdrew consent|0
4534787|NCT01090765|7354477|FG002|Overall Study|Patient withdrew consent|0
4534788|NCT01090765|7354478|FG003|Overall Study|Patient withdrew consent|0
4534789|NCT01090765|7354479|FG004|Overall Study|Patient withdrew consent|1
4534790|NCT01090765|7354480|FG005|Overall Study|Patient withdrew consent|1
4534791|NCT01090765|7354475|FG000|Overall Study|Developed a DVT, needed anticoagulation|0
4534792|NCT01090765|7354476|FG001|Overall Study|Developed a DVT, needed anticoagulation|0
4534793|NCT01090765|7354477|FG002|Overall Study|Developed a DVT, needed anticoagulation|0
4534794|NCT01090765|7354478|FG003|Overall Study|Developed a DVT, needed anticoagulation|1
4534795|NCT01090765|7354479|FG004|Overall Study|Developed a DVT, needed anticoagulation|0
4534796|NCT01090765|7354480|FG005|Overall Study|Developed a DVT, needed anticoagulation|0
4534797|NCT01090765|7354475|FG000|Overall Study|Vasovagal reaction with first infusion|0
4534798|NCT01090765|7354476|FG001|Overall Study|Vasovagal reaction with first infusion|0
4534799|NCT01090765|7354477|FG002|Overall Study|Vasovagal reaction with first infusion|0
4534800|NCT01090765|7354478|FG003|Overall Study|Vasovagal reaction with first infusion|0
4534801|NCT01090765|7354479|FG004|Overall Study|Vasovagal reaction with first infusion|1
4534802|NCT01090765|7354480|FG005|Overall Study|Vasovagal reaction with first infusion|0
4534803|NCT01090973|7354499|FG000|Overall Study|Disease progression|1
4534804|NCT01091103|7354503|FG000|Overall Study|Adverse Event|1
4534805|NCT01091103|7354503|FG000|Overall Study|Progressive Disease|3
4534806|NCT01091168|7354536|FG000|Overall Study|Progressive disease|250
4534807|NCT01091168|7354537|FG001|Overall Study|Progressive disease|234
4534808|NCT01091168|7354536|FG000|Overall Study|Adverse Event|21
4534809|NCT01091168|7354537|FG001|Overall Study|Adverse Event|24
4534810|NCT01091168|7354536|FG000|Overall Study|Lost to Follow-up|0
4534811|NCT01091168|7354537|FG001|Overall Study|Lost to Follow-up|1
4534812|NCT01091168|7354536|FG000|Overall Study|Physician, patient's decision, other|27
4534813|NCT01091168|7354537|FG001|Overall Study|Physician, patient's decision, other|37
4534814|NCT01091246|7354546|FG000|Overall Study|Lost to Follow-up|23
4534815|NCT01091246|7354547|FG001|Overall Study|Lost to Follow-up|11
4534816|NCT01091246|7354548|FG002|Overall Study|Lost to Follow-up|7
4534817|NCT01091246|7354546|FG000|Overall Study|Adverse Event|1
4534818|NCT01091246|7354547|FG001|Overall Study|Adverse Event|0
4534819|NCT01091246|7354548|FG002|Overall Study|Adverse Event|1
4534820|NCT01091246|7354546|FG000|Overall Study|Withdrawal by Subject|9
4534821|NCT01091246|7354547|FG001|Overall Study|Withdrawal by Subject|5
4534822|NCT01091246|7354548|FG002|Overall Study|Withdrawal by Subject|4
4534823|NCT01091246|7354546|FG000|Overall Study|Subject not dosed|2
4534824|NCT01091246|7354547|FG001|Overall Study|Subject not dosed|0
4534825|NCT01091246|7354548|FG002|Overall Study|Subject not dosed|1
4534826|NCT01091259|7354558|FG000|Overall Study|Adverse Event|3
4534827|NCT01091259|7354558|FG000|Overall Study|Lack of Efficacy|2
4534828|NCT01091363|7354564|FG000|Overall Study|Withdrawal by Subject|11
4534829|NCT01091363|7354565|FG001|Overall Study|Withdrawal by Subject|15
4534830|NCT01091363|7354564|FG000|Overall Study|Lost to Follow-up|2
4534831|NCT01091363|7354565|FG001|Overall Study|Lost to Follow-up|2
4534832|NCT01091428|7354575|FG000|Phase 1|Progressive Disease|24
4534833|NCT01091428|7354576|FG001|Phase 1|Progressive Disease|8
4534834|NCT01091428|7354577|FG002|Phase 1|Progressive Disease|0
4534835|NCT01091428|7354578|FG003|Phase 1|Progressive Disease|0
4534836|NCT01091428|7354575|FG000|Phase 1|Symptomatic Deterioration|3
4534837|NCT01091428|7354576|FG001|Phase 1|Symptomatic Deterioration|2
4534838|NCT01091428|7354577|FG002|Phase 1|Symptomatic Deterioration|0
4534839|NCT01091428|7354578|FG003|Phase 1|Symptomatic Deterioration|0
4534840|NCT01091428|7354575|FG000|Phase 1|Adverse Event|2
4534841|NCT01091428|7354576|FG001|Phase 1|Adverse Event|0
4534842|NCT01091428|7354577|FG002|Phase 1|Adverse Event|0
4534843|NCT01091428|7354578|FG003|Phase 1|Adverse Event|0
4534844|NCT01091428|7354575|FG000|Phase 1|Withdrawal by Subject|7
4534845|NCT01091428|7354576|FG001|Phase 1|Withdrawal by Subject|0
4534846|NCT01091428|7354577|FG002|Phase 1|Withdrawal by Subject|0
4534847|NCT01091428|7354578|FG003|Phase 1|Withdrawal by Subject|0
4534848|NCT01091428|7354575|FG000|Phase 1|Reason not specified|0
4534849|NCT01091428|7354576|FG001|Phase 1|Reason not specified|1
4534850|NCT01091428|7354577|FG002|Phase 1|Reason not specified|0
4534851|NCT01091428|7354578|FG003|Phase 1|Reason not specified|0
4534852|NCT01091428|7354575|FG000|Phase 1|Single-Patient IND|2
4534853|NCT01091428|7354576|FG001|Phase 1|Single-Patient IND|0
4534854|NCT01091428|7354577|FG002|Phase 1|Single-Patient IND|0
4534855|NCT01091428|7354578|FG003|Phase 1|Single-Patient IND|0
4534856|NCT01091428|7354575|FG000|Phase 2|Progressive Disease|0
4534857|NCT01091428|7354576|FG001|Phase 2|Progressive Disease|0
4534858|NCT01091428|7354577|FG002|Phase 2|Progressive Disease|44
4610212|NCT01693562|7466676|FG018|Escalation Phase|Death|0
4610213|NCT01693562|7466677|FG019|Escalation Phase|Death|0
4610214|NCT01693562|7466678|FG020|Escalation Phase|Death|0
4610215|NCT01693562|7466679|FG021|Escalation Phase|Death|0
4610216|NCT01693562|7466680|FG022|Escalation Phase|Death|0
4610217|NCT01693562|7466658|FG000|Escalation Phase|Lost to Follow-up|0
4610218|NCT01693562|7466659|FG001|Escalation Phase|Lost to Follow-up|1
4610219|NCT01693562|7466660|FG002|Escalation Phase|Lost to Follow-up|1
4534859|NCT01091428|7354578|FG003|Phase 2|Progressive Disease|46
4534860|NCT01091428|7354575|FG000|Phase 2|Symptomatic Deterioration|0
4534861|NCT01091428|7354576|FG001|Phase 2|Symptomatic Deterioration|0
4534862|NCT01091428|7354577|FG002|Phase 2|Symptomatic Deterioration|1
4534863|NCT01091428|7354578|FG003|Phase 2|Symptomatic Deterioration|6
4534864|NCT01091428|7354575|FG000|Phase 2|Adverse Event|0
4534865|NCT01091428|7354576|FG001|Phase 2|Adverse Event|0
4534866|NCT01091428|7354577|FG002|Phase 2|Adverse Event|12
4534867|NCT01091428|7354578|FG003|Phase 2|Adverse Event|5
4534868|NCT01091428|7354575|FG000|Phase 2|Withdrawal by Subject|0
4534869|NCT01091428|7354576|FG001|Phase 2|Withdrawal by Subject|0
4534870|NCT01091428|7354577|FG002|Phase 2|Withdrawal by Subject|9
4534871|NCT01091428|7354578|FG003|Phase 2|Withdrawal by Subject|8
4534872|NCT01091428|7354575|FG000|Phase 2|Unsatisfactory Therapeutic Response|0
4534873|NCT01091428|7354576|FG001|Phase 2|Unsatisfactory Therapeutic Response|0
4534874|NCT01091428|7354577|FG002|Phase 2|Unsatisfactory Therapeutic Response|1
4534875|NCT01091428|7354578|FG003|Phase 2|Unsatisfactory Therapeutic Response|1
4534876|NCT01091428|7354575|FG000|Phase 2|Reason not specified|0
4534877|NCT01091428|7354576|FG001|Phase 2|Reason not specified|0
4534878|NCT01091428|7354577|FG002|Phase 2|Reason not specified|4
4534879|NCT01091428|7354578|FG003|Phase 2|Reason not specified|3
4534880|NCT01091428|7354575|FG000|Phase 2|Physician Decision|0
4534881|NCT01091428|7354576|FG001|Phase 2|Physician Decision|0
4534882|NCT01091428|7354577|FG002|Phase 2|Physician Decision|2
4534883|NCT01091428|7354578|FG003|Phase 2|Physician Decision|0
4534884|NCT01091454|7354597|FG000|Overall Study|Ineligible|1
4534885|NCT01091519|7354603|FG000|Overall Study|Adverse Event|12
4534886|NCT01091519|7354604|FG001|Overall Study|Adverse Event|16
4534887|NCT01091519|7354603|FG000|Overall Study|Death|1
4534888|NCT01091519|7354604|FG001|Overall Study|Death|0
4534889|NCT01091519|7354603|FG000|Overall Study|Lack of Efficacy|16
4534890|NCT01091519|7354604|FG001|Overall Study|Lack of Efficacy|19
4534891|NCT01091519|7354603|FG000|Overall Study|Lost to Follow-up|14
4534892|NCT01091519|7354604|FG001|Overall Study|Lost to Follow-up|24
4534893|NCT01091519|7354603|FG000|Overall Study|Withdrawal by Subject|2
4534894|NCT01091519|7354604|FG001|Overall Study|Withdrawal by Subject|2
4534895|NCT01091519|7354603|FG000|Overall Study|Other|6
4534896|NCT01091519|7354604|FG001|Overall Study|Other|8
4534897|NCT01091519|7354603|FG000|Overall Study|Randomized not treated|4
4534898|NCT01091519|7354604|FG001|Overall Study|Randomized not treated|4
4534899|NCT01091662|7354612|FG000|Overall Study|Adverse Event|1
4534900|NCT01091662|7354613|FG001|Overall Study|Adverse Event|9
4534901|NCT01091662|7354612|FG000|Overall Study|Physician Decision|1
4534902|NCT01091662|7354613|FG001|Overall Study|Physician Decision|1
4534903|NCT01091662|7354612|FG000|Overall Study|Withdrawal by Subject|7
4534904|NCT01091662|7354613|FG001|Overall Study|Withdrawal by Subject|6
4534905|NCT01091662|7354612|FG000|Overall Study|met exit criteria|7
4534906|NCT01091662|7354613|FG001|Overall Study|met exit criteria|13
4534907|NCT01091662|7354612|FG000|Overall Study|met exclusion criteria|1
4534908|NCT01091662|7354613|FG001|Overall Study|met exclusion criteria|0
4534909|NCT01091662|7354612|FG000|Overall Study|Lost to Follow-up|0
4534910|NCT01091662|7354613|FG001|Overall Study|Lost to Follow-up|1
4534911|NCT01091662|7354612|FG000|Overall Study|Pregnancy|0
4534912|NCT01091662|7354613|FG001|Overall Study|Pregnancy|1
4534913|NCT01091662|7354612|FG000|Overall Study|Protocol Violation|0
4534914|NCT01091662|7354613|FG001|Overall Study|Protocol Violation|2
4534915|NCT01091662|7354612|FG000|Overall Study|unable to swallow capsule|0
4534916|NCT01091662|7354613|FG001|Overall Study|unable to swallow capsule|1
4534917|NCT01091675|7354624|FG000|Overall Study|Adverse Event|7
4534918|NCT01091675|7354624|FG000|Overall Study|Lack of Efficacy|27
4534919|NCT01091974|7354642|FG000|Overall Study|Did not start intervention|3
4534920|NCT01091974|7354643|FG001|Overall Study|Did not start intervention|1
4534921|NCT01091974|7354644|FG002|Overall Study|Did not start intervention|3
4534922|NCT01091974|7354645|FG003|Overall Study|Did not start intervention|1
4534923|NCT01091974|7354642|FG000|Overall Study|resumed sleep medication|0
4534924|NCT01091974|7354643|FG001|Overall Study|resumed sleep medication|0
4610220|NCT01693562|7466661|FG003|Escalation Phase|Lost to Follow-up|0
4534925|NCT01091974|7354644|FG002|Overall Study|resumed sleep medication|1
4534926|NCT01091974|7354645|FG003|Overall Study|resumed sleep medication|2
4534927|NCT01091974|7354642|FG000|Overall Study|Withdrawal by Subject|1
4534928|NCT01091974|7354643|FG001|Overall Study|Withdrawal by Subject|3
4534929|NCT01091974|7354644|FG002|Overall Study|Withdrawal by Subject|2
4534930|NCT01091974|7354645|FG003|Overall Study|Withdrawal by Subject|2
4534931|NCT01091974|7354642|FG000|Overall Study|side-effects|1
4534932|NCT01091974|7354643|FG001|Overall Study|side-effects|1
4534933|NCT01091974|7354644|FG002|Overall Study|side-effects|0
4534934|NCT01091974|7354645|FG003|Overall Study|side-effects|2
4534935|NCT01092182|7354658|FG000|Overall Study|Death|0
4534936|NCT01092182|7354659|FG001|Overall Study|Death|5
4534937|NCT01092182|7354660|FG002|Overall Study|Death|3
4534938|NCT01092182|7354658|FG000|Overall Study|participant safety|1
4534939|NCT01092182|7354659|FG001|Overall Study|participant safety|2
4534940|NCT01092182|7354660|FG002|Overall Study|participant safety|0
4534941|NCT01092182|7354658|FG000|Overall Study|Physician Decision|0
4534942|NCT01092182|7354659|FG001|Overall Study|Physician Decision|6
4534943|NCT01092182|7354660|FG002|Overall Study|Physician Decision|0
4534944|NCT01092182|7354658|FG000|Overall Study|Did not meet criteria|0
4534945|NCT01092182|7354659|FG001|Overall Study|Did not meet criteria|0
4534946|NCT01092182|7354660|FG002|Overall Study|Did not meet criteria|25
4534947|NCT01092182|7354658|FG000|Overall Study|Non-compliance|0
4534948|NCT01092182|7354659|FG001|Overall Study|Non-compliance|3
4534949|NCT01092182|7354660|FG002|Overall Study|Non-compliance|0
4534950|NCT01092182|7354658|FG000|Overall Study|Participant refused follow-up|0
4534951|NCT01092182|7354659|FG001|Overall Study|Participant refused follow-up|2
4534952|NCT01092182|7354660|FG002|Overall Study|Participant refused follow-up|0
4534953|NCT01092416|7354703|FG000|Enrollment|Atherectomy device not inserted|3
4534954|NCT01092416|7354703|FG000|30-Day Follow-up|Death|2
4534955|NCT01092416|7354703|FG000|30-Day Follow-up|Missed 30-day follow-up|3
4534956|NCT01092416|7354703|FG000|30-Day Follow-up|Data collected after close of 30D window|5
4534957|NCT01092416|7354703|FG000|12-Month Follow-up|Death|16
4534958|NCT01092416|7354703|FG000|12-Month Follow-up|Lost to Follow-up|4
4534959|NCT01092416|7354703|FG000|12-Month Follow-up|Withdrawal by Subject|2
4534960|NCT01092416|7354703|FG000|12-Month Follow-up|Missed 1-year follow-up|1
4534961|NCT01092416|7354703|FG000|12-Month Follow-up|Data collected after close of 1Y window|2
4534962|NCT01092507|7354726|FG000|Overall Study|Withdrawal by Subject|2
4534963|NCT01092507|7354727|FG001|Overall Study|Withdrawal by Subject|0
4534964|NCT01092546|7354733|FG000|Overall Study|Subjects withdrawn prior to dosing|4
4534965|NCT01092637|7354743|FG000|Overall Study|Death|47
4534966|NCT01092637|7354744|FG001|Overall Study|Death|49
4534967|NCT01092663|7354753|FG000|Overall Study|Withdrawal by Subject|3
4534968|NCT01092663|7354754|FG001|Overall Study|Withdrawal by Subject|2
4534969|NCT01092663|7354753|FG000|Overall Study|Glucose >300mg/dL|1
4610221|NCT01693562|7466662|FG004|Escalation Phase|Lost to Follow-up|0
4610222|NCT01693562|7466663|FG005|Escalation Phase|Lost to Follow-up|0
4610223|NCT01693562|7466664|FG006|Escalation Phase|Lost to Follow-up|0
4610224|NCT01693562|7466665|FG007|Escalation Phase|Lost to Follow-up|0
4610225|NCT01693562|7466666|FG008|Escalation Phase|Lost to Follow-up|0
4610226|NCT01693562|7466667|FG009|Escalation Phase|Lost to Follow-up|0
4610227|NCT01693562|7466668|FG010|Escalation Phase|Lost to Follow-up|0
4610228|NCT01693562|7466669|FG011|Escalation Phase|Lost to Follow-up|0
4610229|NCT01693562|7466670|FG012|Escalation Phase|Lost to Follow-up|0
4610230|NCT01693562|7466671|FG013|Escalation Phase|Lost to Follow-up|0
4610231|NCT01693562|7466672|FG014|Escalation Phase|Lost to Follow-up|0
4610232|NCT01693562|7466673|FG015|Escalation Phase|Lost to Follow-up|0
4610233|NCT01693562|7466674|FG016|Escalation Phase|Lost to Follow-up|0
4610234|NCT01693562|7466675|FG017|Escalation Phase|Lost to Follow-up|0
4610235|NCT01693562|7466676|FG018|Escalation Phase|Lost to Follow-up|0
4610236|NCT01693562|7466677|FG019|Escalation Phase|Lost to Follow-up|0
4610237|NCT01693562|7466678|FG020|Escalation Phase|Lost to Follow-up|0
4610238|NCT01693562|7466679|FG021|Escalation Phase|Lost to Follow-up|0
4610239|NCT01693562|7466680|FG022|Escalation Phase|Lost to Follow-up|0
4610240|NCT01693562|7466658|FG000|Escalation Phase|Other|0
4610241|NCT01693562|7466659|FG001|Escalation Phase|Other|0
4610242|NCT01693562|7466660|FG002|Escalation Phase|Other|2
4610243|NCT01693562|7466661|FG003|Escalation Phase|Other|0
4610244|NCT01693562|7466662|FG004|Escalation Phase|Other|0
4610245|NCT01693562|7466663|FG005|Escalation Phase|Other|1
4610246|NCT01693562|7466664|FG006|Escalation Phase|Other|0
4610247|NCT01693562|7466665|FG007|Escalation Phase|Other|0
4610248|NCT01693562|7466666|FG008|Escalation Phase|Other|0
4610249|NCT01693562|7466667|FG009|Escalation Phase|Other|0
4610250|NCT01693562|7466668|FG010|Escalation Phase|Other|0
4610251|NCT01693562|7466669|FG011|Escalation Phase|Other|0
4610252|NCT01693562|7466670|FG012|Escalation Phase|Other|0
4610253|NCT01693562|7466671|FG013|Escalation Phase|Other|0
4610254|NCT01693562|7466672|FG014|Escalation Phase|Other|0
4610255|NCT01693562|7466673|FG015|Escalation Phase|Other|0
4610256|NCT01693562|7466674|FG016|Escalation Phase|Other|0
4610257|NCT01693562|7466675|FG017|Escalation Phase|Other|0
4610258|NCT01693562|7466676|FG018|Escalation Phase|Other|0
4610259|NCT01693562|7466677|FG019|Escalation Phase|Other|0
4610260|NCT01693562|7466678|FG020|Escalation Phase|Other|0
4610261|NCT01693562|7466679|FG021|Escalation Phase|Other|0
4534970|NCT01092663|7354754|FG001|Overall Study|Glucose >300mg/dL|0
4534971|NCT01092663|7354753|FG000|Overall Study|High fasting triglyceride|2
4534972|NCT01092663|7354754|FG001|Overall Study|High fasting triglyceride|0
4534973|NCT01092663|7354753|FG000|Overall Study|Adverse Event|1
4534974|NCT01092663|7354754|FG001|Overall Study|Adverse Event|1
4534975|NCT01092663|7354753|FG000|Overall Study|Protocol Violation|0
4534976|NCT01092663|7354754|FG001|Overall Study|Protocol Violation|1
4534977|NCT01092702|7354774|FG000|Overall Study|Withdrawal by Subject|7
4534978|NCT01092702|7354774|FG000|Overall Study|Lost to Follow-up|2
4534979|NCT01092728|7354780|FG000|Overall Study|Withdrawal by Subject|2
4534980|NCT01092728|7354781|FG001|Overall Study|Withdrawal by Subject|0
4534981|NCT01092728|7354780|FG000|Overall Study|Adverse Event|0
4534982|NCT01092728|7354781|FG001|Overall Study|Adverse Event|1
4534983|NCT01092728|7354780|FG000|Overall Study|Disease Progression|1
4534984|NCT01092728|7354781|FG001|Overall Study|Disease Progression|13
4534985|NCT01092728|7354780|FG000|Overall Study|Prohibited Concomitant Medications|1
4534986|NCT01092728|7354781|FG001|Overall Study|Prohibited Concomitant Medications|0
4534987|NCT01092780|7354791|FG000|Washout Period 1|Adverse Event|0
4534988|NCT01092780|7354792|FG001|Washout Period 1|Adverse Event|1
4534989|NCT01092780|7354793|FG002|Washout Period 1|Adverse Event|0
4534990|NCT01092780|7354794|FG003|Washout Period 1|Adverse Event|0
4534991|NCT01092780|7354791|FG000|Washout Period 1|Noncompliance with nCPAP|1
4534992|NCT01092780|7354792|FG001|Washout Period 1|Noncompliance with nCPAP|0
4534993|NCT01092780|7354793|FG002|Washout Period 1|Noncompliance with nCPAP|0
4534994|NCT01092780|7354794|FG003|Washout Period 1|Noncompliance with nCPAP|0
4534995|NCT01092780|7354791|FG000|Washout Period 2|Adverse Event|0
4534996|NCT01092780|7354792|FG001|Washout Period 2|Adverse Event|1
4534997|NCT01092780|7354793|FG002|Washout Period 2|Adverse Event|1
4534998|NCT01092780|7354794|FG003|Washout Period 2|Adverse Event|0
4534999|NCT01092832|7354806|FG000|Overall Study|Other|1
4535000|NCT01092832|7354807|FG001|Overall Study|Other|0
4591024|NCT01525628|7437279|FG004|Overall Study|Other reason not defined above|0
4591025|NCT01525641|7437293|FG000|Overall Study|Case report form not collected|25
4591026|NCT01525641|7437293|FG000|Overall Study|No visit since the first visit|16
4591027|NCT01525641|7437293|FG000|Overall Study|Adverse Event|73
4591028|NCT01525641|7437293|FG000|Overall Study|Lack of Efficacy|24
4591029|NCT01525641|7437293|FG000|Overall Study|Improvement|5
4591030|NCT01525641|7437293|FG000|Overall Study|Lost to follow-up (relocation)|1
4591031|NCT01525641|7437293|FG000|Overall Study|Lost to follow-up (Unknown reason)|10
4591032|NCT01525641|7437293|FG000|Overall Study|Lost to follow-up (Changing hospital)|19
4591033|NCT01525641|7437293|FG000|Overall Study|Other than stated above|7
4591034|NCT01525849|7437314|FG000|Overall Study|Lost to Follow-up|3
4591035|NCT01525849|7437315|FG001|Overall Study|Lost to Follow-up|2
4591036|NCT01525849|7437314|FG000|Overall Study|Withdrawal by Subject|1
4591037|NCT01525849|7437315|FG001|Overall Study|Withdrawal by Subject|9
4591038|NCT01525849|7437314|FG000|Overall Study|Unrelated medical issue (not treated)|1
4591039|NCT01525849|7437315|FG001|Overall Study|Unrelated medical issue (not treated)|2
4591040|NCT01525849|7437314|FG000|Overall Study|Anatomic exclusion criteria identified|0
4591041|NCT01525849|7437315|FG001|Overall Study|Anatomic exclusion criteria identified|3
4591042|NCT01525875|7437327|FG000|Placebo-controlled Period|Withdrawal by Subject|1
4591043|NCT01525875|7437328|FG001|Placebo-controlled Period|Withdrawal by Subject|2
4591044|NCT01525875|7437327|FG000|Open-label Period|Lost to Follow-up|0
4591045|NCT01525875|7437328|FG001|Open-label Period|Lost to Follow-up|2
4591046|NCT01526057|7437337|FG000|Overall Study|Withdrawal by Subject|3
4591047|NCT01526057|7437338|FG001|Overall Study|Withdrawal by Subject|2
4591048|NCT01526057|7437339|FG002|Overall Study|Withdrawal by Subject|2
4591049|NCT01526057|7437337|FG000|Overall Study|Adverse Event|3
4591050|NCT01526057|7437338|FG001|Overall Study|Adverse Event|1
4591051|NCT01526057|7437339|FG002|Overall Study|Adverse Event|1
4591052|NCT01526057|7437337|FG000|Overall Study|Death|1
4591053|NCT01526057|7437338|FG001|Overall Study|Death|0
4591054|NCT01526057|7437339|FG002|Overall Study|Death|0
4591055|NCT01526057|7437337|FG000|Overall Study|Lost to Follow-up|1
4591056|NCT01526057|7437338|FG001|Overall Study|Lost to Follow-up|0
4591057|NCT01526057|7437339|FG002|Overall Study|Lost to Follow-up|1
4610262|NCT01693562|7466680|FG022|Escalation Phase|Other|0
4610263|NCT01693562|7466658|FG000|Exploration Phase|Withdrawal by Subject|0
4610264|NCT01693562|7466659|FG001|Exploration Phase|Withdrawal by Subject|0
4610265|NCT01693562|7466660|FG002|Exploration Phase|Withdrawal by Subject|0
4610266|NCT01693562|7466661|FG003|Exploration Phase|Withdrawal by Subject|0
4610267|NCT01693562|7466662|FG004|Exploration Phase|Withdrawal by Subject|0
4591058|NCT01526057|7437337|FG000|Overall Study|Other|1
4591059|NCT01526057|7437338|FG001|Overall Study|Other|0
4591060|NCT01526057|7437339|FG002|Overall Study|Other|1
4591061|NCT01526057|7437337|FG000|Overall Study|Protocol Violation|0
4591062|NCT01526057|7437338|FG001|Overall Study|Protocol Violation|0
4591063|NCT01526057|7437339|FG002|Overall Study|Protocol Violation|1
4591064|NCT01526148|7437349|FG000|Overall Study|Adverse Event|6
4591065|NCT01526148|7437350|FG001|Overall Study|Adverse Event|5
4591066|NCT01526148|7437349|FG000|Overall Study|Lost to Follow-up|3
4591067|NCT01526148|7437350|FG001|Overall Study|Lost to Follow-up|6
4591068|NCT01526148|7437349|FG000|Overall Study|Withdrawal by Subject|2
4591069|NCT01526148|7437350|FG001|Overall Study|Withdrawal by Subject|0
4591070|NCT01526148|7437349|FG000|Overall Study|Unstable Medical Condition|1
4535001|NCT01093222|7354858|FG000|Overall Study|Ineligible|6
4535002|NCT01093222|7354858|FG000|Overall Study|Adverse Event|7
4535003|NCT01093222|7354858|FG000|Overall Study|Progression/relapse|24
4535004|NCT01093222|7354858|FG000|Overall Study|Death|2
4535005|NCT01093222|7354858|FG000|Overall Study|Not protocol specified|1
4535006|NCT01093534|7354897|FG000|Overall Study|Adverse Event|2
4535007|NCT01093534|7354898|FG001|Overall Study|Adverse Event|5
4535008|NCT01093534|7354899|FG002|Overall Study|Adverse Event|2
4535009|NCT01093534|7354897|FG000|Overall Study|Lack of Efficacy|2
4535010|NCT01093534|7354898|FG001|Overall Study|Lack of Efficacy|1
4535011|NCT01093534|7354899|FG002|Overall Study|Lack of Efficacy|1
4535012|NCT01093534|7354897|FG000|Overall Study|Withdrawal by Subject|5
4535013|NCT01093534|7354898|FG001|Overall Study|Withdrawal by Subject|7
4535014|NCT01093534|7354899|FG002|Overall Study|Withdrawal by Subject|2
4535015|NCT01093534|7354897|FG000|Overall Study|Other|1
4535016|NCT01093534|7354898|FG001|Overall Study|Other|3
4535017|NCT01093534|7354899|FG002|Overall Study|Other|4
4535018|NCT01093573|7354911|FG000|Overall Study|Physician Decision|0
4535019|NCT01093573|7354912|FG001|Overall Study|Physician Decision|0
4535020|NCT01093573|7354913|FG002|Overall Study|Physician Decision|1
4535021|NCT01093573|7354911|FG000|Overall Study|Insurance Denied|0
4535022|NCT01093573|7354912|FG001|Overall Study|Insurance Denied|0
4535023|NCT01093573|7354913|FG002|Overall Study|Insurance Denied|1
4535024|NCT01093586|7354924|FG000|Overall Study|Failed to engraft|3
4535025|NCT01093599|7354930|FG000|Overall Study|Lost to Follow-up|32
4535026|NCT01093599|7354931|FG001|Overall Study|Lost to Follow-up|46
4535027|NCT01093625|7354939|FG000|Baseline and Dispensed|Withdrawal by Subject|2
4535028|NCT01093625|7354940|FG001|Baseline and Dispensed|Withdrawal by Subject|0
4535029|NCT01093625|7354939|FG000|2-Week Visit|Withdrawal by Subject|1
4535030|NCT01093625|7354940|FG001|2-Week Visit|Withdrawal by Subject|0
4535031|NCT01093625|7354939|FG000|1-Month Visit|Lost to Follow-up|2
4535032|NCT01093625|7354940|FG001|1-Month Visit|Lost to Follow-up|0
4535033|NCT01093625|7354939|FG000|3-Month Visit|Lost to Follow-up|2
4535034|NCT01093625|7354940|FG001|3-Month Visit|Lost to Follow-up|0
4535035|NCT01093625|7354939|FG000|6-Month Visit|Withdrawal by Subject|6
4535036|NCT01093625|7354940|FG001|6-Month Visit|Withdrawal by Subject|7
4535037|NCT01093625|7354939|FG000|6-Month Visit|Lost to Follow-up|2
4535038|NCT01093625|7354940|FG001|6-Month Visit|Lost to Follow-up|2
4535039|NCT01093625|7354939|FG000|1-Year Visit|Lost to Follow-up|5
4535040|NCT01093625|7354940|FG001|1-Year Visit|Lost to Follow-up|3
4535041|NCT01093755|7354966|FG000|Overall Study|Withdrawal by Subject|3
4535042|NCT01093755|7354967|FG001|Overall Study|Withdrawal by Subject|4
4535043|NCT01093885|7354986|FG000|Overall Study|Adverse Event|4
4535044|NCT01093885|7354986|FG000|Overall Study|Lost to Follow-up|1
4535045|NCT01094119|7355006|FG000|Overall Study|Lack of Efficacy|2
4535046|NCT01094119|7355007|FG001|Overall Study|Lack of Efficacy|4
4535047|NCT01094171|7355013|FG000|Overall Study|Lost to Follow-up|2
4535048|NCT01094171|7355013|FG000|Overall Study|Informed consent withdrawal|4
4535049|NCT01094171|7355013|FG000|Overall Study|Migration from the study area|3
4535050|NCT01094171|7355013|FG000|Overall Study|Other|1
4535051|NCT01094184|7355019|FG000|Overall Study|Death|35
4535052|NCT01094184|7355020|FG001|Overall Study|Death|11
4535053|NCT01094288|7355034|FG000|Overall Study|Adverse Event|0
4535054|NCT01094288|7355035|FG001|Overall Study|Adverse Event|3
4535055|NCT01094288|7355036|FG002|Overall Study|Adverse Event|1
4535056|NCT01094288|7355037|FG003|Overall Study|Adverse Event|1
4535057|NCT01094288|7355038|FG004|Overall Study|Adverse Event|0
4535058|NCT01094288|7355039|FG005|Overall Study|Adverse Event|0
4535059|NCT01094288|7355040|FG006|Overall Study|Adverse Event|0
4535060|NCT01094288|7355041|FG007|Overall Study|Adverse Event|0
4535061|NCT01094288|7355034|FG000|Overall Study|Withdrawal by Subject|0
4535062|NCT01094288|7355035|FG001|Overall Study|Withdrawal by Subject|1
4535063|NCT01094288|7355036|FG002|Overall Study|Withdrawal by Subject|2
4535064|NCT01094288|7355037|FG003|Overall Study|Withdrawal by Subject|0
4535065|NCT01094288|7355038|FG004|Overall Study|Withdrawal by Subject|0
4535066|NCT01094288|7355039|FG005|Overall Study|Withdrawal by Subject|0
4535067|NCT01094288|7355040|FG006|Overall Study|Withdrawal by Subject|0
4535068|NCT01094288|7355041|FG007|Overall Study|Withdrawal by Subject|2
4535069|NCT01094288|7355034|FG000|Overall Study|Initiation of Alternative Therapy|0
4535070|NCT01094288|7355035|FG001|Overall Study|Initiation of Alternative Therapy|0
4535071|NCT01094288|7355036|FG002|Overall Study|Initiation of Alternative Therapy|1
4535072|NCT01094288|7355037|FG003|Overall Study|Initiation of Alternative Therapy|0
4535073|NCT01094288|7355038|FG004|Overall Study|Initiation of Alternative Therapy|0
4535074|NCT01094288|7355039|FG005|Overall Study|Initiation of Alternative Therapy|0
4535075|NCT01094288|7355040|FG006|Overall Study|Initiation of Alternative Therapy|0
4535076|NCT01094288|7355041|FG007|Overall Study|Initiation of Alternative Therapy|0
4535077|NCT01094288|7355034|FG000|Overall Study|Reason not Specified|2
4535078|NCT01094288|7355035|FG001|Overall Study|Reason not Specified|3
4535079|NCT01094288|7355036|FG002|Overall Study|Reason not Specified|0
4535080|NCT01094288|7355037|FG003|Overall Study|Reason not Specified|1
4535081|NCT01094288|7355038|FG004|Overall Study|Reason not Specified|0
4535082|NCT01094288|7355039|FG005|Overall Study|Reason not Specified|0
4535083|NCT01094288|7355040|FG006|Overall Study|Reason not Specified|0
4535084|NCT01094288|7355041|FG007|Overall Study|Reason not Specified|0
4535085|NCT01094288|7355034|FG000|Overall Study|Ongoing Participants|0
4535086|NCT01094288|7355035|FG001|Overall Study|Ongoing Participants|3
4535087|NCT01094288|7355036|FG002|Overall Study|Ongoing Participants|0
4535088|NCT01094288|7355037|FG003|Overall Study|Ongoing Participants|0
4535089|NCT01094288|7355038|FG004|Overall Study|Ongoing Participants|0
4535090|NCT01094288|7355039|FG005|Overall Study|Ongoing Participants|0
4535091|NCT01094288|7355040|FG006|Overall Study|Ongoing Participants|0
4535092|NCT01094288|7355041|FG007|Overall Study|Ongoing Participants|0
4535093|NCT01094301|7355063|FG000|Trial Stage|Withdrawal by Subject|1
4535094|NCT01094301|7355063|FG000|Implant Stage|Adverse Event|1
4535095|NCT01094301|7355063|FG000|Implant Stage|Protocol Violation|1
4535096|NCT01094301|7355063|FG000|Implant Stage|Withdrawal by Subject|2
4535097|NCT01094301|7355063|FG000|Implant Stage|No return of pain|4
4535098|NCT01094730|7355140|FG000|Period 1 (14 Days)|Lost to Follow-up|0
4535099|NCT01094730|7355141|FG001|Period 1 (14 Days)|Lost to Follow-up|1
4535100|NCT01094730|7355140|FG000|Period 1 (14 Days)|Withdrawal by Subject|0
4535101|NCT01094730|7355141|FG001|Period 1 (14 Days)|Withdrawal by Subject|1
4535102|NCT01094730|7355140|FG000|Period 1 (14 Days)|No time for the follow-up visit|1
4535103|NCT01094730|7355141|FG001|Period 1 (14 Days)|No time for the follow-up visit|0
4535104|NCT01094730|7355140|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1
4535105|NCT01094730|7355141|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0
4535106|NCT01094730|7355140|FG000|Period 2 (14 Days)|Protocol Violation|2
4535107|NCT01094730|7355141|FG001|Period 2 (14 Days)|Protocol Violation|0
4535108|NCT01094730|7355140|FG000|Period 2 (14 Days)|No time for the follow-up visit|1
4535109|NCT01094730|7355141|FG001|Period 2 (14 Days)|No time for the follow-up visit|0
4535110|NCT01094730|7355140|FG000|Period 2 (14 Days)|Adverse Event|0
4535111|NCT01094730|7355141|FG001|Period 2 (14 Days)|Adverse Event|1
4535112|NCT01094730|7355140|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0
4535113|NCT01094730|7355141|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1
4535114|NCT01094743|7355148|FG000|Period 1|Unsatisfactory comfort at lens fitting|2
4535115|NCT01094782|7355159|FG000|Overall Study|Withdrawal by Subject|5
4535116|NCT01094782|7355160|FG001|Overall Study|Withdrawal by Subject|5
4535117|NCT01094782|7355161|FG002|Overall Study|Withdrawal by Subject|1
4535118|NCT01094782|7355162|FG003|Overall Study|Withdrawal by Subject|5
4535119|NCT01094782|7355163|FG004|Overall Study|Withdrawal by Subject|5
4535120|NCT01094782|7355164|FG005|Overall Study|Withdrawal by Subject|0
4535121|NCT01094782|7355159|FG000|Overall Study|Lost to Follow-up|1
4535122|NCT01094782|7355160|FG001|Overall Study|Lost to Follow-up|0
4535123|NCT01094782|7355161|FG002|Overall Study|Lost to Follow-up|0
4535124|NCT01094782|7355162|FG003|Overall Study|Lost to Follow-up|2
4535125|NCT01094782|7355163|FG004|Overall Study|Lost to Follow-up|1
4535126|NCT01094782|7355164|FG005|Overall Study|Lost to Follow-up|4
4535127|NCT01094782|7355159|FG000|Overall Study|Positive Drug Screen|2
4535128|NCT01094782|7355160|FG001|Overall Study|Positive Drug Screen|2
4535129|NCT01094782|7355161|FG002|Overall Study|Positive Drug Screen|1
4535130|NCT01094782|7355162|FG003|Overall Study|Positive Drug Screen|1
4535131|NCT01094782|7355163|FG004|Overall Study|Positive Drug Screen|3
4535132|NCT01094782|7355164|FG005|Overall Study|Positive Drug Screen|2
4535133|NCT01094782|7355159|FG000|Overall Study|Sensory Deficit at Site of QST|0
4535134|NCT01094782|7355160|FG001|Overall Study|Sensory Deficit at Site of QST|1
4535135|NCT01094782|7355161|FG002|Overall Study|Sensory Deficit at Site of QST|0
4535136|NCT01094782|7355162|FG003|Overall Study|Sensory Deficit at Site of QST|0
4535137|NCT01094782|7355163|FG004|Overall Study|Sensory Deficit at Site of QST|0
4535138|NCT01094782|7355164|FG005|Overall Study|Sensory Deficit at Site of QST|0
4535139|NCT01094782|7355159|FG000|Overall Study|Unable to Complete Questionnaires|0
4535140|NCT01094782|7355160|FG001|Overall Study|Unable to Complete Questionnaires|1
4535141|NCT01094782|7355161|FG002|Overall Study|Unable to Complete Questionnaires|0
4535142|NCT01094782|7355162|FG003|Overall Study|Unable to Complete Questionnaires|0
4535143|NCT01094782|7355163|FG004|Overall Study|Unable to Complete Questionnaires|0
4535144|NCT01094782|7355164|FG005|Overall Study|Unable to Complete Questionnaires|0
4535145|NCT01094782|7355159|FG000|Overall Study|Healthy Subject Had Pain|0
4535146|NCT01094782|7355160|FG001|Overall Study|Healthy Subject Had Pain|1
4535147|NCT01094782|7355161|FG002|Overall Study|Healthy Subject Had Pain|0
4535148|NCT01094782|7355162|FG003|Overall Study|Healthy Subject Had Pain|0
4535149|NCT01094782|7355163|FG004|Overall Study|Healthy Subject Had Pain|0
4535150|NCT01094782|7355164|FG005|Overall Study|Healthy Subject Had Pain|0
4535151|NCT01094782|7355159|FG000|Overall Study|Hypertension|0
4535152|NCT01094782|7355160|FG001|Overall Study|Hypertension|0
4535153|NCT01094782|7355161|FG002|Overall Study|Hypertension|1
4535154|NCT01094782|7355162|FG003|Overall Study|Hypertension|0
4535155|NCT01094782|7355163|FG004|Overall Study|Hypertension|0
4535156|NCT01094782|7355164|FG005|Overall Study|Hypertension|0
4535157|NCT01094782|7355159|FG000|Overall Study|Wrong Pain Condition|0
4535158|NCT01094782|7355160|FG001|Overall Study|Wrong Pain Condition|0
4535159|NCT01094782|7355161|FG002|Overall Study|Wrong Pain Condition|0
4535160|NCT01094782|7355162|FG003|Overall Study|Wrong Pain Condition|2
4535161|NCT01094782|7355163|FG004|Overall Study|Wrong Pain Condition|1
4535162|NCT01094782|7355164|FG005|Overall Study|Wrong Pain Condition|1
4535163|NCT01094782|7355159|FG000|Overall Study|Recent Interventional Injection|0
4535164|NCT01094782|7355160|FG001|Overall Study|Recent Interventional Injection|0
4535165|NCT01094782|7355161|FG002|Overall Study|Recent Interventional Injection|0
4535166|NCT01094782|7355162|FG003|Overall Study|Recent Interventional Injection|0
4535167|NCT01094782|7355163|FG004|Overall Study|Recent Interventional Injection|0
4535168|NCT01094782|7355164|FG005|Overall Study|Recent Interventional Injection|1
4535169|NCT01094782|7355159|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0
4535170|NCT01094782|7355160|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0
4535171|NCT01094782|7355161|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0
4535172|NCT01094782|7355162|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0
4535173|NCT01094782|7355163|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1
4535174|NCT01094782|7355164|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0
4535175|NCT01094782|7355159|FG000|Overall Study|Noncompliance With Study Schedule|0
4535176|NCT01094782|7355160|FG001|Overall Study|Noncompliance With Study Schedule|0
4535177|NCT01094782|7355161|FG002|Overall Study|Noncompliance With Study Schedule|0
4535178|NCT01094782|7355162|FG003|Overall Study|Noncompliance With Study Schedule|1
4535179|NCT01094782|7355163|FG004|Overall Study|Noncompliance With Study Schedule|0
4535180|NCT01094782|7355164|FG005|Overall Study|Noncompliance With Study Schedule|0
4535181|NCT01094808|7355181|FG000|Overall Study|Withdrawal by Subject|1
4535182|NCT01094808|7355182|FG001|Overall Study|Withdrawal by Subject|1
4535183|NCT01094808|7355183|FG002|Overall Study|Withdrawal by Subject|0
4535184|NCT01094886|7355191|FG000|Overall Study|Adverse Event|2
4535185|NCT01094886|7355191|FG000|Overall Study|Withdrawal by Subject|5
4535186|NCT01095094|7355206|FG000|Overall Study|Withdrawal by Subject|1
4535187|NCT01095094|7355206|FG000|Overall Study|Death|1
4535188|NCT01095094|7355206|FG000|Overall Study|Physician Decision|1
4535189|NCT01095653|7355241|FG000|Overall Study|Lack of Efficacy|3
4535190|NCT01095653|7355242|FG001|Overall Study|Lack of Efficacy|0
4535191|NCT01095653|7355243|FG002|Overall Study|Lack of Efficacy|0
4535192|NCT01095653|7355241|FG000|Overall Study|Adverse Event|1
4535193|NCT01095653|7355242|FG001|Overall Study|Adverse Event|4
4535194|NCT01095653|7355243|FG002|Overall Study|Adverse Event|4
4535195|NCT01095653|7355241|FG000|Overall Study|Lost to Follow-up|1
4535196|NCT01095653|7355242|FG001|Overall Study|Lost to Follow-up|0
4535197|NCT01095653|7355243|FG002|Overall Study|Lost to Follow-up|4
4535198|NCT01095653|7355241|FG000|Overall Study|Withdrawal by Subject|4
4535199|NCT01095653|7355242|FG001|Overall Study|Withdrawal by Subject|5
4535200|NCT01095653|7355243|FG002|Overall Study|Withdrawal by Subject|3
4535201|NCT01095653|7355241|FG000|Overall Study|non-compliance, not met criteria, etc.|10
4535202|NCT01095653|7355242|FG001|Overall Study|non-compliance, not met criteria, etc.|6
4535203|NCT01095653|7355243|FG002|Overall Study|non-compliance, not met criteria, etc.|5
4535204|NCT01095666|7355254|FG000|Overall Study|Lack of Efficacy|0
4535205|NCT01095666|7355255|FG001|Overall Study|Lack of Efficacy|0
4535206|NCT01095666|7355256|FG002|Overall Study|Lack of Efficacy|1
4535207|NCT01095666|7355254|FG000|Overall Study|Adverse Event|2
4535208|NCT01095666|7355255|FG001|Overall Study|Adverse Event|1
4535209|NCT01095666|7355256|FG002|Overall Study|Adverse Event|3
4535210|NCT01095666|7355254|FG000|Overall Study|Lost to Follow-up|2
4535211|NCT01095666|7355255|FG001|Overall Study|Lost to Follow-up|2
4535212|NCT01095666|7355256|FG002|Overall Study|Lost to Follow-up|0
4535213|NCT01095666|7355254|FG000|Overall Study|Withdrawal by Subject|6
4535214|NCT01095666|7355255|FG001|Overall Study|Withdrawal by Subject|6
4535215|NCT01095666|7355256|FG002|Overall Study|Withdrawal by Subject|1
4535216|NCT01095666|7355254|FG000|Overall Study|Non-compliance, not met criteria etc.|7
4535217|NCT01095666|7355255|FG001|Overall Study|Non-compliance, not met criteria etc.|2
4535218|NCT01095666|7355256|FG002|Overall Study|Non-compliance, not met criteria etc.|2
4535219|NCT01095796|7355271|FG000|Overall Study|Randomized but Not Treated|5
4535220|NCT01095796|7355272|FG001|Overall Study|Randomized but Not Treated|2
4535221|NCT01095796|7355271|FG000|Overall Study|Adverse Event|9
4535222|NCT01095796|7355272|FG001|Overall Study|Adverse Event|19
4535223|NCT01095796|7355271|FG000|Overall Study|Death|3
4535224|NCT01095796|7355272|FG001|Overall Study|Death|2
4535225|NCT01095796|7355271|FG000|Overall Study|Pregnancy|2
4535226|NCT01095796|7355272|FG001|Overall Study|Pregnancy|0
4535227|NCT01095796|7355271|FG000|Overall Study|Lack of Efficacy|5
4535228|NCT01095796|7355272|FG001|Overall Study|Lack of Efficacy|3
4535229|NCT01095796|7355271|FG000|Overall Study|Investigator's Discretion|7
4535230|NCT01095796|7355272|FG001|Overall Study|Investigator's Discretion|2
4535231|NCT01095796|7355271|FG000|Overall Study|Withdrew Consent|16
4535232|NCT01095796|7355272|FG001|Overall Study|Withdrew Consent|22
4535233|NCT01095796|7355271|FG000|Overall Study|Lost to Follow-up|27
4535234|NCT01095796|7355272|FG001|Overall Study|Lost to Follow-up|29
4535235|NCT01095796|7355271|FG000|Overall Study|Participant Noncompliance|5
4535236|NCT01095796|7355272|FG001|Overall Study|Participant Noncompliance|10
4535237|NCT01095796|7355271|FG000|Overall Study|Protocol Violation|1
4535238|NCT01095796|7355272|FG001|Overall Study|Protocol Violation|0
4535239|NCT01095796|7355271|FG000|Overall Study|Participant Transferred to Another Study|215
4535240|NCT01095796|7355272|FG001|Overall Study|Participant Transferred to Another Study|200
4535241|NCT01095835|7355281|FG000|Overall Study|Adverse Event|8
4535242|NCT01095835|7355282|FG001|Overall Study|Adverse Event|6
4535243|NCT01095835|7355283|FG002|Overall Study|Adverse Event|6
4535244|NCT01095835|7355281|FG000|Overall Study|Lack of Efficacy|0
4535245|NCT01095835|7355282|FG001|Overall Study|Lack of Efficacy|1
4535246|NCT01095835|7355283|FG002|Overall Study|Lack of Efficacy|0
4535247|NCT01095835|7355281|FG000|Overall Study|Physician Decision|0
4535248|NCT01095835|7355282|FG001|Overall Study|Physician Decision|0
4535249|NCT01095835|7355283|FG002|Overall Study|Physician Decision|1
4535250|NCT01095835|7355281|FG000|Overall Study|Withdrawal by Subject|1
4535251|NCT01095835|7355282|FG001|Overall Study|Withdrawal by Subject|3
4535252|NCT01095835|7355283|FG002|Overall Study|Withdrawal by Subject|0
4535253|NCT01095835|7355281|FG000|Overall Study|Non study compliance|0
4535254|NCT01095835|7355282|FG001|Overall Study|Non study compliance|0
4535255|NCT01095835|7355283|FG002|Overall Study|Non study compliance|1
4535256|NCT01095835|7355281|FG000|Overall Study|Protocol Violation|1
4535257|NCT01095835|7355282|FG001|Overall Study|Protocol Violation|2
4535258|NCT01095835|7355283|FG002|Overall Study|Protocol Violation|0
4535259|NCT01095978|7355296|FG000|Overall Study|Did not take Klacid SR|2
4535260|NCT01095978|7355296|FG000|Overall Study|Adverse Event|1
4535261|NCT01096017|7355302|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1
4535262|NCT01096017|7355303|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1
4535263|NCT01096056|7355311|FG000|Overall Study|Lost to Follow-up|0
4535264|NCT01096056|7355312|FG001|Overall Study|Lost to Follow-up|1
4535265|NCT01096160|7355328|FG000|Overall Study|Adverse Event|0
4535266|NCT01096160|7355329|FG001|Overall Study|Adverse Event|0
4535267|NCT01096160|7355330|FG002|Overall Study|Adverse Event|1
4535268|NCT01096160|7355331|FG003|Overall Study|Adverse Event|0
4535269|NCT01096160|7355332|FG004|Overall Study|Adverse Event|0
4535270|NCT01096160|7355333|FG005|Overall Study|Adverse Event|0
4535271|NCT01096160|7355334|FG006|Overall Study|Adverse Event|0
4535272|NCT01096160|7355335|FG007|Overall Study|Adverse Event|0
4535273|NCT01096160|7355336|FG008|Overall Study|Adverse Event|0
4535274|NCT01096160|7355337|FG009|Overall Study|Adverse Event|1
4535275|NCT01096160|7355328|FG000|Overall Study|Met stopping criteria per protocol|0
4535276|NCT01096160|7355329|FG001|Overall Study|Met stopping criteria per protocol|0
4535277|NCT01096160|7355330|FG002|Overall Study|Met stopping criteria per protocol|0
4535278|NCT01096160|7355331|FG003|Overall Study|Met stopping criteria per protocol|0
4535279|NCT01096160|7355332|FG004|Overall Study|Met stopping criteria per protocol|1
4535280|NCT01096160|7355333|FG005|Overall Study|Met stopping criteria per protocol|0
4535281|NCT01096160|7355334|FG006|Overall Study|Met stopping criteria per protocol|2
4535282|NCT01096160|7355335|FG007|Overall Study|Met stopping criteria per protocol|0
4535283|NCT01096160|7355336|FG008|Overall Study|Met stopping criteria per protocol|2
4535284|NCT01096160|7355337|FG009|Overall Study|Met stopping criteria per protocol|0
4535285|NCT01096186|7355372|FG000|Overall Study|Adverse Event|16
4535286|NCT01096186|7355372|FG000|Overall Study|Death|4
4535287|NCT01096186|7355372|FG000|Overall Study|Lack of Efficacy|4
4535288|NCT01096186|7355372|FG000|Overall Study|Lost to Follow-up|2
4535289|NCT01096186|7355372|FG000|Overall Study|Withdrawal by Subject|22
4535290|NCT01096186|7355372|FG000|Overall Study|Physician Decision|1
4535291|NCT01096186|7355372|FG000|Overall Study|Noncompliance with study drug|1
4535292|NCT01096316|7355387|FG000|Overall Study|Lost to Follow-up|15
4535293|NCT01096316|7355388|FG001|Overall Study|Lost to Follow-up|9
4535294|NCT01096342|7355394|FG000|Overall Study|Protocol Violation|1
4535295|NCT01096446|7355400|FG000|Overall Study|Death|1
4535296|NCT01096446|7355401|FG001|Overall Study|Death|0
4535297|NCT01096446|7355400|FG000|Overall Study|Protocol Violation|2
4535298|NCT01096446|7355401|FG001|Overall Study|Protocol Violation|0
4535299|NCT01096550|7355408|FG000|Overall Study|discontinued site|10
4535300|NCT01096550|7355409|FG001|Overall Study|discontinued site|11
4535301|NCT01096550|7355408|FG000|Overall Study|non-regular treatment track at clinic|1
4535302|NCT01096550|7355409|FG001|Overall Study|non-regular treatment track at clinic|1
4535303|NCT01096550|7355408|FG000|Overall Study|clinic readmission|1
4535304|NCT01096550|7355409|FG001|Overall Study|clinic readmission|1
4535305|NCT01096550|7355408|FG000|Overall Study|Withdrawal by Subject|0
4535306|NCT01096550|7355409|FG001|Overall Study|Withdrawal by Subject|1
4535307|NCT01096550|7355408|FG000|Overall Study|non-African American participant|13
4535308|NCT01096550|7355409|FG001|Overall Study|non-African American participant|6
4535309|NCT01096550|7355408|FG000|Overall Study|Lost to Follow-up|12
4535310|NCT01096550|7355409|FG001|Overall Study|Lost to Follow-up|9
4535311|NCT01096589|7355419|FG000|Overall Study|Adverse Event|2
4535312|NCT01096589|7355420|FG001|Overall Study|Adverse Event|1
4535313|NCT01096589|7355421|FG002|Overall Study|Adverse Event|2
4535314|NCT01096589|7355422|FG003|Overall Study|Adverse Event|1
4535315|NCT01096589|7355419|FG000|Overall Study|Withdrawal by Subject|2
4535316|NCT01096589|7355420|FG001|Overall Study|Withdrawal by Subject|1
4535317|NCT01096589|7355421|FG002|Overall Study|Withdrawal by Subject|1
4535318|NCT01096589|7355422|FG003|Overall Study|Withdrawal by Subject|1
4535319|NCT01096589|7355419|FG000|Overall Study|Compliance with protocol|0
4535320|NCT01096589|7355420|FG001|Overall Study|Compliance with protocol|0
4535321|NCT01096589|7355421|FG002|Overall Study|Compliance with protocol|1
4535322|NCT01096589|7355422|FG003|Overall Study|Compliance with protocol|0
4535323|NCT01096589|7355419|FG000|Overall Study|found treatment exhausting|0
4535324|NCT01096589|7355420|FG001|Overall Study|found treatment exhausting|0
4535325|NCT01096589|7355421|FG002|Overall Study|found treatment exhausting|0
4535326|NCT01096589|7355422|FG003|Overall Study|found treatment exhausting|1
4535327|NCT01096667|7355441|FG000|Overall Study|Lost to Follow-up|1
4535328|NCT01096667|7355442|FG001|Overall Study|Lost to Follow-up|1
4535329|NCT01096667|7355443|FG002|Overall Study|Lost to Follow-up|1
4535330|NCT01096667|7355444|FG003|Overall Study|Lost to Follow-up|0
4535331|NCT01096667|7355445|FG004|Overall Study|Lost to Follow-up|0
4535332|NCT01096667|7355441|FG000|Overall Study|Withdrawal by Subject|1
4535333|NCT01096667|7355442|FG001|Overall Study|Withdrawal by Subject|0
4535334|NCT01096667|7355443|FG002|Overall Study|Withdrawal by Subject|0
4535335|NCT01096667|7355444|FG003|Overall Study|Withdrawal by Subject|1
4535336|NCT01096667|7355445|FG004|Overall Study|Withdrawal by Subject|0
4535337|NCT01096667|7355441|FG000|Overall Study|Reason not available|0
4535338|NCT01096667|7355442|FG001|Overall Study|Reason not available|1
4535339|NCT01096667|7355443|FG002|Overall Study|Reason not available|1
4535340|NCT01096667|7355444|FG003|Overall Study|Reason not available|1
4535341|NCT01096667|7355445|FG004|Overall Study|Reason not available|0
4535342|NCT01096667|7355441|FG000|Overall Study|Protocol Violation|0
4535343|NCT01096667|7355442|FG001|Overall Study|Protocol Violation|0
4535344|NCT01096667|7355443|FG002|Overall Study|Protocol Violation|0
4535345|NCT01096667|7355444|FG003|Overall Study|Protocol Violation|1
4535346|NCT01096667|7355445|FG004|Overall Study|Protocol Violation|0
4535347|NCT01096667|7355441|FG000|Overall Study|Not treated|1
4535348|NCT01096667|7355442|FG001|Overall Study|Not treated|0
4535349|NCT01096667|7355443|FG002|Overall Study|Not treated|0
4535350|NCT01096667|7355444|FG003|Overall Study|Not treated|0
4535351|NCT01096667|7355445|FG004|Overall Study|Not treated|0
4535352|NCT01096784|7355490|FG000|Overall Study|Withdrawal by Subject|2
4535353|NCT01096784|7355491|FG001|Overall Study|Withdrawal by Subject|1
4535354|NCT01096784|7355490|FG000|Overall Study|Adverse Event|11
4535355|NCT01096784|7355491|FG001|Overall Study|Adverse Event|9
4535356|NCT01096784|7355490|FG000|Overall Study|Protocol Deviation|2
4535357|NCT01096784|7355491|FG001|Overall Study|Protocol Deviation|2
4535358|NCT01096784|7355490|FG000|Overall Study|Administrative Decision|0
4535359|NCT01096784|7355491|FG001|Overall Study|Administrative Decision|1
4535360|NCT01096784|7355490|FG000|Overall Study|Other Unspecified|0
4535361|NCT01096784|7355491|FG001|Overall Study|Other Unspecified|1
4535362|NCT01096849|7355515|FG000|Overall Study|Consent Withdrawn|1
4535363|NCT01096849|7355516|FG001|Overall Study|Consent Withdrawn|4
4535364|NCT01096849|7355517|FG002|Overall Study|Consent Withdrawn|2
4535365|NCT01096849|7355515|FG000|Overall Study|Lack of Efficacy|0
4535366|NCT01096849|7355516|FG001|Overall Study|Lack of Efficacy|2
4535367|NCT01096849|7355517|FG002|Overall Study|Lack of Efficacy|0
4535368|NCT01096849|7355515|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0
4535369|NCT01096849|7355516|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1
4535370|NCT01096849|7355517|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1
4535371|NCT01096849|7355515|FG000|Overall Study|Investigator or Medical Monitor Decision|0
4535372|NCT01096849|7355516|FG001|Overall Study|Investigator or Medical Monitor Decision|1
4535373|NCT01096849|7355517|FG002|Overall Study|Investigator or Medical Monitor Decision|0
4535374|NCT01096849|7355515|FG000|Overall Study|Administrative Reasons|0
4535375|NCT01096849|7355516|FG001|Overall Study|Administrative Reasons|1
4535376|NCT01096849|7355517|FG002|Overall Study|Administrative Reasons|2
4535377|NCT01096849|7355515|FG000|Overall Study|Lost to Follow-up|1
4535378|NCT01096849|7355516|FG001|Overall Study|Lost to Follow-up|3
4535379|NCT01096849|7355517|FG002|Overall Study|Lost to Follow-up|1
4535380|NCT01097044|7355560|FG000|Overall Study|Withdrawal by Subject|4
4535381|NCT01097044|7355561|FG001|Overall Study|Withdrawal by Subject|4
4535382|NCT01097044|7355560|FG000|Overall Study|Lost to Follow-up|1
4535383|NCT01097044|7355561|FG001|Overall Study|Lost to Follow-up|0
4535384|NCT01097044|7355560|FG000|Overall Study|Withdrawal by Sponsor|0
4535385|NCT01097044|7355561|FG001|Overall Study|Withdrawal by Sponsor|1
4535386|NCT01097057|7355569|FG000|Overall Study|Physician Decision|3
4535387|NCT01097330|7355580|FG000|Overall Study|Study terminated early|7
4535388|NCT01097330|7355581|FG001|Overall Study|Study terminated early|5
4535389|NCT01097421|7355603|FG000|Overall Study|Adverse Event|8
4535390|NCT01097421|7355603|FG000|Overall Study|Protocol Violation|2
4535391|NCT01097421|7355603|FG000|Overall Study|Lost to Follow-up|1
4535392|NCT01097421|7355603|FG000|Overall Study|Withdrawal by Subject|3
4535393|NCT01097577|7355613|FG000|Overall Study|Adverse Event|0
4535394|NCT01097577|7355614|FG001|Overall Study|Adverse Event|1
4535395|NCT01097616|7355623|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6
4535396|NCT01097616|7355624|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15
4535397|NCT01097616|7355625|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21
4535398|NCT01097616|7355626|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
4535399|NCT01097616|7355627|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
4535400|NCT01097616|7355628|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
4535401|NCT01097616|7355629|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
4535402|NCT01097616|7355630|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
4535403|NCT01097616|7355623|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6
4535404|NCT01097616|7355624|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8
4535405|NCT01097616|7355625|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12
4535406|NCT01097616|7355626|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
4535407|NCT01097616|7355627|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
4535408|NCT01097616|7355628|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
4535409|NCT01097616|7355629|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
4535410|NCT01097616|7355630|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
4535411|NCT01097616|7355623|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5
4535412|NCT01097616|7355624|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3
4535413|NCT01097616|7355625|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1
4535414|NCT01097616|7355626|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
4535415|NCT01097616|7355627|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
4535416|NCT01097616|7355628|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
4535417|NCT01097616|7355629|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
4535418|NCT01097616|7355630|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
4535419|NCT01097616|7355623|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
4535420|NCT01097616|7355624|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
4535421|NCT01097616|7355625|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
4535422|NCT01097616|7355626|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
4535423|NCT01097616|7355627|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
4535424|NCT01097616|7355628|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
4535425|NCT01097616|7355629|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
4535426|NCT01097616|7355630|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
4535427|NCT01097616|7355623|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1
4535428|NCT01097616|7355624|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7
4535429|NCT01097616|7355625|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9
4535430|NCT01097616|7355626|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
4535431|NCT01097616|7355627|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
4535432|NCT01097616|7355628|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
4535433|NCT01097616|7355629|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
4535434|NCT01097616|7355630|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
4535435|NCT01097616|7355623|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1
4535436|NCT01097616|7355624|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1
4535437|NCT01097616|7355625|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
4535438|NCT01097616|7355626|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
4535439|NCT01097616|7355627|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
4535440|NCT01097616|7355628|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
4535441|NCT01097616|7355629|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
4535442|NCT01097616|7355630|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
4535443|NCT01097616|7355623|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4
4535444|NCT01097616|7355624|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3
4535445|NCT01097616|7355625|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
4535446|NCT01097616|7355626|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
4535447|NCT01097616|7355627|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
4535448|NCT01097616|7355628|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
4535449|NCT01097616|7355629|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
4535450|NCT01097616|7355630|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
4535451|NCT01097616|7355623|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
4535452|NCT01097616|7355624|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
4535453|NCT01097616|7355625|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1
4535454|NCT01097616|7355626|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
4535455|NCT01097616|7355627|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
4535456|NCT01097616|7355628|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
4535457|NCT01097616|7355629|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
4535458|NCT01097616|7355630|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
4535459|NCT01097616|7355623|FG000|Optional DB EXT Phase|Adverse Event|0
4535460|NCT01097616|7355624|FG001|Optional DB EXT Phase|Adverse Event|7
4535461|NCT01097616|7355625|FG002|Optional DB EXT Phase|Adverse Event|2
4535462|NCT01097616|7355626|FG003|Optional DB EXT Phase|Adverse Event|0
4535463|NCT01097616|7355627|FG004|Optional DB EXT Phase|Adverse Event|0
4535464|NCT01097616|7355628|FG005|Optional DB EXT Phase|Adverse Event|0
4535465|NCT01097616|7355629|FG006|Optional DB EXT Phase|Adverse Event|0
4535466|NCT01097616|7355630|FG007|Optional DB EXT Phase|Adverse Event|0
4535467|NCT01097616|7355623|FG000|Optional DB EXT Phase|Withdrawal by Subject|12
4535468|NCT01097616|7355624|FG001|Optional DB EXT Phase|Withdrawal by Subject|6
4535469|NCT01097616|7355625|FG002|Optional DB EXT Phase|Withdrawal by Subject|3
4535470|NCT01097616|7355626|FG003|Optional DB EXT Phase|Withdrawal by Subject|0
4535471|NCT01097616|7355627|FG004|Optional DB EXT Phase|Withdrawal by Subject|0
4535472|NCT01097616|7355628|FG005|Optional DB EXT Phase|Withdrawal by Subject|0
4535473|NCT01097616|7355629|FG006|Optional DB EXT Phase|Withdrawal by Subject|0
4535474|NCT01097616|7355630|FG007|Optional DB EXT Phase|Withdrawal by Subject|0
4535475|NCT01097616|7355623|FG000|Optional DB EXT Phase|Protocol Violation|0
4535476|NCT01097616|7355624|FG001|Optional DB EXT Phase|Protocol Violation|2
4535477|NCT01097616|7355625|FG002|Optional DB EXT Phase|Protocol Violation|3
4535478|NCT01097616|7355626|FG003|Optional DB EXT Phase|Protocol Violation|0
4535479|NCT01097616|7355627|FG004|Optional DB EXT Phase|Protocol Violation|0
4535480|NCT01097616|7355628|FG005|Optional DB EXT Phase|Protocol Violation|0
4535481|NCT01097616|7355629|FG006|Optional DB EXT Phase|Protocol Violation|0
4535482|NCT01097616|7355630|FG007|Optional DB EXT Phase|Protocol Violation|0
4535483|NCT01097616|7355623|FG000|Optional DB EXT Phase|Lost to Follow-up|1
4535484|NCT01097616|7355624|FG001|Optional DB EXT Phase|Lost to Follow-up|5
4535485|NCT01097616|7355625|FG002|Optional DB EXT Phase|Lost to Follow-up|1
4535486|NCT01097616|7355626|FG003|Optional DB EXT Phase|Lost to Follow-up|0
4535487|NCT01097616|7355627|FG004|Optional DB EXT Phase|Lost to Follow-up|0
4535488|NCT01097616|7355628|FG005|Optional DB EXT Phase|Lost to Follow-up|0
4535489|NCT01097616|7355629|FG006|Optional DB EXT Phase|Lost to Follow-up|0
4535490|NCT01097616|7355630|FG007|Optional DB EXT Phase|Lost to Follow-up|0
4535491|NCT01097616|7355623|FG000|Optional DB EXT Phase|Lack of Efficacy|1
4535492|NCT01097616|7355624|FG001|Optional DB EXT Phase|Lack of Efficacy|1
4535493|NCT01097616|7355625|FG002|Optional DB EXT Phase|Lack of Efficacy|1
4535494|NCT01097616|7355626|FG003|Optional DB EXT Phase|Lack of Efficacy|0
4535495|NCT01097616|7355627|FG004|Optional DB EXT Phase|Lack of Efficacy|0
4535496|NCT01097616|7355628|FG005|Optional DB EXT Phase|Lack of Efficacy|0
4535497|NCT01097616|7355629|FG006|Optional DB EXT Phase|Lack of Efficacy|0
4535498|NCT01097616|7355630|FG007|Optional DB EXT Phase|Lack of Efficacy|0
4535499|NCT01097616|7355623|FG000|Optional DB EXT Phase|Physician Decision|1
4535500|NCT01097616|7355624|FG001|Optional DB EXT Phase|Physician Decision|0
4535501|NCT01097616|7355625|FG002|Optional DB EXT Phase|Physician Decision|0
4535502|NCT01097616|7355626|FG003|Optional DB EXT Phase|Physician Decision|0
4535503|NCT01097616|7355627|FG004|Optional DB EXT Phase|Physician Decision|0
4535504|NCT01097616|7355628|FG005|Optional DB EXT Phase|Physician Decision|0
4535505|NCT01097616|7355629|FG006|Optional DB EXT Phase|Physician Decision|0
4535506|NCT01097616|7355630|FG007|Optional DB EXT Phase|Physician Decision|0
4535507|NCT01097616|7355623|FG000|DB RO Phase|Adverse Event|0
4535508|NCT01097616|7355624|FG001|DB RO Phase|Adverse Event|0
4535509|NCT01097616|7355625|FG002|DB RO Phase|Adverse Event|0
4535510|NCT01097616|7355626|FG003|DB RO Phase|Adverse Event|0
4535511|NCT01097616|7355627|FG004|DB RO Phase|Adverse Event|0
4535512|NCT01097616|7355628|FG005|DB RO Phase|Adverse Event|0
4535513|NCT01097616|7355629|FG006|DB RO Phase|Adverse Event|1
4535514|NCT01097616|7355630|FG007|DB RO Phase|Adverse Event|0
4535515|NCT01097616|7355623|FG000|DB RO Phase|Withdrawal by Subject|0
4535516|NCT01097616|7355624|FG001|DB RO Phase|Withdrawal by Subject|0
4535517|NCT01097616|7355625|FG002|DB RO Phase|Withdrawal by Subject|0
4535518|NCT01097616|7355626|FG003|DB RO Phase|Withdrawal by Subject|0
4535519|NCT01097616|7355627|FG004|DB RO Phase|Withdrawal by Subject|0
4535520|NCT01097616|7355628|FG005|DB RO Phase|Withdrawal by Subject|1
4535521|NCT01097616|7355629|FG006|DB RO Phase|Withdrawal by Subject|0
4535522|NCT01097616|7355630|FG007|DB RO Phase|Withdrawal by Subject|0
4535523|NCT01097616|7355623|FG000|DB RO Phase|Lost to Follow-up|0
4535524|NCT01097616|7355624|FG001|DB RO Phase|Lost to Follow-up|0
4535525|NCT01097616|7355625|FG002|DB RO Phase|Lost to Follow-up|0
4535526|NCT01097616|7355626|FG003|DB RO Phase|Lost to Follow-up|1
4535527|NCT01097616|7355627|FG004|DB RO Phase|Lost to Follow-up|1
4535528|NCT01097616|7355628|FG005|DB RO Phase|Lost to Follow-up|0
4535529|NCT01097616|7355629|FG006|DB RO Phase|Lost to Follow-up|0
4535530|NCT01097616|7355630|FG007|DB RO Phase|Lost to Follow-up|1
4535531|NCT01097616|7355623|FG000|DB RO Phase|Not Treated in RO|0
4535532|NCT01097616|7355624|FG001|DB RO Phase|Not Treated in RO|0
4535533|NCT01097616|7355625|FG002|DB RO Phase|Not Treated in RO|0
4535534|NCT01097616|7355626|FG003|DB RO Phase|Not Treated in RO|0
4535535|NCT01097616|7355627|FG004|DB RO Phase|Not Treated in RO|0
4535536|NCT01097616|7355628|FG005|DB RO Phase|Not Treated in RO|1
4535537|NCT01097616|7355629|FG006|DB RO Phase|Not Treated in RO|0
4535538|NCT01097616|7355630|FG007|DB RO Phase|Not Treated in RO|0
4535539|NCT01097629|7355659|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10
4535540|NCT01097629|7355660|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19
4535541|NCT01097629|7355661|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17
4535542|NCT01097629|7355662|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
4535543|NCT01097629|7355663|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
4535544|NCT01097629|7355664|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
4535545|NCT01097629|7355665|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
4535546|NCT01097629|7355666|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
4535547|NCT01097629|7355659|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8
4535548|NCT01097629|7355660|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9
4535549|NCT01097629|7355661|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19
4535550|NCT01097629|7355662|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
4535551|NCT01097629|7355663|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
4535552|NCT01097629|7355664|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
4535553|NCT01097629|7355665|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
4535554|NCT01097629|7355666|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
4535555|NCT01097629|7355659|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5
4535556|NCT01097629|7355660|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4
4535557|NCT01097629|7355661|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8
4535558|NCT01097629|7355662|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
4535559|NCT01097629|7355663|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
4535560|NCT01097629|7355664|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
4535561|NCT01097629|7355665|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
4535562|NCT01097629|7355666|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
4535563|NCT01097629|7355659|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2
4535564|NCT01097629|7355660|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4
4535565|NCT01097629|7355661|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
4535566|NCT01097629|7355662|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
4535567|NCT01097629|7355663|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
4535568|NCT01097629|7355664|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
4535569|NCT01097629|7355665|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
4535570|NCT01097629|7355666|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
4535571|NCT01097629|7355659|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7
4535572|NCT01097629|7355660|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4
4535573|NCT01097629|7355661|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8
4535574|NCT01097629|7355662|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
4535575|NCT01097629|7355663|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
4535576|NCT01097629|7355664|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
4535577|NCT01097629|7355665|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
4535578|NCT01097629|7355666|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
4535579|NCT01097629|7355659|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2
4535580|NCT01097629|7355660|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1
4535581|NCT01097629|7355661|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
4535582|NCT01097629|7355662|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
4535583|NCT01097629|7355663|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
4535584|NCT01097629|7355664|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
4535585|NCT01097629|7355665|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
4535586|NCT01097629|7355666|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
4535587|NCT01097629|7355659|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1
4535588|NCT01097629|7355660|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5
4535589|NCT01097629|7355661|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4
4535590|NCT01097629|7355662|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
4535591|NCT01097629|7355663|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
4535592|NCT01097629|7355664|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
4535593|NCT01097629|7355665|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
4535594|NCT01097629|7355666|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
4535595|NCT01097629|7355659|FG000|DB RO Phase|Withdrawal by Subject|0
4535596|NCT01097629|7355660|FG001|DB RO Phase|Withdrawal by Subject|0
4535597|NCT01097629|7355661|FG002|DB RO Phase|Withdrawal by Subject|0
4535598|NCT01097629|7355662|FG003|DB RO Phase|Withdrawal by Subject|0
4535599|NCT01097629|7355663|FG004|DB RO Phase|Withdrawal by Subject|0
4535600|NCT01097629|7355664|FG005|DB RO Phase|Withdrawal by Subject|0
4535601|NCT01097629|7355665|FG006|DB RO Phase|Withdrawal by Subject|0
4535602|NCT01097629|7355666|FG007|DB RO Phase|Withdrawal by Subject|1
4535603|NCT01097629|7355659|FG000|DB RO Phase|Protocol Violation|0
4535604|NCT01097629|7355660|FG001|DB RO Phase|Protocol Violation|0
4535605|NCT01097629|7355661|FG002|DB RO Phase|Protocol Violation|0
4535606|NCT01097629|7355662|FG003|DB RO Phase|Protocol Violation|1
4535607|NCT01097629|7355663|FG004|DB RO Phase|Protocol Violation|0
4535608|NCT01097629|7355664|FG005|DB RO Phase|Protocol Violation|1
4535609|NCT01097629|7355665|FG006|DB RO Phase|Protocol Violation|1
4535610|NCT01097629|7355666|FG007|DB RO Phase|Protocol Violation|0
4535611|NCT01097629|7355659|FG000|DB RO Phase|Lost to Follow-up|0
4535612|NCT01097629|7355660|FG001|DB RO Phase|Lost to Follow-up|0
4535613|NCT01097629|7355661|FG002|DB RO Phase|Lost to Follow-up|0
4535614|NCT01097629|7355662|FG003|DB RO Phase|Lost to Follow-up|0
4535615|NCT01097629|7355663|FG004|DB RO Phase|Lost to Follow-up|0
4535616|NCT01097629|7355664|FG005|DB RO Phase|Lost to Follow-up|0
4535617|NCT01097629|7355665|FG006|DB RO Phase|Lost to Follow-up|2
4610268|NCT01693562|7466663|FG005|Exploration Phase|Withdrawal by Subject|0
4610269|NCT01693562|7466664|FG006|Exploration Phase|Withdrawal by Subject|2
4610270|NCT01693562|7466665|FG007|Exploration Phase|Withdrawal by Subject|0
4610271|NCT01693562|7466666|FG008|Exploration Phase|Withdrawal by Subject|0
4610272|NCT01693562|7466667|FG009|Exploration Phase|Withdrawal by Subject|0
4610273|NCT01693562|7466668|FG010|Exploration Phase|Withdrawal by Subject|0
4610274|NCT01693562|7466669|FG011|Exploration Phase|Withdrawal by Subject|0
4610275|NCT01693562|7466670|FG012|Exploration Phase|Withdrawal by Subject|0
4610276|NCT01693562|7466671|FG013|Exploration Phase|Withdrawal by Subject|0
4610277|NCT01693562|7466672|FG014|Exploration Phase|Withdrawal by Subject|0
4610278|NCT01693562|7466673|FG015|Exploration Phase|Withdrawal by Subject|0
4610279|NCT01693562|7466674|FG016|Exploration Phase|Withdrawal by Subject|0
4610280|NCT01693562|7466675|FG017|Exploration Phase|Withdrawal by Subject|0
4610281|NCT01693562|7466676|FG018|Exploration Phase|Withdrawal by Subject|0
4610282|NCT01693562|7466677|FG019|Exploration Phase|Withdrawal by Subject|0
4610283|NCT01693562|7466678|FG020|Exploration Phase|Withdrawal by Subject|0
4610284|NCT01693562|7466679|FG021|Exploration Phase|Withdrawal by Subject|0
4610285|NCT01693562|7466680|FG022|Exploration Phase|Withdrawal by Subject|0
4610286|NCT01693562|7466658|FG000|Exploration Phase|Death|0
4610287|NCT01693562|7466659|FG001|Exploration Phase|Death|0
4610288|NCT01693562|7466660|FG002|Exploration Phase|Death|0
4535618|NCT01097629|7355666|FG007|DB RO Phase|Lost to Follow-up|0
4535619|NCT01097655|7355698|FG000|Overall Study|Withdrawal by Subject|1
4535620|NCT01097655|7355698|FG000|Overall Study|Subject Documented Twice|1
4535621|NCT01097655|7355698|FG000|Overall Study|Did Not Meet Inclusion Criteria|8
4535622|NCT01097668|7355704|FG000|Overall Study|Withdrawal by Subject|1
4535623|NCT01097668|7355705|FG001|Overall Study|Withdrawal by Subject|2
4535624|NCT01097668|7355704|FG000|Overall Study|Lost to Follow-up|1
4535625|NCT01097668|7355705|FG001|Overall Study|Lost to Follow-up|0
4535626|NCT01097694|7355717|FG000|Overall Study|Adverse Event|5
4535627|NCT01097694|7355718|FG001|Overall Study|Adverse Event|0
4535628|NCT01097694|7355717|FG000|Overall Study|Lost to Follow-up|0
4535629|NCT01097694|7355718|FG001|Overall Study|Lost to Follow-up|3
4535630|NCT01097694|7355717|FG000|Overall Study|Withdrawal by Subject|3
4535631|NCT01097694|7355718|FG001|Overall Study|Withdrawal by Subject|1
4535632|NCT01097707|7355729|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0
4535633|NCT01097707|7355730|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0
4535634|NCT01097707|7355731|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1
4535635|NCT01097707|7355732|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1
4535636|NCT01097707|7355733|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1
4535637|NCT01097707|7355729|FG000|Overall Study|Adverse Event|4
4535638|NCT01097707|7355730|FG001|Overall Study|Adverse Event|2
4535639|NCT01097707|7355731|FG002|Overall Study|Adverse Event|3
4535640|NCT01097707|7355732|FG003|Overall Study|Adverse Event|1
4535641|NCT01097707|7355733|FG004|Overall Study|Adverse Event|3
4535642|NCT01097707|7355729|FG000|Overall Study|Entry Criteria Not Met|2
4535643|NCT01097707|7355730|FG001|Overall Study|Entry Criteria Not Met|1
4535644|NCT01097707|7355731|FG002|Overall Study|Entry Criteria Not Met|1
4535645|NCT01097707|7355732|FG003|Overall Study|Entry Criteria Not Met|0
4535646|NCT01097707|7355733|FG004|Overall Study|Entry Criteria Not Met|1
4535647|NCT01097707|7355729|FG000|Overall Study|Lack of Efficacy|1
4535648|NCT01097707|7355730|FG001|Overall Study|Lack of Efficacy|0
4535649|NCT01097707|7355731|FG002|Overall Study|Lack of Efficacy|0
4535650|NCT01097707|7355732|FG003|Overall Study|Lack of Efficacy|1
4535651|NCT01097707|7355733|FG004|Overall Study|Lack of Efficacy|0
4535652|NCT01097707|7355729|FG000|Overall Study|Lost to Follow-up|1
4535653|NCT01097707|7355730|FG001|Overall Study|Lost to Follow-up|1
4535654|NCT01097707|7355731|FG002|Overall Study|Lost to Follow-up|2
4535655|NCT01097707|7355732|FG003|Overall Study|Lost to Follow-up|0
4535656|NCT01097707|7355733|FG004|Overall Study|Lost to Follow-up|3
4535657|NCT01097707|7355729|FG000|Overall Study|Protocol Violation|2
4535658|NCT01097707|7355730|FG001|Overall Study|Protocol Violation|2
4535659|NCT01097707|7355731|FG002|Overall Study|Protocol Violation|3
4535660|NCT01097707|7355732|FG003|Overall Study|Protocol Violation|2
4535661|NCT01097707|7355733|FG004|Overall Study|Protocol Violation|2
4535662|NCT01097707|7355729|FG000|Overall Study|Sponsor Decision|31
4535663|NCT01097707|7355730|FG001|Overall Study|Sponsor Decision|31
4535664|NCT01097707|7355731|FG002|Overall Study|Sponsor Decision|34
4535665|NCT01097707|7355732|FG003|Overall Study|Sponsor Decision|35
4535666|NCT01097707|7355733|FG004|Overall Study|Sponsor Decision|36
4535667|NCT01097707|7355729|FG000|Overall Study|Withdrawal by Subject|3
4535668|NCT01097707|7355730|FG001|Overall Study|Withdrawal by Subject|6
4535669|NCT01097707|7355731|FG002|Overall Study|Withdrawal by Subject|1
4535670|NCT01097707|7355732|FG003|Overall Study|Withdrawal by Subject|4
4535671|NCT01097707|7355733|FG004|Overall Study|Withdrawal by Subject|3
4535672|NCT01097707|7355729|FG000|Overall Study|Reason unknown|0
4535673|NCT01097707|7355730|FG001|Overall Study|Reason unknown|0
4535674|NCT01097707|7355731|FG002|Overall Study|Reason unknown|0
4535675|NCT01097707|7355732|FG003|Overall Study|Reason unknown|0
4535676|NCT01097707|7355733|FG004|Overall Study|Reason unknown|1
4535677|NCT01097863|7355758|FG000|Overall Study|Discomfort|1
4535678|NCT01097863|7355759|FG001|Overall Study|Discomfort|0
4535679|NCT01097863|7355760|FG002|Overall Study|Discomfort|1
4535680|NCT01097863|7355758|FG000|Overall Study|Did not return for final visit|0
4535681|NCT01097863|7355759|FG001|Overall Study|Did not return for final visit|0
4535682|NCT01097863|7355760|FG002|Overall Study|Did not return for final visit|1
4535683|NCT01098097|7355805|FG000|Overall Study|Adverse Event|17
4535684|NCT01098097|7355805|FG000|Overall Study|Lost to Follow-up|18
4535685|NCT01098097|7355805|FG000|Overall Study|Status unknown|16
4535686|NCT01098097|7355805|FG000|Overall Study|No reason reported|31
4535687|NCT01098162|7355809|FG000|Overall Study|Adverse Event|37
4535688|NCT01098162|7355809|FG000|Overall Study|Lack of Efficacy|4
4535689|NCT01098162|7355809|FG000|Overall Study|Wish of Patient|7
4535690|NCT01098162|7355809|FG000|Overall Study|Lost to Follow-up|9
4535691|NCT01098162|7355809|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5
4535692|NCT01098162|7355809|FG000|Overall Study|Adverse Event & Lack of Efficacy|6
4535693|NCT01098162|7355809|FG000|Overall Study|Adverse Event & Wish of Patient|13
4535694|NCT01098162|7355809|FG000|Overall Study|Adverse Event & Lost to Follow-up|2
4535695|NCT01098162|7355809|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1
4535696|NCT01098162|7355809|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1
4535697|NCT01098162|7355809|FG000|Overall Study|Other Reason|1
4535698|NCT01098162|7355809|FG000|Overall Study|Reason Unknown|26
4535699|NCT01098240|7355813|FG000|Open-Label Phase|Study Terminated by Sponsor|27
4535700|NCT01098240|7355814|FG001|Open-Label Phase|Study Terminated by Sponsor|0
4535701|NCT01098240|7355815|FG002|Open-Label Phase|Study Terminated by Sponsor|0
4535702|NCT01098240|7355813|FG000|Open-Label Phase|Protocol Violation|4
4535703|NCT01098240|7355814|FG001|Open-Label Phase|Protocol Violation|0
4535704|NCT01098240|7355815|FG002|Open-Label Phase|Protocol Violation|0
4535705|NCT01098240|7355813|FG000|Open-Label Phase|Lost to Follow-up|13
4535706|NCT01098240|7355814|FG001|Open-Label Phase|Lost to Follow-up|0
4535707|NCT01098240|7355815|FG002|Open-Label Phase|Lost to Follow-up|0
4535708|NCT01098240|7355813|FG000|Open-Label Phase|Other|19
4535709|NCT01098240|7355814|FG001|Open-Label Phase|Other|0
4535710|NCT01098240|7355815|FG002|Open-Label Phase|Other|0
4535711|NCT01098240|7355813|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50
4535712|NCT01098240|7355814|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0
4535713|NCT01098240|7355815|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0
4535714|NCT01098240|7355813|FG000|Open-Label Phase|Pregnancy|1
4535715|NCT01098240|7355814|FG001|Open-Label Phase|Pregnancy|0
4535716|NCT01098240|7355815|FG002|Open-Label Phase|Pregnancy|0
4535717|NCT01098240|7355813|FG000|Open-Label Phase|Withdrawal by Subject|9
4535718|NCT01098240|7355814|FG001|Open-Label Phase|Withdrawal by Subject|0
4535719|NCT01098240|7355815|FG002|Open-Label Phase|Withdrawal by Subject|0
4535720|NCT01098240|7355813|FG000|Open-Label Phase|Adverse Event|12
4535721|NCT01098240|7355814|FG001|Open-Label Phase|Adverse Event|0
4535722|NCT01098240|7355815|FG002|Open-Label Phase|Adverse Event|0
4535723|NCT01098240|7355813|FG000|Double-Blind Phase|Study Terminated by Sponsor|0
4535724|NCT01098240|7355814|FG001|Double-Blind Phase|Study Terminated by Sponsor|5
4535725|NCT01098240|7355815|FG002|Double-Blind Phase|Study Terminated by Sponsor|8
4535726|NCT01098240|7355813|FG000|Double-Blind Phase|Protocol Violation|0
4535727|NCT01098240|7355814|FG001|Double-Blind Phase|Protocol Violation|2
4535728|NCT01098240|7355815|FG002|Double-Blind Phase|Protocol Violation|4
4535729|NCT01098240|7355813|FG000|Double-Blind Phase|Lost to Follow-up|0
4535730|NCT01098240|7355814|FG001|Double-Blind Phase|Lost to Follow-up|2
4535731|NCT01098240|7355815|FG002|Double-Blind Phase|Lost to Follow-up|0
4535732|NCT01098240|7355813|FG000|Double-Blind Phase|Other|0
4535733|NCT01098240|7355814|FG001|Double-Blind Phase|Other|2
4535734|NCT01098240|7355815|FG002|Double-Blind Phase|Other|2
4535735|NCT01098240|7355813|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0
4535736|NCT01098240|7355814|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1
4535737|NCT01098240|7355815|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0
4535738|NCT01098240|7355813|FG000|Double-Blind Phase|Insufficient Clinical Response|0
4535739|NCT01098240|7355814|FG001|Double-Blind Phase|Insufficient Clinical Response|1
4535740|NCT01098240|7355815|FG002|Double-Blind Phase|Insufficient Clinical Response|2
4535741|NCT01098240|7355813|FG000|Double-Blind Phase|Withdrawal by Subject|0
4535742|NCT01098240|7355814|FG001|Double-Blind Phase|Withdrawal by Subject|1
4535743|NCT01098240|7355815|FG002|Double-Blind Phase|Withdrawal by Subject|3
4535744|NCT01098240|7355813|FG000|Double-Blind Phase|Adverse Event|0
4535745|NCT01098240|7355814|FG001|Double-Blind Phase|Adverse Event|3
4535746|NCT01098240|7355815|FG002|Double-Blind Phase|Adverse Event|3
4535747|NCT01098266|7355833|FG000|Overall Study|Physician Decision|1
4535748|NCT01098266|7355834|FG001|Overall Study|Physician Decision|0
4535749|NCT01098266|7355833|FG000|Overall Study|Death|3
4535750|NCT01098266|7355834|FG001|Overall Study|Death|2
4535751|NCT01098266|7355833|FG000|Overall Study|Withdrawal by Subject|3
4535752|NCT01098266|7355834|FG001|Overall Study|Withdrawal by Subject|5
4535753|NCT01098305|7355842|FG000|Overall Study|Lost to Follow-up|31
4535754|NCT01098305|7355843|FG001|Overall Study|Lost to Follow-up|33
4535755|NCT01098461|7355870|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10
4535756|NCT01098461|7355871|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2
4535757|NCT01098461|7355872|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0
4535758|NCT01098461|7355873|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0
4535759|NCT01098461|7355870|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1
4535760|NCT01098461|7355871|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2
4535761|NCT01098461|7355872|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1
4535762|NCT01098461|7355873|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3
4535763|NCT01098461|7355870|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1
4535764|NCT01098461|7355871|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2
4535765|NCT01098461|7355872|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0
4535766|NCT01098461|7355873|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0
4535767|NCT01098461|7355870|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
4535768|NCT01098461|7355871|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1
4535769|NCT01098461|7355872|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
4535770|NCT01098461|7355873|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
4535771|NCT01098461|7355870|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
4535772|NCT01098461|7355871|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1
4535773|NCT01098461|7355872|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
4535774|NCT01098461|7355873|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
4535775|NCT01098461|7355870|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
4535776|NCT01098461|7355871|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1
4535777|NCT01098461|7355872|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
4535778|NCT01098461|7355873|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
4535779|NCT01098461|7355870|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0
4535780|NCT01098461|7355871|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1
4535781|NCT01098461|7355872|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1
4535782|NCT01098461|7355873|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0
4535783|NCT01098474|7355890|FG000|Active Phase|Other|0
4535784|NCT01098474|7355891|FG001|Active Phase|Other|0
4535785|NCT01098474|7355892|FG002|Active Phase|Other|3
4535786|NCT01098474|7355893|FG003|Active Phase|Other|0
4535787|NCT01098474|7355894|FG004|Active Phase|Other|0
4535788|NCT01098474|7355895|FG005|Active Phase|Other|0
4535789|NCT01098474|7355890|FG000|Active Phase|Withdrawal by Subject|1
4535790|NCT01098474|7355891|FG001|Active Phase|Withdrawal by Subject|1
4535791|NCT01098474|7355892|FG002|Active Phase|Withdrawal by Subject|2
4535792|NCT01098474|7355893|FG003|Active Phase|Withdrawal by Subject|0
4535793|NCT01098474|7355894|FG004|Active Phase|Withdrawal by Subject|0
4535794|NCT01098474|7355895|FG005|Active Phase|Withdrawal by Subject|0
4535795|NCT01098474|7355890|FG000|Active Phase|Lost to Follow-up|1
4535796|NCT01098474|7355891|FG001|Active Phase|Lost to Follow-up|0
4535797|NCT01098474|7355892|FG002|Active Phase|Lost to Follow-up|0
4535798|NCT01098474|7355893|FG003|Active Phase|Lost to Follow-up|0
4535799|NCT01098474|7355894|FG004|Active Phase|Lost to Follow-up|0
4535800|NCT01098474|7355895|FG005|Active Phase|Lost to Follow-up|0
4535801|NCT01098474|7355890|FG000|Follow Up Phase|Travelled out of study area|0
4535802|NCT01098474|7355891|FG001|Follow Up Phase|Travelled out of study area|0
4535803|NCT01098474|7355892|FG002|Follow Up Phase|Travelled out of study area|0
4535804|NCT01098474|7355893|FG003|Follow Up Phase|Travelled out of study area|0
4535805|NCT01098474|7355894|FG004|Follow Up Phase|Travelled out of study area|1
4535806|NCT01098474|7355895|FG005|Follow Up Phase|Travelled out of study area|0
4535807|NCT01098474|7355890|FG000|Follow Up Phase|Other|0
4535808|NCT01098474|7355891|FG001|Follow Up Phase|Other|0
4535809|NCT01098474|7355892|FG002|Follow Up Phase|Other|0
4535810|NCT01098474|7355893|FG003|Follow Up Phase|Other|0
4535811|NCT01098474|7355894|FG004|Follow Up Phase|Other|0
4535812|NCT01098474|7355895|FG005|Follow Up Phase|Other|4
4535813|NCT01098474|7355890|FG000|Follow Up Phase|Withdrawal by Subject|0
4535814|NCT01098474|7355891|FG001|Follow Up Phase|Withdrawal by Subject|0
4535815|NCT01098474|7355892|FG002|Follow Up Phase|Withdrawal by Subject|0
4535816|NCT01098474|7355893|FG003|Follow Up Phase|Withdrawal by Subject|2
4535817|NCT01098474|7355894|FG004|Follow Up Phase|Withdrawal by Subject|0
4535818|NCT01098474|7355895|FG005|Follow Up Phase|Withdrawal by Subject|1
4535819|NCT01098474|7355890|FG000|Follow Up Phase|Lost to Follow-up|0
4535820|NCT01098474|7355891|FG001|Follow Up Phase|Lost to Follow-up|0
4535821|NCT01098474|7355892|FG002|Follow Up Phase|Lost to Follow-up|0
4535822|NCT01098474|7355893|FG003|Follow Up Phase|Lost to Follow-up|0
4535823|NCT01098474|7355894|FG004|Follow Up Phase|Lost to Follow-up|1
4535824|NCT01098474|7355895|FG005|Follow Up Phase|Lost to Follow-up|0
4535825|NCT01098487|7355919|FG000|Overall Study|Adverse Event|22
4535826|NCT01098487|7355919|FG000|Overall Study|Lack of Efficacy|11
4535827|NCT01098487|7355919|FG000|Overall Study|Withdrawal by Subject|7
4535828|NCT01098487|7355919|FG000|Overall Study|Lost to Follow-up|3
4535829|NCT01098487|7355919|FG000|Overall Study|Physician Decision|1
4535830|NCT01098539|7355929|FG000|Overall Study|Adverse Event|26
4535831|NCT01098539|7355930|FG001|Overall Study|Adverse Event|26
4535832|NCT01098539|7355929|FG000|Overall Study|Protocol Violation|1
4535833|NCT01098539|7355930|FG001|Overall Study|Protocol Violation|4
4535834|NCT01098539|7355929|FG000|Overall Study|Noncompliance|3
4535835|NCT01098539|7355930|FG001|Overall Study|Noncompliance|5
4535836|NCT01098539|7355929|FG000|Overall Study|Lost to Follow-up|4
4535837|NCT01098539|7355930|FG001|Overall Study|Lost to Follow-up|4
4535838|NCT01098539|7355929|FG000|Overall Study|Withdrawal by Subject|12
4535839|NCT01098539|7355930|FG001|Overall Study|Withdrawal by Subject|26
4535840|NCT01098539|7355929|FG000|Overall Study|Physician Decision|5
4535841|NCT01098539|7355930|FG001|Overall Study|Physician Decision|3
4591071|NCT01526148|7437350|FG001|Overall Study|Unstable Medical Condition|0
4591072|NCT01526148|7437349|FG000|Overall Study|Unable to discontinue concomitant med|1
4591073|NCT01526148|7437350|FG001|Overall Study|Unable to discontinue concomitant med|0
4591074|NCT01526148|7437349|FG000|Overall Study|Moved out of state|1
4591075|NCT01526148|7437350|FG001|Overall Study|Moved out of state|0
4591076|NCT01526148|7437349|FG000|Overall Study|Incarcerated|0
4591077|NCT01526148|7437350|FG001|Overall Study|Incarcerated|2
4591078|NCT01526551|7437408|FG000|Overall Study|Lack of returned parental consent form|424
4591079|NCT01526733|7437433|FG000|Phase 1|Protocol Violation|1
4591080|NCT01526733|7437434|FG001|Phase 1|Protocol Violation|0
4591081|NCT01526733|7437433|FG000|Phase 1|Withdrawal by Subject|1
4591082|NCT01526733|7437434|FG001|Phase 1|Withdrawal by Subject|1
4591083|NCT01526785|7437441|FG000|Overall Study|Study Terminated by Sponsor|8
4591084|NCT01526785|7437441|FG000|Overall Study|Death|2
4591085|NCT01526785|7437441|FG000|Overall Study|Physician Decision|1
4591086|NCT01526785|7437441|FG000|Overall Study|Withdrawal by Subject|2
4591087|NCT01526889|7437447|FG000|Treatment Period|Adverse Event|2
4591088|NCT01526889|7437448|FG001|Treatment Period|Adverse Event|0
4591089|NCT01526889|7437447|FG000|Treatment Extension Period|Administrative problems|1
4591090|NCT01526889|7437448|FG001|Treatment Extension Period|Administrative problems|0
4591091|NCT01526928|7437467|FG000|Overall Study|Progressive Disease|35
4535842|NCT01098812|7355961|FG000|Overall Study|Death|2
4535843|NCT01098812|7355962|FG001|Overall Study|Death|0
4610289|NCT01693562|7466661|FG003|Exploration Phase|Death|0
4610290|NCT01693562|7466662|FG004|Exploration Phase|Death|0
4610291|NCT01693562|7466663|FG005|Exploration Phase|Death|0
4610292|NCT01693562|7466664|FG006|Exploration Phase|Death|17
4610293|NCT01693562|7466665|FG007|Exploration Phase|Death|0
4610294|NCT01693562|7466666|FG008|Exploration Phase|Death|0
4610295|NCT01693562|7466667|FG009|Exploration Phase|Death|0
4610296|NCT01693562|7466668|FG010|Exploration Phase|Death|0
4610297|NCT01693562|7466669|FG011|Exploration Phase|Death|0
4610298|NCT01693562|7466670|FG012|Exploration Phase|Death|0
4610299|NCT01693562|7466671|FG013|Exploration Phase|Death|0
4610300|NCT01693562|7466672|FG014|Exploration Phase|Death|0
4610301|NCT01693562|7466673|FG015|Exploration Phase|Death|0
4610302|NCT01693562|7466674|FG016|Exploration Phase|Death|0
4610303|NCT01693562|7466675|FG017|Exploration Phase|Death|0
4610304|NCT01693562|7466676|FG018|Exploration Phase|Death|0
4535844|NCT01098812|7355963|FG002|Overall Study|Death|1
4535845|NCT01098812|7355961|FG000|Overall Study|Lost to Follow-up|0
4535846|NCT01098812|7355962|FG001|Overall Study|Lost to Follow-up|1
4535847|NCT01098812|7355963|FG002|Overall Study|Lost to Follow-up|0
4535848|NCT01098851|7355972|FG000|Overall Study|Equipment failure|1
4535849|NCT01098851|7355973|FG001|Overall Study|Equipment failure|0
4535850|NCT01099215|7356012|FG000|Overall Study|Withdrawal by Subject|1
4535851|NCT01099215|7356013|FG001|Overall Study|Withdrawal by Subject|0
4535852|NCT01099215|7356012|FG000|Overall Study|Adverse Event|0
4535853|NCT01099215|7356013|FG001|Overall Study|Adverse Event|1
4535854|NCT01099267|7356019|FG000|MDS-003 Study|Adverse Event|37
4535855|NCT01099267|7356019|FG000|MDS-003 Study|Lack of Efficacy|52
4535856|NCT01099267|7356019|FG000|MDS-003 Study|Withdrawal by Subject|8
4535857|NCT01099267|7356019|FG000|MDS-003 Study|Lost to Follow-up|1
4535858|NCT01099267|7356019|FG000|MDS-003 Study|Death|11
4535859|NCT01099267|7356019|FG000|MDS-003 Study|Study Closed by Sponsor|2
4535860|NCT01099267|7356019|FG000|MDS-003 Study|Disease Progression|7
4535861|NCT01099267|7356019|FG000|MDS-003 Study|Investigator Decision|2
4535862|NCT01099267|7356019|FG000|MDS-003 Study|Non-Compliance|2
4535863|NCT01099267|7356019|FG000|MDS-003 Study|Loss of Response|1
4535864|NCT01099267|7356019|FG000|MDS-003 Study|Secondary Malign Disease|1
4535865|NCT01099397|7356037|FG000|Overall Study|Lost to Follow-up|4
4535866|NCT01099397|7356037|FG000|Overall Study|Protocol Violation|4
4535867|NCT01099397|7356037|FG000|Overall Study|Withdrawal by Subject|5
4535868|NCT01099579|7356080|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4
4535869|NCT01099579|7356081|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1
4535870|NCT01099579|7356082|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0
4535871|NCT01099579|7356080|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0
4535872|NCT01099579|7356081|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0
4535873|NCT01099579|7356082|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1
4535874|NCT01099579|7356080|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0
4535875|NCT01099579|7356081|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2
4535876|NCT01099579|7356082|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0
4535877|NCT01099579|7356080|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0
4535878|NCT01099579|7356081|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2
4535879|NCT01099579|7356082|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0
4535880|NCT01099579|7356080|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2
4535881|NCT01099579|7356081|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2
4535882|NCT01099579|7356082|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1
4535883|NCT01099579|7356080|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1
4535884|NCT01099579|7356081|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1
4535885|NCT01099579|7356082|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1
4535886|NCT01099579|7356080|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0
4535887|NCT01099579|7356081|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0
4535888|NCT01099579|7356082|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2
4535889|NCT01099579|7356080|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
4535890|NCT01099579|7356081|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
4535891|NCT01099579|7356082|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
4535892|NCT01099579|7356080|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2
4535893|NCT01099579|7356081|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0
4535894|NCT01099579|7356082|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1
4535895|NCT01099579|7356080|FG000|Stage 2 (ATV Capsule)|Adverse Event|0
4535896|NCT01099579|7356081|FG001|Stage 2 (ATV Capsule)|Adverse Event|1
4535897|NCT01099579|7356082|FG002|Stage 2 (ATV Capsule)|Adverse Event|0
4535898|NCT01099709|7356136|FG000|Period 1|Withdrawal by Subject|0
4535899|NCT01099709|7356137|FG001|Period 1|Withdrawal by Subject|1
4535900|NCT01099709|7356136|FG000|Period 1|Positive cotinine test|0
4535901|NCT01099709|7356137|FG001|Period 1|Positive cotinine test|1
4535902|NCT01099709|7356136|FG000|Period 1|Adverse Event|1
4535903|NCT01099709|7356137|FG001|Period 1|Adverse Event|0
4535904|NCT01099917|7356169|FG000|Overall Study|Adverse Event|3
4535905|NCT01099917|7356169|FG000|Overall Study|Not Treated|24
4610305|NCT01693562|7466677|FG019|Exploration Phase|Death|0
4610306|NCT01693562|7466678|FG020|Exploration Phase|Death|0
4610307|NCT01693562|7466679|FG021|Exploration Phase|Death|0
4610308|NCT01693562|7466680|FG022|Exploration Phase|Death|0
4610309|NCT01693562|7466658|FG000|Exploration Phase|Other|0
4535906|NCT01100034|7356190|FG000|Overall Study|Lost to Follow-up|11
4535907|NCT01100034|7356190|FG000|Overall Study|Withdrawal of parent/guardian consent|1
4535908|NCT01100034|7356190|FG000|Overall Study|Withdrawal by Subject|4
4535909|NCT01100034|7356190|FG000|Overall Study|Sponsor decision|21
4535910|NCT01100034|7356190|FG000|Overall Study|Participated in another clinical trial|1
4535911|NCT01100034|7356190|FG000|Overall Study|Participants moved to another hospital|4
4535912|NCT01100034|7356190|FG000|Overall Study|Site closed due to non-responsiveness|1
4535913|NCT01100073|7356194|FG000|Overall Study|Lack of Efficacy|4
4535914|NCT01100073|7356194|FG000|Overall Study|Insufficient Tolerability|21
4535915|NCT01100073|7356194|FG000|Overall Study|Withdrawal by Subject|13
4535916|NCT01100073|7356194|FG000|Overall Study|Lost to Follow-up|39
4535917|NCT01100073|7356194|FG000|Overall Study|Lack of effect + patient's wish|2
4535918|NCT01100073|7356194|FG000|Overall Study|Insufficient tolerability +patients wish|8
4535919|NCT01100073|7356194|FG000|Overall Study|Other|8
4535920|NCT01100073|7356194|FG000|Overall Study|Missing|5
4535921|NCT01100086|7356198|FG000|Period 1|Withdrawal by Subject|1
4535922|NCT01100086|7356199|FG001|Period 1|Withdrawal by Subject|0
4535923|NCT01100307|7356228|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1
4535924|NCT01100307|7356229|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1
4535925|NCT01100307|7356228|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0
4535926|NCT01100307|7356229|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1
4535927|NCT01100307|7356228|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5
4535928|NCT01100307|7356229|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2
4535929|NCT01100307|7356228|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1
4535930|NCT01100307|7356229|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2
4535931|NCT01100307|7356228|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2
4535932|NCT01100307|7356229|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3
4535933|NCT01100307|7356228|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3
4535934|NCT01100307|7356229|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8
4535935|NCT01100320|7356237|FG000|Period 1|Withdrawal by Subject|2
4535936|NCT01100320|7356238|FG001|Period 1|Withdrawal by Subject|4
4535937|NCT01100320|7356237|FG000|Period 1|Positive Drug Screen|1
4535938|NCT01100320|7356238|FG001|Period 1|Positive Drug Screen|1
4535939|NCT01100320|7356237|FG000|Period 1|Adverse Event|2
4535940|NCT01100320|7356238|FG001|Period 1|Adverse Event|2
4535941|NCT01100320|7356237|FG000|Period 2|Withdrawal by Subject|1
4535942|NCT01100320|7356238|FG001|Period 2|Withdrawal by Subject|1
4535943|NCT01100437|7356244|FG000|Titration/Stabilization|Adverse Event|0
4535944|NCT01100437|7356245|FG001|Titration/Stabilization|Adverse Event|0
4535945|NCT01100437|7356246|FG002|Titration/Stabilization|Adverse Event|4
4535946|NCT01100437|7356244|FG000|Titration/Stabilization|Non-compliance|0
4535947|NCT01100437|7356245|FG001|Titration/Stabilization|Non-compliance|0
4535948|NCT01100437|7356246|FG002|Titration/Stabilization|Non-compliance|1
4535949|NCT01100437|7356244|FG000|Titration/Stabilization|Sponsor canceled study|0
4535950|NCT01100437|7356245|FG001|Titration/Stabilization|Sponsor canceled study|0
4535951|NCT01100437|7356246|FG002|Titration/Stabilization|Sponsor canceled study|1
4535952|NCT01100437|7356244|FG000|Maintenance|Withdrawal by Subject|0
4535953|NCT01100437|7356245|FG001|Maintenance|Withdrawal by Subject|0
4535954|NCT01100437|7356246|FG002|Maintenance|Withdrawal by Subject|1
4535955|NCT01100437|7356244|FG000|Maintenance|Sponsor termination of study|0
4535956|NCT01100437|7356245|FG001|Maintenance|Sponsor termination of study|0
4535957|NCT01100437|7356246|FG002|Maintenance|Sponsor termination of study|1
4535958|NCT01100502|7356257|FG000|Overall Study|Withdrawal by Subject|18
4535959|NCT01100502|7356258|FG001|Overall Study|Withdrawal by Subject|25
4535960|NCT01100502|7356257|FG000|Overall Study|Lost to Follow-up|13
4535961|NCT01100502|7356258|FG001|Overall Study|Lost to Follow-up|28
4535962|NCT01100502|7356257|FG000|Overall Study|Site request to end participation in study|0
4535963|NCT01100502|7356258|FG001|Overall Study|Site request to end participation in study|1
4535964|NCT01100502|7356257|FG000|Overall Study|Death|45
4535965|NCT01100502|7356258|FG001|Overall Study|Death|40
4535966|NCT01100528|7356264|FG000|Overall Study|Death|1
4535967|NCT01100528|7356264|FG000|Overall Study|Withdrawal by Subject|2
4535968|NCT01100567|7356270|FG000|Overall Study|Withdrawal by Subject|5
4535969|NCT01100567|7356271|FG001|Overall Study|Withdrawal by Subject|8
4535970|NCT01100567|7356270|FG000|Overall Study|Early Hospital Discharge|6
4535971|NCT01100567|7356271|FG001|Overall Study|Early Hospital Discharge|4
4535972|NCT01100567|7356270|FG000|Overall Study|Lost to Follow-up|1
4535973|NCT01100567|7356271|FG001|Overall Study|Lost to Follow-up|2
4535974|NCT01100567|7356270|FG000|Overall Study|Physician Decision|0
4535975|NCT01100567|7356271|FG001|Overall Study|Physician Decision|1
4535976|NCT01100567|7356270|FG000|Overall Study|Deemed ineligible after consent|0
4535977|NCT01100567|7356271|FG001|Overall Study|Deemed ineligible after consent|1
4535978|NCT01100853|7356301|FG000|Overall Study|Lost to Follow-up|11
4535979|NCT01100853|7356302|FG001|Overall Study|Lost to Follow-up|6
4535980|NCT01100853|7356301|FG000|Overall Study|Received <4 study injections|10
4535981|NCT01100853|7356302|FG001|Overall Study|Received <4 study injections|13
4535982|NCT01100853|7356301|FG000|Overall Study|Withdrawal by Subject|6
4535983|NCT01100853|7356302|FG001|Overall Study|Withdrawal by Subject|4
4535984|NCT01100944|7356318|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2
4535985|NCT01100944|7356319|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0
4535986|NCT01100944|7356320|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0
4535987|NCT01100944|7356318|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1
4535988|NCT01100944|7356319|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0
4535989|NCT01100944|7356320|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0
4535990|NCT01100944|7356318|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1
4535991|NCT01100944|7356319|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0
4535992|NCT01100944|7356320|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0
4535993|NCT01100944|7356318|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0
4535994|NCT01100944|7356319|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2
4535995|NCT01100944|7356320|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0
4535996|NCT01101022|7356343|FG000|Overall Study|Adverse Event|6
4535997|NCT01101022|7356344|FG001|Overall Study|Adverse Event|2
4535998|NCT01101022|7356343|FG000|Overall Study|Protocol Violation|4
4535999|NCT01101022|7356344|FG001|Overall Study|Protocol Violation|3
4536000|NCT01101022|7356343|FG000|Overall Study|Withdrawal by Subject|3
4536001|NCT01101022|7356344|FG001|Overall Study|Withdrawal by Subject|8
4536002|NCT01101022|7356343|FG000|Overall Study|Lost to Follow-up|1
4536003|NCT01101022|7356344|FG001|Overall Study|Lost to Follow-up|4
4536004|NCT01101022|7356343|FG000|Overall Study|Lack of Efficacy|0
4536005|NCT01101022|7356344|FG001|Overall Study|Lack of Efficacy|7
4536006|NCT01101022|7356343|FG000|Overall Study|Sponsor decision|1
4536007|NCT01101022|7356344|FG001|Overall Study|Sponsor decision|1
4536008|NCT01101022|7356343|FG000|Overall Study|Non-compliance|1
4536009|NCT01101022|7356344|FG001|Overall Study|Non-compliance|0
4536010|NCT01101022|7356343|FG000|Overall Study|Work schedule|1
4536011|NCT01101022|7356344|FG001|Overall Study|Work schedule|1
4536012|NCT01101022|7356343|FG000|Overall Study|Vacation|0
4536013|NCT01101022|7356344|FG001|Overall Study|Vacation|1
4536014|NCT01101035|7356352|FG000|Overall Study|Adverse Event|191
4536015|NCT01101035|7356353|FG001|Overall Study|Adverse Event|172
4536016|NCT01101035|7356352|FG000|Overall Study|Major Protocol Deviation|52
4536017|NCT01101035|7356353|FG001|Overall Study|Major Protocol Deviation|46
4536018|NCT01101035|7356352|FG000|Overall Study|Lost to Follow-up|226
4536019|NCT01101035|7356353|FG001|Overall Study|Lost to Follow-up|223
4536020|NCT01101035|7356352|FG000|Overall Study|Voluntary Withdrawal|595
4536021|NCT01101035|7356353|FG001|Overall Study|Voluntary Withdrawal|587
4536022|NCT01101035|7356352|FG000|Overall Study|Reason not Specified|333
4536023|NCT01101035|7356353|FG001|Overall Study|Reason not Specified|363
4536024|NCT01101061|7356365|FG000|Overall Study|Adverse Event|0
4536025|NCT01101061|7356366|FG001|Overall Study|Adverse Event|0
4536026|NCT01101061|7356367|FG002|Overall Study|Adverse Event|1
4536027|NCT01101061|7356368|FG003|Overall Study|Adverse Event|0
4536028|NCT01101061|7356369|FG004|Overall Study|Adverse Event|0
4536029|NCT01101061|7356370|FG005|Overall Study|Adverse Event|0
4536030|NCT01101165|7356393|FG000|Period 1|Adverse Event|1
4536031|NCT01101165|7356394|FG001|Period 1|Adverse Event|2
4536032|NCT01101165|7356393|FG000|Period 1|Withdrawal by Subject|0
4536033|NCT01101165|7356394|FG001|Period 1|Withdrawal by Subject|2
4536034|NCT01101165|7356393|FG000|Period 1|Positive Drug Screen|0
4536035|NCT01101165|7356394|FG001|Period 1|Positive Drug Screen|1
4536036|NCT01101165|7356393|FG000|Period 1|Lost to Follow-up|1
4536037|NCT01101165|7356394|FG001|Period 1|Lost to Follow-up|0
4536038|NCT01101165|7356393|FG000|Period 2|Withdrawal by Subject|3
4536039|NCT01101165|7356394|FG001|Period 2|Withdrawal by Subject|1
4536040|NCT01101165|7356393|FG000|Period 2|Adverse Event|1
4536041|NCT01101165|7356394|FG001|Period 2|Adverse Event|0
4536042|NCT01101178|7356400|FG000|Period 1|Withdrawal by Subject|1
4536043|NCT01101178|7356401|FG001|Period 1|Withdrawal by Subject|2
4536044|NCT01101178|7356400|FG000|Period 1|Positive drug screen|1
4536045|NCT01101178|7356401|FG001|Period 1|Positive drug screen|1
4536046|NCT01101178|7356400|FG000|Period 1|Adverse Event|2
4536047|NCT01101178|7356401|FG001|Period 1|Adverse Event|1
4536048|NCT01101178|7356400|FG000|Period 2|Withdrawal by Subject|0
4536049|NCT01101178|7356401|FG001|Period 2|Withdrawal by Subject|1
4536050|NCT01101191|7356408|FG000|Period 1|Withdrawal by Subject|1
4536051|NCT01101191|7356409|FG001|Period 1|Withdrawal by Subject|0
4536052|NCT01101191|7356408|FG000|Period 1|Adverse Event|1
4536053|NCT01101191|7356409|FG001|Period 1|Adverse Event|2
4536054|NCT01101308|7356416|FG000|Period 1|Adverse Event|2
4536055|NCT01101308|7356417|FG001|Period 1|Adverse Event|1
4536056|NCT01101308|7356416|FG000|Period 1|Positive for cotinine|1
4536057|NCT01101308|7356417|FG001|Period 1|Positive for cotinine|0
4536058|NCT01101321|7356424|FG000|Period 1|Withdrawal by Subject|1
4536059|NCT01101321|7356425|FG001|Period 1|Withdrawal by Subject|1
4536060|NCT01101321|7356424|FG000|Period 1|Adverse Event|3
4536061|NCT01101321|7356425|FG001|Period 1|Adverse Event|3
4536062|NCT01101334|7356433|FG000|Overall Study|Adverse Event|9
4536063|NCT01101334|7356434|FG001|Overall Study|Adverse Event|4
4536064|NCT01101334|7356433|FG000|Overall Study|Death|7
4536065|NCT01101334|7356434|FG001|Overall Study|Death|1
4536066|NCT01101334|7356433|FG000|Overall Study|Withdrawal by Subject|4
4536067|NCT01101334|7356434|FG001|Overall Study|Withdrawal by Subject|3
4536068|NCT01101334|7356433|FG000|Overall Study|Withdrawal by Sponsor|1
4536069|NCT01101334|7356434|FG001|Overall Study|Withdrawal by Sponsor|1
4536070|NCT01101334|7356433|FG000|Overall Study|Progressive Disease|22
4536071|NCT01101334|7356434|FG001|Overall Study|Progressive Disease|35
4536072|NCT01101334|7356433|FG000|Overall Study|Other|2
4536073|NCT01101334|7356434|FG001|Overall Study|Other|1
4536074|NCT01101477|7356443|FG000|Overall Study|Protocol Violation|5
4536075|NCT01101477|7356444|FG001|Overall Study|Protocol Violation|3
4536076|NCT01101477|7356445|FG002|Overall Study|Protocol Violation|1
4536077|NCT01101542|7356453|FG000|Year 3 Surveillance Period|Lost to Follow-up|7
4536078|NCT01101542|7356453|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4
4536079|NCT01101542|7356453|FG000|Year 4 Surveillance Period|Other|287
4536080|NCT01101542|7356453|FG000|Year 5 Surveillance Period|Lost to Follow-up|140
4536081|NCT01101542|7356453|FG000|Year 5 Surveillance Period|Pregnancy|1
4536082|NCT01101542|7356453|FG000|Year 6 Surveillance Period|Lost to Follow-up|986
4536083|NCT01101542|7356453|FG000|Year 6 Surveillance Period|Pregnancy|1
4536084|NCT01101542|7356453|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4
4536085|NCT01101841|7356463|FG000|Overall Study|Adverse Event|15
4536086|NCT01101841|7356464|FG001|Overall Study|Adverse Event|15
4536087|NCT01101841|7356463|FG000|Overall Study|Lost to Follow-up|9
4536088|NCT01101841|7356464|FG001|Overall Study|Lost to Follow-up|3
4536089|NCT01101841|7356463|FG000|Overall Study|Withdrawal by Subject|21
4536090|NCT01101841|7356464|FG001|Overall Study|Withdrawal by Subject|40
4536091|NCT01101841|7356463|FG000|Overall Study|Protocol Violation|1
4536092|NCT01101841|7356464|FG001|Overall Study|Protocol Violation|1
4536093|NCT01101841|7356463|FG000|Overall Study|Physician Decision|0
4536094|NCT01101841|7356464|FG001|Overall Study|Physician Decision|2
4536095|NCT01101841|7356463|FG000|Overall Study|Lack of Efficacy|0
4536096|NCT01101841|7356464|FG001|Overall Study|Lack of Efficacy|2
4536097|NCT01101841|7356463|FG000|Overall Study|Other|0
4536098|NCT01101841|7356464|FG001|Overall Study|Other|1
4536099|NCT01101841|7356463|FG000|Overall Study|Suicidality Tracking Scale|3
4536100|NCT01101841|7356464|FG001|Overall Study|Suicidality Tracking Scale|1
4536101|NCT01101841|7356463|FG000|Overall Study|Eligibility Criteria|1
4536102|NCT01101841|7356464|FG001|Overall Study|Eligibility Criteria|2
4536103|NCT01101997|7356501|FG000|Overall Study|Withdrawal by Subject|2
4536104|NCT01102231|7356516|FG000|Overall Study|Protocol Violation|3
4536105|NCT01102231|7356516|FG000|Overall Study|Lack of Efficacy|2
4536106|NCT01102231|7356516|FG000|Overall Study|Death|2
4536107|NCT01102231|7356516|FG000|Overall Study|Adverse Event|3
4536108|NCT01102231|7356516|FG000|Overall Study|Withdrawal by Subject|1
4536109|NCT01102231|7356516|FG000|Overall Study|Did not received the treatment|4
4536110|NCT01102257|7356523|FG000|Overall Study|Adverse Event|1
4536111|NCT01102257|7356524|FG001|Overall Study|Adverse Event|0
4536112|NCT01102257|7356523|FG000|Overall Study|Adverse Event|1
4536113|NCT01102257|7356524|FG001|Overall Study|Adverse Event|0
4536114|NCT01102374|7356539|FG000|Overall Study|Death|9
4536115|NCT01102374|7356540|FG001|Overall Study|Death|13
4536116|NCT01102374|7356539|FG000|Overall Study|Lost to Follow-up|7
4536117|NCT01102374|7356540|FG001|Overall Study|Lost to Follow-up|6
4536118|NCT01102426|7356557|FG000|Overall Study|Randomized but not treated|4
4536119|NCT01102426|7356558|FG001|Overall Study|Randomized but not treated|1
4536120|NCT01102426|7356557|FG000|Overall Study|Adverse Events (treatment-related)|15
4536121|NCT01102426|7356558|FG001|Overall Study|Adverse Events (treatment-related)|8
4536122|NCT01102426|7356557|FG000|Overall Study|Physician Decision|9
4536123|NCT01102426|7356558|FG001|Overall Study|Physician Decision|6
4536124|NCT01102426|7356557|FG000|Overall Study|Progressive Disease|85
4536125|NCT01102426|7356558|FG001|Overall Study|Progressive Disease|44
4536126|NCT01102426|7356557|FG000|Overall Study|Adverse Events (unrelated to|9
4536127|NCT01102426|7356558|FG001|Overall Study|Adverse Events (unrelated to|1
4536128|NCT01102426|7356557|FG000|Overall Study|Patient Refusal|24
4536129|NCT01102426|7356558|FG001|Overall Study|Patient Refusal|12
4536130|NCT01102426|7356557|FG000|Overall Study|Death (due to adverse events|0
4536131|NCT01102426|7356558|FG001|Overall Study|Death (due to adverse events|1
4536132|NCT01102426|7356557|FG000|Overall Study|Death (non-related to the study|19
4536133|NCT01102426|7356558|FG001|Overall Study|Death (non-related to the study|8
4536134|NCT01102491|7356566|FG000|Overall Study|Protocol Violation|11
4536135|NCT01102491|7356567|FG001|Overall Study|Protocol Violation|12
4536136|NCT01102777|7356588|FG000|Overall Study|Death|2
4536137|NCT01102777|7356589|FG001|Overall Study|Death|6
4536138|NCT01102777|7356588|FG000|Overall Study|Lost to Follow-up|7
4536139|NCT01102777|7356589|FG001|Overall Study|Lost to Follow-up|10
4536140|NCT01102803|7356598|FG000|Baseline to Post-Treatment|Lost to Follow-up|3
4536141|NCT01102803|7356599|FG001|Baseline to Post-Treatment|Lost to Follow-up|0
4536142|NCT01102803|7356598|FG000|Post to Follow-Up|Lost to Follow-up|1
4536143|NCT01102803|7356599|FG001|Post to Follow-Up|Lost to Follow-up|3
4536144|NCT01102972|7356615|FG000|Overall Study|Adverse Event|8
4536145|NCT01102972|7356616|FG001|Overall Study|Adverse Event|2
4536146|NCT01102972|7356615|FG000|Overall Study|Lack of Efficacy|2
4536147|NCT01102972|7356616|FG001|Overall Study|Lack of Efficacy|1
4536148|NCT01102972|7356615|FG000|Overall Study|Protocol Violation|1
4536149|NCT01102972|7356616|FG001|Overall Study|Protocol Violation|0
4536150|NCT01102972|7356615|FG000|Overall Study|Lost to Follow-up|10
4536151|NCT01102972|7356616|FG001|Overall Study|Lost to Follow-up|5
4536152|NCT01102972|7356615|FG000|Overall Study|Investigator Discretion|2
4536153|NCT01102972|7356616|FG001|Overall Study|Investigator Discretion|0
4536154|NCT01102972|7356615|FG000|Overall Study|Withdrawal by Subject|6
4536155|NCT01102972|7356616|FG001|Overall Study|Withdrawal by Subject|6
4536156|NCT01103063|7356624|FG000|Overall Study|Adverse Event|3
4536157|NCT01103063|7356625|FG001|Overall Study|Adverse Event|1
4536158|NCT01103063|7356624|FG000|Overall Study|Lost to Follow-up|68
4536159|NCT01103063|7356625|FG001|Overall Study|Lost to Follow-up|51
4536160|NCT01103063|7356624|FG000|Overall Study|Withdrawal by Subject|60
4536161|NCT01103063|7356625|FG001|Overall Study|Withdrawal by Subject|15
4536162|NCT01103063|7356624|FG000|Overall Study|Other|16
4536163|NCT01103063|7356625|FG001|Overall Study|Other|11
4536164|NCT01103063|7356624|FG000|Overall Study|Protocol Violation|1
4536165|NCT01103063|7356625|FG001|Overall Study|Protocol Violation|0
4536166|NCT01103063|7356624|FG000|Overall Study|Study terminated by Sponsor|326
4536167|NCT01103063|7356625|FG001|Overall Study|Study terminated by Sponsor|342
4536168|NCT01103063|7356624|FG000|Overall Study|Death|3
4536169|NCT01103063|7356625|FG001|Overall Study|Death|1
4536170|NCT01103141|7356635|FG000|Overall Study|Death|0
4536171|NCT01103141|7356636|FG001|Overall Study|Death|1
4536172|NCT01103141|7356635|FG000|Overall Study|Lost to Follow-up|2
4536173|NCT01103141|7356636|FG001|Overall Study|Lost to Follow-up|1
4536174|NCT01103232|7356644|FG000|Overall Study|Withdrawal by Subject|1
4536175|NCT01103232|7356645|FG001|Overall Study|Withdrawal by Subject|1
4536176|NCT01103232|7356644|FG000|Overall Study|Protocol Violation|0
4536177|NCT01103232|7356645|FG001|Overall Study|Protocol Violation|1
4536178|NCT01103245|7356655|FG000|Overall Study|Withdrawal by Subject|1
4536179|NCT01103245|7356656|FG001|Overall Study|Withdrawal by Subject|0
4536180|NCT01103245|7356657|FG002|Overall Study|Withdrawal by Subject|3
4536181|NCT01103245|7356658|FG003|Overall Study|Withdrawal by Subject|0
4536182|NCT01103245|7356655|FG000|Overall Study|Inadequate IV access|1
4536183|NCT01103245|7356656|FG001|Overall Study|Inadequate IV access|0
4536184|NCT01103245|7356657|FG002|Overall Study|Inadequate IV access|0
4536185|NCT01103245|7356658|FG003|Overall Study|Inadequate IV access|0
4536186|NCT01103245|7356655|FG000|Overall Study|Adverse Event|0
4536187|NCT01103245|7356656|FG001|Overall Study|Adverse Event|2
4536188|NCT01103245|7356657|FG002|Overall Study|Adverse Event|1
4536189|NCT01103245|7356658|FG003|Overall Study|Adverse Event|0
4536190|NCT01103245|7356655|FG000|Overall Study|Physician Decision|1
4610310|NCT01693562|7466659|FG001|Exploration Phase|Other|0
4610311|NCT01693562|7466660|FG002|Exploration Phase|Other|0
4610312|NCT01693562|7466661|FG003|Exploration Phase|Other|0
4610313|NCT01693562|7466662|FG004|Exploration Phase|Other|0
4610314|NCT01693562|7466663|FG005|Exploration Phase|Other|0
4610315|NCT01693562|7466664|FG006|Exploration Phase|Other|2
4610316|NCT01693562|7466665|FG007|Exploration Phase|Other|0
4610317|NCT01693562|7466666|FG008|Exploration Phase|Other|0
4610318|NCT01693562|7466667|FG009|Exploration Phase|Other|0
4610319|NCT01693562|7466668|FG010|Exploration Phase|Other|0
4610320|NCT01693562|7466669|FG011|Exploration Phase|Other|0
4610321|NCT01693562|7466670|FG012|Exploration Phase|Other|0
4610322|NCT01693562|7466671|FG013|Exploration Phase|Other|0
4610323|NCT01693562|7466672|FG014|Exploration Phase|Other|0
4610324|NCT01693562|7466673|FG015|Exploration Phase|Other|0
4610325|NCT01693562|7466674|FG016|Exploration Phase|Other|0
4610326|NCT01693562|7466675|FG017|Exploration Phase|Other|0
4610327|NCT01693562|7466676|FG018|Exploration Phase|Other|0
4610328|NCT01693562|7466677|FG019|Exploration Phase|Other|0
4610329|NCT01693562|7466678|FG020|Exploration Phase|Other|0
4610330|NCT01693562|7466679|FG021|Exploration Phase|Other|0
4610331|NCT01693562|7466680|FG022|Exploration Phase|Other|0
4610332|NCT01693562|7466658|FG000|Expansion Phase|Withdrawal by Subject|0
4610333|NCT01693562|7466659|FG001|Expansion Phase|Withdrawal by Subject|0
4610334|NCT01693562|7466660|FG002|Expansion Phase|Withdrawal by Subject|0
4610335|NCT01693562|7466661|FG003|Expansion Phase|Withdrawal by Subject|0
4610336|NCT01693562|7466662|FG004|Expansion Phase|Withdrawal by Subject|0
4610337|NCT01693562|7466663|FG005|Expansion Phase|Withdrawal by Subject|0
4610338|NCT01693562|7466664|FG006|Expansion Phase|Withdrawal by Subject|0
4610339|NCT01693562|7466665|FG007|Expansion Phase|Withdrawal by Subject|16
4610340|NCT01693562|7466666|FG008|Expansion Phase|Withdrawal by Subject|2
4610341|NCT01693562|7466667|FG009|Expansion Phase|Withdrawal by Subject|54
4610342|NCT01693562|7466668|FG010|Expansion Phase|Withdrawal by Subject|2
4610343|NCT01693562|7466669|FG011|Expansion Phase|Withdrawal by Subject|2
4610344|NCT01693562|7466670|FG012|Expansion Phase|Withdrawal by Subject|3
4610345|NCT01693562|7466671|FG013|Expansion Phase|Withdrawal by Subject|5
4610346|NCT01693562|7466672|FG014|Expansion Phase|Withdrawal by Subject|16
4610347|NCT01693562|7466673|FG015|Expansion Phase|Withdrawal by Subject|7
4610348|NCT01693562|7466674|FG016|Expansion Phase|Withdrawal by Subject|40
4610349|NCT01693562|7466675|FG017|Expansion Phase|Withdrawal by Subject|4
4610350|NCT01693562|7466676|FG018|Expansion Phase|Withdrawal by Subject|8
4610351|NCT01693562|7466677|FG019|Expansion Phase|Withdrawal by Subject|3
4610352|NCT01693562|7466678|FG020|Expansion Phase|Withdrawal by Subject|1
4536191|NCT01103245|7356656|FG001|Overall Study|Physician Decision|0
4536192|NCT01103245|7356657|FG002|Overall Study|Physician Decision|0
4536193|NCT01103245|7356658|FG003|Overall Study|Physician Decision|0
4536194|NCT01103284|7356680|FG000|Overall Study|Death|2
4610353|NCT01693562|7466679|FG021|Expansion Phase|Withdrawal by Subject|8
4610354|NCT01693562|7466680|FG022|Expansion Phase|Withdrawal by Subject|1
4610355|NCT01693562|7466658|FG000|Expansion Phase|Death|0
4610356|NCT01693562|7466659|FG001|Expansion Phase|Death|0
4610357|NCT01693562|7466660|FG002|Expansion Phase|Death|0
4536195|NCT01103284|7356681|FG001|Overall Study|Death|0
4536196|NCT01103284|7356680|FG000|Overall Study|Lost to Follow-up|9
4536197|NCT01103284|7356681|FG001|Overall Study|Lost to Follow-up|10
4536198|NCT01103284|7356680|FG000|Overall Study|Pregnancy|3
4536199|NCT01103284|7356681|FG001|Overall Study|Pregnancy|1
4536200|NCT01103284|7356680|FG000|Overall Study|Protocol Violation|12
4536201|NCT01103284|7356681|FG001|Overall Study|Protocol Violation|5
4536202|NCT01103284|7356680|FG000|Overall Study|Adverse Event|0
4536203|NCT01103284|7356681|FG001|Overall Study|Adverse Event|5
4536204|NCT01103284|7356680|FG000|Overall Study|Withdrawal by Subject|14
4536205|NCT01103284|7356681|FG001|Overall Study|Withdrawal by Subject|18
4536206|NCT01103284|7356680|FG000|Overall Study|Dermal Hypersensitivity|0
4536207|NCT01103284|7356681|FG001|Overall Study|Dermal Hypersensitivity|1
4536208|NCT01103284|7356680|FG000|Overall Study|Termination by the Sponsor|0
4536209|NCT01103284|7356681|FG001|Overall Study|Termination by the Sponsor|1
4536210|NCT01103284|7356680|FG000|Overall Study|Not described|2
4536211|NCT01103284|7356681|FG001|Overall Study|Not described|1
4536212|NCT01103284|7356680|FG000|Overall Study|Missing CRF entries for study completion|0
4536213|NCT01103284|7356681|FG001|Overall Study|Missing CRF entries for study completion|2
4536214|NCT01103323|7356689|FG000|Without/Before Drug Switch|Adverse Event|50
4536215|NCT01103323|7356690|FG001|Without/Before Drug Switch|Adverse Event|7
4536216|NCT01103323|7356689|FG000|Without/Before Drug Switch|Withdrawal by Subject|17
4536217|NCT01103323|7356690|FG001|Without/Before Drug Switch|Withdrawal by Subject|5
4536218|NCT01103323|7356689|FG000|Without/Before Drug Switch|Protocol Violation|2
4536219|NCT01103323|7356690|FG001|Without/Before Drug Switch|Protocol Violation|0
4536220|NCT01103323|7356689|FG000|Without/Before Drug Switch|Physician Decision|2
4536221|NCT01103323|7356690|FG001|Without/Before Drug Switch|Physician Decision|0
4536222|NCT01103323|7356689|FG000|Without/Before Drug Switch|did not receive study treatment|5
4536223|NCT01103323|7356690|FG001|Without/Before Drug Switch|did not receive study treatment|2
4536224|NCT01103323|7356689|FG000|Without/Before Drug Switch|Switch to Regorafenib|0
4536225|NCT01103323|7356690|FG001|Without/Before Drug Switch|Switch to Regorafenib|4
4536226|NCT01103323|7356689|FG000|Switched From Placebo to Regorafenib|Adverse Event|0
4536227|NCT01103323|7356690|FG001|Switched From Placebo to Regorafenib|Adverse Event|1
4536228|NCT01103362|7356697|FG000|Overall Study|study terminated|596
4536229|NCT01103466|7356731|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2
4536230|NCT01103466|7356732|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0
4536231|NCT01103466|7356733|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0
4536232|NCT01103466|7356731|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2
4536233|NCT01103466|7356732|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1
4536234|NCT01103466|7356733|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0
4536235|NCT01103466|7356731|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0
4536236|NCT01103466|7356732|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1
4536237|NCT01103466|7356733|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1
4536238|NCT01103466|7356731|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1
4536239|NCT01103466|7356732|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0
4536240|NCT01103466|7356733|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0
4536241|NCT01103466|7356731|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1
4536242|NCT01103466|7356732|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0
4536243|NCT01103466|7356733|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0
4536244|NCT01103466|7356731|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0
4536245|NCT01103466|7356732|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0
4536246|NCT01103466|7356733|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1
4536247|NCT01103479|7356744|FG000|Overall Study|Up to date with CRC screening|1
4536248|NCT01103479|7356745|FG001|Overall Study|Up to date with CRC screening|9
4536249|NCT01103479|7356746|FG002|Overall Study|Up to date with CRC screening|12
4536250|NCT01103479|7356744|FG000|Overall Study|Family history of CRC|1
4536251|NCT01103479|7356745|FG001|Overall Study|Family history of CRC|0
4536252|NCT01103479|7356746|FG002|Overall Study|Family history of CRC|2
4536253|NCT01103479|7356744|FG000|Overall Study|Active cancer|1
4536254|NCT01103479|7356745|FG001|Overall Study|Active cancer|0
4536255|NCT01103479|7356746|FG002|Overall Study|Active cancer|0
4536256|NCT01103479|7356744|FG000|Overall Study|Saw non-study physician|2
4536257|NCT01103479|7356745|FG001|Overall Study|Saw non-study physician|0
4536258|NCT01103479|7356746|FG002|Overall Study|Saw non-study physician|0
4536259|NCT01103713|7356776|FG000|Overall Study|Lost to Follow-up|2
4536260|NCT01103713|7356776|FG000|Overall Study|Withdrawal by Subject|8
4536261|NCT01103713|7356776|FG000|Overall Study|Study terminated by sponsor|2
4536262|NCT01103713|7356776|FG000|Overall Study|Other|1
4536263|NCT01103778|7356783|FG000|Overall Study|Lost to Follow-up|1
4536264|NCT01103778|7356783|FG000|Overall Study|Proteinuria improved prior to enrollment|1
4536265|NCT01103778|7356783|FG000|Overall Study|Screen failure|1
4536266|NCT01103960|7356800|FG000|Overall Study|Adverse Event|2
4536267|NCT01103960|7356801|FG001|Overall Study|Adverse Event|1
4536268|NCT01103960|7356800|FG000|Overall Study|Withdrawal by Subject|2
4536269|NCT01103960|7356801|FG001|Overall Study|Withdrawal by Subject|1
4536270|NCT01103960|7356800|FG000|Overall Study|Other|1
4536271|NCT01103960|7356801|FG001|Overall Study|Other|0
4610358|NCT01693562|7466661|FG003|Expansion Phase|Death|0
4536272|NCT01104155|7356842|FG000|Overall Study|Adverse Event|15
4536273|NCT01104155|7356843|FG001|Overall Study|Adverse Event|8
4536274|NCT01104155|7356842|FG000|Overall Study|Participant choice|6
4536275|NCT01104155|7356843|FG001|Overall Study|Participant choice|5
4536276|NCT01104155|7356842|FG000|Overall Study|Withdrawal of consent|1
4536277|NCT01104155|7356843|FG001|Overall Study|Withdrawal of consent|1
4536278|NCT01104155|7356842|FG000|Overall Study|Other|3
4536279|NCT01104155|7356843|FG001|Overall Study|Other|4
4536280|NCT01104246|7356858|FG000|Overall Study|Withdrawal by Subject|1
4536281|NCT01104246|7356858|FG000|Overall Study|did not meet inclusion criteria|4
4536282|NCT01104311|7356873|FG000|Overall Study|Withdrawal by Subject|6
4536283|NCT01104311|7356874|FG001|Overall Study|Withdrawal by Subject|6
4536284|NCT01104311|7356873|FG000|Overall Study|Protocol Violation|0
4536285|NCT01104311|7356874|FG001|Overall Study|Protocol Violation|1
4536286|NCT01104311|7356873|FG000|Overall Study|Physician Decision|2
4536287|NCT01104311|7356874|FG001|Overall Study|Physician Decision|2
4536288|NCT01104311|7356873|FG000|Overall Study|low compliance|1
4536289|NCT01104311|7356874|FG001|Overall Study|low compliance|1
4536290|NCT01104311|7356873|FG000|Overall Study|Adverse Event|1
4536291|NCT01104311|7356874|FG001|Overall Study|Adverse Event|2
4536292|NCT01104376|7356884|FG000|Overall Study|Withdrawal by Subject|15
4536293|NCT01104376|7356884|FG000|Overall Study|Consented but excluded after labs|13
4536294|NCT01104415|7356897|FG000|Core Phase|Consent withdrawn by subjects|1
4536295|NCT01104415|7356898|FG001|Core Phase|Consent withdrawn by subjects|0
4536296|NCT01104415|7356897|FG000|Extension Period|Progressive disease|0
4536297|NCT01104415|7356898|FG001|Extension Period|Progressive disease|4
4536298|NCT01104415|7356897|FG000|Extension Period|Death|0
4536299|NCT01104415|7356898|FG001|Extension Period|Death|1
4536300|NCT01104415|7356897|FG000|Extension Period|Physician Decision|0
4536301|NCT01104415|7356898|FG001|Extension Period|Physician Decision|1
4536302|NCT01104415|7356897|FG000|Extension Period|Transition to Study LX1606.302|0
4536303|NCT01104415|7356898|FG001|Extension Period|Transition to Study LX1606.302|4
4536304|NCT01104415|7356897|FG000|Extension Period|Heart surgery/feeling miserable|0
4536305|NCT01104415|7356898|FG001|Extension Period|Heart surgery/feeling miserable|1
4591092|NCT01526928|7437468|FG001|Overall Study|Progressive Disease|17
4591093|NCT01526928|7437469|FG002|Overall Study|Progressive Disease|150
4591094|NCT01526928|7437470|FG003|Overall Study|Progressive Disease|182
4591095|NCT01526928|7437471|FG004|Overall Study|Progressive Disease|76
4591096|NCT01526928|7437472|FG005|Overall Study|Progressive Disease|4
4591097|NCT01526928|7437467|FG000|Overall Study|Adverse Event|2
4591098|NCT01526928|7437468|FG001|Overall Study|Adverse Event|1
4591099|NCT01526928|7437469|FG002|Overall Study|Adverse Event|29
4591100|NCT01526928|7437470|FG003|Overall Study|Adverse Event|40
4591101|NCT01526928|7437471|FG004|Overall Study|Adverse Event|13
4591102|NCT01526928|7437472|FG005|Overall Study|Adverse Event|2
4591103|NCT01526928|7437467|FG000|Overall Study|Death|0
4591104|NCT01526928|7437468|FG001|Overall Study|Death|0
4591105|NCT01526928|7437469|FG002|Overall Study|Death|3
4591106|NCT01526928|7437470|FG003|Overall Study|Death|0
4591107|NCT01526928|7437471|FG004|Overall Study|Death|0
4591108|NCT01526928|7437472|FG005|Overall Study|Death|0
4591109|NCT01526928|7437467|FG000|Overall Study|Withdrawal by Subject|1
4591110|NCT01526928|7437468|FG001|Overall Study|Withdrawal by Subject|0
4591111|NCT01526928|7437469|FG002|Overall Study|Withdrawal by Subject|13
4591112|NCT01526928|7437470|FG003|Overall Study|Withdrawal by Subject|11
4591113|NCT01526928|7437471|FG004|Overall Study|Withdrawal by Subject|3
4591114|NCT01526928|7437472|FG005|Overall Study|Withdrawal by Subject|0
4591115|NCT01526928|7437467|FG000|Overall Study|Physician Decision|0
4591116|NCT01526928|7437468|FG001|Overall Study|Physician Decision|0
4591117|NCT01526928|7437469|FG002|Overall Study|Physician Decision|2
4591118|NCT01526928|7437470|FG003|Overall Study|Physician Decision|5
4591119|NCT01526928|7437471|FG004|Overall Study|Physician Decision|0
4591120|NCT01526928|7437472|FG005|Overall Study|Physician Decision|0
4591121|NCT01526928|7437467|FG000|Overall Study|Other Reason|0
4591122|NCT01526928|7437468|FG001|Overall Study|Other Reason|1
4591123|NCT01526928|7437469|FG002|Overall Study|Other Reason|11
4591124|NCT01526928|7437470|FG003|Overall Study|Other Reason|4
4591125|NCT01526928|7437471|FG004|Overall Study|Other Reason|1
4591126|NCT01526928|7437472|FG005|Overall Study|Other Reason|0
4591127|NCT01526928|7437467|FG000|Overall Study|Lost to Follow-up|0
4591128|NCT01526928|7437468|FG001|Overall Study|Lost to Follow-up|0
4591129|NCT01526928|7437469|FG002|Overall Study|Lost to Follow-up|0
4591130|NCT01526928|7437470|FG003|Overall Study|Lost to Follow-up|1
4591131|NCT01526928|7437471|FG004|Overall Study|Lost to Follow-up|0
4591132|NCT01526928|7437472|FG005|Overall Study|Lost to Follow-up|0
4591133|NCT01526928|7437467|FG000|Overall Study|Protocol Deviation|0
4591134|NCT01526928|7437468|FG001|Overall Study|Protocol Deviation|0
4591135|NCT01526928|7437469|FG002|Overall Study|Protocol Deviation|0
4591136|NCT01526928|7437470|FG003|Overall Study|Protocol Deviation|2
4591137|NCT01526928|7437471|FG004|Overall Study|Protocol Deviation|0
4591138|NCT01526928|7437472|FG005|Overall Study|Protocol Deviation|0
4591139|NCT01526928|7437467|FG000|Overall Study|Missing|0
4591140|NCT01526928|7437468|FG001|Overall Study|Missing|0
4591141|NCT01526928|7437469|FG002|Overall Study|Missing|1
4591142|NCT01526928|7437470|FG003|Overall Study|Missing|0
4591143|NCT01526928|7437471|FG004|Overall Study|Missing|2
4591144|NCT01526928|7437472|FG005|Overall Study|Missing|0
4591145|NCT01527006|7437530|FG000|Core Study|Adverse Event|0
4591146|NCT01527006|7437531|FG001|Core Study|Adverse Event|2
4536306|NCT01104493|7356907|FG000|Overall Study|Lost to Follow-up|0
4536307|NCT01104493|7356908|FG001|Overall Study|Lost to Follow-up|2
4536308|NCT01104545|7356917|FG000|Overall Study|Adverse Event|0
4536309|NCT01104545|7356918|FG001|Overall Study|Adverse Event|1
4536310|NCT01104545|7356919|FG002|Overall Study|Adverse Event|2
4536311|NCT01104558|7356964|FG000|Overall Study|Protocol Violation|6
4536312|NCT01104558|7356964|FG000|Overall Study|Missing of primary efficacy assessment|10
4536313|NCT01104558|7356964|FG000|Overall Study|Missing of genetic analysis results|1
4536314|NCT01104584|7356968|FG000|Overall Study|Study drug never administered|21
4536315|NCT01104584|7356968|FG000|Overall Study|Study prematurely discontinued|2
4536316|NCT01104636|7356990|FG000|Overall Study|Lack of Efficacy|43
4536317|NCT01104636|7356990|FG000|Overall Study|Lost to Follow-up|24
4536318|NCT01104636|7356990|FG000|Overall Study|Withdrawal by Subject|4
4536319|NCT01104636|7356990|FG000|Overall Study|Other|43
4536320|NCT01104636|7356990|FG000|Overall Study|Study terminated by sponsor|1
4536321|NCT01104636|7356990|FG000|Overall Study|Pregnancy|2
4536322|NCT01104636|7356990|FG000|Overall Study|Adverse Event|40
4536323|NCT01104636|7356990|FG000|Overall Study|Ongoing|21
4536324|NCT01104662|7357002|FG000|Overall Study|Adverse Event|2
4536325|NCT01104662|7357003|FG001|Overall Study|Adverse Event|2
4536326|NCT01104662|7357004|FG002|Overall Study|Adverse Event|0
4536327|NCT01104662|7357005|FG003|Overall Study|Adverse Event|1
4536328|NCT01104662|7357006|FG004|Overall Study|Adverse Event|1
4536329|NCT01104662|7357007|FG005|Overall Study|Adverse Event|1
4536330|NCT01104662|7357008|FG006|Overall Study|Adverse Event|0
4536331|NCT01104662|7357009|FG007|Overall Study|Adverse Event|0
4536332|NCT01104662|7357002|FG000|Overall Study|Clinical Failure|1
4536333|NCT01104662|7357003|FG001|Overall Study|Clinical Failure|0
4536334|NCT01104662|7357004|FG002|Overall Study|Clinical Failure|0
4536335|NCT01104662|7357005|FG003|Overall Study|Clinical Failure|0
4536336|NCT01104662|7357006|FG004|Overall Study|Clinical Failure|0
4536337|NCT01104662|7357007|FG005|Overall Study|Clinical Failure|1
4536338|NCT01104662|7357008|FG006|Overall Study|Clinical Failure|0
4536339|NCT01104662|7357009|FG007|Overall Study|Clinical Failure|0
4536340|NCT01104662|7357002|FG000|Overall Study|Participant left investigator's care|1
4536341|NCT01104662|7357003|FG001|Overall Study|Participant left investigator's care|1
4536342|NCT01104662|7357004|FG002|Overall Study|Participant left investigator's care|0
4536343|NCT01104662|7357005|FG003|Overall Study|Participant left investigator's care|0
4536344|NCT01104662|7357006|FG004|Overall Study|Participant left investigator's care|0
4536345|NCT01104662|7357007|FG005|Overall Study|Participant left investigator's care|0
4536346|NCT01104662|7357008|FG006|Overall Study|Participant left investigator's care|0
4536347|NCT01104662|7357009|FG007|Overall Study|Participant left investigator's care|0
4536348|NCT01104662|7357002|FG000|Overall Study|Reason not specified|3
4536349|NCT01104662|7357003|FG001|Overall Study|Reason not specified|3
4536350|NCT01104662|7357004|FG002|Overall Study|Reason not specified|0
4536351|NCT01104662|7357005|FG003|Overall Study|Reason not specified|0
4536352|NCT01104662|7357006|FG004|Overall Study|Reason not specified|0
4536353|NCT01104662|7357007|FG005|Overall Study|Reason not specified|1
4536354|NCT01104662|7357008|FG006|Overall Study|Reason not specified|0
4536355|NCT01104662|7357009|FG007|Overall Study|Reason not specified|0
4536356|NCT01104662|7357002|FG000|Overall Study|Randomized but not treated|3
4536357|NCT01104662|7357003|FG001|Overall Study|Randomized but not treated|4
4536358|NCT01104662|7357004|FG002|Overall Study|Randomized but not treated|1
4536359|NCT01104662|7357005|FG003|Overall Study|Randomized but not treated|0
4536360|NCT01104662|7357006|FG004|Overall Study|Randomized but not treated|0
4536361|NCT01104662|7357007|FG005|Overall Study|Randomized but not treated|1
4536362|NCT01104662|7357008|FG006|Overall Study|Randomized but not treated|0
4536363|NCT01104662|7357009|FG007|Overall Study|Randomized but not treated|0
4536364|NCT01104701|7357032|FG000|Overall Study|Withdrawal by Subject|0
4536365|NCT01104701|7357033|FG001|Overall Study|Withdrawal by Subject|1
4536366|NCT01104701|7357034|FG002|Overall Study|Withdrawal by Subject|2
4536367|NCT01104701|7357035|FG003|Overall Study|Withdrawal by Subject|1
4536368|NCT01104701|7357032|FG000|Overall Study|Adverse Event|0
4536369|NCT01104701|7357033|FG001|Overall Study|Adverse Event|0
4536370|NCT01104701|7357034|FG002|Overall Study|Adverse Event|0
4536371|NCT01104701|7357035|FG003|Overall Study|Adverse Event|1
4536372|NCT01104701|7357032|FG000|Overall Study|Physician Decision|0
4536373|NCT01104701|7357033|FG001|Overall Study|Physician Decision|2
4536374|NCT01104701|7357034|FG002|Overall Study|Physician Decision|0
4536375|NCT01104701|7357035|FG003|Overall Study|Physician Decision|0
4536376|NCT01104766|7357049|FG000|Overall Study|Did not meet inc/exc criteria|1
4536377|NCT01104766|7357050|FG001|Overall Study|Did not meet inc/exc criteria|0
4536378|NCT01104766|7357051|FG002|Overall Study|Did not meet inc/exc criteria|0
4536379|NCT01104766|7357052|FG003|Overall Study|Did not meet inc/exc criteria|0
4536380|NCT01104766|7357049|FG000|Overall Study|Adverse Event|17
4536381|NCT01104766|7357050|FG001|Overall Study|Adverse Event|15
4536382|NCT01104766|7357051|FG002|Overall Study|Adverse Event|20
4536383|NCT01104766|7357052|FG003|Overall Study|Adverse Event|14
4536384|NCT01104766|7357049|FG000|Overall Study|Lack of Efficacy|20
4536385|NCT01104766|7357050|FG001|Overall Study|Lack of Efficacy|15
4536386|NCT01104766|7357051|FG002|Overall Study|Lack of Efficacy|14
4536387|NCT01104766|7357052|FG003|Overall Study|Lack of Efficacy|8
4536388|NCT01104766|7357049|FG000|Overall Study|Protocol Violation|2
4536389|NCT01104766|7357050|FG001|Overall Study|Protocol Violation|0
4536390|NCT01104766|7357051|FG002|Overall Study|Protocol Violation|0
4536391|NCT01104766|7357052|FG003|Overall Study|Protocol Violation|0
4536392|NCT01104766|7357049|FG000|Overall Study|Withdrawal by Subject|17
4536393|NCT01104766|7357050|FG001|Overall Study|Withdrawal by Subject|19
4536394|NCT01104766|7357051|FG002|Overall Study|Withdrawal by Subject|25
4536395|NCT01104766|7357052|FG003|Overall Study|Withdrawal by Subject|15
4536396|NCT01104766|7357049|FG000|Overall Study|Lost to Follow-up|1
4536397|NCT01104766|7357050|FG001|Overall Study|Lost to Follow-up|2
4536398|NCT01104766|7357051|FG002|Overall Study|Lost to Follow-up|1
4536399|NCT01104766|7357052|FG003|Overall Study|Lost to Follow-up|1
4536400|NCT01104779|7357065|FG000|Overall Study|Protocol Violation|1
4536401|NCT01104779|7357066|FG001|Overall Study|Protocol Violation|2
4536402|NCT01104779|7357067|FG002|Overall Study|Protocol Violation|2
4536403|NCT01104779|7357065|FG000|Overall Study|Lack of Efficacy|26
4536404|NCT01104779|7357066|FG001|Overall Study|Lack of Efficacy|12
4689952|NCT02556632|7599534|FG001|Overall Study|Withdrew (Unrelated Medical)|0
4689953|NCT02556632|7599535|FG002|Overall Study|Withdrew (Unrelated Medical)|0
4689954|NCT02556632|7599533|FG000|Overall Study|Unrelated Adverse Event|1
4689955|NCT02556632|7599534|FG001|Overall Study|Unrelated Adverse Event|0
4689956|NCT02556632|7599535|FG002|Overall Study|Unrelated Adverse Event|3
4536405|NCT01104779|7357067|FG002|Overall Study|Lack of Efficacy|13
4536406|NCT01104779|7357065|FG000|Overall Study|Adverse Event|13
4536407|NCT01104779|7357066|FG001|Overall Study|Adverse Event|14
4536408|NCT01104779|7357067|FG002|Overall Study|Adverse Event|13
4536409|NCT01104779|7357065|FG000|Overall Study|Did not meet inc/exc criteria|1
4536410|NCT01104779|7357066|FG001|Overall Study|Did not meet inc/exc criteria|1
4689957|NCT02556632|7599533|FG000|Overall Study|Related Adverse Event|0
4689958|NCT02556632|7599534|FG001|Overall Study|Related Adverse Event|1
4689959|NCT02556632|7599535|FG002|Overall Study|Related Adverse Event|0
4689960|NCT02556632|7599533|FG000|Overall Study|Possibly Related Adverse Event|0
4689961|NCT02556632|7599534|FG001|Overall Study|Possibly Related Adverse Event|0
4689962|NCT02556632|7599535|FG002|Overall Study|Possibly Related Adverse Event|1
4689963|NCT02556632|7599533|FG000|Overall Study|Did Not Start RT|0
4689964|NCT02556632|7599534|FG001|Overall Study|Did Not Start RT|1
4536411|NCT01104779|7357067|FG002|Overall Study|Did not meet inc/exc criteria|1
4536412|NCT01104779|7357065|FG000|Overall Study|Other reasons|0
4536413|NCT01104779|7357066|FG001|Overall Study|Other reasons|1
4536414|NCT01104779|7357067|FG002|Overall Study|Other reasons|0
4536415|NCT01104779|7357065|FG000|Overall Study|Lost to Follow-up|2
4536416|NCT01104779|7357066|FG001|Overall Study|Lost to Follow-up|0
4536417|NCT01104779|7357067|FG002|Overall Study|Lost to Follow-up|1
4536418|NCT01104779|7357065|FG000|Overall Study|Withdrawal by Subject|16
4536419|NCT01104779|7357066|FG001|Overall Study|Withdrawal by Subject|25
4536420|NCT01104779|7357067|FG002|Overall Study|Withdrawal by Subject|32
4536421|NCT01104792|7357075|FG000|Overall Study|Adverse Event|77
4536422|NCT01104792|7357075|FG000|Overall Study|Insufficient Therapeutic Response|22
4536423|NCT01104792|7357075|FG000|Overall Study|Protocol Violation|45
4536424|NCT01104792|7357075|FG000|Overall Study|Withdrawal of Consent|179
4536425|NCT01104792|7357075|FG000|Overall Study|Lost to Follow-up|43
4536426|NCT01104792|7357075|FG000|Overall Study|Reasons Not Specified|27
4536427|NCT01104792|7357075|FG000|Overall Study|Did Not Meet Eligibility Criteria|133
4536428|NCT01104870|7357082|FG000|Overall Study|Adverse Event|1
4536429|NCT01104870|7357083|FG001|Overall Study|Adverse Event|1
4536430|NCT01104870|7357084|FG002|Overall Study|Adverse Event|0
4536431|NCT01104870|7357082|FG000|Overall Study|Death|0
4536432|NCT01104870|7357083|FG001|Overall Study|Death|0
4536433|NCT01104870|7357084|FG002|Overall Study|Death|1
4536434|NCT01104870|7357082|FG000|Overall Study|Withdrawal by Subject|0
4536435|NCT01104870|7357083|FG001|Overall Study|Withdrawal by Subject|0
4536436|NCT01104870|7357084|FG002|Overall Study|Withdrawal by Subject|1
4536437|NCT01105065|7357092|FG000|Overall Study|Adverse Event|5
4536438|NCT01105065|7357092|FG000|Overall Study|Technical Problems|1
4536439|NCT01105091|7357100|FG000|Overall Study|Death|2
4536440|NCT01105091|7357101|FG001|Overall Study|Death|0
4536441|NCT01105130|7357121|FG000|Overall Study|Withdrawal by Subject|4
4536442|NCT01105130|7357122|FG001|Overall Study|Withdrawal by Subject|6
4536443|NCT01105130|7357123|FG002|Overall Study|Withdrawal by Subject|2
4536444|NCT01105130|7357121|FG000|Overall Study|Never Started|2
4536445|NCT01105130|7357122|FG001|Overall Study|Never Started|2
4536446|NCT01105130|7357123|FG002|Overall Study|Never Started|4
4536447|NCT01105130|7357121|FG000|Overall Study|Toxicity|1
4536448|NCT01105130|7357122|FG001|Overall Study|Toxicity|3
4536449|NCT01105130|7357123|FG002|Overall Study|Toxicity|2
4536450|NCT01105130|7357121|FG000|Overall Study|Multiple Reasons|3
4536451|NCT01105130|7357122|FG001|Overall Study|Multiple Reasons|0
4536452|NCT01105130|7357123|FG002|Overall Study|Multiple Reasons|2
4536453|NCT01105377|7357160|FG000|Overall Study|Withdrawal by Subject|0
4536454|NCT01105377|7357161|FG001|Overall Study|Withdrawal by Subject|1
4536455|NCT01105533|7357167|FG000|Overall Study|Death|0
4536456|NCT01105533|7357168|FG001|Overall Study|Death|0
4536457|NCT01105533|7357169|FG002|Overall Study|Death|0
4536458|NCT01105533|7357170|FG003|Overall Study|Death|0
4536459|NCT01105533|7357171|FG004|Overall Study|Death|1
4536460|NCT01105533|7357172|FG005|Overall Study|Death|0
4536461|NCT01105533|7357173|FG006|Overall Study|Death|0
4536462|NCT01105533|7357174|FG007|Overall Study|Death|0
4536463|NCT01105533|7357175|FG008|Overall Study|Death|0
4536464|NCT01105533|7357167|FG000|Overall Study|Lack of Efficacy|1
4536465|NCT01105533|7357168|FG001|Overall Study|Lack of Efficacy|1
4536466|NCT01105533|7357169|FG002|Overall Study|Lack of Efficacy|3
4536467|NCT01105533|7357170|FG003|Overall Study|Lack of Efficacy|3
4536468|NCT01105533|7357171|FG004|Overall Study|Lack of Efficacy|4
4536469|NCT01105533|7357172|FG005|Overall Study|Lack of Efficacy|5
4536470|NCT01105533|7357173|FG006|Overall Study|Lack of Efficacy|3
4536471|NCT01105533|7357174|FG007|Overall Study|Lack of Efficacy|2
4536472|NCT01105533|7357175|FG008|Overall Study|Lack of Efficacy|9
4536473|NCT01105533|7357167|FG000|Overall Study|Adverse Event|0
4536474|NCT01105533|7357168|FG001|Overall Study|Adverse Event|0
4536475|NCT01105533|7357169|FG002|Overall Study|Adverse Event|0
4536476|NCT01105533|7357170|FG003|Overall Study|Adverse Event|0
4536477|NCT01105533|7357171|FG004|Overall Study|Adverse Event|1
4536478|NCT01105533|7357172|FG005|Overall Study|Adverse Event|2
4536479|NCT01105533|7357173|FG006|Overall Study|Adverse Event|2
4536480|NCT01105533|7357174|FG007|Overall Study|Adverse Event|0
4536481|NCT01105533|7357175|FG008|Overall Study|Adverse Event|1
4536482|NCT01105533|7357167|FG000|Overall Study|Other|0
4536483|NCT01105533|7357168|FG001|Overall Study|Other|0
4536484|NCT01105533|7357169|FG002|Overall Study|Other|0
4536485|NCT01105533|7357170|FG003|Overall Study|Other|0
4536486|NCT01105533|7357171|FG004|Overall Study|Other|1
4536487|NCT01105533|7357172|FG005|Overall Study|Other|0
4536488|NCT01105533|7357173|FG006|Overall Study|Other|3
4536489|NCT01105533|7357174|FG007|Overall Study|Other|1
4536490|NCT01105533|7357175|FG008|Overall Study|Other|2
4536491|NCT01105533|7357167|FG000|Overall Study|Physician Decision|0
4536492|NCT01105533|7357168|FG001|Overall Study|Physician Decision|0
4536493|NCT01105533|7357169|FG002|Overall Study|Physician Decision|0
4536494|NCT01105533|7357170|FG003|Overall Study|Physician Decision|0
4536495|NCT01105533|7357171|FG004|Overall Study|Physician Decision|0
4536496|NCT01105533|7357172|FG005|Overall Study|Physician Decision|0
4536497|NCT01105533|7357173|FG006|Overall Study|Physician Decision|0
4536498|NCT01105533|7357174|FG007|Overall Study|Physician Decision|1
4536499|NCT01105533|7357175|FG008|Overall Study|Physician Decision|0
4536500|NCT01105767|7357220|FG000|Overall Study|Lost to Follow-up|1160
4536501|NCT01105767|7357221|FG001|Overall Study|Lost to Follow-up|1614
4536502|NCT01105767|7357222|FG002|Overall Study|Lost to Follow-up|1184
4536503|NCT01105936|7357230|FG000|Period 1|Adverse Event|0
4536504|NCT01105936|7357231|FG001|Period 1|Adverse Event|0
4536505|NCT01105936|7357232|FG002|Period 1|Adverse Event|0
4536506|NCT01105936|7357233|FG003|Period 1|Adverse Event|1
4536507|NCT01105936|7357230|FG000|Period 2|Adverse Event|1
4536508|NCT01105936|7357231|FG001|Period 2|Adverse Event|0
4536509|NCT01105936|7357232|FG002|Period 2|Adverse Event|0
4536510|NCT01105936|7357233|FG003|Period 2|Adverse Event|0
4536511|NCT01105936|7357230|FG000|Period 3|Protocol Violation|0
4536512|NCT01105936|7357231|FG001|Period 3|Protocol Violation|2
4536513|NCT01105936|7357232|FG002|Period 3|Protocol Violation|0
4536514|NCT01105936|7357233|FG003|Period 3|Protocol Violation|0
4536515|NCT01105975|7357252|FG000|Overall Study|Adverse Event|2
4536516|NCT01105975|7357253|FG001|Overall Study|Adverse Event|1
4536517|NCT01105975|7357254|FG002|Overall Study|Adverse Event|5
4536518|NCT01105975|7357255|FG003|Overall Study|Adverse Event|1
4536519|NCT01105975|7357256|FG004|Overall Study|Adverse Event|0
4536520|NCT01105975|7357257|FG005|Overall Study|Adverse Event|1
4536521|NCT01105975|7357258|FG006|Overall Study|Adverse Event|2
4536522|NCT01105975|7357259|FG007|Overall Study|Adverse Event|4
4536523|NCT01105975|7357260|FG008|Overall Study|Adverse Event|1
4536524|NCT01105975|7357261|FG009|Overall Study|Adverse Event|4
4536525|NCT01105975|7357252|FG000|Overall Study|Withdrawal by Subject|2
4536526|NCT01105975|7357253|FG001|Overall Study|Withdrawal by Subject|2
4536527|NCT01105975|7357254|FG002|Overall Study|Withdrawal by Subject|2
4536528|NCT01105975|7357255|FG003|Overall Study|Withdrawal by Subject|0
4536529|NCT01105975|7357256|FG004|Overall Study|Withdrawal by Subject|4
4536530|NCT01105975|7357257|FG005|Overall Study|Withdrawal by Subject|1
4536531|NCT01105975|7357258|FG006|Overall Study|Withdrawal by Subject|2
4536532|NCT01105975|7357259|FG007|Overall Study|Withdrawal by Subject|1
4536533|NCT01105975|7357260|FG008|Overall Study|Withdrawal by Subject|0
4536534|NCT01105975|7357261|FG009|Overall Study|Withdrawal by Subject|3
4536535|NCT01105975|7357252|FG000|Overall Study|Lost to Follow-up|1
4536536|NCT01105975|7357253|FG001|Overall Study|Lost to Follow-up|0
4536537|NCT01105975|7357254|FG002|Overall Study|Lost to Follow-up|0
4536538|NCT01105975|7357255|FG003|Overall Study|Lost to Follow-up|1
4536539|NCT01105975|7357256|FG004|Overall Study|Lost to Follow-up|1
4536540|NCT01105975|7357257|FG005|Overall Study|Lost to Follow-up|0
4536541|NCT01105975|7357258|FG006|Overall Study|Lost to Follow-up|0
4536542|NCT01105975|7357259|FG007|Overall Study|Lost to Follow-up|0
4536543|NCT01105975|7357260|FG008|Overall Study|Lost to Follow-up|1
4536544|NCT01105975|7357261|FG009|Overall Study|Lost to Follow-up|0
4536545|NCT01105975|7357252|FG000|Overall Study|Physician Decision|0
4536546|NCT01105975|7357253|FG001|Overall Study|Physician Decision|0
4536547|NCT01105975|7357254|FG002|Overall Study|Physician Decision|0
4536548|NCT01105975|7357255|FG003|Overall Study|Physician Decision|0
4536549|NCT01105975|7357256|FG004|Overall Study|Physician Decision|0
4536550|NCT01105975|7357257|FG005|Overall Study|Physician Decision|0
4536551|NCT01105975|7357258|FG006|Overall Study|Physician Decision|2
4536552|NCT01105975|7357259|FG007|Overall Study|Physician Decision|0
4536553|NCT01105975|7357260|FG008|Overall Study|Physician Decision|0
4536554|NCT01105975|7357261|FG009|Overall Study|Physician Decision|0
4536555|NCT01105975|7357252|FG000|Overall Study|Protocol Violation|0
4536556|NCT01105975|7357253|FG001|Overall Study|Protocol Violation|2
4536557|NCT01105975|7357254|FG002|Overall Study|Protocol Violation|2
4536558|NCT01105975|7357255|FG003|Overall Study|Protocol Violation|0
4536559|NCT01105975|7357256|FG004|Overall Study|Protocol Violation|1
4536560|NCT01105975|7357257|FG005|Overall Study|Protocol Violation|1
4536561|NCT01105975|7357258|FG006|Overall Study|Protocol Violation|1
4536562|NCT01105975|7357259|FG007|Overall Study|Protocol Violation|1
4536563|NCT01105975|7357260|FG008|Overall Study|Protocol Violation|2
4536564|NCT01105975|7357261|FG009|Overall Study|Protocol Violation|2
4536565|NCT01105975|7357252|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0
4536566|NCT01105975|7357253|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0
4536567|NCT01105975|7357254|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1
4536568|NCT01105975|7357255|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0
4536569|NCT01105975|7357256|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0
4536570|NCT01105975|7357257|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2
4536571|NCT01105975|7357258|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1
4536572|NCT01105975|7357259|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1
4536573|NCT01105975|7357260|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2
4536574|NCT01105975|7357261|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0
4536575|NCT01106014|7357304|FG000|Overall Study|Morbidity or Mortality primary endpoint|155
4536576|NCT01106014|7357305|FG001|Overall Study|Morbidity or Mortality primary endpoint|242
4536577|NCT01106014|7357304|FG000|Overall Study|Adverse Event|78
4536578|NCT01106014|7357305|FG001|Overall Study|Adverse Event|42
4536579|NCT01106014|7357304|FG000|Overall Study|Withdrawal by Subject|43
4536580|NCT01106014|7357305|FG001|Overall Study|Withdrawal by Subject|37
4536581|NCT01106014|7357304|FG000|Overall Study|Administrative reason|7
4536582|NCT01106014|7357305|FG001|Overall Study|Administrative reason|6
4536583|NCT01106014|7357304|FG000|Overall Study|Lost to Follow-up|2
4536584|NCT01106014|7357305|FG001|Overall Study|Lost to Follow-up|3
4536585|NCT01106027|7357311|FG000|Overall Study|Lost graft early, discontinued|1
4536586|NCT01106092|7357324|FG000|Overall Study|Withdrawal by Subject|0
4536587|NCT01106092|7357325|FG001|Overall Study|Withdrawal by Subject|0
4536588|NCT01106092|7357326|FG002|Overall Study|Withdrawal by Subject|0
4536589|NCT01106092|7357327|FG003|Overall Study|Withdrawal by Subject|1
4536590|NCT01106157|7357339|FG000|Overall Study|Withdrawal by Subject|1
4536591|NCT01106157|7357340|FG001|Overall Study|Withdrawal by Subject|0
4536592|NCT01106248|7357346|FG000|Overall Study|Adverse Event|1
4536593|NCT01106248|7357346|FG000|Overall Study|Administrative|2
4536594|NCT01106287|7357354|FG000|Overall Study|Adverse Event|1
4536595|NCT01106287|7357355|FG001|Overall Study|Adverse Event|0
4536596|NCT01106287|7357356|FG002|Overall Study|Adverse Event|0
4536597|NCT01106287|7357357|FG003|Overall Study|Adverse Event|0
4536598|NCT01106352|7357382|FG000|Overall Study|Subjects untreated|0
4536599|NCT01106352|7357383|FG001|Overall Study|Subjects untreated|0
4536600|NCT01106352|7357384|FG002|Overall Study|Subjects untreated|0
4536601|NCT01106352|7357385|FG003|Overall Study|Subjects untreated|3
4536602|NCT01106352|7357386|FG004|Overall Study|Subjects untreated|4
4536603|NCT01106352|7357382|FG000|Overall Study|Sponsor Decision|1
4536604|NCT01106352|7357383|FG001|Overall Study|Sponsor Decision|0
4536605|NCT01106352|7357384|FG002|Overall Study|Sponsor Decision|0
4536606|NCT01106352|7357385|FG003|Overall Study|Sponsor Decision|0
4536607|NCT01106352|7357386|FG004|Overall Study|Sponsor Decision|0
4536608|NCT01106352|7357382|FG000|Overall Study|Too ill to come in for the visit|0
4536609|NCT01106352|7357383|FG001|Overall Study|Too ill to come in for the visit|0
4536610|NCT01106352|7357384|FG002|Overall Study|Too ill to come in for the visit|1
4536611|NCT01106352|7357385|FG003|Overall Study|Too ill to come in for the visit|0
4536612|NCT01106352|7357386|FG004|Overall Study|Too ill to come in for the visit|0
4536613|NCT01106352|7357382|FG000|Overall Study|Lost to Follow-up|0
4536614|NCT01106352|7357383|FG001|Overall Study|Lost to Follow-up|0
4536615|NCT01106352|7357384|FG002|Overall Study|Lost to Follow-up|0
4536616|NCT01106352|7357385|FG003|Overall Study|Lost to Follow-up|0
4536617|NCT01106352|7357386|FG004|Overall Study|Lost to Follow-up|1
4536618|NCT01106352|7357382|FG000|Overall Study|Death|0
4536619|NCT01106352|7357383|FG001|Overall Study|Death|0
4536620|NCT01106352|7357384|FG002|Overall Study|Death|1
4536621|NCT01106352|7357385|FG003|Overall Study|Death|3
4536622|NCT01106352|7357386|FG004|Overall Study|Death|1
4536623|NCT01106352|7357382|FG000|Overall Study|Disease progression|0
4536624|NCT01106352|7357383|FG001|Overall Study|Disease progression|0
4536625|NCT01106352|7357384|FG002|Overall Study|Disease progression|0
4536626|NCT01106352|7357385|FG003|Overall Study|Disease progression|1
4536627|NCT01106352|7357386|FG004|Overall Study|Disease progression|0
4536628|NCT01106352|7357382|FG000|Overall Study|Withdrawal by Subject|0
4536629|NCT01106352|7357383|FG001|Overall Study|Withdrawal by Subject|0
4536630|NCT01106352|7357384|FG002|Overall Study|Withdrawal by Subject|0
4536631|NCT01106352|7357385|FG003|Overall Study|Withdrawal by Subject|3
4536632|NCT01106352|7357386|FG004|Overall Study|Withdrawal by Subject|2
4536633|NCT01106352|7357382|FG000|Overall Study|Went on hospice|0
4536634|NCT01106352|7357383|FG001|Overall Study|Went on hospice|0
4536635|NCT01106352|7357384|FG002|Overall Study|Went on hospice|0
4536636|NCT01106352|7357385|FG003|Overall Study|Went on hospice|1
4536637|NCT01106352|7357386|FG004|Overall Study|Went on hospice|0
4536638|NCT01106352|7357382|FG000|Overall Study|Subject entered hospice|0
4536639|NCT01106352|7357383|FG001|Overall Study|Subject entered hospice|0
4536640|NCT01106352|7357384|FG002|Overall Study|Subject entered hospice|0
4536641|NCT01106352|7357385|FG003|Overall Study|Subject entered hospice|1
4536642|NCT01106352|7357386|FG004|Overall Study|Subject entered hospice|0
4536643|NCT01106352|7357382|FG000|Overall Study|Home hospice since July 2013|0
4536644|NCT01106352|7357383|FG001|Overall Study|Home hospice since July 2013|0
4536645|NCT01106352|7357384|FG002|Overall Study|Home hospice since July 2013|0
4536646|NCT01106352|7357385|FG003|Overall Study|Home hospice since July 2013|1
4536647|NCT01106352|7357386|FG004|Overall Study|Home hospice since July 2013|0
4536648|NCT01106404|7357408|FG000|Period I (First 6 Weeks)|Adverse Event|2
4536649|NCT01106404|7357409|FG001|Period I (First 6 Weeks)|Adverse Event|0
4536650|NCT01106404|7357408|FG000|Period I (First 6 Weeks)|Physician Decision|1
4536651|NCT01106404|7357409|FG001|Period I (First 6 Weeks)|Physician Decision|0
4536652|NCT01106404|7357408|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0
4536653|NCT01106404|7357409|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1
4536654|NCT01106404|7357408|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0
4536655|NCT01106404|7357409|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1
4536656|NCT01106430|7357423|FG000|Overall Study|Adverse Event|8
4536657|NCT01106430|7357424|FG001|Overall Study|Adverse Event|10
4536658|NCT01106430|7357423|FG000|Overall Study|Lack of Efficacy|2
4536659|NCT01106430|7357424|FG001|Overall Study|Lack of Efficacy|13
4536660|NCT01106430|7357423|FG000|Overall Study|Lost to Follow-up|5
4536661|NCT01106430|7357424|FG001|Overall Study|Lost to Follow-up|1
4536662|NCT01106430|7357423|FG000|Overall Study|Early Termination Requested By Sponsor|1
4536663|NCT01106430|7357424|FG001|Overall Study|Early Termination Requested By Sponsor|0
4536664|NCT01106430|7357423|FG000|Overall Study|Moved Out Of State|0
4536665|NCT01106430|7357424|FG001|Overall Study|Moved Out Of State|1
4536666|NCT01106430|7357423|FG000|Overall Study|Refused To Take Medication|0
4536667|NCT01106430|7357424|FG001|Overall Study|Refused To Take Medication|1
4536668|NCT01106430|7357423|FG000|Overall Study|Noncompliance|0
4536669|NCT01106430|7357424|FG001|Overall Study|Noncompliance|1
4536670|NCT01106430|7357423|FG000|Overall Study|Hard Time Swallowing The Pills|1
4536671|NCT01106430|7357424|FG001|Overall Study|Hard Time Swallowing The Pills|0
4536672|NCT01106430|7357423|FG000|Overall Study|Previous Use Of Marijuana|1
4536673|NCT01106430|7357424|FG001|Overall Study|Previous Use Of Marijuana|0
4536674|NCT01106430|7357423|FG000|Overall Study|Protocol Violation|7
4536675|NCT01106430|7357424|FG001|Overall Study|Protocol Violation|2
4536676|NCT01106430|7357423|FG000|Overall Study|Withdrawal by Subject|8
4536677|NCT01106430|7357424|FG001|Overall Study|Withdrawal by Subject|4
4536678|NCT01106586|7357441|FG000|Overall Study|Adverse Event|9
4536679|NCT01106586|7357442|FG001|Overall Study|Adverse Event|15
4536680|NCT01106586|7357441|FG000|Overall Study|Death|1
4536681|NCT01106586|7357442|FG001|Overall Study|Death|3
4536682|NCT01106586|7357441|FG000|Overall Study|Pregnancy|2
4536683|NCT01106586|7357442|FG001|Overall Study|Pregnancy|2
4536684|NCT01106586|7357441|FG000|Overall Study|Lack of Efficacy|1
4536685|NCT01106586|7357442|FG001|Overall Study|Lack of Efficacy|0
4536686|NCT01106586|7357441|FG000|Overall Study|Investigator's Discretion|5
4536687|NCT01106586|7357442|FG001|Overall Study|Investigator's Discretion|8
4536688|NCT01106586|7357441|FG000|Overall Study|Withdrew Consent|18
4536689|NCT01106586|7357442|FG001|Overall Study|Withdrew Consent|30
4536690|NCT01106586|7357441|FG000|Overall Study|Lost to Follow-up|24
4536691|NCT01106586|7357442|FG001|Overall Study|Lost to Follow-up|20
4536692|NCT01106586|7357441|FG000|Overall Study|Participant Noncompliance|12
4536693|NCT01106586|7357442|FG001|Overall Study|Participant Noncompliance|10
4536694|NCT01106586|7357441|FG000|Overall Study|Protocol Violation|1
4536695|NCT01106586|7357442|FG001|Overall Study|Protocol Violation|0
4536696|NCT01106586|7357441|FG000|Overall Study|Participant Transferred to Another Study|212
4536697|NCT01106586|7357442|FG001|Overall Study|Participant Transferred to Another Study|197
4536698|NCT01106625|7357451|FG000|Core Period: Baseline to Week 26|Adverse Event|6
4536699|NCT01106625|7357452|FG001|Core Period: Baseline to Week 26|Adverse Event|8
4536700|NCT01106625|7357453|FG002|Core Period: Baseline to Week 26|Adverse Event|8
4536701|NCT01106625|7357451|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5
4536702|NCT01106625|7357452|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0
4536703|NCT01106625|7357453|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4
4536704|NCT01106625|7357451|FG000|Core Period: Baseline to Week 26|Physician Decision|1
4536705|NCT01106625|7357452|FG001|Core Period: Baseline to Week 26|Physician Decision|0
4536706|NCT01106625|7357453|FG002|Core Period: Baseline to Week 26|Physician Decision|0
4536707|NCT01106625|7357451|FG000|Core Period: Baseline to Week 26|Protocol Violation|2
4536708|NCT01106625|7357452|FG001|Core Period: Baseline to Week 26|Protocol Violation|1
4536709|NCT01106625|7357453|FG002|Core Period: Baseline to Week 26|Protocol Violation|3
4536710|NCT01106625|7357451|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6
4536711|NCT01106625|7357452|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9
4536712|NCT01106625|7357453|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7
4536713|NCT01106625|7357451|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4
4536714|NCT01106625|7357452|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
4536715|NCT01106625|7357453|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
4536716|NCT01106625|7357451|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0
4536717|NCT01106625|7357452|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1
4536718|NCT01106625|7357453|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1
4536719|NCT01106625|7357451|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1
4536720|NCT01106625|7357452|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1
4536721|NCT01106625|7357453|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0
4536722|NCT01106625|7357451|FG000|Core Period: Baseline to Week 26|Other|8
4536723|NCT01106625|7357452|FG001|Core Period: Baseline to Week 26|Other|7
4536724|NCT01106625|7357453|FG002|Core Period: Baseline to Week 26|Other|4
4536725|NCT01106625|7357451|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2
4536726|NCT01106625|7357452|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2
4536727|NCT01106625|7357453|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3
4536728|NCT01106625|7357451|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
4536729|NCT01106625|7357452|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3
4536730|NCT01106625|7357453|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
4536731|NCT01106625|7357451|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2
4536732|NCT01106625|7357452|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0
4536733|NCT01106625|7357453|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1
4536734|NCT01106625|7357451|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0
4536735|NCT01106625|7357452|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1
4536736|NCT01106625|7357453|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0
4536737|NCT01106625|7357451|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4
4536738|NCT01106625|7357452|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
4536739|NCT01106625|7357453|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
4536740|NCT01106625|7357451|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14
4536741|NCT01106625|7357452|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5
4536742|NCT01106625|7357453|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4
4536743|NCT01106625|7357451|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
4536744|NCT01106625|7357452|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
4536745|NCT01106625|7357453|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
4536746|NCT01106625|7357451|FG000|Extension Period: Week 26 to Week 52|Other|5
4536747|NCT01106625|7357452|FG001|Extension Period: Week 26 to Week 52|Other|5
4536748|NCT01106625|7357453|FG002|Extension Period: Week 26 to Week 52|Other|4
4536749|NCT01106651|7357467|FG000|Overall Study|Adverse Event|17
4536750|NCT01106651|7357468|FG001|Overall Study|Adverse Event|9
4536751|NCT01106651|7357469|FG002|Overall Study|Adverse Event|23
4536752|NCT01106651|7357467|FG000|Overall Study|Lost to Follow-up|8
4536753|NCT01106651|7357468|FG001|Overall Study|Lost to Follow-up|2
4536754|NCT01106651|7357469|FG002|Overall Study|Lost to Follow-up|6
4536755|NCT01106651|7357467|FG000|Overall Study|Physician Decision|4
4536756|NCT01106651|7357468|FG001|Overall Study|Physician Decision|3
4536757|NCT01106651|7357469|FG002|Overall Study|Physician Decision|1
4536758|NCT01106651|7357467|FG000|Overall Study|Protocol Violation|1
4536759|NCT01106651|7357468|FG001|Overall Study|Protocol Violation|2
4536760|NCT01106651|7357469|FG002|Overall Study|Protocol Violation|1
4536761|NCT01106651|7357467|FG000|Overall Study|Withdrawal by Subject|14
4536762|NCT01106651|7357468|FG001|Overall Study|Withdrawal by Subject|7
4689965|NCT02556632|7599535|FG002|Overall Study|Did Not Start RT|0
4689966|NCT02556632|7599533|FG000|Overall Study|Ineligible|0
4689967|NCT02556632|7599534|FG001|Overall Study|Ineligible|1
4689968|NCT02556632|7599535|FG002|Overall Study|Ineligible|0
4689969|NCT02556632|7599533|FG000|Overall Study|Disliked Study Procedures|0
4689970|NCT02556632|7599534|FG001|Overall Study|Disliked Study Procedures|0
4689971|NCT02556632|7599535|FG002|Overall Study|Disliked Study Procedures|1
4689972|NCT02556632|7599533|FG000|Overall Study|Treatment or Change Delay|0
4689973|NCT02556632|7599534|FG001|Overall Study|Treatment or Change Delay|0
4689974|NCT02556632|7599535|FG002|Overall Study|Treatment or Change Delay|1
4689975|NCT02556775|7599547|FG000|Overall Study|Withdrawal by Subject|1
4689976|NCT02556775|7599548|FG001|Overall Study|Withdrawal by Subject|0
4689977|NCT02556775|7599549|FG002|Overall Study|Withdrawal by Subject|1
4689978|NCT02556775|7599550|FG003|Overall Study|Withdrawal by Subject|0
4689979|NCT02556775|7599547|FG000|Overall Study|Lost to Follow-up|1
4689980|NCT02556775|7599548|FG001|Overall Study|Lost to Follow-up|0
4689981|NCT02556775|7599549|FG002|Overall Study|Lost to Follow-up|0
4689982|NCT02556775|7599550|FG003|Overall Study|Lost to Follow-up|0
4689983|NCT02556801|7599575|FG000|Overall Study|Lost to Follow-up|1
4689984|NCT02556801|7599576|FG001|Overall Study|Lost to Follow-up|0
4689985|NCT02556801|7599577|FG002|Overall Study|Lost to Follow-up|2
4536763|NCT01106651|7357469|FG002|Overall Study|Withdrawal by Subject|4
4689986|NCT02556801|7599578|FG003|Overall Study|Lost to Follow-up|0
4591147|NCT01527006|7437530|FG000|Core Study|Lost to Follow-up|0
4689987|NCT02556801|7599575|FG000|Overall Study|Withdrawal by Subject|1
4689988|NCT02556801|7599576|FG001|Overall Study|Withdrawal by Subject|1
4536764|NCT01106651|7357467|FG000|Overall Study|Noncompliance with study drug|1
4536765|NCT01106651|7357468|FG001|Overall Study|Noncompliance with study drug|0
4536766|NCT01106651|7357469|FG002|Overall Study|Noncompliance with study drug|2
4536767|NCT01106651|7357467|FG000|Overall Study|Other|34
4536768|NCT01106651|7357468|FG001|Overall Study|Other|31
4536769|NCT01106651|7357469|FG002|Overall Study|Other|21
4536770|NCT01106651|7357467|FG000|Overall Study|Death|0
4536771|NCT01106651|7357468|FG001|Overall Study|Death|3
4536772|NCT01106651|7357469|FG002|Overall Study|Death|0
4536773|NCT01106677|7357484|FG000|Core Period: Baseline to Week 26|Adverse Event|7
4536774|NCT01106677|7357485|FG001|Core Period: Baseline to Week 26|Adverse Event|18
4536775|NCT01106677|7357486|FG002|Core Period: Baseline to Week 26|Adverse Event|6
4689989|NCT02556801|7599577|FG002|Overall Study|Withdrawal by Subject|1
4689990|NCT02556801|7599578|FG003|Overall Study|Withdrawal by Subject|0
4689991|NCT02556801|7599575|FG000|Overall Study|Protocol Violation|0
4689992|NCT02556801|7599576|FG001|Overall Study|Protocol Violation|3
4689993|NCT02556801|7599577|FG002|Overall Study|Protocol Violation|1
4689994|NCT02556801|7599578|FG003|Overall Study|Protocol Violation|1
4689995|NCT02556801|7599575|FG000|Overall Study|Adverse Event|0
4689996|NCT02556801|7599576|FG001|Overall Study|Adverse Event|2
4689997|NCT02556801|7599577|FG002|Overall Study|Adverse Event|0
4689998|NCT02556801|7599578|FG003|Overall Study|Adverse Event|3
4689999|NCT02556801|7599575|FG000|Overall Study|Pregnancy|0
4690000|NCT02556801|7599576|FG001|Overall Study|Pregnancy|1
4690001|NCT02556801|7599577|FG002|Overall Study|Pregnancy|0
4690002|NCT02556801|7599578|FG003|Overall Study|Pregnancy|0
4690003|NCT02556801|7599575|FG000|Overall Study|Personal reasons patient|0
4690004|NCT02556801|7599576|FG001|Overall Study|Personal reasons patient|0
4690005|NCT02556801|7599577|FG002|Overall Study|Personal reasons patient|0
4690006|NCT02556801|7599578|FG003|Overall Study|Personal reasons patient|1
4690007|NCT02556918|7599590|FG000|Overall Study|Protocol Violation|5
4690008|NCT02556918|7599591|FG001|Overall Study|Protocol Violation|6
4690009|NCT02556918|7599590|FG000|Overall Study|Withdrawal by Subject|4
4690010|NCT02556918|7599591|FG001|Overall Study|Withdrawal by Subject|4
4690011|NCT02557100|7599610|FG000|Single Blind Treatment Period|Lost to Follow-up|0
4690012|NCT02557100|7599611|FG001|Single Blind Treatment Period|Lost to Follow-up|1
4690013|NCT02557100|7599612|FG002|Single Blind Treatment Period|Lost to Follow-up|0
4690014|NCT02557100|7599610|FG000|Single Blind Treatment Period|Death|0
4690015|NCT02557100|7599611|FG001|Single Blind Treatment Period|Death|1
4690016|NCT02557100|7599612|FG002|Single Blind Treatment Period|Death|0
4690017|NCT02557100|7599610|FG000|Single Blind Treatment Period|Request to Discontinue|0
4690018|NCT02557100|7599611|FG001|Single Blind Treatment Period|Request to Discontinue|1
4690019|NCT02557100|7599612|FG002|Single Blind Treatment Period|Request to Discontinue|0
4690020|NCT02557100|7599610|FG000|Single Blind Treatment Period|Adverse Event|0
4690021|NCT02557100|7599611|FG001|Single Blind Treatment Period|Adverse Event|1
4690022|NCT02557100|7599612|FG002|Single Blind Treatment Period|Adverse Event|0
4690023|NCT02557100|7599610|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40
4690024|NCT02557100|7599611|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36
4690025|NCT02557100|7599612|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0
4690026|NCT02557100|7599610|FG000|Cumulative Abatacept Period|Other Reasons|0
4690027|NCT02557100|7599611|FG001|Cumulative Abatacept Period|Other Reasons|0
4690028|NCT02557100|7599612|FG002|Cumulative Abatacept Period|Other Reasons|1
4690029|NCT02557100|7599610|FG000|Cumulative Abatacept Period|Lost to Follow-up|0
4451676|NCT00520936|7238084|FG000|Overall Study|Physician Decision|0
4451677|NCT00520936|7238085|FG001|Overall Study|Physician Decision|2
4536776|NCT01106677|7357487|FG003|Core Period: Baseline to Week 26|Adverse Event|8
4536777|NCT01106677|7357484|FG000|Core Period: Baseline to Week 26|Death|0
4536778|NCT01106677|7357485|FG001|Core Period: Baseline to Week 26|Death|0
4690030|NCT02557100|7599611|FG001|Cumulative Abatacept Period|Lost to Follow-up|0
4690031|NCT02557100|7599612|FG002|Cumulative Abatacept Period|Lost to Follow-up|2
4690032|NCT02557100|7599610|FG000|Cumulative Abatacept Period|Request to Discontinue|0
4536779|NCT01106677|7357486|FG002|Core Period: Baseline to Week 26|Death|1
4536780|NCT01106677|7357487|FG003|Core Period: Baseline to Week 26|Death|0
4536781|NCT01106677|7357484|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1
4536782|NCT01106677|7357485|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0
4536783|NCT01106677|7357486|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0
4536784|NCT01106677|7357487|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0
4536785|NCT01106677|7357484|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3
4536786|NCT01106677|7357485|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1
4536787|NCT01106677|7357486|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6
4536788|NCT01106677|7357487|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3
4536789|NCT01106677|7357484|FG000|Core Period: Baseline to Week 26|Physician Decision|2
4536790|NCT01106677|7357485|FG001|Core Period: Baseline to Week 26|Physician Decision|1
4536791|NCT01106677|7357486|FG002|Core Period: Baseline to Week 26|Physician Decision|3
4536792|NCT01106677|7357487|FG003|Core Period: Baseline to Week 26|Physician Decision|1
4536793|NCT01106677|7357484|FG000|Core Period: Baseline to Week 26|Protocol Violation|0
4536794|NCT01106677|7357485|FG001|Core Period: Baseline to Week 26|Protocol Violation|1
4536795|NCT01106677|7357486|FG002|Core Period: Baseline to Week 26|Protocol Violation|0
4536796|NCT01106677|7357487|FG003|Core Period: Baseline to Week 26|Protocol Violation|3
4536797|NCT01106677|7357484|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5
4536798|NCT01106677|7357485|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3
4536799|NCT01106677|7357486|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15
4536800|NCT01106677|7357487|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6
4536801|NCT01106677|7357484|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1
4536802|NCT01106677|7357485|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2
4536803|NCT01106677|7357486|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2
4536804|NCT01106677|7357487|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3
4536805|NCT01106677|7357484|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1
4536806|NCT01106677|7357485|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3
4536807|NCT01106677|7357486|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0
4536808|NCT01106677|7357487|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0
4536809|NCT01106677|7357484|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0
4536810|NCT01106677|7357485|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1
4536811|NCT01106677|7357486|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2
4536812|NCT01106677|7357487|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0
4536813|NCT01106677|7357484|FG000|Core Period: Baseline to Week 26|Product quality complaint|0
4536814|NCT01106677|7357485|FG001|Core Period: Baseline to Week 26|Product quality complaint|1
4536815|NCT01106677|7357486|FG002|Core Period: Baseline to Week 26|Product quality complaint|1
4536816|NCT01106677|7357487|FG003|Core Period: Baseline to Week 26|Product quality complaint|0
4536817|NCT01106677|7357484|FG000|Core Period: Baseline to Week 26|Other|8
4536818|NCT01106677|7357485|FG001|Core Period: Baseline to Week 26|Other|14
4536819|NCT01106677|7357486|FG002|Core Period: Baseline to Week 26|Other|8
4536820|NCT01106677|7357487|FG003|Core Period: Baseline to Week 26|Other|23
4536821|NCT01106677|7357484|FG000|Core Period: Baseline to Week 26|Pregnancy|0
4536822|NCT01106677|7357485|FG001|Core Period: Baseline to Week 26|Pregnancy|1
4536823|NCT01106677|7357486|FG002|Core Period: Baseline to Week 26|Pregnancy|0
4536824|NCT01106677|7357487|FG003|Core Period: Baseline to Week 26|Pregnancy|0
4536825|NCT01106677|7357484|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1
4536826|NCT01106677|7357485|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1
4536827|NCT01106677|7357486|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5
4536828|NCT01106677|7357487|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9
4536829|NCT01106677|7357484|FG000|Extension Period: Week 26 to Week 52|Death|0
4536830|NCT01106677|7357485|FG001|Extension Period: Week 26 to Week 52|Death|0
4536831|NCT01106677|7357486|FG002|Extension Period: Week 26 to Week 52|Death|0
4536832|NCT01106677|7357487|FG003|Extension Period: Week 26 to Week 52|Death|1
4536833|NCT01106677|7357484|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2
4536834|NCT01106677|7357485|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0
4536835|NCT01106677|7357486|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0
4536836|NCT01106677|7357487|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4
4536837|NCT01106677|7357484|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
4536838|NCT01106677|7357485|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
4536839|NCT01106677|7357486|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
4536840|NCT01106677|7357487|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
4536841|NCT01106677|7357484|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2
4536842|NCT01106677|7357485|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3
4536843|NCT01106677|7357486|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2
4536844|NCT01106677|7357487|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3
4536845|NCT01106677|7357484|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1
4610359|NCT01693562|7466662|FG004|Expansion Phase|Death|0
4610360|NCT01693562|7466663|FG005|Expansion Phase|Death|0
4610361|NCT01693562|7466664|FG006|Expansion Phase|Death|0
4610362|NCT01693562|7466665|FG007|Expansion Phase|Death|42
4610363|NCT01693562|7466666|FG008|Expansion Phase|Death|17
4610364|NCT01693562|7466667|FG009|Expansion Phase|Death|208
4610365|NCT01693562|7466668|FG010|Expansion Phase|Death|30
4610366|NCT01693562|7466669|FG011|Expansion Phase|Death|8
4447606|NCT00490971|7232837|FG000|Maintenance|Pregnancy|0
4447607|NCT00490971|7232838|FG001|Maintenance|Pregnancy|0
4447608|NCT00490971|7232839|FG002|Maintenance|Pregnancy|1
4447609|NCT00490971|7232840|FG003|Maintenance|Pregnancy|0
4447610|NCT00490971|7232841|FG004|Maintenance|Pregnancy|0
4447611|NCT00490971|7232837|FG000|Maintenance|Protocol Violation|0
4447612|NCT00490971|7232838|FG001|Maintenance|Protocol Violation|0
4447613|NCT00490971|7232839|FG002|Maintenance|Protocol Violation|4
4447614|NCT00490971|7232840|FG003|Maintenance|Protocol Violation|1
4447615|NCT00490971|7232841|FG004|Maintenance|Protocol Violation|1
4447616|NCT00490971|7232837|FG000|Maintenance|Withdrawal by Subject|0
4447617|NCT00490971|7232838|FG001|Maintenance|Withdrawal by Subject|0
4447618|NCT00490971|7232839|FG002|Maintenance|Withdrawal by Subject|26
4447619|NCT00490971|7232840|FG003|Maintenance|Withdrawal by Subject|28
4447620|NCT00490971|7232841|FG004|Maintenance|Withdrawal by Subject|18
4447621|NCT00490971|7232837|FG000|Maintenance|Other|0
4447622|NCT00490971|7232838|FG001|Maintenance|Other|0
4447623|NCT00490971|7232839|FG002|Maintenance|Other|11
4447624|NCT00490971|7232840|FG003|Maintenance|Other|9
4447625|NCT00490971|7232841|FG004|Maintenance|Other|3
4447626|NCT00491075|7232853|FG000|Overall Study|Withdrawal by Subject|1
4447627|NCT00491075|7232853|FG000|Overall Study|Physician Decision|1
4447628|NCT00491179|7232859|FG000|Overall Study|Adverse Event|5
4447629|NCT00491179|7232860|FG001|Overall Study|Adverse Event|1
4447630|NCT00491179|7232859|FG000|Overall Study|Withdrawal by Subject|2
4447631|NCT00491179|7232860|FG001|Overall Study|Withdrawal by Subject|1
4447632|NCT00491322|7232877|FG000|Overall Study|Protocol Violation|1
4447633|NCT00491322|7232878|FG001|Overall Study|Protocol Violation|0
4447634|NCT00491322|7232877|FG000|Overall Study|Pregnancy|0
4447635|NCT00491322|7232878|FG001|Overall Study|Pregnancy|1
4447636|NCT00491530|7232905|FG000|Overall Study|Adverse Event|6
4447637|NCT00491530|7232906|FG001|Overall Study|Adverse Event|1
4447638|NCT00491530|7232907|FG002|Overall Study|Adverse Event|2
4447639|NCT00491530|7232905|FG000|Overall Study|Withdrawal by Subject|3
4447640|NCT00491530|7232906|FG001|Overall Study|Withdrawal by Subject|0
4447641|NCT00491530|7232907|FG002|Overall Study|Withdrawal by Subject|0
4447642|NCT00491530|7232905|FG000|Overall Study|Lost to Follow-up|3
4447643|NCT00491530|7232906|FG001|Overall Study|Lost to Follow-up|2
4447644|NCT00491530|7232907|FG002|Overall Study|Lost to Follow-up|2
4447645|NCT00491530|7232905|FG000|Overall Study|Lack of Efficacy|0
4447646|NCT00491530|7232906|FG001|Overall Study|Lack of Efficacy|1
4447647|NCT00491530|7232907|FG002|Overall Study|Lack of Efficacy|0
4447648|NCT00491530|7232905|FG000|Overall Study|Investigator Discretion|0
4610367|NCT01693562|7466670|FG012|Expansion Phase|Death|19
4610368|NCT01693562|7466671|FG013|Expansion Phase|Death|42
4447649|NCT00491530|7232906|FG001|Overall Study|Investigator Discretion|1
4447650|NCT00491530|7232907|FG002|Overall Study|Investigator Discretion|0
4447651|NCT00491530|7232905|FG000|Overall Study|Patient Request|0
4447652|NCT00491530|7232906|FG001|Overall Study|Patient Request|1
4447653|NCT00491530|7232907|FG002|Overall Study|Patient Request|0
4447654|NCT00491530|7232905|FG000|Overall Study|Use of Prohibited Medication|0
4451678|NCT00520936|7238086|FG002|Overall Study|Physician Decision|1
4536846|NCT01106677|7357485|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0
4536847|NCT01106677|7357486|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0
4536848|NCT01106677|7357487|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0
4536849|NCT01106677|7357484|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
4610369|NCT01693562|7466672|FG014|Expansion Phase|Death|23
4610370|NCT01693562|7466673|FG015|Expansion Phase|Death|23
4610371|NCT01693562|7466674|FG016|Expansion Phase|Death|128
4610372|NCT01693562|7466675|FG017|Expansion Phase|Death|16
4610373|NCT01693562|7466676|FG018|Expansion Phase|Death|36
4610374|NCT01693562|7466677|FG019|Expansion Phase|Death|16
4610375|NCT01693562|7466678|FG020|Expansion Phase|Death|17
4610376|NCT01693562|7466679|FG021|Expansion Phase|Death|35
4610377|NCT01693562|7466680|FG022|Expansion Phase|Death|7
4610378|NCT01693562|7466658|FG000|Expansion Phase|Lost to Follow-up|0
4610379|NCT01693562|7466659|FG001|Expansion Phase|Lost to Follow-up|0
4610380|NCT01693562|7466660|FG002|Expansion Phase|Lost to Follow-up|0
4610381|NCT01693562|7466661|FG003|Expansion Phase|Lost to Follow-up|0
4610382|NCT01693562|7466662|FG004|Expansion Phase|Lost to Follow-up|0
4610383|NCT01693562|7466663|FG005|Expansion Phase|Lost to Follow-up|0
4610384|NCT01693562|7466664|FG006|Expansion Phase|Lost to Follow-up|0
4610385|NCT01693562|7466665|FG007|Expansion Phase|Lost to Follow-up|1
4610386|NCT01693562|7466666|FG008|Expansion Phase|Lost to Follow-up|2
4610387|NCT01693562|7466667|FG009|Expansion Phase|Lost to Follow-up|10
4610388|NCT01693562|7466668|FG010|Expansion Phase|Lost to Follow-up|4
4610389|NCT01693562|7466669|FG011|Expansion Phase|Lost to Follow-up|4
4610390|NCT01693562|7466670|FG012|Expansion Phase|Lost to Follow-up|1
4610391|NCT01693562|7466671|FG013|Expansion Phase|Lost to Follow-up|3
4610392|NCT01693562|7466672|FG014|Expansion Phase|Lost to Follow-up|0
4610393|NCT01693562|7466673|FG015|Expansion Phase|Lost to Follow-up|1
4610394|NCT01693562|7466674|FG016|Expansion Phase|Lost to Follow-up|1
4610395|NCT01693562|7466675|FG017|Expansion Phase|Lost to Follow-up|0
4610396|NCT01693562|7466676|FG018|Expansion Phase|Lost to Follow-up|2
4610397|NCT01693562|7466677|FG019|Expansion Phase|Lost to Follow-up|1
4610398|NCT01693562|7466678|FG020|Expansion Phase|Lost to Follow-up|2
4610399|NCT01693562|7466679|FG021|Expansion Phase|Lost to Follow-up|2
4610400|NCT01693562|7466680|FG022|Expansion Phase|Lost to Follow-up|1
4610401|NCT01693562|7466658|FG000|Expansion Phase|Other|0
4610402|NCT01693562|7466659|FG001|Expansion Phase|Other|0
4610403|NCT01693562|7466660|FG002|Expansion Phase|Other|0
4610404|NCT01693562|7466661|FG003|Expansion Phase|Other|0
4610405|NCT01693562|7466662|FG004|Expansion Phase|Other|0
4770349|NCT03911713|7746692|FG001|Overall Study|Other|0
4770350|NCT03911713|7746693|FG002|Overall Study|Other|0
4770351|NCT03911713|7746694|FG003|Overall Study|Other|1
4770352|NCT03911713|7746695|FG004|Overall Study|Other|0
4770353|NCT03911713|7746691|FG000|Overall Study|Randomized, Never Dosed|1
4770354|NCT03911713|7746692|FG001|Overall Study|Randomized, Never Dosed|0
4770355|NCT03911713|7746693|FG002|Overall Study|Randomized, Never Dosed|0
4770356|NCT03911713|7746694|FG003|Overall Study|Randomized, Never Dosed|1
4770357|NCT03911713|7746695|FG004|Overall Study|Randomized, Never Dosed|0
4770358|NCT03852459|7746720|FG000|Overall Study|Adverse Event|2
4770359|NCT03852459|7746721|FG001|Overall Study|Adverse Event|2
4770360|NCT03852459|7746720|FG000|Overall Study|Withdrawal by Subject|1
4770361|NCT03852459|7746721|FG001|Overall Study|Withdrawal by Subject|1
4610406|NCT01693562|7466663|FG005|Expansion Phase|Other|0
4610407|NCT01693562|7466664|FG006|Expansion Phase|Other|0
4610408|NCT01693562|7466665|FG007|Expansion Phase|Other|3
4610409|NCT01693562|7466666|FG008|Expansion Phase|Other|1
4610410|NCT01693562|7466667|FG009|Expansion Phase|Other|28
4536850|NCT01106677|7357485|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3
4536851|NCT01106677|7357486|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2
4536852|NCT01106677|7357487|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
4610411|NCT01693562|7466668|FG010|Expansion Phase|Other|4
4610412|NCT01693562|7466669|FG011|Expansion Phase|Other|7
4610413|NCT01693562|7466670|FG012|Expansion Phase|Other|0
4610414|NCT01693562|7466671|FG013|Expansion Phase|Other|1
4610415|NCT01693562|7466672|FG014|Expansion Phase|Other|1
4610416|NCT01693562|7466673|FG015|Expansion Phase|Other|0
4610417|NCT01693562|7466674|FG016|Expansion Phase|Other|28
4610418|NCT01693562|7466675|FG017|Expansion Phase|Other|0
4610419|NCT01693562|7466676|FG018|Expansion Phase|Other|1
4610420|NCT01693562|7466677|FG019|Expansion Phase|Other|0
4610421|NCT01693562|7466678|FG020|Expansion Phase|Other|1
4610422|NCT01693562|7466679|FG021|Expansion Phase|Other|17
4610423|NCT01693562|7466680|FG022|Expansion Phase|Other|1
4610424|NCT01693614|7466766|FG000|Overall Study|Adverse Event|7
4610425|NCT01693614|7466767|FG001|Overall Study|Adverse Event|11
4610426|NCT01693614|7466768|FG002|Overall Study|Adverse Event|5
4610427|NCT01693614|7466766|FG000|Overall Study|Disease progression|11
4610428|NCT01693614|7466767|FG001|Overall Study|Disease progression|8
4610429|NCT01693614|7466768|FG002|Overall Study|Disease progression|7
4610430|NCT01693614|7466766|FG000|Overall Study|Protocol Violation|5
4610431|NCT01693614|7466767|FG001|Overall Study|Protocol Violation|2
4610432|NCT01693614|7466768|FG002|Overall Study|Protocol Violation|1
4610433|NCT01693614|7466766|FG000|Overall Study|Death|1
4610434|NCT01693614|7466767|FG001|Overall Study|Death|0
4610435|NCT01693614|7466768|FG002|Overall Study|Death|0
4610436|NCT01693614|7466766|FG000|Overall Study|Physician Decision|1
4610437|NCT01693614|7466767|FG001|Overall Study|Physician Decision|1
4610438|NCT01693614|7466768|FG002|Overall Study|Physician Decision|4
4610439|NCT01693614|7466766|FG000|Overall Study|Withdrawal by subject/guardian|0
4610440|NCT01693614|7466767|FG001|Overall Study|Withdrawal by subject/guardian|0
4610441|NCT01693614|7466768|FG002|Overall Study|Withdrawal by subject/guardian|2
4610442|NCT01693614|7466766|FG000|Overall Study|Withdrawal by Subject|1
4610443|NCT01693614|7466767|FG001|Overall Study|Withdrawal by Subject|0
4610444|NCT01693614|7466768|FG002|Overall Study|Withdrawal by Subject|5
4610445|NCT01694121|7466804|FG000|Overall Study|Participant used false ID, was withdrawn|1
4610446|NCT01694121|7466805|FG001|Overall Study|Participant used false ID, was withdrawn|0
4610447|NCT01694420|7466829|FG000|Overall Study|Lost to Follow-up|3
4610448|NCT01694433|7466835|FG000|Overall Study|Adverse Event|7
4610449|NCT01694433|7466836|FG001|Overall Study|Adverse Event|0
4610450|NCT01694433|7466835|FG000|Overall Study|Physician Decision|1
4610451|NCT01694433|7466836|FG001|Overall Study|Physician Decision|0
4610452|NCT01694433|7466835|FG000|Overall Study|Withdrawal by Subject|3
4610453|NCT01694433|7466836|FG001|Overall Study|Withdrawal by Subject|4
4632610|NCT01903525|7502346|FG001|Overall Study|Lost to Follow-up|9
4632611|NCT01903525|7502345|FG000|Overall Study|Adverse Event|0
4632612|NCT01903525|7502346|FG001|Overall Study|Adverse Event|1
4632613|NCT01903720|7502361|FG000|Overall Study|Inclusion / exclusion criteria not met|6
4632614|NCT01903720|7502361|FG000|Overall Study|Adverse Event|1
4632615|NCT01903720|7502361|FG000|Overall Study|Rescinding of informed consent|2
4770362|NCT03740919|7746730|FG000|Lead-in Period|Lost to Follow-up|1
4770363|NCT03740919|7746731|FG001|Lead-in Period|Lost to Follow-up|0
4770364|NCT03740919|7746732|FG002|Lead-in Period|Lost to Follow-up|0
4770365|NCT03740919|7746733|FG003|Lead-in Period|Lost to Follow-up|0
4770366|NCT03740919|7746730|FG000|Lead-in Period|Physician Decision|2
4770367|NCT03740919|7746731|FG001|Lead-in Period|Physician Decision|0
4770368|NCT03740919|7746732|FG002|Lead-in Period|Physician Decision|0
4536853|NCT01106677|7357484|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
4536854|NCT01106677|7357485|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4
4536855|NCT01106677|7357486|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3
4536856|NCT01106677|7357487|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
4536857|NCT01106677|7357484|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
4536858|NCT01106677|7357485|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
4536859|NCT01106677|7357486|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
4536860|NCT01106677|7357487|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
4536861|NCT01106677|7357484|FG000|Extension Period: Week 26 to Week 52|Other|6
4536862|NCT01106677|7357485|FG001|Extension Period: Week 26 to Week 52|Other|5
4632616|NCT01903720|7502361|FG000|Overall Study|Lost to Follow-up|2
4632617|NCT01903720|7502361|FG000|Overall Study|Treatment with alternative drug|1
4632618|NCT01903733|7502369|FG000|Overall Study|Death|23
4632619|NCT01903733|7502370|FG001|Overall Study|Death|54
4632620|NCT01903733|7502371|FG002|Overall Study|Death|30
4632621|NCT01903733|7502372|FG003|Overall Study|Death|98
4632622|NCT01903733|7502369|FG000|Overall Study|Participant refused further follow-up|35
4632623|NCT01903733|7502370|FG001|Overall Study|Participant refused further follow-up|38
4770369|NCT03740919|7746733|FG003|Lead-in Period|Physician Decision|0
4536863|NCT01106677|7357486|FG002|Extension Period: Week 26 to Week 52|Other|8
4536864|NCT01106677|7357487|FG003|Extension Period: Week 26 to Week 52|Other|5
4536865|NCT01106690|7357507|FG000|Core Period: Baseline to Week 26|Adverse Event|6
4536866|NCT01106690|7357508|FG001|Core Period: Baseline to Week 26|Adverse Event|1
4536867|NCT01106690|7357509|FG002|Core Period: Baseline to Week 26|Adverse Event|4
4536868|NCT01106690|7357507|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1
4536869|NCT01106690|7357508|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1
4536870|NCT01106690|7357509|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2
4536871|NCT01106690|7357507|FG000|Core Period: Baseline to Week 26|Protocol Violation|1
4536872|NCT01106690|7357508|FG001|Core Period: Baseline to Week 26|Protocol Violation|0
4536873|NCT01106690|7357509|FG002|Core Period: Baseline to Week 26|Protocol Violation|0
4536874|NCT01106690|7357507|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4
4536875|NCT01106690|7357508|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1
4536876|NCT01106690|7357509|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0
4536877|NCT01106690|7357507|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0
4536878|NCT01106690|7357508|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3
4536879|NCT01106690|7357509|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1
4536880|NCT01106690|7357507|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0
4610454|NCT01694485|7466847|FG000|Overall Study|Withdrawal by Subject|20
4610455|NCT01694485|7466848|FG001|Overall Study|Withdrawal by Subject|6
4610456|NCT01694485|7466849|FG002|Overall Study|Withdrawal by Subject|7
4610457|NCT01694485|7466850|FG003|Overall Study|Withdrawal by Subject|25
4610458|NCT01694485|7466851|FG004|Overall Study|Withdrawal by Subject|18
4610459|NCT01694485|7466847|FG000|Overall Study|Sponsor Decision|3
4610460|NCT01694485|7466848|FG001|Overall Study|Sponsor Decision|0
4610461|NCT01694485|7466849|FG002|Overall Study|Sponsor Decision|0
4610462|NCT01694485|7466850|FG003|Overall Study|Sponsor Decision|2
4610463|NCT01694485|7466851|FG004|Overall Study|Sponsor Decision|0
4610464|NCT01694485|7466847|FG000|Overall Study|Lost to Follow-up|9
4610465|NCT01694485|7466848|FG001|Overall Study|Lost to Follow-up|1
4610466|NCT01694485|7466849|FG002|Overall Study|Lost to Follow-up|6
4610467|NCT01694485|7466850|FG003|Overall Study|Lost to Follow-up|10
4610468|NCT01694485|7466851|FG004|Overall Study|Lost to Follow-up|7
4610469|NCT01694485|7466847|FG000|Overall Study|Death|1
4610470|NCT01694485|7466848|FG001|Overall Study|Death|0
4610471|NCT01694485|7466849|FG002|Overall Study|Death|0
4610472|NCT01694485|7466850|FG003|Overall Study|Death|1
4610473|NCT01694485|7466851|FG004|Overall Study|Death|0
4610474|NCT01694706|7466894|FG000|Overall Study|Adverse Event|0
4610475|NCT01694706|7466895|FG001|Overall Study|Adverse Event|1
4610476|NCT01694706|7466896|FG002|Overall Study|Adverse Event|0
4610477|NCT01694706|7466894|FG000|Overall Study|other reason not defined above|1
4610478|NCT01694706|7466895|FG001|Overall Study|other reason not defined above|0
4610479|NCT01694706|7466896|FG002|Overall Study|other reason not defined above|0
4610480|NCT01694771|7466907|FG000|Overall Study|Adverse Event|18
4610481|NCT01694771|7466908|FG001|Overall Study|Adverse Event|16
4690033|NCT02557100|7599611|FG001|Cumulative Abatacept Period|Request to Discontinue|0
4690034|NCT02557100|7599612|FG002|Cumulative Abatacept Period|Request to Discontinue|1
4690035|NCT02557399|7599631|FG000|Overall Study|Adverse Event|6
4690036|NCT02557399|7599632|FG001|Overall Study|Adverse Event|5
4690037|NCT02557399|7599631|FG000|Overall Study|Protocol Violation|0
4690038|NCT02557399|7599632|FG001|Overall Study|Protocol Violation|1
4690039|NCT02557399|7599631|FG000|Overall Study|Protocol-defined stopping criteria|0
4690040|NCT02557399|7599632|FG001|Overall Study|Protocol-defined stopping criteria|1
4690041|NCT02557399|7599631|FG000|Overall Study|Withdrawal by Subject|1
4690042|NCT02557399|7599632|FG001|Overall Study|Withdrawal by Subject|1
4690043|NCT02557516|7599645|FG000|Overall Study|Adverse Event|1
4690044|NCT02557516|7599646|FG001|Overall Study|Adverse Event|0
4690045|NCT02557516|7599647|FG002|Overall Study|Adverse Event|2
4690046|NCT02557516|7599648|FG003|Overall Study|Adverse Event|1
4690047|NCT02557516|7599645|FG000|Overall Study|Disease progression|0
4690048|NCT02557516|7599646|FG001|Overall Study|Disease progression|2
4447655|NCT00491530|7232906|FG001|Overall Study|Use of Prohibited Medication|0
4447656|NCT00491530|7232907|FG002|Overall Study|Use of Prohibited Medication|1
4447657|NCT00491556|7232917|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1
4451679|NCT00520936|7238087|FG003|Overall Study|Physician Decision|0
4591148|NCT01527006|7437531|FG001|Core Study|Lost to Follow-up|1
4610482|NCT01694771|7466907|FG000|Overall Study|Lack of Efficacy|1
4610483|NCT01694771|7466908|FG001|Overall Study|Lack of Efficacy|0
4610484|NCT01694771|7466907|FG000|Overall Study|Non compliance protocol|7
4610485|NCT01694771|7466908|FG001|Overall Study|Non compliance protocol|6
4447658|NCT00491556|7232918|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0
4610486|NCT01694771|7466907|FG000|Overall Study|Lost to Follow-up|2
4451680|NCT00520936|7238088|FG004|Overall Study|Physician Decision|0
4451681|NCT00520936|7238089|FG005|Overall Study|Physician Decision|0
4451682|NCT00520936|7238090|FG006|Overall Study|Physician Decision|0
4536881|NCT01106690|7357508|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1
4536882|NCT01106690|7357509|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0
4536883|NCT01106690|7357507|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
4536884|NCT01106690|7357508|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
4536885|NCT01106690|7357509|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
4536886|NCT01106690|7357507|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1
4536887|NCT01106690|7357508|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
4536888|NCT01106690|7357509|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
4451683|NCT00520936|7238091|FG007|Overall Study|Physician Decision|0
4451684|NCT00520936|7238084|FG000|Overall Study|Withdrawal by Subject|0
4451685|NCT00520936|7238085|FG001|Overall Study|Withdrawal by Subject|0
4451686|NCT00520936|7238086|FG002|Overall Study|Withdrawal by Subject|0
4451687|NCT00520936|7238087|FG003|Overall Study|Withdrawal by Subject|0
4451688|NCT00520936|7238088|FG004|Overall Study|Withdrawal by Subject|0
4451689|NCT00520936|7238089|FG005|Overall Study|Withdrawal by Subject|0
4451690|NCT00520936|7238090|FG006|Overall Study|Withdrawal by Subject|0
4451691|NCT00520936|7238091|FG007|Overall Study|Withdrawal by Subject|1
4451692|NCT00520936|7238084|FG000|Overall Study|Toxicity Requiring Removal from Study|0
4451693|NCT00520936|7238085|FG001|Overall Study|Toxicity Requiring Removal from Study|1
4451694|NCT00520936|7238086|FG002|Overall Study|Toxicity Requiring Removal from Study|0
4451695|NCT00520936|7238087|FG003|Overall Study|Toxicity Requiring Removal from Study|0
4451696|NCT00520936|7238088|FG004|Overall Study|Toxicity Requiring Removal from Study|0
4451697|NCT00520936|7238089|FG005|Overall Study|Toxicity Requiring Removal from Study|0
4451698|NCT00520936|7238090|FG006|Overall Study|Toxicity Requiring Removal from Study|2
4451699|NCT00520936|7238091|FG007|Overall Study|Toxicity Requiring Removal from Study|0
4451700|NCT00520936|7238084|FG000|Overall Study|Death|0
4451701|NCT00520936|7238085|FG001|Overall Study|Death|0
4451702|NCT00520936|7238086|FG002|Overall Study|Death|0
4451703|NCT00520936|7238087|FG003|Overall Study|Death|0
4451704|NCT00520936|7238088|FG004|Overall Study|Death|0
4451705|NCT00520936|7238089|FG005|Overall Study|Death|0
4451706|NCT00520936|7238090|FG006|Overall Study|Death|1
4451707|NCT00520936|7238091|FG007|Overall Study|Death|0
4451708|NCT00520936|7238084|FG000|Overall Study|Protocol Violation|0
4451709|NCT00520936|7238085|FG001|Overall Study|Protocol Violation|1
4451710|NCT00520936|7238086|FG002|Overall Study|Protocol Violation|1
4451711|NCT00520936|7238087|FG003|Overall Study|Protocol Violation|0
4451712|NCT00520936|7238088|FG004|Overall Study|Protocol Violation|1
4451713|NCT00520936|7238089|FG005|Overall Study|Protocol Violation|0
4451714|NCT00520936|7238090|FG006|Overall Study|Protocol Violation|1
4451715|NCT00520936|7238091|FG007|Overall Study|Protocol Violation|0
4451716|NCT00520975|7238104|FG000|Overall Study|Disease progression|31
4451717|NCT00520975|7238105|FG001|Overall Study|Disease progression|23
4451718|NCT00520975|7238104|FG000|Overall Study|Adverse Event|7
4451719|NCT00520975|7238105|FG001|Overall Study|Adverse Event|10
4451720|NCT00520975|7238104|FG000|Overall Study|Death|0
4451721|NCT00520975|7238105|FG001|Overall Study|Death|2
4451722|NCT00520975|7238104|FG000|Overall Study|Withdrawal by Subject|3
4451723|NCT00520975|7238105|FG001|Overall Study|Withdrawal by Subject|5
4451724|NCT00520975|7238104|FG000|Overall Study|Other therapy|2
4451725|NCT00520975|7238105|FG001|Overall Study|Other therapy|4
4451726|NCT00520975|7238104|FG000|Overall Study|Other reasons|4
4451727|NCT00520975|7238105|FG001|Overall Study|Other reasons|2
4451728|NCT00520975|7238104|FG000|Overall Study|Not start protocol therapy|1
4451729|NCT00520975|7238105|FG001|Overall Study|Not start protocol therapy|2
4451730|NCT00521001|7238111|FG000|Overall Study|Ineligible|1
4451731|NCT00521014|7238115|FG000|Overall Study|Inevaluable, not treated|1
4451732|NCT00521053|7238119|FG000|Observation Phase|Disease Progression|55
4451733|NCT00521053|7238119|FG000|Observation Phase|Additional PV-10 via alternate protocol|8
4451734|NCT00521053|7238119|FG000|Observation Phase|Death|2
4451735|NCT00521053|7238119|FG000|Observation Phase|Adverse Event|1
4451736|NCT00521053|7238119|FG000|Observation Phase|Other non-study melanoma treatment|1
4451737|NCT00521053|7238119|FG000|Observation Phase|Physician Decision|1
4451738|NCT00521079|7238128|FG000|Overall Study|Adverse Event|7
4451739|NCT00521079|7238129|FG001|Overall Study|Adverse Event|1
4451740|NCT00521079|7238128|FG000|Overall Study|Lost to Follow-up|2
4451741|NCT00521079|7238129|FG001|Overall Study|Lost to Follow-up|1
4451742|NCT00521079|7238128|FG000|Overall Study|Withdrawal by Subject|5
4451743|NCT00521079|7238129|FG001|Overall Study|Withdrawal by Subject|3
4451744|NCT00521144|7238140|FG000|Overall Study|Not Treated|0
4451745|NCT00521144|7238141|FG001|Overall Study|Not Treated|0
4451746|NCT00521144|7238142|FG002|Overall Study|Not Treated|0
4451747|NCT00521144|7238143|FG003|Overall Study|Not Treated|1
4451748|NCT00521144|7238144|FG004|Overall Study|Not Treated|0
4451749|NCT00521144|7238140|FG000|Overall Study|Adverse Event|0
4451750|NCT00521144|7238141|FG001|Overall Study|Adverse Event|1
4536889|NCT01106690|7357507|FG000|Core Period: Baseline to Week 26|Other|10
4536890|NCT01106690|7357508|FG001|Core Period: Baseline to Week 26|Other|2
4610487|NCT01694771|7466908|FG001|Overall Study|Lost to Follow-up|3
4610488|NCT01694771|7466907|FG000|Overall Study|Consent withdrawn|7
4610489|NCT01694771|7466908|FG001|Overall Study|Consent withdrawn|9
4610490|NCT01694771|7466907|FG000|Overall Study|Other reasons|5
4610491|NCT01694771|7466908|FG001|Overall Study|Other reasons|6
4610492|NCT01695135|7466939|FG000|Double-blind Treatment Phase|Progressive disease|50
4610493|NCT01695135|7466940|FG001|Double-blind Treatment Phase|Progressive disease|110
4610494|NCT01695135|7466941|FG002|Double-blind Treatment Phase|Progressive disease|0
4536891|NCT01106690|7357509|FG002|Core Period: Baseline to Week 26|Other|6
4536892|NCT01106690|7357507|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1
4536893|NCT01106690|7357508|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1
4536894|NCT01106690|7357509|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0
4591149|NCT01527006|7437530|FG000|Core Study|Subject Choice|1
4610495|NCT01695135|7466942|FG003|Double-blind Treatment Phase|Progressive disease|0
4610496|NCT01695135|7466939|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6
4536895|NCT01106690|7357507|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
4610497|NCT01695135|7466940|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14
4610498|NCT01695135|7466941|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0
4610499|NCT01695135|7466942|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0
4610500|NCT01695135|7466939|FG000|Double-blind Treatment Phase|Adverse Event|7
4610501|NCT01695135|7466940|FG001|Double-blind Treatment Phase|Adverse Event|7
4610502|NCT01695135|7466941|FG002|Double-blind Treatment Phase|Adverse Event|0
4610503|NCT01695135|7466942|FG003|Double-blind Treatment Phase|Adverse Event|0
4610504|NCT01695135|7466939|FG000|Double-blind Treatment Phase|Other|1
4610505|NCT01695135|7466940|FG001|Double-blind Treatment Phase|Other|3
4610506|NCT01695135|7466941|FG002|Double-blind Treatment Phase|Other|0
4610507|NCT01695135|7466942|FG003|Double-blind Treatment Phase|Other|0
4610508|NCT01695135|7466939|FG000|Double-blind Treatment Phase|Physician Decision|6
4610509|NCT01695135|7466940|FG001|Double-blind Treatment Phase|Physician Decision|3
4610510|NCT01695135|7466941|FG002|Double-blind Treatment Phase|Physician Decision|0
4610511|NCT01695135|7466942|FG003|Double-blind Treatment Phase|Physician Decision|0
4610512|NCT01695135|7466939|FG000|Double-blind Treatment Phase|Death|1
4610513|NCT01695135|7466940|FG001|Double-blind Treatment Phase|Death|1
4610514|NCT01695135|7466941|FG002|Double-blind Treatment Phase|Death|0
4610515|NCT01695135|7466942|FG003|Double-blind Treatment Phase|Death|0
4610516|NCT01695135|7466939|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0
4610517|NCT01695135|7466940|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1
4610518|NCT01695135|7466941|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0
4610519|NCT01695135|7466942|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0
4610520|NCT01695135|7466939|FG000|Open Label Extension Treatment Phase|Progressive disease|0
4610521|NCT01695135|7466940|FG001|Open Label Extension Treatment Phase|Progressive disease|0
4610522|NCT01695135|7466941|FG002|Open Label Extension Treatment Phase|Progressive disease|13
4610523|NCT01695135|7466942|FG003|Open Label Extension Treatment Phase|Progressive disease|22
4610524|NCT01695135|7466939|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0
4610525|NCT01695135|7466940|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0
4610526|NCT01695135|7466941|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6
4610527|NCT01695135|7466942|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16
4610528|NCT01695135|7466939|FG000|Open Label Extension Treatment Phase|Adverse Event|0
4451751|NCT00521144|7238142|FG002|Overall Study|Adverse Event|0
4451752|NCT00521144|7238143|FG003|Overall Study|Adverse Event|0
4451753|NCT00521144|7238144|FG004|Overall Study|Adverse Event|1
4451754|NCT00521144|7238140|FG000|Overall Study|Progressive Disease|4
4451755|NCT00521144|7238141|FG001|Overall Study|Progressive Disease|2
4451756|NCT00521144|7238142|FG002|Overall Study|Progressive Disease|2
4451757|NCT00521144|7238143|FG003|Overall Study|Progressive Disease|0
4451758|NCT00521144|7238144|FG004|Overall Study|Progressive Disease|6
4451759|NCT00521339|7238156|FG000|Treatment Phase|Adverse Event|2
4451760|NCT00521339|7238157|FG001|Treatment Phase|Adverse Event|0
4451761|NCT00521339|7238158|FG002|Treatment Phase|Adverse Event|0
4451762|NCT00521339|7238156|FG000|Treatment Phase|Intolerability to study drug|2
4451763|NCT00521339|7238157|FG001|Treatment Phase|Intolerability to study drug|0
4451764|NCT00521339|7238158|FG002|Treatment Phase|Intolerability to study drug|0
4451765|NCT00521339|7238156|FG000|Treatment Phase|Lack of Efficacy|3
4451766|NCT00521339|7238157|FG001|Treatment Phase|Lack of Efficacy|0
4451767|NCT00521339|7238158|FG002|Treatment Phase|Lack of Efficacy|0
4451768|NCT00521339|7238156|FG000|Treatment Phase|Withdrawal by Subject|3
4451769|NCT00521339|7238157|FG001|Treatment Phase|Withdrawal by Subject|0
4451770|NCT00521339|7238158|FG002|Treatment Phase|Withdrawal by Subject|0
4451771|NCT00521339|7238156|FG000|Treatment Phase|Lost to Follow-up|1
4451772|NCT00521339|7238157|FG001|Treatment Phase|Lost to Follow-up|0
4451773|NCT00521339|7238158|FG002|Treatment Phase|Lost to Follow-up|0
4451774|NCT00521339|7238156|FG000|Treatment Phase|Protocol Violation|1
4451775|NCT00521339|7238157|FG001|Treatment Phase|Protocol Violation|0
4451776|NCT00521339|7238158|FG002|Treatment Phase|Protocol Violation|0
4451777|NCT00521339|7238156|FG000|Treatment Extension Phase|Withdrawal by Subject|0
4451778|NCT00521339|7238157|FG001|Treatment Extension Phase|Withdrawal by Subject|0
4451779|NCT00521339|7238158|FG002|Treatment Extension Phase|Withdrawal by Subject|2
4451780|NCT00521339|7238156|FG000|Treatment Extension Phase|Death|0
4451781|NCT00521339|7238157|FG001|Treatment Extension Phase|Death|0
4451782|NCT00521339|7238158|FG002|Treatment Extension Phase|Death|1
4451783|NCT00521365|7238188|FG000|Overall Study|Adverse Event|3
4451784|NCT00521365|7238188|FG000|Overall Study|Lost to Follow-up|6
4451785|NCT00521365|7238188|FG000|Overall Study|Protocol deviation|2
4451786|NCT00521365|7238188|FG000|Overall Study|Drug compliance|3
4451787|NCT00521365|7238188|FG000|Overall Study|Usage of not allowed drugs|6
4536896|NCT01106690|7357508|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
4610529|NCT01695135|7466940|FG001|Open Label Extension Treatment Phase|Adverse Event|0
4451788|NCT00521404|7238192|FG000|Overall Study|Adverse Event|13
4451789|NCT00521404|7238192|FG000|Overall Study|Disease Progression|33
4536897|NCT01106690|7357509|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
4536898|NCT01106690|7357507|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0
4536899|NCT01106690|7357508|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2
4536900|NCT01106690|7357509|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2
4610530|NCT01695135|7466941|FG002|Open Label Extension Treatment Phase|Adverse Event|11
4610531|NCT01695135|7466942|FG003|Open Label Extension Treatment Phase|Adverse Event|16
4610532|NCT01695135|7466939|FG000|Open Label Extension Treatment Phase|Other|0
4610533|NCT01695135|7466940|FG001|Open Label Extension Treatment Phase|Other|0
4610534|NCT01695135|7466941|FG002|Open Label Extension Treatment Phase|Other|4
4610535|NCT01695135|7466942|FG003|Open Label Extension Treatment Phase|Other|7
4610536|NCT01695135|7466939|FG000|Open Label Extension Treatment Phase|Physician Decision|0
4610537|NCT01695135|7466940|FG001|Open Label Extension Treatment Phase|Physician Decision|0
4610538|NCT01695135|7466941|FG002|Open Label Extension Treatment Phase|Physician Decision|4
4610539|NCT01695135|7466942|FG003|Open Label Extension Treatment Phase|Physician Decision|1
4610540|NCT01695135|7466939|FG000|Open Label Extension Treatment Phase|Death|0
4610541|NCT01695135|7466940|FG001|Open Label Extension Treatment Phase|Death|0
4610542|NCT01695135|7466941|FG002|Open Label Extension Treatment Phase|Death|2
4610543|NCT01695135|7466942|FG003|Open Label Extension Treatment Phase|Death|7
4610544|NCT01695135|7466939|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0
4610545|NCT01695135|7466940|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0
4610546|NCT01695135|7466941|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0
4610547|NCT01695135|7466942|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1
4610548|NCT01695239|7466954|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1
4610549|NCT01695239|7466955|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1
4610550|NCT01695239|7466956|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3
4610551|NCT01695239|7466957|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4
4610552|NCT01695239|7466958|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
4610553|NCT01695239|7466959|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
4610554|NCT01695239|7466960|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
4610555|NCT01695239|7466961|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
4610556|NCT01695239|7466962|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
4610557|NCT01695239|7466963|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
4610558|NCT01695239|7466964|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
4610559|NCT01695239|7466965|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
4536901|NCT01106690|7357507|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
4536902|NCT01106690|7357508|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
4536903|NCT01106690|7357509|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1
4536904|NCT01106690|7357507|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
4536905|NCT01106690|7357508|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
4536906|NCT01106690|7357509|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
4536907|NCT01106690|7357507|FG000|Extension Period: Week 26 to Week 52|Other|8
4536908|NCT01106690|7357508|FG001|Extension Period: Week 26 to Week 52|Other|3
4536909|NCT01106690|7357509|FG002|Extension Period: Week 26 to Week 52|Other|4
4536910|NCT01106690|7357507|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
4536911|NCT01106690|7357508|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
4536912|NCT01106690|7357509|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
4536913|NCT01106846|7357531|FG000|Overall Study|Change in surgical procedure|0
4536914|NCT01106846|7357532|FG001|Overall Study|Change in surgical procedure|1
4536915|NCT01106898|7357549|FG000|Overall Study|Adverse Event|6
4536916|NCT01106911|7357553|FG000|Overall Study|Physician Decision|2
4536917|NCT01106911|7357553|FG000|Overall Study|deemed ineligible after screening|3
4536918|NCT01106976|7357563|FG000|Overall Study|Lost to Follow-up|8
4536919|NCT01107197|7357586|FG000|Overall Study|Death|12
4536920|NCT01107197|7357587|FG001|Overall Study|Death|10
4536921|NCT01107197|7357586|FG000|Overall Study|Lost to Follow-up|5
4536922|NCT01107197|7357587|FG001|Overall Study|Lost to Follow-up|8
4536923|NCT01107197|7357586|FG000|Overall Study|Withdrawal by Subject|3
4536924|NCT01107197|7357587|FG001|Overall Study|Withdrawal by Subject|5
4536925|NCT01107353|7357595|FG000|Overall Study|Positive Drug Screen|1
4536926|NCT01107353|7357596|FG001|Overall Study|Positive Drug Screen|0
4536927|NCT01107379|7357602|FG000|Overall Study|Withdrawal by Subject|18
4536928|NCT01107379|7357602|FG000|Overall Study|Lost to Follow-up|3
4536929|NCT01107392|7357608|FG000|Overall Study|Adverse Event|2
4536930|NCT01107392|7357609|FG001|Overall Study|Adverse Event|0
4536931|NCT01107392|7357608|FG000|Overall Study|Personal Reasons|2
4536932|NCT01107392|7357609|FG001|Overall Study|Personal Reasons|3
4536933|NCT01107392|7357608|FG000|Overall Study|Administrative decision|1
4536934|NCT01107392|7357609|FG001|Overall Study|Administrative decision|0
4536935|NCT01107405|7357620|FG000|Overall Study|Adverse Event|1
4536936|NCT01107405|7357621|FG001|Overall Study|Adverse Event|1
4536937|NCT01107405|7357622|FG002|Overall Study|Adverse Event|0
4536938|NCT01107405|7357623|FG003|Overall Study|Adverse Event|0
4536939|NCT01107405|7357624|FG004|Overall Study|Adverse Event|2
4451790|NCT00521404|7238192|FG000|Overall Study|Investigator decision|5
4451791|NCT00521404|7238192|FG000|Overall Study|Withdrawal of consent|3
4451792|NCT00521404|7238192|FG000|Overall Study|Noncompliance or lack of cooperation|1
4451793|NCT00521404|7238192|FG000|Overall Study|Other|7
4451794|NCT00521586|7238207|FG000|Initial Vaccination (Year 0)|Subject request|8
4451795|NCT00521586|7238208|FG001|Initial Vaccination (Year 0)|Subject request|11
4451796|NCT00521586|7238207|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5
4451797|NCT00521586|7238208|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10
4451798|NCT00521586|7238207|FG000|Initial Vaccination (Year 0)|Protocol Violation|2
4451799|NCT00521586|7238208|FG001|Initial Vaccination (Year 0)|Protocol Violation|5
4451800|NCT00521586|7238207|FG000|Initial Vaccination (Year 0)|Other, unspecified|3
4451801|NCT00521586|7238208|FG001|Initial Vaccination (Year 0)|Other, unspecified|1
4451802|NCT00521586|7238207|FG000|Initial Vaccination (Year 0)|Investigator request|2
4451803|NCT00521586|7238208|FG001|Initial Vaccination (Year 0)|Investigator request|0
4451804|NCT00521586|7238207|FG000|Initial Vaccination (Year 0)|Adverse Event|0
4451805|NCT00521586|7238208|FG001|Initial Vaccination (Year 0)|Adverse Event|1
4451806|NCT00521586|7238207|FG000|Initial Vaccination (Year 0)|Death|1
4451807|NCT00521586|7238208|FG001|Initial Vaccination (Year 0)|Death|0
4451808|NCT00521586|7238207|FG000|Initial Vaccination (Year 0)|Failed to return|0
4451809|NCT00521586|7238208|FG001|Initial Vaccination (Year 0)|Failed to return|1
4451810|NCT00521586|7238207|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5
4451811|NCT00521586|7238208|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1
4451812|NCT00521586|7238207|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5
4451813|NCT00521586|7238208|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2
4451814|NCT00521586|7238207|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7
4451815|NCT00521586|7238208|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3
4451816|NCT00521586|7238207|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3
4451817|NCT00521586|7238208|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3
4451818|NCT00521586|7238207|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55
4451819|NCT00521586|7238208|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56
4451820|NCT00521586|7238207|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22
4633386|NCT01911546|7503544|FG000|Overall Study|Lost to Follow-up|1
4536940|NCT01107405|7357620|FG000|Overall Study|Withdrawal by Subject|1
4536941|NCT01107405|7357621|FG001|Overall Study|Withdrawal by Subject|0
4536942|NCT01107405|7357622|FG002|Overall Study|Withdrawal by Subject|1
4536943|NCT01107405|7357623|FG003|Overall Study|Withdrawal by Subject|2
4536944|NCT01107405|7357624|FG004|Overall Study|Withdrawal by Subject|1
4536945|NCT01107405|7357620|FG000|Overall Study|Protocol Violation|0
4536946|NCT01107405|7357621|FG001|Overall Study|Protocol Violation|0
4536947|NCT01107405|7357622|FG002|Overall Study|Protocol Violation|1
4536948|NCT01107405|7357623|FG003|Overall Study|Protocol Violation|1
4536949|NCT01107405|7357624|FG004|Overall Study|Protocol Violation|0
4536950|NCT01107418|7357640|FG000|Overall Study|Disease Progression|45
4536951|NCT01107418|7357640|FG000|Overall Study|Adverse Event|3
4536952|NCT01107418|7357640|FG000|Overall Study|Withdrawal by Subject|1
4536953|NCT01107418|7357640|FG000|Overall Study|Study Closing|1
4536954|NCT01107418|7357640|FG000|Overall Study|Started Other Therapy|1
4536955|NCT01107418|7357640|FG000|Overall Study|Entered Extension Study|1
4610560|NCT01695239|7466966|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
4610561|NCT01695239|7466967|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
4610562|NCT01695239|7466954|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2
4610563|NCT01695239|7466955|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2
4610564|NCT01695239|7466956|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2
4610565|NCT01695239|7466957|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3
4610566|NCT01695239|7466958|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0
4610567|NCT01695239|7466959|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0
4610568|NCT01695239|7466960|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0
4610569|NCT01695239|7466961|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0
4610570|NCT01695239|7466962|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0
4610571|NCT01695239|7466963|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0
4536956|NCT01107444|7357657|FG000|Overall Study|Withdrawal by Subject|8
4536957|NCT01107444|7357658|FG001|Overall Study|Withdrawal by Subject|12
4536958|NCT01107444|7357657|FG000|Overall Study|Protocol Entry Criteria Not Met|0
4536959|NCT01107444|7357658|FG001|Overall Study|Protocol Entry Criteria Not Met|1
4536960|NCT01107457|7357672|FG000|Part A|Adverse Event|1
4536961|NCT01107457|7357673|FG001|Part A|Adverse Event|2
4536962|NCT01107457|7357674|FG002|Part A|Adverse Event|1
4536963|NCT01107457|7357675|FG003|Part A|Adverse Event|0
4536964|NCT01107457|7357676|FG004|Part A|Adverse Event|0
4536965|NCT01107457|7357677|FG005|Part A|Adverse Event|0
4536966|NCT01107457|7357672|FG000|Part A|Withdrawal by Subject|3
4536967|NCT01107457|7357673|FG001|Part A|Withdrawal by Subject|3
4536968|NCT01107457|7357674|FG002|Part A|Withdrawal by Subject|0
4536969|NCT01107457|7357675|FG003|Part A|Withdrawal by Subject|3
4610572|NCT01695239|7466964|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0
4610573|NCT01695239|7466965|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0
4610574|NCT01695239|7466966|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0
4610575|NCT01695239|7466967|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0
4536970|NCT01107457|7357676|FG004|Part A|Withdrawal by Subject|1
4536971|NCT01107457|7357677|FG005|Part A|Withdrawal by Subject|0
4536972|NCT01107457|7357672|FG000|Part A|Lost to Follow-up|0
4536973|NCT01107457|7357673|FG001|Part A|Lost to Follow-up|1
4536974|NCT01107457|7357674|FG002|Part A|Lost to Follow-up|0
4536975|NCT01107457|7357675|FG003|Part A|Lost to Follow-up|0
4536976|NCT01107457|7357676|FG004|Part A|Lost to Follow-up|0
4536977|NCT01107457|7357677|FG005|Part A|Lost to Follow-up|0
4536978|NCT01107457|7357672|FG000|Part A|Lack of Efficacy|1
4536979|NCT01107457|7357673|FG001|Part A|Lack of Efficacy|0
4536980|NCT01107457|7357674|FG002|Part A|Lack of Efficacy|0
4536981|NCT01107457|7357675|FG003|Part A|Lack of Efficacy|0
4536982|NCT01107457|7357676|FG004|Part A|Lack of Efficacy|0
4536983|NCT01107457|7357677|FG005|Part A|Lack of Efficacy|0
4451821|NCT00521586|7238208|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26
4451822|NCT00521586|7238207|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18
4451823|NCT00521586|7238208|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22
4451824|NCT00521586|7238207|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54
4451825|NCT00521586|7238208|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57
4451826|NCT00521586|7238207|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0
4451827|NCT00521586|7238208|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1
4451828|NCT00521586|7238207|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1
4451829|NCT00521586|7238208|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4
4451830|NCT00521586|7238207|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2
4451831|NCT00521586|7238208|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7
4451832|NCT00522041|7238253|FG000|Overall Study|Adverse Event|9
4451833|NCT00522041|7238254|FG001|Overall Study|Adverse Event|3
4451834|NCT00522041|7238253|FG000|Overall Study|Protocol Violation|2
4610576|NCT01695239|7466954|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4
4610577|NCT01695239|7466955|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
4610578|NCT01695239|7466956|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2
4610579|NCT01695239|7466957|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
4610580|NCT01695239|7466958|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
4536984|NCT01107457|7357672|FG000|Part A|Protocol Violation|0
4610581|NCT01695239|7466959|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
4451835|NCT00522041|7238254|FG001|Overall Study|Protocol Violation|0
4451836|NCT00522041|7238253|FG000|Overall Study|Lost to Follow-up|1
4451837|NCT00522041|7238254|FG001|Overall Study|Lost to Follow-up|4
4451838|NCT00522041|7238253|FG000|Overall Study|Voluntary withdrawal|5
4536985|NCT01107457|7357673|FG001|Part A|Protocol Violation|1
4536986|NCT01107457|7357674|FG002|Part A|Protocol Violation|0
4451839|NCT00522041|7238254|FG001|Overall Study|Voluntary withdrawal|4
4451840|NCT00522041|7238253|FG000|Overall Study|Did not receive treatment|0
4451841|NCT00522041|7238254|FG001|Overall Study|Did not receive treatment|1
4451842|NCT00522275|7238270|FG000|Overall Study|Adverse Event|35
4451843|NCT00522275|7238270|FG000|Overall Study|Lack of Efficacy|80
4451844|NCT00522275|7238270|FG000|Overall Study|Subject withdrew consent|16
4451845|NCT00522275|7238270|FG000|Overall Study|Protocol deviation|1
4690049|NCT02557516|7599647|FG002|Overall Study|Disease progression|0
4690050|NCT02557516|7599648|FG003|Overall Study|Disease progression|0
4690051|NCT02557516|7599645|FG000|Overall Study|Physician Decision|0
4690052|NCT02557516|7599646|FG001|Overall Study|Physician Decision|2
4690053|NCT02557516|7599647|FG002|Overall Study|Physician Decision|0
4690054|NCT02557516|7599648|FG003|Overall Study|Physician Decision|0
4690055|NCT02557516|7599645|FG000|Overall Study|Sponsor decision|0
4690056|NCT02557516|7599646|FG001|Overall Study|Sponsor decision|1
4690057|NCT02557516|7599647|FG002|Overall Study|Sponsor decision|2
4690058|NCT02557516|7599648|FG003|Overall Study|Sponsor decision|8
4690059|NCT02557646|7599672|FG000|Overall Study|Adverse Event|40
4690060|NCT02557646|7599672|FG000|Overall Study|Death|1
4690061|NCT02557646|7599672|FG000|Overall Study|Lack of Efficacy|186
4690062|NCT02557646|7599672|FG000|Overall Study|Withdrawal by Subject|18
4690063|NCT02557646|7599672|FG000|Overall Study|Lost to Follow-up|17
4690064|NCT02557646|7599672|FG000|Overall Study|Other|14
4690065|NCT02558231|7599687|FG000|Overall Study|Death|4
4690066|NCT02558231|7599688|FG001|Overall Study|Death|12
4690067|NCT02558231|7599687|FG000|Overall Study|Lost to Follow-up|7
4690068|NCT02558231|7599688|FG001|Overall Study|Lost to Follow-up|4
4690069|NCT02558231|7599687|FG000|Overall Study|Withdrawal by Subject|7
4690070|NCT02558231|7599688|FG001|Overall Study|Withdrawal by Subject|4
4536987|NCT01107457|7357675|FG003|Part A|Protocol Violation|0
4536988|NCT01107457|7357676|FG004|Part A|Protocol Violation|0
4536989|NCT01107457|7357677|FG005|Part A|Protocol Violation|0
4536990|NCT01107457|7357672|FG000|Part B and C|Adverse Event|0
4536991|NCT01107457|7357673|FG001|Part B and C|Adverse Event|0
4536992|NCT01107457|7357674|FG002|Part B and C|Adverse Event|0
4536993|NCT01107457|7357675|FG003|Part B and C|Adverse Event|0
4536994|NCT01107457|7357676|FG004|Part B and C|Adverse Event|0
4536995|NCT01107457|7357677|FG005|Part B and C|Adverse Event|12
4536996|NCT01107457|7357672|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0
4536997|NCT01107457|7357673|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0
4536998|NCT01107457|7357674|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0
4610582|NCT01695239|7466960|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
4610583|NCT01695239|7466961|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
4610584|NCT01695239|7466962|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
4610585|NCT01695239|7466963|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
4610586|NCT01695239|7466964|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
4610587|NCT01695239|7466965|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
4610588|NCT01695239|7466966|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
4610589|NCT01695239|7466967|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
4610590|NCT01695239|7466954|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3
4610591|NCT01695239|7466955|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1
4610592|NCT01695239|7466956|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1
4610593|NCT01695239|7466957|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
4610594|NCT01695239|7466958|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
4610595|NCT01695239|7466959|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
4610596|NCT01695239|7466960|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
4610597|NCT01695239|7466961|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
4610598|NCT01695239|7466962|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
4610599|NCT01695239|7466963|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
4610600|NCT01695239|7466964|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
4610601|NCT01695239|7466965|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
4610602|NCT01695239|7466966|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
4610603|NCT01695239|7466967|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
4610604|NCT01695239|7466954|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3
4610605|NCT01695239|7466955|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0
4610606|NCT01695239|7466956|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1
4610607|NCT01695239|7466957|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0
4610608|NCT01695239|7466958|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0
4536999|NCT01107457|7357675|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0
4537000|NCT01107457|7357676|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0
4537001|NCT01107457|7357677|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1
4537002|NCT01107457|7357672|FG000|Part B and C|Physician Decision|0
4537003|NCT01107457|7357673|FG001|Part B and C|Physician Decision|0
4537004|NCT01107457|7357674|FG002|Part B and C|Physician Decision|0
4537005|NCT01107457|7357675|FG003|Part B and C|Physician Decision|0
4537006|NCT01107457|7357676|FG004|Part B and C|Physician Decision|0
4537007|NCT01107457|7357677|FG005|Part B and C|Physician Decision|3
4537008|NCT01107457|7357672|FG000|Part B and C|Lack of Efficacy|0
4537009|NCT01107457|7357673|FG001|Part B and C|Lack of Efficacy|0
4537010|NCT01107457|7357674|FG002|Part B and C|Lack of Efficacy|0
4537011|NCT01107457|7357675|FG003|Part B and C|Lack of Efficacy|0
4537012|NCT01107457|7357676|FG004|Part B and C|Lack of Efficacy|0
4537013|NCT01107457|7357677|FG005|Part B and C|Lack of Efficacy|7
4537014|NCT01107457|7357672|FG000|Part B and C|Lost to Follow-up|0
4537015|NCT01107457|7357673|FG001|Part B and C|Lost to Follow-up|0
4537016|NCT01107457|7357674|FG002|Part B and C|Lost to Follow-up|0
4537017|NCT01107457|7357675|FG003|Part B and C|Lost to Follow-up|0
4537018|NCT01107457|7357676|FG004|Part B and C|Lost to Follow-up|0
4451846|NCT00522275|7238270|FG000|Overall Study|Unsatisfactory compliance|11
4451847|NCT00522275|7238270|FG000|Overall Study|Lost to Follow-up|8
4451848|NCT00522275|7238270|FG000|Overall Study|Other: Subject wants to become pregnant|2
4451849|NCT00522275|7238270|FG000|Overall Study|Other: Subject is pregnant|2
4451850|NCT00522275|7238270|FG000|Overall Study|Other: Subject relocated|2
4451851|NCT00522275|7238270|FG000|Overall Study|Other: Subject arrested|1
4451852|NCT00522275|7238270|FG000|Overall Study|Other: Site / clinic closed|4
4451853|NCT00522275|7238270|FG000|Overall Study|Other: Travel to / from site difficulty|3
4451854|NCT00522275|7238270|FG000|Overall Study|Other: Sponsor request|2
4451855|NCT00522275|7238270|FG000|Overall Study|Other: Subject ran out of medication|1
4451856|NCT00522275|7238270|FG000|Overall Study|Other: Subject had surgery for epilepsy|2
4451857|NCT00522379|7238279|FG000|Overall Study|Adverse Event|12
4451858|NCT00522379|7238280|FG001|Overall Study|Adverse Event|15
4451859|NCT00522379|7238281|FG002|Overall Study|Adverse Event|12
4451860|NCT00522379|7238282|FG003|Overall Study|Adverse Event|5
4451861|NCT00522379|7238283|FG004|Overall Study|Adverse Event|17
4451862|NCT00522379|7238279|FG000|Overall Study|Lack of Efficacy|3
4451863|NCT00522379|7238280|FG001|Overall Study|Lack of Efficacy|0
4451864|NCT00522379|7238281|FG002|Overall Study|Lack of Efficacy|2
4451865|NCT00522379|7238282|FG003|Overall Study|Lack of Efficacy|2
4451866|NCT00522379|7238283|FG004|Overall Study|Lack of Efficacy|7
4451867|NCT00522379|7238279|FG000|Overall Study|Withdrawal by Subject|2
4451868|NCT00522379|7238280|FG001|Overall Study|Withdrawal by Subject|3
4451869|NCT00522379|7238281|FG002|Overall Study|Withdrawal by Subject|1
4451870|NCT00522379|7238282|FG003|Overall Study|Withdrawal by Subject|2
4451871|NCT00522379|7238283|FG004|Overall Study|Withdrawal by Subject|0
4451872|NCT00522379|7238279|FG000|Overall Study|Protocol Violation|1
4451873|NCT00522379|7238280|FG001|Overall Study|Protocol Violation|1
4537019|NCT01107457|7357677|FG005|Part B and C|Lost to Follow-up|10
4537020|NCT01107457|7357672|FG000|Part B and C|Protocol Violation|0
4537021|NCT01107457|7357673|FG001|Part B and C|Protocol Violation|0
4537022|NCT01107457|7357674|FG002|Part B and C|Protocol Violation|0
4537023|NCT01107457|7357675|FG003|Part B and C|Protocol Violation|0
4537024|NCT01107457|7357676|FG004|Part B and C|Protocol Violation|0
4537025|NCT01107457|7357677|FG005|Part B and C|Protocol Violation|1
4537026|NCT01107457|7357672|FG000|Part B and C|Sponsor Decision|0
4537027|NCT01107457|7357673|FG001|Part B and C|Sponsor Decision|0
4537028|NCT01107457|7357674|FG002|Part B and C|Sponsor Decision|0
4537029|NCT01107457|7357675|FG003|Part B and C|Sponsor Decision|0
4537030|NCT01107457|7357676|FG004|Part B and C|Sponsor Decision|0
4537031|NCT01107457|7357677|FG005|Part B and C|Sponsor Decision|66
4537032|NCT01107457|7357672|FG000|Part B and C|Withdrawal by Subject|0
4537033|NCT01107457|7357673|FG001|Part B and C|Withdrawal by Subject|0
4610609|NCT01695239|7466959|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0
4610610|NCT01695239|7466960|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0
4610611|NCT01695239|7466961|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0
4610612|NCT01695239|7466962|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0
4610613|NCT01695239|7466963|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0
4451874|NCT00522379|7238281|FG002|Overall Study|Protocol Violation|2
4451875|NCT00522379|7238282|FG003|Overall Study|Protocol Violation|0
4451876|NCT00522379|7238283|FG004|Overall Study|Protocol Violation|0
4451877|NCT00522379|7238279|FG000|Overall Study|Unsatisfactory Subject Compliance|1
4451878|NCT00522379|7238280|FG001|Overall Study|Unsatisfactory Subject Compliance|2
4451879|NCT00522379|7238281|FG002|Overall Study|Unsatisfactory Subject Compliance|0
4451880|NCT00522379|7238282|FG003|Overall Study|Unsatisfactory Subject Compliance|0
4451881|NCT00522379|7238283|FG004|Overall Study|Unsatisfactory Subject Compliance|0
4451882|NCT00522379|7238279|FG000|Overall Study|Lost to Follow-up|1
4610614|NCT01695239|7466964|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0
4610615|NCT01695239|7466965|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0
4451883|NCT00522379|7238280|FG001|Overall Study|Lost to Follow-up|0
4451884|NCT00522379|7238281|FG002|Overall Study|Lost to Follow-up|4
4451885|NCT00522379|7238282|FG003|Overall Study|Lost to Follow-up|2
4451886|NCT00522379|7238283|FG004|Overall Study|Lost to Follow-up|2
4451887|NCT00522379|7238279|FG000|Overall Study|Randomization error|0
4451888|NCT00522379|7238280|FG001|Overall Study|Randomization error|0
4451889|NCT00522379|7238281|FG002|Overall Study|Randomization error|0
4451890|NCT00522379|7238282|FG003|Overall Study|Randomization error|0
4451891|NCT00522379|7238283|FG004|Overall Study|Randomization error|1
4451892|NCT00522379|7238279|FG000|Overall Study|Dispensing error|1
4451893|NCT00522379|7238280|FG001|Overall Study|Dispensing error|0
4451894|NCT00522379|7238281|FG002|Overall Study|Dispensing error|0
4451895|NCT00522379|7238282|FG003|Overall Study|Dispensing error|1
4451896|NCT00522379|7238283|FG004|Overall Study|Dispensing error|0
4451897|NCT00522379|7238279|FG000|Overall Study|Subject Moved|1
4451898|NCT00522379|7238280|FG001|Overall Study|Subject Moved|1
4451899|NCT00522379|7238281|FG002|Overall Study|Subject Moved|0
4537034|NCT01107457|7357674|FG002|Part B and C|Withdrawal by Subject|0
4537035|NCT01107457|7357675|FG003|Part B and C|Withdrawal by Subject|0
4451900|NCT00522379|7238282|FG003|Overall Study|Subject Moved|0
4451901|NCT00522379|7238283|FG004|Overall Study|Subject Moved|0
4537036|NCT01107457|7357676|FG004|Part B and C|Withdrawal by Subject|0
4537037|NCT01107457|7357677|FG005|Part B and C|Withdrawal by Subject|16
4537038|NCT01107457|7357672|FG000|Part B and C|Clinical Relapse|0
4537039|NCT01107457|7357673|FG001|Part B and C|Clinical Relapse|0
4537040|NCT01107457|7357674|FG002|Part B and C|Clinical Relapse|0
4537041|NCT01107457|7357675|FG003|Part B and C|Clinical Relapse|0
4537042|NCT01107457|7357676|FG004|Part B and C|Clinical Relapse|0
4610616|NCT01695239|7466966|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0
4610617|NCT01695239|7466967|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0
4610618|NCT01695239|7466954|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
4610619|NCT01695239|7466955|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
4537043|NCT01107457|7357677|FG005|Part B and C|Clinical Relapse|4
4537044|NCT01107535|7357695|FG000|Overall Study|Death|5
4537045|NCT01107626|7357703|FG000|Step 1: Induction Therapy|Lack of Efficacy|167
4537046|NCT01107626|7357704|FG001|Step 1: Induction Therapy|Lack of Efficacy|0
4537047|NCT01107626|7357705|FG002|Step 1: Induction Therapy|Lack of Efficacy|0
4610620|NCT01695239|7466956|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
4610621|NCT01695239|7466957|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
4610622|NCT01695239|7466958|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
4610623|NCT01695239|7466959|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
4610624|NCT01695239|7466960|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
4610625|NCT01695239|7466961|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
4610626|NCT01695239|7466962|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
4610627|NCT01695239|7466963|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
4610628|NCT01695239|7466964|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
4610629|NCT01695239|7466965|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
4610630|NCT01695239|7466966|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
4610631|NCT01695239|7466967|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
4610632|NCT01695239|7466954|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1
4610633|NCT01695239|7466955|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0
4610634|NCT01695239|7466956|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0
4610635|NCT01695239|7466957|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0
4610636|NCT01695239|7466958|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0
4610637|NCT01695239|7466959|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0
4610638|NCT01695239|7466960|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0
4610639|NCT01695239|7466961|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0
4610640|NCT01695239|7466962|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0
4610641|NCT01695239|7466963|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0
4610642|NCT01695239|7466964|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0
4610643|NCT01695239|7466965|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0
4610644|NCT01695239|7466966|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0
4610645|NCT01695239|7466967|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0
4610646|NCT01695239|7466954|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
4610647|NCT01695239|7466955|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
4537048|NCT01107626|7357706|FG003|Step 1: Induction Therapy|Lack of Efficacy|0
4690071|NCT02558231|7599687|FG000|Overall Study|Physician Decision|7
4690072|NCT02558231|7599688|FG001|Overall Study|Physician Decision|5
4690073|NCT02558231|7599687|FG000|Overall Study|Sponsor Decision|0
4690074|NCT02558231|7599688|FG001|Overall Study|Sponsor Decision|1
4690075|NCT02558296|7599696|FG000|Completed the Study Through Week 24|Adverse Event|9
4690076|NCT02558296|7599697|FG001|Completed the Study Through Week 24|Adverse Event|3
4690077|NCT02558296|7599696|FG000|Completed the Study Through Week 24|Death|7
4690078|NCT02558296|7599697|FG001|Completed the Study Through Week 24|Death|7
4447659|NCT00491556|7232917|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1
4447660|NCT00491556|7232918|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0
4447661|NCT00491556|7232917|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1
4447662|NCT00491556|7232918|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0
4447663|NCT00491556|7232917|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2
4447664|NCT00491556|7232918|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0
4447665|NCT00491556|7232917|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11
4447666|NCT00491556|7232918|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0
4447667|NCT00491556|7232917|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2
4447668|NCT00491556|7232918|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0
4447669|NCT00491556|7232917|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2
4447670|NCT00491556|7232918|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0
4447671|NCT00491556|7232917|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3
4447672|NCT00491556|7232918|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0
4447673|NCT00491556|7232917|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3
4447674|NCT00491556|7232918|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0
4447675|NCT00491556|7232917|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2
4447676|NCT00491556|7232918|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2
4447677|NCT00491556|7232917|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2
4447678|NCT00491556|7232918|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0
4447679|NCT00491556|7232917|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2
4447680|NCT00491556|7232918|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1
4447681|NCT00491556|7232917|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5
4447682|NCT00491556|7232918|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0
4447683|NCT00491556|7232917|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2
4447684|NCT00491556|7232918|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0
4447685|NCT00491556|7232917|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5
4447686|NCT00491556|7232918|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0
4447687|NCT00491556|7232917|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2
4447688|NCT00491556|7232918|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0
4447689|NCT00491556|7232917|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2
4447690|NCT00491556|7232918|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0
4537049|NCT01107626|7357703|FG000|Step 1: Induction Therapy|Adverse Event|198
4537050|NCT01107626|7357704|FG001|Step 1: Induction Therapy|Adverse Event|0
4690079|NCT02558296|7599696|FG000|Completed the Study Through Week 24|Lost to Follow-up|8
4690080|NCT02558296|7599697|FG001|Completed the Study Through Week 24|Lost to Follow-up|1
4690081|NCT02558296|7599696|FG000|Completed the Study Through Week 24|Physician Decision|1
4690082|NCT02558296|7599697|FG001|Completed the Study Through Week 24|Physician Decision|0
4690083|NCT02558296|7599696|FG000|Completed the Study Through Week 24|Protocol Violation|1
4690084|NCT02558296|7599697|FG001|Completed the Study Through Week 24|Protocol Violation|1
4690085|NCT02558296|7599696|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17
4690086|NCT02558296|7599697|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13
4690087|NCT02558296|7599696|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1
4690088|NCT02558296|7599697|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0
4690089|NCT02558296|7599696|FG000|Completed the Study|Adverse Event|14
4690090|NCT02558296|7599697|FG001|Completed the Study|Adverse Event|5
4690091|NCT02558296|7599696|FG000|Completed the Study|Death|39
4690092|NCT02558296|7599697|FG001|Completed the Study|Death|25
4690093|NCT02558296|7599696|FG000|Completed the Study|Lost to Follow-up|31
4537051|NCT01107626|7357705|FG002|Step 1: Induction Therapy|Adverse Event|0
4537052|NCT01107626|7357706|FG003|Step 1: Induction Therapy|Adverse Event|0
4537053|NCT01107626|7357703|FG000|Step 1: Induction Therapy|Death|62
4537054|NCT01107626|7357704|FG001|Step 1: Induction Therapy|Death|0
4537055|NCT01107626|7357705|FG002|Step 1: Induction Therapy|Death|0
4537056|NCT01107626|7357706|FG003|Step 1: Induction Therapy|Death|0
4537057|NCT01107626|7357703|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54
4537058|NCT01107626|7357704|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0
4537059|NCT01107626|7357705|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0
4610648|NCT01695239|7466956|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
4690094|NCT02558296|7599697|FG001|Completed the Study|Lost to Follow-up|23
4690095|NCT02558296|7599696|FG000|Completed the Study|Physician Decision|6
4690096|NCT02558296|7599697|FG001|Completed the Study|Physician Decision|0
4690097|NCT02558296|7599696|FG000|Completed the Study|Protocol Violation|2
4690098|NCT02558296|7599697|FG001|Completed the Study|Protocol Violation|1
4690099|NCT02558296|7599696|FG000|Completed the Study|Withdrawal by Subject|53
4690100|NCT02558296|7599697|FG001|Completed the Study|Withdrawal by Subject|31
4690101|NCT02558296|7599696|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1
4690102|NCT02558296|7599697|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0
4734795|NCT03504917|7682000|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1
4734796|NCT03504917|7681999|FG000|Open Label Extension Treatment Period|Adverse Event|7
4734797|NCT03504917|7682000|FG001|Open Label Extension Treatment Period|Adverse Event|0
4734798|NCT03504917|7681999|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0
4734799|NCT03504917|7682000|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1
4734800|NCT03504917|7681999|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81
4734801|NCT03504917|7682000|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88
4734802|NCT03505021|7682014|FG000|Overall Study|Protocol Violation|1
4734803|NCT03505021|7682015|FG001|Overall Study|Protocol Violation|0
4734804|NCT03505021|7682014|FG000|Overall Study|Death|9
4734805|NCT03505021|7682015|FG001|Overall Study|Death|8
4734806|NCT03505021|7682014|FG000|Overall Study|Consent withdrawn by subject|6
4734807|NCT03505021|7682015|FG001|Overall Study|Consent withdrawn by subject|1
4734808|NCT03505021|7682014|FG000|Overall Study|Lost to Follow-up|5
4734809|NCT03505021|7682015|FG001|Overall Study|Lost to Follow-up|3
4734810|NCT03505021|7682014|FG000|Overall Study|Adverse Event|26
4734811|NCT03505021|7682015|FG001|Overall Study|Adverse Event|9
4734812|NCT03505021|7682014|FG000|Overall Study|Disease progression|33
4734813|NCT03505021|7682015|FG001|Overall Study|Disease progression|17
4690103|NCT02558400|7599719|FG000|Overall Study|Adverse Event|47
4690104|NCT02558400|7599720|FG001|Overall Study|Adverse Event|53
4690105|NCT02558400|7599721|FG002|Overall Study|Adverse Event|4
4690106|NCT02558400|7599719|FG000|Overall Study|Withdrawal by Subject|13
4690107|NCT02558400|7599720|FG001|Overall Study|Withdrawal by Subject|9
4690108|NCT02558400|7599721|FG002|Overall Study|Withdrawal by Subject|8
4690109|NCT02558400|7599719|FG000|Overall Study|Non-Compliant|0
4690110|NCT02558400|7599720|FG001|Overall Study|Non-Compliant|1
4690111|NCT02558400|7599721|FG002|Overall Study|Non-Compliant|3
4451902|NCT00522379|7238279|FG000|Overall Study|Sponsor Request|0
4451903|NCT00522379|7238280|FG001|Overall Study|Sponsor Request|1
4451904|NCT00522379|7238281|FG002|Overall Study|Sponsor Request|0
4451905|NCT00522379|7238282|FG003|Overall Study|Sponsor Request|0
4451906|NCT00522379|7238283|FG004|Overall Study|Sponsor Request|0
4451907|NCT00522379|7238279|FG000|Overall Study|Family Problem|0
4451908|NCT00522379|7238280|FG001|Overall Study|Family Problem|0
4451909|NCT00522379|7238281|FG002|Overall Study|Family Problem|1
4451910|NCT00522379|7238282|FG003|Overall Study|Family Problem|0
4451911|NCT00522379|7238283|FG004|Overall Study|Family Problem|0
4451912|NCT00522379|7238279|FG000|Overall Study|Site Closed|0
4451913|NCT00522379|7238280|FG001|Overall Study|Site Closed|0
4451914|NCT00522379|7238281|FG002|Overall Study|Site Closed|0
4451915|NCT00522379|7238282|FG003|Overall Study|Site Closed|1
4451916|NCT00522379|7238283|FG004|Overall Study|Site Closed|0
4451917|NCT00522379|7238279|FG000|Overall Study|Subject Withdrawal|0
4451918|NCT00522379|7238280|FG001|Overall Study|Subject Withdrawal|0
4451919|NCT00522379|7238281|FG002|Overall Study|Subject Withdrawal|0
4451920|NCT00522379|7238282|FG003|Overall Study|Subject Withdrawal|1
4451921|NCT00522379|7238283|FG004|Overall Study|Subject Withdrawal|0
4451922|NCT00522392|7238297|FG000|Overall Study|Disease progression|0
4451923|NCT00522392|7238298|FG001|Overall Study|Disease progression|3
4451924|NCT00522392|7238297|FG000|Overall Study|Adverse Event|7
4451925|NCT00522392|7238298|FG001|Overall Study|Adverse Event|7
4451926|NCT00522392|7238297|FG000|Overall Study|Withdrawal by Subject|1
4451927|NCT00522392|7238298|FG001|Overall Study|Withdrawal by Subject|1
4451928|NCT00522392|7238297|FG000|Overall Study|Physician Decision|0
4451929|NCT00522392|7238298|FG001|Overall Study|Physician Decision|1
4451930|NCT00522392|7238297|FG000|Overall Study|Non-compliance|0
4451931|NCT00522392|7238298|FG001|Overall Study|Non-compliance|1
4451932|NCT00522418|7238306|FG000|Overall Study|Local IRB Consent Violation|5
4451933|NCT00522418|7238307|FG001|Overall Study|Local IRB Consent Violation|5
4451934|NCT00522418|7238306|FG000|Overall Study|Early Study Termination|46
4451935|NCT00522418|7238307|FG001|Overall Study|Early Study Termination|47
4451936|NCT00522418|7238306|FG000|Overall Study|Noncompliance|2
4451937|NCT00522418|7238307|FG001|Overall Study|Noncompliance|2
4451938|NCT00522418|7238306|FG000|Overall Study|Reason Not Specified|3
4451939|NCT00522418|7238307|FG001|Overall Study|Reason Not Specified|1
4451940|NCT00522418|7238306|FG000|Overall Study|Consent Withdraw|1
4451941|NCT00522418|7238307|FG001|Overall Study|Consent Withdraw|2
4451942|NCT00522418|7238306|FG000|Overall Study|Lack of Efficacy|0
4451943|NCT00522418|7238307|FG001|Overall Study|Lack of Efficacy|1
4451944|NCT00522431|7238315|FG000|Overall Study|Adverse Event|5
4451945|NCT00522431|7238315|FG000|Overall Study|Protocol Violation|2
4451946|NCT00522431|7238315|FG000|Overall Study|Withdrawal by Subject|2
4451947|NCT00522431|7238315|FG000|Overall Study|Subject non-compliance|1
4451948|NCT00522431|7238315|FG000|Overall Study|Other/unknown|1
4451949|NCT00522548|7238321|FG000|Overall Study|Adverse Event|2
4451950|NCT00522548|7238322|FG001|Overall Study|Adverse Event|2
4451951|NCT00522548|7238321|FG000|Overall Study|Withdrawal by Subject|0
4451952|NCT00522548|7238322|FG001|Overall Study|Withdrawal by Subject|2
4451953|NCT00522626|7238328|FG000|Overall Study|Lost to Follow-up|7
4451954|NCT00522873|7238338|FG000|Overall Study|Adverse Event|41
4451955|NCT00522873|7238339|FG001|Overall Study|Adverse Event|26
4451956|NCT00522873|7238338|FG000|Overall Study|Withdrawal by Subject|20
4451957|NCT00522873|7238339|FG001|Overall Study|Withdrawal by Subject|9
4451958|NCT00522873|7238338|FG000|Overall Study|Protocol Violation|14
4451959|NCT00522873|7238339|FG001|Overall Study|Protocol Violation|4
4451960|NCT00522873|7238338|FG000|Overall Study|Lost to Follow-up|11
4451961|NCT00522873|7238339|FG001|Overall Study|Lost to Follow-up|3
4451962|NCT00522873|7238338|FG000|Overall Study|Personal Reasons|8
4451963|NCT00522873|7238339|FG001|Overall Study|Personal Reasons|1
4690112|NCT02558400|7599719|FG000|Overall Study|Lost to Follow-up|5
4451964|NCT00522873|7238338|FG000|Overall Study|Medication Errors|1
4451965|NCT00522873|7238339|FG001|Overall Study|Medication Errors|1
4451966|NCT00522873|7238338|FG000|Overall Study|Never Received Medication|1
4451967|NCT00522873|7238339|FG001|Overall Study|Never Received Medication|0
4451968|NCT00522951|7238358|FG000|Period 1|body motion|0
4451969|NCT00522951|7238359|FG001|Period 1|body motion|1
4451970|NCT00522951|7238358|FG000|Washout Period|Adverse Event|0
4451971|NCT00522951|7238359|FG001|Washout Period|Adverse Event|1
4451972|NCT00522951|7238358|FG000|Washout Period|Death|0
4451973|NCT00522951|7238359|FG001|Washout Period|Death|1
4451974|NCT00522951|7238358|FG000|Period 2|Withdrawal by Subject|1
4451975|NCT00522951|7238359|FG001|Period 2|Withdrawal by Subject|0
4451976|NCT00522951|7238358|FG000|Period 2|residual contrast medium|1
4451977|NCT00522951|7238359|FG001|Period 2|residual contrast medium|1
4690113|NCT02558400|7599720|FG001|Overall Study|Lost to Follow-up|5
4690114|NCT02558400|7599721|FG002|Overall Study|Lost to Follow-up|4
4690115|NCT02558400|7599719|FG000|Overall Study|Lack of Efficacy|0
4537060|NCT01107626|7357706|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0
4690116|NCT02558400|7599720|FG001|Overall Study|Lack of Efficacy|13
4690117|NCT02558400|7599721|FG002|Overall Study|Lack of Efficacy|1
4690118|NCT02558400|7599719|FG000|Overall Study|Disallowed Concurrent Medication|6
4690119|NCT02558400|7599720|FG001|Overall Study|Disallowed Concurrent Medication|7
4690120|NCT02558400|7599721|FG002|Overall Study|Disallowed Concurrent Medication|5
4690121|NCT02558400|7599719|FG000|Overall Study|Physician Decision|2
4690122|NCT02558400|7599720|FG001|Overall Study|Physician Decision|2
4690123|NCT02558400|7599721|FG002|Overall Study|Physician Decision|0
4690124|NCT02558400|7599719|FG000|Overall Study|Protocol Violation|6
4690125|NCT02558400|7599720|FG001|Overall Study|Protocol Violation|3
4690126|NCT02558400|7599721|FG002|Overall Study|Protocol Violation|8
4690127|NCT02558400|7599719|FG000|Overall Study|Death|0
4690128|NCT02558400|7599720|FG001|Overall Study|Death|1
4690129|NCT02558400|7599721|FG002|Overall Study|Death|0
4537061|NCT01107626|7357703|FG000|Step 1: Induction Therapy|Complicating disease|13
4537062|NCT01107626|7357704|FG001|Step 1: Induction Therapy|Complicating disease|0
4610649|NCT01695239|7466957|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
4610650|NCT01695239|7466958|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
4610651|NCT01695239|7466959|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
4610652|NCT01695239|7466960|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
4610653|NCT01695239|7466961|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9
4610654|NCT01695239|7466962|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
4610655|NCT01695239|7466963|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
4610656|NCT01695239|7466964|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
4610657|NCT01695239|7466965|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
4610658|NCT01695239|7466966|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
4690130|NCT02558400|7599719|FG000|Overall Study|Ineligible for the study|0
4690131|NCT02558400|7599720|FG001|Overall Study|Ineligible for the study|2
4690132|NCT02558400|7599721|FG002|Overall Study|Ineligible for the study|0
4690133|NCT02558790|7599732|FG000|Overall Study|Lost to Follow-up|2
4690134|NCT02558790|7599732|FG000|Overall Study|Physician Decision|1
4690135|NCT02558790|7599732|FG000|Overall Study|Withdrawal by Subject|1
4690136|NCT02558790|7599732|FG000|Overall Study|Screen Fail|3
4690137|NCT02558894|7599771|FG000|Overall Study|Death; any cause, entire study duration|28
4690138|NCT02558894|7599772|FG001|Overall Study|Death; any cause, entire study duration|31
4690139|NCT02558894|7599771|FG000|Overall Study|Withdrawal by Subject|2
4690140|NCT02558894|7599772|FG001|Overall Study|Withdrawal by Subject|1
4690141|NCT02558894|7599771|FG000|Overall Study|Closure of Part A|2
4690142|NCT02558894|7599772|FG001|Overall Study|Closure of Part A|1
4690143|NCT02559115|7599778|FG000|Overall Study|Withdrawal by Subject|3
4690144|NCT02559206|7599790|FG000|Overall Study|Adverse Event|0
4690145|NCT02559206|7599791|FG001|Overall Study|Adverse Event|4
4690146|NCT02559206|7599792|FG002|Overall Study|Adverse Event|1
4690147|NCT02559206|7599793|FG003|Overall Study|Adverse Event|5
4690148|NCT02559206|7599794|FG004|Overall Study|Adverse Event|3
4690149|NCT02559206|7599795|FG005|Overall Study|Adverse Event|0
4447691|NCT00491556|7232917|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2
4447692|NCT00491556|7232918|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0
4447693|NCT00491556|7232917|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0
4447694|NCT00491556|7232918|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1
4451978|NCT00523341|7238384|FG000|Overall Study|Withdrawal by Subject|399
4690150|NCT02559206|7599796|FG006|Overall Study|Adverse Event|1
4690151|NCT02559206|7599797|FG007|Overall Study|Adverse Event|0
4690152|NCT02559206|7599790|FG000|Overall Study|Protocol Violation|1
4690153|NCT02559206|7599791|FG001|Overall Study|Protocol Violation|0
4690154|NCT02559206|7599792|FG002|Overall Study|Protocol Violation|1
4537063|NCT01107626|7357705|FG002|Step 1: Induction Therapy|Complicating disease|0
4690155|NCT02559206|7599793|FG003|Overall Study|Protocol Violation|0
4690156|NCT02559206|7599794|FG004|Overall Study|Protocol Violation|0
4690157|NCT02559206|7599795|FG005|Overall Study|Protocol Violation|2
4690158|NCT02559206|7599796|FG006|Overall Study|Protocol Violation|0
4690159|NCT02559206|7599797|FG007|Overall Study|Protocol Violation|0
4690160|NCT02559206|7599790|FG000|Overall Study|Withdrawal by Subject|3
4690161|NCT02559206|7599791|FG001|Overall Study|Withdrawal by Subject|3
4690162|NCT02559206|7599792|FG002|Overall Study|Withdrawal by Subject|1
4690163|NCT02559206|7599793|FG003|Overall Study|Withdrawal by Subject|3
4690164|NCT02559206|7599794|FG004|Overall Study|Withdrawal by Subject|5
4690165|NCT02559206|7599795|FG005|Overall Study|Withdrawal by Subject|4
4690166|NCT02559206|7599796|FG006|Overall Study|Withdrawal by Subject|1
4690167|NCT02559206|7599797|FG007|Overall Study|Withdrawal by Subject|2
4690168|NCT02559206|7599790|FG000|Overall Study|Lost to Follow-up|3
4690169|NCT02559206|7599791|FG001|Overall Study|Lost to Follow-up|5
4690170|NCT02559206|7599792|FG002|Overall Study|Lost to Follow-up|3
4690171|NCT02559206|7599793|FG003|Overall Study|Lost to Follow-up|3
4690172|NCT02559206|7599794|FG004|Overall Study|Lost to Follow-up|2
4690173|NCT02559206|7599795|FG005|Overall Study|Lost to Follow-up|5
4690174|NCT02559206|7599796|FG006|Overall Study|Lost to Follow-up|1
4690175|NCT02559206|7599797|FG007|Overall Study|Lost to Follow-up|4
4690176|NCT02559206|7599790|FG000|Overall Study|Lack of Efficacy|1
4690177|NCT02559206|7599791|FG001|Overall Study|Lack of Efficacy|0
4690178|NCT02559206|7599792|FG002|Overall Study|Lack of Efficacy|3
4690179|NCT02559206|7599793|FG003|Overall Study|Lack of Efficacy|2
4690180|NCT02559206|7599794|FG004|Overall Study|Lack of Efficacy|2
4690181|NCT02559206|7599795|FG005|Overall Study|Lack of Efficacy|3
4690182|NCT02559206|7599796|FG006|Overall Study|Lack of Efficacy|3
4690183|NCT02559206|7599797|FG007|Overall Study|Lack of Efficacy|3
4537064|NCT01107626|7357706|FG003|Step 1: Induction Therapy|Complicating disease|0
4537065|NCT01107626|7357703|FG000|Step 1: Induction Therapy|Alternative therapy|12
4537066|NCT01107626|7357704|FG001|Step 1: Induction Therapy|Alternative therapy|0
4690184|NCT02559206|7599790|FG000|Overall Study|Other Not Specified|0
4690185|NCT02559206|7599791|FG001|Overall Study|Other Not Specified|0
4690186|NCT02559206|7599792|FG002|Overall Study|Other Not Specified|0
4690187|NCT02559206|7599793|FG003|Overall Study|Other Not Specified|1
4690188|NCT02559206|7599794|FG004|Overall Study|Other Not Specified|0
4610659|NCT01695239|7466967|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
4610660|NCT01695239|7466954|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
4610661|NCT01695239|7466955|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
4610662|NCT01695239|7466956|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
4610663|NCT01695239|7466957|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
4610664|NCT01695239|7466958|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
4610665|NCT01695239|7466959|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
4610666|NCT01695239|7466960|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
4610667|NCT01695239|7466961|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1
4610668|NCT01695239|7466962|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
4610669|NCT01695239|7466963|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
4610670|NCT01695239|7466964|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
4610671|NCT01695239|7466965|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
4610672|NCT01695239|7466966|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
4610673|NCT01695239|7466967|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
4690189|NCT02559206|7599795|FG005|Overall Study|Other Not Specified|0
4690190|NCT02559206|7599796|FG006|Overall Study|Other Not Specified|0
4690191|NCT02559206|7599797|FG007|Overall Study|Other Not Specified|0
4690192|NCT02559310|7599817|FG000|Overall Study|Death|4
4690193|NCT02559310|7599818|FG001|Overall Study|Death|3
4690194|NCT02559310|7599817|FG000|Overall Study|Lost to Follow-up|5
4690195|NCT02559310|7599818|FG001|Overall Study|Lost to Follow-up|3
4690196|NCT02559310|7599817|FG000|Overall Study|Physician Decision|2
4690197|NCT02559310|7599818|FG001|Overall Study|Physician Decision|1
4690198|NCT02559310|7599817|FG000|Overall Study|Withdrawal by Subject|13
4690199|NCT02559310|7599818|FG001|Overall Study|Withdrawal by Subject|9
4690200|NCT02559310|7599817|FG000|Overall Study|Sponsor Decision|0
4690201|NCT02559310|7599818|FG001|Overall Study|Sponsor Decision|1
4690202|NCT02559310|7599817|FG000|Overall Study|Randomized but not treated|3
4690203|NCT02559310|7599818|FG001|Overall Study|Randomized but not treated|2
4690204|NCT02559414|7599827|FG000|Overall Study|Lost to Follow-up|0
4690205|NCT02559414|7599828|FG001|Overall Study|Lost to Follow-up|1
4690206|NCT02559414|7599829|FG002|Overall Study|Lost to Follow-up|0
4690207|NCT02559414|7599827|FG000|Overall Study|Withdrawal by Subject|1
4690208|NCT02559414|7599828|FG001|Overall Study|Withdrawal by Subject|0
4690209|NCT02559414|7599829|FG002|Overall Study|Withdrawal by Subject|1
4690210|NCT02559414|7599827|FG000|Overall Study|Other|0
4690211|NCT02559414|7599828|FG001|Overall Study|Other|1
4690212|NCT02559414|7599829|FG002|Overall Study|Other|1
4690213|NCT02559505|7599854|FG000|Overall Study|Lost to Follow-up|23
4690214|NCT02559505|7599855|FG001|Overall Study|Lost to Follow-up|20
4690215|NCT02559505|7599854|FG000|Overall Study|Withdrawal by Subject|4
4690216|NCT02559505|7599855|FG001|Overall Study|Withdrawal by Subject|2
4690217|NCT02559570|7599878|FG000|Overall Study|Adverse Event|0
4690218|NCT02559570|7599879|FG001|Overall Study|Adverse Event|2
4690219|NCT02559570|7599880|FG002|Overall Study|Adverse Event|0
4690220|NCT02559570|7599881|FG003|Overall Study|Adverse Event|1
4690221|NCT02559570|7599882|FG004|Overall Study|Adverse Event|0
4690222|NCT02559570|7599878|FG000|Overall Study|Withdrawal of Consent|0
4690223|NCT02559570|7599879|FG001|Overall Study|Withdrawal of Consent|0
4690224|NCT02559570|7599880|FG002|Overall Study|Withdrawal of Consent|1
4690225|NCT02559570|7599881|FG003|Overall Study|Withdrawal of Consent|2
4451979|NCT00523341|7238385|FG001|Overall Study|Withdrawal by Subject|427
4451980|NCT00523341|7238384|FG000|Overall Study|Other|181
4451981|NCT00523341|7238385|FG001|Overall Study|Other|198
4451982|NCT00523341|7238384|FG000|Overall Study|Adverse Event|122
4451983|NCT00523341|7238385|FG001|Overall Study|Adverse Event|155
4451984|NCT00523341|7238384|FG000|Overall Study|Death|101
4451985|NCT00523341|7238385|FG001|Overall Study|Death|110
4451986|NCT00523341|7238384|FG000|Overall Study|Lost to Follow-up|73
4451987|NCT00523341|7238385|FG001|Overall Study|Lost to Follow-up|61
4451988|NCT00523341|7238384|FG000|Overall Study|Non-compliance|20
4451989|NCT00523341|7238385|FG001|Overall Study|Non-compliance|13
4451990|NCT00523341|7238384|FG000|Overall Study|Physician Decision|14
4451991|NCT00523341|7238385|FG001|Overall Study|Physician Decision|13
4451992|NCT00523341|7238384|FG000|Overall Study|Requirement for Alternative Therapy|4
4451993|NCT00523341|7238385|FG001|Overall Study|Requirement for Alternative Therapy|14
4451994|NCT00523341|7238384|FG000|Overall Study|Protocol Deviation|6
4633387|NCT01911546|7503544|FG000|Overall Study|Everolimus was discontinued|5
4451995|NCT00523341|7238385|FG001|Overall Study|Protocol Deviation|5
4451996|NCT00523341|7238384|FG000|Overall Study|Ineligibility Determined|3
4451997|NCT00523341|7238385|FG001|Overall Study|Ineligibility Determined|4
4451998|NCT00523341|7238384|FG000|Overall Study|Disease Progression|1
4451999|NCT00523341|7238385|FG001|Overall Study|Disease Progression|0
4452000|NCT00523367|7238391|FG000|Overall Study|19 screen failures|19
4452001|NCT00523367|7238391|FG000|Overall Study|4 Withdrawn by PI|4
4452002|NCT00523419|7238395|FG000|Overall Study|Adverse Event|1
4452003|NCT00523419|7238395|FG000|Overall Study|Withdrawal by Subject|1
4452004|NCT00523419|7238395|FG000|Overall Study|Physician Decision|2
4452005|NCT00523419|7238395|FG000|Overall Study|Progressive Disease|22
4452006|NCT00523419|7238395|FG000|Overall Study|Death due to Study Disease|4
4452007|NCT00523419|7238395|FG000|Overall Study|Death due to Adverse Event|2
4452008|NCT00523549|7238401|FG000|Overall Study|Adverse Event|6
4452009|NCT00523549|7238402|FG001|Overall Study|Adverse Event|3
4452010|NCT00523549|7238401|FG000|Overall Study|Unsatisfactory therapeutic effect|0
4452011|NCT00523549|7238402|FG001|Overall Study|Unsatisfactory therapeutic effect|1
4452012|NCT00523549|7238401|FG000|Overall Study|Protocol Deviation|3
4690226|NCT02559570|7599882|FG004|Overall Study|Withdrawal of Consent|1
4690227|NCT02559570|7599878|FG000|Overall Study|Lost to Follow-up|1
4770370|NCT03740919|7746730|FG000|Lead-in Period|Protocol Violation|1
4452013|NCT00523549|7238402|FG001|Overall Study|Protocol Deviation|1
4452014|NCT00523549|7238401|FG000|Overall Study|Patient withdrew consent|7
4452015|NCT00523549|7238402|FG001|Overall Study|Patient withdrew consent|6
4452016|NCT00523549|7238401|FG000|Overall Study|Lost to Follow-up|3
4452017|NCT00523549|7238402|FG001|Overall Study|Lost to Follow-up|5
4452018|NCT00523640|7238417|FG000|Overall Study|Death|1
4452019|NCT00523705|7238423|FG000|Overall Study|No time for study.|0
4452020|NCT00523705|7238424|FG001|Overall Study|No time for study.|1
4452021|NCT00523718|7238432|FG000|Overall Study|Withdrawal by Subject|1
4452022|NCT00523718|7238433|FG001|Overall Study|Withdrawal by Subject|0
4690228|NCT02559570|7599879|FG001|Overall Study|Lost to Follow-up|0
4690229|NCT02559570|7599880|FG002|Overall Study|Lost to Follow-up|0
4690230|NCT02559570|7599881|FG003|Overall Study|Lost to Follow-up|0
4690231|NCT02559570|7599882|FG004|Overall Study|Lost to Follow-up|0
4690232|NCT02559570|7599878|FG000|Overall Study|Protocol Violation|1
4610674|NCT01695239|7466954|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
4610675|NCT01695239|7466955|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
4610676|NCT01695239|7466956|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
4610677|NCT01695239|7466957|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
4610678|NCT01695239|7466958|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
4610679|NCT01695239|7466959|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
4610680|NCT01695239|7466960|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
4610681|NCT01695239|7466961|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1
4610682|NCT01695239|7466962|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
4690233|NCT02559570|7599879|FG001|Overall Study|Protocol Violation|0
4690234|NCT02559570|7599880|FG002|Overall Study|Protocol Violation|0
4690235|NCT02559570|7599881|FG003|Overall Study|Protocol Violation|0
4690236|NCT02559570|7599882|FG004|Overall Study|Protocol Violation|1
4447695|NCT00491556|7232917|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0
4447696|NCT00491556|7232918|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1
4447697|NCT00491608|7232924|FG000|Overall Study|Death|2
4447698|NCT00491608|7232924|FG000|Overall Study|Withdrawal by Subject|1
4447699|NCT00491764|7232949|FG000|Overall Study|Adverse Event|1
4447700|NCT00491764|7232950|FG001|Overall Study|Adverse Event|2
4447701|NCT00491764|7232951|FG002|Overall Study|Adverse Event|4
4447702|NCT00491764|7232952|FG003|Overall Study|Adverse Event|4
4447703|NCT00491764|7232953|FG004|Overall Study|Adverse Event|0
4447704|NCT00491764|7232954|FG005|Overall Study|Adverse Event|1
4447705|NCT00491764|7232949|FG000|Overall Study|Lost to Follow-up|0
4447706|NCT00491764|7232950|FG001|Overall Study|Lost to Follow-up|1
4447707|NCT00491764|7232951|FG002|Overall Study|Lost to Follow-up|0
4447708|NCT00491764|7232952|FG003|Overall Study|Lost to Follow-up|1
4447709|NCT00491764|7232953|FG004|Overall Study|Lost to Follow-up|0
4447710|NCT00491764|7232954|FG005|Overall Study|Lost to Follow-up|3
4447711|NCT00491764|7232949|FG000|Overall Study|Withdrawal by Subject|2
4447712|NCT00491764|7232950|FG001|Overall Study|Withdrawal by Subject|3
4447713|NCT00491764|7232951|FG002|Overall Study|Withdrawal by Subject|1
4447714|NCT00491764|7232952|FG003|Overall Study|Withdrawal by Subject|2
4447715|NCT00491764|7232953|FG004|Overall Study|Withdrawal by Subject|2
4447716|NCT00491764|7232954|FG005|Overall Study|Withdrawal by Subject|4
4447717|NCT00491764|7232949|FG000|Overall Study|Non Compliance with the Protocol|1
4447718|NCT00491764|7232950|FG001|Overall Study|Non Compliance with the Protocol|0
4447719|NCT00491764|7232951|FG002|Overall Study|Non Compliance with the Protocol|0
4447720|NCT00491764|7232952|FG003|Overall Study|Non Compliance with the Protocol|0
4447721|NCT00491764|7232953|FG004|Overall Study|Non Compliance with the Protocol|0
4447722|NCT00491764|7232954|FG005|Overall Study|Non Compliance with the Protocol|0
4447723|NCT00491764|7232949|FG000|Overall Study|Did not Meet Protocol Eligibility|0
4447724|NCT00491764|7232950|FG001|Overall Study|Did not Meet Protocol Eligibility|1
4447725|NCT00491764|7232951|FG002|Overall Study|Did not Meet Protocol Eligibility|1
4447726|NCT00491764|7232952|FG003|Overall Study|Did not Meet Protocol Eligibility|0
4447727|NCT00491764|7232953|FG004|Overall Study|Did not Meet Protocol Eligibility|1
4447728|NCT00491764|7232954|FG005|Overall Study|Did not Meet Protocol Eligibility|1
4447729|NCT00491764|7232949|FG000|Overall Study|Administrative|1
4447730|NCT00491764|7232950|FG001|Overall Study|Administrative|0
4447731|NCT00491764|7232951|FG002|Overall Study|Administrative|2
4447732|NCT00491764|7232952|FG003|Overall Study|Administrative|1
4610683|NCT01695239|7466963|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
4690237|NCT02559570|7599878|FG000|Overall Study|Other Miscellaneous Reasons|0
4447733|NCT00491764|7232953|FG004|Overall Study|Administrative|0
4447734|NCT00491764|7232954|FG005|Overall Study|Administrative|0
4447735|NCT00491894|7232981|FG000|Overall Study|Adverse Event|14
4447736|NCT00491894|7232981|FG000|Overall Study|Withdrawal by Subject|5
4447737|NCT00491894|7232981|FG000|Overall Study|Death|3
4447738|NCT00491894|7232981|FG000|Overall Study|Lost to Follow-up|3
4447739|NCT00491894|7232981|FG000|Overall Study|Lack of Efficacy|2
4447740|NCT00491894|7232981|FG000|Overall Study|Other-Failed to meet any criteria|2
4447741|NCT00491894|7232981|FG000|Overall Study|Physician Decision|2
4447742|NCT00491894|7232981|FG000|Overall Study|Protocol Violation|2
4447743|NCT00491894|7232981|FG000|Overall Study|Other-Intake of prohibited medication|1
4690238|NCT02559570|7599879|FG001|Overall Study|Other Miscellaneous Reasons|0
4690239|NCT02559570|7599880|FG002|Overall Study|Other Miscellaneous Reasons|1
4690240|NCT02559570|7599881|FG003|Overall Study|Other Miscellaneous Reasons|0
4690241|NCT02559570|7599882|FG004|Overall Study|Other Miscellaneous Reasons|0
4690242|NCT02559622|7599897|FG000|Overall Study|Progressive disease|0
4690243|NCT02559622|7599898|FG001|Overall Study|Progressive disease|1
4690244|NCT02559622|7599899|FG002|Overall Study|Progressive disease|0
4690245|NCT02559622|7599900|FG003|Overall Study|Progressive disease|0
4690246|NCT02559622|7599897|FG000|Overall Study|Adverse Event|0
4690247|NCT02559622|7599898|FG001|Overall Study|Adverse Event|2
4447744|NCT00492024|7232987|FG000|Treatment|Adverse Event|3
4447745|NCT00492024|7232988|FG001|Treatment|Adverse Event|1
4452023|NCT00523718|7238432|FG000|Overall Study|Protocol Violation|2
4452024|NCT00523718|7238433|FG001|Overall Study|Protocol Violation|0
4452025|NCT00523744|7238439|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2
4452026|NCT00523744|7238439|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1
4452027|NCT00523744|7238439|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2
4452028|NCT00523744|7238439|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1
4452029|NCT00523744|7238439|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2
4452030|NCT00523744|7238439|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1
4452031|NCT00523848|7238446|FG000|Overall Study|Adverse Event|11
4452032|NCT00523848|7238446|FG000|Overall Study|Withdrawal by Subject|2
4452033|NCT00523848|7238446|FG000|Overall Study|NOT TREATED (Became ineligible)|2
4452034|NCT00523848|7238446|FG000|Overall Study|Disease Progression|5
4452035|NCT00523848|7238446|FG000|Overall Study|Other, unspecified|4
4452036|NCT00523978|7238452|FG000|Overall Study|Withdrawal by Subject|3
4452037|NCT00523978|7238453|FG001|Overall Study|Withdrawal by Subject|7
4452038|NCT00523978|7238452|FG000|Overall Study|Screen Failures|5
4452039|NCT00523978|7238453|FG001|Overall Study|Screen Failures|1
4452040|NCT00523978|7238452|FG000|Overall Study|Death|1
4452041|NCT00523978|7238453|FG001|Overall Study|Death|0
4452042|NCT00523991|7238462|FG000|Overall Study|Adverse Event|6
4452043|NCT00523991|7238463|FG001|Overall Study|Adverse Event|5
4452044|NCT00523991|7238462|FG000|Overall Study|Protocol Violation|1
4452045|NCT00523991|7238463|FG001|Overall Study|Protocol Violation|4
4452046|NCT00523991|7238462|FG000|Overall Study|Lost to Follow-up|4
4452047|NCT00523991|7238463|FG001|Overall Study|Lost to Follow-up|1
4452048|NCT00523991|7238462|FG000|Overall Study|Withdrawal by Subject|7
4452049|NCT00523991|7238463|FG001|Overall Study|Withdrawal by Subject|17
4452050|NCT00523991|7238462|FG000|Overall Study|Other reason (not specified)|3
4452051|NCT00523991|7238463|FG001|Overall Study|Other reason (not specified)|0
4452052|NCT00524030|7238480|FG000|Overall Study|Lack of Efficacy|10
4452053|NCT00524030|7238481|FG001|Overall Study|Lack of Efficacy|24
4452054|NCT00524030|7238480|FG000|Overall Study|Lost to Follow-up|0
4452055|NCT00524030|7238481|FG001|Overall Study|Lost to Follow-up|2
4452056|NCT00524030|7238480|FG000|Overall Study|Withdrawal by Subject|3
4452057|NCT00524030|7238481|FG001|Overall Study|Withdrawal by Subject|8
4452058|NCT00524030|7238480|FG000|Overall Study|Noncompliance/Investigator discretion|0
4452059|NCT00524030|7238481|FG001|Overall Study|Noncompliance/Investigator discretion|2
4452060|NCT00524030|7238480|FG000|Overall Study|Protocol Violation|0
4452061|NCT00524030|7238481|FG001|Overall Study|Protocol Violation|1
4452062|NCT00524030|7238480|FG000|Overall Study|Pregnancy|1
4452063|NCT00524030|7238481|FG001|Overall Study|Pregnancy|0
4452064|NCT00524030|7238480|FG000|Overall Study|Adverse Event|3
4452065|NCT00524030|7238481|FG001|Overall Study|Adverse Event|21
4452066|NCT00524030|7238480|FG000|Overall Study|Death|0
4452067|NCT00524030|7238481|FG001|Overall Study|Death|1
4452068|NCT00524043|7238491|FG000|Overall Study|Lack of Efficacy|15
4452069|NCT00524043|7238492|FG001|Overall Study|Lack of Efficacy|13
4690248|NCT02559622|7599899|FG002|Overall Study|Adverse Event|2
4690249|NCT02559622|7599900|FG003|Overall Study|Adverse Event|2
4452070|NCT00524043|7238493|FG002|Overall Study|Lack of Efficacy|14
4452071|NCT00524043|7238491|FG000|Overall Study|Withdrawal by Subject|5
4452072|NCT00524043|7238492|FG001|Overall Study|Withdrawal by Subject|7
4452073|NCT00524043|7238493|FG002|Overall Study|Withdrawal by Subject|7
4452074|NCT00524043|7238491|FG000|Overall Study|Adverse Event|5
4452075|NCT00524043|7238492|FG001|Overall Study|Adverse Event|2
4452076|NCT00524043|7238493|FG002|Overall Study|Adverse Event|7
4452077|NCT00524043|7238491|FG000|Overall Study|Lost to Follow-up|3
4452078|NCT00524043|7238492|FG001|Overall Study|Lost to Follow-up|5
4452079|NCT00524043|7238493|FG002|Overall Study|Lost to Follow-up|3
4452080|NCT00524043|7238491|FG000|Overall Study|Various (eg, incarceration)|2
4452081|NCT00524043|7238492|FG001|Overall Study|Various (eg, incarceration)|1
4452082|NCT00524043|7238493|FG002|Overall Study|Various (eg, incarceration)|0
4452083|NCT00524121|7238501|FG000|Overall Study|Disease progression|6
4452084|NCT00524121|7238501|FG000|Overall Study|Adverse Event|4
4452085|NCT00524121|7238501|FG000|Overall Study|Patient refused|2
4452086|NCT00524121|7238501|FG000|Overall Study|Other|1
4452087|NCT00524121|7238501|FG000|Overall Study|Death|1
4452088|NCT00524121|7238501|FG000|Overall Study|Not treated (became ineligible)|4
4452089|NCT00524121|7238501|FG000|Overall Study|Not treated (changed mind)|1
4515800|NCT00955682|7326785|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1
4518737|NCT00976027|7331006|FG000|Overall Study|Protocol Violation|60
4690250|NCT02559622|7599897|FG000|Overall Study|Patient/guardian decision|1
4690251|NCT02559622|7599898|FG001|Overall Study|Patient/guardian decision|2
4690252|NCT02559622|7599899|FG002|Overall Study|Patient/guardian decision|0
4690253|NCT02559622|7599900|FG003|Overall Study|Patient/guardian decision|1
4690254|NCT02559687|7599914|FG000|Overall Study|Death|103
4690255|NCT02559687|7599914|FG000|Overall Study|Withdrawal by Subject|4
4690256|NCT02559687|7599914|FG000|Overall Study|Ongoing Follow-Up|14
4690257|NCT02559713|7599918|FG000|Overall Study|Pretreatment Event/ Adverse Event|1
4690258|NCT02559817|7599927|FG000|Treatment Period|Adverse Event|1
4690259|NCT02559817|7599928|FG001|Treatment Period|Adverse Event|0
4690260|NCT02559817|7599929|FG002|Treatment Period|Adverse Event|1
4690261|NCT02559817|7599930|FG003|Treatment Period|Adverse Event|0
4690262|NCT02559817|7599931|FG004|Treatment Period|Adverse Event|0
4690263|NCT02559817|7599927|FG000|Treatment Period|Lack of Efficacy|0
4690264|NCT02559817|7599928|FG001|Treatment Period|Lack of Efficacy|1
4690265|NCT02559817|7599929|FG002|Treatment Period|Lack of Efficacy|0
4690266|NCT02559817|7599930|FG003|Treatment Period|Lack of Efficacy|0
4690267|NCT02559817|7599931|FG004|Treatment Period|Lack of Efficacy|0
4690268|NCT02559817|7599927|FG000|Treatment Period|Lost to Follow-up|0
4690269|NCT02559817|7599928|FG001|Treatment Period|Lost to Follow-up|1
4690270|NCT02559817|7599929|FG002|Treatment Period|Lost to Follow-up|0
4690271|NCT02559817|7599930|FG003|Treatment Period|Lost to Follow-up|1
4690272|NCT02559817|7599931|FG004|Treatment Period|Lost to Follow-up|0
4690273|NCT02559817|7599927|FG000|Treatment Period|Non-Compliance With Study Drug|0
4690274|NCT02559817|7599928|FG001|Treatment Period|Non-Compliance With Study Drug|0
4690275|NCT02559817|7599929|FG002|Treatment Period|Non-Compliance With Study Drug|1
4690276|NCT02559817|7599930|FG003|Treatment Period|Non-Compliance With Study Drug|0
4690277|NCT02559817|7599931|FG004|Treatment Period|Non-Compliance With Study Drug|0
4690278|NCT02559817|7599927|FG000|Treatment Period|Protocol Violation|0
4690279|NCT02559817|7599928|FG001|Treatment Period|Protocol Violation|0
4690280|NCT02559817|7599929|FG002|Treatment Period|Protocol Violation|0
4690281|NCT02559817|7599930|FG003|Treatment Period|Protocol Violation|1
4690282|NCT02559817|7599931|FG004|Treatment Period|Protocol Violation|0
4690283|NCT02559895|7599947|FG000|Overall Study|Adverse Event|3
4690284|NCT02559895|7599948|FG001|Overall Study|Adverse Event|3
4690285|NCT02559895|7599949|FG002|Overall Study|Adverse Event|2
4690286|NCT02559895|7599950|FG003|Overall Study|Adverse Event|1
4690287|NCT02559895|7599947|FG000|Overall Study|Lack of Efficacy|2
4690288|NCT02559895|7599948|FG001|Overall Study|Lack of Efficacy|3
4690289|NCT02559895|7599949|FG002|Overall Study|Lack of Efficacy|2
4690290|NCT02559895|7599950|FG003|Overall Study|Lack of Efficacy|8
4690291|NCT02559895|7599947|FG000|Overall Study|Lost to Follow-up|22
4690292|NCT02559895|7599948|FG001|Overall Study|Lost to Follow-up|16
4690293|NCT02559895|7599949|FG002|Overall Study|Lost to Follow-up|12
4690294|NCT02559895|7599950|FG003|Overall Study|Lost to Follow-up|17
4690295|NCT02559895|7599947|FG000|Overall Study|Physician Decision|1
4690296|NCT02559895|7599948|FG001|Overall Study|Physician Decision|1
4690297|NCT02559895|7599949|FG002|Overall Study|Physician Decision|3
4690298|NCT02559895|7599950|FG003|Overall Study|Physician Decision|0
4690299|NCT02559895|7599947|FG000|Overall Study|Withdrawal by Subject|16
4690300|NCT02559895|7599948|FG001|Overall Study|Withdrawal by Subject|9
4690301|NCT02559895|7599949|FG002|Overall Study|Withdrawal by Subject|20
4690302|NCT02559895|7599950|FG003|Overall Study|Withdrawal by Subject|9
4690303|NCT02559895|7599947|FG000|Overall Study|Study Burden|10
4690304|NCT02559895|7599948|FG001|Overall Study|Study Burden|16
4690305|NCT02559895|7599949|FG002|Overall Study|Study Burden|12
4690306|NCT02559895|7599950|FG003|Overall Study|Study Burden|22
4690307|NCT02559895|7599947|FG000|Overall Study|Other|1
4690308|NCT02559895|7599948|FG001|Overall Study|Other|5
4690309|NCT02559895|7599949|FG002|Overall Study|Other|3
4690310|NCT02559895|7599950|FG003|Overall Study|Other|3
4690311|NCT02560012|7599960|FG000|Overall Study|Study Terminated|2
4690312|NCT02560025|7599964|FG000|Overall Study|Ineligible after consent/ registration|3
4690313|NCT02560389|7600001|FG000|Overall Study|Lost to Follow-up|1
4690314|NCT02560389|7600002|FG001|Overall Study|Lost to Follow-up|2
4690315|NCT02560389|7600003|FG002|Overall Study|Lost to Follow-up|2
4690316|NCT02560389|7600001|FG000|Overall Study|Tested positive for illicit substance|0
4447746|NCT00492024|7232987|FG000|Treatment|Lack of Efficacy|21
4447747|NCT00492024|7232988|FG001|Treatment|Lack of Efficacy|20
4447748|NCT00492024|7232987|FG000|Treatment|Lost to Follow-up|3
4447749|NCT00492024|7232988|FG001|Treatment|Lost to Follow-up|1
4447750|NCT00492024|7232987|FG000|Treatment|Withdrawal by Subject|2
4447751|NCT00492024|7232988|FG001|Treatment|Withdrawal by Subject|0
4447752|NCT00492024|7232987|FG000|Follow up|Lack of Efficacy|0
4447753|NCT00492024|7232988|FG001|Follow up|Lack of Efficacy|1
4447754|NCT00492024|7232987|FG000|Follow up|Lost to Follow-up|1
4690317|NCT02560389|7600002|FG001|Overall Study|Tested positive for illicit substance|1
4610684|NCT01695239|7466964|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
4610685|NCT01695239|7466965|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
4610686|NCT01695239|7466966|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
4610687|NCT01695239|7466967|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
4610688|NCT01695239|7466954|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0
4610689|NCT01695239|7466955|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0
4537067|NCT01107626|7357705|FG002|Step 1: Induction Therapy|Alternative therapy|0
4537068|NCT01107626|7357706|FG003|Step 1: Induction Therapy|Alternative therapy|0
4537069|NCT01107626|7357703|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10
4610690|NCT01695239|7466956|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0
4633408|NCT01911845|7503590|FG000|Overall Study|Other (not specified)|3
4452090|NCT00524173|7238518|FG000|Overall Study|Lost to Follow-up|0
4452091|NCT00524173|7238519|FG001|Overall Study|Lost to Follow-up|1
4452092|NCT00524173|7238518|FG000|Overall Study|Death|1
4452093|NCT00524173|7238519|FG001|Overall Study|Death|0
4452094|NCT00524173|7238518|FG000|Overall Study|Had not reached endpoint at study close|4
4452095|NCT00524173|7238519|FG001|Overall Study|Had not reached endpoint at study close|1
4452096|NCT00524303|7238542|FG000|Overall Study|Lost to Follow-up|6
4452097|NCT00524303|7238543|FG001|Overall Study|Lost to Follow-up|0
4452098|NCT00524303|7238544|FG002|Overall Study|Lost to Follow-up|3
4452099|NCT00524303|7238542|FG000|Overall Study|Protocol Violation|0
4452100|NCT00524303|7238543|FG001|Overall Study|Protocol Violation|1
4452101|NCT00524303|7238544|FG002|Overall Study|Protocol Violation|1
4452102|NCT00524303|7238542|FG000|Overall Study|Withdrawal by Subject|3
4452103|NCT00524303|7238543|FG001|Overall Study|Withdrawal by Subject|0
4452104|NCT00524303|7238544|FG002|Overall Study|Withdrawal by Subject|4
4452105|NCT00524303|7238542|FG000|Overall Study|Death|0
4452106|NCT00524303|7238543|FG001|Overall Study|Death|2
4452107|NCT00524303|7238544|FG002|Overall Study|Death|3
4452108|NCT00524303|7238542|FG000|Overall Study|Adverse Event|1
4452109|NCT00524303|7238543|FG001|Overall Study|Adverse Event|2
4452110|NCT00524303|7238544|FG002|Overall Study|Adverse Event|3
4452111|NCT00524303|7238542|FG000|Overall Study|Did not Complete Study Dosing|1
4452112|NCT00524303|7238543|FG001|Overall Study|Did not Complete Study Dosing|0
4452113|NCT00524303|7238544|FG002|Overall Study|Did not Complete Study Dosing|0
4452114|NCT00524303|7238542|FG000|Overall Study|Worsening Peripheral Neuropathy|1
4452115|NCT00524303|7238543|FG001|Overall Study|Worsening Peripheral Neuropathy|0
4452116|NCT00524303|7238544|FG002|Overall Study|Worsening Peripheral Neuropathy|0
4452117|NCT00524303|7238542|FG000|Overall Study|Disease Progression|0
4452118|NCT00524303|7238543|FG001|Overall Study|Disease Progression|4
4452119|NCT00524303|7238544|FG002|Overall Study|Disease Progression|1
4452120|NCT00524303|7238542|FG000|Overall Study|Disease Recurrence|0
4452121|NCT00524303|7238543|FG001|Overall Study|Disease Recurrence|1
4452122|NCT00524303|7238544|FG002|Overall Study|Disease Recurrence|0
4452123|NCT00524303|7238542|FG000|Overall Study|Sponsor Request|0
4537070|NCT01107626|7357704|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0
4452124|NCT00524303|7238543|FG001|Overall Study|Sponsor Request|0
4452125|NCT00524303|7238544|FG002|Overall Study|Sponsor Request|1
4452126|NCT00524303|7238542|FG000|Overall Study|Physician Decision|0
4452127|NCT00524303|7238543|FG001|Overall Study|Physician Decision|0
4452128|NCT00524303|7238544|FG002|Overall Study|Physician Decision|1
4452129|NCT00524303|7238542|FG000|Overall Study|Completed 5 years|0
4452130|NCT00524303|7238543|FG001|Overall Study|Completed 5 years|0
4452131|NCT00524303|7238544|FG002|Overall Study|Completed 5 years|1
4452132|NCT00524316|7238555|FG000|Overall Study|Withdrawal by Subject|2
4452133|NCT00524316|7238555|FG000|Overall Study|Adverse Event|7
4452134|NCT00524316|7238555|FG000|Overall Study|Disease Progression|7
4452135|NCT00524368|7238565|FG000|Overall Study|Adverse Event|10
4452136|NCT00524368|7238566|FG001|Overall Study|Adverse Event|12
4452137|NCT00524368|7238565|FG000|Overall Study|Lost to Follow-up|9
4452138|NCT00524368|7238566|FG001|Overall Study|Lost to Follow-up|13
4452139|NCT00524368|7238565|FG000|Overall Study|Withdrawal by Subject|4
4452140|NCT00524368|7238566|FG001|Overall Study|Withdrawal by Subject|5
4452141|NCT00524368|7238565|FG000|Overall Study|Non-compliant|8
4452142|NCT00524368|7238566|FG001|Overall Study|Non-compliant|9
4518738|NCT00976027|7331007|FG001|Overall Study|Protocol Violation|27
4537071|NCT01107626|7357705|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0
4447755|NCT00492024|7232988|FG001|Follow up|Lost to Follow-up|1
4537072|NCT01107626|7357706|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0
4537073|NCT01107626|7357703|FG000|Step 1: Induction Therapy|Non-compliance|4
4537074|NCT01107626|7357704|FG001|Step 1: Induction Therapy|Non-compliance|0
4537075|NCT01107626|7357705|FG002|Step 1: Induction Therapy|Non-compliance|0
4537076|NCT01107626|7357706|FG003|Step 1: Induction Therapy|Non-compliance|0
4537077|NCT01107626|7357703|FG000|Step 1: Induction Therapy|Pain|4
4537078|NCT01107626|7357704|FG001|Step 1: Induction Therapy|Pain|0
4537079|NCT01107626|7357705|FG002|Step 1: Induction Therapy|Pain|0
4537080|NCT01107626|7357706|FG003|Step 1: Induction Therapy|Pain|0
4537081|NCT01107626|7357703|FG000|Step 1: Induction Therapy|Protocol Violation|1
4537082|NCT01107626|7357704|FG001|Step 1: Induction Therapy|Protocol Violation|0
4537083|NCT01107626|7357705|FG002|Step 1: Induction Therapy|Protocol Violation|0
4537084|NCT01107626|7357706|FG003|Step 1: Induction Therapy|Protocol Violation|0
4537085|NCT01107626|7357703|FG000|Step 1: Induction Therapy|Hospice care|1
4537086|NCT01107626|7357704|FG001|Step 1: Induction Therapy|Hospice care|0
4537087|NCT01107626|7357705|FG002|Step 1: Induction Therapy|Hospice care|0
4452143|NCT00524368|7238565|FG000|Overall Study|Reached a Virologic Endpoint|3
4452144|NCT00524368|7238566|FG001|Overall Study|Reached a Virologic Endpoint|2
4452145|NCT00524368|7238565|FG000|Overall Study|Sponsor's Decision|2
4452146|NCT00524368|7238566|FG001|Overall Study|Sponsor's Decision|0
4452147|NCT00524368|7238565|FG000|Overall Study|Ineligible to Continue the study|2
4452148|NCT00524368|7238566|FG001|Overall Study|Ineligible to Continue the study|5
4452149|NCT00524368|7238565|FG000|Overall Study|Other|3
4452150|NCT00524368|7238566|FG001|Overall Study|Other|2
4452151|NCT00524420|7238574|FG000|Overall Study|Lack of Efficacy|1
4452152|NCT00524420|7238575|FG001|Overall Study|Lack of Efficacy|0
4452153|NCT00524589|7238605|FG000|Overall Study|Withdrawal by Subject|2
4452154|NCT00524589|7238605|FG000|Overall Study|Disease Progression|16
4452155|NCT00524680|7238613|FG000|Overall Study|progression|0
4452156|NCT00524680|7238614|FG001|Overall Study|progression|0
4452157|NCT00524680|7238615|FG002|Overall Study|progression|0
4452158|NCT00524680|7238616|FG003|Overall Study|progression|1
4452159|NCT00524680|7238613|FG000|Overall Study|Adverse Event|2
4452160|NCT00524680|7238614|FG001|Overall Study|Adverse Event|0
4452161|NCT00524680|7238615|FG002|Overall Study|Adverse Event|0
4452162|NCT00524680|7238616|FG003|Overall Study|Adverse Event|1
4452163|NCT00524680|7238613|FG000|Overall Study|Other|0
4452164|NCT00524680|7238614|FG001|Overall Study|Other|1
4452165|NCT00524680|7238615|FG002|Overall Study|Other|2
4452166|NCT00524680|7238616|FG003|Overall Study|Other|3
4452167|NCT00524680|7238613|FG000|Overall Study|Withdrawal by Subject|1
4452168|NCT00524680|7238614|FG001|Overall Study|Withdrawal by Subject|0
4452169|NCT00524680|7238615|FG002|Overall Study|Withdrawal by Subject|1
4452170|NCT00524680|7238616|FG003|Overall Study|Withdrawal by Subject|1
4452171|NCT00524745|7238630|FG000|Overall Study|subject withdrawal or lost to follow up|34
4452172|NCT00524745|7238631|FG001|Overall Study|subject withdrawal or lost to follow up|13
4452173|NCT00524745|7238632|FG002|Overall Study|subject withdrawal or lost to follow up|29
4452174|NCT00524745|7238633|FG003|Overall Study|subject withdrawal or lost to follow up|22
4452175|NCT00524771|7238645|FG000|Overall Study|Protocol Violation|220
4452176|NCT00524771|7238646|FG001|Overall Study|Protocol Violation|585
4452177|NCT00525031|7238659|FG000|Overall Study|Disease Progression|1
4452178|NCT00525031|7238660|FG001|Overall Study|Disease Progression|1
4452179|NCT00525044|7238669|FG000|Overall Study|Lost to Follow-up|0
4452180|NCT00525044|7238670|FG001|Overall Study|Lost to Follow-up|1
4452181|NCT00525148|7238693|FG000|Overall Study|Other Adverse Event|3
4452182|NCT00525148|7238694|FG001|Overall Study|Other Adverse Event|5
4452183|NCT00525148|7238695|FG002|Overall Study|Other Adverse Event|1
4452184|NCT00525148|7238696|FG003|Overall Study|Other Adverse Event|8
4452185|NCT00525148|7238693|FG000|Overall Study|Progressive disease|18
4452186|NCT00525148|7238694|FG001|Overall Study|Progressive disease|30
4452187|NCT00525148|7238695|FG002|Overall Study|Progressive disease|6
4452188|NCT00525148|7238696|FG003|Overall Study|Progressive disease|49
4452189|NCT00525148|7238693|FG000|Overall Study|Refused continuation of study medication|0
4452190|NCT00525148|7238694|FG001|Overall Study|Refused continuation of study medication|2
4452191|NCT00525148|7238695|FG002|Overall Study|Refused continuation of study medication|0
4452192|NCT00525148|7238696|FG003|Overall Study|Refused continuation of study medication|1
4452193|NCT00525148|7238693|FG000|Overall Study|Other than stated|2
4452194|NCT00525148|7238694|FG001|Overall Study|Other than stated|1
4452195|NCT00525148|7238695|FG002|Overall Study|Other than stated|0
4452196|NCT00525148|7238696|FG003|Overall Study|Other than stated|3
4452197|NCT00525161|7238706|FG000|Overall Study|Adverse Event|1
4452198|NCT00525265|7238721|FG000|Overall Study|Protocol Violation|1
4452199|NCT00525265|7238722|FG001|Overall Study|Protocol Violation|0
4452200|NCT00525499|7238741|FG000|Overall Study|Lost to Follow-up|2
4452201|NCT00525499|7238742|FG001|Overall Study|Lost to Follow-up|4
4452202|NCT00525499|7238743|FG002|Overall Study|Lost to Follow-up|1
4452203|NCT00525499|7238744|FG003|Overall Study|Lost to Follow-up|4
4452204|NCT00525499|7238741|FG000|Overall Study|Adverse Event|0
4452205|NCT00525499|7238742|FG001|Overall Study|Adverse Event|1
4452206|NCT00525499|7238743|FG002|Overall Study|Adverse Event|0
4452207|NCT00525499|7238744|FG003|Overall Study|Adverse Event|1
4452208|NCT00525499|7238741|FG000|Overall Study|Withdrawal by Subject|5
4452209|NCT00525499|7238742|FG001|Overall Study|Withdrawal by Subject|1
4452210|NCT00525499|7238743|FG002|Overall Study|Withdrawal by Subject|5
4452211|NCT00525499|7238744|FG003|Overall Study|Withdrawal by Subject|2
4452212|NCT00525499|7238741|FG000|Overall Study|Protocol Violation|0
4452213|NCT00525499|7238742|FG001|Overall Study|Protocol Violation|1
4452214|NCT00525499|7238743|FG002|Overall Study|Protocol Violation|1
4452215|NCT00525499|7238744|FG003|Overall Study|Protocol Violation|0
4452216|NCT00525512|7238756|FG000|Double-Blind Phase|Adverse Event|48
4452217|NCT00525512|7238757|FG001|Double-Blind Phase|Adverse Event|28
4452218|NCT00525512|7238758|FG002|Double-Blind Phase|Adverse Event|0
4452219|NCT00525512|7238759|FG003|Double-Blind Phase|Adverse Event|0
4452220|NCT00525512|7238756|FG000|Double-Blind Phase|Protocol Violation|3
4452221|NCT00525512|7238757|FG001|Double-Blind Phase|Protocol Violation|1
4452222|NCT00525512|7238758|FG002|Double-Blind Phase|Protocol Violation|0
4452223|NCT00525512|7238759|FG003|Double-Blind Phase|Protocol Violation|0
4452224|NCT00525512|7238756|FG000|Double-Blind Phase|Lost to Follow-up|3
4452225|NCT00525512|7238757|FG001|Double-Blind Phase|Lost to Follow-up|7
4452226|NCT00525512|7238758|FG002|Double-Blind Phase|Lost to Follow-up|0
4452227|NCT00525512|7238759|FG003|Double-Blind Phase|Lost to Follow-up|0
4452228|NCT00525512|7238756|FG000|Double-Blind Phase|Withdrawal by Subject|17
4452229|NCT00525512|7238757|FG001|Double-Blind Phase|Withdrawal by Subject|12
4452230|NCT00525512|7238758|FG002|Double-Blind Phase|Withdrawal by Subject|0
4452231|NCT00525512|7238759|FG003|Double-Blind Phase|Withdrawal by Subject|0
4452232|NCT00525512|7238756|FG000|Double-Blind Phase|Lack of Efficacy|13
4452233|NCT00525512|7238757|FG001|Double-Blind Phase|Lack of Efficacy|5
4452234|NCT00525512|7238758|FG002|Double-Blind Phase|Lack of Efficacy|0
4452235|NCT00525512|7238759|FG003|Double-Blind Phase|Lack of Efficacy|0
4452236|NCT00525512|7238756|FG000|Double-Blind Phase|Other reason (not specified)|12
4452237|NCT00525512|7238757|FG001|Double-Blind Phase|Other reason (not specified)|13
4452238|NCT00525512|7238758|FG002|Double-Blind Phase|Other reason (not specified)|0
4452239|NCT00525512|7238759|FG003|Double-Blind Phase|Other reason (not specified)|0
4452240|NCT00525512|7238756|FG000|Open-Label Phase|Adverse Event|0
4452241|NCT00525512|7238757|FG001|Open-Label Phase|Adverse Event|0
4452242|NCT00525512|7238758|FG002|Open-Label Phase|Adverse Event|1
4452243|NCT00525512|7238759|FG003|Open-Label Phase|Adverse Event|0
4452244|NCT00525512|7238756|FG000|Open-Label Phase|Lost to Follow-up|0
4452245|NCT00525512|7238757|FG001|Open-Label Phase|Lost to Follow-up|0
4452246|NCT00525512|7238758|FG002|Open-Label Phase|Lost to Follow-up|1
4452247|NCT00525512|7238759|FG003|Open-Label Phase|Lost to Follow-up|0
4452248|NCT00525512|7238756|FG000|Open-Label Phase|Other reason (not specified)|0
4452249|NCT00525512|7238757|FG001|Open-Label Phase|Other reason (not specified)|0
4452250|NCT00525512|7238758|FG002|Open-Label Phase|Other reason (not specified)|4
4452251|NCT00525512|7238759|FG003|Open-Label Phase|Other reason (not specified)|5
4452252|NCT00525590|7238780|FG000|Overall Study|Adverse Event|3
4610691|NCT01695239|7466957|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0
4610692|NCT01695239|7466958|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0
4610693|NCT01695239|7466959|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0
4610694|NCT01695239|7466960|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0
4610695|NCT01695239|7466961|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0
4610696|NCT01695239|7466962|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37
4452253|NCT00525590|7238780|FG000|Overall Study|Physician Decision|3
4452254|NCT00525590|7238780|FG000|Overall Study|Withdrawal by Subject|16
4452255|NCT00525590|7238780|FG000|Overall Study|Lost to Follow-up|1
4452256|NCT00525590|7238780|FG000|Overall Study|Death|9
4452257|NCT00525590|7238780|FG000|Overall Study|Other|13
4452258|NCT00525785|7238804|FG000|Overall Study|Withdrawal by Subject|1
4452259|NCT00525785|7238804|FG000|Overall Study|Lack of Efficacy|1
4452260|NCT00525785|7238804|FG000|Overall Study|Physician Decision|1
4452261|NCT00525824|7238821|FG000|Overall Study|Adverse Event|7
4452262|NCT00525824|7238822|FG001|Overall Study|Adverse Event|11
4452263|NCT00525824|7238823|FG002|Overall Study|Adverse Event|6
4452264|NCT00525824|7238824|FG003|Overall Study|Adverse Event|7
4452265|NCT00525824|7238821|FG000|Overall Study|Withdrawal by Subject|5
4452266|NCT00525824|7238822|FG001|Overall Study|Withdrawal by Subject|9
4452267|NCT00525824|7238823|FG002|Overall Study|Withdrawal by Subject|3
4452268|NCT00525824|7238824|FG003|Overall Study|Withdrawal by Subject|4
4452269|NCT00525824|7238821|FG000|Overall Study|Lost to Follow-up|4
4452270|NCT00525824|7238822|FG001|Overall Study|Lost to Follow-up|2
4452271|NCT00525824|7238823|FG002|Overall Study|Lost to Follow-up|4
4452272|NCT00525824|7238824|FG003|Overall Study|Lost to Follow-up|0
4452273|NCT00525824|7238821|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1
4452274|NCT00525824|7238822|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2
4452275|NCT00525824|7238823|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1
4452276|NCT00525824|7238824|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2
4452277|NCT00525824|7238821|FG000|Overall Study|Severe non-compliance|0
4452278|NCT00525824|7238822|FG001|Overall Study|Severe non-compliance|1
4452279|NCT00525824|7238823|FG002|Overall Study|Severe non-compliance|1
4452280|NCT00525824|7238824|FG003|Overall Study|Severe non-compliance|1
4452281|NCT00525824|7238821|FG000|Overall Study|Safety reasons|1
4452282|NCT00525824|7238822|FG001|Overall Study|Safety reasons|0
4452283|NCT00525824|7238823|FG002|Overall Study|Safety reasons|1
4452284|NCT00525824|7238824|FG003|Overall Study|Safety reasons|0
4452285|NCT00525824|7238821|FG000|Overall Study|Other|1
4452286|NCT00525824|7238822|FG001|Overall Study|Other|3
4452287|NCT00525824|7238823|FG002|Overall Study|Other|3
4452288|NCT00525824|7238824|FG003|Overall Study|Other|1
4452289|NCT00525902|7238852|FG000|Overall Study|Lack of Efficacy|1
4452290|NCT00525915|7238858|FG000|Overall Study|Non-Compliance|0
4452291|NCT00525915|7238859|FG001|Overall Study|Non-Compliance|1
4452292|NCT00525915|7238858|FG000|Overall Study|Disease Progression|5
4452293|NCT00525915|7238859|FG001|Overall Study|Disease Progression|6
4452294|NCT00525915|7238858|FG000|Overall Study|Withdrawal by Subject|1
4452295|NCT00525915|7238859|FG001|Overall Study|Withdrawal by Subject|0
4452296|NCT00525915|7238858|FG000|Overall Study|Refused Surgery|1
4452297|NCT00525915|7238859|FG001|Overall Study|Refused Surgery|2
4452298|NCT00525915|7238858|FG000|Overall Study|Unrelated illness|1
4452299|NCT00525915|7238859|FG001|Overall Study|Unrelated illness|0
4452300|NCT00526071|7238874|FG000|Overall Study|Adverse Event|1
4452301|NCT00526071|7238874|FG000|Overall Study|Withdrawal by Subject|1
4452302|NCT00526071|7238874|FG000|Overall Study|Lack of Response to Study Drug|4
4452303|NCT00526097|7238884|FG000|Overall Study|Adverse Event|6
4452304|NCT00526097|7238885|FG001|Overall Study|Adverse Event|44
4452305|NCT00526097|7238884|FG000|Overall Study|Protocol Violation|4
4452306|NCT00526097|7238885|FG001|Overall Study|Protocol Violation|10
4452307|NCT00526097|7238884|FG000|Overall Study|Withdrawal by Subject|3
4452308|NCT00526097|7238885|FG001|Overall Study|Withdrawal by Subject|1
4447756|NCT00492063|7232998|FG000|Overall Study|Death|0
4447757|NCT00492063|7232999|FG001|Overall Study|Death|0
4447758|NCT00492063|7233000|FG002|Overall Study|Death|1
4447759|NCT00492063|7233001|FG003|Overall Study|Death|2
4447760|NCT00492063|7232998|FG000|Overall Study|Withdrawal by Subject|4
4447761|NCT00492063|7232999|FG001|Overall Study|Withdrawal by Subject|3
4447762|NCT00492063|7233000|FG002|Overall Study|Withdrawal by Subject|5
4452309|NCT00526097|7238884|FG000|Overall Study|Other|2
4452310|NCT00526097|7238885|FG001|Overall Study|Other|1
4452311|NCT00526110|7238893|FG000|Overall Study|Adverse Event|2
4452312|NCT00526110|7238894|FG001|Overall Study|Adverse Event|9
4452313|NCT00526110|7238893|FG000|Overall Study|Disease Progression|0
4452314|NCT00526110|7238894|FG001|Overall Study|Disease Progression|19
4452315|NCT00526110|7238893|FG000|Overall Study|Maximal Response|0
4452316|NCT00526110|7238894|FG001|Overall Study|Maximal Response|6
4452317|NCT00526110|7238893|FG000|Overall Study|Withdrawal by Subject|0
4452318|NCT00526110|7238894|FG001|Overall Study|Withdrawal by Subject|2
4452319|NCT00526110|7238893|FG000|Overall Study|Poor Tolerance|0
4452320|NCT00526110|7238894|FG001|Overall Study|Poor Tolerance|5
4452321|NCT00526162|7238909|FG000|Overall Study|Device not implanted|3
4452322|NCT00526630|7238945|FG000|First Intervention Period - 12 Weeks|Withdrawn|0
4452323|NCT00526630|7238946|FG001|First Intervention Period - 12 Weeks|Withdrawn|3
4452324|NCT00526630|7238945|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2
4452325|NCT00526630|7238946|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1
4452326|NCT00526656|7238954|FG000|Overall Study|Death|1
4452327|NCT00526656|7238954|FG000|Overall Study|Refused surgery|1
4452328|NCT00526669|7238959|FG000|Combined Treatment Phase|Lost to Follow-up|0
4452329|NCT00526669|7238960|FG001|Combined Treatment Phase|Lost to Follow-up|2
4452330|NCT00526669|7238959|FG000|Combined Treatment Phase|Withdrawal by Subject|0
4452331|NCT00526669|7238960|FG001|Combined Treatment Phase|Withdrawal by Subject|2
4452332|NCT00526669|7238959|FG000|Combined Treatment Phase|Sponsor Terminated Study|0
4452333|NCT00526669|7238960|FG001|Combined Treatment Phase|Sponsor Terminated Study|2
4452334|NCT00526669|7238959|FG000|Combined Treatment Phase|Death|0
4452335|NCT00526669|7238960|FG001|Combined Treatment Phase|Death|2
4452336|NCT00526799|7238968|FG000|Overall Study|Withdrawal by Subject|1
4452337|NCT00526799|7238969|FG001|Overall Study|Withdrawal by Subject|0
4452338|NCT00526799|7238968|FG000|Overall Study|Intercurrent Complicating Disease|0
4452339|NCT00526799|7238969|FG001|Overall Study|Intercurrent Complicating Disease|1
4452340|NCT00526890|7238975|FG000|Overall Study|Adverse Event|2
4452341|NCT00526994|7238982|FG000|Overall Study|Lost to Follow-up|98
4452342|NCT00526994|7238983|FG001|Overall Study|Lost to Follow-up|108
4452343|NCT00526994|7238984|FG002|Overall Study|Lost to Follow-up|96
4452344|NCT00526994|7238982|FG000|Overall Study|Death|4
4452345|NCT00526994|7238983|FG001|Overall Study|Death|3
4452346|NCT00526994|7238984|FG002|Overall Study|Death|3
4452347|NCT00526994|7238982|FG000|Overall Study|Withdrawal by Subject|2
4447763|NCT00492063|7233001|FG003|Overall Study|Withdrawal by Subject|4
4447764|NCT00492063|7232998|FG000|Overall Study|Lost to Follow-up|6
4447765|NCT00492063|7232999|FG001|Overall Study|Lost to Follow-up|11
4447766|NCT00492063|7233000|FG002|Overall Study|Lost to Follow-up|5
4447767|NCT00492063|7233001|FG003|Overall Study|Lost to Follow-up|3
4447768|NCT00492063|7232998|FG000|Overall Study|Protocol Violation|0
4447769|NCT00492063|7232999|FG001|Overall Study|Protocol Violation|0
4447770|NCT00492063|7233000|FG002|Overall Study|Protocol Violation|0
4447771|NCT00492063|7233001|FG003|Overall Study|Protocol Violation|1
4447772|NCT00492115|7233022|FG000|Overall Study|Withdrawal by Subject|3
4447773|NCT00492115|7233023|FG001|Overall Study|Withdrawal by Subject|4
4447774|NCT00492232|7233037|FG000|Placebo Run-in|Adverse Event|0
4447775|NCT00492232|7233038|FG001|Placebo Run-in|Adverse Event|2
4447776|NCT00492232|7233037|FG000|Placebo Run-in|Protocol Violation|0
4447777|NCT00492232|7233038|FG001|Placebo Run-in|Protocol Violation|3
4447778|NCT00492232|7233037|FG000|Placebo Run-in|Lost to Follow-up|0
4447779|NCT00492232|7233038|FG001|Placebo Run-in|Lost to Follow-up|3
4447780|NCT00492232|7233037|FG000|Placebo Run-in|Withdrawal by Subject|0
4447781|NCT00492232|7233038|FG001|Placebo Run-in|Withdrawal by Subject|8
4537088|NCT01107626|7357706|FG003|Step 1: Induction Therapy|Hospice care|0
4537089|NCT01107626|7357703|FG000|Step 1: Induction Therapy|Physician Decision|1
4537090|NCT01107626|7357704|FG001|Step 1: Induction Therapy|Physician Decision|0
4537091|NCT01107626|7357705|FG002|Step 1: Induction Therapy|Physician Decision|0
4537092|NCT01107626|7357706|FG003|Step 1: Induction Therapy|Physician Decision|0
4537093|NCT01107626|7357703|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50
4537094|NCT01107626|7357704|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0
4537095|NCT01107626|7357705|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0
4537096|NCT01107626|7357706|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0
4537097|NCT01107626|7357703|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0
4537098|NCT01107626|7357704|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217
4537099|NCT01107626|7357705|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217
4537100|NCT01107626|7357706|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170
4537101|NCT01107626|7357703|FG000|Step 2: Maintenance Therapy|Adverse Event|0
4537102|NCT01107626|7357704|FG001|Step 2: Maintenance Therapy|Adverse Event|32
4537103|NCT01107626|7357705|FG002|Step 2: Maintenance Therapy|Adverse Event|29
4610697|NCT01695239|7466963|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31
4610698|NCT01695239|7466964|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0
4610699|NCT01695239|7466965|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0
4610700|NCT01695239|7466966|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0
4610701|NCT01695239|7466967|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0
4610702|NCT01695239|7466954|FG000|Extension Long-Term Extension Periods|Adverse Event|0
4610703|NCT01695239|7466955|FG001|Extension Long-Term Extension Periods|Adverse Event|0
4610704|NCT01695239|7466956|FG002|Extension Long-Term Extension Periods|Adverse Event|0
4537104|NCT01107626|7357706|FG003|Step 2: Maintenance Therapy|Adverse Event|46
4537105|NCT01107626|7357703|FG000|Step 2: Maintenance Therapy|Death|0
4447782|NCT00492232|7233037|FG000|Placebo Run-in|Pregnancy|0
4447783|NCT00492232|7233038|FG001|Placebo Run-in|Pregnancy|1
4447784|NCT00492232|7233037|FG000|Placebo Run-in|Entrance criteria not met|0
4447785|NCT00492232|7233038|FG001|Placebo Run-in|Entrance criteria not met|45
4447786|NCT00492232|7233037|FG000|Placebo Run-in|Other|0
4447787|NCT00492232|7233038|FG001|Placebo Run-in|Other|6
4447788|NCT00492232|7233037|FG000|Placebo Run-in|Missing|0
4447789|NCT00492232|7233038|FG001|Placebo Run-in|Missing|2
4447790|NCT00492232|7233037|FG000|Double-Blind Treatment|Adverse Event|1
4447791|NCT00492232|7233038|FG001|Double-Blind Treatment|Adverse Event|2
4447792|NCT00492232|7233037|FG000|Double-Blind Treatment|Protocol Violation|3
4447793|NCT00492232|7233038|FG001|Double-Blind Treatment|Protocol Violation|7
4447794|NCT00492232|7233037|FG000|Double-Blind Treatment|Lost to Follow-up|2
4447795|NCT00492232|7233038|FG001|Double-Blind Treatment|Lost to Follow-up|3
4447796|NCT00492232|7233037|FG000|Double-Blind Treatment|Withdrawal by Subject|4
4537106|NCT01107626|7357704|FG001|Step 2: Maintenance Therapy|Death|8
4537107|NCT01107626|7357705|FG002|Step 2: Maintenance Therapy|Death|2
4537108|NCT01107626|7357706|FG003|Step 2: Maintenance Therapy|Death|13
4537109|NCT01107626|7357703|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0
4537110|NCT01107626|7357704|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11
4537111|NCT01107626|7357705|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21
4537112|NCT01107626|7357706|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27
4537113|NCT01107626|7357703|FG000|Step 2: Maintenance Therapy|Alternative therapy|0
4447797|NCT00492232|7233038|FG001|Double-Blind Treatment|Withdrawal by Subject|8
4447798|NCT00492232|7233037|FG000|Double-Blind Treatment|Lack of Efficacy|1
4447799|NCT00492232|7233038|FG001|Double-Blind Treatment|Lack of Efficacy|0
4447800|NCT00492232|7233037|FG000|Double-Blind Treatment|Other|6
4447801|NCT00492232|7233038|FG001|Double-Blind Treatment|Other|5
4447802|NCT00492232|7233037|FG000|Double-Blind Treatment|Randomized not treated|1
4447803|NCT00492232|7233038|FG001|Double-Blind Treatment|Randomized not treated|0
4447804|NCT00492232|7233037|FG000|Open-Label Treatment|Withdrawal by Subject|1
4447805|NCT00492232|7233038|FG001|Open-Label Treatment|Withdrawal by Subject|0
4537114|NCT01107626|7357704|FG001|Step 2: Maintenance Therapy|Alternative therapy|2
4537115|NCT01107626|7357705|FG002|Step 2: Maintenance Therapy|Alternative therapy|4
4447806|NCT00492284|7233048|FG000|Overall Study|Adverse Event|0
4447807|NCT00492284|7233049|FG001|Overall Study|Adverse Event|1
4447808|NCT00492284|7233050|FG002|Overall Study|Adverse Event|1
4447809|NCT00492284|7233051|FG003|Overall Study|Adverse Event|2
4447810|NCT00492284|7233048|FG000|Overall Study|Lost to Follow-up|0
4447811|NCT00492284|7233049|FG001|Overall Study|Lost to Follow-up|0
4447812|NCT00492284|7233050|FG002|Overall Study|Lost to Follow-up|3
4447813|NCT00492284|7233051|FG003|Overall Study|Lost to Follow-up|1
4447814|NCT00492284|7233048|FG000|Overall Study|Death|0
4447815|NCT00492284|7233049|FG001|Overall Study|Death|3
4447816|NCT00492284|7233050|FG002|Overall Study|Death|2
4447817|NCT00492284|7233051|FG003|Overall Study|Death|5
4447818|NCT00492284|7233048|FG000|Overall Study|Withdrawal by Subject|1
4537116|NCT01107626|7357706|FG003|Step 2: Maintenance Therapy|Alternative therapy|5
4537117|NCT01107626|7357703|FG000|Step 2: Maintenance Therapy|Other complicating disease|0
4537118|NCT01107626|7357704|FG001|Step 2: Maintenance Therapy|Other complicating disease|2
4447819|NCT00492284|7233049|FG001|Overall Study|Withdrawal by Subject|0
4447820|NCT00492284|7233050|FG002|Overall Study|Withdrawal by Subject|0
4447821|NCT00492284|7233051|FG003|Overall Study|Withdrawal by Subject|2
4447822|NCT00492297|7233061|FG000|Treatment|Death|2
4447823|NCT00492297|7233061|FG000|Treatment|Study terminated by sponsor|3
4537119|NCT01107626|7357705|FG002|Step 2: Maintenance Therapy|Other complicating disease|5
4610705|NCT01695239|7466957|FG003|Extension Long-Term Extension Periods|Adverse Event|0
4610706|NCT01695239|7466958|FG004|Extension Long-Term Extension Periods|Adverse Event|0
4610707|NCT01695239|7466959|FG005|Extension Long-Term Extension Periods|Adverse Event|0
4447824|NCT00492297|7233061|FG000|Active Follow-up 30(+4) Days Duration|Death|17
4447825|NCT00492297|7233061|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2
4447826|NCT00492297|7233061|FG000|Survival Only Follow-up|Death|46
4447827|NCT00492297|7233061|FG000|Survival Only Follow-up|Lack of Efficacy|1
4447828|NCT00492297|7233061|FG000|Survival Only Follow-up|Study terminated by sponsor|12
4447829|NCT00492531|7233082|FG000|Overall Study|Withdrawn(More than one reason selected)|22
4447830|NCT00492531|7233083|FG001|Overall Study|Withdrawn(More than one reason selected)|23
4447831|NCT00492557|7233095|FG000|Overall Study|Subject request|12
4447832|NCT00492557|7233096|FG001|Overall Study|Subject request|11
4447833|NCT00492557|7233095|FG000|Overall Study|Protocol Violation|7
4447834|NCT00492557|7233096|FG001|Overall Study|Protocol Violation|8
4447835|NCT00492557|7233095|FG000|Overall Study|Other|2
4447836|NCT00492557|7233096|FG001|Overall Study|Other|2
4447837|NCT00492557|7233095|FG000|Overall Study|Death|1
4447838|NCT00492557|7233096|FG001|Overall Study|Death|1
4447839|NCT00492557|7233095|FG000|Overall Study|Adverse Event|1
4447840|NCT00492557|7233096|FG001|Overall Study|Adverse Event|0
4447841|NCT00492557|7233095|FG000|Overall Study|Failed to return|1
4447842|NCT00492557|7233096|FG001|Overall Study|Failed to return|0
4447843|NCT00492557|7233095|FG000|Overall Study|Lost to Follow-up|0
4447844|NCT00492557|7233096|FG001|Overall Study|Lost to Follow-up|1
4447845|NCT00492648|7233124|FG000|Month 30 (109671 Study)|Protocol Violation|0
4447846|NCT00492648|7233125|FG001|Month 30 (109671 Study)|Protocol Violation|1
4447847|NCT00492726|7233133|FG000|Overall Study|Adverse Event|10
4447848|NCT00492726|7233134|FG001|Overall Study|Adverse Event|6
4447849|NCT00492726|7233133|FG000|Overall Study|Death|7
4447850|NCT00492726|7233134|FG001|Overall Study|Death|2
4447851|NCT00492726|7233133|FG000|Overall Study|Lack of Efficacy|0
4447852|NCT00492726|7233134|FG001|Overall Study|Lack of Efficacy|2
4447853|NCT00492726|7233133|FG000|Overall Study|Lost to Follow-up|27
4447854|NCT00492726|7233134|FG001|Overall Study|Lost to Follow-up|19
4447855|NCT00492726|7233133|FG000|Overall Study|Physician Decision|0
4447856|NCT00492726|7233134|FG001|Overall Study|Physician Decision|1
4447857|NCT00492726|7233133|FG000|Overall Study|Withdrawal by Subject|6
4447858|NCT00492726|7233134|FG001|Overall Study|Withdrawal by Subject|3
4447859|NCT00492726|7233133|FG000|Overall Study|Non compliant with study medication|0
4447860|NCT00492726|7233134|FG001|Overall Study|Non compliant with study medication|3
4447861|NCT00492752|7233142|FG000|Double Blind Treatment|Death|13
4537120|NCT01107626|7357706|FG003|Step 2: Maintenance Therapy|Other complicating disease|9
4537121|NCT01107626|7357703|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0
4537122|NCT01107626|7357704|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2
4537123|NCT01107626|7357705|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4
4447862|NCT00492752|7233143|FG001|Double Blind Treatment|Death|0
4447863|NCT00492752|7233144|FG002|Double Blind Treatment|Death|2
4447864|NCT00492752|7233145|FG003|Double Blind Treatment|Death|0
4447865|NCT00492752|7233142|FG000|Double Blind Treatment|Adverse Event|1
4447866|NCT00492752|7233143|FG001|Double Blind Treatment|Adverse Event|0
4537124|NCT01107626|7357706|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3
4537125|NCT01107626|7357703|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0
4537126|NCT01107626|7357704|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2
4537127|NCT01107626|7357705|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2
4610708|NCT01695239|7466960|FG006|Extension Long-Term Extension Periods|Adverse Event|0
4610709|NCT01695239|7466961|FG007|Extension Long-Term Extension Periods|Adverse Event|0
4610710|NCT01695239|7466962|FG008|Extension Long-Term Extension Periods|Adverse Event|15
4610711|NCT01695239|7466963|FG009|Extension Long-Term Extension Periods|Adverse Event|21
4610712|NCT01695239|7466964|FG010|Extension Long-Term Extension Periods|Adverse Event|0
4610713|NCT01695239|7466965|FG011|Extension Long-Term Extension Periods|Adverse Event|0
4610714|NCT01695239|7466966|FG012|Extension Long-Term Extension Periods|Adverse Event|0
4610715|NCT01695239|7466967|FG013|Extension Long-Term Extension Periods|Adverse Event|0
4610716|NCT01695239|7466954|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0
4610717|NCT01695239|7466955|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0
4610718|NCT01695239|7466956|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0
4610719|NCT01695239|7466957|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0
4610720|NCT01695239|7466958|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0
4610721|NCT01695239|7466959|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0
4610722|NCT01695239|7466960|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0
4610723|NCT01695239|7466961|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0
4610724|NCT01695239|7466962|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6
4610725|NCT01695239|7466963|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7
4610726|NCT01695239|7466964|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0
4610727|NCT01695239|7466965|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0
4610728|NCT01695239|7466966|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0
4610729|NCT01695239|7466967|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0
4610730|NCT01695239|7466954|FG000|Extension Long-Term Extension Periods|Physician Decision|0
4610731|NCT01695239|7466955|FG001|Extension Long-Term Extension Periods|Physician Decision|0
4610732|NCT01695239|7466956|FG002|Extension Long-Term Extension Periods|Physician Decision|0
4610733|NCT01695239|7466957|FG003|Extension Long-Term Extension Periods|Physician Decision|0
4610734|NCT01695239|7466958|FG004|Extension Long-Term Extension Periods|Physician Decision|0
4610735|NCT01695239|7466959|FG005|Extension Long-Term Extension Periods|Physician Decision|0
4610736|NCT01695239|7466960|FG006|Extension Long-Term Extension Periods|Physician Decision|0
4610737|NCT01695239|7466961|FG007|Extension Long-Term Extension Periods|Physician Decision|0
4610738|NCT01695239|7466962|FG008|Extension Long-Term Extension Periods|Physician Decision|3
4610739|NCT01695239|7466963|FG009|Extension Long-Term Extension Periods|Physician Decision|0
4610740|NCT01695239|7466964|FG010|Extension Long-Term Extension Periods|Physician Decision|0
4610741|NCT01695239|7466965|FG011|Extension Long-Term Extension Periods|Physician Decision|0
4610742|NCT01695239|7466966|FG012|Extension Long-Term Extension Periods|Physician Decision|0
4610743|NCT01695239|7466967|FG013|Extension Long-Term Extension Periods|Physician Decision|0
4610744|NCT01695239|7466954|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0
4610745|NCT01695239|7466955|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0
4610746|NCT01695239|7466956|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0
4610747|NCT01695239|7466957|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0
4610748|NCT01695239|7466958|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0
4610749|NCT01695239|7466959|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0
4610750|NCT01695239|7466960|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0
4610751|NCT01695239|7466961|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0
4537128|NCT01107626|7357706|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3
4770371|NCT03740919|7746731|FG001|Lead-in Period|Protocol Violation|0
4770372|NCT03740919|7746732|FG002|Lead-in Period|Protocol Violation|0
4770373|NCT03740919|7746733|FG003|Lead-in Period|Protocol Violation|0
4537129|NCT01107626|7357703|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0
4537130|NCT01107626|7357704|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1
4537131|NCT01107626|7357705|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1
4770374|NCT03740919|7746730|FG000|Lead-in Period|Withdrawal by Subject|10
4537132|NCT01107626|7357706|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0
4447867|NCT00492752|7233144|FG002|Double Blind Treatment|Adverse Event|0
4447868|NCT00492752|7233145|FG003|Double Blind Treatment|Adverse Event|0
4447869|NCT00492752|7233142|FG000|Double Blind Treatment|Protocol Violation|0
4447870|NCT00492752|7233143|FG001|Double Blind Treatment|Protocol Violation|0
4447871|NCT00492752|7233144|FG002|Double Blind Treatment|Protocol Violation|1
4447872|NCT00492752|7233145|FG003|Double Blind Treatment|Protocol Violation|0
4447873|NCT00492752|7233142|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0
4447874|NCT00492752|7233143|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2
4447875|NCT00492752|7233144|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0
4447876|NCT00492752|7233145|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2
4447877|NCT00492752|7233142|FG000|Follow-up and/or Open Label Sorafenib|Death|75
4447878|NCT00492752|7233143|FG001|Follow-up and/or Open Label Sorafenib|Death|5
4447879|NCT00492752|7233144|FG002|Follow-up and/or Open Label Sorafenib|Death|45
4447880|NCT00492752|7233145|FG003|Follow-up and/or Open Label Sorafenib|Death|1
4537133|NCT01107626|7357703|FG000|Step 2: Maintenance Therapy|Financial reason|0
4537134|NCT01107626|7357704|FG001|Step 2: Maintenance Therapy|Financial reason|2
4537135|NCT01107626|7357705|FG002|Step 2: Maintenance Therapy|Financial reason|0
4537136|NCT01107626|7357706|FG003|Step 2: Maintenance Therapy|Financial reason|0
4537137|NCT01107626|7357703|FG000|Step 2: Maintenance Therapy|Physician Decision|0
4537138|NCT01107626|7357704|FG001|Step 2: Maintenance Therapy|Physician Decision|2
4537139|NCT01107626|7357705|FG002|Step 2: Maintenance Therapy|Physician Decision|3
4537140|NCT01107626|7357706|FG003|Step 2: Maintenance Therapy|Physician Decision|3
4537141|NCT01107626|7357703|FG000|Step 2: Maintenance Therapy|Hospice care|0
4537142|NCT01107626|7357704|FG001|Step 2: Maintenance Therapy|Hospice care|1
4537143|NCT01107626|7357705|FG002|Step 2: Maintenance Therapy|Hospice care|2
4537144|NCT01107626|7357706|FG003|Step 2: Maintenance Therapy|Hospice care|0
4537145|NCT01107626|7357703|FG000|Step 2: Maintenance Therapy|Non-compliance|0
4537146|NCT01107626|7357704|FG001|Step 2: Maintenance Therapy|Non-compliance|0
4447881|NCT00492752|7233142|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8
4447882|NCT00492752|7233143|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1
4447883|NCT00492752|7233144|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2
4447884|NCT00492752|7233145|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0
4452348|NCT00526994|7238983|FG001|Overall Study|Withdrawal by Subject|7
4770375|NCT03740919|7746731|FG001|Lead-in Period|Withdrawal by Subject|0
4452349|NCT00526994|7238984|FG002|Overall Study|Withdrawal by Subject|5
4452350|NCT00526994|7238982|FG000|Overall Study|incarcerated, impaired, incomplete|4
4452351|NCT00526994|7238983|FG001|Overall Study|incarcerated, impaired, incomplete|3
4452352|NCT00526994|7238984|FG002|Overall Study|incarcerated, impaired, incomplete|3
4452353|NCT00527072|7238992|FG000|Overall Study|Adverse Event|13
4452354|NCT00527072|7238992|FG000|Overall Study|Lack of Efficacy|11
4452355|NCT00527072|7238992|FG000|Overall Study|Lost to Follow-up|3
4452356|NCT00527072|7238992|FG000|Overall Study|Protocol Violation|2
4452357|NCT00527072|7238992|FG000|Overall Study|Withdrawal by Subject|7
4452358|NCT00527111|7239007|FG000|Overall Study|Adverse Event|14
4452359|NCT00527111|7239008|FG001|Overall Study|Adverse Event|13
4452360|NCT00527111|7239007|FG000|Overall Study|Death|0
4452361|NCT00527111|7239008|FG001|Overall Study|Death|1
4452362|NCT00527111|7239007|FG000|Overall Study|Investigator Request|2
4452363|NCT00527111|7239008|FG001|Overall Study|Investigator Request|1
4452364|NCT00527111|7239007|FG000|Overall Study|Patient Request|2
4452365|NCT00527111|7239008|FG001|Overall Study|Patient Request|5
4452366|NCT00527111|7239007|FG000|Overall Study|Other|2
4452367|NCT00527111|7239008|FG001|Overall Study|Other|2
4452368|NCT00527319|7239026|FG000|Overall Study|Withdrawal by Subject|5
4452369|NCT00527319|7239027|FG001|Overall Study|Withdrawal by Subject|0
4452370|NCT00527319|7239028|FG002|Overall Study|Withdrawal by Subject|1
4452371|NCT00527319|7239026|FG000|Overall Study|Lost to Follow-up|1
4452372|NCT00527319|7239027|FG001|Overall Study|Lost to Follow-up|0
4537147|NCT01107626|7357705|FG002|Step 2: Maintenance Therapy|Non-compliance|0
4537148|NCT01107626|7357706|FG003|Step 2: Maintenance Therapy|Non-compliance|2
4537149|NCT01107626|7357703|FG000|Step 2: Maintenance Therapy|Pain|0
4537150|NCT01107626|7357704|FG001|Step 2: Maintenance Therapy|Pain|0
4537151|NCT01107626|7357705|FG002|Step 2: Maintenance Therapy|Pain|0
4537152|NCT01107626|7357706|FG003|Step 2: Maintenance Therapy|Pain|1
4537153|NCT01107626|7357703|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0
4537154|NCT01107626|7357704|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4
4537155|NCT01107626|7357705|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4
4537156|NCT01107626|7357706|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10
4610752|NCT01695239|7466962|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2
4447885|NCT00492752|7233142|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2
4447886|NCT00492752|7233143|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1
4447887|NCT00492752|7233144|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0
4447888|NCT00492752|7233145|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0
4447889|NCT00492752|7233142|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0
4452373|NCT00527319|7239028|FG002|Overall Study|Lost to Follow-up|0
4452374|NCT00527319|7239026|FG000|Overall Study|Death|0
4452375|NCT00527319|7239027|FG001|Overall Study|Death|3
4452376|NCT00527319|7239028|FG002|Overall Study|Death|1
4452377|NCT00527319|7239026|FG000|Overall Study|Intercurrent Medical Illness|0
4452378|NCT00527319|7239027|FG001|Overall Study|Intercurrent Medical Illness|1
4452379|NCT00527319|7239028|FG002|Overall Study|Intercurrent Medical Illness|3
4452380|NCT00527319|7239026|FG000|Overall Study|Adverse Event|0
4452381|NCT00527319|7239027|FG001|Overall Study|Adverse Event|0
4452382|NCT00527319|7239028|FG002|Overall Study|Adverse Event|1
4452383|NCT00527332|7239038|FG000|Overall Study|Protocol Violation|4
4452384|NCT00527332|7239039|FG001|Overall Study|Protocol Violation|8
4452385|NCT00527332|7239038|FG000|Overall Study|Withdrew consent|5
4452386|NCT00527332|7239039|FG001|Overall Study|Withdrew consent|1
4452387|NCT00527397|7239045|FG000|Overall Study|Adverse Event|3
4452388|NCT00527397|7239045|FG000|Overall Study|Lack of Efficacy|1
4452389|NCT00527397|7239045|FG000|Overall Study|Protocol Violation|1
4452390|NCT00527397|7239045|FG000|Overall Study|Withdrawal by Subject|6
4452391|NCT00527397|7239045|FG000|Overall Study|Study terminated by sponsor|13
4452392|NCT00527423|7239052|FG000|Overall Study|Protocol Violation|1
4452393|NCT00527423|7239052|FG000|Overall Study|Adverse Event|5
4452394|NCT00527423|7239052|FG000|Overall Study|Physician Decision|4
4452395|NCT00527423|7239052|FG000|Overall Study|Withdrawal by Subject|10
4452396|NCT00527423|7239052|FG000|Overall Study|Lost to Follow-up|4
4452397|NCT00527423|7239052|FG000|Overall Study|OTHER|4
4452398|NCT00527423|7239052|FG000|Overall Study|Death|9
4452399|NCT00527488|7239071|FG000|Overall Study|Withdrawn prior to dosing|0
4452400|NCT00527488|7239072|FG001|Overall Study|Withdrawn prior to dosing|1
4452401|NCT00527488|7239073|FG002|Overall Study|Withdrawn prior to dosing|1
4452402|NCT00527488|7239074|FG003|Overall Study|Withdrawn prior to dosing|0
4452403|NCT00527514|7239084|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1
4452404|NCT00527514|7239084|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2
4452405|NCT00527514|7239084|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1
4452406|NCT00527514|7239084|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1
4452407|NCT00527514|7239084|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1
4452408|NCT00527514|7239084|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1
4452409|NCT00527514|7239084|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1
4452410|NCT00527605|7239109|FG000|Overall Study|Adverse Event|3
4452411|NCT00527605|7239110|FG001|Overall Study|Adverse Event|0
4452412|NCT00527605|7239109|FG000|Overall Study|Withdrawal by Subject|3
4452413|NCT00527605|7239110|FG001|Overall Study|Withdrawal by Subject|7
4452414|NCT00527605|7239109|FG000|Overall Study|Lost to Follow-up|6
4452415|NCT00527605|7239110|FG001|Overall Study|Lost to Follow-up|2
4452416|NCT00527605|7239109|FG000|Overall Study|Protocol Violation|1
4452417|NCT00527605|7239110|FG001|Overall Study|Protocol Violation|2
4452418|NCT00527618|7239116|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3
4452419|NCT00527618|7239117|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1
4452420|NCT00527618|7239116|FG000|Week 1-12 (First Intervention)|Adverse Event|0
4452421|NCT00527618|7239117|FG001|Week 1-12 (First Intervention)|Adverse Event|1
4452422|NCT00527618|7239116|FG000|Week 13-14 (Washout)|Lost to Follow-up|1
4452423|NCT00527618|7239117|FG001|Week 13-14 (Washout)|Lost to Follow-up|0
4452424|NCT00527618|7239116|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0
4452425|NCT00527618|7239117|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1
4452426|NCT00527618|7239116|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0
4452427|NCT00527618|7239117|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1
4452428|NCT00527618|7239116|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0
4452429|NCT00527618|7239117|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1
4447890|NCT00492752|7233143|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1
4447891|NCT00492752|7233144|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0
4447892|NCT00492752|7233145|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2
4447893|NCT00492752|7233142|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
4447894|NCT00492752|7233143|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
4447895|NCT00492752|7233144|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
4447896|NCT00492752|7233145|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1
4447897|NCT00492752|7233142|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
4447898|NCT00492752|7233143|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6
4447899|NCT00492752|7233144|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
4447900|NCT00492752|7233145|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
4447901|NCT00492752|7233142|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1
4452430|NCT00527735|7239140|FG000|Overall Study|Disease progression|47
4452431|NCT00527735|7239141|FG001|Overall Study|Disease progression|61
4452432|NCT00527735|7239142|FG002|Overall Study|Disease progression|53
4452433|NCT00527735|7239140|FG000|Overall Study|Death|23
4452434|NCT00527735|7239141|FG001|Overall Study|Death|13
4452435|NCT00527735|7239142|FG002|Overall Study|Death|15
4452436|NCT00527735|7239140|FG000|Overall Study|Completed treatment in treatment phase|14
4452437|NCT00527735|7239141|FG001|Overall Study|Completed treatment in treatment phase|13
4452438|NCT00527735|7239142|FG002|Overall Study|Completed treatment in treatment phase|18
4452439|NCT00527735|7239140|FG000|Overall Study|Adverse Event|10
4452440|NCT00527735|7239141|FG001|Overall Study|Adverse Event|6
4452441|NCT00527735|7239142|FG002|Overall Study|Adverse Event|7
4452442|NCT00527735|7239140|FG000|Overall Study|Not identified|5
4452443|NCT00527735|7239141|FG001|Overall Study|Not identified|5
4452444|NCT00527735|7239142|FG002|Overall Study|Not identified|5
4452445|NCT00527735|7239140|FG000|Overall Study|Withdrawal by Subject|5
4452446|NCT00527735|7239141|FG001|Overall Study|Withdrawal by Subject|4
4452447|NCT00527735|7239142|FG002|Overall Study|Withdrawal by Subject|3
4452448|NCT00527735|7239140|FG000|Overall Study|No longer met study criteria|2
4452449|NCT00527735|7239141|FG001|Overall Study|No longer met study criteria|2
4452450|NCT00527735|7239142|FG002|Overall Study|No longer met study criteria|1
4452451|NCT00527735|7239140|FG000|Overall Study|Lost to Follow-up|0
4452452|NCT00527735|7239141|FG001|Overall Study|Lost to Follow-up|0
4452453|NCT00527735|7239142|FG002|Overall Study|Lost to Follow-up|3
4452454|NCT00527735|7239140|FG000|Overall Study|Poor compliance or noncompliance|0
4452455|NCT00527735|7239141|FG001|Overall Study|Poor compliance or noncompliance|1
4452456|NCT00527735|7239142|FG002|Overall Study|Poor compliance or noncompliance|1
4452457|NCT00527735|7239140|FG000|Overall Study|Completed treatment during maintenance|2
4452458|NCT00527735|7239141|FG001|Overall Study|Completed treatment during maintenance|2
4452459|NCT00527735|7239142|FG002|Overall Study|Completed treatment during maintenance|1
4452460|NCT00527787|7239164|FG000|Overall Study|Adverse Event|14
4452461|NCT00527787|7239165|FG001|Overall Study|Adverse Event|24
4452462|NCT00527787|7239164|FG000|Overall Study|Withdrawal by Subject|13
4452463|NCT00527787|7239165|FG001|Overall Study|Withdrawal by Subject|25
4452464|NCT00527787|7239164|FG000|Overall Study|Lost to Follow-up|5
4452465|NCT00527787|7239165|FG001|Overall Study|Lost to Follow-up|2
4452466|NCT00527787|7239164|FG000|Overall Study|Duodenal Ulcer|1
4537157|NCT01107743|7357734|FG000|Overall Study|Protocol Violation|46
4537158|NCT01107886|7357794|FG000|Overall Study|Lost to Follow-up|15
4537159|NCT01107886|7357795|FG001|Overall Study|Lost to Follow-up|13
4537160|NCT01107886|7357794|FG000|Overall Study|Withdrawal by Subject|180
4537161|NCT01107886|7357795|FG001|Overall Study|Withdrawal by Subject|196
4537162|NCT01107886|7357794|FG000|Overall Study|Administrative withdrawal of consent|7
4537163|NCT01107886|7357795|FG001|Overall Study|Administrative withdrawal of consent|5
4537164|NCT01107899|7357804|FG000|Overall Study|Physician Decision|5
4452467|NCT00527787|7239165|FG001|Overall Study|Duodenal Ulcer|10
4452468|NCT00527787|7239164|FG000|Overall Study|misc|5
4452469|NCT00527787|7239165|FG001|Overall Study|misc|2
4452470|NCT00527826|7239173|FG000|Overall Study|Adverse Event|10
4452471|NCT00527826|7239174|FG001|Overall Study|Adverse Event|10
4452472|NCT00527826|7239173|FG000|Overall Study|Lost to Follow-up|3
4452473|NCT00527826|7239174|FG001|Overall Study|Lost to Follow-up|2
4452474|NCT00527826|7239173|FG000|Overall Study|Withdrawal by Subject|5
4452475|NCT00527826|7239174|FG001|Overall Study|Withdrawal by Subject|8
4452476|NCT00527826|7239173|FG000|Overall Study|Inclusion Criteria Not Met|3
4537165|NCT01107899|7357805|FG001|Overall Study|Physician Decision|0
4452477|NCT00527826|7239174|FG001|Overall Study|Inclusion Criteria Not Met|3
4452478|NCT00527826|7239173|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0
4452479|NCT00527826|7239174|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1
4452480|NCT00527826|7239173|FG000|Overall Study|Additional Intake of Viani forte|0
4452481|NCT00527826|7239174|FG001|Overall Study|Additional Intake of Viani forte|1
4452482|NCT00527826|7239173|FG000|Overall Study|Participant moved away|0
4452483|NCT00527826|7239174|FG001|Overall Study|Participant moved away|1
4452484|NCT00527904|7239190|FG000|Overall Study|Adverse Event|45
4452485|NCT00527904|7239190|FG000|Overall Study|Withdrawal by Subject|21
4452486|NCT00527904|7239190|FG000|Overall Study|Lost to Follow-up|8
4452487|NCT00527904|7239190|FG000|Overall Study|misc|22
4452488|NCT00528021|7239207|FG000|Overall Study|Lack of Efficacy|17
4537166|NCT01107899|7357806|FG002|Overall Study|Physician Decision|3
4452489|NCT00528021|7239208|FG001|Overall Study|Lack of Efficacy|13
4452490|NCT00528021|7239209|FG002|Overall Study|Lack of Efficacy|7
4452491|NCT00528021|7239210|FG003|Overall Study|Lack of Efficacy|9
4452492|NCT00528112|7239222|FG000|Treatment up to 3 Years|Adverse Event|313
4452493|NCT00528112|7239223|FG001|Treatment up to 3 Years|Adverse Event|278
4452494|NCT00528112|7239222|FG000|Treatment up to 3 Years|Withdrawal by Subject|26
4452495|NCT00528112|7239223|FG001|Treatment up to 3 Years|Withdrawal by Subject|31
4452496|NCT00528112|7239222|FG000|Treatment up to 3 Years|Protocol Violation|16
4452497|NCT00528112|7239223|FG001|Treatment up to 3 Years|Protocol Violation|16
4452498|NCT00528112|7239222|FG000|Treatment up to 3 Years|Death|0
4452499|NCT00528112|7239223|FG001|Treatment up to 3 Years|Death|1
4452500|NCT00528112|7239222|FG000|Treatment up to 3 Years|Lost to Follow-up|63
4452501|NCT00528112|7239223|FG001|Treatment up to 3 Years|Lost to Follow-up|61
4452502|NCT00528112|7239222|FG000|Treatment up to 3 Years|Pregnancy|9
4452503|NCT00528112|7239223|FG001|Treatment up to 3 Years|Pregnancy|10
4452504|NCT00528112|7239222|FG000|Treatment up to 3 Years|Other reasons|186
4452505|NCT00528112|7239223|FG001|Treatment up to 3 Years|Other reasons|186
4452506|NCT00528112|7239222|FG000|Extension Phase|Withdrawal by Subject|0
4452507|NCT00528112|7239223|FG001|Extension Phase|Withdrawal by Subject|3
4452508|NCT00528112|7239222|FG000|Extension Phase|Other reasons|0
4452509|NCT00528112|7239223|FG001|Extension Phase|Other reasons|100
4452510|NCT00528112|7239222|FG000|Extension Phase|Pregnancy|0
4452511|NCT00528112|7239223|FG001|Extension Phase|Pregnancy|3
4452512|NCT00528112|7239222|FG000|Extension Phase|Lost to Follow-up|0
4452513|NCT00528112|7239223|FG001|Extension Phase|Lost to Follow-up|12
4452514|NCT00528112|7239222|FG000|Extension Phase|Death|0
4452515|NCT00528112|7239223|FG001|Extension Phase|Death|1
4452516|NCT00528112|7239222|FG000|Extension Phase|Adverse Event|0
4452517|NCT00528112|7239223|FG001|Extension Phase|Adverse Event|36
4452518|NCT00528112|7239222|FG000|Extension Phase|Protocol Violation|0
4452519|NCT00528112|7239223|FG001|Extension Phase|Protocol Violation|2
4452520|NCT00528372|7239258|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2
4452521|NCT00528372|7239259|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
4452522|NCT00528372|7239260|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
4452523|NCT00528372|7239261|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
4452524|NCT00528372|7239262|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
4452525|NCT00528372|7239263|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
4452526|NCT00528372|7239264|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
4452527|NCT00528372|7239265|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
4452528|NCT00528372|7239266|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
4452529|NCT00528372|7239258|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
4452530|NCT00528372|7239259|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2
4452531|NCT00528372|7239260|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2
4452532|NCT00528372|7239261|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6
4452533|NCT00528372|7239262|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
4452534|NCT00528372|7239263|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3
4452535|NCT00528372|7239264|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3
4452536|NCT00528372|7239265|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
4452537|NCT00528372|7239266|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
4452538|NCT00528372|7239258|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1
4452539|NCT00528372|7239259|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2
4452540|NCT00528372|7239260|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7
4452541|NCT00528372|7239261|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1
4452542|NCT00528372|7239262|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6
4452543|NCT00528372|7239263|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4
4452544|NCT00528372|7239264|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6
4452545|NCT00528372|7239265|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2
4452546|NCT00528372|7239266|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4
4452547|NCT00528372|7239258|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5
4452548|NCT00528372|7239259|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1
4452549|NCT00528372|7239260|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
4452550|NCT00528372|7239261|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
4452551|NCT00528372|7239262|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
4452552|NCT00528372|7239263|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
4452553|NCT00528372|7239264|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
4452554|NCT00528372|7239265|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
4452555|NCT00528372|7239266|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1
4452556|NCT00528372|7239258|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
4452557|NCT00528372|7239259|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
4452558|NCT00528372|7239260|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
4452559|NCT00528372|7239261|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2
4452560|NCT00528372|7239262|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
4452561|NCT00528372|7239263|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1
4452562|NCT00528372|7239264|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
4452563|NCT00528372|7239265|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
4452564|NCT00528372|7239266|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
4452565|NCT00528372|7239258|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
4452566|NCT00528372|7239259|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
4452567|NCT00528372|7239260|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
4452568|NCT00528372|7239261|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
4452569|NCT00528372|7239262|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
4452570|NCT00528372|7239263|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
4452571|NCT00528372|7239264|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
4537167|NCT01107899|7357804|FG000|Overall Study|Withdrawal by Subject|0
4452572|NCT00528372|7239265|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
4452573|NCT00528372|7239266|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
4452574|NCT00528372|7239258|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3
4452575|NCT00528372|7239259|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0
4452576|NCT00528372|7239260|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0
4452577|NCT00528372|7239261|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1
4452578|NCT00528372|7239262|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0
4452579|NCT00528372|7239263|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0
4452580|NCT00528372|7239264|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0
4452581|NCT00528372|7239265|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1
4452582|NCT00528372|7239266|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0
4452583|NCT00528372|7239258|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6
4452584|NCT00528372|7239259|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6
4452585|NCT00528372|7239260|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1
4452586|NCT00528372|7239261|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
4452587|NCT00528372|7239262|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
4452588|NCT00528372|7239263|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
4452589|NCT00528372|7239264|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2
4452590|NCT00528372|7239265|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0
4452591|NCT00528372|7239266|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0
4452592|NCT00528372|7239258|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3
4452593|NCT00528372|7239259|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1
4452594|NCT00528372|7239260|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1
4452595|NCT00528372|7239261|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
4452596|NCT00528372|7239262|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2
4452597|NCT00528372|7239263|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3
4452598|NCT00528372|7239264|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4
4452599|NCT00528372|7239265|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
4452600|NCT00528372|7239266|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
4452601|NCT00528372|7239258|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6
4452602|NCT00528372|7239259|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6
4452603|NCT00528372|7239260|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3
4452604|NCT00528372|7239261|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3
4452605|NCT00528372|7239262|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7
4452606|NCT00528372|7239263|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0
4452607|NCT00528372|7239264|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4
4452608|NCT00528372|7239265|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2
4452609|NCT00528372|7239266|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4
4452610|NCT00528372|7239258|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3
4452611|NCT00528372|7239259|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2
4452612|NCT00528372|7239260|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
4452613|NCT00528372|7239261|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
4452614|NCT00528372|7239262|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0
4452615|NCT00528372|7239263|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4
4452616|NCT00528372|7239264|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2
4452617|NCT00528372|7239265|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3
4452618|NCT00528372|7239266|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
4452619|NCT00528372|7239258|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
4452620|NCT00528372|7239259|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
4452621|NCT00528372|7239260|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
4452622|NCT00528372|7239261|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
4452623|NCT00528372|7239262|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
4452624|NCT00528372|7239263|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
4452625|NCT00528372|7239264|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
4452626|NCT00528372|7239265|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
4452627|NCT00528372|7239266|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
4452628|NCT00528372|7239258|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
4452629|NCT00528372|7239259|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
4452630|NCT00528372|7239260|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
4452631|NCT00528372|7239261|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
4452632|NCT00528372|7239262|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2
4452633|NCT00528372|7239263|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1
4452634|NCT00528372|7239264|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
4452635|NCT00528372|7239265|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
4452636|NCT00528372|7239266|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
4452637|NCT00528372|7239258|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
4452638|NCT00528372|7239259|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
4452639|NCT00528372|7239260|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
4452640|NCT00528372|7239261|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
4452641|NCT00528372|7239262|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
4452642|NCT00528372|7239263|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
4452643|NCT00528372|7239264|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
4537168|NCT01107899|7357805|FG001|Overall Study|Withdrawal by Subject|0
4537169|NCT01107899|7357806|FG002|Overall Study|Withdrawal by Subject|1
4537170|NCT01107912|7357821|FG000|Period 1|Adverse Event|0
4452644|NCT00528372|7239265|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
4452645|NCT00528372|7239266|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
4452646|NCT00528372|7239258|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2
4452647|NCT00528372|7239259|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2
4452648|NCT00528372|7239260|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1
4452649|NCT00528372|7239261|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2
4452650|NCT00528372|7239262|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3
4452651|NCT00528372|7239263|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0
4452652|NCT00528372|7239264|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3
4452653|NCT00528372|7239265|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1
4452654|NCT00528372|7239266|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0
4452655|NCT00528411|7239319|FG000|Overall Study|Adverse Event|4
4452656|NCT00528411|7239320|FG001|Overall Study|Adverse Event|0
4452657|NCT00528411|7239321|FG002|Overall Study|Adverse Event|1
4452658|NCT00528411|7239319|FG000|Overall Study|Incorrect Enrolment|1
4452659|NCT00528411|7239320|FG001|Overall Study|Incorrect Enrolment|1
4452660|NCT00528411|7239321|FG002|Overall Study|Incorrect Enrolment|0
4452661|NCT00528411|7239319|FG000|Overall Study|Severe non-compliance to protocol|0
4452662|NCT00528411|7239320|FG001|Overall Study|Severe non-compliance to protocol|1
4452663|NCT00528411|7239321|FG002|Overall Study|Severe non-compliance to protocol|0
4452664|NCT00528411|7239319|FG000|Overall Study|Prior commitment medication|0
4452665|NCT00528411|7239320|FG001|Overall Study|Prior commitment medication|1
4452666|NCT00528411|7239321|FG002|Overall Study|Prior commitment medication|0
4452667|NCT00528424|7239329|FG000|Overall Study|Lost to Follow-up|13
4452668|NCT00528424|7239329|FG000|Overall Study|Withdrew consent|2
4452669|NCT00528424|7239329|FG000|Overall Study|Administrative reason|2
4452670|NCT00528424|7239329|FG000|Overall Study|Other|12
4452671|NCT00528528|7239341|FG000|Overall Study|Lost to Follow-up|0
4452672|NCT00528528|7239342|FG001|Overall Study|Lost to Follow-up|0
4452673|NCT00528528|7239343|FG002|Overall Study|Lost to Follow-up|1
4452674|NCT00528528|7239344|FG003|Overall Study|Lost to Follow-up|1
4452675|NCT00528528|7239341|FG000|Overall Study|Ineligible to continue the trial|0
4452676|NCT00528528|7239342|FG001|Overall Study|Ineligible to continue the trial|0
4452677|NCT00528528|7239343|FG002|Overall Study|Ineligible to continue the trial|0
4452678|NCT00528528|7239344|FG003|Overall Study|Ineligible to continue the trial|1
4452679|NCT00528528|7239341|FG000|Overall Study|Other|0
4452680|NCT00528528|7239342|FG001|Overall Study|Other|1
4452681|NCT00528528|7239343|FG002|Overall Study|Other|0
4452682|NCT00528528|7239344|FG003|Overall Study|Other|0
4452683|NCT00528528|7239341|FG000|Overall Study|Withdrawal by Subject|3
4452684|NCT00528528|7239342|FG001|Overall Study|Withdrawal by Subject|2
4452685|NCT00528528|7239343|FG002|Overall Study|Withdrawal by Subject|1
4452686|NCT00528528|7239344|FG003|Overall Study|Withdrawal by Subject|1
4452687|NCT00528528|7239341|FG000|Overall Study|Ongoing participant|0
4452688|NCT00528528|7239342|FG001|Overall Study|Ongoing participant|0
4452689|NCT00528528|7239343|FG002|Overall Study|Ongoing participant|1
4452690|NCT00528528|7239344|FG003|Overall Study|Ongoing participant|0
4452691|NCT00528567|7239367|FG000|Overall Study|Death|4
4452692|NCT00528567|7239368|FG001|Overall Study|Death|5
4452693|NCT00528567|7239367|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30
4452694|NCT00528567|7239368|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60
4452695|NCT00528567|7239367|FG000|Overall Study|Adverse Event/Intermittent Illness|255
4452696|NCT00528567|7239368|FG001|Overall Study|Adverse Event/Intermittent Illness|29
4452697|NCT00528567|7239367|FG000|Overall Study|Violation Criteria at Entry|3
4452698|NCT00528567|7239368|FG001|Overall Study|Violation Criteria at Entry|17
4452699|NCT00528567|7239367|FG000|Overall Study|Withdrew Consent|59
4452700|NCT00528567|7239368|FG001|Overall Study|Withdrew Consent|55
4452701|NCT00528567|7239367|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52
4452702|NCT00528567|7239368|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42
4452703|NCT00528567|7239367|FG000|Overall Study|Failure to Return|1
4452704|NCT00528567|7239368|FG001|Overall Study|Failure to Return|4
4452705|NCT00528567|7239367|FG000|Overall Study|Other Protocol Violation|5
4452706|NCT00528567|7239368|FG001|Overall Study|Other Protocol Violation|21
4452707|NCT00528567|7239367|FG000|Overall Study|Administrative/Other|22
4452708|NCT00528567|7239368|FG001|Overall Study|Administrative/Other|75
4452709|NCT00528606|7239392|FG000|Overall Study|Withdrew consent|4
4452710|NCT00528606|7239393|FG001|Overall Study|Withdrew consent|3
4452711|NCT00528606|7239392|FG000|Overall Study|Lost to Follow-up|4
4452712|NCT00528606|7239393|FG001|Overall Study|Lost to Follow-up|1
4452713|NCT00528606|7239392|FG000|Overall Study|Adverse Event|3
4537171|NCT01107912|7357822|FG001|Period 1|Adverse Event|0
4452714|NCT00528606|7239393|FG001|Overall Study|Adverse Event|0
4452715|NCT00528606|7239392|FG000|Overall Study|Other|2
4452716|NCT00528606|7239393|FG001|Overall Study|Other|0
4452717|NCT00528645|7239399|FG000|Overall Study|Adverse Event|3
4452718|NCT00528801|7239410|FG000|Overall Study|Withdrawal by Subject|1
4452719|NCT00528801|7239411|FG001|Overall Study|Withdrawal by Subject|1
4452720|NCT00528801|7239410|FG000|Overall Study|Protocol Violation|11
4452721|NCT00528801|7239411|FG001|Overall Study|Protocol Violation|5
4452722|NCT00528801|7239410|FG000|Overall Study|Lost to Follow-up|15
4452723|NCT00528801|7239411|FG001|Overall Study|Lost to Follow-up|4
4452724|NCT00528801|7239410|FG000|Overall Study|Administrative Reasons|0
4452725|NCT00528801|7239411|FG001|Overall Study|Administrative Reasons|1
4452726|NCT00528840|7239417|FG000|Overall Study|Lost to Follow-up|10
4452727|NCT00528840|7239417|FG000|Overall Study|Adverse Event|1
4452728|NCT00528840|7239417|FG000|Overall Study|Withdrawal by Subject|17
4452729|NCT00528840|7239417|FG000|Overall Study|Death|2
4537172|NCT01107912|7357823|FG002|Period 1|Adverse Event|0
4537173|NCT01107912|7357824|FG003|Period 1|Adverse Event|0
4537174|NCT01107912|7357825|FG004|Period 1|Adverse Event|2
4537175|NCT01107912|7357826|FG005|Period 1|Adverse Event|0
4537176|NCT01107912|7357821|FG000|Period 1|Physician Decision|0
4537177|NCT01107912|7357822|FG001|Period 1|Physician Decision|0
4537178|NCT01107912|7357823|FG002|Period 1|Physician Decision|0
4537179|NCT01107912|7357824|FG003|Period 1|Physician Decision|0
4452730|NCT00528840|7239417|FG000|Overall Study|Administrative Reasons|1
4452731|NCT00528840|7239417|FG000|Overall Study|Other|2
4452732|NCT00528866|7239421|FG000|Overall Study|Protocol Violation|6
4452733|NCT00528879|7239430|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3
4452734|NCT00528879|7239431|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0
4452735|NCT00528879|7239432|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1
4452736|NCT00528879|7239433|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0
4452737|NCT00528879|7239430|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4
4452738|NCT00528879|7239431|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4
4452739|NCT00528879|7239432|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2
4452740|NCT00528879|7239433|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4
4452741|NCT00528879|7239430|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7
4452742|NCT00528879|7239431|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5
4452743|NCT00528879|7239432|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5
4452744|NCT00528879|7239433|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3
4452745|NCT00528879|7239430|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5
4452746|NCT00528879|7239431|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
4452747|NCT00528879|7239432|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
4452748|NCT00528879|7239433|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5
4452749|NCT00528879|7239430|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
4452750|NCT00528879|7239431|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
4452751|NCT00528879|7239432|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2
4452752|NCT00528879|7239433|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
4452753|NCT00528879|7239430|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2
4452754|NCT00528879|7239431|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3
4452755|NCT00528879|7239432|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0
4452756|NCT00528879|7239433|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2
4452757|NCT00528879|7239430|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
4452758|NCT00528879|7239431|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
4452759|NCT00528879|7239432|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0
4452760|NCT00528879|7239433|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
4452761|NCT00528879|7239430|FG000|Short-term Period (Day 1 to Week 24)|Other|0
4452762|NCT00528879|7239431|FG001|Short-term Period (Day 1 to Week 24)|Other|0
4452763|NCT00528879|7239432|FG002|Short-term Period (Day 1 to Week 24)|Other|1
4452764|NCT00528879|7239433|FG003|Short-term Period (Day 1 to Week 24)|Other|1
4452765|NCT00528879|7239430|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27
4452766|NCT00528879|7239431|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16
4452767|NCT00528879|7239432|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17
4452768|NCT00528879|7239433|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9
4452769|NCT00528879|7239430|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5
4452770|NCT00528879|7239431|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4
4537180|NCT01107912|7357825|FG004|Period 1|Physician Decision|1
4537181|NCT01107912|7357826|FG005|Period 1|Physician Decision|0
4537182|NCT01107912|7357821|FG000|Period 1|Withdrawal by Subject|1
4537183|NCT01107912|7357822|FG001|Period 1|Withdrawal by Subject|0
4537184|NCT01107912|7357823|FG002|Period 1|Withdrawal by Subject|0
4537185|NCT01107912|7357824|FG003|Period 1|Withdrawal by Subject|0
4537186|NCT01107912|7357825|FG004|Period 1|Withdrawal by Subject|0
4537187|NCT01107912|7357826|FG005|Period 1|Withdrawal by Subject|0
4537188|NCT01107912|7357821|FG000|Period 2|Physician Decision|0
4537189|NCT01107912|7357822|FG001|Period 2|Physician Decision|0
4537190|NCT01107912|7357823|FG002|Period 2|Physician Decision|1
4452771|NCT00528879|7239432|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3
4452772|NCT00528879|7239433|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2
4452773|NCT00528879|7239430|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4
4452774|NCT00528879|7239431|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6
4452775|NCT00528879|7239432|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8
4452776|NCT00528879|7239433|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4
4452777|NCT00528879|7239430|FG000|Long-term Period (Weeks 24 to 102)|Death|0
4452778|NCT00528879|7239431|FG001|Long-term Period (Weeks 24 to 102)|Death|1
4452779|NCT00528879|7239432|FG002|Long-term Period (Weeks 24 to 102)|Death|0
4452780|NCT00528879|7239433|FG003|Long-term Period (Weeks 24 to 102)|Death|0
4452781|NCT00528879|7239430|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4
4452782|NCT00528879|7239431|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5
4452783|NCT00528879|7239432|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3
4452784|NCT00528879|7239433|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7
4452785|NCT00528879|7239430|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0
4452786|NCT00528879|7239431|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5
4452787|NCT00528879|7239432|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1
4452788|NCT00528879|7239433|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2
4452789|NCT00528879|7239430|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1
4452790|NCT00528879|7239431|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0
4452791|NCT00528879|7239432|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0
4452792|NCT00528879|7239433|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0
4452793|NCT00528879|7239430|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
4452794|NCT00528879|7239431|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
4452795|NCT00528879|7239432|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
4452796|NCT00528879|7239433|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0
4452797|NCT00528931|7239443|FG000|Overall Study|Lost to Follow-up|1
4452798|NCT00528957|7239450|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2
4452799|NCT00528957|7239451|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1
4452800|NCT00528957|7239450|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2
4452801|NCT00528957|7239451|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0
4452802|NCT00528957|7239450|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2
4452803|NCT00528957|7239451|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0
4452804|NCT00528957|7239450|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1
4452805|NCT00528957|7239451|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0
4452806|NCT00528957|7239450|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0
4452807|NCT00528957|7239451|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1
4452808|NCT00528957|7239450|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4
4452809|NCT00528957|7239451|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3
4452810|NCT00528957|7239450|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3
4452811|NCT00528957|7239451|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0
4452812|NCT00528957|7239450|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5
4452813|NCT00528957|7239451|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4
4452814|NCT00528957|7239450|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0
4452815|NCT00528957|7239451|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3
4452816|NCT00528957|7239450|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1
4452817|NCT00528957|7239451|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1
4452818|NCT00528957|7239450|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0
4452819|NCT00528957|7239451|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1
4452820|NCT00528957|7239450|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0
4452821|NCT00528957|7239451|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1
4452822|NCT00528957|7239450|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4
4452823|NCT00528957|7239451|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10
4452824|NCT00528957|7239450|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3
4452825|NCT00528957|7239451|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5
4452826|NCT00528957|7239450|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2
4452827|NCT00528957|7239451|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1
4452828|NCT00528957|7239450|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1
4452829|NCT00528957|7239451|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1
4515801|NCT00955682|7326786|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1
4515802|NCT00955708|7326800|FG000|Overall Study|Death|269
4515803|NCT00955708|7326800|FG000|Overall Study|Lost to Follow-up|72
4515804|NCT00955708|7326800|FG000|Overall Study|Physician Decision|36
4515805|NCT00955708|7326800|FG000|Overall Study|Protocol Violation|134
4515806|NCT00955708|7326800|FG000|Overall Study|Registry Conclusion|186
4515807|NCT00955708|7326800|FG000|Overall Study|Product removed from service|94
4515808|NCT00955708|7326800|FG000|Overall Study|Patient Refused to participate further|116
4515809|NCT00955708|7326800|FG000|Overall Study|Closure of study location|60
4452830|NCT00528970|7239470|FG000|Overall Study|Adverse Event|6
4452831|NCT00528970|7239471|FG001|Overall Study|Adverse Event|8
4452832|NCT00528970|7239472|FG002|Overall Study|Adverse Event|5
4452833|NCT00528970|7239470|FG000|Overall Study|Lost to Follow-up|0
4452834|NCT00528970|7239471|FG001|Overall Study|Lost to Follow-up|0
4452835|NCT00528970|7239472|FG002|Overall Study|Lost to Follow-up|1
4452836|NCT00528970|7239470|FG000|Overall Study|Other than specified|2
4452837|NCT00528970|7239471|FG001|Overall Study|Other than specified|3
4452838|NCT00528970|7239472|FG002|Overall Study|Other than specified|3
4452839|NCT00528970|7239470|FG000|Overall Study|Protocol Violation|2
4452840|NCT00528970|7239471|FG001|Overall Study|Protocol Violation|1
4452841|NCT00528970|7239472|FG002|Overall Study|Protocol Violation|4
4452842|NCT00528970|7239470|FG000|Overall Study|Lack of Efficacy|0
4452843|NCT00528970|7239471|FG001|Overall Study|Lack of Efficacy|0
4452844|NCT00528970|7239472|FG002|Overall Study|Lack of Efficacy|1
4452845|NCT00528970|7239470|FG000|Overall Study|Withdrawal by Subject|4
4452846|NCT00528970|7239471|FG001|Overall Study|Withdrawal by Subject|3
4452847|NCT00528970|7239472|FG002|Overall Study|Withdrawal by Subject|5
4452848|NCT00528970|7239470|FG000|Overall Study|Randomized but not treated|0
4452849|NCT00528970|7239471|FG001|Overall Study|Randomized but not treated|0
4452850|NCT00528970|7239472|FG002|Overall Study|Randomized but not treated|1
4452851|NCT00528996|7239485|FG000|Overall Study|Other reasons than listing|6
4452852|NCT00528996|7239486|FG001|Overall Study|Other reasons than listing|7
4452853|NCT00528996|7239487|FG002|Overall Study|Other reasons than listing|14
4452854|NCT00528996|7239488|FG003|Overall Study|Other reasons than listing|11
4452855|NCT00528996|7239489|FG004|Overall Study|Other reasons than listing|5
4452856|NCT00528996|7239485|FG000|Overall Study|Refused continue medication|16
4452857|NCT00528996|7239486|FG001|Overall Study|Refused continue medication|0
4452858|NCT00528996|7239487|FG002|Overall Study|Refused continue medication|3
4452859|NCT00528996|7239488|FG003|Overall Study|Refused continue medication|3
4452860|NCT00528996|7239489|FG004|Overall Study|Refused continue medication|6
4452861|NCT00528996|7239485|FG000|Overall Study|Lost to Follow-up|2
4452862|NCT00528996|7239486|FG001|Overall Study|Lost to Follow-up|0
4452863|NCT00528996|7239487|FG002|Overall Study|Lost to Follow-up|4
4452864|NCT00528996|7239488|FG003|Overall Study|Lost to Follow-up|1
4452865|NCT00528996|7239489|FG004|Overall Study|Lost to Follow-up|3
4452866|NCT00528996|7239485|FG000|Overall Study|Protocol Violation|1
4452867|NCT00528996|7239486|FG001|Overall Study|Protocol Violation|2
4452868|NCT00528996|7239487|FG002|Overall Study|Protocol Violation|3
4452869|NCT00528996|7239488|FG003|Overall Study|Protocol Violation|3
4452870|NCT00528996|7239489|FG004|Overall Study|Protocol Violation|2
4452871|NCT00528996|7239485|FG000|Overall Study|Lack of Efficacy|7
4452872|NCT00528996|7239486|FG001|Overall Study|Lack of Efficacy|2
4452873|NCT00528996|7239487|FG002|Overall Study|Lack of Efficacy|1
4452874|NCT00528996|7239488|FG003|Overall Study|Lack of Efficacy|3
4452875|NCT00528996|7239489|FG004|Overall Study|Lack of Efficacy|3
4452876|NCT00528996|7239485|FG000|Overall Study|Adverse Event|32
4452877|NCT00528996|7239486|FG001|Overall Study|Adverse Event|13
4452878|NCT00528996|7239487|FG002|Overall Study|Adverse Event|18
4452879|NCT00528996|7239488|FG003|Overall Study|Adverse Event|29
4452880|NCT00528996|7239489|FG004|Overall Study|Adverse Event|18
4452881|NCT00529035|7239504|FG000|Overall Study|Withdrawal by Subject|1
4537191|NCT01107912|7357824|FG003|Period 2|Physician Decision|0
4537192|NCT01107912|7357825|FG004|Period 2|Physician Decision|0
4537193|NCT01107912|7357826|FG005|Period 2|Physician Decision|0
4537194|NCT01107912|7357821|FG000|Period 3|Adverse Event|0
4537195|NCT01107912|7357822|FG001|Period 3|Adverse Event|1
4537196|NCT01107912|7357823|FG002|Period 3|Adverse Event|1
4537197|NCT01107912|7357824|FG003|Period 3|Adverse Event|0
4537198|NCT01107912|7357825|FG004|Period 3|Adverse Event|0
4537199|NCT01107912|7357826|FG005|Period 3|Adverse Event|0
4537200|NCT01107912|7357821|FG000|Period 3|Withdrawal by Subject|0
4537201|NCT01107912|7357822|FG001|Period 3|Withdrawal by Subject|0
4537202|NCT01107912|7357823|FG002|Period 3|Withdrawal by Subject|0
4537203|NCT01107912|7357824|FG003|Period 3|Withdrawal by Subject|1
4537204|NCT01107912|7357825|FG004|Period 3|Withdrawal by Subject|0
4537205|NCT01107912|7357826|FG005|Period 3|Withdrawal by Subject|0
4537206|NCT01107925|7357845|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1
4537207|NCT01107925|7357846|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
4537208|NCT01107925|7357847|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
4537209|NCT01107925|7357848|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
4537210|NCT01107925|7357849|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1
4537211|NCT01107925|7357850|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
4537212|NCT01107925|7357845|FG000|Period 2|Withdrawal by Subject|0
4452882|NCT00529087|7239518|FG000|Overall Study|Adverse Event|10
4452883|NCT00529087|7239519|FG001|Overall Study|Adverse Event|13
4452884|NCT00529087|7239520|FG002|Overall Study|Adverse Event|4
4452885|NCT00529087|7239518|FG000|Overall Study|Lost to Follow-up|6
4452886|NCT00529087|7239519|FG001|Overall Study|Lost to Follow-up|4
4452887|NCT00529087|7239520|FG002|Overall Study|Lost to Follow-up|1
4452888|NCT00529087|7239518|FG000|Overall Study|Protocol Violation|8
4452889|NCT00529087|7239519|FG001|Overall Study|Protocol Violation|7
4452890|NCT00529087|7239520|FG002|Overall Study|Protocol Violation|6
4452891|NCT00529087|7239518|FG000|Overall Study|Withdrawal by Subject|3
4452892|NCT00529087|7239519|FG001|Overall Study|Withdrawal by Subject|3
4452893|NCT00529087|7239520|FG002|Overall Study|Withdrawal by Subject|3
4452894|NCT00529087|7239518|FG000|Overall Study|Protocol deviation|1
4452895|NCT00529087|7239519|FG001|Overall Study|Protocol deviation|1
4452896|NCT00529087|7239520|FG002|Overall Study|Protocol deviation|2
4452897|NCT00529100|7239541|FG000|Overall Study|Adverse Event|0
4452898|NCT00529100|7239542|FG001|Overall Study|Adverse Event|5
4452899|NCT00529100|7239541|FG000|Overall Study|Protocol Violation|0
4452900|NCT00529100|7239542|FG001|Overall Study|Protocol Violation|1
4452901|NCT00529100|7239541|FG000|Overall Study|Progressive Disease|0
4452902|NCT00529100|7239542|FG001|Overall Study|Progressive Disease|1
4452903|NCT00529100|7239541|FG000|Overall Study|Withdrawal by Subject|0
4452904|NCT00529100|7239542|FG001|Overall Study|Withdrawal by Subject|1
4452905|NCT00529100|7239541|FG000|Overall Study|Participant Ineligibility|0
4537213|NCT01107925|7357846|FG001|Period 2|Withdrawal by Subject|1
4537214|NCT01107925|7357847|FG002|Period 2|Withdrawal by Subject|0
4452906|NCT00529100|7239542|FG001|Overall Study|Participant Ineligibility|1
4452907|NCT00529217|7239591|FG000|Overall Study|Lack of Efficacy|2
4452908|NCT00529217|7239591|FG000|Overall Study|Unable to adhere to study schedule|2
4452909|NCT00529243|7239596|FG000|Overall Study|Adverse Event|1
4452910|NCT00529243|7239596|FG000|Overall Study|Death|1
4452911|NCT00529243|7239596|FG000|Overall Study|Relocated|1
4452912|NCT00529308|7239602|FG000|Overall Study|Withdrawal by Subject|1
4452913|NCT00529308|7239603|FG001|Overall Study|Withdrawal by Subject|1
4452914|NCT00529373|7239611|FG000|Base Study|Adverse Event|525
4452915|NCT00529373|7239612|FG001|Base Study|Adverse Event|470
4452916|NCT00529373|7239611|FG000|Base Study|Lack of Efficacy|16
4452917|NCT00529373|7239612|FG001|Base Study|Lack of Efficacy|75
4452918|NCT00529373|7239611|FG000|Base Study|Lost to Follow-up|221
4452919|NCT00529373|7239612|FG001|Base Study|Lost to Follow-up|208
4452920|NCT00529373|7239611|FG000|Base Study|Other Protocol Specified Criteria|19
4452921|NCT00529373|7239612|FG001|Base Study|Other Protocol Specified Criteria|20
4452922|NCT00529373|7239611|FG000|Base Study|Physician Decision|60
4452923|NCT00529373|7239612|FG001|Base Study|Physician Decision|52
4452924|NCT00529373|7239611|FG000|Base Study|Protocol Violation|48
4452925|NCT00529373|7239612|FG001|Base Study|Protocol Violation|38
4452926|NCT00529373|7239611|FG000|Base Study|Withdrawal by Subject|1062
4452927|NCT00529373|7239612|FG001|Base Study|Withdrawal by Subject|967
4452928|NCT00529373|7239611|FG000|Base Study|Did not continue into Extension|1795
4452929|NCT00529373|7239612|FG001|Base Study|Did not continue into Extension|2238
4452930|NCT00529373|7239611|FG000|First Extension Study|Adverse Event|162
4452931|NCT00529373|7239612|FG001|First Extension Study|Adverse Event|142
4452932|NCT00529373|7239611|FG000|First Extension Study|Lack of Efficacy|65
4452933|NCT00529373|7239612|FG001|First Extension Study|Lack of Efficacy|427
4452934|NCT00529373|7239611|FG000|First Extension Study|Lost to Follow-up|41
4452935|NCT00529373|7239612|FG001|First Extension Study|Lost to Follow-up|37
4452936|NCT00529373|7239611|FG000|First Extension Study|Other|27
4452937|NCT00529373|7239612|FG001|First Extension Study|Other|47
4452938|NCT00529373|7239611|FG000|First Extension Study|Physician Decision|50
4452939|NCT00529373|7239612|FG001|First Extension Study|Physician Decision|45
4452940|NCT00529373|7239611|FG000|First Extension Study|Protocol Violation|16
4452941|NCT00529373|7239612|FG001|First Extension Study|Protocol Violation|13
4452942|NCT00529373|7239611|FG000|First Extension Study|Withdrawal by Subject|296
4452943|NCT00529373|7239612|FG001|First Extension Study|Withdrawal by Subject|287
4452944|NCT00529373|7239611|FG000|First Extension Study|Disposition record non-existing|0
4452945|NCT00529373|7239612|FG001|First Extension Study|Disposition record non-existing|1
4452946|NCT00529373|7239611|FG000|First Extension Study|Discontinued after 5 years completion|208
4452947|NCT00529373|7239612|FG001|First Extension Study|Discontinued after 5 years completion|346
4452948|NCT00529373|7239611|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256
4452949|NCT00529373|7239612|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281
4452950|NCT00529373|7239611|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32
4452951|NCT00529373|7239612|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25
4452952|NCT00529373|7239611|FG000|Second Extension Study|Adverse Event|101
4452953|NCT00529373|7239612|FG001|Second Extension Study|Adverse Event|51
4452954|NCT00529373|7239611|FG000|Second Extension Study|Lack of Efficacy|7
4452955|NCT00529373|7239612|FG001|Second Extension Study|Lack of Efficacy|15
4537215|NCT01107925|7357848|FG003|Period 2|Withdrawal by Subject|0
4537216|NCT01107925|7357849|FG004|Period 2|Withdrawal by Subject|0
4537217|NCT01107925|7357850|FG005|Period 2|Withdrawal by Subject|1
4537218|NCT01108068|7357898|FG000|Overall Study|5 not started, 1 stop due to side effect|6
4537219|NCT01108068|7357899|FG001|Overall Study|5 not started, 1 stop due to side effect|0
4537220|NCT01108094|7357927|FG000|Overall Study|Adverse Event|2
4452956|NCT00529373|7239611|FG000|Second Extension Study|Lost to Follow-up|18
4452957|NCT00529373|7239612|FG001|Second Extension Study|Lost to Follow-up|12
4452958|NCT00529373|7239611|FG000|Second Extension Study|Other|7
4452959|NCT00529373|7239612|FG001|Second Extension Study|Other|12
4452960|NCT00529373|7239611|FG000|Second Extension Study|Physician Decision|63
4452961|NCT00529373|7239612|FG001|Second Extension Study|Physician Decision|26
4452962|NCT00529373|7239611|FG000|Second Extension Study|Protocol Violation|2
4452963|NCT00529373|7239612|FG001|Second Extension Study|Protocol Violation|1
4452964|NCT00529373|7239611|FG000|Second Extension Study|Withdrawal by Subject|97
4452965|NCT00529373|7239612|FG001|Second Extension Study|Withdrawal by Subject|75
4452966|NCT00529373|7239611|FG000|Second Extension Study|Status Missing|5
4452967|NCT00529373|7239612|FG001|Second Extension Study|Status Missing|5
4452968|NCT00529386|7239626|FG000|Overall Study|Lost to Follow-up|1
4452969|NCT00529399|7239633|FG000|Overall Study|Lost to Follow-up|1
4452970|NCT00529399|7239634|FG001|Overall Study|Lost to Follow-up|0
4452971|NCT00529399|7239635|FG002|Overall Study|Lost to Follow-up|1
4452972|NCT00529399|7239633|FG000|Overall Study|Withdrawal by Subject|1
4452973|NCT00529399|7239634|FG001|Overall Study|Withdrawal by Subject|0
4452974|NCT00529399|7239635|FG002|Overall Study|Withdrawal by Subject|1
4452975|NCT00529399|7239633|FG000|Overall Study|Non-compliant|0
4452976|NCT00529399|7239634|FG001|Overall Study|Non-compliant|1
4452977|NCT00529399|7239635|FG002|Overall Study|Non-compliant|0
4452978|NCT00529451|7239647|FG000|Overall Study|Subject withdrew consent|16
4452979|NCT00529451|7239648|FG001|Overall Study|Subject withdrew consent|21
4452980|NCT00529451|7239649|FG002|Overall Study|Subject withdrew consent|13
4452981|NCT00529451|7239650|FG003|Overall Study|Subject withdrew consent|12
4452982|NCT00529451|7239647|FG000|Overall Study|Adverse Event|9
4452983|NCT00529451|7239648|FG001|Overall Study|Adverse Event|16
4452984|NCT00529451|7239649|FG002|Overall Study|Adverse Event|14
4452985|NCT00529451|7239650|FG003|Overall Study|Adverse Event|8
4452986|NCT00529451|7239647|FG000|Overall Study|Unsatisfactory therapeutic response|6
4452987|NCT00529451|7239648|FG001|Overall Study|Unsatisfactory therapeutic response|2
4452988|NCT00529451|7239649|FG002|Overall Study|Unsatisfactory therapeutic response|5
4452989|NCT00529451|7239650|FG003|Overall Study|Unsatisfactory therapeutic response|4
4452990|NCT00529451|7239647|FG000|Overall Study|Lost to Follow-up|4
4452991|NCT00529451|7239648|FG001|Overall Study|Lost to Follow-up|7
4452992|NCT00529451|7239649|FG002|Overall Study|Lost to Follow-up|4
4452993|NCT00529451|7239650|FG003|Overall Study|Lost to Follow-up|4
4452994|NCT00529451|7239647|FG000|Overall Study|Protocol deviation|1
4452995|NCT00529451|7239648|FG001|Overall Study|Protocol deviation|1
4452996|NCT00529451|7239649|FG002|Overall Study|Protocol deviation|4
4452997|NCT00529451|7239650|FG003|Overall Study|Protocol deviation|1
4452998|NCT00529451|7239647|FG000|Overall Study|Administrative problems|1
4452999|NCT00529451|7239648|FG001|Overall Study|Administrative problems|1
4453000|NCT00529451|7239649|FG002|Overall Study|Administrative problems|0
4453001|NCT00529451|7239650|FG003|Overall Study|Administrative problems|2
4453002|NCT00529516|7239666|FG000|Overall Study|Adverse Event|2
4453003|NCT00529516|7239667|FG001|Overall Study|Adverse Event|1
4453004|NCT00529516|7239668|FG002|Overall Study|Adverse Event|0
4453005|NCT00529516|7239666|FG000|Overall Study|Withdrawal by Subject|1
4453006|NCT00529516|7239667|FG001|Overall Study|Withdrawal by Subject|1
4453007|NCT00529516|7239668|FG002|Overall Study|Withdrawal by Subject|0
4453008|NCT00529516|7239666|FG000|Overall Study|Lost to Follow-up|0
4453009|NCT00529516|7239667|FG001|Overall Study|Lost to Follow-up|0
4453010|NCT00529516|7239668|FG002|Overall Study|Lost to Follow-up|1
4453011|NCT00529529|7239679|FG000|Overall Study|Adverse Event|12
4453012|NCT00529529|7239680|FG001|Overall Study|Adverse Event|17
4453013|NCT00529529|7239681|FG002|Overall Study|Adverse Event|8
4453014|NCT00529529|7239679|FG000|Overall Study|Subject withdrew consent|12
4453015|NCT00529529|7239680|FG001|Overall Study|Subject withdrew consent|9
4453016|NCT00529529|7239681|FG002|Overall Study|Subject withdrew consent|12
4453017|NCT00529529|7239679|FG000|Overall Study|Protocol deviation|8
4453018|NCT00529529|7239680|FG001|Overall Study|Protocol deviation|12
4453019|NCT00529529|7239681|FG002|Overall Study|Protocol deviation|5
4453020|NCT00529529|7239679|FG000|Overall Study|Lost to Follow-up|5
4453021|NCT00529529|7239680|FG001|Overall Study|Lost to Follow-up|3
4453022|NCT00529529|7239681|FG002|Overall Study|Lost to Follow-up|1
4453023|NCT00529529|7239679|FG000|Overall Study|Unsatisfactory therapeutic effect|2
4453024|NCT00529529|7239680|FG001|Overall Study|Unsatisfactory therapeutic effect|2
4453025|NCT00529529|7239681|FG002|Overall Study|Unsatisfactory therapeutic effect|2
4453026|NCT00529529|7239679|FG000|Overall Study|Death|2
4453027|NCT00529529|7239680|FG001|Overall Study|Death|0
4453028|NCT00529529|7239681|FG002|Overall Study|Death|0
4453029|NCT00529529|7239679|FG000|Overall Study|Abnormal test procedure result(s)|1
4453030|NCT00529529|7239680|FG001|Overall Study|Abnormal test procedure result(s)|0
4453031|NCT00529529|7239681|FG002|Overall Study|Abnormal test procedure result(s)|0
4453032|NCT00529529|7239679|FG000|Overall Study|Administrative problems|1
4453033|NCT00529529|7239680|FG001|Overall Study|Administrative problems|0
4453034|NCT00529529|7239681|FG002|Overall Study|Administrative problems|3
4453035|NCT00529542|7239691|FG000|Overall Study|Withdrawal by Subject|1
4453036|NCT00529542|7239692|FG001|Overall Study|Withdrawal by Subject|0
4453037|NCT00529542|7239691|FG000|Overall Study|Lost to Follow-up|0
4453038|NCT00529542|7239692|FG001|Overall Study|Lost to Follow-up|1
4453039|NCT00529568|7239713|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5
4453040|NCT00529568|7239714|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0
4453041|NCT00529568|7239715|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0
4453042|NCT00529568|7239713|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12
4453043|NCT00529568|7239714|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0
4453044|NCT00529568|7239715|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0
4453045|NCT00529568|7239713|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5
4453046|NCT00529568|7239714|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0
4453047|NCT00529568|7239715|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0
4453048|NCT00529568|7239713|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8
4453049|NCT00529568|7239714|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0
4453050|NCT00529568|7239715|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0
4453051|NCT00529568|7239713|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13
4453052|NCT00529568|7239714|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0
4453053|NCT00529568|7239715|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0
4453054|NCT00529568|7239713|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3
4453055|NCT00529568|7239714|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0
4453056|NCT00529568|7239715|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0
4453057|NCT00529568|7239713|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0
4453058|NCT00529568|7239714|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10
4453059|NCT00529568|7239715|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27
4453060|NCT00529568|7239713|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0
4453061|NCT00529568|7239714|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1
4453062|NCT00529568|7239715|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0
4453063|NCT00529568|7239713|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0
4453064|NCT00529568|7239714|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15
4453065|NCT00529568|7239715|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48
4537221|NCT01108094|7357928|FG001|Overall Study|Adverse Event|0
4537222|NCT01108094|7357929|FG002|Overall Study|Adverse Event|0
4537223|NCT01108094|7357930|FG003|Overall Study|Adverse Event|0
4537224|NCT01108094|7357927|FG000|Overall Study|Withdrawal by Subject|1
4537225|NCT01108094|7357928|FG001|Overall Study|Withdrawal by Subject|0
4537226|NCT01108094|7357929|FG002|Overall Study|Withdrawal by Subject|0
4453066|NCT00529568|7239713|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0
4453067|NCT00529568|7239714|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5
4537227|NCT01108094|7357930|FG003|Overall Study|Withdrawal by Subject|0
4537228|NCT01108185|7357943|FG000|Overall Study|Non-compliance|15
4537229|NCT01108185|7357943|FG000|Overall Study|Lost to Follow-up|12
4537230|NCT01108237|7357949|FG000|Overall Study|No alignment data|2
4537231|NCT01108237|7357950|FG001|Overall Study|No alignment data|17
4537232|NCT01108237|7357949|FG000|Overall Study|Did not meet criteria for analysis|7
4537233|NCT01108237|7357950|FG001|Overall Study|Did not meet criteria for analysis|0
4537234|NCT01108263|7357958|FG000|Overall Study|Adverse Event|0
4537235|NCT01108263|7357959|FG001|Overall Study|Adverse Event|1
4537236|NCT01108341|7357965|FG000|Overall Study|Death|2
4537237|NCT01108341|7357965|FG000|Overall Study|Withdrawal by Subject|1
4537238|NCT01108341|7357965|FG000|Overall Study|Lost to Follow-up|1
4453068|NCT00529568|7239715|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8
4453069|NCT00529568|7239713|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0
4453070|NCT00529568|7239714|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17
4453071|NCT00529568|7239715|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19
4453072|NCT00529633|7239726|FG000|Overall Study|Withdrawal by Subject|1
4453073|NCT00529633|7239727|FG001|Overall Study|Withdrawal by Subject|1
4453074|NCT00529659|7239735|FG000|Overall Study|Adverse Event|8
4537239|NCT01108341|7357965|FG000|Overall Study|Other|1
4537240|NCT01108458|7357984|FG000|Overall Study|Withdrawal by Subject|1
4537241|NCT01108510|7357990|FG000|Overall Study|Randomized but Not Treated|5
4537242|NCT01108510|7357991|FG001|Overall Study|Randomized but Not Treated|1
4537243|NCT01108510|7357990|FG000|Overall Study|Joined Another Gilead-sponsored Study|186
4537244|NCT01108510|7357991|FG001|Overall Study|Joined Another Gilead-sponsored Study|195
4537245|NCT01108510|7357990|FG000|Overall Study|Adverse Event|26
4453075|NCT00529659|7239736|FG001|Overall Study|Adverse Event|7
4453076|NCT00529659|7239735|FG000|Overall Study|Lost to Follow-up|0
4453077|NCT00529659|7239736|FG001|Overall Study|Lost to Follow-up|2
4453078|NCT00529659|7239735|FG000|Overall Study|Physician Decision|0
4453079|NCT00529659|7239736|FG001|Overall Study|Physician Decision|2
4453080|NCT00529659|7239735|FG000|Overall Study|Protocol Violation|2
4453081|NCT00529659|7239736|FG001|Overall Study|Protocol Violation|6
4453082|NCT00529659|7239735|FG000|Overall Study|Withdrawal by Subject|1
4453083|NCT00529659|7239736|FG001|Overall Study|Withdrawal by Subject|6
4453084|NCT00529789|7239742|FG000|Study Period II/III|Parent/Caregiver Decision|9
4453085|NCT00529789|7239742|FG000|Study Period II/III|Adverse Event|3
4537246|NCT01108510|7357991|FG001|Overall Study|Adverse Event|19
4453086|NCT00529789|7239742|FG000|Study Period II/III|Lack of Efficacy|2
4537247|NCT01108510|7357990|FG000|Overall Study|Lost to Follow-up|20
4537248|NCT01108510|7357991|FG001|Overall Study|Lost to Follow-up|17
4537249|NCT01108510|7357990|FG000|Overall Study|Withdrew Consent|21
4537250|NCT01108510|7357991|FG001|Overall Study|Withdrew Consent|15
4537251|NCT01108510|7357990|FG000|Overall Study|Investigator's Discretion|12
4453087|NCT00529789|7239742|FG000|Study Period II/III|Withdrawal by Subject|1
4453088|NCT00529789|7239742|FG000|Study Period II/III|Protocol Violation|3
4453089|NCT00529789|7239742|FG000|Study Period II/III|Physician Decision|3
4453090|NCT00529789|7239742|FG000|Study Period II/III|Lost to Follow-up|3
4453091|NCT00529789|7239742|FG000|Study Period IV|Parent/Caregiver Decision|1
4453092|NCT00529789|7239742|FG000|Study Period IV|Adverse Event|1
4453093|NCT00529789|7239742|FG000|Study Period IV|Lack of Efficacy|1
4453094|NCT00529789|7239742|FG000|Study Period IV|Lost to Follow-up|3
4453095|NCT00529802|7239752|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3
4453096|NCT00529802|7239752|FG000|Evaluable for Primary Endpoint|Worsening performance status|2
4453097|NCT00529802|7239752|FG000|Evaluable for Primary Endpoint|Adverse Event|2
4453098|NCT00529802|7239752|FG000|Evaluable for Primary Endpoint|Death|1
4453099|NCT00529802|7239752|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1
4453100|NCT00529802|7239752|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1
4453101|NCT00529802|7239752|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2
4453102|NCT00529958|7239761|FG000|2-Year Follow-up|Lost to Follow-up|1
4453103|NCT00529958|7239762|FG001|2-Year Follow-up|Lost to Follow-up|2
4453104|NCT00529958|7239763|FG002|2-Year Follow-up|Lost to Follow-up|2
4453105|NCT00529958|7239761|FG000|2-Year Follow-up|Withdrawal by Subject|3
4453106|NCT00529958|7239762|FG001|2-Year Follow-up|Withdrawal by Subject|0
4453107|NCT00529958|7239763|FG002|2-Year Follow-up|Withdrawal by Subject|0
4453108|NCT00529958|7239761|FG000|5-Year Follow-up|Lost to Follow-up|2
4453109|NCT00529958|7239762|FG001|5-Year Follow-up|Lost to Follow-up|3
4453110|NCT00529958|7239763|FG002|5-Year Follow-up|Lost to Follow-up|1
4453111|NCT00529958|7239761|FG000|5-Year Follow-up|Withdrawal by Subject|1
4453112|NCT00529958|7239762|FG001|5-Year Follow-up|Withdrawal by Subject|0
4453113|NCT00529958|7239763|FG002|5-Year Follow-up|Withdrawal by Subject|0
4453114|NCT00530023|7239773|FG000|Overall Study|Withdrawal by Subject|0
4453115|NCT00530023|7239774|FG001|Overall Study|Withdrawal by Subject|1
4453116|NCT00530075|7239780|FG000|Overall Study|Adverse Event|1
4453117|NCT00530075|7239780|FG000|Overall Study|Death|1
4453118|NCT00530075|7239780|FG000|Overall Study|Lack of Efficacy|3
4453119|NCT00530075|7239780|FG000|Overall Study|Protocol Violation|1
4453120|NCT00530075|7239780|FG000|Overall Study|Withdrawal by Subject|1
4453121|NCT00530088|7239784|FG000|Overall Study|Disease Progression|4
4453122|NCT00530088|7239784|FG000|Overall Study|Physician Decision|4
4453123|NCT00530088|7239784|FG000|Overall Study|Other Not Specified|2
4453124|NCT00530218|7239788|FG000|Overall Study|CMV Not Detected|13
4453125|NCT00530218|7239788|FG000|Overall Study|Death|12
4453126|NCT00530257|7239795|FG000|Overall Study|Lost to Follow-up|1
4453127|NCT00530270|7239804|FG000|Overall Study|Protocol Violation|1
4453128|NCT00530270|7239805|FG001|Overall Study|Protocol Violation|0
4453129|NCT00530335|7239811|FG000|Overall Study|Adverse Event|3
4453130|NCT00530335|7239811|FG000|Overall Study|Protocol Violation|1
4453131|NCT00530335|7239811|FG000|Overall Study|Withdrawal by Subject|1
4453132|NCT00530335|7239811|FG000|Overall Study|Physician Decision|1
4453133|NCT00530348|7239817|FG000|Overall Study|Adverse Event|5
4453134|NCT00530348|7239818|FG001|Overall Study|Adverse Event|1
4453135|NCT00530348|7239817|FG000|Overall Study|Death|0
4453136|NCT00530348|7239818|FG001|Overall Study|Death|1
4453137|NCT00530348|7239817|FG000|Overall Study|Lack of Efficacy|2
4453138|NCT00530348|7239818|FG001|Overall Study|Lack of Efficacy|0
4453139|NCT00530348|7239817|FG000|Overall Study|Lost to Follow-up|0
4453140|NCT00530348|7239818|FG001|Overall Study|Lost to Follow-up|2
4453141|NCT00530348|7239817|FG000|Overall Study|Physician Decision|1
4453142|NCT00530348|7239818|FG001|Overall Study|Physician Decision|2
4453143|NCT00530348|7239817|FG000|Overall Study|Pregnancy|1
4453144|NCT00530348|7239818|FG001|Overall Study|Pregnancy|0
4453145|NCT00530348|7239817|FG000|Overall Study|Withdrawal by Subject|12
4453146|NCT00530348|7239818|FG001|Overall Study|Withdrawal by Subject|12
4453147|NCT00530348|7239817|FG000|Overall Study|Randomised in error|1
4453148|NCT00530348|7239818|FG001|Overall Study|Randomised in error|0
4453149|NCT00530348|7239817|FG000|Overall Study|Noncompliance with inclusion criterion 3|0
4453150|NCT00530348|7239818|FG001|Overall Study|Noncompliance with inclusion criterion 3|1
4453151|NCT00530439|7239826|FG000|Overall Study|GDM|9
4453152|NCT00530439|7239827|FG001|Overall Study|GDM|3
4453153|NCT00530439|7239826|FG000|Overall Study|Withdraw|18
4453154|NCT00530439|7239827|FG001|Overall Study|Withdraw|14
4453155|NCT00530439|7239826|FG000|Overall Study|Missed abortion|1
4453156|NCT00530439|7239827|FG001|Overall Study|Missed abortion|4
4453157|NCT00530439|7239826|FG000|Overall Study|Misclassification|2
4453158|NCT00530439|7239827|FG001|Overall Study|Misclassification|0
4453159|NCT00530439|7239826|FG000|Overall Study|Twin pregnancy|0
4453160|NCT00530439|7239827|FG001|Overall Study|Twin pregnancy|2
4453161|NCT00530439|7239826|FG000|Overall Study|Severe malformation/abortion|0
4453162|NCT00530439|7239827|FG001|Overall Study|Severe malformation/abortion|3
4453163|NCT00530504|7239833|FG000|Overall Study|Death|54
4453164|NCT00530504|7239833|FG000|Overall Study|Lost to Follow-up|26
4453165|NCT00530504|7239833|FG000|Overall Study|Withdrawal by Subject|39
4453166|NCT00530504|7239833|FG000|Overall Study|Exited study due to other reasons|33
4453167|NCT00530621|7239839|FG000|Overall Study|Adverse Event|11
4453168|NCT00530621|7239840|FG001|Overall Study|Adverse Event|8
4453169|NCT00530621|7239839|FG000|Overall Study|Physician Decision|2
4453170|NCT00530621|7239840|FG001|Overall Study|Physician Decision|4
4453171|NCT00530621|7239839|FG000|Overall Study|Progressive Disease (PD)|47
4453172|NCT00530621|7239840|FG001|Overall Study|Progressive Disease (PD)|40
4453173|NCT00530621|7239839|FG000|Overall Study|Sponsor Decision|12
4453174|NCT00530621|7239840|FG001|Overall Study|Sponsor Decision|15
4453175|NCT00530621|7239839|FG000|Overall Study|Subject Decision|4
4453176|NCT00530621|7239840|FG001|Overall Study|Subject Decision|7
4453177|NCT00530621|7239839|FG000|Overall Study|Death|3
4453178|NCT00530621|7239840|FG001|Overall Study|Death|6
4453179|NCT00530621|7239839|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1
4453180|NCT00530621|7239840|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0
4453181|NCT00530712|7239854|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2
4453182|NCT00530712|7239854|FG000|30 Day Follow-up Visit|Missed Visit|5
4453183|NCT00530712|7239854|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4
4453184|NCT00530712|7239854|FG000|6 Month Follow-up Visit|Missed Visit|3
4453185|NCT00530712|7239854|FG000|6 Month Follow-up Visit|Lost to Follow-up|3
4453186|NCT00530712|7239854|FG000|6 Month Follow-up Visit|Death|2
4453187|NCT00530712|7239854|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5
4453188|NCT00530712|7239854|FG000|12 Month Follow-up Visit|Missed Visit|3
4537252|NCT01108510|7357991|FG001|Overall Study|Investigator's Discretion|10
4537253|NCT01108510|7357990|FG000|Overall Study|Participant Noncompliance|5
4537254|NCT01108510|7357991|FG001|Overall Study|Participant Noncompliance|7
4537255|NCT01108510|7357990|FG000|Overall Study|Lack of Efficacy|3
4453189|NCT00530712|7239854|FG000|12 Month Follow-up Visit|Lost to Follow-up|7
4453190|NCT00530712|7239854|FG000|12 Month Follow-up Visit|Death|9
4453191|NCT00530777|7239881|FG000|Overall Study|Lost to Follow-up|0
4537256|NCT01108510|7357991|FG001|Overall Study|Lack of Efficacy|0
4537257|NCT01108510|7357990|FG000|Overall Study|Pregnancy|0
4537258|NCT01108510|7357991|FG001|Overall Study|Pregnancy|3
4537259|NCT01108510|7357990|FG000|Overall Study|Death|1
4537260|NCT01108510|7357991|FG001|Overall Study|Death|1
4537261|NCT01108718|7357999|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1
4537262|NCT01108718|7358000|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0
4537263|NCT01108731|7358007|FG000|Overall Study|Withdrawal by Subject|1
4537264|NCT01108731|7358008|FG001|Overall Study|Withdrawal by Subject|1
4537265|NCT01108731|7358007|FG000|Overall Study|Adverse Event|3
4453192|NCT00530777|7239882|FG001|Overall Study|Lost to Follow-up|1
4453193|NCT00530777|7239881|FG000|Overall Study|Death|1
4453194|NCT00530777|7239882|FG001|Overall Study|Death|2
4453195|NCT00530777|7239881|FG000|Overall Study|Physician Decision|1
4453196|NCT00530777|7239882|FG001|Overall Study|Physician Decision|0
4453197|NCT00530777|7239881|FG000|Overall Study|Withdrawal by Subject|0
4453198|NCT00530777|7239882|FG001|Overall Study|Withdrawal by Subject|1
4453199|NCT00530777|7239881|FG000|Overall Study|Unable to adhere to visit schedule|5
4453200|NCT00530777|7239882|FG001|Overall Study|Unable to adhere to visit schedule|1
4453201|NCT00530790|7239888|FG000|Overall Study|Adverse Event|2
4453202|NCT00530790|7239888|FG000|Overall Study|Withdrawal by Subject|2
4453203|NCT00530790|7239888|FG000|Overall Study|Physician Decision|1
4453204|NCT00530816|7239904|FG000|Overall Study|Progressive Disease|16
4453205|NCT00530816|7239905|FG001|Overall Study|Progressive Disease|24
4453206|NCT00530816|7239906|FG002|Overall Study|Progressive Disease|24
4453207|NCT00530816|7239904|FG000|Overall Study|Adverse Event|6
4453208|NCT00530816|7239905|FG001|Overall Study|Adverse Event|13
4537266|NCT01108731|7358008|FG001|Overall Study|Adverse Event|3
4537267|NCT01108796|7358027|FG000|Overall Study|Adverse Event|0
4537268|NCT01108796|7358028|FG001|Overall Study|Adverse Event|1
4537269|NCT01108796|7358027|FG000|Overall Study|Lost to Follow-up|7
4537270|NCT01108796|7358028|FG001|Overall Study|Lost to Follow-up|6
4537271|NCT01108809|7358036|FG000|Overall Study|Adverse Event|3
4537272|NCT01108809|7358036|FG000|Overall Study|Lost to Follow-up|1
4537273|NCT01109173|7358091|FG000|Overall Study|Adverse Event|15
4537274|NCT01109173|7358092|FG001|Overall Study|Adverse Event|17
4537275|NCT01109173|7358093|FG002|Overall Study|Adverse Event|9
4453209|NCT00530816|7239906|FG002|Overall Study|Adverse Event|7
4453210|NCT00530816|7239904|FG000|Overall Study|Other|3
4453211|NCT00530816|7239905|FG001|Overall Study|Other|3
4453212|NCT00530816|7239906|FG002|Overall Study|Other|4
4453213|NCT00530816|7239904|FG000|Overall Study|Withdrawal by Subject|1
4453214|NCT00530816|7239905|FG001|Overall Study|Withdrawal by Subject|2
4453215|NCT00530816|7239906|FG002|Overall Study|Withdrawal by Subject|6
4453216|NCT00530842|7239916|FG000|Overall Study|Adverse Event|10
4453217|NCT00530842|7239917|FG001|Overall Study|Adverse Event|6
4453218|NCT00530842|7239916|FG000|Overall Study|Lack of Efficacy|2
4453219|NCT00530842|7239917|FG001|Overall Study|Lack of Efficacy|1
4453220|NCT00530842|7239916|FG000|Overall Study|Lost to Follow-up|0
4537276|NCT01109173|7358094|FG003|Overall Study|Adverse Event|6
4537277|NCT01109173|7358091|FG000|Overall Study|Lost to Follow-up|0
4537278|NCT01109173|7358092|FG001|Overall Study|Lost to Follow-up|1
4453221|NCT00530842|7239917|FG001|Overall Study|Lost to Follow-up|4
4453222|NCT00530842|7239916|FG000|Overall Study|Protocol Violation|3
4453223|NCT00530842|7239917|FG001|Overall Study|Protocol Violation|2
4453224|NCT00530842|7239916|FG000|Overall Study|Withdrawal by Subject|4
4453225|NCT00530842|7239917|FG001|Overall Study|Withdrawal by Subject|5
4453226|NCT00530842|7239916|FG000|Overall Study|Individual different reasons|4
4453227|NCT00530842|7239917|FG001|Overall Study|Individual different reasons|3
4453228|NCT00530842|7239916|FG000|Period 1|Adverse Event|7
4453229|NCT00530842|7239917|FG001|Period 1|Adverse Event|3
4453230|NCT00530842|7239916|FG000|Period 1|Lack of Efficacy|1
4453231|NCT00530842|7239917|FG001|Period 1|Lack of Efficacy|1
4453232|NCT00530842|7239916|FG000|Period 1|Protocol Violation|2
4537279|NCT01109173|7358093|FG002|Overall Study|Lost to Follow-up|0
4537280|NCT01109173|7358094|FG003|Overall Study|Lost to Follow-up|0
4537281|NCT01109173|7358091|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5
4453233|NCT00530842|7239917|FG001|Period 1|Protocol Violation|1
4453234|NCT00530842|7239916|FG000|Period 1|Withdrawal by Subject|2
4453235|NCT00530842|7239917|FG001|Period 1|Withdrawal by Subject|3
4453236|NCT00530842|7239916|FG000|Period 1|Individual different reasons|2
4453237|NCT00530842|7239917|FG001|Period 1|Individual different reasons|3
4453238|NCT00530842|7239916|FG000|Period 2|Adverse Event|3
4453239|NCT00530842|7239917|FG001|Period 2|Adverse Event|3
4453240|NCT00530842|7239916|FG000|Period 2|Lack of Efficacy|1
4453241|NCT00530842|7239917|FG001|Period 2|Lack of Efficacy|0
4453242|NCT00530842|7239916|FG000|Period 2|Lost to Follow-up|0
4453243|NCT00530842|7239917|FG001|Period 2|Lost to Follow-up|4
4453244|NCT00530842|7239916|FG000|Period 2|Protocol Violation|1
4453245|NCT00530842|7239917|FG001|Period 2|Protocol Violation|0
4453246|NCT00530842|7239916|FG000|Period 2|Withdrawal by Subject|1
4453247|NCT00530842|7239917|FG001|Period 2|Withdrawal by Subject|2
4453248|NCT00530842|7239916|FG000|Period 2|Individual different reasons|2
4453249|NCT00530842|7239917|FG001|Period 2|Individual different reasons|0
4453250|NCT00530855|7239925|FG000|Overall Study|Lack of Efficacy|20
4453251|NCT00530855|7239925|FG000|Overall Study|Withdrawal by Subject|30
4453252|NCT00530855|7239925|FG000|Overall Study|Fatal Serious AE|3
4453253|NCT00530855|7239925|FG000|Overall Study|Non Fatal Serious AE|7
4453254|NCT00530855|7239925|FG000|Overall Study|Non Fatal Non Serious AE|12
4453255|NCT00530855|7239925|FG000|Overall Study|Protocol Violation|3
4453256|NCT00530855|7239925|FG000|Overall Study|Unsatisfactory compliance of subject|11
4453257|NCT00530855|7239925|FG000|Overall Study|Lost to Follow-up|9
4453258|NCT00530855|7239925|FG000|Overall Study|Other reason for premature termination|17
4453259|NCT00530894|7239933|FG000|Overall Study|Death|84
4453260|NCT00530894|7239934|FG001|Overall Study|Death|89
4453261|NCT00530894|7239935|FG002|Overall Study|Death|55
4453262|NCT00530894|7239936|FG003|Overall Study|Death|89
4453263|NCT00530894|7239933|FG000|Overall Study|Lost to Follow-up|1
4453264|NCT00530894|7239934|FG001|Overall Study|Lost to Follow-up|3
4453265|NCT00530894|7239935|FG002|Overall Study|Lost to Follow-up|0
4453266|NCT00530894|7239936|FG003|Overall Study|Lost to Follow-up|0
4453267|NCT00530894|7239933|FG000|Overall Study|Withdrawal by Subject|1
4453268|NCT00530894|7239934|FG001|Overall Study|Withdrawal by Subject|23
4453269|NCT00530894|7239935|FG002|Overall Study|Withdrawal by Subject|0
4453270|NCT00530894|7239936|FG003|Overall Study|Withdrawal by Subject|5
4453271|NCT00530894|7239933|FG000|Overall Study|Alive and censored prior to 1 year|2
4453272|NCT00530894|7239934|FG001|Overall Study|Alive and censored prior to 1 year|0
4453273|NCT00530894|7239935|FG002|Overall Study|Alive and censored prior to 1 year|0
4453274|NCT00530894|7239936|FG003|Overall Study|Alive and censored prior to 1 year|0
4453275|NCT00530920|7239951|FG000|Overall Study|Randomized but not treated|0
4453276|NCT00530920|7239952|FG001|Overall Study|Randomized but not treated|2
4453277|NCT00530920|7239953|FG002|Overall Study|Randomized but not treated|0
4453278|NCT00530920|7239951|FG000|Overall Study|Adverse Event|0
4453279|NCT00530920|7239952|FG001|Overall Study|Adverse Event|0
4453280|NCT00530920|7239953|FG002|Overall Study|Adverse Event|3
4453281|NCT00530920|7239951|FG000|Overall Study|Withdrawal by Subject|0
4453282|NCT00530920|7239952|FG001|Overall Study|Withdrawal by Subject|0
4453283|NCT00530920|7239953|FG002|Overall Study|Withdrawal by Subject|1
4453284|NCT00530946|7239966|FG000|Overall Study|Adverse Event|1
4453285|NCT00530946|7239967|FG001|Overall Study|Adverse Event|2
4453286|NCT00530946|7239968|FG002|Overall Study|Adverse Event|1
4453287|NCT00530946|7239969|FG003|Overall Study|Adverse Event|1
4453288|NCT00530946|7239966|FG000|Overall Study|Protocol Violation|0
4453289|NCT00530946|7239967|FG001|Overall Study|Protocol Violation|0
4453290|NCT00530946|7239968|FG002|Overall Study|Protocol Violation|0
4453291|NCT00530946|7239969|FG003|Overall Study|Protocol Violation|1
4453292|NCT00530946|7239966|FG000|Overall Study|Noncompliance|1
4453293|NCT00530946|7239967|FG001|Overall Study|Noncompliance|0
4453294|NCT00530946|7239968|FG002|Overall Study|Noncompliance|0
4453295|NCT00530946|7239969|FG003|Overall Study|Noncompliance|0
4453296|NCT00531011|7239981|FG000|Overall Study|Withdrawal by Subject|2
4453297|NCT00531011|7239982|FG001|Overall Study|Withdrawal by Subject|4
4453298|NCT00531011|7239981|FG000|Overall Study|Death|1
4453299|NCT00531011|7239982|FG001|Overall Study|Death|0
4453300|NCT00531011|7239981|FG000|Overall Study|Lost to Follow-up|1
4453301|NCT00531011|7239982|FG001|Overall Study|Lost to Follow-up|0
4453302|NCT00531011|7239981|FG000|Overall Study|Physician Decision|0
4453303|NCT00531011|7239982|FG001|Overall Study|Physician Decision|3
4453304|NCT00531050|7239994|FG000|Part 1: Period 1|Adverse Event|0
4453305|NCT00531050|7239995|FG001|Part 1: Period 1|Adverse Event|1
4453306|NCT00531050|7239996|FG002|Part 1: Period 1|Adverse Event|0
4453307|NCT00531050|7239997|FG003|Part 1: Period 1|Adverse Event|0
4453308|NCT00531050|7239998|FG004|Part 1: Period 1|Adverse Event|0
4453309|NCT00531050|7239999|FG005|Part 1: Period 1|Adverse Event|0
4453310|NCT00531050|7239994|FG000|Part 1: Period 1|Protocol Deviation|0
4453311|NCT00531050|7239995|FG001|Part 1: Period 1|Protocol Deviation|0
4453312|NCT00531050|7239996|FG002|Part 1: Period 1|Protocol Deviation|0
4453313|NCT00531050|7239997|FG003|Part 1: Period 1|Protocol Deviation|1
4453314|NCT00531050|7239998|FG004|Part 1: Period 1|Protocol Deviation|0
4453315|NCT00531050|7239999|FG005|Part 1: Period 1|Protocol Deviation|0
4453316|NCT00531050|7239994|FG000|Part 1: Period 3|Adverse Event|1
4453317|NCT00531050|7239995|FG001|Part 1: Period 3|Adverse Event|0
4453318|NCT00531050|7239996|FG002|Part 1: Period 3|Adverse Event|0
4453319|NCT00531050|7239997|FG003|Part 1: Period 3|Adverse Event|0
4453320|NCT00531050|7239998|FG004|Part 1: Period 3|Adverse Event|0
4453321|NCT00531050|7239999|FG005|Part 1: Period 3|Adverse Event|0
4453322|NCT00531050|7239994|FG000|Part 2: Period 1|Adverse Event|0
4453323|NCT00531050|7239995|FG001|Part 2: Period 1|Adverse Event|0
4453324|NCT00531050|7239996|FG002|Part 2: Period 1|Adverse Event|0
4453325|NCT00531050|7239997|FG003|Part 2: Period 1|Adverse Event|0
4453326|NCT00531050|7239998|FG004|Part 2: Period 1|Adverse Event|0
4453327|NCT00531050|7239999|FG005|Part 2: Period 1|Adverse Event|1
4453328|NCT00531050|7239994|FG000|Part 2: Period 3|Abnormal test procedure|1
4453329|NCT00531050|7239995|FG001|Part 2: Period 3|Abnormal test procedure|0
4453330|NCT00531050|7239996|FG002|Part 2: Period 3|Abnormal test procedure|0
4453331|NCT00531050|7239997|FG003|Part 2: Period 3|Abnormal test procedure|0
4453332|NCT00531050|7239998|FG004|Part 2: Period 3|Abnormal test procedure|0
4453333|NCT00531050|7239999|FG005|Part 2: Period 3|Abnormal test procedure|1
4453334|NCT00531206|7240016|FG000|Overall Study|Adverse Event related|5
4453335|NCT00531206|7240016|FG000|Overall Study|Lack of Efficacy|2
4453336|NCT00531206|7240016|FG000|Overall Study|Lost to Follow-up|5
4453337|NCT00531206|7240016|FG000|Overall Study|including non-related adverse events|8
4453338|NCT00531284|7240037|FG000|Overall Study|Progressive Disease|1
4453339|NCT00531284|7240038|FG001|Overall Study|Progressive Disease|3
4453340|NCT00531284|7240039|FG002|Overall Study|Progressive Disease|5
4453341|NCT00531284|7240040|FG003|Overall Study|Progressive Disease|42
4453342|NCT00531284|7240041|FG004|Overall Study|Progressive Disease|4
4453343|NCT00531284|7240042|FG005|Overall Study|Progressive Disease|4
4453344|NCT00531284|7240043|FG006|Overall Study|Progressive Disease|3
4453345|NCT00531284|7240044|FG007|Overall Study|Progressive Disease|8
4453346|NCT00531284|7240045|FG008|Overall Study|Progressive Disease|6
4453347|NCT00531284|7240046|FG009|Overall Study|Progressive Disease|3
4453348|NCT00531284|7240047|FG010|Overall Study|Progressive Disease|3
4453349|NCT00531284|7240048|FG011|Overall Study|Progressive Disease|14
4453350|NCT00531284|7240049|FG012|Overall Study|Progressive Disease|2
4453351|NCT00531284|7240050|FG013|Overall Study|Progressive Disease|1
4453352|NCT00531284|7240051|FG014|Overall Study|Progressive Disease|2
4453353|NCT00531284|7240052|FG015|Overall Study|Progressive Disease|11
4453354|NCT00531284|7240053|FG016|Overall Study|Progressive Disease|5
4453355|NCT00531284|7240037|FG000|Overall Study|Adverse Event|0
4453356|NCT00531284|7240038|FG001|Overall Study|Adverse Event|1
4453357|NCT00531284|7240039|FG002|Overall Study|Adverse Event|1
4453358|NCT00531284|7240040|FG003|Overall Study|Adverse Event|7
4453359|NCT00531284|7240041|FG004|Overall Study|Adverse Event|0
4453360|NCT00531284|7240042|FG005|Overall Study|Adverse Event|2
4453361|NCT00531284|7240043|FG006|Overall Study|Adverse Event|3
4453362|NCT00531284|7240044|FG007|Overall Study|Adverse Event|2
4453363|NCT00531284|7240045|FG008|Overall Study|Adverse Event|3
4453364|NCT00531284|7240046|FG009|Overall Study|Adverse Event|0
4453365|NCT00531284|7240047|FG010|Overall Study|Adverse Event|0
4453366|NCT00531284|7240048|FG011|Overall Study|Adverse Event|5
4453367|NCT00531284|7240049|FG012|Overall Study|Adverse Event|0
4453368|NCT00531284|7240050|FG013|Overall Study|Adverse Event|1
4453369|NCT00531284|7240051|FG014|Overall Study|Adverse Event|1
4453370|NCT00531284|7240052|FG015|Overall Study|Adverse Event|0
4453371|NCT00531284|7240053|FG016|Overall Study|Adverse Event|2
4453372|NCT00531284|7240037|FG000|Overall Study|Withdrawal by Subject|1
4453373|NCT00531284|7240038|FG001|Overall Study|Withdrawal by Subject|0
4453374|NCT00531284|7240039|FG002|Overall Study|Withdrawal by Subject|0
4453375|NCT00531284|7240040|FG003|Overall Study|Withdrawal by Subject|4
4453376|NCT00531284|7240041|FG004|Overall Study|Withdrawal by Subject|0
4453377|NCT00531284|7240042|FG005|Overall Study|Withdrawal by Subject|0
4453378|NCT00531284|7240043|FG006|Overall Study|Withdrawal by Subject|0
4453379|NCT00531284|7240044|FG007|Overall Study|Withdrawal by Subject|0
4453380|NCT00531284|7240045|FG008|Overall Study|Withdrawal by Subject|0
4453381|NCT00531284|7240046|FG009|Overall Study|Withdrawal by Subject|0
4453382|NCT00531284|7240047|FG010|Overall Study|Withdrawal by Subject|0
4453383|NCT00531284|7240048|FG011|Overall Study|Withdrawal by Subject|3
4453384|NCT00531284|7240049|FG012|Overall Study|Withdrawal by Subject|0
4453385|NCT00531284|7240050|FG013|Overall Study|Withdrawal by Subject|1
4453386|NCT00531284|7240051|FG014|Overall Study|Withdrawal by Subject|0
4453387|NCT00531284|7240052|FG015|Overall Study|Withdrawal by Subject|1
4453388|NCT00531284|7240053|FG016|Overall Study|Withdrawal by Subject|1
4453389|NCT00531284|7240037|FG000|Overall Study|Other|1
4453390|NCT00531284|7240038|FG001|Overall Study|Other|0
4453391|NCT00531284|7240039|FG002|Overall Study|Other|0
4453392|NCT00531284|7240040|FG003|Overall Study|Other|10
4453393|NCT00531284|7240041|FG004|Overall Study|Other|2
4453394|NCT00531284|7240042|FG005|Overall Study|Other|1
4453395|NCT00531284|7240043|FG006|Overall Study|Other|0
4453396|NCT00531284|7240044|FG007|Overall Study|Other|0
4453397|NCT00531284|7240045|FG008|Overall Study|Other|2
4453398|NCT00531284|7240046|FG009|Overall Study|Other|1
4453399|NCT00531284|7240047|FG010|Overall Study|Other|0
4453400|NCT00531284|7240048|FG011|Overall Study|Other|2
4453401|NCT00531284|7240049|FG012|Overall Study|Other|0
4453402|NCT00531284|7240050|FG013|Overall Study|Other|0
4453403|NCT00531284|7240051|FG014|Overall Study|Other|1
4453404|NCT00531284|7240052|FG015|Overall Study|Other|0
4453405|NCT00531284|7240053|FG016|Overall Study|Other|0
4453406|NCT00531427|7240111|FG000|Overall Study|Withdrawal by Subject|7
4453407|NCT00531427|7240112|FG001|Overall Study|Withdrawal by Subject|13
4453408|NCT00531427|7240111|FG000|Overall Study|Adverse Event|44
4453409|NCT00531427|7240112|FG001|Overall Study|Adverse Event|30
4453410|NCT00531427|7240111|FG000|Overall Study|Lost to Follow-up|4
4453411|NCT00531427|7240112|FG001|Overall Study|Lost to Follow-up|3
4453412|NCT00531427|7240111|FG000|Overall Study|Lack of Efficacy|14
4453413|NCT00531427|7240112|FG001|Overall Study|Lack of Efficacy|39
4453414|NCT00531427|7240111|FG000|Overall Study|Administrative|4
4453415|NCT00531427|7240112|FG001|Overall Study|Administrative|9
4453416|NCT00531479|7240130|FG000|Overall Study|Death|68
4453417|NCT00531479|7240131|FG001|Overall Study|Death|71
4453418|NCT00531479|7240130|FG000|Overall Study|Lost to Follow-up|0
4453419|NCT00531479|7240131|FG001|Overall Study|Lost to Follow-up|2
4453420|NCT00531479|7240130|FG000|Overall Study|Other|0
4453421|NCT00531479|7240131|FG001|Overall Study|Other|1
4453422|NCT00531479|7240130|FG000|Overall Study|Withdrawal by Subject|6
4453423|NCT00531479|7240131|FG001|Overall Study|Withdrawal by Subject|6
4453424|NCT00531479|7240130|FG000|Overall Study|Did not receive treatment|2
4453425|NCT00531479|7240131|FG001|Overall Study|Did not receive treatment|3
4453426|NCT00531752|7240162|FG000|First Double-blind Intervention Period|Adverse Event|2
4453427|NCT00531752|7240163|FG001|First Double-blind Intervention Period|Adverse Event|0
4453428|NCT00531752|7240164|FG002|First Double-blind Intervention Period|Adverse Event|1
4453429|NCT00531752|7240165|FG003|First Double-blind Intervention Period|Adverse Event|1
4453430|NCT00531752|7240162|FG000|First Double-blind Intervention Period|Other|1
4453431|NCT00531752|7240163|FG001|First Double-blind Intervention Period|Other|4
4453432|NCT00531752|7240164|FG002|First Double-blind Intervention Period|Other|4
4453433|NCT00531752|7240165|FG003|First Double-blind Intervention Period|Other|0
4453434|NCT00531752|7240162|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2
4453435|NCT00531752|7240163|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0
4453436|NCT00531752|7240164|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1
4453437|NCT00531752|7240165|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1
4453438|NCT00531752|7240162|FG000|First Double-blind Intervention Period|Lost to Follow-up|0
4453439|NCT00531752|7240163|FG001|First Double-blind Intervention Period|Lost to Follow-up|0
4453440|NCT00531752|7240164|FG002|First Double-blind Intervention Period|Lost to Follow-up|1
4453441|NCT00531752|7240165|FG003|First Double-blind Intervention Period|Lost to Follow-up|1
4453442|NCT00531752|7240162|FG000|First Double-blind Intervention Period|Randomized but not treated|1
4453443|NCT00531752|7240163|FG001|First Double-blind Intervention Period|Randomized but not treated|0
4453444|NCT00531752|7240164|FG002|First Double-blind Intervention Period|Randomized but not treated|0
4453445|NCT00531752|7240165|FG003|First Double-blind Intervention Period|Randomized but not treated|0
4453446|NCT00531752|7240162|FG000|Second Double-blind Intervention Period|Adverse Event|1
4453447|NCT00531752|7240163|FG001|Second Double-blind Intervention Period|Adverse Event|1
4453448|NCT00531752|7240164|FG002|Second Double-blind Intervention Period|Adverse Event|0
4453449|NCT00531752|7240165|FG003|Second Double-blind Intervention Period|Adverse Event|0
4453450|NCT00531752|7240162|FG000|Second Double-blind Intervention Period|Other|1
4453451|NCT00531752|7240163|FG001|Second Double-blind Intervention Period|Other|1
4453452|NCT00531752|7240164|FG002|Second Double-blind Intervention Period|Other|0
4453453|NCT00531752|7240165|FG003|Second Double-blind Intervention Period|Other|0
4453454|NCT00531752|7240162|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0
4453455|NCT00531752|7240163|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0
4453456|NCT00531752|7240164|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0
4453457|NCT00531752|7240165|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1
4453458|NCT00531752|7240162|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0
4453459|NCT00531752|7240163|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0
4453460|NCT00531752|7240164|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0
4453461|NCT00531752|7240165|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1
4453462|NCT00531934|7240207|FG000|Overall Study|Adverse Event|4
4453463|NCT00531934|7240208|FG001|Overall Study|Adverse Event|8
4453464|NCT00531934|7240207|FG000|Overall Study|Progression|52
4453465|NCT00531934|7240208|FG001|Overall Study|Progression|42
4453466|NCT00531934|7240207|FG000|Overall Study|Death|7
4453467|NCT00531934|7240208|FG001|Overall Study|Death|10
4453468|NCT00531934|7240207|FG000|Overall Study|Withdrawal by Subject|1
4453469|NCT00531934|7240208|FG001|Overall Study|Withdrawal by Subject|1
4453470|NCT00531934|7240207|FG000|Overall Study|Other|2
4453471|NCT00531934|7240208|FG001|Overall Study|Other|2
4453472|NCT00531947|7240216|FG000|Overall Study|Adverse Event|5
4453473|NCT00531947|7240217|FG001|Overall Study|Adverse Event|10
4453474|NCT00531947|7240216|FG000|Overall Study|Lost to Follow-up|12
4453475|NCT00531947|7240217|FG001|Overall Study|Lost to Follow-up|9
4453476|NCT00531947|7240216|FG000|Overall Study|Withdrawal by Subject|14
4453477|NCT00531947|7240217|FG001|Overall Study|Withdrawal by Subject|19
4453478|NCT00531947|7240216|FG000|Overall Study|Protocol Violation|2
4453479|NCT00531947|7240217|FG001|Overall Study|Protocol Violation|1
4453480|NCT00531947|7240216|FG000|Overall Study|Non-Compliance|4
4453481|NCT00531947|7240217|FG001|Overall Study|Non-Compliance|7
4453482|NCT00531947|7240216|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5
4453483|NCT00531947|7240217|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5
4453484|NCT00531960|7240225|FG000|Overall Study|Adverse Event|5
4453485|NCT00531960|7240226|FG001|Overall Study|Adverse Event|4
4453486|NCT00531960|7240225|FG000|Overall Study|Death|3
4453487|NCT00531960|7240226|FG001|Overall Study|Death|2
4453488|NCT00531960|7240225|FG000|Overall Study|Lack of Efficacy|42
4453489|NCT00531960|7240226|FG001|Overall Study|Lack of Efficacy|41
4453490|NCT00531960|7240225|FG000|Overall Study|Violation of Selection Criteria|2
4453491|NCT00531960|7240226|FG001|Overall Study|Violation of Selection Criteria|0
4453492|NCT00531960|7240225|FG000|Overall Study|Refused Treatment|5
4453493|NCT00531960|7240226|FG001|Overall Study|Refused Treatment|6
4453494|NCT00531960|7240225|FG000|Overall Study|Other|4
4453495|NCT00531960|7240226|FG001|Overall Study|Other|10
4453496|NCT00532129|7240232|FG000|Treatment Period|Adverse event/Serious adverse event|25
4453497|NCT00532129|7240232|FG000|Treatment Period|Physician Decision|15
4453498|NCT00532129|7240232|FG000|Treatment Period|Disease progression|3
4453499|NCT00532129|7240232|FG000|Treatment Period|Protocol Violation|1
4453500|NCT00532129|7240232|FG000|Treatment Period|Other|5
4453501|NCT00532129|7240232|FG000|Follow-up Period|Adverse event/Serious adverse event|1
4453502|NCT00532129|7240232|FG000|Follow-up Period|Disease progression|57
4453503|NCT00532129|7240232|FG000|Follow-up Period|Lost to Follow-up|1
4453504|NCT00532129|7240232|FG000|Follow-up Period|Other|6
4453505|NCT00532155|7240238|FG000|Overall Study|Adverse Event|66
4453506|NCT00532155|7240239|FG001|Overall Study|Adverse Event|123
4453507|NCT00532155|7240238|FG000|Overall Study|Lack of Efficacy|332
4453508|NCT00532155|7240239|FG001|Overall Study|Lack of Efficacy|255
4453509|NCT00532155|7240238|FG000|Overall Study|Protocol Violation|1
4453510|NCT00532155|7240239|FG001|Overall Study|Protocol Violation|3
4453511|NCT00532155|7240238|FG000|Overall Study|Lost to Follow-up|2
4453512|NCT00532155|7240239|FG001|Overall Study|Lost to Follow-up|0
4453513|NCT00532155|7240238|FG000|Overall Study|Physician Decision|16
4453514|NCT00532155|7240239|FG001|Overall Study|Physician Decision|15
4453515|NCT00532155|7240238|FG000|Overall Study|Withdrawal by Subject|23
4453516|NCT00532155|7240239|FG001|Overall Study|Withdrawal by Subject|44
4453517|NCT00532155|7240238|FG000|Overall Study|Consent withdrawn|5
4453518|NCT00532155|7240239|FG001|Overall Study|Consent withdrawn|7
4453519|NCT00532155|7240238|FG000|Overall Study|Moved|1
4453520|NCT00532155|7240239|FG001|Overall Study|Moved|0
4453521|NCT00532155|7240238|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1
4453522|NCT00532155|7240239|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0
4453523|NCT00532155|7240238|FG000|Overall Study|Occurence of a second cancer|0
4453524|NCT00532155|7240239|FG001|Overall Study|Occurence of a second cancer|1
4453525|NCT00532155|7240238|FG000|Overall Study|Occurence of a secondary cancer|0
4453526|NCT00532155|7240239|FG001|Overall Study|Occurence of a secondary cancer|1
4453527|NCT00532155|7240238|FG000|Overall Study|Promotor ended study|1
4453528|NCT00532155|7240239|FG001|Overall Study|Promotor ended study|0
4453529|NCT00532155|7240238|FG000|Overall Study|Progressive disease (by incorrect scan)|0
4453530|NCT00532155|7240239|FG001|Overall Study|Progressive disease (by incorrect scan)|1
4453531|NCT00532155|7240238|FG000|Overall Study|Had brain metastasis, was mis-randomized|1
4453532|NCT00532155|7240239|FG001|Overall Study|Had brain metastasis, was mis-randomized|0
4453533|NCT00532155|7240238|FG000|Overall Study|Study stopped|1
4453534|NCT00532155|7240239|FG001|Overall Study|Study stopped|0
4453535|NCT00532155|7240238|FG000|Overall Study|Study terminated by sponsor|1
4453536|NCT00532155|7240239|FG001|Overall Study|Study terminated by sponsor|0
4453537|NCT00532155|7240238|FG000|Overall Study|Study termination stop further treatment|4
4453538|NCT00532155|7240239|FG001|Overall Study|Study termination stop further treatment|0
4453539|NCT00532155|7240238|FG000|Overall Study|Did not receive study medication|2
4453540|NCT00532155|7240239|FG001|Overall Study|Did not receive study medication|6
4453541|NCT00532259|7240245|FG000|Overall Study|Withdrawal by Subject|2
4453542|NCT00532259|7240245|FG000|Overall Study|Adverse Event|1
4453543|NCT00532259|7240245|FG000|Overall Study|Death|1
4453544|NCT00532259|7240245|FG000|Overall Study|Lack of Efficacy|21
4453545|NCT00532259|7240245|FG000|Overall Study|Lost to Follow-up|3
4453546|NCT00532259|7240245|FG000|Overall Study|Physician Decision|3
4453547|NCT00532259|7240245|FG000|Overall Study|Protocol Violation|1
4453548|NCT00532298|7240256|FG000|Overall Study|Adverse Event|1
4453549|NCT00532298|7240257|FG001|Overall Study|Adverse Event|0
4453550|NCT00532298|7240258|FG002|Overall Study|Adverse Event|0
4453551|NCT00532298|7240259|FG003|Overall Study|Adverse Event|0
4453552|NCT00532298|7240260|FG004|Overall Study|Adverse Event|1
4453553|NCT00532298|7240261|FG005|Overall Study|Adverse Event|1
4453554|NCT00532298|7240256|FG000|Overall Study|Lost to Follow-up|1
4453555|NCT00532298|7240257|FG001|Overall Study|Lost to Follow-up|1
4453556|NCT00532298|7240258|FG002|Overall Study|Lost to Follow-up|1
4453557|NCT00532298|7240259|FG003|Overall Study|Lost to Follow-up|0
4453558|NCT00532298|7240260|FG004|Overall Study|Lost to Follow-up|0
4453559|NCT00532298|7240261|FG005|Overall Study|Lost to Follow-up|1
4453560|NCT00532441|7240275|FG000|Overall Study|Death|1
4453561|NCT00532441|7240276|FG001|Overall Study|Death|0
4453562|NCT00532493|7240291|FG000|Overall Study|Death|1
4453563|NCT00532493|7240292|FG001|Overall Study|Death|1
4453564|NCT00532493|7240291|FG000|Overall Study|Lost to Follow-up|10
4453565|NCT00532493|7240292|FG001|Overall Study|Lost to Follow-up|7
4453566|NCT00532493|7240291|FG000|Overall Study|Withdrawal by Subject|7
4453567|NCT00532493|7240292|FG001|Overall Study|Withdrawal by Subject|9
4453568|NCT00532493|7240291|FG000|Overall Study|Physician Decision|1
4453569|NCT00532493|7240292|FG001|Overall Study|Physician Decision|6
4453570|NCT00532493|7240291|FG000|Overall Study|Adverse Event|6
4453571|NCT00532493|7240292|FG001|Overall Study|Adverse Event|5
4453572|NCT00532493|7240291|FG000|Overall Study|Protocol Deviation|1
4453573|NCT00532493|7240292|FG001|Overall Study|Protocol Deviation|0
4453574|NCT00532493|7240291|FG000|Overall Study|Subject Moved Away|3
4453575|NCT00532493|7240292|FG001|Overall Study|Subject Moved Away|1
4453576|NCT00532493|7240291|FG000|Overall Study|Contraindicative Medication|1
4453577|NCT00532493|7240292|FG001|Overall Study|Contraindicative Medication|0
4453578|NCT00532779|7240303|FG000|Overall Study|Adverse Event|122
4453579|NCT00532779|7240304|FG001|Overall Study|Adverse Event|112
4453580|NCT00532779|7240305|FG002|Overall Study|Adverse Event|56
4453581|NCT00532779|7240303|FG000|Overall Study|Lost to Follow-up|76
4453582|NCT00532779|7240304|FG001|Overall Study|Lost to Follow-up|65
4453583|NCT00532779|7240305|FG002|Overall Study|Lost to Follow-up|66
4453584|NCT00532779|7240303|FG000|Overall Study|Withdrawal by Subject|63
4453585|NCT00532779|7240304|FG001|Overall Study|Withdrawal by Subject|60
4453586|NCT00532779|7240305|FG002|Overall Study|Withdrawal by Subject|90
4453587|NCT00532779|7240303|FG000|Overall Study|Lack of Efficacy|12
4453588|NCT00532779|7240304|FG001|Overall Study|Lack of Efficacy|12
4453589|NCT00532779|7240305|FG002|Overall Study|Lack of Efficacy|40
4453590|NCT00532779|7240303|FG000|Overall Study|Protocol Violation|5
4453591|NCT00532779|7240304|FG001|Overall Study|Protocol Violation|9
4453592|NCT00532779|7240305|FG002|Overall Study|Protocol Violation|7
4453593|NCT00532779|7240303|FG000|Overall Study|Pregnancy|2
4453594|NCT00532779|7240304|FG001|Overall Study|Pregnancy|5
4453595|NCT00532779|7240305|FG002|Overall Study|Pregnancy|3
4453596|NCT00532779|7240303|FG000|Overall Study|Death|0
4453597|NCT00532779|7240304|FG001|Overall Study|Death|1
4453598|NCT00532779|7240305|FG002|Overall Study|Death|0
4453599|NCT00532779|7240303|FG000|Overall Study|Drug noncompliance, moved, other|14
4453600|NCT00532779|7240304|FG001|Overall Study|Drug noncompliance, moved, other|23
4453601|NCT00532779|7240305|FG002|Overall Study|Drug noncompliance, moved, other|29
4453602|NCT00532844|7240315|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0
4453603|NCT00532844|7240316|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1
4453604|NCT00532844|7240315|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1
4453605|NCT00532844|7240316|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0
4453606|NCT00532844|7240315|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1
4453607|NCT00532844|7240316|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0
4453608|NCT00532844|7240315|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1
4453609|NCT00532844|7240316|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0
4453610|NCT00532844|7240315|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1
4453611|NCT00532844|7240316|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0
4453612|NCT00532883|7240339|FG000|Overall Study|Adverse Event|1
4453613|NCT00532883|7240340|FG001|Overall Study|Adverse Event|0
4453614|NCT00532883|7240341|FG002|Overall Study|Adverse Event|0
4453615|NCT00532883|7240342|FG003|Overall Study|Adverse Event|1
4453616|NCT00532883|7240339|FG000|Overall Study|Lost to Follow-up|1
4453617|NCT00532883|7240340|FG001|Overall Study|Lost to Follow-up|1
4453618|NCT00532883|7240341|FG002|Overall Study|Lost to Follow-up|1
4453619|NCT00532883|7240342|FG003|Overall Study|Lost to Follow-up|0
4453620|NCT00532883|7240339|FG000|Overall Study|Withdrawal by Subject|0
4453621|NCT00532883|7240340|FG001|Overall Study|Withdrawal by Subject|1
4453622|NCT00532883|7240341|FG002|Overall Study|Withdrawal by Subject|1
4453623|NCT00532883|7240342|FG003|Overall Study|Withdrawal by Subject|0
4453624|NCT00532883|7240339|FG000|Overall Study|Subject was Nonadherent|0
4453625|NCT00532883|7240340|FG001|Overall Study|Subject was Nonadherent|1
4453626|NCT00532883|7240341|FG002|Overall Study|Subject was Nonadherent|1
4453627|NCT00532883|7240342|FG003|Overall Study|Subject was Nonadherent|0
4453628|NCT00532883|7240339|FG000|Overall Study|Early Study Termination|4
4453629|NCT00532883|7240340|FG001|Overall Study|Early Study Termination|4
4453630|NCT00532883|7240341|FG002|Overall Study|Early Study Termination|1
4453631|NCT00532883|7240342|FG003|Overall Study|Early Study Termination|4
4453632|NCT00532935|7240354|FG000|Overall Study|Adverse Event|11
4453633|NCT00532935|7240355|FG001|Overall Study|Adverse Event|12
4453634|NCT00532935|7240354|FG000|Overall Study|Lack of Efficacy|0
4453635|NCT00532935|7240355|FG001|Overall Study|Lack of Efficacy|3
4453636|NCT00532935|7240354|FG000|Overall Study|Lost to Follow-up|10
4453637|NCT00532935|7240355|FG001|Overall Study|Lost to Follow-up|6
4453638|NCT00532935|7240354|FG000|Overall Study|Physician Decision|4
4453639|NCT00532935|7240355|FG001|Overall Study|Physician Decision|5
4453640|NCT00532935|7240354|FG000|Overall Study|Pregnancy|1
4453641|NCT00532935|7240355|FG001|Overall Study|Pregnancy|0
4453642|NCT00532935|7240354|FG000|Overall Study|Protocol Violation|4
4453643|NCT00532935|7240355|FG001|Overall Study|Protocol Violation|2
4453644|NCT00532935|7240354|FG000|Overall Study|Withdrawal by Subject|10
4453645|NCT00532935|7240355|FG001|Overall Study|Withdrawal by Subject|9
4453646|NCT00532935|7240354|FG000|Overall Study|Protocol Specific Criteria|11
4453647|NCT00532935|7240355|FG001|Overall Study|Protocol Specific Criteria|15
4453648|NCT00532948|7240364|FG000|Overall Study|Protocol Violation|1
4453649|NCT00532948|7240365|FG001|Overall Study|Protocol Violation|0
4453650|NCT00532948|7240366|FG002|Overall Study|Protocol Violation|0
4453651|NCT00532948|7240364|FG000|Overall Study|Death|3
4453652|NCT00532948|7240365|FG001|Overall Study|Death|3
4453653|NCT00532948|7240366|FG002|Overall Study|Death|4
4453654|NCT00532948|7240364|FG000|Overall Study|Violation of selection criteria at entry|0
4453655|NCT00532948|7240365|FG001|Overall Study|Violation of selection criteria at entry|1
4453656|NCT00532948|7240366|FG002|Overall Study|Violation of selection criteria at entry|0
4453657|NCT00532948|7240364|FG000|Overall Study|Failure to return|0
4453658|NCT00532948|7240365|FG001|Overall Study|Failure to return|1
4453659|NCT00532948|7240366|FG002|Overall Study|Failure to return|0
4453660|NCT00533273|7240397|FG000|Double-blind|Withdrew consent|0
4453661|NCT00533273|7240398|FG001|Double-blind|Withdrew consent|2
4453662|NCT00533273|7240397|FG000|Open-label|Withdrawal by Subject|6
4453663|NCT00533273|7240398|FG001|Open-label|Withdrawal by Subject|0
4453664|NCT00533429|7240406|FG000|Overall Study|Adverse Event|3
4453665|NCT00533429|7240407|FG001|Overall Study|Adverse Event|1
4453666|NCT00533429|7240406|FG000|Overall Study|Death|1
4453667|NCT00533429|7240407|FG001|Overall Study|Death|0
4453668|NCT00533429|7240406|FG000|Overall Study|Withdrawal by Subject|2
4453669|NCT00533429|7240407|FG001|Overall Study|Withdrawal by Subject|0
4453670|NCT00533429|7240406|FG000|Overall Study|Progressive Disease|12
4453671|NCT00533429|7240407|FG001|Overall Study|Progressive Disease|13
4453672|NCT00533429|7240406|FG000|Overall Study|Symptomatic deterioration|1
4453673|NCT00533429|7240407|FG001|Overall Study|Symptomatic deterioration|2
4453674|NCT00533507|7240426|FG000|Overall Study|Withdrawal by Subject|1
4453675|NCT00533702|7240437|FG000|Overall Study|Withdrawal by Subject|3
4453676|NCT00533702|7240438|FG001|Overall Study|Withdrawal by Subject|1
4453677|NCT00533702|7240437|FG000|Overall Study|Found ineligible after randomization|2
4453678|NCT00533702|7240438|FG001|Overall Study|Found ineligible after randomization|1
4453679|NCT00533845|7240446|FG000|Overall Study|Physician Decision|1
4453680|NCT00533845|7240447|FG001|Overall Study|Physician Decision|0
4453681|NCT00533897|7240456|FG000|Lead-in (LI) Period 1|Adverse Event|1
4453682|NCT00533897|7240457|FG001|Lead-in (LI) Period 1|Adverse Event|0
4453683|NCT00533897|7240458|FG002|Lead-in (LI) Period 1|Adverse Event|0
4453684|NCT00533897|7240459|FG003|Lead-in (LI) Period 1|Adverse Event|0
4453685|NCT00533897|7240460|FG004|Lead-in (LI) Period 1|Adverse Event|0
4453686|NCT00533897|7240461|FG005|Lead-in (LI) Period 1|Adverse Event|0
4453687|NCT00533897|7240462|FG006|Lead-in (LI) Period 1|Adverse Event|0
4453688|NCT00533897|7240463|FG007|Lead-in (LI) Period 1|Adverse Event|0
4453689|NCT00533897|7240456|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2
4453690|NCT00533897|7240457|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0
4453691|NCT00533897|7240458|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0
4453692|NCT00533897|7240459|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0
4453693|NCT00533897|7240460|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0
4453694|NCT00533897|7240461|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0
4453695|NCT00533897|7240462|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0
4453696|NCT00533897|7240463|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0
4453697|NCT00533897|7240456|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1
4453698|NCT00533897|7240457|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0
4453699|NCT00533897|7240458|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0
4453700|NCT00533897|7240459|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0
4453701|NCT00533897|7240460|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0
4453702|NCT00533897|7240461|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0
4453703|NCT00533897|7240462|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0
4453704|NCT00533897|7240463|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0
4453705|NCT00533897|7240456|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2
4453706|NCT00533897|7240457|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
4453707|NCT00533897|7240458|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
4453708|NCT00533897|7240459|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
4453709|NCT00533897|7240460|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
4453710|NCT00533897|7240461|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
4453711|NCT00533897|7240462|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
4453712|NCT00533897|7240463|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
4453713|NCT00533897|7240456|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3
4453714|NCT00533897|7240457|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0
4453715|NCT00533897|7240458|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0
4453716|NCT00533897|7240459|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0
4453717|NCT00533897|7240460|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0
4453718|NCT00533897|7240461|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0
4453719|NCT00533897|7240462|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0
4453720|NCT00533897|7240463|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0
4453721|NCT00533897|7240456|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1
4453722|NCT00533897|7240457|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
4453723|NCT00533897|7240458|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
4453724|NCT00533897|7240459|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
4453725|NCT00533897|7240460|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
4453726|NCT00533897|7240461|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
4453727|NCT00533897|7240462|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
4453728|NCT00533897|7240463|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
4453729|NCT00533897|7240456|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
4453730|NCT00533897|7240457|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1
4453731|NCT00533897|7240458|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2
4453732|NCT00533897|7240459|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
4453733|NCT00533897|7240460|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
4453734|NCT00533897|7240461|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
4453735|NCT00533897|7240462|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
4453736|NCT00533897|7240463|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
4453737|NCT00533897|7240456|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
4453738|NCT00533897|7240457|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
4453739|NCT00533897|7240458|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1
4453740|NCT00533897|7240459|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
4453741|NCT00533897|7240460|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
4453742|NCT00533897|7240461|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
4453743|NCT00533897|7240462|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
4453744|NCT00533897|7240463|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
4453745|NCT00533897|7240456|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
4453746|NCT00533897|7240457|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
4453747|NCT00533897|7240458|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
4453748|NCT00533897|7240459|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
4453749|NCT00533897|7240460|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
4453750|NCT00533897|7240461|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1
4453751|NCT00533897|7240462|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
4453752|NCT00533897|7240463|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
4453753|NCT00533897|7240456|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
4453754|NCT00533897|7240457|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
4453755|NCT00533897|7240458|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
4453756|NCT00533897|7240459|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
4453757|NCT00533897|7240460|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
4453758|NCT00533897|7240461|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1
4453759|NCT00533897|7240462|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
4453760|NCT00533897|7240463|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
4453761|NCT00533897|7240456|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0
4453762|NCT00533897|7240457|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0
4453763|NCT00533897|7240458|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0
4453764|NCT00533897|7240459|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0
4453765|NCT00533897|7240460|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0
4453766|NCT00533897|7240461|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0
4453767|NCT00533897|7240462|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2
4453768|NCT00533897|7240463|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5
4453769|NCT00533897|7240456|FG000|Long Term Extension (LTE)|Death|0
4453770|NCT00533897|7240457|FG001|Long Term Extension (LTE)|Death|0
4453771|NCT00533897|7240458|FG002|Long Term Extension (LTE)|Death|0
4453772|NCT00533897|7240459|FG003|Long Term Extension (LTE)|Death|0
4453773|NCT00533897|7240460|FG004|Long Term Extension (LTE)|Death|0
4453774|NCT00533897|7240461|FG005|Long Term Extension (LTE)|Death|0
4453775|NCT00533897|7240462|FG006|Long Term Extension (LTE)|Death|1
4453776|NCT00533897|7240463|FG007|Long Term Extension (LTE)|Death|3
4453777|NCT00533897|7240456|FG000|Long Term Extension (LTE)|Lack of Efficacy|0
4453778|NCT00533897|7240457|FG001|Long Term Extension (LTE)|Lack of Efficacy|0
4453779|NCT00533897|7240458|FG002|Long Term Extension (LTE)|Lack of Efficacy|0
4453780|NCT00533897|7240459|FG003|Long Term Extension (LTE)|Lack of Efficacy|0
4453781|NCT00533897|7240460|FG004|Long Term Extension (LTE)|Lack of Efficacy|0
4453782|NCT00533897|7240461|FG005|Long Term Extension (LTE)|Lack of Efficacy|0
4453783|NCT00533897|7240462|FG006|Long Term Extension (LTE)|Lack of Efficacy|5
4453784|NCT00533897|7240463|FG007|Long Term Extension (LTE)|Lack of Efficacy|3
4453785|NCT00533897|7240456|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0
4453786|NCT00533897|7240457|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0
4453787|NCT00533897|7240458|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0
4453788|NCT00533897|7240459|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0
4453789|NCT00533897|7240460|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0
4453790|NCT00533897|7240461|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0
4453791|NCT00533897|7240462|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1
4453792|NCT00533897|7240463|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0
4453793|NCT00533897|7240456|FG000|Long Term Extension (LTE)|Adverse Event|0
4453794|NCT00533897|7240457|FG001|Long Term Extension (LTE)|Adverse Event|0
4453795|NCT00533897|7240458|FG002|Long Term Extension (LTE)|Adverse Event|0
4610753|NCT01695239|7466963|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1
4734814|NCT03505021|7682014|FG000|Overall Study|Other|11
4453796|NCT00533897|7240459|FG003|Long Term Extension (LTE)|Adverse Event|0
4453797|NCT00533897|7240460|FG004|Long Term Extension (LTE)|Adverse Event|0
4453798|NCT00533897|7240461|FG005|Long Term Extension (LTE)|Adverse Event|0
4610754|NCT01695239|7466964|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0
4610755|NCT01695239|7466965|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0
4610756|NCT01695239|7466966|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0
4610757|NCT01695239|7466967|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0
4610758|NCT01695239|7466954|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0
4610759|NCT01695239|7466955|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0
4610760|NCT01695239|7466956|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0
4453799|NCT00533897|7240462|FG006|Long Term Extension (LTE)|Adverse Event|2
4453800|NCT00533897|7240463|FG007|Long Term Extension (LTE)|Adverse Event|5
4453801|NCT00533897|7240456|FG000|Long Term Extension (LTE)|Pregnancy|0
4453802|NCT00533897|7240457|FG001|Long Term Extension (LTE)|Pregnancy|0
4453803|NCT00533897|7240458|FG002|Long Term Extension (LTE)|Pregnancy|0
4453804|NCT00533897|7240459|FG003|Long Term Extension (LTE)|Pregnancy|0
4453805|NCT00533897|7240460|FG004|Long Term Extension (LTE)|Pregnancy|0
4453806|NCT00533897|7240461|FG005|Long Term Extension (LTE)|Pregnancy|0
4453807|NCT00533897|7240462|FG006|Long Term Extension (LTE)|Pregnancy|0
4453808|NCT00533897|7240463|FG007|Long Term Extension (LTE)|Pregnancy|2
4453809|NCT00533897|7240456|FG000|Long Term Extension (LTE)|Lost to Follow-up|0
4453810|NCT00533897|7240457|FG001|Long Term Extension (LTE)|Lost to Follow-up|0
4453811|NCT00533897|7240458|FG002|Long Term Extension (LTE)|Lost to Follow-up|0
4453812|NCT00533897|7240459|FG003|Long Term Extension (LTE)|Lost to Follow-up|0
4453813|NCT00533897|7240460|FG004|Long Term Extension (LTE)|Lost to Follow-up|0
4453814|NCT00533897|7240461|FG005|Long Term Extension (LTE)|Lost to Follow-up|0
4453815|NCT00533897|7240462|FG006|Long Term Extension (LTE)|Lost to Follow-up|1
4453816|NCT00533897|7240463|FG007|Long Term Extension (LTE)|Lost to Follow-up|1
4453817|NCT00533897|7240456|FG000|Long Term Extension (LTE)|Other|0
4453818|NCT00533897|7240457|FG001|Long Term Extension (LTE)|Other|0
4453819|NCT00533897|7240458|FG002|Long Term Extension (LTE)|Other|0
4453820|NCT00533897|7240459|FG003|Long Term Extension (LTE)|Other|0
4453821|NCT00533897|7240460|FG004|Long Term Extension (LTE)|Other|0
4453822|NCT00533897|7240461|FG005|Long Term Extension (LTE)|Other|0
4453823|NCT00533897|7240462|FG006|Long Term Extension (LTE)|Other|1
4453824|NCT00533897|7240463|FG007|Long Term Extension (LTE)|Other|6
4453825|NCT00533949|7240507|FG000|Overall Study|Protocol Violation|12
4453826|NCT00533949|7240508|FG001|Overall Study|Protocol Violation|12
4453827|NCT00533949|7240509|FG002|Overall Study|Protocol Violation|9
4453828|NCT00533949|7240510|FG003|Overall Study|Protocol Violation|9
4453829|NCT00533949|7240507|FG000|Overall Study|Withdrawal by Subject|3
4453830|NCT00533949|7240508|FG001|Overall Study|Withdrawal by Subject|2
4453831|NCT00533949|7240509|FG002|Overall Study|Withdrawal by Subject|1
4453832|NCT00533949|7240510|FG003|Overall Study|Withdrawal by Subject|1
4453833|NCT00534092|7240539|FG000|Overall Study|Lost to Follow-up|1
4453834|NCT00534092|7240540|FG001|Overall Study|Lost to Follow-up|0
4453835|NCT00534092|7240539|FG000|Overall Study|personal reasons/family concerns|1
4453836|NCT00534092|7240540|FG001|Overall Study|personal reasons/family concerns|0
4537282|NCT01109173|7358092|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0
4537283|NCT01109173|7358093|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2
4537284|NCT01109173|7358094|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0
4537285|NCT01109173|7358091|FG000|Overall Study|Noncompliance|0
4537286|NCT01109173|7358092|FG001|Overall Study|Noncompliance|1
4537287|NCT01109173|7358093|FG002|Overall Study|Noncompliance|0
4537288|NCT01109173|7358094|FG003|Overall Study|Noncompliance|0
4537289|NCT01109173|7358091|FG000|Overall Study|Treatment Failure|25
4537290|NCT01109173|7358092|FG001|Overall Study|Treatment Failure|32
4537291|NCT01109173|7358093|FG002|Overall Study|Treatment Failure|69
4537292|NCT01109173|7358094|FG003|Overall Study|Treatment Failure|64
4537293|NCT01109173|7358091|FG000|Overall Study|Protocol Violation|4
4537294|NCT01109173|7358092|FG001|Overall Study|Protocol Violation|5
4537295|NCT01109173|7358093|FG002|Overall Study|Protocol Violation|1
4537296|NCT01109173|7358094|FG003|Overall Study|Protocol Violation|2
4537297|NCT01109173|7358091|FG000|Overall Study|Patient Did Not Use Study Medication|34
4537298|NCT01109173|7358092|FG001|Overall Study|Patient Did Not Use Study Medication|26
4537299|NCT01109173|7358093|FG002|Overall Study|Patient Did Not Use Study Medication|11
4537300|NCT01109173|7358094|FG003|Overall Study|Patient Did Not Use Study Medication|7
4537301|NCT01109173|7358091|FG000|Overall Study|Not Specifiied|5
4537302|NCT01109173|7358092|FG001|Overall Study|Not Specifiied|4
4537303|NCT01109173|7358093|FG002|Overall Study|Not Specifiied|9
4537304|NCT01109173|7358094|FG003|Overall Study|Not Specifiied|14
4537305|NCT01109316|7358110|FG000|Study Period 1|Adverse Event|0
4537306|NCT01109316|7358111|FG001|Study Period 1|Adverse Event|0
4537307|NCT01109316|7358112|FG002|Study Period 1|Adverse Event|1
4537308|NCT01109316|7358113|FG003|Study Period 1|Adverse Event|0
4537309|NCT01109316|7358114|FG004|Study Period 1|Adverse Event|0
4537310|NCT01109316|7358115|FG005|Study Period 1|Adverse Event|0
4537311|NCT01109316|7358110|FG000|Study Period 1|Lost to Follow-up|0
4537312|NCT01109316|7358111|FG001|Study Period 1|Lost to Follow-up|0
4537313|NCT01109316|7358112|FG002|Study Period 1|Lost to Follow-up|1
4453837|NCT00534105|7240550|FG000|Overall Study|Lost to Follow-up|23
4453838|NCT00534105|7240551|FG001|Overall Study|Lost to Follow-up|39
4453839|NCT00534248|7240586|FG000|Overall Study|Adverse Event|19
4453840|NCT00534248|7240587|FG001|Overall Study|Adverse Event|29
4453841|NCT00534248|7240586|FG000|Overall Study|Lost to Follow-up|353
4453842|NCT00534248|7240587|FG001|Overall Study|Lost to Follow-up|375
4453843|NCT00534248|7240586|FG000|Overall Study|Other protocol specified criteria|13
4453844|NCT00534248|7240587|FG001|Overall Study|Other protocol specified criteria|3
4453845|NCT00534248|7240586|FG000|Overall Study|Physician Decision|10
4453846|NCT00534248|7240587|FG001|Overall Study|Physician Decision|7
4453847|NCT00534248|7240586|FG000|Overall Study|Protocol Violation|3
4453848|NCT00534248|7240587|FG001|Overall Study|Protocol Violation|4
4453849|NCT00534248|7240586|FG000|Overall Study|Withdrawal by Subject|263
4453850|NCT00534248|7240587|FG001|Overall Study|Withdrawal by Subject|255
4453851|NCT00534313|7240597|FG000|Short-term Period|Adverse Event|1
4453852|NCT00534313|7240598|FG001|Short-term Period|Adverse Event|2
4453853|NCT00534313|7240599|FG002|Short-term Period|Adverse Event|1
4453854|NCT00534313|7240600|FG003|Short-term Period|Adverse Event|3
4453855|NCT00534313|7240597|FG000|Short-term Period|Lack of Efficacy|3
4453856|NCT00534313|7240598|FG001|Short-term Period|Lack of Efficacy|4
4453857|NCT00534313|7240599|FG002|Short-term Period|Lack of Efficacy|0
4453858|NCT00534313|7240600|FG003|Short-term Period|Lack of Efficacy|3
4453859|NCT00534313|7240597|FG000|Short-term Period|Participant not meeting study criteria|0
4453860|NCT00534313|7240598|FG001|Short-term Period|Participant not meeting study criteria|0
4453861|NCT00534313|7240599|FG002|Short-term Period|Participant not meeting study criteria|0
4453862|NCT00534313|7240600|FG003|Short-term Period|Participant not meeting study criteria|1
4453863|NCT00534313|7240597|FG000|Short-term Period|Participant withdrew consent|2
4453864|NCT00534313|7240598|FG001|Short-term Period|Participant withdrew consent|0
4453865|NCT00534313|7240599|FG002|Short-term Period|Participant withdrew consent|0
4453866|NCT00534313|7240600|FG003|Short-term Period|Participant withdrew consent|2
4453867|NCT00534313|7240597|FG000|Short-term Period|Pregnancy|0
4453868|NCT00534313|7240598|FG001|Short-term Period|Pregnancy|0
4453869|NCT00534313|7240599|FG002|Short-term Period|Pregnancy|1
4453870|NCT00534313|7240600|FG003|Short-term Period|Pregnancy|0
4453871|NCT00534313|7240597|FG000|Long-term Period|Adverse Event|2
4453872|NCT00534313|7240598|FG001|Long-term Period|Adverse Event|1
4453873|NCT00534313|7240599|FG002|Long-term Period|Adverse Event|0
4453874|NCT00534313|7240600|FG003|Long-term Period|Adverse Event|1
4453875|NCT00534313|7240597|FG000|Long-term Period|Lack of Efficacy|14
4453876|NCT00534313|7240598|FG001|Long-term Period|Lack of Efficacy|10
4453877|NCT00534313|7240599|FG002|Long-term Period|Lack of Efficacy|14
4453878|NCT00534313|7240600|FG003|Long-term Period|Lack of Efficacy|12
4453879|NCT00534313|7240597|FG000|Long-term Period|Lost to Follow-up|1
4453880|NCT00534313|7240598|FG001|Long-term Period|Lost to Follow-up|2
4453881|NCT00534313|7240599|FG002|Long-term Period|Lost to Follow-up|0
4453882|NCT00534313|7240600|FG003|Long-term Period|Lost to Follow-up|0
4453883|NCT00534313|7240597|FG000|Long-term Period|Withdrawal by Subject|2
4453884|NCT00534313|7240598|FG001|Long-term Period|Withdrawal by Subject|2
4453885|NCT00534313|7240599|FG002|Long-term Period|Withdrawal by Subject|0
4453886|NCT00534313|7240600|FG003|Long-term Period|Withdrawal by Subject|0
4453887|NCT00534313|7240597|FG000|Long-term Period|No longer meets study criteria|0
4453888|NCT00534313|7240598|FG001|Long-term Period|No longer meets study criteria|1
4453889|NCT00534313|7240599|FG002|Long-term Period|No longer meets study criteria|0
4453890|NCT00534313|7240600|FG003|Long-term Period|No longer meets study criteria|0
4453891|NCT00534313|7240597|FG000|Long-term Period|Poor compliance/noncompliance|0
4453892|NCT00534313|7240598|FG001|Long-term Period|Poor compliance/noncompliance|1
4453893|NCT00534313|7240599|FG002|Long-term Period|Poor compliance/noncompliance|1
4453894|NCT00534313|7240600|FG003|Long-term Period|Poor compliance/noncompliance|0
4453895|NCT00534313|7240597|FG000|Long-term Period|Administrative reason by sponsor|17
4453896|NCT00534313|7240598|FG001|Long-term Period|Administrative reason by sponsor|15
4453897|NCT00534313|7240599|FG002|Long-term Period|Administrative reason by sponsor|26
4453898|NCT00534313|7240600|FG003|Long-term Period|Administrative reason by sponsor|18
4453899|NCT00534313|7240597|FG000|Long-term Period|Other|1
4453900|NCT00534313|7240598|FG001|Long-term Period|Other|2
4453901|NCT00534313|7240599|FG002|Long-term Period|Other|2
4453902|NCT00534313|7240600|FG003|Long-term Period|Other|2
4453903|NCT00534352|7240645|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1
4453904|NCT00534352|7240645|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1
4453905|NCT00534352|7240645|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1
4453906|NCT00534352|7240645|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1
4453907|NCT00534352|7240645|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2
4453908|NCT00534352|7240645|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1
4453909|NCT00534404|7240672|FG000|Overall Study|Death|0
4453910|NCT00534404|7240673|FG001|Overall Study|Death|0
4453911|NCT00534404|7240674|FG002|Overall Study|Death|2
4453912|NCT00534404|7240672|FG000|Overall Study|Withdrawal by Subject|8
4453913|NCT00534404|7240673|FG001|Overall Study|Withdrawal by Subject|2
4453914|NCT00534404|7240674|FG002|Overall Study|Withdrawal by Subject|38
4453915|NCT00534404|7240672|FG000|Overall Study|Removed by study staff|2
4453916|NCT00534404|7240673|FG001|Overall Study|Removed by study staff|3
4453917|NCT00534404|7240674|FG002|Overall Study|Removed by study staff|1
4453918|NCT00534404|7240672|FG000|Overall Study|Lost to Follow-up|170
4453919|NCT00534404|7240673|FG001|Overall Study|Lost to Follow-up|138
4453920|NCT00534404|7240674|FG002|Overall Study|Lost to Follow-up|201
4453921|NCT00534495|7240688|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0
4453922|NCT00534495|7240689|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1
4453923|NCT00534495|7240690|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0
4453924|NCT00534495|7240688|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1
4453925|NCT00534495|7240689|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0
4453926|NCT00534495|7240690|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0
4453927|NCT00534495|7240688|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1
4453928|NCT00534495|7240689|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7
4453929|NCT00534495|7240690|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0
4453930|NCT00534495|7240688|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1
4453931|NCT00534495|7240689|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1
4453932|NCT00534495|7240690|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0
4453933|NCT00534495|7240688|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1
4453934|NCT00534495|7240689|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1
4453935|NCT00534495|7240690|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0
4453936|NCT00534495|7240688|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0
4453937|NCT00534495|7240689|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0
4453938|NCT00534495|7240690|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1
4453939|NCT00534495|7240688|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0
4453940|NCT00534495|7240689|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0
4537314|NCT01109316|7358113|FG003|Study Period 1|Lost to Follow-up|1
4537315|NCT01109316|7358114|FG004|Study Period 1|Lost to Follow-up|0
4537316|NCT01109316|7358115|FG005|Study Period 1|Lost to Follow-up|0
4537317|NCT01109316|7358110|FG000|Study Period 1|Withdrawal by Subject|0
4537318|NCT01109316|7358111|FG001|Study Period 1|Withdrawal by Subject|0
4537319|NCT01109316|7358112|FG002|Study Period 1|Withdrawal by Subject|1
4537320|NCT01109316|7358113|FG003|Study Period 1|Withdrawal by Subject|0
4537321|NCT01109316|7358114|FG004|Study Period 1|Withdrawal by Subject|2
4537322|NCT01109316|7358115|FG005|Study Period 1|Withdrawal by Subject|0
4537323|NCT01109316|7358110|FG000|Study Period 1|Sponsor Decision|0
4453941|NCT00534495|7240690|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5
4453942|NCT00534495|7240688|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0
4453943|NCT00534495|7240689|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0
4453944|NCT00534495|7240690|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3
4453945|NCT00534495|7240688|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0
4453946|NCT00534495|7240689|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0
4453947|NCT00534495|7240690|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2
4515810|NCT00955708|7326800|FG000|Overall Study|Patient changed care provider/moved|91
4515811|NCT00955721|7326806|FG000|Overall Study|Physician Decision|1
4515812|NCT00955721|7326807|FG001|Overall Study|Physician Decision|0
4515813|NCT00955721|7326806|FG000|Overall Study|Death|1
4515814|NCT00955721|7326807|FG001|Overall Study|Death|0
4515815|NCT00955721|7326806|FG000|Overall Study|Withdrawal by Subject|1
4515816|NCT00955721|7326807|FG001|Overall Study|Withdrawal by Subject|0
4515817|NCT00955825|7326825|FG000|Overall Study|Adverse Event|15
4515818|NCT00955825|7326826|FG001|Overall Study|Adverse Event|2
4515819|NCT00955825|7326825|FG000|Overall Study|Withdrawal by Subject|4
4515820|NCT00955825|7326826|FG001|Overall Study|Withdrawal by Subject|6
4515821|NCT00955825|7326825|FG000|Overall Study|Any other reason not above-mentioned|7
4515822|NCT00955825|7326826|FG001|Overall Study|Any other reason not above-mentioned|9
4515823|NCT00955955|7326865|FG000|Overall Study|Lost to Follow-up|2
4515824|NCT00955955|7326866|FG001|Overall Study|Lost to Follow-up|0
4515825|NCT00955955|7326867|FG002|Overall Study|Lost to Follow-up|0
4515826|NCT00955968|7326883|FG000|Overall Study|Death|2
4515827|NCT00955968|7326884|FG001|Overall Study|Death|4
4515828|NCT00955968|7326883|FG000|Overall Study|Withdrawal by Subject|35
4515829|NCT00955968|7326884|FG001|Overall Study|Withdrawal by Subject|31
4515830|NCT00955968|7326883|FG000|Overall Study|Lost to Follow-up|45
4515831|NCT00955968|7326884|FG001|Overall Study|Lost to Follow-up|39
4515832|NCT00955968|7326883|FG000|Overall Study|Site closed|55
4515833|NCT00955968|7326884|FG001|Overall Study|Site closed|52
4515834|NCT00956293|7326918|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0
4515835|NCT00956293|7326919|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0
4515836|NCT00956293|7326920|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1
4515837|NCT00956293|7326918|FG000|Main Period (Pre-randomization)|Death|0
4515838|NCT00956293|7326919|FG001|Main Period (Pre-randomization)|Death|0
4515839|NCT00956293|7326920|FG002|Main Period (Pre-randomization)|Death|1
4515840|NCT00956293|7326918|FG000|Main Period (Pre-randomization)|Protocol Violation|0
4515841|NCT00956293|7326919|FG001|Main Period (Pre-randomization)|Protocol Violation|0
4515842|NCT00956293|7326920|FG002|Main Period (Pre-randomization)|Protocol Violation|1
4515843|NCT00956293|7326918|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0
4515844|NCT00956293|7326919|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0
4515845|NCT00956293|7326920|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2
4515846|NCT00956293|7326918|FG000|Main Period (Pre-randomization)|Administrative problems|0
4518739|NCT00976027|7331006|FG000|Overall Study|Lost to Follow-up|208
4537324|NCT01109316|7358111|FG001|Study Period 1|Sponsor Decision|0
4537325|NCT01109316|7358112|FG002|Study Period 1|Sponsor Decision|0
4453948|NCT00534599|7240703|FG000|Overall Study|Adverse Event|25
4453949|NCT00534599|7240704|FG001|Overall Study|Adverse Event|4
4453950|NCT00534599|7240703|FG000|Overall Study|Incorrect enrollment|2
4453951|NCT00534599|7240704|FG001|Overall Study|Incorrect enrollment|1
4453952|NCT00534599|7240703|FG000|Overall Study|Mis-randomization|2
4453953|NCT00534599|7240704|FG001|Overall Study|Mis-randomization|2
4453954|NCT00534599|7240703|FG000|Overall Study|Developed study-specific d/c criteria|5
4453955|NCT00534599|7240704|FG001|Overall Study|Developed study-specific d/c criteria|0
4453956|NCT00534599|7240703|FG000|Overall Study|Lack of Efficacy|0
4453957|NCT00534599|7240704|FG001|Overall Study|Lack of Efficacy|1
4453958|NCT00534599|7240703|FG000|Overall Study|Generalized anxiety disorder worsened|0
4453959|NCT00534599|7240704|FG001|Overall Study|Generalized anxiety disorder worsened|1
4453960|NCT00534599|7240703|FG000|Overall Study|Protocol Violation|1
4453961|NCT00534599|7240704|FG001|Overall Study|Protocol Violation|3
4453962|NCT00534599|7240703|FG000|Overall Study|Lost to Follow-up|11
4453963|NCT00534599|7240704|FG001|Overall Study|Lost to Follow-up|14
4453964|NCT00534599|7240703|FG000|Overall Study|Withdrawal by Subject|4
4453965|NCT00534599|7240704|FG001|Overall Study|Withdrawal by Subject|6
4453966|NCT00534599|7240703|FG000|Overall Study|Other|7
4453967|NCT00534599|7240704|FG001|Overall Study|Other|0
4453968|NCT00534638|7240712|FG000|Overall Study|Withdrawal by Subject|3
4453969|NCT00534638|7240713|FG001|Overall Study|Withdrawal by Subject|4
4453970|NCT00534638|7240712|FG000|Overall Study|Migrated/moved from study area|13
4453971|NCT00534638|7240713|FG001|Overall Study|Migrated/moved from study area|11
4453972|NCT00534638|7240712|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83
4453973|NCT00534638|7240713|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117
4453974|NCT00534638|7240712|FG000|Overall Study|Lost to follow-up, complete vaccination|4707
4453975|NCT00534638|7240713|FG001|Overall Study|Lost to follow-up, complete vaccination|10757
4453976|NCT00534638|7240712|FG000|Overall Study|Other|1685
4453977|NCT00534638|7240713|FG001|Overall Study|Other|902
4453978|NCT00535132|7240797|FG000|Safety Analysis Set|Did Not Receive Study Medication|2
4453979|NCT00535132|7240798|FG001|Safety Analysis Set|Did Not Receive Study Medication|2
4453980|NCT00535132|7240797|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3
4453981|NCT00535132|7240798|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3
4453982|NCT00535145|7240806|FG000|Phase I|Adverse Event|3
4453983|NCT00535145|7240806|FG000|Phase I|Lost to Follow-up|7
4453984|NCT00535145|7240806|FG000|Phase I|Withdrawal by Subject|6
4453985|NCT00535145|7240806|FG000|Phase I|(eligibility)|8
4453986|NCT00535145|7240806|FG000|Phase I|(protocol violation)|1
4453987|NCT00535145|7240806|FG000|Phase I|(PI decision)|1
4453988|NCT00535145|7240806|FG000|Phase I|(diagnosis)|3
4453989|NCT00535145|7240806|FG000|Phase II|Adverse Event|2
4453990|NCT00535145|7240806|FG000|Phase II|Lack of Efficacy|1
4453991|NCT00535145|7240806|FG000|Phase II|Lost to Follow-up|5
4453992|NCT00535145|7240806|FG000|Phase II|Withdrawal by Subject|5
4453993|NCT00535145|7240806|FG000|Phase II|Subject non-compliance|2
4453994|NCT00535223|7240816|FG000|Overall Study|Withdrawal by Subject|4
4453995|NCT00535223|7240817|FG001|Overall Study|Withdrawal by Subject|1
4453996|NCT00535236|7240833|FG000|Overall Study|Adverse Event|1
4453997|NCT00535236|7240834|FG001|Overall Study|Adverse Event|0
4453998|NCT00535236|7240835|FG002|Overall Study|Adverse Event|9
4453999|NCT00535236|7240836|FG003|Overall Study|Adverse Event|3
4454000|NCT00535236|7240837|FG004|Overall Study|Adverse Event|3
4454001|NCT00535236|7240838|FG005|Overall Study|Adverse Event|0
4454002|NCT00535236|7240839|FG006|Overall Study|Adverse Event|5
4454003|NCT00535236|7240840|FG007|Overall Study|Adverse Event|1
4454004|NCT00535236|7240841|FG008|Overall Study|Adverse Event|2
4454005|NCT00535236|7240842|FG009|Overall Study|Adverse Event|1
4454006|NCT00535236|7240833|FG000|Overall Study|Lost to Follow-up|1
4454007|NCT00535236|7240834|FG001|Overall Study|Lost to Follow-up|2
4454008|NCT00535236|7240835|FG002|Overall Study|Lost to Follow-up|0
4454009|NCT00535236|7240836|FG003|Overall Study|Lost to Follow-up|0
4454010|NCT00535236|7240837|FG004|Overall Study|Lost to Follow-up|2
4454011|NCT00535236|7240838|FG005|Overall Study|Lost to Follow-up|0
4454012|NCT00535236|7240839|FG006|Overall Study|Lost to Follow-up|0
4454013|NCT00535236|7240840|FG007|Overall Study|Lost to Follow-up|0
4454014|NCT00535236|7240841|FG008|Overall Study|Lost to Follow-up|6
4454015|NCT00535236|7240842|FG009|Overall Study|Lost to Follow-up|1
4454016|NCT00535236|7240833|FG000|Overall Study|Physician Decision|0
4454017|NCT00535236|7240834|FG001|Overall Study|Physician Decision|0
4537326|NCT01109316|7358113|FG003|Study Period 1|Sponsor Decision|0
4537327|NCT01109316|7358114|FG004|Study Period 1|Sponsor Decision|0
4454018|NCT00535236|7240835|FG002|Overall Study|Physician Decision|0
4454019|NCT00535236|7240836|FG003|Overall Study|Physician Decision|0
4454020|NCT00535236|7240837|FG004|Overall Study|Physician Decision|1
4454021|NCT00535236|7240838|FG005|Overall Study|Physician Decision|0
4454022|NCT00535236|7240839|FG006|Overall Study|Physician Decision|1
4454023|NCT00535236|7240840|FG007|Overall Study|Physician Decision|0
4454024|NCT00535236|7240841|FG008|Overall Study|Physician Decision|0
4454025|NCT00535236|7240842|FG009|Overall Study|Physician Decision|0
4454026|NCT00535236|7240833|FG000|Overall Study|Protocol Violation|2
4454027|NCT00535236|7240834|FG001|Overall Study|Protocol Violation|0
4454028|NCT00535236|7240835|FG002|Overall Study|Protocol Violation|1
4454029|NCT00535236|7240836|FG003|Overall Study|Protocol Violation|0
4537328|NCT01109316|7358115|FG005|Study Period 1|Sponsor Decision|2
4454030|NCT00535236|7240837|FG004|Overall Study|Protocol Violation|0
4454031|NCT00535236|7240838|FG005|Overall Study|Protocol Violation|0
4454032|NCT00535236|7240839|FG006|Overall Study|Protocol Violation|0
4454033|NCT00535236|7240840|FG007|Overall Study|Protocol Violation|0
4454034|NCT00535236|7240841|FG008|Overall Study|Protocol Violation|1
4454035|NCT00535236|7240842|FG009|Overall Study|Protocol Violation|0
4454036|NCT00535236|7240833|FG000|Overall Study|Withdrawal by Subject|3
4454037|NCT00535236|7240834|FG001|Overall Study|Withdrawal by Subject|0
4454038|NCT00535236|7240835|FG002|Overall Study|Withdrawal by Subject|2
4454039|NCT00535236|7240836|FG003|Overall Study|Withdrawal by Subject|1
4454040|NCT00535236|7240837|FG004|Overall Study|Withdrawal by Subject|6
4454041|NCT00535236|7240838|FG005|Overall Study|Withdrawal by Subject|1
4454042|NCT00535236|7240839|FG006|Overall Study|Withdrawal by Subject|5
4454043|NCT00535236|7240840|FG007|Overall Study|Withdrawal by Subject|0
4454044|NCT00535236|7240841|FG008|Overall Study|Withdrawal by Subject|4
4454045|NCT00535236|7240842|FG009|Overall Study|Withdrawal by Subject|2
4454046|NCT00535288|7240872|FG000|Overall Study|Adverse Event|20
4454047|NCT00535288|7240873|FG001|Overall Study|Adverse Event|19
4454048|NCT00535288|7240874|FG002|Overall Study|Adverse Event|25
4454049|NCT00535288|7240875|FG003|Overall Study|Adverse Event|20
4454050|NCT00535288|7240876|FG004|Overall Study|Adverse Event|30
4454051|NCT00535288|7240872|FG000|Overall Study|Lost to Follow-up|0
4454052|NCT00535288|7240873|FG001|Overall Study|Lost to Follow-up|3
4454053|NCT00535288|7240874|FG002|Overall Study|Lost to Follow-up|0
4454054|NCT00535288|7240875|FG003|Overall Study|Lost to Follow-up|0
4454055|NCT00535288|7240876|FG004|Overall Study|Lost to Follow-up|0
4454056|NCT00535288|7240872|FG000|Overall Study|Lack of Efficacy|26
4454057|NCT00535288|7240873|FG001|Overall Study|Lack of Efficacy|3
4454058|NCT00535288|7240874|FG002|Overall Study|Lack of Efficacy|4
4454059|NCT00535288|7240875|FG003|Overall Study|Lack of Efficacy|4
4454060|NCT00535288|7240876|FG004|Overall Study|Lack of Efficacy|7
4454061|NCT00535288|7240872|FG000|Overall Study|Unwilling to cooperate|6
4454062|NCT00535288|7240873|FG001|Overall Study|Unwilling to cooperate|6
4454063|NCT00535288|7240874|FG002|Overall Study|Unwilling to cooperate|3
4454064|NCT00535288|7240875|FG003|Overall Study|Unwilling to cooperate|3
4454065|NCT00535288|7240876|FG004|Overall Study|Unwilling to cooperate|4
4454066|NCT00535288|7240872|FG000|Overall Study|Other|2
4454067|NCT00535288|7240873|FG001|Overall Study|Other|1
4454068|NCT00535288|7240874|FG002|Overall Study|Other|1
4454069|NCT00535288|7240875|FG003|Overall Study|Other|2
4454070|NCT00535288|7240876|FG004|Overall Study|Other|1
4454071|NCT00535496|7240910|FG000|Overall Study|Lost to Follow-up|0
4454072|NCT00535496|7240911|FG001|Overall Study|Lost to Follow-up|1
4454073|NCT00535496|7240912|FG002|Overall Study|Lost to Follow-up|0
4454074|NCT00535496|7240913|FG003|Overall Study|Lost to Follow-up|0
4454075|NCT00535496|7240910|FG000|Overall Study|Not treated with sugammadex|0
4454076|NCT00535496|7240911|FG001|Overall Study|Not treated with sugammadex|1
4454077|NCT00535496|7240912|FG002|Overall Study|Not treated with sugammadex|0
4454078|NCT00535496|7240913|FG003|Overall Study|Not treated with sugammadex|0
4454079|NCT00535626|7240944|FG000|Overall Study|Death|15
4454080|NCT00535626|7240944|FG000|Overall Study|Lost to Follow-up|29
4454081|NCT00535626|7240944|FG000|Overall Study|Withdrawal by Subject|20
4454082|NCT00535626|7240944|FG000|Overall Study|Removal/revision of study component|8
4454083|NCT00535626|7240944|FG000|Overall Study|Subject terminated|31
4454084|NCT00535626|7240944|FG000|Overall Study|Unable to return|2
4454085|NCT00535730|7240955|FG000|Overall Study|Adverse Event|1
4454086|NCT00535730|7240956|FG001|Overall Study|Adverse Event|1
4454087|NCT00535730|7240955|FG000|Overall Study|Lost to Follow-up|0
4454088|NCT00535730|7240956|FG001|Overall Study|Lost to Follow-up|1
4454089|NCT00535730|7240955|FG000|Overall Study|Physician Decision|0
4454090|NCT00535730|7240956|FG001|Overall Study|Physician Decision|1
4454091|NCT00535730|7240955|FG000|Overall Study|Protocol Violation|1
4454092|NCT00535730|7240956|FG001|Overall Study|Protocol Violation|0
4454093|NCT00535730|7240955|FG000|Overall Study|Withdrawal by Subject|0
4454094|NCT00535730|7240956|FG001|Overall Study|Withdrawal by Subject|4
4454095|NCT00535847|7241093|FG000|Overall Study|Adverse Event|5
4454096|NCT00535847|7241094|FG001|Overall Study|Adverse Event|3
4454097|NCT00535847|7241095|FG002|Overall Study|Adverse Event|2
4454098|NCT00535847|7241093|FG000|Overall Study|Non compliance|1
4454099|NCT00535847|7241094|FG001|Overall Study|Non compliance|1
4454100|NCT00535847|7241095|FG002|Overall Study|Non compliance|0
4454101|NCT00535847|7241093|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16
4454102|NCT00535847|7241094|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10
4454103|NCT00535847|7241095|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0
4454104|NCT00536107|7241133|FG000|Overall Study|Death|5
4454105|NCT00536107|7241134|FG001|Overall Study|Death|1
4537329|NCT01109316|7358110|FG000|Study Period 2|Entry Criteria Not Met|0
4454106|NCT00536107|7241133|FG000|Overall Study|Incorrect enrolment|1
4454107|NCT00536107|7241134|FG001|Overall Study|Incorrect enrolment|0
4454108|NCT00536107|7241133|FG000|Overall Study|Withdrawal by Subject|0
4454109|NCT00536107|7241134|FG001|Overall Study|Withdrawal by Subject|1
4454110|NCT00536107|7241133|FG000|Overall Study|Study Termination|2
4454111|NCT00536107|7241134|FG001|Overall Study|Study Termination|4
4454112|NCT00536120|7241142|FG000|Overall Study|Lost to Follow-up|1
4454113|NCT00536120|7241143|FG001|Overall Study|Lost to Follow-up|0
4518740|NCT00976027|7331007|FG001|Overall Study|Lost to Follow-up|103
4454114|NCT00536120|7241142|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3
4454115|NCT00536120|7241143|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0
4454116|NCT00536120|7241142|FG000|Overall Study|Non-compliance|1
4454117|NCT00536120|7241143|FG001|Overall Study|Non-compliance|0
4454118|NCT00536120|7241142|FG000|Overall Study|Sponsor Decision Due to Lab Values|1
4454119|NCT00536120|7241143|FG001|Overall Study|Sponsor Decision Due to Lab Values|0
4454120|NCT00536120|7241142|FG000|Overall Study|Steroid Use|0
4454121|NCT00536120|7241143|FG001|Overall Study|Steroid Use|2
4454122|NCT00536120|7241142|FG000|Overall Study|Missed Study Visit|0
4454123|NCT00536120|7241143|FG001|Overall Study|Missed Study Visit|1
4454124|NCT00536198|7241160|FG000|Overall Study|Lost to Follow-up|15
4454125|NCT00536198|7241161|FG001|Overall Study|Lost to Follow-up|14
4454126|NCT00536198|7241160|FG000|Overall Study|Withdrawal by Subject|16
4454127|NCT00536198|7241161|FG001|Overall Study|Withdrawal by Subject|12
4454128|NCT00536198|7241160|FG000|Overall Study|Adverse Event|2
4454129|NCT00536198|7241161|FG001|Overall Study|Adverse Event|2
4454130|NCT00536198|7241160|FG000|Overall Study|Rescue|3
4454131|NCT00536198|7241161|FG001|Overall Study|Rescue|9
4454132|NCT00536198|7241160|FG000|Overall Study|Pregnancy|1
4454133|NCT00536198|7241161|FG001|Overall Study|Pregnancy|1
4454134|NCT00536198|7241160|FG000|Overall Study|Protocol Violation|0
4454135|NCT00536198|7241161|FG001|Overall Study|Protocol Violation|1
4454136|NCT00536263|7241172|FG000|Overall Study|Adverse Event|5
4454137|NCT00536263|7241173|FG001|Overall Study|Adverse Event|5
4454138|NCT00536263|7241174|FG002|Overall Study|Adverse Event|7
4454139|NCT00536263|7241172|FG000|Overall Study|Lost to Follow-up|3
4454140|NCT00536263|7241173|FG001|Overall Study|Lost to Follow-up|4
4454141|NCT00536263|7241174|FG002|Overall Study|Lost to Follow-up|4
4454142|NCT00536263|7241172|FG000|Overall Study|Subject withdrew - not treatment related|2
4454143|NCT00536263|7241173|FG001|Overall Study|Subject withdrew - not treatment related|0
4454144|NCT00536263|7241174|FG002|Overall Study|Subject withdrew - not treatment related|5
4454145|NCT00536263|7241172|FG000|Overall Study|Subject withdrew - treatment related|0
4454146|NCT00536263|7241173|FG001|Overall Study|Subject withdrew - treatment related|3
4454147|NCT00536263|7241174|FG002|Overall Study|Subject withdrew - treatment related|2
4454148|NCT00536263|7241172|FG000|Overall Study|Noncompliance with protocol|0
4454149|NCT00536263|7241173|FG001|Overall Study|Noncompliance with protocol|0
4454150|NCT00536263|7241174|FG002|Overall Study|Noncompliance with protocol|1
4454151|NCT00536263|7241172|FG000|Overall Study|Did not meet protocol eligibility|1
4454152|NCT00536263|7241173|FG001|Overall Study|Did not meet protocol eligibility|2
4454153|NCT00536263|7241174|FG002|Overall Study|Did not meet protocol eligibility|2
4454154|NCT00536471|7241196|FG000|Overall Study|Lost to Follow-up|48
4454155|NCT00536471|7241197|FG001|Overall Study|Lost to Follow-up|23
4454156|NCT00536471|7241198|FG002|Overall Study|Lost to Follow-up|48
4454157|NCT00536471|7241199|FG003|Overall Study|Lost to Follow-up|22
4454158|NCT00536471|7241196|FG000|Overall Study|Adverse Event|32
4454159|NCT00536471|7241197|FG001|Overall Study|Adverse Event|16
4454160|NCT00536471|7241198|FG002|Overall Study|Adverse Event|28
4454161|NCT00536471|7241199|FG003|Overall Study|Adverse Event|13
4454162|NCT00536471|7241196|FG000|Overall Study|Withdrawal by Subject|40
4454163|NCT00536471|7241197|FG001|Overall Study|Withdrawal by Subject|24
4454164|NCT00536471|7241198|FG002|Overall Study|Withdrawal by Subject|43
4454165|NCT00536471|7241199|FG003|Overall Study|Withdrawal by Subject|21
4454166|NCT00536471|7241196|FG000|Overall Study|Lack of Efficacy|17
4454167|NCT00536471|7241197|FG001|Overall Study|Lack of Efficacy|18
4454168|NCT00536471|7241198|FG002|Overall Study|Lack of Efficacy|11
4454169|NCT00536471|7241199|FG003|Overall Study|Lack of Efficacy|9
4454170|NCT00536471|7241196|FG000|Overall Study|Protocol Violation|8
4454171|NCT00536471|7241197|FG001|Overall Study|Protocol Violation|1
4454172|NCT00536471|7241198|FG002|Overall Study|Protocol Violation|2
4454173|NCT00536471|7241199|FG003|Overall Study|Protocol Violation|3
4454174|NCT00536471|7241196|FG000|Overall Study|Physician Decision|11
4537330|NCT01109316|7358111|FG001|Study Period 2|Entry Criteria Not Met|1
4537331|NCT01109316|7358112|FG002|Study Period 2|Entry Criteria Not Met|0
4537332|NCT01109316|7358113|FG003|Study Period 2|Entry Criteria Not Met|0
4537333|NCT01109316|7358114|FG004|Study Period 2|Entry Criteria Not Met|0
4537334|NCT01109316|7358115|FG005|Study Period 2|Entry Criteria Not Met|0
4537335|NCT01109316|7358110|FG000|Study Period 2|Physician Decision|0
4537336|NCT01109316|7358111|FG001|Study Period 2|Physician Decision|0
4537337|NCT01109316|7358112|FG002|Study Period 2|Physician Decision|0
4537338|NCT01109316|7358113|FG003|Study Period 2|Physician Decision|1
4537339|NCT01109316|7358114|FG004|Study Period 2|Physician Decision|0
4537340|NCT01109316|7358115|FG005|Study Period 2|Physician Decision|0
4537341|NCT01109316|7358110|FG000|Study Period 2|Protocol Violation|1
4537342|NCT01109316|7358111|FG001|Study Period 2|Protocol Violation|0
4537343|NCT01109316|7358112|FG002|Study Period 2|Protocol Violation|0
4537344|NCT01109316|7358113|FG003|Study Period 2|Protocol Violation|0
4537345|NCT01109316|7358114|FG004|Study Period 2|Protocol Violation|0
4454175|NCT00536471|7241197|FG001|Overall Study|Physician Decision|1
4454176|NCT00536471|7241198|FG002|Overall Study|Physician Decision|3
4454177|NCT00536471|7241199|FG003|Overall Study|Physician Decision|2
4454178|NCT00536471|7241196|FG000|Overall Study|Death|0
4454179|NCT00536471|7241197|FG001|Overall Study|Death|0
4454180|NCT00536471|7241198|FG002|Overall Study|Death|1
4454181|NCT00536471|7241199|FG003|Overall Study|Death|2
4454182|NCT00536471|7241196|FG000|Overall Study|Sponsor Decision|0
4537346|NCT01109316|7358115|FG005|Study Period 2|Protocol Violation|0
4537347|NCT01109316|7358110|FG000|Study Period 2|Withdrawal by Subject|0
4537348|NCT01109316|7358111|FG001|Study Period 2|Withdrawal by Subject|0
4537349|NCT01109316|7358112|FG002|Study Period 2|Withdrawal by Subject|1
4537350|NCT01109316|7358113|FG003|Study Period 2|Withdrawal by Subject|0
4537351|NCT01109316|7358114|FG004|Study Period 2|Withdrawal by Subject|0
4537352|NCT01109316|7358115|FG005|Study Period 2|Withdrawal by Subject|1
4537353|NCT01109316|7358110|FG000|Study Period 3|Lost to Follow-up|0
4537354|NCT01109316|7358111|FG001|Study Period 3|Lost to Follow-up|0
4537355|NCT01109316|7358112|FG002|Study Period 3|Lost to Follow-up|0
4537356|NCT01109316|7358113|FG003|Study Period 3|Lost to Follow-up|0
4537357|NCT01109316|7358114|FG004|Study Period 3|Lost to Follow-up|1
4537358|NCT01109316|7358115|FG005|Study Period 3|Lost to Follow-up|0
4537359|NCT01109316|7358110|FG000|Study Period 3|Withdrawal by Subject|1
4537360|NCT01109316|7358111|FG001|Study Period 3|Withdrawal by Subject|0
4537361|NCT01109316|7358112|FG002|Study Period 3|Withdrawal by Subject|0
4537362|NCT01109316|7358113|FG003|Study Period 3|Withdrawal by Subject|0
4537363|NCT01109316|7358114|FG004|Study Period 3|Withdrawal by Subject|1
4537364|NCT01109316|7358115|FG005|Study Period 3|Withdrawal by Subject|0
4537365|NCT01109524|7358129|FG000|Overall Study|Disease Progression|29
4537366|NCT01109524|7358129|FG000|Overall Study|Study Drug toxicity|6
4537367|NCT01109524|7358129|FG000|Overall Study|Adverse Event|4
4537368|NCT01109524|7358129|FG000|Overall Study|Withdrawal by Subject|2
4537369|NCT01109524|7358129|FG000|Overall Study|Maximum clinical benefit|3
4537370|NCT01109524|7358129|FG000|Overall Study|Death|2
4537371|NCT01109524|7358129|FG000|Overall Study|No longer meets criteria|2
4537372|NCT01109524|7358129|FG000|Overall Study|Participant requested to end treatment|4
4537373|NCT01109524|7358129|FG000|Overall Study|Other|5
4537374|NCT01109849|7358151|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9
4537375|NCT01109849|7358152|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35
4537376|NCT01109849|7358153|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
4537377|NCT01109849|7358154|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
4537378|NCT01109849|7358155|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
4537379|NCT01109849|7358151|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1
4537380|NCT01109849|7358152|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0
4537381|NCT01109849|7358153|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0
4537382|NCT01109849|7358154|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0
4537383|NCT01109849|7358155|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0
4537384|NCT01109849|7358151|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6
4537385|NCT01109849|7358152|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7
4537386|NCT01109849|7358153|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
4537387|NCT01109849|7358154|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
4537388|NCT01109849|7358155|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
4537389|NCT01109849|7358151|FG000|Initial Randomization: ADHD Treatment|move away|2
4537390|NCT01109849|7358152|FG001|Initial Randomization: ADHD Treatment|move away|7
4537391|NCT01109849|7358153|FG002|Initial Randomization: ADHD Treatment|move away|0
4537392|NCT01109849|7358154|FG003|Initial Randomization: ADHD Treatment|move away|0
4537393|NCT01109849|7358155|FG004|Initial Randomization: ADHD Treatment|move away|0
4537394|NCT01109849|7358151|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0
4537395|NCT01109849|7358152|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0
4537396|NCT01109849|7358153|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
4537397|NCT01109849|7358154|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
4537398|NCT01109849|7358155|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
4537399|NCT01109849|7358151|FG000|Adaptive Randomization: Weight Recovery|moved away|0
4537400|NCT01109849|7358152|FG001|Adaptive Randomization: Weight Recovery|moved away|0
4537401|NCT01109849|7358153|FG002|Adaptive Randomization: Weight Recovery|moved away|0
4454183|NCT00536471|7241197|FG001|Overall Study|Sponsor Decision|1
4454184|NCT00536471|7241198|FG002|Overall Study|Sponsor Decision|3
4454185|NCT00536471|7241199|FG003|Overall Study|Sponsor Decision|2
4454186|NCT00536484|7241218|FG000|Overall Study|Adverse Event|21
4454187|NCT00536484|7241219|FG001|Overall Study|Adverse Event|34
4454188|NCT00536484|7241218|FG000|Overall Study|Withdrawal by Subject|11
4454189|NCT00536484|7241219|FG001|Overall Study|Withdrawal by Subject|11
4454190|NCT00536484|7241218|FG000|Overall Study|Lost to Follow-up|8
4454191|NCT00536484|7241219|FG001|Overall Study|Lost to Follow-up|6
4454192|NCT00536484|7241218|FG000|Overall Study|Lack of Efficacy|16
4454193|NCT00536484|7241219|FG001|Overall Study|Lack of Efficacy|5
4454194|NCT00536484|7241218|FG000|Overall Study|Other|4
4454195|NCT00536484|7241219|FG001|Overall Study|Other|0
4454196|NCT00536510|7241227|FG000|Overall Study|Adverse Event|27
4454197|NCT00536510|7241228|FG001|Overall Study|Adverse Event|4
4537402|NCT01109849|7358154|FG003|Adaptive Randomization: Weight Recovery|moved away|2
4537403|NCT01109849|7358155|FG004|Adaptive Randomization: Weight Recovery|moved away|0
4537404|NCT01109940|7358179|FG000|Overall Study|Administrative problems|2
4454198|NCT00536510|7241227|FG000|Overall Study|Lost to Follow-up|11
4454199|NCT00536510|7241228|FG001|Overall Study|Lost to Follow-up|8
4454200|NCT00536510|7241227|FG000|Overall Study|Protocol Violation|4
4454201|NCT00536510|7241228|FG001|Overall Study|Protocol Violation|5
4454202|NCT00536510|7241227|FG000|Overall Study|Withdrawal by Subject|16
4537405|NCT01109940|7358180|FG001|Overall Study|Administrative problems|0
4537406|NCT01109940|7358181|FG002|Overall Study|Administrative problems|0
4537407|NCT01109940|7358182|FG003|Overall Study|Administrative problems|0
4537408|NCT01109940|7358179|FG000|Overall Study|Serious Adverse Event|2
4537409|NCT01109940|7358180|FG001|Overall Study|Serious Adverse Event|1
4537410|NCT01109940|7358181|FG002|Overall Study|Serious Adverse Event|0
4537411|NCT01109940|7358182|FG003|Overall Study|Serious Adverse Event|0
4537412|NCT01109940|7358179|FG000|Overall Study|Lost to Follow-up|1
4537413|NCT01109940|7358180|FG001|Overall Study|Lost to Follow-up|0
4537414|NCT01109940|7358181|FG002|Overall Study|Lost to Follow-up|0
4537415|NCT01109940|7358182|FG003|Overall Study|Lost to Follow-up|0
4537416|NCT01109940|7358179|FG000|Overall Study|Patient withdrew consent|1
4537417|NCT01109940|7358180|FG001|Overall Study|Patient withdrew consent|1
4537418|NCT01109940|7358181|FG002|Overall Study|Patient withdrew consent|0
4537419|NCT01109940|7358182|FG003|Overall Study|Patient withdrew consent|0
4537420|NCT01109940|7358179|FG000|Overall Study|Unsatisfactory therapeutic effect|2
4537421|NCT01109940|7358180|FG001|Overall Study|Unsatisfactory therapeutic effect|0
4537422|NCT01109940|7358181|FG002|Overall Study|Unsatisfactory therapeutic effect|1
4537423|NCT01109940|7358182|FG003|Overall Study|Unsatisfactory therapeutic effect|0
4591150|NCT01527006|7437531|FG001|Core Study|Subject Choice|0
4591151|NCT01527006|7437530|FG000|Core Study|Inadequate Therapeutic Effect|1
4591152|NCT01527006|7437531|FG001|Core Study|Inadequate Therapeutic Effect|0
4591153|NCT01527006|7437530|FG000|Core Study|Withdrawal by Subject|0
4591154|NCT01527006|7437531|FG001|Core Study|Withdrawal by Subject|1
4591155|NCT01527006|7437530|FG000|Core Study|Other|0
4591156|NCT01527006|7437531|FG001|Core Study|Other|2
4591157|NCT01527006|7437530|FG000|Extension Phase|Adverse Event|4
4591158|NCT01527006|7437531|FG001|Extension Phase|Adverse Event|2
4591159|NCT01527006|7437530|FG000|Extension Phase|Lost to Follow-up|0
4591160|NCT01527006|7437531|FG001|Extension Phase|Lost to Follow-up|1
4591161|NCT01527006|7437530|FG000|Extension Phase|Subject Choice|1
4591162|NCT01527006|7437531|FG001|Extension Phase|Subject Choice|1
4591163|NCT01527006|7437530|FG000|Extension Phase|Inadequate therapeutic effect|1
4591164|NCT01527006|7437531|FG001|Extension Phase|Inadequate therapeutic effect|1
4591165|NCT01527006|7437530|FG000|Extension Phase|Other|0
4591166|NCT01527006|7437531|FG001|Extension Phase|Other|3
4591167|NCT01527110|7437556|FG000|Overall Study|Adverse Event|1
4591168|NCT01527357|7437571|FG000|Overall Study|Death|8
4591169|NCT01527357|7437572|FG001|Overall Study|Death|2
4591170|NCT01527357|7437571|FG000|Overall Study|Lost to Follow-up|6
4591171|NCT01527357|7437572|FG001|Overall Study|Lost to Follow-up|4
4591172|NCT01527357|7437571|FG000|Overall Study|Withdrew Consent|1
4610761|NCT01695239|7466957|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0
4610762|NCT01695239|7466958|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0
4610763|NCT01695239|7466959|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0
4610764|NCT01695239|7466960|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0
4610765|NCT01695239|7466961|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0
4610766|NCT01695239|7466962|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2
4610767|NCT01695239|7466963|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1
4610768|NCT01695239|7466964|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0
4610769|NCT01695239|7466965|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0
4610770|NCT01695239|7466966|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0
4610771|NCT01695239|7466967|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0
4610772|NCT01695239|7466954|FG000|Extension Long-Term Extension Periods|Death|0
4610773|NCT01695239|7466955|FG001|Extension Long-Term Extension Periods|Death|0
4610774|NCT01695239|7466956|FG002|Extension Long-Term Extension Periods|Death|0
4610775|NCT01695239|7466957|FG003|Extension Long-Term Extension Periods|Death|0
4610776|NCT01695239|7466958|FG004|Extension Long-Term Extension Periods|Death|0
4610777|NCT01695239|7466959|FG005|Extension Long-Term Extension Periods|Death|0
4610778|NCT01695239|7466960|FG006|Extension Long-Term Extension Periods|Death|0
4610779|NCT01695239|7466961|FG007|Extension Long-Term Extension Periods|Death|0
4610780|NCT01695239|7466962|FG008|Extension Long-Term Extension Periods|Death|1
4610781|NCT01695239|7466963|FG009|Extension Long-Term Extension Periods|Death|0
4610782|NCT01695239|7466964|FG010|Extension Long-Term Extension Periods|Death|0
4610783|NCT01695239|7466965|FG011|Extension Long-Term Extension Periods|Death|0
4610784|NCT01695239|7466966|FG012|Extension Long-Term Extension Periods|Death|0
4610785|NCT01695239|7466967|FG013|Extension Long-Term Extension Periods|Death|0
4610786|NCT01695239|7466954|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
4610787|NCT01695239|7466955|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
4591173|NCT01527357|7437572|FG001|Overall Study|Withdrew Consent|1
4591174|NCT01527357|7437571|FG000|Overall Study|Non-compliance|0
4591175|NCT01527357|7437572|FG001|Overall Study|Non-compliance|1
4591176|NCT01527357|7437571|FG000|Overall Study|No Day 29 Visit|0
4591177|NCT01527357|7437572|FG001|Overall Study|No Day 29 Visit|1
4591178|NCT01527357|7437571|FG000|Overall Study|Did Not Receive Treatment|2
4591179|NCT01527357|7437572|FG001|Overall Study|Did Not Receive Treatment|0
4591180|NCT01527370|7437578|FG000|Overall Study|Withdrawal by Subject|4
4591181|NCT01527370|7437578|FG000|Overall Study|Physician Decision|1
4591182|NCT01527370|7437578|FG000|Overall Study|Death|1
4591183|NCT01527383|7437584|FG000|Overall Study|Adverse Event|5
4537424|NCT01109979|7358194|FG000|Overall Study|Physician Decision|2
4537425|NCT01109979|7358195|FG001|Overall Study|Physician Decision|0
4537426|NCT01109979|7358194|FG000|Overall Study|Withdrawal by Subject|0
4537427|NCT01109979|7358195|FG001|Overall Study|Withdrawal by Subject|1
4537428|NCT01109992|7358203|FG000|Overall Study|Withdrawal by Subject|0
4537429|NCT01109992|7358204|FG001|Overall Study|Withdrawal by Subject|1
4537430|NCT01109992|7358203|FG000|Overall Study|Movement during rest scan.|0
4610788|NCT01695239|7466956|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
4610789|NCT01695239|7466957|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
4610790|NCT01695239|7466958|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
4610791|NCT01695239|7466959|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
4610792|NCT01695239|7466960|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
4610793|NCT01695239|7466961|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
4610794|NCT01695239|7466962|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
4610795|NCT01695239|7466963|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
4610796|NCT01695239|7466964|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
4610797|NCT01695239|7466965|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1
4610798|NCT01695239|7466966|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6
4610799|NCT01695239|7466967|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3
4610800|NCT01695239|7466954|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0
4610801|NCT01695239|7466955|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0
4610802|NCT01695239|7466956|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0
4610803|NCT01695239|7466957|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0
4610804|NCT01695239|7466958|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0
4610805|NCT01695239|7466959|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0
4610806|NCT01695239|7466960|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0
4610807|NCT01695239|7466961|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0
4610808|NCT01695239|7466962|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0
4610809|NCT01695239|7466963|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0
4610810|NCT01695239|7466964|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0
4610811|NCT01695239|7466965|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0
4610812|NCT01695239|7466966|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1
4610813|NCT01695239|7466967|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1
4610814|NCT01695239|7466954|FG000|Post-Treatment Follow-Up Period|Physician Decision|0
4610815|NCT01695239|7466955|FG001|Post-Treatment Follow-Up Period|Physician Decision|0
4610816|NCT01695239|7466956|FG002|Post-Treatment Follow-Up Period|Physician Decision|0
4610817|NCT01695239|7466957|FG003|Post-Treatment Follow-Up Period|Physician Decision|0
4610818|NCT01695239|7466958|FG004|Post-Treatment Follow-Up Period|Physician Decision|0
4610819|NCT01695239|7466959|FG005|Post-Treatment Follow-Up Period|Physician Decision|0
4610820|NCT01695239|7466960|FG006|Post-Treatment Follow-Up Period|Physician Decision|0
4610821|NCT01695239|7466961|FG007|Post-Treatment Follow-Up Period|Physician Decision|0
4610822|NCT01695239|7466962|FG008|Post-Treatment Follow-Up Period|Physician Decision|0
4610823|NCT01695239|7466963|FG009|Post-Treatment Follow-Up Period|Physician Decision|0
4610824|NCT01695239|7466964|FG010|Post-Treatment Follow-Up Period|Physician Decision|0
4610825|NCT01695239|7466965|FG011|Post-Treatment Follow-Up Period|Physician Decision|0
4610826|NCT01695239|7466966|FG012|Post-Treatment Follow-Up Period|Physician Decision|2
4610827|NCT01695239|7466967|FG013|Post-Treatment Follow-Up Period|Physician Decision|0
4610828|NCT01695239|7466954|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0
4610829|NCT01695239|7466955|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0
4610830|NCT01695239|7466956|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0
4610831|NCT01695239|7466957|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0
4610832|NCT01695239|7466958|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0
4610833|NCT01695239|7466959|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0
4610834|NCT01695239|7466960|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0
4610835|NCT01695239|7466961|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0
4610836|NCT01695239|7466962|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0
4610837|NCT01695239|7466963|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0
4610838|NCT01695239|7466964|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0
4610839|NCT01695239|7466965|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0
4610840|NCT01695239|7466966|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0
4610841|NCT01695239|7466967|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1
4610842|NCT01695746|7467034|FG000|Overall Study|Adverse Event|1
4610843|NCT01695746|7467034|FG000|Overall Study|Non-compliance by the participant|3
4610844|NCT01695746|7467034|FG000|Overall Study|Protocol Violation|5
4610845|NCT01695746|7467034|FG000|Overall Study|Participant not willing to participate|3
4610846|NCT01695772|7467039|FG000|Overall Study|Withdrawal by Subject|18
4610847|NCT01695772|7467039|FG000|Overall Study|Progressive Disease|8
4610848|NCT01695772|7467039|FG000|Overall Study|Investigator Decision|5
4610849|NCT01695772|7467039|FG000|Overall Study|Lost to Follow-up|4
4610850|NCT01695772|7467039|FG000|Overall Study|Protocol Violation|2
4610851|NCT01695772|7467039|FG000|Overall Study|Unspecified Reason|1
4537431|NCT01109992|7358204|FG001|Overall Study|Movement during rest scan.|1
4537432|NCT01110005|7358215|FG000|Overall Study|ineligible|1
4537433|NCT01110005|7358216|FG001|Overall Study|ineligible|2
4537434|NCT01110005|7358215|FG000|Overall Study|missing consent|3
4537435|NCT01110005|7358216|FG001|Overall Study|missing consent|2
4537436|NCT01110005|7358215|FG000|Overall Study|Withdrawal by Subject|0
4537437|NCT01110005|7358216|FG001|Overall Study|Withdrawal by Subject|1
4537438|NCT01110200|7358239|FG000|Overall Study|Adverse Event|28
4537439|NCT01110200|7358240|FG001|Overall Study|Adverse Event|28
4537440|NCT01110200|7358239|FG000|Overall Study|Withdrawal by Subject|25
4537441|NCT01110200|7358240|FG001|Overall Study|Withdrawal by Subject|32
4537442|NCT01110200|7358239|FG000|Overall Study|Lack of Efficacy|16
4537443|NCT01110200|7358240|FG001|Overall Study|Lack of Efficacy|25
4537444|NCT01110200|7358239|FG000|Overall Study|Protocol Violation|14
4537445|NCT01110200|7358240|FG001|Overall Study|Protocol Violation|12
4537446|NCT01110200|7358239|FG000|Overall Study|Physician Decision|13
4537447|NCT01110200|7358240|FG001|Overall Study|Physician Decision|17
4537448|NCT01110200|7358239|FG000|Overall Study|Lost to Follow-up|10
4537449|NCT01110200|7358240|FG001|Overall Study|Lost to Follow-up|7
4537450|NCT01110239|7358250|FG000|Sham Preconditioning|Withdrawal by Subject|0
4537451|NCT01110239|7358251|FG001|Sham Preconditioning|Withdrawal by Subject|0
4537452|NCT01110239|7358252|FG002|Sham Preconditioning|Withdrawal by Subject|1
4537453|NCT01110239|7358253|FG003|Sham Preconditioning|Withdrawal by Subject|0
4537454|NCT01110239|7358250|FG000|7.5 Min Ischemia|Withdrawal by Subject|0
4537455|NCT01110239|7358251|FG001|7.5 Min Ischemia|Withdrawal by Subject|0
4537456|NCT01110239|7358252|FG002|7.5 Min Ischemia|Withdrawal by Subject|1
4537457|NCT01110239|7358253|FG003|7.5 Min Ischemia|Withdrawal by Subject|0
4537458|NCT01110330|7358272|FG000|Overall Study|Adverse Event|0
4537459|NCT01110330|7358273|FG001|Overall Study|Adverse Event|4
4537460|NCT01110330|7358274|FG002|Overall Study|Adverse Event|3
4537461|NCT01110330|7358272|FG000|Overall Study|Lack of Efficacy|3
4537462|NCT01110330|7358273|FG001|Overall Study|Lack of Efficacy|1
4537463|NCT01110330|7358274|FG002|Overall Study|Lack of Efficacy|1
4537464|NCT01110330|7358272|FG000|Overall Study|Lost to Follow-up|9
4537465|NCT01110330|7358273|FG001|Overall Study|Lost to Follow-up|10
4537466|NCT01110330|7358274|FG002|Overall Study|Lost to Follow-up|15
4537467|NCT01110330|7358272|FG000|Overall Study|Physician Decision|0
4537468|NCT01110330|7358273|FG001|Overall Study|Physician Decision|1
4537469|NCT01110330|7358274|FG002|Overall Study|Physician Decision|0
4537470|NCT01110330|7358272|FG000|Overall Study|Protocol Violation|2
4537471|NCT01110330|7358273|FG001|Overall Study|Protocol Violation|0
4537472|NCT01110330|7358274|FG002|Overall Study|Protocol Violation|4
4537473|NCT01110330|7358272|FG000|Overall Study|Withdrawal by Subject|0
4537474|NCT01110330|7358273|FG001|Overall Study|Withdrawal by Subject|6
4537475|NCT01110330|7358274|FG002|Overall Study|Withdrawal by Subject|2
4537476|NCT01110330|7358272|FG000|Overall Study|Other|1
4537477|NCT01110330|7358273|FG001|Overall Study|Other|1
4537478|NCT01110330|7358274|FG002|Overall Study|Other|1
4537479|NCT01110382|7358284|FG000|Overall Study|Withdrawal by Subject|0
4537480|NCT01110382|7358285|FG001|Overall Study|Withdrawal by Subject|1
4537481|NCT01110382|7358284|FG000|Overall Study|Protocol Violation|0
4537482|NCT01110382|7358285|FG001|Overall Study|Protocol Violation|1
4537483|NCT01110408|7358297|FG000|Overall Study|Protocol Violation|1
4537484|NCT01110408|7358298|FG001|Overall Study|Protocol Violation|0
4537485|NCT01110707|7358363|FG000|Overall Study|Protocol Violation|0
4537486|NCT01110707|7358364|FG001|Overall Study|Protocol Violation|3
4537487|NCT01110915|7358383|FG000|Overall Study|Death|2
4537488|NCT01110915|7358384|FG001|Overall Study|Death|1
4537489|NCT01110915|7358383|FG000|Overall Study|Lost to Follow-up|1
4537490|NCT01110915|7358384|FG001|Overall Study|Lost to Follow-up|0
4537491|NCT01110915|7358383|FG000|Overall Study|Withdrawal by Subject|7
4537492|NCT01110915|7358384|FG001|Overall Study|Withdrawal by Subject|1
4537493|NCT01111123|7358406|FG000|Open- Label Phase|Failed to be clear or almost cleared|14
4454203|NCT00536510|7241228|FG001|Overall Study|Withdrawal by Subject|9
4454204|NCT00536510|7241227|FG000|Overall Study|Flushing with Product|20
4454205|NCT00536510|7241228|FG001|Overall Study|Flushing with Product|0
4454206|NCT00536510|7241227|FG000|Overall Study|Laboratory Adverse Event|2
4454207|NCT00536510|7241228|FG001|Overall Study|Laboratory Adverse Event|1
4454208|NCT00536510|7241227|FG000|Overall Study|Patient Discontinued for Other Reasons|2
4454209|NCT00536510|7241228|FG001|Overall Study|Patient Discontinued for Other Reasons|2
4454210|NCT00536575|7241234|FG000|Overall Study|Withdrawal by Subject|1
4454211|NCT00536575|7241234|FG000|Overall Study|Death|1
4454212|NCT00536731|7241262|FG000|Overall Study|Adverse Event|3
4454213|NCT00536731|7241263|FG001|Overall Study|Adverse Event|2
4454214|NCT00536731|7241264|FG002|Overall Study|Adverse Event|3
4454215|NCT00536731|7241262|FG000|Overall Study|Withdrawal by Subject|0
4454216|NCT00536731|7241263|FG001|Overall Study|Withdrawal by Subject|2
4454217|NCT00536731|7241264|FG002|Overall Study|Withdrawal by Subject|0
4454218|NCT00536731|7241262|FG000|Overall Study|Intake of prohibited conc. medication|0
4454219|NCT00536731|7241263|FG001|Overall Study|Intake of prohibited conc. medication|0
4454220|NCT00536731|7241264|FG002|Overall Study|Intake of prohibited conc. medication|1
4454221|NCT00536731|7241262|FG000|Overall Study|Safety reasons|0
4454222|NCT00536731|7241263|FG001|Overall Study|Safety reasons|0
4454223|NCT00536731|7241264|FG002|Overall Study|Safety reasons|1
4537494|NCT01111123|7358407|FG001|Open- Label Phase|Failed to be clear or almost cleared|0
4537495|NCT01111123|7358406|FG000|Maintenance Phase|Lost to Follow-up|0
4537496|NCT01111123|7358407|FG001|Maintenance Phase|Lost to Follow-up|2
4454224|NCT00536731|7241262|FG000|Overall Study|Other|1
4454225|NCT00536731|7241263|FG001|Overall Study|Other|1
4454226|NCT00536731|7241264|FG002|Overall Study|Other|0
4454227|NCT00536744|7241274|FG000|Overall Study|Adverse Event|13
4454228|NCT00536744|7241275|FG001|Overall Study|Adverse Event|10
4454229|NCT00536744|7241274|FG000|Overall Study|Death|2
4454230|NCT00536744|7241275|FG001|Overall Study|Death|1
4454231|NCT00536744|7241274|FG000|Overall Study|Physician Decision|3
4454232|NCT00536744|7241275|FG001|Overall Study|Physician Decision|1
4454233|NCT00536744|7241274|FG000|Overall Study|Lost to Follow-up|3
4454234|NCT00536744|7241275|FG001|Overall Study|Lost to Follow-up|5
4454235|NCT00536744|7241274|FG000|Overall Study|Withdrawal by Subject|7
4454236|NCT00536744|7241275|FG001|Overall Study|Withdrawal by Subject|8
4454237|NCT00536744|7241274|FG000|Overall Study|PI tried alternative treatment|1
4454238|NCT00536744|7241275|FG001|Overall Study|PI tried alternative treatment|3
4454239|NCT00536809|7241281|FG000|Phase II|Adverse Event|1
4454240|NCT00536809|7241281|FG000|Phase II|Referred for surgical resection|1
4454241|NCT00536874|7241285|FG000|Overall Study|Adverse Event|1
4454242|NCT00536874|7241285|FG000|Overall Study|Death|2
4454243|NCT00536874|7241285|FG000|Overall Study|Withdrawal by Subject|1
4454244|NCT00536939|7241298|FG000|Overall Study|Withdrawal by Subject|1
4454245|NCT00536939|7241299|FG001|Overall Study|Withdrawal by Subject|0
4454246|NCT00536939|7241298|FG000|Overall Study|Other Complicating Disease|1
4454247|NCT00536939|7241299|FG001|Overall Study|Other Complicating Disease|0
4454248|NCT00536991|7241304|FG000|Overall Study|Withdrawal by Subject|10
4454249|NCT00536991|7241304|FG000|Overall Study|Physician Decision|1
4454250|NCT00536991|7241304|FG000|Overall Study|patient ineligible|2
4454251|NCT00537017|7241309|FG000|Treatment Phase|Adverse Event|19
4454252|NCT00537017|7241309|FG000|Treatment Phase|Withdrawal by Subject|13
4454253|NCT00537017|7241309|FG000|Treatment Phase|Protocol Violation|2
4454254|NCT00537017|7241309|FG000|Follow-up Phase|Withdrawal by Subject|9
4454255|NCT00537030|7241313|FG000|Overall Study|Physician Decision|2
4454256|NCT00537030|7241313|FG000|Overall Study|Withdrawal by Subject|2
4454257|NCT00537030|7241313|FG000|Overall Study|≥ Grade 2 allergy|7
4454258|NCT00537030|7241313|FG000|Overall Study|Disease progression/ relapse during Tx|1
4454259|NCT00537030|7241313|FG000|Overall Study|Ineligible|2
4454260|NCT00537030|7241313|FG000|Overall Study|Inevaluable|2
4454261|NCT00537056|7241317|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5
4454262|NCT00537082|7241326|FG000|Overall Study|Adverse Event|6
4454263|NCT00537082|7241327|FG001|Overall Study|Adverse Event|6
4454264|NCT00537082|7241328|FG002|Overall Study|Adverse Event|3
4454265|NCT00537082|7241326|FG000|Overall Study|Protocol Violation|0
4454266|NCT00537082|7241327|FG001|Overall Study|Protocol Violation|2
4454267|NCT00537082|7241328|FG002|Overall Study|Protocol Violation|1
4454268|NCT00537082|7241326|FG000|Overall Study|Lack of Efficacy|0
4454269|NCT00537082|7241327|FG001|Overall Study|Lack of Efficacy|0
4454270|NCT00537082|7241328|FG002|Overall Study|Lack of Efficacy|2
4454271|NCT00537082|7241326|FG000|Overall Study|Withdrawal by Subject|0
4454272|NCT00537082|7241327|FG001|Overall Study|Withdrawal by Subject|1
4454273|NCT00537082|7241328|FG002|Overall Study|Withdrawal by Subject|0
4454274|NCT00537082|7241326|FG000|Overall Study|Discontinued before initiating treatment|3
4454275|NCT00537082|7241327|FG001|Overall Study|Discontinued before initiating treatment|0
4454276|NCT00537082|7241328|FG002|Overall Study|Discontinued before initiating treatment|0
4454277|NCT00537095|7241338|FG000|Overall Study|surgery|1
4454278|NCT00537095|7241339|FG001|Overall Study|surgery|0
4454279|NCT00537095|7241338|FG000|Overall Study|Adverse Event|24
4454280|NCT00537095|7241339|FG001|Overall Study|Adverse Event|4
4454281|NCT00537095|7241338|FG000|Overall Study|disease progression|21
4454282|NCT00537095|7241339|FG001|Overall Study|disease progression|48
4454283|NCT00537095|7241338|FG000|Overall Study|Death|3
4454284|NCT00537095|7241339|FG001|Overall Study|Death|1
4454285|NCT00537095|7241338|FG000|Overall Study|Withdrawal by Subject|2
4454286|NCT00537095|7241339|FG001|Overall Study|Withdrawal by Subject|2
4454287|NCT00537095|7241338|FG000|Overall Study|subjective disease progression|0
4454288|NCT00537095|7241339|FG001|Overall Study|subjective disease progression|1
4454289|NCT00537095|7241338|FG000|Overall Study|Incorrect enrolment|0
4454290|NCT00537095|7241339|FG001|Overall Study|Incorrect enrolment|1
4454291|NCT00537238|7241347|FG000|Overall Study|Death|1
4454292|NCT00537238|7241348|FG001|Overall Study|Death|2
4454293|NCT00537238|7241347|FG000|Overall Study|Adverse Event|31
4454294|NCT00537238|7241348|FG001|Overall Study|Adverse Event|22
4454295|NCT00537238|7241347|FG000|Overall Study|Lack of Efficacy|20
4454296|NCT00537238|7241348|FG001|Overall Study|Lack of Efficacy|21
4454297|NCT00537238|7241347|FG000|Overall Study|Lost to Follow-up|12
4454298|NCT00537238|7241348|FG001|Overall Study|Lost to Follow-up|8
4454299|NCT00537238|7241347|FG000|Overall Study|Withdrawal by Subject|51
4454300|NCT00537238|7241348|FG001|Overall Study|Withdrawal by Subject|47
4454301|NCT00537238|7241347|FG000|Overall Study|Protocol Violation|15
4454302|NCT00537238|7241348|FG001|Overall Study|Protocol Violation|19
4454303|NCT00537238|7241347|FG000|Overall Study|Does not meet entrance criteria|0
4454304|NCT00537238|7241348|FG001|Overall Study|Does not meet entrance criteria|2
4454305|NCT00537238|7241347|FG000|Overall Study|Other|44
4454306|NCT00537238|7241348|FG001|Overall Study|Other|52
4454307|NCT00537277|7241354|FG000|Overall Study|Adverse Event|1
4454308|NCT00537277|7241354|FG000|Overall Study|Lack of Efficacy|2
4454309|NCT00537277|7241354|FG000|Overall Study|Lost to Follow-up|12
4454310|NCT00537277|7241354|FG000|Overall Study|Protocol Violation|11
4454311|NCT00537277|7241354|FG000|Overall Study|Unclassified|4
4454312|NCT00537277|7241354|FG000|Overall Study|Inability to tolerate trial medication|4
4454313|NCT00537277|7241354|FG000|Overall Study|Non-compliance with trial procedures|15
4454314|NCT00537303|7241364|FG000|Overall Study|Adverse Event|1
4454315|NCT00537303|7241365|FG001|Overall Study|Adverse Event|4
4454316|NCT00537303|7241364|FG000|Overall Study|Lack of Efficacy|6
4454317|NCT00537303|7241365|FG001|Overall Study|Lack of Efficacy|7
4454318|NCT00537303|7241364|FG000|Overall Study|Protocol Violation|8
4454319|NCT00537303|7241365|FG001|Overall Study|Protocol Violation|4
4454320|NCT00537303|7241364|FG000|Overall Study|Withdrawal criteria|3
4454321|NCT00537303|7241365|FG001|Overall Study|Withdrawal criteria|3
4454322|NCT00537303|7241364|FG000|Overall Study|Unclassified|8
4454323|NCT00537303|7241365|FG001|Overall Study|Unclassified|7
4454324|NCT00537316|7241377|FG000|Part 1|Adverse Event|7
4454325|NCT00537316|7241378|FG001|Part 1|Adverse Event|11
4454326|NCT00537316|7241379|FG002|Part 1|Adverse Event|8
4454327|NCT00537316|7241380|FG003|Part 1|Adverse Event|0
4454328|NCT00537316|7241381|FG004|Part 1|Adverse Event|0
4454329|NCT00537316|7241382|FG005|Part 1|Adverse Event|0
4454330|NCT00537316|7241383|FG006|Part 1|Adverse Event|0
4454331|NCT00537316|7241377|FG000|Part 1|Protocol defined clinical event|1
4454332|NCT00537316|7241378|FG001|Part 1|Protocol defined clinical event|0
4454333|NCT00537316|7241379|FG002|Part 1|Protocol defined clinical event|0
4454334|NCT00537316|7241380|FG003|Part 1|Protocol defined clinical event|0
4454335|NCT00537316|7241381|FG004|Part 1|Protocol defined clinical event|0
4454336|NCT00537316|7241382|FG005|Part 1|Protocol defined clinical event|0
4454337|NCT00537316|7241383|FG006|Part 1|Protocol defined clinical event|0
4454338|NCT00537316|7241377|FG000|Part 1|Lost to Follow-up|1
4454339|NCT00537316|7241378|FG001|Part 1|Lost to Follow-up|0
4454340|NCT00537316|7241379|FG002|Part 1|Lost to Follow-up|0
4454341|NCT00537316|7241380|FG003|Part 1|Lost to Follow-up|0
4454342|NCT00537316|7241381|FG004|Part 1|Lost to Follow-up|0
4454343|NCT00537316|7241382|FG005|Part 1|Lost to Follow-up|0
4454344|NCT00537316|7241383|FG006|Part 1|Lost to Follow-up|0
4454345|NCT00537316|7241377|FG000|Part 1|Withdrawal by Subject|3
4454346|NCT00537316|7241378|FG001|Part 1|Withdrawal by Subject|8
4454347|NCT00537316|7241379|FG002|Part 1|Withdrawal by Subject|4
4454348|NCT00537316|7241380|FG003|Part 1|Withdrawal by Subject|0
4454349|NCT00537316|7241381|FG004|Part 1|Withdrawal by Subject|0
4454350|NCT00537316|7241382|FG005|Part 1|Withdrawal by Subject|0
4454351|NCT00537316|7241383|FG006|Part 1|Withdrawal by Subject|0
4454352|NCT00537316|7241377|FG000|Part 1|Protocol Violation|1
4454353|NCT00537316|7241378|FG001|Part 1|Protocol Violation|5
4454354|NCT00537316|7241379|FG002|Part 1|Protocol Violation|1
4454355|NCT00537316|7241380|FG003|Part 1|Protocol Violation|0
4454356|NCT00537316|7241381|FG004|Part 1|Protocol Violation|0
4454357|NCT00537316|7241382|FG005|Part 1|Protocol Violation|0
4454358|NCT00537316|7241383|FG006|Part 1|Protocol Violation|0
4454359|NCT00537316|7241377|FG000|Part 1|Did not meet protocol eligibility|1
4454360|NCT00537316|7241378|FG001|Part 1|Did not meet protocol eligibility|3
4537497|NCT01111149|7358418|FG000|Overall Study|Protocol Violation|1
4537498|NCT01111149|7358419|FG001|Overall Study|Protocol Violation|1
4537499|NCT01111149|7358420|FG002|Overall Study|Protocol Violation|2
4537500|NCT01111149|7358418|FG000|Overall Study|Withdrawal by Subject|1
4537501|NCT01111149|7358419|FG001|Overall Study|Withdrawal by Subject|0
4537502|NCT01111149|7358420|FG002|Overall Study|Withdrawal by Subject|2
4537503|NCT01111240|7358433|FG000|Overall Study|Adverse Event|190
4537504|NCT01111240|7358433|FG000|Overall Study|Lack of Efficacy|545
4537505|NCT01111240|7358433|FG000|Overall Study|Lack of Efficacy and Adverse Event|19
4537506|NCT01111240|7358433|FG000|Overall Study|Other|312
4537507|NCT01111292|7358439|FG000|Treatment|Physician Decision|1
4537508|NCT01111292|7358440|FG001|Treatment|Physician Decision|1
4537509|NCT01111461|7358478|FG000|Overall Study|Adverse Event|32
4537510|NCT01111461|7358478|FG000|Overall Study|Participant choice|11
4537511|NCT01111461|7358478|FG000|Overall Study|Lost to Follow-up|1
4537512|NCT01111461|7358478|FG000|Overall Study|Withdrawal by Subject|1
4537513|NCT01111461|7358478|FG000|Overall Study|Other|6
4537514|NCT01111474|7358482|FG000|Overall Study|Lost to Follow-up|12
4537515|NCT01111526|7358488|FG000|Overall Study|GVHD Disease Progression|0
4537516|NCT01111526|7358489|FG001|Overall Study|GVHD Disease Progression|1
4537517|NCT01111526|7358490|FG002|Overall Study|GVHD Disease Progression|2
4537518|NCT01111539|7358494|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6
4537519|NCT01111539|7358495|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0
4454361|NCT00537316|7241379|FG002|Part 1|Did not meet protocol eligibility|2
4454362|NCT00537316|7241380|FG003|Part 1|Did not meet protocol eligibility|0
4454363|NCT00537316|7241381|FG004|Part 1|Did not meet protocol eligibility|0
4454364|NCT00537316|7241382|FG005|Part 1|Did not meet protocol eligibility|0
4454365|NCT00537316|7241383|FG006|Part 1|Did not meet protocol eligibility|0
4537520|NCT01111539|7358496|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0
4537521|NCT01111539|7358497|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0
4537522|NCT01111539|7358498|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0
4537523|NCT01111539|7358494|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5
4537524|NCT01111539|7358495|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0
4537525|NCT01111539|7358496|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0
4537526|NCT01111539|7358497|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0
4454366|NCT00537316|7241377|FG000|Part 1|Administrative|0
4454367|NCT00537316|7241378|FG001|Part 1|Administrative|0
4454368|NCT00537316|7241379|FG002|Part 1|Administrative|2
4454369|NCT00537316|7241380|FG003|Part 1|Administrative|0
4454370|NCT00537316|7241381|FG004|Part 1|Administrative|0
4454371|NCT00537316|7241382|FG005|Part 1|Administrative|0
4454372|NCT00537316|7241383|FG006|Part 1|Administrative|0
4454373|NCT00537316|7241377|FG000|Part 2|Never entered follow-up|0
4454374|NCT00537316|7241378|FG001|Part 2|Never entered follow-up|0
4454375|NCT00537316|7241379|FG002|Part 2|Never entered follow-up|0
4454376|NCT00537316|7241380|FG003|Part 2|Never entered follow-up|0
4454377|NCT00537316|7241381|FG004|Part 2|Never entered follow-up|0
4454378|NCT00537316|7241382|FG005|Part 2|Never entered follow-up|0
4454379|NCT00537316|7241383|FG006|Part 2|Never entered follow-up|1
4454380|NCT00537316|7241377|FG000|Part 2|Adverse Event|4
4454381|NCT00537316|7241378|FG001|Part 2|Adverse Event|0
4454382|NCT00537316|7241379|FG002|Part 2|Adverse Event|2
4454383|NCT00537316|7241380|FG003|Part 2|Adverse Event|0
4454384|NCT00537316|7241381|FG004|Part 2|Adverse Event|0
4454385|NCT00537316|7241382|FG005|Part 2|Adverse Event|0
4454386|NCT00537316|7241383|FG006|Part 2|Adverse Event|0
4454387|NCT00537316|7241377|FG000|Part 2|Lost to Follow-up|1
4454388|NCT00537316|7241378|FG001|Part 2|Lost to Follow-up|0
4454389|NCT00537316|7241379|FG002|Part 2|Lost to Follow-up|2
4454390|NCT00537316|7241380|FG003|Part 2|Lost to Follow-up|0
4454391|NCT00537316|7241381|FG004|Part 2|Lost to Follow-up|0
4454392|NCT00537316|7241382|FG005|Part 2|Lost to Follow-up|0
4454393|NCT00537316|7241383|FG006|Part 2|Lost to Follow-up|0
4454394|NCT00537316|7241377|FG000|Part 2|Withdrawal by Subject|5
4454395|NCT00537316|7241378|FG001|Part 2|Withdrawal by Subject|1
4454396|NCT00537316|7241379|FG002|Part 2|Withdrawal by Subject|4
4454397|NCT00537316|7241380|FG003|Part 2|Withdrawal by Subject|0
4454398|NCT00537316|7241381|FG004|Part 2|Withdrawal by Subject|0
4454399|NCT00537316|7241382|FG005|Part 2|Withdrawal by Subject|0
4454400|NCT00537316|7241383|FG006|Part 2|Withdrawal by Subject|0
4537527|NCT01111539|7358498|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0
4537528|NCT01111539|7358494|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60
4454401|NCT00537316|7241377|FG000|Part 2|Administrative|16
4454402|NCT00537316|7241378|FG001|Part 2|Administrative|8
4454403|NCT00537316|7241379|FG002|Part 2|Administrative|24
4454404|NCT00537316|7241380|FG003|Part 2|Administrative|3
4454405|NCT00537316|7241381|FG004|Part 2|Administrative|1
4454406|NCT00537316|7241382|FG005|Part 2|Administrative|4
4454407|NCT00537316|7241383|FG006|Part 2|Administrative|1
4454408|NCT00537329|7241402|FG000|Overall Study|Death|10
4454409|NCT00537329|7241402|FG000|Overall Study|Adverse Event|3
4454410|NCT00537329|7241402|FG000|Overall Study|Lack of Efficacy|2
4454411|NCT00537329|7241402|FG000|Overall Study|Lost to Follow-up|6
4454412|NCT00537329|7241402|FG000|Overall Study|Withdrawal by Subject|4
4454413|NCT00537329|7241402|FG000|Overall Study|Other|1
4454414|NCT00537381|7241408|FG000|Overall Study|Adverse Event|13
4454415|NCT00537381|7241409|FG001|Overall Study|Adverse Event|9
4454416|NCT00537381|7241408|FG000|Overall Study|Death|3
4454417|NCT00537381|7241409|FG001|Overall Study|Death|3
4454418|NCT00537381|7241408|FG000|Overall Study|Withdrawal by Subject|5
4454419|NCT00537381|7241409|FG001|Overall Study|Withdrawal by Subject|14
4454420|NCT00537381|7241408|FG000|Overall Study|Physician Decision|7
4454421|NCT00537381|7241409|FG001|Overall Study|Physician Decision|6
4454422|NCT00537381|7241408|FG000|Overall Study|Disease Progression|9
4454423|NCT00537381|7241409|FG001|Overall Study|Disease Progression|18
4454424|NCT00537381|7241408|FG000|Overall Study|Sponsor decision|14
4454425|NCT00537381|7241409|FG001|Overall Study|Sponsor decision|9
4454426|NCT00537381|7241408|FG000|Overall Study|Other|5
4454427|NCT00537381|7241409|FG001|Overall Study|Other|3
4454428|NCT00537394|7241420|FG000|First Year of Follow-up|Death|7
4454429|NCT00537394|7241421|FG001|First Year of Follow-up|Death|0
4454430|NCT00537394|7241422|FG002|First Year of Follow-up|Death|0
4454431|NCT00537394|7241420|FG000|First Year of Follow-up|Severe debilitation|1
4454432|NCT00537394|7241421|FG001|First Year of Follow-up|Severe debilitation|0
4454433|NCT00537394|7241422|FG002|First Year of Follow-up|Severe debilitation|1
4454434|NCT00537394|7241420|FG000|First Year of Follow-up|Withdrawal by Subject|3
4454435|NCT00537394|7241421|FG001|First Year of Follow-up|Withdrawal by Subject|6
4454436|NCT00537394|7241422|FG002|First Year of Follow-up|Withdrawal by Subject|1
4454437|NCT00537394|7241420|FG000|First Year of Follow-up|Lost to Follow-up|1
4454438|NCT00537394|7241421|FG001|First Year of Follow-up|Lost to Follow-up|5
4454439|NCT00537394|7241422|FG002|First Year of Follow-up|Lost to Follow-up|1
4454440|NCT00537394|7241420|FG000|2nd Year of Follow-up|Death|4
4454441|NCT00537394|7241421|FG001|2nd Year of Follow-up|Death|1
4454442|NCT00537394|7241422|FG002|2nd Year of Follow-up|Death|2
4454443|NCT00537394|7241420|FG000|2nd Year of Follow-up|Withdrawal by Subject|0
4537529|NCT01111539|7358495|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0
4454444|NCT00537394|7241421|FG001|2nd Year of Follow-up|Withdrawal by Subject|1
4454445|NCT00537394|7241422|FG002|2nd Year of Follow-up|Withdrawal by Subject|2
4454446|NCT00537394|7241420|FG000|2nd Year of Follow-up|Lost to Follow-up|6
4454447|NCT00537394|7241421|FG001|2nd Year of Follow-up|Lost to Follow-up|7
4454448|NCT00537394|7241422|FG002|2nd Year of Follow-up|Lost to Follow-up|2
4454449|NCT00537394|7241420|FG000|2nd Year of Follow-up|Clinic site closure|1
4454450|NCT00537394|7241421|FG001|2nd Year of Follow-up|Clinic site closure|0
4454451|NCT00537394|7241422|FG002|2nd Year of Follow-up|Clinic site closure|0
4454452|NCT00537485|7241455|FG000|Overall Study|Adverse Event|10
4454453|NCT00537485|7241456|FG001|Overall Study|Adverse Event|5
4454454|NCT00537485|7241455|FG000|Overall Study|Withdrawal by Subject|3
4454455|NCT00537485|7241456|FG001|Overall Study|Withdrawal by Subject|2
4454456|NCT00537485|7241455|FG000|Overall Study|Withdrawal by Subject|1
4454457|NCT00537485|7241456|FG001|Overall Study|Withdrawal by Subject|3
4454458|NCT00537485|7241455|FG000|Overall Study|Physician Decision|1
4454459|NCT00537485|7241456|FG001|Overall Study|Physician Decision|0
4454460|NCT00537745|7241517|FG000|Overall Study|Did not meet eligibility criteria|2
4454461|NCT00537745|7241517|FG000|Overall Study|Withdrawal by Subject|2
4537530|NCT01111539|7358496|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0
4454462|NCT00537745|7241517|FG000|Overall Study|Subject unable to provide Interlock info|1
4454463|NCT00537771|7241524|FG000|Overall Study|Withdrawal by Subject|6
4454464|NCT00537771|7241525|FG001|Overall Study|Withdrawal by Subject|23
4454465|NCT00537771|7241524|FG000|Overall Study|Adverse Event|8
4454466|NCT00537771|7241525|FG001|Overall Study|Adverse Event|15
4454467|NCT00537771|7241524|FG000|Overall Study|Lost to Follow-up|9
4454468|NCT00537771|7241525|FG001|Overall Study|Lost to Follow-up|15
4454469|NCT00537771|7241524|FG000|Overall Study|Protocol Violation|2
4454470|NCT00537771|7241525|FG001|Overall Study|Protocol Violation|6
4454471|NCT00537771|7241524|FG000|Overall Study|Severe Non-Compliance to Protocol|4
4454472|NCT00537771|7241525|FG001|Overall Study|Severe Non-Compliance to Protocol|2
4454473|NCT00537810|7241535|FG000|Overall Study|Withdrawal by Subject|4
4454474|NCT00537810|7241536|FG001|Overall Study|Withdrawal by Subject|11
4454475|NCT00537810|7241537|FG002|Overall Study|Withdrawal by Subject|4
4454476|NCT00537810|7241538|FG003|Overall Study|Withdrawal by Subject|3
4454477|NCT00537810|7241535|FG000|Overall Study|Medically withdrawn|2
4454478|NCT00537810|7241536|FG001|Overall Study|Medically withdrawn|2
4454479|NCT00537810|7241537|FG002|Overall Study|Medically withdrawn|0
4454480|NCT00537810|7241538|FG003|Overall Study|Medically withdrawn|1
4454481|NCT00537823|7241550|FG000|Overall Study|Adverse Event|2
4454482|NCT00537823|7241551|FG001|Overall Study|Adverse Event|0
4454483|NCT00537940|7241560|FG000|Overall Study|Adverse Event|20
4454484|NCT00537940|7241561|FG001|Overall Study|Adverse Event|19
4454485|NCT00537940|7241560|FG000|Overall Study|Lack of Efficacy|8
4454486|NCT00537940|7241561|FG001|Overall Study|Lack of Efficacy|16
4454487|NCT00537940|7241560|FG000|Overall Study|Lost to Follow-up|23
4454488|NCT00537940|7241561|FG001|Overall Study|Lost to Follow-up|29
4454489|NCT00537940|7241560|FG000|Overall Study|Withdrawal by Subject|113
4454490|NCT00537940|7241561|FG001|Overall Study|Withdrawal by Subject|95
4454491|NCT00537940|7241560|FG000|Overall Study|Protocol Violation|6
4454492|NCT00537940|7241561|FG001|Overall Study|Protocol Violation|4
4454493|NCT00537940|7241560|FG000|Overall Study|Pregnancy|1
4454494|NCT00537940|7241561|FG001|Overall Study|Pregnancy|1
4454495|NCT00537940|7241560|FG000|Overall Study|Study terminated by sponsor|2
4454496|NCT00537940|7241561|FG001|Overall Study|Study terminated by sponsor|3
4454497|NCT00537940|7241560|FG000|Overall Study|Other|10
4454498|NCT00537940|7241561|FG001|Overall Study|Other|12
4454499|NCT00537979|7241569|FG000|Overall Study|Adverse Event|2
4454500|NCT00537979|7241570|FG001|Overall Study|Adverse Event|2
4454501|NCT00537979|7241569|FG000|Overall Study|Withdrawal by Subject|1
4454502|NCT00537979|7241570|FG001|Overall Study|Withdrawal by Subject|4
4454503|NCT00537979|7241569|FG000|Overall Study|Lost to Follow-up|1
4454504|NCT00537979|7241570|FG001|Overall Study|Lost to Follow-up|4
4454505|NCT00537979|7241569|FG000|Overall Study|Lack of Efficacy|0
4454506|NCT00537979|7241570|FG001|Overall Study|Lack of Efficacy|1
4454507|NCT00537979|7241569|FG000|Overall Study|Non-compliance with treatment/procedure|2
4454508|NCT00537979|7241570|FG001|Overall Study|Non-compliance with treatment/procedure|2
4454509|NCT00537979|7241569|FG000|Overall Study|Death|0
4454510|NCT00537979|7241570|FG001|Overall Study|Death|3
4454511|NCT00537979|7241569|FG000|Overall Study|Kidney transplant|0
4454512|NCT00537979|7241570|FG001|Overall Study|Kidney transplant|3
4454513|NCT00537979|7241569|FG000|Overall Study|Heart failure|0
4454514|NCT00537979|7241570|FG001|Overall Study|Heart failure|1
4454515|NCT00538291|7241591|FG000|Overall Study|Adverse Event|2
4454516|NCT00538291|7241591|FG000|Overall Study|Withdrawal by Subject|1
4454517|NCT00538473|7241624|FG000|Overall Study|Adverse Event|1
4454518|NCT00538473|7241625|FG001|Overall Study|Adverse Event|0
4454519|NCT00538590|7241646|FG000|Overall Study|Death|1
4454520|NCT00538590|7241647|FG001|Overall Study|Death|0
4454521|NCT00538629|7241662|FG000|Overall Study|At subject's request|1
4454522|NCT00538629|7241662|FG000|Overall Study|Adverse Event|2
4454523|NCT00538629|7241662|FG000|Overall Study|Lack of Efficacy|12
4454524|NCT00538629|7241662|FG000|Overall Study|Lost to Follow-up|6
4454525|NCT00538629|7241662|FG000|Overall Study|Subject's untimely distrust of medicine|1
4454526|NCT00538681|7241680|FG000|Overall Study|Progressive Disease|7
4454527|NCT00538681|7241681|FG001|Overall Study|Progressive Disease|0
4454528|NCT00538681|7241682|FG002|Overall Study|Progressive Disease|1
4454529|NCT00538681|7241683|FG003|Overall Study|Progressive Disease|0
4454530|NCT00538681|7241680|FG000|Overall Study|Sponsor Decision|1
4454531|NCT00538681|7241681|FG001|Overall Study|Sponsor Decision|3
4454532|NCT00538681|7241682|FG002|Overall Study|Sponsor Decision|8
4454533|NCT00538681|7241683|FG003|Overall Study|Sponsor Decision|9
4454534|NCT00538681|7241680|FG000|Overall Study|Adverse Event|1
4454535|NCT00538681|7241681|FG001|Overall Study|Adverse Event|1
4454536|NCT00538681|7241682|FG002|Overall Study|Adverse Event|1
4454537|NCT00538681|7241683|FG003|Overall Study|Adverse Event|0
4454538|NCT00538681|7241680|FG000|Overall Study|Death|0
4454539|NCT00538681|7241681|FG001|Overall Study|Death|0
4454540|NCT00538681|7241682|FG002|Overall Study|Death|1
4454541|NCT00538681|7241683|FG003|Overall Study|Death|1
4454542|NCT00538681|7241680|FG000|Overall Study|Investigator Decision|0
4454543|NCT00538681|7241681|FG001|Overall Study|Investigator Decision|0
4454544|NCT00538681|7241682|FG002|Overall Study|Investigator Decision|0
4454545|NCT00538681|7241683|FG003|Overall Study|Investigator Decision|1
4454546|NCT00538733|7241694|FG000|Overall Study|Adverse Event|8
4454547|NCT00538733|7241694|FG000|Overall Study|Death|1
4454548|NCT00538733|7241694|FG000|Overall Study|declined to participate|2
4454549|NCT00538733|7241694|FG000|Overall Study|still on therapy|1
4454550|NCT00538785|7241712|FG000|Overall Study|Death|9
4454551|NCT00538785|7241713|FG001|Overall Study|Death|10
4454552|NCT00538785|7241712|FG000|Overall Study|Withdrawal of consent|9
4454553|NCT00538785|7241713|FG001|Overall Study|Withdrawal of consent|7
4454554|NCT00538785|7241712|FG000|Overall Study|Lost to Follow-up|1
4610852|NCT01695954|7467045|FG000|Overall Study|Withdrawal by Subject|4
4454555|NCT00538785|7241713|FG001|Overall Study|Lost to Follow-up|0
4454556|NCT00538902|7241740|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1
4454557|NCT00538902|7241741|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2
4454558|NCT00538902|7241742|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3
4454559|NCT00538902|7241740|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0
4454560|NCT00538902|7241741|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0
4454561|NCT00538902|7241742|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1
4454562|NCT00538902|7241740|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0
4454563|NCT00538902|7241741|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0
4454564|NCT00538902|7241742|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1
4454565|NCT00538902|7241740|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
4454566|NCT00538902|7241741|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
4454567|NCT00538902|7241742|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
4454568|NCT00538902|7241740|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2
4454569|NCT00538902|7241741|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10
4454570|NCT00538902|7241742|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11
4454571|NCT00538902|7241740|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15
4454572|NCT00538902|7241741|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19
4454573|NCT00538902|7241742|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25
4454574|NCT00538902|7241740|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1
4454575|NCT00538902|7241741|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10
4454576|NCT00538902|7241742|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6
4454577|NCT00538902|7241740|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18
4454578|NCT00538902|7241741|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25
4454579|NCT00538902|7241742|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22
4454580|NCT00539006|7241760|FG000|Pre-treatment|Other|0
4454581|NCT00539006|7241761|FG001|Pre-treatment|Other|1
4454582|NCT00539006|7241762|FG002|Pre-treatment|Other|0
4454583|NCT00539006|7241763|FG003|Pre-treatment|Other|0
4454584|NCT00539006|7241760|FG000|Treatment Period 1|Lost to Follow-up|0
4454585|NCT00539006|7241761|FG001|Treatment Period 1|Lost to Follow-up|0
4454586|NCT00539006|7241762|FG002|Treatment Period 1|Lost to Follow-up|1
4454587|NCT00539006|7241763|FG003|Treatment Period 1|Lost to Follow-up|0
4454588|NCT00539006|7241760|FG000|Treatment Period 1|Protocol Violation|0
4454589|NCT00539006|7241761|FG001|Treatment Period 1|Protocol Violation|0
4454590|NCT00539006|7241762|FG002|Treatment Period 1|Protocol Violation|1
4454591|NCT00539006|7241763|FG003|Treatment Period 1|Protocol Violation|0
4454592|NCT00539006|7241760|FG000|Treatment Period 1|Lack of Efficacy|0
4454593|NCT00539006|7241761|FG001|Treatment Period 1|Lack of Efficacy|0
4454594|NCT00539006|7241762|FG002|Treatment Period 1|Lack of Efficacy|0
4454595|NCT00539006|7241763|FG003|Treatment Period 1|Lack of Efficacy|1
4454596|NCT00539006|7241760|FG000|Washout|Adverse Event|2
4454597|NCT00539006|7241761|FG001|Washout|Adverse Event|1
4454598|NCT00539006|7241762|FG002|Washout|Adverse Event|0
4454599|NCT00539006|7241763|FG003|Washout|Adverse Event|0
4454600|NCT00539006|7241760|FG000|Washout|Protocol Violation|1
4454601|NCT00539006|7241761|FG001|Washout|Protocol Violation|1
4454602|NCT00539006|7241762|FG002|Washout|Protocol Violation|0
4454603|NCT00539006|7241763|FG003|Washout|Protocol Violation|0
4454604|NCT00539006|7241760|FG000|Washout|Withdrawal by Subject|0
4454605|NCT00539006|7241761|FG001|Washout|Withdrawal by Subject|2
4454606|NCT00539006|7241762|FG002|Washout|Withdrawal by Subject|0
4454607|NCT00539006|7241763|FG003|Washout|Withdrawal by Subject|0
4454608|NCT00539006|7241760|FG000|Washout|Failed to meet continuation criteria|16
4454609|NCT00539006|7241761|FG001|Washout|Failed to meet continuation criteria|5
4454610|NCT00539006|7241762|FG002|Washout|Failed to meet continuation criteria|14
4454611|NCT00539006|7241763|FG003|Washout|Failed to meet continuation criteria|6
4454612|NCT00539006|7241760|FG000|Washout|Other|1
4454613|NCT00539006|7241761|FG001|Washout|Other|1
4454614|NCT00539006|7241762|FG002|Washout|Other|2
4454615|NCT00539006|7241763|FG003|Washout|Other|3
4454616|NCT00539006|7241760|FG000|Treatment Period 2|Protocol Violation|1
4454617|NCT00539006|7241761|FG001|Treatment Period 2|Protocol Violation|0
4454618|NCT00539006|7241762|FG002|Treatment Period 2|Protocol Violation|0
4454619|NCT00539006|7241763|FG003|Treatment Period 2|Protocol Violation|0
4454620|NCT00539006|7241760|FG000|Treatment Period 2|Other|0
4454621|NCT00539006|7241761|FG001|Treatment Period 2|Other|1
4454622|NCT00539006|7241762|FG002|Treatment Period 2|Other|0
4454623|NCT00539006|7241763|FG003|Treatment Period 2|Other|0
4454624|NCT00539032|7241781|FG000|Overall Study|Withdrawal by Subject|2
4454625|NCT00539032|7241782|FG001|Overall Study|Withdrawal by Subject|1
4454626|NCT00539188|7241799|FG000|Overall Study|Withdrawal by Subject|1
4454627|NCT00539188|7241800|FG001|Overall Study|Withdrawal by Subject|0
4454628|NCT00539188|7241799|FG000|Overall Study|Lost to Follow-up|2
4454629|NCT00539188|7241800|FG001|Overall Study|Lost to Follow-up|1
4454630|NCT00539240|7241809|FG000|Overall Study|Withdrawal by Subject|0
4454631|NCT00539240|7241810|FG001|Overall Study|Withdrawal by Subject|2
4454632|NCT00539240|7241811|FG002|Overall Study|Withdrawal by Subject|0
4454633|NCT00539240|7241809|FG000|Overall Study|Protocol Violation|1
4454634|NCT00539240|7241810|FG001|Overall Study|Protocol Violation|1
4454635|NCT00539240|7241811|FG002|Overall Study|Protocol Violation|4
4454636|NCT00539240|7241809|FG000|Overall Study|Lost to Follow-up|2
4454637|NCT00539240|7241810|FG001|Overall Study|Lost to Follow-up|3
4454638|NCT00539240|7241811|FG002|Overall Study|Lost to Follow-up|1
4454639|NCT00539240|7241809|FG000|Overall Study|Adverse Event|3
4454640|NCT00539240|7241810|FG001|Overall Study|Adverse Event|1
4454641|NCT00539240|7241811|FG002|Overall Study|Adverse Event|10
4454642|NCT00539279|7241825|FG000|Treatment|Withdrawal by Subject|10
4454643|NCT00539279|7241826|FG001|Treatment|Withdrawal by Subject|8
4454644|NCT00539279|7241825|FG000|Treatment|Death|1
4454645|NCT00539279|7241826|FG001|Treatment|Death|0
4454646|NCT00539279|7241825|FG000|Post-Treatment Assessment|Lost to Follow-up|12
4454647|NCT00539279|7241826|FG001|Post-Treatment Assessment|Lost to Follow-up|9
4454648|NCT00539279|7241825|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1
4454649|NCT00539279|7241826|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7
4454650|NCT00539305|7241834|FG000|Overall Study|Adverse Event|1
4454651|NCT00539305|7241835|FG001|Overall Study|Adverse Event|0
4454652|NCT00539305|7241834|FG000|Overall Study|Substance Use|0
4454653|NCT00539305|7241835|FG001|Overall Study|Substance Use|1
4454654|NCT00539305|7241834|FG000|Overall Study|Withdrawal by Subject|0
4454655|NCT00539305|7241835|FG001|Overall Study|Withdrawal by Subject|1
4454656|NCT00539500|7241841|FG000|Overall Study|Disease Progression|1
4454657|NCT00539500|7241841|FG000|Overall Study|Lost to Follow-up|2
4454658|NCT00539513|7241847|FG000|Overall Study|Withdrawal by Subject|2
4454659|NCT00539513|7241848|FG001|Overall Study|Withdrawal by Subject|1
4454660|NCT00539513|7241847|FG000|Overall Study|Lost to Follow-up|0
4454661|NCT00539513|7241848|FG001|Overall Study|Lost to Follow-up|1
4515847|NCT00956293|7326919|FG001|Main Period (Pre-randomization)|Administrative problems|0
4515848|NCT00956293|7326920|FG002|Main Period (Pre-randomization)|Administrative problems|6
4515849|NCT00956293|7326918|FG000|Main Period (Pre-randomization)|Graft loss|0
4515850|NCT00956293|7326919|FG001|Main Period (Pre-randomization)|Graft loss|0
4515851|NCT00956293|7326920|FG002|Main Period (Pre-randomization)|Graft loss|7
4515852|NCT00956293|7326918|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0
4515853|NCT00956293|7326919|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0
4515854|NCT00956293|7326920|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12
4515855|NCT00956293|7326918|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0
4515856|NCT00956293|7326919|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0
4515857|NCT00956293|7326920|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20
4515858|NCT00956293|7326918|FG000|Main Period (Pre-randomization)|Adverse Event|0
4515859|NCT00956293|7326919|FG001|Main Period (Pre-randomization)|Adverse Event|0
4515860|NCT00956293|7326920|FG002|Main Period (Pre-randomization)|Adverse Event|36
4515861|NCT00956293|7326918|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0
4515862|NCT00956293|7326919|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0
4515863|NCT00956293|7326920|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44
4515864|NCT00956293|7326918|FG000|Main Period (Randomization)|Abnormal laboratory value|0
4515865|NCT00956293|7326919|FG001|Main Period (Randomization)|Abnormal laboratory value|2
4515866|NCT00956293|7326920|FG002|Main Period (Randomization)|Abnormal laboratory value|0
4515867|NCT00956293|7326918|FG000|Main Period (Randomization)|Lack of Efficacy|1
4515868|NCT00956293|7326919|FG001|Main Period (Randomization)|Lack of Efficacy|10
4515869|NCT00956293|7326920|FG002|Main Period (Randomization)|Lack of Efficacy|0
4515870|NCT00956293|7326918|FG000|Main Period (Randomization)|Adverse Event|0
4515871|NCT00956293|7326919|FG001|Main Period (Randomization)|Adverse Event|15
4515872|NCT00956293|7326920|FG002|Main Period (Randomization)|Adverse Event|0
4515873|NCT00956293|7326918|FG000|Follow-up Period|Follow-up period was terminated.|20
4515874|NCT00956293|7326919|FG001|Follow-up Period|Follow-up period was terminated.|32
4515875|NCT00956293|7326920|FG002|Follow-up Period|Follow-up period was terminated.|0
4515876|NCT00956592|7326945|FG000|Overall Study|Protocol Violation|1
4515877|NCT00956592|7326946|FG001|Overall Study|Protocol Violation|3
4515878|NCT00956813|7326985|FG000|Flaxseed and Placebo|Withdrawal by Subject|5
4515879|NCT00956813|7326986|FG001|Flaxseed and Placebo|Withdrawal by Subject|4
4515880|NCT00956813|7326985|FG000|Flaxseed and Placebo|Ineligible|3
4454662|NCT00539734|7241884|FG000|Overall Study|Protocol Violation|1
4454663|NCT00539864|7241890|FG000|Overall Study|Lost to Follow-up|0
4454664|NCT00539864|7241891|FG001|Overall Study|Lost to Follow-up|1
4454665|NCT00539864|7241890|FG000|Overall Study|Withdrawal by Subject|1
4454666|NCT00539864|7241891|FG001|Overall Study|Withdrawal by Subject|1
4454667|NCT00539994|7241909|FG000|Overall Study|Lost to Follow-up|2
4454668|NCT00539994|7241910|FG001|Overall Study|Lost to Follow-up|1
4454669|NCT00539994|7241911|FG002|Overall Study|Lost to Follow-up|0
4454670|NCT00539994|7241909|FG000|Overall Study|Withdrawal by Subject|1
4454671|NCT00539994|7241910|FG001|Overall Study|Withdrawal by Subject|0
4454672|NCT00539994|7241911|FG002|Overall Study|Withdrawal by Subject|1
4454673|NCT00539994|7241909|FG000|Overall Study|Physician Decision|0
4454674|NCT00539994|7241910|FG001|Overall Study|Physician Decision|0
4454675|NCT00539994|7241911|FG002|Overall Study|Physician Decision|1
4454676|NCT00540046|7241938|FG000|Overall Study|Lost to Follow-up|33
4454677|NCT00540046|7241939|FG001|Overall Study|Lost to Follow-up|23
4454678|NCT00540124|7241950|FG000|Overall Study|Adverse Event|0
4454679|NCT00540124|7241951|FG001|Overall Study|Adverse Event|2
4454680|NCT00540124|7241952|FG002|Overall Study|Adverse Event|1
4454681|NCT00540124|7241950|FG000|Overall Study|Entry Criteria Not Met|2
4454682|NCT00540124|7241951|FG001|Overall Study|Entry Criteria Not Met|0
4454683|NCT00540124|7241952|FG002|Overall Study|Entry Criteria Not Met|0
4454684|NCT00540124|7241950|FG000|Overall Study|Lack of Efficacy|1
4454685|NCT00540124|7241951|FG001|Overall Study|Lack of Efficacy|0
4454686|NCT00540124|7241952|FG002|Overall Study|Lack of Efficacy|0
4454687|NCT00540124|7241950|FG000|Overall Study|Withdrawal by Subject|1
4454688|NCT00540124|7241951|FG001|Overall Study|Withdrawal by Subject|1
4454689|NCT00540124|7241952|FG002|Overall Study|Withdrawal by Subject|0
4454690|NCT00540228|7241965|FG000|Overall Study|Adverse Event|2
4454691|NCT00540228|7241966|FG001|Overall Study|Adverse Event|0
4454692|NCT00540228|7241967|FG002|Overall Study|Adverse Event|0
4454693|NCT00540228|7241968|FG003|Overall Study|Adverse Event|0
4454694|NCT00540228|7241969|FG004|Overall Study|Adverse Event|0
4454695|NCT00540228|7241965|FG000|Overall Study|Lost to Follow-up|1
4454696|NCT00540228|7241966|FG001|Overall Study|Lost to Follow-up|1
4454697|NCT00540228|7241967|FG002|Overall Study|Lost to Follow-up|0
4454698|NCT00540228|7241968|FG003|Overall Study|Lost to Follow-up|0
4454699|NCT00540228|7241969|FG004|Overall Study|Lost to Follow-up|0
4454700|NCT00540293|7241981|FG000|Overall Study|Adverse event related to study drug|10
4454701|NCT00540293|7241981|FG000|Overall Study|Adverse event not related to study drug|7
4454702|NCT00540293|7241981|FG000|Overall Study|Withdrawal by Subject|6
4454703|NCT00540293|7241981|FG000|Overall Study|Protocol violation, & subject schedule|12
4454704|NCT00540423|7241993|FG000|Double-Blind Treatment Period|Adverse Event|0
4454705|NCT00540423|7241994|FG001|Double-Blind Treatment Period|Adverse Event|1
4454706|NCT00540423|7241995|FG002|Double-Blind Treatment Period|Adverse Event|0
4454707|NCT00540423|7241993|FG000|Open-Label Treatment Period|Lack of Efficacy|0
4454708|NCT00540423|7241994|FG001|Open-Label Treatment Period|Lack of Efficacy|0
4454709|NCT00540423|7241995|FG002|Open-Label Treatment Period|Lack of Efficacy|2
4454710|NCT00540436|7242013|FG000|First 12-Week Treatment Period|Adverse Event|1
4454711|NCT00540436|7242013|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1
4454712|NCT00540436|7242013|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1
4454713|NCT00540436|7242013|FG000|Second 12-Week Treatment Period|Adverse Event|1
4454714|NCT00540449|7242019|FG000|Overall Study|Adverse Event|12
4454715|NCT00540449|7242020|FG001|Overall Study|Adverse Event|32
4454716|NCT00540449|7242019|FG000|Overall Study|Sponsor's Decision|1
4454717|NCT00540449|7242020|FG001|Overall Study|Sponsor's Decision|1
4454718|NCT00540449|7242019|FG000|Overall Study|Subject Ineligible To Continue The Trial|2
4454719|NCT00540449|7242020|FG001|Overall Study|Subject Ineligible To Continue The Trial|1
4454720|NCT00540449|7242019|FG000|Overall Study|Lost to Follow-up|19
4454721|NCT00540449|7242020|FG001|Overall Study|Lost to Follow-up|17
4454722|NCT00540449|7242019|FG000|Overall Study|Subject Non-Compliant|7
4454723|NCT00540449|7242020|FG001|Overall Study|Subject Non-Compliant|5
4454724|NCT00540449|7242019|FG000|Overall Study|Subject Reached A Virologic Endpoint|32
4454725|NCT00540449|7242020|FG001|Overall Study|Subject Reached A Virologic Endpoint|8
4454726|NCT00540449|7242019|FG000|Overall Study|Withdrawal by Subject|10
4454727|NCT00540449|7242020|FG001|Overall Study|Withdrawal by Subject|10
4454728|NCT00540449|7242019|FG000|Overall Study|Other|1
4454729|NCT00540449|7242020|FG001|Overall Study|Other|4
4454730|NCT00540514|7242028|FG000|Overall Study|Still on treatment|3
4454731|NCT00540514|7242029|FG001|Overall Study|Still on treatment|0
4454732|NCT00540514|7242028|FG000|Overall Study|Unacceptable Toxicity|61
4454733|NCT00540514|7242029|FG001|Overall Study|Unacceptable Toxicity|62
4454734|NCT00540514|7242028|FG000|Overall Study|Adverse Event|20
4454735|NCT00540514|7242029|FG001|Overall Study|Adverse Event|24
4454736|NCT00540514|7242028|FG000|Overall Study|Physician Decision|86
4454737|NCT00540514|7242029|FG001|Overall Study|Physician Decision|99
4454738|NCT00540514|7242028|FG000|Overall Study|Protocol Deviation|3
4454739|NCT00540514|7242029|FG001|Overall Study|Protocol Deviation|4
4537531|NCT01111539|7358497|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0
4537532|NCT01111539|7358498|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0
4537533|NCT01111539|7358494|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1
4537534|NCT01111539|7358495|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0
4454740|NCT00540514|7242028|FG000|Overall Study|Lost to Follow-up|1
4454741|NCT00540514|7242029|FG001|Overall Study|Lost to Follow-up|1
4454742|NCT00540514|7242028|FG000|Overall Study|Withdrawal by Subject|65
4454743|NCT00540514|7242029|FG001|Overall Study|Withdrawal by Subject|67
4454744|NCT00540514|7242028|FG000|Overall Study|Excluded prior to treatment|7
4454745|NCT00540514|7242029|FG001|Overall Study|Excluded prior to treatment|7
4454746|NCT00540514|7242028|FG000|Overall Study|Paclitaxel not available|0
4454747|NCT00540514|7242029|FG001|Overall Study|Paclitaxel not available|2
4454748|NCT00540592|7242050|FG000|Overall Study|Adverse Event|0
4454749|NCT00540592|7242051|FG001|Overall Study|Adverse Event|1
4454750|NCT00540592|7242052|FG002|Overall Study|Adverse Event|0
4537535|NCT01111539|7358496|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0
4537536|NCT01111539|7358497|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0
4537537|NCT01111539|7358498|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0
4537538|NCT01111539|7358494|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7
4537539|NCT01111539|7358495|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0
4537540|NCT01111539|7358496|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0
4537541|NCT01111539|7358497|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0
4537542|NCT01111539|7358498|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0
4537543|NCT01111539|7358494|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2
4537544|NCT01111539|7358495|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0
4537545|NCT01111539|7358496|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0
4537546|NCT01111539|7358497|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0
4454751|NCT00540592|7242053|FG003|Overall Study|Adverse Event|0
4454752|NCT00540592|7242054|FG004|Overall Study|Adverse Event|1
4454753|NCT00540592|7242055|FG005|Overall Study|Adverse Event|0
4454754|NCT00540592|7242056|FG006|Overall Study|Adverse Event|0
4454755|NCT00540592|7242057|FG007|Overall Study|Adverse Event|1
4454756|NCT00540592|7242058|FG008|Overall Study|Adverse Event|1
4454757|NCT00540592|7242059|FG009|Overall Study|Adverse Event|2
4454758|NCT00540592|7242050|FG000|Overall Study|Lost to Follow-up|2
4454759|NCT00540592|7242051|FG001|Overall Study|Lost to Follow-up|0
4454760|NCT00540592|7242052|FG002|Overall Study|Lost to Follow-up|0
4454761|NCT00540592|7242053|FG003|Overall Study|Lost to Follow-up|0
4454762|NCT00540592|7242054|FG004|Overall Study|Lost to Follow-up|0
4454763|NCT00540592|7242055|FG005|Overall Study|Lost to Follow-up|0
4454764|NCT00540592|7242056|FG006|Overall Study|Lost to Follow-up|0
4454765|NCT00540592|7242057|FG007|Overall Study|Lost to Follow-up|0
4454766|NCT00540592|7242058|FG008|Overall Study|Lost to Follow-up|0
4454767|NCT00540592|7242059|FG009|Overall Study|Lost to Follow-up|0
4454768|NCT00540592|7242050|FG000|Overall Study|Withdrawal by Subject|0
4454769|NCT00540592|7242051|FG001|Overall Study|Withdrawal by Subject|0
4454770|NCT00540592|7242052|FG002|Overall Study|Withdrawal by Subject|1
4454771|NCT00540592|7242053|FG003|Overall Study|Withdrawal by Subject|1
4454772|NCT00540592|7242054|FG004|Overall Study|Withdrawal by Subject|0
4454773|NCT00540592|7242055|FG005|Overall Study|Withdrawal by Subject|0
4454774|NCT00540592|7242056|FG006|Overall Study|Withdrawal by Subject|0
4454775|NCT00540592|7242057|FG007|Overall Study|Withdrawal by Subject|0
4454776|NCT00540592|7242058|FG008|Overall Study|Withdrawal by Subject|0
4454777|NCT00540592|7242059|FG009|Overall Study|Withdrawal by Subject|0
4454778|NCT00540644|7242083|FG000|Overall Study|Adverse Event|3
4454779|NCT00540644|7242084|FG001|Overall Study|Adverse Event|1
4454780|NCT00540644|7242083|FG000|Overall Study|Disease Progression|3
4454781|NCT00540644|7242084|FG001|Overall Study|Disease Progression|1
4454782|NCT00540644|7242083|FG000|Overall Study|Physician Decision|0
4454783|NCT00540644|7242084|FG001|Overall Study|Physician Decision|5
4454784|NCT00540644|7242083|FG000|Overall Study|Withdrawal by Subject|2
4454785|NCT00540644|7242084|FG001|Overall Study|Withdrawal by Subject|2
4454786|NCT00540644|7242083|FG000|Overall Study|Noncomplilance|1
4454787|NCT00540644|7242084|FG001|Overall Study|Noncomplilance|0
4454788|NCT00541034|7242117|FG000|Overall Study|Non-Compliance|3
4454789|NCT00541099|7242121|FG000|Overall Study|Ineligible|3
4454790|NCT00541229|7242142|FG000|Treatment Period I (Week 1)|Physician Decision|0
4454791|NCT00541229|7242143|FG001|Treatment Period I (Week 1)|Physician Decision|0
4454792|NCT00541229|7242144|FG002|Treatment Period I (Week 1)|Physician Decision|1
4454793|NCT00541229|7242145|FG003|Treatment Period I (Week 1)|Physician Decision|0
4454794|NCT00541229|7242146|FG004|Treatment Period I (Week 1)|Physician Decision|0
4454795|NCT00541229|7242147|FG005|Treatment Period I (Week 1)|Physician Decision|0
4454796|NCT00541229|7242142|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0
4454797|NCT00541229|7242143|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0
4454798|NCT00541229|7242144|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0
4454799|NCT00541229|7242145|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0
4454800|NCT00541229|7242146|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0
4454801|NCT00541229|7242147|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1
4454802|NCT00541229|7242142|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0
4454803|NCT00541229|7242143|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0
4454804|NCT00541229|7242144|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0
4454805|NCT00541229|7242145|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0
4454806|NCT00541229|7242146|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0
4537547|NCT01111539|7358498|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0
4454807|NCT00541229|7242147|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1
4454808|NCT00541229|7242142|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
4454809|NCT00541229|7242143|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1
4454810|NCT00541229|7242144|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2
4454811|NCT00541229|7242145|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1
4454812|NCT00541229|7242146|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
4454813|NCT00541229|7242147|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
4454814|NCT00541229|7242142|FG000|Washout Period I (Week 2-5)|Adverse Event|1
4454815|NCT00541229|7242143|FG001|Washout Period I (Week 2-5)|Adverse Event|0
4454816|NCT00541229|7242144|FG002|Washout Period I (Week 2-5)|Adverse Event|1
4454817|NCT00541229|7242145|FG003|Washout Period I (Week 2-5)|Adverse Event|0
4454818|NCT00541229|7242146|FG004|Washout Period I (Week 2-5)|Adverse Event|0
4454819|NCT00541229|7242147|FG005|Washout Period I (Week 2-5)|Adverse Event|0
4454820|NCT00541229|7242142|FG000|Washout Period I (Week 2-5)|Physician Decision|0
4454821|NCT00541229|7242143|FG001|Washout Period I (Week 2-5)|Physician Decision|0
4454822|NCT00541229|7242144|FG002|Washout Period I (Week 2-5)|Physician Decision|0
4454823|NCT00541229|7242145|FG003|Washout Period I (Week 2-5)|Physician Decision|1
4454824|NCT00541229|7242146|FG004|Washout Period I (Week 2-5)|Physician Decision|0
4454825|NCT00541229|7242147|FG005|Washout Period I (Week 2-5)|Physician Decision|0
4454826|NCT00541229|7242142|FG000|Washout Period I (Week 2-5)|Protocol Violation|0
4454827|NCT00541229|7242143|FG001|Washout Period I (Week 2-5)|Protocol Violation|0
4454828|NCT00541229|7242144|FG002|Washout Period I (Week 2-5)|Protocol Violation|0
4454829|NCT00541229|7242145|FG003|Washout Period I (Week 2-5)|Protocol Violation|0
4454830|NCT00541229|7242146|FG004|Washout Period I (Week 2-5)|Protocol Violation|0
4454831|NCT00541229|7242147|FG005|Washout Period I (Week 2-5)|Protocol Violation|1
4454832|NCT00541229|7242142|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
4454833|NCT00541229|7242143|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2
4454834|NCT00541229|7242144|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
4454835|NCT00541229|7242145|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
4454836|NCT00541229|7242146|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1
4454837|NCT00541229|7242147|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4
4454838|NCT00541229|7242142|FG000|Treatment Period II (Week 6)|Protocol Violation|0
4454839|NCT00541229|7242143|FG001|Treatment Period II (Week 6)|Protocol Violation|0
4454840|NCT00541229|7242144|FG002|Treatment Period II (Week 6)|Protocol Violation|0
4454841|NCT00541229|7242145|FG003|Treatment Period II (Week 6)|Protocol Violation|0
4454842|NCT00541229|7242146|FG004|Treatment Period II (Week 6)|Protocol Violation|1
4454843|NCT00541229|7242147|FG005|Treatment Period II (Week 6)|Protocol Violation|1
4454844|NCT00541229|7242142|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2
4454845|NCT00541229|7242143|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
4454846|NCT00541229|7242144|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
4454847|NCT00541229|7242145|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
4454848|NCT00541229|7242146|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
4454849|NCT00541229|7242147|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2
4454850|NCT00541229|7242142|FG000|Washout Period II (Week 7-10)|Protocol Violation|1
4454851|NCT00541229|7242143|FG001|Washout Period II (Week 7-10)|Protocol Violation|0
4454852|NCT00541229|7242144|FG002|Washout Period II (Week 7-10)|Protocol Violation|0
4454853|NCT00541229|7242145|FG003|Washout Period II (Week 7-10)|Protocol Violation|0
4454854|NCT00541229|7242146|FG004|Washout Period II (Week 7-10)|Protocol Violation|0
4454855|NCT00541229|7242147|FG005|Washout Period II (Week 7-10)|Protocol Violation|0
4454856|NCT00541229|7242142|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0
4454857|NCT00541229|7242143|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0
4454858|NCT00541229|7242144|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0
4454859|NCT00541229|7242145|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0
4454860|NCT00541229|7242146|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1
4454861|NCT00541229|7242147|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0
4454862|NCT00541229|7242142|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
4454863|NCT00541229|7242143|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4
4454864|NCT00541229|7242144|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2
4454865|NCT00541229|7242145|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4
4454866|NCT00541229|7242146|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
4454867|NCT00541229|7242147|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
4454868|NCT00541229|7242142|FG000|Treatment Period III (Week 11)|Adverse Event|0
4454869|NCT00541229|7242143|FG001|Treatment Period III (Week 11)|Adverse Event|0
4454870|NCT00541229|7242144|FG002|Treatment Period III (Week 11)|Adverse Event|0
4454871|NCT00541229|7242145|FG003|Treatment Period III (Week 11)|Adverse Event|0
4454872|NCT00541229|7242146|FG004|Treatment Period III (Week 11)|Adverse Event|1
4454873|NCT00541229|7242147|FG005|Treatment Period III (Week 11)|Adverse Event|0
4454874|NCT00541229|7242142|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0
4454875|NCT00541229|7242143|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0
4454876|NCT00541229|7242144|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0
4454877|NCT00541229|7242145|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0
4454878|NCT00541229|7242146|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0
4454879|NCT00541229|7242147|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1
4454880|NCT00541229|7242142|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
4454881|NCT00541229|7242143|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
4454882|NCT00541229|7242144|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1
4454883|NCT00541229|7242145|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
4454884|NCT00541229|7242146|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
4454885|NCT00541229|7242147|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
4454886|NCT00541307|7242164|FG000|Overall Study|Death|5
4454887|NCT00541307|7242164|FG000|Overall Study|Physician Decision|3
4454888|NCT00541307|7242164|FG000|Overall Study|Withdrawal by Subject|6
4454889|NCT00541307|7242164|FG000|Overall Study|Lost to Follow-up|4
4454890|NCT00541307|7242164|FG000|Overall Study|Subject returned early (outside window)|1
4454891|NCT00541307|7242164|FG000|Overall Study|Surgical Bypass|5
4454892|NCT00541346|7242168|FG000|Follow-up|Adverse Event|1
4454893|NCT00541385|7242174|FG000|Overall Study|Adverse Event|6
4454894|NCT00541385|7242175|FG001|Overall Study|Adverse Event|3
4454895|NCT00541385|7242174|FG000|Overall Study|Withdrawal by Subject|2
4454896|NCT00541385|7242175|FG001|Overall Study|Withdrawal by Subject|2
4454897|NCT00541385|7242174|FG000|Overall Study|Lost to Follow-up|6
4454898|NCT00541385|7242175|FG001|Overall Study|Lost to Follow-up|1
4454899|NCT00541385|7242174|FG000|Overall Study|Parasite reappearance/malaria|67
4454900|NCT00541385|7242175|FG001|Overall Study|Parasite reappearance/malaria|32
4454901|NCT00541450|7242183|FG000|Phase A|Adverse Event|3
4454902|NCT00541450|7242184|FG001|Phase A|Adverse Event|0
4454903|NCT00541450|7242183|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0
4454904|NCT00541450|7242184|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2
4454905|NCT00541450|7242183|FG000|Phase A|Hyperglycemia|0
4454906|NCT00541450|7242184|FG001|Phase A|Hyperglycemia|1
4454907|NCT00541450|7242183|FG000|Phase A|Lost to Follow-up|6
4454908|NCT00541450|7242184|FG001|Phase A|Lost to Follow-up|4
4454909|NCT00541450|7242183|FG000|Phase A|Physician Decision|2
4454910|NCT00541450|7242184|FG001|Phase A|Physician Decision|0
4454911|NCT00541450|7242183|FG000|Phase A|Protocol Violation|2
4454912|NCT00541450|7242184|FG001|Phase A|Protocol Violation|3
4454913|NCT00541450|7242183|FG000|Phase A|Withdrawal by Subject|7
4454914|NCT00541450|7242184|FG001|Phase A|Withdrawal by Subject|7
4454915|NCT00541450|7242183|FG000|Phase B|Adverse Event|6
4454916|NCT00541450|7242184|FG001|Phase B|Adverse Event|6
4454917|NCT00541450|7242183|FG000|Phase B|Hyperglycemia|10
4454918|NCT00541450|7242184|FG001|Phase B|Hyperglycemia|9
4454919|NCT00541450|7242183|FG000|Phase B|Lost to Follow-up|6
4454920|NCT00541450|7242184|FG001|Phase B|Lost to Follow-up|4
4454921|NCT00541450|7242183|FG000|Phase B|Physician Decision|4
4454922|NCT00541450|7242184|FG001|Phase B|Physician Decision|2
4454923|NCT00541450|7242183|FG000|Phase B|Pregnancy|0
4454924|NCT00541450|7242184|FG001|Phase B|Pregnancy|1
4454925|NCT00541450|7242183|FG000|Phase B|Protocol Violation|3
4454926|NCT00541450|7242184|FG001|Phase B|Protocol Violation|3
4454927|NCT00541450|7242183|FG000|Phase B|Withdrawal by Subject|8
4454928|NCT00541450|7242184|FG001|Phase B|Withdrawal by Subject|6
4454929|NCT00541658|7242201|FG000|Overall Study|Adverse Event|28
4454930|NCT00541658|7242202|FG001|Overall Study|Adverse Event|37
4454931|NCT00541658|7242203|FG002|Overall Study|Adverse Event|25
4454932|NCT00541658|7242201|FG000|Overall Study|Physician Decision|0
4454933|NCT00541658|7242202|FG001|Overall Study|Physician Decision|0
4454934|NCT00541658|7242203|FG002|Overall Study|Physician Decision|4
4454935|NCT00541658|7242201|FG000|Overall Study|Lost to Follow-up|3
4454936|NCT00541658|7242202|FG001|Overall Study|Lost to Follow-up|3
4537548|NCT01111539|7358494|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1
4537549|NCT01111539|7358495|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0
4537550|NCT01111539|7358496|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0
4537551|NCT01111539|7358497|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0
4537552|NCT01111539|7358498|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0
4454937|NCT00541658|7242203|FG002|Overall Study|Lost to Follow-up|6
4454938|NCT00541658|7242201|FG000|Overall Study|Protocol Violation|0
4454939|NCT00541658|7242202|FG001|Overall Study|Protocol Violation|1
4454940|NCT00541658|7242203|FG002|Overall Study|Protocol Violation|1
4454941|NCT00541658|7242201|FG000|Overall Study|Withdrawal by Subject|28
4454942|NCT00541658|7242202|FG001|Overall Study|Withdrawal by Subject|32
4454943|NCT00541658|7242203|FG002|Overall Study|Withdrawal by Subject|32
4454944|NCT00541658|7242201|FG000|Overall Study|Took No Study Drug|1
4454945|NCT00541658|7242202|FG001|Overall Study|Took No Study Drug|0
4454946|NCT00541658|7242203|FG002|Overall Study|Took No Study Drug|0
4454947|NCT00541775|7242225|FG000|Overall Study|Adverse Event|3
4454948|NCT00541775|7242226|FG001|Overall Study|Adverse Event|2
4454949|NCT00541775|7242227|FG002|Overall Study|Adverse Event|1
4537553|NCT01111539|7358494|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0
4537554|NCT01111539|7358495|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0
4454950|NCT00541775|7242225|FG000|Overall Study|Lack of Efficacy|0
4454951|NCT00541775|7242226|FG001|Overall Study|Lack of Efficacy|0
4454952|NCT00541775|7242227|FG002|Overall Study|Lack of Efficacy|3
4454953|NCT00541775|7242225|FG000|Overall Study|Lost to Follow-up|0
4454954|NCT00541775|7242226|FG001|Overall Study|Lost to Follow-up|0
4454955|NCT00541775|7242227|FG002|Overall Study|Lost to Follow-up|2
4454956|NCT00541775|7242225|FG000|Overall Study|Protocol Violation|1
4454957|NCT00541775|7242226|FG001|Overall Study|Protocol Violation|0
4454958|NCT00541775|7242227|FG002|Overall Study|Protocol Violation|0
4454959|NCT00541775|7242225|FG000|Overall Study|Withdrawal by Subject and Other|5
4454960|NCT00541775|7242226|FG001|Overall Study|Withdrawal by Subject and Other|0
4454961|NCT00541775|7242227|FG002|Overall Study|Withdrawal by Subject and Other|2
4454962|NCT00541866|7242240|FG000|Overall Study|Adverse Event|3
4454963|NCT00541866|7242241|FG001|Overall Study|Adverse Event|0
4454964|NCT00541866|7242242|FG002|Overall Study|Adverse Event|0
4454965|NCT00541866|7242243|FG003|Overall Study|Adverse Event|0
4454966|NCT00541866|7242244|FG004|Overall Study|Adverse Event|0
4454967|NCT00541866|7242240|FG000|Overall Study|Death|1
4454968|NCT00541866|7242241|FG001|Overall Study|Death|0
4454969|NCT00541866|7242242|FG002|Overall Study|Death|0
4454970|NCT00541866|7242243|FG003|Overall Study|Death|0
4454971|NCT00541866|7242244|FG004|Overall Study|Death|0
4454972|NCT00541866|7242240|FG000|Overall Study|Lack of Efficacy|19
4454973|NCT00541866|7242241|FG001|Overall Study|Lack of Efficacy|15
4454974|NCT00541866|7242242|FG002|Overall Study|Lack of Efficacy|10
4454975|NCT00541866|7242243|FG003|Overall Study|Lack of Efficacy|12
4454976|NCT00541866|7242244|FG004|Overall Study|Lack of Efficacy|14
4454977|NCT00541866|7242240|FG000|Overall Study|Not Reported or Other|11
4454978|NCT00541866|7242241|FG001|Overall Study|Not Reported or Other|3
4454979|NCT00541866|7242242|FG002|Overall Study|Not Reported or Other|3
4454980|NCT00541866|7242243|FG003|Overall Study|Not Reported or Other|3
4454981|NCT00541866|7242244|FG004|Overall Study|Not Reported or Other|1
4454982|NCT00541866|7242240|FG000|Overall Study|Physician Decision|0
4454983|NCT00541866|7242241|FG001|Overall Study|Physician Decision|0
4454984|NCT00541866|7242242|FG002|Overall Study|Physician Decision|2
4454985|NCT00541866|7242243|FG003|Overall Study|Physician Decision|1
4454986|NCT00541866|7242244|FG004|Overall Study|Physician Decision|0
4454987|NCT00541931|7242274|FG000|Overall Study|Adverse Event|1
4454988|NCT00541931|7242275|FG001|Overall Study|Adverse Event|0
4454989|NCT00541931|7242274|FG000|Overall Study|Lost to Follow-up|3
4454990|NCT00541931|7242275|FG001|Overall Study|Lost to Follow-up|3
4454991|NCT00541931|7242274|FG000|Overall Study|Withdrawal by Subject|1
4454992|NCT00541931|7242275|FG001|Overall Study|Withdrawal by Subject|0
4454993|NCT00541931|7242274|FG000|Overall Study|Transportation Issue|0
4454994|NCT00541931|7242275|FG001|Overall Study|Transportation Issue|1
4454995|NCT00541970|7242287|FG000|Month 7|Protocol Violation|9
4454996|NCT00541970|7242288|FG001|Month 7|Protocol Violation|13
4454997|NCT00541970|7242289|FG002|Month 7|Protocol Violation|11
4454998|NCT00541970|7242290|FG003|Month 7|Protocol Violation|5
4454999|NCT00541970|7242287|FG000|Month 12|Adverse Event|0
4455000|NCT00541970|7242288|FG001|Month 12|Adverse Event|1
4455001|NCT00541970|7242289|FG002|Month 12|Adverse Event|1
4455002|NCT00541970|7242290|FG003|Month 12|Adverse Event|1
4455003|NCT00541970|7242287|FG000|Month 12|Protocol Violation|12
4455004|NCT00541970|7242288|FG001|Month 12|Protocol Violation|21
4455005|NCT00541970|7242289|FG002|Month 12|Protocol Violation|20
4455006|NCT00541970|7242290|FG003|Month 12|Protocol Violation|15
4455007|NCT00541970|7242287|FG000|Month 18|Adverse Event|0
4455008|NCT00541970|7242288|FG001|Month 18|Adverse Event|1
4455009|NCT00541970|7242289|FG002|Month 18|Adverse Event|1
4455010|NCT00541970|7242290|FG003|Month 18|Adverse Event|1
4455011|NCT00541970|7242287|FG000|Month 18|Protocol Violation|14
4455012|NCT00541970|7242288|FG001|Month 18|Protocol Violation|23
4455013|NCT00541970|7242289|FG002|Month 18|Protocol Violation|24
4455014|NCT00541970|7242290|FG003|Month 18|Protocol Violation|16
4455015|NCT00541970|7242287|FG000|Month 24|Adverse Event|0
4455016|NCT00541970|7242288|FG001|Month 24|Adverse Event|1
4455017|NCT00541970|7242289|FG002|Month 24|Adverse Event|1
4455018|NCT00541970|7242290|FG003|Month 24|Adverse Event|1
4455019|NCT00541970|7242287|FG000|Month 24|Protocol Violation|29
4455020|NCT00541970|7242288|FG001|Month 24|Protocol Violation|31
4455021|NCT00541970|7242289|FG002|Month 24|Protocol Violation|31
4455022|NCT00541970|7242290|FG003|Month 24|Protocol Violation|21
4455023|NCT00541970|7242287|FG000|Month 36|Protocol Violation|61
4455024|NCT00541970|7242288|FG001|Month 36|Protocol Violation|66
4455025|NCT00541970|7242289|FG002|Month 36|Protocol Violation|66
4455026|NCT00541970|7242290|FG003|Month 36|Protocol Violation|60
4455027|NCT00541970|7242287|FG000|Month 48|Withdrawal by Subject|2
4455028|NCT00541970|7242288|FG001|Month 48|Withdrawal by Subject|4
4455029|NCT00541970|7242289|FG002|Month 48|Withdrawal by Subject|4
4455030|NCT00541970|7242290|FG003|Month 48|Withdrawal by Subject|2
4455031|NCT00541970|7242287|FG000|Month 48|Other|3
4455032|NCT00541970|7242288|FG001|Month 48|Other|1
4455033|NCT00541970|7242289|FG002|Month 48|Other|1
4455034|NCT00541970|7242290|FG003|Month 48|Other|0
4455035|NCT00541970|7242287|FG000|Month 48|Lost to Follow-up|66
4455036|NCT00541970|7242288|FG001|Month 48|Lost to Follow-up|68
4455037|NCT00541970|7242289|FG002|Month 48|Lost to Follow-up|68
4455038|NCT00541970|7242290|FG003|Month 48|Lost to Follow-up|73
4455039|NCT00541970|7242287|FG000|Month 60|Protocol Violation|78
4455040|NCT00541970|7242288|FG001|Month 60|Protocol Violation|77
4455041|NCT00541970|7242289|FG002|Month 60|Protocol Violation|82
4455042|NCT00541970|7242290|FG003|Month 60|Protocol Violation|72
4455043|NCT00542178|7242306|FG000|Overall Study|did not complete year 4 follow-up|75
4455044|NCT00542178|7242307|FG001|Overall Study|did not complete year 4 follow-up|80
4455045|NCT00542178|7242308|FG002|Overall Study|did not complete year 4 follow-up|74
4455046|NCT00542178|7242309|FG003|Overall Study|did not complete year 4 follow-up|62
4455047|NCT00542178|7242310|FG004|Overall Study|did not complete year 4 follow-up|64
4455048|NCT00542178|7242311|FG005|Overall Study|did not complete year 4 follow-up|89
4455049|NCT00542178|7242312|FG006|Overall Study|did not complete year 4 follow-up|87
4455050|NCT00542178|7242313|FG007|Overall Study|did not complete year 4 follow-up|85
4455051|NCT00542191|7242327|FG000|Overall Study|Death|3
4455052|NCT00542269|7242334|FG000|Overall Study|Adverse Event|10
4455053|NCT00542269|7242335|FG001|Overall Study|Adverse Event|4
4455054|NCT00542269|7242336|FG002|Overall Study|Adverse Event|5
4455055|NCT00542269|7242334|FG000|Overall Study|Protocol Violation|1
4455056|NCT00542269|7242335|FG001|Overall Study|Protocol Violation|1
4455057|NCT00542269|7242336|FG002|Overall Study|Protocol Violation|0
4455058|NCT00542269|7242334|FG000|Overall Study|Withdrawal by Subject|1
4455059|NCT00542269|7242335|FG001|Overall Study|Withdrawal by Subject|0
4455060|NCT00542269|7242336|FG002|Overall Study|Withdrawal by Subject|0
4455061|NCT00542269|7242334|FG000|Overall Study|Administrative problems|1
4455062|NCT00542269|7242335|FG001|Overall Study|Administrative problems|1
4455063|NCT00542269|7242336|FG002|Overall Study|Administrative problems|1
4455064|NCT00542321|7242352|FG000|Overall Study|Death|0
4455065|NCT00542321|7242353|FG001|Overall Study|Death|1
4455066|NCT00542386|7242365|FG000|Overall Study|Adverse Event|1
4455067|NCT00542386|7242366|FG001|Overall Study|Adverse Event|7
4455068|NCT00542386|7242367|FG002|Overall Study|Adverse Event|7
4455069|NCT00542386|7242368|FG003|Overall Study|Adverse Event|8
4455070|NCT00542386|7242369|FG004|Overall Study|Adverse Event|13
4455071|NCT00542386|7242370|FG005|Overall Study|Adverse Event|4
4455072|NCT00542386|7242365|FG000|Overall Study|Death|0
4455073|NCT00542386|7242366|FG001|Overall Study|Death|0
4455074|NCT00542386|7242367|FG002|Overall Study|Death|1
4455075|NCT00542386|7242368|FG003|Overall Study|Death|2
4455076|NCT00542386|7242369|FG004|Overall Study|Death|1
4455077|NCT00542386|7242370|FG005|Overall Study|Death|2
4455078|NCT00542386|7242365|FG000|Overall Study|Lack of Efficacy|32
4455079|NCT00542386|7242366|FG001|Overall Study|Lack of Efficacy|12
4455080|NCT00542386|7242367|FG002|Overall Study|Lack of Efficacy|10
4455081|NCT00542386|7242368|FG003|Overall Study|Lack of Efficacy|13
4455082|NCT00542386|7242369|FG004|Overall Study|Lack of Efficacy|7
4455083|NCT00542386|7242370|FG005|Overall Study|Lack of Efficacy|31
4455084|NCT00542386|7242365|FG000|Overall Study|Physician Decision|1
4455085|NCT00542386|7242366|FG001|Overall Study|Physician Decision|0
4455086|NCT00542386|7242367|FG002|Overall Study|Physician Decision|0
4455087|NCT00542386|7242368|FG003|Overall Study|Physician Decision|1
4455088|NCT00542386|7242369|FG004|Overall Study|Physician Decision|0
4455089|NCT00542386|7242370|FG005|Overall Study|Physician Decision|0
4455090|NCT00542386|7242365|FG000|Overall Study|Protocol Violation|0
4455091|NCT00542386|7242366|FG001|Overall Study|Protocol Violation|0
4455092|NCT00542386|7242367|FG002|Overall Study|Protocol Violation|1
4455093|NCT00542386|7242368|FG003|Overall Study|Protocol Violation|0
4537555|NCT01111539|7358496|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1
4537556|NCT01111539|7358497|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0
4537557|NCT01111539|7358498|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1
4537558|NCT01111539|7358494|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0
4537559|NCT01111539|7358495|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0
4537560|NCT01111539|7358496|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1
4537561|NCT01111539|7358497|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0
4537562|NCT01111539|7358498|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2
4537563|NCT01111539|7358494|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0
4537564|NCT01111539|7358495|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7
4537565|NCT01111539|7358496|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4
4537566|NCT01111539|7358497|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5
4537567|NCT01111539|7358498|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5
4537568|NCT01111539|7358494|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0
4591184|NCT01527383|7437585|FG001|Overall Study|Adverse Event|0
4455094|NCT00542386|7242369|FG004|Overall Study|Protocol Violation|0
4455095|NCT00542386|7242370|FG005|Overall Study|Protocol Violation|4
4455096|NCT00542386|7242365|FG000|Overall Study|Withdrawal by Subject|5
4455097|NCT00542386|7242366|FG001|Overall Study|Withdrawal by Subject|8
4455098|NCT00542386|7242367|FG002|Overall Study|Withdrawal by Subject|10
4455099|NCT00542386|7242368|FG003|Overall Study|Withdrawal by Subject|11
4455100|NCT00542386|7242369|FG004|Overall Study|Withdrawal by Subject|15
4455101|NCT00542386|7242370|FG005|Overall Study|Withdrawal by Subject|7
4455102|NCT00542386|7242365|FG000|Overall Study|Other Reasons|4
4455103|NCT00542386|7242366|FG001|Overall Study|Other Reasons|1
4455104|NCT00542386|7242367|FG002|Overall Study|Other Reasons|4
4455105|NCT00542386|7242368|FG003|Overall Study|Other Reasons|3
4455106|NCT00542386|7242369|FG004|Overall Study|Other Reasons|4
4455107|NCT00542386|7242370|FG005|Overall Study|Other Reasons|2
4455108|NCT00542425|7242389|FG000|Initial 24 Weeks|Administrative reasons|0
4455109|NCT00542425|7242390|FG001|Initial 24 Weeks|Administrative reasons|0
4455110|NCT00542425|7242391|FG002|Initial 24 Weeks|Administrative reasons|1
4455111|NCT00542425|7242392|FG003|Initial 24 Weeks|Administrative reasons|1
4455112|NCT00542425|7242393|FG004|Initial 24 Weeks|Administrative reasons|0
4455113|NCT00542425|7242389|FG000|Initial 24 Weeks|Adverse Event|0
4455114|NCT00542425|7242390|FG001|Initial 24 Weeks|Adverse Event|1
4455115|NCT00542425|7242391|FG002|Initial 24 Weeks|Adverse Event|1
4455116|NCT00542425|7242392|FG003|Initial 24 Weeks|Adverse Event|3
4455117|NCT00542425|7242393|FG004|Initial 24 Weeks|Adverse Event|2
4455118|NCT00542425|7242389|FG000|Initial 24 Weeks|Inability to complete procedures|0
4455119|NCT00542425|7242390|FG001|Initial 24 Weeks|Inability to complete procedures|3
4455120|NCT00542425|7242391|FG002|Initial 24 Weeks|Inability to complete procedures|2
4455121|NCT00542425|7242392|FG003|Initial 24 Weeks|Inability to complete procedures|1
4455122|NCT00542425|7242393|FG004|Initial 24 Weeks|Inability to complete procedures|2
4455123|NCT00542425|7242389|FG000|Initial 24 Weeks|Lost to Follow-up|2
4455124|NCT00542425|7242390|FG001|Initial 24 Weeks|Lost to Follow-up|2
4455125|NCT00542425|7242391|FG002|Initial 24 Weeks|Lost to Follow-up|1
4455126|NCT00542425|7242392|FG003|Initial 24 Weeks|Lost to Follow-up|0
4455127|NCT00542425|7242393|FG004|Initial 24 Weeks|Lost to Follow-up|0
4455128|NCT00542425|7242389|FG000|Initial 24 Weeks|Non-compliance|0
4455129|NCT00542425|7242390|FG001|Initial 24 Weeks|Non-compliance|0
4455130|NCT00542425|7242391|FG002|Initial 24 Weeks|Non-compliance|0
4455131|NCT00542425|7242392|FG003|Initial 24 Weeks|Non-compliance|1
4455132|NCT00542425|7242393|FG004|Initial 24 Weeks|Non-compliance|1
4455133|NCT00542425|7242389|FG000|Initial 24 Weeks|Protocol Violation|0
4455134|NCT00542425|7242390|FG001|Initial 24 Weeks|Protocol Violation|0
4455135|NCT00542425|7242391|FG002|Initial 24 Weeks|Protocol Violation|0
4455136|NCT00542425|7242392|FG003|Initial 24 Weeks|Protocol Violation|1
4455137|NCT00542425|7242393|FG004|Initial 24 Weeks|Protocol Violation|0
4455138|NCT00542425|7242389|FG000|Initial 24 Weeks|Refusal of treatment|2
4455139|NCT00542425|7242390|FG001|Initial 24 Weeks|Refusal of treatment|2
4455140|NCT00542425|7242391|FG002|Initial 24 Weeks|Refusal of treatment|1
4455141|NCT00542425|7242392|FG003|Initial 24 Weeks|Refusal of treatment|4
4455142|NCT00542425|7242393|FG004|Initial 24 Weeks|Refusal of treatment|1
4455143|NCT00542425|7242389|FG000|Initial 24 Weeks|Other|0
4455144|NCT00542425|7242390|FG001|Initial 24 Weeks|Other|2
4455145|NCT00542425|7242391|FG002|Initial 24 Weeks|Other|1
4455146|NCT00542425|7242392|FG003|Initial 24 Weeks|Other|0
4455147|NCT00542425|7242393|FG004|Initial 24 Weeks|Other|0
4455148|NCT00542425|7242389|FG000|Extended 24 Weeks of Treatment|Adverse Event|0
4455149|NCT00542425|7242390|FG001|Extended 24 Weeks of Treatment|Adverse Event|0
4455150|NCT00542425|7242391|FG002|Extended 24 Weeks of Treatment|Adverse Event|1
4455151|NCT00542425|7242392|FG003|Extended 24 Weeks of Treatment|Adverse Event|1
4455152|NCT00542425|7242393|FG004|Extended 24 Weeks of Treatment|Adverse Event|0
4455153|NCT00542425|7242389|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0
4455154|NCT00542425|7242390|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0
4455155|NCT00542425|7242391|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1
4455156|NCT00542425|7242392|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0
4455157|NCT00542425|7242393|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0
4455158|NCT00542425|7242389|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0
4455159|NCT00542425|7242390|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1
4455160|NCT00542425|7242391|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0
4455161|NCT00542425|7242392|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0
4455162|NCT00542425|7242393|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0
4455163|NCT00542425|7242389|FG000|Extended 24 Weeks of Treatment|Other|1
4455164|NCT00542425|7242390|FG001|Extended 24 Weeks of Treatment|Other|1
4455165|NCT00542425|7242391|FG002|Extended 24 Weeks of Treatment|Other|0
4455166|NCT00542425|7242392|FG003|Extended 24 Weeks of Treatment|Other|0
4455167|NCT00542425|7242393|FG004|Extended 24 Weeks of Treatment|Other|1
4455168|NCT00542789|7242424|FG000|Overall Study|Adverse Event|18
4455169|NCT00542789|7242425|FG001|Overall Study|Adverse Event|17
4455170|NCT00542789|7242424|FG000|Overall Study|Withdrawal by Subject|7
4455171|NCT00542789|7242425|FG001|Overall Study|Withdrawal by Subject|3
4455172|NCT00542789|7242424|FG000|Overall Study|Protocol Violation|8
4455173|NCT00542789|7242425|FG001|Overall Study|Protocol Violation|1
4455174|NCT00542789|7242424|FG000|Overall Study|Recurrence of Gastric Ulcer|8
4455175|NCT00542789|7242425|FG001|Overall Study|Recurrence of Gastric Ulcer|57
4455176|NCT00542815|7242434|FG000|Overall Study|Adverse Event|19
4455177|NCT00542815|7242435|FG001|Overall Study|Adverse Event|6
4455178|NCT00542815|7242436|FG002|Overall Study|Adverse Event|9
4455179|NCT00542815|7242434|FG000|Overall Study|Death|10
4455180|NCT00542815|7242435|FG001|Overall Study|Death|7
4455181|NCT00542815|7242436|FG002|Overall Study|Death|3
4455182|NCT00542815|7242434|FG000|Overall Study|Lack of Efficacy|9
4455183|NCT00542815|7242435|FG001|Overall Study|Lack of Efficacy|2
4455184|NCT00542815|7242436|FG002|Overall Study|Lack of Efficacy|0
4455185|NCT00542815|7242434|FG000|Overall Study|Physician Decision|2
4455186|NCT00542815|7242435|FG001|Overall Study|Physician Decision|1
4455187|NCT00542815|7242436|FG002|Overall Study|Physician Decision|0
4455188|NCT00542815|7242434|FG000|Overall Study|Protocol Violation|1
4455189|NCT00542815|7242435|FG001|Overall Study|Protocol Violation|1
4455190|NCT00542815|7242436|FG002|Overall Study|Protocol Violation|2
4455191|NCT00542815|7242434|FG000|Overall Study|Withdrawal by Subject|41
4455192|NCT00542815|7242435|FG001|Overall Study|Withdrawal by Subject|5
4455193|NCT00542815|7242436|FG002|Overall Study|Withdrawal by Subject|8
4455194|NCT00542815|7242434|FG000|Overall Study|Other reasons|24
4455195|NCT00542815|7242435|FG001|Overall Study|Other reasons|10
4455196|NCT00542815|7242436|FG002|Overall Study|Other reasons|10
4455197|NCT00542828|7242444|FG000|Overall Study|Physician Decision|1
4455198|NCT00542828|7242444|FG000|Overall Study|Need for Prohibited Treatment|3
4455199|NCT00542828|7242444|FG000|Overall Study|Study Prematurely Discontinued|7
4455200|NCT00542828|7242444|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2
4455201|NCT00542880|7242450|FG000|Period 1|Eligibility criteria not fulfilled|2
4455202|NCT00542880|7242451|FG001|Period 1|Eligibility criteria not fulfilled|6
4455203|NCT00542880|7242450|FG000|Period 1|Adverse Event|2
4455204|NCT00542880|7242451|FG001|Period 1|Adverse Event|2
4455205|NCT00542880|7242450|FG000|Period 1|Development of study-specific criteria|1
4537569|NCT01111539|7358495|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0
4537570|NCT01111539|7358496|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0
4537571|NCT01111539|7358497|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0
4537572|NCT01111539|7358498|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1
4537573|NCT01111539|7358494|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0
4537574|NCT01111539|7358495|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0
4537575|NCT01111539|7358496|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0
4537576|NCT01111539|7358497|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1
4455206|NCT00542880|7242451|FG001|Period 1|Development of study-specific criteria|2
4455207|NCT00542880|7242450|FG000|Period 1|Withdrawal by Subject|1
4455208|NCT00542880|7242451|FG001|Period 1|Withdrawal by Subject|1
4455209|NCT00542880|7242450|FG000|Period 1|Protocol Violation|0
4455210|NCT00542880|7242451|FG001|Period 1|Protocol Violation|1
4455211|NCT00542880|7242450|FG000|Period 2|Adverse Event|5
4455212|NCT00542880|7242451|FG001|Period 2|Adverse Event|7
4455213|NCT00542880|7242450|FG000|Period 2|Eligibility not fulfilled|0
4455214|NCT00542880|7242451|FG001|Period 2|Eligibility not fulfilled|1
4455215|NCT00542880|7242450|FG000|Period 2|Discontinuation criteria|2
4455216|NCT00542880|7242451|FG001|Period 2|Discontinuation criteria|0
4455217|NCT00542880|7242450|FG000|Period 2|Severe non-compliance|0
4455218|NCT00542880|7242451|FG001|Period 2|Severe non-compliance|1
4455219|NCT00542880|7242450|FG000|Period 2|Other|0
4455220|NCT00542880|7242451|FG001|Period 2|Other|1
4455221|NCT00542880|7242450|FG000|Period 3|Adverse Event|0
4455222|NCT00542880|7242451|FG001|Period 3|Adverse Event|2
4455223|NCT00542919|7242461|FG000|Overall Study|Adverse Event|1
4455224|NCT00542919|7242462|FG001|Overall Study|Adverse Event|5
4455225|NCT00542919|7242463|FG002|Overall Study|Adverse Event|1
4455226|NCT00542919|7242461|FG000|Overall Study|Withdrawal by Subject|1
4455227|NCT00542919|7242462|FG001|Overall Study|Withdrawal by Subject|0
4455228|NCT00542919|7242463|FG002|Overall Study|Withdrawal by Subject|3
4455229|NCT00542919|7242461|FG000|Overall Study|Physician Decision|2
4455230|NCT00542919|7242462|FG001|Overall Study|Physician Decision|2
4455231|NCT00542919|7242463|FG002|Overall Study|Physician Decision|1
4455232|NCT00542919|7242461|FG000|Overall Study|Sponsor Decision|1
4455233|NCT00542919|7242462|FG001|Overall Study|Sponsor Decision|0
4455234|NCT00542919|7242463|FG002|Overall Study|Sponsor Decision|0
4455235|NCT00542919|7242461|FG000|Overall Study|Lost to Follow-up|2
4455236|NCT00542919|7242462|FG001|Overall Study|Lost to Follow-up|0
4455237|NCT00542919|7242463|FG002|Overall Study|Lost to Follow-up|1
4455238|NCT00542997|7242490|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2
4455239|NCT00542997|7242490|FG000|Wash in / Wash Out Period|Adverse Event|3
4455240|NCT00542997|7242490|FG000|Efficacy Period|Adverse Event|3
4455241|NCT00543062|7242497|FG000|Overall Study|Withdrawal by Subject|1
4455242|NCT00543062|7242498|FG001|Overall Study|Withdrawal by Subject|0
4455243|NCT00543062|7242499|FG002|Overall Study|Withdrawal by Subject|2
4455244|NCT00543062|7242500|FG003|Overall Study|Withdrawal by Subject|0
4455245|NCT00543062|7242497|FG000|Overall Study|Adverse Event|0
4455246|NCT00543062|7242498|FG001|Overall Study|Adverse Event|1
4455247|NCT00543062|7242499|FG002|Overall Study|Adverse Event|1
4455248|NCT00543062|7242500|FG003|Overall Study|Adverse Event|1
4455249|NCT00543062|7242497|FG000|Overall Study|Protocol Violation|1
4455250|NCT00543062|7242498|FG001|Overall Study|Protocol Violation|0
4455251|NCT00543062|7242499|FG002|Overall Study|Protocol Violation|0
4455252|NCT00543062|7242500|FG003|Overall Study|Protocol Violation|0
4455253|NCT00543140|7242537|FG000|Overall Study|Lost to Follow-up|33
4455254|NCT00543140|7242537|FG000|Overall Study|Withdrawal by Subject|13
4455255|NCT00543140|7242537|FG000|Overall Study|Protocol Violation|10
4455256|NCT00543140|7242537|FG000|Overall Study|Insufficient weight loss|10
4455257|NCT00543140|7242537|FG000|Overall Study|SAE leading to explant of SAGB|3
4455258|NCT00543140|7242537|FG000|Overall Study|Death|1
4455259|NCT00543140|7242537|FG000|Overall Study|Subject moved|1
4455260|NCT00543140|7242537|FG000|Overall Study|Conversion to different procedure|1
4455261|NCT00543296|7242541|FG000|Overall Study|Physician Decision|7
4455262|NCT00543309|7242548|FG000|Overall Study|Physician Decision|0
4455263|NCT00543309|7242549|FG001|Overall Study|Physician Decision|1
4455264|NCT00543309|7242550|FG002|Overall Study|Physician Decision|0
4455265|NCT00543387|7242568|FG000|Panel 1 + Panel 2|Adverse Event|0
4455266|NCT00543387|7242569|FG001|Panel 1 + Panel 2|Adverse Event|1
4455267|NCT00543387|7242570|FG002|Panel 1 + Panel 2|Adverse Event|0
4455268|NCT00543387|7242571|FG003|Panel 1 + Panel 2|Adverse Event|0
4455269|NCT00543387|7242572|FG004|Panel 1 + Panel 2|Adverse Event|0
4455270|NCT00543387|7242573|FG005|Panel 1 + Panel 2|Adverse Event|0
4455271|NCT00543387|7242574|FG006|Panel 1 + Panel 2|Adverse Event|0
4455272|NCT00543387|7242575|FG007|Panel 1 + Panel 2|Adverse Event|1
4455273|NCT00543387|7242576|FG008|Panel 1 + Panel 2|Adverse Event|1
4591185|NCT01527383|7437584|FG000|Overall Study|Lost to Follow-up|3
4455274|NCT00543387|7242577|FG009|Panel 1 + Panel 2|Adverse Event|0
4455275|NCT00543387|7242578|FG010|Panel 1 + Panel 2|Adverse Event|0
4455276|NCT00543387|7242568|FG000|Panel 1 + Panel 2|Physician Decision|0
4455277|NCT00543387|7242569|FG001|Panel 1 + Panel 2|Physician Decision|0
4455278|NCT00543387|7242570|FG002|Panel 1 + Panel 2|Physician Decision|1
4455279|NCT00543387|7242571|FG003|Panel 1 + Panel 2|Physician Decision|0
4455280|NCT00543387|7242572|FG004|Panel 1 + Panel 2|Physician Decision|0
4455281|NCT00543387|7242573|FG005|Panel 1 + Panel 2|Physician Decision|0
4455282|NCT00543387|7242574|FG006|Panel 1 + Panel 2|Physician Decision|0
4455283|NCT00543387|7242575|FG007|Panel 1 + Panel 2|Physician Decision|1
4610853|NCT01695954|7467046|FG001|Overall Study|Withdrawal by Subject|0
4610854|NCT01695954|7467045|FG000|Overall Study|Adverse Event|0
4610855|NCT01695954|7467046|FG001|Overall Study|Adverse Event|2
4455284|NCT00543387|7242576|FG008|Panel 1 + Panel 2|Physician Decision|0
4455285|NCT00543387|7242577|FG009|Panel 1 + Panel 2|Physician Decision|0
4455286|NCT00543387|7242578|FG010|Panel 1 + Panel 2|Physician Decision|0
4455287|NCT00543387|7242568|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3
4455288|NCT00543387|7242569|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2
4455289|NCT00543387|7242570|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2
4455290|NCT00543387|7242571|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3
4455291|NCT00543387|7242572|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3
4455292|NCT00543387|7242573|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3
4455293|NCT00543387|7242574|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5
4455294|NCT00543387|7242575|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4
4455295|NCT00543387|7242576|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4
4455296|NCT00543387|7242577|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0
4455297|NCT00543387|7242578|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0
4455298|NCT00543387|7242568|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0
4455299|NCT00543387|7242569|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0
4455300|NCT00543387|7242570|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0
4455301|NCT00543387|7242571|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0
4455302|NCT00543387|7242572|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0
4455303|NCT00543387|7242573|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0
4455304|NCT00543387|7242574|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1
4455305|NCT00543387|7242575|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0
4455306|NCT00543387|7242576|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0
4455307|NCT00543387|7242577|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0
4455308|NCT00543387|7242578|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0
4455309|NCT00543387|7242568|FG000|Crossover Participants|Progressive Disease|0
4455310|NCT00543387|7242569|FG001|Crossover Participants|Progressive Disease|0
4537577|NCT01111539|7358498|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0
4537578|NCT01111539|7358494|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0
4537579|NCT01111539|7358495|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0
4537580|NCT01111539|7358496|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0
4537581|NCT01111539|7358497|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2
4537582|NCT01111539|7358498|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0
4537583|NCT01111539|7358494|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0
4537584|NCT01111539|7358495|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0
4537585|NCT01111539|7358496|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0
4610856|NCT01695993|7467057|FG000|Overall Study|Lost to Follow-up|2
4610857|NCT01695993|7467058|FG001|Overall Study|Lost to Follow-up|1
4610858|NCT01695993|7467059|FG002|Overall Study|Lost to Follow-up|3
4610859|NCT01695993|7467057|FG000|Overall Study|Withdrawal by Subject|2
4610860|NCT01695993|7467058|FG001|Overall Study|Withdrawal by Subject|2
4610861|NCT01695993|7467059|FG002|Overall Study|Withdrawal by Subject|2
4610862|NCT01695993|7467057|FG000|Overall Study|To ill to continue|1
4610863|NCT01695993|7467058|FG001|Overall Study|To ill to continue|2
4610864|NCT01695993|7467059|FG002|Overall Study|To ill to continue|0
4610865|NCT01695993|7467057|FG000|Overall Study|Changed Medical Facility|0
4455311|NCT00543387|7242570|FG002|Crossover Participants|Progressive Disease|0
4455312|NCT00543387|7242571|FG003|Crossover Participants|Progressive Disease|0
4455313|NCT00543387|7242572|FG004|Crossover Participants|Progressive Disease|0
4455314|NCT00543387|7242573|FG005|Crossover Participants|Progressive Disease|0
4455315|NCT00543387|7242574|FG006|Crossover Participants|Progressive Disease|0
4455316|NCT00543387|7242575|FG007|Crossover Participants|Progressive Disease|0
4455317|NCT00543387|7242576|FG008|Crossover Participants|Progressive Disease|0
4455318|NCT00543387|7242577|FG009|Crossover Participants|Progressive Disease|1
4455319|NCT00543387|7242578|FG010|Crossover Participants|Progressive Disease|2
4455320|NCT00543387|7242568|FG000|Crossover Participants|Study Terminated by Sponsor|0
4455321|NCT00543387|7242569|FG001|Crossover Participants|Study Terminated by Sponsor|0
4455322|NCT00543387|7242570|FG002|Crossover Participants|Study Terminated by Sponsor|0
4455323|NCT00543387|7242571|FG003|Crossover Participants|Study Terminated by Sponsor|0
4455324|NCT00543387|7242572|FG004|Crossover Participants|Study Terminated by Sponsor|0
4455325|NCT00543387|7242573|FG005|Crossover Participants|Study Terminated by Sponsor|0
4455326|NCT00543387|7242574|FG006|Crossover Participants|Study Terminated by Sponsor|0
4455327|NCT00543387|7242575|FG007|Crossover Participants|Study Terminated by Sponsor|0
4455328|NCT00543387|7242576|FG008|Crossover Participants|Study Terminated by Sponsor|0
4455329|NCT00543387|7242577|FG009|Crossover Participants|Study Terminated by Sponsor|0
4455330|NCT00543387|7242578|FG010|Crossover Participants|Study Terminated by Sponsor|1
4455331|NCT00543439|7242622|FG000|Period 1|Adverse Event|0
4455332|NCT00543439|7242623|FG001|Period 1|Adverse Event|2
4455333|NCT00543439|7242624|FG002|Period 1|Adverse Event|1
4455334|NCT00543439|7242622|FG000|Period 1|Withdrawal by Subject|1
4455335|NCT00543439|7242623|FG001|Period 1|Withdrawal by Subject|1
4455336|NCT00543439|7242624|FG002|Period 1|Withdrawal by Subject|0
4455337|NCT00543439|7242622|FG000|Period 1|Physician Decision|0
4455338|NCT00543439|7242623|FG001|Period 1|Physician Decision|0
4455339|NCT00543439|7242624|FG002|Period 1|Physician Decision|1
4455340|NCT00543439|7242622|FG000|Period 2|Protocol Violation|1
4455341|NCT00543439|7242623|FG001|Period 2|Protocol Violation|0
4455342|NCT00543439|7242624|FG002|Period 2|Protocol Violation|1
4455343|NCT00543439|7242622|FG000|Period 2|Adverse Event|0
4455344|NCT00543439|7242623|FG001|Period 2|Adverse Event|1
4455345|NCT00543439|7242624|FG002|Period 2|Adverse Event|1
4455346|NCT00543543|7242645|FG000|Base Study|Adverse Event|1
4455347|NCT00543543|7242646|FG001|Base Study|Adverse Event|11
4455348|NCT00543543|7242647|FG002|Base Study|Adverse Event|0
4455349|NCT00543543|7242648|FG003|Base Study|Adverse Event|5
4455350|NCT00543543|7242645|FG000|Base Study|Lost to Follow-up|12
4455351|NCT00543543|7242646|FG001|Base Study|Lost to Follow-up|749
4455352|NCT00543543|7242647|FG002|Base Study|Lost to Follow-up|9
4455353|NCT00543543|7242648|FG003|Base Study|Lost to Follow-up|701
4455354|NCT00543543|7242645|FG000|Base Study|Physician Decision|0
4537586|NCT01111539|7358497|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0
4537587|NCT01111539|7358498|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1
4537588|NCT01111552|7358508|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9
4537589|NCT01111552|7358509|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0
4537590|NCT01111552|7358510|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0
4537591|NCT01111552|7358511|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0
4537592|NCT01111552|7358512|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0
4537593|NCT01111552|7358508|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4
4537594|NCT01111552|7358509|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0
4537595|NCT01111552|7358510|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0
4537596|NCT01111552|7358511|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0
4537597|NCT01111552|7358512|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0
4537598|NCT01111552|7358508|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89
4537599|NCT01111552|7358509|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0
4537600|NCT01111552|7358510|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0
4537601|NCT01111552|7358511|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0
4537602|NCT01111552|7358512|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0
4537603|NCT01111552|7358508|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3
4537604|NCT01111552|7358509|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0
4537605|NCT01111552|7358510|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0
4537606|NCT01111552|7358511|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0
4537607|NCT01111552|7358512|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0
4537608|NCT01111552|7358508|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3
4537609|NCT01111552|7358509|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0
4537610|NCT01111552|7358510|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0
4537611|NCT01111552|7358511|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0
4537612|NCT01111552|7358512|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0
4537613|NCT01111552|7358508|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7
4537614|NCT01111552|7358509|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0
4537615|NCT01111552|7358510|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0
4537616|NCT01111552|7358511|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0
4537617|NCT01111552|7358512|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0
4537618|NCT01111552|7358508|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1
4537619|NCT01111552|7358509|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0
4537620|NCT01111552|7358510|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0
4537621|NCT01111552|7358511|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0
4537622|NCT01111552|7358512|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0
4537623|NCT01111552|7358508|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1
4537624|NCT01111552|7358509|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0
4537625|NCT01111552|7358510|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0
4537626|NCT01111552|7358511|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0
4537627|NCT01111552|7358512|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0
4537628|NCT01111552|7358508|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0
4537629|NCT01111552|7358509|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0
4537630|NCT01111552|7358510|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0
4537631|NCT01111552|7358511|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1
4537632|NCT01111552|7358512|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0
4537633|NCT01111552|7358508|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0
4537634|NCT01111552|7358509|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5
4455355|NCT00543543|7242646|FG001|Base Study|Physician Decision|4
4455356|NCT00543543|7242647|FG002|Base Study|Physician Decision|0
4455357|NCT00543543|7242648|FG003|Base Study|Physician Decision|7
4537635|NCT01111552|7358510|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4
4537636|NCT01111552|7358511|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3
4537637|NCT01111552|7358512|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5
4537638|NCT01111552|7358508|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0
4537639|NCT01111552|7358509|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2
4537640|NCT01111552|7358510|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0
4455358|NCT00543543|7242645|FG000|Base Study|Protocol Violation|0
4455359|NCT00543543|7242646|FG001|Base Study|Protocol Violation|6
4455360|NCT00543543|7242647|FG002|Base Study|Protocol Violation|0
4455361|NCT00543543|7242648|FG003|Base Study|Protocol Violation|6
4455362|NCT00543543|7242645|FG000|Base Study|Withdrawal by Subject|7
4455363|NCT00543543|7242646|FG001|Base Study|Withdrawal by Subject|482
4455364|NCT00543543|7242647|FG002|Base Study|Withdrawal by Subject|5
4455365|NCT00543543|7242648|FG003|Base Study|Withdrawal by Subject|503
4455366|NCT00543543|7242645|FG000|Extension Study|Adverse Event|0
4455367|NCT00543543|7242646|FG001|Extension Study|Adverse Event|0
4455368|NCT00543543|7242647|FG002|Extension Study|Adverse Event|0
4455369|NCT00543543|7242648|FG003|Extension Study|Adverse Event|5
4455370|NCT00543543|7242645|FG000|Extension Study|Lost to Follow-up|0
4455371|NCT00543543|7242646|FG001|Extension Study|Lost to Follow-up|0
4455372|NCT00543543|7242647|FG002|Extension Study|Lost to Follow-up|0
4455373|NCT00543543|7242648|FG003|Extension Study|Lost to Follow-up|77
4455374|NCT00543543|7242645|FG000|Extension Study|Physician Decision|0
4455375|NCT00543543|7242646|FG001|Extension Study|Physician Decision|0
4455376|NCT00543543|7242647|FG002|Extension Study|Physician Decision|0
4455377|NCT00543543|7242648|FG003|Extension Study|Physician Decision|7
4455378|NCT00543543|7242645|FG000|Extension Study|Pregnancy|0
4455379|NCT00543543|7242646|FG001|Extension Study|Pregnancy|0
4455380|NCT00543543|7242647|FG002|Extension Study|Pregnancy|0
4455381|NCT00543543|7242648|FG003|Extension Study|Pregnancy|6
4455382|NCT00543543|7242645|FG000|Extension Study|Protocol Violation|0
4455383|NCT00543543|7242646|FG001|Extension Study|Protocol Violation|0
4455384|NCT00543543|7242647|FG002|Extension Study|Protocol Violation|0
4455385|NCT00543543|7242648|FG003|Extension Study|Protocol Violation|11
4455386|NCT00543543|7242645|FG000|Extension Study|Withdrawal by Subject|0
4455387|NCT00543543|7242646|FG001|Extension Study|Withdrawal by Subject|0
4455388|NCT00543543|7242647|FG002|Extension Study|Withdrawal by Subject|0
4455389|NCT00543543|7242648|FG003|Extension Study|Withdrawal by Subject|120
4455390|NCT00543569|7242667|FG000|Overall Study|Death|2
4537641|NCT01111552|7358511|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0
4537642|NCT01111552|7358512|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0
4537643|NCT01111552|7358508|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0
4537644|NCT01111552|7358509|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1
4537645|NCT01111552|7358510|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0
4537646|NCT01111552|7358511|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0
4537647|NCT01111552|7358512|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0
4537648|NCT01111552|7358508|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0
4537649|NCT01111552|7358509|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1
4537650|NCT01111552|7358510|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0
4537651|NCT01111552|7358511|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0
4537652|NCT01111552|7358512|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0
4537653|NCT01111552|7358508|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0
4537654|NCT01111552|7358509|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0
4537655|NCT01111552|7358510|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1
4537656|NCT01111552|7358511|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0
4537657|NCT01111552|7358512|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0
4537658|NCT01111604|7358525|FG000|Overall Study|Lost to Follow-up|0
4537659|NCT01111604|7358526|FG001|Overall Study|Lost to Follow-up|0
4537660|NCT01111604|7358527|FG002|Overall Study|Lost to Follow-up|1
4537661|NCT01111604|7358525|FG000|Overall Study|Withdrew Consent|3
4537662|NCT01111604|7358526|FG001|Overall Study|Withdrew Consent|0
4537663|NCT01111604|7358527|FG002|Overall Study|Withdrew Consent|2
4537664|NCT01111604|7358525|FG000|Overall Study|Withdrawal by Subject|2
4537665|NCT01111604|7358526|FG001|Overall Study|Withdrawal by Subject|0
4537666|NCT01111604|7358527|FG002|Overall Study|Withdrawal by Subject|0
4537667|NCT01111604|7358525|FG000|Overall Study|Death|1
4537668|NCT01111604|7358526|FG001|Overall Study|Death|0
4537669|NCT01111604|7358527|FG002|Overall Study|Death|0
4537670|NCT01111604|7358525|FG000|Overall Study|Met Exclusion Criteria|2
4537671|NCT01111604|7358526|FG001|Overall Study|Met Exclusion Criteria|0
4537672|NCT01111604|7358527|FG002|Overall Study|Met Exclusion Criteria|0
4455391|NCT00543569|7242668|FG001|Overall Study|Death|2
4455392|NCT00543569|7242669|FG002|Overall Study|Death|3
4455393|NCT00543569|7242670|FG003|Overall Study|Death|1
4455394|NCT00543569|7242667|FG000|Overall Study|Lost to Follow-up|0
4455395|NCT00543569|7242668|FG001|Overall Study|Lost to Follow-up|0
4455396|NCT00543569|7242669|FG002|Overall Study|Lost to Follow-up|1
4455397|NCT00543569|7242670|FG003|Overall Study|Lost to Follow-up|1
4455398|NCT00543569|7242667|FG000|Overall Study|Miscellaneous Reasons|7
4455399|NCT00543569|7242668|FG001|Overall Study|Miscellaneous Reasons|3
4455400|NCT00543569|7242669|FG002|Overall Study|Miscellaneous Reasons|11
4455401|NCT00543569|7242670|FG003|Overall Study|Miscellaneous Reasons|4
4455402|NCT00543569|7242667|FG000|Overall Study|Randomized but never received study drug|3
4455403|NCT00543569|7242668|FG001|Overall Study|Randomized but never received study drug|3
4455404|NCT00543569|7242669|FG002|Overall Study|Randomized but never received study drug|5
4537673|NCT01111825|7358557|FG000|Overall Study|Withdrawal by Subject|0
4537674|NCT01111825|7358558|FG001|Overall Study|Withdrawal by Subject|0
4537675|NCT01111825|7358559|FG002|Overall Study|Withdrawal by Subject|1
4537676|NCT01111825|7358560|FG003|Overall Study|Withdrawal by Subject|0
4537677|NCT01111825|7358557|FG000|Overall Study|Lost to Follow-up|0
4537678|NCT01111825|7358558|FG001|Overall Study|Lost to Follow-up|0
4537679|NCT01111825|7358559|FG002|Overall Study|Lost to Follow-up|3
4537680|NCT01111825|7358560|FG003|Overall Study|Lost to Follow-up|1
4537681|NCT01111825|7358557|FG000|Overall Study|Adverse Event|2
4537682|NCT01111825|7358558|FG001|Overall Study|Adverse Event|1
4537683|NCT01111825|7358559|FG002|Overall Study|Adverse Event|4
4537684|NCT01111825|7358560|FG003|Overall Study|Adverse Event|0
4537685|NCT01111825|7358557|FG000|Overall Study|Disease Progression|1
4537686|NCT01111825|7358558|FG001|Overall Study|Disease Progression|0
4537687|NCT01111825|7358559|FG002|Overall Study|Disease Progression|0
4537688|NCT01111825|7358560|FG003|Overall Study|Disease Progression|0
4537689|NCT01111825|7358557|FG000|Overall Study|Discontinuation by Sponsor|0
4537690|NCT01111825|7358558|FG001|Overall Study|Discontinuation by Sponsor|0
4537691|NCT01111825|7358559|FG002|Overall Study|Discontinuation by Sponsor|0
4537692|NCT01111825|7358560|FG003|Overall Study|Discontinuation by Sponsor|20
4537693|NCT01111838|7358570|FG000|Overall Study|Patient Ineligible|2
4537694|NCT01111838|7358570|FG000|Overall Study|Not Treated|3
4537695|NCT01111838|7358570|FG000|Overall Study|Clinical deterioration|1
4537696|NCT01111838|7358570|FG000|Overall Study|Other Complicating Disease|1
4537697|NCT01111851|7358576|FG000|Overall Study|All planned PET scans were not obtained.|2
4537698|NCT01111851|7358577|FG001|Overall Study|All planned PET scans were not obtained.|0
4537699|NCT01112059|7358585|FG000|Overall Study|Withdrawal by Subject|1
4455405|NCT00543569|7242670|FG003|Overall Study|Randomized but never received study drug|3
4455406|NCT00543725|7242682|FG000|Overall Study|Adverse Event|18
4455407|NCT00543725|7242683|FG001|Overall Study|Adverse Event|27
4455408|NCT00543725|7242682|FG000|Overall Study|Sponsor's Decision|0
4455409|NCT00543725|7242683|FG001|Overall Study|Sponsor's Decision|1
4455410|NCT00543725|7242682|FG000|Overall Study|Subject Non-Compliant|4
4455411|NCT00543725|7242683|FG001|Overall Study|Subject Non-Compliant|4
4455412|NCT00543725|7242682|FG000|Overall Study|Subject Ineligible To Continue The Trial|2
4455413|NCT00543725|7242683|FG001|Overall Study|Subject Ineligible To Continue The Trial|0
4455414|NCT00543725|7242682|FG000|Overall Study|Subject Reached A Virologic Endpoint|22
4455415|NCT00543725|7242683|FG001|Overall Study|Subject Reached A Virologic Endpoint|14
4455416|NCT00543725|7242682|FG000|Overall Study|Protocol Violation|0
4455417|NCT00543725|7242683|FG001|Overall Study|Protocol Violation|1
4455418|NCT00543725|7242682|FG000|Overall Study|Withdrawal by Subject|4
4455419|NCT00543725|7242683|FG001|Overall Study|Withdrawal by Subject|13
4455420|NCT00543725|7242682|FG000|Overall Study|Lost to Follow-up|15
4455421|NCT00543725|7242683|FG001|Overall Study|Lost to Follow-up|11
4455422|NCT00543725|7242682|FG000|Overall Study|Other|3
4455423|NCT00543725|7242683|FG001|Overall Study|Other|3
4455424|NCT00543803|7242702|FG000|Overall Study|Adverse Event|14
4455425|NCT00543803|7242702|FG000|Overall Study|Lack of Efficacy|22
4455426|NCT00543803|7242702|FG000|Overall Study|Lost to Follow-up|20
4455427|NCT00543803|7242702|FG000|Overall Study|Other|86
4455428|NCT00543855|7242712|FG000|Overall Study|Adverse Event|3
4455429|NCT00543855|7242713|FG001|Overall Study|Adverse Event|1
4455430|NCT00543855|7242714|FG002|Overall Study|Adverse Event|3
4455431|NCT00543855|7242715|FG003|Overall Study|Adverse Event|4
4455432|NCT00543855|7242712|FG000|Overall Study|Lost to Follow-up|0
4455433|NCT00543855|7242713|FG001|Overall Study|Lost to Follow-up|0
4455434|NCT00543855|7242714|FG002|Overall Study|Lost to Follow-up|1
4455435|NCT00543855|7242715|FG003|Overall Study|Lost to Follow-up|0
4455436|NCT00543855|7242712|FG000|Overall Study|Withdrawal by Subject|0
4455437|NCT00543855|7242713|FG001|Overall Study|Withdrawal by Subject|1
4455438|NCT00543855|7242714|FG002|Overall Study|Withdrawal by Subject|2
4455439|NCT00543855|7242715|FG003|Overall Study|Withdrawal by Subject|0
4455440|NCT00543855|7242712|FG000|Overall Study|Protocol Violation|1
4455441|NCT00543855|7242713|FG001|Overall Study|Protocol Violation|0
4455442|NCT00543855|7242714|FG002|Overall Study|Protocol Violation|0
4455443|NCT00543855|7242715|FG003|Overall Study|Protocol Violation|0
4537700|NCT01112059|7358586|FG001|Overall Study|Withdrawal by Subject|0
4537701|NCT01112267|7358607|FG000|Overall Study|Adverse Event|24
4537702|NCT01112267|7358608|FG001|Overall Study|Adverse Event|6
4455444|NCT00543985|7242725|FG000|Overall Study|Withdrawal by Subject|4
4455445|NCT00544167|7242746|FG000|Overall Study|Adverse Event|21
4455446|NCT00544167|7242746|FG000|Overall Study|Physician Decision|8
4455447|NCT00544440|7242750|FG000|Overall Study|Other|1
4455448|NCT00544440|7242750|FG000|Overall Study|Adverse Event|1
4455449|NCT00544440|7242750|FG000|Overall Study|Withdrawal by Subject|2
4455450|NCT00544440|7242750|FG000|Overall Study|Subject Non-compliance|1
4455451|NCT00544440|7242750|FG000|Overall Study|Progressive Disease|47
4455452|NCT00544440|7242750|FG000|Overall Study|Other|5
4455453|NCT00544544|7242754|FG000|Overall Study|Withdrawal by Subject|1
4455454|NCT00544544|7242754|FG000|Overall Study|Adverse Event|1
4455455|NCT00544544|7242754|FG000|Overall Study|Lost to Follow-up|1
4455456|NCT00544557|7242758|FG000|Overall Study|Adverse Event|140
4455457|NCT00544557|7242758|FG000|Overall Study|Lack of Efficacy|196
4455458|NCT00544557|7242758|FG000|Overall Study|Other|98
4455459|NCT00544648|7242764|FG000|Overall Study|Withdrawal by Subject|1
4455460|NCT00544648|7242765|FG001|Overall Study|Withdrawal by Subject|0
4455461|NCT00544648|7242764|FG000|Overall Study|Adverse Event|1
4455462|NCT00544648|7242765|FG001|Overall Study|Adverse Event|1
4455463|NCT00544648|7242764|FG000|Overall Study|progression of disease|1
4455464|NCT00544648|7242765|FG001|Overall Study|progression of disease|0
4455465|NCT00544817|7242790|FG000|Combined Modality|Lack of Efficacy|2
4455466|NCT00544817|7242790|FG000|Combined Modality|Worsening Neurologic Symptoms|2
4455467|NCT00544817|7242790|FG000|Combined Modality|Adverse Event|2
4455468|NCT00544817|7242790|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1
4455469|NCT00544817|7242790|FG000|No Treatment Interval|Lack of Efficacy|8
4455470|NCT00544817|7242790|FG000|No Treatment Interval|Physician Decision|3
4455471|NCT00544817|7242790|FG000|No Treatment Interval|Adverse Event|1
4455472|NCT00544817|7242790|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15
4455473|NCT00544817|7242790|FG000|Follow-up Systemic Therapy|Physician Decision|3
4455474|NCT00544817|7242790|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1
4455475|NCT00544869|7242797|FG000|Overall Study|Rsolution of congenitive symptoms|3
4455476|NCT00544869|7242798|FG001|Overall Study|Rsolution of congenitive symptoms|0
4537703|NCT01112267|7358607|FG000|Overall Study|Withdrawal by Subject|3
4537704|NCT01112267|7358608|FG001|Overall Study|Withdrawal by Subject|5
4537705|NCT01112267|7358607|FG000|Overall Study|Protocol Violation|5
4537706|NCT01112267|7358608|FG001|Overall Study|Protocol Violation|3
4537707|NCT01112267|7358607|FG000|Overall Study|Participants not compliant|1
4537708|NCT01112267|7358608|FG001|Overall Study|Participants not compliant|2
4537709|NCT01112267|7358607|FG000|Overall Study|Participants not receive any study drug|1
4537710|NCT01112267|7358608|FG001|Overall Study|Participants not receive any study drug|2
4537711|NCT01112514|7358627|FG000|Overall Study|Lost to Follow-up|1
4537712|NCT01112579|7358633|FG000|Overall Study|Missed Visit|1
4537713|NCT01112579|7358634|FG001|Overall Study|Missed Visit|1
4537714|NCT01112579|7358633|FG000|Overall Study|Death|0
4537715|NCT01112579|7358634|FG001|Overall Study|Death|2
4537716|NCT01112917|7358682|FG000|Overall Study|Death|2
4537717|NCT01112917|7358683|FG001|Overall Study|Death|11
4537718|NCT01112917|7358682|FG000|Overall Study|Lost to Follow-up|1
4537719|NCT01112917|7358683|FG001|Overall Study|Lost to Follow-up|1
4537720|NCT01112917|7358682|FG000|Overall Study|Withdrawal by Subject|1
4537721|NCT01112917|7358683|FG001|Overall Study|Withdrawal by Subject|3
4537722|NCT01112917|7358682|FG000|Overall Study|Unable to Convert Filter|3
4537723|NCT01112917|7358683|FG001|Overall Study|Unable to Convert Filter|0
4537724|NCT01112982|7358687|FG000|Overall Study|Withdrawal by Subject|1
4537725|NCT01112982|7358687|FG000|Overall Study|exceeded weight limit to complete MRI|1
4537726|NCT01113463|7358711|FG000|Overall Study|Physician Decision|5
4537727|NCT01113502|7358720|FG000|Overall Study|Withdrawal by Subject|1
4537728|NCT01113502|7358721|FG001|Overall Study|Withdrawal by Subject|0
4537729|NCT01113502|7358722|FG002|Overall Study|Withdrawal by Subject|1
4537730|NCT01113502|7358723|FG003|Overall Study|Withdrawal by Subject|1
4537731|NCT01113502|7358724|FG004|Overall Study|Withdrawal by Subject|0
4537732|NCT01113502|7358720|FG000|Overall Study|Adverse Event|0
4537733|NCT01113502|7358721|FG001|Overall Study|Adverse Event|0
4537734|NCT01113502|7358722|FG002|Overall Study|Adverse Event|3
4537735|NCT01113502|7358723|FG003|Overall Study|Adverse Event|2
4537736|NCT01113502|7358724|FG004|Overall Study|Adverse Event|0
4537737|NCT01113541|7358737|FG000|Overall Study|Withdrawal by Subject|1
4537738|NCT01113541|7358737|FG000|Overall Study|Protocol Violation|1
4537739|NCT01113541|7358737|FG000|Overall Study|Study Terminated by Sponsor|7
4537740|NCT01113541|7358737|FG000|Overall Study|Adverse Event|4
4537741|NCT01113580|7358743|FG000|Overall Study|Protocol Violation|1
4537742|NCT01113580|7358744|FG001|Overall Study|Protocol Violation|0
4537743|NCT01113710|7358759|FG000|Overall Study|Adverse Event|64
4537744|NCT01113710|7358759|FG000|Overall Study|Lack of Efficacy|41
4537745|NCT01113710|7358759|FG000|Overall Study|No Information Available|40
4537746|NCT01113710|7358759|FG000|Overall Study|Withdrawal by Subject|28
4537747|NCT01113710|7358759|FG000|Overall Study|Lost to Follow-up|20
4537748|NCT01113710|7358759|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13
4537749|NCT01113710|7358759|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11
4537750|NCT01113710|7358759|FG000|Overall Study|Lack of Patient's Compliance|8
4455477|NCT00544869|7242799|FG002|Overall Study|Rsolution of congenitive symptoms|0
4455478|NCT00544869|7242797|FG000|Overall Study|Adverse Event|6
4455479|NCT00544869|7242798|FG001|Overall Study|Adverse Event|1
4455480|NCT00544869|7242799|FG002|Overall Study|Adverse Event|0
4455481|NCT00544869|7242797|FG000|Overall Study|Lack of Efficacy|1
4455482|NCT00544869|7242798|FG001|Overall Study|Lack of Efficacy|1
4455483|NCT00544869|7242799|FG002|Overall Study|Lack of Efficacy|0
4537751|NCT01113710|7358759|FG000|Overall Study|Other|7
4455484|NCT00544869|7242797|FG000|Overall Study|Physician Decision|2
4455485|NCT00544869|7242798|FG001|Overall Study|Physician Decision|0
4455486|NCT00544869|7242799|FG002|Overall Study|Physician Decision|0
4455487|NCT00544882|7242809|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2
4455488|NCT00544882|7242810|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0
4455489|NCT00544882|7242811|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0
4537752|NCT01113710|7358759|FG000|Overall Study|Adverse Event/Other|5
4537753|NCT01113710|7358759|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5
4537754|NCT01113710|7358759|FG000|Overall Study|Lack of Efficacy/Other|4
4537755|NCT01113710|7358759|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4
4537756|NCT01113710|7358759|FG000|Overall Study|Lack of Efficacy/Adverse Event|3
4537757|NCT01113710|7358759|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2
4537758|NCT01113710|7358759|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2
4537759|NCT01113710|7358759|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2
4537760|NCT01113710|7358759|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1
4537761|NCT01113710|7358759|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1
4537762|NCT01113710|7358759|FG000|Overall Study|Compliance/Efficacy/AE/Other|1
4610866|NCT01695993|7467058|FG001|Overall Study|Changed Medical Facility|0
4610867|NCT01695993|7467059|FG002|Overall Study|Changed Medical Facility|1
4610868|NCT01696032|7467071|FG000|Overall Study|Withdrawal by Subject|0
4610869|NCT01696032|7467072|FG001|Overall Study|Withdrawal by Subject|0
4610870|NCT01696032|7467073|FG002|Overall Study|Withdrawal by Subject|1
4610871|NCT01696032|7467074|FG003|Overall Study|Withdrawal by Subject|2
4610872|NCT01696032|7467071|FG000|Overall Study|Death|14
4610873|NCT01696032|7467072|FG001|Overall Study|Death|4
4455490|NCT00544882|7242809|FG000|Cycle 1: Run-in Cycle|Adverse Event|1
4537763|NCT01113710|7358759|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1
4537764|NCT01113710|7358759|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1
4537765|NCT01113710|7358759|FG000|Overall Study|Lack of Patient's Compliance/Other|1
4537766|NCT01113710|7358759|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1
4537767|NCT01113710|7358759|FG000|Overall Study|Subject Did Not Receive Neupro|3
4537768|NCT01113749|7358776|FG000|Overall Study|Lost to Follow-up|1
4537769|NCT01113749|7358777|FG001|Overall Study|Lost to Follow-up|2
4537770|NCT01113801|7358787|FG000|Overall Study|Adverse Event|4
4537771|NCT01113801|7358788|FG001|Overall Study|Adverse Event|0
4537772|NCT01113801|7358789|FG002|Overall Study|Adverse Event|2
4537773|NCT01113801|7358790|FG003|Overall Study|Adverse Event|6
4537774|NCT01113801|7358787|FG000|Overall Study|Death|4
4537775|NCT01113801|7358788|FG001|Overall Study|Death|5
4537776|NCT01113801|7358789|FG002|Overall Study|Death|3
4537777|NCT01113801|7358790|FG003|Overall Study|Death|4
4537778|NCT01113801|7358787|FG000|Overall Study|Protocol Violation|0
4537779|NCT01113801|7358788|FG001|Overall Study|Protocol Violation|1
4537780|NCT01113801|7358789|FG002|Overall Study|Protocol Violation|0
4537781|NCT01113801|7358790|FG003|Overall Study|Protocol Violation|0
4537782|NCT01113801|7358787|FG000|Overall Study|Withdrawal by Subject|9
4537783|NCT01113801|7358788|FG001|Overall Study|Withdrawal by Subject|7
4537784|NCT01113801|7358789|FG002|Overall Study|Withdrawal by Subject|7
4537785|NCT01113801|7358790|FG003|Overall Study|Withdrawal by Subject|8
4537786|NCT01113801|7358787|FG000|Overall Study|Physician Decision|2
4537787|NCT01113801|7358788|FG001|Overall Study|Physician Decision|2
4537788|NCT01113801|7358789|FG002|Overall Study|Physician Decision|3
4537789|NCT01113801|7358790|FG003|Overall Study|Physician Decision|3
4537790|NCT01113801|7358787|FG000|Overall Study|Sponsor Decision|15
4537791|NCT01113801|7358788|FG001|Overall Study|Sponsor Decision|21
4537792|NCT01113801|7358789|FG002|Overall Study|Sponsor Decision|20
4537793|NCT01113801|7358790|FG003|Overall Study|Sponsor Decision|15
4537794|NCT01113801|7358787|FG000|Overall Study|Clinical Endpoint (ESRD)|7
4537795|NCT01113801|7358788|FG001|Overall Study|Clinical Endpoint (ESRD)|4
4537796|NCT01113801|7358789|FG002|Overall Study|Clinical Endpoint (ESRD)|2
4537797|NCT01113801|7358790|FG003|Overall Study|Clinical Endpoint (ESRD)|5
4537798|NCT01113879|7358802|FG000|Period 1: Block 1|Withdrawal by Subject|2
4537799|NCT01113879|7358803|FG001|Period 1: Block 1|Withdrawal by Subject|0
4537800|NCT01113892|7358813|FG000|Overall Study|Lost to Follow-up|2
4537801|NCT01113892|7358814|FG001|Overall Study|Lost to Follow-up|2
4537802|NCT01113892|7358813|FG000|Overall Study|Withdrawal by Subject|1
4537803|NCT01113892|7358814|FG001|Overall Study|Withdrawal by Subject|1
4537804|NCT01113892|7358813|FG000|Overall Study|Death|2
4537805|NCT01113892|7358814|FG001|Overall Study|Death|4
4537806|NCT01113892|7358813|FG000|Overall Study|Graft no longer evaluable|9
4537807|NCT01113892|7358814|FG001|Overall Study|Graft no longer evaluable|9
4537808|NCT01113931|7358822|FG000|Overall Study|Adverse Event|2
4537809|NCT01113931|7358823|FG001|Overall Study|Adverse Event|2
4537810|NCT01113931|7358822|FG000|Overall Study|Physician Decision|0
4537811|NCT01113931|7358823|FG001|Overall Study|Physician Decision|2
4537812|NCT01113931|7358822|FG000|Overall Study|Lost to Follow-up|12
4537813|NCT01113931|7358823|FG001|Overall Study|Lost to Follow-up|9
4537814|NCT01113931|7358822|FG000|Overall Study|Various|2
4537815|NCT01113931|7358823|FG001|Overall Study|Various|4
4537816|NCT01113931|7358822|FG000|Overall Study|Withdrawal by Subject|3
4537817|NCT01113931|7358823|FG001|Overall Study|Withdrawal by Subject|0
4537818|NCT01114360|7358848|FG000|Intervention 1 (4 Weeks)|Physician Decision|0
4537819|NCT01114360|7358849|FG001|Intervention 1 (4 Weeks)|Physician Decision|1
4537820|NCT01114373|7358869|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1
4610874|NCT01696032|7467073|FG002|Overall Study|Death|43
4455491|NCT00544882|7242810|FG001|Cycle 1: Run-in Cycle|Adverse Event|0
4455492|NCT00544882|7242811|FG002|Cycle 1: Run-in Cycle|Adverse Event|0
4455493|NCT00544882|7242809|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0
4455494|NCT00544882|7242810|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1
4455495|NCT00544882|7242811|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0
4455496|NCT00544882|7242809|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0
4455497|NCT00544882|7242810|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0
4455498|NCT00544882|7242811|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1
4455499|NCT00544882|7242809|FG000|Cycle 3: Follow-up|Noncompliance|0
4455500|NCT00544882|7242810|FG001|Cycle 3: Follow-up|Noncompliance|1
4455501|NCT00544882|7242811|FG002|Cycle 3: Follow-up|Noncompliance|0
4455502|NCT00544882|7242809|FG000|Cycle 3: Follow-up|Pregnancy|0
4455503|NCT00544882|7242810|FG001|Cycle 3: Follow-up|Pregnancy|1
4455504|NCT00544882|7242811|FG002|Cycle 3: Follow-up|Pregnancy|0
4455505|NCT00545051|7242832|FG000|Overall Study|Adverse Event|7
4455506|NCT00545051|7242833|FG001|Overall Study|Adverse Event|3
4455507|NCT00545051|7242832|FG000|Overall Study|Death|1
4455508|NCT00545051|7242833|FG001|Overall Study|Death|0
4455509|NCT00545051|7242832|FG000|Overall Study|Violation of inclusion/exclusion|0
4455510|NCT00545051|7242833|FG001|Overall Study|Violation of inclusion/exclusion|2
4455511|NCT00545051|7242832|FG000|Overall Study|Protocol Violation|1
4455512|NCT00545051|7242833|FG001|Overall Study|Protocol Violation|0
4455513|NCT00545051|7242832|FG000|Overall Study|Withdrawal by Subject|0
4455514|NCT00545051|7242833|FG001|Overall Study|Withdrawal by Subject|1
4455515|NCT00545051|7242832|FG000|Overall Study|Administrative reasons|0
4455516|NCT00545051|7242833|FG001|Overall Study|Administrative reasons|1
4455517|NCT00545064|7242839|FG000|Overall Study|Lost to Follow-up|3
4455518|NCT00545064|7242839|FG000|Overall Study|Withdrawal by Subject|2
4455519|NCT00545064|7242839|FG000|Overall Study|did not complete course of treatment|1
4455520|NCT00545064|7242839|FG000|Overall Study|cancel all appointments, no rebooking|1
4455521|NCT00545064|7242839|FG000|Overall Study|inclement weather|1
4455522|NCT00545077|7242847|FG000|Overall Study|Treatment not received|5
4455523|NCT00545077|7242848|FG001|Overall Study|Treatment not received|1
4455524|NCT00545077|7242847|FG000|Overall Study|Disease Progression|131
4455525|NCT00545077|7242848|FG001|Overall Study|Disease Progression|98
4537821|NCT01114373|7358870|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0
4537822|NCT01114373|7358869|FG000|Intervention 1 (4 Weeks)|Incarceration|1
4537823|NCT01114373|7358870|FG001|Intervention 1 (4 Weeks)|Incarceration|0
4537824|NCT01114373|7358869|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1
4537825|NCT01114373|7358870|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0
4537826|NCT01114373|7358869|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0
4537827|NCT01114373|7358870|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1
4537828|NCT01114438|7358880|FG000|Overall Study|Adverse Event|10
4537829|NCT01114438|7358880|FG000|Overall Study|concomitant medication|1
4537830|NCT01114438|7358880|FG000|Overall Study|Physician Decision|1
4537831|NCT01114438|7358880|FG000|Overall Study|Withdrawal by Subject|2
4537832|NCT01114516|7358895|FG000|Overall Study|Lost to Follow-up|2
4537833|NCT01114516|7358896|FG001|Overall Study|Lost to Follow-up|1
4537834|NCT01114529|7358905|FG000|Completed Study Medication at Month 24|Adverse Event|87
4537835|NCT01114529|7358906|FG001|Completed Study Medication at Month 24|Adverse Event|18
4537836|NCT01114529|7358907|FG002|Completed Study Medication at Month 24|Adverse Event|17
4537837|NCT01114529|7358905|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6
4537838|NCT01114529|7358906|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0
4537839|NCT01114529|7358907|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1
4537840|NCT01114529|7358905|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3
4537841|NCT01114529|7358906|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0
4537842|NCT01114529|7358907|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1
4537843|NCT01114529|7358905|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2
4537844|NCT01114529|7358906|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1
4537845|NCT01114529|7358907|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2
4537846|NCT01114529|7358905|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1
4537847|NCT01114529|7358906|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1
4537848|NCT01114529|7358907|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1
4537849|NCT01114529|7358905|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18
4537850|NCT01114529|7358906|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8
4537851|NCT01114529|7358907|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2
4537852|NCT01114529|7358905|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1
4537853|NCT01114529|7358906|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4
4537854|NCT01114529|7358907|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2
4537855|NCT01114529|7358905|FG000|Completed Study Medication at Month 24|Administrative problems|2
4591186|NCT01527383|7437585|FG001|Overall Study|Lost to Follow-up|0
4455526|NCT00545077|7242847|FG000|Overall Study|Withdrawal by Subject|3
4455527|NCT00545077|7242848|FG001|Overall Study|Withdrawal by Subject|14
4455528|NCT00545077|7242847|FG000|Overall Study|Physician Decision|6
4455529|NCT00545077|7242848|FG001|Overall Study|Physician Decision|3
4455530|NCT00545077|7242847|FG000|Overall Study|Lost to Follow-up|2
4455531|NCT00545077|7242848|FG001|Overall Study|Lost to Follow-up|0
4455532|NCT00545077|7242847|FG000|Overall Study|Protocol Violation|1
4455533|NCT00545077|7242848|FG001|Overall Study|Protocol Violation|0
4455534|NCT00545077|7242847|FG000|Overall Study|Adverse Event|0
4455535|NCT00545077|7242848|FG001|Overall Study|Adverse Event|31
4455536|NCT00545077|7242847|FG000|Overall Study|Death|0
4455537|NCT00545077|7242848|FG001|Overall Study|Death|8
4455538|NCT00545103|7242858|FG000|Overall Study|Lack of Efficacy|48
4455539|NCT00545103|7242859|FG001|Overall Study|Lack of Efficacy|45
4455540|NCT00545103|7242860|FG002|Overall Study|Lack of Efficacy|31
4455541|NCT00545103|7242861|FG003|Overall Study|Lack of Efficacy|27
4455542|NCT00545103|7242858|FG000|Overall Study|Withdrawal by Subject|6
4455543|NCT00545103|7242859|FG001|Overall Study|Withdrawal by Subject|10
4455544|NCT00545103|7242860|FG002|Overall Study|Withdrawal by Subject|18
4537856|NCT01114529|7358906|FG001|Completed Study Medication at Month 24|Administrative problems|1
4537857|NCT01114529|7358907|FG002|Completed Study Medication at Month 24|Administrative problems|2
4537858|NCT01114529|7358905|FG000|Completed Study Medication at Month 24|Death|2
4537859|NCT01114529|7358906|FG001|Completed Study Medication at Month 24|Death|1
4537860|NCT01114529|7358907|FG002|Completed Study Medication at Month 24|Death|2
4537861|NCT01114529|7358905|FG000|Completed Study Medication at Month 24|Graft loss|0
4537862|NCT01114529|7358906|FG001|Completed Study Medication at Month 24|Graft loss|2
4537863|NCT01114529|7358907|FG002|Completed Study Medication at Month 24|Graft loss|0
4537864|NCT01114529|7358905|FG000|Completed Study Medication at Month 24|Protocol Violation|0
4537865|NCT01114529|7358906|FG001|Completed Study Medication at Month 24|Protocol Violation|5
4537866|NCT01114529|7358907|FG002|Completed Study Medication at Month 24|Protocol Violation|2
4537867|NCT01114529|7358905|FG000|Completed Study Medication at Month 24|Missing|2
4537868|NCT01114529|7358906|FG001|Completed Study Medication at Month 24|Missing|0
4537869|NCT01114529|7358907|FG002|Completed Study Medication at Month 24|Missing|0
4537870|NCT01114529|7358905|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18
4537871|NCT01114529|7358906|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6
4537872|NCT01114529|7358907|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3
4537873|NCT01114529|7358905|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10
4537874|NCT01114529|7358906|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5
4537875|NCT01114529|7358907|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7
4537876|NCT01114529|7358905|FG000|Completed Study Phase at Month 24|Death|8
4537877|NCT01114529|7358906|FG001|Completed Study Phase at Month 24|Death|5
4537878|NCT01114529|7358907|FG002|Completed Study Phase at Month 24|Death|4
4537879|NCT01114529|7358905|FG000|Completed Study Phase at Month 24|Other|2
4537880|NCT01114529|7358906|FG001|Completed Study Phase at Month 24|Other|0
4537881|NCT01114529|7358907|FG002|Completed Study Phase at Month 24|Other|0
4537882|NCT01114529|7358905|FG000|Completed Study Phase at Month 24|Missing|2
4537883|NCT01114529|7358906|FG001|Completed Study Phase at Month 24|Missing|0
4537884|NCT01114529|7358907|FG002|Completed Study Phase at Month 24|Missing|0
4537885|NCT01114646|7358936|FG000|Overall Study|Withdrawal by Subject|3
4537886|NCT01114646|7358937|FG001|Overall Study|Withdrawal by Subject|2
4537887|NCT01114672|7358945|FG000|Overall Study|Death|0
4537888|NCT01114672|7358946|FG001|Overall Study|Death|1
4537889|NCT01114672|7358945|FG000|Overall Study|Withdrawal by Subject|2
4537890|NCT01114672|7358946|FG001|Overall Study|Withdrawal by Subject|1
4537891|NCT01114672|7358945|FG000|Overall Study|Lost to Follow-up|1
4537892|NCT01114672|7358946|FG001|Overall Study|Lost to Follow-up|0
4537893|NCT01114672|7358945|FG000|Overall Study|transplanted|1
4537894|NCT01114672|7358946|FG001|Overall Study|transplanted|0
4537895|NCT01114724|7358952|FG000|Overall Study|Death|8
4537896|NCT01114724|7358952|FG000|Overall Study|Lost to Follow-up|1
4537897|NCT01114724|7358952|FG000|Overall Study|Withdrawal by Subject|1
4537898|NCT01114737|7358959|FG000|Randomized Treatment Period|Withdrawal by Subject|1
4537899|NCT01114737|7358960|FG001|Randomized Treatment Period|Withdrawal by Subject|0
4537900|NCT01114737|7358959|FG000|Randomized Treatment Period|Lost to Follow-up|1
4537901|NCT01114737|7358960|FG001|Randomized Treatment Period|Lost to Follow-up|1
4537902|NCT01114737|7358959|FG000|Randomized Treatment Period|Pregnancy|1
4537903|NCT01114737|7358960|FG001|Randomized Treatment Period|Pregnancy|0
4537904|NCT01114737|7358959|FG000|Open-Label Treatment Period|Withdrawal by Subject|1
4537905|NCT01114737|7358960|FG001|Open-Label Treatment Period|Withdrawal by Subject|1
4537906|NCT01114737|7358959|FG000|Open-Label Treatment Period|Lost to Follow-up|3
4537907|NCT01114737|7358960|FG001|Open-Label Treatment Period|Lost to Follow-up|1
4537908|NCT01114737|7358959|FG000|Open-Label Treatment Period|Difficult Personal Events|1
4537909|NCT01114737|7358960|FG001|Open-Label Treatment Period|Difficult Personal Events|0
4537910|NCT01114828|7358979|FG000|Overall Study|Adverse Event|1
4537911|NCT01114828|7358980|FG001|Overall Study|Adverse Event|1
4537912|NCT01114828|7358979|FG000|Overall Study|Lack of Efficacy|0
4537913|NCT01114828|7358980|FG001|Overall Study|Lack of Efficacy|2
4537914|NCT01114828|7358979|FG000|Overall Study|Protocol Violation|2
4455545|NCT00545103|7242861|FG003|Overall Study|Withdrawal by Subject|22
4455546|NCT00545103|7242858|FG000|Overall Study|Adverse Event|11
4455547|NCT00545103|7242859|FG001|Overall Study|Adverse Event|12
4455548|NCT00545103|7242860|FG002|Overall Study|Adverse Event|17
4455549|NCT00545103|7242861|FG003|Overall Study|Adverse Event|10
4537915|NCT01114828|7358980|FG001|Overall Study|Protocol Violation|0
4537916|NCT01114828|7358979|FG000|Overall Study|Withdrawal by Subject|0
4455550|NCT00545103|7242858|FG000|Overall Study|Lost to Follow-up|4
4455551|NCT00545103|7242859|FG001|Overall Study|Lost to Follow-up|6
4455552|NCT00545103|7242860|FG002|Overall Study|Lost to Follow-up|3
4455553|NCT00545103|7242861|FG003|Overall Study|Lost to Follow-up|4
4455554|NCT00545103|7242858|FG000|Overall Study|Protocol Violation|1
4455555|NCT00545103|7242859|FG001|Overall Study|Protocol Violation|2
4455556|NCT00545103|7242860|FG002|Overall Study|Protocol Violation|3
4455557|NCT00545103|7242861|FG003|Overall Study|Protocol Violation|0
4455558|NCT00545103|7242858|FG000|Overall Study|Suspected recurrence of diverticulitis|1
4455559|NCT00545103|7242859|FG001|Overall Study|Suspected recurrence of diverticulitis|0
4455560|NCT00545103|7242860|FG002|Overall Study|Suspected recurrence of diverticulitis|0
4455561|NCT00545103|7242861|FG003|Overall Study|Suspected recurrence of diverticulitis|3
4455562|NCT00545103|7242858|FG000|Overall Study|Difficult to open package|0
4455563|NCT00545103|7242859|FG001|Overall Study|Difficult to open package|0
4455564|NCT00545103|7242860|FG002|Overall Study|Difficult to open package|0
4537917|NCT01114828|7358980|FG001|Overall Study|Withdrawal by Subject|1
4537918|NCT01114880|7358988|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4
4537919|NCT01114880|7358989|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0
4537920|NCT01114880|7358988|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1
4537921|NCT01114880|7358989|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0
4537922|NCT01114880|7358988|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0
4537923|NCT01114880|7358989|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1
4537924|NCT01114880|7358988|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0
4537925|NCT01114880|7358989|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1
4537926|NCT01114880|7358988|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3
4537927|NCT01114880|7358989|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0
4537928|NCT01114880|7358988|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0
4537929|NCT01114880|7358989|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2
4537930|NCT01115309|7359086|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2
4537931|NCT01115309|7359086|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1
4537932|NCT01115309|7359086|FG000|Long-term Follow-up|Lost to Follow-up|6
4537933|NCT01115491|7359099|FG000|Overall Study|Death|22
4537934|NCT01115491|7359099|FG000|Overall Study|Adverse Event|3
4537935|NCT01115491|7359099|FG000|Overall Study|Lost to Follow-up|3
4537936|NCT01115491|7359099|FG000|Overall Study|Withdrawal by Subject|1
4537937|NCT01115491|7359099|FG000|Overall Study|Physician Decision|1
4537938|NCT01115569|7359123|FG000|Conversion/Titration Phase|Adverse Event|59
4537939|NCT01115569|7359124|FG001|Conversion/Titration Phase|Adverse Event|0
4537940|NCT01115569|7359123|FG000|Conversion/Titration Phase|Lost to Follow-up|3
4537941|NCT01115569|7359124|FG001|Conversion/Titration Phase|Lost to Follow-up|0
4537942|NCT01115569|7359123|FG000|Conversion/Titration Phase|Physician Decision|5
4537943|NCT01115569|7359124|FG001|Conversion/Titration Phase|Physician Decision|0
4537944|NCT01115569|7359123|FG000|Conversion/Titration Phase|Protocol Violation|68
4537945|NCT01115569|7359124|FG001|Conversion/Titration Phase|Protocol Violation|0
4537946|NCT01115569|7359123|FG000|Conversion/Titration Phase|Withdrawal by Subject|26
4537947|NCT01115569|7359124|FG001|Conversion/Titration Phase|Withdrawal by Subject|0
4537948|NCT01115569|7359123|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53
4537949|NCT01115569|7359124|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0
4537950|NCT01115569|7359123|FG000|Maintenance Phase|Adverse Event|0
4537951|NCT01115569|7359124|FG001|Maintenance Phase|Adverse Event|43
4537952|NCT01115569|7359123|FG000|Maintenance Phase|Lost to Follow-up|0
4537953|NCT01115569|7359124|FG001|Maintenance Phase|Lost to Follow-up|8
4537954|NCT01115569|7359123|FG000|Maintenance Phase|Physician Decision|0
4537955|NCT01115569|7359124|FG001|Maintenance Phase|Physician Decision|3
4537956|NCT01115569|7359123|FG000|Maintenance Phase|Protocol Violation|0
4537957|NCT01115569|7359124|FG001|Maintenance Phase|Protocol Violation|9
4537958|NCT01115569|7359123|FG000|Maintenance Phase|Withdrawal by Subject|0
4537959|NCT01115569|7359124|FG001|Maintenance Phase|Withdrawal by Subject|27
4537960|NCT01115569|7359123|FG000|Maintenance Phase|Non-Compliance with Study Drug|0
4537961|NCT01115569|7359124|FG001|Maintenance Phase|Non-Compliance with Study Drug|48
4537962|NCT01115569|7359123|FG000|Maintenance Phase|Administrative|0
4537963|NCT01115569|7359124|FG001|Maintenance Phase|Administrative|1
4591187|NCT01527383|7437584|FG000|Overall Study|Physician Decision|2
4591188|NCT01527383|7437585|FG001|Overall Study|Physician Decision|0
4591189|NCT01527383|7437584|FG000|Overall Study|Pregnancy|1
4591190|NCT01527383|7437585|FG001|Overall Study|Pregnancy|0
4591191|NCT01527383|7437584|FG000|Overall Study|Protocol Violation|1
4591192|NCT01527383|7437585|FG001|Overall Study|Protocol Violation|0
4591193|NCT01527383|7437584|FG000|Overall Study|Screen failure|1
4591194|NCT01527383|7437585|FG001|Overall Study|Screen failure|0
4591195|NCT01527383|7437584|FG000|Overall Study|Participant moved|0
4591196|NCT01527383|7437585|FG001|Overall Study|Participant moved|1
4591197|NCT01527383|7437584|FG000|Overall Study|Withdrawal by Subject|2
4591198|NCT01527383|7437585|FG001|Overall Study|Withdrawal by Subject|3
4591199|NCT01527487|7437593|FG000|Overall Study|MD Discretion/Lack of Efficacy|3
4455565|NCT00545103|7242861|FG003|Overall Study|Difficult to open package|1
4455566|NCT00545103|7242858|FG000|Overall Study|Investigational product not taken|1
4455567|NCT00545103|7242859|FG001|Overall Study|Investigational product not taken|0
4455568|NCT00545103|7242860|FG002|Overall Study|Investigational product not taken|0
4455569|NCT00545103|7242861|FG003|Overall Study|Investigational product not taken|1
4455570|NCT00545103|7242858|FG000|Overall Study|Wish to start a family|0
4455571|NCT00545103|7242859|FG001|Overall Study|Wish to start a family|0
4455572|NCT00545103|7242860|FG002|Overall Study|Wish to start a family|0
4455573|NCT00545103|7242861|FG003|Overall Study|Wish to start a family|1
4455574|NCT00545103|7242858|FG000|Overall Study|Diverticulitis crisis|0
4455575|NCT00545103|7242859|FG001|Overall Study|Diverticulitis crisis|0
4455576|NCT00545103|7242860|FG002|Overall Study|Diverticulitis crisis|0
4537964|NCT01115738|7359158|FG000|Overall Study|Death|1
4537965|NCT01115738|7359159|FG001|Overall Study|Death|0
4537966|NCT01115738|7359160|FG002|Overall Study|Death|0
4537967|NCT01115738|7359158|FG000|Overall Study|Lost to Follow-up|0
4537968|NCT01115738|7359159|FG001|Overall Study|Lost to Follow-up|0
4537969|NCT01115738|7359160|FG002|Overall Study|Lost to Follow-up|1
4537970|NCT01115738|7359158|FG000|Overall Study|Physician Decision|18
4537971|NCT01115738|7359159|FG001|Overall Study|Physician Decision|15
4537972|NCT01115738|7359160|FG002|Overall Study|Physician Decision|17
4537973|NCT01115738|7359158|FG000|Overall Study|Withdrawal by Subject|6
4537974|NCT01115738|7359159|FG001|Overall Study|Withdrawal by Subject|6
4537975|NCT01115738|7359160|FG002|Overall Study|Withdrawal by Subject|9
4537976|NCT01115803|7359183|FG000|Overall Study|Withdrawal by Subject|0
4537977|NCT01115803|7359184|FG001|Overall Study|Withdrawal by Subject|0
4537978|NCT01115803|7359185|FG002|Overall Study|Withdrawal by Subject|0
4537979|NCT01115803|7359186|FG003|Overall Study|Withdrawal by Subject|0
4537980|NCT01115803|7359187|FG004|Overall Study|Withdrawal by Subject|0
4537981|NCT01115803|7359188|FG005|Overall Study|Withdrawal by Subject|0
4537982|NCT01115803|7359189|FG006|Overall Study|Withdrawal by Subject|1
4537983|NCT01115803|7359183|FG000|Overall Study|Lost to Follow-up|0
4455577|NCT00545103|7242861|FG003|Overall Study|Diverticulitis crisis|1
4455578|NCT00545103|7242858|FG000|Overall Study|Personal reasons|1
4455579|NCT00545103|7242859|FG001|Overall Study|Personal reasons|0
4455580|NCT00545103|7242860|FG002|Overall Study|Personal reasons|0
4455581|NCT00545103|7242861|FG003|Overall Study|Personal reasons|0
4455582|NCT00545103|7242858|FG000|Overall Study|Subject's decision|1
4455583|NCT00545103|7242859|FG001|Overall Study|Subject's decision|0
4455584|NCT00545103|7242860|FG002|Overall Study|Subject's decision|0
4455585|NCT00545103|7242861|FG003|Overall Study|Subject's decision|0
4455586|NCT00545103|7242858|FG000|Overall Study|Noncompliance|0
4455587|NCT00545103|7242859|FG001|Overall Study|Noncompliance|1
4455588|NCT00545103|7242860|FG002|Overall Study|Noncompliance|0
4610875|NCT01696032|7467074|FG003|Overall Study|Death|18
4610876|NCT01696032|7467071|FG000|Overall Study|Lost to Follow-up|0
4610877|NCT01696032|7467072|FG001|Overall Study|Lost to Follow-up|1
4610878|NCT01696032|7467073|FG002|Overall Study|Lost to Follow-up|0
4610879|NCT01696032|7467074|FG003|Overall Study|Lost to Follow-up|0
4537984|NCT01115803|7359184|FG001|Overall Study|Lost to Follow-up|0
4537985|NCT01115803|7359185|FG002|Overall Study|Lost to Follow-up|1
4537986|NCT01115803|7359186|FG003|Overall Study|Lost to Follow-up|0
4537987|NCT01115803|7359187|FG004|Overall Study|Lost to Follow-up|0
4537988|NCT01115803|7359188|FG005|Overall Study|Lost to Follow-up|0
4537989|NCT01115803|7359189|FG006|Overall Study|Lost to Follow-up|0
4537990|NCT01115803|7359183|FG000|Overall Study|Progressive Disease during Cycle1|0
4537991|NCT01115803|7359184|FG001|Overall Study|Progressive Disease during Cycle1|0
4610880|NCT01696032|7467071|FG000|Overall Study|Database lock|0
4455589|NCT00545103|7242861|FG003|Overall Study|Noncompliance|0
4455590|NCT00545103|7242858|FG000|Overall Study|Investigator decision|0
4455591|NCT00545103|7242859|FG001|Overall Study|Investigator decision|0
4455592|NCT00545103|7242860|FG002|Overall Study|Investigator decision|1
4455593|NCT00545103|7242861|FG003|Overall Study|Investigator decision|0
4455594|NCT00545103|7242858|FG000|Overall Study|Subject moved|0
4455595|NCT00545103|7242859|FG001|Overall Study|Subject moved|1
4455596|NCT00545103|7242860|FG002|Overall Study|Subject moved|0
4455597|NCT00545103|7242861|FG003|Overall Study|Subject moved|0
4537992|NCT01115803|7359185|FG002|Overall Study|Progressive Disease during Cycle1|0
4537993|NCT01115803|7359186|FG003|Overall Study|Progressive Disease during Cycle1|0
4537994|NCT01115803|7359187|FG004|Overall Study|Progressive Disease during Cycle1|0
4537995|NCT01115803|7359188|FG005|Overall Study|Progressive Disease during Cycle1|0
4537996|NCT01115803|7359189|FG006|Overall Study|Progressive Disease during Cycle1|1
4537997|NCT01115855|7359212|FG000|Overall Study|Adverse Event|16
4455598|NCT00545103|7242858|FG000|Overall Study|Use of prohibited medication|0
4455599|NCT00545103|7242859|FG001|Overall Study|Use of prohibited medication|0
4455600|NCT00545103|7242860|FG002|Overall Study|Use of prohibited medication|1
4455601|NCT00545103|7242861|FG003|Overall Study|Use of prohibited medication|0
4455602|NCT00545103|7242858|FG000|Overall Study|Does not want to take study drug anymore|1
4455603|NCT00545103|7242859|FG001|Overall Study|Does not want to take study drug anymore|0
4455604|NCT00545103|7242860|FG002|Overall Study|Does not want to take study drug anymore|1
4455605|NCT00545103|7242861|FG003|Overall Study|Does not want to take study drug anymore|0
4455606|NCT00545103|7242858|FG000|Overall Study|Subject met endpoint under protocol v. 1|0
4455607|NCT00545103|7242859|FG001|Overall Study|Subject met endpoint under protocol v. 1|0
4537998|NCT01115855|7359213|FG001|Overall Study|Adverse Event|18
4537999|NCT01115855|7359212|FG000|Overall Study|Death|6
4538000|NCT01115855|7359213|FG001|Overall Study|Death|5
4538001|NCT01115855|7359212|FG000|Overall Study|Lab Abnormality|1
4610881|NCT01696032|7467072|FG001|Overall Study|Database lock|1
4455608|NCT00545103|7242860|FG002|Overall Study|Subject met endpoint under protocol v. 1|1
4455609|NCT00545103|7242861|FG003|Overall Study|Subject met endpoint under protocol v. 1|0
4455610|NCT00545103|7242858|FG000|Overall Study|Death|0
4455611|NCT00545103|7242859|FG001|Overall Study|Death|1
4455612|NCT00545103|7242860|FG002|Overall Study|Death|0
4455613|NCT00545103|7242861|FG003|Overall Study|Death|0
4455614|NCT00545168|7242878|FG000|Overall Study|Lost to Follow-up|5
4455615|NCT00545168|7242879|FG001|Overall Study|Lost to Follow-up|5
4455616|NCT00545168|7242880|FG002|Overall Study|Lost to Follow-up|5
4455617|NCT00545168|7242878|FG000|Overall Study|Withdrawal by Subject|9
4455618|NCT00545168|7242879|FG001|Overall Study|Withdrawal by Subject|0
4455619|NCT00545168|7242880|FG002|Overall Study|Withdrawal by Subject|13
4455620|NCT00545168|7242878|FG000|Overall Study|Protocol Violation|1
4538002|NCT01115855|7359213|FG001|Overall Study|Lab Abnormality|1
4538003|NCT01115855|7359212|FG000|Overall Study|Protocol Violation|0
4538004|NCT01115855|7359213|FG001|Overall Study|Protocol Violation|1
4610882|NCT01696032|7467073|FG002|Overall Study|Database lock|7
4610883|NCT01696032|7467074|FG003|Overall Study|Database lock|2
4610884|NCT01696045|7467090|FG000|Overall Study|Study drug toxicity|1
4610885|NCT01696045|7467091|FG001|Overall Study|Study drug toxicity|5
4610886|NCT01696045|7467090|FG000|Overall Study|Disease progression|2
4610887|NCT01696045|7467091|FG001|Overall Study|Disease progression|2
4610888|NCT01696058|7467099|FG000|Overall Study|Adverse Event|21
4610889|NCT01696058|7467100|FG001|Overall Study|Adverse Event|11
4610890|NCT01696058|7467099|FG000|Overall Study|Lack of Efficacy|2
4610891|NCT01696058|7467100|FG001|Overall Study|Lack of Efficacy|3
4610892|NCT01696058|7467099|FG000|Overall Study|Protocol Violation|9
4610893|NCT01696058|7467100|FG001|Overall Study|Protocol Violation|3
4610894|NCT01696058|7467099|FG000|Overall Study|Lost to Follow-up|2
4610895|NCT01696058|7467100|FG001|Overall Study|Lost to Follow-up|5
4610896|NCT01696058|7467099|FG000|Overall Study|Withdrawal by Subject|4
4610897|NCT01696058|7467100|FG001|Overall Study|Withdrawal by Subject|6
4610898|NCT01696058|7467099|FG000|Overall Study|Other reason prematurely discontinued|5
4610899|NCT01696058|7467100|FG001|Overall Study|Other reason prematurely discontinued|3
4610900|NCT01696071|7467106|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1
4610901|NCT01696071|7467107|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0
4610902|NCT01696188|7467125|FG000|Overall Study|Protocol Violation|1
4610903|NCT01696188|7467126|FG001|Overall Study|Protocol Violation|1
4610904|NCT01696214|7467136|FG000|Overall Study|Lost to Follow-up|1
4610905|NCT01696214|7467137|FG001|Overall Study|Lost to Follow-up|0
4610906|NCT01696214|7467138|FG002|Overall Study|Lost to Follow-up|0
4610907|NCT01696214|7467139|FG003|Overall Study|Lost to Follow-up|0
4610908|NCT01696279|7467157|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1
4610909|NCT01696279|7467158|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0
4610910|NCT01696279|7467159|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0
4610911|NCT01696279|7467160|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0
4610912|NCT01696279|7467157|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0
4610913|NCT01696279|7467158|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5
4610914|NCT01696279|7467159|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0
4610915|NCT01696279|7467160|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0
4610916|NCT01696279|7467157|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0
4610917|NCT01696279|7467158|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1
4610918|NCT01696279|7467159|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0
4610919|NCT01696279|7467160|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0
4610920|NCT01696279|7467157|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0
4610921|NCT01696279|7467158|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1
4610922|NCT01696279|7467159|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0
4610923|NCT01696279|7467160|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0
4610924|NCT01696279|7467157|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0
4610925|NCT01696279|7467158|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3
4610926|NCT01696279|7467159|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0
4610927|NCT01696279|7467160|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0
4610928|NCT01696279|7467157|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0
4610929|NCT01696279|7467158|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7
4610930|NCT01696279|7467159|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0
4610931|NCT01696279|7467160|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0
4610932|NCT01696279|7467157|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0
4610933|NCT01696279|7467158|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2
4610934|NCT01696279|7467159|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0
4610935|NCT01696279|7467160|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0
4610936|NCT01696279|7467157|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0
4610937|NCT01696279|7467158|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0
4610938|NCT01696279|7467159|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1
4610939|NCT01696279|7467160|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0
4734815|NCT03505021|7682015|FG001|Overall Study|Other|5
4455621|NCT00545168|7242879|FG001|Overall Study|Protocol Violation|0
4538005|NCT01115855|7359212|FG000|Overall Study|Withdrawal by Subject|5
4455622|NCT00545168|7242880|FG002|Overall Study|Protocol Violation|1
4455623|NCT00545168|7242878|FG000|Overall Study|Visit for Day 21 was not done in error|1
4455624|NCT00545168|7242879|FG001|Overall Study|Visit for Day 21 was not done in error|0
4455625|NCT00545168|7242880|FG002|Overall Study|Visit for Day 21 was not done in error|2
4455626|NCT00545233|7242900|FG000|Overall Study|Adverse Event|10
4455627|NCT00545233|7242901|FG001|Overall Study|Adverse Event|5
4455628|NCT00545233|7242900|FG000|Overall Study|Violation of Selection Criteria at Entry|5
4455629|NCT00545233|7242901|FG001|Overall Study|Violation of Selection Criteria at Entry|1
4455630|NCT00545233|7242900|FG000|Overall Study|Protocol Violation|2
4455631|NCT00545233|7242901|FG001|Overall Study|Protocol Violation|0
4455632|NCT00545233|7242900|FG000|Overall Study|Refused Treatment|9
4455633|NCT00545233|7242901|FG001|Overall Study|Refused Treatment|7
4610940|NCT01696279|7467157|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0
4538006|NCT01115855|7359213|FG001|Overall Study|Withdrawal by Subject|5
4538007|NCT01115855|7359212|FG000|Overall Study|Other|8
4538008|NCT01115855|7359213|FG001|Overall Study|Other|6
4538009|NCT01115933|7359219|FG000|Overall Study|Did not receive XIENCE PRIME SV|1
4538010|NCT01115998|7359278|FG000|Overall Study|Lost to Follow-up|6
4538011|NCT01115998|7359279|FG001|Overall Study|Lost to Follow-up|6
4538012|NCT01116427|7359354|FG000|Core Phase|Adverse Event|0
4538013|NCT01116427|7359355|FG001|Core Phase|Adverse Event|1
4538014|NCT01116427|7359354|FG000|Core Phase|Lost to Follow-up|1
4538015|NCT01116427|7359355|FG001|Core Phase|Lost to Follow-up|0
4538016|NCT01116427|7359354|FG000|Core Phase|Withdrawal by Subject|3
4538017|NCT01116427|7359355|FG001|Core Phase|Withdrawal by Subject|0
4538018|NCT01116427|7359354|FG000|Core Phase|Worsening Multiple Sclerosis|1
4538019|NCT01116427|7359355|FG001|Core Phase|Worsening Multiple Sclerosis|0
4538020|NCT01116427|7359354|FG000|Extension Phase|Adverse Event|1
4538021|NCT01116427|7359355|FG001|Extension Phase|Adverse Event|1
4538022|NCT01116427|7359354|FG000|Extension Phase|Lost to Follow-up|2
4610941|NCT01696279|7467158|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0
4610942|NCT01696279|7467159|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0
4610943|NCT01696279|7467160|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6
4610944|NCT01696279|7467157|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0
4610945|NCT01696279|7467158|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0
4610946|NCT01696279|7467159|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0
4610947|NCT01696279|7467160|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1
4610948|NCT01696279|7467157|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0
4610949|NCT01696279|7467158|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0
4610950|NCT01696279|7467159|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0
4610951|NCT01696279|7467160|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1
4610952|NCT01696396|7467182|FG000|Overall Study|Withdrawal by Subject|19
4610953|NCT01696396|7467183|FG001|Overall Study|Withdrawal by Subject|5
4610954|NCT01696396|7467184|FG002|Overall Study|Withdrawal by Subject|19
4610955|NCT01696396|7467185|FG003|Overall Study|Withdrawal by Subject|11
4538023|NCT01116427|7359355|FG001|Extension Phase|Lost to Follow-up|0
4538024|NCT01116427|7359354|FG000|Extension Phase|Withdrawal by Subject|5
4455634|NCT00545233|7242900|FG000|Overall Study|Failure to Return|4
4538025|NCT01116427|7359355|FG001|Extension Phase|Withdrawal by Subject|1
4538026|NCT01116427|7359354|FG000|Extension Phase|Not using appropriate birth control|1
4538027|NCT01116427|7359355|FG001|Extension Phase|Not using appropriate birth control|0
4538028|NCT01116440|7359367|FG000|Treatment|Withdrawal by Subject|2
4538029|NCT01116440|7359368|FG001|Treatment|Withdrawal by Subject|2
4455635|NCT00545233|7242901|FG001|Overall Study|Failure to Return|6
4538030|NCT01116440|7359367|FG000|Treatment|Lost to Follow-up|1
4538031|NCT01116440|7359368|FG001|Treatment|Lost to Follow-up|1
4538032|NCT01116440|7359367|FG000|Treatment|Protocol Violation|0
4538033|NCT01116440|7359368|FG001|Treatment|Protocol Violation|2
4455636|NCT00545233|7242900|FG000|Overall Study|Insufficient response|14
4538034|NCT01116440|7359367|FG000|Treatment|Lack of Efficacy|0
4538035|NCT01116440|7359368|FG001|Treatment|Lack of Efficacy|1
4538036|NCT01116440|7359367|FG000|Treatment|Adverse Event|0
4538037|NCT01116440|7359368|FG001|Treatment|Adverse Event|1
4538038|NCT01116440|7359367|FG000|Withdrawal|Withdrawal by Subject|0
4538039|NCT01116440|7359368|FG001|Withdrawal|Withdrawal by Subject|1
4538040|NCT01116440|7359367|FG000|Withdrawal|Lost to Follow-up|0
4538041|NCT01116440|7359368|FG001|Withdrawal|Lost to Follow-up|1
4538042|NCT01116440|7359367|FG000|Follow-up|Lost to Follow-up|0
4538043|NCT01116440|7359368|FG001|Follow-up|Lost to Follow-up|1
4538044|NCT01116440|7359367|FG000|Follow-up|Withdrawal by Subject|0
4538045|NCT01116440|7359368|FG001|Follow-up|Withdrawal by Subject|1
4538046|NCT01116544|7359383|FG000|Overall Study|Protocol Violation|1
4538047|NCT01116544|7359384|FG001|Overall Study|Protocol Violation|0
4538048|NCT01116544|7359383|FG000|Overall Study|Withdrawal by Subject|1
4538049|NCT01116544|7359384|FG001|Overall Study|Withdrawal by Subject|1
4538050|NCT01116687|7359394|FG000|Overall Study|Withdrawal by Subject|4
4538051|NCT01116739|7359400|FG000|Overall Study|Child had 2 years of HS|110
4538052|NCT01116739|7359401|FG001|Overall Study|Child had 2 years of HS|128
4538053|NCT01116739|7359400|FG000|Overall Study|Withdrawal by Subject|6
4538054|NCT01116739|7359401|FG001|Overall Study|Withdrawal by Subject|0
4538055|NCT01116739|7359400|FG000|Overall Study|child too young|2
4538056|NCT01116739|7359401|FG001|Overall Study|child too young|6
4538057|NCT01116739|7359400|FG000|Overall Study|child not enrolled in head start|10
4538058|NCT01116739|7359401|FG001|Overall Study|child not enrolled in head start|2
4538059|NCT01116739|7359400|FG000|Overall Study|enrolled caregiver not legal guardian|2
4538060|NCT01116739|7359401|FG001|Overall Study|enrolled caregiver not legal guardian|0
4538061|NCT01116882|7359409|FG000|30-day|Lost to Follow-up|50
4538062|NCT01116882|7359410|FG001|30-day|Lost to Follow-up|21
4538063|NCT01116882|7359409|FG000|30-day|Withdrawal by Subject|2
4538064|NCT01116882|7359410|FG001|30-day|Withdrawal by Subject|4
4538065|NCT01116882|7359409|FG000|30-day|Other Reasons|16
4538066|NCT01116882|7359410|FG001|30-day|Other Reasons|6
4538067|NCT01116882|7359409|FG000|12-month|Lost to Follow-up|111
4538068|NCT01116882|7359410|FG001|12-month|Lost to Follow-up|42
4538069|NCT01116882|7359409|FG000|12-month|Other Reasons|151
4538070|NCT01116882|7359410|FG001|12-month|Other Reasons|49
4538071|NCT01116882|7359409|FG000|12-month|Withdrawal by Subject|5
4538072|NCT01116882|7359410|FG001|12-month|Withdrawal by Subject|8
4538073|NCT01117012|7359539|FG000|Overall Study|Adverse Event|0
4538074|NCT01117012|7359540|FG001|Overall Study|Adverse Event|1
4538075|NCT01117012|7359539|FG000|Overall Study|Death|1
4538076|NCT01117012|7359540|FG001|Overall Study|Death|1
4538077|NCT01117012|7359539|FG000|Overall Study|Withdrawal by Subject|3
4538078|NCT01117012|7359540|FG001|Overall Study|Withdrawal by Subject|0
4538079|NCT01117012|7359539|FG000|Overall Study|Undefined|4
4538080|NCT01117012|7359540|FG001|Overall Study|Undefined|3
4538081|NCT01117051|7359548|FG000|Overall Study|Withdrawal by Subject|5
4538082|NCT01117051|7359549|FG001|Overall Study|Withdrawal by Subject|3
4538083|NCT01117051|7359548|FG000|Overall Study|Adverse Event|4
4538084|NCT01117051|7359549|FG001|Overall Study|Adverse Event|3
4538085|NCT01117051|7359548|FG000|Overall Study|Lost to Follow-up|0
4538086|NCT01117051|7359549|FG001|Overall Study|Lost to Follow-up|1
4538087|NCT01117051|7359548|FG000|Overall Study|Did not meet in-/exclusion criteria|0
4538088|NCT01117051|7359549|FG001|Overall Study|Did not meet in-/exclusion criteria|1
4538089|NCT01117051|7359548|FG000|Overall Study|Sponsor's decision|3
4538090|NCT01117051|7359549|FG001|Overall Study|Sponsor's decision|1
4538091|NCT01117051|7359548|FG000|Overall Study|Surgical procedure|0
4538092|NCT01117051|7359549|FG001|Overall Study|Surgical procedure|1
4538093|NCT01117051|7359548|FG000|Overall Study|Randomized by mistake|0
4538094|NCT01117051|7359549|FG001|Overall Study|Randomized by mistake|1
4538095|NCT01117051|7359548|FG000|Overall Study|Convenience issue|1
4538096|NCT01117051|7359549|FG001|Overall Study|Convenience issue|0
4538097|NCT01117181|7359569|FG000|Overall Study|Lost to Follow-up|1
4538098|NCT01117181|7359570|FG001|Overall Study|Lost to Follow-up|0
4538099|NCT01117181|7359569|FG000|Overall Study|Withdrawal by Subject|0
4538100|NCT01117181|7359570|FG001|Overall Study|Withdrawal by Subject|2
4538101|NCT01117337|7359587|FG000|Overall Study|Lost to Follow-up|4
4538102|NCT01117337|7359588|FG001|Overall Study|Lost to Follow-up|0
4538103|NCT01117350|7359596|FG000|Comparative Period|Not Treated|5
4538104|NCT01117350|7359597|FG001|Comparative Period|Not Treated|8
4538105|NCT01117350|7359596|FG000|Comparative Period|Adverse Event|6
4538106|NCT01117350|7359597|FG001|Comparative Period|Adverse Event|33
4538107|NCT01117350|7359596|FG000|Comparative Period|Lost to Follow-up|11
4538108|NCT01117350|7359597|FG001|Comparative Period|Lost to Follow-up|7
4538109|NCT01117350|7359596|FG000|Comparative Period|Withdrawal by Subject|9
4538110|NCT01117350|7359597|FG001|Comparative Period|Withdrawal by Subject|13
4538111|NCT01117350|7359596|FG000|Comparative Period|Protocol Violation|8
4538112|NCT01117350|7359597|FG001|Comparative Period|Protocol Violation|12
4538113|NCT01117350|7359596|FG000|Comparative Period|Lack of Efficacy|1
4538114|NCT01117350|7359597|FG001|Comparative Period|Lack of Efficacy|0
4538115|NCT01117350|7359596|FG000|Comparative Period|Physician Decision|0
4538116|NCT01117350|7359597|FG001|Comparative Period|Physician Decision|1
4538117|NCT01117350|7359596|FG000|Comparative Period|Move to another city/country|2
4538118|NCT01117350|7359597|FG001|Comparative Period|Move to another city/country|1
4538119|NCT01117350|7359596|FG000|Extension Period|Not included in extension, not treated|0
4538120|NCT01117350|7359597|FG001|Extension Period|Not included in extension, not treated|50
4538121|NCT01117350|7359596|FG000|Extension Period|Adverse Event|0
4538122|NCT01117350|7359597|FG001|Extension Period|Adverse Event|2
4455637|NCT00545233|7242901|FG001|Overall Study|Insufficient response|15
4455638|NCT00545233|7242900|FG000|Overall Study|Physician Decision|2
4538123|NCT01117350|7359596|FG000|Extension Period|Protocol Violation|0
4538124|NCT01117350|7359597|FG001|Extension Period|Protocol Violation|2
4538125|NCT01117350|7359596|FG000|Extension Period|Lost to Follow-up|0
4538126|NCT01117350|7359597|FG001|Extension Period|Lost to Follow-up|2
4538127|NCT01117350|7359596|FG000|Extension Period|Withdrawal by Subject|0
4538128|NCT01117350|7359597|FG001|Extension Period|Withdrawal by Subject|3
4538129|NCT01117350|7359596|FG000|Extension Period|Lack of Efficacy|0
4538130|NCT01117350|7359597|FG001|Extension Period|Lack of Efficacy|2
4538131|NCT01117350|7359596|FG000|Extension Period|Inclusion criteria not respected|0
4538132|NCT01117350|7359597|FG001|Extension Period|Inclusion criteria not respected|1
4538133|NCT01117350|7359596|FG000|Extension Period|Prohibited medication|0
4538134|NCT01117350|7359597|FG001|Extension Period|Prohibited medication|1
4538135|NCT01117428|7359612|FG000|Overall Study|Lack of Efficacy|1
4538136|NCT01117428|7359613|FG001|Overall Study|Lack of Efficacy|0
4538137|NCT01117428|7359614|FG002|Overall Study|Lack of Efficacy|0
4538138|NCT01117428|7359615|FG003|Overall Study|Lack of Efficacy|0
4538139|NCT01117428|7359616|FG004|Overall Study|Lack of Efficacy|0
4538140|NCT01117428|7359617|FG005|Overall Study|Lack of Efficacy|0
4538141|NCT01117428|7359612|FG000|Overall Study|Adverse Event|4
4538142|NCT01117428|7359613|FG001|Overall Study|Adverse Event|0
4538143|NCT01117428|7359614|FG002|Overall Study|Adverse Event|0
4538144|NCT01117428|7359615|FG003|Overall Study|Adverse Event|0
4538145|NCT01117428|7359616|FG004|Overall Study|Adverse Event|1
4538146|NCT01117428|7359617|FG005|Overall Study|Adverse Event|2
4538147|NCT01117428|7359612|FG000|Overall Study|Death|0
4538148|NCT01117428|7359613|FG001|Overall Study|Death|1
4538149|NCT01117428|7359614|FG002|Overall Study|Death|2
4538150|NCT01117428|7359615|FG003|Overall Study|Death|0
4538151|NCT01117428|7359616|FG004|Overall Study|Death|0
4538152|NCT01117428|7359617|FG005|Overall Study|Death|1
4538153|NCT01117428|7359612|FG000|Overall Study|Physician Decision|0
4538154|NCT01117428|7359613|FG001|Overall Study|Physician Decision|1
4538155|NCT01117428|7359614|FG002|Overall Study|Physician Decision|0
4538156|NCT01117428|7359615|FG003|Overall Study|Physician Decision|0
4538157|NCT01117428|7359616|FG004|Overall Study|Physician Decision|0
4538158|NCT01117428|7359617|FG005|Overall Study|Physician Decision|0
4538159|NCT01117428|7359612|FG000|Overall Study|Withdrawal by Subject|0
4538160|NCT01117428|7359613|FG001|Overall Study|Withdrawal by Subject|0
4538161|NCT01117428|7359614|FG002|Overall Study|Withdrawal by Subject|1
4538162|NCT01117428|7359615|FG003|Overall Study|Withdrawal by Subject|0
4538163|NCT01117428|7359616|FG004|Overall Study|Withdrawal by Subject|0
4538164|NCT01117428|7359617|FG005|Overall Study|Withdrawal by Subject|0
4538165|NCT01117428|7359612|FG000|Overall Study|Progressive disease|15
4538166|NCT01117428|7359613|FG001|Overall Study|Progressive disease|27
4538167|NCT01117428|7359614|FG002|Overall Study|Progressive disease|10
4538168|NCT01117428|7359615|FG003|Overall Study|Progressive disease|12
4538169|NCT01117428|7359616|FG004|Overall Study|Progressive disease|16
4538170|NCT01117428|7359617|FG005|Overall Study|Progressive disease|17
4538171|NCT01117454|7359635|FG000|Overall Study|Pregnancy|0
4538172|NCT01117454|7359636|FG001|Overall Study|Pregnancy|1
4538173|NCT01117480|7359642|FG000|Overall Study|Protocol Violation|8
4538174|NCT01117480|7359642|FG000|Overall Study|Did Not Start Adalimumab Therapy|20
4538175|NCT01117623|7359654|FG000|Overall Study|Adverse Event|0
4538176|NCT01117623|7359655|FG001|Overall Study|Adverse Event|2
4538177|NCT01117623|7359656|FG002|Overall Study|Adverse Event|4
4538178|NCT01117623|7359657|FG003|Overall Study|Adverse Event|0
4538179|NCT01117623|7359658|FG004|Overall Study|Adverse Event|2
4538180|NCT01117623|7359659|FG005|Overall Study|Adverse Event|0
4538181|NCT01117623|7359660|FG006|Overall Study|Adverse Event|0
4538182|NCT01117623|7359661|FG007|Overall Study|Adverse Event|2
4538183|NCT01117623|7359654|FG000|Overall Study|Disease progression, recurrence, relapse|3
4538184|NCT01117623|7359655|FG001|Overall Study|Disease progression, recurrence, relapse|6
4538185|NCT01117623|7359656|FG002|Overall Study|Disease progression, recurrence, relapse|5
4538186|NCT01117623|7359657|FG003|Overall Study|Disease progression, recurrence, relapse|6
4610956|NCT01696396|7467182|FG000|Overall Study|Decision by Sponsor|3
4610957|NCT01696396|7467183|FG001|Overall Study|Decision by Sponsor|1
4538187|NCT01117623|7359658|FG004|Overall Study|Disease progression, recurrence, relapse|8
4538188|NCT01117623|7359659|FG005|Overall Study|Disease progression, recurrence, relapse|14
4538189|NCT01117623|7359660|FG006|Overall Study|Disease progression, recurrence, relapse|5
4610958|NCT01696396|7467184|FG002|Overall Study|Decision by Sponsor|2
4538190|NCT01117623|7359661|FG007|Overall Study|Disease progression, recurrence, relapse|22
4538191|NCT01117623|7359654|FG000|Overall Study|Withdrawal by Subject|0
4538192|NCT01117623|7359655|FG001|Overall Study|Withdrawal by Subject|0
4538193|NCT01117623|7359656|FG002|Overall Study|Withdrawal by Subject|2
4538194|NCT01117623|7359657|FG003|Overall Study|Withdrawal by Subject|0
4455639|NCT00545233|7242901|FG001|Overall Study|Physician Decision|1
4455640|NCT00545272|7242914|FG000|Overall Study|Protocol deviation|0
4455641|NCT00545272|7242915|FG001|Overall Study|Protocol deviation|1
4455642|NCT00545272|7242916|FG002|Overall Study|Protocol deviation|0
4455643|NCT00545272|7242917|FG003|Overall Study|Protocol deviation|1
4455644|NCT00545272|7242918|FG004|Overall Study|Protocol deviation|0
4455645|NCT00545272|7242919|FG005|Overall Study|Protocol deviation|1
4455646|NCT00545272|7242914|FG000|Overall Study|Adverse Event|0
4455647|NCT00545272|7242915|FG001|Overall Study|Adverse Event|0
4455648|NCT00545272|7242916|FG002|Overall Study|Adverse Event|1
4455649|NCT00545272|7242917|FG003|Overall Study|Adverse Event|0
4455650|NCT00545272|7242918|FG004|Overall Study|Adverse Event|0
4455651|NCT00545272|7242919|FG005|Overall Study|Adverse Event|1
4455652|NCT00545272|7242914|FG000|Overall Study|Abnormal laboratory value(s)|0
4455653|NCT00545272|7242915|FG001|Overall Study|Abnormal laboratory value(s)|0
4455654|NCT00545272|7242916|FG002|Overall Study|Abnormal laboratory value(s)|0
4455655|NCT00545272|7242917|FG003|Overall Study|Abnormal laboratory value(s)|0
4455656|NCT00545272|7242918|FG004|Overall Study|Abnormal laboratory value(s)|0
4455657|NCT00545272|7242919|FG005|Overall Study|Abnormal laboratory value(s)|1
4455658|NCT00545272|7242914|FG000|Overall Study|Abnormal test procedure result(s)|0
4455659|NCT00545272|7242915|FG001|Overall Study|Abnormal test procedure result(s)|0
4455660|NCT00545272|7242916|FG002|Overall Study|Abnormal test procedure result(s)|0
4455661|NCT00545272|7242917|FG003|Overall Study|Abnormal test procedure result(s)|0
4455662|NCT00545272|7242918|FG004|Overall Study|Abnormal test procedure result(s)|1
4455663|NCT00545272|7242919|FG005|Overall Study|Abnormal test procedure result(s)|0
4455664|NCT00545272|7242914|FG000|Overall Study|Lost to Follow-up|0
4538195|NCT01117623|7359658|FG004|Overall Study|Withdrawal by Subject|0
4538196|NCT01117623|7359659|FG005|Overall Study|Withdrawal by Subject|1
4538197|NCT01117623|7359660|FG006|Overall Study|Withdrawal by Subject|1
4538198|NCT01117623|7359661|FG007|Overall Study|Withdrawal by Subject|1
4538199|NCT01117623|7359654|FG000|Overall Study|Non-compliance with study medication|0
4538200|NCT01117623|7359655|FG001|Overall Study|Non-compliance with study medication|0
4538201|NCT01117623|7359656|FG002|Overall Study|Non-compliance with study medication|0
4538202|NCT01117623|7359657|FG003|Overall Study|Non-compliance with study medication|0
4538203|NCT01117623|7359658|FG004|Overall Study|Non-compliance with study medication|0
4538204|NCT01117623|7359659|FG005|Overall Study|Non-compliance with study medication|0
4538205|NCT01117623|7359660|FG006|Overall Study|Non-compliance with study medication|0
4538206|NCT01117623|7359661|FG007|Overall Study|Non-compliance with study medication|1
4538207|NCT01117623|7359654|FG000|Overall Study|Invest. text: completed all planned txs|0
4538208|NCT01117623|7359655|FG001|Overall Study|Invest. text: completed all planned txs|0
4538209|NCT01117623|7359656|FG002|Overall Study|Invest. text: completed all planned txs|0
4538210|NCT01117623|7359657|FG003|Overall Study|Invest. text: completed all planned txs|0
4538211|NCT01117623|7359658|FG004|Overall Study|Invest. text: completed all planned txs|0
4538212|NCT01117623|7359659|FG005|Overall Study|Invest. text: completed all planned txs|1
4538213|NCT01117623|7359660|FG006|Overall Study|Invest. text: completed all planned txs|0
4538214|NCT01117623|7359661|FG007|Overall Study|Invest. text: completed all planned txs|0
4538215|NCT01117766|7359686|FG000|First Intervention|Adverse Event|0
4538216|NCT01117766|7359687|FG001|First Intervention|Adverse Event|1
4538217|NCT01117766|7359686|FG000|First Intervention|Protocol Violation|1
4538218|NCT01117766|7359687|FG001|First Intervention|Protocol Violation|0
4538219|NCT01117766|7359686|FG000|Washout Period|Protocol Violation|0
4538220|NCT01117766|7359687|FG001|Washout Period|Protocol Violation|2
4538221|NCT01117766|7359686|FG000|Second Intervention|Lost to Follow-up|1
4538222|NCT01117766|7359687|FG001|Second Intervention|Lost to Follow-up|0
4538223|NCT01117766|7359686|FG000|Second Intervention|Other|1
4538224|NCT01117766|7359687|FG001|Second Intervention|Other|2
4538225|NCT01117766|7359686|FG000|Second Intervention|Adverse Event|0
4538226|NCT01117766|7359687|FG001|Second Intervention|Adverse Event|2
4538227|NCT01117766|7359686|FG000|Second Intervention|Withdrawal by Subject|0
4538228|NCT01117766|7359687|FG001|Second Intervention|Withdrawal by Subject|1
4538229|NCT01117792|7359693|FG000|Overall Study|Death|1
4538230|NCT01117792|7359693|FG000|Overall Study|Adverse Event|3
4538231|NCT01117857|7359697|FG000|Overall Study|Lost to Follow-up|4
4538232|NCT01117857|7359697|FG000|Overall Study|Withdrawal by Subject|4
4538233|NCT01117857|7359697|FG000|Overall Study|Physician Decision|1
4538234|NCT01117870|7359703|FG000|Overall Study|Inability to place needle|1
4538235|NCT01117870|7359704|FG001|Overall Study|Inability to place needle|0
4538236|NCT01117987|7359725|FG000|Overall Study|Protocol deviation|0
4538237|NCT01117987|7359726|FG001|Overall Study|Protocol deviation|1
4538238|NCT01117987|7359725|FG000|Overall Study|Subject no longer requires study drug|1
4538239|NCT01117987|7359726|FG001|Overall Study|Subject no longer requires study drug|0
4538240|NCT01117987|7359725|FG000|Overall Study|Lost to Follow-up|1
4538241|NCT01117987|7359726|FG001|Overall Study|Lost to Follow-up|1
4538242|NCT01117987|7359725|FG000|Overall Study|Abnormal test procedure result|2
4538243|NCT01117987|7359726|FG001|Overall Study|Abnormal test procedure result|0
4538244|NCT01117987|7359725|FG000|Overall Study|Lack of Efficacy|3
4538245|NCT01117987|7359726|FG001|Overall Study|Lack of Efficacy|4
4538246|NCT01117987|7359725|FG000|Overall Study|Death|5
4538247|NCT01117987|7359726|FG001|Overall Study|Death|10
4538248|NCT01117987|7359725|FG000|Overall Study|Withdrawal by Subject|5
4538249|NCT01117987|7359726|FG001|Overall Study|Withdrawal by Subject|10
4538250|NCT01117987|7359725|FG000|Overall Study|Adverse Event|19
4538251|NCT01117987|7359726|FG001|Overall Study|Adverse Event|26
4538252|NCT01117987|7359725|FG000|Overall Study|Administrative problems|25
4538253|NCT01117987|7359726|FG001|Overall Study|Administrative problems|22
4538254|NCT01118052|7359732|FG000|Overall Study|Never treated|2
4538255|NCT01118117|7359753|FG000|Overall Study|Death|8
4538256|NCT01118117|7359754|FG001|Overall Study|Death|0
4538257|NCT01118117|7359753|FG000|Overall Study|Lost to Follow-up|6
4538258|NCT01118117|7359754|FG001|Overall Study|Lost to Follow-up|0
4538259|NCT01118117|7359753|FG000|Overall Study|Missed 12 Month Visit|7
4538260|NCT01118117|7359754|FG001|Overall Study|Missed 12 Month Visit|0
4455665|NCT00545272|7242915|FG001|Overall Study|Lost to Follow-up|0
4455666|NCT00545272|7242916|FG002|Overall Study|Lost to Follow-up|0
4455667|NCT00545272|7242917|FG003|Overall Study|Lost to Follow-up|0
4455668|NCT00545272|7242918|FG004|Overall Study|Lost to Follow-up|1
4455669|NCT00545272|7242919|FG005|Overall Study|Lost to Follow-up|0
4455670|NCT00545298|7242936|FG000|Overall Study|Issues with Standard of Care|2
4455671|NCT00545298|7242937|FG001|Overall Study|Issues with Standard of Care|0
4455672|NCT00545298|7242938|FG002|Overall Study|Issues with Standard of Care|1
4455673|NCT00545363|7242951|FG000|Overall Study|Adverse Event|6
4455674|NCT00545363|7242952|FG001|Overall Study|Adverse Event|7
4455675|NCT00545363|7242951|FG000|Overall Study|Withdrawal by Subject|6
4455676|NCT00545363|7242952|FG001|Overall Study|Withdrawal by Subject|5
4455677|NCT00545363|7242951|FG000|Overall Study|Non-compliance|3
4455678|NCT00545363|7242952|FG001|Overall Study|Non-compliance|1
4455679|NCT00545363|7242951|FG000|Overall Study|Did not meet entry criteria|1
4455680|NCT00545363|7242952|FG001|Overall Study|Did not meet entry criteria|1
4455681|NCT00545363|7242951|FG000|Overall Study|Lost to Follow-up|2
4455682|NCT00545363|7242952|FG001|Overall Study|Lost to Follow-up|0
4538261|NCT01118143|7359762|FG000|Overall Study|Withdrawal by Subject|2
4538262|NCT01118143|7359763|FG001|Overall Study|Withdrawal by Subject|5
4538263|NCT01118299|7359811|FG000|Overall Study|Death|7
4538264|NCT01118299|7359812|FG001|Overall Study|Death|5
4538265|NCT01118299|7359811|FG000|Overall Study|Withdrawal by Subject|8
4538266|NCT01118299|7359812|FG001|Overall Study|Withdrawal by Subject|8
4538267|NCT01118299|7359811|FG000|Overall Study|Lost to Follow-up|2
4538268|NCT01118299|7359812|FG001|Overall Study|Lost to Follow-up|1
4538269|NCT01118299|7359811|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6
4538270|NCT01118299|7359812|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15
4538271|NCT01118312|7359819|FG000|Overall Study|Lost to Follow-up|33
4538272|NCT01118312|7359820|FG001|Overall Study|Lost to Follow-up|32
4538273|NCT01118312|7359819|FG000|Overall Study|Withdrawal by Subject|1
4538274|NCT01118312|7359820|FG001|Overall Study|Withdrawal by Subject|3
4538275|NCT01118325|7359829|FG000|Overall Study|Adverse Event|1
4538276|NCT01118325|7359830|FG001|Overall Study|Adverse Event|0
4538277|NCT01118325|7359831|FG002|Overall Study|Adverse Event|1
4538278|NCT01118351|7359861|FG000|Overall Study|Adverse Event|3
4538279|NCT01118351|7359861|FG000|Overall Study|Withdrawal by Subject|1
4538280|NCT01118377|7359865|FG000|Overall Study|Did Not Receive Study Medication|1
4538281|NCT01118377|7359865|FG000|Overall Study|Death|38
4538282|NCT01118377|7359865|FG000|Overall Study|Failure to Return|3
4538283|NCT01118455|7359871|FG000|Baseline [Visits 1 & 2]|Adverse Event|1
4538284|NCT01118455|7359872|FG001|Baseline [Visits 1 & 2]|Adverse Event|0
4538285|NCT01118520|7359889|FG000|Overall Study|AAA repair|9
4538286|NCT01118520|7359890|FG001|Overall Study|AAA repair|7
4538287|NCT01118520|7359891|FG002|Overall Study|AAA repair|9
4538288|NCT01118520|7359889|FG000|Overall Study|Adverse Event|3
4538289|NCT01118520|7359890|FG001|Overall Study|Adverse Event|3
4538290|NCT01118520|7359891|FG002|Overall Study|Adverse Event|3
4538291|NCT01118520|7359889|FG000|Overall Study|Withdrawal by Subject|8
4538292|NCT01118520|7359890|FG001|Overall Study|Withdrawal by Subject|13
4538293|NCT01118520|7359891|FG002|Overall Study|Withdrawal by Subject|8
4538294|NCT01118663|7359905|FG000|Overall Study|Adverse Event|2
4538295|NCT01118663|7359906|FG001|Overall Study|Adverse Event|1
4538296|NCT01118663|7359905|FG000|Overall Study|Withdrawal by Subject|0
4538297|NCT01118663|7359906|FG001|Overall Study|Withdrawal by Subject|1
4538298|NCT01118728|7359942|FG000|Overall Study|Adverse Event|17
4538299|NCT01118728|7359942|FG000|Overall Study|Lack of Efficacy|27
4538300|NCT01118728|7359942|FG000|Overall Study|Sponsor's decision to discontinue study|172
4538301|NCT01118728|7359942|FG000|Overall Study|Withdrawal by Subject|3
4538302|NCT01118728|7359942|FG000|Overall Study|Lost to Follow-up|4
4455683|NCT00545363|7242951|FG000|Overall Study|Other|1
4538303|NCT01118780|7359959|FG000|Overall Study|Adverse Event|15
4538304|NCT01118780|7359960|FG001|Overall Study|Adverse Event|15
4538305|NCT01118780|7359959|FG000|Overall Study|Death|1
4538306|NCT01118780|7359960|FG001|Overall Study|Death|0
4538307|NCT01118780|7359959|FG000|Overall Study|Lack of Efficacy|2
4538308|NCT01118780|7359960|FG001|Overall Study|Lack of Efficacy|6
4538309|NCT01118780|7359959|FG000|Overall Study|Physician Decision|2
4455684|NCT00545363|7242952|FG001|Overall Study|Other|1
4455685|NCT00545402|7242960|FG000|Overall Study|Discontinuation of treatment|17
4455686|NCT00545402|7242961|FG001|Overall Study|Discontinuation of treatment|9
4538310|NCT01118780|7359960|FG001|Overall Study|Physician Decision|0
4538311|NCT01118780|7359959|FG000|Overall Study|Protocol Violation|3
4455687|NCT00545402|7242960|FG000|Overall Study|Use of unauthorized immunosuppressant|8
4455688|NCT00545402|7242961|FG001|Overall Study|Use of unauthorized immunosuppressant|7
4610959|NCT01696396|7467185|FG003|Overall Study|Decision by Sponsor|2
4610960|NCT01696396|7467182|FG000|Overall Study|Lost to Follow-up|9
4610961|NCT01696396|7467183|FG001|Overall Study|Lost to Follow-up|1
4610962|NCT01696396|7467184|FG002|Overall Study|Lost to Follow-up|4
4610963|NCT01696396|7467185|FG003|Overall Study|Lost to Follow-up|1
4610964|NCT01696396|7467182|FG000|Overall Study|Death|0
4610965|NCT01696396|7467183|FG001|Overall Study|Death|0
4610966|NCT01696396|7467184|FG002|Overall Study|Death|1
4610967|NCT01696396|7467185|FG003|Overall Study|Death|0
4610968|NCT01696643|7467201|FG000|Overall Study|Adverse Event|15
4610969|NCT01696643|7467202|FG001|Overall Study|Adverse Event|7
4610970|NCT01696643|7467201|FG000|Overall Study|Death|1
4610971|NCT01696643|7467202|FG001|Overall Study|Death|2
4610972|NCT01696643|7467201|FG000|Overall Study|Lack of Efficacy|3
4610973|NCT01696643|7467202|FG001|Overall Study|Lack of Efficacy|0
4610974|NCT01696643|7467201|FG000|Overall Study|Lost to Follow-up|67
4610975|NCT01696643|7467202|FG001|Overall Study|Lost to Follow-up|67
4610976|NCT01696643|7467201|FG000|Overall Study|Physician Decision|3
4610977|NCT01696643|7467202|FG001|Overall Study|Physician Decision|2
4610978|NCT01696643|7467201|FG000|Overall Study|Pregnancy|0
4610979|NCT01696643|7467202|FG001|Overall Study|Pregnancy|1
4610980|NCT01696643|7467201|FG000|Overall Study|Protocol Violation|7
4610981|NCT01696643|7467202|FG001|Overall Study|Protocol Violation|7
4610982|NCT01696643|7467201|FG000|Overall Study|Study Terminated by Sponsor|286
4538312|NCT01118780|7359960|FG001|Overall Study|Protocol Violation|6
4538313|NCT01118780|7359959|FG000|Overall Study|Withdrawal by Subject|13
4538314|NCT01118780|7359960|FG001|Overall Study|Withdrawal by Subject|8
4538315|NCT01118949|7359973|FG000|Overall Study|Adverse Event|5
4538316|NCT01118949|7359973|FG000|Overall Study|Withdrawal by Subject|4
4538317|NCT01118962|7359977|FG000|Overall Study|Adverse Event|2
4538318|NCT01118962|7359977|FG000|Overall Study|Lack of Efficacy|1
4455689|NCT00545402|7242960|FG000|Overall Study|Death|5
4455690|NCT00545402|7242961|FG001|Overall Study|Death|7
4455691|NCT00545402|7242960|FG000|Overall Study|Graft loss|2
4455692|NCT00545402|7242961|FG001|Overall Study|Graft loss|4
4455693|NCT00545402|7242960|FG000|Overall Study|Withdrawal by Subject|0
4455694|NCT00545402|7242961|FG001|Overall Study|Withdrawal by Subject|1
4455695|NCT00545402|7242960|FG000|Overall Study|Protocol Violation|1
4455696|NCT00545402|7242961|FG001|Overall Study|Protocol Violation|0
4455697|NCT00545402|7242960|FG000|Overall Study|Reason not specified|1
4455698|NCT00545402|7242961|FG001|Overall Study|Reason not specified|1
4455699|NCT00545441|7242969|FG000|Overall Study|Fistula draining at 6 months|2
4455700|NCT00545441|7242970|FG001|Overall Study|Fistula draining at 6 months|4
4455701|NCT00545441|7242969|FG000|Overall Study|Lost to Follow-up|9
4455702|NCT00545441|7242970|FG001|Overall Study|Lost to Follow-up|5
4455703|NCT00545441|7242969|FG000|Overall Study|Technical failure|0
4455704|NCT00545441|7242970|FG001|Overall Study|Technical failure|1
4455705|NCT00545441|7242969|FG000|Overall Study|Withdrawal by Subject|1
4455706|NCT00545441|7242970|FG001|Overall Study|Withdrawal by Subject|1
4455707|NCT00545441|7242969|FG000|Overall Study|Persistence or recurrence of fistula|5
4455708|NCT00545441|7242970|FG001|Overall Study|Persistence or recurrence of fistula|2
4455709|NCT00545441|7242969|FG000|Overall Study|Patients were not treated|1
4455710|NCT00545441|7242970|FG001|Overall Study|Patients were not treated|3
4455711|NCT00545532|7242978|FG000|Overall Study|Withdrawal by Subject|1
4455712|NCT00545532|7242979|FG001|Overall Study|Withdrawal by Subject|3
4455713|NCT00545532|7242978|FG000|Overall Study|Lost to Follow-up|5
4455714|NCT00545532|7242979|FG001|Overall Study|Lost to Follow-up|6
4455715|NCT00545532|7242978|FG000|Overall Study|Death|0
4455716|NCT00545532|7242979|FG001|Overall Study|Death|1
4455717|NCT00545571|7242987|FG000|Overall Study|Administrative Reasons|1
4455718|NCT00545571|7242987|FG000|Overall Study|Adverse Event|2
4455719|NCT00545571|7242987|FG000|Overall Study|Death|5
4538319|NCT01118962|7359977|FG000|Overall Study|Protocol Violation|1
4538320|NCT01118962|7359977|FG000|Overall Study|Withdrawal by Subject|4
4610983|NCT01696643|7467202|FG001|Overall Study|Study Terminated by Sponsor|294
4610984|NCT01696643|7467201|FG000|Overall Study|Withdrawal by Subject|142
4610985|NCT01696643|7467202|FG001|Overall Study|Withdrawal by Subject|149
4455720|NCT00545571|7242987|FG000|Overall Study|Lack of Efficacy|1
4455721|NCT00545571|7242987|FG000|Overall Study|Protocol Violation|2
4455722|NCT00545571|7242987|FG000|Overall Study|Refused Treatment|1
4538321|NCT01118962|7359977|FG000|Overall Study|Pregnancy|1
4538322|NCT01118962|7359977|FG000|Overall Study|Non-compliance with Medicinal Product|1
4538323|NCT01118975|7359983|FG000|Overall Study|Adverse Event|0
4538324|NCT01118975|7359984|FG001|Overall Study|Adverse Event|1
4610986|NCT01696643|7467201|FG000|Overall Study|Participant on Restricted Bed Rest|1
4610987|NCT01696643|7467202|FG001|Overall Study|Participant on Restricted Bed Rest|0
4610988|NCT01696643|7467201|FG000|Overall Study|Site Error|2
4610989|NCT01696643|7467202|FG001|Overall Study|Site Error|1
4455723|NCT00545571|7242987|FG000|Overall Study|Screen Failure|16
4455724|NCT00545571|7242987|FG000|Overall Study|Transfusion|12
4455725|NCT00545571|7242987|FG000|Overall Study|Early Termination of Study|24
4455726|NCT00545571|7242987|FG000|Overall Study|Kidney Transplantation|3
4515881|NCT00956813|7326986|FG001|Flaxseed and Placebo|Ineligible|1
4515882|NCT00956839|7326996|FG000|Overall Study|Lost to Follow-up|3
4455727|NCT00545584|7242994|FG000|Overall Study|Only one reason for discontinuation|62
4455728|NCT00545584|7242995|FG001|Overall Study|Only one reason for discontinuation|61
4455729|NCT00545584|7242996|FG002|Overall Study|Only one reason for discontinuation|48
4455730|NCT00545584|7242994|FG000|Overall Study|Two or more reasons for discontinuation|17
4455731|NCT00545584|7242995|FG001|Overall Study|Two or more reasons for discontinuation|19
4455732|NCT00545584|7242996|FG002|Overall Study|Two or more reasons for discontinuation|8
4455733|NCT00545688|7243034|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1
4455734|NCT00545688|7243035|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2
4455735|NCT00545688|7243036|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1
4455736|NCT00545688|7243037|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1
4455737|NCT00545688|7243034|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1
4455738|NCT00545688|7243035|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1
4455739|NCT00545688|7243036|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4
4455740|NCT00545688|7243037|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1
4455741|NCT00545688|7243034|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1
4455742|NCT00545688|7243035|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
4455743|NCT00545688|7243036|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
4455744|NCT00545688|7243037|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
4455745|NCT00545688|7243034|FG000|Neo-Adjuvant Treatment Period|Death|0
4455746|NCT00545688|7243035|FG001|Neo-Adjuvant Treatment Period|Death|1
4455747|NCT00545688|7243036|FG002|Neo-Adjuvant Treatment Period|Death|0
4455748|NCT00545688|7243037|FG003|Neo-Adjuvant Treatment Period|Death|0
4455749|NCT00545688|7243034|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0
4455750|NCT00545688|7243035|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1
4455751|NCT00545688|7243036|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7
4455752|NCT00545688|7243037|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2
4455753|NCT00545688|7243034|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1
4455754|NCT00545688|7243035|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0
4455755|NCT00545688|7243036|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0
4455756|NCT00545688|7243037|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0
4455757|NCT00545688|7243034|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0
4455758|NCT00545688|7243035|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0
4455759|NCT00545688|7243036|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2
4455760|NCT00545688|7243037|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2
4455761|NCT00545688|7243034|FG000|Adjuvant Treatment Period|Disease Progression|3
4455762|NCT00545688|7243035|FG001|Adjuvant Treatment Period|Disease Progression|3
4455763|NCT00545688|7243036|FG002|Adjuvant Treatment Period|Disease Progression|0
4455764|NCT00545688|7243037|FG003|Adjuvant Treatment Period|Disease Progression|7
4455765|NCT00545688|7243034|FG000|Adjuvant Treatment Period|Refused Treatment|1
4455766|NCT00545688|7243035|FG001|Adjuvant Treatment Period|Refused Treatment|1
4455767|NCT00545688|7243036|FG002|Adjuvant Treatment Period|Refused Treatment|1
4455768|NCT00545688|7243037|FG003|Adjuvant Treatment Period|Refused Treatment|5
4455769|NCT00545688|7243034|FG000|Adjuvant Treatment Period|Lost to Follow-up|1
4455770|NCT00545688|7243035|FG001|Adjuvant Treatment Period|Lost to Follow-up|0
4455771|NCT00545688|7243036|FG002|Adjuvant Treatment Period|Lost to Follow-up|1
4455772|NCT00545688|7243037|FG003|Adjuvant Treatment Period|Lost to Follow-up|0
4455773|NCT00545688|7243034|FG000|Adjuvant Treatment Period|Adverse Event|0
4455774|NCT00545688|7243035|FG001|Adjuvant Treatment Period|Adverse Event|3
4455775|NCT00545688|7243036|FG002|Adjuvant Treatment Period|Adverse Event|2
4455776|NCT00545688|7243037|FG003|Adjuvant Treatment Period|Adverse Event|2
4455777|NCT00545688|7243034|FG000|Adjuvant Treatment Period|Unknown Reason|0
4455778|NCT00545688|7243035|FG001|Adjuvant Treatment Period|Unknown Reason|1
4455779|NCT00545688|7243036|FG002|Adjuvant Treatment Period|Unknown Reason|0
4455780|NCT00545688|7243037|FG003|Adjuvant Treatment Period|Unknown Reason|0
4455781|NCT00545688|7243034|FG000|Follow-Up Period|Death|4
4455782|NCT00545688|7243035|FG001|Follow-Up Period|Death|2
4455783|NCT00545688|7243036|FG002|Follow-Up Period|Death|2
4455784|NCT00545688|7243037|FG003|Follow-Up Period|Death|6
4455785|NCT00545688|7243034|FG000|Follow-Up Period|Disease Progression|6
4455786|NCT00545688|7243035|FG001|Follow-Up Period|Disease Progression|5
4455787|NCT00545688|7243036|FG002|Follow-Up Period|Disease Progression|9
4455788|NCT00545688|7243037|FG003|Follow-Up Period|Disease Progression|9
4455789|NCT00545688|7243034|FG000|Follow-Up Period|Refused Treatment|6
4455790|NCT00545688|7243035|FG001|Follow-Up Period|Refused Treatment|2
4455791|NCT00545688|7243036|FG002|Follow-Up Period|Refused Treatment|0
4455792|NCT00545688|7243037|FG003|Follow-Up Period|Refused Treatment|2
4455793|NCT00545688|7243034|FG000|Follow-Up Period|Lost to Follow-up|3
4455794|NCT00545688|7243035|FG001|Follow-Up Period|Lost to Follow-up|3
4455795|NCT00545688|7243036|FG002|Follow-Up Period|Lost to Follow-up|3
4455796|NCT00545688|7243037|FG003|Follow-Up Period|Lost to Follow-up|1
4455797|NCT00545688|7243034|FG000|Follow-Up Period|Unspecified Reason|2
4455798|NCT00545688|7243035|FG001|Follow-Up Period|Unspecified Reason|5
4455799|NCT00545688|7243036|FG002|Follow-Up Period|Unspecified Reason|6
4455800|NCT00545688|7243037|FG003|Follow-Up Period|Unspecified Reason|8
4455801|NCT00545688|7243034|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0
4455802|NCT00545688|7243035|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2
4515883|NCT00956839|7326997|FG001|Overall Study|Lost to Follow-up|0
4538325|NCT01119001|7360002|FG000|Overall Study|Withdrawal by Subject|2
4455803|NCT00545688|7243036|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0
4455804|NCT00545688|7243037|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1
4455805|NCT00545714|7243050|FG000|Induction Phase (6 Months)|Physician Decision|3
4455806|NCT00545714|7243050|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6
4455807|NCT00545714|7243050|FG000|Induction Phase (6 Months)|Disease Progression|1
4455808|NCT00545714|7243050|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2
4455809|NCT00545714|7243050|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16
4455810|NCT00545714|7243050|FG000|Maintenance Phase (36 Months)|Disease Progression|9
4455811|NCT00545714|7243050|FG000|Maintenance Phase (36 Months)|Physician Decision|1
4455812|NCT00545714|7243050|FG000|Maintenance Phase (36 Months)|Protocol Violation|1
4455813|NCT00545714|7243050|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3
4455814|NCT00545714|7243050|FG000|Maintenance Phase (36 Months)|Death|2
4455815|NCT00545740|7243058|FG000|Overall Study|Lack of Efficacy|34
4455816|NCT00545740|7243059|FG001|Overall Study|Lack of Efficacy|35
4455817|NCT00545740|7243060|FG002|Overall Study|Lack of Efficacy|47
4455818|NCT00545740|7243061|FG003|Overall Study|Lack of Efficacy|36
4455819|NCT00545740|7243058|FG000|Overall Study|Withdrawal by Subject|17
4455820|NCT00545740|7243059|FG001|Overall Study|Withdrawal by Subject|15
4455821|NCT00545740|7243060|FG002|Overall Study|Withdrawal by Subject|16
4455822|NCT00545740|7243061|FG003|Overall Study|Withdrawal by Subject|18
4455823|NCT00545740|7243058|FG000|Overall Study|Adverse Event|10
4455824|NCT00545740|7243059|FG001|Overall Study|Adverse Event|18
4455825|NCT00545740|7243060|FG002|Overall Study|Adverse Event|19
4455826|NCT00545740|7243061|FG003|Overall Study|Adverse Event|9
4455827|NCT00545740|7243058|FG000|Overall Study|Lost to Follow-up|7
4455828|NCT00545740|7243059|FG001|Overall Study|Lost to Follow-up|5
4455829|NCT00545740|7243060|FG002|Overall Study|Lost to Follow-up|5
4455830|NCT00545740|7243061|FG003|Overall Study|Lost to Follow-up|6
4455831|NCT00545740|7243058|FG000|Overall Study|Protocol Violation|1
4455832|NCT00545740|7243059|FG001|Overall Study|Protocol Violation|3
4455833|NCT00545740|7243060|FG002|Overall Study|Protocol Violation|1
4455834|NCT00545740|7243061|FG003|Overall Study|Protocol Violation|0
4455835|NCT00545740|7243058|FG000|Overall Study|Non-compliance|0
4455836|NCT00545740|7243059|FG001|Overall Study|Non-compliance|2
4455837|NCT00545740|7243060|FG002|Overall Study|Non-compliance|1
4455838|NCT00545740|7243061|FG003|Overall Study|Non-compliance|0
4538326|NCT01119105|7360015|FG000|Overall Study|Withdrawal by Subject|1
4538327|NCT01119105|7360016|FG001|Overall Study|Withdrawal by Subject|1
4538328|NCT01119105|7360017|FG002|Overall Study|Withdrawal by Subject|1
4538329|NCT01119105|7360015|FG000|Overall Study|Lost to Follow-up|0
4538330|NCT01119105|7360016|FG001|Overall Study|Lost to Follow-up|2
4538331|NCT01119105|7360017|FG002|Overall Study|Lost to Follow-up|5
4538332|NCT01119105|7360015|FG000|Overall Study|Adverse Event|1
4538333|NCT01119105|7360016|FG001|Overall Study|Adverse Event|0
4538334|NCT01119105|7360017|FG002|Overall Study|Adverse Event|1
4538335|NCT01119105|7360015|FG000|Overall Study|study drug missed on 2 consecutive days|1
4538336|NCT01119105|7360016|FG001|Overall Study|study drug missed on 2 consecutive days|2
4610990|NCT01696643|7467201|FG000|Overall Study|Participant Incarcerated|0
4610991|NCT01696643|7467202|FG001|Overall Study|Participant Incarcerated|1
4610992|NCT01696643|7467201|FG000|Overall Study|Medical Monitor Decision|0
4610993|NCT01696643|7467202|FG001|Overall Study|Medical Monitor Decision|2
4610994|NCT01696643|7467201|FG000|Overall Study|Participant Did Not Receive Study Drug|2
4610995|NCT01696643|7467202|FG001|Overall Study|Participant Did Not Receive Study Drug|2
4610996|NCT01696695|7467208|FG000|Overall Study|Disease progression|373
4610997|NCT01696695|7467208|FG000|Overall Study|Death|29
4610998|NCT01696695|7467208|FG000|Overall Study|Adverse Event|74
4455839|NCT00545740|7243058|FG000|Overall Study|Moved|2
4455840|NCT00545740|7243059|FG001|Overall Study|Moved|0
4455841|NCT00545740|7243060|FG002|Overall Study|Moved|1
4455842|NCT00545740|7243061|FG003|Overall Study|Moved|0
4455843|NCT00545740|7243058|FG000|Overall Study|Diverticulitis attack|0
4455844|NCT00545740|7243059|FG001|Overall Study|Diverticulitis attack|0
4455845|NCT00545740|7243060|FG002|Overall Study|Diverticulitis attack|1
4455846|NCT00545740|7243061|FG003|Overall Study|Diverticulitis attack|1
4455847|NCT00545740|7243058|FG000|Overall Study|Suspected Diverticulitis Recurrence|1
4455848|NCT00545740|7243059|FG001|Overall Study|Suspected Diverticulitis Recurrence|1
4455849|NCT00545740|7243060|FG002|Overall Study|Suspected Diverticulitis Recurrence|1
4455850|NCT00545740|7243061|FG003|Overall Study|Suspected Diverticulitis Recurrence|1
4455851|NCT00545740|7243058|FG000|Overall Study|Site closure|1
4455852|NCT00545740|7243059|FG001|Overall Study|Site closure|0
4455853|NCT00545740|7243060|FG002|Overall Study|Site closure|0
4455854|NCT00545740|7243061|FG003|Overall Study|Site closure|0
4610999|NCT01696695|7467208|FG000|Overall Study|Withdrawal by Subject|92
4611000|NCT01696695|7467208|FG000|Overall Study|Lost to Follow-up|48
4455855|NCT00545740|7243058|FG000|Overall Study|Missed visit|1
4455856|NCT00545740|7243059|FG001|Overall Study|Missed visit|0
4455857|NCT00545740|7243060|FG002|Overall Study|Missed visit|0
4455858|NCT00545740|7243061|FG003|Overall Study|Missed visit|0
4455859|NCT00545740|7243058|FG000|Overall Study|Physician Decision|0
4455860|NCT00545740|7243059|FG001|Overall Study|Physician Decision|0
4455861|NCT00545740|7243060|FG002|Overall Study|Physician Decision|3
4455862|NCT00545740|7243061|FG003|Overall Study|Physician Decision|0
4538337|NCT01119105|7360017|FG002|Overall Study|study drug missed on 2 consecutive days|1
4538338|NCT01119105|7360015|FG000|Overall Study|Other|1
4455863|NCT00545740|7243058|FG000|Overall Study|Accepted only monthly telephone calls|1
4455864|NCT00545740|7243059|FG001|Overall Study|Accepted only monthly telephone calls|0
4455865|NCT00545740|7243060|FG002|Overall Study|Accepted only monthly telephone calls|0
4455866|NCT00545740|7243061|FG003|Overall Study|Accepted only monthly telephone calls|0
4455867|NCT00545740|7243058|FG000|Overall Study|Sponsor decision|0
4455868|NCT00545740|7243059|FG001|Overall Study|Sponsor decision|1
4455869|NCT00545740|7243060|FG002|Overall Study|Sponsor decision|0
4455870|NCT00545740|7243061|FG003|Overall Study|Sponsor decision|0
4455871|NCT00545740|7243058|FG000|Overall Study|Lack of time|0
4455872|NCT00545740|7243059|FG001|Overall Study|Lack of time|1
4455873|NCT00545740|7243060|FG002|Overall Study|Lack of time|0
4455874|NCT00545740|7243061|FG003|Overall Study|Lack of time|0
4455875|NCT00545740|7243058|FG000|Overall Study|Non-adherence to visits|0
4455876|NCT00545740|7243059|FG001|Overall Study|Non-adherence to visits|1
4455877|NCT00545740|7243060|FG002|Overall Study|Non-adherence to visits|0
4455878|NCT00545740|7243061|FG003|Overall Study|Non-adherence to visits|0
4455879|NCT00545740|7243058|FG000|Overall Study|Patient difficulties|0
4455880|NCT00545740|7243059|FG001|Overall Study|Patient difficulties|1
4455881|NCT00545740|7243060|FG002|Overall Study|Patient difficulties|0
4455882|NCT00545740|7243061|FG003|Overall Study|Patient difficulties|0
4455883|NCT00545740|7243058|FG000|Overall Study|Husband against study|0
4455884|NCT00545740|7243059|FG001|Overall Study|Husband against study|0
4455885|NCT00545740|7243060|FG002|Overall Study|Husband against study|1
4455886|NCT00545740|7243061|FG003|Overall Study|Husband against study|0
4455887|NCT00545753|7243074|FG000|Overall Study|Withdrawal by Subject|0
4455888|NCT00545753|7243075|FG001|Overall Study|Withdrawal by Subject|1
4455889|NCT00545753|7243076|FG002|Overall Study|Withdrawal by Subject|10
4455890|NCT00545753|7243074|FG000|Overall Study|Lost to Follow-up|13
4455891|NCT00545753|7243075|FG001|Overall Study|Lost to Follow-up|3
4455892|NCT00545753|7243076|FG002|Overall Study|Lost to Follow-up|12
4455893|NCT00545753|7243074|FG000|Overall Study|Protocol Violation|3
4455894|NCT00545753|7243075|FG001|Overall Study|Protocol Violation|1
4455895|NCT00545753|7243076|FG002|Overall Study|Protocol Violation|4
4455896|NCT00545779|7243085|FG000|Overall Study|Violation of selection criteria at entry|8
4455897|NCT00545779|7243085|FG000|Overall Study|Other protocol violation|1
4455898|NCT00545779|7243085|FG000|Overall Study|Did not cooperate|7
4455899|NCT00545779|7243085|FG000|Overall Study|Withdrawal by Subject|20
4455900|NCT00545779|7243085|FG000|Overall Study|Adverse Event/intercurrent illness|5
4455901|NCT00545779|7243085|FG000|Overall Study|Failure to return|3
4455902|NCT00545792|7243089|FG000|Overall Study|Withdrawal by Subject|1
4455903|NCT00545818|7243095|FG000|Overall Study|Protocol Violation|1
4455904|NCT00545818|7243096|FG001|Overall Study|Protocol Violation|0
4455905|NCT00545818|7243095|FG000|Overall Study|Adverse Event|1
4455906|NCT00545818|7243096|FG001|Overall Study|Adverse Event|1
4455907|NCT00545818|7243095|FG000|Overall Study|Lost to Follow-up|1
4455908|NCT00545818|7243096|FG001|Overall Study|Lost to Follow-up|6
4455909|NCT00545948|7243105|FG000|Overall Study|Not Treated|1
4455910|NCT00545948|7243106|FG001|Overall Study|Not Treated|1
4455911|NCT00545948|7243107|FG002|Overall Study|Not Treated|7
4455912|NCT00546000|7243125|FG000|Overall Study|Adverse Event|1
4455913|NCT00546000|7243125|FG000|Overall Study|Lost to Follow-up|1
4455914|NCT00546000|7243125|FG000|Overall Study|Baseline HPA Axis Supression|2
4455915|NCT00546078|7243131|FG000|Overall Study|Lost to Follow-up|1
4455916|NCT00546078|7243132|FG001|Overall Study|Lost to Follow-up|3
4455917|NCT00546078|7243131|FG000|Overall Study|Withdrawal by Subject|2
4455918|NCT00546078|7243132|FG001|Overall Study|Withdrawal by Subject|3
4455919|NCT00546078|7243131|FG000|Overall Study|Other reason|1
4455920|NCT00546078|7243132|FG001|Overall Study|Other reason|1
4455921|NCT00546117|7243144|FG000|Overall Study|Withdrawal by Subject|3
4455922|NCT00546117|7243145|FG001|Overall Study|Withdrawal by Subject|0
4455923|NCT00546117|7243144|FG000|Overall Study|Inability to schedule follow-up visit|1
4455924|NCT00546117|7243145|FG001|Overall Study|Inability to schedule follow-up visit|0
4455925|NCT00546260|7243163|FG000|Overall Study|Drug not given pre diagnostic angiogr|8
4455926|NCT00546260|7243164|FG001|Overall Study|Drug not given pre diagnostic angiogr|2
4455927|NCT00546351|7243170|FG000|Overall Study|Adverse Event|76
4455928|NCT00546351|7243170|FG000|Overall Study|Lack of Efficacy|15
4455929|NCT00546351|7243170|FG000|Overall Study|Withdrawal by Subject|109
4455930|NCT00546351|7243170|FG000|Overall Study|Lost to Follow-up|9
4455931|NCT00546351|7243170|FG000|Overall Study|Protocol Deviation|1
4455932|NCT00546351|7243170|FG000|Overall Study|Unsatisfactory compliance|9
4455933|NCT00546351|7243170|FG000|Overall Study|Other reasons for premature termination|17
4455934|NCT00546364|7243177|FG000|Overall Study|Disease progression|5
4455935|NCT00546364|7243178|FG001|Overall Study|Disease progression|11
4455936|NCT00546364|7243179|FG002|Overall Study|Disease progression|8
4455937|NCT00546364|7243177|FG000|Overall Study|Completed and off treatment|1
4455938|NCT00546364|7243178|FG001|Overall Study|Completed and off treatment|0
4455939|NCT00546364|7243179|FG002|Overall Study|Completed and off treatment|2
4455940|NCT00546364|7243177|FG000|Overall Study|Administrative reason by sponsor|1
4455941|NCT00546364|7243178|FG001|Overall Study|Administrative reason by sponsor|0
4455942|NCT00546364|7243179|FG002|Overall Study|Administrative reason by sponsor|0
4455943|NCT00546364|7243177|FG000|Overall Study|Poor compliance/noncompliance|0
4455944|NCT00546364|7243178|FG001|Overall Study|Poor compliance/noncompliance|0
4455945|NCT00546364|7243179|FG002|Overall Study|Poor compliance/noncompliance|1
4455946|NCT00546364|7243177|FG000|Overall Study|No longer meets study criteria|1
4455947|NCT00546364|7243178|FG001|Overall Study|No longer meets study criteria|1
4455948|NCT00546364|7243179|FG002|Overall Study|No longer meets study criteria|0
4455949|NCT00546364|7243177|FG000|Overall Study|Withdrawal by Subject|5
4455950|NCT00546364|7243178|FG001|Overall Study|Withdrawal by Subject|6
4455951|NCT00546364|7243179|FG002|Overall Study|Withdrawal by Subject|3
4455952|NCT00546364|7243177|FG000|Overall Study|Prior taxotere|1
4455953|NCT00546364|7243178|FG001|Overall Study|Prior taxotere|0
4455954|NCT00546364|7243179|FG002|Overall Study|Prior taxotere|0
4455955|NCT00546364|7243177|FG000|Overall Study|Mixed response|1
4455956|NCT00546364|7243178|FG001|Overall Study|Mixed response|0
4455957|NCT00546364|7243179|FG002|Overall Study|Mixed response|0
4455958|NCT00546364|7243177|FG000|Overall Study|Palliative treatment|1
4455959|NCT00546364|7243178|FG001|Overall Study|Palliative treatment|0
4455960|NCT00546364|7243179|FG002|Overall Study|Palliative treatment|1
4455961|NCT00546364|7243177|FG000|Overall Study|Target lesions resected|1
4455962|NCT00546364|7243178|FG001|Overall Study|Target lesions resected|0
4455963|NCT00546364|7243179|FG002|Overall Study|Target lesions resected|0
4455964|NCT00546364|7243177|FG000|Overall Study|Physician Decision|0
4455965|NCT00546364|7243178|FG001|Overall Study|Physician Decision|0
4455966|NCT00546364|7243179|FG002|Overall Study|Physician Decision|1
4455967|NCT00546364|7243177|FG000|Overall Study|Sponsor decision|0
4455968|NCT00546364|7243178|FG001|Overall Study|Sponsor decision|0
4455969|NCT00546364|7243179|FG002|Overall Study|Sponsor decision|1
4455970|NCT00546377|7243187|FG000|Overall Study|Deemed ineligible|1
4455971|NCT00546377|7243187|FG000|Overall Study|Adverse Event|6
4455972|NCT00546481|7243207|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1
4455973|NCT00546481|7243208|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0
4455974|NCT00546481|7243209|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0
4455975|NCT00546481|7243207|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1
4455976|NCT00546481|7243208|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3
4455977|NCT00546481|7243209|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0
4455978|NCT00546481|7243207|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1
4455979|NCT00546481|7243208|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0
4455980|NCT00546481|7243209|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0
4455981|NCT00546481|7243207|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2
4455982|NCT00546481|7243208|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0
4455983|NCT00546481|7243209|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0
4455984|NCT00546481|7243207|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1
4455985|NCT00546481|7243208|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1
4455986|NCT00546481|7243209|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0
4455987|NCT00546481|7243207|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0
4455988|NCT00546481|7243208|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1
4455989|NCT00546481|7243209|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0
4455990|NCT00546481|7243207|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0
4455991|NCT00546481|7243208|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0
4455992|NCT00546481|7243209|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2
4455993|NCT00546481|7243207|FG000|Maintenance Phase (CERA)|Kidney transplantation|0
4455994|NCT00546481|7243208|FG001|Maintenance Phase (CERA)|Kidney transplantation|0
4455995|NCT00546481|7243209|FG002|Maintenance Phase (CERA)|Kidney transplantation|1
4455996|NCT00546481|7243207|FG000|Maintenance Phase (CERA)|Other Reason|0
4455997|NCT00546481|7243208|FG001|Maintenance Phase (CERA)|Other Reason|0
4455998|NCT00546481|7243209|FG002|Maintenance Phase (CERA)|Other Reason|1
4455999|NCT00546572|7243219|FG000|Vax 1 / Year 0|Randomized, not treated|1
4456000|NCT00546572|7243220|FG001|Vax 1 / Year 0|Randomized, not treated|1
4456001|NCT00546572|7243219|FG000|Vax 1 / Year 0|Withdrawal by Subject|3
4456002|NCT00546572|7243220|FG001|Vax 1 / Year 0|Withdrawal by Subject|2
4456003|NCT00546572|7243219|FG000|Vax 1 / Year 0|Protocol Violation|3
4456004|NCT00546572|7243220|FG001|Vax 1 / Year 0|Protocol Violation|4
4456005|NCT00546572|7243219|FG000|Vax 1 / Year 0|Death|2
4456006|NCT00546572|7243220|FG001|Vax 1 / Year 0|Death|2
4456007|NCT00546572|7243219|FG000|Vax 1 / Year 0|Adverse Event|0
4456008|NCT00546572|7243220|FG001|Vax 1 / Year 0|Adverse Event|1
4456009|NCT00546572|7243219|FG000|Vax 1 / Year 0|Lost to Follow-up|0
4456010|NCT00546572|7243220|FG001|Vax 1 / Year 0|Lost to Follow-up|1
4456011|NCT00546572|7243219|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64
4456012|NCT00546572|7243220|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59
4456013|NCT00546572|7243219|FG000|Vax 2 / Year 1|Other|1
4456014|NCT00546572|7243220|FG001|Vax 2 / Year 1|Other|1
4456015|NCT00546572|7243219|FG000|Vax 2 / Year 1|Adverse Event|1
4456016|NCT00546572|7243220|FG001|Vax 2 / Year 1|Adverse Event|0
4456017|NCT00546572|7243219|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2
4456018|NCT00546572|7243220|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1
4456019|NCT00546637|7243239|FG000|Overall Study|Adverse Event|46
4538339|NCT01119105|7360016|FG001|Overall Study|Other|1
4456020|NCT00546637|7243240|FG001|Overall Study|Adverse Event|20
4456021|NCT00546637|7243239|FG000|Overall Study|Lack of Efficacy|5
4456022|NCT00546637|7243240|FG001|Overall Study|Lack of Efficacy|5
4456023|NCT00546637|7243239|FG000|Overall Study|Lost to Follow-up|2
4456024|NCT00546637|7243240|FG001|Overall Study|Lost to Follow-up|2
4456025|NCT00546637|7243239|FG000|Overall Study|Other|10
4456026|NCT00546637|7243240|FG001|Overall Study|Other|12
4456027|NCT00546637|7243239|FG000|Overall Study|Withdrawal by Subject|7
4456028|NCT00546637|7243240|FG001|Overall Study|Withdrawal by Subject|9
4456029|NCT00546637|7243239|FG000|Overall Study|Randomized, but not treated|3
4456030|NCT00546637|7243240|FG001|Overall Study|Randomized, but not treated|1
4456031|NCT00546715|7243250|FG000|Overall Study|Withdrawal by Subject|0
4456032|NCT00546715|7243251|FG001|Overall Study|Withdrawal by Subject|1
4456033|NCT00546715|7243252|FG002|Overall Study|Withdrawal by Subject|0
4456034|NCT00546715|7243253|FG003|Overall Study|Withdrawal by Subject|0
4456035|NCT00546819|7243274|FG000|Overall Study|Adverse Event|2
4538340|NCT01119105|7360017|FG002|Overall Study|Other|0
4538341|NCT01119118|7360025|FG000|Overall Study|Adverse Event|1
4538342|NCT01119131|7360032|FG000|Overall Study|Adverse Event|1
4538343|NCT01119131|7360033|FG001|Overall Study|Adverse Event|1
4538344|NCT01119131|7360034|FG002|Overall Study|Adverse Event|1
4538345|NCT01119131|7360032|FG000|Overall Study|Non-Compliance|1
4538346|NCT01119131|7360033|FG001|Overall Study|Non-Compliance|0
4538347|NCT01119131|7360034|FG002|Overall Study|Non-Compliance|4
4538348|NCT01119131|7360032|FG000|Overall Study|Physician Decision|0
4538349|NCT01119131|7360033|FG001|Overall Study|Physician Decision|0
4538350|NCT01119131|7360034|FG002|Overall Study|Physician Decision|1
4538351|NCT01119248|7360058|FG000|Overall Study|Physician Decision|5
4538352|NCT01119287|7360069|FG000|Overall Study|Patient Decision, not related to AE|0
4538353|NCT01119287|7360070|FG001|Overall Study|Patient Decision, not related to AE|0
4538354|NCT01119287|7360071|FG002|Overall Study|Patient Decision, not related to AE|2
4538355|NCT01119287|7360072|FG003|Overall Study|Patient Decision, not related to AE|2
4538356|NCT01119287|7360073|FG004|Overall Study|Patient Decision, not related to AE|1
4538357|NCT01119287|7360074|FG005|Overall Study|Patient Decision, not related to AE|0
4538358|NCT01119443|7360088|FG000|Crossover Period 1 (5 Days)|Adverse Event|0
4538359|NCT01119443|7360089|FG001|Crossover Period 1 (5 Days)|Adverse Event|1
4538360|NCT01119508|7360138|FG000|Overall Study|Adverse Event|56
4538361|NCT01119508|7360138|FG000|Overall Study|Withdrawal by Subject|2
4538362|NCT01119508|7360138|FG000|Overall Study|Died before tumor response evaluation|1
4538363|NCT01119625|7360144|FG000|Overall Study|Lost to Follow-up|1
4538364|NCT01119625|7360145|FG001|Overall Study|Lost to Follow-up|2
4538365|NCT01119625|7360144|FG000|Overall Study|Withdrawal by Subject|2
4538366|NCT01119625|7360145|FG001|Overall Study|Withdrawal by Subject|1
4611001|NCT01696695|7467208|FG000|Overall Study|Other|74
4611002|NCT01696695|7467208|FG000|Overall Study|Major Protocol Violation|192
4611003|NCT01696773|7467223|FG000|Days 15-27, Washout|Adverse Event|1
4611004|NCT01696773|7467224|FG001|Days 15-27, Washout|Adverse Event|0
4611005|NCT01696877|7467232|FG000|Overall Study|Adverse Event|0
4611006|NCT01696877|7467233|FG001|Overall Study|Adverse Event|1
4611007|NCT01696929|7467241|FG000|Overall Study|Physician Decision|1
4611008|NCT01696942|7467247|FG000|Overall Study|Withdrawal by Subject|1
4611009|NCT01696942|7467248|FG001|Overall Study|Withdrawal by Subject|0
4611010|NCT01696942|7467247|FG000|Overall Study|Protocol Violation|1
4611011|NCT01696942|7467248|FG001|Overall Study|Protocol Violation|2
4611012|NCT01696942|7467247|FG000|Overall Study|screen failure|0
4611013|NCT01696942|7467248|FG001|Overall Study|screen failure|1
4611014|NCT01696955|7467256|FG000|Main Study|Protocol Violation|1
4611015|NCT01696955|7467257|FG001|Main Study|Protocol Violation|0
4456036|NCT00546819|7243275|FG001|Overall Study|Adverse Event|3
4538367|NCT01119625|7360144|FG000|Overall Study|Other|0
4538368|NCT01119625|7360145|FG001|Overall Study|Other|1
4538369|NCT01119703|7360153|FG000|Overall Study|Adverse Event|0
4538370|NCT01119703|7360154|FG001|Overall Study|Adverse Event|1
4538371|NCT01119768|7360173|FG000|Treatment Period|Lack of Efficacy|18
4538372|NCT01119768|7360174|FG001|Treatment Period|Lack of Efficacy|25
4538373|NCT01119846|7360187|FG000|Overall Study|Adverse Event|1
4538374|NCT01119846|7360188|FG001|Overall Study|Adverse Event|0
4538375|NCT01119846|7360189|FG002|Overall Study|Adverse Event|6
4538376|NCT01119846|7360187|FG000|Overall Study|Physician Decision|1
4538377|NCT01119846|7360188|FG001|Overall Study|Physician Decision|0
4538378|NCT01119846|7360189|FG002|Overall Study|Physician Decision|0
4538379|NCT01119846|7360187|FG000|Overall Study|Protocol Violation|0
4538380|NCT01119846|7360188|FG001|Overall Study|Protocol Violation|0
4538381|NCT01119846|7360189|FG002|Overall Study|Protocol Violation|1
4538382|NCT01119846|7360187|FG000|Overall Study|Withdrawal by Subject|0
4538383|NCT01119846|7360188|FG001|Overall Study|Withdrawal by Subject|0
4538384|NCT01119846|7360189|FG002|Overall Study|Withdrawal by Subject|4
4456037|NCT00546819|7243274|FG000|Overall Study|Lost to Follow-up|2
4538385|NCT01119859|7360226|FG000|Overall Study|Adverse Event|9
4538386|NCT01119859|7360227|FG001|Overall Study|Adverse Event|10
4456038|NCT00546819|7243275|FG001|Overall Study|Lost to Follow-up|1
4538387|NCT01119859|7360226|FG000|Overall Study|Death|2
4538388|NCT01119859|7360227|FG001|Overall Study|Death|0
4456039|NCT00546819|7243274|FG000|Overall Study|Withdrawal by Subject|4
4611016|NCT01696955|7467256|FG000|Main Study|Withdrawal by Subject|1
4611017|NCT01696955|7467257|FG001|Main Study|Withdrawal by Subject|1
4456040|NCT00546819|7243275|FG001|Overall Study|Withdrawal by Subject|2
4456041|NCT00546871|7243281|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1
4456042|NCT00546871|7243282|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0
4456043|NCT00546871|7243281|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1
4456044|NCT00546871|7243282|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2
4456045|NCT00546871|7243281|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0
4456046|NCT00546871|7243282|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1
4456047|NCT00546871|7243281|FG000|Study Extension Period|Protocol Violation|1
4456048|NCT00546871|7243282|FG001|Study Extension Period|Protocol Violation|0
4456049|NCT00546871|7243281|FG000|Study Extension Period|Withdrawal by Subject|0
4456050|NCT00546871|7243282|FG001|Study Extension Period|Withdrawal by Subject|1
4456051|NCT00546910|7243331|FG000|Overall Study|Adverse Event|2
4456052|NCT00546910|7243332|FG001|Overall Study|Adverse Event|3
4456053|NCT00546910|7243331|FG000|Overall Study|Lack of Efficacy|5
4456054|NCT00546910|7243332|FG001|Overall Study|Lack of Efficacy|7
4456055|NCT00546910|7243331|FG000|Overall Study|Physician Decision|0
4456056|NCT00546910|7243332|FG001|Overall Study|Physician Decision|1
4456057|NCT00546910|7243331|FG000|Overall Study|Withdrawal by Subject|2
4456058|NCT00546910|7243332|FG001|Overall Study|Withdrawal by Subject|0
4456059|NCT00547118|7243344|FG000|Overall Study|Did not qualify prior to starting drug|1
4456060|NCT00547118|7243345|FG001|Overall Study|Did not qualify prior to starting drug|1
4456061|NCT00547118|7243344|FG000|Overall Study|Study suspended|7
4456062|NCT00547118|7243345|FG001|Overall Study|Study suspended|8
4456063|NCT00547157|7243355|FG000|Overall Study|Other|1
4456064|NCT00547157|7243356|FG001|Overall Study|Other|0
4456065|NCT00547157|7243355|FG000|Overall Study|Death|38
4456066|NCT00547157|7243356|FG001|Overall Study|Death|18
4456067|NCT00547157|7243355|FG000|Overall Study|Withdrawal by Subject|3
4456068|NCT00547157|7243356|FG001|Overall Study|Withdrawal by Subject|1
4456069|NCT00547157|7243355|FG000|Overall Study|Administrative decision|3
4456070|NCT00547157|7243356|FG001|Overall Study|Administrative decision|2
4456071|NCT00547157|7243355|FG000|Overall Study|Lost to Follow-up|4
4456072|NCT00547157|7243356|FG001|Overall Study|Lost to Follow-up|2
4456073|NCT00547248|7243366|FG000|Overall Study|Protocol Violation|0
4456074|NCT00547248|7243367|FG001|Overall Study|Protocol Violation|0
4456075|NCT00547248|7243368|FG002|Overall Study|Protocol Violation|1
4456076|NCT00547248|7243369|FG003|Overall Study|Protocol Violation|1
4456077|NCT00547248|7243366|FG000|Overall Study|Migrated/moved from study area|0
4456078|NCT00547248|7243367|FG001|Overall Study|Migrated/moved from study area|0
4456079|NCT00547248|7243368|FG002|Overall Study|Migrated/moved from study area|2
4456080|NCT00547248|7243369|FG003|Overall Study|Migrated/moved from study area|0
4456081|NCT00547248|7243366|FG000|Overall Study|Withdrawal by Subject|0
4456082|NCT00547248|7243367|FG001|Overall Study|Withdrawal by Subject|0
4456083|NCT00547248|7243368|FG002|Overall Study|Withdrawal by Subject|7
4456084|NCT00547248|7243369|FG003|Overall Study|Withdrawal by Subject|1
4456085|NCT00547365|7243382|FG000|Overall Study|Physician Decision|1
4456086|NCT00547365|7243382|FG000|Overall Study|Lost to Follow-up|1
4456087|NCT00547365|7243382|FG000|Overall Study|Protocol Violation|2
4456088|NCT00547365|7243382|FG000|Overall Study|death (not related to study)|4
4456089|NCT00547378|7243390|FG000|Randomized Cohort|Withdrawal by Subject|7
4456090|NCT00547378|7243391|FG001|Randomized Cohort|Withdrawal by Subject|5
4456091|NCT00547378|7243392|FG002|Randomized Cohort|Withdrawal by Subject|0
4456092|NCT00547378|7243390|FG000|Randomized Cohort|Death|0
4456093|NCT00547378|7243391|FG001|Randomized Cohort|Death|1
4456094|NCT00547378|7243392|FG002|Randomized Cohort|Death|0
4456095|NCT00547378|7243390|FG000|Randomized Cohort|Lost to Follow-up|1
4456096|NCT00547378|7243391|FG001|Randomized Cohort|Lost to Follow-up|0
4456097|NCT00547378|7243392|FG002|Randomized Cohort|Lost to Follow-up|0
4456098|NCT00547378|7243390|FG000|Randomized Cohort|Adverse Event|1
4456099|NCT00547378|7243391|FG001|Randomized Cohort|Adverse Event|0
4456100|NCT00547378|7243392|FG002|Randomized Cohort|Adverse Event|0
4456101|NCT00547378|7243390|FG000|Randomized Cohort|Other reasons|2
4456102|NCT00547378|7243391|FG001|Randomized Cohort|Other reasons|0
4456103|NCT00547378|7243392|FG002|Randomized Cohort|Other reasons|0
4456104|NCT00547378|7243390|FG000|All Implanted Cohort|Withdrawal by Subject|5
4456105|NCT00547378|7243391|FG001|All Implanted Cohort|Withdrawal by Subject|4
4456106|NCT00547378|7243392|FG002|All Implanted Cohort|Withdrawal by Subject|27
4456107|NCT00547378|7243390|FG000|All Implanted Cohort|Adverse Event|4
4456108|NCT00547378|7243391|FG001|All Implanted Cohort|Adverse Event|10
4456109|NCT00547378|7243392|FG002|All Implanted Cohort|Adverse Event|17
4456110|NCT00547378|7243390|FG000|All Implanted Cohort|Lost to Follow-up|0
4456111|NCT00547378|7243391|FG001|All Implanted Cohort|Lost to Follow-up|1
4456112|NCT00547378|7243392|FG002|All Implanted Cohort|Lost to Follow-up|14
4456113|NCT00547378|7243390|FG000|All Implanted Cohort|Death|3
4456114|NCT00547378|7243391|FG001|All Implanted Cohort|Death|1
4456115|NCT00547378|7243392|FG002|All Implanted Cohort|Death|4
4456116|NCT00547378|7243390|FG000|All Implanted Cohort|Physician Decision|0
4456117|NCT00547378|7243391|FG001|All Implanted Cohort|Physician Decision|2
4456118|NCT00547378|7243392|FG002|All Implanted Cohort|Physician Decision|6
4456119|NCT00547378|7243390|FG000|All Implanted Cohort|Site closure|2
4456120|NCT00547378|7243391|FG001|All Implanted Cohort|Site closure|0
4456121|NCT00547378|7243392|FG002|All Implanted Cohort|Site closure|1
4456122|NCT00547378|7243390|FG000|All Implanted Cohort|Other reasons|1
4456123|NCT00547378|7243391|FG001|All Implanted Cohort|Other reasons|0
4456124|NCT00547378|7243392|FG002|All Implanted Cohort|Other reasons|1
4456125|NCT00547521|7243402|FG000|Short Term Study (4 Months)|Adverse Event|1
4456126|NCT00547521|7243403|FG001|Short Term Study (4 Months)|Adverse Event|0
4456127|NCT00547521|7243402|FG000|Short Term Study (4 Months)|Lack of Efficacy|0
4456128|NCT00547521|7243403|FG001|Short Term Study (4 Months)|Lack of Efficacy|2
4456129|NCT00547521|7243402|FG000|Short Term Study (4 Months)|Withdrawal of consent|0
4456130|NCT00547521|7243403|FG001|Short Term Study (4 Months)|Withdrawal of consent|1
4456131|NCT00547521|7243402|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0
4456132|NCT00547521|7243403|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1
4456133|NCT00547521|7243402|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0
4456134|NCT00547521|7243403|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14
4456135|NCT00547521|7243402|FG000|Long Term Extension (LTE) Study|Adverse Event|0
4456136|NCT00547521|7243403|FG001|Long Term Extension (LTE) Study|Adverse Event|9
4456137|NCT00547521|7243402|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0
4456138|NCT00547521|7243403|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3
4456139|NCT00547521|7243402|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0
4456140|NCT00547521|7243403|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2
4456141|NCT00547521|7243402|FG000|Long Term Extension (LTE) Study|Other|0
4456142|NCT00547521|7243403|FG001|Long Term Extension (LTE) Study|Other|2
4456143|NCT00547521|7243402|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0
4456144|NCT00547521|7243403|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1
4456145|NCT00547534|7243416|FG000|Overall Study|Adverse Event|7
4456146|NCT00547534|7243416|FG000|Overall Study|Disease Progression|4
4456147|NCT00547703|7243453|FG000|Overall Study|Lost to Follow-up|1
4538389|NCT01119859|7360226|FG000|Overall Study|Insufficient therapeutic response|7
4538390|NCT01119859|7360227|FG001|Overall Study|Insufficient therapeutic response|14
4538391|NCT01119859|7360226|FG000|Overall Study|Refused treatment|3
4538392|NCT01119859|7360227|FG001|Overall Study|Refused treatment|6
4538393|NCT01119859|7360226|FG000|Overall Study|Failure to return|3
4538394|NCT01119859|7360227|FG001|Overall Study|Failure to return|0
4538395|NCT01119898|7360235|FG000|Overall Study|Adverse Event|4
4538396|NCT01119898|7360236|FG001|Overall Study|Adverse Event|5
4538397|NCT01119898|7360235|FG000|Overall Study|Withdrawal by Subject|1
4538398|NCT01119898|7360236|FG001|Overall Study|Withdrawal by Subject|4
4538399|NCT01119898|7360235|FG000|Overall Study|Lack of Efficacy|0
4538400|NCT01119898|7360236|FG001|Overall Study|Lack of Efficacy|2
4538401|NCT01119898|7360235|FG000|Overall Study|Protocol Violation|1
4538402|NCT01119898|7360236|FG001|Overall Study|Protocol Violation|1
4538403|NCT01119898|7360235|FG000|Overall Study|Medical procedure|1
4538404|NCT01119898|7360236|FG001|Overall Study|Medical procedure|0
4538405|NCT01119898|7360235|FG000|Overall Study|Randomized in error did not participate|1
4538406|NCT01119898|7360236|FG001|Overall Study|Randomized in error did not participate|0
4538407|NCT01119937|7360244|FG000|Overall Study|Adverse Event|11
4538408|NCT01119937|7360245|FG001|Overall Study|Adverse Event|5
4538409|NCT01119937|7360244|FG000|Overall Study|Protocol deviation|3
4538410|NCT01119937|7360245|FG001|Overall Study|Protocol deviation|1
4538411|NCT01119937|7360244|FG000|Overall Study|Unsatisfactory therapeutic effect|3
4538412|NCT01119937|7360245|FG001|Overall Study|Unsatisfactory therapeutic effect|0
4538413|NCT01119937|7360244|FG000|Overall Study|Withdrawal by Subject|2
4538414|NCT01119937|7360245|FG001|Overall Study|Withdrawal by Subject|1
4538415|NCT01119950|7360251|FG000|Overall Study|Adverse Event|25
4538416|NCT01119950|7360251|FG000|Overall Study|Withdrawal by Subject|9
4538417|NCT01119950|7360251|FG000|Overall Study|Protocol Violation|5
4538418|NCT01119950|7360251|FG000|Overall Study|Lost to Follow-up|4
4538419|NCT01119950|7360251|FG000|Overall Study|Administrative|2
4538420|NCT01119950|7360251|FG000|Overall Study|Abnormal lab value|1
4538421|NCT01119950|7360251|FG000|Overall Study|Death|1
4538422|NCT01119963|7360279|FG000|Overall Study|Lost to Follow-up|1
4538423|NCT01119963|7360280|FG001|Overall Study|Lost to Follow-up|1
4538424|NCT01120028|7360292|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0
4538425|NCT01120028|7360293|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5
4538426|NCT01120028|7360294|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0
4538427|NCT01120028|7360295|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0
4538428|NCT01120028|7360292|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14
4538429|NCT01120028|7360293|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18
4538430|NCT01120028|7360294|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0
4538431|NCT01120028|7360295|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0
4456148|NCT00547703|7243454|FG001|Overall Study|Lost to Follow-up|0
4456149|NCT00547911|7243487|FG000|Overall Study|Adverse Event|0
4456150|NCT00547911|7243488|FG001|Overall Study|Adverse Event|0
4456151|NCT00547911|7243489|FG002|Overall Study|Adverse Event|0
4456152|NCT00547911|7243490|FG003|Overall Study|Adverse Event|1
4456153|NCT00547911|7243491|FG004|Overall Study|Adverse Event|0
4538432|NCT01120067|7360308|FG000|Overall Study|Lost to Follow-up|3
4538433|NCT01120067|7360309|FG001|Overall Study|Lost to Follow-up|1
4538434|NCT01120067|7360308|FG000|Overall Study|fail to engage >3 sessions|2
4538435|NCT01120067|7360309|FG001|Overall Study|fail to engage >3 sessions|0
4538436|NCT01120093|7360315|FG000|Treatment Period 1|Adverse Event|0
4456154|NCT00547911|7243492|FG005|Overall Study|Adverse Event|0
4456155|NCT00548145|7243522|FG000|Overall Study|Death|0
4456156|NCT00548145|7243523|FG001|Overall Study|Death|1
4456157|NCT00548145|7243522|FG000|Overall Study|Withdrawal by Subject|0
4456158|NCT00548145|7243523|FG001|Overall Study|Withdrawal by Subject|2
4456159|NCT00548145|7243522|FG000|Overall Study|Physician Decision|1
4456160|NCT00548145|7243523|FG001|Overall Study|Physician Decision|1
4456161|NCT00548184|7243538|FG000|Overall Study|Adverse Event|3
4456162|NCT00548184|7243538|FG000|Overall Study|took other drug|1
4456163|NCT00548184|7243538|FG000|Overall Study|Found Her2 negative|1
4456164|NCT00548249|7243558|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3
4456165|NCT00548249|7243559|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
4456166|NCT00548249|7243560|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
4456167|NCT00548249|7243561|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2
4456168|NCT00548249|7243562|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
4456169|NCT00548249|7243558|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5
4456170|NCT00548249|7243559|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1
4456171|NCT00548249|7243560|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3
4456172|NCT00548249|7243561|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1
4456173|NCT00548249|7243562|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2
4456174|NCT00548249|7243558|FG000|Overall Study|Protocol Violation|1
4456175|NCT00548249|7243559|FG001|Overall Study|Protocol Violation|1
4456176|NCT00548249|7243560|FG002|Overall Study|Protocol Violation|4
4456177|NCT00548249|7243561|FG003|Overall Study|Protocol Violation|0
4538437|NCT01120093|7360316|FG001|Treatment Period 1|Adverse Event|0
4538438|NCT01120093|7360317|FG002|Treatment Period 1|Adverse Event|1
4538439|NCT01120093|7360318|FG003|Treatment Period 1|Adverse Event|0
4538440|NCT01120093|7360319|FG004|Treatment Period 1|Adverse Event|1
4538441|NCT01120093|7360315|FG000|Treatment Period 1|Withdrawal by Subject|0
4538442|NCT01120093|7360316|FG001|Treatment Period 1|Withdrawal by Subject|1
4538443|NCT01120093|7360317|FG002|Treatment Period 1|Withdrawal by Subject|0
4538444|NCT01120093|7360318|FG003|Treatment Period 1|Withdrawal by Subject|0
4538445|NCT01120093|7360319|FG004|Treatment Period 1|Withdrawal by Subject|0
4538446|NCT01120093|7360315|FG000|Treatment Period 2|Adverse Event|0
4538447|NCT01120093|7360316|FG001|Treatment Period 2|Adverse Event|0
4538448|NCT01120093|7360317|FG002|Treatment Period 2|Adverse Event|0
4538449|NCT01120093|7360318|FG003|Treatment Period 2|Adverse Event|1
4538450|NCT01120093|7360319|FG004|Treatment Period 2|Adverse Event|0
4538451|NCT01120093|7360315|FG000|Treatment Period 2|Withdrawal by Subject|0
4538452|NCT01120093|7360316|FG001|Treatment Period 2|Withdrawal by Subject|0
4538453|NCT01120093|7360317|FG002|Treatment Period 2|Withdrawal by Subject|0
4538454|NCT01120093|7360318|FG003|Treatment Period 2|Withdrawal by Subject|0
4538455|NCT01120093|7360319|FG004|Treatment Period 2|Withdrawal by Subject|1
4538456|NCT01120093|7360315|FG000|Treatment Period 3|Lack of Efficacy|0
4538457|NCT01120093|7360316|FG001|Treatment Period 3|Lack of Efficacy|0
4538458|NCT01120093|7360317|FG002|Treatment Period 3|Lack of Efficacy|0
4538459|NCT01120093|7360318|FG003|Treatment Period 3|Lack of Efficacy|1
4538460|NCT01120093|7360319|FG004|Treatment Period 3|Lack of Efficacy|0
4538461|NCT01120093|7360315|FG000|Treatment Period 3|Adverse Event|0
4456178|NCT00548249|7243562|FG004|Overall Study|Protocol Violation|3
4456179|NCT00548249|7243558|FG000|Overall Study|Miscellaneous|2
4456180|NCT00548249|7243559|FG001|Overall Study|Miscellaneous|3
4456181|NCT00548249|7243560|FG002|Overall Study|Miscellaneous|2
4456182|NCT00548249|7243561|FG003|Overall Study|Miscellaneous|0
4456183|NCT00548249|7243562|FG004|Overall Study|Miscellaneous|2
4456184|NCT00548249|7243558|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0
4456185|NCT00548249|7243559|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0
4456186|NCT00548249|7243560|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2
4456187|NCT00548249|7243561|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1
4456188|NCT00548249|7243562|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4
4456189|NCT00548249|7243558|FG000|Overall Study|Adverse Event|2
4456190|NCT00548249|7243559|FG001|Overall Study|Adverse Event|2
4456191|NCT00548249|7243560|FG002|Overall Study|Adverse Event|0
4456192|NCT00548249|7243561|FG003|Overall Study|Adverse Event|1
4456193|NCT00548249|7243562|FG004|Overall Study|Adverse Event|1
4456194|NCT00548249|7243558|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0
4538462|NCT01120093|7360316|FG001|Treatment Period 3|Adverse Event|0
4538463|NCT01120093|7360317|FG002|Treatment Period 3|Adverse Event|0
4538464|NCT01120093|7360318|FG003|Treatment Period 3|Adverse Event|0
4538465|NCT01120093|7360319|FG004|Treatment Period 3|Adverse Event|1
4538466|NCT01120093|7360315|FG000|Treatment Period 3|Withdrawal by Subject|0
4456195|NCT00548249|7243559|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0
4456196|NCT00548249|7243560|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1
4456197|NCT00548249|7243561|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3
4456198|NCT00548249|7243562|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2
4456199|NCT00548249|7243558|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0
4456200|NCT00548249|7243559|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0
4538467|NCT01120093|7360316|FG001|Treatment Period 3|Withdrawal by Subject|0
4538468|NCT01120093|7360317|FG002|Treatment Period 3|Withdrawal by Subject|1
4456201|NCT00548249|7243560|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1
4456202|NCT00548249|7243561|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2
4456203|NCT00548249|7243562|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2
4456204|NCT00548249|7243558|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
4456205|NCT00548249|7243559|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
4456206|NCT00548249|7243560|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
4456207|NCT00548249|7243561|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
4456208|NCT00548249|7243562|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0
4456209|NCT00548249|7243558|FG000|Overall Study|Prolonged hospitalization|0
4456210|NCT00548249|7243559|FG001|Overall Study|Prolonged hospitalization|0
4456211|NCT00548249|7243560|FG002|Overall Study|Prolonged hospitalization|2
4456212|NCT00548249|7243561|FG003|Overall Study|Prolonged hospitalization|1
4456213|NCT00548249|7243562|FG004|Overall Study|Prolonged hospitalization|0
4456214|NCT00548249|7243558|FG000|Overall Study|Withdrawal by Subject|2
4456215|NCT00548249|7243559|FG001|Overall Study|Withdrawal by Subject|0
4456216|NCT00548249|7243560|FG002|Overall Study|Withdrawal by Subject|0
4456217|NCT00548249|7243561|FG003|Overall Study|Withdrawal by Subject|0
4456218|NCT00548249|7243562|FG004|Overall Study|Withdrawal by Subject|0
4456219|NCT00548249|7243558|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
4456220|NCT00548249|7243559|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1
4456221|NCT00548249|7243560|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
4456222|NCT00548249|7243561|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
4456223|NCT00548249|7243562|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1
4456224|NCT00548249|7243558|FG000|Overall Study|Sponsor's request|0
4456225|NCT00548249|7243559|FG001|Overall Study|Sponsor's request|0
4456226|NCT00548249|7243560|FG002|Overall Study|Sponsor's request|0
4456227|NCT00548249|7243561|FG003|Overall Study|Sponsor's request|1
4456228|NCT00548249|7243562|FG004|Overall Study|Sponsor's request|0
4456229|NCT00548262|7243574|FG000|Overall Study|Death|21
4456230|NCT00548262|7243574|FG000|Overall Study|Adverse Event|2
4456231|NCT00548262|7243574|FG000|Overall Study|Lack of Efficacy|4
4456232|NCT00548262|7243574|FG000|Overall Study|Lost to Follow-up|1
4456233|NCT00548262|7243574|FG000|Overall Study|Other|3
4456234|NCT00548262|7243574|FG000|Overall Study|Withdrawal by Subject|1
4456235|NCT00548340|7243581|FG000|Overall Study|Protocol Violation|2
4456236|NCT00548340|7243582|FG001|Overall Study|Protocol Violation|3
4456237|NCT00548340|7243583|FG002|Overall Study|Protocol Violation|3
4456238|NCT00548340|7243581|FG000|Overall Study|Adverse Event|2
4456239|NCT00548340|7243582|FG001|Overall Study|Adverse Event|2
4456240|NCT00548340|7243583|FG002|Overall Study|Adverse Event|2
4456241|NCT00548340|7243581|FG000|Overall Study|Lost to Follow-up|1
4456242|NCT00548340|7243582|FG001|Overall Study|Lost to Follow-up|1
4456243|NCT00548340|7243583|FG002|Overall Study|Lost to Follow-up|0
4456244|NCT00548340|7243581|FG000|Overall Study|Withdrawal by Subject|2
4456245|NCT00548340|7243582|FG001|Overall Study|Withdrawal by Subject|4
4456246|NCT00548340|7243583|FG002|Overall Study|Withdrawal by Subject|3
4456247|NCT00548340|7243581|FG000|Overall Study|Other|1
4456248|NCT00548340|7243582|FG001|Overall Study|Other|1
4456249|NCT00548340|7243583|FG002|Overall Study|Other|1
4456250|NCT00548405|7243594|FG000|Overall Study|Adverse Event|6
4456251|NCT00548405|7243595|FG001|Overall Study|Adverse Event|2
4456252|NCT00548405|7243596|FG002|Overall Study|Adverse Event|0
4456253|NCT00548405|7243594|FG000|Overall Study|Lack of Efficacy|6
4456254|NCT00548405|7243595|FG001|Overall Study|Lack of Efficacy|0
4456255|NCT00548405|7243596|FG002|Overall Study|Lack of Efficacy|0
4456256|NCT00548405|7243594|FG000|Overall Study|Physician Decision|3
4456257|NCT00548405|7243595|FG001|Overall Study|Physician Decision|4
4456258|NCT00548405|7243596|FG002|Overall Study|Physician Decision|1
4456259|NCT00548405|7243594|FG000|Overall Study|Pregnancy|1
4456260|NCT00548405|7243595|FG001|Overall Study|Pregnancy|0
4456261|NCT00548405|7243596|FG002|Overall Study|Pregnancy|0
4456262|NCT00548405|7243594|FG000|Overall Study|Protocol Violation|1
4456263|NCT00548405|7243595|FG001|Overall Study|Protocol Violation|0
4456264|NCT00548405|7243596|FG002|Overall Study|Protocol Violation|0
4456265|NCT00548405|7243594|FG000|Overall Study|Withdrawal by Subject|36
4456266|NCT00548405|7243595|FG001|Overall Study|Withdrawal by Subject|12
4456267|NCT00548405|7243596|FG002|Overall Study|Withdrawal by Subject|5
4456268|NCT00548405|7243594|FG000|Overall Study|Lost to Follow-up|1
4456269|NCT00548405|7243595|FG001|Overall Study|Lost to Follow-up|1
4456270|NCT00548405|7243596|FG002|Overall Study|Lost to Follow-up|2
4456271|NCT00548405|7243594|FG000|Overall Study|Death|0
4456272|NCT00548405|7243595|FG001|Overall Study|Death|1
4456273|NCT00548405|7243596|FG002|Overall Study|Death|1
4456274|NCT00548405|7243594|FG000|Overall Study|Sponsor decision|1
4456275|NCT00548405|7243595|FG001|Overall Study|Sponsor decision|0
4456276|NCT00548405|7243596|FG002|Overall Study|Sponsor decision|0
4456277|NCT00548405|7243594|FG000|Overall Study|Randomized but not treated|1
4456278|NCT00548405|7243595|FG001|Overall Study|Randomized but not treated|0
4456279|NCT00548405|7243596|FG002|Overall Study|Randomized but not treated|0
4456280|NCT00548548|7243619|FG000|Overall Study|Death|345
4456281|NCT00548548|7243620|FG001|Overall Study|Death|348
4456282|NCT00548548|7243619|FG000|Overall Study|Lost to Follow-up|17
4456283|NCT00548548|7243620|FG001|Overall Study|Lost to Follow-up|18
4456284|NCT00548717|7243650|FG000|Overall Study|Death|5
4456285|NCT00548717|7243651|FG001|Overall Study|Death|2
4456286|NCT00548717|7243650|FG000|Overall Study|Relapse|3
4456287|NCT00548717|7243651|FG001|Overall Study|Relapse|0
4456288|NCT00548717|7243650|FG000|Overall Study|Alternative treatment for GVHD|1
4456289|NCT00548717|7243651|FG001|Overall Study|Alternative treatment for GVHD|0
4456290|NCT00548808|7243662|FG000|Overall Study|Lost to Follow-up|9
4456291|NCT00548808|7243663|FG001|Overall Study|Lost to Follow-up|3
4456292|NCT00548808|7243662|FG000|Overall Study|Protocol Violation|8
4456293|NCT00548808|7243663|FG001|Overall Study|Protocol Violation|8
4456294|NCT00548808|7243662|FG000|Overall Study|Withdrawal by Subject|8
4456295|NCT00548808|7243663|FG001|Overall Study|Withdrawal by Subject|4
4456296|NCT00548808|7243662|FG000|Overall Study|Physician Decision|6
4456297|NCT00548808|7243663|FG001|Overall Study|Physician Decision|3
4456298|NCT00548808|7243662|FG000|Overall Study|Adverse Event|4
4456299|NCT00548808|7243663|FG001|Overall Study|Adverse Event|5
4456300|NCT00548808|7243662|FG000|Overall Study|Death|2
4456301|NCT00548808|7243663|FG001|Overall Study|Death|0
4456302|NCT00548808|7243662|FG000|Overall Study|Entry Criteria Not Met|2
4456303|NCT00548808|7243663|FG001|Overall Study|Entry Criteria Not Met|2
4456304|NCT00548808|7243662|FG000|Overall Study|Lack of Efficacy|2
4456305|NCT00548808|7243663|FG001|Overall Study|Lack of Efficacy|0
4456306|NCT00548808|7243662|FG000|Overall Study|Sponsor Decision|1
4456307|NCT00548808|7243663|FG001|Overall Study|Sponsor Decision|1
4456308|NCT00548847|7243669|FG000|Overall Study|Disease progression|7
4456309|NCT00549055|7243692|FG000|Overall Study|Adverse Event|4
4456310|NCT00549055|7243692|FG000|Overall Study|Lack of Efficacy|18
4456311|NCT00549055|7243692|FG000|Overall Study|Stabilization|5
4456312|NCT00549055|7243692|FG000|Overall Study|Progression to fibrosis|2
4456313|NCT00549055|7243692|FG000|Overall Study|Decrease of size|1
4538469|NCT01120093|7360318|FG003|Treatment Period 3|Withdrawal by Subject|0
4538470|NCT01120093|7360319|FG004|Treatment Period 3|Withdrawal by Subject|0
4538471|NCT01120093|7360315|FG000|Treatment Period 4|Adverse Event|1
4538472|NCT01120093|7360316|FG001|Treatment Period 4|Adverse Event|0
4538473|NCT01120093|7360317|FG002|Treatment Period 4|Adverse Event|0
4538474|NCT01120093|7360318|FG003|Treatment Period 4|Adverse Event|0
4538475|NCT01120093|7360319|FG004|Treatment Period 4|Adverse Event|0
4538476|NCT01120093|7360315|FG000|Treatment Period 5|Adverse Event|0
4538477|NCT01120093|7360316|FG001|Treatment Period 5|Adverse Event|1
4538478|NCT01120093|7360317|FG002|Treatment Period 5|Adverse Event|0
4538479|NCT01120093|7360318|FG003|Treatment Period 5|Adverse Event|1
4538480|NCT01120093|7360319|FG004|Treatment Period 5|Adverse Event|0
4456314|NCT00549055|7243692|FG000|Overall Study|Active choroidal neovascula increased|1
4456315|NCT00549055|7243692|FG000|Overall Study|Vitreous hemorrhage|1
4456316|NCT00549055|7243692|FG000|Overall Study|Growth choroidal neovascularisation|1
4456317|NCT00549055|7243692|FG000|Overall Study|Choroidal neovascularization|1
4456318|NCT00549055|7243692|FG000|Overall Study|Very low visual acuity (VA)|1
4456319|NCT00549198|7243707|FG000|Overall Study|Adverse Event|28
4456320|NCT00549198|7243708|FG001|Overall Study|Adverse Event|26
4456321|NCT00549198|7243707|FG000|Overall Study|Insufficient Viral Load Response|4
4456322|NCT00549198|7243708|FG001|Overall Study|Insufficient Viral Load Response|2
4456323|NCT00549198|7243707|FG000|Overall Study|Protocol-defined Virological Failure|7
4456324|NCT00549198|7243708|FG001|Overall Study|Protocol-defined Virological Failure|0
4538481|NCT01120184|7360334|FG000|Overall Study|Adverse Event|0
4538482|NCT01120184|7360335|FG001|Overall Study|Adverse Event|1
4538483|NCT01120184|7360336|FG002|Overall Study|Adverse Event|0
4456325|NCT00549198|7243707|FG000|Overall Study|Non-compliance|2
4456326|NCT00549198|7243708|FG001|Overall Study|Non-compliance|4
4456327|NCT00549198|7243707|FG000|Overall Study|Lost to Follow-up|7
4456328|NCT00549198|7243708|FG001|Overall Study|Lost to Follow-up|8
4456329|NCT00549198|7243707|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3
4456330|NCT00549198|7243708|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0
4456331|NCT00549198|7243707|FG000|Overall Study|Protocol Violation|7
4456332|NCT00549198|7243708|FG001|Overall Study|Protocol Violation|2
4456333|NCT00549198|7243707|FG000|Overall Study|Investigator Decision|4
4456334|NCT00549198|7243708|FG001|Overall Study|Investigator Decision|3
4456335|NCT00549198|7243707|FG000|Overall Study|Withdrawal by Subject|7
4456336|NCT00549198|7243708|FG001|Overall Study|Withdrawal by Subject|7
4456337|NCT00549198|7243707|FG000|Overall Study|Disease Progression|1
4456338|NCT00549198|7243708|FG001|Overall Study|Disease Progression|0
4456339|NCT00549198|7243707|FG000|Overall Study|Participant Moved|2
4456340|NCT00549198|7243708|FG001|Overall Study|Participant Moved|0
4456341|NCT00549198|7243707|FG000|Overall Study|Participant not able to perform Week 96|1
4456342|NCT00549198|7243708|FG001|Overall Study|Participant not able to perform Week 96|0
4456343|NCT00549198|7243707|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1
4456344|NCT00549198|7243708|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0
4456345|NCT00549198|7243707|FG000|Overall Study|Prohibited Medication|1
4456346|NCT00549198|7243708|FG001|Overall Study|Prohibited Medication|2
4456347|NCT00549198|7243707|FG000|Overall Study|Participant planning pregnancy|1
4456348|NCT00549198|7243708|FG001|Overall Study|Participant planning pregnancy|0
4456349|NCT00549198|7243707|FG000|Overall Study|Participant overweight, no scan possible|1
4456350|NCT00549198|7243708|FG001|Overall Study|Participant overweight, no scan possible|0
4456351|NCT00549198|7243707|FG000|Overall Study|No scan facilities|0
4456352|NCT00549198|7243708|FG001|Overall Study|No scan facilities|2
4538484|NCT01120184|7360334|FG000|Overall Study|Lost to Follow-up|13
4456353|NCT00549198|7243707|FG000|Overall Study|Pregnancy|0
4456354|NCT00549198|7243708|FG001|Overall Study|Pregnancy|3
4456355|NCT00549198|7243707|FG000|Overall Study|Not Exposed to Study Drug|3
4456356|NCT00549198|7243708|FG001|Overall Study|Not Exposed to Study Drug|4
4456357|NCT00549302|7243716|FG000|Double-Blind|Death|2
4456358|NCT00549302|7243717|FG001|Double-Blind|Death|9
4456359|NCT00549302|7243718|FG002|Double-Blind|Death|0
4456360|NCT00549302|7243716|FG000|Double-Blind|Adverse Event|3
4456361|NCT00549302|7243717|FG001|Double-Blind|Adverse Event|16
4456362|NCT00549302|7243718|FG002|Double-Blind|Adverse Event|0
4456363|NCT00549302|7243716|FG000|Double-Blind|Withdrawal by Subject|3
4456364|NCT00549302|7243717|FG001|Double-Blind|Withdrawal by Subject|8
4456365|NCT00549302|7243718|FG002|Double-Blind|Withdrawal by Subject|0
4456366|NCT00549302|7243716|FG000|Double-Blind|Investigator Decision|1
4456367|NCT00549302|7243717|FG001|Double-Blind|Investigator Decision|5
4456368|NCT00549302|7243718|FG002|Double-Blind|Investigator Decision|0
4456369|NCT00549302|7243716|FG000|Double-Blind|Sponsor Decision|0
4456370|NCT00549302|7243717|FG001|Double-Blind|Sponsor Decision|1
4456371|NCT00549302|7243718|FG002|Double-Blind|Sponsor Decision|0
4456372|NCT00549302|7243716|FG000|Double-Blind|Lost to Follow-up|1
4456373|NCT00549302|7243717|FG001|Double-Blind|Lost to Follow-up|2
4456374|NCT00549302|7243718|FG002|Double-Blind|Lost to Follow-up|0
4456375|NCT00549302|7243716|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1
4456376|NCT00549302|7243717|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10
4456377|NCT00549302|7243718|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0
4456378|NCT00549302|7243716|FG000|Double-Blind|New condition or starts new therapy|0
4456379|NCT00549302|7243717|FG001|Double-Blind|New condition or starts new therapy|2
4456380|NCT00549302|7243718|FG002|Double-Blind|New condition or starts new therapy|0
4456381|NCT00549302|7243716|FG000|Open-Label|Adverse Event|0
4456382|NCT00549302|7243717|FG001|Open-Label|Adverse Event|0
4456383|NCT00549302|7243718|FG002|Open-Label|Adverse Event|11
4456384|NCT00549302|7243716|FG000|Open-Label|Death|0
4456385|NCT00549302|7243717|FG001|Open-Label|Death|0
4456386|NCT00549302|7243718|FG002|Open-Label|Death|40
4456387|NCT00549302|7243716|FG000|Open-Label|Investigator Decision|0
4456388|NCT00549302|7243717|FG001|Open-Label|Investigator Decision|0
4456389|NCT00549302|7243718|FG002|Open-Label|Investigator Decision|5
4456390|NCT00549302|7243716|FG000|Open-Label|Lost to Follow-up|0
4456391|NCT00549302|7243717|FG001|Open-Label|Lost to Follow-up|0
4456392|NCT00549302|7243718|FG002|Open-Label|Lost to Follow-up|2
4456393|NCT00549302|7243716|FG000|Open-Label|Other|0
4456394|NCT00549302|7243717|FG001|Open-Label|Other|0
4456395|NCT00549302|7243718|FG002|Open-Label|Other|3
4456396|NCT00549302|7243716|FG000|Open-Label|New drug pulmonary atrial hypertension|0
4456397|NCT00549302|7243717|FG001|Open-Label|New drug pulmonary atrial hypertension|0
4456398|NCT00549302|7243718|FG002|Open-Label|New drug pulmonary atrial hypertension|2
4456399|NCT00549302|7243716|FG000|Open-Label|Withdrawal by Subject|0
4456400|NCT00549302|7243717|FG001|Open-Label|Withdrawal by Subject|0
4456401|NCT00549302|7243718|FG002|Open-Label|Withdrawal by Subject|6
4456402|NCT00549445|7243739|FG000|Overall Study|Sputum & Blood Samples Not Available|15
4456403|NCT00549445|7243740|FG001|Overall Study|Sputum & Blood Samples Not Available|17
4456404|NCT00549549|7243750|FG000|Overall Study|Adverse Event|5
4456405|NCT00549549|7243751|FG001|Overall Study|Adverse Event|3
4456406|NCT00549549|7243752|FG002|Overall Study|Adverse Event|1
4456407|NCT00549549|7243753|FG003|Overall Study|Adverse Event|9
4456408|NCT00549549|7243750|FG000|Overall Study|Lack of Efficacy|9
4456409|NCT00549549|7243751|FG001|Overall Study|Lack of Efficacy|6
4456410|NCT00549549|7243752|FG002|Overall Study|Lack of Efficacy|4
4456411|NCT00549549|7243753|FG003|Overall Study|Lack of Efficacy|2
4456412|NCT00549549|7243750|FG000|Overall Study|Lost to Follow-up|1
4456413|NCT00549549|7243751|FG001|Overall Study|Lost to Follow-up|0
4456414|NCT00549549|7243752|FG002|Overall Study|Lost to Follow-up|1
4456415|NCT00549549|7243753|FG003|Overall Study|Lost to Follow-up|2
4456416|NCT00549549|7243750|FG000|Overall Study|Withdrawal by Subject|0
4456417|NCT00549549|7243751|FG001|Overall Study|Withdrawal by Subject|4
4456418|NCT00549549|7243752|FG002|Overall Study|Withdrawal by Subject|1
4456419|NCT00549549|7243753|FG003|Overall Study|Withdrawal by Subject|0
4456420|NCT00549549|7243750|FG000|Overall Study|Other|9
4456421|NCT00549549|7243751|FG001|Overall Study|Other|9
4456422|NCT00549549|7243752|FG002|Overall Study|Other|9
4456423|NCT00549549|7243753|FG003|Overall Study|Other|11
4456424|NCT00549549|7243750|FG000|Overall Study|Randomized but not treated|0
4456425|NCT00549549|7243751|FG001|Overall Study|Randomized but not treated|0
4456426|NCT00549549|7243752|FG002|Overall Study|Randomized but not treated|1
4456427|NCT00549549|7243753|FG003|Overall Study|Randomized but not treated|1
4456428|NCT00549562|7243763|FG000|Overall Study|Adverse Event|1
4456429|NCT00549562|7243763|FG000|Overall Study|Lack of Efficacy|1
4456430|NCT00549601|7243770|FG000|Randomized|Protocol Violation|0
4456431|NCT00549601|7243771|FG001|Randomized|Protocol Violation|0
4456432|NCT00549601|7243772|FG002|Randomized|Protocol Violation|1
4456433|NCT00549601|7243770|FG000|Randomized|Withdrawal by Subject|0
4456434|NCT00549601|7243771|FG001|Randomized|Withdrawal by Subject|1
4456435|NCT00549601|7243772|FG002|Randomized|Withdrawal by Subject|1
4456436|NCT00549601|7243770|FG000|Received Study Drug|Adverse Event|2
4456437|NCT00549601|7243771|FG001|Received Study Drug|Adverse Event|5
4456438|NCT00549601|7243772|FG002|Received Study Drug|Adverse Event|1
4456439|NCT00549601|7243770|FG000|Received Study Drug|Death|0
4456440|NCT00549601|7243771|FG001|Received Study Drug|Death|1
4456441|NCT00549601|7243772|FG002|Received Study Drug|Death|0
4456442|NCT00549601|7243770|FG000|Received Study Drug|Lost to Follow-up|0
4456443|NCT00549601|7243771|FG001|Received Study Drug|Lost to Follow-up|1
4456444|NCT00549601|7243772|FG002|Received Study Drug|Lost to Follow-up|1
4456445|NCT00549601|7243770|FG000|Received Study Drug|Protocol Violation|3
4456446|NCT00549601|7243771|FG001|Received Study Drug|Protocol Violation|4
4456447|NCT00549601|7243772|FG002|Received Study Drug|Protocol Violation|1
4456448|NCT00549601|7243770|FG000|Received Study Drug|Withdrawal by Subject|2
4456449|NCT00549601|7243771|FG001|Received Study Drug|Withdrawal by Subject|0
4456450|NCT00549601|7243772|FG002|Received Study Drug|Withdrawal by Subject|1
4456451|NCT00549640|7243784|FG000|Overall Study|Withdrawal by Subject|6
4456452|NCT00549640|7243785|FG001|Overall Study|Withdrawal by Subject|12
4456453|NCT00549640|7243784|FG000|Overall Study|Adverse Event|5
4456454|NCT00549640|7243785|FG001|Overall Study|Adverse Event|0
4456455|NCT00549640|7243784|FG000|Overall Study|Lost to Follow-up|7
4456456|NCT00549640|7243785|FG001|Overall Study|Lost to Follow-up|4
4456457|NCT00549718|7243795|FG000|Overall Study|Insufficient clinical response|20
4456458|NCT00549718|7243796|FG001|Overall Study|Insufficient clinical response|7
4456459|NCT00549718|7243797|FG002|Overall Study|Insufficient clinical response|18
4538485|NCT01120184|7360335|FG001|Overall Study|Lost to Follow-up|13
4538486|NCT01120184|7360336|FG002|Overall Study|Lost to Follow-up|11
4538487|NCT01120184|7360334|FG000|Overall Study|Physician Decision|9
4538488|NCT01120184|7360335|FG001|Overall Study|Physician Decision|1
4538489|NCT01120184|7360336|FG002|Overall Study|Physician Decision|3
4538490|NCT01120184|7360334|FG000|Overall Study|Reason not Specified|8
4538491|NCT01120184|7360335|FG001|Overall Study|Reason not Specified|3
4538492|NCT01120184|7360336|FG002|Overall Study|Reason not Specified|12
4538493|NCT01120184|7360334|FG000|Overall Study|Sponsor Decision to Terminate Study|133
4538494|NCT01120184|7360335|FG001|Overall Study|Sponsor Decision to Terminate Study|144
4538495|NCT01120184|7360336|FG002|Overall Study|Sponsor Decision to Terminate Study|143
4538496|NCT01120184|7360334|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32
4538497|NCT01120184|7360335|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29
4538498|NCT01120184|7360336|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25
4538499|NCT01120184|7360334|FG000|Overall Study|Death|170
4538500|NCT01120184|7360335|FG001|Overall Study|Death|176
4538501|NCT01120184|7360336|FG002|Overall Study|Death|169
4538502|NCT01120210|7360356|FG000|MAIN INFUSION|Adverse Event|1
4538503|NCT01120210|7360357|FG001|MAIN INFUSION|Adverse Event|0
4538504|NCT01120210|7360356|FG000|MAIN INFUSION|Withdrawal by Subject|0
4538505|NCT01120210|7360357|FG001|MAIN INFUSION|Withdrawal by Subject|1
4538506|NCT01120275|7360384|FG000|Overall Study|Adverse Event|3
4538507|NCT01120275|7360384|FG000|Overall Study|Progression|27
4538508|NCT01120275|7360384|FG000|Overall Study|Ineligible|3
4538509|NCT01120275|7360384|FG000|Overall Study|Withdrawal by Subject|1
4538510|NCT01120275|7360384|FG000|Overall Study|Refusal|1
4538511|NCT01120275|7360384|FG000|Overall Study|Not specific|1
4538512|NCT01120379|7360389|FG000|One Year Timepoint|Withdrawal by Subject|41
4538513|NCT01120379|7360389|FG000|One Year Timepoint|Lost to Follow-up|115
4538514|NCT01120379|7360389|FG000|One Year Timepoint|Death|108
4538515|NCT01120379|7360389|FG000|One Year Timepoint|Physician Decision|9
4538516|NCT01120379|7360389|FG000|One Year Timepoint|Any other reason for early termination|5
4538517|NCT01120379|7360389|FG000|Two Year Timepoint|Withdrawal by Subject|11
4538518|NCT01120379|7360389|FG000|Two Year Timepoint|Lost to Follow-up|87
4538519|NCT01120379|7360389|FG000|Two Year Timepoint|Death|123
4538520|NCT01120379|7360389|FG000|Two Year Timepoint|Physician Decision|12
4538521|NCT01120379|7360389|FG000|Two Year Timepoint|Any other reason for early termination|4
4538522|NCT01120379|7360389|FG000|Three Year Timepoint|Withdrawal by Subject|25
4538523|NCT01120379|7360389|FG000|Three Year Timepoint|Lost to Follow-up|43
4538524|NCT01120379|7360389|FG000|Three Year Timepoint|Death|120
4538525|NCT01120379|7360389|FG000|Three Year Timepoint|Physician Decision|9
4538526|NCT01120379|7360389|FG000|Three Year Timepoint|Any other reason for early termination|17
4538527|NCT01120379|7360389|FG000|Four Year Timepoint|Withdrawal by Subject|5
4538528|NCT01120379|7360389|FG000|Four Year Timepoint|Lost to Follow-up|10
4538529|NCT01120379|7360389|FG000|Four Year Timepoint|Death|131
4538530|NCT01120379|7360389|FG000|Four Year Timepoint|Physician Decision|5
4538531|NCT01120379|7360389|FG000|Four Year Timepoint|Any other reason for early termination|217
4538532|NCT01120600|7360406|FG000|Overall Study|Adverse Event|7
4538533|NCT01120600|7360407|FG001|Overall Study|Adverse Event|7
4538534|NCT01120600|7360406|FG000|Overall Study|Excessive Bone Loss|0
4538535|NCT01120600|7360407|FG001|Overall Study|Excessive Bone Loss|4
4538536|NCT01120600|7360406|FG000|Overall Study|Lost to Follow-up|1
4538537|NCT01120600|7360407|FG001|Overall Study|Lost to Follow-up|3
4538538|NCT01120600|7360406|FG000|Overall Study|Physician Decision|1
4538539|NCT01120600|7360407|FG001|Overall Study|Physician Decision|3
4538540|NCT01120600|7360406|FG000|Overall Study|Protocol Violation|0
4538541|NCT01120600|7360407|FG001|Overall Study|Protocol Violation|4
4538542|NCT01120600|7360406|FG000|Overall Study|Withdrawal by Subject|10
4456460|NCT00549718|7243798|FG003|Overall Study|Insufficient clinical response|32
4538543|NCT01120600|7360407|FG001|Overall Study|Withdrawal by Subject|11
4591200|NCT01527487|7437594|FG001|Overall Study|MD Discretion/Lack of Efficacy|4
4591201|NCT01527487|7437593|FG000|Overall Study|Disease Progression|4
4591202|NCT01527487|7437594|FG001|Overall Study|Disease Progression|1
4591203|NCT01527487|7437593|FG000|Overall Study|Adverse Event|1
4456461|NCT00549718|7243795|FG000|Overall Study|Adverse Event|6
4456462|NCT00549718|7243796|FG001|Overall Study|Adverse Event|8
4456463|NCT00549718|7243797|FG002|Overall Study|Adverse Event|7
4456464|NCT00549718|7243798|FG003|Overall Study|Adverse Event|3
4456465|NCT00549718|7243795|FG000|Overall Study|Lost to Follow-up|4
4456466|NCT00549718|7243796|FG001|Overall Study|Lost to Follow-up|2
4456467|NCT00549718|7243797|FG002|Overall Study|Lost to Follow-up|0
4456468|NCT00549718|7243798|FG003|Overall Study|Lost to Follow-up|6
4456469|NCT00549718|7243795|FG000|Overall Study|Withdrawal by Subject|9
4456470|NCT00549718|7243796|FG001|Overall Study|Withdrawal by Subject|18
4456471|NCT00549718|7243797|FG002|Overall Study|Withdrawal by Subject|12
4456472|NCT00549718|7243798|FG003|Overall Study|Withdrawal by Subject|13
4456473|NCT00549718|7243795|FG000|Overall Study|Administrative|2
4456474|NCT00549718|7243796|FG001|Overall Study|Administrative|2
4456475|NCT00549718|7243797|FG002|Overall Study|Administrative|2
4456476|NCT00549718|7243798|FG003|Overall Study|Administrative|1
4456477|NCT00549757|7243810|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590
4456478|NCT00549757|7243811|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462
4456479|NCT00549757|7243810|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98
4456480|NCT00549757|7243811|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58
4456481|NCT00549757|7243810|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7
4456482|NCT00549757|7243811|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7
4456483|NCT00549757|7243810|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47
4456484|NCT00549757|7243811|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53
4456485|NCT00549757|7243810|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38
4456486|NCT00549757|7243811|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38
4456487|NCT00549757|7243810|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41
4456488|NCT00549757|7243811|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29
4456489|NCT00549757|7243810|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857
4456490|NCT00549757|7243811|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019
4456491|NCT00549757|7243810|FG000|Active Treatment Phase: Max. 50 Months|Death|188
4456492|NCT00549757|7243811|FG001|Active Treatment Phase: Max. 50 Months|Death|200
4456493|NCT00549757|7243810|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353
4456494|NCT00549757|7243811|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380
4456495|NCT00549757|7243810|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69
4456496|NCT00549757|7243811|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55
4456497|NCT00549757|7243810|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8
4456498|NCT00549757|7243811|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9
4456499|NCT00549757|7243810|FG000|Extension Period (in Average 9 Months)|Death|143
4456500|NCT00549757|7243811|FG001|Extension Period (in Average 9 Months)|Death|136
4456501|NCT00549757|7243810|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52
4456502|NCT00549757|7243811|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47
4611018|NCT01696968|7467272|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0
4611019|NCT01696968|7467273|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8
4611020|NCT01696968|7467272|FG000|Overall Study|Died Before Randomization|3
4456503|NCT00549757|7243810|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9
4538544|NCT01120626|7360415|FG000|Overall Study|Withdrawal by Subject|1
4538545|NCT01120626|7360416|FG001|Overall Study|Withdrawal by Subject|0
4538546|NCT01120691|7360442|FG000|Overall Study|Adverse Event|59
4538547|NCT01120691|7360443|FG001|Overall Study|Adverse Event|67
4538548|NCT01120691|7360444|FG002|Overall Study|Adverse Event|47
4538549|NCT01120691|7360442|FG000|Overall Study|Subject withdrew consent|33
4538550|NCT01120691|7360443|FG001|Overall Study|Subject withdrew consent|50
4538551|NCT01120691|7360444|FG002|Overall Study|Subject withdrew consent|44
4538552|NCT01120691|7360442|FG000|Overall Study|Death|21
4538553|NCT01120691|7360443|FG001|Overall Study|Death|22
4538554|NCT01120691|7360444|FG002|Overall Study|Death|24
4538555|NCT01120691|7360442|FG000|Overall Study|Unsatisfactory therapeutic effect|18
4456504|NCT00549757|7243811|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16
4456505|NCT00549757|7243810|FG000|Extension Period (in Average 9 Months)|Patient's request|421
4538556|NCT01120691|7360443|FG001|Overall Study|Unsatisfactory therapeutic effect|32
4538557|NCT01120691|7360444|FG002|Overall Study|Unsatisfactory therapeutic effect|38
4538558|NCT01120691|7360442|FG000|Overall Study|Administrative problems|15
4538559|NCT01120691|7360443|FG001|Overall Study|Administrative problems|8
4538560|NCT01120691|7360444|FG002|Overall Study|Administrative problems|9
4538561|NCT01120691|7360442|FG000|Overall Study|Protocol deviation|13
4538562|NCT01120691|7360443|FG001|Overall Study|Protocol deviation|12
4538563|NCT01120691|7360444|FG002|Overall Study|Protocol deviation|12
4538564|NCT01120691|7360442|FG000|Overall Study|Lost to Follow-up|5
4538565|NCT01120691|7360443|FG001|Overall Study|Lost to Follow-up|6
4456506|NCT00549757|7243811|FG001|Extension Period (in Average 9 Months)|Patient's request|436
4538566|NCT01120691|7360444|FG002|Overall Study|Lost to Follow-up|4
4538567|NCT01120691|7360442|FG000|Overall Study|Abnormal test procedure result(s)|3
4538568|NCT01120691|7360443|FG001|Overall Study|Abnormal test procedure result(s)|2
4538569|NCT01120691|7360444|FG002|Overall Study|Abnormal test procedure result(s)|1
4538570|NCT01120691|7360442|FG000|Overall Study|Patient's inability to use the device|3
4456507|NCT00549770|7243831|FG000|Overall Study|Protocol deviation|1
4456508|NCT00549770|7243832|FG001|Overall Study|Protocol deviation|1
4456509|NCT00549770|7243833|FG002|Overall Study|Protocol deviation|1
4456510|NCT00549770|7243834|FG003|Overall Study|Protocol deviation|2
4456511|NCT00549770|7243835|FG004|Overall Study|Protocol deviation|2
4456512|NCT00549770|7243836|FG005|Overall Study|Protocol deviation|2
4456513|NCT00549770|7243837|FG006|Overall Study|Protocol deviation|1
4456514|NCT00549770|7243838|FG007|Overall Study|Protocol deviation|2
4456515|NCT00549770|7243831|FG000|Overall Study|Administrative problems|0
4456516|NCT00549770|7243832|FG001|Overall Study|Administrative problems|1
4456517|NCT00549770|7243833|FG002|Overall Study|Administrative problems|0
4456518|NCT00549770|7243834|FG003|Overall Study|Administrative problems|0
4456519|NCT00549770|7243835|FG004|Overall Study|Administrative problems|0
4456520|NCT00549770|7243836|FG005|Overall Study|Administrative problems|0
4456521|NCT00549770|7243837|FG006|Overall Study|Administrative problems|0
4456522|NCT00549770|7243838|FG007|Overall Study|Administrative problems|1
4456523|NCT00549770|7243831|FG000|Overall Study|Lost to Follow-up|0
4456524|NCT00549770|7243832|FG001|Overall Study|Lost to Follow-up|0
4456525|NCT00549770|7243833|FG002|Overall Study|Lost to Follow-up|2
4456526|NCT00549770|7243834|FG003|Overall Study|Lost to Follow-up|2
4456527|NCT00549770|7243835|FG004|Overall Study|Lost to Follow-up|3
4456528|NCT00549770|7243836|FG005|Overall Study|Lost to Follow-up|2
4456529|NCT00549770|7243837|FG006|Overall Study|Lost to Follow-up|0
4456530|NCT00549770|7243838|FG007|Overall Study|Lost to Follow-up|0
4456531|NCT00549770|7243831|FG000|Overall Study|Withdrawal by Subject|4
4456532|NCT00549770|7243832|FG001|Overall Study|Withdrawal by Subject|6
4456533|NCT00549770|7243833|FG002|Overall Study|Withdrawal by Subject|4
4456534|NCT00549770|7243834|FG003|Overall Study|Withdrawal by Subject|5
4538571|NCT01120691|7360443|FG001|Overall Study|Patient's inability to use the device|1
4538572|NCT01120691|7360444|FG002|Overall Study|Patient's inability to use the device|0
4538573|NCT01120691|7360442|FG000|Overall Study|Abnormal laboratory value(s)|1
4538574|NCT01120691|7360443|FG001|Overall Study|Abnormal laboratory value(s)|3
4538575|NCT01120691|7360444|FG002|Overall Study|Abnormal laboratory value(s)|4
4538576|NCT01120717|7360535|FG000|Overall Study|Withdrawal by Subject|11
4538577|NCT01120717|7360536|FG001|Overall Study|Withdrawal by Subject|6
4538578|NCT01120717|7360535|FG000|Overall Study|Adverse Event|10
4538579|NCT01120717|7360536|FG001|Overall Study|Adverse Event|6
4538580|NCT01120717|7360535|FG000|Overall Study|Protocol Deviation|2
4538581|NCT01120717|7360536|FG001|Overall Study|Protocol Deviation|5
4538582|NCT01120717|7360535|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3
4538583|NCT01120717|7360536|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3
4538584|NCT01120717|7360535|FG000|Overall Study|Lost to Follow-up|2
4538585|NCT01120717|7360536|FG001|Overall Study|Lost to Follow-up|3
4538586|NCT01120717|7360535|FG000|Overall Study|Death|3
4538587|NCT01120717|7360536|FG001|Overall Study|Death|1
4538588|NCT01120717|7360535|FG000|Overall Study|Abnormal Test Procedure Result(s)|1
4538589|NCT01120717|7360536|FG001|Overall Study|Abnormal Test Procedure Result(s)|0
4538590|NCT01120756|7360544|FG000|Overall Study|Withdrawal by Subject|1
4538591|NCT01120756|7360545|FG001|Overall Study|Withdrawal by Subject|1
4538592|NCT01120782|7360551|FG000|Overall Study|Test article shipping error|11
4538593|NCT01120899|7360563|FG000|Overall Study|Withdrawal by Subject|3
4538594|NCT01121146|7360573|FG000|Overall Study|Death|17
4538595|NCT01121146|7360574|FG001|Overall Study|Death|15
4538596|NCT01121146|7360573|FG000|Overall Study|Adverse Event|2
4538597|NCT01121146|7360574|FG001|Overall Study|Adverse Event|11
4538598|NCT01121146|7360573|FG000|Overall Study|Lost to Follow-up|7
4538599|NCT01121146|7360574|FG001|Overall Study|Lost to Follow-up|16
4538600|NCT01121185|7360593|FG000|Overall Study|Not infused|0
4538601|NCT01121185|7360594|FG001|Overall Study|Not infused|1
4538602|NCT01121185|7360593|FG000|Overall Study|Not transplanted|1
4538603|NCT01121185|7360594|FG001|Overall Study|Not transplanted|0
4538604|NCT01121263|7360635|FG000|Overall Study|Death|3
4538605|NCT01121263|7360636|FG001|Overall Study|Death|2
4538606|NCT01121263|7360635|FG000|Overall Study|Lost to Follow-up|22
4538607|NCT01121263|7360636|FG001|Overall Study|Lost to Follow-up|12
4538608|NCT01121263|7360635|FG000|Overall Study|Withdrawal by Subject|0
4538609|NCT01121263|7360636|FG001|Overall Study|Withdrawal by Subject|1
4538610|NCT01121393|7360646|FG000|Overall Study|Progressive disease|201
4538611|NCT01121393|7360647|FG001|Overall Study|Progressive disease|20
4538612|NCT01121393|7360646|FG000|Overall Study|Other Adverse events|24
4538613|NCT01121393|7360647|FG001|Overall Study|Other Adverse events|45
4538614|NCT01121393|7360646|FG000|Overall Study|Non-compliant with protocol|0
4456535|NCT00549770|7243835|FG004|Overall Study|Withdrawal by Subject|6
4538615|NCT01121393|7360647|FG001|Overall Study|Non-compliant with protocol|3
4538616|NCT01121393|7360646|FG000|Overall Study|Lost to Follow-up|1
4538617|NCT01121393|7360647|FG001|Overall Study|Lost to Follow-up|0
4538618|NCT01121393|7360646|FG000|Overall Study|Refused cont. medication|7
4538619|NCT01121393|7360647|FG001|Overall Study|Refused cont. medication|7
4611021|NCT01696968|7467273|FG001|Overall Study|Died Before Randomization|8
4611022|NCT01696968|7467272|FG000|Overall Study|Died Before ASU (Control)|278
4611023|NCT01696968|7467273|FG001|Overall Study|Died Before ASU (Control)|0
4611024|NCT01696968|7467272|FG000|Overall Study|Refused ASU (Control)|920
4611025|NCT01696968|7467273|FG001|Overall Study|Refused ASU (Control)|0
4456536|NCT00549770|7243836|FG005|Overall Study|Withdrawal by Subject|6
4456537|NCT00549770|7243837|FG006|Overall Study|Withdrawal by Subject|4
4456538|NCT00549770|7243838|FG007|Overall Study|Withdrawal by Subject|9
4456539|NCT00549770|7243831|FG000|Overall Study|Lack of Efficacy|1
4456540|NCT00549770|7243832|FG001|Overall Study|Lack of Efficacy|0
4456541|NCT00549770|7243833|FG002|Overall Study|Lack of Efficacy|2
4456542|NCT00549770|7243834|FG003|Overall Study|Lack of Efficacy|3
4456543|NCT00549770|7243835|FG004|Overall Study|Lack of Efficacy|5
4456544|NCT00549770|7243836|FG005|Overall Study|Lack of Efficacy|1
4456545|NCT00549770|7243837|FG006|Overall Study|Lack of Efficacy|3
4456546|NCT00549770|7243838|FG007|Overall Study|Lack of Efficacy|8
4456547|NCT00549770|7243831|FG000|Overall Study|Abnormal test procedure results|0
4456548|NCT00549770|7243832|FG001|Overall Study|Abnormal test procedure results|0
4456549|NCT00549770|7243833|FG002|Overall Study|Abnormal test procedure results|0
4456550|NCT00549770|7243834|FG003|Overall Study|Abnormal test procedure results|2
4456551|NCT00549770|7243835|FG004|Overall Study|Abnormal test procedure results|0
4456552|NCT00549770|7243836|FG005|Overall Study|Abnormal test procedure results|1
4456553|NCT00549770|7243837|FG006|Overall Study|Abnormal test procedure results|1
4456554|NCT00549770|7243838|FG007|Overall Study|Abnormal test procedure results|1
4456555|NCT00549770|7243831|FG000|Overall Study|Abnormal laboratory values|0
4456556|NCT00549770|7243832|FG001|Overall Study|Abnormal laboratory values|0
4456557|NCT00549770|7243833|FG002|Overall Study|Abnormal laboratory values|0
4456558|NCT00549770|7243834|FG003|Overall Study|Abnormal laboratory values|0
4456559|NCT00549770|7243835|FG004|Overall Study|Abnormal laboratory values|0
4456560|NCT00549770|7243836|FG005|Overall Study|Abnormal laboratory values|1
4456561|NCT00549770|7243837|FG006|Overall Study|Abnormal laboratory values|0
4456562|NCT00549770|7243838|FG007|Overall Study|Abnormal laboratory values|0
4456563|NCT00549770|7243831|FG000|Overall Study|Adverse Event|1
4456564|NCT00549770|7243832|FG001|Overall Study|Adverse Event|3
4456565|NCT00549770|7243833|FG002|Overall Study|Adverse Event|1
4456566|NCT00549770|7243834|FG003|Overall Study|Adverse Event|2
4456567|NCT00549770|7243835|FG004|Overall Study|Adverse Event|1
4456568|NCT00549770|7243836|FG005|Overall Study|Adverse Event|0
4456569|NCT00549770|7243837|FG006|Overall Study|Adverse Event|5
4456570|NCT00549770|7243838|FG007|Overall Study|Adverse Event|4
4456571|NCT00549900|7243869|FG000|Overall Study|Adverse Event|1
4456572|NCT00549939|7243876|FG000|12-week Double Blind Treatment Period|Adverse Event|1
4456573|NCT00549939|7243877|FG001|12-week Double Blind Treatment Period|Adverse Event|1
4456574|NCT00549939|7243878|FG002|12-week Double Blind Treatment Period|Adverse Event|2
4456575|NCT00549939|7243876|FG000|12-week Double Blind Treatment Period|Too many blood draws|0
4456576|NCT00549939|7243877|FG001|12-week Double Blind Treatment Period|Too many blood draws|1
4456577|NCT00549939|7243878|FG002|12-week Double Blind Treatment Period|Too many blood draws|0
4456578|NCT00549939|7243876|FG000|40-week Open Label Treatment Period|Adverse Event|0
4456579|NCT00549939|7243877|FG001|40-week Open Label Treatment Period|Adverse Event|2
4456580|NCT00549939|7243878|FG002|40-week Open Label Treatment Period|Adverse Event|1
4456581|NCT00549939|7243876|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0
4456582|NCT00549939|7243877|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1
4456583|NCT00549939|7243878|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0
4456584|NCT00549939|7243876|FG000|40-week Open Label Treatment Period|Protocol Violation|0
4456585|NCT00549939|7243877|FG001|40-week Open Label Treatment Period|Protocol Violation|1
4456586|NCT00549939|7243878|FG002|40-week Open Label Treatment Period|Protocol Violation|0
4456587|NCT00549939|7243876|FG000|40-week Open Label Treatment Period|Other|0
4456588|NCT00549939|7243877|FG001|40-week Open Label Treatment Period|Other|1
4456589|NCT00549939|7243878|FG002|40-week Open Label Treatment Period|Other|4
4456590|NCT00550043|7243893|FG000|Overall Study|Adverse Event|0
4456591|NCT00550043|7243894|FG001|Overall Study|Adverse Event|0
4456592|NCT00550043|7243895|FG002|Overall Study|Adverse Event|0
4456593|NCT00550043|7243896|FG003|Overall Study|Adverse Event|1
4456594|NCT00550043|7243897|FG004|Overall Study|Adverse Event|1
4456595|NCT00550043|7243893|FG000|Overall Study|Subject Withdrew Consent|0
4456596|NCT00550043|7243894|FG001|Overall Study|Subject Withdrew Consent|2
4456597|NCT00550043|7243895|FG002|Overall Study|Subject Withdrew Consent|1
4456598|NCT00550043|7243896|FG003|Overall Study|Subject Withdrew Consent|0
4456599|NCT00550043|7243897|FG004|Overall Study|Subject Withdrew Consent|0
4456600|NCT00550043|7243893|FG000|Overall Study|Other Reasons- Unspecified|0
4456601|NCT00550043|7243894|FG001|Overall Study|Other Reasons- Unspecified|1
4456602|NCT00550043|7243895|FG002|Overall Study|Other Reasons- Unspecified|0
4456603|NCT00550043|7243896|FG003|Overall Study|Other Reasons- Unspecified|1
4456604|NCT00550043|7243897|FG004|Overall Study|Other Reasons- Unspecified|0
4456605|NCT00550147|7243909|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4
4456606|NCT00550147|7243909|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2
4456607|NCT00550147|7243909|FG000|Quetiapine Addition Treatment Period|Adverse Event|3
4456608|NCT00550147|7243909|FG000|Quetiapine Addition Treatment Period|Noncompliance|2
4456609|NCT00550147|7243909|FG000|Quetiapine Addition Treatment Period|Moved out of state|1
4456610|NCT00550173|7243925|FG000|Overall Study|Death|45
4456611|NCT00550173|7243926|FG001|Overall Study|Death|38
4456612|NCT00550173|7243927|FG002|Overall Study|Death|50
4456613|NCT00550173|7243925|FG000|Overall Study|Physician Decision|1
4456614|NCT00550173|7243926|FG001|Overall Study|Physician Decision|2
4456615|NCT00550173|7243927|FG002|Overall Study|Physician Decision|2
4456616|NCT00550173|7243925|FG000|Overall Study|Withdrawal by Subject|9
4456617|NCT00550173|7243926|FG001|Overall Study|Withdrawal by Subject|12
4456618|NCT00550173|7243927|FG002|Overall Study|Withdrawal by Subject|17
4456619|NCT00550173|7243925|FG000|Overall Study|Sponsor Decision|13
4456620|NCT00550173|7243926|FG001|Overall Study|Sponsor Decision|7
4456621|NCT00550173|7243927|FG002|Overall Study|Sponsor Decision|1
4456622|NCT00550173|7243925|FG000|Overall Study|Lost to Follow-up|4
4456623|NCT00550173|7243926|FG001|Overall Study|Lost to Follow-up|4
4456624|NCT00550173|7243927|FG002|Overall Study|Lost to Follow-up|3
4456625|NCT00550238|7243936|FG000|Overall Study|Adverse Event|88
4456626|NCT00550238|7243936|FG000|Overall Study|Death|34
4456627|NCT00550238|7243936|FG000|Overall Study|Disease progression|46
4456628|NCT00550238|7243936|FG000|Overall Study|Withdrawal by Subject|167
4456629|NCT00550238|7243936|FG000|Overall Study|Physician Decision|31
4456630|NCT00550238|7243936|FG000|Overall Study|Patient noncompliance|25
4456631|NCT00550238|7243936|FG000|Overall Study|Lost to Follow-up|13
4456632|NCT00550238|7243936|FG000|Overall Study|Sponsor decision|55
4456633|NCT00550407|7243975|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55
4456634|NCT00550407|7243976|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0
4456635|NCT00550407|7243977|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0
4456636|NCT00550407|7243975|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39
4456637|NCT00550407|7243976|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0
4456638|NCT00550407|7243977|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0
4456639|NCT00550407|7243975|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1
4456640|NCT00550407|7243976|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0
4456641|NCT00550407|7243977|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0
4456642|NCT00550407|7243975|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1
4456643|NCT00550407|7243976|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0
4456644|NCT00550407|7243977|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0
4456645|NCT00550407|7243975|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1
4456646|NCT00550407|7243976|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0
4456647|NCT00550407|7243977|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0
4456648|NCT00550407|7243975|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8
4456649|NCT00550407|7243976|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0
4456650|NCT00550407|7243977|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0
4456651|NCT00550407|7243975|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6
4456652|NCT00550407|7243976|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0
4456653|NCT00550407|7243977|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0
4456654|NCT00550407|7243975|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1
4456655|NCT00550407|7243976|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0
4456656|NCT00550407|7243977|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0
4456657|NCT00550407|7243975|FG000|26-Week Randomized Phase|Adverse Event|0
4456658|NCT00550407|7243976|FG001|26-Week Randomized Phase|Adverse Event|5
4456659|NCT00550407|7243977|FG002|26-Week Randomized Phase|Adverse Event|2
4456660|NCT00550407|7243975|FG000|26-Week Randomized Phase|Lack of Efficacy|0
4456661|NCT00550407|7243976|FG001|26-Week Randomized Phase|Lack of Efficacy|36
4456662|NCT00550407|7243977|FG002|26-Week Randomized Phase|Lack of Efficacy|19
4456663|NCT00550407|7243975|FG000|26-Week Randomized Phase|Investigator Discretion|0
4456664|NCT00550407|7243976|FG001|26-Week Randomized Phase|Investigator Discretion|1
4456665|NCT00550407|7243977|FG002|26-Week Randomized Phase|Investigator Discretion|0
4456666|NCT00550407|7243975|FG000|26-Week Randomized Phase|Withdrawal by Subject|0
4456667|NCT00550407|7243976|FG001|26-Week Randomized Phase|Withdrawal by Subject|1
4456668|NCT00550407|7243977|FG002|26-Week Randomized Phase|Withdrawal by Subject|3
4456669|NCT00550420|7243985|FG000|Overall Study|Adverse Event|28
4456670|NCT00550420|7243985|FG000|Overall Study|Lost to Follow-up|8
4456671|NCT00550420|7243985|FG000|Overall Study|Protocol Violation|11
4456672|NCT00550420|7243985|FG000|Overall Study|Withdrawal by Subject|30
4456673|NCT00550420|7243985|FG000|Overall Study|Still in study at termination|206
4456674|NCT00550420|7243985|FG000|Overall Study|Missing|2
4456675|NCT00550420|7243985|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12
4456676|NCT00550420|7243985|FG000|Overall Study|Investigators opinion|1
4456677|NCT00550420|7243985|FG000|Overall Study|Lack of curative effect|1
4456678|NCT00550420|7243985|FG000|Overall Study|Unethical stop of enrollment|2
4456679|NCT00550420|7243985|FG000|Overall Study|Caregiver's decision to withdraw|1
4456680|NCT00550420|7243985|FG000|Overall Study|Out of Electrocardiogram criteria|1
4456681|NCT00550420|7243985|FG000|Overall Study|Exclusion criteria|1
4456682|NCT00550420|7243985|FG000|Overall Study|Prohibited medicine|1
4456683|NCT00550446|7243998|FG000|Up To Week 12|Adverse Event|2
4456684|NCT00550446|7243999|FG001|Up To Week 12|Adverse Event|2
4456685|NCT00550446|7244000|FG002|Up To Week 12|Adverse Event|0
4456686|NCT00550446|7244001|FG003|Up To Week 12|Adverse Event|0
4456687|NCT00550446|7244002|FG004|Up To Week 12|Adverse Event|2
4456688|NCT00550446|7244003|FG005|Up To Week 12|Adverse Event|2
4456689|NCT00550446|7244004|FG006|Up To Week 12|Adverse Event|1
4456690|NCT00550446|7244005|FG007|Up To Week 12|Adverse Event|0
4456691|NCT00550446|7244006|FG008|Up To Week 12|Adverse Event|0
4456692|NCT00550446|7244007|FG009|Up To Week 12|Adverse Event|0
4456693|NCT00550446|7244008|FG010|Up To Week 12|Adverse Event|0
4456694|NCT00550446|7243998|FG000|Up To Week 12|Lack of Efficacy|3
4456695|NCT00550446|7243999|FG001|Up To Week 12|Lack of Efficacy|1
4456696|NCT00550446|7244000|FG002|Up To Week 12|Lack of Efficacy|0
4456697|NCT00550446|7244001|FG003|Up To Week 12|Lack of Efficacy|1
4456698|NCT00550446|7244002|FG004|Up To Week 12|Lack of Efficacy|0
4456699|NCT00550446|7244003|FG005|Up To Week 12|Lack of Efficacy|3
4456700|NCT00550446|7244004|FG006|Up To Week 12|Lack of Efficacy|3
4456701|NCT00550446|7244005|FG007|Up To Week 12|Lack of Efficacy|0
4456702|NCT00550446|7244006|FG008|Up To Week 12|Lack of Efficacy|0
4456703|NCT00550446|7244007|FG009|Up To Week 12|Lack of Efficacy|0
4456704|NCT00550446|7244008|FG010|Up To Week 12|Lack of Efficacy|0
4456705|NCT00550446|7243998|FG000|Up To Week 12|Lost to Follow-up|0
4456706|NCT00550446|7243999|FG001|Up To Week 12|Lost to Follow-up|1
4456707|NCT00550446|7244000|FG002|Up To Week 12|Lost to Follow-up|0
4456708|NCT00550446|7244001|FG003|Up To Week 12|Lost to Follow-up|0
4456709|NCT00550446|7244002|FG004|Up To Week 12|Lost to Follow-up|1
4456710|NCT00550446|7244003|FG005|Up To Week 12|Lost to Follow-up|1
4456711|NCT00550446|7244004|FG006|Up To Week 12|Lost to Follow-up|2
4456712|NCT00550446|7244005|FG007|Up To Week 12|Lost to Follow-up|0
4456713|NCT00550446|7244006|FG008|Up To Week 12|Lost to Follow-up|0
4456714|NCT00550446|7244007|FG009|Up To Week 12|Lost to Follow-up|0
4456715|NCT00550446|7244008|FG010|Up To Week 12|Lost to Follow-up|0
4456716|NCT00550446|7243998|FG000|Up To Week 12|Withdrawal by Subject|2
4456717|NCT00550446|7243999|FG001|Up To Week 12|Withdrawal by Subject|0
4456718|NCT00550446|7244000|FG002|Up To Week 12|Withdrawal by Subject|3
4456719|NCT00550446|7244001|FG003|Up To Week 12|Withdrawal by Subject|2
4456720|NCT00550446|7244002|FG004|Up To Week 12|Withdrawal by Subject|0
4456721|NCT00550446|7244003|FG005|Up To Week 12|Withdrawal by Subject|1
4456722|NCT00550446|7244004|FG006|Up To Week 12|Withdrawal by Subject|3
4456723|NCT00550446|7244005|FG007|Up To Week 12|Withdrawal by Subject|0
4456724|NCT00550446|7244006|FG008|Up To Week 12|Withdrawal by Subject|0
4456725|NCT00550446|7244007|FG009|Up To Week 12|Withdrawal by Subject|0
4456726|NCT00550446|7244008|FG010|Up To Week 12|Withdrawal by Subject|0
4456727|NCT00550446|7243998|FG000|Up To Week 12|Other|3
4456728|NCT00550446|7243999|FG001|Up To Week 12|Other|0
4456729|NCT00550446|7244000|FG002|Up To Week 12|Other|0
4456730|NCT00550446|7244001|FG003|Up To Week 12|Other|0
4456731|NCT00550446|7244002|FG004|Up To Week 12|Other|0
4456732|NCT00550446|7244003|FG005|Up To Week 12|Other|1
4456733|NCT00550446|7244004|FG006|Up To Week 12|Other|4
4456734|NCT00550446|7244005|FG007|Up To Week 12|Other|0
4456735|NCT00550446|7244006|FG008|Up To Week 12|Other|0
4456736|NCT00550446|7244007|FG009|Up To Week 12|Other|0
4456737|NCT00550446|7244008|FG010|Up To Week 12|Other|0
4456738|NCT00550446|7243998|FG000|Up To Week 12|Randomized not treated|0
4456739|NCT00550446|7243999|FG001|Up To Week 12|Randomized not treated|1
4456740|NCT00550446|7244000|FG002|Up To Week 12|Randomized not treated|1
4456741|NCT00550446|7244001|FG003|Up To Week 12|Randomized not treated|0
4456742|NCT00550446|7244002|FG004|Up To Week 12|Randomized not treated|0
4456743|NCT00550446|7244003|FG005|Up To Week 12|Randomized not treated|0
4456744|NCT00550446|7244004|FG006|Up To Week 12|Randomized not treated|0
4456745|NCT00550446|7244005|FG007|Up To Week 12|Randomized not treated|0
4456746|NCT00550446|7244006|FG008|Up To Week 12|Randomized not treated|0
4538620|NCT01121393|7360646|FG000|Overall Study|Not treated|3
4611026|NCT01696968|7467272|FG000|Overall Study|Refused Screen (Lung Screening)|0
4611027|NCT01696968|7467273|FG001|Overall Study|Refused Screen (Lung Screening)|6796
4611028|NCT01696981|7467282|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0
4611029|NCT01696981|7467283|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20
4611030|NCT01696981|7467282|FG000|Overall Study|Died Before Randomization|3
4611031|NCT01696981|7467283|FG001|Overall Study|Died Before Randomization|8
4611032|NCT01696981|7467282|FG000|Overall Study|Died Before ASU (Control)|278
4611033|NCT01696981|7467283|FG001|Overall Study|Died Before ASU (Control)|0
4611034|NCT01696981|7467282|FG000|Overall Study|Refused ASU (Control)|920
4611035|NCT01696981|7467283|FG001|Overall Study|Refused ASU (Control)|0
4611036|NCT01696981|7467282|FG000|Overall Study|Refused Screen (Colorectal Screening)|0
4611037|NCT01696981|7467283|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346
4611038|NCT01696994|7467291|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0
4734816|NCT03505021|7682014|FG000|Overall Study|Personal reason|21
4456747|NCT00550446|7244007|FG009|Up To Week 12|Randomized not treated|0
4538621|NCT01121393|7360647|FG001|Overall Study|Not treated|9
4538622|NCT01121393|7360646|FG000|Overall Study|Other than listed|6
4538623|NCT01121393|7360647|FG001|Overall Study|Other than listed|0
4538624|NCT01121406|7360661|FG000|Overall Study|Progressive disease RECIST|44
4538625|NCT01121406|7360662|FG001|Overall Study|Progressive disease RECIST|28
4538626|NCT01121406|7360661|FG000|Overall Study|Wors. or AE of underlying cancer disease|4
4456748|NCT00550446|7244008|FG010|Up To Week 12|Randomized not treated|0
4456749|NCT00550446|7243998|FG000|Post Week 12|Adverse Event|2
4456750|NCT00550446|7243999|FG001|Post Week 12|Adverse Event|1
4456751|NCT00550446|7244000|FG002|Post Week 12|Adverse Event|1
4456752|NCT00550446|7244001|FG003|Post Week 12|Adverse Event|1
4538627|NCT01121406|7360662|FG001|Overall Study|Wors. or AE of underlying cancer disease|6
4538628|NCT01121406|7360661|FG000|Overall Study|Other AE|3
4456753|NCT00550446|7244002|FG004|Post Week 12|Adverse Event|1
4456754|NCT00550446|7244003|FG005|Post Week 12|Adverse Event|1
4456755|NCT00550446|7244004|FG006|Post Week 12|Adverse Event|0
4456756|NCT00550446|7244005|FG007|Post Week 12|Adverse Event|0
4456757|NCT00550446|7244006|FG008|Post Week 12|Adverse Event|0
4456758|NCT00550446|7244007|FG009|Post Week 12|Adverse Event|4
4456759|NCT00550446|7244008|FG010|Post Week 12|Adverse Event|0
4456760|NCT00550446|7243998|FG000|Post Week 12|Lack of Efficacy|0
4456761|NCT00550446|7243999|FG001|Post Week 12|Lack of Efficacy|0
4456762|NCT00550446|7244000|FG002|Post Week 12|Lack of Efficacy|1
4456763|NCT00550446|7244001|FG003|Post Week 12|Lack of Efficacy|0
4456764|NCT00550446|7244002|FG004|Post Week 12|Lack of Efficacy|0
4456765|NCT00550446|7244003|FG005|Post Week 12|Lack of Efficacy|0
4456766|NCT00550446|7244004|FG006|Post Week 12|Lack of Efficacy|0
4456767|NCT00550446|7244005|FG007|Post Week 12|Lack of Efficacy|1
4456768|NCT00550446|7244006|FG008|Post Week 12|Lack of Efficacy|1
4456769|NCT00550446|7244007|FG009|Post Week 12|Lack of Efficacy|2
4456770|NCT00550446|7244008|FG010|Post Week 12|Lack of Efficacy|1
4456771|NCT00550446|7243998|FG000|Post Week 12|Lost to Follow-up|0
4456772|NCT00550446|7243999|FG001|Post Week 12|Lost to Follow-up|0
4456773|NCT00550446|7244000|FG002|Post Week 12|Lost to Follow-up|1
4456774|NCT00550446|7244001|FG003|Post Week 12|Lost to Follow-up|1
4456775|NCT00550446|7244002|FG004|Post Week 12|Lost to Follow-up|0
4456776|NCT00550446|7244003|FG005|Post Week 12|Lost to Follow-up|0
4456777|NCT00550446|7244004|FG006|Post Week 12|Lost to Follow-up|1
4456778|NCT00550446|7244005|FG007|Post Week 12|Lost to Follow-up|0
4456779|NCT00550446|7244006|FG008|Post Week 12|Lost to Follow-up|0
4456780|NCT00550446|7244007|FG009|Post Week 12|Lost to Follow-up|0
4456781|NCT00550446|7244008|FG010|Post Week 12|Lost to Follow-up|0
4456782|NCT00550446|7243998|FG000|Post Week 12|Withdrawal by Subject|0
4456783|NCT00550446|7243999|FG001|Post Week 12|Withdrawal by Subject|0
4456784|NCT00550446|7244000|FG002|Post Week 12|Withdrawal by Subject|0
4456785|NCT00550446|7244001|FG003|Post Week 12|Withdrawal by Subject|0
4456786|NCT00550446|7244002|FG004|Post Week 12|Withdrawal by Subject|1
4456787|NCT00550446|7244003|FG005|Post Week 12|Withdrawal by Subject|0
4456788|NCT00550446|7244004|FG006|Post Week 12|Withdrawal by Subject|0
4456789|NCT00550446|7244005|FG007|Post Week 12|Withdrawal by Subject|0
4456790|NCT00550446|7244006|FG008|Post Week 12|Withdrawal by Subject|0
4456791|NCT00550446|7244007|FG009|Post Week 12|Withdrawal by Subject|0
4456792|NCT00550446|7244008|FG010|Post Week 12|Withdrawal by Subject|0
4456793|NCT00550446|7243998|FG000|Post Week 12|Other|1
4456794|NCT00550446|7243999|FG001|Post Week 12|Other|1
4456795|NCT00550446|7244000|FG002|Post Week 12|Other|0
4456796|NCT00550446|7244001|FG003|Post Week 12|Other|1
4456797|NCT00550446|7244002|FG004|Post Week 12|Other|0
4456798|NCT00550446|7244003|FG005|Post Week 12|Other|0
4456799|NCT00550446|7244004|FG006|Post Week 12|Other|1
4456800|NCT00550446|7244005|FG007|Post Week 12|Other|0
4456801|NCT00550446|7244006|FG008|Post Week 12|Other|1
4456802|NCT00550446|7244007|FG009|Post Week 12|Other|1
4456803|NCT00550446|7244008|FG010|Post Week 12|Other|0
4456804|NCT00550459|7244048|FG000|Overall Study|Adverse Event|0
4456805|NCT00550459|7244049|FG001|Overall Study|Adverse Event|2
4456806|NCT00550459|7244048|FG000|Overall Study|Withdrawal by Subject|1
4456807|NCT00550459|7244049|FG001|Overall Study|Withdrawal by Subject|1
4456808|NCT00550537|7244055|FG000|Overall Study|Death|18
4456809|NCT00550537|7244055|FG000|Overall Study|Adverse Event|20
4456810|NCT00550537|7244055|FG000|Overall Study|Disease progression before|46
4456811|NCT00550537|7244055|FG000|Overall Study|Withdrawal by Subject|7
4456812|NCT00550537|7244055|FG000|Overall Study|Change in treatment plan|4
4456813|NCT00550537|7244055|FG000|Overall Study|Other complicating ilness|3
4456814|NCT00550537|7244055|FG000|Overall Study|Declining performance status|2
4456815|NCT00550537|7244055|FG000|Overall Study|Treated closer to home|4
4456816|NCT00550550|7244066|FG000|Overall Study|Adverse Event|13
4456817|NCT00550550|7244067|FG001|Overall Study|Adverse Event|5
4456818|NCT00550550|7244066|FG000|Overall Study|Treatment Failure|0
4456819|NCT00550550|7244067|FG001|Overall Study|Treatment Failure|1
4456820|NCT00550550|7244066|FG000|Overall Study|Lost to Follow-up|4
4456821|NCT00550550|7244067|FG001|Overall Study|Lost to Follow-up|0
4456822|NCT00550550|7244066|FG000|Overall Study|Withdrawal by Subject|10
4456823|NCT00550550|7244067|FG001|Overall Study|Withdrawal by Subject|8
4456824|NCT00550550|7244066|FG000|Overall Study|Protocol Violation|5
4456825|NCT00550550|7244067|FG001|Overall Study|Protocol Violation|14
4456826|NCT00550550|7244066|FG000|Overall Study|Did Not Meet Protocol Eligibility|1
4456827|NCT00550550|7244067|FG001|Overall Study|Did Not Meet Protocol Eligibility|1
4456828|NCT00550550|7244066|FG000|Overall Study|Randomized But Not Treated|1
4456829|NCT00550550|7244067|FG001|Overall Study|Randomized But Not Treated|0
4515884|NCT00956839|7326998|FG002|Overall Study|Lost to Follow-up|3
4515885|NCT00956943|7327019|FG000|Overall Study|Lost to Follow-up|9
4515886|NCT00956943|7327020|FG001|Overall Study|Lost to Follow-up|10
4515887|NCT00957008|7327030|FG000|Overall Study|Withdrawal by Subject|13
4515888|NCT00957008|7327031|FG001|Overall Study|Withdrawal by Subject|10
4515889|NCT00957008|7327032|FG002|Overall Study|Withdrawal by Subject|12
4515890|NCT00957008|7327033|FG003|Overall Study|Withdrawal by Subject|16
4515891|NCT00957008|7327030|FG000|Overall Study|Lost to Follow-up|3
4515892|NCT00957008|7327031|FG001|Overall Study|Lost to Follow-up|1
4515893|NCT00957008|7327032|FG002|Overall Study|Lost to Follow-up|3
4456830|NCT00550615|7244081|FG000|Overall Study|Withdrawal by Subject|0
4456831|NCT00550615|7244082|FG001|Overall Study|Withdrawal by Subject|0
4456832|NCT00550615|7244083|FG002|Overall Study|Withdrawal by Subject|2
4456833|NCT00550615|7244084|FG003|Overall Study|Withdrawal by Subject|3
4456834|NCT00550615|7244081|FG000|Overall Study|Not evaluable|0
4456835|NCT00550615|7244082|FG001|Overall Study|Not evaluable|0
4456836|NCT00550615|7244083|FG002|Overall Study|Not evaluable|2
4456837|NCT00550615|7244084|FG003|Overall Study|Not evaluable|7
4456838|NCT00550680|7244094|FG000|Overall Study|Administrative Reasons|1
4456839|NCT00550680|7244094|FG000|Overall Study|Adverse Event|5
4538629|NCT01121406|7360662|FG001|Overall Study|Other AE|10
4538630|NCT01121406|7360661|FG000|Overall Study|Non-compliant with protocol|0
4538631|NCT01121406|7360662|FG001|Overall Study|Non-compliant with protocol|2
4538632|NCT01121406|7360661|FG000|Overall Study|Lost to Follow-up|0
4538633|NCT01121406|7360662|FG001|Overall Study|Lost to Follow-up|1
4538634|NCT01121406|7360661|FG000|Overall Study|Refused continuation of study med.|1
4538635|NCT01121406|7360662|FG001|Overall Study|Refused continuation of study med.|2
4538636|NCT01121406|7360661|FG000|Overall Study|Reason other than specified above|2
4538637|NCT01121406|7360662|FG001|Overall Study|Reason other than specified above|6
4538638|NCT01121406|7360661|FG000|Overall Study|Not treated|1
4538639|NCT01121406|7360662|FG001|Overall Study|Not treated|0
4538640|NCT01121484|7360673|FG000|Overall Study|Adverse Event|12
4538641|NCT01121484|7360674|FG001|Overall Study|Adverse Event|5
4538642|NCT01121484|7360673|FG000|Overall Study|Lack of Efficacy|3
4538643|NCT01121484|7360674|FG001|Overall Study|Lack of Efficacy|11
4538644|NCT01121484|7360673|FG000|Overall Study|Lost to Follow-up|5
4538645|NCT01121484|7360674|FG001|Overall Study|Lost to Follow-up|9
4538646|NCT01121484|7360673|FG000|Overall Study|Physician Decision|0
4538647|NCT01121484|7360674|FG001|Overall Study|Physician Decision|3
4538648|NCT01121484|7360673|FG000|Overall Study|Protocol Violation|1
4538649|NCT01121484|7360674|FG001|Overall Study|Protocol Violation|0
4538650|NCT01121484|7360673|FG000|Overall Study|Withdrawal by Subject|8
4538651|NCT01121484|7360674|FG001|Overall Study|Withdrawal by Subject|7
4538652|NCT01121484|7360673|FG000|Overall Study|Discontinuation of study by sponsor|0
4538653|NCT01121484|7360674|FG001|Overall Study|Discontinuation of study by sponsor|1
4538654|NCT01121484|7360673|FG000|Overall Study|Other|3
4538655|NCT01121484|7360674|FG001|Overall Study|Other|3
4538656|NCT01121484|7360673|FG000|Overall Study|Randomized, not treated|1
4538657|NCT01121484|7360674|FG001|Overall Study|Randomized, not treated|4
4538658|NCT01121536|7360680|FG000|Overall Study|Adverse Event|63
4538659|NCT01121536|7360680|FG000|Overall Study|Lack of Efficacy|35
4538660|NCT01121536|7360680|FG000|Overall Study|Withdrawal by Subject|65
4538661|NCT01121536|7360680|FG000|Overall Study|Protocol Violation|20
4538662|NCT01121536|7360680|FG000|Overall Study|Noncompliance with study medication|12
4538663|NCT01121536|7360680|FG000|Overall Study|Noncompliance with study procedures|9
4538664|NCT01121536|7360680|FG000|Overall Study|Lost to Follow-up|39
4538665|NCT01121536|7360680|FG000|Overall Study|Other|118
4538666|NCT01121549|7360684|FG000|Overall Study|Adverse Event|10
4538667|NCT01121549|7360684|FG000|Overall Study|Lack of Efficacy|11
4538668|NCT01121549|7360684|FG000|Overall Study|Lost to Follow-up|12
4538669|NCT01121549|7360684|FG000|Overall Study|Did not meet entrance criteria|9
4538670|NCT01121549|7360684|FG000|Overall Study|Study terminated by sponsor|197
4538671|NCT01121549|7360684|FG000|Overall Study|Pregnancy|1
4538672|NCT01121549|7360684|FG000|Overall Study|Protocol Violation|33
4538673|NCT01121549|7360684|FG000|Overall Study|Withdrawal by Subject|16
4611039|NCT01696994|7467292|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2
4611040|NCT01696994|7467291|FG000|Overall Study|Died Before Randomization|1
4611041|NCT01696994|7467292|FG001|Overall Study|Died Before Randomization|2
4611042|NCT01696994|7467291|FG000|Overall Study|Died Before ASU (Control)|73
4611043|NCT01696994|7467292|FG001|Overall Study|Died Before ASU (Control)|0
4611044|NCT01696994|7467291|FG000|Overall Study|No Ovaries at Baseline|4807
4611045|NCT01696994|7467292|FG001|Overall Study|No Ovaries at Baseline|4851
4611046|NCT01696994|7467291|FG000|Overall Study|Refused ASU (Control)|311
4611047|NCT01696994|7467292|FG001|Overall Study|Refused ASU (Control)|0
4611048|NCT01696994|7467291|FG000|Overall Study|Refused Screen (Ovarian Screening)|0
4611049|NCT01696994|7467292|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582
4611050|NCT01697319|7467300|FG000|Primary Phase|Withdrawal by Subject|1
4611051|NCT01697319|7467300|FG000|Extension Phase|Terminated by Sponsor|15
4456840|NCT00550680|7244094|FG000|Overall Study|Death|3
4456841|NCT00550680|7244094|FG000|Overall Study|Early Improvement|1
4456842|NCT00550680|7244094|FG000|Overall Study|Lost to Follow-up|3
4538674|NCT01121549|7360684|FG000|Overall Study|Other|58
4538675|NCT01121562|7360688|FG000|Overall Study|Objective progression or relapse|8
4538676|NCT01121562|7360688|FG000|Overall Study|Withdrawal by Subject|1
4538677|NCT01121562|7360688|FG000|Overall Study|Adverse Event|1
4538678|NCT01121562|7360688|FG000|Overall Study|Sponsor Decision|1
4538679|NCT01121562|7360688|FG000|Overall Study|Met study discontinuation criteria|1
4538680|NCT01121575|7360698|FG000|Overall Study|Participant Refused Further Follow-Up|0
4538681|NCT01121575|7360699|FG001|Overall Study|Participant Refused Further Follow-Up|0
4538682|NCT01121575|7360700|FG002|Overall Study|Participant Refused Further Follow-Up|0
4538683|NCT01121575|7360701|FG003|Overall Study|Participant Refused Further Follow-Up|0
4538684|NCT01121575|7360702|FG004|Overall Study|Participant Refused Further Follow-Up|5
4611052|NCT01697345|7467304|FG000|Overall Study|Withdrawal by Subject|1
4611053|NCT01697358|7467325|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6
4611054|NCT01697358|7467326|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0
4611055|NCT01697358|7467325|FG000|Period I: Randomization to 6 Months|Physician Decision|4
4611056|NCT01697358|7467326|FG001|Period I: Randomization to 6 Months|Physician Decision|0
4456843|NCT00550680|7244094|FG000|Overall Study|Lack of Efficacy|1
4456844|NCT00550680|7244094|FG000|Overall Study|Other|10
4456845|NCT00550680|7244094|FG000|Overall Study|Protocol Violation|7
4456846|NCT00550680|7244094|FG000|Overall Study|Refused Treatment|19
4456847|NCT00550680|7244094|FG000|Overall Study|Screen Failure|6
4456848|NCT00550732|7244098|FG000|Overall Study|Death|4
4456849|NCT00550732|7244098|FG000|Overall Study|Withdrawal by Subject|2
4456850|NCT00550732|7244098|FG000|Overall Study|Physician Decision|2
4456851|NCT00550732|7244098|FG000|Overall Study|Lost to Follow-up|1
4456852|NCT00550732|7244098|FG000|Overall Study|Palliative care|1
4456853|NCT00550732|7244098|FG000|Overall Study|Adverse Event|1
4456854|NCT00550745|7244105|FG000|Overall Study|Death|20
4456855|NCT00550745|7244106|FG001|Overall Study|Death|16
4456856|NCT00550745|7244105|FG000|Overall Study|Lost to Follow-up|45
4456857|NCT00550745|7244106|FG001|Overall Study|Lost to Follow-up|30
4456858|NCT00550745|7244105|FG000|Overall Study|Physician Decision|0
4456859|NCT00550745|7244106|FG001|Overall Study|Physician Decision|2
4456860|NCT00550745|7244105|FG000|Overall Study|Protocol Violation|4
4456861|NCT00550745|7244106|FG001|Overall Study|Protocol Violation|2
4456862|NCT00550745|7244105|FG000|Overall Study|Withdrawal by Subject|17
4456863|NCT00550745|7244106|FG001|Overall Study|Withdrawal by Subject|10
4456864|NCT00550745|7244105|FG000|Overall Study|Screen failure|1
4456865|NCT00550745|7244106|FG001|Overall Study|Screen failure|0
4456866|NCT00550771|7244114|FG000|Overall Study|Adverse Event|11
4456867|NCT00550771|7244115|FG001|Overall Study|Adverse Event|3
4456868|NCT00550771|7244114|FG000|Overall Study|Discontinued for study-related reasons|0
4456869|NCT00550771|7244115|FG001|Overall Study|Discontinued for study-related reasons|1
4456870|NCT00550771|7244114|FG000|Overall Study|Physician Decision|2
4456871|NCT00550771|7244115|FG001|Overall Study|Physician Decision|0
4456872|NCT00550771|7244114|FG000|Overall Study|Withdrawal by Subject|0
4456873|NCT00550771|7244115|FG001|Overall Study|Withdrawal by Subject|1
4456874|NCT00550771|7244114|FG000|Overall Study|Protocol Violation|4
4456875|NCT00550771|7244115|FG001|Overall Study|Protocol Violation|5
4456876|NCT00550836|7244123|FG000|Overall Study|Withdrawal by Subject|3
4456877|NCT00550836|7244124|FG001|Overall Study|Withdrawal by Subject|9
4456878|NCT00550953|7244149|FG000|Overall Study|Adverse Event|4
4456879|NCT00550953|7244150|FG001|Overall Study|Adverse Event|3
4456880|NCT00550953|7244149|FG000|Overall Study|Not able to visit the site|2
4456881|NCT00550953|7244150|FG001|Overall Study|Not able to visit the site|3
4456882|NCT00551031|7244161|FG000|Overall Study|Adverse Event|0
4456883|NCT00551031|7244162|FG001|Overall Study|Adverse Event|1
4456884|NCT00551031|7244163|FG002|Overall Study|Adverse Event|0
4456885|NCT00551031|7244164|FG003|Overall Study|Adverse Event|0
4456886|NCT00551031|7244165|FG004|Overall Study|Adverse Event|0
4456887|NCT00551031|7244161|FG000|Overall Study|Protocol Violation|1
4456888|NCT00551031|7244162|FG001|Overall Study|Protocol Violation|1
4456889|NCT00551031|7244163|FG002|Overall Study|Protocol Violation|0
4456890|NCT00551031|7244164|FG003|Overall Study|Protocol Violation|0
4456891|NCT00551031|7244165|FG004|Overall Study|Protocol Violation|0
4538685|NCT01121575|7360703|FG005|Overall Study|Participant Refused Further Follow-Up|1
4538686|NCT01121575|7360698|FG000|Overall Study|Unspecified Reasons|8
4538687|NCT01121575|7360699|FG001|Overall Study|Unspecified Reasons|6
4538688|NCT01121575|7360700|FG002|Overall Study|Unspecified Reasons|7
4611057|NCT01697358|7467325|FG000|Period I: Randomization to 6 Months|Adverse Event|1
4538689|NCT01121575|7360701|FG003|Overall Study|Unspecified Reasons|5
4611058|NCT01697358|7467326|FG001|Period I: Randomization to 6 Months|Adverse Event|1
4611059|NCT01697358|7467325|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2
4611060|NCT01697358|7467326|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0
4611061|NCT01697358|7467325|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3
4611062|NCT01697358|7467326|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12
4611063|NCT01697358|7467325|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8
4611064|NCT01697358|7467326|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10
4538690|NCT01121575|7360702|FG004|Overall Study|Unspecified Reasons|13
4538691|NCT01121575|7360703|FG005|Overall Study|Unspecified Reasons|10
4538692|NCT01121575|7360698|FG000|Overall Study|Death|6
4538693|NCT01121575|7360699|FG001|Overall Study|Death|0
4538694|NCT01121575|7360700|FG002|Overall Study|Death|0
4611065|NCT01697358|7467325|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3
4456892|NCT00551031|7244161|FG000|Overall Study|Lost to Follow-up|0
4456893|NCT00551031|7244162|FG001|Overall Study|Lost to Follow-up|1
4456894|NCT00551031|7244163|FG002|Overall Study|Lost to Follow-up|0
4456895|NCT00551031|7244164|FG003|Overall Study|Lost to Follow-up|1
4456896|NCT00551031|7244165|FG004|Overall Study|Lost to Follow-up|1
4538695|NCT01121575|7360701|FG003|Overall Study|Death|1
4538696|NCT01121575|7360702|FG004|Overall Study|Death|7
4538697|NCT01121575|7360703|FG005|Overall Study|Death|1
4456897|NCT00551031|7244161|FG000|Overall Study|Withdrawal by Subject|0
4456898|NCT00551031|7244162|FG001|Overall Study|Withdrawal by Subject|4
4538698|NCT01121666|7360724|FG000|Overall Study|Protocol Violation|29
4456899|NCT00551031|7244163|FG002|Overall Study|Withdrawal by Subject|1
4456900|NCT00551031|7244164|FG003|Overall Study|Withdrawal by Subject|2
4456901|NCT00551031|7244165|FG004|Overall Study|Withdrawal by Subject|0
4456902|NCT00551031|7244161|FG000|Overall Study|Serious Adverse Event|0
4456903|NCT00551031|7244162|FG001|Overall Study|Serious Adverse Event|2
4456904|NCT00551031|7244163|FG002|Overall Study|Serious Adverse Event|1
4456905|NCT00551031|7244164|FG003|Overall Study|Serious Adverse Event|0
4456906|NCT00551031|7244165|FG004|Overall Study|Serious Adverse Event|0
4456907|NCT00551031|7244161|FG000|Overall Study|Did not receive vaccine|1
4456908|NCT00551031|7244162|FG001|Overall Study|Did not receive vaccine|2
4456909|NCT00551031|7244163|FG002|Overall Study|Did not receive vaccine|0
4456910|NCT00551031|7244164|FG003|Overall Study|Did not receive vaccine|0
4456911|NCT00551031|7244165|FG004|Overall Study|Did not receive vaccine|0
4456912|NCT00551135|7244185|FG000|Overall Study|Adverse Event|1
4456913|NCT00551135|7244186|FG001|Overall Study|Adverse Event|0
4456914|NCT00551135|7244187|FG002|Overall Study|Adverse Event|1
4456915|NCT00551135|7244188|FG003|Overall Study|Adverse Event|1
4456916|NCT00551135|7244185|FG000|Overall Study|Lost to Follow-up|0
4456917|NCT00551135|7244186|FG001|Overall Study|Lost to Follow-up|0
4456918|NCT00551135|7244187|FG002|Overall Study|Lost to Follow-up|0
4456919|NCT00551135|7244188|FG003|Overall Study|Lost to Follow-up|1
4456920|NCT00551135|7244185|FG000|Overall Study|Other|3
4456921|NCT00551135|7244186|FG001|Overall Study|Other|2
4456922|NCT00551135|7244187|FG002|Overall Study|Other|1
4456923|NCT00551135|7244188|FG003|Overall Study|Other|2
4456924|NCT00551135|7244185|FG000|Overall Study|Withdrawal by Subject|1
4456925|NCT00551135|7244186|FG001|Overall Study|Withdrawal by Subject|0
4456926|NCT00551135|7244187|FG002|Overall Study|Withdrawal by Subject|3
4611066|NCT01697358|7467326|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3
4611067|NCT01697358|7467325|FG000|Period II: 6-24M Long-term Follow-up|Death|1
4611068|NCT01697358|7467326|FG001|Period II: 6-24M Long-term Follow-up|Death|1
4611069|NCT01697358|7467325|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0
4611070|NCT01697358|7467326|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3
4611071|NCT01697358|7467325|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34
4611072|NCT01697358|7467326|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26
4611073|NCT01697449|7467332|FG000|Overall Study|Disease progression|47
4611074|NCT01697449|7467332|FG000|Overall Study|Adverse Event|7
4611075|NCT01697449|7467332|FG000|Overall Study|Lost to Follow-up|5
4611076|NCT01697449|7467332|FG000|Overall Study|Withdrawal by Subject|2
4611077|NCT01697449|7467332|FG000|Overall Study|Physician Decision|1
4611078|NCT01697449|7467332|FG000|Overall Study|Death|2
4611079|NCT01697449|7467332|FG000|Overall Study|Other|1
4611080|NCT01697449|7467332|FG000|Overall Study|Missing|25
4611081|NCT01697462|7467339|FG000|Overall Study|Disease Progression|1
4611082|NCT01697462|7467339|FG000|Overall Study|Adverse Event|6
4611083|NCT01697462|7467339|FG000|Overall Study|Lost to Follow-up|21
4611084|NCT01697462|7467339|FG000|Overall Study|Withdrawal by Subject|12
4611085|NCT01697462|7467339|FG000|Overall Study|Investigator Decision|21
4611086|NCT01697462|7467339|FG000|Overall Study|Death|1
4611087|NCT01697462|7467339|FG000|Overall Study|Other|10
4611088|NCT01697462|7467339|FG000|Overall Study|Missing|5
4611089|NCT01697501|7467343|FG000|Overall Study|Protocol Violation|2
4611090|NCT01697579|7467361|FG000|Base Study-Cycle 1|Adverse Event|1
4611091|NCT01697579|7467362|FG001|Base Study-Cycle 1|Adverse Event|0
4611092|NCT01697579|7467363|FG002|Base Study-Cycle 1|Adverse Event|0
4611093|NCT01697579|7467364|FG003|Base Study-Cycle 1|Adverse Event|0
4611094|NCT01697579|7467365|FG004|Base Study-Cycle 1|Adverse Event|0
4611095|NCT01697579|7467366|FG005|Base Study-Cycle 1|Adverse Event|0
4611096|NCT01697579|7467367|FG006|Base Study-Cycle 1|Adverse Event|0
4611097|NCT01697579|7467361|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1
4611098|NCT01697579|7467362|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
4611099|NCT01697579|7467363|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
4611100|NCT01697579|7467364|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
4611101|NCT01697579|7467365|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
4611102|NCT01697579|7467366|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
4611103|NCT01697579|7467367|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
4611104|NCT01697579|7467361|FG000|Base Study-Cycle 1|Protocol Violation|0
4611105|NCT01697579|7467362|FG001|Base Study-Cycle 1|Protocol Violation|0
4611106|NCT01697579|7467363|FG002|Base Study-Cycle 1|Protocol Violation|0
4611107|NCT01697579|7467364|FG003|Base Study-Cycle 1|Protocol Violation|0
4611108|NCT01697579|7467365|FG004|Base Study-Cycle 1|Protocol Violation|3
4611109|NCT01697579|7467366|FG005|Base Study-Cycle 1|Protocol Violation|0
4611110|NCT01697579|7467367|FG006|Base Study-Cycle 1|Protocol Violation|0
4611111|NCT01697579|7467361|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0
4611112|NCT01697579|7467362|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1
4611113|NCT01697579|7467363|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0
4611114|NCT01697579|7467364|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0
4456927|NCT00551135|7244188|FG003|Overall Study|Withdrawal by Subject|1
4456928|NCT00551161|7244198|FG000|Overall Study|Withdrawal by Subject|1
4456929|NCT00551213|7244223|FG000|Overall Study|Adverse Event|6
4456930|NCT00551213|7244224|FG001|Overall Study|Adverse Event|3
4456931|NCT00551213|7244223|FG000|Overall Study|Progressive Disease|41
4456932|NCT00551213|7244224|FG001|Overall Study|Progressive Disease|12
4456933|NCT00551213|7244223|FG000|Overall Study|Withdrawal by Subject|2
4456934|NCT00551213|7244224|FG001|Overall Study|Withdrawal by Subject|0
4456935|NCT00551213|7244223|FG000|Overall Study|Not Treated|1
4456936|NCT00551213|7244224|FG001|Overall Study|Not Treated|2
4456937|NCT00551291|7244230|FG000|Overall Study|Physician Decision|1
4456938|NCT00551369|7244234|FG000|Overall Study|Protocol Violation|5
4456939|NCT00551369|7244234|FG000|Overall Study|Withdrawal by Subject|1
4456940|NCT00551369|7244234|FG000|Overall Study|Not treated per protocol and re|1
4456941|NCT00551421|7244238|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1
4456942|NCT00551460|7244243|FG000|Overall Study|Adverse Event|1
4456943|NCT00551460|7244243|FG000|Overall Study|Withdrawal by Subject|1
4456944|NCT00551460|7244243|FG000|Overall Study|Physician Decision|1
4456945|NCT00551460|7244243|FG000|Overall Study|Death|7
4456946|NCT00551460|7244243|FG000|Overall Study|Ineligible|4
4456947|NCT00551460|7244243|FG000|Overall Study|Not analyzable (did not start treatment)|4
4456948|NCT00551525|7244247|FG000|Overall Study|Protocol Violation|5
4456949|NCT00551642|7244253|FG000|Treatment Period|Protocol Deviation|6
4456950|NCT00551642|7244254|FG001|Treatment Period|Protocol Deviation|11
4456951|NCT00551642|7244253|FG000|Treatment Period|Delivery device failure|1
4456952|NCT00551642|7244254|FG001|Treatment Period|Delivery device failure|3
4456953|NCT00551642|7244253|FG000|Treatment Period|Physician Decision|0
4456954|NCT00551642|7244254|FG001|Treatment Period|Physician Decision|1
4456955|NCT00551642|7244253|FG000|Treatment Period|Death|33
4456956|NCT00551642|7244254|FG001|Treatment Period|Death|31
4456957|NCT00551642|7244253|FG000|Treatment Period|Inclusion/Exclusion criteria|4
4456958|NCT00551642|7244254|FG001|Treatment Period|Inclusion/Exclusion criteria|4
4456959|NCT00551642|7244253|FG000|Treatment Period|Adverse Event|15
4456960|NCT00551642|7244254|FG001|Treatment Period|Adverse Event|12
4456961|NCT00551642|7244253|FG000|Treatment Period|Withdrawal by Subject|2
4456962|NCT00551642|7244254|FG001|Treatment Period|Withdrawal by Subject|1
4456963|NCT00551759|7244292|FG000|Overall Study|Adverse Event|7
4456964|NCT00551759|7244292|FG000|Overall Study|Death|5
4456965|NCT00551759|7244292|FG000|Overall Study|Ineligible|1
4456966|NCT00552058|7244298|FG000|Overall Study|Adverse Event|8
4456967|NCT00552058|7244299|FG001|Overall Study|Adverse Event|7
4456968|NCT00552058|7244298|FG000|Overall Study|Lack of Efficacy|1
4456969|NCT00552058|7244299|FG001|Overall Study|Lack of Efficacy|5
4456970|NCT00552058|7244298|FG000|Overall Study|Lost to Follow-up|1
4456971|NCT00552058|7244299|FG001|Overall Study|Lost to Follow-up|0
4456972|NCT00552058|7244298|FG000|Overall Study|Withdrawal by Subject|4
4456973|NCT00552058|7244299|FG001|Overall Study|Withdrawal by Subject|4
4456974|NCT00552058|7244298|FG000|Overall Study|Other: Protocol Violation|0
4456975|NCT00552058|7244299|FG001|Overall Study|Other: Protocol Violation|1
4456976|NCT00552058|7244298|FG000|Overall Study|Other: Non Compliance|1
4456977|NCT00552058|7244299|FG001|Overall Study|Other: Non Compliance|2
4456978|NCT00552058|7244298|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0
4456979|NCT00552058|7244299|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1
4456980|NCT00552058|7244298|FG000|Overall Study|Other: Low CDAI score, entry violation|0
4456981|NCT00552058|7244299|FG001|Overall Study|Other: Low CDAI score, entry violation|1
4456982|NCT00552058|7244298|FG000|Overall Study|Other: Positive Stool Result|0
4456983|NCT00552058|7244299|FG001|Overall Study|Other: Positive Stool Result|1
4456984|NCT00552058|7244298|FG000|Overall Study|Other: Randomized in error|0
4456985|NCT00552058|7244299|FG001|Overall Study|Other: Randomized in error|1
4456986|NCT00552058|7244298|FG000|Overall Study|Other: Sponsors Decision|0
4456987|NCT00552058|7244299|FG001|Overall Study|Other: Sponsors Decision|1
4456988|NCT00552058|7244298|FG000|Overall Study|Other: Early Roll Over|1
4456989|NCT00552058|7244299|FG001|Overall Study|Other: Early Roll Over|0
4456990|NCT00552071|7244307|FG000|Overall Study|Adverse Event|1
4456991|NCT00552071|7244308|FG001|Overall Study|Adverse Event|0
4456992|NCT00552071|7244307|FG000|Overall Study|Lack of Efficacy|1
4456993|NCT00552071|7244308|FG001|Overall Study|Lack of Efficacy|0
4456994|NCT00552071|7244307|FG000|Overall Study|Physician Decision|1
4456995|NCT00552071|7244308|FG001|Overall Study|Physician Decision|0
4456996|NCT00552071|7244307|FG000|Overall Study|Pregnancy|1
4456997|NCT00552071|7244308|FG001|Overall Study|Pregnancy|0
4456998|NCT00552071|7244307|FG000|Overall Study|Death|0
4456999|NCT00552071|7244308|FG001|Overall Study|Death|1
4457000|NCT00552071|7244307|FG000|Overall Study|Withdrawal by Subject|0
4457001|NCT00552071|7244308|FG001|Overall Study|Withdrawal by Subject|1
4457002|NCT00552084|7244318|FG000|Overall Study|Adverse Event|2
4457003|NCT00552084|7244319|FG001|Overall Study|Adverse Event|3
4457004|NCT00552084|7244318|FG000|Overall Study|Withdrawal by Subject|4
4457005|NCT00552084|7244319|FG001|Overall Study|Withdrawal by Subject|5
4457006|NCT00552084|7244318|FG000|Overall Study|Protocol Violation|1
4457007|NCT00552084|7244319|FG001|Overall Study|Protocol Violation|0
4457008|NCT00552084|7244318|FG000|Overall Study|change in anti-arrythmic drug|1
4457009|NCT00552084|7244319|FG001|Overall Study|change in anti-arrythmic drug|1
4457010|NCT00552110|7244330|FG000|Overall Study|Serious or Life-Threatening AE|0
4457011|NCT00552110|7244331|FG001|Overall Study|Serious or Life-Threatening AE|0
4457012|NCT00552110|7244332|FG002|Overall Study|Serious or Life-Threatening AE|1
4457013|NCT00552110|7244333|FG003|Overall Study|Serious or Life-Threatening AE|0
4457014|NCT00552110|7244334|FG004|Overall Study|Serious or Life-Threatening AE|0
4457015|NCT00552110|7244330|FG000|Overall Study|Lack of Efficacy|1
4457016|NCT00552110|7244331|FG001|Overall Study|Lack of Efficacy|0
4457017|NCT00552110|7244332|FG002|Overall Study|Lack of Efficacy|0
4457018|NCT00552110|7244333|FG003|Overall Study|Lack of Efficacy|1
4457019|NCT00552110|7244334|FG004|Overall Study|Lack of Efficacy|4
4457020|NCT00552110|7244330|FG000|Overall Study|Withdrawal by Subject|0
4457021|NCT00552110|7244331|FG001|Overall Study|Withdrawal by Subject|2
4457022|NCT00552110|7244332|FG002|Overall Study|Withdrawal by Subject|0
4457023|NCT00552110|7244333|FG003|Overall Study|Withdrawal by Subject|3
4457024|NCT00552110|7244334|FG004|Overall Study|Withdrawal by Subject|2
4457025|NCT00552110|7244330|FG000|Overall Study|Lost to Follow-up|0
4457026|NCT00552110|7244331|FG001|Overall Study|Lost to Follow-up|0
4457027|NCT00552110|7244332|FG002|Overall Study|Lost to Follow-up|0
4457028|NCT00552110|7244333|FG003|Overall Study|Lost to Follow-up|1
4457029|NCT00552110|7244334|FG004|Overall Study|Lost to Follow-up|1
4457030|NCT00552110|7244330|FG000|Overall Study|Failed to Comply With Study Requirements|1
4457031|NCT00552110|7244331|FG001|Overall Study|Failed to Comply With Study Requirements|1
4457032|NCT00552110|7244332|FG002|Overall Study|Failed to Comply With Study Requirements|1
4457033|NCT00552110|7244333|FG003|Overall Study|Failed to Comply With Study Requirements|0
4457034|NCT00552110|7244334|FG004|Overall Study|Failed to Comply With Study Requirements|1
4457035|NCT00552110|7244330|FG000|Overall Study|Withdrawn per Sponsor|0
4457036|NCT00552110|7244331|FG001|Overall Study|Withdrawn per Sponsor|1
4457037|NCT00552110|7244332|FG002|Overall Study|Withdrawn per Sponsor|0
4457038|NCT00552110|7244333|FG003|Overall Study|Withdrawn per Sponsor|0
4457039|NCT00552110|7244334|FG004|Overall Study|Withdrawn per Sponsor|1
4457040|NCT00552110|7244330|FG000|Overall Study|Use of Prohibited Medication|1
4457041|NCT00552110|7244331|FG001|Overall Study|Use of Prohibited Medication|1
4457042|NCT00552110|7244332|FG002|Overall Study|Use of Prohibited Medication|0
4457043|NCT00552110|7244333|FG003|Overall Study|Use of Prohibited Medication|0
4457044|NCT00552110|7244334|FG004|Overall Study|Use of Prohibited Medication|0
4457045|NCT00552110|7244330|FG000|Overall Study|Delay of Study due to Relabeling|0
4457046|NCT00552110|7244331|FG001|Overall Study|Delay of Study due to Relabeling|0
4457047|NCT00552110|7244332|FG002|Overall Study|Delay of Study due to Relabeling|0
4457048|NCT00552110|7244333|FG003|Overall Study|Delay of Study due to Relabeling|1
4457049|NCT00552110|7244334|FG004|Overall Study|Delay of Study due to Relabeling|0
4457050|NCT00552110|7244330|FG000|Overall Study|Increased Blood Pressure at Visit 2|0
4457051|NCT00552110|7244331|FG001|Overall Study|Increased Blood Pressure at Visit 2|0
4457052|NCT00552110|7244332|FG002|Overall Study|Increased Blood Pressure at Visit 2|0
4457053|NCT00552110|7244333|FG003|Overall Study|Increased Blood Pressure at Visit 2|1
4457054|NCT00552110|7244334|FG004|Overall Study|Increased Blood Pressure at Visit 2|0
4457055|NCT00552110|7244330|FG000|Overall Study|Nonserious Adverse Event (AE)|1
4457056|NCT00552110|7244331|FG001|Overall Study|Nonserious Adverse Event (AE)|0
4457057|NCT00552110|7244332|FG002|Overall Study|Nonserious Adverse Event (AE)|0
4457058|NCT00552110|7244333|FG003|Overall Study|Nonserious Adverse Event (AE)|1
4457059|NCT00552110|7244334|FG004|Overall Study|Nonserious Adverse Event (AE)|0
4457060|NCT00552175|7244349|FG000|Overall Study|Lack of Efficacy|2
4457061|NCT00552175|7244350|FG001|Overall Study|Lack of Efficacy|0
4457062|NCT00552175|7244351|FG002|Overall Study|Lack of Efficacy|1
4457063|NCT00552175|7244349|FG000|Overall Study|Adverse Event|9
4457064|NCT00552175|7244350|FG001|Overall Study|Adverse Event|9
4457065|NCT00552175|7244351|FG002|Overall Study|Adverse Event|10
4457066|NCT00552175|7244349|FG000|Overall Study|Withdrawal by Subject|2
4457067|NCT00552175|7244350|FG001|Overall Study|Withdrawal by Subject|2
4457068|NCT00552175|7244351|FG002|Overall Study|Withdrawal by Subject|1
4457069|NCT00552175|7244349|FG000|Overall Study|Lost to Follow-up|0
4457070|NCT00552175|7244350|FG001|Overall Study|Lost to Follow-up|0
4457071|NCT00552175|7244351|FG002|Overall Study|Lost to Follow-up|1
4457072|NCT00552175|7244349|FG000|Overall Study|Entry Criteria Not Met|1
4457073|NCT00552175|7244350|FG001|Overall Study|Entry Criteria Not Met|1
4457074|NCT00552175|7244351|FG002|Overall Study|Entry Criteria Not Met|0
4457075|NCT00552175|7244349|FG000|Overall Study|Reason Not Specified|3
4457076|NCT00552175|7244350|FG001|Overall Study|Reason Not Specified|1
4611115|NCT01697579|7467365|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0
4611116|NCT01697579|7467366|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0
4611117|NCT01697579|7467367|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0
4611118|NCT01697579|7467361|FG000|Base Study-Cycle 1|Technical Problems|0
4611119|NCT01697579|7467362|FG001|Base Study-Cycle 1|Technical Problems|0
4611120|NCT01697579|7467363|FG002|Base Study-Cycle 1|Technical Problems|1
4611121|NCT01697579|7467364|FG003|Base Study-Cycle 1|Technical Problems|1
4611122|NCT01697579|7467365|FG004|Base Study-Cycle 1|Technical Problems|0
4611123|NCT01697579|7467366|FG005|Base Study-Cycle 1|Technical Problems|0
4611124|NCT01697579|7467367|FG006|Base Study-Cycle 1|Technical Problems|0
4611125|NCT01697579|7467361|FG000|Optional Extension-Cycles 2-6|Death|0
4611126|NCT01697579|7467362|FG001|Optional Extension-Cycles 2-6|Death|0
4611127|NCT01697579|7467363|FG002|Optional Extension-Cycles 2-6|Death|0
4611128|NCT01697579|7467364|FG003|Optional Extension-Cycles 2-6|Death|0
4611129|NCT01697579|7467365|FG004|Optional Extension-Cycles 2-6|Death|0
4611130|NCT01697579|7467366|FG005|Optional Extension-Cycles 2-6|Death|0
4457077|NCT00552175|7244351|FG002|Overall Study|Reason Not Specified|1
4457078|NCT00552188|7244362|FG000|Overall Study|Adverse Event|0
4457079|NCT00552188|7244363|FG001|Overall Study|Adverse Event|2
4457080|NCT00552188|7244362|FG000|Overall Study|Lost to Follow-up|2
4457081|NCT00552188|7244363|FG001|Overall Study|Lost to Follow-up|1
4457082|NCT00552188|7244362|FG000|Overall Study|Withdrawal of consent|0
4457083|NCT00552188|7244363|FG001|Overall Study|Withdrawal of consent|1
4457084|NCT00552188|7244362|FG000|Overall Study|Subject returned to home country|0
4457085|NCT00552188|7244363|FG001|Overall Study|Subject returned to home country|1
4457086|NCT00552240|7244371|FG000|Overall Study|Adverse Event|9
4457087|NCT00552240|7244372|FG001|Overall Study|Adverse Event|9
4457088|NCT00552240|7244371|FG000|Overall Study|Protocol Violation|1
4457089|NCT00552240|7244372|FG001|Overall Study|Protocol Violation|1
4457090|NCT00552240|7244371|FG000|Overall Study|Lost to Follow-up|5
4457091|NCT00552240|7244372|FG001|Overall Study|Lost to Follow-up|6
4457092|NCT00552240|7244371|FG000|Overall Study|Withdrawal by Subject|2
4457093|NCT00552240|7244372|FG001|Overall Study|Withdrawal by Subject|2
4457094|NCT00552240|7244371|FG000|Overall Study|Lack of Efficacy|6
4457095|NCT00552240|7244372|FG001|Overall Study|Lack of Efficacy|0
4457096|NCT00552240|7244371|FG000|Overall Study|Other|1
4457097|NCT00552240|7244372|FG001|Overall Study|Other|0
4457098|NCT00552279|7244380|FG000|Overall Study|Adverse Event|0
4457099|NCT00552279|7244381|FG001|Overall Study|Adverse Event|1
4457100|NCT00552279|7244380|FG000|Overall Study|Withdrawal by Subject|12
4457101|NCT00552279|7244381|FG001|Overall Study|Withdrawal by Subject|1
4457102|NCT00552279|7244380|FG000|Overall Study|Lost to Follow-up|1
4457103|NCT00552279|7244381|FG001|Overall Study|Lost to Follow-up|0
4457104|NCT00552279|7244380|FG000|Overall Study|Other|1
4457105|NCT00552279|7244381|FG001|Overall Study|Other|1
4457106|NCT00552305|7244387|FG000|Overall Study|Adverse Event|43
4457107|NCT00552305|7244387|FG000|Overall Study|Lack of Efficacy|120
4457108|NCT00552305|7244387|FG000|Overall Study|Lost to Follow-up|4
4457109|NCT00552305|7244387|FG000|Overall Study|Protocol Violation|3
4611131|NCT01697579|7467367|FG006|Optional Extension-Cycles 2-6|Death|2
4611132|NCT01697579|7467361|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
4611133|NCT01697579|7467362|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
4611134|NCT01697579|7467363|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
4611135|NCT01697579|7467364|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
4611136|NCT01697579|7467365|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
4611137|NCT01697579|7467366|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1
4611138|NCT01697579|7467367|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5
4611139|NCT01697579|7467361|FG000|Optional Extension-Cycles 2-6|Physician Decision|0
4611140|NCT01697579|7467362|FG001|Optional Extension-Cycles 2-6|Physician Decision|0
4611141|NCT01697579|7467363|FG002|Optional Extension-Cycles 2-6|Physician Decision|0
4611142|NCT01697579|7467364|FG003|Optional Extension-Cycles 2-6|Physician Decision|0
4611143|NCT01697579|7467365|FG004|Optional Extension-Cycles 2-6|Physician Decision|0
4611144|NCT01697579|7467366|FG005|Optional Extension-Cycles 2-6|Physician Decision|7
4611145|NCT01697579|7467367|FG006|Optional Extension-Cycles 2-6|Physician Decision|11
4611146|NCT01697579|7467361|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0
4611147|NCT01697579|7467362|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0
4611148|NCT01697579|7467363|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0
4611149|NCT01697579|7467364|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0
4611150|NCT01697579|7467365|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0
4611151|NCT01697579|7467366|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0
4611152|NCT01697579|7467367|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4
4611153|NCT01697579|7467361|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0
4611154|NCT01697579|7467362|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0
4457110|NCT00552305|7244387|FG000|Overall Study|Withdrawal by Subject|44
4457111|NCT00552305|7244387|FG000|Overall Study|Lack of efficacy/withdrew consent|1
4457112|NCT00552305|7244387|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3
4457113|NCT00552305|7244387|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2
4457114|NCT00552305|7244387|FG000|Overall Study|Unsatisfactory compliance|11
4457115|NCT00552305|7244387|FG000|Overall Study|Poor compliance/lost to follow-up|1
4457116|NCT00552305|7244387|FG000|Overall Study|AE/Other: prohibited drug required|1
4457117|NCT00552305|7244387|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1
4457118|NCT00552305|7244387|FG000|Overall Study|Other: Site closed|4
4457119|NCT00552305|7244387|FG000|Overall Study|Other: Personal problems|1
4457120|NCT00552305|7244387|FG000|Overall Study|Other: Unable to attend visits|1
4457121|NCT00552305|7244387|FG000|Overall Study|Other: Subject underwent surgery|4
4457122|NCT00552305|7244387|FG000|Overall Study|Other: Subject became pregnant|1
4457123|NCT00552305|7244387|FG000|Overall Study|Other: Health problems, not drug related|1
4457124|NCT00552305|7244387|FG000|Overall Study|Other: Subject moved from area|2
4457125|NCT00552305|7244387|FG000|Overall Study|Other: Subject incarcerated|1
4457126|NCT00552305|7244387|FG000|Overall Study|Other: Subject went to rehab|1
4457127|NCT00552344|7244391|FG000|Overall Study|Lack of Efficacy|55
4457128|NCT00552344|7244391|FG000|Overall Study|Loss of efficacy|75
4457129|NCT00552344|7244391|FG000|Overall Study|Lost to Follow-up|8
4457130|NCT00552344|7244391|FG000|Overall Study|Withdrawal by Subject|48
4457131|NCT00552344|7244391|FG000|Overall Study|SAE, non-fatal|6
4457132|NCT00552344|7244391|FG000|Overall Study|AE, non-serious non-fatal|38
4457133|NCT00552344|7244391|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62
4457134|NCT00552344|7244391|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1
4457135|NCT00552344|7244391|FG000|Overall Study|Other Reason|22
4457136|NCT00552396|7244403|FG000|Overall Study|protocol withdrawal criteria|3
4457137|NCT00552396|7244404|FG001|Overall Study|protocol withdrawal criteria|3
4457138|NCT00552396|7244405|FG002|Overall Study|protocol withdrawal criteria|3
4457139|NCT00552396|7244406|FG003|Overall Study|protocol withdrawal criteria|6
4457140|NCT00552396|7244407|FG004|Overall Study|protocol withdrawal criteria|3
4457141|NCT00552396|7244408|FG005|Overall Study|protocol withdrawal criteria|3
4457142|NCT00552396|7244409|FG006|Overall Study|protocol withdrawal criteria|9
4457143|NCT00552578|7244467|FG000|Overall Study|Lost to Follow-up|1
4457144|NCT00552578|7244468|FG001|Overall Study|Lost to Follow-up|1
4457145|NCT00552617|7244484|FG000|Overall Study|Not Treated|0
4457146|NCT00552617|7244485|FG001|Overall Study|Not Treated|0
4457147|NCT00552617|7244486|FG002|Overall Study|Not Treated|1
4457148|NCT00552617|7244487|FG003|Overall Study|Not Treated|0
4457149|NCT00552617|7244488|FG004|Overall Study|Not Treated|0
4457150|NCT00552617|7244489|FG005|Overall Study|Not Treated|0
4457151|NCT00552617|7244490|FG006|Overall Study|Not Treated|0
4457152|NCT00552617|7244491|FG007|Overall Study|Not Treated|0
4457153|NCT00552617|7244492|FG008|Overall Study|Not Treated|0
4457154|NCT00552617|7244493|FG009|Overall Study|Not Treated|1
4457155|NCT00552617|7244484|FG000|Overall Study|Lost to Follow-up|0
4457156|NCT00552617|7244485|FG001|Overall Study|Lost to Follow-up|0
4457157|NCT00552617|7244486|FG002|Overall Study|Lost to Follow-up|0
4457158|NCT00552617|7244487|FG003|Overall Study|Lost to Follow-up|1
4457159|NCT00552617|7244488|FG004|Overall Study|Lost to Follow-up|0
4457160|NCT00552617|7244489|FG005|Overall Study|Lost to Follow-up|2
4457161|NCT00552617|7244490|FG006|Overall Study|Lost to Follow-up|0
4457162|NCT00552617|7244491|FG007|Overall Study|Lost to Follow-up|0
4457163|NCT00552617|7244492|FG008|Overall Study|Lost to Follow-up|2
4457164|NCT00552617|7244493|FG009|Overall Study|Lost to Follow-up|0
4457165|NCT00552669|7244517|FG000|Overall Study|Death|3
4457166|NCT00552669|7244518|FG001|Overall Study|Death|7
4457167|NCT00552760|7244535|FG000|Overall Study|Adverse Event|3
4457168|NCT00552760|7244536|FG001|Overall Study|Adverse Event|5
4457169|NCT00552760|7244535|FG000|Overall Study|Relapsed- Depressed Event|10
4457170|NCT00552760|7244536|FG001|Overall Study|Relapsed- Depressed Event|16
4457171|NCT00552760|7244535|FG000|Overall Study|Relapse- Manic Event|3
4457172|NCT00552760|7244536|FG001|Overall Study|Relapse- Manic Event|3
4457173|NCT00552760|7244535|FG000|Overall Study|Relapsed- Mixed Event|3
4457174|NCT00552760|7244536|FG001|Overall Study|Relapsed- Mixed Event|5
4457175|NCT00552760|7244535|FG000|Overall Study|Protocol Violation|0
4457176|NCT00552760|7244536|FG001|Overall Study|Protocol Violation|1
4457177|NCT00552760|7244535|FG000|Overall Study|Lost to Follow-up|1
4457178|NCT00552760|7244536|FG001|Overall Study|Lost to Follow-up|1
4457179|NCT00552760|7244535|FG000|Overall Study|Non-compliance|1
4457180|NCT00552760|7244536|FG001|Overall Study|Non-compliance|1
4457181|NCT00552760|7244535|FG000|Overall Study|Medical Condition|1
4457182|NCT00552760|7244536|FG001|Overall Study|Medical Condition|1
4457183|NCT00552760|7244535|FG000|Overall Study|Withdrawal by Subject|3
4457184|NCT00552760|7244536|FG001|Overall Study|Withdrawal by Subject|0
4457185|NCT00552760|7244535|FG000|Overall Study|Medication Change|1
4457186|NCT00552760|7244536|FG001|Overall Study|Medication Change|0
4457187|NCT00552929|7244565|FG000|Overall Study|Lost to Follow-up|0
4457188|NCT00552929|7244566|FG001|Overall Study|Lost to Follow-up|0
4457189|NCT00552929|7244567|FG002|Overall Study|Lost to Follow-up|0
4457190|NCT00552929|7244568|FG003|Overall Study|Lost to Follow-up|0
4457191|NCT00552929|7244569|FG004|Overall Study|Lost to Follow-up|0
4457192|NCT00552929|7244570|FG005|Overall Study|Lost to Follow-up|0
4457193|NCT00552929|7244571|FG006|Overall Study|Lost to Follow-up|0
4457194|NCT00552929|7244572|FG007|Overall Study|Lost to Follow-up|0
4457195|NCT00552929|7244573|FG008|Overall Study|Lost to Follow-up|1
4457196|NCT00552929|7244574|FG009|Overall Study|Lost to Follow-up|0
4457197|NCT00552929|7244565|FG000|Overall Study|Not Eligible|0
4457198|NCT00552929|7244566|FG001|Overall Study|Not Eligible|0
4457199|NCT00552929|7244567|FG002|Overall Study|Not Eligible|0
4457200|NCT00552929|7244568|FG003|Overall Study|Not Eligible|0
4457201|NCT00552929|7244569|FG004|Overall Study|Not Eligible|0
4457202|NCT00552929|7244570|FG005|Overall Study|Not Eligible|1
4457203|NCT00552929|7244571|FG006|Overall Study|Not Eligible|0
4457204|NCT00552929|7244572|FG007|Overall Study|Not Eligible|0
4457205|NCT00552929|7244573|FG008|Overall Study|Not Eligible|0
4457206|NCT00552929|7244574|FG009|Overall Study|Not Eligible|0
4457207|NCT00553059|7244598|FG000|Overall Study|Deemed ineligible|1
4457208|NCT00553059|7244599|FG001|Overall Study|Deemed ineligible|1
4457209|NCT00553059|7244598|FG000|Overall Study|Drug supply not available|0
4457210|NCT00553059|7244599|FG001|Overall Study|Drug supply not available|1
4457211|NCT00553150|7244615|FG000|Overall Study|Withdrawal by Subject|0
4457212|NCT00553150|7244616|FG001|Overall Study|Withdrawal by Subject|0
4538699|NCT01121666|7360725|FG001|Overall Study|Protocol Violation|10
4457213|NCT00553150|7244617|FG002|Overall Study|Withdrawal by Subject|0
4457214|NCT00553150|7244618|FG003|Overall Study|Withdrawal by Subject|2
4457215|NCT00553150|7244615|FG000|Overall Study|Protocol Violation|0
4457216|NCT00553150|7244616|FG001|Overall Study|Protocol Violation|0
4457217|NCT00553150|7244617|FG002|Overall Study|Protocol Violation|0
4538700|NCT01121757|7360733|FG000|First Drug|Death|1
4457218|NCT00553150|7244618|FG003|Overall Study|Protocol Violation|1
4457219|NCT00553150|7244615|FG000|Overall Study|Ineligible|0
4457220|NCT00553150|7244616|FG001|Overall Study|Ineligible|0
4457221|NCT00553150|7244617|FG002|Overall Study|Ineligible|0
4457222|NCT00553150|7244618|FG003|Overall Study|Ineligible|1
4457223|NCT00553202|7244640|FG000|Overall Study|Death|16
4457224|NCT00553202|7244640|FG000|Overall Study|Lost to Follow-up|1
4457225|NCT00553202|7244640|FG000|Overall Study|Physician Decision|28
4457226|NCT00553202|7244640|FG000|Overall Study|Withdrawal by Subject|1
4457227|NCT00553202|7244640|FG000|Overall Study|No donor identified|16
4457228|NCT00553202|7244640|FG000|Overall Study|Fails to meet organ function|6
4457229|NCT00553254|7244647|FG000|Overall Study|Death|3
4457230|NCT00553254|7244648|FG001|Overall Study|Death|6
4457231|NCT00553254|7244649|FG002|Overall Study|Death|25
4457232|NCT00553254|7244647|FG000|Overall Study|Lost to Follow-up|0
4457233|NCT00553254|7244648|FG001|Overall Study|Lost to Follow-up|0
4457234|NCT00553254|7244649|FG002|Overall Study|Lost to Follow-up|2
4457235|NCT00553254|7244647|FG000|Overall Study|Withdrawal by Subject|2
4457236|NCT00553254|7244648|FG001|Overall Study|Withdrawal by Subject|0
4457237|NCT00553254|7244649|FG002|Overall Study|Withdrawal by Subject|2
4457238|NCT00553254|7244647|FG000|Overall Study|Study terminated by Sponsor|0
4457239|NCT00553254|7244648|FG001|Overall Study|Study terminated by Sponsor|0
4457240|NCT00553254|7244649|FG002|Overall Study|Study terminated by Sponsor|1
4611155|NCT01697579|7467363|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0
4611156|NCT01697579|7467364|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0
4611157|NCT01697579|7467365|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0
4611158|NCT01697579|7467366|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1
4611159|NCT01697579|7467367|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2
4611160|NCT01697579|7467361|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
4611161|NCT01697579|7467362|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
4611162|NCT01697579|7467363|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
4457241|NCT00553254|7244647|FG000|Overall Study|Other|1
4611163|NCT01697579|7467364|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
4611164|NCT01697579|7467365|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
4611165|NCT01697579|7467366|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1
4611166|NCT01697579|7467367|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
4611167|NCT01697579|7467361|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
4611168|NCT01697579|7467362|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
4611169|NCT01697579|7467363|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
4611170|NCT01697579|7467364|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
4611171|NCT01697579|7467365|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
4611172|NCT01697579|7467366|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15
4611173|NCT01697579|7467367|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24
4611174|NCT01697579|7467361|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
4611175|NCT01697579|7467362|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
4611176|NCT01697579|7467363|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
4611177|NCT01697579|7467364|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
4611178|NCT01697579|7467365|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
4611179|NCT01697579|7467366|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4
4611180|NCT01697579|7467367|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11
4611181|NCT01697579|7467361|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
4611182|NCT01697579|7467362|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
4611183|NCT01697579|7467363|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
4611184|NCT01697579|7467364|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
4611185|NCT01697579|7467365|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
4611186|NCT01697579|7467366|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
4611187|NCT01697579|7467367|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2
4611188|NCT01697579|7467361|FG000|Optional Extension-Cycles 2-6|Technical Problems|0
4611189|NCT01697579|7467362|FG001|Optional Extension-Cycles 2-6|Technical Problems|0
4611190|NCT01697579|7467363|FG002|Optional Extension-Cycles 2-6|Technical Problems|0
4611191|NCT01697579|7467364|FG003|Optional Extension-Cycles 2-6|Technical Problems|0
4611192|NCT01697579|7467365|FG004|Optional Extension-Cycles 2-6|Technical Problems|0
4611193|NCT01697579|7467366|FG005|Optional Extension-Cycles 2-6|Technical Problems|0
4611194|NCT01697579|7467367|FG006|Optional Extension-Cycles 2-6|Technical Problems|1
4611195|NCT01697579|7467361|FG000|Optional Extension-Cycles 2-6|Participant Moved|0
4611196|NCT01697579|7467362|FG001|Optional Extension-Cycles 2-6|Participant Moved|0
4611197|NCT01697579|7467363|FG002|Optional Extension-Cycles 2-6|Participant Moved|0
4611198|NCT01697579|7467364|FG003|Optional Extension-Cycles 2-6|Participant Moved|0
4611199|NCT01697579|7467365|FG004|Optional Extension-Cycles 2-6|Participant Moved|0
4457242|NCT00553254|7244648|FG001|Overall Study|Other|0
4457243|NCT00553254|7244649|FG002|Overall Study|Other|13
4457244|NCT00553267|7244664|FG000|Overall Study|Adverse Event|8
4457245|NCT00553267|7244665|FG001|Overall Study|Adverse Event|10
4457246|NCT00553267|7244666|FG002|Overall Study|Adverse Event|5
4457247|NCT00553267|7244664|FG000|Overall Study|Non compliant with protocol|3
4457248|NCT00553267|7244665|FG001|Overall Study|Non compliant with protocol|3
4457249|NCT00553267|7244666|FG002|Overall Study|Non compliant with protocol|2
4457250|NCT00553267|7244664|FG000|Overall Study|Lost to Follow-up|0
4457251|NCT00553267|7244665|FG001|Overall Study|Lost to Follow-up|0
4457252|NCT00553267|7244666|FG002|Overall Study|Lost to Follow-up|1
4457253|NCT00553267|7244664|FG000|Overall Study|Consent withdrawn|2
4457254|NCT00553267|7244665|FG001|Overall Study|Consent withdrawn|3
4457255|NCT00553267|7244666|FG002|Overall Study|Consent withdrawn|1
4457256|NCT00553267|7244664|FG000|Overall Study|Specified category|1
4457257|NCT00553267|7244665|FG001|Overall Study|Specified category|2
4457258|NCT00553267|7244666|FG002|Overall Study|Specified category|1
4457259|NCT00553280|7244674|FG000|Overall Study|Adverse Event|19
4457260|NCT00553280|7244674|FG000|Overall Study|Lack of Efficacy|3
4457261|NCT00553280|7244674|FG000|Overall Study|Withdrawal by Subject|3
4457262|NCT00553280|7244674|FG000|Overall Study|Physician Decision|1
4457263|NCT00553319|7244681|FG000|Overall Study|Lost to Follow-up|10
4457264|NCT00553319|7244682|FG001|Overall Study|Lost to Follow-up|9
4457265|NCT00553319|7244683|FG002|Overall Study|Lost to Follow-up|5
4457266|NCT00553319|7244681|FG000|Overall Study|wanted treatment elsewhere|2
4457267|NCT00553319|7244682|FG001|Overall Study|wanted treatment elsewhere|1
4457268|NCT00553319|7244683|FG002|Overall Study|wanted treatment elsewhere|1
4457269|NCT00553319|7244681|FG000|Overall Study|non-compliance|0
4457270|NCT00553319|7244682|FG001|Overall Study|non-compliance|0
4457271|NCT00553319|7244683|FG002|Overall Study|non-compliance|2
4457272|NCT00553319|7244681|FG000|Overall Study|incarceration|1
4457273|NCT00553319|7244682|FG001|Overall Study|incarceration|0
4457274|NCT00553319|7244683|FG002|Overall Study|incarceration|0
4457275|NCT00553319|7244681|FG000|Overall Study|moved|1
4457276|NCT00553319|7244682|FG001|Overall Study|moved|0
4457277|NCT00553319|7244683|FG002|Overall Study|moved|1
4457278|NCT00553332|7244691|FG000|Overall Study|ineligible, incorrect diagnosis|1
4457279|NCT00553358|7244698|FG000|Overall Study|Randomized but did not receive treatment|3
4457280|NCT00553358|7244699|FG001|Overall Study|Randomized but did not receive treatment|3
4457281|NCT00553358|7244700|FG002|Overall Study|Randomized but did not receive treatment|1
4457282|NCT00553358|7244698|FG000|Overall Study|Lost to Follow-up|22
4457283|NCT00553358|7244699|FG001|Overall Study|Lost to Follow-up|26
4457284|NCT00553358|7244700|FG002|Overall Study|Lost to Follow-up|18
4457285|NCT00553358|7244698|FG000|Overall Study|Withdrew completely|23
4611200|NCT01697579|7467366|FG005|Optional Extension-Cycles 2-6|Participant Moved|0
4611201|NCT01697579|7467367|FG006|Optional Extension-Cycles 2-6|Participant Moved|2
4611202|NCT01697579|7467361|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
4611203|NCT01697579|7467362|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
4611204|NCT01697579|7467363|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
4611205|NCT01697579|7467364|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
4611206|NCT01697579|7467365|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
4611207|NCT01697579|7467366|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6
4611208|NCT01697579|7467367|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4
4611209|NCT01697579|7467361|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0
4611210|NCT01697579|7467362|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0
4611211|NCT01697579|7467363|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0
4611212|NCT01697579|7467364|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0
4611213|NCT01697579|7467365|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0
4611214|NCT01697579|7467366|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0
4611215|NCT01697579|7467367|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1
4632624|NCT01903733|7502371|FG002|Overall Study|Participant refused further follow-up|13
4632625|NCT01903733|7502372|FG003|Overall Study|Participant refused further follow-up|9
4632626|NCT01903733|7502369|FG000|Overall Study|Lost to Follow-up|18
4632627|NCT01903733|7502370|FG001|Overall Study|Lost to Follow-up|19
4632628|NCT01903733|7502371|FG002|Overall Study|Lost to Follow-up|6
4632629|NCT01903733|7502372|FG003|Overall Study|Lost to Follow-up|9
4632630|NCT01903733|7502369|FG000|Overall Study|Other|10
4632631|NCT01903733|7502370|FG001|Overall Study|Other|15
4632632|NCT01903733|7502371|FG002|Overall Study|Other|12
4632633|NCT01903733|7502372|FG003|Overall Study|Other|3
4632634|NCT01903733|7502369|FG000|Overall Study|Missing|2
4632635|NCT01903733|7502370|FG001|Overall Study|Missing|0
4632636|NCT01903733|7502371|FG002|Overall Study|Missing|0
4632637|NCT01903733|7502372|FG003|Overall Study|Missing|0
4632638|NCT01903733|7502369|FG000|Overall Study|Investigator request|18
4632639|NCT01903733|7502370|FG001|Overall Study|Investigator request|0
4632640|NCT01903733|7502371|FG002|Overall Study|Investigator request|0
4632641|NCT01903733|7502372|FG003|Overall Study|Investigator request|0
4632642|NCT01903811|7502411|FG000|Overall Study|No measurable disease|1
4632643|NCT01903811|7502412|FG001|Overall Study|No measurable disease|1
4457286|NCT00553358|7244699|FG001|Overall Study|Withdrew completely|33
4457287|NCT00553358|7244700|FG002|Overall Study|Withdrew completely|34
4457288|NCT00553358|7244698|FG000|Overall Study|Died during clinical follow-up|25
4457289|NCT00553358|7244699|FG001|Overall Study|Died during clinical follow-up|29
4457290|NCT00553358|7244700|FG002|Overall Study|Died during clinical follow-up|32
4515894|NCT00957008|7327033|FG003|Overall Study|Lost to Follow-up|4
4457291|NCT00553358|7244698|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4
4457292|NCT00553358|7244699|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2
4457293|NCT00553358|7244700|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2
4457294|NCT00553358|7244698|FG000|Overall Study|Died after clinical follow-up ended|1
4457295|NCT00553358|7244699|FG001|Overall Study|Died after clinical follow-up ended|2
4457296|NCT00553358|7244700|FG002|Overall Study|Died after clinical follow-up ended|0
4457297|NCT00553358|7244698|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1
4457298|NCT00553358|7244699|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1
4611216|NCT01697592|7467405|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1
4611217|NCT01697592|7467406|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
4611218|NCT01697592|7467407|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
4611219|NCT01697592|7467408|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
4611220|NCT01697592|7467409|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
4611221|NCT01697592|7467410|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
4611222|NCT01697592|7467411|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
4611223|NCT01697592|7467412|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
4611224|NCT01697592|7467413|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
4611225|NCT01697592|7467414|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
4611226|NCT01697592|7467405|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0
4611227|NCT01697592|7467406|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0
4611228|NCT01697592|7467407|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0
4611229|NCT01697592|7467408|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0
4611230|NCT01697592|7467409|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0
4611231|NCT01697592|7467410|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1
4611232|NCT01697592|7467411|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0
4611233|NCT01697592|7467412|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0
4611234|NCT01697592|7467413|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0
4611235|NCT01697592|7467414|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0
4611236|NCT01697592|7467405|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1
4611237|NCT01697592|7467406|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0
4611238|NCT01697592|7467407|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0
4611239|NCT01697592|7467408|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0
4611240|NCT01697592|7467409|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0
4611241|NCT01697592|7467410|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0
4611242|NCT01697592|7467411|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0
4611243|NCT01697592|7467412|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0
4611244|NCT01697592|7467413|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0
4611245|NCT01697592|7467414|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0
4611246|NCT01697592|7467405|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
4611247|NCT01697592|7467406|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
4611248|NCT01697592|7467407|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
4611249|NCT01697592|7467408|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
4611250|NCT01697592|7467409|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
4611251|NCT01697592|7467410|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
4611252|NCT01697592|7467411|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
4611253|NCT01697592|7467412|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
4611254|NCT01697592|7467413|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
4611255|NCT01697592|7467414|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
4611256|NCT01697592|7467405|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0
4611257|NCT01697592|7467406|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2
4611258|NCT01697592|7467407|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1
4611259|NCT01697592|7467408|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2
4611260|NCT01697592|7467409|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0
4611261|NCT01697592|7467410|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0
4611262|NCT01697592|7467411|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1
4611263|NCT01697592|7467412|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0
4611264|NCT01697592|7467413|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0
4611265|NCT01697592|7467414|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1
4611266|NCT01697592|7467405|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1
4611267|NCT01697592|7467406|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0
4611268|NCT01697592|7467407|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0
4611269|NCT01697592|7467408|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1
4611270|NCT01697592|7467409|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0
4611271|NCT01697592|7467410|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0
4611272|NCT01697592|7467411|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0
4611273|NCT01697592|7467412|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0
4611274|NCT01697592|7467413|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0
4611275|NCT01697592|7467414|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0
4611276|NCT01697592|7467405|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2
4611277|NCT01697592|7467406|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
4611278|NCT01697592|7467407|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
4611279|NCT01697592|7467408|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
4611280|NCT01697592|7467409|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
4457299|NCT00553358|7244700|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1
4457300|NCT00553436|7244723|FG000|Overall Study|Conversion to another procedure|1
4457301|NCT00553462|7244727|FG000|Overall Study|Adverse Event|4
4457302|NCT00553462|7244727|FG000|Overall Study|Progression|4
4457303|NCT00553462|7244727|FG000|Overall Study|Withdrawal by Subject|5
4457304|NCT00553462|7244727|FG000|Overall Study|Physician Decision|1
4457305|NCT00553475|7244734|FG000|Overall Study|Adverse Event|7
4457306|NCT00553475|7244735|FG001|Overall Study|Adverse Event|17
4457307|NCT00553475|7244736|FG002|Overall Study|Adverse Event|13
4457308|NCT00553475|7244734|FG000|Overall Study|Lack of Efficacy|7
4457309|NCT00553475|7244735|FG001|Overall Study|Lack of Efficacy|1
4457310|NCT00553475|7244736|FG002|Overall Study|Lack of Efficacy|0
4457311|NCT00553475|7244734|FG000|Overall Study|Withdrawal by Subject|1
4457312|NCT00553475|7244735|FG001|Overall Study|Withdrawal by Subject|1
4457313|NCT00553475|7244736|FG002|Overall Study|Withdrawal by Subject|0
4457314|NCT00553475|7244734|FG000|Overall Study|Physician Decision|1
4457315|NCT00553475|7244735|FG001|Overall Study|Physician Decision|0
4457316|NCT00553475|7244736|FG002|Overall Study|Physician Decision|0
4457317|NCT00553475|7244734|FG000|Overall Study|Due to moving|0
4457318|NCT00553475|7244735|FG001|Overall Study|Due to moving|1
4457319|NCT00553475|7244736|FG002|Overall Study|Due to moving|0
4457320|NCT00553501|7244746|FG000|Overall Study|Adverse Event|2
4457321|NCT00553501|7244746|FG000|Overall Study|Death|1
4457322|NCT00553501|7244746|FG000|Overall Study|Progression|1
4457323|NCT00553514|7244755|FG000|Overall Study|Protocol deviation|0
4457324|NCT00553514|7244756|FG001|Overall Study|Protocol deviation|0
4457325|NCT00553514|7244757|FG002|Overall Study|Protocol deviation|0
4457326|NCT00553514|7244758|FG003|Overall Study|Protocol deviation|1
4457327|NCT00553514|7244759|FG004|Overall Study|Protocol deviation|0
4457328|NCT00553514|7244755|FG000|Overall Study|Lack of ovarian response|4
4457329|NCT00553514|7244756|FG001|Overall Study|Lack of ovarian response|5
4457330|NCT00553514|7244757|FG002|Overall Study|Lack of ovarian response|5
4538701|NCT01121757|7360734|FG001|First Drug|Death|0
4538702|NCT01121757|7360733|FG000|First Drug|Disease Progression|0
4538703|NCT01121757|7360734|FG001|First Drug|Disease Progression|2
4538704|NCT01121757|7360733|FG000|Combination|Physician Decision|0
4457331|NCT00553514|7244758|FG003|Overall Study|Lack of ovarian response|5
4457332|NCT00553514|7244759|FG004|Overall Study|Lack of ovarian response|6
4457333|NCT00553514|7244755|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3
4457334|NCT00553514|7244756|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0
4457335|NCT00553514|7244757|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1
4457336|NCT00553514|7244758|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0
4538705|NCT01121757|7360734|FG001|Combination|Physician Decision|1
4538706|NCT01121757|7360733|FG000|Combination|Disease Progression|2
4538707|NCT01121757|7360734|FG001|Combination|Disease Progression|0
4538708|NCT01121900|7360742|FG000|First Intervention Period|Adverse Event|1
4538709|NCT01121900|7360743|FG001|First Intervention Period|Adverse Event|1
4538710|NCT01121900|7360742|FG000|Washout Period of 7 Days|Withdrawal by Subject|0
4611281|NCT01697592|7467410|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1
4611282|NCT01697592|7467411|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
4611283|NCT01697592|7467412|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1
4611284|NCT01697592|7467413|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
4611285|NCT01697592|7467414|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
4611286|NCT01697592|7467405|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2
4611287|NCT01697592|7467406|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1
4611288|NCT01697592|7467407|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1
4611289|NCT01697592|7467408|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2
4611290|NCT01697592|7467409|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0
4611291|NCT01697592|7467410|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1
4611292|NCT01697592|7467411|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1
4611293|NCT01697592|7467412|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0
4690318|NCT02560389|7600003|FG002|Overall Study|Tested positive for illicit substance|0
4690319|NCT02560558|7600022|FG000|Overall Study|Adverse Event|1
4690320|NCT02560558|7600023|FG001|Overall Study|Adverse Event|0
4690321|NCT02560558|7600022|FG000|Overall Study|Death|0
4690322|NCT02560558|7600023|FG001|Overall Study|Death|2
4690323|NCT02560558|7600022|FG000|Overall Study|Lost to Follow-up|0
4690324|NCT02560558|7600023|FG001|Overall Study|Lost to Follow-up|4
4690325|NCT02560558|7600022|FG000|Overall Study|Protocol Violation|3
4457337|NCT00553514|7244759|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0
4538711|NCT01121900|7360743|FG001|Washout Period of 7 Days|Withdrawal by Subject|1
4538712|NCT01121913|7360749|FG000|First Intervention Period|Adverse Event|0
4538713|NCT01121913|7360750|FG001|First Intervention Period|Adverse Event|0
4457338|NCT00553514|7244755|FG000|Overall Study|Risk of multiple pregnancy|0
4457339|NCT00553514|7244756|FG001|Overall Study|Risk of multiple pregnancy|2
4457340|NCT00553514|7244757|FG002|Overall Study|Risk of multiple pregnancy|0
4457341|NCT00553514|7244758|FG003|Overall Study|Risk of multiple pregnancy|1
4457342|NCT00553514|7244759|FG004|Overall Study|Risk of multiple pregnancy|0
4457343|NCT00553514|7244755|FG000|Overall Study|Other|1
4457344|NCT00553514|7244756|FG001|Overall Study|Other|1
4457345|NCT00553514|7244757|FG002|Overall Study|Other|0
4457346|NCT00553514|7244758|FG003|Overall Study|Other|0
4457347|NCT00553514|7244759|FG004|Overall Study|Other|1
4457348|NCT00553540|7244773|FG000|Overall Study|discharged after first visit|2
4457349|NCT00553540|7244774|FG001|Overall Study|discharged after first visit|5
4457350|NCT00553605|7244782|FG000|Overall Study|Did not meet entrance criteria|1
4611294|NCT01697592|7467413|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2
4611295|NCT01697592|7467414|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0
4611296|NCT01697696|7467452|FG000|Overall Study|Study terminated by sponsor|0
4611297|NCT01697696|7467453|FG001|Overall Study|Study terminated by sponsor|3
4611298|NCT01697696|7467452|FG000|Overall Study|Protocol deviation|1
4611299|NCT01697696|7467453|FG001|Overall Study|Protocol deviation|0
4611300|NCT01697696|7467452|FG000|Overall Study|Physician Decision|1
4611301|NCT01697696|7467453|FG001|Overall Study|Physician Decision|0
4611302|NCT01697696|7467452|FG000|Overall Study|Death|4
4611303|NCT01697696|7467453|FG001|Overall Study|Death|2
4611304|NCT01697696|7467452|FG000|Overall Study|Lost to Follow-up|10
4611305|NCT01697696|7467453|FG001|Overall Study|Lost to Follow-up|7
4611306|NCT01697696|7467452|FG000|Overall Study|Subject/guardian decision|31
4611307|NCT01697696|7467453|FG001|Overall Study|Subject/guardian decision|35
4611308|NCT01697748|7467470|FG000|Overall Study|ineligible skin incision|1
4611309|NCT01697748|7467471|FG001|Overall Study|ineligible skin incision|2
4611310|NCT01697748|7467470|FG000|Overall Study|ineligible uterine incision|4
4611311|NCT01697748|7467471|FG001|Overall Study|ineligible uterine incision|1
4611312|NCT01697748|7467470|FG000|Overall Study|Lost to Follow-up|53
4611313|NCT01697748|7467471|FG001|Overall Study|Lost to Follow-up|65
4611314|NCT01697956|7467479|FG000|Overall Study|Protocol Violation|1
4611315|NCT01697956|7467480|FG001|Overall Study|Protocol Violation|1
4611316|NCT01697969|7467492|FG000|Overall Study|Did not meet inc/exc criteria|3
4611317|NCT01698008|7467499|FG000|Overall Study|Withdrawal by Subject|1
4611318|NCT01698008|7467500|FG001|Overall Study|Withdrawal by Subject|2
4611319|NCT01698268|7467508|FG000|Overall Study|Physician Decision|2
4611320|NCT01698268|7467509|FG001|Overall Study|Physician Decision|1
4611321|NCT01698320|7467517|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24
4611322|NCT01698320|7467518|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0
4611323|NCT01698320|7467519|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0
4611324|NCT01698320|7467517|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1
4611325|NCT01698320|7467518|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0
4611326|NCT01698320|7467519|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0
4611327|NCT01698320|7467517|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1
4611328|NCT01698320|7467518|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0
4611329|NCT01698320|7467519|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0
4611330|NCT01698320|7467517|FG000|Run-In Period (Week -1 to Day 0)|Other|1
4611331|NCT01698320|7467518|FG001|Run-In Period (Week -1 to Day 0)|Other|0
4611332|NCT01698320|7467519|FG002|Run-In Period (Week -1 to Day 0)|Other|0
4611333|NCT01698320|7467517|FG000|12-Week Double-Blind Period|Adverse Event|0
4611334|NCT01698320|7467518|FG001|12-Week Double-Blind Period|Adverse Event|1
4611335|NCT01698320|7467519|FG002|12-Week Double-Blind Period|Adverse Event|1
4611336|NCT01698320|7467517|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0
4611337|NCT01698320|7467518|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2
4611338|NCT01698320|7467519|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2
4611339|NCT01698320|7467517|FG000|12-Week Double-Blind Period|Protocol Violation|0
4611340|NCT01698320|7467518|FG001|12-Week Double-Blind Period|Protocol Violation|0
4611341|NCT01698320|7467519|FG002|12-Week Double-Blind Period|Protocol Violation|2
4611342|NCT01698320|7467517|FG000|12-Week Double-Blind Period|Pregnancy|0
4611343|NCT01698320|7467518|FG001|12-Week Double-Blind Period|Pregnancy|1
4611344|NCT01698320|7467519|FG002|12-Week Double-Blind Period|Pregnancy|1
4611345|NCT01698320|7467517|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0
4611346|NCT01698320|7467518|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0
4611347|NCT01698320|7467519|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2
4611348|NCT01698320|7467517|FG000|12-Week Double-Blind Period|Lost to Follow-up|0
4611349|NCT01698320|7467518|FG001|12-Week Double-Blind Period|Lost to Follow-up|0
4611350|NCT01698320|7467519|FG002|12-Week Double-Blind Period|Lost to Follow-up|4
4611351|NCT01698320|7467517|FG000|40-Week Open-Label Period|Adverse Event|0
4611352|NCT01698320|7467518|FG001|40-Week Open-Label Period|Adverse Event|3
4611353|NCT01698320|7467519|FG002|40-Week Open-Label Period|Adverse Event|2
4611354|NCT01698320|7467517|FG000|40-Week Open-Label Period|Withdrawal by Subject|0
4611355|NCT01698320|7467518|FG001|40-Week Open-Label Period|Withdrawal by Subject|11
4611356|NCT01698320|7467519|FG002|40-Week Open-Label Period|Withdrawal by Subject|7
4611357|NCT01698320|7467517|FG000|40-Week Open-Label Period|Pregnancy|0
4611358|NCT01698320|7467518|FG001|40-Week Open-Label Period|Pregnancy|2
4611359|NCT01698320|7467519|FG002|40-Week Open-Label Period|Pregnancy|1
4611360|NCT01698320|7467517|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0
4611361|NCT01698320|7467518|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1
4611362|NCT01698320|7467519|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0
4611363|NCT01698320|7467517|FG000|40-Week Open-Label Period|Lost to Follow-up|0
4611364|NCT01698320|7467518|FG001|40-Week Open-Label Period|Lost to Follow-up|2
4457351|NCT00553605|7244783|FG001|Overall Study|Did not meet entrance criteria|3
4457352|NCT00553605|7244782|FG000|Overall Study|Did not receive full dose|1
4457353|NCT00553605|7244783|FG001|Overall Study|Did not receive full dose|0
4457354|NCT00553605|7244782|FG000|Overall Study|Randomized but not treated|2
4457355|NCT00553605|7244783|FG001|Overall Study|Randomized but not treated|0
4457356|NCT00553631|7244791|FG000|Overall Study|Withdrawal by Subject|0
4457357|NCT00553631|7244792|FG001|Overall Study|Withdrawal by Subject|1
4457358|NCT00553631|7244791|FG000|Overall Study|Lost to Follow-up|1
4457359|NCT00553631|7244792|FG001|Overall Study|Lost to Follow-up|0
4457360|NCT00553644|7244798|FG000|Overall Study|Adverse Event|17
4457361|NCT00553644|7244798|FG000|Overall Study|Withdrawal by Subject|4
4457362|NCT00553644|7244798|FG000|Overall Study|Physician Decision|1
4457363|NCT00553644|7244798|FG000|Overall Study|Alternative therapy|6
4457364|NCT00553696|7244806|FG000|Overall Study|Adverse Event|2
4457365|NCT00553696|7244807|FG001|Overall Study|Adverse Event|4
4457366|NCT00553696|7244808|FG002|Overall Study|Adverse Event|0
4457367|NCT00553696|7244809|FG003|Overall Study|Adverse Event|1
4457368|NCT00553696|7244806|FG000|Overall Study|Global deterioration of health status|0
4457369|NCT00553696|7244807|FG001|Overall Study|Global deterioration of health status|2
4457370|NCT00553696|7244808|FG002|Overall Study|Global deterioration of health status|0
4457371|NCT00553696|7244809|FG003|Overall Study|Global deterioration of health status|0
4457372|NCT00553696|7244806|FG000|Overall Study|Objective progression or relapse|2
4457373|NCT00553696|7244807|FG001|Overall Study|Objective progression or relapse|9
4457374|NCT00553696|7244808|FG002|Overall Study|Objective progression or relapse|6
4457375|NCT00553696|7244809|FG003|Overall Study|Objective progression or relapse|0
4611365|NCT01698320|7467519|FG002|40-Week Open-Label Period|Lost to Follow-up|0
4611366|NCT01698554|7467557|FG000|Overall Study|Adverse Event|2
4611367|NCT01698554|7467558|FG001|Overall Study|Adverse Event|5
4611368|NCT01698554|7467559|FG002|Overall Study|Adverse Event|0
4611369|NCT01698554|7467560|FG003|Overall Study|Adverse Event|1
4611370|NCT01698554|7467557|FG000|Overall Study|Lost to Follow-up|1
4611371|NCT01698554|7467558|FG001|Overall Study|Lost to Follow-up|0
4611372|NCT01698554|7467559|FG002|Overall Study|Lost to Follow-up|0
4611373|NCT01698554|7467560|FG003|Overall Study|Lost to Follow-up|0
4611374|NCT01698554|7467557|FG000|Overall Study|Personal Reasons|0
4611375|NCT01698554|7467558|FG001|Overall Study|Personal Reasons|5
4611376|NCT01698554|7467559|FG002|Overall Study|Personal Reasons|1
4611377|NCT01698554|7467560|FG003|Overall Study|Personal Reasons|1
4611378|NCT01698554|7467557|FG000|Overall Study|Protocol Violation|2
4611379|NCT01698554|7467558|FG001|Overall Study|Protocol Violation|0
4611380|NCT01698554|7467559|FG002|Overall Study|Protocol Violation|1
4611381|NCT01698554|7467560|FG003|Overall Study|Protocol Violation|0
4611382|NCT01698554|7467557|FG000|Overall Study|Other Miscellaneous Reasons|1
4611383|NCT01698554|7467558|FG001|Overall Study|Other Miscellaneous Reasons|0
4611384|NCT01698554|7467559|FG002|Overall Study|Other Miscellaneous Reasons|0
4611385|NCT01698554|7467560|FG003|Overall Study|Other Miscellaneous Reasons|0
4611386|NCT01698775|7467589|FG000|Phase A|Adverse Event|2
4611387|NCT01698775|7467590|FG001|Phase A|Adverse Event|1
4611388|NCT01698775|7467589|FG000|Phase A|Death|1
4611389|NCT01698775|7467590|FG001|Phase A|Death|1
4611390|NCT01698775|7467589|FG000|Phase A|Lack of Efficacy|1
4611391|NCT01698775|7467590|FG001|Phase A|Lack of Efficacy|0
4611392|NCT01698775|7467589|FG000|Phase A|Lost to Follow-up|1
4611393|NCT01698775|7467590|FG001|Phase A|Lost to Follow-up|2
4611394|NCT01698775|7467589|FG000|Phase A|Protocol Violation|1
4611395|NCT01698775|7467590|FG001|Phase A|Protocol Violation|0
4611396|NCT01698775|7467589|FG000|Phase A|Withdrawal by Subject|3
4611397|NCT01698775|7467590|FG001|Phase A|Withdrawal by Subject|4
4611398|NCT01698775|7467589|FG000|Phase A|Kidney [transplant]|0
4611399|NCT01698775|7467590|FG001|Phase A|Kidney [transplant]|1
4611400|NCT01698775|7467589|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0
4611401|NCT01698775|7467590|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1
4611402|NCT01698775|7467589|FG000|Phase B|Adverse Event|6
4611403|NCT01698775|7467590|FG001|Phase B|Adverse Event|3
4611404|NCT01698775|7467589|FG000|Phase B|Death|0
4611405|NCT01698775|7467590|FG001|Phase B|Death|1
4611406|NCT01698775|7467589|FG000|Phase B|Lack of Efficacy|0
4457376|NCT00553696|7244806|FG000|Overall Study|Withdrawal by Subject|0
4457377|NCT00553696|7244807|FG001|Overall Study|Withdrawal by Subject|1
4457378|NCT00553696|7244808|FG002|Overall Study|Withdrawal by Subject|0
4611407|NCT01698775|7467590|FG001|Phase B|Lack of Efficacy|1
4611408|NCT01698775|7467589|FG000|Phase B|Lost to Follow-up|0
4611409|NCT01698775|7467590|FG001|Phase B|Lost to Follow-up|1
4611410|NCT01698775|7467589|FG000|Phase B|Physician Decision|1
4611411|NCT01698775|7467590|FG001|Phase B|Physician Decision|1
4611412|NCT01698775|7467589|FG000|Phase B|Protocol Violation|1
4611413|NCT01698775|7467590|FG001|Phase B|Protocol Violation|1
4611414|NCT01698775|7467589|FG000|Phase B|Withdrawal by Subject|6
4611415|NCT01698775|7467590|FG001|Phase B|Withdrawal by Subject|2
4611416|NCT01698801|7467600|FG000|Treatment Phase|Adverse Event|4
4611417|NCT01698801|7467600|FG000|Treatment Phase|Protocol Violation|1
4611418|NCT01698801|7467600|FG000|Treatment Phase|Other|4
4611419|NCT01698801|7467600|FG000|Treatment Phase|Withdrawal by Subject|1
4611420|NCT01698801|7467600|FG000|Treatment Phase|Disease progression|1
4611421|NCT01698801|7467600|FG000|Follow Up Phase|Withdrawal by Subject|1
4611422|NCT01698801|7467600|FG000|Follow Up Phase|Death|4
4611423|NCT01698814|7467607|FG000|Overall Study|Adverse Event|0
4611424|NCT01698814|7467608|FG001|Overall Study|Adverse Event|2
4457379|NCT00553696|7244809|FG003|Overall Study|Withdrawal by Subject|0
4457380|NCT00553787|7244832|FG000|Overall Study|Adverse Event|34
4457381|NCT00553787|7244833|FG001|Overall Study|Adverse Event|21
4457382|NCT00553787|7244834|FG002|Overall Study|Adverse Event|67
4611425|NCT01698814|7467607|FG000|Overall Study|Lost to Follow-up|0
4611426|NCT01698814|7467608|FG001|Overall Study|Lost to Follow-up|1
4611427|NCT01698814|7467607|FG000|Overall Study|Pregnancy|1
4611428|NCT01698814|7467608|FG001|Overall Study|Pregnancy|0
4611429|NCT01698814|7467607|FG000|Overall Study|Randomized in error|1
4611430|NCT01698814|7467608|FG001|Overall Study|Randomized in error|0
4611431|NCT01698879|7467617|FG000|Overall Study|Withdrawal by Subject|1
4611432|NCT01698879|7467618|FG001|Overall Study|Withdrawal by Subject|0
4611433|NCT01698879|7467619|FG002|Overall Study|Withdrawal by Subject|0
4611434|NCT01699022|7467633|FG000|Overall Study|Early discontinuation from the study|3
4611435|NCT01699087|7467638|FG000|Overall Study|Lost to Follow-up|7
4611436|NCT01699087|7467638|FG000|Overall Study|Screen failure (prior to treatment)|15
4611437|NCT01699087|7467638|FG000|Overall Study|Unable to make future visits|2
4611438|NCT01699178|7467645|FG000|Overall Study|Adverse Event|1
4611439|NCT01699178|7467646|FG001|Overall Study|Adverse Event|5
4611440|NCT01699178|7467645|FG000|Overall Study|Lost to Follow-up|1
4611441|NCT01699178|7467646|FG001|Overall Study|Lost to Follow-up|6
4611442|NCT01699178|7467645|FG000|Overall Study|Non-compliance with Study Drug|3
4611443|NCT01699178|7467646|FG001|Overall Study|Non-compliance with Study Drug|1
4611444|NCT01699178|7467645|FG000|Overall Study|Physician Decision|1
4611445|NCT01699178|7467646|FG001|Overall Study|Physician Decision|0
4611446|NCT01699178|7467645|FG000|Overall Study|Withdrawal by Subject|4
4611447|NCT01699178|7467646|FG001|Overall Study|Withdrawal by Subject|12
4611448|NCT01699178|7467645|FG000|Overall Study|Hematocrit >54%|1
4611449|NCT01699178|7467646|FG001|Overall Study|Hematocrit >54%|1
4611450|NCT01699178|7467645|FG000|Overall Study|PSA increase of >1.4 ng/mL|4
4611451|NCT01699178|7467646|FG001|Overall Study|PSA increase of >1.4 ng/mL|3
4611452|NCT01699178|7467645|FG000|Overall Study|ineligible/noncompliant/ subject reason|4
4611453|NCT01699178|7467646|FG001|Overall Study|ineligible/noncompliant/ subject reason|4
4611454|NCT01699503|7467663|FG000|Overall Study|Death|31
4611455|NCT01699503|7467664|FG001|Overall Study|Death|40
4611456|NCT01699503|7467663|FG000|Overall Study|Withdrawal by Subject|65
4611457|NCT01699503|7467664|FG001|Overall Study|Withdrawal by Subject|57
4611458|NCT01699503|7467663|FG000|Overall Study|Lost to Follow-up|121
4611459|NCT01699503|7467664|FG001|Overall Study|Lost to Follow-up|117
4611460|NCT01699503|7467663|FG000|Overall Study|Excluded due to quality|783
4611461|NCT01699503|7467664|FG001|Overall Study|Excluded due to quality|791
4611462|NCT01699685|7467689|FG000|Period 1|Adverse Event|1
4611463|NCT01699685|7467690|FG001|Period 1|Adverse Event|1
4611464|NCT01699685|7467689|FG000|Period 1|Medical or ethical, noncompliance|2
4611465|NCT01699685|7467690|FG001|Period 1|Medical or ethical, noncompliance|0
4611466|NCT01699685|7467689|FG000|Period 1|Other|0
4611467|NCT01699685|7467690|FG001|Period 1|Other|1
4611468|NCT01699685|7467689|FG000|Period 1|Patient request|0
4611469|NCT01699685|7467690|FG001|Period 1|Patient request|1
4611470|NCT01699685|7467689|FG000|Period 2|Lost to Follow-up|1
4611471|NCT01699685|7467690|FG001|Period 2|Lost to Follow-up|0
4611472|NCT01699750|7467708|FG000|Overall Study|Withdrew Consent|0
4611473|NCT01699750|7467709|FG001|Overall Study|Withdrew Consent|1
4611474|NCT01699750|7467708|FG000|Overall Study|Other|0
4611475|NCT01699750|7467709|FG001|Overall Study|Other|2
4611476|NCT01699789|7467725|FG000|Overall Study|Withdrawal by Subject|18
4611477|NCT01699789|7467726|FG001|Overall Study|Withdrawal by Subject|23
4611478|NCT01699789|7467725|FG000|Overall Study|Death|1
4611479|NCT01699789|7467726|FG001|Overall Study|Death|2
4457383|NCT00553787|7244832|FG000|Overall Study|Lost to Follow-up|132
4611480|NCT01699789|7467725|FG000|Overall Study|Lost to Follow-up|83
4611481|NCT01699789|7467726|FG001|Overall Study|Lost to Follow-up|101
4611482|NCT01699815|7467736|FG000|Overall Study|Protocol Violation|4
4611483|NCT01699815|7467737|FG001|Overall Study|Protocol Violation|7
4611484|NCT01699815|7467736|FG000|Overall Study|record could not be located|1
4611485|NCT01699815|7467737|FG001|Overall Study|record could not be located|0
4611486|NCT01699815|7467736|FG000|Overall Study|Adverse Event|0
4611487|NCT01699815|7467737|FG001|Overall Study|Adverse Event|1
4611488|NCT01699867|7467743|FG000|Overall Study|Screening Failure|3
4611489|NCT01700049|7467751|FG000|Overall Study|Withdrawal by Subject|1
4611490|NCT01700140|7467759|FG000|Overall Study|Use of rescue drugs|3
4611491|NCT01700140|7467760|FG001|Overall Study|Use of rescue drugs|3
4611492|NCT01700140|7467761|FG002|Overall Study|Use of rescue drugs|1
4611493|NCT01700140|7467759|FG000|Overall Study|Discontinuation of radiotherapy|1
4611494|NCT01700140|7467760|FG001|Overall Study|Discontinuation of radiotherapy|0
4611495|NCT01700140|7467761|FG002|Overall Study|Discontinuation of radiotherapy|0
4611496|NCT01700140|7467759|FG000|Overall Study|Use of chemotherapy or surgical therapy|0
4611497|NCT01700140|7467760|FG001|Overall Study|Use of chemotherapy or surgical therapy|1
4611498|NCT01700140|7467761|FG002|Overall Study|Use of chemotherapy or surgical therapy|0
4611499|NCT01700140|7467759|FG000|Overall Study|Aggravation of symptoms|1
4611500|NCT01700140|7467760|FG001|Overall Study|Aggravation of symptoms|0
4611501|NCT01700140|7467761|FG002|Overall Study|Aggravation of symptoms|0
4611502|NCT01700140|7467759|FG000|Overall Study|Adverse Event|0
4611503|NCT01700140|7467760|FG001|Overall Study|Adverse Event|1
4611504|NCT01700140|7467761|FG002|Overall Study|Adverse Event|0
4457384|NCT00553787|7244833|FG001|Overall Study|Lost to Follow-up|44
4457385|NCT00553787|7244834|FG002|Overall Study|Lost to Follow-up|78
4457386|NCT00553787|7244832|FG000|Overall Study|Withdrawal by Subject|151
4457387|NCT00553787|7244833|FG001|Overall Study|Withdrawal by Subject|40
4457388|NCT00553787|7244834|FG002|Overall Study|Withdrawal by Subject|83
4457389|NCT00553787|7244832|FG000|Overall Study|Lack of Efficacy|31
4457390|NCT00553787|7244833|FG001|Overall Study|Lack of Efficacy|1
4457391|NCT00553787|7244834|FG002|Overall Study|Lack of Efficacy|3
4457392|NCT00553787|7244832|FG000|Overall Study|Pregnancy|0
4457393|NCT00553787|7244833|FG001|Overall Study|Pregnancy|1
4457394|NCT00553787|7244834|FG002|Overall Study|Pregnancy|2
4457395|NCT00553787|7244832|FG000|Overall Study|non compliance|4
4457396|NCT00553787|7244833|FG001|Overall Study|non compliance|0
4457397|NCT00553787|7244834|FG002|Overall Study|non compliance|11
4457398|NCT00553787|7244832|FG000|Overall Study|Requirement for restricted medication|8
4457399|NCT00553787|7244833|FG001|Overall Study|Requirement for restricted medication|7
4457400|NCT00553787|7244834|FG002|Overall Study|Requirement for restricted medication|5
4457401|NCT00553787|7244832|FG000|Overall Study|Other|18
4457402|NCT00553787|7244833|FG001|Overall Study|Other|10
4457403|NCT00553787|7244834|FG002|Overall Study|Other|13
4457404|NCT00554099|7244866|FG000|Treatment Period (12 Weeks)|Adverse Event|3
4457405|NCT00554099|7244867|FG001|Treatment Period (12 Weeks)|Adverse Event|5
4457406|NCT00554099|7244868|FG002|Treatment Period (12 Weeks)|Adverse Event|1
4457407|NCT00554099|7244866|FG000|Treatment Period (12 Weeks)|Physician Decision|3
4457408|NCT00554099|7244867|FG001|Treatment Period (12 Weeks)|Physician Decision|0
4457409|NCT00554099|7244868|FG002|Treatment Period (12 Weeks)|Physician Decision|0
4457410|NCT00554099|7244866|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1
4457411|NCT00554099|7244867|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0
4457412|NCT00554099|7244868|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2
4457413|NCT00554099|7244866|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1
4457414|NCT00554099|7244867|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2
4457415|NCT00554099|7244868|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0
4457416|NCT00554099|7244866|FG000|Treatment Period (12 Weeks)|Protocol Violation|0
4457417|NCT00554099|7244867|FG001|Treatment Period (12 Weeks)|Protocol Violation|0
4457418|NCT00554099|7244868|FG002|Treatment Period (12 Weeks)|Protocol Violation|2
4457419|NCT00554099|7244866|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4
4457420|NCT00554099|7244867|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1
4457421|NCT00554099|7244868|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4
4457422|NCT00554099|7244866|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1
4457423|NCT00554099|7244867|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2
4457424|NCT00554099|7244868|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0
4457425|NCT00554099|7244866|FG000|Non-Treatment Phase (9 Months)|Relapse|2
4457426|NCT00554099|7244867|FG001|Non-Treatment Phase (9 Months)|Relapse|1
4457427|NCT00554099|7244868|FG002|Non-Treatment Phase (9 Months)|Relapse|1
4457428|NCT00554099|7244866|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4
4457429|NCT00554099|7244867|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2
4457430|NCT00554099|7244868|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2
4611505|NCT01700140|7467759|FG000|Overall Study|Inclusion/exclusion criteria deviation|1
4611506|NCT01700140|7467760|FG001|Overall Study|Inclusion/exclusion criteria deviation|4
4611507|NCT01700140|7467761|FG002|Overall Study|Inclusion/exclusion criteria deviation|0
4611508|NCT01700179|7467772|FG000|Overall Study|Physician Decision|2
4611509|NCT01700192|7467778|FG000|Overall Study|Adverse Event|73
4611510|NCT01700192|7467779|FG001|Overall Study|Adverse Event|18
4611511|NCT01700192|7467778|FG000|Overall Study|Lack of Efficacy|1
4611512|NCT01700192|7467779|FG001|Overall Study|Lack of Efficacy|0
4611513|NCT01700192|7467778|FG000|Overall Study|Lost to Follow-up|42
4611514|NCT01700192|7467779|FG001|Overall Study|Lost to Follow-up|29
4611515|NCT01700192|7467778|FG000|Overall Study|Noncompliance with study drug|0
4611516|NCT01700192|7467779|FG001|Overall Study|Noncompliance with study drug|5
4611517|NCT01700192|7467778|FG000|Overall Study|Physician Decision|2
4611518|NCT01700192|7467779|FG001|Overall Study|Physician Decision|3
4611519|NCT01700192|7467778|FG000|Overall Study|Pregnancy|1
4611520|NCT01700192|7467779|FG001|Overall Study|Pregnancy|4
4611521|NCT01700192|7467778|FG000|Overall Study|Progressive disease|1
4611522|NCT01700192|7467779|FG001|Overall Study|Progressive disease|0
4611523|NCT01700192|7467778|FG000|Overall Study|Protocol Violation|3
4457431|NCT00554216|7244879|FG000|Overall Study|Lost to Follow-up|92
4457432|NCT00554216|7244880|FG001|Overall Study|Lost to Follow-up|31
4457433|NCT00554216|7244881|FG002|Overall Study|Lost to Follow-up|63
4457434|NCT00554216|7244879|FG000|Overall Study|Adverse Event|16
4457435|NCT00554216|7244880|FG001|Overall Study|Adverse Event|16
4457436|NCT00554216|7244881|FG002|Overall Study|Adverse Event|36
4457437|NCT00554216|7244879|FG000|Overall Study|Withdrawal by Subject|92
4457438|NCT00554216|7244880|FG001|Overall Study|Withdrawal by Subject|31
4457439|NCT00554216|7244881|FG002|Overall Study|Withdrawal by Subject|43
4611524|NCT01700192|7467779|FG001|Overall Study|Protocol Violation|4
4611525|NCT01700192|7467778|FG000|Overall Study|Technical problems|0
4611526|NCT01700192|7467779|FG001|Overall Study|Technical problems|1
4611527|NCT01700192|7467778|FG000|Overall Study|Withdrawal by Subject|56
4611528|NCT01700192|7467779|FG001|Overall Study|Withdrawal by Subject|64
4611529|NCT01700192|7467778|FG000|Overall Study|Never received study drug|1
4538714|NCT01121913|7360751|FG002|First Intervention Period|Adverse Event|1
4538715|NCT01121913|7360752|FG003|First Intervention Period|Adverse Event|0
4457440|NCT00554216|7244879|FG000|Overall Study|Non compliance|10
4611530|NCT01700192|7467779|FG001|Overall Study|Never received study drug|0
4611531|NCT01700205|7467787|FG000|Overall Study|Withdrawal by Subject|13
4457441|NCT00554216|7244880|FG001|Overall Study|Non compliance|4
4457442|NCT00554216|7244881|FG002|Overall Study|Non compliance|5
4457443|NCT00554216|7244879|FG000|Overall Study|Pregnancy|2
4457444|NCT00554216|7244880|FG001|Overall Study|Pregnancy|1
4538716|NCT01121913|7360749|FG000|First Washout Period|Withdrawal by Subject|1
4457445|NCT00554216|7244881|FG002|Overall Study|Pregnancy|14
4457446|NCT00554216|7244879|FG000|Overall Study|Restricted med|3
4457447|NCT00554216|7244880|FG001|Overall Study|Restricted med|1
4457448|NCT00554216|7244881|FG002|Overall Study|Restricted med|1
4457449|NCT00554216|7244879|FG000|Overall Study|Other|12
4457450|NCT00554216|7244880|FG001|Overall Study|Other|7
4457451|NCT00554216|7244881|FG002|Overall Study|Other|10
4457452|NCT00554216|7244879|FG000|Overall Study|Lack of Efficacy|15
4457453|NCT00554216|7244880|FG001|Overall Study|Lack of Efficacy|3
4457454|NCT00554216|7244881|FG002|Overall Study|Lack of Efficacy|0
4457455|NCT00554229|7244891|FG000|Overall Study|Lost to Follow-up|3
4457456|NCT00554229|7244892|FG001|Overall Study|Lost to Follow-up|6
4457457|NCT00554229|7244891|FG000|Overall Study|Withdrawal by Subject|29
4457458|NCT00554229|7244892|FG001|Overall Study|Withdrawal by Subject|37
4457459|NCT00554229|7244891|FG000|Overall Study|Adverse Event|71
4457460|NCT00554229|7244892|FG001|Overall Study|Adverse Event|39
4457461|NCT00554229|7244891|FG000|Overall Study|Protocol Violation|3
4457462|NCT00554229|7244892|FG001|Overall Study|Protocol Violation|3
4457463|NCT00554229|7244891|FG000|Overall Study|Reason not otherwise captured, eg; death|119
4457464|NCT00554229|7244892|FG001|Overall Study|Reason not otherwise captured, eg; death|140
4457465|NCT00554229|7244891|FG000|Overall Study|Randomised but no treatment received|1
4457466|NCT00554229|7244892|FG001|Overall Study|Randomised but no treatment received|0
4457467|NCT00554515|7244913|FG000|Overall Study|Withdrawal by Subject|3
4457468|NCT00554515|7244913|FG000|Overall Study|Disease progression|52
4457469|NCT00554515|7244913|FG000|Overall Study|Physician Decision|18
4457470|NCT00554515|7244913|FG000|Overall Study|Withdrawal by Subject|11
4457471|NCT00554515|7244913|FG000|Overall Study|Adverse Event|9
4457472|NCT00554515|7244913|FG000|Overall Study|Death|2
4457473|NCT00554515|7244913|FG000|Overall Study|Achieved Stable Disease|7
4457474|NCT00554515|7244913|FG000|Overall Study|Other|1
4457475|NCT00554515|7244913|FG000|Overall Study|Misc|15
4538717|NCT01121913|7360750|FG001|First Washout Period|Withdrawal by Subject|0
4538718|NCT01121913|7360751|FG002|First Washout Period|Withdrawal by Subject|0
4538719|NCT01121913|7360752|FG003|First Washout Period|Withdrawal by Subject|0
4538720|NCT01121913|7360749|FG000|Second Intervention Period|Adverse Event|0
4611532|NCT01700205|7467788|FG001|Overall Study|Withdrawal by Subject|13
4611533|NCT01700205|7467787|FG000|Overall Study|Protocol Violation|2
4611534|NCT01700205|7467788|FG001|Overall Study|Protocol Violation|2
4611535|NCT01700387|7467804|FG000|Overall Study|Withdrawal by Subject|1
4611536|NCT01700387|7467805|FG001|Overall Study|Withdrawal by Subject|2
4611537|NCT01700387|7467804|FG000|Overall Study|Adverse Event|1
4611538|NCT01700387|7467805|FG001|Overall Study|Adverse Event|1
4611539|NCT01700387|7467804|FG000|Overall Study|Lost to Follow-up|2
4611540|NCT01700387|7467805|FG001|Overall Study|Lost to Follow-up|1
4611541|NCT01700530|7467831|FG000|Overall Study|Withdrawal by Subject|0
4611542|NCT01700530|7467832|FG001|Overall Study|Withdrawal by Subject|3
4611543|NCT01700530|7467833|FG002|Overall Study|Withdrawal by Subject|1
4611544|NCT01700621|7467843|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7
4611545|NCT01700621|7467844|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4
4611546|NCT01700621|7467843|FG000|Analyzed for Immunogenicity|Protocol Violation|5
4611547|NCT01700621|7467844|FG001|Analyzed for Immunogenicity|Protocol Violation|1
4611548|NCT01700621|7467843|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1
4611549|NCT01700621|7467844|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2
4611550|NCT01700829|7467889|FG000|Overall Study|Withdrawal by Subject|1
4611551|NCT01700829|7467890|FG001|Overall Study|Withdrawal by Subject|1
4611552|NCT01700959|7467911|FG000|Overall Study|Adverse Event|0
4611553|NCT01700959|7467912|FG001|Overall Study|Adverse Event|1
4611554|NCT01700959|7467913|FG002|Overall Study|Adverse Event|1
4611555|NCT01700959|7467914|FG003|Overall Study|Adverse Event|2
4611556|NCT01700959|7467915|FG004|Overall Study|Adverse Event|0
4611557|NCT01700959|7467916|FG005|Overall Study|Adverse Event|2
4611558|NCT01700959|7467911|FG000|Overall Study|Withdrawal by Subject|15
4457476|NCT00554619|7244938|FG000|Overall Study|Adverse Event|1
4457477|NCT00554619|7244938|FG000|Overall Study|Physician Decision|1
4457478|NCT00554619|7244938|FG000|Overall Study|Liver Function Test Abnormality|1
4457479|NCT00554788|7244959|FG000|Overall Study|Adverse Event|0
4457480|NCT00554788|7244960|FG001|Overall Study|Adverse Event|1
4538721|NCT01121913|7360750|FG001|Second Intervention Period|Adverse Event|0
4457481|NCT00554788|7244961|FG002|Overall Study|Adverse Event|2
4457482|NCT00554788|7244959|FG000|Overall Study|Lost to Follow-up|4
4457483|NCT00554788|7244960|FG001|Overall Study|Lost to Follow-up|3
4457484|NCT00554788|7244961|FG002|Overall Study|Lost to Follow-up|3
4457485|NCT00554788|7244959|FG000|Overall Study|Physician Decision|1
4457486|NCT00554788|7244960|FG001|Overall Study|Physician Decision|1
4457487|NCT00554788|7244961|FG002|Overall Study|Physician Decision|3
4457488|NCT00554788|7244959|FG000|Overall Study|Withdrawal by Subject|0
4457489|NCT00554788|7244960|FG001|Overall Study|Withdrawal by Subject|0
4457490|NCT00554788|7244961|FG002|Overall Study|Withdrawal by Subject|1
4457491|NCT00554788|7244959|FG000|Overall Study|Refusal of further protocol therapy|0
4457492|NCT00554788|7244960|FG001|Overall Study|Refusal of further protocol therapy|1
4457493|NCT00554788|7244961|FG002|Overall Study|Refusal of further protocol therapy|1
4457494|NCT00554788|7244959|FG000|Overall Study|Progressive disease|0
4457495|NCT00554788|7244960|FG001|Overall Study|Progressive disease|0
4457496|NCT00554788|7244961|FG002|Overall Study|Progressive disease|3
4457497|NCT00554788|7244959|FG000|Overall Study|Ineligible|2
4457498|NCT00554788|7244960|FG001|Overall Study|Ineligible|0
4457499|NCT00554788|7244961|FG002|Overall Study|Ineligible|1
4457500|NCT00554801|7244972|FG000|Overall Study|left area before completion|5
4457501|NCT00554801|7244973|FG001|Overall Study|left area before completion|0
4457502|NCT00554801|7244972|FG000|Overall Study|Withdrawal by Subject|14
4457503|NCT00554801|7244973|FG001|Overall Study|Withdrawal by Subject|0
4457504|NCT00555061|7245021|FG000|Overall Study|Adverse Event|3
4457505|NCT00555061|7245021|FG000|Overall Study|Protocol Violation|1
4457506|NCT00555061|7245021|FG000|Overall Study|Lost to Follow-up|2
4457507|NCT00555061|7245021|FG000|Overall Study|Withdrawal by Subject|2
4457508|NCT00555061|7245021|FG000|Overall Study|Participant enrolled, but never treated|1
4457509|NCT00555217|7245044|FG000|Overall Study|Withdrawal by Subject|35
4457510|NCT00555217|7245045|FG001|Overall Study|Withdrawal by Subject|31
4457511|NCT00555217|7245044|FG000|Overall Study|Lost to Follow-up|19
4457512|NCT00555217|7245045|FG001|Overall Study|Lost to Follow-up|20
4457513|NCT00555217|7245044|FG000|Overall Study|close out sites|21
4457514|NCT00555217|7245045|FG001|Overall Study|close out sites|17
4457515|NCT00555321|7245056|FG000|Treatment Phase up to 12-months|Adverse Event|6
4457516|NCT00555321|7245057|FG001|Treatment Phase up to 12-months|Adverse Event|7
4457517|NCT00555321|7245058|FG002|Treatment Phase up to 12-months|Adverse Event|11
4457518|NCT00555321|7245059|FG003|Treatment Phase up to 12-months|Adverse Event|7
4457519|NCT00555321|7245060|FG004|Treatment Phase up to 12-months|Adverse Event|18
4457520|NCT00555321|7245056|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1
4457521|NCT00555321|7245057|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0
4457522|NCT00555321|7245058|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1
4457523|NCT00555321|7245059|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0
4457524|NCT00555321|7245060|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0
4457525|NCT00555321|7245056|FG000|Treatment Phase up to 12-months|Death|2
4457526|NCT00555321|7245057|FG001|Treatment Phase up to 12-months|Death|1
4457527|NCT00555321|7245058|FG002|Treatment Phase up to 12-months|Death|4
4457528|NCT00555321|7245059|FG003|Treatment Phase up to 12-months|Death|0
4457529|NCT00555321|7245060|FG004|Treatment Phase up to 12-months|Death|0
4457530|NCT00555321|7245056|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9
4457531|NCT00555321|7245057|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8
4457532|NCT00555321|7245058|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5
4457533|NCT00555321|7245059|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0
4457534|NCT00555321|7245060|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0
4457535|NCT00555321|7245056|FG000|Treatment Phase up to 12-months|Other Reason|1
4457536|NCT00555321|7245057|FG001|Treatment Phase up to 12-months|Other Reason|3
4457537|NCT00555321|7245058|FG002|Treatment Phase up to 12-months|Other Reason|2
4457538|NCT00555321|7245059|FG003|Treatment Phase up to 12-months|Other Reason|0
4457539|NCT00555321|7245060|FG004|Treatment Phase up to 12-months|Other Reason|0
4457540|NCT00555321|7245056|FG000|Treatment Phase up to 12-months|Never treated|2
4457541|NCT00555321|7245057|FG001|Treatment Phase up to 12-months|Never treated|3
4457542|NCT00555321|7245058|FG002|Treatment Phase up to 12-months|Never treated|1
4457543|NCT00555321|7245059|FG003|Treatment Phase up to 12-months|Never treated|0
4457544|NCT00555321|7245060|FG004|Treatment Phase up to 12-months|Never treated|4
4457545|NCT00555321|7245056|FG000|Long-term Extension Phase|Adverse Event|2
4457546|NCT00555321|7245057|FG001|Long-term Extension Phase|Adverse Event|5
4457547|NCT00555321|7245058|FG002|Long-term Extension Phase|Adverse Event|2
4457548|NCT00555321|7245059|FG003|Long-term Extension Phase|Adverse Event|1
4457549|NCT00555321|7245060|FG004|Long-term Extension Phase|Adverse Event|0
4457550|NCT00555321|7245056|FG000|Long-term Extension Phase|Withdrawal by Subject|2
4457551|NCT00555321|7245057|FG001|Long-term Extension Phase|Withdrawal by Subject|1
4457552|NCT00555321|7245058|FG002|Long-term Extension Phase|Withdrawal by Subject|2
4457553|NCT00555321|7245059|FG003|Long-term Extension Phase|Withdrawal by Subject|3
4457554|NCT00555321|7245060|FG004|Long-term Extension Phase|Withdrawal by Subject|2
4457555|NCT00555321|7245056|FG000|Long-term Extension Phase|Administrative reason by sponsor|23
4457556|NCT00555321|7245057|FG001|Long-term Extension Phase|Administrative reason by sponsor|21
4457557|NCT00555321|7245058|FG002|Long-term Extension Phase|Administrative reason by sponsor|18
4457558|NCT00555321|7245059|FG003|Long-term Extension Phase|Administrative reason by sponsor|31
4457559|NCT00555321|7245060|FG004|Long-term Extension Phase|Administrative reason by sponsor|23
4457560|NCT00555321|7245056|FG000|Long-term Extension Phase|Death|2
4457561|NCT00555321|7245057|FG001|Long-term Extension Phase|Death|0
4457562|NCT00555321|7245058|FG002|Long-term Extension Phase|Death|0
4457563|NCT00555321|7245059|FG003|Long-term Extension Phase|Death|3
4457564|NCT00555321|7245060|FG004|Long-term Extension Phase|Death|0
4457565|NCT00555321|7245056|FG000|Long-term Extension Phase|Participant did not meet study criteria|0
4457566|NCT00555321|7245057|FG001|Long-term Extension Phase|Participant did not meet study criteria|0
4457567|NCT00555321|7245058|FG002|Long-term Extension Phase|Participant did not meet study criteria|0
4457568|NCT00555321|7245059|FG003|Long-term Extension Phase|Participant did not meet study criteria|0
4457569|NCT00555321|7245060|FG004|Long-term Extension Phase|Participant did not meet study criteria|1
4457570|NCT00555321|7245056|FG000|Long-term Extension Phase|Other Reason|1
4457571|NCT00555321|7245057|FG001|Long-term Extension Phase|Other Reason|0
4457572|NCT00555321|7245058|FG002|Long-term Extension Phase|Other Reason|2
4457573|NCT00555321|7245059|FG003|Long-term Extension Phase|Other Reason|0
4457574|NCT00555321|7245060|FG004|Long-term Extension Phase|Other Reason|0
4457575|NCT00555425|7245089|FG000|Overall Study|Missed Medication > 1 wk|34
4457576|NCT00555425|7245090|FG001|Overall Study|Missed Medication > 1 wk|15
4457577|NCT00555425|7245089|FG000|Overall Study|Missed 3 physician management visits|1
4457578|NCT00555425|7245090|FG001|Overall Study|Missed 3 physician management visits|0
4457579|NCT00555425|7245089|FG000|Overall Study|Met criteria for protective transfer|16
4457580|NCT00555425|7245090|FG001|Overall Study|Met criteria for protective transfer|3
4457581|NCT00555425|7245089|FG000|Overall Study|Became pregnant and transferred care|0
4457582|NCT00555425|7245090|FG001|Overall Study|Became pregnant and transferred care|1
4457583|NCT00555438|7245096|FG000|10 Days Post-operative|Death|4
4457584|NCT00555438|7245096|FG000|Between 10 Days and 30 Days Postoperativ|Death|5
4457585|NCT00555477|7245111|FG000|Overall Study|Adverse Event|0
4457586|NCT00555477|7245112|FG001|Overall Study|Adverse Event|9
4457587|NCT00555477|7245111|FG000|Overall Study|Withdrawal by Subject|1
4457588|NCT00555477|7245112|FG001|Overall Study|Withdrawal by Subject|2
4457589|NCT00555477|7245111|FG000|Overall Study|Physician Decision|1
4457590|NCT00555477|7245112|FG001|Overall Study|Physician Decision|2
4457591|NCT00555568|7245120|FG000|Overall Study|Lost to Follow-up|26
4457592|NCT00555568|7245121|FG001|Overall Study|Lost to Follow-up|16
4457593|NCT00555568|7245122|FG002|Overall Study|Lost to Follow-up|16
4611559|NCT01700959|7467912|FG001|Overall Study|Withdrawal by Subject|9
4611560|NCT01700959|7467913|FG002|Overall Study|Withdrawal by Subject|12
4611561|NCT01700959|7467914|FG003|Overall Study|Withdrawal by Subject|11
4611562|NCT01700959|7467915|FG004|Overall Study|Withdrawal by Subject|8
4611563|NCT01700959|7467916|FG005|Overall Study|Withdrawal by Subject|12
4611564|NCT01700959|7467911|FG000|Overall Study|Ineligible|2
4611565|NCT01700959|7467912|FG001|Overall Study|Ineligible|1
4611566|NCT01700959|7467913|FG002|Overall Study|Ineligible|2
4611567|NCT01700959|7467914|FG003|Overall Study|Ineligible|0
4611568|NCT01700959|7467915|FG004|Overall Study|Ineligible|0
4611569|NCT01700959|7467916|FG005|Overall Study|Ineligible|1
4611570|NCT01700959|7467911|FG000|Overall Study|Noncompliant|9
4611571|NCT01700959|7467912|FG001|Overall Study|Noncompliant|9
4611572|NCT01700959|7467913|FG002|Overall Study|Noncompliant|17
4611573|NCT01700959|7467914|FG003|Overall Study|Noncompliant|18
4611574|NCT01700959|7467915|FG004|Overall Study|Noncompliant|15
4611575|NCT01700959|7467916|FG005|Overall Study|Noncompliant|9
4611576|NCT01700959|7467911|FG000|Overall Study|Side effects|1
4611577|NCT01700959|7467912|FG001|Overall Study|Side effects|4
4611578|NCT01700959|7467913|FG002|Overall Study|Side effects|8
4611579|NCT01700959|7467914|FG003|Overall Study|Side effects|4
4611580|NCT01700959|7467915|FG004|Overall Study|Side effects|4
4611581|NCT01700959|7467916|FG005|Overall Study|Side effects|1
4611582|NCT01700985|7467934|FG000|Overall Study|Incarcerated|0
4611583|NCT01700985|7467935|FG001|Overall Study|Incarcerated|1
4611584|NCT01701063|7467972|FG000|Overall Study|Lost to Follow-up|0
4611585|NCT01701063|7467973|FG001|Overall Study|Lost to Follow-up|1
4611586|NCT01701063|7467974|FG002|Overall Study|Lost to Follow-up|0
4611587|NCT01701063|7467972|FG000|Overall Study|Withdrawal by Subject|0
4611588|NCT01701063|7467973|FG001|Overall Study|Withdrawal by Subject|0
4611589|NCT01701063|7467974|FG002|Overall Study|Withdrawal by Subject|1
4611590|NCT01701063|7467972|FG000|Overall Study|Other|0
4611591|NCT01701063|7467973|FG001|Overall Study|Other|0
4611592|NCT01701063|7467974|FG002|Overall Study|Other|1
4611593|NCT01701193|7468013|FG000|Overall Study|Withdrawal by Subject|2
4457594|NCT00555620|7245140|FG000|Overall Study|Death|0
4457595|NCT00555620|7245141|FG001|Overall Study|Death|1
4457596|NCT00555620|7245142|FG002|Overall Study|Death|0
4457597|NCT00555620|7245143|FG003|Overall Study|Death|0
4611594|NCT01701193|7468014|FG001|Overall Study|Withdrawal by Subject|2
4611595|NCT01701193|7468015|FG002|Overall Study|Withdrawal by Subject|1
4611596|NCT01701193|7468016|FG003|Overall Study|Withdrawal by Subject|2
4611597|NCT01701193|7468013|FG000|Overall Study|Adverse Event|1
4611598|NCT01701193|7468014|FG001|Overall Study|Adverse Event|0
4611599|NCT01701193|7468015|FG002|Overall Study|Adverse Event|0
4611600|NCT01701193|7468016|FG003|Overall Study|Adverse Event|0
4611601|NCT01701245|7468031|FG000|Overall Study|Protocol Violation|1
4611602|NCT01701245|7468032|FG001|Overall Study|Protocol Violation|3
4457598|NCT00555620|7245144|FG004|Overall Study|Death|0
4611603|NCT01701245|7468031|FG000|Overall Study|Did not complete the open label period|11
4611604|NCT01701245|7468032|FG001|Overall Study|Did not complete the open label period|12
4611605|NCT01701258|7468042|FG000|Assessment and Scheduling|Found to be Ineligible|57
4457599|NCT00555620|7245145|FG005|Overall Study|Death|1
4611606|NCT01701258|7468043|FG001|Assessment and Scheduling|Found to be Ineligible|0
4457600|NCT00555620|7245140|FG000|Overall Study|Study terminated by sponsor|0
4457601|NCT00555620|7245141|FG001|Overall Study|Study terminated by sponsor|0
4457602|NCT00555620|7245142|FG002|Overall Study|Study terminated by sponsor|1
4457603|NCT00555620|7245143|FG003|Overall Study|Study terminated by sponsor|0
4457604|NCT00555620|7245144|FG004|Overall Study|Study terminated by sponsor|0
4457605|NCT00555620|7245145|FG005|Overall Study|Study terminated by sponsor|0
4457606|NCT00555620|7245140|FG000|Overall Study|Adverse Event|0
4457607|NCT00555620|7245141|FG001|Overall Study|Adverse Event|0
4457608|NCT00555620|7245142|FG002|Overall Study|Adverse Event|1
4457609|NCT00555620|7245143|FG003|Overall Study|Adverse Event|5
4457610|NCT00555620|7245144|FG004|Overall Study|Adverse Event|0
4457611|NCT00555620|7245145|FG005|Overall Study|Adverse Event|1
4457612|NCT00555620|7245140|FG000|Overall Study|Objective progression or relapse|6
4457613|NCT00555620|7245141|FG001|Overall Study|Objective progression or relapse|5
4457614|NCT00555620|7245142|FG002|Overall Study|Objective progression or relapse|12
4457615|NCT00555620|7245143|FG003|Overall Study|Objective progression or relapse|17
4457616|NCT00555620|7245144|FG004|Overall Study|Objective progression or relapse|3
4457617|NCT00555620|7245145|FG005|Overall Study|Objective progression or relapse|16
4457618|NCT00555620|7245140|FG000|Overall Study|Participant refused treatment|0
4457619|NCT00555620|7245141|FG001|Overall Study|Participant refused treatment|1
4457620|NCT00555620|7245142|FG002|Overall Study|Participant refused treatment|1
4457621|NCT00555620|7245143|FG003|Overall Study|Participant refused treatment|0
4457622|NCT00555620|7245144|FG004|Overall Study|Participant refused treatment|0
4457623|NCT00555620|7245145|FG005|Overall Study|Participant refused treatment|1
4457624|NCT00555620|7245140|FG000|Overall Study|Other|0
4457625|NCT00555620|7245141|FG001|Overall Study|Other|0
4457626|NCT00555620|7245142|FG002|Overall Study|Other|0
4457627|NCT00555620|7245143|FG003|Overall Study|Other|1
4457628|NCT00555620|7245144|FG004|Overall Study|Other|0
4457629|NCT00555620|7245145|FG005|Overall Study|Other|3
4515895|NCT00957008|7327030|FG000|Overall Study|Physician Decision|1
4515896|NCT00957008|7327031|FG001|Overall Study|Physician Decision|0
4515897|NCT00957008|7327032|FG002|Overall Study|Physician Decision|1
4515898|NCT00957008|7327033|FG003|Overall Study|Physician Decision|1
4515899|NCT00957008|7327030|FG000|Overall Study|Relocated; Family conflict|4
4515900|NCT00957008|7327031|FG001|Overall Study|Relocated; Family conflict|1
4515901|NCT00957008|7327032|FG002|Overall Study|Relocated; Family conflict|1
4515902|NCT00957008|7327033|FG003|Overall Study|Relocated; Family conflict|3
4515903|NCT00957021|7327047|FG000|Overall Study|Death|5
4611607|NCT01701258|7468044|FG002|Assessment and Scheduling|Found to be Ineligible|0
4611608|NCT01701258|7468045|FG003|Assessment and Scheduling|Found to be Ineligible|0
4611609|NCT01701258|7468046|FG004|Assessment and Scheduling|Found to be Ineligible|0
4611610|NCT01701258|7468047|FG005|Assessment and Scheduling|Found to be Ineligible|0
4611611|NCT01701258|7468048|FG006|Assessment and Scheduling|Found to be Ineligible|0
4611612|NCT01701258|7468049|FG007|Assessment and Scheduling|Found to be Ineligible|0
4611613|NCT01701258|7468050|FG008|Assessment and Scheduling|Found to be Ineligible|0
4611614|NCT01701258|7468051|FG009|Assessment and Scheduling|Found to be Ineligible|0
4611615|NCT01701258|7468052|FG010|Assessment and Scheduling|Found to be Ineligible|0
4611616|NCT01701258|7468053|FG011|Assessment and Scheduling|Found to be Ineligible|0
4611617|NCT01701258|7468054|FG012|Assessment and Scheduling|Found to be Ineligible|0
4611618|NCT01701258|7468042|FG000|Assessment and Scheduling|Lost to Follow-up|10
4611619|NCT01701258|7468043|FG001|Assessment and Scheduling|Lost to Follow-up|0
4611620|NCT01701258|7468044|FG002|Assessment and Scheduling|Lost to Follow-up|0
4611621|NCT01701258|7468045|FG003|Assessment and Scheduling|Lost to Follow-up|0
4611622|NCT01701258|7468046|FG004|Assessment and Scheduling|Lost to Follow-up|0
4611623|NCT01701258|7468047|FG005|Assessment and Scheduling|Lost to Follow-up|0
4611624|NCT01701258|7468048|FG006|Assessment and Scheduling|Lost to Follow-up|0
4611625|NCT01701258|7468049|FG007|Assessment and Scheduling|Lost to Follow-up|0
4611626|NCT01701258|7468050|FG008|Assessment and Scheduling|Lost to Follow-up|0
4611627|NCT01701258|7468051|FG009|Assessment and Scheduling|Lost to Follow-up|0
4611628|NCT01701258|7468052|FG010|Assessment and Scheduling|Lost to Follow-up|0
4611629|NCT01701258|7468053|FG011|Assessment and Scheduling|Lost to Follow-up|0
4611630|NCT01701258|7468054|FG012|Assessment and Scheduling|Lost to Follow-up|0
4611631|NCT01701258|7468042|FG000|Assessment and Scheduling|Withdrawal by Subject|14
4611632|NCT01701258|7468043|FG001|Assessment and Scheduling|Withdrawal by Subject|0
4515904|NCT00957021|7327047|FG000|Overall Study|Lost to Follow-up|8
4515905|NCT00957021|7327047|FG000|Overall Study|Withdrawal by Subject|34
4611633|NCT01701258|7468044|FG002|Assessment and Scheduling|Withdrawal by Subject|0
4611634|NCT01701258|7468045|FG003|Assessment and Scheduling|Withdrawal by Subject|0
4611635|NCT01701258|7468046|FG004|Assessment and Scheduling|Withdrawal by Subject|0
4611636|NCT01701258|7468047|FG005|Assessment and Scheduling|Withdrawal by Subject|0
4611637|NCT01701258|7468048|FG006|Assessment and Scheduling|Withdrawal by Subject|0
4611638|NCT01701258|7468049|FG007|Assessment and Scheduling|Withdrawal by Subject|0
4611639|NCT01701258|7468050|FG008|Assessment and Scheduling|Withdrawal by Subject|0
4611640|NCT01701258|7468051|FG009|Assessment and Scheduling|Withdrawal by Subject|0
4515906|NCT00957021|7327047|FG000|Overall Study|No 2 yr ROM data|35
4515907|NCT00957021|7327047|FG000|Overall Study|Revised study component by 2 yr visit|8
4515908|NCT00957021|7327047|FG000|Overall Study|Site Termination by the 2 yr visit|16
4515909|NCT00957021|7327047|FG000|Overall Study|Surgery Cancelled|9
4457630|NCT00555672|7245165|FG000|Overall Study|Death|0
4457631|NCT00555672|7245166|FG001|Overall Study|Death|2
4457632|NCT00555672|7245165|FG000|Overall Study|Adverse Event|8
4611641|NCT01701258|7468052|FG010|Assessment and Scheduling|Withdrawal by Subject|0
4611642|NCT01701258|7468053|FG011|Assessment and Scheduling|Withdrawal by Subject|0
4611643|NCT01701258|7468054|FG012|Assessment and Scheduling|Withdrawal by Subject|0
4611644|NCT01701258|7468042|FG000|Assessment and Scheduling|Investigator Terminated|2
4611645|NCT01701258|7468043|FG001|Assessment and Scheduling|Investigator Terminated|0
4611646|NCT01701258|7468044|FG002|Assessment and Scheduling|Investigator Terminated|0
4611647|NCT01701258|7468045|FG003|Assessment and Scheduling|Investigator Terminated|0
4611648|NCT01701258|7468046|FG004|Assessment and Scheduling|Investigator Terminated|0
4611649|NCT01701258|7468047|FG005|Assessment and Scheduling|Investigator Terminated|0
4611650|NCT01701258|7468048|FG006|Assessment and Scheduling|Investigator Terminated|0
4611651|NCT01701258|7468049|FG007|Assessment and Scheduling|Investigator Terminated|0
4611652|NCT01701258|7468050|FG008|Assessment and Scheduling|Investigator Terminated|0
4611653|NCT01701258|7468051|FG009|Assessment and Scheduling|Investigator Terminated|0
4611654|NCT01701258|7468052|FG010|Assessment and Scheduling|Investigator Terminated|0
4611655|NCT01701258|7468053|FG011|Assessment and Scheduling|Investigator Terminated|0
4611656|NCT01701258|7468054|FG012|Assessment and Scheduling|Investigator Terminated|0
4611657|NCT01701362|7468089|FG000|Overall Study|Adverse events not related to study drug|1
4611658|NCT01701362|7468090|FG001|Overall Study|Adverse events not related to study drug|6
4611659|NCT01701362|7468089|FG000|Overall Study|Adverse events related to study drug|12
4611660|NCT01701362|7468090|FG001|Overall Study|Adverse events related to study drug|10
4611661|NCT01701362|7468089|FG000|Overall Study|Protocol Violation|5
4611662|NCT01701362|7468090|FG001|Overall Study|Protocol Violation|3
4611663|NCT01701362|7468089|FG000|Overall Study|No longer willing to participate|8
4611664|NCT01701362|7468090|FG001|Overall Study|No longer willing to participate|14
4611665|NCT01701362|7468089|FG000|Overall Study|Lost to Follow-up|6
4611666|NCT01701362|7468090|FG001|Overall Study|Lost to Follow-up|9
4611667|NCT01701362|7468089|FG000|Overall Study|Insufficient clinical response|6
4611668|NCT01701362|7468090|FG001|Overall Study|Insufficient clinical response|6
4611669|NCT01701362|7468089|FG000|Overall Study|Death|0
4611670|NCT01701362|7468090|FG001|Overall Study|Death|1
4611671|NCT01701362|7468089|FG000|Overall Study|Randomized but not treated|1
4611672|NCT01701362|7468090|FG001|Overall Study|Randomized but not treated|2
4611673|NCT01701362|7468089|FG000|Overall Study|Reasons other than those mentioned above|3
4611674|NCT01701362|7468090|FG001|Overall Study|Reasons other than those mentioned above|5
4611675|NCT01701401|7468104|FG000|Overall Study|Randomized But Not Treated|3
4611676|NCT01701401|7468105|FG001|Overall Study|Randomized But Not Treated|1
4611677|NCT01701401|7468106|FG002|Overall Study|Randomized But Not Treated|0
4611678|NCT01701401|7468107|FG003|Overall Study|Randomized But Not Treated|1
4611679|NCT01701401|7468104|FG000|Overall Study|Lost to Follow-up|5
4611680|NCT01701401|7468105|FG001|Overall Study|Lost to Follow-up|5
4611681|NCT01701401|7468106|FG002|Overall Study|Lost to Follow-up|1
4611682|NCT01701401|7468107|FG003|Overall Study|Lost to Follow-up|3
4611683|NCT01701401|7468104|FG000|Overall Study|Withdrew Consent|0
4611684|NCT01701401|7468105|FG001|Overall Study|Withdrew Consent|3
4611685|NCT01701401|7468106|FG002|Overall Study|Withdrew Consent|1
4611686|NCT01701401|7468107|FG003|Overall Study|Withdrew Consent|2
4611687|NCT01701401|7468104|FG000|Overall Study|Lack of Efficacy|1
4611688|NCT01701401|7468105|FG001|Overall Study|Lack of Efficacy|0
4611689|NCT01701401|7468106|FG002|Overall Study|Lack of Efficacy|2
4611690|NCT01701401|7468107|FG003|Overall Study|Lack of Efficacy|0
4611691|NCT01701401|7468104|FG000|Overall Study|Adverse Event|1
4611692|NCT01701401|7468105|FG001|Overall Study|Adverse Event|0
4611693|NCT01701401|7468106|FG002|Overall Study|Adverse Event|0
4611694|NCT01701401|7468107|FG003|Overall Study|Adverse Event|0
4611695|NCT01701401|7468104|FG000|Overall Study|Protocol Violation|0
4611696|NCT01701401|7468105|FG001|Overall Study|Protocol Violation|0
4611697|NCT01701401|7468106|FG002|Overall Study|Protocol Violation|1
4611698|NCT01701401|7468107|FG003|Overall Study|Protocol Violation|0
4611699|NCT01701973|7468154|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0
4611700|NCT01701973|7468155|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1
4611701|NCT01701973|7468156|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0
4611702|NCT01701973|7468157|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0
4611703|NCT01701973|7468158|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0
4611704|NCT01701973|7468159|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0
4611705|NCT01701973|7468160|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0
4611706|NCT01701973|7468161|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0
4611707|NCT01702025|7468214|FG000|Overall Study|Equipment failure|1
4611708|NCT01702025|7468215|FG001|Overall Study|Equipment failure|0
4611709|NCT01702025|7468216|FG002|Overall Study|Equipment failure|0
4611710|NCT01702025|7468217|FG003|Overall Study|Equipment failure|0
4611711|NCT01702025|7468214|FG000|Overall Study|Adverse Event|1
4611712|NCT01702025|7468215|FG001|Overall Study|Adverse Event|1
4611713|NCT01702025|7468216|FG002|Overall Study|Adverse Event|1
4611714|NCT01702025|7468217|FG003|Overall Study|Adverse Event|0
4611715|NCT01702246|7468245|FG000|Overall Study|Lost to Follow-up|2
4611716|NCT01702246|7468245|FG000|Overall Study|Withdrawal by Subject|2
4611717|NCT01702246|7468245|FG000|Overall Study|Physician Decision|1
4457633|NCT00555672|7245166|FG001|Overall Study|Adverse Event|2
4457634|NCT00555672|7245165|FG000|Overall Study|Objective progression or relapse|11
4457635|NCT00555672|7245166|FG001|Overall Study|Objective progression or relapse|5
4457636|NCT00555672|7245165|FG000|Overall Study|Other|3
4457637|NCT00555672|7245166|FG001|Overall Study|Other|1
4457638|NCT00555672|7245165|FG000|Overall Study|Participant refused|2
4457639|NCT00555672|7245166|FG001|Overall Study|Participant refused|0
4457640|NCT00555906|7245203|FG000|Phase 1|Objective Progression or Relapse|3
4457641|NCT00555906|7245204|FG001|Phase 1|Objective Progression or Relapse|5
4457642|NCT00555906|7245205|FG002|Phase 1|Objective Progression or Relapse|3
4457643|NCT00555906|7245206|FG003|Phase 1|Objective Progression or Relapse|1
4457644|NCT00555906|7245207|FG004|Phase 1|Objective Progression or Relapse|0
4457645|NCT00555906|7245203|FG000|Phase 1|Global Deterioration of Health Status|0
4457646|NCT00555906|7245204|FG001|Phase 1|Global Deterioration of Health Status|1
4457647|NCT00555906|7245205|FG002|Phase 1|Global Deterioration of Health Status|1
4457648|NCT00555906|7245206|FG003|Phase 1|Global Deterioration of Health Status|1
4457649|NCT00555906|7245207|FG004|Phase 1|Global Deterioration of Health Status|0
4457650|NCT00555906|7245203|FG000|Phase 1|Adverse Event|0
4457651|NCT00555906|7245204|FG001|Phase 1|Adverse Event|0
4457652|NCT00555906|7245205|FG002|Phase 1|Adverse Event|3
4538722|NCT01121913|7360751|FG002|Second Intervention Period|Adverse Event|1
4538723|NCT01121913|7360752|FG003|Second Intervention Period|Adverse Event|0
4538724|NCT01121913|7360749|FG000|Second Washout Period|Withdrawal by Subject|0
4538725|NCT01121913|7360750|FG001|Second Washout Period|Withdrawal by Subject|0
4538726|NCT01121913|7360751|FG002|Second Washout Period|Withdrawal by Subject|1
4538727|NCT01121913|7360752|FG003|Second Washout Period|Withdrawal by Subject|0
4538728|NCT01121913|7360749|FG000|Third Washout Period|Adverse Event|1
4538729|NCT01121913|7360750|FG001|Third Washout Period|Adverse Event|0
4538730|NCT01121913|7360751|FG002|Third Washout Period|Adverse Event|0
4538731|NCT01121913|7360752|FG003|Third Washout Period|Adverse Event|0
4538732|NCT01121926|7360762|FG000|First Intervention Period|Adverse Event|1
4538733|NCT01121926|7360763|FG001|First Intervention Period|Adverse Event|0
4538734|NCT01121926|7360762|FG000|Washout Period|Adverse Event|0
4538735|NCT01121926|7360763|FG001|Washout Period|Adverse Event|1
4538736|NCT01121926|7360762|FG000|Washout Period|Positive pregnancy test|0
4538737|NCT01121926|7360763|FG001|Washout Period|Positive pregnancy test|1
4538738|NCT01121991|7360776|FG000|Overall Study|Lack of Ovarian Response|2
4538739|NCT01121991|7360776|FG000|Overall Study|No Oocytes Retrieved|3
4538740|NCT01121991|7360776|FG000|Overall Study|No Fertilization|1
4538741|NCT01122173|7360831|FG000|Overall Study|Lost to Follow-up|3
4538742|NCT01122173|7360831|FG000|Overall Study|Withdrawal by Subject|3
4538743|NCT01122173|7360831|FG000|Overall Study|Left study for other reasons|3
4538744|NCT01122264|7360884|FG000|Overall Study|Adverse Event|6
4538745|NCT01122264|7360885|FG001|Overall Study|Adverse Event|5
4538746|NCT01122264|7360886|FG002|Overall Study|Adverse Event|7
4538747|NCT01122264|7360884|FG000|Overall Study|Death|1
4538748|NCT01122264|7360885|FG001|Overall Study|Death|0
4538749|NCT01122264|7360886|FG002|Overall Study|Death|0
4538750|NCT01122264|7360884|FG000|Overall Study|Lost to Follow-up|5
4538751|NCT01122264|7360885|FG001|Overall Study|Lost to Follow-up|9
4538752|NCT01122264|7360886|FG002|Overall Study|Lost to Follow-up|13
4538753|NCT01122264|7360884|FG000|Overall Study|Entry Criteria Not Met|1
4538754|NCT01122264|7360885|FG001|Overall Study|Entry Criteria Not Met|0
4538755|NCT01122264|7360886|FG002|Overall Study|Entry Criteria Not Met|0
4538756|NCT01122264|7360884|FG000|Overall Study|Protocol Violation|7
4538757|NCT01122264|7360885|FG001|Overall Study|Protocol Violation|7
4538758|NCT01122264|7360886|FG002|Overall Study|Protocol Violation|9
4538759|NCT01122264|7360884|FG000|Overall Study|Withdrawal by Subject|6
4538760|NCT01122264|7360885|FG001|Overall Study|Withdrawal by Subject|6
4538761|NCT01122264|7360886|FG002|Overall Study|Withdrawal by Subject|16
4538762|NCT01122264|7360884|FG000|Overall Study|Physician Decision|3
4538763|NCT01122264|7360885|FG001|Overall Study|Physician Decision|1
4611718|NCT01702298|7468261|FG000|Overall Study|Withdrawal by Subject|1
4611719|NCT01702311|7468267|FG000|Overall Study|Withdrawal by Subject|3
4611720|NCT01702311|7468268|FG001|Overall Study|Withdrawal by Subject|2
4611721|NCT01702311|7468267|FG000|Overall Study|Discharge less than 24 hours|10
4611722|NCT01702311|7468268|FG001|Overall Study|Discharge less than 24 hours|7
4611723|NCT01702311|7468267|FG000|Overall Study|Physician Decision|3
4611724|NCT01702311|7468268|FG001|Overall Study|Physician Decision|4
4611725|NCT01702363|7468277|FG000|Overall Study|Adverse Event|14
4611726|NCT01702363|7468277|FG000|Overall Study|Lack of Efficacy|4
4611727|NCT01702363|7468277|FG000|Overall Study|Withdrawal by Subject|2
4611728|NCT01702428|7468286|FG000|Overall Study|Adverse Event|2
4611729|NCT01702428|7468287|FG001|Overall Study|Adverse Event|0
4611730|NCT01702428|7468288|FG002|Overall Study|Adverse Event|0
4611731|NCT01702428|7468289|FG003|Overall Study|Adverse Event|0
4538764|NCT01122264|7360886|FG002|Overall Study|Physician Decision|1
4611732|NCT01702428|7468286|FG000|Overall Study|Lost to Follow-up|33
4611733|NCT01702428|7468287|FG001|Overall Study|Lost to Follow-up|41
4611734|NCT01702428|7468288|FG002|Overall Study|Lost to Follow-up|37
4538765|NCT01122264|7360884|FG000|Overall Study|Lack of Efficacy|3
4538766|NCT01122264|7360885|FG001|Overall Study|Lack of Efficacy|1
4538767|NCT01122264|7360886|FG002|Overall Study|Lack of Efficacy|1
4538768|NCT01122394|7360904|FG000|Overall Study|Withdrawal by Subject|1
4611735|NCT01702428|7468289|FG003|Overall Study|Lost to Follow-up|44
4457653|NCT00555906|7245206|FG003|Phase 1|Adverse Event|2
4457654|NCT00555906|7245207|FG004|Phase 1|Adverse Event|0
4457655|NCT00555906|7245203|FG000|Phase 1|Withdrawal by Subject|0
4457656|NCT00555906|7245204|FG001|Phase 1|Withdrawal by Subject|0
4457657|NCT00555906|7245205|FG002|Phase 1|Withdrawal by Subject|0
4457658|NCT00555906|7245206|FG003|Phase 1|Withdrawal by Subject|1
4457659|NCT00555906|7245207|FG004|Phase 1|Withdrawal by Subject|0
4457660|NCT00555906|7245203|FG000|Phase 2|Adverse Event|0
4457661|NCT00555906|7245204|FG001|Phase 2|Adverse Event|0
4457662|NCT00555906|7245205|FG002|Phase 2|Adverse Event|0
4457663|NCT00555906|7245206|FG003|Phase 2|Adverse Event|0
4457664|NCT00555906|7245207|FG004|Phase 2|Adverse Event|4
4457665|NCT00555906|7245203|FG000|Phase 2|Global Deterioration of Health Status|0
4457666|NCT00555906|7245204|FG001|Phase 2|Global Deterioration of Health Status|0
4457667|NCT00555906|7245205|FG002|Phase 2|Global Deterioration of Health Status|0
4457668|NCT00555906|7245206|FG003|Phase 2|Global Deterioration of Health Status|0
4457669|NCT00555906|7245207|FG004|Phase 2|Global Deterioration of Health Status|2
4457670|NCT00555906|7245203|FG000|Phase 2|Objective Progression or Relapse|0
4457671|NCT00555906|7245204|FG001|Phase 2|Objective Progression or Relapse|0
4457672|NCT00555906|7245205|FG002|Phase 2|Objective Progression or Relapse|0
4457673|NCT00555906|7245206|FG003|Phase 2|Objective Progression or Relapse|0
4457674|NCT00555906|7245207|FG004|Phase 2|Objective Progression or Relapse|16
4457675|NCT00555906|7245203|FG000|Phase 2|Withdrawal by Subject|0
4457676|NCT00555906|7245204|FG001|Phase 2|Withdrawal by Subject|0
4457677|NCT00555906|7245205|FG002|Phase 2|Withdrawal by Subject|0
4457678|NCT00555906|7245206|FG003|Phase 2|Withdrawal by Subject|0
4457679|NCT00555906|7245207|FG004|Phase 2|Withdrawal by Subject|2
4457680|NCT00555906|7245203|FG000|Phase 2|Other|0
4457681|NCT00555906|7245204|FG001|Phase 2|Other|0
4457682|NCT00555906|7245205|FG002|Phase 2|Other|0
4457683|NCT00555906|7245206|FG003|Phase 2|Other|0
4457684|NCT00555906|7245207|FG004|Phase 2|Other|6
4457685|NCT00555906|7245203|FG000|Phase 2|Randomized but not Treated|0
4457686|NCT00555906|7245204|FG001|Phase 2|Randomized but not Treated|0
4457687|NCT00555906|7245205|FG002|Phase 2|Randomized but not Treated|0
4457688|NCT00555906|7245206|FG003|Phase 2|Randomized but not Treated|0
4457689|NCT00555906|7245207|FG004|Phase 2|Randomized but not Treated|2
4457690|NCT00555971|7245224|FG000|Overall Study|Adverse Event|1
4457691|NCT00555971|7245225|FG001|Overall Study|Adverse Event|1
4457692|NCT00556322|7245259|FG000|Overall Study|Insufficient therapeutic response|158
4457693|NCT00556322|7245260|FG001|Overall Study|Insufficient therapeutic response|168
4457694|NCT00556322|7245259|FG000|Overall Study|Adverse Event|7
4457695|NCT00556322|7245260|FG001|Overall Study|Adverse Event|4
4457696|NCT00556322|7245259|FG000|Overall Study|Other|4
4457697|NCT00556322|7245260|FG001|Overall Study|Other|1
4457698|NCT00556322|7245259|FG000|Overall Study|Lost to Follow-up|5
4457699|NCT00556322|7245260|FG001|Overall Study|Lost to Follow-up|3
4457700|NCT00556322|7245259|FG000|Overall Study|Withdrawal by Subject|19
4457701|NCT00556322|7245260|FG001|Overall Study|Withdrawal by Subject|7
4457702|NCT00556322|7245259|FG000|Overall Study|Protocol Violation|5
4457703|NCT00556322|7245260|FG001|Overall Study|Protocol Violation|1
4457704|NCT00556322|7245259|FG000|Overall Study|Ongoing at data cutoff|3
4457705|NCT00556322|7245260|FG001|Overall Study|Ongoing at data cutoff|5
4457706|NCT00556322|7245259|FG000|Overall Study|Death|20
4457707|NCT00556322|7245260|FG001|Overall Study|Death|14
4457708|NCT00556374|7245271|FG000|Overall Study|Withdrawal by Subject|190
4457709|NCT00556374|7245272|FG001|Overall Study|Withdrawal by Subject|172
4457710|NCT00556374|7245271|FG000|Overall Study|Death|50
4457711|NCT00556374|7245272|FG001|Overall Study|Death|43
4457712|NCT00556374|7245271|FG000|Overall Study|Lost to Follow-up|7
4611736|NCT01702428|7468286|FG000|Overall Study|Parents cannot assist to site|1
4611737|NCT01702428|7468287|FG001|Overall Study|Parents cannot assist to site|0
4611738|NCT01702428|7468288|FG002|Overall Study|Parents cannot assist to site|1
4611739|NCT01702428|7468289|FG003|Overall Study|Parents cannot assist to site|0
4611740|NCT01702428|7468286|FG000|Overall Study|Lost Coverage|0
4611741|NCT01702428|7468287|FG001|Overall Study|Lost Coverage|0
4611742|NCT01702428|7468288|FG002|Overall Study|Lost Coverage|0
4457713|NCT00556374|7245272|FG001|Overall Study|Lost to Follow-up|5
4457714|NCT00556426|7245278|FG000|Overall Study|Withdrawal by Subject|3
4690326|NCT02560558|7600023|FG001|Overall Study|Protocol Violation|0
4457715|NCT00556426|7245278|FG000|Overall Study|Death|6
4457716|NCT00556439|7245287|FG000|Study Entry to Week 12|Lack of Efficacy|5
4457717|NCT00556439|7245288|FG001|Study Entry to Week 12|Lack of Efficacy|0
4457718|NCT00556439|7245289|FG002|Study Entry to Week 12|Lack of Efficacy|6
4457719|NCT00556439|7245290|FG003|Study Entry to Week 12|Lack of Efficacy|0
4457720|NCT00556439|7245287|FG000|Study Entry to Week 12|Physician Decision|1
4457721|NCT00556439|7245288|FG001|Study Entry to Week 12|Physician Decision|0
4457722|NCT00556439|7245289|FG002|Study Entry to Week 12|Physician Decision|0
4457723|NCT00556439|7245290|FG003|Study Entry to Week 12|Physician Decision|0
4457724|NCT00556439|7245287|FG000|Study Entry to Week 12|Withdrawal by Subject|1
4457725|NCT00556439|7245288|FG001|Study Entry to Week 12|Withdrawal by Subject|0
4457726|NCT00556439|7245289|FG002|Study Entry to Week 12|Withdrawal by Subject|1
4457727|NCT00556439|7245290|FG003|Study Entry to Week 12|Withdrawal by Subject|0
4457728|NCT00556439|7245287|FG000|Study Entry to Week 12|Recurrent infection|1
4457729|NCT00556439|7245288|FG001|Study Entry to Week 12|Recurrent infection|0
4457730|NCT00556439|7245289|FG002|Study Entry to Week 12|Recurrent infection|0
4457731|NCT00556439|7245290|FG003|Study Entry to Week 12|Recurrent infection|0
4457732|NCT00556439|7245287|FG000|Study Entry to Week 12|Malignancy|0
4457733|NCT00556439|7245288|FG001|Study Entry to Week 12|Malignancy|0
4457734|NCT00556439|7245289|FG002|Study Entry to Week 12|Malignancy|1
4457735|NCT00556439|7245290|FG003|Study Entry to Week 12|Malignancy|0
4457736|NCT00556439|7245287|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1
4457737|NCT00556439|7245288|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3
4457738|NCT00556439|7245289|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0
4457739|NCT00556439|7245290|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0
4457740|NCT00556439|7245287|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1
4457741|NCT00556439|7245288|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0
4457742|NCT00556439|7245289|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0
4457743|NCT00556439|7245290|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0
4457744|NCT00556439|7245287|FG000|After Week 12 (Randomized Study Period)|Malignancy|0
4457745|NCT00556439|7245288|FG001|After Week 12 (Randomized Study Period)|Malignancy|1
4457746|NCT00556439|7245289|FG002|After Week 12 (Randomized Study Period)|Malignancy|0
4457747|NCT00556439|7245290|FG003|After Week 12 (Randomized Study Period)|Malignancy|1
4457748|NCT00556439|7245287|FG000|After Week 12 (Randomized Study Period)|Severe infection|1
4457749|NCT00556439|7245288|FG001|After Week 12 (Randomized Study Period)|Severe infection|0
4457750|NCT00556439|7245289|FG002|After Week 12 (Randomized Study Period)|Severe infection|0
4457751|NCT00556439|7245290|FG003|After Week 12 (Randomized Study Period)|Severe infection|0
4457752|NCT00556673|7245359|FG000|Overall Study|Protocol deviation|3
4457753|NCT00556673|7245360|FG001|Overall Study|Protocol deviation|2
4457754|NCT00556712|7245370|FG000|Overall Study|Adverse Event|7
4457755|NCT00556712|7245371|FG001|Overall Study|Adverse Event|19
4457756|NCT00556712|7245370|FG000|Overall Study|Death|5
4457757|NCT00556712|7245371|FG001|Overall Study|Death|10
4457758|NCT00556712|7245370|FG000|Overall Study|Progressive Disease|383
4457759|NCT00556712|7245371|FG001|Overall Study|Progressive Disease|320
4457760|NCT00556712|7245370|FG000|Overall Study|Protocol Violation|3
4457761|NCT00556712|7245371|FG001|Overall Study|Protocol Violation|2
4457762|NCT00556712|7245370|FG000|Overall Study|Refused Treatment|17
4457763|NCT00556712|7245371|FG001|Overall Study|Refused Treatment|16
4457764|NCT00556712|7245370|FG000|Overall Study|Failure to Return|2
4457765|NCT00556712|7245371|FG001|Overall Study|Failure to Return|3
4457766|NCT00556712|7245370|FG000|Overall Study|Other|2
4457767|NCT00556712|7245371|FG001|Overall Study|Other|2
4457768|NCT00556712|7245370|FG000|Overall Study|Ongoing at Data Cutoff|32
4457769|NCT00556712|7245371|FG001|Overall Study|Ongoing at Data Cutoff|66
4457770|NCT00556894|7245397|FG000|Overall Study|Adverse Event|2
4457771|NCT00556894|7245398|FG001|Overall Study|Adverse Event|3
4457772|NCT00556894|7245399|FG002|Overall Study|Adverse Event|3
4457773|NCT00556894|7245397|FG000|Overall Study|Death|1
4457774|NCT00556894|7245398|FG001|Overall Study|Death|0
4457775|NCT00556894|7245399|FG002|Overall Study|Death|0
4457776|NCT00556894|7245397|FG000|Overall Study|regulatory decision in Bulgaria|10
4457777|NCT00556894|7245398|FG001|Overall Study|regulatory decision in Bulgaria|14
4457778|NCT00556894|7245399|FG002|Overall Study|regulatory decision in Bulgaria|13
4457779|NCT00556894|7245397|FG000|Overall Study|Change in therapy|2
4457780|NCT00556894|7245398|FG001|Overall Study|Change in therapy|1
4457781|NCT00556894|7245399|FG002|Overall Study|Change in therapy|2
4457782|NCT00556894|7245397|FG000|Overall Study|Withdrawal by Subject|1
4457783|NCT00556894|7245398|FG001|Overall Study|Withdrawal by Subject|1
4457784|NCT00556894|7245399|FG002|Overall Study|Withdrawal by Subject|1
4457785|NCT00556933|7245411|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2
4457786|NCT00556933|7245412|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3
4457787|NCT00556933|7245413|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3
4457788|NCT00556933|7245414|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0
4457789|NCT00556933|7245411|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
4457790|NCT00556933|7245412|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
4457791|NCT00556933|7245413|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1
4457792|NCT00556933|7245414|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
4457793|NCT00556933|7245411|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0
4457794|NCT00556933|7245412|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
4457795|NCT00556933|7245413|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
4457796|NCT00556933|7245414|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
4457797|NCT00556933|7245411|FG000|Single vs. Divided-dose rATG Induction|Death|0
4457798|NCT00556933|7245412|FG001|Single vs. Divided-dose rATG Induction|Death|1
4457799|NCT00556933|7245413|FG002|Single vs. Divided-dose rATG Induction|Death|0
4457800|NCT00556933|7245414|FG003|Single vs. Divided-dose rATG Induction|Death|0
4457801|NCT00556933|7245411|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
4457802|NCT00556933|7245412|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1
4457803|NCT00556933|7245413|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
4457804|NCT00556933|7245414|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
4457805|NCT00556933|7245411|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
4457806|NCT00556933|7245412|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1
4457807|NCT00556933|7245413|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
4457808|NCT00556933|7245414|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
4611743|NCT01702428|7468289|FG003|Overall Study|Lost Coverage|1
4611744|NCT01702428|7468286|FG000|Overall Study|Lost Health Plan|3
4611745|NCT01702428|7468287|FG001|Overall Study|Lost Health Plan|5
4611746|NCT01702428|7468288|FG002|Overall Study|Lost Health Plan|0
4611747|NCT01702428|7468289|FG003|Overall Study|Lost Health Plan|2
4611748|NCT01702428|7468286|FG000|Overall Study|Mother transferred care|0
4611749|NCT01702428|7468287|FG001|Overall Study|Mother transferred care|1
4611750|NCT01702428|7468288|FG002|Overall Study|Mother transferred care|0
4611751|NCT01702428|7468289|FG003|Overall Study|Mother transferred care|0
4611752|NCT01702428|7468286|FG000|Overall Study|Parents too busy|1
4611753|NCT01702428|7468287|FG001|Overall Study|Parents too busy|0
4611754|NCT01702428|7468288|FG002|Overall Study|Parents too busy|0
4611755|NCT01702428|7468289|FG003|Overall Study|Parents too busy|0
4611756|NCT01702428|7468286|FG000|Overall Study|Protocol Violation|3
4690327|NCT02560558|7600022|FG000|Overall Study|Withdrawal by Subject|3
4690328|NCT02560558|7600023|FG001|Overall Study|Withdrawal by Subject|0
4690329|NCT02561000|7600082|FG000|Overall Study|Withdrawal by Subject|2
4690330|NCT02561000|7600083|FG001|Overall Study|Withdrawal by Subject|3
4690331|NCT02561000|7600084|FG002|Overall Study|Withdrawal by Subject|0
4690332|NCT02561000|7600082|FG000|Overall Study|Adverse Event|0
4690333|NCT02561000|7600083|FG001|Overall Study|Adverse Event|1
4690334|NCT02561000|7600084|FG002|Overall Study|Adverse Event|0
4690335|NCT02561078|7600094|FG000|Overall Study|Adverse Event|5
4690336|NCT02561078|7600095|FG001|Overall Study|Adverse Event|2
4690337|NCT02561078|7600094|FG000|Overall Study|Death|2
4690338|NCT02561078|7600095|FG001|Overall Study|Death|1
4690339|NCT02561078|7600094|FG000|Overall Study|Lost to Follow-up|2
4690340|NCT02561078|7600095|FG001|Overall Study|Lost to Follow-up|6
4690341|NCT02561078|7600094|FG000|Overall Study|Non-Compliance with Study Drug|6
4690342|NCT02561078|7600095|FG001|Overall Study|Non-Compliance with Study Drug|3
4690343|NCT02561078|7600094|FG000|Overall Study|Physician Decision|2
4690344|NCT02561078|7600095|FG001|Overall Study|Physician Decision|3
4690345|NCT02561078|7600094|FG000|Overall Study|Withdrawal by Subject|13
4457809|NCT00556933|7245411|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1
4457810|NCT00556933|7245412|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1
4457811|NCT00556933|7245413|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0
4457812|NCT00556933|7245414|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0
4457813|NCT00556933|7245411|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0
4457814|NCT00556933|7245412|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1
4457815|NCT00556933|7245413|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0
4457816|NCT00556933|7245414|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1
4457817|NCT00556933|7245411|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0
4457818|NCT00556933|7245412|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1
4457819|NCT00556933|7245413|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1
4457820|NCT00556933|7245414|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0
4457821|NCT00556933|7245411|FG000|CNI Withdrawal vs. Minimization|Graft loss|0
4457822|NCT00556933|7245412|FG001|CNI Withdrawal vs. Minimization|Graft loss|1
4457823|NCT00556933|7245413|FG002|CNI Withdrawal vs. Minimization|Graft loss|2
4457824|NCT00556933|7245414|FG003|CNI Withdrawal vs. Minimization|Graft loss|0
4457825|NCT00556933|7245411|FG000|CNI Withdrawal vs. Minimization|Death|0
4457826|NCT00556933|7245412|FG001|CNI Withdrawal vs. Minimization|Death|0
4457827|NCT00556933|7245413|FG002|CNI Withdrawal vs. Minimization|Death|0
4457828|NCT00556933|7245414|FG003|CNI Withdrawal vs. Minimization|Death|1
4457829|NCT00556998|7245441|FG000|Voriconazole Intravenous (IV)|Adverse Event|1
4457830|NCT00556998|7245441|FG000|Voriconazole Intravenous (IV)|Other|4
4457831|NCT00556998|7245441|FG000|Voriconazole Oral|Adverse Event|1
4457832|NCT00556998|7245441|FG000|Voriconazole Oral|Intolerant of oral treatment|1
4457833|NCT00557076|7245451|FG000|Overall Study|Unblinding|0
4457834|NCT00557076|7245452|FG001|Overall Study|Unblinding|1
4457835|NCT00557245|7245461|FG000|Overall Study|Lost to Follow-up|7
4457836|NCT00557245|7245462|FG001|Overall Study|Lost to Follow-up|8
4457837|NCT00557245|7245463|FG002|Overall Study|Lost to Follow-up|10
4457838|NCT00557245|7245461|FG000|Overall Study|Ineligible|5
4457839|NCT00557245|7245462|FG001|Overall Study|Ineligible|4
4690346|NCT02561078|7600095|FG001|Overall Study|Withdrawal by Subject|10
4690347|NCT02561156|7600123|FG000|Part 2|Adverse Event|0
4690348|NCT02561156|7600124|FG001|Part 2|Adverse Event|0
4690349|NCT02561156|7600125|FG002|Part 2|Adverse Event|0
4690350|NCT02561156|7600126|FG003|Part 2|Adverse Event|0
4690351|NCT02561156|7600127|FG004|Part 2|Adverse Event|0
4457840|NCT00557245|7245463|FG002|Overall Study|Ineligible|2
4457841|NCT00557310|7245483|FG000|Main Study (0 - 18 Months)|Adverse Event|4
4457842|NCT00557310|7245483|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1
4457843|NCT00557310|7245483|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1
4611757|NCT01702428|7468287|FG001|Overall Study|Protocol Violation|0
4690352|NCT02561156|7600128|FG005|Part 2|Adverse Event|0
4690353|NCT02561156|7600129|FG006|Part 2|Adverse Event|0
4690354|NCT02561156|7600130|FG007|Part 2|Adverse Event|0
4690355|NCT02561156|7600131|FG008|Part 2|Adverse Event|0
4457844|NCT00557310|7245483|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1
4538769|NCT01122394|7360905|FG001|Overall Study|Withdrawal by Subject|1
4538770|NCT01122394|7360904|FG000|Overall Study|Lost to Follow-up|2
4538771|NCT01122394|7360905|FG001|Overall Study|Lost to Follow-up|2
4538772|NCT01122394|7360904|FG000|Overall Study|Adverse Event|0
4538773|NCT01122394|7360905|FG001|Overall Study|Adverse Event|1
4538774|NCT01122576|7360925|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0
4538775|NCT01122576|7360926|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1
4538776|NCT01122576|7360927|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2
4538777|NCT01122576|7360925|FG000|Post-Cataract Surgery|Central Macular Edema|0
4538778|NCT01122576|7360926|FG001|Post-Cataract Surgery|Central Macular Edema|0
4538779|NCT01122576|7360927|FG002|Post-Cataract Surgery|Central Macular Edema|1
4538780|NCT01122576|7360925|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0
4538781|NCT01122576|7360926|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0
4538782|NCT01122576|7360927|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1
4538783|NCT01122680|7360938|FG000|Period 1 (4 Weeks)|Adverse Event|1
4538784|NCT01122680|7360939|FG001|Period 1 (4 Weeks)|Adverse Event|0
4538785|NCT01122680|7360940|FG002|Period 1 (4 Weeks)|Adverse Event|0
4538786|NCT01122680|7360941|FG003|Period 1 (4 Weeks)|Adverse Event|0
4538787|NCT01122680|7360938|FG000|Period 1 (4 Weeks)|Protocol Violation|1
4538788|NCT01122680|7360939|FG001|Period 1 (4 Weeks)|Protocol Violation|0
4538789|NCT01122680|7360940|FG002|Period 1 (4 Weeks)|Protocol Violation|0
4538790|NCT01122680|7360941|FG003|Period 1 (4 Weeks)|Protocol Violation|0
4538791|NCT01122680|7360938|FG000|Period 1 (4 Weeks)|Other|1
4538792|NCT01122680|7360939|FG001|Period 1 (4 Weeks)|Other|1
4538793|NCT01122680|7360940|FG002|Period 1 (4 Weeks)|Other|0
4538794|NCT01122680|7360941|FG003|Period 1 (4 Weeks)|Other|0
4538795|NCT01122680|7360938|FG000|Period 2 (4 Weeks)|Protocol Violation|0
4538796|NCT01122680|7360939|FG001|Period 2 (4 Weeks)|Protocol Violation|0
4538797|NCT01122680|7360940|FG002|Period 2 (4 Weeks)|Protocol Violation|0
4538798|NCT01122680|7360941|FG003|Period 2 (4 Weeks)|Protocol Violation|1
4538799|NCT01122680|7360938|FG000|Period 2 (4 Weeks)|Other|1
4611758|NCT01702428|7468288|FG002|Overall Study|Protocol Violation|1
4611759|NCT01702428|7468289|FG003|Overall Study|Protocol Violation|0
4611760|NCT01702428|7468286|FG000|Overall Study|Withdrawal by Subject|21
4611761|NCT01702428|7468287|FG001|Overall Study|Withdrawal by Subject|23
4611762|NCT01702428|7468288|FG002|Overall Study|Withdrawal by Subject|14
4611763|NCT01702428|7468289|FG003|Overall Study|Withdrawal by Subject|10
4611764|NCT01702454|7468308|FG000|Overall Study|Consent withdrawal|0
4611765|NCT01702454|7468309|FG001|Overall Study|Consent withdrawal|1
4611766|NCT01702454|7468308|FG000|Overall Study|Migrated/moved from study area|0
4611767|NCT01702454|7468309|FG001|Overall Study|Migrated/moved from study area|1
4611768|NCT01702454|7468308|FG000|Overall Study|Lost to Follow-up|3
4611769|NCT01702454|7468309|FG001|Overall Study|Lost to Follow-up|6
4611770|NCT01702519|7468320|FG000|Washout Period|Lost to Follow-up|1
4611771|NCT01702519|7468321|FG001|Washout Period|Lost to Follow-up|0
4538800|NCT01122680|7360939|FG001|Period 2 (4 Weeks)|Other|0
4538801|NCT01122680|7360940|FG002|Period 2 (4 Weeks)|Other|0
4538802|NCT01122680|7360941|FG003|Period 2 (4 Weeks)|Other|0
4538803|NCT01122680|7360938|FG000|Period 3 (4 Weeks)|Adverse Event|1
4538804|NCT01122680|7360939|FG001|Period 3 (4 Weeks)|Adverse Event|0
4538805|NCT01122680|7360940|FG002|Period 3 (4 Weeks)|Adverse Event|0
4538806|NCT01122680|7360941|FG003|Period 3 (4 Weeks)|Adverse Event|0
4538807|NCT01122680|7360938|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0
4538808|NCT01122680|7360939|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1
4538809|NCT01122680|7360940|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0
4538810|NCT01122680|7360941|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0
4538811|NCT01122862|7360974|FG000|Period 1|Protocol Violation|0
4538812|NCT01122862|7360975|FG001|Period 1|Protocol Violation|1
4538813|NCT01122862|7360976|FG002|Period 1|Protocol Violation|0
4538814|NCT01122862|7360974|FG000|Period 2|Adverse Event|0
4538815|NCT01122862|7360975|FG001|Period 2|Adverse Event|0
4611772|NCT01702519|7468320|FG000|Washout Period|Withdrawal by Subject|0
4611773|NCT01702519|7468321|FG001|Washout Period|Withdrawal by Subject|2
4611774|NCT01702532|7468333|FG000|Overall Study|Adverse Event|0
4611775|NCT01702532|7468334|FG001|Overall Study|Adverse Event|1
4611776|NCT01702558|7468346|FG000|Overall Study|Withdrawal by Subject|0
4611777|NCT01702558|7468347|FG001|Overall Study|Withdrawal by Subject|0
4611778|NCT01702558|7468348|FG002|Overall Study|Withdrawal by Subject|0
4538816|NCT01122862|7360976|FG002|Period 2|Adverse Event|1
4538817|NCT01122927|7360999|FG000|Period 1 - Conversion Phase|Adverse Event|3
4538818|NCT01122927|7361000|FG001|Period 1 - Conversion Phase|Adverse Event|0
4538819|NCT01122927|7360999|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1
4538820|NCT01122927|7361000|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
4538821|NCT01122927|7360999|FG000|Period 1 - Conversion Phase|Physician Decision|2
4538822|NCT01122927|7361000|FG001|Period 1 - Conversion Phase|Physician Decision|0
4611779|NCT01702558|7468349|FG003|Overall Study|Withdrawal by Subject|12
4611780|NCT01702558|7468350|FG004|Overall Study|Withdrawal by Subject|4
4538823|NCT01122927|7360999|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7
4538824|NCT01122927|7361000|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0
4538825|NCT01122927|7360999|FG000|Period 1 - Conversion Phase|Protocol Deviation|1
4538826|NCT01122927|7361000|FG001|Period 1 - Conversion Phase|Protocol Deviation|0
4457845|NCT00557310|7245483|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2
4457846|NCT00557310|7245483|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1
4457847|NCT00557323|7245487|FG000|Overall Study|Death|3
4457848|NCT00557323|7245487|FG000|Overall Study|Withdrawal by Subject|2
4457849|NCT00557323|7245487|FG000|Overall Study|Administrative change|2
4538827|NCT01122927|7360999|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0
4457850|NCT00557440|7245523|FG000|Treatment Period 1|Adverse Event|0
4457851|NCT00557440|7245524|FG001|Treatment Period 1|Adverse Event|0
4457852|NCT00557440|7245525|FG002|Treatment Period 1|Adverse Event|1
4457853|NCT00557466|7245539|FG000|Overall Study|Adverse Event|3
4457854|NCT00557466|7245540|FG001|Overall Study|Adverse Event|1
4457855|NCT00557466|7245541|FG002|Overall Study|Adverse Event|4
4457856|NCT00557466|7245542|FG003|Overall Study|Adverse Event|1
4457857|NCT00557466|7245543|FG004|Overall Study|Adverse Event|2
4457858|NCT00557466|7245544|FG005|Overall Study|Adverse Event|4
4457859|NCT00557466|7245539|FG000|Overall Study|Abnormal laboratory value(s)|1
4457860|NCT00557466|7245540|FG001|Overall Study|Abnormal laboratory value(s)|2
4457861|NCT00557466|7245541|FG002|Overall Study|Abnormal laboratory value(s)|0
4457862|NCT00557466|7245542|FG003|Overall Study|Abnormal laboratory value(s)|0
4457863|NCT00557466|7245543|FG004|Overall Study|Abnormal laboratory value(s)|0
4457864|NCT00557466|7245544|FG005|Overall Study|Abnormal laboratory value(s)|0
4457865|NCT00557466|7245539|FG000|Overall Study|Protocol deviation|0
4457866|NCT00557466|7245540|FG001|Overall Study|Protocol deviation|1
4457867|NCT00557466|7245541|FG002|Overall Study|Protocol deviation|0
4457868|NCT00557466|7245542|FG003|Overall Study|Protocol deviation|2
4457869|NCT00557466|7245543|FG004|Overall Study|Protocol deviation|0
4457870|NCT00557466|7245544|FG005|Overall Study|Protocol deviation|0
4457871|NCT00557466|7245539|FG000|Overall Study|Subject withdrew consent|0
4457872|NCT00557466|7245540|FG001|Overall Study|Subject withdrew consent|0
4457873|NCT00557466|7245541|FG002|Overall Study|Subject withdrew consent|0
4457874|NCT00557466|7245542|FG003|Overall Study|Subject withdrew consent|0
4457875|NCT00557466|7245543|FG004|Overall Study|Subject withdrew consent|1
4457876|NCT00557466|7245544|FG005|Overall Study|Subject withdrew consent|2
4457877|NCT00557466|7245539|FG000|Overall Study|Administrative problems|0
4457878|NCT00557466|7245540|FG001|Overall Study|Administrative problems|1
4457879|NCT00557466|7245541|FG002|Overall Study|Administrative problems|1
4457880|NCT00557466|7245542|FG003|Overall Study|Administrative problems|0
4457881|NCT00557466|7245543|FG004|Overall Study|Administrative problems|0
4457882|NCT00557466|7245544|FG005|Overall Study|Administrative problems|0
4457883|NCT00557466|7245539|FG000|Overall Study|Abnormal test procedure results|0
4457884|NCT00557466|7245540|FG001|Overall Study|Abnormal test procedure results|0
4457885|NCT00557466|7245541|FG002|Overall Study|Abnormal test procedure results|1
4457886|NCT00557466|7245542|FG003|Overall Study|Abnormal test procedure results|0
4457887|NCT00557466|7245543|FG004|Overall Study|Abnormal test procedure results|0
4457888|NCT00557466|7245544|FG005|Overall Study|Abnormal test procedure results|0
4457889|NCT00557466|7245539|FG000|Overall Study|Lost to Follow-up|0
4457890|NCT00557466|7245540|FG001|Overall Study|Lost to Follow-up|0
4457891|NCT00557466|7245541|FG002|Overall Study|Lost to Follow-up|0
4457892|NCT00557466|7245542|FG003|Overall Study|Lost to Follow-up|1
4457893|NCT00557466|7245543|FG004|Overall Study|Lost to Follow-up|0
4457894|NCT00557466|7245544|FG005|Overall Study|Lost to Follow-up|0
4457895|NCT00557492|7245558|FG000|Overall Study|Change in health insurance|1
4457896|NCT00557505|7245571|FG000|Overall Study|Death|0
4457897|NCT00557505|7245572|FG001|Overall Study|Death|0
4457898|NCT00557505|7245573|FG002|Overall Study|Death|0
4457899|NCT00557505|7245574|FG003|Overall Study|Death|0
4457900|NCT00557505|7245575|FG004|Overall Study|Death|0
4457901|NCT00557505|7245576|FG005|Overall Study|Death|0
4457902|NCT00557505|7245577|FG006|Overall Study|Death|0
4457903|NCT00557505|7245578|FG007|Overall Study|Death|0
4457904|NCT00557505|7245579|FG008|Overall Study|Death|1
4538828|NCT01122927|7361000|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21
4457905|NCT00557505|7245571|FG000|Overall Study|Adverse Event|0
4457906|NCT00557505|7245572|FG001|Overall Study|Adverse Event|0
4457907|NCT00557505|7245573|FG002|Overall Study|Adverse Event|1
4457908|NCT00557505|7245574|FG003|Overall Study|Adverse Event|0
4457909|NCT00557505|7245575|FG004|Overall Study|Adverse Event|0
4457910|NCT00557505|7245576|FG005|Overall Study|Adverse Event|0
4457911|NCT00557505|7245577|FG006|Overall Study|Adverse Event|1
4457912|NCT00557505|7245578|FG007|Overall Study|Adverse Event|0
4457913|NCT00557505|7245579|FG008|Overall Study|Adverse Event|0
4457914|NCT00557505|7245571|FG000|Overall Study|Global deterioration of health|1
4457915|NCT00557505|7245572|FG001|Overall Study|Global deterioration of health|0
4457916|NCT00557505|7245573|FG002|Overall Study|Global deterioration of health|0
4457917|NCT00557505|7245574|FG003|Overall Study|Global deterioration of health|0
4457918|NCT00557505|7245575|FG004|Overall Study|Global deterioration of health|0
4457919|NCT00557505|7245576|FG005|Overall Study|Global deterioration of health|0
4457920|NCT00557505|7245577|FG006|Overall Study|Global deterioration of health|0
4457921|NCT00557505|7245578|FG007|Overall Study|Global deterioration of health|0
4457922|NCT00557505|7245579|FG008|Overall Study|Global deterioration of health|0
4457923|NCT00557505|7245571|FG000|Overall Study|Objective progression or relapse|2
4457924|NCT00557505|7245572|FG001|Overall Study|Objective progression or relapse|3
4457925|NCT00557505|7245573|FG002|Overall Study|Objective progression or relapse|3
4457926|NCT00557505|7245574|FG003|Overall Study|Objective progression or relapse|2
4457927|NCT00557505|7245575|FG004|Overall Study|Objective progression or relapse|2
4457928|NCT00557505|7245576|FG005|Overall Study|Objective progression or relapse|3
4457929|NCT00557505|7245577|FG006|Overall Study|Objective progression or relapse|2
4457930|NCT00557505|7245578|FG007|Overall Study|Objective progression or relapse|5
4457931|NCT00557505|7245579|FG008|Overall Study|Objective progression or relapse|15
4457932|NCT00557505|7245571|FG000|Overall Study|Withdrawal by Subject|0
4457933|NCT00557505|7245572|FG001|Overall Study|Withdrawal by Subject|0
4457934|NCT00557505|7245573|FG002|Overall Study|Withdrawal by Subject|0
4457935|NCT00557505|7245574|FG003|Overall Study|Withdrawal by Subject|1
4457936|NCT00557505|7245575|FG004|Overall Study|Withdrawal by Subject|0
4457937|NCT00557505|7245576|FG005|Overall Study|Withdrawal by Subject|0
4457938|NCT00557505|7245577|FG006|Overall Study|Withdrawal by Subject|0
4457939|NCT00557505|7245578|FG007|Overall Study|Withdrawal by Subject|0
4457940|NCT00557505|7245579|FG008|Overall Study|Withdrawal by Subject|1
4457941|NCT00557622|7245604|FG000|4-Week Run-in Phase|Withdrawal by Subject|1
4457942|NCT00557622|7245605|FG001|4-Week Run-in Phase|Withdrawal by Subject|0
4457943|NCT00557622|7245604|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1
4457944|NCT00557622|7245605|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0
4457945|NCT00557622|7245604|FG000|12-Week Treatment Phase|Lost to Follow-up|0
4457946|NCT00557622|7245605|FG001|12-Week Treatment Phase|Lost to Follow-up|1
4457947|NCT00557830|7245614|FG000|Screening Treatment Phase|Withdrawal by Subject|1
4457948|NCT00557830|7245615|FG001|Screening Treatment Phase|Withdrawal by Subject|0
4538829|NCT01122927|7360999|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0
4538830|NCT01122927|7361000|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33
4457949|NCT00557830|7245616|FG002|Screening Treatment Phase|Withdrawal by Subject|0
4457950|NCT00557830|7245614|FG000|Screening Treatment Phase|Adverse Event|2
4457951|NCT00557830|7245615|FG001|Screening Treatment Phase|Adverse Event|0
4457952|NCT00557830|7245616|FG002|Screening Treatment Phase|Adverse Event|0
4457953|NCT00557830|7245614|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3
4457954|NCT00557830|7245615|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0
4457955|NCT00557830|7245616|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0
4457956|NCT00557856|7245624|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3
4457957|NCT00557856|7245625|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5
4457958|NCT00557856|7245626|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3
4457959|NCT00557856|7245627|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1
4457960|NCT00557856|7245628|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3
4457961|NCT00557856|7245629|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2
4457962|NCT00557856|7245630|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5
4457963|NCT00557856|7245631|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3
4457964|NCT00557856|7245632|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0
4457965|NCT00557856|7245624|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1
4457966|NCT00557856|7245625|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
4457967|NCT00557856|7245626|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1
4457968|NCT00557856|7245627|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
4457969|NCT00557856|7245628|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
4457970|NCT00557856|7245629|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
4457971|NCT00557856|7245630|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
4457972|NCT00557856|7245631|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
4457973|NCT00557856|7245632|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
4538831|NCT01122927|7360999|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0
4538832|NCT01122927|7361000|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165
4538833|NCT01122927|7360999|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0
4538834|NCT01122927|7361000|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9
4538835|NCT01122927|7360999|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0
4611781|NCT01702558|7468346|FG000|Overall Study|Lost to Follow-up|0
4611782|NCT01702558|7468347|FG001|Overall Study|Lost to Follow-up|0
4611783|NCT01702558|7468348|FG002|Overall Study|Lost to Follow-up|0
4611784|NCT01702558|7468349|FG003|Overall Study|Lost to Follow-up|3
4611785|NCT01702558|7468350|FG004|Overall Study|Lost to Follow-up|0
4611786|NCT01702558|7468346|FG000|Overall Study|Death|4
4457974|NCT00557856|7245624|FG000|Part 1: Dose Escalation Phase|Adverse Event|1
4457975|NCT00557856|7245625|FG001|Part 1: Dose Escalation Phase|Adverse Event|0
4457976|NCT00557856|7245626|FG002|Part 1: Dose Escalation Phase|Adverse Event|1
4457977|NCT00557856|7245627|FG003|Part 1: Dose Escalation Phase|Adverse Event|1
4518741|NCT00976027|7331006|FG000|Overall Study|Withdrawal by Subject|107
4538836|NCT01122927|7361000|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12
4538837|NCT01122927|7360999|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0
4538838|NCT01122927|7361000|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65
4538839|NCT01122927|7360999|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0
4538840|NCT01122927|7361000|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7
4538841|NCT01123070|7361014|FG000|Part B Double Blind Period|Protocol Violation|0
4457978|NCT00557856|7245628|FG004|Part 1: Dose Escalation Phase|Adverse Event|1
4457979|NCT00557856|7245629|FG005|Part 1: Dose Escalation Phase|Adverse Event|3
4457980|NCT00557856|7245630|FG006|Part 1: Dose Escalation Phase|Adverse Event|1
4457981|NCT00557856|7245631|FG007|Part 1: Dose Escalation Phase|Adverse Event|2
4457982|NCT00557856|7245632|FG008|Part 1: Dose Escalation Phase|Adverse Event|0
4457983|NCT00557856|7245624|FG000|Part 1: Dose Escalation Phase|Other|0
4457984|NCT00557856|7245625|FG001|Part 1: Dose Escalation Phase|Other|0
4457985|NCT00557856|7245626|FG002|Part 1: Dose Escalation Phase|Other|1
4457986|NCT00557856|7245627|FG003|Part 1: Dose Escalation Phase|Other|1
4457987|NCT00557856|7245628|FG004|Part 1: Dose Escalation Phase|Other|0
4457988|NCT00557856|7245629|FG005|Part 1: Dose Escalation Phase|Other|0
4611787|NCT01702558|7468347|FG001|Overall Study|Death|3
4611788|NCT01702558|7468348|FG002|Overall Study|Death|3
4611789|NCT01702558|7468349|FG003|Overall Study|Death|16
4611790|NCT01702558|7468350|FG004|Overall Study|Death|20
4611791|NCT01702558|7468346|FG000|Overall Study|Safety Follow-Up less than 3 Months|0
4611792|NCT01702558|7468347|FG001|Overall Study|Safety Follow-Up less than 3 Months|0
4611793|NCT01702558|7468348|FG002|Overall Study|Safety Follow-Up less than 3 Months|2
4611794|NCT01702558|7468349|FG003|Overall Study|Safety Follow-Up less than 3 Months|0
4611795|NCT01702558|7468350|FG004|Overall Study|Safety Follow-Up less than 3 Months|0
4611796|NCT01702558|7468346|FG000|Overall Study|Study Terminated by Sponsor|0
4611797|NCT01702558|7468347|FG001|Overall Study|Study Terminated by Sponsor|1
4611798|NCT01702558|7468348|FG002|Overall Study|Study Terminated by Sponsor|0
4611799|NCT01702558|7468349|FG003|Overall Study|Study Terminated by Sponsor|0
4611800|NCT01702558|7468350|FG004|Overall Study|Study Terminated by Sponsor|1
4457989|NCT00557856|7245630|FG006|Part 1: Dose Escalation Phase|Other|0
4457990|NCT00557856|7245631|FG007|Part 1: Dose Escalation Phase|Other|1
4457991|NCT00557856|7245632|FG008|Part 1: Dose Escalation Phase|Other|0
4457992|NCT00557856|7245624|FG000|Part 1: Dose Escalation Phase|Death|0
4457993|NCT00557856|7245625|FG001|Part 1: Dose Escalation Phase|Death|0
4457994|NCT00557856|7245626|FG002|Part 1: Dose Escalation Phase|Death|0
4457995|NCT00557856|7245627|FG003|Part 1: Dose Escalation Phase|Death|0
4457996|NCT00557856|7245628|FG004|Part 1: Dose Escalation Phase|Death|0
4457997|NCT00557856|7245629|FG005|Part 1: Dose Escalation Phase|Death|1
4457998|NCT00557856|7245630|FG006|Part 1: Dose Escalation Phase|Death|0
4457999|NCT00557856|7245631|FG007|Part 1: Dose Escalation Phase|Death|0
4458000|NCT00557856|7245632|FG008|Part 1: Dose Escalation Phase|Death|0
4458001|NCT00557856|7245624|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0
4458002|NCT00557856|7245625|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0
4458003|NCT00557856|7245626|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0
4611801|NCT01702558|7468346|FG000|Overall Study|Other|0
4611802|NCT01702558|7468347|FG001|Overall Study|Other|0
4611803|NCT01702558|7468348|FG002|Overall Study|Other|0
4611804|NCT01702558|7468349|FG003|Overall Study|Other|16
4611805|NCT01702558|7468350|FG004|Overall Study|Other|17
4611806|NCT01702844|7468363|FG000|Overall Study|Adverse Event|9
4611807|NCT01702844|7468363|FG000|Overall Study|Death|1
4611808|NCT01702844|7468363|FG000|Overall Study|Withdrawal by Subject|3
4611809|NCT01702844|7468363|FG000|Overall Study|Physician Decision|6
4611810|NCT01702961|7468367|FG000|Overall Study|Additional treatment|3
4611811|NCT01702961|7468367|FG000|Overall Study|Progressive disease|5
4611812|NCT01702961|7468367|FG000|Overall Study|Relapse|20
4611813|NCT01702961|7468367|FG000|Overall Study|Death|6
4611814|NCT01702961|7468367|FG000|Overall Study|Lost to Follow-up|2
4611815|NCT01702961|7468367|FG000|Overall Study|Ongoing|11
4611816|NCT01702987|7468373|FG000|Overall Study|Withdrawal by Subject|1
4611817|NCT01702987|7468374|FG001|Overall Study|Withdrawal by Subject|0
4611818|NCT01703000|7468380|FG000|Overall Study|Death|1
4611819|NCT01703065|7468397|FG000|Overall Study|Lack of Efficacy|1
4611820|NCT01703065|7468398|FG001|Overall Study|Lack of Efficacy|0
4611821|NCT01703091|7468407|FG000|Overall Study|Adverse Event|5
4611822|NCT01703091|7468408|FG001|Overall Study|Adverse Event|3
4611823|NCT01703091|7468407|FG000|Overall Study|Physician Decision|2
4611824|NCT01703091|7468408|FG001|Overall Study|Physician Decision|1
4611825|NCT01703091|7468407|FG000|Overall Study|Withdrawal by Subject|1
4611826|NCT01703091|7468408|FG001|Overall Study|Withdrawal by Subject|0
4611827|NCT01703091|7468407|FG000|Overall Study|Sponsor Decision|1
4611828|NCT01703091|7468408|FG001|Overall Study|Sponsor Decision|0
4611829|NCT01703117|7468416|FG000|Overall Study|Adverse Event|4
4611830|NCT01703117|7468417|FG001|Overall Study|Adverse Event|3
4611831|NCT01703117|7468416|FG000|Overall Study|Withdrawal by Subject|0
4611832|NCT01703117|7468417|FG001|Overall Study|Withdrawal by Subject|1
4611833|NCT01703208|7468431|FG000|Overall Study|Death|61
4611834|NCT01703208|7468432|FG001|Overall Study|Death|48
4611835|NCT01703208|7468431|FG000|Overall Study|Lack of Efficacy|1
4458004|NCT00557856|7245627|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0
4611836|NCT01703208|7468432|FG001|Overall Study|Lack of Efficacy|2
4611837|NCT01703208|7468431|FG000|Overall Study|Lost to Follow-up|68
4611838|NCT01703208|7468432|FG001|Overall Study|Lost to Follow-up|62
4611839|NCT01703208|7468431|FG000|Overall Study|Non-Compliance with Study Drug|1
4611840|NCT01703208|7468432|FG001|Overall Study|Non-Compliance with Study Drug|0
4611841|NCT01703208|7468431|FG000|Overall Study|Excluded Medication|1
4611842|NCT01703208|7468432|FG001|Overall Study|Excluded Medication|2
4458005|NCT00557856|7245628|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0
4458006|NCT00557856|7245629|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2
4458007|NCT00557856|7245630|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1
4458008|NCT00557856|7245631|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0
4458009|NCT00557856|7245632|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0
4458010|NCT00557856|7245624|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2
4458011|NCT00557856|7245625|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0
4458012|NCT00557856|7245626|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0
4458013|NCT00557856|7245627|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0
4458014|NCT00557856|7245628|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0
4458015|NCT00557856|7245629|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0
4458016|NCT00557856|7245630|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0
4458017|NCT00557856|7245631|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0
4458018|NCT00557856|7245632|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0
4458019|NCT00557856|7245624|FG000|Part 2: Exploratory Phase|objective progression or relapse|0
4458020|NCT00557856|7245625|FG001|Part 2: Exploratory Phase|objective progression or relapse|0
4518742|NCT00976027|7331007|FG001|Overall Study|Withdrawal by Subject|66
4611843|NCT01703208|7468431|FG000|Overall Study|Site Discontinued Study Participation|23
4611844|NCT01703208|7468432|FG001|Overall Study|Site Discontinued Study Participation|27
4611845|NCT01703208|7468431|FG000|Overall Study|Physician Decision|11
4611846|NCT01703208|7468432|FG001|Overall Study|Physician Decision|13
4611847|NCT01703208|7468431|FG000|Overall Study|Progressive disease|2
4611848|NCT01703208|7468432|FG001|Overall Study|Progressive disease|2
4611849|NCT01703208|7468431|FG000|Overall Study|Protocol Violation|1
4611850|NCT01703208|7468432|FG001|Overall Study|Protocol Violation|1
4611851|NCT01703208|7468431|FG000|Overall Study|Study Terminated by Sponsor|1710
4611852|NCT01703208|7468432|FG001|Overall Study|Study Terminated by Sponsor|1716
4611853|NCT01703208|7468431|FG000|Overall Study|Withdrawal by Subject|205
4611854|NCT01703208|7468432|FG001|Overall Study|Withdrawal by Subject|209
4611855|NCT01703208|7468431|FG000|Overall Study|Adverse Event|14
4611856|NCT01703208|7468432|FG001|Overall Study|Adverse Event|19
4611857|NCT01703208|7468431|FG000|Overall Study|Technical Problems|0
4611858|NCT01703208|7468432|FG001|Overall Study|Technical Problems|1
4611859|NCT01703208|7468431|FG000|Overall Study|Protocol Deviation|2
4611860|NCT01703208|7468432|FG001|Overall Study|Protocol Deviation|0
4611861|NCT01703221|7468441|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2
4611862|NCT01703221|7468442|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4
4611863|NCT01703221|7468443|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0
4611864|NCT01703221|7468441|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2
4611865|NCT01703221|7468442|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0
4611866|NCT01703221|7468443|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1
4611867|NCT01703221|7468441|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1
4611868|NCT01703221|7468442|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0
4611869|NCT01703221|7468443|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0
4611870|NCT01703221|7468441|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2
4611871|NCT01703221|7468442|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
4611872|NCT01703221|7468443|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
4611873|NCT01703221|7468441|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0
4611874|NCT01703221|7468442|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0
4611875|NCT01703221|7468443|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1
4611876|NCT01703221|7468441|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2
4611877|NCT01703221|7468442|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1
4611878|NCT01703221|7468443|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0
4611879|NCT01703221|7468441|FG000|Phase B - (Week 25 to 52)|Adverse Event|2
4611880|NCT01703221|7468442|FG001|Phase B - (Week 25 to 52)|Adverse Event|3
4611881|NCT01703221|7468443|FG002|Phase B - (Week 25 to 52)|Adverse Event|2
4611882|NCT01703221|7468441|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12
4611883|NCT01703221|7468442|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10
4611884|NCT01703221|7468443|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3
4611885|NCT01703260|7468460|FG000|Overall Study|Adverse Event|1
4611886|NCT01703260|7468461|FG001|Overall Study|Adverse Event|2
4611887|NCT01703260|7468462|FG002|Overall Study|Adverse Event|2
4611888|NCT01703260|7468460|FG000|Overall Study|Lost to Follow-up|1
4611889|NCT01703260|7468461|FG001|Overall Study|Lost to Follow-up|0
4611890|NCT01703260|7468462|FG002|Overall Study|Lost to Follow-up|0
4611891|NCT01703260|7468460|FG000|Overall Study|Withdrawal by Subject|0
4611892|NCT01703260|7468461|FG001|Overall Study|Withdrawal by Subject|0
4611893|NCT01703260|7468462|FG002|Overall Study|Withdrawal by Subject|1
4611894|NCT01703260|7468460|FG000|Overall Study|Study Termination|1
4611895|NCT01703260|7468461|FG001|Overall Study|Study Termination|2
4611896|NCT01703260|7468462|FG002|Overall Study|Study Termination|0
4611897|NCT01703286|7468470|FG000|Period 1 Including Washout|Withdrawal by Subject|0
4611898|NCT01703286|7468471|FG001|Period 1 Including Washout|Withdrawal by Subject|0
4611899|NCT01703286|7468472|FG002|Period 1 Including Washout|Withdrawal by Subject|0
4611900|NCT01703286|7468473|FG003|Period 1 Including Washout|Withdrawal by Subject|1
4611901|NCT01703286|7468474|FG004|Period 1 Including Washout|Withdrawal by Subject|0
4611902|NCT01703286|7468475|FG005|Period 1 Including Washout|Withdrawal by Subject|1
4611903|NCT01703286|7468470|FG000|Period 2 Including Washout|Adverse Event|0
4611904|NCT01703286|7468471|FG001|Period 2 Including Washout|Adverse Event|0
4611905|NCT01703286|7468472|FG002|Period 2 Including Washout|Adverse Event|0
4458021|NCT00557856|7245626|FG002|Part 2: Exploratory Phase|objective progression or relapse|0
4458022|NCT00557856|7245627|FG003|Part 2: Exploratory Phase|objective progression or relapse|0
4458023|NCT00557856|7245628|FG004|Part 2: Exploratory Phase|objective progression or relapse|0
4458024|NCT00557856|7245629|FG005|Part 2: Exploratory Phase|objective progression or relapse|0
4518743|NCT00976209|7331019|FG000|Treatment Period 1|Protocol Violation|1
4611906|NCT01703286|7468473|FG003|Period 2 Including Washout|Adverse Event|1
4611907|NCT01703286|7468474|FG004|Period 2 Including Washout|Adverse Event|0
4611908|NCT01703286|7468475|FG005|Period 2 Including Washout|Adverse Event|0
4611909|NCT01703741|7468520|FG000|Overall Study|Withdrawal by Subject|6
4611910|NCT01703741|7468520|FG000|Overall Study|Adverse Event|2
4611911|NCT01703741|7468520|FG000|Overall Study|Physician Decision|2
4611912|NCT01703741|7468520|FG000|Overall Study|Protocol Violation|1
4611913|NCT01703741|7468520|FG000|Overall Study|Lost to Follow-up|3
4611914|NCT01703741|7468520|FG000|Overall Study|Subject did not want to continue|2
4611915|NCT01703741|7468520|FG000|Overall Study|Subject cannot comply with study visits|1
4611916|NCT01703741|7468520|FG000|Overall Study|Subject started testosterone injections|1
4611917|NCT01703819|7468526|FG000|Overall Study|Adverse Event|0
4611918|NCT01703819|7468527|FG001|Overall Study|Adverse Event|1
4611919|NCT01703819|7468526|FG000|Overall Study|Withdrawal by Subject|0
4611920|NCT01703819|7468527|FG001|Overall Study|Withdrawal by Subject|1
4632644|NCT01903811|7502411|FG000|Overall Study|Incomplete/discontinued prior therapy|1
4632645|NCT01903811|7502412|FG001|Overall Study|Incomplete/discontinued prior therapy|1
4632646|NCT01903811|7502411|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6
4632647|NCT01903811|7502412|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11
4632648|NCT01903811|7502411|FG000|Overall Study|Withdrawal by Subject|0
4632649|NCT01903811|7502412|FG001|Overall Study|Withdrawal by Subject|1
4632650|NCT01903837|7502425|FG000|Part A|Withdrawal by Subject|4
4632651|NCT01903837|7502426|FG001|Part A|Withdrawal by Subject|9
4632652|NCT01903837|7502427|FG002|Part A|Withdrawal by Subject|8
4632653|NCT01903837|7502428|FG003|Part A|Withdrawal by Subject|5
4632654|NCT01903837|7502425|FG000|Part A|Adverse Event|3
4632655|NCT01903837|7502426|FG001|Part A|Adverse Event|6
4632656|NCT01903837|7502427|FG002|Part A|Adverse Event|9
4632657|NCT01903837|7502428|FG003|Part A|Adverse Event|6
4632658|NCT01903837|7502425|FG000|Part A|Lost to Follow-up|9
4632659|NCT01903837|7502426|FG001|Part A|Lost to Follow-up|7
4632660|NCT01903837|7502427|FG002|Part A|Lost to Follow-up|7
4632661|NCT01903837|7502428|FG003|Part A|Lost to Follow-up|2
4632662|NCT01903837|7502425|FG000|Part A|Non-compliance with study drug|1
4632663|NCT01903837|7502426|FG001|Part A|Non-compliance with study drug|4
4632664|NCT01903837|7502427|FG002|Part A|Non-compliance with study drug|4
4632665|NCT01903837|7502428|FG003|Part A|Non-compliance with study drug|0
4632666|NCT01903837|7502425|FG000|Part A|Physician Decision|1
4632667|NCT01903837|7502426|FG001|Part A|Physician Decision|1
4632668|NCT01903837|7502427|FG002|Part A|Physician Decision|0
4632669|NCT01903837|7502428|FG003|Part A|Physician Decision|0
4632670|NCT01903837|7502425|FG000|Part A|Protocol Violation|1
4632671|NCT01903837|7502426|FG001|Part A|Protocol Violation|1
4632672|NCT01903837|7502427|FG002|Part A|Protocol Violation|0
4632673|NCT01903837|7502428|FG003|Part A|Protocol Violation|0
4632674|NCT01903837|7502425|FG000|Part B|Lost to Follow-up|0
4632675|NCT01903837|7502426|FG001|Part B|Lost to Follow-up|3
4632676|NCT01903837|7502427|FG002|Part B|Lost to Follow-up|3
4632677|NCT01903837|7502428|FG003|Part B|Lost to Follow-up|4
4632678|NCT01903837|7502425|FG000|Part B|Withdrawal by Subject|1
4632679|NCT01903837|7502426|FG001|Part B|Withdrawal by Subject|2
4632680|NCT01903837|7502427|FG002|Part B|Withdrawal by Subject|0
4632681|NCT01903837|7502428|FG003|Part B|Withdrawal by Subject|3
4632682|NCT01903837|7502425|FG000|Part B|Adverse Event|3
4632683|NCT01903837|7502426|FG001|Part B|Adverse Event|0
4632684|NCT01903837|7502427|FG002|Part B|Adverse Event|2
4632685|NCT01903837|7502428|FG003|Part B|Adverse Event|0
4632686|NCT01903837|7502425|FG000|Part B|Non-compliance with study drug|2
4632687|NCT01903837|7502426|FG001|Part B|Non-compliance with study drug|0
4632688|NCT01903837|7502427|FG002|Part B|Non-compliance with study drug|0
4632689|NCT01903837|7502428|FG003|Part B|Non-compliance with study drug|1
4632690|NCT01903837|7502425|FG000|Part B|Incarceration|2
4632691|NCT01903837|7502426|FG001|Part B|Incarceration|0
4632692|NCT01903837|7502427|FG002|Part B|Incarceration|0
4632693|NCT01903837|7502428|FG003|Part B|Incarceration|1
4632694|NCT01903837|7502425|FG000|Part B|Physician Decision|1
4632695|NCT01903837|7502426|FG001|Part B|Physician Decision|0
4632696|NCT01903837|7502427|FG002|Part B|Physician Decision|0
4632697|NCT01903837|7502428|FG003|Part B|Physician Decision|2
4632698|NCT01903837|7502425|FG000|Part B|Lack of Efficacy|0
4632699|NCT01903837|7502426|FG001|Part B|Lack of Efficacy|1
4632700|NCT01903837|7502427|FG002|Part B|Lack of Efficacy|0
4632701|NCT01903837|7502428|FG003|Part B|Lack of Efficacy|0
4632702|NCT01903863|7502461|FG000|Overall Study|Physician Decision|2
4632703|NCT01903863|7502462|FG001|Overall Study|Physician Decision|0
4632704|NCT01903876|7502470|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184
4632705|NCT01903876|7502471|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108
4632706|NCT01903876|7502470|FG000|Six-Month Follow-up Period|Lost to Follow-up|91
4458025|NCT00557856|7245630|FG006|Part 2: Exploratory Phase|objective progression or relapse|0
4458026|NCT00557856|7245631|FG007|Part 2: Exploratory Phase|objective progression or relapse|0
4458027|NCT00557856|7245632|FG008|Part 2: Exploratory Phase|objective progression or relapse|15
4458028|NCT00557856|7245624|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0
4458029|NCT00557856|7245625|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0
4458030|NCT00557856|7245626|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0
4458031|NCT00557856|7245627|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0
4458032|NCT00557856|7245628|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0
4458033|NCT00557856|7245629|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0
4458034|NCT00557856|7245630|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0
4458035|NCT00557856|7245631|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0
4458036|NCT00557856|7245632|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1
4458037|NCT00557856|7245624|FG000|Part 2: Exploratory Phase|Adverse Event|0
4458038|NCT00557856|7245625|FG001|Part 2: Exploratory Phase|Adverse Event|0
4458039|NCT00557856|7245626|FG002|Part 2: Exploratory Phase|Adverse Event|0
4458040|NCT00557856|7245627|FG003|Part 2: Exploratory Phase|Adverse Event|0
4458041|NCT00557856|7245628|FG004|Part 2: Exploratory Phase|Adverse Event|0
4458042|NCT00557856|7245629|FG005|Part 2: Exploratory Phase|Adverse Event|0
4458043|NCT00557856|7245630|FG006|Part 2: Exploratory Phase|Adverse Event|0
4458044|NCT00557856|7245631|FG007|Part 2: Exploratory Phase|Adverse Event|0
4458045|NCT00557856|7245632|FG008|Part 2: Exploratory Phase|Adverse Event|4
4458046|NCT00557856|7245624|FG000|Part 2: Exploratory Phase|Other|0
4458047|NCT00557856|7245625|FG001|Part 2: Exploratory Phase|Other|0
4458048|NCT00557856|7245626|FG002|Part 2: Exploratory Phase|Other|0
4458049|NCT00557856|7245627|FG003|Part 2: Exploratory Phase|Other|0
4458050|NCT00557856|7245628|FG004|Part 2: Exploratory Phase|Other|0
4458051|NCT00557856|7245629|FG005|Part 2: Exploratory Phase|Other|0
4458052|NCT00557856|7245630|FG006|Part 2: Exploratory Phase|Other|0
4458053|NCT00557856|7245631|FG007|Part 2: Exploratory Phase|Other|0
4458054|NCT00557856|7245632|FG008|Part 2: Exploratory Phase|Other|1
4458055|NCT00557856|7245624|FG000|Part 2: Exploratory Phase|Death|0
4458056|NCT00557856|7245625|FG001|Part 2: Exploratory Phase|Death|0
4458057|NCT00557856|7245626|FG002|Part 2: Exploratory Phase|Death|0
4458058|NCT00557856|7245627|FG003|Part 2: Exploratory Phase|Death|0
4458059|NCT00557856|7245628|FG004|Part 2: Exploratory Phase|Death|0
4458060|NCT00557856|7245629|FG005|Part 2: Exploratory Phase|Death|0
4458061|NCT00557856|7245630|FG006|Part 2: Exploratory Phase|Death|0
4458062|NCT00557856|7245631|FG007|Part 2: Exploratory Phase|Death|0
4458063|NCT00557856|7245632|FG008|Part 2: Exploratory Phase|Death|2
4458064|NCT00557856|7245624|FG000|Part 2: Exploratory Phase|global deterioration of health status|0
4458065|NCT00557856|7245625|FG001|Part 2: Exploratory Phase|global deterioration of health status|0
4458066|NCT00557856|7245626|FG002|Part 2: Exploratory Phase|global deterioration of health status|0
4458067|NCT00557856|7245627|FG003|Part 2: Exploratory Phase|global deterioration of health status|0
4458068|NCT00557856|7245628|FG004|Part 2: Exploratory Phase|global deterioration of health status|0
4458069|NCT00557856|7245629|FG005|Part 2: Exploratory Phase|global deterioration of health status|0
4458070|NCT00557856|7245630|FG006|Part 2: Exploratory Phase|global deterioration of health status|0
4458071|NCT00557856|7245631|FG007|Part 2: Exploratory Phase|global deterioration of health status|0
4458072|NCT00557856|7245632|FG008|Part 2: Exploratory Phase|global deterioration of health status|1
4458073|NCT00558025|7245675|FG000|Overall Study|Adverse Event|1
4458074|NCT00558025|7245676|FG001|Overall Study|Adverse Event|1
4458075|NCT00558025|7245675|FG000|Overall Study|Withdrawal by Subject|2
4458076|NCT00558025|7245676|FG001|Overall Study|Withdrawal by Subject|2
4458077|NCT00558025|7245675|FG000|Overall Study|Protocol Violation|1
4458078|NCT00558025|7245676|FG001|Overall Study|Protocol Violation|0
4458079|NCT00558064|7245684|FG000|Overall Study|Adverse Event|3
4458080|NCT00558064|7245685|FG001|Overall Study|Adverse Event|2
4458081|NCT00558064|7245684|FG000|Overall Study|Lack of Efficacy|0
4458082|NCT00558064|7245685|FG001|Overall Study|Lack of Efficacy|1
4458083|NCT00558064|7245684|FG000|Overall Study|Protocol Violation|1
4458084|NCT00558064|7245685|FG001|Overall Study|Protocol Violation|0
4458085|NCT00558064|7245684|FG000|Overall Study|Lost to Follow-up|0
4458086|NCT00558064|7245685|FG001|Overall Study|Lost to Follow-up|1
4458087|NCT00558064|7245684|FG000|Overall Study|Withdrawal by Subject|0
4458088|NCT00558064|7245685|FG001|Overall Study|Withdrawal by Subject|1
4458089|NCT00558064|7245684|FG000|Overall Study|No visit within allowance period|1
4611921|NCT01703832|7468535|FG000|Overall Study|Withdrawal by Subject|1
4611922|NCT01703832|7468536|FG001|Overall Study|Withdrawal by Subject|0
4611923|NCT01703845|7468544|FG000|Overall Study|Adverse Event|1
4611924|NCT01703845|7468545|FG001|Overall Study|Adverse Event|0
4611925|NCT01703845|7468544|FG000|Overall Study|Protocol Violation|1
4611926|NCT01703845|7468545|FG001|Overall Study|Protocol Violation|0
4611927|NCT01703845|7468544|FG000|Overall Study|other than stated above|1
4611928|NCT01703845|7468545|FG001|Overall Study|other than stated above|0
4611929|NCT01703858|7468556|FG000|Overall Study|Withdrawal by Subject|0
4458090|NCT00558064|7245685|FG001|Overall Study|No visit within allowance period|0
4458091|NCT00558103|7245696|FG000|Randomized Treatment Phase|Lost to Follow-up|2
4458092|NCT00558103|7245697|FG001|Randomized Treatment Phase|Lost to Follow-up|2
4458093|NCT00558103|7245698|FG002|Randomized Treatment Phase|Lost to Follow-up|2
4538842|NCT01123070|7361015|FG001|Part B Double Blind Period|Protocol Violation|0
4458094|NCT00558103|7245699|FG003|Randomized Treatment Phase|Lost to Follow-up|1
4458095|NCT00558103|7245700|FG004|Randomized Treatment Phase|Lost to Follow-up|3
4458096|NCT00558103|7245701|FG005|Randomized Treatment Phase|Lost to Follow-up|0
4458097|NCT00558103|7245696|FG000|Randomized Treatment Phase|Withdrawal by Subject|2
4458098|NCT00558103|7245697|FG001|Randomized Treatment Phase|Withdrawal by Subject|2
4458099|NCT00558103|7245698|FG002|Randomized Treatment Phase|Withdrawal by Subject|0
4458100|NCT00558103|7245699|FG003|Randomized Treatment Phase|Withdrawal by Subject|0
4458101|NCT00558103|7245700|FG004|Randomized Treatment Phase|Withdrawal by Subject|1
4458102|NCT00558103|7245701|FG005|Randomized Treatment Phase|Withdrawal by Subject|0
4458103|NCT00558103|7245696|FG000|Randomized Treatment Phase|Disease Progression|1
4458104|NCT00558103|7245697|FG001|Randomized Treatment Phase|Disease Progression|0
4458105|NCT00558103|7245698|FG002|Randomized Treatment Phase|Disease Progression|1
4458106|NCT00558103|7245699|FG003|Randomized Treatment Phase|Disease Progression|0
4458107|NCT00558103|7245700|FG004|Randomized Treatment Phase|Disease Progression|0
4458108|NCT00558103|7245701|FG005|Randomized Treatment Phase|Disease Progression|0
4458109|NCT00558103|7245696|FG000|Randomized Treatment Phase|Adverse Event|0
4458110|NCT00558103|7245697|FG001|Randomized Treatment Phase|Adverse Event|0
4458111|NCT00558103|7245698|FG002|Randomized Treatment Phase|Adverse Event|0
4458112|NCT00558103|7245699|FG003|Randomized Treatment Phase|Adverse Event|1
4458113|NCT00558103|7245700|FG004|Randomized Treatment Phase|Adverse Event|1
4458114|NCT00558103|7245701|FG005|Randomized Treatment Phase|Adverse Event|0
4611930|NCT01703858|7468557|FG001|Overall Study|Withdrawal by Subject|1
4611931|NCT01703858|7468558|FG002|Overall Study|Withdrawal by Subject|0
4611932|NCT01703988|7468575|FG000|Overall Study|Investigator Judgment|0
4611933|NCT01703988|7468576|FG001|Overall Study|Investigator Judgment|0
4611934|NCT01703988|7468577|FG002|Overall Study|Investigator Judgment|0
4611935|NCT01703988|7468578|FG003|Overall Study|Investigator Judgment|1
4611936|NCT01704079|7468591|FG000|Overall Study|Withdrawal by Subject|5
4611937|NCT01704079|7468592|FG001|Overall Study|Withdrawal by Subject|7
4611938|NCT01704079|7468591|FG000|Overall Study|Lost to Follow-up|2
4611939|NCT01704079|7468592|FG001|Overall Study|Lost to Follow-up|5
4611940|NCT01704079|7468591|FG000|Overall Study|Adverse Event|4
4458115|NCT00558103|7245696|FG000|Monotherapy Extension Phase|Protocol Violation|0
4458116|NCT00558103|7245697|FG001|Monotherapy Extension Phase|Protocol Violation|0
4458117|NCT00558103|7245698|FG002|Monotherapy Extension Phase|Protocol Violation|0
4458118|NCT00558103|7245699|FG003|Monotherapy Extension Phase|Protocol Violation|0
4458119|NCT00558103|7245700|FG004|Monotherapy Extension Phase|Protocol Violation|0
4458120|NCT00558103|7245701|FG005|Monotherapy Extension Phase|Protocol Violation|1
4458121|NCT00558103|7245696|FG000|Monotherapy Extension Phase|Disease Progression|0
4458122|NCT00558103|7245697|FG001|Monotherapy Extension Phase|Disease Progression|0
4458123|NCT00558103|7245698|FG002|Monotherapy Extension Phase|Disease Progression|0
4458124|NCT00558103|7245699|FG003|Monotherapy Extension Phase|Disease Progression|0
4458125|NCT00558103|7245700|FG004|Monotherapy Extension Phase|Disease Progression|0
4458126|NCT00558103|7245701|FG005|Monotherapy Extension Phase|Disease Progression|8
4458127|NCT00558259|7245723|FG000|Overall Study|Adverse Event|50
4458128|NCT00558259|7245724|FG001|Overall Study|Adverse Event|81
4458129|NCT00558259|7245723|FG000|Overall Study|Protocol Violation|9
4458130|NCT00558259|7245724|FG001|Overall Study|Protocol Violation|5
4458131|NCT00558259|7245723|FG000|Overall Study|Withdrawal by Subject|12
4458132|NCT00558259|7245724|FG001|Overall Study|Withdrawal by Subject|13
4458133|NCT00558272|7245732|FG000|Overall Study|Adverse Event|10
4458134|NCT00558272|7245733|FG001|Overall Study|Adverse Event|0
4458135|NCT00558272|7245732|FG000|Overall Study|Death|1
4458136|NCT00558272|7245733|FG001|Overall Study|Death|0
4458137|NCT00558272|7245732|FG000|Overall Study|Dev. of study specific discon. criteria|1
4458138|NCT00558272|7245733|FG001|Overall Study|Dev. of study specific discon. criteria|0
4458139|NCT00558272|7245732|FG000|Overall Study|AZ study team decision|0
4458140|NCT00558272|7245733|FG001|Overall Study|AZ study team decision|1
4458141|NCT00558272|7245732|FG000|Overall Study|Incorrectly enrolled|1
4458142|NCT00558272|7245733|FG001|Overall Study|Incorrectly enrolled|0
4458143|NCT00558272|7245732|FG000|Overall Study|Withdrawal by Subject|0
4458144|NCT00558272|7245733|FG001|Overall Study|Withdrawal by Subject|1
4458145|NCT00558285|7245744|FG000|Overall Study|Adverse Event|1
4458146|NCT00558285|7245745|FG001|Overall Study|Adverse Event|1
4458147|NCT00558285|7245746|FG002|Overall Study|Adverse Event|4
4458148|NCT00558285|7245747|FG003|Overall Study|Adverse Event|1
4458149|NCT00558285|7245748|FG004|Overall Study|Adverse Event|2
4458150|NCT00558285|7245744|FG000|Overall Study|Abnormal test procedure result(s)|1
4458151|NCT00558285|7245745|FG001|Overall Study|Abnormal test procedure result(s)|0
4458152|NCT00558285|7245746|FG002|Overall Study|Abnormal test procedure result(s)|0
4458153|NCT00558285|7245747|FG003|Overall Study|Abnormal test procedure result(s)|0
4458154|NCT00558285|7245748|FG004|Overall Study|Abnormal test procedure result(s)|0
4458155|NCT00558285|7245744|FG000|Overall Study|Subject withdrew consent|2
4458156|NCT00558285|7245745|FG001|Overall Study|Subject withdrew consent|0
4458157|NCT00558285|7245746|FG002|Overall Study|Subject withdrew consent|1
4611941|NCT01704079|7468592|FG001|Overall Study|Adverse Event|7
4458158|NCT00558285|7245747|FG003|Overall Study|Subject withdrew consent|1
4458159|NCT00558285|7245748|FG004|Overall Study|Subject withdrew consent|1
4611942|NCT01704079|7468591|FG000|Overall Study|Protocol Violation|1
4611943|NCT01704079|7468592|FG001|Overall Study|Protocol Violation|0
4611944|NCT01704079|7468591|FG000|Overall Study|Subject noncompliance|2
4611945|NCT01704079|7468592|FG001|Overall Study|Subject noncompliance|3
4611946|NCT01704079|7468591|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0
4611947|NCT01704079|7468592|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1
4611948|NCT01704261|7468609|FG000|Overall Study|Withdrawal by Subject|12
4611949|NCT01704261|7468610|FG001|Overall Study|Withdrawal by Subject|15
4611950|NCT01704261|7468609|FG000|Overall Study|Lost to Follow-up|1
4611951|NCT01704261|7468610|FG001|Overall Study|Lost to Follow-up|0
4611952|NCT01704287|7468619|FG000|Initial Treatment Period|Death|139
4611953|NCT01704287|7468620|FG001|Initial Treatment Period|Death|129
4611954|NCT01704287|7468621|FG002|Initial Treatment Period|Death|71
4611955|NCT01704287|7468622|FG003|Initial Treatment Period|Death|0
4611956|NCT01704287|7468623|FG004|Initial Treatment Period|Death|0
4611957|NCT01704287|7468619|FG000|Initial Treatment Period|Withdrawal by Subject|3
4611958|NCT01704287|7468620|FG001|Initial Treatment Period|Withdrawal by Subject|2
4611959|NCT01704287|7468621|FG002|Initial Treatment Period|Withdrawal by Subject|4
4611960|NCT01704287|7468622|FG003|Initial Treatment Period|Withdrawal by Subject|0
4611961|NCT01704287|7468623|FG004|Initial Treatment Period|Withdrawal by Subject|0
4611962|NCT01704287|7468619|FG000|Initial Treatment Period|Lost to Follow-up|5
4611963|NCT01704287|7468620|FG001|Initial Treatment Period|Lost to Follow-up|3
4611964|NCT01704287|7468621|FG002|Initial Treatment Period|Lost to Follow-up|0
4611965|NCT01704287|7468622|FG003|Initial Treatment Period|Lost to Follow-up|0
4611966|NCT01704287|7468623|FG004|Initial Treatment Period|Lost to Follow-up|0
4611967|NCT01704287|7468619|FG000|Initial Treatment Period|Switched to Pembrolizumab|0
4611968|NCT01704287|7468620|FG001|Initial Treatment Period|Switched to Pembrolizumab|0
4611969|NCT01704287|7468621|FG002|Initial Treatment Period|Switched to Pembrolizumab|98
4611970|NCT01704287|7468622|FG003|Initial Treatment Period|Switched to Pembrolizumab|0
4611971|NCT01704287|7468623|FG004|Initial Treatment Period|Switched to Pembrolizumab|0
4611972|NCT01704287|7468619|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
4611973|NCT01704287|7468620|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
4611974|NCT01704287|7468621|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
4611975|NCT01704287|7468622|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2
4611976|NCT01704287|7468623|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1
4611977|NCT01704287|7468619|FG000|Switch to Pembrolizumab Treatment Period|Death|0
4611978|NCT01704287|7468620|FG001|Switch to Pembrolizumab Treatment Period|Death|0
4611979|NCT01704287|7468621|FG002|Switch to Pembrolizumab Treatment Period|Death|0
4611980|NCT01704287|7468622|FG003|Switch to Pembrolizumab Treatment Period|Death|35
4611981|NCT01704287|7468623|FG004|Switch to Pembrolizumab Treatment Period|Death|37
4611982|NCT01704287|7468619|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
4611983|NCT01704287|7468620|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
4611984|NCT01704287|7468621|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
4611985|NCT01704287|7468622|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1
4611986|NCT01704287|7468623|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
4611987|NCT01704456|7468644|FG000|Overall Study|Lost to Follow-up|8
4611988|NCT01704456|7468645|FG001|Overall Study|Lost to Follow-up|14
4611989|NCT01704495|7468655|FG000|Subjects Randomized|Other Reason|3
4611990|NCT01704495|7468656|FG001|Subjects Randomized|Other Reason|2
4611991|NCT01704495|7468657|FG002|Subjects Randomized|Other Reason|3
4458160|NCT00558285|7245744|FG000|Overall Study|Lost to Follow-up|1
4458161|NCT00558285|7245745|FG001|Overall Study|Lost to Follow-up|1
4458162|NCT00558285|7245746|FG002|Overall Study|Lost to Follow-up|0
4458163|NCT00558285|7245747|FG003|Overall Study|Lost to Follow-up|0
4458164|NCT00558285|7245748|FG004|Overall Study|Lost to Follow-up|0
4458165|NCT00558285|7245744|FG000|Overall Study|Administrative problems|0
4458166|NCT00558285|7245745|FG001|Overall Study|Administrative problems|0
4458167|NCT00558285|7245746|FG002|Overall Study|Administrative problems|0
4458168|NCT00558285|7245747|FG003|Overall Study|Administrative problems|1
4458169|NCT00558285|7245748|FG004|Overall Study|Administrative problems|1
4458170|NCT00558285|7245744|FG000|Overall Study|Protocol deviation|1
4458171|NCT00558285|7245745|FG001|Overall Study|Protocol deviation|1
4458172|NCT00558285|7245746|FG002|Overall Study|Protocol deviation|0
4458173|NCT00558285|7245747|FG003|Overall Study|Protocol deviation|1
4458174|NCT00558285|7245748|FG004|Overall Study|Protocol deviation|0
4458175|NCT00558363|7245762|FG000|Overall Study|Physician Decision|18
4458176|NCT00558363|7245763|FG001|Overall Study|Physician Decision|4
4458177|NCT00558363|7245762|FG000|Overall Study|Withdrawal by Subject|11
4458178|NCT00558363|7245763|FG001|Overall Study|Withdrawal by Subject|4
4458179|NCT00558363|7245762|FG000|Overall Study|Adverse Event|5
4458180|NCT00558363|7245763|FG001|Overall Study|Adverse Event|5
4458181|NCT00558363|7245762|FG000|Overall Study|Lack of Efficacy|2
4458182|NCT00558363|7245763|FG001|Overall Study|Lack of Efficacy|2
4458183|NCT00558363|7245762|FG000|Overall Study|Protocol Violation|2
4458184|NCT00558363|7245763|FG001|Overall Study|Protocol Violation|1
4458185|NCT00558363|7245762|FG000|Overall Study|Lost to Follow-up|0
4458186|NCT00558363|7245763|FG001|Overall Study|Lost to Follow-up|1
4458187|NCT00558363|7245762|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32
4458188|NCT00558363|7245763|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16
4458189|NCT00558363|7245762|FG000|Overall Study|Randomized in Error|1
4458190|NCT00558363|7245763|FG001|Overall Study|Randomized in Error|2
4458191|NCT00558363|7245762|FG000|Overall Study|Hospitalized; Unable to Continue|0
4458192|NCT00558363|7245763|FG001|Overall Study|Hospitalized; Unable to Continue|1
4458193|NCT00558428|7245773|FG000|Overall Study|Adverse Event|6
4458194|NCT00558428|7245774|FG001|Overall Study|Adverse Event|22
4458195|NCT00558428|7245775|FG002|Overall Study|Adverse Event|3
4458196|NCT00558428|7245776|FG003|Overall Study|Adverse Event|4
4458197|NCT00558428|7245773|FG000|Overall Study|Lost to Follow-up|0
4458198|NCT00558428|7245774|FG001|Overall Study|Lost to Follow-up|1
4458199|NCT00558428|7245775|FG002|Overall Study|Lost to Follow-up|0
4458200|NCT00558428|7245776|FG003|Overall Study|Lost to Follow-up|0
4458201|NCT00558428|7245773|FG000|Overall Study|Lack of Efficacy|0
4458202|NCT00558428|7245774|FG001|Overall Study|Lack of Efficacy|0
4458203|NCT00558428|7245775|FG002|Overall Study|Lack of Efficacy|1
4458204|NCT00558428|7245776|FG003|Overall Study|Lack of Efficacy|2
4458205|NCT00558428|7245773|FG000|Overall Study|Non compliant with protocol|1
4458206|NCT00558428|7245774|FG001|Overall Study|Non compliant with protocol|0
4458207|NCT00558428|7245775|FG002|Overall Study|Non compliant with protocol|0
4458208|NCT00558428|7245776|FG003|Overall Study|Non compliant with protocol|3
4458209|NCT00558428|7245773|FG000|Overall Study|Consent withdrawn|2
4458210|NCT00558428|7245774|FG001|Overall Study|Consent withdrawn|1
4458211|NCT00558428|7245775|FG002|Overall Study|Consent withdrawn|0
4458212|NCT00558428|7245776|FG003|Overall Study|Consent withdrawn|1
4458213|NCT00558428|7245773|FG000|Overall Study|Other|3
4458214|NCT00558428|7245774|FG001|Overall Study|Other|0
4458215|NCT00558428|7245775|FG002|Overall Study|Other|0
4458216|NCT00558428|7245776|FG003|Overall Study|Other|1
4458217|NCT00558467|7245788|FG000|Overall Study|Adverse Event|1
4611992|NCT01704495|7468658|FG003|Subjects Randomized|Other Reason|2
4611993|NCT01704495|7468655|FG000|Subjects Randomized|Discontinuation criteria met|4
4611994|NCT01704495|7468656|FG001|Subjects Randomized|Discontinuation criteria met|2
4611995|NCT01704495|7468657|FG002|Subjects Randomized|Discontinuation criteria met|2
4611996|NCT01704495|7468658|FG003|Subjects Randomized|Discontinuation criteria met|0
4611997|NCT01704495|7468655|FG000|Subjects Randomized|Adverse Event|8
4611998|NCT01704495|7468656|FG001|Subjects Randomized|Adverse Event|2
4611999|NCT01704495|7468657|FG002|Subjects Randomized|Adverse Event|0
4612000|NCT01704495|7468658|FG003|Subjects Randomized|Adverse Event|7
4612001|NCT01704495|7468655|FG000|Subjects Randomized|Withdrawal by Subject|5
4612002|NCT01704495|7468656|FG001|Subjects Randomized|Withdrawal by Subject|5
4612003|NCT01704495|7468657|FG002|Subjects Randomized|Withdrawal by Subject|5
4612004|NCT01704495|7468658|FG003|Subjects Randomized|Withdrawal by Subject|5
4612005|NCT01704495|7468655|FG000|Subjects Randomized|Protocol Violation|1
4612006|NCT01704495|7468656|FG001|Subjects Randomized|Protocol Violation|1
4612007|NCT01704495|7468657|FG002|Subjects Randomized|Protocol Violation|2
4612008|NCT01704495|7468658|FG003|Subjects Randomized|Protocol Violation|0
4612009|NCT01704495|7468655|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1
4612010|NCT01704495|7468656|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3
4612011|NCT01704495|7468657|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4
4612012|NCT01704495|7468658|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3
4612013|NCT01704495|7468655|FG000|Optional Safety Extension|Adverse Event|0
4612014|NCT01704495|7468656|FG001|Optional Safety Extension|Adverse Event|4
4612015|NCT01704495|7468657|FG002|Optional Safety Extension|Adverse Event|0
4612016|NCT01704495|7468658|FG003|Optional Safety Extension|Adverse Event|1
4612017|NCT01704495|7468655|FG000|Optional Safety Extension|Other reason|27
4612018|NCT01704495|7468656|FG001|Optional Safety Extension|Other reason|29
4612019|NCT01704495|7468657|FG002|Optional Safety Extension|Other reason|30
4612020|NCT01704495|7468658|FG003|Optional Safety Extension|Other reason|28
4612021|NCT01704495|7468655|FG000|Optional Safety Extension|Withdrawal by Subject|2
4612022|NCT01704495|7468656|FG001|Optional Safety Extension|Withdrawal by Subject|0
4612023|NCT01704495|7468657|FG002|Optional Safety Extension|Withdrawal by Subject|1
4612024|NCT01704495|7468658|FG003|Optional Safety Extension|Withdrawal by Subject|2
4612025|NCT01704599|7468677|FG000|Overall Study|Adverse Event|1
4612026|NCT01704651|7468706|FG000|Overall Study|Pre-op withdrawal by subject|1
4612027|NCT01704651|7468707|FG001|Overall Study|Pre-op withdrawal by subject|1
4612028|NCT01704651|7468706|FG000|Overall Study|Pre-op change in treatment plan|1
4612029|NCT01704651|7468707|FG001|Overall Study|Pre-op change in treatment plan|4
4612030|NCT01704651|7468706|FG000|Overall Study|Nasogastric tube placement in surgery|1
4612031|NCT01704651|7468707|FG001|Overall Study|Nasogastric tube placement in surgery|1
4612032|NCT01704651|7468706|FG000|Overall Study|Post-op did not have laparotomy|2
4612033|NCT01704651|7468707|FG001|Overall Study|Post-op did not have laparotomy|1
4612034|NCT01704755|7468715|FG000|Overall Study|Adverse Event|4
4612035|NCT01704755|7468716|FG001|Overall Study|Adverse Event|1
4612036|NCT01704755|7468715|FG000|Overall Study|Lost to Follow-up|3
4612037|NCT01704755|7468716|FG001|Overall Study|Lost to Follow-up|4
4612038|NCT01704755|7468715|FG000|Overall Study|Withdrew consent|1
4612039|NCT01704755|7468716|FG001|Overall Study|Withdrew consent|1
4612040|NCT01704755|7468715|FG000|Overall Study|Other (not specified)|3
4612041|NCT01704755|7468716|FG001|Overall Study|Other (not specified)|1
4458218|NCT00558467|7245789|FG001|Overall Study|Adverse Event|2
4458219|NCT00558467|7245788|FG000|Overall Study|Lack of Efficacy|0
4458220|NCT00558467|7245789|FG001|Overall Study|Lack of Efficacy|1
4458221|NCT00558467|7245788|FG000|Overall Study|Patient moving out of state|0
4458222|NCT00558467|7245789|FG001|Overall Study|Patient moving out of state|1
4458223|NCT00558519|7245795|FG000|Overall Study|Ph+|20
4458224|NCT00558519|7245795|FG000|Overall Study|Ineligible|1
4458225|NCT00558519|7245795|FG000|Overall Study|Insufficient data|1
4458226|NCT00558519|7245795|FG000|Overall Study|Never received treatment|1
4458227|NCT00558636|7245829|FG000|Treatment|Adverse Event|9
4458228|NCT00558636|7245830|FG001|Treatment|Adverse Event|2
4458229|NCT00558636|7245829|FG000|Treatment|Withdrawal by Subject|2
4458230|NCT00558636|7245830|FG001|Treatment|Withdrawal by Subject|0
4458231|NCT00558636|7245829|FG000|Treatment|Premature termination of the study|35
4458232|NCT00558636|7245830|FG001|Treatment|Premature termination of the study|37
4458233|NCT00558636|7245829|FG000|Treatment|Disease progression|1
4458234|NCT00558636|7245830|FG001|Treatment|Disease progression|5
4458235|NCT00558636|7245829|FG000|Follow-up|Premature termination of the study|12
4458236|NCT00558636|7245830|FG001|Follow-up|Premature termination of the study|7
4458237|NCT00558701|7245838|FG000|Overall Study|Protocol Deviations|1
4458238|NCT00558701|7245839|FG001|Overall Study|Protocol Deviations|4
4458239|NCT00558753|7245847|FG000|Overall Study|Lost to Follow-up|5
4458240|NCT00558753|7245848|FG001|Overall Study|Lost to Follow-up|7
4458241|NCT00558831|7245870|FG000|Overall Study|Lost to Follow-up|1
4458242|NCT00558896|7245905|FG000|Overall Study|Adverse Event|1
4458243|NCT00558896|7245906|FG001|Overall Study|Adverse Event|1
4458244|NCT00558896|7245907|FG002|Overall Study|Adverse Event|1
4458245|NCT00558896|7245908|FG003|Overall Study|Adverse Event|3
4458246|NCT00558896|7245909|FG004|Overall Study|Adverse Event|4
4458247|NCT00558896|7245910|FG005|Overall Study|Adverse Event|10
4458248|NCT00558896|7245911|FG006|Overall Study|Adverse Event|3
4458249|NCT00558896|7245905|FG000|Overall Study|Death|3
4458250|NCT00558896|7245906|FG001|Overall Study|Death|0
4458251|NCT00558896|7245907|FG002|Overall Study|Death|2
4458252|NCT00558896|7245908|FG003|Overall Study|Death|3
4458253|NCT00558896|7245909|FG004|Overall Study|Death|2
4458254|NCT00558896|7245910|FG005|Overall Study|Death|2
4458255|NCT00558896|7245911|FG006|Overall Study|Death|6
4458256|NCT00558896|7245905|FG000|Overall Study|Withdrawal by Subject|2
4458257|NCT00558896|7245906|FG001|Overall Study|Withdrawal by Subject|1
4458258|NCT00558896|7245907|FG002|Overall Study|Withdrawal by Subject|1
4458259|NCT00558896|7245908|FG003|Overall Study|Withdrawal by Subject|1
4458260|NCT00558896|7245909|FG004|Overall Study|Withdrawal by Subject|1
4458261|NCT00558896|7245910|FG005|Overall Study|Withdrawal by Subject|5
4458262|NCT00558896|7245911|FG006|Overall Study|Withdrawal by Subject|5
4458263|NCT00558896|7245905|FG000|Overall Study|Alternative Treatment|2
4458264|NCT00558896|7245906|FG001|Overall Study|Alternative Treatment|2
4458265|NCT00558896|7245907|FG002|Overall Study|Alternative Treatment|0
4458266|NCT00558896|7245908|FG003|Overall Study|Alternative Treatment|2
4458267|NCT00558896|7245909|FG004|Overall Study|Alternative Treatment|6
4458268|NCT00558896|7245910|FG005|Overall Study|Alternative Treatment|7
4458269|NCT00558896|7245911|FG006|Overall Study|Alternative Treatment|1
4458270|NCT00558896|7245905|FG000|Overall Study|Physician discretion|3
4458271|NCT00558896|7245906|FG001|Overall Study|Physician discretion|2
4458272|NCT00558896|7245907|FG002|Overall Study|Physician discretion|1
4458273|NCT00558896|7245908|FG003|Overall Study|Physician discretion|2
4458274|NCT00558896|7245909|FG004|Overall Study|Physician discretion|1
4458275|NCT00558896|7245910|FG005|Overall Study|Physician discretion|3
4458276|NCT00558896|7245911|FG006|Overall Study|Physician discretion|3
4458277|NCT00558896|7245905|FG000|Overall Study|Continues on treatment|10
4538843|NCT01123070|7361016|FG002|Part B Double Blind Period|Protocol Violation|0
4538844|NCT01123070|7361017|FG003|Part B Double Blind Period|Protocol Violation|1
4538845|NCT01123070|7361014|FG000|Part B Double Blind Period|Adverse Event|0
4458278|NCT00558896|7245906|FG001|Overall Study|Continues on treatment|1
4458279|NCT00558896|7245907|FG002|Overall Study|Continues on treatment|0
4458280|NCT00558896|7245908|FG003|Overall Study|Continues on treatment|1
4458281|NCT00558896|7245909|FG004|Overall Study|Continues on treatment|9
4458282|NCT00558896|7245910|FG005|Overall Study|Continues on treatment|25
4458283|NCT00558896|7245911|FG006|Overall Study|Continues on treatment|6
4458284|NCT00559104|7245933|FG000|Overall Study|Lack of Efficacy|9
4458285|NCT00559104|7245934|FG001|Overall Study|Lack of Efficacy|0
4458286|NCT00559273|7245942|FG000|Correction Period (20 Weeks)|Death|3
4458287|NCT00559273|7245943|FG001|Correction Period (20 Weeks)|Death|4
4458288|NCT00559273|7245942|FG000|Correction Period (20 Weeks)|Adverse Event|2
4458289|NCT00559273|7245943|FG001|Correction Period (20 Weeks)|Adverse Event|1
4458290|NCT00559273|7245942|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2
4458291|NCT00559273|7245943|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6
4458292|NCT00559273|7245942|FG000|Correction Period (20 Weeks)|Participant treated by another center|0
4458293|NCT00559273|7245943|FG001|Correction Period (20 Weeks)|Participant treated by another center|1
4458294|NCT00559273|7245942|FG000|Correction Period (20 Weeks)|Did not received study treatment|2
4458295|NCT00559273|7245943|FG001|Correction Period (20 Weeks)|Did not received study treatment|0
4458296|NCT00559273|7245942|FG000|Evaluation Period (8 Weeks)|Death|1
4458297|NCT00559273|7245943|FG001|Evaluation Period (8 Weeks)|Death|3
4458298|NCT00559273|7245942|FG000|Evaluation Period (8 Weeks)|Adverse Event|0
4458299|NCT00559273|7245943|FG001|Evaluation Period (8 Weeks)|Adverse Event|1
4458300|NCT00559273|7245942|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2
4458301|NCT00559273|7245943|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0
4458302|NCT00559273|7245942|FG000|Evaluation Period (8 Weeks)|Physician Decision|0
4458303|NCT00559273|7245943|FG001|Evaluation Period (8 Weeks)|Physician Decision|1
4458304|NCT00559364|7245951|FG000|Overall Study|Inclusion/exclusion criteria failure|1
4458305|NCT00559364|7245952|FG001|Overall Study|Inclusion/exclusion criteria failure|0
4458306|NCT00559377|7245958|FG000|Overall Study|Withdrawal by Subject|9
4458307|NCT00559507|7245974|FG000|Overall Study|Not treated, patient ineligible|3
4458308|NCT00559585|7245980|FG000|Double Blind ST Period Main Study|Adverse Event|17
4458309|NCT00559585|7245981|FG001|Double Blind ST Period Main Study|Adverse Event|25
4458310|NCT00559585|7245980|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11
4458311|NCT00559585|7245981|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5
4458312|NCT00559585|7245980|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0
4458313|NCT00559585|7245981|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6
4458314|NCT00559585|7245980|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1
4458315|NCT00559585|7245981|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0
4458316|NCT00559585|7245980|FG000|Double Blind ST Period Main Study|Death|1
4458317|NCT00559585|7245981|FG001|Double Blind ST Period Main Study|Death|1
4458318|NCT00559585|7245980|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2
4458319|NCT00559585|7245981|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1
4458320|NCT00559585|7245980|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6
4458321|NCT00559585|7245981|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1
4458322|NCT00559585|7245980|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3
4458323|NCT00559585|7245981|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0
4458324|NCT00559585|7245980|FG000|Double Blind ST Period Main Study|Missed Doses|0
4458325|NCT00559585|7245981|FG001|Double Blind ST Period Main Study|Missed Doses|1
4458326|NCT00559585|7245980|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0
4458327|NCT00559585|7245981|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1
4458328|NCT00559585|7245980|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0
4458329|NCT00559585|7245981|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1
4458330|NCT00559585|7245980|FG000|Double Blind ST Period Main Study|Early Discontinuation|0
4458331|NCT00559585|7245981|FG001|Double Blind ST Period Main Study|Early Discontinuation|1
4458332|NCT00559585|7245980|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1
4458333|NCT00559585|7245981|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0
4458334|NCT00559585|7245980|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0
4458335|NCT00559585|7245981|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1
4458336|NCT00559585|7245980|FG000|Double Blind ST Period Main Study|Investigator Decision|0
4612042|NCT01704755|7468715|FG000|Overall Study|Withdrew consent and personal issues|1
4612043|NCT01704755|7468716|FG001|Overall Study|Withdrew consent and personal issues|0
4612044|NCT01704846|7468747|FG000|Treatment Period 2|Withdrawal by Subject|0
4612045|NCT01704846|7468748|FG001|Treatment Period 2|Withdrawal by Subject|1
4612046|NCT01705080|7468766|FG000|Overall Study|Missed visit|10
4612047|NCT01705080|7468767|FG001|Overall Study|Missed visit|4
4612048|NCT01705080|7468768|FG002|Overall Study|Missed visit|1
4612049|NCT01705080|7468766|FG000|Overall Study|Death|4
4612050|NCT01705080|7468767|FG001|Overall Study|Death|4
4458337|NCT00559585|7245981|FG001|Double Blind ST Period Main Study|Investigator Decision|1
4458338|NCT00559585|7245980|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1
4458339|NCT00559585|7245981|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0
4458340|NCT00559585|7245980|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1
4458341|NCT00559585|7245981|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1
4458342|NCT00559585|7245980|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100
4458343|NCT00559585|7245981|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0
4458344|NCT00559585|7245980|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81
4458345|NCT00559585|7245981|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0
4458346|NCT00559585|7245980|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16
4458347|NCT00559585|7245981|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0
4458348|NCT00559585|7245980|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32
4458349|NCT00559585|7245981|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0
4458350|NCT00559585|7245980|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9
4458351|NCT00559585|7245981|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0
4458352|NCT00559585|7245980|FG000|Open Label LT Period Main + Sub-Study|Death|20
4458353|NCT00559585|7245981|FG001|Open Label LT Period Main + Sub-Study|Death|0
4458354|NCT00559585|7245980|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1
4458355|NCT00559585|7245981|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0
4458356|NCT00559585|7245980|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89
4458357|NCT00559585|7245981|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0
4458358|NCT00559585|7245980|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8
4458359|NCT00559585|7245981|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0
4538846|NCT01123070|7361015|FG001|Part B Double Blind Period|Adverse Event|0
4612051|NCT01705080|7468768|FG002|Overall Study|Death|6
4612052|NCT01705080|7468766|FG000|Overall Study|Withdrawal by Subject|61
4458360|NCT00559585|7245980|FG000|Open Label LT Period Main + Sub-Study|non-specified|71
4458361|NCT00559585|7245981|FG001|Open Label LT Period Main + Sub-Study|non-specified|0
4458362|NCT00559585|7245980|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1
4458363|NCT00559585|7245981|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0
4458364|NCT00559637|7245998|FG000|Overall Study|Adverse Event|22
4458365|NCT00559637|7245998|FG000|Overall Study|Withdrawal by Subject|4
4458366|NCT00559637|7245998|FG000|Overall Study|Protocol Violation|6
4458367|NCT00559637|7245998|FG000|Overall Study|Withdrawal criteria fulfilled|4
4458368|NCT00559637|7245998|FG000|Overall Study|Failure to return|6
4458369|NCT00559637|7245998|FG000|Overall Study|Insufficient response|3
4458370|NCT00559637|7245998|FG000|Overall Study|Started requiring dialysis after month 7|2
4458371|NCT00559637|7245998|FG000|Overall Study|Suspected lung cancer|1
4458372|NCT00559637|7245998|FG000|Overall Study|Participation in another study|1
4458373|NCT00559637|7245998|FG000|Overall Study|Delayed administration of C.E.R.A|1
4458374|NCT00559637|7245998|FG000|Overall Study|Change of center|1
4458375|NCT00559637|7245998|FG000|Overall Study|Change of home|1
4458376|NCT00559637|7245998|FG000|Overall Study|Inclusion or exclusion criteria violated|2
4458377|NCT00559754|7246002|FG000|Overall Study|Disease progression|1
4458378|NCT00559754|7246002|FG000|Overall Study|Adverse Event|5
4458379|NCT00559754|7246002|FG000|Overall Study|Protocol Violation|1
4458380|NCT00559754|7246002|FG000|Overall Study|Investigator criteria|2
4458381|NCT00559754|7246002|FG000|Overall Study|Withdrawal by Subject|2
4458382|NCT00559845|7246006|FG000|Overall Study|Withdrew Consent|1
4458383|NCT00559845|7246006|FG000|Overall Study|Disease Progression|1
4458384|NCT00559845|7246006|FG000|Overall Study|Adverse Event|3
4458385|NCT00559845|7246006|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1
4458386|NCT00559845|7246006|FG000|Overall Study|Premature Surgery-Investigator Decision|1
4458387|NCT00559949|7246014|FG000|Overall Study|Progressive Disease during cycle 1|1
4458388|NCT00559949|7246014|FG000|Overall Study|Adverse Event|1
4458389|NCT00559949|7246014|FG000|Overall Study|Withdrawal by Subject|4
4458390|NCT00559949|7246014|FG000|Overall Study|No disease evaluation per protocol|1
4458391|NCT00559962|7246026|FG000|Overall Study|Adverse Event|1
4458392|NCT00559962|7246027|FG001|Overall Study|Adverse Event|7
4458393|NCT00559962|7246028|FG002|Overall Study|Adverse Event|8
4458394|NCT00559962|7246029|FG003|Overall Study|Adverse Event|5
4458395|NCT00559962|7246030|FG004|Overall Study|Adverse Event|11
4458396|NCT00559962|7246031|FG005|Overall Study|Adverse Event|4
4458397|NCT00559962|7246032|FG006|Overall Study|Adverse Event|4
4458398|NCT00559962|7246033|FG007|Overall Study|Adverse Event|2
4458399|NCT00559962|7246026|FG000|Overall Study|Lost to Follow-up|0
4458400|NCT00559962|7246027|FG001|Overall Study|Lost to Follow-up|1
4458401|NCT00559962|7246028|FG002|Overall Study|Lost to Follow-up|0
4458402|NCT00559962|7246029|FG003|Overall Study|Lost to Follow-up|0
4458403|NCT00559962|7246030|FG004|Overall Study|Lost to Follow-up|0
4458404|NCT00559962|7246031|FG005|Overall Study|Lost to Follow-up|0
4458405|NCT00559962|7246032|FG006|Overall Study|Lost to Follow-up|0
4458406|NCT00559962|7246033|FG007|Overall Study|Lost to Follow-up|0
4458407|NCT00559962|7246026|FG000|Overall Study|Withdrawal by Subject|1
4458408|NCT00559962|7246027|FG001|Overall Study|Withdrawal by Subject|1
4458409|NCT00559962|7246028|FG002|Overall Study|Withdrawal by Subject|2
4458410|NCT00559962|7246029|FG003|Overall Study|Withdrawal by Subject|0
4458411|NCT00559962|7246030|FG004|Overall Study|Withdrawal by Subject|3
4458412|NCT00559962|7246031|FG005|Overall Study|Withdrawal by Subject|1
4458413|NCT00559962|7246032|FG006|Overall Study|Withdrawal by Subject|0
4458414|NCT00559962|7246033|FG007|Overall Study|Withdrawal by Subject|2
4458415|NCT00559962|7246026|FG000|Overall Study|Inclusion/exclusion criteria not met|0
4458416|NCT00559962|7246027|FG001|Overall Study|Inclusion/exclusion criteria not met|0
4458417|NCT00559962|7246028|FG002|Overall Study|Inclusion/exclusion criteria not met|0
4458418|NCT00559962|7246029|FG003|Overall Study|Inclusion/exclusion criteria not met|0
4458419|NCT00559962|7246030|FG004|Overall Study|Inclusion/exclusion criteria not met|0
4458420|NCT00559962|7246031|FG005|Overall Study|Inclusion/exclusion criteria not met|0
4458421|NCT00559962|7246032|FG006|Overall Study|Inclusion/exclusion criteria not met|1
4458422|NCT00559962|7246033|FG007|Overall Study|Inclusion/exclusion criteria not met|0
4458423|NCT00559988|7246054|FG000|Overall Study|Death|147
4458424|NCT00559988|7246055|FG001|Overall Study|Death|140
4458425|NCT00559988|7246054|FG000|Overall Study|Withdrawal by Subject|152
4458426|NCT00559988|7246055|FG001|Overall Study|Withdrawal by Subject|139
4458427|NCT00559988|7246054|FG000|Overall Study|Lost to Follow-up|42
4458428|NCT00559988|7246055|FG001|Overall Study|Lost to Follow-up|56
4458429|NCT00559988|7246054|FG000|Overall Study|ICD device explanted|10
4458430|NCT00559988|7246055|FG001|Overall Study|ICD device explanted|17
4458431|NCT00560066|7246063|FG000|Overall Study|Death|2
4458432|NCT00560066|7246064|FG001|Overall Study|Death|1
4458433|NCT00560066|7246063|FG000|Overall Study|Withdrawal by Subject|0
4458434|NCT00560066|7246064|FG001|Overall Study|Withdrawal by Subject|3
4458435|NCT00560066|7246063|FG000|Overall Study|Lost to Follow-up|4
4458436|NCT00560066|7246064|FG001|Overall Study|Lost to Follow-up|10
4458437|NCT00560066|7246063|FG000|Overall Study|Protocol Violation|0
4458438|NCT00560066|7246064|FG001|Overall Study|Protocol Violation|1
4458439|NCT00560066|7246063|FG000|Overall Study|Administrative reason|0
4458440|NCT00560066|7246064|FG001|Overall Study|Administrative reason|5
4458441|NCT00560066|7246063|FG000|Overall Study|Missing primary reason|0
4458442|NCT00560066|7246064|FG001|Overall Study|Missing primary reason|2
4538847|NCT01123070|7361016|FG002|Part B Double Blind Period|Adverse Event|2
4538848|NCT01123070|7361017|FG003|Part B Double Blind Period|Adverse Event|0
4538849|NCT01123070|7361014|FG000|Part B Double Blind Period|Sponsor's Decision|0
4538850|NCT01123070|7361015|FG001|Part B Double Blind Period|Sponsor's Decision|0
4538851|NCT01123070|7361016|FG002|Part B Double Blind Period|Sponsor's Decision|2
4538852|NCT01123070|7361017|FG003|Part B Double Blind Period|Sponsor's Decision|2
4538853|NCT01123083|7361030|FG000|Overall Study|Investigator recommendation|1
4538854|NCT01123083|7361031|FG001|Overall Study|Investigator recommendation|1
4538855|NCT01123083|7361030|FG000|Overall Study|Administrative reasons|0
4538856|NCT01123083|7361031|FG001|Overall Study|Administrative reasons|4
4538857|NCT01123083|7361030|FG000|Overall Study|Lost to Follow-up|2
4538858|NCT01123083|7361031|FG001|Overall Study|Lost to Follow-up|6
4538859|NCT01123083|7361030|FG000|Overall Study|Adverse Event|1
4538860|NCT01123083|7361031|FG001|Overall Study|Adverse Event|0
4538861|NCT01123083|7361030|FG000|Overall Study|Withdrew for another reason not covered|0
4538862|NCT01123083|7361031|FG001|Overall Study|Withdrew for another reason not covered|1
4538863|NCT01123083|7361030|FG000|Overall Study|Participant/legal representative request|7
4538864|NCT01123083|7361031|FG001|Overall Study|Participant/legal representative request|3
4538865|NCT01123148|7361037|FG000|Overall Study|Coughing caused unacceptable EEG quality|1
4538866|NCT01123148|7361037|FG000|Overall Study|Didn't meet milestone criteria|1
4538867|NCT01123161|7361043|FG000|Overall Study|Lost to Follow-up|1
4538868|NCT01123161|7361044|FG001|Overall Study|Lost to Follow-up|0
4538869|NCT01123161|7361043|FG000|Overall Study|Withdrawal by Subject|1
4538870|NCT01123161|7361044|FG001|Overall Study|Withdrawal by Subject|0
4538871|NCT01123200|7361053|FG000|Overall Study|Withdrawal by Subject|1
4538872|NCT01123356|7361057|FG000|Overall Study|Adverse Event|2
4538873|NCT01123356|7361057|FG000|Overall Study|Lack of Efficacy|4
4538874|NCT01123356|7361057|FG000|Overall Study|Withdrawal by Subject|1
4538875|NCT01123382|7361064|FG000|Overall Study|Withdrawal by Subject|1
4538876|NCT01123382|7361065|FG001|Overall Study|Withdrawal by Subject|4
4538877|NCT01123382|7361064|FG000|Overall Study|Lost to Follow-up|1
4538878|NCT01123382|7361065|FG001|Overall Study|Lost to Follow-up|2
4538879|NCT01123395|7361071|FG000|Washout Period of 14 Days|Withdrawal by Subject|0
4538880|NCT01123395|7361072|FG001|Washout Period of 14 Days|Withdrawal by Subject|1
4538881|NCT01123642|7361087|FG000|Overall Study|Lost to Follow-up|23
4458443|NCT00560105|7246077|FG000|Overall Study|musculoskeletal chest discomfort with us|1
4458444|NCT00560105|7246078|FG001|Overall Study|musculoskeletal chest discomfort with us|2
4458445|NCT00560235|7246087|FG000|Phase 1|Discontinued|8
4458446|NCT00560235|7246088|FG001|Phase 1|Discontinued|0
4458447|NCT00560235|7246089|FG002|Phase 1|Discontinued|0
4458448|NCT00560235|7246087|FG000|Phase 1B|Discontinued|0
4458449|NCT00560235|7246088|FG001|Phase 1B|Discontinued|19
4458450|NCT00560235|7246089|FG002|Phase 1B|Discontinued|0
4458451|NCT00560235|7246087|FG000|Phase 2|Discontinued|0
4458452|NCT00560235|7246088|FG001|Phase 2|Discontinued|0
4458453|NCT00560235|7246089|FG002|Phase 2|Discontinued|96
4458454|NCT00560235|7246087|FG000|Phase 2|Ongoing at Date of Cut-Off|0
4458455|NCT00560235|7246088|FG001|Phase 2|Ongoing at Date of Cut-Off|0
4458456|NCT00560235|7246089|FG002|Phase 2|Ongoing at Date of Cut-Off|1
4458457|NCT00560313|7246107|FG000|Overall Study|Adverse Events or Death|2
4458458|NCT00560313|7246107|FG000|Overall Study|Withdrawal by Subject|2
4458459|NCT00560313|7246107|FG000|Overall Study|Lost to Follow-up|1
4458460|NCT00560313|7246107|FG000|Overall Study|Protocol Violation|1
4458461|NCT00560352|7246129|FG000|Overall Study|Adverse event unrelated to study drug|2
4458462|NCT00560352|7246130|FG001|Overall Study|Adverse event unrelated to study drug|1
4458463|NCT00560352|7246131|FG002|Overall Study|Adverse event unrelated to study drug|1
4458464|NCT00560352|7246129|FG000|Overall Study|Study drug toxicity|3
4458465|NCT00560352|7246130|FG001|Overall Study|Study drug toxicity|0
4458466|NCT00560352|7246131|FG002|Overall Study|Study drug toxicity|1
4458467|NCT00560352|7246129|FG000|Overall Study|Disease progression|0
4458468|NCT00560352|7246130|FG001|Overall Study|Disease progression|1
4458469|NCT00560352|7246131|FG002|Overall Study|Disease progression|1
4458470|NCT00560352|7246129|FG000|Overall Study|Withdrawal by Subject|1
4458471|NCT00560352|7246130|FG001|Overall Study|Withdrawal by Subject|1
4458472|NCT00560352|7246131|FG002|Overall Study|Withdrawal by Subject|1
4458473|NCT00560352|7246129|FG000|Overall Study|Maximum clinical benefit|1
4458474|NCT00560352|7246130|FG001|Overall Study|Maximum clinical benefit|0
4458475|NCT00560352|7246131|FG002|Overall Study|Maximum clinical benefit|0
4458476|NCT00560391|7246148|FG000|Overall Study|Still on treatment|0
4458477|NCT00560391|7246149|FG001|Overall Study|Still on treatment|0
4458478|NCT00560391|7246150|FG002|Overall Study|Still on treatment|0
4458479|NCT00560391|7246151|FG003|Overall Study|Still on treatment|1
4538882|NCT01123642|7361087|FG000|Overall Study|Withdrawal by Subject|9
4538883|NCT01123642|7361087|FG000|Overall Study|ineligible at baseline assessment|36
4538884|NCT01123655|7361094|FG000|Overall Study|Medication for RA had to be changed|1
4538885|NCT01123655|7361095|FG001|Overall Study|Medication for RA had to be changed|0
4538886|NCT01123655|7361096|FG002|Overall Study|Medication for RA had to be changed|0
4538887|NCT01123655|7361094|FG000|Overall Study|new illness|0
4458480|NCT00560391|7246152|FG004|Overall Study|Still on treatment|2
4458481|NCT00560404|7246167|FG000|Overall Study|Adverse Event|2
4458482|NCT00560404|7246168|FG001|Overall Study|Adverse Event|3
4458483|NCT00560404|7246167|FG000|Overall Study|Death|3
4458484|NCT00560404|7246168|FG001|Overall Study|Death|3
4458485|NCT00560404|7246167|FG000|Overall Study|Protocol Violation|12
4458486|NCT00560404|7246168|FG001|Overall Study|Protocol Violation|7
4458487|NCT00560404|7246167|FG000|Overall Study|Administrative Reasons|1
4458488|NCT00560404|7246168|FG001|Overall Study|Administrative Reasons|1
4458489|NCT00560404|7246167|FG000|Overall Study|Withdrew Consent|4
4458490|NCT00560404|7246168|FG001|Overall Study|Withdrew Consent|0
4458491|NCT00560404|7246167|FG000|Overall Study|Failure to return|1
4458492|NCT00560404|7246168|FG001|Overall Study|Failure to return|2
4458493|NCT00560404|7246167|FG000|Overall Study|Other withdrawal reason|13
4458494|NCT00560404|7246168|FG001|Overall Study|Other withdrawal reason|5
4458495|NCT00560417|7246176|FG000|Overall Study|Adverse Event|3
4458496|NCT00560417|7246177|FG001|Overall Study|Adverse Event|2
4458497|NCT00560417|7246176|FG000|Overall Study|Entry Criteria Not Met|1
4458498|NCT00560417|7246177|FG001|Overall Study|Entry Criteria Not Met|0
4458499|NCT00560417|7246176|FG000|Overall Study|Lost to Follow-up|0
4458500|NCT00560417|7246177|FG001|Overall Study|Lost to Follow-up|1
4458501|NCT00560417|7246176|FG000|Overall Study|Physician Decision|2
4458502|NCT00560417|7246177|FG001|Overall Study|Physician Decision|6
4458503|NCT00560417|7246176|FG000|Overall Study|Protocol Violation|6
4458504|NCT00560417|7246177|FG001|Overall Study|Protocol Violation|5
4458505|NCT00560417|7246176|FG000|Overall Study|Sponsor Decision|2
4458506|NCT00560417|7246177|FG001|Overall Study|Sponsor Decision|0
4458507|NCT00560417|7246176|FG000|Overall Study|Withdrawal by Subject|3
4458508|NCT00560417|7246177|FG001|Overall Study|Withdrawal by Subject|3
4538888|NCT01123655|7361095|FG001|Overall Study|new illness|1
4458509|NCT00560508|7246185|FG000|12 Week Double-blind Period|Adverse Event|3
4458510|NCT00560508|7246186|FG001|12 Week Double-blind Period|Adverse Event|2
4458511|NCT00560508|7246185|FG000|12 Week Double-blind Period|Protocol Violation|1
4458512|NCT00560508|7246186|FG001|12 Week Double-blind Period|Protocol Violation|0
4458513|NCT00560508|7246185|FG000|12 Week Double-blind Period|Withdrawal by Subject|1
4458514|NCT00560508|7246186|FG001|12 Week Double-blind Period|Withdrawal by Subject|1
4458515|NCT00560508|7246185|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6
4458516|NCT00560508|7246186|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6
4458517|NCT00560508|7246185|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1
4458518|NCT00560508|7246186|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1
4458519|NCT00560508|7246185|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0
4458520|NCT00560508|7246186|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3
4458521|NCT00560508|7246185|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1
4458522|NCT00560508|7246186|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1
4458523|NCT00560573|7246206|FG000|Overall Study|Death|4
4458524|NCT00560573|7246207|FG001|Overall Study|Death|1
4458525|NCT00560573|7246208|FG002|Overall Study|Death|4
4458526|NCT00560573|7246209|FG003|Overall Study|Death|5
4458527|NCT00560573|7246210|FG004|Overall Study|Death|1
4458528|NCT00560573|7246211|FG005|Overall Study|Death|10
4458529|NCT00560573|7246206|FG000|Overall Study|Lost to Follow-up|0
4458530|NCT00560573|7246207|FG001|Overall Study|Lost to Follow-up|0
4458531|NCT00560573|7246208|FG002|Overall Study|Lost to Follow-up|0
4458532|NCT00560573|7246209|FG003|Overall Study|Lost to Follow-up|1
4458533|NCT00560573|7246210|FG004|Overall Study|Lost to Follow-up|1
4458534|NCT00560573|7246211|FG005|Overall Study|Lost to Follow-up|0
4458535|NCT00560573|7246206|FG000|Overall Study|Withdrawal by Subject|0
4458536|NCT00560573|7246207|FG001|Overall Study|Withdrawal by Subject|0
4458537|NCT00560573|7246208|FG002|Overall Study|Withdrawal by Subject|0
4458538|NCT00560573|7246209|FG003|Overall Study|Withdrawal by Subject|1
4458539|NCT00560573|7246210|FG004|Overall Study|Withdrawal by Subject|1
4458540|NCT00560573|7246211|FG005|Overall Study|Withdrawal by Subject|0
4458541|NCT00560573|7246206|FG000|Overall Study|Other|2
4458542|NCT00560573|7246207|FG001|Overall Study|Other|2
4458543|NCT00560573|7246208|FG002|Overall Study|Other|2
4458544|NCT00560573|7246209|FG003|Overall Study|Other|3
4458545|NCT00560573|7246210|FG004|Overall Study|Other|3
4458546|NCT00560573|7246211|FG005|Overall Study|Other|3
4458547|NCT00560573|7246206|FG000|Overall Study|Enrolled, not treated|0
4458548|NCT00560573|7246207|FG001|Overall Study|Enrolled, not treated|0
4458549|NCT00560573|7246208|FG002|Overall Study|Enrolled, not treated|0
4458550|NCT00560573|7246209|FG003|Overall Study|Enrolled, not treated|0
4458551|NCT00560573|7246210|FG004|Overall Study|Enrolled, not treated|1
4458552|NCT00560573|7246211|FG005|Overall Study|Enrolled, not treated|0
4458553|NCT00560703|7246252|FG000|Overall Study|Adverse Event|0
4458554|NCT00560703|7246253|FG001|Overall Study|Adverse Event|2
4458555|NCT00560703|7246252|FG000|Overall Study|Protocol Violation|0
4458556|NCT00560703|7246253|FG001|Overall Study|Protocol Violation|2
4458557|NCT00560703|7246252|FG000|Overall Study|Withdrawal by Subject|0
4458558|NCT00560703|7246253|FG001|Overall Study|Withdrawal by Subject|1
4458559|NCT00560703|7246252|FG000|Overall Study|non-compliance|0
4458560|NCT00560703|7246253|FG001|Overall Study|non-compliance|1
4458561|NCT00560755|7246259|FG000|Overall Study|Protocol Violation|15
4458562|NCT00560755|7246259|FG000|Overall Study|Withdrawal by Subject|26
4458563|NCT00560755|7246259|FG000|Overall Study|Lost to Follow-up|9
4538889|NCT01123655|7361096|FG002|Overall Study|new illness|0
4458564|NCT00560755|7246259|FG000|Overall Study|Adverse Event|8
4458565|NCT00560755|7246259|FG000|Overall Study|Physician Decision|2
4458566|NCT00560794|7246264|FG000|Overall Study|Adverse Event|2
4458567|NCT00560794|7246264|FG000|Overall Study|Patient was not Compliant|1
4458568|NCT00560794|7246264|FG000|Overall Study|Minimal Residual Disease Relapse|1
4458569|NCT00560794|7246264|FG000|Overall Study|Hematological Relapse|1
4458570|NCT00560794|7246264|FG000|Overall Study|Received Bone Marrow Transplant|6
4458571|NCT00560833|7246275|FG000|Overall Study|Adverse Event|16
4458572|NCT00560833|7246276|FG001|Overall Study|Adverse Event|10
4458573|NCT00560833|7246277|FG002|Overall Study|Adverse Event|25
4458574|NCT00560833|7246278|FG003|Overall Study|Adverse Event|23
4458575|NCT00560833|7246279|FG004|Overall Study|Adverse Event|35
4458576|NCT00560833|7246275|FG000|Overall Study|Lost to Follow-up|0
4458577|NCT00560833|7246276|FG001|Overall Study|Lost to Follow-up|0
4458578|NCT00560833|7246277|FG002|Overall Study|Lost to Follow-up|1
4458579|NCT00560833|7246278|FG003|Overall Study|Lost to Follow-up|0
4458580|NCT00560833|7246279|FG004|Overall Study|Lost to Follow-up|0
4458581|NCT00560833|7246275|FG000|Overall Study|Lack of Efficacy|22
4458582|NCT00560833|7246276|FG001|Overall Study|Lack of Efficacy|9
4458583|NCT00560833|7246277|FG002|Overall Study|Lack of Efficacy|6
4458584|NCT00560833|7246278|FG003|Overall Study|Lack of Efficacy|4
4458585|NCT00560833|7246279|FG004|Overall Study|Lack of Efficacy|4
4458586|NCT00560833|7246275|FG000|Overall Study|Participant uncooperative|5
4538890|NCT01123655|7361094|FG000|Overall Study|began prohibitive drug|0
4538891|NCT01123655|7361095|FG001|Overall Study|began prohibitive drug|0
4458587|NCT00560833|7246276|FG001|Overall Study|Participant uncooperative|5
4458588|NCT00560833|7246277|FG002|Overall Study|Participant uncooperative|4
4458589|NCT00560833|7246278|FG003|Overall Study|Participant uncooperative|4
4458590|NCT00560833|7246279|FG004|Overall Study|Participant uncooperative|2
4458591|NCT00560833|7246275|FG000|Overall Study|Other|1
4458592|NCT00560833|7246276|FG001|Overall Study|Other|1
4458593|NCT00560833|7246277|FG002|Overall Study|Other|3
4458594|NCT00560833|7246278|FG003|Overall Study|Other|0
4458595|NCT00560833|7246279|FG004|Overall Study|Other|0
4458596|NCT00560833|7246275|FG000|Overall Study|Never received drug|0
4458597|NCT00560833|7246276|FG001|Overall Study|Never received drug|1
4458598|NCT00560833|7246277|FG002|Overall Study|Never received drug|0
4458599|NCT00560833|7246278|FG003|Overall Study|Never received drug|0
4458600|NCT00560833|7246279|FG004|Overall Study|Never received drug|1
4458601|NCT00560885|7246301|FG000|Overall Study|Death|7
4458602|NCT00560885|7246301|FG000|Overall Study|Withdrawal by Subject|1
4458603|NCT00560937|7246307|FG000|Overall Study|Withdrawal by Subject|0
4458604|NCT00560937|7246308|FG001|Overall Study|Withdrawal by Subject|1
4458605|NCT00560937|7246307|FG000|Overall Study|Physician Decision|1
4458606|NCT00560937|7246308|FG001|Overall Study|Physician Decision|1
4458607|NCT00560950|7246316|FG000|Overall Study|Lost to Follow-up|1
4458608|NCT00560950|7246317|FG001|Overall Study|Lost to Follow-up|0
4458609|NCT00561015|7246340|FG000|Overall Study|Adverse Event|0
4458610|NCT00561015|7246341|FG001|Overall Study|Adverse Event|0
4458611|NCT00561015|7246342|FG002|Overall Study|Adverse Event|0
4458612|NCT00561015|7246343|FG003|Overall Study|Adverse Event|0
4458613|NCT00561015|7246344|FG004|Overall Study|Adverse Event|1
4458614|NCT00561015|7246345|FG005|Overall Study|Adverse Event|0
4458615|NCT00561015|7246340|FG000|Overall Study|Lost to Follow-up|2
4458616|NCT00561015|7246341|FG001|Overall Study|Lost to Follow-up|0
4458617|NCT00561015|7246342|FG002|Overall Study|Lost to Follow-up|0
4458618|NCT00561015|7246343|FG003|Overall Study|Lost to Follow-up|1
4458619|NCT00561015|7246344|FG004|Overall Study|Lost to Follow-up|0
4458620|NCT00561015|7246345|FG005|Overall Study|Lost to Follow-up|3
4458621|NCT00561015|7246340|FG000|Overall Study|Participant non-compliance|2
4458622|NCT00561015|7246341|FG001|Overall Study|Participant non-compliance|0
4458623|NCT00561015|7246342|FG002|Overall Study|Participant non-compliance|0
4458624|NCT00561015|7246343|FG003|Overall Study|Participant non-compliance|0
4458625|NCT00561015|7246344|FG004|Overall Study|Participant non-compliance|0
4458626|NCT00561015|7246345|FG005|Overall Study|Participant non-compliance|0
4458627|NCT00561080|7246366|FG000|Vaccination Period (up to Month 4)|Adverse Event|0
4458628|NCT00561080|7246367|FG001|Vaccination Period (up to Month 4)|Adverse Event|4
4458629|NCT00561080|7246368|FG002|Vaccination Period (up to Month 4)|Adverse Event|6
4458630|NCT00561080|7246366|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0
4458631|NCT00561080|7246367|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2
4458632|NCT00561080|7246368|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3
4458633|NCT00561080|7246366|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0
4458634|NCT00561080|7246367|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1
4458635|NCT00561080|7246368|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3
4458636|NCT00561080|7246366|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3
4458637|NCT00561080|7246367|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16
4538892|NCT01123655|7361096|FG002|Overall Study|began prohibitive drug|1
4458638|NCT00561080|7246368|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13
4458639|NCT00561080|7246366|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0
4458640|NCT00561080|7246367|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1
4458641|NCT00561080|7246368|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0
4458642|NCT00561080|7246366|FG000|Vaccination Period (up to Month 4)|Other|0
4458643|NCT00561080|7246367|FG001|Vaccination Period (up to Month 4)|Other|2
4458644|NCT00561080|7246368|FG002|Vaccination Period (up to Month 4)|Other|1
4458645|NCT00561080|7246366|FG000|12-month Post Last Dose Follow-up|Adverse Event|3
4458646|NCT00561080|7246367|FG001|12-month Post Last Dose Follow-up|Adverse Event|3
4458647|NCT00561080|7246368|FG002|12-month Post Last Dose Follow-up|Adverse Event|1
4458648|NCT00561080|7246366|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0
4458649|NCT00561080|7246367|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0
4458650|NCT00561080|7246368|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4
4458651|NCT00561080|7246366|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2
4458652|NCT00561080|7246367|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6
4612053|NCT01705080|7468767|FG001|Overall Study|Withdrawal by Subject|44
4612054|NCT01705080|7468768|FG002|Overall Study|Withdrawal by Subject|9
4612055|NCT01705145|7468776|FG000|Part B|Adverse Event|1
4612056|NCT01705236|7468792|FG000|Overall Study|Lost to Follow-up|1
4612057|NCT01705236|7468792|FG000|Overall Study|Administrative problems|2
4612058|NCT01705236|7468792|FG000|Overall Study|Unsatisfactory therapeutic effect|3
4612059|NCT01705236|7468792|FG000|Overall Study|Protocol Violation|3
4612060|NCT01705236|7468792|FG000|Overall Study|Abnormal test procedure result(s)|4
4612061|NCT01705236|7468792|FG000|Overall Study|Abnormal laboratory value(s)|4
4612062|NCT01705236|7468792|FG000|Overall Study|Withdrawal by Subject|5
4612063|NCT01705236|7468792|FG000|Overall Study|Adverse Event|5
4612064|NCT01705509|7468809|FG000|Inclusion CPET|Screen Failure|5
4612065|NCT01705509|7468809|FG000|Inclusion CPET|Withdrawal by Subject|2
4612066|NCT01705509|7468809|FG000|CPET w/ Ranexa|Screen Failure|2
4458653|NCT00561080|7246368|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5
4458654|NCT00561080|7246366|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2
4458655|NCT00561080|7246367|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0
4458656|NCT00561080|7246368|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0
4515910|NCT00957021|7327047|FG000|Overall Study|Termination due to language issue|2
4515911|NCT00957229|7327080|FG000|Study Start|Adverse Event|0
4538893|NCT01123889|7361104|FG000|Overall Study|Lost to Follow-up|3
4538894|NCT01123889|7361105|FG001|Overall Study|Lost to Follow-up|1
4612067|NCT01705574|7468815|FG000|Double-Blind Phase|Lost to Follow-up|12
4515912|NCT00957229|7327081|FG001|Study Start|Adverse Event|3
4515913|NCT00957229|7327080|FG000|Study Start|Disease Progression|1
4515914|NCT00957229|7327081|FG001|Study Start|Disease Progression|0
4515915|NCT00957229|7327080|FG000|Reallocated to or Continued Vismodegib|Death|1
4515916|NCT00957229|7327081|FG001|Reallocated to or Continued Vismodegib|Death|1
4612068|NCT01705574|7468816|FG001|Double-Blind Phase|Lost to Follow-up|16
4612069|NCT01705574|7468817|FG002|Double-Blind Phase|Lost to Follow-up|0
4612070|NCT01705574|7468818|FG003|Double-Blind Phase|Lost to Follow-up|0
4612071|NCT01705574|7468815|FG000|Double-Blind Phase|Adverse Event|3
4612072|NCT01705574|7468816|FG001|Double-Blind Phase|Adverse Event|10
4612073|NCT01705574|7468817|FG002|Double-Blind Phase|Adverse Event|0
4612074|NCT01705574|7468818|FG003|Double-Blind Phase|Adverse Event|0
4612075|NCT01705574|7468815|FG000|Double-Blind Phase|Withdrew Consent|8
4612076|NCT01705574|7468816|FG001|Double-Blind Phase|Withdrew Consent|5
4612077|NCT01705574|7468817|FG002|Double-Blind Phase|Withdrew Consent|0
4612078|NCT01705574|7468818|FG003|Double-Blind Phase|Withdrew Consent|0
4612079|NCT01705574|7468815|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4
4612080|NCT01705574|7468816|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5
4612081|NCT01705574|7468817|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0
4612082|NCT01705574|7468818|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0
4612083|NCT01705574|7468815|FG000|Double-Blind Phase|Pregnancy|1
4612084|NCT01705574|7468816|FG001|Double-Blind Phase|Pregnancy|1
4612085|NCT01705574|7468817|FG002|Double-Blind Phase|Pregnancy|0
4612086|NCT01705574|7468818|FG003|Double-Blind Phase|Pregnancy|0
4612087|NCT01705574|7468815|FG000|Double-Blind Phase|Protocol Violation|1
4612088|NCT01705574|7468816|FG001|Double-Blind Phase|Protocol Violation|0
4612089|NCT01705574|7468817|FG002|Double-Blind Phase|Protocol Violation|0
4612090|NCT01705574|7468818|FG003|Double-Blind Phase|Protocol Violation|0
4612091|NCT01705574|7468815|FG000|Double-Blind Phase|Randomized but Not Treated|4
4612092|NCT01705574|7468816|FG001|Double-Blind Phase|Randomized but Not Treated|4
4612093|NCT01705574|7468817|FG002|Double-Blind Phase|Randomized but Not Treated|0
4612094|NCT01705574|7468818|FG003|Double-Blind Phase|Randomized but Not Treated|0
4612095|NCT01705574|7468815|FG000|Open-Label Extension Phase|Lost to Follow-up|6
4612096|NCT01705574|7468816|FG001|Open-Label Extension Phase|Lost to Follow-up|0
4612097|NCT01705574|7468817|FG002|Open-Label Extension Phase|Lost to Follow-up|2
4612098|NCT01705574|7468818|FG003|Open-Label Extension Phase|Lost to Follow-up|2
4612099|NCT01705574|7468815|FG000|Open-Label Extension Phase|Withdrew Consent|4
4612100|NCT01705574|7468816|FG001|Open-Label Extension Phase|Withdrew Consent|0
4612101|NCT01705574|7468817|FG002|Open-Label Extension Phase|Withdrew Consent|4
4612102|NCT01705574|7468818|FG003|Open-Label Extension Phase|Withdrew Consent|1
4612103|NCT01705574|7468815|FG000|Open-Label Extension Phase|Adverse Event|3
4612104|NCT01705574|7468816|FG001|Open-Label Extension Phase|Adverse Event|0
4612105|NCT01705574|7468817|FG002|Open-Label Extension Phase|Adverse Event|0
4612106|NCT01705574|7468818|FG003|Open-Label Extension Phase|Adverse Event|1
4515917|NCT00957229|7327080|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2
4518744|NCT00976209|7331020|FG001|Treatment Period 1|Protocol Violation|0
4458657|NCT00561340|7246389|FG000|Overall Study|refused to drink pediasure|6
4458658|NCT00561340|7246390|FG001|Overall Study|refused to drink pediasure|0
4458659|NCT00561353|7246406|FG000|Overall Study|Subject reached a virologic endpoint|2
4458660|NCT00561353|7246407|FG001|Overall Study|Subject reached a virologic endpoint|1
4458661|NCT00561353|7246408|FG002|Overall Study|Subject reached a virologic endpoint|1
4458662|NCT00561353|7246409|FG003|Overall Study|Subject reached a virologic endpoint|4
4458663|NCT00561353|7246410|FG004|Overall Study|Subject reached a virologic endpoint|1
4458664|NCT00561353|7246411|FG005|Overall Study|Subject reached a virologic endpoint|3
4458665|NCT00561353|7246412|FG006|Overall Study|Subject reached a virologic endpoint|4
4458666|NCT00561353|7246413|FG007|Overall Study|Subject reached a virologic endpoint|4
4458667|NCT00561353|7246414|FG008|Overall Study|Subject reached a virologic endpoint|5
4458668|NCT00561353|7246415|FG009|Overall Study|Subject reached a virologic endpoint|0
4458669|NCT00561353|7246406|FG000|Overall Study|Subject ineligible to continue the trial|0
4458670|NCT00561353|7246407|FG001|Overall Study|Subject ineligible to continue the trial|0
4458671|NCT00561353|7246408|FG002|Overall Study|Subject ineligible to continue the trial|0
4458672|NCT00561353|7246409|FG003|Overall Study|Subject ineligible to continue the trial|0
4458673|NCT00561353|7246410|FG004|Overall Study|Subject ineligible to continue the trial|0
4458674|NCT00561353|7246411|FG005|Overall Study|Subject ineligible to continue the trial|1
4458675|NCT00561353|7246412|FG006|Overall Study|Subject ineligible to continue the trial|1
4538895|NCT01123941|7361122|FG000|Overall Study|Lost to Follow-up|2
4538896|NCT01123941|7361123|FG001|Overall Study|Lost to Follow-up|1
4538897|NCT01123980|7361131|FG000|Overall Study|Adverse Event|1
4538898|NCT01123980|7361132|FG001|Overall Study|Adverse Event|1
4612107|NCT01705574|7468815|FG000|Open-Label Extension Phase|Death|2
4612108|NCT01705574|7468816|FG001|Open-Label Extension Phase|Death|0
4612109|NCT01705574|7468817|FG002|Open-Label Extension Phase|Death|1
4538899|NCT01123980|7361131|FG000|Overall Study|Lack of Efficacy|1
4538900|NCT01123980|7361132|FG001|Overall Study|Lack of Efficacy|0
4612110|NCT01705574|7468818|FG003|Open-Label Extension Phase|Death|0
4612111|NCT01705574|7468815|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0
4612112|NCT01705574|7468816|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0
4612113|NCT01705574|7468817|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1
4612114|NCT01705574|7468818|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0
4612115|NCT01705574|7468815|FG000|Open-Label Extension Phase|Physician Decision|0
4612116|NCT01705574|7468816|FG001|Open-Label Extension Phase|Physician Decision|0
4612117|NCT01705574|7468817|FG002|Open-Label Extension Phase|Physician Decision|2
4612118|NCT01705574|7468818|FG003|Open-Label Extension Phase|Physician Decision|0
4612119|NCT01705574|7468815|FG000|Open-Label Extension Phase|Pregnancy|0
4612120|NCT01705574|7468816|FG001|Open-Label Extension Phase|Pregnancy|0
4612121|NCT01705574|7468817|FG002|Open-Label Extension Phase|Pregnancy|1
4612122|NCT01705574|7468818|FG003|Open-Label Extension Phase|Pregnancy|1
4612123|NCT01705587|7468836|FG000|Overall Study|Withdrawal by Subject|0
4612124|NCT01705587|7468837|FG001|Overall Study|Withdrawal by Subject|1
4612125|NCT01705652|7468845|FG000|Overall Study|Adverse Event|1
4612126|NCT01705652|7468846|FG001|Overall Study|Adverse Event|0
4612127|NCT01705652|7468845|FG000|Overall Study|Withdrawal by Subject|1
4612128|NCT01705652|7468846|FG001|Overall Study|Withdrawal by Subject|2
4612129|NCT01705652|7468845|FG000|Overall Study|non-compliance|1
4612130|NCT01705652|7468846|FG001|Overall Study|non-compliance|1
4612131|NCT01705691|7468854|FG000|Overall Study|Death|1
4612132|NCT01705691|7468855|FG001|Overall Study|Death|2
4612133|NCT01705691|7468854|FG000|Overall Study|Withdrawal by Subject|1
4612134|NCT01705691|7468855|FG001|Overall Study|Withdrawal by Subject|2
4612135|NCT01705691|7468854|FG000|Overall Study|Lost to Follow-up|1
4612136|NCT01705691|7468855|FG001|Overall Study|Lost to Follow-up|1
4612137|NCT01705691|7468854|FG000|Overall Study|Other|0
4612138|NCT01705691|7468855|FG001|Overall Study|Other|1
4612139|NCT01705717|7468863|FG000|Overall Study|Adverse Event|2
4612140|NCT01705717|7468864|FG001|Overall Study|Adverse Event|2
4612141|NCT01705717|7468863|FG000|Overall Study|Lack of Efficacy|0
4612142|NCT01705717|7468864|FG001|Overall Study|Lack of Efficacy|1
4612143|NCT01705717|7468863|FG000|Overall Study|Other|0
4612144|NCT01705717|7468864|FG001|Overall Study|Other|2
4612145|NCT01705730|7468869|FG000|Overall Study|Lack of Efficacy|1
4612146|NCT01705730|7468869|FG000|Overall Study|Adverse Event|3
4458676|NCT00561353|7246413|FG007|Overall Study|Subject ineligible to continue the trial|0
4538901|NCT01123980|7361131|FG000|Overall Study|Physician Decision|0
4538902|NCT01123980|7361132|FG001|Overall Study|Physician Decision|1
4538903|NCT01123980|7361131|FG000|Overall Study|Lost to Follow-up|0
4538904|NCT01123980|7361132|FG001|Overall Study|Lost to Follow-up|6
4612147|NCT01705730|7468869|FG000|Overall Study|Lost to Follow-up|1
4612148|NCT01705730|7468869|FG000|Overall Study|Reason not Specified|4
4612149|NCT01706003|7468884|FG000|Overall Study|Withdrawal by Subject|2
4612150|NCT01706003|7468885|FG001|Overall Study|Withdrawal by Subject|0
4612151|NCT01706003|7468884|FG000|Overall Study|Not scheduled|3
4612152|NCT01706003|7468885|FG001|Overall Study|Not scheduled|0
4612153|NCT01706003|7468884|FG000|Overall Study|Lost to Follow-up|6
4612154|NCT01706003|7468885|FG001|Overall Study|Lost to Follow-up|4
4612155|NCT01706146|7468900|FG000|Overall Study|Withdrawal by Subject|1
4612156|NCT01706146|7468900|FG000|Overall Study|Adverse Event|3
4690356|NCT02561156|7600132|FG009|Part 2|Adverse Event|0
4458677|NCT00561353|7246414|FG008|Overall Study|Subject ineligible to continue the trial|2
4458678|NCT00561353|7246415|FG009|Overall Study|Subject ineligible to continue the trial|1
4458679|NCT00561353|7246406|FG000|Overall Study|Other|1
4458680|NCT00561353|7246407|FG001|Overall Study|Other|0
4458681|NCT00561353|7246408|FG002|Overall Study|Other|1
4458682|NCT00561353|7246409|FG003|Overall Study|Other|0
4458683|NCT00561353|7246410|FG004|Overall Study|Other|0
4458684|NCT00561353|7246411|FG005|Overall Study|Other|2
4458685|NCT00561353|7246412|FG006|Overall Study|Other|0
4458686|NCT00561353|7246413|FG007|Overall Study|Other|0
4458687|NCT00561353|7246414|FG008|Overall Study|Other|0
4538905|NCT01123980|7361131|FG000|Overall Study|Protocol Violation|6
4538906|NCT01123980|7361132|FG001|Overall Study|Protocol Violation|6
4538907|NCT01123980|7361131|FG000|Overall Study|Withdrawal by Subject|5
4538908|NCT01123980|7361132|FG001|Overall Study|Withdrawal by Subject|3
4538909|NCT01123980|7361131|FG000|Overall Study|Unclassified|6
4538910|NCT01123980|7361132|FG001|Overall Study|Unclassified|7
4538911|NCT01124006|7361141|FG000|Overall Study|Withdrawal by Subject|2
4538912|NCT01124006|7361142|FG001|Overall Study|Withdrawal by Subject|2
4538913|NCT01124006|7361143|FG002|Overall Study|Withdrawal by Subject|0
4538914|NCT01124006|7361141|FG000|Overall Study|Lost to Follow-up|1
4538915|NCT01124006|7361142|FG001|Overall Study|Lost to Follow-up|0
4538916|NCT01124006|7361143|FG002|Overall Study|Lost to Follow-up|1
4538917|NCT01124006|7361141|FG000|Overall Study|Other|0
4538918|NCT01124006|7361142|FG001|Overall Study|Other|0
4538919|NCT01124006|7361143|FG002|Overall Study|Other|1
4538920|NCT01124045|7361153|FG000|Overall Study|Lost to Follow-up|0
4538921|NCT01124045|7361154|FG001|Overall Study|Lost to Follow-up|1
4538922|NCT01124045|7361153|FG000|Overall Study|Physician Decision|0
4538923|NCT01124045|7361154|FG001|Overall Study|Physician Decision|2
4538924|NCT01124097|7361164|FG000|Overall Study|Withdrawal by Subject|4
4538925|NCT01124097|7361165|FG001|Overall Study|Withdrawal by Subject|3
4538926|NCT01124097|7361166|FG002|Overall Study|Withdrawal by Subject|2
4538927|NCT01124097|7361167|FG003|Overall Study|Withdrawal by Subject|3
4538928|NCT01124097|7361164|FG000|Overall Study|Lack of Efficacy|2
4538929|NCT01124097|7361165|FG001|Overall Study|Lack of Efficacy|3
4538930|NCT01124097|7361166|FG002|Overall Study|Lack of Efficacy|1
4538931|NCT01124097|7361167|FG003|Overall Study|Lack of Efficacy|3
4538932|NCT01124097|7361164|FG000|Overall Study|Adverse Event|24
4538933|NCT01124097|7361165|FG001|Overall Study|Adverse Event|15
4538934|NCT01124097|7361166|FG002|Overall Study|Adverse Event|15
4538935|NCT01124097|7361167|FG003|Overall Study|Adverse Event|7
4538936|NCT01124097|7361164|FG000|Overall Study|Protocol Violation|2
4538937|NCT01124097|7361165|FG001|Overall Study|Protocol Violation|0
4538938|NCT01124097|7361166|FG002|Overall Study|Protocol Violation|2
4538939|NCT01124097|7361167|FG003|Overall Study|Protocol Violation|1
4538940|NCT01124097|7361164|FG000|Overall Study|Physician Decision|2
4538941|NCT01124097|7361165|FG001|Overall Study|Physician Decision|1
4538942|NCT01124097|7361166|FG002|Overall Study|Physician Decision|0
4538943|NCT01124097|7361167|FG003|Overall Study|Physician Decision|0
4538944|NCT01124149|7361177|FG000|Acute Phase|Withdrawal by Subject|22
4538945|NCT01124149|7361177|FG000|Acute Phase|Adverse Event|21
4538946|NCT01124149|7361177|FG000|Acute Phase|Lack of Efficacy|17
4538947|NCT01124149|7361177|FG000|Acute Phase|Protocol Violation|14
4538948|NCT01124149|7361177|FG000|Acute Phase|Lost to Follow-up|2
4538949|NCT01124149|7361177|FG000|Acute Phase|Prolonged antibiotic therapy|1
4538950|NCT01124149|7361177|FG000|Acute Phase|Sponsor request|1
4538951|NCT01124149|7361177|FG000|Acute Phase|UC symptoms not ameliorated|1
4538952|NCT01124149|7361177|FG000|Acute Phase|Non-compliance|1
4538953|NCT01124149|7361177|FG000|Acute Phase|Low hemoglobin|1
4538954|NCT01124149|7361177|FG000|Acute Phase|Travelling to another country|1
4538955|NCT01124149|7361177|FG000|Acute Phase|Sponsor decision|1
4538956|NCT01124149|7361177|FG000|Maintenance Phase|Lack of Efficacy|40
4538957|NCT01124149|7361177|FG000|Maintenance Phase|Adverse Event|24
4538958|NCT01124149|7361177|FG000|Maintenance Phase|Lost to Follow-up|15
4612157|NCT01706146|7468900|FG000|Overall Study|Developed AF and need for antiplatelets|2
4612158|NCT01706159|7468906|FG000|Overall Study|Withdrawal Criteria|2
4612159|NCT01706159|7468907|FG001|Overall Study|Withdrawal Criteria|1
4612160|NCT01706159|7468906|FG000|Overall Study|Unclassified|6
4612161|NCT01706159|7468907|FG001|Overall Study|Unclassified|1
4612162|NCT01706198|7468915|FG000|Overall Study|Adverse Event|12
4612163|NCT01706198|7468916|FG001|Overall Study|Adverse Event|15
4612164|NCT01706198|7468915|FG000|Overall Study|Protocol Violation|7
4612165|NCT01706198|7468916|FG001|Overall Study|Protocol Violation|5
4538959|NCT01124149|7361177|FG000|Maintenance Phase|Withdrawal by Subject|10
4538960|NCT01124149|7361177|FG000|Maintenance Phase|Protocol Violation|5
4538961|NCT01124149|7361177|FG000|Maintenance Phase|Coordinator error|1
4538962|NCT01124149|7361177|FG000|Maintenance Phase|Non-compliance|1
4538963|NCT01124162|7361186|FG000|First Intervention|Adverse Event|2
4538964|NCT01124162|7361187|FG001|First Intervention|Adverse Event|0
4612166|NCT01706198|7468915|FG000|Overall Study|Other: Subject reached stopping criteria|11
4538965|NCT01124162|7361186|FG000|Washout of 7 Days|Withdrawal by Subject|1
4538966|NCT01124162|7361187|FG001|Washout of 7 Days|Withdrawal by Subject|0
4538967|NCT01124175|7361195|FG000|Washout of 7 Days|Withdrawal by Subject|0
4538968|NCT01124175|7361196|FG001|Washout of 7 Days|Withdrawal by Subject|2
4538969|NCT01124292|7361214|FG000|Overall Study|Lost to Follow-up|2
4458688|NCT00561353|7246415|FG009|Overall Study|Other|0
4458689|NCT00561353|7246406|FG000|Overall Study|Adverse Event|0
4458690|NCT00561353|7246407|FG001|Overall Study|Adverse Event|0
4458691|NCT00561353|7246408|FG002|Overall Study|Adverse Event|0
4458692|NCT00561353|7246409|FG003|Overall Study|Adverse Event|2
4458693|NCT00561353|7246410|FG004|Overall Study|Adverse Event|0
4458694|NCT00561353|7246411|FG005|Overall Study|Adverse Event|0
4458695|NCT00561353|7246412|FG006|Overall Study|Adverse Event|1
4458696|NCT00561353|7246413|FG007|Overall Study|Adverse Event|0
4458697|NCT00561353|7246414|FG008|Overall Study|Adverse Event|0
4458698|NCT00561353|7246415|FG009|Overall Study|Adverse Event|1
4612167|NCT01706198|7468916|FG001|Overall Study|Other: Subject reached stopping criteria|13
4612168|NCT01706198|7468915|FG000|Overall Study|Lost to Follow-up|97
4612169|NCT01706198|7468916|FG001|Overall Study|Lost to Follow-up|93
4612170|NCT01706198|7468915|FG000|Overall Study|Physician Decision|23
4612171|NCT01706198|7468916|FG001|Overall Study|Physician Decision|37
4612172|NCT01706198|7468915|FG000|Overall Study|Withdrawal by Subject|23
4612173|NCT01706198|7468916|FG001|Overall Study|Withdrawal by Subject|31
4612174|NCT01706250|7468922|FG000|Overall Study|Lost to Follow-up|2
4612175|NCT01706328|7468938|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140
4612176|NCT01706328|7468939|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
4612177|NCT01706328|7468940|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
4612178|NCT01706328|7468938|FG000|2-week Run-in Period|Withdrawal by Subject|15
4612179|NCT01706328|7468939|FG001|2-week Run-in Period|Withdrawal by Subject|0
4612180|NCT01706328|7468940|FG002|2-week Run-in Period|Withdrawal by Subject|0
4612181|NCT01706328|7468938|FG000|2-week Run-in Period|Physician Decision|4
4612182|NCT01706328|7468939|FG001|2-week Run-in Period|Physician Decision|0
4612183|NCT01706328|7468940|FG002|2-week Run-in Period|Physician Decision|0
4612184|NCT01706328|7468938|FG000|2-week Run-in Period|Adverse Event|4
4612185|NCT01706328|7468939|FG001|2-week Run-in Period|Adverse Event|0
4612186|NCT01706328|7468940|FG002|2-week Run-in Period|Adverse Event|0
4612187|NCT01706328|7468938|FG000|2-week Run-in Period|Lost to Follow-up|2
4612188|NCT01706328|7468939|FG001|2-week Run-in Period|Lost to Follow-up|0
4612189|NCT01706328|7468940|FG002|2-week Run-in Period|Lost to Follow-up|0
4612190|NCT01706328|7468938|FG000|12-week Double-blind Treatment Period|Adverse Event|0
4612191|NCT01706328|7468939|FG001|12-week Double-blind Treatment Period|Adverse Event|14
4612192|NCT01706328|7468940|FG002|12-week Double-blind Treatment Period|Adverse Event|16
4612193|NCT01706328|7468938|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0
4612194|NCT01706328|7468939|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4
4612195|NCT01706328|7468940|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4
4612196|NCT01706328|7468938|FG000|12-week Double-blind Treatment Period|Protocol Violation|0
4612197|NCT01706328|7468939|FG001|12-week Double-blind Treatment Period|Protocol Violation|4
4612198|NCT01706328|7468940|FG002|12-week Double-blind Treatment Period|Protocol Violation|2
4612199|NCT01706328|7468938|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0
4612200|NCT01706328|7468939|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11
4612201|NCT01706328|7468940|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9
4612202|NCT01706328|7468938|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0
4612203|NCT01706328|7468939|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3
4612204|NCT01706328|7468940|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1
4612205|NCT01706328|7468938|FG000|12-week Double-blind Treatment Period|Physician Decision|0
4612206|NCT01706328|7468939|FG001|12-week Double-blind Treatment Period|Physician Decision|2
4612207|NCT01706328|7468940|FG002|12-week Double-blind Treatment Period|Physician Decision|2
4612208|NCT01706328|7468938|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0
4612209|NCT01706328|7468939|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8
4612210|NCT01706328|7468940|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11
4612211|NCT01706458|7468948|FG000|Overall Study|Physician Decision|3
4612212|NCT01706458|7468949|FG001|Overall Study|Physician Decision|4
4612213|NCT01706536|7468964|FG000|Overall Study|Withdrawal by Subject|1
4612214|NCT01706536|7468965|FG001|Overall Study|Withdrawal by Subject|0
4612215|NCT01706536|7468966|FG002|Overall Study|Withdrawal by Subject|1
4612216|NCT01706536|7468967|FG003|Overall Study|Withdrawal by Subject|0
4612217|NCT01706536|7468968|FG004|Overall Study|Withdrawal by Subject|0
4612218|NCT01706536|7468964|FG000|Overall Study|Adverse Event|2
4612219|NCT01706536|7468965|FG001|Overall Study|Adverse Event|3
4612220|NCT01706536|7468966|FG002|Overall Study|Adverse Event|4
4612221|NCT01706536|7468967|FG003|Overall Study|Adverse Event|3
4612222|NCT01706536|7468968|FG004|Overall Study|Adverse Event|2
4612223|NCT01706536|7468964|FG000|Overall Study|Lack of Efficacy|1
4612224|NCT01706536|7468965|FG001|Overall Study|Lack of Efficacy|0
4612225|NCT01706536|7468966|FG002|Overall Study|Lack of Efficacy|0
4612226|NCT01706536|7468967|FG003|Overall Study|Lack of Efficacy|1
4612227|NCT01706536|7468968|FG004|Overall Study|Lack of Efficacy|0
4612228|NCT01706536|7468964|FG000|Overall Study|non compliance|0
4612229|NCT01706536|7468965|FG001|Overall Study|non compliance|1
4612230|NCT01706536|7468966|FG002|Overall Study|non compliance|0
4612231|NCT01706536|7468967|FG003|Overall Study|non compliance|0
4458699|NCT00561353|7246406|FG000|Overall Study|Lost to Follow-up|2
4458700|NCT00561353|7246407|FG001|Overall Study|Lost to Follow-up|0
4458701|NCT00561353|7246408|FG002|Overall Study|Lost to Follow-up|1
4458702|NCT00561353|7246409|FG003|Overall Study|Lost to Follow-up|0
4458703|NCT00561353|7246410|FG004|Overall Study|Lost to Follow-up|0
4458704|NCT00561353|7246411|FG005|Overall Study|Lost to Follow-up|0
4458705|NCT00561353|7246412|FG006|Overall Study|Lost to Follow-up|0
4458706|NCT00561353|7246413|FG007|Overall Study|Lost to Follow-up|0
4458707|NCT00561353|7246414|FG008|Overall Study|Lost to Follow-up|0
4458708|NCT00561353|7246415|FG009|Overall Study|Lost to Follow-up|0
4458709|NCT00561353|7246406|FG000|Overall Study|Withdrawal by Subject|0
4458710|NCT00561353|7246407|FG001|Overall Study|Withdrawal by Subject|2
4458711|NCT00561353|7246408|FG002|Overall Study|Withdrawal by Subject|0
4458712|NCT00561353|7246409|FG003|Overall Study|Withdrawal by Subject|0
4458713|NCT00561353|7246410|FG004|Overall Study|Withdrawal by Subject|0
4458714|NCT00561353|7246411|FG005|Overall Study|Withdrawal by Subject|0
4458715|NCT00561353|7246412|FG006|Overall Study|Withdrawal by Subject|0
4458716|NCT00561353|7246413|FG007|Overall Study|Withdrawal by Subject|0
4458717|NCT00561353|7246414|FG008|Overall Study|Withdrawal by Subject|0
4458718|NCT00561353|7246415|FG009|Overall Study|Withdrawal by Subject|0
4458719|NCT00561392|7246477|FG000|Overall Study|Adverse Event|38
4458720|NCT00561392|7246477|FG000|Overall Study|Lack of Efficacy|2
4458721|NCT00561392|7246477|FG000|Overall Study|Protocol Violation|1
4458722|NCT00561392|7246477|FG000|Overall Study|Withdrawal by Subject|8
4458723|NCT00561392|7246477|FG000|Overall Study|Administrative problems|4
4458724|NCT00561470|7246500|FG000|Overall Study|Adverse Event|74
4458725|NCT00561470|7246501|FG001|Overall Study|Adverse Event|163
4458726|NCT00561470|7246500|FG000|Overall Study|Disease progression|437
4458727|NCT00561470|7246501|FG001|Overall Study|Disease progression|305
4458728|NCT00561470|7246500|FG000|Overall Study|poor compliance to protocol|4
4458729|NCT00561470|7246501|FG001|Overall Study|poor compliance to protocol|4
4458730|NCT00561470|7246500|FG000|Overall Study|Lost to Follow-up|2
4458731|NCT00561470|7246501|FG001|Overall Study|Lost to Follow-up|0
4458732|NCT00561470|7246500|FG000|Overall Study|Physician Decision|21
4458733|NCT00561470|7246501|FG001|Overall Study|Physician Decision|20
4458734|NCT00561470|7246500|FG000|Overall Study|Consent Withdrawn|2
4458735|NCT00561470|7246501|FG001|Overall Study|Consent Withdrawn|6
4458736|NCT00561470|7246500|FG000|Overall Study|Subject request|43
4458737|NCT00561470|7246501|FG001|Overall Study|Subject request|77
4458738|NCT00561470|7246500|FG000|Overall Study|Metastatic surgery|10
4458739|NCT00561470|7246501|FG001|Overall Study|Metastatic surgery|12
4458740|NCT00561470|7246500|FG000|Overall Study|Unauthorized procedure|3
4458741|NCT00561470|7246501|FG001|Overall Study|Unauthorized procedure|1
4458742|NCT00561470|7246500|FG000|Overall Study|Randomized but not treated|5
4458743|NCT00561470|7246501|FG001|Overall Study|Randomized but not treated|5
4458744|NCT00561470|7246500|FG000|Overall Study|Missed visit window|1
4458745|NCT00561470|7246501|FG001|Overall Study|Missed visit window|4
4458746|NCT00561470|7246500|FG000|Overall Study|Planning surgery|1
4458747|NCT00561470|7246501|FG001|Overall Study|Planning surgery|1
4458748|NCT00561470|7246500|FG000|Overall Study|Ongoing Treatment|11
4458749|NCT00561470|7246501|FG001|Overall Study|Ongoing Treatment|14
4458750|NCT00561574|7246511|FG000|Overall Study|Adverse Event|21
4458751|NCT00561574|7246512|FG001|Overall Study|Adverse Event|24
4458752|NCT00561574|7246511|FG000|Overall Study|Lack of Efficacy|11
4458753|NCT00561574|7246512|FG001|Overall Study|Lack of Efficacy|21
4458754|NCT00561574|7246511|FG000|Overall Study|Withdrawal by Subject|4
4458755|NCT00561574|7246512|FG001|Overall Study|Withdrawal by Subject|4
4458756|NCT00561574|7246511|FG000|Overall Study|Reason Unrelated to Trial|6
4458757|NCT00561574|7246512|FG001|Overall Study|Reason Unrelated to Trial|2
4458758|NCT00561574|7246511|FG000|Overall Study|Lost to Follow-up|1
4458759|NCT00561574|7246512|FG001|Overall Study|Lost to Follow-up|0
4458760|NCT00561574|7246511|FG000|Overall Study|Other|5
4458761|NCT00561574|7246512|FG001|Overall Study|Other|7
4458762|NCT00561652|7246531|FG000|Overall Study|Withdrawal by Subject|0
4458763|NCT00561652|7246532|FG001|Overall Study|Withdrawal by Subject|1
4458764|NCT00561678|7246540|FG000|Overall Study|Withdrawal by Subject|4
4458765|NCT00561678|7246541|FG001|Overall Study|Withdrawal by Subject|3
4458766|NCT00561678|7246540|FG000|Overall Study|surgery cancelled|1
4458767|NCT00561678|7246541|FG001|Overall Study|surgery cancelled|1
4458768|NCT00561678|7246540|FG000|Overall Study|surgery rescheduled to different site|2
4458769|NCT00561678|7246541|FG001|Overall Study|surgery rescheduled to different site|2
4458770|NCT00561678|7246540|FG000|Overall Study|anesthesia provider refusal|1
4458771|NCT00561678|7246541|FG001|Overall Study|anesthesia provider refusal|0
4458772|NCT00561730|7246547|FG000|Overall Study|Adverse Event|2
4458773|NCT00561730|7246547|FG000|Overall Study|Handling of the drug|1
4458774|NCT00561730|7246547|FG000|Overall Study|Lost to Follow-up|5
4458775|NCT00561730|7246547|FG000|Overall Study|Not specified reasons|1
4458776|NCT00561821|7246557|FG000|Overall Study|Not treated|0
4458777|NCT00561821|7246558|FG001|Overall Study|Not treated|0
4458778|NCT00561821|7246559|FG002|Overall Study|Not treated|1
4458779|NCT00561821|7246560|FG003|Overall Study|Not treated|0
4458780|NCT00561821|7246557|FG000|Overall Study|Withdrawal by Subject|0
4458781|NCT00561821|7246558|FG001|Overall Study|Withdrawal by Subject|1
4458782|NCT00561821|7246559|FG002|Overall Study|Withdrawal by Subject|0
4458783|NCT00561821|7246560|FG003|Overall Study|Withdrawal by Subject|2
4458784|NCT00561821|7246557|FG000|Overall Study|Reasons not related to trial|2
4458785|NCT00561821|7246558|FG001|Overall Study|Reasons not related to trial|1
4458786|NCT00561821|7246559|FG002|Overall Study|Reasons not related to trial|0
4458787|NCT00561821|7246560|FG003|Overall Study|Reasons not related to trial|0
4458788|NCT00561821|7246557|FG000|Overall Study|Other (reason not specified)|1
4458789|NCT00561821|7246558|FG001|Overall Study|Other (reason not specified)|1
4458790|NCT00561821|7246559|FG002|Overall Study|Other (reason not specified)|0
4458791|NCT00561821|7246560|FG003|Overall Study|Other (reason not specified)|0
4458792|NCT00561821|7246557|FG000|Overall Study|Adverse Event|2
4458793|NCT00561821|7246558|FG001|Overall Study|Adverse Event|3
4458794|NCT00561821|7246559|FG002|Overall Study|Adverse Event|1
4458795|NCT00561821|7246560|FG003|Overall Study|Adverse Event|1
4458796|NCT00561925|7246577|FG000|14 Day Lead-In Period|Adverse Event|38
4458797|NCT00561925|7246578|FG001|14 Day Lead-In Period|Adverse Event|0
4458798|NCT00561925|7246579|FG002|14 Day Lead-In Period|Adverse Event|0
4458799|NCT00561925|7246580|FG003|14 Day Lead-In Period|Adverse Event|0
4458800|NCT00561925|7246581|FG004|14 Day Lead-In Period|Adverse Event|0
4458801|NCT00561925|7246577|FG000|14 Day Lead-In Period|In/Exclusion criteria|4
4458802|NCT00561925|7246578|FG001|14 Day Lead-In Period|In/Exclusion criteria|0
4458803|NCT00561925|7246579|FG002|14 Day Lead-In Period|In/Exclusion criteria|0
4458804|NCT00561925|7246580|FG003|14 Day Lead-In Period|In/Exclusion criteria|0
4458805|NCT00561925|7246581|FG004|14 Day Lead-In Period|In/Exclusion criteria|0
4612232|NCT01706536|7468968|FG004|Overall Study|non compliance|0
4612233|NCT01706575|7468985|FG000|Overall Study|Participant Withdrew Consent|4
4612234|NCT01706575|7468985|FG000|Overall Study|Lost to Follow-up|2
4612235|NCT01706575|7468985|FG000|Overall Study|Started but not Treated|6
4612236|NCT01706770|7469025|FG000|Overall Study|Lost to Follow-up|1
4612237|NCT01706770|7469026|FG001|Overall Study|Lost to Follow-up|0
4612238|NCT01706770|7469025|FG000|Overall Study|Physician Decision|1
4612239|NCT01706770|7469026|FG001|Overall Study|Physician Decision|0
4612240|NCT01706926|7469040|FG000|Overall Study|Lost to Follow-up|0
4612241|NCT01706926|7469041|FG001|Overall Study|Lost to Follow-up|0
4612242|NCT01706926|7469042|FG002|Overall Study|Lost to Follow-up|1
4612243|NCT01706926|7469043|FG003|Overall Study|Lost to Follow-up|0
4612244|NCT01706926|7469040|FG000|Overall Study|Withdrawal by Subject|2
4612245|NCT01706926|7469041|FG001|Overall Study|Withdrawal by Subject|0
4612246|NCT01706926|7469042|FG002|Overall Study|Withdrawal by Subject|1
4612247|NCT01706926|7469043|FG003|Overall Study|Withdrawal by Subject|2
4612248|NCT01706926|7469040|FG000|Overall Study|Other|4
4612249|NCT01706926|7469041|FG001|Overall Study|Other|4
4612250|NCT01706926|7469042|FG002|Overall Study|Other|4
4612251|NCT01706926|7469043|FG003|Overall Study|Other|3
4612252|NCT01707004|7469080|FG000|Overall Study|Physician Decision|3
4612253|NCT01707030|7469087|FG000|Overall Study|Death|1
4612254|NCT01707030|7469088|FG001|Overall Study|Death|1
4612255|NCT01707030|7469087|FG000|Overall Study|Withdrawal by Subject|2
4612256|NCT01707030|7469088|FG001|Overall Study|Withdrawal by Subject|3
4612257|NCT01707030|7469087|FG000|Overall Study|Lost to Follow-up|8
4612258|NCT01707030|7469088|FG001|Overall Study|Lost to Follow-up|13
4612259|NCT01707147|7469121|FG000|Overall Study|Administered Trajenta prior to contract|5
4612260|NCT01707147|7469121|FG000|Overall Study|Patients who have not taken Trajenta|1
4612261|NCT01707147|7469121|FG000|Overall Study|Follow-up failure|17
4612262|NCT01707147|7469121|FG000|Overall Study|Violated inclusion/exclusion criteria|77
4612263|NCT01707290|7469141|FG000|Overall Study|Adverse event (AE)|1
4612264|NCT01707290|7469142|FG001|Overall Study|Adverse event (AE)|0
4612265|NCT01707290|7469141|FG000|Overall Study|Physician Decision|1
4458806|NCT00561925|7246577|FG000|14 Day Lead-In Period|Lost to Follow-up|4
4458807|NCT00561925|7246578|FG001|14 Day Lead-In Period|Lost to Follow-up|0
4458808|NCT00561925|7246579|FG002|14 Day Lead-In Period|Lost to Follow-up|0
4458809|NCT00561925|7246580|FG003|14 Day Lead-In Period|Lost to Follow-up|0
4458810|NCT00561925|7246581|FG004|14 Day Lead-In Period|Lost to Follow-up|0
4458811|NCT00561925|7246577|FG000|14 Day Lead-In Period|Withdrawal by Subject|4
4458812|NCT00561925|7246578|FG001|14 Day Lead-In Period|Withdrawal by Subject|0
4458813|NCT00561925|7246579|FG002|14 Day Lead-In Period|Withdrawal by Subject|0
4458814|NCT00561925|7246580|FG003|14 Day Lead-In Period|Withdrawal by Subject|0
4458815|NCT00561925|7246581|FG004|14 Day Lead-In Period|Withdrawal by Subject|0
4458816|NCT00561925|7246577|FG000|14 Day Lead-In Period|Other|5
4458817|NCT00561925|7246578|FG001|14 Day Lead-In Period|Other|0
4458818|NCT00561925|7246579|FG002|14 Day Lead-In Period|Other|0
4458819|NCT00561925|7246580|FG003|14 Day Lead-In Period|Other|0
4458820|NCT00561925|7246581|FG004|14 Day Lead-In Period|Other|0
4458821|NCT00561925|7246577|FG000|144-week Double-blind, Double-dummy|Adverse Event|0
4458822|NCT00561925|7246578|FG001|144-week Double-blind, Double-dummy|Adverse Event|48
4458823|NCT00561925|7246579|FG002|144-week Double-blind, Double-dummy|Adverse Event|43
4458824|NCT00561925|7246580|FG003|144-week Double-blind, Double-dummy|Adverse Event|0
4458825|NCT00561925|7246581|FG004|144-week Double-blind, Double-dummy|Adverse Event|0
4458826|NCT00561925|7246577|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0
4458827|NCT00561925|7246578|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15
4458828|NCT00561925|7246579|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9
4458829|NCT00561925|7246580|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0
4458830|NCT00561925|7246581|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0
4612266|NCT01707290|7469142|FG001|Overall Study|Physician Decision|0
4612267|NCT01707290|7469141|FG000|Overall Study|Lost to Follow-up|3
4458831|NCT00561925|7246577|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0
4458832|NCT00561925|7246578|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15
4458833|NCT00561925|7246579|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12
4458834|NCT00561925|7246580|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0
4612268|NCT01707290|7469142|FG001|Overall Study|Lost to Follow-up|0
4612269|NCT01707290|7469141|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4
4612270|NCT01707290|7469142|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0
4612271|NCT01707290|7469141|FG000|Overall Study|Commercial drug available|60
4612272|NCT01707290|7469142|FG001|Overall Study|Commercial drug available|1
4458835|NCT00561925|7246581|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0
4458836|NCT00561925|7246577|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
4458837|NCT00561925|7246578|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19
4458838|NCT00561925|7246579|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7
4458839|NCT00561925|7246580|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
4458840|NCT00561925|7246581|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
4458841|NCT00561925|7246577|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0
4458842|NCT00561925|7246578|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36
4458843|NCT00561925|7246579|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33
4458844|NCT00561925|7246580|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0
4458845|NCT00561925|7246581|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0
4458846|NCT00561925|7246577|FG000|144-week Double-blind, Double-dummy|Pregnancy|0
4458847|NCT00561925|7246578|FG001|144-week Double-blind, Double-dummy|Pregnancy|1
4458848|NCT00561925|7246579|FG002|144-week Double-blind, Double-dummy|Pregnancy|9
4458849|NCT00561925|7246580|FG003|144-week Double-blind, Double-dummy|Pregnancy|0
4458850|NCT00561925|7246581|FG004|144-week Double-blind, Double-dummy|Pregnancy|0
4458851|NCT00561925|7246577|FG000|144-week Double-blind, Double-dummy|Death|0
4458852|NCT00561925|7246578|FG001|144-week Double-blind, Double-dummy|Death|6
4458853|NCT00561925|7246579|FG002|144-week Double-blind, Double-dummy|Death|3
4458854|NCT00561925|7246580|FG003|144-week Double-blind, Double-dummy|Death|0
4458855|NCT00561925|7246581|FG004|144-week Double-blind, Double-dummy|Death|0
4458856|NCT00561925|7246577|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0
4458857|NCT00561925|7246578|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2
4458858|NCT00561925|7246579|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0
4458859|NCT00561925|7246580|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0
4458860|NCT00561925|7246581|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0
4458861|NCT00561925|7246577|FG000|144-week Double-blind, Double-dummy|Other|0
4458862|NCT00561925|7246578|FG001|144-week Double-blind, Double-dummy|Other|8
4458863|NCT00561925|7246579|FG002|144-week Double-blind, Double-dummy|Other|11
4458864|NCT00561925|7246580|FG003|144-week Double-blind, Double-dummy|Other|0
4458865|NCT00561925|7246581|FG004|144-week Double-blind, Double-dummy|Other|0
4458866|NCT00561925|7246577|FG000|Open-Label Extension Period|Declined entry into extension period|0
4458867|NCT00561925|7246578|FG001|Open-Label Extension Period|Declined entry into extension period|0
4458868|NCT00561925|7246579|FG002|Open-Label Extension Period|Declined entry into extension period|0
4458869|NCT00561925|7246580|FG003|Open-Label Extension Period|Declined entry into extension period|43
4458870|NCT00561925|7246581|FG004|Open-Label Extension Period|Declined entry into extension period|50
4458871|NCT00561951|7246602|FG000|Overall Study|Adverse Event|11
4458872|NCT00561951|7246603|FG001|Overall Study|Adverse Event|14
4458873|NCT00561951|7246604|FG002|Overall Study|Adverse Event|14
4458874|NCT00561951|7246602|FG000|Overall Study|Lack of Efficacy|5
4458875|NCT00561951|7246603|FG001|Overall Study|Lack of Efficacy|3
4458876|NCT00561951|7246604|FG002|Overall Study|Lack of Efficacy|2
4458877|NCT00561951|7246602|FG000|Overall Study|Lost to Follow-up|1
4458878|NCT00561951|7246603|FG001|Overall Study|Lost to Follow-up|1
4458879|NCT00561951|7246604|FG002|Overall Study|Lost to Follow-up|0
4458880|NCT00561951|7246602|FG000|Overall Study|Withdrawal by Subject|10
4458881|NCT00561951|7246603|FG001|Overall Study|Withdrawal by Subject|9
4458882|NCT00561951|7246604|FG002|Overall Study|Withdrawal by Subject|10
4458883|NCT00561951|7246602|FG000|Overall Study|Protocol Violation|4
4458884|NCT00561951|7246603|FG001|Overall Study|Protocol Violation|3
4458885|NCT00561951|7246604|FG002|Overall Study|Protocol Violation|4
4458886|NCT00561951|7246602|FG000|Overall Study|Physician Decision|1
4458887|NCT00561951|7246603|FG001|Overall Study|Physician Decision|0
4458888|NCT00561951|7246604|FG002|Overall Study|Physician Decision|0
4458889|NCT00561951|7246602|FG000|Overall Study|Pregnancy|0
4458890|NCT00561951|7246603|FG001|Overall Study|Pregnancy|1
4458891|NCT00561951|7246604|FG002|Overall Study|Pregnancy|0
4458892|NCT00561951|7246602|FG000|Overall Study|Meet Withdrawal Criterion|0
4458893|NCT00561951|7246603|FG001|Overall Study|Meet Withdrawal Criterion|1
4458894|NCT00561951|7246604|FG002|Overall Study|Meet Withdrawal Criterion|1
4458895|NCT00561951|7246602|FG000|Overall Study|Adverse Event Occured Before Treatment|1
4458896|NCT00561951|7246603|FG001|Overall Study|Adverse Event Occured Before Treatment|2
4458897|NCT00561951|7246604|FG002|Overall Study|Adverse Event Occured Before Treatment|1
4458898|NCT00561977|7246615|FG000|Overall Study|Withdrawal by Subject|0
4458899|NCT00561977|7246616|FG001|Overall Study|Withdrawal by Subject|2
4458900|NCT00561977|7246617|FG002|Overall Study|Withdrawal by Subject|1
4458901|NCT00561977|7246615|FG000|Overall Study|Pregnancy|0
4612273|NCT01707290|7469141|FG000|Overall Study|Other unspecified|17
4458902|NCT00561977|7246616|FG001|Overall Study|Pregnancy|1
4458903|NCT00561977|7246617|FG002|Overall Study|Pregnancy|1
4458904|NCT00562094|7246625|FG000|Overall Study|Lost to Follow-up|62
4458905|NCT00562120|7246633|FG000|First Intervention Period|Adverse Event|1
4458906|NCT00562120|7246634|FG001|First Intervention Period|Adverse Event|0
4458907|NCT00562120|7246635|FG002|First Intervention Period|Adverse Event|0
4458908|NCT00562120|7246636|FG003|First Intervention Period|Adverse Event|0
4458909|NCT00562120|7246633|FG000|First Intervention Period|Randomized but not Treated|1
4458910|NCT00562120|7246634|FG001|First Intervention Period|Randomized but not Treated|0
4458911|NCT00562120|7246635|FG002|First Intervention Period|Randomized but not Treated|0
4458912|NCT00562120|7246636|FG003|First Intervention Period|Randomized but not Treated|0
4458913|NCT00562159|7246648|FG000|Overall Study|Adverse Event|11
4458914|NCT00562159|7246649|FG001|Overall Study|Adverse Event|8
4458915|NCT00562159|7246648|FG000|Overall Study|Lost to Follow-up|5
4458916|NCT00562159|7246649|FG001|Overall Study|Lost to Follow-up|4
4458917|NCT00562159|7246648|FG000|Overall Study|Withdrawal by Subject|9
4458918|NCT00562159|7246649|FG001|Overall Study|Withdrawal by Subject|8
4458919|NCT00562159|7246648|FG000|Overall Study|Protocol Violation|12
4458920|NCT00562159|7246649|FG001|Overall Study|Protocol Violation|12
4458921|NCT00562159|7246648|FG000|Overall Study|Did not meet protocol eligibility|1
4458922|NCT00562159|7246649|FG001|Overall Study|Did not meet protocol eligibility|1
4458923|NCT00562302|7246658|FG000|Overall Study|Lost to Follow-up|3
4458924|NCT00562302|7246659|FG001|Overall Study|Lost to Follow-up|3
4458925|NCT00562302|7246658|FG000|Overall Study|Adverse Event|0
4458926|NCT00562302|7246659|FG001|Overall Study|Adverse Event|6
4458927|NCT00562302|7246658|FG000|Overall Study|Non-compliance|1
4458928|NCT00562302|7246659|FG001|Overall Study|Non-compliance|2
4458929|NCT00562302|7246658|FG000|Overall Study|Withdrawal by Subject|7
4458930|NCT00562302|7246659|FG001|Overall Study|Withdrawal by Subject|8
4458931|NCT00562302|7246658|FG000|Overall Study|Death|1
4458932|NCT00562302|7246659|FG001|Overall Study|Death|2
4458933|NCT00562302|7246658|FG000|Overall Study|Lung resection prior to study completion|7
4458934|NCT00562302|7246659|FG001|Overall Study|Lung resection prior to study completion|7
4458935|NCT00562302|7246658|FG000|Overall Study|Not stated|1
4458936|NCT00562302|7246659|FG001|Overall Study|Not stated|4
4458937|NCT00562354|7246677|FG000|Overall Study|Physician Decision|0
4458938|NCT00562354|7246678|FG001|Overall Study|Physician Decision|1
4458939|NCT00562354|7246677|FG000|Overall Study|Lost to Follow-up|0
4458940|NCT00562354|7246678|FG001|Overall Study|Lost to Follow-up|1
4458941|NCT00562484|7246688|FG000|Overall Study|Adverse Event|6
4458942|NCT00562484|7246689|FG001|Overall Study|Adverse Event|1
4458943|NCT00562484|7246688|FG000|Overall Study|Protocol Violation|11
4458944|NCT00562484|7246689|FG001|Overall Study|Protocol Violation|2
4458945|NCT00562484|7246688|FG000|Overall Study|Withdrawal by Subject|12
4458946|NCT00562484|7246689|FG001|Overall Study|Withdrawal by Subject|9
4458947|NCT00562484|7246688|FG000|Overall Study|Moved away from the study area|20
4458948|NCT00562484|7246689|FG001|Overall Study|Moved away from the study area|9
4458949|NCT00562484|7246688|FG000|Overall Study|Lost to Follow-up|132
4458950|NCT00562484|7246689|FG001|Overall Study|Lost to Follow-up|71
4458951|NCT00562484|7246688|FG000|Overall Study|Reason not provided or not specified|25
4458952|NCT00562484|7246689|FG001|Overall Study|Reason not provided or not specified|12
4458953|NCT00562588|7246697|FG000|Overall Study|Adverse Event|40
4458954|NCT00562588|7246698|FG001|Overall Study|Adverse Event|58
4458955|NCT00562588|7246697|FG000|Overall Study|Protocol Violation|30
4458956|NCT00562588|7246698|FG001|Overall Study|Protocol Violation|26
4458957|NCT00562588|7246697|FG000|Overall Study|Lost to Follow-up|12
4458958|NCT00562588|7246698|FG001|Overall Study|Lost to Follow-up|4
4458959|NCT00562588|7246697|FG000|Overall Study|Withdrawal by Subject|10
4458960|NCT00562588|7246698|FG001|Overall Study|Withdrawal by Subject|9
4458961|NCT00562588|7246697|FG000|Overall Study|Other|0
4458962|NCT00562588|7246698|FG001|Overall Study|Other|2
4458963|NCT00562627|7246707|FG000|Overall Study|Protocol Violation|1
4458964|NCT00562627|7246708|FG001|Overall Study|Protocol Violation|1
4458965|NCT00562627|7246709|FG002|Overall Study|Protocol Violation|1
4458966|NCT00562718|7246717|FG000|Overall Study|Death|1
4458967|NCT00562718|7246717|FG000|Overall Study|Withdrawal by Subject|3
4458968|NCT00562718|7246717|FG000|Overall Study|Adverse Event|4
4458969|NCT00562718|7246717|FG000|Overall Study|Lack of Efficacy|2
4458970|NCT00562718|7246717|FG000|Overall Study|not stated|1
4458971|NCT00562861|7246723|FG000|Overall Study|Adverse Event|1
4458972|NCT00562861|7246724|FG001|Overall Study|Adverse Event|1
4458973|NCT00562861|7246723|FG000|Overall Study|Lack of Efficacy|5
4458974|NCT00562861|7246724|FG001|Overall Study|Lack of Efficacy|5
4458975|NCT00562861|7246723|FG000|Overall Study|noncompliance, moved|7
4458976|NCT00562861|7246724|FG001|Overall Study|noncompliance, moved|2
4458977|NCT00562861|7246723|FG000|Overall Study|Lost to Follow-up|7
4458978|NCT00562861|7246724|FG001|Overall Study|Lost to Follow-up|3
4458979|NCT00562965|7246732|FG000|Overall Study|Withdrawal by Subject|0
4458980|NCT00562965|7246733|FG001|Overall Study|Withdrawal by Subject|1
4458981|NCT00562965|7246732|FG000|Overall Study|Death|2
4458982|NCT00562965|7246733|FG001|Overall Study|Death|4
4458983|NCT00562965|7246732|FG000|Overall Study|Lost to Follow-up|1
4458984|NCT00562965|7246733|FG001|Overall Study|Lost to Follow-up|0
4458985|NCT00562965|7246732|FG000|Overall Study|Other|0
4458986|NCT00562965|7246733|FG001|Overall Study|Other|1
4458987|NCT00562978|7246741|FG000|Overall Study|Patient had imaging dose only|1
4458988|NCT00562978|7246742|FG001|Overall Study|Patient had imaging dose only|11
4458989|NCT00563186|7246750|FG000|Overall Study|LOS<48 hours|97
4458990|NCT00563186|7246751|FG001|Overall Study|LOS<48 hours|74
4458991|NCT00563186|7246750|FG000|Overall Study|Incomplete data|1
4458992|NCT00563186|7246751|FG001|Overall Study|Incomplete data|1
4458993|NCT00563316|7246771|FG000|Overall Study|Adverse Event|2
4458994|NCT00563316|7246771|FG000|Overall Study|Physician Decision|1
4458995|NCT00563316|7246771|FG000|Overall Study|Lost to Follow-up|2
4458996|NCT00563316|7246771|FG000|Overall Study|Death|1
4458997|NCT00563316|7246771|FG000|Overall Study|On-going in study as of 16 July 2009.|5
4458998|NCT00563316|7246771|FG000|Overall Study|Other|1
4458999|NCT00563368|7246786|FG000|Overall Study|Lost to Follow-up|14
4459000|NCT00563368|7246787|FG001|Overall Study|Lost to Follow-up|14
4459001|NCT00563368|7246788|FG002|Overall Study|Lost to Follow-up|12
4612274|NCT01707290|7469142|FG001|Overall Study|Other unspecified|0
4612275|NCT01707667|7469192|FG000|Period 1|expulsion of colonic sensor catheter|1
4612276|NCT01707667|7469193|FG001|Period 1|expulsion of colonic sensor catheter|0
4612277|NCT01707693|7469201|FG000|Overall Study Allocation|Withdrawal by Subject|9
4612278|NCT01707693|7469202|FG001|Overall Study Allocation|Withdrawal by Subject|5
4612279|NCT01707693|7469201|FG000|Overall Study Allocation|Protocol Violation|4
4612280|NCT01707693|7469202|FG001|Overall Study Allocation|Protocol Violation|3
4612281|NCT01707693|7469201|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0
4612282|NCT01707693|7469202|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3
4612283|NCT01707693|7469201|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0
4612284|NCT01707693|7469202|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2
4612285|NCT01707992|7469212|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8
4612286|NCT01707992|7469213|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13
4612287|NCT01707992|7469214|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9
4612288|NCT01707992|7469215|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0
4612289|NCT01707992|7469216|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0
4612290|NCT01707992|7469217|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0
4612291|NCT01707992|7469212|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10
4612292|NCT01707992|7469213|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3
4612293|NCT01707992|7469214|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2
4612294|NCT01707992|7469215|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0
4612295|NCT01707992|7469216|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0
4612296|NCT01707992|7469217|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0
4612297|NCT01707992|7469212|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88
4612298|NCT01707992|7469213|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68
4612299|NCT01707992|7469214|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154
4612300|NCT01707992|7469215|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0
4612301|NCT01707992|7469216|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0
4612302|NCT01707992|7469217|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0
4612303|NCT01707992|7469212|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1
4612304|NCT01707992|7469213|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
4612305|NCT01707992|7469214|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
4612306|NCT01707992|7469215|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
4612307|NCT01707992|7469216|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
4612308|NCT01707992|7469217|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
4612309|NCT01707992|7469212|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12
4612310|NCT01707992|7469213|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5
4612311|NCT01707992|7469214|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9
4612312|NCT01707992|7469215|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0
4612313|NCT01707992|7469216|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0
4612314|NCT01707992|7469217|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0
4612315|NCT01707992|7469212|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10
4612316|NCT01707992|7469213|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4
4612317|NCT01707992|7469214|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9
4612318|NCT01707992|7469215|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0
4612319|NCT01707992|7469216|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0
4612320|NCT01707992|7469217|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0
4612321|NCT01707992|7469212|FG000|Placebo-Controlled Phase (24 Months)|Death|2
4612322|NCT01707992|7469213|FG001|Placebo-Controlled Phase (24 Months)|Death|1
4612323|NCT01707992|7469214|FG002|Placebo-Controlled Phase (24 Months)|Death|1
4612324|NCT01707992|7469215|FG003|Placebo-Controlled Phase (24 Months)|Death|0
4612325|NCT01707992|7469216|FG004|Placebo-Controlled Phase (24 Months)|Death|0
4612326|NCT01707992|7469217|FG005|Placebo-Controlled Phase (24 Months)|Death|0
4612327|NCT01707992|7469212|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2
4690357|NCT02561156|7600133|FG010|Part 2|Adverse Event|0
4459002|NCT00563368|7246789|FG003|Overall Study|Lost to Follow-up|6
4459003|NCT00563368|7246790|FG004|Overall Study|Lost to Follow-up|9
4459004|NCT00563368|7246791|FG005|Overall Study|Lost to Follow-up|8
4459005|NCT00563368|7246792|FG006|Overall Study|Lost to Follow-up|9
4459006|NCT00563368|7246786|FG000|Overall Study|Adverse Event|3
4459007|NCT00563368|7246787|FG001|Overall Study|Adverse Event|4
4612328|NCT01707992|7469213|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1
4612329|NCT01707992|7469214|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6
4612330|NCT01707992|7469215|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0
4612331|NCT01707992|7469216|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0
4612332|NCT01707992|7469217|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0
4612333|NCT01707992|7469212|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11
4612334|NCT01707992|7469213|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9
4612335|NCT01707992|7469214|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10
4612336|NCT01707992|7469215|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0
4612337|NCT01707992|7469216|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0
4612338|NCT01707992|7469217|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0
4612339|NCT01707992|7469212|FG000|Active Treatment Phase (24 Months)|Adverse Event|0
4612340|NCT01707992|7469213|FG001|Active Treatment Phase (24 Months)|Adverse Event|0
4612341|NCT01707992|7469214|FG002|Active Treatment Phase (24 Months)|Adverse Event|0
4612342|NCT01707992|7469215|FG003|Active Treatment Phase (24 Months)|Adverse Event|4
4612343|NCT01707992|7469216|FG004|Active Treatment Phase (24 Months)|Adverse Event|1
4612344|NCT01707992|7469217|FG005|Active Treatment Phase (24 Months)|Adverse Event|0
4612345|NCT01707992|7469212|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0
4612346|NCT01707992|7469213|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0
4612347|NCT01707992|7469214|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0
4612348|NCT01707992|7469215|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3
4612349|NCT01707992|7469216|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1
4612350|NCT01707992|7469217|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2
4612351|NCT01707992|7469212|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0
4612352|NCT01707992|7469213|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0
4612353|NCT01707992|7469214|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0
4612354|NCT01707992|7469215|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58
4612355|NCT01707992|7469216|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220
4612356|NCT01707992|7469217|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32
4612357|NCT01707992|7469212|FG000|Active Treatment Phase (24 Months)|Pregnancy|0
4612358|NCT01707992|7469213|FG001|Active Treatment Phase (24 Months)|Pregnancy|0
4612359|NCT01707992|7469214|FG002|Active Treatment Phase (24 Months)|Pregnancy|0
4612360|NCT01707992|7469215|FG003|Active Treatment Phase (24 Months)|Pregnancy|2
4612361|NCT01707992|7469216|FG004|Active Treatment Phase (24 Months)|Pregnancy|5
4612362|NCT01707992|7469217|FG005|Active Treatment Phase (24 Months)|Pregnancy|2
4612363|NCT01707992|7469212|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0
4612364|NCT01707992|7469213|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0
4612365|NCT01707992|7469214|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0
4612366|NCT01707992|7469215|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5
4612367|NCT01707992|7469216|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11
4612368|NCT01707992|7469217|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1
4612369|NCT01707992|7469212|FG000|Active Treatment Phase (24 Months)|Death|0
4612370|NCT01707992|7469213|FG001|Active Treatment Phase (24 Months)|Death|0
4612371|NCT01707992|7469214|FG002|Active Treatment Phase (24 Months)|Death|0
4612372|NCT01707992|7469215|FG003|Active Treatment Phase (24 Months)|Death|2
4612373|NCT01707992|7469216|FG004|Active Treatment Phase (24 Months)|Death|0
4612374|NCT01707992|7469217|FG005|Active Treatment Phase (24 Months)|Death|0
4612375|NCT01707992|7469212|FG000|Active Treatment Phase (24 Months)|Other than specified|0
4612376|NCT01707992|7469213|FG001|Active Treatment Phase (24 Months)|Other than specified|0
4612377|NCT01707992|7469214|FG002|Active Treatment Phase (24 Months)|Other than specified|0
4612378|NCT01707992|7469215|FG003|Active Treatment Phase (24 Months)|Other than specified|1
4612379|NCT01707992|7469216|FG004|Active Treatment Phase (24 Months)|Other than specified|5
4612380|NCT01707992|7469217|FG005|Active Treatment Phase (24 Months)|Other than specified|2
4612381|NCT01707992|7469212|FG000|Active Treatment Phase (24 Months)|Noncompliance|0
4612382|NCT01707992|7469213|FG001|Active Treatment Phase (24 Months)|Noncompliance|0
4612383|NCT01707992|7469214|FG002|Active Treatment Phase (24 Months)|Noncompliance|0
4612384|NCT01707992|7469215|FG003|Active Treatment Phase (24 Months)|Noncompliance|0
4612385|NCT01707992|7469216|FG004|Active Treatment Phase (24 Months)|Noncompliance|4
4612386|NCT01707992|7469217|FG005|Active Treatment Phase (24 Months)|Noncompliance|2
4612387|NCT01707992|7469212|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0
4612388|NCT01707992|7469213|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0
4612389|NCT01707992|7469214|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0
4612390|NCT01707992|7469215|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809
4612391|NCT01707992|7469216|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243
4612392|NCT01707992|7469217|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174
4612393|NCT01707992|7469212|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
4459008|NCT00563368|7246788|FG002|Overall Study|Adverse Event|5
4612394|NCT01707992|7469213|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
4612395|NCT01707992|7469214|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
4538970|NCT01124292|7361215|FG001|Overall Study|Lost to Follow-up|4
4538971|NCT01124292|7361216|FG002|Overall Study|Lost to Follow-up|3
4459009|NCT00563368|7246789|FG003|Overall Study|Adverse Event|9
4459010|NCT00563368|7246790|FG004|Overall Study|Adverse Event|6
4459011|NCT00563368|7246791|FG005|Overall Study|Adverse Event|10
4459012|NCT00563368|7246792|FG006|Overall Study|Adverse Event|17
4459013|NCT00563368|7246786|FG000|Overall Study|Withdrawal by Subject|11
4459014|NCT00563368|7246787|FG001|Overall Study|Withdrawal by Subject|6
4459015|NCT00563368|7246788|FG002|Overall Study|Withdrawal by Subject|5
4459016|NCT00563368|7246789|FG003|Overall Study|Withdrawal by Subject|7
4459017|NCT00563368|7246790|FG004|Overall Study|Withdrawal by Subject|8
4459018|NCT00563368|7246791|FG005|Overall Study|Withdrawal by Subject|5
4459019|NCT00563368|7246792|FG006|Overall Study|Withdrawal by Subject|4
4459020|NCT00563368|7246786|FG000|Overall Study|protocol non-compliance|1
4459021|NCT00563368|7246787|FG001|Overall Study|protocol non-compliance|1
4459022|NCT00563368|7246788|FG002|Overall Study|protocol non-compliance|2
4459023|NCT00563368|7246789|FG003|Overall Study|protocol non-compliance|1
4459024|NCT00563368|7246790|FG004|Overall Study|protocol non-compliance|0
4459025|NCT00563368|7246791|FG005|Overall Study|protocol non-compliance|1
4459026|NCT00563368|7246792|FG006|Overall Study|protocol non-compliance|3
4459027|NCT00563368|7246786|FG000|Overall Study|Pregnancy|1
4538972|NCT01124292|7361214|FG000|Overall Study|Physician Decision|0
4538973|NCT01124292|7361215|FG001|Overall Study|Physician Decision|3
4538974|NCT01124292|7361216|FG002|Overall Study|Physician Decision|2
4538975|NCT01124292|7361214|FG000|Overall Study|Withdrawal by Subject|0
4538976|NCT01124292|7361215|FG001|Overall Study|Withdrawal by Subject|6
4612396|NCT01707992|7469215|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
4690358|NCT02561156|7600134|FG011|Part 2|Adverse Event|1
4690359|NCT02561156|7600135|FG012|Part 2|Adverse Event|0
4690360|NCT02561195|7600185|FG000|Vaccination 1 to 3|Adverse Event|4
4690361|NCT02561195|7600186|FG001|Vaccination 1 to 3|Adverse Event|5
4690362|NCT02561195|7600187|FG002|Vaccination 1 to 3|Adverse Event|0
4690363|NCT02561195|7600188|FG003|Vaccination 1 to 3|Adverse Event|3
4690364|NCT02561195|7600189|FG004|Vaccination 1 to 3|Adverse Event|4
4690365|NCT02561195|7600190|FG005|Vaccination 1 to 3|Adverse Event|0
4690366|NCT02561195|7600191|FG006|Vaccination 1 to 3|Adverse Event|0
4690367|NCT02561195|7600192|FG007|Vaccination 1 to 3|Adverse Event|0
4690368|NCT02561195|7600193|FG008|Vaccination 1 to 3|Adverse Event|0
4690369|NCT02561195|7600194|FG009|Vaccination 1 to 3|Adverse Event|0
4690370|NCT02561195|7600195|FG010|Vaccination 1 to 3|Adverse Event|0
4690371|NCT02561195|7600196|FG011|Vaccination 1 to 3|Adverse Event|0
4690372|NCT02561195|7600197|FG012|Vaccination 1 to 3|Adverse Event|0
4690373|NCT02561195|7600198|FG013|Vaccination 1 to 3|Adverse Event|0
4690374|NCT02561195|7600185|FG000|Vaccination 1 to 3|Lost to Follow-up|3
4690375|NCT02561195|7600186|FG001|Vaccination 1 to 3|Lost to Follow-up|4
4690376|NCT02561195|7600187|FG002|Vaccination 1 to 3|Lost to Follow-up|0
4690377|NCT02561195|7600188|FG003|Vaccination 1 to 3|Lost to Follow-up|2
4690378|NCT02561195|7600189|FG004|Vaccination 1 to 3|Lost to Follow-up|3
4690379|NCT02561195|7600190|FG005|Vaccination 1 to 3|Lost to Follow-up|3
4690380|NCT02561195|7600191|FG006|Vaccination 1 to 3|Lost to Follow-up|0
4690381|NCT02561195|7600192|FG007|Vaccination 1 to 3|Lost to Follow-up|0
4690382|NCT02561195|7600193|FG008|Vaccination 1 to 3|Lost to Follow-up|0
4690383|NCT02561195|7600194|FG009|Vaccination 1 to 3|Lost to Follow-up|0
4690384|NCT02561195|7600195|FG010|Vaccination 1 to 3|Lost to Follow-up|0
4459028|NCT00563368|7246787|FG001|Overall Study|Pregnancy|0
4538977|NCT01124292|7361216|FG002|Overall Study|Withdrawal by Subject|2
4538978|NCT01124292|7361214|FG000|Overall Study|medical issue unrelated to the study|0
4538979|NCT01124292|7361215|FG001|Overall Study|medical issue unrelated to the study|0
4538980|NCT01124292|7361216|FG002|Overall Study|medical issue unrelated to the study|2
4538981|NCT01124292|7361214|FG000|Overall Study|piercing track closed|0
4538982|NCT01124292|7361215|FG001|Overall Study|piercing track closed|2
4538983|NCT01124292|7361216|FG002|Overall Study|piercing track closed|1
4538984|NCT01124422|7361242|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5
4538985|NCT01124422|7361243|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0
4538986|NCT01124422|7361244|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0
4538987|NCT01124422|7361242|FG000|4-Week Open-label Run-in Phase|Adverse Event|7
4538988|NCT01124422|7361243|FG001|4-Week Open-label Run-in Phase|Adverse Event|0
4538989|NCT01124422|7361244|FG002|4-Week Open-label Run-in Phase|Adverse Event|0
4538990|NCT01124422|7361242|FG000|4-Week Open-label Run-in Phase|Physician Decision|4
4538991|NCT01124422|7361243|FG001|4-Week Open-label Run-in Phase|Physician Decision|0
4538992|NCT01124422|7361244|FG002|4-Week Open-label Run-in Phase|Physician Decision|0
4538993|NCT01124422|7361242|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1
4538994|NCT01124422|7361243|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0
4538995|NCT01124422|7361244|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0
4690385|NCT02561195|7600196|FG011|Vaccination 1 to 3|Lost to Follow-up|0
4459029|NCT00563368|7246788|FG002|Overall Study|Pregnancy|1
4459030|NCT00563368|7246789|FG003|Overall Study|Pregnancy|2
4459031|NCT00563368|7246790|FG004|Overall Study|Pregnancy|1
4459032|NCT00563368|7246791|FG005|Overall Study|Pregnancy|2
4459033|NCT00563368|7246792|FG006|Overall Study|Pregnancy|0
4518745|NCT00976209|7331019|FG000|Treatment Period 1|Lost to Follow-up|2
4459034|NCT00563368|7246786|FG000|Overall Study|requirement for restricted medication|0
4459035|NCT00563368|7246787|FG001|Overall Study|requirement for restricted medication|0
4459036|NCT00563368|7246788|FG002|Overall Study|requirement for restricted medication|2
4459037|NCT00563368|7246789|FG003|Overall Study|requirement for restricted medication|0
4459038|NCT00563368|7246790|FG004|Overall Study|requirement for restricted medication|0
4459039|NCT00563368|7246791|FG005|Overall Study|requirement for restricted medication|0
4459040|NCT00563368|7246792|FG006|Overall Study|requirement for restricted medication|0
4459041|NCT00563368|7246786|FG000|Overall Study|Other|5
4459042|NCT00563368|7246787|FG001|Overall Study|Other|5
4459043|NCT00563368|7246788|FG002|Overall Study|Other|3
4538996|NCT01124422|7361242|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61
4538997|NCT01124422|7361243|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0
4538998|NCT01124422|7361244|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0
4538999|NCT01124422|7361242|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5
4612397|NCT01707992|7469216|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4
4612398|NCT01707992|7469217|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
4612399|NCT01708161|7469247|FG000|Overall Study|Adverse Event|1
4612400|NCT01708161|7469248|FG001|Overall Study|Adverse Event|3
4612401|NCT01708161|7469249|FG002|Overall Study|Adverse Event|4
4612402|NCT01708161|7469250|FG003|Overall Study|Adverse Event|2
4612403|NCT01708161|7469251|FG004|Overall Study|Adverse Event|3
4612404|NCT01708161|7469252|FG005|Overall Study|Adverse Event|0
4612405|NCT01708161|7469247|FG000|Overall Study|Death|0
4612406|NCT01708161|7469248|FG001|Overall Study|Death|0
4612407|NCT01708161|7469249|FG002|Overall Study|Death|0
4612408|NCT01708161|7469250|FG003|Overall Study|Death|1
4612409|NCT01708161|7469251|FG004|Overall Study|Death|0
4612410|NCT01708161|7469252|FG005|Overall Study|Death|1
4459044|NCT00563368|7246789|FG003|Overall Study|Other|4
4539000|NCT01124422|7361243|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0
4539001|NCT01124422|7361244|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0
4539002|NCT01124422|7361242|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0
4539003|NCT01124422|7361243|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0
4539004|NCT01124422|7361244|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3
4539005|NCT01124422|7361242|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0
4539006|NCT01124422|7361243|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6
4539007|NCT01124422|7361244|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3
4539008|NCT01124422|7361242|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0
4539009|NCT01124422|7361243|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5
4539010|NCT01124422|7361244|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2
4539011|NCT01124422|7361242|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0
4539012|NCT01124422|7361243|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0
4539013|NCT01124422|7361244|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1
4539014|NCT01124448|7361253|FG000|Overall Study|Lost to Follow-up|0
4539015|NCT01124448|7361254|FG001|Overall Study|Lost to Follow-up|3
4539016|NCT01124448|7361253|FG000|Overall Study|Protocol Violation|2
4539017|NCT01124448|7361254|FG001|Overall Study|Protocol Violation|0
4539018|NCT01124604|7361262|FG000|Overall Study|Adverse Event|10
4539019|NCT01124604|7361263|FG001|Overall Study|Adverse Event|1
4539020|NCT01124604|7361262|FG000|Overall Study|Lack of Efficacy|1
4539021|NCT01124604|7361263|FG001|Overall Study|Lack of Efficacy|0
4539022|NCT01124604|7361262|FG000|Overall Study|Withdrawal by Subject|4
4539023|NCT01124604|7361263|FG001|Overall Study|Withdrawal by Subject|0
4539024|NCT01124604|7361262|FG000|Overall Study|Disease Progression|0
4539025|NCT01124604|7361263|FG001|Overall Study|Disease Progression|1
4539026|NCT01124617|7361271|FG000|Overall Study|Adverse Event|5
4539027|NCT01124617|7361272|FG001|Overall Study|Adverse Event|2
4539028|NCT01124617|7361271|FG000|Overall Study|Lack of Efficacy|2
4539029|NCT01124617|7361272|FG001|Overall Study|Lack of Efficacy|1
4539030|NCT01124617|7361271|FG000|Overall Study|Protocol Violation|1
4539031|NCT01124617|7361272|FG001|Overall Study|Protocol Violation|1
4539032|NCT01124617|7361271|FG000|Overall Study|Withdrawal by Subject|9
4539033|NCT01124617|7361272|FG001|Overall Study|Withdrawal by Subject|1
4539034|NCT01124617|7361271|FG000|Overall Study|Other|2
4539035|NCT01124617|7361272|FG001|Overall Study|Other|1
4539036|NCT01124643|7361278|FG000|Overall Study|Death|1
4539037|NCT01124734|7361282|FG000|Overall Study|Disease progression|13
4539038|NCT01124734|7361282|FG000|Overall Study|Adverse Event|1
4539039|NCT01124734|7361282|FG000|Overall Study|Withdrawal by Subject|1
4539040|NCT01124734|7361282|FG000|Overall Study|Elected for alternative treatment|2
4539041|NCT01124838|7361302|FG000|Overall Study|Miscellaneous|4
4539042|NCT01124838|7361303|FG001|Overall Study|Miscellaneous|2
4539043|NCT01124838|7361302|FG000|Overall Study|Adverse Event|7
4539044|NCT01124838|7361303|FG001|Overall Study|Adverse Event|11
4539045|NCT01124838|7361302|FG000|Overall Study|Lack of Efficacy|2
4539046|NCT01124838|7361303|FG001|Overall Study|Lack of Efficacy|0
4539047|NCT01124838|7361302|FG000|Overall Study|Withdrawal by Subject|3
4539048|NCT01124838|7361303|FG001|Overall Study|Withdrawal by Subject|2
4539049|NCT01124838|7361302|FG000|Overall Study|Lost to Follow-up|2
4539050|NCT01124838|7361303|FG001|Overall Study|Lost to Follow-up|0
4459045|NCT00563368|7246790|FG004|Overall Study|Other|4
4459046|NCT00563368|7246791|FG005|Overall Study|Other|4
4459047|NCT00563368|7246792|FG006|Overall Study|Other|0
4459048|NCT00563381|7246810|FG000|Overall Study|Adverse Event|264
4459049|NCT00563381|7246811|FG001|Overall Study|Adverse Event|292
4459050|NCT00563381|7246810|FG000|Overall Study|Protocol Violation|66
4459051|NCT00563381|7246811|FG001|Overall Study|Protocol Violation|74
4459052|NCT00563381|7246810|FG000|Overall Study|Lost to Follow-up|7
4459053|NCT00563381|7246811|FG001|Overall Study|Lost to Follow-up|15
4459054|NCT00563381|7246810|FG000|Overall Study|Withdrawal by Subject|192
4459055|NCT00563381|7246811|FG001|Overall Study|Withdrawal by Subject|209
4459056|NCT00563381|7246810|FG000|Overall Study|Lack of Efficacy|32
4459057|NCT00563381|7246811|FG001|Overall Study|Lack of Efficacy|24
4459058|NCT00563381|7246810|FG000|Overall Study|Individual different reasons|24
4459059|NCT00563381|7246811|FG001|Overall Study|Individual different reasons|34
4459060|NCT00563706|7246826|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4
4459061|NCT00563706|7246827|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
4459062|NCT00563706|7246828|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
4459063|NCT00563706|7246829|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
4459064|NCT00563706|7246830|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
4612411|NCT01708161|7469247|FG000|Overall Study|Withdrawal by Subject|0
4612412|NCT01708161|7469248|FG001|Overall Study|Withdrawal by Subject|1
4612413|NCT01708161|7469249|FG002|Overall Study|Withdrawal by Subject|1
4612414|NCT01708161|7469250|FG003|Overall Study|Withdrawal by Subject|0
4612415|NCT01708161|7469251|FG004|Overall Study|Withdrawal by Subject|0
4612416|NCT01708161|7469252|FG005|Overall Study|Withdrawal by Subject|0
4612417|NCT01708161|7469247|FG000|Overall Study|Administrative problems|0
4612418|NCT01708161|7469248|FG001|Overall Study|Administrative problems|1
4612419|NCT01708161|7469249|FG002|Overall Study|Administrative problems|0
4612420|NCT01708161|7469250|FG003|Overall Study|Administrative problems|0
4612421|NCT01708161|7469251|FG004|Overall Study|Administrative problems|0
4612422|NCT01708161|7469252|FG005|Overall Study|Administrative problems|0
4612423|NCT01708161|7469247|FG000|Overall Study|Disease progression|3
4612424|NCT01708161|7469248|FG001|Overall Study|Disease progression|5
4612425|NCT01708161|7469249|FG002|Overall Study|Disease progression|5
4612426|NCT01708161|7469250|FG003|Overall Study|Disease progression|13
4612427|NCT01708161|7469251|FG004|Overall Study|Disease progression|3
4612428|NCT01708161|7469252|FG005|Overall Study|Disease progression|0
4612429|NCT01708174|7469269|FG000|Treatment Period|Withdrawal by Subject|1
4612430|NCT01708174|7469270|FG001|Treatment Period|Withdrawal by Subject|0
4612431|NCT01708174|7469271|FG002|Treatment Period|Withdrawal by Subject|0
4612432|NCT01708174|7469269|FG000|Treatment Period|Progressive disease|0
4612433|NCT01708174|7469270|FG001|Treatment Period|Progressive disease|1
4612434|NCT01708174|7469271|FG002|Treatment Period|Progressive disease|0
4612435|NCT01708174|7469269|FG000|Treatment Period|Death|0
4612436|NCT01708174|7469270|FG001|Treatment Period|Death|0
4612437|NCT01708174|7469271|FG002|Treatment Period|Death|1
4612438|NCT01708174|7469269|FG000|Treatment Period|Adverse Event|0
4612439|NCT01708174|7469270|FG001|Treatment Period|Adverse Event|1
4612440|NCT01708174|7469271|FG002|Treatment Period|Adverse Event|0
4612441|NCT01708187|7469282|FG000|Overall Study|Lost to Follow-up|0
4612442|NCT01708187|7469283|FG001|Overall Study|Lost to Follow-up|1
4612443|NCT01708291|7469320|FG000|Overall Study|fighting|2
4612444|NCT01708291|7469321|FG001|Overall Study|fighting|1
4612445|NCT01708902|7469407|FG000|Overall Study|Adverse Event|3
4612446|NCT01708902|7469408|FG001|Overall Study|Adverse Event|4
4612447|NCT01708902|7469409|FG002|Overall Study|Adverse Event|9
4612448|NCT01708902|7469410|FG003|Overall Study|Adverse Event|2
4612449|NCT01708902|7469411|FG004|Overall Study|Adverse Event|7
4612450|NCT01708902|7469412|FG005|Overall Study|Adverse Event|3
4612451|NCT01708902|7469413|FG006|Overall Study|Adverse Event|5
4612452|NCT01708902|7469407|FG000|Overall Study|Lack of Efficacy|3
4612453|NCT01708902|7469408|FG001|Overall Study|Lack of Efficacy|1
4612454|NCT01708902|7469409|FG002|Overall Study|Lack of Efficacy|0
4612455|NCT01708902|7469410|FG003|Overall Study|Lack of Efficacy|0
4612456|NCT01708902|7469411|FG004|Overall Study|Lack of Efficacy|0
4612457|NCT01708902|7469412|FG005|Overall Study|Lack of Efficacy|1
4612458|NCT01708902|7469413|FG006|Overall Study|Lack of Efficacy|0
4612459|NCT01708902|7469407|FG000|Overall Study|Non compliance with protocol|0
4612460|NCT01708902|7469408|FG001|Overall Study|Non compliance with protocol|2
4612461|NCT01708902|7469409|FG002|Overall Study|Non compliance with protocol|1
4612462|NCT01708902|7469410|FG003|Overall Study|Non compliance with protocol|3
4612463|NCT01708902|7469411|FG004|Overall Study|Non compliance with protocol|0
4612464|NCT01708902|7469412|FG005|Overall Study|Non compliance with protocol|0
4459065|NCT00563706|7246831|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
4459066|NCT00563706|7246832|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
4459067|NCT00563706|7246833|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
4459068|NCT00563706|7246834|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5
4612465|NCT01708902|7469413|FG006|Overall Study|Non compliance with protocol|0
4612466|NCT01708902|7469407|FG000|Overall Study|Lost to Follow-up|2
4612467|NCT01708902|7469408|FG001|Overall Study|Lost to Follow-up|1
4612468|NCT01708902|7469409|FG002|Overall Study|Lost to Follow-up|2
4612469|NCT01708902|7469410|FG003|Overall Study|Lost to Follow-up|2
4459069|NCT00563706|7246826|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
4459070|NCT00563706|7246827|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
4459071|NCT00563706|7246828|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
4459072|NCT00563706|7246829|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4
4459073|NCT00563706|7246830|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
4612470|NCT01708902|7469411|FG004|Overall Study|Lost to Follow-up|0
4612471|NCT01708902|7469412|FG005|Overall Study|Lost to Follow-up|0
4612472|NCT01708902|7469413|FG006|Overall Study|Lost to Follow-up|1
4612473|NCT01708902|7469407|FG000|Overall Study|Refused to continue trial medication|8
4612474|NCT01708902|7469408|FG001|Overall Study|Refused to continue trial medication|0
4612475|NCT01708902|7469409|FG002|Overall Study|Refused to continue trial medication|4
4612476|NCT01708902|7469410|FG003|Overall Study|Refused to continue trial medication|2
4612477|NCT01708902|7469411|FG004|Overall Study|Refused to continue trial medication|8
4612478|NCT01708902|7469412|FG005|Overall Study|Refused to continue trial medication|1
4612479|NCT01708902|7469413|FG006|Overall Study|Refused to continue trial medication|1
4612480|NCT01708902|7469407|FG000|Overall Study|Other Reason|1
4612481|NCT01708902|7469408|FG001|Overall Study|Other Reason|0
4612482|NCT01708902|7469409|FG002|Overall Study|Other Reason|1
4612483|NCT01708902|7469410|FG003|Overall Study|Other Reason|1
4612484|NCT01708902|7469411|FG004|Overall Study|Other Reason|1
4612485|NCT01708902|7469412|FG005|Overall Study|Other Reason|2
4612486|NCT01708902|7469413|FG006|Overall Study|Other Reason|0
4612487|NCT01708915|7469436|FG000|Overall Study|Adverse Event|1
4612488|NCT01708915|7469437|FG001|Overall Study|Adverse Event|0
4612489|NCT01708915|7469438|FG002|Overall Study|Adverse Event|9
4612490|NCT01708915|7469439|FG003|Overall Study|Adverse Event|13
4612491|NCT01708915|7469436|FG000|Overall Study|Lack of Efficacy|84
4612492|NCT01708915|7469437|FG001|Overall Study|Lack of Efficacy|60
4612493|NCT01708915|7469438|FG002|Overall Study|Lack of Efficacy|35
4612494|NCT01708915|7469439|FG003|Overall Study|Lack of Efficacy|15
4612495|NCT01708915|7469436|FG000|Overall Study|Protocol Violation|0
4612496|NCT01708915|7469437|FG001|Overall Study|Protocol Violation|0
4612497|NCT01708915|7469438|FG002|Overall Study|Protocol Violation|0
4612498|NCT01708915|7469439|FG003|Overall Study|Protocol Violation|1
4612499|NCT01708915|7469436|FG000|Overall Study|Withdrawal by Subject|0
4612500|NCT01708915|7469437|FG001|Overall Study|Withdrawal by Subject|1
4612501|NCT01708915|7469438|FG002|Overall Study|Withdrawal by Subject|2
4612502|NCT01708915|7469439|FG003|Overall Study|Withdrawal by Subject|2
4612503|NCT01708915|7469436|FG000|Overall Study|Other reasons than stated above|1
4612504|NCT01708915|7469437|FG001|Overall Study|Other reasons than stated above|1
4612505|NCT01708915|7469438|FG002|Overall Study|Other reasons than stated above|0
4612506|NCT01708915|7469439|FG003|Overall Study|Other reasons than stated above|2
4612507|NCT01709084|7469465|FG000|Overall Study|Lost to Follow-up|4
4612508|NCT01709084|7469466|FG001|Overall Study|Lost to Follow-up|7
4612509|NCT01709084|7469465|FG000|Overall Study|Withdrawal by Subject|2
4612510|NCT01709084|7469466|FG001|Overall Study|Withdrawal by Subject|2
4612511|NCT01709084|7469465|FG000|Overall Study|Adverse Event|5
4612512|NCT01709084|7469466|FG001|Overall Study|Adverse Event|0
4612513|NCT01709084|7469465|FG000|Overall Study|Other|5
4612514|NCT01709084|7469466|FG001|Overall Study|Other|3
4612515|NCT01709084|7469465|FG000|Overall Study|Participant Reached a Virologic Endpoint|0
4612516|NCT01709084|7469466|FG001|Overall Study|Participant Reached a Virologic Endpoint|1
4612517|NCT01709084|7469465|FG000|Overall Study|Not Treated|0
4612518|NCT01709084|7469466|FG001|Overall Study|Not Treated|2
4612519|NCT01709110|7469474|FG000|Overall Study|Adverse Event|56
4612520|NCT01709110|7469475|FG001|Overall Study|Adverse Event|48
4612521|NCT01709110|7469474|FG000|Overall Study|Death|14
4612522|NCT01709110|7469475|FG001|Overall Study|Death|6
4612523|NCT01709110|7469474|FG000|Overall Study|Lost to Follow-up|7
4612524|NCT01709110|7469475|FG001|Overall Study|Lost to Follow-up|5
4612525|NCT01709110|7469474|FG000|Overall Study|Protocol Violation|4
4612526|NCT01709110|7469475|FG001|Overall Study|Protocol Violation|6
4612527|NCT01709110|7469474|FG000|Overall Study|Withdrawal by Subject|96
4612528|NCT01709110|7469475|FG001|Overall Study|Withdrawal by Subject|89
4612529|NCT01709110|7469474|FG000|Overall Study|Physician Decision|4
4612530|NCT01709110|7469475|FG001|Overall Study|Physician Decision|10
4612531|NCT01709110|7469474|FG000|Overall Study|Sponsor Decision|2
4612532|NCT01709110|7469475|FG001|Overall Study|Sponsor Decision|2
4612533|NCT01709110|7469474|FG000|Overall Study|Lack of Efficacy|1
4612534|NCT01709110|7469475|FG001|Overall Study|Lack of Efficacy|1
4612535|NCT01709110|7469474|FG000|Overall Study|Caregiver Decision|1
4612536|NCT01709110|7469475|FG001|Overall Study|Caregiver Decision|1
4612537|NCT01709149|7469484|FG000|Open-label Lead-in Phase|Adverse Event|109
4612538|NCT01709149|7469485|FG001|Open-label Lead-in Phase|Adverse Event|0
4612539|NCT01709149|7469486|FG002|Open-label Lead-in Phase|Adverse Event|0
4612540|NCT01709149|7469484|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2
4612541|NCT01709149|7469485|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0
4612542|NCT01709149|7469486|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0
4612543|NCT01709149|7469484|FG000|Open-label Lead-in Phase|Death|1
4612544|NCT01709149|7469485|FG001|Open-label Lead-in Phase|Death|0
4612545|NCT01709149|7469486|FG002|Open-label Lead-in Phase|Death|0
4612546|NCT01709149|7469484|FG000|Open-label Lead-in Phase|Protocol Violation|3
4690386|NCT02561195|7600197|FG012|Vaccination 1 to 3|Lost to Follow-up|0
4459074|NCT00563706|7246831|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
4459075|NCT00563706|7246832|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
4459076|NCT00563706|7246833|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5
4459077|NCT00563706|7246834|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
4459078|NCT00563706|7246826|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9
4459079|NCT00563706|7246827|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
4459080|NCT00563706|7246828|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2
4459081|NCT00563706|7246829|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5
4459082|NCT00563706|7246830|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4
4459083|NCT00563706|7246831|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
4459084|NCT00563706|7246832|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1
4459085|NCT00563706|7246833|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6
4459086|NCT00563706|7246834|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
4459087|NCT00563706|7246826|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2
4459088|NCT00563706|7246827|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
4459089|NCT00563706|7246828|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
4459090|NCT00563706|7246829|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
4459091|NCT00563706|7246830|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
4459092|NCT00563706|7246831|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
4459093|NCT00563706|7246832|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
4459094|NCT00563706|7246833|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1
4459095|NCT00563706|7246834|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
4459096|NCT00563706|7246826|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0
4459097|NCT00563706|7246827|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0
4459098|NCT00563706|7246828|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0
4459099|NCT00563706|7246829|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0
4459100|NCT00563706|7246830|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0
4459101|NCT00563706|7246831|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0
4459102|NCT00563706|7246832|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0
4459103|NCT00563706|7246833|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1
4459104|NCT00563706|7246834|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2
4459105|NCT00563784|7246854|FG000|Overall Study|Withdrawal by Subject|2
4459106|NCT00563784|7246854|FG000|Overall Study|Screen Failures|20
4459107|NCT00563797|7246860|FG000|Overall Study|Lost to Follow-up|7
4459108|NCT00563797|7246861|FG001|Overall Study|Lost to Follow-up|2
4459109|NCT00564018|7246872|FG000|Overall Study|Withdrawal by Subject|2
4459110|NCT00564018|7246873|FG001|Overall Study|Withdrawal by Subject|3
4459111|NCT00564018|7246874|FG002|Overall Study|Withdrawal by Subject|1
4459112|NCT00564070|7246884|FG000|Overall Study|Lost to Follow-up|9
4459113|NCT00564070|7246885|FG001|Overall Study|Lost to Follow-up|7
4459114|NCT00564070|7246884|FG000|Overall Study|Worsening depression, referred to care|3
4459115|NCT00564070|7246885|FG001|Overall Study|Worsening depression, referred to care|0
4459116|NCT00564278|7246897|FG000|Overall Study|Lost to Follow-up|35
4459117|NCT00564278|7246898|FG001|Overall Study|Lost to Follow-up|33
4459118|NCT00564278|7246897|FG000|Overall Study|Physician Decision|1
4459119|NCT00564278|7246898|FG001|Overall Study|Physician Decision|2
4459120|NCT00564278|7246897|FG000|Overall Study|Withdrawal by Subject|11
4459121|NCT00564278|7246898|FG001|Overall Study|Withdrawal by Subject|7
4459122|NCT00564395|7246904|FG000|First Intervention (10 Days)|Withdrawal by Subject|1
4459123|NCT00564395|7246905|FG001|First Intervention (10 Days)|Withdrawal by Subject|0
4459124|NCT00564395|7246904|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1
4612547|NCT01709149|7469485|FG001|Open-label Lead-in Phase|Protocol Violation|0
4612548|NCT01709149|7469486|FG002|Open-label Lead-in Phase|Protocol Violation|0
4612549|NCT01709149|7469484|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0
4612550|NCT01709149|7469485|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12
4612551|NCT01709149|7469486|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78
4612552|NCT01709149|7469484|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
4612553|NCT01709149|7469485|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7
4612554|NCT01709149|7469486|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12
4612555|NCT01709149|7469484|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0
4612556|NCT01709149|7469485|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2
4612557|NCT01709149|7469486|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5
4612558|NCT01709149|7469484|FG000|Double-blind, Placebo-controlled Phase|Death|0
4612559|NCT01709149|7469485|FG001|Double-blind, Placebo-controlled Phase|Death|2
4612560|NCT01709149|7469486|FG002|Double-blind, Placebo-controlled Phase|Death|0
4612561|NCT01709149|7469484|FG000|Double-blind, Placebo-controlled Phase|not defined|0
4612562|NCT01709149|7469485|FG001|Double-blind, Placebo-controlled Phase|not defined|1
4612563|NCT01709149|7469486|FG002|Double-blind, Placebo-controlled Phase|not defined|2
4459125|NCT00564395|7246905|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2
4459126|NCT00564486|7246947|FG000|Overall Study|Adverse Event|0
4690387|NCT02561195|7600198|FG013|Vaccination 1 to 3|Lost to Follow-up|0
4459127|NCT00564486|7246948|FG001|Overall Study|Adverse Event|1
4459128|NCT00564486|7246949|FG002|Overall Study|Adverse Event|0
4459129|NCT00564486|7246950|FG003|Overall Study|Adverse Event|0
4459130|NCT00564486|7246947|FG000|Overall Study|Withdrawal by Subject|4
4459131|NCT00564486|7246948|FG001|Overall Study|Withdrawal by Subject|0
4459132|NCT00564486|7246949|FG002|Overall Study|Withdrawal by Subject|0
4459133|NCT00564486|7246950|FG003|Overall Study|Withdrawal by Subject|5
4459134|NCT00564486|7246947|FG000|Overall Study|Subject refused to have blood drawn|0
4459135|NCT00564486|7246948|FG001|Overall Study|Subject refused to have blood drawn|0
4459136|NCT00564486|7246949|FG002|Overall Study|Subject refused to have blood drawn|1
4459137|NCT00564486|7246950|FG003|Overall Study|Subject refused to have blood drawn|0
4459138|NCT00564486|7246947|FG000|Overall Study|Lost to Follow-up|3
4459139|NCT00564486|7246948|FG001|Overall Study|Lost to Follow-up|0
4459140|NCT00564486|7246949|FG002|Overall Study|Lost to Follow-up|2
4459141|NCT00564486|7246950|FG003|Overall Study|Lost to Follow-up|2
4459142|NCT00564629|7246966|FG000|Overall Study|Vomited within 2 hours of receiving drug|15
4459143|NCT00564629|7246967|FG001|Overall Study|Vomited within 2 hours of receiving drug|9
4459144|NCT00564733|7246989|FG000|Overall Study|Withdrawal by Subject|4
4459145|NCT00564733|7246989|FG000|Overall Study|Ineligible|5
4459146|NCT00564850|7246993|FG000|Overall Study|Protocol Violation|2
4459147|NCT00564889|7246997|FG000|Overall Study|Death|7
4459148|NCT00564889|7246997|FG000|Overall Study|Adverse Event|12
4459149|NCT00564889|7246997|FG000|Overall Study|Alternative treatment|3
4459150|NCT00564889|7246997|FG000|Overall Study|Disease progression|3
4459151|NCT00564889|7246997|FG000|Overall Study|Other, not specified|4
4459152|NCT00564902|7247004|FG000|Overall Study|Withdrawal by Subject|0
4459153|NCT00564902|7247005|FG001|Overall Study|Withdrawal by Subject|3
4459154|NCT00564902|7247006|FG002|Overall Study|Withdrawal by Subject|4
4459155|NCT00564902|7247004|FG000|Overall Study|Death|1
4459156|NCT00564902|7247005|FG001|Overall Study|Death|1
4612564|NCT01709149|7469484|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
4612565|NCT01709149|7469485|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2
4612566|NCT01709149|7469486|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
4612567|NCT01709162|7469495|FG000|Overall Study|Disease progression|3
4612568|NCT01709162|7469496|FG001|Overall Study|Disease progression|3
4612569|NCT01709162|7469495|FG000|Overall Study|Study drug toxicity|2
4612570|NCT01709162|7469496|FG001|Overall Study|Study drug toxicity|0
4612571|NCT01709162|7469495|FG000|Overall Study|Administrative reason by sponsor|0
4612572|NCT01709162|7469496|FG001|Overall Study|Administrative reason by sponsor|1
4612573|NCT01709162|7469495|FG000|Overall Study|Other|1
4612574|NCT01709162|7469496|FG001|Overall Study|Other|0
4612575|NCT01709162|7469495|FG000|Overall Study|Withdrawal by Subject|0
4612576|NCT01709162|7469496|FG001|Overall Study|Withdrawal by Subject|1
4612577|NCT01709227|7469504|FG000|Overall Study|Physician Decision|1
4612578|NCT01709227|7469505|FG001|Overall Study|Physician Decision|0
4612579|NCT01709227|7469504|FG000|Overall Study|Pleural Peritoneal communication|0
4612580|NCT01709227|7469505|FG001|Overall Study|Pleural Peritoneal communication|9
4612581|NCT01709305|7469512|FG000|Phase 1|Clinical Adverse Event|80
4612582|NCT01709305|7469513|FG001|Phase 1|Clinical Adverse Event|0
4612583|NCT01709305|7469514|FG002|Phase 1|Clinical Adverse Event|0
4612584|NCT01709305|7469515|FG003|Phase 1|Clinical Adverse Event|0
4612585|NCT01709305|7469516|FG004|Phase 1|Clinical Adverse Event|0
4612586|NCT01709305|7469512|FG000|Phase 1|Death|2
4612587|NCT01709305|7469513|FG001|Phase 1|Death|0
4612588|NCT01709305|7469514|FG002|Phase 1|Death|0
4612589|NCT01709305|7469515|FG003|Phase 1|Death|0
4612590|NCT01709305|7469516|FG004|Phase 1|Death|0
4612591|NCT01709305|7469512|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13
4612592|NCT01709305|7469513|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0
4612593|NCT01709305|7469514|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0
4612594|NCT01709305|7469515|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0
4612595|NCT01709305|7469516|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0
4612596|NCT01709305|7469512|FG000|Phase 1|Laboratory Adverse Event|16
4612597|NCT01709305|7469513|FG001|Phase 1|Laboratory Adverse Event|0
4612598|NCT01709305|7469514|FG002|Phase 1|Laboratory Adverse Event|0
4612599|NCT01709305|7469515|FG003|Phase 1|Laboratory Adverse Event|0
4612600|NCT01709305|7469516|FG004|Phase 1|Laboratory Adverse Event|0
4612601|NCT01709305|7469512|FG000|Phase 1|Lost to Follow-up|147
4612602|NCT01709305|7469513|FG001|Phase 1|Lost to Follow-up|0
4459157|NCT00564902|7247006|FG002|Overall Study|Death|0
4459158|NCT00565058|7247034|FG000|Overall Study|Adverse Event|1
4459159|NCT00565058|7247035|FG001|Overall Study|Adverse Event|0
4459160|NCT00565136|7247060|FG000|Overall Study|Lost to Follow-up|1
4459161|NCT00565136|7247060|FG000|Overall Study|Withdrawal by Subject|1
4459162|NCT00565136|7247060|FG000|Overall Study|Protocol Violation|1
4459163|NCT00565409|7247076|FG000|Period 1 Open Label|Adverse Event|17
4612603|NCT01709305|7469514|FG002|Phase 1|Lost to Follow-up|0
4612604|NCT01709305|7469515|FG003|Phase 1|Lost to Follow-up|0
4459164|NCT00565409|7247077|FG001|Period 1 Open Label|Adverse Event|0
4459165|NCT00565409|7247078|FG002|Period 1 Open Label|Adverse Event|0
4612605|NCT01709305|7469516|FG004|Phase 1|Lost to Follow-up|0
4612606|NCT01709305|7469512|FG000|Phase 1|Travel, moving, etc.|30
4612607|NCT01709305|7469513|FG001|Phase 1|Travel, moving, etc.|0
4612608|NCT01709305|7469514|FG002|Phase 1|Travel, moving, etc.|0
4612609|NCT01709305|7469515|FG003|Phase 1|Travel, moving, etc.|0
4612610|NCT01709305|7469516|FG004|Phase 1|Travel, moving, etc.|0
4459166|NCT00565409|7247079|FG003|Period 1 Open Label|Adverse Event|0
4459167|NCT00565409|7247076|FG000|Period 1 Open Label|Death|2
4459168|NCT00565409|7247077|FG001|Period 1 Open Label|Death|0
4459169|NCT00565409|7247078|FG002|Period 1 Open Label|Death|0
4459170|NCT00565409|7247079|FG003|Period 1 Open Label|Death|0
4459171|NCT00565409|7247076|FG000|Period 1 Open Label|Lost to Follow-up|1
4459172|NCT00565409|7247077|FG001|Period 1 Open Label|Lost to Follow-up|0
4459173|NCT00565409|7247078|FG002|Period 1 Open Label|Lost to Follow-up|0
4459174|NCT00565409|7247079|FG003|Period 1 Open Label|Lost to Follow-up|0
4459175|NCT00565409|7247076|FG000|Period 1 Open Label|Other|21
4459176|NCT00565409|7247077|FG001|Period 1 Open Label|Other|0
4459177|NCT00565409|7247078|FG002|Period 1 Open Label|Other|0
4459178|NCT00565409|7247079|FG003|Period 1 Open Label|Other|0
4459179|NCT00565409|7247076|FG000|Period 1 Open Label|Protocol Violation|14
4459180|NCT00565409|7247077|FG001|Period 1 Open Label|Protocol Violation|0
4459181|NCT00565409|7247078|FG002|Period 1 Open Label|Protocol Violation|0
4459182|NCT00565409|7247079|FG003|Period 1 Open Label|Protocol Violation|0
4459183|NCT00565409|7247076|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22
4459184|NCT00565409|7247077|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
4459185|NCT00565409|7247078|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
4459186|NCT00565409|7247079|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
4459187|NCT00565409|7247076|FG000|Period 1 Open Label|no conclusion of participation record|1
4459188|NCT00565409|7247077|FG001|Period 1 Open Label|no conclusion of participation record|0
4459189|NCT00565409|7247078|FG002|Period 1 Open Label|no conclusion of participation record|0
4459190|NCT00565409|7247079|FG003|Period 1 Open Label|no conclusion of participation record|0
4459191|NCT00565409|7247076|FG000|After Period 1, Prior to Period 2|did not meet criteria|152
4459192|NCT00565409|7247077|FG001|After Period 1, Prior to Period 2|did not meet criteria|0
4459193|NCT00565409|7247078|FG002|After Period 1, Prior to Period 2|did not meet criteria|0
4459194|NCT00565409|7247079|FG003|After Period 1, Prior to Period 2|did not meet criteria|0
4459195|NCT00565409|7247076|FG000|Period 2 Double-Blind|Adverse Event|0
4459196|NCT00565409|7247077|FG001|Period 2 Double-Blind|Adverse Event|7
4459197|NCT00565409|7247078|FG002|Period 2 Double-Blind|Adverse Event|4
4459198|NCT00565409|7247079|FG003|Period 2 Double-Blind|Adverse Event|5
4459199|NCT00565409|7247076|FG000|Period 2 Double-Blind|Death|0
4459200|NCT00565409|7247077|FG001|Period 2 Double-Blind|Death|2
4459201|NCT00565409|7247078|FG002|Period 2 Double-Blind|Death|0
4459202|NCT00565409|7247079|FG003|Period 2 Double-Blind|Death|0
4459203|NCT00565409|7247076|FG000|Period 2 Double-Blind|Protocol Violation|0
4459204|NCT00565409|7247077|FG001|Period 2 Double-Blind|Protocol Violation|4
4459205|NCT00565409|7247078|FG002|Period 2 Double-Blind|Protocol Violation|6
4459206|NCT00565409|7247079|FG003|Period 2 Double-Blind|Protocol Violation|2
4612611|NCT01709305|7469512|FG000|Phase 1|Physician Decision|13
4612612|NCT01709305|7469513|FG001|Phase 1|Physician Decision|0
4612613|NCT01709305|7469514|FG002|Phase 1|Physician Decision|0
4612614|NCT01709305|7469515|FG003|Phase 1|Physician Decision|0
4612615|NCT01709305|7469516|FG004|Phase 1|Physician Decision|0
4612616|NCT01709305|7469512|FG000|Phase 1|Protocol Violation|118
4612617|NCT01709305|7469513|FG001|Phase 1|Protocol Violation|0
4612618|NCT01709305|7469514|FG002|Phase 1|Protocol Violation|0
4612619|NCT01709305|7469515|FG003|Phase 1|Protocol Violation|0
4612620|NCT01709305|7469516|FG004|Phase 1|Protocol Violation|0
4612621|NCT01709305|7469512|FG000|Phase 1|Withdrawal by Subject|218
4612622|NCT01709305|7469513|FG001|Phase 1|Withdrawal by Subject|0
4612623|NCT01709305|7469514|FG002|Phase 1|Withdrawal by Subject|0
4612624|NCT01709305|7469515|FG003|Phase 1|Withdrawal by Subject|0
4612625|NCT01709305|7469516|FG004|Phase 1|Withdrawal by Subject|0
4612626|NCT01709305|7469512|FG000|Phase 2|Clinical Adverse Event|0
4612627|NCT01709305|7469513|FG001|Phase 2|Clinical Adverse Event|10
4612628|NCT01709305|7469514|FG002|Phase 2|Clinical Adverse Event|10
4612629|NCT01709305|7469515|FG003|Phase 2|Clinical Adverse Event|6
4612630|NCT01709305|7469516|FG004|Phase 2|Clinical Adverse Event|11
4612631|NCT01709305|7469512|FG000|Phase 2|Death|0
4612632|NCT01709305|7469513|FG001|Phase 2|Death|0
4612633|NCT01709305|7469514|FG002|Phase 2|Death|1
4612634|NCT01709305|7469515|FG003|Phase 2|Death|0
4612635|NCT01709305|7469516|FG004|Phase 2|Death|0
4612636|NCT01709305|7469512|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0
4612637|NCT01709305|7469513|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0
4612638|NCT01709305|7469514|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0
4612639|NCT01709305|7469515|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0
4612640|NCT01709305|7469516|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2
4612641|NCT01709305|7469512|FG000|Phase 2|Laboratory Adverse Event|0
4459207|NCT00565409|7247076|FG000|Period 2 Double-Blind|Lost to Follow-up|0
4459208|NCT00565409|7247077|FG001|Period 2 Double-Blind|Lost to Follow-up|0
4459209|NCT00565409|7247078|FG002|Period 2 Double-Blind|Lost to Follow-up|1
4459210|NCT00565409|7247079|FG003|Period 2 Double-Blind|Lost to Follow-up|0
4459211|NCT00565409|7247076|FG000|Period 2 Double-Blind|Other|0
4459212|NCT00565409|7247077|FG001|Period 2 Double-Blind|Other|4
4459213|NCT00565409|7247078|FG002|Period 2 Double-Blind|Other|5
4459214|NCT00565409|7247079|FG003|Period 2 Double-Blind|Other|9
4612642|NCT01709305|7469513|FG001|Phase 2|Laboratory Adverse Event|1
4612643|NCT01709305|7469514|FG002|Phase 2|Laboratory Adverse Event|0
4612644|NCT01709305|7469515|FG003|Phase 2|Laboratory Adverse Event|1
4612645|NCT01709305|7469516|FG004|Phase 2|Laboratory Adverse Event|1
4459215|NCT00565409|7247076|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0
4459216|NCT00565409|7247077|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4
4459217|NCT00565409|7247078|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11
4459218|NCT00565409|7247079|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43
4459219|NCT00565448|7247091|FG000|Overall Study|Adverse Event|1
4459220|NCT00565448|7247092|FG001|Overall Study|Adverse Event|2
4459221|NCT00565448|7247091|FG000|Overall Study|Disease progression|1
4459222|NCT00565448|7247092|FG001|Overall Study|Disease progression|0
4459223|NCT00565448|7247091|FG000|Overall Study|Withdrawal by Subject|1
4459224|NCT00565448|7247092|FG001|Overall Study|Withdrawal by Subject|0
4459225|NCT00565604|7247101|FG000|Overall Study|Failure to treat|2
4459226|NCT00565604|7247101|FG000|Overall Study|Lost to Follow-up|2
4459227|NCT00565721|7247124|FG000|Overall Study|Screen Failure|2
4459228|NCT00565721|7247124|FG000|Overall Study|Lost to Follow-up|6
4459229|NCT00565721|7247124|FG000|Overall Study|Technical Problems|1
4459230|NCT00565721|7247124|FG000|Overall Study|Physician Decision|2
4459231|NCT00565721|7247124|FG000|Overall Study|Other reasons|6
4459232|NCT00565747|7247145|FG000|Overall Study|No embryo transfer|67
4459233|NCT00565747|7247146|FG001|Overall Study|No embryo transfer|73
4459234|NCT00565773|7247152|FG000|Overall Study|Withdrawal by Subject|1
4459235|NCT00565773|7247152|FG000|Overall Study|Physician Decision|1
4459236|NCT00565812|7247159|FG000|Overall Study|Death|2
4612646|NCT01709305|7469512|FG000|Phase 2|Lost to Follow-up|0
4612647|NCT01709305|7469513|FG001|Phase 2|Lost to Follow-up|10
4612648|NCT01709305|7469514|FG002|Phase 2|Lost to Follow-up|6
4612649|NCT01709305|7469515|FG003|Phase 2|Lost to Follow-up|9
4612650|NCT01709305|7469516|FG004|Phase 2|Lost to Follow-up|5
4612651|NCT01709305|7469512|FG000|Phase 2|Travel, moving, etc.|0
4612652|NCT01709305|7469513|FG001|Phase 2|Travel, moving, etc.|2
4612653|NCT01709305|7469514|FG002|Phase 2|Travel, moving, etc.|3
4612654|NCT01709305|7469515|FG003|Phase 2|Travel, moving, etc.|3
4612655|NCT01709305|7469516|FG004|Phase 2|Travel, moving, etc.|5
4612656|NCT01709305|7469512|FG000|Phase 2|Physician Decision|0
4612657|NCT01709305|7469513|FG001|Phase 2|Physician Decision|2
4612658|NCT01709305|7469514|FG002|Phase 2|Physician Decision|0
4612659|NCT01709305|7469515|FG003|Phase 2|Physician Decision|1
4612660|NCT01709305|7469516|FG004|Phase 2|Physician Decision|2
4612661|NCT01709305|7469512|FG000|Phase 2|Protocol Violation|0
4612662|NCT01709305|7469513|FG001|Phase 2|Protocol Violation|19
4612663|NCT01709305|7469514|FG002|Phase 2|Protocol Violation|19
4612664|NCT01709305|7469515|FG003|Phase 2|Protocol Violation|13
4612665|NCT01709305|7469516|FG004|Phase 2|Protocol Violation|9
4612666|NCT01709305|7469512|FG000|Phase 2|Withdrawal by Subject|0
4612667|NCT01709305|7469513|FG001|Phase 2|Withdrawal by Subject|8
4612668|NCT01709305|7469514|FG002|Phase 2|Withdrawal by Subject|6
4612669|NCT01709305|7469515|FG003|Phase 2|Withdrawal by Subject|15
4612670|NCT01709305|7469516|FG004|Phase 2|Withdrawal by Subject|12
4612671|NCT01709383|7469533|FG000|Overall Study|Lost to Follow-up|1
4612672|NCT01709383|7469534|FG001|Overall Study|Lost to Follow-up|0
4612673|NCT01709409|7469544|FG000|Overall Study|Protocol Violation|1
4612674|NCT01709409|7469545|FG001|Overall Study|Protocol Violation|0
4612675|NCT01709500|7469573|FG000|Overall Study|Randomized but not treated|0
4612676|NCT01709500|7469574|FG001|Overall Study|Randomized but not treated|1
4612677|NCT01709500|7469573|FG000|Overall Study|Adverse Event|5
4612678|NCT01709500|7469574|FG001|Overall Study|Adverse Event|1
4612679|NCT01709500|7469573|FG000|Overall Study|Poor compliance to protocol|2
4612680|NCT01709500|7469574|FG001|Overall Study|Poor compliance to protocol|1
4612681|NCT01709500|7469573|FG000|Overall Study|Other|3
4612682|NCT01709500|7469574|FG001|Overall Study|Other|1
4612683|NCT01709500|7469573|FG000|Overall Study|Related to IMP administration|1
4612684|NCT01709500|7469574|FG001|Overall Study|Related to IMP administration|0
4612685|NCT01709500|7469573|FG000|Overall Study|Treatment ongoing|156
4612686|NCT01709500|7469574|FG001|Overall Study|Treatment ongoing|78
4612687|NCT01709513|7469583|FG000|Overall Study|Randomized but not treated|0
4612688|NCT01709513|7469584|FG001|Overall Study|Randomized but not treated|1
4612689|NCT01709513|7469585|FG002|Overall Study|Randomized but not treated|0
4612690|NCT01709513|7469583|FG000|Overall Study|Adverse Event|16
4612691|NCT01709513|7469584|FG001|Overall Study|Adverse Event|31
4612692|NCT01709513|7469585|FG002|Overall Study|Adverse Event|23
4612693|NCT01709513|7469583|FG000|Overall Study|Poor compliance to protocol|2
4612694|NCT01709513|7469584|FG001|Overall Study|Poor compliance to protocol|0
4612695|NCT01709513|7469585|FG002|Overall Study|Poor compliance to protocol|0
4612696|NCT01709513|7469583|FG000|Overall Study|Other|3
4612697|NCT01709513|7469584|FG001|Overall Study|Other|11
4612698|NCT01709513|7469585|FG002|Overall Study|Other|7
4612699|NCT01709578|7469599|FG000|Overall Study|Rescued and entered in long term safety|63
4612700|NCT01709578|7469600|FG001|Overall Study|Rescued and entered in long term safety|25
4612701|NCT01709578|7469601|FG002|Overall Study|Rescued and entered in long term safety|26
4612702|NCT01709578|7469599|FG000|Overall Study|Adverse Event|9
4612703|NCT01709578|7469600|FG001|Overall Study|Adverse Event|18
4612704|NCT01709578|7469601|FG002|Overall Study|Adverse Event|17
4612705|NCT01709578|7469599|FG000|Overall Study|Lack of Efficacy|5
4459237|NCT00565812|7247160|FG001|Overall Study|Death|1
4459238|NCT00565812|7247161|FG002|Overall Study|Death|3
4459239|NCT00565812|7247159|FG000|Overall Study|Did not Meet Entrance Criteria|1
4612706|NCT01709578|7469600|FG001|Overall Study|Lack of Efficacy|4
4459240|NCT00565812|7247160|FG001|Overall Study|Did not Meet Entrance Criteria|0
4459241|NCT00565812|7247161|FG002|Overall Study|Did not Meet Entrance Criteria|1
4459242|NCT00565812|7247159|FG000|Overall Study|Lost to Follow-up|10
4459243|NCT00565812|7247160|FG001|Overall Study|Lost to Follow-up|8
4459244|NCT00565812|7247161|FG002|Overall Study|Lost to Follow-up|8
4459245|NCT00565812|7247159|FG000|Overall Study|Withdrawal by Subject|58
4459246|NCT00565812|7247160|FG001|Overall Study|Withdrawal by Subject|47
4459247|NCT00565812|7247161|FG002|Overall Study|Withdrawal by Subject|48
4459248|NCT00565812|7247159|FG000|Overall Study|Work Schedule|5
4459249|NCT00565812|7247160|FG001|Overall Study|Work Schedule|3
4459250|NCT00565812|7247161|FG002|Overall Study|Work Schedule|1
4459251|NCT00565812|7247159|FG000|Overall Study|Protocol Violation|2
4459252|NCT00565812|7247160|FG001|Overall Study|Protocol Violation|6
4612707|NCT01709578|7469601|FG002|Overall Study|Lack of Efficacy|2
4612708|NCT01709578|7469599|FG000|Overall Study|Poor compliance to protocol|1
4612709|NCT01709578|7469600|FG001|Overall Study|Poor compliance to protocol|2
4612710|NCT01709578|7469601|FG002|Overall Study|Poor compliance to protocol|1
4612711|NCT01709578|7469599|FG000|Overall Study|Other, not related to safety or efficacy|2
4612712|NCT01709578|7469600|FG001|Overall Study|Other, not related to safety or efficacy|7
4612713|NCT01709578|7469601|FG002|Overall Study|Other, not related to safety or efficacy|5
4612714|NCT01709695|7469611|FG000|Overall Study|Withdrawal by Subject|1
4612715|NCT01709695|7469612|FG001|Overall Study|Withdrawal by Subject|1
4612716|NCT01709708|7469620|FG000|Overall Study|Protocol Violation|1
4612717|NCT01709708|7469621|FG001|Overall Study|Protocol Violation|2
4612718|NCT01709721|7469631|FG000|Open Label Phase|Withdrawal by Subject|0
4612719|NCT01709721|7469632|FG001|Open Label Phase|Withdrawal by Subject|0
4612720|NCT01709721|7469633|FG002|Open Label Phase|Withdrawal by Subject|5
4612721|NCT01709721|7469631|FG000|Open Label Phase|Adverse Event|0
4612722|NCT01709721|7469632|FG001|Open Label Phase|Adverse Event|0
4612723|NCT01709721|7469633|FG002|Open Label Phase|Adverse Event|8
4612724|NCT01709721|7469631|FG000|Open Label Phase|Non-compliance With Study Drug|0
4612725|NCT01709721|7469632|FG001|Open Label Phase|Non-compliance With Study Drug|0
4612726|NCT01709721|7469633|FG002|Open Label Phase|Non-compliance With Study Drug|3
4612727|NCT01709721|7469631|FG000|Open Label Phase|Investigator Decision|0
4612728|NCT01709721|7469632|FG001|Open Label Phase|Investigator Decision|0
4612729|NCT01709721|7469633|FG002|Open Label Phase|Investigator Decision|1
4612730|NCT01709721|7469631|FG000|Open Label Phase|Sponsor Decision|0
4612731|NCT01709721|7469632|FG001|Open Label Phase|Sponsor Decision|0
4612732|NCT01709721|7469633|FG002|Open Label Phase|Sponsor Decision|2
4612733|NCT01709721|7469631|FG000|Open Label Phase|Protocol Violation|0
4612734|NCT01709721|7469632|FG001|Open Label Phase|Protocol Violation|0
4612735|NCT01709721|7469633|FG002|Open Label Phase|Protocol Violation|1
4612736|NCT01709721|7469631|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0
4612737|NCT01709721|7469632|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0
4612738|NCT01709721|7469633|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1
4612739|NCT01709721|7469631|FG000|Open Label Phase|Inadequate Pain Control|0
4612740|NCT01709721|7469632|FG001|Open Label Phase|Inadequate Pain Control|0
4612741|NCT01709721|7469633|FG002|Open Label Phase|Inadequate Pain Control|37
4612742|NCT01709721|7469631|FG000|Open Label Phase|Other, Specify in text field in database|0
4612743|NCT01709721|7469632|FG001|Open Label Phase|Other, Specify in text field in database|0
4612744|NCT01709721|7469633|FG002|Open Label Phase|Other, Specify in text field in database|14
4612745|NCT01709721|7469631|FG000|Randomized Phase|Adverse Event|0
4612746|NCT01709721|7469632|FG001|Randomized Phase|Adverse Event|1
4612747|NCT01709721|7469633|FG002|Randomized Phase|Adverse Event|0
4612748|NCT01709721|7469631|FG000|Randomized Phase|Lost to Follow-up|1
4612749|NCT01709721|7469632|FG001|Randomized Phase|Lost to Follow-up|0
4612750|NCT01709721|7469633|FG002|Randomized Phase|Lost to Follow-up|0
4612751|NCT01709721|7469631|FG000|Randomized Phase|Inadequate Pain Control|1
4612752|NCT01709721|7469632|FG001|Randomized Phase|Inadequate Pain Control|2
4612753|NCT01709721|7469633|FG002|Randomized Phase|Inadequate Pain Control|0
4612754|NCT01709721|7469631|FG000|Randomized Phase|Other, Specify text field in database|1
4612755|NCT01709721|7469632|FG001|Randomized Phase|Other, Specify text field in database|3
4612756|NCT01709721|7469633|FG002|Randomized Phase|Other, Specify text field in database|0
4632707|NCT01903876|7502471|FG001|Six-Month Follow-up Period|Lost to Follow-up|145
4632708|NCT01903993|7502479|FG000|Overall Study|Death|118
4632709|NCT01903993|7502480|FG001|Overall Study|Death|121
4632710|NCT01903993|7502479|FG000|Overall Study|Withdrawal by Subject|15
4632711|NCT01903993|7502480|FG001|Overall Study|Withdrawal by Subject|4
4459253|NCT00565812|7247161|FG002|Overall Study|Protocol Violation|4
4459254|NCT00565812|7247159|FG000|Overall Study|Adverse Event|41
4459255|NCT00565812|7247160|FG001|Overall Study|Adverse Event|54
4632712|NCT01903993|7502479|FG000|Overall Study|Lost to Follow-up|2
4632713|NCT01903993|7502480|FG001|Overall Study|Lost to Follow-up|3
4632714|NCT01903993|7502479|FG000|Overall Study|Study Terminated by Sponsor|8
4632715|NCT01903993|7502480|FG001|Overall Study|Study Terminated by Sponsor|14
4632716|NCT01903993|7502479|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0
4632717|NCT01903993|7502480|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2
4632718|NCT01904019|7502487|FG000|1 Year Follow-up|Withdrawal by Subject|4
4632719|NCT01904019|7502487|FG000|1 Year Follow-up|Impossibility to contact patient|5
4612757|NCT01709838|7469665|FG000|Overall Study|Withdrawal by Subject|21
4612758|NCT01709838|7469665|FG000|Overall Study|Lost to Follow-up|16
4612759|NCT01709838|7469665|FG000|Overall Study|Pregnancy|10
4612760|NCT01709838|7469665|FG000|Overall Study|Subject/guardian decision|8
4612761|NCT01709838|7469665|FG000|Overall Study|Adverse Event|4
4612762|NCT01709838|7469665|FG000|Overall Study|Physician Decision|4
4612763|NCT01709838|7469665|FG000|Overall Study|Death|3
4612764|NCT01709838|7469665|FG000|Overall Study|Protocol Violation|1
4612765|NCT01709864|7469673|FG000|Overall Study|Physician Decision|0
4612766|NCT01709864|7469674|FG001|Overall Study|Physician Decision|1
4612767|NCT01709864|7469673|FG000|Overall Study|subject/guardian decision|5
4612768|NCT01709864|7469674|FG001|Overall Study|subject/guardian decision|6
4612769|NCT01709864|7469673|FG000|Overall Study|Lost to Follow-up|1
4612770|NCT01709864|7469674|FG001|Overall Study|Lost to Follow-up|0
4612771|NCT01709864|7469673|FG000|Overall Study|non-compliance with study treatment|1
4612772|NCT01709864|7469674|FG001|Overall Study|non-compliance with study treatment|1
4612773|NCT01709864|7469673|FG000|Overall Study|Adverse Event|0
4612774|NCT01709864|7469674|FG001|Overall Study|Adverse Event|2
4612775|NCT01709864|7469673|FG000|Overall Study|Death|0
4612776|NCT01709864|7469674|FG001|Overall Study|Death|1
4612777|NCT01709903|7469682|FG000|Overall Study|administrative problems|2
4612778|NCT01709903|7469683|FG001|Overall Study|administrative problems|6
4612779|NCT01709903|7469682|FG000|Overall Study|Abnormal test procedure results|1
4612780|NCT01709903|7469683|FG001|Overall Study|Abnormal test procedure results|0
4612781|NCT01709903|7469682|FG000|Overall Study|In ability to use device|1
4612782|NCT01709903|7469683|FG001|Overall Study|In ability to use device|1
4612783|NCT01709903|7469682|FG000|Overall Study|no longer needed study drug|0
4612784|NCT01709903|7469683|FG001|Overall Study|no longer needed study drug|1
4612785|NCT01709903|7469682|FG000|Overall Study|Lost to Follow-up|0
4612786|NCT01709903|7469683|FG001|Overall Study|Lost to Follow-up|2
4612787|NCT01709903|7469682|FG000|Overall Study|Death|2
4612788|NCT01709903|7469683|FG001|Overall Study|Death|0
4612789|NCT01709903|7469682|FG000|Overall Study|Protocol Violation|3
4612790|NCT01709903|7469683|FG001|Overall Study|Protocol Violation|2
4612791|NCT01709903|7469682|FG000|Overall Study|Lack of Efficacy|3
4612792|NCT01709903|7469683|FG001|Overall Study|Lack of Efficacy|3
4612793|NCT01709903|7469682|FG000|Overall Study|Withdrawal by Subject|6
4612794|NCT01709903|7469683|FG001|Overall Study|Withdrawal by Subject|6
4612795|NCT01709903|7469682|FG000|Overall Study|Adverse Event|11
4612796|NCT01709903|7469683|FG001|Overall Study|Adverse Event|18
4612797|NCT01710020|7469698|FG000|Period 1|Protocol Violation|1
4612798|NCT01710033|7469708|FG000|Stage 2|Adverse Event|0
4612799|NCT01710033|7469709|FG001|Stage 2|Adverse Event|0
4612800|NCT01710033|7469710|FG002|Stage 2|Adverse Event|0
4612801|NCT01710033|7469711|FG003|Stage 2|Adverse Event|0
4612802|NCT01710033|7469712|FG004|Stage 2|Adverse Event|1
4612803|NCT01710046|7469727|FG000|Overall Study|Lost to Follow-up|1
4612804|NCT01710046|7469728|FG001|Overall Study|Lost to Follow-up|0
4612805|NCT01710345|7469769|FG000|Overall Study|Adverse Event|0
4612806|NCT01710345|7469770|FG001|Overall Study|Adverse Event|2
4612807|NCT01710345|7469771|FG002|Overall Study|Adverse Event|0
4612808|NCT01710345|7469769|FG000|Overall Study|Lack of Efficacy|2
4612809|NCT01710345|7469770|FG001|Overall Study|Lack of Efficacy|3
4612810|NCT01710345|7469771|FG002|Overall Study|Lack of Efficacy|1
4612811|NCT01710345|7469769|FG000|Overall Study|Drug Dosing Error|1
4612812|NCT01710345|7469770|FG001|Overall Study|Drug Dosing Error|0
4612813|NCT01710345|7469771|FG002|Overall Study|Drug Dosing Error|0
4612814|NCT01710358|7469782|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15
4612815|NCT01710358|7469783|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18
4612816|NCT01710358|7469784|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7
4612817|NCT01710358|7469782|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0
4612818|NCT01710358|7469783|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2
4612819|NCT01710358|7469784|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0
4612820|NCT01710358|7469782|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0
4612821|NCT01710358|7469783|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1
4612822|NCT01710358|7469784|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1
4612823|NCT01710358|7469782|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15
4612824|NCT01710358|7469783|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1
4612825|NCT01710358|7469784|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3
4612826|NCT01710358|7469782|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0
4612827|NCT01710358|7469783|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1
4612828|NCT01710358|7469784|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0
4612829|NCT01710358|7469782|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1
4612830|NCT01710358|7469783|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0
4612831|NCT01710358|7469784|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0
4612832|NCT01710358|7469782|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4
4612833|NCT01710358|7469783|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0
4612834|NCT01710358|7469784|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0
4612835|NCT01710358|7469782|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15
4612836|NCT01710358|7469783|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5
4632720|NCT01904019|7502487|FG000|3 Year Follow-up|Withdrawal by Subject|1
4459256|NCT00565812|7247161|FG002|Overall Study|Adverse Event|40
4459257|NCT00565812|7247159|FG000|Overall Study|Jury Duty|1
4459258|NCT00565812|7247160|FG001|Overall Study|Jury Duty|0
4459259|NCT00565812|7247161|FG002|Overall Study|Jury Duty|0
4459260|NCT00565812|7247159|FG000|Overall Study|Relocated Out of Area|5
4612837|NCT01710358|7469784|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12
4612838|NCT01710358|7469782|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1
4612839|NCT01710358|7469783|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1
4612840|NCT01710358|7469784|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0
4612841|NCT01710358|7469782|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10
4612842|NCT01710358|7469783|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16
4612843|NCT01710358|7469784|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5
4612844|NCT01710358|7469782|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1
4612845|NCT01710358|7469783|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0
4612846|NCT01710358|7469784|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1
4612847|NCT01710358|7469782|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0
4612848|NCT01710358|7469783|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0
4612849|NCT01710358|7469784|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1
4612850|NCT01710358|7469782|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0
4612851|NCT01710358|7469783|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0
4612852|NCT01710358|7469784|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1
4612853|NCT01710358|7469782|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0
4612854|NCT01710358|7469783|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1
4612855|NCT01710358|7469784|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0
4612856|NCT01710358|7469782|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1
4612857|NCT01710358|7469783|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2
4612858|NCT01710358|7469784|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0
4612859|NCT01710358|7469782|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4
4612860|NCT01710358|7469783|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3
4612861|NCT01710358|7469784|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7
4612862|NCT01710358|7469782|FG000|Rescue Period|Adverse Event|0
4612863|NCT01710358|7469783|FG001|Rescue Period|Adverse Event|15
4612864|NCT01710358|7469784|FG002|Rescue Period|Adverse Event|0
4612865|NCT01710358|7469782|FG000|Rescue Period|Death|0
4612866|NCT01710358|7469783|FG001|Rescue Period|Death|1
4612867|NCT01710358|7469784|FG002|Rescue Period|Death|0
4612868|NCT01710358|7469782|FG000|Rescue Period|Lack of Efficacy|0
4612869|NCT01710358|7469783|FG001|Rescue Period|Lack of Efficacy|7
4612870|NCT01710358|7469784|FG002|Rescue Period|Lack of Efficacy|0
4612871|NCT01710358|7469782|FG000|Rescue Period|Withdrawal by Subject|0
4612872|NCT01710358|7469783|FG001|Rescue Period|Withdrawal by Subject|8
4612873|NCT01710358|7469784|FG002|Rescue Period|Withdrawal by Subject|0
4612874|NCT01710501|7469808|FG000|Overall Study|Lost to Follow-up|2
4612875|NCT01710501|7469809|FG001|Overall Study|Lost to Follow-up|0
4612876|NCT01710501|7469810|FG002|Overall Study|Lost to Follow-up|0
4612877|NCT01710514|7469820|FG000|Overall Study|Adverse Event|6
4612878|NCT01710514|7469821|FG001|Overall Study|Adverse Event|7
4612879|NCT01710514|7469820|FG000|Overall Study|Withdrawal by Subject|1
4612880|NCT01710514|7469821|FG001|Overall Study|Withdrawal by Subject|0
4612881|NCT01710527|7469830|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0
4612882|NCT01710527|7469831|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1
4612883|NCT01710657|7469840|FG000|Overall Study|Lost to Follow-up|2
4612884|NCT01710657|7469841|FG001|Overall Study|Lost to Follow-up|0
4612885|NCT01710657|7469842|FG002|Overall Study|Lost to Follow-up|1
4612886|NCT01710657|7469840|FG000|Overall Study|Protocol Violation|2
4612887|NCT01710657|7469841|FG001|Overall Study|Protocol Violation|2
4612888|NCT01710657|7469842|FG002|Overall Study|Protocol Violation|0
4612889|NCT01710657|7469840|FG000|Overall Study|Adverse Event|14
4612890|NCT01710657|7469841|FG001|Overall Study|Adverse Event|8
4612891|NCT01710657|7469842|FG002|Overall Study|Adverse Event|28
4612892|NCT01710657|7469840|FG000|Overall Study|Withdrawal by Subject|0
4612893|NCT01710657|7469841|FG001|Overall Study|Withdrawal by Subject|1
4612894|NCT01710657|7469842|FG002|Overall Study|Withdrawal by Subject|2
4612895|NCT01710657|7469840|FG000|Overall Study|Lack of Efficacy|0
4612896|NCT01710657|7469841|FG001|Overall Study|Lack of Efficacy|1
4612897|NCT01710657|7469842|FG002|Overall Study|Lack of Efficacy|1
4459261|NCT00565812|7247160|FG001|Overall Study|Relocated Out of Area|8
4612898|NCT01710709|7469850|FG000|Overall Study|Lost to Follow-up|29
4612899|NCT01710709|7469850|FG000|Overall Study|Adverse Event|48
4612900|NCT01710709|7469850|FG000|Overall Study|Participant met withdrawal criteria|33
4612901|NCT01710709|7469850|FG000|Overall Study|Participant withdrawn by investigator|2
4612902|NCT01710709|7469850|FG000|Overall Study|Withdrawal by Subject|53
4612903|NCT01710709|7469850|FG000|Overall Study|Protocol Violation|5
4612904|NCT01710709|7469850|FG000|Overall Study|Lack of Efficacy|3
4612905|NCT01710800|7469868|FG000|Overall Study|Withdrawal by Subject|21
4612906|NCT01710800|7469868|FG000|Overall Study|Protocol Violation|1
4734817|NCT03505021|7682015|FG001|Overall Study|Personal reason|12
4459262|NCT00565812|7247161|FG002|Overall Study|Relocated Out of Area|9
4459263|NCT00565812|7247159|FG000|Overall Study|Sponsor Decision|1
4459264|NCT00565812|7247160|FG001|Overall Study|Sponsor Decision|5
4459265|NCT00565812|7247161|FG002|Overall Study|Sponsor Decision|1
4459266|NCT00565812|7247159|FG000|Overall Study|Domestic Reasons|7
4459267|NCT00565812|7247160|FG001|Overall Study|Domestic Reasons|1
4459268|NCT00565812|7247161|FG002|Overall Study|Domestic Reasons|3
4612907|NCT01711216|7469905|FG000|Overall Study|Adverse Event|4
4612908|NCT01711216|7469905|FG000|Overall Study|Pregnancy|56
4612909|NCT01711216|7469905|FG000|Overall Study|Withdrawal by Subject|6
4612910|NCT01711216|7469905|FG000|Overall Study|Lost to Follow-up|46
4612911|NCT01711216|7469905|FG000|Overall Study|variety of other minor reasons|83
4612912|NCT01711216|7469905|FG000|Overall Study|no reason specified|22
4612913|NCT01711359|7469925|FG000|Treatment Period|Withdrawal by Subject|18
4612914|NCT01711359|7469926|FG001|Treatment Period|Withdrawal by Subject|7
4612915|NCT01711359|7469927|FG002|Treatment Period|Withdrawal by Subject|13
4612916|NCT01711359|7469925|FG000|Treatment Period|Lack of Efficacy|13
4612917|NCT01711359|7469926|FG001|Treatment Period|Lack of Efficacy|2
4612918|NCT01711359|7469927|FG002|Treatment Period|Lack of Efficacy|2
4612919|NCT01711359|7469925|FG000|Treatment Period|Adverse Event|8
4612920|NCT01711359|7469926|FG001|Treatment Period|Adverse Event|10
4612921|NCT01711359|7469927|FG002|Treatment Period|Adverse Event|24
4612922|NCT01711359|7469925|FG000|Treatment Period|Physician Decision|4
4612923|NCT01711359|7469926|FG001|Treatment Period|Physician Decision|3
4612924|NCT01711359|7469927|FG002|Treatment Period|Physician Decision|2
4612925|NCT01711359|7469925|FG000|Treatment Period|Death|3
4612926|NCT01711359|7469926|FG001|Treatment Period|Death|0
4612927|NCT01711359|7469927|FG002|Treatment Period|Death|0
4612928|NCT01711359|7469925|FG000|Treatment Period|Entry Criteria Not Met|1
4612929|NCT01711359|7469926|FG001|Treatment Period|Entry Criteria Not Met|0
4612930|NCT01711359|7469927|FG002|Treatment Period|Entry Criteria Not Met|0
4612931|NCT01711359|7469925|FG000|Treatment Period|Sponsor Decision|1
4612932|NCT01711359|7469926|FG001|Treatment Period|Sponsor Decision|0
4612933|NCT01711359|7469927|FG002|Treatment Period|Sponsor Decision|0
4612934|NCT01711359|7469925|FG000|Treatment Period|Lost to Follow-up|1
4612935|NCT01711359|7469926|FG001|Treatment Period|Lost to Follow-up|1
4612936|NCT01711359|7469927|FG002|Treatment Period|Lost to Follow-up|1
4612937|NCT01711359|7469925|FG000|Treatment Period|Randomized, Not Treated|3
4612938|NCT01711359|7469926|FG001|Treatment Period|Randomized, Not Treated|1
4612939|NCT01711359|7469927|FG002|Treatment Period|Randomized, Not Treated|0
4612940|NCT01711619|7469954|FG000|Overall Study|Early study termination|10
4612941|NCT01711619|7469955|FG001|Overall Study|Early study termination|14
4612942|NCT01711619|7469954|FG000|Overall Study|Withdrawal by Subject|3
4612943|NCT01711619|7469955|FG001|Overall Study|Withdrawal by Subject|7
4612944|NCT01711619|7469954|FG000|Overall Study|Protocol Violation|2
4612945|NCT01711619|7469955|FG001|Overall Study|Protocol Violation|3
4612946|NCT01711619|7469954|FG000|Overall Study|Adverse Event|2
4612947|NCT01711619|7469955|FG001|Overall Study|Adverse Event|0
4612948|NCT01711619|7469954|FG000|Overall Study|Lost to Follow-up|1
4612949|NCT01711619|7469955|FG001|Overall Study|Lost to Follow-up|0
4612950|NCT01711645|7469961|FG000|Overall Study|Withdrawal by Subject|8
4612951|NCT01711645|7469961|FG000|Overall Study|Lost to Follow-up|6
4612952|NCT01711645|7469961|FG000|Overall Study|Physician Decision|5
4612953|NCT01711736|7469976|FG000|Overall Study|Lost to Follow-up|4
4612954|NCT01711736|7469977|FG001|Overall Study|Lost to Follow-up|1
4612955|NCT01711736|7469976|FG000|Overall Study|Withdrawal by Subject|6
4612956|NCT01711736|7469977|FG001|Overall Study|Withdrawal by Subject|6
4612957|NCT01711736|7469976|FG000|Overall Study|Migrated/moved from study area|2
4612958|NCT01711736|7469977|FG001|Overall Study|Migrated/moved from study area|1
4612959|NCT01711853|7469984|FG000|Overall Study|Not treated|3
4612960|NCT01711866|7469988|FG000|Overall Study|Noncompliant|3
4612961|NCT01711866|7469988|FG000|Overall Study|Withdrawal by Subject|3
4612962|NCT01711866|7469988|FG000|Overall Study|Adverse Event|2
4612963|NCT01711983|7469996|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32
4612964|NCT01711983|7469996|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26
4612965|NCT01711983|7469996|FG000|36-Month Closure Evaluation|Test Device Removal|2
4612966|NCT01711983|7469996|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62
4459269|NCT00565812|7247159|FG000|Overall Study|Research Site Closure|6
4734818|NCT03505593|7682042|FG000|Overall Study|Withdrawal by Subject|1
4612967|NCT01712009|7470003|FG000|Overall Study|Withdrawal by Subject|24
4612968|NCT01712009|7470004|FG001|Overall Study|Withdrawal by Subject|15
4612969|NCT01712009|7470005|FG002|Overall Study|Withdrawal by Subject|8
4612970|NCT01712009|7470003|FG000|Overall Study|Lost to Follow-up|2
4612971|NCT01712009|7470004|FG001|Overall Study|Lost to Follow-up|0
4612972|NCT01712009|7470005|FG002|Overall Study|Lost to Follow-up|1
4612973|NCT01712009|7470003|FG000|Overall Study|Decision by Sponsor|12
4612974|NCT01712009|7470004|FG001|Overall Study|Decision by Sponsor|14
4612975|NCT01712009|7470005|FG002|Overall Study|Decision by Sponsor|12
4612976|NCT01712061|7470015|FG000|Overall Study|Adverse Event|4
4612977|NCT01712061|7470016|FG001|Overall Study|Adverse Event|9
4612978|NCT01712061|7470017|FG002|Overall Study|Adverse Event|5
4612979|NCT01712061|7470015|FG000|Overall Study|Death|0
4612980|NCT01712061|7470016|FG001|Overall Study|Death|0
4612981|NCT01712061|7470017|FG002|Overall Study|Death|1
4612982|NCT01712061|7470015|FG000|Overall Study|Lost to Follow-up|1
4612983|NCT01712061|7470016|FG001|Overall Study|Lost to Follow-up|0
4612984|NCT01712061|7470017|FG002|Overall Study|Lost to Follow-up|1
4459270|NCT00565812|7247160|FG001|Overall Study|Research Site Closure|1
4459271|NCT00565812|7247161|FG002|Overall Study|Research Site Closure|8
4459272|NCT00565812|7247159|FG000|Overall Study|Surgical Intervention|0
4459273|NCT00565812|7247160|FG001|Overall Study|Surgical Intervention|1
4612985|NCT01712061|7470015|FG000|Overall Study|Did Not Meet Entrance Criteria|4
4612986|NCT01712061|7470016|FG001|Overall Study|Did Not Meet Entrance Criteria|6
4612987|NCT01712061|7470017|FG002|Overall Study|Did Not Meet Entrance Criteria|3
4612988|NCT01712061|7470015|FG000|Overall Study|Medication Error Without Associated AE|0
4612989|NCT01712061|7470016|FG001|Overall Study|Medication Error Without Associated AE|1
4612990|NCT01712061|7470017|FG002|Overall Study|Medication Error Without Associated AE|0
4612991|NCT01712061|7470015|FG000|Overall Study|Withdrawal by Subject|1
4612992|NCT01712061|7470016|FG001|Overall Study|Withdrawal by Subject|7
4612993|NCT01712061|7470017|FG002|Overall Study|Withdrawal by Subject|1
4612994|NCT01712061|7470015|FG000|Overall Study|Other|0
4612995|NCT01712061|7470016|FG001|Overall Study|Other|3
4612996|NCT01712061|7470017|FG002|Overall Study|Other|0
4612997|NCT01712074|7470029|FG000|Placebo Run-in Period|Adverse Event|2
4612998|NCT01712074|7470030|FG001|Placebo Run-in Period|Adverse Event|0
4612999|NCT01712074|7470031|FG002|Placebo Run-in Period|Adverse Event|0
4613000|NCT01712074|7470029|FG000|Placebo Run-in Period|Lost to Follow-up|1
4613001|NCT01712074|7470030|FG001|Placebo Run-in Period|Lost to Follow-up|0
4613002|NCT01712074|7470031|FG002|Placebo Run-in Period|Lost to Follow-up|0
4613003|NCT01712074|7470029|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5
4613004|NCT01712074|7470030|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0
4613005|NCT01712074|7470031|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0
4613006|NCT01712074|7470029|FG000|Placebo Run-in Period|Other|1
4613007|NCT01712074|7470030|FG001|Placebo Run-in Period|Other|0
4613008|NCT01712074|7470031|FG002|Placebo Run-in Period|Other|0
4613009|NCT01712074|7470029|FG000|Placebo Run-in Period|No longer willing to participate|1
4613010|NCT01712074|7470030|FG001|Placebo Run-in Period|No longer willing to participate|0
4613011|NCT01712074|7470031|FG002|Placebo Run-in Period|No longer willing to participate|0
4613012|NCT01712074|7470029|FG000|Double Blind Period|Adverse Event|0
4613013|NCT01712074|7470030|FG001|Double Blind Period|Adverse Event|2
4613014|NCT01712074|7470031|FG002|Double Blind Period|Adverse Event|1
4613015|NCT01712074|7470029|FG000|Double Blind Period|No longer willing to participate|0
4613016|NCT01712074|7470030|FG001|Double Blind Period|No longer willing to participate|2
4613017|NCT01712074|7470031|FG002|Double Blind Period|No longer willing to participate|4
4613018|NCT01712074|7470029|FG000|Double Blind Period|Death|0
4613019|NCT01712074|7470030|FG001|Double Blind Period|Death|1
4613020|NCT01712074|7470031|FG002|Double Blind Period|Death|0
4613021|NCT01712074|7470029|FG000|Double Blind Period|Lost to Follow-up|0
4613022|NCT01712074|7470030|FG001|Double Blind Period|Lost to Follow-up|2
4613023|NCT01712074|7470031|FG002|Double Blind Period|Lost to Follow-up|1
4613024|NCT01712074|7470029|FG000|Double Blind Period|Other|0
4613025|NCT01712074|7470030|FG001|Double Blind Period|Other|4
4613026|NCT01712074|7470031|FG002|Double Blind Period|Other|1
4613027|NCT01712074|7470029|FG000|Double Blind Period|Protocol Violation|0
4613028|NCT01712074|7470030|FG001|Double Blind Period|Protocol Violation|0
4613029|NCT01712074|7470031|FG002|Double Blind Period|Protocol Violation|1
4613030|NCT01712074|7470029|FG000|Double Blind Period|No longer met eligibility criteria|0
4613031|NCT01712074|7470030|FG001|Double Blind Period|No longer met eligibility criteria|3
4613032|NCT01712074|7470031|FG002|Double Blind Period|No longer met eligibility criteria|0
4613033|NCT01712178|7470048|FG000|Overall Study|Withdrew consent due to an adverse event|1
4613034|NCT01712178|7470049|FG001|Overall Study|Withdrew consent due to an adverse event|1
4613035|NCT01712178|7470048|FG000|Overall Study|Serious adverse event/withdrew consent|0
4613036|NCT01712178|7470049|FG001|Overall Study|Serious adverse event/withdrew consent|1
4613037|NCT01712178|7470048|FG000|Overall Study|Lost to Follow-up|0
4613038|NCT01712178|7470049|FG001|Overall Study|Lost to Follow-up|1
4613039|NCT01712204|7470057|FG000|Overall Study|Adverse Event|3
4613040|NCT01712204|7470058|FG001|Overall Study|Adverse Event|1
4613041|NCT01712204|7470057|FG000|Overall Study|Withdrawal by Subject|3
4613042|NCT01712204|7470058|FG001|Overall Study|Withdrawal by Subject|3
4613043|NCT01712204|7470057|FG000|Overall Study|Lost to Follow-up|1
4613044|NCT01712204|7470058|FG001|Overall Study|Lost to Follow-up|0
4613045|NCT01712204|7470057|FG000|Overall Study|Protocol Violation|1
4613046|NCT01712204|7470058|FG001|Overall Study|Protocol Violation|1
4613047|NCT01712256|7470077|FG000|Overall Study|Lost to Follow-up|1
4613048|NCT01712334|7470081|FG000|Treatment Period 1|Randomized in Error|0
4613049|NCT01712334|7470082|FG001|Treatment Period 1|Randomized in Error|2
4613050|NCT01712399|7470111|FG000|Overall Study|Lost to Follow-up|1
4613051|NCT01712399|7470111|FG000|Overall Study|Withdrawal by Subject|39
4613052|NCT01712399|7470111|FG000|Overall Study|Death|1
4613053|NCT01712399|7470111|FG000|Overall Study|Adverse Event|11
4613054|NCT01712399|7470111|FG000|Overall Study|Study closure|345
4613055|NCT01712438|7470115|FG000|Overall Study|Not treated with Human-cl rhFVIII|2
4613056|NCT01712438|7470115|FG000|Overall Study|Ongoing ITI treatment|6
4613057|NCT01712438|7470115|FG000|Overall Study|Violated inclusion & exclusion criteria|4
4613058|NCT01712438|7470115|FG000|Overall Study|Prematurely Discontinued|25
4613059|NCT01712516|7470128|FG000|Overall Study|Technical problems|0
4613060|NCT01712516|7470129|FG001|Overall Study|Technical problems|0
4613061|NCT01712516|7470130|FG002|Overall Study|Technical problems|0
4459274|NCT00565812|7247161|FG002|Overall Study|Surgical Intervention|2
4459275|NCT00565812|7247159|FG000|Overall Study|Low Compliance|1
4459276|NCT00565812|7247160|FG001|Overall Study|Low Compliance|0
4459277|NCT00565812|7247161|FG002|Overall Study|Low Compliance|1
4459278|NCT00565812|7247159|FG000|Overall Study|Follow-up Visit Not Completed|2
4459279|NCT00565812|7247160|FG001|Overall Study|Follow-up Visit Not Completed|0
4459280|NCT00565812|7247161|FG002|Overall Study|Follow-up Visit Not Completed|1
4459281|NCT00565812|7247159|FG000|Overall Study|Physician Decision|2
4459282|NCT00565812|7247160|FG001|Overall Study|Physician Decision|0
4459283|NCT00565812|7247161|FG002|Overall Study|Physician Decision|0
4459284|NCT00566020|7247193|FG000|6-week Dosage Adjustment Phase|Adverse Event|5
4459285|NCT00566020|7247194|FG001|6-week Dosage Adjustment Phase|Adverse Event|0
4459286|NCT00566020|7247193|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2
4459287|NCT00566020|7247194|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0
4459288|NCT00566020|7247193|FG000|46-week Long-term Administration Phase|Adverse Event|0
4459289|NCT00566020|7247194|FG001|46-week Long-term Administration Phase|Adverse Event|7
4459290|NCT00566020|7247193|FG000|46-week Long-term Administration Phase|Physician Decision|0
4459291|NCT00566020|7247194|FG001|46-week Long-term Administration Phase|Physician Decision|7
4459292|NCT00566020|7247193|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0
4459293|NCT00566020|7247194|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2
4459294|NCT00566020|7247193|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0
4459295|NCT00566020|7247194|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1
4459296|NCT00566098|7247199|FG000|Collection of MILs|Withdrawal by Subject|1
4459297|NCT00566098|7247199|FG000|Collection of MILs|Relapsed|1
4459298|NCT00566098|7247199|FG000|Generation of MILs Product|Relapsed|1
4459299|NCT00566098|7247199|FG000|Administration of ASCT+MILs|Death|10
4459300|NCT00566098|7247199|FG000|Administration of ASCT+MILs|Lack of Efficacy|8
4459301|NCT00566111|7247206|FG000|Overall Study|Adverse Event|0
4459302|NCT00566111|7247207|FG001|Overall Study|Adverse Event|2
4459303|NCT00566228|7247224|FG000|Overall Study|Withdrawal by Subject|1
4459304|NCT00566228|7247225|FG001|Overall Study|Withdrawal by Subject|0
4459305|NCT00566228|7247224|FG000|Overall Study|Attempt to mobilize stem cells failed|2
4459306|NCT00566228|7247225|FG001|Overall Study|Attempt to mobilize stem cells failed|2
4459307|NCT00566228|7247224|FG000|Overall Study|Unable to collect sufficient CD34 cells|3
4459308|NCT00566228|7247225|FG001|Overall Study|Unable to collect sufficient CD34 cells|2
4459309|NCT00566228|7247224|FG000|Overall Study|progressed before infusion could occur|0
4459310|NCT00566228|7247225|FG001|Overall Study|progressed before infusion could occur|1
4459311|NCT00566254|7247233|FG000|Overall Study|Adverse Event|3
4459312|NCT00566254|7247234|FG001|Overall Study|Adverse Event|1
4459313|NCT00566254|7247233|FG000|Overall Study|Protocol Violation|1
4459314|NCT00566254|7247234|FG001|Overall Study|Protocol Violation|3
4459315|NCT00566254|7247233|FG000|Overall Study|Withdrawal by Subject|1
4459316|NCT00566254|7247234|FG001|Overall Study|Withdrawal by Subject|2
4459317|NCT00566254|7247233|FG000|Overall Study|Lack of Efficacy|5
4459318|NCT00566254|7247234|FG001|Overall Study|Lack of Efficacy|6
4459319|NCT00566254|7247233|FG000|Overall Study|Other|0
4459320|NCT00566254|7247234|FG001|Overall Study|Other|2
4459321|NCT00566501|7247242|FG000|Overall Study|Adverse Event|68
4459322|NCT00566501|7247243|FG001|Overall Study|Adverse Event|59
4459323|NCT00566501|7247242|FG000|Overall Study|Medication Non-compliance|5
4459324|NCT00566501|7247243|FG001|Overall Study|Medication Non-compliance|0
4459325|NCT00566501|7247242|FG000|Overall Study|Protocol Violation|2
4459326|NCT00566501|7247243|FG001|Overall Study|Protocol Violation|2
4459327|NCT00566501|7247242|FG000|Overall Study|Request of Investigator or Sponsor|6
4459328|NCT00566501|7247243|FG001|Overall Study|Request of Investigator or Sponsor|7
4459329|NCT00566501|7247242|FG000|Overall Study|Withdrawal by Subject|33
4459330|NCT00566501|7247243|FG001|Overall Study|Withdrawal by Subject|30
4459331|NCT00566501|7247242|FG000|Overall Study|Lack of Efficacy|8
4459332|NCT00566501|7247243|FG001|Overall Study|Lack of Efficacy|3
4459333|NCT00566501|7247242|FG000|Overall Study|Other|25
4459334|NCT00566501|7247243|FG001|Overall Study|Other|21
4459335|NCT00566527|7247252|FG000|Overall Study|Reason not provided|3
4459336|NCT00566527|7247253|FG001|Overall Study|Reason not provided|11
4459337|NCT00566527|7247254|FG002|Overall Study|Reason not provided|10
4459338|NCT00566527|7247252|FG000|Overall Study|Adverse Event|2
4459339|NCT00566527|7247253|FG001|Overall Study|Adverse Event|0
4459340|NCT00566527|7247254|FG002|Overall Study|Adverse Event|1
4459341|NCT00566527|7247252|FG000|Overall Study|Physician Decision|3
4459342|NCT00566527|7247253|FG001|Overall Study|Physician Decision|8
4459343|NCT00566527|7247254|FG002|Overall Study|Physician Decision|20
4459344|NCT00566527|7247252|FG000|Overall Study|Lost to Follow-up|3
4459345|NCT00566527|7247253|FG001|Overall Study|Lost to Follow-up|4
4459346|NCT00566527|7247254|FG002|Overall Study|Lost to Follow-up|4
4459347|NCT00566527|7247252|FG000|Overall Study|Withdrawal by Subject|6
4459348|NCT00566527|7247253|FG001|Overall Study|Withdrawal by Subject|43
4459349|NCT00566527|7247254|FG002|Overall Study|Withdrawal by Subject|43
4459350|NCT00566631|7247277|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18
4459351|NCT00566631|7247277|FG000|Part 1: Core Treatment Phase|Physician Decision|1
4459352|NCT00566631|7247277|FG000|Part 1: Core Treatment Phase|Adverse Event|9
4459353|NCT00566631|7247277|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4
4459354|NCT00566631|7247277|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26
4539051|NCT01124864|7361317|FG000|Overall Study|Follow up phase competed as per protocol|18
4539052|NCT01124864|7361318|FG001|Overall Study|Follow up phase competed as per protocol|22
4539053|NCT01124864|7361319|FG002|Overall Study|Follow up phase competed as per protocol|24
4539054|NCT01124864|7361320|FG003|Overall Study|Follow up phase competed as per protocol|18
4539055|NCT01124864|7361321|FG004|Overall Study|Follow up phase competed as per protocol|26
4539056|NCT01124864|7361322|FG005|Overall Study|Follow up phase competed as per protocol|2
4539057|NCT01124864|7361317|FG000|Overall Study|Death|6
4539058|NCT01124864|7361318|FG001|Overall Study|Death|9
4539059|NCT01124864|7361319|FG002|Overall Study|Death|6
4539060|NCT01124864|7361320|FG003|Overall Study|Death|2
4539061|NCT01124864|7361321|FG004|Overall Study|Death|1
4539062|NCT01124864|7361322|FG005|Overall Study|Death|0
4539063|NCT01124864|7361317|FG000|Overall Study|Withdrawal by Subject|2
4539064|NCT01124864|7361318|FG001|Overall Study|Withdrawal by Subject|3
4539065|NCT01124864|7361319|FG002|Overall Study|Withdrawal by Subject|4
4539066|NCT01124864|7361320|FG003|Overall Study|Withdrawal by Subject|0
4539067|NCT01124864|7361321|FG004|Overall Study|Withdrawal by Subject|2
4539068|NCT01124864|7361322|FG005|Overall Study|Withdrawal by Subject|1
4539069|NCT01124864|7361317|FG000|Overall Study|Lost to Follow-up|1
4539070|NCT01124864|7361318|FG001|Overall Study|Lost to Follow-up|1
4539071|NCT01124864|7361319|FG002|Overall Study|Lost to Follow-up|0
4539072|NCT01124864|7361320|FG003|Overall Study|Lost to Follow-up|1
4539073|NCT01124864|7361321|FG004|Overall Study|Lost to Follow-up|0
4539074|NCT01124864|7361322|FG005|Overall Study|Lost to Follow-up|0
4539075|NCT01124864|7361317|FG000|Overall Study|Protocol Violation|1
4539076|NCT01124864|7361318|FG001|Overall Study|Protocol Violation|0
4539077|NCT01124864|7361319|FG002|Overall Study|Protocol Violation|0
4539078|NCT01124864|7361320|FG003|Overall Study|Protocol Violation|0
4539079|NCT01124864|7361321|FG004|Overall Study|Protocol Violation|1
4539080|NCT01124864|7361322|FG005|Overall Study|Protocol Violation|0
4539081|NCT01124916|7361340|FG000|Overall Study|Lost to Follow-up|3
4539082|NCT01124916|7361341|FG001|Overall Study|Lost to Follow-up|2
4539083|NCT01125046|7361356|FG000|First 6 Months of Treatment|Death|1
4539084|NCT01125046|7361356|FG000|First 6 Months of Treatment|Withdrawal by Subject|2
4539085|NCT01125046|7361356|FG000|First 6 Months of Treatment|Non-compliance|1
4539086|NCT01125046|7361356|FG000|First 6 Months of Treatment|Surgery|1
4539087|NCT01125046|7361356|FG000|First 6 Months of Treatment|Progressive Disease|7
4539088|NCT01125046|7361356|FG000|First 6 Months of Treatment|Adverse Event|2
4539089|NCT01125046|7361356|FG000|Continued Treatment After 6 Months|Progressive Disease|2
4539090|NCT01125046|7361356|FG000|Continued Treatment After 6 Months|Adverse Event|1
4539091|NCT01125046|7361356|FG000|Follow-up/Data Cut Off Point|Death|29
4539092|NCT01125046|7361356|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4
4539093|NCT01125189|7361382|FG000|Treatment Period|Lack of Efficacy|15
4539094|NCT01125189|7361383|FG001|Treatment Period|Lack of Efficacy|18
4539095|NCT01125189|7361384|FG002|Treatment Period|Lack of Efficacy|25
4539096|NCT01125189|7361382|FG000|Treatment Period|Adverse Event|7
4539097|NCT01125189|7361383|FG001|Treatment Period|Adverse Event|8
4539098|NCT01125189|7361384|FG002|Treatment Period|Adverse Event|8
4539099|NCT01125189|7361382|FG000|Treatment Period|Withdrawal by Subject|3
4539100|NCT01125189|7361383|FG001|Treatment Period|Withdrawal by Subject|1
4539101|NCT01125189|7361384|FG002|Treatment Period|Withdrawal by Subject|1
4539102|NCT01125189|7361382|FG000|Treatment Period|Death|1
4539103|NCT01125189|7361383|FG001|Treatment Period|Death|0
4539104|NCT01125189|7361384|FG002|Treatment Period|Death|0
4539105|NCT01125189|7361382|FG000|Treatment Period|Lost to Follow-up|1
4539106|NCT01125189|7361383|FG001|Treatment Period|Lost to Follow-up|2
4539107|NCT01125189|7361384|FG002|Treatment Period|Lost to Follow-up|1
4539108|NCT01125189|7361382|FG000|Treatment Period|Poor compliance/noncompliance|0
4539109|NCT01125189|7361383|FG001|Treatment Period|Poor compliance/noncompliance|1
4539110|NCT01125189|7361384|FG002|Treatment Period|Poor compliance/noncompliance|0
4459355|NCT00566631|7247277|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1
4459356|NCT00566631|7247277|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1
4459357|NCT00566631|7247277|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95
4459358|NCT00566631|7247277|FG000|Part 2: Extension Phase|Lack of Efficacy|25
4459359|NCT00566631|7247277|FG000|Part 2: Extension Phase|Withdrawal by Subject|34
4459360|NCT00566631|7247277|FG000|Part 2: Extension Phase|Adverse Event|11
4459361|NCT00566631|7247277|FG000|Part 2: Extension Phase|Lost to Follow-up|6
4459362|NCT00566631|7247277|FG000|Part 2: Extension Phase|Death|1
4459363|NCT00566631|7247277|FG000|Part 2: Extension Phase|Other|5
4459364|NCT00566696|7247281|FG000|Overall Study|Met Exclusion Criteria|2
4459365|NCT00566696|7247281|FG000|Overall Study|Muromonab not available|1
4459366|NCT00566696|7247281|FG000|Overall Study|Health Status Change|1
4459367|NCT00566696|7247281|FG000|Overall Study|Physician Decision|1
4459368|NCT00566696|7247281|FG000|Overall Study|Non-Patient Donors|37
4459369|NCT00566709|7247287|FG000|Overall Study|Protocol Violation|5
4459370|NCT00566709|7247288|FG001|Overall Study|Protocol Violation|0
4459371|NCT00566722|7247297|FG000|Overall Study|Adverse Event|0
4459372|NCT00566722|7247298|FG001|Overall Study|Adverse Event|1
4459373|NCT00566722|7247299|FG002|Overall Study|Adverse Event|0
4459374|NCT00566722|7247297|FG000|Overall Study|Withdrawal by Subject|0
4459375|NCT00566722|7247298|FG001|Overall Study|Withdrawal by Subject|0
4459376|NCT00566722|7247299|FG002|Overall Study|Withdrawal by Subject|1
4459377|NCT00566722|7247297|FG000|Overall Study|Lost to Follow-up|1
4459378|NCT00566722|7247298|FG001|Overall Study|Lost to Follow-up|1
4459379|NCT00566722|7247299|FG002|Overall Study|Lost to Follow-up|1
4459380|NCT00566722|7247297|FG000|Overall Study|Lack of Efficacy|1
4459381|NCT00566722|7247298|FG001|Overall Study|Lack of Efficacy|2
4459382|NCT00566722|7247299|FG002|Overall Study|Lack of Efficacy|4
4459383|NCT00566722|7247297|FG000|Overall Study|Did not meet exclusion criteria|0
4459384|NCT00566722|7247298|FG001|Overall Study|Did not meet exclusion criteria|0
4459385|NCT00566722|7247299|FG002|Overall Study|Did not meet exclusion criteria|2
4459386|NCT00566722|7247297|FG000|Overall Study|Serious adverse event|0
4459387|NCT00566722|7247298|FG001|Overall Study|Serious adverse event|1
4459388|NCT00566722|7247299|FG002|Overall Study|Serious adverse event|0
4459389|NCT00566722|7247297|FG000|Overall Study|Noncompliant with drug administration|0
4459390|NCT00566722|7247298|FG001|Overall Study|Noncompliant with drug administration|0
4459391|NCT00566722|7247299|FG002|Overall Study|Noncompliant with drug administration|1
4459392|NCT00566735|7247312|FG000|Overall Study|Withdrawal by Subject|0
4459393|NCT00566735|7247313|FG001|Overall Study|Withdrawal by Subject|1
4459394|NCT00566735|7247312|FG000|Overall Study|Refused neuropsychological testing|2
4459395|NCT00566735|7247313|FG001|Overall Study|Refused neuropsychological testing|5
4459396|NCT00566735|7247312|FG000|Overall Study|Switched into a manic episode|0
4459397|NCT00566735|7247313|FG001|Overall Study|Switched into a manic episode|1
4459398|NCT00566852|7247330|FG000|Overall Study|Protocol Violation|22
4459399|NCT00566852|7247331|FG001|Overall Study|Protocol Violation|24
4459400|NCT00566852|7247330|FG000|Overall Study|Death|95
4459401|NCT00566852|7247331|FG001|Overall Study|Death|78
4459402|NCT00566852|7247330|FG000|Overall Study|Withdrawal by Subject|30
4459403|NCT00566852|7247331|FG001|Overall Study|Withdrawal by Subject|25
4459404|NCT00566852|7247330|FG000|Overall Study|Patient refusal|37
4459405|NCT00566852|7247331|FG001|Overall Study|Patient refusal|37
4459406|NCT00566852|7247330|FG000|Overall Study|Not tested due to disability|6
4459407|NCT00566852|7247331|FG001|Overall Study|Not tested due to disability|12
4459408|NCT00566852|7247330|FG000|Overall Study|Missing reason not specified|1
4459409|NCT00566852|7247331|FG001|Overall Study|Missing reason not specified|2
4459410|NCT00566852|7247330|FG000|Overall Study|Missing reason not reported|16
4459411|NCT00566852|7247331|FG001|Overall Study|Missing reason not reported|20
4459412|NCT00566982|7247380|FG000|Overall Study|Adverse Event|6
4459413|NCT00566982|7247381|FG001|Overall Study|Adverse Event|48
4459414|NCT00566982|7247380|FG000|Overall Study|Withdrawal by Subject|1
4459415|NCT00566982|7247381|FG001|Overall Study|Withdrawal by Subject|14
4459416|NCT00566982|7247380|FG000|Overall Study|Protocol Violation|1
4459417|NCT00566982|7247381|FG001|Overall Study|Protocol Violation|4
4459418|NCT00566982|7247380|FG000|Overall Study|Lost to Follow-up|0
4459419|NCT00566982|7247381|FG001|Overall Study|Lost to Follow-up|1
4459420|NCT00566982|7247380|FG000|Overall Study|Other-family problems & doctor's request|0
4459421|NCT00566982|7247381|FG001|Overall Study|Other-family problems & doctor's request|2
4459422|NCT00567112|7247399|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0
4459423|NCT00567112|7247400|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1
4459424|NCT00567112|7247401|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0
4459425|NCT00567112|7247399|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2
4459426|NCT00567112|7247400|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0
4459427|NCT00567112|7247401|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0
4459428|NCT00567112|7247399|FG000|Washout Period 3 (3 Days)|Protocol Violation|1
4459429|NCT00567112|7247400|FG001|Washout Period 3 (3 Days)|Protocol Violation|0
4459430|NCT00567112|7247401|FG002|Washout Period 3 (3 Days)|Protocol Violation|0
4459431|NCT00567164|7247413|FG000|Overall Study|Withdrawal by Subject|171
4459432|NCT00567164|7247414|FG001|Overall Study|Withdrawal by Subject|21
4459433|NCT00567164|7247415|FG002|Overall Study|Withdrawal by Subject|17
4459434|NCT00567164|7247413|FG000|Overall Study|Protocol Violation|23
4459435|NCT00567164|7247414|FG001|Overall Study|Protocol Violation|4
4459436|NCT00567164|7247415|FG002|Overall Study|Protocol Violation|2
4459437|NCT00567164|7247413|FG000|Overall Study|Adverse Event|92
4459438|NCT00567164|7247414|FG001|Overall Study|Adverse Event|13
4459439|NCT00567164|7247415|FG002|Overall Study|Adverse Event|9
4459440|NCT00567164|7247413|FG000|Overall Study|Death|0
4459441|NCT00567164|7247414|FG001|Overall Study|Death|0
4459442|NCT00567164|7247415|FG002|Overall Study|Death|1
4459443|NCT00567164|7247413|FG000|Overall Study|Lost to Follow-up|202
4459444|NCT00567164|7247414|FG001|Overall Study|Lost to Follow-up|23
4459445|NCT00567164|7247415|FG002|Overall Study|Lost to Follow-up|21
4459446|NCT00567164|7247413|FG000|Overall Study|Pregnancy|20
4459447|NCT00567164|7247414|FG001|Overall Study|Pregnancy|4
4459448|NCT00567164|7247415|FG002|Overall Study|Pregnancy|6
4459449|NCT00567164|7247413|FG000|Overall Study|Primary Reason coded as 'Other'|37
4459450|NCT00567164|7247414|FG001|Overall Study|Primary Reason coded as 'Other'|8
4459451|NCT00567164|7247415|FG002|Overall Study|Primary Reason coded as 'Other'|16
4459452|NCT00567164|7247413|FG000|Overall Study|Missing|1
4459453|NCT00567164|7247414|FG001|Overall Study|Missing|0
4459454|NCT00567164|7247415|FG002|Overall Study|Missing|0
4459455|NCT00567190|7247429|FG000|Overall Study|Death|235
4459456|NCT00567190|7247430|FG001|Overall Study|Death|280
4459457|NCT00567190|7247429|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48
4459458|NCT00567190|7247430|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53
4459459|NCT00567255|7247456|FG000|Overall Study|Adverse Event|241
4459460|NCT00567255|7247457|FG001|Overall Study|Adverse Event|68
4459461|NCT00567255|7247456|FG000|Overall Study|Lost to Follow-up|77
4459462|NCT00567255|7247457|FG001|Overall Study|Lost to Follow-up|48
4459463|NCT00567255|7247456|FG000|Overall Study|Withdrawal by Subject|75
4459464|NCT00567255|7247457|FG001|Overall Study|Withdrawal by Subject|56
4459465|NCT00567255|7247456|FG000|Overall Study|Lack of Efficacy|19
4459466|NCT00567255|7247457|FG001|Overall Study|Lack of Efficacy|33
4459467|NCT00567255|7247456|FG000|Overall Study|Protocol Violation|20
4459468|NCT00567255|7247457|FG001|Overall Study|Protocol Violation|8
4459469|NCT00567255|7247456|FG000|Overall Study|Pregnancy|6
4459470|NCT00567255|7247457|FG001|Overall Study|Pregnancy|0
4459471|NCT00567255|7247456|FG000|Overall Study|Drug noncompliance,moved,other|25
4459472|NCT00567255|7247457|FG001|Overall Study|Drug noncompliance,moved,other|15
4515918|NCT00957229|7327081|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1
4515919|NCT00957268|7327103|FG000|Overall Study|Voluntary Withdrawal|0
4515920|NCT00957268|7327104|FG001|Overall Study|Voluntary Withdrawal|0
4515921|NCT00957268|7327105|FG002|Overall Study|Voluntary Withdrawal|1
4515922|NCT00957268|7327106|FG003|Overall Study|Voluntary Withdrawal|0
4515923|NCT00957268|7327107|FG004|Overall Study|Voluntary Withdrawal|0
4515924|NCT00957372|7327135|FG000|PART I|Lost to Follow-up|0
4515925|NCT00957372|7327136|FG001|PART I|Lost to Follow-up|0
4515926|NCT00957372|7327137|FG002|PART I|Lost to Follow-up|1
4515927|NCT00957372|7327138|FG003|PART I|Lost to Follow-up|0
4515928|NCT00957372|7327135|FG000|PART II|Withdrawal by Subject|0
4515929|NCT00957372|7327136|FG001|PART II|Withdrawal by Subject|0
4515930|NCT00957372|7327137|FG002|PART II|Withdrawal by Subject|0
4515931|NCT00957372|7327138|FG003|PART II|Withdrawal by Subject|8
4515932|NCT00957372|7327135|FG000|PART II|Physician Decision|0
4515933|NCT00957372|7327136|FG001|PART II|Physician Decision|0
4515934|NCT00957372|7327137|FG002|PART II|Physician Decision|0
4613062|NCT01712516|7470131|FG003|Overall Study|Technical problems|2
4613063|NCT01712516|7470128|FG000|Overall Study|Lost to Follow-up|0
4613064|NCT01712516|7470129|FG001|Overall Study|Lost to Follow-up|0
4613065|NCT01712516|7470130|FG002|Overall Study|Lost to Follow-up|2
4613066|NCT01712516|7470131|FG003|Overall Study|Lost to Follow-up|1
4613067|NCT01712516|7470128|FG000|Overall Study|Death|0
4613068|NCT01712516|7470129|FG001|Overall Study|Death|1
4613069|NCT01712516|7470130|FG002|Overall Study|Death|0
4613070|NCT01712516|7470131|FG003|Overall Study|Death|0
4613071|NCT01712516|7470128|FG000|Overall Study|Protocol deviation|1
4613072|NCT01712516|7470129|FG001|Overall Study|Protocol deviation|0
4613073|NCT01712516|7470130|FG002|Overall Study|Protocol deviation|1
4515935|NCT00957372|7327138|FG003|PART II|Physician Decision|1
4515936|NCT00957372|7327135|FG000|PART II|Pregnancy|0
4515937|NCT00957372|7327136|FG001|PART II|Pregnancy|0
4515938|NCT00957372|7327137|FG002|PART II|Pregnancy|0
4515939|NCT00957372|7327138|FG003|PART II|Pregnancy|1
4515940|NCT00957372|7327135|FG000|PART II|Not Know|0
4515941|NCT00957372|7327136|FG001|PART II|Not Know|0
4515942|NCT00957372|7327137|FG002|PART II|Not Know|0
4515943|NCT00957372|7327138|FG003|PART II|Not Know|20
4515944|NCT00957372|7327135|FG000|PART II|Adverse Event|0
4515945|NCT00957372|7327136|FG001|PART II|Adverse Event|0
4515946|NCT00957372|7327137|FG002|PART II|Adverse Event|0
4515947|NCT00957372|7327138|FG003|PART II|Adverse Event|10
4515948|NCT00957372|7327135|FG000|PART II|Patient non-compliance|0
4515949|NCT00957372|7327136|FG001|PART II|Patient non-compliance|0
4515950|NCT00957372|7327137|FG002|PART II|Patient non-compliance|0
4515951|NCT00957372|7327138|FG003|PART II|Patient non-compliance|4
4515952|NCT00957424|7327154|FG000|Overall Study|Lost to Follow-up|19
4613074|NCT01712516|7470131|FG003|Overall Study|Protocol deviation|0
4613075|NCT01712516|7470128|FG000|Overall Study|Physician Decision|2
4613076|NCT01712516|7470129|FG001|Overall Study|Physician Decision|0
4613077|NCT01712516|7470130|FG002|Overall Study|Physician Decision|0
4613078|NCT01712516|7470131|FG003|Overall Study|Physician Decision|1
4459473|NCT00567268|7247463|FG000|Overall Study|Protocol Violation|7
4459474|NCT00567268|7247463|FG000|Overall Study|Lost to Follow-up|36
4459475|NCT00567268|7247463|FG000|Overall Study|No Visit After First Day of Treatment|2
4459476|NCT00567268|7247463|FG000|Overall Study|No Drug Administration|4
4459477|NCT00567268|7247463|FG000|Overall Study|"Safety Evaluation Not Assessable"|1
4459478|NCT00567359|7247520|FG000|Overall Study|Withdrawal by Subject|1
4459479|NCT00567398|7247526|FG000|Overall Study|Adverse Event|6
4459480|NCT00567398|7247527|FG001|Overall Study|Adverse Event|14
4459481|NCT00567398|7247526|FG000|Overall Study|Physician Decision|0
4459482|NCT00567398|7247527|FG001|Overall Study|Physician Decision|4
4459483|NCT00567398|7247526|FG000|Overall Study|Withdrawal by Subject|0
4459484|NCT00567398|7247527|FG001|Overall Study|Withdrawal by Subject|2
4459485|NCT00567398|7247526|FG000|Overall Study|Renal Transplantation|0
4459486|NCT00567398|7247527|FG001|Overall Study|Renal Transplantation|3
4459487|NCT00567398|7247526|FG000|Overall Study|Other|1
4459488|NCT00567398|7247527|FG001|Overall Study|Other|0
4459489|NCT00567476|7247535|FG000|Overall Study|Adverse Event|2
4459490|NCT00567476|7247536|FG001|Overall Study|Adverse Event|0
4459491|NCT00567476|7247535|FG000|Overall Study|Pregnancy|1
4459492|NCT00567476|7247536|FG001|Overall Study|Pregnancy|0
4459493|NCT00567476|7247535|FG000|Overall Study|Protocol Violation|4
4459494|NCT00567476|7247536|FG001|Overall Study|Protocol Violation|1
4459495|NCT00567476|7247535|FG000|Overall Study|Lost to Follow-up|0
4459496|NCT00567476|7247536|FG001|Overall Study|Lost to Follow-up|1
4459497|NCT00567476|7247535|FG000|Overall Study|Administrative issues|1
4459498|NCT00567476|7247536|FG001|Overall Study|Administrative issues|0
4459499|NCT00567476|7247535|FG000|Overall Study|Medical Decision|0
4459500|NCT00567476|7247536|FG001|Overall Study|Medical Decision|1
4459501|NCT00567476|7247535|FG000|Overall Study|Non-adherence to protocol|0
4459502|NCT00567476|7247536|FG001|Overall Study|Non-adherence to protocol|1
4459503|NCT00567489|7247544|FG000|Overall Study|Adverse Event|6
4459504|NCT00567489|7247545|FG001|Overall Study|Adverse Event|14
4459505|NCT00567489|7247544|FG000|Overall Study|Physician Decision|0
4459506|NCT00567489|7247545|FG001|Overall Study|Physician Decision|4
4459507|NCT00567489|7247544|FG000|Overall Study|Withdrawal by Subject|0
4459508|NCT00567489|7247545|FG001|Overall Study|Withdrawal by Subject|2
4459509|NCT00567489|7247544|FG000|Overall Study|Renal Transplantation|0
4459510|NCT00567489|7247545|FG001|Overall Study|Renal Transplantation|3
4459511|NCT00567489|7247544|FG000|Overall Study|Other|1
4459512|NCT00567489|7247545|FG001|Overall Study|Other|0
4459513|NCT00567502|7247555|FG000|Overall Study|Lost to Follow-up|91
4459514|NCT00567502|7247556|FG001|Overall Study|Lost to Follow-up|14
4459515|NCT00567502|7247557|FG002|Overall Study|Lost to Follow-up|351
4459516|NCT00567502|7247558|FG003|Overall Study|Lost to Follow-up|2
4459517|NCT00567502|7247555|FG000|Overall Study|Death|65
4459518|NCT00567502|7247556|FG001|Overall Study|Death|16
4459519|NCT00567502|7247557|FG002|Overall Study|Death|360
4459520|NCT00567502|7247558|FG003|Overall Study|Death|5
4459521|NCT00567502|7247555|FG000|Overall Study|Other|64
4459522|NCT00567502|7247556|FG001|Overall Study|Other|2
4459523|NCT00567502|7247557|FG002|Overall Study|Other|134
4459524|NCT00567502|7247558|FG003|Overall Study|Other|6
4459525|NCT00567502|7247555|FG000|Overall Study|Participant request|12
4459526|NCT00567502|7247556|FG001|Overall Study|Participant request|1
4459527|NCT00567502|7247557|FG002|Overall Study|Participant request|33
4459528|NCT00567502|7247558|FG003|Overall Study|Participant request|1
4459529|NCT00567502|7247555|FG000|Overall Study|Sponsor request|9
4459530|NCT00567502|7247556|FG001|Overall Study|Sponsor request|0
4459531|NCT00567502|7247557|FG002|Overall Study|Sponsor request|30
4459532|NCT00567502|7247558|FG003|Overall Study|Sponsor request|1
4459533|NCT00567502|7247555|FG000|Overall Study|Never Initiated Treatment|0
4459534|NCT00567502|7247556|FG001|Overall Study|Never Initiated Treatment|0
4459535|NCT00567502|7247557|FG002|Overall Study|Never Initiated Treatment|0
4459536|NCT00567502|7247558|FG003|Overall Study|Never Initiated Treatment|72
4459537|NCT00567541|7247581|FG000|Overall Study|Adverse Event|0
4459538|NCT00567541|7247582|FG001|Overall Study|Adverse Event|1
4459539|NCT00567593|7247588|FG000|Overall Study|Adverse Event|1
4459540|NCT00567593|7247588|FG000|Overall Study|Physician Decision|1
4459541|NCT00567879|7247619|FG000|Overall Study|Adverse Event|2
4459542|NCT00567879|7247620|FG001|Overall Study|Adverse Event|0
4459543|NCT00567879|7247621|FG002|Overall Study|Adverse Event|1
4459544|NCT00567879|7247622|FG003|Overall Study|Adverse Event|0
4459545|NCT00567879|7247623|FG004|Overall Study|Adverse Event|1
4459546|NCT00567879|7247624|FG005|Overall Study|Adverse Event|0
4459547|NCT00567879|7247619|FG000|Overall Study|Abnormal test procedure(s)|0
4459548|NCT00567879|7247620|FG001|Overall Study|Abnormal test procedure(s)|0
4459549|NCT00567879|7247621|FG002|Overall Study|Abnormal test procedure(s)|1
4459550|NCT00567879|7247622|FG003|Overall Study|Abnormal test procedure(s)|0
4459551|NCT00567879|7247623|FG004|Overall Study|Abnormal test procedure(s)|0
4459552|NCT00567879|7247624|FG005|Overall Study|Abnormal test procedure(s)|0
4459553|NCT00567879|7247619|FG000|Overall Study|Withdrawal by Subject|0
4459554|NCT00567879|7247620|FG001|Overall Study|Withdrawal by Subject|0
4459555|NCT00567879|7247621|FG002|Overall Study|Withdrawal by Subject|3
4459556|NCT00567879|7247622|FG003|Overall Study|Withdrawal by Subject|1
4459557|NCT00567879|7247623|FG004|Overall Study|Withdrawal by Subject|0
4459558|NCT00567879|7247624|FG005|Overall Study|Withdrawal by Subject|0
4459559|NCT00567879|7247619|FG000|Overall Study|New cancer therapy|0
4459560|NCT00567879|7247620|FG001|Overall Study|New cancer therapy|0
4459561|NCT00567879|7247621|FG002|Overall Study|New cancer therapy|1
4459562|NCT00567879|7247622|FG003|Overall Study|New cancer therapy|0
4459563|NCT00567879|7247623|FG004|Overall Study|New cancer therapy|0
4459564|NCT00567879|7247624|FG005|Overall Study|New cancer therapy|0
4459565|NCT00567879|7247619|FG000|Overall Study|Disease progression|5
4459566|NCT00567879|7247620|FG001|Overall Study|Disease progression|7
4459567|NCT00567879|7247621|FG002|Overall Study|Disease progression|15
4459568|NCT00567879|7247622|FG003|Overall Study|Disease progression|5
4459569|NCT00567879|7247623|FG004|Overall Study|Disease progression|11
4459570|NCT00567879|7247624|FG005|Overall Study|Disease progression|3
4459571|NCT00567892|7247644|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
4459572|NCT00567892|7247645|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
4459573|NCT00567892|7247646|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1
4459574|NCT00567892|7247647|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4
4459575|NCT00567892|7247644|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
4459576|NCT00567892|7247645|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
4539111|NCT01125189|7361382|FG000|Treatment Period|Participants requested to discontinue|1
4539112|NCT01125189|7361383|FG001|Treatment Period|Participants requested to discontinue|3
4459577|NCT00567892|7247646|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
4459578|NCT00567892|7247647|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1
4459579|NCT00567996|7247662|FG000|Overall Study|Adverse Event|18
4459580|NCT00567996|7247663|FG001|Overall Study|Adverse Event|16
4459581|NCT00567996|7247664|FG002|Overall Study|Adverse Event|13
4459582|NCT00567996|7247662|FG000|Overall Study|Protocol Deviation|9
4459583|NCT00567996|7247663|FG001|Overall Study|Protocol Deviation|11
4459584|NCT00567996|7247664|FG002|Overall Study|Protocol Deviation|13
4459585|NCT00567996|7247662|FG000|Overall Study|Withdrawal by Subject|8
4459586|NCT00567996|7247663|FG001|Overall Study|Withdrawal by Subject|12
4459587|NCT00567996|7247664|FG002|Overall Study|Withdrawal by Subject|22
4459588|NCT00567996|7247662|FG000|Overall Study|Abnormal Lab value(s)|2
4459589|NCT00567996|7247663|FG001|Overall Study|Abnormal Lab value(s)|1
4539113|NCT01125189|7361384|FG002|Treatment Period|Participants requested to discontinue|4
4539114|NCT01125189|7361382|FG000|Treatment Period|Other reasons|1
4613079|NCT01712516|7470128|FG000|Overall Study|Withdrawal by Subject|3
4613080|NCT01712516|7470129|FG001|Overall Study|Withdrawal by Subject|9
4613081|NCT01712516|7470130|FG002|Overall Study|Withdrawal by Subject|3
4613082|NCT01712516|7470131|FG003|Overall Study|Withdrawal by Subject|9
4613083|NCT01712685|7470141|FG000|Overall Study|pt declined to participate before trmt|1
4613084|NCT01712984|7470166|FG000|Overall Study|Adverse Event|0
4613085|NCT01712984|7470167|FG001|Overall Study|Adverse Event|0
4613086|NCT01712984|7470168|FG002|Overall Study|Adverse Event|1
4613087|NCT01712984|7470166|FG000|Overall Study|Protocol Violation|2
4613088|NCT01712984|7470167|FG001|Overall Study|Protocol Violation|0
4613089|NCT01712984|7470168|FG002|Overall Study|Protocol Violation|1
4613090|NCT01712984|7470166|FG000|Overall Study|Lost to Follow-up|8
4613091|NCT01712984|7470167|FG001|Overall Study|Lost to Follow-up|10
4613092|NCT01712984|7470168|FG002|Overall Study|Lost to Follow-up|1
4613093|NCT01712984|7470166|FG000|Overall Study|Withdrawal by Subject|6
4613094|NCT01712984|7470167|FG001|Overall Study|Withdrawal by Subject|6
4613095|NCT01712984|7470168|FG002|Overall Study|Withdrawal by Subject|7
4613096|NCT01713036|7470176|FG000|Overall Study|Death|1
4613097|NCT01713283|7470190|FG000|Overall Study|Lack of Efficacy|10
4613098|NCT01713283|7470191|FG001|Overall Study|Lack of Efficacy|2
4613099|NCT01713283|7470190|FG000|Overall Study|Lost to Follow-up|1
4613100|NCT01713283|7470191|FG001|Overall Study|Lost to Follow-up|1
4613101|NCT01713348|7470205|FG000|Overall Study|Withdrawal by Subject|3
4613102|NCT01713348|7470206|FG001|Overall Study|Withdrawal by Subject|2
4613103|NCT01713348|7470207|FG002|Overall Study|Withdrawal by Subject|2
4613104|NCT01713348|7470208|FG003|Overall Study|Withdrawal by Subject|0
4613105|NCT01713348|7470205|FG000|Overall Study|Lost to Follow-up|1
4690388|NCT02561195|7600185|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0
4459590|NCT00567996|7247664|FG002|Overall Study|Abnormal Lab value(s)|2
4539115|NCT01125189|7361383|FG001|Treatment Period|Other reasons|1
4539116|NCT01125189|7361384|FG002|Treatment Period|Other reasons|0
4539117|NCT01125189|7361382|FG000|Treatment Period|Completed 24 week treatment period only|2
4539118|NCT01125189|7361383|FG001|Treatment Period|Completed 24 week treatment period only|1
4539119|NCT01125189|7361384|FG002|Treatment Period|Completed 24 week treatment period only|2
4539120|NCT01125189|7361382|FG000|Follow up Period|Withdrawal by Subject|3
4539121|NCT01125189|7361383|FG001|Follow up Period|Withdrawal by Subject|2
4539122|NCT01125189|7361384|FG002|Follow up Period|Withdrawal by Subject|5
4539123|NCT01125189|7361382|FG000|Follow up Period|Death|1
4613106|NCT01713348|7470206|FG001|Overall Study|Lost to Follow-up|0
4613107|NCT01713348|7470207|FG002|Overall Study|Lost to Follow-up|0
4613108|NCT01713348|7470208|FG003|Overall Study|Lost to Follow-up|0
4613109|NCT01713530|7470229|FG000|Overall Study|Adverse Event|0
4613110|NCT01713530|7470230|FG001|Overall Study|Adverse Event|5
4613111|NCT01713530|7470229|FG000|Overall Study|Withdrawal criteria|21
4613112|NCT01713530|7470230|FG001|Overall Study|Withdrawal criteria|12
4613113|NCT01713530|7470229|FG000|Overall Study|Unclassified|4
4613114|NCT01713530|7470230|FG001|Overall Study|Unclassified|2
4459591|NCT00567996|7247662|FG000|Overall Study|Abnormal test procedure result(s)|2
4459592|NCT00567996|7247663|FG001|Overall Study|Abnormal test procedure result(s)|1
4459593|NCT00567996|7247664|FG002|Overall Study|Abnormal test procedure result(s)|1
4459594|NCT00567996|7247662|FG000|Overall Study|Lost to Follow-up|2
4459595|NCT00567996|7247663|FG001|Overall Study|Lost to Follow-up|5
4459596|NCT00567996|7247664|FG002|Overall Study|Lost to Follow-up|2
4459597|NCT00567996|7247662|FG000|Overall Study|Unsatisfactory therapeutic effect|1
4459598|NCT00567996|7247663|FG001|Overall Study|Unsatisfactory therapeutic effect|2
4459599|NCT00567996|7247664|FG002|Overall Study|Unsatisfactory therapeutic effect|15
4459600|NCT00567996|7247662|FG000|Overall Study|Administrative problems|1
4613115|NCT01713582|7470257|FG000|Overall Study|Disease progression|3
4613116|NCT01713582|7470258|FG001|Overall Study|Disease progression|3
4459601|NCT00567996|7247663|FG001|Overall Study|Administrative problems|1
4459602|NCT00567996|7247664|FG002|Overall Study|Administrative problems|0
4459603|NCT00567996|7247662|FG000|Overall Study|Death|1
4459604|NCT00567996|7247663|FG001|Overall Study|Death|0
4459605|NCT00567996|7247664|FG002|Overall Study|Death|2
4613117|NCT01713582|7470259|FG002|Overall Study|Disease progression|3
4613118|NCT01713582|7470260|FG003|Overall Study|Disease progression|2
4613119|NCT01713582|7470261|FG004|Overall Study|Disease progression|3
4613120|NCT01713582|7470262|FG005|Overall Study|Disease progression|3
4613121|NCT01713582|7470263|FG006|Overall Study|Disease progression|3
4613122|NCT01713582|7470264|FG007|Overall Study|Disease progression|3
4613123|NCT01713582|7470265|FG008|Overall Study|Disease progression|3
4613124|NCT01713582|7470266|FG009|Overall Study|Disease progression|11
4613125|NCT01713582|7470267|FG010|Overall Study|Disease progression|10
4613126|NCT01713582|7470268|FG011|Overall Study|Disease progression|5
4613127|NCT01713582|7470269|FG012|Overall Study|Disease progression|3
4613128|NCT01713582|7470270|FG013|Overall Study|Disease progression|3
4613129|NCT01713582|7470271|FG014|Overall Study|Disease progression|6
4613130|NCT01713582|7470272|FG015|Overall Study|Disease progression|6
4613131|NCT01713582|7470273|FG016|Overall Study|Disease progression|5
4613132|NCT01713582|7470274|FG017|Overall Study|Disease progression|2
4613133|NCT01713582|7470275|FG018|Overall Study|Disease progression|3
4613134|NCT01713582|7470276|FG019|Overall Study|Disease progression|5
4613135|NCT01713582|7470277|FG020|Overall Study|Disease progression|15
4613136|NCT01713582|7470257|FG000|Overall Study|Death|0
4613137|NCT01713582|7470258|FG001|Overall Study|Death|0
4613138|NCT01713582|7470259|FG002|Overall Study|Death|0
4613139|NCT01713582|7470260|FG003|Overall Study|Death|1
4613140|NCT01713582|7470261|FG004|Overall Study|Death|1
4613141|NCT01713582|7470262|FG005|Overall Study|Death|3
4613142|NCT01713582|7470263|FG006|Overall Study|Death|3
4613143|NCT01713582|7470264|FG007|Overall Study|Death|2
4613144|NCT01713582|7470265|FG008|Overall Study|Death|3
4613145|NCT01713582|7470266|FG009|Overall Study|Death|4
4613146|NCT01713582|7470267|FG010|Overall Study|Death|3
4613147|NCT01713582|7470268|FG011|Overall Study|Death|0
4613148|NCT01713582|7470269|FG012|Overall Study|Death|0
4613149|NCT01713582|7470270|FG013|Overall Study|Death|0
4613150|NCT01713582|7470271|FG014|Overall Study|Death|0
4613151|NCT01713582|7470272|FG015|Overall Study|Death|0
4613152|NCT01713582|7470273|FG016|Overall Study|Death|0
4613153|NCT01713582|7470274|FG017|Overall Study|Death|0
4613154|NCT01713582|7470275|FG018|Overall Study|Death|0
4613155|NCT01713582|7470276|FG019|Overall Study|Death|0
4613156|NCT01713582|7470277|FG020|Overall Study|Death|0
4613157|NCT01713582|7470257|FG000|Overall Study|Adverse event-related|0
4613158|NCT01713582|7470258|FG001|Overall Study|Adverse event-related|0
4613159|NCT01713582|7470259|FG002|Overall Study|Adverse event-related|0
4613160|NCT01713582|7470260|FG003|Overall Study|Adverse event-related|0
4613161|NCT01713582|7470261|FG004|Overall Study|Adverse event-related|0
4613162|NCT01713582|7470262|FG005|Overall Study|Adverse event-related|0
4613163|NCT01713582|7470263|FG006|Overall Study|Adverse event-related|0
4613164|NCT01713582|7470264|FG007|Overall Study|Adverse event-related|0
4613165|NCT01713582|7470265|FG008|Overall Study|Adverse event-related|0
4613166|NCT01713582|7470266|FG009|Overall Study|Adverse event-related|1
4613167|NCT01713582|7470267|FG010|Overall Study|Adverse event-related|1
4613168|NCT01713582|7470268|FG011|Overall Study|Adverse event-related|0
4613169|NCT01713582|7470269|FG012|Overall Study|Adverse event-related|0
4613170|NCT01713582|7470270|FG013|Overall Study|Adverse event-related|0
4613171|NCT01713582|7470271|FG014|Overall Study|Adverse event-related|0
4613172|NCT01713582|7470272|FG015|Overall Study|Adverse event-related|0
4613173|NCT01713582|7470273|FG016|Overall Study|Adverse event-related|0
4613174|NCT01713582|7470274|FG017|Overall Study|Adverse event-related|0
4613175|NCT01713582|7470275|FG018|Overall Study|Adverse event-related|1
4613176|NCT01713582|7470276|FG019|Overall Study|Adverse event-related|0
4613177|NCT01713582|7470277|FG020|Overall Study|Adverse event-related|0
4613178|NCT01713582|7470257|FG000|Overall Study|Adverse event-unrelated|0
4459606|NCT00567996|7247662|FG000|Overall Study|Patient's inability to use the device|0
4613179|NCT01713582|7470258|FG001|Overall Study|Adverse event-unrelated|0
4613180|NCT01713582|7470259|FG002|Overall Study|Adverse event-unrelated|0
4613181|NCT01713582|7470260|FG003|Overall Study|Adverse event-unrelated|0
4613182|NCT01713582|7470261|FG004|Overall Study|Adverse event-unrelated|0
4613183|NCT01713582|7470262|FG005|Overall Study|Adverse event-unrelated|1
4613184|NCT01713582|7470263|FG006|Overall Study|Adverse event-unrelated|1
4459607|NCT00567996|7247663|FG001|Overall Study|Patient's inability to use the device|1
4459608|NCT00567996|7247664|FG002|Overall Study|Patient's inability to use the device|0
4459609|NCT00568061|7247688|FG000|Overall Study|Inclusion / exclusion criteria|5
4459610|NCT00568061|7247689|FG001|Overall Study|Inclusion / exclusion criteria|1
4459611|NCT00568061|7247688|FG000|Overall Study|Adverse Event|0
4459612|NCT00568061|7247689|FG001|Overall Study|Adverse Event|1
4459613|NCT00568126|7247707|FG000|Overall Study|Adverse Event|3
4459614|NCT00568126|7247708|FG001|Overall Study|Adverse Event|0
4459615|NCT00568126|7247707|FG000|Overall Study|Withdrawal by Subject|2
4459616|NCT00568126|7247708|FG001|Overall Study|Withdrawal by Subject|3
4459617|NCT00568126|7247707|FG000|Overall Study|Lost to Follow-up|4
4459618|NCT00568126|7247708|FG001|Overall Study|Lost to Follow-up|3
4459619|NCT00568126|7247707|FG000|Overall Study|Lack of Efficacy|0
4459620|NCT00568126|7247708|FG001|Overall Study|Lack of Efficacy|1
4459621|NCT00568126|7247707|FG000|Overall Study|Physician Decision|2
4459622|NCT00568126|7247708|FG001|Overall Study|Physician Decision|2
4459623|NCT00568321|7247717|FG000|Overall Study|Adverse Event|1
4459624|NCT00568321|7247718|FG001|Overall Study|Adverse Event|0
4459625|NCT00568321|7247719|FG002|Overall Study|Adverse Event|0
4459626|NCT00568321|7247717|FG000|Overall Study|Lack of Efficacy|8
4459627|NCT00568321|7247718|FG001|Overall Study|Lack of Efficacy|5
4459628|NCT00568321|7247719|FG002|Overall Study|Lack of Efficacy|6
4459629|NCT00568321|7247717|FG000|Overall Study|Lost to Follow-up|0
4459630|NCT00568321|7247718|FG001|Overall Study|Lost to Follow-up|0
4459631|NCT00568321|7247719|FG002|Overall Study|Lost to Follow-up|1
4613185|NCT01713582|7470264|FG007|Overall Study|Adverse event-unrelated|1
4613186|NCT01713582|7470265|FG008|Overall Study|Adverse event-unrelated|0
4613187|NCT01713582|7470266|FG009|Overall Study|Adverse event-unrelated|0
4613188|NCT01713582|7470267|FG010|Overall Study|Adverse event-unrelated|0
4613189|NCT01713582|7470268|FG011|Overall Study|Adverse event-unrelated|0
4613190|NCT01713582|7470269|FG012|Overall Study|Adverse event-unrelated|0
4613191|NCT01713582|7470270|FG013|Overall Study|Adverse event-unrelated|1
4613192|NCT01713582|7470271|FG014|Overall Study|Adverse event-unrelated|1
4613193|NCT01713582|7470272|FG015|Overall Study|Adverse event-unrelated|0
4459632|NCT00568321|7247717|FG000|Overall Study|Withdrawal by Subject|2
4459633|NCT00568321|7247718|FG001|Overall Study|Withdrawal by Subject|0
4459634|NCT00568321|7247719|FG002|Overall Study|Withdrawal by Subject|0
4459635|NCT00568321|7247717|FG000|Overall Study|Protocol Violation|0
4459636|NCT00568321|7247718|FG001|Overall Study|Protocol Violation|0
4459637|NCT00568321|7247719|FG002|Overall Study|Protocol Violation|1
4459638|NCT00568321|7247717|FG000|Overall Study|Randomized, not treated|2
4459639|NCT00568321|7247718|FG001|Overall Study|Randomized, not treated|0
4459640|NCT00568321|7247719|FG002|Overall Study|Randomized, not treated|1
4459641|NCT00568334|7247731|FG000|Overall Study|Withdrawal by Subject|0
4459642|NCT00568334|7247732|FG001|Overall Study|Withdrawal by Subject|1
4459643|NCT00568334|7247731|FG000|Overall Study|Lost to Follow-up|1
4459644|NCT00568334|7247732|FG001|Overall Study|Lost to Follow-up|0
4459645|NCT00568399|7247747|FG000|Overall Study|Death|2
4459646|NCT00568399|7247747|FG000|Overall Study|Adverse Event|5
4459647|NCT00568399|7247747|FG000|Overall Study|Withdrawal by Subject|8
4459648|NCT00568451|7247755|FG000|Overall Study|Disease Progression|0
4459649|NCT00568451|7247756|FG001|Overall Study|Disease Progression|0
4459650|NCT00568451|7247757|FG002|Overall Study|Disease Progression|2
4459651|NCT00568451|7247758|FG003|Overall Study|Disease Progression|7
4459652|NCT00568555|7247771|FG000|Overall Study|Withdrawal by Subject|1
4459653|NCT00568555|7247772|FG001|Overall Study|Withdrawal by Subject|1
4459654|NCT00568685|7247792|FG000|Overall Study|Adverse Event|2
4459655|NCT00568685|7247793|FG001|Overall Study|Adverse Event|3
4459656|NCT00568685|7247794|FG002|Overall Study|Adverse Event|3
4539124|NCT01125189|7361383|FG001|Follow up Period|Death|0
4539125|NCT01125189|7361384|FG002|Follow up Period|Death|0
4539126|NCT01125189|7361382|FG000|Follow up Period|Lost to Follow-up|12
4539127|NCT01125189|7361383|FG001|Follow up Period|Lost to Follow-up|9
4539128|NCT01125189|7361384|FG002|Follow up Period|Lost to Follow-up|6
4539129|NCT01125189|7361382|FG000|Follow up Period|Other reasons|4
4539130|NCT01125189|7361383|FG001|Follow up Period|Other reasons|4
4539131|NCT01125189|7361384|FG002|Follow up Period|Other reasons|5
4539132|NCT01125293|7361410|FG000|Overall Study|Disease Progression|1
4539133|NCT01125293|7361411|FG001|Overall Study|Disease Progression|3
4539134|NCT01125293|7361412|FG002|Overall Study|Disease Progression|4
4539135|NCT01125293|7361413|FG003|Overall Study|Disease Progression|3
4539136|NCT01125293|7361414|FG004|Overall Study|Disease Progression|5
4539137|NCT01125293|7361415|FG005|Overall Study|Disease Progression|12
4539138|NCT01125293|7361410|FG000|Overall Study|Adverse Event|1
4613194|NCT01713582|7470273|FG016|Overall Study|Adverse event-unrelated|0
4613195|NCT01713582|7470274|FG017|Overall Study|Adverse event-unrelated|0
4613196|NCT01713582|7470275|FG018|Overall Study|Adverse event-unrelated|0
4539139|NCT01125293|7361411|FG001|Overall Study|Adverse Event|0
4539140|NCT01125293|7361412|FG002|Overall Study|Adverse Event|0
4459657|NCT00568685|7247792|FG000|Overall Study|Withdrawal by Subject|7
4459658|NCT00568685|7247793|FG001|Overall Study|Withdrawal by Subject|2
4459659|NCT00568685|7247794|FG002|Overall Study|Withdrawal by Subject|2
4459660|NCT00568685|7247792|FG000|Overall Study|Protocol Violation|1
4539141|NCT01125293|7361413|FG003|Overall Study|Adverse Event|0
4459661|NCT00568685|7247793|FG001|Overall Study|Protocol Violation|0
4459662|NCT00568685|7247794|FG002|Overall Study|Protocol Violation|0
4459663|NCT00568776|7247810|FG000|Overall Study|Adverse Event|8
4459664|NCT00568776|7247811|FG001|Overall Study|Adverse Event|8
4459665|NCT00568776|7247812|FG002|Overall Study|Adverse Event|10
4459666|NCT00568776|7247813|FG003|Overall Study|Adverse Event|8
4459667|NCT00568776|7247810|FG000|Overall Study|Death|0
4459668|NCT00568776|7247811|FG001|Overall Study|Death|1
4459669|NCT00568776|7247812|FG002|Overall Study|Death|4
4459670|NCT00568776|7247813|FG003|Overall Study|Death|3
4459671|NCT00568776|7247810|FG000|Overall Study|Physician Decision|0
4459672|NCT00568776|7247811|FG001|Overall Study|Physician Decision|2
4459673|NCT00568776|7247812|FG002|Overall Study|Physician Decision|0
4459674|NCT00568776|7247813|FG003|Overall Study|Physician Decision|0
4459675|NCT00568776|7247810|FG000|Overall Study|Lack of Efficacy|2
4459676|NCT00568776|7247811|FG001|Overall Study|Lack of Efficacy|2
4459677|NCT00568776|7247812|FG002|Overall Study|Lack of Efficacy|2
4459678|NCT00568776|7247813|FG003|Overall Study|Lack of Efficacy|4
4459679|NCT00568776|7247810|FG000|Overall Study|Lost to Follow-up|1
4459680|NCT00568776|7247811|FG001|Overall Study|Lost to Follow-up|1
4459681|NCT00568776|7247812|FG002|Overall Study|Lost to Follow-up|1
4459682|NCT00568776|7247813|FG003|Overall Study|Lost to Follow-up|1
4459683|NCT00568776|7247810|FG000|Overall Study|Protocol Violation|1
4459684|NCT00568776|7247811|FG001|Overall Study|Protocol Violation|0
4459685|NCT00568776|7247812|FG002|Overall Study|Protocol Violation|1
4459686|NCT00568776|7247813|FG003|Overall Study|Protocol Violation|1
4459687|NCT00568776|7247810|FG000|Overall Study|Withdrawal by Subject|13
4459688|NCT00568776|7247811|FG001|Overall Study|Withdrawal by Subject|15
4459689|NCT00568776|7247812|FG002|Overall Study|Withdrawal by Subject|13
4459690|NCT00568776|7247813|FG003|Overall Study|Withdrawal by Subject|7
4459691|NCT00568776|7247810|FG000|Overall Study|Loss of Caregiver|0
4459692|NCT00568776|7247811|FG001|Overall Study|Loss of Caregiver|2
4459693|NCT00568776|7247812|FG002|Overall Study|Loss of Caregiver|1
4459694|NCT00568776|7247813|FG003|Overall Study|Loss of Caregiver|2
4459695|NCT00568776|7247810|FG000|Overall Study|Sponsor Decision|2
4459696|NCT00568776|7247811|FG001|Overall Study|Sponsor Decision|2
4459697|NCT00568776|7247812|FG002|Overall Study|Sponsor Decision|41
4459698|NCT00568776|7247813|FG003|Overall Study|Sponsor Decision|42
4459699|NCT00568776|7247810|FG000|Overall Study|Miscellaeneous|3
4459700|NCT00568776|7247811|FG001|Overall Study|Miscellaeneous|3
4459701|NCT00568776|7247812|FG002|Overall Study|Miscellaeneous|1
4459702|NCT00568776|7247813|FG003|Overall Study|Miscellaeneous|4
4459703|NCT00568958|7247834|FG000|Allocation|Withdrawal by Subject|7
4459704|NCT00568958|7247835|FG001|Allocation|Withdrawal by Subject|3
4459705|NCT00568958|7247834|FG000|Allocation|Physician Decision|2
4459706|NCT00568958|7247835|FG001|Allocation|Physician Decision|0
4459707|NCT00568958|7247834|FG000|Follow-Up|Withdrawal by Subject|6
4459708|NCT00568958|7247835|FG001|Follow-Up|Withdrawal by Subject|6
4459709|NCT00568958|7247834|FG000|Follow-Up|Physician Decision|1
4459710|NCT00568958|7247835|FG001|Follow-Up|Physician Decision|1
4459711|NCT00568958|7247834|FG000|Follow-Up|Family Emergency|1
4459712|NCT00568958|7247835|FG001|Follow-Up|Family Emergency|0
4459713|NCT00568958|7247834|FG000|Follow-Up|Adverse Event|1
4459714|NCT00568958|7247835|FG001|Follow-Up|Adverse Event|0
4459715|NCT00569166|7247861|FG000|Overall Study|Withdrawal by Subject|7
4459716|NCT00569166|7247862|FG001|Overall Study|Withdrawal by Subject|5
4459717|NCT00569166|7247863|FG002|Overall Study|Withdrawal by Subject|3
4459718|NCT00569166|7247861|FG000|Overall Study|Lost to Follow-up|2
4459719|NCT00569166|7247862|FG001|Overall Study|Lost to Follow-up|1
4459720|NCT00569166|7247863|FG002|Overall Study|Lost to Follow-up|1
4459721|NCT00569231|7247884|FG000|Overall Study|Study unrelated surgery|1
4459722|NCT00569231|7247884|FG000|Overall Study|Airfare expense|2
4459723|NCT00569231|7247884|FG000|Overall Study|Withdrawal by Subject|1
4459724|NCT00569231|7247884|FG000|Overall Study|Car accident injury|1
4459725|NCT00569231|7247884|FG000|Overall Study|Non-compliance|2
4459726|NCT00569270|7247888|FG000|Period: First Intervention|Protocol Violation|0
4459727|NCT00569270|7247889|FG001|Period: First Intervention|Protocol Violation|1
4459728|NCT00569374|7247908|FG000|Overall Study|Withdrawal by Subject|4
4459729|NCT00569582|7247921|FG000|Overall Study|Withdrawal by Subject|5
4459730|NCT00569582|7247921|FG000|Overall Study|Death|2
4459731|NCT00569582|7247921|FG000|Overall Study|Adverse Event|7
4459732|NCT00569582|7247921|FG000|Overall Study|Subject was too ill to travel.|1
4459733|NCT00569582|7247921|FG000|Overall Study|Subject was non-compliant.|1
4459734|NCT00569777|7247935|FG000|Overall Study|Withdrawal by Subject|4
4459735|NCT00569777|7247936|FG001|Overall Study|Withdrawal by Subject|0
4459736|NCT00569777|7247935|FG000|Overall Study|Adverse Event|3
4459737|NCT00569777|7247936|FG001|Overall Study|Adverse Event|0
4459738|NCT00569777|7247935|FG000|Overall Study|Lost to Follow-up|1
4459739|NCT00569777|7247936|FG001|Overall Study|Lost to Follow-up|0
4459740|NCT00569777|7247935|FG000|Overall Study|scheduled eye surgery|0
4459741|NCT00569777|7247936|FG001|Overall Study|scheduled eye surgery|1
4459742|NCT00569777|7247935|FG000|Overall Study|did not meet exclusion criteria|1
4459743|NCT00569777|7247936|FG001|Overall Study|did not meet exclusion criteria|2
4459744|NCT00569777|7247935|FG000|Overall Study|pregnant|1
4459745|NCT00569777|7247936|FG001|Overall Study|pregnant|0
4459746|NCT00569803|7247950|FG000|Overall Study|Lost to Follow-up|1
4459747|NCT00569803|7247951|FG001|Overall Study|Lost to Follow-up|0
4459748|NCT00569803|7247952|FG002|Overall Study|Lost to Follow-up|0
4459749|NCT00569803|7247953|FG003|Overall Study|Lost to Follow-up|0
4459750|NCT00569803|7247954|FG004|Overall Study|Lost to Follow-up|0
4459751|NCT00569803|7247955|FG005|Overall Study|Lost to Follow-up|0
4459752|NCT00569803|7247956|FG006|Overall Study|Lost to Follow-up|0
4459753|NCT00569803|7247957|FG007|Overall Study|Lost to Follow-up|0
4459754|NCT00569803|7247950|FG000|Overall Study|injection syringe leaked during dosing|0
4459755|NCT00569803|7247951|FG001|Overall Study|injection syringe leaked during dosing|0
4459756|NCT00569803|7247952|FG002|Overall Study|injection syringe leaked during dosing|0
4459757|NCT00569803|7247953|FG003|Overall Study|injection syringe leaked during dosing|1
4459758|NCT00569803|7247954|FG004|Overall Study|injection syringe leaked during dosing|0
4459759|NCT00569803|7247955|FG005|Overall Study|injection syringe leaked during dosing|0
4459760|NCT00569803|7247956|FG006|Overall Study|injection syringe leaked during dosing|0
4459761|NCT00569803|7247957|FG007|Overall Study|injection syringe leaked during dosing|0
4459762|NCT00569803|7247950|FG000|Overall Study|Withdrawal by Subject|0
4459763|NCT00569803|7247951|FG001|Overall Study|Withdrawal by Subject|0
4459764|NCT00569803|7247952|FG002|Overall Study|Withdrawal by Subject|0
4459765|NCT00569803|7247953|FG003|Overall Study|Withdrawal by Subject|0
4459766|NCT00569803|7247954|FG004|Overall Study|Withdrawal by Subject|0
4459767|NCT00569803|7247955|FG005|Overall Study|Withdrawal by Subject|0
4459768|NCT00569803|7247956|FG006|Overall Study|Withdrawal by Subject|0
4459769|NCT00569803|7247957|FG007|Overall Study|Withdrawal by Subject|1
4459770|NCT00569946|7247983|FG000|Overall Study|Adverse Event|16
4459771|NCT00569946|7247983|FG000|Overall Study|Objective Progression or Relapse|42
4459772|NCT00569946|7247983|FG000|Overall Study|Global Deterioration of Health Status|1
4459773|NCT00570037|7247989|FG000|Overall Study|Could not reach for 6-8 week contact|44
4459774|NCT00570037|7247990|FG001|Overall Study|Could not reach for 6-8 week contact|69
4459775|NCT00570063|7247998|FG000|Overall Study|Adverse Event|4
4459776|NCT00570063|7247999|FG001|Overall Study|Adverse Event|1
4459777|NCT00570063|7247998|FG000|Overall Study|Lack of Efficacy|0
4459778|NCT00570063|7247999|FG001|Overall Study|Lack of Efficacy|1
4459779|NCT00570063|7247998|FG000|Overall Study|Withdrawal by Subject|4
4459780|NCT00570063|7247999|FG001|Overall Study|Withdrawal by Subject|3
4459781|NCT00570063|7247998|FG000|Overall Study|Sponsor's Decision|7
4459782|NCT00570063|7247999|FG001|Overall Study|Sponsor's Decision|3
4459783|NCT00570128|7248016|FG000|Overall Study|Adverse Event|1
4459784|NCT00570128|7248017|FG001|Overall Study|Adverse Event|0
4459785|NCT00570128|7248016|FG000|Overall Study|Lost to Follow-up|1
4459786|NCT00570128|7248017|FG001|Overall Study|Lost to Follow-up|0
4459787|NCT00570128|7248016|FG000|Overall Study|Withdrawal by Subject|2
4459788|NCT00570128|7248017|FG001|Overall Study|Withdrawal by Subject|0
4459789|NCT00570141|7248023|FG000|Overall Study|Adverse Event|1
4459790|NCT00570141|7248023|FG000|Overall Study|Missed visits|1
4459791|NCT00570141|7248023|FG000|Overall Study|Lost to Follow-up|1
4459792|NCT00570232|7248027|FG000|Overall Study|Adverse Event|10
4459793|NCT00570232|7248027|FG000|Overall Study|discontinued due to medical condition|3
4459794|NCT00570232|7248027|FG000|Overall Study|discontinued due to recurrence|8
4459795|NCT00570232|7248027|FG000|Overall Study|discontinued due to noncompliance|2
4459796|NCT00570310|7248033|FG000|Overall Study|Adverse Event|1
4539142|NCT01125293|7361414|FG004|Overall Study|Adverse Event|2
4539143|NCT01125293|7361415|FG005|Overall Study|Adverse Event|8
4459797|NCT00570310|7248034|FG001|Overall Study|Adverse Event|2
4539144|NCT01125293|7361410|FG000|Overall Study|Symptomatic Deterioration|1
4539145|NCT01125293|7361411|FG001|Overall Study|Symptomatic Deterioration|0
4539146|NCT01125293|7361412|FG002|Overall Study|Symptomatic Deterioration|0
4539147|NCT01125293|7361413|FG003|Overall Study|Symptomatic Deterioration|0
4539148|NCT01125293|7361414|FG004|Overall Study|Symptomatic Deterioration|0
4539149|NCT01125293|7361415|FG005|Overall Study|Symptomatic Deterioration|0
4539150|NCT01125293|7361410|FG000|Overall Study|Death|0
4539151|NCT01125293|7361411|FG001|Overall Study|Death|0
4539152|NCT01125293|7361412|FG002|Overall Study|Death|0
4539153|NCT01125293|7361413|FG003|Overall Study|Death|0
4539154|NCT01125293|7361414|FG004|Overall Study|Death|1
4539155|NCT01125293|7361415|FG005|Overall Study|Death|0
4539156|NCT01125293|7361410|FG000|Overall Study|Withdrawal by Subject|0
4459798|NCT00570310|7248033|FG000|Overall Study|Lack of Efficacy|1
4459799|NCT00570310|7248034|FG001|Overall Study|Lack of Efficacy|4
4459800|NCT00570323|7248042|FG000|Started Treatment After Randomization|Withdrawal by Subject|0
4459801|NCT00570323|7248043|FG001|Started Treatment After Randomization|Withdrawal by Subject|1
4459802|NCT00570323|7248042|FG000|Started Treatment After Randomization|Protocol Violation|1
4459803|NCT00570323|7248043|FG001|Started Treatment After Randomization|Protocol Violation|0
4459804|NCT00570323|7248042|FG000|Started Treatment After Randomization|Physician Decision|1
4459805|NCT00570323|7248043|FG001|Started Treatment After Randomization|Physician Decision|0
4459806|NCT00570323|7248042|FG000|Complete Study After Start|Lost to Follow-up|0
4459807|NCT00570323|7248043|FG001|Complete Study After Start|Lost to Follow-up|1
4459808|NCT00570323|7248042|FG000|Complete Study After Start|Withdrawal by Subject|2
4459809|NCT00570323|7248043|FG001|Complete Study After Start|Withdrawal by Subject|0
4459810|NCT00570323|7248042|FG000|Complete Study After Start|Physician Decision|1
4539157|NCT01125293|7361411|FG001|Overall Study|Withdrawal by Subject|0
4539158|NCT01125293|7361412|FG002|Overall Study|Withdrawal by Subject|0
4459811|NCT00570323|7248043|FG001|Complete Study After Start|Physician Decision|0
4459812|NCT00570401|7248073|FG000|Overall Study|Adverse Event|2
4459813|NCT00570492|7248079|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98
4539159|NCT01125293|7361413|FG003|Overall Study|Withdrawal by Subject|0
4539160|NCT01125293|7361414|FG004|Overall Study|Withdrawal by Subject|2
4539161|NCT01125293|7361415|FG005|Overall Study|Withdrawal by Subject|1
4539162|NCT01125293|7361410|FG000|Overall Study|Physician Decision|0
4539163|NCT01125293|7361411|FG001|Overall Study|Physician Decision|0
4539164|NCT01125293|7361412|FG002|Overall Study|Physician Decision|0
4539165|NCT01125293|7361413|FG003|Overall Study|Physician Decision|0
4539166|NCT01125293|7361414|FG004|Overall Study|Physician Decision|0
4539167|NCT01125293|7361415|FG005|Overall Study|Physician Decision|2
4539168|NCT01125358|7361436|FG000|Overall Study|Adverse Event|3
4539169|NCT01125358|7361437|FG001|Overall Study|Adverse Event|0
4539170|NCT01125358|7361438|FG002|Overall Study|Adverse Event|0
4459814|NCT00570492|7248080|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0
4459815|NCT00570492|7248081|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0
4539171|NCT01125358|7361439|FG003|Overall Study|Adverse Event|2
4539172|NCT01125358|7361436|FG000|Overall Study|Perceived Lack of Efficacy|6
4539173|NCT01125358|7361437|FG001|Overall Study|Perceived Lack of Efficacy|3
4539174|NCT01125358|7361438|FG002|Overall Study|Perceived Lack of Efficacy|7
4539175|NCT01125358|7361439|FG003|Overall Study|Perceived Lack of Efficacy|4
4539176|NCT01125358|7361436|FG000|Overall Study|Protocol Violation|1
4539177|NCT01125358|7361437|FG001|Overall Study|Protocol Violation|0
4539178|NCT01125358|7361438|FG002|Overall Study|Protocol Violation|0
4539179|NCT01125358|7361439|FG003|Overall Study|Protocol Violation|0
4539180|NCT01125358|7361436|FG000|Overall Study|Sponsor Decision|0
4539181|NCT01125358|7361437|FG001|Overall Study|Sponsor Decision|0
4539182|NCT01125358|7361438|FG002|Overall Study|Sponsor Decision|1
4539183|NCT01125358|7361439|FG003|Overall Study|Sponsor Decision|1
4539184|NCT01125358|7361436|FG000|Overall Study|Withdrawal by Subject|2
4539185|NCT01125358|7361437|FG001|Overall Study|Withdrawal by Subject|1
4539186|NCT01125358|7361438|FG002|Overall Study|Withdrawal by Subject|1
4539187|NCT01125358|7361439|FG003|Overall Study|Withdrawal by Subject|1
4591204|NCT01527487|7437594|FG001|Overall Study|Adverse Event|1
4591205|NCT01527487|7437593|FG000|Overall Study|Death|0
4591206|NCT01527487|7437594|FG001|Overall Study|Death|1
4591207|NCT01527500|7437609|FG000|Part A|Administrative|11
4591208|NCT01527500|7437610|FG001|Part A|Administrative|7
4591209|NCT01527500|7437609|FG000|Part A|Adverse Event|4
4591210|NCT01527500|7437610|FG001|Part A|Adverse Event|2
4591211|NCT01527500|7437609|FG000|Part A|Death|4
4591212|NCT01527500|7437610|FG001|Part A|Death|1
4591213|NCT01527500|7437609|FG000|Part A|Lost to Follow-up|0
4591214|NCT01527500|7437610|FG001|Part A|Lost to Follow-up|1
4591215|NCT01527500|7437609|FG000|Part A|Protocol Deviation|9
4591216|NCT01527500|7437610|FG001|Part A|Protocol Deviation|2
4591217|NCT01527500|7437609|FG000|Part A|Withdrawal by Subject|2
4591218|NCT01527500|7437610|FG001|Part A|Withdrawal by Subject|0
4591219|NCT01527500|7437609|FG000|Part B|Adverse Event|1
4591220|NCT01527500|7437610|FG001|Part B|Adverse Event|0
4591221|NCT01527682|7437637|FG000|Overall Study|Protocol Violation|8
4591222|NCT01528033|7437643|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8
4591223|NCT01528033|7437644|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7
4591224|NCT01528033|7437643|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3
4591225|NCT01528033|7437644|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3
4591226|NCT01528033|7437643|FG000|Primary Endpoint Assessment ITT|Death|2
4591227|NCT01528033|7437644|FG001|Primary Endpoint Assessment ITT|Death|2
4591228|NCT01528033|7437643|FG000|Primary Endpoint Assessment ITT|Physician Decision|2
4591229|NCT01528033|7437644|FG001|Primary Endpoint Assessment ITT|Physician Decision|1
4591230|NCT01528033|7437643|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2
4591231|NCT01528033|7437644|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2
4591232|NCT01528033|7437643|FG000|Follow Up|No data available|46
4591233|NCT01528033|7437644|FG001|Follow Up|No data available|44
4591234|NCT01528072|7437650|FG000|Overall Study|Withdrawal by Subject|5
4459816|NCT00570492|7248079|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263
4459817|NCT00570492|7248080|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0
4591235|NCT01528072|7437650|FG000|Overall Study|Physician Decision|1
4613197|NCT01713582|7470276|FG019|Overall Study|Adverse event-unrelated|0
4613198|NCT01713582|7470277|FG020|Overall Study|Adverse event-unrelated|0
4613199|NCT01713582|7470257|FG000|Overall Study|Withdrawal of consent|0
4613200|NCT01713582|7470258|FG001|Overall Study|Withdrawal of consent|0
4459818|NCT00570492|7248081|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0
4591236|NCT01528072|7437650|FG000|Overall Study|Determined not eligible by AEAC|1
4591237|NCT01528072|7437650|FG000|Overall Study|Missed Visit|2
4591238|NCT01528072|7437650|FG000|Overall Study|Lost to Follow-up|5
4591239|NCT01528072|7437650|FG000|Overall Study|Explanted|2
4591240|NCT01528072|7437650|FG000|Overall Study|Site Closure|4
4591241|NCT01528072|7437650|FG000|Overall Study|Death|2
4591242|NCT01528072|7437650|FG000|Overall Study|Early Termination of Study|52
4593711|NCT01554904|7442320|FG000|Overall Study|Withdrawal by Subject|3
4593712|NCT01554904|7442320|FG000|Overall Study|Had sleep apnea on Home Study 1|1
4613201|NCT01713582|7470259|FG002|Overall Study|Withdrawal of consent|1
4613202|NCT01713582|7470260|FG003|Overall Study|Withdrawal of consent|0
4613203|NCT01713582|7470261|FG004|Overall Study|Withdrawal of consent|0
4613204|NCT01713582|7470262|FG005|Overall Study|Withdrawal of consent|1
4613205|NCT01713582|7470263|FG006|Overall Study|Withdrawal of consent|0
4613206|NCT01713582|7470264|FG007|Overall Study|Withdrawal of consent|0
4613207|NCT01713582|7470265|FG008|Overall Study|Withdrawal of consent|0
4613208|NCT01713582|7470266|FG009|Overall Study|Withdrawal of consent|1
4613209|NCT01713582|7470267|FG010|Overall Study|Withdrawal of consent|0
4613210|NCT01713582|7470268|FG011|Overall Study|Withdrawal of consent|0
4613211|NCT01713582|7470269|FG012|Overall Study|Withdrawal of consent|0
4613212|NCT01713582|7470270|FG013|Overall Study|Withdrawal of consent|0
4613213|NCT01713582|7470271|FG014|Overall Study|Withdrawal of consent|0
4613214|NCT01713582|7470272|FG015|Overall Study|Withdrawal of consent|0
4613215|NCT01713582|7470273|FG016|Overall Study|Withdrawal of consent|0
4613216|NCT01713582|7470274|FG017|Overall Study|Withdrawal of consent|0
4613217|NCT01713582|7470275|FG018|Overall Study|Withdrawal of consent|1
4613218|NCT01713582|7470276|FG019|Overall Study|Withdrawal of consent|0
4613219|NCT01713582|7470277|FG020|Overall Study|Withdrawal of consent|0
4613220|NCT01713582|7470257|FG000|Overall Study|Lack of Efficacy|0
4613221|NCT01713582|7470258|FG001|Overall Study|Lack of Efficacy|0
4459819|NCT00570492|7248079|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56
4459820|NCT00570492|7248080|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0
4459821|NCT00570492|7248081|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0
4459822|NCT00570492|7248079|FG000|16-week Single-blind Baseline Period|Protocol Violation|15
4459823|NCT00570492|7248080|FG001|16-week Single-blind Baseline Period|Protocol Violation|0
4459824|NCT00570492|7248081|FG002|16-week Single-blind Baseline Period|Protocol Violation|0
4459825|NCT00570492|7248079|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2
4459826|NCT00570492|7248080|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0
4459827|NCT00570492|7248081|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0
4459828|NCT00570492|7248079|FG000|16-week Single-blind Baseline Period|Adverse Event|1
4459829|NCT00570492|7248080|FG001|16-week Single-blind Baseline Period|Adverse Event|0
4459830|NCT00570492|7248081|FG002|16-week Single-blind Baseline Period|Adverse Event|0
4459831|NCT00570492|7248079|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1
4459832|NCT00570492|7248080|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0
4459833|NCT00570492|7248081|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0
4459834|NCT00570492|7248079|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0
4459835|NCT00570492|7248080|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20
4459836|NCT00570492|7248081|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20
4459837|NCT00570492|7248079|FG000|52-week Double-blind Treatment Period|Protocol Violation|0
4459838|NCT00570492|7248080|FG001|52-week Double-blind Treatment Period|Protocol Violation|12
4459839|NCT00570492|7248081|FG002|52-week Double-blind Treatment Period|Protocol Violation|15
4539188|NCT04516746|7361472|FG000|Overall Study|Ongoing in the study at clinical DCO for the primary analysis.|21090
4539189|NCT04516746|7361473|FG001|Overall Study|Ongoing in the study at clinical DCO for the primary analysis.|10305
4539190|NCT04516746|7361472|FG000|Overall Study|Withdrawal by Subject|362
4539191|NCT04516746|7361473|FG001|Overall Study|Withdrawal by Subject|408
4459840|NCT00570492|7248079|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0
4459841|NCT00570492|7248080|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5
4459842|NCT00570492|7248081|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7
4459843|NCT00570492|7248079|FG000|52-week Double-blind Treatment Period|Adverse Event|0
4459844|NCT00570492|7248080|FG001|52-week Double-blind Treatment Period|Adverse Event|5
4459845|NCT00570492|7248081|FG002|52-week Double-blind Treatment Period|Adverse Event|5
4459846|NCT00570492|7248079|FG000|52-week Double-blind Treatment Period|Physician Decision|0
4459847|NCT00570492|7248080|FG001|52-week Double-blind Treatment Period|Physician Decision|2
4459848|NCT00570492|7248081|FG002|52-week Double-blind Treatment Period|Physician Decision|4
4539192|NCT04516746|7361472|FG000|Overall Study|Lost to Follow-up|157
4539193|NCT04516746|7361473|FG001|Overall Study|Lost to Follow-up|86
4539194|NCT04516746|7361472|FG000|Overall Study|Protocol deviation|18
4539195|NCT04516746|7361473|FG001|Overall Study|Protocol deviation|7
4539196|NCT04516746|7361472|FG000|Overall Study|Death|8
4539197|NCT04516746|7361473|FG001|Overall Study|Death|7
4539198|NCT04516746|7361472|FG000|Overall Study|Physician Decision|0
4539199|NCT04516746|7361473|FG001|Overall Study|Physician Decision|2
4539200|NCT04516746|7361472|FG000|Overall Study|Other|0
4539201|NCT04516746|7361473|FG001|Overall Study|Other|1
4539202|NCT04364737|7361485|FG000|Overall Study|Withdrawal by Subject|4
4539203|NCT04364737|7361486|FG001|Overall Study|Withdrawal by Subject|9
4539204|NCT04364737|7361485|FG000|Overall Study|Lost to Follow-up|1
4539205|NCT04364737|7361486|FG001|Overall Study|Lost to Follow-up|1
4613222|NCT01713582|7470259|FG002|Overall Study|Lack of Efficacy|0
4613223|NCT01713582|7470260|FG003|Overall Study|Lack of Efficacy|0
4613224|NCT01713582|7470261|FG004|Overall Study|Lack of Efficacy|0
4613225|NCT01713582|7470262|FG005|Overall Study|Lack of Efficacy|0
4613226|NCT01713582|7470263|FG006|Overall Study|Lack of Efficacy|0
4613227|NCT01713582|7470264|FG007|Overall Study|Lack of Efficacy|0
4459849|NCT00570492|7248079|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0
4459850|NCT00570492|7248080|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3
4459851|NCT00570492|7248081|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0
4459852|NCT00570492|7248079|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0
4459853|NCT00570492|7248080|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3
4459854|NCT00570492|7248081|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0
4459855|NCT00570505|7248087|FG000|Overall Study|Adverse Event|7
4459856|NCT00570505|7248087|FG000|Overall Study|Withdrawal by Subject|7
4459857|NCT00570505|7248087|FG000|Overall Study|Lost to Follow-up|23
4459858|NCT00570505|7248087|FG000|Overall Study|Other loss to follow-up|4
4459859|NCT00570661|7248091|FG000|Overall Study|Disease worsening|5
4459860|NCT00570661|7248091|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1
4459861|NCT00570661|7248091|FG000|Overall Study|Adverse Event|1
4459862|NCT00570674|7248096|FG000|Overall Study|Withdrawal by Subject|0
4459863|NCT00570674|7248097|FG001|Overall Study|Withdrawal by Subject|0
4459864|NCT00570674|7248098|FG002|Overall Study|Withdrawal by Subject|1
4459865|NCT00570674|7248099|FG003|Overall Study|Withdrawal by Subject|0
4459866|NCT00570674|7248100|FG004|Overall Study|Withdrawal by Subject|0
4459867|NCT00570674|7248101|FG005|Overall Study|Withdrawal by Subject|0
4459868|NCT00570674|7248102|FG006|Overall Study|Withdrawal by Subject|0
4459869|NCT00570687|7248115|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
4459870|NCT00570687|7248116|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
4459871|NCT00570687|7248117|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
4459872|NCT00570687|7248118|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
4459873|NCT00570687|7248119|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
4459874|NCT00570687|7248120|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
4459875|NCT00570687|7248121|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2
4459876|NCT00570687|7248122|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
4459877|NCT00570687|7248123|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2
4459878|NCT00570687|7248124|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
4459879|NCT00570687|7248115|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
4459880|NCT00570687|7248116|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
4613228|NCT01713582|7470265|FG008|Overall Study|Lack of Efficacy|0
4613229|NCT01713582|7470266|FG009|Overall Study|Lack of Efficacy|1
4613230|NCT01713582|7470267|FG010|Overall Study|Lack of Efficacy|2
4613231|NCT01713582|7470268|FG011|Overall Study|Lack of Efficacy|0
4613232|NCT01713582|7470269|FG012|Overall Study|Lack of Efficacy|0
4613233|NCT01713582|7470270|FG013|Overall Study|Lack of Efficacy|0
4613234|NCT01713582|7470271|FG014|Overall Study|Lack of Efficacy|0
4613235|NCT01713582|7470272|FG015|Overall Study|Lack of Efficacy|0
4613236|NCT01713582|7470273|FG016|Overall Study|Lack of Efficacy|0
4613237|NCT01713582|7470274|FG017|Overall Study|Lack of Efficacy|0
4613238|NCT01713582|7470275|FG018|Overall Study|Lack of Efficacy|0
4613239|NCT01713582|7470276|FG019|Overall Study|Lack of Efficacy|0
4613240|NCT01713582|7470277|FG020|Overall Study|Lack of Efficacy|0
4613241|NCT01713582|7470257|FG000|Overall Study|Withdrawal by Subject|0
4613242|NCT01713582|7470258|FG001|Overall Study|Withdrawal by Subject|0
4613243|NCT01713582|7470259|FG002|Overall Study|Withdrawal by Subject|0
4613244|NCT01713582|7470260|FG003|Overall Study|Withdrawal by Subject|0
4613245|NCT01713582|7470261|FG004|Overall Study|Withdrawal by Subject|0
4613246|NCT01713582|7470262|FG005|Overall Study|Withdrawal by Subject|0
4613247|NCT01713582|7470263|FG006|Overall Study|Withdrawal by Subject|0
4613248|NCT01713582|7470264|FG007|Overall Study|Withdrawal by Subject|0
4613249|NCT01713582|7470265|FG008|Overall Study|Withdrawal by Subject|0
4613250|NCT01713582|7470266|FG009|Overall Study|Withdrawal by Subject|0
4613251|NCT01713582|7470267|FG010|Overall Study|Withdrawal by Subject|0
4613252|NCT01713582|7470268|FG011|Overall Study|Withdrawal by Subject|0
4613253|NCT01713582|7470269|FG012|Overall Study|Withdrawal by Subject|0
4613254|NCT01713582|7470270|FG013|Overall Study|Withdrawal by Subject|0
4613255|NCT01713582|7470271|FG014|Overall Study|Withdrawal by Subject|0
4613256|NCT01713582|7470272|FG015|Overall Study|Withdrawal by Subject|0
4613257|NCT01713582|7470273|FG016|Overall Study|Withdrawal by Subject|0
4613258|NCT01713582|7470274|FG017|Overall Study|Withdrawal by Subject|1
4613259|NCT01713582|7470275|FG018|Overall Study|Withdrawal by Subject|0
4613260|NCT01713582|7470276|FG019|Overall Study|Withdrawal by Subject|0
4613261|NCT01713582|7470277|FG020|Overall Study|Withdrawal by Subject|0
4613262|NCT01713582|7470257|FG000|Overall Study|Stopped to receive bone marrow graft|0
4613263|NCT01713582|7470258|FG001|Overall Study|Stopped to receive bone marrow graft|0
4613264|NCT01713582|7470259|FG002|Overall Study|Stopped to receive bone marrow graft|0
4613265|NCT01713582|7470260|FG003|Overall Study|Stopped to receive bone marrow graft|0
4613266|NCT01713582|7470261|FG004|Overall Study|Stopped to receive bone marrow graft|0
4613267|NCT01713582|7470262|FG005|Overall Study|Stopped to receive bone marrow graft|0
4613268|NCT01713582|7470263|FG006|Overall Study|Stopped to receive bone marrow graft|0
4613269|NCT01713582|7470264|FG007|Overall Study|Stopped to receive bone marrow graft|0
4613270|NCT01713582|7470265|FG008|Overall Study|Stopped to receive bone marrow graft|0
4734819|NCT03505593|7682042|FG000|Overall Study|Died before procedure|1
4459881|NCT00570687|7248117|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
4459882|NCT00570687|7248118|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
4459883|NCT00570687|7248119|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
4459884|NCT00570687|7248120|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
4459885|NCT00570687|7248121|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
4459886|NCT00570687|7248122|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
4459887|NCT00570687|7248123|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1
4459888|NCT00570687|7248124|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
4459889|NCT00570687|7248115|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
4459890|NCT00570687|7248116|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
4459891|NCT00570687|7248117|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
4459892|NCT00570687|7248118|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
4459893|NCT00570687|7248119|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
4459894|NCT00570687|7248120|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
4459895|NCT00570687|7248121|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1
4459896|NCT00570687|7248122|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
4459897|NCT00570687|7248123|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
4459898|NCT00570687|7248124|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
4459899|NCT00570713|7248144|FG000|Overall Study|Adverse Event|16
4459900|NCT00570713|7248145|FG001|Overall Study|Adverse Event|9
4459901|NCT00570713|7248144|FG000|Overall Study|Death|7
4459902|NCT00570713|7248145|FG001|Overall Study|Death|7
4459903|NCT00570713|7248144|FG000|Overall Study|Lack of Efficacy|40
4459904|NCT00570713|7248145|FG001|Overall Study|Lack of Efficacy|49
4459905|NCT00570713|7248144|FG000|Overall Study|Physician Decision|2
4459906|NCT00570713|7248145|FG001|Overall Study|Physician Decision|2
4459907|NCT00570713|7248144|FG000|Overall Study|Withdrawal by Subject|3
4459908|NCT00570713|7248145|FG001|Overall Study|Withdrawal by Subject|3
4459909|NCT00570713|7248144|FG000|Overall Study|Discontinuation of Study by the Sponsor|10
4459910|NCT00570713|7248145|FG001|Overall Study|Discontinuation of Study by the Sponsor|7
4459911|NCT00570739|7248155|FG000|Overall Study|Adverse Event|8
4459912|NCT00570739|7248156|FG001|Overall Study|Adverse Event|6
4459913|NCT00570739|7248157|FG002|Overall Study|Adverse Event|2
4459914|NCT00570739|7248158|FG003|Overall Study|Adverse Event|2
4459915|NCT00570739|7248155|FG000|Overall Study|Lost to Follow-up|4
4459916|NCT00570739|7248156|FG001|Overall Study|Lost to Follow-up|5
4459917|NCT00570739|7248157|FG002|Overall Study|Lost to Follow-up|4
4459918|NCT00570739|7248158|FG003|Overall Study|Lost to Follow-up|1
4459919|NCT00570739|7248155|FG000|Overall Study|Physician Decision|1
4459920|NCT00570739|7248156|FG001|Overall Study|Physician Decision|1
4459921|NCT00570739|7248157|FG002|Overall Study|Physician Decision|0
4459922|NCT00570739|7248158|FG003|Overall Study|Physician Decision|0
4459923|NCT00570739|7248155|FG000|Overall Study|Withdrawal by Subject|7
4459924|NCT00570739|7248156|FG001|Overall Study|Withdrawal by Subject|7
4459925|NCT00570739|7248157|FG002|Overall Study|Withdrawal by Subject|3
4459926|NCT00570739|7248158|FG003|Overall Study|Withdrawal by Subject|5
4459927|NCT00570739|7248155|FG000|Overall Study|Required restricted medication|0
4459928|NCT00570739|7248156|FG001|Overall Study|Required restricted medication|0
4459929|NCT00570739|7248157|FG002|Overall Study|Required restricted medication|1
4459930|NCT00570739|7248158|FG003|Overall Study|Required restricted medication|0
4459931|NCT00570739|7248155|FG000|Overall Study|Met discontinuation criteria|1
4459932|NCT00570739|7248156|FG001|Overall Study|Met discontinuation criteria|0
4459933|NCT00570739|7248157|FG002|Overall Study|Met discontinuation criteria|1
4459934|NCT00570739|7248158|FG003|Overall Study|Met discontinuation criteria|1
4459935|NCT00570739|7248155|FG000|Overall Study|Other|0
4459936|NCT00570739|7248156|FG001|Overall Study|Other|2
4459937|NCT00570739|7248157|FG002|Overall Study|Other|5
4459938|NCT00570739|7248158|FG003|Overall Study|Other|3
4459939|NCT00570765|7248191|FG000|DB Phase|Withdrawal by Subject|1
4459940|NCT00570765|7248192|FG001|DB Phase|Withdrawal by Subject|0
4459941|NCT00570765|7248193|FG002|DB Phase|Withdrawal by Subject|0
4459942|NCT00570765|7248194|FG003|DB Phase|Withdrawal by Subject|0
4459943|NCT00570765|7248191|FG000|DB Phase|Protocol Violation|0
4459944|NCT00570765|7248192|FG001|DB Phase|Protocol Violation|1
4459945|NCT00570765|7248193|FG002|DB Phase|Protocol Violation|0
4459946|NCT00570765|7248194|FG003|DB Phase|Protocol Violation|0
4459947|NCT00570765|7248191|FG000|DB Phase|Adverse Event|3
4459948|NCT00570765|7248192|FG001|DB Phase|Adverse Event|6
4459949|NCT00570765|7248193|FG002|DB Phase|Adverse Event|0
4459950|NCT00570765|7248194|FG003|DB Phase|Adverse Event|0
4459951|NCT00570765|7248191|FG000|DB Phase|Did Not Receive Study Drug|0
4459952|NCT00570765|7248192|FG001|DB Phase|Did Not Receive Study Drug|0
4459953|NCT00570765|7248193|FG002|DB Phase|Did Not Receive Study Drug|1
4459954|NCT00570765|7248194|FG003|DB Phase|Did Not Receive Study Drug|0
4459955|NCT00570765|7248191|FG000|LTSE Phase|Withdrawal by Subject|0
4459956|NCT00570765|7248192|FG001|LTSE Phase|Withdrawal by Subject|0
4459957|NCT00570765|7248193|FG002|LTSE Phase|Withdrawal by Subject|0
4459958|NCT00570765|7248194|FG003|LTSE Phase|Withdrawal by Subject|1
4459959|NCT00570765|7248191|FG000|LTSE Phase|Adverse Event|0
4459960|NCT00570765|7248192|FG001|LTSE Phase|Adverse Event|0
4459961|NCT00570765|7248193|FG002|LTSE Phase|Adverse Event|0
4459962|NCT00570765|7248194|FG003|LTSE Phase|Adverse Event|7
4459963|NCT00570765|7248191|FG000|LTSE Phase|Physician Decision|0
4459964|NCT00570765|7248192|FG001|LTSE Phase|Physician Decision|0
4459965|NCT00570765|7248193|FG002|LTSE Phase|Physician Decision|0
4459966|NCT00570765|7248194|FG003|LTSE Phase|Physician Decision|4
4459967|NCT00570778|7248205|FG000|Overall Study|Protocol deviation|2
4459968|NCT00570778|7248206|FG001|Overall Study|Protocol deviation|1
4459969|NCT00570778|7248207|FG002|Overall Study|Protocol deviation|2
4459970|NCT00570778|7248208|FG003|Overall Study|Protocol deviation|2
4459971|NCT00570778|7248205|FG000|Overall Study|Adverse Event|0
4459972|NCT00570778|7248206|FG001|Overall Study|Adverse Event|1
4459973|NCT00570778|7248207|FG002|Overall Study|Adverse Event|4
4459974|NCT00570778|7248208|FG003|Overall Study|Adverse Event|1
4459975|NCT00570778|7248205|FG000|Overall Study|Subject withdrew consent|0
4459976|NCT00570778|7248206|FG001|Overall Study|Subject withdrew consent|1
4459977|NCT00570778|7248207|FG002|Overall Study|Subject withdrew consent|0
4459978|NCT00570778|7248208|FG003|Overall Study|Subject withdrew consent|1
4459979|NCT00570778|7248205|FG000|Overall Study|Abnormal test procedure|1
4459980|NCT00570778|7248206|FG001|Overall Study|Abnormal test procedure|0
4459981|NCT00570778|7248207|FG002|Overall Study|Abnormal test procedure|0
4459982|NCT00570778|7248208|FG003|Overall Study|Abnormal test procedure|0
4459983|NCT00570778|7248205|FG000|Overall Study|Unsatisfactory therapeutic effect|1
4459984|NCT00570778|7248206|FG001|Overall Study|Unsatisfactory therapeutic effect|0
4459985|NCT00570778|7248207|FG002|Overall Study|Unsatisfactory therapeutic effect|0
4459986|NCT00570778|7248208|FG003|Overall Study|Unsatisfactory therapeutic effect|0
4459987|NCT00570778|7248205|FG000|Overall Study|Lost to Follow-up|0
4459988|NCT00570778|7248206|FG001|Overall Study|Lost to Follow-up|0
4459989|NCT00570778|7248207|FG002|Overall Study|Lost to Follow-up|1
4459990|NCT00570778|7248208|FG003|Overall Study|Lost to Follow-up|0
4459991|NCT00570778|7248205|FG000|Overall Study|Subject no longer requires study drug|0
4459992|NCT00570778|7248206|FG001|Overall Study|Subject no longer requires study drug|1
4459993|NCT00570778|7248207|FG002|Overall Study|Subject no longer requires study drug|0
4459994|NCT00570778|7248208|FG003|Overall Study|Subject no longer requires study drug|0
4459995|NCT00570908|7248218|FG000|Overall Study|Adverse Event|5
4459996|NCT00570908|7248218|FG000|Overall Study|Withdrawal by Subject|2
4459997|NCT00570921|7248222|FG000|Overall Study|Protocol Violation|1
4459998|NCT00570921|7248222|FG000|Overall Study|Physician Decision|1
4459999|NCT00571038|7248237|FG000|Overall Study|Lost to Follow-up|1
4460000|NCT00571038|7248238|FG001|Overall Study|Lost to Follow-up|4
4460001|NCT00571038|7248237|FG000|Overall Study|Death|7
4460002|NCT00571038|7248238|FG001|Overall Study|Death|5
4460003|NCT00571038|7248237|FG000|Overall Study|Withdrawal by Subject|1
4460004|NCT00571038|7248238|FG001|Overall Study|Withdrawal by Subject|3
4460005|NCT00571038|7248237|FG000|Overall Study|Moved out of state|2
4460006|NCT00571038|7248238|FG001|Overall Study|Moved out of state|2
4460007|NCT00571064|7248244|FG000|Overall Study|Adverse Event|13
4539206|NCT04354155|7361492|FG000|Overall Study|Withdrawal by Subject|1
4539207|NCT04354155|7361492|FG000|Overall Study|Did not meet criteria for study intervention|1
4539208|NCT04085367|7361498|FG000|Overall Study|Adverse Event|1
4460008|NCT00571064|7248244|FG000|Overall Study|Protocol Violation|4
4460009|NCT00571064|7248244|FG000|Overall Study|Withdrawal by Subject|2
4460010|NCT00571064|7248244|FG000|Overall Study|Other|2
4460011|NCT00571103|7248249|FG000|Overall Study|Withdrawal by Subject|1
4460012|NCT00571103|7248249|FG000|Overall Study|Lost to Follow-up|1
4460013|NCT00571519|7248301|FG000|Overall Study|Subject withdrew consent|0
4460014|NCT00571519|7248302|FG001|Overall Study|Subject withdrew consent|1
4460015|NCT00571519|7248303|FG002|Overall Study|Subject withdrew consent|0
4460016|NCT00571519|7248304|FG003|Overall Study|Subject withdrew consent|2
4460017|NCT00571519|7248305|FG004|Overall Study|Subject withdrew consent|1
4460018|NCT00571519|7248306|FG005|Overall Study|Subject withdrew consent|1
4460019|NCT00571519|7248307|FG006|Overall Study|Subject withdrew consent|2
4460020|NCT00571519|7248301|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1
4460021|NCT00571519|7248302|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0
4460022|NCT00571519|7248303|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1
4460023|NCT00571519|7248304|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1
4460024|NCT00571519|7248305|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0
4460025|NCT00571519|7248306|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0
4460026|NCT00571519|7248307|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0
4460027|NCT00571519|7248301|FG000|Overall Study|Therapeutic failure/lack of efficacy|0
4539209|NCT04085367|7361499|FG001|Overall Study|Adverse Event|1
4460028|NCT00571519|7248302|FG001|Overall Study|Therapeutic failure/lack of efficacy|1
4460029|NCT00571519|7248303|FG002|Overall Study|Therapeutic failure/lack of efficacy|0
4460030|NCT00571519|7248304|FG003|Overall Study|Therapeutic failure/lack of efficacy|0
4460031|NCT00571519|7248305|FG004|Overall Study|Therapeutic failure/lack of efficacy|0
4460032|NCT00571519|7248306|FG005|Overall Study|Therapeutic failure/lack of efficacy|0
4460033|NCT00571519|7248307|FG006|Overall Study|Therapeutic failure/lack of efficacy|0
4460034|NCT00571519|7248301|FG000|Overall Study|Termination of study by Sponsor|2
4460035|NCT00571519|7248302|FG001|Overall Study|Termination of study by Sponsor|7
4460036|NCT00571519|7248303|FG002|Overall Study|Termination of study by Sponsor|10
4460037|NCT00571519|7248304|FG003|Overall Study|Termination of study by Sponsor|24
4460038|NCT00571519|7248305|FG004|Overall Study|Termination of study by Sponsor|8
4460039|NCT00571519|7248306|FG005|Overall Study|Termination of study by Sponsor|9
4460040|NCT00571519|7248307|FG006|Overall Study|Termination of study by Sponsor|22
4460041|NCT00571519|7248301|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0
4460042|NCT00571519|7248302|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0
4460043|NCT00571519|7248303|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1
4460044|NCT00571519|7248304|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0
4460045|NCT00571519|7248305|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0
4460046|NCT00571519|7248306|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0
4460047|NCT00571519|7248307|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0
4460048|NCT00571649|7248325|FG000|Treatment Period|Adverse Event|438
4460049|NCT00571649|7248326|FG001|Treatment Period|Adverse Event|385
4460050|NCT00571649|7248325|FG000|Treatment Period|Clinical endpoint reached|50
4539210|NCT04085367|7361498|FG000|Overall Study|Withdrawal by Subject|13
4539211|NCT04085367|7361499|FG001|Overall Study|Withdrawal by Subject|4
4539212|NCT04085367|7361498|FG000|Overall Study|Lost to Follow-up|3
4539213|NCT04085367|7361499|FG001|Overall Study|Lost to Follow-up|1
4539214|NCT04085367|7361498|FG000|Overall Study|Other unspecified|2
4613271|NCT01713582|7470266|FG009|Overall Study|Stopped to receive bone marrow graft|0
4613272|NCT01713582|7470267|FG010|Overall Study|Stopped to receive bone marrow graft|0
4613273|NCT01713582|7470268|FG011|Overall Study|Stopped to receive bone marrow graft|0
4613274|NCT01713582|7470269|FG012|Overall Study|Stopped to receive bone marrow graft|0
4613275|NCT01713582|7470270|FG013|Overall Study|Stopped to receive bone marrow graft|0
4613276|NCT01713582|7470271|FG014|Overall Study|Stopped to receive bone marrow graft|0
4613277|NCT01713582|7470272|FG015|Overall Study|Stopped to receive bone marrow graft|0
4613278|NCT01713582|7470273|FG016|Overall Study|Stopped to receive bone marrow graft|1
4613279|NCT01713582|7470274|FG017|Overall Study|Stopped to receive bone marrow graft|0
4613280|NCT01713582|7470275|FG018|Overall Study|Stopped to receive bone marrow graft|0
4613281|NCT01713582|7470276|FG019|Overall Study|Stopped to receive bone marrow graft|0
4613282|NCT01713582|7470277|FG020|Overall Study|Stopped to receive bone marrow graft|0
4613283|NCT01713582|7470257|FG000|Overall Study|Disease progression and adverse event|0
4613284|NCT01713582|7470258|FG001|Overall Study|Disease progression and adverse event|0
4613285|NCT01713582|7470259|FG002|Overall Study|Disease progression and adverse event|0
4613286|NCT01713582|7470260|FG003|Overall Study|Disease progression and adverse event|0
4613287|NCT01713582|7470261|FG004|Overall Study|Disease progression and adverse event|0
4613288|NCT01713582|7470262|FG005|Overall Study|Disease progression and adverse event|0
4613289|NCT01713582|7470263|FG006|Overall Study|Disease progression and adverse event|0
4613290|NCT01713582|7470264|FG007|Overall Study|Disease progression and adverse event|0
4613291|NCT01713582|7470265|FG008|Overall Study|Disease progression and adverse event|0
4539215|NCT04085367|7361499|FG001|Overall Study|Other unspecified|1
4539216|NCT04085367|7361498|FG000|Overall Study|Status Unknown|1
4539217|NCT04085367|7361499|FG001|Overall Study|Status Unknown|1
4591243|NCT01528215|7437695|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4
4591244|NCT01528215|7437696|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1
4591245|NCT01528215|7437695|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2
4591246|NCT01528215|7437696|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2
4591247|NCT01528215|7437695|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10
4591248|NCT01528215|7437696|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13
4591249|NCT01528215|7437695|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3
4613292|NCT01713582|7470266|FG009|Overall Study|Disease progression and adverse event|0
4613293|NCT01713582|7470267|FG010|Overall Study|Disease progression and adverse event|0
4613294|NCT01713582|7470268|FG011|Overall Study|Disease progression and adverse event|0
4613295|NCT01713582|7470269|FG012|Overall Study|Disease progression and adverse event|0
4613296|NCT01713582|7470270|FG013|Overall Study|Disease progression and adverse event|0
4613297|NCT01713582|7470271|FG014|Overall Study|Disease progression and adverse event|0
4613298|NCT01713582|7470272|FG015|Overall Study|Disease progression and adverse event|0
4613299|NCT01713582|7470273|FG016|Overall Study|Disease progression and adverse event|1
4613300|NCT01713582|7470274|FG017|Overall Study|Disease progression and adverse event|0
4613301|NCT01713582|7470275|FG018|Overall Study|Disease progression and adverse event|0
4613302|NCT01713582|7470276|FG019|Overall Study|Disease progression and adverse event|0
4613303|NCT01713582|7470277|FG020|Overall Study|Disease progression and adverse event|0
4613304|NCT01713686|7470364|FG000|Overall Study|Lost to Follow-up|9
4613305|NCT01713686|7470364|FG000|Overall Study|Withdrawal by Subject|6
4613306|NCT01713933|7470387|FG000|Overall Study|Lost to Follow-up|2
4613307|NCT01713933|7470387|FG000|Overall Study|Withdrawal by Subject|3
4613308|NCT01713933|7470387|FG000|Overall Study|Excluded from analysis as a BMI outlier|1
4613309|NCT01713946|7470394|FG000|Overall Study|Death|0
4613310|NCT01713946|7470395|FG001|Overall Study|Death|2
4613311|NCT01713946|7470396|FG002|Overall Study|Death|2
4613312|NCT01713946|7470394|FG000|Overall Study|Adverse Event|19
4613313|NCT01713946|7470395|FG001|Overall Study|Adverse Event|14
4613314|NCT01713946|7470396|FG002|Overall Study|Adverse Event|13
4613315|NCT01713946|7470394|FG000|Overall Study|Withdrawal by Subject|12
4613316|NCT01713946|7470395|FG001|Overall Study|Withdrawal by Subject|12
4593713|NCT01555125|7442331|FG000|Induction Period|Lost to Follow-up|0
4539218|NCT03621696|7361513|FG000|Overall Study|Not eligible|0
4539219|NCT03621696|7361514|FG001|Overall Study|Not eligible|0
4539220|NCT03621696|7361515|FG002|Overall Study|Not eligible|0
4539221|NCT03621696|7361516|FG003|Overall Study|Not eligible|5
4460051|NCT00571649|7248326|FG001|Treatment Period|Clinical endpoint reached|56
4460052|NCT00571649|7248325|FG000|Treatment Period|Withdrawal by Subject|285
4460053|NCT00571649|7248326|FG001|Treatment Period|Withdrawal by Subject|255
4460054|NCT00571649|7248325|FG000|Treatment Period|Death|76
4460055|NCT00571649|7248326|FG001|Treatment Period|Death|59
4460056|NCT00571649|7248325|FG000|Treatment Period|Physician Decision|8
4460057|NCT00571649|7248326|FG001|Treatment Period|Physician Decision|9
4460058|NCT00571649|7248325|FG000|Treatment Period|Lost to Follow-up|43
4460059|NCT00571649|7248326|FG001|Treatment Period|Lost to Follow-up|41
4460060|NCT00571649|7248325|FG000|Treatment Period|Non-compliant with study medication|88
4460061|NCT00571649|7248326|FG001|Treatment Period|Non-compliant with study medication|89
4460062|NCT00571649|7248325|FG000|Treatment Period|Patient convenience|11
4460063|NCT00571649|7248326|FG001|Treatment Period|Patient convenience|13
4460064|NCT00571649|7248325|FG000|Treatment Period|Protocol Violation|90
4460065|NCT00571649|7248326|FG001|Treatment Period|Protocol Violation|92
4460066|NCT00571649|7248325|FG000|Treatment Period|Technical problems|3
4460067|NCT00571649|7248326|FG001|Treatment Period|Technical problems|5
4539222|NCT03621696|7361513|FG000|Overall Study|Withdrawal by Subject|1
4539223|NCT03621696|7361514|FG001|Overall Study|Withdrawal by Subject|1
4539224|NCT03621696|7361515|FG002|Overall Study|Withdrawal by Subject|1
4539225|NCT03621696|7361516|FG003|Overall Study|Withdrawal by Subject|0
4539226|NCT03621696|7361513|FG000|Overall Study|Physician Decision|0
4539227|NCT03621696|7361514|FG001|Overall Study|Physician Decision|0
4539228|NCT03621696|7361515|FG002|Overall Study|Physician Decision|1
4539229|NCT03621696|7361516|FG003|Overall Study|Physician Decision|0
4539230|NCT03544268|7361526|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2
4539231|NCT03544268|7361527|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0
4539232|NCT03530995|7361535|FG000|Part 1 Period 3|Withdrawal by Subject|2
4539233|NCT03530995|7361536|FG001|Part 1 Period 3|Withdrawal by Subject|0
4539234|NCT03530995|7361535|FG000|Part 1 Period 3|Protocol Violation|1
4539235|NCT03530995|7361536|FG001|Part 1 Period 3|Protocol Violation|0
4539236|NCT03530995|7361535|FG000|Part 1 Period 4|Physician Decision|1
4539237|NCT03530995|7361536|FG001|Part 1 Period 4|Physician Decision|0
4539238|NCT03530995|7361535|FG000|Part 1 Period 4|Withdrawal by Subject|1
4539239|NCT03530995|7361536|FG001|Part 1 Period 4|Withdrawal by Subject|0
4539240|NCT03038438|7361604|FG000|Overall Study|Death|2
4539241|NCT03038438|7361604|FG000|Overall Study|Lost to Follow-up|4
4539242|NCT03038438|7361604|FG000|Overall Study|Subject Incarceration|1
4539243|NCT03038438|7361604|FG000|Overall Study|Withdrawal by Subject|2
4539244|NCT03038438|7361604|FG000|Overall Study|No 24-Month Follow-Up|43
4539245|NCT02574481|7361621|FG000|Overall Study|Withdrawal by Subject|6
4539246|NCT02574481|7361622|FG001|Overall Study|Withdrawal by Subject|4
4539247|NCT02574481|7361623|FG002|Overall Study|Withdrawal by Subject|1
4539248|NCT02574481|7361624|FG003|Overall Study|Withdrawal by Subject|0
4539249|NCT02574481|7361621|FG000|Overall Study|Adverse Event|2
4539250|NCT02574481|7361622|FG001|Overall Study|Adverse Event|0
4539251|NCT02574481|7361623|FG002|Overall Study|Adverse Event|0
4539252|NCT02574481|7361624|FG003|Overall Study|Adverse Event|0
4539253|NCT02574481|7361621|FG000|Overall Study|Visit Missed|12
4539254|NCT02574481|7361622|FG001|Overall Study|Visit Missed|4
4539255|NCT02574481|7361623|FG002|Overall Study|Visit Missed|2
4539256|NCT02574481|7361624|FG003|Overall Study|Visit Missed|0
4539257|NCT02574481|7361621|FG000|Overall Study|Other|1
4539258|NCT02574481|7361622|FG001|Overall Study|Other|0
4539259|NCT02574481|7361623|FG002|Overall Study|Other|0
4539260|NCT02574481|7361624|FG003|Overall Study|Other|0
4539261|NCT02574481|7361621|FG000|Overall Study|Death|6
4539262|NCT02574481|7361622|FG001|Overall Study|Death|6
4539263|NCT02574481|7361623|FG002|Overall Study|Death|0
4539264|NCT02574481|7361624|FG003|Overall Study|Death|0
4539265|NCT02557139|7361640|FG000|Overall Study|Significant liver elevation|1
4539266|NCT02557139|7361641|FG001|Overall Study|Significant liver elevation|0
4539267|NCT02557139|7361642|FG002|Overall Study|Significant liver elevation|1
4539268|NCT02557139|7361640|FG000|Overall Study|Withdrawal by Subject|1
4539269|NCT02557139|7361641|FG001|Overall Study|Withdrawal by Subject|0
4539270|NCT02557139|7361642|FG002|Overall Study|Withdrawal by Subject|0
4539271|NCT02557139|7361640|FG000|Overall Study|Illness of prohibited medication|0
4539272|NCT02557139|7361641|FG001|Overall Study|Illness of prohibited medication|0
4539273|NCT02557139|7361642|FG002|Overall Study|Illness of prohibited medication|1
4539274|NCT02451943|7361661|FG000|Overall Study|On Treatment|4
4539275|NCT02451943|7361662|FG001|Overall Study|On Treatment|4
4539276|NCT02451943|7361661|FG000|Overall Study|Withdrawal by Subject|13
4539277|NCT02451943|7361662|FG001|Overall Study|Withdrawal by Subject|16
4539278|NCT02451943|7361661|FG000|Overall Study|Lost to Follow-up|3
4460068|NCT00571649|7248325|FG000|Follow-up Period|Adverse Event|46
4460069|NCT00571649|7248326|FG001|Follow-up Period|Adverse Event|40
4515953|NCT00957424|7327154|FG000|Overall Study|Protocol Violation|3
4539279|NCT02451943|7361662|FG001|Overall Study|Lost to Follow-up|4
4539280|NCT02312258|7361670|FG000|Overall Study|Adverse Event|15
4613317|NCT01713946|7470396|FG002|Overall Study|Withdrawal by Subject|8
4460070|NCT00571649|7248325|FG000|Follow-up Period|Clinical endpoint reached|5
4460071|NCT00571649|7248326|FG001|Follow-up Period|Clinical endpoint reached|2
4460072|NCT00571649|7248325|FG000|Follow-up Period|Withdrawal by Subject|119
4460073|NCT00571649|7248326|FG001|Follow-up Period|Withdrawal by Subject|115
4460074|NCT00571649|7248325|FG000|Follow-up Period|Death|132
4460075|NCT00571649|7248326|FG001|Follow-up Period|Death|133
4460076|NCT00571649|7248325|FG000|Follow-up Period|Physician Decision|7
4460077|NCT00571649|7248326|FG001|Follow-up Period|Physician Decision|13
4460078|NCT00571649|7248325|FG000|Follow-up Period|Lost to Follow-up|95
4460079|NCT00571649|7248326|FG001|Follow-up Period|Lost to Follow-up|92
4460080|NCT00571649|7248325|FG000|Follow-up Period|Patient convenience|136
4460081|NCT00571649|7248326|FG001|Follow-up Period|Patient convenience|121
4460082|NCT00571649|7248325|FG000|Follow-up Period|Protocol Violation|5
4460083|NCT00571649|7248326|FG001|Follow-up Period|Protocol Violation|12
4460084|NCT00571662|7248332|FG000|Overall Study|Withdrawal by Subject|2
4460085|NCT00571662|7248332|FG000|Overall Study|psychiatric instability|1
4460086|NCT00571662|7248332|FG000|Overall Study|Adverse Event|5
4460087|NCT00571688|7248340|FG000|Overall Study|Lost to Follow-up|3
4460088|NCT00571688|7248341|FG001|Overall Study|Lost to Follow-up|6
4460089|NCT00571688|7248340|FG000|Overall Study|subject did not tolerate Consta|1
4460090|NCT00571688|7248341|FG001|Overall Study|subject did not tolerate Consta|0
4460091|NCT00571688|7248340|FG000|Overall Study|subject moved out of the area|1
4460092|NCT00571688|7248341|FG001|Overall Study|subject moved out of the area|0
4460093|NCT00571701|7248349|FG000|First Intervention 12 Months|Withdrawal by Subject|2
4460094|NCT00571701|7248350|FG001|First Intervention 12 Months|Withdrawal by Subject|1
4460095|NCT00571701|7248349|FG000|First Intervention 12 Months|Death|1
4460096|NCT00571701|7248350|FG001|First Intervention 12 Months|Death|0
4460097|NCT00571701|7248349|FG000|Second Intervention 12 Months|Adverse Event|0
4460098|NCT00571701|7248350|FG001|Second Intervention 12 Months|Adverse Event|1
4460099|NCT00571701|7248349|FG000|Second Intervention 12 Months|Withdrawal by Subject|3
4460100|NCT00571701|7248350|FG001|Second Intervention 12 Months|Withdrawal by Subject|0
4460101|NCT00571948|7248376|FG000|Overall Study|Lost to Follow-up|2
4460102|NCT00571948|7248377|FG001|Overall Study|Lost to Follow-up|0
4460103|NCT00571948|7248376|FG000|Overall Study|Withdrawal by Subject|1
4460104|NCT00571948|7248377|FG001|Overall Study|Withdrawal by Subject|2
4460105|NCT00571948|7248376|FG000|Overall Study|Protocol Violation|3
4460106|NCT00571948|7248377|FG001|Overall Study|Protocol Violation|3
4460107|NCT00571948|7248376|FG000|Overall Study|infant refused study meal|3
4460108|NCT00571948|7248377|FG001|Overall Study|infant refused study meal|4
4460109|NCT00571948|7248376|FG000|Overall Study|Parent were afraid of blood colection|2
4460110|NCT00571948|7248377|FG001|Overall Study|Parent were afraid of blood colection|5
4460111|NCT00572039|7248403|FG000|Overall Study|Withdrawal by Subject|9
4460112|NCT00572039|7248404|FG001|Overall Study|Withdrawal by Subject|6
4460113|NCT00572039|7248403|FG000|Overall Study|Death|2
4460114|NCT00572039|7248404|FG001|Overall Study|Death|3
4460115|NCT00572039|7248403|FG000|Overall Study|Ill|5
4460116|NCT00572039|7248404|FG001|Overall Study|Ill|1
4460117|NCT00572156|7248427|FG000|Overall Study|Adverse Event|3
4460118|NCT00572156|7248428|FG001|Overall Study|Adverse Event|1
4460119|NCT00572156|7248429|FG002|Overall Study|Adverse Event|5
4460120|NCT00572156|7248430|FG003|Overall Study|Adverse Event|1
4460121|NCT00572156|7248427|FG000|Overall Study|Lost to Follow-up|1
4460122|NCT00572156|7248428|FG001|Overall Study|Lost to Follow-up|1
4460123|NCT00572156|7248429|FG002|Overall Study|Lost to Follow-up|1
4460124|NCT00572156|7248430|FG003|Overall Study|Lost to Follow-up|0
4460125|NCT00572156|7248427|FG000|Overall Study|Protocol Violation|1
4460126|NCT00572156|7248428|FG001|Overall Study|Protocol Violation|2
4460127|NCT00572156|7248429|FG002|Overall Study|Protocol Violation|0
4460128|NCT00572156|7248430|FG003|Overall Study|Protocol Violation|2
4460129|NCT00572156|7248427|FG000|Overall Study|Patient/Parent Decision|1
4460130|NCT00572156|7248428|FG001|Overall Study|Patient/Parent Decision|6
4460131|NCT00572156|7248429|FG002|Overall Study|Patient/Parent Decision|4
4460132|NCT00572156|7248430|FG003|Overall Study|Patient/Parent Decision|3
4460133|NCT00572156|7248427|FG000|Overall Study|Sponsor Decision|20
4460134|NCT00572156|7248428|FG001|Overall Study|Sponsor Decision|16
4460135|NCT00572156|7248429|FG002|Overall Study|Sponsor Decision|17
4460136|NCT00572156|7248430|FG003|Overall Study|Sponsor Decision|19
4460137|NCT00572195|7248440|FG000|Overall Study|Withdrawal by Subject|50
4460138|NCT00572195|7248440|FG000|Overall Study|Death|9
4460139|NCT00572195|7248440|FG000|Overall Study|Adverse Event|4
4460140|NCT00572195|7248440|FG000|Overall Study|Lost to Follow-up|5
4460141|NCT00572455|7248467|FG000|Stage I (14 Days)|Adverse Event|0
4460142|NCT00572455|7248468|FG001|Stage I (14 Days)|Adverse Event|0
4460143|NCT00572455|7248469|FG002|Stage I (14 Days)|Adverse Event|0
4460144|NCT00572455|7248470|FG003|Stage I (14 Days)|Adverse Event|0
4460145|NCT00572455|7248471|FG004|Stage I (14 Days)|Adverse Event|0
4460146|NCT00572455|7248472|FG005|Stage I (14 Days)|Adverse Event|3
4460147|NCT00572455|7248473|FG006|Stage I (14 Days)|Adverse Event|0
4460148|NCT00572455|7248474|FG007|Stage I (14 Days)|Adverse Event|0
4460149|NCT00572455|7248475|FG008|Stage I (14 Days)|Adverse Event|0
4460150|NCT00572455|7248476|FG009|Stage I (14 Days)|Adverse Event|0
4460151|NCT00572455|7248477|FG010|Stage I (14 Days)|Adverse Event|0
4460152|NCT00572455|7248478|FG011|Stage I (14 Days)|Adverse Event|0
4460153|NCT00572455|7248479|FG012|Stage I (14 Days)|Adverse Event|0
4613318|NCT01713946|7470394|FG000|Overall Study|Lack of Efficacy|8
4613319|NCT01713946|7470395|FG001|Overall Study|Lack of Efficacy|8
4613320|NCT01713946|7470396|FG002|Overall Study|Lack of Efficacy|14
4613321|NCT01713946|7470394|FG000|Overall Study|Protocol Violation|2
4613322|NCT01713946|7470395|FG001|Overall Study|Protocol Violation|4
4613323|NCT01713946|7470396|FG002|Overall Study|Protocol Violation|1
4613324|NCT01713946|7470394|FG000|Overall Study|Lost to Follow-up|0
4613325|NCT01713946|7470395|FG001|Overall Study|Lost to Follow-up|0
4613326|NCT01713946|7470396|FG002|Overall Study|Lost to Follow-up|1
4613327|NCT01713946|7470394|FG000|Overall Study|Administrative problems|1
4613328|NCT01713946|7470395|FG001|Overall Study|Administrative problems|0
4613329|NCT01713946|7470396|FG002|Overall Study|Administrative problems|0
4613330|NCT01713946|7470394|FG000|Overall Study|Did not continue in Ext|0
4613331|NCT01713946|7470395|FG001|Overall Study|Did not continue in Ext|3
4613332|NCT01713946|7470396|FG002|Overall Study|Did not continue in Ext|0
4613333|NCT01713946|7470394|FG000|Overall Study|Did not continue in Post-Ext. Phase|1
4613334|NCT01713946|7470395|FG001|Overall Study|Did not continue in Post-Ext. Phase|2
4613335|NCT01713946|7470396|FG002|Overall Study|Did not continue in Post-Ext. Phase|0
4613336|NCT01713946|7470394|FG000|Overall Study|Patients never switched to everolimus|0
4613337|NCT01713946|7470395|FG001|Overall Study|Patients never switched to everolimus|0
4613338|NCT01713946|7470396|FG002|Overall Study|Patients never switched to everolimus|5
4613339|NCT01713998|7470425|FG000|Overall Study|Lost to Follow-up|2
4613340|NCT01713998|7470426|FG001|Overall Study|Lost to Follow-up|0
4613341|NCT01713998|7470427|FG002|Overall Study|Lost to Follow-up|2
4613342|NCT01713998|7470425|FG000|Overall Study|Withdrawal by Subject|1
4613343|NCT01713998|7470426|FG001|Overall Study|Withdrawal by Subject|0
4613344|NCT01713998|7470427|FG002|Overall Study|Withdrawal by Subject|0
4613345|NCT01714063|7470457|FG000|Overall Study|Equipment malfunction|2
4613346|NCT01714310|7470472|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0
4613347|NCT01714310|7470473|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0
4613348|NCT01714310|7470474|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1
4613349|NCT01714310|7470472|FG000|Open Lisdexamfetamine Titration|Adverse Event|0
4613350|NCT01714310|7470473|FG001|Open Lisdexamfetamine Titration|Adverse Event|0
4613351|NCT01714310|7470474|FG002|Open Lisdexamfetamine Titration|Adverse Event|3
4613352|NCT01714310|7470472|FG000|Double Blind Adjunctive Treatment|Adverse Event|1
4613353|NCT01714310|7470473|FG001|Double Blind Adjunctive Treatment|Adverse Event|1
4613354|NCT01714310|7470474|FG002|Double Blind Adjunctive Treatment|Adverse Event|0
4613355|NCT01714310|7470472|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1
4613356|NCT01714310|7470473|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2
4613357|NCT01714310|7470474|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0
4613358|NCT01714544|7470522|FG000|Overall Study|Lost to Follow-up|1
4613359|NCT01714544|7470522|FG000|Overall Study|Physician Decision|1
4613360|NCT01714544|7470522|FG000|Overall Study|Withdrawal by Subject|1
4613361|NCT01714609|7470528|FG000|Overall Study|Protocol Violation|1
4613362|NCT01714609|7470529|FG001|Overall Study|Protocol Violation|0
4613363|NCT01714635|7470538|FG000|Overall Study|Discontinued|1
4613364|NCT01714635|7470539|FG001|Overall Study|Discontinued|0
4613365|NCT01714635|7470540|FG002|Overall Study|Discontinued|2
4613366|NCT01714635|7470538|FG000|Overall Study|Missed 6-month exam|1
4613367|NCT01714635|7470539|FG001|Overall Study|Missed 6-month exam|0
4613368|NCT01714635|7470540|FG002|Overall Study|Missed 6-month exam|0
4613369|NCT01714687|7470550|FG000|Overall Study|Withdrawal by Subject|1
4613370|NCT01714687|7470551|FG001|Overall Study|Withdrawal by Subject|0
4613371|NCT01714687|7470550|FG000|Overall Study|Lost to Follow-up|2
4613372|NCT01714687|7470551|FG001|Overall Study|Lost to Follow-up|4
4613373|NCT01714726|7470561|FG000|Double-Blinded Induction Period|Subject not in open label period|3
4613374|NCT01714726|7470562|FG001|Double-Blinded Induction Period|Subject not in open label period|1
4613375|NCT01714726|7470563|FG002|Double-Blinded Induction Period|Subject not in open label period|0
4613376|NCT01714726|7470564|FG003|Double-Blinded Induction Period|Subject not in open label period|0
4613377|NCT01714726|7470561|FG000|Double-Blinded Induction Period|Adverse Event|0
4613378|NCT01714726|7470562|FG001|Double-Blinded Induction Period|Adverse Event|1
4613379|NCT01714726|7470563|FG002|Double-Blinded Induction Period|Adverse Event|0
4613380|NCT01714726|7470564|FG003|Double-Blinded Induction Period|Adverse Event|0
4613381|NCT01714726|7470561|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5
4613382|NCT01714726|7470562|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3
4613383|NCT01714726|7470563|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0
4613384|NCT01714726|7470564|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0
4613385|NCT01714726|7470561|FG000|Double-Blinded Induction Period|Lost to Follow-up|0
4613386|NCT01714726|7470562|FG001|Double-Blinded Induction Period|Lost to Follow-up|2
4613387|NCT01714726|7470563|FG002|Double-Blinded Induction Period|Lost to Follow-up|0
4613388|NCT01714726|7470564|FG003|Double-Blinded Induction Period|Lost to Follow-up|0
4613389|NCT01714726|7470561|FG000|Open-Label Period|Other|0
4613390|NCT01714726|7470562|FG001|Open-Label Period|Other|0
4613391|NCT01714726|7470563|FG002|Open-Label Period|Other|1
4613392|NCT01714726|7470564|FG003|Open-Label Period|Other|3
4613393|NCT01714726|7470561|FG000|Open-Label Period|Adverse Event|0
4460154|NCT00572455|7248480|FG013|Stage I (14 Days)|Adverse Event|0
4460155|NCT00572455|7248467|FG000|Stage I (14 Days)|Other|0
4613394|NCT01714726|7470562|FG001|Open-Label Period|Adverse Event|0
4613395|NCT01714726|7470563|FG002|Open-Label Period|Adverse Event|1
4613396|NCT01714726|7470564|FG003|Open-Label Period|Adverse Event|0
4613397|NCT01714726|7470561|FG000|Open-Label Period|Withdrawal by Subject|0
4613398|NCT01714726|7470562|FG001|Open-Label Period|Withdrawal by Subject|0
4613399|NCT01714726|7470563|FG002|Open-Label Period|Withdrawal by Subject|9
4613400|NCT01714726|7470564|FG003|Open-Label Period|Withdrawal by Subject|19
4613401|NCT01714726|7470561|FG000|Open-Label Period|Developed specific withdrawal criteria|0
4613402|NCT01714726|7470562|FG001|Open-Label Period|Developed specific withdrawal criteria|0
4613403|NCT01714726|7470563|FG002|Open-Label Period|Developed specific withdrawal criteria|5
4613404|NCT01714726|7470564|FG003|Open-Label Period|Developed specific withdrawal criteria|2
4613405|NCT01714726|7470561|FG000|Open-Label Period|Lost to Follow-up|0
4613406|NCT01714726|7470562|FG001|Open-Label Period|Lost to Follow-up|0
4613407|NCT01714726|7470563|FG002|Open-Label Period|Lost to Follow-up|3
4613408|NCT01714726|7470564|FG003|Open-Label Period|Lost to Follow-up|4
4613409|NCT01714947|7470590|FG000|Part B|Progressive Disease|3
4613410|NCT01715129|7470603|FG000|Overall Study|Adverse Event, fatal|1
4613411|NCT01715129|7470603|FG000|Overall Study|Lack of Efficacy|3
4613412|NCT01715129|7470603|FG000|Overall Study|Protocol Violation|1
4613413|NCT01715129|7470603|FG000|Overall Study|Consent Withdrawn|2
4613414|NCT01715129|7470603|FG000|Overall Study|Lost to Follow-up|1
4613415|NCT01715129|7470603|FG000|Overall Study|Other|1
4613416|NCT01715298|7470625|FG000|Overall Study|Lost to Follow-up|0
4460156|NCT00572455|7248468|FG001|Stage I (14 Days)|Other|0
4460157|NCT00572455|7248469|FG002|Stage I (14 Days)|Other|0
4460158|NCT00572455|7248470|FG003|Stage I (14 Days)|Other|0
4460159|NCT00572455|7248471|FG004|Stage I (14 Days)|Other|1
4460160|NCT00572455|7248472|FG005|Stage I (14 Days)|Other|0
4460161|NCT00572455|7248473|FG006|Stage I (14 Days)|Other|0
4460162|NCT00572455|7248474|FG007|Stage I (14 Days)|Other|0
4460163|NCT00572455|7248475|FG008|Stage I (14 Days)|Other|0
4460164|NCT00572455|7248476|FG009|Stage I (14 Days)|Other|0
4460165|NCT00572455|7248477|FG010|Stage I (14 Days)|Other|0
4460166|NCT00572455|7248478|FG011|Stage I (14 Days)|Other|0
4460167|NCT00572455|7248479|FG012|Stage I (14 Days)|Other|0
4460168|NCT00572455|7248480|FG013|Stage I (14 Days)|Other|0
4460169|NCT00572455|7248467|FG000|Stage II (28 Days)|Adverse Event|0
4460170|NCT00572455|7248468|FG001|Stage II (28 Days)|Adverse Event|0
4460171|NCT00572455|7248469|FG002|Stage II (28 Days)|Adverse Event|0
4460172|NCT00572455|7248470|FG003|Stage II (28 Days)|Adverse Event|0
4460173|NCT00572455|7248471|FG004|Stage II (28 Days)|Adverse Event|0
4460174|NCT00572455|7248472|FG005|Stage II (28 Days)|Adverse Event|0
4460175|NCT00572455|7248473|FG006|Stage II (28 Days)|Adverse Event|0
4460176|NCT00572455|7248474|FG007|Stage II (28 Days)|Adverse Event|0
4460177|NCT00572455|7248475|FG008|Stage II (28 Days)|Adverse Event|1
4460178|NCT00572455|7248476|FG009|Stage II (28 Days)|Adverse Event|3
4460179|NCT00572455|7248477|FG010|Stage II (28 Days)|Adverse Event|3
4460180|NCT00572455|7248478|FG011|Stage II (28 Days)|Adverse Event|4
4460181|NCT00572455|7248479|FG012|Stage II (28 Days)|Adverse Event|5
4460182|NCT00572455|7248480|FG013|Stage II (28 Days)|Adverse Event|1
4460183|NCT00572455|7248467|FG000|Stage II (28 Days)|Death|0
4460184|NCT00572455|7248468|FG001|Stage II (28 Days)|Death|0
4460185|NCT00572455|7248469|FG002|Stage II (28 Days)|Death|0
4460186|NCT00572455|7248470|FG003|Stage II (28 Days)|Death|0
4460187|NCT00572455|7248471|FG004|Stage II (28 Days)|Death|0
4460188|NCT00572455|7248472|FG005|Stage II (28 Days)|Death|0
4460189|NCT00572455|7248473|FG006|Stage II (28 Days)|Death|0
4460190|NCT00572455|7248474|FG007|Stage II (28 Days)|Death|0
4460191|NCT00572455|7248475|FG008|Stage II (28 Days)|Death|1
4460192|NCT00572455|7248476|FG009|Stage II (28 Days)|Death|0
4460193|NCT00572455|7248477|FG010|Stage II (28 Days)|Death|0
4460194|NCT00572455|7248478|FG011|Stage II (28 Days)|Death|0
4460195|NCT00572455|7248479|FG012|Stage II (28 Days)|Death|0
4460196|NCT00572455|7248480|FG013|Stage II (28 Days)|Death|0
4460197|NCT00572455|7248467|FG000|Stage II (28 Days)|Withdrawal by Subject|0
4460198|NCT00572455|7248468|FG001|Stage II (28 Days)|Withdrawal by Subject|0
4460199|NCT00572455|7248469|FG002|Stage II (28 Days)|Withdrawal by Subject|0
4460200|NCT00572455|7248470|FG003|Stage II (28 Days)|Withdrawal by Subject|0
4460201|NCT00572455|7248471|FG004|Stage II (28 Days)|Withdrawal by Subject|0
4460202|NCT00572455|7248472|FG005|Stage II (28 Days)|Withdrawal by Subject|0
4460203|NCT00572455|7248473|FG006|Stage II (28 Days)|Withdrawal by Subject|0
4460204|NCT00572455|7248474|FG007|Stage II (28 Days)|Withdrawal by Subject|1
4460205|NCT00572455|7248475|FG008|Stage II (28 Days)|Withdrawal by Subject|0
4460206|NCT00572455|7248476|FG009|Stage II (28 Days)|Withdrawal by Subject|0
4460207|NCT00572455|7248477|FG010|Stage II (28 Days)|Withdrawal by Subject|2
4460208|NCT00572455|7248478|FG011|Stage II (28 Days)|Withdrawal by Subject|0
4460209|NCT00572455|7248479|FG012|Stage II (28 Days)|Withdrawal by Subject|0
4460210|NCT00572455|7248480|FG013|Stage II (28 Days)|Withdrawal by Subject|0
4460211|NCT00572455|7248467|FG000|Stage II (28 Days)|Other|0
4460212|NCT00572455|7248468|FG001|Stage II (28 Days)|Other|0
4460213|NCT00572455|7248469|FG002|Stage II (28 Days)|Other|0
4613417|NCT01715298|7470626|FG001|Overall Study|Lost to Follow-up|2
4613418|NCT01715298|7470625|FG000|Overall Study|Patient/guardian decision|7
4613419|NCT01715298|7470626|FG001|Overall Study|Patient/guardian decision|9
4613420|NCT01715415|7470634|FG000|Double-blind Treatment|Did Not Receive Study Drug|0
4460214|NCT00572455|7248470|FG003|Stage II (28 Days)|Other|0
4460215|NCT00572455|7248471|FG004|Stage II (28 Days)|Other|0
4460216|NCT00572455|7248472|FG005|Stage II (28 Days)|Other|0
4460217|NCT00572455|7248473|FG006|Stage II (28 Days)|Other|0
4460218|NCT00572455|7248474|FG007|Stage II (28 Days)|Other|0
4460219|NCT00572455|7248475|FG008|Stage II (28 Days)|Other|1
4460220|NCT00572455|7248476|FG009|Stage II (28 Days)|Other|0
4460221|NCT00572455|7248477|FG010|Stage II (28 Days)|Other|0
4460222|NCT00572455|7248478|FG011|Stage II (28 Days)|Other|0
4460223|NCT00572455|7248479|FG012|Stage II (28 Days)|Other|0
4460224|NCT00572455|7248480|FG013|Stage II (28 Days)|Other|0
4460225|NCT00572455|7248467|FG000|Stage II (28 Days)|Randomized, but not treated|0
4460226|NCT00572455|7248468|FG001|Stage II (28 Days)|Randomized, but not treated|0
4460227|NCT00572455|7248469|FG002|Stage II (28 Days)|Randomized, but not treated|0
4460228|NCT00572455|7248470|FG003|Stage II (28 Days)|Randomized, but not treated|0
4460229|NCT00572455|7248471|FG004|Stage II (28 Days)|Randomized, but not treated|0
4460230|NCT00572455|7248472|FG005|Stage II (28 Days)|Randomized, but not treated|0
4460231|NCT00572455|7248473|FG006|Stage II (28 Days)|Randomized, but not treated|0
4460232|NCT00572455|7248474|FG007|Stage II (28 Days)|Randomized, but not treated|0
4460233|NCT00572455|7248475|FG008|Stage II (28 Days)|Randomized, but not treated|0
4460234|NCT00572455|7248476|FG009|Stage II (28 Days)|Randomized, but not treated|0
4460235|NCT00572455|7248477|FG010|Stage II (28 Days)|Randomized, but not treated|0
4460236|NCT00572455|7248478|FG011|Stage II (28 Days)|Randomized, but not treated|0
4460237|NCT00572455|7248479|FG012|Stage II (28 Days)|Randomized, but not treated|0
4460238|NCT00572455|7248480|FG013|Stage II (28 Days)|Randomized, but not treated|1
4460239|NCT00572533|7248521|FG000|Overall Study|Death|4
4460240|NCT00572533|7248522|FG001|Overall Study|Death|1
4460241|NCT00572533|7248521|FG000|Overall Study|Received Kidney Transplant|2
4460242|NCT00572533|7248522|FG001|Overall Study|Received Kidney Transplant|1
4539281|NCT02312258|7361671|FG001|Overall Study|Adverse Event|47
4539282|NCT02312258|7361670|FG000|Overall Study|Lost to Follow-up|0
4539283|NCT02312258|7361671|FG001|Overall Study|Lost to Follow-up|1
4539284|NCT02312258|7361670|FG000|Overall Study|Progressive Disease|174
4539285|NCT02312258|7361671|FG001|Overall Study|Progressive Disease|188
4539286|NCT02312258|7361670|FG000|Overall Study|Withdrawal by Subject|8
4539287|NCT02312258|7361671|FG001|Overall Study|Withdrawal by Subject|9
4539288|NCT02312258|7361670|FG000|Overall Study|Reason not Specified|11
4460243|NCT00572533|7248521|FG000|Overall Study|Social Issues|1
4460244|NCT00572533|7248522|FG001|Overall Study|Social Issues|0
4539289|NCT02312258|7361671|FG001|Overall Study|Reason not Specified|31
4539290|NCT02312258|7361670|FG000|Overall Study|Participants Ongoing Treatment|43
4539291|NCT02312258|7361671|FG001|Overall Study|Participants Ongoing Treatment|83
4539292|NCT02242942|7361680|FG000|Overall Study|Death|17
4539293|NCT02242942|7361681|FG001|Overall Study|Death|20
4539294|NCT02242942|7361682|FG002|Overall Study|Death|2
4539295|NCT02242942|7361680|FG000|Overall Study|Physician Decision|1
4539296|NCT02242942|7361681|FG001|Overall Study|Physician Decision|0
4539297|NCT02242942|7361682|FG002|Overall Study|Physician Decision|0
4539298|NCT02242942|7361680|FG000|Overall Study|Withdrawal by Subject|8
4539299|NCT02242942|7361681|FG001|Overall Study|Withdrawal by Subject|10
4539300|NCT02242942|7361682|FG002|Overall Study|Withdrawal by Subject|0
4539301|NCT02242942|7361680|FG000|Overall Study|On-going in Study|190
4539302|NCT02242942|7361681|FG001|Overall Study|On-going in Study|186
4539303|NCT02242942|7361682|FG002|Overall Study|On-going in Study|11
4591250|NCT01528215|7437696|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0
4591251|NCT01528254|7437713|FG000|Overall Study|Administrative problems|96
4591252|NCT01528254|7437714|FG001|Overall Study|Administrative problems|94
4591253|NCT01528254|7437713|FG000|Overall Study|Adverse Event|28
4591254|NCT01528254|7437714|FG001|Overall Study|Adverse Event|44
4591255|NCT01528254|7437713|FG000|Overall Study|Lost to Follow-up|17
4591256|NCT01528254|7437714|FG001|Overall Study|Lost to Follow-up|24
4591257|NCT01528254|7437713|FG000|Overall Study|Death|13
4591258|NCT01528254|7437714|FG001|Overall Study|Death|9
4591259|NCT01528254|7437713|FG000|Overall Study|Protocol deviation|9
4591260|NCT01528254|7437714|FG001|Overall Study|Protocol deviation|19
4591261|NCT01528254|7437713|FG000|Overall Study|New therapy for study indication|8
4591262|NCT01528254|7437714|FG001|Overall Study|New therapy for study indication|6
4591263|NCT01528254|7437713|FG000|Overall Study|Unsatisfactory therapeutic effect|6
4591264|NCT01528254|7437714|FG001|Overall Study|Unsatisfactory therapeutic effect|8
4591265|NCT01528254|7437713|FG000|Overall Study|Withdrawal by Subject|5
4591266|NCT01528254|7437714|FG001|Overall Study|Withdrawal by Subject|4
4591267|NCT01528254|7437713|FG000|Overall Study|Abnormal laboratory value(s)|3
4591268|NCT01528254|7437714|FG001|Overall Study|Abnormal laboratory value(s)|7
4591269|NCT01528254|7437713|FG000|Overall Study|Abnormal test procedure result(s)|1
4591270|NCT01528254|7437714|FG001|Overall Study|Abnormal test procedure result(s)|0
4734820|NCT03505593|7682042|FG000|Overall Study|Anatomical abnormality|1
4460245|NCT00572533|7248521|FG000|Overall Study|Transfer out of Facility|0
4591271|NCT01528254|7437713|FG000|Overall Study|No longer requires study drug|1
4591272|NCT01528254|7437714|FG001|Overall Study|No longer requires study drug|1
4591273|NCT01528345|7437736|FG000|Overall Study|Adverse Event|10
4591274|NCT01528345|7437737|FG001|Overall Study|Adverse Event|1
4591275|NCT01528345|7437736|FG000|Overall Study|Death|1
4591276|NCT01528345|7437737|FG001|Overall Study|Death|1
4591277|NCT01528345|7437736|FG000|Overall Study|Non-compliance with study treatment|1
4591278|NCT01528345|7437737|FG001|Overall Study|Non-compliance with study treatment|0
4539304|NCT02198794|7361692|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79
4539305|NCT02198794|7361693|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0
4539306|NCT02198794|7361694|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0
4539307|NCT02198794|7361695|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0
4539308|NCT02198794|7361692|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33
4539309|NCT02198794|7361693|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0
4539310|NCT02198794|7361694|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0
4539311|NCT02198794|7361695|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0
4539312|NCT02198794|7361692|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24
4539313|NCT02198794|7361693|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0
4539314|NCT02198794|7361694|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0
4539315|NCT02198794|7361695|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0
4539316|NCT02198794|7361692|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9
4539317|NCT02198794|7361693|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0
4539318|NCT02198794|7361694|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0
4460246|NCT00572533|7248522|FG001|Overall Study|Transfer out of Facility|1
4460247|NCT00572572|7248530|FG000|Overall Study|Withdrawal by Subject|3
4460248|NCT00572572|7248531|FG001|Overall Study|Withdrawal by Subject|6
4460249|NCT00572624|7248539|FG000|Overall Study|Lost to Follow-up|10
4460250|NCT00572624|7248540|FG001|Overall Study|Lost to Follow-up|4
4460251|NCT00572624|7248539|FG000|Overall Study|Wanted to do a different diet program|1
4460252|NCT00572624|7248540|FG001|Overall Study|Wanted to do a different diet program|0
4460253|NCT00572624|7248539|FG000|Overall Study|Medication change|1
4460254|NCT00572624|7248540|FG001|Overall Study|Medication change|0
4539319|NCT02198794|7361695|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0
4613421|NCT01715415|7470635|FG001|Double-blind Treatment|Did Not Receive Study Drug|1
4613422|NCT01715415|7470634|FG000|Double-blind Treatment|Adverse Event|3
4613423|NCT01715415|7470635|FG001|Double-blind Treatment|Adverse Event|0
4613424|NCT01715415|7470634|FG000|Double-blind Treatment|Withdrawal by Subject|1
4613425|NCT01715415|7470635|FG001|Double-blind Treatment|Withdrawal by Subject|1
4613426|NCT01715415|7470634|FG000|Double-blind Treatment|Other|1
4613427|NCT01715415|7470635|FG001|Double-blind Treatment|Other|0
4613428|NCT01715415|7470634|FG000|Open-label Treatment|Adverse Event|0
4613429|NCT01715415|7470635|FG001|Open-label Treatment|Adverse Event|1
4613430|NCT01715415|7470634|FG000|Open-label Treatment|Subject Noncompliant|0
4613431|NCT01715415|7470635|FG001|Open-label Treatment|Subject Noncompliant|1
4613432|NCT01715571|7470642|FG000|Overall Study|Lost to Follow-up|8
4613433|NCT01715805|7470646|FG000|Placebo + ADT Lead-in Period|Adverse Event|41
4613434|NCT01715805|7470647|FG001|Placebo + ADT Lead-in Period|Adverse Event|0
4613435|NCT01715805|7470648|FG002|Placebo + ADT Lead-in Period|Adverse Event|0
4613436|NCT01715805|7470649|FG003|Placebo + ADT Lead-in Period|Adverse Event|0
4613437|NCT01715805|7470646|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6
4613438|NCT01715805|7470647|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0
4613439|NCT01715805|7470648|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0
4613440|NCT01715805|7470649|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0
4613441|NCT01715805|7470646|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74
4613442|NCT01715805|7470647|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0
4613443|NCT01715805|7470648|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0
4613444|NCT01715805|7470649|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0
4613445|NCT01715805|7470646|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49
4613446|NCT01715805|7470647|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0
4613447|NCT01715805|7470648|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0
4613448|NCT01715805|7470649|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0
4613449|NCT01715805|7470646|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34
4613450|NCT01715805|7470647|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0
4613451|NCT01715805|7470648|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0
4613452|NCT01715805|7470649|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0
4613453|NCT01715805|7470646|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1
4613454|NCT01715805|7470647|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0
4613455|NCT01715805|7470648|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0
4613456|NCT01715805|7470649|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0
4613457|NCT01715805|7470646|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10
4613458|NCT01715805|7470647|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0
4613459|NCT01715805|7470648|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0
4613460|NCT01715805|7470649|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0
4613461|NCT01715805|7470646|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0
4613462|NCT01715805|7470647|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0
4613463|NCT01715805|7470648|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0
4460255|NCT00572624|7248539|FG000|Overall Study|Started a new job-- no time for study|1
4613464|NCT01715805|7470649|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1
4613465|NCT01715805|7470646|FG000|Double-Blind or Continued Treatment|Adverse Event|0
4737652|NCT03614975|7687835|FG001|Overall Study|Physician Decision|5
4460256|NCT00572624|7248540|FG001|Overall Study|Started a new job-- no time for study|0
4539320|NCT02198794|7361692|FG000|Part A: Open-Label (158 Weeks)|Death|8
4460257|NCT00572624|7248539|FG000|Overall Study|Admitted to being a smoker|1
4460258|NCT00572624|7248540|FG001|Overall Study|Admitted to being a smoker|0
4460259|NCT00572624|7248539|FG000|Overall Study|Refused to do the stress test|1
4460260|NCT00572624|7248540|FG001|Overall Study|Refused to do the stress test|0
4460261|NCT00572624|7248539|FG000|Overall Study|Problem with vascular access|1
4460262|NCT00572624|7248540|FG001|Overall Study|Problem with vascular access|0
4460263|NCT00572624|7248539|FG000|Overall Study|Health issues unrelated to the study|1
4460264|NCT00572624|7248540|FG001|Overall Study|Health issues unrelated to the study|0
4460265|NCT00572728|7248546|FG000|Overall Study|Withdrawal by Subject|10
4460266|NCT00572728|7248546|FG000|Overall Study|Ineligible|3
4460267|NCT00572728|7248546|FG000|Overall Study|Enrolled under Amendment 4|5
4460268|NCT00572728|7248546|FG000|Overall Study|Offstudy due to complicating disease|1
4460269|NCT00572728|7248546|FG000|Overall Study|FLT1 not completed|4
4460270|NCT00572728|7248546|FG000|Overall Study|First Chemotherapy not initiated|2
4460271|NCT00572728|7248546|FG000|Overall Study|FLT2 not completed|5
4460272|NCT00572728|7248546|FG000|Overall Study|Second chemotherapy not initiated|1
4460273|NCT00572728|7248546|FG000|Overall Study|FLT2 after second chemotherapy initiated|7
4460274|NCT00572728|7248546|FG000|Overall Study|Pathology missing|1
4460275|NCT00572832|7248554|FG000|Overall Study|Lost to Follow-up|0
4460276|NCT00572832|7248555|FG001|Overall Study|Lost to Follow-up|11
4460277|NCT00572832|7248554|FG000|Overall Study|Pregnancy|0
4460278|NCT00572832|7248555|FG001|Overall Study|Pregnancy|1
4460279|NCT00572910|7248576|FG000|Overall Study|Adverse Event|1
4460280|NCT00572910|7248577|FG001|Overall Study|Adverse Event|2
4460281|NCT00572910|7248578|FG002|Overall Study|Adverse Event|0
4460282|NCT00572910|7248579|FG003|Overall Study|Adverse Event|2
4460283|NCT00572910|7248580|FG004|Overall Study|Adverse Event|0
4460284|NCT00572910|7248581|FG005|Overall Study|Adverse Event|0
4613466|NCT01715805|7470647|FG001|Double-Blind or Continued Treatment|Adverse Event|3
4613467|NCT01715805|7470648|FG002|Double-Blind or Continued Treatment|Adverse Event|23
4613468|NCT01715805|7470649|FG003|Double-Blind or Continued Treatment|Adverse Event|2
4613469|NCT01715805|7470646|FG000|Double-Blind or Continued Treatment|Protocol Violation|0
4613470|NCT01715805|7470647|FG001|Double-Blind or Continued Treatment|Protocol Violation|14
4613471|NCT01715805|7470648|FG002|Double-Blind or Continued Treatment|Protocol Violation|12
4613472|NCT01715805|7470649|FG003|Double-Blind or Continued Treatment|Protocol Violation|19
4613473|NCT01715805|7470646|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0
4613474|NCT01715805|7470647|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11
4613475|NCT01715805|7470648|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11
4613476|NCT01715805|7470649|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13
4613477|NCT01715805|7470646|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0
4613478|NCT01715805|7470647|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7
4613479|NCT01715805|7470648|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10
4613480|NCT01715805|7470649|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10
4613481|NCT01715805|7470646|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0
4613482|NCT01715805|7470647|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1
4613483|NCT01715805|7470648|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0
4613484|NCT01715805|7470649|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3
4613485|NCT01715805|7470646|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0
4613486|NCT01715805|7470647|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3
4613487|NCT01715805|7470648|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0
4613488|NCT01715805|7470649|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0
4613489|NCT01715831|7470657|FG000|Overall Study|Adverse Event|1
4613490|NCT01715857|7470661|FG000|Overall Study|Did Not Meet Eligibility Criteria|96
4613491|NCT01715896|7470672|FG000|Overall Study|Lost to Follow-up|0
4613492|NCT01715896|7470673|FG001|Overall Study|Lost to Follow-up|2
4613493|NCT01715896|7470672|FG000|Overall Study|Withdrawal by Subject|1
4613494|NCT01715896|7470673|FG001|Overall Study|Withdrawal by Subject|4
4613495|NCT01715896|7470672|FG000|Overall Study|Other|2
4613496|NCT01715896|7470673|FG001|Overall Study|Other|5
4632721|NCT01904019|7502487|FG000|3 Year Follow-up|Impossibility to contact patient|14
4632722|NCT01904019|7502487|FG000|5 Year Follow-up|Withdrawal by Subject|2
4632723|NCT01904019|7502487|FG000|5 Year Follow-up|Impossibility to contact patient|4
4632724|NCT01904058|7502495|FG000|Overall Study|Adverse Event|2
4632725|NCT01904058|7502496|FG001|Overall Study|Adverse Event|0
4632726|NCT01904058|7502497|FG002|Overall Study|Adverse Event|0
4632727|NCT01904058|7502498|FG003|Overall Study|Adverse Event|0
4632728|NCT01904058|7502495|FG000|Overall Study|Withdrawal by Subject|1
4632729|NCT01904058|7502496|FG001|Overall Study|Withdrawal by Subject|0
4632730|NCT01904058|7502497|FG002|Overall Study|Withdrawal by Subject|1
4632731|NCT01904058|7502498|FG003|Overall Study|Withdrawal by Subject|0
4632732|NCT01904058|7502495|FG000|Overall Study|Pregnancy|0
4632733|NCT01904058|7502496|FG001|Overall Study|Pregnancy|0
4460285|NCT00572910|7248582|FG006|Overall Study|Adverse Event|4
4460286|NCT00572910|7248583|FG007|Overall Study|Adverse Event|2
4460287|NCT00572910|7248584|FG008|Overall Study|Adverse Event|1
4460288|NCT00572910|7248585|FG009|Overall Study|Adverse Event|3
4460289|NCT00572910|7248586|FG010|Overall Study|Adverse Event|2
4460290|NCT00572910|7248576|FG000|Overall Study|Lost to Follow-up|0
4460291|NCT00572910|7248577|FG001|Overall Study|Lost to Follow-up|1
4460292|NCT00572910|7248578|FG002|Overall Study|Lost to Follow-up|1
4460293|NCT00572910|7248579|FG003|Overall Study|Lost to Follow-up|2
4460294|NCT00572910|7248580|FG004|Overall Study|Lost to Follow-up|1
4460295|NCT00572910|7248581|FG005|Overall Study|Lost to Follow-up|0
4460296|NCT00572910|7248582|FG006|Overall Study|Lost to Follow-up|0
4460297|NCT00572910|7248583|FG007|Overall Study|Lost to Follow-up|0
4460298|NCT00572910|7248584|FG008|Overall Study|Lost to Follow-up|0
4460299|NCT00572910|7248585|FG009|Overall Study|Lost to Follow-up|1
4460300|NCT00572910|7248586|FG010|Overall Study|Lost to Follow-up|0
4460301|NCT00572910|7248576|FG000|Overall Study|Withdrawal by Subject|3
4460302|NCT00572910|7248577|FG001|Overall Study|Withdrawal by Subject|0
4460303|NCT00572910|7248578|FG002|Overall Study|Withdrawal by Subject|1
4460304|NCT00572910|7248579|FG003|Overall Study|Withdrawal by Subject|0
4460305|NCT00572910|7248580|FG004|Overall Study|Withdrawal by Subject|1
4460306|NCT00572910|7248581|FG005|Overall Study|Withdrawal by Subject|3
4460307|NCT00572910|7248582|FG006|Overall Study|Withdrawal by Subject|0
4460308|NCT00572910|7248583|FG007|Overall Study|Withdrawal by Subject|2
4460309|NCT00572910|7248584|FG008|Overall Study|Withdrawal by Subject|2
4460310|NCT00572910|7248585|FG009|Overall Study|Withdrawal by Subject|2
4460311|NCT00572910|7248586|FG010|Overall Study|Withdrawal by Subject|1
4460312|NCT00573066|7248634|FG000|Overall Study|Exclusion criteria|18
4460313|NCT00573066|7248634|FG000|Overall Study|IV malfunction|1
4460314|NCT00573066|7248634|FG000|Overall Study|Postoperative bleeding|1
4515954|NCT00957424|7327154|FG000|Overall Study|Withdrawal by Subject|1
4515955|NCT00957528|7327161|FG000|Overall Study|Protocol Violation|0
4515956|NCT00957528|7327162|FG001|Overall Study|Protocol Violation|1
4515957|NCT00957528|7327163|FG002|Overall Study|Protocol Violation|0
4515958|NCT00957528|7327161|FG000|Overall Study|Withdrawal by Subject|0
4515959|NCT00957528|7327162|FG001|Overall Study|Withdrawal by Subject|0
4515960|NCT00957528|7327163|FG002|Overall Study|Withdrawal by Subject|1
4515961|NCT00957580|7327174|FG000|Overall Study|Ongoing at data cut-off|0
4515962|NCT00957580|7327175|FG001|Overall Study|Ongoing at data cut-off|1
4515963|NCT00957580|7327176|FG002|Overall Study|Ongoing at data cut-off|0
4515964|NCT00957580|7327174|FG000|Overall Study|Enrolled but not treated|0
4515965|NCT00957580|7327175|FG001|Overall Study|Enrolled but not treated|1
4515966|NCT00957580|7327176|FG002|Overall Study|Enrolled but not treated|0
4515967|NCT00957658|7327208|FG000|Overall Study|Death|1
4515968|NCT00957658|7327208|FG000|Overall Study|Lost to Follow-up|4
4515969|NCT00957658|7327208|FG000|Overall Study|Withdrawal by Subject|12
4515970|NCT00957658|7327208|FG000|Overall Study|Revision|1
4515971|NCT00957658|7327208|FG000|Overall Study|Incomplete 2 yr data|28
4515972|NCT00957658|7327208|FG000|Overall Study|Site termination|10
4515973|NCT00957658|7327208|FG000|Overall Study|unwilling/unable to return|2
4539321|NCT02198794|7361693|FG001|Part A: Open-Label (158 Weeks)|Death|0
4539322|NCT02198794|7361694|FG002|Part A: Open-Label (158 Weeks)|Death|0
4539323|NCT02198794|7361695|FG003|Part A: Open-Label (158 Weeks)|Death|0
4539324|NCT02198794|7361692|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3
4539325|NCT02198794|7361693|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0
4539326|NCT02198794|7361694|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0
4539327|NCT02198794|7361695|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0
4539328|NCT02198794|7361692|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5
4539329|NCT02198794|7361693|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0
4539330|NCT02198794|7361694|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0
4539331|NCT02198794|7361695|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0
4539332|NCT02198794|7361692|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1
4539333|NCT02198794|7361693|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0
4539334|NCT02198794|7361694|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0
4515974|NCT00957658|7327208|FG000|Overall Study|surgery cancelled|2
4515975|NCT00957658|7327208|FG000|Overall Study|Protocol Violation|5
4515976|NCT00957723|7327237|FG000|Overall Study|Death|3
4515977|NCT00957723|7327237|FG000|Overall Study|Revision/ Removal of Study Implant|3
4515978|NCT00957723|7327237|FG000|Overall Study|Lost to Follow-up|8
4515979|NCT00957723|7327237|FG000|Overall Study|Withdrawal by Subject|24
4515980|NCT00957723|7327237|FG000|Overall Study|Investigative Site Terminated|61
4515981|NCT00957723|7327237|FG000|Overall Study|Intercurrent Illness|2
4515982|NCT00957723|7327237|FG000|Overall Study|2yr ROM Data Not Evaluable|12
4515983|NCT00957801|7327247|FG000|Overall Study|Withdrawal by Subject|0
4515984|NCT00957801|7327248|FG001|Overall Study|Withdrawal by Subject|0
4515985|NCT00957801|7327249|FG002|Overall Study|Withdrawal by Subject|0
4515986|NCT00957801|7327250|FG003|Overall Study|Withdrawal by Subject|1
4515987|NCT00957853|7327263|FG000|Overall Study|Withdrawal by Subject|1
4515988|NCT00957853|7327264|FG001|Overall Study|Withdrawal by Subject|0
4515989|NCT00957853|7327265|FG002|Overall Study|Withdrawal by Subject|0
4515990|NCT00957905|7327275|FG000|Part B|Not Treated|0
4515991|NCT00957905|7327276|FG001|Part B|Not Treated|1
4515992|NCT00957905|7327275|FG000|Part B|Physician Decision|0
4539335|NCT02198794|7361695|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0
4515993|NCT00957905|7327276|FG001|Part B|Physician Decision|1
4515994|NCT00957905|7327275|FG000|Part B|Death|0
4515995|NCT00957905|7327276|FG001|Part B|Death|1
4515996|NCT00957905|7327275|FG000|Part B|Protocol Violation|0
4460315|NCT00573131|7248640|FG000|Overall Study|Withdrawal by Subject|10
4460316|NCT00573131|7248641|FG001|Overall Study|Withdrawal by Subject|8
4460317|NCT00573144|7248649|FG000|Overall Study|Withdrawal by Subject|2
4460318|NCT00573144|7248650|FG001|Overall Study|Withdrawal by Subject|3
4460319|NCT00573170|7248656|FG000|First Treatment Period|Did Not Treat Attack 1|0
4460320|NCT00573170|7248657|FG001|First Treatment Period|Did Not Treat Attack 1|0
4460321|NCT00573170|7248658|FG002|First Treatment Period|Did Not Treat Attack 1|0
4460322|NCT00573170|7248659|FG003|First Treatment Period|Did Not Treat Attack 1|0
4460323|NCT00573170|7248660|FG004|First Treatment Period|Did Not Treat Attack 1|1
4460324|NCT00573170|7248661|FG005|First Treatment Period|Did Not Treat Attack 1|0
4460325|NCT00573170|7248656|FG000|First Washout Period|Adverse Event|1
4460326|NCT00573170|7248657|FG001|First Washout Period|Adverse Event|1
4460327|NCT00573170|7248658|FG002|First Washout Period|Adverse Event|0
4460328|NCT00573170|7248659|FG003|First Washout Period|Adverse Event|0
4460329|NCT00573170|7248660|FG004|First Washout Period|Adverse Event|0
4460330|NCT00573170|7248661|FG005|First Washout Period|Adverse Event|1
4460331|NCT00573170|7248656|FG000|First Washout Period|Lack of Efficacy|0
4460332|NCT00573170|7248657|FG001|First Washout Period|Lack of Efficacy|0
4539336|NCT02198794|7361692|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1
4539337|NCT02198794|7361693|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0
4539338|NCT02198794|7361694|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0
4539339|NCT02198794|7361695|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0
4539340|NCT02198794|7361692|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142
4539341|NCT02198794|7361693|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0
4539342|NCT02198794|7361694|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0
4539343|NCT02198794|7361695|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0
4539344|NCT02198794|7361692|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0
4539345|NCT02198794|7361693|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3
4539346|NCT02198794|7361694|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1
4539347|NCT02198794|7361695|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0
4539348|NCT02198794|7361692|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0
4539349|NCT02198794|7361693|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2
4539350|NCT02198794|7361694|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2
4539351|NCT02198794|7361695|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0
4539352|NCT02198794|7361692|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0
4539353|NCT02198794|7361693|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0
4539354|NCT02198794|7361694|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0
4539355|NCT02198794|7361695|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3
4539356|NCT02198794|7361692|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0
4539357|NCT02198794|7361693|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0
4539358|NCT02198794|7361694|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0
4539359|NCT02198794|7361695|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2
4539360|NCT02198794|7361692|FG000|Part C: Safety Assessment (52 Weeks)|Death|0
4539361|NCT02198794|7361693|FG001|Part C: Safety Assessment (52 Weeks)|Death|0
4539362|NCT02198794|7361694|FG002|Part C: Safety Assessment (52 Weeks)|Death|0
4539363|NCT02198794|7361695|FG003|Part C: Safety Assessment (52 Weeks)|Death|2
4539364|NCT01877655|7361706|FG000|Overall Study|Death|57
4539365|NCT01877655|7361707|FG001|Overall Study|Death|52
4539366|NCT01877655|7361706|FG000|Overall Study|Withdrawal by Subject|18
4539367|NCT01877655|7361707|FG001|Overall Study|Withdrawal by Subject|26
4539368|NCT01877655|7361706|FG000|Overall Study|Physician Decision|11
4539369|NCT01877655|7361707|FG001|Overall Study|Physician Decision|10
4539370|NCT01877655|7361706|FG000|Overall Study|Miscellaneous|4
4539371|NCT01877655|7361707|FG001|Overall Study|Miscellaneous|4
4539372|NCT01877655|7361706|FG000|Overall Study|Randomized but Never Received Drug|8
4539373|NCT01877655|7361707|FG001|Overall Study|Randomized but Never Received Drug|5
4539374|NCT00308685|7361715|FG000|Overall Study|Lost to Follow-up|1
4539375|NCT00308685|7361716|FG001|Overall Study|Lost to Follow-up|0
4539376|NCT00308685|7361715|FG000|Overall Study|Need to administer prohibited medication|1
4539377|NCT00308685|7361716|FG001|Overall Study|Need to administer prohibited medication|2
4539378|NCT00308685|7361715|FG000|Overall Study|Other than specified|1
4539379|NCT00308685|7361716|FG001|Overall Study|Other than specified|3
4539380|NCT01125514|7361722|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1
4539381|NCT01125514|7361722|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1
4539382|NCT01125514|7361722|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3
4539383|NCT01125514|7361722|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2
4539384|NCT01125514|7361722|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1
4539385|NCT01125514|7361722|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1
4539386|NCT01125566|7361738|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182
4591279|NCT01528345|7437736|FG000|Overall Study|Progressive Disease|26
4460333|NCT00573170|7248658|FG002|First Washout Period|Lack of Efficacy|0
4460334|NCT00573170|7248659|FG003|First Washout Period|Lack of Efficacy|0
4460335|NCT00573170|7248660|FG004|First Washout Period|Lack of Efficacy|0
4460336|NCT00573170|7248661|FG005|First Washout Period|Lack of Efficacy|1
4460337|NCT00573170|7248656|FG000|First Washout Period|Lost to Follow-up|1
4460338|NCT00573170|7248657|FG001|First Washout Period|Lost to Follow-up|1
4460339|NCT00573170|7248658|FG002|First Washout Period|Lost to Follow-up|0
4460340|NCT00573170|7248659|FG003|First Washout Period|Lost to Follow-up|2
4539387|NCT01125566|7361739|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119
4460341|NCT00573170|7248660|FG004|First Washout Period|Lost to Follow-up|0
4460342|NCT00573170|7248661|FG005|First Washout Period|Lost to Follow-up|2
4460343|NCT00573170|7248656|FG000|First Washout Period|Withdrawal by Subject|2
4460344|NCT00573170|7248657|FG001|First Washout Period|Withdrawal by Subject|0
4460345|NCT00573170|7248658|FG002|First Washout Period|Withdrawal by Subject|0
4460346|NCT00573170|7248659|FG003|First Washout Period|Withdrawal by Subject|2
4460347|NCT00573170|7248660|FG004|First Washout Period|Withdrawal by Subject|3
4460348|NCT00573170|7248661|FG005|First Washout Period|Withdrawal by Subject|3
4460349|NCT00573170|7248656|FG000|First Washout Period|Other|4
4460350|NCT00573170|7248657|FG001|First Washout Period|Other|0
4460351|NCT00573170|7248658|FG002|First Washout Period|Other|1
4460352|NCT00573170|7248659|FG003|First Washout Period|Other|1
4460353|NCT00573170|7248660|FG004|First Washout Period|Other|0
4460354|NCT00573170|7248661|FG005|First Washout Period|Other|0
4460355|NCT00573170|7248656|FG000|Second Washout Period|Adverse Event|1
4460356|NCT00573170|7248657|FG001|Second Washout Period|Adverse Event|0
4460357|NCT00573170|7248658|FG002|Second Washout Period|Adverse Event|0
4460358|NCT00573170|7248659|FG003|Second Washout Period|Adverse Event|0
4460359|NCT00573170|7248660|FG004|Second Washout Period|Adverse Event|1
4460360|NCT00573170|7248661|FG005|Second Washout Period|Adverse Event|0
4460361|NCT00573170|7248656|FG000|Second Washout Period|Protocol Violation|2
4460362|NCT00573170|7248657|FG001|Second Washout Period|Protocol Violation|1
4460363|NCT00573170|7248658|FG002|Second Washout Period|Protocol Violation|1
4539388|NCT01125566|7361740|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0
4539389|NCT01125566|7361738|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6
4613497|NCT01716104|7470725|FG000|Overall Study|Do not meet inclusion criteria|6
4613498|NCT01716104|7470726|FG001|Overall Study|Do not meet inclusion criteria|7
4613499|NCT01716156|7470735|FG000|Overall Study|Protocol Violation|1
4613500|NCT01716156|7470736|FG001|Overall Study|Protocol Violation|0
4613501|NCT01716156|7470737|FG002|Overall Study|Protocol Violation|0
4613502|NCT01716156|7470735|FG000|Overall Study|Withdrawal by Subject|0
4460364|NCT00573170|7248659|FG003|Second Washout Period|Protocol Violation|0
4460365|NCT00573170|7248660|FG004|Second Washout Period|Protocol Violation|0
4460366|NCT00573170|7248661|FG005|Second Washout Period|Protocol Violation|0
4460367|NCT00573170|7248656|FG000|Second Washout Period|Withdrawal by Subject|1
4539390|NCT01125566|7361739|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6
4539391|NCT01125566|7361740|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0
4539392|NCT01125566|7361738|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25
4539393|NCT01125566|7361739|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5
4539394|NCT01125566|7361740|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0
4539395|NCT01125566|7361738|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0
4539396|NCT01125566|7361739|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2
4539397|NCT01125566|7361740|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0
4539398|NCT01125566|7361738|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24
4539399|NCT01125566|7361739|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23
4539400|NCT01125566|7361740|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0
4539401|NCT01125566|7361738|FG000|Patients Before the Switch (26Apr2013)|Not treated|2
4539402|NCT01125566|7361739|FG001|Patients Before the Switch (26Apr2013)|Not treated|0
4539403|NCT01125566|7361740|FG002|Patients Before the Switch (26Apr2013)|Not treated|0
4539404|NCT01125566|7361738|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25
4539405|NCT01125566|7361739|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13
4539406|NCT01125566|7361740|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0
4539407|NCT01125566|7361738|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1
4539408|NCT01125566|7361739|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1
4539409|NCT01125566|7361740|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0
4539410|NCT01125566|7361738|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0
4539411|NCT01125566|7361739|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0
4539412|NCT01125566|7361740|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59
4539413|NCT01125566|7361738|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0
4539414|NCT01125566|7361739|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0
4591280|NCT01528345|7437737|FG001|Overall Study|Progressive Disease|40
4613503|NCT01716156|7470736|FG001|Overall Study|Withdrawal by Subject|1
4613504|NCT01716156|7470737|FG002|Overall Study|Withdrawal by Subject|2
4460368|NCT00573170|7248657|FG001|Second Washout Period|Withdrawal by Subject|1
4460369|NCT00573170|7248658|FG002|Second Washout Period|Withdrawal by Subject|2
4460370|NCT00573170|7248659|FG003|Second Washout Period|Withdrawal by Subject|0
4460371|NCT00573170|7248660|FG004|Second Washout Period|Withdrawal by Subject|1
4460372|NCT00573170|7248661|FG005|Second Washout Period|Withdrawal by Subject|0
4460373|NCT00573170|7248656|FG000|Second Washout Period|Lost to Follow-up|0
4460374|NCT00573170|7248657|FG001|Second Washout Period|Lost to Follow-up|0
4460375|NCT00573170|7248658|FG002|Second Washout Period|Lost to Follow-up|0
4460376|NCT00573170|7248659|FG003|Second Washout Period|Lost to Follow-up|1
4460377|NCT00573170|7248660|FG004|Second Washout Period|Lost to Follow-up|0
4460378|NCT00573170|7248661|FG005|Second Washout Period|Lost to Follow-up|0
4460379|NCT00573170|7248656|FG000|Second Washout Period|Other|1
4460380|NCT00573170|7248657|FG001|Second Washout Period|Other|2
4460381|NCT00573170|7248658|FG002|Second Washout Period|Other|1
4460382|NCT00573170|7248659|FG003|Second Washout Period|Other|4
4460383|NCT00573170|7248660|FG004|Second Washout Period|Other|6
4613505|NCT01716156|7470735|FG000|Overall Study|Lost to Follow-up|1
4613506|NCT01716156|7470736|FG001|Overall Study|Lost to Follow-up|0
4613507|NCT01716156|7470737|FG002|Overall Study|Lost to Follow-up|0
4613508|NCT01716169|7470749|FG000|Overall Study|Adverse Event|1
4613509|NCT01716169|7470749|FG000|Overall Study|Lost to Follow-up|1
4613510|NCT01716169|7470749|FG000|Overall Study|Withdrawal by Subject|1
4613511|NCT01716169|7470749|FG000|Overall Study|inconsistent dressing application|1
4613512|NCT01716234|7470786|FG000|Overall Study|Protocol Violation|0
4613513|NCT01716234|7470787|FG001|Overall Study|Protocol Violation|0
4613514|NCT01716234|7470788|FG002|Overall Study|Protocol Violation|0
4613515|NCT01716234|7470789|FG003|Overall Study|Protocol Violation|1
4613516|NCT01716234|7470790|FG004|Overall Study|Protocol Violation|1
4613517|NCT01716234|7470791|FG005|Overall Study|Protocol Violation|1
4613518|NCT01716234|7470792|FG006|Overall Study|Protocol Violation|0
4613519|NCT01716234|7470786|FG000|Overall Study|Lack of Efficacy|0
4613520|NCT01716234|7470787|FG001|Overall Study|Lack of Efficacy|0
4613521|NCT01716234|7470788|FG002|Overall Study|Lack of Efficacy|0
4613522|NCT01716234|7470789|FG003|Overall Study|Lack of Efficacy|1
4613523|NCT01716234|7470790|FG004|Overall Study|Lack of Efficacy|0
4613524|NCT01716234|7470791|FG005|Overall Study|Lack of Efficacy|0
4613525|NCT01716234|7470792|FG006|Overall Study|Lack of Efficacy|0
4613526|NCT01716234|7470786|FG000|Overall Study|Did not meet protocol eligibility|0
4613527|NCT01716234|7470787|FG001|Overall Study|Did not meet protocol eligibility|0
4613528|NCT01716234|7470788|FG002|Overall Study|Did not meet protocol eligibility|1
4613529|NCT01716234|7470789|FG003|Overall Study|Did not meet protocol eligibility|0
4613530|NCT01716234|7470790|FG004|Overall Study|Did not meet protocol eligibility|0
4613531|NCT01716234|7470791|FG005|Overall Study|Did not meet protocol eligibility|4
4613532|NCT01716234|7470792|FG006|Overall Study|Did not meet protocol eligibility|0
4613533|NCT01716234|7470786|FG000|Overall Study|Adverse Event|7
4613534|NCT01716234|7470787|FG001|Overall Study|Adverse Event|10
4613535|NCT01716234|7470788|FG002|Overall Study|Adverse Event|2
4613536|NCT01716234|7470789|FG003|Overall Study|Adverse Event|8
4613537|NCT01716234|7470790|FG004|Overall Study|Adverse Event|3
4613538|NCT01716234|7470791|FG005|Overall Study|Adverse Event|6
4613539|NCT01716234|7470792|FG006|Overall Study|Adverse Event|0
4613540|NCT01716234|7470786|FG000|Overall Study|Withdrawal by Subject|3
4613541|NCT01716234|7470787|FG001|Overall Study|Withdrawal by Subject|0
4613542|NCT01716234|7470788|FG002|Overall Study|Withdrawal by Subject|2
4613543|NCT01716234|7470789|FG003|Overall Study|Withdrawal by Subject|2
4613544|NCT01716234|7470790|FG004|Overall Study|Withdrawal by Subject|1
4613545|NCT01716234|7470791|FG005|Overall Study|Withdrawal by Subject|3
4613546|NCT01716234|7470792|FG006|Overall Study|Withdrawal by Subject|0
4613547|NCT01716520|7470834|FG000|Treatment Period 1 (14 Days)|Adverse Event|1
4613548|NCT01716520|7470835|FG001|Treatment Period 1 (14 Days)|Adverse Event|0
4613549|NCT01716520|7470836|FG002|Treatment Period 1 (14 Days)|Adverse Event|0
4613550|NCT01716520|7470837|FG003|Treatment Period 1 (14 Days)|Adverse Event|0
4613551|NCT01716520|7470838|FG004|Treatment Period 1 (14 Days)|Adverse Event|0
4613552|NCT01716520|7470839|FG005|Treatment Period 1 (14 Days)|Adverse Event|0
4613553|NCT01716520|7470834|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
4613554|NCT01716520|7470835|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0
4613555|NCT01716520|7470836|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2
4613556|NCT01716520|7470837|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
4613557|NCT01716520|7470838|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0
4613558|NCT01716520|7470839|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
4613559|NCT01716520|7470834|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
4613560|NCT01716520|7470835|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
4613561|NCT01716520|7470836|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
4613562|NCT01716520|7470837|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
4613563|NCT01716520|7470838|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
4460384|NCT00573170|7248661|FG005|Second Washout Period|Other|2
4460385|NCT00573170|7248656|FG000|Third Treatment Period|Withdrawal by Subject|1
4460386|NCT00573170|7248657|FG001|Third Treatment Period|Withdrawal by Subject|0
4460387|NCT00573170|7248658|FG002|Third Treatment Period|Withdrawal by Subject|0
4460388|NCT00573170|7248659|FG003|Third Treatment Period|Withdrawal by Subject|0
4460389|NCT00573170|7248660|FG004|Third Treatment Period|Withdrawal by Subject|0
4460390|NCT00573170|7248661|FG005|Third Treatment Period|Withdrawal by Subject|0
4613564|NCT01716520|7470839|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
4613565|NCT01716520|7470834|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0
4613566|NCT01716520|7470835|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1
4613567|NCT01716520|7470836|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0
4613568|NCT01716520|7470837|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0
4613569|NCT01716520|7470838|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0
4613570|NCT01716520|7470839|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0
4613571|NCT01716520|7470834|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
4613572|NCT01716520|7470835|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
4613573|NCT01716520|7470836|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
4613574|NCT01716520|7470837|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
4613575|NCT01716520|7470838|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
4613576|NCT01716520|7470839|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1
4613577|NCT01716520|7470834|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
4613578|NCT01716520|7470835|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
4613579|NCT01716520|7470836|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1
4613580|NCT01716520|7470837|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
4613581|NCT01716520|7470838|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
4613582|NCT01716520|7470839|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1
4613583|NCT01716520|7470834|FG000|Treatment Period 2 (14 Days)|Adverse Event|0
4613584|NCT01716520|7470835|FG001|Treatment Period 2 (14 Days)|Adverse Event|0
4613585|NCT01716520|7470836|FG002|Treatment Period 2 (14 Days)|Adverse Event|0
4613586|NCT01716520|7470837|FG003|Treatment Period 2 (14 Days)|Adverse Event|0
4613587|NCT01716520|7470838|FG004|Treatment Period 2 (14 Days)|Adverse Event|1
4613588|NCT01716520|7470839|FG005|Treatment Period 2 (14 Days)|Adverse Event|0
4613589|NCT01716520|7470834|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0
4613590|NCT01716520|7470835|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0
4613591|NCT01716520|7470836|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0
4613592|NCT01716520|7470837|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0
4613593|NCT01716520|7470838|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1
4613594|NCT01716520|7470839|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0
4613595|NCT01716520|7470834|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
4613596|NCT01716520|7470835|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
4613597|NCT01716520|7470836|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
4613598|NCT01716520|7470837|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1
4613599|NCT01716520|7470838|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
4613600|NCT01716520|7470839|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
4613601|NCT01716520|7470834|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1
4613602|NCT01716520|7470835|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0
4613603|NCT01716520|7470836|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1
4613604|NCT01716520|7470837|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0
4613605|NCT01716520|7470838|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0
4613606|NCT01716520|7470839|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1
4613607|NCT01716520|7470834|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1
4613608|NCT01716520|7470835|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
4613609|NCT01716520|7470836|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
4613610|NCT01716520|7470837|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
4613611|NCT01716520|7470838|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
4613612|NCT01716520|7470839|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
4613613|NCT01716520|7470834|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
4613614|NCT01716520|7470835|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
4613615|NCT01716520|7470836|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
4613616|NCT01716520|7470837|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
4613617|NCT01716520|7470838|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
4613618|NCT01716520|7470839|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1
4613619|NCT01716520|7470834|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
4613620|NCT01716520|7470835|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1
4613621|NCT01716520|7470836|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
4613622|NCT01716520|7470837|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
4613623|NCT01716520|7470838|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
4613624|NCT01716520|7470839|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
4613625|NCT01716520|7470834|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0
4613626|NCT01716520|7470835|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0
4613627|NCT01716520|7470836|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0
4613628|NCT01716520|7470837|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0
4613629|NCT01716520|7470838|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0
4460391|NCT00573170|7248656|FG000|Third Treatment Period|Lost to Follow-up|0
4613630|NCT01716520|7470839|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2
4632734|NCT01904058|7502497|FG002|Overall Study|Pregnancy|0
4460392|NCT00573170|7248657|FG001|Third Treatment Period|Lost to Follow-up|0
4460393|NCT00573170|7248658|FG002|Third Treatment Period|Lost to Follow-up|0
4460394|NCT00573170|7248659|FG003|Third Treatment Period|Lost to Follow-up|0
4460395|NCT00573170|7248660|FG004|Third Treatment Period|Lost to Follow-up|0
4460396|NCT00573170|7248661|FG005|Third Treatment Period|Lost to Follow-up|2
4460397|NCT00573183|7248680|FG000|Overall Study|Lost to Follow-up|52
4460398|NCT00573183|7248681|FG001|Overall Study|Lost to Follow-up|50
4460399|NCT00573183|7248680|FG000|Overall Study|Withdrawal by Subject|8
4460400|NCT00573183|7248681|FG001|Overall Study|Withdrawal by Subject|2
4460401|NCT00573183|7248680|FG000|Overall Study|Death|0
4460402|NCT00573183|7248681|FG001|Overall Study|Death|1
4460403|NCT00573183|7248680|FG000|Overall Study|Adverse Event|2
4460404|NCT00573183|7248681|FG001|Overall Study|Adverse Event|0
4460405|NCT00573183|7248680|FG000|Overall Study|Incarceration|5
4460406|NCT00573183|7248681|FG001|Overall Study|Incarceration|8
4460407|NCT00573183|7248680|FG000|Overall Study|Other|5
4460408|NCT00573183|7248681|FG001|Overall Study|Other|2
4460409|NCT00573248|7248691|FG000|Overall Study|scheduling conflicts|15
4460410|NCT00573248|7248692|FG001|Overall Study|scheduling conflicts|11
4460411|NCT00573313|7248722|FG000|Overall Study|Protocol Violation|5
4460412|NCT00573313|7248723|FG001|Overall Study|Protocol Violation|0
4460413|NCT00573313|7248724|FG002|Overall Study|Protocol Violation|6
4460414|NCT00573313|7248725|FG003|Overall Study|Protocol Violation|0
4460415|NCT00573430|7248735|FG000|Overall Study|Incorrect enrollment of randomization|0
4460416|NCT00573430|7248736|FG001|Overall Study|Incorrect enrollment of randomization|4
4460417|NCT00573430|7248737|FG002|Overall Study|Incorrect enrollment of randomization|3
4460418|NCT00573430|7248735|FG000|Overall Study|Adverse Event|0
4460419|NCT00573430|7248736|FG001|Overall Study|Adverse Event|0
4460420|NCT00573430|7248737|FG002|Overall Study|Adverse Event|2
4460421|NCT00573430|7248735|FG000|Overall Study|Withdrawal by Subject|1
4460422|NCT00573430|7248736|FG001|Overall Study|Withdrawal by Subject|0
4460423|NCT00573430|7248737|FG002|Overall Study|Withdrawal by Subject|1
4460424|NCT00573430|7248735|FG000|Overall Study|Protocol Violation|0
4460425|NCT00573430|7248736|FG001|Overall Study|Protocol Violation|1
4460426|NCT00573430|7248737|FG002|Overall Study|Protocol Violation|1
4460427|NCT00573430|7248735|FG000|Overall Study|Eligibility criteria not fulfilled|0
4460428|NCT00573430|7248736|FG001|Overall Study|Eligibility criteria not fulfilled|0
4460429|NCT00573430|7248737|FG002|Overall Study|Eligibility criteria not fulfilled|3
4460430|NCT00573443|7248748|FG000|Double-Blind Phase|Lost to Follow-up|1
4460431|NCT00573443|7248749|FG001|Double-Blind Phase|Lost to Follow-up|3
4460432|NCT00573443|7248750|FG002|Double-Blind Phase|Lost to Follow-up|2
4460433|NCT00573443|7248748|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1
4460434|NCT00573443|7248749|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0
4460435|NCT00573443|7248750|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1
4460436|NCT00573443|7248748|FG000|Double-Blind Phase|Adverse Event|1
4460437|NCT00573443|7248749|FG001|Double-Blind Phase|Adverse Event|5
4460438|NCT00573443|7248750|FG002|Double-Blind Phase|Adverse Event|0
4460439|NCT00573443|7248748|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2
4460440|NCT00573443|7248749|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3
4460441|NCT00573443|7248750|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1
4460442|NCT00573443|7248748|FG000|Double-Blind Phase|Medication refusal due to AE|2
4460443|NCT00573443|7248749|FG001|Double-Blind Phase|Medication refusal due to AE|2
4460444|NCT00573443|7248750|FG002|Double-Blind Phase|Medication refusal due to AE|0
4460445|NCT00573443|7248748|FG000|Double-Blind Phase|Withdrawal by Subject|2
4460446|NCT00573443|7248749|FG001|Double-Blind Phase|Withdrawal by Subject|2
4460447|NCT00573443|7248750|FG002|Double-Blind Phase|Withdrawal by Subject|7
4460448|NCT00573443|7248748|FG000|Double-Blind Phase|Protocol Violation|0
4460449|NCT00573443|7248749|FG001|Double-Blind Phase|Protocol Violation|2
4460450|NCT00573443|7248750|FG002|Double-Blind Phase|Protocol Violation|1
4460451|NCT00573443|7248748|FG000|Double-Blind Phase|Other|0
4460452|NCT00573443|7248749|FG001|Double-Blind Phase|Other|2
4460453|NCT00573443|7248750|FG002|Double-Blind Phase|Other|3
4460454|NCT00573443|7248748|FG000|Open-Label Extension Phase|Lost to Follow-up|1
4460455|NCT00573443|7248749|FG001|Open-Label Extension Phase|Lost to Follow-up|0
4460456|NCT00573443|7248750|FG002|Open-Label Extension Phase|Lost to Follow-up|0
4460457|NCT00573443|7248748|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2
4460458|NCT00573443|7248749|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0
4460459|NCT00573443|7248750|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0
4460460|NCT00573443|7248748|FG000|Open-Label Extension Phase|Adverse Event|3
4460461|NCT00573443|7248749|FG001|Open-Label Extension Phase|Adverse Event|0
4460462|NCT00573443|7248750|FG002|Open-Label Extension Phase|Adverse Event|0
4460463|NCT00573443|7248748|FG000|Open-Label Extension Phase|Serious Adverse Event|5
4460464|NCT00573443|7248749|FG001|Open-Label Extension Phase|Serious Adverse Event|0
4460465|NCT00573443|7248750|FG002|Open-Label Extension Phase|Serious Adverse Event|0
4460466|NCT00573443|7248748|FG000|Open-Label Extension Phase|Withdrawal by Subject|3
4460467|NCT00573443|7248749|FG001|Open-Label Extension Phase|Withdrawal by Subject|0
4460468|NCT00573443|7248750|FG002|Open-Label Extension Phase|Withdrawal by Subject|0
4460469|NCT00573443|7248748|FG000|Open-Label Extension Phase|Protocol Violation|2
4460470|NCT00573443|7248749|FG001|Open-Label Extension Phase|Protocol Violation|0
4460471|NCT00573443|7248750|FG002|Open-Label Extension Phase|Protocol Violation|0
4460472|NCT00573443|7248748|FG000|Open-Label Extension Phase|Other|2
4460473|NCT00573443|7248749|FG001|Open-Label Extension Phase|Other|0
4460474|NCT00573443|7248750|FG002|Open-Label Extension Phase|Other|0
4460475|NCT00573469|7248762|FG000|Overall Study|Adverse Event|1
4460476|NCT00573469|7248763|FG001|Overall Study|Adverse Event|1
4460477|NCT00573469|7248764|FG002|Overall Study|Adverse Event|1
4460478|NCT00573469|7248762|FG000|Overall Study|Withdrawal by Subject|0
4460479|NCT00573469|7248763|FG001|Overall Study|Withdrawal by Subject|2
4460480|NCT00573469|7248764|FG002|Overall Study|Withdrawal by Subject|0
4460481|NCT00573469|7248762|FG000|Overall Study|Other|5
4460482|NCT00573469|7248763|FG001|Overall Study|Other|1
4460483|NCT00573469|7248764|FG002|Overall Study|Other|3
4460484|NCT00573534|7248781|FG000|Overall Study|oppositional behavior|3
4460485|NCT00573755|7248788|FG000|Overall Study|Still receiving treatment|1
4460486|NCT00573755|7248789|FG001|Overall Study|Still receiving treatment|0
4460487|NCT00573768|7248798|FG000|Overall Study|Adverse Event|1
4460488|NCT00573768|7248799|FG001|Overall Study|Adverse Event|1
4460489|NCT00573768|7248800|FG002|Overall Study|Adverse Event|2
4460490|NCT00573768|7248798|FG000|Overall Study|Protocol Violation|1
4460491|NCT00573768|7248799|FG001|Overall Study|Protocol Violation|0
4460492|NCT00573768|7248800|FG002|Overall Study|Protocol Violation|1
4460493|NCT00573768|7248798|FG000|Overall Study|Withdrawal by Subject|0
4460494|NCT00573768|7248799|FG001|Overall Study|Withdrawal by Subject|1
4460495|NCT00573768|7248800|FG002|Overall Study|Withdrawal by Subject|0
4460496|NCT00573768|7248798|FG000|Overall Study|Lost to Follow-up|0
4460497|NCT00573768|7248799|FG001|Overall Study|Lost to Follow-up|0
4460498|NCT00573768|7248800|FG002|Overall Study|Lost to Follow-up|1
4460499|NCT00573794|7248808|FG000|Overall Study|Adverse Event|81
4460500|NCT00573794|7248808|FG000|Overall Study|Withdrew Consent|90
4460501|NCT00573794|7248808|FG000|Overall Study|Lost to Follow-up|13
4460502|NCT00573794|7248808|FG000|Overall Study|Protocol Violation|6
4460503|NCT00573794|7248808|FG000|Overall Study|Lack of Efficacy|94
4460504|NCT00573794|7248808|FG000|Overall Study|Other|46
4460505|NCT00573833|7248812|FG000|Overall Study|Not Treated|2
4460506|NCT00573859|7248816|FG000|Medication Versus Placebo|Scheduling conflicts|12
4460507|NCT00573859|7248816|FG000|Smoking Versus Abstinence|Scheduling conflicts|12
4460508|NCT00574119|7248855|FG000|Overall Study|Adverse Event|1
4460509|NCT00574119|7248855|FG000|Overall Study|Protocol Violation|1
4613631|NCT01716520|7470834|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
4613632|NCT01716520|7470835|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
4613633|NCT01716520|7470836|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1
4613634|NCT01716520|7470837|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
4613635|NCT01716520|7470838|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
4613636|NCT01716520|7470839|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
4613637|NCT01716533|7470851|FG000|Overall Study|Failure of antibiotic treatment to treat|0
4613638|NCT01716533|7470852|FG001|Overall Study|Failure of antibiotic treatment to treat|0
4613639|NCT01716533|7470853|FG002|Overall Study|Failure of antibiotic treatment to treat|5
4613640|NCT01716533|7470854|FG003|Overall Study|Failure of antibiotic treatment to treat|0
4613641|NCT01716533|7470851|FG000|Overall Study|Withdrawal by Subject|0
4613642|NCT01716533|7470852|FG001|Overall Study|Withdrawal by Subject|0
4613643|NCT01716533|7470853|FG002|Overall Study|Withdrawal by Subject|0
4613644|NCT01716533|7470854|FG003|Overall Study|Withdrawal by Subject|5
4613645|NCT01716533|7470851|FG000|Overall Study|Death|0
4613646|NCT01716533|7470852|FG001|Overall Study|Death|0
4613647|NCT01716533|7470853|FG002|Overall Study|Death|0
4613648|NCT01716533|7470854|FG003|Overall Study|Death|2
4613649|NCT01716533|7470851|FG000|Overall Study|Immunosuppressants>14days past 6months|0
4613650|NCT01716533|7470852|FG001|Overall Study|Immunosuppressants>14days past 6months|0
4613651|NCT01716533|7470853|FG002|Overall Study|Immunosuppressants>14days past 6months|0
4613652|NCT01716533|7470854|FG003|Overall Study|Immunosuppressants>14days past 6months|1
4613653|NCT01716559|7470868|FG000|Overall Study|Adverse Event|11
4613654|NCT01716559|7470868|FG000|Overall Study|Death|21
4613655|NCT01716559|7470868|FG000|Overall Study|Withdrawal by Subject|4
4613656|NCT01716559|7470868|FG000|Overall Study|Other withdrawal reason|75
4613657|NCT01716585|7470874|FG000|Double-blind Treatment|Did Not Receive Study Drug|4
4613658|NCT01716585|7470875|FG001|Double-blind Treatment|Did Not Receive Study Drug|1
4613659|NCT01716585|7470874|FG000|Double-blind Treatment|Adverse Event|2
4613660|NCT01716585|7470875|FG001|Double-blind Treatment|Adverse Event|1
4613661|NCT01716585|7470874|FG000|Double-blind Treatment|Withdrawal by Subject|3
4613662|NCT01716585|7470875|FG001|Double-blind Treatment|Withdrawal by Subject|0
4613663|NCT01716585|7470874|FG000|Double-blind Treatment|Lost to Follow-up|2
4613664|NCT01716585|7470875|FG001|Double-blind Treatment|Lost to Follow-up|0
4613665|NCT01716585|7470874|FG000|Double-blind Treatment|Subject Noncompliant|1
4613666|NCT01716585|7470875|FG001|Double-blind Treatment|Subject Noncompliant|0
4613667|NCT01716585|7470874|FG000|Double-blind Treatment|Other|1
4613668|NCT01716585|7470875|FG001|Double-blind Treatment|Other|0
4613669|NCT01716585|7470874|FG000|Open-label Treatment|Adverse Event|0
4460510|NCT00574119|7248855|FG000|Overall Study|Withdrawal by Subject|1
4460511|NCT00574119|7248855|FG000|Overall Study|Physician Decision|1
4460512|NCT00574145|7248861|FG000|Overall Study|Withdrawal by Subject|2
4460513|NCT00574145|7248862|FG001|Overall Study|Withdrawal by Subject|1
4460514|NCT00574249|7248882|FG000|Overall Study|Adverse Event|6
4613670|NCT01716585|7470875|FG001|Open-label Treatment|Adverse Event|2
4460515|NCT00574249|7248883|FG001|Overall Study|Adverse Event|18
4460516|NCT00574249|7248882|FG000|Overall Study|Lack of Efficacy|5
4460517|NCT00574249|7248883|FG001|Overall Study|Lack of Efficacy|3
4460518|NCT00574249|7248882|FG000|Overall Study|Lost to Follow-up|4
4460519|NCT00574249|7248883|FG001|Overall Study|Lost to Follow-up|3
4460520|NCT00574249|7248882|FG000|Overall Study|Protocol Violation|5
4460521|NCT00574249|7248883|FG001|Overall Study|Protocol Violation|2
4460522|NCT00574249|7248882|FG000|Overall Study|History of carcinoma|1
4460523|NCT00574249|7248883|FG001|Overall Study|History of carcinoma|0
4460524|NCT00574249|7248882|FG000|Overall Study|Withdrawal by Subject|3
4460525|NCT00574249|7248883|FG001|Overall Study|Withdrawal by Subject|0
4460526|NCT00574249|7248882|FG000|Overall Study|Physician Decision|1
4460527|NCT00574249|7248883|FG001|Overall Study|Physician Decision|0
4460528|NCT00574249|7248882|FG000|Overall Study|Pregnancy|1
4460529|NCT00574249|7248883|FG001|Overall Study|Pregnancy|0
4460530|NCT00574249|7248882|FG000|Overall Study|Excluded by company|0
4460531|NCT00574249|7248883|FG001|Overall Study|Excluded by company|1
4460532|NCT00574249|7248882|FG000|Overall Study|PPD test taken twice|0
4460533|NCT00574249|7248883|FG001|Overall Study|PPD test taken twice|1
4460534|NCT00574275|7248891|FG000|Overall Study|Randomized but not treated|2
4460535|NCT00574275|7248892|FG001|Overall Study|Randomized but not treated|3
4460536|NCT00574275|7248891|FG000|Overall Study|Adverse Event|32
4460537|NCT00574275|7248892|FG001|Overall Study|Adverse Event|76
4460538|NCT00574275|7248891|FG000|Overall Study|Disease progression|160
4613671|NCT01716585|7470874|FG000|Open-label Treatment|Virologic Failure|0
4613672|NCT01716585|7470875|FG001|Open-label Treatment|Virologic Failure|2
4613673|NCT01716585|7470874|FG000|Open-label Treatment|Withdrawal by Subject|0
4613674|NCT01716585|7470875|FG001|Open-label Treatment|Withdrawal by Subject|3
4613675|NCT01716663|7470882|FG000|Overall Study|Withdrawn prior to procedure|4
4613676|NCT01716663|7470882|FG000|Overall Study|Treated with non-study catheter|2
4613677|NCT01716715|7470888|FG000|Overall Study|Never Treated|2
4613678|NCT01716715|7470889|FG001|Overall Study|Never Treated|4
4613679|NCT01716754|7470901|FG000|Overall Study|Death|0
4613680|NCT01716754|7470902|FG001|Overall Study|Death|0
4613681|NCT01716754|7470903|FG002|Overall Study|Death|0
4460539|NCT00574275|7248892|FG001|Overall Study|Disease progression|146
4460540|NCT00574275|7248891|FG000|Overall Study|Lost to Follow-up|2
4460541|NCT00574275|7248892|FG001|Overall Study|Lost to Follow-up|1
4460542|NCT00574275|7248891|FG000|Overall Study|Study stopped based on DMC decision|62
4460543|NCT00574275|7248892|FG001|Overall Study|Study stopped based on DMC decision|23
4460544|NCT00574275|7248891|FG000|Overall Study|Withdrawal by Subject|15
4460545|NCT00574275|7248892|FG001|Overall Study|Withdrawal by Subject|17
4460546|NCT00574275|7248891|FG000|Overall Study|Error calculating tumor measurement|1
4460547|NCT00574275|7248892|FG001|Overall Study|Error calculating tumor measurement|0
4460548|NCT00574275|7248891|FG000|Overall Study|Physician Decision|1
4460549|NCT00574275|7248892|FG001|Overall Study|Physician Decision|1
4460550|NCT00574275|7248891|FG000|Overall Study|Protocol Violation|0
4460551|NCT00574275|7248892|FG001|Overall Study|Protocol Violation|1
4460552|NCT00574275|7248891|FG000|Overall Study|Patient and Investigator decision|0
4460553|NCT00574275|7248892|FG001|Overall Study|Patient and Investigator decision|1
4460554|NCT00574275|7248891|FG000|Overall Study|Insurance change|0
4460555|NCT00574275|7248892|FG001|Overall Study|Insurance change|1
4460556|NCT00574275|7248891|FG000|Overall Study|Operation for curative intent|0
4460557|NCT00574275|7248892|FG001|Overall Study|Operation for curative intent|1
4460558|NCT00574288|7248905|FG000|Overall Study|Adverse Event|2
4460559|NCT00574288|7248906|FG001|Overall Study|Adverse Event|0
4460560|NCT00574288|7248907|FG002|Overall Study|Adverse Event|0
4460561|NCT00574288|7248908|FG003|Overall Study|Adverse Event|0
4460562|NCT00574288|7248909|FG004|Overall Study|Adverse Event|1
4460563|NCT00574288|7248910|FG005|Overall Study|Adverse Event|0
4460564|NCT00574288|7248911|FG006|Overall Study|Adverse Event|0
4460565|NCT00574288|7248905|FG000|Overall Study|Death|0
4460566|NCT00574288|7248906|FG001|Overall Study|Death|0
4460567|NCT00574288|7248907|FG002|Overall Study|Death|0
4460568|NCT00574288|7248908|FG003|Overall Study|Death|0
4460569|NCT00574288|7248909|FG004|Overall Study|Death|0
4460570|NCT00574288|7248910|FG005|Overall Study|Death|25
4460571|NCT00574288|7248911|FG006|Overall Study|Death|21
4460572|NCT00574288|7248905|FG000|Overall Study|Lost to Follow-up|0
4460573|NCT00574288|7248906|FG001|Overall Study|Lost to Follow-up|0
4460574|NCT00574288|7248907|FG002|Overall Study|Lost to Follow-up|0
4460575|NCT00574288|7248908|FG003|Overall Study|Lost to Follow-up|0
4460576|NCT00574288|7248909|FG004|Overall Study|Lost to Follow-up|0
4460577|NCT00574288|7248910|FG005|Overall Study|Lost to Follow-up|1
4460578|NCT00574288|7248911|FG006|Overall Study|Lost to Follow-up|2
4460579|NCT00574288|7248905|FG000|Overall Study|Study Terminated By Sponsor|0
4460580|NCT00574288|7248906|FG001|Overall Study|Study Terminated By Sponsor|0
4460581|NCT00574288|7248907|FG002|Overall Study|Study Terminated By Sponsor|0
4460582|NCT00574288|7248908|FG003|Overall Study|Study Terminated By Sponsor|0
4460583|NCT00574288|7248909|FG004|Overall Study|Study Terminated By Sponsor|0
4460584|NCT00574288|7248910|FG005|Overall Study|Study Terminated By Sponsor|0
4460585|NCT00574288|7248911|FG006|Overall Study|Study Terminated By Sponsor|5
4460586|NCT00574288|7248905|FG000|Overall Study|Progressive Disease|17
4460587|NCT00574288|7248906|FG001|Overall Study|Progressive Disease|2
4460588|NCT00574288|7248907|FG002|Overall Study|Progressive Disease|3
4460589|NCT00574288|7248908|FG003|Overall Study|Progressive Disease|2
4460590|NCT00574288|7248909|FG004|Overall Study|Progressive Disease|1
4460591|NCT00574288|7248910|FG005|Overall Study|Progressive Disease|0
4460592|NCT00574288|7248911|FG006|Overall Study|Progressive Disease|0
4460593|NCT00574288|7248905|FG000|Overall Study|Other|1
4460594|NCT00574288|7248906|FG001|Overall Study|Other|1
4460595|NCT00574288|7248907|FG002|Overall Study|Other|0
4460596|NCT00574288|7248908|FG003|Overall Study|Other|0
4460597|NCT00574288|7248909|FG004|Overall Study|Other|0
4460598|NCT00574288|7248910|FG005|Overall Study|Other|0
4460599|NCT00574288|7248911|FG006|Overall Study|Other|0
4460600|NCT00574405|7248946|FG000|Overall Study|Withdrawal by Subject|3
4460601|NCT00574405|7248947|FG001|Overall Study|Withdrawal by Subject|2
4460602|NCT00574795|7249015|FG000|Infant Series|Withdrawal by Subject|2
4460603|NCT00574795|7249015|FG000|Infant Series|Protocol Violation|2
4460604|NCT00574795|7249015|FG000|Infant Series|Adverse Event|1
4460605|NCT00574795|7249015|FG000|After Infant Series|Withdrawal by Subject|1
4460606|NCT00574795|7249015|FG000|After Infant Series|Adverse Event|2
4460607|NCT00574795|7249015|FG000|Toddler Dose|Withdrawal by Subject|1
4460608|NCT00574847|7249045|FG000|Overall Study|Adverse Event|2
4460609|NCT00574847|7249046|FG001|Overall Study|Adverse Event|0
4460610|NCT00574847|7249045|FG000|Overall Study|Death|1
4460611|NCT00574847|7249046|FG001|Overall Study|Death|0
4460612|NCT00574847|7249045|FG000|Overall Study|Withdrawal by Subject|2
4613682|NCT01716754|7470904|FG003|Overall Study|Death|1
4613683|NCT01716754|7470901|FG000|Overall Study|Protocol deviation|0
4613684|NCT01716754|7470902|FG001|Overall Study|Protocol deviation|2
4613685|NCT01716754|7470903|FG002|Overall Study|Protocol deviation|7
4613686|NCT01716754|7470904|FG003|Overall Study|Protocol deviation|2
4613687|NCT01716754|7470901|FG000|Overall Study|Non-compliance with study treatment|0
4613688|NCT01716754|7470902|FG001|Overall Study|Non-compliance with study treatment|0
4613689|NCT01716754|7470903|FG002|Overall Study|Non-compliance with study treatment|1
4613690|NCT01716754|7470904|FG003|Overall Study|Non-compliance with study treatment|0
4613691|NCT01716754|7470901|FG000|Overall Study|Physician Decision|1
4613692|NCT01716754|7470902|FG001|Overall Study|Physician Decision|0
4613693|NCT01716754|7470903|FG002|Overall Study|Physician Decision|0
4613694|NCT01716754|7470904|FG003|Overall Study|Physician Decision|0
4613695|NCT01716754|7470901|FG000|Overall Study|Lost to Follow-up|1
4613696|NCT01716754|7470902|FG001|Overall Study|Lost to Follow-up|0
4613697|NCT01716754|7470903|FG002|Overall Study|Lost to Follow-up|0
4613698|NCT01716754|7470904|FG003|Overall Study|Lost to Follow-up|1
4613699|NCT01716754|7470901|FG000|Overall Study|Adverse Event|4
4613700|NCT01716754|7470902|FG001|Overall Study|Adverse Event|2
4613701|NCT01716754|7470903|FG002|Overall Study|Adverse Event|2
4613702|NCT01716754|7470904|FG003|Overall Study|Adverse Event|1
4613703|NCT01716754|7470901|FG000|Overall Study|Withdrawal by Subject|5
4613704|NCT01716754|7470902|FG001|Overall Study|Withdrawal by Subject|0
4613705|NCT01716754|7470903|FG002|Overall Study|Withdrawal by Subject|4
4613706|NCT01716754|7470904|FG003|Overall Study|Withdrawal by Subject|3
4613707|NCT01717040|7470928|FG000|Overall Study|Lost to Follow-up|2
4613708|NCT01717040|7470929|FG001|Overall Study|Lost to Follow-up|3
4613709|NCT01717040|7470928|FG000|Overall Study|Lack of Efficacy|1
4613710|NCT01717040|7470929|FG001|Overall Study|Lack of Efficacy|1
4613711|NCT01717040|7470928|FG000|Overall Study|Adverse Event|1
4613712|NCT01717040|7470929|FG001|Overall Study|Adverse Event|0
4613713|NCT01717040|7470928|FG000|Overall Study|Required Medication Change|0
4613714|NCT01717040|7470929|FG001|Overall Study|Required Medication Change|1
4613715|NCT01717040|7470928|FG000|Overall Study|New Substance Use Disorder|1
4613716|NCT01717040|7470929|FG001|Overall Study|New Substance Use Disorder|0
4613717|NCT01717287|7470945|FG000|Overall Study|Lost to Follow-up|0
4613718|NCT01717287|7470946|FG001|Overall Study|Lost to Follow-up|2
4613719|NCT01717287|7470945|FG000|Overall Study|Protocol Violation|0
4613720|NCT01717287|7470946|FG001|Overall Study|Protocol Violation|1
4613721|NCT01717313|7470954|FG000|Phase A (Weeks 0 to 24)|Death|0
4613722|NCT01717313|7470955|FG001|Phase A (Weeks 0 to 24)|Death|1
4613723|NCT01717313|7470954|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1
4613724|NCT01717313|7470955|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3
4613725|NCT01717313|7470954|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12
4613726|NCT01717313|7470955|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6
4613727|NCT01717313|7470954|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4
4613728|NCT01717313|7470955|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2
4613729|NCT01717313|7470954|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1
4613730|NCT01717313|7470955|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1
4460613|NCT00574847|7249046|FG001|Overall Study|Withdrawal by Subject|2
4460614|NCT00574847|7249045|FG000|Overall Study|Physician Decision|1
4460615|NCT00574847|7249046|FG001|Overall Study|Physician Decision|0
4613731|NCT01717313|7470954|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1
4613732|NCT01717313|7470955|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0
4613733|NCT01717313|7470954|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4
4613734|NCT01717313|7470955|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4
4613735|NCT01717313|7470954|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7
4613736|NCT01717313|7470955|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9
4613737|NCT01717313|7470954|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1
4460616|NCT00574847|7249045|FG000|Overall Study|Did not receive medication (declined)|2
4460617|NCT00574847|7249046|FG001|Overall Study|Did not receive medication (declined)|5
4460618|NCT00574873|7249054|FG000|Overall Study|Withdrawal by Subject|18
4460619|NCT00574873|7249055|FG001|Overall Study|Withdrawal by Subject|19
4460620|NCT00574873|7249054|FG000|Overall Study|Investigator request|18
4460621|NCT00574873|7249055|FG001|Overall Study|Investigator request|8
4613738|NCT01717313|7470955|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3
4613739|NCT01717326|7470981|FG000|Overall Study|Death|0
4613740|NCT01717326|7470982|FG001|Overall Study|Death|0
4613741|NCT01717326|7470983|FG002|Overall Study|Death|0
4613742|NCT01717326|7470984|FG003|Overall Study|Death|0
4613743|NCT01717326|7470985|FG004|Overall Study|Death|0
4613744|NCT01717326|7470986|FG005|Overall Study|Death|0
4613745|NCT01717326|7470987|FG006|Overall Study|Death|0
4613746|NCT01717326|7470988|FG007|Overall Study|Death|0
4613747|NCT01717326|7470989|FG008|Overall Study|Death|0
4613748|NCT01717326|7470990|FG009|Overall Study|Death|0
4613749|NCT01717326|7470991|FG010|Overall Study|Death|1
4613750|NCT01717326|7470992|FG011|Overall Study|Death|0
4613751|NCT01717326|7470993|FG012|Overall Study|Death|0
4613752|NCT01717326|7470994|FG013|Overall Study|Death|0
4613753|NCT01717326|7470995|FG014|Overall Study|Death|0
4613754|NCT01717326|7470996|FG015|Overall Study|Death|0
4613755|NCT01717326|7470997|FG016|Overall Study|Death|0
4613756|NCT01717326|7470998|FG017|Overall Study|Death|0
4613757|NCT01717326|7470999|FG018|Overall Study|Death|0
4613758|NCT01717326|7471000|FG019|Overall Study|Death|0
4613759|NCT01717326|7470981|FG000|Overall Study|Lost to Follow-up|3
4613760|NCT01717326|7470982|FG001|Overall Study|Lost to Follow-up|0
4613761|NCT01717326|7470983|FG002|Overall Study|Lost to Follow-up|0
4613762|NCT01717326|7470984|FG003|Overall Study|Lost to Follow-up|2
4613763|NCT01717326|7470985|FG004|Overall Study|Lost to Follow-up|1
4613764|NCT01717326|7470986|FG005|Overall Study|Lost to Follow-up|0
4613765|NCT01717326|7470987|FG006|Overall Study|Lost to Follow-up|1
4613766|NCT01717326|7470988|FG007|Overall Study|Lost to Follow-up|0
4613767|NCT01717326|7470989|FG008|Overall Study|Lost to Follow-up|0
4613768|NCT01717326|7470990|FG009|Overall Study|Lost to Follow-up|0
4613769|NCT01717326|7470991|FG010|Overall Study|Lost to Follow-up|1
4613770|NCT01717326|7470992|FG011|Overall Study|Lost to Follow-up|0
4613771|NCT01717326|7470993|FG012|Overall Study|Lost to Follow-up|0
4613772|NCT01717326|7470994|FG013|Overall Study|Lost to Follow-up|0
4613773|NCT01717326|7470995|FG014|Overall Study|Lost to Follow-up|0
4613774|NCT01717326|7470996|FG015|Overall Study|Lost to Follow-up|2
4613775|NCT01717326|7470997|FG016|Overall Study|Lost to Follow-up|1
4613776|NCT01717326|7470998|FG017|Overall Study|Lost to Follow-up|0
4613777|NCT01717326|7470999|FG018|Overall Study|Lost to Follow-up|2
4613778|NCT01717326|7471000|FG019|Overall Study|Lost to Follow-up|3
4613779|NCT01717326|7470981|FG000|Overall Study|Physician Decision|0
4613780|NCT01717326|7470982|FG001|Overall Study|Physician Decision|0
4613781|NCT01717326|7470983|FG002|Overall Study|Physician Decision|0
4613782|NCT01717326|7470984|FG003|Overall Study|Physician Decision|0
4613783|NCT01717326|7470985|FG004|Overall Study|Physician Decision|0
4613784|NCT01717326|7470986|FG005|Overall Study|Physician Decision|0
4613785|NCT01717326|7470987|FG006|Overall Study|Physician Decision|0
4613786|NCT01717326|7470988|FG007|Overall Study|Physician Decision|0
4613787|NCT01717326|7470989|FG008|Overall Study|Physician Decision|0
4613788|NCT01717326|7470990|FG009|Overall Study|Physician Decision|1
4613789|NCT01717326|7470991|FG010|Overall Study|Physician Decision|0
4613790|NCT01717326|7470992|FG011|Overall Study|Physician Decision|0
4613791|NCT01717326|7470993|FG012|Overall Study|Physician Decision|0
4613792|NCT01717326|7470994|FG013|Overall Study|Physician Decision|0
4613793|NCT01717326|7470995|FG014|Overall Study|Physician Decision|0
4613794|NCT01717326|7470996|FG015|Overall Study|Physician Decision|0
4613795|NCT01717326|7470997|FG016|Overall Study|Physician Decision|0
4613796|NCT01717326|7470998|FG017|Overall Study|Physician Decision|0
4613797|NCT01717326|7470999|FG018|Overall Study|Physician Decision|0
4613798|NCT01717326|7471000|FG019|Overall Study|Physician Decision|0
4613799|NCT01717326|7470981|FG000|Overall Study|Protocol Violation|0
4613800|NCT01717326|7470982|FG001|Overall Study|Protocol Violation|0
4613801|NCT01717326|7470983|FG002|Overall Study|Protocol Violation|0
4613802|NCT01717326|7470984|FG003|Overall Study|Protocol Violation|0
4613803|NCT01717326|7470985|FG004|Overall Study|Protocol Violation|1
4613804|NCT01717326|7470986|FG005|Overall Study|Protocol Violation|0
4613805|NCT01717326|7470987|FG006|Overall Study|Protocol Violation|0
4613806|NCT01717326|7470988|FG007|Overall Study|Protocol Violation|0
4613807|NCT01717326|7470989|FG008|Overall Study|Protocol Violation|0
4613808|NCT01717326|7470990|FG009|Overall Study|Protocol Violation|0
4613809|NCT01717326|7470991|FG010|Overall Study|Protocol Violation|0
4613810|NCT01717326|7470992|FG011|Overall Study|Protocol Violation|0
4613811|NCT01717326|7470993|FG012|Overall Study|Protocol Violation|0
4613812|NCT01717326|7470994|FG013|Overall Study|Protocol Violation|0
4613813|NCT01717326|7470995|FG014|Overall Study|Protocol Violation|0
4613814|NCT01717326|7470996|FG015|Overall Study|Protocol Violation|0
4613815|NCT01717326|7470997|FG016|Overall Study|Protocol Violation|0
4613816|NCT01717326|7470998|FG017|Overall Study|Protocol Violation|0
4613817|NCT01717326|7470999|FG018|Overall Study|Protocol Violation|0
4613818|NCT01717326|7471000|FG019|Overall Study|Protocol Violation|0
4613819|NCT01717326|7470981|FG000|Overall Study|Withdrawal by Subject|0
4613820|NCT01717326|7470982|FG001|Overall Study|Withdrawal by Subject|1
4613821|NCT01717326|7470983|FG002|Overall Study|Withdrawal by Subject|0
4460622|NCT00574873|7249054|FG000|Overall Study|Death|15
4460623|NCT00574873|7249055|FG001|Overall Study|Death|14
4460624|NCT00574873|7249054|FG000|Overall Study|Lost to Follow-up|14
4460625|NCT00574873|7249055|FG001|Overall Study|Lost to Follow-up|5
4460626|NCT00574873|7249054|FG000|Overall Study|Other|40
4460627|NCT00574873|7249055|FG001|Overall Study|Other|4
4460628|NCT00574873|7249054|FG000|Overall Study|Discontinuation of study by sponsor|5
4460629|NCT00574873|7249055|FG001|Overall Study|Discontinuation of study by sponsor|199
4460630|NCT00574873|7249054|FG000|Overall Study|Blank, site closed per local regulations|2
4460631|NCT00574873|7249055|FG001|Overall Study|Blank, site closed per local regulations|2
4460632|NCT00574873|7249054|FG000|Overall Study|Extension Study|126
4460633|NCT00574873|7249055|FG001|Overall Study|Extension Study|0
4460634|NCT00574912|7249061|FG000|Overall Study|Could not place IV lines.|3
4460635|NCT00574912|7249061|FG000|Overall Study|scheduling conflicts|3
4460636|NCT00574912|7249061|FG000|Overall Study|Physician Decision|2
4613822|NCT01717326|7470984|FG003|Overall Study|Withdrawal by Subject|0
4613823|NCT01717326|7470985|FG004|Overall Study|Withdrawal by Subject|0
4613824|NCT01717326|7470986|FG005|Overall Study|Withdrawal by Subject|0
4613825|NCT01717326|7470987|FG006|Overall Study|Withdrawal by Subject|0
4613826|NCT01717326|7470988|FG007|Overall Study|Withdrawal by Subject|0
4613827|NCT01717326|7470989|FG008|Overall Study|Withdrawal by Subject|0
4613828|NCT01717326|7470990|FG009|Overall Study|Withdrawal by Subject|1
4613829|NCT01717326|7470991|FG010|Overall Study|Withdrawal by Subject|0
4613830|NCT01717326|7470992|FG011|Overall Study|Withdrawal by Subject|0
4613831|NCT01717326|7470993|FG012|Overall Study|Withdrawal by Subject|1
4613832|NCT01717326|7470994|FG013|Overall Study|Withdrawal by Subject|0
4613833|NCT01717326|7470995|FG014|Overall Study|Withdrawal by Subject|0
4613834|NCT01717326|7470996|FG015|Overall Study|Withdrawal by Subject|1
4613835|NCT01717326|7470997|FG016|Overall Study|Withdrawal by Subject|0
4613836|NCT01717326|7470998|FG017|Overall Study|Withdrawal by Subject|0
4613837|NCT01717326|7470999|FG018|Overall Study|Withdrawal by Subject|2
4613838|NCT01717326|7471000|FG019|Overall Study|Withdrawal by Subject|3
4613839|NCT01717391|7471042|FG000|Overall Study|Withdrawal by Subject|5
4613840|NCT01717391|7471042|FG000|Overall Study|Physician Decision|1
4613841|NCT01717391|7471042|FG000|Overall Study|FLT technical failure|3
4613842|NCT01717456|7471050|FG000|End of Treatment|Physician Decision|0
4613843|NCT01717456|7471051|FG001|End of Treatment|Physician Decision|1
4613844|NCT01717456|7471050|FG000|End of Treatment|Lost to Follow-up|0
4613845|NCT01717456|7471051|FG001|End of Treatment|Lost to Follow-up|1
4613846|NCT01717456|7471050|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4
4613847|NCT01717456|7471051|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4
4613848|NCT01717638|7471075|FG000|Overall Study|Lost to Follow-up|0
4613849|NCT01717638|7471076|FG001|Overall Study|Lost to Follow-up|0
4613850|NCT01717638|7471077|FG002|Overall Study|Lost to Follow-up|0
4613851|NCT01717638|7471078|FG003|Overall Study|Lost to Follow-up|0
4613852|NCT01717638|7471079|FG004|Overall Study|Lost to Follow-up|0
4613853|NCT01717638|7471080|FG005|Overall Study|Lost to Follow-up|1
4613854|NCT01717638|7471081|FG006|Overall Study|Lost to Follow-up|0
4613855|NCT01717638|7471082|FG007|Overall Study|Lost to Follow-up|0
4613856|NCT01717638|7471083|FG008|Overall Study|Lost to Follow-up|0
4613857|NCT01717638|7471084|FG009|Overall Study|Lost to Follow-up|0
4613858|NCT01717638|7471085|FG010|Overall Study|Lost to Follow-up|0
4613859|NCT01717638|7471086|FG011|Overall Study|Lost to Follow-up|0
4613860|NCT01717638|7471087|FG012|Overall Study|Lost to Follow-up|0
4613861|NCT01717638|7471075|FG000|Overall Study|Father in hospital|0
4613862|NCT01717638|7471076|FG001|Overall Study|Father in hospital|0
4613863|NCT01717638|7471077|FG002|Overall Study|Father in hospital|0
4613864|NCT01717638|7471078|FG003|Overall Study|Father in hospital|0
4613865|NCT01717638|7471079|FG004|Overall Study|Father in hospital|0
4613866|NCT01717638|7471080|FG005|Overall Study|Father in hospital|0
4613867|NCT01717638|7471081|FG006|Overall Study|Father in hospital|0
4613868|NCT01717638|7471082|FG007|Overall Study|Father in hospital|0
4613869|NCT01717638|7471083|FG008|Overall Study|Father in hospital|0
4613870|NCT01717638|7471084|FG009|Overall Study|Father in hospital|0
4613871|NCT01717638|7471085|FG010|Overall Study|Father in hospital|0
4613872|NCT01717638|7471086|FG011|Overall Study|Father in hospital|0
4613873|NCT01717638|7471087|FG012|Overall Study|Father in hospital|1
4613874|NCT01717638|7471075|FG000|Overall Study|Withdrawal by Subject|0
4613875|NCT01717638|7471076|FG001|Overall Study|Withdrawal by Subject|1
4613876|NCT01717638|7471077|FG002|Overall Study|Withdrawal by Subject|1
4613877|NCT01717638|7471078|FG003|Overall Study|Withdrawal by Subject|0
4613878|NCT01717638|7471079|FG004|Overall Study|Withdrawal by Subject|1
4613879|NCT01717638|7471080|FG005|Overall Study|Withdrawal by Subject|0
4613880|NCT01717638|7471081|FG006|Overall Study|Withdrawal by Subject|2
4613881|NCT01717638|7471082|FG007|Overall Study|Withdrawal by Subject|1
4690389|NCT02561195|7600186|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1
4460637|NCT00574951|7249073|FG000|Overall Study|Ineligible - improper prior treatment|1
4690390|NCT02561195|7600187|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0
4690391|NCT02561195|7600188|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4
4690392|NCT02561195|7600189|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4
4690393|NCT02561195|7600190|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1
4690394|NCT02561195|7600191|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0
4460638|NCT00575042|7249114|FG000|Overall Study|Adverse Event|2
4460639|NCT00575042|7249114|FG000|Overall Study|Lost to Follow-up|1
4460640|NCT00575094|7249119|FG000|Overall Study|Adverse Event|2
4460641|NCT00575094|7249119|FG000|Overall Study|Withdrawal by Subject|1
4460642|NCT00575328|7249156|FG000|Overall Study|Adverse Event|1
4460643|NCT00575328|7249157|FG001|Overall Study|Adverse Event|1
4460644|NCT00575328|7249156|FG000|Overall Study|Lost to Follow-up|2
4460645|NCT00575328|7249157|FG001|Overall Study|Lost to Follow-up|1
4460646|NCT00575380|7249174|FG000|Overall Study|Withdrawal by Subject|1
4460647|NCT00575380|7249175|FG001|Overall Study|Withdrawal by Subject|0
4460648|NCT00575380|7249174|FG000|Overall Study|Adverse Event|0
4460649|NCT00575380|7249175|FG001|Overall Study|Adverse Event|1
4460650|NCT00575380|7249174|FG000|Overall Study|Various|0
4460651|NCT00575380|7249175|FG001|Overall Study|Various|2
4460652|NCT00575510|7249184|FG000|Overall Study|Lost to Follow-up|4
4460653|NCT00575510|7249185|FG001|Overall Study|Lost to Follow-up|6
4460654|NCT00575510|7249186|FG002|Overall Study|Lost to Follow-up|9
4460655|NCT00575510|7249184|FG000|Overall Study|Withdrawal by Subject|1
4460656|NCT00575510|7249185|FG001|Overall Study|Withdrawal by Subject|0
4460657|NCT00575510|7249186|FG002|Overall Study|Withdrawal by Subject|0
4460658|NCT00575510|7249184|FG000|Overall Study|Clinic Called Patient|7
4460659|NCT00575510|7249185|FG001|Overall Study|Clinic Called Patient|7
4460660|NCT00575510|7249186|FG002|Overall Study|Clinic Called Patient|7
4460661|NCT00575510|7249184|FG000|Overall Study|Pregnancy|0
4539415|NCT01125566|7361740|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7
4539416|NCT01125566|7361738|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0
4460662|NCT00575510|7249185|FG001|Overall Study|Pregnancy|0
4460663|NCT00575510|7249186|FG002|Overall Study|Pregnancy|1
4460664|NCT00575588|7249197|FG000|Overall Study|Adverse Event|11
4460665|NCT00575588|7249198|FG001|Overall Study|Adverse Event|13
4460666|NCT00575588|7249197|FG000|Overall Study|Withdrawal by Subject|27
4460667|NCT00575588|7249198|FG001|Overall Study|Withdrawal by Subject|31
4460668|NCT00575588|7249197|FG000|Overall Study|Lost to Follow-up|1
4460669|NCT00575588|7249198|FG001|Overall Study|Lost to Follow-up|3
4460670|NCT00575588|7249197|FG000|Overall Study|Death|4
4460671|NCT00575588|7249198|FG001|Overall Study|Death|2
4460672|NCT00575588|7249197|FG000|Overall Study|Incorrect enrollment|8
4460673|NCT00575588|7249198|FG001|Overall Study|Incorrect enrollment|4
4460674|NCT00575588|7249197|FG000|Overall Study|Study specific discontinuation criteria|203
4460675|NCT00575588|7249198|FG001|Overall Study|Study specific discontinuation criteria|218
4460676|NCT00575588|7249197|FG000|Overall Study|Severe non-compliance to protocol|5
4460677|NCT00575588|7249198|FG001|Overall Study|Severe non-compliance to protocol|7
4460678|NCT00575588|7249197|FG000|Overall Study|Safety reasons|2
4460679|NCT00575588|7249198|FG001|Overall Study|Safety reasons|1
4460680|NCT00575588|7249197|FG000|Overall Study|Elevated triglyceride|1
4460681|NCT00575588|7249198|FG001|Overall Study|Elevated triglyceride|0
4460682|NCT00575588|7249197|FG000|Overall Study|Patient moved|1
4460683|NCT00575588|7249198|FG001|Overall Study|Patient moved|3
4460684|NCT00575588|7249197|FG000|Overall Study|Impossible to determine HbA1c|0
4460685|NCT00575588|7249198|FG001|Overall Study|Impossible to determine HbA1c|1
4460686|NCT00575666|7249206|FG000|Overall Study|Withdrawal by Subject|3
4460687|NCT00575666|7249207|FG001|Overall Study|Withdrawal by Subject|2
4460688|NCT00575666|7249206|FG000|Overall Study|Physician Decision|1
4460689|NCT00575666|7249207|FG001|Overall Study|Physician Decision|1
4460690|NCT00576056|7249221|FG000|Overall Study|Adverse Event|1
4460691|NCT00576056|7249221|FG000|Overall Study|Death|1
4460692|NCT00576056|7249221|FG000|Overall Study|Lack of Efficacy|1
4460693|NCT00576056|7249221|FG000|Overall Study|Withdrawal by Subject|2
4460694|NCT00576056|7249221|FG000|Overall Study|did not meet eligibility criteria|8
4460695|NCT00576056|7249221|FG000|Overall Study|Physician Decision|1
4460696|NCT00576199|7249229|FG000|Overall Study|Adverse Event|12
4460697|NCT00576199|7249229|FG000|Overall Study|Insufficient Therapeutic Response|14
4460698|NCT00576199|7249229|FG000|Overall Study|Refused Treatment|2
4460699|NCT00576199|7249229|FG000|Overall Study|Reason Unspecified|2
4460700|NCT00576303|7249242|FG000|Dose Titration Period|Early withdrawal|17
4460701|NCT00576303|7249242|FG000|Efficacy Evaluation Period|Early withdrawal|5
4460702|NCT00576303|7249242|FG000|Long Term Safety Period|Early withdrawal|16
4460703|NCT00576316|7249246|FG000|Overall Study|Adverse Event|9
4460704|NCT00576316|7249246|FG000|Overall Study|Withdrawal by Subject|2
4460705|NCT00576316|7249246|FG000|Overall Study|Protocol Violation|9
4460706|NCT00576381|7249250|FG000|Overall Study|Reoperation|3
4460707|NCT00576381|7249250|FG000|Overall Study|Adverse Event|4
4460708|NCT00576420|7249257|FG000|Overall Study|Death|0
4460709|NCT00576420|7249258|FG001|Overall Study|Death|0
4613882|NCT01717638|7471083|FG008|Overall Study|Withdrawal by Subject|2
4460710|NCT00576420|7249259|FG002|Overall Study|Death|1
4460711|NCT00576472|7249323|FG000|MPH In-Lab Phase|Declined participation in medication pha|0
4460712|NCT00576472|7249324|FG001|MPH In-Lab Phase|Declined participation in medication pha|0
4460713|NCT00576472|7249325|FG002|MPH In-Lab Phase|Declined participation in medication pha|0
4460714|NCT00576472|7249326|FG003|MPH In-Lab Phase|Declined participation in medication pha|75
4460715|NCT00576472|7249327|FG004|MPH In-Lab Phase|Declined participation in medication pha|0
4460716|NCT00576472|7249328|FG005|MPH In-Lab Phase|Declined participation in medication pha|0
4460717|NCT00576472|7249329|FG006|MPH In-Lab Phase|Declined participation in medication pha|0
4539417|NCT01125566|7361739|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0
4539418|NCT01125566|7361740|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3
4539419|NCT01125566|7361738|FG000|Patients Who Switched From AV to TV|Other than listed above|0
4539420|NCT01125566|7361739|FG001|Patients Who Switched From AV to TV|Other than listed above|0
4539421|NCT01125566|7361740|FG002|Patients Who Switched From AV to TV|Other than listed above|4
4460718|NCT00576472|7249330|FG007|MPH In-Lab Phase|Declined participation in medication pha|0
4460719|NCT00576472|7249331|FG008|MPH In-Lab Phase|Declined participation in medication pha|0
4460720|NCT00576472|7249332|FG009|MPH In-Lab Phase|Declined participation in medication pha|0
4460721|NCT00576472|7249333|FG010|MPH In-Lab Phase|Declined participation in medication pha|0
4460722|NCT00576472|7249334|FG011|MPH In-Lab Phase|Declined participation in medication pha|0
4460723|NCT00576472|7249335|FG012|MPH In-Lab Phase|Declined participation in medication pha|0
4460724|NCT00576472|7249336|FG013|MPH In-Lab Phase|Declined participation in medication pha|0
4460725|NCT00576472|7249337|FG014|MPH In-Lab Phase|Declined participation in medication pha|0
4460726|NCT00576472|7249323|FG000|MPH In-Lab Phase|Lost to Follow-up|0
4460727|NCT00576472|7249324|FG001|MPH In-Lab Phase|Lost to Follow-up|0
4460728|NCT00576472|7249325|FG002|MPH In-Lab Phase|Lost to Follow-up|0
4460729|NCT00576472|7249326|FG003|MPH In-Lab Phase|Lost to Follow-up|1
4460730|NCT00576472|7249327|FG004|MPH In-Lab Phase|Lost to Follow-up|0
4460731|NCT00576472|7249328|FG005|MPH In-Lab Phase|Lost to Follow-up|0
4460732|NCT00576472|7249329|FG006|MPH In-Lab Phase|Lost to Follow-up|0
4460733|NCT00576472|7249330|FG007|MPH In-Lab Phase|Lost to Follow-up|0
4460734|NCT00576472|7249331|FG008|MPH In-Lab Phase|Lost to Follow-up|0
4460735|NCT00576472|7249332|FG009|MPH In-Lab Phase|Lost to Follow-up|0
4539422|NCT01125722|7361766|FG000|Overall Study|Withdrawal by Subject|2
4613883|NCT01717638|7471084|FG009|Overall Study|Withdrawal by Subject|1
4613884|NCT01717638|7471085|FG010|Overall Study|Withdrawal by Subject|0
4613885|NCT01717638|7471086|FG011|Overall Study|Withdrawal by Subject|0
4613886|NCT01717638|7471087|FG012|Overall Study|Withdrawal by Subject|18
4613887|NCT01717768|7471140|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
4613888|NCT01717768|7471141|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1
4613889|NCT01717768|7471142|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
4613890|NCT01717768|7471143|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
4613891|NCT01717768|7471144|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
4613892|NCT01717768|7471145|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
4613893|NCT01717768|7471146|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
4613894|NCT01717768|7471147|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
4613895|NCT01717768|7471148|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
4613896|NCT01717768|7471149|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
4613897|NCT01717768|7471150|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
4613898|NCT01717768|7471151|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
4613899|NCT01717768|7471140|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
4613900|NCT01717768|7471141|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
4613901|NCT01717768|7471142|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
4613902|NCT01717768|7471143|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
4613903|NCT01717768|7471144|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
4613904|NCT01717768|7471145|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
4613905|NCT01717768|7471146|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
4613906|NCT01717768|7471147|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
4613907|NCT01717768|7471148|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
4613908|NCT01717768|7471149|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
4613909|NCT01717768|7471150|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
4613910|NCT01717768|7471151|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1
4613911|NCT01717768|7471140|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
4613912|NCT01717768|7471141|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
4613913|NCT01717768|7471142|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
4613914|NCT01717768|7471143|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
4613915|NCT01717768|7471144|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
4613916|NCT01717768|7471145|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
4613917|NCT01717768|7471146|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
4613918|NCT01717768|7471147|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2
4613919|NCT01717768|7471148|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
4613920|NCT01717768|7471149|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
4613921|NCT01717768|7471150|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
4613922|NCT01717768|7471151|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
4613923|NCT01717768|7471140|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
4613924|NCT01717768|7471141|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
4613925|NCT01717768|7471142|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
4613926|NCT01717768|7471143|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
4613927|NCT01717768|7471144|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
4460736|NCT00576472|7249333|FG010|MPH In-Lab Phase|Lost to Follow-up|0
4460737|NCT00576472|7249334|FG011|MPH In-Lab Phase|Lost to Follow-up|0
4460738|NCT00576472|7249335|FG012|MPH In-Lab Phase|Lost to Follow-up|0
4460739|NCT00576472|7249336|FG013|MPH In-Lab Phase|Lost to Follow-up|0
4460740|NCT00576472|7249337|FG014|MPH In-Lab Phase|Lost to Follow-up|0
4460741|NCT00576472|7249323|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
4460742|NCT00576472|7249324|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
4460743|NCT00576472|7249325|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
4460744|NCT00576472|7249326|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4
4460745|NCT00576472|7249327|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
4460746|NCT00576472|7249328|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
4460747|NCT00576472|7249329|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
4460748|NCT00576472|7249330|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
4460749|NCT00576472|7249331|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
4460750|NCT00576472|7249332|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
4613928|NCT01717768|7471145|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
4613929|NCT01717768|7471146|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
4613930|NCT01717768|7471147|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
4613931|NCT01717768|7471148|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
4613932|NCT01717768|7471149|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1
4613933|NCT01717768|7471150|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
4613934|NCT01717768|7471151|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
4613935|NCT01717859|7471177|FG000|Overall Study|Adverse Event|5
4613936|NCT01717859|7471177|FG000|Overall Study|Moved out of state|1
4613937|NCT01717859|7471177|FG000|Overall Study|Patient concerned about mental health|1
4613938|NCT01717859|7471177|FG000|Overall Study|Lost to Follow-up|1
4613939|NCT01717859|7471177|FG000|Overall Study|Withdrawal by Subject|2
4613940|NCT01717976|7471216|FG000|Overall Study|Protocol Violation|0
4613941|NCT01717976|7471217|FG001|Overall Study|Protocol Violation|1
4613942|NCT01717989|7471223|FG000|Overall Study|Ineligibility determined|6
4613943|NCT01717989|7471223|FG000|Overall Study|Protocol deviation|6
4613944|NCT01717989|7471223|FG000|Overall Study|Withdrawal by Subject|11
4613945|NCT01717989|7471223|FG000|Overall Study|Physician Decision|2
4613946|NCT01717989|7471223|FG000|Overall Study|Lost to Follow-up|11
4613947|NCT01717989|7471223|FG000|Overall Study|Death|439
4613948|NCT01717989|7471223|FG000|Overall Study|Protocol-specified criteria|551
4613949|NCT01717989|7471223|FG000|Overall Study|Other|40
4613950|NCT01718353|7471253|FG000|Overall Study|Lost to Follow-up|0
4613951|NCT01718353|7471254|FG001|Overall Study|Lost to Follow-up|1
4613952|NCT01718353|7471253|FG000|Overall Study|Principal Investigator's Decision|10
4613953|NCT01718353|7471254|FG001|Overall Study|Principal Investigator's Decision|4
4613954|NCT01718353|7471253|FG000|Overall Study|Randomized but not treated|2
4613955|NCT01718353|7471254|FG001|Overall Study|Randomized but not treated|0
4613956|NCT01718483|7471264|FG000|Overall Study|Withdrawal by Subject|14
4613957|NCT01718483|7471265|FG001|Overall Study|Withdrawal by Subject|12
4613958|NCT01718483|7471264|FG000|Overall Study|Adverse Event|5
4613959|NCT01718483|7471265|FG001|Overall Study|Adverse Event|12
4613960|NCT01718483|7471264|FG000|Overall Study|Lost to Follow-up|8
4613961|NCT01718483|7471265|FG001|Overall Study|Lost to Follow-up|3
4613962|NCT01718483|7471264|FG000|Overall Study|Protocol Violation|4
4613963|NCT01718483|7471265|FG001|Overall Study|Protocol Violation|2
4613964|NCT01718483|7471264|FG000|Overall Study|Other|1
4613965|NCT01718483|7471265|FG001|Overall Study|Other|4
4613966|NCT01718483|7471264|FG000|Overall Study|Pregnancy|1
4613967|NCT01718483|7471265|FG001|Overall Study|Pregnancy|1
4613968|NCT01718483|7471264|FG000|Overall Study|Lack of Efficacy|1
4613969|NCT01718483|7471265|FG001|Overall Study|Lack of Efficacy|0
4613970|NCT01718509|7471273|FG000|Overall Study|Lost to Follow-up|18
4613971|NCT01718509|7471274|FG001|Overall Study|Lost to Follow-up|15
4613972|NCT01718509|7471273|FG000|Overall Study|Withdrawal by Subject|7
4613973|NCT01718509|7471274|FG001|Overall Study|Withdrawal by Subject|13
4613974|NCT01718509|7471273|FG000|Overall Study|Adverse Event|5
4613975|NCT01718509|7471274|FG001|Overall Study|Adverse Event|7
4613976|NCT01718509|7471273|FG000|Overall Study|Other|13
4613977|NCT01718509|7471274|FG001|Overall Study|Other|11
4613978|NCT01718509|7471273|FG000|Overall Study|Protocol Violation|4
4613979|NCT01718509|7471274|FG001|Overall Study|Protocol Violation|2
4613980|NCT01718509|7471273|FG000|Overall Study|Lack of Efficacy|1
4613981|NCT01718509|7471274|FG001|Overall Study|Lack of Efficacy|0
4613982|NCT01718535|7471297|FG000|Overall Study|Bidirectional Sequencing not possible|1
4613983|NCT01718535|7471298|FG001|Overall Study|Bidirectional Sequencing not possible|0
4613984|NCT01718535|7471299|FG002|Overall Study|Bidirectional Sequencing not possible|0
4613985|NCT01718535|7471300|FG003|Overall Study|Bidirectional Sequencing not possible|1
4613986|NCT01718535|7471301|FG004|Overall Study|Bidirectional Sequencing not possible|0
4613987|NCT01718535|7471302|FG005|Overall Study|Bidirectional Sequencing not possible|0
4613988|NCT01718535|7471303|FG006|Overall Study|Bidirectional Sequencing not possible|0
4613989|NCT01718535|7471304|FG007|Overall Study|Bidirectional Sequencing not possible|0
4613990|NCT01718535|7471305|FG008|Overall Study|Bidirectional Sequencing not possible|0
4613991|NCT01718535|7471306|FG009|Overall Study|Bidirectional Sequencing not possible|0
4613992|NCT01719003|7471350|FG000|Overall Study|Non compliant with protocol|1
4460751|NCT00576472|7249333|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
4460752|NCT00576472|7249334|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
4613993|NCT01719003|7471351|FG001|Overall Study|Non compliant with protocol|1
4613994|NCT01719003|7471352|FG002|Overall Study|Non compliant with protocol|0
4613995|NCT01719003|7471353|FG003|Overall Study|Non compliant with protocol|1
4613996|NCT01719003|7471354|FG004|Overall Study|Non compliant with protocol|2
4613997|NCT01719003|7471355|FG005|Overall Study|Non compliant with protocol|1
4613998|NCT01719003|7471356|FG006|Overall Study|Non compliant with protocol|2
4613999|NCT01719003|7471357|FG007|Overall Study|Non compliant with protocol|3
4614000|NCT01719003|7471358|FG008|Overall Study|Non compliant with protocol|0
4614001|NCT01719003|7471350|FG000|Overall Study|Adverse Event|6
4614002|NCT01719003|7471351|FG001|Overall Study|Adverse Event|5
4614003|NCT01719003|7471352|FG002|Overall Study|Adverse Event|4
4614004|NCT01719003|7471353|FG003|Overall Study|Adverse Event|3
4614005|NCT01719003|7471354|FG004|Overall Study|Adverse Event|4
4614006|NCT01719003|7471355|FG005|Overall Study|Adverse Event|3
4614007|NCT01719003|7471356|FG006|Overall Study|Adverse Event|6
4614008|NCT01719003|7471357|FG007|Overall Study|Adverse Event|5
4614009|NCT01719003|7471358|FG008|Overall Study|Adverse Event|0
4614010|NCT01719003|7471350|FG000|Overall Study|Lost to Follow-up|0
4614011|NCT01719003|7471351|FG001|Overall Study|Lost to Follow-up|6
4614012|NCT01719003|7471352|FG002|Overall Study|Lost to Follow-up|7
4614013|NCT01719003|7471353|FG003|Overall Study|Lost to Follow-up|2
4614014|NCT01719003|7471354|FG004|Overall Study|Lost to Follow-up|3
4614015|NCT01719003|7471355|FG005|Overall Study|Lost to Follow-up|4
4614016|NCT01719003|7471356|FG006|Overall Study|Lost to Follow-up|3
4614017|NCT01719003|7471357|FG007|Overall Study|Lost to Follow-up|2
4614018|NCT01719003|7471358|FG008|Overall Study|Lost to Follow-up|2
4614019|NCT01719003|7471350|FG000|Overall Study|Refusal to continue, not due to AE|2
4614020|NCT01719003|7471351|FG001|Overall Study|Refusal to continue, not due to AE|5
4614021|NCT01719003|7471352|FG002|Overall Study|Refusal to continue, not due to AE|4
4614022|NCT01719003|7471353|FG003|Overall Study|Refusal to continue, not due to AE|4
4614023|NCT01719003|7471354|FG004|Overall Study|Refusal to continue, not due to AE|4
4614024|NCT01719003|7471355|FG005|Overall Study|Refusal to continue, not due to AE|3
4614025|NCT01719003|7471356|FG006|Overall Study|Refusal to continue, not due to AE|8
4614026|NCT01719003|7471357|FG007|Overall Study|Refusal to continue, not due to AE|7
4614027|NCT01719003|7471358|FG008|Overall Study|Refusal to continue, not due to AE|1
4614028|NCT01719003|7471350|FG000|Overall Study|Reason other than those specified|0
4614029|NCT01719003|7471351|FG001|Overall Study|Reason other than those specified|0
4614030|NCT01719003|7471352|FG002|Overall Study|Reason other than those specified|2
4614031|NCT01719003|7471353|FG003|Overall Study|Reason other than those specified|3
4614032|NCT01719003|7471354|FG004|Overall Study|Reason other than those specified|4
4614033|NCT01719003|7471355|FG005|Overall Study|Reason other than those specified|1
4614034|NCT01719003|7471356|FG006|Overall Study|Reason other than those specified|0
4614035|NCT01719003|7471357|FG007|Overall Study|Reason other than those specified|3
4614036|NCT01719003|7471358|FG008|Overall Study|Reason other than those specified|1
4614037|NCT01719003|7471350|FG000|Overall Study|Lack of Efficacy|0
4614038|NCT01719003|7471351|FG001|Overall Study|Lack of Efficacy|0
4614039|NCT01719003|7471352|FG002|Overall Study|Lack of Efficacy|0
4614040|NCT01719003|7471353|FG003|Overall Study|Lack of Efficacy|0
4614041|NCT01719003|7471354|FG004|Overall Study|Lack of Efficacy|0
4614042|NCT01719003|7471355|FG005|Overall Study|Lack of Efficacy|0
4614043|NCT01719003|7471356|FG006|Overall Study|Lack of Efficacy|1
4614044|NCT01719003|7471357|FG007|Overall Study|Lack of Efficacy|0
4614045|NCT01719003|7471358|FG008|Overall Study|Lack of Efficacy|0
4614046|NCT01719172|7471377|FG000|Overall Study|Lost to Follow-up|1
4614047|NCT01719172|7471377|FG000|Overall Study|Death|1
4614048|NCT01719224|7471381|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4
4614049|NCT01719224|7471382|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2
4614050|NCT01719380|7471408|FG000|Overall Study|Adverse Event|0
4614051|NCT01719380|7471409|FG001|Overall Study|Adverse Event|0
4614052|NCT01719380|7471410|FG002|Overall Study|Adverse Event|1
4614053|NCT01719380|7471411|FG003|Overall Study|Adverse Event|2
4614054|NCT01719380|7471412|FG004|Overall Study|Adverse Event|0
4614055|NCT01719380|7471413|FG005|Overall Study|Adverse Event|1
4614056|NCT01719380|7471414|FG006|Overall Study|Adverse Event|0
4614057|NCT01719380|7471415|FG007|Overall Study|Adverse Event|1
4614058|NCT01719380|7471416|FG008|Overall Study|Adverse Event|4
4614059|NCT01719380|7471417|FG009|Overall Study|Adverse Event|3
4614060|NCT01719380|7471408|FG000|Overall Study|Death|0
4614061|NCT01719380|7471409|FG001|Overall Study|Death|1
4614062|NCT01719380|7471410|FG002|Overall Study|Death|0
4614063|NCT01719380|7471411|FG003|Overall Study|Death|0
4614064|NCT01719380|7471412|FG004|Overall Study|Death|0
4614065|NCT01719380|7471413|FG005|Overall Study|Death|0
4614066|NCT01719380|7471414|FG006|Overall Study|Death|0
4614067|NCT01719380|7471415|FG007|Overall Study|Death|0
4614068|NCT01719380|7471416|FG008|Overall Study|Death|3
4614069|NCT01719380|7471417|FG009|Overall Study|Death|3
4614070|NCT01719380|7471408|FG000|Overall Study|Participant/Guardian Decision|0
4614071|NCT01719380|7471409|FG001|Overall Study|Participant/Guardian Decision|0
4614072|NCT01719380|7471410|FG002|Overall Study|Participant/Guardian Decision|1
4614073|NCT01719380|7471411|FG003|Overall Study|Participant/Guardian Decision|0
4632735|NCT01904058|7502498|FG003|Overall Study|Pregnancy|1
4460753|NCT00576472|7249335|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
4460754|NCT00576472|7249336|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
4460755|NCT00576472|7249337|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
4460756|NCT00576472|7249323|FG000|MPH In-Lab Phase|No attention/academic problems|0
4614074|NCT01719380|7471412|FG004|Overall Study|Participant/Guardian Decision|0
4614075|NCT01719380|7471413|FG005|Overall Study|Participant/Guardian Decision|0
4614076|NCT01719380|7471414|FG006|Overall Study|Participant/Guardian Decision|0
4614077|NCT01719380|7471415|FG007|Overall Study|Participant/Guardian Decision|0
4614078|NCT01719380|7471416|FG008|Overall Study|Participant/Guardian Decision|2
4614079|NCT01719380|7471417|FG009|Overall Study|Participant/Guardian Decision|2
4614080|NCT01719380|7471408|FG000|Overall Study|Physician Decision|0
4614081|NCT01719380|7471409|FG001|Overall Study|Physician Decision|0
4614082|NCT01719380|7471410|FG002|Overall Study|Physician Decision|2
4614083|NCT01719380|7471411|FG003|Overall Study|Physician Decision|0
4614084|NCT01719380|7471412|FG004|Overall Study|Physician Decision|0
4614085|NCT01719380|7471413|FG005|Overall Study|Physician Decision|0
4614086|NCT01719380|7471414|FG006|Overall Study|Physician Decision|0
4614087|NCT01719380|7471415|FG007|Overall Study|Physician Decision|0
4614088|NCT01719380|7471416|FG008|Overall Study|Physician Decision|1
4614089|NCT01719380|7471417|FG009|Overall Study|Physician Decision|1
4614090|NCT01719380|7471408|FG000|Overall Study|Lack of Efficacy|2
4614091|NCT01719380|7471409|FG001|Overall Study|Lack of Efficacy|6
4614092|NCT01719380|7471410|FG002|Overall Study|Lack of Efficacy|5
4614093|NCT01719380|7471411|FG003|Overall Study|Lack of Efficacy|6
4614094|NCT01719380|7471412|FG004|Overall Study|Lack of Efficacy|3
4614095|NCT01719380|7471413|FG005|Overall Study|Lack of Efficacy|7
4614096|NCT01719380|7471414|FG006|Overall Study|Lack of Efficacy|10
4614097|NCT01719380|7471415|FG007|Overall Study|Lack of Efficacy|6
4614098|NCT01719380|7471416|FG008|Overall Study|Lack of Efficacy|39
4614099|NCT01719380|7471417|FG009|Overall Study|Lack of Efficacy|42
4614100|NCT01719380|7471408|FG000|Overall Study|Progressive Disease|0
4614101|NCT01719380|7471409|FG001|Overall Study|Progressive Disease|0
4614102|NCT01719380|7471410|FG002|Overall Study|Progressive Disease|0
4614103|NCT01719380|7471411|FG003|Overall Study|Progressive Disease|0
4614104|NCT01719380|7471412|FG004|Overall Study|Progressive Disease|0
4614105|NCT01719380|7471413|FG005|Overall Study|Progressive Disease|0
4614106|NCT01719380|7471414|FG006|Overall Study|Progressive Disease|0
4614107|NCT01719380|7471415|FG007|Overall Study|Progressive Disease|0
4614108|NCT01719380|7471416|FG008|Overall Study|Progressive Disease|1
4614109|NCT01719380|7471417|FG009|Overall Study|Progressive Disease|0
4614110|NCT01719757|7471471|FG000|Overall Study|Adverse Event|38
4614111|NCT01719757|7471471|FG000|Overall Study|Withdrawal by Subject|15
4614112|NCT01719757|7471471|FG000|Overall Study|Lost to Follow-up|20
4614113|NCT01719757|7471471|FG000|Overall Study|Protocol Violation|1
4614114|NCT01719757|7471471|FG000|Overall Study|well controlled pain|27
4614115|NCT01719783|7471479|FG000|Dose 2|Physician Decision|1
4614116|NCT01719783|7471480|FG001|Dose 2|Physician Decision|0
4614117|NCT01719861|7471506|FG000|Cycle 1|Death|4
4614118|NCT01719861|7471506|FG000|Cycle 2|Death|1
4614119|NCT01720043|7471520|FG000|Overall Study|Withdrawal by Subject|1
4614120|NCT01720069|7471527|FG000|Overall Study|Could not use e-diary correctly|0
4614121|NCT01720069|7471528|FG001|Overall Study|Could not use e-diary correctly|1
4614122|NCT01720069|7471529|FG002|Overall Study|Could not use e-diary correctly|1
4614123|NCT01720069|7471527|FG000|Overall Study|Randomised without baseline values|0
4614124|NCT01720069|7471528|FG001|Overall Study|Randomised without baseline values|0
4614125|NCT01720069|7471529|FG002|Overall Study|Randomised without baseline values|1
4614126|NCT01720069|7471527|FG000|Overall Study|Adverse Event|0
4614127|NCT01720069|7471528|FG001|Overall Study|Adverse Event|0
4614128|NCT01720069|7471529|FG002|Overall Study|Adverse Event|1
4614129|NCT01720069|7471527|FG000|Overall Study|Lack of Efficacy|0
4614130|NCT01720069|7471528|FG001|Overall Study|Lack of Efficacy|4
4614131|NCT01720069|7471529|FG002|Overall Study|Lack of Efficacy|0
4614132|NCT01720069|7471527|FG000|Overall Study|Treatment period withdrawal criteria met|4
4614133|NCT01720069|7471528|FG001|Overall Study|Treatment period withdrawal criteria met|8
4614134|NCT01720069|7471529|FG002|Overall Study|Treatment period withdrawal criteria met|9
4614135|NCT01720069|7471527|FG000|Overall Study|Withdrawal by Subject|0
4614136|NCT01720069|7471528|FG001|Overall Study|Withdrawal by Subject|2
4614137|NCT01720069|7471529|FG002|Overall Study|Withdrawal by Subject|1
4614138|NCT01720069|7471527|FG000|Overall Study|OCS bursts occured, discontinued in line|1
4614139|NCT01720069|7471528|FG001|Overall Study|OCS bursts occured, discontinued in line|0
4460757|NCT00576472|7249324|FG001|MPH In-Lab Phase|No attention/academic problems|0
4614140|NCT01720069|7471529|FG002|Overall Study|OCS bursts occured, discontinued in line|0
4614141|NCT01720069|7471527|FG000|Overall Study|Non-compliance on using e-diary|0
4614142|NCT01720069|7471528|FG001|Overall Study|Non-compliance on using e-diary|0
4614143|NCT01720069|7471529|FG002|Overall Study|Non-compliance on using e-diary|1
4614144|NCT01720069|7471527|FG000|Overall Study|Lost to Follow-up|0
4614145|NCT01720069|7471528|FG001|Overall Study|Lost to Follow-up|0
4614146|NCT01720069|7471529|FG002|Overall Study|Lost to Follow-up|1
4614147|NCT01720225|7471543|FG000|Overall Study|Withdrawal by Subject|0
4614148|NCT01720225|7471544|FG001|Overall Study|Withdrawal by Subject|1
4614149|NCT01720225|7471543|FG000|Overall Study|Did not complete 2 cycles of therapy|3
4614150|NCT01720225|7471544|FG001|Overall Study|Did not complete 2 cycles of therapy|0
4614151|NCT01720264|7471563|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1
4614152|NCT01720264|7471563|FG000|Post-transplant (Day 16) to 1 Year|Death|8
4614153|NCT01720264|7471563|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4
4614154|NCT01720446|7471617|FG000|Overall Study|Lost to Follow-up|12
4614155|NCT01720446|7471618|FG001|Overall Study|Lost to Follow-up|6
4614156|NCT01720446|7471619|FG002|Overall Study|Lost to Follow-up|16
4614157|NCT01720446|7471620|FG003|Overall Study|Lost to Follow-up|16
4614158|NCT01720446|7471617|FG000|Overall Study|Withdrawal by Subject|2
4614159|NCT01720446|7471618|FG001|Overall Study|Withdrawal by Subject|5
4614160|NCT01720446|7471619|FG002|Overall Study|Withdrawal by Subject|4
4614161|NCT01720446|7471620|FG003|Overall Study|Withdrawal by Subject|4
4614162|NCT01720524|7471635|FG000|Part A|Insufficient Clinical Response|2
4614163|NCT01720524|7471636|FG001|Part A|Insufficient Clinical Response|4
4614164|NCT01720524|7471635|FG000|Part A|Adverse Event|2
4614165|NCT01720524|7471636|FG001|Part A|Adverse Event|2
4614166|NCT01720524|7471635|FG000|Part A|Death|2
4614167|NCT01720524|7471636|FG001|Part A|Death|1
4614168|NCT01720524|7471635|FG000|Part A|Lost to Follow-up|0
4614169|NCT01720524|7471636|FG001|Part A|Lost to Follow-up|1
4614170|NCT01720524|7471635|FG000|Part A|Missed 28 day follow-up visit|1
4614171|NCT01720524|7471636|FG001|Part A|Missed 28 day follow-up visit|1
4614172|NCT01720524|7471635|FG000|Part A|Withdrawal by Subject|0
4614173|NCT01720524|7471636|FG001|Part A|Withdrawal by Subject|1
4614174|NCT01720524|7471635|FG000|Part A|Other|0
4614175|NCT01720524|7471636|FG001|Part A|Other|1
4614176|NCT01720524|7471635|FG000|Part A|Lost to Follow-up|0
4614177|NCT01720524|7471636|FG001|Part A|Lost to Follow-up|1
4614178|NCT01720524|7471635|FG000|Part B|No longer willing to participate in study|1
4614179|NCT01720524|7471636|FG001|Part B|No longer willing to participate in study|4
4614180|NCT01720524|7471635|FG000|Part B|Other|2
4614181|NCT01720524|7471636|FG001|Part B|Other|0
4614182|NCT01720524|7471635|FG000|Part B|Lost to Follow-up|2
4614183|NCT01720524|7471636|FG001|Part B|Lost to Follow-up|3
4614184|NCT01720524|7471635|FG000|Part B|Death|0
4614185|NCT01720524|7471636|FG001|Part B|Death|2
4614186|NCT01720602|7471644|FG000|Overall Study|Adverse Event|3
4614187|NCT01720602|7471644|FG000|Overall Study|Progressive disease on therapy|2
4614188|NCT01720667|7471650|FG000|Overall Study|Adverse Event|1
4614189|NCT01720667|7471651|FG001|Overall Study|Adverse Event|1
4614190|NCT01720667|7471650|FG000|Overall Study|Withdrawal by Subject|3
4614191|NCT01720667|7471651|FG001|Overall Study|Withdrawal by Subject|0
4614192|NCT01720797|7471661|FG000|Overall Study|Withdrawal by Subject|3
4614193|NCT01720797|7471662|FG001|Overall Study|Withdrawal by Subject|0
4614194|NCT01721044|7471671|FG000|Treatment Period|Adverse Event|7
4614195|NCT01721044|7471672|FG001|Treatment Period|Adverse Event|7
4614196|NCT01721044|7471673|FG002|Treatment Period|Adverse Event|10
4614197|NCT01721044|7471671|FG000|Treatment Period|Death|0
4614198|NCT01721044|7471672|FG001|Treatment Period|Death|0
4614199|NCT01721044|7471673|FG002|Treatment Period|Death|1
4614200|NCT01721044|7471671|FG000|Treatment Period|Lack of Efficacy|16
4614201|NCT01721044|7471672|FG001|Treatment Period|Lack of Efficacy|4
4614202|NCT01721044|7471673|FG002|Treatment Period|Lack of Efficacy|4
4614203|NCT01721044|7471671|FG000|Treatment Period|Lost to Follow-up|0
4614204|NCT01721044|7471672|FG001|Treatment Period|Lost to Follow-up|0
4614205|NCT01721044|7471673|FG002|Treatment Period|Lost to Follow-up|1
4614206|NCT01721044|7471671|FG000|Treatment Period|Physician Decision|1
4614207|NCT01721044|7471672|FG001|Treatment Period|Physician Decision|0
4614208|NCT01721044|7471673|FG002|Treatment Period|Physician Decision|2
4614209|NCT01721044|7471671|FG000|Treatment Period|Protocol Violation|1
4614210|NCT01721044|7471672|FG001|Treatment Period|Protocol Violation|0
4614211|NCT01721044|7471673|FG002|Treatment Period|Protocol Violation|0
4614212|NCT01721044|7471671|FG000|Treatment Period|Withdrawal by Subject|7
4614213|NCT01721044|7471672|FG001|Treatment Period|Withdrawal by Subject|6
4614214|NCT01721044|7471673|FG002|Treatment Period|Withdrawal by Subject|1
4614215|NCT01721057|7471695|FG000|Treatment Period|Withdrawal by Subject|11
4614216|NCT01721057|7471696|FG001|Treatment Period|Withdrawal by Subject|5
4614217|NCT01721057|7471697|FG002|Treatment Period|Withdrawal by Subject|8
4614218|NCT01721057|7471698|FG003|Treatment Period|Withdrawal by Subject|0
4614219|NCT01721057|7471699|FG004|Treatment Period|Withdrawal by Subject|0
4614220|NCT01721057|7471700|FG005|Treatment Period|Withdrawal by Subject|0
4614221|NCT01721057|7471701|FG006|Treatment Period|Withdrawal by Subject|0
4614222|NCT01721057|7471695|FG000|Treatment Period|Adverse Event|7
4614223|NCT01721057|7471696|FG001|Treatment Period|Adverse Event|10
4614224|NCT01721057|7471697|FG002|Treatment Period|Adverse Event|12
4614225|NCT01721057|7471698|FG003|Treatment Period|Adverse Event|0
4614226|NCT01721057|7471699|FG004|Treatment Period|Adverse Event|0
4614227|NCT01721057|7471700|FG005|Treatment Period|Adverse Event|0
4614228|NCT01721057|7471701|FG006|Treatment Period|Adverse Event|0
4614229|NCT01721057|7471695|FG000|Treatment Period|Lack of Efficacy|7
4614230|NCT01721057|7471696|FG001|Treatment Period|Lack of Efficacy|3
4614231|NCT01721057|7471697|FG002|Treatment Period|Lack of Efficacy|0
4614232|NCT01721057|7471698|FG003|Treatment Period|Lack of Efficacy|0
4614233|NCT01721057|7471699|FG004|Treatment Period|Lack of Efficacy|0
4614234|NCT01721057|7471700|FG005|Treatment Period|Lack of Efficacy|0
4614235|NCT01721057|7471701|FG006|Treatment Period|Lack of Efficacy|0
4614236|NCT01721057|7471695|FG000|Treatment Period|Lost to Follow-up|1
4614237|NCT01721057|7471696|FG001|Treatment Period|Lost to Follow-up|0
4460758|NCT00576472|7249325|FG002|MPH In-Lab Phase|No attention/academic problems|0
4460759|NCT00576472|7249326|FG003|MPH In-Lab Phase|No attention/academic problems|245
4460760|NCT00576472|7249327|FG004|MPH In-Lab Phase|No attention/academic problems|0
4460761|NCT00576472|7249328|FG005|MPH In-Lab Phase|No attention/academic problems|0
4539423|NCT01125722|7361767|FG001|Overall Study|Withdrawal by Subject|1
4539424|NCT01125722|7361766|FG000|Overall Study|Lost to Follow-up|1
4539425|NCT01125722|7361767|FG001|Overall Study|Lost to Follow-up|0
4539426|NCT01125748|7361775|FG000|Overall Study|Adverse Event|0
4539427|NCT01125748|7361776|FG001|Overall Study|Adverse Event|2
4539428|NCT01125748|7361775|FG000|Overall Study|Lost to Follow-up|0
4614238|NCT01721057|7471697|FG002|Treatment Period|Lost to Follow-up|0
4614239|NCT01721057|7471698|FG003|Treatment Period|Lost to Follow-up|0
4614240|NCT01721057|7471699|FG004|Treatment Period|Lost to Follow-up|0
4614241|NCT01721057|7471700|FG005|Treatment Period|Lost to Follow-up|0
4614242|NCT01721057|7471701|FG006|Treatment Period|Lost to Follow-up|0
4614243|NCT01721057|7471695|FG000|Treatment Period|Physician Decision|0
4614244|NCT01721057|7471696|FG001|Treatment Period|Physician Decision|1
4614245|NCT01721057|7471697|FG002|Treatment Period|Physician Decision|3
4614246|NCT01721057|7471698|FG003|Treatment Period|Physician Decision|0
4614247|NCT01721057|7471699|FG004|Treatment Period|Physician Decision|0
4614248|NCT01721057|7471700|FG005|Treatment Period|Physician Decision|0
4614249|NCT01721057|7471701|FG006|Treatment Period|Physician Decision|0
4614250|NCT01721057|7471695|FG000|Treatment Period|Death|2
4614251|NCT01721057|7471696|FG001|Treatment Period|Death|0
4614252|NCT01721057|7471697|FG002|Treatment Period|Death|0
4614253|NCT01721057|7471698|FG003|Treatment Period|Death|0
4614254|NCT01721057|7471699|FG004|Treatment Period|Death|0
4614255|NCT01721057|7471700|FG005|Treatment Period|Death|0
4614256|NCT01721057|7471701|FG006|Treatment Period|Death|0
4614257|NCT01721057|7471695|FG000|Rescue Period|Adverse Event|0
4614258|NCT01721057|7471696|FG001|Rescue Period|Adverse Event|0
4614259|NCT01721057|7471697|FG002|Rescue Period|Adverse Event|0
4614260|NCT01721057|7471698|FG003|Rescue Period|Adverse Event|1
4614261|NCT01721057|7471699|FG004|Rescue Period|Adverse Event|0
4614262|NCT01721057|7471700|FG005|Rescue Period|Adverse Event|0
4614263|NCT01721057|7471701|FG006|Rescue Period|Adverse Event|0
4614264|NCT01721057|7471695|FG000|Rescue Period|Lack of Efficacy|0
4614265|NCT01721057|7471696|FG001|Rescue Period|Lack of Efficacy|0
4614266|NCT01721057|7471697|FG002|Rescue Period|Lack of Efficacy|0
4614267|NCT01721057|7471698|FG003|Rescue Period|Lack of Efficacy|2
4614268|NCT01721057|7471699|FG004|Rescue Period|Lack of Efficacy|0
4614269|NCT01721057|7471700|FG005|Rescue Period|Lack of Efficacy|0
4614270|NCT01721057|7471701|FG006|Rescue Period|Lack of Efficacy|0
4614271|NCT01721070|7471728|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1
4614272|NCT01721109|7471746|FG000|Overall Study|Lack of Efficacy|1
4614273|NCT01721109|7471746|FG000|Overall Study|Non- Compliance with Study Drug|3
4614274|NCT01721109|7471746|FG000|Overall Study|Withdrew Consent|1
4614275|NCT01721109|7471746|FG000|Overall Study|Lost to Follow-up|2
4614276|NCT01721161|7471752|FG000|Overall Study|Adverse Event|2
4614277|NCT01721161|7471753|FG001|Overall Study|Adverse Event|3
4614278|NCT01721161|7471752|FG000|Overall Study|Lost to Follow-up|1
4614279|NCT01721161|7471753|FG001|Overall Study|Lost to Follow-up|2
4614280|NCT01721161|7471752|FG000|Overall Study|Withdrawal by Subject|1
4614281|NCT01721161|7471753|FG001|Overall Study|Withdrawal by Subject|1
4614282|NCT01721161|7471752|FG000|Overall Study|Other|0
4614283|NCT01721161|7471753|FG001|Overall Study|Other|1
4614284|NCT01721200|7471762|FG000|Overall Study|Lost to Follow-up|3
4614285|NCT01721200|7471763|FG001|Overall Study|Lost to Follow-up|5
4614286|NCT01721317|7471785|FG000|Overall Study|Study Closed / Terminated|2
4614287|NCT01721317|7471786|FG001|Overall Study|Study Closed / Terminated|2
4614288|NCT01721317|7471785|FG000|Overall Study|Physician Decision|0
4614289|NCT01721317|7471786|FG001|Overall Study|Physician Decision|1
4614290|NCT01721317|7471785|FG000|Overall Study|Withdrawal by Subject|0
4614291|NCT01721317|7471786|FG001|Overall Study|Withdrawal by Subject|1
4614292|NCT01721330|7471794|FG000|Overall Study|Withdrawal by Subject|0
4614293|NCT01721330|7471795|FG001|Overall Study|Withdrawal by Subject|1
4614294|NCT01721369|7471801|FG000|Overall Study|Not initial etiological diagnosis|12
4460762|NCT00576472|7249329|FG006|MPH In-Lab Phase|No attention/academic problems|0
4460763|NCT00576472|7249330|FG007|MPH In-Lab Phase|No attention/academic problems|0
4460764|NCT00576472|7249331|FG008|MPH In-Lab Phase|No attention/academic problems|0
4460765|NCT00576472|7249332|FG009|MPH In-Lab Phase|No attention/academic problems|0
4539429|NCT01125748|7361776|FG001|Overall Study|Lost to Follow-up|1
4539430|NCT01125748|7361775|FG000|Overall Study|Physician Decision|8
4539431|NCT01125748|7361776|FG001|Overall Study|Physician Decision|7
4539432|NCT01125748|7361775|FG000|Overall Study|Patient Decision to Withdraw|2
4539433|NCT01125748|7361776|FG001|Overall Study|Patient Decision to Withdraw|4
4614295|NCT01721408|7471807|FG000|Overall Study|Adverse Event|6
4614296|NCT01721408|7471808|FG001|Overall Study|Adverse Event|1
4614297|NCT01721408|7471807|FG000|Overall Study|Death|1
4614298|NCT01721408|7471808|FG001|Overall Study|Death|0
4614299|NCT01721408|7471807|FG000|Overall Study|Insufficient clinical response|15
4614300|NCT01721408|7471808|FG001|Overall Study|Insufficient clinical response|6
4614301|NCT01721408|7471807|FG000|Overall Study|No longer willing to participate study|9
4614302|NCT01721408|7471808|FG001|Overall Study|No longer willing to participate study|10
4539434|NCT01125800|7361798|FG000|Phase I|Protocol Violation|0
4539435|NCT01125800|7361799|FG001|Phase I|Protocol Violation|3
4539436|NCT01125800|7361800|FG002|Phase I|Protocol Violation|1
4539437|NCT01125800|7361801|FG003|Phase I|Protocol Violation|1
4539438|NCT01125800|7361802|FG004|Phase I|Protocol Violation|0
4539439|NCT01125800|7361798|FG000|Phase I|Adverse Event|2
4539440|NCT01125800|7361799|FG001|Phase I|Adverse Event|2
4539441|NCT01125800|7361800|FG002|Phase I|Adverse Event|1
4539442|NCT01125800|7361801|FG003|Phase I|Adverse Event|7
4539443|NCT01125800|7361802|FG004|Phase I|Adverse Event|0
4614303|NCT01721408|7471807|FG000|Overall Study|Protocol Violation|0
4460766|NCT00576472|7249333|FG010|MPH In-Lab Phase|No attention/academic problems|0
4460767|NCT00576472|7249334|FG011|MPH In-Lab Phase|No attention/academic problems|0
4460768|NCT00576472|7249335|FG012|MPH In-Lab Phase|No attention/academic problems|0
4460769|NCT00576472|7249336|FG013|MPH In-Lab Phase|No attention/academic problems|0
4460770|NCT00576472|7249337|FG014|MPH In-Lab Phase|No attention/academic problems|0
4460771|NCT00576472|7249323|FG000|MPH In-Lab Phase|Psychiatric exclusion|0
4460772|NCT00576472|7249324|FG001|MPH In-Lab Phase|Psychiatric exclusion|0
4460773|NCT00576472|7249325|FG002|MPH In-Lab Phase|Psychiatric exclusion|0
4460774|NCT00576472|7249326|FG003|MPH In-Lab Phase|Psychiatric exclusion|10
4460775|NCT00576472|7249327|FG004|MPH In-Lab Phase|Psychiatric exclusion|0
4460776|NCT00576472|7249328|FG005|MPH In-Lab Phase|Psychiatric exclusion|0
4460777|NCT00576472|7249329|FG006|MPH In-Lab Phase|Psychiatric exclusion|0
4460778|NCT00576472|7249330|FG007|MPH In-Lab Phase|Psychiatric exclusion|0
4539444|NCT01125800|7361798|FG000|Phase I|Administrative problems|1
4539445|NCT01125800|7361799|FG001|Phase I|Administrative problems|0
4539446|NCT01125800|7361800|FG002|Phase I|Administrative problems|0
4614304|NCT01721408|7471808|FG001|Overall Study|Protocol Violation|2
4614305|NCT01721408|7471807|FG000|Overall Study|Other|3
4614306|NCT01721408|7471808|FG001|Overall Study|Other|3
4614307|NCT01721408|7471807|FG000|Overall Study|Lost to Follow-up|1
4614308|NCT01721408|7471808|FG001|Overall Study|Lost to Follow-up|2
4614309|NCT01721408|7471807|FG000|Overall Study|Does not meet entrance criteria|1
4614310|NCT01721408|7471808|FG001|Overall Study|Does not meet entrance criteria|0
4614311|NCT01721486|7471847|FG000|Overall Study|Protocol Violation|1
4614312|NCT01721486|7471848|FG001|Overall Study|Protocol Violation|0
4614313|NCT01721486|7471847|FG000|Overall Study|Physician Decision|0
4614314|NCT01721486|7471848|FG001|Overall Study|Physician Decision|1
4614315|NCT01721772|7471868|FG000|Overall Study|Disease progression|96
4614316|NCT01721772|7471869|FG001|Overall Study|Disease progression|175
4614317|NCT01721772|7471868|FG000|Overall Study|Study drug toxicity|5
4614318|NCT01721772|7471869|FG001|Overall Study|Study drug toxicity|7
4614319|NCT01721772|7471868|FG000|Overall Study|Unrelated adverse event|2
4614320|NCT01721772|7471869|FG001|Overall Study|Unrelated adverse event|3
4614321|NCT01721772|7471868|FG000|Overall Study|Withdrawal by Subject|7
4614322|NCT01721772|7471869|FG001|Overall Study|Withdrawal by Subject|5
4614323|NCT01721772|7471868|FG000|Overall Study|Maximum clinical benefit|1
4614324|NCT01721772|7471869|FG001|Overall Study|Maximum clinical benefit|1
4614325|NCT01721772|7471868|FG000|Overall Study|Other|0
4614326|NCT01721772|7471869|FG001|Overall Study|Other|1
4614327|NCT01721876|7471881|FG000|Overall Study|Not treated|1
4614328|NCT01721876|7471882|FG001|Overall Study|Not treated|4
4614329|NCT01721876|7471881|FG000|Overall Study|Disease progression / relapse|123
4614330|NCT01721876|7471882|FG001|Overall Study|Disease progression / relapse|156
4614331|NCT01721876|7471881|FG000|Overall Study|Death|6
4614332|NCT01721876|7471882|FG001|Overall Study|Death|13
4614333|NCT01721876|7471881|FG000|Overall Study|Adverse Event|41
4614334|NCT01721876|7471882|FG001|Overall Study|Adverse Event|165
4614335|NCT01721876|7471881|FG000|Overall Study|Protocol Violation|2
4614336|NCT01721876|7471882|FG001|Overall Study|Protocol Violation|1
4614337|NCT01721876|7471881|FG000|Overall Study|Withdrawal by Subject|15
4614338|NCT01721876|7471882|FG001|Overall Study|Withdrawal by Subject|38
4614339|NCT01721876|7471881|FG000|Overall Study|Reason not listed|34
4614340|NCT01721876|7471882|FG001|Overall Study|Reason not listed|63
4614341|NCT01721876|7471881|FG000|Overall Study|Sponsor terminated trial|0
4614342|NCT01721876|7471882|FG001|Overall Study|Sponsor terminated trial|4
4614343|NCT01721954|7471890|FG000|Overall Study|Death|58
4614344|NCT01721954|7471891|FG001|Overall Study|Death|64
4614345|NCT01721954|7471890|FG000|Overall Study|Withdrawal by Subject|8
4614346|NCT01721954|7471891|FG001|Overall Study|Withdrawal by Subject|4
4614347|NCT01721954|7471890|FG000|Overall Study|Adverse Event|2
4614348|NCT01721954|7471891|FG001|Overall Study|Adverse Event|0
4614349|NCT01721954|7471890|FG000|Overall Study|Lost to Follow-up|2
4614350|NCT01721954|7471891|FG001|Overall Study|Lost to Follow-up|1
4614351|NCT01722045|7471901|FG000|Overall Study|Adverse Event|8
4614352|NCT01722045|7471901|FG000|Overall Study|Death|3
4460779|NCT00576472|7249331|FG008|MPH In-Lab Phase|Psychiatric exclusion|0
4460780|NCT00576472|7249332|FG009|MPH In-Lab Phase|Psychiatric exclusion|0
4539447|NCT01125800|7361801|FG003|Phase I|Administrative problems|0
4539448|NCT01125800|7361802|FG004|Phase I|Administrative problems|0
4614353|NCT01722045|7471901|FG000|Overall Study|Withdrawal by Subject|8
4614354|NCT01722045|7471901|FG000|Overall Study|Lost to Follow-up|4
4614355|NCT01722045|7471901|FG000|Overall Study|Protocol Deviation|1
4614356|NCT01722045|7471901|FG000|Overall Study|Physician Decision|3
4614357|NCT01722045|7471901|FG000|Overall Study|Relocation (did not wish to transfer)|1
4614358|NCT01722071|7471905|FG000|Overall Study|Protocol Violation|1
4460781|NCT00576472|7249333|FG010|MPH In-Lab Phase|Psychiatric exclusion|0
4460782|NCT00576472|7249334|FG011|MPH In-Lab Phase|Psychiatric exclusion|0
4460783|NCT00576472|7249335|FG012|MPH In-Lab Phase|Psychiatric exclusion|0
4460784|NCT00576472|7249336|FG013|MPH In-Lab Phase|Psychiatric exclusion|0
4460785|NCT00576472|7249337|FG014|MPH In-Lab Phase|Psychiatric exclusion|0
4460786|NCT00576472|7249323|FG000|MPH Cross Over Phase|Withdrawal by Subject|0
4460787|NCT00576472|7249324|FG001|MPH Cross Over Phase|Withdrawal by Subject|0
4460788|NCT00576472|7249325|FG002|MPH Cross Over Phase|Withdrawal by Subject|0
4460789|NCT00576472|7249326|FG003|MPH Cross Over Phase|Withdrawal by Subject|0
4460790|NCT00576472|7249327|FG004|MPH Cross Over Phase|Withdrawal by Subject|0
4460791|NCT00576472|7249328|FG005|MPH Cross Over Phase|Withdrawal by Subject|0
4460792|NCT00576472|7249329|FG006|MPH Cross Over Phase|Withdrawal by Subject|6
4460793|NCT00576472|7249330|FG007|MPH Cross Over Phase|Withdrawal by Subject|0
4460794|NCT00576472|7249331|FG008|MPH Cross Over Phase|Withdrawal by Subject|0
4460795|NCT00576472|7249332|FG009|MPH Cross Over Phase|Withdrawal by Subject|0
4460796|NCT00576472|7249333|FG010|MPH Cross Over Phase|Withdrawal by Subject|0
4460797|NCT00576472|7249334|FG011|MPH Cross Over Phase|Withdrawal by Subject|0
4460798|NCT00576472|7249335|FG012|MPH Cross Over Phase|Withdrawal by Subject|0
4460799|NCT00576472|7249336|FG013|MPH Cross Over Phase|Withdrawal by Subject|0
4614359|NCT01722071|7471906|FG001|Overall Study|Protocol Violation|0
4614360|NCT01722097|7471914|FG000|Overall Study|Patient sheets not returned|6
4614361|NCT01722097|7471915|FG001|Overall Study|Patient sheets not returned|5
4614362|NCT01722162|7471923|FG000|Overall Study|Withdrawal by Subject|1
4614363|NCT01722162|7471924|FG001|Overall Study|Withdrawal by Subject|1
4614364|NCT01722162|7471923|FG000|Overall Study|Found ineligible|1
4614365|NCT01722162|7471924|FG001|Overall Study|Found ineligible|0
4614366|NCT01722162|7471923|FG000|Overall Study|Unrelated to study adverse event|2
4614367|NCT01722162|7471924|FG001|Overall Study|Unrelated to study adverse event|2
4614368|NCT01722162|7471923|FG000|Overall Study|Adverse Event|1
4614369|NCT01722162|7471924|FG001|Overall Study|Adverse Event|1
4614370|NCT01722162|7471923|FG000|Overall Study|Insurance denial post enrollment|0
4614371|NCT01722162|7471924|FG001|Overall Study|Insurance denial post enrollment|1
4614372|NCT01722162|7471923|FG000|Overall Study|Noncompliance|0
4614373|NCT01722162|7471924|FG001|Overall Study|Noncompliance|1
4614374|NCT01722266|7471934|FG000|Overall Study|Withdrawal by Subject|1
4614375|NCT01722266|7471935|FG001|Overall Study|Withdrawal by Subject|2
4614376|NCT01722266|7471936|FG002|Overall Study|Withdrawal by Subject|0
4614377|NCT01722266|7471937|FG003|Overall Study|Withdrawal by Subject|0
4614378|NCT01722266|7471934|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0
4614379|NCT01722266|7471935|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1
4614380|NCT01722266|7471936|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3
4614381|NCT01722266|7471937|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0
4614382|NCT01722266|7471934|FG000|Overall Study|Dropped out due to Nausea|0
4614383|NCT01722266|7471935|FG001|Overall Study|Dropped out due to Nausea|0
4614384|NCT01722266|7471936|FG002|Overall Study|Dropped out due to Nausea|2
4614385|NCT01722266|7471937|FG003|Overall Study|Dropped out due to Nausea|0
4632736|NCT01904149|7502533|FG000|Overall Study|Adverse Event|3
4632737|NCT01904149|7502534|FG001|Overall Study|Adverse Event|4
4632738|NCT01904149|7502535|FG002|Overall Study|Adverse Event|0
4632739|NCT01904149|7502536|FG003|Overall Study|Adverse Event|1
4632740|NCT01904149|7502537|FG004|Overall Study|Adverse Event|1
4632741|NCT01904149|7502538|FG005|Overall Study|Adverse Event|2
4632742|NCT01904149|7502533|FG000|Overall Study|Lack of Efficacy|0
4632743|NCT01904149|7502534|FG001|Overall Study|Lack of Efficacy|3
4632744|NCT01904149|7502535|FG002|Overall Study|Lack of Efficacy|1
4632745|NCT01904149|7502536|FG003|Overall Study|Lack of Efficacy|3
4632746|NCT01904149|7502537|FG004|Overall Study|Lack of Efficacy|3
4632747|NCT01904149|7502538|FG005|Overall Study|Lack of Efficacy|1
4632748|NCT01904149|7502533|FG000|Overall Study|Withdrawal by Subject|1
4632749|NCT01904149|7502534|FG001|Overall Study|Withdrawal by Subject|3
4632750|NCT01904149|7502535|FG002|Overall Study|Withdrawal by Subject|1
4632751|NCT01904149|7502536|FG003|Overall Study|Withdrawal by Subject|0
4632752|NCT01904149|7502537|FG004|Overall Study|Withdrawal by Subject|1
4632753|NCT01904149|7502538|FG005|Overall Study|Withdrawal by Subject|0
4632754|NCT01904149|7502533|FG000|Overall Study|Protocol Violation|0
4632755|NCT01904149|7502534|FG001|Overall Study|Protocol Violation|1
4632756|NCT01904149|7502535|FG002|Overall Study|Protocol Violation|0
4632757|NCT01904149|7502536|FG003|Overall Study|Protocol Violation|0
4632758|NCT01904149|7502537|FG004|Overall Study|Protocol Violation|0
4632759|NCT01904149|7502538|FG005|Overall Study|Protocol Violation|0
4632760|NCT01904149|7502533|FG000|Overall Study|non compliance with study drug|1
4632761|NCT01904149|7502534|FG001|Overall Study|non compliance with study drug|0
4632762|NCT01904149|7502535|FG002|Overall Study|non compliance with study drug|0
4632763|NCT01904149|7502536|FG003|Overall Study|non compliance with study drug|0
4632764|NCT01904149|7502537|FG004|Overall Study|non compliance with study drug|0
4632765|NCT01904149|7502538|FG005|Overall Study|non compliance with study drug|0
4632766|NCT01904383|7502554|FG000|Overall Study|CRF not collected|117
4632767|NCT01904383|7502554|FG000|Overall Study|Reason not listed|147
4632768|NCT01904383|7502554|FG000|Overall Study|Lost to Follow-up|674
4632769|NCT01904383|7502554|FG000|Overall Study|Lack of Efficacy|370
4632770|NCT01904383|7502554|FG000|Overall Study|Improvement|141
4460800|NCT00576472|7249337|FG014|MPH Cross Over Phase|Withdrawal by Subject|0
4460801|NCT00576472|7249323|FG000|MPH Cross Over Phase|Ineligible due to disease|0
4460802|NCT00576472|7249324|FG001|MPH Cross Over Phase|Ineligible due to disease|0
4460803|NCT00576472|7249325|FG002|MPH Cross Over Phase|Ineligible due to disease|0
4460804|NCT00576472|7249326|FG003|MPH Cross Over Phase|Ineligible due to disease|0
4460805|NCT00576472|7249327|FG004|MPH Cross Over Phase|Ineligible due to disease|0
4460806|NCT00576472|7249328|FG005|MPH Cross Over Phase|Ineligible due to disease|0
4460807|NCT00576472|7249329|FG006|MPH Cross Over Phase|Ineligible due to disease|2
4460808|NCT00576472|7249330|FG007|MPH Cross Over Phase|Ineligible due to disease|0
4460809|NCT00576472|7249331|FG008|MPH Cross Over Phase|Ineligible due to disease|0
4460810|NCT00576472|7249332|FG009|MPH Cross Over Phase|Ineligible due to disease|0
4460811|NCT00576472|7249333|FG010|MPH Cross Over Phase|Ineligible due to disease|0
4460812|NCT00576472|7249334|FG011|MPH Cross Over Phase|Ineligible due to disease|0
4460813|NCT00576472|7249335|FG012|MPH Cross Over Phase|Ineligible due to disease|0
4460814|NCT00576472|7249336|FG013|MPH Cross Over Phase|Ineligible due to disease|0
4614386|NCT01722669|7472046|FG000|Overall Study|Withdrawal by Subject|0
4614387|NCT01722669|7472047|FG001|Overall Study|Withdrawal by Subject|0
4614388|NCT01722669|7472048|FG002|Overall Study|Withdrawal by Subject|0
4614389|NCT01722669|7472049|FG003|Overall Study|Withdrawal by Subject|0
4614390|NCT01722669|7472050|FG004|Overall Study|Withdrawal by Subject|0
4614391|NCT01722669|7472051|FG005|Overall Study|Withdrawal by Subject|2
4614392|NCT01722877|7472084|FG000|Overall Study|Death|1
4614393|NCT01722877|7472084|FG000|Overall Study|Lost to Follow-up|1
4614394|NCT01722994|7472092|FG000|Overall Study|Missing data|25
4614395|NCT01722994|7472093|FG001|Overall Study|Missing data|17
4614396|NCT01723072|7472103|FG000|Overall Study|Withdrawal by Subject|7
4614397|NCT01723072|7472104|FG001|Overall Study|Withdrawal by Subject|13
4614398|NCT01723072|7472103|FG000|Overall Study|Discon for rescue medication after wk 24|0
4614399|NCT01723072|7472104|FG001|Overall Study|Discon for rescue medication after wk 24|5
4614400|NCT01723072|7472103|FG000|Overall Study|Other|4
4614401|NCT01723072|7472104|FG001|Overall Study|Other|3
4614402|NCT01723163|7472112|FG000|Treatment Phase|Withdrawal by Subject|14
4614403|NCT01723163|7472113|FG001|Treatment Phase|Withdrawal by Subject|6
4614404|NCT01723163|7472112|FG000|Treatment Phase|Withdrawal by PI|5
4614405|NCT01723163|7472113|FG001|Treatment Phase|Withdrawal by PI|1
4614406|NCT01723163|7472112|FG000|3-Month Follow-up|Withdrawal by Subject|1
4614407|NCT01723163|7472113|FG001|3-Month Follow-up|Withdrawal by Subject|0
4614408|NCT01723163|7472112|FG000|3-Month Follow-up|Unable to Contact|12
4614409|NCT01723163|7472113|FG001|3-Month Follow-up|Unable to Contact|19
4614410|NCT01723163|7472112|FG000|6-Month Follow-up|Death|1
4614411|NCT01723163|7472113|FG001|6-Month Follow-up|Death|0
4614412|NCT01723163|7472112|FG000|6-Month Follow-up|Unable to Contact|17
4614413|NCT01723163|7472113|FG001|6-Month Follow-up|Unable to Contact|15
4614414|NCT01723163|7472112|FG000|12-Month Follow-up|Death|1
4614415|NCT01723163|7472113|FG001|12-Month Follow-up|Death|0
4614416|NCT01723163|7472112|FG000|12-Month Follow-up|Unable to Contact|23
4614417|NCT01723163|7472113|FG001|12-Month Follow-up|Unable to Contact|28
4614418|NCT01723228|7472121|FG000|Overall Study|Adverse Event|2
4614419|NCT01723228|7472122|FG001|Overall Study|Adverse Event|6
4614420|NCT01723228|7472121|FG000|Overall Study|Withdrawal by Subject|2
4614421|NCT01723228|7472122|FG001|Overall Study|Withdrawal by Subject|1
4614422|NCT01723228|7472121|FG000|Overall Study|Protocol Violation|0
4614423|NCT01723228|7472122|FG001|Overall Study|Protocol Violation|2
4614424|NCT01723228|7472121|FG000|Overall Study|Lost to Follow-up|2
4614425|NCT01723228|7472122|FG001|Overall Study|Lost to Follow-up|1
4614426|NCT01723228|7472121|FG000|Overall Study|Other|2
4614427|NCT01723228|7472122|FG001|Overall Study|Other|1
4614428|NCT01723254|7472136|FG000|Overall Study|Conflict with work schedule|0
4614429|NCT01723254|7472137|FG001|Overall Study|Conflict with work schedule|0
4614430|NCT01723254|7472138|FG002|Overall Study|Conflict with work schedule|0
4614431|NCT01723254|7472139|FG003|Overall Study|Conflict with work schedule|0
4614432|NCT01723254|7472140|FG004|Overall Study|Conflict with work schedule|0
4614433|NCT01723254|7472141|FG005|Overall Study|Conflict with work schedule|0
4614434|NCT01723254|7472142|FG006|Overall Study|Conflict with work schedule|0
4614435|NCT01723254|7472143|FG007|Overall Study|Conflict with work schedule|1
4614436|NCT01723254|7472136|FG000|Overall Study|Personal issues|0
4614437|NCT01723254|7472137|FG001|Overall Study|Personal issues|0
4614438|NCT01723254|7472138|FG002|Overall Study|Personal issues|0
4614439|NCT01723254|7472139|FG003|Overall Study|Personal issues|0
4614440|NCT01723254|7472140|FG004|Overall Study|Personal issues|0
4614441|NCT01723254|7472141|FG005|Overall Study|Personal issues|1
4614442|NCT01723254|7472142|FG006|Overall Study|Personal issues|0
4614443|NCT01723254|7472143|FG007|Overall Study|Personal issues|0
4614444|NCT01723254|7472136|FG000|Overall Study|No longer have time to participate|0
4614445|NCT01723254|7472137|FG001|Overall Study|No longer have time to participate|0
4614446|NCT01723254|7472138|FG002|Overall Study|No longer have time to participate|0
4614447|NCT01723254|7472139|FG003|Overall Study|No longer have time to participate|1
4614448|NCT01723254|7472140|FG004|Overall Study|No longer have time to participate|0
4614449|NCT01723254|7472141|FG005|Overall Study|No longer have time to participate|0
4614450|NCT01723254|7472142|FG006|Overall Study|No longer have time to participate|0
4614451|NCT01723254|7472143|FG007|Overall Study|No longer have time to participate|0
4614452|NCT01723254|7472136|FG000|Overall Study|Move/Left to another country/city|0
4539449|NCT01125800|7361798|FG000|Phase I|Withdrawal by Subject|0
4614453|NCT01723254|7472137|FG001|Overall Study|Move/Left to another country/city|0
4614454|NCT01723254|7472138|FG002|Overall Study|Move/Left to another country/city|2
4614455|NCT01723254|7472139|FG003|Overall Study|Move/Left to another country/city|1
4614456|NCT01723254|7472140|FG004|Overall Study|Move/Left to another country/city|1
4614457|NCT01723254|7472141|FG005|Overall Study|Move/Left to another country/city|0
4614458|NCT01723254|7472142|FG006|Overall Study|Move/Left to another country/city|0
4614459|NCT01723254|7472143|FG007|Overall Study|Move/Left to another country/city|0
4614460|NCT01723254|7472136|FG000|Overall Study|Protocol Violation|0
4614461|NCT01723254|7472137|FG001|Overall Study|Protocol Violation|1
4614462|NCT01723254|7472138|FG002|Overall Study|Protocol Violation|0
4614463|NCT01723254|7472139|FG003|Overall Study|Protocol Violation|0
4614464|NCT01723254|7472140|FG004|Overall Study|Protocol Violation|0
4614465|NCT01723254|7472141|FG005|Overall Study|Protocol Violation|0
4614466|NCT01723254|7472142|FG006|Overall Study|Protocol Violation|0
4614467|NCT01723254|7472143|FG007|Overall Study|Protocol Violation|0
4614468|NCT01723254|7472136|FG000|Overall Study|Withdrawal by Subject|1
4614469|NCT01723254|7472137|FG001|Overall Study|Withdrawal by Subject|2
4614470|NCT01723254|7472138|FG002|Overall Study|Withdrawal by Subject|1
4614471|NCT01723254|7472139|FG003|Overall Study|Withdrawal by Subject|0
4614472|NCT01723254|7472140|FG004|Overall Study|Withdrawal by Subject|1
4614473|NCT01723254|7472141|FG005|Overall Study|Withdrawal by Subject|1
4614474|NCT01723254|7472142|FG006|Overall Study|Withdrawal by Subject|1
4614475|NCT01723254|7472143|FG007|Overall Study|Withdrawal by Subject|2
4614476|NCT01723397|7472172|FG000|Study Period 1|Protocol Violation|0
4614477|NCT01723397|7472173|FG001|Study Period 1|Protocol Violation|1
4614478|NCT01723397|7472172|FG000|Study Period 2|Protocol Violation|0
4614479|NCT01723397|7472173|FG001|Study Period 2|Protocol Violation|1
4614480|NCT01723826|7472236|FG000|Overall Study|Adverse Event|4
4614481|NCT01723826|7472237|FG001|Overall Study|Adverse Event|1
4614482|NCT01723826|7472238|FG002|Overall Study|Adverse Event|4
4614483|NCT01723826|7472239|FG003|Overall Study|Adverse Event|5
4614484|NCT01723826|7472236|FG000|Overall Study|Death according to AE eCRF|2
4614485|NCT01723826|7472237|FG001|Overall Study|Death according to AE eCRF|3
4614486|NCT01723826|7472238|FG002|Overall Study|Death according to AE eCRF|3
4614487|NCT01723826|7472239|FG003|Overall Study|Death according to AE eCRF|7
4614488|NCT01723826|7472236|FG000|Overall Study|Lost to Follow-up|1
4614489|NCT01723826|7472237|FG001|Overall Study|Lost to Follow-up|3
4614490|NCT01723826|7472238|FG002|Overall Study|Lost to Follow-up|1
4614491|NCT01723826|7472239|FG003|Overall Study|Lost to Follow-up|1
4614492|NCT01723826|7472236|FG000|Overall Study|Non-compliance|0
4614493|NCT01723826|7472237|FG001|Overall Study|Non-compliance|1
4614494|NCT01723826|7472238|FG002|Overall Study|Non-compliance|3
4614495|NCT01723826|7472239|FG003|Overall Study|Non-compliance|3
4614496|NCT01723826|7472236|FG000|Overall Study|Non-compliance With Study Drug|0
4614497|NCT01723826|7472237|FG001|Overall Study|Non-compliance With Study Drug|1
4614498|NCT01723826|7472238|FG002|Overall Study|Non-compliance With Study Drug|0
4614499|NCT01723826|7472239|FG003|Overall Study|Non-compliance With Study Drug|0
4614500|NCT01723826|7472236|FG000|Overall Study|Other Reason|8
4614501|NCT01723826|7472237|FG001|Overall Study|Other Reason|6
4614502|NCT01723826|7472238|FG002|Overall Study|Other Reason|12
4614503|NCT01723826|7472239|FG003|Overall Study|Other Reason|14
4614504|NCT01723826|7472236|FG000|Overall Study|Physician Decision|1
4614505|NCT01723826|7472237|FG001|Overall Study|Physician Decision|3
4614506|NCT01723826|7472238|FG002|Overall Study|Physician Decision|4
4614507|NCT01723826|7472239|FG003|Overall Study|Physician Decision|11
4614508|NCT01723826|7472236|FG000|Overall Study|Protocol Violation|1
4614509|NCT01723826|7472237|FG001|Overall Study|Protocol Violation|1
4614510|NCT01723826|7472238|FG002|Overall Study|Protocol Violation|3
4614511|NCT01723826|7472239|FG003|Overall Study|Protocol Violation|1
4614512|NCT01723826|7472236|FG000|Overall Study|Withdrawal by Subject|10
4614513|NCT01723826|7472237|FG001|Overall Study|Withdrawal by Subject|17
4539450|NCT01125800|7361799|FG001|Phase I|Withdrawal by Subject|0
4539451|NCT01125800|7361800|FG002|Phase I|Withdrawal by Subject|1
4539452|NCT01125800|7361801|FG003|Phase I|Withdrawal by Subject|0
4539453|NCT01125800|7361802|FG004|Phase I|Withdrawal by Subject|0
4539454|NCT01125800|7361798|FG000|Phase I|Disease progression|5
4539455|NCT01125800|7361799|FG001|Phase I|Disease progression|4
4539456|NCT01125800|7361800|FG002|Phase I|Disease progression|1
4539457|NCT01125800|7361801|FG003|Phase I|Disease progression|3
4539458|NCT01125800|7361802|FG004|Phase I|Disease progression|0
4539459|NCT01125800|7361798|FG000|Phase II|Protocol Violation|0
4539460|NCT01125800|7361799|FG001|Phase II|Protocol Violation|0
4539461|NCT01125800|7361800|FG002|Phase II|Protocol Violation|0
4614514|NCT01723826|7472238|FG002|Overall Study|Withdrawal by Subject|27
4614515|NCT01723826|7472239|FG003|Overall Study|Withdrawal by Subject|48
4539462|NCT01125800|7361801|FG003|Phase II|Protocol Violation|0
4539463|NCT01125800|7361802|FG004|Phase II|Protocol Violation|1
4539464|NCT01125800|7361798|FG000|Phase II|Adverse Event|0
4539465|NCT01125800|7361799|FG001|Phase II|Adverse Event|0
4539466|NCT01125800|7361800|FG002|Phase II|Adverse Event|0
4539467|NCT01125800|7361801|FG003|Phase II|Adverse Event|0
4539468|NCT01125800|7361802|FG004|Phase II|Adverse Event|2
4460815|NCT00576472|7249337|FG014|MPH Cross Over Phase|Ineligible due to disease|0
4460816|NCT00576472|7249323|FG000|MPH Cross Over Phase|Physician Decision|0
4460817|NCT00576472|7249324|FG001|MPH Cross Over Phase|Physician Decision|0
4460818|NCT00576472|7249325|FG002|MPH Cross Over Phase|Physician Decision|0
4460819|NCT00576472|7249326|FG003|MPH Cross Over Phase|Physician Decision|0
4460820|NCT00576472|7249327|FG004|MPH Cross Over Phase|Physician Decision|0
4460821|NCT00576472|7249328|FG005|MPH Cross Over Phase|Physician Decision|0
4460822|NCT00576472|7249329|FG006|MPH Cross Over Phase|Physician Decision|4
4460823|NCT00576472|7249330|FG007|MPH Cross Over Phase|Physician Decision|0
4460824|NCT00576472|7249331|FG008|MPH Cross Over Phase|Physician Decision|0
4460825|NCT00576472|7249332|FG009|MPH Cross Over Phase|Physician Decision|0
4460826|NCT00576472|7249333|FG010|MPH Cross Over Phase|Physician Decision|0
4460827|NCT00576472|7249334|FG011|MPH Cross Over Phase|Physician Decision|0
4460828|NCT00576472|7249335|FG012|MPH Cross Over Phase|Physician Decision|0
4460829|NCT00576472|7249336|FG013|MPH Cross Over Phase|Physician Decision|0
4460830|NCT00576472|7249337|FG014|MPH Cross Over Phase|Physician Decision|0
4460831|NCT00576472|7249323|FG000|MPH Cross Over Phase|Did not complete cross over phase|0
4460832|NCT00576472|7249324|FG001|MPH Cross Over Phase|Did not complete cross over phase|0
4460833|NCT00576472|7249325|FG002|MPH Cross Over Phase|Did not complete cross over phase|0
4460834|NCT00576472|7249326|FG003|MPH Cross Over Phase|Did not complete cross over phase|0
4460835|NCT00576472|7249327|FG004|MPH Cross Over Phase|Did not complete cross over phase|0
4460836|NCT00576472|7249328|FG005|MPH Cross Over Phase|Did not complete cross over phase|0
4460837|NCT00576472|7249329|FG006|MPH Cross Over Phase|Did not complete cross over phase|0
4460838|NCT00576472|7249330|FG007|MPH Cross Over Phase|Did not complete cross over phase|0
4460839|NCT00576472|7249331|FG008|MPH Cross Over Phase|Did not complete cross over phase|2
4460840|NCT00576472|7249332|FG009|MPH Cross Over Phase|Did not complete cross over phase|0
4460841|NCT00576472|7249333|FG010|MPH Cross Over Phase|Did not complete cross over phase|1
4460842|NCT00576472|7249334|FG011|MPH Cross Over Phase|Did not complete cross over phase|1
4460843|NCT00576472|7249335|FG012|MPH Cross Over Phase|Did not complete cross over phase|0
4460844|NCT00576472|7249336|FG013|MPH Cross Over Phase|Did not complete cross over phase|0
4460845|NCT00576472|7249337|FG014|MPH Cross Over Phase|Did not complete cross over phase|0
4460846|NCT00576472|7249323|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0
4460847|NCT00576472|7249324|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0
4460848|NCT00576472|7249325|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0
4460849|NCT00576472|7249326|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0
4460850|NCT00576472|7249327|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0
4460851|NCT00576472|7249328|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0
4460852|NCT00576472|7249329|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0
4460853|NCT00576472|7249330|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0
4460854|NCT00576472|7249331|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0
4460855|NCT00576472|7249332|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0
4460856|NCT00576472|7249333|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0
4460857|NCT00576472|7249334|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0
4460858|NCT00576472|7249335|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0
4460859|NCT00576472|7249336|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16
4460860|NCT00576472|7249337|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0
4460861|NCT00576472|7249323|FG000|MPH Home Maintenance Phase|Declined to participate|0
4460862|NCT00576472|7249324|FG001|MPH Home Maintenance Phase|Declined to participate|0
4460863|NCT00576472|7249325|FG002|MPH Home Maintenance Phase|Declined to participate|0
4460864|NCT00576472|7249326|FG003|MPH Home Maintenance Phase|Declined to participate|0
4460865|NCT00576472|7249327|FG004|MPH Home Maintenance Phase|Declined to participate|0
4460866|NCT00576472|7249328|FG005|MPH Home Maintenance Phase|Declined to participate|0
4460867|NCT00576472|7249329|FG006|MPH Home Maintenance Phase|Declined to participate|0
4460868|NCT00576472|7249330|FG007|MPH Home Maintenance Phase|Declined to participate|0
4539469|NCT01125800|7361798|FG000|Phase II|Disease progression|0
4539470|NCT01125800|7361799|FG001|Phase II|Disease progression|0
4460869|NCT00576472|7249331|FG008|MPH Home Maintenance Phase|Declined to participate|0
4460870|NCT00576472|7249332|FG009|MPH Home Maintenance Phase|Declined to participate|0
4460871|NCT00576472|7249333|FG010|MPH Home Maintenance Phase|Declined to participate|0
4460872|NCT00576472|7249334|FG011|MPH Home Maintenance Phase|Declined to participate|0
4460873|NCT00576472|7249335|FG012|MPH Home Maintenance Phase|Declined to participate|0
4539471|NCT01125800|7361800|FG002|Phase II|Disease progression|0
4539472|NCT01125800|7361801|FG003|Phase II|Disease progression|1
4460874|NCT00576472|7249336|FG013|MPH Home Maintenance Phase|Declined to participate|7
4460875|NCT00576472|7249337|FG014|MPH Home Maintenance Phase|Declined to participate|0
4460876|NCT00576472|7249323|FG000|MPH Home Maintenance Phase|Insufficient data|0
4460877|NCT00576472|7249324|FG001|MPH Home Maintenance Phase|Insufficient data|0
4460878|NCT00576472|7249325|FG002|MPH Home Maintenance Phase|Insufficient data|0
4460879|NCT00576472|7249326|FG003|MPH Home Maintenance Phase|Insufficient data|0
4460880|NCT00576472|7249327|FG004|MPH Home Maintenance Phase|Insufficient data|0
4460881|NCT00576472|7249328|FG005|MPH Home Maintenance Phase|Insufficient data|0
4460882|NCT00576472|7249329|FG006|MPH Home Maintenance Phase|Insufficient data|0
4460883|NCT00576472|7249330|FG007|MPH Home Maintenance Phase|Insufficient data|0
4460884|NCT00576472|7249331|FG008|MPH Home Maintenance Phase|Insufficient data|0
4460885|NCT00576472|7249332|FG009|MPH Home Maintenance Phase|Insufficient data|0
4460886|NCT00576472|7249333|FG010|MPH Home Maintenance Phase|Insufficient data|0
4460887|NCT00576472|7249334|FG011|MPH Home Maintenance Phase|Insufficient data|0
4460888|NCT00576472|7249335|FG012|MPH Home Maintenance Phase|Insufficient data|0
4460889|NCT00576472|7249336|FG013|MPH Home Maintenance Phase|Insufficient data|4
4460890|NCT00576472|7249337|FG014|MPH Home Maintenance Phase|Insufficient data|0
4460891|NCT00576472|7249323|FG000|MPH Home Maintenance Phase|Side effects|0
4460892|NCT00576472|7249324|FG001|MPH Home Maintenance Phase|Side effects|0
4460893|NCT00576472|7249325|FG002|MPH Home Maintenance Phase|Side effects|0
4460894|NCT00576472|7249326|FG003|MPH Home Maintenance Phase|Side effects|0
4460895|NCT00576472|7249327|FG004|MPH Home Maintenance Phase|Side effects|0
4460896|NCT00576472|7249328|FG005|MPH Home Maintenance Phase|Side effects|0
4460897|NCT00576472|7249329|FG006|MPH Home Maintenance Phase|Side effects|0
4460898|NCT00576472|7249330|FG007|MPH Home Maintenance Phase|Side effects|0
4460899|NCT00576472|7249331|FG008|MPH Home Maintenance Phase|Side effects|0
4460900|NCT00576472|7249332|FG009|MPH Home Maintenance Phase|Side effects|0
4460901|NCT00576472|7249333|FG010|MPH Home Maintenance Phase|Side effects|0
4460902|NCT00576472|7249334|FG011|MPH Home Maintenance Phase|Side effects|0
4460903|NCT00576472|7249335|FG012|MPH Home Maintenance Phase|Side effects|0
4460904|NCT00576472|7249336|FG013|MPH Home Maintenance Phase|Side effects|0
4460905|NCT00576472|7249337|FG014|MPH Home Maintenance Phase|Side effects|8
4460906|NCT00576472|7249323|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0
4460907|NCT00576472|7249324|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0
4460908|NCT00576472|7249325|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0
4460909|NCT00576472|7249326|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0
4460910|NCT00576472|7249327|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0
4460911|NCT00576472|7249328|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0
4460912|NCT00576472|7249329|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0
4460913|NCT00576472|7249330|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0
4460914|NCT00576472|7249331|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0
4460915|NCT00576472|7249332|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0
4460916|NCT00576472|7249333|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0
4460917|NCT00576472|7249334|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0
4460918|NCT00576472|7249335|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0
4460919|NCT00576472|7249336|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0
4460920|NCT00576472|7249337|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6
4460921|NCT00576472|7249323|FG000|MPH Home Maintenance Phase|Medical reasons|0
4460922|NCT00576472|7249324|FG001|MPH Home Maintenance Phase|Medical reasons|0
4460923|NCT00576472|7249325|FG002|MPH Home Maintenance Phase|Medical reasons|0
4460924|NCT00576472|7249326|FG003|MPH Home Maintenance Phase|Medical reasons|0
4460925|NCT00576472|7249327|FG004|MPH Home Maintenance Phase|Medical reasons|0
4460926|NCT00576472|7249328|FG005|MPH Home Maintenance Phase|Medical reasons|0
4460927|NCT00576472|7249329|FG006|MPH Home Maintenance Phase|Medical reasons|0
4460928|NCT00576472|7249330|FG007|MPH Home Maintenance Phase|Medical reasons|0
4460929|NCT00576472|7249331|FG008|MPH Home Maintenance Phase|Medical reasons|0
4460930|NCT00576472|7249332|FG009|MPH Home Maintenance Phase|Medical reasons|0
4460931|NCT00576472|7249333|FG010|MPH Home Maintenance Phase|Medical reasons|0
4460932|NCT00576472|7249334|FG011|MPH Home Maintenance Phase|Medical reasons|0
4460933|NCT00576472|7249335|FG012|MPH Home Maintenance Phase|Medical reasons|0
4460934|NCT00576472|7249336|FG013|MPH Home Maintenance Phase|Medical reasons|0
4460935|NCT00576472|7249337|FG014|MPH Home Maintenance Phase|Medical reasons|6
4460936|NCT00576472|7249323|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0
4460937|NCT00576472|7249324|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0
4460938|NCT00576472|7249325|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0
4460939|NCT00576472|7249326|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0
4460940|NCT00576472|7249327|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0
4460941|NCT00576472|7249328|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0
4460942|NCT00576472|7249329|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0
4460943|NCT00576472|7249330|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0
4460944|NCT00576472|7249331|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0
4460945|NCT00576472|7249332|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0
4460946|NCT00576472|7249333|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0
4460947|NCT00576472|7249334|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0
4460948|NCT00576472|7249335|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0
4460949|NCT00576472|7249336|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0
4460950|NCT00576472|7249337|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3
4460951|NCT00576576|7249368|FG000|Overall Study|Lost to Follow-up|6
4460952|NCT00576576|7249368|FG000|Overall Study|Protocol Violation|1
4460953|NCT00576628|7249372|FG000|Overall Study|Adverse Event|11
4460954|NCT00576628|7249372|FG000|Overall Study|Death|2
4460955|NCT00576628|7249372|FG000|Overall Study|Failure to return|1
4460956|NCT00576628|7249372|FG000|Overall Study|Refused Treatment|8
4460957|NCT00576628|7249372|FG000|Overall Study|Pregnancy|1
4460958|NCT00576628|7249372|FG000|Overall Study|RBC transfusion|1
4460959|NCT00576628|7249372|FG000|Overall Study|Progression of Kidney Disease|1
4460960|NCT00576628|7249372|FG000|Overall Study|Progression of Renal Failure|1
4460961|NCT00576628|7249372|FG000|Overall Study|The patient move into other town|1
4460962|NCT00576628|7249372|FG000|Overall Study|Transplantation|1
4460963|NCT00576628|7249372|FG000|Overall Study|Dialysis|15
4460964|NCT00576693|7249383|FG000|Overall Study|Lost to Follow-up|7
4460965|NCT00576693|7249384|FG001|Overall Study|Lost to Follow-up|11
4460966|NCT00576693|7249383|FG000|Overall Study|Withdrawal by Subject|3
4460967|NCT00576693|7249384|FG001|Overall Study|Withdrawal by Subject|13
4460968|NCT00576732|7249393|FG000|DOUBLE BLIND|Adverse Event|0
4460969|NCT00576732|7249394|FG001|DOUBLE BLIND|Adverse Event|0
4460970|NCT00576732|7249395|FG002|DOUBLE BLIND|Adverse Event|1
4460971|NCT00576732|7249396|FG003|DOUBLE BLIND|Adverse Event|0
4460972|NCT00576732|7249397|FG004|DOUBLE BLIND|Adverse Event|0
4460973|NCT00576732|7249398|FG005|DOUBLE BLIND|Adverse Event|0
4460974|NCT00576732|7249393|FG000|DOUBLE BLIND|Lost to Follow-up|0
4460975|NCT00576732|7249394|FG001|DOUBLE BLIND|Lost to Follow-up|1
4460976|NCT00576732|7249395|FG002|DOUBLE BLIND|Lost to Follow-up|1
4460977|NCT00576732|7249396|FG003|DOUBLE BLIND|Lost to Follow-up|0
4460978|NCT00576732|7249397|FG004|DOUBLE BLIND|Lost to Follow-up|0
4460979|NCT00576732|7249398|FG005|DOUBLE BLIND|Lost to Follow-up|0
4460980|NCT00576732|7249393|FG000|DOUBLE BLIND|Withdrawal by Subject|1
4460981|NCT00576732|7249394|FG001|DOUBLE BLIND|Withdrawal by Subject|1
4460982|NCT00576732|7249395|FG002|DOUBLE BLIND|Withdrawal by Subject|3
4460983|NCT00576732|7249396|FG003|DOUBLE BLIND|Withdrawal by Subject|0
4460984|NCT00576732|7249397|FG004|DOUBLE BLIND|Withdrawal by Subject|0
4460985|NCT00576732|7249398|FG005|DOUBLE BLIND|Withdrawal by Subject|0
4460986|NCT00576732|7249393|FG000|DOUBLE BLIND|OTHER|0
4460987|NCT00576732|7249394|FG001|DOUBLE BLIND|OTHER|2
4460988|NCT00576732|7249395|FG002|DOUBLE BLIND|OTHER|1
4460989|NCT00576732|7249396|FG003|DOUBLE BLIND|OTHER|0
4460990|NCT00576732|7249397|FG004|DOUBLE BLIND|OTHER|0
4460991|NCT00576732|7249398|FG005|DOUBLE BLIND|OTHER|0
4460992|NCT00576732|7249393|FG000|DOUBLE BLIND|Lack of Efficacy|6
4460993|NCT00576732|7249394|FG001|DOUBLE BLIND|Lack of Efficacy|1
4460994|NCT00576732|7249395|FG002|DOUBLE BLIND|Lack of Efficacy|0
4460995|NCT00576732|7249396|FG003|DOUBLE BLIND|Lack of Efficacy|0
4460996|NCT00576732|7249397|FG004|DOUBLE BLIND|Lack of Efficacy|0
4460997|NCT00576732|7249398|FG005|DOUBLE BLIND|Lack of Efficacy|0
4460998|NCT00576732|7249393|FG000|DOUBLE BLIND|Protocol Violation|1
4460999|NCT00576732|7249394|FG001|DOUBLE BLIND|Protocol Violation|0
4461000|NCT00576732|7249395|FG002|DOUBLE BLIND|Protocol Violation|0
4461001|NCT00576732|7249396|FG003|DOUBLE BLIND|Protocol Violation|0
4461002|NCT00576732|7249397|FG004|DOUBLE BLIND|Protocol Violation|0
4461003|NCT00576732|7249398|FG005|DOUBLE BLIND|Protocol Violation|0
4461004|NCT00576732|7249393|FG000|OPEN LABEL|Adverse Event|0
4461005|NCT00576732|7249394|FG001|OPEN LABEL|Adverse Event|0
4461006|NCT00576732|7249395|FG002|OPEN LABEL|Adverse Event|0
4461007|NCT00576732|7249396|FG003|OPEN LABEL|Adverse Event|4
4461008|NCT00576732|7249397|FG004|OPEN LABEL|Adverse Event|0
4461009|NCT00576732|7249398|FG005|OPEN LABEL|Adverse Event|1
4461010|NCT00576732|7249393|FG000|OPEN LABEL|Lost to Follow-up|0
4461011|NCT00576732|7249394|FG001|OPEN LABEL|Lost to Follow-up|0
4461012|NCT00576732|7249395|FG002|OPEN LABEL|Lost to Follow-up|0
4461013|NCT00576732|7249396|FG003|OPEN LABEL|Lost to Follow-up|2
4461014|NCT00576732|7249397|FG004|OPEN LABEL|Lost to Follow-up|1
4461015|NCT00576732|7249398|FG005|OPEN LABEL|Lost to Follow-up|1
4461016|NCT00576732|7249393|FG000|OPEN LABEL|Withdrawal by Subject|0
4461017|NCT00576732|7249394|FG001|OPEN LABEL|Withdrawal by Subject|0
4461018|NCT00576732|7249395|FG002|OPEN LABEL|Withdrawal by Subject|0
4461019|NCT00576732|7249396|FG003|OPEN LABEL|Withdrawal by Subject|1
4461020|NCT00576732|7249397|FG004|OPEN LABEL|Withdrawal by Subject|0
4461021|NCT00576732|7249398|FG005|OPEN LABEL|Withdrawal by Subject|1
4461022|NCT00576732|7249393|FG000|OPEN LABEL|OTHER|0
4461023|NCT00576732|7249394|FG001|OPEN LABEL|OTHER|0
4461024|NCT00576732|7249395|FG002|OPEN LABEL|OTHER|0
4461025|NCT00576732|7249396|FG003|OPEN LABEL|OTHER|0
4461026|NCT00576732|7249397|FG004|OPEN LABEL|OTHER|0
4461027|NCT00576732|7249398|FG005|OPEN LABEL|OTHER|2
4461028|NCT00576732|7249393|FG000|OPEN LABEL|Lack of Efficacy|0
4461029|NCT00576732|7249394|FG001|OPEN LABEL|Lack of Efficacy|0
4461030|NCT00576732|7249395|FG002|OPEN LABEL|Lack of Efficacy|0
4461031|NCT00576732|7249396|FG003|OPEN LABEL|Lack of Efficacy|2
4461032|NCT00576732|7249397|FG004|OPEN LABEL|Lack of Efficacy|2
4461033|NCT00576732|7249398|FG005|OPEN LABEL|Lack of Efficacy|3
4461034|NCT00576732|7249393|FG000|OPEN LABEL|Protocol Violation|0
4461035|NCT00576732|7249394|FG001|OPEN LABEL|Protocol Violation|0
4461036|NCT00576732|7249395|FG002|OPEN LABEL|Protocol Violation|0
4461037|NCT00576732|7249396|FG003|OPEN LABEL|Protocol Violation|2
4461038|NCT00576732|7249397|FG004|OPEN LABEL|Protocol Violation|1
4461039|NCT00576732|7249398|FG005|OPEN LABEL|Protocol Violation|0
4461040|NCT00576758|7249412|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3
4461041|NCT00576758|7249413|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3
4461042|NCT00576758|7249412|FG000|Induction Treatment Period|Insufficient therapeutic response|2
4461043|NCT00576758|7249413|FG001|Induction Treatment Period|Insufficient therapeutic response|0
4461044|NCT00576758|7249412|FG000|Induction Treatment Period|Violation of selection criteria at entry|1
4461045|NCT00576758|7249413|FG001|Induction Treatment Period|Violation of selection criteria at entry|1
4461046|NCT00576758|7249412|FG000|Induction Treatment Period|Death|1
4461047|NCT00576758|7249413|FG001|Induction Treatment Period|Death|0
4461048|NCT00576758|7249412|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0
4461049|NCT00576758|7249413|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1
4461050|NCT00576758|7249412|FG000|Induction Treatment Period|Withdrew consent|1
4461051|NCT00576758|7249413|FG001|Induction Treatment Period|Withdrew consent|0
4461052|NCT00576758|7249412|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6
4461053|NCT00576758|7249413|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7
4461054|NCT00576758|7249412|FG000|Extension Treatment Period|Death|1
4461055|NCT00576758|7249413|FG001|Extension Treatment Period|Death|1
4461056|NCT00576758|7249412|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2
4461057|NCT00576758|7249413|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1
4461058|NCT00576758|7249412|FG000|Extension Treatment Period|Insufficient therapeutic response|30
4461059|NCT00576758|7249413|FG001|Extension Treatment Period|Insufficient therapeutic response|33
4461060|NCT00576758|7249412|FG000|Extension Treatment Period|Administrative/Other|3
4461061|NCT00576758|7249413|FG001|Extension Treatment Period|Administrative/Other|1
4461062|NCT00576758|7249412|FG000|Follow-up Period|Administrative/Other|6
4461063|NCT00576758|7249413|FG001|Follow-up Period|Administrative/Other|8
4461064|NCT00576758|7249412|FG000|Follow-up Period|Death|3
4461065|NCT00576758|7249413|FG001|Follow-up Period|Death|3
4461066|NCT00576758|7249412|FG000|Follow-up Period|Insufficient therapeutic response|16
4461067|NCT00576758|7249413|FG001|Follow-up Period|Insufficient therapeutic response|5
4461068|NCT00576758|7249412|FG000|Follow-up Period|Withdrew consent|2
4461069|NCT00576758|7249413|FG001|Follow-up Period|Withdrew consent|1
4461070|NCT00576823|7249423|FG000|12-week Efficacy Phase|Parent's schedule issue|1
4461071|NCT00576823|7249424|FG001|12-week Efficacy Phase|Parent's schedule issue|0
4461072|NCT00576823|7249425|FG002|12-week Efficacy Phase|Parent's schedule issue|0
4461073|NCT00576823|7249423|FG000|40-week Safety Extension Phase|Lack of Efficacy|1
4461074|NCT00576823|7249424|FG001|40-week Safety Extension Phase|Lack of Efficacy|0
4461075|NCT00576823|7249425|FG002|40-week Safety Extension Phase|Lack of Efficacy|0
4461076|NCT00576901|7249436|FG000|Overall Study|Withdrawal by Subject|1
4461077|NCT00576901|7249436|FG000|Overall Study|Disease course|1
4461078|NCT00576901|7249436|FG000|Overall Study|Protocol Violation|1
4461079|NCT00576927|7249442|FG000|Clinical Assessment|Lack of Efficacy|24
4461080|NCT00576927|7249442|FG000|Clinical Assessment|Death|1
4461081|NCT00576927|7249442|FG000|Clinical Assessment|Withdrawal by Subject|10
4461082|NCT00576927|7249442|FG000|Clinical Assessment|Physician Decision|1
4461083|NCT00576927|7249442|FG000|Baseline|Physician Decision|9
4461084|NCT00576927|7249442|FG000|Baseline|Medication Change by PCP of subject|1
4461085|NCT00576927|7249442|FG000|Baseline|Withdrawal by Subject|3
4461086|NCT00576927|7249442|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4
4461087|NCT00576927|7249442|FG000|Sleep Hygiene Behavioral Intervention|Death|1
4461088|NCT00576927|7249442|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1
4461089|NCT00576927|7249442|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1
4461090|NCT00576927|7249442|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1
4461091|NCT00577005|7249450|FG000|Overall Study|Lost to Follow-up|3
4461092|NCT00577005|7249451|FG001|Overall Study|Lost to Follow-up|2
4461093|NCT00577005|7249450|FG000|Overall Study|Withdrawal by Subject|2
4461094|NCT00577005|7249451|FG001|Overall Study|Withdrawal by Subject|1
4461095|NCT00577031|7249460|FG000|Overall Study|Adverse Event|52
4461096|NCT00577031|7249460|FG000|Overall Study|Progression of disease|93
4461097|NCT00577031|7249460|FG000|Overall Study|Protocol Violation|5
4461098|NCT00577031|7249460|FG000|Overall Study|Participant withdrew consent|13
4461099|NCT00577031|7249460|FG000|Overall Study|Participant non-compliance|5
4461100|NCT00577031|7249460|FG000|Overall Study|Need for surgery|17
4461101|NCT00577031|7249460|FG000|Overall Study|Medical decision|14
4461102|NCT00577031|7249460|FG000|Overall Study|Death|6
4461103|NCT00577096|7249484|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3
4461104|NCT00577096|7249485|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2
4461105|NCT00577096|7249484|FG000|Short Term Participation|Withdrawal by Subject|3
4461106|NCT00577096|7249485|FG001|Short Term Participation|Withdrawal by Subject|5
4461107|NCT00577096|7249484|FG000|Short Term Participation|Death|1
4461108|NCT00577096|7249485|FG001|Short Term Participation|Death|1
4461109|NCT00577122|7249493|FG000|Overall Study|Adverse Event|0
4461110|NCT00577122|7249494|FG001|Overall Study|Adverse Event|2
4461111|NCT00577122|7249493|FG000|Overall Study|Progression, relapse during active trt|6
4461112|NCT00577122|7249494|FG001|Overall Study|Progression, relapse during active trt|8
4461113|NCT00577122|7249493|FG000|Overall Study|Prog, refract disease during active trt|8
4539473|NCT01125800|7361802|FG004|Phase II|Disease progression|8
4539474|NCT01125813|7361817|FG000|Overall Study|Death|1
4461114|NCT00577122|7249494|FG001|Overall Study|Prog, refract disease during active trt|5
4461115|NCT00577122|7249493|FG000|Overall Study|Alternative Therapy|0
4461116|NCT00577122|7249494|FG001|Overall Study|Alternative Therapy|1
4461117|NCT00577382|7249520|FG000|Overall Study|Adverse Event|0
4461118|NCT00577382|7249521|FG001|Overall Study|Adverse Event|6
4461119|NCT00577382|7249520|FG000|Overall Study|Withdrawal by Subject|0
4461120|NCT00577382|7249521|FG001|Overall Study|Withdrawal by Subject|1
4461121|NCT00577382|7249520|FG000|Overall Study|Progressive Disease|17
4461122|NCT00577382|7249521|FG001|Overall Study|Progressive Disease|19
4461123|NCT00577382|7249520|FG000|Overall Study|Intercurrent Illness|1
4461124|NCT00577382|7249521|FG001|Overall Study|Intercurrent Illness|2
4461125|NCT00577382|7249520|FG000|Overall Study|Death|1
4461126|NCT00577382|7249521|FG001|Overall Study|Death|1
4461127|NCT00577382|7249520|FG000|Overall Study|Lost to Follow-up|2
4461128|NCT00577382|7249521|FG001|Overall Study|Lost to Follow-up|2
4461129|NCT00577408|7249529|FG000|Overall Study|Stopped attending study visits|9
4461130|NCT00577408|7249530|FG001|Overall Study|Stopped attending study visits|11
4461131|NCT00577408|7249529|FG000|Overall Study|Continued opioid use|3
4461132|NCT00577408|7249530|FG001|Overall Study|Continued opioid use|2
4461133|NCT00577408|7249529|FG000|Overall Study|Non-compliance with study meds|0
4461134|NCT00577408|7249530|FG001|Overall Study|Non-compliance with study meds|3
4461135|NCT00577408|7249529|FG000|Overall Study|Refused Oral Naltrexone|0
4461136|NCT00577408|7249530|FG001|Overall Study|Refused Oral Naltrexone|1
4461137|NCT00577408|7249529|FG000|Overall Study|Moved out of state|0
4461138|NCT00577408|7249530|FG001|Overall Study|Moved out of state|1
4461139|NCT00577408|7249529|FG000|Overall Study|Scheduling Issues|0
4461140|NCT00577408|7249530|FG001|Overall Study|Scheduling Issues|3
4461141|NCT00577408|7249529|FG000|Overall Study|Death|0
4461142|NCT00577408|7249530|FG001|Overall Study|Death|1
4461143|NCT00577408|7249529|FG000|Overall Study|Psychiatric hospitalization|0
4461144|NCT00577408|7249530|FG001|Overall Study|Psychiatric hospitalization|1
4461145|NCT00577460|7249539|FG000|Overall Study|Adverse Event|11
4461146|NCT00577460|7249540|FG001|Overall Study|Adverse Event|7
4461147|NCT00577460|7249541|FG002|Overall Study|Adverse Event|14
4461148|NCT00577460|7249539|FG000|Overall Study|Protocol Violation|0
4461149|NCT00577460|7249540|FG001|Overall Study|Protocol Violation|1
4461150|NCT00577460|7249541|FG002|Overall Study|Protocol Violation|1
4461151|NCT00577460|7249539|FG000|Overall Study|Lost to Follow-up|0
4461152|NCT00577460|7249540|FG001|Overall Study|Lost to Follow-up|3
4461153|NCT00577460|7249541|FG002|Overall Study|Lost to Follow-up|4
4461154|NCT00577460|7249539|FG000|Overall Study|Withdrawal by Subject|5
4614516|NCT01723904|7472249|FG000|Overall Study|Noncompliant|3
4614517|NCT01723904|7472249|FG000|Overall Study|Adverse Event|5
4614518|NCT01723904|7472249|FG000|Overall Study|Unable to follow protocol/ judged by inv|3
4614519|NCT01724021|7472255|FG000|Overall Study|Adverse Event|11
4461155|NCT00577460|7249540|FG001|Overall Study|Withdrawal by Subject|5
4461156|NCT00577460|7249541|FG002|Overall Study|Withdrawal by Subject|6
4461157|NCT00577460|7249539|FG000|Overall Study|Other|0
4461158|NCT00577460|7249540|FG001|Overall Study|Other|3
4461159|NCT00577460|7249541|FG002|Overall Study|Other|2
4461160|NCT00577473|7249558|FG000|Overall Study|Protocol Violation|1
4539475|NCT01125813|7361817|FG000|Overall Study|Withdrawal by Subject|1
4539476|NCT01125813|7361817|FG000|Overall Study|Screen Failures|4
4539477|NCT01125917|7361821|FG000|Overall Study|Adverse Event|43
4539478|NCT01125917|7361821|FG000|Overall Study|Lost to Follow-up|23
4539479|NCT01125917|7361821|FG000|Overall Study|Withdrawal by Subject|31
4539480|NCT01125917|7361821|FG000|Overall Study|Administrative|223
4539481|NCT01125917|7361821|FG000|Overall Study|Lack of Efficacy|19
4461161|NCT00577473|7249559|FG001|Overall Study|Protocol Violation|4
4461162|NCT00577473|7249558|FG000|Overall Study|Adverse Event|8
4461163|NCT00577473|7249559|FG001|Overall Study|Adverse Event|5
4461164|NCT00577473|7249558|FG000|Overall Study|Withdrawal by Subject|2
4461165|NCT00577473|7249559|FG001|Overall Study|Withdrawal by Subject|6
4461166|NCT00577473|7249558|FG000|Overall Study|Physician Decision|2
4461167|NCT00577473|7249559|FG001|Overall Study|Physician Decision|2
4461168|NCT00577473|7249558|FG000|Overall Study|Lack of Efficacy|8
4539482|NCT01125930|7361827|FG000|Overall Study|Adverse Event|0
4539483|NCT01125930|7361828|FG001|Overall Study|Adverse Event|1
4539484|NCT01125930|7361827|FG000|Overall Study|Withdrawal by Subject|1
4539485|NCT01125930|7361828|FG001|Overall Study|Withdrawal by Subject|6
4614520|NCT01724021|7472256|FG001|Overall Study|Adverse Event|6
4614521|NCT01724021|7472255|FG000|Overall Study|Death|46
4461169|NCT00577473|7249559|FG001|Overall Study|Lack of Efficacy|7
4461170|NCT00577629|7249582|FG000|Treatment Period|Death|1
4461171|NCT00577629|7249582|FG000|Long Term Follow-Up|Death|15
4461172|NCT00577629|7249582|FG000|Long Term Follow-Up|Lost to Follow-up|5
4461173|NCT00577629|7249582|FG000|Long Term Follow-Up|Withdrawal by Subject|4
4461174|NCT00577629|7249582|FG000|Long Term Follow-Up|Physician Decision|1
4461175|NCT00577642|7249588|FG000|Overall Study|Clinical Disease Progression|1
4461176|NCT00577655|7249594|FG000|Overall Study|Patient Request|0
4461177|NCT00577655|7249595|FG001|Overall Study|Patient Request|2
4461178|NCT00577655|7249594|FG000|Overall Study|Protocol Violation|0
4461179|NCT00577655|7249595|FG001|Overall Study|Protocol Violation|1
4461180|NCT00577655|7249594|FG000|Overall Study|Lost to Follow-up|1
4461181|NCT00577655|7249595|FG001|Overall Study|Lost to Follow-up|1
4461182|NCT00577707|7249602|FG000|Overall Study|Withdrawal by Subject|3
4461183|NCT00577720|7249610|FG000|Overall Study|Adverse Event|2
4461184|NCT00577720|7249611|FG001|Overall Study|Adverse Event|1
4461185|NCT00577720|7249612|FG002|Overall Study|Adverse Event|0
4461186|NCT00577720|7249613|FG003|Overall Study|Adverse Event|4
4461187|NCT00577720|7249610|FG000|Overall Study|Lost to Follow-up|0
4461188|NCT00577720|7249611|FG001|Overall Study|Lost to Follow-up|0
4461189|NCT00577720|7249612|FG002|Overall Study|Lost to Follow-up|1
4461190|NCT00577720|7249613|FG003|Overall Study|Lost to Follow-up|0
4461191|NCT00577720|7249610|FG000|Overall Study|Protocol Violation|0
4461192|NCT00577720|7249611|FG001|Overall Study|Protocol Violation|0
4461193|NCT00577720|7249612|FG002|Overall Study|Protocol Violation|0
4461194|NCT00577720|7249613|FG003|Overall Study|Protocol Violation|1
4461195|NCT00577720|7249610|FG000|Overall Study|Withdrawal by Subject|2
4461196|NCT00577720|7249611|FG001|Overall Study|Withdrawal by Subject|0
4461197|NCT00577720|7249612|FG002|Overall Study|Withdrawal by Subject|0
4461198|NCT00577720|7249613|FG003|Overall Study|Withdrawal by Subject|2
4461199|NCT00577824|7249626|FG000|Overall Study|Adverse Event|6
4461200|NCT00577824|7249627|FG001|Overall Study|Adverse Event|18
4461201|NCT00577824|7249628|FG002|Overall Study|Adverse Event|1
4461202|NCT00577824|7249626|FG000|Overall Study|Patient decision|0
4461203|NCT00577824|7249627|FG001|Overall Study|Patient decision|1
4461204|NCT00577824|7249628|FG002|Overall Study|Patient decision|1
4461205|NCT00577824|7249626|FG000|Overall Study|Protocol Violation|1
4461206|NCT00577824|7249627|FG001|Overall Study|Protocol Violation|1
4461207|NCT00577824|7249628|FG002|Overall Study|Protocol Violation|0
4461208|NCT00577863|7249638|FG000|Overall Study|Adverse Event|4
4461209|NCT00577863|7249639|FG001|Overall Study|Adverse Event|2
4461210|NCT00577863|7249638|FG000|Overall Study|Death|1
4461211|NCT00577863|7249639|FG001|Overall Study|Death|0
4461212|NCT00577863|7249638|FG000|Overall Study|Lost to Follow-up|2
4461213|NCT00577863|7249639|FG001|Overall Study|Lost to Follow-up|2
4461214|NCT00577863|7249638|FG000|Overall Study|Entry Criteria Exclusion|1
4461215|NCT00577863|7249639|FG001|Overall Study|Entry Criteria Exclusion|0
4461216|NCT00577863|7249638|FG000|Overall Study|Withdrawal by Subject|0
4461217|NCT00577863|7249639|FG001|Overall Study|Withdrawal by Subject|2
4461218|NCT00577863|7249638|FG000|Overall Study|Sponsor Decision|2
4461219|NCT00577863|7249639|FG001|Overall Study|Sponsor Decision|7
4461220|NCT00577863|7249638|FG000|Overall Study|Did Not Receive at Least One Injection|0
4461221|NCT00577863|7249639|FG001|Overall Study|Did Not Receive at Least One Injection|1
4461222|NCT00577889|7249648|FG000|Overall Study|Withdrawal by Subject|1
4614522|NCT01724021|7472256|FG001|Overall Study|Death|58
4614523|NCT01724021|7472255|FG000|Overall Study|Participant request/ Withdrew consent|18
4614524|NCT01724021|7472256|FG001|Overall Study|Participant request/ Withdrew consent|14
4614525|NCT01724021|7472255|FG000|Overall Study|Lost to Follow-up|15
4614526|NCT01724021|7472256|FG001|Overall Study|Lost to Follow-up|15
4614527|NCT01724021|7472255|FG000|Overall Study|Reason Not Specified|36
4614528|NCT01724021|7472256|FG001|Overall Study|Reason Not Specified|39
4614529|NCT01724021|7472255|FG000|Overall Study|Missing|1
4614530|NCT01724021|7472256|FG001|Overall Study|Missing|1
4614531|NCT01724177|7472297|FG000|Overall Study|Adverse Event|8
4614532|NCT01724177|7472297|FG000|Overall Study|Progressive disease or Relapsed Disease|16
4614533|NCT01724177|7472297|FG000|Overall Study|Nervous participant|1
4614534|NCT01724177|7472297|FG000|Overall Study|Serious Adverse Event Related|1
4614535|NCT01724216|7472302|FG000|Overall Study|Scan was not completed|1
4461223|NCT00577889|7249649|FG001|Overall Study|Withdrawal by Subject|0
4461224|NCT00577889|7249650|FG002|Overall Study|Withdrawal by Subject|0
4461225|NCT00577993|7249661|FG000|Overall Study|Adverse Event|1
4461226|NCT00577993|7249662|FG001|Overall Study|Adverse Event|0
4461227|NCT00577993|7249663|FG002|Overall Study|Adverse Event|0
4461228|NCT00577993|7249661|FG000|Overall Study|Death|0
4461229|NCT00577993|7249662|FG001|Overall Study|Death|1
4461230|NCT00577993|7249663|FG002|Overall Study|Death|1
4461231|NCT00577993|7249661|FG000|Overall Study|Lack of Efficacy|0
4461232|NCT00577993|7249662|FG001|Overall Study|Lack of Efficacy|1
4461233|NCT00577993|7249663|FG002|Overall Study|Lack of Efficacy|0
4461234|NCT00577993|7249661|FG000|Overall Study|Protocol Violation|2
4461235|NCT00577993|7249662|FG001|Overall Study|Protocol Violation|3
4461236|NCT00577993|7249663|FG002|Overall Study|Protocol Violation|0
4461237|NCT00577993|7249661|FG000|Overall Study|Withdrawal by Subject|1
4614536|NCT01724359|7472306|FG000|Overall Study|Adverse Event|10
4614537|NCT01724359|7472306|FG000|Overall Study|Death|1
4690395|NCT02561195|7600192|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0
4461238|NCT00577993|7249662|FG001|Overall Study|Withdrawal by Subject|0
4461239|NCT00577993|7249663|FG002|Overall Study|Withdrawal by Subject|2
4461240|NCT00577993|7249661|FG000|Overall Study|Conversion|2
4461241|NCT00577993|7249662|FG001|Overall Study|Conversion|5
4461242|NCT00577993|7249663|FG002|Overall Study|Conversion|0
4461243|NCT00577993|7249661|FG000|Overall Study|Uninsured|1
4461244|NCT00577993|7249662|FG001|Overall Study|Uninsured|0
4461245|NCT00577993|7249663|FG002|Overall Study|Uninsured|0
4461246|NCT00578136|7249676|FG000|Overall Study|Not given intervention|1
4461247|NCT00578136|7249677|FG001|Overall Study|Not given intervention|1
4461248|NCT00578175|7249686|FG000|Overall Study|Adverse Event|0
4461249|NCT00578175|7249687|FG001|Overall Study|Adverse Event|1
4461250|NCT00578175|7249688|FG002|Overall Study|Adverse Event|1
4461251|NCT00578175|7249686|FG000|Overall Study|Other reasons|70
4461252|NCT00578175|7249687|FG001|Overall Study|Other reasons|42
4461253|NCT00578175|7249688|FG002|Overall Study|Other reasons|23
4461254|NCT00578227|7249714|FG000|Overall Study|Lost to Follow-up|0
4461255|NCT00578227|7249715|FG001|Overall Study|Lost to Follow-up|1
4461256|NCT00578227|7249716|FG002|Overall Study|Lost to Follow-up|1
4461257|NCT00578227|7249714|FG000|Overall Study|Withdrawal by Subject|5
4461258|NCT00578227|7249715|FG001|Overall Study|Withdrawal by Subject|1
4461259|NCT00578227|7249716|FG002|Overall Study|Withdrawal by Subject|3
4515997|NCT00957905|7327276|FG001|Part B|Protocol Violation|1
4515998|NCT00957931|7327282|FG000|Overall Study|Death|4
4515999|NCT00957944|7327288|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0
4516000|NCT00957944|7327289|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1
4516001|NCT00957996|7327297|FG000|Overall Study|Death|4
4516002|NCT00957996|7327298|FG001|Overall Study|Death|10
4516003|NCT00957996|7327297|FG000|Overall Study|Lost to Follow-up|4
4516004|NCT00957996|7327298|FG001|Overall Study|Lost to Follow-up|7
4516005|NCT00957996|7327297|FG000|Overall Study|Withdrawal by Subject|9
4516006|NCT00957996|7327298|FG001|Overall Study|Withdrawal by Subject|2
4516007|NCT00957996|7327297|FG000|Overall Study|Adverse Event|2
4516008|NCT00957996|7327298|FG001|Overall Study|Adverse Event|1
4516009|NCT00957996|7327297|FG000|Overall Study|Physician Decision|1
4516010|NCT00957996|7327298|FG001|Overall Study|Physician Decision|1
4516011|NCT00957996|7327297|FG000|Overall Study|Influenza-related complication|0
4516012|NCT00957996|7327298|FG001|Overall Study|Influenza-related complication|1
4516013|NCT00957996|7327297|FG000|Overall Study|Missing|1
4516014|NCT00957996|7327298|FG001|Overall Study|Missing|0
4516015|NCT00957996|7327297|FG000|Overall Study|Noncompliance; Protocol Deviations|5
4516016|NCT00957996|7327298|FG001|Overall Study|Noncompliance; Protocol Deviations|6
4516017|NCT00958009|7327306|FG000|Overall Study|Adverse Event|1
4516018|NCT00958009|7327306|FG000|Overall Study|Subject found device difficult to use|1
4516019|NCT00958074|7327321|FG000|Overall Study|Withdrawal by Subject|0
4516020|NCT00958074|7327322|FG001|Overall Study|Withdrawal by Subject|1
4516021|NCT00958126|7327336|FG000|Overall Study|Serious Adverse Event|0
4516022|NCT00958126|7327337|FG001|Overall Study|Serious Adverse Event|2
4516023|NCT00958126|7327338|FG002|Overall Study|Serious Adverse Event|0
4516024|NCT00958126|7327339|FG003|Overall Study|Serious Adverse Event|0
4516025|NCT00958126|7327340|FG004|Overall Study|Serious Adverse Event|0
4516026|NCT00958126|7327341|FG005|Overall Study|Serious Adverse Event|0
4516027|NCT00958126|7327342|FG006|Overall Study|Serious Adverse Event|1
4516028|NCT00958126|7327343|FG007|Overall Study|Serious Adverse Event|0
4539486|NCT01125930|7361827|FG000|Overall Study|Protocol Violation|0
4539487|NCT01125930|7361828|FG001|Overall Study|Protocol Violation|1
4539488|NCT01125930|7361827|FG000|Overall Study|Lost to Follow-up|0
4539489|NCT01125930|7361828|FG001|Overall Study|Lost to Follow-up|2
4539490|NCT01126060|7361852|FG000|Overall Study|Protocol Violation|0
4539491|NCT01126060|7361853|FG001|Overall Study|Protocol Violation|2
4539492|NCT01126268|7361868|FG000|Overall Study|Adverse Event|1
4539493|NCT01126359|7361872|FG000|First Intervention (20-minutes)|Physician Decision|0
4539494|NCT01126359|7361873|FG001|First Intervention (20-minutes)|Physician Decision|1
4539495|NCT01126424|7361889|FG000|Overall Study|Adverse Event|0
4539496|NCT01126424|7361890|FG001|Overall Study|Adverse Event|0
4539497|NCT01126424|7361891|FG002|Overall Study|Adverse Event|0
4539498|NCT01126424|7361892|FG003|Overall Study|Adverse Event|0
4539499|NCT01126424|7361893|FG004|Overall Study|Adverse Event|1
4539500|NCT01126424|7361894|FG005|Overall Study|Adverse Event|0
4539501|NCT01126424|7361889|FG000|Overall Study|Withdrawal by Subject|0
4539502|NCT01126424|7361890|FG001|Overall Study|Withdrawal by Subject|0
4539503|NCT01126424|7361891|FG002|Overall Study|Withdrawal by Subject|1
4539504|NCT01126424|7361892|FG003|Overall Study|Withdrawal by Subject|3
4539505|NCT01126424|7361893|FG004|Overall Study|Withdrawal by Subject|1
4539506|NCT01126424|7361894|FG005|Overall Study|Withdrawal by Subject|0
4614538|NCT01724359|7472306|FG000|Overall Study|Other|20
4614539|NCT01724489|7472314|FG000|Overall Study|Adverse Event|8
4614540|NCT01724489|7472315|FG001|Overall Study|Adverse Event|3
4614541|NCT01724489|7472314|FG000|Overall Study|Surgery, medication|1
4614542|NCT01724489|7472315|FG001|Overall Study|Surgery, medication|1
4614543|NCT01724489|7472314|FG000|Overall Study|Lost to Follow-up|1
4516029|NCT00958126|7327336|FG000|Overall Study|Withdrawal by Subject|0
4516030|NCT00958126|7327337|FG001|Overall Study|Withdrawal by Subject|2
4516031|NCT00958126|7327338|FG002|Overall Study|Withdrawal by Subject|0
4516032|NCT00958126|7327339|FG003|Overall Study|Withdrawal by Subject|0
4516033|NCT00958126|7327340|FG004|Overall Study|Withdrawal by Subject|0
4516034|NCT00958126|7327341|FG005|Overall Study|Withdrawal by Subject|0
4516035|NCT00958126|7327342|FG006|Overall Study|Withdrawal by Subject|0
4516036|NCT00958126|7327343|FG007|Overall Study|Withdrawal by Subject|0
4516037|NCT00958126|7327336|FG000|Overall Study|Moved away from study area|0
4516038|NCT00958126|7327337|FG001|Overall Study|Moved away from study area|0
4516039|NCT00958126|7327338|FG002|Overall Study|Moved away from study area|1
4539507|NCT01126437|7361905|FG000|Overall Study|Not treated|11
4539508|NCT01126437|7361906|FG001|Overall Study|Not treated|18
4614544|NCT01724489|7472315|FG001|Overall Study|Lost to Follow-up|2
4614545|NCT01724489|7472314|FG000|Overall Study|Withdrawal by Subject|6
4539509|NCT01126437|7361907|FG002|Overall Study|Not treated|19
4539510|NCT01126437|7361905|FG000|Overall Study|Sites with data irregularities/fraud|6
4539511|NCT01126437|7361906|FG001|Overall Study|Sites with data irregularities/fraud|6
4539512|NCT01126437|7361907|FG002|Overall Study|Sites with data irregularities/fraud|7
4539513|NCT01126437|7361905|FG000|Overall Study|Adverse Event|602
4539514|NCT01126437|7361906|FG001|Overall Study|Adverse Event|606
4539515|NCT01126437|7361907|FG002|Overall Study|Adverse Event|635
4539516|NCT01126437|7361905|FG000|Overall Study|Lack of Efficacy|65
4539517|NCT01126437|7361906|FG001|Overall Study|Lack of Efficacy|60
4539518|NCT01126437|7361907|FG002|Overall Study|Lack of Efficacy|59
4539519|NCT01126437|7361905|FG000|Overall Study|Protocol Violation|64
4539520|NCT01126437|7361906|FG001|Overall Study|Protocol Violation|66
4539521|NCT01126437|7361907|FG002|Overall Study|Protocol Violation|41
4539522|NCT01126437|7361905|FG000|Overall Study|Lost to Follow-up|52
4539523|NCT01126437|7361906|FG001|Overall Study|Lost to Follow-up|63
4539524|NCT01126437|7361907|FG002|Overall Study|Lost to Follow-up|55
4539525|NCT01126437|7361905|FG000|Overall Study|Withdrawal by Subject|331
4539526|NCT01126437|7361906|FG001|Overall Study|Withdrawal by Subject|335
4539527|NCT01126437|7361907|FG002|Overall Study|Withdrawal by Subject|319
4539528|NCT01126437|7361905|FG000|Overall Study|Other reason not specified|210
4539529|NCT01126437|7361906|FG001|Overall Study|Other reason not specified|176
4539530|NCT01126437|7361907|FG002|Overall Study|Other reason not specified|178
4539531|NCT01126541|7361918|FG000|Overall Study|Adverse Event|0
4539532|NCT01126541|7361919|FG001|Overall Study|Adverse Event|2
4539533|NCT01126541|7361920|FG002|Overall Study|Adverse Event|4
4539534|NCT01126541|7361918|FG000|Overall Study|Death|0
4539535|NCT01126541|7361919|FG001|Overall Study|Death|1
4461260|NCT00578292|7249735|FG000|Overall Study|Death|1
4461261|NCT00578292|7249735|FG000|Overall Study|Graft failure|2
4461262|NCT00578318|7249760|FG000|Overall Study|Lost to Follow-up|2
4461263|NCT00578318|7249761|FG001|Overall Study|Lost to Follow-up|0
4461264|NCT00578318|7249760|FG000|Overall Study|Physician Decision|1
4461265|NCT00578318|7249761|FG001|Overall Study|Physician Decision|0
4461266|NCT00578344|7249776|FG000|Overall Study|Insurance problems|1
4461267|NCT00578344|7249776|FG000|Overall Study|Graft failure|1
4461268|NCT00578448|7249801|FG000|Day 1 up to 3 Years of Planned Study|Death|1
4461269|NCT00578448|7249801|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1
4461270|NCT00578448|7249801|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1
4461271|NCT00578448|7249801|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1
4461272|NCT00578565|7249828|FG000|Overall Study|Adverse Event|3
4461273|NCT00578643|7249842|FG000|Overall Study|Death|1
4461274|NCT00578643|7249842|FG000|Overall Study|Lost to Follow-up|1
4461275|NCT00578786|7249867|FG000|Overall Study|Adverse Event|27
4461276|NCT00578786|7249868|FG001|Overall Study|Adverse Event|37
4461277|NCT00578786|7249869|FG002|Overall Study|Adverse Event|17
4461278|NCT00578786|7249867|FG000|Overall Study|Lack of Efficacy|2
4461279|NCT00578786|7249868|FG001|Overall Study|Lack of Efficacy|5
4461280|NCT00578786|7249869|FG002|Overall Study|Lack of Efficacy|2
4461281|NCT00578786|7249867|FG000|Overall Study|Early Escape from Prior Study|2
4539536|NCT01126541|7361920|FG002|Overall Study|Death|0
4539537|NCT01126541|7361918|FG000|Overall Study|Lack of Efficacy|6
4539538|NCT01126541|7361919|FG001|Overall Study|Lack of Efficacy|1
4539539|NCT01126541|7361920|FG002|Overall Study|Lack of Efficacy|11
4539540|NCT01126541|7361918|FG000|Overall Study|Lost to Follow-up|1
4614546|NCT01724489|7472315|FG001|Overall Study|Withdrawal by Subject|6
4614547|NCT01724528|7472323|FG000|Overall Study|Death|3
4614548|NCT01724528|7472324|FG001|Overall Study|Death|0
4614549|NCT01724528|7472323|FG000|Overall Study|Withdrawal by Subject|0
4614550|NCT01724528|7472324|FG001|Overall Study|Withdrawal by Subject|2
4614551|NCT01724528|7472323|FG000|Overall Study|Protocol Violation|0
4614552|NCT01724528|7472324|FG001|Overall Study|Protocol Violation|1
4614553|NCT01724528|7472323|FG000|Overall Study|Patient refused to attend last visit|1
4614554|NCT01724528|7472324|FG001|Overall Study|Patient refused to attend last visit|0
4614555|NCT01725126|7472336|FG000|Overall Study|Protocol Violation|0
4614556|NCT01725126|7472337|FG001|Overall Study|Protocol Violation|1
4614557|NCT01725126|7472338|FG002|Overall Study|Protocol Violation|0
4614558|NCT01725126|7472339|FG003|Overall Study|Protocol Violation|0
4614559|NCT01725126|7472340|FG004|Overall Study|Protocol Violation|0
4614560|NCT01725126|7472341|FG005|Overall Study|Protocol Violation|0
4614561|NCT01725126|7472336|FG000|Overall Study|Withdrawal by Subject|0
4614562|NCT01725126|7472337|FG001|Overall Study|Withdrawal by Subject|0
4614563|NCT01725126|7472338|FG002|Overall Study|Withdrawal by Subject|0
4614564|NCT01725126|7472339|FG003|Overall Study|Withdrawal by Subject|1
4614565|NCT01725126|7472340|FG004|Overall Study|Withdrawal by Subject|0
4461282|NCT00578786|7249868|FG001|Overall Study|Early Escape from Prior Study|1
4614566|NCT01725126|7472341|FG005|Overall Study|Withdrawal by Subject|0
4614567|NCT01725217|7472367|FG000|Overall Study|Withdrawal by Subject|1
4614568|NCT01725217|7472368|FG001|Overall Study|Withdrawal by Subject|0
4614569|NCT01725217|7472369|FG002|Overall Study|Withdrawal by Subject|0
4614570|NCT01725282|7472390|FG000|Overall Study|Adverse Event|1
4614571|NCT01725282|7472391|FG001|Overall Study|Adverse Event|3
4614572|NCT01725282|7472392|FG002|Overall Study|Adverse Event|6
4614573|NCT01725282|7472393|FG003|Overall Study|Adverse Event|4
4614574|NCT01725282|7472390|FG000|Overall Study|Exacerbation of Target Disease|1
4614575|NCT01725282|7472391|FG001|Overall Study|Exacerbation of Target Disease|0
4614576|NCT01725282|7472392|FG002|Overall Study|Exacerbation of Target Disease|0
4614577|NCT01725282|7472393|FG003|Overall Study|Exacerbation of Target Disease|1
4614578|NCT01725282|7472390|FG000|Overall Study|Met Exclusion Criteria|0
4614579|NCT01725282|7472391|FG001|Overall Study|Met Exclusion Criteria|0
4614580|NCT01725282|7472392|FG002|Overall Study|Met Exclusion Criteria|1
4614581|NCT01725282|7472393|FG003|Overall Study|Met Exclusion Criteria|0
4614582|NCT01725282|7472390|FG000|Overall Study|Study Site Withdrawal|0
4614583|NCT01725282|7472391|FG001|Overall Study|Study Site Withdrawal|1
4614584|NCT01725282|7472392|FG002|Overall Study|Study Site Withdrawal|0
4614585|NCT01725282|7472393|FG003|Overall Study|Study Site Withdrawal|0
4614586|NCT01725282|7472390|FG000|Overall Study|Withdrawal by Subject|0
4614587|NCT01725282|7472391|FG001|Overall Study|Withdrawal by Subject|0
4614588|NCT01725282|7472392|FG002|Overall Study|Withdrawal by Subject|1
4614589|NCT01725282|7472393|FG003|Overall Study|Withdrawal by Subject|1
4614590|NCT01725282|7472390|FG000|Overall Study|Lack of Efficacy|0
4614591|NCT01725282|7472391|FG001|Overall Study|Lack of Efficacy|1
4614592|NCT01725282|7472392|FG002|Overall Study|Lack of Efficacy|0
4614593|NCT01725282|7472393|FG003|Overall Study|Lack of Efficacy|1
4614594|NCT01725308|7472406|FG000|Treatment Period I|Did Not Receive Drug|1
4614595|NCT01725308|7472407|FG001|Treatment Period I|Did Not Receive Drug|0
4614596|NCT01725308|7472408|FG002|Treatment Period I|Did Not Receive Drug|0
4614597|NCT01725308|7472406|FG000|Treatment Period I|Adverse Event|5
4614598|NCT01725308|7472407|FG001|Treatment Period I|Adverse Event|4
4614599|NCT01725308|7472408|FG002|Treatment Period I|Adverse Event|21
4614600|NCT01725308|7472406|FG000|Treatment Period I|Insufficient Response|7
4614601|NCT01725308|7472407|FG001|Treatment Period I|Insufficient Response|0
4461283|NCT00578786|7249869|FG002|Overall Study|Early Escape from Prior Study|2
4461284|NCT00578786|7249867|FG000|Overall Study|Withdrawal by Subject|7
4461285|NCT00578786|7249868|FG001|Overall Study|Withdrawal by Subject|8
4461286|NCT00578786|7249869|FG002|Overall Study|Withdrawal by Subject|5
4461287|NCT00578786|7249867|FG000|Overall Study|Protocol Violation|0
4461288|NCT00578786|7249868|FG001|Overall Study|Protocol Violation|3
4461289|NCT00578786|7249869|FG002|Overall Study|Protocol Violation|1
4461290|NCT00578786|7249867|FG000|Overall Study|Physician Decision|1
4461291|NCT00578786|7249868|FG001|Overall Study|Physician Decision|0
4461292|NCT00578786|7249869|FG002|Overall Study|Physician Decision|1
4461293|NCT00578786|7249867|FG000|Overall Study|Sponsor Decision|0
4461294|NCT00578786|7249868|FG001|Overall Study|Sponsor Decision|0
4461295|NCT00578786|7249869|FG002|Overall Study|Sponsor Decision|1
4461296|NCT00578786|7249867|FG000|Overall Study|Lost to Follow-up|0
4461297|NCT00578786|7249868|FG001|Overall Study|Lost to Follow-up|4
4461298|NCT00578786|7249869|FG002|Overall Study|Lost to Follow-up|0
4614602|NCT01725308|7472408|FG002|Treatment Period I|Insufficient Response|5
4614603|NCT01725308|7472406|FG000|Treatment Period I|Worsening of the Target Disease|8
4614604|NCT01725308|7472407|FG001|Treatment Period I|Worsening of the Target Disease|0
4614605|NCT01725308|7472408|FG002|Treatment Period I|Worsening of the Target Disease|2
4461299|NCT00578786|7249867|FG000|Overall Study|Pregnancy|0
4461300|NCT00578786|7249868|FG001|Overall Study|Pregnancy|1
4461301|NCT00578786|7249869|FG002|Overall Study|Pregnancy|0
4461302|NCT00578786|7249867|FG000|Overall Study|Not Otherwise Specified|0
4461303|NCT00578786|7249868|FG001|Overall Study|Not Otherwise Specified|4
4461304|NCT00578786|7249869|FG002|Overall Study|Not Otherwise Specified|1
4461305|NCT00578786|7249867|FG000|Overall Study|Qualified but Not Enrolled in Extension|0
4461306|NCT00578786|7249868|FG001|Overall Study|Qualified but Not Enrolled in Extension|3
4461307|NCT00578786|7249869|FG002|Overall Study|Qualified but Not Enrolled in Extension|0
4461308|NCT00578812|7249889|FG000|Overall Study|Not treated|6
4461309|NCT00578812|7249890|FG001|Overall Study|Not treated|7
4461310|NCT00578864|7249899|FG000|Overall Study|Death|1
4461311|NCT00578864|7249900|FG001|Overall Study|Death|0
4461312|NCT00578877|7249908|FG000|Overall Study|Lost to Follow-up|8
4461313|NCT00578877|7249909|FG001|Overall Study|Lost to Follow-up|10
4461314|NCT00578877|7249908|FG000|Overall Study|early discontinue|61
4461315|NCT00578877|7249909|FG001|Overall Study|early discontinue|101
4461316|NCT00578877|7249908|FG000|Overall Study|did not provide follow-up data|12
4461317|NCT00578877|7249909|FG001|Overall Study|did not provide follow-up data|17
4461318|NCT00578942|7249937|FG000|Overall Study|Lost to Follow-up|1
4461319|NCT00579059|7249957|FG000|Overall Study|Study Canceled at 1 Year|21
4461320|NCT00579059|7249958|FG001|Overall Study|Study Canceled at 1 Year|10
4461321|NCT00579098|7249966|FG000|Overall Study|Lost to Follow-up|2
4461322|NCT00579098|7249967|FG001|Overall Study|Lost to Follow-up|0
4461323|NCT00579098|7249966|FG000|Overall Study|Adverse Event|2
4461324|NCT00579098|7249967|FG001|Overall Study|Adverse Event|3
4461325|NCT00579098|7249966|FG000|Overall Study|Withdrawal by Subject|2
4614606|NCT01725308|7472406|FG000|Treatment Period I|Changes in the Episodes|3
4614607|NCT01725308|7472407|FG001|Treatment Period I|Changes in the Episodes|0
4614608|NCT01725308|7472408|FG002|Treatment Period I|Changes in the Episodes|2
4614609|NCT01725308|7472406|FG000|Treatment Period I|Withdrawal of Consent|12
4614610|NCT01725308|7472407|FG001|Treatment Period I|Withdrawal of Consent|7
4614611|NCT01725308|7472408|FG002|Treatment Period I|Withdrawal of Consent|5
4614612|NCT01725308|7472406|FG000|Treatment Period I|Lost to Follow-up|3
4614613|NCT01725308|7472407|FG001|Treatment Period I|Lost to Follow-up|2
4614614|NCT01725308|7472408|FG002|Treatment Period I|Lost to Follow-up|2
4614615|NCT01725308|7472406|FG000|Treatment Period I|Protocol Deviations|3
4614616|NCT01725308|7472407|FG001|Treatment Period I|Protocol Deviations|1
4614617|NCT01725308|7472408|FG002|Treatment Period I|Protocol Deviations|1
4614618|NCT01725308|7472406|FG000|Treatment Period I|Miscellaneous|2
4614619|NCT01725308|7472407|FG001|Treatment Period I|Miscellaneous|0
4614620|NCT01725308|7472408|FG002|Treatment Period I|Miscellaneous|3
4614621|NCT01725308|7472406|FG000|Treatment Period II|Did Not Meet Transition Criteria|0
4461326|NCT00579098|7249967|FG001|Overall Study|Withdrawal by Subject|3
4461327|NCT00579098|7249966|FG000|Overall Study|AF returned after ablation|3
4461328|NCT00579098|7249967|FG001|Overall Study|AF returned after ablation|2
4461329|NCT00579345|7250007|FG000|Overall Study|Withdrawal by Subject|2
4461330|NCT00579345|7250008|FG001|Overall Study|Withdrawal by Subject|0
4461331|NCT00579345|7250009|FG002|Overall Study|Withdrawal by Subject|0
4461332|NCT00579345|7250010|FG003|Overall Study|Withdrawal by Subject|0
4461333|NCT00579345|7250011|FG004|Overall Study|Withdrawal by Subject|0
4539541|NCT01126541|7361919|FG001|Overall Study|Lost to Follow-up|2
4539542|NCT01126541|7361920|FG002|Overall Study|Lost to Follow-up|2
4539543|NCT01126541|7361918|FG000|Overall Study|Withdrawal by Subject|2
4539544|NCT01126541|7361919|FG001|Overall Study|Withdrawal by Subject|5
4539545|NCT01126541|7361920|FG002|Overall Study|Withdrawal by Subject|6
4539546|NCT01126541|7361918|FG000|Overall Study|Protocol Violation|0
4614622|NCT01725308|7472407|FG001|Treatment Period II|Did Not Meet Transition Criteria|3
4539547|NCT01126541|7361919|FG001|Overall Study|Protocol Violation|0
4539548|NCT01126541|7361920|FG002|Overall Study|Protocol Violation|1
4539549|NCT01126541|7361918|FG000|Overall Study|Administrative reason or other|1
4539550|NCT01126541|7361919|FG001|Overall Study|Administrative reason or other|1
4539551|NCT01126541|7361920|FG002|Overall Study|Administrative reason or other|2
4539552|NCT01126580|7361933|FG000|Overall Study|Adverse Event|14
4539553|NCT01126580|7361934|FG001|Overall Study|Adverse Event|8
4539554|NCT01126580|7361935|FG002|Overall Study|Adverse Event|12
4539555|NCT01126580|7361933|FG000|Overall Study|Withdrawal by Subject|11
4539556|NCT01126580|7361934|FG001|Overall Study|Withdrawal by Subject|19
4539557|NCT01126580|7361935|FG002|Overall Study|Withdrawal by Subject|14
4539558|NCT01126580|7361933|FG000|Overall Study|Sponsor Decision|5
4539559|NCT01126580|7361934|FG001|Overall Study|Sponsor Decision|4
4539560|NCT01126580|7361935|FG002|Overall Study|Sponsor Decision|7
4539561|NCT01126580|7361933|FG000|Overall Study|Physician Decision|1
4614623|NCT01725308|7472408|FG002|Treatment Period II|Did Not Meet Transition Criteria|4
4614624|NCT01725308|7472406|FG000|Treatment Period II|Did Not Receive Drug|4
4614625|NCT01725308|7472407|FG001|Treatment Period II|Did Not Receive Drug|0
4614626|NCT01725308|7472408|FG002|Treatment Period II|Did Not Receive Drug|0
4614627|NCT01725308|7472406|FG000|Treatment Period II|Adverse Event|13
4614628|NCT01725308|7472407|FG001|Treatment Period II|Adverse Event|8
4614629|NCT01725308|7472408|FG002|Treatment Period II|Adverse Event|20
4614630|NCT01725308|7472406|FG000|Treatment Period II|Insufficient Response|2
4614631|NCT01725308|7472407|FG001|Treatment Period II|Insufficient Response|4
4614632|NCT01725308|7472408|FG002|Treatment Period II|Insufficient Response|6
4614633|NCT01725308|7472406|FG000|Treatment Period II|Worsening of the Target Disease|1
4614634|NCT01725308|7472407|FG001|Treatment Period II|Worsening of the Target Disease|4
4614635|NCT01725308|7472408|FG002|Treatment Period II|Worsening of the Target Disease|2
4614636|NCT01725308|7472406|FG000|Treatment Period II|Changes in the Episodes|1
4614637|NCT01725308|7472407|FG001|Treatment Period II|Changes in the Episodes|0
4614638|NCT01725308|7472408|FG002|Treatment Period II|Changes in the Episodes|5
4614639|NCT01725308|7472406|FG000|Treatment Period II|Withdrawal of Consent|28
4614640|NCT01725308|7472407|FG001|Treatment Period II|Withdrawal of Consent|2
4614641|NCT01725308|7472408|FG002|Treatment Period II|Withdrawal of Consent|16
4614642|NCT01725308|7472406|FG000|Treatment Period II|Lost to Follow-up|1
4614643|NCT01725308|7472407|FG001|Treatment Period II|Lost to Follow-up|5
4614644|NCT01725308|7472408|FG002|Treatment Period II|Lost to Follow-up|3
4614645|NCT01725308|7472406|FG000|Treatment Period II|Protocol Deviations|0
4614646|NCT01725308|7472407|FG001|Treatment Period II|Protocol Deviations|0
4614647|NCT01725308|7472408|FG002|Treatment Period II|Protocol Deviations|1
4614648|NCT01725308|7472406|FG000|Treatment Period II|Miscellaneous|5
4614649|NCT01725308|7472407|FG001|Treatment Period II|Miscellaneous|3
4614650|NCT01725308|7472408|FG002|Treatment Period II|Miscellaneous|7
4614651|NCT01725386|7472425|FG000|Overall Study|Death|84
4614652|NCT01725386|7472426|FG001|Overall Study|Death|40
4614653|NCT01725386|7472425|FG000|Overall Study|Lost to Follow-up|81
4614654|NCT01725386|7472426|FG001|Overall Study|Lost to Follow-up|6
4539562|NCT01126580|7361934|FG001|Overall Study|Physician Decision|1
4539563|NCT01126580|7361935|FG002|Overall Study|Physician Decision|2
4614655|NCT01725386|7472425|FG000|Overall Study|Withdrawal by Subject|10
4614656|NCT01725386|7472426|FG001|Overall Study|Withdrawal by Subject|0
4614657|NCT01725451|7472432|FG000|Period 1|Withdrawal by Subject|1
4539564|NCT01126580|7361933|FG000|Overall Study|Entry Criteria Not Met|1
4539565|NCT01126580|7361934|FG001|Overall Study|Entry Criteria Not Met|1
4614658|NCT01725451|7472433|FG001|Period 1|Withdrawal by Subject|0
4614659|NCT01725451|7472434|FG002|Period 1|Withdrawal by Subject|0
4614660|NCT01725451|7472435|FG003|Period 1|Withdrawal by Subject|0
4614661|NCT01725451|7472432|FG000|Washout From Period 3|Protocol Violation|0
4614662|NCT01725451|7472433|FG001|Washout From Period 3|Protocol Violation|0
4539566|NCT01126580|7361935|FG002|Overall Study|Entry Criteria Not Met|2
4539567|NCT01126580|7361933|FG000|Overall Study|Lack of Efficacy|2
4539568|NCT01126580|7361934|FG001|Overall Study|Lack of Efficacy|3
4539569|NCT01126580|7361935|FG002|Overall Study|Lack of Efficacy|4
4539570|NCT01126580|7361933|FG000|Overall Study|Protocol Violation|0
4539571|NCT01126580|7361934|FG001|Overall Study|Protocol Violation|1
4539572|NCT01126580|7361935|FG002|Overall Study|Protocol Violation|2
4539573|NCT01126580|7361933|FG000|Overall Study|Lost to Follow-up|15
4539574|NCT01126580|7361934|FG001|Overall Study|Lost to Follow-up|13
4539575|NCT01126580|7361935|FG002|Overall Study|Lost to Follow-up|9
4539576|NCT01126580|7361933|FG000|Overall Study|Treatment Non-compliance|0
4539577|NCT01126580|7361934|FG001|Overall Study|Treatment Non-compliance|2
4539578|NCT01126580|7361935|FG002|Overall Study|Treatment Non-compliance|3
4614663|NCT01725451|7472434|FG002|Washout From Period 3|Protocol Violation|1
4461334|NCT00579345|7250012|FG005|Overall Study|Withdrawal by Subject|0
4461335|NCT00579345|7250013|FG006|Overall Study|Withdrawal by Subject|0
4461336|NCT00579345|7250014|FG007|Overall Study|Withdrawal by Subject|1
4461337|NCT00579345|7250007|FG000|Overall Study|Lost to Follow-up|1
4461338|NCT00579345|7250008|FG001|Overall Study|Lost to Follow-up|0
4461339|NCT00579345|7250009|FG002|Overall Study|Lost to Follow-up|0
4461340|NCT00579345|7250010|FG003|Overall Study|Lost to Follow-up|0
4461341|NCT00579345|7250011|FG004|Overall Study|Lost to Follow-up|0
4461342|NCT00579345|7250012|FG005|Overall Study|Lost to Follow-up|0
4461343|NCT00579345|7250013|FG006|Overall Study|Lost to Follow-up|0
4461344|NCT00579345|7250014|FG007|Overall Study|Lost to Follow-up|0
4461345|NCT00579345|7250007|FG000|Overall Study|Adverse Event|0
4461346|NCT00579345|7250008|FG001|Overall Study|Adverse Event|0
4461347|NCT00579345|7250009|FG002|Overall Study|Adverse Event|1
4461348|NCT00579345|7250010|FG003|Overall Study|Adverse Event|0
4461349|NCT00579345|7250011|FG004|Overall Study|Adverse Event|0
4461350|NCT00579345|7250012|FG005|Overall Study|Adverse Event|0
4461351|NCT00579345|7250013|FG006|Overall Study|Adverse Event|0
4461352|NCT00579345|7250014|FG007|Overall Study|Adverse Event|0
4461353|NCT00579345|7250007|FG000|Overall Study|Protocol Violation|1
4461354|NCT00579345|7250008|FG001|Overall Study|Protocol Violation|0
4461355|NCT00579345|7250009|FG002|Overall Study|Protocol Violation|0
4461356|NCT00579345|7250010|FG003|Overall Study|Protocol Violation|0
4461357|NCT00579345|7250011|FG004|Overall Study|Protocol Violation|0
4461358|NCT00579345|7250012|FG005|Overall Study|Protocol Violation|0
4461359|NCT00579345|7250013|FG006|Overall Study|Protocol Violation|0
4461360|NCT00579345|7250014|FG007|Overall Study|Protocol Violation|1
4461361|NCT00579345|7250007|FG000|Overall Study|Death|1
4461362|NCT00579345|7250008|FG001|Overall Study|Death|1
4461363|NCT00579345|7250009|FG002|Overall Study|Death|1
4461364|NCT00579345|7250010|FG003|Overall Study|Death|1
4461365|NCT00579345|7250011|FG004|Overall Study|Death|0
4461366|NCT00579345|7250012|FG005|Overall Study|Death|0
4461367|NCT00579345|7250013|FG006|Overall Study|Death|0
4461368|NCT00579345|7250014|FG007|Overall Study|Death|0
4461369|NCT00579501|7250051|FG000|Overall Study|Death|1
4461370|NCT00579501|7250051|FG000|Overall Study|End of neoadjuvant therapy|25
4614664|NCT01725451|7472435|FG003|Washout From Period 3|Protocol Violation|0
4614665|NCT01725451|7472432|FG000|Washout From Period 3|Adverse Event|0
4614666|NCT01725451|7472433|FG001|Washout From Period 3|Adverse Event|1
4614667|NCT01725451|7472434|FG002|Washout From Period 3|Adverse Event|0
4614668|NCT01725451|7472435|FG003|Washout From Period 3|Adverse Event|0
4614669|NCT01725451|7472432|FG000|Period 4|Adverse Event|0
4614670|NCT01725451|7472433|FG001|Period 4|Adverse Event|0
4614671|NCT01725451|7472434|FG002|Period 4|Adverse Event|1
4614672|NCT01725451|7472435|FG003|Period 4|Adverse Event|0
4614673|NCT01725529|7472453|FG000|Overall Study|Adverse Event|1
4614674|NCT01725529|7472454|FG001|Overall Study|Adverse Event|0
4614675|NCT01725529|7472455|FG002|Overall Study|Adverse Event|0
4614676|NCT01725529|7472453|FG000|Overall Study|Lost to Follow-up|2
4614677|NCT01725529|7472454|FG001|Overall Study|Lost to Follow-up|1
4614678|NCT01725529|7472455|FG002|Overall Study|Lost to Follow-up|1
4614679|NCT01725529|7472453|FG000|Overall Study|Protocol Violation|0
4614680|NCT01725529|7472454|FG001|Overall Study|Protocol Violation|1
4614681|NCT01725529|7472455|FG002|Overall Study|Protocol Violation|1
4614682|NCT01725529|7472453|FG000|Overall Study|Withdrawal by Subject|12
4614683|NCT01725529|7472454|FG001|Overall Study|Withdrawal by Subject|14
4614684|NCT01725529|7472455|FG002|Overall Study|Withdrawal by Subject|8
4614685|NCT01725750|7472465|FG000|Overall Study|Adverse Event|1
4614686|NCT01725750|7472466|FG001|Overall Study|Adverse Event|0
4614687|NCT01725750|7472465|FG000|Overall Study|Lost to Follow-up|1
4461371|NCT00579501|7250051|FG000|Overall Study|toxicity|1
4461372|NCT00579501|7250051|FG000|Overall Study|Secondary lesion|1
4461373|NCT00579501|7250051|FG000|Overall Study|Radiation therapy before surgery|1
4461374|NCT00579553|7250057|FG000|Overall Study|Lost to Follow-up|16
4461375|NCT00579553|7250058|FG001|Overall Study|Lost to Follow-up|13
4614688|NCT01725750|7472466|FG001|Overall Study|Lost to Follow-up|1
4614689|NCT01725750|7472465|FG000|Overall Study|Withdrawal by Subject|0
4614690|NCT01725750|7472466|FG001|Overall Study|Withdrawal by Subject|9
4614691|NCT01726023|7472494|FG000|Overall Study|Death|1
4614692|NCT01726023|7472495|FG001|Overall Study|Death|1
4614693|NCT01726023|7472494|FG000|Overall Study|Lost to Follow-up|5
4614694|NCT01726023|7472495|FG001|Overall Study|Lost to Follow-up|10
4614695|NCT01726023|7472494|FG000|Overall Study|Other Eligibility criteria|7
4461376|NCT00579670|7250069|FG000|Overall Study|Death|1
4461377|NCT00579670|7250070|FG001|Overall Study|Death|0
4461378|NCT00579670|7250071|FG002|Overall Study|Death|0
4461379|NCT00579670|7250072|FG003|Overall Study|Death|0
4461380|NCT00579670|7250073|FG004|Overall Study|Death|0
4461381|NCT00579670|7250069|FG000|Overall Study|Adverse Event|1
4461382|NCT00579670|7250070|FG001|Overall Study|Adverse Event|0
4461383|NCT00579670|7250071|FG002|Overall Study|Adverse Event|1
4461384|NCT00579670|7250072|FG003|Overall Study|Adverse Event|2
4461385|NCT00579670|7250073|FG004|Overall Study|Adverse Event|0
4461386|NCT00579670|7250069|FG000|Overall Study|Lack of Efficacy|0
4614696|NCT01726023|7472495|FG001|Overall Study|Other Eligibility criteria|7
4614697|NCT01726023|7472494|FG000|Overall Study|Withdrawal by Subject|16
4614698|NCT01726023|7472495|FG001|Overall Study|Withdrawal by Subject|8
4614699|NCT01726049|7472519|FG000|Overall Study|Death|1
4614700|NCT01726049|7472520|FG001|Overall Study|Death|1
4614701|NCT01726049|7472519|FG000|Overall Study|Adverse Event|4
4614702|NCT01726049|7472520|FG001|Overall Study|Adverse Event|1
4614703|NCT01726049|7472519|FG000|Overall Study|refused second HC|0
4614704|NCT01726049|7472520|FG001|Overall Study|refused second HC|2
4614705|NCT01726270|7472526|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10
4614706|NCT01726270|7472526|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20
4461387|NCT00579670|7250070|FG001|Overall Study|Lack of Efficacy|0
4461388|NCT00579670|7250071|FG002|Overall Study|Lack of Efficacy|1
4461389|NCT00579670|7250072|FG003|Overall Study|Lack of Efficacy|14
4461390|NCT00579670|7250073|FG004|Overall Study|Lack of Efficacy|0
4461391|NCT00579670|7250069|FG000|Overall Study|Lost to Follow-up|0
4461392|NCT00579670|7250070|FG001|Overall Study|Lost to Follow-up|1
4461393|NCT00579670|7250071|FG002|Overall Study|Lost to Follow-up|0
4461394|NCT00579670|7250072|FG003|Overall Study|Lost to Follow-up|4
4461395|NCT00579670|7250073|FG004|Overall Study|Lost to Follow-up|0
4461396|NCT00579670|7250069|FG000|Overall Study|Other|0
4461397|NCT00579670|7250070|FG001|Overall Study|Other|0
4461398|NCT00579670|7250071|FG002|Overall Study|Other|1
4461399|NCT00579670|7250072|FG003|Overall Study|Other|2
4461400|NCT00579670|7250073|FG004|Overall Study|Other|0
4461401|NCT00579670|7250069|FG000|Overall Study|Withdrawal by Subject|0
4461402|NCT00579670|7250070|FG001|Overall Study|Withdrawal by Subject|0
4461403|NCT00579670|7250071|FG002|Overall Study|Withdrawal by Subject|1
4461404|NCT00579670|7250072|FG003|Overall Study|Withdrawal by Subject|0
4461405|NCT00579670|7250073|FG004|Overall Study|Withdrawal by Subject|0
4461406|NCT00579982|7250120|FG000|Overall Study|Adverse Event|4
4461407|NCT00579982|7250120|FG000|Overall Study|Protocol Violation|4
4461408|NCT00580034|7250124|FG000|Overall Study|Toxicity|10
4461409|NCT00580034|7250125|FG001|Overall Study|Toxicity|0
4461410|NCT00580047|7250132|FG000|Overall Study|Lost to Follow-up|1
4461411|NCT00580047|7250133|FG001|Overall Study|Lost to Follow-up|1
4461412|NCT00580047|7250134|FG002|Overall Study|Lost to Follow-up|0
4461413|NCT00580047|7250132|FG000|Overall Study|Withdrawal by Subject|1
4461414|NCT00580047|7250133|FG001|Overall Study|Withdrawal by Subject|1
4461415|NCT00580047|7250134|FG002|Overall Study|Withdrawal by Subject|2
4461416|NCT00580047|7250132|FG000|Overall Study|Withdrawal by Subject|1
4461417|NCT00580047|7250133|FG001|Overall Study|Withdrawal by Subject|0
4461418|NCT00580047|7250134|FG002|Overall Study|Withdrawal by Subject|0
4461419|NCT00580606|7250194|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2
4461420|NCT00580606|7250195|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1
4461421|NCT00580606|7250194|FG000|Open Label (OL)|Withdrawal by Subject|4
4461422|NCT00580606|7250195|FG001|Open Label (OL)|Withdrawal by Subject|6
4461423|NCT00580606|7250194|FG000|Open Label (OL)|Dosing Symptoms|0
4461424|NCT00580606|7250195|FG001|Open Label (OL)|Dosing Symptoms|1
4461425|NCT00580606|7250194|FG000|Open Label (OL)|Lost to Follow-up|0
4461426|NCT00580606|7250195|FG001|Open Label (OL)|Lost to Follow-up|1
4461427|NCT00580606|7250194|FG000|Open Label (OL)|Pregnancy|0
4461428|NCT00580606|7250195|FG001|Open Label (OL)|Pregnancy|1
4461429|NCT00580606|7250194|FG000|Open Label (OL)|Non-compliance|2
4461430|NCT00580606|7250195|FG001|Open Label (OL)|Non-compliance|0
4461431|NCT00580606|7250194|FG000|Open Label (OL)|Physician Decision|1
4461432|NCT00580606|7250195|FG001|Open Label (OL)|Physician Decision|1
4461433|NCT00580606|7250194|FG000|Open Label (OL)|Needed Prohibited Medication|0
4461434|NCT00580606|7250195|FG001|Open Label (OL)|Needed Prohibited Medication|1
4461435|NCT00580723|7250235|FG000|Overall Study|Did not want to participate in extension|3
4461436|NCT00580723|7250235|FG000|Overall Study|Lost to Follow-up|5
4461437|NCT00580788|7250243|FG000|Overall Study|Adverse Event|0
4461438|NCT00580788|7250244|FG001|Overall Study|Adverse Event|0
4461439|NCT00580788|7250245|FG002|Overall Study|Adverse Event|0
4461440|NCT00580788|7250246|FG003|Overall Study|Adverse Event|1
4461441|NCT00580801|7250266|FG000|Overall Study|Physician Decision|1
4461442|NCT00580801|7250267|FG001|Overall Study|Physician Decision|0
4461443|NCT00580801|7250268|FG002|Overall Study|Physician Decision|0
4461444|NCT00580801|7250266|FG000|Overall Study|Adverse Event|2
4461445|NCT00580801|7250267|FG001|Overall Study|Adverse Event|0
4461446|NCT00580801|7250268|FG002|Overall Study|Adverse Event|0
4461447|NCT00580801|7250266|FG000|Overall Study|Lost to Follow-up|2
4461448|NCT00580801|7250267|FG001|Overall Study|Lost to Follow-up|0
4614707|NCT01726270|7472526|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21
4614708|NCT01726270|7472526|FG000|Part 2, Actual-Use Phase|Adverse Event|6
4461449|NCT00580801|7250268|FG002|Overall Study|Lost to Follow-up|0
4461450|NCT00580801|7250266|FG000|Overall Study|Reached a virologic endpoint|0
4461451|NCT00580801|7250267|FG001|Overall Study|Reached a virologic endpoint|1
4461452|NCT00580801|7250268|FG002|Overall Study|Reached a virologic endpoint|2
4461453|NCT00580801|7250266|FG000|Overall Study|Participant non-compliant|0
4461454|NCT00580801|7250267|FG001|Overall Study|Participant non-compliant|0
4461455|NCT00580801|7250268|FG002|Overall Study|Participant non-compliant|1
4461456|NCT00580801|7250266|FG000|Overall Study|Travel|1
4461457|NCT00580801|7250267|FG001|Overall Study|Travel|0
4461458|NCT00580801|7250268|FG002|Overall Study|Travel|0
4461459|NCT00580840|7250276|FG000|Run-in|Adverse Event|17
4461460|NCT00580840|7250277|FG001|Run-in|Adverse Event|0
4461461|NCT00580840|7250278|FG002|Run-in|Adverse Event|0
4461462|NCT00580840|7250279|FG003|Run-in|Adverse Event|0
4461463|NCT00580840|7250276|FG000|Run-in|Lack of Efficacy|93
4461464|NCT00580840|7250277|FG001|Run-in|Lack of Efficacy|0
4461465|NCT00580840|7250278|FG002|Run-in|Lack of Efficacy|0
4461466|NCT00580840|7250279|FG003|Run-in|Lack of Efficacy|0
4461467|NCT00580840|7250276|FG000|Run-in|Loss of Efficacy|1
4461468|NCT00580840|7250277|FG001|Run-in|Loss of Efficacy|0
4461469|NCT00580840|7250278|FG002|Run-in|Loss of Efficacy|0
4461470|NCT00580840|7250279|FG003|Run-in|Loss of Efficacy|0
4461471|NCT00580840|7250276|FG000|Run-in|Lost to Follow-up|4
4461472|NCT00580840|7250277|FG001|Run-in|Lost to Follow-up|0
4461473|NCT00580840|7250278|FG002|Run-in|Lost to Follow-up|0
4461474|NCT00580840|7250279|FG003|Run-in|Lost to Follow-up|0
4461475|NCT00580840|7250276|FG000|Run-in|Withdrawal by Subject|5
4461476|NCT00580840|7250277|FG001|Run-in|Withdrawal by Subject|0
4461477|NCT00580840|7250278|FG002|Run-in|Withdrawal by Subject|0
4461478|NCT00580840|7250279|FG003|Run-in|Withdrawal by Subject|0
4461479|NCT00580840|7250276|FG000|Run-in|Other: Per Sponsor Request|2
4461480|NCT00580840|7250277|FG001|Run-in|Other: Per Sponsor Request|0
4461481|NCT00580840|7250278|FG002|Run-in|Other: Per Sponsor Request|0
4461482|NCT00580840|7250279|FG003|Run-in|Other: Per Sponsor Request|0
4461483|NCT00580840|7250276|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1
4461484|NCT00580840|7250277|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0
4461485|NCT00580840|7250278|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0
4461486|NCT00580840|7250279|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0
4461487|NCT00580840|7250276|FG000|Run-in|Other: Exclusionary Lab Value|1
4461488|NCT00580840|7250277|FG001|Run-in|Other: Exclusionary Lab Value|0
4461489|NCT00580840|7250278|FG002|Run-in|Other: Exclusionary Lab Value|0
4461490|NCT00580840|7250279|FG003|Run-in|Other: Exclusionary Lab Value|0
4461491|NCT00580840|7250276|FG000|Double-Blind|Adverse Event|0
4461492|NCT00580840|7250277|FG001|Double-Blind|Adverse Event|3
4461493|NCT00580840|7250278|FG002|Double-Blind|Adverse Event|4
4539579|NCT01126619|7361957|FG000|Overall Study|Not eligible for the study|2
4461494|NCT00580840|7250279|FG003|Double-Blind|Adverse Event|1
4461495|NCT00580840|7250276|FG000|Double-Blind|Loss of Efficacy|0
4461496|NCT00580840|7250277|FG001|Double-Blind|Loss of Efficacy|1
4539580|NCT01126619|7361957|FG000|Overall Study|Investigator decision|4
4539581|NCT01126619|7361957|FG000|Overall Study|Serious adverse event|1
4539582|NCT01126619|7361957|FG000|Overall Study|Withdrawal by Subject|9
4461497|NCT00580840|7250278|FG002|Double-Blind|Loss of Efficacy|2
4461498|NCT00580840|7250279|FG003|Double-Blind|Loss of Efficacy|10
4461499|NCT00580840|7250276|FG000|Double-Blind|Lost to Follow-up|0
4461500|NCT00580840|7250277|FG001|Double-Blind|Lost to Follow-up|1
4461501|NCT00580840|7250278|FG002|Double-Blind|Lost to Follow-up|0
4461502|NCT00580840|7250279|FG003|Double-Blind|Lost to Follow-up|2
4461503|NCT00580840|7250276|FG000|Double-Blind|Withdrawal by Subject|0
4461504|NCT00580840|7250277|FG001|Double-Blind|Withdrawal by Subject|1
4461505|NCT00580840|7250278|FG002|Double-Blind|Withdrawal by Subject|2
4461506|NCT00580840|7250279|FG003|Double-Blind|Withdrawal by Subject|2
4461507|NCT00580840|7250276|FG000|Double-Blind|Other: Discontinued Methotrexate|0
4461508|NCT00580840|7250277|FG001|Double-Blind|Other: Discontinued Methotrexate|1
4461509|NCT00580840|7250278|FG002|Double-Blind|Other: Discontinued Methotrexate|0
4461510|NCT00580840|7250279|FG003|Double-Blind|Other: Discontinued Methotrexate|0
4461511|NCT00580840|7250276|FG000|Double-Blind|Other: Forbidden Medication|0
4461512|NCT00580840|7250277|FG001|Double-Blind|Other: Forbidden Medication|0
4461513|NCT00580840|7250278|FG002|Double-Blind|Other: Forbidden Medication|1
4461514|NCT00580840|7250279|FG003|Double-Blind|Other: Forbidden Medication|0
4461515|NCT00580866|7250304|FG000|Overall Study|Lost to Follow-up|2
4461516|NCT00580866|7250305|FG001|Overall Study|Lost to Follow-up|2
4461517|NCT00580970|7250322|FG000|Pre-treatment|Non-compliance|1
4461518|NCT00580970|7250322|FG000|Treatment (Lovastatin)|Non-compliance|6
4461519|NCT00580970|7250322|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7
4461520|NCT00580970|7250322|FG000|Treatment (Lovastatin)|Physician Decision|4
4461521|NCT00580970|7250322|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1
4461522|NCT00580970|7250322|FG000|Treatment (Lovastatin)|Death|1
4461523|NCT00580983|7250326|FG000|Overall Study|Did not complete 12 mon post RT studies|7
4539583|NCT01126619|7361957|FG000|Overall Study|Non-compliance|1
4461524|NCT00581100|7250343|FG000|Overall Study|Death|1
4461525|NCT00581100|7250344|FG001|Overall Study|Death|0
4461526|NCT00581100|7250343|FG000|Overall Study|Adverse Event|2
4461527|NCT00581100|7250344|FG001|Overall Study|Adverse Event|1
4461528|NCT00581100|7250343|FG000|Overall Study|Withdrawal by Subject|1
4461529|NCT00581100|7250344|FG001|Overall Study|Withdrawal by Subject|4
4461530|NCT00581100|7250343|FG000|Overall Study|Other|3
4614709|NCT01726270|7472526|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5
4614710|NCT01726270|7472526|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7
4461531|NCT00581100|7250344|FG001|Overall Study|Other|0
4461532|NCT00581308|7250366|FG000|Pre Discharge|Lost to Follow-up|1
4461533|NCT00581308|7250366|FG000|Pre Discharge|Device Removed|1
4461534|NCT00581308|7250366|FG000|Month 1|Lost to Follow-up|3
4461535|NCT00581308|7250366|FG000|Month 1|Withdrawal by Subject|2
4461536|NCT00581308|7250366|FG000|Month 1|Device Removed|2
4461537|NCT00581308|7250366|FG000|Month 1|Uknown|1
4461538|NCT00581308|7250366|FG000|Month 6|Lost to Follow-up|1
4461539|NCT00581308|7250366|FG000|Month 6|Withdrawal by Subject|2
4461540|NCT00581308|7250366|FG000|Month 12|Death|1
4461541|NCT00581308|7250366|FG000|Month 12|Lost to Follow-up|14
4461542|NCT00581308|7250366|FG000|Month 12|Withdrawal by Subject|3
4461543|NCT00581308|7250366|FG000|Month 12|Device Removed|1
4461544|NCT00581308|7250366|FG000|Month 12|Other|1
4461545|NCT00581360|7250382|FG000|Overall Study|Withdrawal by Subject|1
4461546|NCT00581542|7250414|FG000|Overall Study|they met an exclusion criteria|2
4461547|NCT00581542|7250415|FG001|Overall Study|they met an exclusion criteria|2
4461548|NCT00581542|7250414|FG000|Overall Study|Lost to Follow-up|9
4461549|NCT00581542|7250415|FG001|Overall Study|Lost to Follow-up|21
4461550|NCT00581555|7250425|FG000|Overall Study|Adverse Event|4
4461551|NCT00581555|7250426|FG001|Overall Study|Adverse Event|3
4461552|NCT00581555|7250425|FG000|Overall Study|Physician Decision|3
4461553|NCT00581555|7250426|FG001|Overall Study|Physician Decision|2
4461554|NCT00581555|7250425|FG000|Overall Study|Withdrawal by Subject|18
4461555|NCT00581555|7250426|FG001|Overall Study|Withdrawal by Subject|9
4461556|NCT00581555|7250425|FG000|Overall Study|Lost to Follow-up|2
4461557|NCT00581555|7250426|FG001|Overall Study|Lost to Follow-up|2
4461558|NCT00581555|7250425|FG000|Overall Study|Other reasons|16
4461559|NCT00581555|7250426|FG001|Overall Study|Other reasons|4
4461560|NCT00581776|7250441|FG000|Overall Study|Disease progression or no response|3
4461561|NCT00581828|7250445|FG000|Overall Study|Protocol Violation|1
4461562|NCT00581893|7250460|FG000|Second Intervention (1 Month)|Lost to Follow-up|3
4461563|NCT00581893|7250461|FG001|Second Intervention (1 Month)|Lost to Follow-up|2
4461564|NCT00581919|7250467|FG000|Overall Study|Adverse Event|8
4461565|NCT00581919|7250467|FG000|Overall Study|Death|1
4461566|NCT00581919|7250467|FG000|Overall Study|Disease Progression|10
4461567|NCT00581919|7250467|FG000|Overall Study|Physician Decision|1
4461568|NCT00581919|7250467|FG000|Overall Study|Other Complicating Disease|1
4461569|NCT00581919|7250467|FG000|Overall Study|Started Non-Protocol Therapy|2
4461570|NCT00581919|7250467|FG000|Overall Study|Withdrawal by Subject|1
4461571|NCT00581945|7250474|FG000|Overall Study|Adverse Event|4
4461572|NCT00581945|7250475|FG001|Overall Study|Adverse Event|4
4461573|NCT00581945|7250474|FG000|Overall Study|Unsatisfactory therapeutic effect|2
4461574|NCT00581945|7250475|FG001|Overall Study|Unsatisfactory therapeutic effect|0
4461575|NCT00581945|7250474|FG000|Overall Study|Withdrawal by Subject|2
4461576|NCT00581945|7250475|FG001|Overall Study|Withdrawal by Subject|6
4461577|NCT00581945|7250474|FG000|Overall Study|Death|1
4461578|NCT00581945|7250475|FG001|Overall Study|Death|0
4461579|NCT00582010|7250488|FG000|Overall Study|Death|0
4461580|NCT00582010|7250489|FG001|Overall Study|Death|1
4461581|NCT00582114|7250501|FG000|Overall Study|Death|4
4461582|NCT00582114|7250502|FG001|Overall Study|Death|4
4461583|NCT00582114|7250501|FG000|Overall Study|Kidney Transplant|3
4461584|NCT00582114|7250502|FG001|Overall Study|Kidney Transplant|1
4461585|NCT00582114|7250501|FG000|Overall Study|Lost to Follow-up|7
4461586|NCT00582114|7250502|FG001|Overall Study|Lost to Follow-up|6
4461587|NCT00582114|7250501|FG000|Overall Study|Withdrawal by Subject|8
4461588|NCT00582114|7250502|FG001|Overall Study|Withdrawal by Subject|16
4461589|NCT00582114|7250501|FG000|Overall Study|Adverse Event|1
4461590|NCT00582114|7250502|FG001|Overall Study|Adverse Event|1
4461591|NCT00582114|7250501|FG000|Overall Study|Physician Decision|0
4461592|NCT00582114|7250502|FG001|Overall Study|Physician Decision|6
4539584|NCT01127061|7361985|FG000|Overall Study|Lost to Follow-up|7
4461593|NCT00582114|7250501|FG000|Overall Study|Stopped by data safety monitoring board|19
4461594|NCT00582114|7250502|FG001|Overall Study|Stopped by data safety monitoring board|20
4461595|NCT00582166|7250508|FG000|Overall Study|Death|1
4539585|NCT01127061|7361986|FG001|Overall Study|Lost to Follow-up|10
4539586|NCT01127061|7361985|FG000|Overall Study|Physician Decision|3
4539587|NCT01127061|7361986|FG001|Overall Study|Physician Decision|3
4539588|NCT01127139|7362003|FG000|Overall Study|Adverse Event|40
4539589|NCT01127139|7362003|FG000|Overall Study|Incompliance|12
4461596|NCT00582166|7250508|FG000|Overall Study|Ineligible pathology|1
4461597|NCT00582309|7250519|FG000|Overall Study|Protocol Violation|0
4461598|NCT00582309|7250520|FG001|Overall Study|Protocol Violation|0
4461599|NCT00582309|7250521|FG002|Overall Study|Protocol Violation|2
4461600|NCT00582426|7250544|FG000|Overall Study|Lost to Follow-up|0
4461601|NCT00582426|7250545|FG001|Overall Study|Lost to Follow-up|2
4461602|NCT00582426|7250544|FG000|Overall Study|Adverse Event|4
4461603|NCT00582426|7250545|FG001|Overall Study|Adverse Event|2
4461604|NCT00582426|7250544|FG000|Overall Study|Protocol Violation|6
4461605|NCT00582426|7250545|FG001|Overall Study|Protocol Violation|2
4539590|NCT01127139|7362003|FG000|Overall Study|Lack of Efficacy|4
4461606|NCT00582426|7250544|FG000|Overall Study|Death|4
4461607|NCT00582426|7250545|FG001|Overall Study|Death|3
4461608|NCT00582426|7250544|FG000|Overall Study|Withdrawal by Subject|3
4461609|NCT00582426|7250545|FG001|Overall Study|Withdrawal by Subject|2
4461610|NCT00582426|7250544|FG000|Overall Study|Disease Progression|2
4461611|NCT00582426|7250545|FG001|Overall Study|Disease Progression|2
4461612|NCT00582426|7250544|FG000|Overall Study|Use of illicit drugs|1
4461613|NCT00582426|7250545|FG001|Overall Study|Use of illicit drugs|0
4461614|NCT00582491|7250553|FG000|Overall Study|Withdrawal by Subject|1
4461615|NCT00582491|7250554|FG001|Overall Study|Withdrawal by Subject|0
4461616|NCT00582556|7250572|FG000|Overall Study|Withdrawal by Subject|0
4461617|NCT00582556|7250573|FG001|Overall Study|Withdrawal by Subject|1
4461618|NCT00582556|7250574|FG002|Overall Study|Withdrawal by Subject|1
4461619|NCT00582556|7250572|FG000|Overall Study|Physician Decision|0
4461620|NCT00582556|7250573|FG001|Overall Study|Physician Decision|0
4461621|NCT00582556|7250574|FG002|Overall Study|Physician Decision|1
4539591|NCT01127139|7362003|FG000|Overall Study|Reason not specified|1
4539592|NCT01127165|7362012|FG000|Overall Study|Adverse Event|2
4539593|NCT01127165|7362013|FG001|Overall Study|Adverse Event|2
4539594|NCT01127165|7362012|FG000|Overall Study|Lack of Efficacy|10
4539595|NCT01127165|7362013|FG001|Overall Study|Lack of Efficacy|8
4539596|NCT01127165|7362012|FG000|Overall Study|Lost to Follow-up|3
4539597|NCT01127165|7362013|FG001|Overall Study|Lost to Follow-up|5
4614711|NCT01726335|7472532|FG000|Overall Study|Lost to Follow-up|2
4614712|NCT01726335|7472532|FG000|Overall Study|Withdrawal by Subject|15
4614713|NCT01726335|7472532|FG000|Overall Study|Adverse Event|4
4614714|NCT01726335|7472532|FG000|Overall Study|Lost to Follow-up|2
4614715|NCT01726335|7472532|FG000|Overall Study|Exacerbation of psychotic symptoms|1
4614716|NCT01726517|7472550|FG000|Overall Study|Withdrawal by Subject|0
4614717|NCT01726517|7472551|FG001|Overall Study|Withdrawal by Subject|0
4614718|NCT01726517|7472552|FG002|Overall Study|Withdrawal by Subject|1
4614719|NCT01726517|7472553|FG003|Overall Study|Withdrawal by Subject|0
4614720|NCT01726517|7472554|FG004|Overall Study|Withdrawal by Subject|0
4614721|NCT01726803|7472585|FG000|Overall Study|Lost to Follow-up|6
4614722|NCT01726803|7472586|FG001|Overall Study|Lost to Follow-up|1
4614723|NCT01726803|7472585|FG000|Overall Study|Withdrawal by Subject|1
4614724|NCT01726803|7472586|FG001|Overall Study|Withdrawal by Subject|0
4614725|NCT01727024|7472592|FG000|Period 1|Lost to Follow-up|1
4614726|NCT01727024|7472593|FG001|Period 1|Lost to Follow-up|1
4614727|NCT01727024|7472592|FG000|Period 1|Withdrawal by Subject|2
4690396|NCT02561195|7600193|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0
4461622|NCT00582608|7250583|FG000|Overall Study|Not Treated|7
4461623|NCT00582608|7250583|FG000|Overall Study|Patient Ineligible|1
4461624|NCT00582608|7250583|FG000|Overall Study|Lack of accrual|4
4461625|NCT00582738|7250598|FG000|Overall Study|Administrative Problems|7
4461626|NCT00582738|7250599|FG001|Overall Study|Administrative Problems|8
4461627|NCT00582738|7250598|FG000|Overall Study|Adverse Event|0
4461628|NCT00582738|7250599|FG001|Overall Study|Adverse Event|5
4461629|NCT00582738|7250598|FG000|Overall Study|Graft Lost|0
4461630|NCT00582738|7250599|FG001|Overall Study|Graft Lost|1
4461631|NCT00582738|7250598|FG000|Overall Study|Other|1
4461632|NCT00582738|7250599|FG001|Overall Study|Other|0
4461633|NCT00582738|7250598|FG000|Overall Study|Protocol Violation|1
4461634|NCT00582738|7250599|FG001|Overall Study|Protocol Violation|1
4461635|NCT00582738|7250598|FG000|Overall Study|Withdrawal by Subject|0
4461636|NCT00582738|7250599|FG001|Overall Study|Withdrawal by Subject|3
4461637|NCT00582790|7250611|FG000|Overall Study|Rapid progression of disease|1
4461638|NCT00582816|7250616|FG000|Overall Study|Engraftment Failure|3
4516040|NCT00958126|7327339|FG003|Overall Study|Moved away from study area|1
4516041|NCT00958126|7327340|FG004|Overall Study|Moved away from study area|0
4516042|NCT00958126|7327341|FG005|Overall Study|Moved away from study area|0
4516043|NCT00958126|7327342|FG006|Overall Study|Moved away from study area|0
4516044|NCT00958126|7327343|FG007|Overall Study|Moved away from study area|0
4516045|NCT00958126|7327336|FG000|Overall Study|Lost to Follow-up|1
4516046|NCT00958126|7327337|FG001|Overall Study|Lost to Follow-up|5
4516047|NCT00958126|7327338|FG002|Overall Study|Lost to Follow-up|9
4516048|NCT00958126|7327339|FG003|Overall Study|Lost to Follow-up|8
4539598|NCT01127165|7362012|FG000|Overall Study|Withdrawal by Subject|1
4539599|NCT01127165|7362013|FG001|Overall Study|Withdrawal by Subject|3
4539600|NCT01127165|7362012|FG000|Overall Study|Protocol Violation|0
4539601|NCT01127165|7362013|FG001|Overall Study|Protocol Violation|1
4539602|NCT01127373|7362040|FG000|Overall Study|Not Treated|3
4539603|NCT01127373|7362040|FG000|Overall Study|Lost to Follow-up|7
4539604|NCT01127373|7362040|FG000|Overall Study|Withdrawal by Subject|1
4539605|NCT01127373|7362040|FG000|Overall Study|Disease progression|1
4539606|NCT01127607|7362076|FG000|Phase II (Between Subjects)|Lost to Follow-up|0
4539607|NCT01127607|7362077|FG001|Phase II (Between Subjects)|Lost to Follow-up|2
4539608|NCT01127607|7362076|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1
4539609|NCT01127607|7362077|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0
4539610|NCT01127633|7362102|FG000|Overall Study|Adverse Event|74
4614728|NCT01727024|7472593|FG001|Period 1|Withdrawal by Subject|3
4614729|NCT01727141|7472612|FG000|Overall Study|Physician Decision|0
4614730|NCT01727141|7472613|FG001|Overall Study|Physician Decision|1
4614731|NCT01727141|7472614|FG002|Overall Study|Physician Decision|0
4614732|NCT01727141|7472615|FG003|Overall Study|Physician Decision|2
4461639|NCT00582907|7250624|FG000|1st Course|Withdrawal by Subject|1
4461640|NCT00582907|7250625|FG001|1st Course|Withdrawal by Subject|0
4461641|NCT00582907|7250626|FG002|1st Course|Withdrawal by Subject|0
4461642|NCT00582907|7250627|FG003|1st Course|Withdrawal by Subject|0
4461643|NCT00582907|7250624|FG000|1st Course|Lost to Follow-up|0
4461644|NCT00582907|7250625|FG001|1st Course|Lost to Follow-up|0
4461645|NCT00582907|7250626|FG002|1st Course|Lost to Follow-up|0
4461646|NCT00582907|7250627|FG003|1st Course|Lost to Follow-up|1
4461647|NCT00582907|7250624|FG000|2nd Course|Lack of Efficacy|1
4461648|NCT00582907|7250625|FG001|2nd Course|Lack of Efficacy|0
4461649|NCT00582907|7250626|FG002|2nd Course|Lack of Efficacy|0
4461650|NCT00582907|7250627|FG003|2nd Course|Lack of Efficacy|0
4461651|NCT00582933|7250633|FG000|Overall Study|Physician Decision|3
4539611|NCT01127633|7362103|FG001|Overall Study|Adverse Event|73
4461652|NCT00582972|7250641|FG000|Overall Study|Protocol Violation|2
4461653|NCT00583102|7250669|FG000|Overall Study|Adverse Event|3
4461654|NCT00583219|7250673|FG000|Phase 2|Withdrawal by Subject|1
4461655|NCT00583362|7250677|FG000|Overall Study|Adverse Event|44
4461656|NCT00583362|7250677|FG000|Overall Study|Lack of Efficacy|22
4461657|NCT00583362|7250677|FG000|Overall Study|Lost to Follow-up|4
4461658|NCT00583362|7250677|FG000|Overall Study|Non-compliance with study drug|28
4461659|NCT00583362|7250677|FG000|Overall Study|Pregnancy|7
4461660|NCT00583362|7250677|FG000|Overall Study|Miscommunication of visit window|5
4461661|NCT00583362|7250677|FG000|Overall Study|Current site closed|7
4461662|NCT00583362|7250677|FG000|Overall Study|Subject not dosed in LBSL99|1
4461663|NCT00583362|7250677|FG000|Overall Study|Subject moved out of the country/state|2
4461664|NCT00583362|7250677|FG000|Overall Study|Missed visits due to staff changes|1
4461665|NCT00583362|7250677|FG000|Overall Study|Misunderstanding of protocol|1
4461666|NCT00583362|7250677|FG000|Overall Study|Behavioral problems and non-compliance|1
4461667|NCT00583362|7250677|FG000|Overall Study|Sponsor request due to missed doses|1
4461668|NCT00583362|7250677|FG000|Overall Study|Physician Decision|19
4461669|NCT00583362|7250677|FG000|Overall Study|Protocol Violation|2
4461670|NCT00583362|7250677|FG000|Overall Study|Withdrawal by Subject|57
4461671|NCT00583453|7250696|FG000|Overall Study|discontinued intervention|0
4461672|NCT00583453|7250697|FG001|Overall Study|discontinued intervention|2
4461673|NCT00583557|7250714|FG000|Overall Study|Withdrawal by Subject|18
4461674|NCT00583557|7250714|FG000|Overall Study|Adverse Event|9
4461675|NCT00583557|7250714|FG000|Overall Study|Lack of Efficacy|31
4461676|NCT00583557|7250714|FG000|Overall Study|Lack of Compliance|5
4461677|NCT00583557|7250714|FG000|Overall Study|Other|5
4461678|NCT00583557|7250714|FG000|Overall Study|Did not receive belimumab in LBRA99|2
4461679|NCT00583596|7250718|FG000|Overall Study|Lost to Follow-up|110
4461680|NCT00583596|7250718|FG000|Overall Study|Excluded due to Hurricane Katrina|30
4461681|NCT00583596|7250718|FG000|Overall Study|Death|2
4461682|NCT00583596|7250718|FG000|Overall Study|Withdrawal by Subject|6
4461683|NCT00583596|7250718|FG000|Overall Study|Lost to Follow-up|94
4461684|NCT00583596|7250718|FG000|Overall Study|Data not complete|1
4461685|NCT00583596|7250718|FG000|Overall Study|Not consented|15
4539612|NCT01127633|7362102|FG000|Overall Study|Death|40
4539613|NCT01127633|7362103|FG001|Overall Study|Death|43
4539614|NCT01127633|7362102|FG000|Overall Study|Lost to Follow-up|4
4614733|NCT01727141|7472612|FG000|Overall Study|Lost to Follow-up|0
4614734|NCT01727141|7472613|FG001|Overall Study|Lost to Follow-up|2
4614735|NCT01727141|7472614|FG002|Overall Study|Lost to Follow-up|0
4614736|NCT01727141|7472615|FG003|Overall Study|Lost to Follow-up|0
4614737|NCT01727141|7472612|FG000|Overall Study|Death|0
4461686|NCT00583596|7250718|FG000|Overall Study|Outside f-up window|26
4461687|NCT00583791|7250754|FG000|Overall Study|Other|67
4461688|NCT00583791|7250754|FG000|Overall Study|Death|6
4461689|NCT00583947|7250789|FG000|Cross-over Period|Adverse Event|2
4539615|NCT01127633|7362103|FG001|Overall Study|Lost to Follow-up|0
4539616|NCT01127633|7362102|FG000|Overall Study|Parent/Caregiver Decision|246
4539617|NCT01127633|7362103|FG001|Overall Study|Parent/Caregiver Decision|228
4539618|NCT01127633|7362102|FG000|Overall Study|Physician Decision|60
4539619|NCT01127633|7362103|FG001|Overall Study|Physician Decision|45
4539620|NCT01127633|7362102|FG000|Overall Study|Withdrawal by Subject|57
4539621|NCT01127633|7362103|FG001|Overall Study|Withdrawal by Subject|72
4539622|NCT01127633|7362102|FG000|Overall Study|Sponsor Decision|163
4539623|NCT01127633|7362103|FG001|Overall Study|Sponsor Decision|195
4539624|NCT01127633|7362102|FG000|Overall Study|Protocol Violation|8
4539625|NCT01127633|7362103|FG001|Overall Study|Protocol Violation|16
4539626|NCT01127633|7362102|FG000|Overall Study|Abnormal Lab/ECG Result|0
4539627|NCT01127633|7362103|FG001|Overall Study|Abnormal Lab/ECG Result|1
4539628|NCT01127633|7362102|FG000|Overall Study|Not treated|1
4539629|NCT01127633|7362103|FG001|Overall Study|Not treated|0
4539630|NCT01127646|7362111|FG000|Overall Study|Entry Criteria Not Met|1
4539631|NCT01127646|7362112|FG001|Overall Study|Entry Criteria Not Met|0
4539632|NCT01127646|7362111|FG000|Overall Study|Protocol Violation|0
4539633|NCT01127646|7362112|FG001|Overall Study|Protocol Violation|1
4539634|NCT01127763|7362154|FG000|Overall Study|Adverse Event|2
4539635|NCT01127763|7362154|FG000|Overall Study|Withdrawal by Subject|1
4539636|NCT01127763|7362154|FG000|Overall Study|Physician Decision|2
4539637|NCT01127893|7362162|FG000|Overall Study|Study Termination by the Sponsor|1
4614738|NCT01727141|7472613|FG001|Overall Study|Death|1
4614739|NCT01727141|7472614|FG002|Overall Study|Death|1
4461690|NCT00583947|7250790|FG001|Cross-over Period|Adverse Event|0
4461691|NCT00583947|7250789|FG000|Cross-over Period|Withdrawal by Subject|2
4461692|NCT00583947|7250790|FG001|Cross-over Period|Withdrawal by Subject|0
4461693|NCT00583947|7250789|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0
4461694|NCT00583947|7250790|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1
4461695|NCT00583947|7250789|FG000|Cross-over Period|Other|1
4461696|NCT00583947|7250790|FG001|Cross-over Period|Other|1
4461697|NCT00584194|7250803|FG000|Overall Study|Other|135
4461698|NCT00584415|7250822|FG000|Overall Study|Adverse Event|7
4461699|NCT00584454|7250827|FG000|Overall Study|Adverse Event|1
4539638|NCT01128153|7362181|FG000|Overall Study|Adverse Event|1
4539639|NCT01128153|7362182|FG001|Overall Study|Adverse Event|3
4539640|NCT01128153|7362181|FG000|Overall Study|Condition under investigation worsened|8
4539641|NCT01128153|7362182|FG001|Overall Study|Condition under investigation worsened|7
4539642|NCT01128153|7362181|FG000|Overall Study|Withdrawal by Subject|2
4539643|NCT01128153|7362182|FG001|Overall Study|Withdrawal by Subject|3
4539644|NCT01128153|7362181|FG000|Overall Study|Incorrect enrolment to study|2
4539645|NCT01128153|7362182|FG001|Overall Study|Incorrect enrolment to study|1
4539646|NCT01128153|7362181|FG000|Overall Study|Protocol Violation|2
4539647|NCT01128153|7362182|FG001|Overall Study|Protocol Violation|0
4539648|NCT01128153|7362181|FG000|Overall Study|Developed discontinuation criteria|1
4539649|NCT01128153|7362182|FG001|Overall Study|Developed discontinuation criteria|1
4539650|NCT01128179|7362190|FG000|Overall Study|Death|1
4539651|NCT01128179|7362191|FG001|Overall Study|Death|0
4539652|NCT01128179|7362190|FG000|Overall Study|Protocol Violation|1
4539653|NCT01128179|7362191|FG001|Overall Study|Protocol Violation|0
4461700|NCT00584454|7250827|FG000|Overall Study|Relocation|1
4461701|NCT00584454|7250827|FG000|Overall Study|Clinical Hold|2
4461702|NCT00584727|7250845|FG000|First Intervention|Discontinuation|0
4461703|NCT00584727|7250846|FG001|First Intervention|Discontinuation|0
4461704|NCT00584727|7250847|FG002|First Intervention|Discontinuation|1
4461705|NCT00584727|7250848|FG003|First Intervention|Discontinuation|0
4461706|NCT00584727|7250849|FG004|First Intervention|Discontinuation|0
4461707|NCT00584727|7250850|FG005|First Intervention|Discontinuation|0
4461708|NCT00584727|7250845|FG000|Third Intervention|Protocol Violation|0
4461709|NCT00584727|7250846|FG001|Third Intervention|Protocol Violation|0
4461710|NCT00584727|7250847|FG002|Third Intervention|Protocol Violation|1
4614740|NCT01727141|7472615|FG003|Overall Study|Death|1
4614741|NCT01727141|7472612|FG000|Overall Study|Protocol deviation|1
4614742|NCT01727141|7472613|FG001|Overall Study|Protocol deviation|1
4614743|NCT01727141|7472614|FG002|Overall Study|Protocol deviation|0
4614744|NCT01727141|7472615|FG003|Overall Study|Protocol deviation|1
4614745|NCT01727141|7472612|FG000|Overall Study|Withdrawal by Subject|4
4614746|NCT01727141|7472613|FG001|Overall Study|Withdrawal by Subject|4
4614747|NCT01727141|7472614|FG002|Overall Study|Withdrawal by Subject|2
4614748|NCT01727141|7472615|FG003|Overall Study|Withdrawal by Subject|11
4614749|NCT01727154|7472625|FG000|Overall Study|Death|17
4614750|NCT01727154|7472625|FG000|Overall Study|Withdrawal by Subject|14
4614751|NCT01727154|7472625|FG000|Overall Study|Subject Withdrew Consent|18
4614752|NCT01727154|7472625|FG000|Overall Study|Study Terminated|6
4614753|NCT01727154|7472625|FG000|Overall Study|No Discontinuation Documentation|4
4614754|NCT01727258|7472636|FG000|Overall Study|Adverse Event|0
4614755|NCT01727258|7472637|FG001|Overall Study|Adverse Event|2
4614756|NCT01727258|7472638|FG002|Overall Study|Adverse Event|0
4614757|NCT01727258|7472636|FG000|Overall Study|Noncompliance with Study Drug|0
4614758|NCT01727258|7472637|FG001|Overall Study|Noncompliance with Study Drug|0
4614759|NCT01727258|7472638|FG002|Overall Study|Noncompliance with Study Drug|1
4614760|NCT01727258|7472636|FG000|Overall Study|Withdrawal by Subject|1
4614761|NCT01727258|7472637|FG001|Overall Study|Withdrawal by Subject|1
4614762|NCT01727258|7472638|FG002|Overall Study|Withdrawal by Subject|0
4614763|NCT01727258|7472636|FG000|Overall Study|Lost to Follow-up|1
4614764|NCT01727258|7472637|FG001|Overall Study|Lost to Follow-up|0
4614765|NCT01727258|7472638|FG002|Overall Study|Lost to Follow-up|0
4614766|NCT01727297|7472646|FG000|Overall Study|Death|13
4614767|NCT01727297|7472647|FG001|Overall Study|Death|0
4614768|NCT01727297|7472646|FG000|Overall Study|Protocol Violation|1
4614769|NCT01727297|7472647|FG001|Overall Study|Protocol Violation|10
4614770|NCT01727297|7472646|FG000|Overall Study|Adverse Event|3
4614771|NCT01727297|7472647|FG001|Overall Study|Adverse Event|1
4614772|NCT01727297|7472646|FG000|Overall Study|Lost to Follow-up|11
4614773|NCT01727297|7472647|FG001|Overall Study|Lost to Follow-up|0
4614774|NCT01727297|7472646|FG000|Overall Study|Withdrawal by Subject|26
4614775|NCT01727297|7472647|FG001|Overall Study|Withdrawal by Subject|27
4614776|NCT01727297|7472646|FG000|Overall Study|Physician Decision|19
4539654|NCT01128244|7362212|FG000|Overall Study|Adverse Event|1
4539655|NCT01128244|7362212|FG000|Overall Study|Scheduling conflict|2
4614777|NCT01727297|7472647|FG001|Overall Study|Physician Decision|5
4614778|NCT01727297|7472646|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29
4614779|NCT01727297|7472647|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8
4614780|NCT01727336|7472666|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0
4614781|NCT01727336|7472667|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1
4614782|NCT01727336|7472668|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5
4614783|NCT01727336|7472669|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0
4461711|NCT00584727|7250848|FG003|Third Intervention|Protocol Violation|0
4461712|NCT00584727|7250849|FG004|Third Intervention|Protocol Violation|4
4461713|NCT00584727|7250850|FG005|Third Intervention|Protocol Violation|2
4461714|NCT00584740|7250863|FG000|Overall Study|Adverse Event|1
4461715|NCT00584740|7250864|FG001|Overall Study|Adverse Event|1
4461716|NCT00584740|7250863|FG000|Overall Study|Lack of Efficacy|8
4461717|NCT00584740|7250864|FG001|Overall Study|Lack of Efficacy|2
4461718|NCT00584740|7250863|FG000|Overall Study|Withdrawal by Subject|3
4461719|NCT00584740|7250864|FG001|Overall Study|Withdrawal by Subject|2
4461720|NCT00584740|7250863|FG000|Overall Study|Lost to Follow-up|0
4461721|NCT00584740|7250864|FG001|Overall Study|Lost to Follow-up|1
4461722|NCT00584805|7250870|FG000|Overall Study|No longer at risk of exposure|39
4461723|NCT00584805|7250870|FG000|Overall Study|Relocation|36
4461724|NCT00584805|7250870|FG000|Overall Study|Withdrawal by Subject|18
4461725|NCT00584805|7250870|FG000|Overall Study|Non-compliance|1
4461726|NCT00584805|7250870|FG000|Overall Study|Lost to follow up|3
4461727|NCT00584805|7250870|FG000|Overall Study|Screen failures|2
4461728|NCT00584844|7250904|FG000|Overall Study|Withdrawal by Subject|59
4461729|NCT00584844|7250904|FG000|Overall Study|Screen Failure|20
4461730|NCT00584870|7250919|FG000|Overall Study|Adverse Event|4
4461731|NCT00584870|7250920|FG001|Overall Study|Adverse Event|3
4461732|NCT00584870|7250921|FG002|Overall Study|Adverse Event|2
4461733|NCT00584870|7250919|FG000|Overall Study|Lost to Follow-up|4
4461734|NCT00584870|7250920|FG001|Overall Study|Lost to Follow-up|1
4461735|NCT00584870|7250921|FG002|Overall Study|Lost to Follow-up|1
4461736|NCT00584870|7250919|FG000|Overall Study|Lack of Efficacy|7
4461737|NCT00584870|7250920|FG001|Overall Study|Lack of Efficacy|14
4461738|NCT00584870|7250921|FG002|Overall Study|Lack of Efficacy|8
4461739|NCT00584870|7250919|FG000|Overall Study|Withdrawal by Subject|10
4461740|NCT00584870|7250920|FG001|Overall Study|Withdrawal by Subject|5
4461741|NCT00584870|7250921|FG002|Overall Study|Withdrawal by Subject|3
4461742|NCT00584870|7250919|FG000|Overall Study|Protocol Violation|1
4461743|NCT00584870|7250920|FG001|Overall Study|Protocol Violation|1
4461744|NCT00584870|7250921|FG002|Overall Study|Protocol Violation|2
4461745|NCT00584870|7250919|FG000|Overall Study|Did not met entrance criteria|1
4461746|NCT00584870|7250920|FG001|Overall Study|Did not met entrance criteria|0
4461747|NCT00584870|7250921|FG002|Overall Study|Did not met entrance criteria|0
4461748|NCT00584870|7250919|FG000|Overall Study|Other|2
4461749|NCT00584870|7250920|FG001|Overall Study|Other|0
4461750|NCT00584870|7250921|FG002|Overall Study|Other|0
4461751|NCT00584870|7250919|FG000|Overall Study|Randomized but not treated|0
4461752|NCT00584870|7250920|FG001|Overall Study|Randomized but not treated|1
4461753|NCT00584870|7250921|FG002|Overall Study|Randomized but not treated|2
4461754|NCT00584909|7250929|FG000|Overall Study|Adverse Event|4
4461755|NCT00584987|7250950|FG000|Overall Study|Protocol Violation|1
4461756|NCT00584987|7250951|FG001|Overall Study|Protocol Violation|1
4461757|NCT00584987|7250952|FG002|Overall Study|Protocol Violation|1
4461758|NCT00584987|7250953|FG003|Overall Study|Protocol Violation|0
4461759|NCT00584987|7250950|FG000|Overall Study|Adverse Event|0
4461760|NCT00584987|7250951|FG001|Overall Study|Adverse Event|0
4461761|NCT00584987|7250952|FG002|Overall Study|Adverse Event|0
4461762|NCT00584987|7250953|FG003|Overall Study|Adverse Event|1
4461763|NCT00585039|7250976|FG000|Overall Study|medication spilled|2
4461764|NCT00585039|7250977|FG001|Overall Study|medication spilled|0
4461765|NCT00585052|7250985|FG000|Overall Study|Withdrawal by Subject|1
4461766|NCT00585078|7250989|FG000|Overall Study|Withdrawal by Subject|4
4461767|NCT00585078|7250989|FG000|Overall Study|Poor performance status|1
4461768|NCT00585078|7250989|FG000|Overall Study|Disease Progression|24
4461769|NCT00585078|7250989|FG000|Overall Study|Adverse Event|10
4461770|NCT00585078|7250989|FG000|Overall Study|Death|1
4461771|NCT00585169|7250997|FG000|Overall Study|Withdrawal by Subject|1
4461772|NCT00585286|7251016|FG000|Overall Study|Lost to Follow-up|1
4461773|NCT00585312|7251022|FG000|Overall Study|Adverse Event|3
4461774|NCT00585312|7251023|FG001|Overall Study|Adverse Event|0
4461775|NCT00585312|7251022|FG000|Overall Study|Lack of Efficacy|6
4461776|NCT00585312|7251023|FG001|Overall Study|Lack of Efficacy|11
4461777|NCT00585312|7251022|FG000|Overall Study|Lost to Follow-up|1
4461778|NCT00585312|7251023|FG001|Overall Study|Lost to Follow-up|1
4461779|NCT00585312|7251022|FG000|Overall Study|Reason not specified|2
4461780|NCT00585312|7251023|FG001|Overall Study|Reason not specified|0
4461781|NCT00585312|7251022|FG000|Overall Study|Withdrawal by Subject|5
4461782|NCT00585312|7251023|FG001|Overall Study|Withdrawal by Subject|1
4461783|NCT00585312|7251022|FG000|Overall Study|Study terminated by the sponsor|34
4461784|NCT00585312|7251023|FG001|Overall Study|Study terminated by the sponsor|31
4461785|NCT00585325|7251031|FG000|Overall Study|Withdrawal by Subject|1
4461786|NCT00585325|7251032|FG001|Overall Study|Withdrawal by Subject|1
4461787|NCT00585351|7251044|FG000|Notification Period (Informed Consent)|Physician Decision|0
4461788|NCT00585351|7251045|FG001|Notification Period (Informed Consent)|Physician Decision|2
4461789|NCT00585351|7251046|FG002|Notification Period (Informed Consent)|Physician Decision|0
4461790|NCT00585351|7251047|FG003|Notification Period (Informed Consent)|Physician Decision|0
4461791|NCT00585351|7251048|FG004|Notification Period (Informed Consent)|Physician Decision|0
4461792|NCT00585351|7251049|FG005|Notification Period (Informed Consent)|Physician Decision|0
4461793|NCT00585351|7251050|FG006|Notification Period (Informed Consent)|Physician Decision|0
4461794|NCT00585351|7251051|FG007|Notification Period (Informed Consent)|Physician Decision|0
4461795|NCT00585351|7251044|FG000|Notification Period (Informed Consent)|Flight aborted|2
4461796|NCT00585351|7251045|FG001|Notification Period (Informed Consent)|Flight aborted|1
4539656|NCT01128296|7362232|FG000|Overall Study|Physician Decision|0
4539657|NCT01128296|7362233|FG001|Overall Study|Physician Decision|0
4461797|NCT00585351|7251046|FG002|Notification Period (Informed Consent)|Flight aborted|0
4461798|NCT00585351|7251047|FG003|Notification Period (Informed Consent)|Flight aborted|0
4461799|NCT00585351|7251048|FG004|Notification Period (Informed Consent)|Flight aborted|0
4461800|NCT00585351|7251049|FG005|Notification Period (Informed Consent)|Flight aborted|0
4461801|NCT00585351|7251050|FG006|Notification Period (Informed Consent)|Flight aborted|0
4461802|NCT00585351|7251051|FG007|Notification Period (Informed Consent)|Flight aborted|0
4461803|NCT00585351|7251044|FG000|Notification Period (Informed Consent)|No study medication on flight|0
4461804|NCT00585351|7251045|FG001|Notification Period (Informed Consent)|No study medication on flight|1
4461805|NCT00585351|7251046|FG002|Notification Period (Informed Consent)|No study medication on flight|0
4461806|NCT00585351|7251047|FG003|Notification Period (Informed Consent)|No study medication on flight|0
4461807|NCT00585351|7251048|FG004|Notification Period (Informed Consent)|No study medication on flight|0
4461808|NCT00585351|7251049|FG005|Notification Period (Informed Consent)|No study medication on flight|0
4461809|NCT00585351|7251050|FG006|Notification Period (Informed Consent)|No study medication on flight|0
4461810|NCT00585351|7251051|FG007|Notification Period (Informed Consent)|No study medication on flight|0
4461811|NCT00585351|7251044|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21
4461812|NCT00585351|7251045|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21
4461813|NCT00585351|7251046|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
4461814|NCT00585351|7251047|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
4461815|NCT00585351|7251048|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
4461816|NCT00585351|7251049|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
4461817|NCT00585351|7251050|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
4461818|NCT00585351|7251051|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
4461819|NCT00585351|7251044|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0
4461820|NCT00585351|7251045|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0
4461821|NCT00585351|7251046|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0
4461822|NCT00585351|7251047|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0
4461823|NCT00585351|7251048|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0
4461824|NCT00585351|7251049|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0
4461825|NCT00585351|7251050|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1
4461826|NCT00585351|7251051|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1
4461827|NCT00585351|7251044|FG000|Enrollment Period (Intervention)|Death|0
4461828|NCT00585351|7251045|FG001|Enrollment Period (Intervention)|Death|0
4461829|NCT00585351|7251046|FG002|Enrollment Period (Intervention)|Death|0
4461830|NCT00585351|7251047|FG003|Enrollment Period (Intervention)|Death|0
4461831|NCT00585351|7251048|FG004|Enrollment Period (Intervention)|Death|1
4461832|NCT00585351|7251049|FG005|Enrollment Period (Intervention)|Death|0
4461833|NCT00585351|7251050|FG006|Enrollment Period (Intervention)|Death|1
4461834|NCT00585351|7251051|FG007|Enrollment Period (Intervention)|Death|0
4461835|NCT00585351|7251044|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0
4461836|NCT00585351|7251045|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0
4461837|NCT00585351|7251046|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0
4461838|NCT00585351|7251047|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0
4461839|NCT00585351|7251048|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1
4461840|NCT00585351|7251049|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2
4461841|NCT00585351|7251050|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0
4461842|NCT00585351|7251051|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0
4461843|NCT00585468|7251069|FG000|First Intervention|Withdrawal by Subject|1
4461844|NCT00585468|7251070|FG001|First Intervention|Withdrawal by Subject|1
4539658|NCT01128296|7362234|FG002|Overall Study|Physician Decision|0
4539659|NCT01128296|7362235|FG003|Overall Study|Physician Decision|0
4539660|NCT01128296|7362236|FG004|Overall Study|Physician Decision|0
4539661|NCT01128296|7362237|FG005|Overall Study|Physician Decision|3
4539662|NCT01128296|7362232|FG000|Overall Study|Withdrawal by Subject|0
4539663|NCT01128296|7362233|FG001|Overall Study|Withdrawal by Subject|0
4539664|NCT01128296|7362234|FG002|Overall Study|Withdrawal by Subject|0
4539665|NCT01128296|7362235|FG003|Overall Study|Withdrawal by Subject|0
4539666|NCT01128296|7362236|FG004|Overall Study|Withdrawal by Subject|0
4539667|NCT01128296|7362237|FG005|Overall Study|Withdrawal by Subject|2
4539668|NCT01128361|7362250|FG000|Overall Study|Lost to Follow-up|0
4539669|NCT01128361|7362251|FG001|Overall Study|Lost to Follow-up|1
4539670|NCT01128361|7362250|FG000|Overall Study|Withdrawal by Subject|5
4539671|NCT01128361|7362251|FG001|Overall Study|Withdrawal by Subject|2
4539672|NCT01128387|7362259|FG000|Overall Study|Physician Decision|0
4539673|NCT01128387|7362260|FG001|Overall Study|Physician Decision|1
4539674|NCT01128400|7362269|FG000|Overall Study|Lost to Follow-up|1
4539675|NCT01128400|7362270|FG001|Overall Study|Lost to Follow-up|0
4539676|NCT01128400|7362271|FG002|Overall Study|Lost to Follow-up|1
4614784|NCT01727336|7472670|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0
4461845|NCT00585533|7251082|FG000|Overall Study|objective or symptomatic progression|9
4461846|NCT00585546|7251086|FG000|Clenbuterol Treatment - up to 12 Months|Death|1
4461847|NCT00585546|7251086|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3
4461848|NCT00585689|7251116|FG000|Overall Study|Received different ABI-007 schedule|3
4461849|NCT00585689|7251116|FG000|Overall Study|Adverse Event|1
4461850|NCT00585689|7251116|FG000|Overall Study|Patient Declined Surgery|1
4461851|NCT00585689|7251116|FG000|Overall Study|Patient had unresectable disease|1
4461852|NCT00585689|7251116|FG000|Overall Study|Death|1
4461853|NCT00585923|7251157|FG000|Overall Study|Physician decided not to continue|31
4461854|NCT00585923|7251158|FG001|Overall Study|Physician decided not to continue|33
4461855|NCT00585975|7251166|FG000|Overall Study|Withdrawal by Subject|3
4461856|NCT00585975|7251167|FG001|Overall Study|Withdrawal by Subject|3
4461857|NCT00585975|7251166|FG000|Overall Study|Lost to Follow-up|2
4461858|NCT00585975|7251167|FG001|Overall Study|Lost to Follow-up|1
4461859|NCT00585975|7251166|FG000|Overall Study|Enrollment met/over-enrolled|10
4461860|NCT00585975|7251167|FG001|Overall Study|Enrollment met/over-enrolled|9
4461861|NCT00586066|7251185|FG000|Overall Study|Lost to Follow-up|6
4461862|NCT00586066|7251186|FG001|Overall Study|Lost to Follow-up|3
4461863|NCT00586066|7251185|FG000|Overall Study|Lack of Efficacy|5
4461864|NCT00586066|7251186|FG001|Overall Study|Lack of Efficacy|3
4461865|NCT00586066|7251185|FG000|Overall Study|Adverse Event|2
4461866|NCT00586066|7251186|FG001|Overall Study|Adverse Event|2
4461867|NCT00586066|7251185|FG000|Overall Study|Physician Decision|1
4461868|NCT00586066|7251186|FG001|Overall Study|Physician Decision|0
4461869|NCT00586066|7251185|FG000|Overall Study|Withdrawal of consent|4
4461870|NCT00586066|7251186|FG001|Overall Study|Withdrawal of consent|2
4461871|NCT00586105|7251192|FG000|Overall Study|Adverse Event|4
4461872|NCT00586105|7251192|FG000|Overall Study|Death|2
4461873|NCT00586105|7251192|FG000|Overall Study|Protocol Violation|1
4461874|NCT00586105|7251192|FG000|Overall Study|Withdrawal by Subject|3
4461875|NCT00586105|7251192|FG000|Overall Study|Disease progression|19
4461876|NCT00586105|7251192|FG000|Overall Study|Switched to commercial drug|9
4461877|NCT00586105|7251192|FG000|Overall Study|Reason not reported|1
4461878|NCT00586157|7251196|FG000|First Intervention|Worsening behavior|1
4461879|NCT00586157|7251197|FG001|First Intervention|Worsening behavior|0
4461880|NCT00586157|7251196|FG000|Second Intervention|Withdrawal by Subject|1
4461881|NCT00586157|7251197|FG001|Second Intervention|Withdrawal by Subject|0
4461882|NCT00586157|7251196|FG000|Second Intervention|Worsening behavior|1
4461883|NCT00586157|7251197|FG001|Second Intervention|Worsening behavior|0
4461884|NCT00586157|7251196|FG000|Second Intervention|Adverse Event|0
4461885|NCT00586157|7251197|FG001|Second Intervention|Adverse Event|1
4461886|NCT00586313|7251230|FG000|Overall Study|Lack of Efficacy|2
4461887|NCT00586326|7251234|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6
4461888|NCT00586326|7251234|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4
4461889|NCT00586326|7251234|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2
4461890|NCT00586326|7251234|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1
4461891|NCT00586326|7251234|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1
4461892|NCT00586326|7251234|FG000|Enrollment to Device Placement-Enrolled|Other|1
4461893|NCT00586326|7251234|FG000|Device Placed toTreatment-ITT|Skin Distance|7
4461894|NCT00586326|7251234|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6
4461895|NCT00586326|7251234|FG000|Device Placed toTreatment-ITT|Microinvasion|1
4461896|NCT00586326|7251234|FG000|Device Placed toTreatment-ITT|Positive Margins|3
4461897|NCT00586326|7251234|FG000|Device Placed toTreatment-ITT|Physician Decision|1
4461898|NCT00586326|7251234|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1
4461899|NCT00586326|7251234|FG000|Treated Through 5-yr Follow Up-Treated|Death|2
4461900|NCT00586326|7251234|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2
4461901|NCT00586326|7251234|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5
4461902|NCT00586326|7251234|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14
4461903|NCT00586326|7251234|FG000|Treated Through 5-yr Follow Up-Treated|Other|2
4461904|NCT00586339|7251245|FG000|Overall Study|Withdrawal by Subject|1
4461905|NCT00586339|7251246|FG001|Overall Study|Withdrawal by Subject|3
4461906|NCT00586339|7251247|FG002|Overall Study|Withdrawal by Subject|1
4461907|NCT00586339|7251245|FG000|Overall Study|Migrated/moved from study area|3
4461908|NCT00586339|7251246|FG001|Overall Study|Migrated/moved from study area|2
4461909|NCT00586339|7251247|FG002|Overall Study|Migrated/moved from study area|4
4461910|NCT00586339|7251245|FG000|Overall Study|Lost to Follow-up|3
4461911|NCT00586339|7251246|FG001|Overall Study|Lost to Follow-up|2
4461912|NCT00586339|7251247|FG002|Overall Study|Lost to Follow-up|1
4461913|NCT00586469|7251257|FG000|Overall Study|Adverse Event|0
4461914|NCT00586469|7251258|FG001|Overall Study|Adverse Event|1
4461915|NCT00586495|7251273|FG000|Treatment Period|Adverse Event|11
4461916|NCT00586495|7251273|FG000|Treatment Period|Death|1
4461917|NCT00586495|7251273|FG000|Treatment Period|Protocol Violation|1
4461918|NCT00586495|7251273|FG000|Treatment Period|Withdrawal by Subject|1
4461919|NCT00586495|7251273|FG000|Treatment Period|Disease progression, recurrence/relapse|71
4461920|NCT00586495|7251273|FG000|Treatment Period|Switch to commercial drug|10
4461921|NCT00586495|7251273|FG000|Follow-up|Death|40
4539677|NCT01128400|7362269|FG000|Overall Study|Screening failure|1
4461922|NCT00586495|7251273|FG000|Follow-up|Lost to Follow-up|1
4461923|NCT00586495|7251273|FG000|Follow-up|Withdrawal by Subject|4
4461924|NCT00586495|7251273|FG000|Follow-up|Protocol driven decision point|37
4461925|NCT00586495|7251273|FG000|Follow-up|Switch to commercial drug|10
4461926|NCT00586508|7251279|FG000|Overall Study|Progressive disease|52
4461927|NCT00586508|7251280|FG001|Overall Study|Progressive disease|8
4461928|NCT00586508|7251279|FG000|Overall Study|Death|0
4461929|NCT00586508|7251280|FG001|Overall Study|Death|1
4461930|NCT00586508|7251279|FG000|Overall Study|Adverse Event|12
4461931|NCT00586508|7251280|FG001|Overall Study|Adverse Event|4
4461932|NCT00586508|7251279|FG000|Overall Study|Withdrawal by Subject|4
4461933|NCT00586508|7251280|FG001|Overall Study|Withdrawal by Subject|0
4461934|NCT00586521|7251286|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1
4461935|NCT00586612|7251296|FG000|Primary Phase|Protocol Violation|1
4461936|NCT00586612|7251297|FG001|Primary Phase|Protocol Violation|0
4461937|NCT00586612|7251296|FG000|Primary Phase|Lost to Follow-up|0
4461938|NCT00586612|7251297|FG001|Primary Phase|Lost to Follow-up|1
4461939|NCT00586612|7251296|FG000|Primary Phase|Withdrawal by Subject|0
4461940|NCT00586612|7251297|FG001|Primary Phase|Withdrawal by Subject|2
4461941|NCT00586612|7251296|FG000|Booster Phase|Lost to Follow-up|3
4461942|NCT00586612|7251297|FG001|Booster Phase|Lost to Follow-up|1
4461943|NCT00586625|7251305|FG000|Overall Study|Adverse Event|6
4461944|NCT00586625|7251306|FG001|Overall Study|Adverse Event|6
4461945|NCT00586625|7251305|FG000|Overall Study|Protocol Violation|3
4461946|NCT00586625|7251306|FG001|Overall Study|Protocol Violation|0
4614785|NCT01727336|7472671|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0
4614786|NCT01727336|7472666|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3
4614787|NCT01727336|7472667|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1
4614788|NCT01727336|7472668|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3
4614789|NCT01727336|7472669|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0
4614790|NCT01727336|7472670|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0
4614791|NCT01727336|7472671|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0
4614792|NCT01727336|7472666|FG000|Part 2 Blinded|Death|0
4614793|NCT01727336|7472667|FG001|Part 2 Blinded|Death|0
4614794|NCT01727336|7472668|FG002|Part 2 Blinded|Death|0
4614795|NCT01727336|7472669|FG003|Part 2 Blinded|Death|0
4614796|NCT01727336|7472670|FG004|Part 2 Blinded|Death|20
4614797|NCT01727336|7472671|FG005|Part 2 Blinded|Death|16
4614798|NCT01727336|7472666|FG000|Part 2 Blinded|Lack of Efficacy|0
4614799|NCT01727336|7472667|FG001|Part 2 Blinded|Lack of Efficacy|0
4614800|NCT01727336|7472668|FG002|Part 2 Blinded|Lack of Efficacy|0
4614801|NCT01727336|7472669|FG003|Part 2 Blinded|Lack of Efficacy|0
4614802|NCT01727336|7472670|FG004|Part 2 Blinded|Lack of Efficacy|42
4614803|NCT01727336|7472671|FG005|Part 2 Blinded|Lack of Efficacy|44
4614804|NCT01727336|7472666|FG000|Part 2 Blinded|Lost to Follow-up|0
4614805|NCT01727336|7472667|FG001|Part 2 Blinded|Lost to Follow-up|0
4614806|NCT01727336|7472668|FG002|Part 2 Blinded|Lost to Follow-up|0
4614807|NCT01727336|7472669|FG003|Part 2 Blinded|Lost to Follow-up|0
4614808|NCT01727336|7472670|FG004|Part 2 Blinded|Lost to Follow-up|0
4614809|NCT01727336|7472671|FG005|Part 2 Blinded|Lost to Follow-up|1
4614810|NCT01727336|7472666|FG000|Part 2 Blinded|Withdrawal by Subject|0
4614811|NCT01727336|7472667|FG001|Part 2 Blinded|Withdrawal by Subject|0
4614812|NCT01727336|7472668|FG002|Part 2 Blinded|Withdrawal by Subject|0
4614813|NCT01727336|7472669|FG003|Part 2 Blinded|Withdrawal by Subject|0
4614814|NCT01727336|7472670|FG004|Part 2 Blinded|Withdrawal by Subject|0
4614815|NCT01727336|7472671|FG005|Part 2 Blinded|Withdrawal by Subject|4
4614816|NCT01727336|7472666|FG000|Part 2 Blinded|use of prohibited medications|0
4614817|NCT01727336|7472667|FG001|Part 2 Blinded|use of prohibited medications|0
4614818|NCT01727336|7472668|FG002|Part 2 Blinded|use of prohibited medications|0
4614819|NCT01727336|7472669|FG003|Part 2 Blinded|use of prohibited medications|0
4614820|NCT01727336|7472670|FG004|Part 2 Blinded|use of prohibited medications|1
4614821|NCT01727336|7472671|FG005|Part 2 Blinded|use of prohibited medications|3
4614822|NCT01727505|7472700|FG000|First 24 Hours|Adverse Event|0
4614823|NCT01727505|7472701|FG001|First 24 Hours|Adverse Event|1
4614824|NCT01727505|7472700|FG000|Second 24 Hours|Missing data|0
4614825|NCT01727505|7472701|FG001|Second 24 Hours|Missing data|1
4614826|NCT01727700|7472710|FG000|Overall Study|Adverse Event|0
4614827|NCT01727700|7472711|FG001|Overall Study|Adverse Event|7
4614828|NCT01727700|7472712|FG002|Overall Study|Adverse Event|1
4614829|NCT01727700|7472710|FG000|Overall Study|Particpant withdrew consent|0
4614830|NCT01727700|7472711|FG001|Overall Study|Particpant withdrew consent|3
4614831|NCT01727700|7472712|FG002|Overall Study|Particpant withdrew consent|1
4461947|NCT00586625|7251305|FG000|Overall Study|Withdrawal by Subject|32
4461948|NCT00586625|7251306|FG001|Overall Study|Withdrawal by Subject|10
4461949|NCT00586625|7251305|FG000|Overall Study|Subject non-compliance|0
4614832|NCT01727700|7472710|FG000|Overall Study|Protocol Violation|2
4614833|NCT01727700|7472711|FG001|Overall Study|Protocol Violation|0
4614834|NCT01727700|7472712|FG002|Overall Study|Protocol Violation|0
4614835|NCT01727713|7472720|FG000|Overall Study|Lost to Follow-up|5
4614836|NCT01727713|7472720|FG000|Overall Study|Adverse Event|10
4614837|NCT01727713|7472720|FG000|Overall Study|Participant Met Withdrawal Criteria|5
4614838|NCT01727713|7472720|FG000|Overall Study|Withdrawal by Subject|13
4614839|NCT01727713|7472720|FG000|Overall Study|Protocol Deviation|2
4614840|NCT01728077|7472761|FG000|Overall Study|Lack of Efficacy|3
4614841|NCT01728077|7472762|FG001|Overall Study|Lack of Efficacy|1
4461950|NCT00586625|7251306|FG001|Overall Study|Subject non-compliance|1
4461951|NCT00586625|7251305|FG000|Overall Study|Subject unable to return for visit|2
4461952|NCT00586625|7251306|FG001|Overall Study|Subject unable to return for visit|0
4461953|NCT00586664|7251315|FG000|Overall Study|Withdrawal by Subject|3
4461954|NCT00586664|7251316|FG001|Overall Study|Withdrawal by Subject|7
4461955|NCT00586664|7251317|FG002|Overall Study|Withdrawal by Subject|1
4461956|NCT00586664|7251315|FG000|Overall Study|Exclusion criteria met|2
4461957|NCT00586664|7251316|FG001|Overall Study|Exclusion criteria met|0
4461958|NCT00586664|7251317|FG002|Overall Study|Exclusion criteria met|0
4461959|NCT00586690|7251327|FG000|Overall Study|Death|2
4461960|NCT00586690|7251328|FG001|Overall Study|Death|0
4461961|NCT00586690|7251327|FG000|Overall Study|Disease Progression|10
4461962|NCT00586690|7251328|FG001|Overall Study|Disease Progression|0
4461963|NCT00586690|7251327|FG000|Overall Study|Adverse Event|1
4461964|NCT00586690|7251328|FG001|Overall Study|Adverse Event|0
4461965|NCT00586690|7251327|FG000|Overall Study|Lack of Efficacy|2
4461966|NCT00586690|7251328|FG001|Overall Study|Lack of Efficacy|0
4461967|NCT00586690|7251327|FG000|Overall Study|Lab can't accommodate|1
4461968|NCT00586690|7251328|FG001|Overall Study|Lab can't accommodate|0
4461969|NCT00586703|7251333|FG000|Overall Study|Death|12
4461970|NCT00586820|7251348|FG000|Overall Study|Unsuccessful PCI|1
4461971|NCT00586820|7251349|FG001|Overall Study|Unsuccessful PCI|0
4461972|NCT00586846|7251355|FG000|Overall Study|Physician Decision|1
4461973|NCT00586846|7251355|FG000|Overall Study|Death|1
4461974|NCT00586846|7251355|FG000|Overall Study|Evaluable for Toxicity Only|4
4461975|NCT00586898|7251359|FG000|Overall Study|Adverse Event|1
4461976|NCT00586898|7251359|FG000|Overall Study|Patiemt Non-compliance|1
4461977|NCT00586898|7251359|FG000|Overall Study|Evaluable for Toxicity Only|5
4461978|NCT00587054|7251376|FG000|Overall Study|Patient not treated|9
4461979|NCT00587158|7251403|FG000|Overall Study|Did not want to do 24 hr urine collect.|4
4461980|NCT00587158|7251404|FG001|Overall Study|Did not want to do 24 hr urine collect.|3
4461981|NCT00587158|7251403|FG000|Overall Study|Physician Decision|0
4461982|NCT00587158|7251404|FG001|Overall Study|Physician Decision|1
4461983|NCT00587158|7251403|FG000|Overall Study|Lost to Follow-up|1
4461984|NCT00587158|7251404|FG001|Overall Study|Lost to Follow-up|2
4461985|NCT00587158|7251403|FG000|Overall Study|Death|0
4461986|NCT00587158|7251404|FG001|Overall Study|Death|1
4461987|NCT00587158|7251403|FG000|Overall Study|Subject did not want to take study med|0
4461988|NCT00587158|7251404|FG001|Overall Study|Subject did not want to take study med|1
4461989|NCT00587171|7251412|FG000|Overall Study|Lost to Follow-up|1
4461990|NCT00587171|7251413|FG001|Overall Study|Lost to Follow-up|1
4516049|NCT00958126|7327340|FG004|Overall Study|Lost to Follow-up|0
4516050|NCT00958126|7327341|FG005|Overall Study|Lost to Follow-up|0
4516051|NCT00958126|7327342|FG006|Overall Study|Lost to Follow-up|0
4516052|NCT00958126|7327343|FG007|Overall Study|Lost to Follow-up|0
4516053|NCT00958126|7327336|FG000|Overall Study|Sponsor/Investigator decision|0
4516054|NCT00958126|7327337|FG001|Overall Study|Sponsor/Investigator decision|0
4516055|NCT00958126|7327338|FG002|Overall Study|Sponsor/Investigator decision|0
4516056|NCT00958126|7327339|FG003|Overall Study|Sponsor/Investigator decision|1
4516057|NCT00958126|7327340|FG004|Overall Study|Sponsor/Investigator decision|0
4516058|NCT00958126|7327341|FG005|Overall Study|Sponsor/Investigator decision|0
4516059|NCT00958126|7327342|FG006|Overall Study|Sponsor/Investigator decision|0
4516060|NCT00958126|7327343|FG007|Overall Study|Sponsor/Investigator decision|0
4516061|NCT00958126|7327336|FG000|Overall Study|Other Reason|0
4516062|NCT00958126|7327337|FG001|Overall Study|Other Reason|0
4516063|NCT00958126|7327338|FG002|Overall Study|Other Reason|0
4516064|NCT00958126|7327339|FG003|Overall Study|Other Reason|1
4516065|NCT00958126|7327340|FG004|Overall Study|Other Reason|0
4516066|NCT00958126|7327341|FG005|Overall Study|Other Reason|1
4516067|NCT00958126|7327342|FG006|Overall Study|Other Reason|0
4516068|NCT00958126|7327343|FG007|Overall Study|Other Reason|0
4516069|NCT00958165|7327365|FG000|Overall Study|Lost to Follow-up|5
4516070|NCT00958165|7327365|FG000|Overall Study|Not eligible|9
4516071|NCT00958191|7327369|FG000|Overall Study|Death|4
4516072|NCT00958191|7327369|FG000|Overall Study|Lost to Follow-up|5
4516073|NCT00958191|7327369|FG000|Overall Study|Inadequate 5 yr x-ray quality|10
4516074|NCT00958191|7327369|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21
4516075|NCT00958191|7327369|FG000|Overall Study|Revision of study device|4
4516076|NCT00958191|7327369|FG000|Overall Study|Site termination|11
4516077|NCT00958191|7327369|FG000|Overall Study|No 5 yr x-rays|56
4516078|NCT00958217|7327377|FG000|Overall Study|Death|2
4516079|NCT00958217|7327378|FG001|Overall Study|Death|1
4516080|NCT00958217|7327377|FG000|Overall Study|Withdrawal by Subject|4
4516081|NCT00958217|7327378|FG001|Overall Study|Withdrawal by Subject|3
4516082|NCT00958217|7327377|FG000|Overall Study|Lost to Follow-up|17
4516083|NCT00958217|7327378|FG001|Overall Study|Lost to Follow-up|19
4516084|NCT00958217|7327377|FG000|Overall Study|Moved out of area|1
4516085|NCT00958217|7327378|FG001|Overall Study|Moved out of area|1
4516086|NCT00958217|7327377|FG000|Overall Study|Inpatient hospitalization|0
4516087|NCT00958217|7327378|FG001|Overall Study|Inpatient hospitalization|1
4516088|NCT00958243|7327391|FG000|Overall Study|Withdrawal by Subject|0
4516089|NCT00958243|7327392|FG001|Overall Study|Withdrawal by Subject|1
4516090|NCT00958243|7327393|FG002|Overall Study|Withdrawal by Subject|3
4516091|NCT00958243|7327394|FG003|Overall Study|Withdrawal by Subject|1
4461991|NCT00587288|7251421|FG000|Overall Study|Adverse Event|0
4461992|NCT00587288|7251422|FG001|Overall Study|Adverse Event|1
4461993|NCT00587288|7251421|FG000|Overall Study|Lack of Efficacy|2
4461994|NCT00587288|7251422|FG001|Overall Study|Lack of Efficacy|8
4461995|NCT00587288|7251421|FG000|Overall Study|Protocol Violation|1
4461996|NCT00587288|7251422|FG001|Overall Study|Protocol Violation|0
4461997|NCT00587431|7251432|FG000|Overall Study|Adverse Event|1
4461998|NCT00587431|7251433|FG001|Overall Study|Adverse Event|0
4461999|NCT00587431|7251432|FG000|Overall Study|Withdrawal by Subject|0
4462000|NCT00587431|7251433|FG001|Overall Study|Withdrawal by Subject|1
4462001|NCT00587457|7251445|FG000|Overall Study|Adverse Event|1
4462002|NCT00587457|7251446|FG001|Overall Study|Adverse Event|2
4462003|NCT00587457|7251447|FG002|Overall Study|Adverse Event|1
4462004|NCT00587457|7251445|FG000|Overall Study|Disease progression|2
4462005|NCT00587457|7251446|FG001|Overall Study|Disease progression|0
4462006|NCT00587457|7251447|FG002|Overall Study|Disease progression|2
4462007|NCT00587457|7251445|FG000|Overall Study|Initiation of alternative therapy|0
4462008|NCT00587457|7251446|FG001|Overall Study|Initiation of alternative therapy|1
4614842|NCT01728077|7472761|FG000|Overall Study|Lost to Follow-up|1
4614843|NCT01728077|7472762|FG001|Overall Study|Lost to Follow-up|0
4614844|NCT01728077|7472761|FG000|Overall Study|Subject choice|2
4614845|NCT01728077|7472762|FG001|Overall Study|Subject choice|3
4614846|NCT01728077|7472761|FG000|Overall Study|Death|0
4614847|NCT01728077|7472762|FG001|Overall Study|Death|1
4614848|NCT01728077|7472761|FG000|Overall Study|Patient moving|1
4614849|NCT01728077|7472762|FG001|Overall Study|Patient moving|0
4614850|NCT01728077|7472761|FG000|Overall Study|Non compliance|1
4614851|NCT01728077|7472762|FG001|Overall Study|Non compliance|0
4614852|NCT01728116|7472771|FG000|Overall Study|Sponsor Terminated Study|106
4614853|NCT01728116|7472772|FG001|Overall Study|Sponsor Terminated Study|35
4614854|NCT01728116|7472771|FG000|Overall Study|Withdrawal by Subject|16
4462009|NCT00587457|7251447|FG002|Overall Study|Initiation of alternative therapy|0
4462010|NCT00587457|7251445|FG000|Overall Study|Undefined|0
4462011|NCT00587457|7251446|FG001|Overall Study|Undefined|0
4462012|NCT00587457|7251447|FG002|Overall Study|Undefined|1
4462013|NCT00587457|7251445|FG000|Overall Study|Development of neutralizing Abs|0
4462014|NCT00587457|7251446|FG001|Overall Study|Development of neutralizing Abs|0
4462015|NCT00587457|7251447|FG002|Overall Study|Development of neutralizing Abs|1
4462016|NCT00587587|7251470|FG000|Overall Study|Lost to Follow-up|6
4462017|NCT00587587|7251471|FG001|Overall Study|Lost to Follow-up|1
4462018|NCT00587639|7251479|FG000|Overall Study|Withdrawal by Subject|1
4462019|NCT00587847|7251515|FG000|Overall Study|Lack of Efficacy|5
4462020|NCT00587847|7251515|FG000|Overall Study|Adverse Event|2
4516092|NCT00958243|7327395|FG004|Overall Study|Withdrawal by Subject|1
4516093|NCT00958243|7327396|FG005|Overall Study|Withdrawal by Subject|5
4516094|NCT00958243|7327391|FG000|Overall Study|Lost to Follow-up|2
4516095|NCT00958243|7327392|FG001|Overall Study|Lost to Follow-up|5
4516096|NCT00958243|7327393|FG002|Overall Study|Lost to Follow-up|11
4516097|NCT00958243|7327394|FG003|Overall Study|Lost to Follow-up|2
4516098|NCT00958243|7327395|FG004|Overall Study|Lost to Follow-up|8
4516099|NCT00958243|7327396|FG005|Overall Study|Lost to Follow-up|5
4518623|NCT00975221|7330808|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1
4518624|NCT00975221|7330809|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0
4518625|NCT00975221|7330808|FG000|Titration Phase (Weeks 1-12)|Other|0
4518626|NCT00975221|7330809|FG001|Titration Phase (Weeks 1-12)|Other|1
4518627|NCT00975221|7330808|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0
4518628|NCT00975221|7330809|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1
4518629|NCT00975221|7330808|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1
4518630|NCT00975221|7330809|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1
4518631|NCT00975221|7330808|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1
4518632|NCT00975221|7330809|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0
4518633|NCT00975286|7330819|FG000|Overall Study|Adverse Event|9
4518634|NCT00975286|7330820|FG001|Overall Study|Adverse Event|19
4518635|NCT00975286|7330819|FG000|Overall Study|Protocol Violation|1
4518636|NCT00975286|7330820|FG001|Overall Study|Protocol Violation|2
4518637|NCT00975286|7330819|FG000|Overall Study|Withdrawal by Subject|0
4518638|NCT00975286|7330820|FG001|Overall Study|Withdrawal by Subject|2
4518639|NCT00975286|7330819|FG000|Overall Study|Familial and Personal Reasons|2
4518640|NCT00975286|7330820|FG001|Overall Study|Familial and Personal Reasons|2
4518641|NCT00975286|7330819|FG000|Overall Study|Poor Compliance to Protocol|0
4518642|NCT00975286|7330820|FG001|Overall Study|Poor Compliance to Protocol|2
4518643|NCT00975286|7330819|FG000|Overall Study|Sponsor Decision|0
4518644|NCT00975286|7330820|FG001|Overall Study|Sponsor Decision|2
4518645|NCT00975416|7330828|FG000|Overall Study|early discharge from tx|3
4518646|NCT00975416|7330829|FG001|Overall Study|early discharge from tx|5
4518647|NCT00975481|7330836|FG000|Second Intervention Period|Adverse Event|2
4518648|NCT00975481|7330837|FG001|Second Intervention Period|Adverse Event|1
4518649|NCT00975481|7330838|FG002|Second Intervention Period|Adverse Event|0
4518650|NCT00975481|7330839|FG003|Second Intervention Period|Adverse Event|0
4518651|NCT00975481|7330840|FG004|Second Intervention Period|Adverse Event|0
4518652|NCT00975481|7330841|FG005|Second Intervention Period|Adverse Event|0
4614855|NCT01728116|7472772|FG001|Overall Study|Withdrawal by Subject|9
4614856|NCT01728116|7472771|FG000|Overall Study|Adverse Event|13
4462021|NCT04411680|7251526|FG000|Treatment Period|Adverse Event|3
4462022|NCT04411680|7251527|FG001|Treatment Period|Adverse Event|0
4462023|NCT04411680|7251526|FG000|Treatment Period|Discharged from hospital|18
4462024|NCT04411680|7251527|FG001|Treatment Period|Discharged from hospital|7
4462025|NCT04411680|7251526|FG000|Treatment Period|Missed 1 or more doses|8
4462026|NCT04411680|7251527|FG001|Treatment Period|Missed 1 or more doses|0
4462027|NCT04411680|7251526|FG000|Treatment Period|Transferred to another hospital|0
4462028|NCT04411680|7251527|FG001|Treatment Period|Transferred to another hospital|1
4462029|NCT04411680|7251526|FG000|Follow up Period|Withdrawal by Subject|2
4462030|NCT04411680|7251527|FG001|Follow up Period|Withdrawal by Subject|0
4462031|NCT04411680|7251526|FG000|Follow up Period|Lost to Follow-up|5
4462032|NCT04411680|7251527|FG001|Follow up Period|Lost to Follow-up|6
4462033|NCT04411680|7251526|FG000|Follow up Period|Death|11
4462034|NCT04411680|7251527|FG001|Follow up Period|Death|8
4462035|NCT04364984|7251536|FG000|Overall Study|Death|2
4462036|NCT04364984|7251537|FG001|Overall Study|Death|2
4462037|NCT04364984|7251538|FG002|Overall Study|Death|0
4462038|NCT03711266|7251578|FG000|Overall Study|Lost to Follow-up|10
4462039|NCT03630393|7251584|FG000|Overall Study|Death|1
4462040|NCT03630393|7251585|FG001|Overall Study|Death|0
4462041|NCT03359811|7251602|FG000|Overall Study|Protocol Violation|2
4462042|NCT03359811|7251603|FG001|Overall Study|Protocol Violation|0
4770376|NCT03740919|7746732|FG002|Lead-in Period|Withdrawal by Subject|0
4770377|NCT03740919|7746733|FG003|Lead-in Period|Withdrawal by Subject|0
4770378|NCT03740919|7746730|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18
4770379|NCT03740919|7746731|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0
4770380|NCT03740919|7746732|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0
4770381|NCT03740919|7746733|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0
4770382|NCT03740919|7746730|FG000|Lead-in Period|Study Task Too Burdensome|1
4770383|NCT03740919|7746731|FG001|Lead-in Period|Study Task Too Burdensome|0
4462051|NCT02954406|7251670|FG000|Overall Study|Adverse Event|0
4462052|NCT02954406|7251671|FG001|Overall Study|Adverse Event|1
4462053|NCT02954406|7251672|FG002|Overall Study|Adverse Event|0
4462054|NCT02954406|7251673|FG003|Overall Study|Adverse Event|0
4462055|NCT02954406|7251674|FG004|Overall Study|Adverse Event|1
4462056|NCT02954406|7251675|FG005|Overall Study|Adverse Event|0
4462057|NCT02954406|7251676|FG006|Overall Study|Adverse Event|0
4462058|NCT02954406|7251677|FG007|Overall Study|Adverse Event|0
4462059|NCT02954406|7251678|FG008|Overall Study|Adverse Event|1
4462060|NCT02954406|7251679|FG009|Overall Study|Adverse Event|1
4462061|NCT02954406|7251680|FG010|Overall Study|Adverse Event|0
4462062|NCT02954406|7251670|FG000|Overall Study|Progressive Disease|3
4462063|NCT02954406|7251671|FG001|Overall Study|Progressive Disease|4
4462064|NCT02954406|7251672|FG002|Overall Study|Progressive Disease|3
4462065|NCT02954406|7251673|FG003|Overall Study|Progressive Disease|4
4462066|NCT02954406|7251674|FG004|Overall Study|Progressive Disease|3
4462067|NCT02954406|7251675|FG005|Overall Study|Progressive Disease|3
4462068|NCT02954406|7251676|FG006|Overall Study|Progressive Disease|2
4462069|NCT02954406|7251677|FG007|Overall Study|Progressive Disease|2
4462070|NCT02954406|7251678|FG008|Overall Study|Progressive Disease|1
4462071|NCT02954406|7251679|FG009|Overall Study|Progressive Disease|1
4462072|NCT02954406|7251680|FG010|Overall Study|Progressive Disease|0
4462073|NCT02954406|7251670|FG000|Overall Study|Symptomatic Deterioration|0
4462074|NCT02954406|7251671|FG001|Overall Study|Symptomatic Deterioration|1
4462075|NCT02954406|7251672|FG002|Overall Study|Symptomatic Deterioration|0
4462076|NCT02954406|7251673|FG003|Overall Study|Symptomatic Deterioration|0
4462077|NCT02954406|7251674|FG004|Overall Study|Symptomatic Deterioration|0
4462078|NCT02954406|7251675|FG005|Overall Study|Symptomatic Deterioration|0
4462079|NCT02954406|7251676|FG006|Overall Study|Symptomatic Deterioration|0
4462080|NCT02954406|7251677|FG007|Overall Study|Symptomatic Deterioration|0
4462081|NCT02954406|7251678|FG008|Overall Study|Symptomatic Deterioration|0
4462082|NCT02954406|7251679|FG009|Overall Study|Symptomatic Deterioration|0
4462083|NCT02954406|7251680|FG010|Overall Study|Symptomatic Deterioration|0
4462084|NCT02954406|7251670|FG000|Overall Study|Death|0
4462085|NCT02954406|7251671|FG001|Overall Study|Death|0
4462086|NCT02954406|7251672|FG002|Overall Study|Death|0
4462087|NCT02954406|7251673|FG003|Overall Study|Death|0
4462088|NCT02954406|7251674|FG004|Overall Study|Death|1
4462089|NCT02954406|7251675|FG005|Overall Study|Death|0
4462090|NCT02954406|7251676|FG006|Overall Study|Death|0
4462091|NCT02954406|7251677|FG007|Overall Study|Death|0
4462092|NCT02954406|7251678|FG008|Overall Study|Death|1
4462093|NCT02954406|7251679|FG009|Overall Study|Death|1
4462094|NCT02954406|7251680|FG010|Overall Study|Death|0
4462095|NCT02954406|7251670|FG000|Overall Study|Reason Not Specified|0
4462096|NCT02954406|7251671|FG001|Overall Study|Reason Not Specified|0
4462097|NCT02954406|7251672|FG002|Overall Study|Reason Not Specified|3
4462098|NCT02954406|7251673|FG003|Overall Study|Reason Not Specified|2
4462099|NCT02954406|7251674|FG004|Overall Study|Reason Not Specified|2
4462100|NCT02954406|7251675|FG005|Overall Study|Reason Not Specified|0
4462101|NCT02954406|7251676|FG006|Overall Study|Reason Not Specified|1
4462102|NCT02954406|7251677|FG007|Overall Study|Reason Not Specified|0
4462103|NCT02954406|7251678|FG008|Overall Study|Reason Not Specified|1
4462104|NCT02954406|7251679|FG009|Overall Study|Reason Not Specified|0
4462105|NCT02954406|7251680|FG010|Overall Study|Reason Not Specified|0
4462106|NCT02927145|7251715|FG000|Initial Recruitment|Withdrawal by Subject|0
4462107|NCT02927145|7251716|FG001|Initial Recruitment|Withdrawal by Subject|1
4462108|NCT02927145|7251717|FG002|Initial Recruitment|Withdrawal by Subject|1
4462109|NCT02927145|7251718|FG003|Initial Recruitment|Withdrawal by Subject|4
4462110|NCT02927145|7251719|FG004|Initial Recruitment|Withdrawal by Subject|1
4462111|NCT02927145|7251720|FG005|Initial Recruitment|Withdrawal by Subject|1
4462112|NCT02927145|7251721|FG006|Initial Recruitment|Withdrawal by Subject|0
4462113|NCT02927145|7251722|FG007|Initial Recruitment|Withdrawal by Subject|0
4462114|NCT02927145|7251723|FG008|Initial Recruitment|Withdrawal by Subject|2
4462115|NCT02927145|7251715|FG000|Initial Recruitment|Adverse Event|0
4462116|NCT02927145|7251716|FG001|Initial Recruitment|Adverse Event|0
4462117|NCT02927145|7251717|FG002|Initial Recruitment|Adverse Event|0
4462118|NCT02927145|7251718|FG003|Initial Recruitment|Adverse Event|0
4462119|NCT02927145|7251719|FG004|Initial Recruitment|Adverse Event|2
4462120|NCT02927145|7251720|FG005|Initial Recruitment|Adverse Event|0
4462121|NCT02927145|7251721|FG006|Initial Recruitment|Adverse Event|0
4462122|NCT02927145|7251722|FG007|Initial Recruitment|Adverse Event|0
4462123|NCT02927145|7251723|FG008|Initial Recruitment|Adverse Event|0
4462124|NCT02927145|7251715|FG000|Invitation for Additional Challenge|Pregnancy|0
4462125|NCT02927145|7251716|FG001|Invitation for Additional Challenge|Pregnancy|0
4462126|NCT02927145|7251717|FG002|Invitation for Additional Challenge|Pregnancy|0
4462127|NCT02927145|7251718|FG003|Invitation for Additional Challenge|Pregnancy|0
4462128|NCT02927145|7251719|FG004|Invitation for Additional Challenge|Pregnancy|0
4462129|NCT02927145|7251720|FG005|Invitation for Additional Challenge|Pregnancy|0
4462130|NCT02927145|7251721|FG006|Invitation for Additional Challenge|Pregnancy|1
4462131|NCT02927145|7251722|FG007|Invitation for Additional Challenge|Pregnancy|0
4462132|NCT02927145|7251723|FG008|Invitation for Additional Challenge|Pregnancy|0
4462133|NCT02910583|7251746|FG000|Overall Study|Withdrawal by Subject|6
4462134|NCT02910583|7251747|FG001|Overall Study|Withdrawal by Subject|7
4462135|NCT02910583|7251746|FG000|Overall Study|Other, Not Specified|1
4462136|NCT02910583|7251747|FG001|Overall Study|Other, Not Specified|0
4462137|NCT02598388|7251804|FG000|Overall Study|Lost to Follow-up|1
4462138|NCT02598388|7251805|FG001|Overall Study|Lost to Follow-up|0
4462139|NCT02598388|7251806|FG002|Overall Study|Lost to Follow-up|1
4462140|NCT02598388|7251807|FG003|Overall Study|Lost to Follow-up|0
4462141|NCT02598388|7251808|FG004|Overall Study|Lost to Follow-up|5
4462142|NCT02598388|7251809|FG005|Overall Study|Lost to Follow-up|1
4462143|NCT02598388|7251810|FG006|Overall Study|Lost to Follow-up|2
4462144|NCT02598388|7251811|FG007|Overall Study|Lost to Follow-up|1
4462145|NCT02598388|7251812|FG008|Overall Study|Lost to Follow-up|0
4462146|NCT02598388|7251813|FG009|Overall Study|Lost to Follow-up|0
4462147|NCT02598388|7251814|FG010|Overall Study|Lost to Follow-up|1
4462148|NCT02598388|7251815|FG011|Overall Study|Lost to Follow-up|0
4462149|NCT02598388|7251804|FG000|Overall Study|Withdrawal by Subject|0
4462150|NCT02598388|7251805|FG001|Overall Study|Withdrawal by Subject|0
4462151|NCT02598388|7251806|FG002|Overall Study|Withdrawal by Subject|0
4462152|NCT02598388|7251807|FG003|Overall Study|Withdrawal by Subject|0
4462153|NCT02598388|7251808|FG004|Overall Study|Withdrawal by Subject|2
4462154|NCT02598388|7251809|FG005|Overall Study|Withdrawal by Subject|0
4462155|NCT02598388|7251810|FG006|Overall Study|Withdrawal by Subject|2
4462156|NCT02598388|7251811|FG007|Overall Study|Withdrawal by Subject|0
4462157|NCT02598388|7251812|FG008|Overall Study|Withdrawal by Subject|0
4462158|NCT02598388|7251813|FG009|Overall Study|Withdrawal by Subject|1
4462159|NCT02598388|7251814|FG010|Overall Study|Withdrawal by Subject|0
4462160|NCT02598388|7251815|FG011|Overall Study|Withdrawal by Subject|0
4462161|NCT02598388|7251804|FG000|Overall Study|Other|0
4462162|NCT02598388|7251805|FG001|Overall Study|Other|0
4462163|NCT02598388|7251806|FG002|Overall Study|Other|1
4462164|NCT02598388|7251807|FG003|Overall Study|Other|0
4462165|NCT02598388|7251808|FG004|Overall Study|Other|3
4462166|NCT02598388|7251809|FG005|Overall Study|Other|0
4462167|NCT02598388|7251810|FG006|Overall Study|Other|1
4462168|NCT02598388|7251811|FG007|Overall Study|Other|0
4462169|NCT02598388|7251812|FG008|Overall Study|Other|0
4462170|NCT02598388|7251813|FG009|Overall Study|Other|0
4462171|NCT02598388|7251814|FG010|Overall Study|Other|0
4462172|NCT02598388|7251815|FG011|Overall Study|Other|0
4462173|NCT02493751|7251848|FG000|Overall Study|Withdrawal by Subject|2
4462174|NCT02493751|7251849|FG001|Overall Study|Withdrawal by Subject|8
4462175|NCT02493751|7251848|FG000|Overall Study|Death|6
4462176|NCT02493751|7251849|FG001|Overall Study|Death|13
4462177|NCT02493751|7251848|FG000|Overall Study|Lost to Follow-up|2
4462178|NCT02493751|7251849|FG001|Overall Study|Lost to Follow-up|3
4462179|NCT02493751|7251848|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6
4462180|NCT02493751|7251849|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15
4462181|NCT02285166|7251856|FG000|Overall Study|Case Report Forms Uncollected|564
4462182|NCT02285166|7251856|FG000|Overall Study|Protocol Deviation|402
4462183|NCT02278120|7251864|FG000|Overall Study|Progressive disease|122
4462184|NCT02278120|7251865|FG001|Overall Study|Progressive disease|174
4462185|NCT02278120|7251864|FG000|Overall Study|Patient/guardian decision|14
4462186|NCT02278120|7251865|FG001|Overall Study|Patient/guardian decision|8
4462187|NCT02278120|7251864|FG000|Overall Study|Adverse Event|12
4462188|NCT02278120|7251865|FG001|Overall Study|Adverse Event|10
4462189|NCT02278120|7251864|FG000|Overall Study|Physician Decision|8
4462190|NCT02278120|7251865|FG001|Overall Study|Physician Decision|19
4462191|NCT02278120|7251864|FG000|Overall Study|Death|3
4462192|NCT02278120|7251865|FG001|Overall Study|Death|3
4462193|NCT02278120|7251864|FG000|Overall Study|Lost to Follow-up|2
4462194|NCT02278120|7251865|FG001|Overall Study|Lost to Follow-up|0
4462195|NCT02278120|7251864|FG000|Overall Study|Protocol Violation|0
4462196|NCT02278120|7251865|FG001|Overall Study|Protocol Violation|2
4516100|NCT00958256|7327416|FG000|Overall Study|Adverse Event|3
4516101|NCT00958360|7327457|FG000|Overall Study|Withdrawal by Subject|3
4516102|NCT00958360|7327458|FG001|Overall Study|Withdrawal by Subject|1
4516103|NCT00958360|7327457|FG000|Overall Study|Death|6
4516104|NCT00958360|7327458|FG001|Overall Study|Death|7
4516105|NCT00958360|7327457|FG000|Overall Study|Physician Decision|2
4516106|NCT00958360|7327458|FG001|Overall Study|Physician Decision|1
4516107|NCT00958360|7327457|FG000|Overall Study|Lost to Follow-up|0
4516108|NCT00958360|7327458|FG001|Overall Study|Lost to Follow-up|1
4516109|NCT00958412|7327464|FG000|Overall Study|Study prematurely terminated|18
4516110|NCT00958438|7327471|FG000|Overall Study|Protocol Violation|3
4516111|NCT00958438|7327472|FG001|Overall Study|Protocol Violation|2
4516112|NCT00958438|7327473|FG002|Overall Study|Protocol Violation|2
4516113|NCT00958438|7327471|FG000|Overall Study|Withdrawal by Subject|4
4516114|NCT00958438|7327472|FG001|Overall Study|Withdrawal by Subject|2
4516115|NCT00958438|7327473|FG002|Overall Study|Withdrawal by Subject|1
4516116|NCT00958438|7327471|FG000|Overall Study|Adverse Event|0
4516117|NCT00958438|7327472|FG001|Overall Study|Adverse Event|3
4516118|NCT00958438|7327473|FG002|Overall Study|Adverse Event|0
4516119|NCT00958438|7327471|FG000|Overall Study|Physician Decision|1
4516120|NCT00958438|7327472|FG001|Overall Study|Physician Decision|0
4516121|NCT00958438|7327473|FG002|Overall Study|Physician Decision|1
4516122|NCT00958438|7327471|FG000|Overall Study|Other than specified above|2
4516123|NCT00958438|7327472|FG001|Overall Study|Other than specified above|3
4539678|NCT01128400|7362270|FG001|Overall Study|Screening failure|0
4539679|NCT01128400|7362271|FG002|Overall Study|Screening failure|0
4539680|NCT01128400|7362269|FG000|Overall Study|were not invited to participate on taste|0
4539681|NCT01128400|7362270|FG001|Overall Study|were not invited to participate on taste|0
4539682|NCT01128400|7362271|FG002|Overall Study|were not invited to participate on taste|15
4539683|NCT01128400|7362269|FG000|Overall Study|Excluded due to sinus problems|0
4539684|NCT01128400|7362270|FG001|Overall Study|Excluded due to sinus problems|1
4539685|NCT01128400|7362271|FG002|Overall Study|Excluded due to sinus problems|0
4539686|NCT01128413|7362281|FG000|Overall Study|Withdrawal by Subject|1
4539687|NCT01128413|7362282|FG001|Overall Study|Withdrawal by Subject|0
4539688|NCT01128413|7362281|FG000|Overall Study|NICOM Monitor Problems|2
4539689|NCT01128413|7362282|FG001|Overall Study|NICOM Monitor Problems|1
4539690|NCT01128413|7362281|FG000|Overall Study|Pt made DNR|1
4539691|NCT01128413|7362282|FG001|Overall Study|Pt made DNR|0
4539692|NCT01128543|7362294|FG000|Overall Study|Withdrawal by Subject|3
4539693|NCT01128543|7362294|FG000|Overall Study|Protocol Violation|1
4539694|NCT01128569|7362298|FG000|Washout Period 1|Adverse Event|0
4539695|NCT01128569|7362299|FG001|Washout Period 1|Adverse Event|0
4539696|NCT01128569|7362300|FG002|Washout Period 1|Adverse Event|1
4539697|NCT01128569|7362301|FG003|Washout Period 1|Adverse Event|0
4539698|NCT01128569|7362302|FG004|Washout Period 1|Adverse Event|0
4539699|NCT01128569|7362303|FG005|Washout Period 1|Adverse Event|0
4539700|NCT01128569|7362298|FG000|Treatment Period 2|Withdrawal by Subject|0
4539701|NCT01128569|7362299|FG001|Treatment Period 2|Withdrawal by Subject|1
4539702|NCT01128569|7362300|FG002|Treatment Period 2|Withdrawal by Subject|0
4539703|NCT01128569|7362301|FG003|Treatment Period 2|Withdrawal by Subject|0
4539704|NCT01128569|7362302|FG004|Treatment Period 2|Withdrawal by Subject|0
4539705|NCT01128569|7362303|FG005|Treatment Period 2|Withdrawal by Subject|0
4539706|NCT01128595|7362311|FG000|Treatment Period 3|Withdrawal by Subject|0
4539707|NCT01128595|7362312|FG001|Treatment Period 3|Withdrawal by Subject|1
4539708|NCT01128595|7362313|FG002|Treatment Period 3|Withdrawal by Subject|0
4539709|NCT01128595|7362314|FG003|Treatment Period 3|Withdrawal by Subject|0
4539710|NCT01128621|7362327|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0
4539711|NCT01128621|7362328|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2
4539712|NCT01128738|7362352|FG000|First Treatment Phase (TP)|Lost to Follow-up|1
4539713|NCT01128738|7362353|FG001|First Treatment Phase (TP)|Lost to Follow-up|0
4539714|NCT01128738|7362352|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3
4539715|NCT01128738|7362353|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1
4539716|NCT01128738|7362352|FG000|Second TP|Lost to Follow-up|0
4539717|NCT01128738|7362353|FG001|Second TP|Lost to Follow-up|1
4539718|NCT01128738|7362352|FG000|Second TP|Withdrawal by Subject|0
4539719|NCT01128738|7362353|FG001|Second TP|Withdrawal by Subject|2
4539720|NCT01128842|7362365|FG000|Overall Study|Adverse Event|1
4539721|NCT01128842|7362365|FG000|Overall Study|Disease Progression|6
4539722|NCT01128894|7362372|FG000|Overall Study|Adverse Event|31
4539723|NCT01128894|7362373|FG001|Overall Study|Adverse Event|41
4539724|NCT01128894|7362372|FG000|Overall Study|Protocol Violation|2
4539725|NCT01128894|7362373|FG001|Overall Study|Protocol Violation|1
4539726|NCT01128894|7362372|FG000|Overall Study|Noncompliance|4
4539727|NCT01128894|7362373|FG001|Overall Study|Noncompliance|5
4539728|NCT01128894|7362372|FG000|Overall Study|Lost to Follow-up|8
4539729|NCT01128894|7362373|FG001|Overall Study|Lost to Follow-up|8
4516124|NCT00958438|7327473|FG002|Overall Study|Other than specified above|2
4462197|NCT02075593|7251871|FG000|Overall Study|Withdrawal by Subject|1
4462198|NCT02075593|7251871|FG000|Overall Study|Treatment ongoing at the time of analysis|2
4462199|NCT00587860|7251879|FG000|Overall Study|Lost to Follow-up|2
4462200|NCT00587860|7251880|FG001|Overall Study|Lost to Follow-up|2
4462201|NCT00587860|7251879|FG000|Overall Study|Withdrawal by Subject|3
4462202|NCT00587860|7251880|FG001|Overall Study|Withdrawal by Subject|3
4462203|NCT00587964|7251886|FG000|Overall Study|Withdrawal by Subject|1
4462204|NCT00587964|7251886|FG000|Overall Study|Lost to Follow-up|1
4462205|NCT00587964|7251886|FG000|Overall Study|Patient found to be ineligible|1
4462206|NCT00587964|7251886|FG000|Overall Study|Patient did not receive intervention|5
4462207|NCT00587964|7251886|FG000|Overall Study|Progression of Disease|4
4462208|NCT00587990|7251893|FG000|Overall Study|Death|0
4462209|NCT00587990|7251894|FG001|Overall Study|Death|0
4462210|NCT00587990|7251895|FG002|Overall Study|Death|1
4462211|NCT00588094|7251903|FG000|Overall Study|Adverse Event|3
4462212|NCT00588094|7251903|FG000|Overall Study|Progression of Disease|2
4539730|NCT01128894|7362372|FG000|Overall Study|Withdrawal by Subject|10
4539731|NCT01128894|7362373|FG001|Overall Study|Withdrawal by Subject|12
4539732|NCT01128894|7362372|FG000|Overall Study|Physician Decision|2
4539733|NCT01128894|7362373|FG001|Overall Study|Physician Decision|1
4539734|NCT01128894|7362372|FG000|Overall Study|Conflicting HbA1c Results at Screening|1
4539735|NCT01128894|7362373|FG001|Overall Study|Conflicting HbA1c Results at Screening|0
4539736|NCT01128946|7362379|FG000|Period I|Protocol Violation|0
4539737|NCT01128946|7362380|FG001|Period I|Protocol Violation|1
4539738|NCT01128946|7362381|FG002|Period I|Protocol Violation|0
4539739|NCT01128946|7362382|FG003|Period I|Protocol Violation|0
4539740|NCT01128946|7362379|FG000|Period I|Withdrawal by Subject|0
4539741|NCT01128946|7362380|FG001|Period I|Withdrawal by Subject|0
4539742|NCT01128946|7362381|FG002|Period I|Withdrawal by Subject|1
4462213|NCT00588237|7251916|FG000|Overall Study|Evaluable for toxicity only|3
4462214|NCT00588237|7251916|FG000|Overall Study|Patien not treated|1
4462215|NCT00588341|7251920|FG000|Overall Study|Withdrawal by Subject|3
4462216|NCT00588341|7251920|FG000|Overall Study|Not treated due to metastatic disease|1
4462217|NCT00588341|7251920|FG000|Overall Study|Patient ineligible|1
4462218|NCT00588354|7251926|FG000|Baseline to 2 Weeks|Adverse Event|1
4462219|NCT00588354|7251927|FG001|Baseline to 2 Weeks|Adverse Event|0
4462220|NCT00588354|7251926|FG000|Baseline to 2 Weeks|Lack of Efficacy|1
4539743|NCT01128946|7362382|FG003|Period I|Withdrawal by Subject|1
4539744|NCT01128946|7362379|FG000|Period II|Protocol Violation|0
4462221|NCT00588354|7251927|FG001|Baseline to 2 Weeks|Lack of Efficacy|0
4462222|NCT00588354|7251926|FG000|Baseline to 4 Weeks|Lost to Follow-up|0
4462223|NCT00588354|7251927|FG001|Baseline to 4 Weeks|Lost to Follow-up|1
4462224|NCT00588445|7251948|FG000|Overall Study|Protocol Violation|1
4462225|NCT00588445|7251948|FG000|Overall Study|Withdrawal by Subject|3
4462226|NCT00588445|7251948|FG000|Overall Study|Disease Progression|1
4462227|NCT00588445|7251948|FG000|Overall Study|Not Treated|10
4462228|NCT00588640|7251958|FG000|Overall Study|Physician Decision|1
4462229|NCT00588640|7251958|FG000|Overall Study|Ineligible Patient|1
4462230|NCT00588666|7251962|FG000|Overall Study|Adverse Event|4
4462231|NCT00588692|7251968|FG000|Overall Study|Withdrawal by Subject|4
4462232|NCT00588692|7251969|FG001|Overall Study|Withdrawal by Subject|2
4462233|NCT00588692|7251968|FG000|Overall Study|Hip Surgery|0
4462234|NCT00588692|7251969|FG001|Overall Study|Hip Surgery|1
4462235|NCT00588692|7251968|FG000|Overall Study|Severe Peptic Ulcer Disease|1
4462236|NCT00588692|7251969|FG001|Overall Study|Severe Peptic Ulcer Disease|0
4462237|NCT00588692|7251968|FG000|Overall Study|Cancer|1
4462238|NCT00588692|7251969|FG001|Overall Study|Cancer|0
4462239|NCT00588692|7251968|FG000|Overall Study|Death|1
4462240|NCT00588692|7251969|FG001|Overall Study|Death|0
4462241|NCT00588731|7251979|FG000|Overall Study|Withdrawal by Subject|3
4462242|NCT00588731|7251980|FG001|Overall Study|Withdrawal by Subject|2
4462243|NCT00588822|7251990|FG000|Overall Study|progression of disease|8
4462244|NCT00588848|7251996|FG000|Overall Study|Physician Decision|0
4462245|NCT00588848|7251997|FG001|Overall Study|Physician Decision|3
4462246|NCT00588952|7252011|FG000|Overall Study|Adverse Event|0
4462247|NCT00588952|7252012|FG001|Overall Study|Adverse Event|2
4462248|NCT00588952|7252011|FG000|Overall Study|Withdrawal by Subject|3
4462249|NCT00588952|7252012|FG001|Overall Study|Withdrawal by Subject|5
4462250|NCT00589108|7252031|FG000|Overall Study|Lost to Follow-up|1
4462251|NCT00589108|7252032|FG001|Overall Study|Lost to Follow-up|1
4462252|NCT00589108|7252033|FG002|Overall Study|Lost to Follow-up|1
4462253|NCT00589108|7252031|FG000|Overall Study|Death|3
4462254|NCT00589108|7252032|FG001|Overall Study|Death|3
4462255|NCT00589108|7252033|FG002|Overall Study|Death|4
4539745|NCT01128946|7362380|FG001|Period II|Protocol Violation|1
4539746|NCT01128946|7362381|FG002|Period II|Protocol Violation|0
4462256|NCT00589121|7252043|FG000|Overall Study|Protocol Violation|2
4462257|NCT00589121|7252044|FG001|Overall Study|Protocol Violation|6
4462258|NCT00589121|7252043|FG000|Overall Study|No protocol treatment received|0
4539747|NCT01128946|7362382|FG003|Period II|Protocol Violation|0
4539748|NCT01128946|7362379|FG000|Period II|Withdrawal by Subject|0
4539749|NCT01128946|7362380|FG001|Period II|Withdrawal by Subject|0
4462259|NCT00589121|7252044|FG001|Overall Study|No protocol treatment received|1
4462260|NCT00589290|7252062|FG000|Overall Study|Withdrawal by Subject|1
4539750|NCT01128946|7362381|FG002|Period II|Withdrawal by Subject|0
4539751|NCT01128946|7362382|FG003|Period II|Withdrawal by Subject|1
4539752|NCT01128946|7362379|FG000|Period III|Protocol Violation|1
4539753|NCT01128946|7362380|FG001|Period III|Protocol Violation|0
4539754|NCT01128946|7362381|FG002|Period III|Protocol Violation|0
4539755|NCT01128946|7362382|FG003|Period III|Protocol Violation|0
4462261|NCT00589303|7252070|FG000|Overall Study|Withdrawal by Subject|2
4462262|NCT00589303|7252071|FG001|Overall Study|Withdrawal by Subject|1
4462263|NCT00589472|7252087|FG000|Overall Study|Adverse Event|1
4462264|NCT00589602|7252095|FG000|Overall Study|Did not collect enough CD34+ cells|1
4462265|NCT00589628|7252103|FG000|Overall Study|Lost to Follow-up|0
4462266|NCT00589628|7252104|FG001|Overall Study|Lost to Follow-up|1
4462267|NCT00589667|7252110|FG000|Overall Study|Adverse Event|2
4462268|NCT00589667|7252110|FG000|Overall Study|Withdrawal by Subject|1
4462269|NCT00589693|7252116|FG000|Overall Study|randomized in error|12
4462270|NCT00589693|7252117|FG001|Overall Study|randomized in error|6
4462271|NCT00589693|7252116|FG000|Overall Study|Adverse Event|4
4462272|NCT00589693|7252117|FG001|Overall Study|Adverse Event|4
4462273|NCT00589693|7252116|FG000|Overall Study|Death|26
4462274|NCT00589693|7252117|FG001|Overall Study|Death|16
4462275|NCT00589693|7252116|FG000|Overall Study|Lack of Efficacy|0
4462276|NCT00589693|7252117|FG001|Overall Study|Lack of Efficacy|1
4462277|NCT00589693|7252116|FG000|Overall Study|Lost to Follow-up|1
4462278|NCT00589693|7252117|FG001|Overall Study|Lost to Follow-up|0
4462279|NCT00589693|7252116|FG000|Overall Study|Physician Decision|0
4462280|NCT00589693|7252117|FG001|Overall Study|Physician Decision|1
4462281|NCT00589693|7252116|FG000|Overall Study|Protocol Violation|1
4539756|NCT01128959|7362393|FG000|Lead in Period|Adverse Event|3
4539757|NCT01128959|7362393|FG000|Treatment Period|Adverse Event|3
4539758|NCT01128959|7362393|FG000|Treatment Period|Withdrawal by Subject|1
4539759|NCT01129011|7362423|FG000|Overall Study|Adverse Event|20
4614857|NCT01728116|7472772|FG001|Overall Study|Adverse Event|0
4614858|NCT01728116|7472771|FG000|Overall Study|Procedure/device failure|7
4614859|NCT01728116|7472772|FG001|Overall Study|Procedure/device failure|0
4614860|NCT01728116|7472771|FG000|Overall Study|Lost to Follow-up|9
4614861|NCT01728116|7472772|FG001|Overall Study|Lost to Follow-up|2
4614862|NCT01728116|7472771|FG000|Overall Study|Physician Decision|2
4614863|NCT01728116|7472772|FG001|Overall Study|Physician Decision|0
4614864|NCT01728116|7472771|FG000|Overall Study|Subject Non-Compliance|2
4614865|NCT01728116|7472772|FG001|Overall Study|Subject Non-Compliance|0
4614866|NCT01728116|7472771|FG000|Overall Study|Inter-current finding at procedure|1
4462282|NCT00589693|7252117|FG001|Overall Study|Protocol Violation|1
4539760|NCT01129011|7362424|FG001|Overall Study|Adverse Event|30
4539761|NCT01129011|7362423|FG000|Overall Study|Withdrawal by Subject|24
4539762|NCT01129011|7362424|FG001|Overall Study|Withdrawal by Subject|8
4539763|NCT01129011|7362423|FG000|Overall Study|Lost to Follow-up|6
4539764|NCT01129011|7362424|FG001|Overall Study|Lost to Follow-up|7
4539765|NCT01129011|7362423|FG000|Overall Study|Duodenal Ulcer|2
4539766|NCT01129011|7362424|FG001|Overall Study|Duodenal Ulcer|8
4539767|NCT01129011|7362423|FG000|Overall Study|misc|7
4539768|NCT01129011|7362424|FG001|Overall Study|misc|4
4539769|NCT01129024|7362430|FG000|Overall Study|Physician Decision|5
4539770|NCT01129024|7362430|FG000|Overall Study|Study Terminated by Sponsor|8
4539771|NCT01129024|7362430|FG000|Overall Study|Withdrawal by Subject|2
4539772|NCT01129024|7362430|FG000|Overall Study|Lack of Efficacy|3
4539773|NCT01129024|7362430|FG000|Overall Study|Needed a Platelet Transfusion|1
4539774|NCT01129102|7362437|FG000|Overall Study|No study drug treatment|2
4539775|NCT01129102|7362438|FG001|Overall Study|No study drug treatment|3
4539776|NCT01129102|7362439|FG002|Overall Study|No study drug treatment|1
4539777|NCT01129102|7362437|FG000|Overall Study|Withdrawal by Subject|2
4539778|NCT01129102|7362438|FG001|Overall Study|Withdrawal by Subject|0
4539779|NCT01129102|7362439|FG002|Overall Study|Withdrawal by Subject|3
4539780|NCT01129102|7362437|FG000|Overall Study|Protocol Violation|0
4539781|NCT01129102|7362438|FG001|Overall Study|Protocol Violation|1
4539782|NCT01129102|7362439|FG002|Overall Study|Protocol Violation|1
4539783|NCT01129102|7362437|FG000|Overall Study|Pregnancy|0
4539784|NCT01129102|7362438|FG001|Overall Study|Pregnancy|0
4539785|NCT01129102|7362439|FG002|Overall Study|Pregnancy|1
4539786|NCT01129102|7362437|FG000|Overall Study|Adverse Event|2
4539787|NCT01129102|7362438|FG001|Overall Study|Adverse Event|2
4539788|NCT01129102|7362439|FG002|Overall Study|Adverse Event|1
4539789|NCT01129102|7362437|FG000|Overall Study|Lost to Follow-up|2
4539790|NCT01129102|7362438|FG001|Overall Study|Lost to Follow-up|0
4539791|NCT01129102|7362439|FG002|Overall Study|Lost to Follow-up|0
4539792|NCT01129115|7362450|FG000|Overall Study|Adverse Event|1
4614867|NCT01728116|7472772|FG001|Overall Study|Inter-current finding at procedure|0
4462283|NCT00589784|7252125|FG000|Overall Study|Withdrawal by Subject|0
4462284|NCT00589784|7252126|FG001|Overall Study|Withdrawal by Subject|6
4462285|NCT00589784|7252125|FG000|Overall Study|Patient inevaluable|1
4462286|NCT00589784|7252126|FG001|Overall Study|Patient inevaluable|0
4539793|NCT01129115|7362451|FG001|Overall Study|Adverse Event|2
4539794|NCT01129115|7362452|FG002|Overall Study|Adverse Event|3
4539795|NCT01129115|7362453|FG003|Overall Study|Adverse Event|3
4539796|NCT01129115|7362450|FG000|Overall Study|Withdrawal by Subject|1
4614868|NCT01728116|7472771|FG000|Overall Study|Incorrectly enrolled in Study|0
4632771|NCT01904383|7502554|FG000|Overall Study|Adverse Event|271
4462287|NCT00589784|7252125|FG000|Overall Study|Adverse Event|0
4462288|NCT00589784|7252126|FG001|Overall Study|Adverse Event|4
4462289|NCT00589797|7252133|FG000|Overall Study|Death|1
4462290|NCT00589797|7252134|FG001|Overall Study|Death|0
4462291|NCT00589797|7252133|FG000|Overall Study|Lost to Follow-up|12
4462292|NCT00589797|7252134|FG001|Overall Study|Lost to Follow-up|9
4462293|NCT00589797|7252133|FG000|Overall Study|Physician Decision|8
4462294|NCT00589797|7252134|FG001|Overall Study|Physician Decision|3
4462295|NCT00589797|7252133|FG000|Overall Study|Withdrawal by Subject|6
4462296|NCT00589797|7252134|FG001|Overall Study|Withdrawal by Subject|5
4462297|NCT00589797|7252133|FG000|Overall Study|Non-Randomized Training Subjects|46
4462298|NCT00589797|7252134|FG001|Overall Study|Non-Randomized Training Subjects|6
4516125|NCT00958568|7327504|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80
4516126|NCT00958568|7327505|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
4516127|NCT00958568|7327506|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
4516128|NCT00958568|7327507|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
4516129|NCT00958568|7327504|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44
4516130|NCT00958568|7327505|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
4516131|NCT00958568|7327506|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
4516132|NCT00958568|7327507|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
4516133|NCT00958568|7327504|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34
4516134|NCT00958568|7327505|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
4516135|NCT00958568|7327506|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
4516136|NCT00958568|7327507|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
4516137|NCT00958568|7327504|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39
4516138|NCT00958568|7327505|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
4516139|NCT00958568|7327506|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
4516140|NCT00958568|7327507|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
4516141|NCT00958568|7327504|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14
4516142|NCT00958568|7327505|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
4516143|NCT00958568|7327506|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
4516144|NCT00958568|7327507|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
4516145|NCT00958568|7327504|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13
4516146|NCT00958568|7327505|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
4516147|NCT00958568|7327506|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
4516148|NCT00958568|7327507|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
4516149|NCT00958568|7327504|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4
4516150|NCT00958568|7327505|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
4516151|NCT00958568|7327506|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
4516152|NCT00958568|7327507|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
4516153|NCT00958568|7327504|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8
4516154|NCT00958568|7327505|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
4516155|NCT00958568|7327506|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
4516156|NCT00958568|7327507|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
4516157|NCT00958568|7327504|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1
4516158|NCT00958568|7327505|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
4516159|NCT00958568|7327506|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
4516160|NCT00958568|7327507|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
4516161|NCT00958568|7327504|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
4516162|NCT00958568|7327505|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62
4516163|NCT00958568|7327506|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
4516164|NCT00958568|7327507|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
4516165|NCT00958568|7327504|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
4516166|NCT00958568|7327505|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30
4516167|NCT00958568|7327506|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
4516168|NCT00958568|7327507|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
4516169|NCT00958568|7327504|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
4516170|NCT00958568|7327505|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28
4516171|NCT00958568|7327506|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
4516172|NCT00958568|7327507|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
4516173|NCT00958568|7327504|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
4516174|NCT00958568|7327505|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41
4516175|NCT00958568|7327506|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
4516176|NCT00958568|7327507|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
4516177|NCT00958568|7327504|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
4516178|NCT00958568|7327505|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24
4518746|NCT00976209|7331020|FG001|Treatment Period 1|Lost to Follow-up|0
4614869|NCT01728116|7472772|FG001|Overall Study|Incorrectly enrolled in Study|1
4614870|NCT01728116|7472771|FG000|Overall Study|various not noted previously|5
4614871|NCT01728116|7472772|FG001|Overall Study|various not noted previously|0
4614872|NCT01728194|7472781|FG000|Overall Study|Lost to Follow-up|4
4614873|NCT01728194|7472782|FG001|Overall Study|Lost to Follow-up|3
4614874|NCT01728194|7472781|FG000|Overall Study|Physician Decision|4
4614875|NCT01728194|7472782|FG001|Overall Study|Physician Decision|0
4614876|NCT01728194|7472781|FG000|Overall Study|Withdrawal by Subject|7
4614877|NCT01728194|7472782|FG001|Overall Study|Withdrawal by Subject|3
4614878|NCT01728194|7472781|FG000|Overall Study|Perceived Medication Side Effects|4
4614879|NCT01728194|7472782|FG001|Overall Study|Perceived Medication Side Effects|0
4614880|NCT01728194|7472781|FG000|Overall Study|Family Member Request|1
4614881|NCT01728194|7472782|FG001|Overall Study|Family Member Request|0
4614882|NCT01728246|7472790|FG000|Overall Study|Participant needed rescue medication|1
4614883|NCT01728246|7472791|FG001|Overall Study|Participant needed rescue medication|5
4614884|NCT01728246|7472790|FG000|Overall Study|Protocol Violation|1
4614885|NCT01728246|7472791|FG001|Overall Study|Protocol Violation|0
4614886|NCT01728246|7472790|FG000|Overall Study|Withdrawal by Subject|2
4614887|NCT01728246|7472791|FG001|Overall Study|Withdrawal by Subject|3
4614888|NCT01728246|7472790|FG000|Overall Study|Lost to Follow-up|23
4614889|NCT01728246|7472791|FG001|Overall Study|Lost to Follow-up|22
4614890|NCT01728246|7472790|FG000|Overall Study|Lack of Efficacy|1
4614891|NCT01728246|7472791|FG001|Overall Study|Lack of Efficacy|1
4614892|NCT01728246|7472790|FG000|Overall Study|Adverse Event|8
4614893|NCT01728246|7472791|FG001|Overall Study|Adverse Event|5
4614894|NCT01728324|7472800|FG000|Termination of DBV|Adverse Event|14
4614895|NCT01728324|7472801|FG001|Termination of DBV|Adverse Event|13
4614896|NCT01728324|7472802|FG002|Termination of DBV|Adverse Event|4
4614897|NCT01728324|7472800|FG000|Termination of DBV|Lack of Efficacy|14
4614898|NCT01728324|7472801|FG001|Termination of DBV|Lack of Efficacy|12
4614899|NCT01728324|7472802|FG002|Termination of DBV|Lack of Efficacy|8
4614900|NCT01728324|7472800|FG000|Termination of DBV|Withdrawal by Subject|9
4614901|NCT01728324|7472801|FG001|Termination of DBV|Withdrawal by Subject|6
4614902|NCT01728324|7472802|FG002|Termination of DBV|Withdrawal by Subject|2
4614903|NCT01728324|7472800|FG000|Termination of DBV|Other than stated|1
4614904|NCT01728324|7472801|FG001|Termination of DBV|Other than stated|3
4462299|NCT00589914|7252171|FG000|Overall Study|Adverse Event|19
4462300|NCT00589914|7252172|FG001|Overall Study|Adverse Event|10
4462301|NCT00589914|7252171|FG000|Overall Study|Death|2
4462302|NCT00589914|7252172|FG001|Overall Study|Death|0
4462303|NCT00589914|7252171|FG000|Overall Study|Lack of Efficacy|40
4462304|NCT00589914|7252172|FG001|Overall Study|Lack of Efficacy|43
4462305|NCT00589914|7252171|FG000|Overall Study|Lost to Follow-up|11
4462306|NCT00589914|7252172|FG001|Overall Study|Lost to Follow-up|18
4462307|NCT00589914|7252171|FG000|Overall Study|Pregnancy|1
4462308|NCT00589914|7252172|FG001|Overall Study|Pregnancy|0
4614905|NCT01728324|7472802|FG002|Termination of DBV|Other than stated|0
4614906|NCT01728324|7472800|FG000|Termination of DBV|Adverse Event (Placebo Period)|0
4614907|NCT01728324|7472801|FG001|Termination of DBV|Adverse Event (Placebo Period)|1
4614908|NCT01728324|7472802|FG002|Termination of DBV|Adverse Event (Placebo Period)|0
4614909|NCT01728324|7472800|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0
4614910|NCT01728324|7472801|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1
4614911|NCT01728324|7472802|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0
4614912|NCT01728324|7472800|FG000|Termination of FDV|Adverse Event|14
4614913|NCT01728324|7472801|FG001|Termination of FDV|Adverse Event|13
4614914|NCT01728324|7472802|FG002|Termination of FDV|Adverse Event|4
4614915|NCT01728324|7472800|FG000|Termination of FDV|Lack of Efficacy|14
4614916|NCT01728324|7472801|FG001|Termination of FDV|Lack of Efficacy|12
4614917|NCT01728324|7472802|FG002|Termination of FDV|Lack of Efficacy|8
4614918|NCT01728324|7472800|FG000|Termination of FDV|Withdrawal by Subject|9
4614919|NCT01728324|7472801|FG001|Termination of FDV|Withdrawal by Subject|6
4614920|NCT01728324|7472802|FG002|Termination of FDV|Withdrawal by Subject|2
4614921|NCT01728324|7472800|FG000|Termination of FDV|Other than stated|1
4614922|NCT01728324|7472801|FG001|Termination of FDV|Other than stated|3
4614923|NCT01728324|7472802|FG002|Termination of FDV|Other than stated|0
4614924|NCT01728324|7472800|FG000|Termination of FDV|Adverse Event (Placebo Period)|0
4614925|NCT01728324|7472801|FG001|Termination of FDV|Adverse Event (Placebo Period)|1
4614926|NCT01728324|7472802|FG002|Termination of FDV|Adverse Event (Placebo Period)|0
4614927|NCT01728324|7472800|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0
4614928|NCT01728324|7472801|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1
4614929|NCT01728324|7472802|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0
4614930|NCT01728324|7472800|FG000|Termination of RBV|Adverse Event|15
4614931|NCT01728324|7472801|FG001|Termination of RBV|Adverse Event|16
4614932|NCT01728324|7472802|FG002|Termination of RBV|Adverse Event|5
4614933|NCT01728324|7472800|FG000|Termination of RBV|Lack of Efficacy|14
4614934|NCT01728324|7472801|FG001|Termination of RBV|Lack of Efficacy|11
4614935|NCT01728324|7472802|FG002|Termination of RBV|Lack of Efficacy|7
4614936|NCT01728324|7472800|FG000|Termination of RBV|Withdrawal by Subject|9
4614937|NCT01728324|7472801|FG001|Termination of RBV|Withdrawal by Subject|5
4614938|NCT01728324|7472802|FG002|Termination of RBV|Withdrawal by Subject|2
4462309|NCT00589914|7252171|FG000|Overall Study|Withdrawal by Subject|55
4462310|NCT00589914|7252172|FG001|Overall Study|Withdrawal by Subject|49
4462311|NCT00589914|7252171|FG000|Overall Study|Other|22
4614939|NCT01728324|7472800|FG000|Termination of RBV|Other than stated|1
4614940|NCT01728324|7472801|FG001|Termination of RBV|Other than stated|3
4614941|NCT01728324|7472802|FG002|Termination of RBV|Other than stated|1
4462312|NCT00589914|7252172|FG001|Overall Study|Other|17
4462313|NCT00589979|7252180|FG000|Run-In Period|Adverse Event|5
4462314|NCT00589979|7252181|FG001|Run-In Period|Adverse Event|0
4462315|NCT00589979|7252182|FG002|Run-In Period|Adverse Event|0
4462316|NCT00589979|7252180|FG000|Run-In Period|Protocol Violation|3
4462317|NCT00589979|7252181|FG001|Run-In Period|Protocol Violation|0
4462318|NCT00589979|7252182|FG002|Run-In Period|Protocol Violation|0
4462319|NCT00589979|7252180|FG000|Run-In Period|Did not qualify for randomization|54
4462320|NCT00589979|7252181|FG001|Run-In Period|Did not qualify for randomization|0
4462321|NCT00589979|7252182|FG002|Run-In Period|Did not qualify for randomization|0
4462322|NCT00589979|7252180|FG000|Run-In Period|Withdrawal by Subject|10
4462323|NCT00589979|7252181|FG001|Run-In Period|Withdrawal by Subject|0
4462324|NCT00589979|7252182|FG002|Run-In Period|Withdrawal by Subject|0
4462325|NCT00589979|7252180|FG000|Run-In Period|Informed Consent Withdrawn|4
4462326|NCT00589979|7252181|FG001|Run-In Period|Informed Consent Withdrawn|0
4462327|NCT00589979|7252182|FG002|Run-In Period|Informed Consent Withdrawn|0
4462328|NCT00589979|7252180|FG000|Double-Blind Treatment Period 1|Adverse Event|0
4462329|NCT00589979|7252181|FG001|Double-Blind Treatment Period 1|Adverse Event|1
4462330|NCT00589979|7252182|FG002|Double-Blind Treatment Period 1|Adverse Event|0
4462331|NCT00589979|7252180|FG000|Double-Blind Treatment Period 1|Protocol Violation|0
4462332|NCT00589979|7252181|FG001|Double-Blind Treatment Period 1|Protocol Violation|1
4462333|NCT00589979|7252182|FG002|Double-Blind Treatment Period 1|Protocol Violation|1
4462334|NCT00589979|7252180|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0
4462335|NCT00589979|7252181|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0
4462336|NCT00589979|7252182|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1
4462337|NCT00589979|7252180|FG000|Double-Blind Treatment Period 2|Adverse Event|0
4462338|NCT00589979|7252181|FG001|Double-Blind Treatment Period 2|Adverse Event|1
4462339|NCT00589979|7252182|FG002|Double-Blind Treatment Period 2|Adverse Event|0
4462340|NCT00589979|7252180|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0
4462341|NCT00589979|7252181|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0
4462342|NCT00589979|7252182|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1
4462343|NCT00589979|7252180|FG000|Double-Blind Treatment Period 2|Other|0
4462344|NCT00589979|7252181|FG001|Double-Blind Treatment Period 2|Other|0
4614942|NCT01728324|7472800|FG000|Termination of RBV|Adverse Event (Placebo Period)|0
4614943|NCT01728324|7472801|FG001|Termination of RBV|Adverse Event (Placebo Period)|1
4614944|NCT01728324|7472802|FG002|Termination of RBV|Adverse Event (Placebo Period)|0
4614945|NCT01728324|7472800|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0
4614946|NCT01728324|7472801|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1
4614947|NCT01728324|7472802|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0
4614948|NCT01728376|7472824|FG000|Overall Study|Adverse Event|1
4614949|NCT01728376|7472825|FG001|Overall Study|Adverse Event|1
4614950|NCT01728376|7472826|FG002|Overall Study|Adverse Event|1
4614951|NCT01728376|7472827|FG003|Overall Study|Adverse Event|1
4614952|NCT01728376|7472828|FG004|Overall Study|Adverse Event|1
4614953|NCT01728376|7472829|FG005|Overall Study|Adverse Event|0
4614954|NCT01728376|7472824|FG000|Overall Study|Persistent Positive Blood Cultures|1
4614955|NCT01728376|7472825|FG001|Overall Study|Persistent Positive Blood Cultures|0
4614956|NCT01728376|7472826|FG002|Overall Study|Persistent Positive Blood Cultures|1
4462345|NCT00589979|7252182|FG002|Double-Blind Treatment Period 2|Other|1
4462346|NCT00589979|7252180|FG000|Double-Blind Treatment Period 3|Protocol Violation|0
4614957|NCT01728376|7472827|FG003|Overall Study|Persistent Positive Blood Cultures|0
4614958|NCT01728376|7472828|FG004|Overall Study|Persistent Positive Blood Cultures|0
4614959|NCT01728376|7472829|FG005|Overall Study|Persistent Positive Blood Cultures|0
4614960|NCT01728376|7472824|FG000|Overall Study|No relevant bacteria|2
4614961|NCT01728376|7472825|FG001|Overall Study|No relevant bacteria|0
4614962|NCT01728376|7472826|FG002|Overall Study|No relevant bacteria|0
4614963|NCT01728376|7472827|FG003|Overall Study|No relevant bacteria|0
4614964|NCT01728376|7472828|FG004|Overall Study|No relevant bacteria|1
4614965|NCT01728376|7472829|FG005|Overall Study|No relevant bacteria|1
4614966|NCT01728376|7472824|FG000|Overall Study|Did not receive treatment|0
4614967|NCT01728376|7472825|FG001|Overall Study|Did not receive treatment|1
4614968|NCT01728376|7472826|FG002|Overall Study|Did not receive treatment|0
4614969|NCT01728376|7472827|FG003|Overall Study|Did not receive treatment|0
4614970|NCT01728376|7472828|FG004|Overall Study|Did not receive treatment|0
4614971|NCT01728376|7472829|FG005|Overall Study|Did not receive treatment|0
4614972|NCT01728376|7472824|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0
4614973|NCT01728376|7472825|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0
4614974|NCT01728376|7472826|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0
4614975|NCT01728376|7472827|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1
4614976|NCT01728376|7472828|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0
4614977|NCT01728376|7472829|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1
4614978|NCT01728454|7472846|FG000|Stage 1 and 2|Pregnancy|1
4614979|NCT01728454|7472847|FG001|Stage 1 and 2|Pregnancy|0
4462347|NCT00589979|7252181|FG001|Double-Blind Treatment Period 3|Protocol Violation|1
4614980|NCT01728454|7472848|FG002|Stage 1 and 2|Pregnancy|0
4614981|NCT01728454|7472846|FG000|Stage 1 and 2|Non-compliance with Protocol|0
4737653|NCT03614975|7687834|FG000|Overall Study|Withdrawal by Subject|2
4462348|NCT00589979|7252182|FG002|Double-Blind Treatment Period 3|Protocol Violation|0
4462349|NCT00589979|7252180|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0
4462350|NCT00589979|7252181|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0
4462351|NCT00589979|7252182|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1
4462352|NCT00590031|7252210|FG000|Overall Study|Adverse Event|3
4539797|NCT01129115|7362451|FG001|Overall Study|Withdrawal by Subject|3
4539798|NCT01129115|7362452|FG002|Overall Study|Withdrawal by Subject|1
4539799|NCT01129115|7362453|FG003|Overall Study|Withdrawal by Subject|4
4539800|NCT01129115|7362450|FG000|Overall Study|Protocol Violation|0
4539801|NCT01129115|7362451|FG001|Overall Study|Protocol Violation|2
4539802|NCT01129115|7362452|FG002|Overall Study|Protocol Violation|2
4539803|NCT01129115|7362453|FG003|Overall Study|Protocol Violation|2
4539804|NCT01129128|7362466|FG000|Overall Study|Lost to Follow-up|2
4539805|NCT01129128|7362467|FG001|Overall Study|Lost to Follow-up|2
4539806|NCT01129128|7362468|FG002|Overall Study|Lost to Follow-up|1
4539807|NCT01129128|7362466|FG000|Overall Study|Protocol Violation|0
4539808|NCT01129128|7362467|FG001|Overall Study|Protocol Violation|1
4539809|NCT01129128|7362468|FG002|Overall Study|Protocol Violation|0
4539810|NCT01129128|7362466|FG000|Overall Study|Withdrawal by Subject|0
4614982|NCT01728454|7472847|FG001|Stage 1 and 2|Non-compliance with Protocol|0
4614983|NCT01728454|7472848|FG002|Stage 1 and 2|Non-compliance with Protocol|1
4614984|NCT01728454|7472846|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1
4614985|NCT01728454|7472847|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0
4614986|NCT01728454|7472848|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0
4614987|NCT01728454|7472846|FG000|Stage 1 and 2|Lost to Follow-up|1
4614988|NCT01728454|7472847|FG001|Stage 1 and 2|Lost to Follow-up|1
4614989|NCT01728454|7472848|FG002|Stage 1 and 2|Lost to Follow-up|0
4690397|NCT02561195|7600194|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0
4690398|NCT02561195|7600195|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0
4690399|NCT02561195|7600196|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0
4690400|NCT02561195|7600197|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0
4690401|NCT02561195|7600198|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0
4690402|NCT02561195|7600185|FG000|Vaccination 1 to 3|No longer willing to participate|2
4690403|NCT02561195|7600186|FG001|Vaccination 1 to 3|No longer willing to participate|4
4690404|NCT02561195|7600187|FG002|Vaccination 1 to 3|No longer willing to participate|0
4690405|NCT02561195|7600188|FG003|Vaccination 1 to 3|No longer willing to participate|4
4690406|NCT02561195|7600189|FG004|Vaccination 1 to 3|No longer willing to participate|1
4690407|NCT02561195|7600190|FG005|Vaccination 1 to 3|No longer willing to participate|3
4690408|NCT02561195|7600191|FG006|Vaccination 1 to 3|No longer willing to participate|0
4690409|NCT02561195|7600192|FG007|Vaccination 1 to 3|No longer willing to participate|0
4690410|NCT02561195|7600193|FG008|Vaccination 1 to 3|No longer willing to participate|0
4690411|NCT02561195|7600194|FG009|Vaccination 1 to 3|No longer willing to participate|0
4690412|NCT02561195|7600195|FG010|Vaccination 1 to 3|No longer willing to participate|0
4690413|NCT02561195|7600196|FG011|Vaccination 1 to 3|No longer willing to participate|0
4690414|NCT02561195|7600197|FG012|Vaccination 1 to 3|No longer willing to participate|0
4690415|NCT02561195|7600198|FG013|Vaccination 1 to 3|No longer willing to participate|0
4690416|NCT02561195|7600185|FG000|Vaccination 1 to 3|Other|7
4690417|NCT02561195|7600186|FG001|Vaccination 1 to 3|Other|3
4690418|NCT02561195|7600187|FG002|Vaccination 1 to 3|Other|1
4690419|NCT02561195|7600188|FG003|Vaccination 1 to 3|Other|7
4690420|NCT02561195|7600189|FG004|Vaccination 1 to 3|Other|5
4690421|NCT02561195|7600190|FG005|Vaccination 1 to 3|Other|1
4690422|NCT02561195|7600191|FG006|Vaccination 1 to 3|Other|0
4690423|NCT02561195|7600192|FG007|Vaccination 1 to 3|Other|0
4690424|NCT02561195|7600193|FG008|Vaccination 1 to 3|Other|0
4690425|NCT02561195|7600194|FG009|Vaccination 1 to 3|Other|0
4690426|NCT02561195|7600195|FG010|Vaccination 1 to 3|Other|0
4690427|NCT02561195|7600196|FG011|Vaccination 1 to 3|Other|0
4690428|NCT02561195|7600197|FG012|Vaccination 1 to 3|Other|0
4690429|NCT02561195|7600198|FG013|Vaccination 1 to 3|Other|0
4690430|NCT02561195|7600185|FG000|Vaccination 1 to 3|Protocol Violation|1
4690431|NCT02561195|7600186|FG001|Vaccination 1 to 3|Protocol Violation|0
4690432|NCT02561195|7600187|FG002|Vaccination 1 to 3|Protocol Violation|1
4690433|NCT02561195|7600188|FG003|Vaccination 1 to 3|Protocol Violation|2
4690434|NCT02561195|7600189|FG004|Vaccination 1 to 3|Protocol Violation|5
4690435|NCT02561195|7600190|FG005|Vaccination 1 to 3|Protocol Violation|2
4690436|NCT02561195|7600191|FG006|Vaccination 1 to 3|Protocol Violation|0
4690437|NCT02561195|7600192|FG007|Vaccination 1 to 3|Protocol Violation|0
4690438|NCT02561195|7600193|FG008|Vaccination 1 to 3|Protocol Violation|0
4690439|NCT02561195|7600194|FG009|Vaccination 1 to 3|Protocol Violation|0
4690440|NCT02561195|7600195|FG010|Vaccination 1 to 3|Protocol Violation|0
4690441|NCT02561195|7600196|FG011|Vaccination 1 to 3|Protocol Violation|0
4690442|NCT02561195|7600197|FG012|Vaccination 1 to 3|Protocol Violation|0
4690443|NCT02561195|7600198|FG013|Vaccination 1 to 3|Protocol Violation|0
4462353|NCT00590031|7252210|FG000|Overall Study|Withdrawal by Subject|1
4462354|NCT00590031|7252210|FG000|Overall Study|Metastatic Disease|1
4462355|NCT00590031|7252210|FG000|Overall Study|Admin Hold|1
4462356|NCT00590044|7252216|FG000|Overall Study|Withdrawal by Subject|2
4462357|NCT00590044|7252217|FG001|Overall Study|Withdrawal by Subject|2
4462358|NCT00590044|7252216|FG000|Overall Study|wrong insulin arm assigned|1
4539811|NCT01129128|7362467|FG001|Overall Study|Withdrawal by Subject|1
4539812|NCT01129128|7362468|FG002|Overall Study|Withdrawal by Subject|3
4539813|NCT01129128|7362466|FG000|Overall Study|Physician Decision|1
4539814|NCT01129128|7362467|FG001|Overall Study|Physician Decision|0
4539815|NCT01129128|7362468|FG002|Overall Study|Physician Decision|0
4539816|NCT01129284|7362507|FG000|Overall Study|Adverse Event|2
4539817|NCT01129284|7362508|FG001|Overall Study|Adverse Event|0
4539818|NCT01129284|7362509|FG002|Overall Study|Adverse Event|1
4539819|NCT01129336|7362519|FG000|Overall Study|Protocol Violation|1
4539820|NCT01129336|7362520|FG001|Overall Study|Protocol Violation|0
4539821|NCT01129336|7362519|FG000|Overall Study|Disease Progression|1
4539822|NCT01129336|7362520|FG001|Overall Study|Disease Progression|4
4539823|NCT01129336|7362519|FG000|Overall Study|Lost to Follow-up|1
4539824|NCT01129336|7362520|FG001|Overall Study|Lost to Follow-up|0
4462359|NCT00590044|7252217|FG001|Overall Study|wrong insulin arm assigned|0
4462360|NCT00590044|7252216|FG000|Overall Study|Protocol Violation|1
4462361|NCT00590044|7252217|FG001|Overall Study|Protocol Violation|0
4462362|NCT00590317|7252246|FG000|Overall Study|Lack of Efficacy|1
4462363|NCT00590317|7252247|FG001|Overall Study|Lack of Efficacy|5
4462364|NCT00590564|7252275|FG000|Overall Study|Withdrawal by Subject|4
4462365|NCT00590564|7252275|FG000|Overall Study|Lost to Follow-up|6
4462366|NCT00590564|7252275|FG000|Overall Study|Protocol Violation|1
4462367|NCT00590564|7252275|FG000|Overall Study|Patient Found to be Ineligible|1
4462368|NCT00590564|7252275|FG000|Overall Study|Patient Non-compliance|6
4462369|NCT00590577|7252283|FG000|Overall Study|Lack of Efficacy|31
4462370|NCT00590577|7252284|FG001|Overall Study|Lack of Efficacy|28
4462371|NCT00590577|7252285|FG002|Overall Study|Lack of Efficacy|23
4462372|NCT00590577|7252286|FG003|Overall Study|Lack of Efficacy|45
4462373|NCT00590577|7252283|FG000|Overall Study|Withdrawal by Subject|23
4462374|NCT00590577|7252284|FG001|Overall Study|Withdrawal by Subject|28
4462375|NCT00590577|7252285|FG002|Overall Study|Withdrawal by Subject|30
4462376|NCT00590577|7252286|FG003|Overall Study|Withdrawal by Subject|26
4462377|NCT00590577|7252283|FG000|Overall Study|Adverse Event|10
4462378|NCT00590577|7252284|FG001|Overall Study|Adverse Event|10
4462379|NCT00590577|7252285|FG002|Overall Study|Adverse Event|13
4462380|NCT00590577|7252286|FG003|Overall Study|Adverse Event|11
4462381|NCT00590577|7252283|FG000|Overall Study|Lost to Follow-up|12
4462382|NCT00590577|7252284|FG001|Overall Study|Lost to Follow-up|6
4462383|NCT00590577|7252285|FG002|Overall Study|Lost to Follow-up|6
4462384|NCT00590577|7252286|FG003|Overall Study|Lost to Follow-up|9
4462385|NCT00590577|7252283|FG000|Overall Study|Pregnancy|0
4462386|NCT00590577|7252284|FG001|Overall Study|Pregnancy|1
4462387|NCT00590577|7252285|FG002|Overall Study|Pregnancy|0
4462388|NCT00590577|7252286|FG003|Overall Study|Pregnancy|0
4462389|NCT00590577|7252283|FG000|Overall Study|Various reasons|1
4462390|NCT00590577|7252284|FG001|Overall Study|Various reasons|3
4462391|NCT00590577|7252285|FG002|Overall Study|Various reasons|1
4462392|NCT00590577|7252286|FG003|Overall Study|Various reasons|2
4462393|NCT00590590|7252299|FG000|Overall Study|Lack of Efficacy|1
4462394|NCT00590590|7252300|FG001|Overall Study|Lack of Efficacy|2
4462395|NCT00590590|7252301|FG002|Overall Study|Lack of Efficacy|0
4462396|NCT00590590|7252299|FG000|Overall Study|Adverse Event|1
4462397|NCT00590590|7252300|FG001|Overall Study|Adverse Event|0
4462398|NCT00590590|7252301|FG002|Overall Study|Adverse Event|0
4462399|NCT00590590|7252299|FG000|Overall Study|Protocol Violation|0
4462400|NCT00590590|7252300|FG001|Overall Study|Protocol Violation|0
4462401|NCT00590590|7252301|FG002|Overall Study|Protocol Violation|2
4462402|NCT00590590|7252299|FG000|Overall Study|Lost to Follow-up|4
4462403|NCT00590590|7252300|FG001|Overall Study|Lost to Follow-up|1
4462404|NCT00590590|7252301|FG002|Overall Study|Lost to Follow-up|2
4462405|NCT00590590|7252299|FG000|Overall Study|Withdrawal by Subject|0
4462406|NCT00590590|7252300|FG001|Overall Study|Withdrawal by Subject|1
4539825|NCT01129336|7362519|FG000|Overall Study|Withdrawal by Subject|7
4539826|NCT01129336|7362520|FG001|Overall Study|Withdrawal by Subject|4
4539827|NCT01129336|7362519|FG000|Overall Study|Adverse Event|0
4539828|NCT01129336|7362520|FG001|Overall Study|Adverse Event|1
4539829|NCT01129336|7362519|FG000|Overall Study|Missing Study Completion Status|2
4539830|NCT01129336|7362520|FG001|Overall Study|Missing Study Completion Status|3
4539831|NCT01129336|7362519|FG000|Overall Study|Death|0
4539832|NCT01129336|7362520|FG001|Overall Study|Death|4
4462407|NCT00590590|7252301|FG002|Overall Study|Withdrawal by Subject|1
4462408|NCT00590590|7252299|FG000|Overall Study|Did not complete due to study closure|1
4591281|NCT01528345|7437736|FG000|Overall Study|Study Terminated by Sponsor|4
4462409|NCT00590590|7252300|FG001|Overall Study|Did not complete due to study closure|1
4462410|NCT00590590|7252301|FG002|Overall Study|Did not complete due to study closure|1
4462411|NCT00590590|7252299|FG000|Overall Study|Did not complete study|0
4462412|NCT00590590|7252300|FG001|Overall Study|Did not complete study|1
4462413|NCT00590590|7252301|FG002|Overall Study|Did not complete study|0
4462414|NCT00590681|7252309|FG000|Overall Study|Withdrawal by Subject|7
4462415|NCT00590681|7252309|FG000|Overall Study|Adverse Event|8
4462416|NCT00590681|7252309|FG000|Overall Study|Death|3
4462417|NCT00590681|7252309|FG000|Overall Study|Lost to Follow-up|1
4462418|NCT00590681|7252309|FG000|Overall Study|disease progression|1
4462419|NCT00590720|7252324|FG000|Overall Study|Lost to Follow-up|1
4591282|NCT01528345|7437737|FG001|Overall Study|Study Terminated by Sponsor|8
4591283|NCT01528345|7437736|FG000|Overall Study|Subject/Guardian Decision|5
4591284|NCT01528345|7437737|FG001|Overall Study|Subject/Guardian Decision|0
4614990|NCT01728454|7472846|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2
4614991|NCT01728454|7472847|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3
4614992|NCT01728454|7472848|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3
4614993|NCT01728454|7472846|FG000|Stage 3|Reason Missing|0
4614994|NCT01728454|7472847|FG001|Stage 3|Reason Missing|0
4614995|NCT01728454|7472848|FG002|Stage 3|Reason Missing|1
4614996|NCT01728454|7472846|FG000|Stage 3|Subject Required Other Treatment|0
4614997|NCT01728454|7472847|FG001|Stage 3|Subject Required Other Treatment|1
4614998|NCT01728454|7472848|FG002|Stage 3|Subject Required Other Treatment|0
4614999|NCT01728454|7472846|FG000|Stage 3|Pregnancy|1
4462420|NCT00590720|7252325|FG001|Overall Study|Lost to Follow-up|0
4462421|NCT00590720|7252324|FG000|Overall Study|Withdrawal by Subject|0
4615000|NCT01728454|7472847|FG001|Stage 3|Pregnancy|0
4615001|NCT01728454|7472848|FG002|Stage 3|Pregnancy|0
4615002|NCT01728454|7472846|FG000|Stage 3|Withdrew Consent|1
4615003|NCT01728454|7472847|FG001|Stage 3|Withdrew Consent|0
4615004|NCT01728454|7472848|FG002|Stage 3|Withdrew Consent|1
4615005|NCT01728454|7472846|FG000|Stage 3|Non-compliance with Protocol|0
4615006|NCT01728454|7472847|FG001|Stage 3|Non-compliance with Protocol|0
4615007|NCT01728454|7472848|FG002|Stage 3|Non-compliance with Protocol|1
4615008|NCT01728454|7472846|FG000|Stage 3|Lost to Follow-up|0
4615009|NCT01728454|7472847|FG001|Stage 3|Lost to Follow-up|3
4615010|NCT01728454|7472848|FG002|Stage 3|Lost to Follow-up|1
4615011|NCT01728454|7472846|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1
4615012|NCT01728454|7472847|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0
4615013|NCT01728454|7472848|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0
4615014|NCT01728584|7472863|FG000|Overall Study|Adverse Event|1
4615015|NCT01728584|7472864|FG001|Overall Study|Adverse Event|0
4615016|NCT01728584|7472865|FG002|Overall Study|Adverse Event|0
4615017|NCT01728584|7472866|FG003|Overall Study|Adverse Event|0
4615018|NCT01728584|7472863|FG000|Overall Study|Physician Decision|4
4615019|NCT01728584|7472864|FG001|Overall Study|Physician Decision|0
4615020|NCT01728584|7472865|FG002|Overall Study|Physician Decision|1
4615021|NCT01728584|7472866|FG003|Overall Study|Physician Decision|0
4615022|NCT01728584|7472863|FG000|Overall Study|Withdrawal by Subject|1
4615023|NCT01728584|7472864|FG001|Overall Study|Withdrawal by Subject|0
4615024|NCT01728584|7472865|FG002|Overall Study|Withdrawal by Subject|0
4615025|NCT01728584|7472866|FG003|Overall Study|Withdrawal by Subject|0
4615026|NCT01728584|7472863|FG000|Overall Study|Screen failure|1
4615027|NCT01728584|7472864|FG001|Overall Study|Screen failure|0
4615028|NCT01728584|7472865|FG002|Overall Study|Screen failure|0
4615029|NCT01728584|7472866|FG003|Overall Study|Screen failure|0
4615030|NCT01728584|7472863|FG000|Overall Study|Other reason (not specified)|1
4615031|NCT01728584|7472864|FG001|Overall Study|Other reason (not specified)|0
4615032|NCT01728584|7472865|FG002|Overall Study|Other reason (not specified)|0
4615033|NCT01728584|7472866|FG003|Overall Study|Other reason (not specified)|1
4615034|NCT01728623|7472883|FG000|Overall Study|Disease progression|26
4615035|NCT01728623|7472883|FG000|Overall Study|Adverse Event|1
4615036|NCT01728623|7472883|FG000|Overall Study|Withdrawal by Subject|1
4615037|NCT01728779|7472899|FG000|Overall Study|Withdrawal by Subject|1
4615038|NCT01728792|7472908|FG000|Overall Study|Withdrawal of Consent|1
4615039|NCT01728792|7472909|FG001|Overall Study|Withdrawal of Consent|1
4615040|NCT01728792|7472910|FG002|Overall Study|Withdrawal of Consent|0
4615041|NCT01728792|7472911|FG003|Overall Study|Withdrawal of Consent|1
4615042|NCT01728792|7472912|FG004|Overall Study|Withdrawal of Consent|0
4615043|NCT01728792|7472908|FG000|Overall Study|Lost to Follow-up|2
4615044|NCT01728792|7472909|FG001|Overall Study|Lost to Follow-up|1
4615045|NCT01728792|7472910|FG002|Overall Study|Lost to Follow-up|4
4615046|NCT01728792|7472911|FG003|Overall Study|Lost to Follow-up|2
4615047|NCT01728792|7472912|FG004|Overall Study|Lost to Follow-up|0
4615048|NCT01729026|7472954|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2
4615049|NCT01729026|7472955|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2
4615050|NCT01729026|7472954|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1
4615051|NCT01729026|7472955|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2
4615052|NCT01729039|7472966|FG000|Overall Study|disqualified|2
4690444|NCT02561195|7600185|FG000|Vaccination 1 to 3|Death|2
4462422|NCT00590720|7252325|FG001|Overall Study|Withdrawal by Subject|1
4462423|NCT00590759|7252331|FG000|Overall Study|Death|52
4462424|NCT00590759|7252331|FG000|Overall Study|Lost to Follow-up|28
4462425|NCT00590824|7252345|FG000|Overall Study|Disease could not be resected|0
4462426|NCT00590824|7252346|FG001|Overall Study|Disease could not be resected|2
4462427|NCT00590824|7252347|FG002|Overall Study|Disease could not be resected|1
4462428|NCT00590824|7252348|FG003|Overall Study|Disease could not be resected|0
4462429|NCT00590824|7252345|FG000|Overall Study|Adverse Event|0
4462430|NCT00590824|7252346|FG001|Overall Study|Adverse Event|0
4462431|NCT00590824|7252347|FG002|Overall Study|Adverse Event|0
4462432|NCT00590824|7252348|FG003|Overall Study|Adverse Event|1
4462433|NCT00590902|7252381|FG000|Overall Study|Death|1
4462434|NCT00590954|7252385|FG000|Overall Study|Inevaluable|2
4462435|NCT00590967|7252393|FG000|Overall Study|Withdrawal by Subject|1
4462436|NCT00590967|7252394|FG001|Overall Study|Withdrawal by Subject|1
4462437|NCT00590967|7252393|FG000|Overall Study|Ineligible|1
4615053|NCT01729039|7472967|FG001|Overall Study|disqualified|5
4615054|NCT01729039|7472966|FG000|Overall Study|Withdrawal by Subject|8
4462438|NCT00590967|7252394|FG001|Overall Study|Ineligible|0
4462439|NCT00590967|7252393|FG000|Overall Study|Poor performance status|0
4462440|NCT00590967|7252394|FG001|Overall Study|Poor performance status|1
4462441|NCT00590967|7252393|FG000|Overall Study|Non-compliant|0
4462442|NCT00590967|7252394|FG001|Overall Study|Non-compliant|2
4462443|NCT00590967|7252393|FG000|Overall Study|Did not sign consent form|0
4462444|NCT00590967|7252394|FG001|Overall Study|Did not sign consent form|1
4462445|NCT00590967|7252393|FG000|Overall Study|Did not receive chemo per protocol|1
4462446|NCT00590967|7252394|FG001|Overall Study|Did not receive chemo per protocol|0
4462447|NCT00590980|7252400|FG000|Overall Study|Did not meet all inclusion criteria|10
4462448|NCT00591006|7252404|FG000|Overall Study|Withdrawal by Subject|0
4462449|NCT00591006|7252405|FG001|Overall Study|Withdrawal by Subject|0
4462450|NCT00591006|7252406|FG002|Overall Study|Withdrawal by Subject|0
4462451|NCT00591006|7252407|FG003|Overall Study|Withdrawal by Subject|0
4462452|NCT00591006|7252408|FG004|Overall Study|Withdrawal by Subject|0
4462453|NCT00591006|7252409|FG005|Overall Study|Withdrawal by Subject|0
4462454|NCT00591006|7252410|FG006|Overall Study|Withdrawal by Subject|0
4462455|NCT00591006|7252411|FG007|Overall Study|Withdrawal by Subject|0
4462456|NCT00591006|7252412|FG008|Overall Study|Withdrawal by Subject|0
4462457|NCT00591006|7252413|FG009|Overall Study|Withdrawal by Subject|0
4462458|NCT00591006|7252414|FG010|Overall Study|Withdrawal by Subject|0
4462459|NCT00591006|7252415|FG011|Overall Study|Withdrawal by Subject|0
4462460|NCT00591006|7252416|FG012|Overall Study|Withdrawal by Subject|0
4462461|NCT00591006|7252417|FG013|Overall Study|Withdrawal by Subject|0
4462462|NCT00591006|7252418|FG014|Overall Study|Withdrawal by Subject|0
4462463|NCT00591006|7252419|FG015|Overall Study|Withdrawal by Subject|1
4462464|NCT00591006|7252420|FG016|Overall Study|Withdrawal by Subject|0
4462465|NCT00591006|7252421|FG017|Overall Study|Withdrawal by Subject|0
4462466|NCT00591006|7252422|FG018|Overall Study|Withdrawal by Subject|0
4462467|NCT00591006|7252423|FG019|Overall Study|Withdrawal by Subject|0
4462468|NCT00591006|7252424|FG020|Overall Study|Withdrawal by Subject|0
4462469|NCT00591006|7252425|FG021|Overall Study|Withdrawal by Subject|0
4462470|NCT00591006|7252426|FG022|Overall Study|Withdrawal by Subject|0
4462471|NCT00591006|7252427|FG023|Overall Study|Withdrawal by Subject|1
4462472|NCT00591006|7252404|FG000|Overall Study|Adverse Event|0
4462473|NCT00591006|7252405|FG001|Overall Study|Adverse Event|0
4462474|NCT00591006|7252406|FG002|Overall Study|Adverse Event|0
4462475|NCT00591006|7252407|FG003|Overall Study|Adverse Event|0
4462476|NCT00591006|7252408|FG004|Overall Study|Adverse Event|0
4462477|NCT00591006|7252409|FG005|Overall Study|Adverse Event|0
4462478|NCT00591006|7252410|FG006|Overall Study|Adverse Event|0
4462479|NCT00591006|7252411|FG007|Overall Study|Adverse Event|0
4462480|NCT00591006|7252412|FG008|Overall Study|Adverse Event|0
4462481|NCT00591006|7252413|FG009|Overall Study|Adverse Event|0
4462482|NCT00591006|7252414|FG010|Overall Study|Adverse Event|0
4462483|NCT00591006|7252415|FG011|Overall Study|Adverse Event|0
4462484|NCT00591006|7252416|FG012|Overall Study|Adverse Event|0
4462485|NCT00591006|7252417|FG013|Overall Study|Adverse Event|0
4462486|NCT00591006|7252418|FG014|Overall Study|Adverse Event|0
4462487|NCT00591006|7252419|FG015|Overall Study|Adverse Event|0
4462488|NCT00591006|7252420|FG016|Overall Study|Adverse Event|0
4462489|NCT00591006|7252421|FG017|Overall Study|Adverse Event|0
4462490|NCT00591006|7252422|FG018|Overall Study|Adverse Event|0
4462491|NCT00591006|7252423|FG019|Overall Study|Adverse Event|0
4462492|NCT00591006|7252424|FG020|Overall Study|Adverse Event|0
4615055|NCT01729039|7472967|FG001|Overall Study|Withdrawal by Subject|7
4615056|NCT01729156|7472979|FG000|Overall Study|Withdrawal by Subject|1
4615057|NCT01729156|7472980|FG001|Overall Study|Withdrawal by Subject|0
4615058|NCT01729156|7472981|FG002|Overall Study|Withdrawal by Subject|0
4615059|NCT01729208|7472992|FG000|Baseline|Physician Decision|5
4615060|NCT01729208|7472993|FG001|Baseline|Physician Decision|4
4615061|NCT01729208|7472992|FG000|12 Months Follow-up|Withdrawal by Subject|4
4615062|NCT01729208|7472993|FG001|12 Months Follow-up|Withdrawal by Subject|7
4615063|NCT01729208|7472992|FG000|12 Months Follow-up|Lost to Follow-up|3
4615064|NCT01729208|7472993|FG001|12 Months Follow-up|Lost to Follow-up|3
4615065|NCT01729208|7472992|FG000|24 Months Follow-up|Lost to Follow-up|3
4615066|NCT01729208|7472993|FG001|24 Months Follow-up|Lost to Follow-up|0
4615067|NCT01729208|7472992|FG000|36 Months Follow-up|Physician Decision|1
4615068|NCT01729208|7472993|FG001|36 Months Follow-up|Physician Decision|0
4615069|NCT01729208|7472992|FG000|36 Months Follow-up|Withdrawal by Subject|2
4615070|NCT01729208|7472993|FG001|36 Months Follow-up|Withdrawal by Subject|4
4615071|NCT01729559|7473029|FG000|Overall Study|Protocol Violation|31
4615072|NCT01729559|7473030|FG001|Overall Study|Protocol Violation|28
4615073|NCT01729728|7473048|FG000|Overall Study|Adverse Event|0
4615074|NCT01729728|7473049|FG001|Overall Study|Adverse Event|6
4615075|NCT01729728|7473050|FG002|Overall Study|Adverse Event|0
4462493|NCT00591006|7252425|FG021|Overall Study|Adverse Event|0
4462494|NCT00591006|7252426|FG022|Overall Study|Adverse Event|1
4462495|NCT00591006|7252427|FG023|Overall Study|Adverse Event|0
4539833|NCT01129557|7362556|FG000|Overall Study|Adverse Event|1
4462496|NCT00591149|7252457|FG000|Overall Study|Adverse Event|4
4539834|NCT01129557|7362557|FG001|Overall Study|Adverse Event|2
4615076|NCT01729728|7473048|FG000|Overall Study|Protocol Violation|1
4615077|NCT01729728|7473049|FG001|Overall Study|Protocol Violation|0
4462497|NCT00591149|7252457|FG000|Overall Study|Withdrawal by Subject|1
4539835|NCT01129557|7362558|FG002|Overall Study|Adverse Event|2
4539836|NCT01129557|7362556|FG000|Overall Study|Novartis terminated study early|3
4539837|NCT01129557|7362557|FG001|Overall Study|Novartis terminated study early|3
4539838|NCT01129557|7362558|FG002|Overall Study|Novartis terminated study early|2
4539839|NCT01129583|7362579|FG000|Overall Study|Death|1
4539840|NCT01129583|7362580|FG001|Overall Study|Death|0
4539841|NCT01129583|7362579|FG000|Overall Study|Lost to Follow-up|1
4539842|NCT01129583|7362580|FG001|Overall Study|Lost to Follow-up|1
4539843|NCT01129583|7362579|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1
4462498|NCT00591214|7252461|FG000|Overall Study|Physician Decision|7
4462499|NCT00591214|7252461|FG000|Overall Study|Withdrawal by Subject|1
4462500|NCT00591253|7252477|FG000|Overall Study|Adverse Event|3
4462501|NCT00591253|7252478|FG001|Overall Study|Adverse Event|3
4462502|NCT00591253|7252479|FG002|Overall Study|Adverse Event|1
4462503|NCT00591253|7252477|FG000|Overall Study|Protocol Violation|2
4462504|NCT00591253|7252478|FG001|Overall Study|Protocol Violation|2
4462505|NCT00591253|7252479|FG002|Overall Study|Protocol Violation|2
4462506|NCT00591253|7252477|FG000|Overall Study|Lost to Follow-up|2
4462507|NCT00591253|7252478|FG001|Overall Study|Lost to Follow-up|4
4462508|NCT00591253|7252479|FG002|Overall Study|Lost to Follow-up|0
4462509|NCT00591253|7252477|FG000|Overall Study|Withdrawal by Subject|1
4462510|NCT00591253|7252478|FG001|Overall Study|Withdrawal by Subject|7
4539844|NCT01129583|7362580|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1
4539845|NCT01129622|7362590|FG000|Overall Study|Withdrawal by Subject|2
4539846|NCT01129882|7362612|FG000|Overall Study|Adverse Event|39
4539847|NCT01129882|7362612|FG000|Overall Study|Death|6
4539848|NCT01129882|7362612|FG000|Overall Study|Lack of Efficacy|5
4539849|NCT01129882|7362612|FG000|Overall Study|Lost to Follow-up|13
4539850|NCT01129882|7362612|FG000|Overall Study|Physician Decision|27
4539851|NCT01129882|7362612|FG000|Overall Study|Protocol Deviation|3
4539852|NCT01129882|7362612|FG000|Overall Study|Withdrawal Criteria Met|19
4539853|NCT01129882|7362612|FG000|Overall Study|Trial Termination by Sponsor|6
4539854|NCT01129882|7362612|FG000|Overall Study|Withdrawal by Subject|160
4539855|NCT01129921|7362618|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2
4539856|NCT01129921|7362619|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1
4539857|NCT01129921|7362618|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0
4539858|NCT01129921|7362619|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1
4539859|NCT01129921|7362618|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0
4539860|NCT01129921|7362619|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4
4539861|NCT01129921|7362618|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0
4539862|NCT01129921|7362619|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1
4539863|NCT01129960|7362633|FG000|Overall Study|Withdrawal by Subject|3
4539864|NCT01129960|7362634|FG001|Overall Study|Withdrawal by Subject|0
4539865|NCT01129960|7362635|FG002|Overall Study|Withdrawal by Subject|3
4539866|NCT01129960|7362636|FG003|Overall Study|Withdrawal by Subject|2
4539867|NCT01129960|7362633|FG000|Overall Study|Lack of Efficacy|1
4539868|NCT01129960|7362634|FG001|Overall Study|Lack of Efficacy|1
4539869|NCT01129960|7362635|FG002|Overall Study|Lack of Efficacy|1
4539870|NCT01129960|7362636|FG003|Overall Study|Lack of Efficacy|1
4539871|NCT01129960|7362633|FG000|Overall Study|Adverse Event|23
4539872|NCT01129960|7362634|FG001|Overall Study|Adverse Event|16
4539873|NCT01129960|7362635|FG002|Overall Study|Adverse Event|16
4539874|NCT01129960|7362636|FG003|Overall Study|Adverse Event|7
4539875|NCT01129960|7362633|FG000|Overall Study|Protocol Violation|1
4539876|NCT01129960|7362634|FG001|Overall Study|Protocol Violation|2
4539877|NCT01129960|7362635|FG002|Overall Study|Protocol Violation|3
4539878|NCT01129960|7362636|FG003|Overall Study|Protocol Violation|0
4539879|NCT01129960|7362633|FG000|Overall Study|Lost to Follow-up|0
4539880|NCT01129960|7362634|FG001|Overall Study|Lost to Follow-up|2
4539881|NCT01129960|7362635|FG002|Overall Study|Lost to Follow-up|3
4539882|NCT01129960|7362636|FG003|Overall Study|Lost to Follow-up|3
4539883|NCT01129960|7362633|FG000|Overall Study|Discontinuation of the study by Sponsor|0
4539884|NCT01129960|7362634|FG001|Overall Study|Discontinuation of the study by Sponsor|1
4539885|NCT01129960|7362635|FG002|Overall Study|Discontinuation of the study by Sponsor|0
4539886|NCT01129960|7362636|FG003|Overall Study|Discontinuation of the study by Sponsor|0
4539887|NCT01129960|7362633|FG000|Overall Study|Physician Decision|1
4539888|NCT01129960|7362634|FG001|Overall Study|Physician Decision|0
4539889|NCT01129960|7362635|FG002|Overall Study|Physician Decision|0
4539890|NCT01129960|7362636|FG003|Overall Study|Physician Decision|0
4539891|NCT01129960|7362633|FG000|Overall Study|Pregnancy|1
4539892|NCT01129960|7362634|FG001|Overall Study|Pregnancy|0
4539893|NCT01129960|7362635|FG002|Overall Study|Pregnancy|0
4539894|NCT01129960|7362636|FG003|Overall Study|Pregnancy|0
4539895|NCT01130051|7362646|FG000|Washout Period of 14 Days|Withdrawal by Subject|0
4462511|NCT00591253|7252479|FG002|Overall Study|Withdrawal by Subject|6
4539896|NCT01130051|7362647|FG001|Washout Period of 14 Days|Withdrawal by Subject|1
4539897|NCT01130051|7362646|FG000|Washout Period of 14 Days|Protocol Violation|1
4539898|NCT01130051|7362647|FG001|Washout Period of 14 Days|Protocol Violation|1
4539899|NCT01130103|7362655|FG000|Randomized Treatment|Adverse Event|1
4539900|NCT01130103|7362656|FG001|Randomized Treatment|Adverse Event|1
4462512|NCT00591253|7252477|FG000|Overall Study|Lack of Efficacy|1
4462513|NCT00591253|7252478|FG001|Overall Study|Lack of Efficacy|0
4462514|NCT00591253|7252479|FG002|Overall Study|Lack of Efficacy|3
4539901|NCT01130103|7362655|FG000|Randomized Treatment|Lost to Follow-up|1
4615078|NCT01729728|7473050|FG002|Overall Study|Protocol Violation|1
4615079|NCT01729819|7473183|FG000|Overall Study|Adverse Event|2
4615080|NCT01729819|7473184|FG001|Overall Study|Adverse Event|4
4615081|NCT01729819|7473183|FG000|Overall Study|Lack of Efficacy|1
4615082|NCT01729819|7473184|FG001|Overall Study|Lack of Efficacy|0
4615083|NCT01729819|7473183|FG000|Overall Study|Lost to Follow-up|2
4615084|NCT01729819|7473184|FG001|Overall Study|Lost to Follow-up|0
4615085|NCT01729819|7473183|FG000|Overall Study|Other reason|1
4615086|NCT01729819|7473184|FG001|Overall Study|Other reason|0
4615087|NCT01729819|7473183|FG000|Overall Study|Protocol Violation|0
4615088|NCT01729819|7473184|FG001|Overall Study|Protocol Violation|1
4615089|NCT01729819|7473183|FG000|Overall Study|Withdrawal by Subject|0
4615090|NCT01729819|7473184|FG001|Overall Study|Withdrawal by Subject|2
4615091|NCT01729871|7473210|FG000|Overall Study|Adverse Event|7
4615092|NCT01729871|7473211|FG001|Overall Study|Adverse Event|7
4615093|NCT01729871|7473210|FG000|Overall Study|Death|0
4615094|NCT01729871|7473211|FG001|Overall Study|Death|1
4615095|NCT01729871|7473210|FG000|Overall Study|Lack of Efficacy|0
4615096|NCT01729871|7473211|FG001|Overall Study|Lack of Efficacy|1
4615097|NCT01729871|7473210|FG000|Overall Study|Physician Decision|0
4615098|NCT01729871|7473211|FG001|Overall Study|Physician Decision|2
4615099|NCT01729871|7473210|FG000|Overall Study|Protocol Violation|1
4615100|NCT01729871|7473211|FG001|Overall Study|Protocol Violation|0
4615101|NCT01729871|7473210|FG000|Overall Study|Withdrawal by Subject|0
4615102|NCT01729871|7473211|FG001|Overall Study|Withdrawal by Subject|3
4615103|NCT01729871|7473210|FG000|Overall Study|Other|4
4615104|NCT01729871|7473211|FG001|Overall Study|Other|9
4462515|NCT00591253|7252477|FG000|Overall Study|Other|5
4462516|NCT00591253|7252478|FG001|Overall Study|Other|5
4462517|NCT00591253|7252479|FG002|Overall Study|Other|3
4462518|NCT00591266|7252490|FG000|Overall Study|Adverse Event|2
4462519|NCT00591266|7252491|FG001|Overall Study|Adverse Event|2
4462520|NCT00591266|7252492|FG002|Overall Study|Adverse Event|3
4462521|NCT00591266|7252490|FG000|Overall Study|Lost to Follow-up|0
4462522|NCT00591266|7252491|FG001|Overall Study|Lost to Follow-up|1
4462523|NCT00591266|7252492|FG002|Overall Study|Lost to Follow-up|0
4462524|NCT00591266|7252490|FG000|Overall Study|Protocol Violation|0
4462525|NCT00591266|7252491|FG001|Overall Study|Protocol Violation|0
4539902|NCT01130103|7362656|FG001|Randomized Treatment|Lost to Follow-up|0
4539903|NCT01130103|7362655|FG000|Randomized Treatment|Protocol Violation|3
4539904|NCT01130103|7362656|FG001|Randomized Treatment|Protocol Violation|2
4539905|NCT01130103|7362655|FG000|Randomized Treatment|Withdrawal by Subject|1
4539906|NCT01130103|7362656|FG001|Randomized Treatment|Withdrawal by Subject|2
4539907|NCT01130103|7362655|FG000|Maintenance Treatment|Lack of Efficacy|0
4539908|NCT01130103|7362656|FG001|Maintenance Treatment|Lack of Efficacy|1
4539909|NCT01130103|7362655|FG000|Maintenance Treatment|Lost to Follow-up|1
4539910|NCT01130103|7362656|FG001|Maintenance Treatment|Lost to Follow-up|1
4539911|NCT01130103|7362655|FG000|Maintenance Treatment|Withdrawal by Subject|1
4539912|NCT01130103|7362656|FG001|Maintenance Treatment|Withdrawal by Subject|0
4539913|NCT01130168|7362662|FG000|Period 1|Withdrawal by Subject|0
4539914|NCT01130168|7362663|FG001|Period 1|Withdrawal by Subject|1
4539915|NCT01130168|7362664|FG002|Period 1|Withdrawal by Subject|0
4539916|NCT01130168|7362665|FG003|Period 1|Withdrawal by Subject|1
4539917|NCT01130168|7362666|FG004|Period 1|Withdrawal by Subject|0
4539918|NCT01130168|7362667|FG005|Period 1|Withdrawal by Subject|0
4539919|NCT01130168|7362662|FG000|Period 1|Discontinued For Other Reason|0
4539920|NCT01130168|7362663|FG001|Period 1|Discontinued For Other Reason|0
4539921|NCT01130168|7362664|FG002|Period 1|Discontinued For Other Reason|1
4539922|NCT01130168|7362665|FG003|Period 1|Discontinued For Other Reason|1
4539923|NCT01130168|7362666|FG004|Period 1|Discontinued For Other Reason|0
4539924|NCT01130168|7362667|FG005|Period 1|Discontinued For Other Reason|0
4539925|NCT01130168|7362662|FG000|Period 1|Adverse Event|0
4539926|NCT01130168|7362663|FG001|Period 1|Adverse Event|0
4539927|NCT01130168|7362664|FG002|Period 1|Adverse Event|0
4539928|NCT01130168|7362665|FG003|Period 1|Adverse Event|1
4539929|NCT01130168|7362666|FG004|Period 1|Adverse Event|0
4539930|NCT01130168|7362667|FG005|Period 1|Adverse Event|0
4615105|NCT01730040|7473228|FG000|Overall Study|Randomized but not treated|0
4615106|NCT01730040|7473229|FG001|Overall Study|Randomized but not treated|0
4615107|NCT01730040|7473230|FG002|Overall Study|Randomized but not treated|0
4615108|NCT01730040|7473231|FG003|Overall Study|Randomized but not treated|0
4615109|NCT01730040|7473232|FG004|Overall Study|Randomized but not treated|0
4615110|NCT01730040|7473233|FG005|Overall Study|Randomized but not treated|1
4462526|NCT00591266|7252492|FG002|Overall Study|Protocol Violation|1
4462527|NCT00591266|7252490|FG000|Overall Study|Withdrawal by Subject|6
4539931|NCT01130272|7362681|FG000|Overall Study|Adverse Event|2
4539932|NCT01130272|7362682|FG001|Overall Study|Adverse Event|5
4462528|NCT00591266|7252491|FG001|Overall Study|Withdrawal by Subject|2
4539933|NCT01130272|7362683|FG002|Overall Study|Adverse Event|6
4615111|NCT01730040|7473234|FG006|Overall Study|Randomized but not treated|0
4462529|NCT00591266|7252492|FG002|Overall Study|Withdrawal by Subject|5
4462530|NCT00591266|7252490|FG000|Overall Study|Lack of Efficacy|0
4462531|NCT00591266|7252491|FG001|Overall Study|Lack of Efficacy|2
4462532|NCT00591266|7252492|FG002|Overall Study|Lack of Efficacy|0
4462533|NCT00591266|7252490|FG000|Overall Study|Other|1
4462534|NCT00591266|7252491|FG001|Overall Study|Other|4
4462535|NCT00591266|7252492|FG002|Overall Study|Other|5
4462536|NCT00591344|7252512|FG000|Overall Study|Transportation issues|1
4462537|NCT00591344|7252513|FG001|Overall Study|Transportation issues|0
4462538|NCT00591344|7252512|FG000|Overall Study|Moved out of state|1
4462539|NCT00591344|7252513|FG001|Overall Study|Moved out of state|0
4462540|NCT00591344|7252512|FG000|Overall Study|Medical complications|1
4462541|NCT00591344|7252513|FG001|Overall Study|Medical complications|3
4462542|NCT00591344|7252512|FG000|Overall Study|Underwent DBS|2
4462543|NCT00591344|7252513|FG001|Overall Study|Underwent DBS|2
4462544|NCT00591344|7252512|FG000|Overall Study|Death|0
4462545|NCT00591344|7252513|FG001|Overall Study|Death|1
4462546|NCT00591344|7252512|FG000|Overall Study|Lost to Follow-up|0
4462547|NCT00591344|7252513|FG001|Overall Study|Lost to Follow-up|1
4462548|NCT00591344|7252512|FG000|Overall Study|Did not want to come off medication|0
4462549|NCT00591344|7252513|FG001|Overall Study|Did not want to come off medication|1
4462550|NCT00591370|7252523|FG000|Overall Study|Not Treated|2
4462551|NCT00591409|7252537|FG000|Overall Study|Not Treated|0
4462552|NCT00591409|7252538|FG001|Overall Study|Not Treated|0
4462553|NCT00591409|7252539|FG002|Overall Study|Not Treated|0
4462554|NCT00591409|7252540|FG003|Overall Study|Not Treated|0
4462555|NCT00591409|7252541|FG004|Overall Study|Not Treated|1
4462556|NCT00591409|7252542|FG005|Overall Study|Not Treated|0
4462557|NCT00591409|7252543|FG006|Overall Study|Not Treated|0
4462558|NCT00591409|7252544|FG007|Overall Study|Not Treated|0
4462559|NCT00591409|7252545|FG008|Overall Study|Not Treated|0
4462560|NCT00591409|7252546|FG009|Overall Study|Not Treated|1
4462561|NCT00591565|7252568|FG000|Overall Study|lost follow up, withdrawn|5
4462562|NCT00591578|7252575|FG000|Double-Blind Treatment Phase|Adverse Event|20
4462563|NCT00591578|7252576|FG001|Double-Blind Treatment Phase|Adverse Event|26
4462564|NCT00591578|7252577|FG002|Double-Blind Treatment Phase|Adverse Event|19
4462565|NCT00591578|7252575|FG000|Double-Blind Treatment Phase|Protocol Violation|3
4462566|NCT00591578|7252576|FG001|Double-Blind Treatment Phase|Protocol Violation|2
4539934|NCT01130272|7362684|FG003|Overall Study|Adverse Event|22
4539935|NCT01130272|7362685|FG004|Overall Study|Adverse Event|7
4539936|NCT01130272|7362681|FG000|Overall Study|IVRS-confirmed constipation|0
4539937|NCT01130272|7362682|FG001|Overall Study|IVRS-confirmed constipation|1
4539938|NCT01130272|7362683|FG002|Overall Study|IVRS-confirmed constipation|1
4539939|NCT01130272|7362684|FG003|Overall Study|IVRS-confirmed constipation|2
4539940|NCT01130272|7362685|FG004|Overall Study|IVRS-confirmed constipation|0
4539941|NCT01130272|7362681|FG000|Overall Study|Rescue medications due to diarrhea|3
4539942|NCT01130272|7362682|FG001|Overall Study|Rescue medications due to diarrhea|5
4615112|NCT01730040|7473228|FG000|Overall Study|Subject moved|0
4615113|NCT01730040|7473229|FG001|Overall Study|Subject moved|0
4615114|NCT01730040|7473230|FG002|Overall Study|Subject moved|1
4615115|NCT01730040|7473231|FG003|Overall Study|Subject moved|0
4615116|NCT01730040|7473232|FG004|Overall Study|Subject moved|0
4615117|NCT01730040|7473233|FG005|Overall Study|Subject moved|0
4615118|NCT01730040|7473234|FG006|Overall Study|Subject moved|1
4615119|NCT01730040|7473228|FG000|Overall Study|Physician Decision|0
4462567|NCT00591578|7252577|FG002|Double-Blind Treatment Phase|Protocol Violation|3
4462568|NCT00591578|7252575|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12
4462569|NCT00591578|7252576|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12
4462570|NCT00591578|7252577|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11
4462571|NCT00591578|7252575|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22
4462572|NCT00591578|7252576|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22
4462573|NCT00591578|7252577|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22
4462574|NCT00591578|7252575|FG000|Double-Blind Treatment Phase|Pregnancy|1
4462575|NCT00591578|7252576|FG001|Double-Blind Treatment Phase|Pregnancy|0
4462576|NCT00591578|7252577|FG002|Double-Blind Treatment Phase|Pregnancy|0
4462577|NCT00591578|7252575|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16
4462578|NCT00591578|7252576|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9
4462579|NCT00591578|7252577|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25
4462580|NCT00591578|7252575|FG000|Double-Blind Treatment Phase|Other|4
4462581|NCT00591578|7252576|FG001|Double-Blind Treatment Phase|Other|9
4462582|NCT00591578|7252577|FG002|Double-Blind Treatment Phase|Other|4
4462583|NCT00591578|7252575|FG000|Open-Label Extension Phase|Adverse Event|3
4462584|NCT00591578|7252576|FG001|Open-Label Extension Phase|Adverse Event|5
4462585|NCT00591578|7252577|FG002|Open-Label Extension Phase|Adverse Event|0
4462586|NCT00591578|7252575|FG000|Open-Label Extension Phase|Lost to Follow-up|1
4462587|NCT00591578|7252576|FG001|Open-Label Extension Phase|Lost to Follow-up|4
4462588|NCT00591578|7252577|FG002|Open-Label Extension Phase|Lost to Follow-up|0
4462589|NCT00591578|7252575|FG000|Open-Label Extension Phase|Withdrawal by Subject|1
4462590|NCT00591578|7252576|FG001|Open-Label Extension Phase|Withdrawal by Subject|1
4462591|NCT00591578|7252577|FG002|Open-Label Extension Phase|Withdrawal by Subject|0
4539943|NCT01130272|7362683|FG002|Overall Study|Rescue medications due to diarrhea|8
4539944|NCT01130272|7362684|FG003|Overall Study|Rescue medications due to diarrhea|8
4462592|NCT00591578|7252575|FG000|Open-Label Extension Phase|Other|1
4462593|NCT00591578|7252576|FG001|Open-Label Extension Phase|Other|0
4462594|NCT00591578|7252577|FG002|Open-Label Extension Phase|Other|0
4462595|NCT00591591|7252588|FG000|Overall Study|Withdrawal by Subject|1
4462596|NCT00591591|7252589|FG001|Overall Study|Withdrawal by Subject|37
4462597|NCT00591591|7252588|FG000|Overall Study|Lack of Efficacy|10
4462598|NCT00591591|7252589|FG001|Overall Study|Lack of Efficacy|2
4462599|NCT00591630|7252599|FG000|Overall Study|Death|0
4462600|NCT00591630|7252600|FG001|Overall Study|Death|0
4462601|NCT00591630|7252601|FG002|Overall Study|Death|1
4462602|NCT00591630|7252602|FG003|Overall Study|Death|0
4462603|NCT00591721|7252614|FG000|Overall Study|Withdrawal by Subject|10
4462604|NCT00591721|7252615|FG001|Overall Study|Withdrawal by Subject|10
4462605|NCT00591721|7252614|FG000|Overall Study|Lost to Follow-up|1
4462606|NCT00591721|7252615|FG001|Overall Study|Lost to Follow-up|4
4462607|NCT00591721|7252614|FG000|Overall Study|Intervention not received|10
4462608|NCT00591721|7252615|FG001|Overall Study|Intervention not received|8
4462609|NCT00591734|7252621|FG000|Overall Study|Lack of Efficacy|35
4462610|NCT00591734|7252621|FG000|Overall Study|Adverse Event|5
4462611|NCT00591734|7252621|FG000|Overall Study|Physician Decision|5
4462612|NCT00591734|7252621|FG000|Overall Study|Intercurrent Illness|8
4462613|NCT00591773|7252637|FG000|Overall Study|Adverse Event|9
4462614|NCT00591773|7252638|FG001|Overall Study|Adverse Event|9
4462615|NCT00591773|7252639|FG002|Overall Study|Adverse Event|6
4462616|NCT00591773|7252637|FG000|Overall Study|Protocol Violation|2
4462617|NCT00591773|7252638|FG001|Overall Study|Protocol Violation|3
4462618|NCT00591773|7252639|FG002|Overall Study|Protocol Violation|0
4462619|NCT00591773|7252637|FG000|Overall Study|Lost to Follow-up|1
4462620|NCT00591773|7252638|FG001|Overall Study|Lost to Follow-up|4
4462621|NCT00591773|7252639|FG002|Overall Study|Lost to Follow-up|1
4462622|NCT00591773|7252637|FG000|Overall Study|Withdrawal by Subject|2
4462623|NCT00591773|7252638|FG001|Overall Study|Withdrawal by Subject|5
4462624|NCT00591773|7252639|FG002|Overall Study|Withdrawal by Subject|3
4462625|NCT00591773|7252637|FG000|Overall Study|Lack of Efficacy|1
4462626|NCT00591773|7252638|FG001|Overall Study|Lack of Efficacy|2
4462627|NCT00591773|7252639|FG002|Overall Study|Lack of Efficacy|2
4462628|NCT00591773|7252637|FG000|Overall Study|Other|1
4615120|NCT01730040|7473229|FG001|Overall Study|Physician Decision|0
4615121|NCT01730040|7473230|FG002|Overall Study|Physician Decision|0
4615122|NCT01730040|7473231|FG003|Overall Study|Physician Decision|0
4615123|NCT01730040|7473232|FG004|Overall Study|Physician Decision|0
4615124|NCT01730040|7473233|FG005|Overall Study|Physician Decision|1
4615125|NCT01730040|7473234|FG006|Overall Study|Physician Decision|1
4615126|NCT01730040|7473228|FG000|Overall Study|Other than specified|7
4615127|NCT01730040|7473229|FG001|Overall Study|Other than specified|8
4615128|NCT01730040|7473230|FG002|Overall Study|Other than specified|5
4615129|NCT01730040|7473231|FG003|Overall Study|Other than specified|5
4615130|NCT01730040|7473232|FG004|Overall Study|Other than specified|5
4615131|NCT01730040|7473233|FG005|Overall Study|Other than specified|4
4615132|NCT01730040|7473234|FG006|Overall Study|Other than specified|4
4615133|NCT01730040|7473228|FG000|Overall Study|Adverse Event|4
4615134|NCT01730040|7473229|FG001|Overall Study|Adverse Event|3
4615135|NCT01730040|7473230|FG002|Overall Study|Adverse Event|5
4615136|NCT01730040|7473231|FG003|Overall Study|Adverse Event|3
4615137|NCT01730040|7473232|FG004|Overall Study|Adverse Event|1
4615138|NCT01730040|7473233|FG005|Overall Study|Adverse Event|1
4615139|NCT01730040|7473234|FG006|Overall Study|Adverse Event|2
4615140|NCT01730040|7473228|FG000|Overall Study|Poor compliance to protocol|2
4615141|NCT01730040|7473229|FG001|Overall Study|Poor compliance to protocol|4
4615142|NCT01730040|7473230|FG002|Overall Study|Poor compliance to protocol|0
4615143|NCT01730040|7473231|FG003|Overall Study|Poor compliance to protocol|0
4615144|NCT01730040|7473232|FG004|Overall Study|Poor compliance to protocol|0
4615145|NCT01730040|7473233|FG005|Overall Study|Poor compliance to protocol|0
4615146|NCT01730040|7473234|FG006|Overall Study|Poor compliance to protocol|1
4615147|NCT01730053|7473256|FG000|Overall Study|Participant moved|0
4615148|NCT01730053|7473257|FG001|Overall Study|Participant moved|0
4615149|NCT01730053|7473258|FG002|Overall Study|Participant moved|1
4615150|NCT01730053|7473259|FG003|Overall Study|Participant moved|0
4615151|NCT01730053|7473260|FG004|Overall Study|Participant moved|0
4615152|NCT01730053|7473261|FG005|Overall Study|Participant moved|0
4615153|NCT01730053|7473256|FG000|Overall Study|Physician Decision|0
4615154|NCT01730053|7473257|FG001|Overall Study|Physician Decision|0
4615155|NCT01730053|7473258|FG002|Overall Study|Physician Decision|0
4615156|NCT01730053|7473259|FG003|Overall Study|Physician Decision|1
4615157|NCT01730053|7473260|FG004|Overall Study|Physician Decision|0
4615158|NCT01730053|7473261|FG005|Overall Study|Physician Decision|0
4615159|NCT01730053|7473256|FG000|Overall Study|Adverse Event|2
4615160|NCT01730053|7473257|FG001|Overall Study|Adverse Event|6
4462629|NCT00591773|7252638|FG001|Overall Study|Other|1
4462630|NCT00591773|7252639|FG002|Overall Study|Other|4
4462631|NCT00591786|7252657|FG000|Overall Study|Withdrawal of Informed Consent|0
4462632|NCT00591786|7252658|FG001|Overall Study|Withdrawal of Informed Consent|0
4462633|NCT00591786|7252659|FG002|Overall Study|Withdrawal of Informed Consent|1
4462634|NCT00591786|7252660|FG003|Overall Study|Withdrawal of Informed Consent|0
4615161|NCT01730053|7473258|FG002|Overall Study|Adverse Event|3
4615162|NCT01730053|7473259|FG003|Overall Study|Adverse Event|3
4462635|NCT00591786|7252661|FG004|Overall Study|Withdrawal of Informed Consent|0
4462636|NCT00591786|7252662|FG005|Overall Study|Withdrawal of Informed Consent|0
4462637|NCT00591786|7252663|FG006|Overall Study|Withdrawal of Informed Consent|0
4462638|NCT00591786|7252664|FG007|Overall Study|Withdrawal of Informed Consent|0
4462639|NCT00591786|7252665|FG008|Overall Study|Withdrawal of Informed Consent|0
4462640|NCT00591786|7252666|FG009|Overall Study|Withdrawal of Informed Consent|0
4462641|NCT00591838|7252720|FG000|Overall Study|Withdrawal by Subject|0
4462642|NCT00591838|7252721|FG001|Overall Study|Withdrawal by Subject|0
4462643|NCT00591838|7252722|FG002|Overall Study|Withdrawal by Subject|0
4462644|NCT00591838|7252723|FG003|Overall Study|Withdrawal by Subject|1
4462645|NCT00591838|7252724|FG004|Overall Study|Withdrawal by Subject|0
4615163|NCT01730053|7473260|FG004|Overall Study|Adverse Event|2
4615164|NCT01730053|7473261|FG005|Overall Study|Adverse Event|2
4615165|NCT01730053|7473256|FG000|Overall Study|Poor compliance to protocol|1
4615166|NCT01730053|7473257|FG001|Overall Study|Poor compliance to protocol|2
4615167|NCT01730053|7473258|FG002|Overall Study|Poor compliance to protocol|2
4615168|NCT01730053|7473259|FG003|Overall Study|Poor compliance to protocol|0
4615169|NCT01730053|7473260|FG004|Overall Study|Poor compliance to protocol|0
4615170|NCT01730053|7473261|FG005|Overall Study|Poor compliance to protocol|2
4615171|NCT01730053|7473256|FG000|Overall Study|Other than specified|2
4615172|NCT01730053|7473257|FG001|Overall Study|Other than specified|6
4615173|NCT01730053|7473258|FG002|Overall Study|Other than specified|5
4615174|NCT01730053|7473259|FG003|Overall Study|Other than specified|4
4615175|NCT01730053|7473260|FG004|Overall Study|Other than specified|7
4615176|NCT01730053|7473261|FG005|Overall Study|Other than specified|9
4615177|NCT01730339|7473278|FG000|Overall Study|Withdrawal by Subject|3
4615178|NCT01730339|7473279|FG001|Overall Study|Withdrawal by Subject|2
4615179|NCT01730339|7473278|FG000|Overall Study|Lost to Follow-up|1
4615180|NCT01730339|7473279|FG001|Overall Study|Lost to Follow-up|1
4615181|NCT01730339|7473278|FG000|Overall Study|Un-specified|1
4615182|NCT01730339|7473279|FG001|Overall Study|Un-specified|0
4615183|NCT01730378|7473297|FG000|Overall Study|Lost to Follow-up|1
4615184|NCT01730378|7473298|FG001|Overall Study|Lost to Follow-up|0
4615185|NCT01730534|7473307|FG000|Overall Study|Withdrawal by Subject|97
4615186|NCT01730534|7473308|FG001|Overall Study|Withdrawal by Subject|127
4615187|NCT01730534|7473307|FG000|Overall Study|Lost to Follow-up|12
4615188|NCT01730534|7473308|FG001|Overall Study|Lost to Follow-up|18
4615189|NCT01730586|7473314|FG000|Overall Study|Progressive Disease|2
4615190|NCT01730586|7473314|FG000|Overall Study|Inadequate Trial|8
4615191|NCT01730586|7473314|FG000|Overall Study|Adverse Event|2
4615192|NCT01730586|7473314|FG000|Overall Study|Hospice|1
4615193|NCT01730729|7473320|FG000|Overall Study|Adverse Event|1
4615194|NCT01730729|7473320|FG000|Overall Study|Death|1
4615195|NCT01730729|7473320|FG000|Overall Study|Progressive Disease|12
4615196|NCT01730950|7473351|FG000|Overall Study|Protocol Violation|6
4615197|NCT01730950|7473352|FG001|Overall Study|Protocol Violation|6
4632772|NCT01904383|7502554|FG000|Overall Study|No patient visit after entry|54
4632773|NCT01904604|7502574|FG000|Overall Study|Withdrew before receiving dosing|0
4632774|NCT01904604|7502575|FG001|Overall Study|Withdrew before receiving dosing|1
4632775|NCT01904604|7502576|FG002|Overall Study|Withdrew before receiving dosing|0
4632776|NCT01904604|7502574|FG000|Overall Study|Non-compliance|1
4632777|NCT01904604|7502575|FG001|Overall Study|Non-compliance|0
4632778|NCT01904604|7502576|FG002|Overall Study|Non-compliance|0
4632779|NCT01904604|7502574|FG000|Overall Study|Anxiety about OFC/Refused OFC|2
4632780|NCT01904604|7502575|FG001|Overall Study|Anxiety about OFC/Refused OFC|0
4632781|NCT01904604|7502576|FG002|Overall Study|Anxiety about OFC/Refused OFC|0
4632782|NCT01904604|7502574|FG000|Overall Study|Patch site reactions|1
4632783|NCT01904604|7502575|FG001|Overall Study|Patch site reactions|1
4632784|NCT01904604|7502576|FG002|Overall Study|Patch site reactions|0
4632785|NCT01904604|7502574|FG000|Overall Study|Increased syncope|0
4632786|NCT01904604|7502575|FG001|Overall Study|Increased syncope|1
4632787|NCT01904604|7502576|FG002|Overall Study|Increased syncope|0
4632788|NCT01904604|7502574|FG000|Overall Study|Unrelated illness|0
4632789|NCT01904604|7502575|FG001|Overall Study|Unrelated illness|1
4632790|NCT01904604|7502576|FG002|Overall Study|Unrelated illness|0
4632791|NCT01904604|7502574|FG000|Overall Study|Passed Week 52 OFC|1
4632792|NCT01904604|7502575|FG001|Overall Study|Passed Week 52 OFC|0
4632793|NCT01904604|7502576|FG002|Overall Study|Passed Week 52 OFC|0
4632794|NCT01904604|7502574|FG000|Overall Study|Withdrawal by Subject|1
4632795|NCT01904604|7502575|FG001|Overall Study|Withdrawal by Subject|2
4632796|NCT01904604|7502576|FG002|Overall Study|Withdrawal by Subject|0
4632797|NCT01904604|7502574|FG000|Overall Study|Participant Relocated|1
4632798|NCT01904604|7502575|FG001|Overall Study|Participant Relocated|1
4632799|NCT01904604|7502576|FG002|Overall Study|Participant Relocated|1
4632800|NCT01904604|7502574|FG000|Overall Study|Lost to Follow-up|0
4632801|NCT01904604|7502575|FG001|Overall Study|Lost to Follow-up|0
4632802|NCT01904604|7502576|FG002|Overall Study|Lost to Follow-up|1
4632803|NCT01904721|7502594|FG000|Overall Study|Other Reasons|0
4632804|NCT01904721|7502595|FG001|Overall Study|Other Reasons|0
4632805|NCT01904721|7502596|FG002|Overall Study|Other Reasons|1
4462646|NCT00591851|7252737|FG000|Overall Study|Withdrawal by Subject|3
4462647|NCT00591851|7252737|FG000|Overall Study|Adverse Event|2
4632806|NCT01904721|7502597|FG003|Overall Study|Other Reasons|1
4462648|NCT00591851|7252737|FG000|Overall Study|Progressive Disease|1
4462649|NCT00591864|7252741|FG000|Overall Study|Incomplete Imaging|5
4462650|NCT00592072|7252753|FG000|Wash Out Period|Lost to Follow-up|1
4462651|NCT00592072|7252754|FG001|Wash Out Period|Lost to Follow-up|1
4462652|NCT00592319|7252787|FG000|Overall Study|Lost to Follow-up|0
4462653|NCT00592319|7252788|FG001|Overall Study|Lost to Follow-up|3
4462654|NCT00592358|7252796|FG000|Overall Study|Withdrawal by Subject|2
4462655|NCT00592358|7252796|FG000|Overall Study|Adverse Event|1
4539945|NCT01130272|7362685|FG004|Overall Study|Rescue medications due to diarrhea|6
4539946|NCT01130272|7362681|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1
4539947|NCT01130272|7362682|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1
4539948|NCT01130272|7362683|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0
4539949|NCT01130272|7362684|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0
4539950|NCT01130272|7362685|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2
4539951|NCT01130272|7362681|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
4539952|NCT01130272|7362682|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
4539953|NCT01130272|7362683|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
4539954|NCT01130272|7362684|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1
4539955|NCT01130272|7362685|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
4539956|NCT01130272|7362681|FG000|Overall Study|Protocol Violation|0
4615198|NCT01731002|7473362|FG000|Overall Study|Adverse Event|0
4615199|NCT01731002|7473363|FG001|Overall Study|Adverse Event|2
4615200|NCT01731002|7473364|FG002|Overall Study|Adverse Event|2
4615201|NCT01731002|7473362|FG000|Overall Study|Non-Compliant|0
4615202|NCT01731002|7473363|FG001|Overall Study|Non-Compliant|1
4615203|NCT01731002|7473364|FG002|Overall Study|Non-Compliant|0
4615204|NCT01731002|7473362|FG000|Overall Study|Lost to Follow-up|1
4615205|NCT01731002|7473363|FG001|Overall Study|Lost to Follow-up|0
4615206|NCT01731002|7473364|FG002|Overall Study|Lost to Follow-up|0
4615207|NCT01731002|7473362|FG000|Overall Study|Test Agent Discontinuation|0
4615208|NCT01731002|7473363|FG001|Overall Study|Test Agent Discontinuation|1
4615209|NCT01731002|7473364|FG002|Overall Study|Test Agent Discontinuation|0
4615210|NCT01731002|7473362|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2
4615211|NCT01731002|7473363|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0
4615212|NCT01731002|7473364|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0
4615213|NCT01731002|7473362|FG000|Overall Study|Elevated IOP|1
4615214|NCT01731002|7473363|FG001|Overall Study|Elevated IOP|0
4615215|NCT01731002|7473364|FG002|Overall Study|Elevated IOP|0
4615216|NCT01731002|7473362|FG000|Overall Study|Inappropriate use of study medications|0
4615217|NCT01731002|7473363|FG001|Overall Study|Inappropriate use of study medications|0
4615218|NCT01731002|7473364|FG002|Overall Study|Inappropriate use of study medications|1
4615219|NCT01731171|7473387|FG000|Overall Study|Withdrawal by Subject|4
4615220|NCT01731171|7473388|FG001|Overall Study|Withdrawal by Subject|1
4615221|NCT01731171|7473387|FG000|Overall Study|Lost to Follow-up|3
4615222|NCT01731171|7473388|FG001|Overall Study|Lost to Follow-up|2
4615223|NCT01731171|7473387|FG000|Overall Study|Moved out of Area|0
4615224|NCT01731171|7473388|FG001|Overall Study|Moved out of Area|2
4615225|NCT01731171|7473387|FG000|Overall Study|Terminated for Lack of Adherence|0
4615226|NCT01731171|7473388|FG001|Overall Study|Terminated for Lack of Adherence|1
4615227|NCT01731171|7473387|FG000|Overall Study|Terminated for Safety Reasons|0
4615228|NCT01731171|7473388|FG001|Overall Study|Terminated for Safety Reasons|1
4615229|NCT01731470|7473394|FG000|Overall Study|Withdrawal by Subject|1
4615230|NCT01731470|7473394|FG000|Overall Study|Did not meet study criteria|1
4615231|NCT01731600|7473400|FG000|Overall Study|Adverse Event|2
4615232|NCT01731600|7473401|FG001|Overall Study|Adverse Event|0
4615233|NCT01731600|7473400|FG000|Overall Study|Withdrawal criteria|1
4615234|NCT01731600|7473401|FG001|Overall Study|Withdrawal criteria|0
4615235|NCT01731600|7473400|FG000|Overall Study|Other reasons|3
4615236|NCT01731600|7473401|FG001|Overall Study|Other reasons|0
4615237|NCT01731678|7473411|FG000|Overall Study|Withdrawal by Subject|3
4615238|NCT01731678|7473411|FG000|Overall Study|Did not meet inclusion criteria|1
4615239|NCT01731678|7473411|FG000|Overall Study|RMT too high, making TMS difficult|3
4615240|NCT01731886|7473433|FG000|Overall Study|Death|1
4615241|NCT01731886|7473434|FG001|Overall Study|Death|0
4615242|NCT01731886|7473433|FG000|Overall Study|Never started treatment|0
4615243|NCT01731886|7473434|FG001|Overall Study|Never started treatment|1
4615244|NCT01731886|7473433|FG000|Overall Study|Non-compliant|1
4615245|NCT01731886|7473434|FG001|Overall Study|Non-compliant|0
4615246|NCT01731912|7473441|FG000|Overall Study|noncompliance|2
4615247|NCT01731938|7473449|FG000|Preliminary Part I|Withdrawal by Subject|2
4615248|NCT01731938|7473450|FG001|Preliminary Part I|Withdrawal by Subject|2
4615249|NCT01731938|7473449|FG000|Preliminary Part I|Physician Decision|1
4615250|NCT01731938|7473450|FG001|Preliminary Part I|Physician Decision|0
4615251|NCT01731938|7473449|FG000|Preliminary Part I|Lost to Follow-up|0
4615252|NCT01731938|7473450|FG001|Preliminary Part I|Lost to Follow-up|3
4462656|NCT00592358|7252796|FG000|Overall Study|Lack of Efficacy|2
4462657|NCT00592358|7252796|FG000|Overall Study|Inability to swallow pills|1
4462658|NCT00592384|7252802|FG000|Overall Study|Withdrawal by Subject|5
4539957|NCT01130272|7362682|FG001|Overall Study|Protocol Violation|0
4462659|NCT00592384|7252803|FG001|Overall Study|Withdrawal by Subject|6
4462660|NCT00592501|7252833|FG000|Overall Study|Withdrawal by Subject|1
4539958|NCT01130272|7362683|FG002|Overall Study|Protocol Violation|3
4539959|NCT01130272|7362684|FG003|Overall Study|Protocol Violation|5
4539960|NCT01130272|7362685|FG004|Overall Study|Protocol Violation|5
4539961|NCT01130272|7362681|FG000|Overall Study|Lost to Follow-up|4
4539962|NCT01130272|7362682|FG001|Overall Study|Lost to Follow-up|3
4539963|NCT01130272|7362683|FG002|Overall Study|Lost to Follow-up|4
4539964|NCT01130272|7362684|FG003|Overall Study|Lost to Follow-up|7
4539965|NCT01130272|7362685|FG004|Overall Study|Lost to Follow-up|6
4539966|NCT01130272|7362681|FG000|Overall Study|Withdrawal by Subject|4
4539967|NCT01130272|7362682|FG001|Overall Study|Withdrawal by Subject|11
4539968|NCT01130272|7362683|FG002|Overall Study|Withdrawal by Subject|10
4539969|NCT01130272|7362684|FG003|Overall Study|Withdrawal by Subject|9
4539970|NCT01130272|7362685|FG004|Overall Study|Withdrawal by Subject|8
4539971|NCT01130272|7362681|FG000|Overall Study|Physician Decision|1
4462661|NCT00592501|7252833|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1
4462662|NCT00592553|7252840|FG000|Overall Study|Protocol Noncompliance|1
4462663|NCT00592553|7252841|FG001|Overall Study|Protocol Noncompliance|0
4462664|NCT00592553|7252842|FG002|Overall Study|Protocol Noncompliance|0
4462665|NCT00592631|7252852|FG000|Overall Study|Lost to Follow-up|0
4462666|NCT00592631|7252853|FG001|Overall Study|Lost to Follow-up|2
4539972|NCT01130272|7362682|FG001|Overall Study|Physician Decision|1
4539973|NCT01130272|7362683|FG002|Overall Study|Physician Decision|0
4539974|NCT01130272|7362684|FG003|Overall Study|Physician Decision|1
4615253|NCT01731938|7473449|FG000|Preliminary Part I|Missed Week 6 visit|0
4615254|NCT01731938|7473450|FG001|Preliminary Part I|Missed Week 6 visit|3
4615255|NCT01731938|7473449|FG000|Primary Part II|Withdrawal by Subject|5
4615256|NCT01731938|7473450|FG001|Primary Part II|Withdrawal by Subject|4
4615257|NCT01731938|7473449|FG000|Primary Part II|Lost to Follow-up|4
4615258|NCT01731938|7473450|FG001|Primary Part II|Lost to Follow-up|5
4615259|NCT01731938|7473449|FG000|Primary Part II|Death|2
4615260|NCT01731938|7473450|FG001|Primary Part II|Death|1
4615261|NCT01731938|7473449|FG000|Primary Part II|Missed Week 6 visit|2
4615262|NCT01731938|7473450|FG001|Primary Part II|Missed Week 6 visit|3
4615263|NCT01731951|7473463|FG000|Overall Study|Documented Disease Progression|1
4615264|NCT01731951|7473464|FG001|Overall Study|Documented Disease Progression|0
4615265|NCT01731951|7473465|FG002|Overall Study|Documented Disease Progression|0
4615266|NCT01731951|7473466|FG003|Overall Study|Documented Disease Progression|0
4615267|NCT01731951|7473467|FG004|Overall Study|Documented Disease Progression|0
4615268|NCT01731951|7473468|FG005|Overall Study|Documented Disease Progression|0
4615269|NCT01731951|7473463|FG000|Overall Study|Lost to Follow-up|2
4615270|NCT01731951|7473464|FG001|Overall Study|Lost to Follow-up|0
4615271|NCT01731951|7473465|FG002|Overall Study|Lost to Follow-up|0
4615272|NCT01731951|7473466|FG003|Overall Study|Lost to Follow-up|1
4615273|NCT01731951|7473467|FG004|Overall Study|Lost to Follow-up|3
4615274|NCT01731951|7473468|FG005|Overall Study|Lost to Follow-up|1
4615275|NCT01731951|7473463|FG000|Overall Study|Withdrawal of Consent|1
4615276|NCT01731951|7473464|FG001|Overall Study|Withdrawal of Consent|0
4615277|NCT01731951|7473465|FG002|Overall Study|Withdrawal of Consent|0
4615278|NCT01731951|7473466|FG003|Overall Study|Withdrawal of Consent|0
4615279|NCT01731951|7473467|FG004|Overall Study|Withdrawal of Consent|0
4615280|NCT01731951|7473468|FG005|Overall Study|Withdrawal of Consent|2
4615281|NCT01731951|7473463|FG000|Overall Study|Death|13
4615282|NCT01731951|7473464|FG001|Overall Study|Death|15
4615283|NCT01731951|7473465|FG002|Overall Study|Death|9
4615284|NCT01731951|7473466|FG003|Overall Study|Death|8
4615285|NCT01731951|7473467|FG004|Overall Study|Death|9
4615286|NCT01731951|7473468|FG005|Overall Study|Death|6
4615287|NCT01731990|7473488|FG000|Overall Study|Adverse Event|1
4615288|NCT01731990|7473489|FG001|Overall Study|Adverse Event|5
4615289|NCT01731990|7473488|FG000|Overall Study|Withdrawal by Subject|1
4615290|NCT01731990|7473489|FG001|Overall Study|Withdrawal by Subject|1
4615291|NCT01731990|7473488|FG000|Overall Study|Protocol deviation|1
4615292|NCT01731990|7473489|FG001|Overall Study|Protocol deviation|2
4615293|NCT01731990|7473488|FG000|Overall Study|Death|1
4615294|NCT01731990|7473489|FG001|Overall Study|Death|0
4615295|NCT01732107|7473495|FG000|Overall Study|Adverse Event|2
4615296|NCT01732107|7473495|FG000|Overall Study|Disease Progression|8
4462667|NCT00592683|7252861|FG000|Overall Study|Found ineligible|0
4462668|NCT00592683|7252862|FG001|Overall Study|Found ineligible|1
4462669|NCT00592683|7252861|FG000|Overall Study|Withdrawal by Subject|1
4462670|NCT00592683|7252862|FG001|Overall Study|Withdrawal by Subject|0
4462671|NCT00592683|7252861|FG000|Overall Study|Adverse Event|0
4462672|NCT00592683|7252862|FG001|Overall Study|Adverse Event|2
4462673|NCT00592683|7252861|FG000|Overall Study|Protocol Violation|1
4462674|NCT00592683|7252862|FG001|Overall Study|Protocol Violation|0
4462675|NCT00592683|7252861|FG000|Overall Study|Study drug expired|1
4462676|NCT00592683|7252862|FG001|Overall Study|Study drug expired|0
4462677|NCT00592683|7252861|FG000|Overall Study|Other|1
4539975|NCT01130272|7362685|FG004|Overall Study|Physician Decision|2
4615297|NCT01732107|7473495|FG000|Overall Study|Physician Decision|1
4615298|NCT01732107|7473495|FG000|Overall Study|Withdrawal by Subject|2
4615299|NCT01732458|7473546|FG000|Overall Study|Lost to Follow-up|0
4615300|NCT01732458|7473547|FG001|Overall Study|Lost to Follow-up|2
4615301|NCT01732458|7473548|FG002|Overall Study|Lost to Follow-up|0
4615302|NCT01732458|7473549|FG003|Overall Study|Lost to Follow-up|0
4462678|NCT00592683|7252862|FG001|Overall Study|Other|0
4462679|NCT00592683|7252861|FG000|Overall Study|Lost to Follow-up|0
4462680|NCT00592683|7252862|FG001|Overall Study|Lost to Follow-up|1
4462681|NCT00592774|7252880|FG000|Overall Study|Adverse Event|5
4462682|NCT00592774|7252881|FG001|Overall Study|Adverse Event|19
4462683|NCT00592774|7252882|FG002|Overall Study|Adverse Event|2
4462684|NCT00592774|7252883|FG003|Overall Study|Adverse Event|14
4462685|NCT00592774|7252884|FG004|Overall Study|Adverse Event|8
4462686|NCT00592774|7252880|FG000|Overall Study|Protocol Violation|0
4462687|NCT00592774|7252881|FG001|Overall Study|Protocol Violation|1
4615303|NCT01732458|7473546|FG000|Overall Study|Non-Compliance With Study Drug|0
4615304|NCT01732458|7473547|FG001|Overall Study|Non-Compliance With Study Drug|0
4615305|NCT01732458|7473548|FG002|Overall Study|Non-Compliance With Study Drug|1
4615306|NCT01732458|7473549|FG003|Overall Study|Non-Compliance With Study Drug|0
4615307|NCT01732458|7473546|FG000|Overall Study|Physician Decision|1
4615308|NCT01732458|7473547|FG001|Overall Study|Physician Decision|2
4615309|NCT01732458|7473548|FG002|Overall Study|Physician Decision|2
4615310|NCT01732458|7473549|FG003|Overall Study|Physician Decision|0
4615311|NCT01732458|7473546|FG000|Overall Study|Protocol Violation|2
4615312|NCT01732458|7473547|FG001|Overall Study|Protocol Violation|0
4615313|NCT01732458|7473548|FG002|Overall Study|Protocol Violation|0
4615314|NCT01732458|7473549|FG003|Overall Study|Protocol Violation|2
4539976|NCT01130272|7362681|FG000|Overall Study|Sponsor decision|6
4539977|NCT01130272|7362682|FG001|Overall Study|Sponsor decision|15
4539978|NCT01130272|7362683|FG002|Overall Study|Sponsor decision|16
4539979|NCT01130272|7362684|FG003|Overall Study|Sponsor decision|13
4539980|NCT01130272|7362685|FG004|Overall Study|Sponsor decision|16
4539981|NCT01130272|7362681|FG000|Overall Study|Study arm discontinued|38
4539982|NCT01130272|7362682|FG001|Overall Study|Study arm discontinued|0
4539983|NCT01130272|7362683|FG002|Overall Study|Study arm discontinued|0
4539984|NCT01130272|7362684|FG003|Overall Study|Study arm discontinued|0
4539985|NCT01130272|7362685|FG004|Overall Study|Study arm discontinued|0
4539986|NCT01130337|7362697|FG000|Overall Study|Withdrawal by Subject|3
4539987|NCT01130337|7362697|FG000|Overall Study|Principal investigator decision|1
4539988|NCT01130337|7362697|FG000|Overall Study|Death|1
4539989|NCT01130337|7362697|FG000|Overall Study|Disease progression|1
4539990|NCT01130337|7362697|FG000|Overall Study|Toxicity, AE/intercurrent disease|7
4539991|NCT01130337|7362697|FG000|Overall Study|Surgical resection (R2)|1
4539992|NCT01130493|7362701|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1
4539993|NCT01130493|7362702|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0
4539994|NCT01130493|7362703|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0
4539995|NCT01130493|7362701|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3
4539996|NCT01130493|7362702|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0
4539997|NCT01130493|7362703|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0
4539998|NCT01130493|7362701|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7
4539999|NCT01130493|7362702|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0
4540000|NCT01130493|7362703|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0
4540001|NCT01130493|7362701|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7
4540002|NCT01130493|7362702|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0
4540003|NCT01130493|7362703|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0
4540004|NCT01130493|7362701|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1
4540005|NCT01130493|7362702|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0
4540006|NCT01130493|7362703|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0
4615315|NCT01732458|7473546|FG000|Overall Study|Screen Failure|0
4615316|NCT01732458|7473547|FG001|Overall Study|Screen Failure|1
4615317|NCT01732458|7473548|FG002|Overall Study|Screen Failure|0
4615318|NCT01732458|7473549|FG003|Overall Study|Screen Failure|0
4615319|NCT01732471|7473571|FG000|Overall Study|Withdrawal by Subject|1
4615320|NCT01732484|7473575|FG000|Overall Study|Death|7
4615321|NCT01732484|7473575|FG000|Overall Study|Lost to Follow-up|14
4615322|NCT01732484|7473575|FG000|Overall Study|chronical illness|5
4615323|NCT01732510|7473588|FG000|Overall Study|Adverse Event|0
4615324|NCT01732510|7473589|FG001|Overall Study|Adverse Event|1
4615325|NCT01732510|7473590|FG002|Overall Study|Adverse Event|1
4615326|NCT01732510|7473591|FG003|Overall Study|Adverse Event|0
4615327|NCT01732510|7473592|FG004|Overall Study|Adverse Event|0
4615328|NCT01732510|7473593|FG005|Overall Study|Adverse Event|0
4615329|NCT01732510|7473594|FG006|Overall Study|Adverse Event|1
4615330|NCT01732510|7473588|FG000|Overall Study|Protocol Violation|0
4615331|NCT01732510|7473589|FG001|Overall Study|Protocol Violation|0
4615332|NCT01732510|7473590|FG002|Overall Study|Protocol Violation|0
4615333|NCT01732510|7473591|FG003|Overall Study|Protocol Violation|1
4615334|NCT01732510|7473592|FG004|Overall Study|Protocol Violation|0
4615335|NCT01732510|7473593|FG005|Overall Study|Protocol Violation|0
4615336|NCT01732510|7473594|FG006|Overall Study|Protocol Violation|0
4615337|NCT01732510|7473588|FG000|Overall Study|Withdrawal by Subject|1
4615338|NCT01732510|7473589|FG001|Overall Study|Withdrawal by Subject|3
4615339|NCT01732510|7473590|FG002|Overall Study|Withdrawal by Subject|2
4615340|NCT01732510|7473591|FG003|Overall Study|Withdrawal by Subject|1
4462688|NCT00592774|7252882|FG002|Overall Study|Protocol Violation|0
4615341|NCT01732510|7473592|FG004|Overall Study|Withdrawal by Subject|5
4615342|NCT01732510|7473593|FG005|Overall Study|Withdrawal by Subject|0
4615343|NCT01732510|7473594|FG006|Overall Study|Withdrawal by Subject|1
4615344|NCT01732510|7473588|FG000|Overall Study|Lost to Follow-up|0
4615345|NCT01732510|7473589|FG001|Overall Study|Lost to Follow-up|0
4615346|NCT01732510|7473590|FG002|Overall Study|Lost to Follow-up|1
4615347|NCT01732510|7473591|FG003|Overall Study|Lost to Follow-up|1
4615348|NCT01732510|7473592|FG004|Overall Study|Lost to Follow-up|0
4615349|NCT01732510|7473593|FG005|Overall Study|Lost to Follow-up|1
4615350|NCT01732510|7473594|FG006|Overall Study|Lost to Follow-up|0
4615351|NCT01732510|7473588|FG000|Overall Study|Physician Decision|0
4615352|NCT01732510|7473589|FG001|Overall Study|Physician Decision|1
4462689|NCT00592774|7252883|FG003|Overall Study|Protocol Violation|0
4462690|NCT00592774|7252884|FG004|Overall Study|Protocol Violation|1
4462691|NCT00592774|7252880|FG000|Overall Study|Withdrawal by Subject|3
4462692|NCT00592774|7252881|FG001|Overall Study|Withdrawal by Subject|7
4462693|NCT00592774|7252882|FG002|Overall Study|Withdrawal by Subject|0
4615353|NCT01732510|7473590|FG002|Overall Study|Physician Decision|0
4615354|NCT01732510|7473591|FG003|Overall Study|Physician Decision|0
4615355|NCT01732510|7473592|FG004|Overall Study|Physician Decision|0
4615356|NCT01732510|7473593|FG005|Overall Study|Physician Decision|0
4615357|NCT01732510|7473594|FG006|Overall Study|Physician Decision|0
4615358|NCT01732510|7473588|FG000|Overall Study|Pregnancy|0
4615359|NCT01732510|7473589|FG001|Overall Study|Pregnancy|0
4615360|NCT01732510|7473590|FG002|Overall Study|Pregnancy|0
4615361|NCT01732510|7473591|FG003|Overall Study|Pregnancy|1
4615362|NCT01732510|7473592|FG004|Overall Study|Pregnancy|0
4615363|NCT01732510|7473593|FG005|Overall Study|Pregnancy|0
4615364|NCT01732510|7473594|FG006|Overall Study|Pregnancy|0
4615365|NCT01732510|7473588|FG000|Overall Study|Study Terminated By Sponsor|0
4615366|NCT01732510|7473589|FG001|Overall Study|Study Terminated By Sponsor|0
4615367|NCT01732510|7473590|FG002|Overall Study|Study Terminated By Sponsor|0
4615368|NCT01732510|7473591|FG003|Overall Study|Study Terminated By Sponsor|1
4615369|NCT01732510|7473592|FG004|Overall Study|Study Terminated By Sponsor|0
4615370|NCT01732510|7473593|FG005|Overall Study|Study Terminated By Sponsor|12
4615371|NCT01732510|7473594|FG006|Overall Study|Study Terminated By Sponsor|6
4615372|NCT01732536|7473615|FG000|Overall Study|Withdrawal by Subject|1
4615373|NCT01732536|7473616|FG001|Overall Study|Withdrawal by Subject|1
4615374|NCT01732549|7473627|FG000|Overall Study|Adverse Event|13
4615375|NCT01732549|7473628|FG001|Overall Study|Adverse Event|3
4615376|NCT01732549|7473627|FG000|Overall Study|Consent withdrawn|13
4615377|NCT01732549|7473628|FG001|Overall Study|Consent withdrawn|6
4615378|NCT01732549|7473627|FG000|Overall Study|Disease progression|37
4615379|NCT01732549|7473628|FG001|Overall Study|Disease progression|50
4615380|NCT01732549|7473627|FG000|Overall Study|Other|8
4615381|NCT01732549|7473628|FG001|Overall Study|Other|14
4615382|NCT01732588|7473638|FG000|First Intervention (7 Days)|Adverse Event|0
4615383|NCT01732588|7473639|FG001|First Intervention (7 Days)|Adverse Event|1
4615384|NCT01732588|7473640|FG002|First Intervention (7 Days)|Adverse Event|0
4615385|NCT01732640|7473648|FG000|Overall Study|Adverse Event|0
4615386|NCT01732640|7473649|FG001|Overall Study|Adverse Event|1
4615387|NCT01732640|7473648|FG000|Overall Study|Death|0
4615388|NCT01732640|7473649|FG001|Overall Study|Death|1
4615389|NCT01732692|7473661|FG000|Overall Study|Adverse Event|0
4615390|NCT01732692|7473662|FG001|Overall Study|Adverse Event|1
4615391|NCT01732757|7473684|FG000|Overall Study|Lost to Follow-up|1
4615392|NCT01732757|7473685|FG001|Overall Study|Lost to Follow-up|0
4690445|NCT02561195|7600186|FG001|Vaccination 1 to 3|Death|1
4690446|NCT02561195|7600187|FG002|Vaccination 1 to 3|Death|0
4690447|NCT02561195|7600188|FG003|Vaccination 1 to 3|Death|2
4690448|NCT02561195|7600189|FG004|Vaccination 1 to 3|Death|0
4690449|NCT02561195|7600190|FG005|Vaccination 1 to 3|Death|0
4462694|NCT00592774|7252883|FG003|Overall Study|Withdrawal by Subject|0
4462695|NCT00592774|7252884|FG004|Overall Study|Withdrawal by Subject|0
4462696|NCT00592774|7252880|FG000|Overall Study|Lack of Efficacy|3
4462697|NCT00592774|7252881|FG001|Overall Study|Lack of Efficacy|3
4462698|NCT00592774|7252882|FG002|Overall Study|Lack of Efficacy|0
4462699|NCT00592774|7252883|FG003|Overall Study|Lack of Efficacy|0
4462700|NCT00592774|7252884|FG004|Overall Study|Lack of Efficacy|2
4462701|NCT00592774|7252880|FG000|Overall Study|Physician Decision|0
4462702|NCT00592774|7252881|FG001|Overall Study|Physician Decision|1
4462703|NCT00592774|7252882|FG002|Overall Study|Physician Decision|1
4462704|NCT00592774|7252883|FG003|Overall Study|Physician Decision|0
4462705|NCT00592774|7252884|FG004|Overall Study|Physician Decision|1
4462706|NCT00592774|7252880|FG000|Overall Study|Other|0
4462707|NCT00592774|7252881|FG001|Overall Study|Other|1
4462708|NCT00592774|7252882|FG002|Overall Study|Other|1
4462709|NCT00592774|7252883|FG003|Overall Study|Other|0
4462710|NCT00592774|7252884|FG004|Overall Study|Other|2
4462711|NCT00592839|7252899|FG000|Overall Study|Withdrawal by Subject|1
4462712|NCT00592839|7252900|FG001|Overall Study|Withdrawal by Subject|1
4462713|NCT00592839|7252901|FG002|Overall Study|Withdrawal by Subject|3
4462714|NCT00592839|7252899|FG000|Overall Study|Protocol Violation|1
4462715|NCT00592839|7252900|FG001|Overall Study|Protocol Violation|1
4615393|NCT01732757|7473686|FG002|Overall Study|Lost to Follow-up|0
4615394|NCT01732770|7473696|FG000|Overall Study|Lost to Follow-up|2
4615395|NCT01732770|7473697|FG001|Overall Study|Lost to Follow-up|3
4615396|NCT01732770|7473696|FG000|Overall Study|Withdrawal by Subject|5
4690450|NCT02561195|7600191|FG006|Vaccination 1 to 3|Death|0
4690451|NCT02561195|7600192|FG007|Vaccination 1 to 3|Death|0
4540007|NCT01130493|7362701|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0
4540008|NCT01130493|7362702|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1
4462716|NCT00592839|7252901|FG002|Overall Study|Protocol Violation|2
4462717|NCT00592839|7252899|FG000|Overall Study|Adverse Event|0
4462718|NCT00592839|7252900|FG001|Overall Study|Adverse Event|1
4462719|NCT00592839|7252901|FG002|Overall Study|Adverse Event|0
4462720|NCT00592839|7252899|FG000|Overall Study|Lost to Follow-up|0
4462721|NCT00592839|7252900|FG001|Overall Study|Lost to Follow-up|1
4462722|NCT00592839|7252901|FG002|Overall Study|Lost to Follow-up|1
4462723|NCT00592852|7252909|FG000|Overall Study|Non-compliance|1
4462724|NCT00592852|7252909|FG000|Overall Study|Adverse Event|3
4462725|NCT00592852|7252909|FG000|Overall Study|Found ineligible|1
4462726|NCT00592852|7252909|FG000|Overall Study|Withdrawal by Subject|1
4462727|NCT00592904|7252917|FG000|Overall Study|Adverse Event|15
4462728|NCT00592904|7252918|FG001|Overall Study|Adverse Event|25
4462729|NCT00592904|7252919|FG002|Overall Study|Adverse Event|13
4462730|NCT00592904|7252920|FG003|Overall Study|Adverse Event|5
4462731|NCT00592904|7252917|FG000|Overall Study|Protocol Violation|1
4462732|NCT00592904|7252918|FG001|Overall Study|Protocol Violation|1
4462733|NCT00592904|7252919|FG002|Overall Study|Protocol Violation|0
4462734|NCT00592904|7252920|FG003|Overall Study|Protocol Violation|1
4462735|NCT00592904|7252917|FG000|Overall Study|Withdrawal by Subject|4
4462736|NCT00592904|7252918|FG001|Overall Study|Withdrawal by Subject|16
4462737|NCT00592904|7252919|FG002|Overall Study|Withdrawal by Subject|1
4462738|NCT00592904|7252920|FG003|Overall Study|Withdrawal by Subject|2
4540009|NCT01130493|7362703|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0
4540010|NCT01130493|7362701|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0
4540011|NCT01130493|7362702|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1
4540012|NCT01130493|7362703|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0
4540013|NCT01130493|7362701|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0
4540014|NCT01130493|7362702|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1
4540015|NCT01130493|7362703|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0
4540016|NCT01130493|7362701|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0
4540017|NCT01130493|7362702|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0
4540018|NCT01130493|7362703|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1
4540019|NCT01130493|7362701|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0
4540020|NCT01130493|7362702|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0
4540021|NCT01130493|7362703|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1
4540022|NCT01130493|7362701|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0
4540023|NCT01130493|7362702|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0
4540024|NCT01130493|7362703|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1
4540025|NCT01130493|7362701|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0
4540026|NCT01130493|7362702|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0
4540027|NCT01130493|7362703|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1
4540028|NCT01130493|7362701|FG000|Part 2: OLE|Adverse Event|0
4540029|NCT01130493|7362702|FG001|Part 2: OLE|Adverse Event|2
4540030|NCT01130493|7362703|FG002|Part 2: OLE|Adverse Event|1
4540031|NCT01130493|7362701|FG000|Part 2: OLE|Withdrawal by Subject|0
4540032|NCT01130493|7362702|FG001|Part 2: OLE|Withdrawal by Subject|1
4540033|NCT01130493|7362703|FG002|Part 2: OLE|Withdrawal by Subject|4
4540034|NCT01130532|7362717|FG000|Period III (Weeks 0-12)|Adverse Event|3
4540035|NCT01130532|7362718|FG001|Period III (Weeks 0-12)|Adverse Event|3
4540036|NCT01130532|7362719|FG002|Period III (Weeks 0-12)|Adverse Event|2
4540037|NCT01130532|7362720|FG003|Period III (Weeks 0-12)|Adverse Event|0
4540038|NCT01130532|7362717|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4
4540039|NCT01130532|7362718|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2
4540040|NCT01130532|7362719|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4
4540041|NCT01130532|7362720|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0
4540042|NCT01130532|7362717|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2
4540043|NCT01130532|7362718|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0
4462739|NCT00592904|7252917|FG000|Overall Study|Lack of Efficacy|2
4462740|NCT00592904|7252918|FG001|Overall Study|Lack of Efficacy|7
4462741|NCT00592904|7252919|FG002|Overall Study|Lack of Efficacy|2
4462742|NCT00592904|7252920|FG003|Overall Study|Lack of Efficacy|3
4462743|NCT00592904|7252917|FG000|Overall Study|Physician Decision|0
4462744|NCT00592904|7252918|FG001|Overall Study|Physician Decision|3
4462745|NCT00592904|7252919|FG002|Overall Study|Physician Decision|1
4462746|NCT00592904|7252920|FG003|Overall Study|Physician Decision|0
4462747|NCT00592904|7252917|FG000|Overall Study|Other|3
4462748|NCT00592904|7252918|FG001|Overall Study|Other|3
4462749|NCT00592904|7252919|FG002|Overall Study|Other|0
4462750|NCT00592904|7252920|FG003|Overall Study|Other|0
4462751|NCT00593112|7252941|FG000|Overall Study|Scan Anxiety|3
4462752|NCT00593112|7252942|FG001|Overall Study|Scan Anxiety|0
4462753|NCT00593112|7252941|FG000|Overall Study|Abnormal Scan|1
4462754|NCT00593112|7252942|FG001|Overall Study|Abnormal Scan|0
4462755|NCT00593112|7252941|FG000|Overall Study|Unreadable Scan|1
4462756|NCT00593112|7252942|FG001|Overall Study|Unreadable Scan|0
4462757|NCT00593112|7252941|FG000|Overall Study|Withdrawal by Subject|5
4462758|NCT00593112|7252942|FG001|Overall Study|Withdrawal by Subject|0
4462759|NCT00593333|7252950|FG000|Overall Study|Lost to Follow-up|10
4462760|NCT00593333|7252951|FG001|Overall Study|Lost to Follow-up|11
4462761|NCT00593385|7252971|FG000|Overall Study|Death|14
4462762|NCT00593385|7252971|FG000|Overall Study|Lost to Follow-up|17
4462763|NCT00593385|7252971|FG000|Overall Study|Withdrawal by Subject|9
4462764|NCT00593489|7252996|FG000|Allocation|did not attend workshop; allocation not|2
4462765|NCT00593489|7252997|FG001|Allocation|did not attend workshop; allocation not|1
4462766|NCT00593554|7253007|FG000|Overall Study|Death|1
4462767|NCT00593554|7253008|FG001|Overall Study|Death|2
4462768|NCT00593554|7253007|FG000|Overall Study|Physician Decision|0
4462769|NCT00593554|7253008|FG001|Overall Study|Physician Decision|1
4462770|NCT00593554|7253007|FG000|Overall Study|Withdrawal by Subject|1
4462771|NCT00593554|7253008|FG001|Overall Study|Withdrawal by Subject|0
4462772|NCT00593554|7253007|FG000|Overall Study|Disease Progression|1
4462773|NCT00593554|7253008|FG001|Overall Study|Disease Progression|2
4540044|NCT01130532|7362719|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1
4540045|NCT01130532|7362720|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0
4540046|NCT01130532|7362717|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2
4540047|NCT01130532|7362718|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2
4540048|NCT01130532|7362719|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3
4540049|NCT01130532|7362720|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0
4540050|NCT01130532|7362717|FG000|Period III (Weeks 0-12)|Protocol Violation|0
4540051|NCT01130532|7362718|FG001|Period III (Weeks 0-12)|Protocol Violation|0
4540052|NCT01130532|7362719|FG002|Period III (Weeks 0-12)|Protocol Violation|1
4540053|NCT01130532|7362720|FG003|Period III (Weeks 0-12)|Protocol Violation|0
4540054|NCT01130532|7362717|FG000|Period III (Weeks 0-12)|Sponsor Decision|3
4540055|NCT01130532|7362718|FG001|Period III (Weeks 0-12)|Sponsor Decision|4
4540056|NCT01130532|7362719|FG002|Period III (Weeks 0-12)|Sponsor Decision|2
4540057|NCT01130532|7362720|FG003|Period III (Weeks 0-12)|Sponsor Decision|0
4540058|NCT01130532|7362717|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7
4615397|NCT01732770|7473697|FG001|Overall Study|Withdrawal by Subject|3
4615398|NCT01732770|7473696|FG000|Overall Study|Decision by Sponsor|2
4615399|NCT01732770|7473697|FG001|Overall Study|Decision by Sponsor|2
4615400|NCT01732770|7473696|FG000|Overall Study|Death|1
4615401|NCT01732770|7473697|FG001|Overall Study|Death|0
4615402|NCT01732783|7473706|FG000|Overall Study|Discontinued Panitumumab Treatment|106
4615403|NCT01732783|7473707|FG001|Overall Study|Discontinued Panitumumab Treatment|25
4615404|NCT01732783|7473708|FG002|Overall Study|Discontinued Panitumumab Treatment|7
4615405|NCT01732783|7473706|FG000|Overall Study|Death|13
4615406|NCT01732783|7473707|FG001|Overall Study|Death|4
4615407|NCT01732783|7473708|FG002|Overall Study|Death|1
4615408|NCT01732783|7473706|FG000|Overall Study|Lost to Follow-up|7
4615409|NCT01732783|7473707|FG001|Overall Study|Lost to Follow-up|1
4615410|NCT01732783|7473708|FG002|Overall Study|Lost to Follow-up|1
4615411|NCT01732783|7473706|FG000|Overall Study|Administrative Decision|8
4615412|NCT01732783|7473707|FG001|Overall Study|Administrative Decision|2
4615413|NCT01732783|7473708|FG002|Overall Study|Administrative Decision|1
4615414|NCT01732783|7473706|FG000|Overall Study|Withdrawal by Subject|1
4615415|NCT01732783|7473707|FG001|Overall Study|Withdrawal by Subject|0
4615416|NCT01732783|7473708|FG002|Overall Study|Withdrawal by Subject|0
4615417|NCT01732796|7473719|FG000|Overall Study|Adverse Event|16
4615418|NCT01732796|7473720|FG001|Overall Study|Adverse Event|16
4615419|NCT01732796|7473721|FG002|Overall Study|Adverse Event|4
4615420|NCT01732796|7473719|FG000|Overall Study|Lack of Efficacy|21
4615421|NCT01732796|7473720|FG001|Overall Study|Lack of Efficacy|18
4615422|NCT01732796|7473721|FG002|Overall Study|Lack of Efficacy|5
4615423|NCT01732796|7473719|FG000|Overall Study|Lost to Follow-up|2
4615424|NCT01732796|7473720|FG001|Overall Study|Lost to Follow-up|0
4615425|NCT01732796|7473721|FG002|Overall Study|Lost to Follow-up|0
4615426|NCT01732796|7473719|FG000|Overall Study|Withdrawal by Subject|6
4615427|NCT01732796|7473720|FG001|Overall Study|Withdrawal by Subject|8
4615428|NCT01732796|7473721|FG002|Overall Study|Withdrawal by Subject|2
4615429|NCT01732796|7473719|FG000|Overall Study|Other reason not defined above|1
4615430|NCT01732796|7473720|FG001|Overall Study|Other reason not defined above|0
4615431|NCT01732796|7473721|FG002|Overall Study|Other reason not defined above|2
4632807|NCT01904721|7502598|FG004|Overall Study|Other Reasons|2
4632808|NCT01904721|7502599|FG005|Overall Study|Other Reasons|2
4632809|NCT01904721|7502600|FG006|Overall Study|Other Reasons|2
4632810|NCT01904721|7502594|FG000|Overall Study|Personal Reasons|0
4632811|NCT01904721|7502595|FG001|Overall Study|Personal Reasons|0
4632812|NCT01904721|7502596|FG002|Overall Study|Personal Reasons|0
4632813|NCT01904721|7502597|FG003|Overall Study|Personal Reasons|0
4632814|NCT01904721|7502598|FG004|Overall Study|Personal Reasons|2
4632815|NCT01904721|7502599|FG005|Overall Study|Personal Reasons|3
4632816|NCT01904721|7502600|FG006|Overall Study|Personal Reasons|3
4632817|NCT01904721|7502594|FG000|Overall Study|Lost to Follow-up|0
4632818|NCT01904721|7502595|FG001|Overall Study|Lost to Follow-up|0
4632819|NCT01904721|7502596|FG002|Overall Study|Lost to Follow-up|0
4462774|NCT00593606|7253014|FG000|Overall Study|Adverse Event|13
4632820|NCT01904721|7502597|FG003|Overall Study|Lost to Follow-up|0
4462775|NCT00593606|7253014|FG000|Overall Study|Withdrawal by Subject|1
4462776|NCT00593606|7253014|FG000|Overall Study|Protocol Violation|3
4632821|NCT01904721|7502598|FG004|Overall Study|Lost to Follow-up|1
4632822|NCT01904721|7502599|FG005|Overall Study|Lost to Follow-up|3
4632823|NCT01904721|7502600|FG006|Overall Study|Lost to Follow-up|1
4462777|NCT00593606|7253014|FG000|Overall Study|Lost to Follow-up|2
4462778|NCT00593606|7253014|FG000|Overall Study|Run-In Failure|5
4462779|NCT00593606|7253014|FG000|Overall Study|Screen Failure|3
4462780|NCT00593684|7253024|FG000|Overall Study|Death|2
4462781|NCT00593684|7253025|FG001|Overall Study|Death|1
4462782|NCT00593736|7253035|FG000|Screening Period and Placebo Run-in|Adverse Event|0
4462783|NCT00593736|7253036|FG001|Screening Period and Placebo Run-in|Adverse Event|0
4540059|NCT01130532|7362718|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7
4540060|NCT01130532|7362719|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6
4615432|NCT04848662|7473733|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1
4615433|NCT04848662|7473734|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0
4615434|NCT04537234|7473742|FG000|Overall Study|Withdrawal by Subject|2
4615435|NCT04537234|7473743|FG001|Overall Study|Withdrawal by Subject|0
4615436|NCT03594955|7473777|FG000|Overall Study|Adverse Event|1
4615437|NCT03594955|7473777|FG000|Overall Study|Progressive disease|5
4615438|NCT03594955|7473777|FG000|Overall Study|Sponsor's decision|1
4615439|NCT03478956|7473783|FG000|Overall Study|Adverse Event|1
4615440|NCT03478956|7473784|FG001|Overall Study|Adverse Event|0
4615441|NCT03478956|7473783|FG000|Overall Study|Withdrawal by Subject|0
4540061|NCT01130532|7362720|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0
4540062|NCT01130532|7362717|FG000|Period IV (Weeks 13-16)|Adverse Event|0
4615442|NCT03478956|7473784|FG001|Overall Study|Withdrawal by Subject|1
4615443|NCT03478956|7473783|FG000|Overall Study|Ongoing in the Study|11
4615444|NCT03478956|7473784|FG001|Overall Study|Ongoing in the Study|11
4632824|NCT01904721|7502594|FG000|Overall Study|Lack of Efficacy|0
4632825|NCT01904721|7502595|FG001|Overall Study|Lack of Efficacy|0
4632826|NCT01904721|7502596|FG002|Overall Study|Lack of Efficacy|0
4632827|NCT01904721|7502597|FG003|Overall Study|Lack of Efficacy|0
4632828|NCT01904721|7502598|FG004|Overall Study|Lack of Efficacy|0
4632829|NCT01904721|7502599|FG005|Overall Study|Lack of Efficacy|0
4632830|NCT01904721|7502600|FG006|Overall Study|Lack of Efficacy|1
4632831|NCT01904721|7502594|FG000|Overall Study|Adverse Event|0
4632832|NCT01904721|7502595|FG001|Overall Study|Adverse Event|0
4632833|NCT01904721|7502596|FG002|Overall Study|Adverse Event|0
4632834|NCT01904721|7502597|FG003|Overall Study|Adverse Event|0
4632835|NCT01904721|7502598|FG004|Overall Study|Adverse Event|3
4632836|NCT01904721|7502599|FG005|Overall Study|Adverse Event|1
4632837|NCT01904721|7502600|FG006|Overall Study|Adverse Event|0
4632838|NCT01904760|7502614|FG000|Overall Study|Protocol Violation|1
4632839|NCT01904760|7502615|FG001|Overall Study|Protocol Violation|0
4632840|NCT01904773|7502621|FG000|Screen|Screen failure|3
4632841|NCT01904773|7502622|FG001|Screen|Screen failure|0
4632842|NCT01904773|7502623|FG002|Screen|Screen failure|0
4632843|NCT01904773|7502624|FG003|Screen|Screen failure|0
4632844|NCT01904773|7502625|FG004|Screen|Screen failure|0
4632845|NCT01904773|7502626|FG005|Screen|Screen failure|0
4632846|NCT01904773|7502627|FG006|Screen|Screen failure|0
4632847|NCT01904773|7502628|FG007|Screen|Screen failure|0
4632848|NCT01904773|7502629|FG008|Screen|Screen failure|0
4632849|NCT01904773|7502621|FG000|Screen|Withdrawal by Subject|1
4632850|NCT01904773|7502622|FG001|Screen|Withdrawal by Subject|0
4632851|NCT01904773|7502623|FG002|Screen|Withdrawal by Subject|0
4632852|NCT01904773|7502624|FG003|Screen|Withdrawal by Subject|0
4632853|NCT01904773|7502625|FG004|Screen|Withdrawal by Subject|0
4632854|NCT01904773|7502626|FG005|Screen|Withdrawal by Subject|0
4632855|NCT01904773|7502627|FG006|Screen|Withdrawal by Subject|0
4632856|NCT01904773|7502628|FG007|Screen|Withdrawal by Subject|0
4632857|NCT01904773|7502629|FG008|Screen|Withdrawal by Subject|0
4632858|NCT01904773|7502621|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1
4632859|NCT01904773|7502622|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
4632860|NCT01904773|7502623|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
4632861|NCT01904773|7502624|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
4632862|NCT01904773|7502625|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
4632863|NCT01904773|7502626|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
4632864|NCT01904773|7502627|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
4632865|NCT01904773|7502628|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
4632866|NCT01904773|7502629|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
4540063|NCT01130532|7362718|FG001|Period IV (Weeks 13-16)|Adverse Event|0
4540064|NCT01130532|7362719|FG002|Period IV (Weeks 13-16)|Adverse Event|0
4540065|NCT01130532|7362720|FG003|Period IV (Weeks 13-16)|Adverse Event|1
4540066|NCT01130532|7362717|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
4540067|NCT01130532|7362718|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
4540068|NCT01130532|7362719|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
4540069|NCT01130532|7362720|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1
4632867|NCT01904773|7502621|FG000|First Intervention|Adverse Event|0
4632868|NCT01904773|7502622|FG001|First Intervention|Adverse Event|0
4632869|NCT01904773|7502623|FG002|First Intervention|Adverse Event|0
4518747|NCT00976209|7331019|FG000|Treatment Period 1|Other|0
4632870|NCT01904773|7502624|FG003|First Intervention|Adverse Event|0
4632871|NCT01904773|7502625|FG004|First Intervention|Adverse Event|0
4632872|NCT01904773|7502626|FG005|First Intervention|Adverse Event|0
4632873|NCT01904773|7502627|FG006|First Intervention|Adverse Event|1
4632874|NCT01904773|7502628|FG007|First Intervention|Adverse Event|0
4632875|NCT01904773|7502629|FG008|First Intervention|Adverse Event|0
4462784|NCT00593736|7253037|FG002|Screening Period and Placebo Run-in|Adverse Event|0
4462785|NCT00593736|7253038|FG003|Screening Period and Placebo Run-in|Adverse Event|3
4462786|NCT00593736|7253035|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0
4462787|NCT00593736|7253036|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0
4462788|NCT00593736|7253037|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0
4462789|NCT00593736|7253038|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9
4462790|NCT00593736|7253035|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0
4462791|NCT00593736|7253036|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0
4462792|NCT00593736|7253037|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0
4462793|NCT00593736|7253038|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43
4462794|NCT00593736|7253035|FG000|Screening Period and Placebo Run-in|Study Termination|0
4462795|NCT00593736|7253036|FG001|Screening Period and Placebo Run-in|Study Termination|0
4462796|NCT00593736|7253037|FG002|Screening Period and Placebo Run-in|Study Termination|0
4462797|NCT00593736|7253038|FG003|Screening Period and Placebo Run-in|Study Termination|15
4462798|NCT00593736|7253035|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
4462799|NCT00593736|7253036|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
4462800|NCT00593736|7253037|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
4462801|NCT00593736|7253038|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322
4462802|NCT00593736|7253035|FG000|Screening Period and Placebo Run-in|Various|0
4462803|NCT00593736|7253036|FG001|Screening Period and Placebo Run-in|Various|0
4462804|NCT00593736|7253037|FG002|Screening Period and Placebo Run-in|Various|0
4462805|NCT00593736|7253038|FG003|Screening Period and Placebo Run-in|Various|25
4462806|NCT00593736|7253035|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2
4462807|NCT00593736|7253036|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1
4462808|NCT00593736|7253037|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2
4462809|NCT00593736|7253038|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0
4462810|NCT00593736|7253035|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0
4462811|NCT00593736|7253036|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0
4462812|NCT00593736|7253037|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1
4462813|NCT00593736|7253038|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1
4462814|NCT00593736|7253035|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0
4462815|NCT00593736|7253036|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0
4462816|NCT00593736|7253037|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1
4462817|NCT00593736|7253038|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3
4462818|NCT00593736|7253035|FG000|Treatment Period and Placebo Run-out|Various|1
4462819|NCT00593736|7253036|FG001|Treatment Period and Placebo Run-out|Various|1
4462820|NCT00593736|7253037|FG002|Treatment Period and Placebo Run-out|Various|1
4462821|NCT00593736|7253038|FG003|Treatment Period and Placebo Run-out|Various|0
4462822|NCT00593814|7253050|FG000|Overall Study|Death|7
4462823|NCT00593814|7253051|FG001|Overall Study|Death|0
4462824|NCT00593814|7253050|FG000|Overall Study|Withdrawal by Subject|7
4462825|NCT00593814|7253051|FG001|Overall Study|Withdrawal by Subject|0
4462826|NCT00593814|7253050|FG000|Overall Study|Lost to Follow-up|7
4462827|NCT00593814|7253051|FG001|Overall Study|Lost to Follow-up|0
4462828|NCT00593814|7253050|FG000|Overall Study|Physician Decision|3
4462829|NCT00593814|7253051|FG001|Overall Study|Physician Decision|0
4462830|NCT00593827|7253059|FG000|Overall Study|On Active Treatment/Pending|0
4462831|NCT00593827|7253060|FG001|Overall Study|On Active Treatment/Pending|2
4462832|NCT00593840|7253066|FG000|Overall Study|Withdrawal by Subject|1
4462833|NCT00593918|7253076|FG000|Overall Study|Withdrawal by Subject|5
4462834|NCT00593918|7253077|FG001|Overall Study|Withdrawal by Subject|24
4462835|NCT00593957|7253086|FG000|Overall Study|Physician Decision|0
4462836|NCT00593957|7253087|FG001|Overall Study|Physician Decision|1
4462837|NCT00593957|7253088|FG002|Overall Study|Physician Decision|2
4462838|NCT00594035|7253125|FG000|Overall Study|Lost to Follow-up|1
4462839|NCT00594035|7253126|FG001|Overall Study|Lost to Follow-up|1
4462840|NCT00594035|7253125|FG000|Overall Study|Withdrawal by Subject|1
4462841|NCT00594035|7253126|FG001|Overall Study|Withdrawal by Subject|0
4462842|NCT00594035|7253125|FG000|Overall Study|Subject transferred to nursing home|0
4462843|NCT00594035|7253126|FG001|Overall Study|Subject transferred to nursing home|1
4462844|NCT00594035|7253125|FG000|Overall Study|Subject couldn't return due to job|0
4462845|NCT00594035|7253126|FG001|Overall Study|Subject couldn't return due to job|1
4462846|NCT00594100|7253136|FG000|Procedure|Technical Failure|9
4462847|NCT00594100|7253136|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2
4462848|NCT00594100|7253136|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6
4462849|NCT00594100|7253136|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4
4462850|NCT00594165|7253140|FG000|Overall Study|Major protocol violation|1
4462851|NCT00594165|7253140|FG000|Overall Study|Lack of Efficacy|12
4462852|NCT00594165|7253140|FG000|Overall Study|Adverse Event|52
4462853|NCT00594165|7253140|FG000|Overall Study|Unsatisfactory compliance of subject|6
4462854|NCT00594165|7253140|FG000|Overall Study|Subject withdrew consent|27
4462855|NCT00594165|7253140|FG000|Overall Study|Study ended per sponsor|102
4462856|NCT00594165|7253140|FG000|Overall Study|Lost to Follow-up|4
4462857|NCT00594165|7253140|FG000|Overall Study|Other: PI discretion|5
4462858|NCT00594165|7253140|FG000|Overall Study|Other: Subject moving|3
4462859|NCT00594165|7253140|FG000|Overall Study|Other: Brain surgery controlled symptoms|1
4462860|NCT00594165|7253140|FG000|Overall Study|Other: House bound; can't get to clinic|1
4462861|NCT00594165|7253140|FG000|Overall Study|Other: Subject enrolled in other trial|1
4462862|NCT00594165|7253140|FG000|Overall Study|Other: Site terminated participation|2
4462863|NCT00594178|7253144|FG000|Overall Study|Physician Decision|5
4462864|NCT00594204|7253150|FG000|Overall Study|Adverse Event|15
4462865|NCT00594204|7253151|FG001|Overall Study|Adverse Event|3
4462866|NCT00594204|7253150|FG000|Overall Study|Lost to Follow-up|9
4462867|NCT00594204|7253151|FG001|Overall Study|Lost to Follow-up|5
4462868|NCT00594204|7253150|FG000|Overall Study|Withdrawal by Subject|23
4462869|NCT00594204|7253151|FG001|Overall Study|Withdrawal by Subject|29
4462870|NCT00594204|7253150|FG000|Overall Study|Other|4
4462871|NCT00594204|7253151|FG001|Overall Study|Other|3
4462872|NCT00594204|7253150|FG000|Overall Study|Lack of Efficacy|3
4462873|NCT00594204|7253151|FG001|Overall Study|Lack of Efficacy|4
4462874|NCT00594204|7253150|FG000|Overall Study|Randomized but not treated|4
4462875|NCT00594204|7253151|FG001|Overall Study|Randomized but not treated|1
4516179|NCT00958568|7327506|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
4516180|NCT00958568|7327507|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
4516181|NCT00958568|7327504|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
4516182|NCT00958568|7327505|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9
4516183|NCT00958568|7327506|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
4516184|NCT00958568|7327507|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
4516185|NCT00958568|7327504|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
4516186|NCT00958568|7327505|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6
4516187|NCT00958568|7327506|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
4516188|NCT00958568|7327507|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
4516189|NCT00958568|7327504|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
4516190|NCT00958568|7327505|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5
4516191|NCT00958568|7327506|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
4516192|NCT00958568|7327507|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
4516193|NCT00958568|7327504|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
4516194|NCT00958568|7327505|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4
4540070|NCT01130532|7362717|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0
4540071|NCT01130532|7362718|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0
4540072|NCT01130532|7362719|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0
4540073|NCT01130532|7362720|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5
4540074|NCT01130532|7362717|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0
4540075|NCT01130532|7362718|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0
4615445|NCT03348930|7473790|FG000|Washout (1 Week)|Lost to Follow-up|1
4615446|NCT03348930|7473791|FG001|Washout (1 Week)|Lost to Follow-up|1
4615447|NCT03282240|7473800|FG000|Overall Study|Adverse Event|2
4540076|NCT01130532|7362719|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0
4540077|NCT01130532|7362720|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3
4540078|NCT01130597|7362732|FG000|Overall Study|Protocol-specified (High K+)|1
4540079|NCT01130597|7362732|FG000|Overall Study|Adverse Event|4
4540080|NCT01130597|7362732|FG000|Overall Study|Death|1
4540081|NCT01130597|7362732|FG000|Overall Study|Protocol Violation|1
4540082|NCT01130831|7362745|FG000|Overall Study|Withdrawal by Subject|7
4540083|NCT01130831|7362745|FG000|Overall Study|Death|4
4540084|NCT01130831|7362745|FG000|Overall Study|Information was missing|3
4540085|NCT01130883|7362777|FG000|Overall Study|Patient Noncompliance|6
4540086|NCT01130883|7362777|FG000|Overall Study|Reason Unknown|1
4540087|NCT01130883|7362777|FG000|Overall Study|Adverse Event|3
4540088|NCT01130974|7362787|FG000|Overall Study|Protocol Violation|10
4540089|NCT01130974|7362788|FG001|Overall Study|Protocol Violation|10
4540090|NCT01130974|7362787|FG000|Overall Study|Withdrawal by Subject|0
4540091|NCT01130974|7362788|FG001|Overall Study|Withdrawal by Subject|1
4540092|NCT01130974|7362787|FG000|Overall Study|Ineligibility criteria|5
4540093|NCT01130974|7362788|FG001|Overall Study|Ineligibility criteria|2
4540094|NCT01131078|7362811|FG000|Overall Study|Adverse Event|22
4540095|NCT01131078|7362812|FG001|Overall Study|Adverse Event|12
4540096|NCT01131078|7362813|FG002|Overall Study|Adverse Event|17
4540097|NCT01131078|7362811|FG000|Overall Study|Progressive Disease|58
4540098|NCT01131078|7362812|FG001|Overall Study|Progressive Disease|77
4540099|NCT01131078|7362813|FG002|Overall Study|Progressive Disease|71
4540100|NCT01131078|7362811|FG000|Overall Study|Protocol Violation|1
4540101|NCT01131078|7362812|FG001|Overall Study|Protocol Violation|0
4540102|NCT01131078|7362813|FG002|Overall Study|Protocol Violation|0
4540103|NCT01131078|7362811|FG000|Overall Study|Lost to Follow-up|1
4540104|NCT01131078|7362812|FG001|Overall Study|Lost to Follow-up|1
4540105|NCT01131078|7362813|FG002|Overall Study|Lost to Follow-up|1
4540106|NCT01131078|7362811|FG000|Overall Study|Withdrawal by Subject|2
4540107|NCT01131078|7362812|FG001|Overall Study|Withdrawal by Subject|4
4540108|NCT01131078|7362813|FG002|Overall Study|Withdrawal by Subject|3
4540109|NCT01131078|7362811|FG000|Overall Study|Non-compliance|3
4540110|NCT01131078|7362812|FG001|Overall Study|Non-compliance|0
4540111|NCT01131078|7362813|FG002|Overall Study|Non-compliance|0
4540112|NCT01131078|7362811|FG000|Overall Study|Physician Decision|10
4540113|NCT01131078|7362812|FG001|Overall Study|Physician Decision|6
4540114|NCT01131078|7362813|FG002|Overall Study|Physician Decision|8
4540115|NCT01131078|7362811|FG000|Overall Study|Death|4
4540116|NCT01131078|7362812|FG001|Overall Study|Death|0
4540117|NCT01131078|7362813|FG002|Overall Study|Death|2
4540118|NCT01131078|7362811|FG000|Overall Study|Other|0
4540119|NCT01131078|7362812|FG001|Overall Study|Other|1
4540120|NCT01131078|7362813|FG002|Overall Study|Other|0
4540121|NCT01131104|7362823|FG000|Overall Study|Withdrawal by Subject|3
4540122|NCT01131104|7362823|FG000|Overall Study|Physician Decision|4
4540123|NCT01131104|7362823|FG000|Overall Study|Information Not Available|5
4540124|NCT01131104|7362823|FG000|Overall Study|No Information on Index Date of Onset|1
4540125|NCT01131130|7362827|FG000|Period 1 - Baseline|Pregnancy|1
4540126|NCT01131130|7362827|FG000|Period 3- Crossover|+ Slit lamp finding|1
4540127|NCT01131182|7362837|FG000|Overall Study|Withdrawal by Subject|1
4462876|NCT00594386|7253175|FG000|Overall Study|Major protocol violation|2
4540128|NCT01131182|7362838|FG001|Overall Study|Withdrawal by Subject|1
4540129|NCT01131182|7362837|FG000|Overall Study|Lost to Follow-up|14
4540130|NCT01131182|7362838|FG001|Overall Study|Lost to Follow-up|15
4540131|NCT01131182|7362837|FG000|Overall Study|Other Reason|1
4540132|NCT01131182|7362838|FG001|Overall Study|Other Reason|0
4462877|NCT00594386|7253175|FG000|Overall Study|Lack of Efficacy|12
4462878|NCT00594386|7253175|FG000|Overall Study|Adverse Event|68
4462879|NCT00594386|7253175|FG000|Overall Study|Unsatisfactory compliance of subject|11
4462880|NCT00594386|7253175|FG000|Overall Study|Subject withdrew consent|35
4462881|NCT00594386|7253175|FG000|Overall Study|Study ended per sponsor|115
4462882|NCT00594386|7253175|FG000|Overall Study|Lost to Follow-up|6
4540133|NCT01131260|7362846|FG000|Overall Study|Randomization error|5
4540134|NCT01131260|7362847|FG001|Overall Study|Randomization error|1
4540135|NCT01131260|7362846|FG000|Overall Study|Declined to continue participation|8
4540136|NCT01131260|7362847|FG001|Overall Study|Declined to continue participation|13
4540137|NCT01131260|7362846|FG000|Overall Study|Physician Decision|22
4540138|NCT01131260|7362847|FG001|Overall Study|Physician Decision|24
4540139|NCT01131260|7362846|FG000|Overall Study|Technical problems|7
4540140|NCT01131260|7362847|FG001|Overall Study|Technical problems|6
4540141|NCT01131260|7362846|FG000|Overall Study|Staff error|2
4540142|NCT01131260|7362847|FG001|Overall Study|Staff error|1
4540143|NCT01131260|7362846|FG000|Overall Study|Ineligible|0
4540144|NCT01131260|7362847|FG001|Overall Study|Ineligible|2
4540145|NCT01131299|7362855|FG000|Overall Study|Withdrawal by Subject|4
4540146|NCT01131299|7362856|FG001|Overall Study|Withdrawal by Subject|7
4462883|NCT00594386|7253175|FG000|Overall Study|Other: Patient went off patch (hospital)|1
4462884|NCT00594386|7253175|FG000|Overall Study|Other: Subject moved to Seattle|1
4462885|NCT00594386|7253175|FG000|Overall Study|Other: Subject admitted to nursing home|1
4462886|NCT00594386|7253175|FG000|Overall Study|Other: Study terminated per investigator|2
4462887|NCT00594386|7253175|FG000|Overall Study|Other: Sponsor closure of study|1
4462888|NCT00594386|7253175|FG000|Overall Study|Other: Site terminated participation|1
4462889|NCT00594386|7253175|FG000|Overall Study|Other: Patient wants prescription Neupro|1
4462890|NCT00594386|7253175|FG000|Overall Study|Other: Loss of drivers license|1
4462891|NCT00594399|7253181|FG000|Initial 3 Month Counseling|Not ready to exercise|1
4462892|NCT00594399|7253182|FG001|Initial 3 Month Counseling|Not ready to exercise|0
4462893|NCT00594399|7253183|FG002|Initial 3 Month Counseling|Not ready to exercise|0
4462894|NCT00594399|7253181|FG000|Initial 3 Month Counseling|Lack of Interest|3
4462895|NCT00594399|7253182|FG001|Initial 3 Month Counseling|Lack of Interest|3
4462896|NCT00594399|7253183|FG002|Initial 3 Month Counseling|Lack of Interest|0
4462897|NCT00594399|7253181|FG000|Initial 3 Month Counseling|Personal issues|2
4462898|NCT00594399|7253182|FG001|Initial 3 Month Counseling|Personal issues|0
4462899|NCT00594399|7253183|FG002|Initial 3 Month Counseling|Personal issues|0
4462900|NCT00594399|7253181|FG000|Initial 3 Month Counseling|Too busy|7
4462901|NCT00594399|7253182|FG001|Initial 3 Month Counseling|Too busy|1
4462902|NCT00594399|7253183|FG002|Initial 3 Month Counseling|Too busy|0
4462903|NCT00594399|7253181|FG000|Initial 3 Month Counseling|Pain|2
4462904|NCT00594399|7253182|FG001|Initial 3 Month Counseling|Pain|0
4462905|NCT00594399|7253183|FG002|Initial 3 Month Counseling|Pain|0
4462906|NCT00594399|7253181|FG000|Initial 3 Month Counseling|Moved|1
4462907|NCT00594399|7253182|FG001|Initial 3 Month Counseling|Moved|0
4462908|NCT00594399|7253183|FG002|Initial 3 Month Counseling|Moved|0
4462909|NCT00594399|7253181|FG000|Initial 3 Month Counseling|Family illness|1
4540147|NCT01131312|7362864|FG000|Overall Study|Lost to Follow-up|425
4540148|NCT01131312|7362865|FG001|Overall Study|Lost to Follow-up|229
4540149|NCT01131312|7362866|FG002|Overall Study|Lost to Follow-up|351
4540150|NCT01131325|7362874|FG000|Overall Study|Adverse Event|1
4540151|NCT01131325|7362874|FG000|Overall Study|The participants discontinued the study as the study got terminated|2
4540152|NCT01131351|7362880|FG000|Overall Study|Adverse Event|0
4540153|NCT01131351|7362881|FG001|Overall Study|Adverse Event|2
4540154|NCT01131351|7362880|FG000|Overall Study|Protocol Deviation|0
4540155|NCT01131351|7362881|FG001|Overall Study|Protocol Deviation|1
4462910|NCT00594399|7253182|FG001|Initial 3 Month Counseling|Family illness|0
4462911|NCT00594399|7253183|FG002|Initial 3 Month Counseling|Family illness|0
4462912|NCT00594399|7253181|FG000|Rerandomization Arm 1 Only|Death|2
4462913|NCT00594399|7253182|FG001|Rerandomization Arm 1 Only|Death|1
4462914|NCT00594399|7253183|FG002|Rerandomization Arm 1 Only|Death|0
4462915|NCT00594399|7253181|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0
4462916|NCT00594399|7253182|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3
4462917|NCT00594399|7253183|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0
4462918|NCT00594464|7253202|FG000|Overall Study|Withdrawal by Subject|1
4462919|NCT00594464|7253202|FG000|Overall Study|Delay in operation|2
4462920|NCT00594516|7253212|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4
4462921|NCT00594516|7253213|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0
4462922|NCT00594516|7253214|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0
4462923|NCT00594516|7253212|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2
4462924|NCT00594516|7253213|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0
4462925|NCT00594516|7253214|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0
4462926|NCT00594516|7253212|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16
4462927|NCT00594516|7253213|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0
4462928|NCT00594516|7253214|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0
4462929|NCT00594516|7253212|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1
4462930|NCT00594516|7253213|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0
4462931|NCT00594516|7253214|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0
4462932|NCT00594516|7253212|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6
4462933|NCT00594516|7253213|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0
4462934|NCT00594516|7253214|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0
4462935|NCT00594516|7253212|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0
4462936|NCT00594516|7253213|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3
4462937|NCT00594516|7253214|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3
4462938|NCT00594516|7253212|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0
4462939|NCT00594516|7253213|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3
4462940|NCT00594516|7253214|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2
4462941|NCT00594516|7253212|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0
4462942|NCT00594516|7253213|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1
4462943|NCT00594516|7253214|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1
4462944|NCT00594516|7253212|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0
4462945|NCT00594516|7253213|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0
4462946|NCT00594516|7253214|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2
4462947|NCT00594568|7253221|FG000|Initial Treatment|Adverse Event|51
4462948|NCT00594568|7253222|FG001|Initial Treatment|Adverse Event|121
4462949|NCT00594568|7253223|FG002|Initial Treatment|Adverse Event|144
4462950|NCT00594568|7253221|FG000|Initial Treatment|Death|6
4462951|NCT00594568|7253222|FG001|Initial Treatment|Death|11
4462952|NCT00594568|7253223|FG002|Initial Treatment|Death|15
4462953|NCT00594568|7253221|FG000|Initial Treatment|Lost to Follow-up|4
4462954|NCT00594568|7253222|FG001|Initial Treatment|Lost to Follow-up|1
4462955|NCT00594568|7253223|FG002|Initial Treatment|Lost to Follow-up|4
4462956|NCT00594568|7253221|FG000|Initial Treatment|Physician Decision|3
4462957|NCT00594568|7253222|FG001|Initial Treatment|Physician Decision|2
4462958|NCT00594568|7253223|FG002|Initial Treatment|Physician Decision|4
4462959|NCT00594568|7253221|FG000|Initial Treatment|Protocol Violation|2
4462960|NCT00594568|7253222|FG001|Initial Treatment|Protocol Violation|2
4462961|NCT00594568|7253223|FG002|Initial Treatment|Protocol Violation|5
4462962|NCT00594568|7253221|FG000|Initial Treatment|Withdrawal by Subject|25
4462963|NCT00594568|7253222|FG001|Initial Treatment|Withdrawal by Subject|31
4462964|NCT00594568|7253223|FG002|Initial Treatment|Withdrawal by Subject|46
4462965|NCT00594568|7253221|FG000|Initial Treatment|Sponsor decision|193
4462966|NCT00594568|7253222|FG001|Initial Treatment|Sponsor decision|142
4462967|NCT00594568|7253223|FG002|Initial Treatment|Sponsor decision|147
4462968|NCT00594568|7253221|FG000|Initial Treatment|Caregiver decision|21
4462969|NCT00594568|7253222|FG001|Initial Treatment|Caregiver decision|36
4462970|NCT00594568|7253223|FG002|Initial Treatment|Caregiver decision|36
4462971|NCT00594568|7253221|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7
4462972|NCT00594568|7253222|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7
4462973|NCT00594568|7253223|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6
4462974|NCT00594568|7253221|FG000|Initial Treatment|Entry criteria exclusion|0
4462975|NCT00594568|7253222|FG001|Initial Treatment|Entry criteria exclusion|1
4462976|NCT00594568|7253223|FG002|Initial Treatment|Entry criteria exclusion|1
4462977|NCT00594568|7253221|FG000|Delayed Start|Death|0
4462978|NCT00594568|7253222|FG001|Delayed Start|Death|0
4462979|NCT00594568|7253223|FG002|Delayed Start|Death|1
4462980|NCT00594568|7253221|FG000|Delayed Start|Adverse Event|12
4462981|NCT00594568|7253222|FG001|Delayed Start|Adverse Event|2
4462982|NCT00594568|7253223|FG002|Delayed Start|Adverse Event|2
4462983|NCT00594568|7253221|FG000|Delayed Start|Withdrawal by Subject|4
4462984|NCT00594568|7253222|FG001|Delayed Start|Withdrawal by Subject|3
4462985|NCT00594568|7253223|FG002|Delayed Start|Withdrawal by Subject|0
4462986|NCT00594568|7253221|FG000|Delayed Start|Physician Decision|0
4462987|NCT00594568|7253222|FG001|Delayed Start|Physician Decision|0
4462988|NCT00594568|7253223|FG002|Delayed Start|Physician Decision|1
4462989|NCT00594568|7253221|FG000|Delayed Start|Lost to Follow-up|0
4462990|NCT00594568|7253222|FG001|Delayed Start|Lost to Follow-up|0
4462991|NCT00594568|7253223|FG002|Delayed Start|Lost to Follow-up|1
4462992|NCT00594568|7253221|FG000|Delayed Start|Caregiver Decision|5
4462993|NCT00594568|7253222|FG001|Delayed Start|Caregiver Decision|6
4462994|NCT00594568|7253223|FG002|Delayed Start|Caregiver Decision|2
4462995|NCT00594568|7253221|FG000|Delayed Start|Sponsor Decision|77
4462996|NCT00594568|7253222|FG001|Delayed Start|Sponsor Decision|66
4462997|NCT00594568|7253223|FG002|Delayed Start|Sponsor Decision|59
4462998|NCT00594568|7253221|FG000|Safety Follow Up (SFU)-Optional|Death|0
4462999|NCT00594568|7253222|FG001|Safety Follow Up (SFU)-Optional|Death|1
4463000|NCT00594568|7253223|FG002|Safety Follow Up (SFU)-Optional|Death|0
4615448|NCT03282240|7473801|FG001|Overall Study|Adverse Event|2
4615449|NCT03282240|7473802|FG002|Overall Study|Adverse Event|0
4615450|NCT03282240|7473800|FG000|Overall Study|Lost to Follow-up|3
4615451|NCT03282240|7473801|FG001|Overall Study|Lost to Follow-up|0
4615452|NCT03282240|7473802|FG002|Overall Study|Lost to Follow-up|0
4615453|NCT03282240|7473800|FG000|Overall Study|Protocol Deviation|4
4615454|NCT03282240|7473801|FG001|Overall Study|Protocol Deviation|1
4615455|NCT03282240|7473802|FG002|Overall Study|Protocol Deviation|2
4615456|NCT03282240|7473800|FG000|Overall Study|Withdrawal by Subject|1
4615457|NCT03282240|7473801|FG001|Overall Study|Withdrawal by Subject|0
4615458|NCT03282240|7473802|FG002|Overall Study|Withdrawal by Subject|1
4615459|NCT03260868|7473815|FG000|Overall Study|Poor Compliance to Protocol|0
4615460|NCT03260868|7473816|FG001|Overall Study|Poor Compliance to Protocol|2
4615461|NCT03260868|7473815|FG000|Overall Study|Study Terminated By Sponsor|2
4615462|NCT03260868|7473816|FG001|Overall Study|Study Terminated By Sponsor|1
4615463|NCT03260868|7473815|FG000|Overall Study|Other than specified above|1
4615464|NCT03260868|7473816|FG001|Overall Study|Other than specified above|0
4615465|NCT03164616|7473834|FG000|Overall Study|Death|250
4615466|NCT03164616|7473835|FG001|Overall Study|Death|264
4615467|NCT03164616|7473836|FG002|Overall Study|Death|279
4615468|NCT03164616|7473834|FG000|Overall Study|Lost to Follow-up|2
4615469|NCT03164616|7473835|FG001|Overall Study|Lost to Follow-up|2
4615470|NCT03164616|7473836|FG002|Overall Study|Lost to Follow-up|2
4615471|NCT03164616|7473834|FG000|Overall Study|Withdrawal by Subject|6
4615472|NCT03164616|7473835|FG001|Overall Study|Withdrawal by Subject|7
4615473|NCT03164616|7473836|FG002|Overall Study|Withdrawal by Subject|16
4615474|NCT03157037|7473846|FG000|Overall Study|Death|1
4615475|NCT03128931|7473870|FG000|Overall Study|Physician Decision|1
4615476|NCT03128931|7473870|FG000|Overall Study|Equipment Issues|3
4615477|NCT02611960|7473876|FG000|Overall Study|COVID-19 Association Unspecified Adverse Event|7
4615478|NCT02611960|7473877|FG001|Overall Study|COVID-19 Association Unspecified Adverse Event|8
4615479|NCT02611960|7473876|FG000|Overall Study|Death|87
4615480|NCT02611960|7473877|FG001|Overall Study|Death|85
4615481|NCT02611960|7473876|FG000|Overall Study|Withdrawal by Subject|0
4615482|NCT02611960|7473877|FG001|Overall Study|Withdrawal by Subject|1
4615483|NCT02611960|7473876|FG000|Overall Study|COVID-19 Association Unspecified Withdrawal By Participant|1
4615484|NCT02611960|7473877|FG001|Overall Study|COVID-19 Association Unspecified Withdrawal By Participant|4
4615485|NCT02611960|7473876|FG000|Overall Study|Participants Ongoing|22
4615486|NCT02611960|7473877|FG001|Overall Study|Participants Ongoing|18
4632876|NCT01904773|7502621|FG000|Placebo Washout First Intervention|Condition worsened|0
4632877|NCT01904773|7502622|FG001|Placebo Washout First Intervention|Condition worsened|1
4632878|NCT01904773|7502623|FG002|Placebo Washout First Intervention|Condition worsened|0
4632879|NCT01904773|7502624|FG003|Placebo Washout First Intervention|Condition worsened|0
4632880|NCT01904773|7502625|FG004|Placebo Washout First Intervention|Condition worsened|0
4632881|NCT01904773|7502626|FG005|Placebo Washout First Intervention|Condition worsened|0
4632882|NCT01904773|7502627|FG006|Placebo Washout First Intervention|Condition worsened|0
4632883|NCT01904773|7502628|FG007|Placebo Washout First Intervention|Condition worsened|0
4632884|NCT01904773|7502629|FG008|Placebo Washout First Intervention|Condition worsened|0
4632885|NCT01904773|7502621|FG000|Fifth Intervention|Adverse Event|0
4632886|NCT01904773|7502622|FG001|Fifth Intervention|Adverse Event|0
4632887|NCT01904773|7502623|FG002|Fifth Intervention|Adverse Event|0
4632888|NCT01904773|7502624|FG003|Fifth Intervention|Adverse Event|0
4632889|NCT01904773|7502625|FG004|Fifth Intervention|Adverse Event|0
4632890|NCT01904773|7502626|FG005|Fifth Intervention|Adverse Event|0
4632891|NCT01904773|7502627|FG006|Fifth Intervention|Adverse Event|0
4632892|NCT01904773|7502628|FG007|Fifth Intervention|Adverse Event|1
4632893|NCT01904773|7502629|FG008|Fifth Intervention|Adverse Event|0
4632894|NCT01904773|7502621|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
4632895|NCT01904773|7502622|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1
4463001|NCT00594568|7253221|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5
4463002|NCT00594568|7253222|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0
4518748|NCT00976209|7331020|FG001|Treatment Period 1|Other|1
4632896|NCT01904773|7502623|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
4632897|NCT01904773|7502624|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
4632898|NCT01904773|7502625|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
4632899|NCT01904773|7502626|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
4632900|NCT01904773|7502627|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
4463003|NCT00594568|7253223|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0
4463004|NCT00594568|7253221|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12
4463005|NCT00594568|7253222|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15
4463006|NCT00594568|7253223|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13
4463007|NCT00594568|7253221|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2
4463008|NCT00594568|7253222|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1
4463009|NCT00594568|7253223|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2
4463010|NCT00594568|7253221|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17
4463011|NCT00594568|7253222|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16
4463012|NCT00594568|7253223|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9
4463013|NCT00594568|7253221|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25
4463014|NCT00594568|7253222|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22
4463015|NCT00594568|7253223|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18
4463016|NCT00594646|7253239|FG000|Overall Study|Withdrawal by Subject|1
4463017|NCT00594646|7253239|FG000|Overall Study|Lost to Follow-up|15
4540156|NCT01131494|7362887|FG000|Overall Study|Withdrawal by Subject|2
4540157|NCT01131507|7362892|FG000|Overall Study|Adverse Event|1
4540158|NCT01131507|7362892|FG000|Overall Study|Lost to Follow-up|1
4540159|NCT01131507|7362892|FG000|Overall Study|Withdrawal by Subject|1
4540160|NCT01131520|7362898|FG000|Overall Study|Computer problem|1
4540161|NCT01131520|7362899|FG001|Overall Study|Computer problem|0
4540162|NCT01131520|7362898|FG000|Overall Study|Counselor not available|0
4540163|NCT01131520|7362899|FG001|Overall Study|Counselor not available|3
4540164|NCT01131520|7362898|FG000|Overall Study|Subject changed history after enrollment|0
4540165|NCT01131520|7362899|FG001|Overall Study|Subject changed history after enrollment|1
4540166|NCT01131585|7362907|FG000|Overall Study|Adverse Event|0
4540167|NCT01131585|7362908|FG001|Overall Study|Adverse Event|2
4540168|NCT01131585|7362907|FG000|Overall Study|Abnormal laboratory value|1
4540169|NCT01131585|7362908|FG001|Overall Study|Abnormal laboratory value|0
4540170|NCT01131585|7362907|FG000|Overall Study|Unsatisfactory therapeutic effect|0
4540171|NCT01131585|7362908|FG001|Overall Study|Unsatisfactory therapeutic effect|3
4540172|NCT01131585|7362907|FG000|Overall Study|Protocol Violation|2
4540173|NCT01131585|7362908|FG001|Overall Study|Protocol Violation|1
4463018|NCT00594659|7253247|FG000|Overall Study|Lost to Follow-up|13
4463019|NCT00594659|7253248|FG001|Overall Study|Lost to Follow-up|9
4463020|NCT00594659|7253249|FG002|Overall Study|Lost to Follow-up|7
4463021|NCT00594815|7253261|FG000|Overall Study|Never Treated|3
4463022|NCT00594815|7253261|FG000|Overall Study|Withdrawal by Subject|2
4463023|NCT00594815|7253261|FG000|Overall Study|Toxicity|4
4463024|NCT00594854|7253267|FG000|Overall Study|Study terminated|7
4463025|NCT00594854|7253268|FG001|Overall Study|Study terminated|10
4463026|NCT00594880|7253276|FG000|Overall Study|Withdrawal by Subject|1
4463027|NCT00594880|7253277|FG001|Overall Study|Withdrawal by Subject|1
4463028|NCT00594880|7253276|FG000|Overall Study|Lost to Follow-up|1
4463029|NCT00594880|7253277|FG001|Overall Study|Lost to Follow-up|0
4463030|NCT00594906|7253289|FG000|Overall Study|Physician Decision|1
4463031|NCT00594906|7253290|FG001|Overall Study|Physician Decision|0
4463032|NCT00594906|7253289|FG000|Overall Study|Physician Decision|0
4463033|NCT00594906|7253290|FG001|Overall Study|Physician Decision|1
4463034|NCT00594906|7253289|FG000|Overall Study|Death|0
4463035|NCT00594906|7253290|FG001|Overall Study|Death|1
4540174|NCT01131585|7362907|FG000|Overall Study|Withdrawal by Subject|3
4540175|NCT01131585|7362908|FG001|Overall Study|Withdrawal by Subject|3
4540176|NCT01131585|7362907|FG000|Overall Study|Lost to Follow-up|0
4540177|NCT01131585|7362908|FG001|Overall Study|Lost to Follow-up|1
4540178|NCT01131585|7362907|FG000|Overall Study|Administrative problems|1
4540179|NCT01131585|7362908|FG001|Overall Study|Administrative problems|1
4540180|NCT01131585|7362907|FG000|Overall Study|Study termination|78
4540181|NCT01131585|7362908|FG001|Overall Study|Study termination|32
4540182|NCT01131676|7362917|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5
4540183|NCT01131676|7362918|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3
4540184|NCT01131676|7362919|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4
4540185|NCT01131676|7362917|FG000|Discontinuation From Treatment|Not treated|4
4540186|NCT01131676|7362918|FG001|Discontinuation From Treatment|Not treated|2
4540187|NCT01131676|7362919|FG002|Discontinuation From Treatment|Not treated|2
4540188|NCT01131676|7362917|FG000|Discontinuation From Treatment|Lack of Efficacy|11
4540189|NCT01131676|7362918|FG001|Discontinuation From Treatment|Lack of Efficacy|1
4540190|NCT01131676|7362919|FG002|Discontinuation From Treatment|Lack of Efficacy|0
4540191|NCT01131676|7362917|FG000|Discontinuation From Treatment|Non compliant with protocol|15
4463036|NCT00594932|7253298|FG000|First 3 Months|Withdrawal by Subject|1
4463037|NCT00594932|7253299|FG001|First 3 Months|Withdrawal by Subject|3
4463038|NCT00594932|7253298|FG000|Final 3 Months|Withdrawal by Subject|4
4463039|NCT00594932|7253299|FG001|Final 3 Months|Withdrawal by Subject|3
4540192|NCT01131676|7362918|FG001|Discontinuation From Treatment|Non compliant with protocol|15
4540193|NCT01131676|7362919|FG002|Discontinuation From Treatment|Non compliant with protocol|12
4540194|NCT01131676|7362917|FG000|Discontinuation From Treatment|Lost to Follow-up|15
4540195|NCT01131676|7362918|FG001|Discontinuation From Treatment|Lost to Follow-up|9
4463040|NCT00594958|7253319|FG000|Overall Study|Withdrawal by Subject|1
4463041|NCT00594958|7253320|FG001|Overall Study|Withdrawal by Subject|0
4463042|NCT00594958|7253321|FG002|Overall Study|Withdrawal by Subject|1
4463043|NCT00594958|7253319|FG000|Overall Study|Adverse Event|4
4463044|NCT00594958|7253320|FG001|Overall Study|Adverse Event|1
4463045|NCT00594958|7253321|FG002|Overall Study|Adverse Event|2
4463046|NCT00594958|7253319|FG000|Overall Study|Pregnancy|0
4463047|NCT00594958|7253320|FG001|Overall Study|Pregnancy|2
4463048|NCT00594958|7253321|FG002|Overall Study|Pregnancy|0
4463049|NCT00594958|7253319|FG000|Overall Study|Protocol Violation|1
4463050|NCT00594958|7253320|FG001|Overall Study|Protocol Violation|0
4463051|NCT00594958|7253321|FG002|Overall Study|Protocol Violation|2
4463052|NCT00594958|7253319|FG000|Overall Study|Lost to Follow-up|5
4463053|NCT00594958|7253320|FG001|Overall Study|Lost to Follow-up|0
4463054|NCT00594958|7253321|FG002|Overall Study|Lost to Follow-up|3
4463055|NCT00594958|7253319|FG000|Overall Study|administrative|3
4463056|NCT00594958|7253320|FG001|Overall Study|administrative|0
4463057|NCT00594958|7253321|FG002|Overall Study|administrative|2
4463058|NCT00595075|7253342|FG000|Overall Study|Withdrawal by Subject|1
4463059|NCT00595075|7253343|FG001|Overall Study|Withdrawal by Subject|0
4463060|NCT00595127|7253379|FG000|Overall Study|Death|6
4463061|NCT00595127|7253379|FG000|Overall Study|Relapsed|3
4463062|NCT00595127|7253379|FG000|Overall Study|joined another trial|1
4463063|NCT00595309|7253418|FG000|Overall Study|Lost to Follow-up|1
4463064|NCT00595309|7253418|FG000|Overall Study|planned vaccination against yellow fever|1
4463065|NCT00595309|7253418|FG000|Overall Study|acute infection after V0|1
4463066|NCT00595309|7253418|FG000|Overall Study|personal reason|1
4463067|NCT00595335|7253424|FG000|Baseline to Six Months|Withdrawal by Subject|0
4463068|NCT00595335|7253425|FG001|Baseline to Six Months|Withdrawal by Subject|1
4463069|NCT00595335|7253424|FG000|Baseline to Six Months|Disease Progression|1
4463070|NCT00595335|7253425|FG001|Baseline to Six Months|Disease Progression|1
4463071|NCT00595335|7253424|FG000|Baseline to Six Months|Adverse Event|1
4463072|NCT00595335|7253425|FG001|Baseline to Six Months|Adverse Event|0
4463073|NCT00595335|7253424|FG000|Six Months to Twelve Months|Withdrawal by Subject|0
4463074|NCT00595335|7253425|FG001|Six Months to Twelve Months|Withdrawal by Subject|1
4463075|NCT00595335|7253424|FG000|Six Months to Twelve Months|Disease Progression|1
4463076|NCT00595335|7253425|FG001|Six Months to Twelve Months|Disease Progression|0
4463077|NCT00595413|7253448|FG000|Overall Study|Adverse Event|0
4463078|NCT00595413|7253449|FG001|Overall Study|Adverse Event|2
4463079|NCT00595413|7253450|FG002|Overall Study|Adverse Event|1
4463080|NCT00595413|7253451|FG003|Overall Study|Adverse Event|1
4463081|NCT00595413|7253448|FG000|Overall Study|Lost to Follow-up|2
4463082|NCT00595413|7253449|FG001|Overall Study|Lost to Follow-up|2
4463083|NCT00595413|7253450|FG002|Overall Study|Lost to Follow-up|1
4463084|NCT00595413|7253451|FG003|Overall Study|Lost to Follow-up|3
4463085|NCT00595413|7253448|FG000|Overall Study|Death|0
4463086|NCT00595413|7253449|FG001|Overall Study|Death|0
4463087|NCT00595413|7253450|FG002|Overall Study|Death|1
4463088|NCT00595413|7253451|FG003|Overall Study|Death|0
4463089|NCT00595413|7253448|FG000|Overall Study|Other|5
4463090|NCT00595413|7253449|FG001|Overall Study|Other|1
4463091|NCT00595413|7253450|FG002|Overall Study|Other|5
4615487|NCT02498392|7473886|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7
4615488|NCT02498392|7473887|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0
4615489|NCT02498392|7473886|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3
4615490|NCT02498392|7473887|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0
4615491|NCT02498392|7473886|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0
4615492|NCT02498392|7473887|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2
4615493|NCT02498392|7473886|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0
4615494|NCT02498392|7473887|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2
4615495|NCT02498392|7473886|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2
4615496|NCT02498392|7473887|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3
4615497|NCT02498392|7473886|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1
4615498|NCT02498392|7473887|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3
4615499|NCT01899729|7473912|FG000|Overall Study|Adverse Event|1
4615500|NCT01899729|7473913|FG001|Overall Study|Adverse Event|0
4615501|NCT01899729|7473914|FG002|Overall Study|Adverse Event|0
4615502|NCT01899729|7473915|FG003|Overall Study|Adverse Event|0
4615503|NCT01899729|7473916|FG004|Overall Study|Adverse Event|1
4615504|NCT01899729|7473912|FG000|Overall Study|Withdrawal by Subject|1
4615505|NCT01899729|7473913|FG001|Overall Study|Withdrawal by Subject|2
4615506|NCT01899729|7473914|FG002|Overall Study|Withdrawal by Subject|0
4615507|NCT01899729|7473915|FG003|Overall Study|Withdrawal by Subject|0
4615508|NCT01899729|7473916|FG004|Overall Study|Withdrawal by Subject|0
4463092|NCT00595413|7253451|FG003|Overall Study|Other|0
4463093|NCT00595465|7253464|FG000|Overall Study|Adverse Event|4
4463094|NCT00595465|7253465|FG001|Overall Study|Adverse Event|3
4463095|NCT00595465|7253466|FG002|Overall Study|Adverse Event|3
4463096|NCT00595465|7253464|FG000|Overall Study|Pregnancy|0
4463097|NCT00595465|7253465|FG001|Overall Study|Pregnancy|0
4463098|NCT00595465|7253466|FG002|Overall Study|Pregnancy|1
4463099|NCT00595465|7253464|FG000|Overall Study|Protocol Violation|2
4463100|NCT00595465|7253465|FG001|Overall Study|Protocol Violation|1
4615509|NCT01899729|7473912|FG000|Overall Study|Lack of Efficacy|0
4615510|NCT01899729|7473913|FG001|Overall Study|Lack of Efficacy|0
4463101|NCT00595465|7253466|FG002|Overall Study|Protocol Violation|0
4615511|NCT01899729|7473914|FG002|Overall Study|Lack of Efficacy|2
4615512|NCT01899729|7473915|FG003|Overall Study|Lack of Efficacy|0
4615513|NCT01899729|7473916|FG004|Overall Study|Lack of Efficacy|1
4615514|NCT01648205|7473937|FG000|Placebo|Pregnancy|1
4463102|NCT00595465|7253464|FG000|Overall Study|Lost to Follow-up|0
4463103|NCT00595465|7253465|FG001|Overall Study|Lost to Follow-up|0
4463104|NCT00595465|7253466|FG002|Overall Study|Lost to Follow-up|2
4463105|NCT00595465|7253464|FG000|Overall Study|administrative reason|0
4463106|NCT00595465|7253465|FG001|Overall Study|administrative reason|0
4463107|NCT00595465|7253466|FG002|Overall Study|administrative reason|1
4463108|NCT00595478|7253476|FG000|36-week Follow-up Period|Lost to Follow-up|5
4463109|NCT00595478|7253477|FG001|36-week Follow-up Period|Lost to Follow-up|4
4463110|NCT00595478|7253476|FG000|36-week Follow-up Period|Withdrawal by Subject|4
4463111|NCT00595478|7253477|FG001|36-week Follow-up Period|Withdrawal by Subject|4
4463112|NCT00595504|7253485|FG000|Overall Study|Withdrawal by Subject|1
4463113|NCT00595504|7253486|FG001|Overall Study|Withdrawal by Subject|3
4463114|NCT00595504|7253485|FG000|Overall Study|Physician Decision|1
4463115|NCT00595504|7253486|FG001|Overall Study|Physician Decision|0
4463116|NCT00595517|7253492|FG000|Overall Study|Adverse Event|6
4463117|NCT00595517|7253492|FG000|Overall Study|Withdrawal by Subject|4
4463118|NCT00595517|7253492|FG000|Overall Study|Protocol Violation|2
4463119|NCT00595517|7253492|FG000|Overall Study|Recurrence of ulcer|5
4463120|NCT00595517|7253492|FG000|Overall Study|usage of prohibited treatment|1
4463121|NCT00595517|7253492|FG000|Overall Study|No intention to attend regularly|1
4463122|NCT00595621|7253512|FG000|Open Label Run in|Adverse Event|1
4463123|NCT00595621|7253513|FG001|Open Label Run in|Adverse Event|0
4463124|NCT00595621|7253512|FG000|Open Label Run in|Physician Decision|1
4463125|NCT00595621|7253513|FG001|Open Label Run in|Physician Decision|0
4463126|NCT00595621|7253512|FG000|Open Label Run in|Withdrawal by Subject|1
4463127|NCT00595621|7253513|FG001|Open Label Run in|Withdrawal by Subject|0
4463128|NCT00595621|7253512|FG000|Randomization and Study|Adverse Event|2
4463129|NCT00595621|7253513|FG001|Randomization and Study|Adverse Event|0
4463130|NCT00595621|7253512|FG000|Randomization and Study|Withdrawal by Subject|0
4463131|NCT00595621|7253513|FG001|Randomization and Study|Withdrawal by Subject|1
4463132|NCT00595764|7253522|FG000|Overall Study|Protocol Violation|24
4463133|NCT00595764|7253523|FG001|Overall Study|Protocol Violation|19
4463134|NCT00595764|7253522|FG000|Overall Study|Missed Medication >1 week|10
4463135|NCT00595764|7253523|FG001|Overall Study|Missed Medication >1 week|17
4463136|NCT00595764|7253522|FG000|Overall Study|Missed 3 PM visits|1
4463137|NCT00595764|7253523|FG001|Overall Study|Missed 3 PM visits|7
4463138|NCT00595764|7253522|FG000|Overall Study|Withdrawal by Subject|4
4463139|NCT00595764|7253523|FG001|Overall Study|Withdrawal by Subject|0
4463140|NCT00595868|7253544|FG000|Overall Study|Lost to Follow-up|45
4463141|NCT00595868|7253545|FG001|Overall Study|Lost to Follow-up|50
4463142|NCT00595959|7253565|FG000|Overall Study|Withdrawal by Subject|1
4463143|NCT00595959|7253565|FG000|Overall Study|Lost to Follow-up|1
4463144|NCT00596011|7253571|FG000|Overall Study|Withdrawal by Subject|2
4463145|NCT00596011|7253572|FG001|Overall Study|Withdrawal by Subject|3
4463146|NCT00596011|7253571|FG000|Overall Study|Adverse Event|11
4463147|NCT00596011|7253572|FG001|Overall Study|Adverse Event|7
4463148|NCT00596362|7253608|FG000|Overall Study|Progressive Disease|1
4463149|NCT00596427|7253614|FG000|Overall Study|Withdrawal by Subject|2
4463150|NCT00596427|7253615|FG001|Overall Study|Withdrawal by Subject|2
4463151|NCT00596427|7253614|FG000|Overall Study|Increased Fasting Triacylglycerol level|1
4463152|NCT00596427|7253615|FG001|Overall Study|Increased Fasting Triacylglycerol level|0
4463153|NCT00596427|7253614|FG000|Overall Study|Protocol Violation|1
4463154|NCT00596427|7253615|FG001|Overall Study|Protocol Violation|0
4463155|NCT00596466|7253640|FG000|Overall Study|Lack of Efficacy|5
4463156|NCT00596466|7253640|FG000|Overall Study|Adverse Event|4
4463157|NCT00596466|7253640|FG000|Overall Study|Withdrawal by Subject|2
4463158|NCT00596466|7253640|FG000|Overall Study|Protocol Violation|2
4463159|NCT00596466|7253640|FG000|Overall Study|Unpecified|2
4463160|NCT00596466|7253640|FG000|Overall Study|Enrolled, not treated|2
4463161|NCT00596635|7253659|FG000|Overall Study|Lost to Follow-up|0
4463162|NCT00596635|7253660|FG001|Overall Study|Lost to Follow-up|2
4463163|NCT00596635|7253661|FG002|Overall Study|Lost to Follow-up|0
4463164|NCT00596635|7253659|FG000|Overall Study|Treatment for symptomatic UTI|4
4463165|NCT00596635|7253660|FG001|Overall Study|Treatment for symptomatic UTI|6
4463166|NCT00596635|7253661|FG002|Overall Study|Treatment for symptomatic UTI|3
4463167|NCT00596635|7253659|FG000|Overall Study|Hip fracture|2
4463168|NCT00596635|7253660|FG001|Overall Study|Hip fracture|3
4463169|NCT00596635|7253661|FG002|Overall Study|Hip fracture|3
4463170|NCT00596635|7253659|FG000|Overall Study|Could not provide urine specimen|1
4463171|NCT00596635|7253660|FG001|Overall Study|Could not provide urine specimen|2
4463172|NCT00596635|7253661|FG002|Overall Study|Could not provide urine specimen|2
4463173|NCT00596687|7253671|FG000|Overall Study|< 24 hours of insulin treatment|8
4463174|NCT00596687|7253672|FG001|Overall Study|< 24 hours of insulin treatment|6
4463175|NCT00596687|7253671|FG000|Overall Study|continuous insulin infusion during TPN|2
4463176|NCT00596687|7253672|FG001|Overall Study|continuous insulin infusion during TPN|1
4463177|NCT00596687|7253671|FG000|Overall Study|Withdrawal by Subject|3
4615515|NCT01648205|7473937|FG000|Placebo|Withdrawal by Subject|1
4463178|NCT00596687|7253672|FG001|Overall Study|Withdrawal by Subject|1
4463179|NCT00596687|7253671|FG000|Overall Study|cancelled surgery|1
4463180|NCT00596687|7253672|FG001|Overall Study|cancelled surgery|1
4463181|NCT00596752|7253680|FG000|Overall Study|Other Reason|44
4463182|NCT00596752|7253681|FG001|Overall Study|Other Reason|49
4463183|NCT00596752|7253680|FG000|Overall Study|Adverse Event|34
4463184|NCT00596752|7253681|FG001|Overall Study|Adverse Event|34
4463185|NCT00596752|7253680|FG000|Overall Study|Lost to Follow-up|22
4463186|NCT00596752|7253681|FG001|Overall Study|Lost to Follow-up|38
4463187|NCT00596752|7253680|FG000|Overall Study|Withdrawal by Subject|12
4463188|NCT00596752|7253681|FG001|Overall Study|Withdrawal by Subject|9
4463189|NCT00596752|7253680|FG000|Overall Study|Unsatisfactory Compliance|9
4463190|NCT00596752|7253681|FG001|Overall Study|Unsatisfactory Compliance|6
4463191|NCT00596752|7253680|FG000|Overall Study|Lack of Efficacy|4
4463192|NCT00596752|7253681|FG001|Overall Study|Lack of Efficacy|7
4463193|NCT00596752|7253680|FG000|Overall Study|Protocol Violation|1
4463194|NCT00596752|7253681|FG001|Overall Study|Protocol Violation|0
4463195|NCT00596817|7253690|FG000|Open-label Period|Adverse Event|0
4463196|NCT00596817|7253691|FG001|Open-label Period|Adverse Event|49
4463197|NCT00596817|7253690|FG000|Open-label Period|Lack of Efficacy|0
4463198|NCT00596817|7253691|FG001|Open-label Period|Lack of Efficacy|33
4463199|NCT00596817|7253690|FG000|Open-label Period|Other Reasons|0
4540196|NCT01131676|7362919|FG002|Discontinuation From Treatment|Lost to Follow-up|6
4540197|NCT01131676|7362917|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172
4540198|NCT01131676|7362918|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118
4540199|NCT01131676|7362919|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122
4540200|NCT01131676|7362917|FG000|Discontinuation From Treatment|Other than those specified|162
4540201|NCT01131676|7362918|FG001|Discontinuation From Treatment|Other than those specified|142
4540202|NCT01131676|7362919|FG002|Discontinuation From Treatment|Other than those specified|125
4540203|NCT01131676|7362917|FG000|Discontinuation From Treatment|Adverse Event|303
4540204|NCT01131676|7362918|FG001|Discontinuation From Treatment|Adverse Event|267
4540205|NCT01131676|7362919|FG002|Discontinuation From Treatment|Adverse Event|273
4540206|NCT01131676|7362917|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23
4540207|NCT01131676|7362918|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35
4540208|NCT01131676|7362919|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25
4540209|NCT01131676|7362917|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8
4540210|NCT01131676|7362918|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6
4540211|NCT01131676|7362919|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5
4540212|NCT01131676|7362917|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20
4540213|NCT01131676|7362918|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21
4540214|NCT01131676|7362919|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19
4540215|NCT01131676|7362917|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5
4540216|NCT01131676|7362918|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9
4540217|NCT01131676|7362919|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7
4540218|NCT01131676|7362917|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7
4540219|NCT01131676|7362918|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6
4540220|NCT01131676|7362919|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5
4540221|NCT01131676|7362917|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4
4540222|NCT01131676|7362918|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4
4540223|NCT01131676|7362919|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2
4540224|NCT01132118|7362930|FG000|First Intervention (8 Weeks)|Adverse Event|1
4540225|NCT01132118|7362931|FG001|First Intervention (8 Weeks)|Adverse Event|0
4540226|NCT01132118|7362930|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2
4540227|NCT01132118|7362931|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3
4540228|NCT01132118|7362930|FG000|Second Intervention (8 Weeks)|Adverse Event|0
4540229|NCT01132118|7362931|FG001|Second Intervention (8 Weeks)|Adverse Event|1
4540230|NCT01132313|7362960|FG000|Overall Study|Lack of Efficacy|1
4540231|NCT01132313|7362961|FG001|Overall Study|Lack of Efficacy|0
4540232|NCT01132313|7362962|FG002|Overall Study|Lack of Efficacy|0
4540233|NCT01132313|7362963|FG003|Overall Study|Lack of Efficacy|0
4540234|NCT01132313|7362964|FG004|Overall Study|Lack of Efficacy|0
4540235|NCT01132313|7362965|FG005|Overall Study|Lack of Efficacy|0
4540236|NCT01132313|7362966|FG006|Overall Study|Lack of Efficacy|0
4540237|NCT01132313|7362967|FG007|Overall Study|Lack of Efficacy|3
4540238|NCT01132313|7362968|FG008|Overall Study|Lack of Efficacy|14
4540239|NCT01132313|7362969|FG009|Overall Study|Lack of Efficacy|16
4540240|NCT01132313|7362970|FG010|Overall Study|Lack of Efficacy|0
4540241|NCT01132313|7362971|FG011|Overall Study|Lack of Efficacy|0
4540242|NCT01132313|7362960|FG000|Overall Study|Not treated|2
4540243|NCT01132313|7362961|FG001|Overall Study|Not treated|0
4540244|NCT01132313|7362962|FG002|Overall Study|Not treated|0
4540245|NCT01132313|7362963|FG003|Overall Study|Not treated|0
4540246|NCT01132313|7362964|FG004|Overall Study|Not treated|2
4540247|NCT01132313|7362965|FG005|Overall Study|Not treated|1
4540248|NCT01132313|7362966|FG006|Overall Study|Not treated|3
4540249|NCT01132313|7362967|FG007|Overall Study|Not treated|0
4540250|NCT01132313|7362968|FG008|Overall Study|Not treated|0
4540251|NCT01132313|7362969|FG009|Overall Study|Not treated|0
4540252|NCT01132313|7362970|FG010|Overall Study|Not treated|0
4540253|NCT01132313|7362971|FG011|Overall Study|Not treated|0
4540254|NCT01132313|7362960|FG000|Overall Study|Adverse Event|0
4540255|NCT01132313|7362961|FG001|Overall Study|Adverse Event|0
4540256|NCT01132313|7362962|FG002|Overall Study|Adverse Event|4
4540257|NCT01132313|7362963|FG003|Overall Study|Adverse Event|10
4540258|NCT01132313|7362964|FG004|Overall Study|Adverse Event|19
4540259|NCT01132313|7362965|FG005|Overall Study|Adverse Event|6
4540260|NCT01132313|7362966|FG006|Overall Study|Adverse Event|5
4540261|NCT01132313|7362967|FG007|Overall Study|Adverse Event|3
4540262|NCT01132313|7362968|FG008|Overall Study|Adverse Event|7
4540263|NCT01132313|7362969|FG009|Overall Study|Adverse Event|2
4540264|NCT01132313|7362970|FG010|Overall Study|Adverse Event|0
4540265|NCT01132313|7362971|FG011|Overall Study|Adverse Event|0
4540266|NCT01132313|7362960|FG000|Overall Study|Protocol Violation|0
4540267|NCT01132313|7362961|FG001|Overall Study|Protocol Violation|0
4540268|NCT01132313|7362962|FG002|Overall Study|Protocol Violation|0
4540269|NCT01132313|7362963|FG003|Overall Study|Protocol Violation|1
4540270|NCT01132313|7362964|FG004|Overall Study|Protocol Violation|0
4540271|NCT01132313|7362965|FG005|Overall Study|Protocol Violation|0
4540272|NCT01132313|7362966|FG006|Overall Study|Protocol Violation|0
4540273|NCT01132313|7362967|FG007|Overall Study|Protocol Violation|0
4540274|NCT01132313|7362968|FG008|Overall Study|Protocol Violation|0
4540275|NCT01132313|7362969|FG009|Overall Study|Protocol Violation|0
4540276|NCT01132313|7362970|FG010|Overall Study|Protocol Violation|0
4540277|NCT01132313|7362971|FG011|Overall Study|Protocol Violation|0
4540278|NCT01132313|7362960|FG000|Overall Study|Lost to Follow-up|0
4540279|NCT01132313|7362961|FG001|Overall Study|Lost to Follow-up|0
4615516|NCT01648205|7473937|FG000|Placebo|Protocol Violation|2
4540280|NCT01132313|7362962|FG002|Overall Study|Lost to Follow-up|1
4540281|NCT01132313|7362963|FG003|Overall Study|Lost to Follow-up|0
4540282|NCT01132313|7362964|FG004|Overall Study|Lost to Follow-up|0
4540283|NCT01132313|7362965|FG005|Overall Study|Lost to Follow-up|0
4540284|NCT01132313|7362966|FG006|Overall Study|Lost to Follow-up|0
4540285|NCT01132313|7362967|FG007|Overall Study|Lost to Follow-up|1
4540286|NCT01132313|7362968|FG008|Overall Study|Lost to Follow-up|0
4540287|NCT01132313|7362969|FG009|Overall Study|Lost to Follow-up|0
4540288|NCT01132313|7362970|FG010|Overall Study|Lost to Follow-up|0
4540289|NCT01132313|7362971|FG011|Overall Study|Lost to Follow-up|0
4540290|NCT01132313|7362960|FG000|Overall Study|Withdrawal by Subject|0
4540291|NCT01132313|7362961|FG001|Overall Study|Withdrawal by Subject|0
4540292|NCT01132313|7362962|FG002|Overall Study|Withdrawal by Subject|3
4540293|NCT01132313|7362963|FG003|Overall Study|Withdrawal by Subject|3
4540294|NCT01132313|7362964|FG004|Overall Study|Withdrawal by Subject|6
4540295|NCT01132313|7362965|FG005|Overall Study|Withdrawal by Subject|0
4540296|NCT01132313|7362966|FG006|Overall Study|Withdrawal by Subject|1
4540297|NCT01132313|7362967|FG007|Overall Study|Withdrawal by Subject|0
4540298|NCT01132313|7362968|FG008|Overall Study|Withdrawal by Subject|0
4540299|NCT01132313|7362969|FG009|Overall Study|Withdrawal by Subject|2
4540300|NCT01132313|7362970|FG010|Overall Study|Withdrawal by Subject|0
4540301|NCT01132313|7362971|FG011|Overall Study|Withdrawal by Subject|0
4540302|NCT01132313|7362960|FG000|Overall Study|Lack of antiviral response|0
4540303|NCT01132313|7362961|FG001|Overall Study|Lack of antiviral response|0
4540304|NCT01132313|7362962|FG002|Overall Study|Lack of antiviral response|12
4540305|NCT01132313|7362963|FG003|Overall Study|Lack of antiviral response|18
4540306|NCT01132313|7362964|FG004|Overall Study|Lack of antiviral response|18
4540307|NCT01132313|7362965|FG005|Overall Study|Lack of antiviral response|18
4540308|NCT01132313|7362966|FG006|Overall Study|Lack of antiviral response|21
4540309|NCT01132313|7362967|FG007|Overall Study|Lack of antiviral response|0
4540310|NCT01132313|7362968|FG008|Overall Study|Lack of antiviral response|0
4540311|NCT01132313|7362969|FG009|Overall Study|Lack of antiviral response|0
4540312|NCT01132313|7362970|FG010|Overall Study|Lack of antiviral response|1
4540313|NCT01132313|7362971|FG011|Overall Study|Lack of antiviral response|0
4540314|NCT01132313|7362960|FG000|Overall Study|Other reason not defined above|0
4540315|NCT01132313|7362961|FG001|Overall Study|Other reason not defined above|0
4540316|NCT01132313|7362962|FG002|Overall Study|Other reason not defined above|0
4540317|NCT01132313|7362963|FG003|Overall Study|Other reason not defined above|0
4540318|NCT01132313|7362964|FG004|Overall Study|Other reason not defined above|0
4540319|NCT01132313|7362965|FG005|Overall Study|Other reason not defined above|0
4540320|NCT01132313|7362966|FG006|Overall Study|Other reason not defined above|0
4540321|NCT01132313|7362967|FG007|Overall Study|Other reason not defined above|1
4540322|NCT01132313|7362968|FG008|Overall Study|Other reason not defined above|0
4540323|NCT01132313|7362969|FG009|Overall Study|Other reason not defined above|0
4540324|NCT01132313|7362970|FG010|Overall Study|Other reason not defined above|0
4540325|NCT01132313|7362971|FG011|Overall Study|Other reason not defined above|0
4540326|NCT01132326|7363002|FG000|Overall Study|Lack of Efficacy|25
4540327|NCT01132326|7363002|FG000|Overall Study|Adverse Event|37
4540328|NCT01132326|7363002|FG000|Overall Study|Protocol Violation|1
4540329|NCT01132326|7363002|FG000|Overall Study|Lost to Follow-up|16
4540330|NCT01132326|7363002|FG000|Overall Study|Withdrawal by Subject|40
4540331|NCT01132326|7363002|FG000|Overall Study|Physician Decision|10
4540332|NCT01132326|7363002|FG000|Overall Study|Study Termination|80
4540333|NCT01132326|7363002|FG000|Overall Study|Declining Health|1
4540334|NCT01132326|7363002|FG000|Overall Study|Pregnancy|1
4540335|NCT01132326|7363002|FG000|Overall Study|Caregiver Withdrew Consent|1
4540336|NCT01132326|7363002|FG000|Overall Study|Death|5
4540337|NCT01132326|7363002|FG000|Overall Study|Subject Unable to Come To Visits|1
4540338|NCT01132482|7363013|FG000|Overall Study|Adverse Event|1
4540339|NCT01132482|7363014|FG001|Overall Study|Adverse Event|0
4540340|NCT01132495|7363024|FG000|Overall Study|Various reasons|40
4540341|NCT01132495|7363025|FG001|Overall Study|Various reasons|38
4540342|NCT01132495|7363026|FG002|Overall Study|Various reasons|20
4540343|NCT01132495|7363027|FG003|Overall Study|Various reasons|12
4540344|NCT01132547|7363044|FG000|Overall Study|Withdrawal by Subject|3
4540345|NCT01132547|7363045|FG001|Overall Study|Withdrawal by Subject|1
4540346|NCT01132547|7363044|FG000|Overall Study|Death|1
4540347|NCT01132547|7363045|FG001|Overall Study|Death|0
4540348|NCT01132612|7363054|FG000|Overall Study|Death|0
4540349|NCT01132612|7363055|FG001|Overall Study|Death|0
4540350|NCT01132612|7363056|FG002|Overall Study|Death|1
4540351|NCT01132612|7363054|FG000|Overall Study|Protocol deviation|0
4540352|NCT01132612|7363055|FG001|Overall Study|Protocol deviation|0
4540353|NCT01132612|7363056|FG002|Overall Study|Protocol deviation|3
4540354|NCT01132612|7363054|FG000|Overall Study|Lost to Follow-up|2
4540355|NCT01132612|7363055|FG001|Overall Study|Lost to Follow-up|2
4540356|NCT01132612|7363056|FG002|Overall Study|Lost to Follow-up|7
4540357|NCT01132612|7363054|FG000|Overall Study|Adverse Event|5
4540358|NCT01132612|7363055|FG001|Overall Study|Adverse Event|2
4540359|NCT01132612|7363056|FG002|Overall Study|Adverse Event|15
4540360|NCT01132612|7363054|FG000|Overall Study|Withdrawal by Subject|5
4540361|NCT01132612|7363055|FG001|Overall Study|Withdrawal by Subject|8
4540362|NCT01132612|7363056|FG002|Overall Study|Withdrawal by Subject|19
4540363|NCT01132612|7363054|FG000|Overall Study|Administrative problems|5
4540364|NCT01132612|7363055|FG001|Overall Study|Administrative problems|1
4540365|NCT01132612|7363056|FG002|Overall Study|Administrative problems|52
4540366|NCT01132612|7363054|FG000|Overall Study|Lack of Efficacy|23
4540367|NCT01132612|7363055|FG001|Overall Study|Lack of Efficacy|22
4540368|NCT01132612|7363056|FG002|Overall Study|Lack of Efficacy|73
4540369|NCT01132651|7363066|FG000|Overall Study|Lost to Follow-up|1
4540370|NCT01132651|7363067|FG001|Overall Study|Lost to Follow-up|1
4540371|NCT01132664|7363078|FG000|Phase lb|Adverse Event|0
4540372|NCT01132664|7363079|FG001|Phase lb|Adverse Event|1
4540373|NCT01132664|7363080|FG002|Phase lb|Adverse Event|0
4540374|NCT01132664|7363081|FG003|Phase lb|Adverse Event|0
4540375|NCT01132664|7363082|FG004|Phase lb|Adverse Event|0
4540376|NCT01132664|7363078|FG000|Phase lb|Withdrawal by Subject|1
4540377|NCT01132664|7363079|FG001|Phase lb|Withdrawal by Subject|2
4540378|NCT01132664|7363080|FG002|Phase lb|Withdrawal by Subject|0
4540379|NCT01132664|7363081|FG003|Phase lb|Withdrawal by Subject|0
4540380|NCT01132664|7363082|FG004|Phase lb|Withdrawal by Subject|0
4540381|NCT01132664|7363078|FG000|Phase lb|Disease Progression|4
4540382|NCT01132664|7363079|FG001|Phase lb|Disease Progression|9
4540383|NCT01132664|7363080|FG002|Phase lb|Disease Progression|0
4540384|NCT01132664|7363081|FG003|Phase lb|Disease Progression|0
4540385|NCT01132664|7363082|FG004|Phase lb|Disease Progression|0
4540386|NCT01132664|7363078|FG000|Phase ll|Death|0
4540387|NCT01132664|7363079|FG001|Phase ll|Death|0
4540388|NCT01132664|7363080|FG002|Phase ll|Death|2
4540389|NCT01132664|7363081|FG003|Phase ll|Death|0
4540390|NCT01132664|7363082|FG004|Phase ll|Death|0
4540391|NCT01132664|7363078|FG000|Phase ll|Adverse Event|0
4540392|NCT01132664|7363079|FG001|Phase ll|Adverse Event|0
4540393|NCT01132664|7363080|FG002|Phase ll|Adverse Event|10
4540394|NCT01132664|7363081|FG003|Phase ll|Adverse Event|0
4540395|NCT01132664|7363082|FG004|Phase ll|Adverse Event|0
4540396|NCT01132664|7363078|FG000|Phase ll|Withdrawal by Subject|0
4540397|NCT01132664|7363079|FG001|Phase ll|Withdrawal by Subject|0
4540398|NCT01132664|7363080|FG002|Phase ll|Withdrawal by Subject|3
4540399|NCT01132664|7363081|FG003|Phase ll|Withdrawal by Subject|0
4540400|NCT01132664|7363082|FG004|Phase ll|Withdrawal by Subject|0
4540401|NCT01132664|7363078|FG000|Phase ll|Disease progression|0
4540402|NCT01132664|7363079|FG001|Phase ll|Disease progression|0
4540403|NCT01132664|7363080|FG002|Phase ll|Disease progression|35
4540404|NCT01132664|7363081|FG003|Phase ll|Disease progression|0
4540405|NCT01132664|7363082|FG004|Phase ll|Disease progression|0
4540406|NCT01132664|7363078|FG000|BM Cohort|Disease progression|0
4540407|NCT01132664|7363079|FG001|BM Cohort|Disease progression|0
4540408|NCT01132664|7363080|FG002|BM Cohort|Disease progression|0
4540409|NCT01132664|7363081|FG003|BM Cohort|Disease progression|3
4540410|NCT01132664|7363082|FG004|BM Cohort|Disease progression|4
4540411|NCT01132664|7363078|FG000|BM Cohort|Adverse Event|0
4540412|NCT01132664|7363079|FG001|BM Cohort|Adverse Event|0
4540413|NCT01132664|7363080|FG002|BM Cohort|Adverse Event|0
4540414|NCT01132664|7363081|FG003|BM Cohort|Adverse Event|0
4540415|NCT01132664|7363082|FG004|BM Cohort|Adverse Event|1
4540416|NCT01132664|7363078|FG000|BM Cohort|Withdrawal by Subject|0
4540417|NCT01132664|7363079|FG001|BM Cohort|Withdrawal by Subject|0
4540418|NCT01132664|7363080|FG002|BM Cohort|Withdrawal by Subject|0
4540419|NCT01132664|7363081|FG003|BM Cohort|Withdrawal by Subject|0
4540420|NCT01132664|7363082|FG004|BM Cohort|Withdrawal by Subject|1
4540421|NCT01132755|7363103|FG000|Overall Study|Procedure not done due to medical reason|23
4540422|NCT01132755|7363103|FG000|Overall Study|Protocol Violation|15
4540423|NCT01132755|7363103|FG000|Overall Study|Withdrawal by Subject|4
4540424|NCT01132807|7363107|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9
4540425|NCT01132807|7363108|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0
4540426|NCT01132807|7363109|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0
4540427|NCT01132807|7363107|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6
4540428|NCT01132807|7363108|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0
4540429|NCT01132807|7363109|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0
4540430|NCT01132820|7363117|FG000|Overall Study|Ineligible: wrong cell type|1
4540431|NCT01132820|7363117|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1
4615517|NCT01648205|7473937|FG000|Ranolazine|Death|1
4615518|NCT01648205|7473937|FG000|Ranolazine|Withdrawal by Subject|1
4615519|NCT01648205|7473937|FG000|Ranolazine|Protocol Violation|3
4615520|NCT01622088|7473945|FG000|Overall Study|Adverse Event|20
4463200|NCT00596817|7253691|FG001|Open-label Period|Other Reasons|65
4463201|NCT00596817|7253690|FG000|Open-label Period to Double-blind Period|Adverse Event|0
4463202|NCT00596817|7253691|FG001|Open-label Period to Double-blind Period|Adverse Event|5
4463203|NCT00596817|7253690|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0
4463204|NCT00596817|7253691|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24
4463205|NCT00596817|7253690|FG000|Open-label Period to Double-blind Period|Not Eligible|0
4463206|NCT00596817|7253691|FG001|Open-label Period to Double-blind Period|Not Eligible|49
4463207|NCT00596817|7253690|FG000|Open-label Period to Double-blind Period|Other Reasons|0
4463208|NCT00596817|7253691|FG001|Open-label Period to Double-blind Period|Other Reasons|14
4463209|NCT00596817|7253690|FG000|Double-blind Period|Adverse Event|5
4463210|NCT00596817|7253691|FG001|Double-blind Period|Adverse Event|16
4463211|NCT00596817|7253690|FG000|Double-blind Period|Lack of Efficacy|52
4463212|NCT00596817|7253691|FG001|Double-blind Period|Lack of Efficacy|28
4463213|NCT00596817|7253690|FG000|Double-blind Period|Non-compliance With Study Product|3
4463214|NCT00596817|7253691|FG001|Double-blind Period|Non-compliance With Study Product|4
4463215|NCT00596817|7253690|FG000|Double-blind Period|Protocol Violation|11
4463216|NCT00596817|7253691|FG001|Double-blind Period|Protocol Violation|8
4463217|NCT00596817|7253690|FG000|Double-blind Period|Withdrawal of Consent|7
4463218|NCT00596817|7253691|FG001|Double-blind Period|Withdrawal of Consent|3
4463219|NCT00596817|7253690|FG000|Double-blind Period|Lost to Follow-up|0
4463220|NCT00596817|7253691|FG001|Double-blind Period|Lost to Follow-up|2
4463221|NCT00596817|7253690|FG000|Double-blind Period|Other Reasons|10
4463222|NCT00596817|7253691|FG001|Double-blind Period|Other Reasons|18
4463223|NCT00596830|7253700|FG000|Overall Study|Death|258
4463224|NCT00596830|7253701|FG001|Overall Study|Death|247
4463225|NCT00596830|7253700|FG000|Overall Study|Lost to Follow-up|7
4463226|NCT00596830|7253701|FG001|Overall Study|Lost to Follow-up|11
4463227|NCT00596830|7253700|FG000|Overall Study|Withdrawal by Subject|22
4463228|NCT00596830|7253701|FG001|Overall Study|Withdrawal by Subject|12
4463229|NCT00596830|7253700|FG000|Overall Study|Study terminated by sponsor|51
4463230|NCT00596830|7253701|FG001|Overall Study|Study terminated by sponsor|62
4463231|NCT00596830|7253700|FG000|Overall Study|Follow-up was discontinued|1
4463232|NCT00596830|7253701|FG001|Overall Study|Follow-up was discontinued|0
4463233|NCT00596830|7253700|FG000|Overall Study|Randomized but not treated|3
4463234|NCT00596830|7253701|FG001|Overall Study|Randomized but not treated|7
4463235|NCT00596934|7253707|FG000|Overall Study|Protocol Violation|1
4463236|NCT00596934|7253707|FG000|Overall Study|Withdrawal by Subject|1
4463237|NCT00596960|7253715|FG000|Overall Study|Death|1
4463238|NCT00596960|7253716|FG001|Overall Study|Death|2
4463239|NCT00596960|7253715|FG000|Overall Study|Lost to Follow-up|6
4463240|NCT00596960|7253716|FG001|Overall Study|Lost to Follow-up|5
4463241|NCT00596960|7253715|FG000|Overall Study|Withdrawal by Subject|1
4463242|NCT00596960|7253716|FG001|Overall Study|Withdrawal by Subject|0
4463243|NCT00596960|7253715|FG000|Overall Study|Incarcerated|2
4615521|NCT01622088|7473945|FG000|Overall Study|Lost to Follow-up|1
4615522|NCT01622088|7473945|FG000|Overall Study|Withdrawal by Subject|20
4615523|NCT01622088|7473945|FG000|Overall Study|Investigator Decision|1
4615524|NCT01622088|7473945|FG000|Overall Study|Death|53
4615525|NCT01622088|7473945|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521
4615526|NCT01063517|7473965|FG000|Overall Study|Consent withdrawal|1
4463244|NCT00596960|7253716|FG001|Overall Study|Incarcerated|0
4463245|NCT00596960|7253715|FG000|Overall Study|Physician Decision|1
4463246|NCT00596960|7253716|FG001|Overall Study|Physician Decision|0
4463247|NCT00596960|7253715|FG000|Overall Study|Protocol Violation|0
4463248|NCT00596960|7253716|FG001|Overall Study|Protocol Violation|1
4463249|NCT00596960|7253715|FG000|Overall Study|No alcohol use data|0
4463250|NCT00596960|7253716|FG001|Overall Study|No alcohol use data|1
4463251|NCT00597012|7253724|FG000|Overall Study|Death|1
4615527|NCT01063517|7473966|FG001|Overall Study|Consent withdrawal|0
4615528|NCT01063517|7473965|FG000|Overall Study|Study reached data cut-off|19
4615529|NCT01063517|7473966|FG001|Overall Study|Study reached data cut-off|7
4463252|NCT00597012|7253725|FG001|Overall Study|Death|1
4463253|NCT00597012|7253724|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3
4463254|NCT00597012|7253725|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1
4463255|NCT00597012|7253724|FG000|Overall Study|Withdrawal by Subject|7
4463256|NCT00597012|7253725|FG001|Overall Study|Withdrawal by Subject|4
4463257|NCT00597012|7253724|FG000|Overall Study|Ineligible|2
4615530|NCT01063517|7473965|FG000|Overall Study|Lost to Follow-up|4
4615531|NCT01063517|7473966|FG001|Overall Study|Lost to Follow-up|3
4463258|NCT00597012|7253725|FG001|Overall Study|Ineligible|0
4463259|NCT00597012|7253724|FG000|Overall Study|Lost to Follow-up|0
4463260|NCT00597012|7253725|FG001|Overall Study|Lost to Follow-up|2
4463261|NCT00597116|7253746|FG000|Overall Study|Adverse Event|2
4463262|NCT00597116|7253747|FG001|Overall Study|Adverse Event|1
4463263|NCT00597116|7253746|FG000|Overall Study|Withdrawal by Subject|0
4463264|NCT00597116|7253747|FG001|Overall Study|Withdrawal by Subject|2
4463265|NCT00597116|7253746|FG000|Overall Study|Physician Decision|0
4463266|NCT00597116|7253747|FG001|Overall Study|Physician Decision|1
4463267|NCT00597116|7253746|FG000|Overall Study|Death|0
4463268|NCT00597116|7253747|FG001|Overall Study|Death|1
4463269|NCT00597116|7253746|FG000|Overall Study|Lost to Follow-up|1
4463270|NCT00597116|7253747|FG001|Overall Study|Lost to Follow-up|0
4463271|NCT00597116|7253746|FG000|Overall Study|Progressive disease|11
4463272|NCT00597116|7253747|FG001|Overall Study|Progressive disease|6
4463273|NCT00597207|7253755|FG000|Overall Study|Lost to Follow-up|5
4463274|NCT00597207|7253756|FG001|Overall Study|Lost to Follow-up|7
4463275|NCT00597376|7253797|FG000|Overall Study|Withdrawal by Subject|4
4463276|NCT00597376|7253798|FG001|Overall Study|Withdrawal by Subject|3
4463277|NCT00597376|7253797|FG000|Overall Study|Adverse Event|4
4463278|NCT00597376|7253798|FG001|Overall Study|Adverse Event|1
4463279|NCT00597506|7253825|FG000|Overall Study|Subject is being followed for survival|1
4463280|NCT00597519|7253829|FG000|Overall Study|Death|1
4463281|NCT00597584|7253848|FG000|Overall Study|Adverse Event|4
4463282|NCT00597584|7253849|FG001|Overall Study|Adverse Event|2
4463283|NCT00597584|7253848|FG000|Overall Study|Death|53
4463284|NCT00597584|7253849|FG001|Overall Study|Death|30
4463285|NCT00597584|7253848|FG000|Overall Study|Lack of Efficacy|1
4463286|NCT00597584|7253849|FG001|Overall Study|Lack of Efficacy|0
4463287|NCT00597584|7253848|FG000|Overall Study|Lost to Follow-up|2
4463288|NCT00597584|7253849|FG001|Overall Study|Lost to Follow-up|4
4463289|NCT00597584|7253848|FG000|Overall Study|Physician Decision|3
4463290|NCT00597584|7253849|FG001|Overall Study|Physician Decision|0
4463291|NCT00597584|7253848|FG000|Overall Study|Pregnancy|2
4463292|NCT00597584|7253849|FG001|Overall Study|Pregnancy|0
4463293|NCT00597584|7253848|FG000|Overall Study|Withdrawal by Subject|44
4463294|NCT00597584|7253849|FG001|Overall Study|Withdrawal by Subject|12
4463295|NCT00597584|7253848|FG000|Overall Study|Discontinued Dialysis|0
4463296|NCT00597584|7253849|FG001|Overall Study|Discontinued Dialysis|1
4463297|NCT00597584|7253848|FG000|Overall Study|Lost ability to consent|1
4463298|NCT00597584|7253849|FG001|Overall Study|Lost ability to consent|1
4463299|NCT00597584|7253848|FG000|Overall Study|Never dosed|1
4463300|NCT00597584|7253849|FG001|Overall Study|Never dosed|0
4463301|NCT00597584|7253848|FG000|Overall Study|Relocation|8
4463302|NCT00597584|7253849|FG001|Overall Study|Relocation|6
4463303|NCT00597584|7253848|FG000|Overall Study|Renal transplant|9
4463304|NCT00597584|7253849|FG001|Overall Study|Renal transplant|7
4463305|NCT00597701|7253868|FG000|Overall Study|Withdrawal by Subject|5
4463306|NCT00597701|7253869|FG001|Overall Study|Withdrawal by Subject|5
4463307|NCT00597701|7253868|FG000|Overall Study|Death|0
4463308|NCT00597701|7253869|FG001|Overall Study|Death|1
4463309|NCT00597701|7253868|FG000|Overall Study|Physician Decision|2
4463310|NCT00597701|7253869|FG001|Overall Study|Physician Decision|0
4463311|NCT00597701|7253868|FG000|Overall Study|Did not start intervention (pharmacy er)|0
4463312|NCT00597701|7253869|FG001|Overall Study|Did not start intervention (pharmacy er)|2
4463313|NCT00597714|7253877|FG000|Overall Study|Death|56
4463314|NCT00597714|7253878|FG001|Overall Study|Death|46
4463315|NCT00597714|7253879|FG002|Overall Study|Death|0
4463316|NCT00597714|7253877|FG000|Overall Study|Recipient death|0
4540432|NCT01132820|7363117|FG000|Overall Study|Ineligible:Inadequate pathology|1
4540433|NCT01132820|7363117|FG000|Overall Study|Never treated|1
4540434|NCT01132820|7363117|FG000|Overall Study|Inadequate data|1
4540435|NCT01133067|7363136|FG000|Overall Study|Death|136
4540436|NCT01133067|7363136|FG000|Overall Study|Lost to Follow-up|3
4540437|NCT01133171|7363149|FG000|Overall Study|Withdrawal by Subject|1
4463317|NCT00597714|7253878|FG001|Overall Study|Recipient death|0
4463318|NCT00597714|7253879|FG002|Overall Study|Recipient death|10
4463319|NCT00597753|7253912|FG000|Overall Study|Adverse Event|6
4463320|NCT00597753|7253913|FG001|Overall Study|Adverse Event|2
4463321|NCT00597753|7253912|FG000|Overall Study|Death|55
4463322|NCT00597753|7253913|FG001|Overall Study|Death|29
4463323|NCT00597753|7253912|FG000|Overall Study|Lack of Efficacy|2
4463324|NCT00597753|7253913|FG001|Overall Study|Lack of Efficacy|0
4463325|NCT00597753|7253912|FG000|Overall Study|Lost to Follow-up|10
4463326|NCT00597753|7253913|FG001|Overall Study|Lost to Follow-up|3
4463327|NCT00597753|7253912|FG000|Overall Study|Physician Decision|5
4463328|NCT00597753|7253913|FG001|Overall Study|Physician Decision|1
4463329|NCT00597753|7253912|FG000|Overall Study|Pregnancy|1
4615532|NCT01063517|7473965|FG000|Overall Study|Withdrawal by Subject|1
4463330|NCT00597753|7253913|FG001|Overall Study|Pregnancy|0
4463331|NCT00597753|7253912|FG000|Overall Study|Withdrawal by Subject|35
4463332|NCT00597753|7253913|FG001|Overall Study|Withdrawal by Subject|12
4463333|NCT00597753|7253912|FG000|Overall Study|Discontinued Dialysis|0
4463334|NCT00597753|7253913|FG001|Overall Study|Discontinued Dialysis|1
4463335|NCT00597753|7253912|FG000|Overall Study|Never dosed|2
4463336|NCT00597753|7253913|FG001|Overall Study|Never dosed|0
4463337|NCT00597753|7253912|FG000|Overall Study|Noncompliance|2
4463338|NCT00597753|7253913|FG001|Overall Study|Noncompliance|1
4463339|NCT00597753|7253912|FG000|Overall Study|Relocation|17
4463340|NCT00597753|7253913|FG001|Overall Study|Relocation|6
4463341|NCT00597753|7253912|FG000|Overall Study|Renal transplant|10
4463342|NCT00597753|7253913|FG001|Overall Study|Renal transplant|3
4463343|NCT00597753|7253912|FG000|Overall Study|Site closed by sponsor|19
4463344|NCT00597753|7253913|FG001|Overall Study|Site closed by sponsor|7
4463345|NCT00597753|7253912|FG000|Overall Study|Site elected to close|2
4463346|NCT00597753|7253913|FG001|Overall Study|Site elected to close|4
4463347|NCT00597766|7253922|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1
4463348|NCT00597766|7253923|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0
4463349|NCT00597766|7253924|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0
4463350|NCT00597766|7253922|FG000|Follow-up 2, Week 8|Lost to Follow-up|0
4463351|NCT00597766|7253923|FG001|Follow-up 2, Week 8|Lost to Follow-up|0
4463352|NCT00597766|7253924|FG002|Follow-up 2, Week 8|Lost to Follow-up|1
4463353|NCT00598078|7253976|FG000|Period 2 (Day 2)|Adverse Event|1
4463354|NCT00598078|7253977|FG001|Period 2 (Day 2)|Adverse Event|0
4463355|NCT00598273|7253988|FG000|Overall Study|Adverse Event|4
4463356|NCT00598273|7253989|FG001|Overall Study|Adverse Event|5
4463357|NCT00598273|7253990|FG002|Overall Study|Adverse Event|2
4463358|NCT00598273|7253988|FG000|Overall Study|Death|6
4463359|NCT00598273|7253989|FG001|Overall Study|Death|12
4463360|NCT00598273|7253990|FG002|Overall Study|Death|8
4463361|NCT00598273|7253988|FG000|Overall Study|Lost to Follow-up|8
4463362|NCT00598273|7253989|FG001|Overall Study|Lost to Follow-up|3
4463363|NCT00598273|7253990|FG002|Overall Study|Lost to Follow-up|5
4463364|NCT00598273|7253988|FG000|Overall Study|Physician Decision|0
4463365|NCT00598273|7253989|FG001|Overall Study|Physician Decision|0
4463366|NCT00598273|7253990|FG002|Overall Study|Physician Decision|1
4463367|NCT00598273|7253988|FG000|Overall Study|Withdrawal by Subject|12
4463368|NCT00598273|7253989|FG001|Overall Study|Withdrawal by Subject|10
4463369|NCT00598273|7253990|FG002|Overall Study|Withdrawal by Subject|10
4463370|NCT00598273|7253988|FG000|Overall Study|Noncompliance|3
4463371|NCT00598273|7253989|FG001|Overall Study|Noncompliance|2
4463372|NCT00598273|7253990|FG002|Overall Study|Noncompliance|3
4463373|NCT00598273|7253988|FG000|Overall Study|Relocation|0
4463374|NCT00598273|7253989|FG001|Overall Study|Relocation|2
4463375|NCT00598273|7253990|FG002|Overall Study|Relocation|4
4463376|NCT00598273|7253988|FG000|Overall Study|Renal transplant|1
4463377|NCT00598273|7253989|FG001|Overall Study|Renal transplant|0
4463378|NCT00598273|7253990|FG002|Overall Study|Renal transplant|1
4463379|NCT00598273|7253988|FG000|Overall Study|Site elected to close|1
4463380|NCT00598273|7253989|FG001|Overall Study|Site elected to close|0
4463381|NCT00598273|7253990|FG002|Overall Study|Site elected to close|0
4463382|NCT00598273|7253988|FG000|Overall Study|Started dialysis|6
4463383|NCT00598273|7253989|FG001|Overall Study|Started dialysis|4
4463384|NCT00598273|7253990|FG002|Overall Study|Started dialysis|5
4463385|NCT00598442|7254001|FG000|Overall Study|Adverse Event|3
4463386|NCT00598442|7254002|FG001|Overall Study|Adverse Event|0
4463387|NCT00598442|7254003|FG002|Overall Study|Adverse Event|0
4463388|NCT00598442|7254001|FG000|Overall Study|Death|19
4463389|NCT00598442|7254002|FG001|Overall Study|Death|11
4463390|NCT00598442|7254003|FG002|Overall Study|Death|11
4463391|NCT00598442|7254001|FG000|Overall Study|Lost to Follow-up|4
4463392|NCT00598442|7254002|FG001|Overall Study|Lost to Follow-up|3
4463393|NCT00598442|7254003|FG002|Overall Study|Lost to Follow-up|3
4463394|NCT00598442|7254001|FG000|Overall Study|Physician Decision|2
4463395|NCT00598442|7254002|FG001|Overall Study|Physician Decision|1
4463396|NCT00598442|7254003|FG002|Overall Study|Physician Decision|1
4463397|NCT00598442|7254001|FG000|Overall Study|Withdrawal by Subject|8
4463398|NCT00598442|7254002|FG001|Overall Study|Withdrawal by Subject|16
4463399|NCT00598442|7254003|FG002|Overall Study|Withdrawal by Subject|6
4463400|NCT00598442|7254001|FG000|Overall Study|Noncompliance|0
4463401|NCT00598442|7254002|FG001|Overall Study|Noncompliance|2
4463402|NCT00598442|7254003|FG002|Overall Study|Noncompliance|1
4615533|NCT01063517|7473966|FG001|Overall Study|Withdrawal by Subject|2
4463403|NCT00598442|7254001|FG000|Overall Study|Relocation|1
4463404|NCT00598442|7254002|FG001|Overall Study|Relocation|4
4463405|NCT00598442|7254003|FG002|Overall Study|Relocation|0
4463406|NCT00598442|7254001|FG000|Overall Study|Renal transplant|0
4463407|NCT00598442|7254002|FG001|Overall Study|Renal transplant|0
4463408|NCT00598442|7254003|FG002|Overall Study|Renal transplant|1
4463409|NCT00598442|7254001|FG000|Overall Study|Site closed by sponsor|5
4463410|NCT00598442|7254002|FG001|Overall Study|Site closed by sponsor|2
4463411|NCT00598442|7254003|FG002|Overall Study|Site closed by sponsor|1
4463412|NCT00598442|7254001|FG000|Overall Study|Started dialysis|1
4463413|NCT00598442|7254002|FG001|Overall Study|Started dialysis|0
4463414|NCT00598442|7254003|FG002|Overall Study|Started dialysis|0
4463415|NCT00598481|7254011|FG000|Treatment|Physician Decision|1
4463416|NCT00598559|7254025|FG000|Overall Study|Adverse Event|11
4463417|NCT00598559|7254026|FG001|Overall Study|Adverse Event|7
4463418|NCT00598559|7254027|FG002|Overall Study|Adverse Event|0
4463419|NCT00598559|7254025|FG000|Overall Study|Withdrawal by Subject|2
4463420|NCT00598559|7254026|FG001|Overall Study|Withdrawal by Subject|2
4463421|NCT00598559|7254027|FG002|Overall Study|Withdrawal by Subject|0
4463422|NCT00598559|7254025|FG000|Overall Study|Protocol Non-compliance|1
4463423|NCT00598559|7254026|FG001|Overall Study|Protocol Non-compliance|0
4463424|NCT00598559|7254027|FG002|Overall Study|Protocol Non-compliance|0
4463425|NCT00598559|7254025|FG000|Overall Study|Early discharge from hospital|9
4463426|NCT00598559|7254026|FG001|Overall Study|Early discharge from hospital|12
4463427|NCT00598559|7254027|FG002|Overall Study|Early discharge from hospital|3
4615534|NCT01063517|7473965|FG000|Overall Study|Death|33
4463428|NCT00598559|7254025|FG000|Overall Study|Subject unable/unwilling to attend visit|4
4463429|NCT00598559|7254026|FG001|Overall Study|Subject unable/unwilling to attend visit|7
4463430|NCT00598559|7254027|FG002|Overall Study|Subject unable/unwilling to attend visit|0
4463431|NCT00598585|7254037|FG000|Overall Study|Lost to Follow-up|1
4463432|NCT00598585|7254038|FG001|Overall Study|Lost to Follow-up|0
4463433|NCT00598650|7254044|FG000|Overall Study|Withdrawal by Subject|3
4463434|NCT00598650|7254044|FG000|Overall Study|Adverse Event|18
4463435|NCT00598650|7254044|FG000|Overall Study|No treatment for 3 weeks|1
4463436|NCT00598650|7254044|FG000|Overall Study|Not eligible|1
4463437|NCT00598650|7254044|FG000|Overall Study|Prohibited Concomitant Medication|2
4463438|NCT00598650|7254044|FG000|Overall Study|Physician Decision|2
4463439|NCT00598702|7254078|FG000|Overall Study|Other|0
4463440|NCT00598702|7254079|FG001|Overall Study|Other|2
4463441|NCT00598702|7254080|FG002|Overall Study|Other|0
4463442|NCT00598702|7254081|FG003|Overall Study|Other|0
4463443|NCT00598702|7254082|FG004|Overall Study|Other|0
4463444|NCT00598702|7254083|FG005|Overall Study|Other|1
4463445|NCT00598702|7254084|FG006|Overall Study|Other|0
4463446|NCT00598702|7254085|FG007|Overall Study|Other|0
4463447|NCT00598702|7254078|FG000|Overall Study|Early discharge from hospital|0
4463448|NCT00598702|7254079|FG001|Overall Study|Early discharge from hospital|0
4463449|NCT00598702|7254080|FG002|Overall Study|Early discharge from hospital|2
4463450|NCT00598702|7254081|FG003|Overall Study|Early discharge from hospital|5
4463451|NCT00598702|7254082|FG004|Overall Study|Early discharge from hospital|0
4463452|NCT00598702|7254083|FG005|Overall Study|Early discharge from hospital|10
4463453|NCT00598702|7254084|FG006|Overall Study|Early discharge from hospital|1
4463454|NCT00598702|7254085|FG007|Overall Study|Early discharge from hospital|0
4463455|NCT00598702|7254078|FG000|Overall Study|Adverse Event|0
4463456|NCT00598702|7254079|FG001|Overall Study|Adverse Event|0
4463457|NCT00598702|7254080|FG002|Overall Study|Adverse Event|0
4463458|NCT00598702|7254081|FG003|Overall Study|Adverse Event|1
4463459|NCT00598702|7254082|FG004|Overall Study|Adverse Event|0
4463460|NCT00598702|7254083|FG005|Overall Study|Adverse Event|0
4463461|NCT00598702|7254084|FG006|Overall Study|Adverse Event|0
4463462|NCT00598702|7254085|FG007|Overall Study|Adverse Event|0
4463463|NCT00598702|7254078|FG000|Overall Study|Withdrawal by Subject|0
4463464|NCT00598702|7254079|FG001|Overall Study|Withdrawal by Subject|0
4463465|NCT00598702|7254080|FG002|Overall Study|Withdrawal by Subject|0
4463466|NCT00598702|7254081|FG003|Overall Study|Withdrawal by Subject|1
4463467|NCT00598702|7254082|FG004|Overall Study|Withdrawal by Subject|1
4463468|NCT00598702|7254083|FG005|Overall Study|Withdrawal by Subject|0
4463469|NCT00598702|7254084|FG006|Overall Study|Withdrawal by Subject|0
4463470|NCT00598702|7254085|FG007|Overall Study|Withdrawal by Subject|0
4463471|NCT00598702|7254078|FG000|Overall Study|Physician Decision|0
4463472|NCT00598702|7254079|FG001|Overall Study|Physician Decision|0
4463473|NCT00598702|7254080|FG002|Overall Study|Physician Decision|0
4463474|NCT00598702|7254081|FG003|Overall Study|Physician Decision|0
4463475|NCT00598702|7254082|FG004|Overall Study|Physician Decision|1
4463476|NCT00598702|7254083|FG005|Overall Study|Physician Decision|0
4463477|NCT00598702|7254084|FG006|Overall Study|Physician Decision|0
4463478|NCT00598702|7254085|FG007|Overall Study|Physician Decision|0
4463479|NCT00598702|7254078|FG000|Overall Study|Dose limiting toxicity|0
4463480|NCT00598702|7254079|FG001|Overall Study|Dose limiting toxicity|0
4463481|NCT00598702|7254080|FG002|Overall Study|Dose limiting toxicity|0
4463482|NCT00598702|7254081|FG003|Overall Study|Dose limiting toxicity|1
4463483|NCT00598702|7254082|FG004|Overall Study|Dose limiting toxicity|1
4463484|NCT00598702|7254083|FG005|Overall Study|Dose limiting toxicity|1
4463485|NCT00598702|7254084|FG006|Overall Study|Dose limiting toxicity|0
4463486|NCT00598702|7254085|FG007|Overall Study|Dose limiting toxicity|0
4463487|NCT00598832|7254118|FG000|Overall Study|Lack of Efficacy|3
4463488|NCT00598832|7254119|FG001|Overall Study|Lack of Efficacy|7
4463489|NCT00598832|7254118|FG000|Overall Study|Adverse Event|6
4463490|NCT00598832|7254119|FG001|Overall Study|Adverse Event|2
4463491|NCT00598832|7254118|FG000|Overall Study|Withdrawal by Subject|25
4463492|NCT00598832|7254119|FG001|Overall Study|Withdrawal by Subject|36
4463493|NCT00598832|7254118|FG000|Overall Study|Protocol Violation|0
4463494|NCT00598832|7254119|FG001|Overall Study|Protocol Violation|2
4463495|NCT00598832|7254118|FG000|Overall Study|Lost to Follow-up|24
4463496|NCT00598832|7254119|FG001|Overall Study|Lost to Follow-up|29
4463497|NCT00598832|7254118|FG000|Overall Study|Pregnancy|2
4463498|NCT00598832|7254119|FG001|Overall Study|Pregnancy|2
4463499|NCT00598832|7254118|FG000|Overall Study|Physician Decision|1
4463500|NCT00598832|7254119|FG001|Overall Study|Physician Decision|4
4463501|NCT00598832|7254118|FG000|Overall Study|Non compliance|1
4463502|NCT00598832|7254119|FG001|Overall Study|Non compliance|0
4463503|NCT00598871|7254127|FG000|Overall Study|Adverse Event|0
4463504|NCT00598871|7254128|FG001|Overall Study|Adverse Event|1
4463505|NCT00598975|7254136|FG000|Overall Study|Adverse Event|1
4615535|NCT01063517|7473966|FG001|Overall Study|Death|48
4463506|NCT00598975|7254137|FG001|Overall Study|Adverse Event|1
4463507|NCT00598975|7254136|FG000|Overall Study|Brain metastases|1
4463508|NCT00598975|7254137|FG001|Overall Study|Brain metastases|0
4463509|NCT00598975|7254136|FG000|Overall Study|Withdrawal by Subject|1
4463510|NCT00598975|7254137|FG001|Overall Study|Withdrawal by Subject|1
4463511|NCT00598975|7254136|FG000|Overall Study|Withdrawal of consent|0
4463512|NCT00598975|7254137|FG001|Overall Study|Withdrawal of consent|1
4463513|NCT00598975|7254136|FG000|Overall Study|Disease progression|8
4463514|NCT00598975|7254137|FG001|Overall Study|Disease progression|3
4463515|NCT00598975|7254136|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1
4463516|NCT00598975|7254137|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0
4516195|NCT00958568|7327506|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
4516196|NCT00958568|7327507|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
4516197|NCT00958568|7327504|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
4516198|NCT00958568|7327505|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1
4516199|NCT00958568|7327506|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
4516200|NCT00958568|7327507|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
4516201|NCT00958568|7327504|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
4516202|NCT00958568|7327505|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1
4516203|NCT00958568|7327506|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
4516204|NCT00958568|7327507|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
4516205|NCT00958568|7327504|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0
4516206|NCT00958568|7327505|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0
4516207|NCT00958568|7327506|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24
4516208|NCT00958568|7327507|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63
4516209|NCT00958568|7327504|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0
4516210|NCT00958568|7327505|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0
4516211|NCT00958568|7327506|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19
4516212|NCT00958568|7327507|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10
4516213|NCT00958568|7327504|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0
4516214|NCT00958568|7327505|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0
4516215|NCT00958568|7327506|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16
4516216|NCT00958568|7327507|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15
4516217|NCT00958568|7327504|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0
4516218|NCT00958568|7327505|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0
4516219|NCT00958568|7327506|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11
4516220|NCT00958568|7327507|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5
4516221|NCT00958568|7327504|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0
4516222|NCT00958568|7327505|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0
4516223|NCT00958568|7327506|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3
4516224|NCT00958568|7327507|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8
4516225|NCT00958568|7327504|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0
4516226|NCT00958568|7327505|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0
4516227|NCT00958568|7327506|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5
4516228|NCT00958568|7327507|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4
4516229|NCT00958568|7327504|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0
4516230|NCT00958568|7327505|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0
4516231|NCT00958568|7327506|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2
4516232|NCT00958568|7327507|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1
4516233|NCT00958568|7327504|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
4516234|NCT00958568|7327505|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
4516235|NCT00958568|7327506|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1
4516236|NCT00958568|7327507|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
4516237|NCT00958568|7327504|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
4516238|NCT00958568|7327505|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
4516239|NCT00958568|7327506|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1
4516240|NCT00958568|7327507|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
4516241|NCT00958711|7327536|FG000|Overall Study|Withdrawal by Subject|0
4516242|NCT00958711|7327537|FG001|Overall Study|Withdrawal by Subject|4
4516243|NCT00958711|7327536|FG000|Overall Study|Physician Decision|5
4516244|NCT00958711|7327537|FG001|Overall Study|Physician Decision|7
4516245|NCT00958711|7327536|FG000|Overall Study|Lost to Follow-up|4
4516246|NCT00958711|7327537|FG001|Overall Study|Lost to Follow-up|1
4540438|NCT01133171|7363150|FG001|Overall Study|Withdrawal by Subject|2
4540439|NCT01133171|7363151|FG002|Overall Study|Withdrawal by Subject|0
4540440|NCT01133275|7363159|FG000|Overall Study|Withdrawal by Subject|1
4540441|NCT01133275|7363159|FG000|Overall Study|Cerebrovascular accident (CVA)|1
4540442|NCT01133379|7363166|FG000|Overall Study|Withdrawal by Subject|0
4540443|NCT01133379|7363167|FG001|Overall Study|Withdrawal by Subject|1
4516247|NCT00958711|7327536|FG000|Overall Study|Other|2
4516248|NCT00958711|7327537|FG001|Overall Study|Other|5
4516249|NCT00958711|7327536|FG000|Overall Study|Death|1
4463517|NCT00599196|7254158|FG000|Overall Study|Lack of Efficacy|22
4463518|NCT00599196|7254158|FG000|Overall Study|Adverse Event|93
4463519|NCT00599196|7254158|FG000|Overall Study|Unsatisfactory compliance of subject|3
4463520|NCT00599196|7254158|FG000|Overall Study|Subject withdrew consent|43
4463521|NCT00599196|7254158|FG000|Overall Study|Study ended per sponsor|197
4463522|NCT00599196|7254158|FG000|Overall Study|Lost to Follow-up|17
4463523|NCT00599196|7254158|FG000|Overall Study|Other: Patient Leaving For Israel|1
4463524|NCT00599196|7254158|FG000|Overall Study|Other: Spouse Withdrew Consent|1
4463525|NCT00599196|7254158|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1
4463526|NCT00599196|7254158|FG000|Overall Study|Other: Pt Moved To Australia|1
4615536|NCT00915681|7473972|FG000|Overall Study|Screening failures|46
4615537|NCT00145158|7473978|FG000|Overall Study|premature withdrawal|2
4615538|NCT00145158|7473979|FG001|Overall Study|premature withdrawal|3
4615539|NCT01732822|7473997|FG000|Overall Study|Withdrawal by Subject|123
4463527|NCT00599196|7254158|FG000|Overall Study|Other: Patient Stopped Due To Moving|1
4463528|NCT00599196|7254158|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1
4463529|NCT00599313|7254176|FG000|Overall Study|Adverse Event|19
4463530|NCT00599313|7254176|FG000|Overall Study|Disease Progression|12
4463531|NCT00599313|7254176|FG000|Overall Study|Patient Request|4
4463532|NCT00599313|7254176|FG000|Overall Study|Ineligible|1
4463533|NCT00599326|7254180|FG000|Overall Study|Lost to Follow-up|1
4463534|NCT00599326|7254180|FG000|Overall Study|Noncompliant|1
4463535|NCT00599339|7254184|FG000|Overall Study|Adverse Event|79
4463536|NCT00599339|7254184|FG000|Overall Study|Withdrawal by Subject|137
4463537|NCT00599339|7254184|FG000|Overall Study|Other Reason|179
4463538|NCT00599339|7254184|FG000|Overall Study|Lost to Follow-up|221
4463539|NCT00599339|7254184|FG000|Overall Study|No valid data consent|36
4463540|NCT00599339|7254184|FG000|Overall Study|Study Termination Status Unknown|12
4463541|NCT00599521|7254208|FG000|Overall Study|Lack of Efficacy|4
4463542|NCT00599521|7254209|FG001|Overall Study|Lack of Efficacy|8
4463543|NCT00599521|7254208|FG000|Overall Study|Adverse Event|4
4463544|NCT00599521|7254209|FG001|Overall Study|Adverse Event|1
4463545|NCT00599521|7254208|FG000|Overall Study|Withdrawal by Subject|28
4463546|NCT00599521|7254209|FG001|Overall Study|Withdrawal by Subject|34
4463547|NCT00599521|7254208|FG000|Overall Study|Protocol Violation|1
4463548|NCT00599521|7254209|FG001|Overall Study|Protocol Violation|1
4463549|NCT00599521|7254208|FG000|Overall Study|Lost to Follow-up|23
4463550|NCT00599521|7254209|FG001|Overall Study|Lost to Follow-up|23
4463551|NCT00599521|7254208|FG000|Overall Study|Pregnancy|0
4463552|NCT00599521|7254209|FG001|Overall Study|Pregnancy|2
4463553|NCT00599638|7254219|FG000|First Intervention Period (2 Weeks)|Adverse Event|1
4463554|NCT00599638|7254220|FG001|First Intervention Period (2 Weeks)|Adverse Event|0
4463555|NCT00599638|7254221|FG002|First Intervention Period (2 Weeks)|Adverse Event|3
4540444|NCT01133379|7363168|FG002|Overall Study|Withdrawal by Subject|1
4615540|NCT01732822|7473998|FG001|Overall Study|Withdrawal by Subject|113
4615541|NCT01732835|7474026|FG000|6-month Primary Endpoint|Did not receive device|19
4615542|NCT01732835|7474026|FG000|6-month Primary Endpoint|Withdrawal by Subject|2
4615543|NCT01732835|7474026|FG000|6-month Primary Endpoint|Adverse Event|3
4615544|NCT01732835|7474026|FG000|2-year Extended Follow-up|Withdrawal by Subject|1
4615545|NCT01732835|7474026|FG000|2-year Extended Follow-up|Adverse Event|3
4615546|NCT01732835|7474026|FG000|2-year Extended Follow-up|Death|1
4615547|NCT01732874|7474032|FG000|Overall Study|Withdrawal by Subject|5
4615548|NCT01732874|7474033|FG001|Overall Study|Withdrawal by Subject|1
4615549|NCT01732874|7474032|FG000|Overall Study|Death of Infant|3
4615550|NCT01732874|7474033|FG001|Overall Study|Death of Infant|2
4615551|NCT01733121|7474066|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2
4615552|NCT01733121|7474067|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0
4615553|NCT01733121|7474066|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3
4615554|NCT01733121|7474067|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2
4615555|NCT01733121|7474066|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1
4615556|NCT01733121|7474067|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3
4615557|NCT01733121|7474066|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
4615558|NCT01733121|7474067|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0
4615559|NCT01733316|7474106|FG000|RP103 Phase|Non-compliance|1
4615560|NCT01733316|7474106|FG000|Long Term Extension Phase|Adverse Event|1
4615561|NCT01733316|7474106|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2
4615562|NCT01733316|7474106|FG000|Long Term Extension Phase|Sponsor Decision|2
4615563|NCT01733329|7474119|FG000|Overall Study|Protocol Violation|1
4615564|NCT01733329|7474120|FG001|Overall Study|Protocol Violation|1
4615565|NCT01733329|7474119|FG000|Overall Study|Uterine artery injury|1
4463556|NCT00599638|7254222|FG003|First Intervention Period (2 Weeks)|Adverse Event|2
4463557|NCT00599638|7254219|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1
4463558|NCT00599638|7254220|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0
4463559|NCT00599638|7254221|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0
4615566|NCT01733329|7474120|FG001|Overall Study|Uterine artery injury|0
4615567|NCT01733680|7474157|FG000|Overall Study|Withdrawal by Subject|0
4615568|NCT01733680|7474158|FG001|Overall Study|Withdrawal by Subject|1
4615569|NCT01733732|7474170|FG000|Overall Study|Adverse Event|1
4463560|NCT00599638|7254222|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1
4463561|NCT00599638|7254219|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0
4463562|NCT00599638|7254220|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1
4463563|NCT00599638|7254221|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0
4463564|NCT00599638|7254222|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1
4463565|NCT00599638|7254219|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0
4463566|NCT00599638|7254220|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1
4463567|NCT00599638|7254221|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0
4463568|NCT00599638|7254222|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1
4463569|NCT00599638|7254219|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1
4463570|NCT00599638|7254220|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0
4463571|NCT00599638|7254221|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0
4463572|NCT00599638|7254222|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1
4463573|NCT00599638|7254219|FG000|Washout Period (2 Weeks)|Adverse Event|0
4463574|NCT00599638|7254220|FG001|Washout Period (2 Weeks)|Adverse Event|0
4463575|NCT00599638|7254221|FG002|Washout Period (2 Weeks)|Adverse Event|0
4463576|NCT00599638|7254222|FG003|Washout Period (2 Weeks)|Adverse Event|1
4463577|NCT00599638|7254219|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0
4463578|NCT00599638|7254220|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0
4463579|NCT00599638|7254221|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0
4463580|NCT00599638|7254222|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1
4463581|NCT00599638|7254219|FG000|Washout Period (2 Weeks)|Protocol Violation|0
4447902|NCT00492752|7233143|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
4447903|NCT00492752|7233144|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
4447904|NCT00492752|7233145|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
4447905|NCT00492856|7233152|FG000|Induction|Adverse Event|2
4447906|NCT00492856|7233153|FG001|Induction|Adverse Event|0
4447907|NCT00492856|7233154|FG002|Induction|Adverse Event|0
4463582|NCT00599638|7254220|FG001|Washout Period (2 Weeks)|Protocol Violation|1
4463583|NCT00599638|7254221|FG002|Washout Period (2 Weeks)|Protocol Violation|0
4463584|NCT00599638|7254222|FG003|Washout Period (2 Weeks)|Protocol Violation|0
4540445|NCT01133379|7363166|FG000|Overall Study|Lost to Follow-up|1
4540446|NCT01133379|7363167|FG001|Overall Study|Lost to Follow-up|1
4540447|NCT01133379|7363168|FG002|Overall Study|Lost to Follow-up|1
4540448|NCT01133392|7363178|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0
4540449|NCT01133392|7363179|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1
4540450|NCT01133392|7363178|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0
4540451|NCT01133392|7363179|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1
4540452|NCT01133405|7363195|FG000|Period 1|Withdrawal by Subject|0
4540453|NCT01133405|7363196|FG001|Period 1|Withdrawal by Subject|1
4540454|NCT01133405|7363197|FG002|Period 1|Withdrawal by Subject|0
4540455|NCT01133405|7363198|FG003|Period 1|Withdrawal by Subject|1
4540456|NCT01133405|7363199|FG004|Period 1|Withdrawal by Subject|0
4540457|NCT01133405|7363200|FG005|Period 1|Withdrawal by Subject|1
4540458|NCT01133405|7363201|FG006|Period 1|Withdrawal by Subject|0
4540459|NCT01133405|7363202|FG007|Period 1|Withdrawal by Subject|0
4540460|NCT01133405|7363203|FG008|Period 1|Withdrawal by Subject|0
4540461|NCT01133405|7363204|FG009|Period 1|Withdrawal by Subject|0
4540462|NCT01133405|7363195|FG000|Period 1|Physician Decision|0
4540463|NCT01133405|7363196|FG001|Period 1|Physician Decision|0
4540464|NCT01133405|7363197|FG002|Period 1|Physician Decision|0
4540465|NCT01133405|7363198|FG003|Period 1|Physician Decision|1
4540466|NCT01133405|7363199|FG004|Period 1|Physician Decision|0
4540467|NCT01133405|7363200|FG005|Period 1|Physician Decision|0
4540468|NCT01133405|7363201|FG006|Period 1|Physician Decision|0
4540469|NCT01133405|7363202|FG007|Period 1|Physician Decision|0
4540470|NCT01133405|7363203|FG008|Period 1|Physician Decision|0
4540471|NCT01133405|7363204|FG009|Period 1|Physician Decision|0
4540472|NCT01133405|7363195|FG000|Period 1|Discontinued after randomization|1
4540473|NCT01133405|7363196|FG001|Period 1|Discontinued after randomization|0
4540474|NCT01133405|7363197|FG002|Period 1|Discontinued after randomization|0
4540475|NCT01133405|7363198|FG003|Period 1|Discontinued after randomization|0
4540476|NCT01133405|7363199|FG004|Period 1|Discontinued after randomization|0
4540477|NCT01133405|7363200|FG005|Period 1|Discontinued after randomization|0
4447908|NCT00492856|7233155|FG003|Induction|Adverse Event|0
4540478|NCT01133405|7363201|FG006|Period 1|Discontinued after randomization|1
4540479|NCT01133405|7363202|FG007|Period 1|Discontinued after randomization|0
4463585|NCT00599638|7254219|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1
4463586|NCT00599638|7254220|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0
4463587|NCT00599638|7254221|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0
4463588|NCT00599638|7254222|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0
4463589|NCT00599755|7254230|FG000|Overall Study|Adverse Event|11
4463590|NCT00599755|7254230|FG000|Overall Study|Withdrawal by Subject|2
4540480|NCT01133405|7363203|FG008|Period 1|Discontinued after randomization|0
4540481|NCT01133405|7363204|FG009|Period 1|Discontinued after randomization|0
4540482|NCT01133405|7363195|FG000|Period 1|Received drug only in period 2|0
4540483|NCT01133405|7363196|FG001|Period 1|Received drug only in period 2|1
4540484|NCT01133405|7363197|FG002|Period 1|Received drug only in period 2|0
4540485|NCT01133405|7363198|FG003|Period 1|Received drug only in period 2|2
4540486|NCT01133405|7363199|FG004|Period 1|Received drug only in period 2|0
4540487|NCT01133405|7363200|FG005|Period 1|Received drug only in period 2|1
4540488|NCT01133405|7363201|FG006|Period 1|Received drug only in period 2|0
4540489|NCT01133405|7363202|FG007|Period 1|Received drug only in period 2|0
4540490|NCT01133405|7363203|FG008|Period 1|Received drug only in period 2|0
4540491|NCT01133405|7363204|FG009|Period 1|Received drug only in period 2|0
4540492|NCT01133405|7363195|FG000|Period 1|Received drug only in period 3|0
4540493|NCT01133405|7363196|FG001|Period 1|Received drug only in period 3|1
4540494|NCT01133405|7363197|FG002|Period 1|Received drug only in period 3|1
4463591|NCT00599755|7254230|FG000|Overall Study|Progression of Disease|3
4463592|NCT00599755|7254230|FG000|Overall Study|Other Reason|2
4463593|NCT00599755|7254230|FG000|Overall Study|No data available|1
4463594|NCT00599924|7254254|FG000|Overall Study|Lack of Efficacy|3
4463595|NCT00599924|7254255|FG001|Overall Study|Lack of Efficacy|5
4463596|NCT00599924|7254256|FG002|Overall Study|Lack of Efficacy|1
4463597|NCT00599924|7254257|FG003|Overall Study|Lack of Efficacy|2
4463598|NCT00599924|7254258|FG004|Overall Study|Lack of Efficacy|3
4463599|NCT00599924|7254259|FG005|Overall Study|Lack of Efficacy|2
4463600|NCT00599924|7254260|FG006|Overall Study|Lack of Efficacy|0
4463601|NCT00599924|7254254|FG000|Overall Study|Adverse Event|0
4463602|NCT00599924|7254255|FG001|Overall Study|Adverse Event|0
4463603|NCT00599924|7254256|FG002|Overall Study|Adverse Event|0
4463604|NCT00599924|7254257|FG003|Overall Study|Adverse Event|2
4463605|NCT00599924|7254258|FG004|Overall Study|Adverse Event|0
4463606|NCT00599924|7254259|FG005|Overall Study|Adverse Event|0
4463607|NCT00599924|7254260|FG006|Overall Study|Adverse Event|2
4463608|NCT00599924|7254254|FG000|Overall Study|Death|0
4463609|NCT00599924|7254255|FG001|Overall Study|Death|0
4463610|NCT00599924|7254256|FG002|Overall Study|Death|0
4463611|NCT00599924|7254257|FG003|Overall Study|Death|2
4463612|NCT00599924|7254258|FG004|Overall Study|Death|0
4463613|NCT00599924|7254259|FG005|Overall Study|Death|2
4463614|NCT00599924|7254260|FG006|Overall Study|Death|1
4463615|NCT00599924|7254254|FG000|Overall Study|Protocol Violation|0
4615570|NCT01733732|7474171|FG001|Overall Study|Adverse Event|0
4615571|NCT01733732|7474170|FG000|Overall Study|Did not attend all study visits|1
4615572|NCT01733732|7474171|FG001|Overall Study|Did not attend all study visits|0
4615573|NCT01733758|7474200|FG000|Overall Study|Adverse Event|5
4615574|NCT01733758|7474201|FG001|Overall Study|Adverse Event|7
4615575|NCT01733758|7474202|FG002|Overall Study|Adverse Event|8
4615576|NCT01733758|7474203|FG003|Overall Study|Adverse Event|1
4615577|NCT01733758|7474200|FG000|Overall Study|Withdrawal by Subject|1
4615578|NCT01733758|7474201|FG001|Overall Study|Withdrawal by Subject|1
4615579|NCT01733758|7474202|FG002|Overall Study|Withdrawal by Subject|5
4615580|NCT01733758|7474203|FG003|Overall Study|Withdrawal by Subject|3
4615581|NCT01733758|7474200|FG000|Overall Study|Persistent Hyperglycemia|3
4615582|NCT01733758|7474201|FG001|Overall Study|Persistent Hyperglycemia|2
4615583|NCT01733758|7474202|FG002|Overall Study|Persistent Hyperglycemia|0
4615584|NCT01733758|7474203|FG003|Overall Study|Persistent Hyperglycemia|0
4615585|NCT01733758|7474200|FG000|Overall Study|Protocol Violation|0
4615586|NCT01733758|7474201|FG001|Overall Study|Protocol Violation|1
4615587|NCT01733758|7474202|FG002|Overall Study|Protocol Violation|2
4615588|NCT01733758|7474203|FG003|Overall Study|Protocol Violation|2
4615589|NCT01733758|7474200|FG000|Overall Study|Non-compliance|1
4615590|NCT01733758|7474201|FG001|Overall Study|Non-compliance|0
4615591|NCT01733758|7474202|FG002|Overall Study|Non-compliance|0
4463616|NCT00599924|7254255|FG001|Overall Study|Protocol Violation|0
4463617|NCT00599924|7254256|FG002|Overall Study|Protocol Violation|0
4463618|NCT00599924|7254257|FG003|Overall Study|Protocol Violation|1
4463619|NCT00599924|7254258|FG004|Overall Study|Protocol Violation|0
4463620|NCT00599924|7254259|FG005|Overall Study|Protocol Violation|0
4463621|NCT00599924|7254260|FG006|Overall Study|Protocol Violation|0
4463622|NCT00599924|7254254|FG000|Overall Study|Withdrawal by Subject|0
4463623|NCT00599924|7254255|FG001|Overall Study|Withdrawal by Subject|0
4463624|NCT00599924|7254256|FG002|Overall Study|Withdrawal by Subject|1
4463625|NCT00599924|7254257|FG003|Overall Study|Withdrawal by Subject|0
4463626|NCT00599924|7254258|FG004|Overall Study|Withdrawal by Subject|1
4463627|NCT00599924|7254259|FG005|Overall Study|Withdrawal by Subject|0
4463628|NCT00599924|7254260|FG006|Overall Study|Withdrawal by Subject|0
4463629|NCT00599924|7254254|FG000|Overall Study|Other|0
4463630|NCT00599924|7254255|FG001|Overall Study|Other|0
4540495|NCT01133405|7363198|FG003|Period 1|Received drug only in period 3|0
4615592|NCT01733758|7474203|FG003|Overall Study|Non-compliance|0
4615593|NCT01733758|7474200|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4
4615594|NCT01733758|7474201|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0
4615595|NCT01733758|7474202|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0
4615596|NCT01733758|7474203|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1
4463631|NCT00599924|7254256|FG002|Overall Study|Other|0
4463632|NCT00599924|7254257|FG003|Overall Study|Other|1
4463633|NCT00599924|7254258|FG004|Overall Study|Other|2
4463634|NCT00599924|7254259|FG005|Overall Study|Other|0
4463635|NCT00599924|7254260|FG006|Overall Study|Other|2
4463636|NCT00600028|7254283|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1
4463637|NCT00600028|7254284|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0
4463638|NCT00600028|7254283|FG000|First Intervention (12 Weeks)|Adverse Event|0
4463639|NCT00600028|7254284|FG001|First Intervention (12 Weeks)|Adverse Event|1
4463640|NCT00600028|7254283|FG000|Second Intervention (12 Weeks)|Adverse Event|0
4463641|NCT00600028|7254284|FG001|Second Intervention (12 Weeks)|Adverse Event|2
4463642|NCT00600067|7254295|FG000|Overall Study|Adverse Event|0
4463643|NCT00600067|7254296|FG001|Overall Study|Adverse Event|1
4463644|NCT00600067|7254295|FG000|Overall Study|Lost to Follow-up|2
4463645|NCT00600067|7254296|FG001|Overall Study|Lost to Follow-up|3
4463646|NCT00600067|7254295|FG000|Overall Study|protocol non-compliance|0
4463647|NCT00600067|7254296|FG001|Overall Study|protocol non-compliance|3
4463648|NCT00600067|7254295|FG000|Overall Study|Lack of Efficacy|1
4463649|NCT00600067|7254296|FG001|Overall Study|Lack of Efficacy|0
4463650|NCT00600106|7254312|FG000|Overall Study|Withdrawal by Subject|1
4463651|NCT00600106|7254313|FG001|Overall Study|Withdrawal by Subject|1
4463652|NCT00600119|7254325|FG000|Single-blind Placebo run-in Period|Other - Not specified|1
4463653|NCT00600119|7254326|FG001|Single-blind Placebo run-in Period|Other - Not specified|0
4463654|NCT00600119|7254327|FG002|Single-blind Placebo run-in Period|Other - Not specified|0
4463655|NCT00600119|7254328|FG003|Single-blind Placebo run-in Period|Other - Not specified|0
4463656|NCT00600119|7254329|FG004|Single-blind Placebo run-in Period|Other - Not specified|1
4463657|NCT00600119|7254330|FG005|Single-blind Placebo run-in Period|Other - Not specified|1
4463658|NCT00600119|7254325|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
4463659|NCT00600119|7254326|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1
4463660|NCT00600119|7254327|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1
4463661|NCT00600119|7254328|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
4463662|NCT00600119|7254329|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
4463663|NCT00600119|7254330|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
4463664|NCT00600119|7254325|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0
4463665|NCT00600119|7254326|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0
4463666|NCT00600119|7254327|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1
4463667|NCT00600119|7254328|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0
4463668|NCT00600119|7254329|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1
4463669|NCT00600119|7254330|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0
4463670|NCT00600119|7254325|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1
4463671|NCT00600119|7254326|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0
4463672|NCT00600119|7254327|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0
4463673|NCT00600119|7254328|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0
4463674|NCT00600119|7254329|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0
4463675|NCT00600119|7254330|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0
4463676|NCT00600119|7254325|FG000|Single-blind Placebo run-in Period|Adverse Event|0
4463677|NCT00600119|7254326|FG001|Single-blind Placebo run-in Period|Adverse Event|0
4463678|NCT00600119|7254327|FG002|Single-blind Placebo run-in Period|Adverse Event|0
4463679|NCT00600119|7254328|FG003|Single-blind Placebo run-in Period|Adverse Event|1
4463680|NCT00600119|7254329|FG004|Single-blind Placebo run-in Period|Adverse Event|0
4463681|NCT00600119|7254330|FG005|Single-blind Placebo run-in Period|Adverse Event|1
4463682|NCT00600119|7254325|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2
4463683|NCT00600119|7254326|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1
4463684|NCT00600119|7254327|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0
4463685|NCT00600119|7254328|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0
4463686|NCT00600119|7254329|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0
4463687|NCT00600119|7254330|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0
4463688|NCT00600119|7254325|FG000|Double-blind Treatment Period|Withdrawal by Subject|2
4463689|NCT00600119|7254326|FG001|Double-blind Treatment Period|Withdrawal by Subject|0
4463690|NCT00600119|7254327|FG002|Double-blind Treatment Period|Withdrawal by Subject|0
4463691|NCT00600119|7254328|FG003|Double-blind Treatment Period|Withdrawal by Subject|1
4463692|NCT00600119|7254329|FG004|Double-blind Treatment Period|Withdrawal by Subject|0
4463693|NCT00600119|7254330|FG005|Double-blind Treatment Period|Withdrawal by Subject|3
4463694|NCT00600119|7254325|FG000|Double-blind Treatment Period|Other|0
4463695|NCT00600119|7254326|FG001|Double-blind Treatment Period|Other|0
4463696|NCT00600119|7254327|FG002|Double-blind Treatment Period|Other|0
4463697|NCT00600119|7254328|FG003|Double-blind Treatment Period|Other|0
4463698|NCT00600119|7254329|FG004|Double-blind Treatment Period|Other|2
4463699|NCT00600119|7254330|FG005|Double-blind Treatment Period|Other|1
4463700|NCT00600119|7254325|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
4463701|NCT00600119|7254326|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1
4463702|NCT00600119|7254327|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
4463703|NCT00600119|7254328|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
4615597|NCT01733758|7474200|FG000|Overall Study|Inv Decision, HbA1c not controlled|1
4615598|NCT01733758|7474201|FG001|Overall Study|Inv Decision, HbA1c not controlled|1
4615599|NCT01733758|7474202|FG002|Overall Study|Inv Decision, HbA1c not controlled|0
4615600|NCT01733758|7474203|FG003|Overall Study|Inv Decision, HbA1c not controlled|1
4615601|NCT01734382|7474249|FG000|Part 1|Adverse Event|2
4615602|NCT01734382|7474250|FG001|Part 1|Adverse Event|0
4463704|NCT00600119|7254329|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1
4463705|NCT00600119|7254330|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
4463706|NCT00600119|7254325|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
4463707|NCT00600119|7254326|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1
4463708|NCT00600119|7254327|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
4463709|NCT00600119|7254328|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
4615603|NCT01734382|7474251|FG002|Part 1|Adverse Event|0
4615604|NCT01734382|7474249|FG000|Part 2|Adverse Event|0
4615605|NCT01734382|7474250|FG001|Part 2|Adverse Event|0
4615606|NCT01734382|7474251|FG002|Part 2|Adverse Event|1
4615607|NCT01734382|7474249|FG000|Part 2|Lack of Efficacy|0
4615608|NCT01734382|7474250|FG001|Part 2|Lack of Efficacy|1
4615609|NCT01734382|7474251|FG002|Part 2|Lack of Efficacy|1
4615610|NCT01734382|7474249|FG000|Part 2|Other|0
4615611|NCT01734382|7474250|FG001|Part 2|Other|0
4615612|NCT01734382|7474251|FG002|Part 2|Other|1
4615613|NCT01734382|7474249|FG000|Part 2|Physician Decision|0
4615614|NCT01734382|7474250|FG001|Part 2|Physician Decision|0
4615615|NCT01734382|7474251|FG002|Part 2|Physician Decision|3
4615616|NCT01734382|7474249|FG000|Part 2|Protocol Violation|0
4615617|NCT01734382|7474250|FG001|Part 2|Protocol Violation|1
4615618|NCT01734382|7474251|FG002|Part 2|Protocol Violation|0
4615619|NCT01734382|7474249|FG000|Part 2|Withdrawal by Subject|0
4615620|NCT01734382|7474250|FG001|Part 2|Withdrawal by Subject|0
4615621|NCT01734382|7474251|FG002|Part 2|Withdrawal by Subject|1
4615622|NCT01734395|7474263|FG000|Overall Study|Other|65
4615623|NCT01734395|7474263|FG000|Overall Study|Lost to Follow-up|287
4615624|NCT01734395|7474263|FG000|Overall Study|Lack of Efficacy|5
4615625|NCT01734395|7474263|FG000|Overall Study|Adverse Event|40
4615626|NCT01734395|7474263|FG000|Overall Study|Withdrawal by Subject|10
4615627|NCT01734395|7474263|FG000|Overall Study|Missing the reasons for not completed|3
4632901|NCT01904773|7502628|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
4632902|NCT01904773|7502629|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
4632903|NCT01904903|7502650|FG000|Overall Study|Withdrawal by Subject|1
4632904|NCT01905267|7502664|FG000|Overall Study|Physician Decision|2
4632905|NCT01905267|7502665|FG001|Overall Study|Physician Decision|2
4632906|NCT01905540|7502696|FG000|Period 3|Other|1
4632907|NCT01905540|7502697|FG001|Period 3|Other|0
4632908|NCT01905540|7502698|FG002|Period 3|Other|1
4632909|NCT01905540|7502699|FG003|Period 3|Other|1
4632910|NCT01905553|7502711|FG000|Period 2|Adverse Event|1
4632911|NCT01905553|7502712|FG001|Period 2|Adverse Event|0
4632912|NCT01905592|7502720|FG000|Overall Study|Disease Progression|51
4632913|NCT01905592|7502721|FG001|Overall Study|Disease Progression|104
4632914|NCT01905592|7502720|FG000|Overall Study|Toxicity|1
4632915|NCT01905592|7502721|FG001|Overall Study|Toxicity|16
4632916|NCT01905592|7502720|FG000|Overall Study|Physician Decision|0
4632917|NCT01905592|7502721|FG001|Overall Study|Physician Decision|2
4632918|NCT01905592|7502720|FG000|Overall Study|New anti-cancer|1
4632919|NCT01905592|7502721|FG001|Overall Study|New anti-cancer|0
4632920|NCT01905592|7502720|FG000|Overall Study|Protocol Violation|0
4632921|NCT01905592|7502721|FG001|Overall Study|Protocol Violation|1
4632922|NCT01905592|7502720|FG000|Overall Study|Sponsor's decision|1
4632923|NCT01905592|7502721|FG001|Overall Study|Sponsor's decision|0
4632924|NCT01905592|7502720|FG000|Overall Study|Not treated|7
4632925|NCT01905592|7502721|FG001|Overall Study|Not treated|3
4632926|NCT01905592|7502720|FG000|Overall Study|Ongoing in Study|0
4632927|NCT01905592|7502721|FG001|Overall Study|Ongoing in Study|7
4632928|NCT01905592|7502720|FG000|Overall Study|Withdrawal by Subject|10
4632929|NCT01905592|7502721|FG001|Overall Study|Withdrawal by Subject|2
4632930|NCT01905657|7502730|FG000|Overall Study|Adverse Event|23
4632931|NCT01905657|7502731|FG001|Overall Study|Adverse Event|17
4632932|NCT01905657|7502732|FG002|Overall Study|Adverse Event|18
4632933|NCT01905657|7502730|FG000|Overall Study|Clinical Progression|103
4632934|NCT01905657|7502731|FG001|Overall Study|Clinical Progression|78
4632935|NCT01905657|7502732|FG002|Overall Study|Clinical Progression|59
4632936|NCT01905657|7502730|FG000|Overall Study|Death|40
4632937|NCT01905657|7502731|FG001|Overall Study|Death|43
4632938|NCT01905657|7502732|FG002|Overall Study|Death|47
4632939|NCT01905657|7502730|FG000|Overall Study|Excluded Medication|13
4632940|NCT01905657|7502731|FG001|Overall Study|Excluded Medication|16
4632941|NCT01905657|7502732|FG002|Overall Study|Excluded Medication|9
4632942|NCT01905657|7502730|FG000|Overall Study|Lost to Follow-up|1
4632943|NCT01905657|7502731|FG001|Overall Study|Lost to Follow-up|2
4632944|NCT01905657|7502732|FG002|Overall Study|Lost to Follow-up|1
4632945|NCT01905657|7502730|FG000|Overall Study|Physician Decision|5
4632946|NCT01905657|7502731|FG001|Overall Study|Physician Decision|8
4632947|NCT01905657|7502732|FG002|Overall Study|Physician Decision|12
4632948|NCT01905657|7502730|FG000|Overall Study|Protocol Violation|2
4632949|NCT01905657|7502731|FG001|Overall Study|Protocol Violation|1
4632950|NCT01905657|7502732|FG002|Overall Study|Protocol Violation|1
4463710|NCT00600119|7254329|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
4463711|NCT00600119|7254330|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
4463712|NCT00600119|7254325|FG000|Double-blind Treatment Period|Sponsor Decision|0
4463713|NCT00600119|7254326|FG001|Double-blind Treatment Period|Sponsor Decision|1
4463714|NCT00600119|7254327|FG002|Double-blind Treatment Period|Sponsor Decision|0
4463715|NCT00600119|7254328|FG003|Double-blind Treatment Period|Sponsor Decision|0
4463716|NCT00600119|7254329|FG004|Double-blind Treatment Period|Sponsor Decision|1
4463717|NCT00600119|7254330|FG005|Double-blind Treatment Period|Sponsor Decision|0
4463718|NCT00600119|7254325|FG000|Double-blind Treatment Period|Physician Decision|2
4463719|NCT00600119|7254326|FG001|Double-blind Treatment Period|Physician Decision|0
4463720|NCT00600119|7254327|FG002|Double-blind Treatment Period|Physician Decision|0
4463721|NCT00600119|7254328|FG003|Double-blind Treatment Period|Physician Decision|0
4463722|NCT00600119|7254329|FG004|Double-blind Treatment Period|Physician Decision|0
4463723|NCT00600119|7254330|FG005|Double-blind Treatment Period|Physician Decision|0
4463724|NCT00600119|7254325|FG000|Double-blind Treatment Period|Lost to Follow-up|0
4463725|NCT00600119|7254326|FG001|Double-blind Treatment Period|Lost to Follow-up|1
4463726|NCT00600119|7254327|FG002|Double-blind Treatment Period|Lost to Follow-up|0
4463727|NCT00600119|7254328|FG003|Double-blind Treatment Period|Lost to Follow-up|0
4463728|NCT00600119|7254329|FG004|Double-blind Treatment Period|Lost to Follow-up|0
4615628|NCT01734434|7474271|FG000|Overall Study|Death Infant|3
4615629|NCT01734434|7474272|FG001|Overall Study|Death Infant|1
4615630|NCT01734434|7474273|FG002|Overall Study|Death Infant|17
4615631|NCT01734434|7474274|FG003|Overall Study|Death Infant|5
4615632|NCT01734434|7474271|FG000|Overall Study|Lost to Follow-up|2
4615633|NCT01734434|7474272|FG001|Overall Study|Lost to Follow-up|9
4615634|NCT01734434|7474273|FG002|Overall Study|Lost to Follow-up|67
4615635|NCT01734434|7474274|FG003|Overall Study|Lost to Follow-up|11
4615636|NCT01734434|7474271|FG000|Overall Study|No Live Birth|1
4615637|NCT01734434|7474272|FG001|Overall Study|No Live Birth|2
4615638|NCT01734434|7474273|FG002|Overall Study|No Live Birth|32
4615639|NCT01734434|7474274|FG003|Overall Study|No Live Birth|6
4615640|NCT01734434|7474271|FG000|Overall Study|Withdrawal by Subject|4
4615641|NCT01734434|7474272|FG001|Overall Study|Withdrawal by Subject|0
4615642|NCT01734434|7474273|FG002|Overall Study|Withdrawal by Subject|8
4615643|NCT01734434|7474274|FG003|Overall Study|Withdrawal by Subject|1
4615644|NCT01734434|7474271|FG000|Overall Study|Signed Adult Version of Consent Form|0
4615645|NCT01734434|7474272|FG001|Overall Study|Signed Adult Version of Consent Form|0
4615646|NCT01734434|7474273|FG002|Overall Study|Signed Adult Version of Consent Form|1
4615647|NCT01734434|7474274|FG003|Overall Study|Signed Adult Version of Consent Form|0
4615648|NCT01734434|7474271|FG000|Overall Study|Subject Not Reachable|0
4615649|NCT01734434|7474272|FG001|Overall Study|Subject Not Reachable|0
4615650|NCT01734434|7474273|FG002|Overall Study|Subject Not Reachable|1
4615651|NCT01734434|7474274|FG003|Overall Study|Subject Not Reachable|0
4615652|NCT01734434|7474271|FG000|Overall Study|Treatment Defaulter|0
4615653|NCT01734434|7474272|FG001|Overall Study|Treatment Defaulter|0
4615654|NCT01734434|7474273|FG002|Overall Study|Treatment Defaulter|1
4615655|NCT01734434|7474274|FG003|Overall Study|Treatment Defaulter|0
4615656|NCT01734434|7474271|FG000|Overall Study|Wrong Version of Consent Form Signed|0
4615657|NCT01734434|7474272|FG001|Overall Study|Wrong Version of Consent Form Signed|0
4615658|NCT01734434|7474273|FG002|Overall Study|Wrong Version of Consent Form Signed|1
4615659|NCT01734434|7474274|FG003|Overall Study|Wrong Version of Consent Form Signed|0
4615660|NCT01734434|7474271|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0
4615661|NCT01734434|7474272|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0
4615662|NCT01734434|7474273|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1
4615663|NCT01734434|7474274|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0
4615664|NCT01734772|7474323|FG000|Overall Study|Adverse Event|1
4615665|NCT01734772|7474324|FG001|Overall Study|Adverse Event|2
4615666|NCT01734772|7474323|FG000|Overall Study|Withdrawal by Subject|0
4615667|NCT01734772|7474324|FG001|Overall Study|Withdrawal by Subject|1
4615668|NCT01734785|7474339|FG000|Open-Label Period|Adverse Event|0
4615669|NCT01734785|7474340|FG001|Open-Label Period|Adverse Event|0
4615670|NCT01734785|7474341|FG002|Open-Label Period|Adverse Event|0
4615671|NCT01734785|7474342|FG003|Open-Label Period|Adverse Event|9
4615672|NCT01734785|7474339|FG000|Open-Label Period|Lack of Efficacy|0
4615673|NCT01734785|7474340|FG001|Open-Label Period|Lack of Efficacy|0
4615674|NCT01734785|7474341|FG002|Open-Label Period|Lack of Efficacy|0
4615675|NCT01734785|7474342|FG003|Open-Label Period|Lack of Efficacy|1
4463729|NCT00600119|7254330|FG005|Double-blind Treatment Period|Lost to Follow-up|0
4615676|NCT01734785|7474339|FG000|Open-Label Period|Protocol Violation|0
4615677|NCT01734785|7474340|FG001|Open-Label Period|Protocol Violation|0
4615678|NCT01734785|7474341|FG002|Open-Label Period|Protocol Violation|0
4615679|NCT01734785|7474342|FG003|Open-Label Period|Protocol Violation|13
4615680|NCT01734785|7474339|FG000|Open-Label Period|Lost to Follow-up|0
4615681|NCT01734785|7474340|FG001|Open-Label Period|Lost to Follow-up|0
4615682|NCT01734785|7474341|FG002|Open-Label Period|Lost to Follow-up|0
4615683|NCT01734785|7474342|FG003|Open-Label Period|Lost to Follow-up|14
4615684|NCT01734785|7474339|FG000|Open-Label Period|Withdrawal by Subject|0
4615685|NCT01734785|7474340|FG001|Open-Label Period|Withdrawal by Subject|0
4615686|NCT01734785|7474341|FG002|Open-Label Period|Withdrawal by Subject|0
4463730|NCT00600119|7254325|FG000|Double-blind Treatment Period|Adverse Event|1
4463731|NCT00600119|7254326|FG001|Double-blind Treatment Period|Adverse Event|1
4463732|NCT00600119|7254327|FG002|Double-blind Treatment Period|Adverse Event|0
4463733|NCT00600119|7254328|FG003|Double-blind Treatment Period|Adverse Event|1
4463734|NCT00600119|7254329|FG004|Double-blind Treatment Period|Adverse Event|2
4463735|NCT00600119|7254330|FG005|Double-blind Treatment Period|Adverse Event|10
4463736|NCT00600119|7254325|FG000|Follow-up Period|Adverse Event|0
4463737|NCT00600119|7254326|FG001|Follow-up Period|Adverse Event|0
4463738|NCT00600119|7254327|FG002|Follow-up Period|Adverse Event|0
4463739|NCT00600119|7254328|FG003|Follow-up Period|Adverse Event|0
4463740|NCT00600119|7254329|FG004|Follow-up Period|Adverse Event|0
4463741|NCT00600119|7254330|FG005|Follow-up Period|Adverse Event|1
4463742|NCT00600119|7254325|FG000|Follow-up Period|Other|1
4463743|NCT00600119|7254326|FG001|Follow-up Period|Other|0
4463744|NCT00600119|7254327|FG002|Follow-up Period|Other|0
4463745|NCT00600119|7254328|FG003|Follow-up Period|Other|0
4463746|NCT00600119|7254329|FG004|Follow-up Period|Other|0
4463747|NCT00600119|7254330|FG005|Follow-up Period|Other|0
4463748|NCT00600171|7254350|FG000|Overall Study|Adverse Event|0
4463749|NCT00600171|7254351|FG001|Overall Study|Adverse Event|1
4463750|NCT00600171|7254352|FG002|Overall Study|Adverse Event|0
4463751|NCT00600171|7254353|FG003|Overall Study|Adverse Event|0
4463752|NCT00600171|7254354|FG004|Overall Study|Adverse Event|1
4463753|NCT00600171|7254355|FG005|Overall Study|Adverse Event|0
4463754|NCT00600171|7254350|FG000|Overall Study|Lack of Efficacy|9
4463755|NCT00600171|7254351|FG001|Overall Study|Lack of Efficacy|12
4463756|NCT00600171|7254352|FG002|Overall Study|Lack of Efficacy|3
4615687|NCT01734785|7474342|FG003|Open-Label Period|Withdrawal by Subject|12
4615688|NCT01734785|7474339|FG000|Open-Label Period|Other Reasons|0
4463757|NCT00600171|7254353|FG003|Overall Study|Lack of Efficacy|5
4463758|NCT00600171|7254354|FG004|Overall Study|Lack of Efficacy|4
4463759|NCT00600171|7254355|FG005|Overall Study|Lack of Efficacy|0
4463760|NCT00600171|7254350|FG000|Overall Study|Protocol Violation|1
4463761|NCT00600171|7254351|FG001|Overall Study|Protocol Violation|2
4463762|NCT00600171|7254352|FG002|Overall Study|Protocol Violation|0
4463763|NCT00600171|7254353|FG003|Overall Study|Protocol Violation|1
4463764|NCT00600171|7254354|FG004|Overall Study|Protocol Violation|0
4463765|NCT00600171|7254355|FG005|Overall Study|Protocol Violation|0
4463766|NCT00600171|7254350|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3
4463767|NCT00600171|7254351|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1
4463768|NCT00600171|7254352|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7
4463769|NCT00600171|7254353|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3
4463770|NCT00600171|7254354|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2
4463771|NCT00600171|7254355|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2
4463772|NCT00600171|7254350|FG000|Overall Study|Withdrawal by Subject|3
4463773|NCT00600171|7254351|FG001|Overall Study|Withdrawal by Subject|0
4463774|NCT00600171|7254352|FG002|Overall Study|Withdrawal by Subject|0
4463775|NCT00600171|7254353|FG003|Overall Study|Withdrawal by Subject|1
4463776|NCT00600171|7254354|FG004|Overall Study|Withdrawal by Subject|1
4463777|NCT00600171|7254355|FG005|Overall Study|Withdrawal by Subject|1
4463778|NCT00600171|7254350|FG000|Overall Study|Physician Decision|0
4463779|NCT00600171|7254351|FG001|Overall Study|Physician Decision|1
4463780|NCT00600171|7254352|FG002|Overall Study|Physician Decision|0
4463781|NCT00600171|7254353|FG003|Overall Study|Physician Decision|1
4463782|NCT00600171|7254354|FG004|Overall Study|Physician Decision|0
4463783|NCT00600171|7254355|FG005|Overall Study|Physician Decision|2
4463784|NCT00600171|7254350|FG000|Overall Study|Lost to Follow-up|0
4463785|NCT00600171|7254351|FG001|Overall Study|Lost to Follow-up|0
4463786|NCT00600171|7254352|FG002|Overall Study|Lost to Follow-up|0
4463787|NCT00600171|7254353|FG003|Overall Study|Lost to Follow-up|1
4463788|NCT00600171|7254354|FG004|Overall Study|Lost to Follow-up|0
4463789|NCT00600171|7254355|FG005|Overall Study|Lost to Follow-up|0
4463790|NCT00600353|7254382|FG000|Overall Study|history of malignancy within 5 years|1
4463791|NCT00600353|7254383|FG001|Overall Study|history of malignancy within 5 years|0
4463792|NCT00600353|7254382|FG000|Overall Study|History of prepartive regimen|0
4463793|NCT00600353|7254383|FG001|Overall Study|History of prepartive regimen|1
4463794|NCT00600613|7254389|FG000|Overall Study|Protocol Deviation|1
4463795|NCT00600756|7254430|FG000|Analysis After 6 Months|Adverse Event|43
4463796|NCT00600756|7254431|FG001|Analysis After 6 Months|Adverse Event|33
4463797|NCT00600756|7254430|FG000|Analysis After 6 Months|Withdrawal by Subject|38
4463798|NCT00600756|7254431|FG001|Analysis After 6 Months|Withdrawal by Subject|30
4463799|NCT00600756|7254430|FG000|Analysis After 6 Months|Incorrect Enrollment|12
4463800|NCT00600756|7254431|FG001|Analysis After 6 Months|Incorrect Enrollment|21
4463801|NCT00600756|7254430|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11
4463802|NCT00600756|7254431|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14
4463803|NCT00600756|7254430|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11
4463804|NCT00600756|7254431|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11
4463805|NCT00600756|7254430|FG000|Analysis After 6 Months|Lost to Follow-up|10
4463806|NCT00600756|7254431|FG001|Analysis After 6 Months|Lost to Follow-up|8
4463807|NCT00600756|7254430|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6
4516250|NCT00958711|7327537|FG001|Overall Study|Death|2
4463808|NCT00600756|7254431|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3
4463809|NCT00600756|7254430|FG000|Overall Study Analysis After 12 Months|Adverse Event|53
4463810|NCT00600756|7254431|FG001|Overall Study Analysis After 12 Months|Adverse Event|44
4463811|NCT00600756|7254430|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51
4463812|NCT00600756|7254431|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41
4463813|NCT00600756|7254430|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21
4463814|NCT00600756|7254431|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29
4463815|NCT00600756|7254430|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17
4463816|NCT00600756|7254431|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20
4463817|NCT00600756|7254430|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16
4463818|NCT00600756|7254431|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20
4463819|NCT00600756|7254430|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16
4463820|NCT00600756|7254431|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13
4463821|NCT00600756|7254430|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9
4463822|NCT00600756|7254431|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9
4463823|NCT00600821|7254439|FG000|Overall Study|Death|45
4615689|NCT01734785|7474340|FG001|Open-Label Period|Other Reasons|0
4615690|NCT01734785|7474341|FG002|Open-Label Period|Other Reasons|0
4615691|NCT01734785|7474342|FG003|Open-Label Period|Other Reasons|224
4615692|NCT01734785|7474339|FG000|Double-Blind Period|Adverse Event|0
4615693|NCT01734785|7474340|FG001|Double-Blind Period|Adverse Event|3
4615694|NCT01734785|7474341|FG002|Double-Blind Period|Adverse Event|2
4615695|NCT01734785|7474342|FG003|Double-Blind Period|Adverse Event|0
4463824|NCT00600821|7254440|FG001|Overall Study|Death|46
4463825|NCT00600821|7254439|FG000|Overall Study|Lost to Follow-up|2
4463826|NCT00600821|7254440|FG001|Overall Study|Lost to Follow-up|2
4463827|NCT00600821|7254439|FG000|Overall Study|Withdrawal by Subject|1
4463828|NCT00600821|7254440|FG001|Overall Study|Withdrawal by Subject|1
4463829|NCT00600821|7254439|FG000|Overall Study|Terminated by sponsor|8
4463830|NCT00600821|7254440|FG001|Overall Study|Terminated by sponsor|6
4463831|NCT00600821|7254439|FG000|Overall Study|Objective progression or relapse|0
4463832|NCT00600821|7254440|FG001|Overall Study|Objective progression or relapse|1
4463833|NCT00600821|7254439|FG000|Overall Study|Randomized but not treated|0
4463834|NCT00600821|7254440|FG001|Overall Study|Randomized but not treated|1
4463835|NCT00600821|7254439|FG000|Overall Study|Other|2
4463836|NCT00600821|7254440|FG001|Overall Study|Other|3
4463837|NCT00600886|7254450|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14
4463838|NCT00600886|7254451|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6
4463839|NCT00600886|7254450|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7
4463840|NCT00600886|7254451|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8
4463841|NCT00600886|7254450|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5
4463842|NCT00600886|7254451|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8
4463843|NCT00600886|7254450|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5
4463844|NCT00600886|7254451|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3
4463845|NCT00600886|7254450|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2
4463846|NCT00600886|7254451|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0
4463847|NCT00600886|7254450|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1
4463848|NCT00600886|7254451|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0
4463849|NCT00600886|7254450|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1
4463850|NCT00600886|7254451|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0
4463851|NCT00600886|7254450|FG000|Core Phase - Full Analysis Set (FAS)|Death|0
4463852|NCT00600886|7254451|FG001|Core Phase - Full Analysis Set (FAS)|Death|1
4463853|NCT00600886|7254450|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16
4463854|NCT00600886|7254451|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2
4463855|NCT00600886|7254450|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3
4463856|NCT00600886|7254451|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3
4463857|NCT00600886|7254450|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9
4463858|NCT00600886|7254451|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3
4463859|NCT00600886|7254450|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3
4463860|NCT00600886|7254451|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1
4463861|NCT00600886|7254450|FG000|Extension - Same Treatment (FAS)|Adverse Event|4
4463862|NCT00600886|7254451|FG001|Extension - Same Treatment (FAS)|Adverse Event|1
4463863|NCT00600886|7254450|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4
4463864|NCT00600886|7254451|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0
4463865|NCT00600886|7254450|FG000|Extension - Same Treatment (FAS)|Death|1
4463866|NCT00600886|7254451|FG001|Extension - Same Treatment (FAS)|Death|1
4463867|NCT00600886|7254450|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6
4463868|NCT00600886|7254451|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0
4463869|NCT00600886|7254450|FG000|Extension - After Crossover (CAS)|Adverse Event|19
4463870|NCT00600886|7254451|FG001|Extension - After Crossover (CAS)|Adverse Event|1
4615696|NCT01734785|7474339|FG000|Double-Blind Period|Lack of Efficacy|0
4615697|NCT01734785|7474340|FG001|Double-Blind Period|Lack of Efficacy|1
4463871|NCT00600886|7254450|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19
4463872|NCT00600886|7254451|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4
4463873|NCT00600886|7254450|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13
4463874|NCT00600886|7254451|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4
4463875|NCT00600886|7254450|FG000|Extension - After Crossover (CAS)|Administrative Problems|4
4463876|NCT00600886|7254451|FG001|Extension - After Crossover (CAS)|Administrative Problems|4
4463877|NCT00600886|7254450|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3
4463878|NCT00600886|7254451|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0
4463879|NCT00600886|7254450|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3
4463880|NCT00600886|7254451|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0
4463881|NCT00600886|7254450|FG000|Extension - After Crossover (CAS)|Death|1
4463882|NCT00600886|7254451|FG001|Extension - After Crossover (CAS)|Death|0
4463883|NCT00600938|7254482|FG000|Core Study|Abnormal test procedure result(s)|3
4463884|NCT00600938|7254483|FG001|Core Study|Abnormal test procedure result(s)|2
4463885|NCT00600938|7254484|FG002|Core Study|Abnormal test procedure result(s)|0
4463886|NCT00600938|7254485|FG003|Core Study|Abnormal test procedure result(s)|0
4463887|NCT00600938|7254482|FG000|Core Study|Unsatisfactory therapeutic effect|1
4463888|NCT00600938|7254483|FG001|Core Study|Unsatisfactory therapeutic effect|2
4463889|NCT00600938|7254484|FG002|Core Study|Unsatisfactory therapeutic effect|0
4463890|NCT00600938|7254485|FG003|Core Study|Unsatisfactory therapeutic effect|0
4463891|NCT00600938|7254482|FG000|Core Study|Patient withdrew consent|7
4463892|NCT00600938|7254483|FG001|Core Study|Patient withdrew consent|12
4463893|NCT00600938|7254484|FG002|Core Study|Patient withdrew consent|0
4463894|NCT00600938|7254485|FG003|Core Study|Patient withdrew consent|0
4463895|NCT00600938|7254482|FG000|Core Study|Lost to Follow-up|3
4463896|NCT00600938|7254483|FG001|Core Study|Lost to Follow-up|2
4463897|NCT00600938|7254484|FG002|Core Study|Lost to Follow-up|0
4463898|NCT00600938|7254485|FG003|Core Study|Lost to Follow-up|0
4463899|NCT00600938|7254482|FG000|Core Study|Death|1
4463900|NCT00600938|7254483|FG001|Core Study|Death|1
4463901|NCT00600938|7254484|FG002|Core Study|Death|0
4463902|NCT00600938|7254485|FG003|Core Study|Death|0
4463903|NCT00600938|7254482|FG000|Core Study|Protocol Violation|1
4463904|NCT00600938|7254483|FG001|Core Study|Protocol Violation|2
4463905|NCT00600938|7254484|FG002|Core Study|Protocol Violation|0
4463906|NCT00600938|7254485|FG003|Core Study|Protocol Violation|0
4463907|NCT00600938|7254482|FG000|Extension Study|Adverse Event|1
4463908|NCT00600938|7254483|FG001|Extension Study|Adverse Event|0
4463909|NCT00600938|7254484|FG002|Extension Study|Adverse Event|2
4463910|NCT00600938|7254485|FG003|Extension Study|Adverse Event|0
4463911|NCT00600938|7254482|FG000|Extension Study|Abnormal test procedure results|0
4463912|NCT00600938|7254483|FG001|Extension Study|Abnormal test procedure results|1
4463913|NCT00600938|7254484|FG002|Extension Study|Abnormal test procedure results|1
4463914|NCT00600938|7254485|FG003|Extension Study|Abnormal test procedure results|1
4463915|NCT00600938|7254482|FG000|Extension Study|Unsatisfactory therapeutic effect|4
4463916|NCT00600938|7254483|FG001|Extension Study|Unsatisfactory therapeutic effect|1
4463917|NCT00600938|7254484|FG002|Extension Study|Unsatisfactory therapeutic effect|1
4463918|NCT00600938|7254485|FG003|Extension Study|Unsatisfactory therapeutic effect|0
4463919|NCT00600938|7254482|FG000|Extension Study|Withdrawal by Subject|2
4463920|NCT00600938|7254483|FG001|Extension Study|Withdrawal by Subject|2
4463921|NCT00600938|7254484|FG002|Extension Study|Withdrawal by Subject|3
4463922|NCT00600938|7254485|FG003|Extension Study|Withdrawal by Subject|0
4463923|NCT00600938|7254482|FG000|Extension Study|Lost to Follow-up|1
4463924|NCT00600938|7254483|FG001|Extension Study|Lost to Follow-up|1
4463925|NCT00600938|7254484|FG002|Extension Study|Lost to Follow-up|2
4463926|NCT00600938|7254485|FG003|Extension Study|Lost to Follow-up|0
4463927|NCT00600938|7254482|FG000|Extension Study|Death|1
4463928|NCT00600938|7254483|FG001|Extension Study|Death|0
4463929|NCT00600938|7254484|FG002|Extension Study|Death|0
4463930|NCT00600938|7254485|FG003|Extension Study|Death|0
4615698|NCT01734785|7474341|FG002|Double-Blind Period|Lack of Efficacy|0
4615699|NCT01734785|7474342|FG003|Double-Blind Period|Lack of Efficacy|0
4615700|NCT01734785|7474339|FG000|Double-Blind Period|Protocol Violation|0
4615701|NCT01734785|7474340|FG001|Double-Blind Period|Protocol Violation|1
4615702|NCT01734785|7474341|FG002|Double-Blind Period|Protocol Violation|1
4615703|NCT01734785|7474342|FG003|Double-Blind Period|Protocol Violation|0
4615704|NCT01734785|7474339|FG000|Double-Blind Period|Lost to Follow-up|2
4615705|NCT01734785|7474340|FG001|Double-Blind Period|Lost to Follow-up|4
4615706|NCT01734785|7474341|FG002|Double-Blind Period|Lost to Follow-up|2
4615707|NCT01734785|7474342|FG003|Double-Blind Period|Lost to Follow-up|0
4615708|NCT01734785|7474339|FG000|Double-Blind Period|Withdrawal by Subject|2
4615709|NCT01734785|7474340|FG001|Double-Blind Period|Withdrawal by Subject|0
4615710|NCT01734785|7474341|FG002|Double-Blind Period|Withdrawal by Subject|0
4463931|NCT00601107|7254514|FG000|Overall Study|Adverse Event|0
4463932|NCT00601107|7254515|FG001|Overall Study|Adverse Event|1
4463933|NCT00601107|7254516|FG002|Overall Study|Adverse Event|3
4463934|NCT00601107|7254517|FG003|Overall Study|Adverse Event|0
4463935|NCT00601107|7254514|FG000|Overall Study|Withdrawal by Subject|5
4463936|NCT00601107|7254515|FG001|Overall Study|Withdrawal by Subject|4
4615711|NCT01734785|7474342|FG003|Double-Blind Period|Withdrawal by Subject|0
4615712|NCT01734785|7474339|FG000|Double-Blind Period|Not treated|1
4463937|NCT00601107|7254516|FG002|Overall Study|Withdrawal by Subject|7
4463938|NCT00601107|7254517|FG003|Overall Study|Withdrawal by Subject|4
4463939|NCT00601107|7254514|FG000|Overall Study|Lost to Follow-up|3
4463940|NCT00601107|7254515|FG001|Overall Study|Lost to Follow-up|3
4463941|NCT00601107|7254516|FG002|Overall Study|Lost to Follow-up|0
4463942|NCT00601107|7254517|FG003|Overall Study|Lost to Follow-up|3
4463943|NCT00601107|7254514|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
4463944|NCT00601107|7254515|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
4463945|NCT00601107|7254516|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
4463946|NCT00601107|7254517|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1
4463947|NCT00601107|7254514|FG000|Overall Study|Worsening of Psoriasis|4
4463948|NCT00601107|7254515|FG001|Overall Study|Worsening of Psoriasis|1
4463949|NCT00601107|7254516|FG002|Overall Study|Worsening of Psoriasis|1
4463950|NCT00601107|7254517|FG003|Overall Study|Worsening of Psoriasis|4
4463951|NCT00601107|7254514|FG000|Overall Study|Undefined|1
4463952|NCT00601107|7254515|FG001|Overall Study|Undefined|0
4463953|NCT00601107|7254516|FG002|Overall Study|Undefined|1
4463954|NCT00601107|7254517|FG003|Overall Study|Undefined|0
4463955|NCT00601172|7254533|FG000|Overall Study|Adverse Event|43
4463956|NCT00601172|7254534|FG001|Overall Study|Adverse Event|32
4463957|NCT00601172|7254533|FG000|Overall Study|Lack of Efficacy|11
4463958|NCT00601172|7254534|FG001|Overall Study|Lack of Efficacy|12
4463959|NCT00601172|7254533|FG000|Overall Study|Protocol Violation|2
4463960|NCT00601172|7254534|FG001|Overall Study|Protocol Violation|5
4463961|NCT00601172|7254533|FG000|Overall Study|Lost to Follow-up|4
4463962|NCT00601172|7254534|FG001|Overall Study|Lost to Follow-up|3
4540496|NCT01133405|7363199|FG004|Period 1|Received drug only in period 3|0
4540497|NCT01133405|7363200|FG005|Period 1|Received drug only in period 3|0
4540498|NCT01133405|7363201|FG006|Period 1|Received drug only in period 3|0
4540499|NCT01133405|7363202|FG007|Period 1|Received drug only in period 3|0
4540500|NCT01133405|7363203|FG008|Period 1|Received drug only in period 3|0
4540501|NCT01133405|7363204|FG009|Period 1|Received drug only in period 3|0
4540502|NCT01133405|7363195|FG000|Period 2|Adverse Event|0
4540503|NCT01133405|7363196|FG001|Period 2|Adverse Event|0
4540504|NCT01133405|7363197|FG002|Period 2|Adverse Event|1
4540505|NCT01133405|7363198|FG003|Period 2|Adverse Event|0
4540506|NCT01133405|7363199|FG004|Period 2|Adverse Event|0
4540507|NCT01133405|7363200|FG005|Period 2|Adverse Event|0
4540508|NCT01133405|7363201|FG006|Period 2|Adverse Event|0
4540509|NCT01133405|7363202|FG007|Period 2|Adverse Event|0
4540510|NCT01133405|7363203|FG008|Period 2|Adverse Event|0
4540511|NCT01133405|7363204|FG009|Period 2|Adverse Event|0
4463963|NCT00601172|7254533|FG000|Overall Study|Physician Decision|27
4463964|NCT00601172|7254534|FG001|Overall Study|Physician Decision|28
4463965|NCT00601172|7254533|FG000|Overall Study|Withdrawal by Subject|35
4463966|NCT00601172|7254534|FG001|Overall Study|Withdrawal by Subject|27
4463967|NCT00601172|7254533|FG000|Overall Study|Did not meet continuation criteria|19
4463968|NCT00601172|7254534|FG001|Overall Study|Did not meet continuation criteria|20
4463969|NCT00601250|7254543|FG000|Overall Study|Adverse Event|3
4463970|NCT00601250|7254544|FG001|Overall Study|Adverse Event|9
4463971|NCT00601250|7254543|FG000|Overall Study|Protocol Violation|3
4463972|NCT00601250|7254544|FG001|Overall Study|Protocol Violation|2
4463973|NCT00601250|7254543|FG000|Overall Study|Lost to Follow-up|2
4463974|NCT00601250|7254544|FG001|Overall Study|Lost to Follow-up|6
4463975|NCT00601250|7254543|FG000|Overall Study|Withdrawal by Subject|4
4463976|NCT00601250|7254544|FG001|Overall Study|Withdrawal by Subject|13
4463977|NCT00601250|7254543|FG000|Overall Study|Other incl. lack of efficacy|2
4463978|NCT00601250|7254544|FG001|Overall Study|Other incl. lack of efficacy|9
4463979|NCT00601354|7254552|FG000|Overall Study|Lost to Follow-up|4
4463980|NCT00601354|7254553|FG001|Overall Study|Lost to Follow-up|5
4463981|NCT00601419|7254563|FG000|Overall Study|Lost to Follow-up|3
4463982|NCT00601419|7254563|FG000|Overall Study|Missed Visits|1
4463983|NCT00601458|7254586|FG000|Overall Study|Dosing Error|1
4463984|NCT00601458|7254587|FG001|Overall Study|Dosing Error|0
4463985|NCT00601458|7254588|FG002|Overall Study|Dosing Error|0
4463986|NCT00601458|7254586|FG000|Overall Study|Incomplete Data|0
4463987|NCT00601458|7254587|FG001|Overall Study|Incomplete Data|2
4463988|NCT00601458|7254588|FG002|Overall Study|Incomplete Data|0
4463989|NCT00601458|7254586|FG000|Overall Study|Protocol Violation|3
4463990|NCT00601458|7254587|FG001|Overall Study|Protocol Violation|2
4463991|NCT00601458|7254588|FG002|Overall Study|Protocol Violation|1
4463992|NCT00601458|7254586|FG000|Overall Study|Early Termination|0
4463993|NCT00601458|7254587|FG001|Overall Study|Early Termination|1
4463994|NCT00601458|7254588|FG002|Overall Study|Early Termination|1
4463995|NCT00601484|7254598|FG000|Overall Study|Adverse Event|0
4463996|NCT00601484|7254599|FG001|Overall Study|Adverse Event|1
4463997|NCT00601484|7254598|FG000|Overall Study|Lost to Follow-up|4
4463998|NCT00601484|7254599|FG001|Overall Study|Lost to Follow-up|3
4463999|NCT00601484|7254598|FG000|Overall Study|Lack of Efficacy|0
4464000|NCT00601484|7254599|FG001|Overall Study|Lack of Efficacy|2
4464001|NCT00601484|7254598|FG000|Overall Study|Withdrawal by Subject|1
4464002|NCT00601484|7254599|FG001|Overall Study|Withdrawal by Subject|1
4464003|NCT00601484|7254598|FG000|Overall Study|Randomized, but not treated|0
4540512|NCT01133405|7363195|FG000|Period 2|Withdrawal by Subject|0
4540513|NCT01133405|7363196|FG001|Period 2|Withdrawal by Subject|0
4540514|NCT01133405|7363197|FG002|Period 2|Withdrawal by Subject|0
4464004|NCT00601484|7254599|FG001|Overall Study|Randomized, but not treated|1
4464005|NCT00601523|7254607|FG000|Overall Study|Adverse Event|42
4464006|NCT00601523|7254608|FG001|Overall Study|Adverse Event|14
4464007|NCT00601523|7254607|FG000|Overall Study|Lack of Efficacy|3
4540515|NCT01133405|7363198|FG003|Period 2|Withdrawal by Subject|1
4540516|NCT01133405|7363199|FG004|Period 2|Withdrawal by Subject|0
4540517|NCT01133405|7363200|FG005|Period 2|Withdrawal by Subject|1
4540518|NCT01133405|7363201|FG006|Period 2|Withdrawal by Subject|0
4540519|NCT01133405|7363202|FG007|Period 2|Withdrawal by Subject|0
4540520|NCT01133405|7363203|FG008|Period 2|Withdrawal by Subject|0
4540521|NCT01133405|7363204|FG009|Period 2|Withdrawal by Subject|0
4540522|NCT01133405|7363195|FG000|Period 2|Entry Criteria Not Met|0
4540523|NCT01133405|7363196|FG001|Period 2|Entry Criteria Not Met|1
4540524|NCT01133405|7363197|FG002|Period 2|Entry Criteria Not Met|0
4540525|NCT01133405|7363198|FG003|Period 2|Entry Criteria Not Met|0
4540526|NCT01133405|7363199|FG004|Period 2|Entry Criteria Not Met|0
4540527|NCT01133405|7363200|FG005|Period 2|Entry Criteria Not Met|0
4540528|NCT01133405|7363201|FG006|Period 2|Entry Criteria Not Met|0
4540529|NCT01133405|7363202|FG007|Period 2|Entry Criteria Not Met|0
4540530|NCT01133405|7363203|FG008|Period 2|Entry Criteria Not Met|0
4540531|NCT01133405|7363204|FG009|Period 2|Entry Criteria Not Met|0
4540532|NCT01133405|7363195|FG000|Period 2|Physician Decision|0
4540533|NCT01133405|7363196|FG001|Period 2|Physician Decision|0
4540534|NCT01133405|7363197|FG002|Period 2|Physician Decision|0
4540535|NCT01133405|7363198|FG003|Period 2|Physician Decision|0
4540536|NCT01133405|7363199|FG004|Period 2|Physician Decision|0
4540537|NCT01133405|7363200|FG005|Period 2|Physician Decision|1
4540538|NCT01133405|7363201|FG006|Period 2|Physician Decision|0
4540539|NCT01133405|7363202|FG007|Period 2|Physician Decision|0
4540540|NCT01133405|7363203|FG008|Period 2|Physician Decision|0
4540541|NCT01133405|7363204|FG009|Period 2|Physician Decision|0
4540542|NCT01133418|7363236|FG000|Overall Study|Lost to Follow-up|5
4540543|NCT01133418|7363237|FG001|Overall Study|Lost to Follow-up|6
4540544|NCT01133522|7363253|FG000|Overall Study|Withdrawal by Subject|0
4540545|NCT01133522|7363254|FG001|Overall Study|Withdrawal by Subject|1
4540546|NCT01133522|7363255|FG002|Overall Study|Withdrawal by Subject|0
4540547|NCT01133522|7363256|FG003|Overall Study|Withdrawal by Subject|1
4540548|NCT01133522|7363257|FG004|Overall Study|Withdrawal by Subject|0
4540549|NCT01133522|7363258|FG005|Overall Study|Withdrawal by Subject|0
4540550|NCT01133522|7363259|FG006|Overall Study|Withdrawal by Subject|0
4615713|NCT01734785|7474340|FG001|Double-Blind Period|Not treated|0
4615714|NCT01734785|7474341|FG002|Double-Blind Period|Not treated|0
4615715|NCT01734785|7474342|FG003|Double-Blind Period|Not treated|0
4615716|NCT01734811|7474353|FG000|Overall Study|Lost to Follow-up|2
4615717|NCT01734811|7474354|FG001|Overall Study|Lost to Follow-up|3
4615718|NCT01734811|7474353|FG000|Overall Study|Withdrawal by Subject|2
4615719|NCT01734811|7474354|FG001|Overall Study|Withdrawal by Subject|0
4615720|NCT01734850|7474363|FG000|Overall Study|Continued to Week 48 but recommenced ART|3
4615721|NCT01734850|7474364|FG001|Overall Study|Continued to Week 48 but recommenced ART|2
4615722|NCT01734850|7474365|FG002|Overall Study|Continued to Week 48 but recommenced ART|3
4615723|NCT01734850|7474363|FG000|Overall Study|Not infused due to manufacturing failure|0
4615724|NCT01734850|7474364|FG001|Overall Study|Not infused due to manufacturing failure|0
4615725|NCT01734850|7474365|FG002|Overall Study|Not infused due to manufacturing failure|1
4615726|NCT01734902|7474383|FG000|Overall Study|Other than listed|0
4615727|NCT01734902|7474384|FG001|Overall Study|Other than listed|2
4615728|NCT01734993|7474390|FG000|Overall Study|Adverse Event|1
4615729|NCT01734993|7474390|FG000|Overall Study|Lack of Efficacy|1
4615730|NCT01735175|7474397|FG000|Overall Study|Withdrawal by Subject|9
4615731|NCT01735175|7474398|FG001|Overall Study|Withdrawal by Subject|2
4615732|NCT01735175|7474397|FG000|Overall Study|Lost to Follow-up|4
4615733|NCT01735175|7474398|FG001|Overall Study|Lost to Follow-up|2
4615734|NCT01735175|7474397|FG000|Overall Study|Death|3
4615735|NCT01735175|7474398|FG001|Overall Study|Death|2
4615736|NCT01735175|7474397|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13
4615737|NCT01735175|7474398|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7
4615738|NCT01735201|7474412|FG000|Overall Study|Adverse Event|1
4615739|NCT01735201|7474413|FG001|Overall Study|Adverse Event|1
4615740|NCT01735201|7474414|FG002|Overall Study|Adverse Event|0
4615741|NCT01735201|7474415|FG003|Overall Study|Adverse Event|1
4615742|NCT01735201|7474416|FG004|Overall Study|Adverse Event|1
4615743|NCT01735201|7474417|FG005|Overall Study|Adverse Event|3
4615744|NCT01735201|7474418|FG006|Overall Study|Adverse Event|2
4690452|NCT02561195|7600193|FG008|Vaccination 1 to 3|Death|0
4540551|NCT01133522|7363260|FG007|Overall Study|Withdrawal by Subject|0
4540552|NCT01133522|7363261|FG008|Overall Study|Withdrawal by Subject|0
4540553|NCT01133522|7363262|FG009|Overall Study|Withdrawal by Subject|0
4615745|NCT01735201|7474419|FG007|Overall Study|Adverse Event|1
4615746|NCT01735201|7474412|FG000|Overall Study|Personal Reasons|1
4615747|NCT01735201|7474413|FG001|Overall Study|Personal Reasons|0
4615748|NCT01735201|7474414|FG002|Overall Study|Personal Reasons|0
4615749|NCT01735201|7474415|FG003|Overall Study|Personal Reasons|0
4615750|NCT01735201|7474416|FG004|Overall Study|Personal Reasons|0
4615751|NCT01735201|7474417|FG005|Overall Study|Personal Reasons|0
4615752|NCT01735201|7474418|FG006|Overall Study|Personal Reasons|0
4615753|NCT01735201|7474419|FG007|Overall Study|Personal Reasons|0
4464008|NCT00601523|7254608|FG001|Overall Study|Lack of Efficacy|0
4464009|NCT00601523|7254607|FG000|Overall Study|Protocol Violation|5
4464010|NCT00601523|7254608|FG001|Overall Study|Protocol Violation|1
4464011|NCT00601523|7254607|FG000|Overall Study|Lost to Follow-up|0
4464012|NCT00601523|7254608|FG001|Overall Study|Lost to Follow-up|1
4464013|NCT00601523|7254607|FG000|Overall Study|Withdrawal by Subject|18
4464014|NCT00601523|7254608|FG001|Overall Study|Withdrawal by Subject|9
4464015|NCT00601523|7254607|FG000|Overall Study|Other|9
4464016|NCT00601523|7254608|FG001|Overall Study|Other|1
4464017|NCT00601640|7254621|FG000|Overall Study|Withdrawal by Subject|3
4464018|NCT00601640|7254622|FG001|Overall Study|Withdrawal by Subject|0
4464019|NCT00601640|7254623|FG002|Overall Study|Withdrawal by Subject|7
4615754|NCT01735201|7474412|FG000|Overall Study|Protocol Violation|1
4615755|NCT01735201|7474413|FG001|Overall Study|Protocol Violation|0
4615756|NCT01735201|7474414|FG002|Overall Study|Protocol Violation|0
4615757|NCT01735201|7474415|FG003|Overall Study|Protocol Violation|0
4615758|NCT01735201|7474416|FG004|Overall Study|Protocol Violation|0
4615759|NCT01735201|7474417|FG005|Overall Study|Protocol Violation|0
4615760|NCT01735201|7474418|FG006|Overall Study|Protocol Violation|0
4615761|NCT01735201|7474419|FG007|Overall Study|Protocol Violation|0
4615762|NCT01735201|7474412|FG000|Overall Study|Other Miscellaneous Reasons|0
4615763|NCT01735201|7474413|FG001|Overall Study|Other Miscellaneous Reasons|0
4464020|NCT00601640|7254621|FG000|Overall Study|Death|1
4464021|NCT00601640|7254622|FG001|Overall Study|Death|0
4464022|NCT00601640|7254623|FG002|Overall Study|Death|0
4464023|NCT00601640|7254621|FG000|Overall Study|Adverse Event|0
4464024|NCT00601640|7254622|FG001|Overall Study|Adverse Event|4
4464025|NCT00601640|7254623|FG002|Overall Study|Adverse Event|2
4464026|NCT00601640|7254621|FG000|Overall Study|intercurrent illness|1
4464027|NCT00601640|7254622|FG001|Overall Study|intercurrent illness|0
4464028|NCT00601640|7254623|FG002|Overall Study|intercurrent illness|0
4464029|NCT00601640|7254621|FG000|Overall Study|change in eligibility status|0
4464030|NCT00601640|7254622|FG001|Overall Study|change in eligibility status|1
4464031|NCT00601640|7254623|FG002|Overall Study|change in eligibility status|1
4464032|NCT00601705|7254633|FG000|Overall Study|Withdrawal by Subject|1
4615764|NCT01735201|7474414|FG002|Overall Study|Other Miscellaneous Reasons|0
4615765|NCT01735201|7474415|FG003|Overall Study|Other Miscellaneous Reasons|1
4615766|NCT01735201|7474416|FG004|Overall Study|Other Miscellaneous Reasons|0
4615767|NCT01735201|7474417|FG005|Overall Study|Other Miscellaneous Reasons|2
4615768|NCT01735201|7474418|FG006|Overall Study|Other Miscellaneous Reasons|1
4615769|NCT01735201|7474419|FG007|Overall Study|Other Miscellaneous Reasons|1
4615770|NCT01735279|7474443|FG000|Overall Study|Lost to Follow-up|11
4615771|NCT01735279|7474444|FG001|Overall Study|Lost to Follow-up|8
4615772|NCT01735396|7474450|FG000|Overall Study|not evaluable|1
4615773|NCT01735630|7474463|FG000|Overall Study|Adverse Event|8
4615774|NCT01735630|7474464|FG001|Overall Study|Adverse Event|7
4615775|NCT01735630|7474463|FG000|Overall Study|Lost to Follow-up|1
4615776|NCT01735630|7474464|FG001|Overall Study|Lost to Follow-up|0
4615777|NCT01735630|7474463|FG000|Overall Study|Physician Decision|0
4615778|NCT01735630|7474464|FG001|Overall Study|Physician Decision|1
4615779|NCT01735630|7474463|FG000|Overall Study|Sponsor Decision|2
4615780|NCT01735630|7474464|FG001|Overall Study|Sponsor Decision|1
4615781|NCT01735630|7474463|FG000|Overall Study|Withdrawal by Subject|7
4615782|NCT01735630|7474464|FG001|Overall Study|Withdrawal by Subject|9
4615783|NCT01735916|7474482|FG000|Overall Study|Subject not eligible to be randomized|11
4615784|NCT01735916|7474483|FG001|Overall Study|Subject not eligible to be randomized|0
4615785|NCT01735916|7474484|FG002|Overall Study|Subject not eligible to be randomized|0
4615786|NCT01735916|7474482|FG000|Overall Study|Early termination of study by sponsor|4
4615787|NCT01735916|7474483|FG001|Overall Study|Early termination of study by sponsor|19
4615788|NCT01735916|7474484|FG002|Overall Study|Early termination of study by sponsor|7
4615789|NCT01735916|7474482|FG000|Overall Study|Withdrawal by Subject|3
4615790|NCT01735916|7474483|FG001|Overall Study|Withdrawal by Subject|0
4615791|NCT01735916|7474484|FG002|Overall Study|Withdrawal by Subject|0
4615792|NCT01735994|7474504|FG000|Overall Study|Withdrawal by Subject|6
4615793|NCT01735994|7474505|FG001|Overall Study|Withdrawal by Subject|4
4615794|NCT01735994|7474504|FG000|Overall Study|Injury|2
4615795|NCT01735994|7474505|FG001|Overall Study|Injury|0
4615796|NCT01735994|7474504|FG000|Overall Study|Kicked off team|5
4615797|NCT01735994|7474505|FG001|Overall Study|Kicked off team|0
4615798|NCT01735994|7474504|FG000|Overall Study|Lost to Follow-up|50
4615799|NCT01735994|7474505|FG001|Overall Study|Lost to Follow-up|62
4464033|NCT00601835|7254689|FG000|Overall Study|Withdrawal by Subject|9
4464034|NCT00601835|7254690|FG001|Overall Study|Withdrawal by Subject|6
4464035|NCT00601835|7254689|FG000|Overall Study|Physician Decision|1
4615800|NCT01736124|7474535|FG000|Post-intervention Assessment|Death|2
4615801|NCT01736124|7474536|FG001|Post-intervention Assessment|Death|2
4615802|NCT01736124|7474535|FG000|Post-intervention Assessment|lost computer access|1
4615803|NCT01736124|7474536|FG001|Post-intervention Assessment|lost computer access|1
4615804|NCT01736124|7474535|FG000|Post-intervention Assessment|Moved away|3
4615805|NCT01736124|7474536|FG001|Post-intervention Assessment|Moved away|1
4615806|NCT01736124|7474535|FG000|Post-intervention Assessment|Withdrawal by Subject|11
4615807|NCT01736124|7474536|FG001|Post-intervention Assessment|Withdrawal by Subject|9
4615808|NCT01736124|7474535|FG000|Post-intervention Assessment|Illness|3
4464036|NCT00601835|7254690|FG001|Overall Study|Physician Decision|0
4464037|NCT00601835|7254689|FG000|Overall Study|Lost to Follow-up|37
4464038|NCT00601835|7254690|FG001|Overall Study|Lost to Follow-up|5
4464039|NCT00601835|7254689|FG000|Overall Study|Adverse Event|1
4464040|NCT00601835|7254690|FG001|Overall Study|Adverse Event|1
4464041|NCT00601835|7254689|FG000|Overall Study|Relocate|12
4464042|NCT00601835|7254690|FG001|Overall Study|Relocate|2
4464043|NCT00602420|7254766|FG000|Overall Study|Death|1
4464044|NCT00602420|7254767|FG001|Overall Study|Death|4
4464045|NCT00602420|7254766|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5
4464046|NCT00602420|7254767|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3
4464047|NCT00602420|7254766|FG000|Overall Study|Withdrawal by Subject|18
4464048|NCT00602420|7254767|FG001|Overall Study|Withdrawal by Subject|17
4464049|NCT00602420|7254766|FG000|Overall Study|Adverse Event|1
4464050|NCT00602420|7254767|FG001|Overall Study|Adverse Event|0
4464051|NCT00602472|7254779|FG000|Overall Study|Adverse Event|5
4464052|NCT00602472|7254780|FG001|Overall Study|Adverse Event|23
4464053|NCT00602472|7254779|FG000|Overall Study|Protocol Violation|4
4464054|NCT00602472|7254780|FG001|Overall Study|Protocol Violation|19
4615809|NCT01736124|7474536|FG001|Post-intervention Assessment|Illness|2
4615810|NCT01736124|7474535|FG000|Post-intervention Assessment|Lost to Follow-up|8
4615811|NCT01736124|7474536|FG001|Post-intervention Assessment|Lost to Follow-up|5
4615812|NCT01736124|7474535|FG000|Post-intervention Assessment|Temporarily away|3
4615813|NCT01736124|7474536|FG001|Post-intervention Assessment|Temporarily away|1
4615814|NCT01736124|7474535|FG000|6 Mo. Post-Intervention Assessment|Death|0
4615815|NCT01736124|7474536|FG001|6 Mo. Post-Intervention Assessment|Death|1
4615816|NCT01736124|7474535|FG000|6 Mo. Post-Intervention Assessment|Moved away|0
4615817|NCT01736124|7474536|FG001|6 Mo. Post-Intervention Assessment|Moved away|2
4615818|NCT01736124|7474535|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3
4615819|NCT01736124|7474536|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3
4615820|NCT01736124|7474535|FG000|6 Mo. Post-Intervention Assessment|Illness|1
4615821|NCT01736124|7474536|FG001|6 Mo. Post-Intervention Assessment|Illness|2
4615822|NCT01736124|7474535|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1
4615823|NCT01736124|7474536|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4
4615824|NCT01736124|7474535|FG000|12 Mo. Post-Intervention Assessment|Death|1
4615825|NCT01736124|7474536|FG001|12 Mo. Post-Intervention Assessment|Death|0
4615826|NCT01736124|7474535|FG000|12 Mo. Post-Intervention Assessment|Moved away|1
4615827|NCT01736124|7474536|FG001|12 Mo. Post-Intervention Assessment|Moved away|0
4615828|NCT01736124|7474535|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0
4615829|NCT01736124|7474536|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2
4615830|NCT01736124|7474535|FG000|12 Mo. Post-Intervention Assessment|End of study|10
4615831|NCT01736124|7474536|FG001|12 Mo. Post-Intervention Assessment|End of study|10
4615832|NCT01736176|7474544|FG000|Overall Study|Adverse Event|3
4615833|NCT01736176|7474544|FG000|Overall Study|Withdrawal by Subject|4
4615834|NCT01736176|7474544|FG000|Overall Study|Lack of Efficacy|3
4615835|NCT01736176|7474544|FG000|Overall Study|Unable to Complete PEG Placement|1
4615836|NCT01736189|7474552|FG000|Overall Study|Violation of registration criteria|41
4615837|NCT01736189|7474552|FG000|Overall Study|Protocol Violation|4
4615838|NCT01736189|7474552|FG000|Overall Study|Criteria and protocol violations|1
4615839|NCT01736215|7474556|FG000|Overall Study|Early termination of erythropoietin use|1
4615840|NCT01736215|7474556|FG000|Overall Study|Adverse Event|4
4615841|NCT01736215|7474556|FG000|Overall Study|Progressive disease stop chemotherapy|1
4615842|NCT01736215|7474556|FG000|Overall Study|Insufficient data to perform analysis|8
4615843|NCT01736254|7474590|FG000|Period 2 (Days 2 to 12)|Adverse Event|3
4615844|NCT01736254|7474590|FG000|Period 3 (Days 13 to 23)|Adverse Event|1
4615845|NCT01736397|7474613|FG000|Overall Study|Lack of Efficacy|1
4615846|NCT01736397|7474614|FG001|Overall Study|Lack of Efficacy|11
4615847|NCT01736397|7474613|FG000|Overall Study|Withdrawal by Subject|6
4615848|NCT01736397|7474614|FG001|Overall Study|Withdrawal by Subject|5
4615849|NCT01736397|7474613|FG000|Overall Study|Lost to Follow-up|0
4615850|NCT01736397|7474614|FG001|Overall Study|Lost to Follow-up|1
4615851|NCT01736397|7474613|FG000|Overall Study|Adverse Event|6
4615852|NCT01736397|7474614|FG001|Overall Study|Adverse Event|3
4615853|NCT01736397|7474613|FG000|Overall Study|Not stated|1
4615854|NCT01736397|7474614|FG001|Overall Study|Not stated|4
4464055|NCT00602472|7254779|FG000|Overall Study|Withdrawal by Subject|8
4464056|NCT00602472|7254780|FG001|Overall Study|Withdrawal by Subject|14
4464057|NCT00602472|7254779|FG000|Overall Study|Other incl. lack of efficacy|4
4464058|NCT00602472|7254780|FG001|Overall Study|Other incl. lack of efficacy|2
4464059|NCT00602537|7254788|FG000|12 Week Double Blind Comparison|Adverse Event|2
4615855|NCT01736475|7474622|FG000|Overall Study|Adverse Event|4
4615856|NCT01736475|7474623|FG001|Overall Study|Adverse Event|0
4615857|NCT01736475|7474622|FG000|Overall Study|Withdrawal by Subject|2
4615858|NCT01736475|7474623|FG001|Overall Study|Withdrawal by Subject|0
4615859|NCT01736475|7474622|FG000|Overall Study|Protocol Violation|4
4615860|NCT01736475|7474623|FG001|Overall Study|Protocol Violation|0
4615861|NCT01736475|7474622|FG000|Overall Study|Other - Screen failure|1
4615862|NCT01736475|7474623|FG001|Overall Study|Other - Screen failure|0
4615863|NCT01736475|7474622|FG000|Overall Study|Other - Surgical procedure|1
4464060|NCT00602537|7254789|FG001|12 Week Double Blind Comparison|Adverse Event|5
4464061|NCT00602537|7254788|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13
4464062|NCT00602537|7254789|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23
4464063|NCT00602537|7254788|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5
4464064|NCT00602537|7254789|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6
4464065|NCT00602537|7254788|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3
4615864|NCT01736475|7474623|FG001|Overall Study|Other - Surgical procedure|0
4615865|NCT01736540|7474644|FG000|Overall Study|Did not complete scan within 45 days|2
4615866|NCT01736540|7474644|FG000|Overall Study|Death|1
4615867|NCT01736540|7474644|FG000|Overall Study|Abnormal test procedure|1
4615868|NCT01736540|7474644|FG000|Overall Study|Withdrawal by Subject|5
4615869|NCT01736540|7474644|FG000|Overall Study|Protocol Violation|1
4615870|NCT01736540|7474644|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1
4615871|NCT01736540|7474644|FG000|Overall Study|No show for MRI appointment|1
4615872|NCT01736540|7474644|FG000|Overall Study|Unable to make MRI appointment|3
4615873|NCT01736553|7474657|FG000|Overall Study|Death|12
4615874|NCT01736553|7474658|FG001|Overall Study|Death|0
4615875|NCT01736553|7474657|FG000|Overall Study|Withdrawal by Subject|5
4615876|NCT01736553|7474658|FG001|Overall Study|Withdrawal by Subject|2
4615877|NCT01736553|7474657|FG000|Overall Study|Lost to Follow-up|2
4615878|NCT01736553|7474658|FG001|Overall Study|Lost to Follow-up|2
4615879|NCT01736566|7474687|FG000|Long Term Follow-up|Still collecting data|42
4615880|NCT01736566|7474688|FG001|Long Term Follow-up|Still collecting data|0
4615881|NCT01736566|7474689|FG002|Long Term Follow-up|Still collecting data|49
4615882|NCT01736566|7474690|FG003|Long Term Follow-up|Still collecting data|0
4615883|NCT01736566|7474691|FG004|Long Term Follow-up|Still collecting data|1
4615884|NCT01736579|7474718|FG000|Overall Study|Termination of Study by Sponsor|2
4615885|NCT01736579|7474719|FG001|Overall Study|Termination of Study by Sponsor|2
4615886|NCT01736657|7474725|FG000|Overall Study|insufficient vascular access|1
4615887|NCT01736683|7474734|FG000|Overall Study|Disease Relapse|0
4615888|NCT01736683|7474735|FG001|Overall Study|Disease Relapse|0
4615889|NCT01736683|7474736|FG002|Overall Study|Disease Relapse|2
4615890|NCT01736683|7474737|FG003|Overall Study|Disease Relapse|1
4615891|NCT01736683|7474738|FG004|Overall Study|Disease Relapse|0
4615892|NCT01736683|7474734|FG000|Overall Study|Adverse Event|0
4615893|NCT01736683|7474735|FG001|Overall Study|Adverse Event|2
4615894|NCT01736683|7474736|FG002|Overall Study|Adverse Event|2
4615895|NCT01736683|7474737|FG003|Overall Study|Adverse Event|3
4615896|NCT01736683|7474738|FG004|Overall Study|Adverse Event|2
4615897|NCT01736683|7474734|FG000|Overall Study|Withdrawal by Subject|0
4615898|NCT01736683|7474735|FG001|Overall Study|Withdrawal by Subject|0
4615899|NCT01736683|7474736|FG002|Overall Study|Withdrawal by Subject|3
4615900|NCT01736683|7474737|FG003|Overall Study|Withdrawal by Subject|1
4615901|NCT01736683|7474738|FG004|Overall Study|Withdrawal by Subject|1
4615902|NCT01736683|7474734|FG000|Overall Study|Lack of Therapeutic Effect|7
4615903|NCT01736683|7474735|FG001|Overall Study|Lack of Therapeutic Effect|4
4615904|NCT01736683|7474736|FG002|Overall Study|Lack of Therapeutic Effect|13
4615905|NCT01736683|7474737|FG003|Overall Study|Lack of Therapeutic Effect|20
4615906|NCT01736683|7474738|FG004|Overall Study|Lack of Therapeutic Effect|1
4615907|NCT01736683|7474734|FG000|Overall Study|Progressive Disease|0
4615908|NCT01736683|7474735|FG001|Overall Study|Progressive Disease|0
4615909|NCT01736683|7474736|FG002|Overall Study|Progressive Disease|0
4615910|NCT01736683|7474737|FG003|Overall Study|Progressive Disease|1
4615911|NCT01736683|7474738|FG004|Overall Study|Progressive Disease|0
4615912|NCT01736683|7474734|FG000|Overall Study|Other|0
4615913|NCT01736683|7474735|FG001|Overall Study|Other|0
4615914|NCT01736683|7474736|FG002|Overall Study|Other|1
4615915|NCT01736683|7474737|FG003|Overall Study|Other|9
4615916|NCT01736683|7474738|FG004|Overall Study|Other|1
4615917|NCT01736696|7474759|FG000|Overall Study|Withdrawal by Subject|0
4615918|NCT01736696|7474760|FG001|Overall Study|Withdrawal by Subject|0
4615919|NCT01736696|7474761|FG002|Overall Study|Withdrawal by Subject|1
4615920|NCT01736696|7474762|FG003|Overall Study|Withdrawal by Subject|0
4615921|NCT01736696|7474763|FG004|Overall Study|Withdrawal by Subject|0
4615922|NCT01736696|7474764|FG005|Overall Study|Withdrawal by Subject|0
4615923|NCT01736696|7474765|FG006|Overall Study|Withdrawal by Subject|0
4615924|NCT01736917|7474807|FG000|Overall Study|Adverse Event|1
4615925|NCT01736917|7474807|FG000|Overall Study|Protocol Violation|10
4464066|NCT00602537|7254789|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13
4615926|NCT01737021|7474825|FG000|Overall Study|Lost to Follow-up|5
4615927|NCT01737021|7474826|FG001|Overall Study|Lost to Follow-up|3
4615928|NCT01737268|7474832|FG000|Overall Study|Adverse Event|6
4615929|NCT01737268|7474832|FG000|Overall Study|Worsening of Target Disease|2
4615930|NCT01737268|7474832|FG000|Overall Study|In consideration of the patient's safety|1
4615931|NCT01737398|7474848|FG000|Overall Study|Adverse event or SAE|16
4615932|NCT01737398|7474849|FG001|Overall Study|Adverse event or SAE|1
4615933|NCT01737398|7474848|FG000|Overall Study|Stopping rule met|2
4615934|NCT01737398|7474849|FG001|Overall Study|Stopping rule met|1
4615935|NCT01737398|7474848|FG000|Overall Study|Voluntary withdrawal|2
4615936|NCT01737398|7474849|FG001|Overall Study|Voluntary withdrawal|3
4615937|NCT01737398|7474848|FG000|Overall Study|Ineligibility|1
4615938|NCT01737398|7474849|FG001|Overall Study|Ineligibility|0
4615939|NCT01737398|7474848|FG000|Overall Study|Liver transplant|1
4464067|NCT00602537|7254788|FG000|Follow Up Study Comparison|Adverse Event|1
4464068|NCT00602537|7254789|FG001|Follow Up Study Comparison|Adverse Event|0
4464069|NCT00602537|7254788|FG000|Follow Up Study Comparison|Lost to Follow-up|8
4464070|NCT00602537|7254789|FG001|Follow Up Study Comparison|Lost to Follow-up|1
4464071|NCT00602537|7254788|FG000|Follow Up Study Comparison|Withdrawal by Subject|2
4464072|NCT00602537|7254789|FG001|Follow Up Study Comparison|Withdrawal by Subject|2
4464073|NCT00602797|7254804|FG000|Overall Study|Adverse Event|1
4464074|NCT00602927|7254815|FG000|Period 1: 13 Days|Protocol Violation|2
4464075|NCT00602927|7254816|FG001|Period 1: 13 Days|Protocol Violation|4
4464076|NCT00602927|7254815|FG000|Period 1: 13 Days|MRI scanner technical issue|1
4464077|NCT00602927|7254816|FG001|Period 1: 13 Days|MRI scanner technical issue|0
4464078|NCT00602927|7254815|FG000|Period 1: 13 Days|Time|1
4464079|NCT00602927|7254816|FG001|Period 1: 13 Days|Time|0
4464080|NCT00602927|7254815|FG000|Period 1: 13 Days|Claustrophobia|0
4464081|NCT00602927|7254816|FG001|Period 1: 13 Days|Claustrophobia|1
4464082|NCT00602927|7254815|FG000|Period 2: 14 Days|Protocol Violation|0
4464083|NCT00602927|7254816|FG001|Period 2: 14 Days|Protocol Violation|2
4464084|NCT00602927|7254815|FG000|Period 3: 13 Days|Protocol Violation|0
4464085|NCT00602927|7254816|FG001|Period 3: 13 Days|Protocol Violation|1
4464086|NCT00602927|7254815|FG000|Period 3: 13 Days|MRI data quality|2
4464087|NCT00602927|7254816|FG001|Period 3: 13 Days|MRI data quality|2
4464088|NCT00602979|7254848|FG000|Overall Study|Lost to Follow-up|3
4464089|NCT00602979|7254849|FG001|Overall Study|Lost to Follow-up|2
4464090|NCT00602979|7254850|FG002|Overall Study|Lost to Follow-up|3
4464091|NCT00602979|7254851|FG003|Overall Study|Lost to Follow-up|2
4464092|NCT00602979|7254852|FG004|Overall Study|Lost to Follow-up|3
4464093|NCT00602979|7254848|FG000|Overall Study|Failed Intubation|0
4464094|NCT00602979|7254849|FG001|Overall Study|Failed Intubation|1
4464095|NCT00602979|7254850|FG002|Overall Study|Failed Intubation|0
4464096|NCT00602979|7254851|FG003|Overall Study|Failed Intubation|1
4464097|NCT00602979|7254852|FG004|Overall Study|Failed Intubation|0
4464098|NCT00603239|7254884|FG000|Overall Study|Adverse Event|4
4464099|NCT00603239|7254885|FG001|Overall Study|Adverse Event|1
4464100|NCT00603239|7254884|FG000|Overall Study|Entry criteria not met|0
4464101|NCT00603239|7254885|FG001|Overall Study|Entry criteria not met|1
4464102|NCT00603239|7254884|FG000|Overall Study|Loss of glucose control|3
4464103|NCT00603239|7254885|FG001|Overall Study|Loss of glucose control|0
4464104|NCT00603239|7254884|FG000|Overall Study|Lost to Follow-up|2
4540554|NCT01133522|7363253|FG000|Overall Study|Physician Decision|0
4540555|NCT01133522|7363254|FG001|Overall Study|Physician Decision|0
4540556|NCT01133522|7363255|FG002|Overall Study|Physician Decision|0
4540557|NCT01133522|7363256|FG003|Overall Study|Physician Decision|0
4540558|NCT01133522|7363257|FG004|Overall Study|Physician Decision|1
4540559|NCT01133522|7363258|FG005|Overall Study|Physician Decision|0
4540560|NCT01133522|7363259|FG006|Overall Study|Physician Decision|0
4540561|NCT01133522|7363260|FG007|Overall Study|Physician Decision|0
4540562|NCT01133522|7363261|FG008|Overall Study|Physician Decision|0
4540563|NCT01133522|7363262|FG009|Overall Study|Physician Decision|0
4464105|NCT00603239|7254885|FG001|Overall Study|Lost to Follow-up|1
4464106|NCT00603239|7254884|FG000|Overall Study|Physician Decision|2
4464107|NCT00603239|7254885|FG001|Overall Study|Physician Decision|0
4464108|NCT00603239|7254884|FG000|Overall Study|Protocol Violation|2
4464109|NCT00603239|7254885|FG001|Overall Study|Protocol Violation|0
4464110|NCT00603239|7254884|FG000|Overall Study|Subject decision|2
4464111|NCT00603239|7254885|FG001|Overall Study|Subject decision|1
4464112|NCT00603265|7254894|FG000|Overall Study|Adverse Event|2
4464113|NCT00603265|7254895|FG001|Overall Study|Adverse Event|11
4464114|NCT00603265|7254896|FG002|Overall Study|Adverse Event|1
4464115|NCT00603265|7254894|FG000|Overall Study|Withdrawal by Subject|1
4464116|NCT00603265|7254895|FG001|Overall Study|Withdrawal by Subject|2
4464117|NCT00603265|7254896|FG002|Overall Study|Withdrawal by Subject|1
4464118|NCT00603265|7254894|FG000|Overall Study|Lack of Efficacy|3
4464119|NCT00603265|7254895|FG001|Overall Study|Lack of Efficacy|0
4464120|NCT00603265|7254896|FG002|Overall Study|Lack of Efficacy|3
4464121|NCT00603265|7254894|FG000|Overall Study|Lost to Follow-up|0
4464122|NCT00603265|7254895|FG001|Overall Study|Lost to Follow-up|1
4464123|NCT00603265|7254896|FG002|Overall Study|Lost to Follow-up|0
4464124|NCT00603265|7254894|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0
4464125|NCT00603265|7254895|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1
4464126|NCT00603265|7254896|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0
4464127|NCT00603265|7254894|FG000|Overall Study|Participant Left Country, No Responses|0
4464128|NCT00603265|7254895|FG001|Overall Study|Participant Left Country, No Responses|1
4464129|NCT00603265|7254896|FG002|Overall Study|Participant Left Country, No Responses|0
4464130|NCT00603265|7254894|FG000|Overall Study|Protocol Violation|1
4540564|NCT01133626|7363294|FG000|Overall Study|Adverse Event|0
4540565|NCT01133626|7363295|FG001|Overall Study|Adverse Event|1
4464131|NCT00603265|7254895|FG001|Overall Study|Protocol Violation|0
4464132|NCT00603265|7254896|FG002|Overall Study|Protocol Violation|0
4464133|NCT00603278|7254910|FG000|Overall Study|Lack of Efficacy|35
4464134|NCT00603278|7254911|FG001|Overall Study|Lack of Efficacy|10
4464135|NCT00603278|7254912|FG002|Overall Study|Lack of Efficacy|11
4464136|NCT00603278|7254913|FG003|Overall Study|Lack of Efficacy|8
4540566|NCT01133626|7363296|FG002|Overall Study|Adverse Event|0
4464137|NCT00603278|7254914|FG004|Overall Study|Lack of Efficacy|7
4464138|NCT00603278|7254915|FG005|Overall Study|Lack of Efficacy|14
4615940|NCT01737398|7474849|FG001|Overall Study|Liver transplant|0
4615941|NCT01737398|7474848|FG000|Overall Study|Disease progression|2
4615942|NCT01737398|7474849|FG001|Overall Study|Disease progression|3
4615943|NCT01737398|7474848|FG000|Overall Study|Sponsor's decision|2
4615944|NCT01737398|7474849|FG001|Overall Study|Sponsor's decision|0
4615945|NCT01737697|7474889|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0
4615946|NCT01737697|7474890|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1
4615947|NCT01737697|7474891|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0
4615948|NCT01737697|7474892|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1
4615949|NCT01737697|7474893|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1
4615950|NCT01737697|7474894|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0
4615951|NCT01737697|7474895|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0
4615952|NCT01737697|7474896|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0
4615953|NCT01737697|7474897|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0
4615954|NCT01737697|7474898|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0
4615955|NCT01737697|7474899|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0
4615956|NCT01737697|7474900|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0
4615957|NCT01737697|7474901|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0
4615958|NCT01737697|7474902|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0
4615959|NCT01737697|7474903|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0
4615960|NCT01737697|7474889|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1
4615961|NCT01737697|7474890|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1
4615962|NCT01737697|7474891|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3
4615963|NCT01737697|7474892|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
4615964|NCT01737697|7474893|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
4615965|NCT01737697|7474894|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
4615966|NCT01737697|7474895|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
4615967|NCT01737697|7474896|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
4615968|NCT01737697|7474897|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
4615969|NCT01737697|7474898|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
4615970|NCT01737697|7474899|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
4615971|NCT01737697|7474900|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
4615972|NCT01737697|7474901|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
4615973|NCT01737697|7474902|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
4615974|NCT01737697|7474903|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
4615975|NCT01737697|7474889|FG000|Acute Phase-Initial 48 Hours|Family emergency|0
4615976|NCT01737697|7474890|FG001|Acute Phase-Initial 48 Hours|Family emergency|0
4615977|NCT01737697|7474891|FG002|Acute Phase-Initial 48 Hours|Family emergency|0
4615978|NCT01737697|7474892|FG003|Acute Phase-Initial 48 Hours|Family emergency|1
4615979|NCT01737697|7474893|FG004|Acute Phase-Initial 48 Hours|Family emergency|0
4615980|NCT01737697|7474894|FG005|Acute Phase-Initial 48 Hours|Family emergency|0
4615981|NCT01737697|7474895|FG006|Acute Phase-Initial 48 Hours|Family emergency|0
4615982|NCT01737697|7474896|FG007|Acute Phase-Initial 48 Hours|Family emergency|0
4615983|NCT01737697|7474897|FG008|Acute Phase-Initial 48 Hours|Family emergency|0
4615984|NCT01737697|7474898|FG009|Acute Phase-Initial 48 Hours|Family emergency|0
4615985|NCT01737697|7474899|FG010|Acute Phase-Initial 48 Hours|Family emergency|0
4615986|NCT01737697|7474900|FG011|Acute Phase-Initial 48 Hours|Family emergency|0
4615987|NCT01737697|7474901|FG012|Acute Phase-Initial 48 Hours|Family emergency|0
4615988|NCT01737697|7474902|FG013|Acute Phase-Initial 48 Hours|Family emergency|0
4615989|NCT01737697|7474903|FG014|Acute Phase-Initial 48 Hours|Family emergency|0
4615990|NCT01737697|7474889|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0
4615991|NCT01737697|7474890|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1
4615992|NCT01737697|7474891|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0
4615993|NCT01737697|7474892|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0
4615994|NCT01737697|7474893|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0
4615995|NCT01737697|7474894|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0
4615996|NCT01737697|7474895|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0
4615997|NCT01737697|7474896|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0
4615998|NCT01737697|7474897|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0
4615999|NCT01737697|7474898|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0
4616000|NCT01737697|7474899|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0
4616001|NCT01737697|7474900|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0
4616002|NCT01737697|7474901|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0
4616003|NCT01737697|7474902|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0
4616004|NCT01737697|7474903|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0
4616005|NCT01737697|7474889|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
4464139|NCT00603278|7254910|FG000|Overall Study|Adverse Event|0
4616006|NCT01737697|7474890|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
4616007|NCT01737697|7474891|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
4616008|NCT01737697|7474892|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
4616009|NCT01737697|7474893|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1
4616010|NCT01737697|7474894|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
4616011|NCT01737697|7474895|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
4616012|NCT01737697|7474896|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
4616013|NCT01737697|7474897|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
4464140|NCT00603278|7254911|FG001|Overall Study|Adverse Event|3
4464141|NCT00603278|7254912|FG002|Overall Study|Adverse Event|1
4464142|NCT00603278|7254913|FG003|Overall Study|Adverse Event|0
4464143|NCT00603278|7254914|FG004|Overall Study|Adverse Event|2
4464144|NCT00603278|7254915|FG005|Overall Study|Adverse Event|1
4464145|NCT00603278|7254910|FG000|Overall Study|Withdrawal by Subject|2
4464146|NCT00603278|7254911|FG001|Overall Study|Withdrawal by Subject|3
4464147|NCT00603278|7254912|FG002|Overall Study|Withdrawal by Subject|1
4464148|NCT00603278|7254913|FG003|Overall Study|Withdrawal by Subject|2
4464149|NCT00603278|7254914|FG004|Overall Study|Withdrawal by Subject|1
4464150|NCT00603278|7254915|FG005|Overall Study|Withdrawal by Subject|2
4464151|NCT00603278|7254910|FG000|Overall Study|Protocol Violation|3
4464152|NCT00603278|7254911|FG001|Overall Study|Protocol Violation|0
4464153|NCT00603278|7254912|FG002|Overall Study|Protocol Violation|1
4464154|NCT00603278|7254913|FG003|Overall Study|Protocol Violation|1
4464155|NCT00603278|7254914|FG004|Overall Study|Protocol Violation|0
4464156|NCT00603278|7254915|FG005|Overall Study|Protocol Violation|1
4464157|NCT00603278|7254910|FG000|Overall Study|Physician Decision|0
4464158|NCT00603278|7254911|FG001|Overall Study|Physician Decision|1
4464159|NCT00603278|7254912|FG002|Overall Study|Physician Decision|0
4464160|NCT00603278|7254913|FG003|Overall Study|Physician Decision|0
4464161|NCT00603278|7254914|FG004|Overall Study|Physician Decision|2
4464162|NCT00603278|7254915|FG005|Overall Study|Physician Decision|1
4464163|NCT00603278|7254910|FG000|Overall Study|Lost to Follow-up|1
4464164|NCT00603278|7254911|FG001|Overall Study|Lost to Follow-up|0
4464165|NCT00603278|7254912|FG002|Overall Study|Lost to Follow-up|0
4464166|NCT00603278|7254913|FG003|Overall Study|Lost to Follow-up|0
4464167|NCT00603278|7254914|FG004|Overall Study|Lost to Follow-up|1
4464168|NCT00603278|7254915|FG005|Overall Study|Lost to Follow-up|0
4464169|NCT00603304|7254944|FG000|Overall Study|Lost to Follow-up|5
4464170|NCT00603304|7254945|FG001|Overall Study|Lost to Follow-up|7
4464171|NCT00603304|7254944|FG000|Overall Study|Withdrawal by Subject|8
4464172|NCT00603304|7254945|FG001|Overall Study|Withdrawal by Subject|5
4464173|NCT00603304|7254944|FG000|Overall Study|Protocol Violation|1
4464174|NCT00603304|7254945|FG001|Overall Study|Protocol Violation|0
4464175|NCT00603304|7254944|FG000|Overall Study|Adverse Event|4
4464176|NCT00603304|7254945|FG001|Overall Study|Adverse Event|2
4464177|NCT00603304|7254944|FG000|Overall Study|Unacceptable Treatment Toxicity|5
4464178|NCT00603304|7254945|FG001|Overall Study|Unacceptable Treatment Toxicity|8
4464179|NCT00603304|7254944|FG000|Overall Study|Crossed Over to Open Label Therapy|3
4464180|NCT00603304|7254945|FG001|Overall Study|Crossed Over to Open Label Therapy|3
4464181|NCT00603304|7254944|FG000|Overall Study|Exclusionary Medication|2
4464182|NCT00603304|7254945|FG001|Overall Study|Exclusionary Medication|3
4464183|NCT00603304|7254944|FG000|Overall Study|Non-Compliant|0
4464184|NCT00603304|7254945|FG001|Overall Study|Non-Compliant|1
4464185|NCT00603304|7254944|FG000|Overall Study|Moved Away|0
4464186|NCT00603304|7254945|FG001|Overall Study|Moved Away|2
4464187|NCT00603304|7254944|FG000|Overall Study|Other|2
4464188|NCT00603304|7254945|FG001|Overall Study|Other|0
4464189|NCT00603304|7254944|FG000|Overall Study|Patient Decision|2
4464190|NCT00603304|7254945|FG001|Overall Study|Patient Decision|0
4464191|NCT00603382|7254959|FG000|Overall Study|Adverse Event|0
4464192|NCT00603382|7254960|FG001|Overall Study|Adverse Event|1
4464193|NCT00603382|7254961|FG002|Overall Study|Adverse Event|1
4464194|NCT00603382|7254962|FG003|Overall Study|Adverse Event|2
4464195|NCT00603382|7254963|FG004|Overall Study|Adverse Event|1
4464196|NCT00603382|7254964|FG005|Overall Study|Adverse Event|2
4464197|NCT00603382|7254959|FG000|Overall Study|Lack of Efficacy|14
4464198|NCT00603382|7254960|FG001|Overall Study|Lack of Efficacy|9
4464199|NCT00603382|7254961|FG002|Overall Study|Lack of Efficacy|3
4464200|NCT00603382|7254962|FG003|Overall Study|Lack of Efficacy|6
4464201|NCT00603382|7254963|FG004|Overall Study|Lack of Efficacy|6
4464202|NCT00603382|7254964|FG005|Overall Study|Lack of Efficacy|11
4464203|NCT00603382|7254959|FG000|Overall Study|Protocol Violation|1
4464204|NCT00603382|7254960|FG001|Overall Study|Protocol Violation|0
4464205|NCT00603382|7254961|FG002|Overall Study|Protocol Violation|1
4464206|NCT00603382|7254962|FG003|Overall Study|Protocol Violation|2
4464207|NCT00603382|7254963|FG004|Overall Study|Protocol Violation|1
4464208|NCT00603382|7254964|FG005|Overall Study|Protocol Violation|0
4464209|NCT00603382|7254959|FG000|Overall Study|Lost to Follow-up|0
4464210|NCT00603382|7254960|FG001|Overall Study|Lost to Follow-up|1
4464211|NCT00603382|7254961|FG002|Overall Study|Lost to Follow-up|1
4464212|NCT00603382|7254962|FG003|Overall Study|Lost to Follow-up|1
4464213|NCT00603382|7254963|FG004|Overall Study|Lost to Follow-up|0
4464214|NCT00603382|7254964|FG005|Overall Study|Lost to Follow-up|1
4464215|NCT00603382|7254959|FG000|Overall Study|Physician Decision|0
4464216|NCT00603382|7254960|FG001|Overall Study|Physician Decision|0
4464217|NCT00603382|7254961|FG002|Overall Study|Physician Decision|2
4464218|NCT00603382|7254962|FG003|Overall Study|Physician Decision|0
4464219|NCT00603382|7254963|FG004|Overall Study|Physician Decision|1
4464220|NCT00603382|7254964|FG005|Overall Study|Physician Decision|3
4464221|NCT00603382|7254959|FG000|Overall Study|Withdrawal by Subject|3
4464222|NCT00603382|7254960|FG001|Overall Study|Withdrawal by Subject|3
4464223|NCT00603382|7254961|FG002|Overall Study|Withdrawal by Subject|1
4464224|NCT00603382|7254962|FG003|Overall Study|Withdrawal by Subject|1
4464225|NCT00603382|7254963|FG004|Overall Study|Withdrawal by Subject|0
4464226|NCT00603382|7254964|FG005|Overall Study|Withdrawal by Subject|1
4464227|NCT00603447|7254990|FG000|Overall Study|Adverse Event|0
4464228|NCT00603447|7254991|FG001|Overall Study|Adverse Event|1
4464229|NCT00603447|7254992|FG002|Overall Study|Adverse Event|1
4464230|NCT00603447|7254993|FG003|Overall Study|Adverse Event|2
4464231|NCT00603447|7254994|FG004|Overall Study|Adverse Event|1
4464232|NCT00603447|7254995|FG005|Overall Study|Adverse Event|2
4464233|NCT00603447|7254996|FG006|Overall Study|Adverse Event|10
4464234|NCT00603447|7254990|FG000|Overall Study|Other|0
4464235|NCT00603447|7254991|FG001|Overall Study|Other|0
4464236|NCT00603447|7254992|FG002|Overall Study|Other|1
4464237|NCT00603447|7254993|FG003|Overall Study|Other|0
4464238|NCT00603447|7254994|FG004|Overall Study|Other|3
4464239|NCT00603447|7254995|FG005|Overall Study|Other|0
4464240|NCT00603447|7254996|FG006|Overall Study|Other|13
4464241|NCT00603447|7254990|FG000|Overall Study|Withdrew Consent|0
4464242|NCT00603447|7254991|FG001|Overall Study|Withdrew Consent|2
4464243|NCT00603447|7254992|FG002|Overall Study|Withdrew Consent|0
4464244|NCT00603447|7254993|FG003|Overall Study|Withdrew Consent|0
4464245|NCT00603447|7254994|FG004|Overall Study|Withdrew Consent|1
4464246|NCT00603447|7254995|FG005|Overall Study|Withdrew Consent|0
4464247|NCT00603447|7254996|FG006|Overall Study|Withdrew Consent|1
4464248|NCT00603473|7255012|FG000|Overall Study|Adverse Event|4
4464249|NCT00603473|7255012|FG000|Overall Study|Lack of Efficacy|4
4464250|NCT00603473|7255012|FG000|Overall Study|Protocol Violation|1
4464251|NCT00603512|7255021|FG000|Overall Study|Adverse Event|0
4464252|NCT00603512|7255022|FG001|Overall Study|Adverse Event|2
4464253|NCT00603512|7255023|FG002|Overall Study|Adverse Event|4
4464254|NCT00603512|7255024|FG003|Overall Study|Adverse Event|4
4464255|NCT00603512|7255025|FG004|Overall Study|Adverse Event|2
4464256|NCT00603512|7255021|FG000|Overall Study|Lack of Efficacy|0
4464257|NCT00603512|7255022|FG001|Overall Study|Lack of Efficacy|1
4464258|NCT00603512|7255023|FG002|Overall Study|Lack of Efficacy|0
4464259|NCT00603512|7255024|FG003|Overall Study|Lack of Efficacy|0
4464260|NCT00603512|7255025|FG004|Overall Study|Lack of Efficacy|1
4464261|NCT00603512|7255021|FG000|Overall Study|Other|2
4464262|NCT00603512|7255022|FG001|Overall Study|Other|1
4464263|NCT00603512|7255023|FG002|Overall Study|Other|0
4616014|NCT01737697|7474898|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
4616015|NCT01737697|7474899|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
4616016|NCT01737697|7474900|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
4616017|NCT01737697|7474901|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
4616018|NCT01737697|7474902|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
4616019|NCT01737697|7474903|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
4616020|NCT01737697|7474889|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
4616021|NCT01737697|7474890|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1
4616022|NCT01737697|7474891|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1
4616023|NCT01737697|7474892|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4
4616024|NCT01737697|7474893|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1
4616025|NCT01737697|7474894|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
4616026|NCT01737697|7474895|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
4616027|NCT01737697|7474896|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
4616028|NCT01737697|7474897|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
4616029|NCT01737697|7474898|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
4616030|NCT01737697|7474899|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
4616031|NCT01737697|7474900|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
4616032|NCT01737697|7474901|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
4616033|NCT01737697|7474902|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
4616034|NCT01737697|7474903|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
4616035|NCT01737697|7474889|FG000|Subacute Phase|Adverse Event|0
4616036|NCT01737697|7474890|FG001|Subacute Phase|Adverse Event|0
4616037|NCT01737697|7474891|FG002|Subacute Phase|Adverse Event|0
4616038|NCT01737697|7474892|FG003|Subacute Phase|Adverse Event|0
4616039|NCT01737697|7474893|FG004|Subacute Phase|Adverse Event|0
4616040|NCT01737697|7474894|FG005|Subacute Phase|Adverse Event|1
4616041|NCT01737697|7474895|FG006|Subacute Phase|Adverse Event|1
4616042|NCT01737697|7474896|FG007|Subacute Phase|Adverse Event|1
4616043|NCT01737697|7474897|FG008|Subacute Phase|Adverse Event|1
4616044|NCT01737697|7474898|FG009|Subacute Phase|Adverse Event|1
4616045|NCT01737697|7474899|FG010|Subacute Phase|Adverse Event|4
4616046|NCT01737697|7474900|FG011|Subacute Phase|Adverse Event|1
4464264|NCT00603512|7255024|FG003|Overall Study|Other|1
4464265|NCT00603512|7255025|FG004|Overall Study|Other|1
4464266|NCT00603512|7255021|FG000|Overall Study|Withdrawal by Subject|0
4464267|NCT00603512|7255022|FG001|Overall Study|Withdrawal by Subject|0
4464268|NCT00603512|7255023|FG002|Overall Study|Withdrawal by Subject|0
4464269|NCT00603512|7255024|FG003|Overall Study|Withdrawal by Subject|0
4464270|NCT00603512|7255025|FG004|Overall Study|Withdrawal by Subject|1
4464271|NCT00603512|7255021|FG000|Overall Study|Randomized but not treated|0
4464272|NCT00603512|7255022|FG001|Overall Study|Randomized but not treated|1
4616047|NCT01737697|7474901|FG012|Subacute Phase|Adverse Event|1
4616048|NCT01737697|7474902|FG013|Subacute Phase|Adverse Event|0
4616049|NCT01737697|7474903|FG014|Subacute Phase|Adverse Event|0
4616050|NCT01737697|7474889|FG000|Subacute Phase|Withdrawal by Subject|0
4616051|NCT01737697|7474890|FG001|Subacute Phase|Withdrawal by Subject|0
4464273|NCT00603512|7255023|FG002|Overall Study|Randomized but not treated|1
4464274|NCT00603512|7255024|FG003|Overall Study|Randomized but not treated|2
4464275|NCT00603512|7255025|FG004|Overall Study|Randomized but not treated|0
4464276|NCT00603525|7255039|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3
4464277|NCT00603525|7255040|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9
4464278|NCT00603525|7255041|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0
4464279|NCT00603525|7255039|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7
4464280|NCT00603525|7255040|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
4464281|NCT00603525|7255041|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
4464282|NCT00603525|7255039|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1
4464283|NCT00603525|7255040|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2
4464284|NCT00603525|7255041|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0
4464285|NCT00603525|7255039|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1
4464286|NCT00603525|7255040|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3
4464287|NCT00603525|7255041|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0
4464288|NCT00603525|7255039|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5
4464289|NCT00603525|7255040|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6
4464290|NCT00603525|7255041|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0
4464291|NCT00603525|7255039|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0
4464292|NCT00603525|7255040|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1
4464293|NCT00603525|7255041|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0
4464294|NCT00603525|7255039|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0
4464295|NCT00603525|7255040|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1
4464296|NCT00603525|7255041|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0
4464297|NCT00603525|7255039|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0
4464298|NCT00603525|7255040|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12
4464299|NCT00603525|7255041|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0
4464300|NCT00603525|7255039|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
4464301|NCT00603525|7255040|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13
4464302|NCT00603525|7255041|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
4464303|NCT00603525|7255039|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0
4464304|NCT00603525|7255040|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1
4464305|NCT00603525|7255041|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0
4464306|NCT00603525|7255039|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
4464307|NCT00603525|7255040|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5
4464308|NCT00603525|7255041|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
4464309|NCT00603525|7255039|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
4464310|NCT00603525|7255040|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71
4464311|NCT00603525|7255041|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
4464312|NCT00603525|7255039|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0
4464313|NCT00603525|7255040|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2
4464314|NCT00603525|7255041|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0
4464315|NCT00603525|7255039|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
4464316|NCT00603525|7255040|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8
4464317|NCT00603525|7255041|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
4464318|NCT00603525|7255039|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0
4464319|NCT00603525|7255040|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0
4464320|NCT00603525|7255041|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111
4464321|NCT00603538|7255055|FG000|Overall Study|Adverse Event|0
4464322|NCT00603538|7255056|FG001|Overall Study|Adverse Event|4
4464323|NCT00603538|7255057|FG002|Overall Study|Adverse Event|2
4464324|NCT00603538|7255055|FG000|Overall Study|Objective progression or relapse|3
4464325|NCT00603538|7255056|FG001|Overall Study|Objective progression or relapse|0
4464326|NCT00603538|7255057|FG002|Overall Study|Objective progression or relapse|0
4464327|NCT00603590|7255079|FG000|Overall Study|Did not attend study clinic|39
4464328|NCT00603590|7255080|FG001|Overall Study|Did not attend study clinic|30
4464329|NCT00603590|7255079|FG000|Overall Study|Refused blood test|5
4464330|NCT00603590|7255080|FG001|Overall Study|Refused blood test|1
4464331|NCT00603590|7255079|FG000|Overall Study|Patient discontinued study drug|22
4464332|NCT00603590|7255080|FG001|Overall Study|Patient discontinued study drug|15
4464333|NCT00603590|7255079|FG000|Overall Study|Adverse Event|2
4464334|NCT00603590|7255080|FG001|Overall Study|Adverse Event|0
4464335|NCT00603590|7255079|FG000|Overall Study|Lost to Follow-up|8
4464336|NCT00603590|7255080|FG001|Overall Study|Lost to Follow-up|4
4464337|NCT00603590|7255079|FG000|Overall Study|Cardiovascular event|0
4464338|NCT00603590|7255080|FG001|Overall Study|Cardiovascular event|1
4464339|NCT00603733|7255118|FG000|Active Phase ITT|Adverse Event|8
4464340|NCT00603733|7255119|FG001|Active Phase ITT|Adverse Event|7
4464341|NCT00603733|7255118|FG000|Active Phase ITT|Withdrawal by Subject|0
4464342|NCT00603733|7255119|FG001|Active Phase ITT|Withdrawal by Subject|3
4464343|NCT00603733|7255118|FG000|Active Phase ITT|Lost to Follow-up|0
4464344|NCT00603733|7255119|FG001|Active Phase ITT|Lost to Follow-up|1
4464345|NCT00603733|7255118|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1
4464346|NCT00603733|7255119|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3
4464347|NCT00603733|7255118|FG000|Active Phase ITT|Lack of Efficacy|1
4464348|NCT00603733|7255119|FG001|Active Phase ITT|Lack of Efficacy|2
4464349|NCT00603733|7255118|FG000|Active Phase ITT|Subject moved, site closed|1
4464350|NCT00603733|7255119|FG001|Active Phase ITT|Subject moved, site closed|1
4464351|NCT00603733|7255118|FG000|Run-In Phase - 4 Weeks|Adverse Event|2
4464352|NCT00603733|7255119|FG001|Run-In Phase - 4 Weeks|Adverse Event|1
4464353|NCT00603733|7255118|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4
4464354|NCT00603733|7255119|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1
4464355|NCT00603733|7255118|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1
4464356|NCT00603733|7255119|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0
4464357|NCT00603733|7255118|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5
4464358|NCT00603733|7255119|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10
4464359|NCT00603733|7255118|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2
4464360|NCT00603733|7255119|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1
4616052|NCT01737697|7474891|FG002|Subacute Phase|Withdrawal by Subject|0
4616053|NCT01737697|7474892|FG003|Subacute Phase|Withdrawal by Subject|0
4616054|NCT01737697|7474893|FG004|Subacute Phase|Withdrawal by Subject|0
4616055|NCT01737697|7474894|FG005|Subacute Phase|Withdrawal by Subject|1
4616056|NCT01737697|7474895|FG006|Subacute Phase|Withdrawal by Subject|0
4616057|NCT01737697|7474896|FG007|Subacute Phase|Withdrawal by Subject|2
4616058|NCT01737697|7474897|FG008|Subacute Phase|Withdrawal by Subject|0
4616059|NCT01737697|7474898|FG009|Subacute Phase|Withdrawal by Subject|1
4616060|NCT01737697|7474899|FG010|Subacute Phase|Withdrawal by Subject|0
4616061|NCT01737697|7474900|FG011|Subacute Phase|Withdrawal by Subject|1
4616062|NCT01737697|7474901|FG012|Subacute Phase|Withdrawal by Subject|1
4616063|NCT01737697|7474902|FG013|Subacute Phase|Withdrawal by Subject|1
4616064|NCT01737697|7474903|FG014|Subacute Phase|Withdrawal by Subject|0
4616065|NCT01737697|7474889|FG000|Subacute Phase|Lost to Follow-up|0
4616066|NCT01737697|7474890|FG001|Subacute Phase|Lost to Follow-up|0
4616067|NCT01737697|7474891|FG002|Subacute Phase|Lost to Follow-up|0
4616068|NCT01737697|7474892|FG003|Subacute Phase|Lost to Follow-up|0
4616069|NCT01737697|7474893|FG004|Subacute Phase|Lost to Follow-up|0
4616070|NCT01737697|7474894|FG005|Subacute Phase|Lost to Follow-up|0
4616071|NCT01737697|7474895|FG006|Subacute Phase|Lost to Follow-up|0
4616072|NCT01737697|7474896|FG007|Subacute Phase|Lost to Follow-up|0
4616073|NCT01737697|7474897|FG008|Subacute Phase|Lost to Follow-up|0
4616074|NCT01737697|7474898|FG009|Subacute Phase|Lost to Follow-up|0
4616075|NCT01737697|7474899|FG010|Subacute Phase|Lost to Follow-up|0
4616076|NCT01737697|7474900|FG011|Subacute Phase|Lost to Follow-up|0
4616077|NCT01737697|7474901|FG012|Subacute Phase|Lost to Follow-up|0
4616078|NCT01737697|7474902|FG013|Subacute Phase|Lost to Follow-up|0
4616079|NCT01737697|7474903|FG014|Subacute Phase|Lost to Follow-up|1
4616080|NCT01737697|7474889|FG000|Subacute Phase|Hypo-or hyperkalemia|0
4616081|NCT01737697|7474890|FG001|Subacute Phase|Hypo-or hyperkalemia|0
4616082|NCT01737697|7474891|FG002|Subacute Phase|Hypo-or hyperkalemia|0
4616083|NCT01737697|7474892|FG003|Subacute Phase|Hypo-or hyperkalemia|0
4616084|NCT01737697|7474893|FG004|Subacute Phase|Hypo-or hyperkalemia|0
4616085|NCT01737697|7474894|FG005|Subacute Phase|Hypo-or hyperkalemia|0
4616086|NCT01737697|7474895|FG006|Subacute Phase|Hypo-or hyperkalemia|0
4616087|NCT01737697|7474896|FG007|Subacute Phase|Hypo-or hyperkalemia|0
4616088|NCT01737697|7474897|FG008|Subacute Phase|Hypo-or hyperkalemia|0
4616089|NCT01737697|7474898|FG009|Subacute Phase|Hypo-or hyperkalemia|0
4616090|NCT01737697|7474899|FG010|Subacute Phase|Hypo-or hyperkalemia|0
4616091|NCT01737697|7474900|FG011|Subacute Phase|Hypo-or hyperkalemia|1
4616092|NCT01737697|7474901|FG012|Subacute Phase|Hypo-or hyperkalemia|0
4616093|NCT01737697|7474902|FG013|Subacute Phase|Hypo-or hyperkalemia|1
4616094|NCT01737697|7474903|FG014|Subacute Phase|Hypo-or hyperkalemia|0
4616095|NCT01737697|7474889|FG000|Subacute Phase|Protocol Violation|0
4616096|NCT01737697|7474890|FG001|Subacute Phase|Protocol Violation|0
4616097|NCT01737697|7474891|FG002|Subacute Phase|Protocol Violation|0
4616098|NCT01737697|7474892|FG003|Subacute Phase|Protocol Violation|0
4616099|NCT01737697|7474893|FG004|Subacute Phase|Protocol Violation|0
4616100|NCT01737697|7474894|FG005|Subacute Phase|Protocol Violation|1
4616101|NCT01737697|7474895|FG006|Subacute Phase|Protocol Violation|0
4616102|NCT01737697|7474896|FG007|Subacute Phase|Protocol Violation|0
4616103|NCT01737697|7474897|FG008|Subacute Phase|Protocol Violation|0
4464361|NCT00603733|7255118|FG000|Maintenance Phase ITT|Adverse Event|3
4464362|NCT00603733|7255119|FG001|Maintenance Phase ITT|Adverse Event|6
4464363|NCT00603733|7255118|FG000|Maintenance Phase ITT|Withdrawal by Subject|1
4616104|NCT01737697|7474898|FG009|Subacute Phase|Protocol Violation|0
4616105|NCT01737697|7474899|FG010|Subacute Phase|Protocol Violation|1
4616106|NCT01737697|7474900|FG011|Subacute Phase|Protocol Violation|0
4616107|NCT01737697|7474901|FG012|Subacute Phase|Protocol Violation|0
4616108|NCT01737697|7474902|FG013|Subacute Phase|Protocol Violation|0
4616109|NCT01737697|7474903|FG014|Subacute Phase|Protocol Violation|0
4616110|NCT01737697|7474889|FG000|Subacute Phase|Physician Decision|0
4616111|NCT01737697|7474890|FG001|Subacute Phase|Physician Decision|0
4616112|NCT01737697|7474891|FG002|Subacute Phase|Physician Decision|0
4616113|NCT01737697|7474892|FG003|Subacute Phase|Physician Decision|0
4616114|NCT01737697|7474893|FG004|Subacute Phase|Physician Decision|0
4616115|NCT01737697|7474894|FG005|Subacute Phase|Physician Decision|0
4616116|NCT01737697|7474895|FG006|Subacute Phase|Physician Decision|0
4616117|NCT01737697|7474896|FG007|Subacute Phase|Physician Decision|0
4616118|NCT01737697|7474897|FG008|Subacute Phase|Physician Decision|1
4464364|NCT00603733|7255119|FG001|Maintenance Phase ITT|Withdrawal by Subject|0
4464365|NCT00603733|7255118|FG000|Maintenance Phase ITT|Protocol Violation|1
4464366|NCT00603733|7255119|FG001|Maintenance Phase ITT|Protocol Violation|1
4464367|NCT00603733|7255118|FG000|Maintenance Phase ITT|Lost to Follow-up|0
4464368|NCT00603733|7255119|FG001|Maintenance Phase ITT|Lost to Follow-up|1
4464369|NCT00603733|7255118|FG000|Maintenance Phase ITT|Lack of Efficacy|2
4464370|NCT00603733|7255119|FG001|Maintenance Phase ITT|Lack of Efficacy|2
4464371|NCT00603733|7255118|FG000|Maintenance Phase ITT|Physician Decision|0
4464372|NCT00603733|7255119|FG001|Maintenance Phase ITT|Physician Decision|1
4464373|NCT00603733|7255118|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3
4464374|NCT00603733|7255119|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5
4464375|NCT00603746|7255131|FG000|Overall Study|Adverse Event|2
4464376|NCT00603746|7255132|FG001|Overall Study|Adverse Event|3
4464377|NCT00603746|7255133|FG002|Overall Study|Adverse Event|0
4464378|NCT00603746|7255134|FG003|Overall Study|Adverse Event|1
4464379|NCT00603746|7255135|FG004|Overall Study|Adverse Event|0
4464380|NCT00603746|7255136|FG005|Overall Study|Adverse Event|4
4464381|NCT00603746|7255131|FG000|Overall Study|Lack of Efficacy|34
4464382|NCT00603746|7255132|FG001|Overall Study|Lack of Efficacy|11
4464383|NCT00603746|7255133|FG002|Overall Study|Lack of Efficacy|6
4464384|NCT00603746|7255134|FG003|Overall Study|Lack of Efficacy|11
4464385|NCT00603746|7255135|FG004|Overall Study|Lack of Efficacy|12
4464386|NCT00603746|7255136|FG005|Overall Study|Lack of Efficacy|8
4464387|NCT00603746|7255131|FG000|Overall Study|Protocol Violation|0
4464388|NCT00603746|7255132|FG001|Overall Study|Protocol Violation|3
4464389|NCT00603746|7255133|FG002|Overall Study|Protocol Violation|1
4464390|NCT00603746|7255134|FG003|Overall Study|Protocol Violation|0
4464391|NCT00603746|7255135|FG004|Overall Study|Protocol Violation|1
4464392|NCT00603746|7255136|FG005|Overall Study|Protocol Violation|0
4616119|NCT01737697|7474898|FG009|Subacute Phase|Physician Decision|0
4616120|NCT01737697|7474899|FG010|Subacute Phase|Physician Decision|0
4616121|NCT01737697|7474900|FG011|Subacute Phase|Physician Decision|0
4616122|NCT01737697|7474901|FG012|Subacute Phase|Physician Decision|0
4616123|NCT01737697|7474902|FG013|Subacute Phase|Physician Decision|0
4616124|NCT01737697|7474903|FG014|Subacute Phase|Physician Decision|0
4616125|NCT01737697|7474889|FG000|Subacute Phase|Death|0
4616126|NCT01737697|7474890|FG001|Subacute Phase|Death|0
4616127|NCT01737697|7474891|FG002|Subacute Phase|Death|0
4616128|NCT01737697|7474892|FG003|Subacute Phase|Death|0
4616129|NCT01737697|7474893|FG004|Subacute Phase|Death|0
4616130|NCT01737697|7474894|FG005|Subacute Phase|Death|0
4616131|NCT01737697|7474895|FG006|Subacute Phase|Death|0
4616132|NCT01737697|7474896|FG007|Subacute Phase|Death|0
4616133|NCT01737697|7474897|FG008|Subacute Phase|Death|0
4616134|NCT01737697|7474898|FG009|Subacute Phase|Death|0
4616135|NCT01737697|7474899|FG010|Subacute Phase|Death|1
4616136|NCT01737697|7474900|FG011|Subacute Phase|Death|0
4616137|NCT01737697|7474901|FG012|Subacute Phase|Death|0
4616138|NCT01737697|7474902|FG013|Subacute Phase|Death|0
4616139|NCT01737697|7474903|FG014|Subacute Phase|Death|0
4616140|NCT01737710|7474941|FG000|Overall Study|Lost to Follow-up|0
4616141|NCT01737710|7474942|FG001|Overall Study|Lost to Follow-up|2
4616142|NCT01737710|7474943|FG002|Overall Study|Lost to Follow-up|2
4616143|NCT01737710|7474944|FG003|Overall Study|Lost to Follow-up|0
4616144|NCT01737710|7474945|FG004|Overall Study|Lost to Follow-up|0
4616145|NCT01737710|7474941|FG000|Overall Study|Withdrawal by Subject|1
4616146|NCT01737710|7474942|FG001|Overall Study|Withdrawal by Subject|1
4616147|NCT01737710|7474943|FG002|Overall Study|Withdrawal by Subject|1
4616148|NCT01737710|7474944|FG003|Overall Study|Withdrawal by Subject|0
4616149|NCT01737710|7474945|FG004|Overall Study|Withdrawal by Subject|0
4616150|NCT01737710|7474941|FG000|Overall Study|Vaccinated in Error/Ineligible|1
4616151|NCT01737710|7474942|FG001|Overall Study|Vaccinated in Error/Ineligible|1
4616152|NCT01737710|7474943|FG002|Overall Study|Vaccinated in Error/Ineligible|0
4616153|NCT01737710|7474944|FG003|Overall Study|Vaccinated in Error/Ineligible|0
4616154|NCT01737710|7474945|FG004|Overall Study|Vaccinated in Error/Ineligible|0
4616155|NCT01737762|7474958|FG000|Overall Study|Adverse Event|2
4464393|NCT00603746|7255131|FG000|Overall Study|Lost to Follow-up|0
4464394|NCT00603746|7255132|FG001|Overall Study|Lost to Follow-up|1
4464395|NCT00603746|7255133|FG002|Overall Study|Lost to Follow-up|1
4464396|NCT00603746|7255134|FG003|Overall Study|Lost to Follow-up|0
4464397|NCT00603746|7255135|FG004|Overall Study|Lost to Follow-up|0
4464398|NCT00603746|7255136|FG005|Overall Study|Lost to Follow-up|0
4464399|NCT00603746|7255131|FG000|Overall Study|Physician Decision|1
4616156|NCT01737762|7474959|FG001|Overall Study|Adverse Event|2
4616157|NCT01737762|7474958|FG000|Overall Study|Lost to Follow-up|1
4616158|NCT01737762|7474959|FG001|Overall Study|Lost to Follow-up|0
4616159|NCT01737762|7474958|FG000|Overall Study|Withdrawal by Subject|2
4616160|NCT01737762|7474959|FG001|Overall Study|Withdrawal by Subject|2
4616161|NCT01737762|7474958|FG000|Overall Study|Progressive disease|1
4616162|NCT01737762|7474959|FG001|Overall Study|Progressive disease|2
4616163|NCT01737762|7474958|FG000|Overall Study|Physician Decision|1
4616164|NCT01737762|7474959|FG001|Overall Study|Physician Decision|1
4616165|NCT01737762|7474958|FG000|Overall Study|Moved from area|2
4616166|NCT01737762|7474959|FG001|Overall Study|Moved from area|1
4616167|NCT01737762|7474958|FG000|Overall Study|Trial termination|11
4616168|NCT01737762|7474959|FG001|Overall Study|Trial termination|9
4464400|NCT00603746|7255132|FG001|Overall Study|Physician Decision|0
4464401|NCT00603746|7255133|FG002|Overall Study|Physician Decision|0
4464402|NCT00603746|7255134|FG003|Overall Study|Physician Decision|0
4464403|NCT00603746|7255135|FG004|Overall Study|Physician Decision|1
4464404|NCT00603746|7255136|FG005|Overall Study|Physician Decision|0
4464405|NCT00603746|7255131|FG000|Overall Study|Withdrawal by Subject|1
4464406|NCT00603746|7255132|FG001|Overall Study|Withdrawal by Subject|0
4464407|NCT00603746|7255133|FG002|Overall Study|Withdrawal by Subject|0
4464408|NCT00603746|7255134|FG003|Overall Study|Withdrawal by Subject|1
4464409|NCT00603746|7255135|FG004|Overall Study|Withdrawal by Subject|3
4464410|NCT00603746|7255136|FG005|Overall Study|Withdrawal by Subject|1
4464411|NCT00603798|7255153|FG000|Overall Study|Adverse Event|4
4464412|NCT00603798|7255154|FG001|Overall Study|Adverse Event|2
4464413|NCT00603798|7255155|FG002|Overall Study|Adverse Event|1
4464414|NCT00603798|7255153|FG000|Overall Study|Withdrawal by Subject|4
4616169|NCT01737840|7474967|FG000|Overall Study|Diagnosed with an other pathology|2
4616170|NCT01737840|7474968|FG001|Overall Study|Diagnosed with an other pathology|2
4616171|NCT01737879|7474976|FG000|Overall Study|Death|1
4616172|NCT01737879|7474976|FG000|Overall Study|Sponsor decision|40
4616173|NCT01737931|7474983|FG000|Overall Study|Withdrawal by Subject|0
4616174|NCT01737931|7474984|FG001|Overall Study|Withdrawal by Subject|1
4616175|NCT01737931|7474985|FG002|Overall Study|Withdrawal by Subject|1
4616176|NCT01737931|7474983|FG000|Overall Study|Physician Decision|0
4616177|NCT01737931|7474984|FG001|Overall Study|Physician Decision|1
4616178|NCT01737931|7474985|FG002|Overall Study|Physician Decision|0
4616179|NCT01737996|7475010|FG000|Overall Study|Adverse Event|0
4616180|NCT01737996|7475011|FG001|Overall Study|Adverse Event|1
4616181|NCT01737996|7475012|FG002|Overall Study|Adverse Event|1
4616182|NCT01737996|7475010|FG000|Overall Study|Withdrawal by Subject|0
4616183|NCT01737996|7475011|FG001|Overall Study|Withdrawal by Subject|0
4616184|NCT01737996|7475012|FG002|Overall Study|Withdrawal by Subject|1
4616185|NCT01738191|7475022|FG000|Overall Study|Withdrawal by Subject|4
4616186|NCT01738191|7475023|FG001|Overall Study|Withdrawal by Subject|1
4616187|NCT01738438|7475038|FG000|Overall Study|Disease Progression|32
4616188|NCT01738438|7475038|FG000|Overall Study|Adverse Event|3
4616189|NCT01738477|7475044|FG000|Overall Study|Lost to Follow-up|1
4616190|NCT01738477|7475045|FG001|Overall Study|Lost to Follow-up|4
4616191|NCT01738503|7475059|FG000|Induction/Stabilization (Days -14 to -1)|Other|35
4616192|NCT01738503|7475060|FG001|Induction/Stabilization (Days -14 to -1)|Other|0
4616193|NCT01738503|7475061|FG002|Induction/Stabilization (Days -14 to -1)|Other|0
4616194|NCT01738503|7475062|FG003|Induction/Stabilization (Days -14 to -1)|Other|0
4616195|NCT01738503|7475063|FG004|Induction/Stabilization (Days -14 to -1)|Other|0
4616196|NCT01738503|7475064|FG005|Induction/Stabilization (Days -14 to -1)|Other|0
4616197|NCT01738503|7475065|FG006|Induction/Stabilization (Days -14 to -1)|Other|0
4616198|NCT01738503|7475059|FG000|Treatment Period|Adverse Event|0
4616199|NCT01738503|7475060|FG001|Treatment Period|Adverse Event|1
4616200|NCT01738503|7475061|FG002|Treatment Period|Adverse Event|0
4616201|NCT01738503|7475062|FG003|Treatment Period|Adverse Event|1
4616202|NCT01738503|7475063|FG004|Treatment Period|Adverse Event|2
4616203|NCT01738503|7475064|FG005|Treatment Period|Adverse Event|2
4616204|NCT01738503|7475065|FG006|Treatment Period|Adverse Event|2
4616205|NCT01738503|7475059|FG000|Treatment Period|Lost to Follow-up|0
4616206|NCT01738503|7475060|FG001|Treatment Period|Lost to Follow-up|0
4616207|NCT01738503|7475061|FG002|Treatment Period|Lost to Follow-up|3
4616208|NCT01738503|7475062|FG003|Treatment Period|Lost to Follow-up|4
4616209|NCT01738503|7475063|FG004|Treatment Period|Lost to Follow-up|1
4616210|NCT01738503|7475064|FG005|Treatment Period|Lost to Follow-up|1
4616211|NCT01738503|7475065|FG006|Treatment Period|Lost to Follow-up|5
4616212|NCT01738503|7475059|FG000|Treatment Period|Withdrawal by Subject|0
4616213|NCT01738503|7475060|FG001|Treatment Period|Withdrawal by Subject|1
4464415|NCT00603798|7255154|FG001|Overall Study|Withdrawal by Subject|3
4464416|NCT00603798|7255155|FG002|Overall Study|Withdrawal by Subject|4
4464417|NCT00603798|7255153|FG000|Overall Study|Lost to Follow-up|1
4464418|NCT00603798|7255154|FG001|Overall Study|Lost to Follow-up|0
4464419|NCT00603798|7255155|FG002|Overall Study|Lost to Follow-up|1
4464420|NCT00603798|7255153|FG000|Overall Study|Non-compliance with study procedures|0
4464421|NCT00603798|7255154|FG001|Overall Study|Non-compliance with study procedures|1
4464422|NCT00603798|7255155|FG002|Overall Study|Non-compliance with study procedures|0
4464423|NCT00603798|7255153|FG000|Overall Study|Not due to AE|1
4464424|NCT00603798|7255154|FG001|Overall Study|Not due to AE|1
4464425|NCT00603798|7255155|FG002|Overall Study|Not due to AE|4
4616214|NCT01738503|7475061|FG002|Treatment Period|Withdrawal by Subject|0
4616215|NCT01738503|7475062|FG003|Treatment Period|Withdrawal by Subject|1
4616216|NCT01738503|7475063|FG004|Treatment Period|Withdrawal by Subject|1
4616217|NCT01738503|7475064|FG005|Treatment Period|Withdrawal by Subject|1
4616218|NCT01738503|7475065|FG006|Treatment Period|Withdrawal by Subject|1
4616219|NCT01738503|7475059|FG000|Treatment Period|Protocol Violation|0
4616220|NCT01738503|7475060|FG001|Treatment Period|Protocol Violation|3
4616221|NCT01738503|7475061|FG002|Treatment Period|Protocol Violation|1
4616222|NCT01738503|7475062|FG003|Treatment Period|Protocol Violation|0
4616223|NCT01738503|7475063|FG004|Treatment Period|Protocol Violation|4
4616224|NCT01738503|7475064|FG005|Treatment Period|Protocol Violation|2
4540567|NCT01133626|7363294|FG000|Overall Study|Withdrawal by Subject|1
4540568|NCT01133626|7363295|FG001|Overall Study|Withdrawal by Subject|2
4540569|NCT01133626|7363296|FG002|Overall Study|Withdrawal by Subject|2
4540570|NCT01133626|7363294|FG000|Overall Study|Other|0
4540571|NCT01133626|7363295|FG001|Overall Study|Other|2
4540572|NCT01133626|7363296|FG002|Overall Study|Other|0
4540573|NCT01133665|7363304|FG000|Overall Study|Physician Decision|2
4540574|NCT01133678|7363310|FG000|Overall Study|Death|1
4540575|NCT01133678|7363311|FG001|Overall Study|Death|1
4540576|NCT01133704|7363319|FG000|Overall Study|Death|44
4540577|NCT01133704|7363320|FG001|Overall Study|Death|26
4540578|NCT01133704|7363319|FG000|Overall Study|Patient refused to continue|4
4540579|NCT01133704|7363320|FG001|Overall Study|Patient refused to continue|0
4540580|NCT01133704|7363319|FG000|Overall Study|Study Closure|1
4540581|NCT01133704|7363320|FG001|Overall Study|Study Closure|0
4540582|NCT01133756|7363329|FG000|Overall Study|Adverse Event|1
4540583|NCT01133756|7363330|FG001|Overall Study|Adverse Event|2
4540584|NCT01133756|7363331|FG002|Overall Study|Adverse Event|1
4540585|NCT01133756|7363329|FG000|Overall Study|Investigator Decision|1
4540586|NCT01133756|7363330|FG001|Overall Study|Investigator Decision|0
4540587|NCT01133756|7363331|FG002|Overall Study|Investigator Decision|0
4540588|NCT01133756|7363329|FG000|Overall Study|Withdrawal by Subject|0
4540589|NCT01133756|7363330|FG001|Overall Study|Withdrawal by Subject|1
4540590|NCT01133756|7363331|FG002|Overall Study|Withdrawal by Subject|0
4540591|NCT01133756|7363329|FG000|Overall Study|Progression of Disease|0
4540592|NCT01133756|7363330|FG001|Overall Study|Progression of Disease|0
4540593|NCT01133756|7363331|FG002|Overall Study|Progression of Disease|1
4540594|NCT01133821|7363341|FG000|Overall Study|Lost to Follow-up|8
4540595|NCT01133821|7363342|FG001|Overall Study|Lost to Follow-up|11
4616225|NCT01738503|7475065|FG006|Treatment Period|Protocol Violation|0
4616226|NCT01738503|7475059|FG000|Treatment Period|Other|0
4616227|NCT01738503|7475060|FG001|Treatment Period|Other|0
4616228|NCT01738503|7475061|FG002|Treatment Period|Other|1
4616229|NCT01738503|7475062|FG003|Treatment Period|Other|0
4616230|NCT01738503|7475063|FG004|Treatment Period|Other|0
4616231|NCT01738503|7475064|FG005|Treatment Period|Other|0
4464426|NCT00603837|7255165|FG000|Overall Study|Physician Decision|3
4464427|NCT00603837|7255166|FG001|Overall Study|Physician Decision|0
4464428|NCT00603915|7255189|FG000|Overall Study|Physician Decision|1
4464429|NCT00603941|7255196|FG000|Overall Study|Disease progression|6
4464430|NCT00603941|7255197|FG001|Overall Study|Disease progression|7
4464431|NCT00603941|7255198|FG002|Overall Study|Disease progression|1
4464432|NCT00603941|7255196|FG000|Overall Study|Adverse Event|1
4464433|NCT00603941|7255197|FG001|Overall Study|Adverse Event|0
4616232|NCT01738503|7475065|FG006|Treatment Period|Other|0
4616233|NCT01738503|7475059|FG000|PET Imaging Sub-study|Adverse Event|0
4616234|NCT01738503|7475060|FG001|PET Imaging Sub-study|Adverse Event|0
4616235|NCT01738503|7475061|FG002|PET Imaging Sub-study|Adverse Event|0
4616236|NCT01738503|7475062|FG003|PET Imaging Sub-study|Adverse Event|0
4616237|NCT01738503|7475063|FG004|PET Imaging Sub-study|Adverse Event|0
4616238|NCT01738503|7475064|FG005|PET Imaging Sub-study|Adverse Event|1
4616239|NCT01738503|7475065|FG006|PET Imaging Sub-study|Adverse Event|0
4616240|NCT01738503|7475059|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0
4616241|NCT01738503|7475060|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0
4616242|NCT01738503|7475061|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0
4616243|NCT01738503|7475062|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0
4616244|NCT01738503|7475063|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0
4616245|NCT01738503|7475064|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1
4616246|NCT01738503|7475065|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1
4616247|NCT01738581|7475089|FG000|Overall Study|Lost to Follow-up|1
4616248|NCT01738581|7475090|FG001|Overall Study|Lost to Follow-up|0
4616249|NCT01738594|7475099|FG000|Registration and Treatment Start|Adverse Event|0
4616250|NCT01738594|7475100|FG001|Registration and Treatment Start|Adverse Event|1
4616251|NCT01738594|7475101|FG002|Registration and Treatment Start|Adverse Event|0
4616252|NCT01738594|7475102|FG003|Registration and Treatment Start|Adverse Event|0
4616253|NCT01738594|7475103|FG004|Registration and Treatment Start|Adverse Event|0
4616254|NCT01738594|7475104|FG005|Registration and Treatment Start|Adverse Event|0
4616255|NCT01738594|7475105|FG006|Registration and Treatment Start|Adverse Event|0
4616256|NCT01738594|7475106|FG007|Registration and Treatment Start|Adverse Event|0
4616257|NCT01738594|7475099|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
4616258|NCT01738594|7475100|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
4616259|NCT01738594|7475101|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
4690453|NCT02561195|7600194|FG009|Vaccination 1 to 3|Death|0
4464434|NCT00603941|7255198|FG002|Overall Study|Adverse Event|1
4464435|NCT00603941|7255196|FG000|Overall Study|Physician Decision|0
4464436|NCT00603941|7255197|FG001|Overall Study|Physician Decision|1
4464437|NCT00603941|7255198|FG002|Overall Study|Physician Decision|0
4464438|NCT00603941|7255196|FG000|Overall Study|Withdrawal by Subject|0
4540596|NCT01133821|7363341|FG000|Overall Study|Withdrawal by Subject|8
4616260|NCT01738594|7475102|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
4616261|NCT01738594|7475103|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
4690454|NCT02561195|7600195|FG010|Vaccination 1 to 3|Death|0
4464439|NCT00603941|7255197|FG001|Overall Study|Withdrawal by Subject|2
4464440|NCT00603941|7255198|FG002|Overall Study|Withdrawal by Subject|0
4464441|NCT00603980|7255207|FG000|Study Qualification|Protocol Violation|3
4464442|NCT00603980|7255207|FG000|Study Qualification|Inconsistent data reporting|13
4464443|NCT00603980|7255207|FG000|Main Study|14th subject completed trial|1
4464444|NCT00604162|7255249|FG000|Overall Study|Physician Decision|3
4464445|NCT00604162|7255249|FG000|Overall Study|Withdrawal by Subject|1
4464446|NCT00604175|7255259|FG000|Entry Through Week 28|Death|2
4464447|NCT00604175|7255260|FG001|Entry Through Week 28|Death|0
4464448|NCT00604175|7255261|FG002|Entry Through Week 28|Death|0
4464449|NCT00604175|7255259|FG000|Entry Through Week 28|Withdrawal by Subject|1
4464450|NCT00604175|7255260|FG001|Entry Through Week 28|Withdrawal by Subject|0
4464451|NCT00604175|7255261|FG002|Entry Through Week 28|Withdrawal by Subject|0
4464452|NCT00604175|7255259|FG000|Entry Through Week 28|Lost to Follow-up|4
4464453|NCT00604175|7255260|FG001|Entry Through Week 28|Lost to Follow-up|3
4464454|NCT00604175|7255261|FG002|Entry Through Week 28|Lost to Follow-up|0
4464455|NCT00604175|7255259|FG000|Entry Through Week 28|Ineligible|1
4464456|NCT00604175|7255260|FG001|Entry Through Week 28|Ineligible|0
4464457|NCT00604175|7255261|FG002|Entry Through Week 28|Ineligible|0
4464458|NCT00604175|7255259|FG000|Entry Through Week 28|Did not start intervention|2
4464459|NCT00604175|7255260|FG001|Entry Through Week 28|Did not start intervention|0
4464460|NCT00604175|7255261|FG002|Entry Through Week 28|Did not start intervention|1
4464461|NCT00604175|7255259|FG000|Week 29 Through Week 72|Death|0
4464462|NCT00604175|7255260|FG001|Week 29 Through Week 72|Death|0
4464463|NCT00604175|7255261|FG002|Week 29 Through Week 72|Death|1
4464464|NCT00604175|7255259|FG000|Week 29 Through Week 72|Lost to Follow-up|12
4464465|NCT00604175|7255260|FG001|Week 29 Through Week 72|Lost to Follow-up|6
4464466|NCT00604175|7255261|FG002|Week 29 Through Week 72|Lost to Follow-up|2
4464467|NCT00604175|7255259|FG000|Week 29 Through Week 72|Site closure|0
4464468|NCT00604175|7255260|FG001|Week 29 Through Week 72|Site closure|1
4464469|NCT00604175|7255261|FG002|Week 29 Through Week 72|Site closure|0
4464470|NCT00604175|7255259|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0
4464471|NCT00604175|7255260|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0
4464472|NCT00604175|7255261|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1
4540597|NCT01133821|7363342|FG001|Overall Study|Withdrawal by Subject|3
4540598|NCT01133821|7363341|FG000|Overall Study|preferred other treatment|1
4540599|NCT01133821|7363342|FG001|Overall Study|preferred other treatment|1
4540600|NCT01133821|7363341|FG000|Overall Study|Protocol Violation|0
4540601|NCT01133821|7363342|FG001|Overall Study|Protocol Violation|1
4540602|NCT01133821|7363341|FG000|Overall Study|Refused participation|1
4540603|NCT01133821|7363342|FG001|Overall Study|Refused participation|3
4616262|NCT01738594|7475104|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1
4464473|NCT00604188|7255295|FG000|Overall Study|Adverse Event|1
4464474|NCT00604188|7255296|FG001|Overall Study|Adverse Event|4
4464475|NCT00604188|7255295|FG000|Overall Study|Lost to Follow-up|17
4464476|NCT00604188|7255296|FG001|Overall Study|Lost to Follow-up|15
4464477|NCT00604188|7255295|FG000|Overall Study|Withdrawal by Subject|5
4464478|NCT00604188|7255296|FG001|Overall Study|Withdrawal by Subject|1
4464479|NCT00604188|7255295|FG000|Overall Study|Non-compliance with protocol|4
4464480|NCT00604188|7255296|FG001|Overall Study|Non-compliance with protocol|4
4464481|NCT00604188|7255295|FG000|Overall Study|Did not receive study drug|0
4464482|NCT00604188|7255296|FG001|Overall Study|Did not receive study drug|1
4464483|NCT00604214|7255304|FG000|Baseline to Day 28|Death|223
4464484|NCT00604214|7255305|FG001|Baseline to Day 28|Death|202
4464485|NCT00604214|7255304|FG000|Baseline to Day 28|Lost to Follow-up|2
4464486|NCT00604214|7255305|FG001|Baseline to Day 28|Lost to Follow-up|4
4464487|NCT00604214|7255304|FG000|Baseline to Day 28|Withdrawal by Subject|3
4464488|NCT00604214|7255305|FG001|Baseline to Day 28|Withdrawal by Subject|7
4464489|NCT00604214|7255304|FG000|Day 29 to Day 90|Death|64
4464490|NCT00604214|7255305|FG001|Day 29 to Day 90|Death|67
4464491|NCT00604214|7255304|FG000|Day 29 to Day 90|Lost to Follow-up|4
4464492|NCT00604214|7255305|FG001|Day 29 to Day 90|Lost to Follow-up|6
4464493|NCT00604214|7255304|FG000|Day 29 to Day 90|Withdrawal by Subject|0
4464494|NCT00604214|7255305|FG001|Day 29 to Day 90|Withdrawal by Subject|6
4464495|NCT00604214|7255304|FG000|Day 91 to Day 180|Death|19
4540604|NCT01133847|7363351|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5
4540605|NCT01133847|7363352|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1
4616263|NCT01738594|7475105|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
4616264|NCT01738594|7475106|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
4616265|NCT01738594|7475099|FG000|Completed 4 Cycles of Treatment|Progressive disease|0
4616266|NCT01738594|7475100|FG001|Completed 4 Cycles of Treatment|Progressive disease|2
4616267|NCT01738594|7475101|FG002|Completed 4 Cycles of Treatment|Progressive disease|0
4616268|NCT01738594|7475102|FG003|Completed 4 Cycles of Treatment|Progressive disease|0
4540606|NCT01133847|7363353|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3
4540607|NCT01133847|7363351|FG000|Follow-Up Phase|Lost to Follow-up|1
4464496|NCT00604214|7255305|FG001|Day 91 to Day 180|Death|23
4464497|NCT00604214|7255304|FG000|Day 91 to Day 180|Lost to Follow-up|6
4464498|NCT00604214|7255305|FG001|Day 91 to Day 180|Lost to Follow-up|8
4464499|NCT00604214|7255304|FG000|Day 91 to Day 180|Withdrawal by Subject|1
4464500|NCT00604214|7255305|FG001|Day 91 to Day 180|Withdrawal by Subject|1
4464501|NCT00604279|7255313|FG000|Overall Study|Lack of Efficacy|22
4464502|NCT00604279|7255314|FG001|Overall Study|Lack of Efficacy|9
4464503|NCT00604279|7255313|FG000|Overall Study|Lost to Follow-up|9
4464504|NCT00604279|7255314|FG001|Overall Study|Lost to Follow-up|14
4464505|NCT00604279|7255313|FG000|Overall Study|Pregnancy|2
4464506|NCT00604279|7255314|FG001|Overall Study|Pregnancy|0
4464507|NCT00604279|7255313|FG000|Overall Study|Protocol Violation|3
4464508|NCT00604279|7255314|FG001|Overall Study|Protocol Violation|1
4464509|NCT00604279|7255313|FG000|Overall Study|Withdrawal by Subject|16
4464510|NCT00604279|7255314|FG001|Overall Study|Withdrawal by Subject|5
4464511|NCT00604279|7255313|FG000|Overall Study|Adverse Event|4
4464512|NCT00604279|7255314|FG001|Overall Study|Adverse Event|5
4464513|NCT00604279|7255313|FG000|Overall Study|Other|8
4464514|NCT00604279|7255314|FG001|Overall Study|Other|4
4464515|NCT00604383|7255322|FG000|Overall Study|Withdrawal by Subject|33
4464516|NCT00604383|7255323|FG001|Overall Study|Withdrawal by Subject|31
4464517|NCT00604383|7255322|FG000|Overall Study|Lost to Follow-up|24
4464518|NCT00604383|7255323|FG001|Overall Study|Lost to Follow-up|19
4464519|NCT00604383|7255322|FG000|Overall Study|Death|14
4464520|NCT00604383|7255323|FG001|Overall Study|Death|22
4464521|NCT00604383|7255322|FG000|Overall Study|Adverse Event|16
4464522|NCT00604383|7255323|FG001|Overall Study|Adverse Event|9
4464523|NCT00604383|7255322|FG000|Overall Study|Physician Decision|0
4464524|NCT00604383|7255323|FG001|Overall Study|Physician Decision|3
4516251|NCT00958711|7327536|FG000|Overall Study|Adverse Event|1
4516252|NCT00958711|7327537|FG001|Overall Study|Adverse Event|2
4516253|NCT00958724|7327543|FG000|Overall Study|Disease Progression|6
4516254|NCT00958776|7327549|FG000|Overall Study|Adverse Event|0
4516255|NCT00958776|7327550|FG001|Overall Study|Adverse Event|1
4516256|NCT00958776|7327549|FG000|Overall Study|Physician Decision|1
4516257|NCT00958776|7327550|FG001|Overall Study|Physician Decision|0
4516258|NCT00958776|7327549|FG000|Overall Study|Lost to Follow-up|2
4616269|NCT01738594|7475103|FG004|Completed 4 Cycles of Treatment|Progressive disease|0
4616270|NCT01738594|7475104|FG005|Completed 4 Cycles of Treatment|Progressive disease|0
4616271|NCT01738594|7475105|FG006|Completed 4 Cycles of Treatment|Progressive disease|0
4616272|NCT01738594|7475106|FG007|Completed 4 Cycles of Treatment|Progressive disease|0
4616273|NCT01738594|7475099|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0
4616274|NCT01738594|7475100|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0
4616275|NCT01738594|7475101|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0
4616276|NCT01738594|7475102|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0
4616277|NCT01738594|7475103|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0
4616278|NCT01738594|7475104|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1
4616279|NCT01738594|7475105|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0
4616280|NCT01738594|7475106|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0
4616281|NCT01738594|7475099|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0
4616282|NCT01738594|7475100|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0
4616283|NCT01738594|7475101|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0
4616284|NCT01738594|7475102|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0
4616285|NCT01738594|7475103|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0
4616286|NCT01738594|7475104|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1
4616287|NCT01738594|7475105|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0
4616288|NCT01738594|7475106|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0
4616289|NCT01738594|7475099|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
4616290|NCT01738594|7475100|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
4616291|NCT01738594|7475101|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
4616292|NCT01738594|7475102|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
4616293|NCT01738594|7475103|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1
4616294|NCT01738594|7475104|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
4616295|NCT01738594|7475105|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
4616296|NCT01738594|7475106|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
4516259|NCT00958776|7327550|FG001|Overall Study|Lost to Follow-up|6
4516260|NCT00958776|7327549|FG000|Overall Study|Withdrawal by Subject|7
4516261|NCT00958776|7327550|FG001|Overall Study|Withdrawal by Subject|16
4516262|NCT00958776|7327549|FG000|Overall Study|Protocol Violation|1
4516263|NCT00958776|7327550|FG001|Overall Study|Protocol Violation|1
4516264|NCT00958776|7327549|FG000|Overall Study|Death|2
4516265|NCT00958776|7327550|FG001|Overall Study|Death|1
4516266|NCT00958776|7327549|FG000|Overall Study|Noncompliance; Protocol Deviations|2
4516267|NCT00958776|7327550|FG001|Overall Study|Noncompliance; Protocol Deviations|3
4516268|NCT00958776|7327549|FG000|Overall Study|Missing|1
4516269|NCT00958776|7327550|FG001|Overall Study|Missing|1
4516270|NCT00958789|7327557|FG000|Overall Study|Death|5
4516271|NCT00958789|7327557|FG000|Overall Study|Lost to Follow-up|14
4516272|NCT00958789|7327557|FG000|Overall Study|Withdrawal by Subject|17
4516273|NCT00958789|7327557|FG000|Overall Study|No 2 yr. Knee Society Score data|4
4516274|NCT00958789|7327557|FG000|Overall Study|2 yr. Knee Society Score not calculable|1
4516275|NCT00958789|7327557|FG000|Overall Study|Subject terminated|2
4516276|NCT00958789|7327557|FG000|Overall Study|Revision|7
4464525|NCT00604565|7255346|FG000|Overall Study|Study terminated|0
4464526|NCT00604565|7255347|FG001|Overall Study|Study terminated|3
4464527|NCT00604669|7255353|FG000|Overall Study|lack of information in chart|7
4464528|NCT00604695|7255359|FG000|Overall Study|Did not receive first bolus.|0
4464529|NCT00604695|7255360|FG001|Overall Study|Did not receive first bolus.|4
4464530|NCT00604708|7255368|FG000|Overall Study|Withdrawal by Subject|9
4464531|NCT00604708|7255369|FG001|Overall Study|Withdrawal by Subject|10
4464532|NCT00604708|7255368|FG000|Overall Study|Protocol Violation|2
4464533|NCT00604708|7255369|FG001|Overall Study|Protocol Violation|8
4464534|NCT00604708|7255368|FG000|Overall Study|Lost to Follow-up|5
4540608|NCT01133847|7363352|FG001|Follow-Up Phase|Lost to Follow-up|3
4540609|NCT01133847|7363353|FG002|Follow-Up Phase|Lost to Follow-up|7
4540610|NCT01133977|7363372|FG000|Overall Study|Adverse Event|0
4540611|NCT01133977|7363373|FG001|Overall Study|Adverse Event|0
4464535|NCT00604708|7255369|FG001|Overall Study|Lost to Follow-up|5
4464536|NCT00604708|7255368|FG000|Overall Study|administrative reasons|9
4464537|NCT00604708|7255369|FG001|Overall Study|administrative reasons|11
4464538|NCT00604708|7255368|FG000|Overall Study|Adverse Event|6
4464539|NCT00604708|7255369|FG001|Overall Study|Adverse Event|6
4464540|NCT00604721|7255375|FG000|Overall Study|Physician Decision|1
4464541|NCT00604721|7255375|FG000|Overall Study|Withdrawal by Subject|1
4464542|NCT00604786|7255382|FG000|Overall Study|Lost to Follow-up|2
4464543|NCT00604786|7255383|FG001|Overall Study|Lost to Follow-up|0
4464544|NCT00604825|7255393|FG000|Overall Study|Adverse Event|2
4464545|NCT00604825|7255394|FG001|Overall Study|Adverse Event|6
4464546|NCT00604825|7255395|FG002|Overall Study|Adverse Event|7
4464547|NCT00604825|7255396|FG003|Overall Study|Adverse Event|4
4464548|NCT00604825|7255393|FG000|Overall Study|Lost to Follow-up|0
4464549|NCT00604825|7255394|FG001|Overall Study|Lost to Follow-up|3
4464550|NCT00604825|7255395|FG002|Overall Study|Lost to Follow-up|1
4464551|NCT00604825|7255396|FG003|Overall Study|Lost to Follow-up|0
4464552|NCT00604825|7255393|FG000|Overall Study|Protocol Violation|0
4464553|NCT00604825|7255394|FG001|Overall Study|Protocol Violation|1
4464554|NCT00604825|7255395|FG002|Overall Study|Protocol Violation|0
4464555|NCT00604825|7255396|FG003|Overall Study|Protocol Violation|0
4464556|NCT00604825|7255393|FG000|Overall Study|Withdrawal by Subject|4
4464557|NCT00604825|7255394|FG001|Overall Study|Withdrawal by Subject|3
4464558|NCT00604825|7255395|FG002|Overall Study|Withdrawal by Subject|5
4464559|NCT00604825|7255396|FG003|Overall Study|Withdrawal by Subject|5
4464560|NCT00604825|7255393|FG000|Overall Study|Lack of Efficacy|3
4464561|NCT00604825|7255394|FG001|Overall Study|Lack of Efficacy|2
4464562|NCT00604825|7255395|FG002|Overall Study|Lack of Efficacy|1
4464563|NCT00604825|7255396|FG003|Overall Study|Lack of Efficacy|0
4464564|NCT00604825|7255393|FG000|Overall Study|Did not meet eligibility criteria|0
4464565|NCT00604825|7255394|FG001|Overall Study|Did not meet eligibility criteria|0
4464566|NCT00604825|7255395|FG002|Overall Study|Did not meet eligibility criteria|2
4540612|NCT01133977|7363374|FG002|Overall Study|Adverse Event|1
4616297|NCT01738594|7475099|FG000|Follow up for 1 Year|Death|0
4616298|NCT01738594|7475100|FG001|Follow up for 1 Year|Death|0
4616299|NCT01738594|7475101|FG002|Follow up for 1 Year|Death|0
4464567|NCT00604825|7255396|FG003|Overall Study|Did not meet eligibility criteria|0
4464568|NCT00604825|7255393|FG000|Overall Study|Physician Decision|0
4464569|NCT00604825|7255394|FG001|Overall Study|Physician Decision|0
4464570|NCT00604825|7255395|FG002|Overall Study|Physician Decision|0
4540613|NCT01133977|7363375|FG003|Overall Study|Adverse Event|0
4540614|NCT01133977|7363376|FG004|Overall Study|Adverse Event|0
4540615|NCT01133977|7363372|FG000|Overall Study|Death|1
4540616|NCT01133977|7363373|FG001|Overall Study|Death|1
4540617|NCT01133977|7363374|FG002|Overall Study|Death|1
4540618|NCT01133977|7363375|FG003|Overall Study|Death|7
4540619|NCT01133977|7363376|FG004|Overall Study|Death|3
4540620|NCT01133977|7363372|FG000|Overall Study|Started a New Line of Therapy|2
4540621|NCT01133977|7363373|FG001|Overall Study|Started a New Line of Therapy|6
4540622|NCT01133977|7363374|FG002|Overall Study|Started a New Line of Therapy|4
4540623|NCT01133977|7363375|FG003|Overall Study|Started a New Line of Therapy|25
4540624|NCT01133977|7363376|FG004|Overall Study|Started a New Line of Therapy|33
4540625|NCT01133977|7363372|FG000|Overall Study|Lost to Follow-up|0
4540626|NCT01133977|7363373|FG001|Overall Study|Lost to Follow-up|0
4540627|NCT01133977|7363374|FG002|Overall Study|Lost to Follow-up|0
4540628|NCT01133977|7363375|FG003|Overall Study|Lost to Follow-up|2
4540629|NCT01133977|7363376|FG004|Overall Study|Lost to Follow-up|1
4540630|NCT01133977|7363372|FG000|Overall Study|Withdrawal by Subject|0
4540631|NCT01133977|7363373|FG001|Overall Study|Withdrawal by Subject|0
4540632|NCT01133977|7363374|FG002|Overall Study|Withdrawal by Subject|0
4540633|NCT01133977|7363375|FG003|Overall Study|Withdrawal by Subject|5
4540634|NCT01133977|7363376|FG004|Overall Study|Withdrawal by Subject|1
4540635|NCT01134042|7363427|FG000|Overall Study|Adverse Event|3
4540636|NCT01134042|7363428|FG001|Overall Study|Adverse Event|7
4540637|NCT01134042|7363429|FG002|Overall Study|Adverse Event|2
4540638|NCT01134042|7363427|FG000|Overall Study|Lack of Efficacy|21
4540639|NCT01134042|7363428|FG001|Overall Study|Lack of Efficacy|6
4540640|NCT01134042|7363429|FG002|Overall Study|Lack of Efficacy|18
4540641|NCT01134042|7363427|FG000|Overall Study|Protocol Violation|5
4540642|NCT01134042|7363428|FG001|Overall Study|Protocol Violation|3
4464571|NCT00604825|7255396|FG003|Overall Study|Physician Decision|1
4464572|NCT00604825|7255393|FG000|Overall Study|Exclusion criterion met|0
4464573|NCT00604825|7255394|FG001|Overall Study|Exclusion criterion met|0
4616300|NCT01738594|7475102|FG003|Follow up for 1 Year|Death|0
4616301|NCT01738594|7475103|FG004|Follow up for 1 Year|Death|0
4616302|NCT01738594|7475104|FG005|Follow up for 1 Year|Death|1
4616303|NCT01738594|7475105|FG006|Follow up for 1 Year|Death|0
4616304|NCT01738594|7475106|FG007|Follow up for 1 Year|Death|0
4616305|NCT01738594|7475099|FG000|Follow up for 1 Year|Other|0
4616306|NCT01738594|7475100|FG001|Follow up for 1 Year|Other|0
4616307|NCT01738594|7475101|FG002|Follow up for 1 Year|Other|0
4616308|NCT01738594|7475102|FG003|Follow up for 1 Year|Other|0
4616309|NCT01738594|7475103|FG004|Follow up for 1 Year|Other|0
4616310|NCT01738594|7475104|FG005|Follow up for 1 Year|Other|2
4616311|NCT01738594|7475105|FG006|Follow up for 1 Year|Other|0
4616312|NCT01738594|7475106|FG007|Follow up for 1 Year|Other|0
4616313|NCT01738646|7475116|FG000|Overall Study|Still Receiving Treatment|2
4616314|NCT01738919|7475159|FG000|Overall Study|Lost to Follow-up|1
4616315|NCT01738919|7475160|FG001|Overall Study|Lost to Follow-up|0
4616316|NCT01738919|7475159|FG000|Overall Study|Immigrated|0
4616317|NCT01738919|7475160|FG001|Overall Study|Immigrated|1
4616318|NCT01738919|7475159|FG000|Overall Study|Withdrawal by Subject|0
4616319|NCT01738919|7475160|FG001|Overall Study|Withdrawal by Subject|1
4616320|NCT01738919|7475159|FG000|Overall Study|Not treated in accordance to guidelines|0
4616321|NCT01738919|7475160|FG001|Overall Study|Not treated in accordance to guidelines|1
4616322|NCT01738971|7475171|FG000|Overall Study|Lost to Follow-up|19
4616323|NCT01738971|7475172|FG001|Overall Study|Lost to Follow-up|30
4616324|NCT01738971|7475173|FG002|Overall Study|Lost to Follow-up|17
4616325|NCT01738984|7475183|FG000|Overall Study|Pregnancy|4
4616326|NCT01738984|7475184|FG001|Overall Study|Pregnancy|0
4616327|NCT01738984|7475183|FG000|Overall Study|Withdrawal by Subject|1
4616328|NCT01738984|7475184|FG001|Overall Study|Withdrawal by Subject|0
4616329|NCT01738984|7475183|FG000|Overall Study|Lost to Follow-up|59
4616330|NCT01738984|7475184|FG001|Overall Study|Lost to Follow-up|39
4616331|NCT01739309|7475217|FG000|Overall Study|On study treatment|3
4616332|NCT01739335|7475225|FG000|Overall Study|Lost to Follow-up|7
4616333|NCT01739335|7475226|FG001|Overall Study|Lost to Follow-up|4
4616334|NCT01739335|7475225|FG000|Overall Study|Ineligible patient randomized|0
4616335|NCT01739335|7475226|FG001|Overall Study|Ineligible patient randomized|1
4616336|NCT01739348|7475240|FG000|Part I (Base Study)|Adverse Event|41
4616337|NCT01739348|7475241|FG001|Part I (Base Study)|Adverse Event|52
4616338|NCT01739348|7475242|FG002|Part I (Base Study)|Adverse Event|8
4616339|NCT01739348|7475243|FG003|Part I (Base Study)|Adverse Event|33
4616340|NCT01739348|7475240|FG000|Part I (Base Study)|Death|10
4616341|NCT01739348|7475241|FG001|Part I (Base Study)|Death|7
4616342|NCT01739348|7475242|FG002|Part I (Base Study)|Death|2
4616343|NCT01739348|7475243|FG003|Part I (Base Study)|Death|8
4616344|NCT01739348|7475240|FG000|Part I (Base Study)|Lack of Efficacy|3
4616345|NCT01739348|7475241|FG001|Part I (Base Study)|Lack of Efficacy|8
4616346|NCT01739348|7475242|FG002|Part I (Base Study)|Lack of Efficacy|0
4616347|NCT01739348|7475243|FG003|Part I (Base Study)|Lack of Efficacy|7
4616348|NCT01739348|7475240|FG000|Part I (Base Study)|Lost to Follow-up|4
4616349|NCT01739348|7475241|FG001|Part I (Base Study)|Lost to Follow-up|2
4616350|NCT01739348|7475242|FG002|Part I (Base Study)|Lost to Follow-up|4
4616351|NCT01739348|7475243|FG003|Part I (Base Study)|Lost to Follow-up|4
4616352|NCT01739348|7475240|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3
4616353|NCT01739348|7475241|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2
4616354|NCT01739348|7475242|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0
4616355|NCT01739348|7475243|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0
4616356|NCT01739348|7475240|FG000|Part I (Base Study)|Physician Decision|10
4616357|NCT01739348|7475241|FG001|Part I (Base Study)|Physician Decision|7
4616358|NCT01739348|7475242|FG002|Part I (Base Study)|Physician Decision|1
4616359|NCT01739348|7475243|FG003|Part I (Base Study)|Physician Decision|4
4616360|NCT01739348|7475240|FG000|Part I (Base Study)|Protocol Violation|2
4616361|NCT01739348|7475241|FG001|Part I (Base Study)|Protocol Violation|0
4616362|NCT01739348|7475242|FG002|Part I (Base Study)|Protocol Violation|1
4616363|NCT01739348|7475243|FG003|Part I (Base Study)|Protocol Violation|2
4616364|NCT01739348|7475240|FG000|Part I (Base Study)|Screen Failure|2
4616365|NCT01739348|7475241|FG001|Part I (Base Study)|Screen Failure|0
4616366|NCT01739348|7475242|FG002|Part I (Base Study)|Screen Failure|0
4616367|NCT01739348|7475243|FG003|Part I (Base Study)|Screen Failure|0
4616368|NCT01739348|7475240|FG000|Part I (Base Study)|Site Discontinued Study Participation|1
4616369|NCT01739348|7475241|FG001|Part I (Base Study)|Site Discontinued Study Participation|3
4616370|NCT01739348|7475242|FG002|Part I (Base Study)|Site Discontinued Study Participation|0
4616371|NCT01739348|7475243|FG003|Part I (Base Study)|Site Discontinued Study Participation|0
4616372|NCT01739348|7475240|FG000|Part I (Base Study)|Study Terminated by Sponsor|72
4616373|NCT01739348|7475241|FG001|Part I (Base Study)|Study Terminated by Sponsor|73
4616374|NCT01739348|7475242|FG002|Part I (Base Study)|Study Terminated by Sponsor|0
4464574|NCT00604825|7255395|FG002|Overall Study|Exclusion criterion met|0
4616375|NCT01739348|7475243|FG003|Part I (Base Study)|Study Terminated by Sponsor|86
4616376|NCT01739348|7475240|FG000|Part I (Base Study)|Participant Moved|4
4464575|NCT00604825|7255396|FG003|Overall Study|Exclusion criterion met|1
4464576|NCT00605033|7255430|FG000|Overall Study|Adverse Event|2
4464577|NCT00605033|7255431|FG001|Overall Study|Adverse Event|2
4464578|NCT00605033|7255430|FG000|Overall Study|Lost to Follow-up|1
4464579|NCT00605033|7255431|FG001|Overall Study|Lost to Follow-up|1
4464580|NCT00605033|7255430|FG000|Overall Study|Withdrawal by Subject|3
4464581|NCT00605033|7255431|FG001|Overall Study|Withdrawal by Subject|4
4464582|NCT00605033|7255430|FG000|Overall Study|Protocol Violation|1
4464583|NCT00605033|7255431|FG001|Overall Study|Protocol Violation|1
4464584|NCT00605085|7255452|FG000|Overall Study|Withdrawal by Subject|8
4464585|NCT00605085|7255453|FG001|Overall Study|Withdrawal by Subject|5
4464586|NCT00605085|7255452|FG000|Overall Study|Adverse Event|9
4464587|NCT00605085|7255453|FG001|Overall Study|Adverse Event|5
4464588|NCT00605085|7255452|FG000|Overall Study|Pregnancy|2
4464589|NCT00605085|7255453|FG001|Overall Study|Pregnancy|0
4464590|NCT00605085|7255452|FG000|Overall Study|Protocol Violation|3
4464591|NCT00605085|7255453|FG001|Overall Study|Protocol Violation|2
4464592|NCT00605085|7255452|FG000|Overall Study|Lost to Follow-up|10
4464593|NCT00605085|7255453|FG001|Overall Study|Lost to Follow-up|5
4464594|NCT00605085|7255452|FG000|Overall Study|administrative reasons|18
4464595|NCT00605085|7255453|FG001|Overall Study|administrative reasons|8
4464596|NCT00605176|7255462|FG000|Overall Study|Adverse Event|2
4464597|NCT00605176|7255463|FG001|Overall Study|Adverse Event|1
4464598|NCT00605176|7255464|FG002|Overall Study|Adverse Event|3
4464599|NCT00605176|7255462|FG000|Overall Study|Withdrawal by Subject|4
4464600|NCT00605176|7255463|FG001|Overall Study|Withdrawal by Subject|2
4464601|NCT00605176|7255464|FG002|Overall Study|Withdrawal by Subject|4
4464602|NCT00605176|7255462|FG000|Overall Study|Lost to Follow-up|2
4464603|NCT00605176|7255463|FG001|Overall Study|Lost to Follow-up|2
4464604|NCT00605176|7255464|FG002|Overall Study|Lost to Follow-up|1
4464605|NCT00605176|7255462|FG000|Overall Study|Non-complicance with study procedures|1
4616377|NCT01739348|7475241|FG001|Part I (Base Study)|Participant Moved|3
4616378|NCT01739348|7475242|FG002|Part I (Base Study)|Participant Moved|1
4616379|NCT01739348|7475243|FG003|Part I (Base Study)|Participant Moved|7
4616380|NCT01739348|7475240|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27
4616381|NCT01739348|7475241|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25
4616382|NCT01739348|7475242|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2
4616383|NCT01739348|7475243|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18
4616384|NCT01739348|7475240|FG000|Part I (Base Study)|Withdrawal by Subject|23
4616385|NCT01739348|7475241|FG001|Part I (Base Study)|Withdrawal by Subject|21
4616386|NCT01739348|7475242|FG002|Part I (Base Study)|Withdrawal by Subject|7
4616387|NCT01739348|7475243|FG003|Part I (Base Study)|Withdrawal by Subject|20
4616388|NCT01739348|7475240|FG000|Part II (Extension Study)|Adverse Event|10
4616389|NCT01739348|7475241|FG001|Part II (Extension Study)|Adverse Event|11
4616390|NCT01739348|7475242|FG002|Part II (Extension Study)|Adverse Event|7
4616391|NCT01739348|7475243|FG003|Part II (Extension Study)|Adverse Event|26
4616392|NCT01739348|7475240|FG000|Part II (Extension Study)|Death|3
4616393|NCT01739348|7475241|FG001|Part II (Extension Study)|Death|3
4616394|NCT01739348|7475242|FG002|Part II (Extension Study)|Death|2
4616395|NCT01739348|7475243|FG003|Part II (Extension Study)|Death|6
4616396|NCT01739348|7475240|FG000|Part II (Extension Study)|Lack of Efficacy|1
4616397|NCT01739348|7475241|FG001|Part II (Extension Study)|Lack of Efficacy|5
4616398|NCT01739348|7475242|FG002|Part II (Extension Study)|Lack of Efficacy|0
4616399|NCT01739348|7475243|FG003|Part II (Extension Study)|Lack of Efficacy|1
4616400|NCT01739348|7475240|FG000|Part II (Extension Study)|Lost to Follow-up|3
4616401|NCT01739348|7475241|FG001|Part II (Extension Study)|Lost to Follow-up|4
4616402|NCT01739348|7475242|FG002|Part II (Extension Study)|Lost to Follow-up|0
4616403|NCT01739348|7475243|FG003|Part II (Extension Study)|Lost to Follow-up|1
4616404|NCT01739348|7475240|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0
4616405|NCT01739348|7475241|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0
4616406|NCT01739348|7475242|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0
4616407|NCT01739348|7475243|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1
4616408|NCT01739348|7475240|FG000|Part II (Extension Study)|Physician Decision|7
4616409|NCT01739348|7475241|FG001|Part II (Extension Study)|Physician Decision|11
4616410|NCT01739348|7475242|FG002|Part II (Extension Study)|Physician Decision|6
4616411|NCT01739348|7475243|FG003|Part II (Extension Study)|Physician Decision|12
4616412|NCT01739348|7475240|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329
4616413|NCT01739348|7475241|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315
4616414|NCT01739348|7475242|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34
4616415|NCT01739348|7475243|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323
4616416|NCT01739348|7475240|FG000|Part II (Extension Study)|Participant Moved|3
4616417|NCT01739348|7475241|FG001|Part II (Extension Study)|Participant Moved|3
4616418|NCT01739348|7475242|FG002|Part II (Extension Study)|Participant Moved|0
4616419|NCT01739348|7475243|FG003|Part II (Extension Study)|Participant Moved|3
4616420|NCT01739348|7475240|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18
4464606|NCT00605176|7255463|FG001|Overall Study|Non-complicance with study procedures|0
4464607|NCT00605176|7255464|FG002|Overall Study|Non-complicance with study procedures|0
4464608|NCT00605176|7255462|FG000|Overall Study|Use of concomitant therapy|1
4464609|NCT00605176|7255463|FG001|Overall Study|Use of concomitant therapy|0
4464610|NCT00605176|7255464|FG002|Overall Study|Use of concomitant therapy|1
4464611|NCT00605176|7255462|FG000|Overall Study|Other (not due to AE)|1
4464612|NCT00605176|7255463|FG001|Overall Study|Other (not due to AE)|1
4464613|NCT00605176|7255464|FG002|Overall Study|Other (not due to AE)|0
4464614|NCT00605189|7255475|FG000|Overall Study|Adverse Event|1
4464615|NCT00605189|7255476|FG001|Overall Study|Adverse Event|0
4464616|NCT00605189|7255477|FG002|Overall Study|Adverse Event|0
4464617|NCT00605189|7255475|FG000|Overall Study|Other|2
4464618|NCT00605189|7255476|FG001|Overall Study|Other|2
4464619|NCT00605189|7255477|FG002|Overall Study|Other|0
4464620|NCT00605267|7255494|FG000|Overall Study|Adverse Event|0
4464621|NCT00605267|7255495|FG001|Overall Study|Adverse Event|1
4616421|NCT01739348|7475241|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12
4616422|NCT01739348|7475242|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8
4616423|NCT01739348|7475243|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16
4616424|NCT01739348|7475240|FG000|Part II (Extension Study)|Withdrawal by Subject|5
4616425|NCT01739348|7475241|FG001|Part II (Extension Study)|Withdrawal by Subject|2
4616426|NCT01739348|7475242|FG002|Part II (Extension Study)|Withdrawal by Subject|4
4616427|NCT01739348|7475243|FG003|Part II (Extension Study)|Withdrawal by Subject|7
4616428|NCT01739400|7475268|FG000|Overall Study|Physician Decision|3
4616429|NCT01739400|7475269|FG001|Overall Study|Physician Decision|0
4616430|NCT01739400|7475268|FG000|Overall Study|Lost to Follow-up|2
4616431|NCT01739400|7475269|FG001|Overall Study|Lost to Follow-up|0
4616432|NCT01739400|7475268|FG000|Overall Study|Death|5
4616433|NCT01739400|7475269|FG001|Overall Study|Death|2
4616434|NCT01739400|7475268|FG000|Overall Study|Withdrawal by Subject|7
4616435|NCT01739400|7475269|FG001|Overall Study|Withdrawal by Subject|7
4616436|NCT01739595|7475277|FG000|Overall Study|Adverse Event|3
4616437|NCT01739595|7475278|FG001|Overall Study|Adverse Event|0
4616438|NCT01739595|7475279|FG002|Overall Study|Adverse Event|0
4616439|NCT01739595|7475277|FG000|Overall Study|Lost to Follow-up|2
4616440|NCT01739595|7475278|FG001|Overall Study|Lost to Follow-up|0
4616441|NCT01739595|7475279|FG002|Overall Study|Lost to Follow-up|0
4616442|NCT01739595|7475277|FG000|Overall Study|Withdrawal by Subject|2
4616443|NCT01739595|7475278|FG001|Overall Study|Withdrawal by Subject|1
4616444|NCT01739595|7475279|FG002|Overall Study|Withdrawal by Subject|2
4616445|NCT01739595|7475277|FG000|Overall Study|Eligibility issue|3
4616446|NCT01739595|7475278|FG001|Overall Study|Eligibility issue|0
4616447|NCT01739595|7475279|FG002|Overall Study|Eligibility issue|0
4616448|NCT01739595|7475277|FG000|Overall Study|Protocol Violation|1
4616449|NCT01739595|7475278|FG001|Overall Study|Protocol Violation|0
4616450|NCT01739595|7475279|FG002|Overall Study|Protocol Violation|0
4616451|NCT01739595|7475277|FG000|Overall Study|Lab assessment|1
4616452|NCT01739595|7475278|FG001|Overall Study|Lab assessment|0
4616453|NCT01739595|7475279|FG002|Overall Study|Lab assessment|0
4616454|NCT01739595|7475277|FG000|Overall Study|Drug discrepancy|1
4616455|NCT01739595|7475278|FG001|Overall Study|Drug discrepancy|0
4616456|NCT01739595|7475279|FG002|Overall Study|Drug discrepancy|0
4616457|NCT01739764|7475298|FG000|Overall Study|Adverse Event|0
4616458|NCT01739764|7475299|FG001|Overall Study|Adverse Event|3
4616459|NCT01739764|7475300|FG002|Overall Study|Adverse Event|4
4616460|NCT01739764|7475298|FG000|Overall Study|Death|4
4616461|NCT01739764|7475299|FG001|Overall Study|Death|6
4616462|NCT01739764|7475300|FG002|Overall Study|Death|38
4616463|NCT01739764|7475298|FG000|Overall Study|Lost to Follow-up|0
4616464|NCT01739764|7475299|FG001|Overall Study|Lost to Follow-up|0
4616465|NCT01739764|7475300|FG002|Overall Study|Lost to Follow-up|5
4616466|NCT01739764|7475298|FG000|Overall Study|Non-Compliance|0
4616467|NCT01739764|7475299|FG001|Overall Study|Non-Compliance|0
4616468|NCT01739764|7475300|FG002|Overall Study|Non-Compliance|1
4616469|NCT01739764|7475298|FG000|Overall Study|Multiple Reasons|3
4616470|NCT01739764|7475299|FG001|Overall Study|Multiple Reasons|2
4616471|NCT01739764|7475300|FG002|Overall Study|Multiple Reasons|3
4616472|NCT01739764|7475298|FG000|Overall Study|Physician Decision|2
4616473|NCT01739764|7475299|FG001|Overall Study|Physician Decision|2
4616474|NCT01739764|7475300|FG002|Overall Study|Physician Decision|4
4616475|NCT01739764|7475298|FG000|Overall Study|Progressive Disease|3
4616476|NCT01739764|7475299|FG001|Overall Study|Progressive Disease|5
4616477|NCT01739764|7475300|FG002|Overall Study|Progressive Disease|16
4616478|NCT01739764|7475298|FG000|Overall Study|Protocol Violation|0
4616479|NCT01739764|7475299|FG001|Overall Study|Protocol Violation|0
4616480|NCT01739764|7475300|FG002|Overall Study|Protocol Violation|2
4616481|NCT01739764|7475298|FG000|Overall Study|Study Terminated by Sponsor|8
4616482|NCT01739764|7475299|FG001|Overall Study|Study Terminated by Sponsor|13
4616483|NCT01739764|7475300|FG002|Overall Study|Study Terminated by Sponsor|26
4616484|NCT01739764|7475298|FG000|Overall Study|Withdrawal by Subject|6
4616485|NCT01739764|7475299|FG001|Overall Study|Withdrawal by Subject|5
4616486|NCT01739764|7475300|FG002|Overall Study|Withdrawal by Subject|27
4616487|NCT01739790|7475310|FG000|Overall Study|Early Trial Termination|2
4616488|NCT01739790|7475311|FG001|Overall Study|Early Trial Termination|4
4616489|NCT01739803|7475319|FG000|Overall Study|Lost to Follow-up|9
4464622|NCT00605267|7255494|FG000|Overall Study|Lack of Efficacy|1
4464623|NCT00605267|7255495|FG001|Overall Study|Lack of Efficacy|5
4464624|NCT00605267|7255494|FG000|Overall Study|Withdrawal by Subject|2
4616490|NCT01739803|7475320|FG001|Overall Study|Lost to Follow-up|6
4616491|NCT01739933|7475328|FG000|Overall Study|Death|89
4616492|NCT01739933|7475329|FG001|Overall Study|Death|86
4464625|NCT00605267|7255495|FG001|Overall Study|Withdrawal by Subject|3
4540643|NCT01134042|7363429|FG002|Overall Study|Protocol Violation|5
4616493|NCT01739933|7475328|FG000|Overall Study|Withdrawal by Subject|10
4616494|NCT01739933|7475329|FG001|Overall Study|Withdrawal by Subject|8
4616495|NCT01739933|7475328|FG000|Overall Study|Lost to Follow-up|3
4616496|NCT01739933|7475329|FG001|Overall Study|Lost to Follow-up|10
4616497|NCT01739933|7475328|FG000|Overall Study|Did not speak English required for neurospychological testing|4
4616498|NCT01739933|7475329|FG001|Overall Study|Did not speak English required for neurospychological testing|3
4616499|NCT01740089|7475338|FG000|First 12 Weeks of Treatment|Adverse Event|0
4616500|NCT01740089|7475339|FG001|First 12 Weeks of Treatment|Adverse Event|1
4616501|NCT01740089|7475340|FG002|First 12 Weeks of Treatment|Adverse Event|2
4616502|NCT01740089|7475338|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0
4616503|NCT01740089|7475339|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1
4616504|NCT01740089|7475340|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0
4616505|NCT01740089|7475338|FG000|After 12 Weeks|Lack of Efficacy|3
4616506|NCT01740089|7475339|FG001|After 12 Weeks|Lack of Efficacy|1
4616507|NCT01740089|7475340|FG002|After 12 Weeks|Lack of Efficacy|4
4616508|NCT01740089|7475338|FG000|After 12 Weeks|Adverse Event|2
4616509|NCT01740089|7475339|FG001|After 12 Weeks|Adverse Event|0
4616510|NCT01740089|7475340|FG002|After 12 Weeks|Adverse Event|5
4616511|NCT01740089|7475338|FG000|After 12 Weeks|Protocol Violation|1
4616512|NCT01740089|7475339|FG001|After 12 Weeks|Protocol Violation|1
4616513|NCT01740089|7475340|FG002|After 12 Weeks|Protocol Violation|1
4616514|NCT01740089|7475338|FG000|After 12 Weeks|Withdrawal by Subject|1
4616515|NCT01740089|7475339|FG001|After 12 Weeks|Withdrawal by Subject|1
4616516|NCT01740089|7475340|FG002|After 12 Weeks|Withdrawal by Subject|1
4616517|NCT01740128|7475351|FG000|Overall Study|Pregnancy|0
4616518|NCT01740128|7475352|FG001|Overall Study|Pregnancy|1
4616519|NCT01740128|7475351|FG000|Overall Study|Protocol Violation|1
4616520|NCT01740128|7475352|FG001|Overall Study|Protocol Violation|2
4616521|NCT01740128|7475351|FG000|Overall Study|Lost to Follow-up|2
4616522|NCT01740128|7475352|FG001|Overall Study|Lost to Follow-up|2
4616523|NCT01740128|7475351|FG000|Overall Study|Withdrawal by Subject|1
4616524|NCT01740128|7475352|FG001|Overall Study|Withdrawal by Subject|0
4616525|NCT01740128|7475351|FG000|Overall Study|Insufficient protocol compliance|2
4616526|NCT01740128|7475352|FG001|Overall Study|Insufficient protocol compliance|2
4616527|NCT01740323|7475373|FG000|Overall Study|Adverse Event|1
4616528|NCT01740323|7475374|FG001|Overall Study|Adverse Event|0
4616529|NCT01740323|7475373|FG000|Overall Study|Randomized but did not take study drug|1
4616530|NCT01740323|7475374|FG001|Overall Study|Randomized but did not take study drug|0
4616531|NCT01740388|7475399|FG000|Overall Study|Withdrawal by Subject|1
4616532|NCT01740388|7475400|FG001|Overall Study|Withdrawal by Subject|2
4616533|NCT01740388|7475399|FG000|Overall Study|Lost to Follow-up|2
4616534|NCT01740388|7475400|FG001|Overall Study|Lost to Follow-up|0
4616535|NCT01740388|7475399|FG000|Overall Study|Physician Decision|2
4616536|NCT01740388|7475400|FG001|Overall Study|Physician Decision|6
4616537|NCT01740388|7475399|FG000|Overall Study|Subjects missing data, completed|41
4616538|NCT01740388|7475400|FG001|Overall Study|Subjects missing data, completed|36
4616539|NCT01740401|7475406|FG000|Overall Study|Progression of disease|6
4616540|NCT01740401|7475406|FG000|Overall Study|Adverse Event|2
4616541|NCT01740401|7475406|FG000|Overall Study|Did not reach primary endpoint|2
4616542|NCT01740440|7475424|FG000|Overall Study|Lost to Follow-up|3
4632951|NCT01905657|7502730|FG000|Overall Study|Screen Failure|0
4632952|NCT01905657|7502731|FG001|Overall Study|Screen Failure|1
4632953|NCT01905657|7502732|FG002|Overall Study|Screen Failure|0
4632954|NCT01905657|7502730|FG000|Overall Study|Withdrawal by Subject|15
4632955|NCT01905657|7502731|FG001|Overall Study|Withdrawal by Subject|21
4632956|NCT01905657|7502732|FG002|Overall Study|Withdrawal by Subject|53
4632957|NCT01905657|7502730|FG000|Overall Study|Sponsor Decision|1
4632958|NCT01905657|7502731|FG001|Overall Study|Sponsor Decision|0
4632959|NCT01905657|7502732|FG002|Overall Study|Sponsor Decision|0
4464626|NCT00605280|7255505|FG000|Year 1|Protocol Violation|0
4464627|NCT00605280|7255506|FG001|Year 1|Protocol Violation|0
4464628|NCT00605280|7255507|FG002|Year 1|Protocol Violation|0
4464629|NCT00605280|7255508|FG003|Year 1|Protocol Violation|1
4464630|NCT00605280|7255505|FG000|Year 1|Adverse Event|3
4464631|NCT00605280|7255506|FG001|Year 1|Adverse Event|1
4464632|NCT00605280|7255507|FG002|Year 1|Adverse Event|1
4464633|NCT00605280|7255508|FG003|Year 1|Adverse Event|5
4540644|NCT01134042|7363427|FG000|Overall Study|Lost to Follow-up|2
4540645|NCT01134042|7363428|FG001|Overall Study|Lost to Follow-up|0
4540646|NCT01134042|7363429|FG002|Overall Study|Lost to Follow-up|1
4540647|NCT01134042|7363427|FG000|Overall Study|Physician Decision|4
4540648|NCT01134042|7363428|FG001|Overall Study|Physician Decision|8
4540649|NCT01134042|7363429|FG002|Overall Study|Physician Decision|1
4540650|NCT01134042|7363427|FG000|Overall Study|Withdrawal by Subject|13
4540651|NCT01134042|7363428|FG001|Overall Study|Withdrawal by Subject|4
4540652|NCT01134042|7363429|FG002|Overall Study|Withdrawal by Subject|7
4464634|NCT00605280|7255505|FG000|Year 1|Physician Decision|7
4632960|NCT01905683|7502743|FG000|Overall Study|Protocol Violation|1
4632961|NCT01905683|7502743|FG000|Overall Study|Re-injection criteria not met; others|13
4690455|NCT02561195|7600196|FG011|Vaccination 1 to 3|Death|0
4464635|NCT00605280|7255506|FG001|Year 1|Physician Decision|4
4464636|NCT00605280|7255507|FG002|Year 1|Physician Decision|0
4540653|NCT01134055|7363445|FG000|Overall Study|Adverse Event|5
4540654|NCT01134055|7363446|FG001|Overall Study|Adverse Event|2
4540655|NCT01134055|7363447|FG002|Overall Study|Adverse Event|2
4616543|NCT01740791|7475459|FG000|Overall Study|Randomized but never treated|5
4616544|NCT01740791|7475460|FG001|Overall Study|Randomized but never treated|3
4616545|NCT01740791|7475461|FG002|Overall Study|Randomized but never treated|2
4616546|NCT01740791|7475462|FG003|Overall Study|Randomized but never treated|2
4616547|NCT01740791|7475463|FG004|Overall Study|Randomized but never treated|1
4616548|NCT01740791|7475464|FG005|Overall Study|Randomized but never treated|3
4616549|NCT01740791|7475459|FG000|Overall Study|Lost to Follow-up|2
4616550|NCT01740791|7475460|FG001|Overall Study|Lost to Follow-up|0
4616551|NCT01740791|7475461|FG002|Overall Study|Lost to Follow-up|2
4616552|NCT01740791|7475462|FG003|Overall Study|Lost to Follow-up|3
4616553|NCT01740791|7475463|FG004|Overall Study|Lost to Follow-up|2
4616554|NCT01740791|7475464|FG005|Overall Study|Lost to Follow-up|3
4616555|NCT01740791|7475459|FG000|Overall Study|Withdrew Consent|4
4616556|NCT01740791|7475460|FG001|Overall Study|Withdrew Consent|0
4616557|NCT01740791|7475461|FG002|Overall Study|Withdrew Consent|1
4616558|NCT01740791|7475462|FG003|Overall Study|Withdrew Consent|2
4616559|NCT01740791|7475463|FG004|Overall Study|Withdrew Consent|0
4616560|NCT01740791|7475464|FG005|Overall Study|Withdrew Consent|3
4616561|NCT01740791|7475459|FG000|Overall Study|Investigator's discretion|1
4616562|NCT01740791|7475460|FG001|Overall Study|Investigator's discretion|0
4616563|NCT01740791|7475461|FG002|Overall Study|Investigator's discretion|1
4616564|NCT01740791|7475462|FG003|Overall Study|Investigator's discretion|0
4616565|NCT01740791|7475463|FG004|Overall Study|Investigator's discretion|0
4616566|NCT01740791|7475464|FG005|Overall Study|Investigator's discretion|1
4616567|NCT01740791|7475459|FG000|Overall Study|Adverse Event|0
4616568|NCT01740791|7475460|FG001|Overall Study|Adverse Event|0
4616569|NCT01740791|7475461|FG002|Overall Study|Adverse Event|0
4616570|NCT01740791|7475462|FG003|Overall Study|Adverse Event|0
4616571|NCT01740791|7475463|FG004|Overall Study|Adverse Event|0
4616572|NCT01740791|7475464|FG005|Overall Study|Adverse Event|1
4616573|NCT01741012|7475526|FG000|Overall Study|Lost to Follow-up|1
4616574|NCT01741012|7475526|FG000|Overall Study|Withdrawal by Subject|2
4616575|NCT01741259|7475533|FG000|Overall Study|Protocol Violation|6
4616576|NCT01741259|7475534|FG001|Overall Study|Protocol Violation|4
4616577|NCT01741259|7475533|FG000|Overall Study|Withdrawal by Subject|0
4616578|NCT01741259|7475534|FG001|Overall Study|Withdrawal by Subject|2
4616579|NCT01741532|7475590|FG000|Overall Study|Adverse Event|4
4616580|NCT01741532|7475591|FG001|Overall Study|Adverse Event|0
4616581|NCT01741532|7475590|FG000|Overall Study|Withdrawal by Subject|1
4616582|NCT01741532|7475591|FG001|Overall Study|Withdrawal by Subject|1
4616583|NCT01741532|7475590|FG000|Overall Study|Protocol Violation|0
4616584|NCT01741532|7475591|FG001|Overall Study|Protocol Violation|1
4616585|NCT01741532|7475590|FG000|Overall Study|Worsening of the disease|3
4616586|NCT01741532|7475591|FG001|Overall Study|Worsening of the disease|1
4616587|NCT01741532|7475590|FG000|Overall Study|Sponsor decision|1
4616588|NCT01741532|7475591|FG001|Overall Study|Sponsor decision|0
4616589|NCT01741532|7475590|FG000|Overall Study|Medical event|1
4616590|NCT01741532|7475591|FG001|Overall Study|Medical event|0
4616591|NCT01741545|7475603|FG000|Treatment Period|Lack of Efficacy|0
4540656|NCT01134055|7363448|FG003|Overall Study|Adverse Event|2
4540657|NCT01134055|7363449|FG004|Overall Study|Adverse Event|5
4540658|NCT01134055|7363450|FG005|Overall Study|Adverse Event|7
4540659|NCT01134055|7363451|FG006|Overall Study|Adverse Event|2
4540660|NCT01134055|7363445|FG000|Overall Study|Lost to Follow-up|0
4540661|NCT01134055|7363446|FG001|Overall Study|Lost to Follow-up|1
4540662|NCT01134055|7363447|FG002|Overall Study|Lost to Follow-up|0
4540663|NCT01134055|7363448|FG003|Overall Study|Lost to Follow-up|1
4540664|NCT01134055|7363449|FG004|Overall Study|Lost to Follow-up|0
4540665|NCT01134055|7363450|FG005|Overall Study|Lost to Follow-up|0
4540666|NCT01134055|7363451|FG006|Overall Study|Lost to Follow-up|0
4540667|NCT01134055|7363445|FG000|Overall Study|Withdrawal by Subject|3
4540668|NCT01134055|7363446|FG001|Overall Study|Withdrawal by Subject|3
4540669|NCT01134055|7363447|FG002|Overall Study|Withdrawal by Subject|1
4540670|NCT01134055|7363448|FG003|Overall Study|Withdrawal by Subject|2
4540671|NCT01134055|7363449|FG004|Overall Study|Withdrawal by Subject|0
4540672|NCT01134055|7363450|FG005|Overall Study|Withdrawal by Subject|0
4540673|NCT01134055|7363451|FG006|Overall Study|Withdrawal by Subject|8
4616592|NCT01741545|7475604|FG001|Treatment Period|Lack of Efficacy|1
4616593|NCT01741545|7475603|FG000|Treatment Period|Adverse event, non-fatal|1
4540674|NCT01134055|7363445|FG000|Overall Study|Protocol Violation|0
4540675|NCT01134055|7363446|FG001|Overall Study|Protocol Violation|0
4616594|NCT01741545|7475604|FG001|Treatment Period|Adverse event, non-fatal|3
4616595|NCT01741545|7475603|FG000|Follow-up Period (24 Weeks)|Other than specified|0
4616596|NCT01741545|7475604|FG001|Follow-up Period (24 Weeks)|Other than specified|1
4616597|NCT01741545|7475603|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1
4616598|NCT01741545|7475604|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1
4616599|NCT01741688|7475610|FG000|Overall Study|Lack of insurance coverage|2
4616600|NCT01741688|7475610|FG000|Overall Study|Withdrawal by Subject|1
4616601|NCT01741701|7475617|FG000|Overall Study|Adverse Event|5
4616602|NCT01741701|7475618|FG001|Overall Study|Adverse Event|1
4616603|NCT01741701|7475617|FG000|Overall Study|Withdrawal by Subject|0
4540676|NCT01134055|7363447|FG002|Overall Study|Protocol Violation|0
4540677|NCT01134055|7363448|FG003|Overall Study|Protocol Violation|1
4540678|NCT01134055|7363449|FG004|Overall Study|Protocol Violation|1
4540679|NCT01134055|7363450|FG005|Overall Study|Protocol Violation|0
4464637|NCT00605280|7255508|FG003|Year 1|Physician Decision|6
4464638|NCT00605280|7255505|FG000|Year 1|Withdrawal by Subject|2
4464639|NCT00605280|7255506|FG001|Year 1|Withdrawal by Subject|4
4464640|NCT00605280|7255507|FG002|Year 1|Withdrawal by Subject|0
4464641|NCT00605280|7255508|FG003|Year 1|Withdrawal by Subject|4
4464642|NCT00605280|7255505|FG000|Year 1|Other|2
4540680|NCT01134055|7363451|FG006|Overall Study|Protocol Violation|0
4540681|NCT01134055|7363445|FG000|Overall Study|Physician Decision|0
4540682|NCT01134055|7363446|FG001|Overall Study|Physician Decision|0
4616604|NCT01741701|7475618|FG001|Overall Study|Withdrawal by Subject|1
4616605|NCT01741792|7475627|FG000|Overall Study|Death|6
4616606|NCT01741792|7475628|FG001|Overall Study|Death|1
4616607|NCT01741792|7475629|FG002|Overall Study|Death|12
4616608|NCT01742078|7475661|FG000|Overall Study|Withdrawal by Subject|0
4616609|NCT01742078|7475662|FG001|Overall Study|Withdrawal by Subject|0
4616610|NCT01742078|7475663|FG002|Overall Study|Withdrawal by Subject|0
4616611|NCT01742078|7475664|FG003|Overall Study|Withdrawal by Subject|1
4616612|NCT01742078|7475665|FG004|Overall Study|Withdrawal by Subject|0
4616613|NCT01742078|7475666|FG005|Overall Study|Withdrawal by Subject|0
4616614|NCT01742078|7475667|FG006|Overall Study|Withdrawal by Subject|0
4616615|NCT01742078|7475668|FG007|Overall Study|Withdrawal by Subject|0
4616616|NCT01742078|7475669|FG008|Overall Study|Withdrawal by Subject|0
4616617|NCT01742091|7475697|FG000|Overall Study|Adverse Event|0
4616618|NCT01742091|7475698|FG001|Overall Study|Adverse Event|0
4616619|NCT01742091|7475699|FG002|Overall Study|Adverse Event|0
4616620|NCT01742091|7475700|FG003|Overall Study|Adverse Event|0
4616621|NCT01742091|7475701|FG004|Overall Study|Adverse Event|1
4616622|NCT01742091|7475702|FG005|Overall Study|Adverse Event|0
4616623|NCT01742091|7475697|FG000|Overall Study|Physician Decision|0
4616624|NCT01742091|7475698|FG001|Overall Study|Physician Decision|0
4616625|NCT01742091|7475699|FG002|Overall Study|Physician Decision|0
4616626|NCT01742091|7475700|FG003|Overall Study|Physician Decision|0
4616627|NCT01742091|7475701|FG004|Overall Study|Physician Decision|0
4616628|NCT01742091|7475702|FG005|Overall Study|Physician Decision|1
4616629|NCT01742091|7475697|FG000|Overall Study|Withdrawal by Subject|0
4616630|NCT01742091|7475698|FG001|Overall Study|Withdrawal by Subject|0
4616631|NCT01742091|7475699|FG002|Overall Study|Withdrawal by Subject|0
4616632|NCT01742091|7475700|FG003|Overall Study|Withdrawal by Subject|1
4616633|NCT01742091|7475701|FG004|Overall Study|Withdrawal by Subject|0
4616634|NCT01742091|7475702|FG005|Overall Study|Withdrawal by Subject|0
4616635|NCT01742091|7475697|FG000|Overall Study|Lost to Follow-up|0
4616636|NCT01742091|7475698|FG001|Overall Study|Lost to Follow-up|0
4690456|NCT02561195|7600197|FG012|Vaccination 1 to 3|Death|0
4690457|NCT02561195|7600198|FG013|Vaccination 1 to 3|Death|0
4690458|NCT02561195|7600185|FG000|Vaccination 1 to 3|Withdrawal by Subject|3
4690459|NCT02561195|7600186|FG001|Vaccination 1 to 3|Withdrawal by Subject|4
4690460|NCT02561195|7600187|FG002|Vaccination 1 to 3|Withdrawal by Subject|4
4690461|NCT02561195|7600188|FG003|Vaccination 1 to 3|Withdrawal by Subject|2
4690462|NCT02561195|7600189|FG004|Vaccination 1 to 3|Withdrawal by Subject|6
4690463|NCT02561195|7600190|FG005|Vaccination 1 to 3|Withdrawal by Subject|0
4690464|NCT02561195|7600191|FG006|Vaccination 1 to 3|Withdrawal by Subject|0
4690465|NCT02561195|7600192|FG007|Vaccination 1 to 3|Withdrawal by Subject|0
4690466|NCT02561195|7600193|FG008|Vaccination 1 to 3|Withdrawal by Subject|0
4690467|NCT02561195|7600194|FG009|Vaccination 1 to 3|Withdrawal by Subject|0
4690468|NCT02561195|7600195|FG010|Vaccination 1 to 3|Withdrawal by Subject|0
4690469|NCT02561195|7600196|FG011|Vaccination 1 to 3|Withdrawal by Subject|0
4690470|NCT02561195|7600197|FG012|Vaccination 1 to 3|Withdrawal by Subject|0
4690471|NCT02561195|7600198|FG013|Vaccination 1 to 3|Withdrawal by Subject|0
4690472|NCT02561195|7600185|FG000|Vaccination 1 to 3|Randomized but not treated|1
4690473|NCT02561195|7600186|FG001|Vaccination 1 to 3|Randomized but not treated|0
4690474|NCT02561195|7600187|FG002|Vaccination 1 to 3|Randomized but not treated|0
4690475|NCT02561195|7600188|FG003|Vaccination 1 to 3|Randomized but not treated|0
4690476|NCT02561195|7600189|FG004|Vaccination 1 to 3|Randomized but not treated|0
4690477|NCT02561195|7600190|FG005|Vaccination 1 to 3|Randomized but not treated|0
4690478|NCT02561195|7600191|FG006|Vaccination 1 to 3|Randomized but not treated|0
4690479|NCT02561195|7600192|FG007|Vaccination 1 to 3|Randomized but not treated|0
4690480|NCT02561195|7600193|FG008|Vaccination 1 to 3|Randomized but not treated|0
4690481|NCT02561195|7600194|FG009|Vaccination 1 to 3|Randomized but not treated|0
4464643|NCT00605280|7255506|FG001|Year 1|Other|1
4464644|NCT00605280|7255507|FG002|Year 1|Other|0
4464645|NCT00605280|7255508|FG003|Year 1|Other|1
4540683|NCT01134055|7363447|FG002|Overall Study|Physician Decision|0
4690482|NCT02561195|7600195|FG010|Vaccination 1 to 3|Randomized but not treated|0
4690483|NCT02561195|7600196|FG011|Vaccination 1 to 3|Randomized but not treated|0
4690484|NCT02561195|7600197|FG012|Vaccination 1 to 3|Randomized but not treated|0
4464646|NCT00605280|7255505|FG000|Year 1|Lost to Follow-up or Patient non-comply|5
4540684|NCT01134055|7363448|FG003|Overall Study|Physician Decision|0
4464647|NCT00605280|7255506|FG001|Year 1|Lost to Follow-up or Patient non-comply|1
4540685|NCT01134055|7363449|FG004|Overall Study|Physician Decision|0
4540686|NCT01134055|7363450|FG005|Overall Study|Physician Decision|0
4540687|NCT01134055|7363451|FG006|Overall Study|Physician Decision|1
4540688|NCT01134107|7363483|FG000|Period 1-First Treatment Intervention|Adverse Event|1
4540689|NCT01134107|7363484|FG001|Period 1-First Treatment Intervention|Adverse Event|0
4540690|NCT01134107|7363483|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1
4540691|NCT01134107|7363484|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1
4540692|NCT01134107|7363483|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3
4540693|NCT01134107|7363484|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4
4540694|NCT01134107|7363483|FG000|Period 1-First Treatment Intervention|Physician Decision|1
4540695|NCT01134107|7363484|FG001|Period 1-First Treatment Intervention|Physician Decision|0
4540696|NCT01134107|7363483|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2
4540697|NCT01134107|7363484|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0
4540698|NCT01134107|7363483|FG000|Period 2-Second Treatment Intervention|Physician Decision|1
4540699|NCT01134107|7363484|FG001|Period 2-Second Treatment Intervention|Physician Decision|0
4540700|NCT01134107|7363483|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1
4464648|NCT00605280|7255507|FG002|Year 1|Lost to Follow-up or Patient non-comply|0
4464649|NCT00605280|7255508|FG003|Year 1|Lost to Follow-up or Patient non-comply|2
4464650|NCT00605280|7255505|FG000|Year 2|Adverse Event|4
4464651|NCT00605280|7255506|FG001|Year 2|Adverse Event|0
4464652|NCT00605280|7255507|FG002|Year 2|Adverse Event|2
4464653|NCT00605280|7255508|FG003|Year 2|Adverse Event|4
4464654|NCT00605280|7255505|FG000|Year 2|Physician Decision|11
4464655|NCT00605280|7255506|FG001|Year 2|Physician Decision|6
4464656|NCT00605280|7255507|FG002|Year 2|Physician Decision|4
4464657|NCT00605280|7255508|FG003|Year 2|Physician Decision|11
4464658|NCT00605280|7255505|FG000|Year 2|Withdrawal by Subject|4
4616637|NCT01742091|7475699|FG002|Overall Study|Lost to Follow-up|0
4616638|NCT01742091|7475700|FG003|Overall Study|Lost to Follow-up|0
4616639|NCT01742091|7475701|FG004|Overall Study|Lost to Follow-up|0
4616640|NCT01742091|7475702|FG005|Overall Study|Lost to Follow-up|1
4616641|NCT01742286|7475747|FG000|Escalation Phase|Administrative problems|1
4616642|NCT01742286|7475748|FG001|Escalation Phase|Administrative problems|1
4616643|NCT01742286|7475749|FG002|Escalation Phase|Administrative problems|0
4616644|NCT01742286|7475750|FG003|Escalation Phase|Administrative problems|0
4616645|NCT01742286|7475751|FG004|Escalation Phase|Administrative problems|0
4616646|NCT01742286|7475752|FG005|Escalation Phase|Administrative problems|0
4616647|NCT01742286|7475753|FG006|Escalation Phase|Administrative problems|2
4616648|NCT01742286|7475747|FG000|Escalation Phase|Adverse Event|0
4616649|NCT01742286|7475748|FG001|Escalation Phase|Adverse Event|1
4616650|NCT01742286|7475749|FG002|Escalation Phase|Adverse Event|2
4616651|NCT01742286|7475750|FG003|Escalation Phase|Adverse Event|0
4616652|NCT01742286|7475751|FG004|Escalation Phase|Adverse Event|0
4616653|NCT01742286|7475752|FG005|Escalation Phase|Adverse Event|1
4616654|NCT01742286|7475753|FG006|Escalation Phase|Adverse Event|0
4616655|NCT01742286|7475747|FG000|Escalation Phase|Disease progression|3
4616656|NCT01742286|7475748|FG001|Escalation Phase|Disease progression|7
4616657|NCT01742286|7475749|FG002|Escalation Phase|Disease progression|4
4616658|NCT01742286|7475750|FG003|Escalation Phase|Disease progression|1
4616659|NCT01742286|7475751|FG004|Escalation Phase|Disease progression|4
4616660|NCT01742286|7475752|FG005|Escalation Phase|Disease progression|3
4616661|NCT01742286|7475753|FG006|Escalation Phase|Disease progression|2
4616662|NCT01742286|7475747|FG000|Escalation Phase|Death|0
4616663|NCT01742286|7475748|FG001|Escalation Phase|Death|0
4616664|NCT01742286|7475749|FG002|Escalation Phase|Death|0
4616665|NCT01742286|7475750|FG003|Escalation Phase|Death|0
4616666|NCT01742286|7475751|FG004|Escalation Phase|Death|0
4616667|NCT01742286|7475752|FG005|Escalation Phase|Death|1
4616668|NCT01742286|7475753|FG006|Escalation Phase|Death|0
4616669|NCT01742286|7475747|FG000|Escalation Phase|Physician Decision|0
4616670|NCT01742286|7475748|FG001|Escalation Phase|Physician Decision|3
4616671|NCT01742286|7475749|FG002|Escalation Phase|Physician Decision|0
4616672|NCT01742286|7475750|FG003|Escalation Phase|Physician Decision|1
4616673|NCT01742286|7475751|FG004|Escalation Phase|Physician Decision|0
4616674|NCT01742286|7475752|FG005|Escalation Phase|Physician Decision|0
4616675|NCT01742286|7475753|FG006|Escalation Phase|Physician Decision|2
4616676|NCT01742286|7475747|FG000|Escalation Phase|Subject/guardian decision|1
4616677|NCT01742286|7475748|FG001|Escalation Phase|Subject/guardian decision|0
4616678|NCT01742286|7475749|FG002|Escalation Phase|Subject/guardian decision|0
4616679|NCT01742286|7475750|FG003|Escalation Phase|Subject/guardian decision|0
4616680|NCT01742286|7475751|FG004|Escalation Phase|Subject/guardian decision|0
4616681|NCT01742286|7475752|FG005|Escalation Phase|Subject/guardian decision|0
4616682|NCT01742286|7475753|FG006|Escalation Phase|Subject/guardian decision|0
4616683|NCT01742286|7475747|FG000|Expansion Phase|Administrative problems|0
4616684|NCT01742286|7475748|FG001|Expansion Phase|Administrative problems|0
4616685|NCT01742286|7475749|FG002|Expansion Phase|Administrative problems|0
4616686|NCT01742286|7475750|FG003|Expansion Phase|Administrative problems|0
4616687|NCT01742286|7475751|FG004|Expansion Phase|Administrative problems|0
4616688|NCT01742286|7475752|FG005|Expansion Phase|Administrative problems|0
4616689|NCT01742286|7475753|FG006|Expansion Phase|Administrative problems|5
4616690|NCT01742286|7475747|FG000|Expansion Phase|Physician Decision|0
4464659|NCT00605280|7255506|FG001|Year 2|Withdrawal by Subject|0
4464660|NCT00605280|7255507|FG002|Year 2|Withdrawal by Subject|0
4540701|NCT01134107|7363484|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0
4540702|NCT01134263|7363504|FG000|Overall Study|Serious adverse event|2
4464661|NCT00605280|7255508|FG003|Year 2|Withdrawal by Subject|4
4464662|NCT00605280|7255505|FG000|Year 2|Other|1
4464663|NCT00605280|7255506|FG001|Year 2|Other|0
4464664|NCT00605280|7255507|FG002|Year 2|Other|0
4464665|NCT00605280|7255508|FG003|Year 2|Other|1
4464666|NCT00605280|7255505|FG000|Year 2|Lost to Follow-up or Patient non-comply|4
4464667|NCT00605280|7255506|FG001|Year 2|Lost to Follow-up or Patient non-comply|0
4464668|NCT00605280|7255507|FG002|Year 2|Lost to Follow-up or Patient non-comply|0
4464669|NCT00605280|7255508|FG003|Year 2|Lost to Follow-up or Patient non-comply|2
4464670|NCT00605280|7255505|FG000|Year 3 Extension|Adverse Event|2
4464671|NCT00605280|7255506|FG001|Year 3 Extension|Adverse Event|0
4464672|NCT00605280|7255507|FG002|Year 3 Extension|Adverse Event|0
4464673|NCT00605280|7255508|FG003|Year 3 Extension|Adverse Event|2
4464674|NCT00605280|7255505|FG000|Year 3 Extension|Physician Decision|0
4464675|NCT00605280|7255506|FG001|Year 3 Extension|Physician Decision|0
4464676|NCT00605280|7255507|FG002|Year 3 Extension|Physician Decision|0
4464677|NCT00605280|7255508|FG003|Year 3 Extension|Physician Decision|2
4464678|NCT00605280|7255505|FG000|Year 3 Extension|Withdrawal by Subject|2
4464679|NCT00605280|7255506|FG001|Year 3 Extension|Withdrawal by Subject|0
4464680|NCT00605280|7255507|FG002|Year 3 Extension|Withdrawal by Subject|0
4464681|NCT00605280|7255508|FG003|Year 3 Extension|Withdrawal by Subject|5
4464682|NCT00605280|7255505|FG000|Year 3 Extension|Other|2
4464683|NCT00605280|7255506|FG001|Year 3 Extension|Other|0
4464684|NCT00605280|7255507|FG002|Year 3 Extension|Other|0
4464685|NCT00605280|7255508|FG003|Year 3 Extension|Other|0
4464686|NCT00605280|7255505|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2
4464687|NCT00605280|7255506|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
4464688|NCT00605280|7255507|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
4464689|NCT00605280|7255508|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
4464690|NCT00605293|7255520|FG000|Overall Study|Death|2
4464691|NCT00605293|7255521|FG001|Overall Study|Death|1
4464692|NCT00605293|7255520|FG000|Overall Study|Insufficient Therapeutic Response|2
4464693|NCT00605293|7255521|FG001|Overall Study|Insufficient Therapeutic Response|0
4464694|NCT00605293|7255520|FG000|Overall Study|Adverse Event|1
4464695|NCT00605293|7255521|FG001|Overall Study|Adverse Event|0
4464696|NCT00605293|7255520|FG000|Overall Study|Holidays Dialysis Out|1
4464697|NCT00605293|7255521|FG001|Overall Study|Holidays Dialysis Out|0
4464698|NCT00605293|7255520|FG000|Overall Study|Blood Transfusion|7
4616691|NCT01742286|7475748|FG001|Expansion Phase|Physician Decision|0
4616692|NCT01742286|7475749|FG002|Expansion Phase|Physician Decision|4
4616693|NCT01742286|7475750|FG003|Expansion Phase|Physician Decision|0
4616694|NCT01742286|7475751|FG004|Expansion Phase|Physician Decision|0
4616695|NCT01742286|7475752|FG005|Expansion Phase|Physician Decision|0
4616696|NCT01742286|7475753|FG006|Expansion Phase|Physician Decision|9
4616697|NCT01742286|7475747|FG000|Expansion Phase|Adverse Event|0
4616698|NCT01742286|7475748|FG001|Expansion Phase|Adverse Event|0
4616699|NCT01742286|7475749|FG002|Expansion Phase|Adverse Event|0
4616700|NCT01742286|7475750|FG003|Expansion Phase|Adverse Event|0
4616701|NCT01742286|7475751|FG004|Expansion Phase|Adverse Event|0
4616702|NCT01742286|7475752|FG005|Expansion Phase|Adverse Event|0
4616703|NCT01742286|7475753|FG006|Expansion Phase|Adverse Event|6
4616704|NCT01742286|7475747|FG000|Expansion Phase|Disease progression|0
4616705|NCT01742286|7475748|FG001|Expansion Phase|Disease progression|0
4616706|NCT01742286|7475749|FG002|Expansion Phase|Disease progression|3
4616707|NCT01742286|7475750|FG003|Expansion Phase|Disease progression|0
4616708|NCT01742286|7475751|FG004|Expansion Phase|Disease progression|0
4616709|NCT01742286|7475752|FG005|Expansion Phase|Disease progression|0
4616710|NCT01742286|7475753|FG006|Expansion Phase|Disease progression|15
4616711|NCT01742286|7475747|FG000|Expansion Phase|Withdrawal by Subject|0
4616712|NCT01742286|7475748|FG001|Expansion Phase|Withdrawal by Subject|0
4616713|NCT01742286|7475749|FG002|Expansion Phase|Withdrawal by Subject|0
4616714|NCT01742286|7475750|FG003|Expansion Phase|Withdrawal by Subject|0
4616715|NCT01742286|7475751|FG004|Expansion Phase|Withdrawal by Subject|0
4464699|NCT00605293|7255521|FG001|Overall Study|Blood Transfusion|1
4464700|NCT00605293|7255520|FG000|Overall Study|Renal Transplantation|3
4464701|NCT00605293|7255521|FG001|Overall Study|Renal Transplantation|1
4540703|NCT01134263|7363505|FG001|Overall Study|Serious adverse event|1
4540704|NCT01134263|7363506|FG002|Overall Study|Serious adverse event|1
4540705|NCT01134263|7363507|FG003|Overall Study|Serious adverse event|1
4540706|NCT01134263|7363508|FG004|Overall Study|Serious adverse event|1
4540707|NCT01134263|7363504|FG000|Overall Study|Other adverse event|1
4616716|NCT01742286|7475752|FG005|Expansion Phase|Withdrawal by Subject|0
4616717|NCT01742286|7475753|FG006|Expansion Phase|Withdrawal by Subject|1
4616718|NCT01742897|7475803|FG000|Overall Study|Adverse Event|3
4616719|NCT01742897|7475803|FG000|Overall Study|Withdrawal by Subject|1
4616720|NCT01742897|7475803|FG000|Overall Study|Other|1
4616721|NCT01743001|7475828|FG000|Overall Study|Physician Decision|1
4464702|NCT00605293|7255520|FG000|Overall Study|Incorrect Epoetin Beta Administration|1
4540708|NCT01134263|7363505|FG001|Overall Study|Other adverse event|2
4540709|NCT01134263|7363506|FG002|Overall Study|Other adverse event|5
4464703|NCT00605293|7255521|FG001|Overall Study|Incorrect Epoetin Beta Administration|0
4616722|NCT01743001|7475829|FG001|Overall Study|Physician Decision|0
4616723|NCT01743001|7475828|FG000|Overall Study|Pregnancy|1
4616724|NCT01743001|7475829|FG001|Overall Study|Pregnancy|0
4616725|NCT01743001|7475828|FG000|Overall Study|Death|1
4616726|NCT01743001|7475829|FG001|Overall Study|Death|0
4616727|NCT01743027|7475839|FG000|Overall Study|Adverse Event|2
4616728|NCT01743027|7475840|FG001|Overall Study|Adverse Event|0
4616729|NCT01743027|7475841|FG002|Overall Study|Adverse Event|0
4616730|NCT01743027|7475842|FG003|Overall Study|Adverse Event|0
4616731|NCT01743027|7475839|FG000|Overall Study|Lost to Follow-up|0
4616732|NCT01743027|7475840|FG001|Overall Study|Lost to Follow-up|0
4616733|NCT01743027|7475841|FG002|Overall Study|Lost to Follow-up|2
4616734|NCT01743027|7475842|FG003|Overall Study|Lost to Follow-up|0
4616735|NCT01743027|7475839|FG000|Overall Study|Progressive Disease|1
4616736|NCT01743027|7475840|FG001|Overall Study|Progressive Disease|4
4616737|NCT01743027|7475841|FG002|Overall Study|Progressive Disease|3
4616738|NCT01743027|7475842|FG003|Overall Study|Progressive Disease|0
4616739|NCT01743027|7475839|FG000|Overall Study|Protocol Violation|1
4616740|NCT01743027|7475840|FG001|Overall Study|Protocol Violation|1
4616741|NCT01743027|7475841|FG002|Overall Study|Protocol Violation|1
4616742|NCT01743027|7475842|FG003|Overall Study|Protocol Violation|0
4616743|NCT01743027|7475839|FG000|Overall Study|Withdrawal by Subject|1
4616744|NCT01743027|7475840|FG001|Overall Study|Withdrawal by Subject|0
4616745|NCT01743027|7475841|FG002|Overall Study|Withdrawal by Subject|3
4616746|NCT01743027|7475842|FG003|Overall Study|Withdrawal by Subject|1
4616747|NCT01743040|7475852|FG000|Overall Study|Death|1
4616748|NCT01743040|7475852|FG000|Overall Study|Lost to Follow-up|66
4616749|NCT01743040|7475852|FG000|Overall Study|Physician Decision|40
4616750|NCT01743040|7475852|FG000|Overall Study|Protocol Violation|1
4616751|NCT01743040|7475852|FG000|Overall Study|Withdrawal by Subject|121
4616752|NCT01743092|7475858|FG000|Overall Study|Lost to Follow-up|14
4616753|NCT01743092|7475859|FG001|Overall Study|Lost to Follow-up|15
4616754|NCT01743469|7475886|FG000|Active Treatment Phase|Adverse Event|10
4616755|NCT01743469|7475887|FG001|Active Treatment Phase|Adverse Event|5
4616756|NCT01743469|7475888|FG002|Active Treatment Phase|Adverse Event|8
4616757|NCT01743469|7475889|FG003|Active Treatment Phase|Adverse Event|1
4616758|NCT01743469|7475886|FG000|Active Treatment Phase|Disease Progression|40
4616759|NCT01743469|7475887|FG001|Active Treatment Phase|Disease Progression|47
4616760|NCT01743469|7475888|FG002|Active Treatment Phase|Disease Progression|30
4616761|NCT01743469|7475889|FG003|Active Treatment Phase|Disease Progression|20
4616762|NCT01743469|7475886|FG000|Active Treatment Phase|Withdrawal by Subject|2
4616763|NCT01743469|7475887|FG001|Active Treatment Phase|Withdrawal by Subject|3
4616764|NCT01743469|7475888|FG002|Active Treatment Phase|Withdrawal by Subject|0
4616765|NCT01743469|7475889|FG003|Active Treatment Phase|Withdrawal by Subject|0
4616766|NCT01743469|7475886|FG000|Active Treatment Phase|Missing|1
4616767|NCT01743469|7475887|FG001|Active Treatment Phase|Missing|0
4616768|NCT01743469|7475888|FG002|Active Treatment Phase|Missing|0
4616769|NCT01743469|7475889|FG003|Active Treatment Phase|Missing|0
4616770|NCT01743469|7475886|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1
4616771|NCT01743469|7475887|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0
4616772|NCT01743469|7475888|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1
4616773|NCT01743469|7475889|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0
4616774|NCT01743469|7475886|FG000|Follow-up Period - Post-Treatment|Death|43
4616775|NCT01743469|7475887|FG001|Follow-up Period - Post-Treatment|Death|47
4616776|NCT01743469|7475888|FG002|Follow-up Period - Post-Treatment|Death|22
4616777|NCT01743469|7475889|FG003|Follow-up Period - Post-Treatment|Death|16
4616778|NCT01743469|7475886|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1
4616779|NCT01743469|7475887|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1
4616780|NCT01743469|7475888|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0
4616781|NCT01743469|7475889|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0
4616782|NCT01743560|7475914|FG000|Overall Study|Disease progression|26
4616783|NCT01743560|7475914|FG000|Overall Study|Adverse Event|8
4616784|NCT01743560|7475914|FG000|Overall Study|Death|3
4616785|NCT01743560|7475914|FG000|Overall Study|Withdrawal by Subject|2
4616786|NCT01743560|7475914|FG000|Overall Study|Protocol Violation|1
4616787|NCT01743560|7475914|FG000|Overall Study|>1 dose of study drug|3
4616788|NCT01743989|7475976|FG000|Treatment Phase|Unstable MR4.0|0
4616789|NCT01743989|7475977|FG001|Treatment Phase|Unstable MR4.0|6
4616790|NCT01743989|7475978|FG002|Treatment Phase|Unstable MR4.0|263
4616791|NCT01743989|7475976|FG000|Treatment Phase|Adverse Event|0
4616792|NCT01743989|7475977|FG001|Treatment Phase|Adverse Event|4
4616793|NCT01743989|7475978|FG002|Treatment Phase|Adverse Event|67
4616794|NCT01743989|7475976|FG000|Treatment Phase|Withdrawal by Subject|1
4616795|NCT01743989|7475977|FG001|Treatment Phase|Withdrawal by Subject|3
4616796|NCT01743989|7475978|FG002|Treatment Phase|Withdrawal by Subject|28
4616797|NCT01743989|7475976|FG000|Treatment Phase|Death|0
4616798|NCT01743989|7475977|FG001|Treatment Phase|Death|1
4616799|NCT01743989|7475978|FG002|Treatment Phase|Death|3
4616800|NCT01743989|7475976|FG000|Treatment Phase|Abnormal laboratory value(s)|0
4616801|NCT01743989|7475977|FG001|Treatment Phase|Abnormal laboratory value(s)|0
4616802|NCT01743989|7475978|FG002|Treatment Phase|Abnormal laboratory value(s)|3
4616803|NCT01743989|7475976|FG000|Treatment Phase|Protocol deviation|0
4616804|NCT01743989|7475977|FG001|Treatment Phase|Protocol deviation|0
4464704|NCT00605293|7255520|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0
4464705|NCT00605293|7255521|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1
4464706|NCT00605293|7255520|FG000|Overall Study|Principal Investigator Decision|0
4464707|NCT00605293|7255521|FG001|Overall Study|Principal Investigator Decision|1
4464708|NCT00605306|7255529|FG000|Overall Study|Adverse Event|0
4464709|NCT00605306|7255530|FG001|Overall Study|Adverse Event|1
4464710|NCT00605319|7255536|FG000|Overall Study|Adverse Event|6
4464711|NCT00605345|7255548|FG000|Overall Study|Withdrawal by Subject|1
4464712|NCT00605345|7255549|FG001|Overall Study|Withdrawal by Subject|0
4616805|NCT01743989|7475978|FG002|Treatment Phase|Protocol deviation|3
4616806|NCT01743989|7475976|FG000|Treatment Phase|Pregnancy|0
4616807|NCT01743989|7475977|FG001|Treatment Phase|Pregnancy|0
4616808|NCT01743989|7475978|FG002|Treatment Phase|Pregnancy|2
4616809|NCT01743989|7475976|FG000|Treatment Phase|Lost to Follow-up|0
4616810|NCT01743989|7475977|FG001|Treatment Phase|Lost to Follow-up|0
4616811|NCT01743989|7475978|FG002|Treatment Phase|Lost to Follow-up|2
4616812|NCT01743989|7475976|FG000|Treatment Phase|Abnormal test procedure result(s)|0
4616813|NCT01743989|7475977|FG001|Treatment Phase|Abnormal test procedure result(s)|0
4616814|NCT01743989|7475978|FG002|Treatment Phase|Abnormal test procedure result(s)|1
4616815|NCT01743989|7475976|FG000|Treatment Phase|Administrative problems|0
4616816|NCT01743989|7475977|FG001|Treatment Phase|Administrative problems|0
4616817|NCT01743989|7475978|FG002|Treatment Phase|Administrative problems|1
4616818|NCT01743989|7475976|FG000|Treatment Phase|New cancer (CML) therapy|0
4616819|NCT01743989|7475977|FG001|Treatment Phase|New cancer (CML) therapy|1
4616820|NCT01743989|7475978|FG002|Treatment Phase|New cancer (CML) therapy|0
4616821|NCT01743989|7475976|FG000|Treatment Phase|Physician Decision|0
4616822|NCT01743989|7475977|FG001|Treatment Phase|Physician Decision|0
4616823|NCT01743989|7475978|FG002|Treatment Phase|Physician Decision|3
4616824|NCT01743989|7475976|FG000|Treatment Phase|Patient non-compliance to treatment|0
4616825|NCT01743989|7475977|FG001|Treatment Phase|Patient non-compliance to treatment|0
4616826|NCT01743989|7475978|FG002|Treatment Phase|Patient non-compliance to treatment|3
4616827|NCT01743989|7475976|FG000|Treatment Phase|Not randomized by mistake|0
4616828|NCT01743989|7475977|FG001|Treatment Phase|Not randomized by mistake|0
4616829|NCT01743989|7475978|FG002|Treatment Phase|Not randomized by mistake|1
4616830|NCT01743989|7475976|FG000|Treatment Phase|Included by mistake|0
4616831|NCT01743989|7475977|FG001|Treatment Phase|Included by mistake|0
4447909|NCT00492856|7233152|FG000|Induction|Withdrawal by Subject|1
4447910|NCT00492856|7233153|FG001|Induction|Withdrawal by Subject|0
4447911|NCT00492856|7233154|FG002|Induction|Withdrawal by Subject|0
4447912|NCT00492856|7233155|FG003|Induction|Withdrawal by Subject|0
4616832|NCT01743989|7475978|FG002|Treatment Phase|Included by mistake|1
4464713|NCT00605345|7255548|FG000|Overall Study|Adverse Event|0
4464714|NCT00605345|7255549|FG001|Overall Study|Adverse Event|1
4464715|NCT00605345|7255548|FG000|Overall Study|Protocol Violation|0
4464716|NCT00605345|7255549|FG001|Overall Study|Protocol Violation|2
4464717|NCT00605475|7255592|FG000|Overall Study|Abnormal Laboratory Values|0
4464718|NCT00605475|7255593|FG001|Overall Study|Abnormal Laboratory Values|0
4464719|NCT00605475|7255594|FG002|Overall Study|Abnormal Laboratory Values|0
4464720|NCT00605475|7255595|FG003|Overall Study|Abnormal Laboratory Values|0
4464721|NCT00605475|7255596|FG004|Overall Study|Abnormal Laboratory Values|0
4464722|NCT00605475|7255597|FG005|Overall Study|Abnormal Laboratory Values|0
4464723|NCT00605475|7255598|FG006|Overall Study|Abnormal Laboratory Values|0
4464724|NCT00605475|7255599|FG007|Overall Study|Abnormal Laboratory Values|0
4464725|NCT00605475|7255600|FG008|Overall Study|Abnormal Laboratory Values|1
4464726|NCT00605475|7255601|FG009|Overall Study|Abnormal Laboratory Values|0
4464727|NCT00605475|7255592|FG000|Overall Study|Administrative problems|0
4464728|NCT00605475|7255593|FG001|Overall Study|Administrative problems|0
4464729|NCT00605475|7255594|FG002|Overall Study|Administrative problems|0
4540710|NCT01134263|7363507|FG003|Overall Study|Other adverse event|3
4540711|NCT01134263|7363508|FG004|Overall Study|Other adverse event|0
4540712|NCT01134263|7363504|FG000|Overall Study|Protocol Violation|8
4540713|NCT01134263|7363505|FG001|Overall Study|Protocol Violation|7
4540714|NCT01134263|7363506|FG002|Overall Study|Protocol Violation|2
4540715|NCT01134263|7363507|FG003|Overall Study|Protocol Violation|4
4540716|NCT01134263|7363508|FG004|Overall Study|Protocol Violation|2
4540717|NCT01134263|7363504|FG000|Overall Study|Lost to Follow-up|4
4540718|NCT01134263|7363505|FG001|Overall Study|Lost to Follow-up|3
4540719|NCT01134263|7363506|FG002|Overall Study|Lost to Follow-up|5
4540720|NCT01134263|7363507|FG003|Overall Study|Lost to Follow-up|3
4616833|NCT01743989|7475976|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82
4616834|NCT01743989|7475977|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59
4616835|NCT01743989|7475978|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0
4616836|NCT01743989|7475976|FG000|TFR Phase|Adverse Event|0
4616837|NCT01743989|7475977|FG001|TFR Phase|Adverse Event|1
4616838|NCT01743989|7475978|FG002|TFR Phase|Adverse Event|0
4616839|NCT01743989|7475976|FG000|TFR Phase|Lost to Follow-up|0
4616840|NCT01743989|7475977|FG001|TFR Phase|Lost to Follow-up|2
4737654|NCT03614975|7687835|FG001|Overall Study|Withdrawal by Subject|2
4540721|NCT01134263|7363508|FG004|Overall Study|Lost to Follow-up|1
4540722|NCT01134263|7363504|FG000|Overall Study|Withdrawal by Subject|8
4540723|NCT01134263|7363505|FG001|Overall Study|Withdrawal by Subject|6
4540724|NCT01134263|7363506|FG002|Overall Study|Withdrawal by Subject|16
4540725|NCT01134263|7363507|FG003|Overall Study|Withdrawal by Subject|7
4540726|NCT01134263|7363508|FG004|Overall Study|Withdrawal by Subject|5
4616841|NCT01743989|7475978|FG002|TFR Phase|Lost to Follow-up|0
4616842|NCT01743989|7475976|FG000|TFR Phase|Physician Decision|0
4616843|NCT01743989|7475977|FG001|TFR Phase|Physician Decision|1
4616844|NCT01743989|7475978|FG002|TFR Phase|Physician Decision|0
4616845|NCT01743989|7475976|FG000|TFR Phase|Logistical problems|0
4616846|NCT01743989|7475977|FG001|TFR Phase|Logistical problems|2
4616847|NCT01743989|7475978|FG002|TFR Phase|Logistical problems|0
4616848|NCT01743989|7475976|FG000|TFR Phase|Protocol deviation|0
4616849|NCT01743989|7475977|FG001|TFR Phase|Protocol deviation|1
4616850|NCT01743989|7475978|FG002|TFR Phase|Protocol deviation|0
4616851|NCT01743989|7475976|FG000|TFR Phase|Withdrawal by Subject|0
4616852|NCT01743989|7475977|FG001|TFR Phase|Withdrawal by Subject|2
4616853|NCT01743989|7475978|FG002|TFR Phase|Withdrawal by Subject|0
4616854|NCT01743989|7475976|FG000|Re-treatment Phase|Adverse Event|8
4616855|NCT01743989|7475977|FG001|Re-treatment Phase|Adverse Event|4
4616856|NCT01743989|7475978|FG002|Re-treatment Phase|Adverse Event|0
4616857|NCT01743989|7475976|FG000|Re-treatment Phase|Death|1
4616858|NCT01743989|7475977|FG001|Re-treatment Phase|Death|1
4616859|NCT01743989|7475978|FG002|Re-treatment Phase|Death|0
4616860|NCT01743989|7475976|FG000|Re-treatment Phase|Administrative problems|1
4616861|NCT01743989|7475977|FG001|Re-treatment Phase|Administrative problems|1
4616862|NCT01743989|7475978|FG002|Re-treatment Phase|Administrative problems|0
4616863|NCT01743989|7475976|FG000|Re-treatment Phase|Withdrawal by Subject|5
4616864|NCT01743989|7475977|FG001|Re-treatment Phase|Withdrawal by Subject|1
4616865|NCT01743989|7475978|FG002|Re-treatment Phase|Withdrawal by Subject|0
4616866|NCT01743989|7475976|FG000|Re-treatment Phase|Unstable MR|1
4616867|NCT01743989|7475977|FG001|Re-treatment Phase|Unstable MR|0
4616868|NCT01743989|7475978|FG002|Re-treatment Phase|Unstable MR|0
4616869|NCT01743989|7475976|FG000|Re-treatment Phase|Physician Decision|0
4616870|NCT01743989|7475977|FG001|Re-treatment Phase|Physician Decision|1
4616871|NCT01743989|7475978|FG002|Re-treatment Phase|Physician Decision|0
4616872|NCT01743989|7475976|FG000|Re-treatment Phase|Lost to Follow-up|0
4616873|NCT01743989|7475977|FG001|Re-treatment Phase|Lost to Follow-up|1
4616874|NCT01743989|7475978|FG002|Re-treatment Phase|Lost to Follow-up|0
4616875|NCT01744197|7475991|FG000|Overall Study|Received 1 patch|2
4616876|NCT01744197|7475992|FG001|Overall Study|Received 1 patch|1
4616877|NCT01744197|7475991|FG000|Overall Study|No patch received|2
4616878|NCT01744197|7475992|FG001|Overall Study|No patch received|2
4616879|NCT01744392|7476018|FG000|Overall Study|Physician Decision|1
4616880|NCT01744483|7476026|FG000|Overall Study|Death|9
4616881|NCT01744483|7476027|FG001|Overall Study|Death|4
4616882|NCT01744483|7476028|FG002|Overall Study|Death|11
4616883|NCT01744483|7476026|FG000|Overall Study|Lost to Follow-up|8
4616884|NCT01744483|7476027|FG001|Overall Study|Lost to Follow-up|9
4616885|NCT01744483|7476028|FG002|Overall Study|Lost to Follow-up|11
4616886|NCT01744483|7476026|FG000|Overall Study|Protocol Violation|1
4616887|NCT01744483|7476027|FG001|Overall Study|Protocol Violation|2
4616888|NCT01744483|7476028|FG002|Overall Study|Protocol Violation|1
4616889|NCT01744483|7476026|FG000|Overall Study|Withdrawal by Subject|4
4616890|NCT01744483|7476027|FG001|Overall Study|Withdrawal by Subject|6
4616891|NCT01744483|7476028|FG002|Overall Study|Withdrawal by Subject|2
4616892|NCT01744483|7476026|FG000|Overall Study|No ICU Admit|5
4616893|NCT01744483|7476027|FG001|Overall Study|No ICU Admit|1
4616894|NCT01744483|7476028|FG002|Overall Study|No ICU Admit|2
4616895|NCT01744483|7476026|FG000|Overall Study|Routed to OSH|2
4616896|NCT01744483|7476027|FG001|Overall Study|Routed to OSH|0
4616897|NCT01744483|7476028|FG002|Overall Study|Routed to OSH|1
4616898|NCT01744496|7476038|FG000|Titration Period|Adverse Event|2
4616899|NCT01744496|7476039|FG001|Titration Period|Adverse Event|1
4616900|NCT01744496|7476038|FG000|Titration Period|Personal reasons|0
4616901|NCT01744496|7476039|FG001|Titration Period|Personal reasons|1
4616902|NCT01744496|7476038|FG000|Maintenance Period|Adverse Event|1
4616903|NCT01744496|7476039|FG001|Maintenance Period|Adverse Event|3
4540727|NCT01134263|7363504|FG000|Overall Study|Enrolled, but not treated|1
4540728|NCT01134263|7363505|FG001|Overall Study|Enrolled, but not treated|1
4540729|NCT01134263|7363506|FG002|Overall Study|Enrolled, but not treated|0
4540730|NCT01134263|7363507|FG003|Overall Study|Enrolled, but not treated|1
4540731|NCT01134263|7363508|FG004|Overall Study|Enrolled, but not treated|0
4540732|NCT01134315|7363540|FG000|Overall Study|Adverse Event|1
4540733|NCT01134315|7363541|FG001|Overall Study|Adverse Event|2
4540734|NCT01134315|7363540|FG000|Overall Study|Other Reason|8
4540735|NCT01134315|7363541|FG001|Overall Study|Other Reason|17
4616904|NCT01744496|7476038|FG000|Maintenance Period|Protocol Violation|1
4616905|NCT01744496|7476039|FG001|Maintenance Period|Protocol Violation|0
4616906|NCT01744496|7476038|FG000|Maintenance Period|Withdrawal by Subject|1
4616907|NCT01744496|7476039|FG001|Maintenance Period|Withdrawal by Subject|1
4616908|NCT01744496|7476038|FG000|Maintenance Period|Subject left town|1
4616909|NCT01744496|7476039|FG001|Maintenance Period|Subject left town|0
4616910|NCT01744665|7476062|FG000|Monitoring Phase|Adverse Event|4
4632962|NCT01905683|7502743|FG000|Overall Study|Physician Decision|1
4540736|NCT01134393|7363564|FG000|Overall Study|Adverse Event|18
4540737|NCT01134393|7363564|FG000|Overall Study|Lack of Efficacy|2
4540738|NCT01134393|7363564|FG000|Overall Study|Protocol Violation|12
4540739|NCT01134393|7363564|FG000|Overall Study|Lost to Follow-up|3
4540740|NCT01134393|7363564|FG000|Overall Study|Withdrawal by Subject|11
4540741|NCT01134393|7363564|FG000|Overall Study|Other|6
4540742|NCT01134562|7363612|FG000|Overall Study|Adverse Event|0
4540743|NCT01134562|7363613|FG001|Overall Study|Adverse Event|1
4540744|NCT01134562|7363614|FG002|Overall Study|Adverse Event|0
4540745|NCT01134562|7363615|FG003|Overall Study|Adverse Event|0
4540746|NCT01134562|7363616|FG004|Overall Study|Adverse Event|0
4616911|NCT01744665|7476062|FG000|Monitoring Phase|Abnormal laboratory value(s)|1
4616912|NCT01744665|7476062|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7
4616913|NCT01744665|7476062|FG000|Monitoring Phase|Withdrawal by Subject|5
4616914|NCT01744665|7476062|FG000|Monitoring Phase|Did not achieve MR4.5|1
4616915|NCT01744665|7476062|FG000|Consolidation Phase|Adverse Event|2
4616916|NCT01744665|7476062|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4
4770384|NCT03740919|7746732|FG002|Lead-in Period|Study Task Too Burdensome|0
4770385|NCT03740919|7746733|FG003|Lead-in Period|Study Task Too Burdensome|0
4770386|NCT03740919|7746730|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1
4770387|NCT03740919|7746731|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0
4616917|NCT01744665|7476062|FG000|Consolidation Phase|Withdrawal by Subject|4
4616918|NCT01744665|7476062|FG000|Consolidation Phase|Administrative problems|9
4616919|NCT01744665|7476062|FG000|Re-initiation Phase|Administrative problems|10
4616920|NCT01744665|7476062|FG000|Re-initiation Phase|Adverse Event|1
4464730|NCT00605475|7255595|FG003|Overall Study|Administrative problems|0
4464731|NCT00605475|7255596|FG004|Overall Study|Administrative problems|0
4464732|NCT00605475|7255597|FG005|Overall Study|Administrative problems|0
4464733|NCT00605475|7255598|FG006|Overall Study|Administrative problems|1
4464734|NCT00605475|7255599|FG007|Overall Study|Administrative problems|0
4464735|NCT00605475|7255600|FG008|Overall Study|Administrative problems|0
4464736|NCT00605475|7255601|FG009|Overall Study|Administrative problems|0
4464737|NCT00605475|7255592|FG000|Overall Study|Lost to Follow-up|0
4464738|NCT00605475|7255593|FG001|Overall Study|Lost to Follow-up|0
4464739|NCT00605475|7255594|FG002|Overall Study|Lost to Follow-up|0
4464740|NCT00605475|7255595|FG003|Overall Study|Lost to Follow-up|0
4464741|NCT00605475|7255596|FG004|Overall Study|Lost to Follow-up|0
4464742|NCT00605475|7255597|FG005|Overall Study|Lost to Follow-up|0
4464743|NCT00605475|7255598|FG006|Overall Study|Lost to Follow-up|0
4464744|NCT00605475|7255599|FG007|Overall Study|Lost to Follow-up|0
4464745|NCT00605475|7255600|FG008|Overall Study|Lost to Follow-up|1
4464746|NCT00605475|7255601|FG009|Overall Study|Lost to Follow-up|1
4464747|NCT00605475|7255592|FG000|Overall Study|Protocol Violation|0
4464748|NCT00605475|7255593|FG001|Overall Study|Protocol Violation|0
4464749|NCT00605475|7255594|FG002|Overall Study|Protocol Violation|0
4464750|NCT00605475|7255595|FG003|Overall Study|Protocol Violation|0
4464751|NCT00605475|7255596|FG004|Overall Study|Protocol Violation|1
4464752|NCT00605475|7255597|FG005|Overall Study|Protocol Violation|0
4464753|NCT00605475|7255598|FG006|Overall Study|Protocol Violation|0
4464754|NCT00605475|7255599|FG007|Overall Study|Protocol Violation|0
4464755|NCT00605475|7255600|FG008|Overall Study|Protocol Violation|0
4464756|NCT00605475|7255601|FG009|Overall Study|Protocol Violation|0
4464757|NCT00605475|7255592|FG000|Overall Study|Withdrawal by Subject|0
4464758|NCT00605475|7255593|FG001|Overall Study|Withdrawal by Subject|0
4464759|NCT00605475|7255594|FG002|Overall Study|Withdrawal by Subject|0
4464760|NCT00605475|7255595|FG003|Overall Study|Withdrawal by Subject|0
4464761|NCT00605475|7255596|FG004|Overall Study|Withdrawal by Subject|0
4464762|NCT00605475|7255597|FG005|Overall Study|Withdrawal by Subject|2
4464763|NCT00605475|7255598|FG006|Overall Study|Withdrawal by Subject|0
4464764|NCT00605475|7255599|FG007|Overall Study|Withdrawal by Subject|0
4464765|NCT00605475|7255600|FG008|Overall Study|Withdrawal by Subject|0
4464766|NCT00605475|7255601|FG009|Overall Study|Withdrawal by Subject|1
4464767|NCT00605540|7255644|FG000|Overall Study|Death|15
4464768|NCT00605540|7255644|FG000|Overall Study|Lost to Follow-up|23
4464769|NCT00605566|7255648|FG000|Overall Study|Adverse Event|1
4464770|NCT00605566|7255648|FG000|Overall Study|Clinical deterioration|1
4464771|NCT00605566|7255648|FG000|Overall Study|Poor compliance in run-in period|1
4464772|NCT00605657|7255673|FG000|Overall Study|Adverse Event|1
4464773|NCT00605657|7255673|FG000|Overall Study|Protocol Violation|1
4464774|NCT00605722|7255686|FG000|Overall Study|Adverse Event|6
4770388|NCT03740919|7746732|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0
4770389|NCT03740919|7746733|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0
4616921|NCT01744665|7476062|FG000|Re-initiation Phase|No longer required treatment|1
4770390|NCT03740919|7746730|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1
4464775|NCT00605722|7255686|FG000|Overall Study|Insufficient therapeutic response|44
4464776|NCT00605722|7255686|FG000|Overall Study|Failure to return|1
4464777|NCT00605813|7255690|FG000|Overall Study|Protocol Violation|25
4464778|NCT00605839|7255715|FG000|Overall Study|Protocol Violation|1
4464779|NCT00605839|7255716|FG001|Overall Study|Protocol Violation|0
4464780|NCT00605839|7255717|FG002|Overall Study|Protocol Violation|0
4464781|NCT00605865|7255725|FG000|Overall Study|Protocol Violation|115
4464782|NCT00605917|7255766|FG000|Overall Study|Protocol Violation|79
4464783|NCT00606008|7255801|FG000|Overall Study|Adverse Event|1
4464784|NCT00606008|7255801|FG000|Overall Study|Withdrawal by Subject|4
4464785|NCT00606021|7255811|FG000|Induction Phase|Death|73
4464786|NCT00606021|7255812|FG001|Induction Phase|Death|0
4464787|NCT00606021|7255813|FG002|Induction Phase|Death|0
4464788|NCT00606021|7255811|FG000|Induction Phase|Physician Decision|2
4464789|NCT00606021|7255812|FG001|Induction Phase|Physician Decision|0
4464790|NCT00606021|7255813|FG002|Induction Phase|Physician Decision|0
4464791|NCT00606021|7255811|FG000|Induction Phase|Withdrawal by Subject|2
4464792|NCT00606021|7255812|FG001|Induction Phase|Withdrawal by Subject|0
4464793|NCT00606021|7255813|FG002|Induction Phase|Withdrawal by Subject|0
4464794|NCT00606021|7255811|FG000|Induction Phase|Lost to Follow-up|10
4464795|NCT00606021|7255812|FG001|Induction Phase|Lost to Follow-up|0
4464796|NCT00606021|7255813|FG002|Induction Phase|Lost to Follow-up|0
4464797|NCT00606021|7255811|FG000|Maintenance Phase|Death|0
4464798|NCT00606021|7255812|FG001|Maintenance Phase|Death|17
4464799|NCT00606021|7255813|FG002|Maintenance Phase|Death|15
4464800|NCT00606021|7255811|FG000|Maintenance Phase|Physician Decision|0
4464801|NCT00606021|7255812|FG001|Maintenance Phase|Physician Decision|1
4464802|NCT00606021|7255813|FG002|Maintenance Phase|Physician Decision|0
4464803|NCT00606021|7255811|FG000|Maintenance Phase|Lost to Follow-up|0
4464804|NCT00606021|7255812|FG001|Maintenance Phase|Lost to Follow-up|5
4464805|NCT00606021|7255813|FG002|Maintenance Phase|Lost to Follow-up|2
4464806|NCT00606034|7255821|FG000|Overall Study|incarceration|1
4464807|NCT00606086|7255833|FG000|Overall Study|Adverse Event|1
4464808|NCT00606086|7255834|FG001|Overall Study|Adverse Event|1
4464809|NCT00606086|7255833|FG000|Overall Study|Lost to Follow-up|4
4464810|NCT00606086|7255834|FG001|Overall Study|Lost to Follow-up|8
4464811|NCT00606086|7255833|FG000|Overall Study|Protocol Violation|1
4464812|NCT00606086|7255834|FG001|Overall Study|Protocol Violation|0
4464813|NCT00606086|7255833|FG000|Overall Study|Withdrawal by Subject|5
4464814|NCT00606086|7255834|FG001|Overall Study|Withdrawal by Subject|3
4464815|NCT00606086|7255833|FG000|Overall Study|Non-compliance|0
4464816|NCT00606086|7255834|FG001|Overall Study|Non-compliance|1
4464817|NCT00606086|7255833|FG000|Overall Study|Randomized, not treated|1
4464818|NCT00606086|7255834|FG001|Overall Study|Randomized, not treated|2
4464819|NCT00606177|7255851|FG000|Overall Study|Adverse Event|9
4464820|NCT00606177|7255852|FG001|Overall Study|Adverse Event|5
4464821|NCT00606177|7255851|FG000|Overall Study|Lack of Efficacy|3
4464822|NCT00606177|7255852|FG001|Overall Study|Lack of Efficacy|7
4464823|NCT00606177|7255851|FG000|Overall Study|Physician Decision|1
4464824|NCT00606177|7255852|FG001|Overall Study|Physician Decision|0
4464825|NCT00606177|7255851|FG000|Overall Study|Protocol Violation|1
4464826|NCT00606177|7255852|FG001|Overall Study|Protocol Violation|4
4464827|NCT00606177|7255851|FG000|Overall Study|Withdrawal by Subject|5
4464828|NCT00606177|7255852|FG001|Overall Study|Withdrawal by Subject|6
4464829|NCT00606177|7255851|FG000|Overall Study|Progression to depressive phase|6
4464830|NCT00606177|7255852|FG001|Overall Study|Progression to depressive phase|1
4464831|NCT00606177|7255851|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1
4464832|NCT00606177|7255852|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1
4464833|NCT00606177|7255851|FG000|Overall Study|Change of residence or other commitments|1
4464834|NCT00606177|7255852|FG001|Overall Study|Change of residence or other commitments|1
4464835|NCT00606229|7255858|FG000|Overall Study|Adverse Event|11
4464836|NCT00606229|7255858|FG000|Overall Study|Lack of Efficacy|1
4464837|NCT00606229|7255858|FG000|Overall Study|Withdrawal by Subject|4
4464838|NCT00606229|7255858|FG000|Overall Study|does not meet inclusion criterion 1-3|4
4464839|NCT00606229|7255858|FG000|Overall Study|change of residence or other commitments|2
4464840|NCT00606281|7255864|FG000|Overall Study|Adverse Event|11
4464841|NCT00606281|7255865|FG001|Overall Study|Adverse Event|12
4464842|NCT00606281|7255864|FG000|Overall Study|Death|1
4464843|NCT00606281|7255865|FG001|Overall Study|Death|0
4464844|NCT00606281|7255864|FG000|Overall Study|Lack of Efficacy|28
4464845|NCT00606281|7255865|FG001|Overall Study|Lack of Efficacy|35
4464846|NCT00606281|7255864|FG000|Overall Study|Physician Decision|0
4464847|NCT00606281|7255865|FG001|Overall Study|Physician Decision|1
4464848|NCT00606281|7255864|FG000|Overall Study|Protocol Violation|3
4464849|NCT00606281|7255865|FG001|Overall Study|Protocol Violation|3
4464850|NCT00606281|7255864|FG000|Overall Study|Withdrawal by Subject|11
4464851|NCT00606281|7255865|FG001|Overall Study|Withdrawal by Subject|13
4464852|NCT00606281|7255864|FG000|Overall Study|Progression to depressive phase|1
4464853|NCT00606281|7255865|FG001|Overall Study|Progression to depressive phase|1
4464854|NCT00606281|7255864|FG000|Overall Study|Change of residence or other commitments|1
4464855|NCT00606281|7255865|FG001|Overall Study|Change of residence or other commitments|1
4464856|NCT00606294|7255873|FG000|Overall Study|Withdrawal by Subject|36
4464857|NCT00606294|7255874|FG001|Overall Study|Withdrawal by Subject|0
4464858|NCT00606307|7255880|FG000|Overall Study|Adverse Event|2
4464859|NCT00606307|7255880|FG000|Overall Study|Withdrawal by Subject|2
4464860|NCT00606307|7255880|FG000|Overall Study|Disease progression|6
4464861|NCT00606307|7255880|FG000|Overall Study|QTc prolongation|1
4464862|NCT00606320|7255884|FG000|Overall Study|Adverse Event|3
4464863|NCT00606320|7255884|FG000|Overall Study|Lack of Efficacy|5
4464864|NCT00606320|7255884|FG000|Overall Study|Physician Decision|7
4464865|NCT00606320|7255884|FG000|Overall Study|Protocol Violation|8
4464866|NCT00606320|7255884|FG000|Overall Study|Withdrawal by Subject|10
4464867|NCT00606320|7255884|FG000|Overall Study|Progression to depressive phase|4
4464868|NCT00606502|7255899|FG000|Randomization|Randomized but not treated|3
4464869|NCT00606502|7255900|FG001|Randomization|Randomized but not treated|0
4464870|NCT00606502|7255899|FG000|Treatment|Treatment ongoing at time of data cutoff|0
4464871|NCT00606502|7255900|FG001|Treatment|Treatment ongoing at time of data cutoff|3
4464872|NCT00606580|7255922|FG000|Overall Study|Lost to Follow-up|1
4464873|NCT00606580|7255923|FG001|Overall Study|Lost to Follow-up|1
4464874|NCT00606580|7255924|FG002|Overall Study|Lost to Follow-up|4
4464875|NCT00606580|7255922|FG000|Overall Study|Clinical failures|1
4464876|NCT00606580|7255923|FG001|Overall Study|Clinical failures|0
4464877|NCT00606580|7255924|FG002|Overall Study|Clinical failures|12
4464878|NCT00606580|7255922|FG000|Overall Study|Withdrawal by investigator|0
4464879|NCT00606580|7255923|FG001|Overall Study|Withdrawal by investigator|1
4464880|NCT00606580|7255924|FG002|Overall Study|Withdrawal by investigator|6
4770391|NCT03740919|7746731|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0
4770392|NCT03740919|7746732|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0
4464881|NCT00606580|7255922|FG000|Overall Study|Withdrawal by Subject|0
4464882|NCT00606580|7255923|FG001|Overall Study|Withdrawal by Subject|1
4464883|NCT00606580|7255924|FG002|Overall Study|Withdrawal by Subject|0
4464884|NCT00606593|7255932|FG000|Overall Study|Adverse Event|0
4464885|NCT00606593|7255933|FG001|Overall Study|Adverse Event|0
4464886|NCT00606593|7255934|FG002|Overall Study|Adverse Event|0
4464887|NCT00606593|7255935|FG003|Overall Study|Adverse Event|1
4464888|NCT00606593|7255936|FG004|Overall Study|Adverse Event|1
4464889|NCT00606593|7255937|FG005|Overall Study|Adverse Event|0
4464890|NCT00606593|7255938|FG006|Overall Study|Adverse Event|1
4464891|NCT00606593|7255939|FG007|Overall Study|Adverse Event|2
4464892|NCT00606593|7255940|FG008|Overall Study|Adverse Event|1
4464893|NCT00606593|7255941|FG009|Overall Study|Adverse Event|0
4464894|NCT00606593|7255932|FG000|Overall Study|Withdrawal of consent|1
4464895|NCT00606593|7255933|FG001|Overall Study|Withdrawal of consent|0
4464896|NCT00606593|7255934|FG002|Overall Study|Withdrawal of consent|1
4464897|NCT00606593|7255935|FG003|Overall Study|Withdrawal of consent|0
4464898|NCT00606593|7255936|FG004|Overall Study|Withdrawal of consent|0
4464899|NCT00606593|7255937|FG005|Overall Study|Withdrawal of consent|0
4464900|NCT00606593|7255938|FG006|Overall Study|Withdrawal of consent|0
4464901|NCT00606593|7255939|FG007|Overall Study|Withdrawal of consent|0
4464902|NCT00606593|7255940|FG008|Overall Study|Withdrawal of consent|0
4464903|NCT00606593|7255941|FG009|Overall Study|Withdrawal of consent|0
4464904|NCT00606593|7255932|FG000|Overall Study|Administrative/Other|0
4464905|NCT00606593|7255933|FG001|Overall Study|Administrative/Other|0
4464906|NCT00606593|7255934|FG002|Overall Study|Administrative/Other|1
4464907|NCT00606593|7255935|FG003|Overall Study|Administrative/Other|0
4464908|NCT00606593|7255936|FG004|Overall Study|Administrative/Other|0
4464909|NCT00606593|7255937|FG005|Overall Study|Administrative/Other|0
4464910|NCT00606593|7255938|FG006|Overall Study|Administrative/Other|0
4464911|NCT00606593|7255939|FG007|Overall Study|Administrative/Other|0
4464912|NCT00606593|7255940|FG008|Overall Study|Administrative/Other|0
4464913|NCT00606593|7255941|FG009|Overall Study|Administrative/Other|0
4464914|NCT00606632|7255954|FG000|Overall Study|Withdrawal by Subject|13
4464915|NCT00606632|7255954|FG000|Overall Study|Miscellaneous reasons|9
4464916|NCT00606684|7255969|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173
4464917|NCT00606684|7255970|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
4464918|NCT00606684|7255971|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
4770393|NCT03740919|7746733|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0
4770394|NCT03740919|7746730|FG000|Treatment Period|Adverse Event|0
4770395|NCT03740919|7746731|FG001|Treatment Period|Adverse Event|0
4770396|NCT03740919|7746732|FG002|Treatment Period|Adverse Event|2
4770397|NCT03740919|7746733|FG003|Treatment Period|Adverse Event|0
4770398|NCT03740919|7746730|FG000|Treatment Period|Protocol Violation|0
4770399|NCT03740919|7746731|FG001|Treatment Period|Protocol Violation|1
4770400|NCT03740919|7746732|FG002|Treatment Period|Protocol Violation|0
4770401|NCT03740919|7746733|FG003|Treatment Period|Protocol Violation|0
4770402|NCT03740919|7746730|FG000|Treatment Period|Withdrawal by Subject|0
4770403|NCT03740919|7746731|FG001|Treatment Period|Withdrawal by Subject|7
4770404|NCT03740919|7746732|FG002|Treatment Period|Withdrawal by Subject|6
4770405|NCT03740919|7746733|FG003|Treatment Period|Withdrawal by Subject|2
4540771|NCT01134627|7363660|FG000|Overall Study|Adverse Event|47
4540772|NCT01134627|7363661|FG001|Overall Study|Adverse Event|31
4540773|NCT01134627|7363660|FG000|Overall Study|Lost to Follow-up|1
4540774|NCT01134627|7363661|FG001|Overall Study|Lost to Follow-up|2
4540775|NCT01134627|7363660|FG000|Overall Study|Protocol Violation|3
4540776|NCT01134627|7363661|FG001|Overall Study|Protocol Violation|5
4540777|NCT01134627|7363660|FG000|Overall Study|Lack of Efficacy|2
4540778|NCT01134627|7363661|FG001|Overall Study|Lack of Efficacy|12
4540779|NCT01134627|7363660|FG000|Overall Study|Withdrawal by Subject|4
4540780|NCT01134627|7363661|FG001|Overall Study|Withdrawal by Subject|3
4540781|NCT01134627|7363660|FG000|Overall Study|Planning to become pregnant/pregnancy|1
4540782|NCT01134627|7363661|FG001|Overall Study|Planning to become pregnant/pregnancy|0
4540783|NCT01134627|7363660|FG000|Overall Study|Other|11
4616922|NCT01744665|7476062|FG000|Re-initiation Phase|Withdrawal by Subject|1
4616923|NCT01744691|7476069|FG000|Overall Study|Progressive Disease|18
4616924|NCT01744691|7476069|FG000|Overall Study|Unacceptable toxicity, AE or death|18
4616925|NCT01744691|7476069|FG000|Overall Study|Withdrawal of consent for treatment|3
4616926|NCT01744691|7476069|FG000|Overall Study|Physician Decision|4
4616927|NCT01744782|7476145|FG000|Overall Study|Death|1
4616928|NCT01744977|7476180|FG000|Overall Study|Withdrawal by Subject|1
4616929|NCT01744977|7476181|FG001|Overall Study|Withdrawal by Subject|2
4616930|NCT01744977|7476180|FG000|Overall Study|Death|2
4616931|NCT01744977|7476181|FG001|Overall Study|Death|3
4616932|NCT01744977|7476180|FG000|Overall Study|Lost to Follow-up|2
4616933|NCT01744977|7476181|FG001|Overall Study|Lost to Follow-up|0
4616934|NCT01744977|7476180|FG000|Overall Study|No longer meets inclusion|6
4616935|NCT01744977|7476181|FG001|Overall Study|No longer meets inclusion|0
4616936|NCT01745094|7476200|FG000|Overall Study|Not Meeting the Eligibility Criteria|1
4616937|NCT01745094|7476201|FG001|Overall Study|Not Meeting the Eligibility Criteria|0
4616938|NCT01745094|7476202|FG002|Overall Study|Not Meeting the Eligibility Criteria|3
4616939|NCT01745094|7476203|FG003|Overall Study|Not Meeting the Eligibility Criteria|0
4616940|NCT01745094|7476200|FG000|Overall Study|Adverse Event|0
4616941|NCT01745094|7476201|FG001|Overall Study|Adverse Event|0
4616942|NCT01745094|7476202|FG002|Overall Study|Adverse Event|3
4616943|NCT01745094|7476203|FG003|Overall Study|Adverse Event|0
4616944|NCT01745094|7476200|FG000|Overall Study|Withdrawal by Subject|2
4616945|NCT01745094|7476201|FG001|Overall Study|Withdrawal by Subject|0
4616946|NCT01745094|7476202|FG002|Overall Study|Withdrawal by Subject|1
4616947|NCT01745094|7476203|FG003|Overall Study|Withdrawal by Subject|2
4616948|NCT01745094|7476200|FG000|Overall Study|Protocol Violation|1
4616949|NCT01745094|7476201|FG001|Overall Study|Protocol Violation|0
4616950|NCT01745094|7476202|FG002|Overall Study|Protocol Violation|3
4616951|NCT01745094|7476203|FG003|Overall Study|Protocol Violation|1
4616952|NCT01745094|7476200|FG000|Overall Study|Need Further Examinations Due to Biopsy|0
4616953|NCT01745094|7476201|FG001|Overall Study|Need Further Examinations Due to Biopsy|0
4616954|NCT01745094|7476202|FG002|Overall Study|Need Further Examinations Due to Biopsy|1
4616955|NCT01745094|7476203|FG003|Overall Study|Need Further Examinations Due to Biopsy|0
4616956|NCT01745094|7476200|FG000|Overall Study|Show no Stable Solifenacin Intake|0
4616957|NCT01745094|7476201|FG001|Overall Study|Show no Stable Solifenacin Intake|0
4616958|NCT01745094|7476202|FG002|Overall Study|Show no Stable Solifenacin Intake|1
4616959|NCT01745094|7476203|FG003|Overall Study|Show no Stable Solifenacin Intake|0
4616960|NCT01745094|7476200|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1
4616961|NCT01745094|7476201|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0
4616962|NCT01745094|7476202|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0
4616963|NCT01745094|7476203|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0
4616964|NCT01745120|7476218|FG000|Overall Study|Investigator decision|1
4616965|NCT01745120|7476219|FG001|Overall Study|Investigator decision|0
4616966|NCT01745146|7476243|FG000|Overall Study|Withdrawal by Subject|1
4540784|NCT01134627|7363661|FG001|Overall Study|Other|14
4540785|NCT01134705|7363669|FG000|Overall Study|Adverse Event|1
4540786|NCT01134705|7363670|FG001|Overall Study|Adverse Event|7
4540787|NCT01134705|7363669|FG000|Overall Study|Withdrawal by Subject|6
4540788|NCT01134705|7363670|FG001|Overall Study|Withdrawal by Subject|6
4540789|NCT01134705|7363669|FG000|Overall Study|Pregnancy|1
4540790|NCT01134705|7363670|FG001|Overall Study|Pregnancy|0
4540791|NCT01134705|7363669|FG000|Overall Study|Lost to Follow-up|5
4540792|NCT01134705|7363670|FG001|Overall Study|Lost to Follow-up|2
4540793|NCT01134705|7363669|FG000|Overall Study|Protocol Violation|1
4540794|NCT01134705|7363670|FG001|Overall Study|Protocol Violation|1
4540795|NCT01134705|7363669|FG000|Overall Study|Other|1
4540796|NCT01134705|7363670|FG001|Overall Study|Other|6
4540797|NCT01134731|7363679|FG000|Overall Study|Adverse Event|3
4540798|NCT01134731|7363680|FG001|Overall Study|Adverse Event|2
4540799|NCT01134731|7363681|FG002|Overall Study|Adverse Event|1
4540800|NCT01134731|7363679|FG000|Overall Study|Physician Decision|2
4540801|NCT01134731|7363680|FG001|Overall Study|Physician Decision|2
4540802|NCT01134731|7363681|FG002|Overall Study|Physician Decision|2
4540803|NCT01134731|7363679|FG000|Overall Study|Lack of Efficacy|0
4540804|NCT01134731|7363680|FG001|Overall Study|Lack of Efficacy|0
4540805|NCT01134731|7363681|FG002|Overall Study|Lack of Efficacy|1
4540806|NCT01134731|7363679|FG000|Overall Study|Withdrawal by Subject|3
4616967|NCT01745146|7476244|FG001|Overall Study|Withdrawal by Subject|3
4616968|NCT01745146|7476243|FG000|Overall Study|Lost to Follow-up|2
4616969|NCT01745146|7476244|FG001|Overall Study|Lost to Follow-up|0
4616970|NCT01745367|7476257|FG000|Overall Study|Death|1
4616971|NCT01745367|7476258|FG001|Overall Study|Death|0
4540807|NCT01134731|7363680|FG001|Overall Study|Withdrawal by Subject|3
4540808|NCT01134731|7363681|FG002|Overall Study|Withdrawal by Subject|1
4540809|NCT01134731|7363679|FG000|Overall Study|Lost to Follow-up|5
4540810|NCT01134731|7363680|FG001|Overall Study|Lost to Follow-up|4
4616972|NCT01745367|7476257|FG000|Overall Study|Withdrawal by Subject|1
4616973|NCT01745367|7476258|FG001|Overall Study|Withdrawal by Subject|2
4616974|NCT01745367|7476257|FG000|Overall Study|Termination of The Study by The Sponsor|6
4540811|NCT01134731|7363681|FG002|Overall Study|Lost to Follow-up|3
4540812|NCT01134783|7363692|FG000|Overall Study|Pregnancy|16
4540813|NCT01134783|7363693|FG001|Overall Study|Pregnancy|8
4540814|NCT01134783|7363692|FG000|Overall Study|Withdrawal by Subject|15
4540815|NCT01134783|7363693|FG001|Overall Study|Withdrawal by Subject|9
4540816|NCT01134783|7363692|FG000|Overall Study|Lost to Follow-up|5
4540817|NCT01134783|7363693|FG001|Overall Study|Lost to Follow-up|20
4540818|NCT01134939|7363735|FG000|Overall Study|Adverse Event|9
4540819|NCT01134939|7363736|FG001|Overall Study|Adverse Event|3
4540820|NCT01134939|7363737|FG002|Overall Study|Adverse Event|4
4540821|NCT01134939|7363738|FG003|Overall Study|Adverse Event|5
4540822|NCT01134939|7363739|FG004|Overall Study|Adverse Event|5
4540823|NCT01134939|7363740|FG005|Overall Study|Adverse Event|5
4540824|NCT01134939|7363741|FG006|Overall Study|Adverse Event|1
4540825|NCT01134939|7363742|FG007|Overall Study|Adverse Event|0
4540826|NCT01134939|7363735|FG000|Overall Study|Lack of Efficacy|2
4540827|NCT01134939|7363736|FG001|Overall Study|Lack of Efficacy|5
4540828|NCT01134939|7363737|FG002|Overall Study|Lack of Efficacy|1
4540829|NCT01134939|7363738|FG003|Overall Study|Lack of Efficacy|0
4540830|NCT01134939|7363739|FG004|Overall Study|Lack of Efficacy|3
4540831|NCT01134939|7363740|FG005|Overall Study|Lack of Efficacy|0
4540832|NCT01134939|7363741|FG006|Overall Study|Lack of Efficacy|1
4540833|NCT01134939|7363742|FG007|Overall Study|Lack of Efficacy|0
4540834|NCT01134939|7363735|FG000|Overall Study|Lost to Follow-up|2
4540835|NCT01134939|7363736|FG001|Overall Study|Lost to Follow-up|3
4540836|NCT01134939|7363737|FG002|Overall Study|Lost to Follow-up|0
4540837|NCT01134939|7363738|FG003|Overall Study|Lost to Follow-up|1
4540838|NCT01134939|7363739|FG004|Overall Study|Lost to Follow-up|2
4540839|NCT01134939|7363740|FG005|Overall Study|Lost to Follow-up|1
4540840|NCT01134939|7363741|FG006|Overall Study|Lost to Follow-up|0
4540841|NCT01134939|7363742|FG007|Overall Study|Lost to Follow-up|0
4540842|NCT01134939|7363735|FG000|Overall Study|Death|0
4540843|NCT01134939|7363736|FG001|Overall Study|Death|1
4540844|NCT01134939|7363737|FG002|Overall Study|Death|0
4540845|NCT01134939|7363738|FG003|Overall Study|Death|0
4540846|NCT01134939|7363739|FG004|Overall Study|Death|0
4540847|NCT01134939|7363740|FG005|Overall Study|Death|0
4540848|NCT01134939|7363741|FG006|Overall Study|Death|0
4540849|NCT01134939|7363742|FG007|Overall Study|Death|0
4540850|NCT01134939|7363735|FG000|Overall Study|Termination page not available|4
4540851|NCT01134939|7363736|FG001|Overall Study|Termination page not available|6
4540852|NCT01134939|7363737|FG002|Overall Study|Termination page not available|5
4540853|NCT01134939|7363738|FG003|Overall Study|Termination page not available|8
4540854|NCT01134939|7363739|FG004|Overall Study|Termination page not available|0
4540855|NCT01134939|7363740|FG005|Overall Study|Termination page not available|3
4540856|NCT01134939|7363741|FG006|Overall Study|Termination page not available|7
4540857|NCT01134939|7363742|FG007|Overall Study|Termination page not available|0
4591285|NCT01528605|7437753|FG000|Overall Study|Lost to Follow-up|1
4591286|NCT01528605|7437754|FG001|Overall Study|Lost to Follow-up|0
4591287|NCT01528605|7437755|FG002|Overall Study|Lost to Follow-up|1
4591288|NCT01528605|7437756|FG003|Overall Study|Lost to Follow-up|1
4591289|NCT01528605|7437757|FG004|Overall Study|Lost to Follow-up|0
4591290|NCT01528605|7437758|FG005|Overall Study|Lost to Follow-up|0
4591291|NCT01528605|7437753|FG000|Overall Study|Death|1
4591292|NCT01528605|7437754|FG001|Overall Study|Death|0
4591293|NCT01528605|7437755|FG002|Overall Study|Death|0
4591294|NCT01528605|7437756|FG003|Overall Study|Death|0
4591295|NCT01528605|7437757|FG004|Overall Study|Death|0
4591296|NCT01528605|7437758|FG005|Overall Study|Death|0
4591297|NCT01528709|7437774|FG000|Overall Study|Death|2
4591298|NCT01528709|7437775|FG001|Overall Study|Death|0
4591299|NCT01528709|7437774|FG000|Overall Study|Withdrawal by Subject|10
4591300|NCT01528709|7437775|FG001|Overall Study|Withdrawal by Subject|15
4591301|NCT01528709|7437774|FG000|Overall Study|allergy|1
4591302|NCT01528709|7437775|FG001|Overall Study|allergy|0
4591303|NCT01528735|7437783|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1
4591304|NCT01528735|7437784|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1
4591305|NCT01528735|7437783|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1
4591306|NCT01528735|7437784|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0
4591307|NCT01528787|7437796|FG000|Overall Study|Withdrawal by Subject|0
4591308|NCT01528787|7437797|FG001|Overall Study|Withdrawal by Subject|0
4591309|NCT01528787|7437798|FG002|Overall Study|Withdrawal by Subject|0
4591310|NCT01528787|7437799|FG003|Overall Study|Withdrawal by Subject|1
4591311|NCT01528787|7437796|FG000|Overall Study|Family Emergency|0
4591312|NCT01528787|7437797|FG001|Overall Study|Family Emergency|0
4591313|NCT01528787|7437798|FG002|Overall Study|Family Emergency|1
4591314|NCT01528787|7437799|FG003|Overall Study|Family Emergency|0
4591315|NCT01528969|7437828|FG000|Overall Study|absent from the school at baseline|2
4591316|NCT01528969|7437829|FG001|Overall Study|absent from the school at baseline|0
4591317|NCT01529034|7437835|FG000|Overall Study|Discontinued prior to study treatment|14
4591318|NCT01529034|7437835|FG000|Overall Study|Site closure|62
4591319|NCT01529034|7437835|FG000|Overall Study|Study termination|29
4591320|NCT01529034|7437835|FG000|Overall Study|Withdrawal by Subject|25
4591321|NCT01529034|7437835|FG000|Overall Study|No treated SCs within protocol window|13
4591322|NCT01529034|7437835|FG000|Overall Study|Noncompliance|8
4591323|NCT01529034|7437835|FG000|Overall Study|Caregiver no longer available|7
4591324|NCT01529034|7437835|FG000|Overall Study|Adverse Event|4
4591325|NCT01529034|7437835|FG000|Overall Study|Protocol Violation|4
4616975|NCT01745367|7476258|FG001|Overall Study|Termination of The Study by The Sponsor|18
4616976|NCT01745367|7476257|FG000|Overall Study|Other Reasons Unspecified|0
4616977|NCT01745367|7476258|FG001|Overall Study|Other Reasons Unspecified|2
4616978|NCT01745380|7476266|FG000|Overall Study|Lost to Follow-up|1
4616979|NCT01745380|7476267|FG001|Overall Study|Lost to Follow-up|0
4616980|NCT01745380|7476266|FG000|Overall Study|Lack of Efficacy|0
4616981|NCT01745380|7476267|FG001|Overall Study|Lack of Efficacy|1
4616982|NCT01745393|7476275|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20
4616983|NCT01745393|7476276|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8
4616984|NCT01745393|7476275|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1
4616985|NCT01745393|7476276|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0
4616986|NCT01745393|7476275|FG000|12-month Follow-up|Lost to Follow-up|6
4616987|NCT01745393|7476276|FG001|12-month Follow-up|Lost to Follow-up|5
4616988|NCT01745848|7476295|FG000|Overall Study|Adverse Event|6
4540858|NCT01135017|7363766|FG000|Overall Study|Adverse Event|3
4540859|NCT01135017|7363767|FG001|Overall Study|Adverse Event|8
4540860|NCT01135017|7363766|FG000|Overall Study|Other than above|3
4540861|NCT01135017|7363767|FG001|Overall Study|Other than above|4
4540862|NCT01135394|7363856|FG000|Screening|Lost to Follow-up|2
4540863|NCT01135394|7363856|FG000|Screening|Withdrawal by Subject|10
4540864|NCT01135394|7363856|FG000|Screening|Screening failure|16
4540865|NCT01135394|7363856|FG000|Screening|Physician Decision|5
4540866|NCT01135394|7363856|FG000|Baseline Assessment|Withdrawal by Subject|9
4540867|NCT01135394|7363856|FG000|Baseline Assessment|Physician Decision|3
4540868|NCT01135394|7363856|FG000|Baseline Assessment|Lost to Follow-up|2
4540869|NCT01135394|7363856|FG000|Baseline Assessment|Adverse Event|1
4540870|NCT01135394|7363856|FG000|Study Treatment|Withdrawal by Subject|1
4540871|NCT01135394|7363856|FG000|Study Treatment|Physician Decision|1
4540872|NCT01135394|7363856|FG000|Study Treatment|Adverse Event|2
4540873|NCT01135498|7363869|FG000|Overall Study|Adverse Event|20
4540874|NCT01135498|7363869|FG000|Overall Study|Progressive disease|38
4540875|NCT01135498|7363869|FG000|Overall Study|Investigator judgement|25
4540876|NCT01135498|7363869|FG000|Overall Study|Withdrawal by Subject|4
4540877|NCT01135498|7363869|FG000|Overall Study|Death|1
4540878|NCT01135498|7363869|FG000|Overall Study|Ongoing at time of analysis|2
4540879|NCT01135511|7363883|FG000|Overall Study|Adverse Event|0
4540880|NCT01135511|7363884|FG001|Overall Study|Adverse Event|1
4540881|NCT01135511|7363885|FG002|Overall Study|Adverse Event|2
4540882|NCT01135511|7363886|FG003|Overall Study|Adverse Event|0
4540883|NCT01135511|7363887|FG004|Overall Study|Adverse Event|0
4540884|NCT01135511|7363888|FG005|Overall Study|Adverse Event|1
4540885|NCT01135511|7363889|FG006|Overall Study|Adverse Event|0
4540886|NCT01135511|7363890|FG007|Overall Study|Adverse Event|1
4540887|NCT01135511|7363891|FG008|Overall Study|Adverse Event|0
4540888|NCT01135511|7363883|FG000|Overall Study|Lack of Efficacy|0
4540889|NCT01135511|7363884|FG001|Overall Study|Lack of Efficacy|1
4540890|NCT01135511|7363885|FG002|Overall Study|Lack of Efficacy|1
4540891|NCT01135511|7363886|FG003|Overall Study|Lack of Efficacy|2
4540892|NCT01135511|7363887|FG004|Overall Study|Lack of Efficacy|0
4540893|NCT01135511|7363888|FG005|Overall Study|Lack of Efficacy|0
4540894|NCT01135511|7363889|FG006|Overall Study|Lack of Efficacy|0
4540895|NCT01135511|7363890|FG007|Overall Study|Lack of Efficacy|0
4540896|NCT01135511|7363891|FG008|Overall Study|Lack of Efficacy|0
4540897|NCT01135511|7363883|FG000|Overall Study|Protocol Violation|0
4540898|NCT01135511|7363884|FG001|Overall Study|Protocol Violation|0
4540899|NCT01135511|7363885|FG002|Overall Study|Protocol Violation|3
4540900|NCT01135511|7363886|FG003|Overall Study|Protocol Violation|0
4540901|NCT01135511|7363887|FG004|Overall Study|Protocol Violation|0
4540902|NCT01135511|7363888|FG005|Overall Study|Protocol Violation|0
4540903|NCT01135511|7363889|FG006|Overall Study|Protocol Violation|0
4540904|NCT01135511|7363890|FG007|Overall Study|Protocol Violation|0
4540905|NCT01135511|7363891|FG008|Overall Study|Protocol Violation|0
4540906|NCT01135511|7363883|FG000|Overall Study|Pregnancy|0
4540907|NCT01135511|7363884|FG001|Overall Study|Pregnancy|0
4540908|NCT01135511|7363885|FG002|Overall Study|Pregnancy|0
4616989|NCT01746017|7476326|FG000|Period 1|Withdrawal by Subject|0
4540909|NCT01135511|7363886|FG003|Overall Study|Pregnancy|1
4540910|NCT01135511|7363887|FG004|Overall Study|Pregnancy|0
4540911|NCT01135511|7363888|FG005|Overall Study|Pregnancy|0
4540912|NCT01135511|7363889|FG006|Overall Study|Pregnancy|0
4540913|NCT01135511|7363890|FG007|Overall Study|Pregnancy|0
4540914|NCT01135511|7363891|FG008|Overall Study|Pregnancy|0
4540915|NCT01135511|7363883|FG000|Overall Study|could not visit the clinic|0
4540916|NCT01135511|7363884|FG001|Overall Study|could not visit the clinic|1
4540917|NCT01135511|7363885|FG002|Overall Study|could not visit the clinic|2
4540918|NCT01135511|7363886|FG003|Overall Study|could not visit the clinic|0
4540919|NCT01135511|7363887|FG004|Overall Study|could not visit the clinic|0
4540920|NCT01135511|7363888|FG005|Overall Study|could not visit the clinic|0
4540921|NCT01135511|7363889|FG006|Overall Study|could not visit the clinic|0
4540922|NCT01135511|7363890|FG007|Overall Study|could not visit the clinic|0
4540923|NCT01135511|7363891|FG008|Overall Study|could not visit the clinic|0
4540924|NCT01135511|7363883|FG000|Overall Study|noncompliance with study drug taken|0
4540925|NCT01135511|7363884|FG001|Overall Study|noncompliance with study drug taken|0
4616990|NCT01746017|7476327|FG001|Period 1|Withdrawal by Subject|0
4616991|NCT01746017|7476328|FG002|Period 1|Withdrawal by Subject|0
4540926|NCT01135511|7363885|FG002|Overall Study|noncompliance with study drug taken|0
4540927|NCT01135511|7363886|FG003|Overall Study|noncompliance with study drug taken|0
4540928|NCT01135511|7363887|FG004|Overall Study|noncompliance with study drug taken|1
4540929|NCT01135511|7363888|FG005|Overall Study|noncompliance with study drug taken|0
4540930|NCT01135511|7363889|FG006|Overall Study|noncompliance with study drug taken|0
4540931|NCT01135511|7363890|FG007|Overall Study|noncompliance with study drug taken|0
4540932|NCT01135511|7363891|FG008|Overall Study|noncompliance with study drug taken|0
4540933|NCT01135511|7363883|FG000|Overall Study|Withdrawal by Subject|0
4540934|NCT01135511|7363884|FG001|Overall Study|Withdrawal by Subject|0
4540935|NCT01135511|7363885|FG002|Overall Study|Withdrawal by Subject|0
4540936|NCT01135511|7363886|FG003|Overall Study|Withdrawal by Subject|0
4540937|NCT01135511|7363887|FG004|Overall Study|Withdrawal by Subject|0
4540938|NCT01135511|7363888|FG005|Overall Study|Withdrawal by Subject|0
4540939|NCT01135511|7363889|FG006|Overall Study|Withdrawal by Subject|1
4540940|NCT01135511|7363890|FG007|Overall Study|Withdrawal by Subject|0
4540941|NCT01135511|7363891|FG008|Overall Study|Withdrawal by Subject|1
4540942|NCT01135524|7363911|FG000|Overall Study|Withdrawal by Subject|14
4540943|NCT01135524|7363911|FG000|Overall Study|Adverse Event|20
4540944|NCT01135524|7363911|FG000|Overall Study|Lost to Follow-up|3
4540945|NCT01135524|7363911|FG000|Overall Study|Administrative|151
4540946|NCT01135524|7363911|FG000|Overall Study|Lack of Efficacy|8
4540947|NCT01135914|7363922|FG000|Overall Study|Withdrawal by Subject|1
4540948|NCT01135914|7363923|FG001|Overall Study|Withdrawal by Subject|3
4540949|NCT01135914|7363924|FG002|Overall Study|Withdrawal by Subject|6
4540950|NCT01135914|7363922|FG000|Overall Study|Lost to Follow-up|1
4540951|NCT01135914|7363923|FG001|Overall Study|Lost to Follow-up|0
4540952|NCT01135914|7363924|FG002|Overall Study|Lost to Follow-up|1
4540953|NCT01135914|7363922|FG000|Overall Study|Protocol Violation|0
4540954|NCT01135914|7363923|FG001|Overall Study|Protocol Violation|0
4540955|NCT01135914|7363924|FG002|Overall Study|Protocol Violation|3
4540956|NCT01135914|7363922|FG000|Overall Study|Lack of Efficacy|2
4540957|NCT01135914|7363923|FG001|Overall Study|Lack of Efficacy|1
4540958|NCT01135914|7363924|FG002|Overall Study|Lack of Efficacy|10
4540959|NCT01135914|7363922|FG000|Overall Study|Adverse Event|0
4540960|NCT01135914|7363923|FG001|Overall Study|Adverse Event|1
4540961|NCT01135914|7363924|FG002|Overall Study|Adverse Event|2
4540962|NCT01135992|7363932|FG000|Overall Study|Adverse Event|1
4540963|NCT01135992|7363932|FG000|Overall Study|Lack of Efficacy|1
4540964|NCT01135992|7363932|FG000|Overall Study|Protocol Violation|2
4540965|NCT01135992|7363932|FG000|Overall Study|Withdrawal criteria|10
4540966|NCT01135992|7363932|FG000|Overall Study|Unclassified|7
4540967|NCT01136174|7363940|FG000|Overall Study|Adverse Event|0
4540968|NCT01136174|7363941|FG001|Overall Study|Adverse Event|0
4540969|NCT01136174|7363942|FG002|Overall Study|Adverse Event|0
4540970|NCT01136174|7363943|FG003|Overall Study|Adverse Event|4
4540971|NCT01136291|7363969|FG000|Overall Study|Lost to Follow-up|1
4540972|NCT01136291|7363970|FG001|Overall Study|Lost to Follow-up|1
4540973|NCT01136356|7363976|FG000|First 18-day Withdrawal|Withdrawal by Subject|3
4540974|NCT01136356|7363977|FG001|First 18-day Withdrawal|Withdrawal by Subject|0
4540975|NCT01136356|7363976|FG000|First 18-day Withdrawal|Physician Decision|1
4540976|NCT01136356|7363977|FG001|First 18-day Withdrawal|Physician Decision|0
4540977|NCT01136356|7363976|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0
4540978|NCT01136356|7363977|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1
4540979|NCT01136382|7363984|FG000|Overall Study|Other|8
4540980|NCT01136382|7363985|FG001|Overall Study|Other|3
4540981|NCT01136382|7363984|FG000|Overall Study|Study-Specific Withdrawal Criteria|48
4540982|NCT01136382|7363985|FG001|Overall Study|Study-Specific Withdrawal Criteria|25
4540983|NCT01136382|7363984|FG000|Overall Study|Severe Non-Compliance to Protocol|0
4540984|NCT01136382|7363985|FG001|Overall Study|Severe Non-Compliance to Protocol|2
4540985|NCT01136382|7363984|FG000|Overall Study|Withdrawal by Subject|4
4540986|NCT01136382|7363985|FG001|Overall Study|Withdrawal by Subject|1
4540987|NCT01136408|7363994|FG000|Overall Study|Adverse Event|4
4540988|NCT01136408|7363995|FG001|Overall Study|Adverse Event|8
4540989|NCT01136408|7363996|FG002|Overall Study|Adverse Event|4
4540990|NCT01136408|7363994|FG000|Overall Study|Protocol Violation|1
4540991|NCT01136408|7363995|FG001|Overall Study|Protocol Violation|1
4540992|NCT01136408|7363996|FG002|Overall Study|Protocol Violation|1
4540993|NCT01136655|7364012|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1
4540994|NCT01136655|7364012|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1
4540995|NCT01136655|7364012|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1
4540996|NCT01136655|7364012|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1
4540997|NCT01136733|7364032|FG000|Phase 1b|Adverse Event|0
4540998|NCT01136733|7364033|FG001|Phase 1b|Adverse Event|3
4540999|NCT01136733|7364034|FG002|Phase 1b|Adverse Event|1
4541000|NCT01136733|7364035|FG003|Phase 1b|Adverse Event|0
4541001|NCT01136733|7364036|FG004|Phase 1b|Adverse Event|0
4541002|NCT01136733|7364037|FG005|Phase 1b|Adverse Event|0
4541003|NCT01136733|7364038|FG006|Phase 1b|Adverse Event|0
4541004|NCT01136733|7364032|FG000|Phase 1b|Participant Choice|0
4541005|NCT01136733|7364033|FG001|Phase 1b|Participant Choice|0
4541006|NCT01136733|7364034|FG002|Phase 1b|Participant Choice|1
4541007|NCT01136733|7364035|FG003|Phase 1b|Participant Choice|0
4541008|NCT01136733|7364036|FG004|Phase 1b|Participant Choice|0
4541009|NCT01136733|7364037|FG005|Phase 1b|Participant Choice|0
4541010|NCT01136733|7364038|FG006|Phase 1b|Participant Choice|0
4541011|NCT01136733|7364032|FG000|Phase 1b|Administrative-Withdrew Consent|0
4541012|NCT01136733|7364033|FG001|Phase 1b|Administrative-Withdrew Consent|1
4541013|NCT01136733|7364034|FG002|Phase 1b|Administrative-Withdrew Consent|0
4541014|NCT01136733|7364035|FG003|Phase 1b|Administrative-Withdrew Consent|0
4541015|NCT01136733|7364036|FG004|Phase 1b|Administrative-Withdrew Consent|0
4541016|NCT01136733|7364037|FG005|Phase 1b|Administrative-Withdrew Consent|0
4541017|NCT01136733|7364038|FG006|Phase 1b|Administrative-Withdrew Consent|0
4541018|NCT01136733|7364032|FG000|Phase 1b|Clinical Progression|1
4541019|NCT01136733|7364033|FG001|Phase 1b|Clinical Progression|1
4541020|NCT01136733|7364034|FG002|Phase 1b|Clinical Progression|0
4541021|NCT01136733|7364035|FG003|Phase 1b|Clinical Progression|0
4541022|NCT01136733|7364036|FG004|Phase 1b|Clinical Progression|0
4541023|NCT01136733|7364037|FG005|Phase 1b|Clinical Progression|0
4541024|NCT01136733|7364038|FG006|Phase 1b|Clinical Progression|0
4541025|NCT01136733|7364032|FG000|Phase 2|Disease Progression|0
4541026|NCT01136733|7364033|FG001|Phase 2|Disease Progression|0
4541027|NCT01136733|7364034|FG002|Phase 2|Disease Progression|0
4541028|NCT01136733|7364035|FG003|Phase 2|Disease Progression|0
4541029|NCT01136733|7364036|FG004|Phase 2|Disease Progression|30
4541030|NCT01136733|7364037|FG005|Phase 2|Disease Progression|32
4541031|NCT01136733|7364038|FG006|Phase 2|Disease Progression|38
4541032|NCT01136733|7364032|FG000|Phase 2|Adverse Event|0
4541033|NCT01136733|7364033|FG001|Phase 2|Adverse Event|0
4541034|NCT01136733|7364034|FG002|Phase 2|Adverse Event|0
4541035|NCT01136733|7364035|FG003|Phase 2|Adverse Event|0
4541036|NCT01136733|7364036|FG004|Phase 2|Adverse Event|11
4541037|NCT01136733|7364037|FG005|Phase 2|Adverse Event|13
4541038|NCT01136733|7364038|FG006|Phase 2|Adverse Event|5
4541039|NCT01136733|7364032|FG000|Phase 2|Participant Choice|0
4541040|NCT01136733|7364033|FG001|Phase 2|Participant Choice|0
4541041|NCT01136733|7364034|FG002|Phase 2|Participant Choice|0
4541042|NCT01136733|7364035|FG003|Phase 2|Participant Choice|0
4541043|NCT01136733|7364036|FG004|Phase 2|Participant Choice|3
4541044|NCT01136733|7364037|FG005|Phase 2|Participant Choice|0
4541045|NCT01136733|7364038|FG006|Phase 2|Participant Choice|1
4541046|NCT01136733|7364032|FG000|Phase 2|Administrative-Withdrew Consent|0
4541047|NCT01136733|7364033|FG001|Phase 2|Administrative-Withdrew Consent|0
4541048|NCT01136733|7364034|FG002|Phase 2|Administrative-Withdrew Consent|0
4541049|NCT01136733|7364035|FG003|Phase 2|Administrative-Withdrew Consent|0
4541050|NCT01136733|7364036|FG004|Phase 2|Administrative-Withdrew Consent|1
4541051|NCT01136733|7364037|FG005|Phase 2|Administrative-Withdrew Consent|0
4541052|NCT01136733|7364038|FG006|Phase 2|Administrative-Withdrew Consent|0
4541053|NCT01136733|7364032|FG000|Phase 2|Other|0
4541054|NCT01136733|7364033|FG001|Phase 2|Other|0
4541055|NCT01136733|7364034|FG002|Phase 2|Other|0
4541056|NCT01136733|7364035|FG003|Phase 2|Other|0
4541057|NCT01136733|7364036|FG004|Phase 2|Other|6
4541058|NCT01136733|7364037|FG005|Phase 2|Other|7
4541059|NCT01136733|7364038|FG006|Phase 2|Other|6
4541060|NCT01136746|7364070|FG000|Overall Study|Lost to Follow-up|0
4541061|NCT01136746|7364071|FG001|Overall Study|Lost to Follow-up|2
4541062|NCT01136746|7364070|FG000|Overall Study|Protocol Violation|2
4541063|NCT01136746|7364071|FG001|Overall Study|Protocol Violation|1
4541064|NCT01136746|7364070|FG000|Overall Study|Death|1
4541065|NCT01136746|7364071|FG001|Overall Study|Death|0
4541066|NCT01136772|7364079|FG000|Overall Study|Adverse Event|15
4541067|NCT01136772|7364080|FG001|Overall Study|Adverse Event|14
4541068|NCT01136772|7364079|FG000|Overall Study|Lack of Efficacy|42
4541069|NCT01136772|7364080|FG001|Overall Study|Lack of Efficacy|39
4541070|NCT01136772|7364079|FG000|Overall Study|Administrative|14
4541071|NCT01136772|7364080|FG001|Overall Study|Administrative|12
4541072|NCT01136772|7364079|FG000|Overall Study|Withdrawal by Subject|33
4541073|NCT01136772|7364080|FG001|Overall Study|Withdrawal by Subject|36
4541074|NCT01136772|7364079|FG000|Overall Study|Did not receive injection|10
4541075|NCT01136772|7364080|FG001|Overall Study|Did not receive injection|7
4541076|NCT01136772|7364079|FG000|Overall Study|Did not follow up after first injection|2
4541077|NCT01136772|7364080|FG001|Overall Study|Did not follow up after first injection|2
4541078|NCT01136785|7364088|FG000|Overall Study|Protocol Violation|2
4541079|NCT01136785|7364089|FG001|Overall Study|Protocol Violation|1
4541080|NCT01136876|7364110|FG000|Overall Study|Lost to Follow-up|0
4541081|NCT01136876|7364111|FG001|Overall Study|Lost to Follow-up|1
4541082|NCT01136876|7364110|FG000|Overall Study|Physician Decision|3
4541083|NCT01136876|7364111|FG001|Overall Study|Physician Decision|5
4541084|NCT01136876|7364110|FG000|Overall Study|Missing NGAL measurement|2
4541085|NCT01136876|7364111|FG001|Overall Study|Missing NGAL measurement|5
4541086|NCT01136915|7364121|FG000|Overall Study|Lost to Follow-up|2
4541087|NCT01136915|7364122|FG001|Overall Study|Lost to Follow-up|0
4541088|NCT01136915|7364121|FG000|Overall Study|Exclusion criterion met|0
4541089|NCT01136915|7364122|FG001|Overall Study|Exclusion criterion met|1
4541090|NCT01136954|7364132|FG000|Overall Study|Adverse Event|3
4541091|NCT01136954|7364133|FG001|Overall Study|Adverse Event|2
4541092|NCT01136954|7364132|FG000|Overall Study|Withdrawal by Subject|6
4541093|NCT01136954|7364133|FG001|Overall Study|Withdrawal by Subject|2
4541094|NCT01136954|7364132|FG000|Overall Study|Lack of Efficacy|14
4541095|NCT01136954|7364133|FG001|Overall Study|Lack of Efficacy|13
4541096|NCT01136954|7364132|FG000|Overall Study|Physician Decision|0
4541097|NCT01136954|7364133|FG001|Overall Study|Physician Decision|1
4541098|NCT01136954|7364132|FG000|Overall Study|Other|1
4541099|NCT01136954|7364133|FG001|Overall Study|Other|3
4541100|NCT01137071|7364174|FG000|Overall Study|Disease Progression|11
4541101|NCT01137071|7364174|FG000|Overall Study|Withdrawal by Subject|2
4541102|NCT01137071|7364174|FG000|Overall Study|Wrongly Included|1
4541103|NCT01137110|7364185|FG000|Overall Study|Protocol Violation|1
4541104|NCT01137110|7364186|FG001|Overall Study|Protocol Violation|0
4541105|NCT01137292|7364192|FG000|Overall Study|Death|30
4541106|NCT01137292|7364192|FG000|Overall Study|Adverse Event|3
4541107|NCT01137292|7364192|FG000|Overall Study|Lack of Efficacy|13
4541108|NCT01137292|7364192|FG000|Overall Study|Lost to Follow-up|1
4541109|NCT01137292|7364192|FG000|Overall Study|Other|7
4770406|NCT03740919|7746730|FG000|Treatment Period|Terminated by Sponsor|0
4770407|NCT03740919|7746731|FG001|Treatment Period|Terminated by Sponsor|1
4541112|NCT01137474|7364222|FG000|Overall Study|Adverse Event|3
4541113|NCT01137474|7364223|FG001|Overall Study|Adverse Event|5
4541114|NCT01137474|7364224|FG002|Overall Study|Adverse Event|1
4541115|NCT01137474|7364225|FG003|Overall Study|Adverse Event|3
4541116|NCT01137474|7364222|FG000|Overall Study|Withdrawal by Subject|7
4541117|NCT01137474|7364223|FG001|Overall Study|Withdrawal by Subject|2
4541118|NCT01137474|7364224|FG002|Overall Study|Withdrawal by Subject|6
4541119|NCT01137474|7364225|FG003|Overall Study|Withdrawal by Subject|9
4541120|NCT01137474|7364222|FG000|Overall Study|No longer met study criteria|6
4541121|NCT01137474|7364223|FG001|Overall Study|No longer met study criteria|1
4541122|NCT01137474|7364224|FG002|Overall Study|No longer met study criteria|0
4541123|NCT01137474|7364225|FG003|Overall Study|No longer met study criteria|5
4541124|NCT01137474|7364222|FG000|Overall Study|Lost to Follow-up|5
4541125|NCT01137474|7364223|FG001|Overall Study|Lost to Follow-up|1
4541126|NCT01137474|7364224|FG002|Overall Study|Lost to Follow-up|0
4541127|NCT01137474|7364225|FG003|Overall Study|Lost to Follow-up|2
4541128|NCT01137474|7364222|FG000|Overall Study|Lack of Efficacy|0
4541129|NCT01137474|7364223|FG001|Overall Study|Lack of Efficacy|0
4541130|NCT01137474|7364224|FG002|Overall Study|Lack of Efficacy|0
4541131|NCT01137474|7364225|FG003|Overall Study|Lack of Efficacy|2
4541132|NCT01137474|7364222|FG000|Overall Study|Other|3
4541133|NCT01137474|7364223|FG001|Overall Study|Other|1
4541134|NCT01137474|7364224|FG002|Overall Study|Other|0
4541135|NCT01137474|7364225|FG003|Overall Study|Other|0
4541136|NCT01137474|7364222|FG000|Overall Study|Pregnancy|0
4541137|NCT01137474|7364223|FG001|Overall Study|Pregnancy|1
4541138|NCT01137474|7364224|FG002|Overall Study|Pregnancy|0
4541139|NCT01137474|7364225|FG003|Overall Study|Pregnancy|0
4541140|NCT01137474|7364222|FG000|Overall Study|Administrative reason by sponsor|0
4541141|NCT01137474|7364223|FG001|Overall Study|Administrative reason by sponsor|1
4541142|NCT01137474|7364224|FG002|Overall Study|Administrative reason by sponsor|0
4541143|NCT01137474|7364225|FG003|Overall Study|Administrative reason by sponsor|0
4541144|NCT01137578|7364239|FG000|Overall Study|Participant requested to Discontinue|3
4541145|NCT01137578|7364240|FG001|Overall Study|Participant requested to Discontinue|0
4541146|NCT01137578|7364241|FG002|Overall Study|Participant requested to Discontinue|0
4541147|NCT01137578|7364239|FG000|Overall Study|Withdrawal by Subject|1
4541148|NCT01137578|7364240|FG001|Overall Study|Withdrawal by Subject|0
4541149|NCT01137578|7364241|FG002|Overall Study|Withdrawal by Subject|0
4541150|NCT01137578|7364239|FG000|Overall Study|Other|12
4541151|NCT01137578|7364240|FG001|Overall Study|Other|2
4541152|NCT01137578|7364241|FG002|Overall Study|Other|6
4541153|NCT01137604|7364273|FG000|Overall Study|Adverse Event|1
4541154|NCT01137604|7364274|FG001|Overall Study|Adverse Event|6
4541155|NCT01137604|7364275|FG002|Overall Study|Adverse Event|9
4541156|NCT01137604|7364276|FG003|Overall Study|Adverse Event|9
4541157|NCT01137604|7364273|FG000|Overall Study|Withdrawal by Subject|0
4541158|NCT01137604|7364274|FG001|Overall Study|Withdrawal by Subject|2
4541159|NCT01137604|7364275|FG002|Overall Study|Withdrawal by Subject|2
4541160|NCT01137604|7364276|FG003|Overall Study|Withdrawal by Subject|1
4541161|NCT01137604|7364273|FG000|Overall Study|Clinical Progression|0
4541162|NCT01137604|7364274|FG001|Overall Study|Clinical Progression|2
4541163|NCT01137604|7364275|FG002|Overall Study|Clinical Progression|1
4541164|NCT01137604|7364276|FG003|Overall Study|Clinical Progression|0
4541165|NCT01137604|7364273|FG000|Overall Study|Participant's Decision|1
4541166|NCT01137604|7364274|FG001|Overall Study|Participant's Decision|0
4541167|NCT01137604|7364275|FG002|Overall Study|Participant's Decision|0
4541168|NCT01137604|7364276|FG003|Overall Study|Participant's Decision|0
4541169|NCT01137604|7364273|FG000|Overall Study|Clinical Decline|0
4541170|NCT01137604|7364274|FG001|Overall Study|Clinical Decline|0
4541171|NCT01137604|7364275|FG002|Overall Study|Clinical Decline|1
4541172|NCT01137604|7364276|FG003|Overall Study|Clinical Decline|1
4541173|NCT01137682|7364289|FG000|Overall Study|Adverse Event-CORE|2
4541174|NCT01137682|7364290|FG001|Overall Study|Adverse Event-CORE|4
4541175|NCT01137682|7364291|FG002|Overall Study|Adverse Event-CORE|0
4541176|NCT01137682|7364289|FG000|Overall Study|Withdrawal by Subject-CORE|2
4541177|NCT01137682|7364290|FG001|Overall Study|Withdrawal by Subject-CORE|2
4541178|NCT01137682|7364291|FG002|Overall Study|Withdrawal by Subject-CORE|2
4541179|NCT01137682|7364289|FG000|Overall Study|Administrative problems-CORE|2
4541180|NCT01137682|7364290|FG001|Overall Study|Administrative problems-CORE|1
4541181|NCT01137682|7364291|FG002|Overall Study|Administrative problems-CORE|0
4541182|NCT01137682|7364289|FG000|Overall Study|Protocol Violation-CORE|0
4541183|NCT01137682|7364290|FG001|Overall Study|Protocol Violation-CORE|1
4541184|NCT01137682|7364291|FG002|Overall Study|Protocol Violation-CORE|1
4541185|NCT01137682|7364289|FG000|Overall Study|Adverse Event-Extension|4
4541186|NCT01137682|7364290|FG001|Overall Study|Adverse Event-Extension|8
4541187|NCT01137682|7364291|FG002|Overall Study|Adverse Event-Extension|7
4541188|NCT01137682|7364289|FG000|Overall Study|Lack of Efficacy-Extension|15
4541189|NCT01137682|7364290|FG001|Overall Study|Lack of Efficacy-Extension|9
4541190|NCT01137682|7364291|FG002|Overall Study|Lack of Efficacy-Extension|13
4541191|NCT01137682|7364289|FG000|Overall Study|Withdrawal by Subject-Extension|6
4541192|NCT01137682|7364290|FG001|Overall Study|Withdrawal by Subject-Extension|8
4541193|NCT01137682|7364291|FG002|Overall Study|Withdrawal by Subject-Extension|8
4541194|NCT01137682|7364289|FG000|Overall Study|Lost to Follow Up-Extension|0
4541195|NCT01137682|7364290|FG001|Overall Study|Lost to Follow Up-Extension|1
4541196|NCT01137682|7364291|FG002|Overall Study|Lost to Follow Up-Extension|0
4541197|NCT01137682|7364289|FG000|Overall Study|Administrative problems-Extension|0
4541198|NCT01137682|7364290|FG001|Overall Study|Administrative problems-Extension|2
4541199|NCT01137682|7364291|FG002|Overall Study|Administrative problems-Extension|0
4541200|NCT01137682|7364289|FG000|Overall Study|Death-Extension|2
4541201|NCT01137682|7364290|FG001|Overall Study|Death-Extension|0
4541202|NCT01137682|7364291|FG002|Overall Study|Death-Extension|0
4541203|NCT01137682|7364289|FG000|Overall Study|Protocol Violation-Extension|2
4541204|NCT01137682|7364290|FG001|Overall Study|Protocol Violation-Extension|1
4541205|NCT01137682|7364291|FG002|Overall Study|Protocol Violation-Extension|0
4616992|NCT01746017|7476329|FG003|Period 1|Withdrawal by Subject|0
4541206|NCT01137682|7364289|FG000|Overall Study|Did not enter extension|2
4541207|NCT01137682|7364290|FG001|Overall Study|Did not enter extension|3
4541208|NCT01137682|7364291|FG002|Overall Study|Did not enter extension|2
4541209|NCT01137682|7364289|FG000|Overall Study|Did not receive treatment in extension|0
4541210|NCT01137682|7364290|FG001|Overall Study|Did not receive treatment in extension|0
4541211|NCT01137682|7364291|FG002|Overall Study|Did not receive treatment in extension|1
4541212|NCT01137786|7364305|FG000|Overall Study|Lost to Follow-up|0
4541213|NCT01137786|7364306|FG001|Overall Study|Lost to Follow-up|2
4541214|NCT01137786|7364305|FG000|Overall Study|Withdrawal by Subject|1
4541215|NCT01137786|7364306|FG001|Overall Study|Withdrawal by Subject|1
4541216|NCT01137812|7364316|FG000|Overall Study|Adverse Event|21
4541217|NCT01137812|7364317|FG001|Overall Study|Adverse Event|14
4541218|NCT01137812|7364316|FG000|Overall Study|Lost to Follow-up|6
4541219|NCT01137812|7364317|FG001|Overall Study|Lost to Follow-up|8
4541220|NCT01137812|7364316|FG000|Overall Study|Physician Decision|25
4541221|NCT01137812|7364317|FG001|Overall Study|Physician Decision|17
4541222|NCT01137812|7364316|FG000|Overall Study|Protocol Violation|5
4541223|NCT01137812|7364317|FG001|Overall Study|Protocol Violation|4
4541224|NCT01137812|7364316|FG000|Overall Study|Withdrawal by Subject|5
4541225|NCT01137812|7364317|FG001|Overall Study|Withdrawal by Subject|13
4541226|NCT01137812|7364316|FG000|Overall Study|Death|2
4541227|NCT01137812|7364317|FG001|Overall Study|Death|0
4541228|NCT01137812|7364316|FG000|Overall Study|Patient met glycemic withdrawal criteria|40
4616993|NCT01746017|7476330|FG004|Period 1|Withdrawal by Subject|0
4616994|NCT01746017|7476331|FG005|Period 1|Withdrawal by Subject|0
4616995|NCT01746017|7476332|FG006|Period 1|Withdrawal by Subject|1
4616996|NCT01746017|7476333|FG007|Period 1|Withdrawal by Subject|0
4616997|NCT01746017|7476334|FG008|Period 1|Withdrawal by Subject|0
4541229|NCT01137812|7364317|FG001|Overall Study|Patient met glycemic withdrawal criteria|85
4541230|NCT01137812|7364316|FG000|Overall Study|Other|19
4541231|NCT01137812|7364317|FG001|Overall Study|Other|27
4541232|NCT01138007|7364381|FG000|Overall Study|Adverse Event|4
4541233|NCT01138007|7364382|FG001|Overall Study|Adverse Event|12
4541234|NCT01138007|7364383|FG002|Overall Study|Adverse Event|9
4541235|NCT01138007|7364381|FG000|Overall Study|Lack of Efficacy|2
4541236|NCT01138007|7364382|FG001|Overall Study|Lack of Efficacy|0
4541237|NCT01138007|7364383|FG002|Overall Study|Lack of Efficacy|6
4541238|NCT01138007|7364381|FG000|Overall Study|Protocol Violation|2
4541239|NCT01138007|7364382|FG001|Overall Study|Protocol Violation|3
4541240|NCT01138007|7364383|FG002|Overall Study|Protocol Violation|2
4541241|NCT01138007|7364381|FG000|Overall Study|Protocol-Defined Stopping Criteria|6
4541242|NCT01138007|7364382|FG001|Overall Study|Protocol-Defined Stopping Criteria|1
4541243|NCT01138007|7364383|FG002|Overall Study|Protocol-Defined Stopping Criteria|8
4541244|NCT01138007|7364381|FG000|Overall Study|Lost to Follow-up|3
4541245|NCT01138007|7364382|FG001|Overall Study|Lost to Follow-up|3
4541246|NCT01138007|7364383|FG002|Overall Study|Lost to Follow-up|5
4541247|NCT01138007|7364381|FG000|Overall Study|Physician Decision|0
4541248|NCT01138007|7364382|FG001|Overall Study|Physician Decision|5
4541249|NCT01138007|7364383|FG002|Overall Study|Physician Decision|3
4541250|NCT01138007|7364381|FG000|Overall Study|Withdrawal by Subject|5
4541251|NCT01138007|7364382|FG001|Overall Study|Withdrawal by Subject|6
4541252|NCT01138007|7364383|FG002|Overall Study|Withdrawal by Subject|15
4616998|NCT01746017|7476335|FG009|Period 1|Withdrawal by Subject|0
4690485|NCT02561195|7600198|FG013|Vaccination 1 to 3|Randomized but not treated|0
4616999|NCT01746017|7476336|FG010|Period 1|Withdrawal by Subject|0
4541253|NCT01138046|7364393|FG000|Overall Study|Withdrawal due to death|6
4541254|NCT01138111|7364406|FG000|Overall Study|Withdrawal by Subject|5
4541255|NCT01138111|7364406|FG000|Overall Study|Adverse Event|1
4541256|NCT01138111|7364406|FG000|Overall Study|Death|1
4541257|NCT01138111|7364406|FG000|Overall Study|Lost to Follow-up|2
4541258|NCT01138150|7364452|FG000|Overall Study|blood unable to be processed|0
4541259|NCT01138150|7364453|FG001|Overall Study|blood unable to be processed|1
4541260|NCT01138150|7364452|FG000|Overall Study|Physician Decision|1
4541261|NCT01138150|7364453|FG001|Overall Study|Physician Decision|0
4541262|NCT01138501|7364488|FG000|Overall Study|Protocol Violation|2
4541263|NCT01138501|7364488|FG000|Overall Study|Withdrawal by Subject|3
4541264|NCT01138657|7364508|FG000|Overall Study|Adverse Event|3
4541265|NCT01138657|7364509|FG001|Overall Study|Adverse Event|10
4541266|NCT01138657|7364508|FG000|Overall Study|Lack of Efficacy|2
4541267|NCT01138657|7364509|FG001|Overall Study|Lack of Efficacy|1
4541268|NCT01138657|7364508|FG000|Overall Study|Lost to Follow-up|0
4541269|NCT01138657|7364509|FG001|Overall Study|Lost to Follow-up|3
4541270|NCT01138657|7364508|FG000|Overall Study|Miscellaneous Reasons|3
4541271|NCT01138657|7364509|FG001|Overall Study|Miscellaneous Reasons|4
4541272|NCT01138826|7364526|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1
4541273|NCT01138826|7364527|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1
4541274|NCT01138826|7364528|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0
4541275|NCT01138826|7364529|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0
4541276|NCT01138826|7364530|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1
4541277|NCT01138826|7364531|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0
4541278|NCT01139008|7364566|FG000|Overall Study|Withdrawal by Subject|5
4541279|NCT01139008|7364566|FG000|Overall Study|Non-compliant, lost product|1
4541280|NCT01139021|7364579|FG000|Overall Study|Adverse Event|0
4541281|NCT01139021|7364580|FG001|Overall Study|Adverse Event|0
4541282|NCT01139021|7364581|FG002|Overall Study|Adverse Event|0
4541283|NCT01139021|7364582|FG003|Overall Study|Adverse Event|0
4541284|NCT01139021|7364583|FG004|Overall Study|Adverse Event|1
4541285|NCT01139021|7364584|FG005|Overall Study|Adverse Event|0
4541286|NCT01139021|7364579|FG000|Overall Study|Lost to Follow-up|0
4541287|NCT01139021|7364580|FG001|Overall Study|Lost to Follow-up|0
4541288|NCT01139021|7364581|FG002|Overall Study|Lost to Follow-up|0
4541289|NCT01139021|7364582|FG003|Overall Study|Lost to Follow-up|0
4541290|NCT01139021|7364583|FG004|Overall Study|Lost to Follow-up|2
4541291|NCT01139021|7364584|FG005|Overall Study|Lost to Follow-up|0
4541292|NCT01139021|7364579|FG000|Overall Study|Protocol Violation|1
4541293|NCT01139021|7364580|FG001|Overall Study|Protocol Violation|0
4541294|NCT01139021|7364581|FG002|Overall Study|Protocol Violation|0
4541295|NCT01139021|7364582|FG003|Overall Study|Protocol Violation|0
4541296|NCT01139021|7364583|FG004|Overall Study|Protocol Violation|2
4541297|NCT01139021|7364584|FG005|Overall Study|Protocol Violation|0
4541298|NCT01139021|7364579|FG000|Overall Study|Withdrawal by Subject|0
4541299|NCT01139021|7364580|FG001|Overall Study|Withdrawal by Subject|0
4541300|NCT01139021|7364581|FG002|Overall Study|Withdrawal by Subject|0
4541301|NCT01139021|7364582|FG003|Overall Study|Withdrawal by Subject|1
4541302|NCT01139021|7364583|FG004|Overall Study|Withdrawal by Subject|4
4541303|NCT01139021|7364584|FG005|Overall Study|Withdrawal by Subject|0
4541304|NCT01139047|7364599|FG000|Overall Study|Withdrawal by Subject|1
4541305|NCT01139164|7364609|FG000|Overall Study|Withdrawn prior to study start|0
4541306|NCT01139164|7364610|FG001|Overall Study|Withdrawn prior to study start|2
4541307|NCT01139164|7364611|FG002|Overall Study|Withdrawn prior to study start|0
4541308|NCT01139450|7364642|FG000|Overall Study|Withdrawal by Subject|7
4541309|NCT01139450|7364643|FG001|Overall Study|Withdrawal by Subject|10
4541310|NCT01139450|7364644|FG002|Overall Study|Withdrawal by Subject|13
4541311|NCT01139450|7364642|FG000|Overall Study|Lack of Efficacy|3
4541312|NCT01139450|7364643|FG001|Overall Study|Lack of Efficacy|1
4541313|NCT01139450|7364644|FG002|Overall Study|Lack of Efficacy|8
4541314|NCT01139450|7364642|FG000|Overall Study|Protocol Violation|6
4541315|NCT01139450|7364643|FG001|Overall Study|Protocol Violation|5
4541316|NCT01139450|7364644|FG002|Overall Study|Protocol Violation|2
4541317|NCT01139450|7364642|FG000|Overall Study|Lost to Follow-up|9
4541318|NCT01139450|7364643|FG001|Overall Study|Lost to Follow-up|7
4541319|NCT01139450|7364644|FG002|Overall Study|Lost to Follow-up|11
4541320|NCT01139450|7364642|FG000|Overall Study|Administrative|0
4541321|NCT01139450|7364643|FG001|Overall Study|Administrative|0
4541322|NCT01139450|7364644|FG002|Overall Study|Administrative|1
4541323|NCT01139450|7364642|FG000|Overall Study|Adverse Event|2
4541324|NCT01139450|7364643|FG001|Overall Study|Adverse Event|2
4541325|NCT01139450|7364644|FG002|Overall Study|Adverse Event|3
4541326|NCT01139580|7364667|FG000|Overall Study|Adverse Event|5
4541327|NCT01139580|7364668|FG001|Overall Study|Adverse Event|4
4541328|NCT01139580|7364667|FG000|Overall Study|Lost to Follow-up|9
4541329|NCT01139580|7364668|FG001|Overall Study|Lost to Follow-up|1
4541330|NCT01139580|7364667|FG000|Overall Study|Lack of Efficacy|0
4541331|NCT01139580|7364668|FG001|Overall Study|Lack of Efficacy|2
4541332|NCT01139580|7364667|FG000|Overall Study|Withdrawal by Subject|6
4541333|NCT01139580|7364668|FG001|Overall Study|Withdrawal by Subject|9
4541334|NCT01139580|7364667|FG000|Overall Study|Used Excluded Medicine After Enrollment|1
4541335|NCT01139580|7364668|FG001|Overall Study|Used Excluded Medicine After Enrollment|0
4541336|NCT01139580|7364667|FG000|Overall Study|Did Not Meet Exclusion Criteria|1
4541337|NCT01139580|7364668|FG001|Overall Study|Did Not Meet Exclusion Criteria|0
4617000|NCT01746017|7476326|FG000|Period 3|Withdrawal by Subject|0
4617001|NCT01746017|7476327|FG001|Period 3|Withdrawal by Subject|0
4617002|NCT01746017|7476328|FG002|Period 3|Withdrawal by Subject|0
4617003|NCT01746017|7476329|FG003|Period 3|Withdrawal by Subject|0
4617004|NCT01746017|7476330|FG004|Period 3|Withdrawal by Subject|0
4617005|NCT01746017|7476331|FG005|Period 3|Withdrawal by Subject|1
4617006|NCT01746017|7476332|FG006|Period 3|Withdrawal by Subject|0
4617007|NCT01746017|7476333|FG007|Period 3|Withdrawal by Subject|0
4617008|NCT01746017|7476334|FG008|Period 3|Withdrawal by Subject|0
4617009|NCT01746017|7476335|FG009|Period 3|Withdrawal by Subject|0
4617010|NCT01746017|7476336|FG010|Period 3|Withdrawal by Subject|0
4617011|NCT01746108|7476412|FG000|Overall Study|Migrated /moved from study area|0
4541338|NCT01139580|7364667|FG000|Overall Study|Misrandomized|1
4541339|NCT01139580|7364668|FG001|Overall Study|Misrandomized|0
4541340|NCT01139580|7364667|FG000|Overall Study|Beginning Study Exclusion Treatment|0
4541341|NCT01139580|7364668|FG001|Overall Study|Beginning Study Exclusion Treatment|1
4541342|NCT01139580|7364667|FG000|Overall Study|Participant Randomization in Error|0
4541343|NCT01139580|7364668|FG001|Overall Study|Participant Randomization in Error|1
4541344|NCT01139658|7364676|FG000|Overall Study|Adverse Event|10
4541345|NCT01139658|7364677|FG001|Overall Study|Adverse Event|27
4541346|NCT01139658|7364676|FG000|Overall Study|Lack of Efficacy|15
4541347|NCT01139658|7364677|FG001|Overall Study|Lack of Efficacy|7
4541348|NCT01139658|7364676|FG000|Overall Study|Withdrawal by Subject|2
4541349|NCT01139658|7364677|FG001|Overall Study|Withdrawal by Subject|4
4541350|NCT01139658|7364676|FG000|Overall Study|No documentation of treatment|1
4541351|NCT01139658|7364677|FG001|Overall Study|No documentation of treatment|0
4541352|NCT01139658|7364676|FG000|Overall Study|Other|28
4541353|NCT01139658|7364677|FG001|Overall Study|Other|75
4541354|NCT01139762|7364685|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258
4541355|NCT01139762|7364686|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0
4541356|NCT01139762|7364687|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0
4541357|NCT01139762|7364685|FG000|Washout and Placebo Lead-In Period|Adverse Event|1
4541358|NCT01139762|7364686|FG001|Washout and Placebo Lead-In Period|Adverse Event|0
4541359|NCT01139762|7364687|FG002|Washout and Placebo Lead-In Period|Adverse Event|0
4541360|NCT01139762|7364685|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83
4541361|NCT01139762|7364686|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0
4617012|NCT01746108|7476413|FG001|Overall Study|Migrated /moved from study area|1
4617013|NCT01746108|7476414|FG002|Overall Study|Migrated /moved from study area|0
4617014|NCT01746108|7476412|FG000|Overall Study|Adverse event, non-fatal|0
4617015|NCT01746108|7476413|FG001|Overall Study|Adverse event, non-fatal|1
4617016|NCT01746108|7476414|FG002|Overall Study|Adverse event, non-fatal|0
4617017|NCT01746108|7476412|FG000|Overall Study|Withdrawal by Subject|0
4617018|NCT01746108|7476413|FG001|Overall Study|Withdrawal by Subject|1
4617019|NCT01746108|7476414|FG002|Overall Study|Withdrawal by Subject|0
4617020|NCT01746108|7476412|FG000|Overall Study|Lost to Follow-up|0
4617021|NCT01746108|7476413|FG001|Overall Study|Lost to Follow-up|1
4617022|NCT01746108|7476414|FG002|Overall Study|Lost to Follow-up|0
4617023|NCT01746173|7476430|FG000|Overall Study|Disease Progression|2
4617024|NCT01746225|7476437|FG000|Overall Study|Death|1
4617025|NCT01746225|7476438|FG001|Overall Study|Death|0
4617026|NCT01746225|7476439|FG002|Overall Study|Death|1
4617027|NCT01746225|7476437|FG000|Overall Study|Withdrawal by Subject|5
4617028|NCT01746225|7476438|FG001|Overall Study|Withdrawal by Subject|15
4617029|NCT01746225|7476439|FG002|Overall Study|Withdrawal by Subject|19
4617030|NCT01746225|7476437|FG000|Overall Study|Physician Decision|14
4617031|NCT01746225|7476438|FG001|Overall Study|Physician Decision|11
4617032|NCT01746225|7476439|FG002|Overall Study|Physician Decision|3
4617033|NCT01746225|7476437|FG000|Overall Study|Adverse Event|15
4617034|NCT01746225|7476438|FG001|Overall Study|Adverse Event|12
4617035|NCT01746225|7476439|FG002|Overall Study|Adverse Event|17
4617036|NCT01746225|7476437|FG000|Overall Study|Continuing Treatment|5
4617037|NCT01746225|7476438|FG001|Overall Study|Continuing Treatment|8
4617038|NCT01746225|7476439|FG002|Overall Study|Continuing Treatment|3
4617039|NCT01746368|7476453|FG000|Overall Study|Lost to Follow-up|2
4617040|NCT01746368|7476454|FG001|Overall Study|Lost to Follow-up|0
4617041|NCT01746368|7476453|FG000|Overall Study|Withdrawal by Subject|0
4617042|NCT01746368|7476454|FG001|Overall Study|Withdrawal by Subject|1
4617043|NCT01746732|7476491|FG000|Lead-In Period|Withdrawal by Subject|1
4617044|NCT01746732|7476492|FG001|Lead-In Period|Withdrawal by Subject|0
4617045|NCT01746732|7476493|FG002|Lead-In Period|Withdrawal by Subject|0
4617046|NCT01746732|7476491|FG000|Period 1|Physician Decision|0
4617047|NCT01746732|7476492|FG001|Period 1|Physician Decision|1
4541362|NCT01139762|7364687|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0
4617048|NCT01746732|7476493|FG002|Period 1|Physician Decision|0
4617049|NCT01746732|7476491|FG000|Period 2|Withdrawal by Subject|0
4617050|NCT01746732|7476492|FG001|Period 2|Withdrawal by Subject|0
4617051|NCT01746732|7476493|FG002|Period 2|Withdrawal by Subject|2
4541363|NCT01139762|7364685|FG000|Washout and Placebo Lead-In Period|Physician Decision|12
4617052|NCT01746732|7476491|FG000|Period 2|Adverse Event|0
4617053|NCT01746732|7476492|FG001|Period 2|Adverse Event|0
4617054|NCT01746732|7476493|FG002|Period 2|Adverse Event|1
4617055|NCT01746732|7476491|FG000|Period 2|Lost to Follow-up|0
4541364|NCT01139762|7364686|FG001|Washout and Placebo Lead-In Period|Physician Decision|0
4541365|NCT01139762|7364687|FG002|Washout and Placebo Lead-In Period|Physician Decision|0
4541366|NCT01139762|7364685|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10
4541367|NCT01139762|7364686|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0
4541368|NCT01139762|7364687|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0
4541369|NCT01139762|7364685|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10
4541370|NCT01139762|7364686|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0
4541371|NCT01139762|7364687|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0
4541372|NCT01139762|7364685|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0
4541373|NCT01139762|7364686|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4
4541374|NCT01139762|7364687|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10
4541375|NCT01139762|7364685|FG000|Double-Blind Randomized Active Treatment|Death|0
4541376|NCT01139762|7364686|FG001|Double-Blind Randomized Active Treatment|Death|1
4541377|NCT01139762|7364687|FG002|Double-Blind Randomized Active Treatment|Death|1
4541378|NCT01139762|7364685|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0
4541379|NCT01139762|7364686|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14
4541380|NCT01139762|7364687|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17
4541381|NCT01139762|7364685|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0
4541382|NCT01139762|7364686|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2
4541383|NCT01139762|7364687|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8
4541384|NCT01139762|7364685|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0
4541385|NCT01139762|7364686|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6
4541386|NCT01139762|7364687|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13
4541387|NCT01139762|7364685|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0
4541388|NCT01139762|7364686|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2
4541389|NCT01139762|7364687|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0
4541390|NCT01139762|7364685|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0
4541391|NCT01139762|7364686|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5
4541392|NCT01139762|7364687|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6
4541393|NCT01139762|7364685|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0
4541394|NCT01139762|7364686|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3
4541395|NCT01139762|7364687|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5
4541396|NCT01139762|7364685|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0
4541397|NCT01139762|7364686|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3
4541398|NCT01139762|7364687|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4
4541399|NCT01139775|7364697|FG000|Overall Study|Adverse Event|0
4541400|NCT01139775|7364698|FG001|Overall Study|Adverse Event|6
4541401|NCT01139775|7364699|FG002|Overall Study|Adverse Event|2
4541402|NCT01139775|7364697|FG000|Overall Study|Protocol Violation|0
4541403|NCT01139775|7364698|FG001|Overall Study|Protocol Violation|5
4541404|NCT01139775|7364699|FG002|Overall Study|Protocol Violation|0
4541405|NCT01139775|7364697|FG000|Overall Study|Withdrawal by Subject|1
4541406|NCT01139775|7364698|FG001|Overall Study|Withdrawal by Subject|0
4541407|NCT01139775|7364699|FG002|Overall Study|Withdrawal by Subject|2
4541408|NCT01139775|7364697|FG000|Overall Study|Physician Decision|0
4541409|NCT01139775|7364698|FG001|Overall Study|Physician Decision|2
4541410|NCT01139775|7364699|FG002|Overall Study|Physician Decision|2
4541411|NCT01140061|7364739|FG000|Part I|Adverse Event|1
4541412|NCT01140061|7364740|FG001|Part I|Adverse Event|0
4541413|NCT01140061|7364741|FG002|Part I|Adverse Event|0
4541414|NCT01140061|7364742|FG003|Part I|Adverse Event|0
4541415|NCT01140061|7364743|FG004|Part I|Adverse Event|0
4541416|NCT01140061|7364744|FG005|Part I|Adverse Event|0
4541417|NCT01140061|7364745|FG006|Part I|Adverse Event|0
4541418|NCT01140061|7364746|FG007|Part I|Adverse Event|0
4541419|NCT01140061|7364747|FG008|Part I|Adverse Event|0
4541420|NCT01140061|7364748|FG009|Part I|Adverse Event|0
4541421|NCT01140061|7364739|FG000|Extension|Laboratory Adverse Event|0
4541422|NCT01140061|7364740|FG001|Extension|Laboratory Adverse Event|0
4541423|NCT01140061|7364741|FG002|Extension|Laboratory Adverse Event|0
4541424|NCT01140061|7364742|FG003|Extension|Laboratory Adverse Event|0
4541425|NCT01140061|7364743|FG004|Extension|Laboratory Adverse Event|0
4541426|NCT01140061|7364744|FG005|Extension|Laboratory Adverse Event|0
4541427|NCT01140061|7364745|FG006|Extension|Laboratory Adverse Event|0
4541428|NCT01140061|7364746|FG007|Extension|Laboratory Adverse Event|0
4541429|NCT01140061|7364747|FG008|Extension|Laboratory Adverse Event|0
4541430|NCT01140061|7364748|FG009|Extension|Laboratory Adverse Event|1
4541431|NCT01140347|7364780|FG000|Overall Study|Lost to Follow-up|5
4541432|NCT01140347|7364781|FG001|Overall Study|Lost to Follow-up|6
4541433|NCT01140347|7364780|FG000|Overall Study|Withdrawal by Subject|13
4541434|NCT01140347|7364781|FG001|Overall Study|Withdrawal by Subject|8
4541435|NCT01140477|7364793|FG000|Overall Study|Lost to Follow-up|4
4541436|NCT01140477|7364794|FG001|Overall Study|Lost to Follow-up|0
4541437|NCT01140477|7364793|FG000|Overall Study|Withdrawal by Subject|1
4541438|NCT01140477|7364794|FG001|Overall Study|Withdrawal by Subject|4
4541439|NCT01140477|7364793|FG000|Overall Study|Surgical complication preventing implant|2
4591326|NCT01529034|7437835|FG000|Overall Study|Lack of Efficacy|4
4541440|NCT01140477|7364794|FG001|Overall Study|Surgical complication preventing implant|0
4541441|NCT01140477|7364793|FG000|Overall Study|Death|1
4541442|NCT01140477|7364794|FG001|Overall Study|Death|1
4541443|NCT01140477|7364793|FG000|Overall Study|Subject explanted|0
4541444|NCT01140477|7364794|FG001|Overall Study|Subject explanted|1
4541445|NCT01140503|7364800|FG000|Overall Study|Withdrawal by Subject|1
4541446|NCT01140568|7364804|FG000|Overall Study|disease progression|31
4541447|NCT01140568|7364804|FG000|Overall Study|Withdrawal by Subject|1
4541448|NCT01140568|7364804|FG000|Overall Study|Screen Fail|4
4541449|NCT01140646|7364808|FG000|Overall Study|Adverse Event|4
4541450|NCT01140646|7364808|FG000|Overall Study|Refused Further Treatment|5
4541451|NCT01140880|7364825|FG000|Overall Study|Death|0
4541452|NCT01140880|7364826|FG001|Overall Study|Death|1
4541453|NCT01140880|7364825|FG000|Overall Study|Withdrawal by Subject|6
4541454|NCT01140880|7364826|FG001|Overall Study|Withdrawal by Subject|3
4541455|NCT01140880|7364825|FG000|Overall Study|Lost to Follow-up|8
4541456|NCT01140880|7364826|FG001|Overall Study|Lost to Follow-up|10
4541457|NCT01140880|7364825|FG000|Overall Study|Protocol Violation|0
4541458|NCT01140880|7364826|FG001|Overall Study|Protocol Violation|30
4541459|NCT01140906|7364836|FG000|Overall Study|Adverse Event|7
4541460|NCT01140906|7364837|FG001|Overall Study|Adverse Event|10
4541461|NCT01140906|7364838|FG002|Overall Study|Adverse Event|17
4541462|NCT01140906|7364839|FG003|Overall Study|Adverse Event|7
4541463|NCT01140906|7364836|FG000|Overall Study|Lack of Efficacy|6
4541464|NCT01140906|7364837|FG001|Overall Study|Lack of Efficacy|8
4541465|NCT01140906|7364838|FG002|Overall Study|Lack of Efficacy|2
4541466|NCT01140906|7364839|FG003|Overall Study|Lack of Efficacy|1
4541467|NCT01140906|7364836|FG000|Overall Study|Non-compliance|0
4541468|NCT01140906|7364837|FG001|Overall Study|Non-compliance|1
4541469|NCT01140906|7364838|FG002|Overall Study|Non-compliance|0
4541470|NCT01140906|7364839|FG003|Overall Study|Non-compliance|1
4541471|NCT01140906|7364836|FG000|Overall Study|Protocol Violation|5
4541472|NCT01140906|7364837|FG001|Overall Study|Protocol Violation|3
4541473|NCT01140906|7364838|FG002|Overall Study|Protocol Violation|2
4541474|NCT01140906|7364839|FG003|Overall Study|Protocol Violation|1
4541475|NCT01140906|7364836|FG000|Overall Study|Withdrawal of consent|6
4541476|NCT01140906|7364837|FG001|Overall Study|Withdrawal of consent|6
4541477|NCT01140906|7364838|FG002|Overall Study|Withdrawal of consent|2
4541478|NCT01140906|7364839|FG003|Overall Study|Withdrawal of consent|2
4541479|NCT01140906|7364836|FG000|Overall Study|Lost to Follow-up|1
4541480|NCT01140906|7364837|FG001|Overall Study|Lost to Follow-up|1
4541481|NCT01140906|7364838|FG002|Overall Study|Lost to Follow-up|0
4541482|NCT01140906|7364839|FG003|Overall Study|Lost to Follow-up|2
4541483|NCT01140906|7364836|FG000|Overall Study|Administrative or other reason|0
4541484|NCT01140906|7364837|FG001|Overall Study|Administrative or other reason|5
4541485|NCT01140906|7364838|FG002|Overall Study|Administrative or other reason|3
4541486|NCT01140906|7364839|FG003|Overall Study|Administrative or other reason|2
4541487|NCT01141205|7364864|FG000|Overall Study|Physician Decision|1
4541488|NCT01141205|7364865|FG001|Overall Study|Physician Decision|1
4541489|NCT01141205|7364864|FG000|Overall Study|Lost to Follow-up|1
4541490|NCT01141205|7364865|FG001|Overall Study|Lost to Follow-up|0
4541491|NCT01141205|7364864|FG000|Overall Study|Withdrawal by Subject|1
4541492|NCT01141205|7364865|FG001|Overall Study|Withdrawal by Subject|1
4541493|NCT01141283|7364875|FG000|Overall Study|Adverse Event|56
4541494|NCT01141283|7364875|FG000|Overall Study|Lost to Follow-up|4
4541495|NCT01141283|7364875|FG000|Overall Study|Withdrawal by Subject|14
4541496|NCT01141283|7364875|FG000|Overall Study|Administrative|4
4541497|NCT01141283|7364875|FG000|Overall Study|Lack of Efficacy|10
4541498|NCT01141478|7364896|FG000|Overall Study|Withdrawal by Subject|1
4541499|NCT01141478|7364897|FG001|Overall Study|Withdrawal by Subject|1
4591327|NCT01529034|7437835|FG000|Overall Study|Investigator no longer available|2
4591328|NCT01529034|7437835|FG000|Overall Study|Study drug not available|2
4591329|NCT01529112|7437852|FG000|Overall Study|Adverse Event|2
4591330|NCT01529112|7437853|FG001|Overall Study|Adverse Event|0
4591331|NCT01529112|7437852|FG000|Overall Study|Death|59
4591332|NCT01529112|7437853|FG001|Overall Study|Death|38
4591333|NCT01529112|7437852|FG000|Overall Study|Protocol Violation|1
4591334|NCT01529112|7437853|FG001|Overall Study|Protocol Violation|0
4591335|NCT01529112|7437852|FG000|Overall Study|Withdrawal by Subject|7
4591336|NCT01529112|7437853|FG001|Overall Study|Withdrawal by Subject|3
4591337|NCT01529268|7437865|FG000|Overall Study|Lost to Follow-up|9
4591338|NCT01529268|7437866|FG001|Overall Study|Lost to Follow-up|3
4591339|NCT01529268|7437865|FG000|Overall Study|Moved|3
4591340|NCT01529268|7437866|FG001|Overall Study|Moved|0
4591341|NCT01529346|7437877|FG000|Overall Study|Lost to Follow-up|2
4591342|NCT01529346|7437878|FG001|Overall Study|Lost to Follow-up|0
4591343|NCT01529346|7437879|FG002|Overall Study|Lost to Follow-up|1
4591344|NCT01529346|7437880|FG003|Overall Study|Lost to Follow-up|0
4591345|NCT01529346|7437881|FG004|Overall Study|Lost to Follow-up|0
4591346|NCT01529346|7437877|FG000|Overall Study|Other|0
4591347|NCT01529346|7437878|FG001|Overall Study|Other|1
4591348|NCT01529346|7437879|FG002|Overall Study|Other|1
4591349|NCT01529346|7437880|FG003|Overall Study|Other|0
4591350|NCT01529346|7437881|FG004|Overall Study|Other|0
4591351|NCT01529385|7437896|FG000|Overall Study|Lost to Follow-up|2
4591352|NCT01529385|7437897|FG001|Overall Study|Lost to Follow-up|1
4591353|NCT01529515|7437934|FG000|TRANSITION PHASE|Adverse Event|16
4617056|NCT01746732|7476492|FG001|Period 2|Lost to Follow-up|0
4617057|NCT01746732|7476493|FG002|Period 2|Lost to Follow-up|1
4617058|NCT01746862|7476537|FG000|Overall Study|Withdrawal by Subject|1
4617059|NCT01746862|7476538|FG001|Overall Study|Withdrawal by Subject|1
4617060|NCT01746862|7476537|FG000|Overall Study|Protocol Violation|1
4617061|NCT01746862|7476538|FG001|Overall Study|Protocol Violation|0
4617062|NCT01746862|7476537|FG000|Overall Study|Consent withdrawal by parent's guardian|5
4617063|NCT01746862|7476538|FG001|Overall Study|Consent withdrawal by parent's guardian|2
4617064|NCT01746862|7476537|FG000|Overall Study|Entered puberty during the study|1
4617065|NCT01746862|7476538|FG001|Overall Study|Entered puberty during the study|0
4617066|NCT01746901|7476545|FG000|Naloxone Challenge Phase|Adverse Event|2
4541500|NCT01141660|7364940|FG000|Overall Study|Physician Decision|0
4541501|NCT01141660|7364941|FG001|Overall Study|Physician Decision|12
4541502|NCT01142089|7364967|FG000|Overall Study|Physician Decision|1
4541503|NCT01142089|7364968|FG001|Overall Study|Physician Decision|0
4541504|NCT01142089|7364967|FG000|Overall Study|Withdrawal by Subject|1
4541505|NCT01142089|7364968|FG001|Overall Study|Withdrawal by Subject|2
4541506|NCT01142089|7364967|FG000|Overall Study|Use of prohibited medications|0
4541507|NCT01142089|7364968|FG001|Overall Study|Use of prohibited medications|1
4541508|NCT01142089|7364967|FG000|Overall Study|Noncompliance with study procedures|2
4541509|NCT01142089|7364968|FG001|Overall Study|Noncompliance with study procedures|1
4541510|NCT01142089|7364967|FG000|Overall Study|Patient required rescue medication|8
4541511|NCT01142089|7364968|FG001|Overall Study|Patient required rescue medication|17
4541512|NCT01142115|7364974|FG000|First Intervention|Lack of Efficacy|1
4541513|NCT01142115|7364975|FG001|First Intervention|Lack of Efficacy|1
4541514|NCT01142115|7364974|FG000|First Intervention|Adverse Event|1
4541515|NCT01142115|7364975|FG001|First Intervention|Adverse Event|0
4541516|NCT01142193|7364982|FG000|Overall Study|Adverse Event|12
4541517|NCT01142193|7364983|FG001|Overall Study|Adverse Event|4
4541518|NCT01142193|7364982|FG000|Overall Study|Lack of Efficacy|2
4541519|NCT01142193|7364983|FG001|Overall Study|Lack of Efficacy|1
4541520|NCT01142193|7364982|FG000|Overall Study|Physician Decision|1
4541521|NCT01142193|7364983|FG001|Overall Study|Physician Decision|1
4541522|NCT01142193|7364982|FG000|Overall Study|Withdrawal by Subject|4
4541523|NCT01142193|7364983|FG001|Overall Study|Withdrawal by Subject|3
4541524|NCT01142193|7364982|FG000|Overall Study|Protocol Discontinuation Criterion Met|1
4541525|NCT01142193|7364983|FG001|Overall Study|Protocol Discontinuation Criterion Met|0
4541526|NCT01142193|7364982|FG000|Overall Study|Other|1
4541527|NCT01142193|7364983|FG001|Overall Study|Other|2
4541528|NCT01142232|7364994|FG000|Overall Study|Adverse Event|1
4541529|NCT01142232|7364995|FG001|Overall Study|Adverse Event|2
4541530|NCT01142232|7364996|FG002|Overall Study|Adverse Event|1
4541531|NCT01142232|7364997|FG003|Overall Study|Adverse Event|0
4541532|NCT01142232|7364998|FG004|Overall Study|Adverse Event|4
4541533|NCT01142232|7364994|FG000|Overall Study|Death|0
4541534|NCT01142232|7364995|FG001|Overall Study|Death|0
4541535|NCT01142232|7364996|FG002|Overall Study|Death|0
4541536|NCT01142232|7364997|FG003|Overall Study|Death|0
4541537|NCT01142232|7364998|FG004|Overall Study|Death|1
4541538|NCT01142232|7364994|FG000|Overall Study|Disease Progression|2
4541539|NCT01142232|7364995|FG001|Overall Study|Disease Progression|0
4541540|NCT01142232|7364996|FG002|Overall Study|Disease Progression|1
4541541|NCT01142232|7364997|FG003|Overall Study|Disease Progression|2
4541542|NCT01142232|7364998|FG004|Overall Study|Disease Progression|12
4541543|NCT01142232|7364994|FG000|Overall Study|Withdrawal by Subject|0
4541544|NCT01142232|7364995|FG001|Overall Study|Withdrawal by Subject|0
4541545|NCT01142232|7364996|FG002|Overall Study|Withdrawal by Subject|0
4541546|NCT01142232|7364997|FG003|Overall Study|Withdrawal by Subject|1
4541547|NCT01142232|7364998|FG004|Overall Study|Withdrawal by Subject|3
4541548|NCT01142232|7364994|FG000|Overall Study|Physician Decision|0
4541549|NCT01142232|7364995|FG001|Overall Study|Physician Decision|1
4541550|NCT01142232|7364996|FG002|Overall Study|Physician Decision|0
4541551|NCT01142232|7364997|FG003|Overall Study|Physician Decision|2
4541552|NCT01142232|7364998|FG004|Overall Study|Physician Decision|10
4541553|NCT01142232|7364994|FG000|Overall Study|Alternative Therapy|0
4541554|NCT01142232|7364995|FG001|Overall Study|Alternative Therapy|1
4541555|NCT01142232|7364996|FG002|Overall Study|Alternative Therapy|1
4541556|NCT01142232|7364997|FG003|Overall Study|Alternative Therapy|0
4541557|NCT01142232|7364998|FG004|Overall Study|Alternative Therapy|1
4541558|NCT01142232|7364994|FG000|Overall Study|Off Trt for other complicating disease|0
4541559|NCT01142232|7364995|FG001|Overall Study|Off Trt for other complicating disease|0
4541560|NCT01142232|7364996|FG002|Overall Study|Off Trt for other complicating disease|0
4541561|NCT01142232|7364997|FG003|Overall Study|Off Trt for other complicating disease|0
4541562|NCT01142232|7364998|FG004|Overall Study|Off Trt for other complicating disease|1
4617067|NCT01746901|7476546|FG001|Naloxone Challenge Phase|Adverse Event|0
4541563|NCT01142232|7364994|FG000|Overall Study|Noncompliance|0
4541564|NCT01142232|7364995|FG001|Overall Study|Noncompliance|0
4541565|NCT01142232|7364996|FG002|Overall Study|Noncompliance|0
4541566|NCT01142232|7364997|FG003|Overall Study|Noncompliance|0
4541567|NCT01142232|7364998|FG004|Overall Study|Noncompliance|2
4541568|NCT01142336|7365034|FG000|Overall Study|Adverse Event|1
4541569|NCT01142336|7365035|FG001|Overall Study|Adverse Event|1
4617068|NCT01746901|7476547|FG002|Naloxone Challenge Phase|Adverse Event|0
4541570|NCT01142336|7365034|FG000|Overall Study|Lost to Follow-up|0
4541571|NCT01142336|7365035|FG001|Overall Study|Lost to Follow-up|1
4541572|NCT01142466|7365046|FG000|Overall Study|Adverse Event|2
4541573|NCT01142466|7365047|FG001|Overall Study|Adverse Event|1
4541574|NCT01142466|7365046|FG000|Overall Study|Withdrawal by Subject|1
4541575|NCT01142466|7365047|FG001|Overall Study|Withdrawal by Subject|1
4541576|NCT01142661|7365053|FG000|Overall Study|Adverse Event|2
4541577|NCT01142661|7365053|FG000|Overall Study|Withdrawal by Subject|1
4541578|NCT01142661|7365053|FG000|Overall Study|Physician Decision|1
4541579|NCT01142726|7365060|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5
4541580|NCT01142726|7365061|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8
4541581|NCT01142726|7365062|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5
4541582|NCT01142726|7365060|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4
4541583|NCT01142726|7365061|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9
4541584|NCT01142726|7365062|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3
4541585|NCT01142726|7365060|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1
4541586|NCT01142726|7365061|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2
4541587|NCT01142726|7365062|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1
4541588|NCT01142726|7365060|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1
4541589|NCT01142726|7365061|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0
4541590|NCT01142726|7365062|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0
4541591|NCT01142726|7365060|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5
4541592|NCT01142726|7365061|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6
4541593|NCT01142726|7365062|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11
4541594|NCT01142726|7365060|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0
4541595|NCT01142726|7365061|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0
4541596|NCT01142726|7365062|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1
4541597|NCT01142726|7365060|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1
4541598|NCT01142726|7365061|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1
4541599|NCT01142726|7365062|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2
4541600|NCT01142726|7365060|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1
4541601|NCT01142726|7365061|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0
4541602|NCT01142726|7365062|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1
4541603|NCT01142726|7365060|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2
4541604|NCT01142726|7365061|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0
4541605|NCT01142726|7365062|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0
4541606|NCT01142726|7365060|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1
4541607|NCT01142726|7365061|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0
4541608|NCT01142726|7365062|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0
4541609|NCT01142726|7365060|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65
4541610|NCT01142726|7365061|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54
4541611|NCT01142726|7365062|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53
4541612|NCT01142726|7365060|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0
4541613|NCT01142726|7365061|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1
4541614|NCT01142726|7365062|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1
4541615|NCT01142726|7365060|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0
4541616|NCT01142726|7365061|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0
4541617|NCT01142726|7365062|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1
4541618|NCT01142726|7365060|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
4541619|NCT01142726|7365061|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
4541620|NCT01142726|7365062|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
4541621|NCT01142726|7365060|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0
4541622|NCT01142726|7365061|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0
4541623|NCT01142726|7365062|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1
4541624|NCT01142726|7365060|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0
4541625|NCT01142726|7365061|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1
4541626|NCT01142726|7365062|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0
4541627|NCT01142791|7365078|FG000|Overall Study|Alternative Treatment|1
4541628|NCT01142791|7365079|FG001|Overall Study|Alternative Treatment|0
4541629|NCT01142791|7365078|FG000|Overall Study|Lost to Follow-up|1
4541630|NCT01142791|7365079|FG001|Overall Study|Lost to Follow-up|0
4541631|NCT01142791|7365078|FG000|Overall Study|Withdrawal by Subject|5
4541632|NCT01142791|7365079|FG001|Overall Study|Withdrawal by Subject|0
4541633|NCT01142791|7365078|FG000|Overall Study|Received only 1 sonication|0
4541634|NCT01142791|7365079|FG001|Overall Study|Received only 1 sonication|6
4541635|NCT01142908|7365085|FG000|Overall Study|Lost to Follow-up|19
4541636|NCT01142908|7365086|FG001|Overall Study|Lost to Follow-up|13
4541637|NCT01142908|7365085|FG000|Overall Study|Death|1
4541638|NCT01142908|7365086|FG001|Overall Study|Death|4
4541639|NCT01142908|7365085|FG000|Overall Study|Excluded - did not meet criteria|9
4541640|NCT01142908|7365086|FG001|Overall Study|Excluded - did not meet criteria|5
4541641|NCT01142908|7365085|FG000|Overall Study|Withdrawal by Subject|3
4541642|NCT01142908|7365086|FG001|Overall Study|Withdrawal by Subject|0
4541643|NCT01143038|7365096|FG000|Overall Study|Withdrawal by Subject|4
4541644|NCT01143038|7365096|FG000|Overall Study|Requirement for alternative therapy|5
4541645|NCT01143038|7365096|FG000|Overall Study|Adverse Event|3
4541646|NCT01143038|7365096|FG000|Overall Study|Lost to Follow-up|2
4541647|NCT01143038|7365096|FG000|Overall Study|Protocol Deviation|1
4541648|NCT01143038|7365096|FG000|Overall Study|Death|1
4541649|NCT01143051|7365106|FG000|3-14 Day Washout|Withdrawal by Subject|0
4541650|NCT01143051|7365107|FG001|3-14 Day Washout|Withdrawal by Subject|0
4541651|NCT01143051|7365108|FG002|3-14 Day Washout|Withdrawal by Subject|1
4541652|NCT01143051|7365109|FG003|3-14 Day Washout|Withdrawal by Subject|0
4541653|NCT01143051|7365110|FG004|3-14 Day Washout|Withdrawal by Subject|0
4541654|NCT01143051|7365111|FG005|3-14 Day Washout|Withdrawal by Subject|0
4617069|NCT01746901|7476548|FG003|Naloxone Challenge Phase|Adverse Event|0
4617070|NCT01746901|7476549|FG004|Naloxone Challenge Phase|Adverse Event|0
4541655|NCT01143051|7365106|FG000|3-14 Day Washout|Withdrawal by Subject|0
4541656|NCT01143051|7365107|FG001|3-14 Day Washout|Withdrawal by Subject|0
4541657|NCT01143051|7365108|FG002|3-14 Day Washout|Withdrawal by Subject|0
4541658|NCT01143051|7365109|FG003|3-14 Day Washout|Withdrawal by Subject|0
4541659|NCT01143051|7365110|FG004|3-14 Day Washout|Withdrawal by Subject|0
4541660|NCT01143051|7365111|FG005|3-14 Day Washout|Withdrawal by Subject|1
4541661|NCT01143077|7365124|FG000|Overall Study|Lack of Efficacy|0
4541662|NCT01143077|7365125|FG001|Overall Study|Lack of Efficacy|2
4541663|NCT01143077|7365126|FG002|Overall Study|Lack of Efficacy|1
4541664|NCT01143077|7365124|FG000|Overall Study|Adverse Event|5
4541665|NCT01143077|7365125|FG001|Overall Study|Adverse Event|6
4541666|NCT01143077|7365126|FG002|Overall Study|Adverse Event|5
4617071|NCT01746901|7476550|FG005|Naloxone Challenge Phase|Adverse Event|0
4617072|NCT01746901|7476551|FG006|Naloxone Challenge Phase|Adverse Event|0
4617073|NCT01746901|7476552|FG007|Naloxone Challenge Phase|Adverse Event|0
4541667|NCT01143077|7365124|FG000|Overall Study|Lost to Follow-up|2
4541668|NCT01143077|7365125|FG001|Overall Study|Lost to Follow-up|3
4541669|NCT01143077|7365126|FG002|Overall Study|Lost to Follow-up|4
4541670|NCT01143077|7365124|FG000|Overall Study|Protocol Violation|2
4541671|NCT01143077|7365125|FG001|Overall Study|Protocol Violation|0
4541672|NCT01143077|7365126|FG002|Overall Study|Protocol Violation|0
4541673|NCT01143077|7365124|FG000|Overall Study|Withdrawal by Subject|4
4541674|NCT01143077|7365125|FG001|Overall Study|Withdrawal by Subject|3
4541675|NCT01143077|7365126|FG002|Overall Study|Withdrawal by Subject|3
4541676|NCT01143077|7365124|FG000|Overall Study|Non-compliance with study drug|0
4541677|NCT01143077|7365125|FG001|Overall Study|Non-compliance with study drug|1
4541678|NCT01143077|7365126|FG002|Overall Study|Non-compliance with study drug|1
4541679|NCT01143077|7365124|FG000|Overall Study|Administrative|1
4541680|NCT01143077|7365125|FG001|Overall Study|Administrative|0
4617074|NCT01746901|7476553|FG008|Naloxone Challenge Phase|Adverse Event|0
4617075|NCT01746901|7476545|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1
4617076|NCT01746901|7476546|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0
4617077|NCT01746901|7476547|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0
4617078|NCT01746901|7476548|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0
4617079|NCT01746901|7476549|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0
4617080|NCT01746901|7476550|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0
4617081|NCT01746901|7476551|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0
4617082|NCT01746901|7476552|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0
4617083|NCT01746901|7476553|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0
4541681|NCT01143077|7365126|FG002|Overall Study|Administrative|0
4541682|NCT01143077|7365124|FG000|Overall Study|Principal Investigator Decision|2
4541683|NCT01143077|7365125|FG001|Overall Study|Principal Investigator Decision|0
4541684|NCT01143077|7365126|FG002|Overall Study|Principal Investigator Decision|1
4541685|NCT01143090|7365134|FG000|Overall Study|Lack of Efficacy|2
4541686|NCT01143090|7365134|FG000|Overall Study|Adverse Event|17
4541687|NCT01143090|7365134|FG000|Overall Study|Lost to Follow-up|9
4541688|NCT01143090|7365134|FG000|Overall Study|Protocol Violation|2
4541689|NCT01143090|7365134|FG000|Overall Study|Withdrawal by Subject|18
4541690|NCT01143090|7365134|FG000|Overall Study|Non-compliance with study drug|1
4541691|NCT01143090|7365134|FG000|Overall Study|Failure to meet eligibility criteria|1
4541692|NCT01143090|7365134|FG000|Overall Study|Administrative|1
4541693|NCT01143207|7365164|FG000|Overall Study|Lost to Follow-up|2
4541694|NCT01143259|7365170|FG000|Overall Study|Withdrawal by Subject|3
4541695|NCT01143259|7365171|FG001|Overall Study|Withdrawal by Subject|2
4541696|NCT01143259|7365170|FG000|Overall Study|Protocol Violation|13
4541697|NCT01143259|7365171|FG001|Overall Study|Protocol Violation|9
4541698|NCT01143259|7365170|FG000|Overall Study|Screen Failure|7
4541699|NCT01143259|7365171|FG001|Overall Study|Screen Failure|9
4541700|NCT01143324|7365186|FG000|Overall Study|Lost to Follow-up|11
4541701|NCT01143324|7365186|FG000|Overall Study|Withdrawal by Subject|4
4541702|NCT01143324|7365186|FG000|Overall Study|Explant of the device|4
4541703|NCT01143337|7365192|FG000|Overall Study|Adverse Event|3
4541704|NCT01143337|7365193|FG001|Overall Study|Adverse Event|9
4541705|NCT01143337|7365194|FG002|Overall Study|Adverse Event|5
4541706|NCT01143337|7365192|FG000|Overall Study|Lack of Efficacy|6
4541707|NCT01143337|7365193|FG001|Overall Study|Lack of Efficacy|2
4541708|NCT01143337|7365194|FG002|Overall Study|Lack of Efficacy|1
4541709|NCT01143337|7365192|FG000|Overall Study|Protocol Violation|1
4541710|NCT01143337|7365193|FG001|Overall Study|Protocol Violation|0
4541711|NCT01143337|7365194|FG002|Overall Study|Protocol Violation|0
4541712|NCT01143337|7365192|FG000|Overall Study|Withdrawal by Subject|0
4541713|NCT01143337|7365193|FG001|Overall Study|Withdrawal by Subject|0
4541714|NCT01143337|7365194|FG002|Overall Study|Withdrawal by Subject|1
4541715|NCT01143337|7365192|FG000|Overall Study|Other reason|0
4541716|NCT01143337|7365193|FG001|Overall Study|Other reason|0
4541717|NCT01143337|7365194|FG002|Overall Study|Other reason|5
4541718|NCT01143389|7365202|FG000|Overall Study|Lost to Follow-up|26
4541719|NCT01143389|7365203|FG001|Overall Study|Lost to Follow-up|25
4541720|NCT01143402|7365212|FG000|Overall Study|Rapid clinical decline|1
4541721|NCT01143402|7365213|FG001|Overall Study|Rapid clinical decline|1
4541722|NCT01143402|7365214|FG002|Overall Study|Rapid clinical decline|0
4541723|NCT01143402|7365212|FG000|Overall Study|Not Treated|0
4541724|NCT01143402|7365213|FG001|Overall Study|Not Treated|0
4541725|NCT01143402|7365214|FG002|Overall Study|Not Treated|1
4541726|NCT01143714|7365291|FG000|Overall Study|Adverse Event|4
4541727|NCT01143714|7365292|FG001|Overall Study|Adverse Event|2
4541728|NCT01143714|7365291|FG000|Overall Study|Withdrawal by Subject|1
4541729|NCT01143714|7365292|FG001|Overall Study|Withdrawal by Subject|0
4541730|NCT01143714|7365291|FG000|Overall Study|Subject non-compliance|0
4541731|NCT01143714|7365292|FG001|Overall Study|Subject non-compliance|1
4541732|NCT01143714|7365291|FG000|Overall Study|wound closed = deemed healed|1
4541733|NCT01143714|7365292|FG001|Overall Study|wound closed = deemed healed|0
4541734|NCT01143714|7365291|FG000|Overall Study|wound size increased|1
4541735|NCT01143714|7365292|FG001|Overall Study|wound size increased|0
4541736|NCT01143896|7365370|FG000|Overall Study|Did not complete Baseline Interview|5
4541737|NCT01143896|7365371|FG001|Overall Study|Did not complete Baseline Interview|4
4541738|NCT01143896|7365370|FG000|Overall Study|Lost to Follow-up|18
4541739|NCT01143896|7365371|FG001|Overall Study|Lost to Follow-up|13
4541740|NCT01143896|7365370|FG000|Overall Study|Withdrawal by Subject|13
4541741|NCT01143896|7365371|FG001|Overall Study|Withdrawal by Subject|5
4541742|NCT01143896|7365370|FG000|Overall Study|Death|6
4541743|NCT01143896|7365371|FG001|Overall Study|Death|3
4541744|NCT01144052|7365389|FG000|Overall Study|Withdrawal by Subject|1
4541745|NCT01144052|7365390|FG001|Overall Study|Withdrawal by Subject|1
4541746|NCT01144182|7365417|FG000|Overall Study|Death|5
4541747|NCT01144182|7365418|FG001|Overall Study|Death|6
4541748|NCT01144182|7365417|FG000|Overall Study|Withdrawal by Subject|3
4541749|NCT01144182|7365418|FG001|Overall Study|Withdrawal by Subject|6
4541750|NCT01144182|7365417|FG000|Overall Study|Lost to Follow-up|9
4541751|NCT01144182|7365418|FG001|Overall Study|Lost to Follow-up|9
4541752|NCT01144299|7365444|FG000|Overall Study|Lost to Follow-up|1
4541753|NCT01144299|7365445|FG001|Overall Study|Lost to Follow-up|0
4541754|NCT01144299|7365444|FG000|Overall Study|Withdrawal by Subject|1
4541755|NCT01144299|7365445|FG001|Overall Study|Withdrawal by Subject|0
4541756|NCT01144364|7365462|FG000|Induction Phase|Disease progression|14
4541757|NCT01144364|7365463|FG001|Induction Phase|Disease progression|0
4541758|NCT01144364|7365464|FG002|Induction Phase|Disease progression|0
4541759|NCT01144364|7365462|FG000|Induction Phase|Adverse Event|9
4541760|NCT01144364|7365463|FG001|Induction Phase|Adverse Event|0
4541761|NCT01144364|7365464|FG002|Induction Phase|Adverse Event|0
4541762|NCT01144364|7365462|FG000|Induction Phase|Death|1
4541763|NCT01144364|7365463|FG001|Induction Phase|Death|0
4541764|NCT01144364|7365464|FG002|Induction Phase|Death|0
4541765|NCT01144364|7365462|FG000|Induction Phase|Withdrawal by Subject|1
4541766|NCT01144364|7365463|FG001|Induction Phase|Withdrawal by Subject|0
4541767|NCT01144364|7365464|FG002|Induction Phase|Withdrawal by Subject|0
4541768|NCT01144364|7365462|FG000|Induction Phase|Lost to Follow-up|2
4541769|NCT01144364|7365463|FG001|Induction Phase|Lost to Follow-up|0
4541770|NCT01144364|7365464|FG002|Induction Phase|Lost to Follow-up|0
4541771|NCT01144364|7365462|FG000|Induction Phase|Physician Decision|1
4541772|NCT01144364|7365463|FG001|Induction Phase|Physician Decision|0
4541773|NCT01144364|7365464|FG002|Induction Phase|Physician Decision|0
4541774|NCT01144364|7365462|FG000|Induction Phase|Stable disease|2
4541775|NCT01144364|7365463|FG001|Induction Phase|Stable disease|0
4541776|NCT01144364|7365464|FG002|Induction Phase|Stable disease|0
4541777|NCT01144364|7365462|FG000|Induction Phase|Secondary neoplasia|1
4541778|NCT01144364|7365463|FG001|Induction Phase|Secondary neoplasia|0
4541779|NCT01144364|7365464|FG002|Induction Phase|Secondary neoplasia|0
4541780|NCT01144364|7365462|FG000|Induction Phase|Protocol Violation|1
4541781|NCT01144364|7365463|FG001|Induction Phase|Protocol Violation|0
4541782|NCT01144364|7365464|FG002|Induction Phase|Protocol Violation|0
4541783|NCT01144364|7365462|FG000|Follow-Up/Maintenance Phase|Disease progression|0
4541784|NCT01144364|7365463|FG001|Follow-Up/Maintenance Phase|Disease progression|23
4541785|NCT01144364|7365464|FG002|Follow-Up/Maintenance Phase|Disease progression|29
4541786|NCT01144364|7365462|FG000|Follow-Up/Maintenance Phase|Adverse Event|0
4541787|NCT01144364|7365463|FG001|Follow-Up/Maintenance Phase|Adverse Event|3
4541788|NCT01144364|7365464|FG002|Follow-Up/Maintenance Phase|Adverse Event|1
4541789|NCT01144364|7365462|FG000|Follow-Up/Maintenance Phase|Death|0
4541790|NCT01144364|7365463|FG001|Follow-Up/Maintenance Phase|Death|2
4541791|NCT01144364|7365464|FG002|Follow-Up/Maintenance Phase|Death|0
4541792|NCT01144364|7365462|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0
4541793|NCT01144364|7365463|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1
4541794|NCT01144364|7365464|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1
4541795|NCT01144364|7365462|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0
4541796|NCT01144364|7365463|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1
4541797|NCT01144364|7365464|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4
4541798|NCT01144364|7365462|FG000|Follow-Up/Maintenance Phase|Relapse|0
4541799|NCT01144364|7365463|FG001|Follow-Up/Maintenance Phase|Relapse|5
4541800|NCT01144364|7365464|FG002|Follow-Up/Maintenance Phase|Relapse|5
4541801|NCT01144364|7365462|FG000|Follow-Up/Maintenance Phase|Physician Decision|0
4541802|NCT01144364|7365463|FG001|Follow-Up/Maintenance Phase|Physician Decision|0
4541803|NCT01144364|7365464|FG002|Follow-Up/Maintenance Phase|Physician Decision|1
4541804|NCT01144377|7365479|FG000|52 Week Treatment Period|Adverse Event|0
4541805|NCT01144377|7365480|FG001|52 Week Treatment Period|Adverse Event|0
4541806|NCT01144377|7365481|FG002|52 Week Treatment Period|Adverse Event|3
4541807|NCT01144377|7365482|FG003|52 Week Treatment Period|Adverse Event|2
4541808|NCT01144377|7365483|FG004|52 Week Treatment Period|Adverse Event|1
4541809|NCT01144377|7365479|FG000|52 Week Treatment Period|Entry Criteria Not Met|0
4541810|NCT01144377|7365480|FG001|52 Week Treatment Period|Entry Criteria Not Met|0
4541811|NCT01144377|7365481|FG002|52 Week Treatment Period|Entry Criteria Not Met|1
4541812|NCT01144377|7365482|FG003|52 Week Treatment Period|Entry Criteria Not Met|1
4541813|NCT01144377|7365483|FG004|52 Week Treatment Period|Entry Criteria Not Met|0
4541814|NCT01144377|7365479|FG000|52 Week Treatment Period|Protocol Violation|0
4541815|NCT01144377|7365480|FG001|52 Week Treatment Period|Protocol Violation|0
4541816|NCT01144377|7365481|FG002|52 Week Treatment Period|Protocol Violation|0
4541817|NCT01144377|7365482|FG003|52 Week Treatment Period|Protocol Violation|0
4541818|NCT01144377|7365483|FG004|52 Week Treatment Period|Protocol Violation|1
4541819|NCT01144377|7365479|FG000|52 Week Treatment Period|Lost to Follow-up|1
4541820|NCT01144377|7365480|FG001|52 Week Treatment Period|Lost to Follow-up|0
4541821|NCT01144377|7365481|FG002|52 Week Treatment Period|Lost to Follow-up|0
4541822|NCT01144377|7365482|FG003|52 Week Treatment Period|Lost to Follow-up|0
4541823|NCT01144377|7365483|FG004|52 Week Treatment Period|Lost to Follow-up|0
4541824|NCT01144377|7365479|FG000|52 Week Treatment Period|Withdrawal by Subject|4
4541825|NCT01144377|7365480|FG001|52 Week Treatment Period|Withdrawal by Subject|1
4541826|NCT01144377|7365481|FG002|52 Week Treatment Period|Withdrawal by Subject|1
4541827|NCT01144377|7365482|FG003|52 Week Treatment Period|Withdrawal by Subject|1
4541828|NCT01144377|7365483|FG004|52 Week Treatment Period|Withdrawal by Subject|0
4541829|NCT01144377|7365479|FG000|52 Week Treatment Period|Sponsor Decision|0
4541830|NCT01144377|7365480|FG001|52 Week Treatment Period|Sponsor Decision|0
4541831|NCT01144377|7365481|FG002|52 Week Treatment Period|Sponsor Decision|0
4541832|NCT01144377|7365482|FG003|52 Week Treatment Period|Sponsor Decision|0
4541833|NCT01144377|7365483|FG004|52 Week Treatment Period|Sponsor Decision|1
4541834|NCT01144377|7365479|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0
4541835|NCT01144377|7365480|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1
4541836|NCT01144377|7365481|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0
4541837|NCT01144377|7365482|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0
4541838|NCT01144377|7365483|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1
4541839|NCT01144377|7365479|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
4541840|NCT01144377|7365480|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
4541841|NCT01144377|7365481|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
4541842|NCT01144377|7365482|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
4541843|NCT01144377|7365483|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1
4541844|NCT01144377|7365479|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1
4541845|NCT01144377|7365480|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
4541846|NCT01144377|7365481|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
4541847|NCT01144377|7365482|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
4541848|NCT01144377|7365483|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
4541849|NCT01144403|7365497|FG000|Overall Study|Lost to Follow-up|3
4541850|NCT01144403|7365497|FG000|Overall Study|Death|1
4541851|NCT01144403|7365497|FG000|Overall Study|Adverse Event|1
4541852|NCT01144663|7365569|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2
4541853|NCT01144663|7365570|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0
4541854|NCT01144663|7365571|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1
4541855|NCT01144663|7365572|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0
4541856|NCT01144663|7365569|FG000|Primary Vaccination Phase|Adverse Event|1
4541857|NCT01144663|7365570|FG001|Primary Vaccination Phase|Adverse Event|0
4541858|NCT01144663|7365571|FG002|Primary Vaccination Phase|Adverse Event|0
4541859|NCT01144663|7365572|FG003|Primary Vaccination Phase|Adverse Event|1
4541860|NCT01144663|7365569|FG000|Primary Vaccination Phase|Protocol Violation|2
4541861|NCT01144663|7365570|FG001|Primary Vaccination Phase|Protocol Violation|0
4541862|NCT01144663|7365571|FG002|Primary Vaccination Phase|Protocol Violation|1
4541863|NCT01144663|7365572|FG003|Primary Vaccination Phase|Protocol Violation|0
4541864|NCT01144663|7365569|FG000|Primary Vaccination Phase|Withdrawal by Subject|9
4541865|NCT01144663|7365570|FG001|Primary Vaccination Phase|Withdrawal by Subject|5
4541866|NCT01144663|7365571|FG002|Primary Vaccination Phase|Withdrawal by Subject|3
4541867|NCT01144663|7365572|FG003|Primary Vaccination Phase|Withdrawal by Subject|10
4541868|NCT01144663|7365569|FG000|Primary Vaccination Phase|Migrated/moved from study area|4
4541869|NCT01144663|7365570|FG001|Primary Vaccination Phase|Migrated/moved from study area|1
4541870|NCT01144663|7365571|FG002|Primary Vaccination Phase|Migrated/moved from study area|2
4541871|NCT01144663|7365572|FG003|Primary Vaccination Phase|Migrated/moved from study area|3
4541872|NCT01144663|7365569|FG000|Primary Vaccination Phase|Lost to Follow-up|2
4541873|NCT01144663|7365570|FG001|Primary Vaccination Phase|Lost to Follow-up|0
4541874|NCT01144663|7365571|FG002|Primary Vaccination Phase|Lost to Follow-up|1
4541875|NCT01144663|7365572|FG003|Primary Vaccination Phase|Lost to Follow-up|2
4541876|NCT01144663|7365569|FG000|Primary Vaccination Phase|Other|0
4541877|NCT01144663|7365570|FG001|Primary Vaccination Phase|Other|1
4541878|NCT01144663|7365571|FG002|Primary Vaccination Phase|Other|0
4541879|NCT01144663|7365572|FG003|Primary Vaccination Phase|Other|2
4541880|NCT01144663|7365569|FG000|Booster Vaccination Phase|Withdrawal by Subject|0
4541881|NCT01144663|7365570|FG001|Booster Vaccination Phase|Withdrawal by Subject|0
4541882|NCT01144663|7365571|FG002|Booster Vaccination Phase|Withdrawal by Subject|1
4541883|NCT01144663|7365572|FG003|Booster Vaccination Phase|Withdrawal by Subject|1
4541884|NCT01144663|7365569|FG000|Booster Vaccination Phase|Migrated/moved from study area|1
4541885|NCT01144663|7365570|FG001|Booster Vaccination Phase|Migrated/moved from study area|1
4541886|NCT01144663|7365571|FG002|Booster Vaccination Phase|Migrated/moved from study area|1
4541887|NCT01144663|7365572|FG003|Booster Vaccination Phase|Migrated/moved from study area|0
4541888|NCT01144663|7365569|FG000|Booster Vaccination Phase|Lost to Follow-up|2
4541889|NCT01144663|7365570|FG001|Booster Vaccination Phase|Lost to Follow-up|1
4541890|NCT01144663|7365571|FG002|Booster Vaccination Phase|Lost to Follow-up|3
4541891|NCT01144663|7365572|FG003|Booster Vaccination Phase|Lost to Follow-up|0
4541892|NCT01144663|7365569|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0
4541893|NCT01144663|7365570|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0
4541894|NCT01144663|7365571|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1
4541895|NCT01144663|7365572|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1
4541896|NCT01144663|7365569|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1
4541897|NCT01144663|7365570|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3
4541898|NCT01144663|7365571|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1
4541899|NCT01144663|7365572|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0
4541900|NCT01144663|7365569|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4
4541901|NCT01144663|7365570|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6
4541902|NCT01144663|7365571|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5
4541903|NCT01144663|7365572|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0
4541904|NCT01144715|7365584|FG000|Overall Study|Lost to Follow-up|2
4541905|NCT01144715|7365585|FG001|Overall Study|Lost to Follow-up|1
4541906|NCT01144715|7365584|FG000|Overall Study|Withdrawal by Subject|2
4541907|NCT01144715|7365585|FG001|Overall Study|Withdrawal by Subject|1
4541908|NCT01144715|7365584|FG000|Overall Study|Adverse Event|0
4541909|NCT01144715|7365585|FG001|Overall Study|Adverse Event|1
4541910|NCT01145053|7365617|FG000|Overall Study|Adverse Event|22
4541911|NCT01145053|7365617|FG000|Overall Study|Lost to Follow-up|28
4617084|NCT01746901|7476545|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0
4617085|NCT01746901|7476546|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3
4617086|NCT01746901|7476547|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0
4617087|NCT01746901|7476548|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0
4541912|NCT01145053|7365617|FG000|Overall Study|Withdrawal by Subject|25
4541913|NCT01145053|7365617|FG000|Overall Study|Other|18
4541914|NCT01145066|7365624|FG000|Overall Study|To resume NSAIDs|2
4541915|NCT01145066|7365625|FG001|Overall Study|To resume NSAIDs|2
4541916|NCT01145066|7365626|FG002|Overall Study|To resume NSAIDs|1
4541917|NCT01145066|7365624|FG000|Overall Study|Non-related surgery|0
4541918|NCT01145066|7365625|FG001|Overall Study|Non-related surgery|0
4541919|NCT01145066|7365626|FG002|Overall Study|Non-related surgery|1
4541920|NCT01145066|7365624|FG000|Overall Study|Withdrawal by Subject|0
4541921|NCT01145066|7365625|FG001|Overall Study|Withdrawal by Subject|0
4541922|NCT01145066|7365626|FG002|Overall Study|Withdrawal by Subject|2
4541923|NCT01145066|7365624|FG000|Overall Study|To start new med|1
4541924|NCT01145066|7365625|FG001|Overall Study|To start new med|0
4541925|NCT01145066|7365626|FG002|Overall Study|To start new med|0
4541926|NCT01145066|7365624|FG000|Overall Study|problems swallowing capsule|1
4541927|NCT01145066|7365625|FG001|Overall Study|problems swallowing capsule|0
4617088|NCT01746901|7476549|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0
4617089|NCT01746901|7476550|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0
4617090|NCT01746901|7476551|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0
4541928|NCT01145066|7365626|FG002|Overall Study|problems swallowing capsule|0
4541929|NCT01145066|7365624|FG000|Overall Study|Abdominal discomfort|0
4541930|NCT01145066|7365625|FG001|Overall Study|Abdominal discomfort|1
4541931|NCT01145066|7365626|FG002|Overall Study|Abdominal discomfort|0
4541932|NCT01145066|7365624|FG000|Overall Study|Low platelet count|0
4541933|NCT01145066|7365625|FG001|Overall Study|Low platelet count|1
4541934|NCT01145066|7365626|FG002|Overall Study|Low platelet count|0
4541935|NCT01145222|7365655|FG000|Overall Study|Procedure not done (no anesthesiologist)|0
4541936|NCT01145222|7365656|FG001|Overall Study|Procedure not done (no anesthesiologist)|0
4541937|NCT01145222|7365657|FG002|Overall Study|Procedure not done (no anesthesiologist)|1
4541938|NCT01145222|7365658|FG003|Overall Study|Procedure not done (no anesthesiologist)|0
4541939|NCT01145222|7365655|FG000|Overall Study|Poor bowel preparation|0
4541940|NCT01145222|7365656|FG001|Overall Study|Poor bowel preparation|0
4541941|NCT01145222|7365657|FG002|Overall Study|Poor bowel preparation|0
4541942|NCT01145222|7365658|FG003|Overall Study|Poor bowel preparation|1
4541943|NCT01145352|7365668|FG000|Overall Study|Found to have been registered twice|6
4541944|NCT01145352|7365668|FG000|Overall Study|Treated before marketing approval|4
4541945|NCT01145352|7365668|FG000|Overall Study|Syringe formulation was used|1
4541946|NCT01145417|7365685|FG000|Overall Study|Death|1
4541947|NCT01145417|7365686|FG001|Overall Study|Death|0
4541948|NCT01145417|7365685|FG000|Overall Study|Lost to Follow-up|2
4541949|NCT01145417|7365686|FG001|Overall Study|Lost to Follow-up|1
4541950|NCT01145417|7365685|FG000|Overall Study|Withdrawal by Subject|1
4541951|NCT01145417|7365686|FG001|Overall Study|Withdrawal by Subject|2
4541952|NCT01145417|7365685|FG000|Overall Study|Pregnancy|1
4541953|NCT01145417|7365686|FG001|Overall Study|Pregnancy|0
4541954|NCT01145417|7365685|FG000|Overall Study|Adverse Event|0
4541955|NCT01145417|7365686|FG001|Overall Study|Adverse Event|1
4541956|NCT01145417|7365685|FG000|Overall Study|Study terminated by sponsor|35
4541957|NCT01145417|7365686|FG001|Overall Study|Study terminated by sponsor|43
4541958|NCT01145417|7365685|FG000|Overall Study|Other|1
4541959|NCT01145417|7365686|FG001|Overall Study|Other|0
4541960|NCT01145482|7365694|FG000|First Intervention (1 Day)|Withdrawal by Subject|0
4541961|NCT01145482|7365695|FG001|First Intervention (1 Day)|Withdrawal by Subject|1
4541962|NCT01145508|7365703|FG000|Overall Study|Adverse Event|1
4541963|NCT01145508|7365704|FG001|Overall Study|Adverse Event|0
4541964|NCT01145508|7365703|FG000|Overall Study|Death|1
4541965|NCT01145508|7365704|FG001|Overall Study|Death|0
4541966|NCT01145508|7365703|FG000|Overall Study|Physician Decision|2
4541967|NCT01145508|7365704|FG001|Overall Study|Physician Decision|1
4541968|NCT01145508|7365703|FG000|Overall Study|Never started treatment|1
4541969|NCT01145508|7365704|FG001|Overall Study|Never started treatment|1
4541970|NCT01145560|7365720|FG000|Overall Study|Withdrawal by Subject|2
4541971|NCT01145560|7365721|FG001|Overall Study|Withdrawal by Subject|1
4541972|NCT01145560|7365722|FG002|Overall Study|Withdrawal by Subject|0
4541973|NCT01145560|7365720|FG000|Overall Study|Lost to Follow-up|1
4541974|NCT01145560|7365721|FG001|Overall Study|Lost to Follow-up|1
4541975|NCT01145560|7365722|FG002|Overall Study|Lost to Follow-up|1
4541976|NCT01145560|7365720|FG000|Overall Study|No study drug by 24h after organ failure|1
4541977|NCT01145560|7365721|FG001|Overall Study|No study drug by 24h after organ failure|0
4541978|NCT01145560|7365722|FG002|Overall Study|No study drug by 24h after organ failure|0
4541979|NCT01145560|7365720|FG000|Overall Study|Accidental unblinding of study treatment|0
4541980|NCT01145560|7365721|FG001|Overall Study|Accidental unblinding of study treatment|1
4541981|NCT01145560|7365722|FG002|Overall Study|Accidental unblinding of study treatment|0
4541982|NCT01145560|7365720|FG000|Overall Study|False insurance information|0
4541983|NCT01145560|7365721|FG001|Overall Study|False insurance information|1
4541984|NCT01145560|7365722|FG002|Overall Study|False insurance information|0
4617091|NCT01746901|7476552|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0
4617092|NCT01746901|7476553|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0
4617093|NCT01746901|7476545|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0
4617094|NCT01746901|7476546|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2
4617095|NCT01746901|7476547|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1
4617096|NCT01746901|7476548|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0
4617097|NCT01746901|7476549|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0
4617098|NCT01746901|7476550|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0
4617099|NCT01746901|7476551|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0
4617100|NCT01746901|7476552|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0
4617101|NCT01746901|7476553|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0
4617102|NCT01746901|7476545|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
4617103|NCT01746901|7476546|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9
4617104|NCT01746901|7476547|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10
4617105|NCT01746901|7476548|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
4541985|NCT01145560|7365720|FG000|Overall Study|Withdrawal of therapy|0
4541986|NCT01145560|7365721|FG001|Overall Study|Withdrawal of therapy|0
4541987|NCT01145560|7365722|FG002|Overall Study|Withdrawal of therapy|1
4541988|NCT01145625|7365732|FG000|Overall Study|Lost to Follow-up|8
4541989|NCT01145625|7365733|FG001|Overall Study|Lost to Follow-up|9
4541990|NCT01145625|7365732|FG000|Overall Study|Adverse Event|6
4541991|NCT01145625|7365733|FG001|Overall Study|Adverse Event|4
4541992|NCT01145625|7365732|FG000|Overall Study|Protocol Violation|3
4541993|NCT01145625|7365733|FG001|Overall Study|Protocol Violation|1
4541994|NCT01145625|7365732|FG000|Overall Study|Withdrawal by Subject|7
4541995|NCT01145625|7365733|FG001|Overall Study|Withdrawal by Subject|16
4541996|NCT01145625|7365732|FG000|Overall Study|Pregnancy|0
4541997|NCT01145625|7365733|FG001|Overall Study|Pregnancy|1
4541998|NCT01145755|7365751|FG000|Overall Study|Adverse Event|2
4541999|NCT01145755|7365752|FG001|Overall Study|Adverse Event|4
4542000|NCT01145755|7365753|FG002|Overall Study|Adverse Event|2
4542001|NCT01145755|7365751|FG000|Overall Study|Withdrawal by Subject|2
4542002|NCT01145755|7365752|FG001|Overall Study|Withdrawal by Subject|2
4542003|NCT01145755|7365753|FG002|Overall Study|Withdrawal by Subject|2
4542004|NCT01145755|7365751|FG000|Overall Study|Lost to Follow-up|2
4542005|NCT01145755|7365752|FG001|Overall Study|Lost to Follow-up|3
4542006|NCT01145755|7365753|FG002|Overall Study|Lost to Follow-up|1
4542007|NCT01145755|7365751|FG000|Overall Study|Protocol Violation|0
4542008|NCT01145755|7365752|FG001|Overall Study|Protocol Violation|3
4542009|NCT01145755|7365753|FG002|Overall Study|Protocol Violation|1
4542010|NCT01145755|7365751|FG000|Overall Study|Study Closure|14
4542011|NCT01145755|7365752|FG001|Overall Study|Study Closure|14
4542012|NCT01145755|7365753|FG002|Overall Study|Study Closure|17
4542013|NCT01145755|7365751|FG000|Overall Study|Lack of Efficacy|0
4542014|NCT01145755|7365752|FG001|Overall Study|Lack of Efficacy|1
4542015|NCT01145755|7365753|FG002|Overall Study|Lack of Efficacy|0
4542016|NCT01145755|7365751|FG000|Overall Study|Patient could not swollow medication|0
4542017|NCT01145755|7365752|FG001|Overall Study|Patient could not swollow medication|0
4542018|NCT01145755|7365753|FG002|Overall Study|Patient could not swollow medication|1
4542019|NCT01145755|7365751|FG000|Overall Study|Withdrawal by Subject|0
4542020|NCT01145755|7365752|FG001|Overall Study|Withdrawal by Subject|0
4542021|NCT01145755|7365753|FG002|Overall Study|Withdrawal by Subject|1
4542022|NCT01145755|7365751|FG000|Overall Study|Positive urine ethanol|0
4542023|NCT01145755|7365752|FG001|Overall Study|Positive urine ethanol|1
4542024|NCT01145755|7365753|FG002|Overall Study|Positive urine ethanol|0
4542025|NCT01145885|7365770|FG000|Overall Study|Progressive Disease|7
4542026|NCT01145898|7365782|FG000|3-year Treatment|medication change by treating physician|3
4542027|NCT01145898|7365783|FG001|3-year Treatment|medication change by treating physician|16
4542028|NCT01146054|7365788|FG000|Overall Study|Did not meet dose constraints for SBRT|5
4542029|NCT01146054|7365788|FG000|Overall Study|Rapid tumor progression|2
4542030|NCT01146054|7365788|FG000|Overall Study|Other illness precluded treatment|2
4542031|NCT01146054|7365788|FG000|Overall Study|Lost to Follow-up|1
4542032|NCT01146288|7365799|FG000|First Intervention(1 Day)|Adverse Event|0
4542033|NCT01146288|7365800|FG001|First Intervention(1 Day)|Adverse Event|1
4542034|NCT01146561|7365855|FG000|Overall Study|Withdrawal by Subject|1
4617106|NCT01746901|7476549|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
4617107|NCT01746901|7476550|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
4617108|NCT01746901|7476551|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
4617109|NCT01746901|7476552|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
4617110|NCT01746901|7476553|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
4617111|NCT01746901|7476545|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0
4617112|NCT01746901|7476546|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3
4617113|NCT01746901|7476547|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3
4617114|NCT01746901|7476548|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0
4617115|NCT01746901|7476549|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0
4617116|NCT01746901|7476550|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0
4617117|NCT01746901|7476551|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0
4617118|NCT01746901|7476552|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0
4617119|NCT01746901|7476553|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0
4617120|NCT01746901|7476545|FG000|Treatment Phase: First Intervention|Protocol Violation|0
4617121|NCT01746901|7476546|FG001|Treatment Phase: First Intervention|Protocol Violation|0
4617122|NCT01746901|7476547|FG002|Treatment Phase: First Intervention|Protocol Violation|0
4617123|NCT01746901|7476548|FG003|Treatment Phase: First Intervention|Protocol Violation|0
4617124|NCT01746901|7476549|FG004|Treatment Phase: First Intervention|Protocol Violation|0
4617125|NCT01746901|7476550|FG005|Treatment Phase: First Intervention|Protocol Violation|0
4617126|NCT01746901|7476551|FG006|Treatment Phase: First Intervention|Protocol Violation|1
4617127|NCT01746901|7476552|FG007|Treatment Phase: First Intervention|Protocol Violation|0
4617128|NCT01746901|7476553|FG008|Treatment Phase: First Intervention|Protocol Violation|0
4617129|NCT01746901|7476545|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0
4617130|NCT01746901|7476546|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0
4617131|NCT01746901|7476547|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0
4542035|NCT01146561|7365855|FG000|Overall Study|Lost to Follow-up|1
4542036|NCT01146613|7365871|FG000|Overall Study|Lost to Follow-up|3
4542037|NCT01146613|7365872|FG001|Overall Study|Lost to Follow-up|8
4542038|NCT01146613|7365871|FG000|Overall Study|Lack of Efficacy|0
4542039|NCT01146613|7365872|FG001|Overall Study|Lack of Efficacy|1
4542040|NCT01146613|7365871|FG000|Overall Study|Death|1
4542041|NCT01146613|7365872|FG001|Overall Study|Death|0
4542042|NCT01146613|7365871|FG000|Overall Study|Physician Decision|1
4542043|NCT01146613|7365872|FG001|Overall Study|Physician Decision|0
4542044|NCT01146613|7365871|FG000|Overall Study|Withdrawal by Subject|0
4617132|NCT01746901|7476548|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0
4542045|NCT01146613|7365872|FG001|Overall Study|Withdrawal by Subject|3
4542046|NCT01146613|7365871|FG000|Overall Study|schedule conflict|1
4542047|NCT01146613|7365872|FG001|Overall Study|schedule conflict|0
4542048|NCT01146613|7365871|FG000|Overall Study|Outpatient detox|1
4542049|NCT01146613|7365872|FG001|Overall Study|Outpatient detox|0
4542050|NCT01146665|7365880|FG000|Overall Study|Withdrawal by Subject|10
4542051|NCT01146665|7365881|FG001|Overall Study|Withdrawal by Subject|16
4542052|NCT01146782|7365905|FG000|Screening Cohort|Screen Failure|187
4542053|NCT01146782|7365905|FG000|Screening Cohort|Lost to Follow-up|4
4542054|NCT01146782|7365905|FG000|Screening Cohort|Physician Decision|1
4542055|NCT01146782|7365905|FG000|Screening Cohort|Withdrawal by Subject|29
4542056|NCT01146782|7365905|FG000|Safety Cohort|Screen Failure|61
4542057|NCT01146782|7365905|FG000|Safety Cohort|Withdrawal by Subject|4
4542058|NCT01146782|7365905|FG000|Safety Cohort|Control AHI <5|4
4542059|NCT01146782|7365905|FG000|Safety Cohort|TST <4 hrs|14
4542060|NCT01146782|7365905|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5
4542061|NCT01146782|7365905|FG000|Primary Endpoint Cohort|Physician Decision|1
4542062|NCT01146795|7365910|FG000|Overall Study|Withdrawal by Subject|4
4542063|NCT01146795|7365910|FG000|Overall Study|Adverse Event|6
4542064|NCT01146795|7365910|FG000|Overall Study|Still in treatment at study closure|10
4542065|NCT01146860|7365941|FG000|Overall Study|Withdrawal by Subject|0
4542066|NCT01146860|7365942|FG001|Overall Study|Withdrawal by Subject|1
4542067|NCT01146873|7365950|FG000|Overall Study|Transfer out|0
4542068|NCT01146873|7365951|FG001|Overall Study|Transfer out|6
4542069|NCT01146912|7365964|FG000|Overall Study|Already received influenza vaccination|817
4542070|NCT01146912|7365965|FG001|Overall Study|Already received influenza vaccination|822
4542071|NCT01146912|7365966|FG002|Overall Study|Already received influenza vaccination|13
4542072|NCT01146912|7365967|FG003|Overall Study|Already received influenza vaccination|15
4542073|NCT01146912|7365968|FG004|Overall Study|Already received influenza vaccination|41
4542074|NCT01146912|7365969|FG005|Overall Study|Already received influenza vaccination|61
4542075|NCT01146912|7365970|FG006|Overall Study|Already received influenza vaccination|56
4542076|NCT01146912|7365971|FG007|Overall Study|Already received influenza vaccination|0
4542077|NCT01146912|7365964|FG000|Overall Study|< 14 weeks gestational age|0
4542078|NCT01146912|7365965|FG001|Overall Study|< 14 weeks gestational age|0
4542079|NCT01146912|7365966|FG002|Overall Study|< 14 weeks gestational age|3
4542080|NCT01146912|7365967|FG003|Overall Study|< 14 weeks gestational age|2
4542081|NCT01146912|7365968|FG004|Overall Study|< 14 weeks gestational age|0
4542082|NCT01146912|7365969|FG005|Overall Study|< 14 weeks gestational age|0
4542083|NCT01146912|7365970|FG006|Overall Study|< 14 weeks gestational age|0
4542084|NCT01146912|7365971|FG007|Overall Study|< 14 weeks gestational age|0
4542085|NCT01146912|7365964|FG000|Overall Study|Duplicate patient|0
4542086|NCT01146912|7365965|FG001|Overall Study|Duplicate patient|0
4542087|NCT01146912|7365966|FG002|Overall Study|Duplicate patient|1
4542088|NCT01146912|7365967|FG003|Overall Study|Duplicate patient|0
4542089|NCT01146912|7365968|FG004|Overall Study|Duplicate patient|0
4542090|NCT01146912|7365969|FG005|Overall Study|Duplicate patient|0
4542091|NCT01146912|7365970|FG006|Overall Study|Duplicate patient|0
4542092|NCT01146912|7365971|FG007|Overall Study|Duplicate patient|0
4542093|NCT01146951|7365992|FG000|Overall Study|Adverse Event|4
4542094|NCT01146951|7365993|FG001|Overall Study|Adverse Event|1
4542095|NCT01147055|7365999|FG000|First Intervention Period|Lost to Follow-up|1
4542096|NCT01147055|7366000|FG001|First Intervention Period|Lost to Follow-up|0
4591354|NCT01529515|7437935|FG001|TRANSITION PHASE|Adverse Event|0
4591355|NCT01529515|7437936|FG002|TRANSITION PHASE|Adverse Event|0
4591356|NCT01529515|7437937|FG003|TRANSITION PHASE|Adverse Event|0
4591357|NCT01529515|7437934|FG000|TRANSITION PHASE|Death|1
4591358|NCT01529515|7437935|FG001|TRANSITION PHASE|Death|0
4591359|NCT01529515|7437936|FG002|TRANSITION PHASE|Death|0
4591360|NCT01529515|7437937|FG003|TRANSITION PHASE|Death|0
4591361|NCT01529515|7437934|FG000|TRANSITION PHASE|Lack of Efficacy|19
4591362|NCT01529515|7437935|FG001|TRANSITION PHASE|Lack of Efficacy|0
4591363|NCT01529515|7437936|FG002|TRANSITION PHASE|Lack of Efficacy|0
4591364|NCT01529515|7437937|FG003|TRANSITION PHASE|Lack of Efficacy|0
4591365|NCT01529515|7437934|FG000|TRANSITION PHASE|Lost to Follow-up|19
4591366|NCT01529515|7437935|FG001|TRANSITION PHASE|Lost to Follow-up|0
4591367|NCT01529515|7437936|FG002|TRANSITION PHASE|Lost to Follow-up|0
4591368|NCT01529515|7437937|FG003|TRANSITION PHASE|Lost to Follow-up|0
4591369|NCT01529515|7437934|FG000|TRANSITION PHASE|Protocol Violation|4
4591370|NCT01529515|7437935|FG001|TRANSITION PHASE|Protocol Violation|0
4591371|NCT01529515|7437936|FG002|TRANSITION PHASE|Protocol Violation|0
4591372|NCT01529515|7437937|FG003|TRANSITION PHASE|Protocol Violation|0
4591373|NCT01529515|7437934|FG000|TRANSITION PHASE|Withdrawal by Subject|51
4591374|NCT01529515|7437935|FG001|TRANSITION PHASE|Withdrawal by Subject|0
4591375|NCT01529515|7437936|FG002|TRANSITION PHASE|Withdrawal by Subject|0
4591376|NCT01529515|7437937|FG003|TRANSITION PHASE|Withdrawal by Subject|0
4617133|NCT01746901|7476549|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0
4591377|NCT01529515|7437934|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8
4591378|NCT01529515|7437935|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
4591379|NCT01529515|7437936|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
4591380|NCT01529515|7437937|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
4591381|NCT01529515|7437934|FG000|TRANSITION PHASE|Other|9
4591382|NCT01529515|7437935|FG001|TRANSITION PHASE|Other|0
4591383|NCT01529515|7437936|FG002|TRANSITION PHASE|Other|0
4591384|NCT01529515|7437937|FG003|TRANSITION PHASE|Other|0
4542097|NCT01147068|7366013|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1
4542098|NCT01147068|7366014|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0
4542099|NCT01147068|7366015|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0
4542100|NCT01147068|7366016|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0
4542101|NCT01147068|7366017|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0
4542102|NCT01147068|7366018|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1
4542103|NCT01147068|7366019|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0
4542104|NCT01147068|7366013|FG000|Subjects That Received 2nd Dose|Ineligible|0
4542105|NCT01147068|7366014|FG001|Subjects That Received 2nd Dose|Ineligible|1
4542106|NCT01147068|7366015|FG002|Subjects That Received 2nd Dose|Ineligible|0
4542107|NCT01147068|7366016|FG003|Subjects That Received 2nd Dose|Ineligible|0
4542108|NCT01147068|7366017|FG004|Subjects That Received 2nd Dose|Ineligible|0
4542109|NCT01147068|7366018|FG005|Subjects That Received 2nd Dose|Ineligible|0
4542110|NCT01147068|7366019|FG006|Subjects That Received 2nd Dose|Ineligible|0
4542111|NCT01147068|7366013|FG000|Subjects That Received 2nd Dose|Did not complete the study|0
4542112|NCT01147068|7366014|FG001|Subjects That Received 2nd Dose|Did not complete the study|1
4542113|NCT01147068|7366015|FG002|Subjects That Received 2nd Dose|Did not complete the study|0
4542114|NCT01147068|7366016|FG003|Subjects That Received 2nd Dose|Did not complete the study|0
4542115|NCT01147068|7366017|FG004|Subjects That Received 2nd Dose|Did not complete the study|0
4542116|NCT01147068|7366018|FG005|Subjects That Received 2nd Dose|Did not complete the study|1
4542117|NCT01147068|7366019|FG006|Subjects That Received 2nd Dose|Did not complete the study|0
4542118|NCT01147068|7366013|FG000|Subjects That Received 2nd Dose|Other|0
4542119|NCT01147068|7366014|FG001|Subjects That Received 2nd Dose|Other|3
4542120|NCT01147068|7366015|FG002|Subjects That Received 2nd Dose|Other|3
4617134|NCT01746901|7476550|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0
4617135|NCT01746901|7476551|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0
4617136|NCT01746901|7476552|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1
4542121|NCT01147068|7366016|FG003|Subjects That Received 2nd Dose|Other|0
4542122|NCT01147068|7366017|FG004|Subjects That Received 2nd Dose|Other|1
4542123|NCT01147068|7366018|FG005|Subjects That Received 2nd Dose|Other|0
4542124|NCT01147068|7366019|FG006|Subjects That Received 2nd Dose|Other|0
4542125|NCT01147068|7366013|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
4542126|NCT01147068|7366014|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
4542127|NCT01147068|7366015|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
4542128|NCT01147068|7366016|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
4542129|NCT01147068|7366017|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
4542130|NCT01147068|7366018|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
4542131|NCT01147068|7366019|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
4542132|NCT01147068|7366013|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
4542133|NCT01147068|7366014|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
4542134|NCT01147068|7366015|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
4542135|NCT01147068|7366016|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2
4542136|NCT01147068|7366017|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
4542137|NCT01147068|7366018|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
4542138|NCT01147068|7366019|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
4542139|NCT01147068|7366013|FG000|Subjects That Completed Safety Follow-up|Ineligible|0
4542140|NCT01147068|7366014|FG001|Subjects That Completed Safety Follow-up|Ineligible|1
4542141|NCT01147068|7366015|FG002|Subjects That Completed Safety Follow-up|Ineligible|0
4542142|NCT01147068|7366016|FG003|Subjects That Completed Safety Follow-up|Ineligible|0
4542143|NCT01147068|7366017|FG004|Subjects That Completed Safety Follow-up|Ineligible|0
4542144|NCT01147068|7366018|FG005|Subjects That Completed Safety Follow-up|Ineligible|0
4542145|NCT01147068|7366019|FG006|Subjects That Completed Safety Follow-up|Ineligible|0
4542146|NCT01147107|7366037|FG000|Overall Study|Lack of Efficacy|5
4542147|NCT01147107|7366038|FG001|Overall Study|Lack of Efficacy|0
4542148|NCT01147107|7366037|FG000|Overall Study|Withdrawal by Subject|1
4542149|NCT01147107|7366038|FG001|Overall Study|Withdrawal by Subject|1
4542150|NCT01147172|7366044|FG000|Overall Study|Withdrawal by Subject|2
4542151|NCT01147172|7366044|FG000|Overall Study|Lost to Follow-up|2
4542152|NCT01147250|7366052|FG000|Overall Study|Lost to Follow-up|14
4542153|NCT01147250|7366053|FG001|Overall Study|Lost to Follow-up|11
4542154|NCT01147250|7366052|FG000|Overall Study|Withdrawal by Subject|83
4542155|NCT01147250|7366053|FG001|Overall Study|Withdrawal by Subject|88
4542156|NCT01147250|7366052|FG000|Overall Study|Site termination by sponsor|13
4542157|NCT01147250|7366053|FG001|Overall Study|Site termination by sponsor|5
4542158|NCT01147250|7366052|FG000|Overall Study|Other than specified|0
4542159|NCT01147250|7366053|FG001|Overall Study|Other than specified|1
4542160|NCT01147341|7366070|FG000|Double Blind Period|Lack of Efficacy|1
4542161|NCT01147341|7366071|FG001|Double Blind Period|Lack of Efficacy|1
4542162|NCT01147341|7366070|FG000|Double Blind Period|Withdrawal by Subject|0
4542163|NCT01147341|7366071|FG001|Double Blind Period|Withdrawal by Subject|1
4542164|NCT01147341|7366070|FG000|Open Label Period|Lack of Efficacy|3
4542165|NCT01147341|7366071|FG001|Open Label Period|Lack of Efficacy|0
4542166|NCT01147341|7366070|FG000|Open Label Period|Subject moved|1
4542167|NCT01147341|7366071|FG001|Open Label Period|Subject moved|0
4542168|NCT01147458|7366114|FG000|First Intervention|Study terminated by sponsor|8
4542169|NCT01147458|7366115|FG001|First Intervention|Study terminated by sponsor|8
4542170|NCT01147458|7366116|FG002|First Intervention|Study terminated by sponsor|7
4542171|NCT01147458|7366117|FG003|First Intervention|Study terminated by sponsor|8
4542172|NCT01147458|7366114|FG000|First Intervention|Protocol Violation|2
4542173|NCT01147458|7366115|FG001|First Intervention|Protocol Violation|3
4542174|NCT01147458|7366116|FG002|First Intervention|Protocol Violation|2
4542175|NCT01147458|7366117|FG003|First Intervention|Protocol Violation|3
4542176|NCT01147458|7366114|FG000|First Intervention|Withdrawal by Subject|3
4542177|NCT01147458|7366115|FG001|First Intervention|Withdrawal by Subject|0
4542178|NCT01147458|7366116|FG002|First Intervention|Withdrawal by Subject|1
4542179|NCT01147458|7366117|FG003|First Intervention|Withdrawal by Subject|0
4542180|NCT01147458|7366114|FG000|First Intervention|Adverse Event|0
4542181|NCT01147458|7366115|FG001|First Intervention|Adverse Event|3
4542182|NCT01147458|7366116|FG002|First Intervention|Adverse Event|2
4542183|NCT01147458|7366117|FG003|First Intervention|Adverse Event|3
4542184|NCT01147458|7366114|FG000|First Intervention|Other|1
4542185|NCT01147458|7366115|FG001|First Intervention|Other|2
4542186|NCT01147458|7366116|FG002|First Intervention|Other|0
4542187|NCT01147458|7366117|FG003|First Intervention|Other|0
4542188|NCT01147458|7366114|FG000|Second Intervention|Study terminated by sponsor|7
4542189|NCT01147458|7366115|FG001|Second Intervention|Study terminated by sponsor|5
4542190|NCT01147458|7366116|FG002|Second Intervention|Study terminated by sponsor|5
4542191|NCT01147458|7366117|FG003|Second Intervention|Study terminated by sponsor|3
4542192|NCT01147458|7366114|FG000|Second Intervention|Protocol Violation|0
4542193|NCT01147458|7366115|FG001|Second Intervention|Protocol Violation|1
4542194|NCT01147458|7366116|FG002|Second Intervention|Protocol Violation|1
4542195|NCT01147458|7366117|FG003|Second Intervention|Protocol Violation|0
4542196|NCT01147458|7366114|FG000|Second Intervention|Withdrawal by Subject|0
4542197|NCT01147458|7366115|FG001|Second Intervention|Withdrawal by Subject|1
4542198|NCT01147458|7366116|FG002|Second Intervention|Withdrawal by Subject|0
4542199|NCT01147458|7366117|FG003|Second Intervention|Withdrawal by Subject|0
4542200|NCT01147458|7366114|FG000|Second Intervention|Adverse Event|2
4542201|NCT01147458|7366115|FG001|Second Intervention|Adverse Event|0
4542202|NCT01147458|7366116|FG002|Second Intervention|Adverse Event|1
4617137|NCT01746901|7476553|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0
4617138|NCT01746901|7476545|FG000|Treatment Phase: Third Intervention|Protocol Violation|0
4617139|NCT01746901|7476546|FG001|Treatment Phase: Third Intervention|Protocol Violation|0
4617140|NCT01746901|7476547|FG002|Treatment Phase: Third Intervention|Protocol Violation|0
4617141|NCT01746901|7476548|FG003|Treatment Phase: Third Intervention|Protocol Violation|0
4617142|NCT01746901|7476549|FG004|Treatment Phase: Third Intervention|Protocol Violation|0
4617143|NCT01746901|7476550|FG005|Treatment Phase: Third Intervention|Protocol Violation|1
4617144|NCT01746901|7476551|FG006|Treatment Phase: Third Intervention|Protocol Violation|1
4617145|NCT01746901|7476552|FG007|Treatment Phase: Third Intervention|Protocol Violation|0
4617146|NCT01746901|7476553|FG008|Treatment Phase: Third Intervention|Protocol Violation|0
4617147|NCT01746901|7476545|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
4617148|NCT01746901|7476546|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
4617149|NCT01746901|7476547|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
4617150|NCT01746901|7476548|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1
4617151|NCT01746901|7476549|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
4617152|NCT01746901|7476550|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
4617153|NCT01746901|7476551|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
4617154|NCT01746901|7476552|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
4617155|NCT01746901|7476553|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
4617156|NCT01746901|7476545|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0
4617157|NCT01746901|7476546|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0
4617158|NCT01746901|7476547|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0
4617159|NCT01746901|7476548|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0
4617160|NCT01746901|7476549|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0
4617161|NCT01746901|7476550|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1
4617162|NCT01746901|7476551|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0
4617163|NCT01746901|7476552|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0
4617164|NCT01746901|7476553|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1
4617165|NCT01746901|7476545|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0
4617166|NCT01746901|7476546|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0
4617167|NCT01746901|7476547|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0
4542203|NCT01147458|7366117|FG003|Second Intervention|Adverse Event|1
4542204|NCT01147458|7366114|FG000|Second Intervention|Other|0
4542205|NCT01147458|7366115|FG001|Second Intervention|Other|0
4542206|NCT01147458|7366116|FG002|Second Intervention|Other|1
4542207|NCT01147458|7366117|FG003|Second Intervention|Other|0
4542208|NCT01147471|7366131|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0
4542209|NCT01147471|7366132|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1
4542210|NCT01147471|7366131|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0
4542211|NCT01147471|7366132|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1
4542212|NCT01147471|7366131|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0
4542213|NCT01147471|7366132|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1
4542214|NCT01147471|7366131|FG000|3 Month Follow Up|Lost to Follow-up|1
4542215|NCT01147471|7366132|FG001|3 Month Follow Up|Lost to Follow-up|1
4542216|NCT01147471|7366131|FG000|3 Month Follow Up|Physician Decision|0
4542217|NCT01147471|7366132|FG001|3 Month Follow Up|Physician Decision|1
4542218|NCT01147471|7366131|FG000|6 Month Follow Up|Lost to Follow-up|4
4542219|NCT01147471|7366132|FG001|6 Month Follow Up|Lost to Follow-up|2
4542220|NCT01147497|7366140|FG000|Overall Study|failed insertion|2
4542221|NCT01147497|7366141|FG001|Overall Study|failed insertion|0
4542222|NCT01147640|7366171|FG000|Overall Study|Adverse Event|2
4542223|NCT01147640|7366172|FG001|Overall Study|Adverse Event|0
4542224|NCT01147640|7366171|FG000|Overall Study|Physician Decision|1
4542225|NCT01147640|7366172|FG001|Overall Study|Physician Decision|0
4542226|NCT01147640|7366171|FG000|Overall Study|Withdrawal by Subject|1
4542227|NCT01147640|7366172|FG001|Overall Study|Withdrawal by Subject|0
4542228|NCT01147640|7366171|FG000|Overall Study|Lost to Follow-up|0
4542229|NCT01147640|7366172|FG001|Overall Study|Lost to Follow-up|1
4542230|NCT01147640|7366171|FG000|Overall Study|Didn't meet eligibility criteria|1
4542231|NCT01147640|7366172|FG001|Overall Study|Didn't meet eligibility criteria|0
4542232|NCT01147744|7366185|FG000|Overall Study|Protocol Violation|1
4542233|NCT01147744|7366186|FG001|Overall Study|Protocol Violation|0
4542234|NCT01147744|7366187|FG002|Overall Study|Protocol Violation|1
4542235|NCT01147744|7366188|FG003|Overall Study|Protocol Violation|0
4542236|NCT01147744|7366189|FG004|Overall Study|Protocol Violation|1
4542237|NCT01147744|7366190|FG005|Overall Study|Protocol Violation|3
4542238|NCT01147744|7366191|FG006|Overall Study|Protocol Violation|1
4542239|NCT01147744|7366185|FG000|Overall Study|Physician Decision|0
4542240|NCT01147744|7366186|FG001|Overall Study|Physician Decision|1
4542241|NCT01147744|7366187|FG002|Overall Study|Physician Decision|1
4542242|NCT01147744|7366188|FG003|Overall Study|Physician Decision|0
4542243|NCT01147744|7366189|FG004|Overall Study|Physician Decision|0
4542244|NCT01147744|7366190|FG005|Overall Study|Physician Decision|0
4542245|NCT01147744|7366191|FG006|Overall Study|Physician Decision|1
4542246|NCT01147744|7366185|FG000|Overall Study|Lack of Efficacy|11
4542247|NCT01147744|7366186|FG001|Overall Study|Lack of Efficacy|11
4542248|NCT01147744|7366187|FG002|Overall Study|Lack of Efficacy|9
4542249|NCT01147744|7366188|FG003|Overall Study|Lack of Efficacy|11
4542250|NCT01147744|7366189|FG004|Overall Study|Lack of Efficacy|13
4542251|NCT01147744|7366190|FG005|Overall Study|Lack of Efficacy|8
4542252|NCT01147744|7366191|FG006|Overall Study|Lack of Efficacy|7
4542253|NCT01147744|7366185|FG000|Overall Study|Adverse Event|1
4542254|NCT01147744|7366186|FG001|Overall Study|Adverse Event|2
4542255|NCT01147744|7366187|FG002|Overall Study|Adverse Event|3
4542256|NCT01147744|7366188|FG003|Overall Study|Adverse Event|0
4542257|NCT01147744|7366189|FG004|Overall Study|Adverse Event|2
4542258|NCT01147744|7366190|FG005|Overall Study|Adverse Event|1
4542259|NCT01147744|7366191|FG006|Overall Study|Adverse Event|2
4542260|NCT01147744|7366185|FG000|Overall Study|Withdrawal by Subject|8
4542261|NCT01147744|7366186|FG001|Overall Study|Withdrawal by Subject|4
4542262|NCT01147744|7366187|FG002|Overall Study|Withdrawal by Subject|2
4542263|NCT01147744|7366188|FG003|Overall Study|Withdrawal by Subject|2
4542264|NCT01147744|7366189|FG004|Overall Study|Withdrawal by Subject|2
4542265|NCT01147744|7366190|FG005|Overall Study|Withdrawal by Subject|5
4542266|NCT01147744|7366191|FG006|Overall Study|Withdrawal by Subject|2
4542267|NCT01147744|7366185|FG000|Overall Study|Lost to Follow-up|0
4542268|NCT01147744|7366186|FG001|Overall Study|Lost to Follow-up|1
4542269|NCT01147744|7366187|FG002|Overall Study|Lost to Follow-up|0
4542270|NCT01147744|7366188|FG003|Overall Study|Lost to Follow-up|0
4542271|NCT01147744|7366189|FG004|Overall Study|Lost to Follow-up|0
4542272|NCT01147744|7366190|FG005|Overall Study|Lost to Follow-up|0
4542273|NCT01147744|7366191|FG006|Overall Study|Lost to Follow-up|0
4542274|NCT01147744|7366185|FG000|Overall Study|Sponsor decision to amend protocol|7
4542275|NCT01147744|7366186|FG001|Overall Study|Sponsor decision to amend protocol|4
4542276|NCT01147744|7366187|FG002|Overall Study|Sponsor decision to amend protocol|2
4542277|NCT01147744|7366188|FG003|Overall Study|Sponsor decision to amend protocol|5
4542278|NCT01147744|7366189|FG004|Overall Study|Sponsor decision to amend protocol|7
4542279|NCT01147744|7366190|FG005|Overall Study|Sponsor decision to amend protocol|2
4542280|NCT01147744|7366191|FG006|Overall Study|Sponsor decision to amend protocol|6
4542281|NCT01147744|7366185|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1
4542282|NCT01147744|7366186|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0
4542283|NCT01147744|7366187|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0
4542284|NCT01147744|7366188|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0
4542285|NCT01147744|7366189|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0
4542286|NCT01147744|7366190|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1
4542287|NCT01147744|7366191|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0
4542288|NCT01147809|7366219|FG000|Phase I (168 Days)|Adverse Event|0
4542289|NCT01147809|7366220|FG001|Phase I (168 Days)|Adverse Event|0
4542290|NCT01147809|7366221|FG002|Phase I (168 Days)|Adverse Event|0
4542291|NCT01147809|7366222|FG003|Phase I (168 Days)|Adverse Event|1
4542292|NCT01147809|7366223|FG004|Phase I (168 Days)|Adverse Event|0
4542293|NCT01147809|7366224|FG005|Phase I (168 Days)|Adverse Event|0
4542294|NCT01147809|7366219|FG000|Phase I (168 Days)|Lost to Follow-up|1
4542295|NCT01147809|7366220|FG001|Phase I (168 Days)|Lost to Follow-up|0
4542296|NCT01147809|7366221|FG002|Phase I (168 Days)|Lost to Follow-up|0
4542297|NCT01147809|7366222|FG003|Phase I (168 Days)|Lost to Follow-up|1
4542298|NCT01147809|7366223|FG004|Phase I (168 Days)|Lost to Follow-up|0
4542299|NCT01147809|7366224|FG005|Phase I (168 Days)|Lost to Follow-up|0
4542300|NCT01147809|7366219|FG000|Phase I (168 Days)|Physician Decision|0
4542301|NCT01147809|7366220|FG001|Phase I (168 Days)|Physician Decision|1
4542302|NCT01147809|7366221|FG002|Phase I (168 Days)|Physician Decision|2
4542303|NCT01147809|7366222|FG003|Phase I (168 Days)|Physician Decision|0
4542304|NCT01147809|7366223|FG004|Phase I (168 Days)|Physician Decision|0
4542305|NCT01147809|7366224|FG005|Phase I (168 Days)|Physician Decision|0
4542306|NCT01147809|7366219|FG000|Phase I (168 Days)|Withdrawal by Subject|0
4542307|NCT01147809|7366220|FG001|Phase I (168 Days)|Withdrawal by Subject|0
4542308|NCT01147809|7366221|FG002|Phase I (168 Days)|Withdrawal by Subject|0
4542309|NCT01147809|7366222|FG003|Phase I (168 Days)|Withdrawal by Subject|3
4542310|NCT01147809|7366223|FG004|Phase I (168 Days)|Withdrawal by Subject|0
4542311|NCT01147809|7366224|FG005|Phase I (168 Days)|Withdrawal by Subject|0
4542312|NCT01147809|7366219|FG000|Phase II (168 Days)|Adverse Event|0
4542313|NCT01147809|7366220|FG001|Phase II (168 Days)|Adverse Event|0
4542314|NCT01147809|7366221|FG002|Phase II (168 Days)|Adverse Event|0
4542315|NCT01147809|7366222|FG003|Phase II (168 Days)|Adverse Event|0
4542316|NCT01147809|7366223|FG004|Phase II (168 Days)|Adverse Event|3
4542317|NCT01147809|7366224|FG005|Phase II (168 Days)|Adverse Event|6
4542318|NCT01147809|7366219|FG000|Phase II (168 Days)|Protocol Violation|0
4542319|NCT01147809|7366220|FG001|Phase II (168 Days)|Protocol Violation|0
4542320|NCT01147809|7366221|FG002|Phase II (168 Days)|Protocol Violation|0
4542321|NCT01147809|7366222|FG003|Phase II (168 Days)|Protocol Violation|0
4542322|NCT01147809|7366223|FG004|Phase II (168 Days)|Protocol Violation|0
4542323|NCT01147809|7366224|FG005|Phase II (168 Days)|Protocol Violation|1
4542324|NCT01147809|7366219|FG000|Phase II (168 Days)|Physician Decision|0
4542325|NCT01147809|7366220|FG001|Phase II (168 Days)|Physician Decision|0
4542326|NCT01147809|7366221|FG002|Phase II (168 Days)|Physician Decision|0
4542327|NCT01147809|7366222|FG003|Phase II (168 Days)|Physician Decision|0
4542328|NCT01147809|7366223|FG004|Phase II (168 Days)|Physician Decision|5
4542329|NCT01147809|7366224|FG005|Phase II (168 Days)|Physician Decision|11
4542330|NCT01147809|7366219|FG000|Phase II (168 Days)|Withdrawal by Subject|0
4542331|NCT01147809|7366220|FG001|Phase II (168 Days)|Withdrawal by Subject|0
4542332|NCT01147809|7366221|FG002|Phase II (168 Days)|Withdrawal by Subject|0
4542333|NCT01147809|7366222|FG003|Phase II (168 Days)|Withdrawal by Subject|0
4542334|NCT01147809|7366223|FG004|Phase II (168 Days)|Withdrawal by Subject|7
4542335|NCT01147809|7366224|FG005|Phase II (168 Days)|Withdrawal by Subject|15
4542336|NCT01147809|7366219|FG000|Phase II (168 Days)|Ongoing|0
4542337|NCT01147809|7366220|FG001|Phase II (168 Days)|Ongoing|0
4542338|NCT01147809|7366221|FG002|Phase II (168 Days)|Ongoing|0
4542339|NCT01147809|7366222|FG003|Phase II (168 Days)|Ongoing|0
4542340|NCT01147809|7366223|FG004|Phase II (168 Days)|Ongoing|1
4542341|NCT01147809|7366224|FG005|Phase II (168 Days)|Ongoing|0
4542342|NCT01147848|7366241|FG000|Run-in Period|Screen Failure|623
4542343|NCT01147848|7366242|FG001|Run-in Period|Screen Failure|0
4542344|NCT01147848|7366243|FG002|Run-in Period|Screen Failure|0
4542345|NCT01147848|7366241|FG000|Run-in Period|Run-in Failure|135
4542346|NCT01147848|7366242|FG001|Run-in Period|Run-in Failure|0
4542347|NCT01147848|7366243|FG002|Run-in Period|Run-in Failure|0
4542348|NCT01147848|7366241|FG000|Randomized Phase|Adverse Event|0
4542349|NCT01147848|7366242|FG001|Randomized Phase|Adverse Event|6
4542350|NCT01147848|7366243|FG002|Randomized Phase|Adverse Event|8
4542351|NCT01147848|7366241|FG000|Randomized Phase|Lack of Efficacy|0
4542352|NCT01147848|7366242|FG001|Randomized Phase|Lack of Efficacy|20
4542353|NCT01147848|7366243|FG002|Randomized Phase|Lack of Efficacy|11
4542354|NCT01147848|7366241|FG000|Randomized Phase|Protocol Violation|0
4542355|NCT01147848|7366242|FG001|Randomized Phase|Protocol Violation|7
4542356|NCT01147848|7366243|FG002|Randomized Phase|Protocol Violation|10
4542357|NCT01147848|7366241|FG000|Randomized Phase|Lost to Follow-up|0
4542358|NCT01147848|7366242|FG001|Randomized Phase|Lost to Follow-up|5
4542359|NCT01147848|7366243|FG002|Randomized Phase|Lost to Follow-up|7
4542360|NCT01147848|7366241|FG000|Randomized Phase|Physician Decision|0
4542361|NCT01147848|7366242|FG001|Randomized Phase|Physician Decision|0
4542362|NCT01147848|7366243|FG002|Randomized Phase|Physician Decision|1
4542363|NCT01147848|7366241|FG000|Randomized Phase|Withdrawal by Subject|0
4542364|NCT01147848|7366242|FG001|Randomized Phase|Withdrawal by Subject|7
4542365|NCT01147848|7366243|FG002|Randomized Phase|Withdrawal by Subject|9
4542366|NCT01147874|7366250|FG000|Overall Study|Adverse Event|5
4542367|NCT01147874|7366250|FG000|Overall Study|Investigator's Request|1
4542368|NCT01147874|7366250|FG000|Overall Study|Lost to Follow-up|25
4542369|NCT01147874|7366250|FG000|Overall Study|Other|5
4542370|NCT01147874|7366250|FG000|Overall Study|Protocol Violation|5
4542371|NCT01147874|7366250|FG000|Overall Study|Sponsor's Decision|2
4542372|NCT01147874|7366250|FG000|Overall Study|Withdrawal by Subject|24
4542373|NCT01147900|7366257|FG000|At Year 10|Lost to Follow-up|0
4542374|NCT01147900|7366258|FG001|At Year 10|Lost to Follow-up|1
4542375|NCT01147900|7366259|FG002|At Year 10|Lost to Follow-up|0
4542376|NCT01147926|7366269|FG000|Overall Study|Subject Withdrew Consent|9
4542377|NCT01147926|7366270|FG001|Overall Study|Subject Withdrew Consent|10
4542378|NCT01147926|7366269|FG000|Overall Study|Adverse Event|7
4542379|NCT01147926|7366270|FG001|Overall Study|Adverse Event|6
4542380|NCT01147926|7366269|FG000|Overall Study|Subject Non-Compliant|5
4542381|NCT01147926|7366270|FG001|Overall Study|Subject Non-Compliant|4
4542382|NCT01147926|7366269|FG000|Overall Study|Principal investigator left hospital|1
4542383|NCT01147926|7366270|FG001|Overall Study|Principal investigator left hospital|3
4542384|NCT01147926|7366269|FG000|Overall Study|Selection criteria not met|3
4542385|NCT01147926|7366270|FG001|Overall Study|Selection criteria not met|1
4542386|NCT01147926|7366269|FG000|Overall Study|Lost to Follow-up|0
4542387|NCT01147926|7366270|FG001|Overall Study|Lost to Follow-up|2
4542388|NCT01147926|7366269|FG000|Overall Study|Sponsor's Decision|0
4542389|NCT01147926|7366270|FG001|Overall Study|Sponsor's Decision|1
4542390|NCT01147926|7366269|FG000|Overall Study|Lack of Efficacy|1
4542391|NCT01147926|7366270|FG001|Overall Study|Lack of Efficacy|0
4542392|NCT01147926|7366269|FG000|Overall Study|Too busy, no time for study|1
4542393|NCT01147926|7366270|FG001|Overall Study|Too busy, no time for study|0
4542394|NCT01147926|7366269|FG000|Overall Study|Went on holiday|0
4542395|NCT01147926|7366270|FG001|Overall Study|Went on holiday|1
4542396|NCT01147926|7366269|FG000|Overall Study|Colonoscopy result|0
4542397|NCT01147926|7366270|FG001|Overall Study|Colonoscopy result|1
4542398|NCT01148017|7366280|FG000|Overall Study|Withdrawal by Subject|31
4542399|NCT01148017|7366281|FG001|Overall Study|Withdrawal by Subject|14
4542400|NCT01148017|7366282|FG002|Overall Study|Withdrawal by Subject|0
4542401|NCT01148017|7366283|FG003|Overall Study|Withdrawal by Subject|0
4542402|NCT01148017|7366280|FG000|Overall Study|Lost to Follow-up|23
4542403|NCT01148017|7366281|FG001|Overall Study|Lost to Follow-up|10
4542404|NCT01148017|7366282|FG002|Overall Study|Lost to Follow-up|0
4542405|NCT01148017|7366283|FG003|Overall Study|Lost to Follow-up|0
4542406|NCT01148017|7366280|FG000|Overall Study|Inappropriate enrollment|1
4542407|NCT01148017|7366281|FG001|Overall Study|Inappropriate enrollment|0
4542408|NCT01148017|7366282|FG002|Overall Study|Inappropriate enrollment|0
4542409|NCT01148017|7366283|FG003|Overall Study|Inappropriate enrollment|0
4542410|NCT01148017|7366280|FG000|Overall Study|Administrative reason|22
4542411|NCT01148017|7366281|FG001|Overall Study|Administrative reason|9
4542412|NCT01148017|7366282|FG002|Overall Study|Administrative reason|0
4617168|NCT01746901|7476548|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0
4617169|NCT01746901|7476549|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0
4617170|NCT01746901|7476550|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0
4542413|NCT01148017|7366283|FG003|Overall Study|Administrative reason|0
4542414|NCT01148017|7366280|FG000|Overall Study|Unable to classify|3
4542415|NCT01148017|7366281|FG001|Overall Study|Unable to classify|1
4542416|NCT01148017|7366282|FG002|Overall Study|Unable to classify|0
4542417|NCT01148017|7366283|FG003|Overall Study|Unable to classify|0
4542418|NCT01148225|7366294|FG000|Overall Study|Other|185
4542419|NCT01148459|7366308|FG000|Overall Study|Serious Adverse Event|5
4542420|NCT01148459|7366309|FG001|Overall Study|Serious Adverse Event|4
4542421|NCT01148459|7366308|FG000|Overall Study|Withdrawal by Subject|1
4542422|NCT01148459|7366309|FG001|Overall Study|Withdrawal by Subject|0
4542423|NCT01148459|7366308|FG000|Overall Study|Migrated/moved from study area|3
4542424|NCT01148459|7366309|FG001|Overall Study|Migrated/moved from study area|6
4542425|NCT01148459|7366308|FG000|Overall Study|Lost to Follow-up|2
4542426|NCT01148459|7366309|FG001|Overall Study|Lost to Follow-up|0
4542427|NCT01148459|7366308|FG000|Overall Study|Refusal|1
4542428|NCT01148459|7366309|FG001|Overall Study|Refusal|0
4542429|NCT01148459|7366308|FG000|Overall Study|Failure to comply with study procedures|0
4542430|NCT01148459|7366309|FG001|Overall Study|Failure to comply with study procedures|1
4617171|NCT01746901|7476551|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1
4617172|NCT01746901|7476552|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0
4617173|NCT01746901|7476553|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1
4617174|NCT01747486|7476623|FG000|Stage 1|Physician Decision|3
4617175|NCT01747486|7476624|FG001|Stage 1|Physician Decision|0
4617176|NCT01747486|7476623|FG000|Stage 1|Withdrawal by Subject|4
4617177|NCT01747486|7476624|FG001|Stage 1|Withdrawal by Subject|3
4617178|NCT01747486|7476623|FG000|Stage 1|Disease progression|4
4617179|NCT01747486|7476624|FG001|Stage 1|Disease progression|9
4617180|NCT01747486|7476623|FG000|Stage 1|Death|1
4542431|NCT01148511|7366317|FG000|Exposed to Study Drug|Protocol Violation|2
4542432|NCT01148511|7366318|FG001|Exposed to Study Drug|Protocol Violation|0
4542433|NCT01148511|7366319|FG002|Exposed to Study Drug|Protocol Violation|0
4542434|NCT01148511|7366317|FG000|Exposed to Study Drug|Lost to Follow-up|4
4542435|NCT01148511|7366318|FG001|Exposed to Study Drug|Lost to Follow-up|0
4542436|NCT01148511|7366319|FG002|Exposed to Study Drug|Lost to Follow-up|0
4542437|NCT01148511|7366317|FG000|Randomized|Adverse Event|0
4542438|NCT01148511|7366318|FG001|Randomized|Adverse Event|1
4542439|NCT01148511|7366319|FG002|Randomized|Adverse Event|0
4542440|NCT01148511|7366317|FG000|Randomized|Protocol Violation|0
4542441|NCT01148511|7366318|FG001|Randomized|Protocol Violation|2
4542442|NCT01148511|7366319|FG002|Randomized|Protocol Violation|1
4542443|NCT01148511|7366317|FG000|Randomized|Lost to Follow-up|0
4542444|NCT01148511|7366318|FG001|Randomized|Lost to Follow-up|1
4542445|NCT01148511|7366319|FG002|Randomized|Lost to Follow-up|1
4542446|NCT01148511|7366317|FG000|Randomized|Consent withdrawal|0
4542447|NCT01148511|7366318|FG001|Randomized|Consent withdrawal|5
4542448|NCT01148511|7366319|FG002|Randomized|Consent withdrawal|3
4542449|NCT01148511|7366317|FG000|Randomized|Other|0
4542450|NCT01148511|7366318|FG001|Randomized|Other|1
4542451|NCT01148511|7366319|FG002|Randomized|Other|1
4542452|NCT01148537|7366366|FG000|Overall Study|Withdrawal by Subject|1
4542453|NCT01148537|7366367|FG001|Overall Study|Withdrawal by Subject|0
4542454|NCT01148537|7366368|FG002|Overall Study|Withdrawal by Subject|2
4542455|NCT01148537|7366366|FG000|Overall Study|Adverse Event|2
4542456|NCT01148537|7366367|FG001|Overall Study|Adverse Event|0
4617181|NCT01747486|7476624|FG001|Stage 1|Death|1
4617182|NCT01747486|7476623|FG000|Stage 2|Physician Decision|2
4617183|NCT01747486|7476624|FG001|Stage 2|Physician Decision|0
4617184|NCT01747486|7476623|FG000|Stage 2|Withdrawal by Subject|1
4617185|NCT01747486|7476624|FG001|Stage 2|Withdrawal by Subject|0
4542457|NCT01148537|7366368|FG002|Overall Study|Adverse Event|1
4542458|NCT01148693|7366389|FG000|Overall Study|Attempts for cannulation were failed|13
4542459|NCT01148693|7366390|FG001|Overall Study|Attempts for cannulation were failed|10
4542460|NCT01148771|7366404|FG000|Washout Period|Withdrawal by Subject|0
4542461|NCT01148771|7366405|FG001|Washout Period|Withdrawal by Subject|1
4542462|NCT01148810|7366417|FG000|Overall Study|Adverse Event|0
4542463|NCT01148810|7366418|FG001|Overall Study|Adverse Event|2
4542464|NCT01148810|7366417|FG000|Overall Study|Lack of Efficacy|0
4542465|NCT01148810|7366418|FG001|Overall Study|Lack of Efficacy|1
4542466|NCT01148810|7366417|FG000|Overall Study|Withdrawal by Subject|0
4542467|NCT01148810|7366418|FG001|Overall Study|Withdrawal by Subject|2
4542468|NCT01148810|7366417|FG000|Overall Study|Protocol Violation|1
4542469|NCT01148810|7366418|FG001|Overall Study|Protocol Violation|0
4542470|NCT01148862|7366434|FG000|Second Intervention|Withdrawal by Subject|0
4542471|NCT01148862|7366435|FG001|Second Intervention|Withdrawal by Subject|2
4542472|NCT01148979|7366455|FG000|Overall Study|Lost to Follow-up|0
4542473|NCT01148979|7366456|FG001|Overall Study|Lost to Follow-up|1
4542474|NCT01149057|7366462|FG000|Overall Study|Lack of Efficacy|16
4542475|NCT01149057|7366462|FG000|Overall Study|Adverse Event|13
4542476|NCT01149057|7366462|FG000|Overall Study|Withdrawal by Subject|9
4542477|NCT01149057|7366462|FG000|Overall Study|Positive Hepatitis B Core Antibody|5
4542478|NCT01149057|7366462|FG000|Overall Study|B Cell Depletion|4
4542479|NCT01149057|7366462|FG000|Overall Study|Participant Non-Compliance|2
4542480|NCT01149057|7366462|FG000|Overall Study|Lost to Follow-up|1
4542481|NCT01149057|7366462|FG000|Overall Study|High Parathyroid Hormone Value|1
4542482|NCT01149057|7366462|FG000|Overall Study|Other|6
4542483|NCT01149096|7366468|FG000|Overall Study|Lost to Follow-up|0
4542484|NCT01149096|7366469|FG001|Overall Study|Lost to Follow-up|1
4542485|NCT01149148|7366478|FG000|Overall Study|Lost to Follow-up|1
4542486|NCT01149148|7366479|FG001|Overall Study|Lost to Follow-up|2
4542487|NCT01149148|7366478|FG000|Overall Study|Death|1
4542488|NCT01149148|7366479|FG001|Overall Study|Death|0
4542489|NCT01149343|7366490|FG000|Overall Study|Withdrawal by Subject|1
4542490|NCT01149343|7366491|FG001|Overall Study|Withdrawal by Subject|1
4542491|NCT01149343|7366492|FG002|Overall Study|Withdrawal by Subject|1
4542492|NCT01149343|7366493|FG003|Overall Study|Withdrawal by Subject|5
4542493|NCT01149343|7366490|FG000|Overall Study|Death|10
4542494|NCT01149343|7366491|FG001|Overall Study|Death|13
4542495|NCT01149343|7366492|FG002|Overall Study|Death|18
4542496|NCT01149343|7366493|FG003|Overall Study|Death|18
4542497|NCT01149343|7366490|FG000|Overall Study|Lost to Follow-up|1
4542498|NCT01149343|7366491|FG001|Overall Study|Lost to Follow-up|0
4542499|NCT01149343|7366492|FG002|Overall Study|Lost to Follow-up|0
4542500|NCT01149343|7366493|FG003|Overall Study|Lost to Follow-up|1
4542501|NCT01149343|7366490|FG000|Overall Study|Other|8
4542502|NCT01149343|7366491|FG001|Overall Study|Other|10
4542503|NCT01149343|7366492|FG002|Overall Study|Other|2
4542504|NCT01149343|7366493|FG003|Overall Study|Other|14
4542505|NCT01149343|7366490|FG000|Overall Study|Sponsor study termination|0
4542506|NCT01149343|7366491|FG001|Overall Study|Sponsor study termination|0
4542507|NCT01149343|7366492|FG002|Overall Study|Sponsor study termination|0
4542508|NCT01149343|7366493|FG003|Overall Study|Sponsor study termination|2
4542509|NCT01149343|7366490|FG000|Overall Study|Recurrence / Progressive disease|0
4542510|NCT01149343|7366491|FG001|Overall Study|Recurrence / Progressive disease|0
4542511|NCT01149343|7366492|FG002|Overall Study|Recurrence / Progressive disease|1
4542512|NCT01149343|7366493|FG003|Overall Study|Recurrence / Progressive disease|0
4542513|NCT01149369|7366509|FG000|Overall Study|Adverse Event|6
4542514|NCT01149369|7366510|FG001|Overall Study|Adverse Event|3
4542515|NCT01149421|7366519|FG000|Overall Study|Adverse Event|22
4542516|NCT01149421|7366520|FG001|Overall Study|Adverse Event|6
4542517|NCT01149421|7366521|FG002|Overall Study|Adverse Event|11
4542518|NCT01149421|7366519|FG000|Overall Study|Withdrawal by Subject|20
4542519|NCT01149421|7366520|FG001|Overall Study|Withdrawal by Subject|12
4542520|NCT01149421|7366521|FG002|Overall Study|Withdrawal by Subject|13
4542521|NCT01149421|7366519|FG000|Overall Study|Sponsor Decision|0
4542522|NCT01149421|7366520|FG001|Overall Study|Sponsor Decision|1
4542523|NCT01149421|7366521|FG002|Overall Study|Sponsor Decision|1
4542524|NCT01149421|7366519|FG000|Overall Study|Lost to Follow-up|2
4542525|NCT01149421|7366520|FG001|Overall Study|Lost to Follow-up|4
4542526|NCT01149421|7366521|FG002|Overall Study|Lost to Follow-up|5
4542527|NCT01149421|7366519|FG000|Overall Study|Physician Decision|5
4617186|NCT01747486|7476623|FG000|Stage 2|New Cancer Therapy|3
4542528|NCT01149421|7366520|FG001|Overall Study|Physician Decision|3
4542529|NCT01149421|7366521|FG002|Overall Study|Physician Decision|6
4542530|NCT01149421|7366519|FG000|Overall Study|Entry Criteria Not Met|1
4542531|NCT01149421|7366520|FG001|Overall Study|Entry Criteria Not Met|1
4542532|NCT01149421|7366521|FG002|Overall Study|Entry Criteria Not Met|2
4542533|NCT01149421|7366519|FG000|Overall Study|Protocol Violation|2
4542534|NCT01149421|7366520|FG001|Overall Study|Protocol Violation|2
4542535|NCT01149421|7366521|FG002|Overall Study|Protocol Violation|6
4542536|NCT01149460|7366541|FG000|Overall Study|Withdrawal by Subject|0
4542537|NCT01149460|7366542|FG001|Overall Study|Withdrawal by Subject|2
4542538|NCT01149473|7366550|FG000|First Intervention|Adverse Event|1
4542539|NCT01149473|7366551|FG001|First Intervention|Adverse Event|1
4542540|NCT01149473|7366550|FG000|Washout of 7 Days|Withdrawal by Subject|1
4542541|NCT01149473|7366551|FG001|Washout of 7 Days|Withdrawal by Subject|1
4542542|NCT01149486|7366559|FG000|First Intervention|Adverse Event|0
4542543|NCT01149486|7366560|FG001|First Intervention|Adverse Event|1
4542544|NCT01149538|7366572|FG000|Overall Study|Lost to Follow-up|0
4542545|NCT01149538|7366573|FG001|Overall Study|Lost to Follow-up|1
4542546|NCT01149538|7366572|FG000|Overall Study|Withdrawal by Subject|5
4542547|NCT01149538|7366573|FG001|Overall Study|Withdrawal by Subject|3
4542548|NCT01149655|7366592|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1
4542549|NCT01149655|7366593|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0
4542550|NCT01149655|7366594|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0
4542551|NCT01149655|7366595|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0
4542552|NCT01149655|7366592|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4
4542553|NCT01149655|7366593|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
4542554|NCT01149655|7366594|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
4542555|NCT01149655|7366595|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
4542556|NCT01149655|7366592|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1
4542557|NCT01149655|7366593|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
4542558|NCT01149655|7366594|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
4542559|NCT01149655|7366595|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
4542560|NCT01149655|7366592|FG000|Period 1 - Conversion Phase|Physician Decision|2
4542561|NCT01149655|7366593|FG001|Period 1 - Conversion Phase|Physician Decision|0
4542562|NCT01149655|7366594|FG002|Period 1 - Conversion Phase|Physician Decision|0
4542563|NCT01149655|7366595|FG003|Period 1 - Conversion Phase|Physician Decision|0
4542564|NCT01149655|7366592|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7
4542565|NCT01149655|7366593|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0
4542566|NCT01149655|7366594|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0
4542567|NCT01149655|7366595|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0
4542568|NCT01149655|7366592|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3
4542569|NCT01149655|7366593|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
4542570|NCT01149655|7366594|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
4542571|NCT01149655|7366595|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
4542572|NCT01149655|7366592|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
4542573|NCT01149655|7366593|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16
4542574|NCT01149655|7366594|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
4542575|NCT01149655|7366595|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
4542576|NCT01149655|7366592|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
4542577|NCT01149655|7366593|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7
4542578|NCT01149655|7366594|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
4542579|NCT01149655|7366595|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
4542580|NCT01149655|7366592|FG000|Period 2-Stabilization Phase|Physician Decision|0
4542581|NCT01149655|7366593|FG001|Period 2-Stabilization Phase|Physician Decision|3
4542582|NCT01149655|7366594|FG002|Period 2-Stabilization Phase|Physician Decision|0
4542583|NCT01149655|7366595|FG003|Period 2-Stabilization Phase|Physician Decision|0
4542584|NCT01149655|7366592|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0
4542585|NCT01149655|7366593|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5
4542586|NCT01149655|7366594|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0
4542587|NCT01149655|7366595|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0
4542588|NCT01149655|7366592|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
4542589|NCT01149655|7366593|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6
4542590|NCT01149655|7366594|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
4542591|NCT01149655|7366595|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
4542592|NCT01149655|7366592|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0
4542593|NCT01149655|7366593|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0
4542594|NCT01149655|7366594|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58
4542595|NCT01149655|7366595|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19
4542596|NCT01149655|7366592|FG000|Period 3-DB Maintenance Phase|Physician Decision|0
4542597|NCT01149655|7366593|FG001|Period 3-DB Maintenance Phase|Physician Decision|0
4542598|NCT01149655|7366594|FG002|Period 3-DB Maintenance Phase|Physician Decision|1
4542599|NCT01149655|7366595|FG003|Period 3-DB Maintenance Phase|Physician Decision|0
4542600|NCT01149655|7366592|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0
4542601|NCT01149655|7366593|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0
4542602|NCT01149655|7366594|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4
4591385|NCT01529515|7437934|FG000|MAINTENANCE PHASE|Adverse Event|0
4542603|NCT01149655|7366595|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4
4542604|NCT01149655|7366592|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0
4542605|NCT01149655|7366593|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0
4542606|NCT01149655|7366594|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1
4542607|NCT01149655|7366595|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1
4542608|NCT01149655|7366592|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0
4542609|NCT01149655|7366593|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0
4542610|NCT01149655|7366594|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19
4542611|NCT01149655|7366595|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18
4542612|NCT01149681|7366603|FG000|Overall Study|Withdrawal by Subject|7
4542613|NCT01149681|7366603|FG000|Overall Study|Progressive disease|1
4542614|NCT01149681|7366603|FG000|Overall Study|Physician Decision|2
4542615|NCT01149681|7366603|FG000|Overall Study|adverse events nonrelated study drug|2
4542616|NCT01149863|7366639|FG000|Overall Study|Missing data or Not receiveing studydrug|3
4542617|NCT01150097|7366664|FG000|Months 24 to 36 Post-transplantation|Death|2
4542618|NCT01150097|7366665|FG001|Months 24 to 36 Post-transplantation|Death|0
4542619|NCT01150097|7366666|FG002|Months 24 to 36 Post-transplantation|Death|0
4542620|NCT01150097|7366664|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5
4542621|NCT01150097|7366665|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2
4542622|NCT01150097|7366666|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2
4542623|NCT01150097|7366664|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0
4542624|NCT01150097|7366665|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0
4542625|NCT01150097|7366666|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3
4542626|NCT01150097|7366664|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3
4542627|NCT01150097|7366665|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0
4542628|NCT01150097|7366666|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3
4542629|NCT01150097|7366664|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5
4542630|NCT01150097|7366665|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4
4542631|NCT01150097|7366666|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0
4542632|NCT01150097|7366664|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4
4542633|NCT01150097|7366665|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0
4542634|NCT01150097|7366666|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0
4542635|NCT01150097|7366664|FG000|Months 24 to 48 Post-transplantation|Death|2
4542636|NCT01150097|7366665|FG001|Months 24 to 48 Post-transplantation|Death|0
4542637|NCT01150097|7366666|FG002|Months 24 to 48 Post-transplantation|Death|0
4542638|NCT01150123|7366694|FG000|Overall Study|Withdrawal by Subject|1
4542639|NCT01150123|7366695|FG001|Overall Study|Withdrawal by Subject|1
4542640|NCT01150123|7366696|FG002|Overall Study|Withdrawal by Subject|2
4542641|NCT01150123|7366697|FG003|Overall Study|Withdrawal by Subject|1
4542642|NCT01150123|7366698|FG004|Overall Study|Withdrawal by Subject|1
4542643|NCT01150123|7366699|FG005|Overall Study|Withdrawal by Subject|1
4542644|NCT01150123|7366700|FG006|Overall Study|Withdrawal by Subject|0
4542645|NCT01150123|7366701|FG007|Overall Study|Withdrawal by Subject|3
4542646|NCT01150123|7366702|FG008|Overall Study|Withdrawal by Subject|2
4542647|NCT01150123|7366703|FG009|Overall Study|Withdrawal by Subject|0
4542648|NCT01150123|7366704|FG010|Overall Study|Withdrawal by Subject|1
4542649|NCT01150123|7366705|FG011|Overall Study|Withdrawal by Subject|0
4542650|NCT01150123|7366706|FG012|Overall Study|Withdrawal by Subject|1
4542651|NCT01150123|7366707|FG013|Overall Study|Withdrawal by Subject|0
4542652|NCT01150123|7366708|FG014|Overall Study|Withdrawal by Subject|0
4542653|NCT01150123|7366709|FG015|Overall Study|Withdrawal by Subject|1
4542654|NCT01150123|7366710|FG016|Overall Study|Withdrawal by Subject|0
4542655|NCT01150123|7366711|FG017|Overall Study|Withdrawal by Subject|1
4542656|NCT01150123|7366694|FG000|Overall Study|Lost to Follow-up|2
4542657|NCT01150123|7366695|FG001|Overall Study|Lost to Follow-up|1
4542658|NCT01150123|7366696|FG002|Overall Study|Lost to Follow-up|2
4542659|NCT01150123|7366697|FG003|Overall Study|Lost to Follow-up|2
4542660|NCT01150123|7366698|FG004|Overall Study|Lost to Follow-up|2
4542661|NCT01150123|7366699|FG005|Overall Study|Lost to Follow-up|5
4542662|NCT01150123|7366700|FG006|Overall Study|Lost to Follow-up|0
4542663|NCT01150123|7366701|FG007|Overall Study|Lost to Follow-up|0
4542664|NCT01150123|7366702|FG008|Overall Study|Lost to Follow-up|3
4542665|NCT01150123|7366703|FG009|Overall Study|Lost to Follow-up|1
4542666|NCT01150123|7366704|FG010|Overall Study|Lost to Follow-up|1
4542667|NCT01150123|7366705|FG011|Overall Study|Lost to Follow-up|1
4542668|NCT01150123|7366706|FG012|Overall Study|Lost to Follow-up|2
4542669|NCT01150123|7366707|FG013|Overall Study|Lost to Follow-up|0
4542670|NCT01150123|7366708|FG014|Overall Study|Lost to Follow-up|0
4542671|NCT01150123|7366709|FG015|Overall Study|Lost to Follow-up|0
4542672|NCT01150123|7366710|FG016|Overall Study|Lost to Follow-up|0
4542673|NCT01150123|7366711|FG017|Overall Study|Lost to Follow-up|0
4542674|NCT01150357|7366771|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0
4542675|NCT01150357|7366772|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1
4542676|NCT01150357|7366773|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1
4542677|NCT01150357|7366771|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1
4542678|NCT01150357|7366772|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0
4542679|NCT01150357|7366773|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0
4542680|NCT01150357|7366771|FG000|Dose Response Phase (Phase 1)|Adverse Event|0
4542681|NCT01150357|7366772|FG001|Dose Response Phase (Phase 1)|Adverse Event|0
4542682|NCT01150357|7366773|FG002|Dose Response Phase (Phase 1)|Adverse Event|1
4542683|NCT01150357|7366771|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0
4542684|NCT01150357|7366772|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2
4542685|NCT01150357|7366773|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1
4542686|NCT01150357|7366771|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0
4542687|NCT01150357|7366772|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0
4542688|NCT01150357|7366773|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2
4542689|NCT01150357|7366771|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2
4542690|NCT01150357|7366772|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0
4542691|NCT01150357|7366773|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0
4542692|NCT01150357|7366771|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1
4542693|NCT01150357|7366772|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0
4542694|NCT01150357|7366773|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0
4542695|NCT01150474|7366804|FG000|Overall Study|Withdrawal by Subject|5
4542696|NCT01150474|7366805|FG001|Overall Study|Withdrawal by Subject|2
4542697|NCT01150474|7366804|FG000|Overall Study|Cancer found|1
4542698|NCT01150474|7366805|FG001|Overall Study|Cancer found|0
4542699|NCT01150474|7366804|FG000|Overall Study|Multiple Studies|0
4542700|NCT01150474|7366805|FG001|Overall Study|Multiple Studies|1
4542701|NCT01150474|7366804|FG000|Overall Study|Rectotomy|1
4542702|NCT01150474|7366805|FG001|Overall Study|Rectotomy|0
4542703|NCT01150474|7366804|FG000|Overall Study|Drug did not arrive in time|1
4542704|NCT01150474|7366805|FG001|Overall Study|Drug did not arrive in time|0
4542705|NCT01150474|7366804|FG000|Overall Study|Drug not administered|1
4542706|NCT01150474|7366805|FG001|Overall Study|Drug not administered|0
4542707|NCT01150474|7366804|FG000|Overall Study|Surgery Changed|1
4542708|NCT01150474|7366805|FG001|Overall Study|Surgery Changed|0
4542709|NCT01151020|7366860|FG000|Overall Study|Death|25
4542710|NCT01151020|7366860|FG000|Overall Study|Conversion to open repair|1
4542711|NCT01151020|7366860|FG000|Overall Study|Lost to Follow-up|4
4542712|NCT01151020|7366860|FG000|Overall Study|Withdrawal by Subject|22
4542713|NCT01151020|7366860|FG000|Overall Study|Patients did not receive the device|2
4542714|NCT01151085|7366877|FG000|Overall Study|Lost to Follow-up|31
4542715|NCT01151085|7366877|FG000|Overall Study|Protocol Violation|25
4542716|NCT01151098|7366888|FG000|Overall Study|Adverse Event|82
4542717|NCT01151098|7366888|FG000|Overall Study|Lost to Follow-up|6
4542718|NCT01151098|7366888|FG000|Overall Study|Lack of Efficacy|15
4542719|NCT01151098|7366888|FG000|Overall Study|Protocol Violation|1
4542720|NCT01151098|7366888|FG000|Overall Study|Miscellaneous|13
4542721|NCT01151137|7366894|FG000|Overall Study|Death|15
4542722|NCT01151137|7366895|FG001|Overall Study|Death|27
4542723|NCT01151137|7366894|FG000|Overall Study|Lost to Follow-up|1
4542724|NCT01151137|7366895|FG001|Overall Study|Lost to Follow-up|1
4542725|NCT01151215|7366913|FG000|Overall Study|Worsening of condition under study|1
4542726|NCT01151215|7366914|FG001|Overall Study|Worsening of condition under study|1
4542727|NCT01151215|7366915|FG002|Overall Study|Worsening of condition under study|1
4542728|NCT01151215|7366913|FG000|Overall Study|Death|16
4542729|NCT01151215|7366914|FG001|Overall Study|Death|20
4542730|NCT01151215|7366915|FG002|Overall Study|Death|11
4542731|NCT01151215|7366913|FG000|Overall Study|Lost to Follow-up|0
4542732|NCT01151215|7366914|FG001|Overall Study|Lost to Follow-up|0
4542733|NCT01151215|7366915|FG002|Overall Study|Lost to Follow-up|3
4617187|NCT01747486|7476624|FG001|Stage 2|New Cancer Therapy|0
4617188|NCT01747486|7476623|FG000|Stage 2|Disease Progression|3
4617189|NCT01747486|7476624|FG001|Stage 2|Disease Progression|0
4617190|NCT01747499|7476635|FG000|Overall Study|Steroid refractory aGvHD|1
4617191|NCT01747499|7476636|FG001|Overall Study|Steroid refractory aGvHD|0
4617192|NCT01747499|7476637|FG002|Overall Study|Steroid refractory aGvHD|0
4617193|NCT01747499|7476638|FG003|Overall Study|Steroid refractory aGvHD|1
4617194|NCT01747499|7476639|FG004|Overall Study|Steroid refractory aGvHD|4
4617195|NCT01747499|7476635|FG000|Overall Study|Physician Decision|0
4617196|NCT01747499|7476636|FG001|Overall Study|Physician Decision|1
4617197|NCT01747499|7476637|FG002|Overall Study|Physician Decision|0
4617198|NCT01747499|7476638|FG003|Overall Study|Physician Decision|0
4617199|NCT01747499|7476639|FG004|Overall Study|Physician Decision|2
4617200|NCT01747499|7476635|FG000|Overall Study|Death|0
4617201|NCT01747499|7476636|FG001|Overall Study|Death|0
4617202|NCT01747499|7476637|FG002|Overall Study|Death|0
4617203|NCT01747499|7476638|FG003|Overall Study|Death|1
4617204|NCT01747499|7476639|FG004|Overall Study|Death|1
4617205|NCT01747499|7476635|FG000|Overall Study|Withdrawal by Subject|0
4617206|NCT01747499|7476636|FG001|Overall Study|Withdrawal by Subject|0
4617207|NCT01747499|7476637|FG002|Overall Study|Withdrawal by Subject|0
4617208|NCT01747499|7476638|FG003|Overall Study|Withdrawal by Subject|0
4617209|NCT01747499|7476639|FG004|Overall Study|Withdrawal by Subject|6
4617210|NCT01747499|7476635|FG000|Overall Study|Developed AML and death|0
4617211|NCT01747499|7476636|FG001|Overall Study|Developed AML and death|0
4617212|NCT01747499|7476637|FG002|Overall Study|Developed AML and death|0
4617213|NCT01747499|7476638|FG003|Overall Study|Developed AML and death|0
4542734|NCT01151215|7366913|FG000|Overall Study|Withdrawal by Subject|3
4542735|NCT01151215|7366914|FG001|Overall Study|Withdrawal by Subject|1
4542736|NCT01151215|7366915|FG002|Overall Study|Withdrawal by Subject|2
4542737|NCT01151215|7366913|FG000|Overall Study|Disease progression|0
4542738|NCT01151215|7366914|FG001|Overall Study|Disease progression|1
4542739|NCT01151215|7366915|FG002|Overall Study|Disease progression|1
4542740|NCT01151215|7366913|FG000|Overall Study|Safety as judged by the investigator|0
4542741|NCT01151215|7366914|FG001|Overall Study|Safety as judged by the investigator|0
4542742|NCT01151215|7366915|FG002|Overall Study|Safety as judged by the investigator|1
4542743|NCT01151280|7366923|FG000|Overall Study|Adverse Event|1
4542744|NCT01151280|7366923|FG000|Overall Study|Lack of Efficacy|3
4542745|NCT01151345|7366927|FG000|First Intervention Period|Protocol Violation|0
4542746|NCT01151345|7366928|FG001|First Intervention Period|Protocol Violation|1
4542747|NCT01151410|7366949|FG000|Overall Study|Withdrawal by Subject|3
4542748|NCT01151410|7366950|FG001|Overall Study|Withdrawal by Subject|5
4542749|NCT01151410|7366949|FG000|Overall Study|Lost to Follow-up|3
4542750|NCT01151410|7366950|FG001|Overall Study|Lost to Follow-up|4
4542751|NCT01151410|7366949|FG000|Overall Study|Adverse Event|1
4542752|NCT01151410|7366950|FG001|Overall Study|Adverse Event|2
4542753|NCT01151410|7366949|FG000|Overall Study|Protocol deviation|2
4542754|NCT01151410|7366950|FG001|Overall Study|Protocol deviation|1
4542755|NCT01151410|7366949|FG000|Overall Study|Administrative problems|1
4542756|NCT01151410|7366950|FG001|Overall Study|Administrative problems|1
4542757|NCT01151410|7366949|FG000|Overall Study|Unsatisfactory therapeutic effect|1
4542758|NCT01151410|7366950|FG001|Overall Study|Unsatisfactory therapeutic effect|1
4542759|NCT01151410|7366949|FG000|Overall Study|Abnormal laboratory value(s)|0
4542760|NCT01151410|7366950|FG001|Overall Study|Abnormal laboratory value(s)|1
4542761|NCT01151423|7366958|FG000|Overall Study|Study terminated by Sponsor|9
4542762|NCT01151423|7366959|FG001|Overall Study|Study terminated by Sponsor|10
4542763|NCT01151423|7366958|FG000|Overall Study|Protocol Violation|0
4542764|NCT01151423|7366959|FG001|Overall Study|Protocol Violation|1
4542765|NCT01151423|7366958|FG000|Overall Study|Physician Decision|1
4542766|NCT01151423|7366959|FG001|Overall Study|Physician Decision|1
4542767|NCT01151423|7366958|FG000|Overall Study|Pregnancy|0
4542768|NCT01151423|7366959|FG001|Overall Study|Pregnancy|1
4542769|NCT01151423|7366958|FG000|Overall Study|Death|0
4542770|NCT01151423|7366959|FG001|Overall Study|Death|1
4542771|NCT01151423|7366958|FG000|Overall Study|Adverse Event|3
4542772|NCT01151423|7366959|FG001|Overall Study|Adverse Event|0
4542773|NCT01151423|7366958|FG000|Overall Study|Withdrawal by Subject|1
4542774|NCT01151423|7366959|FG001|Overall Study|Withdrawal by Subject|3
4542775|NCT01151423|7366958|FG000|Overall Study|Lost to Follow-up|1
4542776|NCT01151423|7366959|FG001|Overall Study|Lost to Follow-up|0
4542777|NCT01151423|7366958|FG000|Overall Study|Diagnosed as non-TTP patient|0
4542778|NCT01151423|7366959|FG001|Overall Study|Diagnosed as non-TTP patient|1
4542779|NCT01151423|7366958|FG000|Overall Study|Participated in other clinical trial|1
4542780|NCT01151423|7366959|FG001|Overall Study|Participated in other clinical trial|0
4542781|NCT01151540|7366973|FG000|Overall Study|Other|2
4542782|NCT01151540|7366973|FG000|Overall Study|Adverse event, non-fatal|4
4542783|NCT01151540|7366973|FG000|Overall Study|Withdrawal by Subject|7
4542784|NCT01151579|7366979|FG000|Overall Study|Physician Decision|3
4542785|NCT01151579|7366980|FG001|Overall Study|Physician Decision|1
4542786|NCT01151579|7366979|FG000|Overall Study|Withdrawal by Subject|3
4542787|NCT01151579|7366980|FG001|Overall Study|Withdrawal by Subject|2
4542788|NCT01151579|7366979|FG000|Overall Study|Not meet inclusion criteria|6
4542789|NCT01151579|7366980|FG001|Overall Study|Not meet inclusion criteria|4
4542790|NCT01151618|7366986|FG000|Overall Study|Adverse Event|2
4542791|NCT01151618|7366986|FG000|Overall Study|Withdrawal by Subject|7
4542792|NCT01152021|7367013|FG000|Overall Study|Adverse Event|4
4542793|NCT01152021|7367014|FG001|Overall Study|Adverse Event|4
4542794|NCT01152021|7367013|FG000|Overall Study|Study drug had expired|1
4542795|NCT01152021|7367014|FG001|Overall Study|Study drug had expired|0
4542796|NCT01152021|7367013|FG000|Overall Study|Physician Decision|1
4542797|NCT01152021|7367014|FG001|Overall Study|Physician Decision|1
4542798|NCT01152021|7367013|FG000|Overall Study|No access to study drug in Pharmacy|0
4542799|NCT01152021|7367014|FG001|Overall Study|No access to study drug in Pharmacy|1
4542800|NCT01152190|7367033|FG000|Overall Study|Adverse Event|2
4542801|NCT01152190|7367034|FG001|Overall Study|Adverse Event|4
4542802|NCT01152190|7367033|FG000|Overall Study|Death|1
4542803|NCT01152190|7367034|FG001|Overall Study|Death|0
4542804|NCT01152190|7367033|FG000|Overall Study|Protocol Violation|1
4542805|NCT01152190|7367034|FG001|Overall Study|Protocol Violation|1
4542806|NCT01152190|7367033|FG000|Overall Study|Withdrawal by Subject|1
4542807|NCT01152190|7367034|FG001|Overall Study|Withdrawal by Subject|3
4542808|NCT01152385|7367071|FG000|Overall Study|Withdrawal by Subject|3
4542809|NCT01152385|7367072|FG001|Overall Study|Withdrawal by Subject|1
4542810|NCT01152385|7367073|FG002|Overall Study|Withdrawal by Subject|1
4542811|NCT01152385|7367074|FG003|Overall Study|Withdrawal by Subject|1
4542812|NCT01152385|7367071|FG000|Overall Study|Protocol Violation|0
4542813|NCT01152385|7367072|FG001|Overall Study|Protocol Violation|0
4542814|NCT01152385|7367073|FG002|Overall Study|Protocol Violation|0
4542815|NCT01152385|7367074|FG003|Overall Study|Protocol Violation|1
4542816|NCT01152385|7367071|FG000|Overall Study|Adverse Event|1
4617214|NCT01747499|7476639|FG004|Overall Study|Developed AML and death|1
4617215|NCT01747499|7476635|FG000|Overall Study|Determined not to be eligible|0
4617216|NCT01747499|7476636|FG001|Overall Study|Determined not to be eligible|0
4617217|NCT01747499|7476637|FG002|Overall Study|Determined not to be eligible|0
4617218|NCT01747499|7476638|FG003|Overall Study|Determined not to be eligible|0
4617219|NCT01747499|7476639|FG004|Overall Study|Determined not to be eligible|1
4542817|NCT01152385|7367072|FG001|Overall Study|Adverse Event|1
4542818|NCT01152385|7367073|FG002|Overall Study|Adverse Event|0
4542819|NCT01152385|7367074|FG003|Overall Study|Adverse Event|0
4542820|NCT01152385|7367071|FG000|Overall Study|Study-specific withdrawal criteria|1
4542821|NCT01152385|7367072|FG001|Overall Study|Study-specific withdrawal criteria|1
4617220|NCT01747551|7476655|FG000|Overall Study|Progressive Disease|24
4617221|NCT01747551|7476656|FG001|Overall Study|Progressive Disease|17
4617222|NCT01747551|7476655|FG000|Overall Study|Death|3
4617223|NCT01747551|7476656|FG001|Overall Study|Death|1
4617224|NCT01747551|7476655|FG000|Overall Study|Adverse Event|7
4617225|NCT01747551|7476656|FG001|Overall Study|Adverse Event|1
4617226|NCT01747551|7476655|FG000|Overall Study|Prolonged Treatment Delay|2
4617227|NCT01747551|7476656|FG001|Overall Study|Prolonged Treatment Delay|0
4617228|NCT01747551|7476655|FG000|Overall Study|Withdrawal by Subject|3
4617229|NCT01747551|7476656|FG001|Overall Study|Withdrawal by Subject|1
4617230|NCT01747551|7476655|FG000|Overall Study|Physician Decision|2
4617231|NCT01747551|7476656|FG001|Overall Study|Physician Decision|1
4617232|NCT01747551|7476655|FG000|Overall Study|Other|2
4617233|NCT01747551|7476656|FG001|Overall Study|Other|0
4617234|NCT01747629|7476664|FG000|Overall Study|Adverse Event|1
4617235|NCT01747629|7476665|FG001|Overall Study|Adverse Event|2
4617236|NCT01747629|7476664|FG000|Overall Study|Withdrawal by Subject|2
4617237|NCT01747629|7476665|FG001|Overall Study|Withdrawal by Subject|2
4617238|NCT01747629|7476664|FG000|Overall Study|Noncompliance|1
4617239|NCT01747629|7476665|FG001|Overall Study|Noncompliance|1
4617240|NCT01747629|7476664|FG000|Overall Study|Inclusion criteria not met|1
4617241|NCT01747629|7476665|FG001|Overall Study|Inclusion criteria not met|0
4617242|NCT01747629|7476664|FG000|Overall Study|Not treated|1
4617243|NCT01747629|7476665|FG001|Overall Study|Not treated|0
4617244|NCT01747629|7476664|FG000|Overall Study|Other|2
4617245|NCT01747629|7476665|FG001|Overall Study|Other|1
4617246|NCT01747655|7476671|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5
4617247|NCT01747655|7476672|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0
4617248|NCT01747655|7476671|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8
4617249|NCT01747655|7476672|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0
4617250|NCT01747655|7476671|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1
4617251|NCT01747655|7476672|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0
4617252|NCT01747772|7476678|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9
4617253|NCT01747811|7476688|FG000|Overall Study|Lack of Efficacy|2
4617254|NCT01747811|7476689|FG001|Overall Study|Lack of Efficacy|4
4447913|NCT00492856|7233152|FG000|Induction|Death|3
4447914|NCT00492856|7233153|FG001|Induction|Death|0
4447915|NCT00492856|7233154|FG002|Induction|Death|0
4447916|NCT00492856|7233155|FG003|Induction|Death|0
4447917|NCT00492856|7233152|FG000|Consolidation|Adverse Event|6
4447918|NCT00492856|7233153|FG001|Consolidation|Adverse Event|0
4447919|NCT00492856|7233154|FG002|Consolidation|Adverse Event|0
4447920|NCT00492856|7233155|FG003|Consolidation|Adverse Event|0
4447921|NCT00492856|7233152|FG000|Consolidation|Not protocol specified|2
4447922|NCT00492856|7233153|FG001|Consolidation|Not protocol specified|0
4447923|NCT00492856|7233154|FG002|Consolidation|Not protocol specified|0
4447924|NCT00492856|7233155|FG003|Consolidation|Not protocol specified|0
4447925|NCT00492856|7233152|FG000|Consolidation|Lost to Follow-up|1
4447926|NCT00492856|7233153|FG001|Consolidation|Lost to Follow-up|0
4447927|NCT00492856|7233154|FG002|Consolidation|Lost to Follow-up|0
4447928|NCT00492856|7233155|FG003|Consolidation|Lost to Follow-up|0
4447929|NCT00492856|7233152|FG000|Post-consolidation|Adverse Event|0
4542822|NCT01152385|7367073|FG002|Overall Study|Study-specific withdrawal criteria|2
4542823|NCT01152385|7367074|FG003|Overall Study|Study-specific withdrawal criteria|0
4542824|NCT01152385|7367071|FG000|Overall Study|Other|4
4542825|NCT01152385|7367072|FG001|Overall Study|Other|3
4542826|NCT01152385|7367073|FG002|Overall Study|Other|2
4542827|NCT01152385|7367074|FG003|Overall Study|Other|3
4542828|NCT01152437|7367091|FG000|Overall Study|Other Adverse Event|8
4542829|NCT01152437|7367092|FG001|Overall Study|Other Adverse Event|1
4542830|NCT01152437|7367093|FG002|Overall Study|Other Adverse Event|7
4542831|NCT01152437|7367091|FG000|Overall Study|Not treated|0
4542832|NCT01152437|7367092|FG001|Overall Study|Not treated|1
4542833|NCT01152437|7367093|FG002|Overall Study|Not treated|2
4542834|NCT01152437|7367091|FG000|Overall Study|Progressive disease|27
4447930|NCT00492856|7233153|FG001|Post-consolidation|Adverse Event|4
4447931|NCT00492856|7233154|FG002|Post-consolidation|Adverse Event|0
4542835|NCT01152437|7367092|FG001|Overall Study|Progressive disease|13
4542836|NCT01152437|7367093|FG002|Overall Study|Progressive disease|32
4542837|NCT01152437|7367091|FG000|Overall Study|Refusal to continue taking trial medicat|1
4542838|NCT01152437|7367092|FG001|Overall Study|Refusal to continue taking trial medicat|0
4542839|NCT01152437|7367093|FG002|Overall Study|Refusal to continue taking trial medicat|2
4542840|NCT01152450|7367103|FG000|Period 1 (4 Weeks)|Adverse Event|0
4542841|NCT01152450|7367104|FG001|Period 1 (4 Weeks)|Adverse Event|0
4542842|NCT01152450|7367105|FG002|Period 1 (4 Weeks)|Adverse Event|0
4542843|NCT01152450|7367106|FG003|Period 1 (4 Weeks)|Adverse Event|0
4542844|NCT01152450|7367107|FG004|Period 1 (4 Weeks)|Adverse Event|1
4542845|NCT01152450|7367108|FG005|Period 1 (4 Weeks)|Adverse Event|1
4542846|NCT01152450|7367103|FG000|Period 1 (4 Weeks)|Protocol Violation|0
4542847|NCT01152450|7367104|FG001|Period 1 (4 Weeks)|Protocol Violation|0
4542848|NCT01152450|7367105|FG002|Period 1 (4 Weeks)|Protocol Violation|0
4542849|NCT01152450|7367106|FG003|Period 1 (4 Weeks)|Protocol Violation|0
4542850|NCT01152450|7367107|FG004|Period 1 (4 Weeks)|Protocol Violation|1
4542851|NCT01152450|7367108|FG005|Period 1 (4 Weeks)|Protocol Violation|0
4542852|NCT01152450|7367103|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0
4542853|NCT01152450|7367104|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1
4542854|NCT01152450|7367105|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1
4542855|NCT01152450|7367106|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0
4542856|NCT01152450|7367107|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0
4542857|NCT01152450|7367108|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0
4542858|NCT01152554|7367127|FG000|Overall Study|Withdrawal by Subject|73
4542859|NCT01152554|7367128|FG001|Overall Study|Withdrawal by Subject|28
4542860|NCT01152554|7367127|FG000|Overall Study|Eligiblity criteria not fulfilled|0
4542861|NCT01152554|7367128|FG001|Overall Study|Eligiblity criteria not fulfilled|1
4542862|NCT01152554|7367127|FG000|Overall Study|Adverse Event|67
4542863|NCT01152554|7367128|FG001|Overall Study|Adverse Event|14
4542864|NCT01152554|7367127|FG000|Overall Study|Severe non-compliance to protocol|36
4542865|NCT01152554|7367128|FG001|Overall Study|Severe non-compliance to protocol|14
4542866|NCT01152554|7367127|FG000|Overall Study|Condition under investigation worsened|5
4542867|NCT01152554|7367128|FG001|Overall Study|Condition under investigation worsened|2
4542868|NCT01152554|7367127|FG000|Overall Study|Lack of Efficacy|20
4542869|NCT01152554|7367128|FG001|Overall Study|Lack of Efficacy|3
4617255|NCT01747837|7476699|FG000|Overall Study|Lost to Follow-up|5
4542870|NCT01152554|7367127|FG000|Overall Study|Study-specific withdrawal criteria|17
4542871|NCT01152554|7367128|FG001|Overall Study|Study-specific withdrawal criteria|8
4542872|NCT01152554|7367127|FG000|Overall Study|Lost to Follow-up|87
4542873|NCT01152554|7367128|FG001|Overall Study|Lost to Follow-up|32
4542874|NCT01152554|7367127|FG000|Overall Study|Other|28
4542875|NCT01152554|7367128|FG001|Overall Study|Other|8
4542876|NCT01152554|7367127|FG000|Overall Study|Death|1
4542877|NCT01152554|7367128|FG001|Overall Study|Death|1
4542878|NCT01152580|7367136|FG000|Overall Study|Withdrawal by Subject|0
4542879|NCT01152580|7367137|FG001|Overall Study|Withdrawal by Subject|1
4617256|NCT01747837|7476700|FG001|Overall Study|Lost to Follow-up|2
4617257|NCT01747837|7476699|FG000|Overall Study|Death|4
4617258|NCT01747837|7476700|FG001|Overall Study|Death|4
4617259|NCT01747876|7476734|FG000|Overall Study|Adverse Event|1
4542880|NCT01152788|7367149|FG000|Overall Study|Withdrawal by Subject|0
4542881|NCT01152788|7367150|FG001|Overall Study|Withdrawal by Subject|3
4542882|NCT01152788|7367149|FG000|Overall Study|No treatment|0
4542883|NCT01152788|7367150|FG001|Overall Study|No treatment|1
4542884|NCT01152814|7367156|FG000|Overall Study|Lost to Follow-up|2
4542885|NCT01152996|7367160|FG000|Overall Study|Withdrawal by Subject|142
4542886|NCT01152996|7367160|FG000|Overall Study|Adverse Event|115
4542887|NCT01152996|7367160|FG000|Overall Study|Lost to Follow-up|112
4542888|NCT01152996|7367160|FG000|Overall Study|Lack of Efficacy|68
4542889|NCT01152996|7367160|FG000|Overall Study|Noncompliance|41
4542890|NCT01152996|7367160|FG000|Overall Study|Other|36
4542891|NCT01152996|7367160|FG000|Overall Study|Protocol Violation|22
4542892|NCT01152996|7367160|FG000|Overall Study|Elevated liver enzymes|1
4542893|NCT01153009|7367168|FG000|Overall Study|Adverse Event|4
4542894|NCT01153009|7367169|FG001|Overall Study|Adverse Event|14
4542895|NCT01153009|7367170|FG002|Overall Study|Adverse Event|14
4542896|NCT01153009|7367171|FG003|Overall Study|Adverse Event|10
4542897|NCT01153009|7367168|FG000|Overall Study|Lack of Efficacy|9
4542898|NCT01153009|7367169|FG001|Overall Study|Lack of Efficacy|0
4542899|NCT01153009|7367170|FG002|Overall Study|Lack of Efficacy|2
4542900|NCT01153009|7367171|FG003|Overall Study|Lack of Efficacy|1
4542901|NCT01153009|7367168|FG000|Overall Study|Noncompliance with Study Medication|1
4542902|NCT01153009|7367169|FG001|Overall Study|Noncompliance with Study Medication|3
4542903|NCT01153009|7367170|FG002|Overall Study|Noncompliance with Study Medication|4
4542904|NCT01153009|7367171|FG003|Overall Study|Noncompliance with Study Medication|1
4542905|NCT01153009|7367168|FG000|Overall Study|Protocol Deviations|4
4542906|NCT01153009|7367169|FG001|Overall Study|Protocol Deviations|3
4542907|NCT01153009|7367170|FG002|Overall Study|Protocol Deviations|3
4542908|NCT01153009|7367171|FG003|Overall Study|Protocol Deviations|2
4542909|NCT01153009|7367168|FG000|Overall Study|Withdrawal of Consent|5
4542910|NCT01153009|7367169|FG001|Overall Study|Withdrawal of Consent|5
4542911|NCT01153009|7367170|FG002|Overall Study|Withdrawal of Consent|4
4542912|NCT01153009|7367171|FG003|Overall Study|Withdrawal of Consent|6
4542913|NCT01153009|7367168|FG000|Overall Study|Lost to Follow-up|8
4542914|NCT01153009|7367169|FG001|Overall Study|Lost to Follow-up|8
4542915|NCT01153009|7367170|FG002|Overall Study|Lost to Follow-up|11
4542916|NCT01153009|7367171|FG003|Overall Study|Lost to Follow-up|15
4542917|NCT01153009|7367168|FG000|Overall Study|Other|1
4542918|NCT01153009|7367169|FG001|Overall Study|Other|1
4542919|NCT01153009|7367170|FG002|Overall Study|Other|3
4542920|NCT01153009|7367171|FG003|Overall Study|Other|2
4542921|NCT01153269|7367181|FG000|Overall Study|Withdrawal by Subject|1
4542922|NCT01153269|7367181|FG000|Overall Study|Antiretroviral therapy break|1
4542923|NCT01153321|7367190|FG000|Overall Study|Development of study withdrawal criteria|0
4542924|NCT01153321|7367191|FG001|Overall Study|Development of study withdrawal criteria|1
4542925|NCT01153321|7367190|FG000|Overall Study|Withdrawal by Subject|0
4542926|NCT01153321|7367191|FG001|Overall Study|Withdrawal by Subject|1
4542927|NCT01153321|7367190|FG000|Overall Study|Adverse Event|1
4542928|NCT01153321|7367191|FG001|Overall Study|Adverse Event|1
4542929|NCT01153347|7367201|FG000|Overall Study|Withdrawal by Subject|7
4542930|NCT01153347|7367202|FG001|Overall Study|Withdrawal by Subject|7
4542931|NCT01153347|7367203|FG002|Overall Study|Withdrawal by Subject|7
4542932|NCT01153347|7367204|FG003|Overall Study|Withdrawal by Subject|7
4542933|NCT01153347|7367201|FG000|Overall Study|Eligibility criteria not fulfilled|0
4542934|NCT01153347|7367202|FG001|Overall Study|Eligibility criteria not fulfilled|1
4542935|NCT01153347|7367203|FG002|Overall Study|Eligibility criteria not fulfilled|2
4542936|NCT01153347|7367204|FG003|Overall Study|Eligibility criteria not fulfilled|1
4542937|NCT01153347|7367201|FG000|Overall Study|Adverse Event|3
4542938|NCT01153347|7367202|FG001|Overall Study|Adverse Event|9
4542939|NCT01153347|7367203|FG002|Overall Study|Adverse Event|21
4542940|NCT01153347|7367204|FG003|Overall Study|Adverse Event|7
4542941|NCT01153347|7367201|FG000|Overall Study|Severe non-compliance to protocol|6
4542942|NCT01153347|7367202|FG001|Overall Study|Severe non-compliance to protocol|7
4542943|NCT01153347|7367203|FG002|Overall Study|Severe non-compliance to protocol|4
4542944|NCT01153347|7367204|FG003|Overall Study|Severe non-compliance to protocol|3
4542945|NCT01153347|7367201|FG000|Overall Study|Condition under investigation worsened|1
4542946|NCT01153347|7367202|FG001|Overall Study|Condition under investigation worsened|1
4542947|NCT01153347|7367203|FG002|Overall Study|Condition under investigation worsened|0
4542948|NCT01153347|7367204|FG003|Overall Study|Condition under investigation worsened|0
4542949|NCT01153347|7367201|FG000|Overall Study|Lack of Efficacy|2
4542950|NCT01153347|7367202|FG001|Overall Study|Lack of Efficacy|2
4542951|NCT01153347|7367203|FG002|Overall Study|Lack of Efficacy|0
4542952|NCT01153347|7367204|FG003|Overall Study|Lack of Efficacy|4
4542953|NCT01153347|7367201|FG000|Overall Study|Study-specific withdrawal criteria|4
4542954|NCT01153347|7367202|FG001|Overall Study|Study-specific withdrawal criteria|3
4542955|NCT01153347|7367203|FG002|Overall Study|Study-specific withdrawal criteria|1
4542956|NCT01153347|7367204|FG003|Overall Study|Study-specific withdrawal criteria|2
4542957|NCT01153347|7367201|FG000|Overall Study|Lost to Follow-up|4
4542958|NCT01153347|7367202|FG001|Overall Study|Lost to Follow-up|9
4542959|NCT01153347|7367203|FG002|Overall Study|Lost to Follow-up|11
4542960|NCT01153347|7367204|FG003|Overall Study|Lost to Follow-up|8
4542961|NCT01153347|7367201|FG000|Overall Study|Other|5
4542962|NCT01153347|7367202|FG001|Overall Study|Other|5
4542963|NCT01153347|7367203|FG002|Overall Study|Other|4
4542964|NCT01153347|7367204|FG003|Overall Study|Other|0
4542965|NCT01153347|7367201|FG000|Overall Study|Death|1
4542966|NCT01153347|7367202|FG001|Overall Study|Death|0
4542967|NCT01153347|7367203|FG002|Overall Study|Death|0
4542968|NCT01153347|7367204|FG003|Overall Study|Death|0
4542969|NCT01153425|7367216|FG000|Overall Study|Withdrawal by Subject|3
4542970|NCT01153425|7367217|FG001|Overall Study|Withdrawal by Subject|3
4542971|NCT01153516|7367239|FG000|Overall Study|Both subjects refused surgery|2
4542972|NCT01153516|7367240|FG001|Overall Study|Both subjects refused surgery|0
4542973|NCT01153633|7367267|FG000|Overall Study|Protocol Violation|1
4542974|NCT01153633|7367268|FG001|Overall Study|Protocol Violation|1
4542975|NCT01153633|7367267|FG000|Overall Study|Therapeutic failure|3
4542976|NCT01153633|7367268|FG001|Overall Study|Therapeutic failure|3
4542977|NCT01153698|7367289|FG000|Overall Study|Adverse Event|12
4542978|NCT01153698|7367289|FG000|Overall Study|Lost to Follow-up|4
4542979|NCT01153698|7367289|FG000|Overall Study|Withdrawal by Subject|2
4542980|NCT01153698|7367289|FG000|Overall Study|Switch to other anticoagulants|4
4542981|NCT01153698|7367289|FG000|Overall Study|Other|2
4542982|NCT01153698|7367289|FG000|Overall Study|Not treated with Pradaxa|5
4542983|NCT01153724|7367300|FG000|Treatment Period 1|Withdrawal by Subject|1
4542984|NCT01153724|7367300|FG000|Treatment Period 2|Adverse Event|1
4542985|NCT01153724|7367300|FG000|Treatment Period 2|Other reason not defined above|1
4542986|NCT01153763|7367306|FG000|Overall Study|Study Closed|16
4542987|NCT01153763|7367306|FG000|Overall Study|Lost to Follow-up|1
4542988|NCT01153763|7367306|FG000|Overall Study|Physician Decision|2
4542989|NCT01153763|7367306|FG000|Overall Study|Withdrawal by Subject|2
4542990|NCT01153815|7367312|FG000|Overall Study|Adverse Event|3
4542991|NCT01153815|7367313|FG001|Overall Study|Adverse Event|1
4542992|NCT01153815|7367312|FG000|Overall Study|Withdrawal by Subject|6
4542993|NCT01153815|7367313|FG001|Overall Study|Withdrawal by Subject|4
4542994|NCT01153841|7367321|FG000|Overall Study|Adverse Event|1
4542995|NCT01153841|7367322|FG001|Overall Study|Adverse Event|0
4542996|NCT01153841|7367321|FG000|Overall Study|Withdrawal by Subject|1
4542997|NCT01153841|7367322|FG001|Overall Study|Withdrawal by Subject|0
4542998|NCT01153841|7367321|FG000|Overall Study|Protocol Violation|2
4542999|NCT01153841|7367322|FG001|Overall Study|Protocol Violation|0
4543000|NCT01153841|7367321|FG000|Overall Study|Lost to Follow-up|2
4543001|NCT01153841|7367322|FG001|Overall Study|Lost to Follow-up|0
4543002|NCT01153893|7367330|FG000|Overall Study|Adverse Event|1
4543003|NCT01153893|7367331|FG001|Overall Study|Adverse Event|0
4543004|NCT01153958|7367339|FG000|Overall Study|Study Terminated|36
4543005|NCT01153958|7367340|FG001|Overall Study|Study Terminated|32
4543006|NCT01153971|7367346|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2
4543007|NCT01153971|7367346|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1
4543008|NCT01153971|7367346|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2
4543009|NCT01153971|7367346|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1
4543010|NCT01153971|7367346|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1
4543011|NCT01153971|7367346|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1
4543012|NCT01153971|7367346|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2
4543013|NCT01153984|7367350|FG000|Overall Study|Withdrawal by Subject|1
4543014|NCT01153984|7367350|FG000|Overall Study|Adverse Event|1
4543015|NCT01154010|7367356|FG000|Overall Study|Lost to Follow-up|0
4543016|NCT01154010|7367357|FG001|Overall Study|Lost to Follow-up|1
4543017|NCT01154088|7367366|FG000|Overall Study|Lost to Follow-up|4
4543018|NCT01154088|7367367|FG001|Overall Study|Lost to Follow-up|6
4543019|NCT01154088|7367368|FG002|Overall Study|Lost to Follow-up|7
4543020|NCT01154101|7367382|FG000|Overall Study|Adverse Event|0
4543021|NCT01154101|7367383|FG001|Overall Study|Adverse Event|2
4543022|NCT01154101|7367384|FG002|Overall Study|Adverse Event|1
4543023|NCT01154101|7367385|FG003|Overall Study|Adverse Event|1
4543024|NCT01154101|7367386|FG004|Overall Study|Adverse Event|0
4543025|NCT01154101|7367382|FG000|Overall Study|Lost to Follow-up|0
4447932|NCT00492856|7233155|FG003|Post-consolidation|Adverse Event|1
4617260|NCT01747876|7476735|FG001|Overall Study|Adverse Event|0
4617261|NCT01747876|7476736|FG002|Overall Study|Adverse Event|2
4617262|NCT01747876|7476734|FG000|Overall Study|Withdrawal by Subject|0
4617263|NCT01747876|7476735|FG001|Overall Study|Withdrawal by Subject|1
4617264|NCT01747876|7476736|FG002|Overall Study|Withdrawal by Subject|1
4617265|NCT01747876|7476734|FG000|Overall Study|Disease progression|4
4617266|NCT01747876|7476735|FG001|Overall Study|Disease progression|13
4617267|NCT01747876|7476736|FG002|Overall Study|Disease progression|8
4617268|NCT01747876|7476734|FG000|Overall Study|Trtment duration compl. as per protocol|0
4617269|NCT01747876|7476735|FG001|Overall Study|Trtment duration compl. as per protocol|1
4617270|NCT01747876|7476736|FG002|Overall Study|Trtment duration compl. as per protocol|1
4617271|NCT01747915|7476750|FG000|Overall Study|Other|1
4617272|NCT01747915|7476751|FG001|Overall Study|Other|1
4617273|NCT01747915|7476752|FG002|Overall Study|Other|1
4617274|NCT01747915|7476750|FG000|Overall Study|Adverse Event|8
4543026|NCT01154101|7367383|FG001|Overall Study|Lost to Follow-up|1
4543027|NCT01154101|7367384|FG002|Overall Study|Lost to Follow-up|0
4543028|NCT01154101|7367385|FG003|Overall Study|Lost to Follow-up|1
4543029|NCT01154101|7367386|FG004|Overall Study|Lost to Follow-up|0
4617275|NCT01747915|7476751|FG001|Overall Study|Adverse Event|5
4543030|NCT01154101|7367382|FG000|Overall Study|Withdrawal by Subject|0
4543031|NCT01154101|7367383|FG001|Overall Study|Withdrawal by Subject|1
4543032|NCT01154101|7367384|FG002|Overall Study|Withdrawal by Subject|2
4543033|NCT01154101|7367385|FG003|Overall Study|Withdrawal by Subject|0
4543034|NCT01154101|7367386|FG004|Overall Study|Withdrawal by Subject|1
4543035|NCT01154127|7367405|FG000|Period 1 (21 Days)|Adverse Event|3
4543036|NCT01154127|7367406|FG001|Period 1 (21 Days)|Adverse Event|4
4543037|NCT01154127|7367405|FG000|Period 1 (21 Days)|Withdrawal by Subject|0
4543038|NCT01154127|7367406|FG001|Period 1 (21 Days)|Withdrawal by Subject|2
4617276|NCT01747915|7476752|FG002|Overall Study|Adverse Event|2
4617277|NCT01747915|7476750|FG000|Overall Study|Death|0
4617278|NCT01747915|7476751|FG001|Overall Study|Death|0
4617279|NCT01747915|7476752|FG002|Overall Study|Death|1
4617280|NCT01747915|7476750|FG000|Overall Study|Lack of Efficacy|0
4617281|NCT01747915|7476751|FG001|Overall Study|Lack of Efficacy|1
4617282|NCT01747915|7476752|FG002|Overall Study|Lack of Efficacy|0
4543039|NCT01154127|7367405|FG000|Washout (14 - 28 Days)|Adverse Event|2
4543040|NCT01154127|7367406|FG001|Washout (14 - 28 Days)|Adverse Event|0
4543041|NCT01154127|7367405|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1
4543042|NCT01154127|7367406|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0
4543043|NCT01154127|7367405|FG000|Period 2 (21 Days)|Protocol Deviation|0
4543044|NCT01154127|7367406|FG001|Period 2 (21 Days)|Protocol Deviation|1
4543045|NCT01154140|7367414|FG000|Overall Study|Death|71
4617283|NCT01747915|7476750|FG000|Overall Study|Lost to Follow-up|1
4617284|NCT01747915|7476751|FG001|Overall Study|Lost to Follow-up|0
4617285|NCT01747915|7476752|FG002|Overall Study|Lost to Follow-up|0
4617286|NCT01747915|7476750|FG000|Overall Study|Withdrawal by Subject|4
4617287|NCT01747915|7476751|FG001|Overall Study|Withdrawal by Subject|4
4617288|NCT01747915|7476752|FG002|Overall Study|Withdrawal by Subject|1
4617289|NCT01747915|7476750|FG000|Overall Study|Protocol Violation|1
4543046|NCT01154140|7367415|FG001|Overall Study|Death|81
4543047|NCT01154140|7367414|FG000|Overall Study|Lost to Follow-up|4
4543048|NCT01154140|7367415|FG001|Overall Study|Lost to Follow-up|5
4543049|NCT01154140|7367414|FG000|Overall Study|Withdrawal by Subject|12
4543050|NCT01154140|7367415|FG001|Overall Study|Withdrawal by Subject|13
4543051|NCT01154140|7367414|FG000|Overall Study|Other|3
4543052|NCT01154140|7367415|FG001|Overall Study|Other|1
4543053|NCT01154140|7367414|FG000|Overall Study|Randomized but not treated|1
4543054|NCT01154140|7367415|FG001|Overall Study|Randomized but not treated|2
4543055|NCT01154153|7367423|FG000|Overall Study|Poor compliance to protocol|2
4543056|NCT01154153|7367424|FG001|Overall Study|Poor compliance to protocol|0
4543057|NCT01154153|7367423|FG000|Overall Study|Unable to use labs|2
4543058|NCT01154153|7367424|FG001|Overall Study|Unable to use labs|3
4543059|NCT01154153|7367423|FG000|Overall Study|Withdrew consent|1
4543060|NCT01154153|7367424|FG001|Overall Study|Withdrew consent|0
4543061|NCT01154166|7367432|FG000|Overall Study|Adverse Event|14
4543062|NCT01154166|7367433|FG001|Overall Study|Adverse Event|9
4543063|NCT01154166|7367432|FG000|Overall Study|Lost to Follow-up|1
4543064|NCT01154166|7367433|FG001|Overall Study|Lost to Follow-up|1
4543065|NCT01154166|7367432|FG000|Overall Study|Protocol Violation|4
4543066|NCT01154166|7367433|FG001|Overall Study|Protocol Violation|1
4543067|NCT01154166|7367432|FG000|Overall Study|Withdrawal by Subject|10
4543068|NCT01154166|7367433|FG001|Overall Study|Withdrawal by Subject|1
4543069|NCT01154166|7367432|FG000|Overall Study|Lack of Efficacy|3
4543070|NCT01154166|7367433|FG001|Overall Study|Lack of Efficacy|0
4543071|NCT01154166|7367432|FG000|Overall Study|Disease Progression|1
4543072|NCT01154166|7367433|FG001|Overall Study|Disease Progression|0
4617290|NCT01747915|7476751|FG001|Overall Study|Protocol Violation|0
4617291|NCT01747915|7476752|FG002|Overall Study|Protocol Violation|0
4543073|NCT01154166|7367432|FG000|Overall Study|Poor Compliance|1
4617292|NCT01747915|7476750|FG000|Overall Study|Pregnancy|0
4617293|NCT01747915|7476751|FG001|Overall Study|Pregnancy|0
4617294|NCT01747915|7476752|FG002|Overall Study|Pregnancy|1
4617295|NCT01748071|7476812|FG000|Overall Study|Adverse Event|2
4617296|NCT01748071|7476813|FG001|Overall Study|Adverse Event|2
4617297|NCT01748071|7476814|FG002|Overall Study|Adverse Event|0
4632963|NCT01905683|7502743|FG000|Overall Study|Lack of Efficacy|8
4632964|NCT01905683|7502743|FG000|Overall Study|Withdrawal by Subject|20
4632965|NCT01905683|7502743|FG000|Overall Study|Adverse Event|4
4543074|NCT01154166|7367433|FG001|Overall Study|Poor Compliance|0
4543075|NCT01154218|7367453|FG000|Third Intervention Period|Adverse Event|0
4543076|NCT01154218|7367454|FG001|Third Intervention Period|Adverse Event|1
4543077|NCT01154218|7367455|FG002|Third Intervention Period|Adverse Event|0
4543078|NCT01154218|7367456|FG003|Third Intervention Period|Adverse Event|0
4543079|NCT01154218|7367453|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
4543080|NCT01154218|7367454|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
4543081|NCT01154218|7367455|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
4543082|NCT01154218|7367456|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1
4543083|NCT01154218|7367453|FG000|Fourth Intervention Period|Withdrawal by Subject|1
4543084|NCT01154218|7367454|FG001|Fourth Intervention Period|Withdrawal by Subject|0
4543085|NCT01154218|7367455|FG002|Fourth Intervention Period|Withdrawal by Subject|0
4543086|NCT01154218|7367456|FG003|Fourth Intervention Period|Withdrawal by Subject|0
4632966|NCT01905683|7502743|FG000|Overall Study|Lost to Follow-up|4
4632967|NCT01905943|7502747|FG000|Overall Study|Withdrawal of consent|90
4543087|NCT01154231|7367466|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1
4543088|NCT01154231|7367466|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1
4543089|NCT01154283|7367472|FG000|0-6 Weeks|Withdrawal by Subject|7
4543090|NCT01154283|7367473|FG001|0-6 Weeks|Withdrawal by Subject|2
4543091|NCT01154283|7367472|FG000|0-6 Weeks|Death|0
4543092|NCT01154283|7367473|FG001|0-6 Weeks|Death|1
4543093|NCT01154283|7367472|FG000|7-12 Weeks|Death|1
4543094|NCT01154283|7367473|FG001|7-12 Weeks|Death|0
4543095|NCT01154283|7367472|FG000|7-12 Weeks|Withdrawal by Subject|0
4543096|NCT01154283|7367473|FG001|7-12 Weeks|Withdrawal by Subject|1
4543097|NCT01154296|7367481|FG000|Randomization and Intervention|Decided to decline|1
4543098|NCT01154296|7367482|FG001|Randomization and Intervention|Decided to decline|1
4543099|NCT01154296|7367481|FG000|Randomization and Intervention|Declined by staff|1
4543100|NCT01154296|7367482|FG001|Randomization and Intervention|Declined by staff|0
4543101|NCT01154296|7367481|FG000|Randomization and Intervention|Did not return|1
4543102|NCT01154296|7367482|FG001|Randomization and Intervention|Did not return|0
4543103|NCT01154296|7367481|FG000|Randomization and Intervention|Left before test|0
4543104|NCT01154296|7367482|FG001|Randomization and Intervention|Left before test|1
4543105|NCT01154296|7367481|FG000|Randomization and Intervention|Left clinic early|2
4543106|NCT01154296|7367482|FG001|Randomization and Intervention|Left clinic early|0
4543107|NCT01154296|7367481|FG000|6-month Follow-up|Lost contact|269
4543108|NCT01154296|7367482|FG001|6-month Follow-up|Lost contact|275
4543109|NCT01154296|7367481|FG000|6-month Follow-up|Incarcerated|37
4543110|NCT01154296|7367482|FG001|6-month Follow-up|Incarcerated|32
4543111|NCT01154296|7367481|FG000|6-month Follow-up|Withdrew consent|14
4543112|NCT01154296|7367482|FG001|6-month Follow-up|Withdrew consent|15
4543113|NCT01154296|7367481|FG000|6-month Follow-up|Death|3
4543114|NCT01154296|7367482|FG001|6-month Follow-up|Death|2
4543115|NCT01154296|7367481|FG000|6-month Follow-up|Declined by Study Coordinator|5
4543116|NCT01154296|7367482|FG001|6-month Follow-up|Declined by Study Coordinator|4
4543117|NCT01154452|7367509|FG000|Phase Ib|Not Treated|1
4543118|NCT01154452|7367510|FG001|Phase Ib|Not Treated|0
4543119|NCT01154452|7367511|FG002|Phase Ib|Not Treated|0
4543120|NCT01154452|7367512|FG003|Phase Ib|Not Treated|0
4543121|NCT01154452|7367509|FG000|Phase Ib|Adverse Event|2
4543122|NCT01154452|7367510|FG001|Phase Ib|Adverse Event|1
4543123|NCT01154452|7367511|FG002|Phase Ib|Adverse Event|0
4543124|NCT01154452|7367512|FG003|Phase Ib|Adverse Event|0
4543125|NCT01154452|7367509|FG000|Phase II|Withdrawal by Subject|0
4543126|NCT01154452|7367510|FG001|Phase II|Withdrawal by Subject|0
4543127|NCT01154452|7367511|FG002|Phase II|Withdrawal by Subject|1
4543128|NCT01154452|7367512|FG003|Phase II|Withdrawal by Subject|2
4543129|NCT01154452|7367509|FG000|Phase II|Adverse Event|0
4543130|NCT01154452|7367510|FG001|Phase II|Adverse Event|0
4543131|NCT01154452|7367511|FG002|Phase II|Adverse Event|4
4543132|NCT01154452|7367512|FG003|Phase II|Adverse Event|4
4543133|NCT01154673|7367544|FG000|Overall Study|Lost to Follow-up|1
4543134|NCT01154673|7367545|FG001|Overall Study|Lost to Follow-up|0
4543135|NCT01154673|7367544|FG000|Overall Study|moved out of province|1
4543136|NCT01154673|7367545|FG001|Overall Study|moved out of province|0
4543137|NCT01154816|7367578|FG000|Overall Study|Withdrawal by Subject|1
4543138|NCT01154816|7367579|FG001|Overall Study|Withdrawal by Subject|0
4543139|NCT01154816|7367580|FG002|Overall Study|Withdrawal by Subject|0
4543140|NCT01154816|7367581|FG003|Overall Study|Withdrawal by Subject|1
4543141|NCT01154816|7367582|FG004|Overall Study|Withdrawal by Subject|0
4543142|NCT01154816|7367583|FG005|Overall Study|Withdrawal by Subject|0
4543143|NCT01154816|7367584|FG006|Overall Study|Withdrawal by Subject|0
4543144|NCT01154816|7367585|FG007|Overall Study|Withdrawal by Subject|0
4543145|NCT01154816|7367586|FG008|Overall Study|Withdrawal by Subject|1
4543146|NCT01154816|7367587|FG009|Overall Study|Withdrawal by Subject|3
4543147|NCT01154816|7367588|FG010|Overall Study|Withdrawal by Subject|0
4543148|NCT01154816|7367589|FG011|Overall Study|Withdrawal by Subject|0
4543149|NCT01154816|7367578|FG000|Overall Study|Progressive Disease|13
4543150|NCT01154816|7367579|FG001|Overall Study|Progressive Disease|8
4543151|NCT01154816|7367580|FG002|Overall Study|Progressive Disease|9
4543152|NCT01154816|7367581|FG003|Overall Study|Progressive Disease|9
4543153|NCT01154816|7367582|FG004|Overall Study|Progressive Disease|8
4543154|NCT01154816|7367583|FG005|Overall Study|Progressive Disease|8
4543155|NCT01154816|7367584|FG006|Overall Study|Progressive Disease|5
4543156|NCT01154816|7367585|FG007|Overall Study|Progressive Disease|6
4617298|NCT01748292|7476833|FG000|Overall Study|Adverse Event|2
4617299|NCT01748292|7476834|FG001|Overall Study|Adverse Event|4
4617300|NCT01748292|7476833|FG000|Overall Study|Lost to Follow-up|0
4617301|NCT01748292|7476834|FG001|Overall Study|Lost to Follow-up|3
4617302|NCT01748292|7476833|FG000|Overall Study|Death|0
4543157|NCT01154816|7367586|FG008|Overall Study|Progressive Disease|8
4543158|NCT01154816|7367587|FG009|Overall Study|Progressive Disease|6
4543159|NCT01154816|7367588|FG010|Overall Study|Progressive Disease|10
4543160|NCT01154816|7367589|FG011|Overall Study|Progressive Disease|3
4543161|NCT01154816|7367578|FG000|Overall Study|Physician Decision|1
4543162|NCT01154816|7367579|FG001|Overall Study|Physician Decision|0
4543163|NCT01154816|7367580|FG002|Overall Study|Physician Decision|1
4543164|NCT01154816|7367581|FG003|Overall Study|Physician Decision|0
4543165|NCT01154816|7367582|FG004|Overall Study|Physician Decision|2
4543166|NCT01154816|7367583|FG005|Overall Study|Physician Decision|0
4543167|NCT01154816|7367584|FG006|Overall Study|Physician Decision|0
4543168|NCT01154816|7367585|FG007|Overall Study|Physician Decision|0
4543169|NCT01154816|7367586|FG008|Overall Study|Physician Decision|0
4543170|NCT01154816|7367587|FG009|Overall Study|Physician Decision|1
4543171|NCT01154816|7367588|FG010|Overall Study|Physician Decision|1
4543172|NCT01154816|7367589|FG011|Overall Study|Physician Decision|1
4543173|NCT01154816|7367578|FG000|Overall Study|Adverse Event|5
4543174|NCT01154816|7367579|FG001|Overall Study|Adverse Event|2
4543175|NCT01154816|7367580|FG002|Overall Study|Adverse Event|0
4543176|NCT01154816|7367581|FG003|Overall Study|Adverse Event|0
4617303|NCT01748292|7476834|FG001|Overall Study|Death|3
4617304|NCT01748292|7476833|FG000|Overall Study|Withdrawal by Subject|0
4617305|NCT01748292|7476834|FG001|Overall Study|Withdrawal by Subject|2
4617306|NCT01748552|7476852|FG000|Intervention Period 2 and Washout|Physician Decision|0
4617307|NCT01748552|7476853|FG001|Intervention Period 2 and Washout|Physician Decision|0
4617308|NCT01748552|7476854|FG002|Intervention Period 2 and Washout|Physician Decision|1
4617309|NCT01748552|7476855|FG003|Intervention Period 2 and Washout|Physician Decision|0
4617310|NCT01748552|7476856|FG004|Intervention Period 2 and Washout|Physician Decision|0
4617311|NCT01748552|7476857|FG005|Intervention Period 2 and Washout|Physician Decision|0
4617312|NCT01748552|7476858|FG006|Intervention Period 2 and Washout|Physician Decision|0
4617313|NCT01748552|7476859|FG007|Intervention Period 2 and Washout|Physician Decision|0
4617314|NCT01748552|7476860|FG008|Intervention Period 2 and Washout|Physician Decision|0
4617315|NCT01748552|7476861|FG009|Intervention Period 2 and Washout|Physician Decision|0
4617316|NCT01748552|7476862|FG010|Intervention Period 2 and Washout|Physician Decision|0
4617317|NCT01748552|7476863|FG011|Intervention Period 2 and Washout|Physician Decision|0
4617318|NCT01748552|7476852|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0
4617319|NCT01748552|7476853|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0
4617320|NCT01748552|7476854|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0
4617321|NCT01748552|7476855|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0
4617322|NCT01748552|7476856|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0
4617323|NCT01748552|7476857|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0
4617324|NCT01748552|7476858|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3
4617325|NCT01748552|7476859|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3
4617326|NCT01748552|7476860|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3
4617327|NCT01748552|7476861|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0
4617328|NCT01748552|7476862|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0
4617329|NCT01748552|7476863|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0
4617330|NCT01748760|7476921|FG000|Overall Study|Withdrawal by Subject|1
4617331|NCT01748760|7476922|FG001|Overall Study|Withdrawal by Subject|1
4617332|NCT01748760|7476921|FG000|Overall Study|Lost to Follow-up|5
4617333|NCT01748760|7476922|FG001|Overall Study|Lost to Follow-up|1
4617334|NCT01748825|7476979|FG000|Dose Escalation|Refused further treatment|2
4617335|NCT01748825|7476980|FG001|Dose Escalation|Refused further treatment|2
4617336|NCT01748825|7476981|FG002|Dose Escalation|Refused further treatment|0
4617337|NCT01748825|7476982|FG003|Dose Escalation|Refused further treatment|0
4617338|NCT01748825|7476983|FG004|Dose Escalation|Refused further treatment|1
4617339|NCT01748825|7476984|FG005|Dose Escalation|Refused further treatment|2
4617340|NCT01748825|7476985|FG006|Dose Escalation|Refused further treatment|0
4617341|NCT01748825|7476986|FG007|Dose Escalation|Refused further treatment|0
4617342|NCT01748825|7476987|FG008|Dose Escalation|Refused further treatment|0
4617343|NCT01748825|7476988|FG009|Dose Escalation|Refused further treatment|0
4617344|NCT01748825|7476979|FG000|Dose Escalation|Switched to alternative treatment|0
4617345|NCT01748825|7476980|FG001|Dose Escalation|Switched to alternative treatment|0
4617346|NCT01748825|7476981|FG002|Dose Escalation|Switched to alternative treatment|0
4617347|NCT01748825|7476982|FG003|Dose Escalation|Switched to alternative treatment|1
4617348|NCT01748825|7476983|FG004|Dose Escalation|Switched to alternative treatment|0
4617349|NCT01748825|7476984|FG005|Dose Escalation|Switched to alternative treatment|0
4617350|NCT01748825|7476985|FG006|Dose Escalation|Switched to alternative treatment|0
4617351|NCT01748825|7476986|FG007|Dose Escalation|Switched to alternative treatment|0
4617352|NCT01748825|7476987|FG008|Dose Escalation|Switched to alternative treatment|0
4617353|NCT01748825|7476988|FG009|Dose Escalation|Switched to alternative treatment|0
4617354|NCT01748825|7476979|FG000|Dose Escalation|Adverse Event|0
4617355|NCT01748825|7476980|FG001|Dose Escalation|Adverse Event|0
4617356|NCT01748825|7476981|FG002|Dose Escalation|Adverse Event|0
4617357|NCT01748825|7476982|FG003|Dose Escalation|Adverse Event|0
4617358|NCT01748825|7476983|FG004|Dose Escalation|Adverse Event|0
4617359|NCT01748825|7476984|FG005|Dose Escalation|Adverse Event|0
4617360|NCT01748825|7476985|FG006|Dose Escalation|Adverse Event|1
4617361|NCT01748825|7476986|FG007|Dose Escalation|Adverse Event|0
4617362|NCT01748825|7476987|FG008|Dose Escalation|Adverse Event|0
4617363|NCT01748825|7476988|FG009|Dose Escalation|Adverse Event|0
4617364|NCT01748825|7476979|FG000|Dose Expansion|Refused further treatment|0
4617365|NCT01748825|7476980|FG001|Dose Expansion|Refused further treatment|0
4617366|NCT01748825|7476981|FG002|Dose Expansion|Refused further treatment|0
4617367|NCT01748825|7476982|FG003|Dose Expansion|Refused further treatment|0
4617368|NCT01748825|7476983|FG004|Dose Expansion|Refused further treatment|0
4617369|NCT01748825|7476984|FG005|Dose Expansion|Refused further treatment|0
4617370|NCT01748825|7476985|FG006|Dose Expansion|Refused further treatment|0
4543177|NCT01154816|7367582|FG004|Overall Study|Adverse Event|0
4543178|NCT01154816|7367583|FG005|Overall Study|Adverse Event|0
4543179|NCT01154816|7367584|FG006|Overall Study|Adverse Event|1
4543180|NCT01154816|7367585|FG007|Overall Study|Adverse Event|1
4543181|NCT01154816|7367586|FG008|Overall Study|Adverse Event|0
4543182|NCT01154816|7367587|FG009|Overall Study|Adverse Event|0
4543183|NCT01154816|7367588|FG010|Overall Study|Adverse Event|0
4543184|NCT01154816|7367589|FG011|Overall Study|Adverse Event|0
4543185|NCT01155011|7367632|FG000|Baseline to 6 Months|Withdrawal by Subject|18
4543186|NCT01155011|7367633|FG001|Baseline to 6 Months|Withdrawal by Subject|19
4543187|NCT01155011|7367632|FG000|Baseline to 6 Months|investigator decision, moved|4
4543188|NCT01155011|7367633|FG001|Baseline to 6 Months|investigator decision, moved|5
4543189|NCT01155011|7367632|FG000|Baseline to 6 Months|Death|0
4543190|NCT01155011|7367633|FG001|Baseline to 6 Months|Death|1
4543191|NCT01155011|7367632|FG000|6 to 12 Months|Withdrawal by Subject|8
4543192|NCT01155011|7367633|FG001|6 to 12 Months|Withdrawal by Subject|5
4543193|NCT01155011|7367632|FG000|6 to 12 Months|Death|1
4543194|NCT01155011|7367633|FG001|6 to 12 Months|Death|5
4543195|NCT01155024|7367643|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0
4543196|NCT01155024|7367644|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2
4543197|NCT01155024|7367643|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0
4543198|NCT01155024|7367644|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2
4543199|NCT01155024|7367643|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0
4543200|NCT01155024|7367644|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2
4543201|NCT01155050|7367655|FG000|Overall Study|Lost to Follow-up|15
4543202|NCT01155050|7367656|FG001|Overall Study|Lost to Follow-up|20
4543203|NCT01155050|7367657|FG002|Overall Study|Lost to Follow-up|19
4543204|NCT01155050|7367658|FG003|Overall Study|Lost to Follow-up|22
4543205|NCT01155063|7367668|FG000|Overall Study|Adverse Event|1
4543206|NCT01155063|7367668|FG000|Overall Study|Withdrawal by Subject|1
4543207|NCT01155063|7367668|FG000|Overall Study|Study terminated by sponsor|87
4543208|NCT01155141|7367672|FG000|Overall Study|Withdrawal by Subject|1
4543209|NCT01155141|7367672|FG000|Overall Study|Screen Failure|1
4543210|NCT01155167|7367691|FG000|Overall Study|Insufficient ultrasound data|2
4543211|NCT01155167|7367692|FG001|Overall Study|Insufficient ultrasound data|0
4543212|NCT01155167|7367691|FG000|Overall Study|Access site changed to femoral artery|1
4543213|NCT01155167|7367692|FG001|Overall Study|Access site changed to femoral artery|0
4543214|NCT01155219|7367731|FG000|Overall Study|Adverse Event|3
4543215|NCT01155219|7367732|FG001|Overall Study|Adverse Event|1
4543216|NCT01155219|7367731|FG000|Overall Study|non-medical reason|1
4543217|NCT01155219|7367732|FG001|Overall Study|non-medical reason|2
4543218|NCT01155284|7367740|FG000|Overall Study|Withdrawal by Subject|4
4543219|NCT01155284|7367741|FG001|Overall Study|Withdrawal by Subject|3
4543220|NCT01155284|7367740|FG000|Overall Study|Lost to Follow-up|1
4543221|NCT01155284|7367741|FG001|Overall Study|Lost to Follow-up|2
4543222|NCT01155284|7367740|FG000|Overall Study|Physician Decision|1
4543223|NCT01155284|7367741|FG001|Overall Study|Physician Decision|0
4543224|NCT01155284|7367740|FG000|Overall Study|Adverse Event|1
4543225|NCT01155284|7367741|FG001|Overall Study|Adverse Event|0
4543226|NCT01155323|7367749|FG000|First Intervention|exclusion criteria|1
4543227|NCT01155323|7367750|FG001|First Intervention|exclusion criteria|1
4543228|NCT01155323|7367749|FG000|Second Intervention|Lost to Follow-up|1
4543229|NCT01155323|7367750|FG001|Second Intervention|Lost to Follow-up|1
4543230|NCT01155466|7367770|FG000|Overall Study|Adverse Event|13
4617371|NCT01748825|7476986|FG007|Dose Expansion|Refused further treatment|0
4617372|NCT01748825|7476987|FG008|Dose Expansion|Refused further treatment|1
4617373|NCT01748825|7476988|FG009|Dose Expansion|Refused further treatment|1
4617374|NCT01748825|7476979|FG000|Dose Expansion|Switched to alternative treatment|0
4617375|NCT01748825|7476980|FG001|Dose Expansion|Switched to alternative treatment|0
4617376|NCT01748825|7476981|FG002|Dose Expansion|Switched to alternative treatment|0
4617377|NCT01748825|7476982|FG003|Dose Expansion|Switched to alternative treatment|0
4617378|NCT01748825|7476983|FG004|Dose Expansion|Switched to alternative treatment|0
4617379|NCT01748825|7476984|FG005|Dose Expansion|Switched to alternative treatment|0
4617380|NCT01748825|7476985|FG006|Dose Expansion|Switched to alternative treatment|0
4617381|NCT01748825|7476986|FG007|Dose Expansion|Switched to alternative treatment|0
4617382|NCT01748825|7476987|FG008|Dose Expansion|Switched to alternative treatment|0
4617383|NCT01748825|7476988|FG009|Dose Expansion|Switched to alternative treatment|1
4617384|NCT01748825|7476979|FG000|Dose Expansion|Adverse Event|0
4617385|NCT01748825|7476980|FG001|Dose Expansion|Adverse Event|0
4617386|NCT01748825|7476981|FG002|Dose Expansion|Adverse Event|0
4617387|NCT01748825|7476982|FG003|Dose Expansion|Adverse Event|0
4617388|NCT01748825|7476983|FG004|Dose Expansion|Adverse Event|0
4617389|NCT01748825|7476984|FG005|Dose Expansion|Adverse Event|0
4617390|NCT01748825|7476985|FG006|Dose Expansion|Adverse Event|0
4543231|NCT01155466|7367771|FG001|Overall Study|Adverse Event|15
4543232|NCT01155466|7367772|FG002|Overall Study|Adverse Event|6
4543233|NCT01155466|7367773|FG003|Overall Study|Adverse Event|17
4543234|NCT01155466|7367774|FG004|Overall Study|Adverse Event|18
4543235|NCT01155466|7367770|FG000|Overall Study|Lost to Follow-up|0
4543236|NCT01155466|7367771|FG001|Overall Study|Lost to Follow-up|0
4543237|NCT01155466|7367772|FG002|Overall Study|Lost to Follow-up|0
4543238|NCT01155466|7367773|FG003|Overall Study|Lost to Follow-up|0
4543239|NCT01155466|7367774|FG004|Overall Study|Lost to Follow-up|2
4543240|NCT01155466|7367770|FG000|Overall Study|Withdrawal by Subject|7
4543241|NCT01155466|7367771|FG001|Overall Study|Withdrawal by Subject|5
4543242|NCT01155466|7367772|FG002|Overall Study|Withdrawal by Subject|9
4543243|NCT01155466|7367773|FG003|Overall Study|Withdrawal by Subject|4
4543244|NCT01155466|7367774|FG004|Overall Study|Withdrawal by Subject|4
4543245|NCT01155466|7367770|FG000|Overall Study|Protocol Violation|0
4543246|NCT01155466|7367771|FG001|Overall Study|Protocol Violation|0
4543247|NCT01155466|7367772|FG002|Overall Study|Protocol Violation|2
4543248|NCT01155466|7367773|FG003|Overall Study|Protocol Violation|0
4543249|NCT01155466|7367774|FG004|Overall Study|Protocol Violation|1
4543250|NCT01155466|7367770|FG000|Overall Study|Administrative|0
4543251|NCT01155466|7367771|FG001|Overall Study|Administrative|3
4543252|NCT01155466|7367772|FG002|Overall Study|Administrative|0
4543253|NCT01155466|7367773|FG003|Overall Study|Administrative|0
4543254|NCT01155466|7367774|FG004|Overall Study|Administrative|0
4543255|NCT01155466|7367770|FG000|Overall Study|Randomized not treated|2
4543256|NCT01155466|7367771|FG001|Overall Study|Randomized not treated|2
4543257|NCT01155466|7367772|FG002|Overall Study|Randomized not treated|3
4543258|NCT01155466|7367773|FG003|Overall Study|Randomized not treated|0
4543259|NCT01155466|7367774|FG004|Overall Study|Randomized not treated|2
4543260|NCT01155479|7367791|FG000|Part I|Adverse Event|13
4543261|NCT01155479|7367792|FG001|Part I|Adverse Event|8
4543262|NCT01155479|7367793|FG002|Part I|Adverse Event|18
4543263|NCT01155479|7367794|FG003|Part I|Adverse Event|7
4543264|NCT01155479|7367795|FG004|Part I|Adverse Event|6
4543265|NCT01155479|7367791|FG000|Part I|Administrative|2
4543266|NCT01155479|7367792|FG001|Part I|Administrative|2
4543267|NCT01155479|7367793|FG002|Part I|Administrative|2
4543268|NCT01155479|7367794|FG003|Part I|Administrative|0
4543269|NCT01155479|7367795|FG004|Part I|Administrative|0
4543270|NCT01155479|7367791|FG000|Part I|Did Not Meet Protocol Eligibility|3
4543271|NCT01155479|7367792|FG001|Part I|Did Not Meet Protocol Eligibility|1
4543272|NCT01155479|7367793|FG002|Part I|Did Not Meet Protocol Eligibility|2
4543273|NCT01155479|7367794|FG003|Part I|Did Not Meet Protocol Eligibility|1
4543274|NCT01155479|7367795|FG004|Part I|Did Not Meet Protocol Eligibility|3
4543275|NCT01155479|7367791|FG000|Part I|Withdrawal by Subject|11
4543276|NCT01155479|7367792|FG001|Part I|Withdrawal by Subject|13
4543277|NCT01155479|7367793|FG002|Part I|Withdrawal by Subject|8
4543278|NCT01155479|7367794|FG003|Part I|Withdrawal by Subject|8
4543279|NCT01155479|7367795|FG004|Part I|Withdrawal by Subject|9
4543280|NCT01155479|7367791|FG000|Part I|Lost to Follow-up|0
4543281|NCT01155479|7367792|FG001|Part I|Lost to Follow-up|0
4543282|NCT01155479|7367793|FG002|Part I|Lost to Follow-up|1
4543283|NCT01155479|7367794|FG003|Part I|Lost to Follow-up|1
4543284|NCT01155479|7367795|FG004|Part I|Lost to Follow-up|0
4543285|NCT01155479|7367791|FG000|Part I|Treatment Failure|3
4543286|NCT01155479|7367792|FG001|Part I|Treatment Failure|0
4543287|NCT01155479|7367793|FG002|Part I|Treatment Failure|3
4543288|NCT01155479|7367794|FG003|Part I|Treatment Failure|1
4543289|NCT01155479|7367795|FG004|Part I|Treatment Failure|2
4543290|NCT01155479|7367791|FG000|Part I|Did Not Receive Treatment|4
4543291|NCT01155479|7367792|FG001|Part I|Did Not Receive Treatment|2
4543292|NCT01155479|7367793|FG002|Part I|Did Not Receive Treatment|2
4543293|NCT01155479|7367794|FG003|Part I|Did Not Receive Treatment|6
4543294|NCT01155479|7367795|FG004|Part I|Did Not Receive Treatment|1
4543295|NCT01155479|7367791|FG000|Part I|Non-Compliance with Protocol|2
4543296|NCT01155479|7367792|FG001|Part I|Non-Compliance with Protocol|1
4543297|NCT01155479|7367793|FG002|Part I|Non-Compliance with Protocol|3
4543298|NCT01155479|7367794|FG003|Part I|Non-Compliance with Protocol|3
4543299|NCT01155479|7367795|FG004|Part I|Non-Compliance with Protocol|2
4617391|NCT01748825|7476986|FG007|Dose Expansion|Adverse Event|0
4617392|NCT01748825|7476987|FG008|Dose Expansion|Adverse Event|0
4617393|NCT01748825|7476988|FG009|Dose Expansion|Adverse Event|3
4617394|NCT01748825|7476979|FG000|Dose Expansion|Physician Decision|0
4617395|NCT01748825|7476980|FG001|Dose Expansion|Physician Decision|0
4617396|NCT01748825|7476981|FG002|Dose Expansion|Physician Decision|0
4617397|NCT01748825|7476982|FG003|Dose Expansion|Physician Decision|0
4617398|NCT01748825|7476983|FG004|Dose Expansion|Physician Decision|0
4617399|NCT01748825|7476984|FG005|Dose Expansion|Physician Decision|0
4617400|NCT01748825|7476985|FG006|Dose Expansion|Physician Decision|0
4617401|NCT01748825|7476986|FG007|Dose Expansion|Physician Decision|0
4617402|NCT01748825|7476987|FG008|Dose Expansion|Physician Decision|1
4617403|NCT01748825|7476988|FG009|Dose Expansion|Physician Decision|0
4543300|NCT01155479|7367791|FG000|Part II|Adverse Event|7
4543301|NCT01155479|7367792|FG001|Part II|Adverse Event|6
4543302|NCT01155479|7367793|FG002|Part II|Adverse Event|8
4543303|NCT01155479|7367794|FG003|Part II|Adverse Event|3
4543304|NCT01155479|7367795|FG004|Part II|Adverse Event|4
4543305|NCT01155479|7367791|FG000|Part II|Administrative|43
4543306|NCT01155479|7367792|FG001|Part II|Administrative|49
4617404|NCT01748994|7477050|FG000|Overall Study|Lost to Follow-up|8
4543307|NCT01155479|7367793|FG002|Part II|Administrative|36
4543308|NCT01155479|7367794|FG003|Part II|Administrative|38
4543309|NCT01155479|7367795|FG004|Part II|Administrative|46
4543310|NCT01155479|7367791|FG000|Part II|Withdrawal by Subject|8
4543311|NCT01155479|7367792|FG001|Part II|Withdrawal by Subject|4
4543312|NCT01155479|7367793|FG002|Part II|Withdrawal by Subject|12
4543313|NCT01155479|7367794|FG003|Part II|Withdrawal by Subject|7
4543314|NCT01155479|7367795|FG004|Part II|Withdrawal by Subject|3
4543315|NCT01155479|7367791|FG000|Part II|Lost to Follow-up|1
4543316|NCT01155479|7367792|FG001|Part II|Lost to Follow-up|0
4543317|NCT01155479|7367793|FG002|Part II|Lost to Follow-up|0
4543318|NCT01155479|7367794|FG003|Part II|Lost to Follow-up|0
4543319|NCT01155479|7367795|FG004|Part II|Lost to Follow-up|1
4543320|NCT01155479|7367791|FG000|Part II|Treatment Failure|0
4617405|NCT01748994|7477051|FG001|Overall Study|Lost to Follow-up|6
4617406|NCT01749033|7477060|FG000|Overall Study|Did not receive allocated intervention|3
4617407|NCT01749033|7477061|FG001|Overall Study|Did not receive allocated intervention|3
4617408|NCT01749033|7477062|FG002|Overall Study|Did not receive allocated intervention|0
4617409|NCT01749033|7477060|FG000|Overall Study|Lost to Follow-up|0
4617410|NCT01749033|7477061|FG001|Overall Study|Lost to Follow-up|2
4617411|NCT01749033|7477062|FG002|Overall Study|Lost to Follow-up|1
4617412|NCT01749735|7477113|FG000|Overall Study|Withdrawal by Subject|1
4543321|NCT01155479|7367792|FG001|Part II|Treatment Failure|1
4617413|NCT01749735|7477114|FG001|Overall Study|Withdrawal by Subject|0
4617414|NCT01749800|7477123|FG000|Overall Study|not meeting inclusion criteria|3
4617415|NCT01749800|7477124|FG001|Overall Study|not meeting inclusion criteria|0
4617416|NCT01749800|7477125|FG002|Overall Study|not meeting inclusion criteria|0
4617417|NCT01749800|7477123|FG000|Overall Study|Withdrawal by Subject|0
4617418|NCT01749800|7477124|FG001|Overall Study|Withdrawal by Subject|1
4617419|NCT01749800|7477125|FG002|Overall Study|Withdrawal by Subject|0
4617420|NCT01749982|7477168|FG000|Overall Study|Physician Decision|0
4617421|NCT01749982|7477169|FG001|Overall Study|Physician Decision|0
4617422|NCT01749982|7477170|FG002|Overall Study|Physician Decision|0
4617423|NCT01749982|7477171|FG003|Overall Study|Physician Decision|1
4617424|NCT01749982|7477168|FG000|Overall Study|Lost to Follow-up|0
4617425|NCT01749982|7477169|FG001|Overall Study|Lost to Follow-up|0
4617426|NCT01749982|7477170|FG002|Overall Study|Lost to Follow-up|0
4617427|NCT01749982|7477171|FG003|Overall Study|Lost to Follow-up|1
4617428|NCT01749982|7477168|FG000|Overall Study|Withdrawal by Subject|0
4617429|NCT01749982|7477169|FG001|Overall Study|Withdrawal by Subject|0
4617430|NCT01749982|7477170|FG002|Overall Study|Withdrawal by Subject|0
4617431|NCT01749982|7477171|FG003|Overall Study|Withdrawal by Subject|1
4617432|NCT01750190|7477196|FG000|Overall Study|Adverse Event|47
4617433|NCT01750190|7477197|FG001|Overall Study|Adverse Event|19
4617434|NCT01750190|7477196|FG000|Overall Study|Death|38
4617435|NCT01750190|7477197|FG001|Overall Study|Death|11
4617436|NCT01750190|7477196|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2
4617437|NCT01750190|7477197|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43
4617438|NCT01750190|7477196|FG000|Overall Study|Lost to Follow-up|28
4617439|NCT01750190|7477197|FG001|Overall Study|Lost to Follow-up|7
4690486|NCT02561195|7600185|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0
4690487|NCT02561195|7600186|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0
4690488|NCT02561195|7600187|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0
4690489|NCT02561195|7600188|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0
4690490|NCT02561195|7600189|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0
4690491|NCT02561195|7600190|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0
4690492|NCT02561195|7600191|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0
4690493|NCT02561195|7600192|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0
4690494|NCT02561195|7600193|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3
4543322|NCT01155479|7367793|FG002|Part II|Treatment Failure|2
4543323|NCT01155479|7367794|FG003|Part II|Treatment Failure|0
4543324|NCT01155479|7367795|FG004|Part II|Treatment Failure|1
4543325|NCT01155479|7367791|FG000|Part II|Non-Compliance with Protocol|0
4543326|NCT01155479|7367792|FG001|Part II|Non-Compliance with Protocol|1
4543327|NCT01155479|7367793|FG002|Part II|Non-Compliance with Protocol|0
4543328|NCT01155479|7367794|FG003|Part II|Non-Compliance with Protocol|2
4543329|NCT01155479|7367795|FG004|Part II|Non-Compliance with Protocol|0
4543330|NCT01155531|7367827|FG000|Overall Study|Adverse Event|0
4543331|NCT01155531|7367828|FG001|Overall Study|Adverse Event|0
4543332|NCT01155531|7367829|FG002|Overall Study|Adverse Event|1
4543333|NCT01155531|7367830|FG003|Overall Study|Adverse Event|0
4543334|NCT01155531|7367827|FG000|Overall Study|Lost to Follow-up|0
4543335|NCT01155531|7367828|FG001|Overall Study|Lost to Follow-up|0
4543336|NCT01155531|7367829|FG002|Overall Study|Lost to Follow-up|0
4543337|NCT01155531|7367830|FG003|Overall Study|Lost to Follow-up|1
4543338|NCT01155531|7367827|FG000|Overall Study|Withdrawal by Subject|1
4543339|NCT01155531|7367828|FG001|Overall Study|Withdrawal by Subject|0
4543340|NCT01155531|7367829|FG002|Overall Study|Withdrawal by Subject|1
4543341|NCT01155531|7367830|FG003|Overall Study|Withdrawal by Subject|0
4543342|NCT01155570|7367840|FG000|Overall Study|Adverse Event|39
4543343|NCT01155570|7367840|FG000|Overall Study|Lack of Efficacy|46
4543344|NCT01155570|7367840|FG000|Overall Study|Participant's Economic Reasons|17
4543345|NCT01155570|7367840|FG000|Overall Study|No Hospital Visits|7
4543346|NCT01155570|7367840|FG000|Overall Study|Adverse Event + Lack of Efficacy|2
4543347|NCT01155570|7367840|FG000|Overall Study|Adverse Event + Other Reasons|7
4617440|NCT01750190|7477196|FG000|Overall Study|Physician Decision|16
4617441|NCT01750190|7477197|FG001|Overall Study|Physician Decision|17
4617442|NCT01750190|7477196|FG000|Overall Study|Protocol Violation|6
4543348|NCT01155570|7367840|FG000|Overall Study|Participant's Economic Reasons + Other|1
4543349|NCT01155570|7367840|FG000|Overall Study|Other Reasons|23
4543350|NCT01155583|7367855|FG000|Phase I|Screen failure - did not start treatment|0
4543351|NCT01155583|7367856|FG001|Phase I|Screen failure - did not start treatment|0
4543352|NCT01155583|7367857|FG002|Phase I|Screen failure - did not start treatment|0
4543353|NCT01155583|7367858|FG003|Phase I|Screen failure - did not start treatment|0
4543354|NCT01155583|7367859|FG004|Phase I|Screen failure - did not start treatment|1
4543355|NCT01155583|7367860|FG005|Phase I|Screen failure - did not start treatment|0
4543356|NCT01155583|7367861|FG006|Phase I|Screen failure - did not start treatment|0
4543357|NCT01155583|7367862|FG007|Phase I|Screen failure - did not start treatment|2
4543358|NCT01155583|7367863|FG008|Phase I|Screen failure - did not start treatment|0
4543359|NCT01155583|7367855|FG000|Phase I|Withdrawal by Subject|0
4543360|NCT01155583|7367856|FG001|Phase I|Withdrawal by Subject|0
4543361|NCT01155583|7367857|FG002|Phase I|Withdrawal by Subject|0
4543362|NCT01155583|7367858|FG003|Phase I|Withdrawal by Subject|0
4543363|NCT01155583|7367859|FG004|Phase I|Withdrawal by Subject|0
4543364|NCT01155583|7367860|FG005|Phase I|Withdrawal by Subject|0
4617443|NCT01750190|7477197|FG001|Overall Study|Protocol Violation|5
4617444|NCT01750190|7477196|FG000|Overall Study|Study/Site Terminated by Sponsor|4
4617445|NCT01750190|7477197|FG001|Overall Study|Study/Site Terminated by Sponsor|1
4617446|NCT01750190|7477196|FG000|Overall Study|Withdrawal by Subject|83
4617447|NCT01750190|7477197|FG001|Overall Study|Withdrawal by Subject|89
4617448|NCT01750190|7477196|FG000|Overall Study|Kidney Transplant|8
4617449|NCT01750190|7477197|FG001|Overall Study|Kidney Transplant|4
4617450|NCT01750190|7477196|FG000|Overall Study|Dialysis|22
4617451|NCT01750190|7477197|FG001|Overall Study|Dialysis|8
4617452|NCT01750190|7477196|FG000|Overall Study|Other than Specified|13
4617453|NCT01750190|7477197|FG001|Overall Study|Other than Specified|4
4617454|NCT01750229|7477203|FG000|Randomized Crossover Phase|Adverse Event|1
4617455|NCT01750229|7477203|FG000|Randomized Crossover Phase|Withdrawal by Subject|1
4617456|NCT01750229|7477203|FG000|Long-term Follow-up Phase|Adverse Event|2
4617457|NCT01750229|7477203|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1
4617458|NCT01750242|7477213|FG000|Overall Study|Unreadable Images|3
4617459|NCT01750268|7477230|FG000|Overall Study|Lost to Follow-up|0
4617460|NCT01750268|7477231|FG001|Overall Study|Lost to Follow-up|2
4617461|NCT01750268|7477230|FG000|Overall Study|Physician Decision|0
4617462|NCT01750268|7477231|FG001|Overall Study|Physician Decision|3
4617463|NCT01750268|7477230|FG000|Overall Study|Withdrawal by Subject|2
4617464|NCT01750268|7477231|FG001|Overall Study|Withdrawal by Subject|0
4617465|NCT01750294|7477237|FG000|Overall Study|Withdrawal by Subject|1
4617466|NCT01750294|7477237|FG000|Overall Study|Safety Endpoint|1
4617467|NCT01750346|7477244|FG000|Overall Study|Adverse Event|1
4617468|NCT01750346|7477245|FG001|Overall Study|Adverse Event|0
4617469|NCT01750346|7477246|FG002|Overall Study|Adverse Event|0
4617470|NCT01750684|7477274|FG000|Overall Study|Death|1
4617471|NCT01750684|7477275|FG001|Overall Study|Death|0
4617472|NCT01750684|7477274|FG000|Overall Study|Non-compliance with Study Drug|0
4617473|NCT01750684|7477275|FG001|Overall Study|Non-compliance with Study Drug|1
4617474|NCT01750684|7477274|FG000|Overall Study|Withdrawn by Sponsor|0
4617475|NCT01750684|7477275|FG001|Overall Study|Withdrawn by Sponsor|1
4617476|NCT01750684|7477274|FG000|Overall Study|Protocol Violation|1
4617477|NCT01750684|7477275|FG001|Overall Study|Protocol Violation|0
4617478|NCT01750697|7477282|FG000|Overall Study|Transferred Back to Local Hospital|1
4617479|NCT01750697|7477282|FG000|Overall Study|Physician and Family Decision|1
4617480|NCT01750697|7477282|FG000|Overall Study|Transferred to Adult Services|5
4617481|NCT01750697|7477282|FG000|Overall Study|Physician Decision|1
4617482|NCT01750697|7477282|FG000|Overall Study|Withdrawal by Subject|1
4617483|NCT01750840|7477289|FG000|Overall Study|Lost to Follow-up|4
4617484|NCT01750879|7477296|FG000|Overall Study|Adverse Event|8
4617485|NCT01750879|7477297|FG001|Overall Study|Adverse Event|0
4617486|NCT01750879|7477296|FG000|Overall Study|Lack of Efficacy|1
4617487|NCT01750879|7477297|FG001|Overall Study|Lack of Efficacy|0
4617488|NCT01750879|7477296|FG000|Overall Study|Withdrawal by Subject|1
4617489|NCT01750879|7477297|FG001|Overall Study|Withdrawal by Subject|0
4617490|NCT01750879|7477296|FG000|Overall Study|Did not complete per protocol|0
4617491|NCT01750879|7477297|FG001|Overall Study|Did not complete per protocol|3
4543365|NCT01155583|7367861|FG006|Phase I|Withdrawal by Subject|0
4543366|NCT01155583|7367862|FG007|Phase I|Withdrawal by Subject|1
4617492|NCT01750918|7477324|FG000|Overall Study|Last patient transitioned to a rollover protocol|0
4617493|NCT01750918|7477325|FG001|Overall Study|Last patient transitioned to a rollover protocol|0
4617494|NCT01750918|7477326|FG002|Overall Study|Last patient transitioned to a rollover protocol|5
4617495|NCT01750918|7477327|FG003|Overall Study|Last patient transitioned to a rollover protocol|2
4617496|NCT01750918|7477328|FG004|Overall Study|Last patient transitioned to a rollover protocol|0
4617497|NCT01750918|7477329|FG005|Overall Study|Last patient transitioned to a rollover protocol|2
4617498|NCT01750918|7477330|FG006|Overall Study|Last patient transitioned to a rollover protocol|1
4617499|NCT01750918|7477331|FG007|Overall Study|Last patient transitioned to a rollover protocol|1
4617500|NCT01750918|7477324|FG000|Overall Study|Lost to Follow-up|0
4617501|NCT01750918|7477325|FG001|Overall Study|Lost to Follow-up|0
4617502|NCT01750918|7477326|FG002|Overall Study|Lost to Follow-up|2
4617503|NCT01750918|7477327|FG003|Overall Study|Lost to Follow-up|2
4617504|NCT01750918|7477328|FG004|Overall Study|Lost to Follow-up|0
4617505|NCT01750918|7477329|FG005|Overall Study|Lost to Follow-up|0
4617506|NCT01750918|7477330|FG006|Overall Study|Lost to Follow-up|0
4617507|NCT01750918|7477331|FG007|Overall Study|Lost to Follow-up|1
4617508|NCT01750918|7477324|FG000|Overall Study|Withdrawal by Subject|0
4617509|NCT01750918|7477325|FG001|Overall Study|Withdrawal by Subject|0
4617510|NCT01750918|7477326|FG002|Overall Study|Withdrawal by Subject|1
4617511|NCT01750918|7477327|FG003|Overall Study|Withdrawal by Subject|2
4617512|NCT01750918|7477328|FG004|Overall Study|Withdrawal by Subject|1
4617513|NCT01750918|7477329|FG005|Overall Study|Withdrawal by Subject|1
4617514|NCT01750918|7477330|FG006|Overall Study|Withdrawal by Subject|2
4543367|NCT01155583|7367863|FG008|Phase I|Withdrawal by Subject|0
4543368|NCT01155661|7367879|FG000|Overall Study|Adverse Event|101
4543369|NCT01155661|7367879|FG000|Overall Study|Death|1
4543370|NCT01155661|7367879|FG000|Overall Study|Lack of Efficacy|32
4543371|NCT01155661|7367879|FG000|Overall Study|Lost to Follow-up|22
4543372|NCT01155661|7367879|FG000|Overall Study|Physician Decision|3
4543373|NCT01155661|7367879|FG000|Overall Study|Protocol Violation|35
4543374|NCT01155661|7367879|FG000|Overall Study|Withdrawal by Subject|73
4543375|NCT01155661|7367879|FG000|Overall Study|Sponsor Decision|13
4543376|NCT01155726|7367885|FG000|Period 1, 3 Days (Masked)|Inconvenience|1
4543377|NCT01155726|7367886|FG001|Period 1, 3 Days (Masked)|Inconvenience|0
4543378|NCT01155726|7367887|FG002|Period 1, 3 Days (Masked)|Inconvenience|2
4543379|NCT01155726|7367888|FG003|Period 1, 3 Days (Masked)|Inconvenience|0
4543380|NCT01155869|7367938|FG000|Overall Study|Lost to Follow-up|3
4543381|NCT01155869|7367939|FG001|Overall Study|Lost to Follow-up|1
4543382|NCT01156012|7367956|FG000|Overall Study|Adverse Event|3
4543383|NCT01156012|7367957|FG001|Overall Study|Adverse Event|1
4543384|NCT01156012|7367956|FG000|Overall Study|Lost to Follow-up|1
4543385|NCT01156012|7367957|FG001|Overall Study|Lost to Follow-up|0
4543386|NCT01156012|7367956|FG000|Overall Study|Withdrawal by Subject|1
4543387|NCT01156012|7367957|FG001|Overall Study|Withdrawal by Subject|0
4543388|NCT01156012|7367956|FG000|Overall Study|use of commercial drug instead of study|0
4543389|NCT01156012|7367957|FG001|Overall Study|use of commercial drug instead of study|1
4543390|NCT01156012|7367956|FG000|Overall Study|Non respect of one of inclusion criteria|2
4543391|NCT01156012|7367957|FG001|Overall Study|Non respect of one of inclusion criteria|1
4617515|NCT01750918|7477331|FG007|Overall Study|Withdrawal by Subject|2
4617516|NCT01751061|7477402|FG000|Overall Study|Death|1
4617517|NCT01751061|7477403|FG001|Overall Study|Death|0
4617518|NCT01751061|7477402|FG000|Overall Study|patient death|5
4617519|NCT01751061|7477403|FG001|Overall Study|patient death|0
4617520|NCT01751061|7477402|FG000|Overall Study|Lost to Follow-up|40
4617521|NCT01751061|7477403|FG001|Overall Study|Lost to Follow-up|25
4617522|NCT01751061|7477402|FG000|Overall Study|patient regained decisional capacity|4
4617523|NCT01751061|7477403|FG001|Overall Study|patient regained decisional capacity|8
4617524|NCT01751061|7477402|FG000|Overall Study|Withdrawal by Subject|4
4617525|NCT01751061|7477403|FG001|Overall Study|Withdrawal by Subject|1
4617526|NCT01751061|7477402|FG000|Overall Study|Physician Decision|2
4617527|NCT01751061|7477403|FG001|Overall Study|Physician Decision|0
4617528|NCT01751087|7477412|FG000|Overall Study|Withdrawal by Subject|1
4617529|NCT01751087|7477413|FG001|Overall Study|Withdrawal by Subject|0
4617530|NCT01751087|7477414|FG002|Overall Study|Withdrawal by Subject|0
4617531|NCT01751087|7477412|FG000|Overall Study|Physician Decision|0
4617532|NCT01751087|7477413|FG001|Overall Study|Physician Decision|0
4617533|NCT01751087|7477414|FG002|Overall Study|Physician Decision|1
4617534|NCT01751113|7477422|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0
4543392|NCT01156051|7367965|FG000|Overall Study|Lost to Follow-up|1
4543393|NCT01156051|7367966|FG001|Overall Study|Lost to Follow-up|0
4543394|NCT01156051|7367965|FG000|Overall Study|patient not compliant with protocol|0
4543395|NCT01156051|7367966|FG001|Overall Study|patient not compliant with protocol|1
4543396|NCT01156116|7367974|FG000|Overall Study|Withdrawal by Subject|3
4543397|NCT01156116|7367975|FG001|Overall Study|Withdrawal by Subject|1
4543398|NCT01156116|7367974|FG000|Overall Study|CPAP intolerance|2
4543399|NCT01156116|7367975|FG001|Overall Study|CPAP intolerance|0
4543400|NCT01156142|7367983|FG000|Overall Study|Withdrawal by Subject|8
4543401|NCT01156142|7367984|FG001|Overall Study|Withdrawal by Subject|6
4543402|NCT01156142|7367983|FG000|Overall Study|Ineligible|0
4543403|NCT01156142|7367984|FG001|Overall Study|Ineligible|1
4543404|NCT01156311|7367992|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1
4543405|NCT01156311|7367993|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1
4543406|NCT01156311|7367994|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0
4543407|NCT01156311|7367995|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0
4617535|NCT01751113|7477423|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0
4617536|NCT01751113|7477424|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0
4617537|NCT01751113|7477425|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1
4617538|NCT01751113|7477426|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1
4543408|NCT01156311|7367992|FG000|2-Month Monotherapy Period|Physician Decision|0
4543409|NCT01156311|7367993|FG001|2-Month Monotherapy Period|Physician Decision|1
4543410|NCT01156311|7367994|FG002|2-Month Monotherapy Period|Physician Decision|0
4617539|NCT01751113|7477427|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0
4617540|NCT01751113|7477422|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0
4617541|NCT01751113|7477423|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0
4543411|NCT01156311|7367995|FG003|2-Month Monotherapy Period|Physician Decision|0
4543412|NCT01156311|7367992|FG000|2-Month Monotherapy Period|Other|1
4543413|NCT01156311|7367993|FG001|2-Month Monotherapy Period|Other|0
4543414|NCT01156311|7367994|FG002|2-Month Monotherapy Period|Other|0
4543415|NCT01156311|7367995|FG003|2-Month Monotherapy Period|Other|0
4543416|NCT01156311|7367992|FG000|6-month Add-on Therapy Period|Adverse Event|0
4543417|NCT01156311|7367993|FG001|6-month Add-on Therapy Period|Adverse Event|0
4543418|NCT01156311|7367994|FG002|6-month Add-on Therapy Period|Adverse Event|7
4543419|NCT01156311|7367995|FG003|6-month Add-on Therapy Period|Adverse Event|6
4617542|NCT01751113|7477424|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0
4617543|NCT01751113|7477425|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0
4617544|NCT01751113|7477426|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0
4543420|NCT01156311|7367992|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0
4543421|NCT01156311|7367993|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0
4543422|NCT01156311|7367994|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2
4543423|NCT01156311|7367995|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0
4543424|NCT01156311|7367992|FG000|6-month Add-on Therapy Period|Disease Activity|0
4543425|NCT01156311|7367993|FG001|6-month Add-on Therapy Period|Disease Activity|0
4543426|NCT01156311|7367994|FG002|6-month Add-on Therapy Period|Disease Activity|1
4543427|NCT01156311|7367995|FG003|6-month Add-on Therapy Period|Disease Activity|2
4543428|NCT01156311|7367992|FG000|6-month Add-on Therapy Period|Physician Decision|0
4543429|NCT01156311|7367993|FG001|6-month Add-on Therapy Period|Physician Decision|0
4543430|NCT01156311|7367994|FG002|6-month Add-on Therapy Period|Physician Decision|1
4543431|NCT01156311|7367995|FG003|6-month Add-on Therapy Period|Physician Decision|0
4543432|NCT01156311|7367992|FG000|6-month Add-on Therapy Period|Other|0
4543433|NCT01156311|7367993|FG001|6-month Add-on Therapy Period|Other|0
4543434|NCT01156311|7367994|FG002|6-month Add-on Therapy Period|Other|1
4543435|NCT01156311|7367995|FG003|6-month Add-on Therapy Period|Other|2
4543436|NCT01156363|7368006|FG000|Overall Study|Adverse Event|6
4543437|NCT01156363|7368006|FG000|Overall Study|Insufficient Therapeutic Response|5
4543438|NCT01156363|7368006|FG000|Overall Study|Failure to Return|1
4543439|NCT01156363|7368006|FG000|Overall Study|Refused Treatment|4
4543440|NCT01156363|7368006|FG000|Overall Study|Other|6
4543441|NCT01156376|7368020|FG000|Overall Study|Adverse Event|1
4543442|NCT01156376|7368021|FG001|Overall Study|Adverse Event|0
4543443|NCT01156376|7368022|FG002|Overall Study|Adverse Event|1
4543444|NCT01156376|7368020|FG000|Overall Study|Withdrawal by Subject|0
4543445|NCT01156376|7368021|FG001|Overall Study|Withdrawal by Subject|0
4543446|NCT01156376|7368022|FG002|Overall Study|Withdrawal by Subject|3
4543447|NCT01156480|7368032|FG000|Overall Study|change in diagnosis|0
4543448|NCT01156480|7368033|FG001|Overall Study|change in diagnosis|1
4543449|NCT01156532|7368041|FG000|Overall Study|Family Reasons|1
4543450|NCT01156532|7368041|FG000|Overall Study|Lost to Follow-up|1
4543451|NCT01156675|7368067|FG000|Overall Study|Death|5
4543452|NCT01156675|7368068|FG001|Overall Study|Death|3
4543453|NCT01156675|7368069|FG002|Overall Study|Death|0
4543454|NCT01156675|7368067|FG000|Overall Study|No data|29
4543455|NCT01156675|7368068|FG001|Overall Study|No data|22
4543456|NCT01156675|7368069|FG002|Overall Study|No data|2
4543457|NCT01156714|7368094|FG000|Overall Study|Withdrawal by Subject|9
4543458|NCT01156714|7368095|FG001|Overall Study|Withdrawal by Subject|4
4543459|NCT01156714|7368096|FG002|Overall Study|Withdrawal by Subject|3
4543460|NCT01156792|7368107|FG000|Overall Study|Adverse Event|1
4543461|NCT01156792|7368107|FG000|Overall Study|Lack of Efficacy|36
4543462|NCT01156792|7368107|FG000|Overall Study|Protocol Violation|6
4543463|NCT01156792|7368107|FG000|Overall Study|Lost to Follow-up|3
4543464|NCT01156792|7368107|FG000|Overall Study|Physician Decision|3
4543465|NCT01156792|7368107|FG000|Overall Study|Withdrawal by Subject|9
4543466|NCT01156792|7368107|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11
4543467|NCT01156844|7368135|FG000|Overall Study|Adverse Event|0
4543468|NCT01156844|7368136|FG001|Overall Study|Adverse Event|0
4543469|NCT01156844|7368137|FG002|Overall Study|Adverse Event|1
4543470|NCT01156844|7368138|FG003|Overall Study|Adverse Event|1
4543471|NCT01156844|7368135|FG000|Overall Study|Abnormal test procedure result(s)|0
4543472|NCT01156844|7368136|FG001|Overall Study|Abnormal test procedure result(s)|1
4543473|NCT01156844|7368137|FG002|Overall Study|Abnormal test procedure result(s)|2
4543474|NCT01156844|7368138|FG003|Overall Study|Abnormal test procedure result(s)|2
4543475|NCT01156844|7368135|FG000|Overall Study|Withdrawal by Subject|0
4543476|NCT01156844|7368136|FG001|Overall Study|Withdrawal by Subject|0
4543477|NCT01156844|7368137|FG002|Overall Study|Withdrawal by Subject|2
4543478|NCT01156844|7368138|FG003|Overall Study|Withdrawal by Subject|2
4543479|NCT01156844|7368135|FG000|Overall Study|Lost to Follow-up|0
4543480|NCT01156844|7368136|FG001|Overall Study|Lost to Follow-up|0
4543481|NCT01156844|7368137|FG002|Overall Study|Lost to Follow-up|1
4543482|NCT01156844|7368138|FG003|Overall Study|Lost to Follow-up|0
4543483|NCT01156844|7368135|FG000|Overall Study|Administrative problems|0
4543484|NCT01156844|7368136|FG001|Overall Study|Administrative problems|1
4543485|NCT01156844|7368137|FG002|Overall Study|Administrative problems|0
4617545|NCT01751113|7477427|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1
4543486|NCT01156844|7368138|FG003|Overall Study|Administrative problems|1
4543487|NCT01156844|7368135|FG000|Overall Study|Protocol deviation|2
4543488|NCT01156844|7368136|FG001|Overall Study|Protocol deviation|0
4543489|NCT01156844|7368137|FG002|Overall Study|Protocol deviation|0
4543490|NCT01156844|7368138|FG003|Overall Study|Protocol deviation|0
4543491|NCT01157065|7368162|FG000|Overall Study|Death|0
4543492|NCT01157065|7368163|FG001|Overall Study|Death|1
4543493|NCT01157078|7368171|FG000|Overall Study|Withdrawal by Subject|12
4543494|NCT01157078|7368172|FG001|Overall Study|Withdrawal by Subject|14
4543495|NCT01157078|7368171|FG000|Overall Study|Eligibility criteria not fulfilled|2
4543496|NCT01157078|7368172|FG001|Overall Study|Eligibility criteria not fulfilled|0
4543497|NCT01157078|7368171|FG000|Overall Study|Adverse Event|6
4543498|NCT01157078|7368172|FG001|Overall Study|Adverse Event|6
4543499|NCT01157078|7368171|FG000|Overall Study|Severe non-compliance to protocol|2
4543500|NCT01157078|7368172|FG001|Overall Study|Severe non-compliance to protocol|4
4543501|NCT01157078|7368171|FG000|Overall Study|Condition under investigation worsened|0
4543502|NCT01157078|7368172|FG001|Overall Study|Condition under investigation worsened|1
4543503|NCT01157078|7368171|FG000|Overall Study|Lack of Efficacy|2
4543504|NCT01157078|7368172|FG001|Overall Study|Lack of Efficacy|0
4543505|NCT01157078|7368171|FG000|Overall Study|Study-specific withdrawal criteria|2
4543506|NCT01157078|7368172|FG001|Overall Study|Study-specific withdrawal criteria|2
4543507|NCT01157078|7368171|FG000|Overall Study|Lost to Follow-up|7
4543508|NCT01157078|7368172|FG001|Overall Study|Lost to Follow-up|5
4543509|NCT01157078|7368171|FG000|Overall Study|Other|2
4543510|NCT01157078|7368172|FG001|Overall Study|Other|4
4617546|NCT01751139|7477436|FG000|Overall Study|Other|135
4617547|NCT01751139|7477436|FG000|Overall Study|Sponsor study termination|1609
4543511|NCT01157117|7368181|FG000|Overall Study|Dosing Symptoms|0
4543512|NCT01157117|7368182|FG001|Overall Study|Dosing Symptoms|4
4543513|NCT01157117|7368183|FG002|Overall Study|Dosing Symptoms|0
4543514|NCT01157117|7368181|FG000|Overall Study|Withdrawal by Subject|4
4543515|NCT01157117|7368182|FG001|Overall Study|Withdrawal by Subject|1
4543516|NCT01157117|7368183|FG002|Overall Study|Withdrawal by Subject|1
4543517|NCT01157117|7368181|FG000|Overall Study|Lack of Efficacy|1
4543518|NCT01157117|7368182|FG001|Overall Study|Lack of Efficacy|1
4543519|NCT01157117|7368183|FG002|Overall Study|Lack of Efficacy|0
4543520|NCT01157117|7368181|FG000|Overall Study|Lost to Follow-up|0
4543521|NCT01157117|7368182|FG001|Overall Study|Lost to Follow-up|0
4543522|NCT01157117|7368183|FG002|Overall Study|Lost to Follow-up|1
4543523|NCT01157117|7368181|FG000|Overall Study|Unknown (Pending Final Form Submission)|4
4543524|NCT01157117|7368182|FG001|Overall Study|Unknown (Pending Final Form Submission)|5
4543525|NCT01157117|7368183|FG002|Overall Study|Unknown (Pending Final Form Submission)|13
4543526|NCT01157169|7368193|FG000|First Intervention|Emesis Within 4 hrs of Administration|4
4543527|NCT01157169|7368194|FG001|First Intervention|Emesis Within 4 hrs of Administration|2
4543528|NCT01157169|7368193|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0
4543529|NCT01157169|7368194|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1
4543530|NCT01157182|7368202|FG000|Washout of 28 Days|Adverse Event|2
4543531|NCT01157182|7368203|FG001|Washout of 28 Days|Adverse Event|0
4543532|NCT01157234|7368211|FG000|Overall Study|Withdrawal by Subject|1
4543533|NCT01157234|7368212|FG001|Overall Study|Withdrawal by Subject|0
4543534|NCT01157351|7368227|FG000|Overall Study|Adverse Event|5
4543535|NCT01157351|7368228|FG001|Overall Study|Adverse Event|4
4543536|NCT01157351|7368227|FG000|Overall Study|Death|1
4617548|NCT01751139|7477436|FG000|Overall Study|Lost to Follow-up|240
4617549|NCT01751139|7477436|FG000|Overall Study|Withdrawal by Subject|251
4617550|NCT01751139|7477436|FG000|Overall Study|Adverse Event|1
4617551|NCT01751139|7477436|FG000|Overall Study|Death|31
4617552|NCT01751165|7477443|FG000|Overall Study|Adverse event, serious fatal|1
4617553|NCT01751165|7477444|FG001|Overall Study|Adverse event, serious fatal|0
4617554|NCT01751165|7477445|FG002|Overall Study|Adverse event, serious fatal|1
4617555|NCT01751165|7477443|FG000|Overall Study|Withdrawal by Subject|0
4617556|NCT01751165|7477444|FG001|Overall Study|Withdrawal by Subject|0
4617557|NCT01751165|7477445|FG002|Overall Study|Withdrawal by Subject|1
4617558|NCT01751165|7477443|FG000|Overall Study|Serious adverse event|0
4617559|NCT01751165|7477444|FG001|Overall Study|Serious adverse event|2
4617560|NCT01751165|7477445|FG002|Overall Study|Serious adverse event|0
4617561|NCT01751165|7477443|FG000|Overall Study|Lost to Follow-up|1
4617562|NCT01751165|7477444|FG001|Overall Study|Lost to Follow-up|1
4617563|NCT01751165|7477445|FG002|Overall Study|Lost to Follow-up|1
4617564|NCT01751178|7477458|FG000|Overall Study|Adverse Event|2
4617565|NCT01751178|7477459|FG001|Overall Study|Adverse Event|0
4617566|NCT01751178|7477460|FG002|Overall Study|Adverse Event|0
4617567|NCT01751178|7477458|FG000|Overall Study|Other Reason (unknown)|1
4617568|NCT01751178|7477459|FG001|Overall Study|Other Reason (unknown)|0
4543537|NCT01157351|7368228|FG001|Overall Study|Death|0
4543538|NCT01157351|7368227|FG000|Overall Study|Lost to Follow-up|53
4543539|NCT01157351|7368228|FG001|Overall Study|Lost to Follow-up|55
4543540|NCT01157351|7368227|FG000|Overall Study|Withdrawal by Subject|37
4543541|NCT01157351|7368228|FG001|Overall Study|Withdrawal by Subject|27
4617569|NCT01751178|7477460|FG002|Overall Study|Other Reason (unknown)|2
4617570|NCT01751412|7477536|FG000|Overall Study|Disease Progression Before Treatment|1
4617571|NCT01751568|7477556|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1
4543542|NCT01157351|7368227|FG000|Overall Study|Physician Decision|5
4543543|NCT01157351|7368228|FG001|Overall Study|Physician Decision|4
4543544|NCT01157351|7368227|FG000|Overall Study|Protocol Violation|0
4543545|NCT01157351|7368228|FG001|Overall Study|Protocol Violation|1
4543546|NCT01157351|7368227|FG000|Overall Study|Other|32
4543547|NCT01157351|7368228|FG001|Overall Study|Other|36
4543548|NCT01157351|7368227|FG000|Overall Study|Noncompliance with Study Drug|0
4543549|NCT01157351|7368228|FG001|Overall Study|Noncompliance with Study Drug|3
4543550|NCT01157351|7368227|FG000|Overall Study|Randomized but not Treated|4
4543551|NCT01157351|7368228|FG001|Overall Study|Randomized but not Treated|2
4543552|NCT01157364|7368240|FG000|Overall Study|Other Reasons|1
4543553|NCT01157364|7368241|FG001|Overall Study|Other Reasons|1
4617572|NCT01751568|7477557|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0
4617573|NCT01751568|7477558|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0
4617574|NCT01751646|7477568|FG000|Overall Study|Lost to Follow-up|5
4617575|NCT01751646|7477569|FG001|Overall Study|Lost to Follow-up|1
4617576|NCT01751646|7477568|FG000|Overall Study|Withdrawal by Subject|0
4617577|NCT01751646|7477569|FG001|Overall Study|Withdrawal by Subject|4
4617578|NCT01751646|7477568|FG000|Overall Study|Starting hormone therapy|1
4617579|NCT01751646|7477569|FG001|Overall Study|Starting hormone therapy|0
4617580|NCT01751646|7477568|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2
4617581|NCT01751646|7477569|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3
4617582|NCT01751646|7477568|FG000|Overall Study|Inadvertent enrollment|1
4617583|NCT01751646|7477569|FG001|Overall Study|Inadvertent enrollment|1
4617584|NCT01751646|7477568|FG000|Overall Study|Moved out of the area|1
4617585|NCT01751646|7477569|FG001|Overall Study|Moved out of the area|5
4617586|NCT01751646|7477568|FG000|Overall Study|Inability to attend required visits|0
4617587|NCT01751646|7477569|FG001|Overall Study|Inability to attend required visits|1
4617588|NCT01751646|7477568|FG000|Overall Study|Off study due to multiple obligations|0
4617589|NCT01751646|7477569|FG001|Overall Study|Off study due to multiple obligations|1
4617590|NCT01751646|7477568|FG000|Overall Study|Fails to comply with study requirements|0
4617591|NCT01751646|7477569|FG001|Overall Study|Fails to comply with study requirements|1
4617592|NCT01751646|7477568|FG000|Overall Study|Childcare issues|1
4617593|NCT01751646|7477569|FG001|Overall Study|Childcare issues|1
4617594|NCT01751724|7477581|FG000|Overall Study|extubated bef.start assigned treatment|1
4617595|NCT01751724|7477582|FG001|Overall Study|extubated bef.start assigned treatment|0
4617596|NCT01751724|7477581|FG000|Overall Study|withdrawn by parent|0
4617597|NCT01751724|7477582|FG001|Overall Study|withdrawn by parent|2
4617598|NCT01751802|7477590|FG000|Overall Study|Adverse Event|4
4617599|NCT01751802|7477591|FG001|Overall Study|Adverse Event|2
4617600|NCT01751867|7477605|FG000|Overall Study|Completed treatment,dropped in follow-up|4
4617601|NCT01751867|7477606|FG001|Overall Study|Completed treatment,dropped in follow-up|8
4617602|NCT01751867|7477605|FG000|Overall Study|Diease Progression|4
4617603|NCT01751867|7477606|FG001|Overall Study|Diease Progression|18
4617604|NCT01751867|7477605|FG000|Overall Study|Adverse Event|8
4617605|NCT01751867|7477606|FG001|Overall Study|Adverse Event|15
4617606|NCT01751867|7477605|FG000|Overall Study|Poor Compliance|0
4617607|NCT01751867|7477606|FG001|Overall Study|Poor Compliance|5
4617608|NCT01751867|7477605|FG000|Overall Study|Withdrawal by Subject|3
4617609|NCT01751867|7477606|FG001|Overall Study|Withdrawal by Subject|1
4617610|NCT01751867|7477605|FG000|Overall Study|Physician Decision|4
4617611|NCT01751867|7477606|FG001|Overall Study|Physician Decision|7
4617612|NCT01751867|7477605|FG000|Overall Study|Protocol Violation|0
4617613|NCT01751867|7477606|FG001|Overall Study|Protocol Violation|2
4617614|NCT01751867|7477605|FG000|Overall Study|Death|0
4617615|NCT01751867|7477606|FG001|Overall Study|Death|5
4617616|NCT01751867|7477605|FG000|Overall Study|Other|11
4617617|NCT01751867|7477606|FG001|Overall Study|Other|37
4617618|NCT01751867|7477605|FG000|Overall Study|Randomized but not treated.|2
4617619|NCT01751867|7477606|FG001|Overall Study|Randomized but not treated.|1
4617620|NCT01752036|7477627|FG000|Overall Study|Death|2
4617621|NCT01752634|7477655|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1
4617622|NCT01752634|7477656|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1
4617623|NCT01752634|7477657|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1
4617624|NCT01752634|7477658|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0
4617625|NCT01752634|7477659|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0
4617626|NCT01752634|7477660|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3
4617627|NCT01752634|7477655|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0
4617628|NCT01752634|7477656|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1
4617629|NCT01752634|7477657|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0
4617630|NCT01752634|7477658|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0
4617631|NCT01752634|7477659|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0
4617632|NCT01752634|7477660|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0
4617633|NCT01752634|7477655|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2
4617634|NCT01752634|7477656|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3
4617635|NCT01752634|7477657|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0
4617636|NCT01752634|7477658|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0
4617637|NCT01752634|7477659|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0
4617638|NCT01752634|7477660|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3
4617639|NCT01752634|7477655|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3
4543554|NCT01157364|7368242|FG002|Overall Study|Other Reasons|2
4543555|NCT01157364|7368243|FG003|Overall Study|Other Reasons|1
4543556|NCT01157364|7368244|FG004|Overall Study|Other Reasons|0
4543557|NCT01157364|7368245|FG005|Overall Study|Other Reasons|0
4543558|NCT01157364|7368240|FG000|Overall Study|Personal Reasons|0
4543559|NCT01157364|7368241|FG001|Overall Study|Personal Reasons|2
4543560|NCT01157364|7368242|FG002|Overall Study|Personal Reasons|0
4543561|NCT01157364|7368243|FG003|Overall Study|Personal Reasons|0
4543562|NCT01157364|7368244|FG004|Overall Study|Personal Reasons|1
4543563|NCT01157364|7368245|FG005|Overall Study|Personal Reasons|1
4543564|NCT01157364|7368240|FG000|Overall Study|Lost to Follow-up|1
4543565|NCT01157364|7368241|FG001|Overall Study|Lost to Follow-up|0
4543566|NCT01157364|7368242|FG002|Overall Study|Lost to Follow-up|1
4543567|NCT01157364|7368243|FG003|Overall Study|Lost to Follow-up|0
4543568|NCT01157364|7368244|FG004|Overall Study|Lost to Follow-up|0
4543569|NCT01157364|7368245|FG005|Overall Study|Lost to Follow-up|0
4543570|NCT01157364|7368240|FG000|Overall Study|Lack of Efficacy|0
4543571|NCT01157364|7368241|FG001|Overall Study|Lack of Efficacy|0
4543572|NCT01157364|7368242|FG002|Overall Study|Lack of Efficacy|0
4543573|NCT01157364|7368243|FG003|Overall Study|Lack of Efficacy|1
4543574|NCT01157364|7368244|FG004|Overall Study|Lack of Efficacy|0
4543575|NCT01157364|7368245|FG005|Overall Study|Lack of Efficacy|0
4543576|NCT01157364|7368240|FG000|Overall Study|Adverse Event|0
4617640|NCT01752634|7477656|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0
4617641|NCT01752634|7477657|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2
4617642|NCT01752634|7477658|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0
4617643|NCT01752634|7477659|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0
4617644|NCT01752634|7477660|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4
4617645|NCT01752634|7477655|FG000|Week 24 to Week 260|Lack of Efficacy|15
4617646|NCT01752634|7477656|FG001|Week 24 to Week 260|Lack of Efficacy|7
4617647|NCT01752634|7477657|FG002|Week 24 to Week 260|Lack of Efficacy|7
4617648|NCT01752634|7477658|FG003|Week 24 to Week 260|Lack of Efficacy|3
4617649|NCT01752634|7477659|FG004|Week 24 to Week 260|Lack of Efficacy|4
4617650|NCT01752634|7477660|FG005|Week 24 to Week 260|Lack of Efficacy|0
4617651|NCT01752634|7477655|FG000|Week 24 to Week 260|Subject/guardian decision|12
4617652|NCT01752634|7477656|FG001|Week 24 to Week 260|Subject/guardian decision|10
4617653|NCT01752634|7477657|FG002|Week 24 to Week 260|Subject/guardian decision|9
4617654|NCT01752634|7477658|FG003|Week 24 to Week 260|Subject/guardian decision|5
4617655|NCT01752634|7477659|FG004|Week 24 to Week 260|Subject/guardian decision|5
4617656|NCT01752634|7477660|FG005|Week 24 to Week 260|Subject/guardian decision|0
4617657|NCT01752634|7477655|FG000|Week 24 to Week 260|Physician Decision|1
4617658|NCT01752634|7477656|FG001|Week 24 to Week 260|Physician Decision|2
4617659|NCT01752634|7477657|FG002|Week 24 to Week 260|Physician Decision|4
4617660|NCT01752634|7477658|FG003|Week 24 to Week 260|Physician Decision|2
4617661|NCT01752634|7477659|FG004|Week 24 to Week 260|Physician Decision|1
4617662|NCT01752634|7477660|FG005|Week 24 to Week 260|Physician Decision|0
4617663|NCT01752634|7477655|FG000|Week 24 to Week 260|Death|0
4617664|NCT01752634|7477656|FG001|Week 24 to Week 260|Death|1
4617665|NCT01752634|7477657|FG002|Week 24 to Week 260|Death|0
4617666|NCT01752634|7477658|FG003|Week 24 to Week 260|Death|0
4617667|NCT01752634|7477659|FG004|Week 24 to Week 260|Death|0
4617668|NCT01752634|7477660|FG005|Week 24 to Week 260|Death|0
4617669|NCT01752634|7477655|FG000|Week 24 to Week 260|Pregnancy|0
4617670|NCT01752634|7477656|FG001|Week 24 to Week 260|Pregnancy|0
4617671|NCT01752634|7477657|FG002|Week 24 to Week 260|Pregnancy|1
4617672|NCT01752634|7477658|FG003|Week 24 to Week 260|Pregnancy|0
4617673|NCT01752634|7477659|FG004|Week 24 to Week 260|Pregnancy|0
4617674|NCT01752634|7477660|FG005|Week 24 to Week 260|Pregnancy|0
4617675|NCT01752634|7477655|FG000|Week 24 to Week 260|Noncompliance with study treatment|0
4617676|NCT01752634|7477656|FG001|Week 24 to Week 260|Noncompliance with study treatment|0
4617677|NCT01752634|7477657|FG002|Week 24 to Week 260|Noncompliance with study treatment|1
4617678|NCT01752634|7477658|FG003|Week 24 to Week 260|Noncompliance with study treatment|0
4617679|NCT01752634|7477659|FG004|Week 24 to Week 260|Noncompliance with study treatment|0
4617680|NCT01752634|7477660|FG005|Week 24 to Week 260|Noncompliance with study treatment|0
4617681|NCT01752634|7477655|FG000|Week 24 to Week 260|Lost to Follow-up|2
4617682|NCT01752634|7477656|FG001|Week 24 to Week 260|Lost to Follow-up|2
4617683|NCT01752634|7477657|FG002|Week 24 to Week 260|Lost to Follow-up|3
4617684|NCT01752634|7477658|FG003|Week 24 to Week 260|Lost to Follow-up|0
4617685|NCT01752634|7477659|FG004|Week 24 to Week 260|Lost to Follow-up|2
4617686|NCT01752634|7477660|FG005|Week 24 to Week 260|Lost to Follow-up|0
4617687|NCT01752634|7477655|FG000|Week 24 to Week 260|Adverse Event|4
4617688|NCT01752634|7477656|FG001|Week 24 to Week 260|Adverse Event|8
4617689|NCT01752634|7477657|FG002|Week 24 to Week 260|Adverse Event|8
4617690|NCT01752634|7477658|FG003|Week 24 to Week 260|Adverse Event|4
4543577|NCT01157364|7368241|FG001|Overall Study|Adverse Event|1
4543578|NCT01157364|7368242|FG002|Overall Study|Adverse Event|1
4543579|NCT01157364|7368243|FG003|Overall Study|Adverse Event|0
4543580|NCT01157364|7368244|FG004|Overall Study|Adverse Event|1
4617691|NCT01752634|7477659|FG004|Week 24 to Week 260|Adverse Event|2
4617692|NCT01752634|7477660|FG005|Week 24 to Week 260|Adverse Event|0
4617693|NCT01752842|7477681|FG000|Overall Study|Adverse Event|3
4617694|NCT01752842|7477682|FG001|Overall Study|Adverse Event|0
4617695|NCT01752842|7477681|FG000|Overall Study|Withdrawal by Subject|0
4617696|NCT01752842|7477682|FG001|Overall Study|Withdrawal by Subject|2
4617697|NCT01752855|7477690|FG000|Overall Study|Adverse Event|1
4543581|NCT01157364|7368245|FG005|Overall Study|Adverse Event|0
4543582|NCT01157377|7368266|FG000|Overall Study|Lost to Follow-up|0
4543583|NCT01157377|7368267|FG001|Overall Study|Lost to Follow-up|0
4543584|NCT01157377|7368268|FG002|Overall Study|Lost to Follow-up|1
4543585|NCT01157377|7368269|FG003|Overall Study|Lost to Follow-up|0
4543586|NCT01157377|7368270|FG004|Overall Study|Lost to Follow-up|1
4617698|NCT01752855|7477691|FG001|Overall Study|Adverse Event|0
4617699|NCT01752855|7477690|FG000|Overall Study|Withdrew Consent|0
4617700|NCT01752855|7477691|FG001|Overall Study|Withdrew Consent|2
4617701|NCT01752855|7477690|FG000|Overall Study|Lack of Efficacy|0
4617702|NCT01752855|7477691|FG001|Overall Study|Lack of Efficacy|2
4617703|NCT01752907|7477699|FG000|Overall Study|Withdrawal by Subject|4
4617704|NCT01752907|7477700|FG001|Overall Study|Withdrawal by Subject|10
4617705|NCT01752907|7477699|FG000|Overall Study|Lost to Follow-up|2
4617706|NCT01752907|7477700|FG001|Overall Study|Lost to Follow-up|1
4617707|NCT01752907|7477699|FG000|Overall Study|Decision by Sponsor|6
4617708|NCT01752907|7477700|FG001|Overall Study|Decision by Sponsor|9
4617709|NCT01752933|7477708|FG000|Treatment|Disease Progression|3
4617710|NCT01752933|7477709|FG001|Treatment|Disease Progression|29
4617711|NCT01752933|7477708|FG000|Treatment|Withdrawal by Subject|0
4617712|NCT01752933|7477709|FG001|Treatment|Withdrawal by Subject|5
4617713|NCT01752933|7477708|FG000|Treatment|Adverse Event|1
4617714|NCT01752933|7477709|FG001|Treatment|Adverse Event|4
4617715|NCT01752933|7477708|FG000|Treatment|Physician Decision|0
4617716|NCT01752933|7477709|FG001|Treatment|Physician Decision|3
4617717|NCT01752933|7477708|FG000|Treatment|Death|0
4617718|NCT01752933|7477709|FG001|Treatment|Death|2
4617719|NCT01752933|7477708|FG000|Treatment|Hepatocellular carcinoma not confirmed|0
4617720|NCT01752933|7477709|FG001|Treatment|Hepatocellular carcinoma not confirmed|1
4617721|NCT01752933|7477708|FG000|Treatment|Patient noncompliant|0
4617722|NCT01752933|7477709|FG001|Treatment|Patient noncompliant|1
4617723|NCT01752933|7477708|FG000|Treatment|Patient unable to travel to appointments|0
4617724|NCT01752933|7477709|FG001|Treatment|Patient unable to travel to appointments|1
4617725|NCT01752933|7477708|FG000|Overall Study and Follow-up|Death|4
4617726|NCT01752933|7477709|FG001|Overall Study and Follow-up|Death|34
4617727|NCT01752933|7477708|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0
4617728|NCT01752933|7477709|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7
4617729|NCT01752933|7477708|FG000|Overall Study and Follow-up|Withdrawal by Subject|0
4617730|NCT01752933|7477709|FG001|Overall Study and Follow-up|Withdrawal by Subject|3
4617731|NCT01752933|7477708|FG000|Overall Study and Follow-up|Lost to Follow-up|0
4617732|NCT01752933|7477709|FG001|Overall Study and Follow-up|Lost to Follow-up|2
4617733|NCT01752985|7477719|FG000|Treatment Period|Subject request to discontinue treatment|1
4617734|NCT01752985|7477720|FG001|Treatment Period|Subject request to discontinue treatment|0
4617735|NCT01752985|7477721|FG002|Treatment Period|Subject request to discontinue treatment|1
4617736|NCT01752985|7477719|FG000|Treatment Period|Subject no longer meets study criteria|0
4617737|NCT01752985|7477720|FG001|Treatment Period|Subject no longer meets study criteria|1
4617738|NCT01752985|7477721|FG002|Treatment Period|Subject no longer meets study criteria|1
4617739|NCT01752985|7477719|FG000|Treatment Period|Adverse Event|2
4617740|NCT01752985|7477720|FG001|Treatment Period|Adverse Event|1
4543587|NCT01157377|7368271|FG005|Overall Study|Lost to Follow-up|1
4543588|NCT01157377|7368272|FG006|Overall Study|Lost to Follow-up|0
4543589|NCT01157377|7368266|FG000|Overall Study|Personal Reasons|2
4543590|NCT01157377|7368267|FG001|Overall Study|Personal Reasons|1
4543591|NCT01157377|7368268|FG002|Overall Study|Personal Reasons|0
4543592|NCT01157377|7368269|FG003|Overall Study|Personal Reasons|1
4543593|NCT01157377|7368270|FG004|Overall Study|Personal Reasons|0
4543594|NCT01157377|7368271|FG005|Overall Study|Personal Reasons|0
4543595|NCT01157377|7368272|FG006|Overall Study|Personal Reasons|0
4543596|NCT01157377|7368266|FG000|Overall Study|Protocol Violation|0
4543597|NCT01157377|7368267|FG001|Overall Study|Protocol Violation|0
4543598|NCT01157377|7368268|FG002|Overall Study|Protocol Violation|0
4543599|NCT01157377|7368269|FG003|Overall Study|Protocol Violation|0
4543600|NCT01157377|7368270|FG004|Overall Study|Protocol Violation|0
4543601|NCT01157377|7368271|FG005|Overall Study|Protocol Violation|1
4543602|NCT01157377|7368272|FG006|Overall Study|Protocol Violation|0
4543603|NCT01157377|7368266|FG000|Overall Study|Lack of Efficacy|0
4543604|NCT01157377|7368267|FG001|Overall Study|Lack of Efficacy|0
4543605|NCT01157377|7368268|FG002|Overall Study|Lack of Efficacy|0
4543606|NCT01157377|7368269|FG003|Overall Study|Lack of Efficacy|0
4543607|NCT01157377|7368270|FG004|Overall Study|Lack of Efficacy|0
4543608|NCT01157377|7368271|FG005|Overall Study|Lack of Efficacy|0
4543609|NCT01157377|7368272|FG006|Overall Study|Lack of Efficacy|1
4543610|NCT01157377|7368266|FG000|Overall Study|Other Miscellaneous Reasons|0
4617741|NCT01752985|7477721|FG002|Treatment Period|Adverse Event|2
4617742|NCT01752985|7477719|FG000|Treatment Period|Withdrawal by Subject|1
4617743|NCT01752985|7477720|FG001|Treatment Period|Withdrawal by Subject|1
4617744|NCT01752985|7477721|FG002|Treatment Period|Withdrawal by Subject|0
4617745|NCT01752985|7477719|FG000|Treatment Period|Lost to Follow-up|0
4617746|NCT01752985|7477720|FG001|Treatment Period|Lost to Follow-up|0
4617747|NCT01752985|7477721|FG002|Treatment Period|Lost to Follow-up|1
4617748|NCT01753076|7477731|FG000|Overall Study|Adverse Event|17
4617749|NCT01753076|7477732|FG001|Overall Study|Adverse Event|18
4617750|NCT01753076|7477731|FG000|Overall Study|Lack of Efficacy|3
4543611|NCT01157377|7368267|FG001|Overall Study|Other Miscellaneous Reasons|2
4543612|NCT01157377|7368268|FG002|Overall Study|Other Miscellaneous Reasons|0
4543613|NCT01157377|7368269|FG003|Overall Study|Other Miscellaneous Reasons|0
4543614|NCT01157377|7368270|FG004|Overall Study|Other Miscellaneous Reasons|1
4543615|NCT01157377|7368271|FG005|Overall Study|Other Miscellaneous Reasons|1
4543616|NCT01157377|7368272|FG006|Overall Study|Other Miscellaneous Reasons|1
4543617|NCT01157676|7368308|FG000|Randomization|Death|1
4543618|NCT01157676|7368309|FG001|Randomization|Death|1
4543619|NCT01157676|7368308|FG000|Randomization|unresectable|2
4543620|NCT01157676|7368309|FG001|Randomization|unresectable|3
4543621|NCT01157676|7368308|FG000|Randomization|Withdrawal by Subject|17
4543622|NCT01157676|7368309|FG001|Randomization|Withdrawal by Subject|13
4543623|NCT01157676|7368308|FG000|Randomization|Physician Decision|1
4543624|NCT01157676|7368309|FG001|Randomization|Physician Decision|0
4543625|NCT01157676|7368308|FG000|Surgery|underwent open cystectomy|0
4543626|NCT01157676|7368309|FG001|Surgery|underwent open cystectomy|4
4543627|NCT01157676|7368308|FG000|Surgery|converted to open procedure|0
4543628|NCT01157676|7368309|FG001|Surgery|converted to open procedure|5
4617751|NCT01753076|7477732|FG001|Overall Study|Lack of Efficacy|1
4617752|NCT01753076|7477731|FG000|Overall Study|Lost to Follow-up|2
4617753|NCT01753076|7477732|FG001|Overall Study|Lost to Follow-up|1
4617754|NCT01753076|7477731|FG000|Overall Study|Physician Decision|4
4617755|NCT01753076|7477732|FG001|Overall Study|Physician Decision|2
4617756|NCT01753076|7477731|FG000|Overall Study|Withdrawal by Subject|14
4617757|NCT01753076|7477732|FG001|Overall Study|Withdrawal by Subject|24
4617758|NCT01753076|7477731|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1
4617759|NCT01753076|7477732|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0
4617760|NCT01753115|7477743|FG000|Overall Study|Lost to Follow-up|3
4617761|NCT01753115|7477744|FG001|Overall Study|Lost to Follow-up|6
4617762|NCT01753115|7477745|FG002|Overall Study|Lost to Follow-up|8
4617763|NCT01753115|7477743|FG000|Overall Study|Withdrawal by Subject|6
4617764|NCT01753115|7477744|FG001|Overall Study|Withdrawal by Subject|5
4617765|NCT01753115|7477745|FG002|Overall Study|Withdrawal by Subject|6
4617766|NCT01753115|7477743|FG000|Overall Study|Subject non-compliant|3
4617767|NCT01753115|7477744|FG001|Overall Study|Subject non-compliant|3
4617768|NCT01753115|7477745|FG002|Overall Study|Subject non-compliant|0
4617769|NCT01753115|7477743|FG000|Overall Study|Used excluded drug|0
4617770|NCT01753115|7477744|FG001|Overall Study|Used excluded drug|1
4617771|NCT01753115|7477745|FG002|Overall Study|Used excluded drug|0
4617772|NCT01753193|7477753|FG000|Overall Study|Withdrawal by Subject|23
4617773|NCT01753193|7477753|FG000|Overall Study|Lost to Follow-up|6
4617774|NCT01753193|7477753|FG000|Overall Study|Death|1
4543629|NCT01157676|7368308|FG000|Surgery|underwent robotic cystectomy|1
4617775|NCT01753193|7477753|FG000|Overall Study|Other|16
4617776|NCT01753297|7477759|FG000|Overall Study|Lost to Follow-up|7
4617777|NCT01753297|7477760|FG001|Overall Study|Lost to Follow-up|2
4617778|NCT01753297|7477759|FG000|Overall Study|Withdrawal by Subject|26
4617779|NCT01753297|7477760|FG001|Overall Study|Withdrawal by Subject|23
4617780|NCT01753297|7477759|FG000|Overall Study|Adverse Event (up to Month 36)|1
4617781|NCT01753297|7477760|FG001|Overall Study|Adverse Event (up to Month 36)|1
4617782|NCT01753297|7477759|FG000|Overall Study|Death|0
4617783|NCT01753297|7477760|FG001|Overall Study|Death|2
4617784|NCT01753297|7477759|FG000|Overall Study|Did not attend end of study visit|7
4617785|NCT01753297|7477760|FG001|Overall Study|Did not attend end of study visit|8
4617786|NCT01753310|7477770|FG000|Overall Study|Entered into open label extension study|25
4617787|NCT01753310|7477771|FG001|Overall Study|Entered into open label extension study|22
4617788|NCT01753310|7477770|FG000|Overall Study|Adverse Event|1
4617789|NCT01753310|7477771|FG001|Overall Study|Adverse Event|0
4617790|NCT01753310|7477770|FG000|Overall Study|Lost to Follow-up|2
4617791|NCT01753310|7477771|FG001|Overall Study|Lost to Follow-up|0
4617792|NCT01753310|7477770|FG000|Overall Study|Subject decision|2
4617793|NCT01753310|7477771|FG001|Overall Study|Subject decision|2
4617794|NCT01753310|7477770|FG000|Overall Study|Sponsor decision|1
4617795|NCT01753310|7477771|FG001|Overall Study|Sponsor decision|0
4617796|NCT01753310|7477770|FG000|Overall Study|Withdrawal by Subject|1
4617797|NCT01753310|7477771|FG001|Overall Study|Withdrawal by Subject|0
4617798|NCT01753323|7477780|FG000|Overall Study|Lack of Efficacy|0
4617799|NCT01753323|7477781|FG001|Overall Study|Lack of Efficacy|0
4617800|NCT01753323|7477782|FG002|Overall Study|Lack of Efficacy|8
4617801|NCT01753323|7477780|FG000|Overall Study|Protocol deviation|1
4543630|NCT01157676|7368309|FG001|Surgery|underwent robotic cystectomy|0
4591386|NCT01529515|7437935|FG001|MAINTENANCE PHASE|Adverse Event|10
4591387|NCT01529515|7437936|FG002|MAINTENANCE PHASE|Adverse Event|0
4591388|NCT01529515|7437937|FG003|MAINTENANCE PHASE|Adverse Event|0
4591389|NCT01529515|7437934|FG000|MAINTENANCE PHASE|Lack of Efficacy|0
4617802|NCT01753323|7477781|FG001|Overall Study|Protocol deviation|0
4617803|NCT01753323|7477782|FG002|Overall Study|Protocol deviation|0
4617804|NCT01753323|7477780|FG000|Overall Study|Adverse Event|0
4617805|NCT01753323|7477781|FG001|Overall Study|Adverse Event|0
4617806|NCT01753323|7477782|FG002|Overall Study|Adverse Event|1
4617807|NCT01753336|7477791|FG000|Overall Study|Patient decision|12
4617808|NCT01753336|7477791|FG000|Overall Study|Lost to Follow-up|3
4617809|NCT01753336|7477791|FG000|Overall Study|Physician Decision|2
4617810|NCT01753336|7477791|FG000|Overall Study|Sponsor's decision|2
4617811|NCT01753336|7477791|FG000|Overall Study|Withdrawal by Subject|1
4543631|NCT01157845|7368321|FG000|Overall Study|Lost to Follow-up|5
4617812|NCT01753401|7477806|FG000|Double-blind Period (8 Weeks)|Adverse Event|0
4617813|NCT01753401|7477807|FG001|Double-blind Period (8 Weeks)|Adverse Event|2
4617814|NCT01753401|7477808|FG002|Double-blind Period (8 Weeks)|Adverse Event|0
4617815|NCT01753401|7477809|FG003|Double-blind Period (8 Weeks)|Adverse Event|0
4617816|NCT01753401|7477806|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1
4617817|NCT01753401|7477807|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1
4617818|NCT01753401|7477808|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0
4617819|NCT01753401|7477809|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0
4617820|NCT01753401|7477806|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0
4617821|NCT01753401|7477807|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1
4617822|NCT01753401|7477808|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0
4617823|NCT01753401|7477809|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0
4617824|NCT01753401|7477806|FG000|Open Label Period (44 Weeks)|Adverse Event|0
4617825|NCT01753401|7477807|FG001|Open Label Period (44 Weeks)|Adverse Event|0
4617826|NCT01753401|7477808|FG002|Open Label Period (44 Weeks)|Adverse Event|3
4617827|NCT01753401|7477809|FG003|Open Label Period (44 Weeks)|Adverse Event|4
4617828|NCT01753401|7477806|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0
4617829|NCT01753401|7477807|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0
4617830|NCT01753401|7477808|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0
4617831|NCT01753401|7477809|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2
4617832|NCT01753401|7477806|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0
4617833|NCT01753401|7477807|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0
4617834|NCT01753401|7477808|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1
4543632|NCT01157845|7368321|FG000|Overall Study|Withdrawal by Subject|12
4543633|NCT01157845|7368321|FG000|Overall Study|Physician Decision|3
4543634|NCT01157845|7368321|FG000|Overall Study|Protocol Violation|13
4543635|NCT01157845|7368321|FG000|Overall Study|Study was ended|1
4543636|NCT01157845|7368321|FG000|Overall Study|Device malfunction|1
4543637|NCT01157897|7368329|FG000|Overall Study|Lost to Follow-up|2
4543638|NCT01157897|7368330|FG001|Overall Study|Lost to Follow-up|0
4543639|NCT01157897|7368331|FG002|Overall Study|Lost to Follow-up|0
4543640|NCT01157897|7368332|FG003|Overall Study|Lost to Follow-up|1
4543641|NCT01157897|7368329|FG000|Overall Study|Relocated|0
4543642|NCT01157897|7368330|FG001|Overall Study|Relocated|2
4543643|NCT01157897|7368331|FG002|Overall Study|Relocated|0
4543644|NCT01157897|7368332|FG003|Overall Study|Relocated|0
4543645|NCT01158118|7368344|FG000|Overall Study|Screen failure|1
4543646|NCT01158118|7368345|FG001|Overall Study|Screen failure|0
4543647|NCT01158118|7368344|FG000|Overall Study|Donor match was a screen failure|0
4543648|NCT01158118|7368345|FG001|Overall Study|Donor match was a screen failure|1
4543649|NCT01158118|7368344|FG000|Overall Study|Suffered stroke prior to transplant|0
4543650|NCT01158118|7368345|FG001|Overall Study|Suffered stroke prior to transplant|1
4543651|NCT01158118|7368344|FG000|Overall Study|Death|0
4543652|NCT01158118|7368345|FG001|Overall Study|Death|1
4543653|NCT01158222|7368355|FG000|Overall Study|Not eligible for intermediate phase|17
4543654|NCT01158261|7368359|FG000|Overall Study|Lost to Follow-up|9
4543655|NCT01158261|7368359|FG000|Overall Study|Death|7
4543656|NCT01158261|7368359|FG000|Overall Study|Withdrawal by Subject|1
4543657|NCT01158378|7368365|FG000|Overall Study|Death|4
4543658|NCT01158378|7368366|FG001|Overall Study|Death|5
4543659|NCT01158378|7368365|FG000|Overall Study|Lost to Follow-up|2
4543660|NCT01158378|7368366|FG001|Overall Study|Lost to Follow-up|4
4543661|NCT01158378|7368365|FG000|Overall Study|Withdrawal by Subject|4
4543662|NCT01158378|7368366|FG001|Overall Study|Withdrawal by Subject|0
4543663|NCT01158404|7368381|FG000|Overall Study|Withdrawal by Subject|0
4543664|NCT01158404|7368382|FG001|Overall Study|Withdrawal by Subject|1
4543665|NCT01158404|7368383|FG002|Overall Study|Withdrawal by Subject|0
4543666|NCT01158404|7368384|FG003|Overall Study|Withdrawal by Subject|0
4543667|NCT01158404|7368385|FG004|Overall Study|Withdrawal by Subject|3
4543668|NCT01158404|7368386|FG005|Overall Study|Withdrawal by Subject|1
4543669|NCT01158404|7368387|FG006|Overall Study|Withdrawal by Subject|0
4543670|NCT01158404|7368388|FG007|Overall Study|Withdrawal by Subject|1
4543671|NCT01158404|7368381|FG000|Overall Study|Physician Decision|0
4543672|NCT01158404|7368382|FG001|Overall Study|Physician Decision|0
4543673|NCT01158404|7368383|FG002|Overall Study|Physician Decision|0
4543674|NCT01158404|7368384|FG003|Overall Study|Physician Decision|0
4543675|NCT01158404|7368385|FG004|Overall Study|Physician Decision|0
4543676|NCT01158404|7368386|FG005|Overall Study|Physician Decision|0
4543677|NCT01158404|7368387|FG006|Overall Study|Physician Decision|0
4543678|NCT01158404|7368388|FG007|Overall Study|Physician Decision|1
4543679|NCT01158404|7368381|FG000|Overall Study|Progressive Disease|0
4617835|NCT01753401|7477809|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1
4543680|NCT01158404|7368382|FG001|Overall Study|Progressive Disease|0
4543681|NCT01158404|7368383|FG002|Overall Study|Progressive Disease|0
4543682|NCT01158404|7368384|FG003|Overall Study|Progressive Disease|0
4543683|NCT01158404|7368385|FG004|Overall Study|Progressive Disease|0
4543684|NCT01158404|7368386|FG005|Overall Study|Progressive Disease|0
4617836|NCT01753401|7477806|FG000|Open Label Period (44 Weeks)|Reason not provided|0
4632968|NCT01905943|7502747|FG000|Overall Study|Lost to Follow-up|16
4543685|NCT01158404|7368387|FG006|Overall Study|Progressive Disease|1
4543686|NCT01158404|7368388|FG007|Overall Study|Progressive Disease|0
4543687|NCT01158534|7368414|FG000|Overall Study|Withdrawal by Subject|1
4543688|NCT01158534|7368414|FG000|Overall Study|Death|1
4543689|NCT01158534|7368414|FG000|Overall Study|Other|1
4543690|NCT01158924|7368473|FG000|Overall Study|Withdrawal by Subject|1
4543691|NCT01158924|7368474|FG001|Overall Study|Withdrawal by Subject|2
4543692|NCT01158924|7368473|FG000|Overall Study|Lost to Follow-up|0
4543693|NCT01158924|7368474|FG001|Overall Study|Lost to Follow-up|1
4543694|NCT01158950|7368480|FG000|1st Intervention (1 Day)|Physician Decision|1
4543695|NCT01158950|7368481|FG001|1st Intervention (1 Day)|Physician Decision|2
4543696|NCT01159171|7368512|FG000|Overall Study|Adverse Event|11
4543697|NCT01159171|7368512|FG000|Overall Study|Progression of Disease|28
4543698|NCT01159171|7368512|FG000|Overall Study|Protocol Violation|1
4543699|NCT01159171|7368512|FG000|Overall Study|Need for Surgery|5
4543700|NCT01159171|7368512|FG000|Overall Study|Medical Decision|4
4543701|NCT01159171|7368512|FG000|Overall Study|Death|1
4543702|NCT01159431|7368532|FG000|Overall Study|Adverse Event|1
4543703|NCT01159431|7368533|FG001|Overall Study|Adverse Event|2
4543704|NCT01159431|7368532|FG000|Overall Study|non-compliance|1
4543705|NCT01159431|7368533|FG001|Overall Study|non-compliance|1
4543706|NCT01159431|7368532|FG000|Overall Study|Lack of Efficacy|0
4543707|NCT01159431|7368533|FG001|Overall Study|Lack of Efficacy|3
4543708|NCT01159574|7368559|FG000|Treatment Phase|non-evaluable/not included in analysis|1
4543709|NCT01159574|7368559|FG000|Treatment Phase|Adverse Event|3
4543710|NCT01159574|7368559|FG000|Treatment Phase|Death|6
4543711|NCT01159574|7368559|FG000|Treatment Phase|Physician Decision|2
4543712|NCT01159574|7368559|FG000|Treatment Phase|Withdrawal by Subject|7
4543713|NCT01159574|7368559|FG000|Treatment Phase|still on treatment|2
4543714|NCT01159574|7368559|FG000|Follow Up Phase|Lost to Follow-up|2
4543715|NCT01159574|7368559|FG000|Follow Up Phase|still being followed for overall surviva|18
4543716|NCT01159600|7368571|FG000|Overall Study|Not treated|0
4543717|NCT01159600|7368572|FG001|Overall Study|Not treated|0
4543718|NCT01159600|7368573|FG002|Overall Study|Not treated|1
4543719|NCT01159600|7368574|FG003|Overall Study|Not treated|0
4543720|NCT01159600|7368575|FG004|Overall Study|Not treated|0
4543721|NCT01159600|7368576|FG005|Overall Study|Not treated|1
4543722|NCT01159600|7368577|FG006|Overall Study|Not treated|2
4543723|NCT01159600|7368578|FG007|Overall Study|Not treated|2
4543724|NCT01159600|7368571|FG000|Overall Study|Adverse Event|7
4543725|NCT01159600|7368572|FG001|Overall Study|Adverse Event|2
4543726|NCT01159600|7368573|FG002|Overall Study|Adverse Event|5
4543727|NCT01159600|7368574|FG003|Overall Study|Adverse Event|1
4543728|NCT01159600|7368575|FG004|Overall Study|Adverse Event|8
4543729|NCT01159600|7368576|FG005|Overall Study|Adverse Event|6
4543730|NCT01159600|7368577|FG006|Overall Study|Adverse Event|7
4543731|NCT01159600|7368578|FG007|Overall Study|Adverse Event|5
4543732|NCT01159600|7368571|FG000|Overall Study|Lack of Efficacy|0
4543733|NCT01159600|7368572|FG001|Overall Study|Lack of Efficacy|0
4543734|NCT01159600|7368573|FG002|Overall Study|Lack of Efficacy|0
4543735|NCT01159600|7368574|FG003|Overall Study|Lack of Efficacy|0
4543736|NCT01159600|7368575|FG004|Overall Study|Lack of Efficacy|2
4543737|NCT01159600|7368576|FG005|Overall Study|Lack of Efficacy|0
4543738|NCT01159600|7368577|FG006|Overall Study|Lack of Efficacy|0
4543739|NCT01159600|7368578|FG007|Overall Study|Lack of Efficacy|1
4543740|NCT01159600|7368571|FG000|Overall Study|Non compliant with protocol|2
4543741|NCT01159600|7368572|FG001|Overall Study|Non compliant with protocol|1
4543742|NCT01159600|7368573|FG002|Overall Study|Non compliant with protocol|0
4543743|NCT01159600|7368574|FG003|Overall Study|Non compliant with protocol|0
4543744|NCT01159600|7368575|FG004|Overall Study|Non compliant with protocol|2
4543745|NCT01159600|7368576|FG005|Overall Study|Non compliant with protocol|0
4543746|NCT01159600|7368577|FG006|Overall Study|Non compliant with protocol|2
4543747|NCT01159600|7368578|FG007|Overall Study|Non compliant with protocol|0
4543748|NCT01159600|7368571|FG000|Overall Study|Lost to Follow-up|2
4543749|NCT01159600|7368572|FG001|Overall Study|Lost to Follow-up|3
4543750|NCT01159600|7368573|FG002|Overall Study|Lost to Follow-up|4
4543751|NCT01159600|7368574|FG003|Overall Study|Lost to Follow-up|3
4543752|NCT01159600|7368575|FG004|Overall Study|Lost to Follow-up|3
4543753|NCT01159600|7368576|FG005|Overall Study|Lost to Follow-up|0
4543754|NCT01159600|7368577|FG006|Overall Study|Lost to Follow-up|3
4543755|NCT01159600|7368578|FG007|Overall Study|Lost to Follow-up|2
4543756|NCT01159600|7368571|FG000|Overall Study|Patient refusal to continue,not due toAE|7
4543757|NCT01159600|7368572|FG001|Overall Study|Patient refusal to continue,not due toAE|2
4543758|NCT01159600|7368573|FG002|Overall Study|Patient refusal to continue,not due toAE|4
4543759|NCT01159600|7368574|FG003|Overall Study|Patient refusal to continue,not due toAE|5
4543760|NCT01159600|7368575|FG004|Overall Study|Patient refusal to continue,not due toAE|4
4543761|NCT01159600|7368576|FG005|Overall Study|Patient refusal to continue,not due toAE|4
4543762|NCT01159600|7368577|FG006|Overall Study|Patient refusal to continue,not due toAE|2
4543763|NCT01159600|7368578|FG007|Overall Study|Patient refusal to continue,not due toAE|5
4543764|NCT01159600|7368571|FG000|Overall Study|Other reason not defined above|3
4543765|NCT01159600|7368572|FG001|Overall Study|Other reason not defined above|0
4543766|NCT01159600|7368573|FG002|Overall Study|Other reason not defined above|4
4543767|NCT01159600|7368574|FG003|Overall Study|Other reason not defined above|2
4543768|NCT01159600|7368575|FG004|Overall Study|Other reason not defined above|5
4543769|NCT01159600|7368576|FG005|Overall Study|Other reason not defined above|7
4543770|NCT01159600|7368577|FG006|Overall Study|Other reason not defined above|3
4543771|NCT01159600|7368578|FG007|Overall Study|Other reason not defined above|3
4543772|NCT01159665|7368603|FG000|Overall Study|Withdrawal by Subject|0
4543773|NCT01159665|7368604|FG001|Overall Study|Withdrawal by Subject|1
4543774|NCT01159665|7368605|FG002|Overall Study|Withdrawal by Subject|0
4543775|NCT01159665|7368606|FG003|Overall Study|Withdrawal by Subject|0
4543776|NCT01159665|7368607|FG004|Overall Study|Withdrawal by Subject|0
4543777|NCT01159665|7368608|FG005|Overall Study|Withdrawal by Subject|0
4543778|NCT01159691|7368622|FG000|Overall Study|Lost to Follow-up|2
4543779|NCT01159691|7368622|FG000|Overall Study|Unknown reasons|1
4543780|NCT01159691|7368622|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6
4543781|NCT01159691|7368622|FG000|Overall Study|Discontinued Neupro due to other reasons|1
4543782|NCT01159691|7368622|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2
4543783|NCT01159691|7368622|FG000|Overall Study|Disc. Neupro other & unknown reasons|7
4543784|NCT01159691|7368622|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2
4543785|NCT01159691|7368622|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1
4543786|NCT01159769|7368635|FG000|Overall Study|Adverse Event|1
4543787|NCT01159912|7368642|FG000|Overall Study|Adverse Event|2
4543788|NCT01159912|7368643|FG001|Overall Study|Adverse Event|2
4543789|NCT01159912|7368644|FG002|Overall Study|Adverse Event|3
4543790|NCT01159912|7368642|FG000|Overall Study|Lack of Efficacy|23
4543791|NCT01159912|7368643|FG001|Overall Study|Lack of Efficacy|15
4543792|NCT01159912|7368644|FG002|Overall Study|Lack of Efficacy|14
4543793|NCT01159912|7368642|FG000|Overall Study|Protocol Violation|1
4543794|NCT01159912|7368643|FG001|Overall Study|Protocol Violation|2
4543795|NCT01159912|7368644|FG002|Overall Study|Protocol Violation|3
4543796|NCT01159912|7368642|FG000|Overall Study|Lost to Follow-up|4
4543797|NCT01159912|7368643|FG001|Overall Study|Lost to Follow-up|0
4543798|NCT01159912|7368644|FG002|Overall Study|Lost to Follow-up|0
4543799|NCT01159912|7368642|FG000|Overall Study|Physician Decision|0
4543800|NCT01159912|7368643|FG001|Overall Study|Physician Decision|0
4543801|NCT01159912|7368644|FG002|Overall Study|Physician Decision|3
4543802|NCT01159912|7368642|FG000|Overall Study|Withdrawal by Subject|10
4543803|NCT01159912|7368643|FG001|Overall Study|Withdrawal by Subject|3
4543804|NCT01159912|7368644|FG002|Overall Study|Withdrawal by Subject|3
4543805|NCT01159938|7368655|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0
4543806|NCT01159938|7368656|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0
4543807|NCT01159938|7368657|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1
4543808|NCT01159938|7368658|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0
4543809|NCT01159938|7368659|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0
4543810|NCT01160198|7368683|FG000|Overall Study|Withdrawal by Subject|2
4543811|NCT01160198|7368684|FG001|Overall Study|Withdrawal by Subject|1
4543812|NCT01160198|7368685|FG002|Overall Study|Withdrawal by Subject|0
4543813|NCT01160198|7368683|FG000|Overall Study|Adverse Event|0
4543814|NCT01160198|7368684|FG001|Overall Study|Adverse Event|1
4543815|NCT01160198|7368685|FG002|Overall Study|Adverse Event|0
4543816|NCT01160198|7368683|FG000|Overall Study|Lost to Follow-up|0
4543817|NCT01160198|7368684|FG001|Overall Study|Lost to Follow-up|1
4543818|NCT01160198|7368685|FG002|Overall Study|Lost to Follow-up|0
4543819|NCT01160198|7368683|FG000|Overall Study|Participant lost drug; withdrew consent|0
4543820|NCT01160198|7368684|FG001|Overall Study|Participant lost drug; withdrew consent|0
4543821|NCT01160198|7368685|FG002|Overall Study|Participant lost drug; withdrew consent|1
4543822|NCT01160211|7368696|FG000|Overall Study|ongoing|90
4543823|NCT01160211|7368697|FG001|Overall Study|ongoing|75
4543824|NCT01160211|7368698|FG002|Overall Study|ongoing|79
4543825|NCT01160211|7368696|FG000|Overall Study|Withdrawal by Subject|3
4543826|NCT01160211|7368697|FG001|Overall Study|Withdrawal by Subject|5
4543827|NCT01160211|7368698|FG002|Overall Study|Withdrawal by Subject|3
4543828|NCT01160211|7368696|FG000|Overall Study|Physician Decision|2
4543829|NCT01160211|7368697|FG001|Overall Study|Physician Decision|0
4543830|NCT01160211|7368698|FG002|Overall Study|Physician Decision|0
4543831|NCT01160211|7368696|FG000|Overall Study|Lost to Follow-up|4
4543832|NCT01160211|7368697|FG001|Overall Study|Lost to Follow-up|7
4543833|NCT01160211|7368698|FG002|Overall Study|Lost to Follow-up|5
4543834|NCT01160289|7368725|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8
4543835|NCT01160289|7368726|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0
4543836|NCT01160289|7368727|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0
4543837|NCT01160289|7368728|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0
4543838|NCT01160289|7368729|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0
4543839|NCT01160289|7368730|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0
4543840|NCT01160289|7368725|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308
4543841|NCT01160289|7368726|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
4543842|NCT01160289|7368727|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
4543843|NCT01160289|7368728|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
4543844|NCT01160289|7368729|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
4543845|NCT01160289|7368730|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
4543846|NCT01160289|7368725|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1
4543847|NCT01160289|7368726|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
4543848|NCT01160289|7368727|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
4543849|NCT01160289|7368728|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
4543850|NCT01160289|7368729|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
4543851|NCT01160289|7368730|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
4543852|NCT01160289|7368725|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9
4543853|NCT01160289|7368726|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
4543854|NCT01160289|7368727|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
4543855|NCT01160289|7368728|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
4543856|NCT01160289|7368729|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
4543857|NCT01160289|7368730|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
4543858|NCT01160289|7368725|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26
4543859|NCT01160289|7368726|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0
4543860|NCT01160289|7368727|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0
4543861|NCT01160289|7368728|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0
4543862|NCT01160289|7368729|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0
4543863|NCT01160289|7368730|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0
4543864|NCT01160289|7368725|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1
4543865|NCT01160289|7368726|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0
4617837|NCT01753401|7477807|FG001|Open Label Period (44 Weeks)|Reason not provided|0
4617838|NCT01753401|7477808|FG002|Open Label Period (44 Weeks)|Reason not provided|0
4617839|NCT01753401|7477809|FG003|Open Label Period (44 Weeks)|Reason not provided|2
4617840|NCT01753518|7477821|FG000|Intention-to-Treat Analysis|Missing consent form|5
4543866|NCT01160289|7368727|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0
4543867|NCT01160289|7368728|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0
4543868|NCT01160289|7368729|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0
4543869|NCT01160289|7368730|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0
4543870|NCT01160289|7368725|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67
4543871|NCT01160289|7368726|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
4543872|NCT01160289|7368727|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
4543873|NCT01160289|7368728|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
4543874|NCT01160289|7368729|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
4543875|NCT01160289|7368730|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
4543876|NCT01160289|7368725|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64
4543877|NCT01160289|7368726|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
4543878|NCT01160289|7368727|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
4543879|NCT01160289|7368728|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
4543880|NCT01160289|7368729|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
4543881|NCT01160289|7368730|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
4543882|NCT01160289|7368725|FG000|Post-Randomization Period|Adverse Event|0
4543883|NCT01160289|7368726|FG001|Post-Randomization Period|Adverse Event|4
4543884|NCT01160289|7368727|FG002|Post-Randomization Period|Adverse Event|4
4543885|NCT01160289|7368728|FG003|Post-Randomization Period|Adverse Event|2
4543886|NCT01160289|7368729|FG004|Post-Randomization Period|Adverse Event|0
4543887|NCT01160289|7368730|FG005|Post-Randomization Period|Adverse Event|0
4543888|NCT01160289|7368725|FG000|Post-Randomization Period|Death|0
4543889|NCT01160289|7368726|FG001|Post-Randomization Period|Death|0
4543890|NCT01160289|7368727|FG002|Post-Randomization Period|Death|0
4543891|NCT01160289|7368728|FG003|Post-Randomization Period|Death|1
4543892|NCT01160289|7368729|FG004|Post-Randomization Period|Death|0
4543893|NCT01160289|7368730|FG005|Post-Randomization Period|Death|0
4543894|NCT01160289|7368725|FG000|Post-Randomization Period|Lack of Efficacy|0
4543895|NCT01160289|7368726|FG001|Post-Randomization Period|Lack of Efficacy|1
4543896|NCT01160289|7368727|FG002|Post-Randomization Period|Lack of Efficacy|0
4543897|NCT01160289|7368728|FG003|Post-Randomization Period|Lack of Efficacy|3
4543898|NCT01160289|7368729|FG004|Post-Randomization Period|Lack of Efficacy|0
4543899|NCT01160289|7368730|FG005|Post-Randomization Period|Lack of Efficacy|0
4543900|NCT01160289|7368725|FG000|Post-Randomization Period|Lost to Follow-up|0
4543901|NCT01160289|7368726|FG001|Post-Randomization Period|Lost to Follow-up|3
4543902|NCT01160289|7368727|FG002|Post-Randomization Period|Lost to Follow-up|2
4543903|NCT01160289|7368728|FG003|Post-Randomization Period|Lost to Follow-up|5
4543904|NCT01160289|7368729|FG004|Post-Randomization Period|Lost to Follow-up|3
4543905|NCT01160289|7368730|FG005|Post-Randomization Period|Lost to Follow-up|4
4543906|NCT01160289|7368725|FG000|Post-Randomization Period|Physician Decision|0
4543907|NCT01160289|7368726|FG001|Post-Randomization Period|Physician Decision|0
4543908|NCT01160289|7368727|FG002|Post-Randomization Period|Physician Decision|1
4543909|NCT01160289|7368728|FG003|Post-Randomization Period|Physician Decision|0
4543910|NCT01160289|7368729|FG004|Post-Randomization Period|Physician Decision|0
4543911|NCT01160289|7368730|FG005|Post-Randomization Period|Physician Decision|0
4543912|NCT01160289|7368725|FG000|Post-Randomization Period|Protocol Violation|0
4543913|NCT01160289|7368726|FG001|Post-Randomization Period|Protocol Violation|4
4543914|NCT01160289|7368727|FG002|Post-Randomization Period|Protocol Violation|2
4543915|NCT01160289|7368728|FG003|Post-Randomization Period|Protocol Violation|0
4543916|NCT01160289|7368729|FG004|Post-Randomization Period|Protocol Violation|1
4543917|NCT01160289|7368730|FG005|Post-Randomization Period|Protocol Violation|3
4543918|NCT01160289|7368725|FG000|Post-Randomization Period|Withdrawal by Subject|0
4543919|NCT01160289|7368726|FG001|Post-Randomization Period|Withdrawal by Subject|5
4543920|NCT01160289|7368727|FG002|Post-Randomization Period|Withdrawal by Subject|13
4543921|NCT01160289|7368728|FG003|Post-Randomization Period|Withdrawal by Subject|8
4543922|NCT01160289|7368729|FG004|Post-Randomization Period|Withdrawal by Subject|5
4543923|NCT01160289|7368730|FG005|Post-Randomization Period|Withdrawal by Subject|7
4543924|NCT01160289|7368725|FG000|Post-Randomization Period|Entry Criteria Not Met|0
4543925|NCT01160289|7368726|FG001|Post-Randomization Period|Entry Criteria Not Met|2
4543926|NCT01160289|7368727|FG002|Post-Randomization Period|Entry Criteria Not Met|2
4543927|NCT01160289|7368728|FG003|Post-Randomization Period|Entry Criteria Not Met|2
4543928|NCT01160289|7368729|FG004|Post-Randomization Period|Entry Criteria Not Met|0
4543929|NCT01160289|7368730|FG005|Post-Randomization Period|Entry Criteria Not Met|0
4543930|NCT01160289|7368725|FG000|Post-Randomization Period|Sponsor Decision|0
4543931|NCT01160289|7368726|FG001|Post-Randomization Period|Sponsor Decision|1
4543932|NCT01160289|7368727|FG002|Post-Randomization Period|Sponsor Decision|0
4543933|NCT01160289|7368728|FG003|Post-Randomization Period|Sponsor Decision|0
4543934|NCT01160289|7368729|FG004|Post-Randomization Period|Sponsor Decision|0
4543935|NCT01160289|7368730|FG005|Post-Randomization Period|Sponsor Decision|0
4543936|NCT01160354|7368746|FG000|Overall Study|Death|0
4543937|NCT01160354|7368747|FG001|Overall Study|Death|1
4543938|NCT01160354|7368748|FG002|Overall Study|Death|1
4543939|NCT01160484|7368778|FG000|Overall Study|Lack of Efficacy|9
4543940|NCT01160484|7368778|FG000|Overall Study|Adverse Event|6
4543941|NCT01160484|7368778|FG000|Overall Study|Withdrawal by Subject|2
4543942|NCT01160484|7368778|FG000|Overall Study|inclusion/exclusion criteria failure|1
4543943|NCT01160614|7368784|FG000|Overall Study|Withdrawal by Subject|0
4543944|NCT01160614|7368785|FG001|Overall Study|Withdrawal by Subject|2
4543945|NCT01160640|7368811|FG000|Overall Study|Physician Decision|3
4543946|NCT01160640|7368812|FG001|Overall Study|Physician Decision|3
4543947|NCT01160640|7368811|FG000|Overall Study|Incarceration|1
4543948|NCT01160640|7368812|FG001|Overall Study|Incarceration|0
4543949|NCT01160640|7368811|FG000|Overall Study|Withdrawal by Subject|0
4543950|NCT01160640|7368812|FG001|Overall Study|Withdrawal by Subject|3
4543951|NCT01160744|7368824|FG000|Overall Study|Withdrawal by Subject|11
4543952|NCT01160744|7368825|FG001|Overall Study|Withdrawal by Subject|5
4543953|NCT01160744|7368826|FG002|Overall Study|Withdrawal by Subject|6
4543954|NCT01160744|7368827|FG003|Overall Study|Withdrawal by Subject|4
4543955|NCT01160744|7368824|FG000|Overall Study|Not meet inclusion/exclusion criteria|0
4543956|NCT01160744|7368825|FG001|Overall Study|Not meet inclusion/exclusion criteria|0
4543957|NCT01160744|7368826|FG002|Overall Study|Not meet inclusion/exclusion criteria|1
4543958|NCT01160744|7368827|FG003|Overall Study|Not meet inclusion/exclusion criteria|0
4543959|NCT01160770|7368839|FG000|Overall Study|Adverse Event|10
4543960|NCT01160770|7368839|FG000|Overall Study|Protocol Violation|2
4543961|NCT01160770|7368839|FG000|Overall Study|Subject/parent/caregiver request|33
4543962|NCT01160770|7368839|FG000|Overall Study|Physician Decision|1
4543963|NCT01160770|7368839|FG000|Overall Study|Lost to Follow-up|7
4543964|NCT01160770|7368839|FG000|Overall Study|Study termination or sponsor request|1
4543965|NCT01160770|7368839|FG000|Overall Study|Death|9
4543966|NCT01160770|7368839|FG000|Overall Study|Lack of Efficacy|15
4543967|NCT01160770|7368839|FG000|Overall Study|Other Reasons|1
4543968|NCT01160822|7368850|FG000|Overall Study|Adverse Event|0
4543969|NCT01160822|7368851|FG001|Overall Study|Adverse Event|0
4543970|NCT01160822|7368852|FG002|Overall Study|Adverse Event|0
4543971|NCT01160822|7368853|FG003|Overall Study|Adverse Event|0
4543972|NCT01160822|7368854|FG004|Overall Study|Adverse Event|1
4543973|NCT01160822|7368855|FG005|Overall Study|Adverse Event|2
4543974|NCT01160822|7368856|FG006|Overall Study|Adverse Event|5
4543975|NCT01160822|7368850|FG000|Overall Study|Unsatisfactory therapeutic effect|0
4543976|NCT01160822|7368851|FG001|Overall Study|Unsatisfactory therapeutic effect|0
4543977|NCT01160822|7368852|FG002|Overall Study|Unsatisfactory therapeutic effect|0
4543978|NCT01160822|7368853|FG003|Overall Study|Unsatisfactory therapeutic effect|0
4543979|NCT01160822|7368854|FG004|Overall Study|Unsatisfactory therapeutic effect|4
4543980|NCT01160822|7368855|FG005|Overall Study|Unsatisfactory therapeutic effect|5
4543981|NCT01160822|7368856|FG006|Overall Study|Unsatisfactory therapeutic effect|3
4543982|NCT01160822|7368850|FG000|Overall Study|Withdrawal by Subject|0
4543983|NCT01160822|7368851|FG001|Overall Study|Withdrawal by Subject|0
4543984|NCT01160822|7368852|FG002|Overall Study|Withdrawal by Subject|0
4543985|NCT01160822|7368853|FG003|Overall Study|Withdrawal by Subject|0
4543986|NCT01160822|7368854|FG004|Overall Study|Withdrawal by Subject|0
4543987|NCT01160822|7368855|FG005|Overall Study|Withdrawal by Subject|0
4543988|NCT01160822|7368856|FG006|Overall Study|Withdrawal by Subject|1
4543989|NCT01160822|7368850|FG000|Overall Study|Lost to Follow-up|0
4543990|NCT01160822|7368851|FG001|Overall Study|Lost to Follow-up|0
4543991|NCT01160822|7368852|FG002|Overall Study|Lost to Follow-up|0
4543992|NCT01160822|7368853|FG003|Overall Study|Lost to Follow-up|0
4543993|NCT01160822|7368854|FG004|Overall Study|Lost to Follow-up|1
4543994|NCT01160822|7368855|FG005|Overall Study|Lost to Follow-up|0
4543995|NCT01160822|7368856|FG006|Overall Study|Lost to Follow-up|0
4543996|NCT01160822|7368850|FG000|Overall Study|Administrative problems|0
4543997|NCT01160822|7368851|FG001|Overall Study|Administrative problems|0
4543998|NCT01160822|7368852|FG002|Overall Study|Administrative problems|0
4543999|NCT01160822|7368853|FG003|Overall Study|Administrative problems|0
4544000|NCT01160822|7368854|FG004|Overall Study|Administrative problems|1
4544001|NCT01160822|7368855|FG005|Overall Study|Administrative problems|0
4544002|NCT01160822|7368856|FG006|Overall Study|Administrative problems|0
4544003|NCT01160822|7368850|FG000|Overall Study|Protocol deviation|0
4544004|NCT01160822|7368851|FG001|Overall Study|Protocol deviation|0
4544005|NCT01160822|7368852|FG002|Overall Study|Protocol deviation|0
4544006|NCT01160822|7368853|FG003|Overall Study|Protocol deviation|0
4544007|NCT01160822|7368854|FG004|Overall Study|Protocol deviation|2
4544008|NCT01160822|7368855|FG005|Overall Study|Protocol deviation|0
4544009|NCT01160822|7368856|FG006|Overall Study|Protocol deviation|0
4544010|NCT01161043|7368886|FG000|Overall Study|Withdrawal by Subject|3
4544011|NCT01161173|7368911|FG000|Overall Study|Protocol Violation|13
4544012|NCT01161173|7368911|FG000|Overall Study|Lost to Follow-up|7
4544013|NCT01161173|7368911|FG000|Overall Study|Progressive Disease|82
4544014|NCT01161173|7368911|FG000|Overall Study|Withdrawal of Consent|5
4544015|NCT01161173|7368911|FG000|Overall Study|Unacceptable Toxicity|21
4544016|NCT01161173|7368911|FG000|Overall Study|Death|194
4544017|NCT01161173|7368911|FG000|Overall Study|End of Study|2
4544018|NCT01161173|7368911|FG000|Overall Study|Reasons Not Specified|23
4544019|NCT01161407|7368944|FG000|Overall Study|Protocol Violation|3
4617841|NCT01753518|7477822|FG001|Intention-to-Treat Analysis|Missing consent form|3
4617842|NCT01753518|7477821|FG000|Intention-to-Treat Analysis|Multifetal gestation|2
4617843|NCT01753518|7477822|FG001|Intention-to-Treat Analysis|Multifetal gestation|3
4617844|NCT01753518|7477821|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0
4617845|NCT01753518|7477822|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1
4617846|NCT01753518|7477821|FG000|Postpartum Follow-up|Lost to Follow-up|22
4617847|NCT01753518|7477822|FG001|Postpartum Follow-up|Lost to Follow-up|15
4617848|NCT01753570|7477841|FG000|Overall Study|Adverse Event|1
4617849|NCT01753570|7477842|FG001|Overall Study|Adverse Event|0
4617850|NCT01753570|7477843|FG002|Overall Study|Adverse Event|1
4617851|NCT01753570|7477841|FG000|Overall Study|Physician Decision|0
4544020|NCT01161407|7368945|FG001|Overall Study|Protocol Violation|1
4544021|NCT01161446|7368963|FG000|Overall Study|Lost to Follow-up|18
4544022|NCT01161446|7368964|FG001|Overall Study|Lost to Follow-up|14
4544023|NCT01161446|7368963|FG000|Overall Study|Withdrawal by Subject|0
4544024|NCT01161446|7368964|FG001|Overall Study|Withdrawal by Subject|1
4544025|NCT01161472|7368970|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1
4544026|NCT01161472|7368971|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
4544027|NCT01161472|7368972|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
4544028|NCT01161472|7368973|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
4544029|NCT01161498|7368985|FG000|Overall Study|Disease Progression|0
4544030|NCT01161498|7368986|FG001|Overall Study|Disease Progression|1
4544031|NCT01161524|7368994|FG000|Core Study (23 Weeks)|Adverse Event|3
4544032|NCT01161524|7368995|FG001|Core Study (23 Weeks)|Adverse Event|0
4544033|NCT01161524|7368996|FG002|Core Study (23 Weeks)|Adverse Event|0
4544034|NCT01161524|7368994|FG000|Core Study (23 Weeks)|Other|1
4544035|NCT01161524|7368995|FG001|Core Study (23 Weeks)|Other|0
4544036|NCT01161524|7368996|FG002|Core Study (23 Weeks)|Other|0
4544037|NCT01161524|7368994|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1
4544038|NCT01161524|7368995|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1
4544039|NCT01161524|7368996|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0
4544040|NCT01161524|7368994|FG000|Core Study (23 Weeks)|Lost to Follow-up|1
4544041|NCT01161524|7368995|FG001|Core Study (23 Weeks)|Lost to Follow-up|2
4544042|NCT01161524|7368996|FG002|Core Study (23 Weeks)|Lost to Follow-up|0
4544043|NCT01161524|7368994|FG000|Core Study (23 Weeks)|Subject Choice|3
4544044|NCT01161524|7368995|FG001|Core Study (23 Weeks)|Subject Choice|2
4617852|NCT01753570|7477842|FG001|Overall Study|Physician Decision|1
4617853|NCT01753570|7477843|FG002|Overall Study|Physician Decision|0
4617854|NCT01753570|7477841|FG000|Overall Study|Withdrawal by Subject|1
4544045|NCT01161524|7368996|FG002|Core Study (23 Weeks)|Subject Choice|0
4544046|NCT01161524|7368994|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0
4544047|NCT01161524|7368995|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0
4544048|NCT01161524|7368996|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8
4544049|NCT01161524|7368994|FG000|Extension Phase (Approximately 83 Weeks)|Other|0
4544050|NCT01161524|7368995|FG001|Extension Phase (Approximately 83 Weeks)|Other|0
4544051|NCT01161524|7368996|FG002|Extension Phase (Approximately 83 Weeks)|Other|6
4544052|NCT01161524|7368994|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0
4544053|NCT01161524|7368995|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0
4544054|NCT01161524|7368996|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1
4544055|NCT01161524|7368994|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0
4544056|NCT01161524|7368995|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0
4544057|NCT01161524|7368996|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5
4544058|NCT01161524|7368994|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0
4544059|NCT01161524|7368995|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0
4544060|NCT01161524|7368996|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4
4544061|NCT01161537|7369005|FG000|Part B|Withdrawal by Subject|2
4544062|NCT01161628|7369023|FG000|Overall Study|Death|6
4544063|NCT01161628|7369023|FG000|Overall Study|Lack of Efficacy|2
4544064|NCT01162122|7369061|FG000|Overall Study|Withdrawal by Subject|52
4544065|NCT01162122|7369062|FG001|Overall Study|Withdrawal by Subject|43
4544066|NCT01162122|7369061|FG000|Overall Study|Lost to Follow-up|73
4544067|NCT01162122|7369062|FG001|Overall Study|Lost to Follow-up|91
4544068|NCT01162122|7369061|FG000|Overall Study|Adverse Event|3
4544069|NCT01162122|7369062|FG001|Overall Study|Adverse Event|2
4544070|NCT01162122|7369061|FG000|Overall Study|Death|51
4544071|NCT01162122|7369062|FG001|Overall Study|Death|46
4544072|NCT01162122|7369061|FG000|Overall Study|Protocol Violation|2
4544073|NCT01162122|7369062|FG001|Overall Study|Protocol Violation|2
4544074|NCT01162122|7369061|FG000|Overall Study|Inappropriate enrollment|5
4544075|NCT01162122|7369062|FG001|Overall Study|Inappropriate enrollment|4
4544076|NCT01162122|7369061|FG000|Overall Study|Administrative reason|1
4544077|NCT01162122|7369062|FG001|Overall Study|Administrative reason|1
4544078|NCT01162122|7369061|FG000|Overall Study|Unable to classify|3
4544079|NCT01162122|7369062|FG001|Overall Study|Unable to classify|7
4544080|NCT01162122|7369061|FG000|Overall Study|Missing primary reason|1
4544081|NCT01162122|7369062|FG001|Overall Study|Missing primary reason|0
4544082|NCT01162135|7369071|FG000|Overall Study|Withdrawal by Subject|1
4544083|NCT01162135|7369071|FG000|Overall Study|Severe back pain|1
4544084|NCT01162135|7369071|FG000|Overall Study|Ineligible|1
4544085|NCT01162239|7369079|FG000|Treatment Phase|Withdrawal by Subject|1
4544086|NCT01162239|7369080|FG001|Treatment Phase|Withdrawal by Subject|3
4544087|NCT01162239|7369081|FG002|Treatment Phase|Withdrawal by Subject|2
4544088|NCT01162239|7369082|FG003|Treatment Phase|Withdrawal by Subject|3
4544089|NCT01162239|7369079|FG000|Treatment Phase|Death|0
4544090|NCT01162239|7369080|FG001|Treatment Phase|Death|0
4544091|NCT01162239|7369081|FG002|Treatment Phase|Death|0
4544092|NCT01162239|7369082|FG003|Treatment Phase|Death|1
4544093|NCT01162239|7369079|FG000|Treatment Phase|Lost to Follow-up|5
4544094|NCT01162239|7369080|FG001|Treatment Phase|Lost to Follow-up|4
4544095|NCT01162239|7369081|FG002|Treatment Phase|Lost to Follow-up|2
4544096|NCT01162239|7369082|FG003|Treatment Phase|Lost to Follow-up|1
4544097|NCT01162239|7369079|FG000|Extended Follow-up|Lost to Follow-up|8
4544098|NCT01162239|7369080|FG001|Extended Follow-up|Lost to Follow-up|13
4544099|NCT01162239|7369081|FG002|Extended Follow-up|Lost to Follow-up|8
4544100|NCT01162239|7369082|FG003|Extended Follow-up|Lost to Follow-up|6
4544101|NCT01162343|7369102|FG000|Overall Study|Left ED prior to psychiatrist assessment|80
4544102|NCT01162343|7369102|FG000|Overall Study|Refused psychiatrist assessment|12
4544103|NCT01162421|7369108|FG000|Overall Study|Did not receive study drug|2
4544104|NCT01162421|7369109|FG001|Overall Study|Did not receive study drug|1
4544105|NCT01162421|7369108|FG000|Overall Study|Adverse Event|2
4544106|NCT01162421|7369109|FG001|Overall Study|Adverse Event|5
4544107|NCT01162421|7369108|FG000|Overall Study|Lost to Follow-up|0
4544108|NCT01162421|7369109|FG001|Overall Study|Lost to Follow-up|2
4544109|NCT01162421|7369108|FG000|Overall Study|Lack of Efficacy|2
4544110|NCT01162421|7369109|FG001|Overall Study|Lack of Efficacy|2
4544111|NCT01162421|7369108|FG000|Overall Study|Other|2
4544112|NCT01162421|7369109|FG001|Overall Study|Other|3
4544113|NCT01162473|7369117|FG000|Overall Study|Adverse Event|2
4544114|NCT01162473|7369118|FG001|Overall Study|Adverse Event|1
4544115|NCT01162473|7369117|FG000|Overall Study|Withdrawal by Subject|0
4544116|NCT01162473|7369118|FG001|Overall Study|Withdrawal by Subject|4
4544117|NCT01162486|7369129|FG000|Overall Study|low ANC|1
4544118|NCT01162486|7369130|FG001|Overall Study|low ANC|0
4544119|NCT01162486|7369131|FG002|Overall Study|low ANC|0
4544120|NCT01162486|7369132|FG003|Overall Study|low ANC|0
4544121|NCT01162486|7369133|FG004|Overall Study|low ANC|0
4544122|NCT01162486|7369129|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1
4544123|NCT01162486|7369130|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0
4544124|NCT01162486|7369131|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0
4544125|NCT01162486|7369132|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0
4544126|NCT01162486|7369133|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0
4544127|NCT01162486|7369129|FG000|Overall Study|elevated LFTs|0
4544128|NCT01162486|7369130|FG001|Overall Study|elevated LFTs|0
4544129|NCT01162486|7369131|FG002|Overall Study|elevated LFTs|1
4544130|NCT01162486|7369132|FG003|Overall Study|elevated LFTs|0
4544131|NCT01162486|7369133|FG004|Overall Study|elevated LFTs|0
4544132|NCT01162486|7369129|FG000|Overall Study|Pregnancy|0
4544133|NCT01162486|7369130|FG001|Overall Study|Pregnancy|0
4544134|NCT01162486|7369131|FG002|Overall Study|Pregnancy|0
4544135|NCT01162486|7369132|FG003|Overall Study|Pregnancy|1
4544136|NCT01162486|7369133|FG004|Overall Study|Pregnancy|0
4544137|NCT01162499|7369149|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0
4544138|NCT01162499|7369150|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1
4544139|NCT01162863|7369174|FG000|Overall Study|Lack of Efficacy|1
4544140|NCT01162863|7369175|FG001|Overall Study|Lack of Efficacy|0
4544141|NCT01162863|7369176|FG002|Overall Study|Lack of Efficacy|0
4544142|NCT01162863|7369174|FG000|Overall Study|Adverse Event|0
4544143|NCT01162863|7369175|FG001|Overall Study|Adverse Event|1
4544144|NCT01162863|7369176|FG002|Overall Study|Adverse Event|0
4544145|NCT01163032|7369187|FG000|Randomization Phase|Withdrawal by Subject|2
4544146|NCT01163032|7369188|FG001|Randomization Phase|Withdrawal by Subject|3
4544147|NCT01163032|7369189|FG002|Randomization Phase|Withdrawal by Subject|0
4544148|NCT01163032|7369187|FG000|Randomization Phase|Adverse Event|3
4544149|NCT01163032|7369188|FG001|Randomization Phase|Adverse Event|3
4544150|NCT01163032|7369189|FG002|Randomization Phase|Adverse Event|0
4544151|NCT01163032|7369187|FG000|Randomization Phase|Protocol Violation|0
4544152|NCT01163032|7369188|FG001|Randomization Phase|Protocol Violation|1
4544153|NCT01163032|7369189|FG002|Randomization Phase|Protocol Violation|0
4544154|NCT01163032|7369187|FG000|Randomization Phase|Various*|5
4544155|NCT01163032|7369188|FG001|Randomization Phase|Various*|4
4617855|NCT01753570|7477842|FG001|Overall Study|Withdrawal by Subject|4
4617856|NCT01753570|7477843|FG002|Overall Study|Withdrawal by Subject|0
4617857|NCT01753856|7477893|FG000|Overall Study|Adverse Event|1
4617858|NCT01753856|7477894|FG001|Overall Study|Adverse Event|0
4617859|NCT01753856|7477893|FG000|Overall Study|Withdrawal by Subject|0
4544156|NCT01163032|7369189|FG002|Randomization Phase|Various*|0
4544157|NCT01163032|7369187|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0
4544158|NCT01163032|7369188|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1
4544159|NCT01163032|7369189|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0
4544160|NCT01163032|7369187|FG000|Open Label Extension Phase|Adverse Event|0
4544161|NCT01163032|7369188|FG001|Open Label Extension Phase|Adverse Event|0
4544162|NCT01163032|7369189|FG002|Open Label Extension Phase|Adverse Event|3
4544163|NCT01163032|7369187|FG000|Open Label Extension Phase|Withdrawal by Subject|0
4544164|NCT01163032|7369188|FG001|Open Label Extension Phase|Withdrawal by Subject|0
4544165|NCT01163032|7369189|FG002|Open Label Extension Phase|Withdrawal by Subject|3
4544166|NCT01163032|7369187|FG000|Open Label Extension Phase|Protocol Violation|0
4544167|NCT01163032|7369188|FG001|Open Label Extension Phase|Protocol Violation|0
4544168|NCT01163032|7369189|FG002|Open Label Extension Phase|Protocol Violation|1
4544169|NCT01163032|7369187|FG000|Open Label Extension Phase|Study Termination|0
4544170|NCT01163032|7369188|FG001|Open Label Extension Phase|Study Termination|0
4544171|NCT01163032|7369189|FG002|Open Label Extension Phase|Study Termination|7
4544172|NCT01163032|7369187|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0
4544173|NCT01163032|7369188|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0
4544174|NCT01163032|7369189|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2
4544175|NCT01163149|7369215|FG000|Extension Treatment Period|Withdrawal by Subject|2
4544176|NCT01163149|7369216|FG001|Extension Treatment Period|Withdrawal by Subject|0
4544177|NCT01163149|7369217|FG002|Extension Treatment Period|Withdrawal by Subject|1
4544178|NCT01163149|7369215|FG000|Extension Treatment Period|Adverse Event|0
4544179|NCT01163149|7369216|FG001|Extension Treatment Period|Adverse Event|1
4544180|NCT01163149|7369217|FG002|Extension Treatment Period|Adverse Event|0
4544181|NCT01163149|7369215|FG000|Extension Treatment Period|Noncompliance|0
4544182|NCT01163149|7369216|FG001|Extension Treatment Period|Noncompliance|0
4544183|NCT01163149|7369217|FG002|Extension Treatment Period|Noncompliance|1
4544184|NCT01163253|7369254|FG000|Overall Study|Withdrawn Due to Pregnancy|12
4544185|NCT01163253|7369255|FG001|Overall Study|Withdrawn Due to Pregnancy|2
4544186|NCT01163253|7369254|FG000|Overall Study|Study Terminated by Sponsor|978
4544187|NCT01163253|7369255|FG001|Overall Study|Study Terminated by Sponsor|349
4544188|NCT01163253|7369254|FG000|Overall Study|Protocol Violation|43
4544189|NCT01163253|7369255|FG001|Overall Study|Protocol Violation|12
4544190|NCT01163253|7369254|FG000|Overall Study|Withdrawal by Subject|199
4544191|NCT01163253|7369255|FG001|Overall Study|Withdrawal by Subject|50
4544192|NCT01163253|7369254|FG000|Overall Study|Medication Error|1
4544193|NCT01163253|7369255|FG001|Overall Study|Medication Error|0
4544194|NCT01163253|7369254|FG000|Overall Study|Lost to Follow-up|125
4544195|NCT01163253|7369255|FG001|Overall Study|Lost to Follow-up|23
4544196|NCT01163253|7369254|FG000|Overall Study|Insufficient Clinical Response|423
4544197|NCT01163253|7369255|FG001|Overall Study|Insufficient Clinical Response|29
4544198|NCT01163253|7369254|FG000|Overall Study|Adverse Event|300
4544199|NCT01163253|7369255|FG001|Overall Study|Adverse Event|78
4617860|NCT01753856|7477894|FG001|Overall Study|Withdrawal by Subject|2
4617861|NCT01753856|7477893|FG000|Overall Study|Sponsor Decision|2
4544200|NCT01163253|7369254|FG000|Overall Study|Death|17
4544201|NCT01163253|7369255|FG001|Overall Study|Death|5
4544202|NCT01163253|7369254|FG000|Overall Study|Ongoing|13
4544203|NCT01163253|7369255|FG001|Overall Study|Ongoing|4
4544204|NCT01163253|7369254|FG000|Overall Study|Other Unspecified|170
4544205|NCT01163253|7369255|FG001|Overall Study|Other Unspecified|34
4544206|NCT01163266|7369264|FG000|Overall Study|Pretreatment Event or Adverse Event|2
4544207|NCT01163266|7369265|FG001|Overall Study|Pretreatment Event or Adverse Event|9
4544208|NCT01163266|7369266|FG002|Overall Study|Pretreatment Event or Adverse Event|7
4544209|NCT01163266|7369264|FG000|Overall Study|Lack of Efficacy|1
4544210|NCT01163266|7369265|FG001|Overall Study|Lack of Efficacy|3
4544211|NCT01163266|7369266|FG002|Overall Study|Lack of Efficacy|1
4544212|NCT01163266|7369264|FG000|Overall Study|Noncompliance with Study Drug|0
4544213|NCT01163266|7369265|FG001|Overall Study|Noncompliance with Study Drug|2
4544214|NCT01163266|7369266|FG002|Overall Study|Noncompliance with Study Drug|0
4544215|NCT01163266|7369264|FG000|Overall Study|Protocol Deviations|2
4544216|NCT01163266|7369265|FG001|Overall Study|Protocol Deviations|2
4544217|NCT01163266|7369266|FG002|Overall Study|Protocol Deviations|5
4544218|NCT01163266|7369264|FG000|Overall Study|Withdrawal of Consent|5
4544219|NCT01163266|7369265|FG001|Overall Study|Withdrawal of Consent|7
4544220|NCT01163266|7369266|FG002|Overall Study|Withdrawal of Consent|3
4544221|NCT01163266|7369264|FG000|Overall Study|Lost to Follow-up|7
4544222|NCT01163266|7369265|FG001|Overall Study|Lost to Follow-up|7
4544223|NCT01163266|7369266|FG002|Overall Study|Lost to Follow-up|10
4544224|NCT01163266|7369264|FG000|Overall Study|Other|1
4544225|NCT01163266|7369265|FG001|Overall Study|Other|1
4544226|NCT01163266|7369266|FG002|Overall Study|Other|2
4544227|NCT01163279|7369276|FG000|Overall Study|Withdrawal by Subject|2
4544228|NCT01163279|7369277|FG001|Overall Study|Withdrawal by Subject|0
4544229|NCT01163292|7369286|FG000|Overall Study|Lack of Efficacy|9
4544230|NCT01163292|7369287|FG001|Overall Study|Lack of Efficacy|0
4544231|NCT01163292|7369286|FG000|Overall Study|Adverse Event|6
4544232|NCT01163292|7369287|FG001|Overall Study|Adverse Event|0
4544233|NCT01163292|7369286|FG000|Overall Study|Initiation of biological therapy|0
4544234|NCT01163292|7369287|FG001|Overall Study|Initiation of biological therapy|15
4544235|NCT01163292|7369286|FG000|Overall Study|Sufficient response to adalimumab|8
4544236|NCT01163292|7369287|FG001|Overall Study|Sufficient response to adalimumab|0
4544237|NCT01163292|7369286|FG000|Overall Study|Refusal to receive adalimumab|7
4544238|NCT01163292|7369287|FG001|Overall Study|Refusal to receive adalimumab|0
4544239|NCT01163292|7369286|FG000|Overall Study|Economic reasons|6
4544240|NCT01163292|7369287|FG001|Overall Study|Economic reasons|0
4544241|NCT01163292|7369286|FG000|Overall Study|No further visits|5
4544242|NCT01163292|7369287|FG001|Overall Study|No further visits|7
4544243|NCT01163318|7369293|FG000|Overall Study|Off-Label Use of Adalimumab|8
4544244|NCT01163318|7369293|FG000|Overall Study|Did Not Continue Use of Adalimumab|26
4544245|NCT01163318|7369293|FG000|Overall Study|History/comorbidity of malignant tumor|3
4544246|NCT01163318|7369293|FG000|Overall Study|Participants Without Case Report Form|7
4544247|NCT01163318|7369293|FG000|Overall Study|Multiple Reasons Per Participant|224
4544248|NCT01163474|7369302|FG000|Overall Study|Withdrawal by Subject|1
4544249|NCT01163474|7369302|FG000|Overall Study|Tech barriers to videoteleconference vis|12
4544250|NCT01163474|7369302|FG000|Overall Study|Lost to Follow-up|3
4544251|NCT01163617|7369318|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
4544252|NCT01163617|7369319|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1
4544253|NCT01163617|7369320|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
4544254|NCT01163617|7369321|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
4544255|NCT01163617|7369322|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
4544256|NCT01163617|7369323|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
4544257|NCT01163617|7369324|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
4544258|NCT01163617|7369325|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
4544259|NCT01163617|7369318|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
4544260|NCT01163617|7369319|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1
4544261|NCT01163617|7369320|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
4544262|NCT01163617|7369321|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
4544263|NCT01163617|7369322|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
4544264|NCT01163617|7369323|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
4544265|NCT01163617|7369324|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
4544266|NCT01163617|7369325|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
4544267|NCT01163617|7369318|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
4544268|NCT01163617|7369319|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
4544269|NCT01163617|7369320|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1
4544270|NCT01163617|7369321|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
4544271|NCT01163617|7369322|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
4544272|NCT01163617|7369323|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
4544273|NCT01163617|7369324|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
4591390|NCT01529515|7437935|FG001|MAINTENANCE PHASE|Lack of Efficacy|9
4544274|NCT01163617|7369325|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
4544275|NCT01163721|7369381|FG000|Overall Study|Adverse Event|5
4544276|NCT01163721|7369382|FG001|Overall Study|Adverse Event|6
4544277|NCT01163721|7369381|FG000|Overall Study|Withdrawal by Subject|3
4544278|NCT01163721|7369382|FG001|Overall Study|Withdrawal by Subject|4
4544279|NCT01163721|7369381|FG000|Overall Study|Lost to Follow-up|0
4544280|NCT01163721|7369382|FG001|Overall Study|Lost to Follow-up|1
4544281|NCT01163721|7369381|FG000|Overall Study|Physician Decision|0
4617862|NCT01753856|7477894|FG001|Overall Study|Sponsor Decision|0
4544282|NCT01163721|7369382|FG001|Overall Study|Physician Decision|1
4544283|NCT01163747|7369390|FG000|Overall Study|Adverse Event|0
4544284|NCT01163747|7369391|FG001|Overall Study|Adverse Event|5
4544285|NCT01163747|7369390|FG000|Overall Study|Insufficient Therapeutic Response|0
4544286|NCT01163747|7369391|FG001|Overall Study|Insufficient Therapeutic Response|1
4544287|NCT01163747|7369390|FG000|Overall Study|Protocol Violation|0
4544288|NCT01163747|7369391|FG001|Overall Study|Protocol Violation|1
4544289|NCT01163747|7369390|FG000|Overall Study|Refused Treatment|6
4544290|NCT01163747|7369391|FG001|Overall Study|Refused Treatment|4
4544291|NCT01163786|7369408|FG000|Treatment With Bortezomib|Withdrawal by Subject|1
4544292|NCT01163786|7369408|FG000|Treatment With Bortezomib|Adverse Event|2
4544293|NCT01163786|7369408|FG000|Completed Follow up (Visit 9 and 10)|Other|1
4591391|NCT01529515|7437936|FG002|MAINTENANCE PHASE|Lack of Efficacy|0
4591392|NCT01529515|7437937|FG003|MAINTENANCE PHASE|Lack of Efficacy|0
4591393|NCT01529515|7437934|FG000|MAINTENANCE PHASE|Lost to Follow-up|0
4591394|NCT01529515|7437935|FG001|MAINTENANCE PHASE|Lost to Follow-up|5
4591395|NCT01529515|7437936|FG002|MAINTENANCE PHASE|Lost to Follow-up|0
4591396|NCT01529515|7437937|FG003|MAINTENANCE PHASE|Lost to Follow-up|0
4591397|NCT01529515|7437934|FG000|MAINTENANCE PHASE|Protocol Violation|0
4591398|NCT01529515|7437935|FG001|MAINTENANCE PHASE|Protocol Violation|12
4591399|NCT01529515|7437936|FG002|MAINTENANCE PHASE|Protocol Violation|0
4591400|NCT01529515|7437937|FG003|MAINTENANCE PHASE|Protocol Violation|0
4591401|NCT01529515|7437934|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0
4591402|NCT01529515|7437935|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15
4591403|NCT01529515|7437936|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0
4591404|NCT01529515|7437937|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0
4591405|NCT01529515|7437934|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0
4591406|NCT01529515|7437935|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13
4591407|NCT01529515|7437936|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0
4591408|NCT01529515|7437937|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0
4591409|NCT01529515|7437934|FG000|MAINTENANCE PHASE|Other|0
4591410|NCT01529515|7437935|FG001|MAINTENANCE PHASE|Other|10
4591411|NCT01529515|7437936|FG002|MAINTENANCE PHASE|Other|0
4591412|NCT01529515|7437937|FG003|MAINTENANCE PHASE|Other|0
4591413|NCT01529515|7437934|FG000|DOUBLE BLIND PHASE|Adverse Event|0
4591414|NCT01529515|7437935|FG001|DOUBLE BLIND PHASE|Adverse Event|0
4591415|NCT01529515|7437936|FG002|DOUBLE BLIND PHASE|Adverse Event|1
4591416|NCT01529515|7437937|FG003|DOUBLE BLIND PHASE|Adverse Event|0
4591417|NCT01529515|7437934|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0
4591418|NCT01529515|7437935|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0
4591419|NCT01529515|7437936|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1
4591420|NCT01529515|7437937|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3
4591421|NCT01529515|7437934|FG000|DOUBLE BLIND PHASE|Pregnancy|0
4591422|NCT01529515|7437935|FG001|DOUBLE BLIND PHASE|Pregnancy|0
4591423|NCT01529515|7437936|FG002|DOUBLE BLIND PHASE|Pregnancy|1
4591424|NCT01529515|7437937|FG003|DOUBLE BLIND PHASE|Pregnancy|0
4591425|NCT01529515|7437934|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0
4591426|NCT01529515|7437935|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0
4591427|NCT01529515|7437936|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10
4591428|NCT01529515|7437937|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7
4591429|NCT01529515|7437934|FG000|DOUBLE BLIND PHASE|Protocol Violation|0
4591430|NCT01529515|7437935|FG001|DOUBLE BLIND PHASE|Protocol Violation|0
4591431|NCT01529515|7437936|FG002|DOUBLE BLIND PHASE|Protocol Violation|1
4591432|NCT01529515|7437937|FG003|DOUBLE BLIND PHASE|Protocol Violation|0
4591433|NCT01529515|7437934|FG000|DOUBLE BLIND PHASE|Other|0
4591434|NCT01529515|7437935|FG001|DOUBLE BLIND PHASE|Other|0
4591435|NCT01529515|7437936|FG002|DOUBLE BLIND PHASE|Other|9
4591436|NCT01529515|7437937|FG003|DOUBLE BLIND PHASE|Other|2
4591437|NCT01529606|7437946|FG000|Overall Study|Lost to Follow-up|21
4591438|NCT01529606|7437947|FG001|Overall Study|Lost to Follow-up|18
4591439|NCT01529632|7437955|FG000|Overall Study|Administrative problem|2
4591440|NCT01529632|7437956|FG001|Overall Study|Administrative problem|1
4591441|NCT01529632|7437955|FG000|Overall Study|Protocol Violation|0
4591442|NCT01529632|7437956|FG001|Overall Study|Protocol Violation|1
4591443|NCT01529632|7437955|FG000|Overall Study|Adverse Event|1
4591444|NCT01529632|7437956|FG001|Overall Study|Adverse Event|1
4591445|NCT01529645|7437972|FG000|Overall Study|Lost to Follow-up|0
4591446|NCT01529645|7437973|FG001|Overall Study|Lost to Follow-up|1
4591447|NCT01529645|7437974|FG002|Overall Study|Lost to Follow-up|1
4591448|NCT01529645|7437975|FG003|Overall Study|Lost to Follow-up|1
4591449|NCT01529645|7437976|FG004|Overall Study|Lost to Follow-up|1
4591450|NCT01529645|7437977|FG005|Overall Study|Lost to Follow-up|0
4591451|NCT01529645|7437978|FG006|Overall Study|Lost to Follow-up|2
4591452|NCT01529645|7437979|FG007|Overall Study|Lost to Follow-up|0
4591453|NCT01529645|7437980|FG008|Overall Study|Lost to Follow-up|1
4544294|NCT01163851|7369414|FG000|Overall Study|Site Closure|0
4544295|NCT01163851|7369415|FG001|Overall Study|Site Closure|1
4617863|NCT01753999|7477903|FG000|Period 1 - Initial Assignment|Physician Decision|2
4617864|NCT01753999|7477904|FG001|Period 1 - Initial Assignment|Physician Decision|3
4617865|NCT01753999|7477903|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19
4617866|NCT01753999|7477904|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20
4617867|NCT01753999|7477903|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18
4617868|NCT01753999|7477904|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27
4617869|NCT01753999|7477903|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13
4617870|NCT01753999|7477904|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17
4544296|NCT01163851|7369414|FG000|Overall Study|Enrolled but not treated|1
4544297|NCT01163851|7369415|FG001|Overall Study|Enrolled but not treated|0
4544298|NCT01163916|7369424|FG000|Overall Study|Withdrawal by Subject|2
4544299|NCT01163916|7369425|FG001|Overall Study|Withdrawal by Subject|0
4544300|NCT01163916|7369426|FG002|Overall Study|Withdrawal by Subject|2
4544301|NCT01163916|7369424|FG000|Overall Study|Adverse Event|2
4544302|NCT01163916|7369425|FG001|Overall Study|Adverse Event|0
4544303|NCT01163916|7369426|FG002|Overall Study|Adverse Event|1
4544304|NCT01163916|7369424|FG000|Overall Study|Lack of Efficacy|2
4544305|NCT01163916|7369425|FG001|Overall Study|Lack of Efficacy|0
4544306|NCT01163916|7369426|FG002|Overall Study|Lack of Efficacy|1
4544307|NCT01163916|7369424|FG000|Overall Study|Other|24
4544308|NCT01163916|7369425|FG001|Overall Study|Other|4
4544309|NCT01163916|7369426|FG002|Overall Study|Other|16
4544310|NCT01164007|7369448|FG000|Overall Study|Adverse Event|5
4544311|NCT01164007|7369448|FG000|Overall Study|Progression of Disease|30
4544312|NCT01164007|7369448|FG000|Overall Study|Protocol Violation|1
4544313|NCT01164007|7369448|FG000|Overall Study|Withdrawal by Subject|1
4544314|NCT01164007|7369448|FG000|Overall Study|Medical Decision|3
4544315|NCT01164475|7369472|FG000|Overall Study|Lack of Efficacy|1
4544316|NCT01164475|7369473|FG001|Overall Study|Lack of Efficacy|0
4544317|NCT01164475|7369472|FG000|Overall Study|Other|0
4544318|NCT01164475|7369473|FG001|Overall Study|Other|1
4544319|NCT01164475|7369472|FG000|Overall Study|Progressive disease|0
4544320|NCT01164475|7369473|FG001|Overall Study|Progressive disease|1
4544321|NCT01164475|7369472|FG000|Overall Study|Protocol Violation|1
4544322|NCT01164475|7369473|FG001|Overall Study|Protocol Violation|0
4544323|NCT01164501|7369482|FG000|Overall Study|Not treated|2
4544324|NCT01164501|7369483|FG001|Overall Study|Not treated|0
4544325|NCT01164501|7369484|FG002|Overall Study|Not treated|1
4544326|NCT01164501|7369482|FG000|Overall Study|Adverse Event|18
4544327|NCT01164501|7369483|FG001|Overall Study|Adverse Event|4
4544328|NCT01164501|7369484|FG002|Overall Study|Adverse Event|21
4544329|NCT01164501|7369482|FG000|Overall Study|Lack of Efficacy|0
4544330|NCT01164501|7369483|FG001|Overall Study|Lack of Efficacy|0
4544331|NCT01164501|7369484|FG002|Overall Study|Lack of Efficacy|1
4544332|NCT01164501|7369482|FG000|Overall Study|Non compliant with protocol|1
4544333|NCT01164501|7369483|FG001|Overall Study|Non compliant with protocol|1
4544334|NCT01164501|7369484|FG002|Overall Study|Non compliant with protocol|4
4544335|NCT01164501|7369482|FG000|Overall Study|Lost to Follow-up|3
4544336|NCT01164501|7369483|FG001|Overall Study|Lost to Follow-up|0
4544337|NCT01164501|7369484|FG002|Overall Study|Lost to Follow-up|3
4544338|NCT01164501|7369482|FG000|Overall Study|Patient refusal to continue,not due toAE|10
4544339|NCT01164501|7369483|FG001|Overall Study|Patient refusal to continue,not due toAE|4
4544340|NCT01164501|7369484|FG002|Overall Study|Patient refusal to continue,not due toAE|8
4544341|NCT01164501|7369482|FG000|Overall Study|Other reason not defined above|9
4544342|NCT01164501|7369483|FG001|Overall Study|Other reason not defined above|1
4544343|NCT01164501|7369484|FG002|Overall Study|Other reason not defined above|4
4544344|NCT01164579|7369497|FG000|Overall Study|Lack of Efficacy|0
4617871|NCT01753999|7477903|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3
4617872|NCT01753999|7477904|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5
4617873|NCT01753999|7477903|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1
4617874|NCT01753999|7477904|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1
4617875|NCT01754129|7477915|FG000|Overall Study|Death|13
4617876|NCT01754129|7477915|FG000|Overall Study|Duodopa discontinuation|9
4617877|NCT01754129|7477915|FG000|Overall Study|Lost to Follow-up|7
4617878|NCT01754129|7477915|FG000|Overall Study|Withdrew consent|1
4617879|NCT01754129|7477915|FG000|Overall Study|Inclusion/exclusion criteria violation|3
4617880|NCT01754194|7477928|FG000|Overall Study|Lost to Follow-up|39
4617881|NCT01754194|7477929|FG001|Overall Study|Lost to Follow-up|14
4617882|NCT01754194|7477928|FG000|Overall Study|Withdrawal by Subject|4
4617883|NCT01754194|7477929|FG001|Overall Study|Withdrawal by Subject|5
4617884|NCT01754194|7477928|FG000|Overall Study|Other|9
4617885|NCT01754194|7477929|FG001|Overall Study|Other|8
4617886|NCT01754259|7477943|FG000|Overall Study|Withdrawal by Subject|2
4544345|NCT01164579|7369498|FG001|Overall Study|Lack of Efficacy|0
4544346|NCT01164579|7369499|FG002|Overall Study|Lack of Efficacy|6
4544347|NCT01164579|7369497|FG000|Overall Study|Lost to Follow-up|1
4544348|NCT01164579|7369498|FG001|Overall Study|Lost to Follow-up|1
4544349|NCT01164579|7369499|FG002|Overall Study|Lost to Follow-up|0
4617887|NCT01754259|7477944|FG001|Overall Study|Withdrawal by Subject|4
4617888|NCT01754259|7477943|FG000|Overall Study|Adverse Event|3
4617889|NCT01754259|7477944|FG001|Overall Study|Adverse Event|1
4544350|NCT01164579|7369497|FG000|Overall Study|Withdrawal by Subject|2
4544351|NCT01164579|7369498|FG001|Overall Study|Withdrawal by Subject|5
4544352|NCT01164579|7369499|FG002|Overall Study|Withdrawal by Subject|3
4544353|NCT01164579|7369497|FG000|Overall Study|Protocol Violation|0
4617890|NCT01754259|7477943|FG000|Overall Study|Lost to Follow-up|0
4617891|NCT01754259|7477944|FG001|Overall Study|Lost to Follow-up|1
4617892|NCT01754376|7477959|FG000|Overall Study|Adverse Event|1
4617893|NCT01754376|7477959|FG000|Overall Study|Lack of Efficacy|2
4617894|NCT01754402|7477980|FG000|Overall Study|Death|0
4617895|NCT01754402|7477981|FG001|Overall Study|Death|0
4617896|NCT01754402|7477982|FG002|Overall Study|Death|1
4617897|NCT01754402|7477980|FG000|Overall Study|Adverse Event|2
4617898|NCT01754402|7477981|FG001|Overall Study|Adverse Event|2
4617899|NCT01754402|7477982|FG002|Overall Study|Adverse Event|1
4617900|NCT01754402|7477980|FG000|Overall Study|Withdrawal by Subject|0
4617901|NCT01754402|7477981|FG001|Overall Study|Withdrawal by Subject|0
4544354|NCT01164579|7369498|FG001|Overall Study|Protocol Violation|1
4544355|NCT01164579|7369499|FG002|Overall Study|Protocol Violation|2
4544356|NCT01164579|7369497|FG000|Overall Study|Adverse Event|4
4544357|NCT01164579|7369498|FG001|Overall Study|Adverse Event|2
4544358|NCT01164579|7369499|FG002|Overall Study|Adverse Event|5
4544359|NCT01164579|7369497|FG000|Overall Study|Reason not specified|1
4544360|NCT01164579|7369498|FG001|Overall Study|Reason not specified|0
4544361|NCT01164579|7369499|FG002|Overall Study|Reason not specified|0
4544362|NCT01164722|7369519|FG000|Overall Study|Adverse Event|0
4544363|NCT01164722|7369520|FG001|Overall Study|Adverse Event|1
4544364|NCT01164722|7369519|FG000|Overall Study|Withdrawal by Subject|3
4544365|NCT01164722|7369520|FG001|Overall Study|Withdrawal by Subject|4
4544366|NCT01164722|7369519|FG000|Overall Study|Lost to Follow-up|3
4544367|NCT01164722|7369520|FG001|Overall Study|Lost to Follow-up|6
4544368|NCT01164722|7369519|FG000|Overall Study|met protocol criteria for non-treatment|11
4544369|NCT01164722|7369520|FG001|Overall Study|met protocol criteria for non-treatment|1
4544370|NCT01164722|7369519|FG000|Overall Study|enrolled on other study, concomitant med|1
4544371|NCT01164722|7369520|FG001|Overall Study|enrolled on other study, concomitant med|3
4544372|NCT01164865|7369528|FG000|Overall Study|Lost to Follow-up|2
4544373|NCT01164865|7369529|FG001|Overall Study|Lost to Follow-up|1
4544374|NCT01164891|7369535|FG000|Overall Study|Disease Progression|5
4544375|NCT01164891|7369535|FG000|Overall Study|Adverse Event|1
4544376|NCT01164956|7369540|FG000|Overall Study|Side Effects|1
4544377|NCT01164956|7369541|FG001|Overall Study|Side Effects|0
4544378|NCT01164956|7369542|FG002|Overall Study|Side Effects|1
4544379|NCT01165021|7369550|FG000|Overall Study|Death|1
4544380|NCT01165138|7369565|FG000|Overall Study|Adverse Event|0
4544381|NCT01165138|7369566|FG001|Overall Study|Adverse Event|1
4544382|NCT01165138|7369567|FG002|Overall Study|Adverse Event|0
4544383|NCT01165138|7369568|FG003|Overall Study|Adverse Event|2
4544384|NCT01165138|7369565|FG000|Overall Study|Lack of Efficacy|0
4544385|NCT01165138|7369566|FG001|Overall Study|Lack of Efficacy|32
4544386|NCT01165138|7369567|FG002|Overall Study|Lack of Efficacy|6
4544387|NCT01165138|7369568|FG003|Overall Study|Lack of Efficacy|7
4544388|NCT01165138|7369565|FG000|Overall Study|Protocol Violation|0
4544389|NCT01165138|7369566|FG001|Overall Study|Protocol Violation|7
4544390|NCT01165138|7369567|FG002|Overall Study|Protocol Violation|0
4544391|NCT01165138|7369568|FG003|Overall Study|Protocol Violation|2
4544392|NCT01165138|7369565|FG000|Overall Study|Lost to Follow-up|0
4544393|NCT01165138|7369566|FG001|Overall Study|Lost to Follow-up|0
4544394|NCT01165138|7369567|FG002|Overall Study|Lost to Follow-up|1
4617902|NCT01754402|7477982|FG002|Overall Study|Withdrawal by Subject|1
4617903|NCT01754402|7477980|FG000|Overall Study|Lack of Efficacy|0
4617904|NCT01754402|7477981|FG001|Overall Study|Lack of Efficacy|0
4617905|NCT01754402|7477982|FG002|Overall Study|Lack of Efficacy|1
4617906|NCT01754467|7477991|FG000|Overall Study|Lost to Follow-up|1
4617907|NCT01754493|7478005|FG000|Overall Study|Adverse Event|1
4617908|NCT01754493|7478005|FG000|Overall Study|Lost to Follow-up|3
4617909|NCT01754493|7478005|FG000|Overall Study|Withdrawal by Subject|1
4617910|NCT01754493|7478005|FG000|Overall Study|Moved out of town|1
4617911|NCT01754493|7478005|FG000|Overall Study|Scheduling conflict|1
4632969|NCT01905943|7502747|FG000|Overall Study|Investigator discretion|7
4632970|NCT01905943|7502747|FG000|Overall Study|Death|186
4544395|NCT01165138|7369568|FG003|Overall Study|Lost to Follow-up|2
4544396|NCT01165138|7369565|FG000|Overall Study|Physician Decision|0
4544397|NCT01165138|7369566|FG001|Overall Study|Physician Decision|6
4632971|NCT01905943|7502747|FG000|Overall Study|Adverse Event|3
4632972|NCT01905943|7502747|FG000|Overall Study|Other|12
4632973|NCT01906008|7502777|FG000|Overall Study|Lost to Follow-up|2
4617912|NCT01754727|7478042|FG000|Overall Study|Adalimumab Treatment was not Documented|2
4617913|NCT01754753|7478048|FG000|Overall Study|Study close|43
4617914|NCT01754753|7478049|FG001|Overall Study|Study close|44
4544398|NCT01165138|7369567|FG002|Overall Study|Physician Decision|7
4544399|NCT01165138|7369568|FG003|Overall Study|Physician Decision|6
4544400|NCT01165138|7369565|FG000|Overall Study|Withdrawal by Subject|0
4544401|NCT01165138|7369566|FG001|Overall Study|Withdrawal by Subject|6
4544402|NCT01165138|7369567|FG002|Overall Study|Withdrawal by Subject|6
4544403|NCT01165138|7369568|FG003|Overall Study|Withdrawal by Subject|3
4544404|NCT01165177|7369578|FG000|Overall Study|Serious Adverse Event|227
4544405|NCT01165177|7369579|FG001|Overall Study|Serious Adverse Event|235
4544406|NCT01165177|7369578|FG000|Overall Study|Withdrawal by Subject|368
4544407|NCT01165177|7369579|FG001|Overall Study|Withdrawal by Subject|354
4544408|NCT01165177|7369578|FG000|Overall Study|Protocol Violation|19
4544409|NCT01165177|7369579|FG001|Overall Study|Protocol Violation|21
4544410|NCT01165177|7369578|FG000|Overall Study|Non-serious adverse event|30
4544411|NCT01165177|7369579|FG001|Overall Study|Non-serious adverse event|18
4544412|NCT01165177|7369578|FG000|Overall Study|Other unspecified reasons|47
4544413|NCT01165177|7369579|FG001|Overall Study|Other unspecified reasons|35
4544414|NCT01165177|7369578|FG000|Overall Study|Suspected HZ episode|0
4544415|NCT01165177|7369579|FG001|Overall Study|Suspected HZ episode|2
4544416|NCT01165177|7369578|FG000|Overall Study|Lost to Follow-up|183
4544417|NCT01165177|7369579|FG001|Overall Study|Lost to Follow-up|194
4544418|NCT01165177|7369578|FG000|Overall Study|Migrated/ moved from study area|48
4544419|NCT01165177|7369579|FG001|Overall Study|Migrated/ moved from study area|43
4544420|NCT01165203|7369595|FG000|Active Phase|Serious Adverse Event|1
4544421|NCT01165203|7369596|FG001|Active Phase|Serious Adverse Event|0
4544422|NCT01165203|7369595|FG000|Active Phase|Withdrawal by Subject|2
4544423|NCT01165203|7369596|FG001|Active Phase|Withdrawal by Subject|1
4544424|NCT01165203|7369595|FG000|Active Phase|Migrated/moved from study area|0
4544425|NCT01165203|7369596|FG001|Active Phase|Migrated/moved from study area|1
4544426|NCT01165203|7369595|FG000|Active Phase|Lost to Follow-up|2
4544427|NCT01165203|7369596|FG001|Active Phase|Lost to Follow-up|0
4544428|NCT01165203|7369595|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1
4544429|NCT01165203|7369596|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0
4544430|NCT01165203|7369595|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2
4544431|NCT01165203|7369596|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2
4544432|NCT01165203|7369595|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2
4544433|NCT01165203|7369596|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1
4544434|NCT01165203|7369595|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2
4544435|NCT01165203|7369596|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0
4544436|NCT01165203|7369595|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0
4544437|NCT01165203|7369596|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1
4544438|NCT01165216|7369611|FG000|Overall Study|Adverse Event|6
4544439|NCT01165216|7369612|FG001|Overall Study|Adverse Event|3
4544440|NCT01165216|7369611|FG000|Overall Study|Withdrawal by Subject|1
4544441|NCT01165216|7369612|FG001|Overall Study|Withdrawal by Subject|1
4544442|NCT01165216|7369611|FG000|Overall Study|Disease progression|1
4544443|NCT01165216|7369612|FG001|Overall Study|Disease progression|3
4544444|NCT01165229|7369622|FG000|Overall Study|Serious Adverse Event|456
4544445|NCT01165229|7369623|FG001|Overall Study|Serious Adverse Event|487
4544446|NCT01165229|7369622|FG000|Overall Study|Non-Serious Adverse Event|47
4544447|NCT01165229|7369623|FG001|Overall Study|Non-Serious Adverse Event|15
4544448|NCT01165229|7369622|FG000|Overall Study|Protocol Violation|6
4544449|NCT01165229|7369623|FG001|Overall Study|Protocol Violation|8
4544450|NCT01165229|7369622|FG000|Overall Study|Withdrawal by Subject|387
4544451|NCT01165229|7369623|FG001|Overall Study|Withdrawal by Subject|396
4544452|NCT01165229|7369622|FG000|Overall Study|Migrated/moved from study area|51
4544453|NCT01165229|7369623|FG001|Overall Study|Migrated/moved from study area|46
4544454|NCT01165229|7369622|FG000|Overall Study|Lost to Follow-up|123
4544455|NCT01165229|7369623|FG001|Overall Study|Lost to Follow-up|133
4544456|NCT01165229|7369622|FG000|Overall Study|Suspected HZ Episode|2
4544457|NCT01165229|7369623|FG001|Overall Study|Suspected HZ Episode|2
4544458|NCT01165229|7369622|FG000|Overall Study|No reason from the subject|108
4544459|NCT01165229|7369623|FG001|Overall Study|No reason from the subject|102
4544460|NCT01165229|7369622|FG000|Overall Study|Unknown completion status|0
4544461|NCT01165229|7369623|FG001|Overall Study|Unknown completion status|1
4544462|NCT01165242|7369662|FG000|Overall Study|Unreachable Subjects|1
4544463|NCT01165242|7369663|FG001|Overall Study|Unreachable Subjects|0
4544464|NCT01165242|7369664|FG002|Overall Study|Unreachable Subjects|0
4544465|NCT01165242|7369662|FG000|Overall Study|Incarcerated Subjects|0
4544466|NCT01165242|7369663|FG001|Overall Study|Incarcerated Subjects|1
4544467|NCT01165242|7369664|FG002|Overall Study|Incarcerated Subjects|0
4544468|NCT01165242|7369662|FG000|Overall Study|Visit 2 Declined by Subject|0
4544469|NCT01165242|7369663|FG001|Overall Study|Visit 2 Declined by Subject|0
4544470|NCT01165242|7369664|FG002|Overall Study|Visit 2 Declined by Subject|1
4544471|NCT01165242|7369662|FG000|Overall Study|Withdrawal by Subject|0
4544472|NCT01165242|7369663|FG001|Overall Study|Withdrawal by Subject|2
4544473|NCT01165242|7369664|FG002|Overall Study|Withdrawal by Subject|2
4617915|NCT01754753|7478048|FG000|Overall Study|Lost to Follow-up|9
4544474|NCT01165242|7369662|FG000|Overall Study|Extended Holiday|0
4544475|NCT01165242|7369663|FG001|Overall Study|Extended Holiday|0
4544476|NCT01165242|7369664|FG002|Overall Study|Extended Holiday|1
4544477|NCT01165242|7369662|FG000|Overall Study|Lost to Follow-up|9
4544478|NCT01165242|7369663|FG001|Overall Study|Lost to Follow-up|7
4544479|NCT01165242|7369664|FG002|Overall Study|Lost to Follow-up|10
4544480|NCT01165281|7369676|FG000|Overall Study|Adverse Event|12
4544481|NCT01165281|7369677|FG001|Overall Study|Adverse Event|14
4544482|NCT01165281|7369676|FG000|Overall Study|Death|3
4544483|NCT01165281|7369677|FG001|Overall Study|Death|4
4544484|NCT01165281|7369676|FG000|Overall Study|Lack of Efficacy|4
4544485|NCT01165281|7369677|FG001|Overall Study|Lack of Efficacy|1
4544486|NCT01165281|7369676|FG000|Overall Study|Lost to Follow-up|0
4544487|NCT01165281|7369677|FG001|Overall Study|Lost to Follow-up|1
4544488|NCT01165281|7369676|FG000|Overall Study|Physician Decision|8
4544489|NCT01165281|7369677|FG001|Overall Study|Physician Decision|1
4544490|NCT01165281|7369676|FG000|Overall Study|Protocol Violation|6
4544491|NCT01165281|7369677|FG001|Overall Study|Protocol Violation|5
4544492|NCT01165281|7369676|FG000|Overall Study|Withdrawal by Subject|8
4544493|NCT01165281|7369677|FG001|Overall Study|Withdrawal by Subject|7
4544494|NCT01165281|7369676|FG000|Overall Study|Noncompliance with Study Drug|1
4544495|NCT01165281|7369677|FG001|Overall Study|Noncompliance with Study Drug|4
4544496|NCT01165281|7369676|FG000|Overall Study|Progressive Disease|10
4544497|NCT01165281|7369677|FG001|Overall Study|Progressive Disease|14
4544498|NCT01165281|7369676|FG000|Overall Study|Other|6
4544499|NCT01165281|7369677|FG001|Overall Study|Other|0
4544500|NCT01165307|7369685|FG000|Overall Study|Lost to Follow-up|11
4544501|NCT01165307|7369686|FG001|Overall Study|Lost to Follow-up|3
4544502|NCT01165307|7369685|FG000|Overall Study|Withdrawal by Subject|2
4544503|NCT01165307|7369686|FG001|Overall Study|Withdrawal by Subject|0
4544504|NCT01165307|7369685|FG000|Overall Study|Subject not available for contact|1
4544505|NCT01165307|7369686|FG001|Overall Study|Subject not available for contact|0
4544506|NCT01165320|7369694|FG000|Overall Study|Clinical adverse experience|2
4544507|NCT01165320|7369695|FG001|Overall Study|Clinical adverse experience|1
4544508|NCT01165320|7369696|FG002|Overall Study|Clinical adverse experience|0
4544509|NCT01165320|7369694|FG000|Overall Study|Laboratory adverse experience|1
4544510|NCT01165320|7369695|FG001|Overall Study|Laboratory adverse experience|0
4544511|NCT01165320|7369696|FG002|Overall Study|Laboratory adverse experience|0
4544512|NCT01165320|7369694|FG000|Overall Study|Lack of Efficacy|0
4544513|NCT01165320|7369695|FG001|Overall Study|Lack of Efficacy|2
4544514|NCT01165320|7369696|FG002|Overall Study|Lack of Efficacy|0
4544515|NCT01165320|7369694|FG000|Overall Study|Reason unknown|0
4544516|NCT01165320|7369695|FG001|Overall Study|Reason unknown|1
4544517|NCT01165320|7369696|FG002|Overall Study|Reason unknown|0
4544518|NCT01165554|7369708|FG000|Overall Study|Withdrawal by Subject|23
4544519|NCT01165684|7369717|FG000|Overall Study|Adverse Event|1
4544520|NCT01165684|7369718|FG001|Overall Study|Adverse Event|1
4544521|NCT01165684|7369717|FG000|Overall Study|Lack of Efficacy|2
4544522|NCT01165684|7369718|FG001|Overall Study|Lack of Efficacy|1
4544523|NCT01165684|7369717|FG000|Overall Study|Protocol Violation|7
4544524|NCT01165684|7369718|FG001|Overall Study|Protocol Violation|15
4544525|NCT01165684|7369717|FG000|Overall Study|Withdrawal Criteria|2
4544526|NCT01165684|7369718|FG001|Overall Study|Withdrawal Criteria|13
4544527|NCT01165684|7369717|FG000|Overall Study|Unclassified|16
4544528|NCT01165684|7369718|FG001|Overall Study|Unclassified|22
4544529|NCT01165996|7369747|FG000|Overall Study|Death|1
4544530|NCT01165996|7369747|FG000|Overall Study|Physician Decision|1
4544531|NCT01166282|7369771|FG000|Open-label Period|Adverse Event|0
4544532|NCT01166282|7369772|FG001|Open-label Period|Adverse Event|0
4544533|NCT01166282|7369773|FG002|Open-label Period|Adverse Event|6
4544534|NCT01166282|7369771|FG000|Open-label Period|Withdrawal by Subject|0
4544535|NCT01166282|7369772|FG001|Open-label Period|Withdrawal by Subject|0
4544536|NCT01166282|7369773|FG002|Open-label Period|Withdrawal by Subject|4
4544537|NCT01166282|7369771|FG000|Open-label Period|Lack of Efficacy|0
4544538|NCT01166282|7369772|FG001|Open-label Period|Lack of Efficacy|0
4544539|NCT01166282|7369773|FG002|Open-label Period|Lack of Efficacy|2
4544540|NCT01166282|7369771|FG000|Open-label Period|Remission|0
4544541|NCT01166282|7369772|FG001|Open-label Period|Remission|0
4544542|NCT01166282|7369773|FG002|Open-label Period|Remission|4
4544543|NCT01166282|7369771|FG000|Open-label Period|Irregular Compliance|0
4544544|NCT01166282|7369772|FG001|Open-label Period|Irregular Compliance|0
4544545|NCT01166282|7369773|FG002|Open-label Period|Irregular Compliance|1
4544546|NCT01166373|7369794|FG000|Overall Study|Lost to Follow-up|3
4544547|NCT01166373|7369795|FG001|Overall Study|Lost to Follow-up|2
4544548|NCT01166373|7369796|FG002|Overall Study|Lost to Follow-up|2
4544549|NCT01166373|7369797|FG003|Overall Study|Lost to Follow-up|2
4544550|NCT01166373|7369794|FG000|Overall Study|Withdrawal by Subject|1
4544551|NCT01166373|7369795|FG001|Overall Study|Withdrawal by Subject|2
4544552|NCT01166373|7369796|FG002|Overall Study|Withdrawal by Subject|2
4544553|NCT01166373|7369797|FG003|Overall Study|Withdrawal by Subject|3
4544554|NCT01166373|7369794|FG000|Overall Study|Physician Decision|1
4544555|NCT01166373|7369795|FG001|Overall Study|Physician Decision|0
4544556|NCT01166373|7369796|FG002|Overall Study|Physician Decision|0
4544557|NCT01166373|7369797|FG003|Overall Study|Physician Decision|0
4544558|NCT01166438|7369811|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8
4544559|NCT01166438|7369812|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4
4544560|NCT01166438|7369811|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0
4544561|NCT01166438|7369812|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4
4544562|NCT01166438|7369811|FG000|Double-blind Phase: 1st 6 Months|Not treated|1
4544563|NCT01166438|7369812|FG001|Double-blind Phase: 1st 6 Months|Not treated|1
4544564|NCT01166438|7369811|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1
4544565|NCT01166438|7369812|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2
4544566|NCT01166438|7369811|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4
4544567|NCT01166438|7369812|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2
4544568|NCT01166438|7369811|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29
4544569|NCT01166438|7369812|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52
4544570|NCT01166568|7369822|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0
4544571|NCT01166568|7369823|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0
4544572|NCT01166568|7369824|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1
4544573|NCT01166568|7369822|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7
4544574|NCT01166568|7369823|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1
4544575|NCT01166568|7369824|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0
4544576|NCT01166568|7369822|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7
4544577|NCT01166568|7369823|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0
4544578|NCT01166568|7369824|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1
4544579|NCT01166646|7369832|FG000|Overall Study|Protocol Violation|0
4544580|NCT01166646|7369833|FG001|Overall Study|Protocol Violation|1
4544581|NCT01166646|7369832|FG000|Overall Study|Adverse Event|1
4544582|NCT01166646|7369833|FG001|Overall Study|Adverse Event|0
4544583|NCT01166659|7369839|FG000|Overall Study|Subject Decision|8
4544584|NCT01166659|7369839|FG000|Overall Study|Investigator Decision|2
4544585|NCT01166659|7369839|FG000|Overall Study|Death|1
4544586|NCT01166659|7369839|FG000|Overall Study|Lost to Follow-up|1
4544587|NCT01166659|7369839|FG000|Overall Study|Study Closed at Site|1
4544588|NCT01166750|7369846|FG000|Overall Study|Lost to Follow-up|1
4544589|NCT01166750|7369847|FG001|Overall Study|Lost to Follow-up|0
4544590|NCT01166763|7369853|FG000|Overall Study|Withdrawal by Subject|3
4544591|NCT01166945|7369859|FG000|Randomized|diagnosed with Group A strep|4
4544592|NCT01166945|7369860|FG001|Randomized|diagnosed with Group A strep|4
4544593|NCT01166945|7369859|FG000|Day 10|NonCompliance/Lost to Follow Up|3
4617916|NCT01754753|7478049|FG001|Overall Study|Lost to Follow-up|5
4617917|NCT01754766|7478058|FG000|Overall Study|Personal reasons|1
4617918|NCT01754766|7478059|FG001|Overall Study|Personal reasons|1
4617919|NCT01754766|7478060|FG002|Overall Study|Personal reasons|0
4617920|NCT01754922|7478079|FG000|Overall Study|Adverse Event|0
4617921|NCT01754922|7478080|FG001|Overall Study|Adverse Event|1
4617922|NCT01755026|7478089|FG000|Overall Study|Adverse Event|1
4617923|NCT01755026|7478090|FG001|Overall Study|Adverse Event|0
4617924|NCT01755026|7478089|FG000|Overall Study|Withdrawal by Subject|1
4617925|NCT01755026|7478090|FG001|Overall Study|Withdrawal by Subject|1
4617926|NCT01755091|7478099|FG000|Overall Study|Withdrawal by Subject|6
4617927|NCT01755091|7478100|FG001|Overall Study|Withdrawal by Subject|1
4617928|NCT01755091|7478101|FG002|Overall Study|Withdrawal by Subject|3
4617929|NCT01755091|7478099|FG000|Overall Study|Adverse Event|1
4617930|NCT01755091|7478100|FG001|Overall Study|Adverse Event|1
4617931|NCT01755091|7478101|FG002|Overall Study|Adverse Event|1
4617932|NCT01755091|7478099|FG000|Overall Study|Lost to Follow-up|1
4617933|NCT01755091|7478100|FG001|Overall Study|Lost to Follow-up|0
4617934|NCT01755091|7478101|FG002|Overall Study|Lost to Follow-up|1
4617935|NCT01755091|7478099|FG000|Overall Study|Physician Decision|1
4617936|NCT01755091|7478100|FG001|Overall Study|Physician Decision|1
4617937|NCT01755091|7478101|FG002|Overall Study|Physician Decision|2
4617938|NCT01755156|7478120|FG000|Phase A (Weeks 0-24)|Adverse Event|2
4617939|NCT01755156|7478121|FG001|Phase A (Weeks 0-24)|Adverse Event|3
4617940|NCT01755156|7478120|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1
4617941|NCT01755156|7478121|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0
4617942|NCT01755156|7478120|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5
4617943|NCT01755156|7478121|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3
4617944|NCT01755156|7478120|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1
4617945|NCT01755156|7478121|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0
4617946|NCT01755156|7478120|FG000|Phase A (Weeks 0-24)|Physician Decision|0
4617947|NCT01755156|7478121|FG001|Phase A (Weeks 0-24)|Physician Decision|1
4617948|NCT01755156|7478120|FG000|Phase A (Weeks 0-24)|Protocol Violation|1
4617949|NCT01755156|7478121|FG001|Phase A (Weeks 0-24)|Protocol Violation|1
4617950|NCT01755156|7478120|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6
4544594|NCT01166945|7369860|FG001|Day 10|NonCompliance/Lost to Follow Up|2
4544595|NCT01166945|7369859|FG000|Day 15|NonCompliance/Lost to Follow Up|2
4544596|NCT01166945|7369860|FG001|Day 15|NonCompliance/Lost to Follow Up|1
4544597|NCT01166945|7369859|FG000|Day 30|Lost to Follow-up|4
4544598|NCT01166945|7369860|FG001|Day 30|Lost to Follow-up|3
4544599|NCT01166958|7369870|FG000|Overall Study|Withdrawal by Subject|1
4544600|NCT01166958|7369871|FG001|Overall Study|Withdrawal by Subject|0
4617951|NCT01755156|7478121|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13
4617952|NCT01755156|7478120|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0
4617953|NCT01755156|7478121|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2
4617954|NCT01755156|7478120|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1
4617955|NCT01755156|7478121|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1
4617956|NCT01755156|7478120|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12
4617957|NCT01755156|7478121|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5
4617958|NCT01755156|7478120|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27
4617959|NCT01755156|7478121|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31
4617960|NCT01755195|7478148|FG000|Overall Study|Participant noncompliance|2
4617961|NCT01755195|7478148|FG000|Overall Study|Switched to alternative treatment|4
4617962|NCT01755195|7478148|FG000|Overall Study|Withdrawal by Subject|1
4617963|NCT01755195|7478148|FG000|Overall Study|Participant refused to start treatment|1
4617964|NCT01755195|7478148|FG000|Overall Study|Participant has been consented for another trial|1
4617965|NCT01755195|7478148|FG000|Overall Study|Refused further treatment|3
4617966|NCT01755195|7478148|FG000|Overall Study|Complicating disease/intercurrent illness|1
4617967|NCT01755234|7478154|FG000|Overall Study|Lost to Follow-up|11
4617968|NCT01755234|7478155|FG001|Overall Study|Lost to Follow-up|6
4617969|NCT01755234|7478154|FG000|Overall Study|Change in surgical case|2
4617970|NCT01755234|7478155|FG001|Overall Study|Change in surgical case|1
4617971|NCT01755234|7478154|FG000|Overall Study|case cancelled|1
4617972|NCT01755234|7478155|FG001|Overall Study|case cancelled|0
4617973|NCT01755234|7478154|FG000|Overall Study|Withdrawal by Subject|0
4617974|NCT01755234|7478155|FG001|Overall Study|Withdrawal by Subject|1
4617975|NCT01755234|7478154|FG000|Overall Study|unblinded|1
4617976|NCT01755234|7478155|FG001|Overall Study|unblinded|0
4617977|NCT01755416|7478161|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1
4617978|NCT01755416|7478162|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2
4617979|NCT01755546|7478175|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1
4617980|NCT01755546|7478175|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3
4617981|NCT01755546|7478175|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1
4617982|NCT01755546|7478175|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5
4617983|NCT01755546|7478175|FG000|Titration Phase|Adverse Event|11
4617984|NCT01755546|7478175|FG000|Titration Phase|Lack of Efficacy|18
4617985|NCT01755546|7478175|FG000|Titration Phase|Protocol Violation|9
4617986|NCT01755546|7478175|FG000|Titration Phase|Lost to Follow-up|2
4617987|NCT01755546|7478175|FG000|Titration Phase|Other and Continuing|22
4617988|NCT01755546|7478175|FG000|Titration Phase|Withdrawal by Subject|8
4617989|NCT01755546|7478175|FG000|Long Term Treatment|Adverse Event|12
4617990|NCT01755546|7478175|FG000|Long Term Treatment|Lack of Efficacy|6
4617991|NCT01755546|7478175|FG000|Long Term Treatment|Protocol Violation|10
4617992|NCT01755546|7478175|FG000|Long Term Treatment|Withdrawal by Subject|35
4617993|NCT01755546|7478175|FG000|Long Term Treatment|Lost to Follow-up|17
4617994|NCT01755546|7478175|FG000|Long Term Treatment|other and ongoing|41
4617995|NCT01755598|7478181|FG000|Overall Study|Other|109
4617996|NCT01755598|7478182|FG001|Overall Study|Other|109
4544601|NCT01167023|7369930|FG000|Overall Study|Lost to Follow-up|0
4544602|NCT01167023|7369931|FG001|Overall Study|Lost to Follow-up|1
4544603|NCT01167023|7369932|FG002|Overall Study|Lost to Follow-up|1
4544604|NCT01167023|7369930|FG000|Overall Study|Screen Failure|0
4544605|NCT01167023|7369931|FG001|Overall Study|Screen Failure|1
4544606|NCT01167023|7369932|FG002|Overall Study|Screen Failure|0
4544607|NCT01167023|7369930|FG000|Overall Study|Sponsor Decision|0
4544608|NCT01167023|7369931|FG001|Overall Study|Sponsor Decision|1
4544609|NCT01167023|7369932|FG002|Overall Study|Sponsor Decision|0
4544610|NCT01167023|7369930|FG000|Overall Study|Withdrawal by Subject|0
4544611|NCT01167023|7369931|FG001|Overall Study|Withdrawal by Subject|0
4544612|NCT01167023|7369932|FG002|Overall Study|Withdrawal by Subject|1
4544613|NCT01167140|7369938|FG000|Overall Study|Withdrawal by Subject|1
4544614|NCT01167153|7369944|FG000|Overall Study|Non-effective therapy|1
4544615|NCT01167153|7369945|FG001|Overall Study|Non-effective therapy|4
4544616|NCT01167153|7369944|FG000|Overall Study|AE including clinical laboratory AE|2
4544617|NCT01167153|7369945|FG001|Overall Study|AE including clinical laboratory AE|8
4544618|NCT01167153|7369944|FG000|Overall Study|Hypotension|1
4544619|NCT01167153|7369945|FG001|Overall Study|Hypotension|0
4544620|NCT01167153|7369944|FG000|Overall Study|Lost to Follow-up|7
4544621|NCT01167153|7369945|FG001|Overall Study|Lost to Follow-up|9
4544622|NCT01167153|7369944|FG000|Overall Study|Non-compliance to concomitant medication|0
4544623|NCT01167153|7369945|FG001|Overall Study|Non-compliance to concomitant medication|2
4544624|NCT01167153|7369944|FG000|Overall Study|Investigator initiation withdrawal,Other|1
4544625|NCT01167153|7369945|FG001|Overall Study|Investigator initiation withdrawal,Other|1
4544626|NCT01167153|7369944|FG000|Overall Study|Withdrawal consent|1
4544627|NCT01167153|7369945|FG001|Overall Study|Withdrawal consent|1
4544628|NCT01167153|7369944|FG000|Overall Study|Subject initiation withdrawal, Other|5
4617997|NCT01755598|7478181|FG000|Overall Study|Lost to Follow-up|32
4617998|NCT01755598|7478182|FG001|Overall Study|Lost to Follow-up|43
4617999|NCT01755598|7478181|FG000|Overall Study|Migrated/moved from study area|76
4618000|NCT01755598|7478182|FG001|Overall Study|Migrated/moved from study area|65
4618001|NCT01755598|7478181|FG000|Overall Study|Withdrawal by Subject|22
4618002|NCT01755598|7478182|FG001|Overall Study|Withdrawal by Subject|31
4618003|NCT01755598|7478181|FG000|Overall Study|Protocol Violation|7
4618004|NCT01755598|7478182|FG001|Overall Study|Protocol Violation|7
4544629|NCT01167153|7369945|FG001|Overall Study|Subject initiation withdrawal, Other|8
4544630|NCT01167179|7369953|FG000|Overall Study|disease recurrence|4
4544631|NCT01167179|7369954|FG001|Overall Study|disease recurrence|4
4544632|NCT01167179|7369953|FG000|Overall Study|Death|4
4544633|NCT01167179|7369954|FG001|Overall Study|Death|10
4544634|NCT01167179|7369953|FG000|Overall Study|Withdrawal by Subject|1
4544635|NCT01167179|7369954|FG001|Overall Study|Withdrawal by Subject|2
4544636|NCT01167179|7369953|FG000|Overall Study|diverse|6
4544637|NCT01167179|7369954|FG001|Overall Study|diverse|5
4544638|NCT01167192|7369960|FG000|Overall Study|Adverse Event|1
4544639|NCT01167192|7369960|FG000|Overall Study|Death|1
4544640|NCT01167192|7369960|FG000|Overall Study|Withdrawal by Subject|1
4544641|NCT01167192|7369960|FG000|Overall Study|Insurance denial|1
4544642|NCT01167257|7369966|FG000|Overall Study|Lost to Follow-up|2
4544643|NCT01167257|7369967|FG001|Overall Study|Lost to Follow-up|2
4544644|NCT01167257|7369966|FG000|Overall Study|Withdrew consent|1
4544645|NCT01167257|7369967|FG001|Overall Study|Withdrew consent|1
4544646|NCT01167426|7369977|FG000|Overall Study|Lost to Follow-up|6
4544647|NCT01167426|7369977|FG000|Overall Study|Protocol Violation|1
4544648|NCT01167426|7369977|FG000|Overall Study|Withdrawal by Subject|2
4544649|NCT01167426|7369977|FG000|Overall Study|Sponsor Decision|1
4544650|NCT01167582|7370004|FG000|Overall Study|Lost to Follow-up|0
4544651|NCT01167582|7370005|FG001|Overall Study|Lost to Follow-up|1
4544652|NCT01167634|7370029|FG000|Overall Study|Lost to Follow-up|1
4544653|NCT01167634|7370030|FG001|Overall Study|Lost to Follow-up|3
4544654|NCT01167634|7370031|FG002|Overall Study|Lost to Follow-up|3
4544655|NCT01167634|7370032|FG003|Overall Study|Lost to Follow-up|4
4544656|NCT01167634|7370029|FG000|Overall Study|Withdrawal by Subject|1
4544657|NCT01167634|7370030|FG001|Overall Study|Withdrawal by Subject|1
4544658|NCT01167634|7370031|FG002|Overall Study|Withdrawal by Subject|0
4544659|NCT01167634|7370032|FG003|Overall Study|Withdrawal by Subject|0
4544660|NCT01167881|7370059|FG000|Overall Study|Adverse Event|47
4544661|NCT01167881|7370060|FG001|Overall Study|Adverse Event|51
4544662|NCT01167881|7370059|FG000|Overall Study|Lack of Efficacy|4
4544663|NCT01167881|7370060|FG001|Overall Study|Lack of Efficacy|7
4544664|NCT01167881|7370059|FG000|Overall Study|Non compliant with protocol|9
4544665|NCT01167881|7370060|FG001|Overall Study|Non compliant with protocol|18
4544666|NCT01167881|7370059|FG000|Overall Study|Lost to Follow-up|19
4544667|NCT01167881|7370060|FG001|Overall Study|Lost to Follow-up|20
4544668|NCT01167881|7370059|FG000|Overall Study|Patient refusal to cont., not due to AE|45
4544669|NCT01167881|7370060|FG001|Overall Study|Patient refusal to cont., not due to AE|40
4544670|NCT01167881|7370059|FG000|Overall Study|Not treated|4
4544671|NCT01167881|7370060|FG001|Overall Study|Not treated|0
4544672|NCT01167881|7370059|FG000|Overall Study|Other not defined above|31
4544673|NCT01167881|7370060|FG001|Overall Study|Other not defined above|55
4544674|NCT01167907|7370068|FG000|Overall Study|Protocol Violation|1
4544675|NCT01167907|7370069|FG001|Overall Study|Protocol Violation|0
4544676|NCT01167907|7370068|FG000|Overall Study|saphenous catheter dislodged before comp|1
4544677|NCT01167907|7370069|FG001|Overall Study|saphenous catheter dislodged before comp|1
4544678|NCT01168232|7370084|FG000|Overall Study|Ineligible-Second primary cancer site|1
4544679|NCT01168232|7370084|FG000|Overall Study|Ineligible- Wrong cell type|6
4544680|NCT01168232|7370084|FG000|Overall Study|Ineligible-Inadequate pathology|1
4544681|NCT01168349|7370088|FG000|Overall Study|Death|157
4544682|NCT01168349|7370088|FG000|Overall Study|Lost to Follow-up|34
4544683|NCT01168349|7370088|FG000|Overall Study|Withdrawal by Subject|9
4544684|NCT01168349|7370088|FG000|Overall Study|Kidney transplantation|3
4544685|NCT01168349|7370088|FG000|Overall Study|Other|22
4544686|NCT01168349|7370088|FG000|Overall Study|Protocol Violation|76
4544687|NCT01168401|7370119|FG000|Overall Study|Lost to Follow-up|1
4544688|NCT01168401|7370120|FG001|Overall Study|Lost to Follow-up|1
4544689|NCT01168401|7370121|FG002|Overall Study|Lost to Follow-up|2
4544690|NCT01168401|7370122|FG003|Overall Study|Lost to Follow-up|1
4544691|NCT01168401|7370123|FG004|Overall Study|Lost to Follow-up|0
4544692|NCT01168401|7370124|FG005|Overall Study|Lost to Follow-up|0
4544693|NCT01168401|7370125|FG006|Overall Study|Lost to Follow-up|0
4544694|NCT01168401|7370126|FG007|Overall Study|Lost to Follow-up|0
4544695|NCT01168401|7370127|FG008|Overall Study|Lost to Follow-up|0
4544696|NCT01168401|7370128|FG009|Overall Study|Lost to Follow-up|0
4544697|NCT01168401|7370129|FG010|Overall Study|Lost to Follow-up|0
4544698|NCT01168401|7370119|FG000|Overall Study|Withdrawal by Subject|0
4544699|NCT01168401|7370120|FG001|Overall Study|Withdrawal by Subject|0
4544700|NCT01168401|7370121|FG002|Overall Study|Withdrawal by Subject|0
4544701|NCT01168401|7370122|FG003|Overall Study|Withdrawal by Subject|1
4544702|NCT01168401|7370123|FG004|Overall Study|Withdrawal by Subject|0
4544703|NCT01168401|7370124|FG005|Overall Study|Withdrawal by Subject|0
4544704|NCT01168401|7370125|FG006|Overall Study|Withdrawal by Subject|0
4544705|NCT01168401|7370126|FG007|Overall Study|Withdrawal by Subject|0
4544706|NCT01168401|7370127|FG008|Overall Study|Withdrawal by Subject|0
4544707|NCT01168401|7370128|FG009|Overall Study|Withdrawal by Subject|0
4544708|NCT01168401|7370129|FG010|Overall Study|Withdrawal by Subject|0
4544709|NCT01168427|7370153|FG000|Overall Study|Patient exited prior to implant|1
4544710|NCT01168596|7370159|FG000|Overall Study|Withdrawal by Subject|3
4544711|NCT01168596|7370160|FG001|Overall Study|Withdrawal by Subject|1
4544712|NCT01168856|7370198|FG000|Overall Study|Lost to Follow-up|4
4544713|NCT01168856|7370199|FG001|Overall Study|Lost to Follow-up|34
4544714|NCT01168856|7370198|FG000|Overall Study|Withdrawal by Subject|6
4544715|NCT01168856|7370199|FG001|Overall Study|Withdrawal by Subject|8
4544716|NCT01168856|7370198|FG000|Overall Study|Physician Decision|2
4544717|NCT01168856|7370199|FG001|Overall Study|Physician Decision|1
4544718|NCT01168856|7370198|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0
4544719|NCT01168856|7370199|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1
4544720|NCT01168856|7370198|FG000|Overall Study|Participant received anti-HCV treatment|1
4544721|NCT01168856|7370199|FG001|Overall Study|Participant received anti-HCV treatment|0
4544722|NCT01168856|7370198|FG000|Overall Study|Death|0
4544723|NCT01168856|7370199|FG001|Overall Study|Death|2
4544724|NCT01168856|7370198|FG000|Overall Study|Other|1
4544725|NCT01168856|7370199|FG001|Overall Study|Other|291
4544726|NCT01168856|7370198|FG000|Overall Study|Protocol Violation|4
4544727|NCT01168856|7370199|FG001|Overall Study|Protocol Violation|6
4544728|NCT01168973|7370229|FG000|Overall Study|Progressive Disease|341
4544729|NCT01168973|7370230|FG001|Overall Study|Progressive Disease|429
4544730|NCT01168973|7370229|FG000|Overall Study|Adverse Event|94
4544731|NCT01168973|7370230|FG001|Overall Study|Adverse Event|55
4544732|NCT01168973|7370229|FG000|Overall Study|Withdrawal by Subject|90
4544733|NCT01168973|7370230|FG001|Overall Study|Withdrawal by Subject|53
4544734|NCT01168973|7370229|FG000|Overall Study|Death|42
4544735|NCT01168973|7370230|FG001|Overall Study|Death|45
4544736|NCT01168973|7370229|FG000|Overall Study|Physician Decision|37
4544737|NCT01168973|7370230|FG001|Overall Study|Physician Decision|19
4544738|NCT01168973|7370229|FG000|Overall Study|Sponsor Decision|2
4544739|NCT01168973|7370230|FG001|Overall Study|Sponsor Decision|1
4544740|NCT01168973|7370229|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7
4544741|NCT01168973|7370230|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9
4544742|NCT01168999|7370253|FG000|Overall Study|Lost to Follow-up|2
4544743|NCT01168999|7370254|FG001|Overall Study|Lost to Follow-up|1
4544744|NCT01168999|7370255|FG002|Overall Study|Lost to Follow-up|0
4544745|NCT01168999|7370256|FG003|Overall Study|Lost to Follow-up|0
4544746|NCT01169038|7370266|FG000|Overall Study|Death|1
4544747|NCT01169038|7370266|FG000|Overall Study|Adverse Event|5
4544748|NCT01169038|7370266|FG000|Overall Study|Required antibiotic administration|1
4544749|NCT01169103|7370283|FG000|Overall Study|Lost to Follow-up|3
4544750|NCT01169103|7370284|FG001|Overall Study|Lost to Follow-up|3
4544751|NCT01169103|7370283|FG000|Overall Study|Withdrawal by Subject|3
4544752|NCT01169103|7370284|FG001|Overall Study|Withdrawal by Subject|1
4544753|NCT01169337|7370298|FG000|Overall Study|Lack of Efficacy|5
4544754|NCT01169337|7370299|FG001|Overall Study|Lack of Efficacy|7
4544755|NCT01169337|7370300|FG002|Overall Study|Lack of Efficacy|0
4544756|NCT01169337|7370298|FG000|Overall Study|Adverse Event|12
4544757|NCT01169337|7370299|FG001|Overall Study|Adverse Event|18
4544758|NCT01169337|7370300|FG002|Overall Study|Adverse Event|0
4544759|NCT01169337|7370298|FG000|Overall Study|Death|2
4544760|NCT01169337|7370299|FG001|Overall Study|Death|0
4544761|NCT01169337|7370300|FG002|Overall Study|Death|0
4544762|NCT01169337|7370298|FG000|Overall Study|Withdrawal by Subject|11
4544763|NCT01169337|7370299|FG001|Overall Study|Withdrawal by Subject|11
4544764|NCT01169337|7370300|FG002|Overall Study|Withdrawal by Subject|6
4544765|NCT01169337|7370298|FG000|Overall Study|Noncompliance|2
4544766|NCT01169337|7370299|FG001|Overall Study|Noncompliance|0
4544767|NCT01169337|7370300|FG002|Overall Study|Noncompliance|0
4544768|NCT01169337|7370298|FG000|Overall Study|Other complicating disease|1
4544769|NCT01169337|7370299|FG001|Overall Study|Other complicating disease|1
4544770|NCT01169337|7370300|FG002|Overall Study|Other complicating disease|0
4544771|NCT01169337|7370298|FG000|Overall Study|Physician Decision|1
4544772|NCT01169337|7370299|FG001|Overall Study|Physician Decision|5
4544773|NCT01169337|7370300|FG002|Overall Study|Physician Decision|0
4544774|NCT01169337|7370298|FG000|Overall Study|Alternative therapy|0
4544775|NCT01169337|7370299|FG001|Overall Study|Alternative therapy|2
4544776|NCT01169337|7370300|FG002|Overall Study|Alternative therapy|0
4544777|NCT01169337|7370298|FG000|Overall Study|Changed hospital|0
4544778|NCT01169337|7370299|FG001|Overall Study|Changed hospital|1
4544779|NCT01169337|7370300|FG002|Overall Study|Changed hospital|0
4544780|NCT01169337|7370298|FG000|Overall Study|Never started treatment|0
4544781|NCT01169337|7370299|FG001|Overall Study|Never started treatment|2
4544782|NCT01169337|7370300|FG002|Overall Study|Never started treatment|0
4544783|NCT01169337|7370298|FG000|Overall Study|Reason not reported|1
4544784|NCT01169337|7370299|FG001|Overall Study|Reason not reported|0
4544785|NCT01169337|7370300|FG002|Overall Study|Reason not reported|0
4544786|NCT01169337|7370298|FG000|Overall Study|Continuing lenalidomide|9
4544787|NCT01169337|7370299|FG001|Overall Study|Continuing lenalidomide|43
4544788|NCT01169337|7370300|FG002|Overall Study|Continuing lenalidomide|0
4544789|NCT01169350|7370308|FG000|Overall Study|Physician Decision|3
4544790|NCT01169350|7370308|FG000|Overall Study|Lost to Follow-up|2
4544791|NCT01169493|7370327|FG000|Period 1 (6 Months)|Withdrawal by Subject|0
4544792|NCT01169493|7370328|FG001|Period 1 (6 Months)|Withdrawal by Subject|1
4544793|NCT01169493|7370329|FG002|Period 1 (6 Months)|Withdrawal by Subject|2
4544794|NCT01169493|7370330|FG003|Period 1 (6 Months)|Withdrawal by Subject|0
4544795|NCT01169493|7370331|FG004|Period 1 (6 Months)|Withdrawal by Subject|0
4544796|NCT01169493|7370332|FG005|Period 1 (6 Months)|Withdrawal by Subject|3
4544797|NCT01169493|7370327|FG000|Period 3 (6 Months)|Adverse Event|0
4544798|NCT01169493|7370328|FG001|Period 3 (6 Months)|Adverse Event|1
4544799|NCT01169493|7370329|FG002|Period 3 (6 Months)|Adverse Event|0
4618005|NCT01755598|7478181|FG000|Overall Study|Adverse Event|19
4618006|NCT01755598|7478182|FG001|Overall Study|Adverse Event|28
4618007|NCT01755637|7478188|FG000|Period 1|Adverse Event|0
4618008|NCT01755637|7478189|FG001|Period 1|Adverse Event|1
4618009|NCT01755702|7478201|FG000|Wash Out Period I|Other Reason|3
4618010|NCT01755702|7478201|FG000|Washout Period II|Other Reason|5
4544800|NCT01169493|7370330|FG003|Period 3 (6 Months)|Adverse Event|0
4544801|NCT01169493|7370331|FG004|Period 3 (6 Months)|Adverse Event|0
4544802|NCT01169493|7370332|FG005|Period 3 (6 Months)|Adverse Event|0
4544803|NCT01169493|7370327|FG000|Period 3 (6 Months)|Physician Decision|0
4544804|NCT01169493|7370328|FG001|Period 3 (6 Months)|Physician Decision|1
4544805|NCT01169493|7370329|FG002|Period 3 (6 Months)|Physician Decision|1
4544806|NCT01169493|7370330|FG003|Period 3 (6 Months)|Physician Decision|0
4544807|NCT01169493|7370331|FG004|Period 3 (6 Months)|Physician Decision|0
4544808|NCT01169493|7370332|FG005|Period 3 (6 Months)|Physician Decision|0
4544809|NCT01169532|7370352|FG000|Overall Study|Withdrawal by Subject|1
4544810|NCT01169558|7370356|FG000|Overall Study|Disease progression|98
4544811|NCT01169558|7370356|FG000|Overall Study|Adverse Event|25
4544812|NCT01169558|7370356|FG000|Overall Study|Withdrawal of Consent|8
4544813|NCT01169558|7370356|FG000|Overall Study|Medical Decision|7
4544814|NCT01169558|7370356|FG000|Overall Study|Stable Disease|4
4544815|NCT01169558|7370356|FG000|Overall Study|Lost to Follow-up|4
4544816|NCT01169558|7370356|FG000|Overall Study|Need for Surgery|4
4544817|NCT01169558|7370356|FG000|Overall Study|Non-compliance|2
4544818|NCT01169558|7370356|FG000|Overall Study|Protocol Violation|2
4544819|NCT01169558|7370356|FG000|Overall Study|Partial response|2
4544820|NCT01169636|7370365|FG000|Overall Study|Adverse Event|0
4618011|NCT01755767|7478215|FG000|Overall Study|Progressive Disease|8
4618012|NCT01755767|7478216|FG001|Overall Study|Progressive Disease|7
4618013|NCT01755767|7478217|FG002|Overall Study|Progressive Disease|91
4618014|NCT01755767|7478218|FG003|Overall Study|Progressive Disease|43
4618015|NCT01755767|7478215|FG000|Overall Study|Clinical Disease Progression|4
4618016|NCT01755767|7478216|FG001|Overall Study|Clinical Disease Progression|2
4618017|NCT01755767|7478217|FG002|Overall Study|Clinical Disease Progression|29
4618018|NCT01755767|7478218|FG003|Overall Study|Clinical Disease Progression|20
4618019|NCT01755767|7478215|FG000|Overall Study|Radiographic Disease Progression|9
4618020|NCT01755767|7478216|FG001|Overall Study|Radiographic Disease Progression|4
4618021|NCT01755767|7478217|FG002|Overall Study|Radiographic Disease Progression|44
4618022|NCT01755767|7478218|FG003|Overall Study|Radiographic Disease Progression|27
4618023|NCT01755767|7478215|FG000|Overall Study|Adverse Event|6
4618024|NCT01755767|7478216|FG001|Overall Study|Adverse Event|0
4618025|NCT01755767|7478217|FG002|Overall Study|Adverse Event|28
4618026|NCT01755767|7478218|FG003|Overall Study|Adverse Event|11
4618027|NCT01755767|7478215|FG000|Overall Study|Death|1
4618028|NCT01755767|7478216|FG001|Overall Study|Death|2
4618029|NCT01755767|7478217|FG002|Overall Study|Death|15
4618030|NCT01755767|7478218|FG003|Overall Study|Death|4
4618031|NCT01755767|7478215|FG000|Overall Study|Subject Decision|0
4618032|NCT01755767|7478216|FG001|Overall Study|Subject Decision|0
4618033|NCT01755767|7478217|FG002|Overall Study|Subject Decision|10
4618034|NCT01755767|7478218|FG003|Overall Study|Subject Decision|3
4618035|NCT01755767|7478215|FG000|Overall Study|Withdrawal by Subject|0
4618036|NCT01755767|7478216|FG001|Overall Study|Withdrawal by Subject|0
4618037|NCT01755767|7478217|FG002|Overall Study|Withdrawal by Subject|2
4618038|NCT01755767|7478218|FG003|Overall Study|Withdrawal by Subject|1
4618039|NCT01755767|7478215|FG000|Overall Study|Other|0
4618040|NCT01755767|7478216|FG001|Overall Study|Other|0
4618041|NCT01755767|7478217|FG002|Overall Study|Other|2
4618042|NCT01755767|7478218|FG003|Overall Study|Other|3
4618043|NCT01755767|7478215|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0
4618044|NCT01755767|7478216|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0
4618045|NCT01755767|7478217|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5
4618046|NCT01755767|7478218|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2
4618047|NCT01755858|7478230|FG000|Overall Study|Adverse Event|1
4618048|NCT01755858|7478231|FG001|Overall Study|Adverse Event|1
4618049|NCT01756053|7478264|FG000|Period 1 (10 Days)|Protocol Violation|1
4618050|NCT01756053|7478265|FG001|Period 1 (10 Days)|Protocol Violation|1
4618051|NCT01756053|7478264|FG000|Period 2 (10 Days)|Protocol Violation|0
4618052|NCT01756053|7478265|FG001|Period 2 (10 Days)|Protocol Violation|2
4618053|NCT01756079|7478271|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4
4544821|NCT01169636|7370366|FG001|Overall Study|Adverse Event|0
4544822|NCT01169636|7370367|FG002|Overall Study|Adverse Event|1
4544823|NCT01169636|7370368|FG003|Overall Study|Adverse Event|1
4544824|NCT01169636|7370369|FG004|Overall Study|Adverse Event|0
4544825|NCT01169636|7370365|FG000|Overall Study|Screen failure|0
4544826|NCT01169636|7370366|FG001|Overall Study|Screen failure|0
4544827|NCT01169636|7370367|FG002|Overall Study|Screen failure|2
4618054|NCT01756079|7478271|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5
4618055|NCT01756079|7478271|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2
4544828|NCT01169636|7370368|FG003|Overall Study|Screen failure|0
4544829|NCT01169636|7370369|FG004|Overall Study|Screen failure|0
4544830|NCT01169636|7370365|FG000|Overall Study|Withdrawal by Subject|0
4618056|NCT01756079|7478271|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20
4618057|NCT01756079|7478271|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4
4544831|NCT01169636|7370366|FG001|Overall Study|Withdrawal by Subject|0
4544832|NCT01169636|7370367|FG002|Overall Study|Withdrawal by Subject|0
4544833|NCT01169636|7370368|FG003|Overall Study|Withdrawal by Subject|0
4544834|NCT01169636|7370369|FG004|Overall Study|Withdrawal by Subject|3
4544835|NCT01169649|7370379|FG000|Overall Study|Patient Not Treated|3
4544836|NCT01169675|7370388|FG000|Overall Study|Progressive disease|13
4544837|NCT01169675|7370389|FG001|Overall Study|Progressive disease|2
4544838|NCT01169675|7370390|FG002|Overall Study|Progressive disease|5
4544839|NCT01169675|7370391|FG003|Overall Study|Progressive disease|15
4544840|NCT01169675|7370392|FG004|Overall Study|Progressive disease|1
4544841|NCT01169675|7370388|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1
4544842|NCT01169675|7370389|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0
4544843|NCT01169675|7370390|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0
4544844|NCT01169675|7370391|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0
4544845|NCT01169675|7370392|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2
4544846|NCT01169675|7370388|FG000|Overall Study|Adverse Event|5
4544847|NCT01169675|7370389|FG001|Overall Study|Adverse Event|1
4544848|NCT01169675|7370390|FG002|Overall Study|Adverse Event|2
4544849|NCT01169675|7370391|FG003|Overall Study|Adverse Event|0
4544850|NCT01169675|7370392|FG004|Overall Study|Adverse Event|0
4544851|NCT01169675|7370388|FG000|Overall Study|Withdrawal by Subject|1
4544852|NCT01169675|7370389|FG001|Overall Study|Withdrawal by Subject|0
4544853|NCT01169675|7370390|FG002|Overall Study|Withdrawal by Subject|0
4544854|NCT01169675|7370391|FG003|Overall Study|Withdrawal by Subject|1
4544855|NCT01169675|7370392|FG004|Overall Study|Withdrawal by Subject|2
4618058|NCT01756157|7478276|FG000|First Intervention Period|Withdrawal by Subject|1
4618059|NCT01756157|7478277|FG001|First Intervention Period|Withdrawal by Subject|0
4618060|NCT01756157|7478276|FG000|First Intervention Period|Lost to Follow-up|0
4618061|NCT01756157|7478277|FG001|First Intervention Period|Lost to Follow-up|2
4618062|NCT01756235|7478300|FG000|Overall Study|Adalimumab Treatment was not Documented|2
4618063|NCT01756274|7478304|FG000|Overall Study|Protocol Violation|2
4618064|NCT01756274|7478304|FG000|Overall Study|Laboratory error|1
4618065|NCT01756300|7478309|FG000|Overall Study|Death|1
4618066|NCT01756300|7478309|FG000|Overall Study|Withdrawal by Subject|1
4618067|NCT01756352|7478330|FG000|Overall Study|moved away and lost to followup|1
4618068|NCT01756456|7478344|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0
4618069|NCT01756456|7478345|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0
4618070|NCT01756456|7478346|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0
4618071|NCT01756456|7478347|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1
4618072|NCT01756456|7478348|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1
4618073|NCT01756456|7478349|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1
4618074|NCT01756456|7478344|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0
4618075|NCT01756456|7478345|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0
4618076|NCT01756456|7478346|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0
4618077|NCT01756456|7478347|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2
4618078|NCT01756456|7478348|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1
4618079|NCT01756456|7478349|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0
4618080|NCT01756456|7478344|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0
4618081|NCT01756456|7478345|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1
4618082|NCT01756456|7478346|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0
4618083|NCT01756456|7478347|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0
4618084|NCT01756456|7478348|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0
4618085|NCT01756456|7478349|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0
4618086|NCT01756456|7478344|FG000|Treatment Period: Phase I/II|Adverse Event|1
4618087|NCT01756456|7478345|FG001|Treatment Period: Phase I/II|Adverse Event|0
4618088|NCT01756456|7478346|FG002|Treatment Period: Phase I/II|Adverse Event|2
4618089|NCT01756456|7478347|FG003|Treatment Period: Phase I/II|Adverse Event|3
4618090|NCT01756456|7478348|FG004|Treatment Period: Phase I/II|Adverse Event|9
4618091|NCT01756456|7478349|FG005|Treatment Period: Phase I/II|Adverse Event|1
4618092|NCT01756456|7478344|FG000|Treatment Period: Phase I/II|Other causes|0
4618093|NCT01756456|7478345|FG001|Treatment Period: Phase I/II|Other causes|0
4618094|NCT01756456|7478346|FG002|Treatment Period: Phase I/II|Other causes|0
4618095|NCT01756456|7478347|FG003|Treatment Period: Phase I/II|Other causes|1
4618096|NCT01756456|7478348|FG004|Treatment Period: Phase I/II|Other causes|2
4618097|NCT01756456|7478349|FG005|Treatment Period: Phase I/II|Other causes|2
4618098|NCT01756456|7478344|FG000|Follow Up Period Phase I/II|still in study after week 20|0
4618099|NCT01756456|7478345|FG001|Follow Up Period Phase I/II|still in study after week 20|0
4618100|NCT01756456|7478346|FG002|Follow Up Period Phase I/II|still in study after week 20|0
4618101|NCT01756456|7478347|FG003|Follow Up Period Phase I/II|still in study after week 20|25
4618102|NCT01756456|7478348|FG004|Follow Up Period Phase I/II|still in study after week 20|23
4544856|NCT01169675|7370388|FG000|Overall Study|Other Reason Not Defined Above|0
4544857|NCT01169675|7370389|FG001|Overall Study|Other Reason Not Defined Above|0
4544858|NCT01169675|7370390|FG002|Overall Study|Other Reason Not Defined Above|0
4544859|NCT01169675|7370391|FG003|Overall Study|Other Reason Not Defined Above|1
4544860|NCT01169675|7370392|FG004|Overall Study|Other Reason Not Defined Above|1
4544861|NCT01169701|7370406|FG000|Overall Study|Lost to Follow-up|1
4544862|NCT01169701|7370407|FG001|Overall Study|Lost to Follow-up|1
4544863|NCT01169701|7370406|FG000|Overall Study|Withdrawal by Subject|1
4544864|NCT01169701|7370407|FG001|Overall Study|Withdrawal by Subject|3
4618103|NCT01756456|7478349|FG005|Follow Up Period Phase I/II|still in study after week 20|25
4618104|NCT01756456|7478344|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
4618105|NCT01756456|7478345|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1
4618106|NCT01756456|7478346|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
4618107|NCT01756456|7478347|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
4618108|NCT01756456|7478348|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
4544865|NCT01169701|7370406|FG000|Overall Study|Adverse Event|1
4544866|NCT01169701|7370407|FG001|Overall Study|Adverse Event|2
4544867|NCT01169701|7370406|FG000|Overall Study|Exclusion criteria|2
4544868|NCT01169701|7370407|FG001|Overall Study|Exclusion criteria|0
4544869|NCT01169701|7370406|FG000|Overall Study|Death|0
4544870|NCT01169701|7370407|FG001|Overall Study|Death|1
4544871|NCT01169701|7370406|FG000|Overall Study|Administrative problems|0
4544872|NCT01169701|7370407|FG001|Overall Study|Administrative problems|1
4544873|NCT01169701|7370406|FG000|Overall Study|Serious adverse event|0
4544874|NCT01169701|7370407|FG001|Overall Study|Serious adverse event|1
4544875|NCT01169701|7370406|FG000|Overall Study|Sponsor decision|0
4544876|NCT01169701|7370407|FG001|Overall Study|Sponsor decision|1
4618109|NCT01756456|7478349|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
4618110|NCT01756456|7478344|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0
4618111|NCT01756456|7478345|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0
4618112|NCT01756456|7478346|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0
4618113|NCT01756456|7478347|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0
4618114|NCT01756456|7478348|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0
4618115|NCT01756456|7478349|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1
4618116|NCT01756456|7478344|FG000|Follow Up Period Phase I/II|Adverse Event|1
4618117|NCT01756456|7478345|FG001|Follow Up Period Phase I/II|Adverse Event|0
4618118|NCT01756456|7478346|FG002|Follow Up Period Phase I/II|Adverse Event|0
4618119|NCT01756456|7478347|FG003|Follow Up Period Phase I/II|Adverse Event|5
4618120|NCT01756456|7478348|FG004|Follow Up Period Phase I/II|Adverse Event|0
4618121|NCT01756456|7478349|FG005|Follow Up Period Phase I/II|Adverse Event|1
4618122|NCT01756456|7478344|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0
4618123|NCT01756456|7478345|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0
4618124|NCT01756456|7478346|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1
4618125|NCT01756456|7478347|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2
4618126|NCT01756456|7478348|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0
4618127|NCT01756456|7478349|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1
4618128|NCT01756456|7478344|FG000|Follow Up Period Phase I/II|Other causes|0
4618129|NCT01756456|7478345|FG001|Follow Up Period Phase I/II|Other causes|0
4618130|NCT01756456|7478346|FG002|Follow Up Period Phase I/II|Other causes|0
4618131|NCT01756456|7478347|FG003|Follow Up Period Phase I/II|Other causes|1
4618132|NCT01756456|7478348|FG004|Follow Up Period Phase I/II|Other causes|3
4618133|NCT01756456|7478349|FG005|Follow Up Period Phase I/II|Other causes|5
4618134|NCT01756833|7478374|FG000|Overall Study|Withdrawal by Subject|4
4544877|NCT01169779|7370415|FG000|Overall Study|Adverse Event|3
4544878|NCT01169779|7370416|FG001|Overall Study|Adverse Event|11
4544879|NCT01169779|7370415|FG000|Overall Study|Lack of Efficacy|1
4544880|NCT01169779|7370416|FG001|Overall Study|Lack of Efficacy|0
4544881|NCT01169779|7370415|FG000|Overall Study|Protocol Violation|1
4544882|NCT01169779|7370416|FG001|Overall Study|Protocol Violation|1
4544883|NCT01169779|7370415|FG000|Overall Study|Withdrawal by Subject|3
4544884|NCT01169779|7370416|FG001|Overall Study|Withdrawal by Subject|2
4544885|NCT01169779|7370415|FG000|Overall Study|Familial and personal reasons|3
4544886|NCT01169779|7370416|FG001|Overall Study|Familial and personal reasons|3
4544887|NCT01169844|7370424|FG000|Overall Study|Adverse Event|0
4544888|NCT01169844|7370425|FG001|Overall Study|Adverse Event|1
4544889|NCT01169844|7370424|FG000|Overall Study|Patient withdrew consent|4
4544890|NCT01169844|7370425|FG001|Overall Study|Patient withdrew consent|0
4544891|NCT01169844|7370424|FG000|Overall Study|Unsatisfactory therapeutic effect|1
4544892|NCT01169844|7370425|FG001|Overall Study|Unsatisfactory therapeutic effect|0
4591454|NCT01529645|7437981|FG009|Overall Study|Lost to Follow-up|0
4591455|NCT01529645|7437972|FG000|Overall Study|SAE - Premature contractions|0
4591456|NCT01529645|7437973|FG001|Overall Study|SAE - Premature contractions|0
4591457|NCT01529645|7437974|FG002|Overall Study|SAE - Premature contractions|1
4591458|NCT01529645|7437975|FG003|Overall Study|SAE - Premature contractions|0
4591459|NCT01529645|7437976|FG004|Overall Study|SAE - Premature contractions|0
4591460|NCT01529645|7437977|FG005|Overall Study|SAE - Premature contractions|0
4591461|NCT01529645|7437978|FG006|Overall Study|SAE - Premature contractions|0
4591462|NCT01529645|7437979|FG007|Overall Study|SAE - Premature contractions|0
4591463|NCT01529645|7437980|FG008|Overall Study|SAE - Premature contractions|0
4591464|NCT01529645|7437981|FG009|Overall Study|SAE - Premature contractions|0
4591465|NCT01529645|7437972|FG000|Overall Study|Withdrawal by Subject|2
4591466|NCT01529645|7437973|FG001|Overall Study|Withdrawal by Subject|0
4591467|NCT01529645|7437974|FG002|Overall Study|Withdrawal by Subject|0
4591468|NCT01529645|7437975|FG003|Overall Study|Withdrawal by Subject|1
4591469|NCT01529645|7437976|FG004|Overall Study|Withdrawal by Subject|1
4544893|NCT01169987|7370431|FG000|Overall Study|Withdrawal by Subject|3
4544894|NCT01169987|7370431|FG000|Overall Study|Lost to Follow-up|24
4544895|NCT01169987|7370431|FG000|Overall Study|Other|4
4544896|NCT01170039|7370443|FG000|Overall Study|Withdrawal by Subject|5
4544897|NCT01170039|7370444|FG001|Overall Study|Withdrawal by Subject|3
4544898|NCT01170039|7370443|FG000|Overall Study|Lack of funding, drug not available|3
4544899|NCT01170039|7370444|FG001|Overall Study|Lack of funding, drug not available|3
4544900|NCT01170065|7370453|FG000|Overall Study|Adverse Event|17
4544901|NCT01170065|7370454|FG001|Overall Study|Adverse Event|50
4544902|NCT01170065|7370455|FG002|Overall Study|Adverse Event|10
4544903|NCT01170065|7370453|FG000|Overall Study|Lost to Follow-up|1
4544904|NCT01170065|7370454|FG001|Overall Study|Lost to Follow-up|4
4544905|NCT01170065|7370455|FG002|Overall Study|Lost to Follow-up|1
4544906|NCT01170065|7370453|FG000|Overall Study|Consent withdrawn, not due to AE|2
4544907|NCT01170065|7370454|FG001|Overall Study|Consent withdrawn, not due to AE|4
4544908|NCT01170065|7370455|FG002|Overall Study|Consent withdrawn, not due to AE|2
4544909|NCT01170065|7370453|FG000|Overall Study|Reason other than specified|3
4544910|NCT01170065|7370454|FG001|Overall Study|Reason other than specified|8
4544911|NCT01170065|7370455|FG002|Overall Study|Reason other than specified|3
4544912|NCT01170065|7370453|FG000|Overall Study|Ongoing after planned observation time|5
4544913|NCT01170065|7370454|FG001|Overall Study|Ongoing after planned observation time|26
4544914|NCT01170065|7370455|FG002|Overall Study|Ongoing after planned observation time|10
4544915|NCT01170091|7370463|FG000|Overall Study|Missing efficacy evaluation|3
4544916|NCT01170091|7370463|FG000|Overall Study|Treatment duration is less than 4 weeks|21
4544917|NCT01170208|7370479|FG000|Overall Study|Withdrawal by Subject|5
4544918|NCT01170208|7370480|FG001|Overall Study|Withdrawal by Subject|0
4544919|NCT01170208|7370481|FG002|Overall Study|Withdrawal by Subject|1
4544920|NCT01170208|7370479|FG000|Overall Study|Protocol Violation|1
4544921|NCT01170208|7370480|FG001|Overall Study|Protocol Violation|0
4544922|NCT01170208|7370481|FG002|Overall Study|Protocol Violation|1
4544923|NCT01170221|7370494|FG000|Overall Study|Lost to Follow-up|22
4544924|NCT01170221|7370495|FG001|Overall Study|Lost to Follow-up|21
4544925|NCT01170221|7370494|FG000|Overall Study|Withdrawal by Subject|9
4544926|NCT01170221|7370495|FG001|Overall Study|Withdrawal by Subject|7
4544927|NCT01170221|7370494|FG000|Overall Study|Subject completed only screening and LFU|1
4544928|NCT01170221|7370495|FG001|Overall Study|Subject completed only screening and LFU|0
4544929|NCT01170221|7370494|FG000|Overall Study|Randomized but not treated|1
4544930|NCT01170221|7370495|FG001|Overall Study|Randomized but not treated|0
4544931|NCT01170273|7370512|FG000|Overall Study|Lost to Follow-up|6
4544932|NCT01170273|7370513|FG001|Overall Study|Lost to Follow-up|8
4544933|NCT01170273|7370512|FG000|Overall Study|Protocol Violation|1
4544934|NCT01170273|7370513|FG001|Overall Study|Protocol Violation|0
4544935|NCT01170273|7370512|FG000|Overall Study|Death|1
4544936|NCT01170273|7370513|FG001|Overall Study|Death|0
4544937|NCT01170273|7370512|FG000|Overall Study|Adverse Event|0
4544938|NCT01170273|7370513|FG001|Overall Study|Adverse Event|1
4544939|NCT01170364|7370521|FG000|Overall Study|Protocol Violation|4
4544940|NCT01170364|7370522|FG001|Overall Study|Protocol Violation|1
4544941|NCT01170598|7370568|FG000|Overall Study|Withdrawal by Subject|1
4544942|NCT01170598|7370568|FG000|Overall Study|Death|3
4544943|NCT01170598|7370568|FG000|Overall Study|Lost to Follow-up|1
4544944|NCT01170598|7370568|FG000|Overall Study|Refused|1
4544945|NCT01170663|7370574|FG000|Overall Study|Lost to Follow-up|3
4544946|NCT01170663|7370575|FG001|Overall Study|Lost to Follow-up|9
4544947|NCT01170663|7370574|FG000|Overall Study|Withdrawal of consent without follow-up|11
4544948|NCT01170663|7370575|FG001|Overall Study|Withdrawal of consent without follow-up|11
4544949|NCT01170962|7370617|FG000|Treatment Period|Lack of Efficacy|96
4544950|NCT01170962|7370618|FG001|Treatment Period|Lack of Efficacy|91
4544951|NCT01170962|7370619|FG002|Treatment Period|Lack of Efficacy|7
4544952|NCT01170962|7370617|FG000|Treatment Period|Adverse Event|11
4544953|NCT01170962|7370618|FG001|Treatment Period|Adverse Event|12
4544954|NCT01170962|7370619|FG002|Treatment Period|Adverse Event|3
4544955|NCT01170962|7370617|FG000|Treatment Period|Withdrawal by Subject|2
4544956|NCT01170962|7370618|FG001|Treatment Period|Withdrawal by Subject|1
4544957|NCT01170962|7370619|FG002|Treatment Period|Withdrawal by Subject|0
4544958|NCT01170962|7370617|FG000|Treatment Period|Lost to Follow-up|1
4544959|NCT01170962|7370618|FG001|Treatment Period|Lost to Follow-up|1
4544960|NCT01170962|7370619|FG002|Treatment Period|Lost to Follow-up|1
4544961|NCT01170962|7370617|FG000|Treatment Period|Participant no longer meets criteria|0
4544962|NCT01170962|7370618|FG001|Treatment Period|Participant no longer meets criteria|1
4544963|NCT01170962|7370619|FG002|Treatment Period|Participant no longer meets criteria|0
4544964|NCT01170962|7370617|FG000|Treatment Period|Request to discontinue treatment|7
4544965|NCT01170962|7370618|FG001|Treatment Period|Request to discontinue treatment|3
4544966|NCT01170962|7370619|FG002|Treatment Period|Request to discontinue treatment|1
4544967|NCT01170962|7370617|FG000|Treatment Period|Completed 24 Week treatment period only|10
4544968|NCT01170962|7370618|FG001|Treatment Period|Completed 24 Week treatment period only|2
4544969|NCT01170962|7370619|FG002|Treatment Period|Completed 24 Week treatment period only|0
4544970|NCT01170962|7370617|FG000|Follow up Period|Withdrawal by Subject|14
4544971|NCT01170962|7370618|FG001|Follow up Period|Withdrawal by Subject|10
4544972|NCT01170962|7370619|FG002|Follow up Period|Withdrawal by Subject|2
4544973|NCT01170962|7370617|FG000|Follow up Period|Lost to Follow-up|13
4544974|NCT01170962|7370618|FG001|Follow up Period|Lost to Follow-up|8
4544975|NCT01170962|7370619|FG002|Follow up Period|Lost to Follow-up|1
4544976|NCT01170962|7370617|FG000|Follow up Period|Death|2
4544977|NCT01170962|7370618|FG001|Follow up Period|Death|2
4544978|NCT01170962|7370619|FG002|Follow up Period|Death|0
4544979|NCT01170962|7370617|FG000|Follow up Period|Others|10
4544980|NCT01170962|7370618|FG001|Follow up Period|Others|7
4544981|NCT01170962|7370619|FG002|Follow up Period|Others|3
4544982|NCT01171183|7370648|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2
4544983|NCT01171183|7370649|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2
4544984|NCT01171183|7370648|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0
4544985|NCT01171183|7370649|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1
4544986|NCT01171183|7370648|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0
4544987|NCT01171183|7370649|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3
4544988|NCT01171183|7370648|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2
4544989|NCT01171183|7370649|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2
4544990|NCT01171183|7370648|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7
4544991|NCT01171183|7370649|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3
4544992|NCT01171183|7370648|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1
4544993|NCT01171183|7370649|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0
4544994|NCT01171521|7370655|FG000|Overall Study|Lost to Follow-up|5
4544995|NCT01171521|7370655|FG000|Overall Study|screen failure|1
4544996|NCT01171612|7370659|FG000|Overall Study|Lost to Follow-up|51
4544997|NCT01171625|7370666|FG000|Overall Study|On-Protocol|67
4544998|NCT01171625|7370666|FG000|Overall Study|Death|38
4544999|NCT01171625|7370666|FG000|Overall Study|Withdrawal by Subject|31
4545000|NCT01171625|7370666|FG000|Overall Study|Explanted|10
4545001|NCT01171625|7370666|FG000|Overall Study|Lost to Follow-up|5
4545002|NCT01171625|7370666|FG000|Overall Study|Patient received valve-in-valve|3
4545003|NCT01171625|7370666|FG000|Overall Study|Other|1
4545004|NCT01171625|7370666|FG000|Overall Study|Consented but did not receive device|25
4545005|NCT01171677|7370680|FG000|Overall Study|Withdrawal by Subject|0
4545006|NCT01171677|7370681|FG001|Overall Study|Withdrawal by Subject|3
4545007|NCT01171677|7370680|FG000|Overall Study|Adverse Event|1
4545008|NCT01171677|7370681|FG001|Overall Study|Adverse Event|0
4545009|NCT01171677|7370680|FG000|Overall Study|completed <70% IntenSati classes|5
4545010|NCT01171677|7370681|FG001|Overall Study|completed <70% IntenSati classes|0
4545011|NCT01171820|7370707|FG000|Overall Study|Death|3
4545012|NCT01171820|7370708|FG001|Overall Study|Death|3
4545013|NCT01171820|7370707|FG000|Overall Study|Lost to Follow-up|0
4545014|NCT01171820|7370708|FG001|Overall Study|Lost to Follow-up|1
4545015|NCT01171820|7370707|FG000|Overall Study|Withdrawal by Subject|2
4545016|NCT01171820|7370708|FG001|Overall Study|Withdrawal by Subject|0
4545017|NCT01171820|7370707|FG000|Overall Study|Physician Decision|0
4545018|NCT01171820|7370708|FG001|Overall Study|Physician Decision|1
4545019|NCT01171820|7370707|FG000|Overall Study|1-Year Missed Visit|1
4545020|NCT01171820|7370708|FG001|Overall Study|1-Year Missed Visit|1
4545021|NCT01171963|7370725|FG000|Overall Study|Adverse Event|10
4545022|NCT01171963|7370726|FG001|Overall Study|Adverse Event|15
4545023|NCT01171963|7370725|FG000|Overall Study|Lost to Follow-up|23
4545024|NCT01171963|7370726|FG001|Overall Study|Lost to Follow-up|24
4545025|NCT01171963|7370725|FG000|Overall Study|Other - diarrhoea|1
4545026|NCT01171963|7370726|FG001|Overall Study|Other - diarrhoea|0
4545027|NCT01171963|7370725|FG000|Overall Study|Withdrawal by Subject|114
4545028|NCT01171963|7370726|FG001|Overall Study|Withdrawal by Subject|129
4545029|NCT01171976|7370738|FG000|Overall Study|Protocol Violation|0
4545030|NCT01171976|7370739|FG001|Overall Study|Protocol Violation|0
4545031|NCT01171976|7370740|FG002|Overall Study|Protocol Violation|1
4545032|NCT01171976|7370738|FG000|Overall Study|Death|2
4618135|NCT01756833|7478375|FG001|Overall Study|Withdrawal by Subject|3
4618136|NCT01756846|7478383|FG000|Overall Study|Lost to Follow-up|5
4618137|NCT01756846|7478384|FG001|Overall Study|Lost to Follow-up|10
4618138|NCT01756846|7478383|FG000|Overall Study|Withdrawal by Subject|1
4618139|NCT01756846|7478384|FG001|Overall Study|Withdrawal by Subject|2
4618140|NCT01756898|7478403|FG000|Overall Study|Adverse Event|7
4618141|NCT01756898|7478404|FG001|Overall Study|Adverse Event|1
4618142|NCT01756898|7478405|FG002|Overall Study|Adverse Event|0
4618143|NCT01756898|7478406|FG003|Overall Study|Adverse Event|0
4618144|NCT01756898|7478403|FG000|Overall Study|Lack of Efficacy|4
4618145|NCT01756898|7478404|FG001|Overall Study|Lack of Efficacy|7
4618146|NCT01756898|7478405|FG002|Overall Study|Lack of Efficacy|6
4618147|NCT01756898|7478406|FG003|Overall Study|Lack of Efficacy|6
4618148|NCT01756898|7478403|FG000|Overall Study|Lost to Follow-up|2
4618149|NCT01756898|7478404|FG001|Overall Study|Lost to Follow-up|4
4618150|NCT01756898|7478405|FG002|Overall Study|Lost to Follow-up|2
4618151|NCT01756898|7478406|FG003|Overall Study|Lost to Follow-up|3
4618152|NCT01756898|7478403|FG000|Overall Study|Protocol Violation|1
4618153|NCT01756898|7478404|FG001|Overall Study|Protocol Violation|2
4545033|NCT01171976|7370739|FG001|Overall Study|Death|4
4545034|NCT01171976|7370740|FG002|Overall Study|Death|1
4545035|NCT01171976|7370738|FG000|Overall Study|Lost to Follow-up|4
4618154|NCT01756898|7478405|FG002|Overall Study|Protocol Violation|2
4618155|NCT01756898|7478406|FG003|Overall Study|Protocol Violation|1
4618156|NCT01756898|7478403|FG000|Overall Study|Withdrew Consent|5
4618157|NCT01756898|7478404|FG001|Overall Study|Withdrew Consent|3
4618158|NCT01756898|7478405|FG002|Overall Study|Withdrew Consent|5
4618159|NCT01756898|7478406|FG003|Overall Study|Withdrew Consent|6
4618160|NCT01756898|7478403|FG000|Overall Study|Other|0
4618161|NCT01756898|7478404|FG001|Overall Study|Other|2
4618162|NCT01756898|7478405|FG002|Overall Study|Other|2
4618163|NCT01756898|7478406|FG003|Overall Study|Other|0
4618164|NCT01757171|7478439|FG000|Overall Study|Adverse Event|5
4618165|NCT01757171|7478440|FG001|Overall Study|Adverse Event|1
4618166|NCT01757171|7478439|FG000|Overall Study|Disease Progression|1
4618167|NCT01757171|7478440|FG001|Overall Study|Disease Progression|0
4618168|NCT01757171|7478439|FG000|Overall Study|Hospitalization|1
4618169|NCT01757171|7478440|FG001|Overall Study|Hospitalization|0
4618170|NCT01757171|7478439|FG000|Overall Study|ECOG decline|1
4545036|NCT01171976|7370739|FG001|Overall Study|Lost to Follow-up|0
4545037|NCT01171976|7370740|FG002|Overall Study|Lost to Follow-up|2
4545038|NCT01171976|7370738|FG000|Overall Study|Withdrawal by Subject|1
4545039|NCT01171976|7370739|FG001|Overall Study|Withdrawal by Subject|5
4545040|NCT01171976|7370740|FG002|Overall Study|Withdrawal by Subject|6
4545041|NCT01171976|7370738|FG000|Overall Study|Abnormal test result|1
4545042|NCT01171976|7370739|FG001|Overall Study|Abnormal test result|0
4545043|NCT01171976|7370740|FG002|Overall Study|Abnormal test result|0
4545044|NCT01171976|7370738|FG000|Overall Study|Adverse Event|6
4545045|NCT01171976|7370739|FG001|Overall Study|Adverse Event|2
4545046|NCT01171976|7370740|FG002|Overall Study|Adverse Event|5
4545047|NCT01171989|7370751|FG000|Overall Study|Lost to Follow-up|0
4545048|NCT01171989|7370752|FG001|Overall Study|Lost to Follow-up|0
4545049|NCT01171989|7370753|FG002|Overall Study|Lost to Follow-up|1
4545050|NCT01172275|7370794|FG000|Overall Study|Lost to Follow-up|1
4545051|NCT01172275|7370795|FG001|Overall Study|Lost to Follow-up|0
4545052|NCT01172275|7370794|FG000|Overall Study|Protocol Violation|1
4545053|NCT01172275|7370795|FG001|Overall Study|Protocol Violation|0
4545054|NCT01172288|7370803|FG000|Overall Study|Adverse Event|1
4545055|NCT01172288|7370804|FG001|Overall Study|Adverse Event|0
4545056|NCT01172288|7370803|FG000|Overall Study|Protocol Violation|0
4545057|NCT01172288|7370804|FG001|Overall Study|Protocol Violation|1
4545058|NCT01172535|7370838|FG000|Overall Study|Death|3
4545059|NCT01172535|7370838|FG000|Overall Study|Withdrawal by Subject|2
4545060|NCT01172535|7370838|FG000|Overall Study|Lost to Follow-up|1
4545061|NCT01172535|7370838|FG000|Overall Study|Ineligible at study entry|1
4545062|NCT01172535|7370838|FG000|Overall Study|Unwilling to adhere to study requirement|1
4545063|NCT01172639|7370859|FG000|Overall Study|Death|1
4545064|NCT01172639|7370860|FG001|Overall Study|Death|1
4545065|NCT01172639|7370861|FG002|Overall Study|Death|0
4545066|NCT01172639|7370862|FG003|Overall Study|Death|0
4545067|NCT01172639|7370863|FG004|Overall Study|Death|0
4545068|NCT01172639|7370859|FG000|Overall Study|Lost to Follow-up|9
4545069|NCT01172639|7370860|FG001|Overall Study|Lost to Follow-up|7
4545070|NCT01172639|7370861|FG002|Overall Study|Lost to Follow-up|11
4545071|NCT01172639|7370862|FG003|Overall Study|Lost to Follow-up|6
4545072|NCT01172639|7370863|FG004|Overall Study|Lost to Follow-up|6
4545073|NCT01172639|7370859|FG000|Overall Study|Withdrawal by Subject|3
4545074|NCT01172639|7370860|FG001|Overall Study|Withdrawal by Subject|3
4545075|NCT01172639|7370861|FG002|Overall Study|Withdrawal by Subject|5
4545076|NCT01172639|7370862|FG003|Overall Study|Withdrawal by Subject|5
4545077|NCT01172639|7370863|FG004|Overall Study|Withdrawal by Subject|0
4545078|NCT01172808|7370879|FG000|Overall Study|Adverse Event|8
4545079|NCT01172808|7370880|FG001|Overall Study|Adverse Event|4
4545080|NCT01172808|7370881|FG002|Overall Study|Adverse Event|8
4545081|NCT01172808|7370882|FG003|Overall Study|Adverse Event|3
4545082|NCT01172808|7370879|FG000|Overall Study|Lack of Efficacy|1
4545083|NCT01172808|7370880|FG001|Overall Study|Lack of Efficacy|0
4545084|NCT01172808|7370881|FG002|Overall Study|Lack of Efficacy|0
4545085|NCT01172808|7370882|FG003|Overall Study|Lack of Efficacy|0
4545086|NCT01172808|7370879|FG000|Overall Study|Protocol Violation|2
4545087|NCT01172808|7370880|FG001|Overall Study|Protocol Violation|2
4545088|NCT01172808|7370881|FG002|Overall Study|Protocol Violation|2
4545089|NCT01172808|7370882|FG003|Overall Study|Protocol Violation|0
4545090|NCT01172808|7370879|FG000|Overall Study|Lost to Follow-up|0
4545091|NCT01172808|7370880|FG001|Overall Study|Lost to Follow-up|1
4545092|NCT01172808|7370881|FG002|Overall Study|Lost to Follow-up|1
4545093|NCT01172808|7370882|FG003|Overall Study|Lost to Follow-up|3
4545094|NCT01172808|7370879|FG000|Overall Study|Withdrawal by Subject|4
4545095|NCT01172808|7370880|FG001|Overall Study|Withdrawal by Subject|1
4545096|NCT01172808|7370881|FG002|Overall Study|Withdrawal by Subject|3
4545097|NCT01172808|7370882|FG003|Overall Study|Withdrawal by Subject|2
4545098|NCT01172808|7370879|FG000|Overall Study|Other|6
4545099|NCT01172808|7370880|FG001|Overall Study|Other|5
4545100|NCT01172808|7370881|FG002|Overall Study|Other|9
4545101|NCT01172808|7370882|FG003|Overall Study|Other|7
4545102|NCT01172821|7370896|FG000|Overall Study|Adverse Event|5
4545103|NCT01172821|7370897|FG001|Overall Study|Adverse Event|2
4545104|NCT01172821|7370898|FG002|Overall Study|Adverse Event|2
4545105|NCT01172821|7370899|FG003|Overall Study|Adverse Event|7
4545106|NCT01172821|7370896|FG000|Overall Study|Protocol Violation|0
4545107|NCT01172821|7370897|FG001|Overall Study|Protocol Violation|2
4618171|NCT01757171|7478440|FG001|Overall Study|ECOG decline|0
4618172|NCT01757184|7478448|FG000|Double-blind Period|Adverse Event|1
4618173|NCT01757184|7478449|FG001|Double-blind Period|Adverse Event|0
4618174|NCT01757184|7478450|FG002|Double-blind Period|Adverse Event|0
4618175|NCT01757184|7478451|FG003|Double-blind Period|Adverse Event|0
4618176|NCT01757184|7478448|FG000|Open-label Period|Lost to Follow-up|0
4618177|NCT01757184|7478449|FG001|Open-label Period|Lost to Follow-up|0
4618178|NCT01757184|7478450|FG002|Open-label Period|Lost to Follow-up|2
4618179|NCT01757184|7478451|FG003|Open-label Period|Lost to Follow-up|0
4618180|NCT01757184|7478448|FG000|Open-label Period|Withdrawal by Subject|0
4618181|NCT01757184|7478449|FG001|Open-label Period|Withdrawal by Subject|0
4618182|NCT01757184|7478450|FG002|Open-label Period|Withdrawal by Subject|1
4618183|NCT01757184|7478451|FG003|Open-label Period|Withdrawal by Subject|1
4618184|NCT01757184|7478448|FG000|Open-label Period|Discontinued by Sponsor|0
4618185|NCT01757184|7478449|FG001|Open-label Period|Discontinued by Sponsor|0
4618186|NCT01757184|7478450|FG002|Open-label Period|Discontinued by Sponsor|1
4545108|NCT01172821|7370898|FG002|Overall Study|Protocol Violation|1
4545109|NCT01172821|7370899|FG003|Overall Study|Protocol Violation|2
4545110|NCT01172821|7370896|FG000|Overall Study|Lost to Follow-up|4
4545111|NCT01172821|7370897|FG001|Overall Study|Lost to Follow-up|1
4545112|NCT01172821|7370898|FG002|Overall Study|Lost to Follow-up|2
4545113|NCT01172821|7370899|FG003|Overall Study|Lost to Follow-up|2
4545114|NCT01172821|7370896|FG000|Overall Study|Withdrawal by Subject|2
4545115|NCT01172821|7370897|FG001|Overall Study|Withdrawal by Subject|3
4545116|NCT01172821|7370898|FG002|Overall Study|Withdrawal by Subject|3
4545117|NCT01172821|7370899|FG003|Overall Study|Withdrawal by Subject|3
4545118|NCT01172821|7370896|FG000|Overall Study|Other|3
4545119|NCT01172821|7370897|FG001|Overall Study|Other|4
4545120|NCT01172821|7370898|FG002|Overall Study|Other|5
4545121|NCT01172821|7370899|FG003|Overall Study|Other|3
4545122|NCT01172847|7370909|FG000|Overall Study|Withdrawal by Subject|3
4545123|NCT01172873|7370921|FG000|Overall Study|Withdrawal by Subject|3
4545124|NCT01172873|7370922|FG001|Overall Study|Withdrawal by Subject|2
4545125|NCT01172938|7370931|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11
4545126|NCT01172938|7370932|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8
4545127|NCT01172938|7370933|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10
4545128|NCT01172938|7370934|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
4545129|NCT01172938|7370935|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
4545130|NCT01172938|7370936|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
4545131|NCT01172938|7370937|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
4545132|NCT01172938|7370938|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
4545133|NCT01172938|7370939|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
4545134|NCT01172938|7370931|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4
4545135|NCT01172938|7370932|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5
4545136|NCT01172938|7370933|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4
4545137|NCT01172938|7370934|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
4545138|NCT01172938|7370935|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
4545139|NCT01172938|7370936|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
4545140|NCT01172938|7370937|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
4545141|NCT01172938|7370938|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
4545142|NCT01172938|7370939|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
4545143|NCT01172938|7370931|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
4545144|NCT01172938|7370932|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1
4545145|NCT01172938|7370933|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2
4545146|NCT01172938|7370934|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
4545147|NCT01172938|7370935|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
4545148|NCT01172938|7370936|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
4545149|NCT01172938|7370937|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
4545150|NCT01172938|7370938|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
4545151|NCT01172938|7370939|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
4545152|NCT01172938|7370931|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2
4545153|NCT01172938|7370932|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5
4545154|NCT01172938|7370933|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3
4545155|NCT01172938|7370934|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
4545156|NCT01172938|7370935|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
4545157|NCT01172938|7370936|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
4545158|NCT01172938|7370937|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
4545159|NCT01172938|7370938|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
4545160|NCT01172938|7370939|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
4545161|NCT01172938|7370931|FG000|Placebo-controlled Phase (Week 0-24)|Death|0
4545162|NCT01172938|7370932|FG001|Placebo-controlled Phase (Week 0-24)|Death|1
4545163|NCT01172938|7370933|FG002|Placebo-controlled Phase (Week 0-24)|Death|0
4618187|NCT01757184|7478451|FG003|Open-label Period|Discontinued by Sponsor|2
4618188|NCT01757197|7478465|FG000|Overall Study|Death|2
4618189|NCT01757275|7478471|FG000|Overall Study|Lost to Follow-up|1
4618190|NCT01757275|7478472|FG001|Overall Study|Lost to Follow-up|2
4545164|NCT01172938|7370934|FG003|Placebo-controlled Phase (Week 0-24)|Death|0
4545165|NCT01172938|7370935|FG004|Placebo-controlled Phase (Week 0-24)|Death|0
4545166|NCT01172938|7370936|FG005|Placebo-controlled Phase (Week 0-24)|Death|0
4545167|NCT01172938|7370937|FG006|Placebo-controlled Phase (Week 0-24)|Death|0
4545168|NCT01172938|7370938|FG007|Placebo-controlled Phase (Week 0-24)|Death|0
4545169|NCT01172938|7370939|FG008|Placebo-controlled Phase (Week 0-24)|Death|0
4545170|NCT01172938|7370931|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1
4545171|NCT01172938|7370932|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
4545172|NCT01172938|7370933|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
4545173|NCT01172938|7370934|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
4545174|NCT01172938|7370935|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
4545175|NCT01172938|7370936|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
4545176|NCT01172938|7370937|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
4545177|NCT01172938|7370938|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
4545178|NCT01172938|7370939|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
4545179|NCT01172938|7370931|FG000|Placebo-controlled Phase (Week 0-24)|Other|0
4545180|NCT01172938|7370932|FG001|Placebo-controlled Phase (Week 0-24)|Other|2
4545181|NCT01172938|7370933|FG002|Placebo-controlled Phase (Week 0-24)|Other|1
4545182|NCT01172938|7370934|FG003|Placebo-controlled Phase (Week 0-24)|Other|0
4545183|NCT01172938|7370935|FG004|Placebo-controlled Phase (Week 0-24)|Other|0
4545184|NCT01172938|7370936|FG005|Placebo-controlled Phase (Week 0-24)|Other|0
4545185|NCT01172938|7370937|FG006|Placebo-controlled Phase (Week 0-24)|Other|0
4545186|NCT01172938|7370938|FG007|Placebo-controlled Phase (Week 0-24)|Other|0
4545187|NCT01172938|7370939|FG008|Placebo-controlled Phase (Week 0-24)|Other|0
4545188|NCT01172938|7370931|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
4545189|NCT01172938|7370932|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2
4545190|NCT01172938|7370933|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5
4545191|NCT01172938|7370934|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1
4545192|NCT01172938|7370935|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1
4545193|NCT01172938|7370936|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2
4545194|NCT01172938|7370937|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
4545195|NCT01172938|7370938|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
4545196|NCT01172938|7370939|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
4545197|NCT01172938|7370931|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
4618191|NCT01757275|7478471|FG000|Overall Study|Adverse Event|3
4618192|NCT01757275|7478472|FG001|Overall Study|Adverse Event|3
4618193|NCT01757275|7478471|FG000|Overall Study|Withdrawal by Subject|2
4618194|NCT01757275|7478472|FG001|Overall Study|Withdrawal by Subject|4
4618195|NCT01757275|7478471|FG000|Overall Study|Not treated|3
4618196|NCT01757275|7478472|FG001|Overall Study|Not treated|4
4618197|NCT01757288|7478481|FG000|Overall Study|Consent withdrawal|0
4618198|NCT01757288|7478482|FG001|Overall Study|Consent withdrawal|4
4545198|NCT01172938|7370932|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4
4545199|NCT01172938|7370933|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7
4545200|NCT01172938|7370934|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3
4545201|NCT01172938|7370935|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1
4545202|NCT01172938|7370936|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3
4545203|NCT01172938|7370937|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
4545204|NCT01172938|7370938|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
4545205|NCT01172938|7370939|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
4545206|NCT01172938|7370931|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
4545207|NCT01172938|7370932|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
4545208|NCT01172938|7370933|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1
4545209|NCT01172938|7370934|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
4545210|NCT01172938|7370935|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
4545211|NCT01172938|7370936|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
4545212|NCT01172938|7370937|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
4545213|NCT01172938|7370938|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
4545214|NCT01172938|7370939|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
4545215|NCT01172938|7370931|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
4545216|NCT01172938|7370932|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5
4545217|NCT01172938|7370933|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1
4618199|NCT01757288|7478483|FG002|Overall Study|Consent withdrawal|4
4618200|NCT01757288|7478481|FG000|Overall Study|Patient off study, IRB hold.|0
4618201|NCT01757288|7478482|FG001|Overall Study|Patient off study, IRB hold.|0
4618202|NCT01757288|7478483|FG002|Overall Study|Patient off study, IRB hold.|1
4618203|NCT01757288|7478481|FG000|Overall Study|Patient death prior to starting treatment|0
4618204|NCT01757288|7478482|FG001|Overall Study|Patient death prior to starting treatment|0
4618205|NCT01757288|7478483|FG002|Overall Study|Patient death prior to starting treatment|1
4618206|NCT01757288|7478481|FG000|Overall Study|Wrong medication administered|0
4618207|NCT01757288|7478482|FG001|Overall Study|Wrong medication administered|1
4545218|NCT01172938|7370934|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2
4545219|NCT01172938|7370935|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2
4545220|NCT01172938|7370936|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9
4545221|NCT01172938|7370937|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1
4545222|NCT01172938|7370938|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
4545223|NCT01172938|7370939|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
4545224|NCT01172938|7370931|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
4545225|NCT01172938|7370932|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
4545226|NCT01172938|7370933|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
4545227|NCT01172938|7370934|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
4545228|NCT01172938|7370935|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
4545229|NCT01172938|7370936|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
4545230|NCT01172938|7370937|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
4545231|NCT01172938|7370938|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
4545232|NCT01172938|7370939|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
4545233|NCT01172938|7370931|FG000|Active Treatment Phase (Weeks 25-52)|Other|0
4545234|NCT01172938|7370932|FG001|Active Treatment Phase (Weeks 25-52)|Other|0
4545235|NCT01172938|7370933|FG002|Active Treatment Phase (Weeks 25-52)|Other|0
4545236|NCT01172938|7370934|FG003|Active Treatment Phase (Weeks 25-52)|Other|0
4545237|NCT01172938|7370935|FG004|Active Treatment Phase (Weeks 25-52)|Other|0
4545238|NCT01172938|7370936|FG005|Active Treatment Phase (Weeks 25-52)|Other|1
4545239|NCT01172938|7370937|FG006|Active Treatment Phase (Weeks 25-52)|Other|1
4545240|NCT01172938|7370938|FG007|Active Treatment Phase (Weeks 25-52)|Other|0
4545241|NCT01172938|7370939|FG008|Active Treatment Phase (Weeks 25-52)|Other|0
4545242|NCT01172938|7370931|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
4545243|NCT01172938|7370932|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2
4545244|NCT01172938|7370933|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1
4545245|NCT01172938|7370934|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
4545246|NCT01172938|7370935|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
4545247|NCT01172938|7370936|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
4545248|NCT01172938|7370937|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
4545249|NCT01172938|7370938|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3
4545250|NCT01172938|7370939|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1
4545251|NCT01172938|7370931|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
4545252|NCT01172938|7370932|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7
4545253|NCT01172938|7370933|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8
4545254|NCT01172938|7370934|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
4545255|NCT01172938|7370935|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
4545256|NCT01172938|7370936|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
4545257|NCT01172938|7370937|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
4545258|NCT01172938|7370938|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4
4545259|NCT01172938|7370939|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
4545260|NCT01172938|7370931|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
4545261|NCT01172938|7370932|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
4545262|NCT01172938|7370933|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2
4545263|NCT01172938|7370934|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
4545264|NCT01172938|7370935|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
4545265|NCT01172938|7370936|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
4545266|NCT01172938|7370937|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
4545267|NCT01172938|7370938|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
4545268|NCT01172938|7370939|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
4545269|NCT01172938|7370931|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
4545270|NCT01172938|7370932|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10
4545271|NCT01172938|7370933|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8
4545272|NCT01172938|7370934|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
4545273|NCT01172938|7370935|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
4545274|NCT01172938|7370936|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
4545275|NCT01172938|7370937|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
4545276|NCT01172938|7370938|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5
4545277|NCT01172938|7370939|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2
4545278|NCT01172938|7370931|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0
4545279|NCT01172938|7370932|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0
4545280|NCT01172938|7370933|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1
4545281|NCT01172938|7370934|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0
4545282|NCT01172938|7370935|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0
4545283|NCT01172938|7370936|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0
4545284|NCT01172938|7370937|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0
4545285|NCT01172938|7370938|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0
4545286|NCT01172938|7370939|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0
4545287|NCT01172938|7370931|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
4545288|NCT01172938|7370932|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1
4545289|NCT01172938|7370933|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1
4545290|NCT01172938|7370934|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
4545291|NCT01172938|7370935|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
4545292|NCT01172938|7370936|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
4545293|NCT01172938|7370937|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
4545294|NCT01172938|7370938|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3
4545295|NCT01172938|7370939|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
4545296|NCT01172938|7370931|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
4545297|NCT01172938|7370932|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2
4545298|NCT01172938|7370933|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
4545299|NCT01172938|7370934|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
4545300|NCT01172938|7370935|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
4545301|NCT01172938|7370936|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
4545302|NCT01172938|7370937|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
4545303|NCT01172938|7370938|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
4545304|NCT01172938|7370939|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1
4545305|NCT01172938|7370931|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0
4545306|NCT01172938|7370932|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1
4545307|NCT01172938|7370933|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0
4545308|NCT01172938|7370934|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0
4545309|NCT01172938|7370935|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0
4545310|NCT01172938|7370936|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0
4545311|NCT01172938|7370937|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0
4545312|NCT01172938|7370938|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0
4545313|NCT01172938|7370939|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0
4545314|NCT01172938|7370931|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
4545315|NCT01172938|7370932|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
4545316|NCT01172938|7370933|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
4545317|NCT01172938|7370934|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
4545318|NCT01172938|7370935|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
4545319|NCT01172938|7370936|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
4545320|NCT01172938|7370937|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
4545321|NCT01172938|7370938|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
4545322|NCT01172938|7370939|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1
4545323|NCT01172938|7370931|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
4545324|NCT01172938|7370932|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4
4545325|NCT01172938|7370933|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
4545326|NCT01172938|7370934|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
4545327|NCT01172938|7370935|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
4545328|NCT01172938|7370936|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
4545329|NCT01172938|7370937|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
4545330|NCT01172938|7370938|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
4545331|NCT01172938|7370939|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
4545332|NCT01172938|7370931|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
4545333|NCT01172938|7370932|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6
4545334|NCT01172938|7370933|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3
4545335|NCT01172938|7370934|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
4545336|NCT01172938|7370935|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
4545337|NCT01172938|7370936|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
4545338|NCT01172938|7370937|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
4545339|NCT01172938|7370938|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2
4545340|NCT01172938|7370939|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1
4545341|NCT01172938|7370931|FG000|Active-Treatment Phase Weeks (104-156)|Death|0
4545342|NCT01172938|7370932|FG001|Active-Treatment Phase Weeks (104-156)|Death|0
4545343|NCT01172938|7370933|FG002|Active-Treatment Phase Weeks (104-156)|Death|0
4545344|NCT01172938|7370934|FG003|Active-Treatment Phase Weeks (104-156)|Death|0
4545345|NCT01172938|7370935|FG004|Active-Treatment Phase Weeks (104-156)|Death|0
4545346|NCT01172938|7370936|FG005|Active-Treatment Phase Weeks (104-156)|Death|0
4545347|NCT01172938|7370937|FG006|Active-Treatment Phase Weeks (104-156)|Death|0
4545348|NCT01172938|7370938|FG007|Active-Treatment Phase Weeks (104-156)|Death|1
4545349|NCT01172938|7370939|FG008|Active-Treatment Phase Weeks (104-156)|Death|0
4545350|NCT01172938|7370931|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
4545351|NCT01172938|7370932|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1
4545352|NCT01172938|7370933|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
4545353|NCT01172938|7370934|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
4545354|NCT01172938|7370935|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
4545355|NCT01172938|7370936|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
4545356|NCT01172938|7370937|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
4545357|NCT01172938|7370938|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
4545358|NCT01172938|7370939|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
4545359|NCT01172938|7370931|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
4545360|NCT01172938|7370932|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
4545361|NCT01172938|7370933|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2
4545362|NCT01172938|7370934|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
4545363|NCT01172938|7370935|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
4545364|NCT01172938|7370936|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
4545365|NCT01172938|7370937|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
4545366|NCT01172938|7370938|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
4545367|NCT01172938|7370939|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
4545368|NCT01172938|7370931|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
4545369|NCT01172938|7370932|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4
4545370|NCT01172938|7370933|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1
4545371|NCT01172938|7370934|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
4545372|NCT01172938|7370935|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
4545373|NCT01172938|7370936|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
4545374|NCT01172938|7370937|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
4545375|NCT01172938|7370938|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3
4545376|NCT01172938|7370939|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
4545377|NCT01172938|7370931|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
4545378|NCT01172938|7370932|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1
4545379|NCT01172938|7370933|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1
4545380|NCT01172938|7370934|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
4545381|NCT01172938|7370935|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
4545382|NCT01172938|7370936|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
4545383|NCT01172938|7370937|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
4545384|NCT01172938|7370938|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3
4545385|NCT01172938|7370939|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2
4545386|NCT01172938|7370931|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
4545387|NCT01172938|7370932|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4
4545388|NCT01172938|7370933|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2
4545389|NCT01172938|7370934|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
4545390|NCT01172938|7370935|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
4545391|NCT01172938|7370936|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
4545392|NCT01172938|7370937|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
4545393|NCT01172938|7370938|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2
4545394|NCT01172938|7370939|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4
4545395|NCT01172938|7370931|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
4545396|NCT01172938|7370932|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
4545397|NCT01172938|7370933|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1
4545398|NCT01172938|7370934|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
4545399|NCT01172938|7370935|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
4545400|NCT01172938|7370936|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
4545401|NCT01172938|7370937|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
4545402|NCT01172938|7370938|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
4545403|NCT01172938|7370939|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1
4545404|NCT01172938|7370931|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
4545405|NCT01172938|7370932|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
4545406|NCT01172938|7370933|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
4545407|NCT01172938|7370934|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
4545408|NCT01172938|7370935|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
4545409|NCT01172938|7370936|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
4545410|NCT01172938|7370937|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
4545411|NCT01172938|7370938|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1
4545412|NCT01172938|7370939|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
4545413|NCT01172938|7370931|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
4545414|NCT01172938|7370932|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
4545415|NCT01172938|7370933|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
4545416|NCT01172938|7370934|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
4545417|NCT01172938|7370935|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
4545418|NCT01172938|7370936|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
4545419|NCT01172938|7370937|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
4545420|NCT01172938|7370938|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
4545421|NCT01172938|7370939|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
4545422|NCT01172938|7370931|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
4545423|NCT01172938|7370932|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
4545424|NCT01172938|7370933|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2
4545425|NCT01172938|7370934|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
4545426|NCT01172938|7370935|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
4545427|NCT01172938|7370936|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
4545428|NCT01172938|7370937|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
4545429|NCT01172938|7370938|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
4545430|NCT01172938|7370939|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
4545431|NCT01172938|7370931|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
4545432|NCT01172938|7370932|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1
4545433|NCT01172938|7370933|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
4545434|NCT01172938|7370934|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
4545435|NCT01172938|7370935|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
4545436|NCT01172938|7370936|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
4545437|NCT01172938|7370937|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
4545438|NCT01172938|7370938|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1
4545439|NCT01172938|7370939|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
4545440|NCT01172938|7370931|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
4545441|NCT01172938|7370932|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2
4545442|NCT01172938|7370933|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3
4545443|NCT01172938|7370934|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
4545444|NCT01172938|7370935|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
4545445|NCT01172938|7370936|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
4545446|NCT01172938|7370937|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
4545447|NCT01172938|7370938|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1
4545448|NCT01172938|7370939|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
4545449|NCT01172938|7370931|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0
4545450|NCT01172938|7370932|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0
4545451|NCT01172938|7370933|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1
4545452|NCT01172938|7370934|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0
4545453|NCT01172938|7370935|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0
4545454|NCT01172938|7370936|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0
4545455|NCT01172938|7370937|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0
4545456|NCT01172938|7370938|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0
4545457|NCT01172938|7370939|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0
4545458|NCT01172938|7370931|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
4545459|NCT01172938|7370932|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
4545460|NCT01172938|7370933|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1
4545461|NCT01172938|7370934|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
4545462|NCT01172938|7370935|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
4545463|NCT01172938|7370936|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
4545464|NCT01172938|7370937|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
4545465|NCT01172938|7370938|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
4545466|NCT01172938|7370939|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
4545467|NCT01172938|7370931|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
4545468|NCT01172938|7370932|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
4545469|NCT01172938|7370933|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
4545470|NCT01172938|7370934|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
4545471|NCT01172938|7370935|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
4545472|NCT01172938|7370936|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
4545473|NCT01172938|7370937|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
4545474|NCT01172938|7370938|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
4545475|NCT01172938|7370939|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1
4545476|NCT01173055|7370981|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2
4545477|NCT01173055|7370982|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2
4545478|NCT01173055|7370981|FG000|Period 2 - Day 64 to 112|Adverse Event|0
4545479|NCT01173055|7370982|FG001|Period 2 - Day 64 to 112|Adverse Event|1
4545480|NCT01173120|7370988|FG000|Overall Study|Lack of Efficacy|2
4545481|NCT01173120|7370988|FG000|Overall Study|Lost to Follow-up|1
4545482|NCT01173120|7370988|FG000|Overall Study|Participant Decision|2
4545483|NCT01173120|7370988|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33
4545484|NCT01173120|7370988|FG000|Overall Study|Switch-Participant Decision|12
4545485|NCT01173120|7370988|FG000|Overall Study|Switch-Difficulty With Device|12
4545486|NCT01173471|7371027|FG000|Overall Study|Eligibility criteria not fulfilled|0
4545487|NCT01173471|7371028|FG001|Overall Study|Eligibility criteria not fulfilled|0
4618208|NCT01757288|7478483|FG002|Overall Study|Wrong medication administered|0
4618209|NCT01757288|7478481|FG000|Overall Study|Liver metastasis identified at CT simulation|0
4618210|NCT01757288|7478482|FG001|Overall Study|Liver metastasis identified at CT simulation|1
4632974|NCT01906008|7502778|FG001|Overall Study|Lost to Follow-up|0
4545488|NCT01173471|7371029|FG002|Overall Study|Eligibility criteria not fulfilled|1
4545489|NCT01173471|7371030|FG003|Overall Study|Eligibility criteria not fulfilled|1
4591470|NCT01529645|7437977|FG005|Overall Study|Withdrawal by Subject|1
4545490|NCT01173471|7371027|FG000|Overall Study|Condition under investigation worsened|2
4545491|NCT01173471|7371028|FG001|Overall Study|Condition under investigation worsened|0
4545492|NCT01173471|7371029|FG002|Overall Study|Condition under investigation worsened|0
4545493|NCT01173471|7371030|FG003|Overall Study|Condition under investigation worsened|0
4545494|NCT01173471|7371027|FG000|Overall Study|Lost to Follow-up|0
4545495|NCT01173471|7371028|FG001|Overall Study|Lost to Follow-up|0
4545496|NCT01173471|7371029|FG002|Overall Study|Lost to Follow-up|1
4545497|NCT01173471|7371030|FG003|Overall Study|Lost to Follow-up|0
4545498|NCT01173471|7371027|FG000|Overall Study|Reason given as Other|0
4545499|NCT01173471|7371028|FG001|Overall Study|Reason given as Other|0
4545500|NCT01173471|7371029|FG002|Overall Study|Reason given as Other|1
4545501|NCT01173471|7371030|FG003|Overall Study|Reason given as Other|0
4545502|NCT01173523|7371042|FG000|Overall Study|Clinical Progression|1
4545503|NCT01173523|7371043|FG001|Overall Study|Clinical Progression|1
4545504|NCT01173523|7371042|FG000|Overall Study|Progressive Disease|10
4545505|NCT01173523|7371043|FG001|Overall Study|Progressive Disease|8
4545506|NCT01173523|7371042|FG000|Overall Study|Other|2
4545507|NCT01173523|7371043|FG001|Overall Study|Other|3
4545508|NCT01173601|7371053|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23
4545509|NCT01173601|7371054|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
4545510|NCT01173601|7371055|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
4545511|NCT01173601|7371056|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
4545512|NCT01173601|7371057|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
4545513|NCT01173601|7371053|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9
4545514|NCT01173601|7371054|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
4545515|NCT01173601|7371055|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
4545516|NCT01173601|7371056|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
4545517|NCT01173601|7371057|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
4545518|NCT01173601|7371053|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7
4545519|NCT01173601|7371054|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
4545520|NCT01173601|7371055|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
4545521|NCT01173601|7371056|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
4545522|NCT01173601|7371057|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
4545523|NCT01173601|7371053|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3
4545524|NCT01173601|7371054|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
4545525|NCT01173601|7371055|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
4545526|NCT01173601|7371056|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
4545527|NCT01173601|7371057|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
4545528|NCT01173601|7371053|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15
4545529|NCT01173601|7371054|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
4545530|NCT01173601|7371055|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
4545531|NCT01173601|7371056|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
4545532|NCT01173601|7371057|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
4545533|NCT01173601|7371053|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25
4545534|NCT01173601|7371054|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
4545535|NCT01173601|7371055|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
4545536|NCT01173601|7371056|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
4545537|NCT01173601|7371057|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
4545538|NCT01173601|7371053|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6
4545539|NCT01173601|7371054|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
4545540|NCT01173601|7371055|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
4545541|NCT01173601|7371056|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
4545542|NCT01173601|7371057|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
4545543|NCT01173601|7371053|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
4545544|NCT01173601|7371054|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10
4545545|NCT01173601|7371055|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15
4545546|NCT01173601|7371056|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7
4545547|NCT01173601|7371057|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14
4545548|NCT01173601|7371053|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
4545549|NCT01173601|7371054|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10
4545550|NCT01173601|7371055|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6
4545551|NCT01173601|7371056|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8
4545552|NCT01173601|7371057|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9
4545553|NCT01173601|7371053|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
4545554|NCT01173601|7371054|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3
4545555|NCT01173601|7371055|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
4545556|NCT01173601|7371056|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2
4545557|NCT01173601|7371057|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9
4545558|NCT01173601|7371053|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
4545559|NCT01173601|7371054|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
4545560|NCT01173601|7371055|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
4545561|NCT01173601|7371056|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
4591471|NCT01529645|7437978|FG006|Overall Study|Withdrawal by Subject|0
4545562|NCT01173601|7371057|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
4545563|NCT01173601|7371053|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
4545564|NCT01173601|7371054|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1
4545565|NCT01173601|7371055|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
4545566|NCT01173601|7371056|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4
4545567|NCT01173601|7371057|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
4545568|NCT01173601|7371053|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
4545569|NCT01173601|7371054|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
4545570|NCT01173601|7371055|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7
4545571|NCT01173601|7371056|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5
4545572|NCT01173601|7371057|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24
4545573|NCT01173601|7371053|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
4545574|NCT01173601|7371054|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
4545575|NCT01173601|7371055|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
4618211|NCT01757288|7478483|FG002|Overall Study|Liver metastasis identified at CT simulation|0
4618212|NCT01757288|7478481|FG000|Overall Study|Not meeting protocol constraints|0
4618213|NCT01757288|7478482|FG001|Overall Study|Not meeting protocol constraints|1
4618214|NCT01757288|7478483|FG002|Overall Study|Not meeting protocol constraints|1
4618215|NCT01757288|7478481|FG000|Overall Study|Multiple missed appointments|0
4618216|NCT01757288|7478482|FG001|Overall Study|Multiple missed appointments|1
4618217|NCT01757288|7478483|FG002|Overall Study|Multiple missed appointments|0
4618218|NCT01757288|7478481|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0
4618219|NCT01757288|7478482|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0
4618220|NCT01757288|7478483|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1
4618221|NCT01757288|7478481|FG000|Overall Study|>2 weeks treatment break|0
4618222|NCT01757288|7478482|FG001|Overall Study|>2 weeks treatment break|0
4618223|NCT01757288|7478483|FG002|Overall Study|>2 weeks treatment break|1
4618224|NCT01757392|7478503|FG000|Overall Study|Withdrawal by Subject|1
4618225|NCT01757392|7478503|FG000|Overall Study|Screen Fail|3
4618226|NCT01757405|7478509|FG000|Overall Study|Lost to Follow-up|1
4618227|NCT01757405|7478510|FG001|Overall Study|Lost to Follow-up|1
4618228|NCT01757405|7478509|FG000|Overall Study|Withdrawal by Subject|0
4618229|NCT01757405|7478510|FG001|Overall Study|Withdrawal by Subject|1
4618230|NCT01757691|7478541|FG000|Overall Study|Administrative problems|2
4618231|NCT01757691|7478542|FG001|Overall Study|Administrative problems|0
4618232|NCT01757704|7478550|FG000|Overall Study|Protocol Violation|1
4618233|NCT01757704|7478551|FG001|Overall Study|Protocol Violation|3
4618234|NCT01757821|7478561|FG000|Overall Study|Adverse Event|1
4618235|NCT01757847|7478571|FG000|Overall Study|Withdrawal by Subject|3
4618236|NCT01757847|7478572|FG001|Overall Study|Withdrawal by Subject|4
4618237|NCT01758289|7478585|FG000|Overall Study|Premature Study Termination|44
4618238|NCT01758289|7478585|FG000|Overall Study|Adverse Event|9
4618239|NCT01758523|7478624|FG000|Overall Study|Adverse Event|2
4618240|NCT01758523|7478625|FG001|Overall Study|Adverse Event|1
4618241|NCT01758523|7478624|FG000|Overall Study|Lack of Efficacy|4
4618242|NCT01758523|7478625|FG001|Overall Study|Lack of Efficacy|2
4618243|NCT01758523|7478624|FG000|Overall Study|Lost to Follow-up|3
4618244|NCT01758523|7478625|FG001|Overall Study|Lost to Follow-up|4
4618245|NCT01758523|7478624|FG000|Overall Study|Withdrawal by Subject|12
4618246|NCT01758523|7478625|FG001|Overall Study|Withdrawal by Subject|7
4618247|NCT01758731|7478646|FG000|Overall Study|Physician Decision|1
4618248|NCT01758900|7478652|FG000|Overall Study|difficulty for further intubation|7
4618249|NCT01758900|7478653|FG001|Overall Study|difficulty for further intubation|8
4618250|NCT01759264|7478672|FG000|Overall Study|Serious Adverse Events (SAEs)|1
4618251|NCT01759264|7478672|FG000|Overall Study|Adverse Event|1
4618252|NCT01759264|7478672|FG000|Overall Study|Other|2
4618253|NCT01759264|7478672|FG000|Overall Study|Lost to Follow-up|2
4618254|NCT01759264|7478672|FG000|Overall Study|Withdrawal by Subject|3
4618255|NCT01759264|7478672|FG000|Overall Study|Discontinued Humira Due to Business Trip|1
4618256|NCT01759290|7478688|FG000|Overall Study|Subjects withdrawn consent|5
4618257|NCT01759290|7478688|FG000|Overall Study|Physician Decision|2
4618258|NCT01759290|7478688|FG000|Overall Study|Death|17
4618259|NCT01759290|7478688|FG000|Overall Study|Lost to Follow-up|53
4618260|NCT01759290|7478688|FG000|Overall Study|Unknown reason|4
4618261|NCT01759368|7478694|FG000|Overall Study|Lost to Follow-up|1
4618262|NCT01759368|7478695|FG001|Overall Study|Lost to Follow-up|0
4618263|NCT01759381|7478705|FG000|Overall Study|Death|1
4618264|NCT01759381|7478706|FG001|Overall Study|Death|0
4618265|NCT01759407|7478714|FG000|Overall Study|Protocol Violation|0
4618266|NCT01759407|7478715|FG001|Overall Study|Protocol Violation|2
4618267|NCT01759420|7478721|FG000|Overall Study|Screen failure|5
4618268|NCT01759420|7478721|FG000|Overall Study|Inaccurate EKG machine readings|1
4618269|NCT01759446|7478730|FG000|Overall Study|Protocol Violation|1
4618270|NCT01759446|7478731|FG001|Overall Study|Protocol Violation|0
4618271|NCT01759446|7478732|FG002|Overall Study|Protocol Violation|1
4618272|NCT01759446|7478733|FG003|Overall Study|Protocol Violation|0
4618273|NCT01759446|7478734|FG004|Overall Study|Protocol Violation|0
4618274|NCT01759446|7478730|FG000|Overall Study|Withdrawal by Subject|0
4618275|NCT01759446|7478731|FG001|Overall Study|Withdrawal by Subject|1
4545576|NCT01173601|7371056|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
4545577|NCT01173601|7371057|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6
4545578|NCT01173653|7371077|FG000|Overall Study|Pts unwilling to provide follow-up|53
4545579|NCT01173653|7371078|FG001|Overall Study|Pts unwilling to provide follow-up|41
4545580|NCT01173679|7371084|FG000|Overall Study|Death|1
4545581|NCT01173692|7371091|FG000|Overall Study|Adverse Event|1
4545582|NCT01173692|7371092|FG001|Overall Study|Adverse Event|2
4545583|NCT01173692|7371091|FG000|Overall Study|Withdrawal by Subject|1
4545584|NCT01173692|7371092|FG001|Overall Study|Withdrawal by Subject|3
4545585|NCT01173718|7371098|FG000|Overall Study|Death|17
4545586|NCT01173718|7371098|FG000|Overall Study|Abandonment of study graft|27
4545587|NCT01174004|7371121|FG000|Overall Study|Adverse Event|2
4545588|NCT01174004|7371122|FG001|Overall Study|Adverse Event|10
4545589|NCT01174004|7371121|FG000|Overall Study|Withdrawal by Subject|2
4545590|NCT01174004|7371122|FG001|Overall Study|Withdrawal by Subject|3
4545591|NCT01174004|7371121|FG000|Overall Study|At Discretion of Sponsor|2
4545592|NCT01174004|7371122|FG001|Overall Study|At Discretion of Sponsor|2
4545593|NCT01174004|7371121|FG000|Overall Study|Protocol Violation|0
4545594|NCT01174004|7371122|FG001|Overall Study|Protocol Violation|1
4545595|NCT01174004|7371121|FG000|Overall Study|Physician Decision|1
4545596|NCT01174004|7371122|FG001|Overall Study|Physician Decision|0
4545597|NCT01174043|7371149|FG000|Overall Study|Disease progression|5
4545598|NCT01174043|7371149|FG000|Overall Study|Adverse Event|3
4545599|NCT01174043|7371149|FG000|Overall Study|Death|1
4545600|NCT01174043|7371149|FG000|Overall Study|Withdrawal by Subject|2
4545601|NCT01174160|7371164|FG000|Overall Study|Adverse Event|1
4545602|NCT01174160|7371165|FG001|Overall Study|Adverse Event|0
4545603|NCT01174160|7371164|FG000|Overall Study|Lost to Follow-up|1
4545604|NCT01174160|7371165|FG001|Overall Study|Lost to Follow-up|0
4545605|NCT01174160|7371164|FG000|Overall Study|Physician Decision|1
4618276|NCT01759446|7478732|FG002|Overall Study|Withdrawal by Subject|0
4545606|NCT01174160|7371165|FG001|Overall Study|Physician Decision|0
4545607|NCT01174160|7371164|FG000|Overall Study|Protocol Violation|4
4545608|NCT01174160|7371165|FG001|Overall Study|Protocol Violation|6
4545609|NCT01174160|7371164|FG000|Overall Study|Withdrawal by Subject|1
4545610|NCT01174160|7371165|FG001|Overall Study|Withdrawal by Subject|0
4545611|NCT01174173|7371171|FG000|Overall Study|drug-drug interaction|1
4545612|NCT01174186|7371178|FG000|Overall Study|Lost to Follow-up|0
4545613|NCT01174186|7371179|FG001|Overall Study|Lost to Follow-up|1
4545614|NCT01174186|7371178|FG000|Overall Study|Withdrawal by Subject|0
4545615|NCT01174186|7371179|FG001|Overall Study|Withdrawal by Subject|2
4545616|NCT01174238|7371185|FG000|Overall Study|Lost to Follow-up|2
4545617|NCT01174264|7371195|FG000|Single Dose Pharmacokinetics|Early progressive disease|1
4545618|NCT01174264|7371196|FG001|Single Dose Pharmacokinetics|Early progressive disease|0
4545619|NCT01174264|7371197|FG002|Single Dose Pharmacokinetics|Early progressive disease|1
4545620|NCT01174264|7371195|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0
4545621|NCT01174264|7371196|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0
4545622|NCT01174264|7371197|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1
4545623|NCT01174264|7371195|FG000|Steady-state Pharmacokinetics|Not evaluable|6
4545624|NCT01174264|7371196|FG001|Steady-state Pharmacokinetics|Not evaluable|0
4545625|NCT01174264|7371197|FG002|Steady-state Pharmacokinetics|Not evaluable|2
4545626|NCT01174342|7371205|FG000|Overall Study|Conversion to cesarean section|4
4545627|NCT01174446|7371209|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
4545628|NCT01174446|7371210|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
4545629|NCT01174446|7371211|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1
4545630|NCT01174446|7371212|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
4545631|NCT01174446|7371209|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
4545632|NCT01174446|7371210|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
4545633|NCT01174446|7371211|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1
4545634|NCT01174446|7371212|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
4545635|NCT01174446|7371209|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1
4545636|NCT01174446|7371210|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
4545637|NCT01174446|7371211|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
4545638|NCT01174446|7371212|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
4545639|NCT01174446|7371209|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
4545640|NCT01174446|7371210|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1
4545641|NCT01174446|7371211|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
4545642|NCT01174446|7371212|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
4545643|NCT01174459|7371259|FG000|Overall Study|case report form (CRF) not collected|5
4545644|NCT01174550|7371265|FG000|Overall Study|Death|75
4545645|NCT01174550|7371266|FG001|Overall Study|Death|74
4545646|NCT01174550|7371265|FG000|Overall Study|Lost to Follow-up|652
4545647|NCT01174550|7371266|FG001|Overall Study|Lost to Follow-up|510
4545648|NCT01174550|7371265|FG000|Overall Study|Withdrawal by Subject|543
4545649|NCT01174550|7371266|FG001|Overall Study|Withdrawal by Subject|289
4545650|NCT01174784|7371285|FG000|Overall Study|Screen fails|4
4545651|NCT01175018|7371306|FG000|Overall Study|Adverse Event|3
4618277|NCT01759446|7478733|FG003|Overall Study|Withdrawal by Subject|1
4545652|NCT01175018|7371307|FG001|Overall Study|Adverse Event|1
4545653|NCT01175083|7371329|FG000|Primary Epoch|Withdrawal by Subject|0
4545654|NCT01175083|7371330|FG001|Primary Epoch|Withdrawal by Subject|0
4545655|NCT01175083|7371331|FG002|Primary Epoch|Withdrawal by Subject|0
4545656|NCT01175083|7371332|FG003|Primary Epoch|Withdrawal by Subject|0
4545657|NCT01175083|7371333|FG004|Primary Epoch|Withdrawal by Subject|0
4545658|NCT01175083|7371334|FG005|Primary Epoch|Withdrawal by Subject|2
4545659|NCT01175083|7371329|FG000|Primary Epoch|Lost to Follow-up|0
4545660|NCT01175083|7371330|FG001|Primary Epoch|Lost to Follow-up|0
4545661|NCT01175083|7371331|FG002|Primary Epoch|Lost to Follow-up|0
4545662|NCT01175083|7371332|FG003|Primary Epoch|Lost to Follow-up|0
4545663|NCT01175083|7371333|FG004|Primary Epoch|Lost to Follow-up|0
4545664|NCT01175083|7371334|FG005|Primary Epoch|Lost to Follow-up|1
4545665|NCT01175083|7371329|FG000|Booster Epoch|Death|0
4545666|NCT01175083|7371330|FG001|Booster Epoch|Death|0
4545667|NCT01175083|7371331|FG002|Booster Epoch|Death|1
4545668|NCT01175083|7371332|FG003|Booster Epoch|Death|0
4545669|NCT01175083|7371333|FG004|Booster Epoch|Death|0
4545670|NCT01175083|7371334|FG005|Booster Epoch|Death|0
4545671|NCT01175083|7371329|FG000|Booster Epoch|Withdrawal by Subject|0
4545672|NCT01175083|7371330|FG001|Booster Epoch|Withdrawal by Subject|0
4545673|NCT01175083|7371331|FG002|Booster Epoch|Withdrawal by Subject|0
4545674|NCT01175083|7371332|FG003|Booster Epoch|Withdrawal by Subject|1
4545675|NCT01175083|7371333|FG004|Booster Epoch|Withdrawal by Subject|0
4545676|NCT01175083|7371334|FG005|Booster Epoch|Withdrawal by Subject|0
4545677|NCT01175135|7371356|FG000|Overall Study|Adverse Event|2
4545678|NCT01175135|7371357|FG001|Overall Study|Adverse Event|5
4545679|NCT01175135|7371358|FG002|Overall Study|Adverse Event|3
4545680|NCT01175135|7371359|FG003|Overall Study|Adverse Event|4
4545681|NCT01175135|7371356|FG000|Overall Study|Death|1
4545682|NCT01175135|7371357|FG001|Overall Study|Death|0
4545683|NCT01175135|7371358|FG002|Overall Study|Death|0
4545684|NCT01175135|7371359|FG003|Overall Study|Death|0
4545685|NCT01175135|7371356|FG000|Overall Study|Lack of Efficacy|4
4545686|NCT01175135|7371357|FG001|Overall Study|Lack of Efficacy|5
4545687|NCT01175135|7371358|FG002|Overall Study|Lack of Efficacy|0
4545688|NCT01175135|7371359|FG003|Overall Study|Lack of Efficacy|5
4545689|NCT01175135|7371356|FG000|Overall Study|Lost to Follow-up|1
4545690|NCT01175135|7371357|FG001|Overall Study|Lost to Follow-up|2
4545691|NCT01175135|7371358|FG002|Overall Study|Lost to Follow-up|0
4545692|NCT01175135|7371359|FG003|Overall Study|Lost to Follow-up|0
4545693|NCT01175135|7371356|FG000|Overall Study|Protocol Violation|1
4545694|NCT01175135|7371357|FG001|Overall Study|Protocol Violation|1
4545695|NCT01175135|7371358|FG002|Overall Study|Protocol Violation|0
4545696|NCT01175135|7371359|FG003|Overall Study|Protocol Violation|0
4545697|NCT01175135|7371356|FG000|Overall Study|Withdrawal by Subject|4
4545698|NCT01175135|7371357|FG001|Overall Study|Withdrawal by Subject|8
4545699|NCT01175135|7371358|FG002|Overall Study|Withdrawal by Subject|5
4545700|NCT01175135|7371359|FG003|Overall Study|Withdrawal by Subject|5
4545701|NCT01175135|7371356|FG000|Overall Study|Other|3
4545702|NCT01175135|7371357|FG001|Overall Study|Other|1
4545703|NCT01175135|7371358|FG002|Overall Study|Other|3
4545704|NCT01175135|7371359|FG003|Overall Study|Other|0
4545705|NCT01175135|7371356|FG000|Overall Study|Randomized But Not Treated|0
4545706|NCT01175135|7371357|FG001|Overall Study|Randomized But Not Treated|0
4545707|NCT01175135|7371358|FG002|Overall Study|Randomized But Not Treated|1
4545708|NCT01175135|7371359|FG003|Overall Study|Randomized But Not Treated|0
4545709|NCT01175213|7371381|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4
4545710|NCT01175213|7371382|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0
4545711|NCT01175213|7371381|FG000|IGSC, 10%/rHuPH20|Death|1
4545712|NCT01175213|7371382|FG001|IGSC, 10%/rHuPH20|Death|0
4545713|NCT01175213|7371381|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1
4545714|NCT01175213|7371382|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0
4545715|NCT01175213|7371381|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6
4545716|NCT01175213|7371382|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0
4545717|NCT01175213|7371381|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3
4545718|NCT01175213|7371382|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0
4545719|NCT01175213|7371381|FG000|Safety Follow-up|Adverse Event|1
4545720|NCT01175213|7371382|FG001|Safety Follow-up|Adverse Event|0
4545721|NCT01175382|7371425|FG000|Overall Study|Lost to Follow-up|4
4545722|NCT01175382|7371426|FG001|Overall Study|Lost to Follow-up|3
4545723|NCT01175382|7371427|FG002|Overall Study|Lost to Follow-up|1
4545724|NCT01175382|7371425|FG000|Overall Study|Physician Decision|0
4545725|NCT01175382|7371426|FG001|Overall Study|Physician Decision|1
4545726|NCT01175382|7371427|FG002|Overall Study|Physician Decision|0
4545727|NCT01175382|7371425|FG000|Overall Study|Withdrawal by Subject|0
4545728|NCT01175382|7371426|FG001|Overall Study|Withdrawal by Subject|0
4545729|NCT01175382|7371427|FG002|Overall Study|Withdrawal by Subject|1
4545730|NCT01175382|7371425|FG000|Overall Study|No longer having problem|1
4545731|NCT01175382|7371426|FG001|Overall Study|No longer having problem|0
4545732|NCT01175382|7371427|FG002|Overall Study|No longer having problem|1
4545733|NCT01175382|7371425|FG000|Overall Study|Unable/unwilling to attend visits|3
4545734|NCT01175382|7371426|FG001|Overall Study|Unable/unwilling to attend visits|1
4545735|NCT01175382|7371427|FG002|Overall Study|Unable/unwilling to attend visits|2
4545736|NCT01175382|7371425|FG000|Overall Study|Unwilling to follow protocol|0
4545737|NCT01175382|7371426|FG001|Overall Study|Unwilling to follow protocol|1
4545738|NCT01175382|7371427|FG002|Overall Study|Unwilling to follow protocol|0
4545739|NCT01175382|7371425|FG000|Overall Study|Unable to tolerate study meds|0
4545740|NCT01175382|7371426|FG001|Overall Study|Unable to tolerate study meds|1
4545741|NCT01175382|7371427|FG002|Overall Study|Unable to tolerate study meds|1
4545742|NCT01175473|7371450|FG000|Overall Study|Adverse Event|2
4545743|NCT01175473|7371451|FG001|Overall Study|Adverse Event|2
4545744|NCT01175590|7371459|FG000|Overall Study|Lost to Follow-up|1
4545745|NCT01175590|7371460|FG001|Overall Study|Lost to Follow-up|0
4545746|NCT01175590|7371459|FG000|Overall Study|Withdrawal by Subject|0
4545747|NCT01175590|7371460|FG001|Overall Study|Withdrawal by Subject|2
4545748|NCT01175590|7371459|FG000|Overall Study|Adverse Event|4
4545749|NCT01175590|7371460|FG001|Overall Study|Adverse Event|0
4545750|NCT01175590|7371459|FG000|Overall Study|Physician Decision|1
4545751|NCT01175590|7371460|FG001|Overall Study|Physician Decision|4
4545752|NCT01175590|7371459|FG000|Overall Study|Lack of Efficacy|1
4545753|NCT01175590|7371460|FG001|Overall Study|Lack of Efficacy|1
4545754|NCT01175590|7371459|FG000|Overall Study|Residual Bacterial Conjunctivitis|1
4545755|NCT01175590|7371460|FG001|Overall Study|Residual Bacterial Conjunctivitis|0
4545756|NCT01175590|7371459|FG000|Overall Study|Treated not as randomized|3
4545757|NCT01175590|7371460|FG001|Overall Study|Treated not as randomized|2
4545758|NCT01175590|7371459|FG000|Overall Study|Herpes Simplex Dermatitis|1
4545759|NCT01175590|7371460|FG001|Overall Study|Herpes Simplex Dermatitis|0
4545760|NCT01175590|7371459|FG000|Overall Study|Protocol Violation|0
4545761|NCT01175590|7371460|FG001|Overall Study|Protocol Violation|1
4545762|NCT01175668|7371469|FG000|Overall Study|Withdrawal by Subject|2
4545763|NCT01175668|7371470|FG001|Overall Study|Withdrawal by Subject|0
4545764|NCT01175707|7371478|FG000|Overall Study|Adverse Event|4
4545765|NCT01175707|7371479|FG001|Overall Study|Adverse Event|6
4591472|NCT01529645|7437979|FG007|Overall Study|Withdrawal by Subject|0
4591473|NCT01529645|7437980|FG008|Overall Study|Withdrawal by Subject|0
4591474|NCT01529645|7437981|FG009|Overall Study|Withdrawal by Subject|0
4591475|NCT01529749|7438015|FG000|Overall Study|Lost to Follow-up|0
4591476|NCT01529749|7438016|FG001|Overall Study|Lost to Follow-up|1
4591477|NCT01529749|7438017|FG002|Overall Study|Lost to Follow-up|1
4591478|NCT01529749|7438018|FG003|Overall Study|Lost to Follow-up|0
4591479|NCT01529749|7438015|FG000|Overall Study|Physician Decision|0
4591480|NCT01529749|7438016|FG001|Overall Study|Physician Decision|0
4591481|NCT01529749|7438017|FG002|Overall Study|Physician Decision|0
4591482|NCT01529749|7438018|FG003|Overall Study|Physician Decision|1
4591483|NCT01529749|7438015|FG000|Overall Study|Withdrawal by Subject|0
4591484|NCT01529749|7438016|FG001|Overall Study|Withdrawal by Subject|1
4591485|NCT01529749|7438017|FG002|Overall Study|Withdrawal by Subject|1
4591486|NCT01529749|7438018|FG003|Overall Study|Withdrawal by Subject|0
4591487|NCT01529749|7438015|FG000|Overall Study|Protocol Violation|0
4591488|NCT01529749|7438016|FG001|Overall Study|Protocol Violation|0
4591489|NCT01529749|7438017|FG002|Overall Study|Protocol Violation|0
4591490|NCT01529749|7438018|FG003|Overall Study|Protocol Violation|1
4591491|NCT01530256|7438063|FG000|Overall Study|Death|2
4591492|NCT01530334|7438067|FG000|Overall Study|Adverse Event|3
4591493|NCT01530334|7438067|FG000|Overall Study|unknown reason|1
4591494|NCT01530334|7438067|FG000|Overall Study|Progressive disease|47
4591495|NCT01530464|7438098|FG000|Washout (24h)|Withdrawal by Subject|1
4591496|NCT01530464|7438099|FG001|Washout (24h)|Withdrawal by Subject|0
4591497|NCT01530464|7438098|FG000|Washout (24h)|Withdrawal by Subject|0
4591498|NCT01530464|7438099|FG001|Washout (24h)|Withdrawal by Subject|1
4591499|NCT01531153|7438124|FG000|Overall Study|Withdrawal by Subject|10
4591500|NCT01531153|7438125|FG001|Overall Study|Withdrawal by Subject|9
4591501|NCT01531153|7438126|FG002|Overall Study|Withdrawal by Subject|15
4591502|NCT01531205|7438137|FG000|Overall Study|Did not proceed to surgery|1
4591503|NCT01531673|7438189|FG000|Overall Study|Non-Compliance|0
4591504|NCT01531673|7438190|FG001|Overall Study|Non-Compliance|0
4591505|NCT01531673|7438191|FG002|Overall Study|Non-Compliance|0
4591506|NCT01531673|7438192|FG003|Overall Study|Non-Compliance|0
4591507|NCT01531673|7438193|FG004|Overall Study|Non-Compliance|0
4591508|NCT01531673|7438194|FG005|Overall Study|Non-Compliance|1
4591509|NCT01531673|7438195|FG006|Overall Study|Non-Compliance|0
4591510|NCT01531673|7438196|FG007|Overall Study|Non-Compliance|0
4591511|NCT01531673|7438197|FG008|Overall Study|Non-Compliance|0
4591512|NCT01531673|7438198|FG009|Overall Study|Non-Compliance|0
4591513|NCT01531673|7438199|FG010|Overall Study|Non-Compliance|0
4591514|NCT01531673|7438200|FG011|Overall Study|Non-Compliance|0
4591515|NCT01531673|7438201|FG012|Overall Study|Non-Compliance|0
4591516|NCT01531673|7438189|FG000|Overall Study|Adverse Event|0
4591517|NCT01531673|7438190|FG001|Overall Study|Adverse Event|1
4591518|NCT01531673|7438191|FG002|Overall Study|Adverse Event|0
4591519|NCT01531673|7438192|FG003|Overall Study|Adverse Event|0
4591520|NCT01531673|7438193|FG004|Overall Study|Adverse Event|0
4591521|NCT01531673|7438194|FG005|Overall Study|Adverse Event|0
4591522|NCT01531673|7438195|FG006|Overall Study|Adverse Event|0
4591523|NCT01531673|7438196|FG007|Overall Study|Adverse Event|0
4591524|NCT01531673|7438197|FG008|Overall Study|Adverse Event|0
4591525|NCT01531673|7438198|FG009|Overall Study|Adverse Event|0
4591526|NCT01531673|7438199|FG010|Overall Study|Adverse Event|0
4591527|NCT01531673|7438200|FG011|Overall Study|Adverse Event|0
4618278|NCT01759446|7478734|FG004|Overall Study|Withdrawal by Subject|0
4618279|NCT01759511|7478746|FG000|Overall Study|Adverse Event|4
4618280|NCT01759511|7478746|FG000|Overall Study|Death|2
4618281|NCT01759511|7478746|FG000|Overall Study|Lack of Efficacy|2
4618282|NCT01759511|7478746|FG000|Overall Study|Physician Decision|1
4545766|NCT01175811|7371497|FG000|Overall Study|Adverse Event|1
4545767|NCT01175811|7371498|FG001|Overall Study|Adverse Event|1
4545768|NCT01175811|7371497|FG000|Overall Study|Entry criteria not met|3
4545769|NCT01175811|7371498|FG001|Overall Study|Entry criteria not met|1
4545770|NCT01175811|7371497|FG000|Overall Study|Lack of Efficacy|1
4545771|NCT01175811|7371498|FG001|Overall Study|Lack of Efficacy|0
4545772|NCT01175811|7371497|FG000|Overall Study|Lost to Follow-up|3
4545773|NCT01175811|7371498|FG001|Overall Study|Lost to Follow-up|2
4545774|NCT01175811|7371497|FG000|Overall Study|Physician Decision|1
4545775|NCT01175811|7371498|FG001|Overall Study|Physician Decision|1
4545776|NCT01175811|7371497|FG000|Overall Study|Protocol Violation|1
4545777|NCT01175811|7371498|FG001|Overall Study|Protocol Violation|2
4545778|NCT01175811|7371497|FG000|Overall Study|Withdrawal by Subject|6
4545779|NCT01175811|7371498|FG001|Overall Study|Withdrawal by Subject|7
4545780|NCT01175824|7371506|FG000|Overall Study|Adverse Event|2
4545781|NCT01175824|7371507|FG001|Overall Study|Adverse Event|1
4545782|NCT01175824|7371506|FG000|Overall Study|Lack of Efficacy|2
4545783|NCT01175824|7371507|FG001|Overall Study|Lack of Efficacy|0
4545784|NCT01175824|7371506|FG000|Overall Study|Lost to Follow-up|0
4545785|NCT01175824|7371507|FG001|Overall Study|Lost to Follow-up|1
4545786|NCT01175824|7371506|FG000|Overall Study|Physician Decision|0
4545787|NCT01175824|7371507|FG001|Overall Study|Physician Decision|4
4545788|NCT01175824|7371506|FG000|Overall Study|Protocol Violation|2
4545789|NCT01175824|7371507|FG001|Overall Study|Protocol Violation|5
4545790|NCT01175824|7371506|FG000|Overall Study|Withdrawal by Subject|3
4545791|NCT01175824|7371507|FG001|Overall Study|Withdrawal by Subject|7
4545792|NCT01175824|7371506|FG000|Overall Study|Sponsor Decision|1
4545793|NCT01175824|7371507|FG001|Overall Study|Sponsor Decision|0
4545794|NCT01175824|7371506|FG000|Overall Study|Entry Criteria Not Met|6
4545795|NCT01175824|7371507|FG001|Overall Study|Entry Criteria Not Met|4
4545796|NCT01176032|7371540|FG000|Overall Study|Adverse Event|1
4545797|NCT01176032|7371541|FG001|Overall Study|Adverse Event|0
4545798|NCT01176032|7371540|FG000|Overall Study|Unsatisfactory therapeutic effect|0
4545799|NCT01176032|7371541|FG001|Overall Study|Unsatisfactory therapeutic effect|1
4545800|NCT01176032|7371540|FG000|Overall Study|Protocol Violation|1
4545801|NCT01176032|7371541|FG001|Overall Study|Protocol Violation|0
4545802|NCT01176032|7371540|FG000|Overall Study|Informed consent withdrawn|3
4545803|NCT01176032|7371541|FG001|Overall Study|Informed consent withdrawn|0
4545804|NCT01176032|7371540|FG000|Overall Study|Other|1
4545805|NCT01176032|7371541|FG001|Overall Study|Other|0
4545806|NCT01176058|7371554|FG000|Overall Study|Adverse Event|1
4545807|NCT01176058|7371555|FG001|Overall Study|Adverse Event|0
4545808|NCT01176058|7371554|FG000|Overall Study|Insufficient clinical response|2
4545809|NCT01176058|7371555|FG001|Overall Study|Insufficient clinical response|2
4545810|NCT01176058|7371554|FG000|Overall Study|Insufficient mycological response|0
4545811|NCT01176058|7371555|FG001|Overall Study|Insufficient mycological response|1
4545812|NCT01176058|7371554|FG000|Overall Study|Withdrawal by Subject|1
4545813|NCT01176058|7371555|FG001|Overall Study|Withdrawal by Subject|0
4545814|NCT01176240|7371565|FG000|Study 306A|Lack of Efficacy|2
4545815|NCT01176240|7371566|FG001|Study 306A|Lack of Efficacy|1
4545816|NCT01176240|7371565|FG000|Study 306A|Protocol Violation|0
4545817|NCT01176240|7371566|FG001|Study 306A|Protocol Violation|1
4545818|NCT01176240|7371565|FG000|Study 306A|Withdrawal by Subject|0
4545819|NCT01176240|7371566|FG001|Study 306A|Withdrawal by Subject|1
4545820|NCT01176240|7371565|FG000|Study 306A|Stop due to diverse problems|1
4545821|NCT01176240|7371566|FG001|Study 306A|Stop due to diverse problems|0
4545822|NCT01176240|7371565|FG000|Study 306B|Lack of Efficacy|5
4545823|NCT01176240|7371566|FG001|Study 306B|Lack of Efficacy|3
4545824|NCT01176240|7371565|FG000|Study 306B|Adverse Event|10
4545825|NCT01176240|7371566|FG001|Study 306B|Adverse Event|5
4545826|NCT01176240|7371565|FG000|Study 306B|Protocol Violation|2
4545827|NCT01176240|7371566|FG001|Study 306B|Protocol Violation|3
4545828|NCT01176240|7371565|FG000|Study 306B|Withdrawal by Subject|4
4545829|NCT01176240|7371566|FG001|Study 306B|Withdrawal by Subject|1
4545830|NCT01176240|7371565|FG000|Study 306B|Physician Decision|2
4545831|NCT01176240|7371566|FG001|Study 306B|Physician Decision|1
4545832|NCT01176240|7371565|FG000|Study 306B|Supine Hypertension|1
4545833|NCT01176240|7371566|FG001|Study 306B|Supine Hypertension|2
4545834|NCT01176240|7371565|FG000|Study 306B|Lost to Follow-up|0
4545835|NCT01176240|7371566|FG001|Study 306B|Lost to Follow-up|1
4545836|NCT01176240|7371565|FG000|Study 306B|withdrew prior to dosing|2
4545837|NCT01176240|7371566|FG001|Study 306B|withdrew prior to dosing|1
4545838|NCT01176266|7371572|FG000|Overall Study|Death|6
4545839|NCT01176266|7371572|FG000|Overall Study|Withdrawal by Subject|3
4545840|NCT01176292|7371582|FG000|Overall Study|Lost to Follow-up|2
4618283|NCT01759511|7478746|FG000|Overall Study|Progressive Disease|5
4545841|NCT01176292|7371583|FG001|Overall Study|Lost to Follow-up|4
4545842|NCT01176292|7371582|FG000|Overall Study|Adverse Event|1
4545843|NCT01176292|7371583|FG001|Overall Study|Adverse Event|1
4618284|NCT01759511|7478746|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4
4618285|NCT01759511|7478746|FG000|Overall Study|Study Terminated by Sponsor|13
4545844|NCT01176292|7371582|FG000|Overall Study|Physician Decision|0
4545845|NCT01176292|7371583|FG001|Overall Study|Physician Decision|2
4545846|NCT01176292|7371582|FG000|Overall Study|Has not scheduled one-year visit yet|2
4545847|NCT01176292|7371583|FG001|Overall Study|Has not scheduled one-year visit yet|2
4545848|NCT01176565|7371612|FG000|Overall Study|Lost to Follow-up|12
4545849|NCT01176565|7371613|FG001|Overall Study|Lost to Follow-up|16
4545850|NCT01176565|7371612|FG000|Overall Study|Withdrawal by Subject|7
4545851|NCT01176565|7371613|FG001|Overall Study|Withdrawal by Subject|1
4545852|NCT01176565|7371612|FG000|Overall Study|Not Analyzed (any other reason)|1
4545853|NCT01176565|7371613|FG001|Overall Study|Not Analyzed (any other reason)|2
4545854|NCT01176773|7371642|FG000|Overall Study|Screen Failure|2
4545855|NCT01176773|7371642|FG000|Overall Study|Withdrew consent|1
4545856|NCT01176916|7371652|FG000|Overall Study|Adverse Event|61
4545857|NCT01176916|7371652|FG000|Overall Study|Death|1
4545858|NCT01176916|7371652|FG000|Overall Study|Lost to Follow-up|15
4545859|NCT01176916|7371652|FG000|Overall Study|Objective progression or relapse|17
4545860|NCT01176916|7371652|FG000|Overall Study|Protocol Violation|24
4545861|NCT01176916|7371652|FG000|Overall Study|Withdrawal by Subject|37
4545862|NCT01176916|7371652|FG000|Overall Study|Other|6
4545863|NCT01176916|7371652|FG000|Overall Study|Withdrawal prior to Treatment|6
4545864|NCT01176968|7371670|FG000|Overall Study|Adverse Event|10
4545865|NCT01176968|7371671|FG001|Overall Study|Adverse Event|11
4545866|NCT01176968|7371670|FG000|Overall Study|Death|2
4545867|NCT01176968|7371671|FG001|Overall Study|Death|3
4545868|NCT01176968|7371670|FG000|Overall Study|Lack of Efficacy|0
4545869|NCT01176968|7371671|FG001|Overall Study|Lack of Efficacy|1
4545870|NCT01176968|7371670|FG000|Overall Study|Lost to Follow-up|16
4545871|NCT01176968|7371671|FG001|Overall Study|Lost to Follow-up|14
4545872|NCT01176968|7371670|FG000|Overall Study|Withdrawal by Subject|48
4545873|NCT01176968|7371671|FG001|Overall Study|Withdrawal by Subject|48
4545874|NCT01176968|7371670|FG000|Overall Study|Protocol Violation|2
4545875|NCT01176968|7371671|FG001|Overall Study|Protocol Violation|1
4545876|NCT01176968|7371670|FG000|Overall Study|Did Not Meet Entrance Criteria|1
4545877|NCT01176968|7371671|FG001|Overall Study|Did Not Meet Entrance Criteria|0
4545878|NCT01176968|7371670|FG000|Overall Study|Study terminated by sponsor|0
4545879|NCT01176968|7371671|FG001|Overall Study|Study terminated by sponsor|1
4545880|NCT01176968|7371670|FG000|Overall Study|Reason not defined|5
4545881|NCT01176968|7371671|FG001|Overall Study|Reason not defined|3
4545882|NCT01177007|7371681|FG000|Overall Study|Lost to Follow-up|2
4545883|NCT01177007|7371681|FG000|Overall Study|Death|4
4545884|NCT01177007|7371681|FG000|Overall Study|Entered hospice care|5
4545885|NCT01177007|7371681|FG000|Overall Study|Required additional Y90 treatment|6
4545886|NCT01177007|7371681|FG000|Overall Study|Change in treatment modality|21
4545887|NCT01177059|7371687|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30
4545888|NCT01177059|7371687|FG000|Overall Study|Withdrew consent|2
4545889|NCT01177059|7371687|FG000|Overall Study|Lost to Follow-up|18
4545890|NCT01177137|7371703|FG000|Overall Study|Withdrawal by Subject|10
4618286|NCT01759511|7478746|FG000|Overall Study|Withdrawal by Subject|3
4618287|NCT01759862|7478756|FG000|Overall Study|Physician Decision|3
4618288|NCT01759862|7478757|FG001|Overall Study|Physician Decision|1
4618289|NCT01759862|7478756|FG000|Overall Study|Adverse Event|0
4618290|NCT01759862|7478757|FG001|Overall Study|Adverse Event|1
4618291|NCT01760447|7478824|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0
4618292|NCT01760447|7478825|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0
4618293|NCT01760447|7478826|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1
4618294|NCT01760447|7478827|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3
4618295|NCT01760447|7478824|FG000|Weeks 0-20|Withdrawal by Subject|2
4618296|NCT01760447|7478825|FG001|Weeks 0-20|Withdrawal by Subject|0
4618297|NCT01760447|7478826|FG002|Weeks 0-20|Withdrawal by Subject|1
4618298|NCT01760447|7478827|FG003|Weeks 0-20|Withdrawal by Subject|0
4618299|NCT01760447|7478824|FG000|Weeks 0-20|Lost to Follow-up|1
4618300|NCT01760447|7478825|FG001|Weeks 0-20|Lost to Follow-up|0
4618301|NCT01760447|7478826|FG002|Weeks 0-20|Lost to Follow-up|1
4618302|NCT01760447|7478827|FG003|Weeks 0-20|Lost to Follow-up|1
4618303|NCT01760447|7478824|FG000|Weeks 0-20|Randomized but not treated|0
4618304|NCT01760447|7478825|FG001|Weeks 0-20|Randomized but not treated|0
4618305|NCT01760447|7478826|FG002|Weeks 0-20|Randomized but not treated|2
4618306|NCT01760447|7478827|FG003|Weeks 0-20|Randomized but not treated|0
4618307|NCT01760447|7478824|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1
4618308|NCT01760447|7478825|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1
4545891|NCT01177137|7371704|FG001|Overall Study|Withdrawal by Subject|10
4545892|NCT01177137|7371705|FG002|Overall Study|Withdrawal by Subject|2
4545893|NCT01177228|7371729|FG000|Overall Study|Positive tuberculosis test|0
4545894|NCT01177228|7371730|FG001|Overall Study|Positive tuberculosis test|1
4545895|NCT01177228|7371731|FG002|Overall Study|Positive tuberculosis test|0
4545896|NCT01177228|7371732|FG003|Overall Study|Positive tuberculosis test|0
4545897|NCT01177228|7371729|FG000|Overall Study|Worsening disease activity|1
4618309|NCT01760447|7478826|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1
4618310|NCT01760447|7478827|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0
4618311|NCT01760447|7478824|FG000|Weeks 20-54|Withdrawal by Subject|2
4618312|NCT01760447|7478825|FG001|Weeks 20-54|Withdrawal by Subject|1
4545898|NCT01177228|7371730|FG001|Overall Study|Worsening disease activity|0
4545899|NCT01177228|7371731|FG002|Overall Study|Worsening disease activity|0
4545900|NCT01177228|7371732|FG003|Overall Study|Worsening disease activity|0
4545901|NCT01177228|7371729|FG000|Overall Study|Withdrawal by Subject|0
4545902|NCT01177228|7371730|FG001|Overall Study|Withdrawal by Subject|1
4545903|NCT01177228|7371731|FG002|Overall Study|Withdrawal by Subject|0
4545904|NCT01177228|7371732|FG003|Overall Study|Withdrawal by Subject|0
4618313|NCT01760447|7478826|FG002|Weeks 20-54|Withdrawal by Subject|1
4618314|NCT01760447|7478827|FG003|Weeks 20-54|Withdrawal by Subject|2
4618315|NCT01760447|7478824|FG000|Weeks 20-54|Lost to Follow-up|0
4618316|NCT01760447|7478825|FG001|Weeks 20-54|Lost to Follow-up|0
4618317|NCT01760447|7478826|FG002|Weeks 20-54|Lost to Follow-up|1
4618318|NCT01760447|7478827|FG003|Weeks 20-54|Lost to Follow-up|2
4618319|NCT01760733|7478855|FG000|Waiting List|Death|18
4618320|NCT01760733|7478855|FG000|Waiting List|Removed from waiting list|41
4618321|NCT01760733|7478855|FG000|Waiting List|Not received a transplant yet|13
4618322|NCT01760733|7478855|FG000|Transplanted|Not reached 10 years post transplant|184
4618323|NCT01760733|7478855|FG000|Transplanted|Death|26
4618324|NCT01760733|7478855|FG000|Transplanted|Graft loss|7
4618325|NCT01760876|7478869|FG000|Overall Study|Non-cardiac death (head injury)|1
4618326|NCT01760876|7478869|FG000|Overall Study|Carcinoma of prostate|1
4618327|NCT01760876|7478869|FG000|Overall Study|Impaired renal function|1
4618328|NCT01760876|7478869|FG000|Overall Study|Major depression|1
4618329|NCT01760876|7478869|FG000|Overall Study|Very poor baseline OCT quality|2
4618330|NCT01760954|7478877|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8
4618331|NCT01760954|7478878|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8
4618332|NCT01760954|7478879|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4
4618333|NCT01760954|7478880|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5
4618334|NCT01760954|7478877|FG000|Treatment Period (6 Months)|Adverse Event|5
4618335|NCT01760954|7478878|FG001|Treatment Period (6 Months)|Adverse Event|3
4618336|NCT01760954|7478879|FG002|Treatment Period (6 Months)|Adverse Event|4
4618337|NCT01760954|7478880|FG003|Treatment Period (6 Months)|Adverse Event|10
4618338|NCT01760954|7478877|FG000|Treatment Period (6 Months)|Lost to Follow-up|9
4618339|NCT01760954|7478878|FG001|Treatment Period (6 Months)|Lost to Follow-up|1
4618340|NCT01760954|7478879|FG002|Treatment Period (6 Months)|Lost to Follow-up|4
4618341|NCT01760954|7478880|FG003|Treatment Period (6 Months)|Lost to Follow-up|3
4618342|NCT01760954|7478877|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3
4618343|NCT01760954|7478878|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3
4618344|NCT01760954|7478879|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3
4618345|NCT01760954|7478880|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2
4618346|NCT01760954|7478877|FG000|Treatment Period (6 Months)|Pregnancy|5
4618347|NCT01760954|7478878|FG001|Treatment Period (6 Months)|Pregnancy|0
4618348|NCT01760954|7478879|FG002|Treatment Period (6 Months)|Pregnancy|3
4618349|NCT01760954|7478880|FG003|Treatment Period (6 Months)|Pregnancy|2
4618350|NCT01760954|7478877|FG000|Treatment Period (6 Months)|Non-compliance|1
4618351|NCT01760954|7478878|FG001|Treatment Period (6 Months)|Non-compliance|4
4618352|NCT01760954|7478879|FG002|Treatment Period (6 Months)|Non-compliance|0
4618353|NCT01760954|7478880|FG003|Treatment Period (6 Months)|Non-compliance|3
4618354|NCT01760954|7478877|FG000|Treatment Period (6 Months)|Other|0
4618355|NCT01760954|7478878|FG001|Treatment Period (6 Months)|Other|3
4618356|NCT01760954|7478879|FG002|Treatment Period (6 Months)|Other|3
4618357|NCT01760954|7478880|FG003|Treatment Period (6 Months)|Other|1
4618358|NCT01760954|7478877|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1
4618359|NCT01760954|7478878|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6
4618360|NCT01760954|7478879|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0
4618361|NCT01760954|7478880|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0
4618362|NCT01760954|7478877|FG000|Treatment Period (6 Months)|Exclusionary Medication|1
4618363|NCT01760954|7478878|FG001|Treatment Period (6 Months)|Exclusionary Medication|0
4618364|NCT01760954|7478879|FG002|Treatment Period (6 Months)|Exclusionary Medication|0
4618365|NCT01760954|7478880|FG003|Treatment Period (6 Months)|Exclusionary Medication|0
4618366|NCT01760954|7478877|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6
4618367|NCT01760954|7478878|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6
4690495|NCT02561195|7600194|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1
4690496|NCT02561195|7600195|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2
4690497|NCT02561195|7600196|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2
4690498|NCT02561195|7600197|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3
4690499|NCT02561195|7600198|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0
4690500|NCT02561195|7600185|FG000|Extension Stage (Vaccination 4)|Adverse Event|0
4690501|NCT02561195|7600186|FG001|Extension Stage (Vaccination 4)|Adverse Event|0
4690502|NCT02561195|7600187|FG002|Extension Stage (Vaccination 4)|Adverse Event|0
4690503|NCT02561195|7600188|FG003|Extension Stage (Vaccination 4)|Adverse Event|0
4690504|NCT02561195|7600189|FG004|Extension Stage (Vaccination 4)|Adverse Event|0
4690505|NCT02561195|7600190|FG005|Extension Stage (Vaccination 4)|Adverse Event|0
4690506|NCT02561195|7600191|FG006|Extension Stage (Vaccination 4)|Adverse Event|0
4690507|NCT02561195|7600192|FG007|Extension Stage (Vaccination 4)|Adverse Event|0
4690508|NCT02561195|7600193|FG008|Extension Stage (Vaccination 4)|Adverse Event|0
4690509|NCT02561195|7600194|FG009|Extension Stage (Vaccination 4)|Adverse Event|0
4545905|NCT01177293|7371747|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0
4545906|NCT01177293|7371748|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1
4545907|NCT01177384|7371756|FG000|Overall Study|Adverse Event|6
4545908|NCT01177384|7371757|FG001|Overall Study|Adverse Event|4
4618368|NCT01760954|7478879|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4
4545909|NCT01177384|7371756|FG000|Overall Study|Lack of Efficacy|0
4545910|NCT01177384|7371757|FG001|Overall Study|Lack of Efficacy|1
4545911|NCT01177384|7371756|FG000|Overall Study|Lost to Follow-up|3
4545912|NCT01177384|7371757|FG001|Overall Study|Lost to Follow-up|4
4545913|NCT01177384|7371756|FG000|Overall Study|Physician Decision|0
4545914|NCT01177384|7371757|FG001|Overall Study|Physician Decision|3
4545915|NCT01177384|7371756|FG000|Overall Study|Protocol Violation|0
4545916|NCT01177384|7371757|FG001|Overall Study|Protocol Violation|2
4545917|NCT01177384|7371756|FG000|Overall Study|Withdrawal by Subject|5
4545918|NCT01177384|7371757|FG001|Overall Study|Withdrawal by Subject|12
4545919|NCT01177410|7371766|FG000|Overall Study|Adverse Event|0
4618369|NCT01760954|7478880|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9
4618370|NCT01760954|7478877|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4
4618371|NCT01760954|7478878|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7
4618372|NCT01760954|7478879|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2
4618373|NCT01760954|7478880|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0
4618374|NCT01760954|7478877|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6
4618375|NCT01760954|7478878|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10
4618376|NCT01760954|7478879|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5
4618377|NCT01760954|7478880|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5
4618378|NCT01760954|7478877|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1
4618379|NCT01760954|7478878|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4
4618380|NCT01760954|7478879|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0
4618381|NCT01760954|7478880|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0
4618382|NCT01760954|7478877|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0
4618383|NCT01760954|7478878|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0
4618384|NCT01760954|7478879|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1
4618385|NCT01760954|7478880|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0
4618386|NCT01760954|7478877|FG000|Post-treatment Follow-up (12 Months)|Other|13
4618387|NCT01760954|7478878|FG001|Post-treatment Follow-up (12 Months)|Other|8
4618388|NCT01760954|7478879|FG002|Post-treatment Follow-up (12 Months)|Other|9
4618389|NCT01760954|7478880|FG003|Post-treatment Follow-up (12 Months)|Other|6
4618390|NCT01761162|7478904|FG000|Overall Study|Withdrawal by Subject|3
4618391|NCT01761292|7478926|FG000|Part 1|Adverse Event|1
4618392|NCT01761292|7478926|FG000|Part 1|not receiving treatment in Part 1|1
4618393|NCT01761292|7478926|FG000|Extension 1|Withdrawal by Subject|1
4618394|NCT01761565|7478937|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1
4618395|NCT01762345|7478967|FG000|Overall Study|Adverse Event|5
4618396|NCT01762345|7478967|FG000|Overall Study|Protocol Violation|2
4618397|NCT01762800|7479001|FG000|Overall Study|Adverse Event|8
4618398|NCT01762800|7479002|FG001|Overall Study|Adverse Event|13
4618399|NCT01762800|7479001|FG000|Overall Study|Lack of Efficacy|3
4618400|NCT01762800|7479002|FG001|Overall Study|Lack of Efficacy|2
4618401|NCT01762800|7479001|FG000|Overall Study|Study Closed/Terminated|0
4618402|NCT01762800|7479002|FG001|Overall Study|Study Closed/Terminated|1
4618403|NCT01762800|7479001|FG000|Overall Study|Physician Decision|1
4618404|NCT01762800|7479002|FG001|Overall Study|Physician Decision|1
4618405|NCT01762800|7479001|FG000|Overall Study|Withdrawal by Subject|7
4618406|NCT01762800|7479002|FG001|Overall Study|Withdrawal by Subject|4
4632975|NCT01906008|7502777|FG000|Overall Study|Oxaliplatin toxicity|2
4632976|NCT01906008|7502778|FG001|Overall Study|Oxaliplatin toxicity|0
4632977|NCT01906008|7502777|FG000|Overall Study|Protocol Violation|0
4632978|NCT01906008|7502778|FG001|Overall Study|Protocol Violation|1
4632979|NCT01906008|7502777|FG000|Overall Study|Withdrawal by Subject|1
4632980|NCT01906008|7502778|FG001|Overall Study|Withdrawal by Subject|5
4632981|NCT01906008|7502777|FG000|Overall Study|Did not start study med|3
4632982|NCT01906008|7502778|FG001|Overall Study|Did not start study med|4
4632983|NCT01906008|7502777|FG000|Overall Study|Oxaliplatin stops|10
4632984|NCT01906008|7502778|FG001|Overall Study|Oxaliplatin stops|8
4632985|NCT01906008|7502777|FG000|Overall Study|Hospice|1
4632986|NCT01906008|7502778|FG001|Overall Study|Hospice|0
4632987|NCT01906008|7502777|FG000|Overall Study|Physician Decision|3
4632988|NCT01906008|7502778|FG001|Overall Study|Physician Decision|3
4632989|NCT01906008|7502777|FG000|Overall Study|Lack of compliance of study med|5
4632990|NCT01906008|7502778|FG001|Overall Study|Lack of compliance of study med|3
4632991|NCT01906008|7502777|FG000|Overall Study|Adverse Event|0
4632992|NCT01906008|7502778|FG001|Overall Study|Adverse Event|3
4632993|NCT01906346|7502784|FG000|Overall Study|AEs|1
4632994|NCT01906372|7502790|FG000|Overall Study|Withdrawal by Subject|2
4545920|NCT01177410|7371767|FG001|Overall Study|Adverse Event|2
4632995|NCT01906476|7502797|FG000|Overall Study|Lost to Follow-up|17
4632996|NCT01906476|7502798|FG001|Overall Study|Lost to Follow-up|16
4632997|NCT01907087|7502843|FG000|Overall Study|Withdrawal by Subject|1
4545921|NCT01177410|7371768|FG002|Overall Study|Adverse Event|2
4545922|NCT01177410|7371766|FG000|Overall Study|Withdrawal by Subject|1
4618407|NCT01762943|7479023|FG000|Overall Study|Physician Decision|1
4618408|NCT01762943|7479024|FG001|Overall Study|Physician Decision|1
4618409|NCT01762943|7479023|FG000|Overall Study|Protocol Violation|1
4618410|NCT01762943|7479024|FG001|Overall Study|Protocol Violation|0
4618411|NCT01762943|7479023|FG000|Overall Study|Withdrawal by Subject|2
4618412|NCT01762943|7479024|FG001|Overall Study|Withdrawal by Subject|1
4618413|NCT01763047|7479040|FG000|Period 1|Test Article Not Available|4
4618414|NCT01763047|7479041|FG001|Period 1|Test Article Not Available|1
4618415|NCT01763047|7479040|FG000|Period 1|Protocol Violation|4
4618416|NCT01763047|7479041|FG001|Period 1|Protocol Violation|4
4618417|NCT01763047|7479040|FG000|Period 1|No Longer Meets Eligibility criteria|1
4618418|NCT01763047|7479041|FG001|Period 1|No Longer Meets Eligibility criteria|0
4618419|NCT01763047|7479040|FG000|Period 1|Adverse Event|0
4618420|NCT01763047|7479041|FG001|Period 1|Adverse Event|1
4618421|NCT01763047|7479040|FG000|Period 1|Unsatisfactory Visual Response|0
4618422|NCT01763047|7479041|FG001|Period 1|Unsatisfactory Visual Response|3
4618423|NCT01763047|7479040|FG000|Period 1|Lens Power Not Available|0
4618424|NCT01763047|7479041|FG001|Period 1|Lens Power Not Available|1
4618425|NCT01763047|7479040|FG000|Period 1|Study Site office Closed|0
4618426|NCT01763047|7479041|FG001|Period 1|Study Site office Closed|1
4618427|NCT01763047|7479040|FG000|Period 2|Lens Discomfort|1
4618428|NCT01763047|7479041|FG001|Period 2|Lens Discomfort|0
4618429|NCT01763047|7479040|FG000|Period 2|No longer meets Eligibility Criteria|1
4618430|NCT01763047|7479041|FG001|Period 2|No longer meets Eligibility Criteria|0
4618431|NCT01763047|7479040|FG000|Period 2|Study Site office Closed|1
4618432|NCT01763047|7479041|FG001|Period 2|Study Site office Closed|1
4618433|NCT01763047|7479040|FG000|Period 2|Unsatisfactory Visual Response|1
4618434|NCT01763047|7479041|FG001|Period 2|Unsatisfactory Visual Response|1
4618435|NCT01763047|7479040|FG000|Period 2|Protocol Violation|0
4618436|NCT01763047|7479041|FG001|Period 2|Protocol Violation|2
4618437|NCT01763047|7479040|FG000|Period 2|Unsatisfactory lens Fitting|0
4618438|NCT01763047|7479041|FG001|Period 2|Unsatisfactory lens Fitting|1
4618439|NCT01763164|7479052|FG000|Treatment Phase|Participant/Guardian decision|26
4618440|NCT01763164|7479053|FG001|Treatment Phase|Participant/Guardian decision|14
4618441|NCT01763164|7479052|FG000|Treatment Phase|Protocol Violation|1
4618442|NCT01763164|7479053|FG001|Treatment Phase|Protocol Violation|1
4618443|NCT01763164|7479052|FG000|Treatment Phase|Progressive Disease|142
4618444|NCT01763164|7479053|FG001|Treatment Phase|Progressive Disease|76
4618445|NCT01763164|7479052|FG000|Treatment Phase|Physician Decision|24
4618446|NCT01763164|7479053|FG001|Treatment Phase|Physician Decision|13
4618447|NCT01763164|7479052|FG000|Treatment Phase|Death|10
4618448|NCT01763164|7479053|FG001|Treatment Phase|Death|1
4618449|NCT01763164|7479052|FG000|Treatment Phase|Adverse Event|66
4618450|NCT01763164|7479053|FG001|Treatment Phase|Adverse Event|8
4618451|NCT01763164|7479052|FG000|Treatment Phase|Randomized but not Treated|0
4618452|NCT01763164|7479053|FG001|Treatment Phase|Randomized but not Treated|19
4618453|NCT01763164|7479052|FG000|Treatment Phase|Other|0
4618454|NCT01763164|7479053|FG001|Treatment Phase|Other|1
4618455|NCT01763164|7479052|FG000|Follow up Phase|New therapy for study indication|12
4618456|NCT01763164|7479053|FG001|Follow up Phase|New therapy for study indication|3
4618457|NCT01763164|7479052|FG000|Follow up Phase|Death|21
4545923|NCT01177410|7371767|FG001|Overall Study|Withdrawal by Subject|4
4545924|NCT01177410|7371768|FG002|Overall Study|Withdrawal by Subject|3
4545925|NCT01177410|7371766|FG000|Overall Study|Lost to Follow-up|0
4545926|NCT01177410|7371767|FG001|Overall Study|Lost to Follow-up|1
4545927|NCT01177410|7371768|FG002|Overall Study|Lost to Follow-up|0
4545928|NCT01177553|7371778|FG000|Overall Study|babies not yet 6 months of age|1
4545929|NCT01177553|7371779|FG001|Overall Study|babies not yet 6 months of age|0
4545930|NCT01177670|7371785|FG000|Overall Study|Study Terminated|115
4545931|NCT01177670|7371785|FG000|Overall Study|Physician Decision|50
4545932|NCT01177670|7371785|FG000|Overall Study|Withdrawal by Subject|4
4545933|NCT01177722|7371797|FG000|Overall Study|Serious Adverse Event|0
4545934|NCT01177722|7371798|FG001|Overall Study|Serious Adverse Event|0
4545935|NCT01177722|7371799|FG002|Overall Study|Serious Adverse Event|1
4545936|NCT01177722|7371800|FG003|Overall Study|Serious Adverse Event|0
4545937|NCT01177722|7371797|FG000|Overall Study|Protocol Violation|0
4545938|NCT01177722|7371798|FG001|Overall Study|Protocol Violation|0
4545939|NCT01177722|7371799|FG002|Overall Study|Protocol Violation|1
4545940|NCT01177722|7371800|FG003|Overall Study|Protocol Violation|0
4545941|NCT01177722|7371797|FG000|Overall Study|Lost to Follow-up|3
4545942|NCT01177722|7371798|FG001|Overall Study|Lost to Follow-up|4
4545943|NCT01177722|7371799|FG002|Overall Study|Lost to Follow-up|3
4545944|NCT01177722|7371800|FG003|Overall Study|Lost to Follow-up|1
4545945|NCT01177722|7371797|FG000|Overall Study|Withdrawal by Subject|10
4545946|NCT01177722|7371798|FG001|Overall Study|Withdrawal by Subject|6
4545947|NCT01177722|7371799|FG002|Overall Study|Withdrawal by Subject|4
4545948|NCT01177722|7371800|FG003|Overall Study|Withdrawal by Subject|6
4618458|NCT01763164|7479053|FG001|Follow up Phase|Death|4
4618459|NCT01763164|7479052|FG000|Follow up Phase|Subject/guardian decision|9
4618460|NCT01763164|7479053|FG001|Follow up Phase|Subject/guardian decision|2
4618461|NCT01763164|7479052|FG000|Follow up Phase|Progressive disease|127
4545949|NCT01177787|7371815|FG000|Cryolipolysis on Thigh|Protocol Violation|4
4545950|NCT01177787|7371815|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9
4545951|NCT01177787|7371815|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1
4545952|NCT01177800|7371829|FG000|Overall Study|Adverse Event|9
4545953|NCT01177800|7371830|FG001|Overall Study|Adverse Event|3
4545954|NCT01177800|7371829|FG000|Overall Study|Protocol Violation|0
4545955|NCT01177800|7371830|FG001|Overall Study|Protocol Violation|1
4545956|NCT01177800|7371829|FG000|Overall Study|Physician Decision|1
4545957|NCT01177800|7371830|FG001|Overall Study|Physician Decision|0
4545958|NCT01177800|7371829|FG000|Overall Study|Withdrawal of informed consent|0
4545959|NCT01177800|7371830|FG001|Overall Study|Withdrawal of informed consent|1
4545960|NCT01177813|7371841|FG000|Overall Study|Adverse Event|8
4545961|NCT01177813|7371842|FG001|Overall Study|Adverse Event|2
4545962|NCT01177813|7371843|FG002|Overall Study|Adverse Event|4
4545963|NCT01177813|7371844|FG003|Overall Study|Adverse Event|6
4545964|NCT01177813|7371845|FG004|Overall Study|Adverse Event|3
4545965|NCT01177813|7371841|FG000|Overall Study|Lack of Efficacy|1
4545966|NCT01177813|7371842|FG001|Overall Study|Lack of Efficacy|0
4545967|NCT01177813|7371843|FG002|Overall Study|Lack of Efficacy|0
4545968|NCT01177813|7371844|FG003|Overall Study|Lack of Efficacy|0
4545969|NCT01177813|7371845|FG004|Overall Study|Lack of Efficacy|0
4545970|NCT01177813|7371841|FG000|Overall Study|Protocol Violation|3
4545971|NCT01177813|7371842|FG001|Overall Study|Protocol Violation|2
4545972|NCT01177813|7371843|FG002|Overall Study|Protocol Violation|2
4545973|NCT01177813|7371844|FG003|Overall Study|Protocol Violation|0
4545974|NCT01177813|7371845|FG004|Overall Study|Protocol Violation|1
4545975|NCT01177813|7371841|FG000|Overall Study|Lost to Follow-up|12
4545976|NCT01177813|7371842|FG001|Overall Study|Lost to Follow-up|5
4545977|NCT01177813|7371843|FG002|Overall Study|Lost to Follow-up|6
4545978|NCT01177813|7371844|FG003|Overall Study|Lost to Follow-up|3
4545979|NCT01177813|7371845|FG004|Overall Study|Lost to Follow-up|0
4618462|NCT01763164|7479053|FG001|Follow up Phase|Progressive disease|62
4618463|NCT01763164|7479052|FG000|Follow up Phase|Physician Decision|10
4618464|NCT01763164|7479053|FG001|Follow up Phase|Physician Decision|3
4618465|NCT01763164|7479052|FG000|Follow up Phase|Lost to Follow-up|1
4618466|NCT01763164|7479053|FG001|Follow up Phase|Lost to Follow-up|0
4618467|NCT01763164|7479052|FG000|Follow up Phase|Adverse Event|17
4618468|NCT01763164|7479053|FG001|Follow up Phase|Adverse Event|1
4618469|NCT01763203|7479061|FG000|Overall Study|Death|4
4618470|NCT01763203|7479062|FG001|Overall Study|Death|7
4618471|NCT01763203|7479061|FG000|Overall Study|Lost to Follow-up|12
4618472|NCT01763203|7479062|FG001|Overall Study|Lost to Follow-up|12
4618473|NCT01763203|7479061|FG000|Overall Study|Withdrawal by Subject|8
4618474|NCT01763203|7479062|FG001|Overall Study|Withdrawal by Subject|12
4618475|NCT01763203|7479061|FG000|Overall Study|Moved out of study region|7
4618476|NCT01763203|7479062|FG001|Overall Study|Moved out of study region|10
4618477|NCT01763203|7479061|FG000|Overall Study|Physician Decision|2
4618478|NCT01763203|7479062|FG001|Overall Study|Physician Decision|1
4618479|NCT01763684|7479164|FG000|Overall Study|Study terminated early due to low enrollment|126
4618480|NCT01763684|7479165|FG001|Overall Study|Study terminated early due to low enrollment|127
4618481|NCT01763684|7479164|FG000|Overall Study|Study surgery not performed|7
4618482|NCT01763684|7479165|FG001|Overall Study|Study surgery not performed|6
4545980|NCT01177813|7371841|FG000|Overall Study|Withdrawal by Subject|12
4545981|NCT01177813|7371842|FG001|Overall Study|Withdrawal by Subject|7
4545982|NCT01177813|7371843|FG002|Overall Study|Withdrawal by Subject|6
4545983|NCT01177813|7371844|FG003|Overall Study|Withdrawal by Subject|5
4545984|NCT01177813|7371845|FG004|Overall Study|Withdrawal by Subject|3
4545985|NCT01177813|7371841|FG000|Overall Study|Other reason not defined above|5
4545986|NCT01177813|7371842|FG001|Overall Study|Other reason not defined above|2
4545987|NCT01177813|7371843|FG002|Overall Study|Other reason not defined above|2
4545988|NCT01177813|7371844|FG003|Overall Study|Other reason not defined above|3
4545989|NCT01177813|7371845|FG004|Overall Study|Other reason not defined above|2
4545990|NCT01177943|7371859|FG000|First Intervention|Withdrawal by Subject|2
4545991|NCT01177943|7371860|FG001|First Intervention|Withdrawal by Subject|0
4545992|NCT01177969|7371873|FG000|Overall Study|Protocol Violation|2
4545993|NCT01177969|7371874|FG001|Overall Study|Protocol Violation|1
4545994|NCT01177969|7371873|FG000|Overall Study|Withdrawal by Subject|1
4545995|NCT01177969|7371874|FG001|Overall Study|Withdrawal by Subject|2
4545996|NCT01178073|7371883|FG000|Overall Study|Adverse Event|34
4545997|NCT01178073|7371884|FG001|Overall Study|Adverse Event|27
4545998|NCT01178073|7371885|FG002|Overall Study|Adverse Event|24
4545999|NCT01178073|7371883|FG000|Overall Study|Protocol Violation|1
4546000|NCT01178073|7371884|FG001|Overall Study|Protocol Violation|1
4546001|NCT01178073|7371885|FG002|Overall Study|Protocol Violation|1
4546002|NCT01178073|7371883|FG000|Overall Study|Lost to Follow-up|2
4546003|NCT01178073|7371884|FG001|Overall Study|Lost to Follow-up|0
4546004|NCT01178073|7371885|FG002|Overall Study|Lost to Follow-up|3
4546005|NCT01178073|7371883|FG000|Overall Study|Physician Decision|14
4546006|NCT01178073|7371884|FG001|Overall Study|Physician Decision|10
4546007|NCT01178073|7371885|FG002|Overall Study|Physician Decision|10
4546008|NCT01178073|7371883|FG000|Overall Study|Withdrawal by Subject|10
4546009|NCT01178073|7371884|FG001|Overall Study|Withdrawal by Subject|6
4546010|NCT01178073|7371885|FG002|Overall Study|Withdrawal by Subject|8
4546011|NCT01178073|7371883|FG000|Overall Study|Missing Completion Status|1
4546012|NCT01178073|7371884|FG001|Overall Study|Missing Completion Status|0
4546013|NCT01178073|7371885|FG002|Overall Study|Missing Completion Status|0
4546014|NCT01178086|7371896|FG000|Overall Study|Participant refusal|7
4546015|NCT01178086|7371896|FG000|Overall Study|Physician Decision|44
4546016|NCT01178086|7371896|FG000|Overall Study|Switch to other CLL therapy|113
4546017|NCT01178086|7371896|FG000|Overall Study|Death|59
4546018|NCT01178086|7371896|FG000|Overall Study|Other unspecified|89
4618483|NCT01763827|7479177|FG000|Overall Study|Withdrawal by Subject|1
4618484|NCT01763827|7479178|FG001|Overall Study|Withdrawal by Subject|0
4618485|NCT01763827|7479179|FG002|Overall Study|Withdrawal by Subject|0
4618486|NCT01763827|7479180|FG003|Overall Study|Withdrawal by Subject|0
4618487|NCT01763827|7479181|FG004|Overall Study|Withdrawal by Subject|2
4618488|NCT01763827|7479182|FG005|Overall Study|Withdrawal by Subject|0
4618489|NCT01763827|7479177|FG000|Overall Study|Decision by sponsor|2
4618490|NCT01763827|7479178|FG001|Overall Study|Decision by sponsor|0
4618491|NCT01763827|7479179|FG002|Overall Study|Decision by sponsor|3
4618492|NCT01763827|7479180|FG003|Overall Study|Decision by sponsor|0
4618493|NCT01763827|7479181|FG004|Overall Study|Decision by sponsor|2
4618494|NCT01763827|7479182|FG005|Overall Study|Decision by sponsor|1
4618495|NCT01763827|7479177|FG000|Overall Study|Lost to Follow-up|0
4618496|NCT01763827|7479178|FG001|Overall Study|Lost to Follow-up|1
4618497|NCT01763827|7479179|FG002|Overall Study|Lost to Follow-up|1
4618498|NCT01763827|7479180|FG003|Overall Study|Lost to Follow-up|1
4618499|NCT01763827|7479181|FG004|Overall Study|Lost to Follow-up|2
4618500|NCT01763827|7479182|FG005|Overall Study|Lost to Follow-up|1
4618501|NCT01763866|7479220|FG000|Overall Study|Withdrawal by Subject|2
4618502|NCT01763866|7479221|FG001|Overall Study|Withdrawal by Subject|1
4618503|NCT01763866|7479222|FG002|Overall Study|Withdrawal by Subject|4
4618504|NCT01763866|7479223|FG003|Overall Study|Withdrawal by Subject|0
4618505|NCT01763866|7479224|FG004|Overall Study|Withdrawal by Subject|0
4618506|NCT01763866|7479225|FG005|Overall Study|Withdrawal by Subject|3
4618507|NCT01763866|7479226|FG006|Overall Study|Withdrawal by Subject|4
4618508|NCT01763866|7479227|FG007|Overall Study|Withdrawal by Subject|0
4618509|NCT01763866|7479228|FG008|Overall Study|Withdrawal by Subject|1
4618510|NCT01763866|7479229|FG009|Overall Study|Withdrawal by Subject|1
4618511|NCT01763866|7479230|FG010|Overall Study|Withdrawal by Subject|2
4618512|NCT01763866|7479231|FG011|Overall Study|Withdrawal by Subject|2
4618513|NCT01763866|7479232|FG012|Overall Study|Withdrawal by Subject|2
4618514|NCT01763866|7479233|FG013|Overall Study|Withdrawal by Subject|0
4618515|NCT01763866|7479234|FG014|Overall Study|Withdrawal by Subject|6
4618516|NCT01763866|7479235|FG015|Overall Study|Withdrawal by Subject|3
4618517|NCT01763866|7479236|FG016|Overall Study|Withdrawal by Subject|0
4618518|NCT01763866|7479237|FG017|Overall Study|Withdrawal by Subject|1
4618519|NCT01763866|7479238|FG018|Overall Study|Withdrawal by Subject|1
4618520|NCT01763866|7479239|FG019|Overall Study|Withdrawal by Subject|1
4618521|NCT01763866|7479240|FG020|Overall Study|Withdrawal by Subject|2
4618522|NCT01763866|7479241|FG021|Overall Study|Withdrawal by Subject|1
4618523|NCT01763866|7479242|FG022|Overall Study|Withdrawal by Subject|2
4618524|NCT01763866|7479243|FG023|Overall Study|Withdrawal by Subject|1
4618525|NCT01763866|7479220|FG000|Overall Study|Decision by sponsor|0
4618526|NCT01763866|7479221|FG001|Overall Study|Decision by sponsor|0
4618527|NCT01763866|7479222|FG002|Overall Study|Decision by sponsor|1
4618528|NCT01763866|7479223|FG003|Overall Study|Decision by sponsor|0
4618529|NCT01763866|7479224|FG004|Overall Study|Decision by sponsor|2
4618530|NCT01763866|7479225|FG005|Overall Study|Decision by sponsor|0
4618531|NCT01763866|7479226|FG006|Overall Study|Decision by sponsor|2
4618532|NCT01763866|7479227|FG007|Overall Study|Decision by sponsor|0
4618533|NCT01763866|7479228|FG008|Overall Study|Decision by sponsor|2
4618534|NCT01763866|7479229|FG009|Overall Study|Decision by sponsor|0
4618535|NCT01763866|7479230|FG010|Overall Study|Decision by sponsor|6
4618536|NCT01763866|7479231|FG011|Overall Study|Decision by sponsor|0
4618537|NCT01763866|7479232|FG012|Overall Study|Decision by sponsor|1
4618538|NCT01763866|7479233|FG013|Overall Study|Decision by sponsor|0
4618539|NCT01763866|7479234|FG014|Overall Study|Decision by sponsor|5
4618540|NCT01763866|7479235|FG015|Overall Study|Decision by sponsor|0
4618541|NCT01763866|7479236|FG016|Overall Study|Decision by sponsor|0
4618542|NCT01763866|7479237|FG017|Overall Study|Decision by sponsor|0
4618543|NCT01763866|7479238|FG018|Overall Study|Decision by sponsor|4
4618544|NCT01763866|7479239|FG019|Overall Study|Decision by sponsor|0
4618545|NCT01763866|7479240|FG020|Overall Study|Decision by sponsor|2
4618546|NCT01763866|7479241|FG021|Overall Study|Decision by sponsor|0
4618547|NCT01763866|7479242|FG022|Overall Study|Decision by sponsor|1
4618548|NCT01763866|7479243|FG023|Overall Study|Decision by sponsor|0
4618549|NCT01763866|7479220|FG000|Overall Study|Lost to Follow-up|0
4618550|NCT01763866|7479221|FG001|Overall Study|Lost to Follow-up|0
4618551|NCT01763866|7479222|FG002|Overall Study|Lost to Follow-up|0
4618552|NCT01763866|7479223|FG003|Overall Study|Lost to Follow-up|0
4618553|NCT01763866|7479224|FG004|Overall Study|Lost to Follow-up|0
4618554|NCT01763866|7479225|FG005|Overall Study|Lost to Follow-up|0
4618555|NCT01763866|7479226|FG006|Overall Study|Lost to Follow-up|1
4618556|NCT01763866|7479227|FG007|Overall Study|Lost to Follow-up|0
4618557|NCT01763866|7479228|FG008|Overall Study|Lost to Follow-up|0
4618558|NCT01763866|7479229|FG009|Overall Study|Lost to Follow-up|0
4618559|NCT01763866|7479230|FG010|Overall Study|Lost to Follow-up|0
4618560|NCT01763866|7479231|FG011|Overall Study|Lost to Follow-up|0
4546019|NCT01178086|7371896|FG000|Overall Study|Excluded from EAS|20
4618561|NCT01763866|7479232|FG012|Overall Study|Lost to Follow-up|1
4618562|NCT01763866|7479233|FG013|Overall Study|Lost to Follow-up|0
4618563|NCT01763866|7479234|FG014|Overall Study|Lost to Follow-up|1
4546020|NCT01178099|7371906|FG000|Overall Study|Physician Decision|0
4546021|NCT01178099|7371907|FG001|Overall Study|Physician Decision|1
4546022|NCT01178125|7371917|FG000|Overall Study|Lost to Follow-up|397
4546023|NCT01178125|7371917|FG000|Overall Study|Adverse Event|244
4546024|NCT01178125|7371917|FG000|Overall Study|Withdrawal by Subject|209
4546025|NCT01178125|7371917|FG000|Overall Study|Noncompliance|184
4546026|NCT01178125|7371917|FG000|Overall Study|Pregnancy|55
4546027|NCT01178125|7371917|FG000|Overall Study|Other Reason|39
4546028|NCT01178125|7371917|FG000|Overall Study|Sponsor Decision|28
4546029|NCT01178125|7371917|FG000|Overall Study|Protocol Violation|17
4546030|NCT01178125|7371917|FG000|Overall Study|Investigator Decision|5
4546031|NCT01178138|7371926|FG000|Overall Study|Lost to Follow-up|8
4546032|NCT01178138|7371926|FG000|Overall Study|Withdrawal by Subject|7
4546033|NCT01178138|7371926|FG000|Overall Study|Physician Decision|8
4546034|NCT01178294|7371963|FG000|Overall Study|Adverse Event|4
4546035|NCT01178294|7371963|FG000|Overall Study|Lost to Follow-up|2
4546036|NCT01178294|7371963|FG000|Overall Study|Lack of Efficacy|1
4546037|NCT01178294|7371963|FG000|Overall Study|Death|1
4546038|NCT01178294|7371963|FG000|Overall Study|Development of inhibitors to OBI-1|1
4546039|NCT01178294|7371963|FG000|Overall Study|Subject status is terminal|1
4546040|NCT01178294|7371963|FG000|Overall Study|Completion status could not be verified|1
4546041|NCT01178385|7371984|FG000|Overall Study|Withdrawal by Subject|2
4546042|NCT01178385|7371985|FG001|Overall Study|Withdrawal by Subject|0
4546043|NCT01178411|7371991|FG000|Overall Study|Adverse Event|5
4546044|NCT01178411|7371991|FG000|Overall Study|Withdrawal by Subject|4
4546045|NCT01178411|7371991|FG000|Overall Study|Protocol Violation|1
4546046|NCT01178411|7371991|FG000|Overall Study|Progressive disease per RECIST|32
4546047|NCT01178411|7371991|FG000|Overall Study|Progressive disease per clinician|9
4546048|NCT01178411|7371991|FG000|Overall Study|Physician Decision|6
4546049|NCT01178411|7371991|FG000|Overall Study|Death|1
4546050|NCT01178411|7371991|FG000|Overall Study|No reason provided|1
4546051|NCT01178411|7371991|FG000|Overall Study|Drug manufacturing ended|1
4546052|NCT01178671|7372011|FG000|Overall Study|Adverse Event|4
4546053|NCT01178671|7372012|FG001|Overall Study|Adverse Event|6
4546054|NCT01178671|7372011|FG000|Overall Study|Protocol Violation|1
4546055|NCT01178671|7372012|FG001|Overall Study|Protocol Violation|1
4546056|NCT01178671|7372011|FG000|Overall Study|Lack of Efficacy|0
4546057|NCT01178671|7372012|FG001|Overall Study|Lack of Efficacy|1
4546058|NCT01178671|7372011|FG000|Overall Study|Lost to Follow-up|3
4546059|NCT01178671|7372012|FG001|Overall Study|Lost to Follow-up|1
4546060|NCT01178671|7372011|FG000|Overall Study|Physician Decision|4
4546061|NCT01178671|7372012|FG001|Overall Study|Physician Decision|6
4546062|NCT01178762|7372018|FG000|Overall Study|Lost to Follow-up|15
4546063|NCT01178853|7372037|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1
4546064|NCT01178853|7372038|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2
4546065|NCT01178853|7372037|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1
4546066|NCT01178853|7372038|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0
4546067|NCT01178853|7372037|FG000|Period 3 (Warfarin Titration)|Adverse Event|1
4546068|NCT01178853|7372038|FG001|Period 3 (Warfarin Titration)|Adverse Event|0
4546069|NCT01178853|7372037|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0
4546070|NCT01178853|7372038|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2
4546071|NCT01178853|7372037|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0
4546072|NCT01178853|7372038|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1
4546073|NCT01179048|7372050|FG000|Overall Study|Withdrawn - does not allow contact|4
4546074|NCT01179048|7372051|FG001|Overall Study|Withdrawn - does not allow contact|8
4546075|NCT01179048|7372050|FG000|Overall Study|Lost to Follow-up|8
4546076|NCT01179048|7372051|FG001|Overall Study|Lost to Follow-up|9
4546077|NCT01179048|7372050|FG000|Overall Study|Alive|127
4546078|NCT01179048|7372051|FG001|Overall Study|Alive|142
4546079|NCT01179191|7372066|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47
4546080|NCT01179191|7372066|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19
4546081|NCT01179191|7372066|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30
4546082|NCT01179191|7372066|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162
4546083|NCT01179191|7372066|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13
4546084|NCT01179191|7372066|FG000|Titration Phase (up to 6 Weeks)|Other|62
4546085|NCT01179191|7372066|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10
4546086|NCT01179191|7372066|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9
4546087|NCT01179191|7372066|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3
4546088|NCT01179191|7372066|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29
4546089|NCT01179191|7372066|FG000|Maintenance Phase (8 Weeks)|Other|66
4546090|NCT01179334|7372083|FG000|Treatment Period|Adverse Event|1
4546091|NCT01179334|7372084|FG001|Treatment Period|Adverse Event|0
4546092|NCT01179334|7372083|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6
4546093|NCT01179334|7372084|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2
4546094|NCT01179334|7372083|FG000|Long-term Extension (LTE) Period|Death|3
4546095|NCT01179334|7372084|FG001|Long-term Extension (LTE) Period|Death|0
4546096|NCT01179334|7372083|FG000|Long-term Extension (LTE) Period|Adverse Event|2
4546097|NCT01179334|7372084|FG001|Long-term Extension (LTE) Period|Adverse Event|4
4546098|NCT01179347|7372092|FG000|Double-blind Period (12 Weeks)|Adverse Event|2
4546099|NCT01179347|7372093|FG001|Double-blind Period (12 Weeks)|Adverse Event|6
4546100|NCT01179347|7372092|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2
4546101|NCT01179347|7372093|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0
4546102|NCT01179347|7372092|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1
4546103|NCT01179347|7372093|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2
4546104|NCT01179347|7372092|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1
4546105|NCT01179347|7372093|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2
4546106|NCT01179347|7372092|FG000|Double-blind Period (12 Weeks)|Other|2
4546107|NCT01179347|7372093|FG001|Double-blind Period (12 Weeks)|Other|4
4546108|NCT01179347|7372092|FG000|Open-label Period (12 Weeks)|Adverse Event|5
4546109|NCT01179347|7372093|FG001|Open-label Period (12 Weeks)|Adverse Event|9
4546110|NCT01179347|7372092|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0
4546111|NCT01179347|7372093|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2
4546112|NCT01179347|7372092|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1
4546113|NCT01179347|7372093|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0
4546114|NCT01179347|7372092|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1
4546115|NCT01179347|7372093|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1
4546116|NCT01179347|7372092|FG000|Open-label Period (12 Weeks)|Protocol Violation|1
4546117|NCT01179347|7372093|FG001|Open-label Period (12 Weeks)|Protocol Violation|0
4546118|NCT01179347|7372092|FG000|Open-label Period (12 Weeks)|Other|7
4546119|NCT01179347|7372093|FG001|Open-label Period (12 Weeks)|Other|4
4546120|NCT01179477|7372101|FG000|Overall Study|Death|542
4546121|NCT01179477|7372101|FG000|Overall Study|Unsuccessful implant|80
4546122|NCT01179477|7372101|FG000|Overall Study|Non-death withdrawal|438
4546123|NCT01179477|7372101|FG000|Overall Study|Did not complete final visit|27
4546124|NCT01179516|7372112|FG000|Overall Study|Pretreatment Event or Adverse Event|6
4546125|NCT01179516|7372113|FG001|Overall Study|Pretreatment Event or Adverse Event|8
4546126|NCT01179516|7372114|FG002|Overall Study|Pretreatment Event or Adverse Event|12
4546127|NCT01179516|7372112|FG000|Overall Study|Lack of Efficacy|4
4546128|NCT01179516|7372113|FG001|Overall Study|Lack of Efficacy|2
4546129|NCT01179516|7372114|FG002|Overall Study|Lack of Efficacy|0
4546130|NCT01179516|7372112|FG000|Overall Study|Noncompliance with Study Drug|2
4546131|NCT01179516|7372113|FG001|Overall Study|Noncompliance with Study Drug|0
4546132|NCT01179516|7372114|FG002|Overall Study|Noncompliance with Study Drug|1
4546133|NCT01179516|7372112|FG000|Overall Study|Protocol Deviations|4
4546134|NCT01179516|7372113|FG001|Overall Study|Protocol Deviations|3
4546135|NCT01179516|7372114|FG002|Overall Study|Protocol Deviations|3
4546136|NCT01179516|7372112|FG000|Overall Study|Withdrawal of Consent|2
4546137|NCT01179516|7372113|FG001|Overall Study|Withdrawal of Consent|6
4546138|NCT01179516|7372114|FG002|Overall Study|Withdrawal of Consent|10
4546139|NCT01179516|7372112|FG000|Overall Study|Lost to Follow-up|7
4546140|NCT01179516|7372113|FG001|Overall Study|Lost to Follow-up|7
4546141|NCT01179516|7372114|FG002|Overall Study|Lost to Follow-up|3
4546142|NCT01179516|7372112|FG000|Overall Study|Other|2
4546143|NCT01179516|7372113|FG001|Overall Study|Other|0
4546144|NCT01179516|7372114|FG002|Overall Study|Other|2
4546145|NCT01179672|7372144|FG000|Overall Study|Adverse Event|17
4546146|NCT01179672|7372145|FG001|Overall Study|Adverse Event|8
4546147|NCT01179672|7372144|FG000|Overall Study|Withdrawal by Subject|10
4546148|NCT01179672|7372145|FG001|Overall Study|Withdrawal by Subject|12
4546149|NCT01179672|7372144|FG000|Overall Study|Entry Criteria Not Met|0
4546150|NCT01179672|7372145|FG001|Overall Study|Entry Criteria Not Met|2
4546151|NCT01179672|7372144|FG000|Overall Study|Lost to Follow-up|0
4546152|NCT01179672|7372145|FG001|Overall Study|Lost to Follow-up|1
4546153|NCT01179672|7372144|FG000|Overall Study|Protocol Violation|2
4546154|NCT01179672|7372145|FG001|Overall Study|Protocol Violation|2
4546155|NCT01179672|7372144|FG000|Overall Study|Physician Decision|1
4546156|NCT01179672|7372145|FG001|Overall Study|Physician Decision|1
4546157|NCT01179919|7372155|FG000|Overall Study|Protocol Violation|1
4546158|NCT01179919|7372155|FG000|Overall Study|Adverse Event|1
4546159|NCT01180049|7372177|FG000|Overall Study|Other|9
4546160|NCT01180049|7372178|FG001|Overall Study|Other|7
4546161|NCT01180049|7372177|FG000|Overall Study|Lost to Follow-up|8
4546162|NCT01180049|7372178|FG001|Overall Study|Lost to Follow-up|6
4546163|NCT01180049|7372177|FG000|Overall Study|Death|36
4546164|NCT01180049|7372178|FG001|Overall Study|Death|35
4546165|NCT01180244|7372207|FG000|Overall Study|Lack of Efficacy|0
4546166|NCT01180244|7372208|FG001|Overall Study|Lack of Efficacy|7
4546167|NCT01180244|7372207|FG000|Overall Study|Physician Decision|3
4546168|NCT01180244|7372208|FG001|Overall Study|Physician Decision|0
4546169|NCT01180244|7372207|FG000|Overall Study|Adverse Event|1
4546170|NCT01180244|7372208|FG001|Overall Study|Adverse Event|0
4546171|NCT01180244|7372207|FG000|Overall Study|Withdrawal by Subject|0
4546172|NCT01180244|7372208|FG001|Overall Study|Withdrawal by Subject|1
4546173|NCT01180244|7372207|FG000|Overall Study|Protocol Violation|1
4546174|NCT01180244|7372208|FG001|Overall Study|Protocol Violation|0
4546175|NCT01180244|7372207|FG000|Overall Study|Lost to Follow-up|1
4546176|NCT01180244|7372208|FG001|Overall Study|Lost to Follow-up|0
4546177|NCT01180296|7372216|FG000|Overall Study|Protocol Violation|1
4546178|NCT01180296|7372217|FG001|Overall Study|Protocol Violation|2
4546179|NCT01180400|7372227|FG000|Overall Study|Withdrawal by Subject|5
4546180|NCT01180400|7372228|FG001|Overall Study|Withdrawal by Subject|6
4546181|NCT01180400|7372227|FG000|Overall Study|Eligibility criteria not fulfilled|0
4546182|NCT01180400|7372228|FG001|Overall Study|Eligibility criteria not fulfilled|2
4546183|NCT01180400|7372227|FG000|Overall Study|Adverse Event|12
4546184|NCT01180400|7372228|FG001|Overall Study|Adverse Event|10
4546185|NCT01180400|7372227|FG000|Overall Study|Severe non-compliance to protocol|1
4546186|NCT01180400|7372228|FG001|Overall Study|Severe non-compliance to protocol|2
4546187|NCT01180400|7372227|FG000|Overall Study|Condition under investigation worsened|2
4546188|NCT01180400|7372228|FG001|Overall Study|Condition under investigation worsened|1
4546189|NCT01180400|7372227|FG000|Overall Study|Lack of Efficacy|2
4546190|NCT01180400|7372228|FG001|Overall Study|Lack of Efficacy|0
4546191|NCT01180400|7372227|FG000|Overall Study|Study-specific withdrawal criteria|1
4546192|NCT01180400|7372228|FG001|Overall Study|Study-specific withdrawal criteria|2
4546193|NCT01180400|7372227|FG000|Overall Study|Lost to Follow-up|2
4546194|NCT01180400|7372228|FG001|Overall Study|Lost to Follow-up|3
4546195|NCT01180400|7372227|FG000|Overall Study|Other|0
4546196|NCT01180400|7372228|FG001|Overall Study|Other|1
4546197|NCT01180647|7372247|FG000|Overall Study|Lost to Follow-up|5
4546198|NCT01180647|7372248|FG001|Overall Study|Lost to Follow-up|6
4546199|NCT01180660|7372256|FG000|Overall Study|Changed to open surgery|1
4546200|NCT01180660|7372257|FG001|Overall Study|Changed to open surgery|0
4546201|NCT01180777|7372263|FG000|Overall Study|Protocol Violation|6
4546202|NCT01180777|7372263|FG000|Overall Study|Poor lens fit|4
4546203|NCT01180777|7372263|FG000|Overall Study|Lost to Follow-up|1
4546204|NCT01180777|7372263|FG000|Overall Study|Adverse Event|1
4546205|NCT01180790|7372276|FG000|Overall Study|Adverse Event|1
4546206|NCT01180790|7372277|FG001|Overall Study|Adverse Event|1
4546207|NCT01180790|7372278|FG002|Overall Study|Adverse Event|2
4546208|NCT01180790|7372279|FG003|Overall Study|Adverse Event|0
4546209|NCT01180790|7372280|FG004|Overall Study|Adverse Event|1
4546210|NCT01180790|7372281|FG005|Overall Study|Adverse Event|3
4546211|NCT01180790|7372282|FG006|Overall Study|Adverse Event|0
4546212|NCT01180790|7372276|FG000|Overall Study|Withdrawal by Subject|3
4546213|NCT01180790|7372277|FG001|Overall Study|Withdrawal by Subject|0
4546214|NCT01180790|7372278|FG002|Overall Study|Withdrawal by Subject|5
4546215|NCT01180790|7372279|FG003|Overall Study|Withdrawal by Subject|0
4546216|NCT01180790|7372280|FG004|Overall Study|Withdrawal by Subject|2
4546217|NCT01180790|7372281|FG005|Overall Study|Withdrawal by Subject|1
4546218|NCT01180790|7372282|FG006|Overall Study|Withdrawal by Subject|0
4546219|NCT01180790|7372276|FG000|Overall Study|Lost to Follow-up|3
4546220|NCT01180790|7372277|FG001|Overall Study|Lost to Follow-up|1
4546221|NCT01180790|7372278|FG002|Overall Study|Lost to Follow-up|0
4546222|NCT01180790|7372279|FG003|Overall Study|Lost to Follow-up|2
4546223|NCT01180790|7372280|FG004|Overall Study|Lost to Follow-up|1
4546224|NCT01180790|7372281|FG005|Overall Study|Lost to Follow-up|0
4546225|NCT01180790|7372282|FG006|Overall Study|Lost to Follow-up|1
4546226|NCT01180790|7372276|FG000|Overall Study|Physician Decision|1
4546227|NCT01180790|7372277|FG001|Overall Study|Physician Decision|0
4546228|NCT01180790|7372278|FG002|Overall Study|Physician Decision|0
4546229|NCT01180790|7372279|FG003|Overall Study|Physician Decision|1
4546230|NCT01180790|7372280|FG004|Overall Study|Physician Decision|0
4546231|NCT01180790|7372281|FG005|Overall Study|Physician Decision|0
4546232|NCT01180790|7372282|FG006|Overall Study|Physician Decision|0
4546233|NCT01180790|7372276|FG000|Overall Study|Lack of Efficacy|1
4546234|NCT01180790|7372277|FG001|Overall Study|Lack of Efficacy|2
4546235|NCT01180790|7372278|FG002|Overall Study|Lack of Efficacy|5
4546236|NCT01180790|7372279|FG003|Overall Study|Lack of Efficacy|6
4546237|NCT01180790|7372280|FG004|Overall Study|Lack of Efficacy|1
4546238|NCT01180790|7372281|FG005|Overall Study|Lack of Efficacy|3
4618564|NCT01763866|7479235|FG015|Overall Study|Lost to Follow-up|0
4618565|NCT01763866|7479236|FG016|Overall Study|Lost to Follow-up|0
4618566|NCT01763866|7479237|FG017|Overall Study|Lost to Follow-up|0
4618567|NCT01763866|7479238|FG018|Overall Study|Lost to Follow-up|1
4618568|NCT01763866|7479239|FG019|Overall Study|Lost to Follow-up|1
4618569|NCT01763866|7479240|FG020|Overall Study|Lost to Follow-up|0
4618570|NCT01763866|7479241|FG021|Overall Study|Lost to Follow-up|0
4618571|NCT01763866|7479242|FG022|Overall Study|Lost to Follow-up|0
4618572|NCT01763866|7479243|FG023|Overall Study|Lost to Follow-up|1
4618573|NCT01763866|7479220|FG000|Overall Study|Death|0
4618574|NCT01763866|7479221|FG001|Overall Study|Death|0
4618575|NCT01763866|7479222|FG002|Overall Study|Death|0
4618576|NCT01763866|7479223|FG003|Overall Study|Death|0
4618577|NCT01763866|7479224|FG004|Overall Study|Death|0
4618578|NCT01763866|7479225|FG005|Overall Study|Death|0
4618579|NCT01763866|7479226|FG006|Overall Study|Death|0
4618580|NCT01763866|7479227|FG007|Overall Study|Death|0
4618581|NCT01763866|7479228|FG008|Overall Study|Death|0
4618582|NCT01763866|7479229|FG009|Overall Study|Death|0
4618583|NCT01763866|7479230|FG010|Overall Study|Death|0
4618584|NCT01763866|7479231|FG011|Overall Study|Death|0
4618585|NCT01763866|7479232|FG012|Overall Study|Death|0
4618586|NCT01763866|7479233|FG013|Overall Study|Death|0
4546239|NCT01180790|7372282|FG006|Overall Study|Lack of Efficacy|0
4546240|NCT01180790|7372276|FG000|Overall Study|compliance|0
4618587|NCT01763866|7479234|FG014|Overall Study|Death|0
4618588|NCT01763866|7479235|FG015|Overall Study|Death|0
4618589|NCT01763866|7479236|FG016|Overall Study|Death|1
4618590|NCT01763866|7479237|FG017|Overall Study|Death|0
4618591|NCT01763866|7479238|FG018|Overall Study|Death|0
4618592|NCT01763866|7479239|FG019|Overall Study|Death|0
4618593|NCT01763866|7479240|FG020|Overall Study|Death|0
4618594|NCT01763866|7479241|FG021|Overall Study|Death|0
4618595|NCT01763866|7479242|FG022|Overall Study|Death|0
4546241|NCT01180790|7372277|FG001|Overall Study|compliance|1
4546242|NCT01180790|7372278|FG002|Overall Study|compliance|0
4618596|NCT01763866|7479243|FG023|Overall Study|Death|0
4618597|NCT01763905|7479297|FG000|Overall Study|Withdrawal by Subject|1
4618598|NCT01763905|7479298|FG001|Overall Study|Withdrawal by Subject|1
4618599|NCT01763905|7479299|FG002|Overall Study|Withdrawal by Subject|0
4618600|NCT01763905|7479300|FG003|Overall Study|Withdrawal by Subject|1
4618601|NCT01763905|7479297|FG000|Overall Study|Decision by sponsor|5
4618602|NCT01763905|7479298|FG001|Overall Study|Decision by sponsor|0
4618603|NCT01763905|7479299|FG002|Overall Study|Decision by sponsor|8
4618604|NCT01763905|7479300|FG003|Overall Study|Decision by sponsor|0
4618605|NCT01763905|7479297|FG000|Overall Study|Lost to Follow-up|0
4618606|NCT01763905|7479298|FG001|Overall Study|Lost to Follow-up|0
4618607|NCT01763905|7479299|FG002|Overall Study|Lost to Follow-up|1
4618608|NCT01763905|7479300|FG003|Overall Study|Lost to Follow-up|0
4618609|NCT01763918|7479314|FG000|Overall Study|Withdrawal by Subject|2
4618610|NCT01763918|7479315|FG001|Overall Study|Withdrawal by Subject|1
4618611|NCT01763918|7479316|FG002|Overall Study|Withdrawal by Subject|1
4618612|NCT01763918|7479317|FG003|Overall Study|Withdrawal by Subject|2
4618613|NCT01763918|7479314|FG000|Overall Study|Sponsor Decision|4
4618614|NCT01763918|7479315|FG001|Overall Study|Sponsor Decision|0
4618615|NCT01763918|7479316|FG002|Overall Study|Sponsor Decision|9
4618616|NCT01763918|7479317|FG003|Overall Study|Sponsor Decision|0
4618617|NCT01763996|7479343|FG000|Treatment Period 2|Adverse Event|0
4618618|NCT01763996|7479344|FG001|Treatment Period 2|Adverse Event|1
4618619|NCT01764022|7479352|FG000|Overall Study|Death|3
4618620|NCT01764022|7479353|FG001|Overall Study|Death|5
4618621|NCT01764022|7479352|FG000|Overall Study|Withdrawal by Subject|2
4618622|NCT01764022|7479353|FG001|Overall Study|Withdrawal by Subject|6
4618623|NCT01764022|7479352|FG000|Overall Study|Lack of Efficacy|0
4618624|NCT01764022|7479353|FG001|Overall Study|Lack of Efficacy|1
4618625|NCT01764022|7479352|FG000|Overall Study|Physician Decision|0
4618626|NCT01764022|7479353|FG001|Overall Study|Physician Decision|2
4618627|NCT01764022|7479352|FG000|Overall Study|Lost to Follow-up|2
4618628|NCT01764022|7479353|FG001|Overall Study|Lost to Follow-up|0
4618629|NCT01764022|7479352|FG000|Overall Study|Protocol Violation|1
4618630|NCT01764022|7479353|FG001|Overall Study|Protocol Violation|0
4618631|NCT01764256|7479365|FG000|Received All Vaccinations|Adverse Event|1
4618632|NCT01764256|7479366|FG001|Received All Vaccinations|Adverse Event|1
4618633|NCT01764256|7479367|FG002|Received All Vaccinations|Adverse Event|0
4618634|NCT01764256|7479368|FG003|Received All Vaccinations|Adverse Event|0
4618635|NCT01764256|7479365|FG000|Received All Vaccinations|Did not meet inclusion criteria|0
4618636|NCT01764256|7479366|FG001|Received All Vaccinations|Did not meet inclusion criteria|0
4618637|NCT01764256|7479367|FG002|Received All Vaccinations|Did not meet inclusion criteria|1
4618638|NCT01764256|7479368|FG003|Received All Vaccinations|Did not meet inclusion criteria|0
4618639|NCT01764256|7479365|FG000|Received All Vaccinations|Lost to Follow-up|1
4618640|NCT01764256|7479366|FG001|Received All Vaccinations|Lost to Follow-up|0
4618641|NCT01764256|7479367|FG002|Received All Vaccinations|Lost to Follow-up|0
4618642|NCT01764256|7479368|FG003|Received All Vaccinations|Lost to Follow-up|0
4618643|NCT01764256|7479365|FG000|Completed Study|Lost to Follow-up|0
4618644|NCT01764256|7479366|FG001|Completed Study|Lost to Follow-up|0
4618645|NCT01764256|7479367|FG002|Completed Study|Lost to Follow-up|0
4618646|NCT01764256|7479368|FG003|Completed Study|Lost to Follow-up|1
4618647|NCT01764386|7479384|FG000|Controlled Treatment Period (CTP)|Adverse Event|35
4618648|NCT01764386|7479385|FG001|Controlled Treatment Period (CTP)|Adverse Event|0
4618649|NCT01764386|7479384|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32
4618650|NCT01764386|7479385|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0
4618651|NCT01764386|7479384|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9
4618652|NCT01764386|7479385|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5
4618653|NCT01764386|7479384|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6
4618654|NCT01764386|7479385|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2
4618655|NCT01764386|7479384|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2
4618656|NCT01764386|7479385|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13
4618657|NCT01764386|7479384|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0
4618658|NCT01764386|7479385|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26
4618659|NCT01764386|7479384|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9
4618660|NCT01764386|7479385|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9
4618661|NCT01764386|7479384|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5
4618662|NCT01764386|7479385|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5
4618663|NCT01764464|7479394|FG000|First Intervention|Withdrawal by Subject|1
4618664|NCT01764464|7479395|FG001|First Intervention|Withdrawal by Subject|0
4618665|NCT01764464|7479394|FG000|First Intervention|Lost to Follow-up|1
4618666|NCT01764464|7479395|FG001|First Intervention|Lost to Follow-up|0
4618667|NCT01764464|7479394|FG000|First Intervention|Adverse Event|0
4618668|NCT01764464|7479395|FG001|First Intervention|Adverse Event|2
4618669|NCT01764464|7479394|FG000|First Intervention|did not receive study drug|0
4546243|NCT01180790|7372279|FG003|Overall Study|compliance|0
4546244|NCT01180790|7372280|FG004|Overall Study|compliance|0
4546245|NCT01180790|7372281|FG005|Overall Study|compliance|0
4546246|NCT01180790|7372282|FG006|Overall Study|compliance|0
4546247|NCT01180790|7372276|FG000|Overall Study|Severe coronary atherosclerosis (death)|0
4546248|NCT01180790|7372277|FG001|Overall Study|Severe coronary atherosclerosis (death)|0
4546249|NCT01180790|7372278|FG002|Overall Study|Severe coronary atherosclerosis (death)|1
4546250|NCT01180790|7372279|FG003|Overall Study|Severe coronary atherosclerosis (death)|0
4546251|NCT01180790|7372280|FG004|Overall Study|Severe coronary atherosclerosis (death)|0
4546252|NCT01180790|7372281|FG005|Overall Study|Severe coronary atherosclerosis (death)|0
4546253|NCT01180790|7372282|FG006|Overall Study|Severe coronary atherosclerosis (death)|0
4546254|NCT01180985|7372337|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1
4546255|NCT01180985|7372338|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0
4546256|NCT01180998|7372348|FG000|Overall Study|Poor Vision|0
4546257|NCT01180998|7372349|FG001|Overall Study|Poor Vision|2
4546258|NCT01180998|7372350|FG002|Overall Study|Poor Vision|2
4546259|NCT01180998|7372348|FG000|Overall Study|Lost to Follow-up|0
4546260|NCT01180998|7372349|FG001|Overall Study|Lost to Follow-up|0
4546261|NCT01180998|7372350|FG002|Overall Study|Lost to Follow-up|1
4546262|NCT01180998|7372348|FG000|Overall Study|Protocol Violation|1
4546263|NCT01180998|7372349|FG001|Overall Study|Protocol Violation|2
4546264|NCT01180998|7372350|FG002|Overall Study|Protocol Violation|0
4546265|NCT01180998|7372348|FG000|Overall Study|Withdrawal by Subject|0
4546266|NCT01180998|7372349|FG001|Overall Study|Withdrawal by Subject|0
4546267|NCT01180998|7372350|FG002|Overall Study|Withdrawal by Subject|1
4546268|NCT01180998|7372348|FG000|Overall Study|Poor comfort|3
4546269|NCT01180998|7372349|FG001|Overall Study|Poor comfort|0
4546270|NCT01180998|7372350|FG002|Overall Study|Poor comfort|4
4546271|NCT01180998|7372348|FG000|Overall Study|Poor lens handling|0
4546272|NCT01180998|7372349|FG001|Overall Study|Poor lens handling|0
4546273|NCT01180998|7372350|FG002|Overall Study|Poor lens handling|2
4546274|NCT01181011|7372359|FG000|Overall Study|Adverse Event|2
4546275|NCT01181011|7372359|FG000|Overall Study|Lost to Follow-up|1
4546276|NCT01181102|7372388|FG000|Overall Study|Adverse Event|28
4546277|NCT01181102|7372389|FG001|Overall Study|Adverse Event|26
4546278|NCT01181102|7372388|FG000|Overall Study|Lack of Efficacy|3
4546279|NCT01181102|7372389|FG001|Overall Study|Lack of Efficacy|1
4546280|NCT01181102|7372388|FG000|Overall Study|Lost to Follow-up|2
4618670|NCT01764464|7479395|FG001|First Intervention|did not receive study drug|1
4618671|NCT01764464|7479394|FG000|Second Intervention (Cross-over)|Adverse Event|2
4618672|NCT01764464|7479395|FG001|Second Intervention (Cross-over)|Adverse Event|0
4618673|NCT01764633|7479407|FG000|Overall Study|Withdrawal by Subject|105
4618674|NCT01764633|7479408|FG001|Overall Study|Withdrawal by Subject|88
4690510|NCT02561195|7600195|FG010|Extension Stage (Vaccination 4)|Adverse Event|0
4690511|NCT02561195|7600196|FG011|Extension Stage (Vaccination 4)|Adverse Event|0
4690512|NCT02561195|7600197|FG012|Extension Stage (Vaccination 4)|Adverse Event|0
4690513|NCT02561195|7600198|FG013|Extension Stage (Vaccination 4)|Adverse Event|2
4690514|NCT02561195|7600185|FG000|Extension Stage (Vaccination 4)|Death|0
4690515|NCT02561195|7600186|FG001|Extension Stage (Vaccination 4)|Death|0
4690516|NCT02561195|7600187|FG002|Extension Stage (Vaccination 4)|Death|0
4690517|NCT02561195|7600188|FG003|Extension Stage (Vaccination 4)|Death|0
4690518|NCT02561195|7600189|FG004|Extension Stage (Vaccination 4)|Death|0
4618675|NCT01764633|7479407|FG000|Overall Study|Lost to Follow-up|13
4618676|NCT01764633|7479408|FG001|Overall Study|Lost to Follow-up|5
4618677|NCT01764659|7479414|FG000|Overall Study|Death|1
4618678|NCT01764659|7479414|FG000|Overall Study|Physician Decision|1
4618679|NCT01764841|7479433|FG000|Overall Study|Logistical Difficulties|0
4618680|NCT01764841|7479434|FG001|Overall Study|Logistical Difficulties|1
4618681|NCT01764841|7479435|FG002|Overall Study|Logistical Difficulties|0
4690519|NCT02561195|7600190|FG005|Extension Stage (Vaccination 4)|Death|0
4618682|NCT01764841|7479436|FG003|Overall Study|Logistical Difficulties|0
4618683|NCT01764841|7479433|FG000|Overall Study|Death|3
4618684|NCT01764841|7479434|FG001|Overall Study|Death|0
4618685|NCT01764841|7479435|FG002|Overall Study|Death|1
4690520|NCT02561195|7600191|FG006|Extension Stage (Vaccination 4)|Death|0
4546281|NCT01181102|7372389|FG001|Overall Study|Lost to Follow-up|0
4546282|NCT01181102|7372388|FG000|Overall Study|Physician Decision|3
4546283|NCT01181102|7372389|FG001|Overall Study|Physician Decision|1
4546284|NCT01181102|7372388|FG000|Overall Study|Protocol Violation|5
4546285|NCT01181102|7372389|FG001|Overall Study|Protocol Violation|6
4546286|NCT01181102|7372388|FG000|Overall Study|Withdrawal by Subject|10
4546287|NCT01181102|7372389|FG001|Overall Study|Withdrawal by Subject|12
4546288|NCT01181128|7372398|FG000|Overall Study|Withdrawal by Subject|2
4618686|NCT01764841|7479436|FG003|Overall Study|Death|4
4618687|NCT01764841|7479433|FG000|Overall Study|No Follow Up|1
4618688|NCT01764841|7479434|FG001|Overall Study|No Follow Up|0
4618689|NCT01764841|7479435|FG002|Overall Study|No Follow Up|1
4618690|NCT01764841|7479436|FG003|Overall Study|No Follow Up|0
4618691|NCT01764841|7479433|FG000|Overall Study|Protocol Violation|0
4618692|NCT01764841|7479434|FG001|Overall Study|Protocol Violation|1
4618693|NCT01764841|7479435|FG002|Overall Study|Protocol Violation|0
4618694|NCT01764841|7479436|FG003|Overall Study|Protocol Violation|0
4618695|NCT01764841|7479433|FG000|Overall Study|Withdrawal by Subject|16
4618696|NCT01764841|7479434|FG001|Overall Study|Withdrawal by Subject|24
4618697|NCT01764841|7479435|FG002|Overall Study|Withdrawal by Subject|11
4618698|NCT01764841|7479436|FG003|Overall Study|Withdrawal by Subject|15
4618699|NCT01764841|7479433|FG000|Overall Study|Lost to Follow-up|3
4618700|NCT01764841|7479434|FG001|Overall Study|Lost to Follow-up|0
4618701|NCT01764841|7479435|FG002|Overall Study|Lost to Follow-up|1
4618702|NCT01764841|7479436|FG003|Overall Study|Lost to Follow-up|0
4618703|NCT01764854|7479450|FG000|Overall Study|Adverse Event|0
4618704|NCT01764854|7479451|FG001|Overall Study|Adverse Event|0
4618705|NCT01764854|7479452|FG002|Overall Study|Adverse Event|2
4618706|NCT01764854|7479453|FG003|Overall Study|Adverse Event|0
4618707|NCT01764854|7479450|FG000|Overall Study|Withdrawal by Subject|0
4618708|NCT01764854|7479451|FG001|Overall Study|Withdrawal by Subject|0
4618709|NCT01764854|7479452|FG002|Overall Study|Withdrawal by Subject|1
4618710|NCT01764854|7479453|FG003|Overall Study|Withdrawal by Subject|0
4618711|NCT01764854|7479450|FG000|Overall Study|relocation|0
4618712|NCT01764854|7479451|FG001|Overall Study|relocation|0
4618713|NCT01764854|7479452|FG002|Overall Study|relocation|2
4618714|NCT01764854|7479453|FG003|Overall Study|relocation|0
4618715|NCT01764854|7479450|FG000|Overall Study|Protocol Violation|0
4618716|NCT01764854|7479451|FG001|Overall Study|Protocol Violation|0
4618717|NCT01764854|7479452|FG002|Overall Study|Protocol Violation|1
4618718|NCT01764854|7479453|FG003|Overall Study|Protocol Violation|2
4618719|NCT01764945|7479475|FG000|Overall Study|Adverse Event|0
4618720|NCT01764945|7479476|FG001|Overall Study|Adverse Event|1
4618721|NCT01764945|7479477|FG002|Overall Study|Adverse Event|0
4618722|NCT01764945|7479478|FG003|Overall Study|Adverse Event|0
4618723|NCT01764945|7479479|FG004|Overall Study|Adverse Event|0
4618724|NCT01764945|7479480|FG005|Overall Study|Adverse Event|0
4618725|NCT01764945|7479481|FG006|Overall Study|Adverse Event|1
4618726|NCT01764945|7479482|FG007|Overall Study|Adverse Event|0
4618727|NCT01765153|7479502|FG000|Training Phase 1|Format of intervention differed|1
4618728|NCT01765153|7479503|FG001|Training Phase 1|Format of intervention differed|0
4618729|NCT01765153|7479502|FG000|Training Phase 1|Poor participation in intervention|0
4618730|NCT01765153|7479503|FG001|Training Phase 1|Poor participation in intervention|1
4618731|NCT01765153|7479502|FG000|Rest Phase 1|Withdrawal by Subject|0
4618732|NCT01765153|7479503|FG001|Rest Phase 1|Withdrawal by Subject|1
4618733|NCT01765153|7479502|FG000|Training Phase 2|Withdrawal by Subject|0
4618734|NCT01765153|7479503|FG001|Training Phase 2|Withdrawal by Subject|1
4618735|NCT01765153|7479502|FG000|Rest Phase 2|Lost to Follow-up|2
4618736|NCT01765153|7479503|FG001|Rest Phase 2|Lost to Follow-up|1
4618737|NCT01765179|7479513|FG000|Overall Study|Adverse Event|3
4618738|NCT01765179|7479513|FG000|Overall Study|Lost to Follow-up|5
4618739|NCT01765179|7479513|FG000|Overall Study|Non-compliance with study drug|2
4618740|NCT01765179|7479513|FG000|Overall Study|Protocol Violation|1
4618741|NCT01765179|7479513|FG000|Overall Study|Withdrawal by Subject|8
4618742|NCT01765179|7479513|FG000|Overall Study|Hematocrit >54%|3
4618743|NCT01765179|7479513|FG000|Overall Study|prohibited med|1
4618744|NCT01765179|7479513|FG000|Overall Study|Out of country unable to finish study|1
4618745|NCT01765179|7479513|FG000|Overall Study|lack of venous access|1
4618746|NCT01765179|7479513|FG000|Overall Study|work conflict|1
4618747|NCT01765179|7479513|FG000|Overall Study|Ca elevated 10.6|1
4618748|NCT01765192|7479519|FG000|Treatment Period 1|Adverse Event|0
4618749|NCT01765192|7479520|FG001|Treatment Period 1|Adverse Event|1
4618750|NCT01765192|7479519|FG000|Washout Period|Voluntary Withdrawal|1
4618751|NCT01765192|7479520|FG001|Washout Period|Voluntary Withdrawal|1
4618752|NCT01765192|7479519|FG000|Washout Period|Reason not specified|1
4618753|NCT01765192|7479520|FG001|Washout Period|Reason not specified|0
4618754|NCT01765192|7479519|FG000|Treatment Period 2|Reason not specified|0
4618755|NCT01765192|7479520|FG001|Treatment Period 2|Reason not specified|2
4618756|NCT01765192|7479519|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0
4618757|NCT01765192|7479520|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1
4618758|NCT01765270|7479528|FG000|Overall Study|Physician Decision|1
4546289|NCT01181128|7372399|FG001|Overall Study|Withdrawal by Subject|2
4546290|NCT01181128|7372400|FG002|Overall Study|Withdrawal by Subject|0
4618759|NCT01765270|7479529|FG001|Overall Study|Physician Decision|0
4618760|NCT01765270|7479528|FG000|Overall Study|Withdrawal by Subject|0
4546291|NCT01181128|7372398|FG000|Overall Study|Death|1
4546292|NCT01181128|7372399|FG001|Overall Study|Death|0
4546293|NCT01181128|7372400|FG002|Overall Study|Death|0
4546294|NCT01181128|7372398|FG000|Overall Study|Physician Decision|2
4546295|NCT01181128|7372399|FG001|Overall Study|Physician Decision|0
4546296|NCT01181128|7372400|FG002|Overall Study|Physician Decision|0
4546297|NCT01181128|7372398|FG000|Overall Study|Adverse Event|0
4546298|NCT01181128|7372399|FG001|Overall Study|Adverse Event|2
4546299|NCT01181128|7372400|FG002|Overall Study|Adverse Event|0
4546300|NCT01181128|7372398|FG000|Overall Study|Other|1
4546301|NCT01181128|7372399|FG001|Overall Study|Other|1
4546302|NCT01181128|7372400|FG002|Overall Study|Other|1
4546303|NCT01181141|7372422|FG000|Overall Study|Adverse Event|2
4546304|NCT01181141|7372423|FG001|Overall Study|Adverse Event|1
4546305|NCT01181141|7372422|FG000|Overall Study|Lack of Efficacy|1
4546306|NCT01181141|7372423|FG001|Overall Study|Lack of Efficacy|0
4546307|NCT01181141|7372422|FG000|Overall Study|Lost to Follow-up|1
4546308|NCT01181141|7372423|FG001|Overall Study|Lost to Follow-up|1
4546309|NCT01181141|7372422|FG000|Overall Study|Physician Decision|2
4546310|NCT01181141|7372423|FG001|Overall Study|Physician Decision|0
4546311|NCT01181141|7372422|FG000|Overall Study|Protocol Violation|3
4546312|NCT01181141|7372423|FG001|Overall Study|Protocol Violation|1
4546313|NCT01181141|7372422|FG000|Overall Study|Withdrawal by Subject|3
4546314|NCT01181141|7372423|FG001|Overall Study|Withdrawal by Subject|1
4546315|NCT01181167|7372431|FG000|Overall Study|Adverse Event|11
4546316|NCT01181167|7372432|FG001|Overall Study|Adverse Event|21
4546317|NCT01181167|7372431|FG000|Overall Study|Lost to Follow-up|1
4546318|NCT01181167|7372432|FG001|Overall Study|Lost to Follow-up|0
4546319|NCT01181167|7372431|FG000|Overall Study|Physician Decision|2
4546320|NCT01181167|7372432|FG001|Overall Study|Physician Decision|3
4546321|NCT01181167|7372431|FG000|Overall Study|Protocol Violation|3
4546322|NCT01181167|7372432|FG001|Overall Study|Protocol Violation|0
4618761|NCT01765270|7479529|FG001|Overall Study|Withdrawal by Subject|1
4618762|NCT01765426|7479540|FG000|Overall Study|Lost to Follow-up|0
4618763|NCT01765426|7479541|FG001|Overall Study|Lost to Follow-up|1
4618764|NCT01765426|7479542|FG002|Overall Study|Lost to Follow-up|0
4618765|NCT01765426|7479543|FG003|Overall Study|Lost to Follow-up|0
4618766|NCT01765543|7479573|FG000|Overall Study|Death|1
4618767|NCT01765543|7479573|FG000|Overall Study|Withdrawal by Subject|2
4618768|NCT01765569|7479581|FG000|Period B|Withdrawal by Subject|1
4618769|NCT01765569|7479581|FG000|Period C|Death|1
4618770|NCT01765582|7479591|FG000|Overall Study|Other|3
4618771|NCT01765582|7479592|FG001|Overall Study|Other|6
4618772|NCT01765582|7479593|FG002|Overall Study|Other|9
4618773|NCT01765582|7479591|FG000|Overall Study|Lost to Follow-up|2
4618774|NCT01765582|7479592|FG001|Overall Study|Lost to Follow-up|2
4618775|NCT01765582|7479593|FG002|Overall Study|Lost to Follow-up|1
4618776|NCT01765582|7479591|FG000|Overall Study|Death|31
4618777|NCT01765582|7479592|FG001|Overall Study|Death|36
4618778|NCT01765582|7479593|FG002|Overall Study|Death|33
4618779|NCT01765582|7479591|FG000|Overall Study|Sponsor Decision|46
4618780|NCT01765582|7479592|FG001|Overall Study|Sponsor Decision|42
4618781|NCT01765582|7479593|FG002|Overall Study|Sponsor Decision|42
4618782|NCT01765582|7479591|FG000|Overall Study|Withdrawal of Consent|11
4618783|NCT01765582|7479592|FG001|Overall Study|Withdrawal of Consent|6
4618784|NCT01765582|7479593|FG002|Overall Study|Withdrawal of Consent|10
4618785|NCT01765673|7479606|FG000|Overall Study|No transportation for 2nd/3rd visits|1
4618786|NCT01765751|7479625|FG000|Overall Study|Lost to Follow-up|0
4618787|NCT01765751|7479626|FG001|Overall Study|Lost to Follow-up|2
4618788|NCT01765751|7479627|FG002|Overall Study|Lost to Follow-up|1
4618789|NCT01765764|7479641|FG000|Treatment Period|Adverse Event|1
4618790|NCT01765764|7479642|FG001|Treatment Period|Adverse Event|2
4618791|NCT01765764|7479643|FG002|Treatment Period|Adverse Event|1
4618792|NCT01765764|7479641|FG000|Treatment Period|Lost to Follow-up|0
4618793|NCT01765764|7479642|FG001|Treatment Period|Lost to Follow-up|3
4618794|NCT01765764|7479643|FG002|Treatment Period|Lost to Follow-up|2
4618795|NCT01765764|7479641|FG000|Treatment Period|Personal Reasons|1
4618796|NCT01765764|7479642|FG001|Treatment Period|Personal Reasons|2
4618797|NCT01765764|7479643|FG002|Treatment Period|Personal Reasons|1
4618798|NCT01765764|7479641|FG000|Treatment Period|Other Miscellaneous Reasons|1
4618799|NCT01765764|7479642|FG001|Treatment Period|Other Miscellaneous Reasons|2
4618800|NCT01765764|7479643|FG002|Treatment Period|Other Miscellaneous Reasons|2
4618801|NCT01765920|7479657|FG000|Overall Study|Incorrect inclusion ineligible patient|2
4618802|NCT01765920|7479658|FG001|Overall Study|Incorrect inclusion ineligible patient|5
4618803|NCT01765920|7479657|FG000|Overall Study|Patient code disclosure|0
4546323|NCT01181167|7372431|FG000|Overall Study|Withdrawal by Subject|6
4546324|NCT01181167|7372432|FG001|Overall Study|Withdrawal by Subject|8
4618804|NCT01765920|7479658|FG001|Overall Study|Patient code disclosure|1
4618805|NCT01766037|7479690|FG000|Overall Study|Adverse Event|1
4618806|NCT01766037|7479691|FG001|Overall Study|Adverse Event|0
4618807|NCT01766037|7479690|FG000|Overall Study|Lack of Efficacy|1
4618808|NCT01766037|7479691|FG001|Overall Study|Lack of Efficacy|0
4546325|NCT01181271|7372442|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6
4546326|NCT01181271|7372442|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4
4618809|NCT01766037|7479690|FG000|Overall Study|Lost to Follow-up|0
4618810|NCT01766037|7479691|FG001|Overall Study|Lost to Follow-up|10
4546327|NCT01181271|7372442|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2
4546328|NCT01181271|7372442|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1
4546329|NCT01181531|7372512|FG000|Overall Study|Other|17
4546330|NCT01181531|7372513|FG001|Overall Study|Other|12
4546331|NCT01181531|7372512|FG000|Overall Study|Partial consent by subject withdrawn|0
4546332|NCT01181531|7372513|FG001|Overall Study|Partial consent by subject withdrawn|1
4546333|NCT01181531|7372512|FG000|Overall Study|Physician Decision|3
4546334|NCT01181531|7372513|FG001|Overall Study|Physician Decision|1
4546335|NCT01181531|7372512|FG000|Overall Study|Noncompliance|2
4546336|NCT01181531|7372513|FG001|Overall Study|Noncompliance|2
4546337|NCT01181531|7372512|FG000|Overall Study|Ineligibility determined|1
4546338|NCT01181531|7372513|FG001|Overall Study|Ineligibility determined|2
4546339|NCT01181531|7372512|FG000|Overall Study|Protocol Specified Criteria|15
4546340|NCT01181531|7372513|FG001|Overall Study|Protocol Specified Criteria|8
4546341|NCT01181531|7372512|FG000|Overall Study|Pregnancy|0
4546342|NCT01181531|7372513|FG001|Overall Study|Pregnancy|1
4546343|NCT01181531|7372512|FG000|Overall Study|Withdrawal by Subject|8
4546344|NCT01181531|7372513|FG001|Overall Study|Withdrawal by Subject|7
4546345|NCT01181531|7372512|FG000|Overall Study|Protocol Violation|6
4546346|NCT01181531|7372513|FG001|Overall Study|Protocol Violation|6
4546347|NCT01181531|7372512|FG000|Overall Study|Death|9
4546348|NCT01181531|7372513|FG001|Overall Study|Death|12
4546349|NCT01181531|7372512|FG000|Overall Study|Adverse Event|0
4546350|NCT01181531|7372513|FG001|Overall Study|Adverse Event|1
4591528|NCT01531673|7438201|FG012|Overall Study|Adverse Event|0
4591529|NCT01531673|7438189|FG000|Overall Study|Lost to Follow-up|0
4591530|NCT01531673|7438190|FG001|Overall Study|Lost to Follow-up|0
4618811|NCT01766037|7479690|FG000|Overall Study|Physician Decision|0
4618812|NCT01766037|7479691|FG001|Overall Study|Physician Decision|1
4618813|NCT01766037|7479690|FG000|Overall Study|Withdrawal by Subject|18
4618814|NCT01766037|7479691|FG001|Overall Study|Withdrawal by Subject|16
4618815|NCT01766037|7479690|FG000|Overall Study|Moved from area|5
4618816|NCT01766037|7479691|FG001|Overall Study|Moved from area|0
4618817|NCT01766037|7479690|FG000|Overall Study|medical - unrelated|1
4618818|NCT01766037|7479691|FG001|Overall Study|medical - unrelated|2
4618819|NCT01766037|7479690|FG000|Overall Study|nausea / discomfort|3
4618820|NCT01766037|7479691|FG001|Overall Study|nausea / discomfort|0
4618821|NCT01766050|7479697|FG000|Overall Study|Adverse Event|1
4618822|NCT01766050|7479697|FG000|Overall Study|Lost to Follow-up|1
4618823|NCT01766050|7479697|FG000|Overall Study|Withdrawal by Subject|2
4618824|NCT01766206|7479733|FG000|Overall Study|Withdrawal by Subject|22
4618825|NCT01766206|7479733|FG000|Overall Study|Lost to Follow-up|10
4618826|NCT01766206|7479733|FG000|Overall Study|Inappropriate enrollment|18
4618827|NCT01766206|7479733|FG000|Overall Study|Withdrawal and inappropriate enrollment|1
4618828|NCT01766310|7479753|FG000|Overall Study|Lost to Follow-up|1
4618829|NCT01766310|7479754|FG001|Overall Study|Lost to Follow-up|3
4618830|NCT01766336|7479762|FG000|Overall Study|Adverse Event|11
4618831|NCT01766336|7479763|FG001|Overall Study|Adverse Event|8
4618832|NCT01766336|7479762|FG000|Overall Study|Death|4
4618833|NCT01766336|7479763|FG001|Overall Study|Death|3
4618834|NCT01766336|7479762|FG000|Overall Study|Lost to Follow-up|1
4618835|NCT01766336|7479763|FG001|Overall Study|Lost to Follow-up|3
4618836|NCT01766336|7479762|FG000|Overall Study|Physician Decision|4
4618837|NCT01766336|7479763|FG001|Overall Study|Physician Decision|2
4618838|NCT01766336|7479762|FG000|Overall Study|Protocol Violation|0
4618839|NCT01766336|7479763|FG001|Overall Study|Protocol Violation|1
4618840|NCT01766336|7479762|FG000|Overall Study|Sponsor Decision|52
4618841|NCT01766336|7479763|FG001|Overall Study|Sponsor Decision|43
4618842|NCT01766336|7479762|FG000|Overall Study|Withdrawal by Subject|18
4618843|NCT01766336|7479763|FG001|Overall Study|Withdrawal by Subject|15
4618844|NCT01766401|7479771|FG000|Overall Study|Adverse Event|7
4618845|NCT01766401|7479772|FG001|Overall Study|Adverse Event|22
4618846|NCT01766401|7479771|FG000|Overall Study|Lack of Efficacy|1
4618847|NCT01766401|7479772|FG001|Overall Study|Lack of Efficacy|2
4618848|NCT01766401|7479771|FG000|Overall Study|Protocol Violation|3
4618849|NCT01766401|7479772|FG001|Overall Study|Protocol Violation|8
4618850|NCT01766401|7479771|FG000|Overall Study|Withdrawal by Subject|15
4618851|NCT01766401|7479772|FG001|Overall Study|Withdrawal by Subject|12
4618852|NCT01766401|7479771|FG000|Overall Study|Lost to Follow-up|10
4618853|NCT01766401|7479772|FG001|Overall Study|Lost to Follow-up|11
4591531|NCT01531673|7438191|FG002|Overall Study|Lost to Follow-up|0
4591532|NCT01531673|7438192|FG003|Overall Study|Lost to Follow-up|0
4591533|NCT01531673|7438193|FG004|Overall Study|Lost to Follow-up|1
4591534|NCT01531673|7438194|FG005|Overall Study|Lost to Follow-up|0
4591535|NCT01531673|7438195|FG006|Overall Study|Lost to Follow-up|0
4618854|NCT01766401|7479771|FG000|Overall Study|Pregnancy|1
4618855|NCT01766401|7479772|FG001|Overall Study|Pregnancy|1
4591536|NCT01531673|7438196|FG007|Overall Study|Lost to Follow-up|0
4591537|NCT01531673|7438197|FG008|Overall Study|Lost to Follow-up|0
4618856|NCT01766778|7479807|FG000|Overall Study|Adverse Event|4
4618857|NCT01766778|7479808|FG001|Overall Study|Adverse Event|4
4618858|NCT01766778|7479807|FG000|Overall Study|Withdrawal by Subject|1
4618859|NCT01766778|7479808|FG001|Overall Study|Withdrawal by Subject|0
4618860|NCT01766817|7479817|FG000|Overall Study|Drug-related adverse event|1
4618861|NCT01766817|7479818|FG001|Overall Study|Drug-related adverse event|2
4618862|NCT01766817|7479819|FG002|Overall Study|Drug-related adverse event|1
4546351|NCT01181609|7372524|FG000|Overall Study|Adverse Event|1
4546352|NCT01181609|7372524|FG000|Overall Study|Withdrawal by Subject|1
4546353|NCT01181609|7372524|FG000|Overall Study|Lost to Follow-up|1
4546354|NCT01181609|7372524|FG000|Overall Study|Death|50
4546355|NCT01181726|7372543|FG000|First Intervention|Adverse Event|1
4546356|NCT01181726|7372544|FG001|First Intervention|Adverse Event|0
4546357|NCT01181895|7372570|FG000|Overall Study|Adverse Event|3
4546358|NCT01181895|7372571|FG001|Overall Study|Adverse Event|1
4546359|NCT01181895|7372572|FG002|Overall Study|Adverse Event|1
4546360|NCT01181895|7372570|FG000|Overall Study|Lack of Efficacy|8
4546361|NCT01181895|7372571|FG001|Overall Study|Lack of Efficacy|9
4546362|NCT01181895|7372572|FG002|Overall Study|Lack of Efficacy|9
4546363|NCT01181895|7372570|FG000|Overall Study|Protocol Violation|2
4546364|NCT01181895|7372571|FG001|Overall Study|Protocol Violation|1
4546365|NCT01181895|7372572|FG002|Overall Study|Protocol Violation|0
4546366|NCT01181895|7372570|FG000|Overall Study|Lost to Follow-up|0
4546367|NCT01181895|7372571|FG001|Overall Study|Lost to Follow-up|1
4546368|NCT01181895|7372572|FG002|Overall Study|Lost to Follow-up|2
4546369|NCT01181895|7372570|FG000|Overall Study|Investigator Discretion|1
4546370|NCT01181895|7372571|FG001|Overall Study|Investigator Discretion|2
4546371|NCT01181895|7372572|FG002|Overall Study|Investigator Discretion|1
4546372|NCT01181895|7372570|FG000|Overall Study|Withdrawal by Subject|3
4546373|NCT01181895|7372571|FG001|Overall Study|Withdrawal by Subject|0
4546374|NCT01181895|7372572|FG002|Overall Study|Withdrawal by Subject|5
4546375|NCT01181986|7372587|FG000|Phase 1|Lost to Follow-up|0
4546376|NCT01181986|7372588|FG001|Phase 1|Lost to Follow-up|1
4546377|NCT01181986|7372589|FG002|Phase 1|Lost to Follow-up|1
4546378|NCT01181986|7372587|FG000|Phase 1|Adverse Event|0
4546379|NCT01181986|7372588|FG001|Phase 1|Adverse Event|0
4546380|NCT01181986|7372589|FG002|Phase 1|Adverse Event|1
4546381|NCT01181986|7372587|FG000|Phase 1|Protocol Violation|1
4546382|NCT01181986|7372588|FG001|Phase 1|Protocol Violation|0
4546383|NCT01181986|7372589|FG002|Phase 1|Protocol Violation|0
4546384|NCT01181986|7372587|FG000|Phase 2|Adverse Event|0
4546385|NCT01181986|7372588|FG001|Phase 2|Adverse Event|3
4546386|NCT01181986|7372589|FG002|Phase 2|Adverse Event|0
4546387|NCT01181986|7372587|FG000|Phase 2|Medical condition|0
4546388|NCT01181986|7372588|FG001|Phase 2|Medical condition|1
4546389|NCT01181986|7372589|FG002|Phase 2|Medical condition|0
4546390|NCT01182181|7372617|FG000|First Intervention|Adverse Event|1
4546391|NCT01182181|7372618|FG001|First Intervention|Adverse Event|0
4546392|NCT01182181|7372617|FG000|Washout of 21 Days|Withdrawal by Subject|0
4546393|NCT01182181|7372618|FG001|Washout of 21 Days|Withdrawal by Subject|1
4546394|NCT01182194|7372626|FG000|Washout of 28 Days|Withdrawal by Subject|1
4618863|NCT01766817|7479817|FG000|Overall Study|Drug-unrelated adverse event|3
4618864|NCT01766817|7479818|FG001|Overall Study|Drug-unrelated adverse event|3
4618865|NCT01766817|7479819|FG002|Overall Study|Drug-unrelated adverse event|3
4618866|NCT01766817|7479817|FG000|Overall Study|Death|1
4618867|NCT01766817|7479818|FG001|Overall Study|Death|1
4618868|NCT01766817|7479819|FG002|Overall Study|Death|0
4618869|NCT01766817|7479817|FG000|Overall Study|Unable to take study drug|0
4618870|NCT01766817|7479818|FG001|Overall Study|Unable to take study drug|1
4618871|NCT01766817|7479819|FG002|Overall Study|Unable to take study drug|0
4618872|NCT01766817|7479817|FG000|Overall Study|Withdrawal by Subject|2
4618873|NCT01766817|7479818|FG001|Overall Study|Withdrawal by Subject|0
4618874|NCT01766817|7479819|FG002|Overall Study|Withdrawal by Subject|3
4618875|NCT01766817|7479817|FG000|Overall Study|Subject non-compliance|0
4618876|NCT01766817|7479818|FG001|Overall Study|Subject non-compliance|1
4618877|NCT01766817|7479819|FG002|Overall Study|Subject non-compliance|2
4618878|NCT01766817|7479817|FG000|Overall Study|Physician Decision|3
4618879|NCT01766817|7479818|FG001|Overall Study|Physician Decision|3
4618880|NCT01766817|7479819|FG002|Overall Study|Physician Decision|4
4618881|NCT01766817|7479817|FG000|Overall Study|Other|1
4618882|NCT01766817|7479818|FG001|Overall Study|Other|0
4618883|NCT01766817|7479819|FG002|Overall Study|Other|0
4618884|NCT01766921|7479829|FG000|Overall Study|Administrative Reason|5
4618885|NCT01766921|7479830|FG001|Overall Study|Administrative Reason|5
4618886|NCT01766921|7479829|FG000|Overall Study|Death|1
4618887|NCT01766921|7479830|FG001|Overall Study|Death|1
4618888|NCT01766921|7479829|FG000|Overall Study|Lost to Follow-up|1
4618889|NCT01766921|7479830|FG001|Overall Study|Lost to Follow-up|3
4618890|NCT01766921|7479829|FG000|Overall Study|Unclassified|2
4618891|NCT01766921|7479830|FG001|Overall Study|Unclassified|2
4618892|NCT01766921|7479829|FG000|Overall Study|Protocol Violation|1
4618893|NCT01766921|7479830|FG001|Overall Study|Protocol Violation|1
4618894|NCT01766921|7479829|FG000|Overall Study|Withdrawal by Subject|14
4546395|NCT01182194|7372627|FG001|Washout of 28 Days|Withdrawal by Subject|0
4546396|NCT01182207|7372635|FG000|First Intervention|Positive Hepatitis Results|0
4546397|NCT01182207|7372636|FG001|First Intervention|Positive Hepatitis Results|1
4546398|NCT01182207|7372635|FG000|Second Intervention|Emeses within 1 hour of dosing|1
4618895|NCT01766921|7479830|FG001|Overall Study|Withdrawal by Subject|5
4618896|NCT01767116|7479875|FG000|Overall Study|Lost to Follow-up|2
4591538|NCT01531673|7438198|FG009|Overall Study|Lost to Follow-up|0
4618897|NCT01767116|7479876|FG001|Overall Study|Lost to Follow-up|2
4618898|NCT01767142|7479882|FG000|Overall Study|Lost to Follow-up|3
4618899|NCT01767376|7479907|FG000|Overall Study|Lost to Follow-up|3
4618900|NCT01767376|7479908|FG001|Overall Study|Lost to Follow-up|2
4546399|NCT01182207|7372636|FG001|Second Intervention|Emeses within 1 hour of dosing|0
4546400|NCT01182285|7372642|FG000|First Intervention Week 1-10|Disease progression|1
4546401|NCT01182285|7372643|FG001|First Intervention Week 1-10|Disease progression|0
4546402|NCT01182285|7372644|FG002|First Intervention Week 1-10|Disease progression|0
4546403|NCT01182285|7372642|FG000|First Intervention Week 1-10|Adverse Event|1
4546404|NCT01182285|7372643|FG001|First Intervention Week 1-10|Adverse Event|0
4546405|NCT01182285|7372644|FG002|First Intervention Week 1-10|Adverse Event|0
4546406|NCT01182285|7372642|FG000|First Intervention Week 1-10|Non-compliance|1
4546407|NCT01182285|7372643|FG001|First Intervention Week 1-10|Non-compliance|0
4546408|NCT01182285|7372644|FG002|First Intervention Week 1-10|Non-compliance|0
4546409|NCT01182285|7372642|FG000|Third Intervention Week 11-52|Disease Progression|0
4546410|NCT01182285|7372643|FG001|Third Intervention Week 11-52|Disease Progression|0
4546411|NCT01182285|7372644|FG002|Third Intervention Week 11-52|Disease Progression|6
4546412|NCT01182285|7372642|FG000|Third Intervention Week 11-52|Other|0
4546413|NCT01182285|7372643|FG001|Third Intervention Week 11-52|Other|0
4546414|NCT01182285|7372644|FG002|Third Intervention Week 11-52|Other|2
4618901|NCT01767376|7479909|FG002|Overall Study|Lost to Follow-up|0
4618902|NCT01767376|7479907|FG000|Overall Study|Withdrawal by Subject|1
4618903|NCT01767376|7479908|FG001|Overall Study|Withdrawal by Subject|1
4618904|NCT01767376|7479909|FG002|Overall Study|Withdrawal by Subject|0
4618905|NCT01767467|7479925|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8
4618906|NCT01767467|7479926|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8
4618907|NCT01767467|7479925|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1
4618908|NCT01767467|7479926|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0
4618909|NCT01767467|7479925|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7
4618910|NCT01767467|7479926|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10
4618911|NCT01767467|7479925|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0
4618912|NCT01767467|7479926|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1
4618913|NCT01767467|7479925|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1
4618914|NCT01767467|7479926|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0
4618915|NCT01767467|7479925|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0
4618916|NCT01767467|7479926|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1
4618917|NCT01767467|7479925|FG000|End of Study Phase (up to Month 13)|Adverse Event|29
4618918|NCT01767467|7479926|FG001|End of Study Phase (up to Month 13)|Adverse Event|39
4618919|NCT01767467|7479925|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2
4618920|NCT01767467|7479926|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0
4618921|NCT01767467|7479925|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9
4618922|NCT01767467|7479926|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14
4618923|NCT01767467|7479925|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0
4618924|NCT01767467|7479926|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3
4618925|NCT01767467|7479925|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6
4618926|NCT01767467|7479926|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4
4618927|NCT01767467|7479925|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0
4618928|NCT01767467|7479926|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1
4618929|NCT01767467|7479925|FG000|End of Study Phase (up to Month 13)|Physician Decision|1
4618930|NCT01767467|7479926|FG001|End of Study Phase (up to Month 13)|Physician Decision|0
4618931|NCT01767467|7479925|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0
4618932|NCT01767467|7479926|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2
4618933|NCT01767493|7479939|FG000|Overall Study|screen failures|3
4618934|NCT01767519|7479955|FG000|Overall Study|Other Reasons|4
4618935|NCT01767519|7479956|FG001|Overall Study|Other Reasons|4
4618936|NCT01767519|7479957|FG002|Overall Study|Other Reasons|2
4618937|NCT01767519|7479955|FG000|Overall Study|Protocol Violation|0
4618938|NCT01767519|7479956|FG001|Overall Study|Protocol Violation|3
4618939|NCT01767519|7479957|FG002|Overall Study|Protocol Violation|0
4618940|NCT01767519|7479955|FG000|Overall Study|Personal Reasons|1
4618941|NCT01767519|7479956|FG001|Overall Study|Personal Reasons|0
4618942|NCT01767519|7479957|FG002|Overall Study|Personal Reasons|0
4690521|NCT02561195|7600192|FG007|Extension Stage (Vaccination 4)|Death|0
4690522|NCT02561195|7600193|FG008|Extension Stage (Vaccination 4)|Death|0
4690523|NCT02561195|7600194|FG009|Extension Stage (Vaccination 4)|Death|1
4690524|NCT02561195|7600195|FG010|Extension Stage (Vaccination 4)|Death|0
4690525|NCT02561195|7600196|FG011|Extension Stage (Vaccination 4)|Death|0
4690526|NCT02561195|7600197|FG012|Extension Stage (Vaccination 4)|Death|0
4690527|NCT02561195|7600198|FG013|Extension Stage (Vaccination 4)|Death|0
4690528|NCT02561195|7600185|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0
4690529|NCT02561195|7600186|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0
4690530|NCT02561195|7600187|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0
4690531|NCT02561195|7600188|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0
4690532|NCT02561195|7600189|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0
4690533|NCT02561195|7600190|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0
4690534|NCT02561195|7600191|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1
4690535|NCT02561195|7600192|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1
4690536|NCT02561195|7600193|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0
4690537|NCT02561195|7600194|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0
4546415|NCT01182298|7372651|FG000|Overall Study|Lack of Efficacy|4
4546416|NCT01182298|7372651|FG000|Overall Study|Withdrawal by Subject|2
4546417|NCT01182337|7372657|FG000|Overall Study|Withdrawal by Subject|3
4546418|NCT01182337|7372658|FG001|Overall Study|Withdrawal by Subject|1
4546419|NCT01182337|7372657|FG000|Overall Study|Lost to Follow-up|0
4546420|NCT01182337|7372658|FG001|Overall Study|Lost to Follow-up|1
4546421|NCT01182350|7372665|FG000|Overall Study|Adverse Event|5
4546422|NCT01182350|7372666|FG001|Overall Study|Adverse Event|0
4546423|NCT01182350|7372667|FG002|Overall Study|Adverse Event|0
4546424|NCT01182350|7372668|FG003|Overall Study|Adverse Event|0
4546425|NCT01182350|7372669|FG004|Overall Study|Adverse Event|0
4546426|NCT01182350|7372665|FG000|Overall Study|Disease Progression|15
4546427|NCT01182350|7372666|FG001|Overall Study|Disease Progression|12
4546428|NCT01182350|7372667|FG002|Overall Study|Disease Progression|0
4546429|NCT01182350|7372668|FG003|Overall Study|Disease Progression|1
4546430|NCT01182350|7372669|FG004|Overall Study|Disease Progression|0
4546431|NCT01182350|7372665|FG000|Overall Study|Death|0
4546432|NCT01182350|7372666|FG001|Overall Study|Death|1
4546433|NCT01182350|7372667|FG002|Overall Study|Death|1
4546434|NCT01182350|7372668|FG003|Overall Study|Death|0
4546435|NCT01182350|7372669|FG004|Overall Study|Death|0
4546436|NCT01182350|7372665|FG000|Overall Study|Withdrawal by Subject|3
4546437|NCT01182350|7372666|FG001|Overall Study|Withdrawal by Subject|1
4546438|NCT01182350|7372667|FG002|Overall Study|Withdrawal by Subject|0
4546439|NCT01182350|7372668|FG003|Overall Study|Withdrawal by Subject|1
4546440|NCT01182350|7372669|FG004|Overall Study|Withdrawal by Subject|0
4546441|NCT01182350|7372665|FG000|Overall Study|Alternative Therapy|2
4546442|NCT01182350|7372666|FG001|Overall Study|Alternative Therapy|0
4546443|NCT01182350|7372667|FG002|Overall Study|Alternative Therapy|1
4546444|NCT01182350|7372668|FG003|Overall Study|Alternative Therapy|0
4618943|NCT01767519|7479955|FG000|Overall Study|Lost to Follow-up|3
4618944|NCT01767519|7479956|FG001|Overall Study|Lost to Follow-up|1
4618945|NCT01767519|7479957|FG002|Overall Study|Lost to Follow-up|2
4618946|NCT01767519|7479955|FG000|Overall Study|Lack of Efficacy|1
4618947|NCT01767519|7479956|FG001|Overall Study|Lack of Efficacy|0
4618948|NCT01767519|7479957|FG002|Overall Study|Lack of Efficacy|0
4618949|NCT01767519|7479955|FG000|Overall Study|Adverse Event|5
4618950|NCT01767519|7479956|FG001|Overall Study|Adverse Event|5
4618951|NCT01767519|7479957|FG002|Overall Study|Adverse Event|1
4618952|NCT01767597|7479967|FG000|Overall Study|Incomplete intervention|3
4618953|NCT01767597|7479968|FG001|Overall Study|Incomplete intervention|1
4618954|NCT01767597|7479967|FG000|Overall Study|Withdrawal by Subject|1
4618955|NCT01767597|7479968|FG001|Overall Study|Withdrawal by Subject|0
4618956|NCT01767857|7479999|FG000|Overall Study|Adverse Event|27
4618957|NCT01767857|7480000|FG001|Overall Study|Adverse Event|7
4618958|NCT01767857|7479999|FG000|Overall Study|Death|28
4618959|NCT01767857|7480000|FG001|Overall Study|Death|13
4618960|NCT01767857|7479999|FG000|Overall Study|Lack of Efficacy|299
4618961|NCT01767857|7480000|FG001|Overall Study|Lack of Efficacy|151
4618962|NCT01767857|7479999|FG000|Overall Study|Lost to Follow-up|1
4618963|NCT01767857|7480000|FG001|Overall Study|Lost to Follow-up|1
4618964|NCT01767857|7479999|FG000|Overall Study|Withdrawal by Subject|38
4618965|NCT01767857|7480000|FG001|Overall Study|Withdrawal by Subject|18
4618966|NCT01767857|7479999|FG000|Overall Study|Physician Decision|17
4618967|NCT01767857|7480000|FG001|Overall Study|Physician Decision|10
4618968|NCT01767857|7479999|FG000|Overall Study|Protocol Terminated|1
4618969|NCT01767857|7480000|FG001|Overall Study|Protocol Terminated|0
4618970|NCT01767857|7479999|FG000|Overall Study|Randomized But Never Treated|19
4618971|NCT01767857|7480000|FG001|Overall Study|Randomized But Never Treated|13
4618972|NCT01767909|7480009|FG000|Overall Study|Withdrawal by Subject|4
4618973|NCT01767909|7480010|FG001|Overall Study|Withdrawal by Subject|7
4618974|NCT01767909|7480009|FG000|Overall Study|Adverse Event|3
4618975|NCT01767909|7480010|FG001|Overall Study|Adverse Event|1
4618976|NCT01767909|7480009|FG000|Overall Study|Withdrawal by Study Partner|3
4618977|NCT01767909|7480010|FG001|Overall Study|Withdrawal by Study Partner|1
4618978|NCT01767909|7480009|FG000|Overall Study|Non-Compliance|2
4618979|NCT01767909|7480010|FG001|Overall Study|Non-Compliance|0
4618980|NCT01767909|7480009|FG000|Overall Study|Perceived Lack of Efficacy|1
4618981|NCT01767909|7480010|FG001|Overall Study|Perceived Lack of Efficacy|0
4618982|NCT01767909|7480009|FG000|Overall Study|Investigator Recommendation|0
4618983|NCT01767909|7480010|FG001|Overall Study|Investigator Recommendation|1
4618984|NCT01767909|7480009|FG000|Overall Study|Lost to Follow-up|0
4618985|NCT01767909|7480010|FG001|Overall Study|Lost to Follow-up|1
4618986|NCT01767909|7480009|FG000|Overall Study|LP uncessessful|0
4618987|NCT01767909|7480010|FG001|Overall Study|LP uncessessful|1
4546445|NCT01182350|7372669|FG004|Overall Study|Alternative Therapy|0
4546446|NCT01182350|7372665|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2
4546447|NCT01182350|7372666|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0
4546448|NCT01182350|7372667|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1
4618988|NCT01767987|7480024|FG000|Overall Study|Physician Decision|4
4618989|NCT01767987|7480025|FG001|Overall Study|Physician Decision|1
4618990|NCT01768117|7480054|FG000|Overall Study|Lost to Follow-up|1
4618991|NCT01768117|7480054|FG000|Overall Study|Withdrawal by Subject|2
4618992|NCT01768117|7480054|FG000|Overall Study|Protocol Violation|3
4618993|NCT01768286|7480062|FG000|Overall Study|Randomized But Not Treated|0
4618994|NCT01768286|7480063|FG001|Overall Study|Randomized But Not Treated|0
4546449|NCT01182350|7372668|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1
4546450|NCT01182350|7372669|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0
4546451|NCT01182350|7372665|FG000|Overall Study|Unevaluable for Biopsy|0
4546452|NCT01182350|7372666|FG001|Overall Study|Unevaluable for Biopsy|0
4546453|NCT01182350|7372667|FG002|Overall Study|Unevaluable for Biopsy|0
4618995|NCT01768286|7480064|FG002|Overall Study|Randomized But Not Treated|1
4618996|NCT01768286|7480065|FG003|Overall Study|Randomized But Not Treated|0
4618997|NCT01768286|7480062|FG000|Overall Study|Lack of Efficacy|7
4618998|NCT01768286|7480063|FG001|Overall Study|Lack of Efficacy|4
4618999|NCT01768286|7480064|FG002|Overall Study|Lack of Efficacy|0
4619000|NCT01768286|7480065|FG003|Overall Study|Lack of Efficacy|1
4619001|NCT01768286|7480062|FG000|Overall Study|Withdrew Consent|0
4619002|NCT01768286|7480063|FG001|Overall Study|Withdrew Consent|0
4619003|NCT01768286|7480064|FG002|Overall Study|Withdrew Consent|1
4619004|NCT01768286|7480065|FG003|Overall Study|Withdrew Consent|0
4619005|NCT01768559|7480102|FG000|Overall Study|Randomized but not treated|0
4619006|NCT01768559|7480103|FG001|Overall Study|Randomized but not treated|0
4619007|NCT01768559|7480104|FG002|Overall Study|Randomized but not treated|1
4619008|NCT01768559|7480102|FG000|Overall Study|Adverse Event|15
4619009|NCT01768559|7480103|FG001|Overall Study|Adverse Event|2
4619010|NCT01768559|7480104|FG002|Overall Study|Adverse Event|5
4619011|NCT01768559|7480102|FG000|Overall Study|Lack of Efficacy|6
4619012|NCT01768559|7480103|FG001|Overall Study|Lack of Efficacy|4
4619013|NCT01768559|7480104|FG002|Overall Study|Lack of Efficacy|0
4619014|NCT01768559|7480102|FG000|Overall Study|Poor compliance to protocol|0
4619015|NCT01768559|7480103|FG001|Overall Study|Poor compliance to protocol|3
4619016|NCT01768559|7480104|FG002|Overall Study|Poor compliance to protocol|2
4619017|NCT01768559|7480102|FG000|Overall Study|Other than specified|9
4619018|NCT01768559|7480103|FG001|Overall Study|Other than specified|8
4619019|NCT01768559|7480104|FG002|Overall Study|Other than specified|5
4619020|NCT01768572|7480119|FG000|Overall Study|Adverse Event|7
4619021|NCT01768572|7480120|FG001|Overall Study|Adverse Event|8
4619022|NCT01768572|7480121|FG002|Overall Study|Adverse Event|4
4619023|NCT01768572|7480119|FG000|Overall Study|Lack of Efficacy|1
4619024|NCT01768572|7480120|FG001|Overall Study|Lack of Efficacy|3
4619025|NCT01768572|7480121|FG002|Overall Study|Lack of Efficacy|1
4619026|NCT01768572|7480119|FG000|Overall Study|Other, Not due to an adverse event|1
4619027|NCT01768572|7480120|FG001|Overall Study|Other, Not due to an adverse event|1
4619028|NCT01768572|7480121|FG002|Overall Study|Other, Not due to an adverse event|1
4619029|NCT01768637|7480131|FG000|Overall Study|Lost to Follow-up|2
4619030|NCT01768637|7480132|FG001|Overall Study|Lost to Follow-up|7
4619031|NCT01768637|7480131|FG000|Overall Study|Difficult blood draw|1
4619032|NCT01768637|7480132|FG001|Overall Study|Difficult blood draw|0
4619033|NCT01768676|7480140|FG000|Overall Study|Adverse Event|3
4619034|NCT01768676|7480141|FG001|Overall Study|Adverse Event|3
4546454|NCT01182350|7372668|FG003|Overall Study|Unevaluable for Biopsy|0
4619035|NCT01768676|7480140|FG000|Overall Study|Lost to Follow-up|13
4619036|NCT01768676|7480141|FG001|Overall Study|Lost to Follow-up|16
4619037|NCT01768676|7480140|FG000|Overall Study|Protocol Violation|1
4619038|NCT01768676|7480141|FG001|Overall Study|Protocol Violation|1
4619039|NCT01768676|7480140|FG000|Overall Study|Physician Decision|4
4619040|NCT01768676|7480141|FG001|Overall Study|Physician Decision|1
4619041|NCT01768676|7480140|FG000|Overall Study|Withdrawal by Subject|3
4619042|NCT01768676|7480141|FG001|Overall Study|Withdrawal by Subject|10
4619043|NCT01768858|7480164|FG000|Overall Study|Lost to Follow-up|9
4619044|NCT01768858|7480164|FG000|Overall Study|Lack of Efficacy|8
4619045|NCT01768858|7480164|FG000|Overall Study|Serious Adverse Event|1
4619046|NCT01768858|7480164|FG000|Overall Study|Participant moved to Germany|1
4619047|NCT01768858|7480164|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1
4619048|NCT01768858|7480164|FG000|Overall Study|Exanthema|1
4619049|NCT01768858|7480164|FG000|Overall Study|Withdrawal by Subject|1
4546455|NCT01182350|7372669|FG004|Overall Study|Unevaluable for Biopsy|3
4546456|NCT01182415|7372694|FG000|Overall Study|Lost to Follow-up|1
4546457|NCT01182428|7372700|FG000|Overall Study|Physician Decision|1
4546458|NCT01182428|7372701|FG001|Overall Study|Physician Decision|0
4546459|NCT01182428|7372700|FG000|Overall Study|Lost to Follow-up|9
4546460|NCT01182428|7372701|FG001|Overall Study|Lost to Follow-up|1
4546461|NCT01182428|7372700|FG000|Overall Study|Withdrawal by Subject|1
4632998|NCT01907100|7502851|FG000|Overall Study|PD based on modified RECIST criteria|31
4632999|NCT01907100|7502852|FG001|Overall Study|PD based on modified RECIST criteria|32
4633000|NCT01907100|7502853|FG002|Overall Study|PD based on modified RECIST criteria|95
4546462|NCT01182428|7372701|FG001|Overall Study|Withdrawal by Subject|0
4546463|NCT01182441|7372709|FG000|Overall Study|Patient Still in Follow-up|152
4546464|NCT01182441|7372710|FG001|Overall Study|Patient Still in Follow-up|72
4546465|NCT01182441|7372709|FG000|Overall Study|Death|37
4546466|NCT01182441|7372710|FG001|Overall Study|Death|25
4546467|NCT01182441|7372709|FG000|Overall Study|Implant Attempt Unsuccessful|13
4633001|NCT01907100|7502854|FG003|Overall Study|PD based on modified RECIST criteria|92
4633002|NCT01907100|7502851|FG000|Overall Study|Withdrawal by Subject|2
4633003|NCT01907100|7502852|FG001|Overall Study|Withdrawal by Subject|5
4633004|NCT01907100|7502853|FG002|Overall Study|Withdrawal by Subject|10
4633005|NCT01907100|7502854|FG003|Overall Study|Withdrawal by Subject|13
4770408|NCT03740919|7746732|FG002|Treatment Period|Terminated by Sponsor|0
4619050|NCT01769105|7480170|FG000|First Intervention|Protocol Violation|2
4619051|NCT01769105|7480171|FG001|First Intervention|Protocol Violation|2
4619052|NCT01769105|7480170|FG000|Cross-over|Lost to Follow-up|5
4619053|NCT01769105|7480171|FG001|Cross-over|Lost to Follow-up|0
4619054|NCT01769196|7480190|FG000|Overall Study|Adverse Event|24
4619055|NCT01769196|7480191|FG001|Overall Study|Adverse Event|20
4546468|NCT01182441|7372710|FG001|Overall Study|Implant Attempt Unsuccessful|0
4546469|NCT01182441|7372709|FG000|Overall Study|Lost to Follow-up|5
4619056|NCT01769196|7480190|FG000|Overall Study|Death|21
4619057|NCT01769196|7480191|FG001|Overall Study|Death|26
4619058|NCT01769196|7480190|FG000|Overall Study|Investigator Discretion|7
4619059|NCT01769196|7480191|FG001|Overall Study|Investigator Discretion|3
4619060|NCT01769196|7480190|FG000|Overall Study|Lack of Efficacy|3
4619061|NCT01769196|7480191|FG001|Overall Study|Lack of Efficacy|2
4619062|NCT01769196|7480190|FG000|Overall Study|Progressive disease|11
4619063|NCT01769196|7480191|FG001|Overall Study|Progressive disease|6
4619064|NCT01769196|7480190|FG000|Overall Study|Protocol defined criteria for withdrawal|9
4619065|NCT01769196|7480191|FG001|Overall Study|Protocol defined criteria for withdrawal|11
4619066|NCT01769196|7480190|FG000|Overall Study|Protocol Violation|0
4619067|NCT01769196|7480191|FG001|Overall Study|Protocol Violation|3
4619068|NCT01769196|7480190|FG000|Overall Study|Study terminated by sponsor|160
4619069|NCT01769196|7480191|FG001|Overall Study|Study terminated by sponsor|161
4619070|NCT01769196|7480190|FG000|Overall Study|Participant never dosed with study drug|1
4619071|NCT01769196|7480191|FG001|Overall Study|Participant never dosed with study drug|0
4619072|NCT01769196|7480190|FG000|Overall Study|Withdrew consent|36
4619073|NCT01769196|7480191|FG001|Overall Study|Withdrew consent|40
4619074|NCT01769326|7480238|FG000|Overall Study|Lost to Follow-up|1
4619075|NCT01769326|7480239|FG001|Overall Study|Lost to Follow-up|2
4619076|NCT01769326|7480240|FG002|Overall Study|Lost to Follow-up|0
4619077|NCT01769326|7480241|FG003|Overall Study|Lost to Follow-up|0
4619078|NCT01769326|7480238|FG000|Overall Study|unrelated injry|1
4619079|NCT01769326|7480239|FG001|Overall Study|unrelated injry|1
4619080|NCT01769326|7480240|FG002|Overall Study|unrelated injry|0
4619081|NCT01769326|7480241|FG003|Overall Study|unrelated injry|0
4619082|NCT01769326|7480238|FG000|Overall Study|got a job|0
4619083|NCT01769326|7480239|FG001|Overall Study|got a job|1
4619084|NCT01769326|7480240|FG002|Overall Study|got a job|0
4619085|NCT01769326|7480241|FG003|Overall Study|got a job|0
4619086|NCT01769326|7480238|FG000|Overall Study|Got sick and could not complete study|0
4619087|NCT01769326|7480239|FG001|Overall Study|Got sick and could not complete study|0
4619088|NCT01769326|7480240|FG002|Overall Study|Got sick and could not complete study|1
4619089|NCT01769326|7480241|FG003|Overall Study|Got sick and could not complete study|0
4619090|NCT01769339|7480251|FG000|Overall Study|Lost to Follow-up|42
4619091|NCT01769339|7480251|FG000|Overall Study|Adverse Event|1
4619092|NCT01769378|7480288|FG000|Overall Study|Adverse Event|10
4619093|NCT01769378|7480289|FG001|Overall Study|Adverse Event|0
4619094|NCT01769378|7480288|FG000|Overall Study|Entry criteria not met|1
4619095|NCT01769378|7480289|FG001|Overall Study|Entry criteria not met|0
4619096|NCT01769378|7480288|FG000|Overall Study|Protocol Violation|1
4619097|NCT01769378|7480289|FG001|Overall Study|Protocol Violation|1
4619098|NCT01769378|7480288|FG000|Overall Study|Withdrawal by Subject|10
4619099|NCT01769378|7480289|FG001|Overall Study|Withdrawal by Subject|3
4619100|NCT01769378|7480288|FG000|Overall Study|Sponsor Decision|1
4619101|NCT01769378|7480289|FG001|Overall Study|Sponsor Decision|0
4619102|NCT01769378|7480288|FG000|Overall Study|Lost to Follow-up|2
4619103|NCT01769378|7480289|FG001|Overall Study|Lost to Follow-up|0
4619104|NCT01769391|7480297|FG000|Overall Study|Death|10
4619105|NCT01769391|7480298|FG001|Overall Study|Death|1
4619106|NCT01769391|7480297|FG000|Overall Study|Adverse Event|0
4619107|NCT01769391|7480298|FG001|Overall Study|Adverse Event|3
4619108|NCT01769391|7480297|FG000|Overall Study|Progressive Disease|1
4619109|NCT01769391|7480298|FG001|Overall Study|Progressive Disease|2
4619110|NCT01769391|7480297|FG000|Overall Study|Withdrawal by Subject|4
4619111|NCT01769391|7480298|FG001|Overall Study|Withdrawal by Subject|3
4619112|NCT01769391|7480297|FG000|Overall Study|Investigator Decision|2
4546470|NCT01182441|7372710|FG001|Overall Study|Lost to Follow-up|8
4546471|NCT01182441|7372709|FG000|Overall Study|Withdrawal by Subject|6
4546472|NCT01182441|7372710|FG001|Overall Study|Withdrawal by Subject|13
4546473|NCT01182441|7372709|FG000|Overall Study|Implant Not Attempted|4
4546474|NCT01182441|7372710|FG001|Overall Study|Implant Not Attempted|0
4619113|NCT01769391|7480298|FG001|Overall Study|Investigator Decision|0
4619114|NCT01769404|7480310|FG000|Treatment Period 1|Did not meet eligibility criteria|1
4619115|NCT01769404|7480311|FG001|Treatment Period 1|Did not meet eligibility criteria|0
4619116|NCT01769404|7480310|FG000|Treatment Period 1|Withdrawal by Subject|3
4619117|NCT01769404|7480311|FG001|Treatment Period 1|Withdrawal by Subject|0
4619118|NCT01769404|7480310|FG000|Treatment Period 1|Sponsor decision|1
4619119|NCT01769404|7480311|FG001|Treatment Period 1|Sponsor decision|0
4619120|NCT01769404|7480310|FG000|Treatment Period 2|Sponsor decision|7
4619121|NCT01769404|7480311|FG001|Treatment Period 2|Sponsor decision|0
4619122|NCT01769456|7480319|FG000|Overall Study|Lost to Follow-up|19
4619123|NCT01769456|7480319|FG000|Overall Study|Withdrawal by Subject|3
4619124|NCT01769456|7480319|FG000|Overall Study|Did not receive PCC intervention|6
4619125|NCT01769456|7480319|FG000|Overall Study|Moved out of the area|3
4546475|NCT01182441|7372709|FG000|Overall Study|Adverse Event|2
4546476|NCT01182441|7372710|FG001|Overall Study|Adverse Event|0
4546477|NCT01182441|7372709|FG000|Overall Study|Physician Decision|1
4546478|NCT01182441|7372710|FG001|Overall Study|Physician Decision|1
4546479|NCT01182844|7372748|FG000|Overall Study|Withdrawal by Subject|0
4546480|NCT01182844|7372749|FG001|Overall Study|Withdrawal by Subject|2
4546481|NCT01183013|7372762|FG000|Overall Study|Adverse Event|6
4546482|NCT01183013|7372763|FG001|Overall Study|Adverse Event|8
4546483|NCT01183013|7372764|FG002|Overall Study|Adverse Event|5
4619126|NCT01769456|7480319|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5
4619127|NCT01769456|7480319|FG000|Overall Study|Parental request to youth to withdraw|1
4619128|NCT01769469|7480324|FG000|Overall Study|Consent Withdrawn|5
4619129|NCT01769469|7480324|FG000|Overall Study|Moved Out Of Area|3
4619130|NCT01769469|7480324|FG000|Overall Study|Lost to Follow-up|17
4619131|NCT01769469|7480324|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7
4619132|NCT01769469|7480324|FG000|Overall Study|Subject Confirmed HIV Positive|3
4619133|NCT01769508|7480330|FG000|Overall Study|Death|3
4619134|NCT01769508|7480330|FG000|Overall Study|Withdrawal by Subject|1
4619135|NCT01769508|7480330|FG000|Overall Study|Adverse Event|1
4619136|NCT01769508|7480330|FG000|Overall Study|Lost to Follow-up|1
4619137|NCT01770145|7480370|FG000|Baseline|Adverse Event|20
4619138|NCT01770145|7480370|FG000|Baseline|Withdrawal by Subject|1
4690538|NCT02561195|7600195|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2
4690539|NCT02561195|7600196|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1
4690540|NCT02561195|7600197|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2
4690541|NCT02561195|7600198|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1
4690542|NCT02561195|7600185|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
4546484|NCT01183013|7372765|FG003|Overall Study|Adverse Event|5
4546485|NCT01183013|7372766|FG004|Overall Study|Adverse Event|10
4546486|NCT01183013|7372767|FG005|Overall Study|Adverse Event|10
4546487|NCT01183013|7372768|FG006|Overall Study|Adverse Event|6
4546488|NCT01183013|7372762|FG000|Overall Study|Lack of Efficacy|3
4546489|NCT01183013|7372763|FG001|Overall Study|Lack of Efficacy|2
4546490|NCT01183013|7372764|FG002|Overall Study|Lack of Efficacy|1
4546491|NCT01183013|7372765|FG003|Overall Study|Lack of Efficacy|2
4546492|NCT01183013|7372766|FG004|Overall Study|Lack of Efficacy|1
4546493|NCT01183013|7372767|FG005|Overall Study|Lack of Efficacy|2
4546494|NCT01183013|7372768|FG006|Overall Study|Lack of Efficacy|0
4546495|NCT01183013|7372762|FG000|Overall Study|Protocol Violation|5
4546496|NCT01183013|7372763|FG001|Overall Study|Protocol Violation|2
4546497|NCT01183013|7372764|FG002|Overall Study|Protocol Violation|4
4546498|NCT01183013|7372765|FG003|Overall Study|Protocol Violation|0
4546499|NCT01183013|7372766|FG004|Overall Study|Protocol Violation|4
4546500|NCT01183013|7372767|FG005|Overall Study|Protocol Violation|3
4690543|NCT02561195|7600186|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
4546501|NCT01183013|7372768|FG006|Overall Study|Protocol Violation|3
4546502|NCT01183013|7372762|FG000|Overall Study|Lost to Follow-up|7
4546503|NCT01183013|7372763|FG001|Overall Study|Lost to Follow-up|3
4546504|NCT01183013|7372764|FG002|Overall Study|Lost to Follow-up|4
4546505|NCT01183013|7372765|FG003|Overall Study|Lost to Follow-up|3
4546506|NCT01183013|7372766|FG004|Overall Study|Lost to Follow-up|2
4546507|NCT01183013|7372767|FG005|Overall Study|Lost to Follow-up|6
4546508|NCT01183013|7372768|FG006|Overall Study|Lost to Follow-up|5
4546509|NCT01183013|7372762|FG000|Overall Study|Withdrawal by Subject|9
4546510|NCT01183013|7372763|FG001|Overall Study|Withdrawal by Subject|13
4546511|NCT01183013|7372764|FG002|Overall Study|Withdrawal by Subject|10
4546512|NCT01183013|7372765|FG003|Overall Study|Withdrawal by Subject|8
4546513|NCT01183013|7372766|FG004|Overall Study|Withdrawal by Subject|7
4546514|NCT01183013|7372767|FG005|Overall Study|Withdrawal by Subject|9
4546515|NCT01183013|7372768|FG006|Overall Study|Withdrawal by Subject|10
4546516|NCT01183013|7372762|FG000|Overall Study|Reasons other than stated above|15
4546517|NCT01183013|7372763|FG001|Overall Study|Reasons other than stated above|11
4546518|NCT01183013|7372764|FG002|Overall Study|Reasons other than stated above|17
4546519|NCT01183013|7372765|FG003|Overall Study|Reasons other than stated above|12
4546520|NCT01183013|7372766|FG004|Overall Study|Reasons other than stated above|12
4546521|NCT01183013|7372767|FG005|Overall Study|Reasons other than stated above|15
4546522|NCT01183013|7372768|FG006|Overall Study|Reasons other than stated above|13
4546523|NCT01183065|7372785|FG000|Overall Study|Patient no longer fits eligibility crite|1
4546524|NCT01183104|7372791|FG000|Overall Study|Adverse Event|8
4546525|NCT01183104|7372792|FG001|Overall Study|Adverse Event|6
4546526|NCT01183104|7372791|FG000|Overall Study|Death|0
4546527|NCT01183104|7372792|FG001|Overall Study|Death|1
4546528|NCT01183104|7372791|FG000|Overall Study|Lost to Follow-up|14
4546529|NCT01183104|7372792|FG001|Overall Study|Lost to Follow-up|7
4546530|NCT01183104|7372791|FG000|Overall Study|Physician Decision|5
4546531|NCT01183104|7372792|FG001|Overall Study|Physician Decision|8
4546532|NCT01183104|7372791|FG000|Overall Study|Withdrawal by Subject|6
4546533|NCT01183104|7372792|FG001|Overall Study|Withdrawal by Subject|11
4546534|NCT01183104|7372791|FG000|Overall Study|Nonparticipation in Extension Study|39
4546535|NCT01183104|7372792|FG001|Overall Study|Nonparticipation in Extension Study|50
4546536|NCT01183104|7372791|FG000|Overall Study|Did not receive study drug|5
4546537|NCT01183104|7372792|FG001|Overall Study|Did not receive study drug|9
4546538|NCT01183143|7372798|FG000|Overall Study|Protocol Violation|115
4546539|NCT01183143|7372798|FG000|Overall Study|Withdrawal by Subject|19
4546540|NCT01183143|7372798|FG000|Overall Study|Subject Questionnaires not returned|5
4546541|NCT01183143|7372798|FG000|Overall Study|Subjects enrolled, but not treated|11
4546542|NCT01183234|7372832|FG000|First Intervention|Adverse Event|1
4546543|NCT01183234|7372833|FG001|First Intervention|Adverse Event|0
4546544|NCT01183260|7372841|FG000|Overall Study|Intraop screen failure|2
4546545|NCT01183260|7372842|FG001|Overall Study|Intraop screen failure|0
4546546|NCT01183260|7372841|FG000|Overall Study|Withdrawal by Subject|1
4619139|NCT01770145|7480370|FG000|Baseline|Lost to Follow-up|1
4619140|NCT01770145|7480370|FG000|Baseline|Unable to define optimal dose|4
4619141|NCT01770145|7480370|FG000|Treatment|Adverse Event|3
4619142|NCT01770145|7480370|FG000|Treatment|Withdrawal by Subject|1
4619143|NCT01770353|7480385|FG000|Overall Study|Progressive disease|2
4619144|NCT01770353|7480386|FG001|Overall Study|Progressive disease|1
4619145|NCT01770353|7480385|FG000|Overall Study|Adverse Event|0
4619146|NCT01770353|7480386|FG001|Overall Study|Adverse Event|1
4619147|NCT01770353|7480385|FG000|Overall Study|Protocol Violation|1
4619148|NCT01770353|7480386|FG001|Overall Study|Protocol Violation|0
4619149|NCT01770353|7480385|FG000|Overall Study|Physician Decision|0
4619150|NCT01770353|7480386|FG001|Overall Study|Physician Decision|3
4619151|NCT01770353|7480385|FG000|Overall Study|Clinical deterioration|3
4619152|NCT01770353|7480386|FG001|Overall Study|Clinical deterioration|6
4619153|NCT01770353|7480385|FG000|Overall Study|Toxicity related diarrhoea + progression|0
4619154|NCT01770353|7480386|FG001|Overall Study|Toxicity related diarrhoea + progression|1
4619155|NCT01770379|7480412|FG000|Overall Study|Technical issues|1
4619156|NCT01770379|7480413|FG001|Overall Study|Technical issues|0
4619157|NCT01770379|7480414|FG002|Overall Study|Technical issues|0
4546547|NCT01183260|7372842|FG001|Overall Study|Withdrawal by Subject|1
4546548|NCT01183260|7372841|FG000|Overall Study|Revised within 30 days|0
4546549|NCT01183260|7372842|FG001|Overall Study|Revised within 30 days|1
4546550|NCT01183260|7372841|FG000|Overall Study|Death|1
4546551|NCT01183260|7372842|FG001|Overall Study|Death|0
4546552|NCT01183390|7372859|FG000|First Intervention|Adverse Event|0
4546553|NCT01183390|7372860|FG001|First Intervention|Adverse Event|1
4546554|NCT01183780|7372915|FG000|Overall Study|Withdrawal by Subject|25
4546555|NCT01183780|7372916|FG001|Overall Study|Withdrawal by Subject|14
4546556|NCT01183780|7372915|FG000|Overall Study|Lost to Follow-up|6
4546557|NCT01183780|7372916|FG001|Overall Study|Lost to Follow-up|11
4546558|NCT01183858|7372924|FG000|Overall Study|Death not related to Progressive Disease|5
4546559|NCT01183858|7372925|FG001|Overall Study|Death not related to Progressive Disease|6
4546560|NCT01183858|7372924|FG000|Overall Study|Adverse Event|14
4546561|NCT01183858|7372925|FG001|Overall Study|Adverse Event|11
4546562|NCT01183858|7372924|FG000|Overall Study|Investigator's Decision|0
4546563|NCT01183858|7372925|FG001|Overall Study|Investigator's Decision|3
4546564|NCT01183858|7372924|FG000|Overall Study|Insufficient Therapeutic Response|2
4546565|NCT01183858|7372925|FG001|Overall Study|Insufficient Therapeutic Response|0
4546566|NCT01183858|7372924|FG000|Overall Study|Refused Treatment|1
4546567|NCT01183858|7372925|FG001|Overall Study|Refused Treatment|4
4546568|NCT01183858|7372924|FG000|Overall Study|Withdrew Consent|4
4546569|NCT01183858|7372925|FG001|Overall Study|Withdrew Consent|4
4546570|NCT01183858|7372924|FG000|Overall Study|Discontinued Smoking|3
4546571|NCT01183858|7372925|FG001|Overall Study|Discontinued Smoking|1
4546572|NCT01183858|7372924|FG000|Overall Study|Protocol Violation|1
4546573|NCT01183858|7372925|FG001|Overall Study|Protocol Violation|0
4546574|NCT01183858|7372924|FG000|Overall Study|Administrative/Other|6
4546575|NCT01183858|7372925|FG001|Overall Study|Administrative/Other|6
4546576|NCT01183858|7372924|FG000|Overall Study|Progressive Disease|112
4546577|NCT01183858|7372925|FG001|Overall Study|Progressive Disease|115
4546578|NCT01183858|7372924|FG000|Overall Study|Death related to Progressive Disease|4
4546579|NCT01183858|7372925|FG001|Overall Study|Death related to Progressive Disease|5
4546580|NCT01183858|7372924|FG000|Overall Study|Lost to Follow-up|1
4619158|NCT01770379|7480412|FG000|Overall Study|Withdrawal by Subject|7
4619159|NCT01770379|7480413|FG001|Overall Study|Withdrawal by Subject|10
4619160|NCT01770379|7480414|FG002|Overall Study|Withdrawal by Subject|7
4619161|NCT01770379|7480412|FG000|Overall Study|study terminated by sponsor|22
4619162|NCT01770379|7480413|FG001|Overall Study|study terminated by sponsor|23
4619163|NCT01770379|7480414|FG002|Overall Study|study terminated by sponsor|22
4619164|NCT01770379|7480412|FG000|Overall Study|Protocol Violation|0
4619165|NCT01770379|7480413|FG001|Overall Study|Protocol Violation|1
4619166|NCT01770379|7480414|FG002|Overall Study|Protocol Violation|1
4619167|NCT01770379|7480412|FG000|Overall Study|Physician Decision|0
4619168|NCT01770379|7480413|FG001|Overall Study|Physician Decision|1
4546581|NCT01183858|7372925|FG001|Overall Study|Lost to Follow-up|1
4546582|NCT01183975|7372937|FG000|Overall Study|Lost to Follow-up|73
4546583|NCT01184053|7372950|FG000|Overall Study|progression while on treatment|3
4546584|NCT01184079|7372957|FG000|Overall Study|Lost to Follow-up|14
4546585|NCT01184079|7372958|FG001|Overall Study|Lost to Follow-up|2
4546586|NCT01184118|7372966|FG000|Overall Study|Only asthma step 1 - screen fail|1
4546587|NCT01184118|7372966|FG000|Overall Study|No physiologic confirmation of asthma|8
4546588|NCT01184118|7372966|FG000|Overall Study|FEV1 <60% predicted|2
4619169|NCT01770379|7480414|FG002|Overall Study|Physician Decision|2
4546589|NCT01184118|7372966|FG000|Overall Study|Exclusionary medical condition|2
4546590|NCT01184118|7372966|FG000|Overall Study|Withdrawal by Subject|5
4546591|NCT01184326|7372973|FG000|Overall Study|Adverse Event|1
4546592|NCT01184326|7372974|FG001|Overall Study|Adverse Event|2
4546593|NCT01184326|7372975|FG002|Overall Study|Adverse Event|0
4546594|NCT01184326|7372973|FG000|Overall Study|Death|0
4546595|NCT01184326|7372974|FG001|Overall Study|Death|0
4546596|NCT01184326|7372975|FG002|Overall Study|Death|1
4546597|NCT01184326|7372973|FG000|Overall Study|Withdrawal by Subject|0
4546598|NCT01184326|7372974|FG001|Overall Study|Withdrawal by Subject|0
4546599|NCT01184326|7372975|FG002|Overall Study|Withdrawal by Subject|1
4546600|NCT01184326|7372973|FG000|Overall Study|Physician Decision|1
4546601|NCT01184326|7372974|FG001|Overall Study|Physician Decision|1
4546602|NCT01184326|7372975|FG002|Overall Study|Physician Decision|0
4546603|NCT01184326|7372973|FG000|Overall Study|Disease Progression|1
4546604|NCT01184326|7372974|FG001|Overall Study|Disease Progression|3
4546605|NCT01184326|7372975|FG002|Overall Study|Disease Progression|12
4546606|NCT01184508|7372997|FG000|Overall Study|Adverse Event|4
4546607|NCT01184508|7372998|FG001|Overall Study|Adverse Event|6
4546608|NCT01184508|7372997|FG000|Overall Study|Lack of Efficacy|1
4546609|NCT01184508|7372998|FG001|Overall Study|Lack of Efficacy|1
4546610|NCT01184508|7372997|FG000|Overall Study|Lost to Follow-up|1
4546611|NCT01184508|7372998|FG001|Overall Study|Lost to Follow-up|1
4546612|NCT01184508|7372997|FG000|Overall Study|Physician Decision|1
4546613|NCT01184508|7372998|FG001|Overall Study|Physician Decision|0
4546614|NCT01184508|7372997|FG000|Overall Study|Protocol Violation|3
4546615|NCT01184508|7372998|FG001|Overall Study|Protocol Violation|1
4546616|NCT01184508|7372997|FG000|Overall Study|Sponsor Decision|5
4546617|NCT01184508|7372998|FG001|Overall Study|Sponsor Decision|2
4546618|NCT01184508|7372997|FG000|Overall Study|Withdrawal by Subject|1
4546619|NCT01184508|7372998|FG001|Overall Study|Withdrawal by Subject|3
4546620|NCT01184508|7372997|FG000|Overall Study|Randomized, Not Treated|0
4546621|NCT01184508|7372998|FG001|Overall Study|Randomized, Not Treated|1
4546622|NCT01184846|7373018|FG000|Overall Study|Adverse Event|2
4546623|NCT01184846|7373018|FG000|Overall Study|Insufficient response|1
4546624|NCT01184859|7373029|FG000|Period 1: Single Dose|Insufficient urine production|0
4546625|NCT01184859|7373030|FG001|Period 1: Single Dose|Insufficient urine production|1
4546626|NCT01184859|7373031|FG002|Period 1: Single Dose|Insufficient urine production|0
4546627|NCT01184859|7373032|FG003|Period 1: Single Dose|Insufficient urine production|0
4546628|NCT01184859|7373033|FG004|Period 1: Single Dose|Insufficient urine production|0
4546629|NCT01184859|7373029|FG000|Period 1: Single Dose|Protocol Violation|0
4546630|NCT01184859|7373030|FG001|Period 1: Single Dose|Protocol Violation|1
4619170|NCT01770379|7480412|FG000|Overall Study|Lost to Follow-up|0
4619171|NCT01770379|7480413|FG001|Overall Study|Lost to Follow-up|0
4619172|NCT01770379|7480414|FG002|Overall Study|Lost to Follow-up|2
4619173|NCT01770379|7480412|FG000|Overall Study|Lack of Efficacy|8
4619174|NCT01770379|7480413|FG001|Overall Study|Lack of Efficacy|6
4619175|NCT01770379|7480414|FG002|Overall Study|Lack of Efficacy|6
4619176|NCT01770379|7480412|FG000|Overall Study|Adverse Event|1
4619177|NCT01770379|7480413|FG001|Overall Study|Adverse Event|3
4619178|NCT01770379|7480414|FG002|Overall Study|Adverse Event|2
4619179|NCT01770392|7480424|FG000|Washout Period of at Least 14 Days|Adverse Event|1
4619180|NCT01770509|7480455|FG000|Overall Study|Injury|0
4619181|NCT01770509|7480456|FG001|Overall Study|Injury|1
4619182|NCT01770509|7480455|FG000|Overall Study|Lost to Follow-up|1
4619183|NCT01770509|7480456|FG001|Overall Study|Lost to Follow-up|2
4619184|NCT01770743|7480495|FG000|Overall Study|Adverse Event|1
4619185|NCT01770743|7480496|FG001|Overall Study|Adverse Event|0
4619186|NCT01770743|7480497|FG002|Overall Study|Adverse Event|0
4619187|NCT01770743|7480498|FG003|Overall Study|Adverse Event|0
4619188|NCT01770743|7480499|FG004|Overall Study|Adverse Event|0
4619189|NCT01770743|7480495|FG000|Overall Study|Withdrawal by Subject|0
4619190|NCT01770743|7480496|FG001|Overall Study|Withdrawal by Subject|0
4619191|NCT01770743|7480497|FG002|Overall Study|Withdrawal by Subject|1
4619192|NCT01770743|7480498|FG003|Overall Study|Withdrawal by Subject|1
4619193|NCT01770743|7480499|FG004|Overall Study|Withdrawal by Subject|1
4619194|NCT01770743|7480495|FG000|Overall Study|Lost to Follow-up|0
4619195|NCT01770743|7480496|FG001|Overall Study|Lost to Follow-up|2
4619196|NCT01770743|7480497|FG002|Overall Study|Lost to Follow-up|0
4619197|NCT01770743|7480498|FG003|Overall Study|Lost to Follow-up|0
4619198|NCT01770743|7480499|FG004|Overall Study|Lost to Follow-up|1
4619199|NCT01770743|7480495|FG000|Overall Study|Sponsor Terminated Subject|1
4619200|NCT01770743|7480496|FG001|Overall Study|Sponsor Terminated Subject|0
4619201|NCT01770743|7480497|FG002|Overall Study|Sponsor Terminated Subject|0
4619202|NCT01770743|7480498|FG003|Overall Study|Sponsor Terminated Subject|1
4619203|NCT01770743|7480499|FG004|Overall Study|Sponsor Terminated Subject|0
4619204|NCT01770743|7480495|FG000|Overall Study|Moving Out of State|0
4546631|NCT01184859|7373031|FG002|Period 1: Single Dose|Protocol Violation|0
4546632|NCT01184859|7373032|FG003|Period 1: Single Dose|Protocol Violation|0
4546633|NCT01184859|7373033|FG004|Period 1: Single Dose|Protocol Violation|0
4546634|NCT01184859|7373029|FG000|Period 1: Single Dose|Adverse Event|0
4546635|NCT01184859|7373030|FG001|Period 1: Single Dose|Adverse Event|0
4619205|NCT01770743|7480496|FG001|Overall Study|Moving Out of State|1
4619206|NCT01770743|7480497|FG002|Overall Study|Moving Out of State|0
4619207|NCT01770743|7480498|FG003|Overall Study|Moving Out of State|0
4546636|NCT01184859|7373031|FG002|Period 1: Single Dose|Adverse Event|0
4546637|NCT01184859|7373032|FG003|Period 1: Single Dose|Adverse Event|0
4546638|NCT01184859|7373033|FG004|Period 1: Single Dose|Adverse Event|1
4546639|NCT01184859|7373029|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
4546640|NCT01184859|7373030|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
4546641|NCT01184859|7373031|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
4546642|NCT01184859|7373032|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
4546643|NCT01184859|7373033|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1
4546644|NCT01184859|7373029|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1
4546645|NCT01184859|7373030|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0
4546646|NCT01184859|7373031|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0
4546647|NCT01184859|7373032|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0
4546648|NCT01184859|7373033|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0
4546649|NCT01184872|7373052|FG000|Overall Study|Adverse Event|3
4546650|NCT01184872|7373053|FG001|Overall Study|Adverse Event|4
4546651|NCT01184872|7373052|FG000|Overall Study|Unsatisfactory therapeutic effect|3
4546652|NCT01184872|7373053|FG001|Overall Study|Unsatisfactory therapeutic effect|2
4546653|NCT01184872|7373052|FG000|Overall Study|Withdrawal by Subject|2
4546654|NCT01184872|7373053|FG001|Overall Study|Withdrawal by Subject|0
4546655|NCT01184872|7373052|FG000|Overall Study|Lost to Follow-up|0
4546656|NCT01184872|7373053|FG001|Overall Study|Lost to Follow-up|1
4546657|NCT01184872|7373052|FG000|Overall Study|Administrative problems|1
4546658|NCT01184872|7373053|FG001|Overall Study|Administrative problems|1
4546659|NCT01184872|7373052|FG000|Overall Study|Protocol deviation|1
4546660|NCT01184872|7373053|FG001|Overall Study|Protocol deviation|0
4546661|NCT01184989|7373068|FG000|Overall Study|Adverse Event|11
4546662|NCT01184989|7373068|FG000|Overall Study|Withdrawal by Subject|1
4546663|NCT01185080|7373079|FG000|Overall Study|Adverse Event|1
4546664|NCT01185080|7373080|FG001|Overall Study|Adverse Event|1
4546665|NCT01185080|7373081|FG002|Overall Study|Adverse Event|0
4546666|NCT01185080|7373079|FG000|Overall Study|Personal reasons|0
4619208|NCT01770743|7480499|FG004|Overall Study|Moving Out of State|0
4619209|NCT01770860|7480511|FG000|Overall Study|Withdrawal by Subject|4
4619210|NCT01770860|7480511|FG000|Overall Study|Lost to Follow-up|1
4619211|NCT01770860|7480511|FG000|Overall Study|Administrative decision made by the PI|1
4619212|NCT01770912|7480521|FG000|Overall Study|Lost to Follow-up|2
4619213|NCT01770912|7480522|FG001|Overall Study|Lost to Follow-up|0
4619214|NCT01771250|7480541|FG000|Period 1|Met exclusion criteria|1
4619215|NCT01771250|7480542|FG001|Period 1|Met exclusion criteria|0
4619216|NCT01771731|7480563|FG000|Overall Study|Physician Decision|1
4619217|NCT01771731|7480564|FG001|Overall Study|Physician Decision|0
4619218|NCT01771731|7480563|FG000|Overall Study|Protocol Violation|0
4619219|NCT01771731|7480564|FG001|Overall Study|Protocol Violation|1
4619220|NCT01771731|7480563|FG000|Overall Study|Adverse event: Pain Crisis|1
4619221|NCT01771731|7480564|FG001|Overall Study|Adverse event: Pain Crisis|1
4619222|NCT01771809|7480572|FG000|Overall Study|Adverse Event|4
4619223|NCT01771809|7480573|FG001|Overall Study|Adverse Event|12
4619224|NCT01771809|7480572|FG000|Overall Study|Protocol Violation|0
4619225|NCT01771809|7480573|FG001|Overall Study|Protocol Violation|1
4619226|NCT01771809|7480572|FG000|Overall Study|Withdrawal by Subject|34
4619227|NCT01771809|7480573|FG001|Overall Study|Withdrawal by Subject|42
4619228|NCT01771809|7480572|FG000|Overall Study|Lost to Follow-up|1
4619229|NCT01771809|7480573|FG001|Overall Study|Lost to Follow-up|3
4619230|NCT01771809|7480572|FG000|Overall Study|Other (Insufficient clinical response)|22
4619231|NCT01771809|7480573|FG001|Overall Study|Other (Insufficient clinical response)|20
4619232|NCT01771809|7480572|FG000|Overall Study|Death|1
4619233|NCT01771809|7480573|FG001|Overall Study|Death|0
4619234|NCT01771809|7480572|FG000|Overall Study|Other (other)|9
4619235|NCT01771809|7480573|FG001|Overall Study|Other (other)|5
4619236|NCT01771913|7480581|FG000|Overall Study|Withdrawal by Subject|1
4619237|NCT01771913|7480582|FG001|Overall Study|Withdrawal by Subject|0
4619238|NCT01772134|7480619|FG000|Overall Study|Adverse Event|6
4619239|NCT01772134|7480620|FG001|Overall Study|Adverse Event|5
4619240|NCT01772134|7480621|FG002|Overall Study|Adverse Event|10
4619241|NCT01772134|7480619|FG000|Overall Study|Withdrew Consent|3
4619242|NCT01772134|7480620|FG001|Overall Study|Withdrew Consent|1
4619243|NCT01772134|7480621|FG002|Overall Study|Withdrew Consent|5
4619244|NCT01772134|7480619|FG000|Overall Study|Lost to Follow-up|2
4546667|NCT01185080|7373080|FG001|Overall Study|Personal reasons|0
4546668|NCT01185080|7373081|FG002|Overall Study|Personal reasons|1
4546669|NCT01185171|7373089|FG000|Induction Chemotherapy|Withdrawal by Subject|1
4546670|NCT01185171|7373089|FG000|Induction Chemotherapy|Duodenal Ulcer|1
4619245|NCT01772134|7480620|FG001|Overall Study|Lost to Follow-up|0
4619246|NCT01772134|7480621|FG002|Overall Study|Lost to Follow-up|0
4619247|NCT01772134|7480619|FG000|Overall Study|Protocol Deviation|4
4619248|NCT01772134|7480620|FG001|Overall Study|Protocol Deviation|3
4619249|NCT01772134|7480621|FG002|Overall Study|Protocol Deviation|3
4619250|NCT01772134|7480619|FG000|Overall Study|Lack of Efficacy|11
4619251|NCT01772134|7480620|FG001|Overall Study|Lack of Efficacy|5
4619252|NCT01772134|7480621|FG002|Overall Study|Lack of Efficacy|3
4619253|NCT01772134|7480619|FG000|Overall Study|Protocol-defined Stopping Criteria|1
4619254|NCT01772134|7480620|FG001|Overall Study|Protocol-defined Stopping Criteria|0
4619255|NCT01772134|7480621|FG002|Overall Study|Protocol-defined Stopping Criteria|0
4546671|NCT01185171|7373089|FG000|Concurrent Chemo and Radiation Treatment|Death|3
4546672|NCT01185171|7373089|FG000|Maintenance|Elevated liver transaminases|3
4546673|NCT01185171|7373089|FG000|Maintenance|Rush|2
4546674|NCT01185171|7373089|FG000|Maintenance|Diarrhea|1
4546675|NCT01185171|7373089|FG000|Maintenance|Xerostomia|1
4619256|NCT01772134|7480619|FG000|Overall Study|Randomized Study Medication Not Received|2
4619257|NCT01772134|7480620|FG001|Overall Study|Randomized Study Medication Not Received|0
4619258|NCT01772134|7480621|FG002|Overall Study|Randomized Study Medication Not Received|1
4619259|NCT01772147|7480632|FG000|Overall Study|Adverse Event|13
4619260|NCT01772147|7480633|FG001|Overall Study|Adverse Event|10
4619261|NCT01772147|7480634|FG002|Overall Study|Adverse Event|6
4619262|NCT01772147|7480632|FG000|Overall Study|Withdrew Consent|7
4619263|NCT01772147|7480633|FG001|Overall Study|Withdrew Consent|8
4619264|NCT01772147|7480634|FG002|Overall Study|Withdrew Consent|4
4619265|NCT01772147|7480632|FG000|Overall Study|Lost to Follow-up|1
4619266|NCT01772147|7480633|FG001|Overall Study|Lost to Follow-up|0
4619267|NCT01772147|7480634|FG002|Overall Study|Lost to Follow-up|1
4619268|NCT01772147|7480632|FG000|Overall Study|Protocol Deviation|2
4619269|NCT01772147|7480633|FG001|Overall Study|Protocol Deviation|1
4619270|NCT01772147|7480634|FG002|Overall Study|Protocol Deviation|1
4619271|NCT01772147|7480632|FG000|Overall Study|Lack of Efficacy|8
4619272|NCT01772147|7480633|FG001|Overall Study|Lack of Efficacy|6
4619273|NCT01772147|7480634|FG002|Overall Study|Lack of Efficacy|6
4619274|NCT01772160|7480642|FG000|Overall Study|Death|3
4619275|NCT01772160|7480642|FG000|Overall Study|Eligibility criteria not fulfilled|3
4619276|NCT01772160|7480642|FG000|Overall Study|Consent withdrawal|3
4619277|NCT01772160|7480642|FG000|Overall Study|Migrated / moved from the study area|4
4619278|NCT01772160|7480642|FG000|Overall Study|Lost to Follow-up|30
4619279|NCT01772160|7480642|FG000|Overall Study|Other|5
4619280|NCT01772316|7480646|FG000|Overall Study|Serious adverse event|1
4619281|NCT01772316|7480646|FG000|Overall Study|Inform consent withdrawn|1
4619282|NCT01772316|7480646|FG000|Overall Study|Withdrawn by sponsor decision|5
4619283|NCT01772368|7480650|FG000|Overall Study|Adverse Event|1
4619284|NCT01772368|7480650|FG000|Overall Study|Withdrawal by Subject|3
4619285|NCT01772368|7480650|FG000|Overall Study|Protocol Violation|2
4619286|NCT01772368|7480650|FG000|Overall Study|Other|1
4619287|NCT01772537|7480669|FG000|Overall Study|unsuccessful lumbar drain placement|1
4619288|NCT01772537|7480670|FG001|Overall Study|unsuccessful lumbar drain placement|0
4619289|NCT01772537|7480671|FG002|Overall Study|unsuccessful lumbar drain placement|0
4619290|NCT01772550|7480684|FG000|Overall Study|Unable to insert IV in antecubital vein|1
4619291|NCT01772550|7480685|FG001|Overall Study|Unable to insert IV in antecubital vein|1
4619292|NCT01772550|7480686|FG002|Overall Study|Unable to insert IV in antecubital vein|5
4619293|NCT01772550|7480684|FG000|Overall Study|Adverse Event|0
4619294|NCT01772550|7480685|FG001|Overall Study|Adverse Event|0
4619295|NCT01772550|7480686|FG002|Overall Study|Adverse Event|1
4619296|NCT01772576|7480694|FG000|Overall Study|Death|15
4619297|NCT01772576|7480694|FG000|Overall Study|Protocol Violation|1
4619298|NCT01772576|7480694|FG000|Overall Study|Lost to Follow-up|3
4619299|NCT01772576|7480694|FG000|Overall Study|Study device not used|3
4619300|NCT01772576|7480694|FG000|Overall Study|Adverse Event|6
4619301|NCT01772576|7480694|FG000|Overall Study|Withdrawal by Subject|6
4619302|NCT01772693|7480709|FG000|Overall Study|Health Concerns Unrelated to Study|2
4619303|NCT01772693|7480710|FG001|Overall Study|Health Concerns Unrelated to Study|1
4619304|NCT01772693|7480709|FG000|Overall Study|Withdrawal by Subject|2
4619305|NCT01772693|7480710|FG001|Overall Study|Withdrawal by Subject|0
4619306|NCT01772693|7480709|FG000|Overall Study|Alternative Treatment|2
4619307|NCT01772693|7480710|FG001|Overall Study|Alternative Treatment|0
4619308|NCT01772823|7480735|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1
4619309|NCT01772823|7480736|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0
4619310|NCT01772823|7480735|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1
4619311|NCT01772823|7480736|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1
4619312|NCT01772823|7480735|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1
4619313|NCT01772823|7480736|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0
4619314|NCT01772823|7480735|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2
4619315|NCT01772823|7480736|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1
4619316|NCT01772823|7480735|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6
4619317|NCT01772823|7480736|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0
4619318|NCT01772823|7480735|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1
4619319|NCT01772823|7480736|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0
4619320|NCT01772823|7480735|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15
4619321|NCT01772823|7480736|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13
4619322|NCT01772823|7480735|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6
4619323|NCT01772823|7480736|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1
4619324|NCT01772823|7480735|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4
4619325|NCT01772823|7480736|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3
4546676|NCT01185171|7373089|FG000|Maintenance|Nausea|1
4619326|NCT01772823|7480735|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1
4619327|NCT01772823|7480736|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0
4546677|NCT01185171|7373089|FG000|Maintenance|Comorbid Illness|2
4546678|NCT01185171|7373089|FG000|Maintenance|Withdrawal by Subject|1
4546679|NCT01185171|7373089|FG000|Maintenance|Disease Recurrence|1
4619328|NCT01772823|7480735|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1
4619329|NCT01772823|7480736|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0
4619330|NCT01772823|7480735|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1
4619331|NCT01772823|7480736|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1
4619332|NCT01772823|7480735|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6
4619333|NCT01772823|7480736|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5
4619334|NCT01772823|7480735|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1
4619335|NCT01772823|7480736|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2
4619336|NCT01772823|7480735|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2
4619337|NCT01772823|7480736|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2
4619338|NCT01772823|7480735|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1
4619339|NCT01772823|7480736|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0
4619340|NCT01773070|7480747|FG000|Overall Study|Withdrawal by Subject|24
4619341|NCT01773070|7480747|FG000|Overall Study|Lost to Follow-up|39
4619342|NCT01773070|7480747|FG000|Overall Study|Other|15
4619343|NCT01773070|7480747|FG000|Overall Study|Death (unrelated to study procedures)|3
4619344|NCT01773109|7480751|FG000|Overall Study|Symptomatic Progression|2
4619345|NCT01773109|7480751|FG000|Overall Study|Death|1
4619346|NCT01773122|7480759|FG000|Overall Study|Due to amended age eligibility criteria|3
4619347|NCT01773122|7480760|FG001|Overall Study|Due to amended age eligibility criteria|1
4619348|NCT01773122|7480761|FG002|Overall Study|Due to amended age eligibility criteria|0
4619349|NCT01773122|7480762|FG003|Overall Study|Due to amended age eligibility criteria|1
4619350|NCT01773226|7480788|FG000|Overall Study|Withdrawal by Subject|1
4619351|NCT01773291|7480795|FG000|Overall Study|Protocol Violation|1
4619352|NCT01773291|7480796|FG001|Overall Study|Protocol Violation|0
4619353|NCT01773291|7480797|FG002|Overall Study|Protocol Violation|0
4619354|NCT01773291|7480795|FG000|Overall Study|Withdrawal by Subject|0
4619355|NCT01773291|7480796|FG001|Overall Study|Withdrawal by Subject|0
4619356|NCT01773291|7480797|FG002|Overall Study|Withdrawal by Subject|1
4619357|NCT01773421|7480810|FG000|Treatment Phase|Other|0
4619358|NCT01773421|7480811|FG001|Treatment Phase|Other|0
4619359|NCT01773421|7480812|FG002|Treatment Phase|Other|2
4619360|NCT01773421|7480813|FG003|Treatment Phase|Other|0
4619361|NCT01773421|7480814|FG004|Treatment Phase|Other|0
4619362|NCT01773421|7480815|FG005|Treatment Phase|Other|0
4619363|NCT01773421|7480816|FG006|Treatment Phase|Other|0
4619364|NCT01773421|7480810|FG000|Treatment Phase|Adverse Event|0
4619365|NCT01773421|7480811|FG001|Treatment Phase|Adverse Event|0
4619366|NCT01773421|7480812|FG002|Treatment Phase|Adverse Event|3
4619367|NCT01773421|7480813|FG003|Treatment Phase|Adverse Event|1
4619368|NCT01773421|7480814|FG004|Treatment Phase|Adverse Event|0
4619369|NCT01773421|7480815|FG005|Treatment Phase|Adverse Event|0
4619370|NCT01773421|7480816|FG006|Treatment Phase|Adverse Event|0
4619371|NCT01773421|7480810|FG000|Treatment Phase|Withdrawal by Subject|0
4619372|NCT01773421|7480811|FG001|Treatment Phase|Withdrawal by Subject|0
4619373|NCT01773421|7480812|FG002|Treatment Phase|Withdrawal by Subject|1
4619374|NCT01773421|7480813|FG003|Treatment Phase|Withdrawal by Subject|1
4619375|NCT01773421|7480814|FG004|Treatment Phase|Withdrawal by Subject|0
4619376|NCT01773421|7480815|FG005|Treatment Phase|Withdrawal by Subject|0
4619377|NCT01773421|7480816|FG006|Treatment Phase|Withdrawal by Subject|0
4619378|NCT01773421|7480810|FG000|Extension Phase|Other|0
4619379|NCT01773421|7480811|FG001|Extension Phase|Other|0
4619380|NCT01773421|7480812|FG002|Extension Phase|Other|0
4619381|NCT01773421|7480813|FG003|Extension Phase|Other|0
4619382|NCT01773421|7480814|FG004|Extension Phase|Other|1
4619383|NCT01773421|7480815|FG005|Extension Phase|Other|2
4619384|NCT01773421|7480816|FG006|Extension Phase|Other|0
4619385|NCT01773421|7480810|FG000|Extension Phase|Adverse Event|0
4619386|NCT01773421|7480811|FG001|Extension Phase|Adverse Event|0
4619387|NCT01773421|7480812|FG002|Extension Phase|Adverse Event|0
4619388|NCT01773421|7480813|FG003|Extension Phase|Adverse Event|0
4619389|NCT01773421|7480814|FG004|Extension Phase|Adverse Event|2
4619390|NCT01773421|7480815|FG005|Extension Phase|Adverse Event|0
4619391|NCT01773421|7480816|FG006|Extension Phase|Adverse Event|0
4619392|NCT01773473|7480834|FG000|Overall Study|Adverse Event|3
4619393|NCT01773473|7480835|FG001|Overall Study|Adverse Event|2
4619394|NCT01773473|7480834|FG000|Overall Study|Protocol Violation|0
4619395|NCT01773473|7480835|FG001|Overall Study|Protocol Violation|4
4619396|NCT01773473|7480834|FG000|Overall Study|Physician Decision|3
4619397|NCT01773473|7480835|FG001|Overall Study|Physician Decision|5
4619398|NCT01773473|7480834|FG000|Overall Study|Sponsor Decision|2
4619399|NCT01773473|7480835|FG001|Overall Study|Sponsor Decision|0
4619400|NCT01773473|7480834|FG000|Overall Study|Lack of Efficacy|0
4619401|NCT01773473|7480835|FG001|Overall Study|Lack of Efficacy|1
4619402|NCT01773473|7480834|FG000|Overall Study|Non-Compliance with study drug|1
4619403|NCT01773473|7480835|FG001|Overall Study|Non-Compliance with study drug|4
4619404|NCT01773473|7480834|FG000|Overall Study|Withdrawal by Subject|5
4619405|NCT01773473|7480835|FG001|Overall Study|Withdrawal by Subject|3
4619406|NCT01773473|7480834|FG000|Overall Study|Lost to Follow-up|2
4546680|NCT01185249|7373093|FG000|Overall Study|Patients discharged or change in status|42
4546681|NCT01185288|7373100|FG000|Overall Study|Adverse Event|7
4546682|NCT01185288|7373101|FG001|Overall Study|Adverse Event|6
4546683|NCT01185288|7373100|FG000|Overall Study|Withdrawal by Subject|6
4546684|NCT01185288|7373101|FG001|Overall Study|Withdrawal by Subject|4
4546685|NCT01185288|7373100|FG000|Overall Study|Lost to Follow-up|2
4546686|NCT01185288|7373101|FG001|Overall Study|Lost to Follow-up|5
4546687|NCT01185288|7373100|FG000|Overall Study|Lack of Efficacy|2
4546688|NCT01185288|7373101|FG001|Overall Study|Lack of Efficacy|0
4546689|NCT01185288|7373100|FG000|Overall Study|Investigator discretion|1
4546690|NCT01185288|7373101|FG001|Overall Study|Investigator discretion|0
4546691|NCT01185288|7373100|FG000|Overall Study|Did not meet inclusion criteria|1
4546692|NCT01185288|7373101|FG001|Overall Study|Did not meet inclusion criteria|0
4546693|NCT01185288|7373100|FG000|Overall Study|Noncompliance|0
4546694|NCT01185288|7373101|FG001|Overall Study|Noncompliance|1
4546695|NCT01185301|7373111|FG000|Overall Study|Adverse Event|3
4546696|NCT01185301|7373112|FG001|Overall Study|Adverse Event|0
4546697|NCT01185301|7373113|FG002|Overall Study|Adverse Event|2
4546698|NCT01185301|7373114|FG003|Overall Study|Adverse Event|3
4546699|NCT01185301|7373111|FG000|Overall Study|Withdrawal by Subject|7
4546700|NCT01185301|7373112|FG001|Overall Study|Withdrawal by Subject|5
4546701|NCT01185301|7373113|FG002|Overall Study|Withdrawal by Subject|2
4546702|NCT01185301|7373114|FG003|Overall Study|Withdrawal by Subject|3
4546703|NCT01185301|7373111|FG000|Overall Study|Lost to Follow-up|2
4546704|NCT01185301|7373112|FG001|Overall Study|Lost to Follow-up|0
4546705|NCT01185301|7373113|FG002|Overall Study|Lost to Follow-up|0
4546706|NCT01185301|7373114|FG003|Overall Study|Lost to Follow-up|1
4546707|NCT01185301|7373111|FG000|Overall Study|Other Reason|3
4546708|NCT01185301|7373112|FG001|Overall Study|Other Reason|2
4546709|NCT01185301|7373113|FG002|Overall Study|Other Reason|2
4546710|NCT01185301|7373114|FG003|Overall Study|Other Reason|2
4546711|NCT01185340|7373127|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24
4546712|NCT01185340|7373128|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
4546713|NCT01185340|7373129|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
4546714|NCT01185340|7373130|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
4546715|NCT01185340|7373127|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6
4546716|NCT01185340|7373128|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
4546717|NCT01185340|7373129|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
4546718|NCT01185340|7373130|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
4546719|NCT01185340|7373127|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5
4546720|NCT01185340|7373128|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
4546721|NCT01185340|7373129|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
4546722|NCT01185340|7373130|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
4546723|NCT01185340|7373127|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2
4546724|NCT01185340|7373128|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
4546725|NCT01185340|7373129|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
4546726|NCT01185340|7373130|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
4546727|NCT01185340|7373127|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16
4546728|NCT01185340|7373128|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
4546729|NCT01185340|7373129|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
4546730|NCT01185340|7373130|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
4546731|NCT01185340|7373127|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32
4546732|NCT01185340|7373128|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
4546733|NCT01185340|7373129|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
4546734|NCT01185340|7373130|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
4546735|NCT01185340|7373127|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3
4546736|NCT01185340|7373128|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
4546737|NCT01185340|7373129|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
4546738|NCT01185340|7373130|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
4546739|NCT01185340|7373127|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
4546740|NCT01185340|7373128|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
4619407|NCT01773473|7480835|FG001|Overall Study|Lost to Follow-up|0
4619408|NCT01773889|7480841|FG000|Overall Study|lack of funding|2
4619409|NCT01773967|7480851|FG000|Overall Study|Lost to Follow-up|15
4619410|NCT01773967|7480852|FG001|Overall Study|Lost to Follow-up|13
4619411|NCT01773993|7480858|FG000|Overall Study|No Visit After Treatment|35
4619412|NCT01774084|7480874|FG000|Overall Study|Personal reasons|1
4619413|NCT01774084|7480875|FG001|Overall Study|Personal reasons|0
4619414|NCT01774097|7480883|FG000|Overall Study|Withdrawal by Subject|1
4619415|NCT01774097|7480884|FG001|Overall Study|Withdrawal by Subject|1
4546741|NCT01185340|7373129|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8
4546742|NCT01185340|7373130|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
4546743|NCT01185340|7373127|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
4546744|NCT01185340|7373128|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4
4546745|NCT01185340|7373129|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7
4619416|NCT01774097|7480883|FG000|Overall Study|Adverse Event|1
4619417|NCT01774097|7480884|FG001|Overall Study|Adverse Event|1
4619418|NCT01774110|7480892|FG000|Overall Study|Lost to Follow-up|7
4546746|NCT01185340|7373130|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4
4546747|NCT01185340|7373127|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
4546748|NCT01185340|7373128|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4
4546749|NCT01185340|7373129|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5
4546750|NCT01185340|7373130|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7
4546751|NCT01185340|7373127|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
4546752|NCT01185340|7373128|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
4546753|NCT01185340|7373129|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
4546754|NCT01185340|7373130|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
4546755|NCT01185340|7373127|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
4546756|NCT01185340|7373128|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
4546757|NCT01185340|7373129|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2
4546758|NCT01185340|7373130|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
4546759|NCT01185340|7373127|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
4546760|NCT01185340|7373128|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8
4546761|NCT01185340|7373129|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8
4546762|NCT01185340|7373130|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24
4546763|NCT01185340|7373127|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
4546764|NCT01185340|7373128|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
4546765|NCT01185340|7373129|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3
4546766|NCT01185340|7373130|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7
4546767|NCT01185353|7373147|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1
4546768|NCT01185353|7373148|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1
4546769|NCT01185353|7373149|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1
4546770|NCT01185353|7373150|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1
4546771|NCT01185353|7373151|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5
4546772|NCT01185353|7373152|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0
4546773|NCT01185353|7373153|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0
4546774|NCT01185353|7373154|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0
4546775|NCT01185353|7373155|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0
4546776|NCT01185353|7373156|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0
4546777|NCT01185353|7373147|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
4546778|NCT01185353|7373148|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
4546779|NCT01185353|7373149|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
4546780|NCT01185353|7373150|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
4546781|NCT01185353|7373151|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4
4546782|NCT01185353|7373152|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
4546783|NCT01185353|7373153|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
4546784|NCT01185353|7373154|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
4546785|NCT01185353|7373155|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
4546786|NCT01185353|7373156|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
4546787|NCT01185353|7373147|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2
4546788|NCT01185353|7373148|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
4546789|NCT01185353|7373149|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
4546790|NCT01185353|7373150|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
4546791|NCT01185353|7373151|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1
4546792|NCT01185353|7373152|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
4546793|NCT01185353|7373153|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
4546794|NCT01185353|7373154|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
4546795|NCT01185353|7373155|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
4546796|NCT01185353|7373156|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
4546797|NCT01185353|7373147|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0
4546798|NCT01185353|7373148|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0
4546799|NCT01185353|7373149|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1
4546800|NCT01185353|7373150|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0
4546801|NCT01185353|7373151|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2
4546802|NCT01185353|7373152|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0
4546803|NCT01185353|7373153|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0
4546804|NCT01185353|7373154|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0
4546805|NCT01185353|7373155|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0
4546806|NCT01185353|7373156|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0
4546807|NCT01185353|7373147|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0
4546808|NCT01185353|7373148|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0
4546809|NCT01185353|7373149|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0
4546810|NCT01185353|7373150|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0
4546811|NCT01185353|7373151|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1
4546812|NCT01185353|7373152|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0
4546813|NCT01185353|7373153|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0
4546814|NCT01185353|7373154|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0
4546815|NCT01185353|7373155|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0
4546816|NCT01185353|7373156|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0
4546817|NCT01185353|7373147|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2
4546818|NCT01185353|7373148|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
4546819|NCT01185353|7373149|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
4546820|NCT01185353|7373150|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
4546821|NCT01185353|7373151|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3
4546822|NCT01185353|7373152|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
4546823|NCT01185353|7373153|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
4546824|NCT01185353|7373154|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
4546825|NCT01185353|7373155|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
4546826|NCT01185353|7373156|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
4546827|NCT01185353|7373147|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0
4546828|NCT01185353|7373148|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0
4546829|NCT01185353|7373149|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1
4546830|NCT01185353|7373150|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0
4546831|NCT01185353|7373151|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0
4546832|NCT01185353|7373152|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1
4546833|NCT01185353|7373153|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0
4546834|NCT01185353|7373154|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0
4546835|NCT01185353|7373155|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0
4546836|NCT01185353|7373156|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0
4546837|NCT01185353|7373147|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
4546838|NCT01185353|7373148|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1
4546839|NCT01185353|7373149|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
4546840|NCT01185353|7373150|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1
4546841|NCT01185353|7373151|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
4546842|NCT01185353|7373152|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
4546843|NCT01185353|7373153|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
4546844|NCT01185353|7373154|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
4546845|NCT01185353|7373155|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
4546846|NCT01185353|7373156|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
4546847|NCT01185353|7373147|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
4546848|NCT01185353|7373148|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
4546849|NCT01185353|7373149|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
4546850|NCT01185353|7373150|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1
4546851|NCT01185353|7373151|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
4546852|NCT01185353|7373152|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
4546853|NCT01185353|7373153|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1
4546854|NCT01185353|7373154|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
4546855|NCT01185353|7373155|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
4546856|NCT01185353|7373156|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
4546857|NCT01185353|7373147|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
4546858|NCT01185353|7373148|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
4546859|NCT01185353|7373149|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1
4546860|NCT01185353|7373150|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2
4546861|NCT01185353|7373151|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
4546862|NCT01185353|7373152|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3
4546863|NCT01185353|7373153|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4
4546864|NCT01185353|7373154|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
4546865|NCT01185353|7373155|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
4546866|NCT01185353|7373156|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
4546867|NCT01185353|7373147|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
4546868|NCT01185353|7373148|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
4546869|NCT01185353|7373149|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
4546870|NCT01185353|7373150|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
4546871|NCT01185353|7373151|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
4546872|NCT01185353|7373152|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
4546873|NCT01185353|7373153|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1
4546874|NCT01185353|7373154|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
4546875|NCT01185353|7373155|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
4546876|NCT01185353|7373156|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
4546877|NCT01185353|7373147|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0
4546878|NCT01185353|7373148|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0
4546879|NCT01185353|7373149|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0
4546880|NCT01185353|7373150|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0
4546881|NCT01185353|7373151|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0
4546882|NCT01185353|7373152|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0
4546883|NCT01185353|7373153|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0
4546884|NCT01185353|7373154|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8
4546885|NCT01185353|7373155|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2
4546886|NCT01185353|7373156|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2
4546887|NCT01185353|7373147|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
4546888|NCT01185353|7373148|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
4546889|NCT01185353|7373149|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
4546890|NCT01185353|7373150|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
4546891|NCT01185353|7373151|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
4546892|NCT01185353|7373152|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
4546893|NCT01185353|7373153|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
4546894|NCT01185353|7373154|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6
4546895|NCT01185353|7373155|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2
4546896|NCT01185353|7373156|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2
4546897|NCT01185353|7373147|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
4546898|NCT01185353|7373148|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
4546899|NCT01185353|7373149|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
4546900|NCT01185353|7373150|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
4546901|NCT01185353|7373151|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
4546902|NCT01185353|7373152|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
4546903|NCT01185353|7373153|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
4546904|NCT01185353|7373154|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2
4546905|NCT01185353|7373155|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1
4546906|NCT01185353|7373156|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1
4546907|NCT01185353|7373147|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
4546908|NCT01185353|7373148|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
4546909|NCT01185353|7373149|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
4546910|NCT01185353|7373150|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
4546911|NCT01185353|7373151|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
4546912|NCT01185353|7373152|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
4546913|NCT01185353|7373153|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
4546914|NCT01185353|7373154|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
4546915|NCT01185353|7373155|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2
4546916|NCT01185353|7373156|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
4546917|NCT01185353|7373147|FG000|Part C (Weeks 24 Through 76)|Death|0
4546918|NCT01185353|7373148|FG001|Part C (Weeks 24 Through 76)|Death|0
4546919|NCT01185353|7373149|FG002|Part C (Weeks 24 Through 76)|Death|0
4546920|NCT01185353|7373150|FG003|Part C (Weeks 24 Through 76)|Death|0
4546921|NCT01185353|7373151|FG004|Part C (Weeks 24 Through 76)|Death|0
4546922|NCT01185353|7373152|FG005|Part C (Weeks 24 Through 76)|Death|0
4546923|NCT01185353|7373153|FG006|Part C (Weeks 24 Through 76)|Death|0
4546924|NCT01185353|7373154|FG007|Part C (Weeks 24 Through 76)|Death|0
4546925|NCT01185353|7373155|FG008|Part C (Weeks 24 Through 76)|Death|0
4546926|NCT01185353|7373156|FG009|Part C (Weeks 24 Through 76)|Death|1
4546927|NCT01185353|7373147|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
4546928|NCT01185353|7373148|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
4546929|NCT01185353|7373149|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
4546930|NCT01185353|7373150|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
4546931|NCT01185353|7373151|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
4546932|NCT01185353|7373152|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
4546933|NCT01185353|7373153|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
4546934|NCT01185353|7373154|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
4546935|NCT01185353|7373155|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
4546936|NCT01185353|7373156|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1
4546937|NCT01185353|7373147|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0
4546938|NCT01185353|7373148|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0
4546939|NCT01185353|7373149|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0
4546940|NCT01185353|7373150|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0
4546941|NCT01185353|7373151|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0
4546942|NCT01185353|7373152|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0
4546943|NCT01185353|7373153|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0
4546944|NCT01185353|7373154|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0
4546945|NCT01185353|7373155|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0
4546946|NCT01185353|7373156|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1
4546947|NCT01185353|7373147|FG000|Part C (Weeks 24 Through 76)|Reason missing|0
4546948|NCT01185353|7373148|FG001|Part C (Weeks 24 Through 76)|Reason missing|0
4546949|NCT01185353|7373149|FG002|Part C (Weeks 24 Through 76)|Reason missing|0
4546950|NCT01185353|7373150|FG003|Part C (Weeks 24 Through 76)|Reason missing|0
4546951|NCT01185353|7373151|FG004|Part C (Weeks 24 Through 76)|Reason missing|0
4546952|NCT01185353|7373152|FG005|Part C (Weeks 24 Through 76)|Reason missing|0
4546953|NCT01185353|7373153|FG006|Part C (Weeks 24 Through 76)|Reason missing|0
4546954|NCT01185353|7373154|FG007|Part C (Weeks 24 Through 76)|Reason missing|0
4546955|NCT01185353|7373155|FG008|Part C (Weeks 24 Through 76)|Reason missing|1
4546956|NCT01185353|7373156|FG009|Part C (Weeks 24 Through 76)|Reason missing|0
4546957|NCT01185353|7373147|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
4546958|NCT01185353|7373148|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
4546959|NCT01185353|7373149|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
4546960|NCT01185353|7373150|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
4546961|NCT01185353|7373151|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
4546962|NCT01185353|7373152|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
4546963|NCT01185353|7373153|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
4546964|NCT01185353|7373154|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1
4546965|NCT01185353|7373155|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3
4546966|NCT01185353|7373156|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
4546967|NCT01185353|7373147|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
4546968|NCT01185353|7373148|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
4546969|NCT01185353|7373149|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
4546970|NCT01185353|7373150|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
4546971|NCT01185353|7373151|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
4546972|NCT01185353|7373152|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
4546973|NCT01185353|7373153|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
4546974|NCT01185353|7373154|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1
4546975|NCT01185353|7373155|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2
4546976|NCT01185353|7373156|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1
4546977|NCT01185353|7373147|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0
4546978|NCT01185353|7373148|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0
4546979|NCT01185353|7373149|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0
4546980|NCT01185353|7373150|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0
4546981|NCT01185353|7373151|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0
4546982|NCT01185353|7373152|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0
4546983|NCT01185353|7373153|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0
4546984|NCT01185353|7373154|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1
4546985|NCT01185353|7373155|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2
4546986|NCT01185353|7373156|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0
4546987|NCT01185366|7373197|FG000|First Line Therapy|Insurance Coverage Denied|1
4546988|NCT01185366|7373198|FG001|First Line Therapy|Insurance Coverage Denied|1
4546989|NCT01185366|7373197|FG000|First Line Therapy|Withdrawal by Subject|1
4546990|NCT01185366|7373198|FG001|First Line Therapy|Withdrawal by Subject|0
4546991|NCT01185366|7373197|FG000|First Line Therapy|Lack of Metastatic Site|1
4546992|NCT01185366|7373198|FG001|First Line Therapy|Lack of Metastatic Site|0
4546993|NCT01185366|7373197|FG000|Crossover to Second Line Therapy|Adverse Event|3
4546994|NCT01185366|7373198|FG001|Crossover to Second Line Therapy|Adverse Event|6
4546995|NCT01185366|7373197|FG000|Crossover to Second Line Therapy|Physician Decision|5
4546996|NCT01185366|7373198|FG001|Crossover to Second Line Therapy|Physician Decision|1
4546997|NCT01185366|7373197|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1
4546998|NCT01185366|7373198|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0
4546999|NCT01185366|7373197|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5
4547000|NCT01185366|7373198|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3
4547001|NCT01185509|7373208|FG000|Overall Study|Progression/Relapse|9
4547002|NCT01185509|7373209|FG001|Overall Study|Progression/Relapse|15
4547003|NCT01185509|7373208|FG000|Overall Study|Physician Decision|2
4547004|NCT01185509|7373209|FG001|Overall Study|Physician Decision|2
4547005|NCT01185509|7373208|FG000|Overall Study|Withdrawal by Subject|0
4547006|NCT01185509|7373209|FG001|Overall Study|Withdrawal by Subject|1
4547007|NCT01185509|7373208|FG000|Overall Study|Death|0
4547008|NCT01185509|7373209|FG001|Overall Study|Death|1
4547009|NCT01185509|7373208|FG000|Overall Study|Intercurrent Illness|0
4547010|NCT01185509|7373209|FG001|Overall Study|Intercurrent Illness|1
4547011|NCT01185522|7373216|FG000|Overall Study|Lack of Efficacy|28
4547012|NCT01185522|7373216|FG000|Overall Study|Lost to Follow-up|19
4547013|NCT01185522|7373216|FG000|Overall Study|Withdrawal by Subject|10
4547014|NCT01185522|7373216|FG000|Overall Study|Poor tolerance|39
4547015|NCT01185522|7373216|FG000|Overall Study|Other reasons|12
4547016|NCT01185548|7373221|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2
4547017|NCT01185561|7373236|FG000|Overall Study|Lost to Follow-up|0
4547018|NCT01185561|7373237|FG001|Overall Study|Lost to Follow-up|4
4547019|NCT01185561|7373236|FG000|Overall Study|Withdrawal by Subject|2
4547020|NCT01185561|7373237|FG001|Overall Study|Withdrawal by Subject|8
4547021|NCT01185600|7373245|FG000|Overall Study|Adverse Event|1
4547022|NCT01185600|7373246|FG001|Overall Study|Adverse Event|1
4547023|NCT01185600|7373245|FG000|Overall Study|Death|0
4547024|NCT01185600|7373246|FG001|Overall Study|Death|1
4547025|NCT01185600|7373245|FG000|Overall Study|Lost to Follow-up|0
4547026|NCT01185600|7373246|FG001|Overall Study|Lost to Follow-up|5
4547027|NCT01185600|7373245|FG000|Overall Study|Physician Decision|29
4547028|NCT01185600|7373246|FG001|Overall Study|Physician Decision|35
4547029|NCT01185600|7373245|FG000|Overall Study|Withdrawal by Subject|1
4547030|NCT01185600|7373246|FG001|Overall Study|Withdrawal by Subject|1
4547031|NCT01185600|7373245|FG000|Overall Study|Hold by DSMB|1
4547032|NCT01185600|7373246|FG001|Overall Study|Hold by DSMB|2
4547033|NCT01185639|7373255|FG000|Overall Study|Progressed and didn't receive therapy|2
4547034|NCT01185704|7373261|FG000|Overall Study|Randomized but not treated|3
4547035|NCT01185704|7373262|FG001|Overall Study|Randomized but not treated|3
4547036|NCT01185704|7373261|FG000|Overall Study|Lack of ovarian response|5
4547037|NCT01185704|7373262|FG001|Overall Study|Lack of ovarian response|1
4547038|NCT01185704|7373261|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5
4547039|NCT01185704|7373262|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3
4547040|NCT01185704|7373261|FG000|Overall Study|Ectopic pregnancy|0
4547041|NCT01185704|7373262|FG001|Overall Study|Ectopic pregnancy|1
4547042|NCT01185782|7373270|FG000|Overall Study|Adverse Event|0
4547043|NCT01185782|7373271|FG001|Overall Study|Adverse Event|1
4547044|NCT01185782|7373270|FG000|Overall Study|Protocol Violation|1
4547045|NCT01185782|7373271|FG001|Overall Study|Protocol Violation|0
4547046|NCT01185782|7373270|FG000|Overall Study|Poor Response to Treatment|3
4547047|NCT01185782|7373271|FG001|Overall Study|Poor Response to Treatment|1
4547048|NCT01185782|7373270|FG000|Overall Study|Other|2
4547049|NCT01185782|7373271|FG001|Overall Study|Other|5
4547050|NCT01185782|7373270|FG000|Overall Study|Randomized but not treated|0
4547051|NCT01185782|7373271|FG001|Overall Study|Randomized but not treated|4
4547052|NCT01185821|7373282|FG000|Overall Study|Abnormal laboratory value(s)|1
4547053|NCT01185821|7373283|FG001|Overall Study|Abnormal laboratory value(s)|2
4547054|NCT01185821|7373284|FG002|Overall Study|Abnormal laboratory value(s)|1
4547055|NCT01185821|7373285|FG003|Overall Study|Abnormal laboratory value(s)|0
4547056|NCT01185821|7373286|FG004|Overall Study|Abnormal laboratory value(s)|0
4547057|NCT01185821|7373282|FG000|Overall Study|Protocol Violation|0
4547058|NCT01185821|7373283|FG001|Overall Study|Protocol Violation|0
4547059|NCT01185821|7373284|FG002|Overall Study|Protocol Violation|0
4547060|NCT01185821|7373285|FG003|Overall Study|Protocol Violation|1
4547061|NCT01185821|7373286|FG004|Overall Study|Protocol Violation|1
4547062|NCT01185821|7373282|FG000|Overall Study|Abnormal test procedure result|0
4547063|NCT01185821|7373283|FG001|Overall Study|Abnormal test procedure result|0
4547064|NCT01185821|7373284|FG002|Overall Study|Abnormal test procedure result|0
4547065|NCT01185821|7373285|FG003|Overall Study|Abnormal test procedure result|0
4547066|NCT01185821|7373286|FG004|Overall Study|Abnormal test procedure result|1
4547067|NCT01185821|7373282|FG000|Overall Study|Death|0
4547068|NCT01185821|7373283|FG001|Overall Study|Death|1
4547069|NCT01185821|7373284|FG002|Overall Study|Death|0
4547070|NCT01185821|7373285|FG003|Overall Study|Death|0
4547071|NCT01185821|7373286|FG004|Overall Study|Death|0
4547072|NCT01185821|7373282|FG000|Overall Study|Condition no longer required study drug|0
4547073|NCT01185821|7373283|FG001|Overall Study|Condition no longer required study drug|0
4547074|NCT01185821|7373284|FG002|Overall Study|Condition no longer required study drug|0
4547075|NCT01185821|7373285|FG003|Overall Study|Condition no longer required study drug|0
4547076|NCT01185821|7373286|FG004|Overall Study|Condition no longer required study drug|1
4547077|NCT01185821|7373282|FG000|Overall Study|Adverse Event|2
4547078|NCT01185821|7373283|FG001|Overall Study|Adverse Event|3
4547079|NCT01185821|7373284|FG002|Overall Study|Adverse Event|1
4547080|NCT01185821|7373285|FG003|Overall Study|Adverse Event|2
4547081|NCT01185821|7373286|FG004|Overall Study|Adverse Event|5
4547082|NCT01185821|7373282|FG000|Overall Study|Lack of Efficacy|0
4547083|NCT01185821|7373283|FG001|Overall Study|Lack of Efficacy|0
4547084|NCT01185821|7373284|FG002|Overall Study|Lack of Efficacy|3
4547085|NCT01185821|7373285|FG003|Overall Study|Lack of Efficacy|0
4547086|NCT01185821|7373286|FG004|Overall Study|Lack of Efficacy|9
4547087|NCT01185821|7373282|FG000|Overall Study|Withdrawal by Subject|3
4547088|NCT01185821|7373283|FG001|Overall Study|Withdrawal by Subject|2
4547089|NCT01185821|7373284|FG002|Overall Study|Withdrawal by Subject|2
4547090|NCT01185821|7373285|FG003|Overall Study|Withdrawal by Subject|1
4547091|NCT01185821|7373286|FG004|Overall Study|Withdrawal by Subject|3
4547092|NCT01185821|7373282|FG000|Overall Study|Lost to Follow-up|1
4547093|NCT01185821|7373283|FG001|Overall Study|Lost to Follow-up|1
4547094|NCT01185821|7373284|FG002|Overall Study|Lost to Follow-up|2
4547095|NCT01185821|7373285|FG003|Overall Study|Lost to Follow-up|1
4547096|NCT01185821|7373286|FG004|Overall Study|Lost to Follow-up|2
4547097|NCT01185821|7373282|FG000|Overall Study|Administrative problems|0
4547098|NCT01185821|7373283|FG001|Overall Study|Administrative problems|0
4547099|NCT01185821|7373284|FG002|Overall Study|Administrative problems|1
4547100|NCT01185821|7373285|FG003|Overall Study|Administrative problems|1
4547101|NCT01185821|7373286|FG004|Overall Study|Administrative problems|2
4547102|NCT01185834|7373300|FG000|Overall Study|Lost to Follow-up|2
4547103|NCT01185834|7373300|FG000|Overall Study|Discomfort|4
4547104|NCT01185834|7373300|FG000|Overall Study|Biomicroscopy|4
4547105|NCT01185834|7373300|FG000|Overall Study|Time/Job Conflict|2
4547106|NCT01185834|7373300|FG000|Overall Study|Early exit - Site error|2
4547107|NCT01185964|7373307|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1
4547108|NCT01185964|7373308|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6
4547109|NCT01185964|7373309|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2
4547110|NCT01185964|7373310|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0
4547111|NCT01185964|7373307|FG000|Phase 1b and Phase 2|Other Therapy Started|0
4547112|NCT01185964|7373308|FG001|Phase 1b and Phase 2|Other Therapy Started|3
4547113|NCT01185964|7373309|FG002|Phase 1b and Phase 2|Other Therapy Started|3
4547114|NCT01185964|7373310|FG003|Phase 1b and Phase 2|Other Therapy Started|0
4547115|NCT01185964|7373307|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0
4547116|NCT01185964|7373308|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0
4547117|NCT01185964|7373309|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1
4547118|NCT01185964|7373310|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0
4547119|NCT01185964|7373307|FG000|Phase 1b and Phase 2|Adverse Event|1
4547120|NCT01185964|7373308|FG001|Phase 1b and Phase 2|Adverse Event|0
4547121|NCT01185964|7373309|FG002|Phase 1b and Phase 2|Adverse Event|2
4547122|NCT01185964|7373310|FG003|Phase 1b and Phase 2|Adverse Event|0
4547123|NCT01185964|7373307|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0
4547124|NCT01185964|7373308|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1
4619419|NCT01774305|7480908|FG000|Overall Study|Physician Decision|1
4619420|NCT01774305|7480909|FG001|Overall Study|Physician Decision|0
4619421|NCT01774344|7480917|FG000|Overall Study|Withdrawal by Subject|3
4619422|NCT01774344|7480918|FG001|Overall Study|Withdrawal by Subject|10
4619423|NCT01774344|7480917|FG000|Overall Study|Protocol Violation|0
4547125|NCT01185964|7373309|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1
4547126|NCT01185964|7373310|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0
4547127|NCT01185964|7373307|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
4547128|NCT01185964|7373308|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
4547129|NCT01185964|7373309|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
4619424|NCT01774344|7480918|FG001|Overall Study|Protocol Violation|1
4619425|NCT01774344|7480917|FG000|Overall Study|Lost to Follow-up|4
4619426|NCT01774344|7480918|FG001|Overall Study|Lost to Follow-up|10
4690544|NCT02561195|7600187|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
4690545|NCT02561195|7600188|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
4690546|NCT02561195|7600189|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
4690547|NCT02561195|7600190|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
4690548|NCT02561195|7600191|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
4690549|NCT02561195|7600192|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
4690550|NCT02561195|7600193|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
4690551|NCT02561195|7600194|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
4690552|NCT02561195|7600195|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0
4690553|NCT02561195|7600196|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1
4619427|NCT01774344|7480917|FG000|Overall Study|End of survival follow-up not available|2
4690554|NCT02561195|7600197|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1
4690555|NCT02561195|7600198|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1
4690556|NCT02561195|7600185|FG000|Extension Stage (Vaccination 4)|Other|0
4690557|NCT02561195|7600186|FG001|Extension Stage (Vaccination 4)|Other|0
4690558|NCT02561195|7600187|FG002|Extension Stage (Vaccination 4)|Other|0
4690559|NCT02561195|7600188|FG003|Extension Stage (Vaccination 4)|Other|0
4690560|NCT02561195|7600189|FG004|Extension Stage (Vaccination 4)|Other|0
4690561|NCT02561195|7600190|FG005|Extension Stage (Vaccination 4)|Other|0
4690562|NCT02561195|7600191|FG006|Extension Stage (Vaccination 4)|Other|0
4690563|NCT02561195|7600192|FG007|Extension Stage (Vaccination 4)|Other|0
4690564|NCT02561195|7600193|FG008|Extension Stage (Vaccination 4)|Other|0
4690565|NCT02561195|7600194|FG009|Extension Stage (Vaccination 4)|Other|0
4690566|NCT02561195|7600195|FG010|Extension Stage (Vaccination 4)|Other|2
4690567|NCT02561195|7600196|FG011|Extension Stage (Vaccination 4)|Other|2
4690568|NCT02561195|7600197|FG012|Extension Stage (Vaccination 4)|Other|1
4690569|NCT02561195|7600198|FG013|Extension Stage (Vaccination 4)|Other|0
4690570|NCT02561195|7600185|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0
4690571|NCT02561195|7600186|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0
4690572|NCT02561195|7600187|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0
4690573|NCT02561195|7600188|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0
4690574|NCT02561195|7600189|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0
4690575|NCT02561195|7600190|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0
4690576|NCT02561195|7600191|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1
4690577|NCT02561195|7600192|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0
4690578|NCT02561195|7600193|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0
4690579|NCT02561195|7600194|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0
4690580|NCT02561195|7600195|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2
4690581|NCT02561195|7600196|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1
4690582|NCT02561195|7600197|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0
4690583|NCT02561195|7600198|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1
4690584|NCT02561247|7600239|FG000|Overall Study|Protocol Violation|1
4690585|NCT02561247|7600239|FG000|Overall Study|Withdrawal by Subject|1
4690586|NCT02561247|7600239|FG000|Overall Study|Two filter changes required within the first 24 hours.|4
4690587|NCT02561273|7600245|FG000|Overall Study|Protocol Violation|1
4690588|NCT02561273|7600246|FG001|Overall Study|Protocol Violation|0
4690589|NCT02561455|7600281|FG000|Overall Study|Participant Transitioned to Commercial Drug|1
4690590|NCT02561455|7600282|FG001|Overall Study|Participant Transitioned to Commercial Drug|1
4690591|NCT02561455|7600283|FG002|Overall Study|Participant Transitioned to Commercial Drug|2
4547130|NCT01185964|7373310|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2
4547131|NCT01185964|7373307|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
4547132|NCT01185964|7373308|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
4547133|NCT01185964|7373309|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
4591539|NCT01531673|7438199|FG010|Overall Study|Lost to Follow-up|0
4619428|NCT01774344|7480918|FG001|Overall Study|End of survival follow-up not available|2
4619429|NCT01774344|7480917|FG000|Overall Study|Data collection finished|4
4619430|NCT01774344|7480918|FG001|Overall Study|Data collection finished|14
4619431|NCT01774344|7480917|FG000|Overall Study|Other|0
4619432|NCT01774344|7480918|FG001|Overall Study|Other|1
4690592|NCT02561455|7600284|FG003|Overall Study|Participant Transitioned to Commercial Drug|1
4690593|NCT02561455|7600281|FG000|Overall Study|Withdrawal by Subject|1
4690594|NCT02561455|7600282|FG001|Overall Study|Withdrawal by Subject|0
4690595|NCT02561455|7600283|FG002|Overall Study|Withdrawal by Subject|1
4547134|NCT01185964|7373310|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1
4547135|NCT01185964|7373307|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
4547136|NCT01185964|7373308|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
4547137|NCT01185964|7373309|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
4547138|NCT01185964|7373310|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2
4547139|NCT01186328|7373335|FG000|Overall Study|Death|1
4547140|NCT01186328|7373336|FG001|Overall Study|Death|0
4547141|NCT01186328|7373337|FG002|Overall Study|Death|0
4547142|NCT01186419|7373348|FG000|Overall Study|Withdrawal by Subject|5
4547143|NCT01186419|7373349|FG001|Overall Study|Withdrawal by Subject|3
4547144|NCT01186419|7373348|FG000|Overall Study|Adverse Event|1
4547145|NCT01186419|7373349|FG001|Overall Study|Adverse Event|2
4547146|NCT01186419|7373348|FG000|Overall Study|Physician Decision|0
4547147|NCT01186419|7373349|FG001|Overall Study|Physician Decision|3
4547148|NCT01186419|7373348|FG000|Overall Study|Other|1
4547149|NCT01186419|7373349|FG001|Overall Study|Other|1
4547150|NCT01186458|7373354|FG000|Overall Study|Adverse Event|1
4547151|NCT01186692|7373367|FG000|Overall Study|Not Catheterized|11
4547152|NCT01186692|7373367|FG000|Overall Study|Futher testing contraindicated implant|19
4547153|NCT01186692|7373367|FG000|Overall Study|Adverse Event|2
4547154|NCT01186744|7373385|FG000|Overall Study|Lack of Efficacy|156
4547155|NCT01186744|7373386|FG001|Overall Study|Lack of Efficacy|99
4547156|NCT01186744|7373387|FG002|Overall Study|Lack of Efficacy|0
4547157|NCT01186744|7373388|FG003|Overall Study|Lack of Efficacy|2
4547158|NCT01186744|7373389|FG004|Overall Study|Lack of Efficacy|2
4547159|NCT01186744|7373390|FG005|Overall Study|Lack of Efficacy|5
4547160|NCT01186744|7373385|FG000|Overall Study|Protocol Violation|1
4547161|NCT01186744|7373386|FG001|Overall Study|Protocol Violation|2
4547162|NCT01186744|7373387|FG002|Overall Study|Protocol Violation|0
4547163|NCT01186744|7373388|FG003|Overall Study|Protocol Violation|1
4547164|NCT01186744|7373389|FG004|Overall Study|Protocol Violation|1
4547165|NCT01186744|7373390|FG005|Overall Study|Protocol Violation|2
4547166|NCT01186744|7373385|FG000|Overall Study|Lost to Follow-up|15
4547167|NCT01186744|7373386|FG001|Overall Study|Lost to Follow-up|16
4547168|NCT01186744|7373387|FG002|Overall Study|Lost to Follow-up|2
4547169|NCT01186744|7373388|FG003|Overall Study|Lost to Follow-up|1
4547170|NCT01186744|7373389|FG004|Overall Study|Lost to Follow-up|1
4619433|NCT01774344|7480917|FG000|Overall Study|Did not enter Survival Follow up|49
4619434|NCT01774344|7480918|FG001|Overall Study|Did not enter Survival Follow up|83
4619435|NCT01774591|7480926|FG000|Overall Study|Physician Decision|1
4619436|NCT01774591|7480927|FG001|Overall Study|Physician Decision|1
4619437|NCT01774591|7480926|FG000|Overall Study|Withdrawal by Subject|0
4619438|NCT01774591|7480927|FG001|Overall Study|Withdrawal by Subject|1
4619439|NCT01774591|7480926|FG000|Overall Study|Adverse Event|0
4619440|NCT01774591|7480927|FG001|Overall Study|Adverse Event|2
4619441|NCT01774786|7480948|FG000|Overall Study|Death|300
4619442|NCT01774786|7480949|FG001|Overall Study|Death|319
4619443|NCT01774786|7480948|FG000|Overall Study|Lost to Follow-up|6
4619444|NCT01774786|7480949|FG001|Overall Study|Lost to Follow-up|7
4619445|NCT01774786|7480948|FG000|Overall Study|Withdrawal by Subject|18
4619446|NCT01774786|7480949|FG001|Overall Study|Withdrawal by Subject|14
4619447|NCT01774786|7480948|FG000|Overall Study|Physician Decision|2
4619448|NCT01774786|7480949|FG001|Overall Study|Physician Decision|0
4690596|NCT02561455|7600284|FG003|Overall Study|Withdrawal by Subject|0
4547171|NCT01186744|7373390|FG005|Overall Study|Lost to Follow-up|4
4547172|NCT01186744|7373385|FG000|Overall Study|Screen failure|1
4547173|NCT01186744|7373386|FG001|Overall Study|Screen failure|1
4547174|NCT01186744|7373387|FG002|Overall Study|Screen failure|0
4547175|NCT01186744|7373388|FG003|Overall Study|Screen failure|1
4547176|NCT01186744|7373389|FG004|Overall Study|Screen failure|0
4547177|NCT01186744|7373390|FG005|Overall Study|Screen failure|0
4547178|NCT01186744|7373385|FG000|Overall Study|Withdrawal by Subject|14
4547179|NCT01186744|7373386|FG001|Overall Study|Withdrawal by Subject|10
4547180|NCT01186744|7373387|FG002|Overall Study|Withdrawal by Subject|2
4547181|NCT01186744|7373388|FG003|Overall Study|Withdrawal by Subject|5
4547182|NCT01186744|7373389|FG004|Overall Study|Withdrawal by Subject|0
4547183|NCT01186744|7373390|FG005|Overall Study|Withdrawal by Subject|6
4547184|NCT01186744|7373385|FG000|Overall Study|Study terminated by Sponsor|1
4547185|NCT01186744|7373386|FG001|Overall Study|Study terminated by Sponsor|0
4547186|NCT01186744|7373387|FG002|Overall Study|Study terminated by Sponsor|0
4547187|NCT01186744|7373388|FG003|Overall Study|Study terminated by Sponsor|0
4547188|NCT01186744|7373389|FG004|Overall Study|Study terminated by Sponsor|0
4547189|NCT01186744|7373390|FG005|Overall Study|Study terminated by Sponsor|0
4547190|NCT01186744|7373385|FG000|Overall Study|Other|9
4547191|NCT01186744|7373386|FG001|Overall Study|Other|10
4547192|NCT01186744|7373387|FG002|Overall Study|Other|1
4619449|NCT01774786|7480948|FG000|Overall Study|Non-compliance|0
4619450|NCT01774786|7480949|FG001|Overall Study|Non-compliance|1
4619451|NCT01774786|7480948|FG000|Overall Study|Reason Not Specified|2
4619452|NCT01774786|7480949|FG001|Overall Study|Reason Not Specified|5
4619453|NCT01774799|7480959|FG000|Overall Study|Lost to Follow-up|1
4690597|NCT02561455|7600281|FG000|Overall Study|Disease Progression|0
4547193|NCT01186744|7373388|FG003|Overall Study|Other|2
4547194|NCT01186744|7373389|FG004|Overall Study|Other|1
4547195|NCT01186744|7373390|FG005|Overall Study|Other|5
4547196|NCT01186744|7373385|FG000|Overall Study|Adverse Event|10
4547197|NCT01186744|7373386|FG001|Overall Study|Adverse Event|14
4547198|NCT01186744|7373387|FG002|Overall Study|Adverse Event|1
4547199|NCT01186744|7373388|FG003|Overall Study|Adverse Event|0
4547200|NCT01186744|7373389|FG004|Overall Study|Adverse Event|1
4547201|NCT01186744|7373390|FG005|Overall Study|Adverse Event|4
4547202|NCT01186744|7373385|FG000|Overall Study|Death|1
4547203|NCT01186744|7373386|FG001|Overall Study|Death|0
4547204|NCT01186744|7373387|FG002|Overall Study|Death|0
4547205|NCT01186744|7373388|FG003|Overall Study|Death|0
4547206|NCT01186744|7373389|FG004|Overall Study|Death|0
4547207|NCT01186744|7373390|FG005|Overall Study|Death|0
4547208|NCT01186770|7373429|FG000|Overall Study|Ineligibility|0
4547209|NCT01186770|7373430|FG001|Overall Study|Ineligibility|0
4547210|NCT01186770|7373431|FG002|Overall Study|Ineligibility|2
4547211|NCT01186770|7373432|FG003|Overall Study|Ineligibility|0
4547212|NCT01186770|7373429|FG000|Overall Study|Protocol Violation|7
4547213|NCT01186770|7373430|FG001|Overall Study|Protocol Violation|9
4547214|NCT01186770|7373431|FG002|Overall Study|Protocol Violation|12
4547215|NCT01186770|7373432|FG003|Overall Study|Protocol Violation|14
4547216|NCT01186770|7373429|FG000|Overall Study|Adverse Event|2
4547217|NCT01186770|7373430|FG001|Overall Study|Adverse Event|9
4547218|NCT01186770|7373431|FG002|Overall Study|Adverse Event|7
4547219|NCT01186770|7373432|FG003|Overall Study|Adverse Event|9
4547220|NCT01186770|7373429|FG000|Overall Study|Withdrawal by Subject|15
4547221|NCT01186770|7373430|FG001|Overall Study|Withdrawal by Subject|13
4547222|NCT01186770|7373431|FG002|Overall Study|Withdrawal by Subject|11
4547223|NCT01186770|7373432|FG003|Overall Study|Withdrawal by Subject|17
4547224|NCT01186770|7373429|FG000|Overall Study|Lost to Follow-up|10
4547225|NCT01186770|7373430|FG001|Overall Study|Lost to Follow-up|6
4547226|NCT01186770|7373431|FG002|Overall Study|Lost to Follow-up|14
4547227|NCT01186770|7373432|FG003|Overall Study|Lost to Follow-up|9
4547228|NCT01186770|7373429|FG000|Overall Study|Insufficient response to treatment|7
4547229|NCT01186770|7373430|FG001|Overall Study|Insufficient response to treatment|8
4547230|NCT01186770|7373431|FG002|Overall Study|Insufficient response to treatment|5
4547231|NCT01186770|7373432|FG003|Overall Study|Insufficient response to treatment|7
4547232|NCT01186770|7373429|FG000|Overall Study|Other than specified|0
4547233|NCT01186770|7373430|FG001|Overall Study|Other than specified|1
4547234|NCT01186770|7373431|FG002|Overall Study|Other than specified|1
4547235|NCT01186770|7373432|FG003|Overall Study|Other than specified|2
4547236|NCT01186796|7373444|FG000|Overall Study|Adverse Event|3
4547237|NCT01186796|7373445|FG001|Overall Study|Adverse Event|0
4547238|NCT01186796|7373444|FG000|Overall Study|Withdrawal by Subject|1
4547239|NCT01186796|7373445|FG001|Overall Study|Withdrawal by Subject|1
4547240|NCT01186796|7373444|FG000|Overall Study|Protocol Violation|0
4547241|NCT01186796|7373445|FG001|Overall Study|Protocol Violation|1
4547242|NCT01186809|7373451|FG000|Overall Study|Death|30
4547243|NCT01186939|7373455|FG000|Overall Study|Death|7
4547244|NCT01186939|7373455|FG000|Overall Study|Withdrawal by Subject|2
4547245|NCT01186939|7373455|FG000|Overall Study|No longer receiving clinical benefit|17
4547246|NCT01186939|7373455|FG000|Overall Study|Program closed|5
4547247|NCT01186939|7373455|FG000|Overall Study|Sponsor decision|4
4547248|NCT01186939|7373455|FG000|Overall Study|Started additional treatment|1
4547249|NCT01186939|7373455|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1
4547250|NCT01186939|7373455|FG000|Overall Study|Myocardial infarction|1
4547251|NCT01186939|7373455|FG000|Overall Study|Bone marrow transplant|1
4547252|NCT01186939|7373455|FG000|Overall Study|Transformation to AML|1
4547253|NCT01186978|7373459|FG000|Overall Study|Withdrawal by Subject|1
4547254|NCT01187043|7373484|FG000|Overall Study|Adverse Event|0
4547255|NCT01187043|7373485|FG001|Overall Study|Adverse Event|0
4547256|NCT01187043|7373486|FG002|Overall Study|Adverse Event|0
4547257|NCT01187043|7373487|FG003|Overall Study|Adverse Event|0
4547258|NCT01187043|7373488|FG004|Overall Study|Adverse Event|1
4547259|NCT01187043|7373484|FG000|Overall Study|Unable to make scheduled visits|1
4547260|NCT01187043|7373485|FG001|Overall Study|Unable to make scheduled visits|0
4547261|NCT01187043|7373486|FG002|Overall Study|Unable to make scheduled visits|4
4547262|NCT01187043|7373487|FG003|Overall Study|Unable to make scheduled visits|0
4547263|NCT01187043|7373488|FG004|Overall Study|Unable to make scheduled visits|1
4591540|NCT01531673|7438200|FG011|Overall Study|Lost to Follow-up|0
4591541|NCT01531673|7438201|FG012|Overall Study|Lost to Follow-up|0
4591542|NCT01531673|7438189|FG000|Overall Study|Other|0
4591543|NCT01531673|7438190|FG001|Overall Study|Other|0
4591544|NCT01531673|7438191|FG002|Overall Study|Other|0
4591545|NCT01531673|7438192|FG003|Overall Study|Other|1
4591546|NCT01531673|7438193|FG004|Overall Study|Other|0
4591547|NCT01531673|7438194|FG005|Overall Study|Other|0
4591548|NCT01531673|7438195|FG006|Overall Study|Other|0
4591549|NCT01531673|7438196|FG007|Overall Study|Other|0
4591550|NCT01531673|7438197|FG008|Overall Study|Other|0
4591551|NCT01531673|7438198|FG009|Overall Study|Other|1
4591552|NCT01531673|7438199|FG010|Overall Study|Other|0
4591553|NCT01531673|7438200|FG011|Overall Study|Other|0
4591554|NCT01531673|7438201|FG012|Overall Study|Other|0
4591555|NCT01531725|7438253|FG000|Overall Study|Protocol Violation|5
4547264|NCT01187407|7373535|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29
4547265|NCT01187407|7373536|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
4547266|NCT01187407|7373537|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
4547267|NCT01187407|7373538|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
4547268|NCT01187407|7373539|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
4547269|NCT01187407|7373535|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4
4547270|NCT01187407|7373536|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
4547271|NCT01187407|7373537|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
4547272|NCT01187407|7373538|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
4547273|NCT01187407|7373539|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
4547274|NCT01187407|7373535|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9
4547275|NCT01187407|7373536|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
4547276|NCT01187407|7373537|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
4547277|NCT01187407|7373538|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
4547278|NCT01187407|7373539|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
4547279|NCT01187407|7373535|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2
4547280|NCT01187407|7373536|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
4547281|NCT01187407|7373537|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
4547282|NCT01187407|7373538|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
4547283|NCT01187407|7373539|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
4547284|NCT01187407|7373535|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13
4547285|NCT01187407|7373536|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
4547286|NCT01187407|7373537|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
4547287|NCT01187407|7373538|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
4547288|NCT01187407|7373539|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
4547289|NCT01187407|7373535|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29
4547290|NCT01187407|7373536|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
4547291|NCT01187407|7373537|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
4547292|NCT01187407|7373538|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
4547293|NCT01187407|7373539|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
4547294|NCT01187407|7373535|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4
4547295|NCT01187407|7373536|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
4547296|NCT01187407|7373537|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
4547297|NCT01187407|7373538|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
4547298|NCT01187407|7373539|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
4547299|NCT01187407|7373535|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
4547300|NCT01187407|7373536|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
4547301|NCT01187407|7373537|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6
4547302|NCT01187407|7373538|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5
4547303|NCT01187407|7373539|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12
4547304|NCT01187407|7373535|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
4547305|NCT01187407|7373536|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3
4547306|NCT01187407|7373537|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8
4547307|NCT01187407|7373538|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5
4547308|NCT01187407|7373539|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13
4547309|NCT01187407|7373535|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
4547310|NCT01187407|7373536|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3
4547311|NCT01187407|7373537|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5
4547312|NCT01187407|7373538|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2
4547313|NCT01187407|7373539|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9
4547314|NCT01187407|7373535|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
4547315|NCT01187407|7373536|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
4547316|NCT01187407|7373537|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
4547317|NCT01187407|7373538|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
4547318|NCT01187407|7373539|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
4547319|NCT01187407|7373535|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
4547320|NCT01187407|7373536|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6
4547321|NCT01187407|7373537|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
4619454|NCT01774799|7480960|FG001|Overall Study|Lost to Follow-up|1
4619455|NCT01774799|7480961|FG002|Overall Study|Lost to Follow-up|0
4619456|NCT01774799|7480962|FG003|Overall Study|Lost to Follow-up|0
4619457|NCT01774903|7480977|FG000|Overall Study|Adverse Event|7
4619458|NCT01774903|7480977|FG000|Overall Study|Withdrawal by Subject|2
4619459|NCT01774903|7480977|FG000|Overall Study|Lack of Efficacy|1
4619460|NCT01774903|7480977|FG000|Overall Study|Ineligible to continue the trial|1
4619461|NCT01774929|7480982|FG000|Overall Study|Adverse Event|3
4619462|NCT01774968|7480988|FG000|Overall Study|Adverse Event|4
4619463|NCT01774968|7480989|FG001|Overall Study|Adverse Event|4
4619464|NCT01774968|7480988|FG000|Overall Study|Death|0
4619465|NCT01774968|7480989|FG001|Overall Study|Death|1
4619466|NCT01774968|7480988|FG000|Overall Study|Lost to Follow-up|1
4619467|NCT01774968|7480989|FG001|Overall Study|Lost to Follow-up|3
4619468|NCT01774968|7480988|FG000|Overall Study|Physician Decision|5
4547322|NCT01187407|7373538|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3
4547323|NCT01187407|7373539|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10
4547324|NCT01187407|7373535|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
4547325|NCT01187407|7373536|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
4547326|NCT01187407|7373537|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
4547327|NCT01187407|7373538|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11
4547328|NCT01187407|7373539|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22
4547329|NCT01187407|7373535|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
4547330|NCT01187407|7373536|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
4547331|NCT01187407|7373537|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
4547332|NCT01187407|7373538|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
4547333|NCT01187407|7373539|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7
4547334|NCT01187446|7373558|FG000|Overall Study|Patient started non-protocol therapy|0
4547335|NCT01187446|7373559|FG001|Overall Study|Patient started non-protocol therapy|1
4547336|NCT01187550|7373585|FG000|Overall Study|Protocol Violation|3
4547337|NCT01187550|7373586|FG001|Overall Study|Protocol Violation|1
4547338|NCT01187550|7373585|FG000|Overall Study|Other|3
4547339|NCT01187550|7373586|FG001|Overall Study|Other|0
4547340|NCT01187550|7373585|FG000|Overall Study|Randomized but not treated|8
4547341|NCT01187550|7373586|FG001|Overall Study|Randomized but not treated|0
4547342|NCT01187901|7373605|FG000|Overall Study|Protocol Violation|1
4547343|NCT01187901|7373606|FG001|Overall Study|Protocol Violation|0
4547344|NCT01187901|7373605|FG000|Overall Study|Lost to Follow-up|1
4547345|NCT01187901|7373606|FG001|Overall Study|Lost to Follow-up|2
4547346|NCT01187901|7373605|FG000|Overall Study|Unrelated Health Reasons|1
4547347|NCT01187901|7373606|FG001|Overall Study|Unrelated Health Reasons|2
4547348|NCT01187901|7373605|FG000|Overall Study|Suspected Allergic Reaction|1
4547349|NCT01187901|7373606|FG001|Overall Study|Suspected Allergic Reaction|1
4547350|NCT01187901|7373605|FG000|Overall Study|Adverse Event|3
4547351|NCT01187901|7373606|FG001|Overall Study|Adverse Event|0
4547352|NCT01187901|7373605|FG000|Overall Study|No Endpoint due to Early Study Halt|2
4547353|NCT01187901|7373606|FG001|Overall Study|No Endpoint due to Early Study Halt|3
4547354|NCT01187901|7373605|FG000|Overall Study|Pregnancy|0
4547355|NCT01187901|7373606|FG001|Overall Study|Pregnancy|2
4547356|NCT01187953|7373618|FG000|Overall Study|Death|11
4547357|NCT01187953|7373619|FG001|Overall Study|Death|13
4547358|NCT01187953|7373618|FG000|Overall Study|Adverse Event|1
4547359|NCT01187953|7373619|FG001|Overall Study|Adverse Event|2
4547360|NCT01187953|7373618|FG000|Overall Study|Lost to Follow-up|0
4547361|NCT01187953|7373619|FG001|Overall Study|Lost to Follow-up|3
4547362|NCT01187953|7373618|FG000|Overall Study|Withdrawal by Subject|3
4547363|NCT01187953|7373619|FG001|Overall Study|Withdrawal by Subject|3
4547364|NCT01188226|7373629|FG000|Overall Study|Withdrawal by Subject|4
4547365|NCT01188343|7373646|FG000|Overall Study|Not vaccinated|0
4547366|NCT01188343|7373647|FG001|Overall Study|Not vaccinated|2
4547367|NCT01188343|7373648|FG002|Overall Study|Not vaccinated|1
4547368|NCT01188343|7373646|FG000|Overall Study|Withdrawal by Subject|1
4547369|NCT01188343|7373647|FG001|Overall Study|Withdrawal by Subject|24
4547370|NCT01188343|7373648|FG002|Overall Study|Withdrawal by Subject|0
4547371|NCT01188538|7373718|FG000|Overall Study|Lost to Follow-up|0
4547372|NCT01188538|7373719|FG001|Overall Study|Lost to Follow-up|1
4547373|NCT01188551|7373731|FG000|Overall Study|Pharmacy issues|1
4547374|NCT01188551|7373732|FG001|Overall Study|Pharmacy issues|0
4547375|NCT01188551|7373733|FG002|Overall Study|Pharmacy issues|0
4547376|NCT01188551|7373734|FG003|Overall Study|Pharmacy issues|0
4547377|NCT01188564|7373746|FG000|Double-blind Phase|randomized not treated|1
4547378|NCT01188564|7373747|FG001|Double-blind Phase|randomized not treated|0
4547379|NCT01188655|7373766|FG000|Overall Study|Lack of Efficacy|1
4547380|NCT01188655|7373766|FG000|Overall Study|Lost to Follow-up|1
4547381|NCT01188655|7373766|FG000|Overall Study|Other|11
4547382|NCT01188668|7373770|FG000|Period 1: ARIP Alone|Protocol Violation|2
4547383|NCT01188668|7373770|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2
4547384|NCT01188668|7373770|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1
4547385|NCT01188681|7373781|FG000|Overall Study|bladder cancer|0
4547386|NCT01188681|7373782|FG001|Overall Study|bladder cancer|0
4547387|NCT01188681|7373783|FG002|Overall Study|bladder cancer|1
4547388|NCT01188681|7373784|FG003|Overall Study|bladder cancer|0
4547389|NCT01188681|7373781|FG000|Overall Study|Withdrawal by Subject|0
4547390|NCT01188681|7373782|FG001|Overall Study|Withdrawal by Subject|0
4547391|NCT01188681|7373783|FG002|Overall Study|Withdrawal by Subject|0
4547392|NCT01188681|7373784|FG003|Overall Study|Withdrawal by Subject|1
4547393|NCT01188772|7373815|FG000|Overall Study|Randomized but Not Treated|0
4547394|NCT01188772|7373816|FG001|Overall Study|Randomized but Not Treated|1
4547395|NCT01188772|7373817|FG002|Overall Study|Randomized but Not Treated|0
4547396|NCT01188772|7373818|FG003|Overall Study|Randomized but Not Treated|0
4547397|NCT01188772|7373815|FG000|Overall Study|Adverse Event|0
4547398|NCT01188772|7373816|FG001|Overall Study|Adverse Event|1
4547399|NCT01188772|7373817|FG002|Overall Study|Adverse Event|2
4547400|NCT01188772|7373818|FG003|Overall Study|Adverse Event|0
4547401|NCT01188772|7373815|FG000|Overall Study|Lost to Follow-up|4
4547402|NCT01188772|7373816|FG001|Overall Study|Lost to Follow-up|1
4547403|NCT01188772|7373817|FG002|Overall Study|Lost to Follow-up|1
4547404|NCT01188772|7373818|FG003|Overall Study|Lost to Follow-up|1
4547405|NCT01188772|7373815|FG000|Overall Study|Non-responder|0
4547406|NCT01188772|7373816|FG001|Overall Study|Non-responder|0
4547407|NCT01188772|7373817|FG002|Overall Study|Non-responder|3
4547408|NCT01188772|7373818|FG003|Overall Study|Non-responder|0
4547409|NCT01188772|7373815|FG000|Overall Study|Physician Decision|0
4547410|NCT01188772|7373816|FG001|Overall Study|Physician Decision|0
4547411|NCT01188772|7373817|FG002|Overall Study|Physician Decision|1
4547412|NCT01188772|7373818|FG003|Overall Study|Physician Decision|0
4547413|NCT01188772|7373815|FG000|Overall Study|Terminated by Sponsor|0
4547414|NCT01188772|7373816|FG001|Overall Study|Terminated by Sponsor|0
4547415|NCT01188772|7373817|FG002|Overall Study|Terminated by Sponsor|1
4547416|NCT01188772|7373818|FG003|Overall Study|Terminated by Sponsor|0
4547417|NCT01188772|7373815|FG000|Overall Study|Treatment Failure|0
4547418|NCT01188772|7373816|FG001|Overall Study|Treatment Failure|0
4547419|NCT01188772|7373817|FG002|Overall Study|Treatment Failure|1
4547420|NCT01188772|7373818|FG003|Overall Study|Treatment Failure|0
4547421|NCT01188772|7373815|FG000|Overall Study|Virologic Failure|1
4547422|NCT01188772|7373816|FG001|Overall Study|Virologic Failure|0
4547423|NCT01188772|7373817|FG002|Overall Study|Virologic Failure|0
4547424|NCT01188772|7373818|FG003|Overall Study|Virologic Failure|0
4547425|NCT01188772|7373815|FG000|Overall Study|Withdrawal by Subject|0
4619469|NCT01774968|7480989|FG001|Overall Study|Physician Decision|1
4619470|NCT01774968|7480988|FG000|Overall Study|Protocol Violation|14
4619471|NCT01774968|7480989|FG001|Overall Study|Protocol Violation|13
4619472|NCT01774968|7480988|FG000|Overall Study|Sponsor Decision|0
4547426|NCT01188772|7373816|FG001|Overall Study|Withdrawal by Subject|0
4619473|NCT01774968|7480989|FG001|Overall Study|Sponsor Decision|2
4619474|NCT01774968|7480988|FG000|Overall Study|Withdrawal by Subject|6
4619475|NCT01774968|7480989|FG001|Overall Study|Withdrawal by Subject|11
4619476|NCT01774981|7481003|FG000|Overall Study|Adverse Event|0
4619477|NCT01774981|7481004|FG001|Overall Study|Adverse Event|0
4619478|NCT01774981|7481005|FG002|Overall Study|Adverse Event|0
4619479|NCT01774981|7481006|FG003|Overall Study|Adverse Event|0
4619480|NCT01774981|7481007|FG004|Overall Study|Adverse Event|0
4619481|NCT01774981|7481008|FG005|Overall Study|Adverse Event|1
4619482|NCT01774981|7481009|FG006|Overall Study|Adverse Event|0
4619483|NCT01774981|7481010|FG007|Overall Study|Adverse Event|0
4619484|NCT01774981|7481003|FG000|Overall Study|Withdrawal by Subject|0
4619485|NCT01774981|7481004|FG001|Overall Study|Withdrawal by Subject|0
4619486|NCT01774981|7481005|FG002|Overall Study|Withdrawal by Subject|0
4619487|NCT01774981|7481006|FG003|Overall Study|Withdrawal by Subject|0
4619488|NCT01774981|7481007|FG004|Overall Study|Withdrawal by Subject|0
4619489|NCT01774981|7481008|FG005|Overall Study|Withdrawal by Subject|0
4619490|NCT01774981|7481009|FG006|Overall Study|Withdrawal by Subject|0
4619491|NCT01774981|7481010|FG007|Overall Study|Withdrawal by Subject|1
4619492|NCT01774981|7481003|FG000|Overall Study|Death|0
4547427|NCT01188772|7373817|FG002|Overall Study|Withdrawal by Subject|2
4547428|NCT01188772|7373818|FG003|Overall Study|Withdrawal by Subject|0
4547429|NCT01188811|7373833|FG000|Overall Study|Withdrawal by Subject|0
4547430|NCT01188811|7373834|FG001|Overall Study|Withdrawal by Subject|2
4547431|NCT01188811|7373833|FG000|Overall Study|Adverse Event|6
4547432|NCT01188811|7373834|FG001|Overall Study|Adverse Event|0
4547433|NCT01188967|7373863|FG000|Overall Study|Withdrawal by Subject|1
4547434|NCT01188967|7373864|FG001|Overall Study|Withdrawal by Subject|1
4547435|NCT01188967|7373863|FG000|Overall Study|Physician Decision|1
4547436|NCT01188967|7373864|FG001|Overall Study|Physician Decision|1
4547437|NCT01188967|7373863|FG000|Overall Study|Lost to Follow-up|3
4547438|NCT01188967|7373864|FG001|Overall Study|Lost to Follow-up|2
4547439|NCT01189032|7373875|FG000|Overall Study|Adverse Event|1
4547440|NCT01189032|7373876|FG001|Overall Study|Adverse Event|3
4547441|NCT01189032|7373877|FG002|Overall Study|Adverse Event|4
4547442|NCT01189032|7373875|FG000|Overall Study|Lack of Efficacy|2
4547443|NCT01189032|7373876|FG001|Overall Study|Lack of Efficacy|3
4547444|NCT01189032|7373877|FG002|Overall Study|Lack of Efficacy|0
4547445|NCT01189032|7373875|FG000|Overall Study|Withdrawal by Subject|1
4547446|NCT01189032|7373876|FG001|Overall Study|Withdrawal by Subject|0
4619493|NCT01774981|7481004|FG001|Overall Study|Death|0
4619494|NCT01774981|7481005|FG002|Overall Study|Death|0
4619495|NCT01774981|7481006|FG003|Overall Study|Death|0
4619496|NCT01774981|7481007|FG004|Overall Study|Death|1
4619497|NCT01774981|7481008|FG005|Overall Study|Death|0
4619498|NCT01774981|7481009|FG006|Overall Study|Death|0
4547447|NCT01189032|7373877|FG002|Overall Study|Withdrawal by Subject|1
4547448|NCT01189032|7373875|FG000|Overall Study|Protocol Violation|1
4547449|NCT01189032|7373876|FG001|Overall Study|Protocol Violation|1
4547450|NCT01189032|7373877|FG002|Overall Study|Protocol Violation|1
4547451|NCT01189201|7373912|FG000|Overall Study|Adverse Event|1
4547452|NCT01189266|7373942|FG000|Overall Study|Adverse Event|1
4547453|NCT01189266|7373943|FG001|Overall Study|Adverse Event|0
4547454|NCT01189266|7373944|FG002|Overall Study|Adverse Event|5
4547455|NCT01189266|7373942|FG000|Overall Study|Death|0
4547456|NCT01189266|7373943|FG001|Overall Study|Death|0
4619499|NCT01774981|7481010|FG007|Overall Study|Death|0
4619500|NCT01775124|7481035|FG000|Core Period|Disease Progression|0
4619501|NCT01775124|7481036|FG001|Core Period|Disease Progression|1
4547457|NCT01189266|7373944|FG002|Overall Study|Death|5
4547458|NCT01189266|7373942|FG000|Overall Study|Lack of Efficacy|4
4547459|NCT01189266|7373943|FG001|Overall Study|Lack of Efficacy|5
4547460|NCT01189266|7373944|FG002|Overall Study|Lack of Efficacy|44
4547461|NCT01189266|7373942|FG000|Overall Study|Physician Decision|0
4547462|NCT01189266|7373943|FG001|Overall Study|Physician Decision|0
4547463|NCT01189266|7373944|FG002|Overall Study|Physician Decision|1
4547464|NCT01189266|7373942|FG000|Overall Study|Protocol Violation|0
4547465|NCT01189266|7373943|FG001|Overall Study|Protocol Violation|1
4547466|NCT01189266|7373944|FG002|Overall Study|Protocol Violation|1
4547467|NCT01189266|7373942|FG000|Overall Study|Withdrawal by Subject|0
4547468|NCT01189266|7373943|FG001|Overall Study|Withdrawal by Subject|0
4547469|NCT01189266|7373944|FG002|Overall Study|Withdrawal by Subject|1
4547470|NCT01189266|7373942|FG000|Overall Study|Patient refuses further therapy|1
4547471|NCT01189266|7373943|FG001|Overall Study|Patient refuses further therapy|0
4547472|NCT01189266|7373944|FG002|Overall Study|Patient refuses further therapy|7
4547473|NCT01189266|7373942|FG000|Overall Study|No treatment|0
4547474|NCT01189266|7373943|FG001|Overall Study|No treatment|0
4547475|NCT01189266|7373944|FG002|Overall Study|No treatment|1
4547476|NCT01189461|7374000|FG000|Overall Study|Lack of Efficacy|13
4547477|NCT01189461|7374000|FG000|Overall Study|Lost to Follow-up|1
4547478|NCT01189461|7374000|FG000|Overall Study|Withdrawal by Subject|6
4547479|NCT01189461|7374000|FG000|Overall Study|Protocol Violation|1
4547480|NCT01189461|7374000|FG000|Overall Study|Adverse Event|2
4547481|NCT01189461|7374000|FG000|Overall Study|Did not meet entrance criteria|3
4547482|NCT01189461|7374000|FG000|Overall Study|Other|8
4547483|NCT01189487|7374004|FG000|Overall Study|Lack of Efficacy|2
4547484|NCT01189487|7374004|FG000|Overall Study|Adverse Event|1
4547485|NCT01189500|7374008|FG000|Period 1: TAMOX Alone|Adverse Event|1
4547486|NCT01189500|7374008|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1
4547487|NCT01189604|7374022|FG000|Overall Study|Impossible to visit|0
4547488|NCT01189604|7374023|FG001|Overall Study|Impossible to visit|0
4547489|NCT01189604|7374024|FG002|Overall Study|Impossible to visit|0
4547490|NCT01189604|7374025|FG003|Overall Study|Impossible to visit|0
4547491|NCT01189604|7374026|FG004|Overall Study|Impossible to visit|0
4547492|NCT01189604|7374027|FG005|Overall Study|Impossible to visit|1
4547493|NCT01189604|7374028|FG006|Overall Study|Impossible to visit|0
4547494|NCT01189604|7374022|FG000|Overall Study|Adverse Event|0
4547495|NCT01189604|7374023|FG001|Overall Study|Adverse Event|1
4547496|NCT01189604|7374024|FG002|Overall Study|Adverse Event|0
4547497|NCT01189604|7374025|FG003|Overall Study|Adverse Event|0
4547498|NCT01189604|7374026|FG004|Overall Study|Adverse Event|2
4547499|NCT01189604|7374027|FG005|Overall Study|Adverse Event|0
4547500|NCT01189604|7374028|FG006|Overall Study|Adverse Event|1
4547501|NCT01189604|7374022|FG000|Overall Study|Withdrawal by Subject|1
4547502|NCT01189604|7374023|FG001|Overall Study|Withdrawal by Subject|0
4547503|NCT01189604|7374024|FG002|Overall Study|Withdrawal by Subject|0
4547504|NCT01189604|7374025|FG003|Overall Study|Withdrawal by Subject|0
4619502|NCT01775124|7481035|FG000|Core Period|Physician Decision|1
4619503|NCT01775124|7481036|FG001|Core Period|Physician Decision|1
4619504|NCT01775124|7481035|FG000|Core Period|Death|0
4619505|NCT01775124|7481036|FG001|Core Period|Death|1
4619506|NCT01775124|7481035|FG000|Core Period|Administrative problems|1
4619507|NCT01775124|7481036|FG001|Core Period|Administrative problems|0
4619508|NCT01775124|7481035|FG000|Core Period|Withdrawal by Subject|4
4619509|NCT01775124|7481036|FG001|Core Period|Withdrawal by Subject|2
4619510|NCT01775124|7481035|FG000|Core Period|Adverse Event|5
4619511|NCT01775124|7481036|FG001|Core Period|Adverse Event|5
4619512|NCT01775124|7481035|FG000|Extension Period|Adverse Event|3
4619513|NCT01775124|7481036|FG001|Extension Period|Adverse Event|2
4619514|NCT01775124|7481035|FG000|Extension Period|Physician Decision|0
4619515|NCT01775124|7481036|FG001|Extension Period|Physician Decision|2
4619516|NCT01775124|7481035|FG000|Extension Period|Administrative problems|0
4619517|NCT01775124|7481036|FG001|Extension Period|Administrative problems|1
4619518|NCT01775124|7481035|FG000|Extension Period|Lost to Follow-up|0
4619519|NCT01775124|7481036|FG001|Extension Period|Lost to Follow-up|1
4619520|NCT01775124|7481035|FG000|Extension Period|Withdrawal by Subject|9
4619521|NCT01775124|7481036|FG001|Extension Period|Withdrawal by Subject|12
4619522|NCT01775137|7481043|FG000|Overall Study|Death|1
4619523|NCT01775137|7481043|FG000|Overall Study|Protocol deviation|2
4619524|NCT01775137|7481043|FG000|Overall Study|Unsatisfactory therapeutic effect|2
4619525|NCT01775137|7481043|FG000|Overall Study|Adverse Event|1
4619526|NCT01775137|7481043|FG000|Overall Study|Withdrawal by participants|5
4619527|NCT01775189|7481050|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0
4619528|NCT01775189|7481051|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3
4619529|NCT01775189|7481052|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0
4619530|NCT01775189|7481053|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0
4619531|NCT01775189|7481054|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0
4619532|NCT01775189|7481055|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0
4547505|NCT01189604|7374026|FG004|Overall Study|Withdrawal by Subject|0
4547506|NCT01189604|7374027|FG005|Overall Study|Withdrawal by Subject|0
4547507|NCT01189604|7374028|FG006|Overall Study|Withdrawal by Subject|0
4547508|NCT01189812|7374077|FG000|Overall Study|Withdrawal by Subject|2
4547509|NCT01189812|7374078|FG001|Overall Study|Withdrawal by Subject|3
4547510|NCT01189812|7374077|FG000|Overall Study|Adverse Event|1
4547511|NCT01189812|7374078|FG001|Overall Study|Adverse Event|0
4547512|NCT01189812|7374077|FG000|Overall Study|Out of Window|4
4547513|NCT01189812|7374078|FG001|Overall Study|Out of Window|3
4547514|NCT01189812|7374077|FG000|Overall Study|Moved out of State|1
4547515|NCT01189812|7374078|FG001|Overall Study|Moved out of State|2
4547516|NCT01189890|7374086|FG000|Overall Study|Adverse Event|3
4547517|NCT01189890|7374087|FG001|Overall Study|Adverse Event|4
4547518|NCT01189890|7374086|FG000|Overall Study|Lack of Efficacy|7
4547519|NCT01189890|7374087|FG001|Overall Study|Lack of Efficacy|2
4547520|NCT01189890|7374086|FG000|Overall Study|Lost to Follow-up|1
4547521|NCT01189890|7374087|FG001|Overall Study|Lost to Follow-up|7
4547522|NCT01189890|7374086|FG000|Overall Study|Protocol Violation|1
4547523|NCT01189890|7374087|FG001|Overall Study|Protocol Violation|5
4547524|NCT01189890|7374086|FG000|Overall Study|Withdrawal by Subject|15
4547525|NCT01189890|7374087|FG001|Overall Study|Withdrawal by Subject|11
4547526|NCT01189890|7374086|FG000|Overall Study|Non Compliance|0
4547527|NCT01189890|7374087|FG001|Overall Study|Non Compliance|1
4547528|NCT01189890|7374086|FG000|Overall Study|Physician Decision|5
4547529|NCT01189890|7374087|FG001|Overall Study|Physician Decision|4
4547530|NCT01189890|7374086|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5
4547531|NCT01189890|7374087|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5
4547532|NCT01190007|7374093|FG000|Overall Study|Withdrawal by Subject|4
4547533|NCT01190007|7374093|FG000|Overall Study|Adverse Event|8
4619533|NCT01775189|7481056|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0
4619534|NCT01775189|7481050|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0
4633006|NCT01907100|7502851|FG000|Overall Study|Protocol Violation|0
4547534|NCT01190007|7374093|FG000|Overall Study|Difficulty of visit for complications|1
4547535|NCT01190007|7374093|FG000|Overall Study|Participant was arrested|1
4547536|NCT01190020|7374099|FG000|Overall Study|Adverse Event|2
4547537|NCT01190020|7374100|FG001|Overall Study|Adverse Event|0
4547538|NCT01190020|7374099|FG000|Overall Study|Lost to Follow-up|2
4547539|NCT01190020|7374100|FG001|Overall Study|Lost to Follow-up|0
4547540|NCT01190020|7374099|FG000|Overall Study|Withdrawal by Subject|3
4547541|NCT01190020|7374100|FG001|Overall Study|Withdrawal by Subject|0
4547542|NCT01190098|7374121|FG000|Overall Study|Adverse Event|2
4547543|NCT01190098|7374122|FG001|Overall Study|Adverse Event|0
4547544|NCT01190098|7374121|FG000|Overall Study|Patient coomorbidity|0
4547545|NCT01190098|7374122|FG001|Overall Study|Patient coomorbidity|1
4547546|NCT01190098|7374121|FG000|Overall Study|Lack of transportation|1
4547547|NCT01190098|7374122|FG001|Overall Study|Lack of transportation|0
4547548|NCT01190098|7374121|FG000|Overall Study|Other|0
4547549|NCT01190098|7374122|FG001|Overall Study|Other|1
4547550|NCT01190124|7374131|FG000|Overall Study|Death|3
4547551|NCT01190124|7374132|FG001|Overall Study|Death|0
4547552|NCT01190124|7374133|FG002|Overall Study|Death|0
4547553|NCT01190124|7374131|FG000|Overall Study|Therapeutic Failure|12
4547554|NCT01190124|7374132|FG001|Overall Study|Therapeutic Failure|0
4547555|NCT01190124|7374133|FG002|Overall Study|Therapeutic Failure|1
4547556|NCT01190124|7374131|FG000|Overall Study|Lost to Follow-up|2
4547557|NCT01190124|7374132|FG001|Overall Study|Lost to Follow-up|0
4547558|NCT01190124|7374133|FG002|Overall Study|Lost to Follow-up|0
4547559|NCT01190150|7374146|FG000|First Treatment|Withdrawal by Subject|1
4547560|NCT01190150|7374147|FG001|First Treatment|Withdrawal by Subject|0
4547561|NCT01190150|7374146|FG000|Washout|Withdrawal by Subject|0
4547562|NCT01190150|7374147|FG001|Washout|Withdrawal by Subject|1
4547563|NCT01190150|7374146|FG000|Washout|Difficulty in adherence|0
4547564|NCT01190150|7374147|FG001|Washout|Difficulty in adherence|1
4547565|NCT01190176|7374153|FG000|Overall Study|Withdrawal by Subject|1
4547566|NCT01190176|7374153|FG000|Overall Study|Lost to Follow-up|1
4547567|NCT01190189|7374157|FG000|Overall Study|Lost to Follow-up|4
4547568|NCT01190189|7374157|FG000|Overall Study|Withdrawal by Subject|1
4547569|NCT01190189|7374157|FG000|Overall Study|Migrated/moved from study area|1
4547570|NCT01190215|7374163|FG000|Up to Month 6|Lost to Follow-up|2
4547571|NCT01190215|7374164|FG001|Up to Month 6|Lost to Follow-up|0
4547572|NCT01190410|7374172|FG000|Overall Study|Adverse Event|0
4547573|NCT01190410|7374173|FG001|Overall Study|Adverse Event|3
4547574|NCT01190410|7374172|FG000|Overall Study|Lack of Efficacy|0
4547575|NCT01190410|7374173|FG001|Overall Study|Lack of Efficacy|2
4547576|NCT01190410|7374172|FG000|Overall Study|Withdrawal by Subject|0
4547577|NCT01190410|7374173|FG001|Overall Study|Withdrawal by Subject|2
4547578|NCT01190410|7374172|FG000|Overall Study|Administrative decision|1
4547579|NCT01190410|7374173|FG001|Overall Study|Administrative decision|0
4547580|NCT01190410|7374172|FG000|Overall Study|PI discretion|0
4547581|NCT01190410|7374173|FG001|Overall Study|PI discretion|2
4547582|NCT01190436|7374185|FG000|Overall Study|Lost to Follow-up|35
4547583|NCT01190436|7374185|FG000|Overall Study|Other|4
4547584|NCT01190449|7374192|FG000|Overall Study|Ineligible|0
4547585|NCT01190449|7374193|FG001|Overall Study|Ineligible|4
4547586|NCT01190475|7374202|FG000|Overall Study|Withdrawal by Subject|0
4547587|NCT01190475|7374203|FG001|Overall Study|Withdrawal by Subject|0
4547588|NCT01190475|7374204|FG002|Overall Study|Withdrawal by Subject|1
4547589|NCT01190514|7374214|FG000|First Intervention (Period 1)|Adverse Event|1
4547590|NCT01190514|7374215|FG001|First Intervention (Period 1)|Adverse Event|0
4547591|NCT01190514|7374216|FG002|First Intervention (Period 1)|Adverse Event|0
4547592|NCT01190514|7374217|FG003|First Intervention (Period 1)|Adverse Event|0
4547593|NCT01190514|7374214|FG000|Third Intervention (Period 3)|Adverse Event|1
4547594|NCT01190514|7374215|FG001|Third Intervention (Period 3)|Adverse Event|0
4547595|NCT01190514|7374216|FG002|Third Intervention (Period 3)|Adverse Event|0
4547596|NCT01190514|7374217|FG003|Third Intervention (Period 3)|Adverse Event|0
4547597|NCT01190813|7374243|FG000|Overall Study|Lost to Follow-up|1
4547598|NCT01190813|7374244|FG001|Overall Study|Lost to Follow-up|2
4547599|NCT01190813|7374243|FG000|Overall Study|Withdrawal by Subject|2
4547600|NCT01190813|7374244|FG001|Overall Study|Withdrawal by Subject|1
4547601|NCT01190813|7374243|FG000|Overall Study|Refused study treatment after randomized|1
4547602|NCT01190813|7374244|FG001|Overall Study|Refused study treatment after randomized|0
4547603|NCT01190813|7374243|FG000|Overall Study|Adverse Event|0
4547604|NCT01190813|7374244|FG001|Overall Study|Adverse Event|1
4547605|NCT01190839|7374252|FG000|Overall Study|Adverse Event|32
4547606|NCT01190839|7374253|FG001|Overall Study|Adverse Event|41
4547607|NCT01190839|7374252|FG000|Overall Study|Protocol Violation|2
4547608|NCT01190839|7374253|FG001|Overall Study|Protocol Violation|2
4547609|NCT01190839|7374252|FG000|Overall Study|Lost to Follow-up|7
4547610|NCT01190839|7374253|FG001|Overall Study|Lost to Follow-up|1
4547611|NCT01190839|7374252|FG000|Overall Study|Death|1
4547612|NCT01190839|7374253|FG001|Overall Study|Death|0
4547613|NCT01190839|7374252|FG000|Overall Study|Trial stopped by Sponsor|71
4547614|NCT01190839|7374253|FG001|Overall Study|Trial stopped by Sponsor|68
4547615|NCT01190839|7374252|FG000|Overall Study|Undefined|35
4547616|NCT01190839|7374253|FG001|Overall Study|Undefined|31
4547617|NCT01190839|7374252|FG000|Overall Study|Randomized but not treated|2
4547618|NCT01190839|7374253|FG001|Overall Study|Randomized but not treated|4
4547619|NCT01190865|7374261|FG000|Overall Study|Withdrawal by Subject|1
4547620|NCT01190865|7374261|FG000|Overall Study|Non-compliance|2
4547621|NCT01190891|7374284|FG000|Overall Study|Protocol Violation|1
4547622|NCT01190891|7374285|FG001|Overall Study|Protocol Violation|0
4547623|NCT01190891|7374284|FG000|Overall Study|Withdrawal by Subject|5
4547624|NCT01190891|7374285|FG001|Overall Study|Withdrawal by Subject|0
4547625|NCT01190930|7374293|FG000|Induction|Adverse Event|17
4547626|NCT01190930|7374294|FG001|Induction|Adverse Event|0
4547627|NCT01190930|7374295|FG002|Induction|Adverse Event|0
4547628|NCT01190930|7374296|FG003|Induction|Adverse Event|0
4547629|NCT01190930|7374297|FG004|Induction|Adverse Event|0
4547630|NCT01190930|7374298|FG005|Induction|Adverse Event|0
4547631|NCT01190930|7374299|FG006|Induction|Adverse Event|0
4547632|NCT01190930|7374300|FG007|Induction|Adverse Event|0
4547633|NCT01190930|7374301|FG008|Induction|Adverse Event|0
4547634|NCT01190930|7374302|FG009|Induction|Adverse Event|0
4547635|NCT01190930|7374293|FG000|Induction|Death|34
4619535|NCT01775189|7481051|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1
4619536|NCT01775189|7481052|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0
4619537|NCT01775189|7481053|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0
4619538|NCT01775189|7481054|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0
4619539|NCT01775189|7481055|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0
4547636|NCT01190930|7374294|FG001|Induction|Death|0
4547637|NCT01190930|7374295|FG002|Induction|Death|0
4547638|NCT01190930|7374296|FG003|Induction|Death|0
4547639|NCT01190930|7374297|FG004|Induction|Death|0
4547640|NCT01190930|7374298|FG005|Induction|Death|0
4547641|NCT01190930|7374299|FG006|Induction|Death|0
4547642|NCT01190930|7374300|FG007|Induction|Death|0
4547643|NCT01190930|7374301|FG008|Induction|Death|0
4547644|NCT01190930|7374302|FG009|Induction|Death|0
4547645|NCT01190930|7374293|FG000|Induction|Lost to Follow-up|1
4547646|NCT01190930|7374294|FG001|Induction|Lost to Follow-up|0
4547647|NCT01190930|7374295|FG002|Induction|Lost to Follow-up|0
4547648|NCT01190930|7374296|FG003|Induction|Lost to Follow-up|0
4547649|NCT01190930|7374297|FG004|Induction|Lost to Follow-up|0
4547650|NCT01190930|7374298|FG005|Induction|Lost to Follow-up|0
4547651|NCT01190930|7374299|FG006|Induction|Lost to Follow-up|0
4547652|NCT01190930|7374300|FG007|Induction|Lost to Follow-up|0
4547653|NCT01190930|7374301|FG008|Induction|Lost to Follow-up|0
4547654|NCT01190930|7374302|FG009|Induction|Lost to Follow-up|0
4547655|NCT01190930|7374293|FG000|Induction|Physician Decision|125
4547656|NCT01190930|7374294|FG001|Induction|Physician Decision|3
4547657|NCT01190930|7374295|FG002|Induction|Physician Decision|0
4547658|NCT01190930|7374296|FG003|Induction|Physician Decision|0
4547659|NCT01190930|7374297|FG004|Induction|Physician Decision|0
4547660|NCT01190930|7374298|FG005|Induction|Physician Decision|0
4547661|NCT01190930|7374299|FG006|Induction|Physician Decision|0
4547662|NCT01190930|7374300|FG007|Induction|Physician Decision|0
4547663|NCT01190930|7374301|FG008|Induction|Physician Decision|0
4547664|NCT01190930|7374302|FG009|Induction|Physician Decision|0
4547665|NCT01190930|7374293|FG000|Induction|Withdrawal by Subject|9
4547666|NCT01190930|7374294|FG001|Induction|Withdrawal by Subject|0
4547667|NCT01190930|7374295|FG002|Induction|Withdrawal by Subject|0
4547668|NCT01190930|7374296|FG003|Induction|Withdrawal by Subject|0
4547669|NCT01190930|7374297|FG004|Induction|Withdrawal by Subject|0
4547670|NCT01190930|7374298|FG005|Induction|Withdrawal by Subject|0
4547671|NCT01190930|7374299|FG006|Induction|Withdrawal by Subject|0
4619540|NCT01775189|7481056|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0
4619541|NCT01775189|7481050|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
4619542|NCT01775189|7481051|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2
4547672|NCT01190930|7374300|FG007|Induction|Withdrawal by Subject|0
4547673|NCT01190930|7374301|FG008|Induction|Withdrawal by Subject|0
4547674|NCT01190930|7374302|FG009|Induction|Withdrawal by Subject|0
4547675|NCT01190930|7374293|FG000|Induction|Refusal|235
4547676|NCT01190930|7374294|FG001|Induction|Refusal|0
4547677|NCT01190930|7374295|FG002|Induction|Refusal|0
4547678|NCT01190930|7374296|FG003|Induction|Refusal|0
4547679|NCT01190930|7374297|FG004|Induction|Refusal|0
4547680|NCT01190930|7374298|FG005|Induction|Refusal|0
4547681|NCT01190930|7374299|FG006|Induction|Refusal|0
4547682|NCT01190930|7374300|FG007|Induction|Refusal|0
4547683|NCT01190930|7374301|FG008|Induction|Refusal|0
4547684|NCT01190930|7374302|FG009|Induction|Refusal|0
4547685|NCT01190930|7374293|FG000|Induction|Inevaluable|23
4547686|NCT01190930|7374294|FG001|Induction|Inevaluable|1
4547687|NCT01190930|7374295|FG002|Induction|Inevaluable|0
4547688|NCT01190930|7374296|FG003|Induction|Inevaluable|0
4547689|NCT01190930|7374297|FG004|Induction|Inevaluable|0
4547690|NCT01190930|7374298|FG005|Induction|Inevaluable|0
4547691|NCT01190930|7374299|FG006|Induction|Inevaluable|0
4547692|NCT01190930|7374300|FG007|Induction|Inevaluable|0
4547693|NCT01190930|7374301|FG008|Induction|Inevaluable|0
4547694|NCT01190930|7374302|FG009|Induction|Inevaluable|0
4547695|NCT01190930|7374293|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61
4547696|NCT01190930|7374294|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
4547697|NCT01190930|7374295|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
4547698|NCT01190930|7374296|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
4547699|NCT01190930|7374297|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
4547700|NCT01190930|7374298|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
4547701|NCT01190930|7374299|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
4547702|NCT01190930|7374300|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
4547703|NCT01190930|7374301|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
4547704|NCT01190930|7374302|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
4547705|NCT01190930|7374293|FG000|Induction|High Risk Downs|80
4547706|NCT01190930|7374294|FG001|Induction|High Risk Downs|0
4547707|NCT01190930|7374295|FG002|Induction|High Risk Downs|0
4547708|NCT01190930|7374296|FG003|Induction|High Risk Downs|0
4547709|NCT01190930|7374297|FG004|Induction|High Risk Downs|0
4547710|NCT01190930|7374298|FG005|Induction|High Risk Downs|0
4547711|NCT01190930|7374299|FG006|Induction|High Risk Downs|0
4547712|NCT01190930|7374300|FG007|Induction|High Risk Downs|0
4547713|NCT01190930|7374301|FG008|Induction|High Risk Downs|0
4547714|NCT01190930|7374302|FG009|Induction|High Risk Downs|0
4547715|NCT01190930|7374293|FG000|Induction|Enrollment onto another COG Protocol|1
4547716|NCT01190930|7374294|FG001|Induction|Enrollment onto another COG Protocol|0
4547717|NCT01190930|7374295|FG002|Induction|Enrollment onto another COG Protocol|0
4547718|NCT01190930|7374296|FG003|Induction|Enrollment onto another COG Protocol|0
4547719|NCT01190930|7374297|FG004|Induction|Enrollment onto another COG Protocol|0
4547720|NCT01190930|7374298|FG005|Induction|Enrollment onto another COG Protocol|0
4547721|NCT01190930|7374299|FG006|Induction|Enrollment onto another COG Protocol|0
4547722|NCT01190930|7374300|FG007|Induction|Enrollment onto another COG Protocol|0
4619543|NCT01775189|7481052|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7
4619544|NCT01775189|7481053|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
4619545|NCT01775189|7481054|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
4619546|NCT01775189|7481055|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
4619547|NCT01775189|7481056|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
4619548|NCT01775189|7481050|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0
4619549|NCT01775189|7481051|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0
4619550|NCT01775189|7481052|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0
4619551|NCT01775189|7481053|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0
4619552|NCT01775189|7481054|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0
4619553|NCT01775189|7481055|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1
4619554|NCT01775189|7481056|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0
4619555|NCT01775189|7481050|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0
4619556|NCT01775189|7481051|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0
4547723|NCT01190930|7374301|FG008|Induction|Enrollment onto another COG Protocol|0
4547724|NCT01190930|7374302|FG009|Induction|Enrollment onto another COG Protocol|0
4547725|NCT01190930|7374293|FG000|Induction|Average Risk|1847
4547726|NCT01190930|7374294|FG001|Induction|Average Risk|0
4547727|NCT01190930|7374295|FG002|Induction|Average Risk|0
4547728|NCT01190930|7374296|FG003|Induction|Average Risk|0
4547729|NCT01190930|7374297|FG004|Induction|Average Risk|0
4547730|NCT01190930|7374298|FG005|Induction|Average Risk|0
4547731|NCT01190930|7374299|FG006|Induction|Average Risk|0
4547732|NCT01190930|7374300|FG007|Induction|Average Risk|0
4547733|NCT01190930|7374301|FG008|Induction|Average Risk|0
4547734|NCT01190930|7374302|FG009|Induction|Average Risk|0
4547735|NCT01190930|7374293|FG000|Induction|High Risk|1227
4547736|NCT01190930|7374294|FG001|Induction|High Risk|0
4547737|NCT01190930|7374295|FG002|Induction|High Risk|0
4547738|NCT01190930|7374296|FG003|Induction|High Risk|0
4547739|NCT01190930|7374297|FG004|Induction|High Risk|0
4547740|NCT01190930|7374298|FG005|Induction|High Risk|0
4619557|NCT01775189|7481052|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0
4619558|NCT01775189|7481053|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1
4619559|NCT01775189|7481054|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0
4619560|NCT01775189|7481055|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0
4547741|NCT01190930|7374299|FG006|Induction|High Risk|0
4547742|NCT01190930|7374300|FG007|Induction|High Risk|0
4547743|NCT01190930|7374301|FG008|Induction|High Risk|0
4547744|NCT01190930|7374302|FG009|Induction|High Risk|0
4547745|NCT01190930|7374293|FG000|Induction|Low Risk|443
4547746|NCT01190930|7374294|FG001|Induction|Low Risk|0
4547747|NCT01190930|7374295|FG002|Induction|Low Risk|0
4547748|NCT01190930|7374296|FG003|Induction|Low Risk|0
4619561|NCT01775189|7481056|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0
4619562|NCT01775189|7481050|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0
4619563|NCT01775189|7481051|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0
4547749|NCT01190930|7374297|FG004|Induction|Low Risk|0
4547750|NCT01190930|7374298|FG005|Induction|Low Risk|0
4547751|NCT01190930|7374299|FG006|Induction|Low Risk|0
4547752|NCT01190930|7374300|FG007|Induction|Low Risk|0
4547753|NCT01190930|7374301|FG008|Induction|Low Risk|0
4547754|NCT01190930|7374302|FG009|Induction|Low Risk|0
4547755|NCT01190930|7374293|FG000|Induction|Very High Risk|1012
4547756|NCT01190930|7374294|FG001|Induction|Very High Risk|0
4547757|NCT01190930|7374295|FG002|Induction|Very High Risk|0
4547758|NCT01190930|7374296|FG003|Induction|Very High Risk|0
4547759|NCT01190930|7374297|FG004|Induction|Very High Risk|0
4547760|NCT01190930|7374298|FG005|Induction|Very High Risk|0
4547761|NCT01190930|7374299|FG006|Induction|Very High Risk|0
4547762|NCT01190930|7374300|FG007|Induction|Very High Risk|0
4547763|NCT01190930|7374301|FG008|Induction|Very High Risk|0
4547764|NCT01190930|7374302|FG009|Induction|Very High Risk|0
4547765|NCT01190930|7374293|FG000|Induction|Philadelphia chromosome-positive|99
4547766|NCT01190930|7374294|FG001|Induction|Philadelphia chromosome-positive|0
4547767|NCT01190930|7374295|FG002|Induction|Philadelphia chromosome-positive|0
4547768|NCT01190930|7374296|FG003|Induction|Philadelphia chromosome-positive|0
4547769|NCT01190930|7374297|FG004|Induction|Philadelphia chromosome-positive|0
4547770|NCT01190930|7374298|FG005|Induction|Philadelphia chromosome-positive|0
4547771|NCT01190930|7374299|FG006|Induction|Philadelphia chromosome-positive|0
4547772|NCT01190930|7374300|FG007|Induction|Philadelphia chromosome-positive|0
4547773|NCT01190930|7374301|FG008|Induction|Philadelphia chromosome-positive|0
4547774|NCT01190930|7374302|FG009|Induction|Philadelphia chromosome-positive|0
4547775|NCT01190930|7374293|FG000|Induction|Incomplete Induction data|63
4547776|NCT01190930|7374294|FG001|Induction|Incomplete Induction data|0
4547777|NCT01190930|7374295|FG002|Induction|Incomplete Induction data|0
4547778|NCT01190930|7374296|FG003|Induction|Incomplete Induction data|0
4547779|NCT01190930|7374297|FG004|Induction|Incomplete Induction data|0
4547780|NCT01190930|7374298|FG005|Induction|Incomplete Induction data|0
4547781|NCT01190930|7374299|FG006|Induction|Incomplete Induction data|0
4547782|NCT01190930|7374300|FG007|Induction|Incomplete Induction data|0
4547783|NCT01190930|7374301|FG008|Induction|Incomplete Induction data|0
4547784|NCT01190930|7374302|FG009|Induction|Incomplete Induction data|0
4547785|NCT01190930|7374293|FG000|Induction|Progressive disease|0
4547786|NCT01190930|7374294|FG001|Induction|Progressive disease|1
4547787|NCT01190930|7374295|FG002|Induction|Progressive disease|0
4547788|NCT01190930|7374296|FG003|Induction|Progressive disease|0
4547789|NCT01190930|7374297|FG004|Induction|Progressive disease|0
4547790|NCT01190930|7374298|FG005|Induction|Progressive disease|0
4547791|NCT01190930|7374299|FG006|Induction|Progressive disease|0
4547792|NCT01190930|7374300|FG007|Induction|Progressive disease|0
4547793|NCT01190930|7374301|FG008|Induction|Progressive disease|0
4547794|NCT01190930|7374302|FG009|Induction|Progressive disease|0
4547795|NCT01190930|7374293|FG000|Induction|No treatment|3
4547796|NCT01190930|7374294|FG001|Induction|No treatment|0
4547797|NCT01190930|7374295|FG002|Induction|No treatment|0
4547798|NCT01190930|7374296|FG003|Induction|No treatment|0
4547799|NCT01190930|7374297|FG004|Induction|No treatment|0
4547800|NCT01190930|7374298|FG005|Induction|No treatment|0
4547801|NCT01190930|7374299|FG006|Induction|No treatment|0
4547802|NCT01190930|7374300|FG007|Induction|No treatment|0
4547803|NCT01190930|7374301|FG008|Induction|No treatment|0
4547804|NCT01190930|7374302|FG009|Induction|No treatment|0
4547805|NCT01190930|7374293|FG000|Induction|Ineligible|69
4547806|NCT01190930|7374294|FG001|Induction|Ineligible|4
4547807|NCT01190930|7374295|FG002|Induction|Ineligible|0
4547808|NCT01190930|7374296|FG003|Induction|Ineligible|0
4547809|NCT01190930|7374297|FG004|Induction|Ineligible|0
4547810|NCT01190930|7374298|FG005|Induction|Ineligible|0
4547811|NCT01190930|7374299|FG006|Induction|Ineligible|0
4547812|NCT01190930|7374300|FG007|Induction|Ineligible|0
4547813|NCT01190930|7374301|FG008|Induction|Ineligible|0
4547814|NCT01190930|7374302|FG009|Induction|Ineligible|0
4547815|NCT01190930|7374293|FG000|Post Induction Pre-Maintenance|Adverse Event|0
4547816|NCT01190930|7374294|FG001|Post Induction Pre-Maintenance|Adverse Event|0
4547817|NCT01190930|7374295|FG002|Post Induction Pre-Maintenance|Adverse Event|8
4547818|NCT01190930|7374296|FG003|Post Induction Pre-Maintenance|Adverse Event|0
4619564|NCT01775189|7481052|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0
4547819|NCT01190930|7374297|FG004|Post Induction Pre-Maintenance|Adverse Event|0
4547820|NCT01190930|7374298|FG005|Post Induction Pre-Maintenance|Adverse Event|0
4547821|NCT01190930|7374299|FG006|Post Induction Pre-Maintenance|Adverse Event|0
4547822|NCT01190930|7374300|FG007|Post Induction Pre-Maintenance|Adverse Event|0
4547823|NCT01190930|7374301|FG008|Post Induction Pre-Maintenance|Adverse Event|0
4547824|NCT01190930|7374302|FG009|Post Induction Pre-Maintenance|Adverse Event|0
4547825|NCT01190930|7374293|FG000|Post Induction Pre-Maintenance|Death|0
4619565|NCT01775189|7481053|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1
4547826|NCT01190930|7374294|FG001|Post Induction Pre-Maintenance|Death|0
4547827|NCT01190930|7374295|FG002|Post Induction Pre-Maintenance|Death|8
4547828|NCT01190930|7374296|FG003|Post Induction Pre-Maintenance|Death|4
4547829|NCT01190930|7374297|FG004|Post Induction Pre-Maintenance|Death|0
4547830|NCT01190930|7374298|FG005|Post Induction Pre-Maintenance|Death|0
4547831|NCT01190930|7374299|FG006|Post Induction Pre-Maintenance|Death|0
4547832|NCT01190930|7374300|FG007|Post Induction Pre-Maintenance|Death|0
4547833|NCT01190930|7374301|FG008|Post Induction Pre-Maintenance|Death|0
4547834|NCT01190930|7374302|FG009|Post Induction Pre-Maintenance|Death|0
4547835|NCT01190930|7374293|FG000|Post Induction Pre-Maintenance|Physician Decision|0
4547836|NCT01190930|7374294|FG001|Post Induction Pre-Maintenance|Physician Decision|2
4547837|NCT01190930|7374295|FG002|Post Induction Pre-Maintenance|Physician Decision|35
4547838|NCT01190930|7374296|FG003|Post Induction Pre-Maintenance|Physician Decision|7
4547839|NCT01190930|7374297|FG004|Post Induction Pre-Maintenance|Physician Decision|5
4547840|NCT01190930|7374298|FG005|Post Induction Pre-Maintenance|Physician Decision|3
4547841|NCT01190930|7374299|FG006|Post Induction Pre-Maintenance|Physician Decision|0
4547842|NCT01190930|7374300|FG007|Post Induction Pre-Maintenance|Physician Decision|0
4547843|NCT01190930|7374301|FG008|Post Induction Pre-Maintenance|Physician Decision|0
4547844|NCT01190930|7374302|FG009|Post Induction Pre-Maintenance|Physician Decision|0
4547845|NCT01190930|7374293|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0
4547846|NCT01190930|7374294|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1
4547847|NCT01190930|7374295|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5
4547848|NCT01190930|7374296|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2
4547849|NCT01190930|7374297|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0
4547850|NCT01190930|7374298|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0
4547851|NCT01190930|7374299|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0
4547852|NCT01190930|7374300|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0
4547853|NCT01190930|7374301|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0
4547854|NCT01190930|7374302|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0
4547855|NCT01190930|7374293|FG000|Post Induction Pre-Maintenance|Refusal|0
4547856|NCT01190930|7374294|FG001|Post Induction Pre-Maintenance|Refusal|2
4547857|NCT01190930|7374295|FG002|Post Induction Pre-Maintenance|Refusal|694
4547858|NCT01190930|7374296|FG003|Post Induction Pre-Maintenance|Refusal|4
4547859|NCT01190930|7374297|FG004|Post Induction Pre-Maintenance|Refusal|0
4547860|NCT01190930|7374298|FG005|Post Induction Pre-Maintenance|Refusal|3
4547861|NCT01190930|7374299|FG006|Post Induction Pre-Maintenance|Refusal|0
4547862|NCT01190930|7374300|FG007|Post Induction Pre-Maintenance|Refusal|0
4547863|NCT01190930|7374301|FG008|Post Induction Pre-Maintenance|Refusal|0
4547864|NCT01190930|7374302|FG009|Post Induction Pre-Maintenance|Refusal|0
4547865|NCT01190930|7374293|FG000|Post Induction Pre-Maintenance|Inevaluable|0
4547866|NCT01190930|7374294|FG001|Post Induction Pre-Maintenance|Inevaluable|0
4547867|NCT01190930|7374295|FG002|Post Induction Pre-Maintenance|Inevaluable|6
4547868|NCT01190930|7374296|FG003|Post Induction Pre-Maintenance|Inevaluable|0
4547869|NCT01190930|7374297|FG004|Post Induction Pre-Maintenance|Inevaluable|0
4547870|NCT01190930|7374298|FG005|Post Induction Pre-Maintenance|Inevaluable|0
4547871|NCT01190930|7374299|FG006|Post Induction Pre-Maintenance|Inevaluable|0
4547872|NCT01190930|7374300|FG007|Post Induction Pre-Maintenance|Inevaluable|0
4547873|NCT01190930|7374301|FG008|Post Induction Pre-Maintenance|Inevaluable|0
4547874|NCT01190930|7374302|FG009|Post Induction Pre-Maintenance|Inevaluable|0
4547875|NCT01190930|7374293|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
4547876|NCT01190930|7374294|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1
4547877|NCT01190930|7374295|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
4547878|NCT01190930|7374296|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
4547879|NCT01190930|7374297|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
4547880|NCT01190930|7374298|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
4547881|NCT01190930|7374299|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
4547882|NCT01190930|7374300|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
4547883|NCT01190930|7374301|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
4547884|NCT01190930|7374302|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
4547885|NCT01190930|7374293|FG000|Post Induction Pre-Maintenance|Progressive disease|0
4547886|NCT01190930|7374294|FG001|Post Induction Pre-Maintenance|Progressive disease|0
4547887|NCT01190930|7374295|FG002|Post Induction Pre-Maintenance|Progressive disease|1
4547888|NCT01190930|7374296|FG003|Post Induction Pre-Maintenance|Progressive disease|0
4619566|NCT01775189|7481054|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0
4547889|NCT01190930|7374297|FG004|Post Induction Pre-Maintenance|Progressive disease|0
4547890|NCT01190930|7374298|FG005|Post Induction Pre-Maintenance|Progressive disease|0
4547891|NCT01190930|7374299|FG006|Post Induction Pre-Maintenance|Progressive disease|0
4547892|NCT01190930|7374300|FG007|Post Induction Pre-Maintenance|Progressive disease|0
4547893|NCT01190930|7374301|FG008|Post Induction Pre-Maintenance|Progressive disease|0
4547894|NCT01190930|7374302|FG009|Post Induction Pre-Maintenance|Progressive disease|0
4547895|NCT01190930|7374293|FG000|Post Induction Pre-Maintenance|Relapse|0
4547896|NCT01190930|7374294|FG001|Post Induction Pre-Maintenance|Relapse|0
4547897|NCT01190930|7374295|FG002|Post Induction Pre-Maintenance|Relapse|1
4547898|NCT01190930|7374296|FG003|Post Induction Pre-Maintenance|Relapse|0
4547899|NCT01190930|7374297|FG004|Post Induction Pre-Maintenance|Relapse|0
4547900|NCT01190930|7374298|FG005|Post Induction Pre-Maintenance|Relapse|0
4547901|NCT01190930|7374299|FG006|Post Induction Pre-Maintenance|Relapse|0
4547902|NCT01190930|7374300|FG007|Post Induction Pre-Maintenance|Relapse|0
4547903|NCT01190930|7374301|FG008|Post Induction Pre-Maintenance|Relapse|0
4547904|NCT01190930|7374302|FG009|Post Induction Pre-Maintenance|Relapse|0
4547905|NCT01190930|7374293|FG000|Maintenance|Adverse Event|0
4547906|NCT01190930|7374294|FG001|Maintenance|Adverse Event|0
4547907|NCT01190930|7374295|FG002|Maintenance|Adverse Event|0
4547908|NCT01190930|7374296|FG003|Maintenance|Adverse Event|0
4547909|NCT01190930|7374297|FG004|Maintenance|Adverse Event|0
4547910|NCT01190930|7374298|FG005|Maintenance|Adverse Event|1
4547911|NCT01190930|7374299|FG006|Maintenance|Adverse Event|1
4547912|NCT01190930|7374300|FG007|Maintenance|Adverse Event|3
4547913|NCT01190930|7374301|FG008|Maintenance|Adverse Event|3
4547914|NCT01190930|7374302|FG009|Maintenance|Adverse Event|0
4547915|NCT01190930|7374293|FG000|Maintenance|Death|0
4547916|NCT01190930|7374294|FG001|Maintenance|Death|0
4547917|NCT01190930|7374295|FG002|Maintenance|Death|0
4547918|NCT01190930|7374296|FG003|Maintenance|Death|1
4547919|NCT01190930|7374297|FG004|Maintenance|Death|0
4547920|NCT01190930|7374298|FG005|Maintenance|Death|0
4547921|NCT01190930|7374299|FG006|Maintenance|Death|2
4547922|NCT01190930|7374300|FG007|Maintenance|Death|2
4547923|NCT01190930|7374301|FG008|Maintenance|Death|2
4619567|NCT01775189|7481055|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0
4619568|NCT01775189|7481056|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1
4619569|NCT01775501|7481099|FG000|Overall Study|Discontinued prior to treatment|1
4619570|NCT01775553|7481103|FG000|Overall Study|Adverse Event|1
4619571|NCT01775553|7481103|FG000|Overall Study|Disease Progression|12
4619572|NCT01775670|7481109|FG000|Overall Study|Lost to Follow-up|1
4619573|NCT01775670|7481110|FG001|Overall Study|Lost to Follow-up|1
4547924|NCT01190930|7374302|FG009|Maintenance|Death|2
4547925|NCT01190930|7374293|FG000|Maintenance|Lost to Follow-up|0
4547926|NCT01190930|7374294|FG001|Maintenance|Lost to Follow-up|0
4547927|NCT01190930|7374295|FG002|Maintenance|Lost to Follow-up|0
4547928|NCT01190930|7374296|FG003|Maintenance|Lost to Follow-up|0
4547929|NCT01190930|7374297|FG004|Maintenance|Lost to Follow-up|0
4547930|NCT01190930|7374298|FG005|Maintenance|Lost to Follow-up|0
4547931|NCT01190930|7374299|FG006|Maintenance|Lost to Follow-up|1
4547932|NCT01190930|7374300|FG007|Maintenance|Lost to Follow-up|1
4547933|NCT01190930|7374301|FG008|Maintenance|Lost to Follow-up|1
4547934|NCT01190930|7374302|FG009|Maintenance|Lost to Follow-up|0
4547935|NCT01190930|7374293|FG000|Maintenance|Physician Decision|0
4547936|NCT01190930|7374294|FG001|Maintenance|Physician Decision|1
4547937|NCT01190930|7374295|FG002|Maintenance|Physician Decision|0
4547938|NCT01190930|7374296|FG003|Maintenance|Physician Decision|5
4547939|NCT01190930|7374297|FG004|Maintenance|Physician Decision|9
4547940|NCT01190930|7374298|FG005|Maintenance|Physician Decision|4
4547941|NCT01190930|7374299|FG006|Maintenance|Physician Decision|8
4547942|NCT01190930|7374300|FG007|Maintenance|Physician Decision|8
4547943|NCT01190930|7374301|FG008|Maintenance|Physician Decision|10
4547944|NCT01190930|7374302|FG009|Maintenance|Physician Decision|17
4547945|NCT01190930|7374293|FG000|Maintenance|Withdrawal by Subject|0
4547946|NCT01190930|7374294|FG001|Maintenance|Withdrawal by Subject|0
4547947|NCT01190930|7374295|FG002|Maintenance|Withdrawal by Subject|0
4547948|NCT01190930|7374296|FG003|Maintenance|Withdrawal by Subject|0
4547949|NCT01190930|7374297|FG004|Maintenance|Withdrawal by Subject|0
4547950|NCT01190930|7374298|FG005|Maintenance|Withdrawal by Subject|0
4547951|NCT01190930|7374299|FG006|Maintenance|Withdrawal by Subject|2
4547952|NCT01190930|7374300|FG007|Maintenance|Withdrawal by Subject|1
4547953|NCT01190930|7374301|FG008|Maintenance|Withdrawal by Subject|4
4547954|NCT01190930|7374302|FG009|Maintenance|Withdrawal by Subject|1
4547955|NCT01190930|7374293|FG000|Maintenance|Refusal|0
4547956|NCT01190930|7374294|FG001|Maintenance|Refusal|1
4547957|NCT01190930|7374295|FG002|Maintenance|Refusal|0
4547958|NCT01190930|7374296|FG003|Maintenance|Refusal|2
4547959|NCT01190930|7374297|FG004|Maintenance|Refusal|0
4547960|NCT01190930|7374298|FG005|Maintenance|Refusal|4
4547961|NCT01190930|7374299|FG006|Maintenance|Refusal|5
4547962|NCT01190930|7374300|FG007|Maintenance|Refusal|17
4547963|NCT01190930|7374301|FG008|Maintenance|Refusal|13
4547964|NCT01190930|7374302|FG009|Maintenance|Refusal|6
4547965|NCT01190930|7374293|FG000|Maintenance|second malignant neoplasm|0
4547966|NCT01190930|7374294|FG001|Maintenance|second malignant neoplasm|0
4547967|NCT01190930|7374295|FG002|Maintenance|second malignant neoplasm|0
4547968|NCT01190930|7374296|FG003|Maintenance|second malignant neoplasm|1
4547969|NCT01190930|7374297|FG004|Maintenance|second malignant neoplasm|0
4547970|NCT01190930|7374298|FG005|Maintenance|second malignant neoplasm|1
4547971|NCT01190930|7374299|FG006|Maintenance|second malignant neoplasm|0
4547972|NCT01190930|7374300|FG007|Maintenance|second malignant neoplasm|0
4547973|NCT01190930|7374301|FG008|Maintenance|second malignant neoplasm|1
4547974|NCT01190930|7374302|FG009|Maintenance|second malignant neoplasm|0
4547975|NCT01190930|7374293|FG000|Maintenance|Inevaluable|0
4547976|NCT01190930|7374294|FG001|Maintenance|Inevaluable|0
4547977|NCT01190930|7374295|FG002|Maintenance|Inevaluable|0
4547978|NCT01190930|7374296|FG003|Maintenance|Inevaluable|0
4547979|NCT01190930|7374297|FG004|Maintenance|Inevaluable|0
4547980|NCT01190930|7374298|FG005|Maintenance|Inevaluable|1
4547981|NCT01190930|7374299|FG006|Maintenance|Inevaluable|1
4547982|NCT01190930|7374300|FG007|Maintenance|Inevaluable|1
4547983|NCT01190930|7374301|FG008|Maintenance|Inevaluable|0
4547984|NCT01190930|7374302|FG009|Maintenance|Inevaluable|0
4547985|NCT01190930|7374293|FG000|Maintenance|Enrollment onto another COG Protocol|0
4547986|NCT01190930|7374294|FG001|Maintenance|Enrollment onto another COG Protocol|0
4547987|NCT01190930|7374295|FG002|Maintenance|Enrollment onto another COG Protocol|0
4547988|NCT01190930|7374296|FG003|Maintenance|Enrollment onto another COG Protocol|0
4547989|NCT01190930|7374297|FG004|Maintenance|Enrollment onto another COG Protocol|0
4547990|NCT01190930|7374298|FG005|Maintenance|Enrollment onto another COG Protocol|0
4547991|NCT01190930|7374299|FG006|Maintenance|Enrollment onto another COG Protocol|0
4547992|NCT01190930|7374300|FG007|Maintenance|Enrollment onto another COG Protocol|0
4547993|NCT01190930|7374301|FG008|Maintenance|Enrollment onto another COG Protocol|1
4547994|NCT01190930|7374302|FG009|Maintenance|Enrollment onto another COG Protocol|0
4547995|NCT01190930|7374293|FG000|Maintenance|Relapse|0
4547996|NCT01190930|7374294|FG001|Maintenance|Relapse|0
4547997|NCT01190930|7374295|FG002|Maintenance|Relapse|0
4547998|NCT01190930|7374296|FG003|Maintenance|Relapse|2
4547999|NCT01190930|7374297|FG004|Maintenance|Relapse|0
4548000|NCT01190930|7374298|FG005|Maintenance|Relapse|1
4548001|NCT01190930|7374299|FG006|Maintenance|Relapse|6
4548002|NCT01190930|7374300|FG007|Maintenance|Relapse|13
4548003|NCT01190930|7374301|FG008|Maintenance|Relapse|11
4548004|NCT01190930|7374302|FG009|Maintenance|Relapse|11
4548005|NCT01190930|7374293|FG000|Maintenance|Still on therapy|0
4548006|NCT01190930|7374294|FG001|Maintenance|Still on therapy|8
4548007|NCT01190930|7374295|FG002|Maintenance|Still on therapy|0
4548008|NCT01190930|7374296|FG003|Maintenance|Still on therapy|29
4548009|NCT01190930|7374297|FG004|Maintenance|Still on therapy|0
4548010|NCT01190930|7374298|FG005|Maintenance|Still on therapy|0
4548011|NCT01190930|7374299|FG006|Maintenance|Still on therapy|0
4548012|NCT01190930|7374300|FG007|Maintenance|Still on therapy|0
4548013|NCT01190930|7374301|FG008|Maintenance|Still on therapy|0
4548014|NCT01190930|7374302|FG009|Maintenance|Still on therapy|0
4548015|NCT01191008|7374326|FG000|Overall Study|Protocol Violation|7
4548016|NCT01191008|7374326|FG000|Overall Study|Lost to Follow-up|8
4548017|NCT01191086|7374330|FG000|Overall Study|Adverse Event|20
4548018|NCT01191086|7374330|FG000|Overall Study|Lack of Efficacy|10
4548019|NCT01191086|7374330|FG000|Overall Study|Lost to Follow-up|4
4548020|NCT01191086|7374330|FG000|Overall Study|Physician Decision|2
4548021|NCT01191086|7374330|FG000|Overall Study|Withdrawal by Subject|24
4548022|NCT01191086|7374330|FG000|Overall Study|Discontinuation criterion met|1
4548023|NCT01191086|7374330|FG000|Overall Study|Other|1
4548024|NCT01191190|7374334|FG000|Overall Study|Withdrawal by Subject|1
4548025|NCT01191268|7374362|FG000|Overall Study|Withdrawal by Subject|19
4548026|NCT01191268|7374363|FG001|Overall Study|Withdrawal by Subject|25
4548027|NCT01191268|7374364|FG002|Overall Study|Withdrawal by Subject|21
4548028|NCT01191268|7374362|FG000|Overall Study|Adverse Event|21
4548029|NCT01191268|7374363|FG001|Overall Study|Adverse Event|13
4548030|NCT01191268|7374364|FG002|Overall Study|Adverse Event|8
4548031|NCT01191268|7374362|FG000|Overall Study|Physician Decision|6
4548032|NCT01191268|7374363|FG001|Overall Study|Physician Decision|8
4548033|NCT01191268|7374364|FG002|Overall Study|Physician Decision|9
4548034|NCT01191268|7374362|FG000|Overall Study|Lost to Follow-up|8
4548035|NCT01191268|7374363|FG001|Overall Study|Lost to Follow-up|5
4548036|NCT01191268|7374364|FG002|Overall Study|Lost to Follow-up|9
4548037|NCT01191268|7374362|FG000|Overall Study|Entry Criteria Not Met|3
4548038|NCT01191268|7374363|FG001|Overall Study|Entry Criteria Not Met|1
4548039|NCT01191268|7374364|FG002|Overall Study|Entry Criteria Not Met|1
4548040|NCT01191268|7374362|FG000|Overall Study|Death|0
4548041|NCT01191268|7374363|FG001|Overall Study|Death|1
4548042|NCT01191268|7374364|FG002|Overall Study|Death|3
4548043|NCT01191268|7374362|FG000|Overall Study|Protocol Violation|1
4548044|NCT01191268|7374363|FG001|Overall Study|Protocol Violation|0
4548045|NCT01191268|7374364|FG002|Overall Study|Protocol Violation|1
4548046|NCT01191268|7374362|FG000|Overall Study|Sponsor Decision|0
4548047|NCT01191268|7374363|FG001|Overall Study|Sponsor Decision|2
4548048|NCT01191268|7374364|FG002|Overall Study|Sponsor Decision|0
4548049|NCT01191762|7374504|FG000|Overall Study|Adverse Event|1
4548050|NCT01191762|7374505|FG001|Overall Study|Adverse Event|0
4548051|NCT01191788|7374513|FG000|Overall Study|Lost to Follow-up|21
4548052|NCT01191788|7374514|FG001|Overall Study|Lost to Follow-up|22
4548053|NCT01191801|7374523|FG000|Overall Study|Death|36
4548054|NCT01191801|7374524|FG001|Overall Study|Death|12
4548055|NCT01191801|7374523|FG000|Overall Study|Lack of Efficacy|176
4548056|NCT01191801|7374524|FG001|Overall Study|Lack of Efficacy|258
4548057|NCT01191801|7374523|FG000|Overall Study|Adverse Event|9
4548058|NCT01191801|7374524|FG001|Overall Study|Adverse Event|8
4548059|NCT01191801|7374523|FG000|Overall Study|Protocol Violation|2
4548060|NCT01191801|7374524|FG001|Overall Study|Protocol Violation|4
4548061|NCT01191801|7374523|FG000|Overall Study|Physician Decision|47
4548062|NCT01191801|7374524|FG001|Overall Study|Physician Decision|24
4548063|NCT01191801|7374523|FG000|Overall Study|Withdrawal by Subject|1
4548064|NCT01191801|7374524|FG001|Overall Study|Withdrawal by Subject|4
4548065|NCT01191801|7374523|FG000|Overall Study|Not Provided|45
4548066|NCT01191801|7374524|FG001|Overall Study|Not Provided|27
4548067|NCT01191840|7374541|FG000|Overall Study|withdrew consent|2
4548068|NCT01191840|7374542|FG001|Overall Study|withdrew consent|1
4548069|NCT01191840|7374541|FG000|Overall Study|Subject discontinued treatment|1
4548070|NCT01191840|7374542|FG001|Overall Study|Subject discontinued treatment|2
4548071|NCT01191840|7374541|FG000|Overall Study|Lost to Follow-up|4
4548072|NCT01191840|7374542|FG001|Overall Study|Lost to Follow-up|6
4548073|NCT01191840|7374541|FG000|Overall Study|Non Staph Infection|4
4548074|NCT01191840|7374542|FG001|Overall Study|Non Staph Infection|3
4548075|NCT01191840|7374541|FG000|Overall Study|ineligible at enrollment|1
4548076|NCT01191840|7374542|FG001|Overall Study|ineligible at enrollment|0
4548077|NCT01191840|7374541|FG000|Overall Study|IRB approval lapse|0
4548078|NCT01191840|7374542|FG001|Overall Study|IRB approval lapse|2
4548079|NCT01191840|7374541|FG000|Overall Study|lab error speciation - non Staph infecti|0
4548080|NCT01191840|7374542|FG001|Overall Study|lab error speciation - non Staph infecti|1
4548081|NCT01191840|7374541|FG000|Overall Study|Withdrawal by Subject|2
4548082|NCT01191840|7374542|FG001|Overall Study|Withdrawal by Subject|0
4548083|NCT01191944|7374550|FG000|Overall Study|Adverse Event|11
4548084|NCT01191944|7374551|FG001|Overall Study|Adverse Event|12
4548085|NCT01191944|7374550|FG000|Overall Study|Protocol Violation|1
4548086|NCT01191944|7374551|FG001|Overall Study|Protocol Violation|2
4548087|NCT01191944|7374550|FG000|Overall Study|Withdrawal by Subject|4
4548088|NCT01191944|7374551|FG001|Overall Study|Withdrawal by Subject|2
4548089|NCT01191944|7374550|FG000|Overall Study|Other|1
4548090|NCT01191944|7374551|FG001|Overall Study|Other|3
4548091|NCT01192022|7374561|FG000|Overall Study|Withdrawal of Consent|3
4548092|NCT01192022|7374562|FG001|Overall Study|Withdrawal of Consent|1
4548093|NCT01192022|7374563|FG002|Overall Study|Withdrawal of Consent|0
4548094|NCT01192022|7374564|FG003|Overall Study|Withdrawal of Consent|0
4548095|NCT01192022|7374565|FG004|Overall Study|Withdrawal of Consent|0
4548096|NCT01192022|7374561|FG000|Overall Study|Lost to Follow-up|4
4548097|NCT01192022|7374562|FG001|Overall Study|Lost to Follow-up|2
4548098|NCT01192022|7374563|FG002|Overall Study|Lost to Follow-up|1
4548099|NCT01192022|7374564|FG003|Overall Study|Lost to Follow-up|1
4548100|NCT01192022|7374565|FG004|Overall Study|Lost to Follow-up|0
4548101|NCT01192022|7374561|FG000|Overall Study|Adverse Event|1
4548102|NCT01192022|7374562|FG001|Overall Study|Adverse Event|0
4548103|NCT01192022|7374563|FG002|Overall Study|Adverse Event|0
4548104|NCT01192022|7374564|FG003|Overall Study|Adverse Event|0
4548105|NCT01192022|7374565|FG004|Overall Study|Adverse Event|0
4548106|NCT01192022|7374561|FG000|Overall Study|Fatal Adverse Event|4
4548107|NCT01192022|7374562|FG001|Overall Study|Fatal Adverse Event|6
4548108|NCT01192022|7374563|FG002|Overall Study|Fatal Adverse Event|0
4548109|NCT01192022|7374564|FG003|Overall Study|Fatal Adverse Event|0
4548110|NCT01192022|7374565|FG004|Overall Study|Fatal Adverse Event|1
4548111|NCT01192022|7374561|FG000|Overall Study|Physician withdrew-patient hardship|1
4548112|NCT01192022|7374562|FG001|Overall Study|Physician withdrew-patient hardship|0
4548113|NCT01192022|7374563|FG002|Overall Study|Physician withdrew-patient hardship|0
4548114|NCT01192022|7374564|FG003|Overall Study|Physician withdrew-patient hardship|0
4548115|NCT01192022|7374565|FG004|Overall Study|Physician withdrew-patient hardship|0
4548116|NCT01192022|7374561|FG000|Overall Study|Patient too sick from chemotherapy|0
4548117|NCT01192022|7374562|FG001|Overall Study|Patient too sick from chemotherapy|1
4548118|NCT01192022|7374563|FG002|Overall Study|Patient too sick from chemotherapy|0
4548119|NCT01192022|7374564|FG003|Overall Study|Patient too sick from chemotherapy|0
4548120|NCT01192022|7374565|FG004|Overall Study|Patient too sick from chemotherapy|0
4548121|NCT01192022|7374561|FG000|Overall Study|Patient needed surgery|0
4548122|NCT01192022|7374562|FG001|Overall Study|Patient needed surgery|1
4548123|NCT01192022|7374563|FG002|Overall Study|Patient needed surgery|0
4548124|NCT01192022|7374564|FG003|Overall Study|Patient needed surgery|0
4548125|NCT01192022|7374565|FG004|Overall Study|Patient needed surgery|0
4548126|NCT01192022|7374561|FG000|Overall Study|Parents did not allow all follow up|0
4548127|NCT01192022|7374562|FG001|Overall Study|Parents did not allow all follow up|0
4548128|NCT01192022|7374563|FG002|Overall Study|Parents did not allow all follow up|0
4548129|NCT01192022|7374564|FG003|Overall Study|Parents did not allow all follow up|1
4548130|NCT01192022|7374565|FG004|Overall Study|Parents did not allow all follow up|0
4548131|NCT01192100|7374576|FG000|Overall Study|Withdrawal by Subject|0
4548132|NCT01192100|7374577|FG001|Overall Study|Withdrawal by Subject|0
4548133|NCT01192100|7374578|FG002|Overall Study|Withdrawal by Subject|0
4548134|NCT01192100|7374579|FG003|Overall Study|Withdrawal by Subject|0
4548135|NCT01192100|7374580|FG004|Overall Study|Withdrawal by Subject|1
4548136|NCT01192100|7374581|FG005|Overall Study|Withdrawal by Subject|0
4548137|NCT01192100|7374576|FG000|Overall Study|Protocol Violation|0
4548138|NCT01192100|7374577|FG001|Overall Study|Protocol Violation|0
4548139|NCT01192100|7374578|FG002|Overall Study|Protocol Violation|0
4548140|NCT01192100|7374579|FG003|Overall Study|Protocol Violation|1
4548141|NCT01192100|7374580|FG004|Overall Study|Protocol Violation|0
4548142|NCT01192100|7374581|FG005|Overall Study|Protocol Violation|0
4548143|NCT01192126|7374591|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1
4548144|NCT01192126|7374592|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0
4548145|NCT01192126|7374591|FG000|First Intervention (1 Week)|Lost to Follow-up|1
4548146|NCT01192126|7374592|FG001|First Intervention (1 Week)|Lost to Follow-up|1
4548147|NCT01192152|7374611|FG000|Period 1|left prematurely (while on treatment B)|0
4548148|NCT01192152|7374612|FG001|Period 1|left prematurely (while on treatment B)|1
4548149|NCT01192152|7374611|FG000|Period 3|family emergency|1
4548150|NCT01192152|7374612|FG001|Period 3|family emergency|0
4548151|NCT01192178|7374622|FG000|Overall Study|Withdrawal by Subject|6
4548152|NCT01192178|7374623|FG001|Overall Study|Withdrawal by Subject|10
4548153|NCT01192178|7374622|FG000|Overall Study|Protocol Violation|10
4548154|NCT01192178|7374623|FG001|Overall Study|Protocol Violation|3
4548155|NCT01192178|7374622|FG000|Overall Study|Physician Decision|2
4548156|NCT01192178|7374623|FG001|Overall Study|Physician Decision|4
4548157|NCT01192178|7374622|FG000|Overall Study|Lost to Follow-up|3
4548158|NCT01192178|7374623|FG001|Overall Study|Lost to Follow-up|3
4548159|NCT01192178|7374622|FG000|Overall Study|Adverse Event|2
4548160|NCT01192178|7374623|FG001|Overall Study|Adverse Event|1
4548161|NCT01192178|7374622|FG000|Overall Study|Lack of Efficacy|1
4548162|NCT01192178|7374623|FG001|Overall Study|Lack of Efficacy|2
4591556|NCT01531894|7438275|FG000|Overall Study|Physician Decision|8
4591557|NCT01531894|7438275|FG000|Overall Study|Death|1
4591558|NCT01531998|7438288|FG000|Overall Study|Withdrawal by Subject|3
4591559|NCT01532388|7438342|FG000|3-month Follow-up|Lost to Follow-up|68
4591560|NCT01532388|7438343|FG001|3-month Follow-up|Lost to Follow-up|68
4591561|NCT01532388|7438342|FG000|6-month Follow-up|Lost to Follow-up|74
4591562|NCT01532388|7438343|FG001|6-month Follow-up|Lost to Follow-up|66
4591563|NCT01532388|7438342|FG000|12-month Follow-up|Lost to Follow-up|69
4591564|NCT01532388|7438343|FG001|12-month Follow-up|Lost to Follow-up|67
4591565|NCT01532414|7438352|FG000|Overall Study|Lost to Follow-up|3
4591566|NCT01532414|7438353|FG001|Overall Study|Lost to Follow-up|0
4591567|NCT01532414|7438354|FG002|Overall Study|Lost to Follow-up|1
4591568|NCT01532414|7438352|FG000|Overall Study|Withdrawal by Subject|3
4591569|NCT01532414|7438353|FG001|Overall Study|Withdrawal by Subject|0
4591570|NCT01532414|7438354|FG002|Overall Study|Withdrawal by Subject|0
4591571|NCT01532414|7438352|FG000|Overall Study|No V6 semen sample|0
4591572|NCT01532414|7438353|FG001|Overall Study|No V6 semen sample|1
4591573|NCT01532414|7438354|FG002|Overall Study|No V6 semen sample|0
4591574|NCT01532414|7438352|FG000|Overall Study|Adverse Event|0
4591575|NCT01532414|7438353|FG001|Overall Study|Adverse Event|1
4591576|NCT01532414|7438354|FG002|Overall Study|Adverse Event|1
4591577|NCT01532414|7438352|FG000|Overall Study|Unable to complete 24 hour PK|0
4591578|NCT01532414|7438353|FG001|Overall Study|Unable to complete 24 hour PK|0
4591579|NCT01532414|7438354|FG002|Overall Study|Unable to complete 24 hour PK|1
4591580|NCT01532414|7438352|FG000|Overall Study|Withdrawn by sponsor|1
4591581|NCT01532414|7438353|FG001|Overall Study|Withdrawn by sponsor|0
4591582|NCT01532414|7438354|FG002|Overall Study|Withdrawn by sponsor|0
4591583|NCT01532570|7438375|FG000|Overall Study|Lack of Efficacy|1
4591584|NCT01532570|7438376|FG001|Overall Study|Lack of Efficacy|0
4591585|NCT01532570|7438377|FG002|Overall Study|Lack of Efficacy|0
4591586|NCT01532570|7438378|FG003|Overall Study|Lack of Efficacy|0
4591587|NCT01532570|7438375|FG000|Overall Study|Withdrawal by Subject|0
4591588|NCT01532570|7438376|FG001|Overall Study|Withdrawal by Subject|1
4591589|NCT01532570|7438377|FG002|Overall Study|Withdrawal by Subject|0
4591590|NCT01532570|7438378|FG003|Overall Study|Withdrawal by Subject|0
4591591|NCT01532648|7438397|FG000|Overall Study|Lost to Follow-up|3
4591592|NCT01532648|7438398|FG001|Overall Study|Lost to Follow-up|4
4591593|NCT01532648|7438397|FG000|Overall Study|Lack of Efficacy|4
4591594|NCT01532648|7438398|FG001|Overall Study|Lack of Efficacy|1
4591595|NCT01532648|7438397|FG000|Overall Study|Protocol Violation|1
4591596|NCT01532648|7438398|FG001|Overall Study|Protocol Violation|1
4591597|NCT01532648|7438397|FG000|Overall Study|Adverse Event|12
4591598|NCT01532648|7438398|FG001|Overall Study|Adverse Event|9
4591599|NCT01532648|7438397|FG000|Overall Study|Withdrawal by Subject|16
4591600|NCT01532648|7438398|FG001|Overall Study|Withdrawal by Subject|2
4591601|NCT01532687|7438406|FG000|Overall Study|Death|2
4591602|NCT01532687|7438407|FG001|Overall Study|Death|0
4591603|NCT01532687|7438406|FG000|Overall Study|Adverse Event|6
4591604|NCT01532687|7438407|FG001|Overall Study|Adverse Event|1
4591605|NCT01532687|7438406|FG000|Overall Study|Withdrawal by Subject|1
4591606|NCT01532687|7438407|FG001|Overall Study|Withdrawal by Subject|0
4591607|NCT01532687|7438406|FG000|Overall Study|Physician Decision|2
4591608|NCT01532687|7438407|FG001|Overall Study|Physician Decision|1
4591609|NCT01532687|7438406|FG000|Overall Study|Protocol-defined delay > 3 weeks|3
4591610|NCT01532687|7438407|FG001|Overall Study|Protocol-defined delay > 3 weeks|0
4591611|NCT01532869|7438429|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0
4591612|NCT01532869|7438430|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1
4591613|NCT01532869|7438429|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2
4591614|NCT01532869|7438430|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3
4591615|NCT01532869|7438429|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0
4591616|NCT01532869|7438430|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1
4619574|NCT01775787|7481144|FG000|First 7-10 Days|Adverse Event|0
4619575|NCT01775787|7481145|FG001|First 7-10 Days|Adverse Event|1
4619576|NCT01775787|7481144|FG000|First 7-10 Days|family emergency|0
4619577|NCT01775787|7481145|FG001|First 7-10 Days|family emergency|1
4619578|NCT01775787|7481144|FG000|First 7-10 Days|time commitment|0
4619579|NCT01775787|7481145|FG001|First 7-10 Days|time commitment|2
4619580|NCT01775787|7481144|FG000|First 7-10 Days|concerns with using IV|1
4619581|NCT01775787|7481145|FG001|First 7-10 Days|concerns with using IV|2
4619582|NCT01775787|7481144|FG000|Second 7-10 Days|time commitment|0
4619583|NCT01775787|7481145|FG001|Second 7-10 Days|time commitment|1
4619584|NCT01775787|7481144|FG000|Second 7-10 Days|concerns with using IV|0
4619585|NCT01775787|7481145|FG001|Second 7-10 Days|concerns with using IV|1
4633007|NCT01907100|7502852|FG001|Overall Study|Protocol Violation|0
4633008|NCT01907100|7502853|FG002|Overall Study|Protocol Violation|1
4633009|NCT01907100|7502854|FG003|Overall Study|Protocol Violation|1
4633010|NCT01907100|7502851|FG000|Overall Study|Lost to Follow-up|0
4633011|NCT01907100|7502852|FG001|Overall Study|Lost to Follow-up|0
4633012|NCT01907100|7502853|FG002|Overall Study|Lost to Follow-up|0
4633013|NCT01907100|7502854|FG003|Overall Study|Lost to Follow-up|1
4633014|NCT01907100|7502851|FG000|Overall Study|Not treated|2
4548163|NCT01192191|7374633|FG000|Overall Study|Adverse Event|7
4548164|NCT01192191|7374634|FG001|Overall Study|Adverse Event|12
4548165|NCT01192191|7374633|FG000|Overall Study|Participants Reached Stopping Criteria|3
4548166|NCT01192191|7374634|FG001|Overall Study|Participants Reached Stopping Criteria|2
4548167|NCT01192191|7374633|FG000|Overall Study|Lost to Follow-up|0
4548168|NCT01192191|7374634|FG001|Overall Study|Lost to Follow-up|1
4548169|NCT01192191|7374633|FG000|Overall Study|Withdrawal by Subject|1
4548170|NCT01192191|7374634|FG001|Overall Study|Withdrawal by Subject|6
4548171|NCT01192204|7374642|FG000|Overall Study|could not keep recall appointments|1
4548172|NCT01192204|7374643|FG001|Overall Study|could not keep recall appointments|0
4548173|NCT01192295|7374668|FG000|Overall Study|Adverse Event|3
4548174|NCT01192295|7374669|FG001|Overall Study|Adverse Event|7
4548175|NCT01192295|7374668|FG000|Overall Study|Withdrawal by Subject|3
4548176|NCT01192295|7374669|FG001|Overall Study|Withdrawal by Subject|4
4548177|NCT01192295|7374668|FG000|Overall Study|Lost to Follow-up|0
4548178|NCT01192295|7374669|FG001|Overall Study|Lost to Follow-up|1
4548179|NCT01192295|7374668|FG000|Overall Study|Lack of Efficacy|0
4548180|NCT01192295|7374669|FG001|Overall Study|Lack of Efficacy|5
4548181|NCT01192295|7374668|FG000|Overall Study|Administrative|4
4548182|NCT01192295|7374669|FG001|Overall Study|Administrative|6
4548183|NCT01192347|7374677|FG000|Overall Study|Death|3
4548184|NCT01192347|7374677|FG000|Overall Study|Lost to Follow-up|3
4548185|NCT01192347|7374677|FG000|Overall Study|Withdrawal by Subject|1
4548186|NCT01192347|7374677|FG000|Overall Study|Adverse Event|1
4548187|NCT01192347|7374677|FG000|Overall Study|Suspected serious adverse drug reaction|1
4548188|NCT01192347|7374677|FG000|Overall Study|Patient seen in different hospital|1
4548189|NCT01192347|7374677|FG000|Overall Study|Patient not visiting hospital regularly|1
4548190|NCT01192347|7374677|FG000|Overall Study|Patient did not show up for visits|1
4548191|NCT01192399|7374681|FG000|Overall Study|Lack of Efficacy|2
4548192|NCT01192412|7374687|FG000|Overall Study|Lost to Follow-up|2
4548193|NCT01192412|7374688|FG001|Overall Study|Lost to Follow-up|1
4548194|NCT01192412|7374687|FG000|Overall Study|Withdrawal by Subject|2
4548195|NCT01192412|7374688|FG001|Overall Study|Withdrawal by Subject|1
4548196|NCT01192516|7374697|FG000|Overall Study|Lost to Follow-up|7
4548197|NCT01192516|7374698|FG001|Overall Study|Lost to Follow-up|10
4548198|NCT01192516|7374699|FG002|Overall Study|Lost to Follow-up|7
4548199|NCT01192516|7374697|FG000|Overall Study|Withdrawal by Subject|4
4548200|NCT01192516|7374698|FG001|Overall Study|Withdrawal by Subject|4
4548201|NCT01192516|7374699|FG002|Overall Study|Withdrawal by Subject|1
4548202|NCT01192516|7374697|FG000|Overall Study|started new treatment|5
4548203|NCT01192516|7374698|FG001|Overall Study|started new treatment|1
4548204|NCT01192516|7374699|FG002|Overall Study|started new treatment|0
4548205|NCT01192516|7374697|FG000|Overall Study|Unable to follow Actiwatch instructions|4
4548206|NCT01192516|7374698|FG001|Overall Study|Unable to follow Actiwatch instructions|2
4548207|NCT01192516|7374699|FG002|Overall Study|Unable to follow Actiwatch instructions|0
4548208|NCT01192815|7374720|FG000|Overall Study|Withdrawal by Subject|1
4548209|NCT01192815|7374720|FG000|Overall Study|Lack of Efficacy|1
4633015|NCT01907100|7502852|FG001|Overall Study|Not treated|0
4633016|NCT01907100|7502853|FG002|Overall Study|Not treated|1
4633017|NCT01907100|7502854|FG003|Overall Study|Not treated|2
4633018|NCT01907100|7502851|FG000|Overall Study|Other than reasons specified|1
4633019|NCT01907100|7502852|FG001|Overall Study|Other than reasons specified|0
4633020|NCT01907100|7502853|FG002|Overall Study|Other than reasons specified|10
4633021|NCT01907100|7502854|FG003|Overall Study|Other than reasons specified|6
4770409|NCT03740919|7746733|FG003|Treatment Period|Terminated by Sponsor|0
4548210|NCT01193101|7374750|FG000|Overall Study|Adverse Event|0
4548211|NCT01193101|7374751|FG001|Overall Study|Adverse Event|1
4548212|NCT01193101|7374752|FG002|Overall Study|Adverse Event|1
4548213|NCT01193101|7374753|FG003|Overall Study|Adverse Event|3
4548214|NCT01193101|7374750|FG000|Overall Study|Lack of Efficacy|3
4548215|NCT01193101|7374751|FG001|Overall Study|Lack of Efficacy|1
4548216|NCT01193101|7374752|FG002|Overall Study|Lack of Efficacy|0
4633022|NCT01907100|7502851|FG000|Overall Study|Adverse event (AE)|6
4633023|NCT01907100|7502852|FG001|Overall Study|Adverse event (AE)|3
4548217|NCT01193101|7374753|FG003|Overall Study|Lack of Efficacy|8
4548218|NCT01193101|7374750|FG000|Overall Study|Withdrawal by Subject|2
4548219|NCT01193101|7374751|FG001|Overall Study|Withdrawal by Subject|4
4548220|NCT01193101|7374752|FG002|Overall Study|Withdrawal by Subject|1
4548221|NCT01193101|7374753|FG003|Overall Study|Withdrawal by Subject|1
4548222|NCT01193101|7374750|FG000|Overall Study|Administrative problems|0
4548223|NCT01193101|7374751|FG001|Overall Study|Administrative problems|0
4548224|NCT01193101|7374752|FG002|Overall Study|Administrative problems|1
4548225|NCT01193101|7374753|FG003|Overall Study|Administrative problems|0
4548226|NCT01193101|7374750|FG000|Overall Study|Abnormal test procedure results|0
4548227|NCT01193101|7374751|FG001|Overall Study|Abnormal test procedure results|1
4548228|NCT01193101|7374752|FG002|Overall Study|Abnormal test procedure results|0
4548229|NCT01193101|7374753|FG003|Overall Study|Abnormal test procedure results|0
4548230|NCT01193127|7374776|FG000|Randomized|Surgery Cancelled|0
4548231|NCT01193127|7374777|FG001|Randomized|Surgery Cancelled|0
4548232|NCT01193127|7374778|FG002|Randomized|Surgery Cancelled|0
4548233|NCT01193127|7374779|FG003|Randomized|Surgery Cancelled|1
4548234|NCT01193127|7374776|FG000|Treated|Withdrawal by Subject|0
4548235|NCT01193127|7374777|FG001|Treated|Withdrawal by Subject|0
4548236|NCT01193127|7374778|FG002|Treated|Withdrawal by Subject|0
4548237|NCT01193127|7374779|FG003|Treated|Withdrawal by Subject|1
4548238|NCT01193153|7374791|FG000|Open-label Lead in Period|Lost to Follow-up|32
4548239|NCT01193153|7374792|FG001|Open-label Lead in Period|Lost to Follow-up|0
4548240|NCT01193153|7374791|FG000|Open-label Lead in Period|Pregnancy|1
4548241|NCT01193153|7374792|FG001|Open-label Lead in Period|Pregnancy|0
4548242|NCT01193153|7374791|FG000|Open-label Lead in Period|Withdrawal by Subject|69
4548243|NCT01193153|7374792|FG001|Open-label Lead in Period|Withdrawal by Subject|0
4548244|NCT01193153|7374791|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4
4548245|NCT01193153|7374792|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0
4548246|NCT01193153|7374791|FG000|Open-label Lead in Period|Other|14
4548247|NCT01193153|7374792|FG001|Open-label Lead in Period|Other|0
4548248|NCT01193153|7374791|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47
4548249|NCT01193153|7374792|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0
4548250|NCT01193153|7374791|FG000|Open-label Lead in Period|Adverse Event|41
4548251|NCT01193153|7374792|FG001|Open-label Lead in Period|Adverse Event|0
4548252|NCT01193153|7374791|FG000|Open-label Lead in Period|Death|1
4548253|NCT01193153|7374792|FG001|Open-label Lead in Period|Death|0
4548254|NCT01193153|7374791|FG000|Open-label Lead in Period|Lack of Efficacy|26
4548255|NCT01193153|7374792|FG001|Open-label Lead in Period|Lack of Efficacy|0
4548256|NCT01193153|7374791|FG000|Open-label Stabilization Period|Adverse Event|9
4548257|NCT01193153|7374792|FG001|Open-label Stabilization Period|Adverse Event|0
4548258|NCT01193153|7374791|FG000|Open-label Stabilization Period|Death|2
4548259|NCT01193153|7374792|FG001|Open-label Stabilization Period|Death|0
4548260|NCT01193153|7374791|FG000|Open-label Stabilization Period|Lost to Follow-up|10
4548261|NCT01193153|7374792|FG001|Open-label Stabilization Period|Lost to Follow-up|0
4548262|NCT01193153|7374791|FG000|Open-label Stabilization Period|Lack of Efficacy|5
4548263|NCT01193153|7374792|FG001|Open-label Stabilization Period|Lack of Efficacy|0
4548264|NCT01193153|7374791|FG000|Open-label Stabilization Period|Withdrawal by Subject|29
4548265|NCT01193153|7374792|FG001|Open-label Stabilization Period|Withdrawal by Subject|0
4548266|NCT01193153|7374791|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35
4548267|NCT01193153|7374792|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0
4548268|NCT01193153|7374791|FG000|Open-label Stabilization Period|Other|8
4548269|NCT01193153|7374792|FG001|Open-label Stabilization Period|Other|0
4548270|NCT01193153|7374791|FG000|Double Blind Relapse Prevention Period|Other|2
4548271|NCT01193153|7374792|FG001|Double Blind Relapse Prevention Period|Other|3
4548272|NCT01193153|7374791|FG000|Double Blind Relapse Prevention Period|Adverse Event|12
4548273|NCT01193153|7374792|FG001|Double Blind Relapse Prevention Period|Adverse Event|3
4548274|NCT01193153|7374791|FG000|Double Blind Relapse Prevention Period|Death|2
4548275|NCT01193153|7374792|FG001|Double Blind Relapse Prevention Period|Death|0
4548276|NCT01193153|7374791|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2
4548277|NCT01193153|7374792|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9
4548278|NCT01193153|7374791|FG000|Double Blind Relapse Prevention Period|Pregnancy|1
4548279|NCT01193153|7374792|FG001|Double Blind Relapse Prevention Period|Pregnancy|0
4548280|NCT01193153|7374791|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19
4548281|NCT01193153|7374792|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30
4548282|NCT01193153|7374791|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25
4548283|NCT01193153|7374792|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57
4548284|NCT01193153|7374791|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1
4548285|NCT01193153|7374792|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3
4548286|NCT01193218|7374806|FG000|0-12 Weeks|Adverse Event|6
4548287|NCT01193218|7374807|FG001|0-12 Weeks|Adverse Event|0
4548288|NCT01193218|7374808|FG002|0-12 Weeks|Adverse Event|1
4548289|NCT01193218|7374809|FG003|0-12 Weeks|Adverse Event|0
4548290|NCT01193218|7374810|FG004|0-12 Weeks|Adverse Event|0
4548291|NCT01193218|7374811|FG005|0-12 Weeks|Adverse Event|2
4548292|NCT01193218|7374812|FG006|0-12 Weeks|Adverse Event|2
4548293|NCT01193218|7374813|FG007|0-12 Weeks|Adverse Event|0
4548294|NCT01193218|7374806|FG000|0-12 Weeks|Protocol Violation|0
4548295|NCT01193218|7374807|FG001|0-12 Weeks|Protocol Violation|0
4548296|NCT01193218|7374808|FG002|0-12 Weeks|Protocol Violation|0
4548297|NCT01193218|7374809|FG003|0-12 Weeks|Protocol Violation|0
4548298|NCT01193218|7374810|FG004|0-12 Weeks|Protocol Violation|1
4548299|NCT01193218|7374811|FG005|0-12 Weeks|Protocol Violation|1
4548300|NCT01193218|7374812|FG006|0-12 Weeks|Protocol Violation|0
4548301|NCT01193218|7374813|FG007|0-12 Weeks|Protocol Violation|0
4548302|NCT01193218|7374806|FG000|0-12 Weeks|Withdrawal by Subject|3
4548303|NCT01193218|7374807|FG001|0-12 Weeks|Withdrawal by Subject|0
4548304|NCT01193218|7374808|FG002|0-12 Weeks|Withdrawal by Subject|2
4548305|NCT01193218|7374809|FG003|0-12 Weeks|Withdrawal by Subject|0
4548306|NCT01193218|7374810|FG004|0-12 Weeks|Withdrawal by Subject|0
4548307|NCT01193218|7374811|FG005|0-12 Weeks|Withdrawal by Subject|0
4619586|NCT01775904|7481190|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1
4619587|NCT01775904|7481190|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1
4548308|NCT01193218|7374812|FG006|0-12 Weeks|Withdrawal by Subject|1
4548309|NCT01193218|7374813|FG007|0-12 Weeks|Withdrawal by Subject|0
4548310|NCT01193218|7374806|FG000|12-52 Weeks|Adverse Event|1
4548311|NCT01193218|7374807|FG001|12-52 Weeks|Adverse Event|0
4548312|NCT01193218|7374808|FG002|12-52 Weeks|Adverse Event|1
4548313|NCT01193218|7374809|FG003|12-52 Weeks|Adverse Event|2
4548314|NCT01193218|7374810|FG004|12-52 Weeks|Adverse Event|3
4548315|NCT01193218|7374811|FG005|12-52 Weeks|Adverse Event|3
4548316|NCT01193218|7374812|FG006|12-52 Weeks|Adverse Event|1
4548317|NCT01193218|7374813|FG007|12-52 Weeks|Adverse Event|2
4548318|NCT01193218|7374806|FG000|12-52 Weeks|Lack of Efficacy|0
4548319|NCT01193218|7374807|FG001|12-52 Weeks|Lack of Efficacy|0
4548320|NCT01193218|7374808|FG002|12-52 Weeks|Lack of Efficacy|0
4548321|NCT01193218|7374809|FG003|12-52 Weeks|Lack of Efficacy|0
4548322|NCT01193218|7374810|FG004|12-52 Weeks|Lack of Efficacy|0
4548323|NCT01193218|7374811|FG005|12-52 Weeks|Lack of Efficacy|0
4548324|NCT01193218|7374812|FG006|12-52 Weeks|Lack of Efficacy|1
4548325|NCT01193218|7374813|FG007|12-52 Weeks|Lack of Efficacy|0
4548326|NCT01193218|7374806|FG000|12-52 Weeks|Withdrawal by Subject|3
4548327|NCT01193218|7374807|FG001|12-52 Weeks|Withdrawal by Subject|0
4548328|NCT01193218|7374808|FG002|12-52 Weeks|Withdrawal by Subject|3
4548329|NCT01193218|7374809|FG003|12-52 Weeks|Withdrawal by Subject|0
4548330|NCT01193218|7374810|FG004|12-52 Weeks|Withdrawal by Subject|0
4548331|NCT01193218|7374811|FG005|12-52 Weeks|Withdrawal by Subject|2
4548332|NCT01193218|7374812|FG006|12-52 Weeks|Withdrawal by Subject|1
4548333|NCT01193218|7374813|FG007|12-52 Weeks|Withdrawal by Subject|2
4548334|NCT01193218|7374806|FG000|12-52 Weeks|Other reason than above|1
4548335|NCT01193218|7374807|FG001|12-52 Weeks|Other reason than above|0
4548336|NCT01193218|7374808|FG002|12-52 Weeks|Other reason than above|0
4619588|NCT01775930|7481200|FG000|Overall Study|Futility stopping boundary met|1
4619589|NCT01775995|7481206|FG000|Overall Study|Lost to Follow-up|1
4619590|NCT01775995|7481207|FG001|Overall Study|Lost to Follow-up|1
4619591|NCT01776008|7481213|FG000|Overall Study|ineligible|2
4619592|NCT01776424|7481230|FG000|Overall Study|Lost to Follow-up|10
4619593|NCT01776424|7481231|FG001|Overall Study|Lost to Follow-up|8
4619594|NCT01776424|7481232|FG002|Overall Study|Lost to Follow-up|9
4619595|NCT01776424|7481230|FG000|Overall Study|Withdrawal by Subject|10
4619596|NCT01776424|7481231|FG001|Overall Study|Withdrawal by Subject|11
4619597|NCT01776424|7481232|FG002|Overall Study|Withdrawal by Subject|15
4619598|NCT01776541|7481242|FG000|Overall Study|Administrative Reason|6
4619599|NCT01776541|7481243|FG001|Overall Study|Administrative Reason|2
4619600|NCT01776541|7481242|FG000|Overall Study|Death|4
4619601|NCT01776541|7481243|FG001|Overall Study|Death|0
4619602|NCT01776541|7481242|FG000|Overall Study|Lost to Follow-up|27
4619603|NCT01776541|7481243|FG001|Overall Study|Lost to Follow-up|48
4619604|NCT01776541|7481242|FG000|Overall Study|Unclassified|5
4619605|NCT01776541|7481243|FG001|Overall Study|Unclassified|4
4619606|NCT01776541|7481242|FG000|Overall Study|Protocol Violation|2
4619607|NCT01776541|7481243|FG001|Overall Study|Protocol Violation|1
4619608|NCT01776541|7481242|FG000|Overall Study|Withdrawal by Subject|12
4619609|NCT01776541|7481243|FG001|Overall Study|Withdrawal by Subject|20
4619610|NCT01776554|7481252|FG000|Overall Study|Adverse Event|1
4619611|NCT01776554|7481253|FG001|Overall Study|Adverse Event|0
4619612|NCT01776554|7481252|FG000|Overall Study|Withdrawal by Subject|3
4619613|NCT01776554|7481253|FG001|Overall Study|Withdrawal by Subject|8
4619614|NCT01776554|7481252|FG000|Overall Study|Lost to Follow-up|6
4619615|NCT01776554|7481253|FG001|Overall Study|Lost to Follow-up|9
4619616|NCT01776554|7481252|FG000|Overall Study|Administrative Reason|2
4548337|NCT01193218|7374809|FG003|12-52 Weeks|Other reason than above|1
4548338|NCT01193218|7374810|FG004|12-52 Weeks|Other reason than above|1
4548339|NCT01193218|7374811|FG005|12-52 Weeks|Other reason than above|0
4548340|NCT01193218|7374812|FG006|12-52 Weeks|Other reason than above|0
4619617|NCT01776554|7481253|FG001|Overall Study|Administrative Reason|5
4619618|NCT01776554|7481252|FG000|Overall Study|Protocol Violation|1
4619619|NCT01776554|7481253|FG001|Overall Study|Protocol Violation|0
4619620|NCT01776554|7481252|FG000|Overall Study|Unclassified|4
4548341|NCT01193218|7374813|FG007|12-52 Weeks|Other reason than above|0
4548342|NCT01193244|7374831|FG000|Overall Study|Withdrawal by Subject|79
4619621|NCT01776554|7481253|FG001|Overall Study|Unclassified|1
4548343|NCT01193244|7374832|FG001|Overall Study|Withdrawal by Subject|97
4548344|NCT01193244|7374831|FG000|Overall Study|Other|303
4548345|NCT01193244|7374832|FG001|Overall Study|Other|278
4548346|NCT01193244|7374831|FG000|Overall Study|Lost to Follow-up|6
4548347|NCT01193244|7374832|FG001|Overall Study|Lost to Follow-up|15
4548348|NCT01193257|7374840|FG000|Overall Study|Death|202
4548349|NCT01193257|7374841|FG001|Overall Study|Death|391
4548350|NCT01193257|7374840|FG000|Overall Study|Study termination by sponsor|0
4548351|NCT01193257|7374841|FG001|Overall Study|Study termination by sponsor|3
4548352|NCT01193257|7374840|FG000|Overall Study|Withdrawal by Subject|26
4548353|NCT01193257|7374841|FG001|Overall Study|Withdrawal by Subject|86
4548354|NCT01193257|7374840|FG000|Overall Study|Lost to Follow-up|2
4548355|NCT01193257|7374841|FG001|Overall Study|Lost to Follow-up|3
4548356|NCT01193257|7374840|FG000|Overall Study|Unblinded due to futility|135
4548357|NCT01193257|7374841|FG001|Overall Study|Unblinded due to futility|251
4548358|NCT01193283|7374847|FG000|Overall Study|Death|1
4548359|NCT01193335|7374853|FG000|After Infant Series|Lost to Follow-up|1
4548360|NCT01193335|7374854|FG001|After Infant Series|Lost to Follow-up|2
4548361|NCT01193335|7374853|FG000|After Infant Series|No Longer Met Eligibility Criteria|0
4548362|NCT01193335|7374854|FG001|After Infant Series|No Longer Met Eligibility Criteria|1
4548363|NCT01193335|7374853|FG000|1-Year Follow-up|No Longer Willing to Participate|7
4548364|NCT01193335|7374854|FG001|1-Year Follow-up|No Longer Willing to Participate|9
4548365|NCT01193335|7374853|FG000|1-Year Follow-up|Lost to Follow-up|4
4548366|NCT01193335|7374854|FG001|1-Year Follow-up|Lost to Follow-up|0
4548367|NCT01193335|7374853|FG000|2-Year Follow-up|No Longer Willing to Participate|5
4548368|NCT01193335|7374854|FG001|2-Year Follow-up|No Longer Willing to Participate|6
4548369|NCT01193335|7374853|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2
4548370|NCT01193335|7374854|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2
4548371|NCT01193348|7374876|FG000|Screening Period|Screen Failure|5
4548372|NCT01193348|7374876|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1
4548373|NCT01193348|7374876|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1
4548374|NCT01193348|7374876|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1
4548375|NCT01193348|7374876|FG000|Extension Treatment Period|Physician Decision|1
4548376|NCT01193348|7374876|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2
4548377|NCT01193517|7374888|FG000|Overall Study|Early Progression|1
4548378|NCT01193517|7374889|FG001|Overall Study|Early Progression|0
4548379|NCT01193517|7374890|FG002|Overall Study|Early Progression|0
4548380|NCT01193582|7374903|FG000|Vaccination Series|Withdrawal by Subject|11
4548381|NCT01193582|7374904|FG001|Vaccination Series|Withdrawal by Subject|13
4548382|NCT01193582|7374905|FG002|Vaccination Series|Withdrawal by Subject|8
4548383|NCT01193582|7374906|FG003|Vaccination Series|Withdrawal by Subject|3
4548384|NCT01193582|7374903|FG000|12 Month Follow-up|Death|0
4548385|NCT01193582|7374904|FG001|12 Month Follow-up|Death|0
4548386|NCT01193582|7374905|FG002|12 Month Follow-up|Death|1
4548387|NCT01193582|7374906|FG003|12 Month Follow-up|Death|0
4548388|NCT01193582|7374903|FG000|12 Month Follow-up|Withdrawal by Subject|6
4548389|NCT01193582|7374904|FG001|12 Month Follow-up|Withdrawal by Subject|0
4548390|NCT01193582|7374905|FG002|12 Month Follow-up|Withdrawal by Subject|3
4548391|NCT01193582|7374906|FG003|12 Month Follow-up|Withdrawal by Subject|11
4548392|NCT01193608|7374924|FG000|Overall Study|Other|0
4548393|NCT01193608|7374925|FG001|Overall Study|Other|1
4548394|NCT01193608|7374926|FG002|Overall Study|Other|0
4548395|NCT01193608|7374927|FG003|Overall Study|Other|0
4548396|NCT01193608|7374928|FG004|Overall Study|Other|0
4548397|NCT01193608|7374929|FG005|Overall Study|Other|0
4548398|NCT01193608|7374924|FG000|Overall Study|Withdrawal by Subject|0
4548399|NCT01193608|7374925|FG001|Overall Study|Withdrawal by Subject|1
4548400|NCT01193608|7374926|FG002|Overall Study|Withdrawal by Subject|2
4548401|NCT01193608|7374927|FG003|Overall Study|Withdrawal by Subject|3
4548402|NCT01193608|7374928|FG004|Overall Study|Withdrawal by Subject|3
4548403|NCT01193608|7374929|FG005|Overall Study|Withdrawal by Subject|0
4548404|NCT01193608|7374924|FG000|Overall Study|Lost to Follow-up|0
4548405|NCT01193608|7374925|FG001|Overall Study|Lost to Follow-up|0
4548406|NCT01193608|7374926|FG002|Overall Study|Lost to Follow-up|0
4548407|NCT01193608|7374927|FG003|Overall Study|Lost to Follow-up|0
4548408|NCT01193608|7374928|FG004|Overall Study|Lost to Follow-up|1
4548409|NCT01193608|7374929|FG005|Overall Study|Lost to Follow-up|2
4548410|NCT01193608|7374924|FG000|Overall Study|Adverse Event|0
4548411|NCT01193608|7374925|FG001|Overall Study|Adverse Event|0
4548412|NCT01193608|7374926|FG002|Overall Study|Adverse Event|0
4548413|NCT01193608|7374927|FG003|Overall Study|Adverse Event|0
4548414|NCT01193608|7374928|FG004|Overall Study|Adverse Event|1
4548415|NCT01193608|7374929|FG005|Overall Study|Adverse Event|0
4548416|NCT01193660|7374951|FG000|Overall Study|Withdrawal by Subject|2
4548417|NCT01193660|7374952|FG001|Overall Study|Withdrawal by Subject|3
4548418|NCT01193660|7374953|FG002|Overall Study|Withdrawal by Subject|1
4548419|NCT01193660|7374951|FG000|Overall Study|Death|1
4548420|NCT01193660|7374952|FG001|Overall Study|Death|0
4548421|NCT01193660|7374953|FG002|Overall Study|Death|0
4548422|NCT01193660|7374951|FG000|Overall Study|Physician Decision|1
4548423|NCT01193660|7374952|FG001|Overall Study|Physician Decision|0
4548424|NCT01193660|7374953|FG002|Overall Study|Physician Decision|1
4548425|NCT01193686|7374963|FG000|Overall Study|Withdrawal by Subject|4
4548426|NCT01193686|7374964|FG001|Overall Study|Withdrawal by Subject|1
4548427|NCT01193686|7374963|FG000|Overall Study|Removed by Investigators; unable to matc|3
4548428|NCT01193686|7374964|FG001|Overall Study|Removed by Investigators; unable to matc|0
4548429|NCT01193920|7375002|FG000|Overall Study|Withdrawal by Subject|1
4548430|NCT01193920|7375003|FG001|Overall Study|Withdrawal by Subject|0
4548431|NCT01193920|7375004|FG002|Overall Study|Withdrawal by Subject|5
4548432|NCT01193920|7375005|FG003|Overall Study|Withdrawal by Subject|1
4548433|NCT01193920|7375006|FG004|Overall Study|Withdrawal by Subject|3
4548434|NCT01193920|7375007|FG005|Overall Study|Withdrawal by Subject|1
4548435|NCT01193920|7375008|FG006|Overall Study|Withdrawal by Subject|3
4548436|NCT01193920|7375009|FG007|Overall Study|Withdrawal by Subject|0
4548437|NCT01193920|7375010|FG008|Overall Study|Withdrawal by Subject|1
4548438|NCT01193920|7375011|FG009|Overall Study|Withdrawal by Subject|0
4548439|NCT01193920|7375002|FG000|Overall Study|Lost to Follow-up|1
4548440|NCT01193920|7375003|FG001|Overall Study|Lost to Follow-up|0
4548441|NCT01193920|7375004|FG002|Overall Study|Lost to Follow-up|1
4548442|NCT01193920|7375005|FG003|Overall Study|Lost to Follow-up|1
4548443|NCT01193920|7375006|FG004|Overall Study|Lost to Follow-up|3
4548444|NCT01193920|7375007|FG005|Overall Study|Lost to Follow-up|3
4548445|NCT01193920|7375008|FG006|Overall Study|Lost to Follow-up|1
4548446|NCT01193920|7375009|FG007|Overall Study|Lost to Follow-up|0
4548447|NCT01193920|7375010|FG008|Overall Study|Lost to Follow-up|2
4548448|NCT01193920|7375011|FG009|Overall Study|Lost to Follow-up|3
4548449|NCT01193920|7375002|FG000|Overall Study|Protocol Violation|1
4548450|NCT01193920|7375003|FG001|Overall Study|Protocol Violation|0
4548451|NCT01193920|7375004|FG002|Overall Study|Protocol Violation|0
4548452|NCT01193920|7375005|FG003|Overall Study|Protocol Violation|0
4548453|NCT01193920|7375006|FG004|Overall Study|Protocol Violation|0
4548454|NCT01193920|7375007|FG005|Overall Study|Protocol Violation|0
4548455|NCT01193920|7375008|FG006|Overall Study|Protocol Violation|0
4548456|NCT01193920|7375009|FG007|Overall Study|Protocol Violation|0
4548457|NCT01193920|7375010|FG008|Overall Study|Protocol Violation|0
4548458|NCT01193920|7375011|FG009|Overall Study|Protocol Violation|0
4548459|NCT01193920|7375002|FG000|Overall Study|Death|0
4548460|NCT01193920|7375003|FG001|Overall Study|Death|0
4548461|NCT01193920|7375004|FG002|Overall Study|Death|0
4548462|NCT01193920|7375005|FG003|Overall Study|Death|1
4548463|NCT01193920|7375006|FG004|Overall Study|Death|0
4548464|NCT01193920|7375007|FG005|Overall Study|Death|0
4548465|NCT01193920|7375008|FG006|Overall Study|Death|2
4548466|NCT01193920|7375009|FG007|Overall Study|Death|3
4548467|NCT01193920|7375010|FG008|Overall Study|Death|2
4548468|NCT01193920|7375011|FG009|Overall Study|Death|4
4548469|NCT01193920|7375002|FG000|Overall Study|Unable to classify|0
4548470|NCT01193920|7375003|FG001|Overall Study|Unable to classify|0
4548471|NCT01193920|7375004|FG002|Overall Study|Unable to classify|0
4548472|NCT01193920|7375005|FG003|Overall Study|Unable to classify|1
4548473|NCT01193920|7375006|FG004|Overall Study|Unable to classify|0
4548474|NCT01193920|7375007|FG005|Overall Study|Unable to classify|0
4548475|NCT01193920|7375008|FG006|Overall Study|Unable to classify|0
4548476|NCT01193920|7375009|FG007|Overall Study|Unable to classify|1
4548477|NCT01193920|7375010|FG008|Overall Study|Unable to classify|0
4548478|NCT01193920|7375011|FG009|Overall Study|Unable to classify|0
4548479|NCT01194154|7375045|FG000|Overall Study|Adverse Event|12
4548480|NCT01194154|7375046|FG001|Overall Study|Adverse Event|7
4548481|NCT01194154|7375045|FG000|Overall Study|Lost to Follow-up|2
4548482|NCT01194154|7375046|FG001|Overall Study|Lost to Follow-up|3
4548483|NCT01194154|7375045|FG000|Overall Study|Protocol Violation|0
4548484|NCT01194154|7375046|FG001|Overall Study|Protocol Violation|1
4548485|NCT01194154|7375045|FG000|Overall Study|Withdrawal by Subject|5
4548486|NCT01194154|7375046|FG001|Overall Study|Withdrawal by Subject|6
4548487|NCT01194154|7375045|FG000|Overall Study|Blood pressure increase|5
4548488|NCT01194154|7375046|FG001|Overall Study|Blood pressure increase|3
4548489|NCT01194154|7375045|FG000|Overall Study|Hemoglobin decrease|0
4548490|NCT01194154|7375046|FG001|Overall Study|Hemoglobin decrease|1
4548491|NCT01194154|7375045|FG000|Overall Study|Hemoglobin increase|12
4548492|NCT01194154|7375046|FG001|Overall Study|Hemoglobin increase|3
4548493|NCT01194154|7375045|FG000|Overall Study|Skipping of CERA treatment at two visits|3
4548494|NCT01194154|7375046|FG001|Overall Study|Skipping of CERA treatment at two visits|0
4548495|NCT01194154|7375045|FG000|Overall Study|Treatment with prohibited medication|4
4548496|NCT01194154|7375046|FG001|Overall Study|Treatment with prohibited medication|5
4548497|NCT01194154|7375045|FG000|Overall Study|Other|4
4548498|NCT01194154|7375046|FG001|Overall Study|Other|0
4548499|NCT01194154|7375045|FG000|Overall Study|Did not receive study medication|2
4548500|NCT01194154|7375046|FG001|Overall Study|Did not receive study medication|4
4548501|NCT01194245|7375059|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5
4548502|NCT01194245|7375060|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
4548503|NCT01194245|7375061|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
4548504|NCT01194245|7375062|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
4548505|NCT01194245|7375063|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
4548506|NCT01194245|7375059|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3
4548507|NCT01194245|7375060|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0
4548508|NCT01194245|7375061|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0
4548509|NCT01194245|7375062|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0
4548510|NCT01194245|7375063|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0
4548511|NCT01194245|7375059|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3
4548512|NCT01194245|7375060|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0
4548513|NCT01194245|7375061|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0
4548514|NCT01194245|7375062|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0
4548515|NCT01194245|7375063|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0
4548516|NCT01194245|7375059|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7
4548517|NCT01194245|7375060|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
4548518|NCT01194245|7375061|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
4548519|NCT01194245|7375062|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
4548520|NCT01194245|7375063|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
4548521|NCT01194245|7375059|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
4548522|NCT01194245|7375060|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
4548523|NCT01194245|7375061|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
4548524|NCT01194245|7375062|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
4548525|NCT01194245|7375063|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1
4548526|NCT01194245|7375059|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
4548527|NCT01194245|7375060|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
4548528|NCT01194245|7375061|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
4548529|NCT01194245|7375062|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
4548530|NCT01194245|7375063|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
4548531|NCT01194258|7375072|FG000|Titration Period|Withdrawal by Subject|6
4548532|NCT01194258|7375073|FG001|Titration Period|Withdrawal by Subject|0
4548533|NCT01194258|7375074|FG002|Titration Period|Withdrawal by Subject|0
4548534|NCT01194258|7375075|FG003|Titration Period|Withdrawal by Subject|0
4548535|NCT01194258|7375076|FG004|Titration Period|Withdrawal by Subject|0
4548536|NCT01194258|7375072|FG000|Titration Period|Lost to Follow-up|2
4548537|NCT01194258|7375073|FG001|Titration Period|Lost to Follow-up|0
4548538|NCT01194258|7375074|FG002|Titration Period|Lost to Follow-up|0
4548539|NCT01194258|7375075|FG003|Titration Period|Lost to Follow-up|0
4548540|NCT01194258|7375076|FG004|Titration Period|Lost to Follow-up|0
4548541|NCT01194258|7375072|FG000|Titration Period|Titration failure|3
4548542|NCT01194258|7375073|FG001|Titration Period|Titration failure|0
4548543|NCT01194258|7375074|FG002|Titration Period|Titration failure|0
4548544|NCT01194258|7375075|FG003|Titration Period|Titration failure|0
4548545|NCT01194258|7375076|FG004|Titration Period|Titration failure|0
4548546|NCT01194258|7375072|FG000|Period 1 (12 Weeks)|Death|0
4548547|NCT01194258|7375073|FG001|Period 1 (12 Weeks)|Death|0
4548548|NCT01194258|7375074|FG002|Period 1 (12 Weeks)|Death|0
4548549|NCT01194258|7375075|FG003|Period 1 (12 Weeks)|Death|0
4548550|NCT01194258|7375076|FG004|Period 1 (12 Weeks)|Death|1
4548551|NCT01194258|7375072|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0
4548552|NCT01194258|7375073|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0
4548553|NCT01194258|7375074|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0
4548554|NCT01194258|7375075|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0
4548555|NCT01194258|7375076|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2
4548556|NCT01194258|7375072|FG000|Period 2 (12 Weeks)|Adverse Event|0
4548557|NCT01194258|7375073|FG001|Period 2 (12 Weeks)|Adverse Event|1
4548558|NCT01194258|7375074|FG002|Period 2 (12 Weeks)|Adverse Event|0
4548559|NCT01194258|7375075|FG003|Period 2 (12 Weeks)|Adverse Event|0
4548560|NCT01194258|7375076|FG004|Period 2 (12 Weeks)|Adverse Event|0
4548561|NCT01194258|7375072|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0
4548562|NCT01194258|7375073|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1
4548563|NCT01194258|7375074|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1
4548564|NCT01194258|7375075|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0
4548565|NCT01194258|7375076|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0
4548566|NCT01194271|7375087|FG000|Overall Study|Withdrawal by Subject|1
4548567|NCT01194271|7375087|FG000|Overall Study|Ineligible, Screen Failure|1
4548568|NCT01194271|7375087|FG000|Overall Study|Death|1
4548569|NCT01194414|7375102|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11
4548570|NCT01194414|7375103|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8
4548571|NCT01194414|7375104|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0
4548572|NCT01194414|7375105|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0
4548573|NCT01194414|7375102|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9
4548574|NCT01194414|7375103|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5
4548575|NCT01194414|7375104|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0
4548576|NCT01194414|7375105|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0
4548577|NCT01194414|7375102|FG000|24 Weeks Double Blind Period|Protocol Violation|5
4548578|NCT01194414|7375103|FG001|24 Weeks Double Blind Period|Protocol Violation|3
4548579|NCT01194414|7375104|FG002|24 Weeks Double Blind Period|Protocol Violation|0
4548580|NCT01194414|7375105|FG003|24 Weeks Double Blind Period|Protocol Violation|0
4548581|NCT01194414|7375102|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
4548582|NCT01194414|7375103|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5
4548583|NCT01194414|7375104|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
4619622|NCT01777139|7481288|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7
4619623|NCT01777139|7481289|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0
4548584|NCT01194414|7375105|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
4548585|NCT01194414|7375102|FG000|24 Weeks Double Blind Period|Pregnancy|2
4548586|NCT01194414|7375103|FG001|24 Weeks Double Blind Period|Pregnancy|2
4548587|NCT01194414|7375104|FG002|24 Weeks Double Blind Period|Pregnancy|0
4548588|NCT01194414|7375105|FG003|24 Weeks Double Blind Period|Pregnancy|0
4548589|NCT01194414|7375102|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2
4548590|NCT01194414|7375103|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1
4548591|NCT01194414|7375104|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0
4548592|NCT01194414|7375105|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0
4548593|NCT01194414|7375102|FG000|24 Weeks Double Blind Period|Other|0
4548594|NCT01194414|7375103|FG001|24 Weeks Double Blind Period|Other|1
4548595|NCT01194414|7375104|FG002|24 Weeks Double Blind Period|Other|0
4548596|NCT01194414|7375105|FG003|24 Weeks Double Blind Period|Other|0
4548597|NCT01194414|7375102|FG000|24 Weeks Double Blind Period|Adverse Event|28
4548598|NCT01194414|7375103|FG001|24 Weeks Double Blind Period|Adverse Event|40
4548599|NCT01194414|7375104|FG002|24 Weeks Double Blind Period|Adverse Event|0
4548600|NCT01194414|7375105|FG003|24 Weeks Double Blind Period|Adverse Event|0
4548601|NCT01194414|7375102|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2
4548602|NCT01194414|7375103|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1
4548603|NCT01194414|7375104|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0
4548604|NCT01194414|7375105|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0
4548605|NCT01194414|7375102|FG000|24 Weeks Double Blind Period|Death|0
4548606|NCT01194414|7375103|FG001|24 Weeks Double Blind Period|Death|1
4548607|NCT01194414|7375104|FG002|24 Weeks Double Blind Period|Death|0
4548608|NCT01194414|7375105|FG003|24 Weeks Double Blind Period|Death|0
4548609|NCT01194414|7375102|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3
4548610|NCT01194414|7375103|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5
4548611|NCT01194414|7375104|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0
4548612|NCT01194414|7375105|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0
4548613|NCT01194414|7375102|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20
4548614|NCT01194414|7375103|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14
4548615|NCT01194414|7375104|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1
4548616|NCT01194414|7375105|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6
4548617|NCT01194414|7375102|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9
4548618|NCT01194414|7375103|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11
4548619|NCT01194414|7375104|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2
4548620|NCT01194414|7375105|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3
4548621|NCT01194414|7375102|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4
4548622|NCT01194414|7375103|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3
4548623|NCT01194414|7375104|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2
4548624|NCT01194414|7375105|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1
4548625|NCT01194414|7375102|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3
4548626|NCT01194414|7375103|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5
4548627|NCT01194414|7375104|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0
4548628|NCT01194414|7375105|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0
4548629|NCT01194414|7375102|FG000|72 Weeks Open Label Extension|Pregnancy|1
4548630|NCT01194414|7375103|FG001|72 Weeks Open Label Extension|Pregnancy|3
4548631|NCT01194414|7375104|FG002|72 Weeks Open Label Extension|Pregnancy|1
4548632|NCT01194414|7375105|FG003|72 Weeks Open Label Extension|Pregnancy|1
4548633|NCT01194414|7375102|FG000|72 Weeks Open Label Extension|Other|2
4548634|NCT01194414|7375103|FG001|72 Weeks Open Label Extension|Other|1
4548635|NCT01194414|7375104|FG002|72 Weeks Open Label Extension|Other|0
4548636|NCT01194414|7375105|FG003|72 Weeks Open Label Extension|Other|0
4548637|NCT01194414|7375102|FG000|72 Weeks Open Label Extension|Protocol Violation|0
4548638|NCT01194414|7375103|FG001|72 Weeks Open Label Extension|Protocol Violation|0
4548639|NCT01194414|7375104|FG002|72 Weeks Open Label Extension|Protocol Violation|0
4548640|NCT01194414|7375105|FG003|72 Weeks Open Label Extension|Protocol Violation|1
4548641|NCT01194414|7375102|FG000|72 Weeks Open Label Extension|Adverse Event|35
4548642|NCT01194414|7375103|FG001|72 Weeks Open Label Extension|Adverse Event|21
4548643|NCT01194414|7375104|FG002|72 Weeks Open Label Extension|Adverse Event|2
4548644|NCT01194414|7375105|FG003|72 Weeks Open Label Extension|Adverse Event|12
4548645|NCT01194414|7375102|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1
4548646|NCT01194414|7375103|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1
4548647|NCT01194414|7375104|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0
4548648|NCT01194414|7375105|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0
4548649|NCT01194414|7375102|FG000|72 Weeks Open Label Extension|Death|1
4548650|NCT01194414|7375103|FG001|72 Weeks Open Label Extension|Death|2
4548651|NCT01194414|7375104|FG002|72 Weeks Open Label Extension|Death|0
4548652|NCT01194414|7375105|FG003|72 Weeks Open Label Extension|Death|2
4548653|NCT01194440|7375117|FG000|Baseline (First Dose)|Reason not specified|4
4548654|NCT01194440|7375117|FG000|Baseline (First Dose)|Lack of Efficacy|1
4548655|NCT01194440|7375117|FG000|Baseline (First Dose)|Change in therapy|1
4548656|NCT01194440|7375117|FG000|Baseline (First Dose)|Adverse Event|1
4548657|NCT01194440|7375117|FG000|6-months (2nd Dose)|Change in therapy|4
4548658|NCT01194531|7375158|FG000|Overall Study|Withdrawal by Subject|1
4548659|NCT01194531|7375159|FG001|Overall Study|Withdrawal by Subject|0
4548660|NCT01194531|7375158|FG000|Overall Study|Protocol Violation|4
4548661|NCT01194531|7375159|FG001|Overall Study|Protocol Violation|1
4548662|NCT01194531|7375158|FG000|Overall Study|Physician Decision|0
4548663|NCT01194531|7375159|FG001|Overall Study|Physician Decision|2
4548664|NCT01194804|7375170|FG000|Overall Study|Withdrawal by Subject|1
4548665|NCT01194830|7375176|FG000|Overall Study|Adverse Event|3
4548666|NCT01194830|7375177|FG001|Overall Study|Adverse Event|2
4548667|NCT01194830|7375176|FG000|Overall Study|Protocol Violation|5
4548668|NCT01194830|7375177|FG001|Overall Study|Protocol Violation|4
4548669|NCT01194830|7375176|FG000|Overall Study|Lost to Follow-up|9
4548670|NCT01194830|7375177|FG001|Overall Study|Lost to Follow-up|7
4548671|NCT01194830|7375176|FG000|Overall Study|Withdrawal by Subject|2
4548672|NCT01194830|7375177|FG001|Overall Study|Withdrawal by Subject|1
4548673|NCT01194830|7375176|FG000|Overall Study|Lack of Efficacy|1
4548674|NCT01194830|7375177|FG001|Overall Study|Lack of Efficacy|1
4548675|NCT01194830|7375176|FG000|Overall Study|Non-compliance issues|4
4548676|NCT01194830|7375177|FG001|Overall Study|Non-compliance issues|4
4548677|NCT01194830|7375176|FG000|Overall Study|Other Reason|12
4548678|NCT01194830|7375177|FG001|Overall Study|Other Reason|8
4548679|NCT01194869|7375183|FG000|Overall Study|Disease Progression|2
4548680|NCT01194869|7375183|FG000|Overall Study|Toxicity|2
4548681|NCT01194973|7375187|FG000|Screening Period|Screen Failure|3
4548682|NCT01194973|7375187|FG000|26 Week Treatment Period|Adverse Event|1
4548683|NCT01194973|7375187|FG000|26 Week Treatment Period|Lack of Efficacy|1
4548684|NCT01194973|7375187|FG000|26 Week Treatment Period|Pregnancy|1
4548685|NCT01194999|7375191|FG000|Overall Study|Lost to Follow-up|17
4548686|NCT01195090|7375207|FG000|Overall Study|Adverse Event|1
4548687|NCT01195090|7375208|FG001|Overall Study|Adverse Event|2
4548688|NCT01195090|7375207|FG000|Overall Study|Lost to Follow-up|2
4548689|NCT01195090|7375208|FG001|Overall Study|Lost to Follow-up|2
4548690|NCT01195090|7375207|FG000|Overall Study|Protocol Violation|3
4548691|NCT01195090|7375208|FG001|Overall Study|Protocol Violation|4
4548692|NCT01195103|7375217|FG000|Overall Study|Withdrawal by Subject|1
4548693|NCT01195103|7375218|FG001|Overall Study|Withdrawal by Subject|0
4548694|NCT01195103|7375219|FG002|Overall Study|Withdrawal by Subject|0
4548695|NCT01195272|7375236|FG000|Overall Study|Adverse Event|1
4548696|NCT01195272|7375236|FG000|Overall Study|Lack of Efficacy|3
4548697|NCT01195363|7375242|FG000|Overall Study|Lost to Follow-up|7
4548698|NCT01195363|7375243|FG001|Overall Study|Lost to Follow-up|4
4548699|NCT01195363|7375242|FG000|Overall Study|Adverse Event|3
4548700|NCT01195363|7375243|FG001|Overall Study|Adverse Event|1
4548701|NCT01195363|7375242|FG000|Overall Study|Lack of Efficacy|0
4548702|NCT01195363|7375243|FG001|Overall Study|Lack of Efficacy|4
4548703|NCT01195363|7375242|FG000|Overall Study|incarceration|1
4548704|NCT01195363|7375243|FG001|Overall Study|incarceration|0
4548705|NCT01195415|7375249|FG000|Overall Study|No repeat biopsy due to progression|2
4548706|NCT01195545|7375257|FG000|Overall Study|Protocol Violation|4
4548707|NCT01195623|7375282|FG000|Overall Study|Lost to Follow-up|35
4548708|NCT01195623|7375283|FG001|Overall Study|Lost to Follow-up|37
4548709|NCT01195636|7375291|FG000|First Intervention (3 Weeks)|Adverse Event|2
4548710|NCT01195636|7375292|FG001|First Intervention (3 Weeks)|Adverse Event|3
4548711|NCT01195636|7375291|FG000|First Intervention (3 Weeks)|Protocol Violation|1
4548712|NCT01195636|7375292|FG001|First Intervention (3 Weeks)|Protocol Violation|0
4548713|NCT01195636|7375291|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1
4548714|NCT01195636|7375292|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0
4548715|NCT01195636|7375291|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1
4548716|NCT01195636|7375292|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0
4548717|NCT01195636|7375291|FG000|Washout Period (2 Weeks)|Adverse Event|1
4548718|NCT01195636|7375292|FG001|Washout Period (2 Weeks)|Adverse Event|1
4548719|NCT01195636|7375291|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1
4548720|NCT01195636|7375292|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2
4548721|NCT01195636|7375291|FG000|Second Intervention (3 Weeks)|Adverse Event|1
4548722|NCT01195636|7375292|FG001|Second Intervention (3 Weeks)|Adverse Event|1
4548723|NCT01195636|7375291|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0
4548724|NCT01195636|7375292|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1
4548725|NCT01195662|7375301|FG000|Double Blind Treatment Period|Adverse Event|4
4548726|NCT01195662|7375302|FG001|Double Blind Treatment Period|Adverse Event|1
4548727|NCT01195662|7375303|FG002|Double Blind Treatment Period|Adverse Event|2
4548728|NCT01195662|7375301|FG000|Double Blind Treatment Period|Withdrawal by Subject|6
4548729|NCT01195662|7375302|FG001|Double Blind Treatment Period|Withdrawal by Subject|4
4548730|NCT01195662|7375303|FG002|Double Blind Treatment Period|Withdrawal by Subject|4
4548731|NCT01195662|7375301|FG000|Double Blind Treatment Period|Lost to Follow-up|3
4548732|NCT01195662|7375302|FG001|Double Blind Treatment Period|Lost to Follow-up|2
4548733|NCT01195662|7375303|FG002|Double Blind Treatment Period|Lost to Follow-up|3
4548734|NCT01195662|7375301|FG000|Double Blind Treatment Period|Administrative reason|2
4548735|NCT01195662|7375302|FG001|Double Blind Treatment Period|Administrative reason|1
4548736|NCT01195662|7375303|FG002|Double Blind Treatment Period|Administrative reason|1
4548737|NCT01195662|7375301|FG000|Double Blind Treatment Period|Requested discontinue treatment|1
4548738|NCT01195662|7375302|FG001|Double Blind Treatment Period|Requested discontinue treatment|0
4548739|NCT01195662|7375303|FG002|Double Blind Treatment Period|Requested discontinue treatment|1
4548740|NCT01195662|7375301|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1
4548741|NCT01195662|7375302|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5
4548742|NCT01195662|7375303|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2
4548743|NCT01195662|7375301|FG000|Double Blind Treatment Period|Lack of Efficacy|2
4548744|NCT01195662|7375302|FG001|Double Blind Treatment Period|Lack of Efficacy|0
4548745|NCT01195662|7375303|FG002|Double Blind Treatment Period|Lack of Efficacy|0
4548746|NCT01195662|7375301|FG000|Double Blind Treatment Period|Non-specified|3
4548747|NCT01195662|7375302|FG001|Double Blind Treatment Period|Non-specified|0
4548748|NCT01195662|7375303|FG002|Double Blind Treatment Period|Non-specified|0
4690598|NCT02561455|7600282|FG001|Overall Study|Disease Progression|1
4548749|NCT01195662|7375301|FG000|Double Blind Treatment Period|Missing disposition information|0
4548750|NCT01195662|7375302|FG001|Double Blind Treatment Period|Missing disposition information|1
4548751|NCT01195662|7375303|FG002|Double Blind Treatment Period|Missing disposition information|1
4548752|NCT01195662|7375301|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2
4548753|NCT01195662|7375302|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0
4548754|NCT01195662|7375303|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1
4548755|NCT01195662|7375301|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1
4548756|NCT01195662|7375302|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0
4548757|NCT01195662|7375303|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0
4548758|NCT01195675|7375312|FG000|Overall Study|Adverse Event|1
4548759|NCT01195675|7375312|FG000|Overall Study|Withdrawal by Subject|2
4548760|NCT01195831|7375395|FG000|Overall Study|Lost to Follow-up|2
4548761|NCT01195831|7375396|FG001|Overall Study|Lost to Follow-up|4
4548762|NCT01195831|7375395|FG000|Overall Study|Withdrawal by Subject|2
4548763|NCT01195831|7375396|FG001|Overall Study|Withdrawal by Subject|2
4548764|NCT01195831|7375395|FG000|Overall Study|Adverse Event|4
4548765|NCT01195831|7375396|FG001|Overall Study|Adverse Event|2
4548766|NCT01195831|7375395|FG000|Overall Study|Protocol Violation|0
4548767|NCT01195831|7375396|FG001|Overall Study|Protocol Violation|2
4548768|NCT01195844|7375402|FG000|Overall Study|Fecal sample not collected|40
4548769|NCT01195948|7375432|FG000|Overall Study|Lost to Follow-up|0
4548770|NCT01195948|7375433|FG001|Overall Study|Lost to Follow-up|1
4548771|NCT01195948|7375434|FG002|Overall Study|Lost to Follow-up|2
4548772|NCT01196026|7375451|FG000|Overall Study|Withdrawal by Subject|1
4548773|NCT01196026|7375452|FG001|Overall Study|Withdrawal by Subject|4
4548774|NCT01196026|7375453|FG002|Overall Study|Withdrawal by Subject|0
4548775|NCT01196026|7375454|FG003|Overall Study|Withdrawal by Subject|0
4548776|NCT01196026|7375455|FG004|Overall Study|Withdrawal by Subject|0
4548777|NCT01196026|7375456|FG005|Overall Study|Withdrawal by Subject|0
4548778|NCT01196026|7375451|FG000|Overall Study|Lost to Follow-up|0
4548779|NCT01196026|7375452|FG001|Overall Study|Lost to Follow-up|3
4548780|NCT01196026|7375453|FG002|Overall Study|Lost to Follow-up|0
4548781|NCT01196026|7375454|FG003|Overall Study|Lost to Follow-up|0
4548782|NCT01196026|7375455|FG004|Overall Study|Lost to Follow-up|1
4548783|NCT01196026|7375456|FG005|Overall Study|Lost to Follow-up|0
4548784|NCT01196026|7375451|FG000|Overall Study|Other|0
4548785|NCT01196026|7375452|FG001|Overall Study|Other|1
4548786|NCT01196026|7375453|FG002|Overall Study|Other|0
4548787|NCT01196026|7375454|FG003|Overall Study|Other|0
4548788|NCT01196026|7375455|FG004|Overall Study|Other|0
4548789|NCT01196026|7375456|FG005|Overall Study|Other|0
4548790|NCT01196052|7375472|FG000|Overall Study|Adverse Event|9
4548791|NCT01196052|7375472|FG000|Overall Study|Lost to Follow-up|1
4548792|NCT01196052|7375472|FG000|Overall Study|Noncompliance to Protocol Requirements|2
4548793|NCT01196052|7375472|FG000|Overall Study|Reason not Specified|5
4548794|NCT01196052|7375472|FG000|Overall Study|Withdrawal by Subject|6
4548795|NCT01196078|7375478|FG000|Overall Study|Withdrawal by Subject|3
4548796|NCT01196078|7375479|FG001|Overall Study|Withdrawal by Subject|5
4548797|NCT01196078|7375478|FG000|Overall Study|Adverse Event|4
4548798|NCT01196078|7375479|FG001|Overall Study|Adverse Event|4
4548799|NCT01196078|7375478|FG000|Overall Study|Protocol Violation|2
4548800|NCT01196078|7375479|FG001|Overall Study|Protocol Violation|1
4548801|NCT01196078|7375478|FG000|Overall Study|Lack of Efficacy|17
4548802|NCT01196078|7375479|FG001|Overall Study|Lack of Efficacy|23
4548803|NCT01196078|7375478|FG000|Overall Study|Lost to Follow-up|1
4548804|NCT01196078|7375479|FG001|Overall Study|Lost to Follow-up|0
4548805|NCT01196078|7375478|FG000|Overall Study|Death|6
4548806|NCT01196078|7375479|FG001|Overall Study|Death|4
4548807|NCT01196091|7375488|FG000|Overall Study|Adverse Event|22
4548808|NCT01196091|7375489|FG001|Overall Study|Adverse Event|27
4548809|NCT01196091|7375490|FG002|Overall Study|Adverse Event|26
4548810|NCT01196091|7375488|FG000|Overall Study|Death|3
4548811|NCT01196091|7375489|FG001|Overall Study|Death|2
4548812|NCT01196091|7375490|FG002|Overall Study|Death|2
4548813|NCT01196091|7375488|FG000|Overall Study|Entry Criteria Not Met|11
4548814|NCT01196091|7375489|FG001|Overall Study|Entry Criteria Not Met|11
4548815|NCT01196091|7375490|FG002|Overall Study|Entry Criteria Not Met|10
4548816|NCT01196091|7375488|FG000|Overall Study|Lack of Efficacy|15
4548817|NCT01196091|7375489|FG001|Overall Study|Lack of Efficacy|12
4548818|NCT01196091|7375490|FG002|Overall Study|Lack of Efficacy|17
4548819|NCT01196091|7375488|FG000|Overall Study|Lost to Follow-up|5
4548820|NCT01196091|7375489|FG001|Overall Study|Lost to Follow-up|5
4548821|NCT01196091|7375490|FG002|Overall Study|Lost to Follow-up|6
4548822|NCT01196091|7375488|FG000|Overall Study|Parent/Caregiver Decision|0
4548823|NCT01196091|7375489|FG001|Overall Study|Parent/Caregiver Decision|0
4548824|NCT01196091|7375490|FG002|Overall Study|Parent/Caregiver Decision|1
4548825|NCT01196091|7375488|FG000|Overall Study|Withdrawal by Subject|16
4548826|NCT01196091|7375489|FG001|Overall Study|Withdrawal by Subject|19
4548827|NCT01196091|7375490|FG002|Overall Study|Withdrawal by Subject|22
4548828|NCT01196091|7375488|FG000|Overall Study|Physician Decision|3
4548829|NCT01196091|7375489|FG001|Overall Study|Physician Decision|3
4548830|NCT01196091|7375490|FG002|Overall Study|Physician Decision|4
4548831|NCT01196091|7375488|FG000|Overall Study|Protocol Violation|1
4548832|NCT01196091|7375489|FG001|Overall Study|Protocol Violation|3
4548833|NCT01196091|7375490|FG002|Overall Study|Protocol Violation|3
4548834|NCT01196091|7375488|FG000|Overall Study|Sponsor Decision|6
4548835|NCT01196091|7375489|FG001|Overall Study|Sponsor Decision|5
4548836|NCT01196091|7375490|FG002|Overall Study|Sponsor Decision|4
4548837|NCT01196091|7375488|FG000|Overall Study|Excluded Site|5
4548838|NCT01196091|7375489|FG001|Overall Study|Excluded Site|11
4548839|NCT01196091|7375490|FG002|Overall Study|Excluded Site|8
4548840|NCT01196091|7375488|FG000|Overall Study|Randomized, No Study Drug Received|1
4548841|NCT01196091|7375489|FG001|Overall Study|Randomized, No Study Drug Received|0
4548842|NCT01196091|7375490|FG002|Overall Study|Randomized, No Study Drug Received|1
4548843|NCT01196104|7375505|FG000|Overall Study|Lost to Follow-up|1
4548844|NCT01196104|7375506|FG001|Overall Study|Lost to Follow-up|0
4548845|NCT01196104|7375505|FG000|Overall Study|Physician Decision|0
4548846|NCT01196104|7375506|FG001|Overall Study|Physician Decision|1
4548847|NCT01196104|7375505|FG000|Overall Study|Withdrawal by Subject|3
4548848|NCT01196104|7375506|FG001|Overall Study|Withdrawal by Subject|3
4548849|NCT01196104|7375505|FG000|Overall Study|Various|0
4548850|NCT01196104|7375506|FG001|Overall Study|Various|1
4548851|NCT01196416|7375542|FG000|Overall Study|Withdrawal by Subject|2
4548852|NCT01196429|7375548|FG000|Overall Study|Ineligible - inadequate pathology|1
4548853|NCT01196429|7375549|FG001|Overall Study|Ineligible - inadequate pathology|0
4548854|NCT01196429|7375548|FG000|Overall Study|Ineligible - wrong cell type|1
4548855|NCT01196429|7375549|FG001|Overall Study|Ineligible - wrong cell type|0
4548856|NCT01196429|7375548|FG000|Overall Study|Refused - Never Treated|1
4548857|NCT01196429|7375549|FG001|Overall Study|Refused - Never Treated|0
4548858|NCT01196741|7375568|FG000|Overall Study|Disease progression|34
4548859|NCT01196741|7375569|FG001|Overall Study|Disease progression|14
4548860|NCT01196741|7375568|FG000|Overall Study|Adverse Event|10
4548861|NCT01196741|7375569|FG001|Overall Study|Adverse Event|6
4548862|NCT01196741|7375568|FG000|Overall Study|Serious Adverse Event|3
4548863|NCT01196741|7375569|FG001|Overall Study|Serious Adverse Event|1
4548864|NCT01196741|7375568|FG000|Overall Study|Dose limiting Adverse Event|2
4548865|NCT01196741|7375569|FG001|Overall Study|Dose limiting Adverse Event|1
4548866|NCT01196741|7375568|FG000|Overall Study|Withdrawal by Subject|3
4548867|NCT01196741|7375569|FG001|Overall Study|Withdrawal by Subject|0
4548868|NCT01196741|7375568|FG000|Overall Study|Other reason|3
4548869|NCT01196741|7375569|FG001|Overall Study|Other reason|3
4548870|NCT01196741|7375568|FG000|Overall Study|Other|3
4548871|NCT01196741|7375569|FG001|Overall Study|Other|2
4548872|NCT01196741|7375568|FG000|Overall Study|Protocol Violation|2
4548873|NCT01196741|7375569|FG001|Overall Study|Protocol Violation|1
4548874|NCT01196975|7375631|FG000|Overall Study|Adverse Event|2
4548875|NCT01196975|7375632|FG001|Overall Study|Adverse Event|2
4548876|NCT01196975|7375633|FG002|Overall Study|Adverse Event|0
4548877|NCT01196975|7375634|FG003|Overall Study|Adverse Event|0
4548878|NCT01196975|7375635|FG004|Overall Study|Adverse Event|2
4548879|NCT01196975|7375631|FG000|Overall Study|Withdrawal by Subject|2
4548880|NCT01196975|7375632|FG001|Overall Study|Withdrawal by Subject|1
4548881|NCT01196975|7375633|FG002|Overall Study|Withdrawal by Subject|0
4548882|NCT01196975|7375634|FG003|Overall Study|Withdrawal by Subject|1
4548883|NCT01196975|7375635|FG004|Overall Study|Withdrawal by Subject|0
4548884|NCT01196975|7375631|FG000|Overall Study|Lost to Follow-up|11
4548885|NCT01196975|7375632|FG001|Overall Study|Lost to Follow-up|6
4548886|NCT01196975|7375633|FG002|Overall Study|Lost to Follow-up|5
4548887|NCT01196975|7375634|FG003|Overall Study|Lost to Follow-up|5
4548888|NCT01196975|7375635|FG004|Overall Study|Lost to Follow-up|11
4548889|NCT01196988|7375674|FG000|Overall Study|Adverse Event|1
4548890|NCT01196988|7375675|FG001|Overall Study|Adverse Event|2
4548891|NCT01196988|7375676|FG002|Overall Study|Adverse Event|0
4548892|NCT01196988|7375677|FG003|Overall Study|Adverse Event|0
4548893|NCT01196988|7375674|FG000|Overall Study|Withdrawal by Subject|5
4548894|NCT01196988|7375675|FG001|Overall Study|Withdrawal by Subject|1
4548895|NCT01196988|7375676|FG002|Overall Study|Withdrawal by Subject|4
4548896|NCT01196988|7375677|FG003|Overall Study|Withdrawal by Subject|0
4548897|NCT01196988|7375674|FG000|Overall Study|Lost to Follow-up|16
4548898|NCT01196988|7375675|FG001|Overall Study|Lost to Follow-up|29
4548899|NCT01196988|7375676|FG002|Overall Study|Lost to Follow-up|21
4548900|NCT01196988|7375677|FG003|Overall Study|Lost to Follow-up|1
4548901|NCT01196988|7375674|FG000|Overall Study|Other|2
4548902|NCT01196988|7375675|FG001|Overall Study|Other|0
4548903|NCT01196988|7375676|FG002|Overall Study|Other|0
4548904|NCT01196988|7375677|FG003|Overall Study|Other|0
4548905|NCT01197300|7375690|FG000|Overall Study|Lost to Follow-up|0
4548906|NCT01197300|7375691|FG001|Overall Study|Lost to Follow-up|1
4548907|NCT01197300|7375690|FG000|Overall Study|Protocol Violation|0
4548908|NCT01197300|7375691|FG001|Overall Study|Protocol Violation|1
4619624|NCT01777139|7481288|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6
4619625|NCT01777139|7481289|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0
4619626|NCT01777139|7481288|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8
4619627|NCT01777139|7481289|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0
4619628|NCT01777139|7481288|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3
4619629|NCT01777139|7481289|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0
4619630|NCT01777139|7481288|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2
4619631|NCT01777139|7481289|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0
4619632|NCT01777139|7481288|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4
4619633|NCT01777139|7481289|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0
4619634|NCT01777139|7481288|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0
4619635|NCT01777139|7481289|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1
4619636|NCT01777139|7481288|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0
4619637|NCT01777139|7481289|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3
4619638|NCT01777152|7481298|FG000|Overall Study|Withdrawal by Subject|22
4619639|NCT01777152|7481299|FG001|Overall Study|Withdrawal by Subject|16
4619640|NCT01777152|7481298|FG000|Overall Study|Lost to Follow-up|3
4619641|NCT01777152|7481299|FG001|Overall Study|Lost to Follow-up|5
4619642|NCT01777152|7481298|FG000|Overall Study|Death|68
4619643|NCT01777152|7481299|FG001|Overall Study|Death|89
4548909|NCT01197378|7375708|FG000|Overall Study|Adverse Event|3
4548910|NCT01197378|7375708|FG000|Overall Study|Withdrawal by Subject|1
4548911|NCT01197378|7375708|FG000|Overall Study|Physician Decision|1
4548912|NCT01197378|7375708|FG000|Overall Study|Other|2
4548913|NCT01197417|7375714|FG000|Overall Study|Physician Decision|3
4548914|NCT01197417|7375715|FG001|Overall Study|Physician Decision|2
4548915|NCT01197417|7375714|FG000|Overall Study|Withdrawal by Subject|2
4548916|NCT01197417|7375715|FG001|Overall Study|Withdrawal by Subject|4
4548917|NCT01197417|7375714|FG000|Overall Study|Site miscommunication|0
4548918|NCT01197417|7375715|FG001|Overall Study|Site miscommunication|1
4548919|NCT01197417|7375714|FG000|Overall Study|Subject transferred to intensive care|0
4548920|NCT01197417|7375715|FG001|Overall Study|Subject transferred to intensive care|1
4548921|NCT01197417|7375714|FG000|Overall Study|Not consented in time to receive drug|0
4548922|NCT01197417|7375715|FG001|Overall Study|Not consented in time to receive drug|1
4548923|NCT01197417|7375714|FG000|Overall Study|Hypotension|1
4548924|NCT01197417|7375715|FG001|Overall Study|Hypotension|2
4548925|NCT01197417|7375714|FG000|Overall Study|Found to be ineligible|2
4548926|NCT01197417|7375715|FG001|Overall Study|Found to be ineligible|5
4548927|NCT01197417|7375714|FG000|Overall Study|No 25-hour magnesium level|0
4548928|NCT01197417|7375715|FG001|Overall Study|No 25-hour magnesium level|2
4548929|NCT01197508|7375743|FG000|Overall Study|Withdrawal by Subject|8
4548930|NCT01197508|7375744|FG001|Overall Study|Withdrawal by Subject|7
4548931|NCT01197508|7375745|FG002|Overall Study|Withdrawal by Subject|15
4548932|NCT01197508|7375746|FG003|Overall Study|Withdrawal by Subject|4
4548933|NCT01197508|7375743|FG000|Overall Study|Eligiblity criteria not fulfilled|0
4548934|NCT01197508|7375744|FG001|Overall Study|Eligiblity criteria not fulfilled|0
4548935|NCT01197508|7375745|FG002|Overall Study|Eligiblity criteria not fulfilled|2
4548936|NCT01197508|7375746|FG003|Overall Study|Eligiblity criteria not fulfilled|0
4548937|NCT01197508|7375743|FG000|Overall Study|Adverse Event|10
4548938|NCT01197508|7375744|FG001|Overall Study|Adverse Event|13
4548939|NCT01197508|7375745|FG002|Overall Study|Adverse Event|23
4548940|NCT01197508|7375746|FG003|Overall Study|Adverse Event|3
4548941|NCT01197508|7375743|FG000|Overall Study|Severe non-compliance to protocol|0
4548942|NCT01197508|7375744|FG001|Overall Study|Severe non-compliance to protocol|3
4548943|NCT01197508|7375745|FG002|Overall Study|Severe non-compliance to protocol|1
4548944|NCT01197508|7375746|FG003|Overall Study|Severe non-compliance to protocol|3
4548945|NCT01197508|7375743|FG000|Overall Study|Condition under investigation worsened|1
4548946|NCT01197508|7375744|FG001|Overall Study|Condition under investigation worsened|1
4548947|NCT01197508|7375745|FG002|Overall Study|Condition under investigation worsened|1
4548948|NCT01197508|7375746|FG003|Overall Study|Condition under investigation worsened|1
4548949|NCT01197508|7375743|FG000|Overall Study|Lack of Efficacy|1
4548950|NCT01197508|7375744|FG001|Overall Study|Lack of Efficacy|2
4548951|NCT01197508|7375745|FG002|Overall Study|Lack of Efficacy|2
4548952|NCT01197508|7375746|FG003|Overall Study|Lack of Efficacy|1
4548953|NCT01197508|7375743|FG000|Overall Study|Study-specific withdrawal criteria|0
4548954|NCT01197508|7375744|FG001|Overall Study|Study-specific withdrawal criteria|0
4548955|NCT01197508|7375745|FG002|Overall Study|Study-specific withdrawal criteria|1
4548956|NCT01197508|7375746|FG003|Overall Study|Study-specific withdrawal criteria|2
4548957|NCT01197508|7375743|FG000|Overall Study|Lost to Follow-up|1
4548958|NCT01197508|7375744|FG001|Overall Study|Lost to Follow-up|1
4548959|NCT01197508|7375745|FG002|Overall Study|Lost to Follow-up|2
4619644|NCT01777152|7481298|FG000|Overall Study|Not eligible, no study drug received|1
4619645|NCT01777152|7481299|FG001|Overall Study|Not eligible, no study drug received|0
4548960|NCT01197508|7375746|FG003|Overall Study|Lost to Follow-up|0
4548961|NCT01197508|7375743|FG000|Overall Study|Other|2
4548962|NCT01197508|7375744|FG001|Overall Study|Other|3
4548963|NCT01197508|7375745|FG002|Overall Study|Other|2
4548964|NCT01197508|7375746|FG003|Overall Study|Other|2
4548965|NCT01197521|7375759|FG000|Overall Study|Not reported|24
4548966|NCT01197521|7375760|FG001|Overall Study|Not reported|25
4548967|NCT01197521|7375761|FG002|Overall Study|Not reported|21
4548968|NCT01197521|7375759|FG000|Overall Study|Enrolment in long term extension|42
4548969|NCT01197521|7375760|FG001|Overall Study|Enrolment in long term extension|36
4548970|NCT01197521|7375761|FG002|Overall Study|Enrolment in long term extension|87
4548971|NCT01197521|7375759|FG000|Overall Study|Severe non-compliance to protocol|1
4548972|NCT01197521|7375760|FG001|Overall Study|Severe non-compliance to protocol|3
4548973|NCT01197521|7375761|FG002|Overall Study|Severe non-compliance to protocol|3
4548974|NCT01197521|7375759|FG000|Overall Study|Lack of therapeutic response|2
4548975|NCT01197521|7375760|FG001|Overall Study|Lack of therapeutic response|3
4548976|NCT01197521|7375761|FG002|Overall Study|Lack of therapeutic response|4
4548977|NCT01197521|7375759|FG000|Overall Study|Dev. of study specific discont. criteria|6
4548978|NCT01197521|7375760|FG001|Overall Study|Dev. of study specific discont. criteria|16
4548979|NCT01197521|7375761|FG002|Overall Study|Dev. of study specific discont. criteria|2
4548980|NCT01197521|7375759|FG000|Overall Study|Lost to Follow-up|3
4548981|NCT01197521|7375760|FG001|Overall Study|Lost to Follow-up|2
4548982|NCT01197521|7375761|FG002|Overall Study|Lost to Follow-up|2
4548983|NCT01197521|7375759|FG000|Overall Study|Adverse Event|25
4548984|NCT01197521|7375760|FG001|Overall Study|Adverse Event|28
4548985|NCT01197521|7375761|FG002|Overall Study|Adverse Event|24
4548986|NCT01197534|7375775|FG000|Overall Study|Not reported|16
4548987|NCT01197534|7375776|FG001|Overall Study|Not reported|10
4619646|NCT01777152|7481298|FG000|Overall Study|Change of diagnosis|1
4619647|NCT01777152|7481299|FG001|Overall Study|Change of diagnosis|0
4619648|NCT01777191|7481308|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2
4619649|NCT01777191|7481309|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1
4619650|NCT01777191|7481308|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1
4619651|NCT01777191|7481309|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1
4619652|NCT01777191|7481308|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1
4619653|NCT01777191|7481309|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2
4619654|NCT01777191|7481308|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0
4619655|NCT01777191|7481309|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3
4619656|NCT01777191|7481308|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1
4619657|NCT01777191|7481309|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1
4619658|NCT01777191|7481308|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1
4619659|NCT01777191|7481309|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0
4619660|NCT01777191|7481308|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3
4619661|NCT01777191|7481309|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3
4619662|NCT01777191|7481308|FG000|Safety Extension Per (Week 12-Week 48)|Death|0
4619663|NCT01777191|7481309|FG001|Safety Extension Per (Week 12-Week 48)|Death|1
4619664|NCT01777191|7481308|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4
4619665|NCT01777191|7481309|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4
4619666|NCT01777191|7481308|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1
4619667|NCT01777191|7481309|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2
4619668|NCT01777191|7481308|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1
4619669|NCT01777191|7481309|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3
4619670|NCT01777269|7481329|FG000|Overall Study|Adverse Event|24
4619671|NCT01777269|7481330|FG001|Overall Study|Adverse Event|33
4619672|NCT01777269|7481329|FG000|Overall Study|Lack of Efficacy|8
4619673|NCT01777269|7481330|FG001|Overall Study|Lack of Efficacy|10
4619674|NCT01777269|7481329|FG000|Overall Study|Protocol Violation|4
4619675|NCT01777269|7481330|FG001|Overall Study|Protocol Violation|4
4619676|NCT01777269|7481329|FG000|Overall Study|Participants reached stopping criteria|1
4619677|NCT01777269|7481330|FG001|Overall Study|Participants reached stopping criteria|1
4619678|NCT01777269|7481329|FG000|Overall Study|Lost to Follow-up|4
4619679|NCT01777269|7481330|FG001|Overall Study|Lost to Follow-up|0
4619680|NCT01777269|7481329|FG000|Overall Study|Physician Decision|5
4619681|NCT01777269|7481330|FG001|Overall Study|Physician Decision|2
4619682|NCT01777269|7481329|FG000|Overall Study|Withdrawal by Subject|9
4619683|NCT01777269|7481330|FG001|Overall Study|Withdrawal by Subject|9
4619684|NCT01777282|7481341|FG000|Overall Study|Persistent Hyperglycemia|0
4619685|NCT01777282|7481342|FG001|Overall Study|Persistent Hyperglycemia|0
4619686|NCT01777282|7481343|FG002|Overall Study|Persistent Hyperglycemia|1
4619687|NCT01777282|7481344|FG003|Overall Study|Persistent Hyperglycemia|0
4619688|NCT01777282|7481345|FG004|Overall Study|Persistent Hyperglycemia|0
4619689|NCT01777282|7481341|FG000|Overall Study|New Antidiabetic Medication|0
4619690|NCT01777282|7481342|FG001|Overall Study|New Antidiabetic Medication|0
4548988|NCT01197534|7375777|FG002|Overall Study|Not reported|16
4619691|NCT01777282|7481343|FG002|Overall Study|New Antidiabetic Medication|1
4548989|NCT01197534|7375775|FG000|Overall Study|Enrolment in long term extension|57
4548990|NCT01197534|7375776|FG001|Overall Study|Enrolment in long term extension|66
4548991|NCT01197534|7375777|FG002|Overall Study|Enrolment in long term extension|119
4548992|NCT01197534|7375775|FG000|Overall Study|Severe non-compliance to protocol|3
4548993|NCT01197534|7375776|FG001|Overall Study|Severe non-compliance to protocol|4
4548994|NCT01197534|7375777|FG002|Overall Study|Severe non-compliance to protocol|1
4548995|NCT01197534|7375775|FG000|Overall Study|Lack of therapeutic response|9
4548996|NCT01197534|7375776|FG001|Overall Study|Lack of therapeutic response|4
4548997|NCT01197534|7375777|FG002|Overall Study|Lack of therapeutic response|9
4548998|NCT01197534|7375775|FG000|Overall Study|Dev. of study specific discont. criteria|13
4548999|NCT01197534|7375776|FG001|Overall Study|Dev. of study specific discont. criteria|6
4549000|NCT01197534|7375777|FG002|Overall Study|Dev. of study specific discont. criteria|2
4549001|NCT01197534|7375775|FG000|Overall Study|Lost to Follow-up|1
4549002|NCT01197534|7375776|FG001|Overall Study|Lost to Follow-up|4
4549003|NCT01197534|7375777|FG002|Overall Study|Lost to Follow-up|2
4549004|NCT01197534|7375775|FG000|Overall Study|Adverse Event|35
4549005|NCT01197534|7375776|FG001|Overall Study|Adverse Event|36
4549006|NCT01197534|7375777|FG002|Overall Study|Adverse Event|24
4549007|NCT01197560|7375794|FG000|Overall Study|Adverse Event|6
4549008|NCT01197560|7375795|FG001|Overall Study|Adverse Event|8
4549009|NCT01197560|7375794|FG000|Overall Study|Death|3
4549010|NCT01197560|7375795|FG001|Overall Study|Death|5
4549011|NCT01197560|7375794|FG000|Overall Study|Withdrawal by Subject|1
4549012|NCT01197560|7375795|FG001|Overall Study|Withdrawal by Subject|1
4549013|NCT01197560|7375794|FG000|Overall Study|Disease progression|40
4549014|NCT01197560|7375795|FG001|Overall Study|Disease progression|35
4549015|NCT01197560|7375794|FG000|Overall Study|Miscellaneous|4
4549016|NCT01197560|7375795|FG001|Overall Study|Miscellaneous|3
4549017|NCT01197560|7375794|FG000|Overall Study|Missing|0
4549018|NCT01197560|7375795|FG001|Overall Study|Missing|1
4591617|NCT01532869|7438429|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1
4591618|NCT01532869|7438430|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0
4591619|NCT01532869|7438429|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1
4591620|NCT01532869|7438430|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1
4591621|NCT01532869|7438429|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4
4591622|NCT01532869|7438430|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2
4591623|NCT01532869|7438429|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0
4591624|NCT01532869|7438430|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3
4591625|NCT01532869|7438429|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4
4591626|NCT01532869|7438430|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5
4591627|NCT01532869|7438429|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0
4591628|NCT01532869|7438430|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1
4591629|NCT01532869|7438429|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1
4591630|NCT01532869|7438430|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0
4591631|NCT01532869|7438429|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0
4591632|NCT01532869|7438430|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1
4591633|NCT01532869|7438429|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5
4591634|NCT01532869|7438430|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3
4591635|NCT01532869|7438429|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1
4591636|NCT01532869|7438430|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0
4591637|NCT01532869|7438429|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4
4591638|NCT01532869|7438430|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1
4591639|NCT01532869|7438429|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1
4591640|NCT01532869|7438430|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0
4591641|NCT01532869|7438429|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1
4591642|NCT01532869|7438430|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1
4591643|NCT01532869|7438429|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1
4591644|NCT01532869|7438430|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1
4591645|NCT01532908|7438443|FG000|Overall Study|Not Transplanted|1
4591646|NCT01532908|7438444|FG001|Overall Study|Not Transplanted|0
4591647|NCT01532921|7438450|FG000|Overall Study|Death|3
4591648|NCT01532921|7438450|FG000|Overall Study|Withdrawal by Subject|2
4591649|NCT01532921|7438450|FG000|Overall Study|Lost to Follow-up|3
4591650|NCT01532921|7438450|FG000|Overall Study|Physician Decision|7
4591651|NCT01532921|7438450|FG000|Overall Study|Device was explanted during procedure|1
4591652|NCT01532934|7438460|FG000|Overall Study|Lost to Follow-up|11
4591653|NCT01532934|7438461|FG001|Overall Study|Lost to Follow-up|11
4591654|NCT01532934|7438460|FG000|Overall Study|In controlled environment|3
4591655|NCT01532934|7438461|FG001|Overall Study|In controlled environment|2
4591656|NCT01532986|7438513|FG000|Overall Study|Death|9
4591657|NCT01532986|7438514|FG001|Overall Study|Death|9
4591658|NCT01532986|7438513|FG000|Overall Study|Withdrawal by Subject|7
4591659|NCT01532986|7438514|FG001|Overall Study|Withdrawal by Subject|10
4591660|NCT01532986|7438513|FG000|Overall Study|Physician Decision|7
4591661|NCT01532986|7438514|FG001|Overall Study|Physician Decision|5
4591662|NCT01532999|7438523|FG000|Overall Study|Lost to Follow-up|14
4591663|NCT01532999|7438524|FG001|Overall Study|Lost to Follow-up|8
4549019|NCT01197755|7375829|FG000|Overall Study|Adverse Event|8
4549020|NCT01197755|7375830|FG001|Overall Study|Adverse Event|10
4549021|NCT01197755|7375831|FG002|Overall Study|Adverse Event|10
4549022|NCT01197755|7375829|FG000|Overall Study|Study-specific discontinuation criteria|2
4549023|NCT01197755|7375830|FG001|Overall Study|Study-specific discontinuation criteria|1
4549024|NCT01197755|7375831|FG002|Overall Study|Study-specific discontinuation criteria|0
4549025|NCT01197755|7375829|FG000|Overall Study|Entered the long-term extension study|18
4549026|NCT01197755|7375830|FG001|Overall Study|Entered the long-term extension study|21
4549027|NCT01197755|7375831|FG002|Overall Study|Entered the long-term extension study|35
4549028|NCT01197755|7375829|FG000|Overall Study|Lack of therapeutic response|0
4549029|NCT01197755|7375830|FG001|Overall Study|Lack of therapeutic response|7
4549030|NCT01197755|7375831|FG002|Overall Study|Lack of therapeutic response|4
4549031|NCT01197755|7375829|FG000|Overall Study|Severe non-compliance to the protocol|2
4549032|NCT01197755|7375830|FG001|Overall Study|Severe non-compliance to the protocol|1
4549033|NCT01197755|7375831|FG002|Overall Study|Severe non-compliance to the protocol|2
4549034|NCT01197755|7375829|FG000|Overall Study|Withdrawal by Subject|1
4549035|NCT01197755|7375830|FG001|Overall Study|Withdrawal by Subject|0
4549036|NCT01197755|7375831|FG002|Overall Study|Withdrawal by Subject|0
4549037|NCT01197755|7375829|FG000|Overall Study|Lost to Follow-up|0
4549038|NCT01197755|7375830|FG001|Overall Study|Lost to Follow-up|0
4619692|NCT01777282|7481344|FG003|Overall Study|New Antidiabetic Medication|0
4619693|NCT01777282|7481345|FG004|Overall Study|New Antidiabetic Medication|0
4619694|NCT01777282|7481341|FG000|Overall Study|Adverse Event|4
4619695|NCT01777282|7481342|FG001|Overall Study|Adverse Event|4
4619696|NCT01777282|7481343|FG002|Overall Study|Adverse Event|2
4619697|NCT01777282|7481344|FG003|Overall Study|Adverse Event|1
4619698|NCT01777282|7481345|FG004|Overall Study|Adverse Event|3
4619699|NCT01777282|7481341|FG000|Overall Study|Withdrawal by Subject|4
4619700|NCT01777282|7481342|FG001|Overall Study|Withdrawal by Subject|0
4619701|NCT01777282|7481343|FG002|Overall Study|Withdrawal by Subject|0
4619702|NCT01777282|7481344|FG003|Overall Study|Withdrawal by Subject|1
4619703|NCT01777282|7481345|FG004|Overall Study|Withdrawal by Subject|2
4619704|NCT01777282|7481341|FG000|Overall Study|Protocol Violation|2
4619705|NCT01777282|7481342|FG001|Overall Study|Protocol Violation|0
4619706|NCT01777282|7481343|FG002|Overall Study|Protocol Violation|1
4619707|NCT01777282|7481344|FG003|Overall Study|Protocol Violation|0
4619708|NCT01777282|7481345|FG004|Overall Study|Protocol Violation|2
4619709|NCT01777282|7481341|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1
4619710|NCT01777282|7481342|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0
4619711|NCT01777282|7481343|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1
4619712|NCT01777282|7481344|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0
4619713|NCT01777282|7481345|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0
4619714|NCT01777308|7481359|FG000|Overall Study|Withdrawal by Subject|5
4619715|NCT01777308|7481360|FG001|Overall Study|Withdrawal by Subject|1
4619716|NCT01777308|7481359|FG000|Overall Study|Migrated/moved from study area|1
4619717|NCT01777308|7481360|FG001|Overall Study|Migrated/moved from study area|0
4619718|NCT01777308|7481359|FG000|Overall Study|Lost to Follow-up|7
4619719|NCT01777308|7481360|FG001|Overall Study|Lost to Follow-up|2
4619720|NCT01777308|7481359|FG000|Overall Study|Blood draw refusal at Visit 3|1
4619721|NCT01777308|7481360|FG001|Overall Study|Blood draw refusal at Visit 3|0
4619722|NCT01777321|7481369|FG000|Overall Study|Withdrawal by Subject|0
4619723|NCT01777321|7481370|FG001|Overall Study|Withdrawal by Subject|1
4619724|NCT01777334|7481378|FG000|Overall Study|Adverse Event|18
4619725|NCT01777334|7481379|FG001|Overall Study|Adverse Event|14
4619726|NCT01777334|7481378|FG000|Overall Study|Lack of Efficacy|15
4619727|NCT01777334|7481379|FG001|Overall Study|Lack of Efficacy|29
4619728|NCT01777334|7481378|FG000|Overall Study|Protocol Violation|3
4619729|NCT01777334|7481379|FG001|Overall Study|Protocol Violation|7
4619730|NCT01777334|7481378|FG000|Overall Study|Lost to Follow-up|3
4619731|NCT01777334|7481379|FG001|Overall Study|Lost to Follow-up|2
4619732|NCT01777334|7481378|FG000|Overall Study|Withdrawal by Subject|14
4619733|NCT01777334|7481379|FG001|Overall Study|Withdrawal by Subject|11
4619734|NCT01777490|7481407|FG000|Overall Study|Dyad withdrew with data use prohibition|0
4619735|NCT01777490|7481408|FG001|Overall Study|Dyad withdrew with data use prohibition|0
4619736|NCT01777490|7481409|FG002|Overall Study|Dyad withdrew with data use prohibition|1
4619737|NCT01777490|7481410|FG003|Overall Study|Dyad withdrew with data use prohibition|1
4619738|NCT01777542|7481422|FG000|Second Intervention (20 Weeks)|Adverse Event|0
4619739|NCT01777542|7481423|FG001|Second Intervention (20 Weeks)|Adverse Event|1
4619740|NCT01777581|7481441|FG000|Overall Study|Lost to Follow-up|1
4619741|NCT01777581|7481442|FG001|Overall Study|Lost to Follow-up|1
4619742|NCT01777581|7481441|FG000|Overall Study|Adverse Event|2
4619743|NCT01777581|7481442|FG001|Overall Study|Adverse Event|0
4619744|NCT01777581|7481441|FG000|Overall Study|Lack of Efficacy|0
4619745|NCT01777581|7481442|FG001|Overall Study|Lack of Efficacy|1
4619746|NCT01777620|7481450|FG000|Overall Study|Subject Withdrawal|1
4619747|NCT01777620|7481451|FG001|Overall Study|Subject Withdrawal|0
4619748|NCT01777763|7481459|FG000|Overall Study|Adverse Event|2
4619749|NCT01777763|7481460|FG001|Overall Study|Adverse Event|32
4619750|NCT01777763|7481459|FG000|Overall Study|Protocol Violation|1
4690599|NCT02561455|7600283|FG002|Overall Study|Disease Progression|0
4619751|NCT01777763|7481460|FG001|Overall Study|Protocol Violation|7
4619752|NCT01777763|7481459|FG000|Overall Study|Withdrawal by Subject|0
4619753|NCT01777763|7481460|FG001|Overall Study|Withdrawal by Subject|2
4619754|NCT01777763|7481459|FG000|Overall Study|Treatment Failure|1
4619755|NCT01777763|7481460|FG001|Overall Study|Treatment Failure|6
4619756|NCT01777776|7481470|FG000|Overall Study|Adverse Event|2
4549039|NCT01197755|7375831|FG002|Overall Study|Lost to Follow-up|1
4549040|NCT01197755|7375829|FG000|Overall Study|eg, change in circumstances|7
4549041|NCT01197755|7375830|FG001|Overall Study|eg, change in circumstances|3
4549042|NCT01197755|7375831|FG002|Overall Study|eg, change in circumstances|2
4549043|NCT01197794|7375848|FG000|Overall Study|Adverse Event|3
4549044|NCT01197794|7375849|FG001|Overall Study|Adverse Event|2
4549045|NCT01197794|7375850|FG002|Overall Study|Adverse Event|4
4549046|NCT01197794|7375851|FG003|Overall Study|Adverse Event|4
4549047|NCT01197794|7375852|FG004|Overall Study|Adverse Event|4
4549048|NCT01197794|7375853|FG005|Overall Study|Adverse Event|2
4549049|NCT01197794|7375854|FG006|Overall Study|Adverse Event|3
4549050|NCT01197794|7375848|FG000|Overall Study|Protocol Violation|0
4549051|NCT01197794|7375849|FG001|Overall Study|Protocol Violation|0
4549052|NCT01197794|7375850|FG002|Overall Study|Protocol Violation|0
4549053|NCT01197794|7375851|FG003|Overall Study|Protocol Violation|0
4549054|NCT01197794|7375852|FG004|Overall Study|Protocol Violation|2
4549055|NCT01197794|7375853|FG005|Overall Study|Protocol Violation|0
4549056|NCT01197794|7375854|FG006|Overall Study|Protocol Violation|1
4549057|NCT01197794|7375848|FG000|Overall Study|Development of study withdrawal criteria|3
4549058|NCT01197794|7375849|FG001|Overall Study|Development of study withdrawal criteria|0
4549059|NCT01197794|7375850|FG002|Overall Study|Development of study withdrawal criteria|0
4549060|NCT01197794|7375851|FG003|Overall Study|Development of study withdrawal criteria|1
4549061|NCT01197794|7375852|FG004|Overall Study|Development of study withdrawal criteria|0
4549062|NCT01197794|7375853|FG005|Overall Study|Development of study withdrawal criteria|0
4549063|NCT01197794|7375854|FG006|Overall Study|Development of study withdrawal criteria|1
4549064|NCT01197794|7375848|FG000|Overall Study|Eligibility criteria not fulfilled|5
4549065|NCT01197794|7375849|FG001|Overall Study|Eligibility criteria not fulfilled|8
4549066|NCT01197794|7375850|FG002|Overall Study|Eligibility criteria not fulfilled|2
4549067|NCT01197794|7375851|FG003|Overall Study|Eligibility criteria not fulfilled|5
4549068|NCT01197794|7375852|FG004|Overall Study|Eligibility criteria not fulfilled|5
4549069|NCT01197794|7375853|FG005|Overall Study|Eligibility criteria not fulfilled|9
4549070|NCT01197794|7375854|FG006|Overall Study|Eligibility criteria not fulfilled|6
4549071|NCT01197794|7375848|FG000|Overall Study|Withdrawal by Subject|3
4549072|NCT01197794|7375849|FG001|Overall Study|Withdrawal by Subject|3
4549073|NCT01197794|7375850|FG002|Overall Study|Withdrawal by Subject|4
4549074|NCT01197794|7375851|FG003|Overall Study|Withdrawal by Subject|1
4549075|NCT01197794|7375852|FG004|Overall Study|Withdrawal by Subject|1
4549076|NCT01197794|7375853|FG005|Overall Study|Withdrawal by Subject|5
4549077|NCT01197794|7375854|FG006|Overall Study|Withdrawal by Subject|6
4549078|NCT01197794|7375848|FG000|Overall Study|Lost to Follow-up|1
4549079|NCT01197794|7375849|FG001|Overall Study|Lost to Follow-up|1
4549080|NCT01197794|7375850|FG002|Overall Study|Lost to Follow-up|0
4549081|NCT01197794|7375851|FG003|Overall Study|Lost to Follow-up|1
4549082|NCT01197794|7375852|FG004|Overall Study|Lost to Follow-up|0
4549083|NCT01197794|7375853|FG005|Overall Study|Lost to Follow-up|1
4549084|NCT01197794|7375854|FG006|Overall Study|Lost to Follow-up|0
4549085|NCT01197794|7375848|FG000|Overall Study|Other|1
4549086|NCT01197794|7375849|FG001|Overall Study|Other|1
4549087|NCT01197794|7375850|FG002|Overall Study|Other|3
4549088|NCT01197794|7375851|FG003|Overall Study|Other|0
4549089|NCT01197794|7375852|FG004|Overall Study|Other|2
4549090|NCT01197794|7375853|FG005|Overall Study|Other|2
4549091|NCT01197794|7375854|FG006|Overall Study|Other|4
4549092|NCT01197911|7375896|FG000|Overall Study|Adverse Event|0
4549093|NCT01197911|7375897|FG001|Overall Study|Adverse Event|0
4549094|NCT01197911|7375898|FG002|Overall Study|Adverse Event|1
4549095|NCT01198002|7375910|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18
4549096|NCT01198002|7375911|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11
4549097|NCT01198002|7375912|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11
4549098|NCT01198002|7375910|FG000|Treatment Period 1 (Weeks 0-52)|Death|2
4549099|NCT01198002|7375911|FG001|Treatment Period 1 (Weeks 0-52)|Death|0
4549100|NCT01198002|7375912|FG002|Treatment Period 1 (Weeks 0-52)|Death|1
4549101|NCT01198002|7375910|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10
4549102|NCT01198002|7375911|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9
4549103|NCT01198002|7375912|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6
4549104|NCT01198002|7375910|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1
4549105|NCT01198002|7375911|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3
4549106|NCT01198002|7375912|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3
4549107|NCT01198002|7375910|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0
4549108|NCT01198002|7375911|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2
4549109|NCT01198002|7375912|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0
4549110|NCT01198002|7375910|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16
4549111|NCT01198002|7375911|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21
4549112|NCT01198002|7375912|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12
4619757|NCT01777776|7481471|FG001|Overall Study|Adverse Event|4
4549113|NCT01198002|7375910|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1
4549114|NCT01198002|7375911|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2
4549115|NCT01198002|7375912|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2
4549116|NCT01198002|7375910|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14
4549117|NCT01198002|7375911|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10
4549118|NCT01198002|7375912|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10
4549119|NCT01198002|7375910|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213
4549120|NCT01198002|7375911|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216
4549121|NCT01198002|7375912|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224
4549122|NCT01198002|7375910|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2
4549123|NCT01198002|7375911|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0
4549124|NCT01198002|7375912|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1
4549125|NCT01198002|7375910|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3
4549126|NCT01198002|7375911|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1
4549127|NCT01198002|7375912|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1
4549128|NCT01198002|7375910|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1
4549129|NCT01198002|7375911|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0
4549130|NCT01198002|7375912|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0
4549131|NCT01198002|7375910|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0
4549132|NCT01198002|7375911|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2
4591664|NCT01532999|7438523|FG000|Overall Study|Physician Decision|1
4619758|NCT01777776|7481472|FG002|Overall Study|Adverse Event|0
4619759|NCT01777776|7481473|FG003|Overall Study|Adverse Event|0
4619760|NCT01777776|7481470|FG000|Overall Study|Disease Progression|4
4619761|NCT01777776|7481471|FG001|Overall Study|Disease Progression|8
4619762|NCT01777776|7481472|FG002|Overall Study|Disease Progression|6
4619763|NCT01777776|7481473|FG003|Overall Study|Disease Progression|3
4619764|NCT01777776|7481470|FG000|Overall Study|Withdrawal by Subject|0
4619765|NCT01777776|7481471|FG001|Overall Study|Withdrawal by Subject|0
4619766|NCT01777776|7481472|FG002|Overall Study|Withdrawal by Subject|0
4619767|NCT01777776|7481473|FG003|Overall Study|Withdrawal by Subject|1
4619768|NCT01777932|7481492|FG000|Overall Study|Disease progression|136
4619769|NCT01777932|7481492|FG000|Overall Study|Death|3
4619770|NCT01777932|7481492|FG000|Overall Study|Adverse Event|34
4619771|NCT01777932|7481492|FG000|Overall Study|Lost to Follow-up|3
4619772|NCT01777932|7481492|FG000|Overall Study|Investigator decision|10
4619773|NCT01777932|7481492|FG000|Overall Study|Reimbursement limit|9
4619774|NCT01777932|7481492|FG000|Overall Study|Patient refused further treatment|10
4619775|NCT01777997|7481500|FG000|12 Week lead-in of no ART|Severe debilitation|2
4619776|NCT01777997|7481500|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1
4619777|NCT01777997|7481500|FG000|Weeks 48 to 72/96 on ART|Death|1
4619778|NCT01777997|7481500|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1
4619779|NCT01778010|7481504|FG000|Overall Study|Withdrawal by Subject|2
4619780|NCT01778010|7481504|FG000|Overall Study|abnormal ECG before meds|1
4619781|NCT01778010|7481504|FG000|Overall Study|Arrested|1
4619782|NCT01778010|7481504|FG000|Overall Study|rash while on placebo|1
4619783|NCT01778023|7481523|FG000|Overall Study|Withdrawal by Subject|0
4619784|NCT01778023|7481524|FG001|Overall Study|Withdrawal by Subject|3
4619785|NCT01778049|7481532|FG000|Open Label Treatment Period|Adverse Event|5
4619786|NCT01778049|7481533|FG001|Open Label Treatment Period|Adverse Event|15
4619787|NCT01778049|7481534|FG002|Open Label Treatment Period|Adverse Event|0
4619788|NCT01778049|7481535|FG003|Open Label Treatment Period|Adverse Event|0
4619789|NCT01778049|7481536|FG004|Open Label Treatment Period|Adverse Event|0
4619790|NCT01778049|7481537|FG005|Open Label Treatment Period|Adverse Event|0
4619791|NCT01778049|7481532|FG000|Open Label Treatment Period|Lack of Efficacy|1
4619792|NCT01778049|7481533|FG001|Open Label Treatment Period|Lack of Efficacy|1
4619793|NCT01778049|7481534|FG002|Open Label Treatment Period|Lack of Efficacy|0
4619794|NCT01778049|7481535|FG003|Open Label Treatment Period|Lack of Efficacy|0
4619795|NCT01778049|7481536|FG004|Open Label Treatment Period|Lack of Efficacy|0
4619796|NCT01778049|7481537|FG005|Open Label Treatment Period|Lack of Efficacy|0
4690600|NCT02561455|7600284|FG003|Overall Study|Disease Progression|0
4690601|NCT02561572|7600308|FG000|Overall Study|Inadequate time before surgery|2
4690602|NCT02561572|7600309|FG001|Overall Study|Inadequate time before surgery|1
4690603|NCT02561572|7600308|FG000|Overall Study|Protocol Violation|0
4690604|NCT02561572|7600309|FG001|Overall Study|Protocol Violation|1
4690605|NCT02561806|7600337|FG000|Induction Period|Adverse Event|0
4690606|NCT02561806|7600338|FG001|Induction Period|Adverse Event|2
4690607|NCT02561806|7600337|FG000|Induction Period|Lack of Efficacy|1
4690608|NCT02561806|7600338|FG001|Induction Period|Lack of Efficacy|0
4690609|NCT02561806|7600337|FG000|Induction Period|Withdrawal by Subject|0
4690610|NCT02561806|7600338|FG001|Induction Period|Withdrawal by Subject|2
4690611|NCT02561806|7600337|FG000|Induction Period|Site staff became unblinded|1
4690612|NCT02561806|7600338|FG001|Induction Period|Site staff became unblinded|0
4690613|NCT02561806|7600337|FG000|Induction Period|Randomized but not treated|0
4690614|NCT02561806|7600338|FG001|Induction Period|Randomized but not treated|1
4690615|NCT02561806|7600337|FG000|Maintenance Period|Adverse Event|2
4619797|NCT01778049|7481532|FG000|Open Label Treatment Period|Protocol Violation|5
4619798|NCT01778049|7481533|FG001|Open Label Treatment Period|Protocol Violation|5
4549133|NCT01198002|7375912|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0
4549134|NCT01198002|7375910|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1
4549135|NCT01198002|7375911|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0
4549136|NCT01198002|7375912|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1
4549137|NCT01198002|7375910|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62
4549138|NCT01198002|7375911|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70
4549139|NCT01198002|7375912|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75
4549140|NCT01198028|7375942|FG000|Overall Study|Adverse Event|5
4549141|NCT01198028|7375942|FG000|Overall Study|Death|3
4549142|NCT01198028|7375942|FG000|Overall Study|Physician Decision|2
4549143|NCT01198132|7375948|FG000|Overall Study|Withdrawal by Subject|4
4549144|NCT01198132|7375949|FG001|Overall Study|Withdrawal by Subject|5
4549145|NCT01198132|7375948|FG000|Overall Study|Physician Decision|5
4549146|NCT01198132|7375949|FG001|Overall Study|Physician Decision|4
4549147|NCT01198132|7375948|FG000|Overall Study|Other Unspecified|3
4549148|NCT01198132|7375949|FG001|Overall Study|Other Unspecified|6
4549149|NCT01198132|7375948|FG000|Overall Study|Lack of Efficacy|2
4549150|NCT01198132|7375949|FG001|Overall Study|Lack of Efficacy|3
4549151|NCT01198132|7375948|FG000|Overall Study|Sign/symptoms of underlying disease|2
4549152|NCT01198132|7375949|FG001|Overall Study|Sign/symptoms of underlying disease|1
4549153|NCT01198132|7375948|FG000|Overall Study|Abnormal/clinically significant biologic|1
4549154|NCT01198132|7375949|FG001|Overall Study|Abnormal/clinically significant biologic|1
4549155|NCT01198132|7375948|FG000|Overall Study|Adverse Event|0
4549156|NCT01198132|7375949|FG001|Overall Study|Adverse Event|1
4549157|NCT01198132|7375948|FG000|Overall Study|Protocol Violation|1
4549158|NCT01198132|7375949|FG001|Overall Study|Protocol Violation|0
4549159|NCT01198145|7375959|FG000|Overall Study|Withdrawal by Subject|1
4549160|NCT01198145|7375960|FG001|Overall Study|Withdrawal by Subject|1
4549161|NCT01198275|7375978|FG000|Overall Study|Adverse Event|2
4549162|NCT01198275|7375979|FG001|Overall Study|Adverse Event|3
4549163|NCT01198275|7375978|FG000|Overall Study|spontaneous return to sinus rhythm|4
4549164|NCT01198275|7375979|FG001|Overall Study|spontaneous return to sinus rhythm|2
4549165|NCT01198470|7376017|FG000|Overall Study|Adverse Event|2
4549166|NCT01198509|7376027|FG000|Overall Study|Withdrawal by Subject|1
4549167|NCT01198509|7376028|FG001|Overall Study|Withdrawal by Subject|0
4549168|NCT01198509|7376029|FG002|Overall Study|Withdrawal by Subject|0
4549169|NCT01198509|7376030|FG003|Overall Study|Withdrawal by Subject|0
4549170|NCT01198509|7376031|FG004|Overall Study|Withdrawal by Subject|0
4549171|NCT01198509|7376032|FG005|Overall Study|Withdrawal by Subject|0
4549172|NCT01198574|7376048|FG000|Overall Study|Resigned from schools|4
4549173|NCT01198574|7376049|FG001|Overall Study|Resigned from schools|1
4549174|NCT01198574|7376050|FG002|Overall Study|Resigned from schools|1
4549175|NCT01198574|7376051|FG003|Overall Study|Resigned from schools|4
4619799|NCT01778049|7481534|FG002|Open Label Treatment Period|Protocol Violation|0
4619800|NCT01778049|7481535|FG003|Open Label Treatment Period|Protocol Violation|0
4619801|NCT01778049|7481536|FG004|Open Label Treatment Period|Protocol Violation|0
4619802|NCT01778049|7481537|FG005|Open Label Treatment Period|Protocol Violation|0
4619803|NCT01778049|7481532|FG000|Open Label Treatment Period|Lost to Follow-up|4
4619804|NCT01778049|7481533|FG001|Open Label Treatment Period|Lost to Follow-up|3
4619805|NCT01778049|7481534|FG002|Open Label Treatment Period|Lost to Follow-up|0
4619806|NCT01778049|7481535|FG003|Open Label Treatment Period|Lost to Follow-up|0
4619807|NCT01778049|7481536|FG004|Open Label Treatment Period|Lost to Follow-up|0
4619808|NCT01778049|7481537|FG005|Open Label Treatment Period|Lost to Follow-up|0
4619809|NCT01778049|7481532|FG000|Open Label Treatment Period|Withdrawal by Subject|4
4619810|NCT01778049|7481533|FG001|Open Label Treatment Period|Withdrawal by Subject|10
4619811|NCT01778049|7481534|FG002|Open Label Treatment Period|Withdrawal by Subject|0
4619812|NCT01778049|7481535|FG003|Open Label Treatment Period|Withdrawal by Subject|0
4619813|NCT01778049|7481536|FG004|Open Label Treatment Period|Withdrawal by Subject|0
4619814|NCT01778049|7481537|FG005|Open Label Treatment Period|Withdrawal by Subject|0
4619815|NCT01778049|7481532|FG000|Open Label Treatment Period|Not treated|2
4619816|NCT01778049|7481533|FG001|Open Label Treatment Period|Not treated|1
4619817|NCT01778049|7481534|FG002|Open Label Treatment Period|Not treated|0
4619818|NCT01778049|7481535|FG003|Open Label Treatment Period|Not treated|0
4619819|NCT01778049|7481536|FG004|Open Label Treatment Period|Not treated|0
4619820|NCT01778049|7481537|FG005|Open Label Treatment Period|Not treated|0
4619821|NCT01778049|7481532|FG000|Open Label Treatment Period|Other reason not defined above|77
4619822|NCT01778049|7481533|FG001|Open Label Treatment Period|Other reason not defined above|94
4619823|NCT01778049|7481534|FG002|Open Label Treatment Period|Other reason not defined above|0
4619824|NCT01778049|7481535|FG003|Open Label Treatment Period|Other reason not defined above|0
4619825|NCT01778049|7481536|FG004|Open Label Treatment Period|Other reason not defined above|0
4619826|NCT01778049|7481537|FG005|Open Label Treatment Period|Other reason not defined above|0
4619827|NCT01778049|7481532|FG000|Double Blind Treatment Period|Adverse Event|0
4619828|NCT01778049|7481533|FG001|Double Blind Treatment Period|Adverse Event|0
4619829|NCT01778049|7481534|FG002|Double Blind Treatment Period|Adverse Event|4
4619830|NCT01778049|7481535|FG003|Double Blind Treatment Period|Adverse Event|5
4549176|NCT01198587|7376065|FG000|Overall Study|Lost to Follow-up|8
4549177|NCT01198587|7376066|FG001|Overall Study|Lost to Follow-up|0
4549178|NCT01198587|7376067|FG002|Overall Study|Lost to Follow-up|9
4549179|NCT01198587|7376068|FG003|Overall Study|Lost to Follow-up|0
4549180|NCT01198600|7376083|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1
4549181|NCT01198600|7376084|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
4549182|NCT01198600|7376085|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
4619831|NCT01778049|7481536|FG004|Double Blind Treatment Period|Adverse Event|3
4619832|NCT01778049|7481537|FG005|Double Blind Treatment Period|Adverse Event|2
4619833|NCT01778049|7481532|FG000|Double Blind Treatment Period|Lack of Efficacy|0
4619834|NCT01778049|7481533|FG001|Double Blind Treatment Period|Lack of Efficacy|0
4619835|NCT01778049|7481534|FG002|Double Blind Treatment Period|Lack of Efficacy|0
4619836|NCT01778049|7481535|FG003|Double Blind Treatment Period|Lack of Efficacy|0
4619837|NCT01778049|7481536|FG004|Double Blind Treatment Period|Lack of Efficacy|0
4619838|NCT01778049|7481537|FG005|Double Blind Treatment Period|Lack of Efficacy|1
4619839|NCT01778049|7481532|FG000|Double Blind Treatment Period|Protocol Violation|0
4619840|NCT01778049|7481533|FG001|Double Blind Treatment Period|Protocol Violation|0
4619841|NCT01778049|7481534|FG002|Double Blind Treatment Period|Protocol Violation|2
4619842|NCT01778049|7481535|FG003|Double Blind Treatment Period|Protocol Violation|0
4619843|NCT01778049|7481536|FG004|Double Blind Treatment Period|Protocol Violation|0
4619844|NCT01778049|7481537|FG005|Double Blind Treatment Period|Protocol Violation|0
4619845|NCT01778049|7481532|FG000|Double Blind Treatment Period|Lost to Follow-up|0
4619846|NCT01778049|7481533|FG001|Double Blind Treatment Period|Lost to Follow-up|0
4619847|NCT01778049|7481534|FG002|Double Blind Treatment Period|Lost to Follow-up|4
4619848|NCT01778049|7481535|FG003|Double Blind Treatment Period|Lost to Follow-up|1
4619849|NCT01778049|7481536|FG004|Double Blind Treatment Period|Lost to Follow-up|5
4619850|NCT01778049|7481537|FG005|Double Blind Treatment Period|Lost to Follow-up|2
4619851|NCT01778049|7481532|FG000|Double Blind Treatment Period|Withdrawal by Subject|0
4619852|NCT01778049|7481533|FG001|Double Blind Treatment Period|Withdrawal by Subject|0
4619853|NCT01778049|7481534|FG002|Double Blind Treatment Period|Withdrawal by Subject|1
4619854|NCT01778049|7481535|FG003|Double Blind Treatment Period|Withdrawal by Subject|2
4619855|NCT01778049|7481536|FG004|Double Blind Treatment Period|Withdrawal by Subject|0
4619856|NCT01778049|7481537|FG005|Double Blind Treatment Period|Withdrawal by Subject|1
4619857|NCT01778049|7481532|FG000|Double Blind Treatment Period|Not treated|0
4619858|NCT01778049|7481533|FG001|Double Blind Treatment Period|Not treated|0
4619859|NCT01778049|7481534|FG002|Double Blind Treatment Period|Not treated|0
4619860|NCT01778049|7481535|FG003|Double Blind Treatment Period|Not treated|2
4619861|NCT01778049|7481536|FG004|Double Blind Treatment Period|Not treated|2
4619862|NCT01778049|7481537|FG005|Double Blind Treatment Period|Not treated|0
4619863|NCT01778049|7481532|FG000|Double Blind Treatment Period|Other reason not defined above|0
4619864|NCT01778049|7481533|FG001|Double Blind Treatment Period|Other reason not defined above|0
4619865|NCT01778049|7481534|FG002|Double Blind Treatment Period|Other reason not defined above|4
4619866|NCT01778049|7481535|FG003|Double Blind Treatment Period|Other reason not defined above|2
4619867|NCT01778049|7481536|FG004|Double Blind Treatment Period|Other reason not defined above|2
4619868|NCT01778049|7481537|FG005|Double Blind Treatment Period|Other reason not defined above|1
4619869|NCT01778062|7481551|FG000|Overall Study|Adverse Event|1
4619870|NCT01778062|7481552|FG001|Overall Study|Adverse Event|3
4619871|NCT01778062|7481551|FG000|Overall Study|Consent Withdrawal|1
4619872|NCT01778062|7481552|FG001|Overall Study|Consent Withdrawal|5
4619873|NCT01778062|7481551|FG000|Overall Study|major protocol deviation|4
4619874|NCT01778062|7481552|FG001|Overall Study|major protocol deviation|3
4619875|NCT01778127|7481561|FG000|Overall Study|Lost to Follow-up|5
4619876|NCT01778127|7481562|FG001|Overall Study|Lost to Follow-up|1
4619877|NCT01778127|7481563|FG002|Overall Study|Lost to Follow-up|2
4619878|NCT01778127|7481561|FG000|Overall Study|Withdrawal by Subject|3
4619879|NCT01778127|7481562|FG001|Overall Study|Withdrawal by Subject|1
4619880|NCT01778127|7481563|FG002|Overall Study|Withdrawal by Subject|4
4619881|NCT01778530|7481606|FG000|Overall Study|Progression on study|1
4619882|NCT01778530|7481606|FG000|Overall Study|Adverse event/side effect|1
4619883|NCT01778556|7481612|FG000|Intervention 1 (5 Days)|Protocol Violation|0
4619884|NCT01778556|7481613|FG001|Intervention 1 (5 Days)|Protocol Violation|1
4619885|NCT01778556|7481612|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0
4619886|NCT01778556|7481613|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1
4619887|NCT01778556|7481612|FG000|Intervention 2 (14 Days)|Protocol Violation|1
4619888|NCT01778556|7481613|FG001|Intervention 2 (14 Days)|Protocol Violation|0
4619889|NCT01778556|7481612|FG000|Long-term Follow-up|noncompliance with metreleptin|1
4619890|NCT01778556|7481613|FG001|Long-term Follow-up|noncompliance with metreleptin|0
4619891|NCT01778751|7481634|FG000|Overall Study|Lost to Follow-up|1
4619892|NCT01778751|7481635|FG001|Overall Study|Lost to Follow-up|0
4619893|NCT01778751|7481634|FG000|Overall Study|Withdrawal by Subject|0
4619894|NCT01778751|7481635|FG001|Overall Study|Withdrawal by Subject|2
4619895|NCT01778751|7481634|FG000|Overall Study|Transfered care|1
4619896|NCT01778751|7481635|FG001|Overall Study|Transfered care|0
4619897|NCT01778855|7481643|FG000|Overall Study|Death|0
4619898|NCT01778855|7481644|FG001|Overall Study|Death|1
4619899|NCT01778985|7481652|FG000|Overall Study|Lost to Follow-up|1
4619900|NCT01778985|7481653|FG001|Overall Study|Lost to Follow-up|0
4619901|NCT01778985|7481652|FG000|Overall Study|Physician Decision|2
4549183|NCT01198600|7376086|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
4549184|NCT01198600|7376083|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1
4549185|NCT01198600|7376084|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
4549186|NCT01198600|7376085|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
4549187|NCT01198600|7376086|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
4549188|NCT01198600|7376083|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
4549189|NCT01198600|7376084|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1
4549190|NCT01198600|7376085|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
4549191|NCT01198600|7376086|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
4549192|NCT01198600|7376083|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
4549193|NCT01198600|7376084|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1
4549194|NCT01198600|7376085|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
4549195|NCT01198600|7376086|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
4549196|NCT01198600|7376083|FG000|Phase 2: 56 Days of Wear|Inconvenience|0
4549197|NCT01198600|7376084|FG001|Phase 2: 56 Days of Wear|Inconvenience|0
4549198|NCT01198600|7376085|FG002|Phase 2: 56 Days of Wear|Inconvenience|2
4549199|NCT01198600|7376086|FG003|Phase 2: 56 Days of Wear|Inconvenience|0
4549200|NCT01198600|7376083|FG000|Phase 2: 56 Days of Wear|Relocation|0
4549201|NCT01198600|7376084|FG001|Phase 2: 56 Days of Wear|Relocation|0
4549202|NCT01198600|7376085|FG002|Phase 2: 56 Days of Wear|Relocation|2
4549203|NCT01198600|7376086|FG003|Phase 2: 56 Days of Wear|Relocation|0
4549204|NCT01198600|7376083|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
4549205|NCT01198600|7376084|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
4549206|NCT01198600|7376085|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1
4619902|NCT01778985|7481653|FG001|Overall Study|Physician Decision|2
4619903|NCT01778985|7481652|FG000|Overall Study|Protocol Violation|4
4619904|NCT01778985|7481653|FG001|Overall Study|Protocol Violation|1
4619905|NCT01779440|7481696|FG000|Overall Study|Withdrawal by Subject|3
4619906|NCT01779440|7481697|FG001|Overall Study|Withdrawal by Subject|5
4619907|NCT01779648|7481705|FG000|Overall Study|Protocol Violation|1
4619908|NCT01779648|7481706|FG001|Overall Study|Protocol Violation|0
4619909|NCT01779700|7481714|FG000|Overall Study|Adverse Event|4
4619910|NCT01779700|7481715|FG001|Overall Study|Adverse Event|3
4619911|NCT01779700|7481714|FG000|Overall Study|Withdrawal by Subject|0
4619912|NCT01779700|7481715|FG001|Overall Study|Withdrawal by Subject|2
4619913|NCT01779856|7481721|FG000|Overall Study|Withdrawal by Subject|15
4619914|NCT01779856|7481721|FG000|Overall Study|Death|3
4619915|NCT01779856|7481721|FG000|Overall Study|Physician Decision|1
4619916|NCT01779856|7481721|FG000|Overall Study|Inclusion/Exclusion Not Met|2
4619917|NCT01779856|7481721|FG000|Overall Study|Delays in scheduling implant|1
4619918|NCT01779856|7481721|FG000|Overall Study|Subject ineligible for Implant|2
4619919|NCT01779869|7481732|FG000|Overall Study|Physician Decision|2
4619920|NCT01780389|7481758|FG000|Overall Study|Adverse Event|1
4619921|NCT01780506|7481769|FG000|Double-Blind Phase|Randomized but not Treated|3
4619922|NCT01780506|7481770|FG001|Double-Blind Phase|Randomized but not Treated|2
4619923|NCT01780506|7481769|FG000|Double-Blind Phase|Adverse Event|4
4619924|NCT01780506|7481770|FG001|Double-Blind Phase|Adverse Event|14
4619925|NCT01780506|7481769|FG000|Double-Blind Phase|Death|1
4619926|NCT01780506|7481770|FG001|Double-Blind Phase|Death|2
4619927|NCT01780506|7481769|FG000|Double-Blind Phase|Pregnancy|2
4619928|NCT01780506|7481770|FG001|Double-Blind Phase|Pregnancy|1
4619929|NCT01780506|7481769|FG000|Double-Blind Phase|Lack of Efficacy|1
4619930|NCT01780506|7481770|FG001|Double-Blind Phase|Lack of Efficacy|1
4619931|NCT01780506|7481769|FG000|Double-Blind Phase|Investigator's Discretion|5
4619932|NCT01780506|7481770|FG001|Double-Blind Phase|Investigator's Discretion|2
4619933|NCT01780506|7481769|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4
4619934|NCT01780506|7481770|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3
4619935|NCT01780506|7481769|FG000|Double-Blind Phase|Protocol Violation|4
4619936|NCT01780506|7481770|FG001|Double-Blind Phase|Protocol Violation|3
4619937|NCT01780506|7481769|FG000|Double-Blind Phase|Withdrew Consent|23
4619938|NCT01780506|7481770|FG001|Double-Blind Phase|Withdrew Consent|24
4619939|NCT01780506|7481769|FG000|Double-Blind Phase|Lost to Follow-up|23
4619940|NCT01780506|7481770|FG001|Double-Blind Phase|Lost to Follow-up|26
4619941|NCT01780506|7481769|FG000|Open-Label Extension Phase|Enrolled but not Treated|0
4619942|NCT01780506|7481770|FG001|Open-Label Extension Phase|Enrolled but not Treated|1
4619943|NCT01780545|7481780|FG000|Overall Study|Withdrawal by Subject|3
4619944|NCT01780545|7481781|FG001|Overall Study|Withdrawal by Subject|1
4619945|NCT01780545|7481780|FG000|Overall Study|Lost to Follow-up|1
4619946|NCT01780545|7481781|FG001|Overall Study|Lost to Follow-up|1
4619947|NCT01780584|7481793|FG000|Overall Study|Death|1
4619948|NCT01780584|7481794|FG001|Overall Study|Death|0
4619949|NCT01780584|7481795|FG002|Overall Study|Death|1
4619950|NCT01780584|7481793|FG000|Overall Study|Adverse Event|0
4619951|NCT01780584|7481794|FG001|Overall Study|Adverse Event|1
4619952|NCT01780584|7481795|FG002|Overall Study|Adverse Event|0
4619953|NCT01780584|7481793|FG000|Overall Study|Protocol Violation|0
4619954|NCT01780584|7481794|FG001|Overall Study|Protocol Violation|0
4619955|NCT01780584|7481795|FG002|Overall Study|Protocol Violation|1
4619956|NCT01780662|7481806|FG000|Overall Study|Adverse Event|1
4619957|NCT01780662|7481807|FG001|Overall Study|Adverse Event|0
4549207|NCT01198600|7376086|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
4549208|NCT01198756|7376107|FG000|Overall Study|Adverse Event|0
4549209|NCT01198756|7376108|FG001|Overall Study|Adverse Event|0
4549210|NCT01198756|7376109|FG002|Overall Study|Adverse Event|0
4549211|NCT01198756|7376110|FG003|Overall Study|Adverse Event|1
4549212|NCT01198756|7376107|FG000|Overall Study|Protocol Violation|0
4549213|NCT01198756|7376108|FG001|Overall Study|Protocol Violation|0
4549214|NCT01198756|7376109|FG002|Overall Study|Protocol Violation|0
4549215|NCT01198756|7376110|FG003|Overall Study|Protocol Violation|2
4549216|NCT01198756|7376107|FG000|Overall Study|Withdrawal by Subject|9
4549217|NCT01198756|7376108|FG001|Overall Study|Withdrawal by Subject|4
4549218|NCT01198756|7376109|FG002|Overall Study|Withdrawal by Subject|7
4549219|NCT01198756|7376110|FG003|Overall Study|Withdrawal by Subject|5
4549220|NCT01198756|7376107|FG000|Overall Study|Lost to Follow-up|29
4549221|NCT01198756|7376108|FG001|Overall Study|Lost to Follow-up|36
4549222|NCT01198756|7376109|FG002|Overall Study|Lost to Follow-up|23
4549223|NCT01198756|7376110|FG003|Overall Study|Lost to Follow-up|18
4549224|NCT01198795|7376131|FG000|Overall Study|Did not meet InclusionExclusion criteria|30
4549225|NCT01198795|7376131|FG000|Overall Study|Withdrawal by Subject|17
4549226|NCT01198795|7376131|FG000|Overall Study|Lost to Follow-up|15
4549227|NCT01198795|7376131|FG000|Overall Study|Adverse Event|9
4549228|NCT01198795|7376131|FG000|Overall Study|Lack of Efficacy|5
4549229|NCT01198795|7376131|FG000|Overall Study|Protocol Violation|2
4549230|NCT01198795|7376131|FG000|Overall Study|Other Reason|4
4549231|NCT01198873|7376137|FG000|Overall Study|Adverse Event|4
4549232|NCT01198873|7376138|FG001|Overall Study|Adverse Event|7
4549233|NCT01198873|7376137|FG000|Overall Study|Study closure|29
4549234|NCT01198873|7376138|FG001|Overall Study|Study closure|23
4549235|NCT01198873|7376137|FG000|Overall Study|Other than above|4
4549236|NCT01198873|7376138|FG001|Overall Study|Other than above|2
4549237|NCT01198977|7376146|FG000|Overall Study|Lost to Follow-up|1
4619958|NCT01780662|7481808|FG002|Overall Study|Adverse Event|2
4619959|NCT01780662|7481806|FG000|Overall Study|Physician Decision|0
4619960|NCT01780662|7481807|FG001|Overall Study|Physician Decision|5
4619961|NCT01780662|7481808|FG002|Overall Study|Physician Decision|7
4619962|NCT01780662|7481806|FG000|Overall Study|Protocol Violation|0
4619963|NCT01780662|7481807|FG001|Overall Study|Protocol Violation|1
4619964|NCT01780662|7481808|FG002|Overall Study|Protocol Violation|0
4619965|NCT01780662|7481806|FG000|Overall Study|Ineligible|0
4619966|NCT01780662|7481807|FG001|Overall Study|Ineligible|0
4619967|NCT01780662|7481808|FG002|Overall Study|Ineligible|1
4619968|NCT01780831|7481821|FG000|Overall Study|Withdrawal by Subject|0
4619969|NCT01780831|7481822|FG001|Overall Study|Withdrawal by Subject|0
4619970|NCT01780831|7481823|FG002|Overall Study|Withdrawal by Subject|4
4619971|NCT01780831|7481824|FG003|Overall Study|Withdrawal by Subject|0
4619972|NCT01780831|7481821|FG000|Overall Study|Lost to Follow-up|0
4619973|NCT01780831|7481822|FG001|Overall Study|Lost to Follow-up|0
4619974|NCT01780831|7481823|FG002|Overall Study|Lost to Follow-up|0
4619975|NCT01780831|7481824|FG003|Overall Study|Lost to Follow-up|1
4619976|NCT01780935|7481905|FG000|Overall Study|Admin problems due to early termination|321
4619977|NCT01780935|7481906|FG001|Overall Study|Admin problems due to early termination|309
4619978|NCT01780935|7481905|FG000|Overall Study|Adverse Event|2
4619979|NCT01780935|7481906|FG001|Overall Study|Adverse Event|4
4619980|NCT01780935|7481905|FG000|Overall Study|Death|1
4619981|NCT01780935|7481906|FG001|Overall Study|Death|6
4619982|NCT01780935|7481905|FG000|Overall Study|Lost to Follow-up|2
4619983|NCT01780935|7481906|FG001|Overall Study|Lost to Follow-up|6
4619984|NCT01780935|7481905|FG000|Overall Study|Physician Decision|1
4619985|NCT01780935|7481906|FG001|Overall Study|Physician Decision|1
4619986|NCT01780935|7481905|FG000|Overall Study|Protocol deviation|0
4619987|NCT01780935|7481906|FG001|Overall Study|Protocol deviation|1
4619988|NCT01780935|7481905|FG000|Overall Study|Patient withdrew consent|8
4619989|NCT01780935|7481906|FG001|Overall Study|Patient withdrew consent|9
4619990|NCT01780974|7481914|FG000|Overall Study|Death|1
4619991|NCT01780974|7481915|FG001|Overall Study|Death|0
4619992|NCT01780974|7481914|FG000|Overall Study|Adverse Event|1
4619993|NCT01780974|7481915|FG001|Overall Study|Adverse Event|3
4619994|NCT01780987|7481923|FG000|Overall Study|Adverse Event|0
4619995|NCT01780987|7481924|FG001|Overall Study|Adverse Event|4
4619996|NCT01780987|7481923|FG000|Overall Study|Withdrawal by Subject|2
4619997|NCT01780987|7481924|FG001|Overall Study|Withdrawal by Subject|0
4619998|NCT01780987|7481923|FG000|Overall Study|Request of Changing Hospital|0
4619999|NCT01780987|7481924|FG001|Overall Study|Request of Changing Hospital|1
4620000|NCT01780987|7481923|FG000|Overall Study|Changing Residence|1
4620001|NCT01780987|7481924|FG001|Overall Study|Changing Residence|0
4620002|NCT01780987|7481923|FG000|Overall Study|Not Receiving any Study Medication|0
4620003|NCT01780987|7481924|FG001|Overall Study|Not Receiving any Study Medication|1
4620004|NCT01781234|7481959|FG000|Overall Study|Adverse Event|2
4620005|NCT01781234|7481960|FG001|Overall Study|Adverse Event|0
4620006|NCT01781234|7481959|FG000|Overall Study|Protocol Violation|3
4620007|NCT01781234|7481960|FG001|Overall Study|Protocol Violation|0
4549238|NCT01198977|7376147|FG001|Overall Study|Lost to Follow-up|0
4549239|NCT01199016|7376155|FG000|Overall Study|No longer meets eligibility criteria|4
4620008|NCT01781234|7481959|FG000|Overall Study|Withdrawal by Subject|4
4620009|NCT01781234|7481960|FG001|Overall Study|Withdrawal by Subject|3
4549240|NCT01199016|7376155|FG000|Overall Study|Entrance criteria|5
4549241|NCT01199016|7376155|FG000|Overall Study|Protocol Violation|9
4549242|NCT01199016|7376155|FG000|Overall Study|Other|13
4549243|NCT01199016|7376155|FG000|Overall Study|Withdrawal by Subject|21
4549244|NCT01199016|7376155|FG000|Overall Study|Lost to Follow-up|25
4549245|NCT01199042|7376159|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2
4549246|NCT01199042|7376159|FG000|At Home (3 Months)|Lost to Follow-up|1
4549247|NCT01199055|7376171|FG000|Overall Study|Death|0
4549248|NCT01199055|7376172|FG001|Overall Study|Death|1
4549249|NCT01199055|7376173|FG002|Overall Study|Death|0
4549250|NCT01199055|7376171|FG000|Overall Study|Physician Decision|0
4549251|NCT01199055|7376172|FG001|Overall Study|Physician Decision|1
4549252|NCT01199055|7376173|FG002|Overall Study|Physician Decision|1
4549253|NCT01199055|7376171|FG000|Overall Study|Progressive disease|2
4549254|NCT01199055|7376172|FG001|Overall Study|Progressive disease|1
4549255|NCT01199055|7376173|FG002|Overall Study|Progressive disease|2
4549256|NCT01199055|7376171|FG000|Overall Study|Withdrawal by Subject|0
4549257|NCT01199055|7376172|FG001|Overall Study|Withdrawal by Subject|0
4549258|NCT01199055|7376173|FG002|Overall Study|Withdrawal by Subject|1
4549259|NCT01199068|7376186|FG000|Overall Study|Unacceptable toxicity|0
4549260|NCT01199068|7376187|FG001|Overall Study|Unacceptable toxicity|0
4549261|NCT01199068|7376188|FG002|Overall Study|Unacceptable toxicity|2
4549262|NCT01199068|7376186|FG000|Overall Study|Progressive disease|3
4549263|NCT01199068|7376187|FG001|Overall Study|Progressive disease|3
4549264|NCT01199068|7376188|FG002|Overall Study|Progressive disease|6
4549265|NCT01199068|7376186|FG000|Overall Study|Withdrawal by Subject|0
4549266|NCT01199068|7376187|FG001|Overall Study|Withdrawal by Subject|0
4549267|NCT01199068|7376188|FG002|Overall Study|Withdrawal by Subject|1
4549268|NCT01199198|7376209|FG000|Overall Study|Adverse Event|3
4549269|NCT01199198|7376210|FG001|Overall Study|Adverse Event|0
4549270|NCT01199198|7376209|FG000|Overall Study|Lost to Follow-up|1
4549271|NCT01199198|7376210|FG001|Overall Study|Lost to Follow-up|5
4549272|NCT01199198|7376209|FG000|Overall Study|Withdrawal by Subject|1
4549273|NCT01199198|7376210|FG001|Overall Study|Withdrawal by Subject|2
4549274|NCT01199198|7376209|FG000|Overall Study|ICU Transfer|1
4549275|NCT01199198|7376210|FG001|Overall Study|ICU Transfer|2
4549276|NCT01199198|7376209|FG000|Overall Study|Hospice-care transfer|1
4549277|NCT01199198|7376210|FG001|Overall Study|Hospice-care transfer|2
4549278|NCT01199263|7376229|FG000|Overall Study|Ineligible|0
4549279|NCT01199263|7376230|FG001|Overall Study|Ineligible|2
4549280|NCT01199263|7376229|FG000|Overall Study|Never Treated|6
4549281|NCT01199263|7376230|FG001|Overall Study|Never Treated|0
4549282|NCT01199289|7376242|FG000|Overall Study|Ineligibility determined|2
4549283|NCT01199289|7376243|FG001|Overall Study|Ineligibility determined|1
4549284|NCT01199289|7376244|FG002|Overall Study|Ineligibility determined|0
4549285|NCT01199289|7376245|FG003|Overall Study|Ineligibility determined|0
4549286|NCT01199289|7376242|FG000|Overall Study|Protocol Violation|1
4549287|NCT01199289|7376243|FG001|Overall Study|Protocol Violation|0
4549288|NCT01199289|7376244|FG002|Overall Study|Protocol Violation|0
4549289|NCT01199289|7376245|FG003|Overall Study|Protocol Violation|1
4549290|NCT01199289|7376242|FG000|Overall Study|Noncompliance|1
4549291|NCT01199289|7376243|FG001|Overall Study|Noncompliance|0
4549292|NCT01199289|7376244|FG002|Overall Study|Noncompliance|2
4549293|NCT01199289|7376245|FG003|Overall Study|Noncompliance|0
4549294|NCT01199289|7376242|FG000|Overall Study|Adverse Event|0
4549295|NCT01199289|7376243|FG001|Overall Study|Adverse Event|3
4549296|NCT01199289|7376244|FG002|Overall Study|Adverse Event|1
4549297|NCT01199289|7376245|FG003|Overall Study|Adverse Event|4
4549298|NCT01199289|7376242|FG000|Overall Study|Full consent withdrawn|2
4549299|NCT01199289|7376243|FG001|Overall Study|Full consent withdrawn|2
4549300|NCT01199289|7376244|FG002|Overall Study|Full consent withdrawn|2
4549301|NCT01199289|7376245|FG003|Overall Study|Full consent withdrawn|3
4549302|NCT01199289|7376242|FG000|Overall Study|Administrative decision|0
4549303|NCT01199289|7376243|FG001|Overall Study|Administrative decision|0
4549304|NCT01199289|7376244|FG002|Overall Study|Administrative decision|0
4549305|NCT01199289|7376245|FG003|Overall Study|Administrative decision|1
4549306|NCT01199289|7376242|FG000|Overall Study|Lost to Follow-up|0
4620010|NCT01781286|7481968|FG000|Overall Study|Lost to Follow-up|0
4549307|NCT01199289|7376243|FG001|Overall Study|Lost to Follow-up|0
4549308|NCT01199289|7376244|FG002|Overall Study|Lost to Follow-up|0
4549309|NCT01199289|7376245|FG003|Overall Study|Lost to Follow-up|1
4549310|NCT01199289|7376242|FG000|Overall Study|Protocol-specified criteria|3
4549311|NCT01199289|7376243|FG001|Overall Study|Protocol-specified criteria|0
4549312|NCT01199289|7376244|FG002|Overall Study|Protocol-specified criteria|0
4549313|NCT01199289|7376245|FG003|Overall Study|Protocol-specified criteria|1
4549314|NCT01199289|7376242|FG000|Overall Study|Pregnancy|0
4549315|NCT01199289|7376243|FG001|Overall Study|Pregnancy|1
4620011|NCT01781286|7481969|FG001|Overall Study|Lost to Follow-up|0
4549316|NCT01199289|7376244|FG002|Overall Study|Pregnancy|0
4549317|NCT01199289|7376245|FG003|Overall Study|Pregnancy|1
4549318|NCT01199471|7376267|FG000|Overall Study|Protocol Violation|4
4549319|NCT01199471|7376267|FG000|Overall Study|Withdrawal by Subject|1
4549320|NCT01199471|7376267|FG000|Overall Study|Physician Decision|1
4549321|NCT01199575|7376272|FG000|Overall Study|Withdrawal by Subject|5
4549322|NCT01199601|7376279|FG000|Overall Study|Lost to Follow-up|47
4549323|NCT01199601|7376280|FG001|Overall Study|Lost to Follow-up|66
4549324|NCT01199601|7376279|FG000|Overall Study|Withdrawal by Subject|15
4549325|NCT01199601|7376280|FG001|Overall Study|Withdrawal by Subject|3
4549326|NCT01199601|7376279|FG000|Overall Study|Insecurity prevented staff interviewing.|7
4549327|NCT01199601|7376280|FG001|Overall Study|Insecurity prevented staff interviewing.|9
4549328|NCT01199705|7376286|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1
4549329|NCT01199731|7376304|FG000|Overall Study|Adverse Event|0
4549330|NCT01199731|7376305|FG001|Overall Study|Adverse Event|1
4549331|NCT01199731|7376306|FG002|Overall Study|Adverse Event|0
4549332|NCT01199731|7376304|FG000|Overall Study|Study closed/terminated|7
4549333|NCT01199731|7376305|FG001|Overall Study|Study closed/terminated|9
4549334|NCT01199731|7376306|FG002|Overall Study|Study closed/terminated|7
4549335|NCT01199731|7376304|FG000|Overall Study|Lost to Follow-up|0
4549336|NCT01199731|7376305|FG001|Overall Study|Lost to Follow-up|0
4549337|NCT01199731|7376306|FG002|Overall Study|Lost to Follow-up|2
4549338|NCT01199731|7376304|FG000|Overall Study|Physician Decision|0
4549339|NCT01199731|7376305|FG001|Overall Study|Physician Decision|1
4549340|NCT01199731|7376306|FG002|Overall Study|Physician Decision|1
4549341|NCT01199731|7376304|FG000|Overall Study|Withdrawal by Subject|2
4549342|NCT01199731|7376305|FG001|Overall Study|Withdrawal by Subject|0
4549343|NCT01199731|7376306|FG002|Overall Study|Withdrawal by Subject|0
4549344|NCT01199822|7376321|FG000|Overall Study|Investigator discontinued therapy|0
4549345|NCT01199822|7376322|FG001|Overall Study|Investigator discontinued therapy|1
4549346|NCT01199822|7376323|FG002|Overall Study|Investigator discontinued therapy|0
4549347|NCT01199861|7376350|FG000|Overall Study|Administrative problems|1
4549348|NCT01199861|7376351|FG001|Overall Study|Administrative problems|0
4549349|NCT01199861|7376350|FG000|Overall Study|Adverse Event|1
4549350|NCT01199861|7376351|FG001|Overall Study|Adverse Event|0
4549351|NCT01199939|7376366|FG000|Overall Study|Adverse Event|4
4549352|NCT01199939|7376366|FG000|Overall Study|Protocol Violation|3
4549353|NCT01199939|7376366|FG000|Overall Study|Lost to Follow-up|2
4620012|NCT01781286|7481970|FG002|Overall Study|Lost to Follow-up|0
4620013|NCT01781286|7481971|FG003|Overall Study|Lost to Follow-up|0
4620014|NCT01781286|7481972|FG004|Overall Study|Lost to Follow-up|0
4620015|NCT01781286|7481973|FG005|Overall Study|Lost to Follow-up|1
4620016|NCT01781286|7481968|FG000|Overall Study|Time Constraints|2
4620017|NCT01781286|7481969|FG001|Overall Study|Time Constraints|0
4620018|NCT01781286|7481970|FG002|Overall Study|Time Constraints|2
4620019|NCT01781286|7481971|FG003|Overall Study|Time Constraints|0
4620020|NCT01781286|7481972|FG004|Overall Study|Time Constraints|0
4620021|NCT01781286|7481973|FG005|Overall Study|Time Constraints|0
4620022|NCT01781286|7481968|FG000|Overall Study|Noncompliance|0
4620023|NCT01781286|7481969|FG001|Overall Study|Noncompliance|0
4620024|NCT01781286|7481970|FG002|Overall Study|Noncompliance|0
4620025|NCT01781286|7481971|FG003|Overall Study|Noncompliance|1
4620026|NCT01781286|7481972|FG004|Overall Study|Noncompliance|0
4620027|NCT01781286|7481973|FG005|Overall Study|Noncompliance|0
4620028|NCT01781299|7481985|FG000|Overall Study|Withdrawal by Subject|0
4620029|NCT01781299|7481986|FG001|Overall Study|Withdrawal by Subject|1
4620030|NCT01781429|7482019|FG000|Overall Study|Death|0
4620031|NCT01781429|7482020|FG001|Overall Study|Death|0
4620032|NCT01781429|7482021|FG002|Overall Study|Death|0
4620033|NCT01781429|7482022|FG003|Overall Study|Death|0
4620034|NCT01781429|7482023|FG004|Overall Study|Death|0
4620035|NCT01781429|7482024|FG005|Overall Study|Death|0
4620036|NCT01781429|7482025|FG006|Overall Study|Death|0
4620037|NCT01781429|7482026|FG007|Overall Study|Death|0
4620038|NCT01781429|7482027|FG008|Overall Study|Death|0
4620039|NCT01781429|7482028|FG009|Overall Study|Death|1
4620040|NCT01781429|7482029|FG010|Overall Study|Death|0
4620041|NCT01781429|7482030|FG011|Overall Study|Death|0
4620042|NCT01781429|7482031|FG012|Overall Study|Death|1
4620043|NCT01781429|7482032|FG013|Overall Study|Death|0
4620044|NCT01781429|7482033|FG014|Overall Study|Death|1
4620045|NCT01781429|7482034|FG015|Overall Study|Death|0
4620046|NCT01781429|7482019|FG000|Overall Study|Withdrawal by Subject|0
4620047|NCT01781429|7482020|FG001|Overall Study|Withdrawal by Subject|0
4620048|NCT01781429|7482021|FG002|Overall Study|Withdrawal by Subject|0
4620049|NCT01781429|7482022|FG003|Overall Study|Withdrawal by Subject|0
4620050|NCT01781429|7482023|FG004|Overall Study|Withdrawal by Subject|0
4620051|NCT01781429|7482024|FG005|Overall Study|Withdrawal by Subject|0
4620052|NCT01781429|7482025|FG006|Overall Study|Withdrawal by Subject|0
4620053|NCT01781429|7482026|FG007|Overall Study|Withdrawal by Subject|0
4620054|NCT01781429|7482027|FG008|Overall Study|Withdrawal by Subject|1
4620055|NCT01781429|7482028|FG009|Overall Study|Withdrawal by Subject|3
4620056|NCT01781429|7482029|FG010|Overall Study|Withdrawal by Subject|1
4620057|NCT01781429|7482030|FG011|Overall Study|Withdrawal by Subject|1
4620058|NCT01781429|7482031|FG012|Overall Study|Withdrawal by Subject|5
4620059|NCT01781429|7482032|FG013|Overall Study|Withdrawal by Subject|2
4620060|NCT01781429|7482033|FG014|Overall Study|Withdrawal by Subject|3
4620061|NCT01781429|7482034|FG015|Overall Study|Withdrawal by Subject|0
4620062|NCT01781429|7482019|FG000|Overall Study|Disease Progression|1
4620063|NCT01781429|7482020|FG001|Overall Study|Disease Progression|0
4620064|NCT01781429|7482021|FG002|Overall Study|Disease Progression|1
4549354|NCT01199939|7376366|FG000|Overall Study|Reached a virologic endpoint|4
4620065|NCT01781429|7482022|FG003|Overall Study|Disease Progression|1
4620066|NCT01781429|7482023|FG004|Overall Study|Disease Progression|1
4549355|NCT01200069|7376412|FG000|Overall Study|Withdrawal by Subject|0
4549356|NCT01200069|7376413|FG001|Overall Study|Withdrawal by Subject|1
4549357|NCT01200238|7376468|FG000|Overall Study|Adverse Event|2
4549358|NCT01200238|7376469|FG001|Overall Study|Adverse Event|1
4549359|NCT01200238|7376468|FG000|Overall Study|Progressive Disease|5
4549360|NCT01200238|7376469|FG001|Overall Study|Progressive Disease|8
4549361|NCT01200238|7376468|FG000|Overall Study|Withdrawal by Subject|0
4549362|NCT01200238|7376469|FG001|Overall Study|Withdrawal by Subject|1
4549363|NCT01200290|7376475|FG000|Treatment Period|Adverse Event|1
4549364|NCT01200290|7376475|FG000|Post-Treatment Follow-Up Period|Death|2
4549365|NCT01200329|7376479|FG000|Overall Study|Lack of financial coverage|2
4549366|NCT01200329|7376479|FG000|Overall Study|Progressive disease|1
4549367|NCT01200342|7376483|FG000|Overall Study|Disease Progression|1
4549368|NCT01200355|7376489|FG000|Overall Study|Death|7
4549369|NCT01200355|7376490|FG001|Overall Study|Death|2
4549370|NCT01200368|7376499|FG000|Infant Series|Adverse Event|2
4549371|NCT01200368|7376500|FG001|Infant Series|Adverse Event|2
4549372|NCT01200368|7376501|FG002|Infant Series|Adverse Event|3
4549373|NCT01200368|7376499|FG000|Infant Series|Withdrawal by Subject|0
4549374|NCT01200368|7376500|FG001|Infant Series|Withdrawal by Subject|2
4549375|NCT01200368|7376501|FG002|Infant Series|Withdrawal by Subject|2
4549376|NCT01200368|7376499|FG000|Infant Series|Did not meet entrance criteria|0
4549377|NCT01200368|7376500|FG001|Infant Series|Did not meet entrance criteria|1
4549378|NCT01200368|7376501|FG002|Infant Series|Did not meet entrance criteria|0
4549379|NCT01200368|7376499|FG000|Infant Series|Randomized, not vaccinated|0
4549380|NCT01200368|7376500|FG001|Infant Series|Randomized, not vaccinated|1
4549381|NCT01200368|7376501|FG002|Infant Series|Randomized, not vaccinated|1
4549382|NCT01200368|7376499|FG000|Infant Series|Other|1
4549383|NCT01200368|7376500|FG001|Infant Series|Other|0
4549384|NCT01200368|7376501|FG002|Infant Series|Other|0
4549385|NCT01200368|7376499|FG000|After Infant Series|Adverse Event|6
4549386|NCT01200368|7376500|FG001|After Infant Series|Adverse Event|6
4549387|NCT01200368|7376501|FG002|After Infant Series|Adverse Event|3
4549388|NCT01200368|7376499|FG000|After Infant Series|Withdrawal by Subject|10
4549389|NCT01200368|7376500|FG001|After Infant Series|Withdrawal by Subject|8
4549390|NCT01200368|7376501|FG002|After Infant Series|Withdrawal by Subject|4
4549391|NCT01200368|7376499|FG000|After Infant Series|Lost to Follow-up|1
4549392|NCT01200368|7376500|FG001|After Infant Series|Lost to Follow-up|0
4549393|NCT01200368|7376501|FG002|After Infant Series|Lost to Follow-up|0
4549394|NCT01200368|7376499|FG000|After Infant Series|Other|1
4549395|NCT01200368|7376500|FG001|After Infant Series|Other|2
4549396|NCT01200368|7376501|FG002|After Infant Series|Other|2
4549397|NCT01200368|7376499|FG000|Toddler Dose|Adverse Event|0
4549398|NCT01200368|7376500|FG001|Toddler Dose|Adverse Event|3
4549399|NCT01200368|7376501|FG002|Toddler Dose|Adverse Event|1
4549400|NCT01200394|7376518|FG000|Overall Study|Adverse Event|0
4549401|NCT01200394|7376519|FG001|Overall Study|Adverse Event|14
4549402|NCT01200394|7376518|FG000|Overall Study|Death|1
4549403|NCT01200394|7376519|FG001|Overall Study|Death|0
4549404|NCT01200394|7376518|FG000|Overall Study|Lost to Follow-up|0
4549405|NCT01200394|7376519|FG001|Overall Study|Lost to Follow-up|1
4549406|NCT01200394|7376518|FG000|Overall Study|Did Not Meet Entrance Criteria|1
4549407|NCT01200394|7376519|FG001|Overall Study|Did Not Meet Entrance Criteria|4
4549408|NCT01200394|7376518|FG000|Overall Study|Protocol Violation|0
4549409|NCT01200394|7376519|FG001|Overall Study|Protocol Violation|3
4620067|NCT01781429|7482024|FG005|Overall Study|Disease Progression|4
4620068|NCT01781429|7482025|FG006|Overall Study|Disease Progression|7
4620069|NCT01781429|7482026|FG007|Overall Study|Disease Progression|4
4620070|NCT01781429|7482027|FG008|Overall Study|Disease Progression|6
4620071|NCT01781429|7482028|FG009|Overall Study|Disease Progression|15
4620072|NCT01781429|7482029|FG010|Overall Study|Disease Progression|15
4620073|NCT01781429|7482030|FG011|Overall Study|Disease Progression|15
4620074|NCT01781429|7482031|FG012|Overall Study|Disease Progression|15
4620075|NCT01781429|7482032|FG013|Overall Study|Disease Progression|4
4620076|NCT01781429|7482033|FG014|Overall Study|Disease Progression|11
4620077|NCT01781429|7482034|FG015|Overall Study|Disease Progression|0
4620078|NCT01781429|7482019|FG000|Overall Study|Unacceptable Toxicity|0
4620079|NCT01781429|7482020|FG001|Overall Study|Unacceptable Toxicity|0
4620080|NCT01781429|7482021|FG002|Overall Study|Unacceptable Toxicity|0
4620081|NCT01781429|7482022|FG003|Overall Study|Unacceptable Toxicity|0
4620082|NCT01781429|7482023|FG004|Overall Study|Unacceptable Toxicity|0
4620083|NCT01781429|7482024|FG005|Overall Study|Unacceptable Toxicity|0
4620084|NCT01781429|7482025|FG006|Overall Study|Unacceptable Toxicity|0
4620085|NCT01781429|7482026|FG007|Overall Study|Unacceptable Toxicity|0
4620086|NCT01781429|7482027|FG008|Overall Study|Unacceptable Toxicity|0
4549410|NCT01200394|7376518|FG000|Overall Study|Withdrawal by Subject|0
4549411|NCT01200394|7376519|FG001|Overall Study|Withdrawal by Subject|5
4549412|NCT01200394|7376518|FG000|Overall Study|Other|0
4620087|NCT01781429|7482028|FG009|Overall Study|Unacceptable Toxicity|0
4620088|NCT01781429|7482029|FG010|Overall Study|Unacceptable Toxicity|0
4620089|NCT01781429|7482030|FG011|Overall Study|Unacceptable Toxicity|2
4549413|NCT01200394|7376519|FG001|Overall Study|Other|1
4549414|NCT01200407|7376526|FG000|Overall Study|Lost to Follow-up|56
4549415|NCT01200407|7376526|FG000|Overall Study|Adverse Event|3
4549416|NCT01200407|7376526|FG000|Overall Study|Withdrawal by Subject|4
4549417|NCT01200407|7376526|FG000|Overall Study|Other|19
4549418|NCT01200485|7376539|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1
4549419|NCT01200485|7376540|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0
4549420|NCT01200485|7376541|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0
4549421|NCT01200485|7376539|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2
4549422|NCT01200485|7376540|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0
4549423|NCT01200485|7376541|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0
4549424|NCT01200511|7376552|FG000|Overall Study|Lost to Follow-up|3
4549425|NCT01200511|7376552|FG000|Overall Study|Withdrawal by Subject|1
4549426|NCT01200511|7376552|FG000|Overall Study|Adverse Event|1
4549427|NCT01200524|7376561|FG000|Overall Study|Withdrawal by Subject|1
4549428|NCT01200524|7376562|FG001|Overall Study|Withdrawal by Subject|1
4549429|NCT01200524|7376563|FG002|Overall Study|Withdrawal by Subject|3
4549430|NCT01200524|7376561|FG000|Overall Study|Adverse Event|1
4549431|NCT01200524|7376562|FG001|Overall Study|Adverse Event|0
4549432|NCT01200524|7376563|FG002|Overall Study|Adverse Event|0
4549433|NCT01200524|7376561|FG000|Overall Study|Non availability of study nurse|0
4549434|NCT01200524|7376562|FG001|Overall Study|Non availability of study nurse|0
4549435|NCT01200524|7376563|FG002|Overall Study|Non availability of study nurse|1
4549436|NCT01200589|7376573|FG000|Overall Study|Withdrawal by Subject|13
4549437|NCT01200589|7376574|FG001|Overall Study|Withdrawal by Subject|11
4549438|NCT01200589|7376573|FG000|Overall Study|Physician Decision|2
4549439|NCT01200589|7376574|FG001|Overall Study|Physician Decision|2
4549440|NCT01200589|7376573|FG000|Overall Study|Lost to Follow-up|5
4549441|NCT01200589|7376574|FG001|Overall Study|Lost to Follow-up|4
4549442|NCT01200589|7376573|FG000|Overall Study|Study terminated|170
4549443|NCT01200589|7376574|FG001|Overall Study|Study terminated|172
4549444|NCT01200758|7376582|FG000|Stage I|Death|0
4549445|NCT01200758|7376583|FG001|Stage I|Death|1
4549446|NCT01200758|7376584|FG002|Stage I|Death|0
4549447|NCT01200758|7376585|FG003|Stage I|Death|0
4549448|NCT01200758|7376582|FG000|Stage I|Physician Decision|1
4549449|NCT01200758|7376583|FG001|Stage I|Physician Decision|1
4549450|NCT01200758|7376584|FG002|Stage I|Physician Decision|0
4549451|NCT01200758|7376585|FG003|Stage I|Physician Decision|0
4549452|NCT01200758|7376582|FG000|Stage I|Lack of Efficacy|2
4549453|NCT01200758|7376583|FG001|Stage I|Lack of Efficacy|1
4549454|NCT01200758|7376584|FG002|Stage I|Lack of Efficacy|0
4549455|NCT01200758|7376585|FG003|Stage I|Lack of Efficacy|0
4549456|NCT01200758|7376582|FG000|Stage I|Adverse Event|5
4549457|NCT01200758|7376583|FG001|Stage I|Adverse Event|5
4549458|NCT01200758|7376584|FG002|Stage I|Adverse Event|0
4549459|NCT01200758|7376585|FG003|Stage I|Adverse Event|0
4549460|NCT01200758|7376582|FG000|Stage I|Withdrawal by Subject|1
4549461|NCT01200758|7376583|FG001|Stage I|Withdrawal by Subject|2
4549462|NCT01200758|7376584|FG002|Stage I|Withdrawal by Subject|0
4549463|NCT01200758|7376585|FG003|Stage I|Withdrawal by Subject|0
4549464|NCT01200758|7376582|FG000|Stage I|Disease Progression|9
4549465|NCT01200758|7376583|FG001|Stage I|Disease Progression|7
4549466|NCT01200758|7376584|FG002|Stage I|Disease Progression|0
4549467|NCT01200758|7376585|FG003|Stage I|Disease Progression|0
4549468|NCT01200758|7376582|FG000|Stage 2|Disease Progression|0
4549469|NCT01200758|7376583|FG001|Stage 2|Disease Progression|0
4549470|NCT01200758|7376584|FG002|Stage 2|Disease Progression|16
4549471|NCT01200758|7376585|FG003|Stage 2|Disease Progression|21
4549472|NCT01200758|7376582|FG000|Stage 2|Lack of Efficacy|0
4549473|NCT01200758|7376583|FG001|Stage 2|Lack of Efficacy|0
4549474|NCT01200758|7376584|FG002|Stage 2|Lack of Efficacy|4
4620090|NCT01781429|7482031|FG012|Overall Study|Unacceptable Toxicity|0
4620091|NCT01781429|7482032|FG013|Overall Study|Unacceptable Toxicity|0
4620092|NCT01781429|7482033|FG014|Overall Study|Unacceptable Toxicity|0
4620093|NCT01781429|7482034|FG015|Overall Study|Unacceptable Toxicity|0
4620094|NCT01781429|7482019|FG000|Overall Study|Patient Condition Changed|0
4620095|NCT01781429|7482020|FG001|Overall Study|Patient Condition Changed|0
4620096|NCT01781429|7482021|FG002|Overall Study|Patient Condition Changed|0
4620097|NCT01781429|7482022|FG003|Overall Study|Patient Condition Changed|0
4620098|NCT01781429|7482023|FG004|Overall Study|Patient Condition Changed|0
4620099|NCT01781429|7482024|FG005|Overall Study|Patient Condition Changed|0
4620100|NCT01781429|7482025|FG006|Overall Study|Patient Condition Changed|0
4549475|NCT01200758|7376585|FG003|Stage 2|Lack of Efficacy|2
4549476|NCT01200758|7376582|FG000|Stage 2|Physician Decision|0
4549477|NCT01200758|7376583|FG001|Stage 2|Physician Decision|0
4549478|NCT01200758|7376584|FG002|Stage 2|Physician Decision|5
4549479|NCT01200758|7376585|FG003|Stage 2|Physician Decision|7
4549480|NCT01200758|7376582|FG000|Stage 2|Adverse Event|0
4549481|NCT01200758|7376583|FG001|Stage 2|Adverse Event|0
4549482|NCT01200758|7376584|FG002|Stage 2|Adverse Event|5
4549483|NCT01200758|7376585|FG003|Stage 2|Adverse Event|9
4549484|NCT01200758|7376582|FG000|Stage 2|Withdrawal by Subject|0
4549485|NCT01200758|7376583|FG001|Stage 2|Withdrawal by Subject|0
4549486|NCT01200758|7376584|FG002|Stage 2|Withdrawal by Subject|4
4549487|NCT01200758|7376585|FG003|Stage 2|Withdrawal by Subject|1
4549488|NCT01200758|7376582|FG000|Stage 2|Lost to Follow-up|0
4549489|NCT01200758|7376583|FG001|Stage 2|Lost to Follow-up|0
4620101|NCT01781429|7482026|FG007|Overall Study|Patient Condition Changed|0
4620102|NCT01781429|7482027|FG008|Overall Study|Patient Condition Changed|0
4549490|NCT01200758|7376584|FG002|Stage 2|Lost to Follow-up|3
4549491|NCT01200758|7376585|FG003|Stage 2|Lost to Follow-up|1
4620103|NCT01781429|7482028|FG009|Overall Study|Patient Condition Changed|4
4549492|NCT01200758|7376582|FG000|Stage 2|Protocol Violation|0
4549493|NCT01200758|7376583|FG001|Stage 2|Protocol Violation|0
4549494|NCT01200758|7376584|FG002|Stage 2|Protocol Violation|1
4549495|NCT01200758|7376585|FG003|Stage 2|Protocol Violation|4
4549496|NCT01200758|7376582|FG000|Stage 2|Death|0
4549497|NCT01200758|7376583|FG001|Stage 2|Death|0
4549498|NCT01200758|7376584|FG002|Stage 2|Death|3
4549499|NCT01200758|7376585|FG003|Stage 2|Death|5
4549500|NCT01200797|7376597|FG000|Overall Study|symptomatic deterioration|2
4549501|NCT01200797|7376597|FG000|Overall Study|Adverse Event|4
4549502|NCT01200797|7376597|FG000|Overall Study|Disease Progression|13
4549503|NCT01200810|7376604|FG000|Overall Study|Physician Decision|1
4549504|NCT01200810|7376605|FG001|Overall Study|Physician Decision|0
4549505|NCT01200810|7376604|FG000|Overall Study|Withdrawal by Subject|1
4549506|NCT01200810|7376605|FG001|Overall Study|Withdrawal by Subject|2
4549507|NCT01200810|7376604|FG000|Overall Study|Sponsor stopped making study drug|3
4549508|NCT01200810|7376605|FG001|Overall Study|Sponsor stopped making study drug|3
4549509|NCT01200992|7376617|FG000|Overall Study|Study terminated early|35
4549510|NCT01200992|7376618|FG001|Overall Study|Study terminated early|41
4549511|NCT01200992|7376617|FG000|Overall Study|Randomized but not treated|2
4549512|NCT01200992|7376618|FG001|Overall Study|Randomized but not treated|0
4549513|NCT01201265|7376643|FG000|Overall Study|Death|14
4549514|NCT01201265|7376643|FG000|Overall Study|Insufficient Therapeutic Response|3
4549515|NCT01201265|7376643|FG000|Overall Study|Lost to Follow-up|10
4549516|NCT01201265|7376643|FG000|Overall Study|Withdrawal by Subject|7
4549517|NCT01201265|7376643|FG000|Overall Study|Disease Progression|4
4549518|NCT01201317|7376650|FG000|Overall Study|Withdrawal by Subject|5
4549519|NCT01201317|7376651|FG001|Overall Study|Withdrawal by Subject|0
4549520|NCT01201317|7376652|FG002|Overall Study|Withdrawal by Subject|3
4549521|NCT01201317|7376650|FG000|Overall Study|Adverse Event|2
4549522|NCT01201317|7376651|FG001|Overall Study|Adverse Event|2
4549523|NCT01201317|7376652|FG002|Overall Study|Adverse Event|2
4549524|NCT01201317|7376650|FG000|Overall Study|Screen failure|1
4549525|NCT01201317|7376651|FG001|Overall Study|Screen failure|1
4549526|NCT01201317|7376652|FG002|Overall Study|Screen failure|0
4549527|NCT01201317|7376650|FG000|Overall Study|Protocol Violation|0
4549528|NCT01201317|7376651|FG001|Overall Study|Protocol Violation|1
4620104|NCT01781429|7482029|FG010|Overall Study|Patient Condition Changed|0
4620105|NCT01781429|7482030|FG011|Overall Study|Patient Condition Changed|1
4620106|NCT01781429|7482031|FG012|Overall Study|Patient Condition Changed|0
4620107|NCT01781429|7482032|FG013|Overall Study|Patient Condition Changed|1
4620108|NCT01781429|7482033|FG014|Overall Study|Patient Condition Changed|0
4620109|NCT01781429|7482034|FG015|Overall Study|Patient Condition Changed|0
4620110|NCT01781429|7482019|FG000|Overall Study|Other - as entered by PI in eCRF|0
4620111|NCT01781429|7482020|FG001|Overall Study|Other - as entered by PI in eCRF|1
4620112|NCT01781429|7482021|FG002|Overall Study|Other - as entered by PI in eCRF|0
4620113|NCT01781429|7482022|FG003|Overall Study|Other - as entered by PI in eCRF|0
4620114|NCT01781429|7482023|FG004|Overall Study|Other - as entered by PI in eCRF|0
4620115|NCT01781429|7482024|FG005|Overall Study|Other - as entered by PI in eCRF|0
4620116|NCT01781429|7482025|FG006|Overall Study|Other - as entered by PI in eCRF|0
4620117|NCT01781429|7482026|FG007|Overall Study|Other - as entered by PI in eCRF|0
4620118|NCT01781429|7482027|FG008|Overall Study|Other - as entered by PI in eCRF|0
4620119|NCT01781429|7482028|FG009|Overall Study|Other - as entered by PI in eCRF|1
4620120|NCT01781429|7482029|FG010|Overall Study|Other - as entered by PI in eCRF|1
4620121|NCT01781429|7482030|FG011|Overall Study|Other - as entered by PI in eCRF|2
4620122|NCT01781429|7482031|FG012|Overall Study|Other - as entered by PI in eCRF|1
4620123|NCT01781429|7482032|FG013|Overall Study|Other - as entered by PI in eCRF|1
4620124|NCT01781429|7482033|FG014|Overall Study|Other - as entered by PI in eCRF|1
4620125|NCT01781429|7482034|FG015|Overall Study|Other - as entered by PI in eCRF|0
4620126|NCT01781429|7482019|FG000|Overall Study|Enrolled, but not treated|0
4620127|NCT01781429|7482020|FG001|Overall Study|Enrolled, but not treated|0
4620128|NCT01781429|7482021|FG002|Overall Study|Enrolled, but not treated|0
4620129|NCT01781429|7482022|FG003|Overall Study|Enrolled, but not treated|0
4620130|NCT01781429|7482023|FG004|Overall Study|Enrolled, but not treated|0
4620131|NCT01781429|7482024|FG005|Overall Study|Enrolled, but not treated|0
4620132|NCT01781429|7482025|FG006|Overall Study|Enrolled, but not treated|0
4620133|NCT01781429|7482026|FG007|Overall Study|Enrolled, but not treated|0
4620134|NCT01781429|7482027|FG008|Overall Study|Enrolled, but not treated|0
4620135|NCT01781429|7482028|FG009|Overall Study|Enrolled, but not treated|0
4620136|NCT01781429|7482029|FG010|Overall Study|Enrolled, but not treated|1
4620137|NCT01781429|7482030|FG011|Overall Study|Enrolled, but not treated|0
4620138|NCT01781429|7482031|FG012|Overall Study|Enrolled, but not treated|0
4620139|NCT01781429|7482032|FG013|Overall Study|Enrolled, but not treated|0
4549529|NCT01201317|7376652|FG002|Overall Study|Protocol Violation|1
4549530|NCT01201317|7376650|FG000|Overall Study|Death|0
4549531|NCT01201317|7376651|FG001|Overall Study|Death|1
4549532|NCT01201317|7376652|FG002|Overall Study|Death|0
4549533|NCT01201317|7376650|FG000|Overall Study|Study-specific withdrawal criteria|0
4549534|NCT01201317|7376651|FG001|Overall Study|Study-specific withdrawal criteria|0
4549535|NCT01201317|7376652|FG002|Overall Study|Study-specific withdrawal criteria|1
4549536|NCT01201317|7376650|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0
4549537|NCT01201317|7376651|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1
4549538|NCT01201317|7376652|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0
4549539|NCT01201317|7376650|FG000|Overall Study|Decrease in renal function|0
4549540|NCT01201317|7376651|FG001|Overall Study|Decrease in renal function|1
4549541|NCT01201317|7376652|FG002|Overall Study|Decrease in renal function|0
4549542|NCT01201317|7376650|FG000|Overall Study|Lack of Efficacy|1
4549543|NCT01201317|7376651|FG001|Overall Study|Lack of Efficacy|0
4549544|NCT01201317|7376652|FG002|Overall Study|Lack of Efficacy|0
4549545|NCT01201317|7376650|FG000|Overall Study|Safety, possible history of tuberculosis|0
4549546|NCT01201317|7376651|FG001|Overall Study|Safety, possible history of tuberculosis|0
4549547|NCT01201317|7376652|FG002|Overall Study|Safety, possible history of tuberculosis|1
4549548|NCT01201343|7376660|FG000|Overall Study|Adverse Event|6
4549549|NCT01201343|7376660|FG000|Overall Study|Withdrawal by Subject|5
4549550|NCT01201343|7376660|FG000|Overall Study|Lost to Follow-up|2
4549551|NCT01201343|7376660|FG000|Overall Study|Lack of Efficacy|2
4549552|NCT01201343|7376660|FG000|Overall Study|Participant wrongly included in trial|1
4549553|NCT01201343|7376660|FG000|Overall Study|Randomized, not treated|3
4549554|NCT01201356|7376664|FG000|Overall Study|Adverse Event|170
4549555|NCT01201356|7376664|FG000|Overall Study|Abnormal laboratory value(s)|51
4549556|NCT01201356|7376664|FG000|Overall Study|Abnormal test procedure result(s)|3
4549557|NCT01201356|7376664|FG000|Overall Study|Unsatisfactory therapeutic effect|112
4549558|NCT01201356|7376664|FG000|Overall Study|Condition no longer requires study drug|12
4549559|NCT01201356|7376664|FG000|Overall Study|Withdrawal by Subject|144
4549560|NCT01201356|7376664|FG000|Overall Study|Lost to Follow-up|50
4549561|NCT01201356|7376664|FG000|Overall Study|administrative problems|74
4549562|NCT01201356|7376664|FG000|Overall Study|Death|16
4549563|NCT01201356|7376664|FG000|Overall Study|Protocol Violation|12
4549564|NCT01201759|7376683|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2
4549565|NCT01201759|7376684|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1
4620140|NCT01781429|7482033|FG014|Overall Study|Enrolled, but not treated|0
4549566|NCT01201759|7376683|FG000|Visit 3 - Washout|Adverse Event|0
4549567|NCT01201759|7376684|FG001|Visit 3 - Washout|Adverse Event|3
4549568|NCT01201759|7376683|FG000|Visit 3 - Washout|Lost to Follow-up|1
4549569|NCT01201759|7376684|FG001|Visit 3 - Washout|Lost to Follow-up|0
4549570|NCT01201759|7376683|FG000|Visit 4 Crossover|Lost to Follow-up|0
4549571|NCT01201759|7376684|FG001|Visit 4 Crossover|Lost to Follow-up|1
4549572|NCT01201785|7376703|FG000|Overall Study|Lost to Follow-up|16
4549573|NCT01201798|7376709|FG000|Overall Study|Adverse Event|2
4549574|NCT01201798|7376710|FG001|Overall Study|Adverse Event|0
4549575|NCT01201798|7376709|FG000|Overall Study|Lost to Follow-up|3
4549576|NCT01201798|7376710|FG001|Overall Study|Lost to Follow-up|5
4549577|NCT01201798|7376709|FG000|Overall Study|Decision Unrelated to an Adverse Event|1
4549578|NCT01201798|7376710|FG001|Overall Study|Decision Unrelated to an Adverse Event|1
4549579|NCT01201798|7376709|FG000|Overall Study|Noncompliance|1
4549580|NCT01201798|7376710|FG001|Overall Study|Noncompliance|0
4549581|NCT01201798|7376709|FG000|Overall Study|Protocol Violation|1
4549582|NCT01201798|7376710|FG001|Overall Study|Protocol Violation|1
4549583|NCT01201798|7376709|FG000|Overall Study|Treatment Failure|1
4549584|NCT01201798|7376710|FG001|Overall Study|Treatment Failure|8
4549585|NCT01201811|7376716|FG000|Overall Study|Adverse Event|6
4549586|NCT01201811|7376716|FG000|Overall Study|Disease progression|3
4549587|NCT01201811|7376716|FG000|Overall Study|Withdrawal by Subject|3
4549588|NCT01201811|7376716|FG000|Overall Study|Death|4
4549589|NCT01201811|7376716|FG000|Overall Study|Treatment Failure|2
4549590|NCT01201811|7376716|FG000|Overall Study|Physician Decision|1
4549591|NCT01201850|7376720|FG000|Overall Study|Tumor progression|4
4549592|NCT01201915|7376740|FG000|Overall Study|Adverse Event|2
4549593|NCT01201915|7376741|FG001|Overall Study|Adverse Event|1
4549594|NCT01201915|7376742|FG002|Overall Study|Adverse Event|1
4549595|NCT01201915|7376740|FG000|Overall Study|Lost to Follow-up|0
4549596|NCT01201915|7376741|FG001|Overall Study|Lost to Follow-up|4
4549597|NCT01201915|7376742|FG002|Overall Study|Lost to Follow-up|0
4549598|NCT01201915|7376740|FG000|Overall Study|Physician Decision|3
4549599|NCT01201915|7376741|FG001|Overall Study|Physician Decision|0
4549600|NCT01201915|7376742|FG002|Overall Study|Physician Decision|0
4549601|NCT01201915|7376740|FG000|Overall Study|Subject Decision|3
4549602|NCT01201915|7376741|FG001|Overall Study|Subject Decision|3
4549603|NCT01201915|7376742|FG002|Overall Study|Subject Decision|5
4549604|NCT01201915|7376740|FG000|Overall Study|Target Lesion Progression|0
4549605|NCT01201915|7376741|FG001|Overall Study|Target Lesion Progression|3
4549606|NCT01201915|7376742|FG002|Overall Study|Target Lesion Progression|0
4549607|NCT01201967|7376752|FG000|Overall Study|Lost to Follow-up|6
4549608|NCT01201967|7376753|FG001|Overall Study|Lost to Follow-up|5
4549609|NCT01202175|7376784|FG000|Overall Study|Lost to Follow-up|2
4549610|NCT01202175|7376784|FG000|Overall Study|Withdrawal by Subject|1
4620141|NCT01781429|7482034|FG015|Overall Study|Enrolled, but not treated|0
4549611|NCT01202175|7376784|FG000|Overall Study|Adverse Event|2
4549612|NCT01202188|7376794|FG000|Overall Study|Protocol deviation|14
4549613|NCT01202188|7376795|FG001|Overall Study|Protocol deviation|8
4549614|NCT01202188|7376796|FG002|Overall Study|Protocol deviation|12
4549615|NCT01202188|7376797|FG003|Overall Study|Protocol deviation|10
4549616|NCT01202188|7376798|FG004|Overall Study|Protocol deviation|11
4549617|NCT01202188|7376794|FG000|Overall Study|Subject withdrew consent|12
4549618|NCT01202188|7376795|FG001|Overall Study|Subject withdrew consent|13
4549619|NCT01202188|7376796|FG002|Overall Study|Subject withdrew consent|22
4549620|NCT01202188|7376797|FG003|Overall Study|Subject withdrew consent|11
4549621|NCT01202188|7376798|FG004|Overall Study|Subject withdrew consent|13
4549622|NCT01202188|7376794|FG000|Overall Study|Adverse Event|5
4549623|NCT01202188|7376795|FG001|Overall Study|Adverse Event|23
4549624|NCT01202188|7376796|FG002|Overall Study|Adverse Event|13
4549625|NCT01202188|7376797|FG003|Overall Study|Adverse Event|10
4549626|NCT01202188|7376798|FG004|Overall Study|Adverse Event|10
4549627|NCT01202188|7376794|FG000|Overall Study|Administrative problems|3
4549628|NCT01202188|7376795|FG001|Overall Study|Administrative problems|2
4549629|NCT01202188|7376796|FG002|Overall Study|Administrative problems|1
4549630|NCT01202188|7376797|FG003|Overall Study|Administrative problems|1
4620142|NCT01781572|7482137|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7
4620143|NCT01781572|7482138|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0
4620144|NCT01781572|7482139|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11
4620145|NCT01781572|7482137|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8
4620146|NCT01781572|7482138|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6
4620147|NCT01781572|7482139|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23
4620148|NCT01781572|7482137|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1
4620149|NCT01781572|7482138|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0
4620150|NCT01781572|7482139|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2
4620151|NCT01781572|7482137|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0
4620152|NCT01781572|7482138|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0
4620153|NCT01781572|7482139|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4
4620154|NCT01781572|7482137|FG000|MEK162 45mg BID+LEE011 200mg|Death|0
4620155|NCT01781572|7482138|FG001|MEK162 45mg BID+LEE011 200mg|Death|0
4620156|NCT01781572|7482139|FG002|MEK162 45mg BID+LEE011 200mg|Death|1
4620157|NCT01781572|7482137|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2
4620158|NCT01781572|7482138|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0
4620159|NCT01781572|7482139|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0
4620160|NCT01781572|7482137|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1
4620161|NCT01781572|7482138|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0
4620162|NCT01781572|7482139|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0
4620163|NCT01781572|7482137|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1
4620164|NCT01781572|7482138|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0
4620165|NCT01781572|7482139|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0
4620166|NCT01781572|7482137|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3
4620167|NCT01781572|7482138|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2
4620168|NCT01781572|7482139|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0
4620169|NCT01781572|7482137|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1
4620170|NCT01781572|7482138|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1
4620171|NCT01781572|7482139|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0
4620172|NCT01781572|7482137|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4
4620173|NCT01781572|7482138|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3
4620174|NCT01781572|7482139|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0
4620175|NCT01781572|7482137|FG000|MEK162 45mg BID+LEE011 300mg|Death|1
4620176|NCT01781572|7482138|FG001|MEK162 45mg BID+LEE011 300mg|Death|0
4620177|NCT01781572|7482139|FG002|MEK162 45mg BID+LEE011 300mg|Death|0
4620178|NCT01781572|7482137|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0
4620179|NCT01781572|7482138|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5
4620180|NCT01781572|7482139|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0
4620181|NCT01781572|7482137|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0
4620182|NCT01781572|7482138|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1
4620183|NCT01781572|7482139|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0
4620184|NCT01781572|7482137|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0
4620185|NCT01781572|7482138|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2
4620186|NCT01781572|7482139|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0
4620187|NCT01781572|7482137|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0
4620188|NCT01781572|7482138|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6
4620189|NCT01781572|7482139|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0
4620190|NCT01781572|7482137|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0
4620191|NCT01781572|7482138|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1
4620192|NCT01781572|7482139|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0
4620193|NCT01781572|7482137|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0
4620194|NCT01781572|7482138|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5
4620195|NCT01781572|7482139|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0
4620196|NCT01781611|7482170|FG000|Overall Study|Adverse Event|4
4620197|NCT01781611|7482171|FG001|Overall Study|Adverse Event|0
4620198|NCT01781832|7482187|FG000|Overall Study|Withdrawal by Subject|1
4620199|NCT01781962|7482191|FG000|Overall Study|Other Miscellaneous Reasons|5
4620200|NCT01781975|7482197|FG000|Overall Study|Death|1
4620201|NCT01781975|7482198|FG001|Overall Study|Death|0
4620202|NCT01781975|7482197|FG000|Overall Study|Withdrawal by Subject|1
4620203|NCT01781975|7482198|FG001|Overall Study|Withdrawal by Subject|1
4620204|NCT01782131|7482206|FG000|Overall Study|Death|93
4549631|NCT01202188|7376798|FG004|Overall Study|Administrative problems|2
4549632|NCT01202188|7376794|FG000|Overall Study|Unsatisfactory therapeutic effect|2
4549633|NCT01202188|7376795|FG001|Overall Study|Unsatisfactory therapeutic effect|8
4549634|NCT01202188|7376796|FG002|Overall Study|Unsatisfactory therapeutic effect|2
4549635|NCT01202188|7376797|FG003|Overall Study|Unsatisfactory therapeutic effect|5
4549636|NCT01202188|7376798|FG004|Overall Study|Unsatisfactory therapeutic effect|8
4549637|NCT01202188|7376794|FG000|Overall Study|Lost to Follow-up|1
4549638|NCT01202188|7376795|FG001|Overall Study|Lost to Follow-up|1
4549639|NCT01202188|7376796|FG002|Overall Study|Lost to Follow-up|0
4549640|NCT01202188|7376797|FG003|Overall Study|Lost to Follow-up|4
4549641|NCT01202188|7376798|FG004|Overall Study|Lost to Follow-up|1
4549642|NCT01202188|7376794|FG000|Overall Study|Death|1
4549643|NCT01202188|7376795|FG001|Overall Study|Death|1
4549644|NCT01202188|7376796|FG002|Overall Study|Death|1
4549645|NCT01202188|7376797|FG003|Overall Study|Death|1
4549646|NCT01202188|7376798|FG004|Overall Study|Death|0
4549647|NCT01202188|7376794|FG000|Overall Study|Abnormal test procedure result (s)|0
4549648|NCT01202188|7376795|FG001|Overall Study|Abnormal test procedure result (s)|0
4549649|NCT01202188|7376796|FG002|Overall Study|Abnormal test procedure result (s)|2
4549650|NCT01202188|7376797|FG003|Overall Study|Abnormal test procedure result (s)|0
4549651|NCT01202188|7376798|FG004|Overall Study|Abnormal test procedure result (s)|0
4549652|NCT01202227|7376816|FG000|Overall Study|Adverse Event|16
4549653|NCT01202227|7376816|FG000|Overall Study|Withdrawal by Subject|2
4549654|NCT01202227|7376816|FG000|Overall Study|Lack of Efficacy|1
4549655|NCT01202279|7376826|FG000|Overall Study|Adverse Event|8
4549656|NCT01202279|7376827|FG001|Overall Study|Adverse Event|6
4549657|NCT01202279|7376826|FG000|Overall Study|Withdrawal by Subject|13
4549658|NCT01202279|7376827|FG001|Overall Study|Withdrawal by Subject|10
4549659|NCT01202279|7376826|FG000|Overall Study|Physician Decision|0
4549660|NCT01202279|7376827|FG001|Overall Study|Physician Decision|1
4549661|NCT01202279|7376826|FG000|Overall Study|Lost to Follow-up|10
4549662|NCT01202279|7376827|FG001|Overall Study|Lost to Follow-up|7
4549663|NCT01202279|7376826|FG000|Overall Study|Protocol Violation|1
4549664|NCT01202279|7376827|FG001|Overall Study|Protocol Violation|1
4549665|NCT01202279|7376826|FG000|Overall Study|study compliance|5
4549666|NCT01202279|7376827|FG001|Overall Study|study compliance|2
4549667|NCT01202409|7376833|FG000|Overall Study|Adverse Event|1
4549668|NCT01202409|7376833|FG000|Overall Study|Ineligible - KRAS mutants|7
4591665|NCT01532999|7438524|FG001|Overall Study|Physician Decision|2
4591666|NCT01532999|7438523|FG000|Overall Study|Withdrawal by Subject|5
4591667|NCT01532999|7438524|FG001|Overall Study|Withdrawal by Subject|0
4591668|NCT01532999|7438523|FG000|Overall Study|Relocated|2
4591669|NCT01532999|7438524|FG001|Overall Study|Relocated|0
4591670|NCT01532999|7438523|FG000|Overall Study|should not have been randomized|1
4591671|NCT01532999|7438524|FG001|Overall Study|should not have been randomized|0
4591672|NCT01532999|7438523|FG000|Overall Study|substantial noncompliance|2
4591673|NCT01532999|7438524|FG001|Overall Study|substantial noncompliance|0
4591674|NCT01532999|7438523|FG000|Overall Study|no show for week 9 assessments|6
4591675|NCT01532999|7438524|FG001|Overall Study|no show for week 9 assessments|4
4591676|NCT01532999|7438523|FG000|Overall Study|Adverse Event|0
4591677|NCT01532999|7438524|FG001|Overall Study|Adverse Event|1
4591678|NCT01532999|7438523|FG000|Overall Study|incarcerated|0
4591679|NCT01532999|7438524|FG001|Overall Study|incarcerated|1
4591680|NCT01532999|7438523|FG000|Overall Study|New job|0
4591681|NCT01532999|7438524|FG001|Overall Study|New job|2
4591682|NCT01533181|7438575|FG000|Overall Study|Disease progression pre-active treatment|0
4591683|NCT01533181|7438576|FG001|Overall Study|Disease progression pre-active treatment|1
4620205|NCT01782131|7482207|FG001|Overall Study|Death|96
4620206|NCT01782131|7482206|FG000|Overall Study|Lost to Follow-up|1
4620207|NCT01782131|7482207|FG001|Overall Study|Lost to Follow-up|3
4620208|NCT01782131|7482206|FG000|Overall Study|Withdrawal by Subject|10
4620209|NCT01782131|7482207|FG001|Overall Study|Withdrawal by Subject|10
4620210|NCT01782131|7482206|FG000|Overall Study|Randomized but not treated|5
4620211|NCT01782131|7482207|FG001|Overall Study|Randomized but not treated|5
4620212|NCT01782131|7482206|FG000|Overall Study|Reason not provided|0
4620213|NCT01782131|7482207|FG001|Overall Study|Reason not provided|1
4620214|NCT01782222|7482220|FG000|Overall Study|Adverse Event|4
4620215|NCT01782222|7482221|FG001|Overall Study|Adverse Event|5
4620216|NCT01782222|7482222|FG002|Overall Study|Adverse Event|3
4620217|NCT01782222|7482220|FG000|Overall Study|Lack of Efficacy|2
4620218|NCT01782222|7482221|FG001|Overall Study|Lack of Efficacy|1
4620219|NCT01782222|7482222|FG002|Overall Study|Lack of Efficacy|0
4620220|NCT01782222|7482220|FG000|Overall Study|Protocol Violation|1
4620221|NCT01782222|7482221|FG001|Overall Study|Protocol Violation|0
4620222|NCT01782222|7482222|FG002|Overall Study|Protocol Violation|0
4591684|NCT01533181|7438575|FG000|Overall Study|Patient withdrawal pre-active treatment|1
4591685|NCT01533181|7438576|FG001|Overall Study|Patient withdrawal pre-active treatment|0
4591686|NCT01533246|7438591|FG000|Overall Study|Adverse Event|1
4591687|NCT01533246|7438591|FG000|Overall Study|Withdrawal by Subject|1
4591688|NCT01533428|7438601|FG000|Overall Study|Adverse Event|0
4591689|NCT01533428|7438602|FG001|Overall Study|Adverse Event|1
4591690|NCT01533428|7438601|FG000|Overall Study|Lost to Follow-up|2
4591691|NCT01533428|7438602|FG001|Overall Study|Lost to Follow-up|1
4620223|NCT01782222|7482220|FG000|Overall Study|Withdrawal by Subject|1
4591692|NCT01533428|7438601|FG000|Overall Study|Withdrawal by Subject|7
4620224|NCT01782222|7482221|FG001|Overall Study|Withdrawal by Subject|4
4549669|NCT01202591|7376851|FG000|Overall Study|Adverse Event|2
4549670|NCT01202591|7376852|FG001|Overall Study|Adverse Event|1
4549671|NCT01202591|7376853|FG002|Overall Study|Adverse Event|4
4549672|NCT01202591|7376854|FG003|Overall Study|Adverse Event|4
4549673|NCT01202591|7376855|FG004|Overall Study|Adverse Event|0
4549674|NCT01202591|7376856|FG005|Overall Study|Adverse Event|0
4549675|NCT01202591|7376851|FG000|Overall Study|Other reason as per investigator|3
4549676|NCT01202591|7376852|FG001|Overall Study|Other reason as per investigator|4
4549677|NCT01202591|7376853|FG002|Overall Study|Other reason as per investigator|7
4549678|NCT01202591|7376854|FG003|Overall Study|Other reason as per investigator|3
4549679|NCT01202591|7376855|FG004|Overall Study|Other reason as per investigator|1
4549680|NCT01202591|7376856|FG005|Overall Study|Other reason as per investigator|3
4549681|NCT01202591|7376851|FG000|Overall Study|Withdrawal by Subject|0
4549682|NCT01202591|7376852|FG001|Overall Study|Withdrawal by Subject|0
4549683|NCT01202591|7376853|FG002|Overall Study|Withdrawal by Subject|0
4549684|NCT01202591|7376854|FG003|Overall Study|Withdrawal by Subject|0
4549685|NCT01202591|7376855|FG004|Overall Study|Withdrawal by Subject|2
4549686|NCT01202591|7376856|FG005|Overall Study|Withdrawal by Subject|1
4549687|NCT01202591|7376851|FG000|Overall Study|Objective Disease Progression|0
4549688|NCT01202591|7376852|FG001|Overall Study|Objective Disease Progression|0
4549689|NCT01202591|7376853|FG002|Overall Study|Objective Disease Progression|0
4549690|NCT01202591|7376854|FG003|Overall Study|Objective Disease Progression|0
4549691|NCT01202591|7376855|FG004|Overall Study|Objective Disease Progression|2
4549692|NCT01202591|7376856|FG005|Overall Study|Objective Disease Progression|0
4591693|NCT01533428|7438602|FG001|Overall Study|Withdrawal by Subject|6
4591694|NCT01533493|7438610|FG000|Overall Study|Adverse Event|2
4591695|NCT01533493|7438611|FG001|Overall Study|Adverse Event|1
4591696|NCT01533493|7438610|FG000|Overall Study|Withdrawal by Subject|1
4591697|NCT01533493|7438611|FG001|Overall Study|Withdrawal by Subject|2
4591698|NCT01533493|7438610|FG000|Overall Study|Lost to Follow-up|2
4591699|NCT01533493|7438611|FG001|Overall Study|Lost to Follow-up|0
4591700|NCT01533688|7438629|FG000|Overall Study|Withdrawal by Subject|5
4591701|NCT01533688|7438630|FG001|Overall Study|Withdrawal by Subject|4
4591702|NCT01533688|7438631|FG002|Overall Study|Withdrawal by Subject|3
4591703|NCT01533688|7438629|FG000|Overall Study|Medically unstable|1
4591704|NCT01533688|7438630|FG001|Overall Study|Medically unstable|3
4591705|NCT01533688|7438631|FG002|Overall Study|Medically unstable|3
4591706|NCT01533688|7438629|FG000|Overall Study|Had colonoscopy at outside hospital|2
4591707|NCT01533688|7438630|FG001|Overall Study|Had colonoscopy at outside hospital|3
4591708|NCT01533688|7438631|FG002|Overall Study|Had colonoscopy at outside hospital|2
4591709|NCT01533922|7438641|FG000|Overall Study|Adverse Event|5
4591710|NCT01533922|7438642|FG001|Overall Study|Adverse Event|8
4591711|NCT01533922|7438643|FG002|Overall Study|Adverse Event|6
4591712|NCT01533922|7438644|FG003|Overall Study|Adverse Event|3
4591713|NCT01533922|7438645|FG004|Overall Study|Adverse Event|4
4591714|NCT01533922|7438641|FG000|Overall Study|Lack of Efficacy|0
4591715|NCT01533922|7438642|FG001|Overall Study|Lack of Efficacy|0
4591716|NCT01533922|7438643|FG002|Overall Study|Lack of Efficacy|1
4591717|NCT01533922|7438644|FG003|Overall Study|Lack of Efficacy|0
4591718|NCT01533922|7438645|FG004|Overall Study|Lack of Efficacy|0
4591719|NCT01533922|7438641|FG000|Overall Study|Protocol Violation|0
4591720|NCT01533922|7438642|FG001|Overall Study|Protocol Violation|3
4620225|NCT01782222|7482222|FG002|Overall Study|Withdrawal by Subject|1
4620226|NCT01782222|7482220|FG000|Overall Study|Moved to other state|0
4620227|NCT01782222|7482221|FG001|Overall Study|Moved to other state|1
4620228|NCT01782222|7482222|FG002|Overall Study|Moved to other state|0
4620229|NCT01782313|7482230|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3
4620230|NCT01782313|7482230|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3
4620231|NCT01782313|7482230|FG000|Treated Cycle 3|Progressive Disease|21
4620232|NCT01782313|7482230|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5
4620233|NCT01782313|7482230|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1
4620234|NCT01782313|7482230|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6
4620235|NCT01782313|7482230|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1
4620236|NCT01782313|7482230|FG000|Survival Follow up|Lost to Follow-up|1
4620237|NCT01782326|7482236|FG000|Planned Treatment Epoch|Subject/guardian decision|149
4620238|NCT01782326|7482237|FG001|Planned Treatment Epoch|Subject/guardian decision|151
4620239|NCT01782326|7482236|FG000|Planned Treatment Epoch|Death|29
4620240|NCT01782326|7482237|FG001|Planned Treatment Epoch|Death|30
4620241|NCT01782326|7482236|FG000|Planned Treatment Epoch|Physician Decision|18
4620242|NCT01782326|7482237|FG001|Planned Treatment Epoch|Physician Decision|16
4591721|NCT01533922|7438643|FG002|Overall Study|Protocol Violation|0
4591722|NCT01533922|7438644|FG003|Overall Study|Protocol Violation|0
4591723|NCT01533922|7438645|FG004|Overall Study|Protocol Violation|1
4591724|NCT01533922|7438641|FG000|Overall Study|Withdrawal by Subject|3
4591725|NCT01533922|7438642|FG001|Overall Study|Withdrawal by Subject|1
4633024|NCT01907100|7502853|FG002|Overall Study|Adverse event (AE)|22
4591726|NCT01533922|7438643|FG002|Overall Study|Withdrawal by Subject|2
4591727|NCT01533922|7438644|FG003|Overall Study|Withdrawal by Subject|2
4591728|NCT01533922|7438645|FG004|Overall Study|Withdrawal by Subject|1
4591729|NCT01533922|7438641|FG000|Overall Study|Other reason not defined above|2
4591730|NCT01533922|7438642|FG001|Overall Study|Other reason not defined above|0
4549693|NCT01202747|7376907|FG000|Overall Study|Withdrawal by Subject|1
4549694|NCT01202760|7376914|FG000|Overall Study|Entry Criteria Not Met|0
4549695|NCT01202760|7376915|FG001|Overall Study|Entry Criteria Not Met|3
4549696|NCT01202760|7376916|FG002|Overall Study|Entry Criteria Not Met|1
4549697|NCT01202760|7376914|FG000|Overall Study|Adverse Event|11
4549698|NCT01202760|7376915|FG001|Overall Study|Adverse Event|9
4549699|NCT01202760|7376916|FG002|Overall Study|Adverse Event|10
4549700|NCT01202760|7376914|FG000|Overall Study|Death|2
4549701|NCT01202760|7376915|FG001|Overall Study|Death|1
4549702|NCT01202760|7376916|FG002|Overall Study|Death|0
4549703|NCT01202760|7376914|FG000|Overall Study|Lack of Efficacy|6
4549704|NCT01202760|7376915|FG001|Overall Study|Lack of Efficacy|8
4549705|NCT01202760|7376916|FG002|Overall Study|Lack of Efficacy|7
4549706|NCT01202760|7376914|FG000|Overall Study|Lost to Follow-up|0
4549707|NCT01202760|7376915|FG001|Overall Study|Lost to Follow-up|2
4549708|NCT01202760|7376916|FG002|Overall Study|Lost to Follow-up|1
4549709|NCT01202760|7376914|FG000|Overall Study|Parent / Caregiver Decision|0
4549710|NCT01202760|7376915|FG001|Overall Study|Parent / Caregiver Decision|1
4549711|NCT01202760|7376916|FG002|Overall Study|Parent / Caregiver Decision|0
4549712|NCT01202760|7376914|FG000|Overall Study|Withdrawal by Subject|17
4549713|NCT01202760|7376915|FG001|Overall Study|Withdrawal by Subject|18
4549714|NCT01202760|7376916|FG002|Overall Study|Withdrawal by Subject|14
4549715|NCT01202760|7376914|FG000|Overall Study|Physician Decision|0
4549716|NCT01202760|7376915|FG001|Overall Study|Physician Decision|1
4549717|NCT01202760|7376916|FG002|Overall Study|Physician Decision|0
4549718|NCT01202760|7376914|FG000|Overall Study|Protocol Violation|7
4549719|NCT01202760|7376915|FG001|Overall Study|Protocol Violation|5
4549720|NCT01202760|7376916|FG002|Overall Study|Protocol Violation|2
4549721|NCT01202760|7376914|FG000|Overall Study|Sponsor Decision|4
4549722|NCT01202760|7376915|FG001|Overall Study|Sponsor Decision|4
4549723|NCT01202760|7376916|FG002|Overall Study|Sponsor Decision|0
4549724|NCT01202773|7376939|FG000|Overall Study|Adverse Event|4
4549725|NCT01202773|7376940|FG001|Overall Study|Adverse Event|5
4549726|NCT01202773|7376941|FG002|Overall Study|Adverse Event|5
4549727|NCT01202773|7376939|FG000|Overall Study|Lack of Efficacy|5
4549728|NCT01202773|7376940|FG001|Overall Study|Lack of Efficacy|4
4620243|NCT01782326|7482236|FG000|Planned Treatment Epoch|Protocol deviation|2
4620244|NCT01782326|7482237|FG001|Planned Treatment Epoch|Protocol deviation|3
4620245|NCT01782326|7482236|FG000|Planned Treatment Epoch|Lost to Follow-up|4
4620246|NCT01782326|7482237|FG001|Planned Treatment Epoch|Lost to Follow-up|4
4620247|NCT01782326|7482236|FG000|Planned Treatment Epoch|Technical problems|0
4620248|NCT01782326|7482237|FG001|Planned Treatment Epoch|Technical problems|4
4620249|NCT01782326|7482236|FG000|Double-blind Treatment|Adverse Event|129
4620250|NCT01782326|7482237|FG001|Double-blind Treatment|Adverse Event|145
4620251|NCT01782326|7482236|FG000|Double-blind Treatment|Subject/guardian decision|111
4620252|NCT01782326|7482237|FG001|Double-blind Treatment|Subject/guardian decision|125
4620253|NCT01782326|7482236|FG000|Double-blind Treatment|Lack of Efficacy|17
4620254|NCT01782326|7482237|FG001|Double-blind Treatment|Lack of Efficacy|22
4620255|NCT01782326|7482236|FG000|Double-blind Treatment|Physician Decision|13
4620256|NCT01782326|7482237|FG001|Double-blind Treatment|Physician Decision|16
4620257|NCT01782326|7482236|FG000|Double-blind Treatment|Protocol deviation|8
4620258|NCT01782326|7482237|FG001|Double-blind Treatment|Protocol deviation|7
4620259|NCT01782326|7482236|FG000|Double-blind Treatment|Technical problems|0
4620260|NCT01782326|7482237|FG001|Double-blind Treatment|Technical problems|5
4620261|NCT01782378|7482245|FG000|First Series|Lost to Follow-up|7
4620262|NCT01782378|7482246|FG001|First Series|Lost to Follow-up|8
4620263|NCT01782378|7482245|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0
4620264|NCT01782378|7482246|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25
4620265|NCT01782378|7482245|FG000|Second Series|Lost to Follow-up|8
4620266|NCT01782378|7482246|FG001|Second Series|Lost to Follow-up|7
4620267|NCT01782378|7482245|FG000|Second Series|Did not choose to complete S2 Optional|18
4620268|NCT01782378|7482246|FG001|Second Series|Did not choose to complete S2 Optional|0
4620269|NCT01782469|7482252|FG000|Overall Study|Lost to Follow-up|1
4620270|NCT01782482|7482258|FG000|Overall Study|Adverse Event|2
4620271|NCT01782482|7482259|FG001|Overall Study|Adverse Event|1
4620272|NCT01782482|7482258|FG000|Overall Study|Lost to Follow-up|2
4620273|NCT01782482|7482259|FG001|Overall Study|Lost to Follow-up|3
4620274|NCT01782482|7482258|FG000|Overall Study|Physician Decision|1
4620275|NCT01782482|7482259|FG001|Overall Study|Physician Decision|0
4620276|NCT01782482|7482258|FG000|Overall Study|Protocol Violation|1
4620277|NCT01782482|7482259|FG001|Overall Study|Protocol Violation|0
4549729|NCT01202773|7376941|FG002|Overall Study|Lack of Efficacy|9
4549730|NCT01202773|7376939|FG000|Overall Study|Entry Criteria Not Met|2
4549731|NCT01202773|7376940|FG001|Overall Study|Entry Criteria Not Met|0
4549732|NCT01202773|7376941|FG002|Overall Study|Entry Criteria Not Met|1
4549733|NCT01202773|7376939|FG000|Overall Study|Lost to Follow-up|1
4549734|NCT01202773|7376940|FG001|Overall Study|Lost to Follow-up|2
4549735|NCT01202773|7376941|FG002|Overall Study|Lost to Follow-up|2
4549736|NCT01202773|7376939|FG000|Overall Study|Withdrawal by Subject|13
4549737|NCT01202773|7376940|FG001|Overall Study|Withdrawal by Subject|6
4549738|NCT01202773|7376941|FG002|Overall Study|Withdrawal by Subject|5
4549739|NCT01202773|7376939|FG000|Overall Study|Physician Decision|2
4549740|NCT01202773|7376940|FG001|Overall Study|Physician Decision|0
4549741|NCT01202773|7376941|FG002|Overall Study|Physician Decision|0
4549742|NCT01202773|7376939|FG000|Overall Study|Protocol Violation|11
4549743|NCT01202773|7376940|FG001|Overall Study|Protocol Violation|6
4549744|NCT01202773|7376941|FG002|Overall Study|Protocol Violation|10
4549745|NCT01202773|7376939|FG000|Overall Study|Sponsor Decision|19
4549746|NCT01202773|7376940|FG001|Overall Study|Sponsor Decision|20
4549747|NCT01202773|7376941|FG002|Overall Study|Sponsor Decision|23
4549748|NCT01202877|7376962|FG000|Overall Study|Disease Progression|0
4549749|NCT01202877|7376963|FG001|Overall Study|Disease Progression|1
4620278|NCT01782482|7482258|FG000|Overall Study|Withdrawal by Subject|2
4620279|NCT01782482|7482259|FG001|Overall Study|Withdrawal by Subject|3
4620280|NCT01782482|7482258|FG000|Overall Study|Randomized in Error|2
4620281|NCT01782482|7482259|FG001|Overall Study|Randomized in Error|2
4620282|NCT01782482|7482258|FG000|Overall Study|Habitually wearing toric lens OS|0
4620283|NCT01782482|7482259|FG001|Overall Study|Habitually wearing toric lens OS|1
4620284|NCT01782495|7482276|FG000|Overall Study|Adverse Event|0
4620285|NCT01782495|7482277|FG001|Overall Study|Adverse Event|0
4620286|NCT01782495|7482278|FG002|Overall Study|Adverse Event|0
4620287|NCT01782495|7482279|FG003|Overall Study|Adverse Event|0
4620288|NCT01782495|7482280|FG004|Overall Study|Adverse Event|0
4620289|NCT01782495|7482281|FG005|Overall Study|Adverse Event|0
4620290|NCT01782495|7482282|FG006|Overall Study|Adverse Event|0
4620291|NCT01782495|7482283|FG007|Overall Study|Adverse Event|2
4620292|NCT01782495|7482284|FG008|Overall Study|Adverse Event|0
4620293|NCT01782495|7482285|FG009|Overall Study|Adverse Event|0
4620294|NCT01782495|7482286|FG010|Overall Study|Adverse Event|0
4620295|NCT01782495|7482276|FG000|Overall Study|Withdrew Consent|0
4620296|NCT01782495|7482277|FG001|Overall Study|Withdrew Consent|1
4620297|NCT01782495|7482278|FG002|Overall Study|Withdrew Consent|0
4620298|NCT01782495|7482279|FG003|Overall Study|Withdrew Consent|0
4620299|NCT01782495|7482280|FG004|Overall Study|Withdrew Consent|0
4620300|NCT01782495|7482281|FG005|Overall Study|Withdrew Consent|0
4620301|NCT01782495|7482282|FG006|Overall Study|Withdrew Consent|0
4620302|NCT01782495|7482283|FG007|Overall Study|Withdrew Consent|1
4620303|NCT01782495|7482284|FG008|Overall Study|Withdrew Consent|0
4620304|NCT01782495|7482285|FG009|Overall Study|Withdrew Consent|0
4620305|NCT01782495|7482286|FG010|Overall Study|Withdrew Consent|0
4633025|NCT01907100|7502854|FG003|Overall Study|Adverse event (AE)|23
4633026|NCT01907100|7502851|FG000|Overall Study|Worsening/AE underlying cancer disease|0
4633027|NCT01907100|7502852|FG001|Overall Study|Worsening/AE underlying cancer disease|0
4633028|NCT01907100|7502853|FG002|Overall Study|Worsening/AE underlying cancer disease|8
4633029|NCT01907100|7502854|FG003|Overall Study|Worsening/AE underlying cancer disease|8
4633030|NCT01907217|7502885|FG000|Overall Study|Withdrawal by Subject|0
4633031|NCT01907217|7502886|FG001|Overall Study|Withdrawal by Subject|2
4633032|NCT01907516|7502920|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5
4633033|NCT01907516|7502921|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9
4633034|NCT01907516|7502920|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1
4633035|NCT01907516|7502921|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3
4633036|NCT01907516|7502920|FG000|First Intervention (3 Weeks)|Delivered before second arm|3
4633037|NCT01907516|7502921|FG001|First Intervention (3 Weeks)|Delivered before second arm|4
4633038|NCT01907516|7502920|FG000|First Intervention (3 Weeks)|Developed DKA during study|1
4633039|NCT01907516|7502921|FG001|First Intervention (3 Weeks)|Developed DKA during study|0
4633040|NCT01907737|7502932|FG000|Overall Study|Withdrawal by Subject|1
4633041|NCT01907815|7502944|FG000|Overall Study|Withdrawal by Subject|1
4633042|NCT01907815|7502945|FG001|Overall Study|Withdrawal by Subject|0
4633043|NCT01907828|7502955|FG000|Overall Study|Exclusion criteria not met|0
4633044|NCT01907828|7502956|FG001|Overall Study|Exclusion criteria not met|1
4633045|NCT01907828|7502955|FG000|Overall Study|Withdrawal by Subject|3
4633046|NCT01907828|7502956|FG001|Overall Study|Withdrawal by Subject|4
4633047|NCT01907828|7502955|FG000|Overall Study|Lost to Follow-up|3
4633048|NCT01907828|7502956|FG001|Overall Study|Lost to Follow-up|0
4633049|NCT01907828|7502955|FG000|Overall Study|Participant refused 24-month follow-up|1
4633050|NCT01907828|7502956|FG001|Overall Study|Participant refused 24-month follow-up|0
4633051|NCT01907828|7502955|FG000|Overall Study|Participant met exclusion criteria|0
4633052|NCT01907828|7502956|FG001|Overall Study|Participant met exclusion criteria|1
4633053|NCT01907854|7502964|FG000|Overall Study|Protocol Violation|1
4633054|NCT01907854|7502965|FG001|Overall Study|Protocol Violation|1
4633055|NCT01907854|7502964|FG000|Overall Study|Withdrawal by Subject|9
4633056|NCT01907854|7502965|FG001|Overall Study|Withdrawal by Subject|7
4549750|NCT01202877|7376964|FG002|Overall Study|Disease Progression|2
4633057|NCT01907854|7502964|FG000|Overall Study|Lost to Follow-up|2
4633058|NCT01907854|7502965|FG001|Overall Study|Lost to Follow-up|2
4633059|NCT01907854|7502964|FG000|Overall Study|Unclassified|4
4633060|NCT01907854|7502965|FG001|Overall Study|Unclassified|3
4633061|NCT01907906|7502973|FG000|Overall Study|Withdrawal by Subject|1
4633062|NCT01907906|7502974|FG001|Overall Study|Withdrawal by Subject|0
4633063|NCT01907906|7502973|FG000|Overall Study|Physician Decision|3
4633064|NCT01907906|7502974|FG001|Overall Study|Physician Decision|1
4549751|NCT01202877|7376962|FG000|Overall Study|Adverse Event|0
4549752|NCT01202877|7376963|FG001|Overall Study|Adverse Event|0
4633065|NCT01908101|7502994|FG000|Overall Study|Physician Decision|1
4633066|NCT01908101|7502994|FG000|Overall Study|Withdrawal by Subject|1
4633067|NCT01908101|7502994|FG000|Overall Study|Incorrect Diagnosis|2
4633068|NCT01908101|7502994|FG000|Overall Study|Incorrect Starting Dose|1
4549753|NCT01202877|7376964|FG002|Overall Study|Adverse Event|2
4549754|NCT01202877|7376962|FG000|Overall Study|Withdrawal by Subject|0
4549755|NCT01202877|7376963|FG001|Overall Study|Withdrawal by Subject|0
4549756|NCT01202877|7376964|FG002|Overall Study|Withdrawal by Subject|1
4549757|NCT01202877|7376962|FG000|Overall Study|Death|0
4549758|NCT01202877|7376963|FG001|Overall Study|Death|0
4549759|NCT01202877|7376964|FG002|Overall Study|Death|1
4549760|NCT01202903|7376974|FG000|Overall Study|Administrative Probelms|1
4549761|NCT01202903|7376975|FG001|Overall Study|Administrative Probelms|4
4549762|NCT01202903|7376974|FG000|Overall Study|Protocol Violation|0
4549763|NCT01202903|7376975|FG001|Overall Study|Protocol Violation|1
4549764|NCT01202903|7376974|FG000|Overall Study|Death|1
4549765|NCT01202903|7376975|FG001|Overall Study|Death|0
4549766|NCT01202903|7376974|FG000|Overall Study|Lost to Follow-up|1
4549767|NCT01202903|7376975|FG001|Overall Study|Lost to Follow-up|1
4549768|NCT01202903|7376974|FG000|Overall Study|Lack of Efficacy|1
4549769|NCT01202903|7376975|FG001|Overall Study|Lack of Efficacy|3
4549770|NCT01202903|7376974|FG000|Overall Study|Adverse Event|3
4549771|NCT01202903|7376975|FG001|Overall Study|Adverse Event|3
4549772|NCT01202903|7376974|FG000|Overall Study|Withdrawal by Subject|4
4549773|NCT01202903|7376975|FG001|Overall Study|Withdrawal by Subject|4
4549774|NCT01202955|7376983|FG000|Period 1: 10 Days|Withdrawal by Subject|0
4549775|NCT01202955|7376984|FG001|Period 1: 10 Days|Withdrawal by Subject|2
4620306|NCT01782664|7482316|FG000|Overall Study|Adverse Event|2
4620307|NCT01782664|7482317|FG001|Overall Study|Adverse Event|2
4620308|NCT01782664|7482318|FG002|Overall Study|Adverse Event|2
4620309|NCT01782664|7482319|FG003|Overall Study|Adverse Event|2
4620310|NCT01782664|7482320|FG004|Overall Study|Adverse Event|0
4620311|NCT01782664|7482321|FG005|Overall Study|Adverse Event|0
4620312|NCT01782664|7482316|FG000|Overall Study|Lack of Efficacy|2
4620313|NCT01782664|7482317|FG001|Overall Study|Lack of Efficacy|0
4620314|NCT01782664|7482318|FG002|Overall Study|Lack of Efficacy|2
4620315|NCT01782664|7482319|FG003|Overall Study|Lack of Efficacy|2
4620316|NCT01782664|7482320|FG004|Overall Study|Lack of Efficacy|0
4620317|NCT01782664|7482321|FG005|Overall Study|Lack of Efficacy|0
4620318|NCT01782664|7482316|FG000|Overall Study|Protocol Violation|0
4620319|NCT01782664|7482317|FG001|Overall Study|Protocol Violation|1
4620320|NCT01782664|7482318|FG002|Overall Study|Protocol Violation|0
4620321|NCT01782664|7482319|FG003|Overall Study|Protocol Violation|1
4620322|NCT01782664|7482320|FG004|Overall Study|Protocol Violation|0
4620323|NCT01782664|7482321|FG005|Overall Study|Protocol Violation|0
4620324|NCT01782664|7482316|FG000|Overall Study|Withdrawal by Subject|2
4620325|NCT01782664|7482317|FG001|Overall Study|Withdrawal by Subject|2
4620326|NCT01782664|7482318|FG002|Overall Study|Withdrawal by Subject|0
4620327|NCT01782664|7482319|FG003|Overall Study|Withdrawal by Subject|0
4620328|NCT01782664|7482320|FG004|Overall Study|Withdrawal by Subject|0
4620329|NCT01782664|7482321|FG005|Overall Study|Withdrawal by Subject|0
4620330|NCT01782690|7482335|FG000|Overall Study|Not reported|7
4620331|NCT01782690|7482335|FG000|Overall Study|Toxicity of gemcitabine|1
4620332|NCT01782690|7482335|FG000|Overall Study|Toxicity of erlotinib|1
4620333|NCT01782690|7482335|FG000|Overall Study|Lost to Follow-up|31
4620334|NCT01782690|7482335|FG000|Overall Study|Withdrawal of informed consent|2
4620335|NCT01782690|7482335|FG000|Overall Study|Absent rash|9
4620336|NCT01782690|7482335|FG000|Overall Study|Physician Decision|13
4620337|NCT01782690|7482335|FG000|Overall Study|Patient's wish|21
4620338|NCT01782690|7482335|FG000|Overall Study|Tumor progression|74
4620339|NCT01782690|7482335|FG000|Overall Study|Death|133
4620340|NCT01782690|7482335|FG000|Overall Study|Study completion unknown|7
4620341|NCT01782742|7482341|FG000|Double-blind Treatment Phase|Adverse Event|1
4620342|NCT01782742|7482342|FG001|Double-blind Treatment Phase|Adverse Event|0
4620343|NCT01782859|7482356|FG000|Overall Study|Protocol Violation|6
4620344|NCT01782859|7482357|FG001|Overall Study|Protocol Violation|6
4620345|NCT01782859|7482356|FG000|Overall Study|Withdrawal by Subject|0
4620346|NCT01782859|7482357|FG001|Overall Study|Withdrawal by Subject|1
4620347|NCT01782872|7482368|FG000|Overall Study|Protocol Violation|0
4620348|NCT01782872|7482369|FG001|Overall Study|Protocol Violation|0
4620349|NCT01782872|7482370|FG002|Overall Study|Protocol Violation|0
4620350|NCT01782872|7482371|FG003|Overall Study|Protocol Violation|1
4620351|NCT01782872|7482368|FG000|Overall Study|Withdrawal by Subject|0
4620352|NCT01782872|7482369|FG001|Overall Study|Withdrawal by Subject|1
4620353|NCT01782872|7482370|FG002|Overall Study|Withdrawal by Subject|0
4620354|NCT01782872|7482371|FG003|Overall Study|Withdrawal by Subject|0
4620355|NCT01782885|7482383|FG000|Overall Study|Lost to Follow-up|4
4620356|NCT01782885|7482384|FG001|Overall Study|Lost to Follow-up|6
4549776|NCT01203072|7377011|FG000|Overall Study|Adverse Event|5
4549777|NCT01203072|7377012|FG001|Overall Study|Adverse Event|3
4549778|NCT01203072|7377013|FG002|Overall Study|Adverse Event|2
4549779|NCT01203072|7377014|FG003|Overall Study|Adverse Event|4
4549780|NCT01203072|7377015|FG004|Overall Study|Adverse Event|2
4620357|NCT01783418|7482426|FG000|Overall Study|Withdrawal by Subject|1
4620358|NCT01783418|7482427|FG001|Overall Study|Withdrawal by Subject|0
4690616|NCT02561806|7600338|FG001|Maintenance Period|Adverse Event|1
4549781|NCT01203072|7377011|FG000|Overall Study|Lack of Efficacy|1
4549782|NCT01203072|7377012|FG001|Overall Study|Lack of Efficacy|0
4620359|NCT01783444|7482436|FG000|Treatment Phase|Adverse Event|9
4620360|NCT01783444|7482437|FG001|Treatment Phase|Adverse Event|20
4549783|NCT01203072|7377013|FG002|Overall Study|Lack of Efficacy|0
4549784|NCT01203072|7377014|FG003|Overall Study|Lack of Efficacy|0
4549785|NCT01203072|7377015|FG004|Overall Study|Lack of Efficacy|0
4549786|NCT01203072|7377011|FG000|Overall Study|Lost to Follow-up|0
4549787|NCT01203072|7377012|FG001|Overall Study|Lost to Follow-up|1
4549788|NCT01203072|7377013|FG002|Overall Study|Lost to Follow-up|0
4549789|NCT01203072|7377014|FG003|Overall Study|Lost to Follow-up|0
4549790|NCT01203072|7377015|FG004|Overall Study|Lost to Follow-up|0
4549791|NCT01203072|7377011|FG000|Overall Study|Protocol Violation|2
4549792|NCT01203072|7377012|FG001|Overall Study|Protocol Violation|0
4549793|NCT01203072|7377013|FG002|Overall Study|Protocol Violation|0
4549794|NCT01203072|7377014|FG003|Overall Study|Protocol Violation|0
4549795|NCT01203072|7377015|FG004|Overall Study|Protocol Violation|1
4549796|NCT01203072|7377011|FG000|Overall Study|Withdrawal by Subject|2
4549797|NCT01203072|7377012|FG001|Overall Study|Withdrawal by Subject|2
4549798|NCT01203072|7377013|FG002|Overall Study|Withdrawal by Subject|1
4549799|NCT01203072|7377014|FG003|Overall Study|Withdrawal by Subject|2
4549800|NCT01203072|7377015|FG004|Overall Study|Withdrawal by Subject|3
4549801|NCT01203098|7377030|FG000|Overall Study|Adverse Event|3
4549802|NCT01203098|7377031|FG001|Overall Study|Adverse Event|1
4549803|NCT01203098|7377032|FG002|Overall Study|Adverse Event|7
4549804|NCT01203098|7377030|FG000|Overall Study|Lost to Follow-up|0
4549805|NCT01203098|7377031|FG001|Overall Study|Lost to Follow-up|0
4549806|NCT01203098|7377032|FG002|Overall Study|Lost to Follow-up|1
4549807|NCT01203098|7377030|FG000|Overall Study|Physician Decision|2
4549808|NCT01203098|7377031|FG001|Overall Study|Physician Decision|2
4549809|NCT01203098|7377032|FG002|Overall Study|Physician Decision|0
4549810|NCT01203098|7377030|FG000|Overall Study|Withdrawal by Subject|1
4549811|NCT01203098|7377031|FG001|Overall Study|Withdrawal by Subject|1
4549812|NCT01203098|7377032|FG002|Overall Study|Withdrawal by Subject|3
4549813|NCT01203787|7377087|FG000|Overall Study|Death|12
4549814|NCT01203787|7377088|FG001|Overall Study|Death|10
4549815|NCT01203787|7377087|FG000|Overall Study|Withdrawal by Subject|6
4549816|NCT01203787|7377088|FG001|Overall Study|Withdrawal by Subject|2
4549817|NCT01203787|7377087|FG000|Overall Study|Lost to Follow-up|2
4549818|NCT01203787|7377088|FG001|Overall Study|Lost to Follow-up|0
4549819|NCT01203787|7377087|FG000|Overall Study|Adverse Event|11
4549820|NCT01203787|7377088|FG001|Overall Study|Adverse Event|15
4549821|NCT01203852|7377105|FG000|Metoprolol 8 Weeks|Physician Decision|470
4549822|NCT01203852|7377105|FG000|Washout 2 Weeks|Physician Decision|46
4549823|NCT01203878|7377115|FG000|Overall Study|Withdrawal by Subject|0
4549824|NCT01203878|7377116|FG001|Overall Study|Withdrawal by Subject|0
4549825|NCT01203878|7377117|FG002|Overall Study|Withdrawal by Subject|1
4549826|NCT01203878|7377115|FG000|Overall Study|Adverse Event|0
4620361|NCT01783444|7482438|FG002|Treatment Phase|Adverse Event|19
4620362|NCT01783444|7482436|FG000|Treatment Phase|Disease Progression|76
4620363|NCT01783444|7482437|FG001|Treatment Phase|Disease Progression|66
4620364|NCT01783444|7482438|FG002|Treatment Phase|Disease Progression|64
4620365|NCT01783444|7482436|FG000|Treatment Phase|Death|2
4620366|NCT01783444|7482437|FG001|Treatment Phase|Death|2
4620367|NCT01783444|7482438|FG002|Treatment Phase|Death|2
4620368|NCT01783444|7482436|FG000|Treatment Phase|Protocol Violation|1
4620369|NCT01783444|7482437|FG001|Treatment Phase|Protocol Violation|1
4620370|NCT01783444|7482438|FG002|Treatment Phase|Protocol Violation|2
4620371|NCT01783444|7482436|FG000|Treatment Phase|Withdrawal by Subject|6
4620372|NCT01783444|7482437|FG001|Treatment Phase|Withdrawal by Subject|8
4620373|NCT01783444|7482438|FG002|Treatment Phase|Withdrawal by Subject|9
4620374|NCT01783444|7482436|FG000|Treatment Phase|Administrative problems|2
4620375|NCT01783444|7482437|FG001|Treatment Phase|Administrative problems|0
4620376|NCT01783444|7482438|FG002|Treatment Phase|Administrative problems|1
4620377|NCT01783444|7482436|FG000|Treatment Phase|Physician Decision|8
4620378|NCT01783444|7482437|FG001|Treatment Phase|Physician Decision|6
4620379|NCT01783444|7482438|FG002|Treatment Phase|Physician Decision|5
4620380|NCT01783444|7482436|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7
4620381|NCT01783444|7482437|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8
4620382|NCT01783444|7482438|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11
4620383|NCT01783444|7482436|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9
4620384|NCT01783444|7482437|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7
4620385|NCT01783444|7482438|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5
4549827|NCT01203878|7377116|FG001|Overall Study|Adverse Event|0
4549828|NCT01203878|7377117|FG002|Overall Study|Adverse Event|2
4620386|NCT01783444|7482436|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4
4620387|NCT01783444|7482437|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8
4549829|NCT01203917|7377124|FG000|Overall Study|Death|29
4549830|NCT01203917|7377124|FG000|Overall Study|Lost to Follow-up|2
4549831|NCT01203917|7377124|FG000|Overall Study|Withdrawal by Subject|3
4549832|NCT01203917|7377124|FG000|Overall Study|Due to objective disease progression|1
4549833|NCT01203917|7377124|FG000|Overall Study|Due to EGFR M+I patient|1
4549834|NCT01203930|7377130|FG000|Overall Study|Disease Progression|0
4549835|NCT01203930|7377131|FG001|Overall Study|Disease Progression|4
4549836|NCT01203930|7377130|FG000|Overall Study|Death|3
4620388|NCT01783444|7482438|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8
4620389|NCT01783444|7482436|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0
4549837|NCT01203930|7377131|FG001|Overall Study|Death|1
4549838|NCT01203930|7377130|FG000|Overall Study|Withdrew Consent|1
4549839|NCT01203930|7377131|FG001|Overall Study|Withdrew Consent|10
4549840|NCT01203930|7377130|FG000|Overall Study|Investigator Request|0
4549841|NCT01203930|7377131|FG001|Overall Study|Investigator Request|8
4549842|NCT01203930|7377130|FG000|Overall Study|Study Terminated by Sponsor|0
4549843|NCT01203930|7377131|FG001|Overall Study|Study Terminated by Sponsor|12
4549844|NCT01203930|7377130|FG000|Overall Study|Poor tolerance of study drug|0
4620390|NCT01783444|7482437|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1
4620391|NCT01783444|7482438|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0
4620392|NCT01783444|7482436|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7
4620393|NCT01783444|7482437|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16
4620394|NCT01783444|7482438|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15
4620395|NCT01783444|7482436|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69
4620396|NCT01783444|7482437|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53
4620397|NCT01783444|7482438|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52
4620398|NCT01783483|7482457|FG000|Overall Study|Death|3
4620399|NCT01783483|7482458|FG001|Overall Study|Death|3
4620400|NCT01783483|7482457|FG000|Overall Study|Lost to Follow-up|14
4620401|NCT01783483|7482458|FG001|Overall Study|Lost to Follow-up|10
4620402|NCT01783483|7482457|FG000|Overall Study|Withdrawal by Subject|2
4620403|NCT01783483|7482458|FG001|Overall Study|Withdrawal by Subject|1
4620404|NCT01783483|7482457|FG000|Overall Study|Physician Decision|1
4620405|NCT01783483|7482458|FG001|Overall Study|Physician Decision|1
4620406|NCT01783496|7482470|FG000|Overall Study|Lost to Follow-up|0
4620407|NCT01783496|7482471|FG001|Overall Study|Lost to Follow-up|0
4620408|NCT01783496|7482472|FG002|Overall Study|Lost to Follow-up|0
4620409|NCT01783496|7482473|FG003|Overall Study|Lost to Follow-up|2
4620410|NCT01783496|7482474|FG004|Overall Study|Lost to Follow-up|0
4620411|NCT01783496|7482475|FG005|Overall Study|Lost to Follow-up|1
4620412|NCT01783496|7482470|FG000|Overall Study|Withdrawal by Subject|1
4620413|NCT01783496|7482471|FG001|Overall Study|Withdrawal by Subject|0
4620414|NCT01783496|7482472|FG002|Overall Study|Withdrawal by Subject|0
4620415|NCT01783496|7482473|FG003|Overall Study|Withdrawal by Subject|0
4620416|NCT01783496|7482474|FG004|Overall Study|Withdrawal by Subject|0
4620417|NCT01783496|7482475|FG005|Overall Study|Withdrawal by Subject|0
4620418|NCT01783548|7482500|FG000|Overall Study|Adverse Event|8
4620419|NCT01783548|7482501|FG001|Overall Study|Adverse Event|4
4620420|NCT01783548|7482500|FG000|Overall Study|Withdrawal by Subject|11
4620421|NCT01783548|7482501|FG001|Overall Study|Withdrawal by Subject|8
4620422|NCT01783548|7482500|FG000|Overall Study|Non-compliance|4
4620423|NCT01783548|7482501|FG001|Overall Study|Non-compliance|0
4620424|NCT01783548|7482500|FG000|Overall Study|Protocol Violation|2
4620425|NCT01783548|7482501|FG001|Overall Study|Protocol Violation|2
4620426|NCT01783548|7482500|FG000|Overall Study|Lost to Follow-up|8
4620427|NCT01783548|7482501|FG001|Overall Study|Lost to Follow-up|3
4620428|NCT01783548|7482500|FG000|Overall Study|Lack of Efficacy|1
4620429|NCT01783548|7482501|FG001|Overall Study|Lack of Efficacy|1
4620430|NCT01783678|7482535|FG000|Overall Study|Randomized but Not Treated|0
4620431|NCT01783678|7482536|FG001|Overall Study|Randomized but Not Treated|0
4620432|NCT01783678|7482537|FG002|Overall Study|Randomized but Not Treated|0
4620433|NCT01783678|7482538|FG003|Overall Study|Randomized but Not Treated|1
4620434|NCT01783678|7482539|FG004|Overall Study|Randomized but Not Treated|0
4620435|NCT01783678|7482540|FG005|Overall Study|Randomized but Not Treated|0
4620436|NCT01783678|7482535|FG000|Overall Study|Lack of Efficacy|1
4620437|NCT01783678|7482536|FG001|Overall Study|Lack of Efficacy|13
4620438|NCT01783678|7482537|FG002|Overall Study|Lack of Efficacy|1
4620439|NCT01783678|7482538|FG003|Overall Study|Lack of Efficacy|3
4620440|NCT01783678|7482539|FG004|Overall Study|Lack of Efficacy|6
4620441|NCT01783678|7482540|FG005|Overall Study|Lack of Efficacy|5
4620442|NCT01783678|7482535|FG000|Overall Study|Lost to Follow-up|0
4620443|NCT01783678|7482536|FG001|Overall Study|Lost to Follow-up|4
4620444|NCT01783678|7482537|FG002|Overall Study|Lost to Follow-up|0
4620445|NCT01783678|7482538|FG003|Overall Study|Lost to Follow-up|2
4620446|NCT01783678|7482539|FG004|Overall Study|Lost to Follow-up|1
4620447|NCT01783678|7482540|FG005|Overall Study|Lost to Follow-up|0
4620448|NCT01783678|7482535|FG000|Overall Study|Withdrew Consent|1
4620449|NCT01783678|7482536|FG001|Overall Study|Withdrew Consent|1
4620450|NCT01783678|7482537|FG002|Overall Study|Withdrew Consent|0
4620451|NCT01783678|7482538|FG003|Overall Study|Withdrew Consent|2
4620452|NCT01783678|7482539|FG004|Overall Study|Withdrew Consent|0
4620453|NCT01783678|7482540|FG005|Overall Study|Withdrew Consent|0
4620454|NCT01783730|7482555|FG000|Overall Study|Failed to meet inclusion criteria|6
4620455|NCT01783743|7482561|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427
4620456|NCT01783743|7482562|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439
4620457|NCT01783743|7482561|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591
4620458|NCT01783743|7482562|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684
4620459|NCT01783743|7482561|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305
4633069|NCT01908101|7502994|FG000|Overall Study|Did not complete the first cycle|4
4690617|NCT02561806|7600337|FG000|Maintenance Period|Lack of Efficacy|3
4690618|NCT02561806|7600338|FG001|Maintenance Period|Lack of Efficacy|1
4549845|NCT01203930|7377131|FG001|Overall Study|Poor tolerance of study drug|1
4549846|NCT01203930|7377130|FG000|Overall Study|Adverse Event|17
4549847|NCT01203930|7377131|FG001|Overall Study|Adverse Event|5
4549848|NCT01203956|7377139|FG000|Second Two-week Period|Non-compliant: no evaluable results|5
4549849|NCT01203956|7377140|FG001|Second Two-week Period|Non-compliant: no evaluable results|6
4549850|NCT01204294|7377162|FG000|Overall Study|Adverse Event|2
4549851|NCT01204294|7377163|FG001|Overall Study|Adverse Event|6
4549852|NCT01204294|7377164|FG002|Overall Study|Adverse Event|0
4549853|NCT01204294|7377165|FG003|Overall Study|Adverse Event|7
4549854|NCT01204294|7377166|FG004|Overall Study|Adverse Event|1
4620460|NCT01783743|7482562|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236
4620461|NCT01783821|7482570|FG000|Overall Study|Screen Failure|1
4620462|NCT01783821|7482571|FG001|Overall Study|Screen Failure|1
4620463|NCT01783886|7482605|FG000|Overall Study|Lost to Follow-up|0
4620464|NCT01783886|7482606|FG001|Overall Study|Lost to Follow-up|3
4620465|NCT01783886|7482607|FG002|Overall Study|Lost to Follow-up|0
4620466|NCT01783886|7482605|FG000|Overall Study|Protocol deviation|0
4620467|NCT01783886|7482606|FG001|Overall Study|Protocol deviation|0
4620468|NCT01783886|7482607|FG002|Overall Study|Protocol deviation|2
4620469|NCT01783886|7482605|FG000|Overall Study|Withdrawal of consent by participant|1
4620470|NCT01783886|7482606|FG001|Overall Study|Withdrawal of consent by participant|3
4620471|NCT01783886|7482607|FG002|Overall Study|Withdrawal of consent by participant|4
4620472|NCT01783886|7482605|FG000|Overall Study|Adverse Event|4
4620473|NCT01783886|7482606|FG001|Overall Study|Adverse Event|5
4620474|NCT01783886|7482607|FG002|Overall Study|Adverse Event|4
4620475|NCT01783938|7482630|FG000|Overall Study|Disease Progression|18
4620476|NCT01783938|7482631|FG001|Overall Study|Disease Progression|41
4620477|NCT01783938|7482630|FG000|Overall Study|Study Drug Toxicity|27
4620478|NCT01783938|7482631|FG001|Overall Study|Study Drug Toxicity|14
4620479|NCT01783938|7482630|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4
4620480|NCT01783938|7482631|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2
4620481|NCT01783938|7482630|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2
4620482|NCT01783938|7482631|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3
4620483|NCT01783938|7482630|FG000|Overall Study|Participant Withdrew Consent|2
4620484|NCT01783938|7482631|FG001|Overall Study|Participant Withdrew Consent|0
4620485|NCT01783938|7482630|FG000|Overall Study|Maximum Clinical Benefit|1
4620486|NCT01783938|7482631|FG001|Overall Study|Maximum Clinical Benefit|0
4620487|NCT01783938|7482630|FG000|Overall Study|Other Reasons|3
4620488|NCT01783938|7482631|FG001|Overall Study|Other Reasons|1
4620489|NCT01784029|7482651|FG000|Overall Study|Lost to Follow-up|19
4620490|NCT01784029|7482652|FG001|Overall Study|Lost to Follow-up|20
4620491|NCT01784029|7482653|FG002|Overall Study|Lost to Follow-up|22
4620492|NCT01784068|7482665|FG000|NTCS Phase|Adverse Event|5
4620493|NCT01784068|7482666|FG001|NTCS Phase|Adverse Event|0
4620494|NCT01784068|7482665|FG000|NTCS Phase|Physician Decision|2
4620495|NCT01784068|7482666|FG001|NTCS Phase|Physician Decision|0
4620496|NCT01784068|7482665|FG000|NTCS Phase|Patient/guardian decision|3
4620497|NCT01784068|7482666|FG001|NTCS Phase|Patient/guardian decision|0
4620498|NCT01784068|7482665|FG000|NTCS Phase|Death|2
4620499|NCT01784068|7482666|FG001|NTCS Phase|Death|0
4620500|NCT01784068|7482665|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203
4620501|NCT01784068|7482666|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0
4620502|NCT01784068|7482665|FG000|TFR Phase|Physician Decision|0
4620503|NCT01784068|7482666|FG001|TFR Phase|Physician Decision|1
4620504|NCT01784068|7482665|FG000|TFR Phase|Patient/guardian decision|0
4620505|NCT01784068|7482666|FG001|TFR Phase|Patient/guardian decision|3
4620506|NCT01784068|7482665|FG000|TFR Phase|Death|0
4620507|NCT01784068|7482666|FG001|TFR Phase|Death|1
4620508|NCT01784068|7482665|FG000|TFR Phase|Lack of Efficacy|0
4620509|NCT01784068|7482666|FG001|TFR Phase|Lack of Efficacy|88
4620510|NCT01784211|7482679|FG000|Part A (Days 1-15)|Adverse Event|1
4620511|NCT01784211|7482680|FG001|Part A (Days 1-15)|Adverse Event|1
4620512|NCT01784211|7482681|FG002|Part A (Days 1-15)|Adverse Event|0
4620513|NCT01784211|7482682|FG003|Part A (Days 1-15)|Adverse Event|0
4620514|NCT01784211|7482683|FG004|Part A (Days 1-15)|Adverse Event|0
4620515|NCT01784211|7482684|FG005|Part A (Days 1-15)|Adverse Event|0
4620516|NCT01784211|7482679|FG000|Part A (Days 1-15)|Withdrawal by Subject|2
4620517|NCT01784211|7482680|FG001|Part A (Days 1-15)|Withdrawal by Subject|1
4620518|NCT01784211|7482681|FG002|Part A (Days 1-15)|Withdrawal by Subject|0
4620519|NCT01784211|7482682|FG003|Part A (Days 1-15)|Withdrawal by Subject|0
4620520|NCT01784211|7482683|FG004|Part A (Days 1-15)|Withdrawal by Subject|0
4620521|NCT01784211|7482684|FG005|Part A (Days 1-15)|Withdrawal by Subject|0
4549855|NCT01204294|7377167|FG005|Overall Study|Adverse Event|4
4549856|NCT01204294|7377168|FG006|Overall Study|Adverse Event|0
4620522|NCT01784419|7482696|FG000|Overall Study|Adverse Event|3
4620523|NCT01784523|7482702|FG000|Overall Study|Study closed early|7
4620524|NCT01784523|7482703|FG001|Overall Study|Study closed early|4
4620525|NCT01784861|7482778|FG000|Overall Study|Adverse Event|0
4620526|NCT01784861|7482779|FG001|Overall Study|Adverse Event|0
4620527|NCT01784861|7482780|FG002|Overall Study|Adverse Event|1
4620528|NCT01784861|7482781|FG003|Overall Study|Adverse Event|2
4620529|NCT01784861|7482782|FG004|Overall Study|Adverse Event|1
4549857|NCT01204294|7377162|FG000|Overall Study|Protocol Violation|1
4549858|NCT01204294|7377163|FG001|Overall Study|Protocol Violation|0
4549859|NCT01204294|7377164|FG002|Overall Study|Protocol Violation|2
4549860|NCT01204294|7377165|FG003|Overall Study|Protocol Violation|1
4549861|NCT01204294|7377166|FG004|Overall Study|Protocol Violation|0
4549862|NCT01204294|7377167|FG005|Overall Study|Protocol Violation|0
4549863|NCT01204294|7377168|FG006|Overall Study|Protocol Violation|0
4549864|NCT01204294|7377162|FG000|Overall Study|Withdrawal by Subject|0
4549865|NCT01204294|7377163|FG001|Overall Study|Withdrawal by Subject|2
4549866|NCT01204294|7377164|FG002|Overall Study|Withdrawal by Subject|2
4549867|NCT01204294|7377165|FG003|Overall Study|Withdrawal by Subject|1
4549868|NCT01204294|7377166|FG004|Overall Study|Withdrawal by Subject|1
4549869|NCT01204294|7377167|FG005|Overall Study|Withdrawal by Subject|1
4549870|NCT01204294|7377168|FG006|Overall Study|Withdrawal by Subject|2
4549871|NCT01204294|7377162|FG000|Overall Study|Lack of Efficacy|0
4549872|NCT01204294|7377163|FG001|Overall Study|Lack of Efficacy|0
4549873|NCT01204294|7377164|FG002|Overall Study|Lack of Efficacy|0
4549874|NCT01204294|7377165|FG003|Overall Study|Lack of Efficacy|2
4549875|NCT01204294|7377166|FG004|Overall Study|Lack of Efficacy|0
4549876|NCT01204294|7377167|FG005|Overall Study|Lack of Efficacy|0
4549877|NCT01204294|7377168|FG006|Overall Study|Lack of Efficacy|0
4549878|NCT01204294|7377162|FG000|Overall Study|Other (house moving)|0
4549879|NCT01204294|7377163|FG001|Overall Study|Other (house moving)|0
4549880|NCT01204294|7377164|FG002|Overall Study|Other (house moving)|1
4620530|NCT01784861|7482783|FG005|Overall Study|Adverse Event|0
4620531|NCT01784861|7482778|FG000|Overall Study|Withdrawal by Subject|0
4620532|NCT01784861|7482779|FG001|Overall Study|Withdrawal by Subject|0
4620533|NCT01784861|7482780|FG002|Overall Study|Withdrawal by Subject|0
4620534|NCT01784861|7482781|FG003|Overall Study|Withdrawal by Subject|1
4620535|NCT01784861|7482782|FG004|Overall Study|Withdrawal by Subject|0
4620536|NCT01784861|7482783|FG005|Overall Study|Withdrawal by Subject|0
4620537|NCT01784861|7482778|FG000|Overall Study|Physician Decision|0
4620538|NCT01784861|7482779|FG001|Overall Study|Physician Decision|0
4620539|NCT01784861|7482780|FG002|Overall Study|Physician Decision|0
4620540|NCT01784861|7482781|FG003|Overall Study|Physician Decision|2
4620541|NCT01784861|7482782|FG004|Overall Study|Physician Decision|0
4620542|NCT01784861|7482783|FG005|Overall Study|Physician Decision|1
4620543|NCT01784965|7482810|FG000|Overall Study|Withdrawal by Subject|6
4620544|NCT01784965|7482811|FG001|Overall Study|Withdrawal by Subject|3
4620545|NCT01784965|7482810|FG000|Overall Study|Adverse Event|0
4620546|NCT01784965|7482811|FG001|Overall Study|Adverse Event|8
4620547|NCT01785069|7482823|FG000|Overall Study|Implanted with nonstudy device|1
4620548|NCT01785069|7482824|FG001|Overall Study|Implanted with nonstudy device|2
4620549|NCT01785069|7482825|FG002|Overall Study|Implanted with nonstudy device|1
4620550|NCT01785069|7482826|FG003|Overall Study|Implanted with nonstudy device|0
4620551|NCT01785069|7482823|FG000|Overall Study|Death|0
4620552|NCT01785069|7482824|FG001|Overall Study|Death|0
4620553|NCT01785069|7482825|FG002|Overall Study|Death|2
4620554|NCT01785069|7482826|FG003|Overall Study|Death|0
4620555|NCT01785069|7482823|FG000|Overall Study|Subject choice|2
4620556|NCT01785069|7482824|FG001|Overall Study|Subject choice|2
4620557|NCT01785069|7482825|FG002|Overall Study|Subject choice|0
4620558|NCT01785069|7482826|FG003|Overall Study|Subject choice|1
4620559|NCT01785069|7482823|FG000|Overall Study|Lost to Follow-up|1
4620560|NCT01785069|7482824|FG001|Overall Study|Lost to Follow-up|2
4620561|NCT01785069|7482825|FG002|Overall Study|Lost to Follow-up|4
4620562|NCT01785069|7482826|FG003|Overall Study|Lost to Follow-up|1
4620563|NCT01785069|7482823|FG000|Overall Study|Reason not Specified|1
4620564|NCT01785069|7482824|FG001|Overall Study|Reason not Specified|2
4620565|NCT01785069|7482825|FG002|Overall Study|Reason not Specified|1
4620566|NCT01785069|7482826|FG003|Overall Study|Reason not Specified|4
4620567|NCT01785069|7482823|FG000|Overall Study|Not evaluable|7
4620568|NCT01785069|7482824|FG001|Overall Study|Not evaluable|4
4620569|NCT01785069|7482825|FG002|Overall Study|Not evaluable|5
4620570|NCT01785069|7482826|FG003|Overall Study|Not evaluable|8
4620571|NCT01785160|7482852|FG000|Treatment Period 1: Raltegravir|Not treated|1
4620572|NCT01785160|7482852|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1
4620573|NCT01785472|7482893|FG000|Overall Study|Adverse Event|5
4620574|NCT01785472|7482894|FG001|Overall Study|Adverse Event|4
4620575|NCT01785472|7482895|FG002|Overall Study|Adverse Event|6
4620576|NCT01785472|7482893|FG000|Overall Study|Lack of Efficacy|2
4620577|NCT01785472|7482894|FG001|Overall Study|Lack of Efficacy|0
4620578|NCT01785472|7482895|FG002|Overall Study|Lack of Efficacy|1
4620579|NCT01785472|7482893|FG000|Overall Study|Lost to Follow-up|1
4620580|NCT01785472|7482894|FG001|Overall Study|Lost to Follow-up|2
4549881|NCT01204294|7377165|FG003|Overall Study|Other (house moving)|0
4620581|NCT01785472|7482895|FG002|Overall Study|Lost to Follow-up|0
4620582|NCT01785472|7482893|FG000|Overall Study|Physician Decision|1
4620583|NCT01785472|7482894|FG001|Overall Study|Physician Decision|1
4620584|NCT01785472|7482895|FG002|Overall Study|Physician Decision|1
4620585|NCT01785472|7482893|FG000|Overall Study|Protocol deviation|0
4620586|NCT01785472|7482894|FG001|Overall Study|Protocol deviation|2
4620587|NCT01785472|7482895|FG002|Overall Study|Protocol deviation|2
4549882|NCT01204294|7377166|FG004|Overall Study|Other (house moving)|0
4620588|NCT01785472|7482893|FG000|Overall Study|Subject/guardian decision|15
4620589|NCT01785472|7482894|FG001|Overall Study|Subject/guardian decision|10
4549883|NCT01204294|7377167|FG005|Overall Study|Other (house moving)|0
4549884|NCT01204294|7377168|FG006|Overall Study|Other (house moving)|0
4549885|NCT01204398|7377184|FG000|Overall Study|Adverse Event|1
4549886|NCT01204658|7377192|FG000|Primary Phase|Adverse Event|0
4549887|NCT01204658|7377193|FG001|Primary Phase|Adverse Event|0
4549888|NCT01204658|7377194|FG002|Primary Phase|Adverse Event|1
4549889|NCT01204658|7377195|FG003|Primary Phase|Adverse Event|0
4549890|NCT01204671|7377213|FG000|Overall Study|Adverse Event|4
4549891|NCT01204671|7377214|FG001|Overall Study|Adverse Event|3
4549892|NCT01204671|7377215|FG002|Overall Study|Adverse Event|3
4549893|NCT01204671|7377216|FG003|Overall Study|Adverse Event|3
4549894|NCT01204671|7377217|FG004|Overall Study|Adverse Event|1
4549895|NCT01204671|7377213|FG000|Overall Study|Withdrawal by Subject|2
4549896|NCT01204671|7377214|FG001|Overall Study|Withdrawal by Subject|3
4549897|NCT01204671|7377215|FG002|Overall Study|Withdrawal by Subject|4
4549898|NCT01204671|7377216|FG003|Overall Study|Withdrawal by Subject|5
4549899|NCT01204671|7377217|FG004|Overall Study|Withdrawal by Subject|3
4549900|NCT01204671|7377213|FG000|Overall Study|Lost to Follow-up|7
4549901|NCT01204671|7377214|FG001|Overall Study|Lost to Follow-up|8
4549902|NCT01204671|7377215|FG002|Overall Study|Lost to Follow-up|6
4549903|NCT01204671|7377216|FG003|Overall Study|Lost to Follow-up|4
4549904|NCT01204671|7377217|FG004|Overall Study|Lost to Follow-up|0
4549905|NCT01204671|7377213|FG000|Overall Study|Unknown Completion Status|1
4549906|NCT01204671|7377214|FG001|Overall Study|Unknown Completion Status|1
4549907|NCT01204671|7377215|FG002|Overall Study|Unknown Completion Status|0
4549908|NCT01204671|7377216|FG003|Overall Study|Unknown Completion Status|0
4549909|NCT01204671|7377217|FG004|Overall Study|Unknown Completion Status|0
4549910|NCT01204671|7377213|FG000|Overall Study|Physician Decision|0
4549911|NCT01204671|7377214|FG001|Overall Study|Physician Decision|0
4549912|NCT01204671|7377215|FG002|Overall Study|Physician Decision|0
4549913|NCT01204671|7377216|FG003|Overall Study|Physician Decision|1
4549914|NCT01204671|7377217|FG004|Overall Study|Physician Decision|0
4549915|NCT01204697|7377235|FG000|Overall Study|Death|26
4549916|NCT01204697|7377236|FG001|Overall Study|Death|27
4549917|NCT01204697|7377235|FG000|Overall Study|Lost to Follow-up|3
4549918|NCT01204697|7377236|FG001|Overall Study|Lost to Follow-up|4
4549919|NCT01204697|7377235|FG000|Overall Study|Withdrawal by Subject|2
4549920|NCT01204697|7377236|FG001|Overall Study|Withdrawal by Subject|4
4549921|NCT01204697|7377235|FG000|Overall Study|Randomized, but not treated|0
4549922|NCT01204697|7377236|FG001|Overall Study|Randomized, but not treated|1
4549923|NCT01204710|7377244|FG000|Randomization Treatment|Lost to Follow-up|1
4549924|NCT01204710|7377245|FG001|Randomization Treatment|Lost to Follow-up|0
4549925|NCT01204710|7377244|FG000|Randomization Treatment|Withdrawal by Subject|6
4549926|NCT01204710|7377245|FG001|Randomization Treatment|Withdrawal by Subject|5
4549927|NCT01204710|7377244|FG000|Randomization Treatment|Physician Decision|3
4549928|NCT01204710|7377245|FG001|Randomization Treatment|Physician Decision|2
4549929|NCT01204710|7377244|FG000|Randomization Treatment|Entry criteria not met|0
4549930|NCT01204710|7377245|FG001|Randomization Treatment|Entry criteria not met|1
4549931|NCT01204710|7377244|FG000|Randomization Treatment|Adverse Event|4
4549932|NCT01204710|7377245|FG001|Randomization Treatment|Adverse Event|2
4549933|NCT01204710|7377244|FG000|Randomization Treatment|Sponsor Decision|0
4549934|NCT01204710|7377245|FG001|Randomization Treatment|Sponsor Decision|1
4549935|NCT01204710|7377244|FG000|Randomization Treatment|Worsening of General condition|0
4620590|NCT01785472|7482895|FG002|Overall Study|Subject/guardian decision|11
4620591|NCT01785472|7482893|FG000|Overall Study|Technical problems|0
4620592|NCT01785472|7482894|FG001|Overall Study|Technical problems|0
4620593|NCT01785472|7482895|FG002|Overall Study|Technical problems|1
4620594|NCT01785524|7482907|FG000|Overall Study|Withdrawal by Subject|2
4620595|NCT01785524|7482908|FG001|Overall Study|Withdrawal by Subject|2
4620596|NCT01785602|7482916|FG000|Overall Study|Withdrawal by Subject|2
4620597|NCT01785602|7482917|FG001|Overall Study|Withdrawal by Subject|0
4620598|NCT01785602|7482916|FG000|Overall Study|Lost to Follow-up|1
4620599|NCT01785602|7482917|FG001|Overall Study|Lost to Follow-up|1
4620600|NCT01785602|7482916|FG000|Overall Study|Adverse Event|3
4620601|NCT01785602|7482917|FG001|Overall Study|Adverse Event|5
4620602|NCT01785602|7482916|FG000|Overall Study|Administrative problems|7
4620603|NCT01785602|7482917|FG001|Overall Study|Administrative problems|3
4620604|NCT01785615|7482926|FG000|Dietary Phase|Lost to Follow-up|0
4620605|NCT01785615|7482927|FG001|Dietary Phase|Lost to Follow-up|0
4620606|NCT01785615|7482928|FG002|Dietary Phase|Lost to Follow-up|0
4620607|NCT01785615|7482929|FG003|Dietary Phase|Lost to Follow-up|24
4620608|NCT01785628|7482943|FG000|Overall Study|Lost to Follow-up|2
4620609|NCT01785628|7482944|FG001|Overall Study|Lost to Follow-up|3
4620610|NCT01785849|7482965|FG000|Overall Study|Death|7
4549936|NCT01204710|7377245|FG001|Randomization Treatment|Worsening of General condition|1
4549937|NCT01204710|7377244|FG000|Randomization Treatment|Moved and Followed for Survival|0
4549938|NCT01204710|7377245|FG001|Randomization Treatment|Moved and Followed for Survival|1
4549939|NCT01204710|7377244|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0
4549940|NCT01204710|7377245|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1
4549941|NCT01204710|7377244|FG000|Optional Olaratumab Monotherapy|Physician Decision|0
4549942|NCT01204710|7377245|FG001|Optional Olaratumab Monotherapy|Physician Decision|1
4549943|NCT01204710|7377244|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0
4690619|NCT02561806|7600337|FG000|Maintenance Period|Lost to Follow-up|2
4690620|NCT02561806|7600338|FG001|Maintenance Period|Lost to Follow-up|2
4690621|NCT02561806|7600337|FG000|Maintenance Period|Protocol Violation|1
4690622|NCT02561806|7600338|FG001|Maintenance Period|Protocol Violation|0
4690623|NCT02561806|7600337|FG000|Maintenance Period|Withdrawal by Subject|5
4690624|NCT02561806|7600338|FG001|Maintenance Period|Withdrawal by Subject|3
4690625|NCT02561806|7600337|FG000|Maintenance Period|Site staff became unblinded|0
4690626|NCT02561806|7600338|FG001|Maintenance Period|Site staff became unblinded|1
4690627|NCT02561806|7600337|FG000|Post-Treatment Follow-up|Lost to Follow-up|1
4690628|NCT02561806|7600338|FG001|Post-Treatment Follow-up|Lost to Follow-up|1
4690629|NCT02561806|7600337|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1
4690630|NCT02561806|7600338|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0
4690631|NCT02561832|7600361|FG000|Overall Study|Withdrawal by Subject|1
4690632|NCT02561832|7600362|FG001|Overall Study|Withdrawal by Subject|1
4690633|NCT02561832|7600361|FG000|Overall Study|Adverse Event|3
4690634|NCT02561832|7600362|FG001|Overall Study|Adverse Event|0
4690635|NCT02561832|7600361|FG000|Overall Study|Disease progression|3
4690636|NCT02561832|7600362|FG001|Overall Study|Disease progression|3
4690637|NCT02562482|7600391|FG000|Overall Study|Enrolled, but did not receive product|4
4690638|NCT02562482|7600392|FG001|Overall Study|Enrolled, but did not receive product|0
4690639|NCT02562482|7600391|FG000|Overall Study|Lost to Follow-up|9
4690640|NCT02562482|7600392|FG001|Overall Study|Lost to Follow-up|6
4690641|NCT02562482|7600391|FG000|Overall Study|Moved from area|2
4690642|NCT02562482|7600392|FG001|Overall Study|Moved from area|3
4690643|NCT02562482|7600391|FG000|Overall Study|Withdrawal by Subject|5
4690644|NCT02562482|7600392|FG001|Overall Study|Withdrawal by Subject|3
4549944|NCT01204710|7377245|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1
4549945|NCT01204775|7377277|FG000|Overall Study|Poor/non-compliance|0
4549946|NCT01204775|7377278|FG001|Overall Study|Poor/non-compliance|1
4549947|NCT01204775|7377277|FG000|Overall Study|Withdrawal by Subject|1
4549948|NCT01204775|7377278|FG001|Overall Study|Withdrawal by Subject|0
4549949|NCT01204918|7377295|FG000|Overall Study|Withdrawal by Subject|4
4549950|NCT01204918|7377296|FG001|Overall Study|Withdrawal by Subject|10
4549951|NCT01204918|7377297|FG002|Overall Study|Withdrawal by Subject|5
4549952|NCT01205035|7377307|FG000|Overall Study|Withdrawal by Subject|1
4549953|NCT01205035|7377308|FG001|Overall Study|Withdrawal by Subject|0
4549954|NCT01205035|7377307|FG000|Overall Study|Physician Decision|1
4549955|NCT01205035|7377308|FG001|Overall Study|Physician Decision|0
4549956|NCT01205126|7377316|FG000|Titration Phase|Adverse Event|5
4549957|NCT01205126|7377317|FG001|Titration Phase|Adverse Event|3
4549958|NCT01205126|7377316|FG000|Titration Phase|Withdrawal by Subject|5
4549959|NCT01205126|7377317|FG001|Titration Phase|Withdrawal by Subject|5
4549960|NCT01205126|7377316|FG000|Titration Phase|Lost to Follow-up|2
4549961|NCT01205126|7377317|FG001|Titration Phase|Lost to Follow-up|2
4549962|NCT01205126|7377316|FG000|Titration Phase|No stable titration dose|1
4549963|NCT01205126|7377317|FG001|Titration Phase|No stable titration dose|0
4549964|NCT01205126|7377316|FG000|Titration Phase|More than maximum dosage required|2
4549965|NCT01205126|7377317|FG001|Titration Phase|More than maximum dosage required|3
4549966|NCT01205126|7377316|FG000|Titration Phase|Other|8
4549967|NCT01205126|7377317|FG001|Titration Phase|Other|6
4549968|NCT01205126|7377316|FG000|Between Titration & Maintenance Phase|Other|0
4549969|NCT01205126|7377317|FG001|Between Titration & Maintenance Phase|Other|4
4549970|NCT01205126|7377316|FG000|Maintenance Phase|Adverse Event|3
4549971|NCT01205126|7377317|FG001|Maintenance Phase|Adverse Event|7
4549972|NCT01205126|7377316|FG000|Maintenance Phase|Death|4
4549973|NCT01205126|7377317|FG001|Maintenance Phase|Death|4
4549974|NCT01205126|7377316|FG000|Maintenance Phase|More than the maximum dosage required|5
4549975|NCT01205126|7377317|FG001|Maintenance Phase|More than the maximum dosage required|5
4549976|NCT01205126|7377316|FG000|Maintenance Phase|Prohibited drugs used|1
4549977|NCT01205126|7377317|FG001|Maintenance Phase|Prohibited drugs used|0
4549978|NCT01205126|7377316|FG000|Maintenance Phase|Other|11
4549979|NCT01205126|7377317|FG001|Maintenance Phase|Other|8
4549980|NCT01205126|7377316|FG000|Maintenance Phase|Lost to Follow-up|5
4549981|NCT01205126|7377317|FG001|Maintenance Phase|Lost to Follow-up|5
4549982|NCT01205126|7377316|FG000|Maintenance Phase|Withdrawal by Subject|8
4549983|NCT01205126|7377317|FG001|Maintenance Phase|Withdrawal by Subject|11
4549984|NCT01205152|7377323|FG000|Overall Study|Death|1
4549985|NCT01205165|7377329|FG000|Overall Study|Lost to Follow-up|2
4549986|NCT01205230|7377336|FG000|Overall Study|Adverse Event|4
4549987|NCT01205230|7377337|FG001|Overall Study|Adverse Event|0
4549988|NCT01205230|7377336|FG000|Overall Study|Physician Decision|1
4549989|NCT01205230|7377337|FG001|Overall Study|Physician Decision|0
4549990|NCT01205269|7377348|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0
4549991|NCT01205269|7377349|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0
4549992|NCT01205269|7377350|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0
4549993|NCT01205269|7377351|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1
4549994|NCT01205269|7377352|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0
4690645|NCT02562482|7600391|FG000|Overall Study|Physician Decision|1
4690646|NCT02562482|7600392|FG001|Overall Study|Physician Decision|3
4690647|NCT02562482|7600391|FG000|Overall Study|Illness/Injury unrelated to product|0
4690648|NCT02562482|7600392|FG001|Overall Study|Illness/Injury unrelated to product|1
4690649|NCT02563028|7600454|FG000|Overall Study|Lack of equipment|1
4549995|NCT01205269|7377353|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0
4549996|NCT01205438|7377368|FG000|Overall Study|Adverse Event|19
4549997|NCT01205438|7377369|FG001|Overall Study|Adverse Event|17
4549998|NCT01205438|7377370|FG002|Overall Study|Adverse Event|24
4549999|NCT01205438|7377368|FG000|Overall Study|Death|1
4550000|NCT01205438|7377369|FG001|Overall Study|Death|1
4550001|NCT01205438|7377370|FG002|Overall Study|Death|3
4550002|NCT01205438|7377368|FG000|Overall Study|Entry Criteria Not Met|16
4550003|NCT01205438|7377369|FG001|Overall Study|Entry Criteria Not Met|15
4550004|NCT01205438|7377370|FG002|Overall Study|Entry Criteria Not Met|13
4550005|NCT01205438|7377368|FG000|Overall Study|Lack of Efficacy|14
4550006|NCT01205438|7377369|FG001|Overall Study|Lack of Efficacy|11
4550007|NCT01205438|7377370|FG002|Overall Study|Lack of Efficacy|14
4550008|NCT01205438|7377368|FG000|Overall Study|Lost to Follow-up|6
4550009|NCT01205438|7377369|FG001|Overall Study|Lost to Follow-up|7
4550010|NCT01205438|7377370|FG002|Overall Study|Lost to Follow-up|8
4550011|NCT01205438|7377368|FG000|Overall Study|Withdrawal by Subject|19
4550012|NCT01205438|7377369|FG001|Overall Study|Withdrawal by Subject|25
4550013|NCT01205438|7377370|FG002|Overall Study|Withdrawal by Subject|19
4550014|NCT01205438|7377368|FG000|Overall Study|Physician Decision|0
4550015|NCT01205438|7377369|FG001|Overall Study|Physician Decision|3
4550016|NCT01205438|7377370|FG002|Overall Study|Physician Decision|2
4550017|NCT01205438|7377368|FG000|Overall Study|Protocol Violation|2
4550018|NCT01205438|7377369|FG001|Overall Study|Protocol Violation|7
4550019|NCT01205438|7377370|FG002|Overall Study|Protocol Violation|4
4550020|NCT01205438|7377368|FG000|Overall Study|Sponsor Decision|0
4550021|NCT01205438|7377369|FG001|Overall Study|Sponsor Decision|1
4550022|NCT01205438|7377370|FG002|Overall Study|Sponsor Decision|1
4550023|NCT01205451|7377383|FG000|Overall Study|Lost to Follow-up|1
4550024|NCT01205451|7377384|FG001|Overall Study|Lost to Follow-up|1
4550025|NCT01205451|7377383|FG000|Overall Study|Withdrawal by Subject|5
4550026|NCT01205451|7377384|FG001|Overall Study|Withdrawal by Subject|9
4550027|NCT01205529|7377399|FG000|Overall Study|Procedure Cancelled|4
4550028|NCT01205529|7377399|FG000|Overall Study|Withdrawal by Subject|2
4550029|NCT01205529|7377399|FG000|Overall Study|Physician Decision|4
4550030|NCT01205529|7377399|FG000|Overall Study|Unstable post op|15
4550031|NCT01205529|7377399|FG000|Overall Study|No longer met criteria|30
4550032|NCT01205581|7377414|FG000|Overall Study|Withdrawal by Subject|1
4550033|NCT01205581|7377415|FG001|Overall Study|Withdrawal by Subject|0
4550034|NCT01205581|7377416|FG002|Overall Study|Withdrawal by Subject|0
4550035|NCT01205581|7377417|FG003|Overall Study|Withdrawal by Subject|0
4550036|NCT01205581|7377418|FG004|Overall Study|Withdrawal by Subject|0
4550037|NCT01205581|7377419|FG005|Overall Study|Withdrawal by Subject|0
4550038|NCT01205685|7377454|FG000|Overall Study|Disease Progression|10
4550039|NCT01205685|7377454|FG000|Overall Study|Withdrawal by Subject|1
4550040|NCT01205776|7377460|FG000|Overall Study|Lost to Follow-up|53
4550041|NCT01205776|7377461|FG001|Overall Study|Lost to Follow-up|61
4550042|NCT01205776|7377460|FG000|Overall Study|Withdrawal by Subject|11
4550043|NCT01205776|7377461|FG001|Overall Study|Withdrawal by Subject|34
4550044|NCT01206140|7377485|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1
4550045|NCT01206140|7377486|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0
4550046|NCT01206166|7377494|FG000|Overall Study|No evaluable data|2
4550047|NCT01206166|7377495|FG001|Overall Study|No evaluable data|3
4550048|NCT01206322|7377506|FG000|Overall Study|Adverse Event|0
4550049|NCT01206322|7377507|FG001|Overall Study|Adverse Event|0
4550050|NCT01206322|7377508|FG002|Overall Study|Adverse Event|0
4550051|NCT01206322|7377509|FG003|Overall Study|Adverse Event|1
4550052|NCT01206582|7377568|FG000|Overall Study|Withdrew prior to study|1
4550053|NCT01206582|7377569|FG001|Overall Study|Withdrew prior to study|0
4550054|NCT01206582|7377568|FG000|Overall Study|Discontinued intervention before week 8|1
4550055|NCT01206582|7377569|FG001|Overall Study|Discontinued intervention before week 8|2
4550056|NCT01206764|7377619|FG000|Overall Study|Adverse Event|20
4550057|NCT01206764|7377619|FG000|Overall Study|Abnormal laboratory value|2
4550058|NCT01206764|7377619|FG000|Overall Study|Abnormal test procedure result|1
4550059|NCT01206764|7377619|FG000|Overall Study|Patient withdrew consent|5
4550060|NCT01206764|7377619|FG000|Overall Study|Lost to Follow-up|6
4550061|NCT01206764|7377619|FG000|Overall Study|Death|11
4550062|NCT01206764|7377619|FG000|Overall Study|New cancer therapy|2
4550063|NCT01206764|7377619|FG000|Overall Study|Disease progression|88
4550064|NCT01206764|7377619|FG000|Overall Study|Protocol deviation|3
4550065|NCT01206777|7377623|FG000|Overall Study|Death|1
4550066|NCT01206777|7377623|FG000|Overall Study|Adverse Event|1
4550067|NCT01206816|7377634|FG000|Overall Study|Protocol Violation|0
4550068|NCT01206816|7377635|FG001|Overall Study|Protocol Violation|0
4550069|NCT01206816|7377636|FG002|Overall Study|Protocol Violation|1
4550070|NCT01206816|7377637|FG003|Overall Study|Protocol Violation|0
4550071|NCT01206816|7377638|FG004|Overall Study|Protocol Violation|0
4550072|NCT01206816|7377639|FG005|Overall Study|Protocol Violation|0
4550073|NCT01206816|7377640|FG006|Overall Study|Protocol Violation|0
4550074|NCT01206816|7377634|FG000|Overall Study|Withdrawal by Subject|0
4550075|NCT01206816|7377635|FG001|Overall Study|Withdrawal by Subject|0
4550076|NCT01206816|7377636|FG002|Overall Study|Withdrawal by Subject|1
4550077|NCT01206816|7377637|FG003|Overall Study|Withdrawal by Subject|0
4550078|NCT01206816|7377638|FG004|Overall Study|Withdrawal by Subject|0
4550079|NCT01206816|7377639|FG005|Overall Study|Withdrawal by Subject|0
4550080|NCT01206816|7377640|FG006|Overall Study|Withdrawal by Subject|0
4550081|NCT01206816|7377634|FG000|Overall Study|Progressive disease|3
4550082|NCT01206816|7377635|FG001|Overall Study|Progressive disease|3
4550083|NCT01206816|7377636|FG002|Overall Study|Progressive disease|13
4550084|NCT01206816|7377637|FG003|Overall Study|Progressive disease|3
4550085|NCT01206816|7377638|FG004|Overall Study|Progressive disease|3
4550086|NCT01206816|7377639|FG005|Overall Study|Progressive disease|16
4550087|NCT01206816|7377640|FG006|Overall Study|Progressive disease|3
4550088|NCT01206816|7377634|FG000|Overall Study|Other AE|0
4550089|NCT01206816|7377635|FG001|Overall Study|Other AE|0
4550090|NCT01206816|7377636|FG002|Overall Study|Other AE|4
4550091|NCT01206816|7377637|FG003|Overall Study|Other AE|0
4550092|NCT01206816|7377638|FG004|Overall Study|Other AE|0
4550093|NCT01206816|7377639|FG005|Overall Study|Other AE|3
4550094|NCT01206816|7377640|FG006|Overall Study|Other AE|2
4550095|NCT01206816|7377634|FG000|Overall Study|other than stated above|0
4550096|NCT01206816|7377635|FG001|Overall Study|other than stated above|0
4550097|NCT01206816|7377636|FG002|Overall Study|other than stated above|1
4550098|NCT01206816|7377637|FG003|Overall Study|other than stated above|0
4550099|NCT01206816|7377638|FG004|Overall Study|other than stated above|0
4550100|NCT01206816|7377639|FG005|Overall Study|other than stated above|0
4550101|NCT01206816|7377640|FG006|Overall Study|other than stated above|1
4550102|NCT01207219|7377663|FG000|Overall Study|changed diagnosis during study period|5
4550103|NCT01207219|7377664|FG001|Overall Study|changed diagnosis during study period|3
4550104|NCT01207219|7377665|FG002|Overall Study|changed diagnosis during study period|1
4550105|NCT01207219|7377663|FG000|Overall Study|Lost to Follow-up|6
4550106|NCT01207219|7377664|FG001|Overall Study|Lost to Follow-up|8
4550107|NCT01207219|7377665|FG002|Overall Study|Lost to Follow-up|6
4550108|NCT01207388|7377673|FG000|Overall Study|Death|67
4550109|NCT01207388|7377673|FG000|Overall Study|Withdrawal by Subject|1
4550110|NCT01207414|7377696|FG000|Overall Study|Adverse Event|25
4550111|NCT01207414|7377697|FG001|Overall Study|Adverse Event|39
4550112|NCT01207414|7377696|FG000|Overall Study|Abnormal test procedure results|0
4550113|NCT01207414|7377697|FG001|Overall Study|Abnormal test procedure results|1
4550114|NCT01207414|7377696|FG000|Overall Study|Unsatisfactory therapeutic effect|5
4550115|NCT01207414|7377697|FG001|Overall Study|Unsatisfactory therapeutic effect|4
4550116|NCT01207414|7377696|FG000|Overall Study|Patient withdrew consent|14
4550117|NCT01207414|7377697|FG001|Overall Study|Patient withdrew consent|11
4550118|NCT01207414|7377696|FG000|Overall Study|Lost to Follow-up|15
4550119|NCT01207414|7377697|FG001|Overall Study|Lost to Follow-up|17
4550120|NCT01207414|7377696|FG000|Overall Study|Administrative problems|1
4620611|NCT01785849|7482966|FG001|Overall Study|Death|9
4550121|NCT01207414|7377697|FG001|Overall Study|Administrative problems|1
4550122|NCT01207414|7377696|FG000|Overall Study|Protocol deviation|12
4550123|NCT01207414|7377697|FG001|Overall Study|Protocol deviation|9
4550124|NCT01207414|7377696|FG000|Overall Study|Randomized in error|1
4550125|NCT01207414|7377697|FG001|Overall Study|Randomized in error|0
4550126|NCT01207427|7377706|FG000|Double-blind Treatment Period|Adverse Event|0
4550127|NCT01207427|7377707|FG001|Double-blind Treatment Period|Adverse Event|1
4550128|NCT01207427|7377708|FG002|Double-blind Treatment Period|Adverse Event|0
4550129|NCT01207427|7377706|FG000|Double-blind Treatment Period|Lost to Follow-up|0
4550130|NCT01207427|7377707|FG001|Double-blind Treatment Period|Lost to Follow-up|0
4550131|NCT01207427|7377708|FG002|Double-blind Treatment Period|Lost to Follow-up|1
4550132|NCT01207427|7377706|FG000|Double-blind Treatment Period|Protocol Violation|2
4550133|NCT01207427|7377707|FG001|Double-blind Treatment Period|Protocol Violation|1
4550134|NCT01207427|7377708|FG002|Double-blind Treatment Period|Protocol Violation|1
4550135|NCT01207427|7377706|FG000|Double-blind Treatment Period|Withdrawal by Subject|1
4550136|NCT01207427|7377707|FG001|Double-blind Treatment Period|Withdrawal by Subject|0
4550137|NCT01207427|7377708|FG002|Double-blind Treatment Period|Withdrawal by Subject|0
4550138|NCT01207440|7377723|FG000|Overall Study|Adverse Event|46
4550139|NCT01207440|7377724|FG001|Overall Study|Adverse Event|11
4550140|NCT01207440|7377725|FG002|Overall Study|Adverse Event|7
4550141|NCT01207440|7377726|FG003|Overall Study|Adverse Event|2
4550142|NCT01207440|7377727|FG004|Overall Study|Adverse Event|6
4550143|NCT01207440|7377728|FG005|Overall Study|Adverse Event|6
4550144|NCT01207440|7377729|FG006|Overall Study|Adverse Event|2
4550145|NCT01207440|7377723|FG000|Overall Study|Death|6
4550146|NCT01207440|7377724|FG001|Overall Study|Death|3
4550147|NCT01207440|7377725|FG002|Overall Study|Death|2
4550148|NCT01207440|7377726|FG003|Overall Study|Death|2
4550149|NCT01207440|7377727|FG004|Overall Study|Death|7
4550150|NCT01207440|7377728|FG005|Overall Study|Death|5
4550151|NCT01207440|7377729|FG006|Overall Study|Death|1
4550152|NCT01207440|7377723|FG000|Overall Study|Lack of Efficacy|13
4550153|NCT01207440|7377724|FG001|Overall Study|Lack of Efficacy|2
4550154|NCT01207440|7377725|FG002|Overall Study|Lack of Efficacy|5
4550155|NCT01207440|7377726|FG003|Overall Study|Lack of Efficacy|1
4550156|NCT01207440|7377727|FG004|Overall Study|Lack of Efficacy|2
4550157|NCT01207440|7377728|FG005|Overall Study|Lack of Efficacy|3
4550158|NCT01207440|7377729|FG006|Overall Study|Lack of Efficacy|0
4550159|NCT01207440|7377723|FG000|Overall Study|Lost to Follow-up|0
4550160|NCT01207440|7377724|FG001|Overall Study|Lost to Follow-up|0
4550161|NCT01207440|7377725|FG002|Overall Study|Lost to Follow-up|2
4550162|NCT01207440|7377726|FG003|Overall Study|Lost to Follow-up|1
4550163|NCT01207440|7377727|FG004|Overall Study|Lost to Follow-up|0
4550164|NCT01207440|7377728|FG005|Overall Study|Lost to Follow-up|0
4550165|NCT01207440|7377729|FG006|Overall Study|Lost to Follow-up|0
4550166|NCT01207440|7377723|FG000|Overall Study|Non-compliance with Study Drug|3
4550167|NCT01207440|7377724|FG001|Overall Study|Non-compliance with Study Drug|0
4550168|NCT01207440|7377725|FG002|Overall Study|Non-compliance with Study Drug|1
4550169|NCT01207440|7377726|FG003|Overall Study|Non-compliance with Study Drug|0
4550170|NCT01207440|7377727|FG004|Overall Study|Non-compliance with Study Drug|0
4550171|NCT01207440|7377728|FG005|Overall Study|Non-compliance with Study Drug|0
4550172|NCT01207440|7377729|FG006|Overall Study|Non-compliance with Study Drug|0
4550173|NCT01207440|7377723|FG000|Overall Study|Physician Decision|6
4550174|NCT01207440|7377724|FG001|Overall Study|Physician Decision|5
4550175|NCT01207440|7377725|FG002|Overall Study|Physician Decision|5
4550176|NCT01207440|7377726|FG003|Overall Study|Physician Decision|0
4550177|NCT01207440|7377727|FG004|Overall Study|Physician Decision|1
4550178|NCT01207440|7377728|FG005|Overall Study|Physician Decision|0
4550179|NCT01207440|7377729|FG006|Overall Study|Physician Decision|0
4550180|NCT01207440|7377723|FG000|Overall Study|Progressive Disease|19
4550181|NCT01207440|7377724|FG001|Overall Study|Progressive Disease|10
4550182|NCT01207440|7377725|FG002|Overall Study|Progressive Disease|19
4550183|NCT01207440|7377726|FG003|Overall Study|Progressive Disease|7
4550184|NCT01207440|7377727|FG004|Overall Study|Progressive Disease|23
4550185|NCT01207440|7377728|FG005|Overall Study|Progressive Disease|27
4550186|NCT01207440|7377729|FG006|Overall Study|Progressive Disease|0
4550187|NCT01207440|7377723|FG000|Overall Study|Protocol Violation|2
4550188|NCT01207440|7377724|FG001|Overall Study|Protocol Violation|0
4550189|NCT01207440|7377725|FG002|Overall Study|Protocol Violation|0
4550190|NCT01207440|7377726|FG003|Overall Study|Protocol Violation|0
4550191|NCT01207440|7377727|FG004|Overall Study|Protocol Violation|0
4550192|NCT01207440|7377728|FG005|Overall Study|Protocol Violation|0
4550193|NCT01207440|7377729|FG006|Overall Study|Protocol Violation|0
4550194|NCT01207440|7377723|FG000|Overall Study|Site Terminated by Sponsor|69
4550195|NCT01207440|7377724|FG001|Overall Study|Site Terminated by Sponsor|19
4550196|NCT01207440|7377725|FG002|Overall Study|Site Terminated by Sponsor|12
4550197|NCT01207440|7377726|FG003|Overall Study|Site Terminated by Sponsor|2
4550198|NCT01207440|7377727|FG004|Overall Study|Site Terminated by Sponsor|3
4550199|NCT01207440|7377728|FG005|Overall Study|Site Terminated by Sponsor|0
4550200|NCT01207440|7377729|FG006|Overall Study|Site Terminated by Sponsor|2
4550201|NCT01207440|7377723|FG000|Overall Study|Withdrawal by Subject|29
4550202|NCT01207440|7377724|FG001|Overall Study|Withdrawal by Subject|4
4550203|NCT01207440|7377725|FG002|Overall Study|Withdrawal by Subject|5
4550204|NCT01207440|7377726|FG003|Overall Study|Withdrawal by Subject|3
4550205|NCT01207440|7377727|FG004|Overall Study|Withdrawal by Subject|2
4550206|NCT01207440|7377728|FG005|Overall Study|Withdrawal by Subject|2
4550207|NCT01207440|7377729|FG006|Overall Study|Withdrawal by Subject|0
4550208|NCT01207440|7377723|FG000|Overall Study|Reason Not Specified|10
4550209|NCT01207440|7377724|FG001|Overall Study|Reason Not Specified|10
4550210|NCT01207440|7377725|FG002|Overall Study|Reason Not Specified|7
4550211|NCT01207440|7377726|FG003|Overall Study|Reason Not Specified|0
4550212|NCT01207440|7377727|FG004|Overall Study|Reason Not Specified|4
4550213|NCT01207440|7377728|FG005|Overall Study|Reason Not Specified|3
4550214|NCT01207440|7377729|FG006|Overall Study|Reason Not Specified|0
4550215|NCT01207453|7377753|FG000|First Intervention|Adverse Event|2
4550216|NCT01207453|7377754|FG001|First Intervention|Adverse Event|1
4550217|NCT01207453|7377753|FG000|Washout|Adverse Event|1
4550218|NCT01207453|7377754|FG001|Washout|Adverse Event|0
4550219|NCT01207453|7377753|FG000|Washout|Lost to Follow-up|1
4550220|NCT01207453|7377754|FG001|Washout|Lost to Follow-up|0
4550221|NCT01207453|7377753|FG000|2nd Intervention|Adverse Event|1
4550222|NCT01207453|7377754|FG001|2nd Intervention|Adverse Event|2
4550223|NCT01207453|7377753|FG000|2nd Intervention|Lost to Follow-up|1
4550224|NCT01207453|7377754|FG001|2nd Intervention|Lost to Follow-up|0
4550225|NCT01207583|7377784|FG000|Overall Study|Withdrawal by Subject|0
4550226|NCT01207583|7377785|FG001|Overall Study|Withdrawal by Subject|3
4550227|NCT01207583|7377786|FG002|Overall Study|Withdrawal by Subject|1
4550228|NCT01207583|7377784|FG000|Overall Study|Participant failed to return|1
4550229|NCT01207583|7377785|FG001|Overall Study|Participant failed to return|0
4550230|NCT01207583|7377786|FG002|Overall Study|Participant failed to return|0
4550231|NCT01207583|7377784|FG000|Overall Study|Lost to Follow-up|0
4550232|NCT01207583|7377785|FG001|Overall Study|Lost to Follow-up|2
4550233|NCT01207583|7377786|FG002|Overall Study|Lost to Follow-up|0
4550234|NCT01207596|7377807|FG000|Overall Study|Physician Decision|4
4550235|NCT01207596|7377807|FG000|Overall Study|Lack of Efficacy|1
4550236|NCT01207596|7377807|FG000|Overall Study|Adverse Event|3
4550237|NCT01207596|7377807|FG000|Overall Study|Withdrawal by Subject|1
4550238|NCT01207687|7377815|FG000|Overall Study|Adverse Event|1
4550239|NCT01207687|7377815|FG000|Overall Study|Withdrawal by Subject|1
4550240|NCT01208038|7377860|FG000|Overall Study|Withdrawal by Subject|1
4550241|NCT01208051|7377869|FG000|Total Enrollment|Withdrawal by Subject|0
4550242|NCT01208051|7377870|FG001|Total Enrollment|Withdrawal by Subject|1
4550243|NCT01208051|7377871|FG002|Total Enrollment|Withdrawal by Subject|0
4550244|NCT01208051|7377872|FG003|Total Enrollment|Withdrawal by Subject|0
4550245|NCT01208051|7377873|FG004|Total Enrollment|Withdrawal by Subject|2
4550246|NCT01208051|7377869|FG000|Total Enrollment|Brain metastases|0
4550247|NCT01208051|7377870|FG001|Total Enrollment|Brain metastases|0
4550248|NCT01208051|7377871|FG002|Total Enrollment|Brain metastases|1
4550249|NCT01208051|7377872|FG003|Total Enrollment|Brain metastases|0
4550250|NCT01208051|7377873|FG004|Total Enrollment|Brain metastases|0
4550251|NCT01208103|7377889|FG000|Overall Study|Adverse Event|1
4550252|NCT01208103|7377889|FG000|Overall Study|Withdrawal by Subject|1
4550253|NCT01208233|7377909|FG000|Overall Study|Adverse Event|0
4550254|NCT01208233|7377910|FG001|Overall Study|Adverse Event|1
4550255|NCT01208233|7377911|FG002|Overall Study|Adverse Event|2
4550256|NCT01208233|7377912|FG003|Overall Study|Adverse Event|0
4550257|NCT01208233|7377913|FG004|Overall Study|Adverse Event|3
4550258|NCT01208233|7377914|FG005|Overall Study|Adverse Event|5
4550259|NCT01208233|7377909|FG000|Overall Study|Death|0
4550260|NCT01208233|7377910|FG001|Overall Study|Death|0
4550261|NCT01208233|7377911|FG002|Overall Study|Death|0
4550262|NCT01208233|7377912|FG003|Overall Study|Death|0
4550263|NCT01208233|7377913|FG004|Overall Study|Death|3
4550264|NCT01208233|7377914|FG005|Overall Study|Death|5
4550265|NCT01208233|7377909|FG000|Overall Study|Did not meet entrance criteria|2
4550266|NCT01208233|7377910|FG001|Overall Study|Did not meet entrance criteria|1
4550267|NCT01208233|7377911|FG002|Overall Study|Did not meet entrance criteria|1
4550268|NCT01208233|7377912|FG003|Overall Study|Did not meet entrance criteria|0
4550269|NCT01208233|7377913|FG004|Overall Study|Did not meet entrance criteria|1
4550270|NCT01208233|7377914|FG005|Overall Study|Did not meet entrance criteria|0
4550271|NCT01208233|7377909|FG000|Overall Study|Medication error without adverse event|0
4550272|NCT01208233|7377910|FG001|Overall Study|Medication error without adverse event|0
4550273|NCT01208233|7377911|FG002|Overall Study|Medication error without adverse event|0
4550274|NCT01208233|7377912|FG003|Overall Study|Medication error without adverse event|0
4550275|NCT01208233|7377913|FG004|Overall Study|Medication error without adverse event|0
4550276|NCT01208233|7377914|FG005|Overall Study|Medication error without adverse event|1
4550277|NCT01208233|7377909|FG000|Overall Study|Study terminated by sponsor|0
4550278|NCT01208233|7377910|FG001|Overall Study|Study terminated by sponsor|0
4550279|NCT01208233|7377911|FG002|Overall Study|Study terminated by sponsor|0
4550280|NCT01208233|7377912|FG003|Overall Study|Study terminated by sponsor|0
4550281|NCT01208233|7377913|FG004|Overall Study|Study terminated by sponsor|10
4550282|NCT01208233|7377914|FG005|Overall Study|Study terminated by sponsor|7
4550283|NCT01208233|7377909|FG000|Overall Study|Protocol Violation|0
4550284|NCT01208233|7377910|FG001|Overall Study|Protocol Violation|0
4550285|NCT01208233|7377911|FG002|Overall Study|Protocol Violation|0
4550286|NCT01208233|7377912|FG003|Overall Study|Protocol Violation|0
4550287|NCT01208233|7377913|FG004|Overall Study|Protocol Violation|3
4550288|NCT01208233|7377914|FG005|Overall Study|Protocol Violation|0
4550289|NCT01208233|7377909|FG000|Overall Study|Other|2
4550290|NCT01208233|7377910|FG001|Overall Study|Other|1
4550291|NCT01208233|7377911|FG002|Overall Study|Other|0
4550292|NCT01208233|7377912|FG003|Overall Study|Other|0
4550293|NCT01208233|7377913|FG004|Overall Study|Other|0
4550294|NCT01208233|7377914|FG005|Overall Study|Other|1
4550295|NCT01208233|7377909|FG000|Overall Study|Withdrawal by Subject|1
4550296|NCT01208233|7377910|FG001|Overall Study|Withdrawal by Subject|0
4550297|NCT01208233|7377911|FG002|Overall Study|Withdrawal by Subject|1
4550298|NCT01208233|7377912|FG003|Overall Study|Withdrawal by Subject|1
4550299|NCT01208233|7377913|FG004|Overall Study|Withdrawal by Subject|4
4550300|NCT01208233|7377914|FG005|Overall Study|Withdrawal by Subject|2
4550301|NCT01208324|7377938|FG000|Post-randomization of Patch|Withdrawal by Subject|1
4550302|NCT01208324|7377939|FG001|Post-randomization of Patch|Withdrawal by Subject|0
4550303|NCT01208324|7377940|FG002|Post-randomization of Patch|Withdrawal by Subject|0
4550304|NCT01208324|7377941|FG003|Post-randomization of Patch|Withdrawal by Subject|0
4550305|NCT01208337|7377951|FG000|Overall Study|Death|3
4620612|NCT01785849|7482965|FG000|Overall Study|Protocol Specified Criteria|29
4620613|NCT01785849|7482966|FG001|Overall Study|Protocol Specified Criteria|1
4620614|NCT01785849|7482965|FG000|Overall Study|Withdrawal by Subject|15
4620615|NCT01785849|7482966|FG001|Overall Study|Withdrawal by Subject|12
4620616|NCT01785849|7482965|FG000|Overall Study|Sponsor Decision|0
4620617|NCT01785849|7482966|FG001|Overall Study|Sponsor Decision|1
4620618|NCT01785849|7482965|FG000|Overall Study|Lost to Follow-up|10
4620619|NCT01785849|7482966|FG001|Overall Study|Lost to Follow-up|11
4620620|NCT01785875|7482972|FG000|Overall Study|Withdrawal by Subject|41
4620621|NCT01785875|7482973|FG001|Overall Study|Withdrawal by Subject|34
4620622|NCT01785875|7482974|FG002|Overall Study|Withdrawal by Subject|36
4620623|NCT01785875|7482972|FG000|Overall Study|Lost to Follow-up|19
4620624|NCT01785875|7482973|FG001|Overall Study|Lost to Follow-up|22
4620625|NCT01785875|7482974|FG002|Overall Study|Lost to Follow-up|6
4620626|NCT01785875|7482972|FG000|Overall Study|Death|27
4550306|NCT01208402|7377957|FG000|Overall Study|Withdrawal by Subject|1
4550307|NCT01208402|7377958|FG001|Overall Study|Withdrawal by Subject|0
4550308|NCT01208415|7377964|FG000|Overall Study|Death|1
4550309|NCT01208415|7377964|FG000|Overall Study|Lost to Follow-up|2
4550310|NCT01208415|7377964|FG000|Overall Study|Withdrawal by Subject|3
4620627|NCT01785875|7482973|FG001|Overall Study|Death|16
4620628|NCT01785875|7482974|FG002|Overall Study|Death|7
4620629|NCT01785875|7482972|FG000|Overall Study|Sponsor Decision|0
4620630|NCT01785875|7482973|FG001|Overall Study|Sponsor Decision|2
4550311|NCT01208415|7377964|FG000|Overall Study|Device not placed|1
4550312|NCT01208415|7377964|FG000|Overall Study|Still be eligible for follow-up|33
4550313|NCT01208870|7377970|FG000|Overall Study|Lost to Follow-up|2
4550314|NCT01208870|7377971|FG001|Overall Study|Lost to Follow-up|8
4550315|NCT01208961|7377988|FG000|High-Fat Period III|Protocol Violation|1
4550316|NCT01208961|7377989|FG001|High-Fat Period III|Protocol Violation|0
4550317|NCT01209078|7377996|FG000|Overall Study|Adverse Event|5
4550318|NCT01209078|7377997|FG001|Overall Study|Adverse Event|0
4550319|NCT01209078|7377996|FG000|Overall Study|Lost to Follow-up|4
4550320|NCT01209078|7377997|FG001|Overall Study|Lost to Follow-up|0
4550321|NCT01209078|7377996|FG000|Overall Study|Physician Decision|5
4550322|NCT01209078|7377997|FG001|Overall Study|Physician Decision|2
4550323|NCT01209078|7377996|FG000|Overall Study|Withdrawal by Subject|2
4550324|NCT01209078|7377997|FG001|Overall Study|Withdrawal by Subject|1
4550325|NCT01209143|7378007|FG000|Overall Study|Adverse Event|2
4550326|NCT01209143|7378008|FG001|Overall Study|Adverse Event|1
4550327|NCT01209143|7378007|FG000|Overall Study|Death|0
4550328|NCT01209143|7378008|FG001|Overall Study|Death|1
4550329|NCT01209143|7378007|FG000|Overall Study|Physician Decision|3
4550330|NCT01209143|7378008|FG001|Overall Study|Physician Decision|1
4550331|NCT01209143|7378007|FG000|Overall Study|Lost to Follow-up|1
4550332|NCT01209143|7378008|FG001|Overall Study|Lost to Follow-up|0
4550333|NCT01209143|7378007|FG000|Overall Study|Withdrawal by Subject|2
4550334|NCT01209143|7378008|FG001|Overall Study|Withdrawal by Subject|1
4550335|NCT01209143|7378007|FG000|Overall Study|Disease progression|11
4550336|NCT01209143|7378008|FG001|Overall Study|Disease progression|16
4591731|NCT01533922|7438643|FG002|Overall Study|Other reason not defined above|1
4591732|NCT01533922|7438644|FG003|Overall Study|Other reason not defined above|0
4591733|NCT01533922|7438645|FG004|Overall Study|Other reason not defined above|0
4591734|NCT01533935|7438657|FG000|Overall Study|Adverse Event|5
4591735|NCT01533935|7438658|FG001|Overall Study|Adverse Event|7
4591736|NCT01533935|7438659|FG002|Overall Study|Adverse Event|1
4591737|NCT01533935|7438660|FG003|Overall Study|Adverse Event|5
4591738|NCT01533935|7438661|FG004|Overall Study|Adverse Event|3
4591739|NCT01533935|7438657|FG000|Overall Study|Protocol Violation|0
4591740|NCT01533935|7438658|FG001|Overall Study|Protocol Violation|2
4591741|NCT01533935|7438659|FG002|Overall Study|Protocol Violation|0
4591742|NCT01533935|7438660|FG003|Overall Study|Protocol Violation|0
4591743|NCT01533935|7438661|FG004|Overall Study|Protocol Violation|0
4591744|NCT01533935|7438657|FG000|Overall Study|Lost to Follow-up|0
4591745|NCT01533935|7438658|FG001|Overall Study|Lost to Follow-up|0
4591746|NCT01533935|7438659|FG002|Overall Study|Lost to Follow-up|1
4591747|NCT01533935|7438660|FG003|Overall Study|Lost to Follow-up|0
4591748|NCT01533935|7438661|FG004|Overall Study|Lost to Follow-up|0
4591749|NCT01533935|7438657|FG000|Overall Study|Withdrawal by Subject|0
4591750|NCT01533935|7438658|FG001|Overall Study|Withdrawal by Subject|4
4591751|NCT01533935|7438659|FG002|Overall Study|Withdrawal by Subject|5
4591752|NCT01533935|7438660|FG003|Overall Study|Withdrawal by Subject|2
4591753|NCT01533935|7438661|FG004|Overall Study|Withdrawal by Subject|4
4591754|NCT01533935|7438657|FG000|Overall Study|Other reason not defined above|1
4591755|NCT01533935|7438658|FG001|Overall Study|Other reason not defined above|0
4591756|NCT01533935|7438659|FG002|Overall Study|Other reason not defined above|1
4591757|NCT01533935|7438660|FG003|Overall Study|Other reason not defined above|0
4591758|NCT01533935|7438661|FG004|Overall Study|Other reason not defined above|1
4591759|NCT01534078|7438699|FG000|Overall Study|Death|1
4591760|NCT01534078|7438699|FG000|Overall Study|Withdrawal by Subject|1
4591761|NCT01534182|7438705|FG000|Overall Study|Administrative problems|1
4591762|NCT01534182|7438706|FG001|Overall Study|Administrative problems|0
4591763|NCT01534182|7438705|FG000|Overall Study|Withdrawal by Subject|4
4591764|NCT01534182|7438706|FG001|Overall Study|Withdrawal by Subject|7
4591765|NCT01534182|7438705|FG000|Overall Study|Adverse Event|7
4591766|NCT01534182|7438706|FG001|Overall Study|Adverse Event|3
4591767|NCT01534195|7438715|FG000|Overall Study|Withdrawal by Subject|1
4591768|NCT01534195|7438716|FG001|Overall Study|Withdrawal by Subject|1
4591769|NCT01534208|7438724|FG000|Overall Study|Lost to Follow-up|19
4591770|NCT01534208|7438725|FG001|Overall Study|Lost to Follow-up|14
4591771|NCT01534208|7438724|FG000|Overall Study|Withdrawal by Subject|6
4591772|NCT01534208|7438725|FG001|Overall Study|Withdrawal by Subject|20
4591773|NCT01534208|7438724|FG000|Overall Study|Adverse Event|15
4591774|NCT01534208|7438725|FG001|Overall Study|Adverse Event|8
4591775|NCT01534208|7438724|FG000|Overall Study|Physician Decision|2
4591776|NCT01534208|7438725|FG001|Overall Study|Physician Decision|0
4591777|NCT01534208|7438724|FG000|Overall Study|Lack of Efficacy|0
4591778|NCT01534208|7438725|FG001|Overall Study|Lack of Efficacy|3
4591779|NCT01534208|7438724|FG000|Overall Study|Protocol Violation|2
4591780|NCT01534208|7438725|FG001|Overall Study|Protocol Violation|2
4591781|NCT01534208|7438724|FG000|Overall Study|Sponsor decision|4
4591782|NCT01534208|7438725|FG001|Overall Study|Sponsor decision|1
4591783|NCT01534208|7438724|FG000|Overall Study|Subject relocation|2
4591784|NCT01534208|7438725|FG001|Overall Study|Subject relocation|0
4591785|NCT01534208|7438724|FG000|Overall Study|Lab assessment|2
4591786|NCT01534208|7438725|FG001|Overall Study|Lab assessment|1
4591787|NCT01534208|7438724|FG000|Overall Study|Eligibility error|3
4550337|NCT01209286|7378060|FG000|Overall Study|Adverse Event|4
4550338|NCT01209286|7378061|FG001|Overall Study|Adverse Event|3
4550339|NCT01209286|7378062|FG002|Overall Study|Adverse Event|1
4550340|NCT01209286|7378060|FG000|Overall Study|Hematological Relapse After Remission|0
4550341|NCT01209286|7378061|FG001|Overall Study|Hematological Relapse After Remission|1
4550342|NCT01209286|7378062|FG002|Overall Study|Hematological Relapse After Remission|1
4550343|NCT01209286|7378060|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1
4550344|NCT01209286|7378061|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3
4550345|NCT01209286|7378062|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1
4550346|NCT01209286|7378060|FG000|Overall Study|Physician Decision|0
4550347|NCT01209286|7378061|FG001|Overall Study|Physician Decision|2
4550348|NCT01209286|7378062|FG002|Overall Study|Physician Decision|0
4550349|NCT01209286|7378060|FG000|Overall Study|Other|0
4550350|NCT01209286|7378061|FG001|Overall Study|Other|1
4550351|NCT01209286|7378062|FG002|Overall Study|Other|0
4550352|NCT01209325|7378079|FG000|Overall Study|Lost to Follow-up|24
4550353|NCT01209325|7378079|FG000|Overall Study|Adverse Event|1
4550354|NCT01209325|7378079|FG000|Overall Study|Relocated|3
4550355|NCT01209325|7378079|FG000|Overall Study|Refusal after starting therapy|8
4550356|NCT01209325|7378079|FG000|Overall Study|Protocol Violation|4
4550357|NCT01209325|7378079|FG000|Overall Study|Refusal prior to therapy|1
4550358|NCT01209325|7378079|FG000|Overall Study|Incarceration|2
4550359|NCT01209598|7378111|FG000|Overall Study|Withdrawal by Subject|1
4550360|NCT01209598|7378112|FG001|Overall Study|Withdrawal by Subject|0
4550361|NCT01209624|7378119|FG000|Overall Study|Death|2
4550362|NCT01209624|7378119|FG000|Overall Study|Adverse Event|13
4550363|NCT01209624|7378119|FG000|Overall Study|Lack of Efficacy|17
4550364|NCT01209624|7378119|FG000|Overall Study|Lost to Follow-up|290
4550365|NCT01209624|7378119|FG000|Overall Study|Other|4
4550366|NCT01209689|7378125|FG000|Overall Study|Insufficient Therapeutic Response|7
4550367|NCT01209689|7378126|FG001|Overall Study|Insufficient Therapeutic Response|2
4550368|NCT01209689|7378125|FG000|Overall Study|Refused Treatment|8
4550369|NCT01209689|7378126|FG001|Overall Study|Refused Treatment|3
4550370|NCT01209689|7378125|FG000|Overall Study|Adverse Event|4
4550371|NCT01209689|7378126|FG001|Overall Study|Adverse Event|0
4550372|NCT01209689|7378125|FG000|Overall Study|Violation of Selection Criteria at Entry|1
4550373|NCT01209689|7378126|FG001|Overall Study|Violation of Selection Criteria at Entry|0
4550374|NCT01209689|7378125|FG000|Overall Study|Failure to Return|3
4550375|NCT01209689|7378126|FG001|Overall Study|Failure to Return|0
4550376|NCT01209689|7378125|FG000|Overall Study|Sponsor's Decision to Stop the Study|68
4550377|NCT01209689|7378126|FG001|Overall Study|Sponsor's Decision to Stop the Study|17
4550378|NCT01209780|7378160|FG000|Overall Study|Adverse Event|0
4550379|NCT01209780|7378161|FG001|Overall Study|Adverse Event|1
4550380|NCT01209780|7378162|FG002|Overall Study|Adverse Event|0
4550381|NCT01209780|7378163|FG003|Overall Study|Adverse Event|0
4550382|NCT01209780|7378164|FG004|Overall Study|Adverse Event|0
4550383|NCT01209780|7378160|FG000|Overall Study|Withdrawal by Subject|9
4550384|NCT01209780|7378161|FG001|Overall Study|Withdrawal by Subject|2
4550385|NCT01209780|7378162|FG002|Overall Study|Withdrawal by Subject|1
4550386|NCT01209780|7378163|FG003|Overall Study|Withdrawal by Subject|1
4550387|NCT01209780|7378164|FG004|Overall Study|Withdrawal by Subject|0
4550388|NCT01209780|7378160|FG000|Overall Study|Lost to Follow-up|17
4550389|NCT01209780|7378161|FG001|Overall Study|Lost to Follow-up|12
4550390|NCT01209780|7378162|FG002|Overall Study|Lost to Follow-up|3
4550391|NCT01209780|7378163|FG003|Overall Study|Lost to Follow-up|9
4550392|NCT01209780|7378164|FG004|Overall Study|Lost to Follow-up|4
4550393|NCT01209780|7378160|FG000|Overall Study|Protocol Violation|0
4550394|NCT01209780|7378161|FG001|Overall Study|Protocol Violation|1
4550395|NCT01209780|7378162|FG002|Overall Study|Protocol Violation|0
4550396|NCT01209780|7378163|FG003|Overall Study|Protocol Violation|0
4550397|NCT01209780|7378164|FG004|Overall Study|Protocol Violation|0
4550398|NCT01209780|7378160|FG000|Overall Study|Inappropriate enrollment|0
4550399|NCT01209780|7378161|FG001|Overall Study|Inappropriate enrollment|2
4550400|NCT01209780|7378162|FG002|Overall Study|Inappropriate enrollment|0
4550401|NCT01209780|7378163|FG003|Overall Study|Inappropriate enrollment|0
4550402|NCT01209780|7378164|FG004|Overall Study|Inappropriate enrollment|1
4550403|NCT01209832|7378177|FG000|Period 1|Sponsor Decision and was not dosed|1
4550404|NCT01209832|7378177|FG000|Period 2|Sponsor Decision|1
4550405|NCT01209949|7378188|FG000|Overall Study|Lost to Follow-up|3
4550406|NCT01210001|7378195|FG000|Overall Study|Not treated|1
4550407|NCT01210001|7378196|FG001|Overall Study|Not treated|0
4550408|NCT01210001|7378197|FG002|Overall Study|Not treated|0
4550409|NCT01210001|7378195|FG000|Overall Study|Adverse Event|4
4550410|NCT01210001|7378196|FG001|Overall Study|Adverse Event|2
4550411|NCT01210001|7378197|FG002|Overall Study|Adverse Event|5
4770410|NCT03740919|7746730|FG000|Treatment Period|Issue with Insulin Pump|0
4550412|NCT01210001|7378195|FG000|Overall Study|Non compliant with protocol|2
4550413|NCT01210001|7378196|FG001|Overall Study|Non compliant with protocol|2
4550414|NCT01210001|7378197|FG002|Overall Study|Non compliant with protocol|3
4550415|NCT01210001|7378195|FG000|Overall Study|Lost to Follow-up|4
4550416|NCT01210001|7378196|FG001|Overall Study|Lost to Follow-up|3
4550417|NCT01210001|7378197|FG002|Overall Study|Lost to Follow-up|2
4550418|NCT01210001|7378195|FG000|Overall Study|Patient refusal to continue,not due toAE|6
4550419|NCT01210001|7378196|FG001|Overall Study|Patient refusal to continue,not due toAE|2
4550420|NCT01210001|7378197|FG002|Overall Study|Patient refusal to continue,not due toAE|1
4550421|NCT01210001|7378195|FG000|Overall Study|Other reason not defined above|2
4550422|NCT01210001|7378196|FG001|Overall Study|Other reason not defined above|2
4550423|NCT01210001|7378197|FG002|Overall Study|Other reason not defined above|1
4550424|NCT01210118|7378216|FG000|Overall Study|Lost to Follow-up|1
4550425|NCT01210118|7378217|FG001|Overall Study|Lost to Follow-up|1
4550426|NCT01210118|7378216|FG000|Overall Study|Protocol Violation|1
4550427|NCT01210118|7378217|FG001|Overall Study|Protocol Violation|1
4550428|NCT01210118|7378216|FG000|Overall Study|Spontaneous abortion|1
4550429|NCT01210118|7378217|FG001|Overall Study|Spontaneous abortion|3
4550430|NCT01210144|7378228|FG000|Overall Study|Lack of ovarian response|1
4550431|NCT01210144|7378229|FG001|Overall Study|Lack of ovarian response|0
4550432|NCT01210144|7378228|FG000|Overall Study|No fertilization|1
4550433|NCT01210144|7378229|FG001|Overall Study|No fertilization|0
4550434|NCT01210144|7378228|FG000|Overall Study|No transfer|1
4550435|NCT01210144|7378229|FG001|Overall Study|No transfer|0
4550436|NCT01210222|7378257|FG000|Overall Study|Ineligible|2
4550437|NCT01210222|7378257|FG000|Overall Study|Never treated|1
4550438|NCT01210352|7378276|FG000|Overall Study|Adverse Event|0
4550439|NCT01210352|7378277|FG001|Overall Study|Adverse Event|0
4550440|NCT01210352|7378278|FG002|Overall Study|Adverse Event|0
4550441|NCT01210352|7378279|FG003|Overall Study|Adverse Event|0
4550442|NCT01210352|7378280|FG004|Overall Study|Adverse Event|0
4550443|NCT01210352|7378281|FG005|Overall Study|Adverse Event|0
4550444|NCT01210352|7378282|FG006|Overall Study|Adverse Event|0
4550445|NCT01210352|7378283|FG007|Overall Study|Adverse Event|2
4550446|NCT01210352|7378284|FG008|Overall Study|Adverse Event|1
4550447|NCT01210352|7378276|FG000|Overall Study|Lack of Efficacy|0
4550448|NCT01210352|7378277|FG001|Overall Study|Lack of Efficacy|0
4550449|NCT01210352|7378278|FG002|Overall Study|Lack of Efficacy|0
4550450|NCT01210352|7378279|FG003|Overall Study|Lack of Efficacy|0
4550451|NCT01210352|7378280|FG004|Overall Study|Lack of Efficacy|0
4550452|NCT01210352|7378281|FG005|Overall Study|Lack of Efficacy|0
4550453|NCT01210352|7378282|FG006|Overall Study|Lack of Efficacy|1
4550454|NCT01210352|7378283|FG007|Overall Study|Lack of Efficacy|0
4550455|NCT01210352|7378284|FG008|Overall Study|Lack of Efficacy|0
4550456|NCT01210352|7378276|FG000|Overall Study|Physician Decision|0
4550457|NCT01210352|7378277|FG001|Overall Study|Physician Decision|0
4550458|NCT01210352|7378278|FG002|Overall Study|Physician Decision|0
4550459|NCT01210352|7378279|FG003|Overall Study|Physician Decision|0
4550460|NCT01210352|7378280|FG004|Overall Study|Physician Decision|0
4550461|NCT01210352|7378281|FG005|Overall Study|Physician Decision|0
4550462|NCT01210352|7378282|FG006|Overall Study|Physician Decision|0
4550463|NCT01210352|7378283|FG007|Overall Study|Physician Decision|1
4550464|NCT01210352|7378284|FG008|Overall Study|Physician Decision|2
4550465|NCT01210352|7378276|FG000|Overall Study|Withdrawal by Subject|0
4550466|NCT01210352|7378277|FG001|Overall Study|Withdrawal by Subject|0
4550467|NCT01210352|7378278|FG002|Overall Study|Withdrawal by Subject|1
4550468|NCT01210352|7378279|FG003|Overall Study|Withdrawal by Subject|0
4550469|NCT01210352|7378280|FG004|Overall Study|Withdrawal by Subject|0
4620631|NCT01785875|7482974|FG002|Overall Study|Sponsor Decision|0
4620632|NCT01785875|7482972|FG000|Overall Study|Protocol Specified Criteria|207
4620633|NCT01785875|7482973|FG001|Overall Study|Protocol Specified Criteria|214
4620634|NCT01785875|7482974|FG002|Overall Study|Protocol Specified Criteria|55
4620635|NCT01785875|7482972|FG000|Overall Study|Missing|0
4620636|NCT01785875|7482973|FG001|Overall Study|Missing|1
4620637|NCT01785875|7482974|FG002|Overall Study|Missing|3
4620638|NCT01786109|7482988|FG000|Overall Study|fail manometry barostat tube placement|1
4620639|NCT01786109|7482989|FG001|Overall Study|fail manometry barostat tube placement|0
4620640|NCT01786109|7482990|FG002|Overall Study|fail manometry barostat tube placement|0
4620641|NCT01786109|7482988|FG000|Overall Study|unrelated illness|0
4620642|NCT01786109|7482989|FG001|Overall Study|unrelated illness|0
4620643|NCT01786109|7482990|FG002|Overall Study|unrelated illness|1
4620644|NCT01786109|7482988|FG000|Overall Study|adverse effects colon preparation|0
4620645|NCT01786109|7482989|FG001|Overall Study|adverse effects colon preparation|0
4620646|NCT01786109|7482990|FG002|Overall Study|adverse effects colon preparation|1
4620647|NCT01786148|7483000|FG000|Overall Study|Lost to Follow-up|21
4620648|NCT01786148|7483001|FG001|Overall Study|Lost to Follow-up|13
4620649|NCT01786148|7483000|FG000|Overall Study|Death|0
4620650|NCT01786148|7483001|FG001|Overall Study|Death|1
4620651|NCT01786148|7483000|FG000|Overall Study|Withdrawal by Subject|0
4620652|NCT01786148|7483001|FG001|Overall Study|Withdrawal by Subject|7
4620653|NCT01786148|7483000|FG000|Overall Study|Incarceration|1
4550470|NCT01210352|7378281|FG005|Overall Study|Withdrawal by Subject|0
4550471|NCT01210352|7378282|FG006|Overall Study|Withdrawal by Subject|1
4550472|NCT01210352|7378283|FG007|Overall Study|Withdrawal by Subject|0
4550473|NCT01210352|7378284|FG008|Overall Study|Withdrawal by Subject|1
4550474|NCT01210352|7378276|FG000|Overall Study|Patient Discharged Early|0
4550475|NCT01210352|7378277|FG001|Overall Study|Patient Discharged Early|0
4550476|NCT01210352|7378278|FG002|Overall Study|Patient Discharged Early|1
4550477|NCT01210352|7378279|FG003|Overall Study|Patient Discharged Early|0
4550478|NCT01210352|7378280|FG004|Overall Study|Patient Discharged Early|0
4550479|NCT01210352|7378281|FG005|Overall Study|Patient Discharged Early|0
4620654|NCT01786148|7483001|FG001|Overall Study|Incarceration|1
4620655|NCT01786174|7483020|FG000|Overall Study|Discontinued Study Drug|2
4550480|NCT01210352|7378282|FG006|Overall Study|Patient Discharged Early|0
4550481|NCT01210352|7378283|FG007|Overall Study|Patient Discharged Early|0
4550482|NCT01210352|7378284|FG008|Overall Study|Patient Discharged Early|0
4550483|NCT01210443|7378389|FG000|Overall Study|Study terminated by sponsor|2
4550484|NCT01210495|7378397|FG000|Overall Study|Participant Refused Further Follow-Up|1
4550485|NCT01210495|7378398|FG001|Overall Study|Participant Refused Further Follow-Up|0
4550486|NCT01210495|7378399|FG002|Overall Study|Participant Refused Further Follow-Up|11
4550487|NCT01210495|7378400|FG003|Overall Study|Participant Refused Further Follow-Up|2
4550488|NCT01210495|7378397|FG000|Overall Study|Death|14
4550489|NCT01210495|7378398|FG001|Overall Study|Death|7
4550490|NCT01210495|7378399|FG002|Overall Study|Death|112
4550491|NCT01210495|7378400|FG003|Overall Study|Death|54
4550492|NCT01210495|7378397|FG000|Overall Study|Study Terminated by Sponsor|0
4550493|NCT01210495|7378398|FG001|Overall Study|Study Terminated by Sponsor|0
4550494|NCT01210495|7378399|FG002|Overall Study|Study Terminated by Sponsor|4
4550495|NCT01210495|7378400|FG003|Overall Study|Study Terminated by Sponsor|11
4550496|NCT01210495|7378397|FG000|Overall Study|Lost to Follow-up|0
4550497|NCT01210495|7378398|FG001|Overall Study|Lost to Follow-up|0
4550498|NCT01210495|7378399|FG002|Overall Study|Lost to Follow-up|1
4550499|NCT01210495|7378400|FG003|Overall Study|Lost to Follow-up|1
4550500|NCT01210495|7378397|FG000|Overall Study|Other unspecified|0
4550501|NCT01210495|7378398|FG001|Overall Study|Other unspecified|0
4550502|NCT01210495|7378399|FG002|Overall Study|Other unspecified|6
4550503|NCT01210495|7378400|FG003|Overall Study|Other unspecified|0
4550504|NCT01210651|7378435|FG000|Overall Study|Lost to Follow-up|1
4550505|NCT01210651|7378436|FG001|Overall Study|Lost to Follow-up|1
4550506|NCT01210651|7378435|FG000|Overall Study|schedule conflicts|1
4550507|NCT01210651|7378436|FG001|Overall Study|schedule conflicts|5
4550508|NCT01210651|7378435|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0
4550509|NCT01210651|7378436|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1
4550510|NCT01210651|7378435|FG000|Overall Study|Withdrawal by Subject|1
4550511|NCT01210651|7378436|FG001|Overall Study|Withdrawal by Subject|1
4550512|NCT01210651|7378435|FG000|Overall Study|Injury outside study|2
4550513|NCT01210651|7378436|FG001|Overall Study|Injury outside study|0
4550514|NCT01210664|7378446|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0
4550515|NCT01210664|7378447|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0
4550516|NCT01210664|7378448|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1
4550517|NCT01210664|7378449|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0
4550518|NCT01210664|7378446|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0
4550519|NCT01210664|7378447|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0
4550520|NCT01210664|7378448|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1
4550521|NCT01210664|7378449|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0
4550522|NCT01210664|7378446|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0
4550523|NCT01210664|7378447|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0
4550524|NCT01210664|7378448|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0
4550525|NCT01210664|7378449|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1
4550526|NCT01210690|7378459|FG000|Overall Study|Adverse Event|7
4550527|NCT01210690|7378459|FG000|Overall Study|Lack of Efficacy|12
4550528|NCT01210690|7378459|FG000|Overall Study|Lost to Follow-up|3
4550529|NCT01210690|7378459|FG000|Overall Study|Disease Remission|1
4550530|NCT01210690|7378459|FG000|Overall Study|Withdrawal by Subject|1
4550531|NCT01210690|7378459|FG000|Overall Study|Patient refused to swallow|1
4550532|NCT01210690|7378459|FG000|Overall Study|Patient could not take glucose|1
4550533|NCT01210807|7378473|FG000|Overall Study|Lost to Follow-up|1
4550534|NCT01210807|7378474|FG001|Overall Study|Lost to Follow-up|2
4550535|NCT01210807|7378473|FG000|Overall Study|Not implanted bilaterally|2
4550536|NCT01210807|7378474|FG001|Overall Study|Not implanted bilaterally|1
4550537|NCT01211145|7378504|FG000|Overall Study|Reason not specified|3
4550538|NCT01211145|7378505|FG001|Overall Study|Reason not specified|2
4550539|NCT01211145|7378506|FG002|Overall Study|Reason not specified|2
4550540|NCT01211145|7378507|FG003|Overall Study|Reason not specified|1
4550541|NCT01211145|7378504|FG000|Overall Study|Lost to Follow-up|3
4550542|NCT01211145|7378505|FG001|Overall Study|Lost to Follow-up|2
4550543|NCT01211145|7378506|FG002|Overall Study|Lost to Follow-up|1
4550544|NCT01211145|7378507|FG003|Overall Study|Lost to Follow-up|2
4550545|NCT01211145|7378504|FG000|Overall Study|Study-specific withdrawal criteria|1
4550546|NCT01211145|7378505|FG001|Overall Study|Study-specific withdrawal criteria|0
4550547|NCT01211145|7378506|FG002|Overall Study|Study-specific withdrawal criteria|0
4550548|NCT01211145|7378507|FG003|Overall Study|Study-specific withdrawal criteria|0
4550549|NCT01211145|7378504|FG000|Overall Study|Severe noncompliance to protocol|1
4550550|NCT01211145|7378505|FG001|Overall Study|Severe noncompliance to protocol|0
4550551|NCT01211145|7378506|FG002|Overall Study|Severe noncompliance to protocol|0
4550552|NCT01211145|7378507|FG003|Overall Study|Severe noncompliance to protocol|0
4550553|NCT01211145|7378504|FG000|Overall Study|Eligibility criteria not fulfilled|16
4550554|NCT01211145|7378505|FG001|Overall Study|Eligibility criteria not fulfilled|12
4550555|NCT01211145|7378506|FG002|Overall Study|Eligibility criteria not fulfilled|10
4550556|NCT01211145|7378507|FG003|Overall Study|Eligibility criteria not fulfilled|15
4550557|NCT01211145|7378504|FG000|Overall Study|Patient decision|2
4550558|NCT01211145|7378505|FG001|Overall Study|Patient decision|1
4620656|NCT01786174|7483021|FG001|Overall Study|Discontinued Study Drug|0
4620657|NCT01786330|7483059|FG000|Overall Study|Withdrawal by Subject|0
4620658|NCT01786330|7483060|FG001|Overall Study|Withdrawal by Subject|1
4550559|NCT01211145|7378506|FG002|Overall Study|Patient decision|0
4550560|NCT01211145|7378507|FG003|Overall Study|Patient decision|2
4550561|NCT01211184|7378520|FG000|Overall Study|Withdrawal by Subject|0
4550562|NCT01211184|7378521|FG001|Overall Study|Withdrawal by Subject|2
4550563|NCT01211184|7378522|FG002|Overall Study|Withdrawal by Subject|1
4550564|NCT01211197|7378533|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0
4550565|NCT01211197|7378534|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0
4550566|NCT01211197|7378535|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1
4550567|NCT01211197|7378536|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0
4550568|NCT01211197|7378537|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0
4550569|NCT01211197|7378538|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0
4550570|NCT01211197|7378533|FG000|Washout Period 2 (7 Days)|Adverse Event|1
4550571|NCT01211197|7378534|FG001|Washout Period 2 (7 Days)|Adverse Event|0
4550572|NCT01211197|7378535|FG002|Washout Period 2 (7 Days)|Adverse Event|0
4550573|NCT01211197|7378536|FG003|Washout Period 2 (7 Days)|Adverse Event|0
4550574|NCT01211197|7378537|FG004|Washout Period 2 (7 Days)|Adverse Event|0
4550575|NCT01211197|7378538|FG005|Washout Period 2 (7 Days)|Adverse Event|0
4550576|NCT01211262|7378548|FG000|Overall Study|Progressive Disease|18
4550577|NCT01211262|7378549|FG001|Overall Study|Progressive Disease|9
4550578|NCT01211262|7378548|FG000|Overall Study|Adverse Event|4
4550579|NCT01211262|7378549|FG001|Overall Study|Adverse Event|0
4550580|NCT01211262|7378548|FG000|Overall Study|Withdrawal of Consent|1
4550581|NCT01211262|7378549|FG001|Overall Study|Withdrawal of Consent|0
4550582|NCT01211262|7378548|FG000|Overall Study|Other|0
4550583|NCT01211262|7378549|FG001|Overall Study|Other|1
4550584|NCT01211288|7378560|FG000|Overall Study|Lost to Follow-up|1
4550585|NCT01211288|7378561|FG001|Overall Study|Lost to Follow-up|1
4550586|NCT01211483|7378582|FG000|Phase 1b|Death|6
4550587|NCT01211483|7378583|FG001|Phase 1b|Death|0
4550588|NCT01211483|7378584|FG002|Phase 1b|Death|0
4550589|NCT01211483|7378585|FG003|Phase 1b|Death|0
4550590|NCT01211483|7378582|FG000|Phase 1b|Withdrawal by Subject|1
4550591|NCT01211483|7378583|FG001|Phase 1b|Withdrawal by Subject|0
4550592|NCT01211483|7378584|FG002|Phase 1b|Withdrawal by Subject|0
4550593|NCT01211483|7378585|FG003|Phase 1b|Withdrawal by Subject|0
4550594|NCT01211483|7378582|FG000|Phase 2|Lost to Follow-up|0
4550595|NCT01211483|7378583|FG001|Phase 2|Lost to Follow-up|1
4550596|NCT01211483|7378584|FG002|Phase 2|Lost to Follow-up|1
4550597|NCT01211483|7378585|FG003|Phase 2|Lost to Follow-up|2
4550598|NCT01211483|7378582|FG000|Phase 2|Death|0
4550599|NCT01211483|7378583|FG001|Phase 2|Death|64
4550600|NCT01211483|7378584|FG002|Phase 2|Death|53
4550601|NCT01211483|7378585|FG003|Phase 2|Death|53
4550602|NCT01211483|7378582|FG000|Phase 2|Withdrawal by Subject|0
4550603|NCT01211483|7378583|FG001|Phase 2|Withdrawal by Subject|1
4550604|NCT01211483|7378584|FG002|Phase 2|Withdrawal by Subject|10
4550605|NCT01211483|7378585|FG003|Phase 2|Withdrawal by Subject|5
4550606|NCT01211483|7378582|FG000|Phase 2|Study terminated by Sponsor|0
4550607|NCT01211483|7378583|FG001|Phase 2|Study terminated by Sponsor|6
4550608|NCT01211483|7378584|FG002|Phase 2|Study terminated by Sponsor|8
4550609|NCT01211483|7378585|FG003|Phase 2|Study terminated by Sponsor|11
4620659|NCT01786330|7483059|FG000|Overall Study|Lost to Follow-up|0
4620660|NCT01786330|7483060|FG001|Overall Study|Lost to Follow-up|1
4620661|NCT01786330|7483059|FG000|Overall Study|Excluded intraoperatively|0
4620662|NCT01786330|7483060|FG001|Overall Study|Excluded intraoperatively|1
4620663|NCT01786330|7483059|FG000|Overall Study|Protocol Violation|1
4620664|NCT01786330|7483060|FG001|Overall Study|Protocol Violation|0
4620665|NCT01786512|7483086|FG000|Overall Study|Lost to Follow-up|0
4620666|NCT01786512|7483087|FG001|Overall Study|Lost to Follow-up|0
4620667|NCT01786512|7483088|FG002|Overall Study|Lost to Follow-up|0
4620668|NCT01786512|7483089|FG003|Overall Study|Lost to Follow-up|0
4620669|NCT01786512|7483090|FG004|Overall Study|Lost to Follow-up|0
4620670|NCT01786512|7483091|FG005|Overall Study|Lost to Follow-up|0
4620671|NCT01786512|7483092|FG006|Overall Study|Lost to Follow-up|0
4620672|NCT01786512|7483093|FG007|Overall Study|Lost to Follow-up|0
4620673|NCT01786512|7483094|FG008|Overall Study|Lost to Follow-up|0
4550610|NCT01211522|7378602|FG000|Overall Study|Withdrawal by Subject|3
4550611|NCT01211522|7378603|FG001|Overall Study|Withdrawal by Subject|7
4550612|NCT01211522|7378604|FG002|Overall Study|Withdrawal by Subject|5
4550613|NCT01211535|7378614|FG000|Overall Study|Adverse Event|0
4550614|NCT01211535|7378615|FG001|Overall Study|Adverse Event|1
4550615|NCT01211613|7378635|FG000|Overall Study|Lost to Follow-up|2
4550616|NCT01211613|7378636|FG001|Overall Study|Lost to Follow-up|2
4550617|NCT01211613|7378637|FG002|Overall Study|Lost to Follow-up|2
4550618|NCT01211613|7378635|FG000|Overall Study|Withdrawal by Subject|1
4550619|NCT01211613|7378636|FG001|Overall Study|Withdrawal by Subject|0
4550620|NCT01211613|7378637|FG002|Overall Study|Withdrawal by Subject|0
4550621|NCT01211665|7378647|FG000|Overall Study|Withdrawal by Subject|1
4550622|NCT01211665|7378648|FG001|Overall Study|Withdrawal by Subject|0
4550623|NCT01211665|7378647|FG000|Overall Study|Death|1
4550624|NCT01211665|7378648|FG001|Overall Study|Death|0
4550625|NCT01211769|7378667|FG000|Overall Study|Lost to Follow-up|7
4550626|NCT01211769|7378668|FG001|Overall Study|Lost to Follow-up|9
4620674|NCT01786512|7483095|FG009|Overall Study|Lost to Follow-up|1
4550627|NCT01211769|7378669|FG002|Overall Study|Lost to Follow-up|5
4550628|NCT01211769|7378670|FG003|Overall Study|Lost to Follow-up|9
4550629|NCT01211769|7378667|FG000|Overall Study|Physician Decision|2
4550630|NCT01211769|7378668|FG001|Overall Study|Physician Decision|0
4550631|NCT01211769|7378669|FG002|Overall Study|Physician Decision|2
4550632|NCT01211769|7378670|FG003|Overall Study|Physician Decision|1
4550633|NCT01211769|7378667|FG000|Overall Study|Adverse Event|0
4550634|NCT01211769|7378668|FG001|Overall Study|Adverse Event|1
4550635|NCT01211769|7378669|FG002|Overall Study|Adverse Event|1
4550636|NCT01211769|7378670|FG003|Overall Study|Adverse Event|1
4550637|NCT01212094|7378697|FG000|Year 1: Baseline Monitoring|Study terminated|7
4550638|NCT01212094|7378698|FG001|Year 1: Baseline Monitoring|Study terminated|0
4550639|NCT01212094|7378699|FG002|Year 1: Baseline Monitoring|Study terminated|0
4550640|NCT01212094|7378697|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7
4550641|NCT01212094|7378698|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0
4550642|NCT01212094|7378699|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0
4550643|NCT01212094|7378697|FG000|Year 1: Baseline Monitoring|Started on DMT|2
4550644|NCT01212094|7378698|FG001|Year 1: Baseline Monitoring|Started on DMT|0
4550645|NCT01212094|7378699|FG002|Year 1: Baseline Monitoring|Started on DMT|0
4550646|NCT01212094|7378697|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0
4550647|NCT01212094|7378698|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4
4550648|NCT01212094|7378699|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7
4550649|NCT01212094|7378697|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0
4550650|NCT01212094|7378698|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0
4550651|NCT01212094|7378699|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3
4550652|NCT01212094|7378697|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0
4550653|NCT01212094|7378698|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0
4550654|NCT01212094|7378699|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1
4550655|NCT01212159|7378773|FG000|Overall Study|Withdrawal by Subject|12
4550656|NCT01212159|7378774|FG001|Overall Study|Withdrawal by Subject|12
4550657|NCT01212185|7378791|FG000|Overall Study|Protocol Violation|2
4550658|NCT01212185|7378792|FG001|Overall Study|Protocol Violation|1
4550659|NCT01212588|7378838|FG000|Overall Study|Physician Decision|0
4550660|NCT01212588|7378839|FG001|Overall Study|Physician Decision|1
4550661|NCT01212588|7378838|FG000|Overall Study|Protocol Violation|1
4550662|NCT01212588|7378839|FG001|Overall Study|Protocol Violation|1
4550663|NCT01212744|7378849|FG000|Overall Study|Withdrawal by Subject|1
4550664|NCT01212757|7378858|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
4550665|NCT01212757|7378859|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5
4550666|NCT01212757|7378860|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12
4550667|NCT01212757|7378861|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
4550668|NCT01212757|7378862|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
4550669|NCT01212757|7378863|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
4550670|NCT01212757|7378864|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
4550671|NCT01212757|7378865|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
4550672|NCT01212757|7378866|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
4550673|NCT01212757|7378858|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
4550674|NCT01212757|7378859|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
4550675|NCT01212757|7378860|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
4550676|NCT01212757|7378861|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
4550677|NCT01212757|7378862|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
4550678|NCT01212757|7378863|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
4550679|NCT01212757|7378864|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
4550680|NCT01212757|7378865|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
4550681|NCT01212757|7378866|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
4550682|NCT01212757|7378858|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7
4550683|NCT01212757|7378859|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9
4550684|NCT01212757|7378860|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3
4550685|NCT01212757|7378861|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
4550686|NCT01212757|7378862|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
4550687|NCT01212757|7378863|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
4550688|NCT01212757|7378864|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
4550689|NCT01212757|7378865|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
4550690|NCT01212757|7378866|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
4550691|NCT01212757|7378858|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3
4550692|NCT01212757|7378859|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
4550693|NCT01212757|7378860|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1
4550694|NCT01212757|7378861|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
4550695|NCT01212757|7378862|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
4550696|NCT01212757|7378863|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
4550697|NCT01212757|7378864|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
4550698|NCT01212757|7378865|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
4550699|NCT01212757|7378866|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
4550700|NCT01212757|7378858|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
4550701|NCT01212757|7378859|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
4550702|NCT01212757|7378860|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2
4550703|NCT01212757|7378861|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
4550704|NCT01212757|7378862|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
4550705|NCT01212757|7378863|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
4550706|NCT01212757|7378864|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
4550707|NCT01212757|7378865|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
4550708|NCT01212757|7378866|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
4550709|NCT01212757|7378858|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
4550710|NCT01212757|7378859|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
4550711|NCT01212757|7378860|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
4550712|NCT01212757|7378861|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
4550713|NCT01212757|7378862|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
4550714|NCT01212757|7378863|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
4550715|NCT01212757|7378864|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
4550716|NCT01212757|7378865|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
4550717|NCT01212757|7378866|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
4550718|NCT01212757|7378858|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1
4620675|NCT01786512|7483096|FG010|Overall Study|Lost to Follow-up|0
4620676|NCT01786512|7483086|FG000|Overall Study|Decision by sponsor|0
4620677|NCT01786512|7483087|FG001|Overall Study|Decision by sponsor|0
4620678|NCT01786512|7483088|FG002|Overall Study|Decision by sponsor|0
4550719|NCT01212757|7378859|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2
4550720|NCT01212757|7378860|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0
4550721|NCT01212757|7378861|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0
4550722|NCT01212757|7378862|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0
4550723|NCT01212757|7378863|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0
4550724|NCT01212757|7378864|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0
4550725|NCT01212757|7378865|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0
4550726|NCT01212757|7378866|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0
4550727|NCT01212757|7378858|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
4550728|NCT01212757|7378859|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2
4550729|NCT01212757|7378860|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3
4550730|NCT01212757|7378861|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1
4550731|NCT01212757|7378862|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
4550732|NCT01212757|7378863|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2
4550733|NCT01212757|7378864|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
4550734|NCT01212757|7378865|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
4550735|NCT01212757|7378866|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
4550736|NCT01212757|7378858|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
4550737|NCT01212757|7378859|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5
4550738|NCT01212757|7378860|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7
4550739|NCT01212757|7378861|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4
4550740|NCT01212757|7378862|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
4550741|NCT01212757|7378863|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2
4550742|NCT01212757|7378864|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
4550743|NCT01212757|7378865|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
4550744|NCT01212757|7378866|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
4550745|NCT01212757|7378858|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
4550746|NCT01212757|7378859|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
4550747|NCT01212757|7378860|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2
4550748|NCT01212757|7378861|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
4550749|NCT01212757|7378862|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
4550750|NCT01212757|7378863|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
4550751|NCT01212757|7378864|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
4550752|NCT01212757|7378865|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
4550753|NCT01212757|7378866|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
4550754|NCT01212757|7378858|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
4550755|NCT01212757|7378859|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
4550756|NCT01212757|7378860|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7
4550757|NCT01212757|7378861|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
4550758|NCT01212757|7378862|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1
4550759|NCT01212757|7378863|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
4550760|NCT01212757|7378864|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
4550761|NCT01212757|7378865|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
4620679|NCT01786512|7483089|FG003|Overall Study|Decision by sponsor|0
4620680|NCT01786512|7483090|FG004|Overall Study|Decision by sponsor|0
4550762|NCT01212757|7378866|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
4550763|NCT01212757|7378858|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
4550764|NCT01212757|7378859|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1
4550765|NCT01212757|7378860|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
4550766|NCT01212757|7378861|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
4550767|NCT01212757|7378862|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1
4550768|NCT01212757|7378863|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
4550769|NCT01212757|7378864|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
4550770|NCT01212757|7378865|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
4550771|NCT01212757|7378866|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
4550772|NCT01212757|7378858|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0
4550773|NCT01212757|7378859|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1
4550774|NCT01212757|7378860|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1
4550775|NCT01212757|7378861|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0
4550776|NCT01212757|7378862|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0
4550777|NCT01212757|7378863|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0
4550778|NCT01212757|7378864|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0
4550779|NCT01212757|7378865|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0
4550780|NCT01212757|7378866|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0
4550781|NCT01212757|7378858|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0
4550782|NCT01212757|7378859|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0
4550783|NCT01212757|7378860|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0
4550784|NCT01212757|7378861|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0
4550785|NCT01212757|7378862|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0
4550786|NCT01212757|7378863|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0
4550787|NCT01212757|7378864|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0
4550788|NCT01212757|7378865|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0
4550789|NCT01212757|7378866|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1
4550790|NCT01212757|7378858|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0
4550791|NCT01212757|7378859|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1
4550792|NCT01212757|7378860|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1
4550793|NCT01212757|7378861|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0
4550794|NCT01212757|7378862|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0
4550795|NCT01212757|7378863|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0
4550796|NCT01212757|7378864|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0
4550797|NCT01212757|7378865|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2
4550798|NCT01212757|7378866|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2
4550799|NCT01212757|7378858|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
4550800|NCT01212757|7378859|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4
4550801|NCT01212757|7378860|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2
4550802|NCT01212757|7378861|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
4550803|NCT01212757|7378862|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
4550804|NCT01212757|7378863|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
4550805|NCT01212757|7378864|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
4550806|NCT01212757|7378865|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4
4550807|NCT01212757|7378866|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
4550808|NCT01212757|7378858|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
4550809|NCT01212757|7378859|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7
4550810|NCT01212757|7378860|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9
4550811|NCT01212757|7378861|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
4550812|NCT01212757|7378862|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
4550813|NCT01212757|7378863|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
4550814|NCT01212757|7378864|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
4550815|NCT01212757|7378865|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4
4550816|NCT01212757|7378866|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6
4550817|NCT01212757|7378858|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
4550818|NCT01212757|7378859|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
4550819|NCT01212757|7378860|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2
4550820|NCT01212757|7378861|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
4550821|NCT01212757|7378862|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
4550822|NCT01212757|7378863|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
4550823|NCT01212757|7378864|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
4550824|NCT01212757|7378865|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
4550825|NCT01212757|7378866|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
4550826|NCT01212757|7378858|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0
4550827|NCT01212757|7378859|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4
4550828|NCT01212757|7378860|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1
4550829|NCT01212757|7378861|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0
4550830|NCT01212757|7378862|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0
4550831|NCT01212757|7378863|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0
4550832|NCT01212757|7378864|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0
4550833|NCT01212757|7378865|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2
4550834|NCT01212757|7378866|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0
4550835|NCT01212757|7378858|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
4550836|NCT01212757|7378859|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8
4550837|NCT01212757|7378860|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5
4550838|NCT01212757|7378861|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
4550839|NCT01212757|7378862|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
4550840|NCT01212757|7378863|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
4550841|NCT01212757|7378864|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
4550842|NCT01212757|7378865|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3
4550843|NCT01212757|7378866|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1
4550844|NCT01212757|7378858|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
4550845|NCT01212757|7378859|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
4550846|NCT01212757|7378860|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1
4550847|NCT01212757|7378861|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
4550848|NCT01212757|7378862|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
4550849|NCT01212757|7378863|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
4550850|NCT01212757|7378864|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
4550851|NCT01212757|7378865|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
4550852|NCT01212757|7378866|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
4550853|NCT01212757|7378858|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
4550854|NCT01212757|7378859|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5
4550855|NCT01212757|7378860|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
4550856|NCT01212757|7378861|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
4550857|NCT01212757|7378862|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
4550858|NCT01212757|7378863|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
4620681|NCT01786512|7483091|FG005|Overall Study|Decision by sponsor|0
4620682|NCT01786512|7483092|FG006|Overall Study|Decision by sponsor|0
4550859|NCT01212757|7378864|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
4550860|NCT01212757|7378865|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
4550861|NCT01212757|7378866|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
4550862|NCT01212757|7378858|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
4550863|NCT01212757|7378859|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
4550864|NCT01212757|7378860|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
4550865|NCT01212757|7378861|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
4550866|NCT01212757|7378862|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
4550867|NCT01212757|7378863|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
4550868|NCT01212757|7378864|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
4550869|NCT01212757|7378865|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
4550870|NCT01212757|7378866|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1
4550871|NCT01212757|7378858|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0
4550872|NCT01212757|7378859|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1
4550873|NCT01212757|7378860|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0
4550874|NCT01212757|7378861|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0
4550875|NCT01212757|7378862|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0
4550876|NCT01212757|7378863|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0
4550877|NCT01212757|7378864|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0
4550878|NCT01212757|7378865|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0
4550879|NCT01212757|7378866|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0
4550880|NCT01212757|7378858|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0
4550881|NCT01212757|7378859|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0
4550882|NCT01212757|7378860|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3
4620683|NCT01786512|7483093|FG007|Overall Study|Decision by sponsor|0
4620684|NCT01786512|7483094|FG008|Overall Study|Decision by sponsor|0
4620685|NCT01786512|7483095|FG009|Overall Study|Decision by sponsor|0
4620686|NCT01786512|7483096|FG010|Overall Study|Decision by sponsor|2
4620687|NCT01786512|7483086|FG000|Overall Study|Withdrawal by Subject|0
4620688|NCT01786512|7483087|FG001|Overall Study|Withdrawal by Subject|1
4620689|NCT01786512|7483088|FG002|Overall Study|Withdrawal by Subject|0
4620690|NCT01786512|7483089|FG003|Overall Study|Withdrawal by Subject|0
4620691|NCT01786512|7483090|FG004|Overall Study|Withdrawal by Subject|0
4620692|NCT01786512|7483091|FG005|Overall Study|Withdrawal by Subject|0
4620693|NCT01786512|7483092|FG006|Overall Study|Withdrawal by Subject|1
4620694|NCT01786512|7483093|FG007|Overall Study|Withdrawal by Subject|0
4620695|NCT01786512|7483094|FG008|Overall Study|Withdrawal by Subject|0
4620696|NCT01786512|7483095|FG009|Overall Study|Withdrawal by Subject|3
4620697|NCT01786512|7483096|FG010|Overall Study|Withdrawal by Subject|7
4620698|NCT01786512|7483086|FG000|Overall Study|Death|0
4620699|NCT01786512|7483087|FG001|Overall Study|Death|0
4620700|NCT01786512|7483088|FG002|Overall Study|Death|0
4620701|NCT01786512|7483089|FG003|Overall Study|Death|0
4620702|NCT01786512|7483090|FG004|Overall Study|Death|0
4620703|NCT01786512|7483091|FG005|Overall Study|Death|0
4620704|NCT01786512|7483092|FG006|Overall Study|Death|0
4620705|NCT01786512|7483093|FG007|Overall Study|Death|0
4620706|NCT01786512|7483094|FG008|Overall Study|Death|4
4620707|NCT01786512|7483095|FG009|Overall Study|Death|1
4620708|NCT01786512|7483096|FG010|Overall Study|Death|3
4550883|NCT01212757|7378861|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0
4550884|NCT01212757|7378862|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0
4550885|NCT01212757|7378863|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0
4550886|NCT01212757|7378864|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0
4550887|NCT01212757|7378865|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0
4550888|NCT01212757|7378866|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2
4550889|NCT01212757|7378858|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0
4550890|NCT01212757|7378859|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2
4550891|NCT01212757|7378860|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0
4550892|NCT01212757|7378861|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0
4550893|NCT01212757|7378862|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0
4550894|NCT01212757|7378863|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0
4550895|NCT01212757|7378864|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0
4550896|NCT01212757|7378865|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0
4550897|NCT01212757|7378866|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1
4550898|NCT01212757|7378858|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0
4550899|NCT01212757|7378859|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1
4550900|NCT01212757|7378860|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2
4550901|NCT01212757|7378861|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0
4550902|NCT01212757|7378862|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0
4550903|NCT01212757|7378863|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0
4550904|NCT01212757|7378864|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0
4550905|NCT01212757|7378865|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1
4550906|NCT01212757|7378866|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1
4550907|NCT01212757|7378858|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
4550908|NCT01212757|7378859|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2
4550909|NCT01212757|7378860|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2
4550910|NCT01212757|7378861|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
4550911|NCT01212757|7378862|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
4550912|NCT01212757|7378863|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
4550913|NCT01212757|7378864|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
4550914|NCT01212757|7378865|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1
4550915|NCT01212757|7378866|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1
4550916|NCT01212757|7378858|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
4550917|NCT01212757|7378859|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4
4550918|NCT01212757|7378860|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2
4550919|NCT01212757|7378861|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
4550920|NCT01212757|7378862|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
4550921|NCT01212757|7378863|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
4620709|NCT01786551|7483128|FG000|Overall Study|Participant withdrew consent|2
4620710|NCT01786564|7483132|FG000|Overall Study|Lost to Follow-up|47
4620711|NCT01786564|7483132|FG000|Overall Study|Ineligible|17
4620712|NCT01786603|7483138|FG000|Overall Study|Death|5
4620713|NCT01786603|7483139|FG001|Overall Study|Death|1
4550922|NCT01212757|7378864|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
4550923|NCT01212757|7378865|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1
4550924|NCT01212757|7378866|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3
4550925|NCT01212757|7378858|FG000|Long-Term Safety Phase (Year 4)|Death|0
4550926|NCT01212757|7378859|FG001|Long-Term Safety Phase (Year 4)|Death|0
4550927|NCT01212757|7378860|FG002|Long-Term Safety Phase (Year 4)|Death|1
4620714|NCT01786603|7483138|FG000|Overall Study|Adverse Event|6
4620715|NCT01786603|7483139|FG001|Overall Study|Adverse Event|2
4620716|NCT01786603|7483138|FG000|Overall Study|Physician decision to withdraw|6
4620717|NCT01786603|7483139|FG001|Overall Study|Physician decision to withdraw|7
4620718|NCT01786603|7483138|FG000|Overall Study|Lost to Follow-up|1
4620719|NCT01786603|7483139|FG001|Overall Study|Lost to Follow-up|2
4620720|NCT01786629|7483147|FG000|Overall Study|Lack of Efficacy|0
4620721|NCT01786629|7483148|FG001|Overall Study|Lack of Efficacy|4
4620722|NCT01786629|7483147|FG000|Overall Study|Adverse Event|0
4620723|NCT01786629|7483148|FG001|Overall Study|Adverse Event|1
4620724|NCT01786668|7483158|FG000|Overall Study|Adverse Event|0
4620725|NCT01786668|7483159|FG001|Overall Study|Adverse Event|1
4620726|NCT01786668|7483160|FG002|Overall Study|Adverse Event|1
4620727|NCT01786668|7483161|FG003|Overall Study|Adverse Event|2
4620728|NCT01786668|7483158|FG000|Overall Study|Withdrawal by Subject|0
4620729|NCT01786668|7483159|FG001|Overall Study|Withdrawal by Subject|0
4620730|NCT01786668|7483160|FG002|Overall Study|Withdrawal by Subject|3
4620731|NCT01786668|7483161|FG003|Overall Study|Withdrawal by Subject|1
4620732|NCT01786668|7483158|FG000|Overall Study|Pregnancy|0
4620733|NCT01786668|7483159|FG001|Overall Study|Pregnancy|0
4620734|NCT01786668|7483160|FG002|Overall Study|Pregnancy|0
4620735|NCT01786668|7483161|FG003|Overall Study|Pregnancy|1
4620736|NCT01786668|7483158|FG000|Overall Study|Lost to Follow-up|1
4620737|NCT01786668|7483159|FG001|Overall Study|Lost to Follow-up|0
4620738|NCT01786668|7483160|FG002|Overall Study|Lost to Follow-up|1
4620739|NCT01786668|7483161|FG003|Overall Study|Lost to Follow-up|0
4620740|NCT01786707|7483173|FG000|Overall Study|Lost to Follow-up|1
4620741|NCT01786707|7483174|FG001|Overall Study|Lost to Follow-up|1
4550928|NCT01212757|7378861|FG003|Long-Term Safety Phase (Year 4)|Death|0
4550929|NCT01212757|7378862|FG004|Long-Term Safety Phase (Year 4)|Death|0
4550930|NCT01212757|7378863|FG005|Long-Term Safety Phase (Year 4)|Death|0
4550931|NCT01212757|7378864|FG006|Long-Term Safety Phase (Year 4)|Death|0
4550932|NCT01212757|7378865|FG007|Long-Term Safety Phase (Year 4)|Death|0
4550933|NCT01212757|7378866|FG008|Long-Term Safety Phase (Year 4)|Death|1
4550934|NCT01212757|7378858|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
4550935|NCT01212757|7378859|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
4550936|NCT01212757|7378860|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
4550937|NCT01212757|7378861|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
4550938|NCT01212757|7378862|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
4550939|NCT01212757|7378863|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
4550940|NCT01212757|7378864|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
4550941|NCT01212757|7378865|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1
4550942|NCT01212757|7378866|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
4550943|NCT01212757|7378858|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
4550944|NCT01212757|7378859|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3
4550945|NCT01212757|7378860|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3
4550946|NCT01212757|7378861|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
4550947|NCT01212757|7378862|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
4550948|NCT01212757|7378863|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
4550949|NCT01212757|7378864|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
4550950|NCT01212757|7378865|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1
4550951|NCT01212757|7378866|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1
4550952|NCT01212757|7378858|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0
4550953|NCT01212757|7378859|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2
4550954|NCT01212757|7378860|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2
4550955|NCT01212757|7378861|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0
4550956|NCT01212757|7378862|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0
4550957|NCT01212757|7378863|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0
4550958|NCT01212757|7378864|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0
4550959|NCT01212757|7378865|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2
4550960|NCT01212757|7378866|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0
4550961|NCT01212757|7378858|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
4550962|NCT01212757|7378859|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1
4550963|NCT01212757|7378860|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2
4550964|NCT01212757|7378861|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
4550965|NCT01212757|7378862|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
4550966|NCT01212757|7378863|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
4550967|NCT01212757|7378864|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
4550968|NCT01212757|7378865|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2
4550969|NCT01212757|7378866|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1
4550970|NCT01212757|7378858|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
4550971|NCT01212757|7378859|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1
4550972|NCT01212757|7378860|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
4550973|NCT01212757|7378861|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
4550974|NCT01212757|7378862|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
4550975|NCT01212757|7378863|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
4550976|NCT01212757|7378864|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
4550977|NCT01212757|7378865|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
4550978|NCT01212757|7378866|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
4550979|NCT01212757|7378858|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0
4550980|NCT01212757|7378859|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1
4550981|NCT01212757|7378860|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1
4550982|NCT01212757|7378861|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0
4550983|NCT01212757|7378862|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0
4550984|NCT01212757|7378863|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0
4550985|NCT01212757|7378864|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0
4550986|NCT01212757|7378865|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0
4550987|NCT01212757|7378866|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0
4550988|NCT01212770|7378887|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10
4550989|NCT01212770|7378888|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12
4550990|NCT01212770|7378889|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8
4550991|NCT01212770|7378890|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
4550992|NCT01212770|7378891|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
4550993|NCT01212770|7378892|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
4550994|NCT01212770|7378893|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
4550995|NCT01212770|7378894|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
4550996|NCT01212770|7378895|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
4550997|NCT01212770|7378887|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6
4550998|NCT01212770|7378888|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5
4550999|NCT01212770|7378889|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7
4551000|NCT01212770|7378890|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
4551001|NCT01212770|7378891|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
4551002|NCT01212770|7378892|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
4551003|NCT01212770|7378893|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
4551004|NCT01212770|7378894|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
4551005|NCT01212770|7378895|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
4551006|NCT01212770|7378887|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3
4551007|NCT01212770|7378888|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
4551008|NCT01212770|7378889|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1
4551009|NCT01212770|7378890|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
4551010|NCT01212770|7378891|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
4551011|NCT01212770|7378892|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
4551012|NCT01212770|7378893|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
4551013|NCT01212770|7378894|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
4551014|NCT01212770|7378895|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
4551015|NCT01212770|7378887|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
4551016|NCT01212770|7378888|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
4551017|NCT01212770|7378889|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3
4551018|NCT01212770|7378890|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
4551019|NCT01212770|7378891|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
4551020|NCT01212770|7378892|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
4551021|NCT01212770|7378893|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
4551022|NCT01212770|7378894|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
4551023|NCT01212770|7378895|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
4551024|NCT01212770|7378887|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
4551025|NCT01212770|7378888|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
4551026|NCT01212770|7378889|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
4551027|NCT01212770|7378890|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
4551028|NCT01212770|7378891|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
4551029|NCT01212770|7378892|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
4551030|NCT01212770|7378893|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
4551031|NCT01212770|7378894|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
4551032|NCT01212770|7378895|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
4551033|NCT01212770|7378887|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3
4551034|NCT01212770|7378888|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1
4551035|NCT01212770|7378889|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2
4551036|NCT01212770|7378890|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
4551037|NCT01212770|7378891|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
4551038|NCT01212770|7378892|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
4551039|NCT01212770|7378893|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
4551040|NCT01212770|7378894|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
4551041|NCT01212770|7378895|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
4551042|NCT01212770|7378887|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
4551043|NCT01212770|7378888|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6
4551044|NCT01212770|7378889|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
4551045|NCT01212770|7378890|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
4551046|NCT01212770|7378891|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
4551047|NCT01212770|7378892|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
4551048|NCT01212770|7378893|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1
4551049|NCT01212770|7378894|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
4551050|NCT01212770|7378895|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
4551051|NCT01212770|7378887|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
4551052|NCT01212770|7378888|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7
4551053|NCT01212770|7378889|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5
4551054|NCT01212770|7378890|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4
4551055|NCT01212770|7378891|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1
4551056|NCT01212770|7378892|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2
4551057|NCT01212770|7378893|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
4551058|NCT01212770|7378894|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
4551059|NCT01212770|7378895|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
4551060|NCT01212770|7378887|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
4551061|NCT01212770|7378888|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6
4551062|NCT01212770|7378889|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
4551063|NCT01212770|7378890|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
4551064|NCT01212770|7378891|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
4551065|NCT01212770|7378892|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
4551066|NCT01212770|7378893|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
4551067|NCT01212770|7378894|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
4551068|NCT01212770|7378895|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
4551069|NCT01212770|7378887|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
4551070|NCT01212770|7378888|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
4551071|NCT01212770|7378889|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1
4551072|NCT01212770|7378890|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
4551073|NCT01212770|7378891|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
4551074|NCT01212770|7378892|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
4551075|NCT01212770|7378893|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
4551076|NCT01212770|7378894|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
4551077|NCT01212770|7378895|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
4620742|NCT01786993|7483215|FG000|Overall Study|Death|6
4620743|NCT01786993|7483216|FG001|Overall Study|Death|7
4620744|NCT01786993|7483215|FG000|Overall Study|Withdrawal by Subject|3
4620745|NCT01786993|7483216|FG001|Overall Study|Withdrawal by Subject|2
4620746|NCT01786993|7483215|FG000|Overall Study|Lost to Follow-up|0
4620747|NCT01786993|7483216|FG001|Overall Study|Lost to Follow-up|1
4620748|NCT01786993|7483215|FG000|Overall Study|Subject Non-Compliance|1
4620749|NCT01786993|7483216|FG001|Overall Study|Subject Non-Compliance|0
4620750|NCT01786993|7483215|FG000|Overall Study|System Explant|1
4551078|NCT01212770|7378887|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
4551079|NCT01212770|7378888|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
4551080|NCT01212770|7378889|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
4551081|NCT01212770|7378890|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1
4551082|NCT01212770|7378891|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
4551083|NCT01212770|7378892|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
4551084|NCT01212770|7378893|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
4551085|NCT01212770|7378894|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
4551086|NCT01212770|7378895|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
4551087|NCT01212770|7378887|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
4551088|NCT01212770|7378888|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
4551089|NCT01212770|7378889|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1
4551090|NCT01212770|7378890|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1
4551091|NCT01212770|7378891|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
4551092|NCT01212770|7378892|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
4551093|NCT01212770|7378893|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
4551094|NCT01212770|7378894|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
4551095|NCT01212770|7378895|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
4551096|NCT01212770|7378887|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0
4551097|NCT01212770|7378888|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3
4551098|NCT01212770|7378889|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3
4551099|NCT01212770|7378890|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0
4551100|NCT01212770|7378891|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0
4551101|NCT01212770|7378892|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0
4551102|NCT01212770|7378893|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0
4551103|NCT01212770|7378894|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0
4551104|NCT01212770|7378895|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2
4551105|NCT01212770|7378887|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
4551106|NCT01212770|7378888|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6
4551107|NCT01212770|7378889|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7
4551108|NCT01212770|7378890|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
4551109|NCT01212770|7378891|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
4551110|NCT01212770|7378892|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
4551111|NCT01212770|7378893|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
4551112|NCT01212770|7378894|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4
4551113|NCT01212770|7378895|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6
4551114|NCT01212770|7378887|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
4551115|NCT01212770|7378888|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1
4551116|NCT01212770|7378889|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
4551117|NCT01212770|7378890|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
4551118|NCT01212770|7378891|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
4551119|NCT01212770|7378892|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
4551120|NCT01212770|7378893|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
4551121|NCT01212770|7378894|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
4551122|NCT01212770|7378895|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
4551123|NCT01212770|7378887|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
4551124|NCT01212770|7378888|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9
4551125|NCT01212770|7378889|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3
4551126|NCT01212770|7378890|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
4551127|NCT01212770|7378891|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
4591788|NCT01534208|7438725|FG001|Overall Study|Eligibility error|0
4620751|NCT01786993|7483216|FG001|Overall Study|System Explant|0
4620752|NCT01786993|7483215|FG000|Overall Study|Hospice Admission|1
4551128|NCT01212770|7378892|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
4551129|NCT01212770|7378893|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
4551130|NCT01212770|7378894|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4
4551131|NCT01212770|7378895|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4
4551132|NCT01212770|7378887|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
4551133|NCT01212770|7378888|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2
4551134|NCT01212770|7378889|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
4551135|NCT01212770|7378890|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
4551136|NCT01212770|7378891|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
4551137|NCT01212770|7378892|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
4551138|NCT01212770|7378893|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
4551139|NCT01212770|7378894|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
4551140|NCT01212770|7378895|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
4551141|NCT01212770|7378887|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0
4551142|NCT01212770|7378888|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2
4551143|NCT01212770|7378889|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1
4551144|NCT01212770|7378890|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0
4551145|NCT01212770|7378891|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0
4551146|NCT01212770|7378892|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0
4551147|NCT01212770|7378893|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0
4551148|NCT01212770|7378894|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0
4551149|NCT01212770|7378895|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1
4551150|NCT01212770|7378887|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0
4551151|NCT01212770|7378888|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2
4551152|NCT01212770|7378889|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2
4551153|NCT01212770|7378890|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0
4551154|NCT01212770|7378891|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0
4551155|NCT01212770|7378892|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0
4551156|NCT01212770|7378893|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0
4551157|NCT01212770|7378894|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2
4551158|NCT01212770|7378895|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1
4551159|NCT01212770|7378887|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
4551160|NCT01212770|7378888|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3
4551161|NCT01212770|7378889|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4
4551162|NCT01212770|7378890|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
4551163|NCT01212770|7378891|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
4551164|NCT01212770|7378892|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
4551165|NCT01212770|7378893|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
4551166|NCT01212770|7378894|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
4551167|NCT01212770|7378895|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
4551168|NCT01212770|7378887|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
4551169|NCT01212770|7378888|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3
4551170|NCT01212770|7378889|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4
4551171|NCT01212770|7378890|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
4551172|NCT01212770|7378891|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
4551173|NCT01212770|7378892|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
4551174|NCT01212770|7378893|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
4551175|NCT01212770|7378894|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1
4551176|NCT01212770|7378895|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1
4551177|NCT01212770|7378887|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
4551178|NCT01212770|7378888|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1
4551179|NCT01212770|7378889|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
4551180|NCT01212770|7378890|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
4551181|NCT01212770|7378891|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
4551182|NCT01212770|7378892|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
4551183|NCT01212770|7378893|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
4551184|NCT01212770|7378894|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
4551185|NCT01212770|7378895|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
4551186|NCT01212770|7378887|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0
4551187|NCT01212770|7378888|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0
4551188|NCT01212770|7378889|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0
4551189|NCT01212770|7378890|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0
4551190|NCT01212770|7378891|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0
4551191|NCT01212770|7378892|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0
4551192|NCT01212770|7378893|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0
4551193|NCT01212770|7378894|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1
4551194|NCT01212770|7378895|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0
4551195|NCT01212770|7378887|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0
4551196|NCT01212770|7378888|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2
4551197|NCT01212770|7378889|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1
4551198|NCT01212770|7378890|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0
4551199|NCT01212770|7378891|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0
4551200|NCT01212770|7378892|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0
4551201|NCT01212770|7378893|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0
4551202|NCT01212770|7378894|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1
4551203|NCT01212770|7378895|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1
4551204|NCT01212770|7378887|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0
4551205|NCT01212770|7378888|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1
4551206|NCT01212770|7378889|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1
4551207|NCT01212770|7378890|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0
4551208|NCT01212770|7378891|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0
4551209|NCT01212770|7378892|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0
4551210|NCT01212770|7378893|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0
4551211|NCT01212770|7378894|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0
4551212|NCT01212770|7378895|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1
4551213|NCT01212770|7378887|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
4551214|NCT01212770|7378888|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1
4551215|NCT01212770|7378889|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5
4551216|NCT01212770|7378890|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
4551217|NCT01212770|7378891|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
4551218|NCT01212770|7378892|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
4551219|NCT01212770|7378893|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
4551220|NCT01212770|7378894|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2
4551221|NCT01212770|7378895|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
4551222|NCT01212770|7378887|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
4551223|NCT01212770|7378888|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
4551224|NCT01212770|7378889|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
4551225|NCT01212770|7378890|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
4551226|NCT01212770|7378891|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
4551227|NCT01212770|7378892|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
4551228|NCT01212770|7378893|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
4551229|NCT01212770|7378894|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
4551230|NCT01212770|7378895|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
4551231|NCT01212770|7378887|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
4551232|NCT01212770|7378888|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2
4551233|NCT01212770|7378889|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3
4551234|NCT01212770|7378890|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
4551235|NCT01212770|7378891|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
4551236|NCT01212770|7378892|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
4551237|NCT01212770|7378893|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
4551238|NCT01212770|7378894|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
4551239|NCT01212770|7378895|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
4551240|NCT01212770|7378887|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
4551241|NCT01212770|7378888|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
4551242|NCT01212770|7378889|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1
4551243|NCT01212770|7378890|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
4551244|NCT01212770|7378891|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
4551245|NCT01212770|7378892|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
4551246|NCT01212770|7378893|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
4551247|NCT01212770|7378894|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
4551248|NCT01212770|7378895|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
4551249|NCT01212770|7378887|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0
4551250|NCT01212770|7378888|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1
4551251|NCT01212770|7378889|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0
4551252|NCT01212770|7378890|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0
4620753|NCT01786993|7483216|FG001|Overall Study|Hospice Admission|0
4620754|NCT01787032|7483238|FG000|Overall Study|Protocol Violation|0
4620755|NCT01787032|7483239|FG001|Overall Study|Protocol Violation|0
4620756|NCT01787032|7483240|FG002|Overall Study|Protocol Violation|0
4620757|NCT01787032|7483241|FG003|Overall Study|Protocol Violation|0
4620758|NCT01787032|7483242|FG004|Overall Study|Protocol Violation|1
4620759|NCT01787032|7483243|FG005|Overall Study|Protocol Violation|1
4620760|NCT01787097|7483253|FG000|Overall Study|Withdrawal by Subject|1
4620761|NCT01787097|7483254|FG001|Overall Study|Withdrawal by Subject|0
4620762|NCT01787097|7483255|FG002|Overall Study|Withdrawal by Subject|0
4620763|NCT01787097|7483256|FG003|Overall Study|Withdrawal by Subject|0
4620764|NCT01787188|7483288|FG000|Overall Study|Adverse Event|2
4620765|NCT01787188|7483289|FG001|Overall Study|Adverse Event|4
4620766|NCT01787188|7483290|FG002|Overall Study|Adverse Event|6
4620767|NCT01787188|7483288|FG000|Overall Study|Lack of Efficacy|7
4620768|NCT01787188|7483289|FG001|Overall Study|Lack of Efficacy|3
4620769|NCT01787188|7483290|FG002|Overall Study|Lack of Efficacy|5
4620770|NCT01787188|7483288|FG000|Overall Study|Non-compliance with Study Drug|0
4620771|NCT01787188|7483289|FG001|Overall Study|Non-compliance with Study Drug|1
4620772|NCT01787188|7483290|FG002|Overall Study|Non-compliance with Study Drug|0
4620773|NCT01787188|7483288|FG000|Overall Study|Withdrawal by Subject|4
4620774|NCT01787188|7483289|FG001|Overall Study|Withdrawal by Subject|3
4620775|NCT01787188|7483290|FG002|Overall Study|Withdrawal by Subject|2
4551253|NCT01212770|7378891|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0
4551254|NCT01212770|7378892|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0
4551255|NCT01212770|7378893|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0
4551256|NCT01212770|7378894|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0
4551257|NCT01212770|7378895|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1
4551258|NCT01212770|7378887|FG000|Long-term Safety Phase (Year 5)|Missing|0
4551259|NCT01212770|7378888|FG001|Long-term Safety Phase (Year 5)|Missing|0
4551260|NCT01212770|7378889|FG002|Long-term Safety Phase (Year 5)|Missing|1
4551261|NCT01212770|7378890|FG003|Long-term Safety Phase (Year 5)|Missing|0
4551262|NCT01212770|7378891|FG004|Long-term Safety Phase (Year 5)|Missing|0
4551263|NCT01212770|7378892|FG005|Long-term Safety Phase (Year 5)|Missing|0
4551264|NCT01212770|7378893|FG006|Long-term Safety Phase (Year 5)|Missing|0
4551265|NCT01212770|7378894|FG007|Long-term Safety Phase (Year 5)|Missing|0
4551266|NCT01212770|7378895|FG008|Long-term Safety Phase (Year 5)|Missing|0
4551267|NCT01212770|7378887|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0
4551268|NCT01212770|7378888|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0
4551269|NCT01212770|7378889|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3
4551270|NCT01212770|7378890|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0
4551271|NCT01212770|7378891|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0
4551272|NCT01212770|7378892|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0
4551273|NCT01212770|7378893|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0
4551274|NCT01212770|7378894|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0
4551275|NCT01212770|7378895|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0
4551276|NCT01212770|7378887|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0
4551277|NCT01212770|7378888|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0
4551278|NCT01212770|7378889|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2
4551279|NCT01212770|7378890|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0
4551280|NCT01212770|7378891|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0
4551281|NCT01212770|7378892|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0
4551282|NCT01212770|7378893|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0
4551283|NCT01212770|7378894|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0
4551284|NCT01212770|7378895|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1
4551285|NCT01212770|7378887|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
4551286|NCT01212770|7378888|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
4551287|NCT01212770|7378889|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4
4551288|NCT01212770|7378890|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
4551289|NCT01212770|7378891|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
4551290|NCT01212770|7378892|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
4551291|NCT01212770|7378893|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
4551292|NCT01212770|7378894|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
4551293|NCT01212770|7378895|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
4551294|NCT01212770|7378887|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
4551295|NCT01212770|7378888|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2
4551296|NCT01212770|7378889|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1
4551297|NCT01212770|7378890|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
4551298|NCT01212770|7378891|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
4551299|NCT01212770|7378892|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
4551300|NCT01212770|7378893|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
4551301|NCT01212770|7378894|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1
4551302|NCT01212770|7378895|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
4551303|NCT01212770|7378887|FG000|Long-term Safety Phase (Year 5)|Death|0
4551304|NCT01212770|7378888|FG001|Long-term Safety Phase (Year 5)|Death|0
4551305|NCT01212770|7378889|FG002|Long-term Safety Phase (Year 5)|Death|0
4551306|NCT01212770|7378890|FG003|Long-term Safety Phase (Year 5)|Death|0
4551307|NCT01212770|7378891|FG004|Long-term Safety Phase (Year 5)|Death|0
4551308|NCT01212770|7378892|FG005|Long-term Safety Phase (Year 5)|Death|0
4620776|NCT01787188|7483288|FG000|Overall Study|Protocol Violation|3
4620777|NCT01787188|7483289|FG001|Overall Study|Protocol Violation|2
4620778|NCT01787188|7483290|FG002|Overall Study|Protocol Violation|3
4620779|NCT01787188|7483288|FG000|Overall Study|Lost to Follow-up|1
4620780|NCT01787188|7483289|FG001|Overall Study|Lost to Follow-up|2
4620781|NCT01787188|7483290|FG002|Overall Study|Lost to Follow-up|2
4620782|NCT01787188|7483288|FG000|Overall Study|Other, including patient moved|0
4620783|NCT01787188|7483289|FG001|Overall Study|Other, including patient moved|3
4620784|NCT01787188|7483290|FG002|Overall Study|Other, including patient moved|0
4620785|NCT01787279|7483310|FG000|Overall Study|Lost to Follow-up|2
4620786|NCT01787279|7483310|FG000|Overall Study|Lack of Efficacy|1
4620787|NCT01787292|7483314|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2
4620788|NCT01787292|7483315|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2
4620789|NCT01787292|7483314|FG000|Home Based Exercise Program|Withdrawal by Subject|3
4620790|NCT01787292|7483315|FG001|Home Based Exercise Program|Withdrawal by Subject|1
4620791|NCT01787331|7483326|FG000|Overall Study|Physician Decision|1
4551309|NCT01212770|7378893|FG006|Long-term Safety Phase (Year 5)|Death|0
4551310|NCT01212770|7378894|FG007|Long-term Safety Phase (Year 5)|Death|1
4551311|NCT01212770|7378895|FG008|Long-term Safety Phase (Year 5)|Death|0
4620792|NCT01787331|7483326|FG000|Overall Study|Withdrawal by Subject|1
4620793|NCT01787461|7483349|FG000|Overall Study|Adverse Event|4
4551312|NCT01212991|7378952|FG000|Double-blind|Lost to Follow-up|8
4551313|NCT01212991|7378953|FG001|Double-blind|Lost to Follow-up|4
4551314|NCT01212991|7378954|FG002|Double-blind|Lost to Follow-up|0
4551315|NCT01212991|7378952|FG000|Double-blind|Death|699
4551316|NCT01212991|7378953|FG001|Double-blind|Death|550
4551317|NCT01212991|7378954|FG002|Double-blind|Death|0
4551318|NCT01212991|7378952|FG000|Double-blind|Withdrawal by Subject|16
4551319|NCT01212991|7378953|FG001|Double-blind|Withdrawal by Subject|19
4551320|NCT01212991|7378954|FG002|Double-blind|Withdrawal by Subject|0
4551321|NCT01212991|7378952|FG000|Double-blind|Other|7
4551322|NCT01212991|7378953|FG001|Double-blind|Other|0
4551323|NCT01212991|7378954|FG002|Double-blind|Other|0
4551324|NCT01212991|7378952|FG000|Double-blind|Sponsor decision|142
4551325|NCT01212991|7378953|FG001|Double-blind|Sponsor decision|38
4551326|NCT01212991|7378954|FG002|Double-blind|Sponsor decision|0
4551327|NCT01212991|7378952|FG000|Open-label|Death|0
4551328|NCT01212991|7378953|FG001|Open-label|Death|0
4551329|NCT01212991|7378954|FG002|Open-label|Death|166
4551330|NCT01212991|7378952|FG000|Open-label|Lost to Follow-up|0
4551331|NCT01212991|7378953|FG001|Open-label|Lost to Follow-up|0
4551332|NCT01212991|7378954|FG002|Open-label|Lost to Follow-up|5
4551333|NCT01212991|7378952|FG000|Open-label|Withdrawal by Subject|0
4551334|NCT01212991|7378953|FG001|Open-label|Withdrawal by Subject|0
4551335|NCT01212991|7378954|FG002|Open-label|Withdrawal by Subject|7
4551336|NCT01212991|7378952|FG000|Open-label|Sponsor decision|0
4551337|NCT01212991|7378953|FG001|Open-label|Sponsor decision|0
4551338|NCT01212991|7378954|FG002|Open-label|Sponsor decision|53
4551339|NCT01212991|7378952|FG000|Open-label|Other|0
4551340|NCT01212991|7378953|FG001|Open-label|Other|0
4551341|NCT01212991|7378954|FG002|Open-label|Other|3
4551342|NCT01213082|7378974|FG000|Overall Study|Lost to Follow-up|6
4551343|NCT01213082|7378975|FG001|Overall Study|Lost to Follow-up|7
4551344|NCT01213082|7378976|FG002|Overall Study|Lost to Follow-up|4
4551345|NCT01213082|7378974|FG000|Overall Study|Physician Decision|0
4551346|NCT01213082|7378975|FG001|Overall Study|Physician Decision|0
4551347|NCT01213082|7378976|FG002|Overall Study|Physician Decision|1
4551348|NCT01213173|7378986|FG000|Overall Study|Protocol Violation|2
4551349|NCT01213173|7378987|FG001|Overall Study|Protocol Violation|0
4551350|NCT01213173|7378986|FG000|Overall Study|Adverse Event|4
4551351|NCT01213173|7378987|FG001|Overall Study|Adverse Event|8
4551352|NCT01213173|7378986|FG000|Overall Study|Withdrawal by Subject|5
4551353|NCT01213173|7378987|FG001|Overall Study|Withdrawal by Subject|5
4551354|NCT01213173|7378986|FG000|Overall Study|Incorrect Enrollment|1
4551355|NCT01213173|7378987|FG001|Overall Study|Incorrect Enrollment|3
4551356|NCT01213251|7379000|FG000|Overall Study|Death|2
4551357|NCT01213251|7379001|FG001|Overall Study|Death|1
4551358|NCT01213251|7379002|FG002|Overall Study|Death|2
4551359|NCT01213251|7379000|FG000|Overall Study|Exit|3
4551360|NCT01213251|7379001|FG001|Overall Study|Exit|2
4551361|NCT01213251|7379002|FG002|Overall Study|Exit|8
4551362|NCT01213251|7379000|FG000|Overall Study|Protocol Violation|1
4551363|NCT01213251|7379001|FG001|Overall Study|Protocol Violation|1
4551364|NCT01213251|7379002|FG002|Overall Study|Protocol Violation|0
4551365|NCT01213251|7379000|FG000|Overall Study|Missed 18-Month Follow-up|0
4551366|NCT01213251|7379001|FG001|Overall Study|Missed 18-Month Follow-up|0
4551367|NCT01213251|7379002|FG002|Overall Study|Missed 18-Month Follow-up|1
4551368|NCT01213264|7379018|FG000|Overall Study|Adverse Event|1
4551369|NCT01213264|7379019|FG001|Overall Study|Adverse Event|0
4551370|NCT01213264|7379020|FG002|Overall Study|Adverse Event|0
4551371|NCT01213264|7379018|FG000|Overall Study|Lost to Follow-up|1
4551372|NCT01213264|7379019|FG001|Overall Study|Lost to Follow-up|2
4551373|NCT01213264|7379020|FG002|Overall Study|Lost to Follow-up|6
4551374|NCT01213472|7379039|FG000|Overall Study|Recurrence/Progressive disease|25
4551375|NCT01213472|7379039|FG000|Overall Study|Withdrawal by Subject|1
4551376|NCT01213472|7379039|FG000|Overall Study|Physician Decision|1
4551377|NCT01213524|7379045|FG000|Baseline|Withdrawal by Subject|5
4551378|NCT01213524|7379045|FG000|Baseline|high breath alcohol levels|1
4551379|NCT01213524|7379045|FG000|Baseline|Physician Decision|1
4551380|NCT01213524|7379045|FG000|Session 2|Withdrawal by Subject|5
4551381|NCT01213524|7379045|FG000|Session 3|Withdrawal by Subject|4
4551382|NCT01213524|7379045|FG000|Session 4|Physician Decision|1
4551383|NCT01213524|7379045|FG000|Session 4|Withdrawal by Subject|2
4551384|NCT01213836|7379103|FG000|Period 1, First Intervention|Adverse Event|2
4551385|NCT01213836|7379104|FG001|Period 1, First Intervention|Adverse Event|1
4551386|NCT01213836|7379103|FG000|Period 1, First Intervention|Protocol Violation|0
4551387|NCT01213836|7379104|FG001|Period 1, First Intervention|Protocol Violation|1
4551388|NCT01213836|7379103|FG000|Period 1, First Intervention|Withdrawal by Subject|1
4551389|NCT01213836|7379104|FG001|Period 1, First Intervention|Withdrawal by Subject|1
4551390|NCT01213966|7379126|FG000|Overall Study|Protocol Violation|1
4551391|NCT01213966|7379127|FG001|Overall Study|Protocol Violation|0
4551392|NCT01213966|7379128|FG002|Overall Study|Protocol Violation|3
4551393|NCT01213966|7379129|FG003|Overall Study|Protocol Violation|1
4551394|NCT01214044|7379139|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5
4551395|NCT01214044|7379139|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3
4551396|NCT01214044|7379139|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4
4551397|NCT01214044|7379139|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3
4591789|NCT01534208|7438724|FG000|Overall Study|PCP decision|1
4551398|NCT01214044|7379139|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3
4551399|NCT01214044|7379139|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1
4551400|NCT01214174|7379199|FG000|Overall Study|Withdrawal by Subject|0
4551401|NCT01214174|7379200|FG001|Overall Study|Withdrawal by Subject|0
4551402|NCT01214174|7379201|FG002|Overall Study|Withdrawal by Subject|1
4551403|NCT01214187|7379211|FG000|Overall Study|Adverse Event|6
4551404|NCT01214187|7379212|FG001|Overall Study|Adverse Event|2
4551405|NCT01214187|7379211|FG000|Overall Study|Death|1
4551406|NCT01214187|7379212|FG001|Overall Study|Death|1
4551407|NCT01214187|7379211|FG000|Overall Study|Withdrawal by Subject|0
4551408|NCT01214187|7379212|FG001|Overall Study|Withdrawal by Subject|3
4551409|NCT01214200|7379218|FG000|Overall Study|Did not meet inclusion/exclusion|9
4551410|NCT01214200|7379218|FG000|Overall Study|Withdrawal by Subject|2
4551411|NCT01214239|7379226|FG000|Overall Study|Adverse Event|3
4551412|NCT01214239|7379227|FG001|Overall Study|Adverse Event|4
4551413|NCT01214239|7379226|FG000|Overall Study|Protocol Violation|2
4551414|NCT01214239|7379227|FG001|Overall Study|Protocol Violation|1
4551415|NCT01214239|7379226|FG000|Overall Study|Lost to Follow-up|1
4551416|NCT01214239|7379227|FG001|Overall Study|Lost to Follow-up|1
4551417|NCT01214239|7379226|FG000|Overall Study|Withdrawal by Subject|4
4551418|NCT01214239|7379227|FG001|Overall Study|Withdrawal by Subject|9
4551419|NCT01214239|7379226|FG000|Overall Study|Lack of Efficacy|1
4551420|NCT01214239|7379227|FG001|Overall Study|Lack of Efficacy|2
4551421|NCT01214239|7379226|FG000|Overall Study|patient's private reason|1
4551422|NCT01214239|7379227|FG001|Overall Study|patient's private reason|1
4551423|NCT01214252|7379233|FG000|Overall Study|Not eligible per protocol|82
4551424|NCT01214395|7379262|FG000|Overall Study|All patients had infection|5
4551425|NCT01214421|7379271|FG000|Overall Study|Lost to Follow-up|7
4551426|NCT01214421|7379272|FG001|Overall Study|Lost to Follow-up|3
4551427|NCT01214421|7379273|FG002|Overall Study|Lost to Follow-up|7
4551428|NCT01214421|7379274|FG003|Overall Study|Lost to Follow-up|3
4551429|NCT01214421|7379271|FG000|Overall Study|Adverse Event|16
4551430|NCT01214421|7379272|FG001|Overall Study|Adverse Event|35
4551431|NCT01214421|7379273|FG002|Overall Study|Adverse Event|14
4551432|NCT01214421|7379274|FG003|Overall Study|Adverse Event|3
4551433|NCT01214421|7379271|FG000|Overall Study|Sponsor Discontinued Site|1
4551434|NCT01214421|7379272|FG001|Overall Study|Sponsor Discontinued Site|2
4551435|NCT01214421|7379273|FG002|Overall Study|Sponsor Discontinued Site|0
4551436|NCT01214421|7379274|FG003|Overall Study|Sponsor Discontinued Site|0
4551437|NCT01214421|7379271|FG000|Overall Study|Withdrawal Criteria Met|3
4551438|NCT01214421|7379272|FG001|Overall Study|Withdrawal Criteria Met|0
4551439|NCT01214421|7379273|FG002|Overall Study|Withdrawal Criteria Met|2
4551440|NCT01214421|7379274|FG003|Overall Study|Withdrawal Criteria Met|1
4551441|NCT01214421|7379271|FG000|Overall Study|Physician Decision|2
4551442|NCT01214421|7379272|FG001|Overall Study|Physician Decision|0
4551443|NCT01214421|7379273|FG002|Overall Study|Physician Decision|4
4551444|NCT01214421|7379274|FG003|Overall Study|Physician Decision|0
4551445|NCT01214421|7379271|FG000|Overall Study|Withdrawal by Subject|21
4551446|NCT01214421|7379272|FG001|Overall Study|Withdrawal by Subject|18
4551447|NCT01214421|7379273|FG002|Overall Study|Withdrawal by Subject|11
4551448|NCT01214421|7379274|FG003|Overall Study|Withdrawal by Subject|2
4551449|NCT01214434|7379286|FG000|Overall Study|Withdrawal by Subject|1
4551450|NCT01214434|7379287|FG001|Overall Study|Withdrawal by Subject|0
4551451|NCT01214434|7379286|FG000|Overall Study|Lost to Follow-up|2
4551452|NCT01214434|7379287|FG001|Overall Study|Lost to Follow-up|2
4551453|NCT01214434|7379286|FG000|Overall Study|Site error|1
4551454|NCT01214434|7379287|FG001|Overall Study|Site error|0
4551455|NCT01214603|7379296|FG000|Overall Study|Adverse Event|0
4551456|NCT01214603|7379297|FG001|Overall Study|Adverse Event|0
4551457|NCT01214603|7379298|FG002|Overall Study|Adverse Event|1
4551458|NCT01214603|7379296|FG000|Overall Study|Death|1
4551459|NCT01214603|7379297|FG001|Overall Study|Death|0
4551460|NCT01214603|7379298|FG002|Overall Study|Death|0
4551461|NCT01214603|7379296|FG000|Overall Study|Progressive Disease|4
4551462|NCT01214603|7379297|FG001|Overall Study|Progressive Disease|1
4551463|NCT01214603|7379298|FG002|Overall Study|Progressive Disease|3
4551464|NCT01214616|7379311|FG000|Overall Study|Progressive disease|2
4551465|NCT01214616|7379312|FG001|Overall Study|Progressive disease|2
4551466|NCT01214616|7379313|FG002|Overall Study|Progressive disease|2
4551467|NCT01214616|7379314|FG003|Overall Study|Progressive disease|4
4551468|NCT01214616|7379311|FG000|Overall Study|Dose limiting toxicity|0
4551469|NCT01214616|7379312|FG001|Overall Study|Dose limiting toxicity|2
4551470|NCT01214616|7379313|FG002|Overall Study|Dose limiting toxicity|0
4551471|NCT01214616|7379314|FG003|Overall Study|Dose limiting toxicity|0
4551472|NCT01214616|7379311|FG000|Overall Study|Other adverse events|0
4551473|NCT01214616|7379312|FG001|Overall Study|Other adverse events|1
4551474|NCT01214616|7379313|FG002|Overall Study|Other adverse events|1
4551475|NCT01214616|7379314|FG003|Overall Study|Other adverse events|1
4551476|NCT01214616|7379311|FG000|Overall Study|Withdrawal by Subject|1
4551477|NCT01214616|7379312|FG001|Overall Study|Withdrawal by Subject|0
4551478|NCT01214616|7379313|FG002|Overall Study|Withdrawal by Subject|0
4551479|NCT01214616|7379314|FG003|Overall Study|Withdrawal by Subject|1
4551480|NCT01214629|7379343|FG000|Overall Study|Progressive Disease|1
4551481|NCT01214629|7379344|FG001|Overall Study|Progressive Disease|1
4551482|NCT01214629|7379345|FG002|Overall Study|Progressive Disease|0
4551483|NCT01214629|7379346|FG003|Overall Study|Progressive Disease|1
4551484|NCT01214629|7379347|FG004|Overall Study|Progressive Disease|2
4551485|NCT01214629|7379348|FG005|Overall Study|Progressive Disease|3
4551486|NCT01214629|7379349|FG006|Overall Study|Progressive Disease|1
4551487|NCT01214629|7379350|FG007|Overall Study|Progressive Disease|1
4551488|NCT01214629|7379351|FG008|Overall Study|Progressive Disease|1
4551489|NCT01214629|7379352|FG009|Overall Study|Progressive Disease|5
4551490|NCT01214629|7379353|FG010|Overall Study|Progressive Disease|1
4551491|NCT01214629|7379343|FG000|Overall Study|Adverse Event|0
4551492|NCT01214629|7379344|FG001|Overall Study|Adverse Event|0
4551493|NCT01214629|7379345|FG002|Overall Study|Adverse Event|0
4551494|NCT01214629|7379346|FG003|Overall Study|Adverse Event|1
4551495|NCT01214629|7379347|FG004|Overall Study|Adverse Event|0
4551496|NCT01214629|7379348|FG005|Overall Study|Adverse Event|1
4551497|NCT01214629|7379349|FG006|Overall Study|Adverse Event|0
4551498|NCT01214629|7379350|FG007|Overall Study|Adverse Event|0
4551499|NCT01214629|7379351|FG008|Overall Study|Adverse Event|0
4551500|NCT01214629|7379352|FG009|Overall Study|Adverse Event|1
4551501|NCT01214629|7379353|FG010|Overall Study|Adverse Event|0
4551502|NCT01214629|7379343|FG000|Overall Study|Physician Decision|0
4551503|NCT01214629|7379344|FG001|Overall Study|Physician Decision|0
4551504|NCT01214629|7379345|FG002|Overall Study|Physician Decision|0
4551505|NCT01214629|7379346|FG003|Overall Study|Physician Decision|0
4551506|NCT01214629|7379347|FG004|Overall Study|Physician Decision|0
4551507|NCT01214629|7379348|FG005|Overall Study|Physician Decision|0
4551508|NCT01214629|7379349|FG006|Overall Study|Physician Decision|0
4551509|NCT01214629|7379350|FG007|Overall Study|Physician Decision|0
4551510|NCT01214629|7379351|FG008|Overall Study|Physician Decision|0
4551511|NCT01214629|7379352|FG009|Overall Study|Physician Decision|0
4551512|NCT01214629|7379353|FG010|Overall Study|Physician Decision|1
4551513|NCT01214629|7379343|FG000|Overall Study|Withdrawal by Subject|0
4551514|NCT01214629|7379344|FG001|Overall Study|Withdrawal by Subject|0
4551515|NCT01214629|7379345|FG002|Overall Study|Withdrawal by Subject|0
4551516|NCT01214629|7379346|FG003|Overall Study|Withdrawal by Subject|0
4551517|NCT01214629|7379347|FG004|Overall Study|Withdrawal by Subject|0
4551518|NCT01214629|7379348|FG005|Overall Study|Withdrawal by Subject|0
4551519|NCT01214629|7379349|FG006|Overall Study|Withdrawal by Subject|0
4551520|NCT01214629|7379350|FG007|Overall Study|Withdrawal by Subject|0
4551521|NCT01214629|7379351|FG008|Overall Study|Withdrawal by Subject|0
4551522|NCT01214629|7379352|FG009|Overall Study|Withdrawal by Subject|1
4551523|NCT01214629|7379353|FG010|Overall Study|Withdrawal by Subject|0
4551524|NCT01214642|7379403|FG000|Overall Study|Progressive Disease|3
4551525|NCT01214642|7379404|FG001|Overall Study|Progressive Disease|2
4551526|NCT01214642|7379405|FG002|Overall Study|Progressive Disease|3
4551527|NCT01214642|7379406|FG003|Overall Study|Progressive Disease|5
4551528|NCT01214642|7379407|FG004|Overall Study|Progressive Disease|5
4551529|NCT01214642|7379408|FG005|Overall Study|Progressive Disease|3
4551530|NCT01214642|7379409|FG006|Overall Study|Progressive Disease|5
4551531|NCT01214642|7379410|FG007|Overall Study|Progressive Disease|3
4551532|NCT01214642|7379411|FG008|Overall Study|Progressive Disease|10
4551533|NCT01214642|7379412|FG009|Overall Study|Progressive Disease|2
4551534|NCT01214642|7379413|FG010|Overall Study|Progressive Disease|1
4551535|NCT01214642|7379414|FG011|Overall Study|Progressive Disease|4
4551536|NCT01214642|7379403|FG000|Overall Study|Adverse Event|0
4551537|NCT01214642|7379404|FG001|Overall Study|Adverse Event|1
4551538|NCT01214642|7379405|FG002|Overall Study|Adverse Event|0
4551539|NCT01214642|7379406|FG003|Overall Study|Adverse Event|0
4551540|NCT01214642|7379407|FG004|Overall Study|Adverse Event|0
4551541|NCT01214642|7379408|FG005|Overall Study|Adverse Event|0
4551542|NCT01214642|7379409|FG006|Overall Study|Adverse Event|1
4551543|NCT01214642|7379410|FG007|Overall Study|Adverse Event|0
4551544|NCT01214642|7379411|FG008|Overall Study|Adverse Event|0
4551545|NCT01214642|7379412|FG009|Overall Study|Adverse Event|1
4551546|NCT01214642|7379413|FG010|Overall Study|Adverse Event|1
4551547|NCT01214642|7379414|FG011|Overall Study|Adverse Event|0
4551548|NCT01214642|7379403|FG000|Overall Study|Death|0
4551549|NCT01214642|7379404|FG001|Overall Study|Death|0
4551550|NCT01214642|7379405|FG002|Overall Study|Death|1
4551551|NCT01214642|7379406|FG003|Overall Study|Death|0
4551552|NCT01214642|7379407|FG004|Overall Study|Death|0
4551553|NCT01214642|7379408|FG005|Overall Study|Death|0
4551554|NCT01214642|7379409|FG006|Overall Study|Death|0
4551555|NCT01214642|7379410|FG007|Overall Study|Death|0
4551556|NCT01214642|7379411|FG008|Overall Study|Death|0
4551557|NCT01214642|7379412|FG009|Overall Study|Death|0
4551558|NCT01214642|7379413|FG010|Overall Study|Death|1
4551559|NCT01214642|7379414|FG011|Overall Study|Death|0
4551560|NCT01214642|7379403|FG000|Overall Study|Withdrawal by Subject|0
4551561|NCT01214642|7379404|FG001|Overall Study|Withdrawal by Subject|0
4551562|NCT01214642|7379405|FG002|Overall Study|Withdrawal by Subject|1
4551563|NCT01214642|7379406|FG003|Overall Study|Withdrawal by Subject|0
4551564|NCT01214642|7379407|FG004|Overall Study|Withdrawal by Subject|0
4551565|NCT01214642|7379408|FG005|Overall Study|Withdrawal by Subject|0
4551566|NCT01214642|7379409|FG006|Overall Study|Withdrawal by Subject|0
4551567|NCT01214642|7379410|FG007|Overall Study|Withdrawal by Subject|0
4551568|NCT01214642|7379411|FG008|Overall Study|Withdrawal by Subject|3
4551569|NCT01214642|7379412|FG009|Overall Study|Withdrawal by Subject|1
4551570|NCT01214642|7379413|FG010|Overall Study|Withdrawal by Subject|1
4551571|NCT01214642|7379414|FG011|Overall Study|Withdrawal by Subject|0
4551572|NCT01214642|7379403|FG000|Overall Study|Physician Decision|0
4551573|NCT01214642|7379404|FG001|Overall Study|Physician Decision|0
4551574|NCT01214642|7379405|FG002|Overall Study|Physician Decision|1
4551575|NCT01214642|7379406|FG003|Overall Study|Physician Decision|1
4551576|NCT01214642|7379407|FG004|Overall Study|Physician Decision|1
4551577|NCT01214642|7379408|FG005|Overall Study|Physician Decision|0
4551578|NCT01214642|7379409|FG006|Overall Study|Physician Decision|0
4551579|NCT01214642|7379410|FG007|Overall Study|Physician Decision|0
4551580|NCT01214642|7379411|FG008|Overall Study|Physician Decision|0
4551581|NCT01214642|7379412|FG009|Overall Study|Physician Decision|0
4551582|NCT01214642|7379413|FG010|Overall Study|Physician Decision|0
4551583|NCT01214642|7379414|FG011|Overall Study|Physician Decision|2
4551584|NCT01214655|7379460|FG000|Part A|Progressive Disease|7
4551585|NCT01214655|7379461|FG001|Part A|Progressive Disease|0
4551586|NCT01214655|7379462|FG002|Part A|Progressive Disease|0
4551587|NCT01214655|7379460|FG000|Part A|Physician Decision|1
4551588|NCT01214655|7379461|FG001|Part A|Physician Decision|0
4551589|NCT01214655|7379462|FG002|Part A|Physician Decision|0
4551590|NCT01214655|7379460|FG000|Part B|Progressive disease|0
4551591|NCT01214655|7379461|FG001|Part B|Progressive disease|10
4551592|NCT01214655|7379462|FG002|Part B|Progressive disease|0
4551593|NCT01214655|7379460|FG000|Part B|Death|0
4551594|NCT01214655|7379461|FG001|Part B|Death|1
4551595|NCT01214655|7379462|FG002|Part B|Death|0
4551596|NCT01214655|7379460|FG000|Part B|Withdrawal by Subject|0
4551597|NCT01214655|7379461|FG001|Part B|Withdrawal by Subject|2
4551598|NCT01214655|7379462|FG002|Part B|Withdrawal by Subject|0
4551599|NCT01214655|7379460|FG000|Part C|Progressive Disease|0
4551600|NCT01214655|7379461|FG001|Part C|Progressive Disease|0
4551601|NCT01214655|7379462|FG002|Part C|Progressive Disease|5
4551602|NCT01214655|7379460|FG000|Part C|Death|0
4551603|NCT01214655|7379461|FG001|Part C|Death|0
4551604|NCT01214655|7379462|FG002|Part C|Death|1
4551605|NCT01214655|7379460|FG000|Part C|Physician Decision|0
4551606|NCT01214655|7379461|FG001|Part C|Physician Decision|0
4551607|NCT01214655|7379462|FG002|Part C|Physician Decision|1
4551608|NCT01214668|7379514|FG000|Overall Study|Adverse Event|0
4551609|NCT01214668|7379515|FG001|Overall Study|Adverse Event|1
4551610|NCT01214668|7379516|FG002|Overall Study|Adverse Event|0
4551611|NCT01214668|7379517|FG003|Overall Study|Adverse Event|2
4551612|NCT01214668|7379518|FG004|Overall Study|Adverse Event|1
4551613|NCT01214668|7379519|FG005|Overall Study|Adverse Event|1
4551614|NCT01214668|7379514|FG000|Overall Study|Death|0
4551615|NCT01214668|7379515|FG001|Overall Study|Death|0
4551616|NCT01214668|7379516|FG002|Overall Study|Death|1
4551617|NCT01214668|7379517|FG003|Overall Study|Death|0
4551618|NCT01214668|7379518|FG004|Overall Study|Death|0
4551619|NCT01214668|7379519|FG005|Overall Study|Death|0
4551620|NCT01214668|7379514|FG000|Overall Study|Progressive Disease|4
4551621|NCT01214668|7379515|FG001|Overall Study|Progressive Disease|2
4620794|NCT01787461|7483350|FG001|Overall Study|Adverse Event|3
4620795|NCT01787461|7483349|FG000|Overall Study|Lost to Follow-up|3
4620796|NCT01787461|7483350|FG001|Overall Study|Lost to Follow-up|2
4620797|NCT01787461|7483349|FG000|Overall Study|No longer met eligibility criteria|1
4620798|NCT01787461|7483350|FG001|Overall Study|No longer met eligibility criteria|0
4620799|NCT01787461|7483349|FG000|Overall Study|Withdrawal by Subject|3
4620800|NCT01787461|7483350|FG001|Overall Study|Withdrawal by Subject|4
4620801|NCT01787461|7483349|FG000|Overall Study|Protocol Violation|3
4620802|NCT01787461|7483350|FG001|Overall Study|Protocol Violation|0
4620803|NCT01787591|7483358|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
4620804|NCT01787591|7483359|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
4620805|NCT01787591|7483360|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
4620806|NCT01787591|7483361|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1
4620807|NCT01787760|7483384|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1
4620808|NCT01787760|7483385|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0
4620809|NCT01787760|7483386|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0
4620810|NCT01787760|7483384|FG000|Overall Study|Decompensated on left exotropia|0
4620811|NCT01787760|7483385|FG001|Overall Study|Decompensated on left exotropia|0
4620812|NCT01787760|7483386|FG002|Overall Study|Decompensated on left exotropia|1
4551622|NCT01214668|7379516|FG002|Overall Study|Progressive Disease|5
4551623|NCT01214668|7379517|FG003|Overall Study|Progressive Disease|4
4551624|NCT01214668|7379518|FG004|Overall Study|Progressive Disease|4
4551625|NCT01214668|7379519|FG005|Overall Study|Progressive Disease|5
4551626|NCT01214668|7379514|FG000|Overall Study|Withdrawal by Subject|0
4551627|NCT01214668|7379515|FG001|Overall Study|Withdrawal by Subject|0
4551628|NCT01214668|7379516|FG002|Overall Study|Withdrawal by Subject|0
4551629|NCT01214668|7379517|FG003|Overall Study|Withdrawal by Subject|0
4551630|NCT01214668|7379518|FG004|Overall Study|Withdrawal by Subject|1
4551631|NCT01214668|7379519|FG005|Overall Study|Withdrawal by Subject|0
4591790|NCT01534208|7438725|FG001|Overall Study|PCP decision|0
4591791|NCT01534208|7438724|FG000|Overall Study|Needed prohibited meds|1
4591792|NCT01534208|7438725|FG001|Overall Study|Needed prohibited meds|0
4591793|NCT01534260|7438733|FG000|Overall Study|Adverse Event|1
4591794|NCT01534260|7438734|FG001|Overall Study|Adverse Event|8
4620813|NCT01787760|7483384|FG000|Overall Study|Dryness|0
4620814|NCT01787760|7483385|FG001|Overall Study|Dryness|1
4620815|NCT01787760|7483386|FG002|Overall Study|Dryness|0
4620816|NCT01787760|7483384|FG000|Overall Study|Relocation|1
4620817|NCT01787760|7483385|FG001|Overall Study|Relocation|1
4620818|NCT01787760|7483386|FG002|Overall Study|Relocation|0
4620819|NCT01787760|7483384|FG000|Overall Study|Lens discomfort|3
4551632|NCT01214720|7379536|FG000|Overall Study|Alive and still on treatment|34
4551633|NCT01214720|7379537|FG001|Overall Study|Alive and still on treatment|18
4551634|NCT01214720|7379536|FG000|Overall Study|Alive and in follow-up|45
4551635|NCT01214720|7379537|FG001|Overall Study|Alive and in follow-up|48
4551636|NCT01214720|7379536|FG000|Overall Study|Lost to Follow-up|6
4551637|NCT01214720|7379537|FG001|Overall Study|Lost to Follow-up|2
4551638|NCT01214837|7379559|FG000|Overall Study|Death|0
4551639|NCT01214837|7379560|FG001|Overall Study|Death|0
4551640|NCT01214837|7379561|FG002|Overall Study|Death|1
4551641|NCT01214837|7379559|FG000|Overall Study|Adverse Event|1
4551642|NCT01214837|7379560|FG001|Overall Study|Adverse Event|2
4551643|NCT01214837|7379561|FG002|Overall Study|Adverse Event|1
4551644|NCT01214837|7379559|FG000|Overall Study|Withdrawal by Subject|27
4620820|NCT01787760|7483385|FG001|Overall Study|Lens discomfort|0
4620821|NCT01787760|7483386|FG002|Overall Study|Lens discomfort|0
4551645|NCT01214837|7379560|FG001|Overall Study|Withdrawal by Subject|36
4551646|NCT01214837|7379561|FG002|Overall Study|Withdrawal by Subject|28
4551647|NCT01214837|7379559|FG000|Overall Study|Lost to Follow-up|20
4551648|NCT01214837|7379560|FG001|Overall Study|Lost to Follow-up|15
4551649|NCT01214837|7379561|FG002|Overall Study|Lost to Follow-up|21
4551650|NCT01214837|7379559|FG000|Overall Study|Inappropriate Enrolment|0
4551651|NCT01214837|7379560|FG001|Overall Study|Inappropriate Enrolment|1
4551652|NCT01214837|7379561|FG002|Overall Study|Inappropriate Enrolment|2
4551653|NCT01214837|7379559|FG000|Overall Study|Administrative Reason|2
4551654|NCT01214837|7379560|FG001|Overall Study|Administrative Reason|6
4551655|NCT01214837|7379561|FG002|Overall Study|Administrative Reason|4
4551656|NCT01214837|7379559|FG000|Overall Study|Protocol Violation|3
4551657|NCT01214837|7379560|FG001|Overall Study|Protocol Violation|1
4551658|NCT01214837|7379561|FG002|Overall Study|Protocol Violation|5
4551659|NCT01214837|7379559|FG000|Overall Study|Unable to Classify|1
4551660|NCT01214837|7379560|FG001|Overall Study|Unable to Classify|3
4551661|NCT01214837|7379561|FG002|Overall Study|Unable to Classify|0
4551662|NCT01214850|7379573|FG000|Overall Study|Withdrawal by Subject|38
4551663|NCT01214850|7379574|FG001|Overall Study|Withdrawal by Subject|31
4551664|NCT01214850|7379575|FG002|Overall Study|Withdrawal by Subject|28
4551665|NCT01214850|7379573|FG000|Overall Study|Lost to Follow-up|124
4551666|NCT01214850|7379574|FG001|Overall Study|Lost to Follow-up|98
4551667|NCT01214850|7379575|FG002|Overall Study|Lost to Follow-up|123
4551668|NCT01214850|7379573|FG000|Overall Study|Protocol Violation|5
4551669|NCT01214850|7379574|FG001|Overall Study|Protocol Violation|5
4551670|NCT01214850|7379575|FG002|Overall Study|Protocol Violation|6
4551671|NCT01214850|7379573|FG000|Overall Study|Adverse event or death|11
4551672|NCT01214850|7379574|FG001|Overall Study|Adverse event or death|8
4551673|NCT01214850|7379575|FG002|Overall Study|Adverse event or death|3
4551674|NCT01214850|7379573|FG000|Overall Study|Inappropriate enrollment|2
4551675|NCT01214850|7379574|FG001|Overall Study|Inappropriate enrollment|1
4551676|NCT01214850|7379575|FG002|Overall Study|Inappropriate enrollment|0
4551677|NCT01214850|7379573|FG000|Overall Study|Administrative reason|1
4551678|NCT01214850|7379574|FG001|Overall Study|Administrative reason|0
4551679|NCT01214850|7379575|FG002|Overall Study|Administrative reason|0
4551680|NCT01214850|7379573|FG000|Overall Study|Unable to classify|2
4551681|NCT01214850|7379574|FG001|Overall Study|Unable to classify|1
4551682|NCT01214850|7379575|FG002|Overall Study|Unable to classify|1
4551683|NCT01214915|7379586|FG000|Overall Study|Adverse Event|8
4551684|NCT01214915|7379586|FG000|Overall Study|Lack of Efficacy|3
4551685|NCT01215032|7379599|FG000|Overall Study|Adverse Event|3
4551686|NCT01215032|7379599|FG000|Overall Study|Lack of Efficacy|17
4551687|NCT01215097|7379607|FG000|Overall Study|Adverse Event|1
4551688|NCT01215097|7379608|FG001|Overall Study|Adverse Event|3
4551689|NCT01215097|7379607|FG000|Overall Study|Protocol Violation|0
4551690|NCT01215097|7379608|FG001|Overall Study|Protocol Violation|2
4551691|NCT01215097|7379607|FG000|Overall Study|Lost to Follow-up|2
4551692|NCT01215097|7379608|FG001|Overall Study|Lost to Follow-up|0
4551693|NCT01215097|7379607|FG000|Overall Study|Withdrawal by Subject|6
4551694|NCT01215097|7379608|FG001|Overall Study|Withdrawal by Subject|3
4551695|NCT01215097|7379607|FG000|Overall Study|Lack of Efficacy|0
4551696|NCT01215097|7379608|FG001|Overall Study|Lack of Efficacy|3
4551697|NCT01215097|7379607|FG000|Overall Study|patient's refusal to come|2
4551698|NCT01215097|7379608|FG001|Overall Study|patient's refusal to come|2
4551699|NCT01215097|7379607|FG000|Overall Study|patient's private reason|1
4551700|NCT01215097|7379608|FG001|Overall Study|patient's private reason|1
4551701|NCT01215175|7379648|FG000|Overall Study|Lost to Follow-up|0
4551702|NCT01215175|7379649|FG001|Overall Study|Lost to Follow-up|1
4551703|NCT01215175|7379650|FG002|Overall Study|Lost to Follow-up|0
4551704|NCT01215175|7379651|FG003|Overall Study|Lost to Follow-up|1
4551705|NCT01215175|7379652|FG004|Overall Study|Lost to Follow-up|0
4551706|NCT01215188|7379667|FG000|Overall Study|Lost to Follow-up|22
4551707|NCT01215188|7379668|FG001|Overall Study|Lost to Follow-up|22
4551708|NCT01215188|7379669|FG002|Overall Study|Lost to Follow-up|16
4620822|NCT01787760|7483384|FG000|Overall Study|Lens handling difficulty|1
4551709|NCT01215188|7379667|FG000|Overall Study|Adverse Event|1
4551710|NCT01215188|7379668|FG001|Overall Study|Adverse Event|1
4551711|NCT01215188|7379669|FG002|Overall Study|Adverse Event|3
4551712|NCT01215188|7379667|FG000|Overall Study|Physician Decision|2
4551713|NCT01215188|7379668|FG001|Overall Study|Physician Decision|1
4551714|NCT01215188|7379669|FG002|Overall Study|Physician Decision|0
4551715|NCT01215188|7379667|FG000|Overall Study|Lack of Efficacy|0
4551716|NCT01215188|7379668|FG001|Overall Study|Lack of Efficacy|0
4551717|NCT01215188|7379669|FG002|Overall Study|Lack of Efficacy|1
4551718|NCT01215188|7379667|FG000|Overall Study|Protocol Violation|1
4551719|NCT01215188|7379668|FG001|Overall Study|Protocol Violation|1
4551720|NCT01215188|7379669|FG002|Overall Study|Protocol Violation|1
4551721|NCT01215188|7379667|FG000|Overall Study|Withdrawal by Subject|32
4551722|NCT01215188|7379668|FG001|Overall Study|Withdrawal by Subject|34
4551723|NCT01215188|7379669|FG002|Overall Study|Withdrawal by Subject|31
4551724|NCT01215227|7379683|FG000|Overall Study|Adverse Event|11
4551725|NCT01215227|7379684|FG001|Overall Study|Adverse Event|11
4551726|NCT01215227|7379685|FG002|Overall Study|Adverse Event|4
4551727|NCT01215227|7379686|FG003|Overall Study|Adverse Event|8
4551728|NCT01215227|7379687|FG004|Overall Study|Adverse Event|7
4551729|NCT01215227|7379688|FG005|Overall Study|Adverse Event|6
4551730|NCT01215227|7379683|FG000|Overall Study|Treatment Failure|8
4551731|NCT01215227|7379684|FG001|Overall Study|Treatment Failure|4
4551732|NCT01215227|7379685|FG002|Overall Study|Treatment Failure|1
4551733|NCT01215227|7379686|FG003|Overall Study|Treatment Failure|5
4551734|NCT01215227|7379687|FG004|Overall Study|Treatment Failure|1
4551735|NCT01215227|7379688|FG005|Overall Study|Treatment Failure|1
4551736|NCT01215227|7379683|FG000|Overall Study|Lost to Follow-up|1
4551737|NCT01215227|7379684|FG001|Overall Study|Lost to Follow-up|4
4551738|NCT01215227|7379685|FG002|Overall Study|Lost to Follow-up|1
4551739|NCT01215227|7379686|FG003|Overall Study|Lost to Follow-up|1
4551740|NCT01215227|7379687|FG004|Overall Study|Lost to Follow-up|1
4551741|NCT01215227|7379688|FG005|Overall Study|Lost to Follow-up|2
4551742|NCT01215227|7379683|FG000|Overall Study|Subject Withdrew Consent|16
4551743|NCT01215227|7379684|FG001|Overall Study|Subject Withdrew Consent|20
4551744|NCT01215227|7379685|FG002|Overall Study|Subject Withdrew Consent|7
4551745|NCT01215227|7379686|FG003|Overall Study|Subject Withdrew Consent|10
4551746|NCT01215227|7379687|FG004|Overall Study|Subject Withdrew Consent|11
4551747|NCT01215227|7379688|FG005|Overall Study|Subject Withdrew Consent|8
4551748|NCT01215227|7379683|FG000|Overall Study|Non-Compliance With Protocol|2
4551749|NCT01215227|7379684|FG001|Overall Study|Non-Compliance With Protocol|6
4551750|NCT01215227|7379685|FG002|Overall Study|Non-Compliance With Protocol|1
4551751|NCT01215227|7379686|FG003|Overall Study|Non-Compliance With Protocol|0
4551752|NCT01215227|7379687|FG004|Overall Study|Non-Compliance With Protocol|0
4551753|NCT01215227|7379688|FG005|Overall Study|Non-Compliance With Protocol|0
4551754|NCT01215227|7379683|FG000|Overall Study|Administrative|83
4551755|NCT01215227|7379684|FG001|Overall Study|Administrative|73
4551756|NCT01215227|7379685|FG002|Overall Study|Administrative|42
4551757|NCT01215227|7379686|FG003|Overall Study|Administrative|24
4551758|NCT01215227|7379687|FG004|Overall Study|Administrative|28
4551759|NCT01215227|7379688|FG005|Overall Study|Administrative|40
4551760|NCT01215227|7379683|FG000|Overall Study|Missing Status|0
4551761|NCT01215227|7379684|FG001|Overall Study|Missing Status|1
4551762|NCT01215227|7379685|FG002|Overall Study|Missing Status|0
4551763|NCT01215227|7379686|FG003|Overall Study|Missing Status|0
4551764|NCT01215227|7379687|FG004|Overall Study|Missing Status|0
4551765|NCT01215227|7379688|FG005|Overall Study|Missing Status|0
4551766|NCT01215227|7379683|FG000|Overall Study|Randomized but not treated|0
4551767|NCT01215227|7379684|FG001|Overall Study|Randomized but not treated|0
4551768|NCT01215227|7379685|FG002|Overall Study|Randomized but not treated|1
4551769|NCT01215227|7379686|FG003|Overall Study|Randomized but not treated|1
4551770|NCT01215227|7379687|FG004|Overall Study|Randomized but not treated|0
4551771|NCT01215227|7379688|FG005|Overall Study|Randomized but not treated|1
4551772|NCT01215253|7379713|FG000|Overall Study|Withdrawal by Subject|57
4551773|NCT01215253|7379714|FG001|Overall Study|Withdrawal by Subject|35
4551774|NCT01215253|7379713|FG000|Overall Study|Physician Decision|9
4551775|NCT01215253|7379714|FG001|Overall Study|Physician Decision|12
4551776|NCT01215253|7379713|FG000|Overall Study|Lost to Follow-up|6
4551777|NCT01215253|7379714|FG001|Overall Study|Lost to Follow-up|4
4551778|NCT01215253|7379713|FG000|Overall Study|Other|14
4551779|NCT01215253|7379714|FG001|Overall Study|Other|12
4551780|NCT01215357|7379781|FG000|Overall Study|Withdrawal by Subject|3
4551781|NCT01215357|7379781|FG000|Overall Study|Protocol Violation|9
4551782|NCT01215422|7379789|FG000|Overall Study|Relocation|1
4551783|NCT01215422|7379790|FG001|Overall Study|Relocation|0
4551784|NCT01215422|7379791|FG002|Overall Study|Relocation|0
4551785|NCT01215422|7379792|FG003|Overall Study|Relocation|0
4551786|NCT01215422|7379789|FG000|Overall Study|Failed intubations|0
4551787|NCT01215422|7379790|FG001|Overall Study|Failed intubations|0
4551788|NCT01215422|7379791|FG002|Overall Study|Failed intubations|3
4551789|NCT01215422|7379792|FG003|Overall Study|Failed intubations|8
4551790|NCT01215422|7379789|FG000|Overall Study|Did not complete all intubations|7
4551791|NCT01215422|7379790|FG001|Overall Study|Did not complete all intubations|0
4551792|NCT01215422|7379791|FG002|Overall Study|Did not complete all intubations|0
4551793|NCT01215422|7379792|FG003|Overall Study|Did not complete all intubations|0
4551794|NCT01215435|7379816|FG000|Overall Study|Adverse Event|1
4551795|NCT01215435|7379817|FG001|Overall Study|Adverse Event|0
4551796|NCT01215435|7379816|FG000|Overall Study|Protocol Violation|2
4551797|NCT01215435|7379817|FG001|Overall Study|Protocol Violation|0
4551798|NCT01215435|7379816|FG000|Overall Study|Withdrawal Criteria|8
4551799|NCT01215435|7379817|FG001|Overall Study|Withdrawal Criteria|11
4551800|NCT01215435|7379816|FG000|Overall Study|Lost to Follow-up|3
4551801|NCT01215435|7379817|FG001|Overall Study|Lost to Follow-up|0
4551802|NCT01215435|7379816|FG000|Overall Study|Unclassified|5
4551803|NCT01215435|7379817|FG001|Overall Study|Unclassified|5
4551804|NCT01215513|7379823|FG000|Overall Study|Not completed CS42|9
4551805|NCT01215513|7379823|FG000|Overall Study|Not enrolled from CS42 to CS42A|21
4551806|NCT01215513|7379823|FG000|Overall Study|Adverse event (CS42A)|2
4551807|NCT01215513|7379823|FG000|Overall Study|Physician decision (CS42A)|6
4551808|NCT01215513|7379823|FG000|Overall Study|Withdrawal by subject (CS42A)|5
4551809|NCT01215513|7379823|FG000|Overall Study|Miscellaneous reasons (CS42A)|2
4551810|NCT01215721|7379863|FG000|Overall Study|Adverse Event|2
4551811|NCT01215734|7379869|FG000|Overall Study|Death|0
4551812|NCT01215734|7379870|FG001|Overall Study|Death|1
4551813|NCT01215851|7379895|FG000|Treatment Period|Adverse Event|1
4551814|NCT01215851|7379896|FG001|Treatment Period|Adverse Event|1
4551815|NCT01215851|7379897|FG002|Treatment Period|Adverse Event|1
4551816|NCT01215851|7379898|FG003|Treatment Period|Adverse Event|3
4551817|NCT01215851|7379899|FG004|Treatment Period|Adverse Event|0
4551818|NCT01215851|7379900|FG005|Treatment Period|Adverse Event|1
4620823|NCT01787760|7483385|FG001|Overall Study|Lens handling difficulty|2
4620824|NCT01787760|7483386|FG002|Overall Study|Lens handling difficulty|0
4620825|NCT01787760|7483384|FG000|Overall Study|Protocol Violation|6
4620826|NCT01787760|7483385|FG001|Overall Study|Protocol Violation|0
4620827|NCT01787760|7483386|FG002|Overall Study|Protocol Violation|1
4620828|NCT01787760|7483384|FG000|Overall Study|Withdrawal by Subject|5
4551819|NCT01215851|7379895|FG000|Follow up Period|Lost to Follow-up|0
4551820|NCT01215851|7379896|FG001|Follow up Period|Lost to Follow-up|0
4551821|NCT01215851|7379897|FG002|Follow up Period|Lost to Follow-up|0
4551822|NCT01215851|7379898|FG003|Follow up Period|Lost to Follow-up|0
4551823|NCT01215851|7379899|FG004|Follow up Period|Lost to Follow-up|0
4551824|NCT01215851|7379900|FG005|Follow up Period|Lost to Follow-up|1
4551825|NCT01215916|7379924|FG000|Overall Study|Progressive Disease|0
4551826|NCT01215916|7379925|FG001|Overall Study|Progressive Disease|2
4551827|NCT01215916|7379926|FG002|Overall Study|Progressive Disease|1
4551828|NCT01215916|7379927|FG003|Overall Study|Progressive Disease|2
4551829|NCT01215916|7379928|FG004|Overall Study|Progressive Disease|5
4551830|NCT01215916|7379929|FG005|Overall Study|Progressive Disease|4
4551831|NCT01215916|7379930|FG006|Overall Study|Progressive Disease|5
4551832|NCT01215916|7379931|FG007|Overall Study|Progressive Disease|3
4551833|NCT01215916|7379932|FG008|Overall Study|Progressive Disease|1
4551834|NCT01215916|7379924|FG000|Overall Study|Adverse Event|1
4551835|NCT01215916|7379925|FG001|Overall Study|Adverse Event|1
4551836|NCT01215916|7379926|FG002|Overall Study|Adverse Event|0
4551837|NCT01215916|7379927|FG003|Overall Study|Adverse Event|1
4551838|NCT01215916|7379928|FG004|Overall Study|Adverse Event|0
4551839|NCT01215916|7379929|FG005|Overall Study|Adverse Event|0
4551840|NCT01215916|7379930|FG006|Overall Study|Adverse Event|3
4551841|NCT01215916|7379931|FG007|Overall Study|Adverse Event|0
4551842|NCT01215916|7379932|FG008|Overall Study|Adverse Event|0
4551843|NCT01215916|7379924|FG000|Overall Study|Withdrawal by Subject|0
4551844|NCT01215916|7379925|FG001|Overall Study|Withdrawal by Subject|1
4551845|NCT01215916|7379926|FG002|Overall Study|Withdrawal by Subject|1
4551846|NCT01215916|7379927|FG003|Overall Study|Withdrawal by Subject|2
4551847|NCT01215916|7379928|FG004|Overall Study|Withdrawal by Subject|0
4551848|NCT01215916|7379929|FG005|Overall Study|Withdrawal by Subject|0
4551849|NCT01215916|7379930|FG006|Overall Study|Withdrawal by Subject|1
4551850|NCT01215916|7379931|FG007|Overall Study|Withdrawal by Subject|0
4551851|NCT01215916|7379932|FG008|Overall Study|Withdrawal by Subject|0
4551852|NCT01215916|7379924|FG000|Overall Study|Death|0
4551853|NCT01215916|7379925|FG001|Overall Study|Death|1
4551854|NCT01215916|7379926|FG002|Overall Study|Death|0
4551855|NCT01215916|7379927|FG003|Overall Study|Death|0
4551856|NCT01215916|7379928|FG004|Overall Study|Death|1
4551857|NCT01215916|7379929|FG005|Overall Study|Death|0
4551858|NCT01215916|7379930|FG006|Overall Study|Death|0
4551859|NCT01215916|7379931|FG007|Overall Study|Death|0
4551860|NCT01215916|7379932|FG008|Overall Study|Death|1
4620829|NCT01787760|7483385|FG001|Overall Study|Withdrawal by Subject|1
4620830|NCT01787760|7483386|FG002|Overall Study|Withdrawal by Subject|2
4620831|NCT01787760|7483384|FG000|Overall Study|Lost to Follow-up|1
4620832|NCT01787760|7483385|FG001|Overall Study|Lost to Follow-up|0
4620833|NCT01787760|7483386|FG002|Overall Study|Lost to Follow-up|1
4620834|NCT01787760|7483384|FG000|Overall Study|Stroke|1
4551861|NCT01215916|7379924|FG000|Overall Study|Physician Decision|0
4551862|NCT01215916|7379925|FG001|Overall Study|Physician Decision|0
4551863|NCT01215916|7379926|FG002|Overall Study|Physician Decision|1
4551864|NCT01215916|7379927|FG003|Overall Study|Physician Decision|1
4551865|NCT01215916|7379928|FG004|Overall Study|Physician Decision|0
4620835|NCT01787760|7483385|FG001|Overall Study|Stroke|0
4620836|NCT01787760|7483386|FG002|Overall Study|Stroke|0
4620837|NCT01787760|7483384|FG000|Overall Study|Unsatisfactory lens fitting performance|3
4551866|NCT01215916|7379929|FG005|Overall Study|Physician Decision|0
4551867|NCT01215916|7379930|FG006|Overall Study|Physician Decision|0
4551868|NCT01215916|7379931|FG007|Overall Study|Physician Decision|0
4551869|NCT01215916|7379932|FG008|Overall Study|Physician Decision|0
4551870|NCT01215942|7379967|FG000|Treatment Period|Adverse Event|15
4551871|NCT01215942|7379968|FG001|Treatment Period|Adverse Event|26
4551872|NCT01215942|7379967|FG000|Treatment Period|Death|2
4551873|NCT01215942|7379968|FG001|Treatment Period|Death|4
4551874|NCT01215942|7379967|FG000|Treatment Period|Lack of Efficacy|23
4551875|NCT01215942|7379968|FG001|Treatment Period|Lack of Efficacy|62
4551876|NCT01215942|7379967|FG000|Treatment Period|Lost to Follow-up|3
4551877|NCT01215942|7379968|FG001|Treatment Period|Lost to Follow-up|4
4551878|NCT01215942|7379967|FG000|Treatment Period|Withdrawal by Subject|17
4551879|NCT01215942|7379968|FG001|Treatment Period|Withdrawal by Subject|40
4551880|NCT01215942|7379967|FG000|Treatment Period|Physician Decision|5
4551881|NCT01215942|7379968|FG001|Treatment Period|Physician Decision|5
4551882|NCT01215942|7379967|FG000|Treatment Period|Protocol Violation|0
4551883|NCT01215942|7379968|FG001|Treatment Period|Protocol Violation|1
4551884|NCT01215942|7379967|FG000|Treatment Period|Sponsor Decision|349
4551885|NCT01215942|7379968|FG001|Treatment Period|Sponsor Decision|530
4551886|NCT01215942|7379967|FG000|Post-Treatment Follow-Up Period|Death|0
4551887|NCT01215942|7379968|FG001|Post-Treatment Follow-Up Period|Death|1
4551888|NCT01215942|7379967|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13
4551889|NCT01215942|7379968|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13
4551890|NCT01215942|7379967|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43
4551891|NCT01215942|7379968|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69
4551892|NCT01215942|7379967|FG000|Post-Treatment Follow-Up Period|Physician Decision|1
4551893|NCT01215942|7379968|FG001|Post-Treatment Follow-Up Period|Physician Decision|2
4551894|NCT01215942|7379967|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28
4551895|NCT01215942|7379968|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61
4551896|NCT01215955|7379989|FG000|Overall Study|Adverse Event|1
4551897|NCT01215955|7379990|FG001|Overall Study|Adverse Event|4
4551898|NCT01215955|7379991|FG002|Overall Study|Adverse Event|2
4551899|NCT01215955|7379992|FG003|Overall Study|Adverse Event|3
4551900|NCT01215955|7379989|FG000|Overall Study|Death|2
4551901|NCT01215955|7379990|FG001|Overall Study|Death|0
4551902|NCT01215955|7379991|FG002|Overall Study|Death|1
4551903|NCT01215955|7379992|FG003|Overall Study|Death|3
4551904|NCT01215955|7379989|FG000|Overall Study|Entry Criteria Not Met|1
4551905|NCT01215955|7379990|FG001|Overall Study|Entry Criteria Not Met|3
4551906|NCT01215955|7379991|FG002|Overall Study|Entry Criteria Not Met|4
4551907|NCT01215955|7379992|FG003|Overall Study|Entry Criteria Not Met|7
4551908|NCT01215955|7379989|FG000|Overall Study|Lack of Efficacy|1
4551909|NCT01215955|7379990|FG001|Overall Study|Lack of Efficacy|2
4551910|NCT01215955|7379991|FG002|Overall Study|Lack of Efficacy|1
4551911|NCT01215955|7379992|FG003|Overall Study|Lack of Efficacy|0
4551912|NCT01215955|7379989|FG000|Overall Study|Lost to Follow-up|4
4551913|NCT01215955|7379990|FG001|Overall Study|Lost to Follow-up|4
4551914|NCT01215955|7379991|FG002|Overall Study|Lost to Follow-up|8
4551915|NCT01215955|7379992|FG003|Overall Study|Lost to Follow-up|9
4551916|NCT01215955|7379989|FG000|Overall Study|Physician Decision|4
4551917|NCT01215955|7379990|FG001|Overall Study|Physician Decision|10
4551918|NCT01215955|7379991|FG002|Overall Study|Physician Decision|8
4551919|NCT01215955|7379992|FG003|Overall Study|Physician Decision|11
4551920|NCT01215955|7379989|FG000|Overall Study|Protocol Violation|17
4551921|NCT01215955|7379990|FG001|Overall Study|Protocol Violation|13
4551922|NCT01215955|7379991|FG002|Overall Study|Protocol Violation|8
4551923|NCT01215955|7379992|FG003|Overall Study|Protocol Violation|8
4551924|NCT01215955|7379989|FG000|Overall Study|Sponsor Decision|1
4551925|NCT01215955|7379990|FG001|Overall Study|Sponsor Decision|2
4551926|NCT01215955|7379991|FG002|Overall Study|Sponsor Decision|0
4551927|NCT01215955|7379992|FG003|Overall Study|Sponsor Decision|1
4551928|NCT01215955|7379989|FG000|Overall Study|Withdrawal by Subject|14
4551929|NCT01215955|7379990|FG001|Overall Study|Withdrawal by Subject|15
4551930|NCT01215955|7379991|FG002|Overall Study|Withdrawal by Subject|13
4551931|NCT01215955|7379992|FG003|Overall Study|Withdrawal by Subject|9
4551932|NCT01215955|7379989|FG000|Overall Study|Quality Issues|0
4551933|NCT01215955|7379990|FG001|Overall Study|Quality Issues|0
4551934|NCT01215955|7379991|FG002|Overall Study|Quality Issues|3
4551935|NCT01215955|7379992|FG003|Overall Study|Quality Issues|2
4620838|NCT01787760|7483385|FG001|Overall Study|Unsatisfactory lens fitting performance|6
4620839|NCT01787760|7483386|FG002|Overall Study|Unsatisfactory lens fitting performance|0
4620840|NCT01787760|7483384|FG000|Overall Study|Unsatisfactory physiological response|2
4620841|NCT01787760|7483385|FG001|Overall Study|Unsatisfactory physiological response|4
4620842|NCT01787760|7483386|FG002|Overall Study|Unsatisfactory physiological response|0
4551936|NCT01215968|7380007|FG000|Overall Study|Adverse Event|0
4551937|NCT01215968|7380008|FG001|Overall Study|Adverse Event|2
4551938|NCT01215968|7380007|FG000|Overall Study|Protocol Violation|2
4551939|NCT01215968|7380008|FG001|Overall Study|Protocol Violation|4
4551940|NCT01215968|7380007|FG000|Overall Study|Not received study drug|0
4551941|NCT01215968|7380008|FG001|Overall Study|Not received study drug|1
4551942|NCT01215981|7380019|FG000|Overall Study|Physician Decision|0
4551943|NCT01215981|7380020|FG001|Overall Study|Physician Decision|1
4551944|NCT01215981|7380019|FG000|Overall Study|Protocol Violation|1
4551945|NCT01215981|7380020|FG001|Overall Study|Protocol Violation|0
4551946|NCT01215981|7380019|FG000|Overall Study|Withdrawal by Subject|1
4551947|NCT01215981|7380020|FG001|Overall Study|Withdrawal by Subject|0
4551948|NCT01216072|7380028|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40
4551949|NCT01216072|7380029|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4
4551950|NCT01216072|7380028|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2
4551951|NCT01216072|7380029|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0
4551952|NCT01216072|7380028|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3
4551953|NCT01216072|7380029|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0
4551954|NCT01216072|7380028|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3
4551955|NCT01216072|7380029|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4
4551956|NCT01216072|7380028|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12
4551957|NCT01216072|7380029|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22
4551958|NCT01216072|7380028|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5
4551959|NCT01216072|7380029|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0
4551960|NCT01216072|7380028|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11
4551961|NCT01216072|7380029|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4
4551962|NCT01216072|7380028|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0
4551963|NCT01216072|7380029|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10
4551964|NCT01216072|7380028|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0
4551965|NCT01216072|7380029|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1
4551966|NCT01216072|7380028|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0
4551967|NCT01216072|7380029|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3
4551968|NCT01216163|7380041|FG000|Overall Study|Withdrawal by Subject|1
4551969|NCT01216163|7380042|FG001|Overall Study|Withdrawal by Subject|1
4551970|NCT01216163|7380043|FG002|Overall Study|Withdrawal by Subject|0
4551971|NCT01216176|7380054|FG000|Overall Study|Adverse Event|0
4551972|NCT01216176|7380055|FG001|Overall Study|Adverse Event|8
4551973|NCT01216176|7380056|FG002|Overall Study|Adverse Event|0
4551974|NCT01216176|7380054|FG000|Overall Study|Physician Decision|0
4551975|NCT01216176|7380055|FG001|Overall Study|Physician Decision|0
4551976|NCT01216176|7380056|FG002|Overall Study|Physician Decision|1
4551977|NCT01216189|7380067|FG000|Overall Study|Lost to Follow-up|21
4551978|NCT01216189|7380068|FG001|Overall Study|Lost to Follow-up|3
4551979|NCT01216189|7380067|FG000|Overall Study|Death|4
4551980|NCT01216189|7380068|FG001|Overall Study|Death|2
4551981|NCT01216202|7380076|FG000|Overall Study|Withdrawal by Subject|8
4551982|NCT01216202|7380077|FG001|Overall Study|Withdrawal by Subject|0
4551983|NCT01216202|7380076|FG000|Overall Study|Death|0
4551984|NCT01216202|7380077|FG001|Overall Study|Death|2
4551985|NCT01216202|7380076|FG000|Overall Study|Lost to Follow-up|14
4551986|NCT01216202|7380077|FG001|Overall Study|Lost to Follow-up|0
4551987|NCT01216319|7380094|FG000|Overall Study|Lost to Follow-up|2
4551988|NCT01216319|7380094|FG000|Overall Study|Unanticipated chemo for breast cancer|2
4551989|NCT01216332|7380100|FG000|Overall Study|Withdrawal by Subject|4
4620843|NCT01787760|7483384|FG000|Overall Study|Unsatisfactory visual response|1
4620844|NCT01787760|7483385|FG001|Overall Study|Unsatisfactory visual response|1
4620845|NCT01787760|7483386|FG002|Overall Study|Unsatisfactory visual response|0
4620846|NCT01787760|7483384|FG000|Overall Study|Near vision blur|1
4620847|NCT01787760|7483385|FG001|Overall Study|Near vision blur|0
4620848|NCT01787760|7483386|FG002|Overall Study|Near vision blur|0
4620849|NCT01787825|7483399|FG000|Overall Study|Subject Did Not Ingest Capsules|1
4620850|NCT01787825|7483400|FG001|Overall Study|Subject Did Not Ingest Capsules|0
4620851|NCT01787825|7483399|FG000|Overall Study|Data Not Analyzable|5
4620852|NCT01787825|7483400|FG001|Overall Study|Data Not Analyzable|1
4620853|NCT01787838|7483407|FG000|Overall Study|refused|1413
4633070|NCT01908140|7503009|FG000|Overall Study|Other or Progressive Disease|5
4633071|NCT01908140|7503010|FG001|Overall Study|Other or Progressive Disease|12
4633072|NCT01908140|7503009|FG000|Overall Study|Lack of Efficacy|7
4633073|NCT01908140|7503010|FG001|Overall Study|Lack of Efficacy|5
4633074|NCT01908140|7503009|FG000|Overall Study|Withdrawal by Subject|23
4633075|NCT01908140|7503010|FG001|Overall Study|Withdrawal by Subject|24
4633076|NCT01908140|7503009|FG000|Overall Study|Lost to Follow-up|1
4633077|NCT01908140|7503010|FG001|Overall Study|Lost to Follow-up|6
4633078|NCT01908140|7503009|FG000|Overall Study|Protocol Violation|8
4633079|NCT01908140|7503010|FG001|Overall Study|Protocol Violation|9
4633080|NCT01908140|7503009|FG000|Overall Study|Adverse Event|22
4633081|NCT01908140|7503010|FG001|Overall Study|Adverse Event|23
4633082|NCT01908205|7503018|FG000|Overall Study|Lost to Follow-up|2
4633083|NCT01908205|7503019|FG001|Overall Study|Lost to Follow-up|0
4551990|NCT01216332|7380101|FG001|Overall Study|Withdrawal by Subject|0
4551991|NCT01217073|7380160|FG000|Base Period|Adverse Event|1
4551992|NCT01217073|7380161|FG001|Base Period|Adverse Event|0
4551993|NCT01217073|7380162|FG002|Base Period|Adverse Event|1
4551994|NCT01217073|7380163|FG003|Base Period|Adverse Event|0
4551995|NCT01217073|7380164|FG004|Base Period|Adverse Event|4
4551996|NCT01217073|7380165|FG005|Base Period|Adverse Event|1
4551997|NCT01217073|7380166|FG006|Base Period|Adverse Event|0
4551998|NCT01217073|7380167|FG007|Base Period|Adverse Event|0
4633084|NCT01908205|7503018|FG000|Overall Study|Withdrawal by Subject|3
4551999|NCT01217073|7380160|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1
4552000|NCT01217073|7380161|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0
4552001|NCT01217073|7380162|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0
4552002|NCT01217073|7380163|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0
4552003|NCT01217073|7380164|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0
4552004|NCT01217073|7380165|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0
4552005|NCT01217073|7380166|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0
4552006|NCT01217073|7380167|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0
4552007|NCT01217073|7380160|FG000|Base Period|Excluded medication|0
4552008|NCT01217073|7380161|FG001|Base Period|Excluded medication|0
4552009|NCT01217073|7380162|FG002|Base Period|Excluded medication|0
4552010|NCT01217073|7380163|FG003|Base Period|Excluded medication|0
4552011|NCT01217073|7380164|FG004|Base Period|Excluded medication|1
4552012|NCT01217073|7380165|FG005|Base Period|Excluded medication|0
4552013|NCT01217073|7380166|FG006|Base Period|Excluded medication|0
4552014|NCT01217073|7380167|FG007|Base Period|Excluded medication|0
4552015|NCT01217073|7380160|FG000|Base Period|Lack of Efficacy|0
4552016|NCT01217073|7380161|FG001|Base Period|Lack of Efficacy|0
4552017|NCT01217073|7380162|FG002|Base Period|Lack of Efficacy|0
4552018|NCT01217073|7380163|FG003|Base Period|Lack of Efficacy|0
4552019|NCT01217073|7380164|FG004|Base Period|Lack of Efficacy|0
4552020|NCT01217073|7380165|FG005|Base Period|Lack of Efficacy|1
4552021|NCT01217073|7380166|FG006|Base Period|Lack of Efficacy|0
4552022|NCT01217073|7380167|FG007|Base Period|Lack of Efficacy|0
4552023|NCT01217073|7380160|FG000|Base Period|Lost to Follow-up|0
4552024|NCT01217073|7380161|FG001|Base Period|Lost to Follow-up|0
4552025|NCT01217073|7380162|FG002|Base Period|Lost to Follow-up|1
4552026|NCT01217073|7380163|FG003|Base Period|Lost to Follow-up|1
4552027|NCT01217073|7380164|FG004|Base Period|Lost to Follow-up|3
4552028|NCT01217073|7380165|FG005|Base Period|Lost to Follow-up|0
4552029|NCT01217073|7380166|FG006|Base Period|Lost to Follow-up|0
4552030|NCT01217073|7380167|FG007|Base Period|Lost to Follow-up|0
4552031|NCT01217073|7380160|FG000|Base Period|Physician Decision|0
4552032|NCT01217073|7380161|FG001|Base Period|Physician Decision|0
4552033|NCT01217073|7380162|FG002|Base Period|Physician Decision|0
4552034|NCT01217073|7380163|FG003|Base Period|Physician Decision|0
4552035|NCT01217073|7380164|FG004|Base Period|Physician Decision|1
4552036|NCT01217073|7380165|FG005|Base Period|Physician Decision|0
4552037|NCT01217073|7380166|FG006|Base Period|Physician Decision|0
4552038|NCT01217073|7380167|FG007|Base Period|Physician Decision|0
4552039|NCT01217073|7380160|FG000|Base Period|Protocol Violation|1
4552040|NCT01217073|7380161|FG001|Base Period|Protocol Violation|0
4552041|NCT01217073|7380162|FG002|Base Period|Protocol Violation|0
4552042|NCT01217073|7380163|FG003|Base Period|Protocol Violation|0
4552043|NCT01217073|7380164|FG004|Base Period|Protocol Violation|1
4552044|NCT01217073|7380165|FG005|Base Period|Protocol Violation|2
4552045|NCT01217073|7380166|FG006|Base Period|Protocol Violation|0
4552046|NCT01217073|7380167|FG007|Base Period|Protocol Violation|0
4552047|NCT01217073|7380160|FG000|Base Period|Withdrawal by Subject|4
4552048|NCT01217073|7380161|FG001|Base Period|Withdrawal by Subject|5
4552049|NCT01217073|7380162|FG002|Base Period|Withdrawal by Subject|5
4552050|NCT01217073|7380163|FG003|Base Period|Withdrawal by Subject|1
4552051|NCT01217073|7380164|FG004|Base Period|Withdrawal by Subject|5
4552052|NCT01217073|7380165|FG005|Base Period|Withdrawal by Subject|5
4552053|NCT01217073|7380166|FG006|Base Period|Withdrawal by Subject|0
4552054|NCT01217073|7380167|FG007|Base Period|Withdrawal by Subject|0
4620854|NCT01788046|7483420|FG000|Overall Study|Withdrawal by Subject|12
4620855|NCT01788046|7483421|FG001|Overall Study|Withdrawal by Subject|12
4620856|NCT01788046|7483420|FG000|Overall Study|Lost to Follow-up|12
4620857|NCT01788046|7483421|FG001|Overall Study|Lost to Follow-up|19
4620858|NCT01788046|7483420|FG000|Overall Study|Death|7
4620859|NCT01788046|7483421|FG001|Overall Study|Death|5
4620860|NCT01788046|7483420|FG000|Overall Study|Protocol Specified Criteria|25
4620861|NCT01788046|7483421|FG001|Overall Study|Protocol Specified Criteria|1
4620862|NCT01788163|7483445|FG000|Overall Study|Other|53
4620863|NCT01788163|7483446|FG001|Overall Study|Other|0
4620864|NCT01788163|7483447|FG002|Overall Study|Other|0
4552055|NCT01217073|7380160|FG000|Extension Period|Adverse Event|0
4552056|NCT01217073|7380161|FG001|Extension Period|Adverse Event|0
4552057|NCT01217073|7380162|FG002|Extension Period|Adverse Event|0
4552058|NCT01217073|7380163|FG003|Extension Period|Adverse Event|0
4552059|NCT01217073|7380164|FG004|Extension Period|Adverse Event|0
4552060|NCT01217073|7380165|FG005|Extension Period|Adverse Event|0
4552061|NCT01217073|7380166|FG006|Extension Period|Adverse Event|19
4552062|NCT01217073|7380167|FG007|Extension Period|Adverse Event|5
4552063|NCT01217073|7380160|FG000|Extension Period|ALT/AST|0
4552064|NCT01217073|7380161|FG001|Extension Period|ALT/AST|0
4552065|NCT01217073|7380162|FG002|Extension Period|ALT/AST|0
4552066|NCT01217073|7380163|FG003|Extension Period|ALT/AST|0
4552067|NCT01217073|7380164|FG004|Extension Period|ALT/AST|0
4552068|NCT01217073|7380165|FG005|Extension Period|ALT/AST|0
4620865|NCT01788163|7483448|FG003|Overall Study|Other|0
4552069|NCT01217073|7380166|FG006|Extension Period|ALT/AST|2
4552070|NCT01217073|7380167|FG007|Extension Period|ALT/AST|0
4552071|NCT01217073|7380160|FG000|Extension Period|Contraindication to study medication|0
4552072|NCT01217073|7380161|FG001|Extension Period|Contraindication to study medication|0
4620866|NCT01788163|7483449|FG004|Overall Study|Other|0
4552073|NCT01217073|7380162|FG002|Extension Period|Contraindication to study medication|0
4552074|NCT01217073|7380163|FG003|Extension Period|Contraindication to study medication|0
4552075|NCT01217073|7380164|FG004|Extension Period|Contraindication to study medication|0
4552076|NCT01217073|7380165|FG005|Extension Period|Contraindication to study medication|0
4552077|NCT01217073|7380166|FG006|Extension Period|Contraindication to study medication|1
4552078|NCT01217073|7380167|FG007|Extension Period|Contraindication to study medication|0
4552079|NCT01217073|7380160|FG000|Extension Period|Creatinine/eGFR|0
4552080|NCT01217073|7380161|FG001|Extension Period|Creatinine/eGFR|0
4552081|NCT01217073|7380162|FG002|Extension Period|Creatinine/eGFR|0
4552082|NCT01217073|7380163|FG003|Extension Period|Creatinine/eGFR|0
4552083|NCT01217073|7380164|FG004|Extension Period|Creatinine/eGFR|0
4552084|NCT01217073|7380165|FG005|Extension Period|Creatinine/eGFR|0
4552085|NCT01217073|7380166|FG006|Extension Period|Creatinine/eGFR|11
4552086|NCT01217073|7380167|FG007|Extension Period|Creatinine/eGFR|1
4552087|NCT01217073|7380160|FG000|Extension Period|Death|0
4552088|NCT01217073|7380161|FG001|Extension Period|Death|0
4552089|NCT01217073|7380162|FG002|Extension Period|Death|0
4552090|NCT01217073|7380163|FG003|Extension Period|Death|0
4552091|NCT01217073|7380164|FG004|Extension Period|Death|0
4552092|NCT01217073|7380165|FG005|Extension Period|Death|0
4552093|NCT01217073|7380166|FG006|Extension Period|Death|1
4552094|NCT01217073|7380167|FG007|Extension Period|Death|0
4552095|NCT01217073|7380160|FG000|Extension Period|Excluded medication|0
4552096|NCT01217073|7380161|FG001|Extension Period|Excluded medication|0
4552097|NCT01217073|7380162|FG002|Extension Period|Excluded medication|0
4552098|NCT01217073|7380163|FG003|Extension Period|Excluded medication|0
4552099|NCT01217073|7380164|FG004|Extension Period|Excluded medication|0
4552100|NCT01217073|7380165|FG005|Extension Period|Excluded medication|0
4552101|NCT01217073|7380166|FG006|Extension Period|Excluded medication|2
4552102|NCT01217073|7380167|FG007|Extension Period|Excluded medication|0
4552103|NCT01217073|7380160|FG000|Extension Period|Lack of Efficacy|0
4552104|NCT01217073|7380161|FG001|Extension Period|Lack of Efficacy|0
4552105|NCT01217073|7380162|FG002|Extension Period|Lack of Efficacy|0
4552106|NCT01217073|7380163|FG003|Extension Period|Lack of Efficacy|0
4552107|NCT01217073|7380164|FG004|Extension Period|Lack of Efficacy|0
4552108|NCT01217073|7380165|FG005|Extension Period|Lack of Efficacy|0
4552109|NCT01217073|7380166|FG006|Extension Period|Lack of Efficacy|3
4552110|NCT01217073|7380167|FG007|Extension Period|Lack of Efficacy|0
4552111|NCT01217073|7380160|FG000|Extension Period|Lost to Follow-up|0
4552112|NCT01217073|7380161|FG001|Extension Period|Lost to Follow-up|0
4552113|NCT01217073|7380162|FG002|Extension Period|Lost to Follow-up|0
4552114|NCT01217073|7380163|FG003|Extension Period|Lost to Follow-up|0
4552115|NCT01217073|7380164|FG004|Extension Period|Lost to Follow-up|0
4552116|NCT01217073|7380165|FG005|Extension Period|Lost to Follow-up|0
4552117|NCT01217073|7380166|FG006|Extension Period|Lost to Follow-up|9
4552118|NCT01217073|7380167|FG007|Extension Period|Lost to Follow-up|1
4552119|NCT01217073|7380160|FG000|Extension Period|Non-compliance with study drug|0
4552120|NCT01217073|7380161|FG001|Extension Period|Non-compliance with study drug|0
4552121|NCT01217073|7380162|FG002|Extension Period|Non-compliance with study drug|0
4552122|NCT01217073|7380163|FG003|Extension Period|Non-compliance with study drug|0
4552123|NCT01217073|7380164|FG004|Extension Period|Non-compliance with study drug|0
4552124|NCT01217073|7380165|FG005|Extension Period|Non-compliance with study drug|0
4552125|NCT01217073|7380166|FG006|Extension Period|Non-compliance with study drug|0
4552126|NCT01217073|7380167|FG007|Extension Period|Non-compliance with study drug|1
4552127|NCT01217073|7380160|FG000|Extension Period|Physician Decision|0
4552128|NCT01217073|7380161|FG001|Extension Period|Physician Decision|0
4552129|NCT01217073|7380162|FG002|Extension Period|Physician Decision|0
4552130|NCT01217073|7380163|FG003|Extension Period|Physician Decision|0
4552131|NCT01217073|7380164|FG004|Extension Period|Physician Decision|0
4552132|NCT01217073|7380165|FG005|Extension Period|Physician Decision|0
4552133|NCT01217073|7380166|FG006|Extension Period|Physician Decision|4
4552134|NCT01217073|7380167|FG007|Extension Period|Physician Decision|1
4552135|NCT01217073|7380160|FG000|Extension Period|Protocol Violation|0
4552136|NCT01217073|7380161|FG001|Extension Period|Protocol Violation|0
4552137|NCT01217073|7380162|FG002|Extension Period|Protocol Violation|0
4552138|NCT01217073|7380163|FG003|Extension Period|Protocol Violation|0
4552139|NCT01217073|7380164|FG004|Extension Period|Protocol Violation|0
4552140|NCT01217073|7380165|FG005|Extension Period|Protocol Violation|0
4552141|NCT01217073|7380166|FG006|Extension Period|Protocol Violation|2
4552142|NCT01217073|7380167|FG007|Extension Period|Protocol Violation|1
4552143|NCT01217073|7380160|FG000|Extension Period|Site discontinued study participation|0
4552144|NCT01217073|7380161|FG001|Extension Period|Site discontinued study participation|0
4552145|NCT01217073|7380162|FG002|Extension Period|Site discontinued study participation|0
4552146|NCT01217073|7380163|FG003|Extension Period|Site discontinued study participation|0
4552147|NCT01217073|7380164|FG004|Extension Period|Site discontinued study participation|0
4552148|NCT01217073|7380165|FG005|Extension Period|Site discontinued study participation|0
4552149|NCT01217073|7380166|FG006|Extension Period|Site discontinued study participation|7
4552150|NCT01217073|7380167|FG007|Extension Period|Site discontinued study participation|2
4552151|NCT01217073|7380160|FG000|Extension Period|Withdrawal by Subject|0
4552152|NCT01217073|7380161|FG001|Extension Period|Withdrawal by Subject|0
4552153|NCT01217073|7380162|FG002|Extension Period|Withdrawal by Subject|0
4552154|NCT01217073|7380163|FG003|Extension Period|Withdrawal by Subject|0
4552155|NCT01217073|7380164|FG004|Extension Period|Withdrawal by Subject|0
4552156|NCT01217073|7380165|FG005|Extension Period|Withdrawal by Subject|0
4552157|NCT01217073|7380166|FG006|Extension Period|Withdrawal by Subject|30
4552158|NCT01217073|7380167|FG007|Extension Period|Withdrawal by Subject|8
4552159|NCT01217112|7380196|FG000|Overall Study|Adverse Event|0
4552160|NCT01217112|7380197|FG001|Overall Study|Adverse Event|2
4552161|NCT01217112|7380198|FG002|Overall Study|Adverse Event|0
4552162|NCT01217112|7380199|FG003|Overall Study|Adverse Event|2
4552163|NCT01217112|7380200|FG004|Overall Study|Adverse Event|0
4552164|NCT01217112|7380196|FG000|Overall Study|Withdrawal by Subject|0
4552165|NCT01217112|7380197|FG001|Overall Study|Withdrawal by Subject|0
4552166|NCT01217112|7380198|FG002|Overall Study|Withdrawal by Subject|1
4552167|NCT01217112|7380199|FG003|Overall Study|Withdrawal by Subject|0
4552168|NCT01217112|7380200|FG004|Overall Study|Withdrawal by Subject|0
4552169|NCT01217112|7380196|FG000|Overall Study|Physician Decision|0
4552170|NCT01217112|7380197|FG001|Overall Study|Physician Decision|0
4620867|NCT01788163|7483450|FG005|Overall Study|Other|7
4620868|NCT01788163|7483451|FG006|Overall Study|Other|1
4620869|NCT01788163|7483452|FG007|Overall Study|Other|48
4620870|NCT01788163|7483453|FG008|Overall Study|Other|15
4620871|NCT01788163|7483445|FG000|Overall Study|Withdrawal by Subject|2
4620872|NCT01788163|7483446|FG001|Overall Study|Withdrawal by Subject|0
4620873|NCT01788163|7483447|FG002|Overall Study|Withdrawal by Subject|0
4620874|NCT01788163|7483448|FG003|Overall Study|Withdrawal by Subject|0
4620875|NCT01788163|7483449|FG004|Overall Study|Withdrawal by Subject|0
4620876|NCT01788163|7483450|FG005|Overall Study|Withdrawal by Subject|0
4620877|NCT01788163|7483451|FG006|Overall Study|Withdrawal by Subject|0
4620878|NCT01788163|7483452|FG007|Overall Study|Withdrawal by Subject|0
4620879|NCT01788163|7483453|FG008|Overall Study|Withdrawal by Subject|1
4620880|NCT01788215|7483534|FG000|Overall Study|Withdrawal by Subject|0
4620881|NCT01788215|7483535|FG001|Overall Study|Withdrawal by Subject|1
4620882|NCT01788215|7483534|FG000|Overall Study|Lost to Follow-up|2
4620883|NCT01788215|7483535|FG001|Overall Study|Lost to Follow-up|0
4620884|NCT01788228|7483543|FG000|Overall Study|Migrated/moved from study area|1
4620885|NCT01788228|7483544|FG001|Overall Study|Migrated/moved from study area|0
4620886|NCT01788358|7483553|FG000|Overall Study|Other|11
4620887|NCT01788358|7483553|FG000|Overall Study|Logistical difficulties|1
4620888|NCT01788358|7483553|FG000|Overall Study|Lost to Follow-up|5
4620889|NCT01788358|7483553|FG000|Overall Study|Protocol Violation|3
4620890|NCT01788358|7483553|FG000|Overall Study|Withdrawal by Subject|26
4620891|NCT01788358|7483553|FG000|Overall Study|Lack of Efficacy|1
4620892|NCT01788358|7483553|FG000|Overall Study|Adverse Event|51
4620893|NCT01788423|7483560|FG000|Overall Study|See Comments in Completed (above)|0
4620894|NCT01788423|7483561|FG001|Overall Study|See Comments in Completed (above)|4
4620895|NCT01788423|7483562|FG002|Overall Study|See Comments in Completed (above)|5
4620896|NCT01788566|7483570|FG000|Overall Study|Death|4
4620897|NCT01788566|7483570|FG000|Overall Study|Adverse Event|1
4620898|NCT01788566|7483570|FG000|Overall Study|Clinical Progressive Disease|3
4620899|NCT01788943|7483585|FG000|Overall Study|Withdrawal by Subject|1
4620900|NCT01788943|7483586|FG001|Overall Study|Withdrawal by Subject|0
4620901|NCT01789047|7483594|FG000|Overall Study|Adverse Event|3
4620902|NCT01789047|7483595|FG001|Overall Study|Adverse Event|2
4620903|NCT01789047|7483594|FG000|Overall Study|Withdrawal by Subject|1
4620904|NCT01789047|7483595|FG001|Overall Study|Withdrawal by Subject|2
4620905|NCT01789203|7483612|FG000|Overall Study|Adverse Event|2
4620906|NCT01789203|7483613|FG001|Overall Study|Adverse Event|2
4620907|NCT01789203|7483612|FG000|Overall Study|Withdrawal by Subject|1
4620908|NCT01789203|7483613|FG001|Overall Study|Withdrawal by Subject|0
4620909|NCT01789203|7483612|FG000|Overall Study|Death|1
4620910|NCT01789203|7483613|FG001|Overall Study|Death|0
4620911|NCT01789203|7483612|FG000|Overall Study|Protocol Violation|2
4620912|NCT01789203|7483613|FG001|Overall Study|Protocol Violation|1
4620913|NCT01789203|7483612|FG000|Overall Study|Other|1
4620914|NCT01789203|7483613|FG001|Overall Study|Other|1
4620915|NCT01789203|7483612|FG000|Overall Study|patient non-adherent|2
4620916|NCT01789203|7483613|FG001|Overall Study|patient non-adherent|0
4620917|NCT01789281|7483627|FG000|Overall Study|Disease progression|15
4620918|NCT01789281|7483628|FG001|Overall Study|Disease progression|4
4620919|NCT01789281|7483627|FG000|Overall Study|Adverse Event|5
4620920|NCT01789281|7483628|FG001|Overall Study|Adverse Event|5
4620921|NCT01789281|7483627|FG000|Overall Study|Withdrawal by Subject|1
4620922|NCT01789281|7483628|FG001|Overall Study|Withdrawal by Subject|0
4620923|NCT01789281|7483627|FG000|Overall Study|Lost to Follow-up|1
4620924|NCT01789281|7483628|FG001|Overall Study|Lost to Follow-up|0
4620925|NCT01789281|7483627|FG000|Overall Study|Administrative problems|0
4620926|NCT01789281|7483628|FG001|Overall Study|Administrative problems|1
4620927|NCT01789320|7483635|FG000|Overall Study|Re-enrolled into study|1
4620928|NCT01789320|7483635|FG000|Overall Study|Lost to Follow-up|1
4620929|NCT01789476|7483641|FG000|Overall Study|Lack of Efficacy|6
4552171|NCT01217112|7380198|FG002|Overall Study|Physician Decision|0
4552172|NCT01217112|7380199|FG003|Overall Study|Physician Decision|0
4552173|NCT01217112|7380200|FG004|Overall Study|Physician Decision|1
4620930|NCT01789476|7483642|FG001|Overall Study|Lack of Efficacy|2
4620931|NCT01789476|7483641|FG000|Overall Study|Adverse Event|1
4620932|NCT01789476|7483642|FG001|Overall Study|Adverse Event|0
4620933|NCT01789476|7483641|FG000|Overall Study|Unable to get IV access|1
4620934|NCT01789476|7483642|FG001|Overall Study|Unable to get IV access|0
4620935|NCT01789567|7483648|FG000|Overall Study|Death|6
4620936|NCT01789606|7483654|FG000|Overall Study|Participant not Purchased the Product|0
4620937|NCT01789606|7483655|FG001|Overall Study|Participant not Purchased the Product|20
4620938|NCT01789606|7483654|FG000|Overall Study|Withdrawal by Subject|0
4620939|NCT01789606|7483655|FG001|Overall Study|Withdrawal by Subject|1
4620940|NCT01789606|7483654|FG000|Overall Study|Ineligible|6
4620941|NCT01789606|7483655|FG001|Overall Study|Ineligible|2
4620942|NCT01789606|7483654|FG000|Overall Study|Administrative Reasons|17
4620943|NCT01789606|7483655|FG001|Overall Study|Administrative Reasons|6
4620944|NCT01789606|7483654|FG000|Overall Study|No Study Medication Taken|0
4620945|NCT01789606|7483655|FG001|Overall Study|No Study Medication Taken|1
4620946|NCT01789606|7483654|FG000|Overall Study|Protocol Violation|0
4620947|NCT01789606|7483655|FG001|Overall Study|Protocol Violation|55
4620948|NCT01789606|7483654|FG000|Overall Study|Adverse Event|0
4620949|NCT01789606|7483655|FG001|Overall Study|Adverse Event|3
4620950|NCT01789606|7483654|FG000|Overall Study|Lost to Follow-up|0
4620951|NCT01789606|7483655|FG001|Overall Study|Lost to Follow-up|14
4620952|NCT01789606|7483654|FG000|Overall Study|Ineligible or not Willing to Continue|0
4620953|NCT01789606|7483655|FG001|Overall Study|Ineligible or not Willing to Continue|348
4620954|NCT01789970|7483695|FG000|Open-label Titration Period|Adverse Event|68
4620955|NCT01789970|7483696|FG001|Open-label Titration Period|Adverse Event|0
4620956|NCT01789970|7483697|FG002|Open-label Titration Period|Adverse Event|0
4620957|NCT01789970|7483695|FG000|Open-label Titration Period|Lack of Efficacy|31
4620958|NCT01789970|7483696|FG001|Open-label Titration Period|Lack of Efficacy|0
4620959|NCT01789970|7483697|FG002|Open-label Titration Period|Lack of Efficacy|0
4620960|NCT01789970|7483695|FG000|Open-label Titration Period|Withdrawal by Subject|31
4620961|NCT01789970|7483696|FG001|Open-label Titration Period|Withdrawal by Subject|0
4620962|NCT01789970|7483697|FG002|Open-label Titration Period|Withdrawal by Subject|0
4620963|NCT01789970|7483695|FG000|Open-label Titration Period|Protocol Violation|18
4620964|NCT01789970|7483696|FG001|Open-label Titration Period|Protocol Violation|0
4620965|NCT01789970|7483697|FG002|Open-label Titration Period|Protocol Violation|0
4620966|NCT01789970|7483695|FG000|Open-label Titration Period|Lost to Follow-up|5
4620967|NCT01789970|7483696|FG001|Open-label Titration Period|Lost to Follow-up|0
4620968|NCT01789970|7483697|FG002|Open-label Titration Period|Lost to Follow-up|0
4620969|NCT01789970|7483695|FG000|Open-label Titration Period|Noncompliance to study drug admin|11
4620970|NCT01789970|7483696|FG001|Open-label Titration Period|Noncompliance to study drug admin|0
4620971|NCT01789970|7483697|FG002|Open-label Titration Period|Noncompliance to study drug admin|0
4620972|NCT01789970|7483695|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2
4620973|NCT01789970|7483696|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0
4620974|NCT01789970|7483697|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0
4620975|NCT01789970|7483695|FG000|Open-label Titration Period|Noncompliance with study procedures|8
4620976|NCT01789970|7483696|FG001|Open-label Titration Period|Noncompliance with study procedures|0
4620977|NCT01789970|7483697|FG002|Open-label Titration Period|Noncompliance with study procedures|0
4620978|NCT01789970|7483695|FG000|Open-label Titration Period|Pregnancy|2
4620979|NCT01789970|7483696|FG001|Open-label Titration Period|Pregnancy|0
4620980|NCT01789970|7483697|FG002|Open-label Titration Period|Pregnancy|0
4620981|NCT01789970|7483695|FG000|Open-label Titration Period|Other|76
4620982|NCT01789970|7483696|FG001|Open-label Titration Period|Other|0
4620983|NCT01789970|7483697|FG002|Open-label Titration Period|Other|0
4620984|NCT01789970|7483695|FG000|Open-label Titration Period|Dropped out prior to dosing|2
4620985|NCT01789970|7483696|FG001|Open-label Titration Period|Dropped out prior to dosing|0
4620986|NCT01789970|7483697|FG002|Open-label Titration Period|Dropped out prior to dosing|0
4620987|NCT01789970|7483695|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0
4620988|NCT01789970|7483696|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9
4620989|NCT01789970|7483697|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15
4620990|NCT01789970|7483695|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0
4620991|NCT01789970|7483696|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17
4620992|NCT01789970|7483697|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5
4620993|NCT01789970|7483695|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
4620994|NCT01789970|7483696|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7
4620995|NCT01789970|7483697|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9
4620996|NCT01789970|7483695|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0
4620997|NCT01789970|7483696|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9
4620998|NCT01789970|7483697|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7
4620999|NCT01789970|7483695|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0
4621000|NCT01789970|7483696|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2
4621001|NCT01789970|7483697|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2
4621002|NCT01789970|7483695|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0
4621003|NCT01789970|7483696|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2
4621004|NCT01789970|7483697|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1
4621005|NCT01789970|7483695|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0
4621006|NCT01789970|7483696|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1
4621007|NCT01789970|7483697|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2
4621008|NCT01789970|7483695|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0
4621009|NCT01789970|7483696|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1
4621010|NCT01789970|7483697|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0
4621011|NCT01789970|7483695|FG000|Double-blind Treatment Period (12 Weeks)|Other|0
4621012|NCT01789970|7483696|FG001|Double-blind Treatment Period (12 Weeks)|Other|1
4621013|NCT01789970|7483697|FG002|Double-blind Treatment Period (12 Weeks)|Other|3
4552174|NCT01217190|7380214|FG000|Second Dosing|Withdrawal by Subject|0
4552175|NCT01217190|7380215|FG001|Second Dosing|Withdrawal by Subject|2
4552176|NCT01217229|7380224|FG000|Overall Study|Adverse Event|1
4552177|NCT01217229|7380224|FG000|Overall Study|Disease progression, deterioration|2
4552178|NCT01217229|7380224|FG000|Overall Study|Disease progression, Cheson criteria|14
4552179|NCT01217229|7380224|FG000|Overall Study|Protocol Violation|1
4552180|NCT01217229|7380224|FG000|Overall Study|Disease progression not confirmed|2
4552181|NCT01217307|7380230|FG000|Overall Study|Withdrawal by Subject|0
4552182|NCT01217307|7380231|FG001|Overall Study|Withdrawal by Subject|1
4552183|NCT01217385|7380237|FG000|Overall Study|Withdrawal by Subject|3
4552184|NCT01217385|7380237|FG000|Overall Study|DOSI not performed/not eval|12
4552185|NCT01217385|7380237|FG000|Overall Study|Central Path not Available|1
4552186|NCT01217385|7380237|FG000|Overall Study|Normal Breast TOI not available|10
4552187|NCT01217437|7380260|FG000|Overall Study|Adverse Event|0
4552188|NCT01217437|7380261|FG001|Overall Study|Adverse Event|8
4552189|NCT01217437|7380260|FG000|Overall Study|Death|5
4552190|NCT01217437|7380261|FG001|Overall Study|Death|0
4552191|NCT01217437|7380260|FG000|Overall Study|Lack of Efficacy|29
4552192|NCT01217437|7380261|FG001|Overall Study|Lack of Efficacy|25
4621014|NCT01789970|7483695|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0
4621015|NCT01789970|7483696|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1
4621016|NCT01789970|7483697|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0
4621017|NCT01790048|7483713|FG000|Overall Study|Incorrect Age|9
4621018|NCT01790048|7483714|FG001|Overall Study|Incorrect Age|14
4621019|NCT01790048|7483713|FG000|Overall Study|data entry error|0
4621020|NCT01790048|7483714|FG001|Overall Study|data entry error|1
4621021|NCT01790048|7483713|FG000|Overall Study|Other|0
4621022|NCT01790048|7483714|FG001|Overall Study|Other|2
4621023|NCT01790048|7483713|FG000|Overall Study|SAM at Enrollment|2
4621024|NCT01790048|7483714|FG001|Overall Study|SAM at Enrollment|0
4621025|NCT01790048|7483713|FG000|Overall Study|Measurement error|1
4621026|NCT01790048|7483714|FG001|Overall Study|Measurement error|0
4621027|NCT01790113|7483724|FG000|Overall Study|Adverse Event|2
4621028|NCT01790113|7483725|FG001|Overall Study|Adverse Event|7
4621029|NCT01790113|7483724|FG000|Overall Study|Study ended due to FDA clearance|1
4621030|NCT01790113|7483725|FG001|Overall Study|Study ended due to FDA clearance|68
4621031|NCT01790126|7483734|FG000|Overall Study|PSA Progression|12
4621032|NCT01790126|7483735|FG001|Overall Study|PSA Progression|16
4621033|NCT01790126|7483736|FG002|Overall Study|PSA Progression|16
4621034|NCT01790126|7483734|FG000|Overall Study|Other|5
4621035|NCT01790126|7483735|FG001|Overall Study|Other|4
4621036|NCT01790126|7483736|FG002|Overall Study|Other|8
4621037|NCT01790126|7483734|FG000|Overall Study|Initiation of Non-Protocol Therapy|3
4621038|NCT01790126|7483735|FG001|Overall Study|Initiation of Non-Protocol Therapy|4
4621039|NCT01790126|7483736|FG002|Overall Study|Initiation of Non-Protocol Therapy|2
4621040|NCT01790126|7483734|FG000|Overall Study|Withdrawal by Physician|1
4621041|NCT01790126|7483735|FG001|Overall Study|Withdrawal by Physician|1
4621042|NCT01790126|7483736|FG002|Overall Study|Withdrawal by Physician|2
4621043|NCT01790126|7483734|FG000|Overall Study|Withdrawal by Subject|3
4621044|NCT01790126|7483735|FG001|Overall Study|Withdrawal by Subject|1
4621045|NCT01790126|7483736|FG002|Overall Study|Withdrawal by Subject|2
4621046|NCT01790126|7483734|FG000|Overall Study|Lost to Follow-up|1
4621047|NCT01790126|7483735|FG001|Overall Study|Lost to Follow-up|0
4552193|NCT01217437|7380260|FG000|Overall Study|Physician Decision|8
4552194|NCT01217437|7380261|FG001|Overall Study|Physician Decision|5
4552195|NCT01217437|7380260|FG000|Overall Study|Withdrawal by Subject|0
4552196|NCT01217437|7380261|FG001|Overall Study|Withdrawal by Subject|2
4552197|NCT01217437|7380260|FG000|Overall Study|Ineligible|1
4621048|NCT01790126|7483736|FG002|Overall Study|Lost to Follow-up|1
4621049|NCT01790126|7483734|FG000|Overall Study|Adverse Event|0
4621050|NCT01790126|7483735|FG001|Overall Study|Adverse Event|2
4621051|NCT01790126|7483736|FG002|Overall Study|Adverse Event|0
4621052|NCT01790126|7483734|FG000|Overall Study|Death|2
4621053|NCT01790126|7483735|FG001|Overall Study|Death|0
4447933|NCT00492856|7233152|FG000|Post-consolidation|Withdrawal by Subject|0
4552198|NCT01217437|7380261|FG001|Overall Study|Ineligible|1
4552199|NCT01217463|7380269|FG000|Overall Study|Adverse Event|8
4552200|NCT01217463|7380270|FG001|Overall Study|Adverse Event|5
4552201|NCT01217463|7380269|FG000|Overall Study|Physician Decision|0
4552202|NCT01217463|7380270|FG001|Overall Study|Physician Decision|1
4552203|NCT01217463|7380269|FG000|Overall Study|Withdrawal by Subject|3
4552204|NCT01217463|7380270|FG001|Overall Study|Withdrawal by Subject|0
4552205|NCT01217463|7380269|FG000|Overall Study|Surgery on the Target Limb|0
4552206|NCT01217463|7380270|FG001|Overall Study|Surgery on the Target Limb|1
4552207|NCT01217463|7380269|FG000|Overall Study|Patient Non-compliant|1
4552208|NCT01217463|7380270|FG001|Overall Study|Patient Non-compliant|0
4552209|NCT01217463|7380269|FG000|Overall Study|Other|1
4552210|NCT01217463|7380270|FG001|Overall Study|Other|1
4552211|NCT01217476|7380280|FG000|Overall Study|Adverse Event|6
4552212|NCT01217476|7380281|FG001|Overall Study|Adverse Event|1
4552213|NCT01217476|7380280|FG000|Overall Study|Physician Decision|0
4552214|NCT01217476|7380281|FG001|Overall Study|Physician Decision|1
4552215|NCT01217476|7380280|FG000|Overall Study|Withdrawal by Subject|3
4552216|NCT01217476|7380281|FG001|Overall Study|Withdrawal by Subject|3
4552217|NCT01217476|7380280|FG000|Overall Study|Surgery on the Target Limb|0
4552218|NCT01217476|7380281|FG001|Overall Study|Surgery on the Target Limb|2
4552219|NCT01217476|7380280|FG000|Overall Study|Protocol Deviation|1
4552220|NCT01217476|7380281|FG001|Overall Study|Protocol Deviation|0
4552221|NCT01217476|7380280|FG000|Overall Study|Other|2
4552222|NCT01217476|7380281|FG001|Overall Study|Other|0
4552223|NCT01217606|7380302|FG000|Initial Treatment Phase|Other Reasons|0
4552224|NCT01217606|7380303|FG001|Initial Treatment Phase|Other Reasons|2
4552225|NCT01217606|7380302|FG000|Initial Treatment Phase|Protocol Violation|3
4552226|NCT01217606|7380303|FG001|Initial Treatment Phase|Protocol Violation|2
4552227|NCT01217606|7380302|FG000|Initial Treatment Phase|Personal Reasons|0
4552228|NCT01217606|7380303|FG001|Initial Treatment Phase|Personal Reasons|2
4552229|NCT01217606|7380302|FG000|Initial Treatment Phase|Lack of Efficacy|1
4552230|NCT01217606|7380303|FG001|Initial Treatment Phase|Lack of Efficacy|0
4552231|NCT01217606|7380302|FG000|Initial Treatment Phase|Adverse Event|10
4552232|NCT01217606|7380303|FG001|Initial Treatment Phase|Adverse Event|6
4552233|NCT01217606|7380302|FG000|9-Month Masked Extension|Adverse Event|3
4552234|NCT01217606|7380303|FG001|9-Month Masked Extension|Adverse Event|6
4552235|NCT01217606|7380302|FG000|9-Month Masked Extension|Other Reasons|4
4552236|NCT01217606|7380303|FG001|9-Month Masked Extension|Other Reasons|4
4552237|NCT01217606|7380302|FG000|9-Month Masked Extension|Personal Reasons|2
4552238|NCT01217606|7380303|FG001|9-Month Masked Extension|Personal Reasons|1
4552239|NCT01217606|7380302|FG000|9-Month Masked Extension|Lost to Follow-up|1
4552240|NCT01217606|7380303|FG001|9-Month Masked Extension|Lost to Follow-up|0
4552241|NCT01217606|7380302|FG000|9-Month Masked Extension|Pregnancy|1
4552242|NCT01217606|7380303|FG001|9-Month Masked Extension|Pregnancy|0
4552243|NCT01217606|7380302|FG000|9-Month Masked Extension|Lack of Efficacy|2
4552244|NCT01217606|7380303|FG001|9-Month Masked Extension|Lack of Efficacy|0
4552245|NCT01217801|7380326|FG000|Period 1|Protocol Violation|1
4552246|NCT01217801|7380327|FG001|Period 1|Protocol Violation|1
4552247|NCT01217801|7380326|FG000|Period 1|Withdrawal by Subject|0
4552248|NCT01217801|7380327|FG001|Period 1|Withdrawal by Subject|1
4552249|NCT01217814|7380336|FG000|Overall Study|Adverse Event|1
4552250|NCT01217814|7380337|FG001|Overall Study|Adverse Event|1
4552251|NCT01217814|7380338|FG002|Overall Study|Adverse Event|0
4552252|NCT01217814|7380336|FG000|Overall Study|Lack of Efficacy|0
4552253|NCT01217814|7380337|FG001|Overall Study|Lack of Efficacy|0
4552254|NCT01217814|7380338|FG002|Overall Study|Lack of Efficacy|1
4552255|NCT01217892|7380370|FG000|Overall Study|Adverse Event|1
4552256|NCT01217892|7380371|FG001|Overall Study|Adverse Event|1
4552257|NCT01217892|7380372|FG002|Overall Study|Adverse Event|1
4552258|NCT01217892|7380373|FG003|Overall Study|Adverse Event|0
4552259|NCT01217892|7380370|FG000|Overall Study|Withdrawal by Subject|0
4552260|NCT01217892|7380371|FG001|Overall Study|Withdrawal by Subject|2
4552261|NCT01217892|7380372|FG002|Overall Study|Withdrawal by Subject|1
4552262|NCT01217892|7380373|FG003|Overall Study|Withdrawal by Subject|0
4552263|NCT01217892|7380370|FG000|Overall Study|Lab value|1
4552264|NCT01217892|7380371|FG001|Overall Study|Lab value|0
4552265|NCT01217892|7380372|FG002|Overall Study|Lab value|1
4552266|NCT01217892|7380373|FG003|Overall Study|Lab value|0
4552267|NCT01217892|7380370|FG000|Overall Study|Subject no longer meets study criteria|5
4552268|NCT01217892|7380371|FG001|Overall Study|Subject no longer meets study criteria|2
4552269|NCT01217892|7380372|FG002|Overall Study|Subject no longer meets study criteria|4
4552270|NCT01217892|7380373|FG003|Overall Study|Subject no longer meets study criteria|8
4552271|NCT01217892|7380370|FG000|Overall Study|Incorrect enrollment|0
4552272|NCT01217892|7380371|FG001|Overall Study|Incorrect enrollment|1
4552273|NCT01217892|7380372|FG002|Overall Study|Incorrect enrollment|1
4552274|NCT01217892|7380373|FG003|Overall Study|Incorrect enrollment|0
4552275|NCT01217892|7380370|FG000|Overall Study|Poor/Non-Compliance|0
4552276|NCT01217892|7380371|FG001|Overall Study|Poor/Non-Compliance|0
4552277|NCT01217892|7380372|FG002|Overall Study|Poor/Non-Compliance|1
4552278|NCT01217892|7380373|FG003|Overall Study|Poor/Non-Compliance|0
4552279|NCT01217944|7380386|FG000|Overall Study|Protocol Violation|1
4552280|NCT01217944|7380387|FG001|Overall Study|Protocol Violation|1
4552281|NCT01217944|7380388|FG002|Overall Study|Protocol Violation|0
4552282|NCT01217944|7380386|FG000|Overall Study|Lost to Follow-up|3
4552283|NCT01217944|7380387|FG001|Overall Study|Lost to Follow-up|1
4552284|NCT01217944|7380388|FG002|Overall Study|Lost to Follow-up|0
4552285|NCT01217944|7380386|FG000|Overall Study|Withdrawal by Subject|1
4552286|NCT01217944|7380387|FG001|Overall Study|Withdrawal by Subject|2
4552287|NCT01217944|7380388|FG002|Overall Study|Withdrawal by Subject|0
4552288|NCT01217944|7380386|FG000|Overall Study|Lack of Efficacy|1
4552289|NCT01217944|7380387|FG001|Overall Study|Lack of Efficacy|0
4552290|NCT01217944|7380388|FG002|Overall Study|Lack of Efficacy|0
4552291|NCT01217957|7380403|FG000|Phase 1|Withdrawal by Patient|1
4552292|NCT01217957|7380404|FG001|Phase 1|Withdrawal by Patient|0
4552293|NCT01217957|7380405|FG002|Phase 1|Withdrawal by Patient|1
4552294|NCT01217957|7380406|FG003|Phase 1|Withdrawal by Patient|1
4552295|NCT01217957|7380407|FG004|Phase 1|Withdrawal by Patient|0
4552296|NCT01217957|7380403|FG000|Phase 2|Withdrawal by Patient|0
4552297|NCT01217957|7380404|FG001|Phase 2|Withdrawal by Patient|0
4552298|NCT01217957|7380405|FG002|Phase 2|Withdrawal by Patient|0
4552299|NCT01217957|7380406|FG003|Phase 2|Withdrawal by Patient|0
4552300|NCT01217957|7380407|FG004|Phase 2|Withdrawal by Patient|1
4552301|NCT01218009|7380430|FG000|Overall Study|Protocol Violation|2
4552302|NCT01218009|7380431|FG001|Overall Study|Protocol Violation|1
4552303|NCT01218009|7380430|FG000|Overall Study|Withdrawal by Subject|3
4552304|NCT01218009|7380431|FG001|Overall Study|Withdrawal by Subject|1
4552305|NCT01218009|7380430|FG000|Overall Study|Sponsor terminated study|161
4552306|NCT01218009|7380431|FG001|Overall Study|Sponsor terminated study|163
4552307|NCT01218087|7380444|FG000|Overall Study|Death|2
4552308|NCT01218087|7380445|FG001|Overall Study|Death|1
4552309|NCT01218087|7380444|FG000|Overall Study|Withdrawal by Subject|5
4552310|NCT01218087|7380445|FG001|Overall Study|Withdrawal by Subject|0
4552311|NCT01218087|7380444|FG000|Overall Study|Transferred|8
4552312|NCT01218087|7380445|FG001|Overall Study|Transferred|5
4552313|NCT01218100|7380455|FG000|Overall Study|Did not meet InclusionExclusion criteria|1
4552314|NCT01218100|7380456|FG001|Overall Study|Did not meet InclusionExclusion criteria|1
4552315|NCT01218100|7380457|FG002|Overall Study|Did not meet InclusionExclusion criteria|1
4552316|NCT01218100|7380458|FG003|Overall Study|Did not meet InclusionExclusion criteria|2
4552317|NCT01218100|7380455|FG000|Overall Study|Adverse Event|4
4552318|NCT01218100|7380456|FG001|Overall Study|Adverse Event|6
4552319|NCT01218100|7380457|FG002|Overall Study|Adverse Event|6
4552320|NCT01218100|7380458|FG003|Overall Study|Adverse Event|7
4552321|NCT01218100|7380455|FG000|Overall Study|Lack of Efficacy|9
4552322|NCT01218100|7380456|FG001|Overall Study|Lack of Efficacy|6
4552323|NCT01218100|7380457|FG002|Overall Study|Lack of Efficacy|5
4552324|NCT01218100|7380458|FG003|Overall Study|Lack of Efficacy|12
4552325|NCT01218100|7380455|FG000|Overall Study|Protocol Violation|0
4552326|NCT01218100|7380456|FG001|Overall Study|Protocol Violation|0
4552327|NCT01218100|7380457|FG002|Overall Study|Protocol Violation|1
4552328|NCT01218100|7380458|FG003|Overall Study|Protocol Violation|1
4552329|NCT01218100|7380455|FG000|Overall Study|Withdrawal by Subject|5
4552330|NCT01218100|7380456|FG001|Overall Study|Withdrawal by Subject|2
4552331|NCT01218100|7380457|FG002|Overall Study|Withdrawal by Subject|6
4552332|NCT01218100|7380458|FG003|Overall Study|Withdrawal by Subject|7
4552333|NCT01218100|7380455|FG000|Overall Study|Lost to Follow-up|3
4552334|NCT01218100|7380456|FG001|Overall Study|Lost to Follow-up|8
4552335|NCT01218100|7380457|FG002|Overall Study|Lost to Follow-up|2
4552336|NCT01218100|7380458|FG003|Overall Study|Lost to Follow-up|1
4552337|NCT01218100|7380455|FG000|Overall Study|Other Reason|2
4552338|NCT01218100|7380456|FG001|Overall Study|Other Reason|2
4552339|NCT01218100|7380457|FG002|Overall Study|Other Reason|6
4552340|NCT01218100|7380458|FG003|Overall Study|Other Reason|4
4552341|NCT01218113|7380471|FG000|Overall Study|Withdrawal by Subject|1
4552342|NCT01218113|7380472|FG001|Overall Study|Withdrawal by Subject|0
4552343|NCT01218113|7380473|FG002|Overall Study|Withdrawal by Subject|1
4552344|NCT01218113|7380471|FG000|Overall Study|Lost to Follow-up|4
4552345|NCT01218113|7380472|FG001|Overall Study|Lost to Follow-up|1
4552346|NCT01218113|7380473|FG002|Overall Study|Lost to Follow-up|4
4552347|NCT01218113|7380471|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0
4552348|NCT01218113|7380472|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0
4552349|NCT01218113|7380473|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1
4552350|NCT01218126|7380492|FG000|Overall Study|Adverse Event|8
4552351|NCT01218126|7380493|FG001|Overall Study|Adverse Event|10
4552352|NCT01218126|7380494|FG002|Overall Study|Adverse Event|12
4552353|NCT01218126|7380495|FG003|Overall Study|Adverse Event|16
4552354|NCT01218126|7380492|FG000|Overall Study|Lack of Efficacy|7
4552355|NCT01218126|7380493|FG001|Overall Study|Lack of Efficacy|2
4552356|NCT01218126|7380494|FG002|Overall Study|Lack of Efficacy|2
4552357|NCT01218126|7380495|FG003|Overall Study|Lack of Efficacy|6
4552358|NCT01218126|7380492|FG000|Overall Study|Protocol Violation|5
4552359|NCT01218126|7380493|FG001|Overall Study|Protocol Violation|2
4552360|NCT01218126|7380494|FG002|Overall Study|Protocol Violation|2
4552361|NCT01218126|7380495|FG003|Overall Study|Protocol Violation|3
4552362|NCT01218126|7380492|FG000|Overall Study|Protocol-defined stopping criteria|1
4552363|NCT01218126|7380493|FG001|Overall Study|Protocol-defined stopping criteria|1
4552364|NCT01218126|7380494|FG002|Overall Study|Protocol-defined stopping criteria|0
4552365|NCT01218126|7380495|FG003|Overall Study|Protocol-defined stopping criteria|0
4552366|NCT01218126|7380492|FG000|Overall Study|Lost to Follow-up|0
4552367|NCT01218126|7380493|FG001|Overall Study|Lost to Follow-up|0
4552368|NCT01218126|7380494|FG002|Overall Study|Lost to Follow-up|0
4552369|NCT01218126|7380495|FG003|Overall Study|Lost to Follow-up|2
4552370|NCT01218126|7380492|FG000|Overall Study|Physician Decision|1
4552371|NCT01218126|7380493|FG001|Overall Study|Physician Decision|2
4552372|NCT01218126|7380494|FG002|Overall Study|Physician Decision|4
4552373|NCT01218126|7380495|FG003|Overall Study|Physician Decision|2
4552374|NCT01218126|7380492|FG000|Overall Study|Withdrawal by Subject|2
4552375|NCT01218126|7380493|FG001|Overall Study|Withdrawal by Subject|5
4552376|NCT01218126|7380494|FG002|Overall Study|Withdrawal by Subject|4
4552377|NCT01218126|7380495|FG003|Overall Study|Withdrawal by Subject|6
4552378|NCT01218204|7380507|FG000|Part B Washout|Adverse Event|0
4552379|NCT01218204|7380508|FG001|Part B Washout|Adverse Event|1
4552380|NCT01218204|7380509|FG002|Part B Washout|Adverse Event|0
4552381|NCT01218204|7380510|FG003|Part B Washout|Adverse Event|0
4552382|NCT01218204|7380507|FG000|Part B Washout|Lost to Follow-up|0
4552383|NCT01218204|7380508|FG001|Part B Washout|Lost to Follow-up|2
4552384|NCT01218204|7380509|FG002|Part B Washout|Lost to Follow-up|0
4552385|NCT01218204|7380510|FG003|Part B Washout|Lost to Follow-up|0
4552386|NCT01218204|7380507|FG000|Part B Washout|Physician Decision|0
4552387|NCT01218204|7380508|FG001|Part B Washout|Physician Decision|14
4552388|NCT01218204|7380509|FG002|Part B Washout|Physician Decision|0
4552389|NCT01218204|7380510|FG003|Part B Washout|Physician Decision|0
4552390|NCT01218204|7380507|FG000|Part B Washout|Withdrawal by Subject|0
4552391|NCT01218204|7380508|FG001|Part B Washout|Withdrawal by Subject|14
4552392|NCT01218204|7380509|FG002|Part B Washout|Withdrawal by Subject|0
4552393|NCT01218204|7380510|FG003|Part B Washout|Withdrawal by Subject|0
4552394|NCT01218204|7380507|FG000|Part B Washout|Reached defined stopping criteria|0
4552395|NCT01218204|7380508|FG001|Part B Washout|Reached defined stopping criteria|2
4552396|NCT01218204|7380509|FG002|Part B Washout|Reached defined stopping criteria|0
4552397|NCT01218204|7380510|FG003|Part B Washout|Reached defined stopping criteria|0
4552398|NCT01218204|7380507|FG000|Part B Washout|Did not meet continuation criteria|0
4552399|NCT01218204|7380508|FG001|Part B Washout|Did not meet continuation criteria|112
4552400|NCT01218204|7380509|FG002|Part B Washout|Did not meet continuation criteria|0
4621054|NCT01790126|7483736|FG002|Overall Study|Death|0
4621055|NCT01790126|7483734|FG000|Overall Study|Radiographic Progression|3
4621056|NCT01790126|7483735|FG001|Overall Study|Radiographic Progression|1
4621057|NCT01790126|7483736|FG002|Overall Study|Radiographic Progression|0
4621058|NCT01790295|7483763|FG000|Overall Study|Adverse Event|1
4621059|NCT01790295|7483763|FG000|Overall Study|Death|4
4621060|NCT01790295|7483763|FG000|Overall Study|Lack of Efficacy|2
4621061|NCT01790295|7483763|FG000|Overall Study|Study closure|4
4621062|NCT01790438|7483770|FG000|Overall Study|Adverse Event|3
4621063|NCT01790438|7483771|FG001|Overall Study|Adverse Event|2
4621064|NCT01790438|7483770|FG000|Overall Study|Death|4
4621065|NCT01790438|7483771|FG001|Overall Study|Death|0
4621066|NCT01790438|7483770|FG000|Overall Study|Lost to Follow-up|5
4621067|NCT01790438|7483771|FG001|Overall Study|Lost to Follow-up|2
4621068|NCT01790438|7483770|FG000|Overall Study|Withdrawal by Subject|13
4621069|NCT01790438|7483771|FG001|Overall Study|Withdrawal by Subject|2
4621070|NCT01790438|7483770|FG000|Overall Study|Physician Decision|3
4621071|NCT01790438|7483771|FG001|Overall Study|Physician Decision|1
4621072|NCT01790438|7483770|FG000|Overall Study|Sponsor Decision|0
4621073|NCT01790438|7483771|FG001|Overall Study|Sponsor Decision|3
4621074|NCT01790438|7483770|FG000|Overall Study|Protocol Required Discontinuation|7
4621075|NCT01790438|7483771|FG001|Overall Study|Protocol Required Discontinuation|1
4621076|NCT01790503|7483806|FG000|Overall Study|Adverse Event|1
4621077|NCT01790503|7483807|FG001|Overall Study|Adverse Event|0
4621078|NCT01790503|7483808|FG002|Overall Study|Adverse Event|0
4621079|NCT01790503|7483809|FG003|Overall Study|Adverse Event|0
4621080|NCT01790503|7483810|FG004|Overall Study|Adverse Event|0
4621081|NCT01790503|7483811|FG005|Overall Study|Adverse Event|2
4621082|NCT01790503|7483812|FG006|Overall Study|Adverse Event|0
4621083|NCT01790503|7483813|FG007|Overall Study|Adverse Event|0
4621084|NCT01790503|7483814|FG008|Overall Study|Adverse Event|2
4621085|NCT01790503|7483815|FG009|Overall Study|Adverse Event|4
4621086|NCT01790503|7483816|FG010|Overall Study|Adverse Event|7
4621087|NCT01790503|7483806|FG000|Overall Study|Withdrawal by Subject|0
4621088|NCT01790503|7483807|FG001|Overall Study|Withdrawal by Subject|0
4621089|NCT01790503|7483808|FG002|Overall Study|Withdrawal by Subject|1
4621090|NCT01790503|7483809|FG003|Overall Study|Withdrawal by Subject|1
4621091|NCT01790503|7483810|FG004|Overall Study|Withdrawal by Subject|1
4552401|NCT01218204|7380510|FG003|Part B Washout|Did not meet continuation criteria|0
4552402|NCT01218204|7380507|FG000|Part B Run-in|Adverse Event|0
4552403|NCT01218204|7380508|FG001|Part B Run-in|Adverse Event|0
4552404|NCT01218204|7380509|FG002|Part B Run-in|Adverse Event|1
4621092|NCT01790503|7483811|FG005|Overall Study|Withdrawal by Subject|2
4552405|NCT01218204|7380510|FG003|Part B Run-in|Adverse Event|0
4552406|NCT01218204|7380507|FG000|Part B Run-in|Protocol Violation|0
4552407|NCT01218204|7380508|FG001|Part B Run-in|Protocol Violation|0
4552408|NCT01218204|7380509|FG002|Part B Run-in|Protocol Violation|2
4552409|NCT01218204|7380510|FG003|Part B Run-in|Protocol Violation|0
4552410|NCT01218204|7380507|FG000|Part B Run-in|Withdrawal by Subject|0
4621093|NCT01790503|7483812|FG006|Overall Study|Withdrawal by Subject|1
4621094|NCT01790503|7483813|FG007|Overall Study|Withdrawal by Subject|0
4552411|NCT01218204|7380508|FG001|Part B Run-in|Withdrawal by Subject|0
4552412|NCT01218204|7380509|FG002|Part B Run-in|Withdrawal by Subject|3
4552413|NCT01218204|7380510|FG003|Part B Run-in|Withdrawal by Subject|0
4552414|NCT01218204|7380507|FG000|Part B Pooled Treatment Arm|Adverse Event|0
4552415|NCT01218204|7380508|FG001|Part B Pooled Treatment Arm|Adverse Event|0
4552416|NCT01218204|7380509|FG002|Part B Pooled Treatment Arm|Adverse Event|0
4552417|NCT01218204|7380510|FG003|Part B Pooled Treatment Arm|Adverse Event|2
4552418|NCT01218204|7380507|FG000|Part B Pooled Treatment Arm|Protocol Violation|0
4552419|NCT01218204|7380508|FG001|Part B Pooled Treatment Arm|Protocol Violation|0
4552420|NCT01218204|7380509|FG002|Part B Pooled Treatment Arm|Protocol Violation|0
4552421|NCT01218204|7380510|FG003|Part B Pooled Treatment Arm|Protocol Violation|1
4552422|NCT01218243|7380559|FG000|Overall Study|Lack of Efficacy|1
4552423|NCT01218243|7380560|FG001|Overall Study|Lack of Efficacy|1
4552424|NCT01218243|7380559|FG000|Overall Study|Lost to Follow-up|3
4552425|NCT01218243|7380560|FG001|Overall Study|Lost to Follow-up|3
4621095|NCT01790503|7483814|FG008|Overall Study|Withdrawal by Subject|0
4621096|NCT01790503|7483815|FG009|Overall Study|Withdrawal by Subject|0
4552426|NCT01218243|7380559|FG000|Overall Study|Protocol Violation|5
4552427|NCT01218243|7380560|FG001|Overall Study|Protocol Violation|10
4552428|NCT01218308|7380568|FG000|Overall Study|Adverse Event|1
4552429|NCT01218308|7380569|FG001|Overall Study|Adverse Event|2
4552430|NCT01218308|7380568|FG000|Overall Study|Protocol Violation|0
4552431|NCT01218308|7380569|FG001|Overall Study|Protocol Violation|2
4552432|NCT01218308|7380568|FG000|Overall Study|Withdrawal by Subject|61
4552433|NCT01218308|7380569|FG001|Overall Study|Withdrawal by Subject|64
4552434|NCT01218308|7380568|FG000|Overall Study|Lost to Follow-up|27
4552435|NCT01218308|7380569|FG001|Overall Study|Lost to Follow-up|31
4552436|NCT01218308|7380568|FG000|Overall Study|Other|14
4552437|NCT01218308|7380569|FG001|Overall Study|Other|21
4552438|NCT01218438|7380584|FG000|Epoch 1|Physician Decision|2
4552439|NCT01218438|7380584|FG000|Epoch 1|Adverse Event|1
4552440|NCT01218438|7380584|FG000|Epoch 3|Withdrawal by Subject|3
4552441|NCT01218438|7380584|FG000|Epoch 3|Adverse Event|1
4552442|NCT01218438|7380584|FG000|Epoch 4|Physician Decision|1
4552443|NCT01218438|7380584|FG000|Epoch 4|Withdrawal by Subject|2
4552444|NCT01218477|7380662|FG000|Overall Study|Disease progression|2
4552445|NCT01218477|7380663|FG001|Overall Study|Disease progression|3
4552446|NCT01218477|7380664|FG002|Overall Study|Disease progression|6
4552447|NCT01218477|7380665|FG003|Overall Study|Disease progression|2
4552448|NCT01218477|7380662|FG000|Overall Study|Study drug toxicity|0
4552449|NCT01218477|7380663|FG001|Overall Study|Study drug toxicity|2
4552450|NCT01218477|7380664|FG002|Overall Study|Study drug toxicity|5
4552451|NCT01218477|7380665|FG003|Overall Study|Study drug toxicity|0
4552452|NCT01218477|7380662|FG000|Overall Study|No longer meets study criteria|1
4552453|NCT01218477|7380663|FG001|Overall Study|No longer meets study criteria|0
4552454|NCT01218477|7380664|FG002|Overall Study|No longer meets study criteria|0
4552455|NCT01218477|7380665|FG003|Overall Study|No longer meets study criteria|0
4552456|NCT01218477|7380662|FG000|Overall Study|Withdrawal by Subject|0
4552457|NCT01218477|7380663|FG001|Overall Study|Withdrawal by Subject|0
4552458|NCT01218477|7380664|FG002|Overall Study|Withdrawal by Subject|1
4552459|NCT01218477|7380665|FG003|Overall Study|Withdrawal by Subject|0
4552460|NCT01218477|7380662|FG000|Overall Study|Prepared for cell transplantation|0
4552461|NCT01218477|7380663|FG001|Overall Study|Prepared for cell transplantation|1
4552462|NCT01218477|7380664|FG002|Overall Study|Prepared for cell transplantation|1
4552463|NCT01218477|7380665|FG003|Overall Study|Prepared for cell transplantation|0
4552464|NCT01218477|7380662|FG000|Overall Study|Administrative reason by sponsor|0
4552465|NCT01218477|7380663|FG001|Overall Study|Administrative reason by sponsor|0
4552466|NCT01218477|7380664|FG002|Overall Study|Administrative reason by sponsor|1
4552467|NCT01218477|7380665|FG003|Overall Study|Administrative reason by sponsor|0
4552468|NCT01218477|7380662|FG000|Overall Study|Maximum clinical benefit|0
4552469|NCT01218477|7380663|FG001|Overall Study|Maximum clinical benefit|2
4552470|NCT01218477|7380664|FG002|Overall Study|Maximum clinical benefit|0
4552471|NCT01218477|7380665|FG003|Overall Study|Maximum clinical benefit|0
4552472|NCT01218516|7380681|FG000|Combination Therapy (up to 4.5 Months)|Death|2
4552473|NCT01218516|7380682|FG001|Combination Therapy (up to 4.5 Months)|Death|1
4552474|NCT01218516|7380683|FG002|Combination Therapy (up to 4.5 Months)|Death|0
4552475|NCT01218516|7380684|FG003|Combination Therapy (up to 4.5 Months)|Death|0
4552476|NCT01218516|7380681|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0
4552477|NCT01218516|7380682|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3
4552478|NCT01218516|7380683|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0
4552479|NCT01218516|7380684|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0
4552480|NCT01218516|7380681|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2
4552481|NCT01218516|7380682|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2
4552482|NCT01218516|7380683|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0
4552483|NCT01218516|7380684|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0
4552484|NCT01218516|7380681|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2
4552485|NCT01218516|7380682|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0
4552486|NCT01218516|7380683|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0
4621097|NCT01790503|7483816|FG010|Overall Study|Withdrawal by Subject|1
4552487|NCT01218516|7380684|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0
4552488|NCT01218516|7380681|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17
4552489|NCT01218516|7380682|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15
4552490|NCT01218516|7380683|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0
4552491|NCT01218516|7380684|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0
4552492|NCT01218516|7380681|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0
4552493|NCT01218516|7380682|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1
4552494|NCT01218516|7380683|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0
4552495|NCT01218516|7380684|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0
4552496|NCT01218516|7380681|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0
4552497|NCT01218516|7380682|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1
4552498|NCT01218516|7380683|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0
4552499|NCT01218516|7380684|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0
4552500|NCT01218516|7380681|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0
4552501|NCT01218516|7380682|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3
4552502|NCT01218516|7380683|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0
4552503|NCT01218516|7380684|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0
4552504|NCT01218516|7380681|FG000|Combination Therapy (up to 4.5 Months)|Other|3
4552505|NCT01218516|7380682|FG001|Combination Therapy (up to 4.5 Months)|Other|4
4552506|NCT01218516|7380683|FG002|Combination Therapy (up to 4.5 Months)|Other|0
4552507|NCT01218516|7380684|FG003|Combination Therapy (up to 4.5 Months)|Other|0
4552508|NCT01218516|7380681|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0
4552509|NCT01218516|7380682|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1
4552510|NCT01218516|7380683|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0
4552511|NCT01218516|7380684|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0
4552512|NCT01218516|7380681|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2
4552513|NCT01218516|7380682|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3
4552514|NCT01218516|7380683|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0
4552515|NCT01218516|7380684|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0
4552516|NCT01218516|7380681|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1
4552517|NCT01218516|7380682|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1
4552518|NCT01218516|7380683|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0
4552519|NCT01218516|7380684|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0
4552520|NCT01218594|7380699|FG000|Overall Study|Death|1
4552521|NCT01218594|7380699|FG000|Overall Study|Withdrawal by Subject|3
4552522|NCT01218594|7380699|FG000|Overall Study|Adverse Event|2
4552523|NCT01218594|7380699|FG000|Overall Study|Physician Decision|6
4552524|NCT01218646|7380707|FG000|Overall Study|Adverse Event|0
4552525|NCT01218646|7380708|FG001|Overall Study|Adverse Event|0
4552526|NCT01218646|7380709|FG002|Overall Study|Adverse Event|1
4552527|NCT01218646|7380710|FG003|Overall Study|Adverse Event|0
4552528|NCT01218646|7380707|FG000|Overall Study|Lost to Follow-up|1
4552529|NCT01218646|7380708|FG001|Overall Study|Lost to Follow-up|0
4552530|NCT01218646|7380709|FG002|Overall Study|Lost to Follow-up|0
4621098|NCT01790503|7483806|FG000|Overall Study|Disease progression|2
4621099|NCT01790503|7483807|FG001|Overall Study|Disease progression|1
4621100|NCT01790503|7483808|FG002|Overall Study|Disease progression|0
4621101|NCT01790503|7483809|FG003|Overall Study|Disease progression|1
4621102|NCT01790503|7483810|FG004|Overall Study|Disease progression|2
4621103|NCT01790503|7483811|FG005|Overall Study|Disease progression|1
4621104|NCT01790503|7483812|FG006|Overall Study|Disease progression|0
4621105|NCT01790503|7483813|FG007|Overall Study|Disease progression|1
4621106|NCT01790503|7483814|FG008|Overall Study|Disease progression|0
4621107|NCT01790503|7483815|FG009|Overall Study|Disease progression|17
4621108|NCT01790503|7483816|FG010|Overall Study|Disease progression|7
4621109|NCT01790503|7483806|FG000|Overall Study|Protocol Violation|0
4621110|NCT01790503|7483807|FG001|Overall Study|Protocol Violation|0
4621111|NCT01790503|7483808|FG002|Overall Study|Protocol Violation|0
4621112|NCT01790503|7483809|FG003|Overall Study|Protocol Violation|0
4621113|NCT01790503|7483810|FG004|Overall Study|Protocol Violation|0
4621114|NCT01790503|7483811|FG005|Overall Study|Protocol Violation|0
4621115|NCT01790503|7483812|FG006|Overall Study|Protocol Violation|0
4621116|NCT01790503|7483813|FG007|Overall Study|Protocol Violation|0
4621117|NCT01790503|7483814|FG008|Overall Study|Protocol Violation|0
4621118|NCT01790503|7483815|FG009|Overall Study|Protocol Violation|1
4621119|NCT01790503|7483816|FG010|Overall Study|Protocol Violation|0
4621120|NCT01790503|7483806|FG000|Overall Study|Physician Decision|0
4621121|NCT01790503|7483807|FG001|Overall Study|Physician Decision|0
4621122|NCT01790503|7483808|FG002|Overall Study|Physician Decision|0
4621123|NCT01790503|7483809|FG003|Overall Study|Physician Decision|0
4621124|NCT01790503|7483810|FG004|Overall Study|Physician Decision|0
4621125|NCT01790503|7483811|FG005|Overall Study|Physician Decision|0
4690650|NCT02563028|7600454|FG000|Overall Study|Unable to elicit VEP post induction|1
4690651|NCT02563067|7600461|FG000|Overall Study|Subject/guardian decision|14
4690652|NCT02563067|7600462|FG001|Overall Study|Subject/guardian decision|20
4552531|NCT01218646|7380710|FG003|Overall Study|Lost to Follow-up|0
4552532|NCT01218646|7380707|FG000|Overall Study|Protocol Violation|0
4552533|NCT01218646|7380708|FG001|Overall Study|Protocol Violation|0
4552534|NCT01218646|7380709|FG002|Overall Study|Protocol Violation|1
4552535|NCT01218646|7380710|FG003|Overall Study|Protocol Violation|1
4552536|NCT01218659|7380722|FG000|18-Month Randomized Period|Withdrawal by Subject|2
4552537|NCT01218659|7380723|FG001|18-Month Randomized Period|Withdrawal by Subject|3
4552538|NCT01218659|7380724|FG002|18-Month Randomized Period|Withdrawal by Subject|0
4552539|NCT01218659|7380722|FG000|18-Month Randomized Period|Did not receive study drug|0
4552540|NCT01218659|7380723|FG001|18-Month Randomized Period|Did not receive study drug|3
4552541|NCT01218659|7380724|FG002|18-Month Randomized Period|Did not receive study drug|0
4552542|NCT01218659|7380722|FG000|12-Month OLE|Withdrawal by Subject|0
4552543|NCT01218659|7380723|FG001|12-Month OLE|Withdrawal by Subject|0
4552544|NCT01218659|7380724|FG002|12-Month OLE|Withdrawal by Subject|2
4552545|NCT01218659|7380722|FG000|12-Month OLE|Physician Decision|0
4552546|NCT01218659|7380723|FG001|12-Month OLE|Physician Decision|0
4552547|NCT01218659|7380724|FG002|12-Month OLE|Physician Decision|1
4552548|NCT01218659|7380722|FG000|12-Month OLE|Lost to Follow-up|0
4552549|NCT01218659|7380723|FG001|12-Month OLE|Lost to Follow-up|0
4552550|NCT01218659|7380724|FG002|12-Month OLE|Lost to Follow-up|1
4552551|NCT01218659|7380722|FG000|12-Month OLE|Pregnancy|0
4552552|NCT01218659|7380723|FG001|12-Month OLE|Pregnancy|0
4552553|NCT01218659|7380724|FG002|12-Month OLE|Pregnancy|1
4552554|NCT01218659|7380722|FG000|12-Month OLE|Lack of Efficacy|0
4552555|NCT01218659|7380723|FG001|12-Month OLE|Lack of Efficacy|0
4552556|NCT01218659|7380724|FG002|12-Month OLE|Lack of Efficacy|1
4552557|NCT01218659|7380722|FG000|12-Month OLE|Declined to participate in the OLE|0
4552558|NCT01218659|7380723|FG001|12-Month OLE|Declined to participate in the OLE|0
4552559|NCT01218659|7380724|FG002|12-Month OLE|Declined to participate in the OLE|4
4552560|NCT01218802|7380744|FG000|Overall Study|Lost to Follow-up|5
4552561|NCT01218802|7380745|FG001|Overall Study|Lost to Follow-up|6
4552562|NCT01218802|7380744|FG000|Overall Study|Withdrawal by Subject|3
4552563|NCT01218802|7380745|FG001|Overall Study|Withdrawal by Subject|10
4552564|NCT01218802|7380744|FG000|Overall Study|Adverse Event|0
4552565|NCT01218802|7380745|FG001|Overall Study|Adverse Event|2
4552566|NCT01218802|7380744|FG000|Overall Study|Incarcerated|2
4552567|NCT01218802|7380745|FG001|Overall Study|Incarcerated|0
4552568|NCT01218867|7380762|FG000|Overall Study|Death during treatment|0
4552569|NCT01218867|7380763|FG001|Overall Study|Death during treatment|0
4552570|NCT01218867|7380764|FG002|Overall Study|Death during treatment|0
4552571|NCT01218867|7380765|FG003|Overall Study|Death during treatment|0
4552572|NCT01218867|7380766|FG004|Overall Study|Death during treatment|0
4552573|NCT01218867|7380767|FG005|Overall Study|Death during treatment|0
4552574|NCT01218867|7380768|FG006|Overall Study|Death during treatment|1
4552575|NCT01218867|7380769|FG007|Overall Study|Death during treatment|0
4552576|NCT01218867|7380770|FG008|Overall Study|Death during treatment|0
4552577|NCT01218867|7380771|FG009|Overall Study|Death during treatment|0
4552578|NCT01218867|7380772|FG010|Overall Study|Death during treatment|0
4552579|NCT01219933|7380902|FG000|Overall Study|Adverse Event|8
4552580|NCT01219933|7380902|FG000|Overall Study|No LDA reached|5
4552581|NCT01219933|7380902|FG000|Overall Study|No LDA maintained|7
4552582|NCT01219933|7380902|FG000|Overall Study|Lost to Follow-up|3
4552583|NCT01219933|7380902|FG000|Overall Study|GC free|1
4552584|NCT01219933|7380902|FG000|Overall Study|Withdrawal by Subject|5
4552585|NCT01219933|7380902|FG000|Overall Study|Protocol Violation|8
4552586|NCT01219933|7380902|FG000|Overall Study|Lack of Efficacy|1
4591795|NCT01534260|7438733|FG000|Overall Study|Death|2
4591796|NCT01534260|7438734|FG001|Overall Study|Death|0
4591797|NCT01534260|7438733|FG000|Overall Study|Lack of Efficacy|1
4591798|NCT01534260|7438734|FG001|Overall Study|Lack of Efficacy|1
4591799|NCT01534260|7438733|FG000|Overall Study|Withdrawal by Subject|1
4591800|NCT01534260|7438734|FG001|Overall Study|Withdrawal by Subject|3
4591801|NCT01534260|7438733|FG000|Overall Study|Disease Progression|8
4591802|NCT01534260|7438734|FG001|Overall Study|Disease Progression|6
4591803|NCT01534260|7438733|FG000|Overall Study|Physician Decision|3
4591804|NCT01534260|7438734|FG001|Overall Study|Physician Decision|1
4591805|NCT01534260|7438733|FG000|Overall Study|No treatment, per protocol|0
4591806|NCT01534260|7438734|FG001|Overall Study|No treatment, per protocol|1
4591807|NCT01534273|7438744|FG000|Period 1|Physician Decision|0
4591808|NCT01534273|7438745|FG001|Period 1|Physician Decision|0
4591809|NCT01534273|7438746|FG002|Period 1|Physician Decision|0
4591810|NCT01534273|7438747|FG003|Period 1|Physician Decision|1
4591811|NCT01534273|7438748|FG004|Period 1|Physician Decision|0
4591812|NCT01534273|7438749|FG005|Period 1|Physician Decision|0
4591813|NCT01534273|7438750|FG006|Period 1|Physician Decision|0
4591814|NCT01534351|7438774|FG000|Overall Study|Study Terminated Early|1
4591815|NCT01534351|7438775|FG001|Overall Study|Study Terminated Early|0
4591816|NCT01534351|7438776|FG002|Overall Study|Study Terminated Early|0
4591817|NCT01534520|7438805|FG000|Overall Study|Adverse Event|0
4591818|NCT01534520|7438806|FG001|Overall Study|Adverse Event|1
4591819|NCT01534533|7438820|FG000|Overall Study|Lost to Follow-up|3
4591820|NCT01534533|7438821|FG001|Overall Study|Lost to Follow-up|0
4591821|NCT01534533|7438822|FG002|Overall Study|Lost to Follow-up|4
4591822|NCT01534533|7438823|FG003|Overall Study|Lost to Follow-up|3
4591823|NCT01534533|7438820|FG000|Overall Study|Withdrawal by Subject|5
4552587|NCT01219959|7380909|FG000|Overall Study|Adverse Event|6
4552588|NCT01219959|7380910|FG001|Overall Study|Adverse Event|14
4552589|NCT01219959|7380909|FG000|Overall Study|Physician Decision|0
4552590|NCT01219959|7380910|FG001|Overall Study|Physician Decision|4
4552591|NCT01219959|7380909|FG000|Overall Study|Withdrawal by Subject|0
4552592|NCT01219959|7380910|FG001|Overall Study|Withdrawal by Subject|2
4552593|NCT01219959|7380909|FG000|Overall Study|Renal Transplantation|0
4552594|NCT01219959|7380910|FG001|Overall Study|Renal Transplantation|3
4552595|NCT01219959|7380909|FG000|Overall Study|Other|1
4552596|NCT01219959|7380910|FG001|Overall Study|Other|0
4552597|NCT01219985|7380916|FG000|Overall Study|Physician Decision|20
4552598|NCT01220024|7380924|FG000|Overall Study|Lost to Follow-up|1
4552599|NCT01220024|7380925|FG001|Overall Study|Lost to Follow-up|1
4552600|NCT01220128|7380938|FG000|Overall Study|Progressive disease|0
4552601|NCT01220128|7380939|FG001|Overall Study|Progressive disease|0
4552602|NCT01220128|7380940|FG002|Overall Study|Progressive disease|2
4552603|NCT01220128|7380941|FG003|Overall Study|Progressive disease|0
4552604|NCT01220128|7380942|FG004|Overall Study|Progressive disease|0
4552605|NCT01220128|7380943|FG005|Overall Study|Progressive disease|0
4552606|NCT01220128|7380944|FG006|Overall Study|Progressive disease|0
4552607|NCT01220128|7380938|FG000|Overall Study|Sponsor study termination|0
4552608|NCT01220128|7380939|FG001|Overall Study|Sponsor study termination|1
4552609|NCT01220128|7380940|FG002|Overall Study|Sponsor study termination|0
4552610|NCT01220128|7380941|FG003|Overall Study|Sponsor study termination|0
4552611|NCT01220128|7380942|FG004|Overall Study|Sponsor study termination|0
4552612|NCT01220128|7380943|FG005|Overall Study|Sponsor study termination|0
4552613|NCT01220128|7380944|FG006|Overall Study|Sponsor study termination|1
4552614|NCT01220128|7380938|FG000|Overall Study|Adverse event, serious fatal|2
4552615|NCT01220128|7380939|FG001|Overall Study|Adverse event, serious fatal|0
4552616|NCT01220128|7380940|FG002|Overall Study|Adverse event, serious fatal|0
4552617|NCT01220128|7380941|FG003|Overall Study|Adverse event, serious fatal|0
4552618|NCT01220128|7380942|FG004|Overall Study|Adverse event, serious fatal|0
4552619|NCT01220128|7380943|FG005|Overall Study|Adverse event, serious fatal|0
4552620|NCT01220128|7380944|FG006|Overall Study|Adverse event, serious fatal|1
4552621|NCT01220128|7380938|FG000|Overall Study|Adverse event, non-fatal|1
4552622|NCT01220128|7380939|FG001|Overall Study|Adverse event, non-fatal|0
4552623|NCT01220128|7380940|FG002|Overall Study|Adverse event, non-fatal|0
4552624|NCT01220128|7380941|FG003|Overall Study|Adverse event, non-fatal|0
4552625|NCT01220128|7380942|FG004|Overall Study|Adverse event, non-fatal|0
4552626|NCT01220128|7380943|FG005|Overall Study|Adverse event, non-fatal|0
4552627|NCT01220128|7380944|FG006|Overall Study|Adverse event, non-fatal|3
4552628|NCT01220128|7380938|FG000|Overall Study|Other|0
4552629|NCT01220128|7380939|FG001|Overall Study|Other|0
4552630|NCT01220128|7380940|FG002|Overall Study|Other|1
4552631|NCT01220128|7380941|FG003|Overall Study|Other|0
4552632|NCT01220128|7380942|FG004|Overall Study|Other|0
4552633|NCT01220128|7380943|FG005|Overall Study|Other|0
4552634|NCT01220128|7380944|FG006|Overall Study|Other|0
4552635|NCT01220128|7380938|FG000|Overall Study|Consent withdrawn by subject|1
4552636|NCT01220128|7380939|FG001|Overall Study|Consent withdrawn by subject|0
4552637|NCT01220128|7380940|FG002|Overall Study|Consent withdrawn by subject|0
4552638|NCT01220128|7380941|FG003|Overall Study|Consent withdrawn by subject|0
4552639|NCT01220128|7380942|FG004|Overall Study|Consent withdrawn by subject|0
4552640|NCT01220128|7380943|FG005|Overall Study|Consent withdrawn by subject|0
4552641|NCT01220128|7380944|FG006|Overall Study|Consent withdrawn by subject|0
4552642|NCT01220167|7380964|FG000|Period 3|Urine positive for substance abuse|0
4552643|NCT01220167|7380965|FG001|Period 3|Urine positive for substance abuse|1
4552644|NCT01220167|7380966|FG002|Period 3|Urine positive for substance abuse|0
4552645|NCT01220180|7380975|FG000|Overall Study|Lost to Follow-up|76
4552646|NCT01220180|7380975|FG000|Overall Study|Other|72
4552647|NCT01220180|7380975|FG000|Overall Study|Adverse Event|35
4552648|NCT01220180|7380975|FG000|Overall Study|Lack of Efficacy|22
4552649|NCT01220180|7380975|FG000|Overall Study|Death|1
4552650|NCT01220180|7380975|FG000|Overall Study|Randomized but not treated|1
4552651|NCT01220297|7380981|FG000|Overall Study|Death|2
4552652|NCT01220297|7380981|FG000|Overall Study|Lost to Follow-up|1
4552653|NCT01220401|7380987|FG000|Overall Study|Withdrawal by Subject|2
4552654|NCT01220401|7380987|FG000|Overall Study|Protocol Violation|1
4552655|NCT01220414|7380993|FG000|Overall Study|Withdrawal by Subject|1
4552656|NCT01220414|7380994|FG001|Overall Study|Withdrawal by Subject|0
4552657|NCT01220414|7380995|FG002|Overall Study|Withdrawal by Subject|0
4552658|NCT01220414|7380996|FG003|Overall Study|Withdrawal by Subject|1
4552659|NCT01220557|7381018|FG000|Overall Study|Lost to Follow-up|5
4552660|NCT01220557|7381019|FG001|Overall Study|Lost to Follow-up|3
4552661|NCT01220557|7381018|FG000|Overall Study|attended less than 6 lessons|1
4621126|NCT01790503|7483812|FG006|Overall Study|Physician Decision|0
4552662|NCT01220557|7381019|FG001|Overall Study|attended less than 6 lessons|2
4552663|NCT01220609|7381025|FG000|Overall Study|Ineligible-Wrong primary cancer site|1
4552664|NCT01220609|7381025|FG000|Overall Study|Ineligible- Wrong cell type|1
4552665|NCT01220609|7381025|FG000|Overall Study|Ineligible-Never treated|1
4552666|NCT01220856|7381064|FG000|Overall Study|graft loss|3
4552667|NCT01220856|7381065|FG001|Overall Study|graft loss|3
4552668|NCT01220856|7381064|FG000|Overall Study|Lost to Follow-up|1
4621127|NCT01790503|7483813|FG007|Overall Study|Physician Decision|0
4552669|NCT01220856|7381065|FG001|Overall Study|Lost to Follow-up|0
4552670|NCT01220999|7381087|FG000|Overall Study|Progressive disease|0
4552671|NCT01220999|7381088|FG001|Overall Study|Progressive disease|0
4552672|NCT01220999|7381089|FG002|Overall Study|Progressive disease|1
4552673|NCT01220999|7381090|FG003|Overall Study|Progressive disease|0
4552674|NCT01220999|7381091|FG004|Overall Study|Progressive disease|0
4552675|NCT01221090|7381107|FG000|Overall Study|Non-Compliant or Unable to Contact|15
4552676|NCT01221090|7381108|FG001|Overall Study|Non-Compliant or Unable to Contact|12
4552677|NCT01221090|7381109|FG002|Overall Study|Non-Compliant or Unable to Contact|15
4552678|NCT01221090|7381110|FG003|Overall Study|Non-Compliant or Unable to Contact|20
4552679|NCT01221090|7381107|FG000|Overall Study|Withdrawal by Subject|0
4552680|NCT01221090|7381108|FG001|Overall Study|Withdrawal by Subject|22
4552681|NCT01221090|7381109|FG002|Overall Study|Withdrawal by Subject|27
4552682|NCT01221090|7381110|FG003|Overall Study|Withdrawal by Subject|2
4552683|NCT01221181|7381120|FG000|Overall Study|Lost to Follow-up|1
4552684|NCT01221233|7381148|FG000|Overall Study|Withdrawal by Subject|3
4552685|NCT01221233|7381149|FG001|Overall Study|Withdrawal by Subject|1
4552686|NCT01221272|7381155|FG000|Period 1|Adverse Event|2
4552687|NCT01221272|7381156|FG001|Period 1|Adverse Event|0
4552688|NCT01221272|7381155|FG000|Period 1|Consent Withdrawal|0
4552689|NCT01221272|7381156|FG001|Period 1|Consent Withdrawal|1
4552690|NCT01221272|7381155|FG000|Period 1|Significant Dosing Noncompliance|0
4552691|NCT01221272|7381156|FG001|Period 1|Significant Dosing Noncompliance|1
4552692|NCT01221272|7381155|FG000|Period 2|Adverse Event|0
4552693|NCT01221272|7381156|FG001|Period 2|Adverse Event|2
4552694|NCT01221285|7381165|FG000|Overall Study|Withdrawal by Subject|1
4552695|NCT01221350|7381184|FG000|Overall Study|Discontinued intervention (GERD)|1
4552696|NCT01221350|7381185|FG001|Overall Study|Discontinued intervention (GERD)|0
4552697|NCT01221350|7381184|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0
4552698|NCT01221350|7381185|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1
4552699|NCT01221350|7381184|FG000|Overall Study|Withdrawal by Subject|4
4552700|NCT01221350|7381185|FG001|Overall Study|Withdrawal by Subject|2
4552701|NCT01221363|7381195|FG000|Overall Study|Pregnancy|1
4552702|NCT01221363|7381196|FG001|Overall Study|Pregnancy|0
4552703|NCT01221363|7381195|FG000|Overall Study|Withdrawal by Subject|11
4552704|NCT01221363|7381196|FG001|Overall Study|Withdrawal by Subject|5
4552705|NCT01221597|7381213|FG000|Overall Study|Adverse Event|4
4552706|NCT01221597|7381214|FG001|Overall Study|Adverse Event|1
4552707|NCT01221597|7381213|FG000|Overall Study|Withdrawal by Subject|20
4552708|NCT01221597|7381214|FG001|Overall Study|Withdrawal by Subject|6
4552709|NCT01221597|7381213|FG000|Overall Study|Lost to Follow-up|6
4552710|NCT01221597|7381214|FG001|Overall Study|Lost to Follow-up|5
4552711|NCT01221597|7381213|FG000|Overall Study|Protocol Violation|1
4552712|NCT01221597|7381214|FG001|Overall Study|Protocol Violation|0
4552713|NCT01221597|7381213|FG000|Overall Study|Other|3
4552714|NCT01221597|7381214|FG001|Overall Study|Other|4
4552715|NCT01221597|7381213|FG000|Overall Study|Death|2
4621128|NCT01790503|7483814|FG008|Overall Study|Physician Decision|0
4621129|NCT01790503|7483815|FG009|Overall Study|Physician Decision|1
4621130|NCT01790503|7483816|FG010|Overall Study|Physician Decision|1
4621131|NCT01790503|7483806|FG000|Overall Study|Death|0
4621132|NCT01790503|7483807|FG001|Overall Study|Death|0
4621133|NCT01790503|7483808|FG002|Overall Study|Death|0
4621134|NCT01790503|7483809|FG003|Overall Study|Death|0
4621135|NCT01790503|7483810|FG004|Overall Study|Death|0
4621136|NCT01790503|7483811|FG005|Overall Study|Death|0
4621137|NCT01790503|7483812|FG006|Overall Study|Death|0
4621138|NCT01790503|7483813|FG007|Overall Study|Death|0
4621139|NCT01790503|7483814|FG008|Overall Study|Death|0
4621140|NCT01790503|7483815|FG009|Overall Study|Death|1
4621141|NCT01790503|7483816|FG010|Overall Study|Death|0
4621142|NCT01790503|7483806|FG000|Overall Study|Non Compliance|0
4621143|NCT01790503|7483807|FG001|Overall Study|Non Compliance|0
4621144|NCT01790503|7483808|FG002|Overall Study|Non Compliance|0
4621145|NCT01790503|7483809|FG003|Overall Study|Non Compliance|0
4621146|NCT01790503|7483810|FG004|Overall Study|Non Compliance|1
4621147|NCT01790503|7483811|FG005|Overall Study|Non Compliance|0
4621148|NCT01790503|7483812|FG006|Overall Study|Non Compliance|0
4621149|NCT01790503|7483813|FG007|Overall Study|Non Compliance|0
4621150|NCT01790503|7483814|FG008|Overall Study|Non Compliance|0
4621151|NCT01790503|7483815|FG009|Overall Study|Non Compliance|0
4621152|NCT01790503|7483816|FG010|Overall Study|Non Compliance|0
4621153|NCT01790503|7483806|FG000|Overall Study|Other|0
4621154|NCT01790503|7483807|FG001|Overall Study|Other|0
4621155|NCT01790503|7483808|FG002|Overall Study|Other|0
4621156|NCT01790503|7483809|FG003|Overall Study|Other|0
4621157|NCT01790503|7483810|FG004|Overall Study|Other|1
4621158|NCT01790503|7483811|FG005|Overall Study|Other|0
4621159|NCT01790503|7483812|FG006|Overall Study|Other|0
4621160|NCT01790503|7483813|FG007|Overall Study|Other|0
4621161|NCT01790503|7483814|FG008|Overall Study|Other|1
4552716|NCT01221597|7381214|FG001|Overall Study|Death|0
4552717|NCT01221623|7381223|FG000|Overall Study|Withdrawal by Subject|19
4552718|NCT01221623|7381224|FG001|Overall Study|Withdrawal by Subject|8
4621162|NCT01790503|7483815|FG009|Overall Study|Other|2
4621163|NCT01790503|7483816|FG010|Overall Study|Other|0
4621164|NCT01790516|7483855|FG000|Overall Study|Physician Decision|1
4621165|NCT01790516|7483856|FG001|Overall Study|Physician Decision|0
4552719|NCT01221623|7381223|FG000|Overall Study|Lost to Follow-up|7
4552720|NCT01221623|7381224|FG001|Overall Study|Lost to Follow-up|1
4552721|NCT01221623|7381223|FG000|Overall Study|Adverse Event|6
4552722|NCT01221623|7381224|FG001|Overall Study|Adverse Event|3
4552723|NCT01221623|7381223|FG000|Overall Study|Death|1
4552724|NCT01221623|7381224|FG001|Overall Study|Death|0
4552725|NCT01221623|7381223|FG000|Overall Study|Other|5
4552726|NCT01221623|7381224|FG001|Overall Study|Other|2
4552727|NCT01221727|7381232|FG000|Overall Study|Physician Decision|2
4552728|NCT01221727|7381233|FG001|Overall Study|Physician Decision|0
4552729|NCT01221727|7381232|FG000|Overall Study|Withdrawal by Subject|1
4552730|NCT01221727|7381233|FG001|Overall Study|Withdrawal by Subject|1
4552731|NCT01221753|7381245|FG000|Overall Study|Adverse Event|1
4552732|NCT01221948|7381257|FG000|Overall Study|Physician Decision|5
4552733|NCT01221948|7381257|FG000|Overall Study|Withdrawal by Subject|2
4552734|NCT01221948|7381257|FG000|Overall Study|not disclosed|2
4552735|NCT01221948|7381257|FG000|Overall Study|Death|1
4552736|NCT01221948|7381257|FG000|Overall Study|Protocol Violation|4
4552737|NCT01222078|7381261|FG000|Overall Study|Early termination of the study|1
4552738|NCT01222104|7381273|FG000|Overall Study|Lost to Follow-up|37
4552739|NCT01222104|7381273|FG000|Overall Study|Death|10
4552740|NCT01222403|7381386|FG000|Overall Study|Inappropriate enrollment|0
4552741|NCT01222403|7381387|FG001|Overall Study|Inappropriate enrollment|2
4552742|NCT01222416|7381395|FG000|Overall Study|ineligible;metastasis|3
4552743|NCT01222416|7381396|FG001|Overall Study|ineligible;metastasis|0
4552744|NCT01222416|7381395|FG000|Overall Study|Adverse Event|4
4552745|NCT01222416|7381396|FG001|Overall Study|Adverse Event|0
4552746|NCT01222416|7381395|FG000|Overall Study|Withdrawal by Subject|5
4552747|NCT01222416|7381396|FG001|Overall Study|Withdrawal by Subject|0
4552748|NCT01222416|7381395|FG000|Overall Study|scheduling|6
4552749|NCT01222416|7381396|FG001|Overall Study|scheduling|0
4552750|NCT01222416|7381395|FG000|Overall Study|missed view/scan|1
4552751|NCT01222416|7381396|FG001|Overall Study|missed view/scan|0
4552752|NCT01222416|7381395|FG000|Overall Study|Death|1
4552753|NCT01222416|7381396|FG001|Overall Study|Death|0
4552754|NCT01222507|7381415|FG000|Overall Study|Physician Decision|1
4552755|NCT01222507|7381415|FG000|Overall Study|Withdrawal by Subject|1
4552756|NCT01222520|7381421|FG000|Open-label run-in Period|Withdrawal by Subject|0
4552757|NCT01222520|7381422|FG001|Open-label run-in Period|Withdrawal by Subject|2
4552758|NCT01222520|7381421|FG000|Open-label run-in Period|Blood pressure criteria not met|0
4552759|NCT01222520|7381422|FG001|Open-label run-in Period|Blood pressure criteria not met|18
4552760|NCT01222520|7381421|FG000|Open-label run-in Period|Number of patients fulfilled|0
4552761|NCT01222520|7381422|FG001|Open-label run-in Period|Number of patients fulfilled|3
4552762|NCT01222520|7381421|FG000|Double-blind Period|Adverse Event|0
4552763|NCT01222520|7381422|FG001|Double-blind Period|Adverse Event|1
4552764|NCT01222520|7381421|FG000|Double-blind Period|Lack of Efficacy|0
4552765|NCT01222520|7381422|FG001|Double-blind Period|Lack of Efficacy|1
4552766|NCT01222520|7381421|FG000|Double-blind Period|Study medication stolen|1
4552767|NCT01222520|7381422|FG001|Double-blind Period|Study medication stolen|0
4552768|NCT01222533|7381428|FG000|Overall Study|Adverse Event|5
4552769|NCT01222533|7381428|FG000|Overall Study|Withdrawal by Subject|5
4552770|NCT01222533|7381428|FG000|Overall Study|Other|4
4552771|NCT01222715|7381456|FG000|Overall Study|Adverse Event|0
4552772|NCT01222715|7381457|FG001|Overall Study|Adverse Event|4
4552773|NCT01222715|7381456|FG000|Overall Study|Death|0
4552774|NCT01222715|7381457|FG001|Overall Study|Death|1
4552775|NCT01222715|7381456|FG000|Overall Study|Lack of Efficacy|22
4552776|NCT01222715|7381457|FG001|Overall Study|Lack of Efficacy|14
4552777|NCT01222715|7381456|FG000|Overall Study|Physician Decision|12
4552778|NCT01222715|7381457|FG001|Overall Study|Physician Decision|2
4552779|NCT01222715|7381456|FG000|Overall Study|Refusal of further protocol therapy|0
4552780|NCT01222715|7381457|FG001|Overall Study|Refusal of further protocol therapy|4
4552781|NCT01222715|7381456|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1
4552782|NCT01222715|7381457|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1
4552783|NCT01222715|7381456|FG000|Overall Study|Ineligible|0
4552784|NCT01222715|7381457|FG001|Overall Study|Ineligible|1
4552785|NCT01222715|7381456|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1
4552786|NCT01222715|7381457|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0
4552787|NCT01222767|7381463|FG000|Overall Study|Progressive disease|13
4552788|NCT01222767|7381463|FG000|Overall Study|Adverse Event|2
4552789|NCT01222767|7381463|FG000|Overall Study|Surgical resection|1
4552790|NCT01222767|7381463|FG000|Overall Study|Never treated|1
4552791|NCT01223027|7381487|FG000|Overall Study|Adverse Event|20
4552792|NCT01223027|7381488|FG001|Overall Study|Adverse Event|10
4552793|NCT01223027|7381487|FG000|Overall Study|Death|42
4552794|NCT01223027|7381488|FG001|Overall Study|Death|42
4621166|NCT01790568|7483862|FG000|Overall Study|Progression prior to transplant|0
4621167|NCT01790568|7483863|FG001|Overall Study|Progression prior to transplant|1
4621168|NCT01790594|7483878|FG000|Overall Study|Death|1
4552795|NCT01223027|7381487|FG000|Overall Study|Lost to Follow-up|2
4552796|NCT01223027|7381488|FG001|Overall Study|Lost to Follow-up|1
4552797|NCT01223027|7381487|FG000|Overall Study|Physician Decision|4
4552798|NCT01223027|7381488|FG001|Overall Study|Physician Decision|8
4552799|NCT01223027|7381487|FG000|Overall Study|Progressive Disease|167
4621169|NCT01790594|7483879|FG001|Overall Study|Death|0
4552800|NCT01223027|7381488|FG001|Overall Study|Progressive Disease|183
4552801|NCT01223027|7381487|FG000|Overall Study|Protocol Violation|2
4552802|NCT01223027|7381488|FG001|Overall Study|Protocol Violation|1
4552803|NCT01223027|7381487|FG000|Overall Study|Subject/guardian decicion|18
4552804|NCT01223027|7381488|FG001|Overall Study|Subject/guardian decicion|16
4552805|NCT01223027|7381487|FG000|Overall Study|New therapy for study indication|17
4552806|NCT01223027|7381488|FG001|Overall Study|New therapy for study indication|8
4552807|NCT01223027|7381487|FG000|Overall Study|Study terminated by sponsor|2
4552808|NCT01223027|7381488|FG001|Overall Study|Study terminated by sponsor|8
4552809|NCT01223183|7381496|FG000|Imaging Day 1|Physician Decision|0
4552810|NCT01223183|7381497|FG001|Imaging Day 1|Physician Decision|1
4552811|NCT01223183|7381496|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1
4552812|NCT01223183|7381497|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0
4552813|NCT01223183|7381496|FG000|Washout Period (5-24 Days)|Physician Decision|1
4552814|NCT01223183|7381497|FG001|Washout Period (5-24 Days)|Physician Decision|0
4552815|NCT01223196|7381506|FG000|Overall Study|Lost to Follow-up|2
4552816|NCT01223196|7381507|FG001|Overall Study|Lost to Follow-up|0
4552817|NCT01223196|7381506|FG000|Overall Study|Physician Decision|1
4552818|NCT01223196|7381507|FG001|Overall Study|Physician Decision|0
4552819|NCT01223196|7381506|FG000|Overall Study|Withdrawal by Subject|1
4552820|NCT01223196|7381507|FG001|Overall Study|Withdrawal by Subject|0
4552821|NCT01223235|7381515|FG000|Overall Study|Withdrawal by Subject|1
4552822|NCT01223365|7381534|FG000|Open-label Titration Period|Enrolled but not treated|1
4552823|NCT01223365|7381534|FG000|Open-label Titration Period|Adverse Event|23
4552824|NCT01223365|7381534|FG000|Open-label Titration Period|Lack of Efficacy|3
4552825|NCT01223365|7381534|FG000|Open-label Titration Period|Withdrawal by Subject|5
4552826|NCT01223365|7381534|FG000|Open-label Titration Period|Protocol Violation|1
4552827|NCT01223365|7381534|FG000|Open-label Titration Period|Lost to Follow-up|2
4552828|NCT01223365|7381534|FG000|Open-label Titration Period|Noncompliance with study drug admin|1
4552829|NCT01223365|7381534|FG000|Open-label Titration Period|Noncompliance with study procedures|2
4552830|NCT01223365|7381534|FG000|Open-label Titration Period|Starting physical therapy|1
4552831|NCT01223365|7381534|FG000|Open-label Treatment Period|Adverse Event|39
4552832|NCT01223365|7381534|FG000|Open-label Treatment Period|Lack of Efficacy|2
4552833|NCT01223365|7381534|FG000|Open-label Treatment Period|Withdrawal by Subject|19
4552834|NCT01223365|7381534|FG000|Open-label Treatment Period|Protocol Violation|15
4552835|NCT01223365|7381534|FG000|Open-label Treatment Period|Lost to Follow-up|7
4552836|NCT01223365|7381534|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7
4552837|NCT01223365|7381534|FG000|Open-label Treatment Period|Noncompliance with study procedures|6
4552838|NCT01223365|7381534|FG000|Open-label Treatment Period|Moved out of area|2
4552839|NCT01223365|7381534|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1
4552840|NCT01223365|7381534|FG000|Open-label Treatment Period|"Out of window"|1
4552841|NCT01223365|7381534|FG000|Open-label Treatment Period|Starting physical therapy|1
4552842|NCT01223365|7381534|FG000|Open-label Treatment Period|Physician Decision|2
4552843|NCT01223404|7381564|FG000|First Intervention (1 Day)|Adverse Event|0
4552844|NCT01223404|7381565|FG001|First Intervention (1 Day)|Adverse Event|0
4552845|NCT01223404|7381566|FG002|First Intervention (1 Day)|Adverse Event|0
4552846|NCT01223404|7381567|FG003|First Intervention (1 Day)|Adverse Event|1
4552847|NCT01223404|7381568|FG004|First Intervention (1 Day)|Adverse Event|0
4552848|NCT01223404|7381569|FG005|First Intervention (1 Day)|Adverse Event|0
4552849|NCT01223404|7381564|FG000|Second Intervention (1 Day)|Adverse Event|1
4552850|NCT01223404|7381565|FG001|Second Intervention (1 Day)|Adverse Event|0
4552851|NCT01223404|7381566|FG002|Second Intervention (1 Day)|Adverse Event|0
4552852|NCT01223404|7381567|FG003|Second Intervention (1 Day)|Adverse Event|0
4552853|NCT01223404|7381568|FG004|Second Intervention (1 Day)|Adverse Event|0
4552854|NCT01223404|7381569|FG005|Second Intervention (1 Day)|Adverse Event|0
4552855|NCT01223404|7381564|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0
4552856|NCT01223404|7381565|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0
4552857|NCT01223404|7381566|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0
4552858|NCT01223404|7381567|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1
4552859|NCT01223404|7381568|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0
4552860|NCT01223404|7381569|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0
4552861|NCT01223937|7381605|FG000|Overall Study|Withdrawal by Subject|3
4552862|NCT01223937|7381606|FG001|Overall Study|Withdrawal by Subject|2
4552863|NCT01223937|7381605|FG000|Overall Study|Lost to Follow-up|1
4552864|NCT01223937|7381606|FG001|Overall Study|Lost to Follow-up|4
4552865|NCT01223937|7381605|FG000|Overall Study|Adverse Event|1
4552866|NCT01223937|7381606|FG001|Overall Study|Adverse Event|4
4552867|NCT01223937|7381605|FG000|Overall Study|Protocol Violation|8
4552868|NCT01223937|7381606|FG001|Overall Study|Protocol Violation|7
4552869|NCT01223937|7381605|FG000|Overall Study|Other|4
4552870|NCT01223937|7381606|FG001|Overall Study|Other|1
4552871|NCT01224158|7381637|FG000|Overall Study|Withdrawal by Subject|1
4552872|NCT01224158|7381638|FG001|Overall Study|Withdrawal by Subject|0
4552873|NCT01224171|7381646|FG000|Overall Study|Adverse Event|8
4552874|NCT01224171|7381647|FG001|Overall Study|Adverse Event|4
4552875|NCT01224171|7381646|FG000|Overall Study|Protocol Violation|0
4552876|NCT01224171|7381647|FG001|Overall Study|Protocol Violation|1
4552877|NCT01224171|7381646|FG000|Overall Study|Lack of Efficacy|5
4552878|NCT01224171|7381647|FG001|Overall Study|Lack of Efficacy|1
4552879|NCT01224171|7381646|FG000|Overall Study|Withdrawal of Consent|2
4552880|NCT01224171|7381647|FG001|Overall Study|Withdrawal of Consent|4
4552881|NCT01224171|7381646|FG000|Overall Study|Lost to Follow-up|0
4552882|NCT01224171|7381647|FG001|Overall Study|Lost to Follow-up|3
4552883|NCT01224431|7381669|FG000|Overall Study|not randomized|0
4552884|NCT01224431|7381670|FG001|Overall Study|not randomized|4
4552885|NCT01224431|7381669|FG000|Overall Study|no video record|0
4552886|NCT01224431|7381670|FG001|Overall Study|no video record|1
4552887|NCT01224639|7381694|FG000|Overall Study|Withdrawal by Subject|0
4552888|NCT01224639|7381695|FG001|Overall Study|Withdrawal by Subject|0
4552889|NCT01224639|7381696|FG002|Overall Study|Withdrawal by Subject|0
4552890|NCT01224639|7381697|FG003|Overall Study|Withdrawal by Subject|0
4552891|NCT01224639|7381698|FG004|Overall Study|Withdrawal by Subject|2
4552892|NCT01224639|7381699|FG005|Overall Study|Withdrawal by Subject|0
4552893|NCT01224639|7381700|FG006|Overall Study|Withdrawal by Subject|1
4552894|NCT01224639|7381701|FG007|Overall Study|Withdrawal by Subject|1
4552895|NCT01224639|7381694|FG000|Overall Study|Adverse Event|0
4552896|NCT01224639|7381695|FG001|Overall Study|Adverse Event|0
4552897|NCT01224639|7381696|FG002|Overall Study|Adverse Event|0
4552898|NCT01224639|7381697|FG003|Overall Study|Adverse Event|0
4552899|NCT01224639|7381698|FG004|Overall Study|Adverse Event|0
4552900|NCT01224639|7381699|FG005|Overall Study|Adverse Event|0
4552901|NCT01224639|7381700|FG006|Overall Study|Adverse Event|0
4552902|NCT01224639|7381701|FG007|Overall Study|Adverse Event|1
4552903|NCT01224782|7381728|FG000|Overall Study|Lost to Follow-up|177
4552904|NCT01224782|7381728|FG000|Overall Study|Withdrawal by Subject|16
4552905|NCT01224782|7381728|FG000|Overall Study|Death|14
4552906|NCT01224782|7381728|FG000|Overall Study|Improvement|13
4552907|NCT01224782|7381728|FG000|Overall Study|Adverse Event|12
4552908|NCT01224782|7381728|FG000|Overall Study|Adverse Reaction|11
4552909|NCT01224782|7381728|FG000|Overall Study|Noncompliance|10
4552910|NCT01224782|7381728|FG000|Overall Study|Other|4
4552911|NCT01224782|7381728|FG000|Overall Study|Start of Dialysis|3
4552912|NCT01224782|7381728|FG000|Overall Study|Change of Treatment|1
4552913|NCT01224782|7381728|FG000|Overall Study|Financial Reasons|1
4552914|NCT01224782|7381728|FG000|Overall Study|Deterioration|1
4552915|NCT01224782|7381728|FG000|Overall Study|Transplantation|1
4552916|NCT01224821|7381732|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1
4552917|NCT01224821|7381732|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38
4552918|NCT01224821|7381732|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3
4552919|NCT01224821|7381732|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2
4552920|NCT01224821|7381732|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1
4552921|NCT01224821|7381732|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1
4552922|NCT01224821|7381732|FG000|Long-Term Follow-Up|Death|2
4552923|NCT01224821|7381732|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9
4552924|NCT01224925|7381738|FG000|Overall Study|Lost to Follow-up|3
4552925|NCT01224925|7381739|FG001|Overall Study|Lost to Follow-up|2
4552926|NCT01225146|7381780|FG000|Overall Study|Sponsor discontinued making 2mg drug|0
4552927|NCT01225146|7381781|FG001|Overall Study|Sponsor discontinued making 2mg drug|2
4552928|NCT01225159|7381791|FG000|Overall Study|Change operation|1
4552929|NCT01225159|7381792|FG001|Overall Study|Change operation|0
4552930|NCT01225172|7381800|FG000|Overall Study|Subject decision to stop|1
4552931|NCT01225172|7381801|FG001|Overall Study|Subject decision to stop|0
4552932|NCT01225172|7381800|FG000|Overall Study|Subject request to discontinue treatment|3
4552933|NCT01225172|7381801|FG001|Overall Study|Subject request to discontinue treatment|1
4552934|NCT01225172|7381800|FG000|Overall Study|Subject no longer meets study criteria|1
4552935|NCT01225172|7381801|FG001|Overall Study|Subject no longer meets study criteria|0
4552936|NCT01225172|7381800|FG000|Overall Study|Withdrawal by Subject|1
4552937|NCT01225172|7381801|FG001|Overall Study|Withdrawal by Subject|0
4552938|NCT01225211|7381817|FG000|Overall Study|Adverse Event|0
4552939|NCT01225211|7381818|FG001|Overall Study|Adverse Event|0
4552940|NCT01225211|7381819|FG002|Overall Study|Adverse Event|1
4621170|NCT01790594|7483880|FG002|Overall Study|Death|0
4621171|NCT01790594|7483878|FG000|Overall Study|Physician Decision|2
4621172|NCT01790594|7483879|FG001|Overall Study|Physician Decision|1
4621173|NCT01790594|7483880|FG002|Overall Study|Physician Decision|0
4621174|NCT01790594|7483878|FG000|Overall Study|Withdrawal by Subject|2
4621175|NCT01790594|7483879|FG001|Overall Study|Withdrawal by Subject|0
4621176|NCT01790594|7483880|FG002|Overall Study|Withdrawal by Subject|0
4621177|NCT01790594|7483878|FG000|Overall Study|Transplant was not done|0
4621178|NCT01790594|7483879|FG001|Overall Study|Transplant was not done|0
4621179|NCT01790594|7483880|FG002|Overall Study|Transplant was not done|3
4621180|NCT01790594|7483878|FG000|Overall Study|Terminated prior to week 76|0
4621181|NCT01790594|7483879|FG001|Overall Study|Terminated prior to week 76|2
4621182|NCT01790594|7483880|FG002|Overall Study|Terminated prior to week 76|0
4621183|NCT01790633|7483889|FG000|Overall Study|Protocol Violation|1
4621184|NCT01790633|7483890|FG001|Overall Study|Protocol Violation|2
4552941|NCT01225211|7381820|FG003|Overall Study|Adverse Event|0
4552942|NCT01225211|7381821|FG004|Overall Study|Adverse Event|0
4552943|NCT01225211|7381822|FG005|Overall Study|Adverse Event|0
4621185|NCT01790633|7483889|FG000|Overall Study|Did not have serology performed|47
4621186|NCT01790633|7483890|FG001|Overall Study|Did not have serology performed|0
4552944|NCT01225211|7381823|FG006|Overall Study|Adverse Event|0
4552945|NCT01225211|7381824|FG007|Overall Study|Adverse Event|0
4552946|NCT01225211|7381825|FG008|Overall Study|Adverse Event|0
4552947|NCT01225211|7381826|FG009|Overall Study|Adverse Event|1
4552948|NCT01225211|7381817|FG000|Overall Study|Withdrawal by Subject|0
4552949|NCT01225211|7381818|FG001|Overall Study|Withdrawal by Subject|0
4552950|NCT01225211|7381819|FG002|Overall Study|Withdrawal by Subject|0
4552951|NCT01225211|7381820|FG003|Overall Study|Withdrawal by Subject|0
4552952|NCT01225211|7381821|FG004|Overall Study|Withdrawal by Subject|0
4552953|NCT01225211|7381822|FG005|Overall Study|Withdrawal by Subject|0
4552954|NCT01225211|7381823|FG006|Overall Study|Withdrawal by Subject|1
4552955|NCT01225211|7381824|FG007|Overall Study|Withdrawal by Subject|0
4552956|NCT01225211|7381825|FG008|Overall Study|Withdrawal by Subject|1
4552957|NCT01225211|7381826|FG009|Overall Study|Withdrawal by Subject|3
4552958|NCT01225211|7381817|FG000|Overall Study|Other|0
4552959|NCT01225211|7381818|FG001|Overall Study|Other|0
4552960|NCT01225211|7381819|FG002|Overall Study|Other|0
4552961|NCT01225211|7381820|FG003|Overall Study|Other|0
4552962|NCT01225211|7381821|FG004|Overall Study|Other|0
4552963|NCT01225211|7381822|FG005|Overall Study|Other|0
4552964|NCT01225211|7381823|FG006|Overall Study|Other|0
4552965|NCT01225211|7381824|FG007|Overall Study|Other|0
4552966|NCT01225211|7381825|FG008|Overall Study|Other|0
4552967|NCT01225211|7381826|FG009|Overall Study|Other|1
4552968|NCT01225549|7381916|FG000|Period 4 - Washout|Disallowed medication|0
4552969|NCT01225549|7381917|FG001|Period 4 - Washout|Disallowed medication|1
4621187|NCT01790633|7483889|FG000|Overall Study|RT failure and no follow-up ELISA|0
4621188|NCT01790633|7483890|FG001|Overall Study|RT failure and no follow-up ELISA|3
4621189|NCT01790828|7483920|FG000|Overall Study|Other|34
4621190|NCT01790932|7483924|FG000|Overall Study|Disease Progression|41
4621191|NCT01790932|7483924|FG000|Overall Study|Adverse Event|7
4621192|NCT01790932|7483924|FG000|Overall Study|Physician Decision|1
4621193|NCT01790932|7483924|FG000|Overall Study|Withdrawal by Subject|1
4621194|NCT01790984|7483930|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1
4621195|NCT01790984|7483931|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1
4621196|NCT01790984|7483932|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0
4621197|NCT01790984|7483933|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0
4621198|NCT01791127|7483956|FG000|Overall Study|Death|356
4621199|NCT01791127|7483956|FG000|Overall Study|Patient has withdrawn from study|293
4621200|NCT01791127|7483956|FG000|Overall Study|Lost to Follow-up|42
4621201|NCT01791127|7483956|FG000|Overall Study|All Siello leads are explanted|31
4621202|NCT01791127|7483956|FG000|Overall Study|Completion of 30 day safety registry|1
4621203|NCT01791127|7483956|FG000|Overall Study|Study terminated for EP Passion|749
4621204|NCT01791153|7483977|FG000|Part 1: Blinded Period|Adverse Event|7
4621205|NCT01791153|7483978|FG001|Part 1: Blinded Period|Adverse Event|3
4621206|NCT01791153|7483979|FG002|Part 1: Blinded Period|Adverse Event|2
4621207|NCT01791153|7483980|FG003|Part 1: Blinded Period|Adverse Event|0
4621208|NCT01791153|7483981|FG004|Part 1: Blinded Period|Adverse Event|0
4621209|NCT01791153|7483982|FG005|Part 1: Blinded Period|Adverse Event|0
4621210|NCT01791153|7483983|FG006|Part 1: Blinded Period|Adverse Event|0
4621211|NCT01791153|7483984|FG007|Part 1: Blinded Period|Adverse Event|0
4621212|NCT01791153|7483977|FG000|Part 1: Blinded Period|Lack of Efficacy|1
4621213|NCT01791153|7483978|FG001|Part 1: Blinded Period|Lack of Efficacy|3
4621214|NCT01791153|7483979|FG002|Part 1: Blinded Period|Lack of Efficacy|2
4621215|NCT01791153|7483980|FG003|Part 1: Blinded Period|Lack of Efficacy|2
4621216|NCT01791153|7483981|FG004|Part 1: Blinded Period|Lack of Efficacy|0
4621217|NCT01791153|7483982|FG005|Part 1: Blinded Period|Lack of Efficacy|0
4621218|NCT01791153|7483983|FG006|Part 1: Blinded Period|Lack of Efficacy|0
4621219|NCT01791153|7483984|FG007|Part 1: Blinded Period|Lack of Efficacy|0
4621220|NCT01791153|7483977|FG000|Part 1: Blinded Period|Non-Compliance|1
4621221|NCT01791153|7483978|FG001|Part 1: Blinded Period|Non-Compliance|0
4621222|NCT01791153|7483979|FG002|Part 1: Blinded Period|Non-Compliance|0
4621223|NCT01791153|7483980|FG003|Part 1: Blinded Period|Non-Compliance|0
4621224|NCT01791153|7483981|FG004|Part 1: Blinded Period|Non-Compliance|0
4621225|NCT01791153|7483982|FG005|Part 1: Blinded Period|Non-Compliance|0
4621226|NCT01791153|7483983|FG006|Part 1: Blinded Period|Non-Compliance|0
4621227|NCT01791153|7483984|FG007|Part 1: Blinded Period|Non-Compliance|0
4621228|NCT01791153|7483977|FG000|Part 1: Blinded Period|Physician Decision|0
4621229|NCT01791153|7483978|FG001|Part 1: Blinded Period|Physician Decision|0
4621230|NCT01791153|7483979|FG002|Part 1: Blinded Period|Physician Decision|0
4621231|NCT01791153|7483980|FG003|Part 1: Blinded Period|Physician Decision|1
4621232|NCT01791153|7483981|FG004|Part 1: Blinded Period|Physician Decision|0
4621233|NCT01791153|7483982|FG005|Part 1: Blinded Period|Physician Decision|0
4621234|NCT01791153|7483983|FG006|Part 1: Blinded Period|Physician Decision|0
4621235|NCT01791153|7483984|FG007|Part 1: Blinded Period|Physician Decision|0
4621236|NCT01791153|7483977|FG000|Part 1: Blinded Period|Protocol Violation|0
4621237|NCT01791153|7483978|FG001|Part 1: Blinded Period|Protocol Violation|0
4552970|NCT01225549|7381918|FG002|Period 4 - Washout|Disallowed medication|0
4621238|NCT01791153|7483979|FG002|Part 1: Blinded Period|Protocol Violation|0
4621239|NCT01791153|7483980|FG003|Part 1: Blinded Period|Protocol Violation|1
4621240|NCT01791153|7483981|FG004|Part 1: Blinded Period|Protocol Violation|0
4621241|NCT01791153|7483982|FG005|Part 1: Blinded Period|Protocol Violation|0
4552971|NCT01225549|7381919|FG003|Period 4 - Washout|Disallowed medication|0
4552972|NCT01225549|7381920|FG004|Period 4 - Washout|Disallowed medication|0
4552973|NCT01225549|7381921|FG005|Period 4 - Washout|Disallowed medication|0
4552974|NCT01225549|7381922|FG006|Period 4 - Washout|Disallowed medication|0
4552975|NCT01225549|7381923|FG007|Period 4 - Washout|Disallowed medication|0
4552976|NCT01225549|7381924|FG008|Period 4 - Washout|Disallowed medication|0
4552977|NCT01225549|7381925|FG009|Period 4 - Washout|Disallowed medication|0
4552978|NCT01225549|7381916|FG000|Period 6 - Washout|Disallowed medication|0
4552979|NCT01225549|7381917|FG001|Period 6 - Washout|Disallowed medication|0
4552980|NCT01225549|7381918|FG002|Period 6 - Washout|Disallowed medication|0
4552981|NCT01225549|7381919|FG003|Period 6 - Washout|Disallowed medication|1
4552982|NCT01225549|7381920|FG004|Period 6 - Washout|Disallowed medication|0
4552983|NCT01225549|7381921|FG005|Period 6 - Washout|Disallowed medication|0
4552984|NCT01225549|7381922|FG006|Period 6 - Washout|Disallowed medication|0
4552985|NCT01225549|7381923|FG007|Period 6 - Washout|Disallowed medication|0
4552986|NCT01225549|7381924|FG008|Period 6 - Washout|Disallowed medication|0
4552987|NCT01225549|7381925|FG009|Period 6 - Washout|Disallowed medication|0
4552988|NCT01225562|7381938|FG000|Overall Study|Withdrawal by Subject|52
4552989|NCT01225562|7381939|FG001|Overall Study|Withdrawal by Subject|50
4552990|NCT01225562|7381940|FG002|Overall Study|Withdrawal by Subject|52
4552991|NCT01225562|7381938|FG000|Overall Study|Lost to Follow-up|3
4552992|NCT01225562|7381939|FG001|Overall Study|Lost to Follow-up|6
4552993|NCT01225562|7381940|FG002|Overall Study|Lost to Follow-up|1
4591824|NCT01534533|7438821|FG001|Overall Study|Withdrawal by Subject|3
4591825|NCT01534533|7438822|FG002|Overall Study|Withdrawal by Subject|4
4591826|NCT01534533|7438823|FG003|Overall Study|Withdrawal by Subject|1
4591827|NCT01534637|7438835|FG000|Overall Study|Physician Decision|3
4591828|NCT01534637|7438835|FG000|Overall Study|Lack of Efficacy|3
4591829|NCT01534637|7438835|FG000|Overall Study|Withdrawal by Subject|1
4591830|NCT01534637|7438835|FG000|Overall Study|Adverse Event|1
4591831|NCT01534637|7438835|FG000|Overall Study|Liver Mets before treatment|1
4591832|NCT01534663|7438841|FG000|Overall Study|Lost to Follow-up|0
4591833|NCT01534663|7438842|FG001|Overall Study|Lost to Follow-up|2
4591834|NCT01534663|7438841|FG000|Overall Study|Adverse Event|2
4591835|NCT01534663|7438842|FG001|Overall Study|Adverse Event|1
4593714|NCT01555125|7442332|FG001|Induction Period|Lost to Follow-up|2
4593715|NCT01555125|7442333|FG002|Induction Period|Lost to Follow-up|0
4593716|NCT01555125|7442334|FG003|Induction Period|Lost to Follow-up|0
4593717|NCT01555125|7442335|FG004|Induction Period|Lost to Follow-up|0
4593718|NCT01555125|7442331|FG000|Induction Period|Adverse Event|0
4593719|NCT01555125|7442332|FG001|Induction Period|Adverse Event|1
4593720|NCT01555125|7442333|FG002|Induction Period|Adverse Event|0
4593721|NCT01555125|7442334|FG003|Induction Period|Adverse Event|0
4593722|NCT01555125|7442335|FG004|Induction Period|Adverse Event|1
4593723|NCT01555125|7442331|FG000|Induction Period|Subject / guardian decision|0
4593724|NCT01555125|7442332|FG001|Induction Period|Subject / guardian decision|0
4593725|NCT01555125|7442333|FG002|Induction Period|Subject / guardian decision|0
4593726|NCT01555125|7442334|FG003|Induction Period|Subject / guardian decision|0
4593727|NCT01555125|7442335|FG004|Induction Period|Subject / guardian decision|2
4593728|NCT01555125|7442331|FG000|Induction Period|Death|1
4593729|NCT01555125|7442332|FG001|Induction Period|Death|0
4593730|NCT01555125|7442333|FG002|Induction Period|Death|0
4593731|NCT01555125|7442334|FG003|Induction Period|Death|0
4593732|NCT01555125|7442335|FG004|Induction Period|Death|0
4593733|NCT01555125|7442331|FG000|Maintenance Period|Adverse Event|1
4593734|NCT01555125|7442332|FG001|Maintenance Period|Adverse Event|1
4593735|NCT01555125|7442333|FG002|Maintenance Period|Adverse Event|0
4621242|NCT01791153|7483983|FG006|Part 1: Blinded Period|Protocol Violation|0
4621243|NCT01791153|7483984|FG007|Part 1: Blinded Period|Protocol Violation|0
4621244|NCT01791153|7483977|FG000|Part 1: Blinded Period|Withdrawal by Subject|6
4621245|NCT01791153|7483978|FG001|Part 1: Blinded Period|Withdrawal by Subject|2
4621246|NCT01791153|7483979|FG002|Part 1: Blinded Period|Withdrawal by Subject|2
4621247|NCT01791153|7483980|FG003|Part 1: Blinded Period|Withdrawal by Subject|1
4621248|NCT01791153|7483981|FG004|Part 1: Blinded Period|Withdrawal by Subject|0
4621249|NCT01791153|7483982|FG005|Part 1: Blinded Period|Withdrawal by Subject|0
4621250|NCT01791153|7483983|FG006|Part 1: Blinded Period|Withdrawal by Subject|0
4621251|NCT01791153|7483984|FG007|Part 1: Blinded Period|Withdrawal by Subject|0
4621252|NCT01791153|7483977|FG000|Part 2: Open-label Period|Adverse Event|0
4621253|NCT01791153|7483978|FG001|Part 2: Open-label Period|Adverse Event|0
4621254|NCT01791153|7483979|FG002|Part 2: Open-label Period|Adverse Event|0
4621255|NCT01791153|7483980|FG003|Part 2: Open-label Period|Adverse Event|0
4621256|NCT01791153|7483981|FG004|Part 2: Open-label Period|Adverse Event|0
4621257|NCT01791153|7483982|FG005|Part 2: Open-label Period|Adverse Event|1
4621258|NCT01791153|7483983|FG006|Part 2: Open-label Period|Adverse Event|1
4621259|NCT01791153|7483984|FG007|Part 2: Open-label Period|Adverse Event|2
4621260|NCT01791153|7483977|FG000|Part 2: Open-label Period|Death|0
4621261|NCT01791153|7483978|FG001|Part 2: Open-label Period|Death|0
4621262|NCT01791153|7483979|FG002|Part 2: Open-label Period|Death|0
4593736|NCT01555125|7442334|FG003|Maintenance Period|Adverse Event|0
4593737|NCT01555125|7442335|FG004|Maintenance Period|Adverse Event|0
4593738|NCT01555125|7442331|FG000|Maintenance Period|Subject / guardian decision|1
4593847|NCT01555164|7442380|FG001|Overall Study|Hyperglycemia|1
4621263|NCT01791153|7483980|FG003|Part 2: Open-label Period|Death|0
4552994|NCT01225731|7381953|FG000|Part 1|Did not meet eligibility criteria|1
4552995|NCT01225731|7381954|FG001|Part 1|Did not meet eligibility criteria|0
4552996|NCT01225731|7381955|FG002|Part 1|Did not meet eligibility criteria|0
4552997|NCT01225731|7381956|FG003|Part 1|Did not meet eligibility criteria|0
4552998|NCT01225731|7381957|FG004|Part 1|Did not meet eligibility criteria|1
4552999|NCT01225731|7381958|FG005|Part 1|Did not meet eligibility criteria|0
4553000|NCT01225731|7381959|FG006|Part 1|Did not meet eligibility criteria|0
4553001|NCT01225731|7381960|FG007|Part 1|Did not meet eligibility criteria|0
4553002|NCT01225731|7381961|FG008|Part 1|Did not meet eligibility criteria|0
4553003|NCT01225731|7381962|FG009|Part 1|Did not meet eligibility criteria|0
4553004|NCT01225731|7381963|FG010|Part 1|Did not meet eligibility criteria|0
4553005|NCT01225731|7381964|FG011|Part 1|Did not meet eligibility criteria|0
4553006|NCT01225731|7381965|FG012|Part 1|Did not meet eligibility criteria|0
4553007|NCT01225731|7381953|FG000|Part 1|Adverse Event|1
4553008|NCT01225731|7381954|FG001|Part 1|Adverse Event|2
4553009|NCT01225731|7381955|FG002|Part 1|Adverse Event|1
4553010|NCT01225731|7381956|FG003|Part 1|Adverse Event|1
4553011|NCT01225731|7381957|FG004|Part 1|Adverse Event|1
4553012|NCT01225731|7381958|FG005|Part 1|Adverse Event|0
4553013|NCT01225731|7381959|FG006|Part 1|Adverse Event|0
4553014|NCT01225731|7381960|FG007|Part 1|Adverse Event|0
4553015|NCT01225731|7381961|FG008|Part 1|Adverse Event|0
4553016|NCT01225731|7381962|FG009|Part 1|Adverse Event|0
4553017|NCT01225731|7381963|FG010|Part 1|Adverse Event|0
4553018|NCT01225731|7381964|FG011|Part 1|Adverse Event|0
4553019|NCT01225731|7381965|FG012|Part 1|Adverse Event|0
4553020|NCT01225731|7381953|FG000|Part 1|Withdrawal by Subject|0
4553021|NCT01225731|7381954|FG001|Part 1|Withdrawal by Subject|3
4553022|NCT01225731|7381955|FG002|Part 1|Withdrawal by Subject|0
4553023|NCT01225731|7381956|FG003|Part 1|Withdrawal by Subject|0
4553024|NCT01225731|7381957|FG004|Part 1|Withdrawal by Subject|4
4553025|NCT01225731|7381958|FG005|Part 1|Withdrawal by Subject|0
4553026|NCT01225731|7381959|FG006|Part 1|Withdrawal by Subject|0
4553027|NCT01225731|7381960|FG007|Part 1|Withdrawal by Subject|0
4553028|NCT01225731|7381961|FG008|Part 1|Withdrawal by Subject|0
4553029|NCT01225731|7381962|FG009|Part 1|Withdrawal by Subject|0
4553030|NCT01225731|7381963|FG010|Part 1|Withdrawal by Subject|0
4553031|NCT01225731|7381964|FG011|Part 1|Withdrawal by Subject|0
4553032|NCT01225731|7381965|FG012|Part 1|Withdrawal by Subject|0
4553033|NCT01225731|7381953|FG000|Part 1|Protocol Violation|0
4553034|NCT01225731|7381954|FG001|Part 1|Protocol Violation|0
4553035|NCT01225731|7381955|FG002|Part 1|Protocol Violation|0
4553036|NCT01225731|7381956|FG003|Part 1|Protocol Violation|1
4553037|NCT01225731|7381957|FG004|Part 1|Protocol Violation|0
4553038|NCT01225731|7381958|FG005|Part 1|Protocol Violation|0
4553039|NCT01225731|7381959|FG006|Part 1|Protocol Violation|0
4553040|NCT01225731|7381960|FG007|Part 1|Protocol Violation|0
4553041|NCT01225731|7381961|FG008|Part 1|Protocol Violation|0
4553042|NCT01225731|7381962|FG009|Part 1|Protocol Violation|0
4553043|NCT01225731|7381963|FG010|Part 1|Protocol Violation|0
4553044|NCT01225731|7381964|FG011|Part 1|Protocol Violation|0
4553045|NCT01225731|7381965|FG012|Part 1|Protocol Violation|0
4553046|NCT01225731|7381953|FG000|Part 2|Protocol Violation|0
4553047|NCT01225731|7381954|FG001|Part 2|Protocol Violation|0
4553048|NCT01225731|7381955|FG002|Part 2|Protocol Violation|0
4553049|NCT01225731|7381956|FG003|Part 2|Protocol Violation|0
4553050|NCT01225731|7381957|FG004|Part 2|Protocol Violation|0
4553051|NCT01225731|7381958|FG005|Part 2|Protocol Violation|1
4553052|NCT01225731|7381959|FG006|Part 2|Protocol Violation|0
4553053|NCT01225731|7381960|FG007|Part 2|Protocol Violation|0
4553054|NCT01225731|7381961|FG008|Part 2|Protocol Violation|1
4553055|NCT01225731|7381962|FG009|Part 2|Protocol Violation|0
4553056|NCT01225731|7381963|FG010|Part 2|Protocol Violation|0
4553057|NCT01225731|7381964|FG011|Part 2|Protocol Violation|0
4553058|NCT01225731|7381965|FG012|Part 2|Protocol Violation|0
4553059|NCT01225731|7381953|FG000|Part 2|Adverse Event|0
4553060|NCT01225731|7381954|FG001|Part 2|Adverse Event|0
4553061|NCT01225731|7381955|FG002|Part 2|Adverse Event|0
4553062|NCT01225731|7381956|FG003|Part 2|Adverse Event|0
4553063|NCT01225731|7381957|FG004|Part 2|Adverse Event|0
4553064|NCT01225731|7381958|FG005|Part 2|Adverse Event|0
4553065|NCT01225731|7381959|FG006|Part 2|Adverse Event|4
4553066|NCT01225731|7381960|FG007|Part 2|Adverse Event|4
4553067|NCT01225731|7381961|FG008|Part 2|Adverse Event|2
4553068|NCT01225731|7381962|FG009|Part 2|Adverse Event|0
4553069|NCT01225731|7381963|FG010|Part 2|Adverse Event|0
4553070|NCT01225731|7381964|FG011|Part 2|Adverse Event|0
4553071|NCT01225731|7381965|FG012|Part 2|Adverse Event|0
4553072|NCT01225731|7381953|FG000|Part 2|Lack of Efficacy|0
4553073|NCT01225731|7381954|FG001|Part 2|Lack of Efficacy|0
4553074|NCT01225731|7381955|FG002|Part 2|Lack of Efficacy|0
4553075|NCT01225731|7381956|FG003|Part 2|Lack of Efficacy|0
4553076|NCT01225731|7381957|FG004|Part 2|Lack of Efficacy|0
4553077|NCT01225731|7381958|FG005|Part 2|Lack of Efficacy|1
4553078|NCT01225731|7381959|FG006|Part 2|Lack of Efficacy|0
4553079|NCT01225731|7381960|FG007|Part 2|Lack of Efficacy|12
4553080|NCT01225731|7381961|FG008|Part 2|Lack of Efficacy|3
4553081|NCT01225731|7381962|FG009|Part 2|Lack of Efficacy|0
4553082|NCT01225731|7381963|FG010|Part 2|Lack of Efficacy|0
4553083|NCT01225731|7381964|FG011|Part 2|Lack of Efficacy|0
4553084|NCT01225731|7381965|FG012|Part 2|Lack of Efficacy|0
4553085|NCT01225731|7381953|FG000|Part 2|Pregnancy|0
4553086|NCT01225731|7381954|FG001|Part 2|Pregnancy|0
4553087|NCT01225731|7381955|FG002|Part 2|Pregnancy|0
4553088|NCT01225731|7381956|FG003|Part 2|Pregnancy|0
4553089|NCT01225731|7381957|FG004|Part 2|Pregnancy|0
4553090|NCT01225731|7381958|FG005|Part 2|Pregnancy|0
4553091|NCT01225731|7381959|FG006|Part 2|Pregnancy|1
4553092|NCT01225731|7381960|FG007|Part 2|Pregnancy|0
4553093|NCT01225731|7381961|FG008|Part 2|Pregnancy|1
4553094|NCT01225731|7381962|FG009|Part 2|Pregnancy|0
4553095|NCT01225731|7381963|FG010|Part 2|Pregnancy|0
4553096|NCT01225731|7381964|FG011|Part 2|Pregnancy|0
4553097|NCT01225731|7381965|FG012|Part 2|Pregnancy|0
4553098|NCT01225731|7381953|FG000|Part 2|Lost to Follow-up|0
4553099|NCT01225731|7381954|FG001|Part 2|Lost to Follow-up|0
4553100|NCT01225731|7381955|FG002|Part 2|Lost to Follow-up|0
4553101|NCT01225731|7381956|FG003|Part 2|Lost to Follow-up|0
4553102|NCT01225731|7381957|FG004|Part 2|Lost to Follow-up|0
4553103|NCT01225731|7381958|FG005|Part 2|Lost to Follow-up|0
4553104|NCT01225731|7381959|FG006|Part 2|Lost to Follow-up|0
4553105|NCT01225731|7381960|FG007|Part 2|Lost to Follow-up|3
4553106|NCT01225731|7381961|FG008|Part 2|Lost to Follow-up|1
4553107|NCT01225731|7381962|FG009|Part 2|Lost to Follow-up|0
4553108|NCT01225731|7381963|FG010|Part 2|Lost to Follow-up|0
4553109|NCT01225731|7381964|FG011|Part 2|Lost to Follow-up|0
4553110|NCT01225731|7381965|FG012|Part 2|Lost to Follow-up|0
4553111|NCT01225731|7381953|FG000|Part 2|Physician Decision|0
4553112|NCT01225731|7381954|FG001|Part 2|Physician Decision|0
4553113|NCT01225731|7381955|FG002|Part 2|Physician Decision|0
4553114|NCT01225731|7381956|FG003|Part 2|Physician Decision|0
4553115|NCT01225731|7381957|FG004|Part 2|Physician Decision|0
4553116|NCT01225731|7381958|FG005|Part 2|Physician Decision|0
4553117|NCT01225731|7381959|FG006|Part 2|Physician Decision|0
4553118|NCT01225731|7381960|FG007|Part 2|Physician Decision|2
4553119|NCT01225731|7381961|FG008|Part 2|Physician Decision|2
4553120|NCT01225731|7381962|FG009|Part 2|Physician Decision|0
4553121|NCT01225731|7381963|FG010|Part 2|Physician Decision|0
4553122|NCT01225731|7381964|FG011|Part 2|Physician Decision|0
4553123|NCT01225731|7381965|FG012|Part 2|Physician Decision|0
4553124|NCT01225731|7381953|FG000|Part 2|Withdrawal by Subject|0
4553125|NCT01225731|7381954|FG001|Part 2|Withdrawal by Subject|0
4553126|NCT01225731|7381955|FG002|Part 2|Withdrawal by Subject|0
4553127|NCT01225731|7381956|FG003|Part 2|Withdrawal by Subject|0
4553128|NCT01225731|7381957|FG004|Part 2|Withdrawal by Subject|0
4553129|NCT01225731|7381958|FG005|Part 2|Withdrawal by Subject|1
4553130|NCT01225731|7381959|FG006|Part 2|Withdrawal by Subject|3
4553131|NCT01225731|7381960|FG007|Part 2|Withdrawal by Subject|4
4553132|NCT01225731|7381961|FG008|Part 2|Withdrawal by Subject|1
4553133|NCT01225731|7381962|FG009|Part 2|Withdrawal by Subject|0
4553134|NCT01225731|7381963|FG010|Part 2|Withdrawal by Subject|0
4553135|NCT01225731|7381964|FG011|Part 2|Withdrawal by Subject|0
4553136|NCT01225731|7381965|FG012|Part 2|Withdrawal by Subject|0
4553137|NCT01225731|7381953|FG000|Part 3|Adverse Event|0
4553138|NCT01225731|7381954|FG001|Part 3|Adverse Event|0
4553139|NCT01225731|7381955|FG002|Part 3|Adverse Event|0
4553140|NCT01225731|7381956|FG003|Part 3|Adverse Event|0
4553141|NCT01225731|7381957|FG004|Part 3|Adverse Event|0
4553142|NCT01225731|7381958|FG005|Part 3|Adverse Event|0
4553143|NCT01225731|7381959|FG006|Part 3|Adverse Event|0
4553144|NCT01225731|7381960|FG007|Part 3|Adverse Event|0
4621264|NCT01791153|7483981|FG004|Part 2: Open-label Period|Death|0
4621265|NCT01791153|7483982|FG005|Part 2: Open-label Period|Death|1
4621266|NCT01791153|7483983|FG006|Part 2: Open-label Period|Death|1
4621267|NCT01791153|7483984|FG007|Part 2: Open-label Period|Death|1
4621268|NCT01791153|7483977|FG000|Part 2: Open-label Period|Lost to Follow-up|0
4621269|NCT01791153|7483978|FG001|Part 2: Open-label Period|Lost to Follow-up|0
4621270|NCT01791153|7483979|FG002|Part 2: Open-label Period|Lost to Follow-up|0
4621271|NCT01791153|7483980|FG003|Part 2: Open-label Period|Lost to Follow-up|0
4621272|NCT01791153|7483981|FG004|Part 2: Open-label Period|Lost to Follow-up|0
4621273|NCT01791153|7483982|FG005|Part 2: Open-label Period|Lost to Follow-up|0
4621274|NCT01791153|7483983|FG006|Part 2: Open-label Period|Lost to Follow-up|1
4553145|NCT01225731|7381961|FG008|Part 3|Adverse Event|0
4553146|NCT01225731|7381962|FG009|Part 3|Adverse Event|0
4553147|NCT01225731|7381963|FG010|Part 3|Adverse Event|1
4553148|NCT01225731|7381964|FG011|Part 3|Adverse Event|1
4553149|NCT01225731|7381965|FG012|Part 3|Adverse Event|0
4553150|NCT01225731|7381953|FG000|Part 3|Lost to Follow-up|0
4553151|NCT01225731|7381954|FG001|Part 3|Lost to Follow-up|0
4553152|NCT01225731|7381955|FG002|Part 3|Lost to Follow-up|0
4553153|NCT01225731|7381956|FG003|Part 3|Lost to Follow-up|0
4553154|NCT01225731|7381957|FG004|Part 3|Lost to Follow-up|0
4553155|NCT01225731|7381958|FG005|Part 3|Lost to Follow-up|0
4553156|NCT01225731|7381959|FG006|Part 3|Lost to Follow-up|0
4553157|NCT01225731|7381960|FG007|Part 3|Lost to Follow-up|0
4553158|NCT01225731|7381961|FG008|Part 3|Lost to Follow-up|0
4553159|NCT01225731|7381962|FG009|Part 3|Lost to Follow-up|0
4553160|NCT01225731|7381963|FG010|Part 3|Lost to Follow-up|1
4553161|NCT01225731|7381964|FG011|Part 3|Lost to Follow-up|2
4553162|NCT01225731|7381965|FG012|Part 3|Lost to Follow-up|1
4553163|NCT01225731|7381953|FG000|Part 3|Physician Decision|0
4553164|NCT01225731|7381954|FG001|Part 3|Physician Decision|0
4553165|NCT01225731|7381955|FG002|Part 3|Physician Decision|0
4553166|NCT01225731|7381956|FG003|Part 3|Physician Decision|0
4553167|NCT01225731|7381957|FG004|Part 3|Physician Decision|0
4553168|NCT01225731|7381958|FG005|Part 3|Physician Decision|0
4621275|NCT01791153|7483984|FG007|Part 2: Open-label Period|Lost to Follow-up|0
4621276|NCT01791153|7483977|FG000|Part 2: Open-label Period|Lack of Efficacy|0
4621277|NCT01791153|7483978|FG001|Part 2: Open-label Period|Lack of Efficacy|0
4621278|NCT01791153|7483979|FG002|Part 2: Open-label Period|Lack of Efficacy|0
4553169|NCT01225731|7381959|FG006|Part 3|Physician Decision|0
4553170|NCT01225731|7381960|FG007|Part 3|Physician Decision|0
4553171|NCT01225731|7381961|FG008|Part 3|Physician Decision|0
4553172|NCT01225731|7381962|FG009|Part 3|Physician Decision|0
4553173|NCT01225731|7381963|FG010|Part 3|Physician Decision|0
4553174|NCT01225731|7381964|FG011|Part 3|Physician Decision|1
4553175|NCT01225731|7381965|FG012|Part 3|Physician Decision|2
4553176|NCT01225731|7381953|FG000|Part 3|Withdrawal by Subject|0
4553177|NCT01225731|7381954|FG001|Part 3|Withdrawal by Subject|0
4553178|NCT01225731|7381955|FG002|Part 3|Withdrawal by Subject|0
4553179|NCT01225731|7381956|FG003|Part 3|Withdrawal by Subject|0
4553180|NCT01225731|7381957|FG004|Part 3|Withdrawal by Subject|0
4553181|NCT01225731|7381958|FG005|Part 3|Withdrawal by Subject|0
4553182|NCT01225731|7381959|FG006|Part 3|Withdrawal by Subject|0
4553183|NCT01225731|7381960|FG007|Part 3|Withdrawal by Subject|0
4553184|NCT01225731|7381961|FG008|Part 3|Withdrawal by Subject|0
4553185|NCT01225731|7381962|FG009|Part 3|Withdrawal by Subject|0
4553186|NCT01225731|7381963|FG010|Part 3|Withdrawal by Subject|4
4553187|NCT01225731|7381964|FG011|Part 3|Withdrawal by Subject|6
4553188|NCT01225731|7381965|FG012|Part 3|Withdrawal by Subject|4
4553189|NCT01225822|7381999|FG000|Overall Study|Adverse Event|13
4621279|NCT01791153|7483980|FG003|Part 2: Open-label Period|Lack of Efficacy|0
4621280|NCT01791153|7483981|FG004|Part 2: Open-label Period|Lack of Efficacy|0
4621281|NCT01791153|7483982|FG005|Part 2: Open-label Period|Lack of Efficacy|0
4621282|NCT01791153|7483983|FG006|Part 2: Open-label Period|Lack of Efficacy|0
4621283|NCT01791153|7483984|FG007|Part 2: Open-label Period|Lack of Efficacy|1
4621284|NCT01791153|7483977|FG000|Part 2: Open-label Period|Withdrawal by Subject|0
4621285|NCT01791153|7483978|FG001|Part 2: Open-label Period|Withdrawal by Subject|0
4621286|NCT01791153|7483979|FG002|Part 2: Open-label Period|Withdrawal by Subject|0
4621287|NCT01791153|7483980|FG003|Part 2: Open-label Period|Withdrawal by Subject|0
4621288|NCT01791153|7483981|FG004|Part 2: Open-label Period|Withdrawal by Subject|1
4621289|NCT01791153|7483982|FG005|Part 2: Open-label Period|Withdrawal by Subject|1
4621290|NCT01791153|7483983|FG006|Part 2: Open-label Period|Withdrawal by Subject|3
4621291|NCT01791153|7483984|FG007|Part 2: Open-label Period|Withdrawal by Subject|2
4621292|NCT01791153|7483977|FG000|Part 2: Open-label Period|Physician Decision|0
4621293|NCT01791153|7483978|FG001|Part 2: Open-label Period|Physician Decision|0
4621294|NCT01791153|7483979|FG002|Part 2: Open-label Period|Physician Decision|0
4621295|NCT01791153|7483980|FG003|Part 2: Open-label Period|Physician Decision|0
4621296|NCT01791153|7483981|FG004|Part 2: Open-label Period|Physician Decision|1
4621297|NCT01791153|7483982|FG005|Part 2: Open-label Period|Physician Decision|1
4621298|NCT01791153|7483983|FG006|Part 2: Open-label Period|Physician Decision|0
4621299|NCT01791153|7483984|FG007|Part 2: Open-label Period|Physician Decision|0
4621300|NCT01791205|7484001|FG000|Phase II|Lack of Efficacy|6
4621301|NCT01791205|7484002|FG001|Phase II|Lack of Efficacy|0
4621302|NCT01791205|7484001|FG000|Phase II|Adverse Event|2
4621303|NCT01791205|7484002|FG001|Phase II|Adverse Event|0
4621304|NCT01791205|7484001|FG000|Phase II|Safety|1
4621305|NCT01791205|7484002|FG001|Phase II|Safety|0
4621306|NCT01791205|7484001|FG000|Phase II|Lost to Follow-up|1
4621307|NCT01791205|7484002|FG001|Phase II|Lost to Follow-up|0
4621308|NCT01791205|7484001|FG000|Phase II|Remission of disease|1
4621309|NCT01791205|7484002|FG001|Phase II|Remission of disease|0
4621310|NCT01791205|7484001|FG000|Phase II|Physician's decision|1
4621311|NCT01791205|7484002|FG001|Phase II|Physician's decision|0
4621312|NCT01791244|7484010|FG000|Overall Study|Adverse Event|5
4621313|NCT01791244|7484011|FG001|Overall Study|Adverse Event|7
4621314|NCT01791244|7484010|FG000|Overall Study|Insufficient clinical response|10
4621315|NCT01791244|7484011|FG001|Overall Study|Insufficient clinical response|10
4621316|NCT01791244|7484010|FG000|Overall Study|Laboratory Abnormality|0
4621317|NCT01791244|7484011|FG001|Overall Study|Laboratory Abnormality|1
4621318|NCT01791413|7484021|FG000|Overall Study|Lost to Follow-up|5
4621319|NCT01791413|7484022|FG001|Overall Study|Lost to Follow-up|1
4621320|NCT01791517|7484041|FG000|Phase I: Period 1|Withdrawal by Subject|0
4621321|NCT01791517|7484042|FG001|Phase I: Period 1|Withdrawal by Subject|1
4621322|NCT01791517|7484043|FG002|Phase I: Period 1|Withdrawal by Subject|1
4621323|NCT01791517|7484044|FG003|Phase I: Period 1|Withdrawal by Subject|0
4621324|NCT01791517|7484045|FG004|Phase I: Period 1|Withdrawal by Subject|1
4621325|NCT01791517|7484046|FG005|Phase I: Period 1|Withdrawal by Subject|1
4621326|NCT01791517|7484047|FG006|Phase I: Period 1|Withdrawal by Subject|0
4621327|NCT01791517|7484048|FG007|Phase I: Period 1|Withdrawal by Subject|0
4621328|NCT01791517|7484049|FG008|Phase I: Period 1|Withdrawal by Subject|0
4690653|NCT02563067|7600463|FG002|Overall Study|Subject/guardian decision|16
4553190|NCT01225822|7382000|FG001|Overall Study|Adverse Event|31
4553191|NCT01225822|7382001|FG002|Overall Study|Adverse Event|18
4553192|NCT01225822|7382002|FG003|Overall Study|Adverse Event|23
4553193|NCT01225822|7382003|FG004|Overall Study|Adverse Event|14
4553194|NCT01225822|7381999|FG000|Overall Study|Protocol Violation|6
4621329|NCT01791517|7484050|FG009|Phase I: Period 1|Withdrawal by Subject|0
4621330|NCT01791517|7484051|FG010|Phase I: Period 1|Withdrawal by Subject|0
4621331|NCT01791517|7484052|FG011|Phase I: Period 1|Withdrawal by Subject|0
4621332|NCT01791517|7484041|FG000|Phase I: Period 1|Adverse Event|0
4621333|NCT01791517|7484042|FG001|Phase I: Period 1|Adverse Event|0
4621334|NCT01791517|7484043|FG002|Phase I: Period 1|Adverse Event|1
4621335|NCT01791517|7484044|FG003|Phase I: Period 1|Adverse Event|1
4621336|NCT01791517|7484045|FG004|Phase I: Period 1|Adverse Event|0
4621337|NCT01791517|7484046|FG005|Phase I: Period 1|Adverse Event|0
4621338|NCT01791517|7484047|FG006|Phase I: Period 1|Adverse Event|0
4621339|NCT01791517|7484048|FG007|Phase I: Period 1|Adverse Event|0
4621340|NCT01791517|7484049|FG008|Phase I: Period 1|Adverse Event|0
4621341|NCT01791517|7484050|FG009|Phase I: Period 1|Adverse Event|0
4621342|NCT01791517|7484051|FG010|Phase I: Period 1|Adverse Event|0
4621343|NCT01791517|7484052|FG011|Phase I: Period 1|Adverse Event|0
4621344|NCT01791517|7484041|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1
4621345|NCT01791517|7484042|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0
4621346|NCT01791517|7484043|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0
4621347|NCT01791517|7484044|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0
4621348|NCT01791517|7484045|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0
4621349|NCT01791517|7484046|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0
4621350|NCT01791517|7484047|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0
4621351|NCT01791517|7484048|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0
4621352|NCT01791517|7484049|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0
4621353|NCT01791517|7484050|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0
4621354|NCT01791517|7484051|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0
4621355|NCT01791517|7484052|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0
4621356|NCT01791517|7484041|FG000|Phase I: Period 1|Protocol Violation|0
4621357|NCT01791517|7484042|FG001|Phase I: Period 1|Protocol Violation|1
4621358|NCT01791517|7484043|FG002|Phase I: Period 1|Protocol Violation|0
4621359|NCT01791517|7484044|FG003|Phase I: Period 1|Protocol Violation|0
4621360|NCT01791517|7484045|FG004|Phase I: Period 1|Protocol Violation|0
4621361|NCT01791517|7484046|FG005|Phase I: Period 1|Protocol Violation|0
4621362|NCT01791517|7484047|FG006|Phase I: Period 1|Protocol Violation|0
4621363|NCT01791517|7484048|FG007|Phase I: Period 1|Protocol Violation|0
4621364|NCT01791517|7484049|FG008|Phase I: Period 1|Protocol Violation|0
4621365|NCT01791517|7484050|FG009|Phase I: Period 1|Protocol Violation|0
4621366|NCT01791517|7484051|FG010|Phase I: Period 1|Protocol Violation|0
4621367|NCT01791517|7484052|FG011|Phase I: Period 1|Protocol Violation|0
4621368|NCT01791517|7484041|FG000|Phase I: Period 1|Lost to Follow-up|0
4621369|NCT01791517|7484042|FG001|Phase I: Period 1|Lost to Follow-up|0
4621370|NCT01791517|7484043|FG002|Phase I: Period 1|Lost to Follow-up|0
4621371|NCT01791517|7484044|FG003|Phase I: Period 1|Lost to Follow-up|1
4621372|NCT01791517|7484045|FG004|Phase I: Period 1|Lost to Follow-up|0
4621373|NCT01791517|7484046|FG005|Phase I: Period 1|Lost to Follow-up|0
4621374|NCT01791517|7484047|FG006|Phase I: Period 1|Lost to Follow-up|1
4621375|NCT01791517|7484048|FG007|Phase I: Period 1|Lost to Follow-up|0
4621376|NCT01791517|7484049|FG008|Phase I: Period 1|Lost to Follow-up|1
4621377|NCT01791517|7484050|FG009|Phase I: Period 1|Lost to Follow-up|1
4621378|NCT01791517|7484051|FG010|Phase I: Period 1|Lost to Follow-up|0
4621379|NCT01791517|7484052|FG011|Phase I: Period 1|Lost to Follow-up|0
4621380|NCT01791517|7484041|FG000|Phase I: Period 1|Lens Handling DIfficulties|0
4621381|NCT01791517|7484042|FG001|Phase I: Period 1|Lens Handling DIfficulties|0
4621382|NCT01791517|7484043|FG002|Phase I: Period 1|Lens Handling DIfficulties|0
4621383|NCT01791517|7484044|FG003|Phase I: Period 1|Lens Handling DIfficulties|0
4621384|NCT01791517|7484045|FG004|Phase I: Period 1|Lens Handling DIfficulties|0
4621385|NCT01791517|7484046|FG005|Phase I: Period 1|Lens Handling DIfficulties|0
4621386|NCT01791517|7484047|FG006|Phase I: Period 1|Lens Handling DIfficulties|0
4621387|NCT01791517|7484048|FG007|Phase I: Period 1|Lens Handling DIfficulties|0
4621388|NCT01791517|7484049|FG008|Phase I: Period 1|Lens Handling DIfficulties|0
4621389|NCT01791517|7484050|FG009|Phase I: Period 1|Lens Handling DIfficulties|0
4621390|NCT01791517|7484051|FG010|Phase I: Period 1|Lens Handling DIfficulties|0
4621391|NCT01791517|7484052|FG011|Phase I: Period 1|Lens Handling DIfficulties|1
4621392|NCT01791517|7484041|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1
4621393|NCT01791517|7484042|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0
4621394|NCT01791517|7484043|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0
4621395|NCT01791517|7484044|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0
4621396|NCT01791517|7484045|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0
4621397|NCT01791517|7484046|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0
4621398|NCT01791517|7484047|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0
4621399|NCT01791517|7484048|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0
4621400|NCT01791517|7484049|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0
4621401|NCT01791517|7484050|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0
4621402|NCT01791517|7484051|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0
4621403|NCT01791517|7484052|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0
4621404|NCT01791517|7484041|FG000|Phase I: Period 2|Protocol Violation|0
4621405|NCT01791517|7484042|FG001|Phase I: Period 2|Protocol Violation|0
4621406|NCT01791517|7484043|FG002|Phase I: Period 2|Protocol Violation|0
4621407|NCT01791517|7484044|FG003|Phase I: Period 2|Protocol Violation|1
4621408|NCT01791517|7484045|FG004|Phase I: Period 2|Protocol Violation|0
4621409|NCT01791517|7484046|FG005|Phase I: Period 2|Protocol Violation|0
4621410|NCT01791517|7484047|FG006|Phase I: Period 2|Protocol Violation|0
4621411|NCT01791517|7484048|FG007|Phase I: Period 2|Protocol Violation|0
4621412|NCT01791517|7484049|FG008|Phase I: Period 2|Protocol Violation|0
4553195|NCT01225822|7382000|FG001|Overall Study|Protocol Violation|8
4553196|NCT01225822|7382001|FG002|Overall Study|Protocol Violation|6
4553197|NCT01225822|7382002|FG003|Overall Study|Protocol Violation|7
4553198|NCT01225822|7382003|FG004|Overall Study|Protocol Violation|4
4553199|NCT01225822|7381999|FG000|Overall Study|Lost to Follow-up|0
4553200|NCT01225822|7382000|FG001|Overall Study|Lost to Follow-up|0
4553201|NCT01225822|7382001|FG002|Overall Study|Lost to Follow-up|0
4553202|NCT01225822|7382002|FG003|Overall Study|Lost to Follow-up|1
4553203|NCT01225822|7382003|FG004|Overall Study|Lost to Follow-up|0
4553204|NCT01225822|7381999|FG000|Overall Study|Withdrawal by Subject|6
4553205|NCT01225822|7382000|FG001|Overall Study|Withdrawal by Subject|7
4553206|NCT01225822|7382001|FG002|Overall Study|Withdrawal by Subject|7
4553207|NCT01225822|7382002|FG003|Overall Study|Withdrawal by Subject|11
4553208|NCT01225822|7382003|FG004|Overall Study|Withdrawal by Subject|6
4553209|NCT01225822|7381999|FG000|Overall Study|Other|13
4553210|NCT01225822|7382000|FG001|Overall Study|Other|10
4553211|NCT01225822|7382001|FG002|Overall Study|Other|7
4553212|NCT01225822|7382002|FG003|Overall Study|Other|10
4553213|NCT01225822|7382003|FG004|Overall Study|Other|7
4553214|NCT01225835|7382020|FG000|Overall Study|Completed protocol|2
4553215|NCT01225835|7382021|FG001|Overall Study|Completed protocol|1
4553216|NCT01225835|7382020|FG000|Overall Study|Did not meet hCG criterion|2
4553217|NCT01225835|7382021|FG001|Overall Study|Did not meet hCG criterion|0
4553218|NCT01225835|7382020|FG000|Overall Study|Adverse Event|2
4553219|NCT01225835|7382021|FG001|Overall Study|Adverse Event|1
4553220|NCT01225835|7382020|FG000|Overall Study|Other|1
4553221|NCT01225835|7382021|FG001|Overall Study|Other|1
4553222|NCT01225887|7382033|FG000|Overall Study|Ineligible:required test not done|2
4553223|NCT01225887|7382033|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1
4553224|NCT01225887|7382033|FG000|Overall Study|Ineligible:inadequate pathology|2
4553225|NCT01225952|7382049|FG000|Overall Study|Lost to Follow-up|1
4553226|NCT01225952|7382050|FG001|Overall Study|Lost to Follow-up|0
4621413|NCT01791517|7484050|FG009|Phase I: Period 2|Protocol Violation|0
4621414|NCT01791517|7484051|FG010|Phase I: Period 2|Protocol Violation|0
4621415|NCT01791517|7484052|FG011|Phase I: Period 2|Protocol Violation|0
4621416|NCT01791517|7484041|FG000|Phase I: Period 2|Withdrawal by Subject|0
4621417|NCT01791517|7484042|FG001|Phase I: Period 2|Withdrawal by Subject|0
4621418|NCT01791517|7484043|FG002|Phase I: Period 2|Withdrawal by Subject|0
4621419|NCT01791517|7484044|FG003|Phase I: Period 2|Withdrawal by Subject|0
4621420|NCT01791517|7484045|FG004|Phase I: Period 2|Withdrawal by Subject|0
4621421|NCT01791517|7484046|FG005|Phase I: Period 2|Withdrawal by Subject|0
4621422|NCT01791517|7484047|FG006|Phase I: Period 2|Withdrawal by Subject|0
4621423|NCT01791517|7484048|FG007|Phase I: Period 2|Withdrawal by Subject|0
4621424|NCT01791517|7484049|FG008|Phase I: Period 2|Withdrawal by Subject|0
4621425|NCT01791517|7484050|FG009|Phase I: Period 2|Withdrawal by Subject|1
4621426|NCT01791517|7484051|FG010|Phase I: Period 2|Withdrawal by Subject|1
4621427|NCT01791517|7484052|FG011|Phase I: Period 2|Withdrawal by Subject|0
4621428|NCT01791517|7484041|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0
4621429|NCT01791517|7484042|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0
4621430|NCT01791517|7484043|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0
4621431|NCT01791517|7484044|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0
4621432|NCT01791517|7484045|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0
4621433|NCT01791517|7484046|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0
4621434|NCT01791517|7484047|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0
4621435|NCT01791517|7484048|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0
4621436|NCT01791517|7484049|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0
4621437|NCT01791517|7484050|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0
4621438|NCT01791517|7484051|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1
4621439|NCT01791517|7484052|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0
4621440|NCT01791517|7484041|FG000|Phase I: Period 2|Lens Discomfort|0
4621441|NCT01791517|7484042|FG001|Phase I: Period 2|Lens Discomfort|0
4621442|NCT01791517|7484043|FG002|Phase I: Period 2|Lens Discomfort|0
4621443|NCT01791517|7484044|FG003|Phase I: Period 2|Lens Discomfort|0
4621444|NCT01791517|7484045|FG004|Phase I: Period 2|Lens Discomfort|0
4621445|NCT01791517|7484046|FG005|Phase I: Period 2|Lens Discomfort|1
4621446|NCT01791517|7484047|FG006|Phase I: Period 2|Lens Discomfort|0
4621447|NCT01791517|7484048|FG007|Phase I: Period 2|Lens Discomfort|0
4621448|NCT01791517|7484049|FG008|Phase I: Period 2|Lens Discomfort|0
4621449|NCT01791517|7484050|FG009|Phase I: Period 2|Lens Discomfort|0
4621450|NCT01791517|7484051|FG010|Phase I: Period 2|Lens Discomfort|0
4621451|NCT01791517|7484052|FG011|Phase I: Period 2|Lens Discomfort|0
4621452|NCT01791517|7484041|FG000|Phase I: Period 2|Lost to Follow-up|0
4621453|NCT01791517|7484042|FG001|Phase I: Period 2|Lost to Follow-up|3
4621454|NCT01791517|7484043|FG002|Phase I: Period 2|Lost to Follow-up|2
4553227|NCT01225952|7382051|FG002|Overall Study|Lost to Follow-up|0
4553228|NCT01225952|7382049|FG000|Overall Study|Study Eye Explanted|0
4553229|NCT01225952|7382050|FG001|Overall Study|Study Eye Explanted|0
4553230|NCT01225952|7382051|FG002|Overall Study|Study Eye Explanted|1
4553231|NCT01225952|7382049|FG000|Overall Study|Withdrawal by Subject|4
4553232|NCT01225952|7382050|FG001|Overall Study|Withdrawal by Subject|4
4553233|NCT01225952|7382051|FG002|Overall Study|Withdrawal by Subject|5
4621455|NCT01791517|7484044|FG003|Phase I: Period 2|Lost to Follow-up|0
4621456|NCT01791517|7484045|FG004|Phase I: Period 2|Lost to Follow-up|0
4553234|NCT01225952|7382049|FG000|Overall Study|Surgical complications|1
4553235|NCT01225952|7382050|FG001|Overall Study|Surgical complications|0
4553236|NCT01225952|7382051|FG002|Overall Study|Surgical complications|0
4553237|NCT01225991|7382059|FG000|Overall Study|Withdrawal by Subject|6
4553238|NCT01226043|7382065|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1
4553239|NCT01226043|7382066|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2
4553240|NCT01226043|7382067|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0
4553241|NCT01226043|7382068|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0
4553242|NCT01226043|7382065|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0
4553243|NCT01226043|7382066|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1
4553244|NCT01226043|7382067|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0
4553245|NCT01226043|7382068|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0
4553246|NCT01226043|7382065|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2
4553247|NCT01226043|7382066|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
4553248|NCT01226043|7382067|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
4553249|NCT01226043|7382068|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
4553250|NCT01226043|7382065|FG000|4-week Crossover Phase - Period 1|Physician Decision|0
4553251|NCT01226043|7382066|FG001|4-week Crossover Phase - Period 1|Physician Decision|6
4553252|NCT01226043|7382067|FG002|4-week Crossover Phase - Period 1|Physician Decision|0
4553253|NCT01226043|7382068|FG003|4-week Crossover Phase - Period 1|Physician Decision|0
4553254|NCT01226043|7382065|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
4553255|NCT01226043|7382066|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1
4553256|NCT01226043|7382067|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
4553257|NCT01226043|7382068|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
4553258|NCT01226043|7382065|FG000|4-week Crossover Phase - Period 2|Physician Decision|4
4553259|NCT01226043|7382066|FG001|4-week Crossover Phase - Period 2|Physician Decision|5
4553260|NCT01226043|7382067|FG002|4-week Crossover Phase - Period 2|Physician Decision|0
4553261|NCT01226043|7382068|FG003|4-week Crossover Phase - Period 2|Physician Decision|0
4553262|NCT01226043|7382065|FG000|6-week Re-randomization Phase|Adverse Event|0
4553263|NCT01226043|7382066|FG001|6-week Re-randomization Phase|Adverse Event|0
4553264|NCT01226043|7382067|FG002|6-week Re-randomization Phase|Adverse Event|1
4553265|NCT01226043|7382068|FG003|6-week Re-randomization Phase|Adverse Event|1
4553266|NCT01226043|7382065|FG000|6-week Re-randomization Phase|Protocol Violation|0
4553267|NCT01226043|7382066|FG001|6-week Re-randomization Phase|Protocol Violation|0
4553268|NCT01226043|7382067|FG002|6-week Re-randomization Phase|Protocol Violation|1
4621457|NCT01791517|7484046|FG005|Phase I: Period 2|Lost to Follow-up|0
4621458|NCT01791517|7484047|FG006|Phase I: Period 2|Lost to Follow-up|0
4621459|NCT01791517|7484048|FG007|Phase I: Period 2|Lost to Follow-up|0
4621460|NCT01791517|7484049|FG008|Phase I: Period 2|Lost to Follow-up|0
4621461|NCT01791517|7484050|FG009|Phase I: Period 2|Lost to Follow-up|0
4621462|NCT01791517|7484051|FG010|Phase I: Period 2|Lost to Follow-up|0
4621463|NCT01791517|7484052|FG011|Phase I: Period 2|Lost to Follow-up|0
4621464|NCT01791517|7484041|FG000|Phase I: Period 3|Lens Discomfort|0
4621465|NCT01791517|7484042|FG001|Phase I: Period 3|Lens Discomfort|0
4621466|NCT01791517|7484043|FG002|Phase I: Period 3|Lens Discomfort|0
4621467|NCT01791517|7484044|FG003|Phase I: Period 3|Lens Discomfort|0
4621468|NCT01791517|7484045|FG004|Phase I: Period 3|Lens Discomfort|0
4621469|NCT01791517|7484046|FG005|Phase I: Period 3|Lens Discomfort|0
4621470|NCT01791517|7484047|FG006|Phase I: Period 3|Lens Discomfort|0
4621471|NCT01791517|7484048|FG007|Phase I: Period 3|Lens Discomfort|0
4621472|NCT01791517|7484049|FG008|Phase I: Period 3|Lens Discomfort|0
4621473|NCT01791517|7484050|FG009|Phase I: Period 3|Lens Discomfort|0
4621474|NCT01791517|7484051|FG010|Phase I: Period 3|Lens Discomfort|0
4621475|NCT01791517|7484052|FG011|Phase I: Period 3|Lens Discomfort|1
4621476|NCT01791517|7484041|FG000|Phase I: Period 3|Lost to Follow-up|0
4621477|NCT01791517|7484042|FG001|Phase I: Period 3|Lost to Follow-up|1
4621478|NCT01791517|7484043|FG002|Phase I: Period 3|Lost to Follow-up|0
4621479|NCT01791517|7484044|FG003|Phase I: Period 3|Lost to Follow-up|0
4621480|NCT01791517|7484045|FG004|Phase I: Period 3|Lost to Follow-up|1
4621481|NCT01791517|7484046|FG005|Phase I: Period 3|Lost to Follow-up|0
4621482|NCT01791517|7484047|FG006|Phase I: Period 3|Lost to Follow-up|0
4621483|NCT01791517|7484048|FG007|Phase I: Period 3|Lost to Follow-up|0
4621484|NCT01791517|7484049|FG008|Phase I: Period 3|Lost to Follow-up|0
4621485|NCT01791517|7484050|FG009|Phase I: Period 3|Lost to Follow-up|0
4621486|NCT01791517|7484051|FG010|Phase I: Period 3|Lost to Follow-up|0
4621487|NCT01791517|7484052|FG011|Phase I: Period 3|Lost to Follow-up|0
4621488|NCT01791517|7484041|FG000|Phase I: Period 3|Adverse Event|0
4621489|NCT01791517|7484042|FG001|Phase I: Period 3|Adverse Event|0
4621490|NCT01791517|7484043|FG002|Phase I: Period 3|Adverse Event|0
4621491|NCT01791517|7484044|FG003|Phase I: Period 3|Adverse Event|1
4621492|NCT01791517|7484045|FG004|Phase I: Period 3|Adverse Event|0
4621493|NCT01791517|7484046|FG005|Phase I: Period 3|Adverse Event|0
4621494|NCT01791517|7484047|FG006|Phase I: Period 3|Adverse Event|0
4621495|NCT01791517|7484048|FG007|Phase I: Period 3|Adverse Event|0
4621496|NCT01791517|7484049|FG008|Phase I: Period 3|Adverse Event|0
4621497|NCT01791517|7484050|FG009|Phase I: Period 3|Adverse Event|0
4621498|NCT01791517|7484051|FG010|Phase I: Period 3|Adverse Event|0
4621499|NCT01791517|7484052|FG011|Phase I: Period 3|Adverse Event|0
4553269|NCT01226043|7382068|FG003|6-week Re-randomization Phase|Protocol Violation|1
4553270|NCT01226043|7382065|FG000|6-week Re-randomization Phase|Lost to Follow-up|0
4553271|NCT01226043|7382066|FG001|6-week Re-randomization Phase|Lost to Follow-up|0
4553272|NCT01226043|7382067|FG002|6-week Re-randomization Phase|Lost to Follow-up|1
4553273|NCT01226043|7382068|FG003|6-week Re-randomization Phase|Lost to Follow-up|3
4553274|NCT01226043|7382065|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0
4553275|NCT01226043|7382066|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0
4553276|NCT01226043|7382067|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1
4553277|NCT01226043|7382068|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3
4553278|NCT01226043|7382065|FG000|6-week Re-randomization Phase|Physician Decision|0
4553279|NCT01226043|7382066|FG001|6-week Re-randomization Phase|Physician Decision|0
4553280|NCT01226043|7382067|FG002|6-week Re-randomization Phase|Physician Decision|3
4553281|NCT01226043|7382068|FG003|6-week Re-randomization Phase|Physician Decision|2
4553282|NCT01226043|7382065|FG000|6-week Re-randomization Phase|completed in error|0
4553283|NCT01226043|7382066|FG001|6-week Re-randomization Phase|completed in error|0
4553284|NCT01226043|7382067|FG002|6-week Re-randomization Phase|completed in error|0
4553285|NCT01226043|7382068|FG003|6-week Re-randomization Phase|completed in error|1
4553286|NCT01226043|7382065|FG000|30-week Observational Phase|Adverse Event|0
4553287|NCT01226043|7382066|FG001|30-week Observational Phase|Adverse Event|0
4553288|NCT01226043|7382067|FG002|30-week Observational Phase|Adverse Event|1
4553289|NCT01226043|7382068|FG003|30-week Observational Phase|Adverse Event|1
4553290|NCT01226043|7382065|FG000|30-week Observational Phase|Protocol Violation|0
4553291|NCT01226043|7382066|FG001|30-week Observational Phase|Protocol Violation|0
4553292|NCT01226043|7382067|FG002|30-week Observational Phase|Protocol Violation|0
4553293|NCT01226043|7382068|FG003|30-week Observational Phase|Protocol Violation|1
4553294|NCT01226043|7382065|FG000|30-week Observational Phase|Lost to Follow-up|0
4553295|NCT01226043|7382066|FG001|30-week Observational Phase|Lost to Follow-up|0
4553296|NCT01226043|7382067|FG002|30-week Observational Phase|Lost to Follow-up|2
4553297|NCT01226043|7382068|FG003|30-week Observational Phase|Lost to Follow-up|2
4553298|NCT01226043|7382065|FG000|30-week Observational Phase|Withdrawal by Subject|0
4553299|NCT01226043|7382066|FG001|30-week Observational Phase|Withdrawal by Subject|0
4553300|NCT01226043|7382067|FG002|30-week Observational Phase|Withdrawal by Subject|1
4553301|NCT01226043|7382068|FG003|30-week Observational Phase|Withdrawal by Subject|7
4553302|NCT01226043|7382065|FG000|30-week Observational Phase|Physician Decision|0
4553303|NCT01226043|7382066|FG001|30-week Observational Phase|Physician Decision|0
4553304|NCT01226043|7382067|FG002|30-week Observational Phase|Physician Decision|2
4553305|NCT01226043|7382068|FG003|30-week Observational Phase|Physician Decision|2
4553306|NCT01226095|7382098|FG000|Overall Study|Poor compliance|1
4553307|NCT01226121|7382112|FG000|Overall Study|Lost to Follow-up|2
4553308|NCT01226121|7382113|FG001|Overall Study|Lost to Follow-up|0
4553309|NCT01226121|7382114|FG002|Overall Study|Lost to Follow-up|1
4553310|NCT01226459|7382128|FG000|Overall Study|Adverse Event|2
4553311|NCT01226459|7382129|FG001|Overall Study|Adverse Event|8
4553312|NCT01226459|7382128|FG000|Overall Study|Protocol Violation|4
4553313|NCT01226459|7382129|FG001|Overall Study|Protocol Violation|3
4553314|NCT01226459|7382128|FG000|Overall Study|Withdrawal by Subject|10
4553315|NCT01226459|7382129|FG001|Overall Study|Withdrawal by Subject|13
4553316|NCT01226459|7382128|FG000|Overall Study|Lost to Follow-up|4
4553317|NCT01226459|7382129|FG001|Overall Study|Lost to Follow-up|8
4553318|NCT01226459|7382128|FG000|Overall Study|Pregnancy|1
4553319|NCT01226459|7382129|FG001|Overall Study|Pregnancy|0
4553320|NCT01226472|7382135|FG000|Overall Study|Progressive Disease|1
4553321|NCT01226511|7382178|FG000|Acute Treatment Period|Adverse Event|7
4553322|NCT01226511|7382179|FG001|Acute Treatment Period|Adverse Event|6
4553323|NCT01226511|7382178|FG000|Acute Treatment Period|Lack of Efficacy|2
4553324|NCT01226511|7382179|FG001|Acute Treatment Period|Lack of Efficacy|1
4553325|NCT01226511|7382178|FG000|Acute Treatment Period|Lost to Follow-up|3
4553326|NCT01226511|7382179|FG001|Acute Treatment Period|Lost to Follow-up|6
4553327|NCT01226511|7382178|FG000|Acute Treatment Period|Parent/caregiver decision|5
4553328|NCT01226511|7382179|FG001|Acute Treatment Period|Parent/caregiver decision|7
4553329|NCT01226511|7382178|FG000|Acute Treatment Period|Protocol Violation|5
4553330|NCT01226511|7382179|FG001|Acute Treatment Period|Protocol Violation|5
4553331|NCT01226511|7382178|FG000|Acute Treatment Period|Withdrawal by Subject|10
4553332|NCT01226511|7382179|FG001|Acute Treatment Period|Withdrawal by Subject|6
4553333|NCT01226511|7382178|FG000|Extension Treatment Period|Adverse Event|8
4553334|NCT01226511|7382179|FG001|Extension Treatment Period|Adverse Event|8
4553335|NCT01226511|7382178|FG000|Extension Treatment Period|Lack of Efficacy|3
4553336|NCT01226511|7382179|FG001|Extension Treatment Period|Lack of Efficacy|2
4553337|NCT01226511|7382178|FG000|Extension Treatment Period|Lost to Follow-up|4
4553338|NCT01226511|7382179|FG001|Extension Treatment Period|Lost to Follow-up|3
4553339|NCT01226511|7382178|FG000|Extension Treatment Period|Protocol Violation|2
4553340|NCT01226511|7382179|FG001|Extension Treatment Period|Protocol Violation|2
4553341|NCT01226511|7382178|FG000|Extension Treatment Period|Withdrawal by Subject|1
4553342|NCT01226511|7382179|FG001|Extension Treatment Period|Withdrawal by Subject|3
4553343|NCT01226511|7382178|FG000|Extension Treatment Period|Parent/Caregiver Decision|8
4553344|NCT01226511|7382179|FG001|Extension Treatment Period|Parent/Caregiver Decision|8
4553345|NCT01226511|7382178|FG000|Extension Treatment Period|Sponsor Decision|1
4553346|NCT01226511|7382179|FG001|Extension Treatment Period|Sponsor Decision|1
4553347|NCT01226511|7382178|FG000|Taper Period|Adverse Event|1
4553348|NCT01226511|7382179|FG001|Taper Period|Adverse Event|0
4553349|NCT01226511|7382178|FG000|Taper Period|Lost to Follow-up|2
4553350|NCT01226511|7382179|FG001|Taper Period|Lost to Follow-up|2
4553351|NCT01226511|7382178|FG000|Taper Period|Protocol Violation|1
4553352|NCT01226511|7382179|FG001|Taper Period|Protocol Violation|0
4553353|NCT01226511|7382178|FG000|Taper Period|Parent/Caregiver Decision|1
4553354|NCT01226511|7382179|FG001|Taper Period|Parent/Caregiver Decision|1
4553355|NCT01226745|7382212|FG000|Overall Study|Did not complete schedule of assessments|8
4553356|NCT01226745|7382213|FG001|Overall Study|Did not complete schedule of assessments|3
4553357|NCT01226745|7382214|FG002|Overall Study|Did not complete schedule of assessments|6
4553358|NCT01226745|7382215|FG003|Overall Study|Did not complete schedule of assessments|0
4553359|NCT01226745|7382216|FG004|Overall Study|Did not complete schedule of assessments|0
4553360|NCT01226745|7382217|FG005|Overall Study|Did not complete schedule of assessments|1
4553361|NCT01226745|7382212|FG000|Overall Study|Lost to Follow-up|2
4553362|NCT01226745|7382213|FG001|Overall Study|Lost to Follow-up|6
4553363|NCT01226745|7382214|FG002|Overall Study|Lost to Follow-up|6
4553364|NCT01226745|7382215|FG003|Overall Study|Lost to Follow-up|1
4553365|NCT01226745|7382216|FG004|Overall Study|Lost to Follow-up|1
4553366|NCT01226745|7382217|FG005|Overall Study|Lost to Follow-up|2
4553367|NCT01226745|7382212|FG000|Overall Study|Death|1
4553368|NCT01226745|7382213|FG001|Overall Study|Death|0
4553369|NCT01226745|7382214|FG002|Overall Study|Death|0
4553370|NCT01226745|7382215|FG003|Overall Study|Death|0
4553371|NCT01226745|7382216|FG004|Overall Study|Death|0
4621500|NCT01791517|7484041|FG000|Phase II|Lost to Follow-up|1
4621501|NCT01791517|7484042|FG001|Phase II|Lost to Follow-up|0
4621502|NCT01791517|7484043|FG002|Phase II|Lost to Follow-up|1
4621503|NCT01791517|7484044|FG003|Phase II|Lost to Follow-up|0
4621504|NCT01791517|7484045|FG004|Phase II|Lost to Follow-up|1
4621505|NCT01791517|7484046|FG005|Phase II|Lost to Follow-up|2
4621506|NCT01791517|7484047|FG006|Phase II|Lost to Follow-up|0
4621507|NCT01791517|7484048|FG007|Phase II|Lost to Follow-up|1
4621508|NCT01791517|7484049|FG008|Phase II|Lost to Follow-up|1
4621509|NCT01791517|7484050|FG009|Phase II|Lost to Follow-up|1
4621510|NCT01791517|7484051|FG010|Phase II|Lost to Follow-up|0
4621511|NCT01791517|7484052|FG011|Phase II|Lost to Follow-up|0
4621512|NCT01791517|7484041|FG000|Phase II|Withdrawal by Subject|1
4621513|NCT01791517|7484042|FG001|Phase II|Withdrawal by Subject|0
4621514|NCT01791517|7484043|FG002|Phase II|Withdrawal by Subject|0
4621515|NCT01791517|7484044|FG003|Phase II|Withdrawal by Subject|0
4621516|NCT01791517|7484045|FG004|Phase II|Withdrawal by Subject|0
4621517|NCT01791517|7484046|FG005|Phase II|Withdrawal by Subject|2
4621518|NCT01791517|7484047|FG006|Phase II|Withdrawal by Subject|0
4621519|NCT01791517|7484048|FG007|Phase II|Withdrawal by Subject|1
4621520|NCT01791517|7484049|FG008|Phase II|Withdrawal by Subject|0
4621521|NCT01791517|7484050|FG009|Phase II|Withdrawal by Subject|0
4621522|NCT01791517|7484051|FG010|Phase II|Withdrawal by Subject|1
4621523|NCT01791517|7484052|FG011|Phase II|Withdrawal by Subject|0
4621524|NCT01791517|7484041|FG000|Phase II|Lack of Efficacy|0
4621525|NCT01791517|7484042|FG001|Phase II|Lack of Efficacy|0
4621526|NCT01791517|7484043|FG002|Phase II|Lack of Efficacy|0
4621527|NCT01791517|7484044|FG003|Phase II|Lack of Efficacy|0
4621528|NCT01791517|7484045|FG004|Phase II|Lack of Efficacy|1
4621529|NCT01791517|7484046|FG005|Phase II|Lack of Efficacy|0
4621530|NCT01791517|7484047|FG006|Phase II|Lack of Efficacy|0
4621531|NCT01791517|7484048|FG007|Phase II|Lack of Efficacy|0
4621532|NCT01791517|7484049|FG008|Phase II|Lack of Efficacy|0
4621533|NCT01791517|7484050|FG009|Phase II|Lack of Efficacy|0
4621534|NCT01791517|7484051|FG010|Phase II|Lack of Efficacy|0
4621535|NCT01791517|7484052|FG011|Phase II|Lack of Efficacy|0
4621536|NCT01791517|7484041|FG000|Phase II|Adverse Event|0
4621537|NCT01791517|7484042|FG001|Phase II|Adverse Event|0
4621538|NCT01791517|7484043|FG002|Phase II|Adverse Event|0
4621539|NCT01791517|7484044|FG003|Phase II|Adverse Event|0
4621540|NCT01791517|7484045|FG004|Phase II|Adverse Event|0
4621541|NCT01791517|7484046|FG005|Phase II|Adverse Event|0
4621542|NCT01791517|7484047|FG006|Phase II|Adverse Event|2
4621543|NCT01791517|7484048|FG007|Phase II|Adverse Event|1
4621544|NCT01791517|7484049|FG008|Phase II|Adverse Event|0
4621545|NCT01791517|7484050|FG009|Phase II|Adverse Event|1
4621546|NCT01791517|7484051|FG010|Phase II|Adverse Event|0
4621547|NCT01791517|7484052|FG011|Phase II|Adverse Event|0
4621548|NCT01791517|7484041|FG000|Phase II|Lens Handling Difficulties|0
4621549|NCT01791517|7484042|FG001|Phase II|Lens Handling Difficulties|0
4621550|NCT01791517|7484043|FG002|Phase II|Lens Handling Difficulties|0
4621551|NCT01791517|7484044|FG003|Phase II|Lens Handling Difficulties|0
4621552|NCT01791517|7484045|FG004|Phase II|Lens Handling Difficulties|0
4621553|NCT01791517|7484046|FG005|Phase II|Lens Handling Difficulties|0
4553372|NCT01226745|7382217|FG005|Overall Study|Death|1
4553373|NCT01226745|7382212|FG000|Overall Study|Other|6
4553374|NCT01226745|7382213|FG001|Overall Study|Other|7
4553375|NCT01226745|7382214|FG002|Overall Study|Other|8
4553376|NCT01226745|7382215|FG003|Overall Study|Other|4
4621554|NCT01791517|7484047|FG006|Phase II|Lens Handling Difficulties|0
4621555|NCT01791517|7484048|FG007|Phase II|Lens Handling Difficulties|0
4621556|NCT01791517|7484049|FG008|Phase II|Lens Handling Difficulties|1
4621557|NCT01791517|7484050|FG009|Phase II|Lens Handling Difficulties|0
4621558|NCT01791517|7484051|FG010|Phase II|Lens Handling Difficulties|0
4553377|NCT01226745|7382216|FG004|Overall Study|Other|3
4553378|NCT01226745|7382217|FG005|Overall Study|Other|1
4553379|NCT01227018|7382255|FG000|Overall Study|Disease progression|9
4553380|NCT01227018|7382255|FG000|Overall Study|Toxicity|2
4553381|NCT01227018|7382255|FG000|Overall Study|Withdrew after beginning treatment|4
4553382|NCT01227044|7382261|FG000|Overall Study|Lost to Follow-up|5
4553383|NCT01227044|7382262|FG001|Overall Study|Lost to Follow-up|7
4553384|NCT01227044|7382261|FG000|Overall Study|Discontinued Intervention|1
4553385|NCT01227044|7382262|FG001|Overall Study|Discontinued Intervention|2
4553386|NCT01227252|7382282|FG000|Overall Study|Sponsor Decision|0
4553387|NCT01227252|7382283|FG001|Overall Study|Sponsor Decision|1
4553388|NCT01227252|7382284|FG002|Overall Study|Sponsor Decision|0
4553389|NCT01227252|7382285|FG003|Overall Study|Sponsor Decision|0
4553390|NCT01227252|7382282|FG000|Overall Study|Lost to Follow-up|0
4553391|NCT01227252|7382283|FG001|Overall Study|Lost to Follow-up|1
4553392|NCT01227252|7382284|FG002|Overall Study|Lost to Follow-up|0
4553393|NCT01227252|7382285|FG003|Overall Study|Lost to Follow-up|0
4553394|NCT01227252|7382282|FG000|Overall Study|Withdrawal by Subject|0
4553395|NCT01227252|7382283|FG001|Overall Study|Withdrawal by Subject|1
4553396|NCT01227252|7382284|FG002|Overall Study|Withdrawal by Subject|0
4553397|NCT01227252|7382285|FG003|Overall Study|Withdrawal by Subject|0
4553398|NCT01227265|7382301|FG000|Overall Study|Did Not Receive Treatment|1
4553399|NCT01227265|7382302|FG001|Overall Study|Did Not Receive Treatment|2
4553400|NCT01227265|7382303|FG002|Overall Study|Did Not Receive Treatment|0
4553401|NCT01227265|7382301|FG000|Overall Study|Administrative|1
4553402|NCT01227265|7382302|FG001|Overall Study|Administrative|0
4553403|NCT01227265|7382303|FG002|Overall Study|Administrative|2
4553404|NCT01227265|7382301|FG000|Overall Study|Did Not Meet Protocol Eligibility|0
4553405|NCT01227265|7382302|FG001|Overall Study|Did Not Meet Protocol Eligibility|0
4553406|NCT01227265|7382303|FG002|Overall Study|Did Not Meet Protocol Eligibility|1
4553407|NCT01227265|7382301|FG000|Overall Study|Protocol Violation|2
4553408|NCT01227265|7382302|FG001|Overall Study|Protocol Violation|1
4553409|NCT01227265|7382303|FG002|Overall Study|Protocol Violation|0
4553410|NCT01227265|7382301|FG000|Overall Study|Withdrawal by Subject|7
4553411|NCT01227265|7382302|FG001|Overall Study|Withdrawal by Subject|7
4553412|NCT01227265|7382303|FG002|Overall Study|Withdrawal by Subject|3
4553413|NCT01227265|7382301|FG000|Overall Study|Lost to Follow-up|2
4553414|NCT01227265|7382302|FG001|Overall Study|Lost to Follow-up|0
4553415|NCT01227265|7382303|FG002|Overall Study|Lost to Follow-up|3
4553416|NCT01227265|7382301|FG000|Overall Study|Adverse Event|6
4553417|NCT01227265|7382302|FG001|Overall Study|Adverse Event|10
4553418|NCT01227265|7382303|FG002|Overall Study|Adverse Event|5
4553419|NCT01227278|7382313|FG000|Overall Study|Withdrawal by Subject|4
4553420|NCT01227278|7382314|FG001|Overall Study|Withdrawal by Subject|4
4553421|NCT01227278|7382313|FG000|Overall Study|Death|0
4553422|NCT01227278|7382314|FG001|Overall Study|Death|2
4553423|NCT01227278|7382313|FG000|Overall Study|Other|1
4553424|NCT01227278|7382314|FG001|Overall Study|Other|2
4553425|NCT01227395|7382328|FG000|Overall Study|Protocol Violation|0
4553426|NCT01227395|7382329|FG001|Overall Study|Protocol Violation|1
4553427|NCT01227421|7382357|FG000|Overall Study|Lost to Follow-up|6
4553428|NCT01227421|7382358|FG001|Overall Study|Lost to Follow-up|7
4553429|NCT01227421|7382359|FG002|Overall Study|Lost to Follow-up|5
4553430|NCT01227421|7382357|FG000|Overall Study|Adverse Event|2
4553431|NCT01227421|7382358|FG001|Overall Study|Adverse Event|7
4553432|NCT01227421|7382359|FG002|Overall Study|Adverse Event|2
4553433|NCT01227421|7382357|FG000|Overall Study|Withdrawal by Subject|1
4553434|NCT01227421|7382358|FG001|Overall Study|Withdrawal by Subject|2
4553435|NCT01227421|7382359|FG002|Overall Study|Withdrawal by Subject|1
4553436|NCT01227421|7382357|FG000|Overall Study|Protocol Violation|1
4553437|NCT01227421|7382358|FG001|Overall Study|Protocol Violation|1
4553438|NCT01227421|7382359|FG002|Overall Study|Protocol Violation|2
4553439|NCT01227421|7382357|FG000|Overall Study|Randomized in error|1
4553440|NCT01227421|7382358|FG001|Overall Study|Randomized in error|1
4553441|NCT01227421|7382359|FG002|Overall Study|Randomized in error|0
4553442|NCT01227512|7382379|FG000|Overall Study|Physician Decision|6
4553443|NCT01227512|7382380|FG001|Overall Study|Physician Decision|6
4553444|NCT01227512|7382379|FG000|Overall Study|Adverse Event|4
4553445|NCT01227512|7382380|FG001|Overall Study|Adverse Event|3
4553446|NCT01227512|7382379|FG000|Overall Study|Withdrawal by Subject|3
4553447|NCT01227512|7382380|FG001|Overall Study|Withdrawal by Subject|0
4553448|NCT01227512|7382379|FG000|Overall Study|Participant met withdrawal criteria|0
4553449|NCT01227512|7382380|FG001|Overall Study|Participant met withdrawal criteria|1
4553450|NCT01227564|7382395|FG000|Overall Study|No Longer Willing to Participate|4
4553451|NCT01227564|7382396|FG001|Overall Study|No Longer Willing to Participate|2
4553452|NCT01227564|7382397|FG002|Overall Study|No Longer Willing to Participate|5
4553453|NCT01227564|7382395|FG000|Overall Study|Participant moved to another town|0
4553454|NCT01227564|7382396|FG001|Overall Study|Participant moved to another town|0
4553455|NCT01227564|7382397|FG002|Overall Study|Participant moved to another town|1
4553456|NCT01227577|7382407|FG000|Overall Study|Protocol deviation|3
4553457|NCT01227577|7382407|FG000|Overall Study|Death|3
4553458|NCT01227577|7382407|FG000|Overall Study|Administrative problems|2
4553459|NCT01227577|7382407|FG000|Overall Study|Lost to Follow-up|1
4553460|NCT01227577|7382407|FG000|Overall Study|Withdrawal by Subject|4
4553461|NCT01227577|7382407|FG000|Overall Study|Lack of Efficacy|5
4553462|NCT01227577|7382407|FG000|Overall Study|Adverse Event|17
4553463|NCT01227629|7382421|FG000|Overall Study|Adverse Event|2
4553464|NCT01227629|7382422|FG001|Overall Study|Adverse Event|2
4553465|NCT01227629|7382423|FG002|Overall Study|Adverse Event|1
4553466|NCT01227629|7382424|FG003|Overall Study|Adverse Event|6
4553467|NCT01227629|7382425|FG004|Overall Study|Adverse Event|1
4553468|NCT01227629|7382426|FG005|Overall Study|Adverse Event|1
4553469|NCT01227629|7382427|FG006|Overall Study|Adverse Event|6
4553470|NCT01227629|7382428|FG007|Overall Study|Adverse Event|6
4553471|NCT01227629|7382429|FG008|Overall Study|Adverse Event|4
4553472|NCT01227629|7382430|FG009|Overall Study|Adverse Event|0
4553473|NCT01227629|7382421|FG000|Overall Study|Protocol Violation|0
4553474|NCT01227629|7382422|FG001|Overall Study|Protocol Violation|0
4553475|NCT01227629|7382423|FG002|Overall Study|Protocol Violation|0
4553476|NCT01227629|7382424|FG003|Overall Study|Protocol Violation|1
4553477|NCT01227629|7382425|FG004|Overall Study|Protocol Violation|0
4553478|NCT01227629|7382426|FG005|Overall Study|Protocol Violation|0
4553479|NCT01227629|7382427|FG006|Overall Study|Protocol Violation|0
4553480|NCT01227629|7382428|FG007|Overall Study|Protocol Violation|0
4553481|NCT01227629|7382429|FG008|Overall Study|Protocol Violation|0
4553482|NCT01227629|7382430|FG009|Overall Study|Protocol Violation|0
4553483|NCT01227629|7382421|FG000|Overall Study|Lost to Follow-up|0
4553484|NCT01227629|7382422|FG001|Overall Study|Lost to Follow-up|0
4553485|NCT01227629|7382423|FG002|Overall Study|Lost to Follow-up|0
4553486|NCT01227629|7382424|FG003|Overall Study|Lost to Follow-up|0
4553487|NCT01227629|7382425|FG004|Overall Study|Lost to Follow-up|1
4553488|NCT01227629|7382426|FG005|Overall Study|Lost to Follow-up|0
4553489|NCT01227629|7382427|FG006|Overall Study|Lost to Follow-up|0
4553490|NCT01227629|7382428|FG007|Overall Study|Lost to Follow-up|0
4553491|NCT01227629|7382429|FG008|Overall Study|Lost to Follow-up|0
4553492|NCT01227629|7382430|FG009|Overall Study|Lost to Follow-up|0
4553493|NCT01227629|7382421|FG000|Overall Study|Withdrawal by Subject|0
4553494|NCT01227629|7382422|FG001|Overall Study|Withdrawal by Subject|0
4553495|NCT01227629|7382423|FG002|Overall Study|Withdrawal by Subject|0
4553496|NCT01227629|7382424|FG003|Overall Study|Withdrawal by Subject|0
4553497|NCT01227629|7382425|FG004|Overall Study|Withdrawal by Subject|0
4553498|NCT01227629|7382426|FG005|Overall Study|Withdrawal by Subject|0
4553499|NCT01227629|7382427|FG006|Overall Study|Withdrawal by Subject|2
4553500|NCT01227629|7382428|FG007|Overall Study|Withdrawal by Subject|0
4553501|NCT01227629|7382429|FG008|Overall Study|Withdrawal by Subject|0
4553502|NCT01227629|7382430|FG009|Overall Study|Withdrawal by Subject|1
4553503|NCT01227629|7382421|FG000|Overall Study|Other|0
4553504|NCT01227629|7382422|FG001|Overall Study|Other|0
4553505|NCT01227629|7382423|FG002|Overall Study|Other|0
4553506|NCT01227629|7382424|FG003|Overall Study|Other|1
4553507|NCT01227629|7382425|FG004|Overall Study|Other|0
4553508|NCT01227629|7382426|FG005|Overall Study|Other|0
4553509|NCT01227629|7382427|FG006|Overall Study|Other|0
4553510|NCT01227629|7382428|FG007|Overall Study|Other|0
4553511|NCT01227629|7382429|FG008|Overall Study|Other|2
4553512|NCT01227629|7382430|FG009|Overall Study|Other|1
4553513|NCT01227668|7382491|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12
4553514|NCT01227668|7382492|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0
4553515|NCT01227668|7382491|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7
4553516|NCT01227668|7382492|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0
4553517|NCT01227668|7382491|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8
4553518|NCT01227668|7382492|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0
4553519|NCT01227668|7382491|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11
4553520|NCT01227668|7382492|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0
4553521|NCT01227668|7382491|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7
4553522|NCT01227668|7382492|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0
4553523|NCT01227668|7382491|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25
4553524|NCT01227668|7382492|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0
4553525|NCT01227668|7382491|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2
4553526|NCT01227668|7382492|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0
4553527|NCT01227668|7382491|FG000|Phase 2 (Randomization Phase)|Adverse Event|0
4553528|NCT01227668|7382492|FG001|Phase 2 (Randomization Phase)|Adverse Event|1
4553529|NCT01227668|7382491|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5
4553530|NCT01227668|7382492|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0
4553531|NCT01227668|7382491|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1
4553532|NCT01227668|7382492|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0
4553533|NCT01227668|7382491|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13
4553534|NCT01227668|7382492|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23
4553535|NCT01227668|7382491|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0
4553536|NCT01227668|7382492|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1
4553537|NCT01227707|7382511|FG000|Overall Study|Adverse Event|10
4553538|NCT01227707|7382511|FG000|Overall Study|Progression of disease|3
4553539|NCT01227707|7382511|FG000|Overall Study|Withdrawal by Subject|1
4553540|NCT01227707|7382511|FG000|Overall Study|Patient non-compliance|3
4553541|NCT01227707|7382511|FG000|Overall Study|Medical decision|6
4553542|NCT01227707|7382511|FG000|Overall Study|Death|1
4553543|NCT01227824|7382528|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12
4553544|NCT01227824|7382529|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7
4553545|NCT01227824|7382530|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0
4553546|NCT01227824|7382528|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22
4553547|NCT01227824|7382529|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25
4553548|NCT01227824|7382530|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0
4553549|NCT01227824|7382528|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18
4553550|NCT01227824|7382529|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16
4553551|NCT01227824|7382530|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0
4553552|NCT01227824|7382528|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6
4553553|NCT01227824|7382529|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3
4553554|NCT01227824|7382530|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0
4553555|NCT01227824|7382528|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6
4553556|NCT01227824|7382529|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4
4553557|NCT01227824|7382530|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0
4553558|NCT01227824|7382528|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22
4553559|NCT01227824|7382529|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10
4553560|NCT01227824|7382530|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0
4553561|NCT01227824|7382528|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18
4553562|NCT01227824|7382529|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14
4553563|NCT01227824|7382530|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0
4553564|NCT01227824|7382528|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3
4553565|NCT01227824|7382529|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0
4553566|NCT01227824|7382530|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0
4553567|NCT01227824|7382528|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0
4553568|NCT01227824|7382529|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0
4553569|NCT01227824|7382530|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4
4553570|NCT01227824|7382528|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0
4553571|NCT01227824|7382529|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0
4553572|NCT01227824|7382530|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5
4553573|NCT01227824|7382528|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0
4553574|NCT01227824|7382529|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0
4553575|NCT01227824|7382530|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5
4553576|NCT01227824|7382528|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0
4553577|NCT01227824|7382529|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0
4553578|NCT01227824|7382530|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4
4553579|NCT01227824|7382528|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0
4553580|NCT01227824|7382529|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0
4553581|NCT01227824|7382530|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15
4553582|NCT01227824|7382528|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0
4553583|NCT01227824|7382529|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0
4553584|NCT01227824|7382530|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8
4553585|NCT01227824|7382528|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0
4553586|NCT01227824|7382529|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0
4553587|NCT01227824|7382530|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3
4553588|NCT01227889|7382539|FG000|Randomized Phase (RP)|Adverse Event|13
4553589|NCT01227889|7382540|FG001|Randomized Phase (RP)|Adverse Event|0
4553590|NCT01227889|7382539|FG000|Randomized Phase (RP)|Physician Decision|13
4553591|NCT01227889|7382540|FG001|Randomized Phase (RP)|Physician Decision|5
4553592|NCT01227889|7382539|FG000|Randomized Phase (RP)|Progressive Disease|135
4553593|NCT01227889|7382540|FG001|Randomized Phase (RP)|Progressive Disease|52
4553594|NCT01227889|7382539|FG000|Randomized Phase (RP)|Study terminated by sponsor|10
4553595|NCT01227889|7382540|FG001|Randomized Phase (RP)|Study terminated by sponsor|0
4553596|NCT01227889|7382539|FG000|Randomized Phase (RP)|Missing|1
4553597|NCT01227889|7382540|FG001|Randomized Phase (RP)|Missing|3
4553598|NCT01227889|7382539|FG000|Randomized Phase (RP)|Withdrawal by Subject|15
4553599|NCT01227889|7382540|FG001|Randomized Phase (RP)|Withdrawal by Subject|3
4553600|NCT01227889|7382539|FG000|Crossover Phase|Adverse Event|0
4553601|NCT01227889|7382540|FG001|Crossover Phase|Adverse Event|1
4553602|NCT01227889|7382539|FG000|Crossover Phase|Physician Decision|0
4553603|NCT01227889|7382540|FG001|Crossover Phase|Physician Decision|3
4553604|NCT01227889|7382539|FG000|Crossover Phase|Progressive Disease|0
4553605|NCT01227889|7382540|FG001|Crossover Phase|Progressive Disease|31
4553606|NCT01227889|7382539|FG000|Crossover Phase|Study Terminated By Sponsor|0
4553607|NCT01227889|7382540|FG001|Crossover Phase|Study Terminated By Sponsor|1
4553608|NCT01227889|7382539|FG000|Crossover Phase|Withdrawal by Subject|0
4553609|NCT01227889|7382540|FG001|Crossover Phase|Withdrawal by Subject|1
4553610|NCT01227902|7382558|FG000|Overall Study|Adverse Event|12
4553611|NCT01227902|7382559|FG001|Overall Study|Adverse Event|8
4553612|NCT01227902|7382560|FG002|Overall Study|Adverse Event|11
4553613|NCT01227902|7382561|FG003|Overall Study|Adverse Event|4
4553614|NCT01227902|7382558|FG000|Overall Study|Lack of Efficacy|1
4553615|NCT01227902|7382559|FG001|Overall Study|Lack of Efficacy|2
4553616|NCT01227902|7382560|FG002|Overall Study|Lack of Efficacy|2
4553617|NCT01227902|7382561|FG003|Overall Study|Lack of Efficacy|1
4553618|NCT01227902|7382558|FG000|Overall Study|Protocol Violation|1
4553619|NCT01227902|7382559|FG001|Overall Study|Protocol Violation|0
4553620|NCT01227902|7382560|FG002|Overall Study|Protocol Violation|0
4553621|NCT01227902|7382561|FG003|Overall Study|Protocol Violation|0
4553622|NCT01227902|7382558|FG000|Overall Study|Lost to Follow-up|0
4553623|NCT01227902|7382559|FG001|Overall Study|Lost to Follow-up|0
4553624|NCT01227902|7382560|FG002|Overall Study|Lost to Follow-up|1
4553625|NCT01227902|7382561|FG003|Overall Study|Lost to Follow-up|2
4553626|NCT01227902|7382558|FG000|Overall Study|Physician Decision|0
4553627|NCT01227902|7382559|FG001|Overall Study|Physician Decision|1
4553628|NCT01227902|7382560|FG002|Overall Study|Physician Decision|1
4553629|NCT01227902|7382561|FG003|Overall Study|Physician Decision|0
4553630|NCT01227902|7382558|FG000|Overall Study|Withdrawal by Subject|4
4553631|NCT01227902|7382559|FG001|Overall Study|Withdrawal by Subject|2
4553632|NCT01227902|7382560|FG002|Overall Study|Withdrawal by Subject|4
4553633|NCT01227902|7382561|FG003|Overall Study|Withdrawal by Subject|3
4553634|NCT01227928|7382574|FG000|Overall Study|Lost to Follow-up|4
4553635|NCT01227928|7382575|FG001|Overall Study|Lost to Follow-up|2
4553636|NCT01227928|7382574|FG000|Overall Study|Withdrawal by Subject|4
4553637|NCT01227928|7382575|FG001|Overall Study|Withdrawal by Subject|3
4553638|NCT01227928|7382574|FG000|Overall Study|Death|14
4553639|NCT01227928|7382575|FG001|Overall Study|Death|12
4553640|NCT01227954|7382581|FG000|Overall Study|Protocol Violation|6
4553641|NCT01227954|7382581|FG000|Overall Study|No protocol treatment|7
4553642|NCT01227967|7382587|FG000|Overall Study|Protocol Violation|3
4553643|NCT01227967|7382588|FG001|Overall Study|Protocol Violation|1
4553644|NCT01227967|7382587|FG000|Overall Study|Death|0
4553645|NCT01227967|7382588|FG001|Overall Study|Death|1
4553646|NCT01227967|7382587|FG000|Overall Study|Lost to Follow-up|8
4553647|NCT01227967|7382588|FG001|Overall Study|Lost to Follow-up|3
4553648|NCT01227967|7382587|FG000|Overall Study|Withdrawal by Subject|4
4553649|NCT01227967|7382588|FG001|Overall Study|Withdrawal by Subject|3
4553650|NCT01227967|7382587|FG000|Overall Study|Physician Decision|0
4553651|NCT01227967|7382588|FG001|Overall Study|Physician Decision|1
4553652|NCT01227967|7382587|FG000|Overall Study|Never Started Treatment|0
4553653|NCT01227967|7382588|FG001|Overall Study|Never Started Treatment|4
4553654|NCT01227967|7382587|FG000|Overall Study|Taking Additional Antiviral Drug|1
4553655|NCT01227967|7382588|FG001|Overall Study|Taking Additional Antiviral Drug|0
4553656|NCT01228019|7382607|FG000|Overall Study|Dose Violation|70
4553657|NCT01228019|7382607|FG000|Overall Study|Duplicate enrollment|1
4553658|NCT01228019|7382607|FG000|Overall Study|Missing pre-treatment data|72
4553659|NCT01228019|7382607|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152
4553660|NCT01228019|7382607|FG000|Overall Study|Violation of Entry Criterion|9
4553661|NCT01228071|7382611|FG000|Overall Study|Protocol Violation|1
4553662|NCT01228071|7382611|FG000|Overall Study|Withdrawal by Subject|1
4553663|NCT01228175|7382633|FG000|Overall Study|Lost to Follow-up|64
4553664|NCT01228175|7382634|FG001|Overall Study|Lost to Follow-up|50
4553665|NCT01228175|7382633|FG000|Overall Study|Withdrawal by Subject|1
4553666|NCT01228175|7382634|FG001|Overall Study|Withdrawal by Subject|2
4553667|NCT01228175|7382633|FG000|Overall Study|Physician Decision|1
4553668|NCT01228175|7382634|FG001|Overall Study|Physician Decision|1
4553669|NCT01228318|7382642|FG000|Overall Study|Clinic no show to receive intervention|1
4553670|NCT01228318|7382643|FG001|Overall Study|Clinic no show to receive intervention|0
4553671|NCT01228318|7382642|FG000|Overall Study|Unable to contact|2
4553672|NCT01228318|7382643|FG001|Overall Study|Unable to contact|5
4553673|NCT01228318|7382642|FG000|Overall Study|Moved|0
4553674|NCT01228318|7382643|FG001|Overall Study|Moved|2
4553675|NCT01228318|7382642|FG000|Overall Study|Incarcerated|1
4553676|NCT01228318|7382643|FG001|Overall Study|Incarcerated|0
4553677|NCT01228591|7382658|FG000|Baseline|Lack of Efficacy|1
4553678|NCT01228591|7382659|FG001|Baseline|Lack of Efficacy|2
4553679|NCT01228734|7382671|FG000|Overall Study|Randomized, but not treated|0
4553680|NCT01228734|7382672|FG001|Overall Study|Randomized, but not treated|4
4553681|NCT01228747|7382680|FG000|Overall Study|Adverse Event|8
4553682|NCT01228747|7382681|FG001|Overall Study|Adverse Event|4
4553683|NCT01228747|7382680|FG000|Overall Study|Lack of Efficacy|40
4553684|NCT01228747|7382681|FG001|Overall Study|Lack of Efficacy|27
4553685|NCT01228747|7382680|FG000|Overall Study|Protocol Violation|6
4553686|NCT01228747|7382681|FG001|Overall Study|Protocol Violation|5
4553687|NCT01228747|7382680|FG000|Overall Study|Lost to Follow-up|4
4553688|NCT01228747|7382681|FG001|Overall Study|Lost to Follow-up|3
4553689|NCT01228747|7382680|FG000|Overall Study|Withdrawal by Subject|5
4553690|NCT01228747|7382681|FG001|Overall Study|Withdrawal by Subject|1
4553691|NCT01228747|7382680|FG000|Overall Study|Other Reason|2
4553692|NCT01228747|7382681|FG001|Overall Study|Other Reason|5
4553693|NCT01229111|7382713|FG000|Overall Study|Death|1
4553694|NCT01229150|7382721|FG000|Overall Study|Toxicity|2
4553695|NCT01229150|7382722|FG001|Overall Study|Toxicity|2
4553696|NCT01229150|7382723|FG002|Overall Study|Toxicity|0
4553697|NCT01229150|7382724|FG003|Overall Study|Toxicity|0
4553698|NCT01229176|7382746|FG000|Overall Study|Withdrawal by Subject|0
4553699|NCT01229176|7382747|FG001|Overall Study|Withdrawal by Subject|0
4553700|NCT01229176|7382748|FG002|Overall Study|Withdrawal by Subject|0
4553701|NCT01229176|7382749|FG003|Overall Study|Withdrawal by Subject|1
4553702|NCT01229176|7382750|FG004|Overall Study|Withdrawal by Subject|1
4553703|NCT01229176|7382751|FG005|Overall Study|Withdrawal by Subject|1
4553704|NCT01229176|7382752|FG006|Overall Study|Withdrawal by Subject|0
4553705|NCT01229176|7382753|FG007|Overall Study|Withdrawal by Subject|1
4553706|NCT01229176|7382746|FG000|Overall Study|Lost to Follow-up|0
4553707|NCT01229176|7382747|FG001|Overall Study|Lost to Follow-up|3
4553708|NCT01229176|7382748|FG002|Overall Study|Lost to Follow-up|0
4553709|NCT01229176|7382749|FG003|Overall Study|Lost to Follow-up|0
4553710|NCT01229176|7382750|FG004|Overall Study|Lost to Follow-up|1
4553711|NCT01229176|7382751|FG005|Overall Study|Lost to Follow-up|1
4553712|NCT01229176|7382752|FG006|Overall Study|Lost to Follow-up|0
4553713|NCT01229176|7382753|FG007|Overall Study|Lost to Follow-up|2
4553714|NCT01229254|7382795|FG000|Overall Study|Not Continuing Into Safety Extension|3
4553715|NCT01229254|7382796|FG001|Overall Study|Not Continuing Into Safety Extension|1
4553716|NCT01229254|7382797|FG002|Overall Study|Not Continuing Into Safety Extension|1
4553717|NCT01229254|7382795|FG000|Overall Study|Adverse Event|4
4553718|NCT01229254|7382796|FG001|Overall Study|Adverse Event|5
4553719|NCT01229254|7382797|FG002|Overall Study|Adverse Event|3
4553720|NCT01229254|7382795|FG000|Overall Study|Lost to Follow-up|3
4553721|NCT01229254|7382796|FG001|Overall Study|Lost to Follow-up|0
4553722|NCT01229254|7382797|FG002|Overall Study|Lost to Follow-up|1
4553723|NCT01229254|7382795|FG000|Overall Study|Physician Decision|0
4553724|NCT01229254|7382796|FG001|Overall Study|Physician Decision|3
4553725|NCT01229254|7382797|FG002|Overall Study|Physician Decision|0
4553726|NCT01229254|7382795|FG000|Overall Study|Protocol Violation|4
4621559|NCT01791517|7484052|FG011|Phase II|Lens Handling Difficulties|0
4621560|NCT01791517|7484041|FG000|Phase II|Unsatisfactory Lens Fitting|0
4621561|NCT01791517|7484042|FG001|Phase II|Unsatisfactory Lens Fitting|0
4621562|NCT01791517|7484043|FG002|Phase II|Unsatisfactory Lens Fitting|0
4621563|NCT01791517|7484044|FG003|Phase II|Unsatisfactory Lens Fitting|0
4621564|NCT01791517|7484045|FG004|Phase II|Unsatisfactory Lens Fitting|0
4621565|NCT01791517|7484046|FG005|Phase II|Unsatisfactory Lens Fitting|0
4621566|NCT01791517|7484047|FG006|Phase II|Unsatisfactory Lens Fitting|0
4621567|NCT01791517|7484048|FG007|Phase II|Unsatisfactory Lens Fitting|0
4621568|NCT01791517|7484049|FG008|Phase II|Unsatisfactory Lens Fitting|0
4621569|NCT01791517|7484050|FG009|Phase II|Unsatisfactory Lens Fitting|1
4621570|NCT01791517|7484051|FG010|Phase II|Unsatisfactory Lens Fitting|0
4621571|NCT01791517|7484052|FG011|Phase II|Unsatisfactory Lens Fitting|0
4621572|NCT01791517|7484041|FG000|Phase II|Pre-Existing Ocular Issue|0
4621573|NCT01791517|7484042|FG001|Phase II|Pre-Existing Ocular Issue|0
4621574|NCT01791517|7484043|FG002|Phase II|Pre-Existing Ocular Issue|0
4621575|NCT01791517|7484044|FG003|Phase II|Pre-Existing Ocular Issue|0
4621576|NCT01791517|7484045|FG004|Phase II|Pre-Existing Ocular Issue|0
4621577|NCT01791517|7484046|FG005|Phase II|Pre-Existing Ocular Issue|0
4621578|NCT01791517|7484047|FG006|Phase II|Pre-Existing Ocular Issue|0
4621579|NCT01791517|7484048|FG007|Phase II|Pre-Existing Ocular Issue|0
4621580|NCT01791517|7484049|FG008|Phase II|Pre-Existing Ocular Issue|0
4621581|NCT01791517|7484050|FG009|Phase II|Pre-Existing Ocular Issue|0
4621582|NCT01791517|7484051|FG010|Phase II|Pre-Existing Ocular Issue|0
4621583|NCT01791517|7484052|FG011|Phase II|Pre-Existing Ocular Issue|1
4621584|NCT01791725|7484073|FG000|Overall Study|Withdrawal by Subject|0
4621585|NCT01791725|7484074|FG001|Overall Study|Withdrawal by Subject|1
4621586|NCT01791725|7484075|FG002|Overall Study|Withdrawal by Subject|0
4621587|NCT01791803|7484087|FG000|Overall Study|Withdrawal by Subject|0
4621588|NCT01791803|7484088|FG001|Overall Study|Withdrawal by Subject|0
4621589|NCT01791803|7484089|FG002|Overall Study|Withdrawal by Subject|0
4621590|NCT01791803|7484090|FG003|Overall Study|Withdrawal by Subject|2
4621591|NCT01791803|7484087|FG000|Overall Study|Physician Decision|0
4621592|NCT01791803|7484088|FG001|Overall Study|Physician Decision|2
4621593|NCT01791803|7484089|FG002|Overall Study|Physician Decision|0
4621594|NCT01791803|7484090|FG003|Overall Study|Physician Decision|1
4621595|NCT01791803|7484087|FG000|Overall Study|Death|0
4621596|NCT01791803|7484088|FG001|Overall Study|Death|0
4621597|NCT01791803|7484089|FG002|Overall Study|Death|2
4621598|NCT01791803|7484090|FG003|Overall Study|Death|2
4621599|NCT01791894|7484103|FG000|Overall Study|Adverse Event|1
4621600|NCT01792115|7484124|FG000|Overall Study|Lost to Follow-up|0
4621601|NCT01792115|7484125|FG001|Overall Study|Lost to Follow-up|1
4621602|NCT01792115|7484126|FG002|Overall Study|Lost to Follow-up|0
4621603|NCT01792284|7484134|FG000|Lead-in Period|Adverse Event|15
4553727|NCT01229254|7382796|FG001|Overall Study|Protocol Violation|6
4553728|NCT01229254|7382797|FG002|Overall Study|Protocol Violation|5
4621604|NCT01792284|7484135|FG001|Lead-in Period|Adverse Event|0
4621605|NCT01792284|7484136|FG002|Lead-in Period|Adverse Event|0
4621606|NCT01792284|7484134|FG000|Lead-in Period|Lost to Follow-up|2
4621607|NCT01792284|7484135|FG001|Lead-in Period|Lost to Follow-up|0
4621608|NCT01792284|7484136|FG002|Lead-in Period|Lost to Follow-up|0
4621609|NCT01792284|7484134|FG000|Lead-in Period|Protocol Violation|1
4621610|NCT01792284|7484135|FG001|Lead-in Period|Protocol Violation|0
4621611|NCT01792284|7484136|FG002|Lead-in Period|Protocol Violation|0
4621612|NCT01792284|7484134|FG000|Lead-in Period|Withdrawal by Subject|10
4553729|NCT01229254|7382795|FG000|Overall Study|Withdrawal by Subject|1
4621613|NCT01792284|7484135|FG001|Lead-in Period|Withdrawal by Subject|0
4553730|NCT01229254|7382796|FG001|Overall Study|Withdrawal by Subject|0
4553731|NCT01229254|7382797|FG002|Overall Study|Withdrawal by Subject|1
4553732|NCT01229254|7382795|FG000|Overall Study|Non-compliance with Study Drug|0
4621614|NCT01792284|7484136|FG002|Lead-in Period|Withdrawal by Subject|0
4621615|NCT01792284|7484134|FG000|Lead-in Period|Physician Decision|1
4621616|NCT01792284|7484135|FG001|Lead-in Period|Physician Decision|0
4621617|NCT01792284|7484136|FG002|Lead-in Period|Physician Decision|0
4621618|NCT01792284|7484134|FG000|Lead-in Period|Protocol Required Discontinuation|1
4621619|NCT01792284|7484135|FG001|Lead-in Period|Protocol Required Discontinuation|0
4621620|NCT01792284|7484136|FG002|Lead-in Period|Protocol Required Discontinuation|0
4621621|NCT01792284|7484134|FG000|Randomization Period 1|Withdrawal by Subject|0
4621622|NCT01792284|7484135|FG001|Randomization Period 1|Withdrawal by Subject|1
4621623|NCT01792284|7484136|FG002|Randomization Period 1|Withdrawal by Subject|1
4621624|NCT01792284|7484134|FG000|Randomization Period 1|Physician Decision|0
4621625|NCT01792284|7484135|FG001|Randomization Period 1|Physician Decision|1
4621626|NCT01792284|7484136|FG002|Randomization Period 1|Physician Decision|1
4621627|NCT01792284|7484134|FG000|Randomization Period 1|Adverse Event|0
4621628|NCT01792284|7484135|FG001|Randomization Period 1|Adverse Event|0
4621629|NCT01792284|7484136|FG002|Randomization Period 1|Adverse Event|2
4621630|NCT01792284|7484134|FG000|Randomization Period 1|Lost to Follow-up|0
4621631|NCT01792284|7484135|FG001|Randomization Period 1|Lost to Follow-up|0
4621632|NCT01792284|7484136|FG002|Randomization Period 1|Lost to Follow-up|1
4621633|NCT01792284|7484134|FG000|Randomization Period 2|Protocol Violation|0
4621634|NCT01792284|7484135|FG001|Randomization Period 2|Protocol Violation|1
4621635|NCT01792284|7484136|FG002|Randomization Period 2|Protocol Violation|0
4621636|NCT01792284|7484134|FG000|Randomization Period 2|Withdrawal by Subject|0
4621637|NCT01792284|7484135|FG001|Randomization Period 2|Withdrawal by Subject|2
4621638|NCT01792284|7484136|FG002|Randomization Period 2|Withdrawal by Subject|0
4621639|NCT01792518|7484146|FG000|Overall Study|Adverse Event|3
4621640|NCT01792518|7484147|FG001|Overall Study|Adverse Event|4
4621641|NCT01792518|7484146|FG000|Overall Study|Protocol Violation|0
4621642|NCT01792518|7484147|FG001|Overall Study|Protocol Violation|1
4621643|NCT01792518|7484146|FG000|Overall Study|Lost to Follow-up|3
4621644|NCT01792518|7484147|FG001|Overall Study|Lost to Follow-up|1
4621645|NCT01792518|7484146|FG000|Overall Study|Withdrawal by Subject|2
4621646|NCT01792518|7484147|FG001|Overall Study|Withdrawal by Subject|0
4621647|NCT01792518|7484146|FG000|Overall Study|Other Reason|0
4621648|NCT01792518|7484147|FG001|Overall Study|Other Reason|1
4621649|NCT01792635|7484156|FG000|Part B|Adverse Event|0
4621650|NCT01792635|7484157|FG001|Part B|Adverse Event|0
4621651|NCT01792635|7484158|FG002|Part B|Adverse Event|1
4621652|NCT01792635|7484156|FG000|Part B|Study terminated|0
4621653|NCT01792635|7484157|FG001|Part B|Study terminated|4
4621654|NCT01792635|7484158|FG002|Part B|Study terminated|3
4621655|NCT01792830|7484189|FG000|Overall Study|Withdrawal by Subject|22
4621656|NCT01792830|7484190|FG001|Overall Study|Withdrawal by Subject|0
4621657|NCT01792830|7484191|FG002|Overall Study|Withdrawal by Subject|0
4621658|NCT01792830|7484192|FG003|Overall Study|Withdrawal by Subject|2
4621659|NCT01792830|7484193|FG004|Overall Study|Withdrawal by Subject|1
4621660|NCT01792830|7484194|FG005|Overall Study|Withdrawal by Subject|1
4621661|NCT01792830|7484195|FG006|Overall Study|Withdrawal by Subject|1
4621662|NCT01792830|7484196|FG007|Overall Study|Withdrawal by Subject|1
4621663|NCT01792830|7484197|FG008|Overall Study|Withdrawal by Subject|7
4621664|NCT01792830|7484198|FG009|Overall Study|Withdrawal by Subject|0
4621665|NCT01792830|7484199|FG010|Overall Study|Withdrawal by Subject|2
4621666|NCT01792830|7484189|FG000|Overall Study|Death|3
4621667|NCT01792830|7484190|FG001|Overall Study|Death|0
4621668|NCT01792830|7484191|FG002|Overall Study|Death|0
4553733|NCT01229254|7382796|FG001|Overall Study|Non-compliance with Study Drug|1
4553734|NCT01229254|7382797|FG002|Overall Study|Non-compliance with Study Drug|1
4553735|NCT01229267|7382811|FG000|Overall Study|Adverse Event|4
4553736|NCT01229267|7382812|FG001|Overall Study|Adverse Event|6
4553737|NCT01229267|7382813|FG002|Overall Study|Adverse Event|3
4553738|NCT01229267|7382814|FG003|Overall Study|Adverse Event|2
4553739|NCT01229267|7382815|FG004|Overall Study|Adverse Event|10
4553740|NCT01229267|7382811|FG000|Overall Study|Death|40
4553741|NCT01229267|7382812|FG001|Overall Study|Death|37
4553742|NCT01229267|7382813|FG002|Overall Study|Death|35
4553743|NCT01229267|7382814|FG003|Overall Study|Death|13
4553744|NCT01229267|7382815|FG004|Overall Study|Death|103
4553745|NCT01229267|7382811|FG000|Overall Study|Withdrawal by Subject|23
4621669|NCT01792830|7484192|FG003|Overall Study|Death|1
4621670|NCT01792830|7484193|FG004|Overall Study|Death|0
4553746|NCT01229267|7382812|FG001|Overall Study|Withdrawal by Subject|22
4553747|NCT01229267|7382813|FG002|Overall Study|Withdrawal by Subject|32
4553748|NCT01229267|7382814|FG003|Overall Study|Withdrawal by Subject|14
4553749|NCT01229267|7382815|FG004|Overall Study|Withdrawal by Subject|59
4553750|NCT01229267|7382811|FG000|Overall Study|Protocol Violation|0
4621671|NCT01792830|7484194|FG005|Overall Study|Death|0
4621672|NCT01792830|7484195|FG006|Overall Study|Death|1
4621673|NCT01792830|7484196|FG007|Overall Study|Death|0
4621674|NCT01792830|7484197|FG008|Overall Study|Death|1
4621675|NCT01792830|7484198|FG009|Overall Study|Death|0
4621676|NCT01792830|7484199|FG010|Overall Study|Death|1
4621677|NCT01792830|7484189|FG000|Overall Study|Adverse Event|0
4553751|NCT01229267|7382812|FG001|Overall Study|Protocol Violation|1
4553752|NCT01229267|7382813|FG002|Overall Study|Protocol Violation|0
4553753|NCT01229267|7382814|FG003|Overall Study|Protocol Violation|0
4553754|NCT01229267|7382815|FG004|Overall Study|Protocol Violation|0
4553755|NCT01229267|7382811|FG000|Overall Study|Progressive disease|0
4553756|NCT01229267|7382812|FG001|Overall Study|Progressive disease|0
4553757|NCT01229267|7382813|FG002|Overall Study|Progressive disease|0
4553758|NCT01229267|7382814|FG003|Overall Study|Progressive disease|0
4553759|NCT01229267|7382815|FG004|Overall Study|Progressive disease|1
4553760|NCT01229267|7382811|FG000|Overall Study|Physician Decision|8
4553761|NCT01229267|7382812|FG001|Overall Study|Physician Decision|11
4553762|NCT01229267|7382813|FG002|Overall Study|Physician Decision|8
4553763|NCT01229267|7382814|FG003|Overall Study|Physician Decision|3
4553764|NCT01229267|7382815|FG004|Overall Study|Physician Decision|25
4553765|NCT01229267|7382811|FG000|Overall Study|Lost to Follow-up|6
4553766|NCT01229267|7382812|FG001|Overall Study|Lost to Follow-up|5
4553767|NCT01229267|7382813|FG002|Overall Study|Lost to Follow-up|8
4553768|NCT01229267|7382814|FG003|Overall Study|Lost to Follow-up|3
4553769|NCT01229267|7382815|FG004|Overall Study|Lost to Follow-up|22
4553770|NCT01229371|7382826|FG000|Overall Study|Withdrawal by Subject|0
4553771|NCT01229371|7382827|FG001|Overall Study|Withdrawal by Subject|1
4553772|NCT01229371|7382828|FG002|Overall Study|Withdrawal by Subject|0
4553773|NCT01229371|7382829|FG003|Overall Study|Withdrawal by Subject|0
4553774|NCT01229397|7382841|FG000|Overall Study|Withdrawal by Subject|3
4553775|NCT01229397|7382842|FG001|Overall Study|Withdrawal by Subject|3
4553776|NCT01229397|7382841|FG000|Overall Study|Lost to Follow-up|7
4553777|NCT01229397|7382842|FG001|Overall Study|Lost to Follow-up|6
4553778|NCT01229397|7382841|FG000|Overall Study|Migrated/moved from study area|1
4553779|NCT01229397|7382842|FG001|Overall Study|Migrated/moved from study area|0
4553780|NCT01229436|7382865|FG000|Overall Study|Withdrawal by Subject|2
4553781|NCT01229436|7382865|FG000|Overall Study|Lost to Follow-up|3
4553782|NCT01229449|7382874|FG000|Overall Study|Withdrawal by Subject|0
4553783|NCT01229449|7382875|FG001|Overall Study|Withdrawal by Subject|3
4553784|NCT01229449|7382876|FG002|Overall Study|Withdrawal by Subject|0
4553785|NCT01229449|7382877|FG003|Overall Study|Withdrawal by Subject|1
4553786|NCT01229449|7382878|FG004|Overall Study|Withdrawal by Subject|1
4553787|NCT01229449|7382874|FG000|Overall Study|Lost to Follow-up|1
4553788|NCT01229449|7382875|FG001|Overall Study|Lost to Follow-up|1
4553789|NCT01229449|7382876|FG002|Overall Study|Lost to Follow-up|1
4553790|NCT01229449|7382877|FG003|Overall Study|Lost to Follow-up|0
4553791|NCT01229449|7382878|FG004|Overall Study|Lost to Follow-up|0
4553792|NCT01229449|7382874|FG000|Overall Study|Physician Decision|0
4553793|NCT01229449|7382875|FG001|Overall Study|Physician Decision|0
4553794|NCT01229449|7382876|FG002|Overall Study|Physician Decision|1
4553795|NCT01229449|7382877|FG003|Overall Study|Physician Decision|0
4553796|NCT01229449|7382878|FG004|Overall Study|Physician Decision|0
4553797|NCT01229735|7382927|FG000|Overall Study|Lack of Efficacy|8
4553798|NCT01229735|7382928|FG001|Overall Study|Lack of Efficacy|8
4553799|NCT01229735|7382927|FG000|Overall Study|Protocol Violation|13
4553800|NCT01229735|7382928|FG001|Overall Study|Protocol Violation|8
4553801|NCT01229735|7382927|FG000|Overall Study|Lost to Follow-up|0
4553802|NCT01229735|7382928|FG001|Overall Study|Lost to Follow-up|2
4553803|NCT01229735|7382927|FG000|Overall Study|Withdrawal by Subject|18
4553804|NCT01229735|7382928|FG001|Overall Study|Withdrawal by Subject|17
4553805|NCT01229735|7382927|FG000|Overall Study|Other Reason|13
4553806|NCT01229735|7382928|FG001|Overall Study|Other Reason|10
4553807|NCT01229735|7382927|FG000|Overall Study|SAE, non-fatal|0
4553808|NCT01229735|7382928|FG001|Overall Study|SAE, non-fatal|4
4553809|NCT01229735|7382927|FG000|Overall Study|AE, non-serious non-fatal|13
4553810|NCT01229735|7382928|FG001|Overall Study|AE, non-serious non-fatal|17
4553811|NCT01229735|7382927|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
4553812|NCT01229735|7382928|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
4553813|NCT01230060|7382953|FG000|Overall Study|Withdrawal by Subject|1
4553814|NCT01230554|7382998|FG000|Overall Study|Lost to Follow-up|2
4553815|NCT01230554|7382998|FG000|Overall Study|Inability to maintain visit schedule|1
4553816|NCT01230710|7383015|FG000|Overall Study|Disease Progression|41
4553817|NCT01230710|7383015|FG000|Overall Study|Lost to Follow-up|3
4553818|NCT01230710|7383015|FG000|Overall Study|Death|4
4553819|NCT01230710|7383015|FG000|Overall Study|Withdrawal of Consent|1
4553820|NCT01230749|7383023|FG000|Overall Study|Adverse Event|0
4553821|NCT01230749|7383024|FG001|Overall Study|Adverse Event|0
4553822|NCT01230749|7383025|FG002|Overall Study|Adverse Event|0
4553823|NCT01230749|7383026|FG003|Overall Study|Adverse Event|1
4553824|NCT01230749|7383023|FG000|Overall Study|Physician Decision|0
4553825|NCT01230749|7383024|FG001|Overall Study|Physician Decision|0
4553826|NCT01230749|7383025|FG002|Overall Study|Physician Decision|1
4553827|NCT01230749|7383026|FG003|Overall Study|Physician Decision|0
4553828|NCT01230749|7383023|FG000|Overall Study|Withdrawal by Subject|0
4553829|NCT01230749|7383024|FG001|Overall Study|Withdrawal by Subject|1
4553830|NCT01230749|7383025|FG002|Overall Study|Withdrawal by Subject|0
4553831|NCT01230749|7383026|FG003|Overall Study|Withdrawal by Subject|0
4553832|NCT01230749|7383023|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0
4553833|NCT01230749|7383024|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1
4553834|NCT01230749|7383025|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1
4593848|NCT01555164|7442379|FG000|Overall Study|Investigator's Discretion|2
4553835|NCT01230749|7383026|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1
4553836|NCT01230814|7383057|FG000|Overall Study|Lost to Follow-up|11
4553837|NCT01230814|7383058|FG001|Overall Study|Lost to Follow-up|3
4553838|NCT01230814|7383057|FG000|Overall Study|Discontinued (not due to adverse event)|2
4553839|NCT01230814|7383058|FG001|Overall Study|Discontinued (not due to adverse event)|1
4553840|NCT01230827|7383068|FG000|Overall Study|Lost to Follow-up|0
4553841|NCT01230827|7383069|FG001|Overall Study|Lost to Follow-up|0
4553842|NCT01230827|7383070|FG002|Overall Study|Lost to Follow-up|1
4553843|NCT01230827|7383071|FG003|Overall Study|Lost to Follow-up|3
4553844|NCT01230827|7383068|FG000|Overall Study|Withdrawal by Subject|1
4553845|NCT01230827|7383069|FG001|Overall Study|Withdrawal by Subject|0
4553846|NCT01230827|7383070|FG002|Overall Study|Withdrawal by Subject|3
4553847|NCT01230827|7383071|FG003|Overall Study|Withdrawal by Subject|2
4553848|NCT01230827|7383068|FG000|Overall Study|Lack of Efficacy|14
4553849|NCT01230827|7383069|FG001|Overall Study|Lack of Efficacy|1
4553850|NCT01230827|7383070|FG002|Overall Study|Lack of Efficacy|2
4553851|NCT01230827|7383071|FG003|Overall Study|Lack of Efficacy|3
4553852|NCT01230827|7383068|FG000|Overall Study|Adverse Event|4
4553853|NCT01230827|7383069|FG001|Overall Study|Adverse Event|2
4553854|NCT01230827|7383070|FG002|Overall Study|Adverse Event|3
4553855|NCT01230827|7383071|FG003|Overall Study|Adverse Event|7
4553856|NCT01230827|7383068|FG000|Overall Study|Recovery|0
4553857|NCT01230827|7383069|FG001|Overall Study|Recovery|6
4553858|NCT01230827|7383070|FG002|Overall Study|Recovery|0
4553859|NCT01230827|7383071|FG003|Overall Study|Recovery|0
4553860|NCT01230827|7383068|FG000|Overall Study|Study terminated by Sponsor|0
4553861|NCT01230827|7383069|FG001|Overall Study|Study terminated by Sponsor|2
4553862|NCT01230827|7383070|FG002|Overall Study|Study terminated by Sponsor|56
4553863|NCT01230827|7383071|FG003|Overall Study|Study terminated by Sponsor|63
4553864|NCT01230892|7383081|FG000|Overall Study|Withdrawal by Subject|1
4553865|NCT01230892|7383082|FG001|Overall Study|Withdrawal by Subject|1
4553866|NCT01230892|7383081|FG000|Overall Study|Lost to Follow-up|2
4553867|NCT01230892|7383082|FG001|Overall Study|Lost to Follow-up|0
4553868|NCT01231321|7383108|FG000|Overall Study|Adverse Event|3
4553869|NCT01231321|7383108|FG000|Overall Study|Lack of Efficacy|2
4553870|NCT01231373|7383131|FG000|Overall Study|Withdrew consent prior to randomization|2
4553871|NCT01231373|7383132|FG001|Overall Study|Withdrew consent prior to randomization|1
4553872|NCT01231373|7383133|FG002|Overall Study|Withdrew consent prior to randomization|0
4553873|NCT01231373|7383134|FG003|Overall Study|Withdrew consent prior to randomization|0
4553874|NCT01231373|7383131|FG000|Overall Study|Lost to Follow-up|0
4553875|NCT01231373|7383132|FG001|Overall Study|Lost to Follow-up|0
4553876|NCT01231373|7383133|FG002|Overall Study|Lost to Follow-up|0
4553877|NCT01231373|7383134|FG003|Overall Study|Lost to Follow-up|1
4553878|NCT01231373|7383131|FG000|Overall Study|Withdrew Consent|1
4553879|NCT01231373|7383132|FG001|Overall Study|Withdrew Consent|0
4553880|NCT01231373|7383133|FG002|Overall Study|Withdrew Consent|0
4553881|NCT01231373|7383134|FG003|Overall Study|Withdrew Consent|0
4591836|NCT01534962|7438872|FG000|Overall Study|Randomized but did not start treatment|2
4591837|NCT01534962|7438873|FG001|Overall Study|Randomized but did not start treatment|0
4591838|NCT01534962|7438874|FG002|Overall Study|Randomized but did not start treatment|0
4591839|NCT01534962|7438875|FG003|Overall Study|Randomized but did not start treatment|1
4591840|NCT01534962|7438872|FG000|Overall Study|Discontinued at AF recurrence|35
4591841|NCT01534962|7438873|FG001|Overall Study|Discontinued at AF recurrence|26
4591842|NCT01534962|7438874|FG002|Overall Study|Discontinued at AF recurrence|24
4591843|NCT01534962|7438875|FG003|Overall Study|Discontinued at AF recurrence|31
4591844|NCT01535040|7438928|FG000|Overall Study|Physician Decision|0
4591845|NCT01535040|7438929|FG001|Overall Study|Physician Decision|1
4591846|NCT01535040|7438928|FG000|Overall Study|Withdrawal by Subject|13
4591847|NCT01535040|7438929|FG001|Overall Study|Withdrawal by Subject|10
4591848|NCT01535040|7438928|FG000|Overall Study|Never Started|9
4591849|NCT01535040|7438929|FG001|Overall Study|Never Started|4
4591850|NCT01535040|7438928|FG000|Overall Study|Toxicity|7
4591851|NCT01535040|7438929|FG001|Overall Study|Toxicity|5
4591852|NCT01535040|7438928|FG000|Overall Study|Multiple Reasons|1
4591853|NCT01535040|7438929|FG001|Overall Study|Multiple Reasons|1
4591854|NCT01535053|7438937|FG000|Overall Study|Ineligible|1
4591855|NCT01535053|7438938|FG001|Overall Study|Ineligible|2
4591856|NCT01535222|7438954|FG000|Overall Study|Inclusion/exclusion|0
4591857|NCT01535222|7438955|FG001|Overall Study|Inclusion/exclusion|0
4591858|NCT01535222|7438956|FG002|Overall Study|Inclusion/exclusion|1
4591859|NCT01535222|7438957|FG003|Overall Study|Inclusion/exclusion|0
4591860|NCT01535222|7438958|FG004|Overall Study|Inclusion/exclusion|0
4591861|NCT01535222|7438959|FG005|Overall Study|Inclusion/exclusion|0
4591862|NCT01535235|7438975|FG000|Overall Study|Adverse Event|1
4591863|NCT01535235|7438976|FG001|Overall Study|Adverse Event|0
4591864|NCT01535261|7438982|FG000|Overall Study|Physician Decision|8
4591865|NCT01535261|7438982|FG000|Overall Study|Protocol Violation|3
4591866|NCT01535261|7438982|FG000|Overall Study|Death|5
4591867|NCT01535261|7438982|FG000|Overall Study|Lost to Follow-up|8
4591868|NCT01535261|7438982|FG000|Overall Study|Withdrawal by Subject|14
4591869|NCT01535261|7438982|FG000|Overall Study|Adverse Event|12
4591870|NCT01535287|7438988|FG000|Overall Study|drug not prepared in time|5
4591871|NCT01535287|7438989|FG001|Overall Study|drug not prepared in time|6
4591872|NCT01535443|7439022|FG000|Overall Study|Physician Decision|3
4553882|NCT01231464|7383166|FG000|Overall Study|Adverse Event|0
4553883|NCT01231464|7383167|FG001|Overall Study|Adverse Event|1
4553884|NCT01231464|7383166|FG000|Overall Study|Protocol Violation|1
4553885|NCT01231464|7383167|FG001|Overall Study|Protocol Violation|2
4553886|NCT01231464|7383166|FG000|Overall Study|Lost to Follow-up|1
4553887|NCT01231464|7383167|FG001|Overall Study|Lost to Follow-up|2
4553888|NCT01231464|7383166|FG000|Overall Study|Withdrawal by Subject|3
4553889|NCT01231464|7383167|FG001|Overall Study|Withdrawal by Subject|2
4553890|NCT01231503|7383183|FG000|Overall Study|Adverse Event|0
4553891|NCT01231503|7383184|FG001|Overall Study|Adverse Event|0
4553892|NCT01231503|7383185|FG002|Overall Study|Adverse Event|0
4553893|NCT01231503|7383186|FG003|Overall Study|Adverse Event|0
4553894|NCT01231503|7383187|FG004|Overall Study|Adverse Event|0
4553895|NCT01231503|7383188|FG005|Overall Study|Adverse Event|1
4553896|NCT01231503|7383189|FG006|Overall Study|Adverse Event|0
4553897|NCT01231503|7383190|FG007|Overall Study|Adverse Event|0
4553898|NCT01231503|7383183|FG000|Overall Study|Adverse event, serious fatal|0
4553899|NCT01231503|7383184|FG001|Overall Study|Adverse event, serious fatal|0
4553900|NCT01231503|7383185|FG002|Overall Study|Adverse event, serious fatal|1
4553901|NCT01231503|7383186|FG003|Overall Study|Adverse event, serious fatal|1
4553902|NCT01231503|7383187|FG004|Overall Study|Adverse event, serious fatal|0
4553903|NCT01231503|7383188|FG005|Overall Study|Adverse event, serious fatal|1
4553904|NCT01231503|7383189|FG006|Overall Study|Adverse event, serious fatal|0
4553905|NCT01231503|7383190|FG007|Overall Study|Adverse event, serious fatal|0
4553906|NCT01231503|7383183|FG000|Overall Study|Withdrawal by Subject|6
4553907|NCT01231503|7383184|FG001|Overall Study|Withdrawal by Subject|3
4553908|NCT01231503|7383185|FG002|Overall Study|Withdrawal by Subject|3
4553909|NCT01231503|7383186|FG003|Overall Study|Withdrawal by Subject|1
4553910|NCT01231503|7383187|FG004|Overall Study|Withdrawal by Subject|3
4553911|NCT01231503|7383188|FG005|Overall Study|Withdrawal by Subject|5
4553912|NCT01231503|7383189|FG006|Overall Study|Withdrawal by Subject|1
4553913|NCT01231503|7383190|FG007|Overall Study|Withdrawal by Subject|2
4553914|NCT01231503|7383183|FG000|Overall Study|Lost to Follow-up|8
4553915|NCT01231503|7383184|FG001|Overall Study|Lost to Follow-up|10
4553916|NCT01231503|7383185|FG002|Overall Study|Lost to Follow-up|8
4553917|NCT01231503|7383186|FG003|Overall Study|Lost to Follow-up|5
4553918|NCT01231503|7383187|FG004|Overall Study|Lost to Follow-up|7
4553919|NCT01231503|7383188|FG005|Overall Study|Lost to Follow-up|9
4553920|NCT01231503|7383189|FG006|Overall Study|Lost to Follow-up|6
4553921|NCT01231503|7383190|FG007|Overall Study|Lost to Follow-up|6
4553922|NCT01231503|7383183|FG000|Overall Study|Protocol Violation|0
4553923|NCT01231503|7383184|FG001|Overall Study|Protocol Violation|0
4553924|NCT01231503|7383185|FG002|Overall Study|Protocol Violation|0
4553925|NCT01231503|7383186|FG003|Overall Study|Protocol Violation|1
4553926|NCT01231503|7383187|FG004|Overall Study|Protocol Violation|0
4553927|NCT01231503|7383188|FG005|Overall Study|Protocol Violation|0
4553928|NCT01231503|7383189|FG006|Overall Study|Protocol Violation|0
4553929|NCT01231503|7383190|FG007|Overall Study|Protocol Violation|0
4553930|NCT01231555|7383221|FG000|Overall Study|Study terminated|8
4553931|NCT01231555|7383222|FG001|Overall Study|Study terminated|5
4553932|NCT01231555|7383223|FG002|Overall Study|Study terminated|8
4553933|NCT01231555|7383221|FG000|Overall Study|Withdrawal by Subject|0
4553934|NCT01231555|7383222|FG001|Overall Study|Withdrawal by Subject|2
4553935|NCT01231555|7383223|FG002|Overall Study|Withdrawal by Subject|0
4553936|NCT01231581|7383233|FG000|Overall Study|Lost to Follow-up|2
4553937|NCT01231581|7383234|FG001|Overall Study|Lost to Follow-up|2
4553938|NCT01231581|7383233|FG000|Overall Study|Withdrawal by Subject|6
4553939|NCT01231581|7383234|FG001|Overall Study|Withdrawal by Subject|9
4553940|NCT01231581|7383233|FG000|Overall Study|Study Closed/Terminated|6
4553941|NCT01231581|7383234|FG001|Overall Study|Study Closed/Terminated|5
4621678|NCT01792830|7484190|FG001|Overall Study|Adverse Event|0
4621679|NCT01792830|7484191|FG002|Overall Study|Adverse Event|0
4621680|NCT01792830|7484192|FG003|Overall Study|Adverse Event|0
4621681|NCT01792830|7484193|FG004|Overall Study|Adverse Event|0
4621682|NCT01792830|7484194|FG005|Overall Study|Adverse Event|0
4621683|NCT01792830|7484195|FG006|Overall Study|Adverse Event|0
4621684|NCT01792830|7484196|FG007|Overall Study|Adverse Event|0
4621685|NCT01792830|7484197|FG008|Overall Study|Adverse Event|1
4621686|NCT01792830|7484198|FG009|Overall Study|Adverse Event|0
4621687|NCT01792830|7484199|FG010|Overall Study|Adverse Event|0
4621688|NCT01793051|7484235|FG000|Overall Study|Withdrawal by Subject|6
4621689|NCT01793051|7484236|FG001|Overall Study|Withdrawal by Subject|4
4621690|NCT01793051|7484235|FG000|Overall Study|Adverse Event|0
4621691|NCT01793051|7484236|FG001|Overall Study|Adverse Event|2
4621692|NCT01793051|7484235|FG000|Overall Study|Too ill to continue|1
4621693|NCT01793051|7484236|FG001|Overall Study|Too ill to continue|0
4621694|NCT01793051|7484235|FG000|Overall Study|Switched chemo|1
4553942|NCT01231581|7383233|FG000|Overall Study|Death|65
4621695|NCT01793051|7484236|FG001|Overall Study|Switched chemo|1
4621696|NCT01793051|7484235|FG000|Overall Study|Lack of compliance|1
4621697|NCT01793051|7484236|FG001|Overall Study|Lack of compliance|0
4553943|NCT01231581|7383234|FG001|Overall Study|Death|64
4553944|NCT01231581|7383233|FG000|Overall Study|Ongoing|1
4553945|NCT01231581|7383234|FG001|Overall Study|Ongoing|0
4553946|NCT01231607|7383245|FG000|Overall Study|Adverse Event|0
4621698|NCT01793051|7484235|FG000|Overall Study|Requested to be removed from the study|1
4621699|NCT01793051|7484236|FG001|Overall Study|Requested to be removed from the study|1
4621700|NCT01793142|7484242|FG000|Overall Study|Randomized not treated|7
4621701|NCT01793688|7484250|FG000|Overall Study|Protocol Violation|2
4621702|NCT01793792|7484254|FG000|Overall Study|Death|5
4621703|NCT01793792|7484254|FG000|Overall Study|Lost to Follow-up|5
4621704|NCT01793792|7484254|FG000|Overall Study|Withdrawal by Subject|1
4621705|NCT01793792|7484254|FG000|Overall Study|Device Not Implanted|1
4621706|NCT01793883|7484261|FG000|Overall Study|Withdrawal by Subject|3
4621707|NCT01793883|7484262|FG001|Overall Study|Withdrawal by Subject|7
4621708|NCT01793883|7484263|FG002|Overall Study|Withdrawal by Subject|3
4621709|NCT01793883|7484261|FG000|Overall Study|Subject noncompliance|0
4621710|NCT01793883|7484262|FG001|Overall Study|Subject noncompliance|1
4621711|NCT01793883|7484263|FG002|Overall Study|Subject noncompliance|1
4621712|NCT01793883|7484261|FG000|Overall Study|Lost to Follow-up|5
4621713|NCT01793883|7484262|FG001|Overall Study|Lost to Follow-up|1
4621714|NCT01793883|7484263|FG002|Overall Study|Lost to Follow-up|3
4621715|NCT01793883|7484261|FG000|Overall Study|Randomized in error|1
4621716|NCT01793883|7484262|FG001|Overall Study|Randomized in error|0
4621717|NCT01793883|7484263|FG002|Overall Study|Randomized in error|0
4621718|NCT01793883|7484261|FG000|Overall Study|Unable to complete spriometry|1
4621719|NCT01793883|7484262|FG001|Overall Study|Unable to complete spriometry|0
4621720|NCT01793883|7484263|FG002|Overall Study|Unable to complete spriometry|0
4621721|NCT01793883|7484261|FG000|Overall Study|Unable to complete measurements|1
4621722|NCT01793883|7484262|FG001|Overall Study|Unable to complete measurements|0
4621723|NCT01793883|7484263|FG002|Overall Study|Unable to complete measurements|0
4621724|NCT01793883|7484261|FG000|Overall Study|Met exclusion criteria|1
4621725|NCT01793883|7484262|FG001|Overall Study|Met exclusion criteria|0
4621726|NCT01793883|7484263|FG002|Overall Study|Met exclusion criteria|0
4621727|NCT01793883|7484261|FG000|Overall Study|Dosing error|0
4621728|NCT01793883|7484262|FG001|Overall Study|Dosing error|1
4621729|NCT01793883|7484263|FG002|Overall Study|Dosing error|0
4621730|NCT01793883|7484261|FG000|Overall Study|Respiratory distress during spirometry|0
4621731|NCT01793883|7484262|FG001|Overall Study|Respiratory distress during spirometry|0
4621732|NCT01793883|7484263|FG002|Overall Study|Respiratory distress during spirometry|1
4621733|NCT01793935|7484282|FG000|Overall Study|Pregnancy|1
4621734|NCT01793935|7484283|FG001|Overall Study|Pregnancy|0
4621735|NCT01793935|7484282|FG000|Overall Study|Protocol Violation|2
4621736|NCT01793935|7484283|FG001|Overall Study|Protocol Violation|1
4621737|NCT01793935|7484282|FG000|Overall Study|Adverse Event|2
4621738|NCT01793935|7484283|FG001|Overall Study|Adverse Event|0
4621739|NCT01793935|7484282|FG000|Overall Study|Patient did not take study medication|1
4621740|NCT01793935|7484283|FG001|Overall Study|Patient did not take study medication|1
4621741|NCT01793935|7484282|FG000|Overall Study|Lost to Follow-up|0
4621742|NCT01793935|7484283|FG001|Overall Study|Lost to Follow-up|1
4621743|NCT01794000|7484291|FG000|Double-Blind Phase (DBP)|Adverse Event|5
4621744|NCT01794000|7484292|FG001|Double-Blind Phase (DBP)|Adverse Event|2
4621745|NCT01794000|7484291|FG000|Double-Blind Phase (DBP)|Death|1
4621746|NCT01794000|7484292|FG001|Double-Blind Phase (DBP)|Death|2
4621747|NCT01794000|7484291|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2
4621748|NCT01794000|7484292|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0
4621749|NCT01794000|7484291|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5
4621750|NCT01794000|7484292|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2
4621751|NCT01794000|7484291|FG000|Double-Blind Phase (DBP)|Physician Decision|2
4621752|NCT01794000|7484292|FG001|Double-Blind Phase (DBP)|Physician Decision|0
4621753|NCT01794000|7484291|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148
4621754|NCT01794000|7484292|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149
4621755|NCT01794000|7484291|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6
4621756|NCT01794000|7484292|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11
4621757|NCT01794000|7484291|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3
4621758|NCT01794000|7484292|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0
4621759|NCT01794117|7484314|FG000|Overall Study|Adverse Event|1
4621760|NCT01794117|7484315|FG001|Overall Study|Adverse Event|0
4621761|NCT01794117|7484316|FG002|Overall Study|Adverse Event|0
4621762|NCT01794117|7484317|FG003|Overall Study|Adverse Event|0
4621763|NCT01794117|7484314|FG000|Overall Study|Participant noncompliance|0
4621764|NCT01794117|7484315|FG001|Overall Study|Participant noncompliance|1
4621765|NCT01794117|7484316|FG002|Overall Study|Participant noncompliance|0
4621766|NCT01794117|7484317|FG003|Overall Study|Participant noncompliance|0
4621767|NCT01794117|7484314|FG000|Overall Study|Refused further treatment|0
4621768|NCT01794117|7484315|FG001|Overall Study|Refused further treatment|2
4621769|NCT01794117|7484316|FG002|Overall Study|Refused further treatment|0
4621770|NCT01794117|7484317|FG003|Overall Study|Refused further treatment|0
4621771|NCT01794299|7484328|FG000|Overall Study|ATIR manufacturing not possible|1
4621772|NCT01794299|7484328|FG000|Overall Study|Death|14
4621773|NCT01794299|7484328|FG000|Overall Study|Graft failure|1
4621774|NCT01794299|7484328|FG000|Overall Study|ATIR batch rejected|2
4621775|NCT01794299|7484328|FG000|Overall Study|Relapse|2
4621776|NCT01794299|7484328|FG000|Overall Study|Discontinued from active follow-up|1
4621777|NCT01794299|7484328|FG000|Overall Study|Relapse and rejection of ATIR batch|1
4621778|NCT01794689|7484354|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3
4621779|NCT01794689|7484355|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0
4553947|NCT01231607|7383246|FG001|Overall Study|Adverse Event|8
4553948|NCT01231607|7383247|FG002|Overall Study|Adverse Event|4
4553949|NCT01231607|7383248|FG003|Overall Study|Adverse Event|4
4553950|NCT01231607|7383249|FG004|Overall Study|Adverse Event|5
4553951|NCT01231607|7383245|FG000|Overall Study|Lost to Follow-up|13
4553952|NCT01231607|7383246|FG001|Overall Study|Lost to Follow-up|11
4553953|NCT01231607|7383247|FG002|Overall Study|Lost to Follow-up|10
4553954|NCT01231607|7383248|FG003|Overall Study|Lost to Follow-up|10
4553955|NCT01231607|7383249|FG004|Overall Study|Lost to Follow-up|4
4553956|NCT01231607|7383245|FG000|Overall Study|Physician Decision|4
4553957|NCT01231607|7383246|FG001|Overall Study|Physician Decision|4
4553958|NCT01231607|7383247|FG002|Overall Study|Physician Decision|3
4553959|NCT01231607|7383248|FG003|Overall Study|Physician Decision|5
4553960|NCT01231607|7383249|FG004|Overall Study|Physician Decision|4
4553961|NCT01231607|7383245|FG000|Overall Study|Protocol Violation|3
4553962|NCT01231607|7383246|FG001|Overall Study|Protocol Violation|2
4553963|NCT01231607|7383247|FG002|Overall Study|Protocol Violation|0
4553964|NCT01231607|7383248|FG003|Overall Study|Protocol Violation|2
4553965|NCT01231607|7383249|FG004|Overall Study|Protocol Violation|2
4553966|NCT01231607|7383245|FG000|Overall Study|Withdrawal by Subject|9
4553967|NCT01231607|7383246|FG001|Overall Study|Withdrawal by Subject|9
4553968|NCT01231607|7383247|FG002|Overall Study|Withdrawal by Subject|14
4553969|NCT01231607|7383248|FG003|Overall Study|Withdrawal by Subject|17
4553970|NCT01231607|7383249|FG004|Overall Study|Withdrawal by Subject|9
4553971|NCT01231620|7383267|FG000|Overall Study|Physician Decision|3
4553972|NCT01231620|7383268|FG001|Overall Study|Physician Decision|5
4553973|NCT01231620|7383269|FG002|Overall Study|Physician Decision|10
4553974|NCT01231620|7383267|FG000|Overall Study|Death|12
4553975|NCT01231620|7383268|FG001|Overall Study|Death|14
4553976|NCT01231620|7383269|FG002|Overall Study|Death|11
4553977|NCT01231620|7383267|FG000|Overall Study|Adverse Event|2
4553978|NCT01231620|7383268|FG001|Overall Study|Adverse Event|2
4553979|NCT01231620|7383269|FG002|Overall Study|Adverse Event|1
4553980|NCT01231620|7383267|FG000|Overall Study|Withdrawal by Subject|6
4553981|NCT01231620|7383268|FG001|Overall Study|Withdrawal by Subject|6
4553982|NCT01231620|7383269|FG002|Overall Study|Withdrawal by Subject|8
4553983|NCT01231620|7383267|FG000|Overall Study|Lost to Follow-up|3
4553984|NCT01231620|7383268|FG001|Overall Study|Lost to Follow-up|4
4553985|NCT01231620|7383269|FG002|Overall Study|Lost to Follow-up|9
4553986|NCT01231659|7383297|FG000|Overall Study|Adverse Event|9
4553987|NCT01231659|7383297|FG000|Overall Study|Disease Progression|48
4553988|NCT01231659|7383297|FG000|Overall Study|Death|2
4553989|NCT01231659|7383297|FG000|Overall Study|Patient refused to complete study visit|1
4553990|NCT01231659|7383297|FG000|Overall Study|Other protocol defined criteria|12
4553991|NCT01231906|7383307|FG000|Overall Study|Lack of Efficacy|75
4553992|NCT01231906|7383308|FG001|Overall Study|Lack of Efficacy|68
4553993|NCT01231906|7383307|FG000|Overall Study|Lost to Follow-up|1
4553994|NCT01231906|7383308|FG001|Overall Study|Lost to Follow-up|0
4553995|NCT01231906|7383307|FG000|Overall Study|Physician Decision|34
4553996|NCT01231906|7383308|FG001|Overall Study|Physician Decision|24
4553997|NCT01231906|7383307|FG000|Overall Study|Withdrawal by Subject|0
4553998|NCT01231906|7383308|FG001|Overall Study|Withdrawal by Subject|4
4553999|NCT01231906|7383307|FG000|Overall Study|Ineligible|10
4554000|NCT01231906|7383308|FG001|Overall Study|Ineligible|3
4554001|NCT01231906|7383307|FG000|Overall Study|No treatment|1
4554002|NCT01231906|7383308|FG001|Overall Study|No treatment|2
4554003|NCT01231984|7383316|FG000|Study Period 1|Withdrawal by Subject|0
4554004|NCT01231984|7383317|FG001|Study Period 1|Withdrawal by Subject|0
4554005|NCT01231984|7383318|FG002|Study Period 1|Withdrawal by Subject|0
4554006|NCT01231984|7383319|FG003|Study Period 1|Withdrawal by Subject|1
4554007|NCT01231984|7383316|FG000|Study Period 1|Lost to Follow-up|1
4554008|NCT01231984|7383317|FG001|Study Period 1|Lost to Follow-up|1
4554009|NCT01231984|7383318|FG002|Study Period 1|Lost to Follow-up|1
4554010|NCT01231984|7383319|FG003|Study Period 1|Lost to Follow-up|0
4554011|NCT01231984|7383316|FG000|Study Period 1|Did not continue to meet I/E Criteria|2
4554012|NCT01231984|7383317|FG001|Study Period 1|Did not continue to meet I/E Criteria|2
4621780|NCT01794689|7484356|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2
4621781|NCT01794689|7484357|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4
4621782|NCT01794689|7484354|FG000|Intervention 1 (2 Nights)|Protocol Violation|1
4621783|NCT01794689|7484355|FG001|Intervention 1 (2 Nights)|Protocol Violation|0
4621784|NCT01794689|7484356|FG002|Intervention 1 (2 Nights)|Protocol Violation|1
4621785|NCT01794689|7484357|FG003|Intervention 1 (2 Nights)|Protocol Violation|0
4621786|NCT01794689|7484354|FG000|Intervention 1 (2 Nights)|Physician Decision|1
4621787|NCT01794689|7484355|FG001|Intervention 1 (2 Nights)|Physician Decision|1
4621788|NCT01794689|7484356|FG002|Intervention 1 (2 Nights)|Physician Decision|0
4621789|NCT01794689|7484357|FG003|Intervention 1 (2 Nights)|Physician Decision|0
4621790|NCT01794689|7484354|FG000|Intervention 1 (2 Nights)|Adverse Event|0
4621791|NCT01794689|7484355|FG001|Intervention 1 (2 Nights)|Adverse Event|1
4554013|NCT01231984|7383318|FG002|Study Period 1|Did not continue to meet I/E Criteria|2
4554014|NCT01231984|7383319|FG003|Study Period 1|Did not continue to meet I/E Criteria|2
4554015|NCT01231984|7383316|FG000|Study Period 1|Screen Failure|0
4554016|NCT01231984|7383317|FG001|Study Period 1|Screen Failure|0
4554017|NCT01231984|7383318|FG002|Study Period 1|Screen Failure|0
4554018|NCT01231984|7383319|FG003|Study Period 1|Screen Failure|1
4554019|NCT01231984|7383316|FG000|Study Period 1|Non-compliance with study requirements|5
4554020|NCT01231984|7383317|FG001|Study Period 1|Non-compliance with study requirements|0
4554021|NCT01231984|7383318|FG002|Study Period 1|Non-compliance with study requirements|2
4554022|NCT01231984|7383319|FG003|Study Period 1|Non-compliance with study requirements|1
4554023|NCT01231984|7383316|FG000|Study Period 1|Protocol Violation|3
4554024|NCT01231984|7383317|FG001|Study Period 1|Protocol Violation|4
4554025|NCT01231984|7383318|FG002|Study Period 1|Protocol Violation|2
4554026|NCT01231984|7383319|FG003|Study Period 1|Protocol Violation|3
4554027|NCT01231984|7383316|FG000|Study Period 1|Adverse Event|1
4554028|NCT01231984|7383317|FG001|Study Period 1|Adverse Event|0
4554029|NCT01231984|7383318|FG002|Study Period 1|Adverse Event|0
4554030|NCT01231984|7383319|FG003|Study Period 1|Adverse Event|0
4554031|NCT01231984|7383316|FG000|Study Period 1|Other|0
4554032|NCT01231984|7383317|FG001|Study Period 1|Other|0
4554033|NCT01231984|7383318|FG002|Study Period 1|Other|0
4554034|NCT01231984|7383319|FG003|Study Period 1|Other|1
4554035|NCT01231984|7383316|FG000|Study Period 2|Withdrawal by Subject|1
4554036|NCT01231984|7383317|FG001|Study Period 2|Withdrawal by Subject|1
4554037|NCT01231984|7383318|FG002|Study Period 2|Withdrawal by Subject|0
4554038|NCT01231984|7383319|FG003|Study Period 2|Withdrawal by Subject|0
4554039|NCT01231984|7383316|FG000|Study Period 2|Lost to Follow-up|1
4554040|NCT01231984|7383317|FG001|Study Period 2|Lost to Follow-up|0
4554041|NCT01231984|7383318|FG002|Study Period 2|Lost to Follow-up|0
4554042|NCT01231984|7383319|FG003|Study Period 2|Lost to Follow-up|3
4554043|NCT01231984|7383316|FG000|Study Period 2|Did not continue to meet I/E Criteria|1
4554044|NCT01231984|7383317|FG001|Study Period 2|Did not continue to meet I/E Criteria|1
4554045|NCT01231984|7383318|FG002|Study Period 2|Did not continue to meet I/E Criteria|0
4554046|NCT01231984|7383319|FG003|Study Period 2|Did not continue to meet I/E Criteria|1
4554047|NCT01232127|7383337|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1
4554048|NCT01232127|7383338|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0
4554049|NCT01232127|7383339|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0
4554050|NCT01232296|7383362|FG000|Overall Study|Adverse Event|24
4554051|NCT01232296|7383363|FG001|Overall Study|Adverse Event|12
4554052|NCT01232296|7383362|FG000|Overall Study|Physician Decision|1
4554053|NCT01232296|7383363|FG001|Overall Study|Physician Decision|1
4554054|NCT01232296|7383362|FG000|Overall Study|Progressive disease|43
4554055|NCT01232296|7383363|FG001|Overall Study|Progressive disease|61
4554056|NCT01232296|7383362|FG000|Overall Study|Study terminated by sponsor|0
4554057|NCT01232296|7383363|FG001|Overall Study|Study terminated by sponsor|1
4554058|NCT01232296|7383362|FG000|Overall Study|Technical problems|3
4554059|NCT01232296|7383363|FG001|Overall Study|Technical problems|0
4554060|NCT01232296|7383362|FG000|Overall Study|Subject/guardian decision|10
4554061|NCT01232296|7383363|FG001|Overall Study|Subject/guardian decision|2
4554062|NCT01232296|7383362|FG000|Overall Study|Death|1
4554063|NCT01232296|7383363|FG001|Overall Study|Death|6
4554064|NCT01232452|7383371|FG000|Overall Study|Adverse Event|17
4554065|NCT01232452|7383372|FG001|Overall Study|Adverse Event|15
4554066|NCT01232452|7383371|FG000|Overall Study|Withdrawal by Subject|11
4554067|NCT01232452|7383372|FG001|Overall Study|Withdrawal by Subject|8
4554068|NCT01232452|7383371|FG000|Overall Study|Physician Decision|8
4554069|NCT01232452|7383372|FG001|Overall Study|Physician Decision|12
4554070|NCT01232452|7383371|FG000|Overall Study|Protocol entry criterion not met|0
4554071|NCT01232452|7383372|FG001|Overall Study|Protocol entry criterion not met|2
4554072|NCT01232452|7383371|FG000|Overall Study|Sponsor Decision|3
4554073|NCT01232452|7383372|FG001|Overall Study|Sponsor Decision|1
4554074|NCT01232452|7383371|FG000|Overall Study|Protocol Violation|0
4554075|NCT01232452|7383372|FG001|Overall Study|Protocol Violation|1
4554076|NCT01232491|7383389|FG000|Overall Study|Adverse Event|13
4554077|NCT01232491|7383390|FG001|Overall Study|Adverse Event|8
4554078|NCT01232491|7383389|FG000|Overall Study|Lack of Efficacy|1
4554079|NCT01232491|7383390|FG001|Overall Study|Lack of Efficacy|5
4554080|NCT01232491|7383389|FG000|Overall Study|Protocol Violation|13
4554081|NCT01232491|7383390|FG001|Overall Study|Protocol Violation|11
4554082|NCT01232491|7383389|FG000|Overall Study|Withdrawal Criteria|12
4554083|NCT01232491|7383390|FG001|Overall Study|Withdrawal Criteria|21
4554084|NCT01232491|7383389|FG000|Overall Study|Other|21
4554085|NCT01232491|7383390|FG001|Overall Study|Other|18
4554086|NCT01232556|7383419|FG000|Overall Study|Withdrawal by Subject|21
4554087|NCT01232556|7383420|FG001|Overall Study|Withdrawal by Subject|17
4554088|NCT01232556|7383419|FG000|Overall Study|Death|97
4554089|NCT01232556|7383420|FG001|Overall Study|Death|97
4554090|NCT01232556|7383419|FG000|Overall Study|Lost to Follow-up|0
4554091|NCT01232556|7383420|FG001|Overall Study|Lost to Follow-up|2
4554092|NCT01232556|7383419|FG000|Overall Study|Terminated by Sponsor|35
4554093|NCT01232556|7383420|FG001|Overall Study|Terminated by Sponsor|51
4554094|NCT01232556|7383419|FG000|Overall Study|Other|6
4554095|NCT01232556|7383420|FG001|Overall Study|Other|4
4554096|NCT01232569|7383428|FG000|Double-blind Treatment Period|Withdrawal by Subject|9
4554097|NCT01232569|7383429|FG001|Double-blind Treatment Period|Withdrawal by Subject|2
4554098|NCT01232569|7383430|FG002|Double-blind Treatment Period|Withdrawal by Subject|0
4554099|NCT01232569|7383431|FG003|Double-blind Treatment Period|Withdrawal by Subject|0
4554100|NCT01232569|7383428|FG000|Double-blind Treatment Period|Escape|2
4554101|NCT01232569|7383429|FG001|Double-blind Treatment Period|Escape|2
4554102|NCT01232569|7383430|FG002|Double-blind Treatment Period|Escape|0
4554103|NCT01232569|7383431|FG003|Double-blind Treatment Period|Escape|0
4554104|NCT01232569|7383428|FG000|Double-blind Treatment Period|Lost to Follow-up|4
4554105|NCT01232569|7383429|FG001|Double-blind Treatment Period|Lost to Follow-up|0
4554106|NCT01232569|7383430|FG002|Double-blind Treatment Period|Lost to Follow-up|0
4554107|NCT01232569|7383431|FG003|Double-blind Treatment Period|Lost to Follow-up|0
4554108|NCT01232569|7383428|FG000|Double-blind Treatment Period|Lack of Efficacy|1
4554109|NCT01232569|7383429|FG001|Double-blind Treatment Period|Lack of Efficacy|2
4554110|NCT01232569|7383430|FG002|Double-blind Treatment Period|Lack of Efficacy|0
4554111|NCT01232569|7383431|FG003|Double-blind Treatment Period|Lack of Efficacy|0
4554112|NCT01232569|7383428|FG000|Double-blind Treatment Period|Physician Decision|1
4554113|NCT01232569|7383429|FG001|Double-blind Treatment Period|Physician Decision|0
4554114|NCT01232569|7383430|FG002|Double-blind Treatment Period|Physician Decision|0
4554115|NCT01232569|7383431|FG003|Double-blind Treatment Period|Physician Decision|0
4554116|NCT01232569|7383428|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9
4554117|NCT01232569|7383429|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3
4554118|NCT01232569|7383430|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0
4554119|NCT01232569|7383431|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0
4554120|NCT01232569|7383428|FG000|Double-blind Treatment Period|Death|2
4554121|NCT01232569|7383429|FG001|Double-blind Treatment Period|Death|0
4554122|NCT01232569|7383430|FG002|Double-blind Treatment Period|Death|0
4554123|NCT01232569|7383431|FG003|Double-blind Treatment Period|Death|0
4554124|NCT01232738|7383440|FG000|Overall Study|Death|3
4554125|NCT01232738|7383440|FG000|Overall Study|Physician Decision|2
4554126|NCT01232738|7383440|FG000|Overall Study|Lost to Follow-up|1
4554127|NCT01232738|7383440|FG000|Overall Study|Withdrawal by Subject|2
4554128|NCT01232738|7383440|FG000|Overall Study|Adverse Event|5
4554129|NCT01232790|7383448|FG000|Randomization|Withdrawal by Subject|2
4554130|NCT01232790|7383449|FG001|Randomization|Withdrawal by Subject|0
4554131|NCT01232790|7383448|FG000|Randomization|Protocol Violation|0
4554132|NCT01232790|7383449|FG001|Randomization|Protocol Violation|1
4554133|NCT01232790|7383448|FG000|Randomization|Physician Decision|0
4554134|NCT01232790|7383449|FG001|Randomization|Physician Decision|1
4554135|NCT01232790|7383448|FG000|Initial Assessment|Withdrawal by Subject|0
4554136|NCT01232790|7383449|FG001|Initial Assessment|Withdrawal by Subject|1
4554137|NCT01232790|7383448|FG000|First Crossover|Withdrawal by Subject|1
4554138|NCT01232790|7383449|FG001|First Crossover|Withdrawal by Subject|0
4554139|NCT01232790|7383448|FG000|Second Crossover|Withdrawal by Subject|1
4554140|NCT01232790|7383449|FG001|Second Crossover|Withdrawal by Subject|2
4554141|NCT01232868|7383471|FG000|Overall Study|Lost to Follow-up|2
4554142|NCT01232868|7383472|FG001|Overall Study|Lost to Follow-up|4
4554143|NCT01232894|7383480|FG000|Overall Study|Lost to Follow-up|0
4554144|NCT01232894|7383481|FG001|Overall Study|Lost to Follow-up|1
4554145|NCT01232894|7383480|FG000|Overall Study|Death|1
4554146|NCT01232894|7383481|FG001|Overall Study|Death|0
4554147|NCT01232894|7383480|FG000|Overall Study|Protocol Violation|1
4554148|NCT01232894|7383481|FG001|Overall Study|Protocol Violation|1
4554149|NCT01232894|7383480|FG000|Overall Study|Withdrawal by Subject|8
4554150|NCT01232894|7383481|FG001|Overall Study|Withdrawal by Subject|5
4554151|NCT01232894|7383480|FG000|Overall Study|Physician Decision|2
4554152|NCT01232894|7383481|FG001|Overall Study|Physician Decision|1
4554153|NCT01233050|7383511|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8
4554154|NCT01233050|7383512|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6
4554155|NCT01233076|7383518|FG000|Period 2, One Week|Lost to Follow-up|1
4554156|NCT01233076|7383519|FG001|Period 2, One Week|Lost to Follow-up|0
4554157|NCT01233232|7383528|FG000|Overall Study|Voluntary Discontinuation by Subject|1
4554158|NCT01233232|7383529|FG001|Overall Study|Voluntary Discontinuation by Subject|0
4554159|NCT01233232|7383530|FG002|Overall Study|Voluntary Discontinuation by Subject|0
4554160|NCT01233258|7383543|FG000|First Intervention (6 Months)|Withdrawal by Subject|0
4554161|NCT01233258|7383544|FG001|First Intervention (6 Months)|Withdrawal by Subject|0
4554162|NCT01233258|7383545|FG002|First Intervention (6 Months)|Withdrawal by Subject|0
4554163|NCT01233258|7383546|FG003|First Intervention (6 Months)|Withdrawal by Subject|1
4554164|NCT01233258|7383547|FG004|First Intervention (6 Months)|Withdrawal by Subject|0
4554165|NCT01233258|7383548|FG005|First Intervention (6 Months)|Withdrawal by Subject|1
4554166|NCT01233258|7383543|FG000|First Intervention (6 Months)|Protocol Violation|0
4554167|NCT01233258|7383544|FG001|First Intervention (6 Months)|Protocol Violation|0
4554168|NCT01233258|7383545|FG002|First Intervention (6 Months)|Protocol Violation|1
4554169|NCT01233258|7383546|FG003|First Intervention (6 Months)|Protocol Violation|0
4554170|NCT01233258|7383547|FG004|First Intervention (6 Months)|Protocol Violation|0
4554171|NCT01233258|7383548|FG005|First Intervention (6 Months)|Protocol Violation|0
4554172|NCT01233258|7383543|FG000|First Intervention (6 Months)|Non-compliance with study medication|1
4554173|NCT01233258|7383544|FG001|First Intervention (6 Months)|Non-compliance with study medication|0
4554174|NCT01233258|7383545|FG002|First Intervention (6 Months)|Non-compliance with study medication|0
4554175|NCT01233258|7383546|FG003|First Intervention (6 Months)|Non-compliance with study medication|0
4554176|NCT01233258|7383547|FG004|First Intervention (6 Months)|Non-compliance with study medication|0
4554177|NCT01233258|7383548|FG005|First Intervention (6 Months)|Non-compliance with study medication|0
4554178|NCT01233284|7383563|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1
4554179|NCT01233284|7383564|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0
4554180|NCT01233284|7383565|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0
4554181|NCT01233284|7383566|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0
4554182|NCT01233284|7383567|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0
4554183|NCT01233284|7383563|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0
4554184|NCT01233284|7383564|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1
4554185|NCT01233284|7383565|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0
4554186|NCT01233284|7383566|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0
4554187|NCT01233284|7383567|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0
4554188|NCT01233284|7383563|FG000|Period 1 (4 Weeks)|Other|0
4554189|NCT01233284|7383564|FG001|Period 1 (4 Weeks)|Other|0
4554190|NCT01233284|7383565|FG002|Period 1 (4 Weeks)|Other|1
4554191|NCT01233284|7383566|FG003|Period 1 (4 Weeks)|Other|0
4554192|NCT01233284|7383567|FG004|Period 1 (4 Weeks)|Other|0
4554193|NCT01233284|7383563|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0
4554194|NCT01233284|7383564|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0
4554195|NCT01233284|7383565|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1
4554196|NCT01233284|7383566|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0
4554197|NCT01233284|7383567|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0
4554198|NCT01233284|7383563|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0
4554199|NCT01233284|7383564|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0
4554200|NCT01233284|7383565|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1
4554201|NCT01233284|7383566|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0
4554202|NCT01233284|7383567|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0
4554203|NCT01233284|7383563|FG000|Period 3 (4 Weeks)|Other|0
4554204|NCT01233284|7383564|FG001|Period 3 (4 Weeks)|Other|0
4554205|NCT01233284|7383565|FG002|Period 3 (4 Weeks)|Other|0
4554206|NCT01233284|7383566|FG003|Period 3 (4 Weeks)|Other|1
4554207|NCT01233284|7383567|FG004|Period 3 (4 Weeks)|Other|0
4554208|NCT01233284|7383563|FG000|Period 4 (4 Weeks)|Adverse Event|0
4554209|NCT01233284|7383564|FG001|Period 4 (4 Weeks)|Adverse Event|1
4554210|NCT01233284|7383565|FG002|Period 4 (4 Weeks)|Adverse Event|0
4554211|NCT01233284|7383566|FG003|Period 4 (4 Weeks)|Adverse Event|0
4554212|NCT01233284|7383567|FG004|Period 4 (4 Weeks)|Adverse Event|0
4554213|NCT01233284|7383563|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0
4554214|NCT01233284|7383564|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0
4554215|NCT01233284|7383565|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0
4554216|NCT01233284|7383566|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1
4554217|NCT01233284|7383567|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0
4554218|NCT01233609|7383584|FG000|Overall Study|Death|1
4554219|NCT01233609|7383585|FG001|Overall Study|Death|0
4554220|NCT01233609|7383584|FG000|Overall Study|Lost to Follow-up|3
4554221|NCT01233609|7383585|FG001|Overall Study|Lost to Follow-up|1
4554222|NCT01233609|7383584|FG000|Overall Study|Adverse Event|2
4554223|NCT01233609|7383585|FG001|Overall Study|Adverse Event|1
4554224|NCT01233609|7383584|FG000|Overall Study|Withdrawal by Subject|3
4554225|NCT01233609|7383585|FG001|Overall Study|Withdrawal by Subject|0
4554226|NCT01233687|7383599|FG000|Phase II AMG 102 + Erlotinib|Death|1
4554227|NCT01233687|7383599|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2
4554228|NCT01233687|7383599|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1
4554229|NCT01233817|7383619|FG000|Overall Study|Lost to Follow-up|1
4554230|NCT01233817|7383619|FG000|Overall Study|Withdrawal by Subject|2
4554231|NCT01233869|7383627|FG000|Initial Treatment Period (24 Months)|Death|1
4554232|NCT01233869|7383628|FG001|Initial Treatment Period (24 Months)|Death|0
4554233|NCT01233869|7383629|FG002|Initial Treatment Period (24 Months)|Death|0
4554234|NCT01233869|7383630|FG003|Initial Treatment Period (24 Months)|Death|0
4554235|NCT01233869|7383627|FG000|Initial Treatment Period (24 Months)|Adverse Event|9
4554236|NCT01233869|7383628|FG001|Initial Treatment Period (24 Months)|Adverse Event|17
4554237|NCT01233869|7383629|FG002|Initial Treatment Period (24 Months)|Adverse Event|0
4554238|NCT01233869|7383630|FG003|Initial Treatment Period (24 Months)|Adverse Event|3
4554239|NCT01233869|7383627|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14
4554240|NCT01233869|7383628|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11
4554241|NCT01233869|7383629|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2
4554242|NCT01233869|7383630|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19
4554243|NCT01233869|7383627|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0
4554244|NCT01233869|7383628|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0
4554245|NCT01233869|7383629|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0
4554246|NCT01233869|7383630|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1
4554247|NCT01233869|7383627|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10
4554248|NCT01233869|7383628|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3
4554249|NCT01233869|7383629|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5
4554250|NCT01233869|7383630|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11
4554251|NCT01233869|7383627|FG000|Extended Treatment Period (46 Months)|Other|3
4554252|NCT01233869|7383628|FG001|Extended Treatment Period (46 Months)|Other|0
4554253|NCT01233869|7383629|FG002|Extended Treatment Period (46 Months)|Other|0
4554254|NCT01233869|7383630|FG003|Extended Treatment Period (46 Months)|Other|3
4554255|NCT01233869|7383627|FG000|Extended Treatment Period (46 Months)|Adverse Event|1
4554256|NCT01233869|7383628|FG001|Extended Treatment Period (46 Months)|Adverse Event|0
4554257|NCT01233869|7383629|FG002|Extended Treatment Period (46 Months)|Adverse Event|0
4554258|NCT01233869|7383630|FG003|Extended Treatment Period (46 Months)|Adverse Event|1
4554259|NCT01233999|7383649|FG000|Overall Study|Withdrawal by Subject|1
4554260|NCT01233999|7383649|FG000|Overall Study|Lost to Follow-up|1
4554261|NCT01234337|7383664|FG000|Overall Study|Adverse Event|58
4554262|NCT01234337|7383665|FG001|Overall Study|Adverse Event|21
4554263|NCT01234337|7383664|FG000|Overall Study|Disease progression/recurrence/relapse|181
4554264|NCT01234337|7383665|FG001|Overall Study|Disease progression/recurrence/relapse|223
4554265|NCT01234337|7383664|FG000|Overall Study|Investi. decision not protocol driven|5
4554266|NCT01234337|7383665|FG001|Overall Study|Investi. decision not protocol driven|6
4554267|NCT01234337|7383664|FG000|Overall Study|Non-compliant with study medication|3
4554268|NCT01234337|7383665|FG001|Overall Study|Non-compliant with study medication|2
4554269|NCT01234337|7383664|FG000|Overall Study|Randomized but not treated|6
4554270|NCT01234337|7383665|FG001|Overall Study|Randomized but not treated|4
4554271|NCT01234337|7383664|FG000|Overall Study|Lost to Follow-up|0
4554272|NCT01234337|7383665|FG001|Overall Study|Lost to Follow-up|1
4554273|NCT01234337|7383664|FG000|Overall Study|Protocol Violation|2
4554274|NCT01234337|7383665|FG001|Overall Study|Protocol Violation|3
4554275|NCT01234337|7383664|FG000|Overall Study|Withdrawal by Subject|11
4554276|NCT01234337|7383665|FG001|Overall Study|Withdrawal by Subject|9
4554277|NCT01234337|7383664|FG000|Overall Study|Death|0
4554278|NCT01234337|7383665|FG001|Overall Study|Death|1
4554279|NCT01234337|7383664|FG000|Overall Study|Switch to commercial drug|0
4554280|NCT01234337|7383665|FG001|Overall Study|Switch to commercial drug|1
4554281|NCT01234350|7383673|FG000|Overall Study|Adverse Event|277
4554282|NCT01234350|7383674|FG001|Overall Study|Adverse Event|92
4554283|NCT01234350|7383673|FG000|Overall Study|Withdrawal by Subject|61
4554284|NCT01234350|7383674|FG001|Overall Study|Withdrawal by Subject|36
4554285|NCT01234350|7383673|FG000|Overall Study|Lost to Follow-up|115
4554286|NCT01234350|7383674|FG001|Overall Study|Lost to Follow-up|47
4554287|NCT01234350|7383673|FG000|Overall Study|Covers a diverse set of reasons|234
4554288|NCT01234350|7383674|FG001|Overall Study|Covers a diverse set of reasons|92
4554289|NCT01234402|7383685|FG000|Overall Study|Lost to Follow-up|0
4554290|NCT01234402|7383686|FG001|Overall Study|Lost to Follow-up|1
4554291|NCT01234402|7383687|FG002|Overall Study|Lost to Follow-up|3
4554292|NCT01234402|7383685|FG000|Overall Study|Withdrawal by Subject|1
4554293|NCT01234402|7383686|FG001|Overall Study|Withdrawal by Subject|3
4554294|NCT01234402|7383687|FG002|Overall Study|Withdrawal by Subject|4
4554295|NCT01234402|7383685|FG000|Overall Study|Never treated: Death|0
4554296|NCT01234402|7383686|FG001|Overall Study|Never treated: Death|0
4554297|NCT01234402|7383687|FG002|Overall Study|Never treated: Death|1
4554298|NCT01234402|7383685|FG000|Overall Study|Never treated: Withdrawal By Subject|0
4554299|NCT01234402|7383686|FG001|Overall Study|Never treated: Withdrawal By Subject|1
4554300|NCT01234402|7383687|FG002|Overall Study|Never treated: Withdrawal By Subject|0
4554301|NCT01234402|7383685|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0
4554302|NCT01234402|7383686|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1
4554303|NCT01234402|7383687|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0
4554304|NCT01234467|7383697|FG000|Overall Study|Adverse Event|3
4554305|NCT01234467|7383697|FG000|Overall Study|Death|2
4554306|NCT01234467|7383697|FG000|Overall Study|Withdrawal by Subject|2
4554307|NCT01234467|7383697|FG000|Overall Study|Disease Progression|2
4554308|NCT01234467|7383697|FG000|Overall Study|Clinical deterioration|1
4554309|NCT01234467|7383697|FG000|Overall Study|Physician Decision|1
4554310|NCT01234467|7383697|FG000|Overall Study|Other complicating disease (stroke)|1
4554311|NCT01234480|7383701|FG000|Overall Study|Pregnancy|88
4554312|NCT01234480|7383701|FG000|Overall Study|>36/Normal History|50
4554313|NCT01234480|7383701|FG000|Overall Study|Age|3
4554314|NCT01234480|7383701|FG000|Overall Study|HPV Vaccine History|28
4554315|NCT01234480|7383701|FG000|Overall Study|HPV Vaccine after Enrollment|17
4554316|NCT01234480|7383701|FG000|Overall Study|Hysterectomy|2
4554317|NCT01234480|7383701|FG000|Overall Study|Hysterectomy post enrollment|1
4554318|NCT01234480|7383701|FG000|Overall Study|Inclusion/Exclusion Violation|3
4554319|NCT01234480|7383701|FG000|Overall Study|Informed Consent Form Violation|30
4554320|NCT01234480|7383701|FG000|Overall Study|Incorrect Visit|3
4554321|NCT01234480|7383701|FG000|Overall Study|No Florida Lab License|20
4554322|NCT01234480|7383701|FG000|Overall Study|Out of Window|42
4554323|NCT01234480|7383701|FG000|Overall Study|Sample Processing/Storage|92
4554324|NCT01234480|7383701|FG000|Overall Study|Site Amendment prohibited colposcopy|11
4554325|NCT01234480|7383701|FG000|Overall Study|Site/Subject non-compliance|44
4554326|NCT01234480|7383701|FG000|Overall Study|Missing Sample|9
4554327|NCT01234649|7383710|FG000|Overall Study|Withdrawal by Subject|32
4554328|NCT01234649|7383711|FG001|Overall Study|Withdrawal by Subject|26
4554329|NCT01234649|7383710|FG000|Overall Study|Pregnancy|6
4554330|NCT01234649|7383711|FG001|Overall Study|Pregnancy|6
4554331|NCT01234649|7383710|FG000|Overall Study|intolerant to side effects|4
4554332|NCT01234649|7383711|FG001|Overall Study|intolerant to side effects|3
4554333|NCT01234649|7383710|FG000|Overall Study|Allergic reaction|1
4554334|NCT01234649|7383711|FG001|Overall Study|Allergic reaction|0
4554335|NCT01234649|7383710|FG000|Overall Study|Lack of Efficacy|0
4554336|NCT01234649|7383711|FG001|Overall Study|Lack of Efficacy|3
4554337|NCT01234675|7383717|FG000|First Intervention (6 Weeks)|Adverse Event|0
4554338|NCT01234675|7383718|FG001|First Intervention (6 Weeks)|Adverse Event|1
4554339|NCT01234675|7383717|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1
4554340|NCT01234675|7383718|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0
4554341|NCT01234883|7383752|FG000|Overall Study|Early treatment release|8
4554342|NCT01234883|7383753|FG001|Overall Study|Early treatment release|10
4554343|NCT01234883|7383752|FG000|Overall Study|Parent/guardian withdrew consent|1
4554344|NCT01234883|7383753|FG001|Overall Study|Parent/guardian withdrew consent|2
4554345|NCT01234883|7383752|FG000|Overall Study|Technical difficulties with IV infusion|0
4554346|NCT01234883|7383753|FG001|Overall Study|Technical difficulties with IV infusion|1
4554347|NCT01234883|7383752|FG000|Overall Study|Inclusion/exclusion failure|1
4554348|NCT01234883|7383753|FG001|Overall Study|Inclusion/exclusion failure|0
4554349|NCT01235234|7383786|FG000|Overall Study|Adverse Event|2
4554350|NCT01235234|7383787|FG001|Overall Study|Adverse Event|2
4554351|NCT01235234|7383788|FG002|Overall Study|Adverse Event|1
4554352|NCT01235338|7383798|FG000|Overall Study|Adverse Event|3
4554353|NCT01235338|7383799|FG001|Overall Study|Adverse Event|2
4554354|NCT01235338|7383798|FG000|Overall Study|Protocol Violation|1
4554355|NCT01235338|7383799|FG001|Overall Study|Protocol Violation|1
4554356|NCT01235338|7383798|FG000|Overall Study|Withdrawal by Subject|5
4554357|NCT01235338|7383799|FG001|Overall Study|Withdrawal by Subject|0
4554358|NCT01235338|7383798|FG000|Overall Study|Exclusion criteria violations|1
4554359|NCT01235338|7383799|FG001|Overall Study|Exclusion criteria violations|1
4554360|NCT01235338|7383798|FG000|Overall Study|Positive drug screen|0
4554361|NCT01235338|7383799|FG001|Overall Study|Positive drug screen|1
4554362|NCT01235338|7383798|FG000|Overall Study|Prohibited meds|1
4554363|NCT01235338|7383799|FG001|Overall Study|Prohibited meds|0
4554364|NCT01235351|7383809|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10
4554365|NCT01235351|7383810|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4
4554366|NCT01235403|7383829|FG000|Overall Study|Adverse Event|14
4554367|NCT01235403|7383829|FG000|Overall Study|Lost to Follow-up|2
4554368|NCT01235403|7383829|FG000|Overall Study|Withdrawal by Subject|4
4554369|NCT01235403|7383829|FG000|Overall Study|Lack of Efficacy|2
4554370|NCT01235403|7383829|FG000|Overall Study|Other reasons for premature termination|4
4554371|NCT01235442|7383835|FG000|Overall Study|Lost to Follow-up|12
4554372|NCT01235442|7383836|FG001|Overall Study|Lost to Follow-up|10
4554373|NCT01235442|7383835|FG000|Overall Study|Death|0
4554374|NCT01235442|7383836|FG001|Overall Study|Death|2
4554375|NCT01235442|7383835|FG000|Overall Study|Pregnancy|1
4554376|NCT01235442|7383836|FG001|Overall Study|Pregnancy|1
4554377|NCT01235442|7383835|FG000|Overall Study|Ineligibility determined|5
4554378|NCT01235442|7383836|FG001|Overall Study|Ineligibility determined|4
4554379|NCT01235442|7383835|FG000|Overall Study|Protocol Violation|3
4554380|NCT01235442|7383836|FG001|Overall Study|Protocol Violation|3
4554381|NCT01235442|7383835|FG000|Overall Study|Adverse Event|4
4554382|NCT01235442|7383836|FG001|Overall Study|Adverse Event|6
4554383|NCT01235442|7383835|FG000|Overall Study|Withdrawal by Subject|15
4554384|NCT01235442|7383836|FG001|Overall Study|Withdrawal by Subject|9
4554385|NCT01235442|7383835|FG000|Overall Study|Lack of Efficacy|1
4621792|NCT01794689|7484356|FG002|Intervention 1 (2 Nights)|Adverse Event|0
4621793|NCT01794689|7484357|FG003|Intervention 1 (2 Nights)|Adverse Event|0
4621794|NCT01794780|7484403|FG000|Overall Study|Adverse Event|0
4621795|NCT01794780|7484404|FG001|Overall Study|Adverse Event|1
4621796|NCT01794780|7484405|FG002|Overall Study|Adverse Event|2
4621797|NCT01794780|7484406|FG003|Overall Study|Adverse Event|0
4621798|NCT01794780|7484407|FG004|Overall Study|Adverse Event|0
4621799|NCT01794780|7484408|FG005|Overall Study|Adverse Event|0
4621800|NCT01794780|7484409|FG006|Overall Study|Adverse Event|0
4621801|NCT01794780|7484410|FG007|Overall Study|Adverse Event|0
4621802|NCT01794780|7484403|FG000|Overall Study|Death|0
4621803|NCT01794780|7484404|FG001|Overall Study|Death|2
4621804|NCT01794780|7484405|FG002|Overall Study|Death|14
4621805|NCT01794780|7484406|FG003|Overall Study|Death|1
4621806|NCT01794780|7484407|FG004|Overall Study|Death|0
4621807|NCT01794780|7484408|FG005|Overall Study|Death|9
4621808|NCT01794780|7484409|FG006|Overall Study|Death|4
4621809|NCT01794780|7484410|FG007|Overall Study|Death|0
4621810|NCT01794780|7484403|FG000|Overall Study|Lost to Follow-up|10
4554386|NCT01235442|7383836|FG001|Overall Study|Lack of Efficacy|3
4554387|NCT01235442|7383835|FG000|Overall Study|Noncompliance|1
4554388|NCT01235442|7383836|FG001|Overall Study|Noncompliance|2
4554389|NCT01235442|7383835|FG000|Overall Study|Administrative decision|1
4554390|NCT01235442|7383836|FG001|Overall Study|Administrative decision|2
4554391|NCT01235442|7383835|FG000|Overall Study|Other unspecified|1
4554392|NCT01235442|7383836|FG001|Overall Study|Other unspecified|2
4554393|NCT01235507|7383842|FG000|Overall Study|Adverse Event|1
4554394|NCT01235507|7383842|FG000|Overall Study|Withdrawal by Subject|1
4554395|NCT01235546|7383848|FG000|Overall Study|Staff error, medication not administered|1
4554396|NCT01235546|7383849|FG001|Overall Study|Staff error, medication not administered|0
4554397|NCT01235546|7383848|FG000|Overall Study|Protocol Violation|1
4554398|NCT01235546|7383849|FG001|Overall Study|Protocol Violation|1
4554399|NCT01235598|7383866|FG000|Overall Study|Adverse Event|0
4554400|NCT01235598|7383867|FG001|Overall Study|Adverse Event|3
4621811|NCT01794780|7484404|FG001|Overall Study|Lost to Follow-up|64
4621812|NCT01794780|7484405|FG002|Overall Study|Lost to Follow-up|165
4554401|NCT01235598|7383866|FG000|Overall Study|Lack of Efficacy|0
4554402|NCT01235598|7383867|FG001|Overall Study|Lack of Efficacy|1
4554403|NCT01235598|7383866|FG000|Overall Study|Withdrawal by Subject|1
4554404|NCT01235598|7383867|FG001|Overall Study|Withdrawal by Subject|0
4554405|NCT01235689|7383876|FG000|Overall Study|Adverse Event|12
4554406|NCT01235689|7383877|FG001|Overall Study|Adverse Event|16
4554407|NCT01235689|7383876|FG000|Overall Study|Lack of Efficacy|12
4554408|NCT01235689|7383877|FG001|Overall Study|Lack of Efficacy|5
4554409|NCT01235689|7383876|FG000|Overall Study|Withdrawal by Subject|3
4554410|NCT01235689|7383877|FG001|Overall Study|Withdrawal by Subject|4
4554411|NCT01235689|7383876|FG000|Overall Study|Lost to Follow-up|1
4554412|NCT01235689|7383877|FG001|Overall Study|Lost to Follow-up|2
4554413|NCT01235689|7383876|FG000|Overall Study|Miscellaneous|1
4554414|NCT01235689|7383877|FG001|Overall Study|Miscellaneous|5
4554415|NCT01235715|7383885|FG000|Overall Study|Physician Decision|0
4554416|NCT01235715|7383886|FG001|Overall Study|Physician Decision|2
4554417|NCT01235728|7383893|FG000|Overall Study|Protocol Violation|0
4554418|NCT01235728|7383894|FG001|Overall Study|Protocol Violation|0
4554419|NCT01235728|7383895|FG002|Overall Study|Protocol Violation|0
4554420|NCT01235728|7383896|FG003|Overall Study|Protocol Violation|1
4554421|NCT01235728|7383897|FG004|Overall Study|Protocol Violation|0
4554422|NCT01235728|7383898|FG005|Overall Study|Protocol Violation|0
4554423|NCT01235728|7383899|FG006|Overall Study|Protocol Violation|0
4554424|NCT01235728|7383900|FG007|Overall Study|Protocol Violation|0
4554425|NCT01235741|7383911|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9
4554426|NCT01235741|7383912|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0
4554427|NCT01235741|7383913|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0
4554428|NCT01235741|7383911|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121
4554429|NCT01235741|7383912|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0
4554430|NCT01235741|7383913|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0
4554431|NCT01235741|7383911|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1
4554432|NCT01235741|7383912|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0
4554433|NCT01235741|7383913|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0
4554434|NCT01235741|7383911|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1
4554435|NCT01235741|7383912|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0
4554436|NCT01235741|7383913|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0
4554437|NCT01235741|7383911|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5
4554438|NCT01235741|7383912|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0
4554439|NCT01235741|7383913|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0
4554440|NCT01235741|7383911|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4
4554441|NCT01235741|7383912|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0
4554442|NCT01235741|7383913|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0
4554443|NCT01235741|7383911|FG000|Randomized to Treatment|Withdrawal by Subject|0
4554444|NCT01235741|7383912|FG001|Randomized to Treatment|Withdrawal by Subject|0
4554445|NCT01235741|7383913|FG002|Randomized to Treatment|Withdrawal by Subject|1
4554446|NCT01235741|7383911|FG000|Randomized to Treatment|Adverse Event|0
4554447|NCT01235741|7383912|FG001|Randomized to Treatment|Adverse Event|1
4554448|NCT01235741|7383913|FG002|Randomized to Treatment|Adverse Event|1
4554449|NCT01235741|7383911|FG000|Randomized to Treatment|Sponsor terminated study|0
4554450|NCT01235741|7383912|FG001|Randomized to Treatment|Sponsor terminated study|35
4554451|NCT01235741|7383913|FG002|Randomized to Treatment|Sponsor terminated study|34
4554452|NCT01235741|7383911|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0
4554453|NCT01235741|7383912|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3
4554454|NCT01235741|7383913|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6
4554455|NCT01235741|7383911|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0
4554456|NCT01235741|7383912|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5
4554457|NCT01235741|7383913|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1
4554458|NCT01235741|7383911|FG000|Follow-Up Post Treatment up to Month 6|Other|0
4554459|NCT01235741|7383912|FG001|Follow-Up Post Treatment up to Month 6|Other|1
4554460|NCT01235741|7383913|FG002|Follow-Up Post Treatment up to Month 6|Other|0
4554461|NCT01235793|7383925|FG000|Overall Study|Death|6
4554462|NCT01235949|7383966|FG000|Primary Phase|Migrated/moved from study area|1
4554463|NCT01235949|7383967|FG001|Primary Phase|Migrated/moved from study area|1
4554464|NCT01235949|7383968|FG002|Primary Phase|Migrated/moved from study area|0
4554465|NCT01235949|7383969|FG003|Primary Phase|Migrated/moved from study area|0
4554466|NCT01235949|7383970|FG004|Primary Phase|Migrated/moved from study area|1
4554467|NCT01235949|7383971|FG005|Primary Phase|Migrated/moved from study area|2
4554468|NCT01235949|7383972|FG006|Primary Phase|Migrated/moved from study area|0
4554469|NCT01235949|7383973|FG007|Primary Phase|Migrated/moved from study area|0
4554470|NCT01235949|7383974|FG008|Primary Phase|Migrated/moved from study area|0
4554471|NCT01235949|7383975|FG009|Primary Phase|Migrated/moved from study area|0
4554472|NCT01235949|7383976|FG010|Primary Phase|Migrated/moved from study area|0
4554473|NCT01235949|7383977|FG011|Primary Phase|Migrated/moved from study area|0
4554474|NCT01235949|7383978|FG012|Primary Phase|Migrated/moved from study area|0
4554475|NCT01235949|7383979|FG013|Primary Phase|Migrated/moved from study area|0
4554476|NCT01235949|7383980|FG014|Primary Phase|Migrated/moved from study area|0
4554477|NCT01235949|7383981|FG015|Primary Phase|Migrated/moved from study area|0
4554478|NCT01235949|7383982|FG016|Primary Phase|Migrated/moved from study area|0
4554479|NCT01235949|7383983|FG017|Primary Phase|Migrated/moved from study area|0
4554480|NCT01235949|7383966|FG000|Primary Phase|Adverse Event|0
4554481|NCT01235949|7383967|FG001|Primary Phase|Adverse Event|0
4554482|NCT01235949|7383968|FG002|Primary Phase|Adverse Event|0
4554483|NCT01235949|7383969|FG003|Primary Phase|Adverse Event|1
4554484|NCT01235949|7383970|FG004|Primary Phase|Adverse Event|0
4554485|NCT01235949|7383971|FG005|Primary Phase|Adverse Event|0
4554486|NCT01235949|7383972|FG006|Primary Phase|Adverse Event|0
4554487|NCT01235949|7383973|FG007|Primary Phase|Adverse Event|0
4554488|NCT01235949|7383974|FG008|Primary Phase|Adverse Event|0
4554489|NCT01235949|7383975|FG009|Primary Phase|Adverse Event|0
4554490|NCT01235949|7383976|FG010|Primary Phase|Adverse Event|0
4554491|NCT01235949|7383977|FG011|Primary Phase|Adverse Event|0
4554492|NCT01235949|7383978|FG012|Primary Phase|Adverse Event|0
4554493|NCT01235949|7383979|FG013|Primary Phase|Adverse Event|0
4554494|NCT01235949|7383980|FG014|Primary Phase|Adverse Event|0
4554495|NCT01235949|7383981|FG015|Primary Phase|Adverse Event|0
4554496|NCT01235949|7383982|FG016|Primary Phase|Adverse Event|0
4554497|NCT01235949|7383983|FG017|Primary Phase|Adverse Event|0
4554498|NCT01235949|7383966|FG000|Primary Phase|Withdrawal by Subject|3
4554499|NCT01235949|7383967|FG001|Primary Phase|Withdrawal by Subject|2
4554500|NCT01235949|7383968|FG002|Primary Phase|Withdrawal by Subject|2
4554501|NCT01235949|7383969|FG003|Primary Phase|Withdrawal by Subject|0
4554502|NCT01235949|7383970|FG004|Primary Phase|Withdrawal by Subject|0
4554503|NCT01235949|7383971|FG005|Primary Phase|Withdrawal by Subject|3
4554504|NCT01235949|7383972|FG006|Primary Phase|Withdrawal by Subject|0
4554505|NCT01235949|7383973|FG007|Primary Phase|Withdrawal by Subject|0
4554506|NCT01235949|7383974|FG008|Primary Phase|Withdrawal by Subject|0
4554507|NCT01235949|7383975|FG009|Primary Phase|Withdrawal by Subject|0
4554508|NCT01235949|7383976|FG010|Primary Phase|Withdrawal by Subject|0
4554509|NCT01235949|7383977|FG011|Primary Phase|Withdrawal by Subject|0
4554510|NCT01235949|7383978|FG012|Primary Phase|Withdrawal by Subject|0
4554511|NCT01235949|7383979|FG013|Primary Phase|Withdrawal by Subject|0
4554512|NCT01235949|7383980|FG014|Primary Phase|Withdrawal by Subject|0
4554513|NCT01235949|7383981|FG015|Primary Phase|Withdrawal by Subject|0
4554514|NCT01235949|7383982|FG016|Primary Phase|Withdrawal by Subject|0
4554515|NCT01235949|7383983|FG017|Primary Phase|Withdrawal by Subject|0
4554516|NCT01235949|7383966|FG000|Primary Phase|Lost to Follow-up|0
4554517|NCT01235949|7383967|FG001|Primary Phase|Lost to Follow-up|0
4554518|NCT01235949|7383968|FG002|Primary Phase|Lost to Follow-up|1
4554519|NCT01235949|7383969|FG003|Primary Phase|Lost to Follow-up|1
4554520|NCT01235949|7383970|FG004|Primary Phase|Lost to Follow-up|0
4554521|NCT01235949|7383971|FG005|Primary Phase|Lost to Follow-up|2
4554522|NCT01235949|7383972|FG006|Primary Phase|Lost to Follow-up|0
4554523|NCT01235949|7383973|FG007|Primary Phase|Lost to Follow-up|0
4554524|NCT01235949|7383974|FG008|Primary Phase|Lost to Follow-up|0
4554525|NCT01235949|7383975|FG009|Primary Phase|Lost to Follow-up|0
4554526|NCT01235949|7383976|FG010|Primary Phase|Lost to Follow-up|0
4554527|NCT01235949|7383977|FG011|Primary Phase|Lost to Follow-up|0
4554528|NCT01235949|7383978|FG012|Primary Phase|Lost to Follow-up|0
4554529|NCT01235949|7383979|FG013|Primary Phase|Lost to Follow-up|0
4554530|NCT01235949|7383980|FG014|Primary Phase|Lost to Follow-up|0
4554531|NCT01235949|7383981|FG015|Primary Phase|Lost to Follow-up|0
4554532|NCT01235949|7383982|FG016|Primary Phase|Lost to Follow-up|0
4554533|NCT01235949|7383983|FG017|Primary Phase|Lost to Follow-up|0
4554534|NCT01235949|7383966|FG000|Booster Phase|Migrated/moved from study area|0
4554535|NCT01235949|7383967|FG001|Booster Phase|Migrated/moved from study area|0
4554536|NCT01235949|7383968|FG002|Booster Phase|Migrated/moved from study area|0
4554537|NCT01235949|7383969|FG003|Booster Phase|Migrated/moved from study area|0
4554538|NCT01235949|7383970|FG004|Booster Phase|Migrated/moved from study area|0
4554539|NCT01235949|7383971|FG005|Booster Phase|Migrated/moved from study area|0
4554540|NCT01235949|7383972|FG006|Booster Phase|Migrated/moved from study area|0
4554541|NCT01235949|7383973|FG007|Booster Phase|Migrated/moved from study area|0
4554542|NCT01235949|7383974|FG008|Booster Phase|Migrated/moved from study area|0
4554543|NCT01235949|7383975|FG009|Booster Phase|Migrated/moved from study area|0
4554544|NCT01235949|7383976|FG010|Booster Phase|Migrated/moved from study area|0
4554545|NCT01235949|7383977|FG011|Booster Phase|Migrated/moved from study area|1
4554546|NCT01235949|7383978|FG012|Booster Phase|Migrated/moved from study area|1
4554547|NCT01235949|7383979|FG013|Booster Phase|Migrated/moved from study area|0
4554548|NCT01235949|7383980|FG014|Booster Phase|Migrated/moved from study area|0
4554549|NCT01235949|7383981|FG015|Booster Phase|Migrated/moved from study area|0
4554550|NCT01235949|7383982|FG016|Booster Phase|Migrated/moved from study area|0
4554551|NCT01235949|7383983|FG017|Booster Phase|Migrated/moved from study area|1
4554552|NCT01235949|7383966|FG000|Booster Phase|Adverse Event|0
4554553|NCT01235949|7383967|FG001|Booster Phase|Adverse Event|0
4554554|NCT01235949|7383968|FG002|Booster Phase|Adverse Event|0
4554555|NCT01235949|7383969|FG003|Booster Phase|Adverse Event|0
4554556|NCT01235949|7383970|FG004|Booster Phase|Adverse Event|0
4554557|NCT01235949|7383971|FG005|Booster Phase|Adverse Event|0
4554558|NCT01235949|7383972|FG006|Booster Phase|Adverse Event|0
4554559|NCT01235949|7383973|FG007|Booster Phase|Adverse Event|0
4554560|NCT01235949|7383974|FG008|Booster Phase|Adverse Event|0
4554561|NCT01235949|7383975|FG009|Booster Phase|Adverse Event|0
4554562|NCT01235949|7383976|FG010|Booster Phase|Adverse Event|0
4554563|NCT01235949|7383977|FG011|Booster Phase|Adverse Event|0
4554564|NCT01235949|7383978|FG012|Booster Phase|Adverse Event|0
4554565|NCT01235949|7383979|FG013|Booster Phase|Adverse Event|0
4554566|NCT01235949|7383980|FG014|Booster Phase|Adverse Event|0
4554567|NCT01235949|7383981|FG015|Booster Phase|Adverse Event|1
4554568|NCT01235949|7383982|FG016|Booster Phase|Adverse Event|0
4554569|NCT01235949|7383983|FG017|Booster Phase|Adverse Event|0
4554570|NCT01235949|7383966|FG000|Booster Phase|Withdrawal by Subject|0
4554571|NCT01235949|7383967|FG001|Booster Phase|Withdrawal by Subject|0
4554572|NCT01235949|7383968|FG002|Booster Phase|Withdrawal by Subject|0
4554573|NCT01235949|7383969|FG003|Booster Phase|Withdrawal by Subject|0
4554574|NCT01235949|7383970|FG004|Booster Phase|Withdrawal by Subject|0
4554575|NCT01235949|7383971|FG005|Booster Phase|Withdrawal by Subject|0
4554576|NCT01235949|7383972|FG006|Booster Phase|Withdrawal by Subject|0
4554577|NCT01235949|7383973|FG007|Booster Phase|Withdrawal by Subject|1
4554578|NCT01235949|7383974|FG008|Booster Phase|Withdrawal by Subject|1
4554579|NCT01235949|7383975|FG009|Booster Phase|Withdrawal by Subject|0
4554580|NCT01235949|7383976|FG010|Booster Phase|Withdrawal by Subject|1
4554581|NCT01235949|7383977|FG011|Booster Phase|Withdrawal by Subject|1
4554582|NCT01235949|7383978|FG012|Booster Phase|Withdrawal by Subject|2
4554583|NCT01235949|7383979|FG013|Booster Phase|Withdrawal by Subject|0
4554584|NCT01235949|7383980|FG014|Booster Phase|Withdrawal by Subject|2
4554585|NCT01235949|7383981|FG015|Booster Phase|Withdrawal by Subject|0
4554586|NCT01235949|7383982|FG016|Booster Phase|Withdrawal by Subject|0
4554587|NCT01235949|7383983|FG017|Booster Phase|Withdrawal by Subject|0
4554588|NCT01235949|7383966|FG000|Booster Phase|Lost to Follow-up|0
4554589|NCT01235949|7383967|FG001|Booster Phase|Lost to Follow-up|0
4554590|NCT01235949|7383968|FG002|Booster Phase|Lost to Follow-up|0
4554591|NCT01235949|7383969|FG003|Booster Phase|Lost to Follow-up|0
4554592|NCT01235949|7383970|FG004|Booster Phase|Lost to Follow-up|0
4554593|NCT01235949|7383971|FG005|Booster Phase|Lost to Follow-up|0
4554594|NCT01235949|7383972|FG006|Booster Phase|Lost to Follow-up|0
4554595|NCT01235949|7383973|FG007|Booster Phase|Lost to Follow-up|0
4554596|NCT01235949|7383974|FG008|Booster Phase|Lost to Follow-up|1
4554597|NCT01235949|7383975|FG009|Booster Phase|Lost to Follow-up|1
4554598|NCT01235949|7383976|FG010|Booster Phase|Lost to Follow-up|1
4554599|NCT01235949|7383977|FG011|Booster Phase|Lost to Follow-up|1
4554600|NCT01235949|7383978|FG012|Booster Phase|Lost to Follow-up|0
4554601|NCT01235949|7383979|FG013|Booster Phase|Lost to Follow-up|0
4554602|NCT01235949|7383980|FG014|Booster Phase|Lost to Follow-up|0
4554603|NCT01235949|7383981|FG015|Booster Phase|Lost to Follow-up|0
4554604|NCT01235949|7383982|FG016|Booster Phase|Lost to Follow-up|0
4554605|NCT01235949|7383983|FG017|Booster Phase|Lost to Follow-up|1
4554606|NCT01235975|7384023|FG000|Overall Study|Serious Adverse Event|0
4554607|NCT01235975|7384024|FG001|Overall Study|Serious Adverse Event|1
4554608|NCT01235975|7384023|FG000|Overall Study|Withdrawal by Subject|8
4554609|NCT01235975|7384024|FG001|Overall Study|Withdrawal by Subject|2
4554610|NCT01235975|7384023|FG000|Overall Study|Migrated/moved from study area|2
4554611|NCT01235975|7384024|FG001|Overall Study|Migrated/moved from study area|1
4554612|NCT01235975|7384023|FG000|Overall Study|Lost to Follow-up|7
4554613|NCT01235975|7384024|FG001|Overall Study|Lost to Follow-up|3
4554614|NCT01236001|7384032|FG000|Overall Study|Adverse Event|5
4554615|NCT01236001|7384033|FG001|Overall Study|Adverse Event|14
4554616|NCT01236001|7384032|FG000|Overall Study|Lack of Efficacy|6
4554617|NCT01236001|7384033|FG001|Overall Study|Lack of Efficacy|6
4554618|NCT01236001|7384032|FG000|Overall Study|Lost to Follow-up|6
4554619|NCT01236001|7384033|FG001|Overall Study|Lost to Follow-up|1
4554620|NCT01236001|7384032|FG000|Overall Study|Incompliance|1
4554621|NCT01236001|7384033|FG001|Overall Study|Incompliance|0
4621813|NCT01794780|7484406|FG003|Overall Study|Lost to Follow-up|53
4621814|NCT01794780|7484407|FG004|Overall Study|Lost to Follow-up|2
4621815|NCT01794780|7484408|FG005|Overall Study|Lost to Follow-up|99
4621816|NCT01794780|7484409|FG006|Overall Study|Lost to Follow-up|30
4621817|NCT01794780|7484410|FG007|Overall Study|Lost to Follow-up|5
4621818|NCT01794780|7484403|FG000|Overall Study|Withdrew informed consent|7
4621819|NCT01794780|7484404|FG001|Overall Study|Withdrew informed consent|17
4621820|NCT01794780|7484405|FG002|Overall Study|Withdrew informed consent|36
4621821|NCT01794780|7484406|FG003|Overall Study|Withdrew informed consent|9
4554622|NCT01236001|7384032|FG000|Overall Study|Planned Visit After End of Study|0
4554623|NCT01236001|7384033|FG001|Overall Study|Planned Visit After End of Study|1
4554624|NCT01236118|7384143|FG000|Overall Study|Adverse Event|2
4554625|NCT01236118|7384144|FG001|Overall Study|Adverse Event|0
4554626|NCT01236118|7384145|FG002|Overall Study|Adverse Event|2
4554627|NCT01236118|7384143|FG000|Overall Study|Physician Decision|0
4554628|NCT01236118|7384144|FG001|Overall Study|Physician Decision|1
4554629|NCT01236118|7384145|FG002|Overall Study|Physician Decision|0
4554630|NCT01236118|7384143|FG000|Overall Study|Withdrawal by Subject|0
4554631|NCT01236118|7384144|FG001|Overall Study|Withdrawal by Subject|0
4554632|NCT01236118|7384145|FG002|Overall Study|Withdrawal by Subject|1
4554633|NCT01236339|7384182|FG000|Overall Study|Termination of study by sponsor|11
4554634|NCT01236339|7384183|FG001|Overall Study|Termination of study by sponsor|13
4554635|NCT01236352|7384201|FG000|Overall Study|Death|0
4554636|NCT01236352|7384202|FG001|Overall Study|Death|0
4554637|NCT01236352|7384203|FG002|Overall Study|Death|0
4554638|NCT01236352|7384204|FG003|Overall Study|Death|0
4554639|NCT01236352|7384205|FG004|Overall Study|Death|0
4554640|NCT01236352|7384206|FG005|Overall Study|Death|0
4554641|NCT01236352|7384207|FG006|Overall Study|Death|0
4554642|NCT01236352|7384208|FG007|Overall Study|Death|1
4554643|NCT01236352|7384209|FG008|Overall Study|Death|0
4554644|NCT01236352|7384210|FG009|Overall Study|Death|0
4554645|NCT01236352|7384211|FG010|Overall Study|Death|0
4554646|NCT01236352|7384201|FG000|Overall Study|Withdrawal by Subject|0
4554647|NCT01236352|7384202|FG001|Overall Study|Withdrawal by Subject|0
4554648|NCT01236352|7384203|FG002|Overall Study|Withdrawal by Subject|0
4554649|NCT01236352|7384204|FG003|Overall Study|Withdrawal by Subject|0
4554650|NCT01236352|7384205|FG004|Overall Study|Withdrawal by Subject|0
4554651|NCT01236352|7384206|FG005|Overall Study|Withdrawal by Subject|0
4554652|NCT01236352|7384207|FG006|Overall Study|Withdrawal by Subject|0
4554653|NCT01236352|7384208|FG007|Overall Study|Withdrawal by Subject|0
4554654|NCT01236352|7384209|FG008|Overall Study|Withdrawal by Subject|0
4554655|NCT01236352|7384210|FG009|Overall Study|Withdrawal by Subject|2
4554656|NCT01236352|7384211|FG010|Overall Study|Withdrawal by Subject|1
4554657|NCT01236352|7384201|FG000|Overall Study|Adverse Event|0
4554658|NCT01236352|7384202|FG001|Overall Study|Adverse Event|0
4554659|NCT01236352|7384203|FG002|Overall Study|Adverse Event|0
4554660|NCT01236352|7384204|FG003|Overall Study|Adverse Event|0
4554661|NCT01236352|7384205|FG004|Overall Study|Adverse Event|0
4554662|NCT01236352|7384206|FG005|Overall Study|Adverse Event|0
4554663|NCT01236352|7384207|FG006|Overall Study|Adverse Event|2
4554664|NCT01236352|7384208|FG007|Overall Study|Adverse Event|0
4554665|NCT01236352|7384209|FG008|Overall Study|Adverse Event|0
4554666|NCT01236352|7384210|FG009|Overall Study|Adverse Event|4
4554667|NCT01236352|7384211|FG010|Overall Study|Adverse Event|1
4554668|NCT01236352|7384201|FG000|Overall Study|Study drug toxicity|0
4554669|NCT01236352|7384202|FG001|Overall Study|Study drug toxicity|0
4554670|NCT01236352|7384203|FG002|Overall Study|Study drug toxicity|0
4554671|NCT01236352|7384204|FG003|Overall Study|Study drug toxicity|0
4554672|NCT01236352|7384205|FG004|Overall Study|Study drug toxicity|0
4554673|NCT01236352|7384206|FG005|Overall Study|Study drug toxicity|1
4554674|NCT01236352|7384207|FG006|Overall Study|Study drug toxicity|1
4554675|NCT01236352|7384208|FG007|Overall Study|Study drug toxicity|0
4554676|NCT01236352|7384209|FG008|Overall Study|Study drug toxicity|0
4554677|NCT01236352|7384210|FG009|Overall Study|Study drug toxicity|2
4554678|NCT01236352|7384211|FG010|Overall Study|Study drug toxicity|2
4554679|NCT01236352|7384201|FG000|Overall Study|Disease progression|1
4554680|NCT01236352|7384202|FG001|Overall Study|Disease progression|2
4554681|NCT01236352|7384203|FG002|Overall Study|Disease progression|1
4554682|NCT01236352|7384204|FG003|Overall Study|Disease progression|2
4554683|NCT01236352|7384205|FG004|Overall Study|Disease progression|2
4554684|NCT01236352|7384206|FG005|Overall Study|Disease progression|2
4554685|NCT01236352|7384207|FG006|Overall Study|Disease progression|1
4554686|NCT01236352|7384208|FG007|Overall Study|Disease progression|3
4554687|NCT01236352|7384209|FG008|Overall Study|Disease progression|2
4554688|NCT01236352|7384210|FG009|Overall Study|Disease progression|2
4554689|NCT01236352|7384211|FG010|Overall Study|Disease progression|2
4554690|NCT01236352|7384201|FG000|Overall Study|Poor/Non-compliance|1
4554691|NCT01236352|7384202|FG001|Overall Study|Poor/Non-compliance|0
4554692|NCT01236352|7384203|FG002|Overall Study|Poor/Non-compliance|0
4554693|NCT01236352|7384204|FG003|Overall Study|Poor/Non-compliance|0
4554694|NCT01236352|7384205|FG004|Overall Study|Poor/Non-compliance|0
4554695|NCT01236352|7384206|FG005|Overall Study|Poor/Non-compliance|0
4554696|NCT01236352|7384207|FG006|Overall Study|Poor/Non-compliance|0
4554697|NCT01236352|7384208|FG007|Overall Study|Poor/Non-compliance|0
4554698|NCT01236352|7384209|FG008|Overall Study|Poor/Non-compliance|0
4554699|NCT01236352|7384210|FG009|Overall Study|Poor/Non-compliance|0
4554700|NCT01236352|7384211|FG010|Overall Study|Poor/Non-compliance|0
4554701|NCT01236352|7384201|FG000|Overall Study|Maximum clinical benefit|1
4554702|NCT01236352|7384202|FG001|Overall Study|Maximum clinical benefit|1
4554703|NCT01236352|7384203|FG002|Overall Study|Maximum clinical benefit|1
4554704|NCT01236352|7384204|FG003|Overall Study|Maximum clinical benefit|0
4554705|NCT01236352|7384205|FG004|Overall Study|Maximum clinical benefit|2
4554706|NCT01236352|7384206|FG005|Overall Study|Maximum clinical benefit|0
4554707|NCT01236352|7384207|FG006|Overall Study|Maximum clinical benefit|3
4554708|NCT01236352|7384208|FG007|Overall Study|Maximum clinical benefit|1
4554709|NCT01236352|7384209|FG008|Overall Study|Maximum clinical benefit|1
4554710|NCT01236352|7384210|FG009|Overall Study|Maximum clinical benefit|4
4554711|NCT01236352|7384211|FG010|Overall Study|Maximum clinical benefit|2
4554712|NCT01236352|7384201|FG000|Overall Study|Subject request to discontinue treatment|0
4554713|NCT01236352|7384202|FG001|Overall Study|Subject request to discontinue treatment|0
4554714|NCT01236352|7384203|FG002|Overall Study|Subject request to discontinue treatment|1
4554715|NCT01236352|7384204|FG003|Overall Study|Subject request to discontinue treatment|1
4554716|NCT01236352|7384205|FG004|Overall Study|Subject request to discontinue treatment|0
4554717|NCT01236352|7384206|FG005|Overall Study|Subject request to discontinue treatment|1
4554718|NCT01236352|7384207|FG006|Overall Study|Subject request to discontinue treatment|0
4554719|NCT01236352|7384208|FG007|Overall Study|Subject request to discontinue treatment|0
4554720|NCT01236352|7384209|FG008|Overall Study|Subject request to discontinue treatment|0
4554721|NCT01236352|7384210|FG009|Overall Study|Subject request to discontinue treatment|1
4554722|NCT01236352|7384211|FG010|Overall Study|Subject request to discontinue treatment|4
4554723|NCT01236352|7384201|FG000|Overall Study|Subject to receive drug via EAP|1
4554724|NCT01236352|7384202|FG001|Overall Study|Subject to receive drug via EAP|1
4554725|NCT01236352|7384203|FG002|Overall Study|Subject to receive drug via EAP|1
4554726|NCT01236352|7384204|FG003|Overall Study|Subject to receive drug via EAP|0
4554727|NCT01236352|7384205|FG004|Overall Study|Subject to receive drug via EAP|0
4554728|NCT01236352|7384206|FG005|Overall Study|Subject to receive drug via EAP|0
4554729|NCT01236352|7384207|FG006|Overall Study|Subject to receive drug via EAP|0
4554730|NCT01236352|7384208|FG007|Overall Study|Subject to receive drug via EAP|2
4554731|NCT01236352|7384209|FG008|Overall Study|Subject to receive drug via EAP|0
4554732|NCT01236352|7384210|FG009|Overall Study|Subject to receive drug via EAP|4
4554733|NCT01236352|7384211|FG010|Overall Study|Subject to receive drug via EAP|0
4554734|NCT01236352|7384201|FG000|Overall Study|Patient moving to allogeneic transplant|0
4554735|NCT01236352|7384202|FG001|Overall Study|Patient moving to allogeneic transplant|0
4554736|NCT01236352|7384203|FG002|Overall Study|Patient moving to allogeneic transplant|0
4554737|NCT01236352|7384204|FG003|Overall Study|Patient moving to allogeneic transplant|0
4554738|NCT01236352|7384205|FG004|Overall Study|Patient moving to allogeneic transplant|0
4554739|NCT01236352|7384206|FG005|Overall Study|Patient moving to allogeneic transplant|0
4554740|NCT01236352|7384207|FG006|Overall Study|Patient moving to allogeneic transplant|1
4554741|NCT01236352|7384208|FG007|Overall Study|Patient moving to allogeneic transplant|0
4554742|NCT01236352|7384209|FG008|Overall Study|Patient moving to allogeneic transplant|0
4554743|NCT01236352|7384210|FG009|Overall Study|Patient moving to allogeneic transplant|0
4554744|NCT01236352|7384211|FG010|Overall Study|Patient moving to allogeneic transplant|0
4554745|NCT01236352|7384201|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0
4554746|NCT01236352|7384202|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0
4554747|NCT01236352|7384203|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0
4554748|NCT01236352|7384204|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0
4554749|NCT01236352|7384205|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0
4554750|NCT01236352|7384206|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0
4554751|NCT01236352|7384207|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0
4554752|NCT01236352|7384208|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0
4554753|NCT01236352|7384209|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0
4554754|NCT01236352|7384210|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0
4554755|NCT01236352|7384211|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1
4554756|NCT01236352|7384201|FG000|Overall Study|Lack of response to drug|0
4554757|NCT01236352|7384202|FG001|Overall Study|Lack of response to drug|0
4554758|NCT01236352|7384203|FG002|Overall Study|Lack of response to drug|0
4554759|NCT01236352|7384204|FG003|Overall Study|Lack of response to drug|0
4554760|NCT01236352|7384205|FG004|Overall Study|Lack of response to drug|0
4554761|NCT01236352|7384206|FG005|Overall Study|Lack of response to drug|0
4554762|NCT01236352|7384207|FG006|Overall Study|Lack of response to drug|0
4554763|NCT01236352|7384208|FG007|Overall Study|Lack of response to drug|0
4554764|NCT01236352|7384209|FG008|Overall Study|Lack of response to drug|0
4554765|NCT01236352|7384210|FG009|Overall Study|Lack of response to drug|1
4554766|NCT01236352|7384211|FG010|Overall Study|Lack of response to drug|1
4554767|NCT01236352|7384201|FG000|Overall Study|Patient transferred to IST|0
4554768|NCT01236352|7384202|FG001|Overall Study|Patient transferred to IST|0
4554769|NCT01236352|7384203|FG002|Overall Study|Patient transferred to IST|0
4554770|NCT01236352|7384204|FG003|Overall Study|Patient transferred to IST|0
4554771|NCT01236352|7384205|FG004|Overall Study|Patient transferred to IST|0
4554772|NCT01236352|7384206|FG005|Overall Study|Patient transferred to IST|0
4554773|NCT01236352|7384207|FG006|Overall Study|Patient transferred to IST|0
4554774|NCT01236352|7384208|FG007|Overall Study|Patient transferred to IST|0
4554775|NCT01236352|7384209|FG008|Overall Study|Patient transferred to IST|0
4554776|NCT01236352|7384210|FG009|Overall Study|Patient transferred to IST|2
4554777|NCT01236352|7384211|FG010|Overall Study|Patient transferred to IST|6
4554778|NCT01236365|7384237|FG000|Overall Study|Lost to Follow-up|0
4554779|NCT01236365|7384238|FG001|Overall Study|Lost to Follow-up|2
4554780|NCT01236365|7384237|FG000|Overall Study|Moved Out of State|1
4554781|NCT01236365|7384238|FG001|Overall Study|Moved Out of State|0
4554782|NCT01236365|7384237|FG000|Overall Study|Dropped at Randomization due to high LFT|1
4554783|NCT01236365|7384238|FG001|Overall Study|Dropped at Randomization due to high LFT|0
4554784|NCT01236521|7384269|FG000|Overall Study|Withdrawal by Subject|12
4554785|NCT01236521|7384270|FG001|Overall Study|Withdrawal by Subject|17
4554786|NCT01236521|7384269|FG000|Overall Study|Death|2
4554787|NCT01236521|7384270|FG001|Overall Study|Death|1
4554788|NCT01236521|7384269|FG000|Overall Study|Lost to Follow-up|7
4554789|NCT01236521|7384270|FG001|Overall Study|Lost to Follow-up|7
4554790|NCT01236534|7384278|FG000|Overall Study|Adverse Event|3
4554791|NCT01236534|7384279|FG001|Overall Study|Adverse Event|0
4621822|NCT01794780|7484407|FG004|Overall Study|Withdrew informed consent|0
4621823|NCT01794780|7484408|FG005|Overall Study|Withdrew informed consent|48
4554792|NCT01236573|7384296|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
4621824|NCT01794780|7484409|FG006|Overall Study|Withdrew informed consent|4
4554793|NCT01236573|7384297|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
4554794|NCT01236573|7384298|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
4554795|NCT01236573|7384299|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
4554796|NCT01236573|7384300|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
4554797|NCT01236573|7384301|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
4554798|NCT01236573|7384302|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
4554799|NCT01236573|7384303|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
4554800|NCT01236573|7384304|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
4554801|NCT01236573|7384305|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
4554802|NCT01236573|7384306|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
4554803|NCT01236573|7384296|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
4554804|NCT01236573|7384297|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
4554805|NCT01236573|7384298|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
4554806|NCT01236573|7384299|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
4554807|NCT01236573|7384300|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
4554808|NCT01236573|7384301|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
4554809|NCT01236573|7384302|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
4554810|NCT01236573|7384303|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
4554811|NCT01236573|7384304|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1
4554812|NCT01236573|7384305|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
4554813|NCT01236573|7384306|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
4554814|NCT01236573|7384296|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
4554815|NCT01236573|7384297|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
4554816|NCT01236573|7384298|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
4554817|NCT01236573|7384299|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
4554818|NCT01236573|7384300|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
4554819|NCT01236573|7384301|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
4554820|NCT01236573|7384302|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
4554821|NCT01236573|7384303|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
4554822|NCT01236573|7384304|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
4554823|NCT01236573|7384305|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
4554824|NCT01236573|7384306|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1
4554825|NCT01236755|7384344|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8
4554826|NCT01236755|7384344|FG000|Spectacles Wearing Phase|Lost to Follow-up|9
4554827|NCT01236755|7384344|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5
4554828|NCT01236755|7384344|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3
4554829|NCT01237054|7384378|FG000|Overall Study|imaging 10C0096|1
4554830|NCT01237223|7384409|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29
4554831|NCT01237223|7384410|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
4554832|NCT01237223|7384411|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
4554833|NCT01237223|7384412|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
4554834|NCT01237223|7384413|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
4554835|NCT01237223|7384414|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
4554836|NCT01237223|7384409|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25
4554837|NCT01237223|7384410|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
4554838|NCT01237223|7384411|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
4554839|NCT01237223|7384412|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
4554840|NCT01237223|7384413|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
4554841|NCT01237223|7384414|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
4554842|NCT01237223|7384409|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308
4554843|NCT01237223|7384410|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
4554844|NCT01237223|7384411|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
4554845|NCT01237223|7384412|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
4554846|NCT01237223|7384413|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
4554847|NCT01237223|7384414|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
4554848|NCT01237223|7384409|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28
4554849|NCT01237223|7384410|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
4554850|NCT01237223|7384411|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
4554851|NCT01237223|7384412|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
4554852|NCT01237223|7384413|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
4554853|NCT01237223|7384414|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
4554854|NCT01237223|7384409|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8
4554855|NCT01237223|7384410|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
4554856|NCT01237223|7384411|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
4554857|NCT01237223|7384412|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
4554858|NCT01237223|7384413|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
4591873|NCT01535560|7439029|FG000|Overall Study|Adverse Event|12
4554859|NCT01237223|7384414|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
4554860|NCT01237223|7384409|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12
4554861|NCT01237223|7384410|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4
4554862|NCT01237223|7384411|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3
4554863|NCT01237223|7384412|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2
4554864|NCT01237223|7384413|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2
4554865|NCT01237223|7384414|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1
4554866|NCT01237223|7384409|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20
4554867|NCT01237223|7384410|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6
4554868|NCT01237223|7384411|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7
4554869|NCT01237223|7384412|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1
4554870|NCT01237223|7384413|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0
4554871|NCT01237223|7384414|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1
4554872|NCT01237223|7384409|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
4554873|NCT01237223|7384410|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4
4554874|NCT01237223|7384411|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4
4554875|NCT01237223|7384412|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0
4554876|NCT01237223|7384413|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
4554877|NCT01237223|7384414|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
4554878|NCT01237223|7384409|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
4554879|NCT01237223|7384410|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
4554880|NCT01237223|7384411|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
4554881|NCT01237223|7384412|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
4554882|NCT01237223|7384413|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
4554883|NCT01237223|7384414|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1
4554884|NCT01237223|7384409|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0
4554885|NCT01237223|7384410|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
4554886|NCT01237223|7384411|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
4554887|NCT01237223|7384412|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2
4554888|NCT01237223|7384413|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
4554889|NCT01237223|7384414|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
4591874|NCT01535560|7439030|FG001|Overall Study|Adverse Event|7
4591875|NCT01535560|7439029|FG000|Overall Study|Lost to Follow-up|1
4591876|NCT01535560|7439030|FG001|Overall Study|Lost to Follow-up|3
4591877|NCT01535560|7439029|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3
4591878|NCT01535560|7439030|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1
4591879|NCT01535560|7439029|FG000|Overall Study|Treatment Failure|21
4591880|NCT01535560|7439030|FG001|Overall Study|Treatment Failure|83
4591881|NCT01535560|7439029|FG000|Overall Study|Other|0
4591882|NCT01535560|7439030|FG001|Overall Study|Other|1
4591883|NCT01535560|7439029|FG000|Overall Study|Randomized in Error|0
4591884|NCT01535560|7439030|FG001|Overall Study|Randomized in Error|1
4591885|NCT01535599|7439051|FG000|Overall Study|Adverse Event|6
4591886|NCT01535599|7439052|FG001|Overall Study|Adverse Event|15
4591887|NCT01535599|7439051|FG000|Overall Study|Lost to Follow-up|3
4591888|NCT01535599|7439052|FG001|Overall Study|Lost to Follow-up|4
4591889|NCT01535599|7439051|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4
4591890|NCT01535599|7439052|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3
4591891|NCT01535599|7439051|FG000|Overall Study|Treatment Failure|33
4591892|NCT01535599|7439052|FG001|Overall Study|Treatment Failure|66
4591893|NCT01535599|7439051|FG000|Overall Study|BL Culture + for Group A Strep|0
4591894|NCT01535599|7439052|FG001|Overall Study|BL Culture + for Group A Strep|1
4591895|NCT01535599|7439051|FG000|Overall Study|BL Culture + for Yeast//Fungi|0
4591896|NCT01535599|7439052|FG001|Overall Study|BL Culture + for Yeast//Fungi|1
4591897|NCT01535599|7439051|FG000|Overall Study|Randomized in Error|2
4591898|NCT01535599|7439052|FG001|Overall Study|Randomized in Error|4
4591899|NCT01535599|7439051|FG000|Overall Study|Did not use product|1
4591900|NCT01535599|7439052|FG001|Overall Study|Did not use product|0
4591901|NCT01535599|7439051|FG000|Overall Study|Other|1
4591902|NCT01535599|7439052|FG001|Overall Study|Other|0
4591903|NCT01535599|7439051|FG000|Overall Study|Stopped medication|0
4591904|NCT01535599|7439052|FG001|Overall Study|Stopped medication|1
4591905|NCT01535599|7439051|FG000|Overall Study|Noncompliance|0
4591906|NCT01535599|7439052|FG001|Overall Study|Noncompliance|1
4591907|NCT01535638|7439058|FG000|Treatment 1 (Single Dose)|Protocol Violation|0
4591908|NCT01535638|7439059|FG001|Treatment 1 (Single Dose)|Protocol Violation|0
4591909|NCT01535638|7439060|FG002|Treatment 1 (Single Dose)|Protocol Violation|0
4591910|NCT01535638|7439061|FG003|Treatment 1 (Single Dose)|Protocol Violation|0
4591911|NCT01535638|7439062|FG004|Treatment 1 (Single Dose)|Protocol Violation|0
4591912|NCT01535638|7439063|FG005|Treatment 1 (Single Dose)|Protocol Violation|1
4591913|NCT01535638|7439058|FG000|Treatment 3 (Single Dose)|Protocol Violation|0
4591914|NCT01535638|7439059|FG001|Treatment 3 (Single Dose)|Protocol Violation|0
4591915|NCT01535638|7439060|FG002|Treatment 3 (Single Dose)|Protocol Violation|0
4554890|NCT01237327|7384443|FG000|Overall Study|Protocol Violation: Core Study|1
4554891|NCT01237327|7384444|FG001|Overall Study|Protocol Violation: Core Study|0
4554892|NCT01237327|7384443|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3
4554893|NCT01237327|7384444|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2
4554894|NCT01237327|7384443|FG000|Overall Study|Progression of Disease: Core Study|18
4554895|NCT01237327|7384444|FG001|Overall Study|Progression of Disease: Core Study|22
4554896|NCT01237327|7384443|FG000|Overall Study|Progression of Disease: Extension Study|15
4554897|NCT01237327|7384444|FG001|Overall Study|Progression of Disease: Extension Study|13
4554898|NCT01237327|7384443|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1
4554899|NCT01237327|7384444|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0
4554900|NCT01237327|7384443|FG000|Overall Study|Withdrawal by Subject|1
4554901|NCT01237327|7384444|FG001|Overall Study|Withdrawal by Subject|3
4554902|NCT01237327|7384443|FG000|Overall Study|Lost to Follow-up|3
4554903|NCT01237327|7384444|FG001|Overall Study|Lost to Follow-up|0
4554904|NCT01237340|7384450|FG000|Overall Study|Adverse Event|3
4554905|NCT01237340|7384450|FG000|Overall Study|Withdrawal by Subject|1
4554906|NCT01237340|7384450|FG000|Overall Study|Early termination of the trial|36
4554907|NCT01237587|7384463|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5
4554908|NCT01237587|7384464|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1
4554909|NCT01237587|7384463|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1
4554910|NCT01237587|7384464|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3
4554911|NCT01237587|7384463|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2
4554912|NCT01237587|7384464|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3
4554913|NCT01237587|7384463|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2
4554914|NCT01237587|7384464|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4
4554915|NCT01237587|7384463|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4
4554916|NCT01237587|7384464|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3
4554917|NCT01237587|7384463|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3
4554918|NCT01237587|7384464|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4
4554919|NCT01237587|7384463|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4
4621825|NCT01794780|7484410|FG007|Overall Study|Withdrew informed consent|3
4621826|NCT01794780|7484403|FG000|Overall Study|Other|0
4621827|NCT01794780|7484404|FG001|Overall Study|Other|12
4621828|NCT01794780|7484405|FG002|Overall Study|Other|25
4621829|NCT01794780|7484406|FG003|Overall Study|Other|20
4621830|NCT01794780|7484407|FG004|Overall Study|Other|1
4621831|NCT01794780|7484408|FG005|Overall Study|Other|24
4621832|NCT01794780|7484409|FG006|Overall Study|Other|4
4621833|NCT01794780|7484410|FG007|Overall Study|Other|1
4621834|NCT01794845|7484444|FG000|Overall Study|Withdrawal by Subject|1
4621835|NCT01794923|7484451|FG000|Overall Study|Adverse Event|0
4621836|NCT01794923|7484452|FG001|Overall Study|Adverse Event|0
4621837|NCT01794923|7484453|FG002|Overall Study|Adverse Event|1
4621838|NCT01794949|7484463|FG000|Overall Study|Lost to Follow-up|1
4621839|NCT01794949|7484464|FG001|Overall Study|Lost to Follow-up|0
4621840|NCT01795495|7484487|FG000|Overall Study|Protocol Violation|1
4621841|NCT01795495|7484488|FG001|Overall Study|Protocol Violation|0
4621842|NCT01795495|7484489|FG002|Overall Study|Protocol Violation|1
4621843|NCT01795495|7484487|FG000|Overall Study|Physician Decision|0
4621844|NCT01795495|7484488|FG001|Overall Study|Physician Decision|0
4621845|NCT01795495|7484489|FG002|Overall Study|Physician Decision|1
4621846|NCT01795547|7484506|FG000|Overall Study|Adverse Event|16
4621847|NCT01795547|7484507|FG001|Overall Study|Adverse Event|27
4621848|NCT01795547|7484506|FG000|Overall Study|Lack of Efficacy|8
4621849|NCT01795547|7484507|FG001|Overall Study|Lack of Efficacy|3
4621850|NCT01795547|7484506|FG000|Overall Study|Protocol Violation|6
4621851|NCT01795547|7484507|FG001|Overall Study|Protocol Violation|4
4621852|NCT01795547|7484506|FG000|Overall Study|Lost to Follow-up|2
4621853|NCT01795547|7484507|FG001|Overall Study|Lost to Follow-up|5
4621854|NCT01795547|7484506|FG000|Overall Study|Withdrawal of consent|7
4621855|NCT01795547|7484507|FG001|Overall Study|Withdrawal of consent|12
4621856|NCT01795547|7484506|FG000|Overall Study|Not Treated|4
4621857|NCT01795547|7484507|FG001|Overall Study|Not Treated|10
4621858|NCT01795547|7484506|FG000|Overall Study|Non-compliance with IMP|1
4621859|NCT01795547|7484507|FG001|Overall Study|Non-compliance with IMP|1
4621860|NCT01795547|7484506|FG000|Overall Study|Others|4
4621861|NCT01795547|7484507|FG001|Overall Study|Others|1
4621862|NCT01795547|7484506|FG000|Overall Study|Not stated|0
4621863|NCT01795547|7484507|FG001|Overall Study|Not stated|1
4621864|NCT01795638|7484517|FG000|Overall Study|Death|0
4621865|NCT01795638|7484518|FG001|Overall Study|Death|3
4621866|NCT01795638|7484517|FG000|Overall Study|transferred to quaternary hospital|2
4621867|NCT01795638|7484518|FG001|Overall Study|transferred to quaternary hospital|3
4554920|NCT01237587|7384464|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3
4554921|NCT01237587|7384463|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5
4554922|NCT01237587|7384464|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5
4621868|NCT01795638|7484517|FG000|Overall Study|Protocol Violation|3
4621869|NCT01795638|7484518|FG001|Overall Study|Protocol Violation|0
4621870|NCT01795638|7484517|FG000|Overall Study|discharged from hospital|7
4621871|NCT01795638|7484518|FG001|Overall Study|discharged from hospital|5
4621872|NCT01795638|7484517|FG000|Overall Study|Withdrawal by Subject|1
4554923|NCT01237587|7384463|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2
4554924|NCT01237587|7384464|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4
4554925|NCT01237587|7384463|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2
4554926|NCT01237587|7384464|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4
4554927|NCT01237587|7384463|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0
4554928|NCT01237587|7384464|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5
4554929|NCT01237587|7384463|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1
4554930|NCT01237587|7384464|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0
4554931|NCT01237587|7384463|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4
4554932|NCT01237587|7384464|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4
4554933|NCT01237587|7384463|FG000|Taper Phase|Adverse Event|0
4554934|NCT01237587|7384464|FG001|Taper Phase|Adverse Event|2
4554935|NCT01237587|7384463|FG000|Taper Phase|Protocol Violation|2
4554936|NCT01237587|7384464|FG001|Taper Phase|Protocol Violation|0
4554937|NCT01237587|7384463|FG000|Taper Phase|Lack of Efficacy|2
4554938|NCT01237587|7384464|FG001|Taper Phase|Lack of Efficacy|5
4554939|NCT01237587|7384463|FG000|Taper Phase|Parent/Guardian Decision|0
4554940|NCT01237587|7384464|FG001|Taper Phase|Parent/Guardian Decision|2
4554941|NCT01237587|7384463|FG000|Taper Phase|Sponsor Decision|1
4554942|NCT01237587|7384464|FG001|Taper Phase|Sponsor Decision|0
4554943|NCT01237587|7384463|FG000|Taper Phase|Withdrawal by Subject|0
4554944|NCT01237587|7384464|FG001|Taper Phase|Withdrawal by Subject|1
4554945|NCT01237678|7384480|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5
4554946|NCT01237678|7384481|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0
4554947|NCT01237678|7384482|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0
4554948|NCT01237678|7384480|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24
4554949|NCT01237678|7384481|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0
4554950|NCT01237678|7384482|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0
4554951|NCT01237678|7384480|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3
4554952|NCT01237678|7384481|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0
4554953|NCT01237678|7384482|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0
4554954|NCT01237678|7384480|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1
4554955|NCT01237678|7384481|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0
4554956|NCT01237678|7384482|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0
4554957|NCT01237678|7384480|FG000|Phase II|Adverse Event|0
4554958|NCT01237678|7384481|FG001|Phase II|Adverse Event|39
4554959|NCT01237678|7384482|FG002|Phase II|Adverse Event|9
4554960|NCT01237678|7384480|FG000|Phase II|Death|0
4554961|NCT01237678|7384481|FG001|Phase II|Death|0
4554962|NCT01237678|7384482|FG002|Phase II|Death|2
4554963|NCT01237678|7384480|FG000|Phase II|Lack of Efficacy|0
4554964|NCT01237678|7384481|FG001|Phase II|Lack of Efficacy|25
4554965|NCT01237678|7384482|FG002|Phase II|Lack of Efficacy|3
4554966|NCT01237678|7384480|FG000|Phase II|Withdrawal by Subject|0
4554967|NCT01237678|7384481|FG001|Phase II|Withdrawal by Subject|1
4554968|NCT01237678|7384482|FG002|Phase II|Withdrawal by Subject|5
4554969|NCT01237678|7384480|FG000|Phase II|Completed Cycles 4-6|0
4554970|NCT01237678|7384481|FG001|Phase II|Completed Cycles 4-6|11
4554971|NCT01237678|7384482|FG002|Phase II|Completed Cycles 4-6|21
4554972|NCT01237678|7384480|FG000|Phase II|Sponsor Decision/Study Closed|0
4554973|NCT01237678|7384481|FG001|Phase II|Sponsor Decision/Study Closed|18
4554974|NCT01237678|7384482|FG002|Phase II|Sponsor Decision/Study Closed|7
4554975|NCT01237678|7384480|FG000|Phase II|Randomized but were not treated|0
4554976|NCT01237678|7384481|FG001|Phase II|Randomized but were not treated|4
4554977|NCT01237678|7384482|FG002|Phase II|Randomized but were not treated|3
4554978|NCT01237899|7384517|FG000|Washout Period of at Least 7 Days|Adverse Event|0
4554979|NCT01237899|7384518|FG001|Washout Period of at Least 7 Days|Adverse Event|0
4554980|NCT01237899|7384519|FG002|Washout Period of at Least 7 Days|Adverse Event|1
4554981|NCT01237899|7384520|FG003|Washout Period of at Least 7 Days|Adverse Event|0
4554982|NCT01237899|7384521|FG004|Washout Period of at Least 7 Days|Adverse Event|0
4554983|NCT01237899|7384522|FG005|Washout Period of at Least 7 Days|Adverse Event|0
4554984|NCT01237899|7384523|FG006|Washout Period of at Least 7 Days|Adverse Event|0
4554985|NCT01237899|7384524|FG007|Washout Period of at Least 7 Days|Adverse Event|0
4554986|NCT01237899|7384525|FG008|Washout Period of at Least 7 Days|Adverse Event|0
4554987|NCT01237899|7384526|FG009|Washout Period of at Least 7 Days|Adverse Event|0
4554988|NCT01237899|7384527|FG010|Washout Period of at Least 7 Days|Adverse Event|0
4554989|NCT01237951|7384545|FG000|Overall Study|Death|1
4554990|NCT01238120|7384553|FG000|Overall Study|Withdrawal by Subject|4
4554991|NCT01238120|7384554|FG001|Overall Study|Withdrawal by Subject|1
4554992|NCT01238120|7384555|FG002|Overall Study|Withdrawal by Subject|2
4554993|NCT01238120|7384556|FG003|Overall Study|Withdrawal by Subject|5
4554994|NCT01238120|7384553|FG000|Overall Study|Lost to Follow-up|2
4554995|NCT01238120|7384554|FG001|Overall Study|Lost to Follow-up|0
4554996|NCT01238120|7384555|FG002|Overall Study|Lost to Follow-up|1
4554997|NCT01238120|7384556|FG003|Overall Study|Lost to Follow-up|1
4554998|NCT01238120|7384553|FG000|Overall Study|Withdrawn due to Medical Problem|2
4554999|NCT01238120|7384554|FG001|Overall Study|Withdrawn due to Medical Problem|0
4555000|NCT01238120|7384555|FG002|Overall Study|Withdrawn due to Medical Problem|1
4555001|NCT01238120|7384556|FG003|Overall Study|Withdrawn due to Medical Problem|0
4555002|NCT01238172|7384568|FG000|Overall Study|Ineligible: based on Eligibility Review|2
4555003|NCT01238172|7384569|FG001|Overall Study|Ineligible: based on Eligibility Review|5
4555004|NCT01238172|7384568|FG000|Overall Study|Ineligible: based on Central Path Review|9
4555005|NCT01238172|7384569|FG001|Overall Study|Ineligible: based on Central Path Review|19
4555006|NCT01238575|7384605|FG000|Overall Study|Lack of Efficacy|2
4555007|NCT01238575|7384606|FG001|Overall Study|Lack of Efficacy|4
4555008|NCT01238575|7384605|FG000|Overall Study|Adverse Event|2
4555009|NCT01238575|7384606|FG001|Overall Study|Adverse Event|0
4555010|NCT01238588|7384612|FG000|Overall Study|Withdrawal by Subject|1
4555011|NCT01238588|7384612|FG000|Overall Study|Physician Decision|2
4555012|NCT01238822|7384624|FG000|Overall Study|COULD NOT SWALLOW PILLS|3
4555013|NCT01238835|7384634|FG000|Overall Study|Death|124
4555014|NCT01238835|7384634|FG000|Overall Study|Withdrawal by Subject|9
4555015|NCT01238835|7384634|FG000|Overall Study|Lost to Follow-up|1
4555016|NCT01238835|7384634|FG000|Overall Study|Site early discontinuation|2
4555017|NCT01238848|7384640|FG000|Overall Study|Physician Decision|13
4555018|NCT01238848|7384641|FG001|Overall Study|Physician Decision|5
4555019|NCT01238861|7384653|FG000|Overall Study|Lost to Follow-up|4
4555020|NCT01238861|7384654|FG001|Overall Study|Lost to Follow-up|2
4555021|NCT01238861|7384655|FG002|Overall Study|Lost to Follow-up|3
4555022|NCT01238861|7384656|FG003|Overall Study|Lost to Follow-up|1
4555023|NCT01238861|7384657|FG004|Overall Study|Lost to Follow-up|1
4555024|NCT01238861|7384658|FG005|Overall Study|Lost to Follow-up|2
4555025|NCT01238861|7384653|FG000|Overall Study|Unplanned surgery|1
4555026|NCT01238861|7384654|FG001|Overall Study|Unplanned surgery|0
4555027|NCT01238861|7384655|FG002|Overall Study|Unplanned surgery|0
4555028|NCT01238861|7384656|FG003|Overall Study|Unplanned surgery|0
4555029|NCT01238861|7384657|FG004|Overall Study|Unplanned surgery|0
4555030|NCT01238861|7384658|FG005|Overall Study|Unplanned surgery|0
4555031|NCT01238861|7384653|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0
4555032|NCT01238861|7384654|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0
4555033|NCT01238861|7384655|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1
4555034|NCT01238861|7384656|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0
4555035|NCT01238861|7384657|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1
4555036|NCT01238861|7384658|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1
4555037|NCT01238861|7384653|FG000|Overall Study|Incorrect enrollment/randomization|0
4555038|NCT01238861|7384654|FG001|Overall Study|Incorrect enrollment/randomization|0
4555039|NCT01238861|7384655|FG002|Overall Study|Incorrect enrollment/randomization|1
4555040|NCT01238861|7384656|FG003|Overall Study|Incorrect enrollment/randomization|0
4555041|NCT01238861|7384657|FG004|Overall Study|Incorrect enrollment/randomization|1
4555042|NCT01238861|7384658|FG005|Overall Study|Incorrect enrollment/randomization|0
4555043|NCT01238861|7384653|FG000|Overall Study|Subject traveled to Argentina by 1 year|0
4555044|NCT01238861|7384654|FG001|Overall Study|Subject traveled to Argentina by 1 year|0
4555045|NCT01238861|7384655|FG002|Overall Study|Subject traveled to Argentina by 1 year|1
4555046|NCT01238861|7384656|FG003|Overall Study|Subject traveled to Argentina by 1 year|0
4555047|NCT01238861|7384657|FG004|Overall Study|Subject traveled to Argentina by 1 year|0
4555048|NCT01238861|7384658|FG005|Overall Study|Subject traveled to Argentina by 1 year|0
4555049|NCT01238861|7384653|FG000|Overall Study|Subject moved out of state/area|0
4555050|NCT01238861|7384654|FG001|Overall Study|Subject moved out of state/area|0
4555051|NCT01238861|7384655|FG002|Overall Study|Subject moved out of state/area|1
4555052|NCT01238861|7384656|FG003|Overall Study|Subject moved out of state/area|1
4555053|NCT01238861|7384657|FG004|Overall Study|Subject moved out of state/area|0
4555054|NCT01238861|7384658|FG005|Overall Study|Subject moved out of state/area|0
4555055|NCT01238861|7384653|FG000|Overall Study|Strongyloides stercoralis antibodies +|0
4555056|NCT01238861|7384654|FG001|Overall Study|Strongyloides stercoralis antibodies +|0
4555057|NCT01238861|7384655|FG002|Overall Study|Strongyloides stercoralis antibodies +|0
4555058|NCT01238861|7384656|FG003|Overall Study|Strongyloides stercoralis antibodies +|1
4555059|NCT01238861|7384657|FG004|Overall Study|Strongyloides stercoralis antibodies +|0
4555060|NCT01238861|7384658|FG005|Overall Study|Strongyloides stercoralis antibodies +|0
4555061|NCT01238861|7384653|FG000|Overall Study|Personal problems|0
4555062|NCT01238861|7384654|FG001|Overall Study|Personal problems|0
4555063|NCT01238861|7384655|FG002|Overall Study|Personal problems|0
4555064|NCT01238861|7384656|FG003|Overall Study|Personal problems|1
4555065|NCT01238861|7384657|FG004|Overall Study|Personal problems|0
4555066|NCT01238861|7384658|FG005|Overall Study|Personal problems|0
4555067|NCT01238861|7384653|FG000|Overall Study|Unable to continue visits|0
4555068|NCT01238861|7384654|FG001|Overall Study|Unable to continue visits|0
4555069|NCT01238861|7384655|FG002|Overall Study|Unable to continue visits|0
4555070|NCT01238861|7384656|FG003|Overall Study|Unable to continue visits|1
4555071|NCT01238861|7384657|FG004|Overall Study|Unable to continue visits|0
4555072|NCT01238861|7384658|FG005|Overall Study|Unable to continue visits|1
4555073|NCT01238861|7384653|FG000|Overall Study|Serious adverse event|0
4555074|NCT01238861|7384654|FG001|Overall Study|Serious adverse event|0
4555075|NCT01238861|7384655|FG002|Overall Study|Serious adverse event|0
4555076|NCT01238861|7384656|FG003|Overall Study|Serious adverse event|0
4555077|NCT01238861|7384657|FG004|Overall Study|Serious adverse event|0
4555078|NCT01238861|7384658|FG005|Overall Study|Serious adverse event|1
4555079|NCT01238861|7384653|FG000|Overall Study|Lack of compliance|0
4555080|NCT01238861|7384654|FG001|Overall Study|Lack of compliance|0
4555081|NCT01238861|7384655|FG002|Overall Study|Lack of compliance|0
4555082|NCT01238861|7384656|FG003|Overall Study|Lack of compliance|0
4555083|NCT01238861|7384657|FG004|Overall Study|Lack of compliance|0
4555084|NCT01238861|7384658|FG005|Overall Study|Lack of compliance|1
4555085|NCT01238861|7384653|FG000|Overall Study|Adverse Event|0
4555086|NCT01238861|7384654|FG001|Overall Study|Adverse Event|1
4555087|NCT01238861|7384655|FG002|Overall Study|Adverse Event|0
4555088|NCT01238861|7384656|FG003|Overall Study|Adverse Event|0
4555089|NCT01238861|7384657|FG004|Overall Study|Adverse Event|0
4555090|NCT01238861|7384658|FG005|Overall Study|Adverse Event|0
4555091|NCT01238861|7384653|FG000|Overall Study|Withdrawal by Subject|6
4555092|NCT01238861|7384654|FG001|Overall Study|Withdrawal by Subject|5
4690654|NCT02563067|7600461|FG000|Overall Study|Physician Decision|0
4690655|NCT02563067|7600462|FG001|Overall Study|Physician Decision|1
4555093|NCT01238861|7384655|FG002|Overall Study|Withdrawal by Subject|4
4690656|NCT02563067|7600463|FG002|Overall Study|Physician Decision|3
4690657|NCT02563067|7600461|FG000|Overall Study|Lost to Follow-up|1
4690658|NCT02563067|7600462|FG001|Overall Study|Lost to Follow-up|2
4690659|NCT02563067|7600463|FG002|Overall Study|Lost to Follow-up|0
4690660|NCT02563067|7600461|FG000|Overall Study|Technical problems|0
4690661|NCT02563067|7600462|FG001|Overall Study|Technical problems|1
4555094|NCT01238861|7384656|FG003|Overall Study|Withdrawal by Subject|8
4555095|NCT01238861|7384657|FG004|Overall Study|Withdrawal by Subject|10
4555096|NCT01238861|7384658|FG005|Overall Study|Withdrawal by Subject|9
4555097|NCT01238900|7384679|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4
4555098|NCT01238900|7384679|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1
4555099|NCT01238991|7384694|FG000|Overall Study|Adverse Event|1
4555100|NCT01238991|7384695|FG001|Overall Study|Adverse Event|0
4555101|NCT01238991|7384696|FG002|Overall Study|Adverse Event|3
4555102|NCT01238991|7384697|FG003|Overall Study|Adverse Event|1
4555103|NCT01238991|7384698|FG004|Overall Study|Adverse Event|1
4555104|NCT01238991|7384699|FG005|Overall Study|Adverse Event|0
4555105|NCT01238991|7384700|FG006|Overall Study|Adverse Event|1
4555106|NCT01238991|7384701|FG007|Overall Study|Adverse Event|1
4555107|NCT01238991|7384702|FG008|Overall Study|Adverse Event|0
4555108|NCT01238991|7384703|FG009|Overall Study|Adverse Event|0
4555109|NCT01238991|7384694|FG000|Overall Study|Death|0
4555110|NCT01238991|7384695|FG001|Overall Study|Death|0
4555111|NCT01238991|7384696|FG002|Overall Study|Death|0
4555112|NCT01238991|7384697|FG003|Overall Study|Death|1
4555113|NCT01238991|7384698|FG004|Overall Study|Death|0
4555114|NCT01238991|7384699|FG005|Overall Study|Death|0
4555115|NCT01238991|7384700|FG006|Overall Study|Death|0
4555116|NCT01238991|7384701|FG007|Overall Study|Death|0
4555117|NCT01238991|7384702|FG008|Overall Study|Death|0
4555118|NCT01238991|7384703|FG009|Overall Study|Death|0
4555119|NCT01238991|7384694|FG000|Overall Study|Lack of Efficacy|0
4555120|NCT01238991|7384695|FG001|Overall Study|Lack of Efficacy|0
4555121|NCT01238991|7384696|FG002|Overall Study|Lack of Efficacy|1
4555122|NCT01238991|7384697|FG003|Overall Study|Lack of Efficacy|0
4555123|NCT01238991|7384698|FG004|Overall Study|Lack of Efficacy|0
4555124|NCT01238991|7384699|FG005|Overall Study|Lack of Efficacy|0
4555125|NCT01238991|7384700|FG006|Overall Study|Lack of Efficacy|0
4555126|NCT01238991|7384701|FG007|Overall Study|Lack of Efficacy|0
4555127|NCT01238991|7384702|FG008|Overall Study|Lack of Efficacy|1
4555128|NCT01238991|7384703|FG009|Overall Study|Lack of Efficacy|0
4621873|NCT01795638|7484518|FG001|Overall Study|Withdrawal by Subject|0
4621874|NCT01795898|7484553|FG000|Overall Study|Adverse Event|27
4621875|NCT01795898|7484553|FG000|Overall Study|Lost to Follow-up|20
4621876|NCT01795898|7484553|FG000|Overall Study|Withdrawal of consent|6
4621877|NCT01795898|7484553|FG000|Overall Study|Diagnosed with metastasis|1
4621878|NCT01795898|7484553|FG000|Overall Study|No pain|1
4621879|NCT01795898|7484553|FG000|Overall Study|Death|1
4690662|NCT02563067|7600463|FG002|Overall Study|Technical problems|0
4690663|NCT02563067|7600461|FG000|Overall Study|Lack of Efficacy|1
4690664|NCT02563067|7600462|FG001|Overall Study|Lack of Efficacy|0
4690665|NCT02563067|7600463|FG002|Overall Study|Lack of Efficacy|0
4690666|NCT02563067|7600461|FG000|Overall Study|Death|0
4690667|NCT02563067|7600462|FG001|Overall Study|Death|1
4690668|NCT02563067|7600463|FG002|Overall Study|Death|1
4555129|NCT01238991|7384694|FG000|Overall Study|Withdrawal by Subject|0
4555130|NCT01238991|7384695|FG001|Overall Study|Withdrawal by Subject|0
4555131|NCT01238991|7384696|FG002|Overall Study|Withdrawal by Subject|1
4690669|NCT02563067|7600461|FG000|Overall Study|Adverse Event|2
4690670|NCT02563067|7600462|FG001|Overall Study|Adverse Event|1
4555132|NCT01238991|7384697|FG003|Overall Study|Withdrawal by Subject|0
4555133|NCT01238991|7384698|FG004|Overall Study|Withdrawal by Subject|0
4555134|NCT01238991|7384699|FG005|Overall Study|Withdrawal by Subject|0
4555135|NCT01238991|7384700|FG006|Overall Study|Withdrawal by Subject|0
4555136|NCT01238991|7384701|FG007|Overall Study|Withdrawal by Subject|0
4555137|NCT01238991|7384702|FG008|Overall Study|Withdrawal by Subject|0
4555138|NCT01238991|7384703|FG009|Overall Study|Withdrawal by Subject|0
4555139|NCT01238991|7384694|FG000|Overall Study|Study Terminated by Sponsor|0
4555140|NCT01238991|7384695|FG001|Overall Study|Study Terminated by Sponsor|0
4690671|NCT02563067|7600463|FG002|Overall Study|Adverse Event|0
4690672|NCT02563067|7600461|FG000|Overall Study|Death post Treatment/safety period|1
4690673|NCT02563067|7600462|FG001|Overall Study|Death post Treatment/safety period|0
4555141|NCT01238991|7384696|FG002|Overall Study|Study Terminated by Sponsor|0
4555142|NCT01238991|7384697|FG003|Overall Study|Study Terminated by Sponsor|0
4555143|NCT01238991|7384698|FG004|Overall Study|Study Terminated by Sponsor|1
4555144|NCT01238991|7384699|FG005|Overall Study|Study Terminated by Sponsor|0
4555145|NCT01238991|7384700|FG006|Overall Study|Study Terminated by Sponsor|7
4555146|NCT01238991|7384701|FG007|Overall Study|Study Terminated by Sponsor|4
4555147|NCT01238991|7384702|FG008|Overall Study|Study Terminated by Sponsor|2
4555148|NCT01238991|7384703|FG009|Overall Study|Study Terminated by Sponsor|2
4555149|NCT01238991|7384694|FG000|Overall Study|Caregiver's request|0
4555150|NCT01238991|7384695|FG001|Overall Study|Caregiver's request|0
4555151|NCT01238991|7384696|FG002|Overall Study|Caregiver's request|0
4555152|NCT01238991|7384697|FG003|Overall Study|Caregiver's request|0
4555153|NCT01238991|7384698|FG004|Overall Study|Caregiver's request|0
4555154|NCT01238991|7384699|FG005|Overall Study|Caregiver's request|0
4555155|NCT01238991|7384700|FG006|Overall Study|Caregiver's request|0
4555156|NCT01238991|7384701|FG007|Overall Study|Caregiver's request|0
4555157|NCT01238991|7384702|FG008|Overall Study|Caregiver's request|1
4555158|NCT01238991|7384703|FG009|Overall Study|Caregiver's request|0
4555159|NCT01238991|7384694|FG000|Overall Study|Admission to a nursing home|1
4555160|NCT01238991|7384695|FG001|Overall Study|Admission to a nursing home|0
4555161|NCT01238991|7384696|FG002|Overall Study|Admission to a nursing home|1
4555162|NCT01238991|7384697|FG003|Overall Study|Admission to a nursing home|0
4555163|NCT01238991|7384698|FG004|Overall Study|Admission to a nursing home|0
4555164|NCT01238991|7384699|FG005|Overall Study|Admission to a nursing home|0
4555165|NCT01238991|7384700|FG006|Overall Study|Admission to a nursing home|0
4555166|NCT01238991|7384701|FG007|Overall Study|Admission to a nursing home|0
4555167|NCT01238991|7384702|FG008|Overall Study|Admission to a nursing home|0
4555168|NCT01238991|7384703|FG009|Overall Study|Admission to a nursing home|0
4555169|NCT01239043|7384730|FG000|Overall Study|Protocol Violation|2
4555170|NCT01239043|7384731|FG001|Overall Study|Protocol Violation|1
4555171|NCT01239121|7384745|FG000|Overall Study|Withdrawal by Subject|2
4555172|NCT01239121|7384746|FG001|Overall Study|Withdrawal by Subject|4
4555173|NCT01239121|7384747|FG002|Overall Study|Withdrawal by Subject|0
4555174|NCT01239160|7384757|FG000|Overall Study|Lost to Follow-up|3
4555175|NCT01239160|7384758|FG001|Overall Study|Lost to Follow-up|5
4555176|NCT01239160|7384759|FG002|Overall Study|Lost to Follow-up|0
4555177|NCT01239160|7384757|FG000|Overall Study|Withdrawal by Subject|17
4555178|NCT01239160|7384758|FG001|Overall Study|Withdrawal by Subject|6
4555179|NCT01239160|7384759|FG002|Overall Study|Withdrawal by Subject|2
4555180|NCT01239160|7384757|FG000|Overall Study|Physician Decision|5
4555181|NCT01239160|7384758|FG001|Overall Study|Physician Decision|7
4555182|NCT01239160|7384759|FG002|Overall Study|Physician Decision|2
4555183|NCT01239160|7384757|FG000|Overall Study|Early Termination Due to Study Closure|0
4555184|NCT01239160|7384758|FG001|Overall Study|Early Termination Due to Study Closure|1
4555185|NCT01239160|7384759|FG002|Overall Study|Early Termination Due to Study Closure|6
4555186|NCT01239316|7384769|FG000|Overall Study|Progression/Relapse|11
4555187|NCT01239316|7384769|FG000|Overall Study|Adverse Event|1
4555188|NCT01239342|7384775|FG000|Overall Study|Adverse Event|1
4555189|NCT01239342|7384776|FG001|Overall Study|Adverse Event|0
4555190|NCT01239342|7384775|FG000|Overall Study|Withdrawal by Subject|1
4555191|NCT01239342|7384776|FG001|Overall Study|Withdrawal by Subject|5
4555192|NCT01239342|7384775|FG000|Overall Study|Reason Unknown|1
4555193|NCT01239342|7384776|FG001|Overall Study|Reason Unknown|1
4555194|NCT01239381|7384786|FG000|Overall Study|Protocol Violation|1
4690674|NCT02563067|7600463|FG002|Overall Study|Death post Treatment/safety period|0
4690675|NCT02563106|7600491|FG000|Overall Study|Withdrawal by Subject|7
4690676|NCT02563106|7600492|FG001|Overall Study|Withdrawal by Subject|8
4690677|NCT02563106|7600491|FG000|Overall Study|Adverse Event|17
4690678|NCT02563106|7600492|FG001|Overall Study|Adverse Event|15
4690679|NCT02563106|7600491|FG000|Overall Study|Protocol Violation|1
4690680|NCT02563106|7600492|FG001|Overall Study|Protocol Violation|0
4690681|NCT02563106|7600491|FG000|Overall Study|Use of non-permitted concurrent therapy|1
4690682|NCT02563106|7600492|FG001|Overall Study|Use of non-permitted concurrent therapy|2
4690683|NCT02563106|7600491|FG000|Overall Study|Lost to Follow-up|3
4690684|NCT02563106|7600492|FG001|Overall Study|Lost to Follow-up|2
4690685|NCT02563106|7600491|FG000|Overall Study|Physician Decision|3
4690686|NCT02563106|7600492|FG001|Overall Study|Physician Decision|1
4690687|NCT02563106|7600491|FG000|Overall Study|Other reason - not specified|2
4690688|NCT02563106|7600492|FG001|Overall Study|Other reason - not specified|1
4690689|NCT02563548|7600521|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2
4690690|NCT02563548|7600522|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0
4690691|NCT02563548|7600523|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0
4690692|NCT02563548|7600524|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1
4690693|NCT02563548|7600525|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0
4690694|NCT02563548|7600526|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0
4555195|NCT01239381|7384786|FG000|Overall Study|Withdrawal by Subject|1
4555196|NCT01239394|7384791|FG000|Overall Study|Adverse Event|1
4555197|NCT01239472|7384797|FG000|Overall Study|Withdrawal by Subject|5
4690695|NCT02563548|7600521|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1
4690696|NCT02563548|7600522|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2
4690697|NCT02563548|7600523|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2
4770411|NCT03740919|7746731|FG001|Treatment Period|Issue with Insulin Pump|1
4555198|NCT01239472|7384798|FG001|Overall Study|Withdrawal by Subject|1
4555199|NCT01239472|7384797|FG000|Overall Study|Adverse Event|0
4555200|NCT01239472|7384798|FG001|Overall Study|Adverse Event|1
4555201|NCT01239472|7384797|FG000|Overall Study|Lack of Efficacy|0
4555202|NCT01239472|7384798|FG001|Overall Study|Lack of Efficacy|1
4555203|NCT01239732|7384823|FG000|Overall Study|Termination of study per protocol|667
4555204|NCT01239732|7384823|FG000|Overall Study|Death|226
4555205|NCT01239732|7384823|FG000|Overall Study|Withdrawal by Subject|87
4555206|NCT01239732|7384823|FG000|Overall Study|Adverse Event|6
4555207|NCT01239732|7384823|FG000|Overall Study|Protocol Violation|3
4555208|NCT01239732|7384823|FG000|Overall Study|Participant non compliance|5
4555209|NCT01239732|7384823|FG000|Overall Study|Study termination by sponsor|2
4555210|NCT01239732|7384823|FG000|Overall Study|Investigator's decision|4
4555211|NCT01239732|7384823|FG000|Overall Study|Treatment failure|2
4555212|NCT01239732|7384823|FG000|Overall Study|Other|19
4555213|NCT01239745|7384827|FG000|Overall Study|Study terminated by sponsor|45
4555214|NCT01239745|7384827|FG000|Overall Study|Adverse Event|1
4555215|NCT01239797|7384833|FG000|Treated Participants|Disease Progression|153
4555216|NCT01239797|7384834|FG001|Treated Participants|Disease Progression|161
4555217|NCT01239797|7384833|FG000|Treated Participants|Study Drug Toxicity|30
4555218|NCT01239797|7384834|FG001|Treated Participants|Study Drug Toxicity|44
4555219|NCT01239797|7384833|FG000|Treated Participants|Adverse Event Unrelated to Study Drug|22
4555220|NCT01239797|7384834|FG001|Treated Participants|Adverse Event Unrelated to Study Drug|32
4555221|NCT01239797|7384833|FG000|Treated Participants|Withdrawal by Subject|27
4555222|NCT01239797|7384834|FG001|Treated Participants|Withdrawal by Subject|23
4555223|NCT01239797|7384833|FG000|Treated Participants|Non-specified|1
4555224|NCT01239797|7384834|FG001|Treated Participants|Non-specified|11
4555225|NCT01239797|7384833|FG000|Treated Participants|Death|1
4555226|NCT01239797|7384834|FG001|Treated Participants|Death|1
4555227|NCT01239797|7384833|FG000|Treated Participants|Subject No Longer Meets Study Criteria|1
4555228|NCT01239797|7384834|FG001|Treated Participants|Subject No Longer Meets Study Criteria|1
4555229|NCT01239797|7384833|FG000|Treated Participants|Poor/Non-compliance|0
4555230|NCT01239797|7384834|FG001|Treated Participants|Poor/Non-compliance|1
4555231|NCT01239992|7384840|FG000|Overall Study|Withdrawal by Subject|2
4555232|NCT01240135|7384855|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1
4555233|NCT01240135|7384856|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1
4555234|NCT01240135|7384855|FG000|Period Two, 14 Days of Wear|Adverse Event|0
4555235|NCT01240135|7384856|FG001|Period Two, 14 Days of Wear|Adverse Event|1
4555236|NCT01240200|7384864|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2
4555237|NCT01240200|7384865|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1
4555238|NCT01240356|7384880|FG000|Overall Study|Withdrawal by Subject|2
4555239|NCT01240356|7384881|FG001|Overall Study|Withdrawal by Subject|0
4555240|NCT01240356|7384880|FG000|Overall Study|MRI contraindication|1
4555241|NCT01240356|7384881|FG001|Overall Study|MRI contraindication|0
4555242|NCT01240382|7384892|FG000|Overall Study|Adverse Event|2
4555243|NCT01240382|7384893|FG001|Overall Study|Adverse Event|1
4555244|NCT01240382|7384892|FG000|Overall Study|Lack of Efficacy|0
4555245|NCT01240382|7384893|FG001|Overall Study|Lack of Efficacy|2
4555246|NCT01240382|7384892|FG000|Overall Study|Fear of adverse events|0
4555247|NCT01240382|7384893|FG001|Overall Study|Fear of adverse events|1
4555248|NCT01240551|7384901|FG000|Overall Study|Refused further treatment|3
4555249|NCT01240551|7384902|FG001|Overall Study|Refused further treatment|2
4555250|NCT01240551|7384901|FG000|Overall Study|Lost to Follow-up|1
4555251|NCT01240551|7384902|FG001|Overall Study|Lost to Follow-up|1
4555252|NCT01240590|7384913|FG000|Phase I|Refused further treatment|0
4555253|NCT01240590|7384914|FG001|Phase I|Refused further treatment|0
4555254|NCT01240590|7384915|FG002|Phase I|Refused further treatment|3
4555255|NCT01240590|7384916|FG003|Phase I|Refused further treatment|0
4555256|NCT01240590|7384917|FG004|Phase I|Refused further treatment|0
4555257|NCT01240590|7384913|FG000|Phase II|Refused further treatment|0
4555258|NCT01240590|7384914|FG001|Phase II|Refused further treatment|0
4555259|NCT01240590|7384915|FG002|Phase II|Refused further treatment|0
4555260|NCT01240590|7384916|FG003|Phase II|Refused further treatment|2
4555261|NCT01240590|7384917|FG004|Phase II|Refused further treatment|1
4621880|NCT01795898|7484553|FG000|Overall Study|Withdrew consent & had adverse events|3
4621881|NCT01795898|7484553|FG000|Overall Study|Physician Decision|1
4555262|NCT01240746|7384946|FG000|Overall Study|Adverse Event|2
4555263|NCT01240746|7384947|FG001|Overall Study|Adverse Event|0
4555264|NCT01240746|7384948|FG002|Overall Study|Adverse Event|10
4555265|NCT01240746|7384946|FG000|Overall Study|Lost to Follow-up|23
4555266|NCT01240746|7384947|FG001|Overall Study|Lost to Follow-up|20
4555267|NCT01240746|7384948|FG002|Overall Study|Lost to Follow-up|102
4555268|NCT01240746|7384946|FG000|Overall Study|Protocol Violation|24
4555269|NCT01240746|7384947|FG001|Overall Study|Protocol Violation|15
4555270|NCT01240746|7384948|FG002|Overall Study|Protocol Violation|72
4555271|NCT01240746|7384946|FG000|Overall Study|Withdrawal by Subject|10
4555272|NCT01240746|7384947|FG001|Overall Study|Withdrawal by Subject|13
4555273|NCT01240746|7384948|FG002|Overall Study|Withdrawal by Subject|59
4555274|NCT01240785|7384958|FG000|Overall Study|Lost to Follow-up|1
4555275|NCT01240785|7384959|FG001|Overall Study|Lost to Follow-up|0
4555276|NCT01240785|7384958|FG000|Overall Study|Protocol Violation|0
4555277|NCT01240785|7384959|FG001|Overall Study|Protocol Violation|3
4555278|NCT01240811|7384968|FG000|Overall Study|Physician Decision|0
4555279|NCT01240811|7384969|FG001|Overall Study|Physician Decision|1
4555280|NCT01240811|7384970|FG002|Overall Study|Physician Decision|0
4555281|NCT01240811|7384968|FG000|Overall Study|Withdrawal by Subject|0
4555282|NCT01240811|7384969|FG001|Overall Study|Withdrawal by Subject|0
4555283|NCT01240811|7384970|FG002|Overall Study|Withdrawal by Subject|1
4555284|NCT01240863|7384982|FG000|Open-label Titration Period|Adverse Event|47
4555285|NCT01240863|7384983|FG001|Open-label Titration Period|Adverse Event|0
4555286|NCT01240863|7384984|FG002|Open-label Titration Period|Adverse Event|0
4555287|NCT01240863|7384982|FG000|Open-label Titration Period|Lack of Efficacy|19
4555288|NCT01240863|7384983|FG001|Open-label Titration Period|Lack of Efficacy|0
4555289|NCT01240863|7384984|FG002|Open-label Titration Period|Lack of Efficacy|0
4555290|NCT01240863|7384982|FG000|Open-label Titration Period|Withdrawal by Subject|9
4555291|NCT01240863|7384983|FG001|Open-label Titration Period|Withdrawal by Subject|0
4555292|NCT01240863|7384984|FG002|Open-label Titration Period|Withdrawal by Subject|0
4555293|NCT01240863|7384982|FG000|Open-label Titration Period|Protocol Violation|7
4555294|NCT01240863|7384983|FG001|Open-label Titration Period|Protocol Violation|0
4555295|NCT01240863|7384984|FG002|Open-label Titration Period|Protocol Violation|0
4555296|NCT01240863|7384982|FG000|Open-label Titration Period|Noncompliance to study drug admin|3
4555297|NCT01240863|7384983|FG001|Open-label Titration Period|Noncompliance to study drug admin|0
4555298|NCT01240863|7384984|FG002|Open-label Titration Period|Noncompliance to study drug admin|0
4555299|NCT01240863|7384982|FG000|Open-label Titration Period|Noncompliance to study procedures|3
4621882|NCT01795937|7484560|FG000|Overall Study|Withdrawal by Subject|1
4621883|NCT01795937|7484561|FG001|Overall Study|Withdrawal by Subject|0
4621884|NCT01795937|7484562|FG002|Overall Study|Withdrawal by Subject|0
4555300|NCT01240863|7384983|FG001|Open-label Titration Period|Noncompliance to study procedures|0
4555301|NCT01240863|7384984|FG002|Open-label Titration Period|Noncompliance to study procedures|0
4555302|NCT01240863|7384982|FG000|Open-label Titration Period|Dropped out prior to dosing|2
4555303|NCT01240863|7384983|FG001|Open-label Titration Period|Dropped out prior to dosing|0
4555304|NCT01240863|7384984|FG002|Open-label Titration Period|Dropped out prior to dosing|0
4555305|NCT01240863|7384982|FG000|Open-label Titration Period|Other|7
4555306|NCT01240863|7384983|FG001|Open-label Titration Period|Other|0
4555307|NCT01240863|7384984|FG002|Open-label Titration Period|Other|0
4621885|NCT01795937|7484560|FG000|Overall Study|Physician Decision|0
4555308|NCT01240863|7384982|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0
4555309|NCT01240863|7384983|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4
4555310|NCT01240863|7384984|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10
4555311|NCT01240863|7384982|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0
4555312|NCT01240863|7384983|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17
4555313|NCT01240863|7384984|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5
4555314|NCT01240863|7384982|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
4555315|NCT01240863|7384983|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3
4555316|NCT01240863|7384984|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5
4555317|NCT01240863|7384982|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0
4555318|NCT01240863|7384983|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9
4555319|NCT01240863|7384984|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14
4555320|NCT01240863|7384982|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0
4555321|NCT01240863|7384983|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9
4555322|NCT01240863|7384984|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11
4555323|NCT01240863|7384982|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0
4555324|NCT01240863|7384983|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2
4555325|NCT01240863|7384984|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2
4555326|NCT01240863|7384982|FG000|Double-blind Treatment Period (12 Weeks)|Other|0
4555327|NCT01240863|7384983|FG001|Double-blind Treatment Period (12 Weeks)|Other|1
4555328|NCT01240863|7384984|FG002|Double-blind Treatment Period (12 Weeks)|Other|5
4555329|NCT01240863|7384982|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0
4555330|NCT01240863|7384983|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1
4555331|NCT01240863|7384984|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0
4555332|NCT01240915|7385021|FG000|Overall Study|Adverse Event|0
4555333|NCT01240915|7385022|FG001|Overall Study|Adverse Event|0
4555334|NCT01240915|7385023|FG002|Overall Study|Adverse Event|0
4555335|NCT01240915|7385024|FG003|Overall Study|Adverse Event|1
4555336|NCT01240915|7385025|FG004|Overall Study|Adverse Event|0
4555337|NCT01240915|7385026|FG005|Overall Study|Adverse Event|2
4555338|NCT01240915|7385027|FG006|Overall Study|Adverse Event|0
4621886|NCT01795937|7484561|FG001|Overall Study|Physician Decision|1
4621887|NCT01795937|7484562|FG002|Overall Study|Physician Decision|0
4621888|NCT01796301|7484590|FG000|Overall Study|Withdrawal by Subject|15
4621889|NCT01796301|7484591|FG001|Overall Study|Withdrawal by Subject|15
4621890|NCT01796301|7484590|FG000|Overall Study|Lost to Follow-up|3
4621891|NCT01796301|7484591|FG001|Overall Study|Lost to Follow-up|3
4621892|NCT01796301|7484590|FG000|Overall Study|Death|0
4621893|NCT01796301|7484591|FG001|Overall Study|Death|1
4621894|NCT01796301|7484590|FG000|Overall Study|Decision by Sponsor|0
4555339|NCT01240915|7385028|FG007|Overall Study|Adverse Event|0
4555340|NCT01240915|7385029|FG008|Overall Study|Adverse Event|1
4555341|NCT01240915|7385021|FG000|Overall Study|Lost to Follow-up|0
4621895|NCT01796301|7484591|FG001|Overall Study|Decision by Sponsor|1
4621896|NCT01796392|7484599|FG000|Overall Study|Withdrawal by Subject|2
4621897|NCT01796392|7484600|FG001|Overall Study|Withdrawal by Subject|0
4621898|NCT01796392|7484599|FG000|Overall Study|Death|5
4621899|NCT01796392|7484600|FG001|Overall Study|Death|1
4555342|NCT01240915|7385022|FG001|Overall Study|Lost to Follow-up|0
4555343|NCT01240915|7385023|FG002|Overall Study|Lost to Follow-up|0
4555344|NCT01240915|7385024|FG003|Overall Study|Lost to Follow-up|0
4555345|NCT01240915|7385025|FG004|Overall Study|Lost to Follow-up|1
4555346|NCT01240915|7385026|FG005|Overall Study|Lost to Follow-up|1
4555347|NCT01240915|7385027|FG006|Overall Study|Lost to Follow-up|0
4555348|NCT01240915|7385028|FG007|Overall Study|Lost to Follow-up|1
4555349|NCT01240915|7385029|FG008|Overall Study|Lost to Follow-up|1
4555350|NCT01240915|7385021|FG000|Overall Study|Withdrawal by Subject|2
4555351|NCT01240915|7385022|FG001|Overall Study|Withdrawal by Subject|1
4555352|NCT01240915|7385023|FG002|Overall Study|Withdrawal by Subject|0
4555353|NCT01240915|7385024|FG003|Overall Study|Withdrawal by Subject|2
4555354|NCT01240915|7385025|FG004|Overall Study|Withdrawal by Subject|0
4555355|NCT01240915|7385026|FG005|Overall Study|Withdrawal by Subject|4
4555356|NCT01240915|7385027|FG006|Overall Study|Withdrawal by Subject|2
4555357|NCT01240915|7385028|FG007|Overall Study|Withdrawal by Subject|3
4555358|NCT01240915|7385029|FG008|Overall Study|Withdrawal by Subject|3
4555359|NCT01240915|7385021|FG000|Overall Study|Other|0
4555360|NCT01240915|7385022|FG001|Overall Study|Other|0
4555361|NCT01240915|7385023|FG002|Overall Study|Other|0
4555362|NCT01240915|7385024|FG003|Overall Study|Other|0
4555363|NCT01240915|7385025|FG004|Overall Study|Other|2
4555364|NCT01240915|7385026|FG005|Overall Study|Other|0
4555365|NCT01240915|7385027|FG006|Overall Study|Other|0
4555366|NCT01240915|7385028|FG007|Overall Study|Other|0
4555367|NCT01240915|7385029|FG008|Overall Study|Other|0
4555368|NCT01240915|7385021|FG000|Overall Study|Insufficient Clinical Response|0
4555369|NCT01240915|7385022|FG001|Overall Study|Insufficient Clinical Response|0
4555370|NCT01240915|7385023|FG002|Overall Study|Insufficient Clinical Response|0
4555371|NCT01240915|7385024|FG003|Overall Study|Insufficient Clinical Response|0
4555372|NCT01240915|7385025|FG004|Overall Study|Insufficient Clinical Response|1
4555373|NCT01240915|7385026|FG005|Overall Study|Insufficient Clinical Response|3
4555374|NCT01240915|7385027|FG006|Overall Study|Insufficient Clinical Response|6
4555375|NCT01240915|7385028|FG007|Overall Study|Insufficient Clinical Response|0
4555376|NCT01240915|7385029|FG008|Overall Study|Insufficient Clinical Response|3
4555377|NCT01241240|7385053|FG000|Overall Study|Adverse Event|5
4555378|NCT01241240|7385054|FG001|Overall Study|Adverse Event|4
4555379|NCT01241240|7385053|FG000|Overall Study|Lost to Follow-up|2
4555380|NCT01241240|7385054|FG001|Overall Study|Lost to Follow-up|4
4555381|NCT01241240|7385053|FG000|Overall Study|Personal Reasons|1
4555382|NCT01241240|7385054|FG001|Overall Study|Personal Reasons|1
4555383|NCT01241292|7385062|FG000|Overall Study|Administrative Reason by Sponsor|1
4555384|NCT01241292|7385063|FG001|Overall Study|Administrative Reason by Sponsor|0
4555385|NCT01241292|7385062|FG000|Overall Study|Disease Progression|2
4555386|NCT01241292|7385063|FG001|Overall Study|Disease Progression|0
4555387|NCT01241292|7385062|FG000|Overall Study|Study Drug Toxicity|0
4555388|NCT01241292|7385063|FG001|Overall Study|Study Drug Toxicity|1
4555389|NCT01241292|7385062|FG000|Overall Study|Participant Discontinued Treatment|0
4555390|NCT01241292|7385063|FG001|Overall Study|Participant Discontinued Treatment|2
4555391|NCT01241318|7385075|FG000|Overall Study|Woman: false pregnancies|27
4621900|NCT01796392|7484599|FG000|Overall Study|Excluded for medical reasons|1
4621901|NCT01796392|7484600|FG001|Overall Study|Excluded for medical reasons|2
4621902|NCT01796392|7484599|FG000|Overall Study|Lost to Follow-up|1
4621903|NCT01796392|7484600|FG001|Overall Study|Lost to Follow-up|0
4633085|NCT01908205|7503019|FG001|Overall Study|Withdrawal by Subject|1
4633086|NCT01908426|7503040|FG000|Overall Study|Adverse Event|98
4633087|NCT01908426|7503041|FG001|Overall Study|Adverse Event|11
4633088|NCT01908426|7503040|FG000|Overall Study|Clinical Deterioration|72
4633089|NCT01908426|7503041|FG001|Overall Study|Clinical Deterioration|38
4633090|NCT01908426|7503040|FG000|Overall Study|Lack of Efficacy|3
4633091|NCT01908426|7503041|FG001|Overall Study|Lack of Efficacy|0
4633092|NCT01908426|7503040|FG000|Overall Study|Lost to Follow-up|0
4555392|NCT01241318|7385076|FG001|Overall Study|Woman: false pregnancies|15
4633093|NCT01908426|7503041|FG001|Overall Study|Lost to Follow-up|1
4555393|NCT01241318|7385075|FG000|Overall Study|Woman: miscarriage/abortion|46
4555394|NCT01241318|7385076|FG001|Overall Study|Woman: miscarriage/abortion|38
4555395|NCT01241318|7385075|FG000|Overall Study|Withdrawal by Subject|175
4555396|NCT01241318|7385076|FG001|Overall Study|Withdrawal by Subject|46
4555397|NCT01241318|7385075|FG000|Overall Study|Lost to Follow-up|740
4555398|NCT01241318|7385076|FG001|Overall Study|Lost to Follow-up|455
4555399|NCT01241318|7385075|FG000|Overall Study|Death|2
4555400|NCT01241318|7385076|FG001|Overall Study|Death|4
4555401|NCT01241318|7385075|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60
4555402|NCT01241318|7385076|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38
4555403|NCT01241318|7385075|FG000|Overall Study|Woman: Stillborn infant|129
4555404|NCT01241318|7385076|FG001|Overall Study|Woman: Stillborn infant|146
4555405|NCT01241448|7385122|FG000|Overall Study|Adverse Event|1
4555406|NCT01241448|7385123|FG001|Overall Study|Adverse Event|0
4555407|NCT01241448|7385124|FG002|Overall Study|Adverse Event|2
4555408|NCT01241448|7385125|FG003|Overall Study|Adverse Event|2
4555409|NCT01241448|7385122|FG000|Overall Study|Lost to Follow-up|2
4555410|NCT01241448|7385123|FG001|Overall Study|Lost to Follow-up|1
4555411|NCT01241448|7385124|FG002|Overall Study|Lost to Follow-up|1
4555412|NCT01241448|7385125|FG003|Overall Study|Lost to Follow-up|1
4555413|NCT01241448|7385122|FG000|Overall Study|Physician Decision|0
4621904|NCT01796470|7484611|FG000|Overall Study|Adverse Event|4
4621905|NCT01796470|7484612|FG001|Overall Study|Adverse Event|2
4621906|NCT01796470|7484613|FG002|Overall Study|Adverse Event|2
4621907|NCT01796470|7484614|FG003|Overall Study|Adverse Event|1
4621908|NCT01796470|7484615|FG004|Overall Study|Adverse Event|3
4621909|NCT01796470|7484611|FG000|Overall Study|Death|2
4621910|NCT01796470|7484612|FG001|Overall Study|Death|0
4621911|NCT01796470|7484613|FG002|Overall Study|Death|0
4621912|NCT01796470|7484614|FG003|Overall Study|Death|0
4621913|NCT01796470|7484615|FG004|Overall Study|Death|1
4555414|NCT01241448|7385123|FG001|Overall Study|Physician Decision|2
4555415|NCT01241448|7385124|FG002|Overall Study|Physician Decision|0
4555416|NCT01241448|7385125|FG003|Overall Study|Physician Decision|0
4555417|NCT01241448|7385122|FG000|Overall Study|Protocol Violation|10
4555418|NCT01241448|7385123|FG001|Overall Study|Protocol Violation|5
4555419|NCT01241448|7385124|FG002|Overall Study|Protocol Violation|3
4555420|NCT01241448|7385125|FG003|Overall Study|Protocol Violation|6
4555421|NCT01241448|7385122|FG000|Overall Study|Sponsor Decision|17
4555422|NCT01241448|7385123|FG001|Overall Study|Sponsor Decision|14
4555423|NCT01241448|7385124|FG002|Overall Study|Sponsor Decision|12
4555424|NCT01241448|7385125|FG003|Overall Study|Sponsor Decision|6
4555425|NCT01241448|7385122|FG000|Overall Study|Withdrawal by Subject|4
4555426|NCT01241448|7385123|FG001|Overall Study|Withdrawal by Subject|5
4555427|NCT01241448|7385124|FG002|Overall Study|Withdrawal by Subject|3
4555428|NCT01241448|7385125|FG003|Overall Study|Withdrawal by Subject|6
4555429|NCT01241448|7385122|FG000|Overall Study|Excluded due to data integrity issues|3
4555430|NCT01241448|7385123|FG001|Overall Study|Excluded due to data integrity issues|2
4555431|NCT01241448|7385124|FG002|Overall Study|Excluded due to data integrity issues|2
4555432|NCT01241448|7385125|FG003|Overall Study|Excluded due to data integrity issues|2
4555433|NCT01241461|7385138|FG000|Overall Study|Progressive Disease|3
4555434|NCT01241461|7385139|FG001|Overall Study|Progressive Disease|6
4555435|NCT01241552|7385167|FG000|Overall Study|Lack of Efficacy|1
4555436|NCT01241552|7385168|FG001|Overall Study|Lack of Efficacy|0
4555437|NCT01241552|7385169|FG002|Overall Study|Lack of Efficacy|0
4555438|NCT01241552|7385170|FG003|Overall Study|Lack of Efficacy|0
4555439|NCT01241552|7385167|FG000|Overall Study|Death|26
4555440|NCT01241552|7385168|FG001|Overall Study|Death|30
4555441|NCT01241552|7385169|FG002|Overall Study|Death|20
4555442|NCT01241552|7385170|FG003|Overall Study|Death|25
4555443|NCT01241552|7385167|FG000|Overall Study|Adverse Event|1
4555444|NCT01241552|7385168|FG001|Overall Study|Adverse Event|1
4555445|NCT01241552|7385169|FG002|Overall Study|Adverse Event|0
4555446|NCT01241552|7385170|FG003|Overall Study|Adverse Event|0
4555447|NCT01241552|7385167|FG000|Overall Study|Technical Problems|2
4555448|NCT01241552|7385168|FG001|Overall Study|Technical Problems|0
4621914|NCT01796470|7484611|FG000|Overall Study|Initiated New Therapy|9
4621915|NCT01796470|7484612|FG001|Overall Study|Initiated New Therapy|0
4621916|NCT01796470|7484613|FG002|Overall Study|Initiated New Therapy|0
4621917|NCT01796470|7484614|FG003|Overall Study|Initiated New Therapy|0
4621918|NCT01796470|7484615|FG004|Overall Study|Initiated New Therapy|2
4621919|NCT01796470|7484611|FG000|Overall Study|Lost to Follow-up|0
4621920|NCT01796470|7484612|FG001|Overall Study|Lost to Follow-up|1
4621921|NCT01796470|7484613|FG002|Overall Study|Lost to Follow-up|0
4621922|NCT01796470|7484614|FG003|Overall Study|Lost to Follow-up|0
4621923|NCT01796470|7484615|FG004|Overall Study|Lost to Follow-up|0
4621924|NCT01796470|7484611|FG000|Overall Study|Physician Decision|5
4621925|NCT01796470|7484612|FG001|Overall Study|Physician Decision|4
4621926|NCT01796470|7484613|FG002|Overall Study|Physician Decision|1
4621927|NCT01796470|7484614|FG003|Overall Study|Physician Decision|0
4621928|NCT01796470|7484615|FG004|Overall Study|Physician Decision|1
4621929|NCT01796470|7484611|FG000|Overall Study|Progressive Disease|7
4621930|NCT01796470|7484612|FG001|Overall Study|Progressive Disease|7
4621931|NCT01796470|7484613|FG002|Overall Study|Progressive Disease|3
4621932|NCT01796470|7484614|FG003|Overall Study|Progressive Disease|2
4621933|NCT01796470|7484615|FG004|Overall Study|Progressive Disease|0
4555449|NCT01241552|7385169|FG002|Overall Study|Technical Problems|2
4555450|NCT01241552|7385170|FG003|Overall Study|Technical Problems|2
4555451|NCT01241552|7385167|FG000|Overall Study|Progressive Disease|0
4555452|NCT01241552|7385168|FG001|Overall Study|Progressive Disease|0
4555453|NCT01241552|7385169|FG002|Overall Study|Progressive Disease|1
4621934|NCT01796470|7484611|FG000|Overall Study|Protocol Criteria for Withdrawal|1
4621935|NCT01796470|7484612|FG001|Overall Study|Protocol Criteria for Withdrawal|0
4621936|NCT01796470|7484613|FG002|Overall Study|Protocol Criteria for Withdrawal|0
4621937|NCT01796470|7484614|FG003|Overall Study|Protocol Criteria for Withdrawal|0
4621938|NCT01796470|7484615|FG004|Overall Study|Protocol Criteria for Withdrawal|0
4555454|NCT01241552|7385170|FG003|Overall Study|Progressive Disease|2
4555455|NCT01241552|7385167|FG000|Overall Study|Protocol Violation|0
4555456|NCT01241552|7385168|FG001|Overall Study|Protocol Violation|2
4555457|NCT01241552|7385169|FG002|Overall Study|Protocol Violation|6
4555458|NCT01241552|7385170|FG003|Overall Study|Protocol Violation|1
4555459|NCT01241552|7385167|FG000|Overall Study|Withdrawal by Subject|7
4555460|NCT01241552|7385168|FG001|Overall Study|Withdrawal by Subject|15
4555461|NCT01241552|7385169|FG002|Overall Study|Withdrawal by Subject|14
4555462|NCT01241552|7385170|FG003|Overall Study|Withdrawal by Subject|15
4555463|NCT01241552|7385167|FG000|Overall Study|Physician Decision|2
4555464|NCT01241552|7385168|FG001|Overall Study|Physician Decision|4
4555465|NCT01241552|7385169|FG002|Overall Study|Physician Decision|2
4621939|NCT01796470|7484611|FG000|Overall Study|Withdrawal by Subject|7
4621940|NCT01796470|7484612|FG001|Overall Study|Withdrawal by Subject|0
4621941|NCT01796470|7484613|FG002|Overall Study|Withdrawal by Subject|0
4621942|NCT01796470|7484614|FG003|Overall Study|Withdrawal by Subject|0
4555466|NCT01241552|7385170|FG003|Overall Study|Physician Decision|3
4555467|NCT01241552|7385167|FG000|Overall Study|Lost to Follow-up|2
4555468|NCT01241552|7385168|FG001|Overall Study|Lost to Follow-up|11
4555469|NCT01241552|7385169|FG002|Overall Study|Lost to Follow-up|15
4555470|NCT01241552|7385170|FG003|Overall Study|Lost to Follow-up|16
4555471|NCT01241591|7385189|FG000|Overall Study|Lack of Efficacy|5
4555472|NCT01241591|7385190|FG001|Overall Study|Lack of Efficacy|2
4555473|NCT01241591|7385191|FG002|Overall Study|Lack of Efficacy|2
4555474|NCT01241591|7385192|FG003|Overall Study|Lack of Efficacy|3
4555475|NCT01241591|7385189|FG000|Overall Study|Protocol Violation|5
4555476|NCT01241591|7385190|FG001|Overall Study|Protocol Violation|2
4555477|NCT01241591|7385191|FG002|Overall Study|Protocol Violation|3
4555478|NCT01241591|7385192|FG003|Overall Study|Protocol Violation|0
4555479|NCT01241591|7385189|FG000|Overall Study|Lost to Follow-up|1
4555480|NCT01241591|7385190|FG001|Overall Study|Lost to Follow-up|2
4555481|NCT01241591|7385191|FG002|Overall Study|Lost to Follow-up|2
4555482|NCT01241591|7385192|FG003|Overall Study|Lost to Follow-up|2
4555483|NCT01241591|7385189|FG000|Overall Study|Screen Failure|3
4555484|NCT01241591|7385190|FG001|Overall Study|Screen Failure|2
4555485|NCT01241591|7385191|FG002|Overall Study|Screen Failure|1
4555486|NCT01241591|7385192|FG003|Overall Study|Screen Failure|0
4555487|NCT01241591|7385189|FG000|Overall Study|Withdrawal by Subject|6
4555488|NCT01241591|7385190|FG001|Overall Study|Withdrawal by Subject|4
4555489|NCT01241591|7385191|FG002|Overall Study|Withdrawal by Subject|2
4555490|NCT01241591|7385192|FG003|Overall Study|Withdrawal by Subject|2
4621943|NCT01796470|7484615|FG004|Overall Study|Withdrawal by Subject|1
4621944|NCT01796548|7484631|FG000|Overall Study|Lost to Follow-up|1
4621945|NCT01796548|7484631|FG000|Overall Study|Other|2
4621946|NCT01796860|7484648|FG000|Overall Study|Withdrawal by Subject|3
4621947|NCT01796964|7484663|FG000|Overall Study|Adverse Event|1
4621948|NCT01796964|7484664|FG001|Overall Study|Adverse Event|1
4621949|NCT01796964|7484663|FG000|Overall Study|Death|1
4621950|NCT01796964|7484664|FG001|Overall Study|Death|0
4621951|NCT01796964|7484663|FG000|Overall Study|Protocol Violation|0
4621952|NCT01796964|7484664|FG001|Overall Study|Protocol Violation|1
4621953|NCT01796964|7484663|FG000|Overall Study|Withdrawal by Subject|1
4621954|NCT01796964|7484664|FG001|Overall Study|Withdrawal by Subject|1
4621955|NCT01797081|7484693|FG000|Overall Study|Adverse Event|1
4621956|NCT01797081|7484694|FG001|Overall Study|Adverse Event|0
4621957|NCT01797081|7484695|FG002|Overall Study|Adverse Event|1
4621958|NCT01797081|7484696|FG003|Overall Study|Adverse Event|0
4621959|NCT01797081|7484693|FG000|Overall Study|Pregnancy|1
4621960|NCT01797081|7484694|FG001|Overall Study|Pregnancy|0
4621961|NCT01797081|7484695|FG002|Overall Study|Pregnancy|0
4621962|NCT01797081|7484696|FG003|Overall Study|Pregnancy|0
4621963|NCT01797081|7484693|FG000|Overall Study|Personal Reasons|12
4621964|NCT01797081|7484694|FG001|Overall Study|Personal Reasons|4
4621965|NCT01797081|7484695|FG002|Overall Study|Personal Reasons|4
4621966|NCT01797081|7484696|FG003|Overall Study|Personal Reasons|8
4621967|NCT01797081|7484693|FG000|Overall Study|Protocol Violation|0
4621968|NCT01797081|7484694|FG001|Overall Study|Protocol Violation|0
4621969|NCT01797081|7484695|FG002|Overall Study|Protocol Violation|0
4621970|NCT01797081|7484696|FG003|Overall Study|Protocol Violation|1
4621971|NCT01797094|7484706|FG000|Overall Study|Adverse Event|1
4621972|NCT01797094|7484707|FG001|Overall Study|Adverse Event|1
4621973|NCT01797094|7484706|FG000|Overall Study|Personal Reasons|4
4621974|NCT01797094|7484707|FG001|Overall Study|Personal Reasons|0
4621975|NCT01797094|7484706|FG000|Overall Study|Protocol Violation|0
4555491|NCT01241591|7385189|FG000|Overall Study|Other|0
4555492|NCT01241591|7385190|FG001|Overall Study|Other|1
4621976|NCT01797094|7484707|FG001|Overall Study|Protocol Violation|1
4621977|NCT01797094|7484706|FG000|Overall Study|Other Miscellaneous Reasons|1
4621978|NCT01797094|7484707|FG001|Overall Study|Other Miscellaneous Reasons|0
4621979|NCT01797120|7484715|FG000|Overall Study|Disesae progression|37
4621980|NCT01797120|7484716|FG001|Overall Study|Disesae progression|49
4621981|NCT01797120|7484715|FG000|Overall Study|Adverse Event|13
4621982|NCT01797120|7484716|FG001|Overall Study|Adverse Event|5
4621983|NCT01797120|7484715|FG000|Overall Study|Withdrawal by Subject|6
4555493|NCT01241591|7385191|FG002|Overall Study|Other|0
4621984|NCT01797120|7484716|FG001|Overall Study|Withdrawal by Subject|6
4621985|NCT01797120|7484715|FG000|Overall Study|Symptomatic progression|2
4555494|NCT01241591|7385192|FG003|Overall Study|Other|1
4555495|NCT01241591|7385189|FG000|Overall Study|Adverse Event|3
4555496|NCT01241591|7385190|FG001|Overall Study|Adverse Event|11
4555497|NCT01241591|7385191|FG002|Overall Study|Adverse Event|12
4555498|NCT01241591|7385192|FG003|Overall Study|Adverse Event|4
4555499|NCT01241604|7385202|FG000|Screening Period|Screen Failure|3
4555500|NCT01241604|7385203|FG001|Screening Period|Screen Failure|0
4555501|NCT01241604|7385204|FG002|Screening Period|Screen Failure|0
4555502|NCT01241760|7385213|FG000|Overall Study|Adverse Event|1
4555503|NCT01241760|7385214|FG001|Overall Study|Adverse Event|0
4555504|NCT01241760|7385213|FG000|Overall Study|Lost to Follow-up|18
4555505|NCT01241760|7385214|FG001|Overall Study|Lost to Follow-up|22
4555506|NCT01241760|7385213|FG000|Overall Study|Withdrawal by Subject|13
4555507|NCT01241760|7385214|FG001|Overall Study|Withdrawal by Subject|13
4555508|NCT01241760|7385213|FG000|Overall Study|Switch To Commercially Available Medicat|1
4555509|NCT01241760|7385214|FG001|Overall Study|Switch To Commercially Available Medicat|4
4555510|NCT01241760|7385213|FG000|Overall Study|Other|1
4555511|NCT01241760|7385214|FG001|Overall Study|Other|1
4555512|NCT01242085|7385242|FG000|Overall Study|Withdrawal by Subject|4
4555513|NCT01242085|7385243|FG001|Overall Study|Withdrawal by Subject|2
4555514|NCT01242085|7385244|FG002|Overall Study|Withdrawal by Subject|0
4555515|NCT01242085|7385242|FG000|Overall Study|medically unable to have surgery|4
4555516|NCT01242085|7385243|FG001|Overall Study|medically unable to have surgery|5
4555517|NCT01242085|7385244|FG002|Overall Study|medically unable to have surgery|0
4555518|NCT01242111|7385250|FG000|Overall Study|Adverse Event|1
4555519|NCT01242111|7385250|FG000|Overall Study|Withdrawal by Subject|1
4555520|NCT01242111|7385250|FG000|Overall Study|Did not consent to MOR-100 follow-up|1
4555521|NCT01242176|7385254|FG000|Washout Period of 7 Days|Adverse Event|0
4555522|NCT01242176|7385255|FG001|Washout Period of 7 Days|Adverse Event|2
4555523|NCT01242176|7385254|FG000|Washout Period of 7 Days|Non-compliant with protocol|1
4555524|NCT01242176|7385255|FG001|Washout Period of 7 Days|Non-compliant with protocol|0
4555525|NCT01242371|7385272|FG000|Overall Study|Withdrawal by Subject|2
4555526|NCT01242371|7385273|FG001|Overall Study|Withdrawal by Subject|2
4555527|NCT01242371|7385272|FG000|Overall Study|Protocol Violation|0
4555528|NCT01242371|7385273|FG001|Overall Study|Protocol Violation|3
4555529|NCT01242514|7385282|FG000|Overall Study|e.g., project closure|1042
4555530|NCT01242514|7385283|FG001|Overall Study|e.g., project closure|305
4555531|NCT01242514|7385284|FG002|Overall Study|e.g., project closure|171
4555532|NCT01242514|7385282|FG000|Overall Study|Subject decision|33
4555533|NCT01242514|7385283|FG001|Overall Study|Subject decision|8
4555534|NCT01242514|7385284|FG002|Overall Study|Subject decision|2
4555535|NCT01242514|7385282|FG000|Overall Study|Severe non-compliance to protocol|5
4555536|NCT01242514|7385283|FG001|Overall Study|Severe non-compliance to protocol|2
4555537|NCT01242514|7385284|FG002|Overall Study|Severe non-compliance to protocol|1
4555538|NCT01242514|7385282|FG000|Overall Study|Lack of therapeutic response|99
4555539|NCT01242514|7385283|FG001|Overall Study|Lack of therapeutic response|16
4555540|NCT01242514|7385284|FG002|Overall Study|Lack of therapeutic response|10
4555541|NCT01242514|7385282|FG000|Overall Study|Dev. of study specific discont. criteria|21
4555542|NCT01242514|7385283|FG001|Overall Study|Dev. of study specific discont. criteria|3
4555543|NCT01242514|7385284|FG002|Overall Study|Dev. of study specific discont. criteria|5
4555544|NCT01242514|7385282|FG000|Overall Study|Lost to Follow-up|14
4555545|NCT01242514|7385283|FG001|Overall Study|Lost to Follow-up|5
4555546|NCT01242514|7385284|FG002|Overall Study|Lost to Follow-up|4
4555547|NCT01242514|7385282|FG000|Overall Study|Adverse Event|129
4555548|NCT01242514|7385283|FG001|Overall Study|Adverse Event|18
4555549|NCT01242514|7385284|FG002|Overall Study|Adverse Event|19
4555550|NCT01242748|7385324|FG000|Overall Study|Adverse Event|10
4555551|NCT01242748|7385325|FG001|Overall Study|Adverse Event|5
4555552|NCT01242748|7385324|FG000|Overall Study|Lost to Follow-up|6
4555553|NCT01242748|7385325|FG001|Overall Study|Lost to Follow-up|2
4555554|NCT01242748|7385324|FG000|Overall Study|Physician Decision|3
4555555|NCT01242748|7385325|FG001|Overall Study|Physician Decision|2
4555556|NCT01242748|7385324|FG000|Overall Study|Protocol Violation|1
4555557|NCT01242748|7385325|FG001|Overall Study|Protocol Violation|0
4555558|NCT01242748|7385324|FG000|Overall Study|Withdrawal by Subject|10
4555559|NCT01242748|7385325|FG001|Overall Study|Withdrawal by Subject|2
4555560|NCT01242748|7385324|FG000|Overall Study|Miscellaneous reasons|8
4555561|NCT01242748|7385325|FG001|Overall Study|Miscellaneous reasons|3
4555562|NCT01242813|7385331|FG000|Overall Study|Lost to Follow-up|2
4555563|NCT01243151|7385344|FG000|Overall Study|Adverse Event|0
4555564|NCT01243151|7385345|FG001|Overall Study|Adverse Event|1
4555565|NCT01243151|7385346|FG002|Overall Study|Adverse Event|0
4555566|NCT01243151|7385347|FG003|Overall Study|Adverse Event|0
4555567|NCT01243151|7385348|FG004|Overall Study|Adverse Event|0
4555568|NCT01243151|7385344|FG000|Overall Study|Protocol Violation|0
4555569|NCT01243151|7385345|FG001|Overall Study|Protocol Violation|0
4555570|NCT01243151|7385346|FG002|Overall Study|Protocol Violation|1
4555571|NCT01243151|7385347|FG003|Overall Study|Protocol Violation|0
4555572|NCT01243151|7385348|FG004|Overall Study|Protocol Violation|0
4555573|NCT01243151|7385344|FG000|Overall Study|Other|0
4555574|NCT01243151|7385345|FG001|Overall Study|Other|0
4555575|NCT01243151|7385346|FG002|Overall Study|Other|0
4555576|NCT01243151|7385347|FG003|Overall Study|Other|1
4555577|NCT01243151|7385348|FG004|Overall Study|Other|0
4555578|NCT01243151|7385344|FG000|Overall Study|Randomized but not treated|0
4555579|NCT01243151|7385345|FG001|Overall Study|Randomized but not treated|0
4555580|NCT01243151|7385346|FG002|Overall Study|Randomized but not treated|0
4555581|NCT01243151|7385347|FG003|Overall Study|Randomized but not treated|1
4555582|NCT01243151|7385348|FG004|Overall Study|Randomized but not treated|0
4555583|NCT01243177|7385366|FG000|Overall Study|Lack of Efficacy|47
4555584|NCT01243177|7385367|FG001|Overall Study|Lack of Efficacy|31
4555585|NCT01243177|7385366|FG000|Overall Study|Protocol Violation|11
4555586|NCT01243177|7385367|FG001|Overall Study|Protocol Violation|10
4555587|NCT01243177|7385366|FG000|Overall Study|Lost to Follow-up|15
4555588|NCT01243177|7385367|FG001|Overall Study|Lost to Follow-up|18
4621986|NCT01797120|7484716|FG001|Overall Study|Symptomatic progression|1
4621987|NCT01797120|7484715|FG000|Overall Study|Non-compliance|1
4621988|NCT01797120|7484716|FG001|Overall Study|Non-compliance|0
4621989|NCT01797120|7484715|FG000|Overall Study|Physician Decision|3
4621990|NCT01797120|7484716|FG001|Overall Study|Physician Decision|0
4621991|NCT01797120|7484715|FG000|Overall Study|still on treatment|2
4555589|NCT01243177|7385366|FG000|Overall Study|Withdrawal by Subject|46
4555590|NCT01243177|7385367|FG001|Overall Study|Withdrawal by Subject|38
4555591|NCT01243177|7385366|FG000|Overall Study|AE, serious fatal|0
4555592|NCT01243177|7385367|FG001|Overall Study|AE, serious fatal|1
4555593|NCT01243177|7385366|FG000|Overall Study|SAE, non-fatal|7
4555594|NCT01243177|7385367|FG001|Overall Study|SAE, non-fatal|9
4555595|NCT01243177|7385366|FG000|Overall Study|AE, non-serious non-fatal|40
4555596|NCT01243177|7385367|FG001|Overall Study|AE, non-serious non-fatal|58
4555597|NCT01243177|7385366|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1
4555598|NCT01243177|7385367|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0
4555599|NCT01243177|7385366|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
4555600|NCT01243177|7385367|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
4555601|NCT01243177|7385366|FG000|Overall Study|Other Reason|11
4555602|NCT01243177|7385367|FG001|Overall Study|Other Reason|12
4555603|NCT01243242|7385375|FG000|Overall Study|Adverse Event|1
4555604|NCT01243242|7385376|FG001|Overall Study|Adverse Event|1
4555605|NCT01243242|7385375|FG000|Overall Study|Withdrawal by Subject|1
4555606|NCT01243242|7385376|FG001|Overall Study|Withdrawal by Subject|1
4555607|NCT01243242|7385375|FG000|Overall Study|Physician Decision|0
4555608|NCT01243242|7385376|FG001|Overall Study|Physician Decision|1
4555609|NCT01243242|7385375|FG000|Overall Study|sponsor decision|0
4621992|NCT01797120|7484716|FG001|Overall Study|still on treatment|4
4621993|NCT01797120|7484715|FG000|Overall Study|never start protocol therapy|2
4621994|NCT01797120|7484716|FG001|Overall Study|never start protocol therapy|0
4621995|NCT01797185|7484730|FG000|Overall Study|Adverse Event|5
4621996|NCT01797185|7484731|FG001|Overall Study|Adverse Event|15
4621997|NCT01797185|7484732|FG002|Overall Study|Adverse Event|6
4621998|NCT01797185|7484730|FG000|Overall Study|Withdrawal by Subject|6
4621999|NCT01797185|7484731|FG001|Overall Study|Withdrawal by Subject|9
4622000|NCT01797185|7484732|FG002|Overall Study|Withdrawal by Subject|5
4622001|NCT01797185|7484730|FG000|Overall Study|Site terminated|8
4622002|NCT01797185|7484731|FG001|Overall Study|Site terminated|4
4622003|NCT01797185|7484732|FG002|Overall Study|Site terminated|0
4622004|NCT01797185|7484730|FG000|Overall Study|Lost to Follow-up|2
4622005|NCT01797185|7484731|FG001|Overall Study|Lost to Follow-up|6
4622006|NCT01797185|7484732|FG002|Overall Study|Lost to Follow-up|1
4622007|NCT01797185|7484730|FG000|Overall Study|Withdrawn per sponsor|5
4622008|NCT01797185|7484731|FG001|Overall Study|Withdrawn per sponsor|0
4622009|NCT01797185|7484732|FG002|Overall Study|Withdrawn per sponsor|0
4622010|NCT01797185|7484730|FG000|Overall Study|Physician Decision|1
4622011|NCT01797185|7484731|FG001|Overall Study|Physician Decision|3
4622012|NCT01797185|7484732|FG002|Overall Study|Physician Decision|0
4622013|NCT01797185|7484730|FG000|Overall Study|Protocol Violation|1
4622014|NCT01797185|7484731|FG001|Overall Study|Protocol Violation|1
4622015|NCT01797185|7484732|FG002|Overall Study|Protocol Violation|0
4622016|NCT01797263|7484742|FG000|Overall Study|Withdrawal by Subject|21
4622017|NCT01797263|7484743|FG001|Overall Study|Withdrawal by Subject|25
4622018|NCT01797263|7484742|FG000|Overall Study|Death|1
4622019|NCT01797263|7484743|FG001|Overall Study|Death|0
4622020|NCT01797263|7484742|FG000|Overall Study|Lost to Follow-up|15
4622021|NCT01797263|7484743|FG001|Overall Study|Lost to Follow-up|15
4622022|NCT01797302|7484752|FG000|Overall Study|Lost to Follow-up|16
4622023|NCT01797302|7484753|FG001|Overall Study|Lost to Follow-up|23
4622024|NCT01797302|7484754|FG002|Overall Study|Lost to Follow-up|22
4622025|NCT01797302|7484752|FG000|Overall Study|Withdrawal by Subject|1
4770412|NCT03740919|7746732|FG002|Treatment Period|Issue with Insulin Pump|0
4555610|NCT01243242|7385376|FG001|Overall Study|sponsor decision|1
4555611|NCT01243242|7385375|FG000|Overall Study|non compliance|1
4555612|NCT01243242|7385376|FG001|Overall Study|non compliance|0
4555613|NCT01243268|7385382|FG000|Overall Study|Lost to Follow-up|4
4555614|NCT01243268|7385382|FG000|Overall Study|Protocol Violation|51
4622026|NCT01797302|7484753|FG001|Overall Study|Withdrawal by Subject|3
4622027|NCT01797302|7484754|FG002|Overall Study|Withdrawal by Subject|4
4622028|NCT01797432|7484771|FG000|Overall Study|Lost to Follow-up|1
4622029|NCT01797432|7484771|FG000|Overall Study|Adverse Event|1
4622030|NCT01797432|7484771|FG000|Overall Study|Withdrawal by Subject|1
4622031|NCT01797432|7484771|FG000|Overall Study|lived too far from study site|1
4622032|NCT01797445|7484777|FG000|Double-Blind Phase|Randomized but Not Treated|4
4622033|NCT01797445|7484778|FG001|Double-Blind Phase|Randomized but Not Treated|2
4555615|NCT01243268|7385382|FG000|Overall Study|Deviation with contract date|7
4555616|NCT01243268|7385382|FG000|Overall Study|Duplicate subject|2
4555617|NCT01243411|7385403|FG000|Overall Study|Withdrawal by Subject|18
4555618|NCT01243411|7385403|FG000|Overall Study|Lost to Follow-up|10
4555619|NCT01243411|7385403|FG000|Overall Study|Adverse Event|5
4555620|NCT01243411|7385403|FG000|Overall Study|Other|8
4555621|NCT01243424|7385409|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49
4555622|NCT01243424|7385410|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37
4555623|NCT01243424|7385409|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14
4555624|NCT01243424|7385410|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12
4555625|NCT01243424|7385409|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15
4555626|NCT01243424|7385410|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22
4555627|NCT01243424|7385409|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0
4555628|NCT01243424|7385410|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1
4555629|NCT01243424|7385409|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38
4555630|NCT01243424|7385410|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35
4555631|NCT01243424|7385409|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8
4555632|NCT01243424|7385410|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8
4555633|NCT01243424|7385409|FG000|Discontinuation From Study (Treated Set)|Not treated|5
4555634|NCT01243424|7385410|FG001|Discontinuation From Study (Treated Set)|Not treated|4
4555635|NCT01243424|7385409|FG000|Discontinuation From Treatment|Not treated|5
4555636|NCT01243424|7385410|FG001|Discontinuation From Treatment|Not treated|4
4555637|NCT01243424|7385409|FG000|Discontinuation From Treatment|Adverse Event|457
4555638|NCT01243424|7385410|FG001|Discontinuation From Treatment|Adverse Event|523
4555639|NCT01243424|7385409|FG000|Discontinuation From Treatment|Lack of Efficacy|61
4555640|NCT01243424|7385410|FG001|Discontinuation From Treatment|Lack of Efficacy|41
4555641|NCT01243424|7385409|FG000|Discontinuation From Treatment|Protocol Violation|46
4555642|NCT01243424|7385410|FG001|Discontinuation From Treatment|Protocol Violation|47
4555643|NCT01243424|7385409|FG000|Discontinuation From Treatment|Lost to Follow-up|24
4555644|NCT01243424|7385410|FG001|Discontinuation From Treatment|Lost to Follow-up|28
4555645|NCT01243424|7385409|FG000|Discontinuation From Treatment|Withdrawal by Subject|309
4555646|NCT01243424|7385410|FG001|Discontinuation From Treatment|Withdrawal by Subject|328
4555647|NCT01243424|7385409|FG000|Discontinuation From Treatment|Other than listed above|230
4555648|NCT01243424|7385410|FG001|Discontinuation From Treatment|Other than listed above|211
4555649|NCT01243671|7385463|FG000|Overall Study|Adverse Event|3
4555650|NCT01243671|7385463|FG000|Overall Study|Anti-adalimumab antibody positive|1
4555651|NCT01243671|7385463|FG000|Overall Study|Other|1
4555652|NCT01243762|7385474|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0
4555653|NCT01243762|7385475|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2
4555654|NCT01243762|7385476|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0
4555655|NCT01243762|7385477|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0
4555656|NCT01243762|7385478|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1
4555657|NCT01243762|7385479|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1
4555658|NCT01243762|7385480|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0
4555659|NCT01243762|7385474|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0
4555660|NCT01243762|7385475|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1
4555661|NCT01243762|7385476|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0
4555662|NCT01243762|7385477|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1
4555663|NCT01243762|7385478|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0
4555664|NCT01243762|7385479|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0
4555665|NCT01243762|7385480|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0
4555666|NCT01243762|7385474|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3
4555667|NCT01243762|7385475|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2
4555668|NCT01243762|7385476|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3
4555669|NCT01243762|7385477|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5
4555670|NCT01243762|7385478|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5
4555671|NCT01243762|7385479|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2
4555672|NCT01243762|7385480|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0
4555673|NCT01243762|7385474|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
4555674|NCT01243762|7385475|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3
4555675|NCT01243762|7385476|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
4555676|NCT01243762|7385477|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
4555677|NCT01243762|7385478|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
4555678|NCT01243762|7385479|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
4555679|NCT01243762|7385480|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
4555680|NCT01243762|7385474|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
4555681|NCT01243762|7385475|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1
4555682|NCT01243762|7385476|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
4555683|NCT01243762|7385477|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
4555684|NCT01243762|7385478|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
4555685|NCT01243762|7385479|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
4555686|NCT01243762|7385480|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3
4555687|NCT01243762|7385474|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1
4555688|NCT01243762|7385475|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3
4555689|NCT01243762|7385476|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0
4555690|NCT01243762|7385477|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1
4555691|NCT01243762|7385478|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2
4555692|NCT01243762|7385479|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0
4555693|NCT01243762|7385480|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3
4555694|NCT01243762|7385474|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
4555695|NCT01243762|7385475|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1
4555696|NCT01243762|7385476|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
4555697|NCT01243762|7385477|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
4555698|NCT01243762|7385478|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1
4555699|NCT01243762|7385479|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
4555700|NCT01243762|7385480|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
4555701|NCT01243762|7385474|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
4555702|NCT01243762|7385475|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
4555703|NCT01243762|7385476|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
4555704|NCT01243762|7385477|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1
4555705|NCT01243762|7385478|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1
4555706|NCT01243762|7385479|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
4555707|NCT01243762|7385480|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
4555708|NCT01243775|7385499|FG000|Overall Study|Withdrawal by Subject|2
4555709|NCT01243944|7385505|FG000|Overall Study|Adverse Event|15
4555710|NCT01243944|7385506|FG001|Overall Study|Adverse Event|13
4555711|NCT01243944|7385505|FG000|Overall Study|Lost to Follow-up|2
4555712|NCT01243944|7385506|FG001|Overall Study|Lost to Follow-up|1
4555713|NCT01243944|7385505|FG000|Overall Study|Physician Decision|2
4555714|NCT01243944|7385506|FG001|Overall Study|Physician Decision|7
4555715|NCT01243944|7385505|FG000|Overall Study|Disease progression|12
4555716|NCT01243944|7385506|FG001|Overall Study|Disease progression|11
4555717|NCT01243944|7385505|FG000|Overall Study|Protocol deviation|1
4555718|NCT01243944|7385506|FG001|Overall Study|Protocol deviation|1
4555719|NCT01243944|7385505|FG000|Overall Study|Participant decision|10
4555720|NCT01243944|7385506|FG001|Overall Study|Participant decision|15
4555721|NCT01243944|7385505|FG000|Overall Study|Death|2
4555722|NCT01243944|7385506|FG001|Overall Study|Death|3
4555723|NCT01243944|7385505|FG000|Overall Study|Non-compliance with study treatment|1
4555724|NCT01243944|7385506|FG001|Overall Study|Non-compliance with study treatment|0
4555725|NCT01244035|7385519|FG000|Part 1: Period 1|Adverse Event|0
4555726|NCT01244035|7385520|FG001|Part 1: Period 1|Adverse Event|0
4555727|NCT01244035|7385521|FG002|Part 1: Period 1|Adverse Event|0
4555728|NCT01244035|7385522|FG003|Part 1: Period 1|Adverse Event|0
4555729|NCT01244035|7385523|FG004|Part 1: Period 1|Adverse Event|0
4555730|NCT01244035|7385524|FG005|Part 1: Period 1|Adverse Event|1
4555731|NCT01244035|7385519|FG000|Part 1: Period 1|Withdrawal by Subject|0
4555732|NCT01244035|7385520|FG001|Part 1: Period 1|Withdrawal by Subject|2
4555733|NCT01244035|7385521|FG002|Part 1: Period 1|Withdrawal by Subject|0
4555734|NCT01244035|7385522|FG003|Part 1: Period 1|Withdrawal by Subject|0
4555735|NCT01244035|7385523|FG004|Part 1: Period 1|Withdrawal by Subject|0
4555736|NCT01244035|7385524|FG005|Part 1: Period 1|Withdrawal by Subject|0
4555737|NCT01244035|7385519|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1
4555738|NCT01244035|7385520|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0
4555739|NCT01244035|7385521|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2
4555740|NCT01244035|7385522|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0
4555741|NCT01244035|7385523|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1
4555742|NCT01244035|7385524|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1
4555743|NCT01244035|7385519|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0
4555744|NCT01244035|7385520|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0
4555745|NCT01244035|7385521|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1
4555746|NCT01244035|7385522|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0
4555747|NCT01244035|7385523|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0
4555748|NCT01244035|7385524|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0
4555749|NCT01244035|7385519|FG000|Part 1: Period 3|Adverse Event|0
4555750|NCT01244035|7385520|FG001|Part 1: Period 3|Adverse Event|0
4555751|NCT01244035|7385521|FG002|Part 1: Period 3|Adverse Event|0
4555752|NCT01244035|7385522|FG003|Part 1: Period 3|Adverse Event|0
4555753|NCT01244035|7385523|FG004|Part 1: Period 3|Adverse Event|0
4555754|NCT01244035|7385524|FG005|Part 1: Period 3|Adverse Event|1
4555755|NCT01244035|7385519|FG000|Part 1: Period 3|Withdrawal by Subject|0
4555756|NCT01244035|7385520|FG001|Part 1: Period 3|Withdrawal by Subject|0
4555757|NCT01244035|7385521|FG002|Part 1: Period 3|Withdrawal by Subject|0
4555758|NCT01244035|7385522|FG003|Part 1: Period 3|Withdrawal by Subject|0
4555759|NCT01244035|7385523|FG004|Part 1: Period 3|Withdrawal by Subject|1
4555760|NCT01244035|7385524|FG005|Part 1: Period 3|Withdrawal by Subject|0
4555761|NCT01244035|7385519|FG000|Part 1: Period 3|Protocol Deviation|0
4555762|NCT01244035|7385520|FG001|Part 1: Period 3|Protocol Deviation|1
4555763|NCT01244035|7385521|FG002|Part 1: Period 3|Protocol Deviation|0
4555764|NCT01244035|7385522|FG003|Part 1: Period 3|Protocol Deviation|0
4555765|NCT01244035|7385523|FG004|Part 1: Period 3|Protocol Deviation|0
4555766|NCT01244035|7385524|FG005|Part 1: Period 3|Protocol Deviation|0
4591916|NCT01535638|7439061|FG003|Treatment 3 (Single Dose)|Protocol Violation|1
4591917|NCT01535638|7439062|FG004|Treatment 3 (Single Dose)|Protocol Violation|0
4591918|NCT01535638|7439063|FG005|Treatment 3 (Single Dose)|Protocol Violation|0
4591919|NCT01535729|7439080|FG000|Overall Study|Withdrawal by Subject|2
4591920|NCT01535729|7439080|FG000|Overall Study|Disease progression|230
4591921|NCT01535729|7439080|FG000|Overall Study|Discontinued treatment|25
4591922|NCT01535729|7439080|FG000|Overall Study|Lost to Follow-up|8
4591923|NCT01535729|7439080|FG000|Overall Study|Death|52
4591924|NCT01535729|7439080|FG000|Overall Study|Other|19
4591925|NCT01535729|7439080|FG000|Overall Study|Did not sign informed consent|1
4591926|NCT01535729|7439080|FG000|Overall Study|No previous chemotherapy|33
4591927|NCT01535729|7439080|FG000|Overall Study|NSCLC grade IV histology not confirmed|20
4591928|NCT01535729|7439080|FG000|Overall Study|Protocol Violation|11
4591929|NCT01535729|7439080|FG000|Overall Study|Screening failure|1
4591930|NCT01535729|7439080|FG000|Overall Study|Not treated|9
4591931|NCT01535729|7439080|FG000|Overall Study|No participant record available|5
4591932|NCT01536067|7439128|FG000|Overall Study|Disease Progression|1
4591933|NCT01536093|7439134|FG000|Overall Study|Death|1
4622034|NCT01797445|7484777|FG000|Double-Blind Phase|Adverse Event|3
4622035|NCT01797445|7484778|FG001|Double-Blind Phase|Adverse Event|0
4622036|NCT01797445|7484777|FG000|Double-Blind Phase|Death|5
4622037|NCT01797445|7484778|FG001|Double-Blind Phase|Death|4
4622038|NCT01797445|7484777|FG000|Double-Blind Phase|Pregnancy|0
4591934|NCT01536093|7439135|FG001|Overall Study|Death|2
4591935|NCT01536093|7439134|FG000|Overall Study|absence of maternal colostrum|2
4591936|NCT01536093|7439135|FG001|Overall Study|absence of maternal colostrum|0
4591937|NCT01536093|7439134|FG000|Overall Study|Withdrawal by Subject|0
4591938|NCT01536093|7439135|FG001|Overall Study|Withdrawal by Subject|1
4591939|NCT01536119|7439143|FG000|Overall Study|Lost to Follow-up|17
4591940|NCT01536119|7439144|FG001|Overall Study|Lost to Follow-up|14
4591941|NCT01536145|7439150|FG000|Overall Study|Progressive disease|3
4591942|NCT01536145|7439151|FG001|Overall Study|Progressive disease|4
4591943|NCT01536145|7439152|FG002|Overall Study|Progressive disease|1
4591944|NCT01536145|7439153|FG003|Overall Study|Progressive disease|2
4591945|NCT01536145|7439154|FG004|Overall Study|Progressive disease|1
4591946|NCT01536145|7439155|FG005|Overall Study|Progressive disease|2
4591947|NCT01536145|7439156|FG006|Overall Study|Progressive disease|1
4591948|NCT01536145|7439157|FG007|Overall Study|Progressive disease|2
4591949|NCT01536145|7439158|FG008|Overall Study|Progressive disease|1
4591950|NCT01536145|7439159|FG009|Overall Study|Progressive disease|3
4591951|NCT01536145|7439160|FG010|Overall Study|Progressive disease|3
4591952|NCT01536145|7439150|FG000|Overall Study|Withdrawal by Subject|0
4591953|NCT01536145|7439151|FG001|Overall Study|Withdrawal by Subject|0
4591954|NCT01536145|7439152|FG002|Overall Study|Withdrawal by Subject|1
4591955|NCT01536145|7439153|FG003|Overall Study|Withdrawal by Subject|0
4591956|NCT01536145|7439154|FG004|Overall Study|Withdrawal by Subject|0
4591957|NCT01536145|7439155|FG005|Overall Study|Withdrawal by Subject|1
4591958|NCT01536145|7439156|FG006|Overall Study|Withdrawal by Subject|0
4591959|NCT01536145|7439157|FG007|Overall Study|Withdrawal by Subject|0
4591960|NCT01536145|7439158|FG008|Overall Study|Withdrawal by Subject|2
4591961|NCT01536145|7439159|FG009|Overall Study|Withdrawal by Subject|0
4591962|NCT01536145|7439160|FG010|Overall Study|Withdrawal by Subject|2
4591963|NCT01536145|7439150|FG000|Overall Study|Other|0
4591964|NCT01536145|7439151|FG001|Overall Study|Other|0
4591965|NCT01536145|7439152|FG002|Overall Study|Other|0
4591966|NCT01536145|7439153|FG003|Overall Study|Other|0
4591967|NCT01536145|7439154|FG004|Overall Study|Other|1
4591968|NCT01536145|7439155|FG005|Overall Study|Other|0
4591969|NCT01536145|7439156|FG006|Overall Study|Other|0
4591970|NCT01536145|7439157|FG007|Overall Study|Other|0
4591971|NCT01536145|7439158|FG008|Overall Study|Other|0
4591972|NCT01536145|7439159|FG009|Overall Study|Other|3
4591973|NCT01536145|7439160|FG010|Overall Study|Other|2
4591974|NCT01536145|7439150|FG000|Overall Study|Death|0
4591975|NCT01536145|7439151|FG001|Overall Study|Death|0
4591976|NCT01536145|7439152|FG002|Overall Study|Death|0
4591977|NCT01536145|7439153|FG003|Overall Study|Death|0
4591978|NCT01536145|7439154|FG004|Overall Study|Death|0
4591979|NCT01536145|7439155|FG005|Overall Study|Death|0
4591980|NCT01536145|7439156|FG006|Overall Study|Death|1
4591981|NCT01536145|7439157|FG007|Overall Study|Death|0
4591982|NCT01536145|7439158|FG008|Overall Study|Death|0
4591983|NCT01536145|7439159|FG009|Overall Study|Death|0
4591984|NCT01536145|7439160|FG010|Overall Study|Death|0
4591985|NCT01536145|7439150|FG000|Overall Study|Adverse Event|0
4591986|NCT01536145|7439151|FG001|Overall Study|Adverse Event|0
4591987|NCT01536145|7439152|FG002|Overall Study|Adverse Event|0
4591988|NCT01536145|7439153|FG003|Overall Study|Adverse Event|0
4591989|NCT01536145|7439154|FG004|Overall Study|Adverse Event|0
4591990|NCT01536145|7439155|FG005|Overall Study|Adverse Event|0
4591991|NCT01536145|7439156|FG006|Overall Study|Adverse Event|0
4591992|NCT01536145|7439157|FG007|Overall Study|Adverse Event|2
4591993|NCT01536145|7439158|FG008|Overall Study|Adverse Event|0
4591994|NCT01536145|7439159|FG009|Overall Study|Adverse Event|0
4622039|NCT01797445|7484778|FG001|Double-Blind Phase|Pregnancy|1
4555767|NCT01244061|7385546|FG000|Overall Study|Death|1
4555768|NCT01244061|7385547|FG001|Overall Study|Death|0
4555769|NCT01244061|7385546|FG000|Overall Study|Did not meet entrance criteria|1
4555770|NCT01244061|7385547|FG001|Overall Study|Did not meet entrance criteria|0
4555771|NCT01244061|7385546|FG000|Overall Study|Lack of Efficacy|1
4555772|NCT01244061|7385547|FG001|Overall Study|Lack of Efficacy|3
4555773|NCT01244061|7385546|FG000|Overall Study|Lost to Follow-up|34
4555774|NCT01244061|7385547|FG001|Overall Study|Lost to Follow-up|30
4555775|NCT01244061|7385546|FG000|Overall Study|Withdrawal by Subject|29
4555776|NCT01244061|7385547|FG001|Overall Study|Withdrawal by Subject|46
4555777|NCT01244061|7385546|FG000|Overall Study|Other|8
4555778|NCT01244061|7385547|FG001|Overall Study|Other|19
4555779|NCT01244061|7385546|FG000|Overall Study|Protocol Violation|1
4555780|NCT01244061|7385547|FG001|Overall Study|Protocol Violation|1
4555781|NCT01244061|7385546|FG000|Overall Study|Adverse Event|5
4555782|NCT01244061|7385547|FG001|Overall Study|Adverse Event|2
4555783|NCT01244061|7385546|FG000|Overall Study|Randomized but not treated|2
4555784|NCT01244061|7385547|FG001|Overall Study|Randomized but not treated|2
4555785|NCT01244126|7385556|FG000|Overall Study|Protocol Violation|3
4555786|NCT01244126|7385557|FG001|Overall Study|Protocol Violation|3
4555787|NCT01244126|7385558|FG002|Overall Study|Protocol Violation|9
4555788|NCT01244191|7385568|FG000|Overall Study|Progressive disease|295
4555789|NCT01244191|7385569|FG001|Overall Study|Progressive disease|350
4555790|NCT01244191|7385568|FG000|Overall Study|Clinical disease progression|54
4555791|NCT01244191|7385569|FG001|Overall Study|Clinical disease progression|36
4555792|NCT01244191|7385568|FG000|Overall Study|Adverse Event|65
4555793|NCT01244191|7385569|FG001|Overall Study|Adverse Event|48
4555794|NCT01244191|7385568|FG000|Overall Study|Death|22
4555795|NCT01244191|7385569|FG001|Overall Study|Death|29
4555796|NCT01244191|7385568|FG000|Overall Study|Lost to Follow-up|0
4555797|NCT01244191|7385569|FG001|Overall Study|Lost to Follow-up|2
4555798|NCT01244191|7385568|FG000|Overall Study|Protocol Violation|1
4555799|NCT01244191|7385569|FG001|Overall Study|Protocol Violation|2
4555800|NCT01244191|7385568|FG000|Overall Study|Withdrawal by Subject|31
4555801|NCT01244191|7385569|FG001|Overall Study|Withdrawal by Subject|23
4555802|NCT01244191|7385568|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12
4555803|NCT01244191|7385569|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8
4555804|NCT01244425|7385585|FG000|Overall Study|Withdrawal by Subject|2
4555805|NCT01244425|7385586|FG001|Overall Study|Withdrawal by Subject|2
4555806|NCT01244425|7385585|FG000|Overall Study|Adverse Event|1
4555807|NCT01244425|7385586|FG001|Overall Study|Adverse Event|1
4555808|NCT01244490|7385619|FG000|Overall Study|Lack of Efficacy|14
4555809|NCT01244490|7385620|FG001|Overall Study|Lack of Efficacy|5
4555810|NCT01244490|7385621|FG002|Overall Study|Lack of Efficacy|5
4555811|NCT01244490|7385619|FG000|Overall Study|Withdrawal by Subject|4
4555812|NCT01244490|7385620|FG001|Overall Study|Withdrawal by Subject|4
4555813|NCT01244490|7385621|FG002|Overall Study|Withdrawal by Subject|9
4555814|NCT01244490|7385619|FG000|Overall Study|Adverse Event|1
4555815|NCT01244490|7385620|FG001|Overall Study|Adverse Event|9
4555816|NCT01244490|7385621|FG002|Overall Study|Adverse Event|5
4555817|NCT01244490|7385619|FG000|Overall Study|Lost to Follow-up|0
4555818|NCT01244490|7385620|FG001|Overall Study|Lost to Follow-up|6
4555819|NCT01244490|7385621|FG002|Overall Study|Lost to Follow-up|3
4555820|NCT01244490|7385619|FG000|Overall Study|Other|0
4555821|NCT01244490|7385620|FG001|Overall Study|Other|0
4555822|NCT01244490|7385621|FG002|Overall Study|Other|1
4555823|NCT01244516|7385636|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4
4555824|NCT01244516|7385637|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5
4555825|NCT01244516|7385638|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2
4555826|NCT01244516|7385636|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0
4555827|NCT01244516|7385637|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1
4555828|NCT01244516|7385638|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0
4555829|NCT01244516|7385636|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0
4555830|NCT01244516|7385637|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0
4555831|NCT01244516|7385638|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1
4555832|NCT01244516|7385636|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2
4555833|NCT01244516|7385637|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0
4555834|NCT01244516|7385638|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0
4555835|NCT01244516|7385636|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1
4555836|NCT01244516|7385637|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0
4555837|NCT01244516|7385638|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1
4555838|NCT01244516|7385636|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0
4555839|NCT01244516|7385637|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1
4555840|NCT01244516|7385638|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0
4555841|NCT01244516|7385636|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0
4555842|NCT01244516|7385637|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0
4555843|NCT01244516|7385638|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1
4555844|NCT01244893|7385675|FG000|Baseline|Protocol Violation|0
4555845|NCT01244893|7385676|FG001|Baseline|Protocol Violation|1
4555846|NCT01244893|7385675|FG000|1-Week Follow Up|Lost to Follow-up|1
4555847|NCT01244893|7385676|FG001|1-Week Follow Up|Lost to Follow-up|0
4555848|NCT01244906|7385687|FG000|Overall Study|Death|2
4555849|NCT01244906|7385687|FG000|Overall Study|Progression of disease post treatment|6
4555850|NCT01244984|7385694|FG000|Overall Study|Adverse Event|2
4555851|NCT01244984|7385695|FG001|Overall Study|Adverse Event|11
4555852|NCT01244984|7385696|FG002|Overall Study|Adverse Event|2
4555853|NCT01244984|7385694|FG000|Overall Study|Protocol Violation|1
4555854|NCT01244984|7385695|FG001|Overall Study|Protocol Violation|0
4555855|NCT01244984|7385696|FG002|Overall Study|Protocol Violation|0
4555856|NCT01244984|7385694|FG000|Overall Study|Protocol Defined Stopping Criteria|1
4555857|NCT01244984|7385695|FG001|Overall Study|Protocol Defined Stopping Criteria|1
4555858|NCT01244984|7385696|FG002|Overall Study|Protocol Defined Stopping Criteria|0
4555859|NCT01244984|7385694|FG000|Overall Study|Withdrawal by Subject|1
4555860|NCT01244984|7385695|FG001|Overall Study|Withdrawal by Subject|2
4555861|NCT01244984|7385696|FG002|Overall Study|Withdrawal by Subject|2
4555862|NCT01245049|7385707|FG000|Overall Study|Migrated/moved from study area|0
4555863|NCT01245049|7385708|FG001|Overall Study|Migrated/moved from study area|1
4555864|NCT01245049|7385707|FG000|Overall Study|Withdrawal by Subject|0
4555865|NCT01245049|7385708|FG001|Overall Study|Withdrawal by Subject|1
4555866|NCT01245049|7385707|FG000|Overall Study|Lost to Follow-up|1
4555867|NCT01245049|7385708|FG001|Overall Study|Lost to Follow-up|2
4555868|NCT01245062|7385716|FG000|Randomization and Crossover Phase|Lost to Follow-up|4
4555869|NCT01245062|7385717|FG001|Randomization and Crossover Phase|Lost to Follow-up|2
4555870|NCT01245062|7385718|FG002|Randomization and Crossover Phase|Lost to Follow-up|0
4555871|NCT01245062|7385716|FG000|Randomization and Crossover Phase|Physician Decision|2
4555872|NCT01245062|7385717|FG001|Randomization and Crossover Phase|Physician Decision|4
4555873|NCT01245062|7385718|FG002|Randomization and Crossover Phase|Physician Decision|0
4555874|NCT01245062|7385716|FG000|Randomization and Crossover Phase|Withdrew Consent|12
4555875|NCT01245062|7385717|FG001|Randomization and Crossover Phase|Withdrew Consent|11
4555876|NCT01245062|7385718|FG002|Randomization and Crossover Phase|Withdrew Consent|0
4555877|NCT01245062|7385716|FG000|Randomization and Crossover Phase|Study closed/ terminated|23
4555878|NCT01245062|7385717|FG001|Randomization and Crossover Phase|Study closed/ terminated|14
4555879|NCT01245062|7385718|FG002|Randomization and Crossover Phase|Study closed/ terminated|0
4555880|NCT01245062|7385716|FG000|Cross-over Phase|Lost to Follow-up|0
4555881|NCT01245062|7385717|FG001|Cross-over Phase|Lost to Follow-up|0
4555882|NCT01245062|7385718|FG002|Cross-over Phase|Lost to Follow-up|1
4555883|NCT01245062|7385716|FG000|Cross-over Phase|Physician Decision|0
4555884|NCT01245062|7385717|FG001|Cross-over Phase|Physician Decision|0
4555885|NCT01245062|7385718|FG002|Cross-over Phase|Physician Decision|1
4555886|NCT01245062|7385716|FG000|Cross-over Phase|Withdrew Consent|0
4555887|NCT01245062|7385717|FG001|Cross-over Phase|Withdrew Consent|0
4555888|NCT01245062|7385718|FG002|Cross-over Phase|Withdrew Consent|4
4555889|NCT01245062|7385716|FG000|Cross-over Phase|Study closed/ terminated|0
4555890|NCT01245062|7385717|FG001|Cross-over Phase|Study closed/ terminated|0
4555891|NCT01245062|7385718|FG002|Cross-over Phase|Study closed/ terminated|11
4555892|NCT01245101|7385728|FG000|Period 1 (Treatment)|Withdrawal by Subject|2
4555893|NCT01245101|7385729|FG001|Period 1 (Treatment)|Withdrawal by Subject|0
4555894|NCT01245101|7385728|FG000|Period 2 (Washout)|Withdrawal by Subject|1
4555895|NCT01245101|7385729|FG001|Period 2 (Washout)|Withdrawal by Subject|0
4555896|NCT01245101|7385728|FG000|Period 3 (Treatment)|Withdrawal by Subject|1
4555897|NCT01245101|7385729|FG001|Period 3 (Treatment)|Withdrawal by Subject|0
4555898|NCT01245140|7385737|FG000|Overall Study|Adverse Event|1
4555899|NCT01245140|7385738|FG001|Overall Study|Adverse Event|3
4555900|NCT01245140|7385737|FG000|Overall Study|Lack of Efficacy|2
4555901|NCT01245140|7385738|FG001|Overall Study|Lack of Efficacy|4
4555902|NCT01245140|7385737|FG000|Overall Study|Protocol Violation|0
4555903|NCT01245140|7385738|FG001|Overall Study|Protocol Violation|1
4622040|NCT01797445|7484777|FG000|Double-Blind Phase|Lack of Efficacy|1
4555904|NCT01245140|7385737|FG000|Overall Study|Withdrawal by Subject|0
4555905|NCT01245140|7385738|FG001|Overall Study|Withdrawal by Subject|1
4555906|NCT01245140|7385737|FG000|Overall Study|Refused Treatment/Did Not Coopera|0
4555907|NCT01245140|7385738|FG001|Overall Study|Refused Treatment/Did Not Coopera|1
4555908|NCT01245283|7385758|FG000|Overall Study|Lost to Follow-up|14
4555909|NCT01245283|7385759|FG001|Overall Study|Lost to Follow-up|11
4555910|NCT01245283|7385760|FG002|Overall Study|Lost to Follow-up|11
4555911|NCT01245374|7385771|FG000|Overall Study|Protocol Violation|1
4555912|NCT01245374|7385771|FG000|Overall Study|Withdrawal by Subject|3
4555913|NCT01245387|7385776|FG000|Overall Study|Lost to Follow-up|106
4555914|NCT01245387|7385776|FG000|Overall Study|Lack of Efficacy|195
4622041|NCT01797445|7484778|FG001|Double-Blind Phase|Lack of Efficacy|2
4622042|NCT01797445|7484777|FG000|Double-Blind Phase|Investigator's Discretion|15
4555915|NCT01245387|7385776|FG000|Overall Study|Adverse Event|9
4555916|NCT01245387|7385776|FG000|Overall Study|Death|3
4555917|NCT01245387|7385776|FG000|Overall Study|Other|131
4555918|NCT01245387|7385776|FG000|Overall Study|Missing discontinuation status|369
4555919|NCT01245673|7385811|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1
4555920|NCT01245751|7385833|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2
4555921|NCT01245751|7385834|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1
4555922|NCT01245751|7385835|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0
4555923|NCT01245751|7385836|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0
4555924|NCT01245751|7385833|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
4555925|NCT01245751|7385834|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
4555926|NCT01245751|7385835|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
4555927|NCT01245751|7385836|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2
4555928|NCT01245751|7385833|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
4555929|NCT01245751|7385834|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4
4555930|NCT01245751|7385835|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
4555931|NCT01245751|7385836|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
4555932|NCT01245764|7385851|FG000|Study Phase A|Other|3
4555933|NCT01245764|7385852|FG001|Study Phase A|Other|2
4555934|NCT01245764|7385853|FG002|Study Phase A|Other|3
4555935|NCT01245764|7385854|FG003|Study Phase A|Other|1
4555936|NCT01245764|7385851|FG000|Study Phase A|Protocol Violation|6
4555937|NCT01245764|7385852|FG001|Study Phase A|Protocol Violation|3
4555938|NCT01245764|7385853|FG002|Study Phase A|Protocol Violation|2
4555939|NCT01245764|7385854|FG003|Study Phase A|Protocol Violation|2
4555940|NCT01245764|7385851|FG000|Study Phase A|Lost to Follow-up|0
4555941|NCT01245764|7385852|FG001|Study Phase A|Lost to Follow-up|0
4555942|NCT01245764|7385853|FG002|Study Phase A|Lost to Follow-up|5
4555943|NCT01245764|7385854|FG003|Study Phase A|Lost to Follow-up|0
4555944|NCT01246206|7385927|FG000|Overall Study|Patient did not receive study regiments.|1
4555945|NCT01246466|7385956|FG000|Overall Study|Death|1
4555946|NCT01246466|7385956|FG000|Overall Study|Withdrawal by Subject|1
4555947|NCT01246583|7385969|FG000|Overall Study|Lost to Follow-up|0
4555948|NCT01246583|7385970|FG001|Overall Study|Lost to Follow-up|0
4555949|NCT01246583|7385971|FG002|Overall Study|Lost to Follow-up|0
4555950|NCT01246583|7385972|FG003|Overall Study|Lost to Follow-up|1
4555951|NCT01246583|7385969|FG000|Overall Study|Protocol Violation|0
4555952|NCT01246583|7385970|FG001|Overall Study|Protocol Violation|0
4555953|NCT01246583|7385971|FG002|Overall Study|Protocol Violation|1
4555954|NCT01246583|7385972|FG003|Overall Study|Protocol Violation|0
4555955|NCT01246583|7385969|FG000|Overall Study|Withdrawal by Subject|1
4555956|NCT01246583|7385970|FG001|Overall Study|Withdrawal by Subject|0
4555957|NCT01246583|7385971|FG002|Overall Study|Withdrawal by Subject|0
4555958|NCT01246583|7385972|FG003|Overall Study|Withdrawal by Subject|0
4555959|NCT01246960|7386007|FG000|Overall Study|Lost to Follow-up|3
4555960|NCT01246960|7386008|FG001|Overall Study|Lost to Follow-up|1
4555961|NCT01246960|7386007|FG000|Overall Study|Withdrawal (by participant or physician)|3
4555962|NCT01246960|7386008|FG001|Overall Study|Withdrawal (by participant or physician)|3
4555963|NCT01246973|7386016|FG000|Overall Study|Other|38
4555964|NCT01246973|7386017|FG001|Overall Study|Other|25
4555965|NCT01246973|7386016|FG000|Overall Study|Adverse Event|16
4555966|NCT01246973|7386017|FG001|Overall Study|Adverse Event|9
4555967|NCT01246973|7386016|FG000|Overall Study|Withdrawal by Subject|7
4555968|NCT01246973|7386017|FG001|Overall Study|Withdrawal by Subject|13
4555969|NCT01246986|7386030|FG000|Overall Study|Lost to Follow-up|0
4555970|NCT01246986|7386031|FG001|Overall Study|Lost to Follow-up|1
4555971|NCT01246986|7386032|FG002|Overall Study|Lost to Follow-up|3
4622043|NCT01797445|7484778|FG001|Double-Blind Phase|Investigator's Discretion|17
4622044|NCT01797445|7484777|FG000|Double-Blind Phase|Noncompliance with Study Drug|5
4555972|NCT01246986|7386033|FG003|Overall Study|Lost to Follow-up|0
4555973|NCT01246986|7386034|FG004|Overall Study|Lost to Follow-up|0
4555974|NCT01246986|7386035|FG005|Overall Study|Lost to Follow-up|1
4555975|NCT01246986|7386036|FG006|Overall Study|Lost to Follow-up|0
4555976|NCT01246986|7386030|FG000|Overall Study|Withdrawal by Subject|3
4555977|NCT01246986|7386031|FG001|Overall Study|Withdrawal by Subject|4
4555978|NCT01246986|7386032|FG002|Overall Study|Withdrawal by Subject|3
4555979|NCT01246986|7386033|FG003|Overall Study|Withdrawal by Subject|0
4555980|NCT01246986|7386034|FG004|Overall Study|Withdrawal by Subject|4
4555981|NCT01246986|7386035|FG005|Overall Study|Withdrawal by Subject|0
4555982|NCT01246986|7386036|FG006|Overall Study|Withdrawal by Subject|0
4555983|NCT01246999|7386071|FG000|Overall Study|Lost to Follow-up|0
4555984|NCT01246999|7386072|FG001|Overall Study|Lost to Follow-up|1
4555985|NCT01246999|7386073|FG002|Overall Study|Lost to Follow-up|0
4555986|NCT01246999|7386074|FG003|Overall Study|Lost to Follow-up|0
4555987|NCT01246999|7386071|FG000|Overall Study|Withdrawal by Subject|0
4555988|NCT01246999|7386072|FG001|Overall Study|Withdrawal by Subject|0
4555989|NCT01246999|7386073|FG002|Overall Study|Withdrawal by Subject|0
4555990|NCT01246999|7386074|FG003|Overall Study|Withdrawal by Subject|2
4555991|NCT01247090|7386099|FG000|Overall Study|Physician Decision|1
4555992|NCT01247090|7386100|FG001|Overall Study|Physician Decision|0
4555993|NCT01247090|7386101|FG002|Overall Study|Physician Decision|0
4555994|NCT01247090|7386099|FG000|Overall Study|Withdrawal by Subject|0
4555995|NCT01247090|7386100|FG001|Overall Study|Withdrawal by Subject|1
4555996|NCT01247090|7386101|FG002|Overall Study|Withdrawal by Subject|0
4555997|NCT01247350|7386146|FG000|Overall Study|Adverse Event|0
4555998|NCT01247350|7386147|FG001|Overall Study|Adverse Event|0
4555999|NCT01247350|7386148|FG002|Overall Study|Adverse Event|1
4556000|NCT01247350|7386149|FG003|Overall Study|Adverse Event|0
4556001|NCT01247350|7386150|FG004|Overall Study|Adverse Event|0
4556002|NCT01247350|7386146|FG000|Overall Study|Withdrawal by Subject|0
4556003|NCT01247350|7386147|FG001|Overall Study|Withdrawal by Subject|0
4622045|NCT01797445|7484778|FG001|Double-Blind Phase|Noncompliance with Study Drug|1
4556004|NCT01247350|7386148|FG002|Overall Study|Withdrawal by Subject|0
4556005|NCT01247350|7386149|FG003|Overall Study|Withdrawal by Subject|1
4556006|NCT01247350|7386150|FG004|Overall Study|Withdrawal by Subject|0
4556007|NCT01247350|7386146|FG000|Overall Study|Entry criteria not met|0
4556008|NCT01247350|7386147|FG001|Overall Study|Entry criteria not met|0
4556009|NCT01247350|7386148|FG002|Overall Study|Entry criteria not met|0
4556010|NCT01247350|7386149|FG003|Overall Study|Entry criteria not met|0
4556011|NCT01247350|7386150|FG004|Overall Study|Entry criteria not met|1
4556012|NCT01247922|7386218|FG000|Overall Study|Disease progression|4
4556013|NCT01248013|7386231|FG000|Overall Study|Withdrawal by Subject|14
4556014|NCT01248065|7386237|FG000|Overall Study|Lost to Follow-up|3
4556015|NCT01248065|7386238|FG001|Overall Study|Lost to Follow-up|5
4556016|NCT01248065|7386237|FG000|Overall Study|Withdrawal by Subject|14
4556017|NCT01248065|7386238|FG001|Overall Study|Withdrawal by Subject|11
4556018|NCT01248065|7386237|FG000|Overall Study|Adverse Event|3
4556019|NCT01248065|7386238|FG001|Overall Study|Adverse Event|0
4556020|NCT01248065|7386237|FG000|Overall Study|Third treatment failure event|3
4556021|NCT01248065|7386238|FG001|Overall Study|Third treatment failure event|1
4556022|NCT01248065|7386237|FG000|Overall Study|Other|3
4556023|NCT01248065|7386238|FG001|Overall Study|Other|5
4556024|NCT01248364|7386268|FG000|Overall Study|Adverse Event|0
4556025|NCT01248364|7386269|FG001|Overall Study|Adverse Event|1
4556026|NCT01248364|7386270|FG002|Overall Study|Adverse Event|0
4556027|NCT01248364|7386271|FG003|Overall Study|Adverse Event|0
4556028|NCT01248455|7386296|FG000|Overall Study|switched to alternate treatment|1
4556029|NCT01248468|7386303|FG000|Overall Study|Administrative problem|1
4556030|NCT01248468|7386304|FG001|Overall Study|Administrative problem|0
4556031|NCT01248468|7386305|FG002|Overall Study|Administrative problem|0
4556032|NCT01248468|7386303|FG000|Overall Study|Lost to Follow-up|9
4556033|NCT01248468|7386304|FG001|Overall Study|Lost to Follow-up|12
4556034|NCT01248468|7386305|FG002|Overall Study|Lost to Follow-up|4
4556035|NCT01248468|7386303|FG000|Overall Study|Pregnancy|1
4622046|NCT01797445|7484777|FG000|Double-Blind Phase|Protocol Violation|0
4622047|NCT01797445|7484778|FG001|Double-Blind Phase|Protocol Violation|1
4622048|NCT01797445|7484777|FG000|Double-Blind Phase|Withdrew Consent|20
4622049|NCT01797445|7484778|FG001|Double-Blind Phase|Withdrew Consent|35
4622050|NCT01797445|7484777|FG000|Double-Blind Phase|Lost to Follow-up|34
4622051|NCT01797445|7484778|FG001|Double-Blind Phase|Lost to Follow-up|26
4556036|NCT01248468|7386304|FG001|Overall Study|Pregnancy|0
4556037|NCT01248468|7386305|FG002|Overall Study|Pregnancy|0
4556038|NCT01248468|7386303|FG000|Overall Study|Withdrawal by Subject|4
4556039|NCT01248468|7386304|FG001|Overall Study|Withdrawal by Subject|2
4556040|NCT01248468|7386305|FG002|Overall Study|Withdrawal by Subject|0
4556041|NCT01248715|7386324|FG000|Overall Study|Not influenza positive|501
4556042|NCT01248715|7386325|FG001|Overall Study|Not influenza positive|510
4556043|NCT01248728|7386333|FG000|Overall Study|Adverse Event|1
4556044|NCT01248728|7386334|FG001|Overall Study|Adverse Event|1
4556045|NCT01248728|7386333|FG000|Overall Study|Withdrawal by Subject|2
4556046|NCT01248728|7386334|FG001|Overall Study|Withdrawal by Subject|1
4556047|NCT01248728|7386333|FG000|Overall Study|Lack of Efficacy|1
4556048|NCT01248728|7386334|FG001|Overall Study|Lack of Efficacy|0
4556049|NCT01248780|7386348|FG000|Overall Study|Lack of Efficacy|2
4556050|NCT01248780|7386349|FG001|Overall Study|Lack of Efficacy|0
4556051|NCT01248780|7386348|FG000|Overall Study|Lost to Follow-up|0
4556052|NCT01248780|7386349|FG001|Overall Study|Lost to Follow-up|1
4556053|NCT01248780|7386348|FG000|Overall Study|Death|0
4556054|NCT01248780|7386349|FG001|Overall Study|Death|1
4556055|NCT01248780|7386348|FG000|Overall Study|Adverse Event|2
4556056|NCT01248780|7386349|FG001|Overall Study|Adverse Event|7
4556057|NCT01248780|7386348|FG000|Overall Study|Protocol Violation|1
4556058|NCT01248780|7386349|FG001|Overall Study|Protocol Violation|1
4556059|NCT01248780|7386348|FG000|Overall Study|Withdrawal by Subject|4
4556060|NCT01248780|7386349|FG001|Overall Study|Withdrawal by Subject|4
4556061|NCT01248780|7386348|FG000|Overall Study|Not treated|0
4556062|NCT01248780|7386349|FG001|Overall Study|Not treated|1
4556063|NCT01248793|7386357|FG000|Overall Study|Lost to Follow-up|0
4556064|NCT01248793|7386358|FG001|Overall Study|Lost to Follow-up|1
4556065|NCT01248793|7386357|FG000|Overall Study|Adverse Event|1
4622052|NCT01797445|7484777|FG000|Open-Label Extension Phase|Investigator's Discretion|1
4622053|NCT01797445|7484778|FG001|Open-Label Extension Phase|Investigator's Discretion|0
4622054|NCT01797536|7484825|FG000|Overall Study|Adverse Event|0
4622055|NCT01797536|7484826|FG001|Overall Study|Adverse Event|1
4622056|NCT01797536|7484827|FG002|Overall Study|Adverse Event|0
4622057|NCT01797536|7484828|FG003|Overall Study|Adverse Event|0
4556066|NCT01248793|7386358|FG001|Overall Study|Adverse Event|1
4556067|NCT01248793|7386357|FG000|Overall Study|Protocol Violation|0
4556068|NCT01248793|7386358|FG001|Overall Study|Protocol Violation|1
4556069|NCT01248793|7386357|FG000|Overall Study|Withdrawal by Subject|3
4556070|NCT01248793|7386358|FG001|Overall Study|Withdrawal by Subject|3
4556071|NCT01248884|7386367|FG000|Overall Study|Withdrawal by Subject|1
4556072|NCT01248884|7386368|FG001|Overall Study|Withdrawal by Subject|3
4556073|NCT01248884|7386369|FG002|Overall Study|Withdrawal by Subject|1
4556074|NCT01248884|7386367|FG000|Overall Study|Adverse Event|1
4556075|NCT01248884|7386368|FG001|Overall Study|Adverse Event|0
4622058|NCT01797562|7484838|FG000|Overall Study|Protocol Violation|5
4622059|NCT01797705|7484864|FG000|Overall Study|Equipment anomalies during sleep studies|4
4556076|NCT01248884|7386369|FG002|Overall Study|Adverse Event|0
4556077|NCT01248936|7386379|FG000|Overall Study|Sponsor Decision|259
4556078|NCT01248936|7386379|FG000|Overall Study|Progression of Disease|50
4556079|NCT01248936|7386379|FG000|Overall Study|Death|26
4556080|NCT01248936|7386379|FG000|Overall Study|Withdrawal of Consent|20
4556081|NCT01248936|7386379|FG000|Overall Study|Adverse Event|8
4556082|NCT01248936|7386379|FG000|Overall Study|Lost to Follow-up|7
4556083|NCT01248936|7386379|FG000|Overall Study|Refused Treatment|1
4556084|NCT01248936|7386379|FG000|Overall Study|Other reason|3
4556085|NCT01248949|7386389|FG000|Overall Study|Lost to Follow-up|2
4556086|NCT01248949|7386390|FG001|Overall Study|Lost to Follow-up|2
4556087|NCT01248949|7386391|FG002|Overall Study|Lost to Follow-up|2
4556088|NCT01248949|7386392|FG003|Overall Study|Lost to Follow-up|1
4556089|NCT01248949|7386393|FG004|Overall Study|Lost to Follow-up|0
4556090|NCT01248949|7386389|FG000|Overall Study|Withdrawal by Subject|5
4556091|NCT01248949|7386390|FG001|Overall Study|Withdrawal by Subject|3
4556092|NCT01248949|7386391|FG002|Overall Study|Withdrawal by Subject|11
4556093|NCT01248949|7386392|FG003|Overall Study|Withdrawal by Subject|3
4556094|NCT01248949|7386393|FG004|Overall Study|Withdrawal by Subject|1
4556095|NCT01248949|7386389|FG000|Overall Study|Death|22
4556096|NCT01248949|7386390|FG001|Overall Study|Death|7
4556097|NCT01248949|7386391|FG002|Overall Study|Death|21
4556098|NCT01248949|7386392|FG003|Overall Study|Death|6
4556099|NCT01248949|7386393|FG004|Overall Study|Death|2
4556100|NCT01248949|7386389|FG000|Overall Study|Alternative Therapy|1
4556101|NCT01248949|7386390|FG001|Overall Study|Alternative Therapy|0
4556102|NCT01248949|7386391|FG002|Overall Study|Alternative Therapy|0
4556103|NCT01248949|7386392|FG003|Overall Study|Alternative Therapy|0
4556104|NCT01248949|7386393|FG004|Overall Study|Alternative Therapy|0
4556105|NCT01248949|7386389|FG000|Overall Study|Alternative Therapy.|1
4556106|NCT01248949|7386390|FG001|Overall Study|Alternative Therapy.|0
4556107|NCT01248949|7386391|FG002|Overall Study|Alternative Therapy.|0
4556108|NCT01248949|7386392|FG003|Overall Study|Alternative Therapy.|0
4556109|NCT01248949|7386393|FG004|Overall Study|Alternative Therapy.|0
4556110|NCT01248949|7386389|FG000|Overall Study|Palliative Radiation To Brain Metastases|1
4556111|NCT01248949|7386390|FG001|Overall Study|Palliative Radiation To Brain Metastases|0
4556112|NCT01248949|7386391|FG002|Overall Study|Palliative Radiation To Brain Metastases|0
4556113|NCT01248949|7386392|FG003|Overall Study|Palliative Radiation To Brain Metastases|0
4556114|NCT01248949|7386393|FG004|Overall Study|Palliative Radiation To Brain Metastases|0
4556115|NCT01248949|7386389|FG000|Overall Study|Entered Hospice And Refused Follow Up|0
4556116|NCT01248949|7386390|FG001|Overall Study|Entered Hospice And Refused Follow Up|0
4556117|NCT01248949|7386391|FG002|Overall Study|Entered Hospice And Refused Follow Up|0
4556118|NCT01248949|7386392|FG003|Overall Study|Entered Hospice And Refused Follow Up|0
4556119|NCT01248949|7386393|FG004|Overall Study|Entered Hospice And Refused Follow Up|1
4556120|NCT01248949|7386389|FG000|Overall Study|Participant Went To Hospice|0
4556121|NCT01248949|7386390|FG001|Overall Study|Participant Went To Hospice|0
4556122|NCT01248949|7386391|FG002|Overall Study|Participant Went To Hospice|1
4556123|NCT01248949|7386392|FG003|Overall Study|Participant Went To Hospice|0
4556124|NCT01248949|7386393|FG004|Overall Study|Participant Went To Hospice|0
4556125|NCT01248949|7386389|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1
4556126|NCT01248949|7386390|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0
4556127|NCT01248949|7386391|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0
4556128|NCT01248949|7386392|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0
4556129|NCT01248949|7386393|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0
4556130|NCT01248949|7386389|FG000|Overall Study|Pi Decision Due To Declining Status|0
4556131|NCT01248949|7386390|FG001|Overall Study|Pi Decision Due To Declining Status|0
4556132|NCT01248949|7386391|FG002|Overall Study|Pi Decision Due To Declining Status|1
4556133|NCT01248949|7386392|FG003|Overall Study|Pi Decision Due To Declining Status|0
4556134|NCT01248949|7386393|FG004|Overall Study|Pi Decision Due To Declining Status|0
4556135|NCT01248949|7386389|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0
4556136|NCT01248949|7386390|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1
4556137|NCT01248949|7386391|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0
4556138|NCT01248949|7386392|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0
4556139|NCT01248949|7386393|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0
4556140|NCT01248949|7386389|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
4556141|NCT01248949|7386390|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
4556142|NCT01248949|7386391|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1
4556143|NCT01248949|7386392|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
4556144|NCT01248949|7386393|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
4556145|NCT01248962|7386407|FG000|Overall Study|Withdrawal by Subject|1
4556146|NCT01248962|7386408|FG001|Overall Study|Withdrawal by Subject|1
4556147|NCT01248962|7386407|FG000|Overall Study|Adverse Event|2
4556148|NCT01248962|7386408|FG001|Overall Study|Adverse Event|1
4556149|NCT01248962|7386407|FG000|Overall Study|Complete Response after 4 Cycles|1
4556150|NCT01248962|7386408|FG001|Overall Study|Complete Response after 4 Cycles|0
4556151|NCT01248962|7386407|FG000|Overall Study|Complete Response after 3 Cycles|0
4556152|NCT01248962|7386408|FG001|Overall Study|Complete Response after 3 Cycles|1
4591995|NCT01536145|7439160|FG010|Overall Study|Adverse Event|3
4556153|NCT01248962|7386407|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12
4556154|NCT01248962|7386408|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13
4556155|NCT01249092|7386419|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1
4556156|NCT01249092|7386419|FG000|Overall Study|Unable to tolerate expected SE -nausea|1
4556157|NCT01249118|7386425|FG000|First Washout Period|Physician Decision|0
4556158|NCT01249118|7386426|FG001|First Washout Period|Physician Decision|1
4556159|NCT01249118|7386427|FG002|First Washout Period|Physician Decision|0
4556160|NCT01249131|7386434|FG000|Washout Period of 10 Days|Adverse Event|0
4556161|NCT01249131|7386435|FG001|Washout Period of 10 Days|Adverse Event|0
4556162|NCT01249131|7386436|FG002|Washout Period of 10 Days|Adverse Event|0
4556163|NCT01249131|7386437|FG003|Washout Period of 10 Days|Adverse Event|0
4556164|NCT01249131|7386438|FG004|Washout Period of 10 Days|Adverse Event|1
4556165|NCT01249131|7386439|FG005|Washout Period of 10 Days|Adverse Event|0
4556166|NCT01249261|7386449|FG000|Overall Study|Withdrawal by Subject|1
4556167|NCT01249261|7386450|FG001|Overall Study|Withdrawal by Subject|0
4556168|NCT01249274|7386458|FG000|Overall Study|Lost to Follow-up|3
4556169|NCT01249274|7386459|FG001|Overall Study|Lost to Follow-up|4
4556170|NCT01249274|7386458|FG000|Overall Study|Received inpatient substance treatment|1
4556171|NCT01249274|7386459|FG001|Overall Study|Received inpatient substance treatment|2
4556172|NCT01249365|7386467|FG000|Overall Study|Lost to Follow-up|1
4556173|NCT01249404|7386474|FG000|Overall Study|Study treatment not received|0
4556174|NCT01249404|7386475|FG001|Overall Study|Study treatment not received|1
4556175|NCT01249404|7386476|FG002|Overall Study|Study treatment not received|2
4556176|NCT01249404|7386474|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2
4556177|NCT01249404|7386475|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0
4556178|NCT01249404|7386476|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2
4556179|NCT01249404|7386474|FG000|Overall Study|Adverse Event|2
4556180|NCT01249404|7386475|FG001|Overall Study|Adverse Event|2
4556181|NCT01249404|7386476|FG002|Overall Study|Adverse Event|2
4556182|NCT01249404|7386474|FG000|Overall Study|Withdrawal by Subject|2
4556183|NCT01249404|7386475|FG001|Overall Study|Withdrawal by Subject|2
4556184|NCT01249404|7386476|FG002|Overall Study|Withdrawal by Subject|0
4556185|NCT01249404|7386474|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1
4556186|NCT01249404|7386475|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2
4556187|NCT01249404|7386476|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1
4556188|NCT01249404|7386474|FG000|Overall Study|Non compliance to visit schedule|0
4556189|NCT01249404|7386475|FG001|Overall Study|Non compliance to visit schedule|1
4556190|NCT01249404|7386476|FG002|Overall Study|Non compliance to visit schedule|0
4556191|NCT01249417|7386487|FG000|Randomised Population|Study treatment not received|0
4556192|NCT01249417|7386488|FG001|Randomised Population|Study treatment not received|0
4556193|NCT01249417|7386489|FG002|Randomised Population|Study treatment not received|2
4556194|NCT01249417|7386487|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1
4556195|NCT01249417|7386488|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1
4556196|NCT01249417|7386489|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2
4556197|NCT01249417|7386487|FG000|Treatment Phase - ITT Population|Other|0
4556198|NCT01249417|7386488|FG001|Treatment Phase - ITT Population|Other|0
4556199|NCT01249417|7386489|FG002|Treatment Phase - ITT Population|Other|1
4556200|NCT01249417|7386487|FG000|Treatment Phase - ITT Population|Adverse Event|0
4556201|NCT01249417|7386488|FG001|Treatment Phase - ITT Population|Adverse Event|0
4556202|NCT01249417|7386489|FG002|Treatment Phase - ITT Population|Adverse Event|1
4556203|NCT01249417|7386487|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1
4556204|NCT01249417|7386488|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3
4556205|NCT01249417|7386489|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1
4556206|NCT01249417|7386487|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0
4556207|NCT01249417|7386488|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1
4556208|NCT01249417|7386489|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1
4556209|NCT01249651|7386506|FG000|Overall Study|Withdrawal by Subject|4
4556210|NCT01249651|7386506|FG000|Overall Study|Adverse Event|1
4556211|NCT01249651|7386506|FG000|Overall Study|Protocol Violation|1
4556212|NCT01249651|7386506|FG000|Overall Study|Sponsor Decision|1
4556213|NCT01249664|7386512|FG000|Overall Study|Withdrawal by Subject|5
4556214|NCT01249664|7386513|FG001|Overall Study|Withdrawal by Subject|0
4556215|NCT01249664|7386512|FG000|Overall Study|Adverse Event|1
4556216|NCT01249664|7386513|FG001|Overall Study|Adverse Event|0
4556217|NCT01249833|7386523|FG000|Overall Study|Lost to Follow-up|0
4556218|NCT01249833|7386524|FG001|Overall Study|Lost to Follow-up|1
4556219|NCT01250002|7386565|FG000|Overall Study|Change to open surgical procedure|4
4556220|NCT01250002|7386566|FG001|Overall Study|Change to open surgical procedure|3
4556221|NCT01250054|7386572|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1
4556222|NCT01250054|7386573|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0
4591996|NCT01536171|7439191|FG000|Overall Study|Withdrawal by Subject|1
4591997|NCT01536262|7439217|FG000|Overall Study|Adverse Event|6
4591998|NCT01536262|7439218|FG001|Overall Study|Adverse Event|1
4591999|NCT01536262|7439219|FG002|Overall Study|Adverse Event|2
4592000|NCT01536262|7439217|FG000|Overall Study|Withdrawal by Subject|1
4592001|NCT01536262|7439218|FG001|Overall Study|Withdrawal by Subject|1
4592002|NCT01536262|7439219|FG002|Overall Study|Withdrawal by Subject|0
4556223|NCT01250119|7386579|FG000|Diagnostic Phase|Failed to Produce a Test Results|69
4556224|NCT01250119|7386580|FG001|Diagnostic Phase|Failed to Produce a Test Results|0
4556225|NCT01250119|7386579|FG000|Diagnostic Phase|Participants Not Tested|44
4556226|NCT01250119|7386580|FG001|Diagnostic Phase|Participants Not Tested|0
4556227|NCT01250119|7386579|FG000|Treatment Phase|Progressive Disease|0
4556228|NCT01250119|7386580|FG001|Treatment Phase|Progressive Disease|32
4622060|NCT01797705|7484864|FG000|Overall Study|Withdrawal by Subject|1
4622061|NCT01797731|7484870|FG000|Overall Study|Didn't have proper radiographs required|3
4556229|NCT01250119|7386579|FG000|Treatment Phase|Death|0
4556230|NCT01250119|7386580|FG001|Treatment Phase|Death|2
4556231|NCT01250119|7386579|FG000|Treatment Phase|Withdrawal by Subject|0
4556232|NCT01250119|7386580|FG001|Treatment Phase|Withdrawal by Subject|1
4556233|NCT01250119|7386579|FG000|Treatment Phase|Adverse Event|0
4556234|NCT01250119|7386580|FG001|Treatment Phase|Adverse Event|2
4556235|NCT01250119|7386579|FG000|Treatment Phase|Unknown reason|0
4556236|NCT01250119|7386580|FG001|Treatment Phase|Unknown reason|4
4556237|NCT01250145|7386589|FG000|Overall Study|Adverse Event|2
4556238|NCT01250145|7386590|FG001|Overall Study|Adverse Event|1
4556239|NCT01250145|7386589|FG000|Overall Study|Withdrawal by Subject|0
4556240|NCT01250145|7386590|FG001|Overall Study|Withdrawal by Subject|4
4556241|NCT01250171|7386613|FG000|Overall Study|Administrative reasons|1
4556242|NCT01250171|7386614|FG001|Overall Study|Administrative reasons|0
4556243|NCT01250171|7386615|FG002|Overall Study|Administrative reasons|0
4556244|NCT01250379|7386651|FG000|Overall Study|Death|141
4556245|NCT01250379|7386652|FG001|Overall Study|Death|148
4556246|NCT01250379|7386651|FG000|Overall Study|Withdrawal by Subject|32
4556247|NCT01250379|7386652|FG001|Overall Study|Withdrawal by Subject|20
4556248|NCT01250379|7386651|FG000|Overall Study|Physician Decision|11
4556249|NCT01250379|7386652|FG001|Overall Study|Physician Decision|3
4556250|NCT01250379|7386651|FG000|Overall Study|Protocol Violation|2
4556251|NCT01250379|7386652|FG001|Overall Study|Protocol Violation|8
4556252|NCT01250379|7386651|FG000|Overall Study|Lost to Follow-up|9
4556253|NCT01250379|7386652|FG001|Overall Study|Lost to Follow-up|6
4556254|NCT01250379|7386651|FG000|Overall Study|Adverse Event|5
4556255|NCT01250379|7386652|FG001|Overall Study|Adverse Event|4
4556256|NCT01250379|7386651|FG000|Overall Study|Other|0
4556257|NCT01250379|7386652|FG001|Overall Study|Other|4
4556258|NCT01250379|7386651|FG000|Overall Study|Participant noncompliance|2
4622062|NCT01797731|7484871|FG001|Overall Study|Didn't have proper radiographs required|3
4622063|NCT01797783|7484879|FG000|Overall Study|Adverse Event|1
4622064|NCT01797783|7484880|FG001|Overall Study|Adverse Event|1
4622065|NCT01797783|7484879|FG000|Overall Study|Withdrawal by Subject|1
4622066|NCT01797783|7484880|FG001|Overall Study|Withdrawal by Subject|0
4622067|NCT01797835|7484902|FG000|Overall Study|Lost to Follow-up|31
4556259|NCT01250379|7386652|FG001|Overall Study|Participant noncompliance|0
4556260|NCT01250418|7386660|FG000|Overall Study|monitor data failure|1
4556261|NCT01250418|7386661|FG001|Overall Study|monitor data failure|1
4622068|NCT01797835|7484903|FG001|Overall Study|Lost to Follow-up|27
4622069|NCT01797965|7484913|FG000|Overall Study|Adverse Event|104
4622070|NCT01797965|7484914|FG001|Overall Study|Adverse Event|129
4622071|NCT01797965|7484915|FG002|Overall Study|Adverse Event|4
4622072|NCT01797965|7484916|FG003|Overall Study|Adverse Event|21
4622073|NCT01797965|7484913|FG000|Overall Study|Lost to Follow-up|9
4622074|NCT01797965|7484914|FG001|Overall Study|Lost to Follow-up|8
4622075|NCT01797965|7484915|FG002|Overall Study|Lost to Follow-up|1
4622076|NCT01797965|7484916|FG003|Overall Study|Lost to Follow-up|2
4622077|NCT01797965|7484913|FG000|Overall Study|Consent withdrawn|130
4622078|NCT01797965|7484914|FG001|Overall Study|Consent withdrawn|117
4622079|NCT01797965|7484915|FG002|Overall Study|Consent withdrawn|3
4622080|NCT01797965|7484916|FG003|Overall Study|Consent withdrawn|35
4622081|NCT01797965|7484913|FG000|Overall Study|Investigator decision|21
4622082|NCT01797965|7484914|FG001|Overall Study|Investigator decision|15
4622083|NCT01797965|7484915|FG002|Overall Study|Investigator decision|0
4556262|NCT01250509|7386669|FG000|Overall Study|Lost to Follow-up|5
4556263|NCT01250509|7386670|FG001|Overall Study|Lost to Follow-up|2
4556264|NCT01250756|7386697|FG000|Infant Series|Withdrawal by Subject|4
4556265|NCT01250756|7386698|FG001|Infant Series|Withdrawal by Subject|5
4556266|NCT01250756|7386697|FG000|Infant Series|Randomized, Not Vaccinated|2
4556267|NCT01250756|7386698|FG001|Infant Series|Randomized, Not Vaccinated|2
4556268|NCT01250756|7386697|FG000|Infant Series|Other|22
4556269|NCT01250756|7386698|FG001|Infant Series|Other|0
4556270|NCT01250756|7386697|FG000|After Infant Series|Adverse Event|5
4556271|NCT01250756|7386698|FG001|After Infant Series|Adverse Event|2
4556272|NCT01250756|7386697|FG000|After Infant Series|Withdrawal by Subject|4
4556273|NCT01250756|7386698|FG001|After Infant Series|Withdrawal by Subject|1
4556274|NCT01250756|7386697|FG000|After Infant Series|Other|2
4556275|NCT01250756|7386698|FG001|After Infant Series|Other|1
4556276|NCT01250756|7386697|FG000|Toddler Dose|Adverse Event|0
4556277|NCT01250756|7386698|FG001|Toddler Dose|Adverse Event|1
4556278|NCT01250756|7386697|FG000|After Toddler Dose|Adverse Event|0
4622084|NCT01797965|7484916|FG003|Overall Study|Investigator decision|0
4622085|NCT01797965|7484913|FG000|Overall Study|Death|2
4622086|NCT01797965|7484914|FG001|Overall Study|Death|4
4622087|NCT01797965|7484915|FG002|Overall Study|Death|0
4622088|NCT01797965|7484916|FG003|Overall Study|Death|0
4633094|NCT01908426|7503040|FG000|Overall Study|Physician Decision|3
4556279|NCT01250756|7386698|FG001|After Toddler Dose|Adverse Event|1
4556280|NCT01250769|7386714|FG000|Overall Study|Withdrawal by Subject|0
4556281|NCT01250769|7386715|FG001|Overall Study|Withdrawal by Subject|1
4556282|NCT01250769|7386716|FG002|Overall Study|Withdrawal by Subject|1
4556283|NCT01250769|7386717|FG003|Overall Study|Withdrawal by Subject|0
4556284|NCT01250769|7386714|FG000|Overall Study|Adverse Event|0
4556285|NCT01250769|7386715|FG001|Overall Study|Adverse Event|0
4556286|NCT01250769|7386716|FG002|Overall Study|Adverse Event|1
4556287|NCT01250769|7386717|FG003|Overall Study|Adverse Event|0
4556288|NCT01250873|7386734|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2
4556289|NCT01250873|7386734|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1
4556290|NCT01250925|7386750|FG000|Overall Study|Lost to Follow-up|1
4556291|NCT01250925|7386751|FG001|Overall Study|Lost to Follow-up|1
4556292|NCT01250925|7386752|FG002|Overall Study|Lost to Follow-up|0
4556293|NCT01250925|7386750|FG000|Overall Study|Withdrawal by Subject|2
4556294|NCT01250925|7386751|FG001|Overall Study|Withdrawal by Subject|0
4556295|NCT01250925|7386752|FG002|Overall Study|Withdrawal by Subject|0
4556296|NCT01250925|7386750|FG000|Overall Study|Protocol Violation|2
4556297|NCT01250925|7386751|FG001|Overall Study|Protocol Violation|0
4556298|NCT01250925|7386752|FG002|Overall Study|Protocol Violation|0
4556299|NCT01250925|7386750|FG000|Overall Study|Physician Decision|0
4556300|NCT01250925|7386751|FG001|Overall Study|Physician Decision|2
4556301|NCT01250925|7386752|FG002|Overall Study|Physician Decision|1
4556302|NCT01250925|7386750|FG000|Overall Study|Adverse Event|0
4556303|NCT01250925|7386751|FG001|Overall Study|Adverse Event|0
4556304|NCT01250925|7386752|FG002|Overall Study|Adverse Event|1
4556305|NCT01251146|7386789|FG000|Overall Study|Lost to Follow-up|3
4556306|NCT01251146|7386790|FG001|Overall Study|Lost to Follow-up|10
4556307|NCT01251276|7386798|FG000|Overall Study|Protocol Violation|1
4556308|NCT01251276|7386799|FG001|Overall Study|Protocol Violation|0
4556309|NCT01251276|7386798|FG000|Overall Study|Lost to Follow-up|0
4556310|NCT01251276|7386799|FG001|Overall Study|Lost to Follow-up|1
4556311|NCT01251354|7386834|FG000|Overall Study|Adverse Event|1
4556312|NCT01251354|7386834|FG000|Overall Study|Investigator's Decision|1
4556313|NCT01251354|7386834|FG000|Overall Study|Disease Progression|4
4556314|NCT01251367|7386838|FG000|Overall Study|Protocol Violation|1
4556315|NCT01251367|7386838|FG000|Overall Study|Lack of Efficacy|2
4556316|NCT01251367|7386838|FG000|Overall Study|Adverse Event|19
4556317|NCT01251367|7386838|FG000|Overall Study|Withdrawal by Subject|36
4556318|NCT01251367|7386838|FG000|Overall Study|Lost to Follow-up|5
4556319|NCT01251367|7386838|FG000|Overall Study|Subject Required Alternative Treatment|7
4556320|NCT01251367|7386838|FG000|Overall Study|No Study Drug Available|1
4556321|NCT01251367|7386838|FG000|Overall Study|Subject had Personal or Medical Issues|4
4556322|NCT01251367|7386838|FG000|Overall Study|End of Study Visit Performed in Error|1
4556323|NCT01251380|7386842|FG000|Overall Study|Other (Not otherwise specified)|12
4556324|NCT01251380|7386842|FG000|Overall Study|Withdrawal by Subject|6
4556325|NCT01251380|7386842|FG000|Overall Study|Lack of Efficacy|1
4556326|NCT01251380|7386842|FG000|Overall Study|Adverse Event|1
4556327|NCT01251380|7386842|FG000|Overall Study|Lost to Follow-up|2
4556328|NCT01251614|7386895|FG000|Overall Study|Adverse Event|1
4556329|NCT01251614|7386896|FG001|Overall Study|Adverse Event|0
4556330|NCT01251614|7386897|FG002|Overall Study|Adverse Event|1
4556331|NCT01251614|7386895|FG000|Overall Study|Lack of Efficacy|1
4556332|NCT01251614|7386896|FG001|Overall Study|Lack of Efficacy|9
4556333|NCT01251614|7386897|FG002|Overall Study|Lack of Efficacy|4
4556334|NCT01251614|7386895|FG000|Overall Study|Clearing of Psoriatic Lesions|1
4556335|NCT01251614|7386896|FG001|Overall Study|Clearing of Psoriatic Lesions|0
4556336|NCT01251614|7386897|FG002|Overall Study|Clearing of Psoriatic Lesions|0
4556337|NCT01251614|7386895|FG000|Overall Study|Pregnancy|0
4556338|NCT01251614|7386896|FG001|Overall Study|Pregnancy|0
4556339|NCT01251614|7386897|FG002|Overall Study|Pregnancy|2
4556340|NCT01251614|7386895|FG000|Overall Study|Loss of Disease Control|0
4556341|NCT01251614|7386896|FG001|Overall Study|Loss of Disease Control|1
4690698|NCT02563548|7600524|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0
4690699|NCT02563548|7600525|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0
4690700|NCT02563548|7600526|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0
4690701|NCT02563548|7600521|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
4690702|NCT02563548|7600522|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
4690703|NCT02563548|7600523|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3
4690704|NCT02563548|7600524|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
4690705|NCT02563548|7600525|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
4556342|NCT01251614|7386897|FG002|Overall Study|Loss of Disease Control|0
4556343|NCT01251614|7386895|FG000|Overall Study|Withdrawal by Subject|0
4556344|NCT01251614|7386896|FG001|Overall Study|Withdrawal by Subject|2
4556345|NCT01251614|7386897|FG002|Overall Study|Withdrawal by Subject|1
4556346|NCT01251614|7386895|FG000|Overall Study|Lost to Follow-up|0
4556347|NCT01251614|7386896|FG001|Overall Study|Lost to Follow-up|1
4556348|NCT01251614|7386897|FG002|Overall Study|Lost to Follow-up|0
4556349|NCT01251653|7386924|FG000|Overall Study|Progressive Disease|1
4556350|NCT01251653|7386925|FG001|Overall Study|Progressive Disease|7
4556351|NCT01251653|7386926|FG002|Overall Study|Progressive Disease|16
4556352|NCT01251653|7386927|FG003|Overall Study|Progressive Disease|4
4556353|NCT01251653|7386928|FG004|Overall Study|Progressive Disease|0
4690706|NCT02563548|7600526|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
4690707|NCT02563548|7600521|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0
4690708|NCT02563548|7600522|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0
4690709|NCT02563548|7600523|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2
4690710|NCT02563548|7600524|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1
4690711|NCT02563548|7600525|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0
4556354|NCT01251653|7386929|FG005|Overall Study|Progressive Disease|17
4556355|NCT01251653|7386930|FG006|Overall Study|Progressive Disease|14
4556356|NCT01251653|7386931|FG007|Overall Study|Progressive Disease|7
4556357|NCT01251653|7386932|FG008|Overall Study|Progressive Disease|5
4556358|NCT01251653|7386924|FG000|Overall Study|Dose-limiting toxicity|0
4556359|NCT01251653|7386925|FG001|Overall Study|Dose-limiting toxicity|1
4556360|NCT01251653|7386926|FG002|Overall Study|Dose-limiting toxicity|1
4556361|NCT01251653|7386927|FG003|Overall Study|Dose-limiting toxicity|1
4556362|NCT01251653|7386928|FG004|Overall Study|Dose-limiting toxicity|0
4556363|NCT01251653|7386929|FG005|Overall Study|Dose-limiting toxicity|0
4556364|NCT01251653|7386930|FG006|Overall Study|Dose-limiting toxicity|2
4556365|NCT01251653|7386931|FG007|Overall Study|Dose-limiting toxicity|0
4556366|NCT01251653|7386932|FG008|Overall Study|Dose-limiting toxicity|0
4556367|NCT01251653|7386924|FG000|Overall Study|Adverse Event|1
4556368|NCT01251653|7386925|FG001|Overall Study|Adverse Event|0
4556369|NCT01251653|7386926|FG002|Overall Study|Adverse Event|2
4556370|NCT01251653|7386927|FG003|Overall Study|Adverse Event|1
4556371|NCT01251653|7386928|FG004|Overall Study|Adverse Event|1
4556372|NCT01251653|7386929|FG005|Overall Study|Adverse Event|0
4556373|NCT01251653|7386930|FG006|Overall Study|Adverse Event|2
4556374|NCT01251653|7386931|FG007|Overall Study|Adverse Event|2
4556375|NCT01251653|7386932|FG008|Overall Study|Adverse Event|1
4556376|NCT01251653|7386924|FG000|Overall Study|Withdrawal by Subject|1
4556377|NCT01251653|7386925|FG001|Overall Study|Withdrawal by Subject|0
4556378|NCT01251653|7386926|FG002|Overall Study|Withdrawal by Subject|1
4556379|NCT01251653|7386927|FG003|Overall Study|Withdrawal by Subject|0
4556380|NCT01251653|7386928|FG004|Overall Study|Withdrawal by Subject|1
4556381|NCT01251653|7386929|FG005|Overall Study|Withdrawal by Subject|1
4556382|NCT01251653|7386930|FG006|Overall Study|Withdrawal by Subject|0
4556383|NCT01251653|7386931|FG007|Overall Study|Withdrawal by Subject|1
4556384|NCT01251653|7386932|FG008|Overall Study|Withdrawal by Subject|0
4556385|NCT01251653|7386924|FG000|Overall Study|Other reason not mentioned above|0
4556386|NCT01251653|7386925|FG001|Overall Study|Other reason not mentioned above|0
4556387|NCT01251653|7386926|FG002|Overall Study|Other reason not mentioned above|0
4556388|NCT01251653|7386927|FG003|Overall Study|Other reason not mentioned above|0
4556389|NCT01251653|7386928|FG004|Overall Study|Other reason not mentioned above|0
4556390|NCT01251653|7386929|FG005|Overall Study|Other reason not mentioned above|0
4556391|NCT01251653|7386930|FG006|Overall Study|Other reason not mentioned above|0
4556392|NCT01251653|7386931|FG007|Overall Study|Other reason not mentioned above|2
4556393|NCT01251653|7386932|FG008|Overall Study|Other reason not mentioned above|0
4556394|NCT01251744|7386970|FG000|Overall Study|Lost to Follow-up|1
4556395|NCT01251744|7386971|FG001|Overall Study|Lost to Follow-up|0
4556396|NCT01251770|7387003|FG000|Overall Study|Protocol Violation|13
4556397|NCT01251770|7387004|FG001|Overall Study|Protocol Violation|7
4556398|NCT01251887|7387013|FG000|Overall Study|Scheduling conflict|1
4556399|NCT01251887|7387014|FG001|Overall Study|Scheduling conflict|2
4556400|NCT01251887|7387015|FG002|Overall Study|Scheduling conflict|2
4556401|NCT01251887|7387013|FG000|Overall Study|Physician Decision|0
4556402|NCT01251887|7387014|FG001|Overall Study|Physician Decision|1
4556403|NCT01251887|7387015|FG002|Overall Study|Physician Decision|0
4556404|NCT01251965|7387026|FG000|Overall Study|Participant/physician decision|1
4556405|NCT01251965|7387027|FG001|Overall Study|Participant/physician decision|2
4556406|NCT01251965|7387028|FG002|Overall Study|Participant/physician decision|0
4556407|NCT01251965|7387026|FG000|Overall Study|Death|0
4556408|NCT01251965|7387027|FG001|Overall Study|Death|0
4622089|NCT01797965|7484913|FG000|Overall Study|Disease progression, defined by protocol|3
4622090|NCT01797965|7484914|FG001|Overall Study|Disease progression, defined by protocol|1
4622091|NCT01797965|7484915|FG002|Overall Study|Disease progression, defined by protocol|0
4622092|NCT01797965|7484916|FG003|Overall Study|Disease progression, defined by protocol|0
4622093|NCT01797965|7484913|FG000|Overall Study|Reason Not Specified|280
4622094|NCT01797965|7484914|FG001|Overall Study|Reason Not Specified|295
4622095|NCT01797965|7484915|FG002|Overall Study|Reason Not Specified|0
4622096|NCT01797965|7484916|FG003|Overall Study|Reason Not Specified|15
4622097|NCT01798056|7484929|FG000|Overall Study|Serious Adverse Event|13
4556409|NCT01251965|7387028|FG002|Overall Study|Death|11
4556410|NCT01252095|7387048|FG000|Overall Study|Disease progression|1
4556411|NCT01252095|7387049|FG001|Overall Study|Disease progression|0
4556412|NCT01252134|7387055|FG000|Period 1, 8 Hours|Personal Reasons|0
4556413|NCT01252134|7387056|FG001|Period 1, 8 Hours|Personal Reasons|1
4556414|NCT01252134|7387057|FG002|Period 1, 8 Hours|Personal Reasons|1
4556415|NCT01252134|7387058|FG003|Period 1, 8 Hours|Personal Reasons|0
4556416|NCT01252134|7387059|FG004|Period 1, 8 Hours|Personal Reasons|0
4556417|NCT01252134|7387060|FG005|Period 1, 8 Hours|Personal Reasons|0
4556418|NCT01252186|7387075|FG000|Overall Study|Adverse Event|9
4622098|NCT01798056|7484930|FG001|Overall Study|Serious Adverse Event|12
4556419|NCT01252186|7387076|FG001|Overall Study|Adverse Event|6
4556420|NCT01252186|7387077|FG002|Overall Study|Adverse Event|8
4556421|NCT01252186|7387075|FG000|Overall Study|Withdrawal by Subject|2
4556422|NCT01252186|7387076|FG001|Overall Study|Withdrawal by Subject|5
4556423|NCT01252186|7387077|FG002|Overall Study|Withdrawal by Subject|2
4556424|NCT01252186|7387075|FG000|Overall Study|Physician Decision|0
4556425|NCT01252186|7387076|FG001|Overall Study|Physician Decision|0
4556426|NCT01252186|7387077|FG002|Overall Study|Physician Decision|1
4556427|NCT01252186|7387075|FG000|Overall Study|Non-compliance|0
4556428|NCT01252186|7387076|FG001|Overall Study|Non-compliance|3
4556429|NCT01252186|7387077|FG002|Overall Study|Non-compliance|4
4556430|NCT01252186|7387075|FG000|Overall Study|Protocol Violation|0
4556431|NCT01252186|7387076|FG001|Overall Study|Protocol Violation|0
4556432|NCT01252186|7387077|FG002|Overall Study|Protocol Violation|1
4556433|NCT01252186|7387075|FG000|Overall Study|Pregnancy|2
4556434|NCT01252186|7387076|FG001|Overall Study|Pregnancy|2
4556435|NCT01252186|7387077|FG002|Overall Study|Pregnancy|0
4556436|NCT01252186|7387075|FG000|Overall Study|Sponsor Request|2
4556437|NCT01252186|7387076|FG001|Overall Study|Sponsor Request|1
4556438|NCT01252186|7387077|FG002|Overall Study|Sponsor Request|0
4556439|NCT01252186|7387075|FG000|Overall Study|Lost to Follow-up|10
4556440|NCT01252186|7387076|FG001|Overall Study|Lost to Follow-up|10
4556441|NCT01252186|7387077|FG002|Overall Study|Lost to Follow-up|11
4556442|NCT01252186|7387075|FG000|Overall Study|Other - Miscellaneous Reasons|5
4556443|NCT01252186|7387076|FG001|Overall Study|Other - Miscellaneous Reasons|5
4556444|NCT01252186|7387077|FG002|Overall Study|Other - Miscellaneous Reasons|7
4556445|NCT01252238|7387088|FG000|Overall Study|Sponsor terminated study|4
4556446|NCT01252238|7387089|FG001|Overall Study|Sponsor terminated study|4
4556447|NCT01252238|7387090|FG002|Overall Study|Sponsor terminated study|4
4556448|NCT01252251|7387101|FG000|Overall Study|Withdrawal by Subject|1
4556449|NCT01252290|7387110|FG000|Overall Study|Withdrawal by Subject|1
4556450|NCT01252355|7387117|FG000|Overall Study|Adverse Event|9
4556451|NCT01252355|7387118|FG001|Overall Study|Adverse Event|17
4556452|NCT01252355|7387119|FG002|Overall Study|Adverse Event|22
4556453|NCT01252355|7387117|FG000|Overall Study|Lack of Efficacy|6
4556454|NCT01252355|7387118|FG001|Overall Study|Lack of Efficacy|4
4556455|NCT01252355|7387119|FG002|Overall Study|Lack of Efficacy|2
4556456|NCT01252355|7387117|FG000|Overall Study|Lost to Follow-up|0
4556457|NCT01252355|7387118|FG001|Overall Study|Lost to Follow-up|0
4556458|NCT01252355|7387119|FG002|Overall Study|Lost to Follow-up|1
4556459|NCT01252355|7387117|FG000|Overall Study|Poor Compliance to Protocol|1
4622099|NCT01798056|7484929|FG000|Overall Study|Withdrawal by Subject|12
4622100|NCT01798056|7484930|FG001|Overall Study|Withdrawal by Subject|9
4622101|NCT01798056|7484929|FG000|Overall Study|Migrated/moved from study area|1
4622102|NCT01798056|7484930|FG001|Overall Study|Migrated/moved from study area|1
4622103|NCT01798056|7484929|FG000|Overall Study|Lost to Follow-up|1
4622104|NCT01798056|7484930|FG001|Overall Study|Lost to Follow-up|1
4622105|NCT01798056|7484929|FG000|Overall Study|Other|0
4622106|NCT01798056|7484930|FG001|Overall Study|Other|2
4622107|NCT01798134|7484938|FG000|Overall Study|Lost to Follow-up|1
4622108|NCT01798134|7484938|FG000|Overall Study|Withdrawal by Subject|3
4622109|NCT01798134|7484938|FG000|Overall Study|Death|2
4622110|NCT01798134|7484938|FG000|Overall Study|Adverse Event|3
4622111|NCT01798134|7484938|FG000|Overall Study|Physician Decision|3
4622112|NCT01798134|7484938|FG000|Overall Study|Liver transplant/surgery|4
4622113|NCT01798485|7485010|FG000|Overall Study|Adverse Event|32
4622114|NCT01798485|7485011|FG001|Overall Study|Adverse Event|40
4622115|NCT01798485|7485010|FG000|Overall Study|Withdrawal by Subject|27
4622116|NCT01798485|7485011|FG001|Overall Study|Withdrawal by Subject|31
4622117|NCT01798485|7485010|FG000|Overall Study|Lost to Follow-up|0
4622118|NCT01798485|7485011|FG001|Overall Study|Lost to Follow-up|3
4622119|NCT01798485|7485010|FG000|Overall Study|Physician Decision|14
4622120|NCT01798485|7485011|FG001|Overall Study|Physician Decision|10
4622121|NCT01798485|7485010|FG000|Overall Study|Objective Disease Progression|152
4622122|NCT01798485|7485011|FG001|Overall Study|Objective Disease Progression|106
4622123|NCT01798485|7485010|FG000|Overall Study|Death|25
4622124|NCT01798485|7485011|FG001|Overall Study|Death|22
4622125|NCT01798485|7485010|FG000|Overall Study|Sponsor Decision|61
4622126|NCT01798485|7485011|FG001|Overall Study|Sponsor Decision|54
4556460|NCT01252355|7387118|FG001|Overall Study|Poor Compliance to Protocol|1
4556461|NCT01252355|7387119|FG002|Overall Study|Poor Compliance to Protocol|1
4556462|NCT01252355|7387117|FG000|Overall Study|Progressive Disease|2
4556463|NCT01252355|7387118|FG001|Overall Study|Progressive Disease|0
4556464|NCT01252355|7387119|FG002|Overall Study|Progressive Disease|0
4556465|NCT01252355|7387117|FG000|Overall Study|Sponsor Early Termination of Study|149
4556466|NCT01252355|7387118|FG001|Overall Study|Sponsor Early Termination of Study|149
4556467|NCT01252355|7387119|FG002|Overall Study|Sponsor Early Termination of Study|146
4622127|NCT01798485|7485010|FG000|Overall Study|Clinical Progression|35
4622128|NCT01798485|7485011|FG001|Overall Study|Clinical Progression|24
4622129|NCT01798706|7485046|FG000|Overall Study|Adverse Event|15
4622130|NCT01798706|7485047|FG001|Overall Study|Adverse Event|10
4622131|NCT01798706|7485046|FG000|Overall Study|Lack of Efficacy|0
4622132|NCT01798706|7485047|FG001|Overall Study|Lack of Efficacy|2
4622133|NCT01798706|7485046|FG000|Overall Study|Poor compliance to protocol|1
4622134|NCT01798706|7485047|FG001|Overall Study|Poor compliance to protocol|0
4556468|NCT01252355|7387117|FG000|Overall Study|Randomized but not Treated|2
4556469|NCT01252355|7387118|FG001|Overall Study|Randomized but not Treated|0
4556470|NCT01252355|7387119|FG002|Overall Study|Randomized but not Treated|0
4556471|NCT01252355|7387117|FG000|Overall Study|Other Than Above|8
4556472|NCT01252355|7387118|FG001|Overall Study|Other Than Above|7
4556473|NCT01252355|7387119|FG002|Overall Study|Other Than Above|7
4556474|NCT01252563|7387127|FG000|Overall Study|Contract Deviation|41
4556475|NCT01252563|7387127|FG000|Overall Study|Centralized Registration Deviation|30
4556476|NCT01252563|7387127|FG000|Overall Study|Lost to Follow-up|161
4556477|NCT01252563|7387127|FG000|Overall Study|No visit after first day of treatment|194
4556478|NCT01252563|7387127|FG000|Overall Study|No drug administration|6
4556479|NCT01252667|7387168|FG000|Overall Study|Transplant aborted post-conditioning|0
4556480|NCT01252667|7387169|FG001|Overall Study|Transplant aborted post-conditioning|0
4556481|NCT01252667|7387170|FG002|Overall Study|Transplant aborted post-conditioning|0
4556482|NCT01252667|7387171|FG003|Overall Study|Transplant aborted post-conditioning|0
4556483|NCT01252667|7387172|FG004|Overall Study|Transplant aborted post-conditioning|0
4556484|NCT01252667|7387173|FG005|Overall Study|Transplant aborted post-conditioning|1
4556485|NCT01252810|7387214|FG000|Overall Study|Withdrawal by Subject|4
4556486|NCT01252810|7387215|FG001|Overall Study|Withdrawal by Subject|1
4556487|NCT01252810|7387214|FG000|Overall Study|Lost to Follow-up|0
4556488|NCT01252810|7387215|FG001|Overall Study|Lost to Follow-up|1
4556489|NCT01252810|7387214|FG000|Overall Study|Physician Decision|2
4556490|NCT01252810|7387215|FG001|Overall Study|Physician Decision|1
4556491|NCT01252810|7387214|FG000|Overall Study|Various reasons|8
4556492|NCT01252810|7387215|FG001|Overall Study|Various reasons|0
4556493|NCT01252940|7387223|FG000|Main Study Phase|Randomized but not treated|4
4556494|NCT01252940|7387224|FG001|Main Study Phase|Randomized but not treated|2
4556495|NCT01252940|7387223|FG000|Main Study Phase|Adverse Event|3
4556496|NCT01252940|7387224|FG001|Main Study Phase|Adverse Event|1
4556497|NCT01252940|7387223|FG000|Main Study Phase|Lack of Efficacy|1
4556498|NCT01252940|7387224|FG001|Main Study Phase|Lack of Efficacy|0
4556499|NCT01252940|7387223|FG000|Main Study Phase|Lost to Follow-up|6
4556500|NCT01252940|7387224|FG001|Main Study Phase|Lost to Follow-up|1
4556501|NCT01252940|7387223|FG000|Main Study Phase|Physician Decision|1
4556502|NCT01252940|7387224|FG001|Main Study Phase|Physician Decision|0
4556503|NCT01252940|7387223|FG000|Main Study Phase|Protocol Violation|4
4556504|NCT01252940|7387224|FG001|Main Study Phase|Protocol Violation|2
4556505|NCT01252940|7387223|FG000|Main Study Phase|Withdrawal by Subject|6
4556506|NCT01252940|7387224|FG001|Main Study Phase|Withdrawal by Subject|5
4556507|NCT01252940|7387223|FG000|Main Study Phase|Subject Non-compliance|1
4556508|NCT01252940|7387224|FG001|Main Study Phase|Subject Non-compliance|1
4556509|NCT01252940|7387223|FG000|Extension Phase|Adverse Event|2
4556510|NCT01252940|7387224|FG001|Extension Phase|Adverse Event|1
4556511|NCT01252940|7387223|FG000|Extension Phase|Lack of Efficacy|1
4556512|NCT01252940|7387224|FG001|Extension Phase|Lack of Efficacy|0
4556513|NCT01252940|7387223|FG000|Extension Phase|Lost to Follow-up|5
4556514|NCT01252940|7387224|FG001|Extension Phase|Lost to Follow-up|0
4556515|NCT01252940|7387223|FG000|Extension Phase|Physician Decision|0
4556516|NCT01252940|7387224|FG001|Extension Phase|Physician Decision|1
4556517|NCT01252940|7387223|FG000|Extension Phase|Subject Non-compliance|1
4556518|NCT01252940|7387224|FG001|Extension Phase|Subject Non-compliance|0
4556519|NCT01252940|7387223|FG000|Extension Phase|Withdrawal by Subject|1
4556520|NCT01252940|7387224|FG001|Extension Phase|Withdrawal by Subject|1
4556521|NCT01252966|7387233|FG000|Overall Study|Lost to Follow-up|16
4556522|NCT01252966|7387234|FG001|Overall Study|Lost to Follow-up|10
4556523|NCT01252966|7387233|FG000|Overall Study|Withdrawal by Subject|7
4622135|NCT01798706|7485046|FG000|Overall Study|Other than specified above|5
4622136|NCT01798706|7485047|FG001|Overall Study|Other than specified above|9
4622137|NCT01798849|7485056|FG000|Overall Study|Physician Decision|0
4622138|NCT01798849|7485057|FG001|Overall Study|Physician Decision|0
4622139|NCT01798849|7485058|FG002|Overall Study|Physician Decision|1
4622140|NCT01798927|7485095|FG000|Overall Study|Withdrawal by Subject|1
4622141|NCT01798992|7485108|FG000|Overall Study|Administrative withdrawal|0
4622142|NCT01798992|7485109|FG001|Overall Study|Administrative withdrawal|1
4622143|NCT01798992|7485110|FG002|Overall Study|Administrative withdrawal|0
4622144|NCT01798992|7485111|FG003|Overall Study|Administrative withdrawal|1
4622145|NCT01798992|7485108|FG000|Overall Study|Lost to Follow-up|0
4622146|NCT01798992|7485109|FG001|Overall Study|Lost to Follow-up|1
4622147|NCT01798992|7485110|FG002|Overall Study|Lost to Follow-up|1
4622148|NCT01798992|7485111|FG003|Overall Study|Lost to Follow-up|0
4622149|NCT01798992|7485108|FG000|Overall Study|Insufficient biopsy tissue|0
4622150|NCT01798992|7485109|FG001|Overall Study|Insufficient biopsy tissue|0
4622151|NCT01798992|7485110|FG002|Overall Study|Insufficient biopsy tissue|1
4556524|NCT01252966|7387234|FG001|Overall Study|Withdrawal by Subject|3
4556525|NCT01253018|7387244|FG000|Overall Study|Lost to Follow-up|1
4556526|NCT01253018|7387245|FG001|Overall Study|Lost to Follow-up|1
4556527|NCT01253018|7387244|FG000|Overall Study|Robot Repair Issues|2
4556528|NCT01253018|7387245|FG001|Overall Study|Robot Repair Issues|0
4622152|NCT01798992|7485111|FG003|Overall Study|Insufficient biopsy tissue|0
4622153|NCT01799226|7485141|FG000|Overall Study|Withdrawal by Subject|1
4622154|NCT01799226|7485142|FG001|Overall Study|Withdrawal by Subject|0
4622155|NCT01799226|7485141|FG000|Overall Study|Disqualified at Day 14|1
4622156|NCT01799226|7485142|FG001|Overall Study|Disqualified at Day 14|0
4622157|NCT01799239|7485148|FG000|Period 1 (7 Days)|Lack of Efficacy|1
4622158|NCT01799239|7485149|FG001|Period 1 (7 Days)|Lack of Efficacy|0
4622159|NCT01799239|7485148|FG000|Period 1 (7 Days)|Withdrawal by Subject|2
4622160|NCT01799239|7485149|FG001|Period 1 (7 Days)|Withdrawal by Subject|0
4622161|NCT01799239|7485148|FG000|Period 1 (7 Days)|Protocol Violation|0
4622162|NCT01799239|7485149|FG001|Period 1 (7 Days)|Protocol Violation|1
4622163|NCT01799239|7485148|FG000|Period 2 (7 Days)|Withdrawal by Subject|1
4622164|NCT01799239|7485149|FG001|Period 2 (7 Days)|Withdrawal by Subject|1
4622165|NCT01799239|7485148|FG000|Period 2 (7 Days)|Protocol Violation|1
4622166|NCT01799239|7485149|FG001|Period 2 (7 Days)|Protocol Violation|0
4622167|NCT01799590|7485166|FG000|Overall Study|Adverse Event|13
4556529|NCT01253018|7387244|FG000|Overall Study|Withdrawal by Subject|1
4556530|NCT01253018|7387245|FG001|Overall Study|Withdrawal by Subject|1
4556531|NCT01253044|7387254|FG000|Overall Study|Lost to Follow-up|38
4556532|NCT01253044|7387255|FG001|Overall Study|Lost to Follow-up|29
4556533|NCT01253135|7387261|FG000|Original Protocol|Protocol Amendment|15
4556534|NCT01253135|7387261|FG000|Amended Protocol|Non-compliance|1
4556535|NCT01253174|7387273|FG000|Period 1|Randomized but not treated|0
4556536|NCT01253174|7387274|FG001|Period 1|Randomized but not treated|1
4556537|NCT01253174|7387275|FG002|Period 1|Randomized but not treated|1
4556538|NCT01253174|7387276|FG003|Period 1|Randomized but not treated|0
4556539|NCT01253174|7387277|FG004|Period 1|Randomized but not treated|1
4556540|NCT01253174|7387278|FG005|Period 1|Randomized but not treated|0
4556541|NCT01253174|7387273|FG000|Period 2|Adverse Event|0
4556542|NCT01253174|7387274|FG001|Period 2|Adverse Event|0
4556543|NCT01253174|7387275|FG002|Period 2|Adverse Event|1
4556544|NCT01253174|7387276|FG003|Period 2|Adverse Event|0
4556545|NCT01253174|7387277|FG004|Period 2|Adverse Event|0
4556546|NCT01253174|7387278|FG005|Period 2|Adverse Event|0
4556547|NCT01253174|7387273|FG000|Period 3|Withdrawal by Subject|0
4556548|NCT01253174|7387274|FG001|Period 3|Withdrawal by Subject|1
4556549|NCT01253174|7387275|FG002|Period 3|Withdrawal by Subject|0
4556550|NCT01253174|7387276|FG003|Period 3|Withdrawal by Subject|0
4556551|NCT01253174|7387277|FG004|Period 3|Withdrawal by Subject|1
4556552|NCT01253174|7387278|FG005|Period 3|Withdrawal by Subject|0
4556553|NCT01253174|7387273|FG000|Period 3|Pregnancy|0
4556554|NCT01253174|7387274|FG001|Period 3|Pregnancy|0
4556555|NCT01253174|7387275|FG002|Period 3|Pregnancy|1
4556556|NCT01253174|7387276|FG003|Period 3|Pregnancy|0
4556557|NCT01253174|7387277|FG004|Period 3|Pregnancy|0
4556558|NCT01253174|7387278|FG005|Period 3|Pregnancy|0
4556559|NCT01253187|7387287|FG000|Period 2|Withdrawal by Subject|0
4556560|NCT01253187|7387288|FG001|Period 2|Withdrawal by Subject|0
4556561|NCT01253187|7387289|FG002|Period 2|Withdrawal by Subject|0
4556562|NCT01253187|7387290|FG003|Period 2|Withdrawal by Subject|0
4622168|NCT01799590|7485167|FG001|Overall Study|Adverse Event|7
4622169|NCT01799590|7485168|FG002|Overall Study|Adverse Event|5
4622170|NCT01799590|7485166|FG000|Overall Study|Pregnancy|2
4622171|NCT01799590|7485167|FG001|Overall Study|Pregnancy|0
4622172|NCT01799590|7485168|FG002|Overall Study|Pregnancy|0
4622173|NCT01799590|7485166|FG000|Overall Study|Lack of Efficacy|3
4622174|NCT01799590|7485167|FG001|Overall Study|Lack of Efficacy|1
4622175|NCT01799590|7485168|FG002|Overall Study|Lack of Efficacy|3
4622176|NCT01799590|7485166|FG000|Overall Study|Participants convenience|4
4622177|NCT01799590|7485167|FG001|Overall Study|Participants convenience|4
4622178|NCT01799590|7485168|FG002|Overall Study|Participants convenience|2
4622179|NCT01799590|7485166|FG000|Overall Study|Aggravation of complications|0
4622180|NCT01799590|7485167|FG001|Overall Study|Aggravation of complications|1
4622181|NCT01799590|7485168|FG002|Overall Study|Aggravation of complications|1
4622182|NCT01799590|7485166|FG000|Overall Study|Using drugs with restricted days of use|0
4622183|NCT01799590|7485167|FG001|Overall Study|Using drugs with restricted days of use|3
4622184|NCT01799590|7485168|FG002|Overall Study|Using drugs with restricted days of use|2
4622185|NCT01799590|7485166|FG000|Overall Study|Use of prohibited concomitant drugs|1
4622186|NCT01799590|7485167|FG001|Overall Study|Use of prohibited concomitant drugs|0
4622187|NCT01799590|7485168|FG002|Overall Study|Use of prohibited concomitant drugs|0
4622188|NCT01799590|7485166|FG000|Overall Study|Other|3
4622189|NCT01799590|7485167|FG001|Overall Study|Other|0
4690712|NCT02563548|7600526|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0
4556563|NCT01253187|7387291|FG004|Period 2|Withdrawal by Subject|1
4556564|NCT01253187|7387292|FG005|Period 2|Withdrawal by Subject|0
4556565|NCT01253187|7387287|FG000|Period 3|Pregnancy|1
4556566|NCT01253187|7387288|FG001|Period 3|Pregnancy|0
4556567|NCT01253187|7387289|FG002|Period 3|Pregnancy|0
4556568|NCT01253187|7387290|FG003|Period 3|Pregnancy|0
4556569|NCT01253187|7387291|FG004|Period 3|Pregnancy|0
4556570|NCT01253187|7387292|FG005|Period 3|Pregnancy|0
4556571|NCT01253187|7387287|FG000|Period 3|difficulty with blood sampling|0
4556572|NCT01253187|7387288|FG001|Period 3|difficulty with blood sampling|1
4556573|NCT01253187|7387289|FG002|Period 3|difficulty with blood sampling|0
4622190|NCT01799590|7485168|FG002|Overall Study|Other|1
4622191|NCT01799720|7485179|FG000|Overall Study|Withdrawal by Subject|3
4622192|NCT01799720|7485180|FG001|Overall Study|Withdrawal by Subject|0
4622193|NCT01799720|7485181|FG002|Overall Study|Withdrawal by Subject|0
4622194|NCT01799720|7485179|FG000|Overall Study|Protocol Violation|0
4622195|NCT01799720|7485180|FG001|Overall Study|Protocol Violation|1
4556574|NCT01253187|7387290|FG003|Period 3|difficulty with blood sampling|0
4556575|NCT01253187|7387291|FG004|Period 3|difficulty with blood sampling|0
4556576|NCT01253187|7387292|FG005|Period 3|difficulty with blood sampling|0
4556577|NCT01253187|7387287|FG000|Period 3|non-compliance|0
4556578|NCT01253187|7387288|FG001|Period 3|non-compliance|0
4556579|NCT01253187|7387289|FG002|Period 3|non-compliance|0
4556580|NCT01253187|7387290|FG003|Period 3|non-compliance|0
4556581|NCT01253187|7387291|FG004|Period 3|non-compliance|1
4556582|NCT01253187|7387292|FG005|Period 3|non-compliance|0
4556583|NCT01253200|7387308|FG000|Overall Study|Death|1
4556584|NCT01253200|7387309|FG001|Overall Study|Death|0
4556585|NCT01253200|7387310|FG002|Overall Study|Death|0
4556586|NCT01253200|7387311|FG003|Overall Study|Death|0
4556587|NCT01253200|7387312|FG004|Overall Study|Death|0
4556588|NCT01253200|7387308|FG000|Overall Study|Lost to Follow-up|1
4556589|NCT01253200|7387309|FG001|Overall Study|Lost to Follow-up|1
4556590|NCT01253200|7387310|FG002|Overall Study|Lost to Follow-up|0
4556591|NCT01253200|7387311|FG003|Overall Study|Lost to Follow-up|0
4556592|NCT01253200|7387312|FG004|Overall Study|Lost to Follow-up|0
4556593|NCT01253200|7387308|FG000|Overall Study|Withdrawal by Subject|2
4556594|NCT01253200|7387309|FG001|Overall Study|Withdrawal by Subject|0
4556595|NCT01253200|7387310|FG002|Overall Study|Withdrawal by Subject|0
4556596|NCT01253200|7387311|FG003|Overall Study|Withdrawal by Subject|0
4556597|NCT01253200|7387312|FG004|Overall Study|Withdrawal by Subject|0
4556598|NCT01253200|7387308|FG000|Overall Study|Protocol Violation|1
4556599|NCT01253200|7387309|FG001|Overall Study|Protocol Violation|4
4556600|NCT01253200|7387310|FG002|Overall Study|Protocol Violation|0
4556601|NCT01253200|7387311|FG003|Overall Study|Protocol Violation|0
4556602|NCT01253200|7387312|FG004|Overall Study|Protocol Violation|5
4556603|NCT01253200|7387308|FG000|Overall Study|intents|10
4556604|NCT01253200|7387309|FG001|Overall Study|intents|10
4556605|NCT01253200|7387310|FG002|Overall Study|intents|1
4556606|NCT01253200|7387311|FG003|Overall Study|intents|3
4556607|NCT01253200|7387312|FG004|Overall Study|intents|0
4556608|NCT01253200|7387308|FG000|Overall Study|Attempts|6
4556609|NCT01253200|7387309|FG001|Overall Study|Attempts|4
4556610|NCT01253200|7387310|FG002|Overall Study|Attempts|1
4556611|NCT01253200|7387311|FG003|Overall Study|Attempts|2
4556612|NCT01253200|7387312|FG004|Overall Study|Attempts|0
4556613|NCT01253226|7387326|FG000|Overall Study|Adverse Event|0
4556614|NCT01253226|7387327|FG001|Overall Study|Adverse Event|0
4556615|NCT01253226|7387328|FG002|Overall Study|Adverse Event|1
4556616|NCT01253226|7387329|FG003|Overall Study|Adverse Event|0
4556617|NCT01253226|7387330|FG004|Overall Study|Adverse Event|0
4556618|NCT01253226|7387326|FG000|Overall Study|Death|0
4556619|NCT01253226|7387327|FG001|Overall Study|Death|1
4556620|NCT01253226|7387328|FG002|Overall Study|Death|0
4556621|NCT01253226|7387329|FG003|Overall Study|Death|0
4556622|NCT01253226|7387330|FG004|Overall Study|Death|0
4556623|NCT01253226|7387326|FG000|Overall Study|Physician Decision|0
4556624|NCT01253226|7387327|FG001|Overall Study|Physician Decision|0
4556625|NCT01253226|7387328|FG002|Overall Study|Physician Decision|0
4556626|NCT01253226|7387329|FG003|Overall Study|Physician Decision|0
4556627|NCT01253226|7387330|FG004|Overall Study|Physician Decision|2
4556628|NCT01253226|7387326|FG000|Overall Study|Withdrawal by Subject|0
4556629|NCT01253226|7387327|FG001|Overall Study|Withdrawal by Subject|0
4556630|NCT01253226|7387328|FG002|Overall Study|Withdrawal by Subject|0
4556631|NCT01253226|7387329|FG003|Overall Study|Withdrawal by Subject|1
4556632|NCT01253226|7387330|FG004|Overall Study|Withdrawal by Subject|0
4556633|NCT01253265|7387347|FG000|Overall Study|Met Predefined Discontinuation Criteria|1
4556634|NCT01253265|7387348|FG001|Overall Study|Met Predefined Discontinuation Criteria|0
4556635|NCT01253265|7387349|FG002|Overall Study|Met Predefined Discontinuation Criteria|0
4556636|NCT01253265|7387350|FG003|Overall Study|Met Predefined Discontinuation Criteria|0
4556637|NCT01253265|7387351|FG004|Overall Study|Met Predefined Discontinuation Criteria|0
4556638|NCT01253265|7387347|FG000|Overall Study|Withdrawal by Subject|0
4556639|NCT01253265|7387348|FG001|Overall Study|Withdrawal by Subject|0
4556640|NCT01253265|7387349|FG002|Overall Study|Withdrawal by Subject|0
4556641|NCT01253265|7387350|FG003|Overall Study|Withdrawal by Subject|0
4556642|NCT01253265|7387351|FG004|Overall Study|Withdrawal by Subject|1
4556643|NCT01253291|7387368|FG000|Overall Study|Withdrawal by Subject|1
4556644|NCT01253291|7387369|FG001|Overall Study|Withdrawal by Subject|1
4556645|NCT01253291|7387370|FG002|Overall Study|Withdrawal by Subject|0
4556646|NCT01253291|7387371|FG003|Overall Study|Withdrawal by Subject|0
4556647|NCT01253291|7387372|FG004|Overall Study|Withdrawal by Subject|0
4556648|NCT01253291|7387368|FG000|Overall Study|Adverse Event|0
4556649|NCT01253291|7387369|FG001|Overall Study|Adverse Event|1
4556650|NCT01253291|7387370|FG002|Overall Study|Adverse Event|0
4556651|NCT01253291|7387371|FG003|Overall Study|Adverse Event|0
4556652|NCT01253291|7387372|FG004|Overall Study|Adverse Event|0
4556653|NCT01253291|7387368|FG000|Overall Study|Lack of Efficacy|1
4556654|NCT01253291|7387369|FG001|Overall Study|Lack of Efficacy|0
4556655|NCT01253291|7387370|FG002|Overall Study|Lack of Efficacy|0
4556656|NCT01253291|7387371|FG003|Overall Study|Lack of Efficacy|0
4556657|NCT01253291|7387372|FG004|Overall Study|Lack of Efficacy|0
4556658|NCT01253291|7387368|FG000|Overall Study|Physician Decision|2
4556659|NCT01253291|7387369|FG001|Overall Study|Physician Decision|0
4556660|NCT01253291|7387370|FG002|Overall Study|Physician Decision|0
4556661|NCT01253291|7387371|FG003|Overall Study|Physician Decision|0
4556662|NCT01253291|7387372|FG004|Overall Study|Physician Decision|2
4556663|NCT01253304|7387389|FG000|Overall Study|Adverse Event|0
4556664|NCT01253304|7387390|FG001|Overall Study|Adverse Event|0
4556665|NCT01253304|7387391|FG002|Overall Study|Adverse Event|0
4556666|NCT01253304|7387392|FG003|Overall Study|Adverse Event|1
4556667|NCT01253317|7387402|FG000|Overall Study|Adverse Event|2
4556668|NCT01253369|7387435|FG000|Overall Study|Adverse Event|4
4556669|NCT01253369|7387435|FG000|Overall Study|Withdrawal by Subject|2
4556670|NCT01253369|7387435|FG000|Overall Study|Death|1
4556671|NCT01253369|7387435|FG000|Overall Study|Progressive disease|23
4556672|NCT01253369|7387435|FG000|Overall Study|Not Evaluable|3
4556673|NCT01253408|7387442|FG000|Overall Study|Adverse Event|0
4556674|NCT01253408|7387443|FG001|Overall Study|Adverse Event|1
4556675|NCT01253408|7387444|FG002|Overall Study|Adverse Event|0
4556676|NCT01253421|7387456|FG000|Assessment and Scheduling|Found to be Ineligible|74
4556677|NCT01253421|7387457|FG001|Assessment and Scheduling|Found to be Ineligible|0
4556678|NCT01253421|7387458|FG002|Assessment and Scheduling|Found to be Ineligible|0
4556679|NCT01253421|7387459|FG003|Assessment and Scheduling|Found to be Ineligible|0
4556680|NCT01253421|7387460|FG004|Assessment and Scheduling|Found to be Ineligible|0
4556681|NCT01253421|7387456|FG000|Assessment and Scheduling|Lost to Follow-up|17
4556682|NCT01253421|7387457|FG001|Assessment and Scheduling|Lost to Follow-up|0
4556683|NCT01253421|7387458|FG002|Assessment and Scheduling|Lost to Follow-up|0
4556684|NCT01253421|7387459|FG003|Assessment and Scheduling|Lost to Follow-up|0
4556685|NCT01253421|7387460|FG004|Assessment and Scheduling|Lost to Follow-up|0
4556686|NCT01253421|7387456|FG000|Assessment and Scheduling|Withdrawal by Subject|7
4556687|NCT01253421|7387457|FG001|Assessment and Scheduling|Withdrawal by Subject|0
4556688|NCT01253421|7387458|FG002|Assessment and Scheduling|Withdrawal by Subject|0
4556689|NCT01253421|7387459|FG003|Assessment and Scheduling|Withdrawal by Subject|0
4556690|NCT01253421|7387460|FG004|Assessment and Scheduling|Withdrawal by Subject|0
4556691|NCT01253421|7387456|FG000|Assessment and Scheduling|Physician Decision|1
4556692|NCT01253421|7387457|FG001|Assessment and Scheduling|Physician Decision|0
4556693|NCT01253421|7387458|FG002|Assessment and Scheduling|Physician Decision|0
4556694|NCT01253421|7387459|FG003|Assessment and Scheduling|Physician Decision|0
4556695|NCT01253421|7387460|FG004|Assessment and Scheduling|Physician Decision|0
4556696|NCT01253421|7387456|FG000|Drug+Scanning Visit|Physician Decision|0
4556697|NCT01253421|7387457|FG001|Drug+Scanning Visit|Physician Decision|0
4556698|NCT01253421|7387458|FG002|Drug+Scanning Visit|Physician Decision|0
4556699|NCT01253421|7387459|FG003|Drug+Scanning Visit|Physician Decision|0
4556700|NCT01253421|7387460|FG004|Drug+Scanning Visit|Physician Decision|1
4556701|NCT01253447|7387470|FG000|Overall Study|Adverse Event|2
4556702|NCT01253564|7387483|FG000|Overall Study|Disease Progression|22
4556703|NCT01253564|7387483|FG000|Overall Study|Withdrawal by Subject|1
4556704|NCT01253564|7387483|FG000|Overall Study|Serious Adverse Event|1
4556705|NCT01253577|7387487|FG000|Overall Study|Lost to Follow-up|3
4556706|NCT01253811|7387498|FG000|Overall Study|Withdrawal criteria|1
4556707|NCT01254019|7387535|FG000|Overall Study|Adverse Event|0
4556708|NCT01254019|7387536|FG001|Overall Study|Adverse Event|2
4556709|NCT01254019|7387535|FG000|Overall Study|Protocol Violation|1
4556710|NCT01254019|7387536|FG001|Overall Study|Protocol Violation|0
4556711|NCT01254019|7387535|FG000|Overall Study|Withdrawal by Subject|0
4556712|NCT01254019|7387536|FG001|Overall Study|Withdrawal by Subject|2
4556713|NCT01254045|7387545|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1
4556714|NCT01254045|7387546|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
4556715|NCT01254045|7387547|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
4556716|NCT01254045|7387548|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
4556717|NCT01254045|7387549|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
4556718|NCT01254045|7387550|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
4556719|NCT01254188|7387560|FG000|Overall Study|Disease Progression|6
4556720|NCT01254188|7387560|FG000|Overall Study|Protocol Violation|6
4556721|NCT01254188|7387560|FG000|Overall Study|Pregnancy|2
4556722|NCT01254188|7387560|FG000|Overall Study|Death|4
4556723|NCT01254188|7387560|FG000|Overall Study|Lost to Follow-up|5
4556724|NCT01254188|7387560|FG000|Overall Study|Withdrawal by Subject|7
4556725|NCT01254188|7387560|FG000|Overall Study|Adverse Event|43
4556726|NCT01254188|7387560|FG000|Overall Study|per investigator discretion|20
4556727|NCT01254227|7387573|FG000|Overall Study|Withdrawal by Subject|6
4556728|NCT01254227|7387573|FG000|Overall Study|Lost to Follow-up|6
4556729|NCT01254227|7387573|FG000|Overall Study|Adverse Event|5
4556730|NCT01254227|7387573|FG000|Overall Study|Abnormal test procedure result|5
4556731|NCT01254227|7387573|FG000|Overall Study|Administrative problems|2
4556732|NCT01254227|7387573|FG000|Overall Study|Death|1
4556733|NCT01254227|7387573|FG000|Overall Study|Protocol deviation|1
4556734|NCT01254292|7387579|FG000|Comparative Phase|Adverse Event|25
4556735|NCT01254292|7387580|FG001|Comparative Phase|Adverse Event|25
4556736|NCT01254292|7387579|FG000|Comparative Phase|Lost to Follow-up|3
4556737|NCT01254292|7387580|FG001|Comparative Phase|Lost to Follow-up|21
4556738|NCT01254292|7387579|FG000|Comparative Phase|Pregnancy|2
4556739|NCT01254292|7387580|FG001|Comparative Phase|Pregnancy|6
4556740|NCT01254292|7387579|FG000|Comparative Phase|Withdrawal by Subject|20
4556741|NCT01254292|7387580|FG001|Comparative Phase|Withdrawal by Subject|21
4556742|NCT01254292|7387579|FG000|Comparative Phase|Protocol Violation|1
4556743|NCT01254292|7387580|FG001|Comparative Phase|Protocol Violation|2
4556744|NCT01254292|7387579|FG000|Comparative Phase|Wish for pregnancy|4
4556745|NCT01254292|7387580|FG001|Comparative Phase|Wish for pregnancy|6
4556746|NCT01254292|7387579|FG000|LCS12 Extension Phase|Wish for pregnancy|14
4556747|NCT01254292|7387580|FG001|LCS12 Extension Phase|Wish for pregnancy|0
4556748|NCT01254292|7387579|FG000|LCS12 Extension Phase|Adverse Event|9
4556749|NCT01254292|7387580|FG001|LCS12 Extension Phase|Adverse Event|0
4556750|NCT01254292|7387579|FG000|LCS12 Extension Phase|Withdrawal by Subject|7
4556751|NCT01254292|7387580|FG001|LCS12 Extension Phase|Withdrawal by Subject|0
4556752|NCT01254292|7387579|FG000|LCS12 Extension Phase|Other unknown|4
4556753|NCT01254292|7387580|FG001|LCS12 Extension Phase|Other unknown|0
4556754|NCT01254292|7387579|FG000|LCS12 Extension Phase|Pregnancy|2
4556755|NCT01254292|7387580|FG001|LCS12 Extension Phase|Pregnancy|0
4556756|NCT01254292|7387579|FG000|LCS12 Extension Phase|Lost to Follow-up|1
4556757|NCT01254292|7387580|FG001|LCS12 Extension Phase|Lost to Follow-up|0
4556758|NCT01254305|7387590|FG000|Overall Study|Adverse Event|6
4556759|NCT01254305|7387591|FG001|Overall Study|Adverse Event|3
4556760|NCT01254305|7387592|FG002|Overall Study|Adverse Event|2
4556761|NCT01254305|7387590|FG000|Overall Study|Lack of Efficacy|1
4556762|NCT01254305|7387591|FG001|Overall Study|Lack of Efficacy|0
4556763|NCT01254305|7387592|FG002|Overall Study|Lack of Efficacy|1
4556764|NCT01254305|7387590|FG000|Overall Study|Protocol Violation|1
4556765|NCT01254305|7387591|FG001|Overall Study|Protocol Violation|7
4556766|NCT01254305|7387592|FG002|Overall Study|Protocol Violation|3
4556767|NCT01254305|7387590|FG000|Overall Study|Withdrawal by Subject|4
4556768|NCT01254305|7387591|FG001|Overall Study|Withdrawal by Subject|2
4556769|NCT01254305|7387592|FG002|Overall Study|Withdrawal by Subject|4
4556770|NCT01254305|7387590|FG000|Overall Study|Lost to Follow-up|10
4556771|NCT01254305|7387591|FG001|Overall Study|Lost to Follow-up|6
4556772|NCT01254305|7387592|FG002|Overall Study|Lost to Follow-up|5
4556773|NCT01254305|7387590|FG000|Overall Study|Other Reasons|0
4556774|NCT01254305|7387591|FG001|Overall Study|Other Reasons|0
4556775|NCT01254305|7387592|FG002|Overall Study|Other Reasons|2
4556776|NCT01254318|7387603|FG000|Overall Study|Lost to Follow-up|5
4556777|NCT01254318|7387603|FG000|Overall Study|Death|47
4556778|NCT01254331|7387607|FG000|Initial Phase|Adverse Event|3
4556779|NCT01254331|7387607|FG000|Initial Phase|Withdrawal by Subject|1
4556780|NCT01254331|7387607|FG000|Initial Phase|Pregnancy|1
4556781|NCT01254331|7387607|FG000|Extension Phase|Lack of Efficacy|1
4556782|NCT01254331|7387607|FG000|Extension Phase|Lost to Follow-up|3
4556783|NCT01254344|7387613|FG000|Overall Study|Adverse Event|2
4556784|NCT01254344|7387614|FG001|Overall Study|Adverse Event|5
4556785|NCT01254344|7387613|FG000|Overall Study|Physician Decision|7
4556786|NCT01254344|7387614|FG001|Overall Study|Physician Decision|4
4556787|NCT01254344|7387613|FG000|Overall Study|Protocol Violation|1
4556788|NCT01254344|7387614|FG001|Overall Study|Protocol Violation|4
4556789|NCT01254344|7387613|FG000|Overall Study|Withdrawal by Subject|3
4556790|NCT01254344|7387614|FG001|Overall Study|Withdrawal by Subject|6
4556791|NCT01254565|7387641|FG000|Overall Study|Non-compliance to Study Procedures|0
4556792|NCT01254565|7387642|FG001|Overall Study|Non-compliance to Study Procedures|0
4556793|NCT01254565|7387643|FG002|Overall Study|Non-compliance to Study Procedures|0
4556794|NCT01254565|7387644|FG003|Overall Study|Non-compliance to Study Procedures|0
4556795|NCT01254565|7387645|FG004|Overall Study|Non-compliance to Study Procedures|1
4556796|NCT01254565|7387646|FG005|Overall Study|Non-compliance to Study Procedures|0
4556797|NCT01254565|7387641|FG000|Overall Study|Did not Receive Treatment|1
4556798|NCT01254565|7387642|FG001|Overall Study|Did not Receive Treatment|1
4556799|NCT01254565|7387643|FG002|Overall Study|Did not Receive Treatment|0
4556800|NCT01254565|7387644|FG003|Overall Study|Did not Receive Treatment|0
4556801|NCT01254565|7387645|FG004|Overall Study|Did not Receive Treatment|3
4556802|NCT01254565|7387646|FG005|Overall Study|Did not Receive Treatment|4
4556803|NCT01254565|7387641|FG000|Overall Study|Other|0
4556804|NCT01254565|7387642|FG001|Overall Study|Other|0
4556805|NCT01254565|7387643|FG002|Overall Study|Other|0
4556806|NCT01254565|7387644|FG003|Overall Study|Other|1
4556807|NCT01254565|7387645|FG004|Overall Study|Other|0
4556808|NCT01254565|7387646|FG005|Overall Study|Other|0
4556809|NCT01254604|7387662|FG000|Overall Study|Lost to Follow-up|1
4556810|NCT01254604|7387663|FG001|Overall Study|Lost to Follow-up|1
4556811|NCT01254604|7387662|FG000|Overall Study|Protocol Violation|2
4556812|NCT01254604|7387663|FG001|Overall Study|Protocol Violation|2
4556813|NCT01254604|7387662|FG000|Overall Study|Withdrawal by Subject|2
4556814|NCT01254604|7387663|FG001|Overall Study|Withdrawal by Subject|4
4556815|NCT01254604|7387662|FG000|Overall Study|Adverse Event|3
4556816|NCT01254604|7387663|FG001|Overall Study|Adverse Event|2
4556817|NCT01254630|7387673|FG000|Overall Study|Adverse Event|36
4556818|NCT01254630|7387674|FG001|Overall Study|Adverse Event|15
4556819|NCT01254630|7387675|FG002|Overall Study|Adverse Event|40
4556820|NCT01254630|7387676|FG003|Overall Study|Adverse Event|8
4556821|NCT01254630|7387673|FG000|Overall Study|Death|461
4556822|NCT01254630|7387674|FG001|Overall Study|Death|151
4556823|NCT01254630|7387675|FG002|Overall Study|Death|478
4556824|NCT01254630|7387676|FG003|Overall Study|Death|139
4556825|NCT01254630|7387673|FG000|Overall Study|Lost to Follow-up|80
4556826|NCT01254630|7387674|FG001|Overall Study|Lost to Follow-up|26
4556827|NCT01254630|7387675|FG002|Overall Study|Lost to Follow-up|89
4556828|NCT01254630|7387676|FG003|Overall Study|Lost to Follow-up|32
4622196|NCT01799720|7485181|FG002|Overall Study|Protocol Violation|0
4690713|NCT02563548|7600521|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0
4556829|NCT01254630|7387673|FG000|Overall Study|Physician Decision|24
4556830|NCT01254630|7387674|FG001|Overall Study|Physician Decision|8
4556831|NCT01254630|7387675|FG002|Overall Study|Physician Decision|16
4556832|NCT01254630|7387676|FG003|Overall Study|Physician Decision|7
4556833|NCT01254630|7387673|FG000|Overall Study|Withdrawal by Subject|201
4556834|NCT01254630|7387674|FG001|Overall Study|Withdrawal by Subject|94
4556835|NCT01254630|7387675|FG002|Overall Study|Withdrawal by Subject|188
4556836|NCT01254630|7387676|FG003|Overall Study|Withdrawal by Subject|89
4556837|NCT01254630|7387673|FG000|Overall Study|Study terminated by sponsor|0
4556838|NCT01254630|7387674|FG001|Overall Study|Study terminated by sponsor|994
4556839|NCT01254630|7387675|FG002|Overall Study|Study terminated by sponsor|0
4556840|NCT01254630|7387676|FG003|Overall Study|Study terminated by sponsor|1010
4556841|NCT01254630|7387673|FG000|Overall Study|Status not recorded|0
4556842|NCT01254630|7387674|FG001|Overall Study|Status not recorded|0
4556843|NCT01254630|7387675|FG002|Overall Study|Status not recorded|1
4556844|NCT01254630|7387676|FG003|Overall Study|Status not recorded|0
4556845|NCT01254643|7387684|FG000|Overall Study|Withdrawal by Subject|1
4556846|NCT01254656|7387691|FG000|Overall Study|Discontinued due to termination of study|40
4556847|NCT01254656|7387692|FG001|Overall Study|Discontinued due to termination of study|39
4556848|NCT01254656|7387693|FG002|Overall Study|Discontinued due to termination of study|13
4556849|NCT01254656|7387691|FG000|Overall Study|Lack of Efficacy|3
4556850|NCT01254656|7387692|FG001|Overall Study|Lack of Efficacy|0
4556851|NCT01254656|7387693|FG002|Overall Study|Lack of Efficacy|0
4556852|NCT01254656|7387691|FG000|Overall Study|Lost to Follow-up|1
4556853|NCT01254656|7387692|FG001|Overall Study|Lost to Follow-up|0
4556854|NCT01254656|7387693|FG002|Overall Study|Lost to Follow-up|2
4556855|NCT01254656|7387691|FG000|Overall Study|Withdrawal by Subject|2
4556856|NCT01254656|7387692|FG001|Overall Study|Withdrawal by Subject|2
4556857|NCT01254656|7387693|FG002|Overall Study|Withdrawal by Subject|1
4556858|NCT01254656|7387691|FG000|Overall Study|Pregnancy|0
4556859|NCT01254656|7387692|FG001|Overall Study|Pregnancy|0
4556860|NCT01254656|7387693|FG002|Overall Study|Pregnancy|2
4556861|NCT01254656|7387691|FG000|Overall Study|Adverse Event|1
4556862|NCT01254656|7387692|FG001|Overall Study|Adverse Event|1
4556863|NCT01254656|7387693|FG002|Overall Study|Adverse Event|0
4556864|NCT01254656|7387691|FG000|Overall Study|Death|0
4556865|NCT01254656|7387692|FG001|Overall Study|Death|1
4556866|NCT01254656|7387693|FG002|Overall Study|Death|0
4556867|NCT01254669|7387703|FG000|Overall Study|Withdrawal by Subject|0
4556868|NCT01254669|7387704|FG001|Overall Study|Withdrawal by Subject|1
4556869|NCT01254669|7387703|FG000|Overall Study|time constraint|2
4556870|NCT01254669|7387704|FG001|Overall Study|time constraint|2
4556871|NCT01254669|7387703|FG000|Overall Study|called to clinic during intervention|1
4556872|NCT01254669|7387704|FG001|Overall Study|called to clinic during intervention|1
4556873|NCT01254721|7387714|FG000|Overall Study|Lost to Follow-up|0
4556874|NCT01254721|7387715|FG001|Overall Study|Lost to Follow-up|4
4556875|NCT01254721|7387714|FG000|Overall Study|Lack of Efficacy|4
4556876|NCT01254721|7387715|FG001|Overall Study|Lack of Efficacy|2
4556877|NCT01254721|7387714|FG000|Overall Study|Death|0
4556878|NCT01254721|7387715|FG001|Overall Study|Death|1
4556879|NCT01254721|7387714|FG000|Overall Study|technical problum|1
4556880|NCT01254721|7387715|FG001|Overall Study|technical problum|0
4556881|NCT01254721|7387714|FG000|Overall Study|Adverse Event|2
4556882|NCT01254721|7387715|FG001|Overall Study|Adverse Event|3
4556883|NCT01254721|7387714|FG000|Overall Study|Withdrawal by Subject|8
4556884|NCT01254721|7387715|FG001|Overall Study|Withdrawal by Subject|11
4556885|NCT01254721|7387714|FG000|Overall Study|Wrongly randomization|0
4556886|NCT01254721|7387715|FG001|Overall Study|Wrongly randomization|1
4556887|NCT01254747|7387725|FG000|Overall Study|Unacceptable subjective vision|0
4556888|NCT01254747|7387726|FG001|Overall Study|Unacceptable subjective vision|0
4556889|NCT01254747|7387727|FG002|Overall Study|Unacceptable subjective vision|0
4556890|NCT01254747|7387728|FG003|Overall Study|Unacceptable subjective vision|2
4556891|NCT01254747|7387725|FG000|Overall Study|Difficult removal handling|0
4556892|NCT01254747|7387726|FG001|Overall Study|Difficult removal handling|0
4556893|NCT01254747|7387727|FG002|Overall Study|Difficult removal handling|1
4556894|NCT01254747|7387728|FG003|Overall Study|Difficult removal handling|0
4556895|NCT01254747|7387725|FG000|Overall Study|Symptoms and problems|0
4556896|NCT01254747|7387726|FG001|Overall Study|Symptoms and problems|2
4556897|NCT01254747|7387727|FG002|Overall Study|Symptoms and problems|1
4556898|NCT01254747|7387728|FG003|Overall Study|Symptoms and problems|0
4556899|NCT01254747|7387725|FG000|Overall Study|Lost to Follow-up|0
4556900|NCT01254747|7387726|FG001|Overall Study|Lost to Follow-up|0
4556901|NCT01254747|7387727|FG002|Overall Study|Lost to Follow-up|1
4556902|NCT01254747|7387728|FG003|Overall Study|Lost to Follow-up|0
4556903|NCT01254747|7387725|FG000|Overall Study|Biomicroscopy|0
4556904|NCT01254747|7387726|FG001|Overall Study|Biomicroscopy|0
4556905|NCT01254747|7387727|FG002|Overall Study|Biomicroscopy|1
4556906|NCT01254747|7387728|FG003|Overall Study|Biomicroscopy|0
4556907|NCT01254747|7387725|FG000|Overall Study|Discomfort|0
4556908|NCT01254747|7387726|FG001|Overall Study|Discomfort|4
4622197|NCT01799720|7485179|FG000|Overall Study|Pregnancy|0
4556909|NCT01254747|7387727|FG002|Overall Study|Discomfort|0
4556910|NCT01254747|7387728|FG003|Overall Study|Discomfort|0
4592003|NCT01536262|7439217|FG000|Overall Study|Other than stated above|1
4592004|NCT01536262|7439218|FG001|Overall Study|Other than stated above|0
4592005|NCT01536262|7439219|FG002|Overall Study|Other than stated above|0
4592006|NCT01536379|7439239|FG000|Overall Study|Adverse Event|1
4592007|NCT01536379|7439240|FG001|Overall Study|Adverse Event|2
4592008|NCT01536379|7439239|FG000|Overall Study|Withdrawal by Subject|1
4592009|NCT01536379|7439240|FG001|Overall Study|Withdrawal by Subject|1
4592010|NCT01536392|7439248|FG000|Overall Study|Adverse Event|2
4592011|NCT01536392|7439249|FG001|Overall Study|Adverse Event|2
4592012|NCT01536392|7439248|FG000|Overall Study|Physician Decision|2
4592013|NCT01536392|7439249|FG001|Overall Study|Physician Decision|3
4592014|NCT01536392|7439248|FG000|Overall Study|Withdrawal by Subject|3
4592015|NCT01536392|7439249|FG001|Overall Study|Withdrawal by Subject|6
4592016|NCT01536392|7439248|FG000|Overall Study|Non Compliance|3
4592017|NCT01536392|7439249|FG001|Overall Study|Non Compliance|4
4592018|NCT01536392|7439248|FG000|Overall Study|Completed therapy early|3
4592019|NCT01536392|7439249|FG001|Overall Study|Completed therapy early|0
4592020|NCT01536405|7439257|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8
4592021|NCT01536405|7439258|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4
4592022|NCT01536405|7439257|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12
4592023|NCT01536405|7439258|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18
4592024|NCT01536405|7439257|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20
4592025|NCT01536405|7439258|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22
4592026|NCT01536405|7439257|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17
4592027|NCT01536405|7439258|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13
4592028|NCT01536405|7439257|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3
4592029|NCT01536405|7439258|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3
4592030|NCT01536405|7439257|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9
4592031|NCT01536405|7439258|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10
4592032|NCT01536405|7439257|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2
4592033|NCT01536405|7439258|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2
4592034|NCT01536405|7439257|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3
4592035|NCT01536405|7439258|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2
4592036|NCT01536405|7439257|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1
4592037|NCT01536405|7439258|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0
4592038|NCT01536405|7439257|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16
4622198|NCT01799720|7485180|FG001|Overall Study|Pregnancy|0
4622199|NCT01799720|7485181|FG002|Overall Study|Pregnancy|1
4622200|NCT01799889|7485201|FG000|Overall Study|Adverse Event|4
4622201|NCT01799889|7485202|FG001|Overall Study|Adverse Event|4
4622202|NCT01799889|7485203|FG002|Overall Study|Adverse Event|5
4622203|NCT01799889|7485204|FG003|Overall Study|Adverse Event|1
4622204|NCT01799889|7485205|FG004|Overall Study|Adverse Event|11
4622205|NCT01799889|7485206|FG005|Overall Study|Adverse Event|1
4622206|NCT01799889|7485207|FG006|Overall Study|Adverse Event|5
4622207|NCT01799889|7485208|FG007|Overall Study|Adverse Event|2
4622208|NCT01799889|7485209|FG008|Overall Study|Adverse Event|3
4622209|NCT01799889|7485210|FG009|Overall Study|Adverse Event|1
4622210|NCT01799889|7485211|FG010|Overall Study|Adverse Event|1
4622211|NCT01799889|7485212|FG011|Overall Study|Adverse Event|0
4622212|NCT01799889|7485201|FG000|Overall Study|Death|1
4622213|NCT01799889|7485202|FG001|Overall Study|Death|0
4622214|NCT01799889|7485203|FG002|Overall Study|Death|5
4622215|NCT01799889|7485204|FG003|Overall Study|Death|3
4622216|NCT01799889|7485205|FG004|Overall Study|Death|1
4690714|NCT02563548|7600522|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0
4690715|NCT02563548|7600523|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0
4690716|NCT02563548|7600524|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0
4690717|NCT02563548|7600525|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1
4690718|NCT02563548|7600526|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8
4690719|NCT02563548|7600521|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0
4592039|NCT01536405|7439258|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14
4592040|NCT01536405|7439257|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0
4592041|NCT01536405|7439258|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2
4592042|NCT01536405|7439257|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0
4592043|NCT01536405|7439258|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1
4592044|NCT01536405|7439257|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20
4592045|NCT01536405|7439258|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20
4592046|NCT01536418|7439266|FG000|Overall Study|Protocol Violation|2
4592047|NCT01536418|7439267|FG001|Overall Study|Protocol Violation|3
4622217|NCT01799889|7485206|FG005|Overall Study|Death|0
4622218|NCT01799889|7485207|FG006|Overall Study|Death|0
4622219|NCT01799889|7485208|FG007|Overall Study|Death|0
4622220|NCT01799889|7485209|FG008|Overall Study|Death|1
4622221|NCT01799889|7485210|FG009|Overall Study|Death|0
4622222|NCT01799889|7485211|FG010|Overall Study|Death|1
4622223|NCT01799889|7485212|FG011|Overall Study|Death|0
4622224|NCT01799889|7485201|FG000|Overall Study|Lack of Efficacy|1
4690720|NCT02563548|7600522|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0
4556911|NCT01254890|7387770|FG000|Overall Study|Ineligible|0
4556912|NCT01254890|7387771|FG001|Overall Study|Ineligible|3
4556913|NCT01254890|7387770|FG000|Overall Study|Withdrawal by Subject|1
4556914|NCT01254890|7387771|FG001|Overall Study|Withdrawal by Subject|2
4556915|NCT01254890|7387770|FG000|Overall Study|Disease Progression|0
4556916|NCT01254890|7387771|FG001|Overall Study|Disease Progression|5
4556917|NCT01255163|7387782|FG000|Overall Study|Withdrawal by Subject|1
4556918|NCT01255163|7387783|FG001|Overall Study|Withdrawal by Subject|0
4556919|NCT01255163|7387782|FG000|Overall Study|Lost to Follow-up|2
4556920|NCT01255163|7387783|FG001|Overall Study|Lost to Follow-up|0
4556921|NCT01255163|7387782|FG000|Overall Study|Adverse Event|0
4556922|NCT01255163|7387783|FG001|Overall Study|Adverse Event|2
4556923|NCT01255163|7387782|FG000|Overall Study|AstraZeneca stopped support of the study|1
4556924|NCT01255163|7387783|FG001|Overall Study|AstraZeneca stopped support of the study|3
4556925|NCT01255306|7387793|FG000|Overall Study|Physician Decision|1
4556926|NCT01255306|7387794|FG001|Overall Study|Physician Decision|1
4556927|NCT01255423|7387805|FG000|Overall Study|Abnormal Laboratory value|3
4622225|NCT01799889|7485202|FG001|Overall Study|Lack of Efficacy|1
4622226|NCT01799889|7485203|FG002|Overall Study|Lack of Efficacy|0
4622227|NCT01799889|7485204|FG003|Overall Study|Lack of Efficacy|1
4622228|NCT01799889|7485205|FG004|Overall Study|Lack of Efficacy|2
4622229|NCT01799889|7485206|FG005|Overall Study|Lack of Efficacy|2
4622230|NCT01799889|7485207|FG006|Overall Study|Lack of Efficacy|0
4622231|NCT01799889|7485208|FG007|Overall Study|Lack of Efficacy|0
4622232|NCT01799889|7485209|FG008|Overall Study|Lack of Efficacy|2
4622233|NCT01799889|7485210|FG009|Overall Study|Lack of Efficacy|0
4622234|NCT01799889|7485211|FG010|Overall Study|Lack of Efficacy|1
4622235|NCT01799889|7485212|FG011|Overall Study|Lack of Efficacy|0
4622236|NCT01799889|7485201|FG000|Overall Study|Lost to Follow-up|0
4622237|NCT01799889|7485202|FG001|Overall Study|Lost to Follow-up|1
4622238|NCT01799889|7485203|FG002|Overall Study|Lost to Follow-up|0
4622239|NCT01799889|7485204|FG003|Overall Study|Lost to Follow-up|0
4622240|NCT01799889|7485205|FG004|Overall Study|Lost to Follow-up|0
4622241|NCT01799889|7485206|FG005|Overall Study|Lost to Follow-up|0
4622242|NCT01799889|7485207|FG006|Overall Study|Lost to Follow-up|0
4622243|NCT01799889|7485208|FG007|Overall Study|Lost to Follow-up|0
4622244|NCT01799889|7485209|FG008|Overall Study|Lost to Follow-up|0
4622245|NCT01799889|7485210|FG009|Overall Study|Lost to Follow-up|0
4622246|NCT01799889|7485211|FG010|Overall Study|Lost to Follow-up|0
4622247|NCT01799889|7485212|FG011|Overall Study|Lost to Follow-up|0
4622248|NCT01799889|7485201|FG000|Overall Study|Physician Decision|3
4622249|NCT01799889|7485202|FG001|Overall Study|Physician Decision|2
4622250|NCT01799889|7485203|FG002|Overall Study|Physician Decision|4
4622251|NCT01799889|7485204|FG003|Overall Study|Physician Decision|4
4622252|NCT01799889|7485205|FG004|Overall Study|Physician Decision|5
4622253|NCT01799889|7485206|FG005|Overall Study|Physician Decision|5
4622254|NCT01799889|7485207|FG006|Overall Study|Physician Decision|5
4622255|NCT01799889|7485208|FG007|Overall Study|Physician Decision|2
4622256|NCT01799889|7485209|FG008|Overall Study|Physician Decision|6
4622257|NCT01799889|7485210|FG009|Overall Study|Physician Decision|0
4622258|NCT01799889|7485211|FG010|Overall Study|Physician Decision|0
4622259|NCT01799889|7485212|FG011|Overall Study|Physician Decision|1
4622260|NCT01799889|7485201|FG000|Overall Study|Progressive Disease|30
4622261|NCT01799889|7485202|FG001|Overall Study|Progressive Disease|26
4622262|NCT01799889|7485203|FG002|Overall Study|Progressive Disease|25
4622263|NCT01799889|7485204|FG003|Overall Study|Progressive Disease|30
4622264|NCT01799889|7485205|FG004|Overall Study|Progressive Disease|23
4622265|NCT01799889|7485206|FG005|Overall Study|Progressive Disease|9
4622266|NCT01799889|7485207|FG006|Overall Study|Progressive Disease|8
4622267|NCT01799889|7485208|FG007|Overall Study|Progressive Disease|13
4622268|NCT01799889|7485209|FG008|Overall Study|Progressive Disease|18
4622269|NCT01799889|7485210|FG009|Overall Study|Progressive Disease|5
4622270|NCT01799889|7485211|FG010|Overall Study|Progressive Disease|3
4622271|NCT01799889|7485212|FG011|Overall Study|Progressive Disease|1
4622272|NCT01799889|7485201|FG000|Overall Study|Specified Criteria for Withdrawal|0
4622273|NCT01799889|7485202|FG001|Overall Study|Specified Criteria for Withdrawal|1
4690721|NCT02563548|7600523|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0
4556928|NCT01255423|7387806|FG001|Overall Study|Abnormal Laboratory value|2
4556929|NCT01255423|7387805|FG000|Overall Study|Use of prohibited medications|0
4556930|NCT01255423|7387806|FG001|Overall Study|Use of prohibited medications|1
4556931|NCT01255436|7387814|FG000|Overall Study|Lost to Follow-up|178
4622274|NCT01799889|7485203|FG002|Overall Study|Specified Criteria for Withdrawal|1
4622275|NCT01799889|7485204|FG003|Overall Study|Specified Criteria for Withdrawal|0
4622276|NCT01799889|7485205|FG004|Overall Study|Specified Criteria for Withdrawal|0
4622277|NCT01799889|7485206|FG005|Overall Study|Specified Criteria for Withdrawal|0
4622278|NCT01799889|7485207|FG006|Overall Study|Specified Criteria for Withdrawal|0
4622279|NCT01799889|7485208|FG007|Overall Study|Specified Criteria for Withdrawal|0
4622280|NCT01799889|7485209|FG008|Overall Study|Specified Criteria for Withdrawal|0
4622281|NCT01799889|7485210|FG009|Overall Study|Specified Criteria for Withdrawal|0
4622282|NCT01799889|7485211|FG010|Overall Study|Specified Criteria for Withdrawal|0
4622283|NCT01799889|7485212|FG011|Overall Study|Specified Criteria for Withdrawal|0
4622284|NCT01799889|7485201|FG000|Overall Study|Study Terminated By Sponsor|1
4622285|NCT01799889|7485202|FG001|Overall Study|Study Terminated By Sponsor|0
4622286|NCT01799889|7485203|FG002|Overall Study|Study Terminated By Sponsor|0
4556932|NCT01255436|7387815|FG001|Overall Study|Lost to Follow-up|191
4556933|NCT01255436|7387814|FG000|Overall Study|Death, stroke, or MI|4
4556934|NCT01255436|7387815|FG001|Overall Study|Death, stroke, or MI|3
4556935|NCT01255592|7387828|FG000|Overall Study|Adverse Event|5
4556936|NCT01255592|7387829|FG001|Overall Study|Adverse Event|0
4556937|NCT01255592|7387828|FG000|Overall Study|Withdrawal by Subject|1
4556938|NCT01255592|7387829|FG001|Overall Study|Withdrawal by Subject|0
4556939|NCT01255592|7387828|FG000|Overall Study|Other|0
4556940|NCT01255592|7387829|FG001|Overall Study|Other|1
4556941|NCT01255631|7387838|FG000|Overall Study|poor enrollment, no data analyzed|9
4556942|NCT01255631|7387839|FG001|Overall Study|poor enrollment, no data analyzed|6
4556943|NCT01255670|7387847|FG000|Overall Study|Adverse Event|10
4556944|NCT01255670|7387848|FG001|Overall Study|Adverse Event|10
4556945|NCT01255670|7387847|FG000|Overall Study|Lost to Follow-up|16
4556946|NCT01255670|7387848|FG001|Overall Study|Lost to Follow-up|10
4556947|NCT01255722|7387857|FG000|Overall Study|Adverse Event|0
4556948|NCT01255722|7387858|FG001|Overall Study|Adverse Event|1
4556949|NCT01255722|7387859|FG002|Overall Study|Adverse Event|1
4556950|NCT01255722|7387857|FG000|Overall Study|asymptomatic patient|1
4556951|NCT01255722|7387858|FG001|Overall Study|asymptomatic patient|0
4556952|NCT01255722|7387859|FG002|Overall Study|asymptomatic patient|0
4556953|NCT01255722|7387857|FG000|Overall Study|beta-blocker contraindicated|2
4556954|NCT01255722|7387858|FG001|Overall Study|beta-blocker contraindicated|0
4556955|NCT01255722|7387859|FG002|Overall Study|beta-blocker contraindicated|0
4556956|NCT01255761|7387870|FG000|Overall Study|Adverse Event|29
4556957|NCT01255761|7387871|FG001|Overall Study|Adverse Event|43
4556958|NCT01255761|7387870|FG000|Overall Study|Lack of Efficacy|86
4556959|NCT01255761|7387871|FG001|Overall Study|Lack of Efficacy|74
4556960|NCT01255761|7387870|FG000|Overall Study|Protocol Violation|9
4556961|NCT01255761|7387871|FG001|Overall Study|Protocol Violation|5
4556962|NCT01255761|7387870|FG000|Overall Study|Lost to Follow-up|10
4556963|NCT01255761|7387871|FG001|Overall Study|Lost to Follow-up|8
4556964|NCT01255761|7387870|FG000|Overall Study|Withdrawal by Subject|11
4556965|NCT01255761|7387871|FG001|Overall Study|Withdrawal by Subject|27
4556966|NCT01255761|7387870|FG000|Overall Study|Other Reasons|37
4556967|NCT01255761|7387871|FG001|Overall Study|Other Reasons|18
4556968|NCT01255787|7387881|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6
4556969|NCT01255787|7387882|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2
4556970|NCT01255787|7387883|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9
4556971|NCT01255787|7387884|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9
4556972|NCT01255787|7387881|FG000|Overall Study|Major Protocol Deviation|1
4556973|NCT01255787|7387882|FG001|Overall Study|Major Protocol Deviation|1
4556974|NCT01255787|7387883|FG002|Overall Study|Major Protocol Deviation|0
4556975|NCT01255787|7387884|FG003|Overall Study|Major Protocol Deviation|4
4556976|NCT01255787|7387881|FG000|Overall Study|Lost to Follow-up|1
4556977|NCT01255787|7387882|FG001|Overall Study|Lost to Follow-up|2
4556978|NCT01255787|7387883|FG002|Overall Study|Lost to Follow-up|4
4556979|NCT01255787|7387884|FG003|Overall Study|Lost to Follow-up|2
4556980|NCT01255787|7387881|FG000|Overall Study|Withdrawal of Consent|3
4556981|NCT01255787|7387882|FG001|Overall Study|Withdrawal of Consent|9
4556982|NCT01255787|7387883|FG002|Overall Study|Withdrawal of Consent|3
4556983|NCT01255787|7387884|FG003|Overall Study|Withdrawal of Consent|4
4556984|NCT01255787|7387881|FG000|Overall Study|Pregnancy|0
4556985|NCT01255787|7387882|FG001|Overall Study|Pregnancy|0
4556986|NCT01255787|7387883|FG002|Overall Study|Pregnancy|0
4556987|NCT01255787|7387884|FG003|Overall Study|Pregnancy|1
4556988|NCT01255787|7387881|FG000|Overall Study|Lack of Efficacy|2
4556989|NCT01255787|7387882|FG001|Overall Study|Lack of Efficacy|2
4556990|NCT01255787|7387883|FG002|Overall Study|Lack of Efficacy|2
4556991|NCT01255787|7387884|FG003|Overall Study|Lack of Efficacy|2
4556992|NCT01255787|7387881|FG000|Overall Study|Noncompliance with Study Drug|3
4556993|NCT01255787|7387882|FG001|Overall Study|Noncompliance with Study Drug|1
4556994|NCT01255787|7387883|FG002|Overall Study|Noncompliance with Study Drug|0
4556995|NCT01255787|7387884|FG003|Overall Study|Noncompliance with Study Drug|0
4556996|NCT01255904|7387925|FG000|Overall Study|Physician Decision|1
4556997|NCT01255904|7387926|FG001|Overall Study|Physician Decision|4
4556998|NCT01256008|7387935|FG000|Overall Study|Lost to Follow-up|6
4556999|NCT01256008|7387936|FG001|Overall Study|Lost to Follow-up|4
4557000|NCT01256008|7387937|FG002|Overall Study|Lost to Follow-up|11
4557001|NCT01256008|7387935|FG000|Overall Study|Withdrawal by Subject|2
4557002|NCT01256008|7387936|FG001|Overall Study|Withdrawal by Subject|3
4557003|NCT01256008|7387937|FG002|Overall Study|Withdrawal by Subject|10
4557004|NCT01256060|7387956|FG000|Overall Study|Lost to Follow-up|0
4622287|NCT01799889|7485204|FG003|Overall Study|Study Terminated By Sponsor|0
4690722|NCT02563548|7600524|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0
4557005|NCT01256060|7387957|FG001|Overall Study|Lost to Follow-up|1
4557006|NCT01256060|7387958|FG002|Overall Study|Lost to Follow-up|0
4557007|NCT01256060|7387959|FG003|Overall Study|Lost to Follow-up|0
4557008|NCT01256177|7387976|FG000|Overall Study|Withdrawal by Subject|23
4557009|NCT01256177|7387977|FG001|Overall Study|Withdrawal by Subject|22
4557010|NCT01256177|7387976|FG000|Overall Study|Lost to Follow-up|2
4557011|NCT01256177|7387977|FG001|Overall Study|Lost to Follow-up|2
4557012|NCT01256177|7387976|FG000|Overall Study|Adverse Event|8
4557013|NCT01256177|7387977|FG001|Overall Study|Adverse Event|9
4557014|NCT01256177|7387976|FG000|Overall Study|Severe Non-Compliance to Protocol|4
4557015|NCT01256177|7387977|FG001|Overall Study|Severe Non-Compliance to Protocol|2
4557016|NCT01256177|7387976|FG000|Overall Study|Condition under Investigation Worsened|1
4557017|NCT01256177|7387977|FG001|Overall Study|Condition under Investigation Worsened|0
4557018|NCT01256177|7387976|FG000|Overall Study|Lack of Efficacy|11
4557019|NCT01256177|7387977|FG001|Overall Study|Lack of Efficacy|2
4557020|NCT01256177|7387976|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1
4557021|NCT01256177|7387977|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0
4557022|NCT01256190|7387985|FG000|Overall Study|Lost to Follow-up|2
4557023|NCT01256190|7387986|FG001|Overall Study|Lost to Follow-up|0
4557024|NCT01256294|7387992|FG000|Overall Study|Adverse Event|1
4557025|NCT01256294|7387993|FG001|Overall Study|Adverse Event|0
4557026|NCT01256294|7387992|FG000|Overall Study|Withdrawal by Subject|1
4557027|NCT01256294|7387993|FG001|Overall Study|Withdrawal by Subject|1
4557028|NCT01256294|7387992|FG000|Overall Study|Protocol deviation|2
4557029|NCT01256294|7387993|FG001|Overall Study|Protocol deviation|1
4557030|NCT01256385|7388001|FG000|Overall Study|Physician Decision|1
4557031|NCT01256385|7388002|FG001|Overall Study|Physician Decision|1
4557032|NCT01256385|7388001|FG000|Overall Study|Withdrawal by Subject|2
4557033|NCT01256385|7388002|FG001|Overall Study|Withdrawal by Subject|2
4557034|NCT01256411|7388012|FG000|Extension by Maximum Treatment|Protocol deviation|0
4557035|NCT01256411|7388013|FG001|Extension by Maximum Treatment|Protocol deviation|0
4557036|NCT01256411|7388014|FG002|Extension by Maximum Treatment|Protocol deviation|1
4557037|NCT01256411|7388015|FG003|Extension by Maximum Treatment|Protocol deviation|0
4557038|NCT01256411|7388016|FG004|Extension by Maximum Treatment|Protocol deviation|0
4557039|NCT01256411|7388017|FG005|Extension by Maximum Treatment|Protocol deviation|0
4557040|NCT01256411|7388012|FG000|Extension by Maximum Treatment|Lost to Follow-up|1
4557041|NCT01256411|7388013|FG001|Extension by Maximum Treatment|Lost to Follow-up|2
4557042|NCT01256411|7388014|FG002|Extension by Maximum Treatment|Lost to Follow-up|0
4557043|NCT01256411|7388015|FG003|Extension by Maximum Treatment|Lost to Follow-up|0
4557044|NCT01256411|7388016|FG004|Extension by Maximum Treatment|Lost to Follow-up|0
4557045|NCT01256411|7388017|FG005|Extension by Maximum Treatment|Lost to Follow-up|0
4557046|NCT01256411|7388012|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1
4557047|NCT01256411|7388013|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6
4557048|NCT01256411|7388014|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1
4557049|NCT01256411|7388015|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0
4557050|NCT01256411|7388016|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0
4557051|NCT01256411|7388017|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0
4557052|NCT01256411|7388012|FG000|Extension by Maximum Treatment|Lack of Efficacy|1
4557053|NCT01256411|7388013|FG001|Extension by Maximum Treatment|Lack of Efficacy|0
4557054|NCT01256411|7388014|FG002|Extension by Maximum Treatment|Lack of Efficacy|1
4557055|NCT01256411|7388015|FG003|Extension by Maximum Treatment|Lack of Efficacy|0
4557056|NCT01256411|7388016|FG004|Extension by Maximum Treatment|Lack of Efficacy|0
4557057|NCT01256411|7388017|FG005|Extension by Maximum Treatment|Lack of Efficacy|0
4557058|NCT01256411|7388012|FG000|Extension by Maximum Treatment|Adverse Event|4
4557059|NCT01256411|7388013|FG001|Extension by Maximum Treatment|Adverse Event|2
4557060|NCT01256411|7388014|FG002|Extension by Maximum Treatment|Adverse Event|1
4557061|NCT01256411|7388015|FG003|Extension by Maximum Treatment|Adverse Event|0
4557062|NCT01256411|7388016|FG004|Extension by Maximum Treatment|Adverse Event|0
4557063|NCT01256411|7388017|FG005|Extension by Maximum Treatment|Adverse Event|0
4557064|NCT01256411|7388012|FG000|Extension by Mono or Combination Therapy|Adverse Event|0
4557065|NCT01256411|7388013|FG001|Extension by Mono or Combination Therapy|Adverse Event|0
4557066|NCT01256411|7388014|FG002|Extension by Mono or Combination Therapy|Adverse Event|0
4557067|NCT01256411|7388015|FG003|Extension by Mono or Combination Therapy|Adverse Event|0
4557068|NCT01256411|7388016|FG004|Extension by Mono or Combination Therapy|Adverse Event|6
4557069|NCT01256411|7388017|FG005|Extension by Mono or Combination Therapy|Adverse Event|1
4557070|NCT01256411|7388012|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0
4557071|NCT01256411|7388013|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0
4557072|NCT01256411|7388014|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0
4557073|NCT01256411|7388015|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0
4557074|NCT01256411|7388016|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0
4557075|NCT01256411|7388017|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1
4557076|NCT01256411|7388012|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0
4557077|NCT01256411|7388013|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0
4557078|NCT01256411|7388014|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0
4557079|NCT01256411|7388015|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0
4557080|NCT01256411|7388016|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3
4557081|NCT01256411|7388017|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0
4557082|NCT01256411|7388012|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
4557083|NCT01256411|7388013|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
4557084|NCT01256411|7388014|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
4557085|NCT01256411|7388015|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
4557086|NCT01256411|7388016|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7
4557087|NCT01256411|7388017|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1
4557088|NCT01256411|7388012|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0
4557089|NCT01256411|7388013|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0
4557090|NCT01256411|7388014|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0
4557091|NCT01256411|7388015|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0
4557092|NCT01256411|7388016|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1
4557093|NCT01256411|7388017|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1
4557094|NCT01256450|7388051|FG000|Open-label Titration|Adverse Event|39
4557095|NCT01256450|7388052|FG001|Open-label Titration|Adverse Event|0
4557096|NCT01256450|7388053|FG002|Open-label Titration|Adverse Event|0
4557097|NCT01256450|7388051|FG000|Open-label Titration|Lost to Follow-up|7
4557098|NCT01256450|7388052|FG001|Open-label Titration|Lost to Follow-up|0
4557099|NCT01256450|7388053|FG002|Open-label Titration|Lost to Follow-up|0
4557100|NCT01256450|7388051|FG000|Open-label Titration|Lack of analgesic effect|30
4557101|NCT01256450|7388052|FG001|Open-label Titration|Lack of analgesic effect|0
4557102|NCT01256450|7388053|FG002|Open-label Titration|Lack of analgesic effect|0
4557103|NCT01256450|7388051|FG000|Open-label Titration|Non-compliance|9
4557104|NCT01256450|7388052|FG001|Open-label Titration|Non-compliance|0
4557105|NCT01256450|7388053|FG002|Open-label Titration|Non-compliance|0
4557106|NCT01256450|7388051|FG000|Open-label Titration|Screen failure|1
4557107|NCT01256450|7388052|FG001|Open-label Titration|Screen failure|0
4557108|NCT01256450|7388053|FG002|Open-label Titration|Screen failure|0
4557109|NCT01256450|7388051|FG000|Open-label Titration|Other|13
4557110|NCT01256450|7388052|FG001|Open-label Titration|Other|0
4557111|NCT01256450|7388053|FG002|Open-label Titration|Other|0
4557112|NCT01256450|7388051|FG000|Double-blind Treatment|Adverse Event|0
4557113|NCT01256450|7388052|FG001|Double-blind Treatment|Adverse Event|8
4557114|NCT01256450|7388053|FG002|Double-blind Treatment|Adverse Event|6
4557115|NCT01256450|7388051|FG000|Double-blind Treatment|Lost to Follow-up|0
4557116|NCT01256450|7388052|FG001|Double-blind Treatment|Lost to Follow-up|1
4557117|NCT01256450|7388053|FG002|Double-blind Treatment|Lost to Follow-up|7
4557118|NCT01256450|7388051|FG000|Double-blind Treatment|Withdrawal by Subject|0
4557119|NCT01256450|7388052|FG001|Double-blind Treatment|Withdrawal by Subject|0
4557120|NCT01256450|7388053|FG002|Double-blind Treatment|Withdrawal by Subject|1
4557121|NCT01256450|7388051|FG000|Double-blind Treatment|Lack of analgesic effect|0
4557122|NCT01256450|7388052|FG001|Double-blind Treatment|Lack of analgesic effect|5
4557123|NCT01256450|7388053|FG002|Double-blind Treatment|Lack of analgesic effect|6
4557124|NCT01256450|7388051|FG000|Double-blind Treatment|Non-compliance|0
4557125|NCT01256450|7388052|FG001|Double-blind Treatment|Non-compliance|5
4557126|NCT01256450|7388053|FG002|Double-blind Treatment|Non-compliance|4
4557127|NCT01256450|7388051|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0
4557128|NCT01256450|7388052|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0
4557129|NCT01256450|7388053|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1
4557130|NCT01256450|7388051|FG000|Double-blind Treatment|Other|0
4557131|NCT01256450|7388052|FG001|Double-blind Treatment|Other|9
4557132|NCT01256450|7388053|FG002|Double-blind Treatment|Other|12
4557133|NCT01256476|7388062|FG000|Overall Study|Adverse Event|2
4557134|NCT01256476|7388063|FG001|Overall Study|Adverse Event|1
4622288|NCT01799889|7485205|FG004|Overall Study|Study Terminated By Sponsor|2
4622289|NCT01799889|7485206|FG005|Overall Study|Study Terminated By Sponsor|1
4622290|NCT01799889|7485207|FG006|Overall Study|Study Terminated By Sponsor|0
4622291|NCT01799889|7485208|FG007|Overall Study|Study Terminated By Sponsor|2
4622292|NCT01799889|7485209|FG008|Overall Study|Study Terminated By Sponsor|1
4622293|NCT01799889|7485210|FG009|Overall Study|Study Terminated By Sponsor|1
4622294|NCT01799889|7485211|FG010|Overall Study|Study Terminated By Sponsor|0
4622295|NCT01799889|7485212|FG011|Overall Study|Study Terminated By Sponsor|0
4622296|NCT01799889|7485201|FG000|Overall Study|Withdrawal by Subject|1
4622297|NCT01799889|7485202|FG001|Overall Study|Withdrawal by Subject|6
4622298|NCT01799889|7485203|FG002|Overall Study|Withdrawal by Subject|4
4622299|NCT01799889|7485204|FG003|Overall Study|Withdrawal by Subject|0
4622300|NCT01799889|7485205|FG004|Overall Study|Withdrawal by Subject|5
4622301|NCT01799889|7485206|FG005|Overall Study|Withdrawal by Subject|1
4622302|NCT01799889|7485207|FG006|Overall Study|Withdrawal by Subject|3
4622303|NCT01799889|7485208|FG007|Overall Study|Withdrawal by Subject|1
4622304|NCT01799889|7485209|FG008|Overall Study|Withdrawal by Subject|2
4622305|NCT01799889|7485210|FG009|Overall Study|Withdrawal by Subject|1
4622306|NCT01799889|7485211|FG010|Overall Study|Withdrawal by Subject|1
4622307|NCT01799889|7485212|FG011|Overall Study|Withdrawal by Subject|1
4622308|NCT01799889|7485201|FG000|Overall Study|Non-Compliance With Study Drug|0
4622309|NCT01799889|7485202|FG001|Overall Study|Non-Compliance With Study Drug|0
4622310|NCT01799889|7485203|FG002|Overall Study|Non-Compliance With Study Drug|0
4622311|NCT01799889|7485204|FG003|Overall Study|Non-Compliance With Study Drug|0
4622312|NCT01799889|7485205|FG004|Overall Study|Non-Compliance With Study Drug|0
4557135|NCT01256476|7388062|FG000|Overall Study|Withdrawal by Subject|2
4557136|NCT01256476|7388063|FG001|Overall Study|Withdrawal by Subject|1
4622313|NCT01799889|7485206|FG005|Overall Study|Non-Compliance With Study Drug|1
4622314|NCT01799889|7485207|FG006|Overall Study|Non-Compliance With Study Drug|0
4622315|NCT01799889|7485208|FG007|Overall Study|Non-Compliance With Study Drug|0
4622316|NCT01799889|7485209|FG008|Overall Study|Non-Compliance With Study Drug|0
4557137|NCT01256476|7388062|FG000|Overall Study|Lost to Follow-up|1
4557138|NCT01256476|7388063|FG001|Overall Study|Lost to Follow-up|2
4557139|NCT01256476|7388062|FG000|Overall Study|Persistent ALT or AST elevation|1
4557140|NCT01256476|7388063|FG001|Overall Study|Persistent ALT or AST elevation|0
4557141|NCT01256476|7388062|FG000|Overall Study|Physician Decision|0
4557142|NCT01256476|7388063|FG001|Overall Study|Physician Decision|1
4557143|NCT01256476|7388062|FG000|Overall Study|Subject non-compliance|0
4557144|NCT01256476|7388063|FG001|Overall Study|Subject non-compliance|1
4557145|NCT01256476|7388062|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0
4557146|NCT01256476|7388063|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1
4557147|NCT01256502|7388069|FG000|Overall Study|Had scaffold removed|4
4557148|NCT01256502|7388069|FG000|Overall Study|Personal reasons|5
4557149|NCT01256502|7388069|FG000|Overall Study|Protocol deviation|1
4557150|NCT01256567|7388078|FG000|Overall Study|Withdrawal by Subject|1
4557151|NCT01256593|7388083|FG000|Overall Study|Protocol Violation|26
4557152|NCT01256593|7388083|FG000|Overall Study|No Drug Administration Information|2
4557153|NCT01256593|7388083|FG000|Overall Study|No Visit After Treatment|186
4557154|NCT01256658|7388089|FG000|Period 1|Lost to Follow-up|837
4557155|NCT01256658|7388090|FG001|Period 1|Lost to Follow-up|661
4557156|NCT01256658|7388089|FG000|Period 1|Withdrawal by Subject|35
4557157|NCT01256658|7388090|FG001|Period 1|Withdrawal by Subject|43
4557158|NCT01256658|7388089|FG000|Period 1|Death|48
4557159|NCT01256658|7388090|FG001|Period 1|Death|44
4557160|NCT01256671|7388099|FG000|Overall Study|Adverse Event|29
4557161|NCT01256671|7388099|FG000|Overall Study|Lost to Follow-up|16
4557162|NCT01256671|7388099|FG000|Overall Study|Withdrawal by Subject|31
4557163|NCT01256671|7388099|FG000|Overall Study|Physician Decision|3
4557164|NCT01256671|7388099|FG000|Overall Study|Lack of Efficacy|4
4557165|NCT01256671|7388099|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12
4557166|NCT01256684|7388106|FG000|Overall Study|Adverse Event|1
4557167|NCT01256684|7388107|FG001|Overall Study|Adverse Event|4
4557168|NCT01256684|7388108|FG002|Overall Study|Adverse Event|2
4557169|NCT01256684|7388106|FG000|Overall Study|Withdrawal by Subject|4
4557170|NCT01256684|7388107|FG001|Overall Study|Withdrawal by Subject|0
4557171|NCT01256684|7388108|FG002|Overall Study|Withdrawal by Subject|2
4557172|NCT01256684|7388106|FG000|Overall Study|Physician Decision|0
4557173|NCT01256684|7388107|FG001|Overall Study|Physician Decision|1
4557174|NCT01256684|7388108|FG002|Overall Study|Physician Decision|0
4557175|NCT01256684|7388106|FG000|Overall Study|Lack of Efficacy|0
4557176|NCT01256684|7388107|FG001|Overall Study|Lack of Efficacy|1
4557177|NCT01256684|7388108|FG002|Overall Study|Lack of Efficacy|1
4557178|NCT01256684|7388106|FG000|Overall Study|Entry criteria not met/non-compliance|4
4557179|NCT01256684|7388107|FG001|Overall Study|Entry criteria not met/non-compliance|7
4557180|NCT01256684|7388108|FG002|Overall Study|Entry criteria not met/non-compliance|6
4557181|NCT01256788|7388119|FG000|Overall Study|Lost to Follow-up|5
4557182|NCT01256788|7388120|FG001|Overall Study|Lost to Follow-up|8
4557183|NCT01256788|7388121|FG002|Overall Study|Lost to Follow-up|3
4557184|NCT01256879|7388142|FG000|Overall Study|Withdrawal by Subject|1
4557185|NCT01257204|7388197|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0
4557186|NCT01257204|7388198|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1
4557187|NCT01257204|7388199|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3
4557188|NCT01257204|7388197|FG000|Treatment Period (up to Week 24)|Adverse Event|3
4557189|NCT01257204|7388198|FG001|Treatment Period (up to Week 24)|Adverse Event|1
4557190|NCT01257204|7388199|FG002|Treatment Period (up to Week 24)|Adverse Event|2
4557191|NCT01257204|7388197|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1
4557192|NCT01257204|7388198|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0
4557193|NCT01257204|7388199|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1
4557194|NCT01257204|7388197|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0
4557195|NCT01257204|7388198|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2
4557196|NCT01257204|7388199|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0
4557197|NCT01257204|7388197|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0
4557198|NCT01257204|7388198|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0
4557199|NCT01257204|7388199|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1
4557200|NCT01257204|7388197|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1
4557201|NCT01257204|7388198|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2
4557202|NCT01257204|7388199|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2
4557203|NCT01257204|7388197|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0
4557204|NCT01257204|7388198|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2
4557205|NCT01257204|7388199|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1
4557206|NCT01257204|7388197|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1
4557207|NCT01257204|7388198|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4
4557208|NCT01257204|7388199|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4
4557209|NCT01257204|7388197|FG000|Follow-up Period (up to Week 48)|Other|0
4557210|NCT01257204|7388198|FG001|Follow-up Period (up to Week 48)|Other|0
4557211|NCT01257204|7388199|FG002|Follow-up Period (up to Week 48)|Other|5
4557212|NCT01257230|7388235|FG000|Overall Study|Not Treated|0
4557213|NCT01257230|7388236|FG001|Overall Study|Not Treated|0
4557214|NCT01257230|7388237|FG002|Overall Study|Not Treated|1
4557215|NCT01257230|7388235|FG000|Overall Study|Adverse Event|2
4557216|NCT01257230|7388236|FG001|Overall Study|Adverse Event|0
4557217|NCT01257230|7388237|FG002|Overall Study|Adverse Event|0
4557218|NCT01257230|7388235|FG000|Overall Study|Lack of Efficacy|0
4557219|NCT01257230|7388236|FG001|Overall Study|Lack of Efficacy|1
4557220|NCT01257230|7388237|FG002|Overall Study|Lack of Efficacy|0
4557221|NCT01257230|7388235|FG000|Overall Study|Protocol Violation|3
4557222|NCT01257230|7388236|FG001|Overall Study|Protocol Violation|0
4557223|NCT01257230|7388237|FG002|Overall Study|Protocol Violation|1
4557224|NCT01257230|7388235|FG000|Overall Study|Withdrawal by Subject|0
4557225|NCT01257230|7388236|FG001|Overall Study|Withdrawal by Subject|4
4557226|NCT01257230|7388237|FG002|Overall Study|Withdrawal by Subject|1
4557227|NCT01257230|7388235|FG000|Overall Study|Other reason not defined above|1
4557228|NCT01257230|7388236|FG001|Overall Study|Other reason not defined above|5
4557229|NCT01257230|7388237|FG002|Overall Study|Other reason not defined above|3
4557230|NCT01257425|7388268|FG000|Overall Study|Lack of Efficacy|3
4557231|NCT01257425|7388269|FG001|Overall Study|Lack of Efficacy|3
4557232|NCT01257425|7388268|FG000|Overall Study|Adverse Event|1
4557233|NCT01257425|7388269|FG001|Overall Study|Adverse Event|1
4557234|NCT01257425|7388268|FG000|Overall Study|Protocol Violation|1
4557235|NCT01257425|7388269|FG001|Overall Study|Protocol Violation|1
4557236|NCT01257425|7388268|FG000|Overall Study|Withdrawal by Subject|0
4557237|NCT01257425|7388269|FG001|Overall Study|Withdrawal by Subject|1
4557238|NCT01257425|7388268|FG000|Overall Study|Death|1
4557239|NCT01257425|7388269|FG001|Overall Study|Death|0
4557240|NCT01257503|7388286|FG000|Overall Study|Lost to Follow-up|7
4557241|NCT01257503|7388287|FG001|Overall Study|Lost to Follow-up|10
4557242|NCT01257503|7388286|FG000|Overall Study|Over 5 years old at enrollment|0
4557243|NCT01257503|7388287|FG001|Overall Study|Over 5 years old at enrollment|1
4557244|NCT01257503|7388286|FG000|Overall Study|strep culture positive at enrollment|1
4557245|NCT01257503|7388287|FG001|Overall Study|strep culture positive at enrollment|0
4557246|NCT01257542|7388295|FG000|Overall Study|Protocol Violation|3
4557247|NCT01257542|7388296|FG001|Overall Study|Protocol Violation|5
4557248|NCT01257542|7388295|FG000|Overall Study|Withdrawal by Subject|0
4557249|NCT01257542|7388296|FG001|Overall Study|Withdrawal by Subject|2
4557250|NCT01257581|7388305|FG000|Overall Study|Early Termination|3
4557251|NCT01257581|7388306|FG001|Overall Study|Early Termination|1
4557252|NCT01257581|7388307|FG002|Overall Study|Early Termination|2
4557253|NCT01257581|7388305|FG000|Overall Study|Death|2
4557254|NCT01257581|7388306|FG001|Overall Study|Death|2
4557255|NCT01257581|7388307|FG002|Overall Study|Death|4
4557256|NCT01257698|7388317|FG000|Overall Study|Protocol Violation|4
4557257|NCT01257698|7388318|FG001|Overall Study|Protocol Violation|0
4557258|NCT01257737|7388326|FG000|Overall Study|Lost to Follow-up|1
4557259|NCT01257737|7388327|FG001|Overall Study|Lost to Follow-up|2
4557260|NCT01257737|7388326|FG000|Overall Study|Liver transplant|1
4557261|NCT01257737|7388327|FG001|Overall Study|Liver transplant|0
4557262|NCT01257737|7388326|FG000|Overall Study|Relocation out of the country|0
4557263|NCT01257737|7388327|FG001|Overall Study|Relocation out of the country|1
4557264|NCT01257737|7388326|FG000|Overall Study|Withdrew from study|0
4557265|NCT01257737|7388327|FG001|Overall Study|Withdrew from study|1
4557266|NCT01258075|7388369|FG000|Overall Study|Adverse Event|8
4557267|NCT01258075|7388370|FG001|Overall Study|Adverse Event|3
4557268|NCT01258075|7388369|FG000|Overall Study|Lost to Follow-up|11
4557269|NCT01258075|7388370|FG001|Overall Study|Lost to Follow-up|6
4622317|NCT01799889|7485210|FG009|Overall Study|Non-Compliance With Study Drug|0
4622318|NCT01799889|7485211|FG010|Overall Study|Non-Compliance With Study Drug|0
4622319|NCT01799889|7485212|FG011|Overall Study|Non-Compliance With Study Drug|0
4622320|NCT01799941|7485249|FG000|Overall Study|Adverse Event|34
4622321|NCT01799941|7485249|FG000|Overall Study|Withdrawal by Subject|21
4622322|NCT01799941|7485249|FG000|Overall Study|Death|2
4622323|NCT01799941|7485249|FG000|Overall Study|Investigator Decision|4
4622324|NCT01799941|7485249|FG000|Overall Study|Lack of Efficacy|3
4622325|NCT01799941|7485249|FG000|Overall Study|Lost to Follow-up|17
4622326|NCT01799941|7485249|FG000|Overall Study|Other|15
4622327|NCT01799993|7485261|FG000|Overall Study|"Didn't complete CRF page End of FU"|30
4622328|NCT01799993|7485262|FG001|Overall Study|"Didn't complete CRF page End of FU"|40
4622329|NCT01799993|7485261|FG000|Overall Study|Death|61
4622330|NCT01799993|7485262|FG001|Overall Study|Death|45
4622331|NCT01799993|7485261|FG000|Overall Study|Withdrawal by Subject|23
4622332|NCT01799993|7485262|FG001|Overall Study|Withdrawal by Subject|24
4622333|NCT01799993|7485261|FG000|Overall Study|Lost to Follow-up|5
4622334|NCT01799993|7485262|FG001|Overall Study|Lost to Follow-up|8
4622335|NCT01799993|7485261|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5
4622336|NCT01799993|7485262|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3
4622337|NCT01799993|7485261|FG000|Overall Study|Protocol driven decision point|0
4622338|NCT01799993|7485262|FG001|Overall Study|Protocol driven decision point|3
4622339|NCT01799993|7485261|FG000|Overall Study|Protocol Violation|1
4770413|NCT03740919|7746733|FG003|Treatment Period|Issue with Insulin Pump|0
4557270|NCT01258075|7388369|FG000|Overall Study|Withdrawal by Subject|10
4557271|NCT01258075|7388370|FG001|Overall Study|Withdrawal by Subject|7
4622340|NCT01799993|7485262|FG001|Overall Study|Protocol Violation|1
4622341|NCT01799993|7485261|FG000|Overall Study|Deterioration of general conditions|2
4622342|NCT01799993|7485262|FG001|Overall Study|Deterioration of general conditions|0
4622343|NCT01799993|7485261|FG000|Overall Study|Screen failure|0
4622344|NCT01799993|7485262|FG001|Overall Study|Screen failure|1
4622345|NCT01799993|7485261|FG000|Overall Study|Adverse Event|1
4622346|NCT01799993|7485262|FG001|Overall Study|Adverse Event|0
4622347|NCT01799993|7485261|FG000|Overall Study|Lack of Efficacy|1
4622348|NCT01799993|7485262|FG001|Overall Study|Lack of Efficacy|0
4622349|NCT01799993|7485261|FG000|Overall Study|Recovery|0
4622350|NCT01799993|7485262|FG001|Overall Study|Recovery|1
4557272|NCT01258075|7388369|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1
4557273|NCT01258075|7388370|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2
4557274|NCT01258075|7388369|FG000|Overall Study|Other|12
4557275|NCT01258075|7388370|FG001|Overall Study|Other|5
4557276|NCT01258101|7388380|FG000|Overall Study|Adverse Event|5
4557277|NCT01258101|7388381|FG001|Overall Study|Adverse Event|6
4557278|NCT01258101|7388382|FG002|Overall Study|Adverse Event|0
4557279|NCT01258101|7388383|FG003|Overall Study|Adverse Event|0
4557280|NCT01258101|7388380|FG000|Overall Study|Extra exclusion criterion amended|2
4557281|NCT01258101|7388381|FG001|Overall Study|Extra exclusion criterion amended|1
4557282|NCT01258101|7388382|FG002|Overall Study|Extra exclusion criterion amended|1
4557283|NCT01258101|7388383|FG003|Overall Study|Extra exclusion criterion amended|1
4557284|NCT01258101|7388380|FG000|Overall Study|Informed consent has been withdrawn|2
4557285|NCT01258101|7388381|FG001|Overall Study|Informed consent has been withdrawn|2
4557286|NCT01258101|7388382|FG002|Overall Study|Informed consent has been withdrawn|1
4557287|NCT01258101|7388383|FG003|Overall Study|Informed consent has been withdrawn|1
4557288|NCT01258101|7388380|FG000|Overall Study|Patient is not able to attend visits|8
4557289|NCT01258101|7388381|FG001|Overall Study|Patient is not able to attend visits|9
4557290|NCT01258101|7388382|FG002|Overall Study|Patient is not able to attend visits|7
4557291|NCT01258101|7388383|FG003|Overall Study|Patient is not able to attend visits|6
4557292|NCT01258101|7388380|FG000|Overall Study|Patient´s compliance|4
4557293|NCT01258101|7388381|FG001|Overall Study|Patient´s compliance|3
4557294|NCT01258101|7388382|FG002|Overall Study|Patient´s compliance|1
4557295|NCT01258101|7388383|FG003|Overall Study|Patient´s compliance|2
4557296|NCT01258101|7388380|FG000|Overall Study|Lost to Follow-up|5
4557297|NCT01258101|7388381|FG001|Overall Study|Lost to Follow-up|5
4557298|NCT01258101|7388382|FG002|Overall Study|Lost to Follow-up|0
4557299|NCT01258101|7388383|FG003|Overall Study|Lost to Follow-up|6
4557300|NCT01258101|7388380|FG000|Overall Study|PCR positive at week 24|0
4557301|NCT01258101|7388381|FG001|Overall Study|PCR positive at week 24|0
4557302|NCT01258101|7388382|FG002|Overall Study|PCR positive at week 24|0
4557303|NCT01258101|7388383|FG003|Overall Study|PCR positive at week 24|1
4557304|NCT01258101|7388380|FG000|Overall Study|Other reason|7
4557305|NCT01258101|7388381|FG001|Overall Study|Other reason|8
4557306|NCT01258101|7388382|FG002|Overall Study|Other reason|1
4557307|NCT01258101|7388383|FG003|Overall Study|Other reason|8
4557308|NCT01258348|7388408|FG000|Overall Study|Adverse Event|1
4557309|NCT01258348|7388409|FG001|Overall Study|Adverse Event|1
4557310|NCT01258348|7388410|FG002|Overall Study|Adverse Event|3
4557311|NCT01258348|7388411|FG003|Overall Study|Adverse Event|2
4557312|NCT01258348|7388412|FG004|Overall Study|Adverse Event|4
4557313|NCT01258348|7388408|FG000|Overall Study|Progressive Disease|0
4622351|NCT01799993|7485261|FG000|Overall Study|Logistical difficulties|1
4622352|NCT01799993|7485262|FG001|Overall Study|Logistical difficulties|0
4622353|NCT01799993|7485261|FG000|Overall Study|Protocol deviation|1
4622354|NCT01799993|7485262|FG001|Overall Study|Protocol deviation|0
4622355|NCT01799993|7485261|FG000|Overall Study|Non-compliance with medical device|1
4622356|NCT01799993|7485262|FG001|Overall Study|Non-compliance with medical device|0
4622357|NCT01799993|7485261|FG000|Overall Study|Withdrawal by parent/guardian|0
4622358|NCT01799993|7485262|FG001|Overall Study|Withdrawal by parent/guardian|1
4622359|NCT01799993|7485261|FG000|Overall Study|Other|1
4622360|NCT01799993|7485262|FG001|Overall Study|Other|0
4622361|NCT01799993|7485261|FG000|Overall Study|Subject didn't return for follow-up|0
4622362|NCT01799993|7485262|FG001|Overall Study|Subject didn't return for follow-up|1
4622363|NCT01800058|7485268|FG000|Overall Study|Lost to Follow-up|1
4622364|NCT01800201|7485275|FG000|Overall Study|Withdrawal by Subject|2
4622365|NCT01800201|7485276|FG001|Overall Study|Withdrawal by Subject|0
4622366|NCT01800201|7485275|FG000|Overall Study|patient privacy concerns|1
4557314|NCT01258348|7388409|FG001|Overall Study|Progressive Disease|3
4557315|NCT01258348|7388410|FG002|Overall Study|Progressive Disease|0
4557316|NCT01258348|7388411|FG003|Overall Study|Progressive Disease|2
4557317|NCT01258348|7388412|FG004|Overall Study|Progressive Disease|2
4557318|NCT01258348|7388408|FG000|Overall Study|Physician Decision|0
4557319|NCT01258348|7388409|FG001|Overall Study|Physician Decision|0
4557320|NCT01258348|7388410|FG002|Overall Study|Physician Decision|0
4557321|NCT01258348|7388411|FG003|Overall Study|Physician Decision|2
4557322|NCT01258348|7388412|FG004|Overall Study|Physician Decision|0
4557323|NCT01258348|7388408|FG000|Overall Study|Withdrawal by Subject|0
4557324|NCT01258348|7388409|FG001|Overall Study|Withdrawal by Subject|1
4557325|NCT01258348|7388410|FG002|Overall Study|Withdrawal by Subject|0
4557326|NCT01258348|7388411|FG003|Overall Study|Withdrawal by Subject|0
4622367|NCT01800201|7485276|FG001|Overall Study|patient privacy concerns|1
4622368|NCT01800201|7485275|FG000|Overall Study|did not want to use device|0
4622369|NCT01800201|7485276|FG001|Overall Study|did not want to use device|1
4622370|NCT01800201|7485275|FG000|Overall Study|PI withdrawal, cognitive concerns|0
4557327|NCT01258348|7388412|FG004|Overall Study|Withdrawal by Subject|0
4557328|NCT01258595|7388483|FG000|Overall Study|Lost to Follow-up|1
4557329|NCT01258595|7388484|FG001|Overall Study|Lost to Follow-up|0
4557330|NCT01258595|7388483|FG000|Overall Study|Withdrawal by Subject|0
4557331|NCT01258595|7388484|FG001|Overall Study|Withdrawal by Subject|1
4557332|NCT01258608|7388492|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1
4557333|NCT01258608|7388493|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0
4557334|NCT01258608|7388492|FG000|Overall Study|Clinical progression|1
4557335|NCT01258608|7388493|FG001|Overall Study|Clinical progression|0
4557336|NCT01258608|7388492|FG000|Overall Study|Sponsor decision|0
4557337|NCT01258608|7388493|FG001|Overall Study|Sponsor decision|1
4557338|NCT01258608|7388492|FG000|Overall Study|Physician Decision|6
4557339|NCT01258608|7388493|FG001|Overall Study|Physician Decision|1
4557340|NCT01258608|7388492|FG000|Overall Study|Lost to Follow-up|0
4557341|NCT01258608|7388493|FG001|Overall Study|Lost to Follow-up|1
4557342|NCT01258608|7388492|FG000|Overall Study|Lack of compliance|1
4557343|NCT01258608|7388493|FG001|Overall Study|Lack of compliance|0
4557344|NCT01258608|7388492|FG000|Overall Study|Lack of Efficacy|0
4557345|NCT01258608|7388493|FG001|Overall Study|Lack of Efficacy|1
4557346|NCT01258608|7388492|FG000|Overall Study|Adverse Event|6
4557347|NCT01258608|7388493|FG001|Overall Study|Adverse Event|10
4557348|NCT01258608|7388492|FG000|Overall Study|Withdrawal by Subject|6
4557349|NCT01258608|7388493|FG001|Overall Study|Withdrawal by Subject|5
4557350|NCT01258660|7388502|FG000|Overall Study|Adverse Event|2
4557351|NCT01258660|7388503|FG001|Overall Study|Adverse Event|4
4557352|NCT01258660|7388502|FG000|Overall Study|Withdrawal by Subject|3
4557353|NCT01258660|7388503|FG001|Overall Study|Withdrawal by Subject|0
4557354|NCT01258660|7388502|FG000|Overall Study|due to relocation|2
4557355|NCT01258660|7388503|FG001|Overall Study|due to relocation|0
4557356|NCT01258660|7388502|FG000|Overall Study|Protocol Violation|0
4557357|NCT01258660|7388503|FG001|Overall Study|Protocol Violation|1
4557358|NCT01258660|7388502|FG000|Overall Study|Invalid for primary analysis data set|4
4557359|NCT01258660|7388503|FG001|Overall Study|Invalid for primary analysis data set|6
4557360|NCT01258738|7388512|FG000|Double-blind Period|Did not meet inclusion criteria|3
4557361|NCT01258738|7388513|FG001|Double-blind Period|Did not meet inclusion criteria|3
4557362|NCT01258738|7388512|FG000|Double-blind Period|Withdrawal by Subject|2
4557363|NCT01258738|7388513|FG001|Double-blind Period|Withdrawal by Subject|2
4557364|NCT01258738|7388512|FG000|Double-blind Period|Protocol Violation|1
4557365|NCT01258738|7388513|FG001|Double-blind Period|Protocol Violation|1
4557366|NCT01258738|7388512|FG000|Double-blind Period|Adverse Event|3
4557367|NCT01258738|7388513|FG001|Double-blind Period|Adverse Event|1
4557368|NCT01258738|7388512|FG000|Open-label Period|Did not meet inclusion criteria|0
4557369|NCT01258738|7388513|FG001|Open-label Period|Did not meet inclusion criteria|1
4622371|NCT01800201|7485276|FG001|Overall Study|PI withdrawal, cognitive concerns|1
4622372|NCT01800903|7485351|FG000|Second Test Period|unable to catheterise|1
4622373|NCT01800903|7485352|FG001|Second Test Period|unable to catheterise|0
4622374|NCT01800903|7485353|FG002|Second Test Period|unable to catheterise|0
4622375|NCT01800903|7485354|FG003|Second Test Period|unable to catheterise|0
4622376|NCT01800903|7485355|FG004|Second Test Period|unable to catheterise|0
4622377|NCT01800903|7485356|FG005|Second Test Period|unable to catheterise|0
4622378|NCT01800916|7485362|FG000|Test Period 1 (1 Week)|Convex product user|0
4622379|NCT01800916|7485363|FG001|Test Period 1 (1 Week)|Convex product user|0
4622380|NCT01800916|7485364|FG002|Test Period 1 (1 Week)|Convex product user|0
4622381|NCT01800916|7485365|FG003|Test Period 1 (1 Week)|Convex product user|1
4622382|NCT01800916|7485366|FG004|Test Period 1 (1 Week)|Convex product user|0
4622383|NCT01800916|7485367|FG005|Test Period 1 (1 Week)|Convex product user|0
4622384|NCT01800916|7485368|FG006|Test Period 1 (1 Week)|Convex product user|0
4622385|NCT01800916|7485369|FG007|Test Period 1 (1 Week)|Convex product user|0
4622386|NCT01800916|7485370|FG008|Test Period 1 (1 Week)|Convex product user|0
4622387|NCT01800916|7485362|FG000|Test Period 1 (1 Week)|Adverse Event|0
4622388|NCT01800916|7485363|FG001|Test Period 1 (1 Week)|Adverse Event|0
4622389|NCT01800916|7485364|FG002|Test Period 1 (1 Week)|Adverse Event|0
4622390|NCT01800916|7485365|FG003|Test Period 1 (1 Week)|Adverse Event|0
4622391|NCT01800916|7485366|FG004|Test Period 1 (1 Week)|Adverse Event|1
4622392|NCT01800916|7485367|FG005|Test Period 1 (1 Week)|Adverse Event|0
4622393|NCT01800916|7485368|FG006|Test Period 1 (1 Week)|Adverse Event|0
4622394|NCT01800916|7485369|FG007|Test Period 1 (1 Week)|Adverse Event|0
4622395|NCT01800916|7485370|FG008|Test Period 1 (1 Week)|Adverse Event|0
4622396|NCT01800968|7485382|FG000|Overall Study|Death|23
4622397|NCT01800968|7485383|FG001|Overall Study|Death|16
4622398|NCT01800968|7485382|FG000|Overall Study|Lost to Follow-up|5
4622399|NCT01800968|7485383|FG001|Overall Study|Lost to Follow-up|7
4622400|NCT01800968|7485382|FG000|Overall Study|Withdrawal by Subject|7
4557370|NCT01258738|7388512|FG000|Open-label Period|Insufficient clinical response|5
4557371|NCT01258738|7388513|FG001|Open-label Period|Insufficient clinical response|3
4557372|NCT01258738|7388512|FG000|Open-label Period|Lost to Follow-up|0
4557373|NCT01258738|7388513|FG001|Open-label Period|Lost to Follow-up|2
4557374|NCT01258738|7388512|FG000|Open-label Period|Withdrawal by Subject|5
4622401|NCT01800968|7485383|FG001|Overall Study|Withdrawal by Subject|9
4622402|NCT01800968|7485382|FG000|Overall Study|Physician Decision|1
4622403|NCT01800968|7485383|FG001|Overall Study|Physician Decision|0
4557375|NCT01258738|7388513|FG001|Open-label Period|Withdrawal by Subject|6
4557376|NCT01258738|7388512|FG000|Open-label Period|Protocol Violation|2
4557377|NCT01258738|7388513|FG001|Open-label Period|Protocol Violation|2
4557378|NCT01258738|7388512|FG000|Open-label Period|Adverse Event|4
4557379|NCT01258738|7388513|FG001|Open-label Period|Adverse Event|5
4557380|NCT01258738|7388512|FG000|Open-label Period|Other Reasons|0
4557381|NCT01258738|7388513|FG001|Open-label Period|Other Reasons|1
4557382|NCT01258738|7388512|FG000|Open-label Period|Withdrawn due to pregnancy|1
4557383|NCT01258738|7388513|FG001|Open-label Period|Withdrawn due to pregnancy|1
4557384|NCT01258998|7388546|FG000|Overall Study|Ineligible|1
4557385|NCT01259089|7388565|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0
4557386|NCT01259089|7388566|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0
4557387|NCT01259089|7388567|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0
4557388|NCT01259089|7388568|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0
4557389|NCT01259089|7388569|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0
4557390|NCT01259089|7388570|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1
4557391|NCT01259089|7388565|FG000|Reached First Response at 4 Weeks|Adverse Event|0
4557392|NCT01259089|7388566|FG001|Reached First Response at 4 Weeks|Adverse Event|0
4557393|NCT01259089|7388567|FG002|Reached First Response at 4 Weeks|Adverse Event|0
4557394|NCT01259089|7388568|FG003|Reached First Response at 4 Weeks|Adverse Event|0
4557395|NCT01259089|7388569|FG004|Reached First Response at 4 Weeks|Adverse Event|0
4557396|NCT01259089|7388570|FG005|Reached First Response at 4 Weeks|Adverse Event|1
4557397|NCT01259089|7388565|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
4557398|NCT01259089|7388566|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
4557399|NCT01259089|7388567|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
4557400|NCT01259089|7388568|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
4557401|NCT01259089|7388569|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
4557402|NCT01259089|7388570|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1
4557403|NCT01259089|7388565|FG000|Confirmed Response at 8 Weeks|Adverse Event|0
4557404|NCT01259089|7388566|FG001|Confirmed Response at 8 Weeks|Adverse Event|0
4557405|NCT01259089|7388567|FG002|Confirmed Response at 8 Weeks|Adverse Event|0
4557406|NCT01259089|7388568|FG003|Confirmed Response at 8 Weeks|Adverse Event|0
4557407|NCT01259089|7388569|FG004|Confirmed Response at 8 Weeks|Adverse Event|1
4557408|NCT01259089|7388570|FG005|Confirmed Response at 8 Weeks|Adverse Event|2
4557409|NCT01259089|7388565|FG000|Confirmed Response at 8 Weeks|Progressive disease|0
4557410|NCT01259089|7388566|FG001|Confirmed Response at 8 Weeks|Progressive disease|0
4557411|NCT01259089|7388567|FG002|Confirmed Response at 8 Weeks|Progressive disease|1
4557412|NCT01259089|7388568|FG003|Confirmed Response at 8 Weeks|Progressive disease|1
4557413|NCT01259089|7388569|FG004|Confirmed Response at 8 Weeks|Progressive disease|3
4557414|NCT01259089|7388570|FG005|Confirmed Response at 8 Weeks|Progressive disease|7
4557415|NCT01259089|7388565|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1
4557416|NCT01259089|7388566|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
4557417|NCT01259089|7388567|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
4557418|NCT01259089|7388568|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
4557419|NCT01259089|7388569|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
4557420|NCT01259089|7388570|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
4557421|NCT01259089|7388565|FG000|Continued Treatment After 8 Weeks|Adverse Event|0
4557422|NCT01259089|7388566|FG001|Continued Treatment After 8 Weeks|Adverse Event|0
4557423|NCT01259089|7388567|FG002|Continued Treatment After 8 Weeks|Adverse Event|0
4557424|NCT01259089|7388568|FG003|Continued Treatment After 8 Weeks|Adverse Event|0
4557425|NCT01259089|7388569|FG004|Continued Treatment After 8 Weeks|Adverse Event|2
4557426|NCT01259089|7388570|FG005|Continued Treatment After 8 Weeks|Adverse Event|1
4557427|NCT01259089|7388565|FG000|Continued Treatment After 8 Weeks|Progressive disease|1
4557428|NCT01259089|7388566|FG001|Continued Treatment After 8 Weeks|Progressive disease|1
4557429|NCT01259089|7388567|FG002|Continued Treatment After 8 Weeks|Progressive disease|1
4557430|NCT01259089|7388568|FG003|Continued Treatment After 8 Weeks|Progressive disease|1
4557431|NCT01259089|7388569|FG004|Continued Treatment After 8 Weeks|Progressive disease|0
4557432|NCT01259089|7388570|FG005|Continued Treatment After 8 Weeks|Progressive disease|0
4557433|NCT01259089|7388565|FG000|Survival Follow up for Two Years|Death|3
4557434|NCT01259089|7388566|FG001|Survival Follow up for Two Years|Death|2
4557435|NCT01259089|7388567|FG002|Survival Follow up for Two Years|Death|2
4557436|NCT01259089|7388568|FG003|Survival Follow up for Two Years|Death|3
4557437|NCT01259089|7388569|FG004|Survival Follow up for Two Years|Death|6
4557438|NCT01259089|7388570|FG005|Survival Follow up for Two Years|Death|13
4557439|NCT01259089|7388565|FG000|Survival Follow up for Two Years|Lost to Follow-up|0
4557440|NCT01259089|7388566|FG001|Survival Follow up for Two Years|Lost to Follow-up|0
4557441|NCT01259089|7388567|FG002|Survival Follow up for Two Years|Lost to Follow-up|0
4557442|NCT01259089|7388568|FG003|Survival Follow up for Two Years|Lost to Follow-up|0
4557443|NCT01259089|7388569|FG004|Survival Follow up for Two Years|Lost to Follow-up|0
4557444|NCT01259089|7388570|FG005|Survival Follow up for Two Years|Lost to Follow-up|2
4557445|NCT01259089|7388565|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0
4557446|NCT01259089|7388566|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0
4592048|NCT01536418|7439266|FG000|Overall Study|Physician Decision|1
4557447|NCT01259089|7388567|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0
4557448|NCT01259089|7388568|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0
4557449|NCT01259089|7388569|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0
4557450|NCT01259089|7388570|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4
4557451|NCT01259102|7388589|FG000|Overall Study|Adverse Event|1
4557452|NCT01259102|7388590|FG001|Overall Study|Adverse Event|0
4557453|NCT01259102|7388591|FG002|Overall Study|Adverse Event|1
4557454|NCT01259102|7388592|FG003|Overall Study|Adverse Event|1
4557455|NCT01259102|7388593|FG004|Overall Study|Adverse Event|0
4557456|NCT01259102|7388589|FG000|Overall Study|Other|0
4557457|NCT01259102|7388590|FG001|Overall Study|Other|0
4557458|NCT01259102|7388591|FG002|Overall Study|Other|1
4557459|NCT01259102|7388592|FG003|Overall Study|Other|1
4557460|NCT01259102|7388593|FG004|Overall Study|Other|1
4557461|NCT01259115|7388605|FG000|Period 1|Adverse Event|1
4557462|NCT01259115|7388606|FG001|Period 1|Adverse Event|0
4557463|NCT01259115|7388605|FG000|Period 1|Protocol Violation|2
4557464|NCT01259115|7388606|FG001|Period 1|Protocol Violation|0
4557465|NCT01259115|7388605|FG000|Period 1|Lost to Follow-up|0
4557466|NCT01259115|7388606|FG001|Period 1|Lost to Follow-up|1
4557467|NCT01259115|7388605|FG000|Period 2|Adverse Event|1
4557468|NCT01259115|7388606|FG001|Period 2|Adverse Event|0
4557469|NCT01259245|7388628|FG000|Overall Study|Withdrawal by Subject|27
4557470|NCT01259245|7388629|FG001|Overall Study|Withdrawal by Subject|24
4557471|NCT01259245|7388628|FG000|Overall Study|Death|1
4557472|NCT01259245|7388629|FG001|Overall Study|Death|2
4557473|NCT01259297|7388645|FG000|Double Blind Randomized Period|Death|1
4557474|NCT01259297|7388646|FG001|Double Blind Randomized Period|Death|1
4557475|NCT01259297|7388647|FG002|Double Blind Randomized Period|Death|1
4557476|NCT01259297|7388648|FG003|Double Blind Randomized Period|Death|2
4557477|NCT01259297|7388649|FG004|Double Blind Randomized Period|Death|1
4557478|NCT01259297|7388650|FG005|Double Blind Randomized Period|Death|5
4557479|NCT01259297|7388651|FG006|Double Blind Randomized Period|Death|2
4557480|NCT01259297|7388652|FG007|Double Blind Randomized Period|Death|1
4557481|NCT01259297|7388645|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
4557482|NCT01259297|7388646|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
4557483|NCT01259297|7388647|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0
4557484|NCT01259297|7388648|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2
4557485|NCT01259297|7388649|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2
4557486|NCT01259297|7388650|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
4557487|NCT01259297|7388651|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
4557488|NCT01259297|7388652|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
4557489|NCT01259297|7388645|FG000|Double Blind Randomized Period|Other reasons|0
4557490|NCT01259297|7388646|FG001|Double Blind Randomized Period|Other reasons|1
4557491|NCT01259297|7388647|FG002|Double Blind Randomized Period|Other reasons|0
4557492|NCT01259297|7388648|FG003|Double Blind Randomized Period|Other reasons|0
4557493|NCT01259297|7388649|FG004|Double Blind Randomized Period|Other reasons|1
4622404|NCT01801007|7485389|FG000|Overall Study|Adverse Event|2
4622405|NCT01801007|7485389|FG000|Overall Study|Lost to Follow-up|4
4622406|NCT01801007|7485389|FG000|Overall Study|Withdrawal by Subject|5
4622407|NCT01801111|7485393|FG000|Overall Study|Adverse Event|12
4622408|NCT01801111|7485393|FG000|Overall Study|Death|8
4622409|NCT01801111|7485393|FG000|Overall Study|Physician Decision|5
4622410|NCT01801111|7485393|FG000|Overall Study|Other|1
4622411|NCT01801111|7485393|FG000|Overall Study|Withdrawal by Subject|4
4622412|NCT01801111|7485393|FG000|Overall Study|Study Terminated by Sponsor|27
4622413|NCT01801111|7485393|FG000|Overall Study|Progressive Disease|81
4622414|NCT01801280|7485414|FG000|Period 1|Withdrawal by Subject|0
4622415|NCT01801280|7485415|FG001|Period 1|Withdrawal by Subject|1
4622416|NCT01801280|7485416|FG002|Period 1|Withdrawal by Subject|0
4622417|NCT01801280|7485417|FG003|Period 1|Withdrawal by Subject|0
4622418|NCT01801280|7485414|FG000|Period 2|Withdrawal by Subject|1
4622419|NCT01801280|7485415|FG001|Period 2|Withdrawal by Subject|0
4622420|NCT01801280|7485416|FG002|Period 2|Withdrawal by Subject|0
4622421|NCT01801280|7485417|FG003|Period 2|Withdrawal by Subject|0
4622422|NCT01801280|7485414|FG000|Period 4|Protocol Violation|0
4622423|NCT01801280|7485415|FG001|Period 4|Protocol Violation|0
4622424|NCT01801280|7485416|FG002|Period 4|Protocol Violation|1
4622425|NCT01801280|7485417|FG003|Period 4|Protocol Violation|0
4622426|NCT01801358|7485433|FG000|Overall Study|Adverse Event|0
4622427|NCT01801358|7485434|FG001|Overall Study|Adverse Event|2
4622428|NCT01801358|7485435|FG002|Overall Study|Adverse Event|1
4622429|NCT01801358|7485436|FG003|Overall Study|Adverse Event|0
4622430|NCT01801358|7485437|FG004|Overall Study|Adverse Event|0
4622431|NCT01801358|7485438|FG005|Overall Study|Adverse Event|1
4622432|NCT01801358|7485433|FG000|Overall Study|Physician Decision|0
4622433|NCT01801358|7485434|FG001|Overall Study|Physician Decision|0
4622434|NCT01801358|7485435|FG002|Overall Study|Physician Decision|1
4622435|NCT01801358|7485436|FG003|Overall Study|Physician Decision|0
4622436|NCT01801358|7485437|FG004|Overall Study|Physician Decision|0
4622437|NCT01801358|7485438|FG005|Overall Study|Physician Decision|0
4770414|NCT03740919|7746730|FG000|Treatment Period|Due to COVID-19 Pandemic|0
4557494|NCT01259297|7388650|FG005|Double Blind Randomized Period|Other reasons|2
4557495|NCT01259297|7388651|FG006|Double Blind Randomized Period|Other reasons|3
4557496|NCT01259297|7388652|FG007|Double Blind Randomized Period|Other reasons|1
4557497|NCT01259375|7388669|FG000|Overall Study|Adverse Event|1
4557498|NCT01259388|7388677|FG000|Overall Study|Adverse Event|3
4557499|NCT01259388|7388678|FG001|Overall Study|Adverse Event|0
4557500|NCT01259388|7388677|FG000|Overall Study|Withdrawal by Subject|1
4557501|NCT01259388|7388678|FG001|Overall Study|Withdrawal by Subject|1
4557502|NCT01259388|7388677|FG000|Overall Study|Physician Decision|1
4557503|NCT01259388|7388678|FG001|Overall Study|Physician Decision|0
4557504|NCT01259401|7388686|FG000|4-month Follow-up|Death|0
4557505|NCT01259401|7388687|FG001|4-month Follow-up|Death|1
4557506|NCT01259401|7388686|FG000|4-month Follow-up|Lost to Follow-up|0
4557507|NCT01259401|7388687|FG001|4-month Follow-up|Lost to Follow-up|1
4557508|NCT01259466|7388714|FG000|Overall Study|Withdrawal by Subject|1
4557509|NCT01259466|7388715|FG001|Overall Study|Withdrawal by Subject|9
4557510|NCT01259492|7388725|FG000|Period 1 (9 Weeks)|Adverse Event|13
4557511|NCT01259492|7388726|FG001|Period 1 (9 Weeks)|Adverse Event|18
4557512|NCT01259492|7388727|FG002|Period 1 (9 Weeks)|Adverse Event|26
4557513|NCT01259492|7388728|FG003|Period 1 (9 Weeks)|Adverse Event|3
4557514|NCT01259492|7388725|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2
4557515|NCT01259492|7388726|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2
4557516|NCT01259492|7388727|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4
4557517|NCT01259492|7388728|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11
4557518|NCT01259492|7388725|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5
4557519|NCT01259492|7388726|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8
4557520|NCT01259492|7388727|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6
4557521|NCT01259492|7388728|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7
4557522|NCT01259492|7388725|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4
4557523|NCT01259492|7388726|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6
4557524|NCT01259492|7388727|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3
4557525|NCT01259492|7388728|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4
4557526|NCT01259492|7388725|FG000|Period 1 (9 Weeks)|Administrative Problems|0
4557527|NCT01259492|7388726|FG001|Period 1 (9 Weeks)|Administrative Problems|1
4557528|NCT01259492|7388727|FG002|Period 1 (9 Weeks)|Administrative Problems|1
4557529|NCT01259492|7388728|FG003|Period 1 (9 Weeks)|Administrative Problems|2
4557530|NCT01259492|7388725|FG000|Period 1 (9 Weeks)|Protocol Violation|5
4557531|NCT01259492|7388726|FG001|Period 1 (9 Weeks)|Protocol Violation|6
4557532|NCT01259492|7388727|FG002|Period 1 (9 Weeks)|Protocol Violation|3
4557533|NCT01259492|7388728|FG003|Period 1 (9 Weeks)|Protocol Violation|1
4557534|NCT01259492|7388725|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3
4557535|NCT01259492|7388726|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4
4622438|NCT01801358|7485433|FG000|Overall Study|Progressive Disease|6
4622439|NCT01801358|7485434|FG001|Overall Study|Progressive Disease|4
4622440|NCT01801358|7485435|FG002|Overall Study|Progressive Disease|4
4622441|NCT01801358|7485436|FG003|Overall Study|Progressive Disease|5
4622442|NCT01801358|7485437|FG004|Overall Study|Progressive Disease|6
4622443|NCT01801358|7485438|FG005|Overall Study|Progressive Disease|5
4622444|NCT01801358|7485433|FG000|Overall Study|Withdrawal by Subject|0
4622445|NCT01801358|7485434|FG001|Overall Study|Withdrawal by Subject|0
4622446|NCT01801358|7485435|FG002|Overall Study|Withdrawal by Subject|0
4622447|NCT01801358|7485436|FG003|Overall Study|Withdrawal by Subject|1
4622448|NCT01801358|7485437|FG004|Overall Study|Withdrawal by Subject|0
4622449|NCT01801358|7485438|FG005|Overall Study|Withdrawal by Subject|2
4622450|NCT01801436|7485473|FG000|Overall Study|Withdrawal by Subject|3
4622451|NCT01801436|7485473|FG000|Overall Study|Adverse Event|2
4622452|NCT01801436|7485473|FG000|Overall Study|Progressive disease|4
4622453|NCT01801475|7485485|FG000|Overall Study|Withdrawal by Subject|0
4622454|NCT01801475|7485486|FG001|Overall Study|Withdrawal by Subject|0
4622455|NCT01801475|7485487|FG002|Overall Study|Withdrawal by Subject|0
4622456|NCT01801475|7485488|FG003|Overall Study|Withdrawal by Subject|0
4622457|NCT01801475|7485489|FG004|Overall Study|Withdrawal by Subject|1
4622458|NCT01801735|7485498|FG000|Overall Study|Adverse Event|79
4622459|NCT01801735|7485498|FG000|Overall Study|Lack of Efficacy|28
4622460|NCT01801735|7485498|FG000|Overall Study|Withdrawal by Subject|27
4622461|NCT01801735|7485498|FG000|Overall Study|Protocol Violation|25
4622462|NCT01801735|7485498|FG000|Overall Study|Lost to Follow-up|15
4622463|NCT01801735|7485498|FG000|Overall Study|Non-compliance with Trial Drug|13
4622464|NCT01801735|7485498|FG000|Overall Study|Physician Decision|3
4622465|NCT01801735|7485498|FG000|Overall Study|Death|1
4622466|NCT01801735|7485498|FG000|Overall Study|Other, including site closure|19
4622467|NCT01801865|7485502|FG000|Overall Study|Patients scanned on another MRI scanner|35
4622468|NCT01801865|7485502|FG000|Overall Study|Physician Decision|7
4622469|NCT01801917|7485510|FG000|Period 1 - Randomized|Adverse Event|1
4622470|NCT01801917|7485511|FG001|Period 1 - Randomized|Adverse Event|0
4622471|NCT01801917|7485512|FG002|Period 1 - Randomized|Adverse Event|1
4557536|NCT01259492|7388727|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7
4622472|NCT01801917|7485513|FG003|Period 1 - Randomized|Adverse Event|0
4622473|NCT01801930|7485528|FG000|Overall Study|Clear progression of the primary disease is observed|6
4622474|NCT01801930|7485529|FG001|Overall Study|Clear progression of the primary disease is observed|5
4622475|NCT01801930|7485530|FG002|Overall Study|Clear progression of the primary disease is observed|6
4557537|NCT01259492|7388728|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8
4557538|NCT01259492|7388725|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13
4557539|NCT01259492|7388726|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7
4557540|NCT01259492|7388727|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7
4557541|NCT01259492|7388728|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13
4557542|NCT01259492|7388725|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6
4557543|NCT01259492|7388726|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2
4557544|NCT01259492|7388727|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8
4557545|NCT01259492|7388728|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4
4557546|NCT01259492|7388725|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
4557547|NCT01259492|7388726|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
4557548|NCT01259492|7388727|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1
4557549|NCT01259492|7388728|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
4557550|NCT01259492|7388725|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0
4557551|NCT01259492|7388726|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2
4557552|NCT01259492|7388727|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1
4557553|NCT01259492|7388728|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0
4557554|NCT01259492|7388725|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5
4557555|NCT01259492|7388726|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11
4557556|NCT01259492|7388727|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6
4557557|NCT01259492|7388728|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5
4557558|NCT01259492|7388725|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
4557559|NCT01259492|7388726|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
4557560|NCT01259492|7388727|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
4557561|NCT01259492|7388728|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1
4557562|NCT01259492|7388725|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
4557563|NCT01259492|7388726|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
4557564|NCT01259492|7388727|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1
4557565|NCT01259492|7388728|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
4557566|NCT01259492|7388725|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28
4557567|NCT01259492|7388726|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42
4557568|NCT01259492|7388727|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29
4557569|NCT01259492|7388728|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62
4557570|NCT01259492|7388725|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1
4557571|NCT01259492|7388726|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
4557572|NCT01259492|7388727|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
4557573|NCT01259492|7388728|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
4557574|NCT01259492|7388725|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12
4557575|NCT01259492|7388726|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6
4557576|NCT01259492|7388727|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4
4557577|NCT01259492|7388728|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3
4557578|NCT01259492|7388725|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3
4557579|NCT01259492|7388726|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4
4557580|NCT01259492|7388727|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6
4557581|NCT01259492|7388728|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3
4557582|NCT01259492|7388725|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
4557583|NCT01259492|7388726|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
4557584|NCT01259492|7388727|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1
4557585|NCT01259492|7388728|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
4557586|NCT01259492|7388725|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5
4557587|NCT01259492|7388726|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6
4557588|NCT01259492|7388727|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3
4557589|NCT01259492|7388728|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7
4557590|NCT01259713|7388750|FG000|Overall Study|Adverse Event|54
4557591|NCT01259713|7388751|FG001|Overall Study|Adverse Event|23
4557592|NCT01259713|7388750|FG000|Overall Study|Death Not Related to IFI|8
4557593|NCT01259713|7388751|FG001|Overall Study|Death Not Related to IFI|1
4557594|NCT01259713|7388750|FG000|Overall Study|Investigators Discretion|14
4557595|NCT01259713|7388751|FG001|Overall Study|Investigators Discretion|6
4557596|NCT01259713|7388750|FG000|Overall Study|Lack of Efficacy|2
4557597|NCT01259713|7388751|FG001|Overall Study|Lack of Efficacy|0
4557598|NCT01259713|7388750|FG000|Overall Study|Protocol Violation|5
4557599|NCT01259713|7388751|FG001|Overall Study|Protocol Violation|4
4557600|NCT01259713|7388750|FG000|Overall Study|Subject Withdrew Consent|12
4557601|NCT01259713|7388751|FG001|Overall Study|Subject Withdrew Consent|7
4557602|NCT01259726|7388761|FG000|Overall Study|Death|1
4557603|NCT01259726|7388762|FG001|Overall Study|Death|0
4557604|NCT01259726|7388763|FG002|Overall Study|Death|0
4557605|NCT01259726|7388764|FG003|Overall Study|Death|0
4557606|NCT01259726|7388761|FG000|Overall Study|Physician Decision|2
4557607|NCT01259726|7388762|FG001|Overall Study|Physician Decision|0
4557608|NCT01259726|7388763|FG002|Overall Study|Physician Decision|1
4557609|NCT01259726|7388764|FG003|Overall Study|Physician Decision|1
4557610|NCT01259726|7388761|FG000|Overall Study|Withdrawal by Subject|1
4557611|NCT01259726|7388762|FG001|Overall Study|Withdrawal by Subject|3
4557612|NCT01259726|7388763|FG002|Overall Study|Withdrawal by Subject|2
4557613|NCT01259726|7388764|FG003|Overall Study|Withdrawal by Subject|1
4557614|NCT01259726|7388761|FG000|Overall Study|Lost to Follow-up|1
4557615|NCT01259726|7388762|FG001|Overall Study|Lost to Follow-up|1
4557616|NCT01259726|7388763|FG002|Overall Study|Lost to Follow-up|1
4557617|NCT01259726|7388764|FG003|Overall Study|Lost to Follow-up|3
4557618|NCT01259856|7388776|FG000|Overall Study|Adverse Event|12
4557619|NCT01259856|7388777|FG001|Overall Study|Adverse Event|9
4557620|NCT01259856|7388776|FG000|Overall Study|Death|0
4622476|NCT01801930|7485531|FG003|Overall Study|Clear progression of the primary disease is observed|6
4622477|NCT01801930|7485528|FG000|Overall Study|DLT occurs|0
4622478|NCT01801930|7485529|FG001|Overall Study|DLT occurs|1
4622479|NCT01801930|7485530|FG002|Overall Study|DLT occurs|0
4622480|NCT01801930|7485531|FG003|Overall Study|DLT occurs|0
4622481|NCT01801982|7485541|FG000|Overall Study|Lost to Follow-up|1
4622482|NCT01802073|7485547|FG000|Overall Study|Lost to Follow-up|0
4622483|NCT01802073|7485548|FG001|Overall Study|Lost to Follow-up|1
4622484|NCT01802073|7485547|FG000|Overall Study|Non-compliant|4
4622485|NCT01802073|7485548|FG001|Overall Study|Non-compliant|2
4622486|NCT01802073|7485547|FG000|Overall Study|Withdrawal by Subject|1
4622487|NCT01802073|7485548|FG001|Overall Study|Withdrawal by Subject|1
4622488|NCT01802073|7485547|FG000|Overall Study|Physician Decision|0
4622489|NCT01802073|7485548|FG001|Overall Study|Physician Decision|7
4622490|NCT01802216|7485573|FG000|4 Month Visit|Participant did not show to visit|3
4622491|NCT01802216|7485574|FG001|4 Month Visit|Participant did not show to visit|4
4622492|NCT01802216|7485573|FG000|8 Month Visit|Participant did not show to visit|3
4622493|NCT01802216|7485574|FG001|8 Month Visit|Participant did not show to visit|5
4622494|NCT01802216|7485573|FG000|12 Month Visit|Participant did not show to visit|3
4622495|NCT01802216|7485574|FG001|12 Month Visit|Participant did not show to visit|4
4622496|NCT01802320|7485580|FG000|Overall Study|Death|1
4622497|NCT01802320|7485580|FG000|Overall Study|Withdrawal by Subject|1
4622498|NCT01802333|7485587|FG000|Overall Study|Ineligible|2
4622499|NCT01802333|7485588|FG001|Overall Study|Ineligible|6
4622500|NCT01802333|7485589|FG002|Overall Study|Ineligible|8
4622501|NCT01802333|7485587|FG000|Overall Study|Adverse Event|1
4622502|NCT01802333|7485588|FG001|Overall Study|Adverse Event|8
4622503|NCT01802333|7485589|FG002|Overall Study|Adverse Event|8
4622504|NCT01802333|7485587|FG000|Overall Study|Withdrawal by Subject|6
4622505|NCT01802333|7485588|FG001|Overall Study|Withdrawal by Subject|6
4622506|NCT01802333|7485589|FG002|Overall Study|Withdrawal by Subject|5
4622507|NCT01802333|7485587|FG000|Overall Study|Progression/relapse|1
4622508|NCT01802333|7485588|FG001|Overall Study|Progression/relapse|3
4622509|NCT01802333|7485589|FG002|Overall Study|Progression/relapse|0
4622510|NCT01802333|7485587|FG000|Overall Study|Death|7
4622511|NCT01802333|7485588|FG001|Overall Study|Death|14
4622512|NCT01802333|7485589|FG002|Overall Study|Death|13
4622513|NCT01802333|7485587|FG000|Overall Study|Other - not protocol specified|32
4690723|NCT02563548|7600525|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15
4770415|NCT03740919|7746731|FG001|Treatment Period|Due to COVID-19 Pandemic|0
4622514|NCT01802333|7485588|FG001|Overall Study|Other - not protocol specified|22
4622515|NCT01802333|7485589|FG002|Overall Study|Other - not protocol specified|24
4622516|NCT01802333|7485587|FG000|Overall Study|Did not start treatment|0
4622517|NCT01802333|7485588|FG001|Overall Study|Did not start treatment|2
4622518|NCT01802333|7485589|FG002|Overall Study|Did not start treatment|5
4622519|NCT01802385|7485605|FG000|Overall Study|Death|106
4622520|NCT01802385|7485606|FG001|Overall Study|Death|120
4622521|NCT01802411|7485614|FG000|Overall Study|Death|2
4622522|NCT01802411|7485615|FG001|Overall Study|Death|1
4622523|NCT01802411|7485614|FG000|Overall Study|Adverse Event|2
4622524|NCT01802411|7485615|FG001|Overall Study|Adverse Event|7
4622525|NCT01802411|7485614|FG000|Overall Study|Lack of Efficacy|8
4622526|NCT01802411|7485615|FG001|Overall Study|Lack of Efficacy|10
4622527|NCT01802411|7485614|FG000|Overall Study|Withdrawal by Subject|0
4622528|NCT01802411|7485615|FG001|Overall Study|Withdrawal by Subject|2
4622529|NCT01802411|7485614|FG000|Overall Study|Planned pleurodesis as part of the proc|1
4622530|NCT01802411|7485615|FG001|Overall Study|Planned pleurodesis as part of the proc|0
4622531|NCT01802411|7485614|FG000|Overall Study|Surgery aborted after bronchoscopy|1
4622532|NCT01802411|7485615|FG001|Overall Study|Surgery aborted after bronchoscopy|0
4622533|NCT01802411|7485614|FG000|Overall Study|Proc changed to video-asst thorascopic|0
4622534|NCT01802411|7485615|FG001|Overall Study|Proc changed to video-asst thorascopic|1
4622535|NCT01802437|7485623|FG000|Overall Study|Lost to Follow-up|1
4622536|NCT01802437|7485624|FG001|Overall Study|Lost to Follow-up|0
4622537|NCT01802437|7485623|FG000|Overall Study|Withdrawal by Subject|3
4622538|NCT01802437|7485624|FG001|Overall Study|Withdrawal by Subject|4
4622539|NCT01802515|7485633|FG000|Overall Study|Withdrawal by Subject|3
4622540|NCT01802515|7485634|FG001|Overall Study|Withdrawal by Subject|0
4557621|NCT01259856|7388777|FG001|Overall Study|Death|1
4557622|NCT01259856|7388776|FG000|Overall Study|Lack of Efficacy|3
4557623|NCT01259856|7388777|FG001|Overall Study|Lack of Efficacy|1
4622541|NCT01802515|7485635|FG002|Overall Study|Withdrawal by Subject|0
4622542|NCT01802580|7485654|FG000|Overall Study|Physician Decision|1
4557624|NCT01259856|7388776|FG000|Overall Study|Lost to Follow-up|1
4557625|NCT01259856|7388777|FG001|Overall Study|Lost to Follow-up|1
4557626|NCT01259856|7388776|FG000|Overall Study|Physician Decision|2
4557627|NCT01259856|7388777|FG001|Overall Study|Physician Decision|1
4557628|NCT01259856|7388776|FG000|Overall Study|Withdrawal by Subject|9
4557629|NCT01259856|7388777|FG001|Overall Study|Withdrawal by Subject|10
4557630|NCT01259856|7388776|FG000|Overall Study|Treatment never started|0
4557631|NCT01259856|7388777|FG001|Overall Study|Treatment never started|6
4557632|NCT01259856|7388776|FG000|Overall Study|Study closure by sponsor|40
4622543|NCT01802580|7485655|FG001|Overall Study|Physician Decision|0
4622544|NCT01802580|7485654|FG000|Overall Study|Protocol Violation|2
4622545|NCT01802580|7485655|FG001|Overall Study|Protocol Violation|0
4622546|NCT01802580|7485654|FG000|Overall Study|Withdrawal by Subject|5
4622547|NCT01802580|7485655|FG001|Overall Study|Withdrawal by Subject|6
4622548|NCT01802580|7485654|FG000|Overall Study|Other|1
4622549|NCT01802580|7485655|FG001|Overall Study|Other|3
4622550|NCT01802580|7485654|FG000|Overall Study|Lack of Efficacy|0
4622551|NCT01802580|7485655|FG001|Overall Study|Lack of Efficacy|2
4622552|NCT01802775|7485674|FG000|Overall Study|Death|0
4622553|NCT01802775|7485675|FG001|Overall Study|Death|3
4622554|NCT01802775|7485674|FG000|Overall Study|Reason not provided|0
4622555|NCT01802775|7485675|FG001|Overall Study|Reason not provided|1
4622556|NCT01802775|7485674|FG000|Overall Study|Physician Decision|1
4622557|NCT01802775|7485675|FG001|Overall Study|Physician Decision|0
4622558|NCT01802775|7485674|FG000|Overall Study|Adverse Event|1
4622559|NCT01802775|7485675|FG001|Overall Study|Adverse Event|1
4622560|NCT01802775|7485674|FG000|Overall Study|Withdrawal by Subject|3
4622561|NCT01802775|7485675|FG001|Overall Study|Withdrawal by Subject|5
4622562|NCT01802775|7485674|FG000|Overall Study|Lost to Follow-up|1
4622563|NCT01802775|7485675|FG001|Overall Study|Lost to Follow-up|2
4622564|NCT01802879|7485681|FG000|Overall Study|Administrative problems|2
4622565|NCT01802879|7485681|FG000|Overall Study|Disease progression|6
4622566|NCT01803269|7485763|FG000|Overall Study|Withdrawal by Subject|3
4622567|NCT01803269|7485764|FG001|Overall Study|Withdrawal by Subject|0
4622568|NCT01803269|7485765|FG002|Overall Study|Withdrawal by Subject|0
4622569|NCT01803282|7485785|FG000|Overall Study|Progressive Disease|4
4622570|NCT01803282|7485786|FG001|Overall Study|Progressive Disease|3
4622571|NCT01803282|7485787|FG002|Overall Study|Progressive Disease|6
4622572|NCT01803282|7485788|FG003|Overall Study|Progressive Disease|22
4622573|NCT01803282|7485789|FG004|Overall Study|Progressive Disease|5
4622574|NCT01803282|7485790|FG005|Overall Study|Progressive Disease|8
4622575|NCT01803282|7485791|FG006|Overall Study|Progressive Disease|23
4622576|NCT01803282|7485792|FG007|Overall Study|Progressive Disease|24
4622577|NCT01803282|7485793|FG008|Overall Study|Progressive Disease|3
4622578|NCT01803282|7485794|FG009|Overall Study|Progressive Disease|29
4622579|NCT01803282|7485795|FG010|Overall Study|Progressive Disease|6
4622580|NCT01803282|7485796|FG011|Overall Study|Progressive Disease|11
4622581|NCT01803282|7485785|FG000|Overall Study|Death|0
4622582|NCT01803282|7485786|FG001|Overall Study|Death|0
4622583|NCT01803282|7485787|FG002|Overall Study|Death|0
4622584|NCT01803282|7485788|FG003|Overall Study|Death|0
4622585|NCT01803282|7485789|FG004|Overall Study|Death|2
4622586|NCT01803282|7485790|FG005|Overall Study|Death|1
4622587|NCT01803282|7485791|FG006|Overall Study|Death|1
4622588|NCT01803282|7485792|FG007|Overall Study|Death|5
4622589|NCT01803282|7485793|FG008|Overall Study|Death|1
4622590|NCT01803282|7485794|FG009|Overall Study|Death|1
4622591|NCT01803282|7485795|FG010|Overall Study|Death|0
4622592|NCT01803282|7485796|FG011|Overall Study|Death|0
4622593|NCT01803282|7485785|FG000|Overall Study|Withdrew Consent|0
4622594|NCT01803282|7485786|FG001|Overall Study|Withdrew Consent|0
4622595|NCT01803282|7485787|FG002|Overall Study|Withdrew Consent|0
4622596|NCT01803282|7485788|FG003|Overall Study|Withdrew Consent|6
4622597|NCT01803282|7485789|FG004|Overall Study|Withdrew Consent|1
4622598|NCT01803282|7485790|FG005|Overall Study|Withdrew Consent|0
4622599|NCT01803282|7485791|FG006|Overall Study|Withdrew Consent|8
4622600|NCT01803282|7485792|FG007|Overall Study|Withdrew Consent|3
4622601|NCT01803282|7485793|FG008|Overall Study|Withdrew Consent|1
4622602|NCT01803282|7485794|FG009|Overall Study|Withdrew Consent|5
4622603|NCT01803282|7485795|FG010|Overall Study|Withdrew Consent|0
4622604|NCT01803282|7485796|FG011|Overall Study|Withdrew Consent|1
4622605|NCT01803282|7485785|FG000|Overall Study|Investigator's Discretion|0
4622606|NCT01803282|7485786|FG001|Overall Study|Investigator's Discretion|0
4622607|NCT01803282|7485787|FG002|Overall Study|Investigator's Discretion|0
4622608|NCT01803282|7485788|FG003|Overall Study|Investigator's Discretion|7
4622609|NCT01803282|7485789|FG004|Overall Study|Investigator's Discretion|2
4622610|NCT01803282|7485790|FG005|Overall Study|Investigator's Discretion|1
4622611|NCT01803282|7485791|FG006|Overall Study|Investigator's Discretion|7
4557633|NCT01259856|7388777|FG001|Overall Study|Study closure by sponsor|41
4557634|NCT01259856|7388776|FG000|Overall Study|Patient developed other disease|0
4622612|NCT01803282|7485792|FG007|Overall Study|Investigator's Discretion|10
4622613|NCT01803282|7485793|FG008|Overall Study|Investigator's Discretion|6
4622614|NCT01803282|7485794|FG009|Overall Study|Investigator's Discretion|7
4622615|NCT01803282|7485795|FG010|Overall Study|Investigator's Discretion|1
4622616|NCT01803282|7485796|FG011|Overall Study|Investigator's Discretion|0
4622617|NCT01803282|7485785|FG000|Overall Study|Adverse Event|0
4622618|NCT01803282|7485786|FG001|Overall Study|Adverse Event|0
4557635|NCT01259856|7388777|FG001|Overall Study|Patient developed other disease|1
4557636|NCT01259856|7388776|FG000|Overall Study|Transfer to another study|0
4557637|NCT01259856|7388777|FG001|Overall Study|Transfer to another study|1
4557638|NCT01259856|7388776|FG000|Overall Study|Unknown/missing|2
4557639|NCT01259856|7388777|FG001|Overall Study|Unknown/missing|2
4557640|NCT01259869|7388783|FG000|Overall Study|Duplicated registration|1
4557641|NCT01260142|7388793|FG000|Treatment Period 1|Study on hold|1
4557642|NCT01260142|7388794|FG001|Treatment Period 1|Study on hold|1
4557643|NCT01260142|7388795|FG002|Treatment Period 1|Study on hold|0
4557644|NCT01260142|7388796|FG003|Treatment Period 1|Study on hold|0
4557645|NCT01260142|7388797|FG004|Treatment Period 1|Study on hold|1
4557646|NCT01260142|7388798|FG005|Treatment Period 1|Study on hold|2
4557647|NCT01260142|7388793|FG000|Treatment Period 1|Unexplained elevated sys. BP|0
4557648|NCT01260142|7388794|FG001|Treatment Period 1|Unexplained elevated sys. BP|0
4557649|NCT01260142|7388795|FG002|Treatment Period 1|Unexplained elevated sys. BP|0
4622619|NCT01803282|7485787|FG002|Overall Study|Adverse Event|0
4622620|NCT01803282|7485788|FG003|Overall Study|Adverse Event|0
4622621|NCT01803282|7485789|FG004|Overall Study|Adverse Event|0
4622622|NCT01803282|7485790|FG005|Overall Study|Adverse Event|0
4622623|NCT01803282|7485791|FG006|Overall Study|Adverse Event|1
4622624|NCT01803282|7485792|FG007|Overall Study|Adverse Event|2
4622625|NCT01803282|7485793|FG008|Overall Study|Adverse Event|0
4622626|NCT01803282|7485794|FG009|Overall Study|Adverse Event|1
4622627|NCT01803282|7485795|FG010|Overall Study|Adverse Event|0
4622628|NCT01803282|7485796|FG011|Overall Study|Adverse Event|3
4622629|NCT01803282|7485785|FG000|Overall Study|Non-Compliance with Study Drug|0
4622630|NCT01803282|7485786|FG001|Overall Study|Non-Compliance with Study Drug|0
4622631|NCT01803282|7485787|FG002|Overall Study|Non-Compliance with Study Drug|0
4622632|NCT01803282|7485788|FG003|Overall Study|Non-Compliance with Study Drug|1
4622633|NCT01803282|7485789|FG004|Overall Study|Non-Compliance with Study Drug|0
4622634|NCT01803282|7485790|FG005|Overall Study|Non-Compliance with Study Drug|0
4622635|NCT01803282|7485791|FG006|Overall Study|Non-Compliance with Study Drug|0
4622636|NCT01803282|7485792|FG007|Overall Study|Non-Compliance with Study Drug|0
4622637|NCT01803282|7485793|FG008|Overall Study|Non-Compliance with Study Drug|0
4622638|NCT01803282|7485794|FG009|Overall Study|Non-Compliance with Study Drug|0
4622639|NCT01803282|7485795|FG010|Overall Study|Non-Compliance with Study Drug|0
4622640|NCT01803282|7485796|FG011|Overall Study|Non-Compliance with Study Drug|0
4622641|NCT01803282|7485785|FG000|Overall Study|Unknown Reason|0
4622642|NCT01803282|7485786|FG001|Overall Study|Unknown Reason|0
4622643|NCT01803282|7485787|FG002|Overall Study|Unknown Reason|0
4622644|NCT01803282|7485788|FG003|Overall Study|Unknown Reason|0
4622645|NCT01803282|7485789|FG004|Overall Study|Unknown Reason|0
4622646|NCT01803282|7485790|FG005|Overall Study|Unknown Reason|0
4622647|NCT01803282|7485791|FG006|Overall Study|Unknown Reason|0
4622648|NCT01803282|7485792|FG007|Overall Study|Unknown Reason|1
4622649|NCT01803282|7485793|FG008|Overall Study|Unknown Reason|0
4622650|NCT01803282|7485794|FG009|Overall Study|Unknown Reason|0
4622651|NCT01803282|7485795|FG010|Overall Study|Unknown Reason|0
4622652|NCT01803282|7485796|FG011|Overall Study|Unknown Reason|0
4622653|NCT01803282|7485785|FG000|Overall Study|Specified Criteria for Withdrawal|0
4622654|NCT01803282|7485786|FG001|Overall Study|Specified Criteria for Withdrawal|0
4622655|NCT01803282|7485787|FG002|Overall Study|Specified Criteria for Withdrawal|0
4622656|NCT01803282|7485788|FG003|Overall Study|Specified Criteria for Withdrawal|0
4622657|NCT01803282|7485789|FG004|Overall Study|Specified Criteria for Withdrawal|0
4622658|NCT01803282|7485790|FG005|Overall Study|Specified Criteria for Withdrawal|0
4622659|NCT01803282|7485791|FG006|Overall Study|Specified Criteria for Withdrawal|0
4622660|NCT01803282|7485792|FG007|Overall Study|Specified Criteria for Withdrawal|0
4622661|NCT01803282|7485793|FG008|Overall Study|Specified Criteria for Withdrawal|0
4622662|NCT01803282|7485794|FG009|Overall Study|Specified Criteria for Withdrawal|1
4622663|NCT01803282|7485795|FG010|Overall Study|Specified Criteria for Withdrawal|1
4622664|NCT01803282|7485796|FG011|Overall Study|Specified Criteria for Withdrawal|0
4622665|NCT01803282|7485785|FG000|Overall Study|Enrolled but Never Treated|0
4622666|NCT01803282|7485786|FG001|Overall Study|Enrolled but Never Treated|0
4622667|NCT01803282|7485787|FG002|Overall Study|Enrolled but Never Treated|0
4622668|NCT01803282|7485788|FG003|Overall Study|Enrolled but Never Treated|0
4622669|NCT01803282|7485789|FG004|Overall Study|Enrolled but Never Treated|1
4622670|NCT01803282|7485790|FG005|Overall Study|Enrolled but Never Treated|0
4622671|NCT01803282|7485791|FG006|Overall Study|Enrolled but Never Treated|1
4622672|NCT01803282|7485792|FG007|Overall Study|Enrolled but Never Treated|1
4622673|NCT01803282|7485793|FG008|Overall Study|Enrolled but Never Treated|0
4622674|NCT01803282|7485794|FG009|Overall Study|Enrolled but Never Treated|1
4557650|NCT01260142|7388796|FG003|Treatment Period 1|Unexplained elevated sys. BP|0
4557651|NCT01260142|7388797|FG004|Treatment Period 1|Unexplained elevated sys. BP|1
4622675|NCT01803282|7485795|FG010|Overall Study|Enrolled but Never Treated|0
4622676|NCT01803282|7485796|FG011|Overall Study|Enrolled but Never Treated|0
4622677|NCT01803464|7485826|FG000|Overall Study|Incomplete data|0
4622678|NCT01803464|7485827|FG001|Overall Study|Incomplete data|0
4557652|NCT01260142|7388798|FG005|Treatment Period 1|Unexplained elevated sys. BP|0
4622679|NCT01803464|7485828|FG002|Overall Study|Incomplete data|4
4622680|NCT01803464|7485829|FG003|Overall Study|Incomplete data|0
4622681|NCT01803464|7485826|FG000|Overall Study|Withdrawal by Subject|1
4557653|NCT01260142|7388793|FG000|Treatment Period 1|Withdrawal by Subject|0
4557654|NCT01260142|7388794|FG001|Treatment Period 1|Withdrawal by Subject|0
4557655|NCT01260142|7388795|FG002|Treatment Period 1|Withdrawal by Subject|0
4557656|NCT01260142|7388796|FG003|Treatment Period 1|Withdrawal by Subject|0
4557657|NCT01260142|7388797|FG004|Treatment Period 1|Withdrawal by Subject|0
4557658|NCT01260142|7388798|FG005|Treatment Period 1|Withdrawal by Subject|1
4557659|NCT01260181|7388818|FG000|Overall Study|Decision of Investigator|1
4557660|NCT01260194|7388822|FG000|Overall Study|Withdrawal of Consent|1
4557661|NCT01260311|7388837|FG000|Overall Study|Adverse Event|11
4557662|NCT01260311|7388837|FG000|Overall Study|Lack of Efficacy|4
4557663|NCT01260311|7388837|FG000|Overall Study|Lost to Follow-up|25
4557664|NCT01260311|7388837|FG000|Overall Study|Withdrawal by Subject|6
4557665|NCT01260311|7388837|FG000|Overall Study|Financial Constraints|77
4557666|NCT01260311|7388837|FG000|Overall Study|Gone to Province|2
4557667|NCT01260311|7388837|FG000|Overall Study|Medication Stopped|1
4557668|NCT01260311|7388837|FG000|Overall Study|Fesoterodine Started Before Enrollment|1
4557669|NCT01260350|7388870|FG000|Overall Study|Lack of Efficacy|0
4557670|NCT01260350|7388871|FG001|Overall Study|Lack of Efficacy|0
4557671|NCT01260350|7388872|FG002|Overall Study|Lack of Efficacy|0
4557672|NCT01260350|7388873|FG003|Overall Study|Lack of Efficacy|0
4557673|NCT01260350|7388874|FG004|Overall Study|Lack of Efficacy|0
4557674|NCT01260350|7388875|FG005|Overall Study|Lack of Efficacy|0
4557675|NCT01260350|7388876|FG006|Overall Study|Lack of Efficacy|0
4557676|NCT01260350|7388877|FG007|Overall Study|Lack of Efficacy|0
4557677|NCT01260350|7388878|FG008|Overall Study|Lack of Efficacy|0
4557678|NCT01260350|7388879|FG009|Overall Study|Lack of Efficacy|0
4557679|NCT01260350|7388880|FG010|Overall Study|Lack of Efficacy|0
4557680|NCT01260350|7388881|FG011|Overall Study|Lack of Efficacy|0
4557681|NCT01260350|7388882|FG012|Overall Study|Lack of Efficacy|0
4557682|NCT01260350|7388883|FG013|Overall Study|Lack of Efficacy|0
4557683|NCT01260350|7388884|FG014|Overall Study|Lack of Efficacy|0
4557684|NCT01260350|7388885|FG015|Overall Study|Lack of Efficacy|0
4557685|NCT01260350|7388886|FG016|Overall Study|Lack of Efficacy|0
4557686|NCT01260350|7388887|FG017|Overall Study|Lack of Efficacy|1
4557687|NCT01260350|7388888|FG018|Overall Study|Lack of Efficacy|0
4557688|NCT01260350|7388889|FG019|Overall Study|Lack of Efficacy|0
4557689|NCT01260350|7388890|FG020|Overall Study|Lack of Efficacy|3
4557690|NCT01260350|7388891|FG021|Overall Study|Lack of Efficacy|0
4557691|NCT01260350|7388870|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0
4622682|NCT01803464|7485827|FG001|Overall Study|Withdrawal by Subject|0
4622683|NCT01803464|7485828|FG002|Overall Study|Withdrawal by Subject|0
4622684|NCT01803464|7485829|FG003|Overall Study|Withdrawal by Subject|0
4622685|NCT01803607|7485845|FG000|Overall Study|Adverse Event|5
4622686|NCT01803607|7485846|FG001|Overall Study|Adverse Event|3
4622687|NCT01803607|7485845|FG000|Overall Study|Lack of Efficacy|0
4622688|NCT01803607|7485846|FG001|Overall Study|Lack of Efficacy|1
4622689|NCT01803607|7485845|FG000|Overall Study|Protocol Violation|3
4622690|NCT01803607|7485846|FG001|Overall Study|Protocol Violation|2
4622691|NCT01803607|7485845|FG000|Overall Study|Study terminated by sponsor|54
4622692|NCT01803607|7485846|FG001|Overall Study|Study terminated by sponsor|56
4622693|NCT01803607|7485845|FG000|Overall Study|Withdrawal by Subject|6
4622694|NCT01803607|7485846|FG001|Overall Study|Withdrawal by Subject|5
4633095|NCT01908426|7503041|FG001|Overall Study|Physician Decision|3
4633096|NCT01908426|7503040|FG000|Overall Study|Withdrawal by Subject|11
4633097|NCT01908426|7503041|FG001|Overall Study|Withdrawal by Subject|6
4633098|NCT01908426|7503040|FG000|Overall Study|Progressive Disease|206
4633099|NCT01908426|7503041|FG001|Overall Study|Progressive Disease|152
4633100|NCT01908426|7503040|FG000|Overall Study|Protocol Violation|1
4633101|NCT01908426|7503041|FG001|Overall Study|Protocol Violation|0
4633102|NCT01908426|7503040|FG000|Overall Study|No Study Treatment Given|3
4633103|NCT01908426|7503041|FG001|Overall Study|No Study Treatment Given|0
4633104|NCT01908582|7503063|FG000|Period 2|Physician Decision|1
4633105|NCT01908582|7503063|FG000|Period 2|Withdrawal by Subject|1
4633106|NCT01908634|7503070|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1
4690724|NCT02563548|7600526|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3
4690725|NCT02563548|7600521|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
4690726|NCT02563548|7600522|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
4557692|NCT01260350|7388871|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0
4557693|NCT01260350|7388872|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0
4557694|NCT01260350|7388873|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0
4557695|NCT01260350|7388874|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0
4557696|NCT01260350|7388875|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0
4557697|NCT01260350|7388876|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0
4690727|NCT02563548|7600523|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
4690728|NCT02563548|7600524|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
4690729|NCT02563548|7600525|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6
4690730|NCT02563548|7600526|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
4690731|NCT02563548|7600521|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0
4690732|NCT02563548|7600522|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0
4770416|NCT03740919|7746732|FG002|Treatment Period|Due to COVID-19 Pandemic|3
4557698|NCT01260350|7388877|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0
4557699|NCT01260350|7388878|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1
4557700|NCT01260350|7388879|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0
4557701|NCT01260350|7388880|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0
4557702|NCT01260350|7388881|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0
4557703|NCT01260350|7388882|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0
4557704|NCT01260350|7388883|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0
4557705|NCT01260350|7388884|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0
4557706|NCT01260350|7388885|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0
4557707|NCT01260350|7388886|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0
4557708|NCT01260350|7388887|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0
4557709|NCT01260350|7388888|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0
4557710|NCT01260350|7388889|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0
4557711|NCT01260350|7388890|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0
4557712|NCT01260350|7388891|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0
4622695|NCT01803646|7485854|FG000|Overall Study|Protocol Violation|1
4622696|NCT01803646|7485855|FG001|Overall Study|Protocol Violation|0
4622697|NCT01803646|7485854|FG000|Overall Study|Adverse Event|1
4622698|NCT01803646|7485855|FG001|Overall Study|Adverse Event|1
4622699|NCT01803646|7485854|FG000|Overall Study|Withdrawal by Subject|9
4622700|NCT01803646|7485855|FG001|Overall Study|Withdrawal by Subject|6
4622701|NCT01803646|7485854|FG000|Overall Study|Randomization error|1
4622702|NCT01803646|7485855|FG001|Overall Study|Randomization error|2
4622703|NCT01803646|7485854|FG000|Overall Study|Lost to Follow-up|5
4622704|NCT01803646|7485855|FG001|Overall Study|Lost to Follow-up|1
4622705|NCT01803737|7485863|FG000|Overall Study|Lack of Time|1
4622706|NCT01803737|7485864|FG001|Overall Study|Lack of Time|0
4622707|NCT01803737|7485863|FG000|Overall Study|Medical Reason|0
4622708|NCT01803737|7485864|FG001|Overall Study|Medical Reason|1
4622709|NCT01803737|7485863|FG000|Overall Study|Lost to Follow-up|0
4622710|NCT01803737|7485864|FG001|Overall Study|Lost to Follow-up|2
4622711|NCT01803880|7485873|FG000|Overall Study|Adverse Event|1
4622712|NCT01803880|7485874|FG001|Overall Study|Adverse Event|0
4622713|NCT01803880|7485875|FG002|Overall Study|Adverse Event|0
4622714|NCT01803880|7485873|FG000|Overall Study|Withdrawal by Subject|1
4622715|NCT01803880|7485874|FG001|Overall Study|Withdrawal by Subject|1
4622716|NCT01803880|7485875|FG002|Overall Study|Withdrawal by Subject|4
4622717|NCT01803880|7485873|FG000|Overall Study|Physician Decision|0
4622718|NCT01803880|7485874|FG001|Overall Study|Physician Decision|0
4622719|NCT01803880|7485875|FG002|Overall Study|Physician Decision|1
4622720|NCT01803880|7485873|FG000|Overall Study|Unable to return for follow-up visits|0
4622721|NCT01803880|7485874|FG001|Overall Study|Unable to return for follow-up visits|1
4622722|NCT01803880|7485875|FG002|Overall Study|Unable to return for follow-up visits|2
4622723|NCT01803880|7485873|FG000|Overall Study|Lost to Follow-up|1
4622724|NCT01803880|7485874|FG001|Overall Study|Lost to Follow-up|2
4622725|NCT01803880|7485875|FG002|Overall Study|Lost to Follow-up|3
4622726|NCT01803880|7485873|FG000|Overall Study|Protocol Violation|1
4622727|NCT01803880|7485874|FG001|Overall Study|Protocol Violation|0
4622728|NCT01803880|7485875|FG002|Overall Study|Protocol Violation|0
4622729|NCT01803880|7485873|FG000|Overall Study|Early study termination|0
4622730|NCT01803880|7485874|FG001|Overall Study|Early study termination|6
4622731|NCT01803880|7485875|FG002|Overall Study|Early study termination|5
4622732|NCT01803880|7485873|FG000|Overall Study|Incomplete data entry by sites|2
4622733|NCT01803880|7485874|FG001|Overall Study|Incomplete data entry by sites|0
4622734|NCT01803880|7485875|FG002|Overall Study|Incomplete data entry by sites|0
4622735|NCT01804049|7485897|FG000|Overall Study|Adverse Event|2
4622736|NCT01804049|7485898|FG001|Overall Study|Adverse Event|10
4622737|NCT01804049|7485897|FG000|Overall Study|Lost to Follow-up|2
4622738|NCT01804049|7485898|FG001|Overall Study|Lost to Follow-up|1
4622739|NCT01804049|7485897|FG000|Overall Study|Decreased interest/personal|4
4622740|NCT01804049|7485898|FG001|Overall Study|Decreased interest/personal|5
4622741|NCT01804049|7485897|FG000|Overall Study|Other health concerns|2
4622742|NCT01804049|7485898|FG001|Overall Study|Other health concerns|7
4622743|NCT01804049|7485897|FG000|Overall Study|Moved out of area|0
4622744|NCT01804049|7485898|FG001|Overall Study|Moved out of area|7
4622745|NCT01804049|7485897|FG000|Overall Study|other MD recommended|1
4622746|NCT01804049|7485898|FG001|Overall Study|other MD recommended|1
4622747|NCT01804049|7485897|FG000|Overall Study|Enrollment in dual studies|0
4622748|NCT01804049|7485898|FG001|Overall Study|Enrollment in dual studies|1
4622749|NCT01804140|7485941|FG000|Overall Study|No sampling or biopsy procedures done|114
4592049|NCT01536418|7439267|FG001|Overall Study|Physician Decision|3
4622750|NCT01804582|7485960|FG000|Overall Study|Lost to Follow-up|47
4622751|NCT01804582|7485961|FG001|Overall Study|Lost to Follow-up|56
4622752|NCT01804582|7485960|FG000|Overall Study|Physician Decision|2
4622753|NCT01804582|7485961|FG001|Overall Study|Physician Decision|0
4622754|NCT01804673|7485968|FG000|Overall Study|Adverse Event|4
4622755|NCT01804673|7485968|FG000|Overall Study|Withdrawal by Subject|1
4622756|NCT01804673|7485968|FG000|Overall Study|Lack of Efficacy|9
4622757|NCT01804673|7485968|FG000|Overall Study|Change to Oral Therapy|37
4622758|NCT01804673|7485968|FG000|Overall Study|No Further Therapy Required|84
4622759|NCT01804673|7485968|FG000|Overall Study|Use of Prohibited Medication|1
4622760|NCT01804673|7485968|FG000|Overall Study|Other|4
4622761|NCT01804842|7485975|FG000|Overall Study|Adverse Event|1
4622762|NCT01804842|7485976|FG001|Overall Study|Adverse Event|1
4557713|NCT01260467|7388949|FG000|Overall Study|Withdrawal by Subject|2
4557714|NCT01260584|7388968|FG000|Period 1|Protocol Violation|0
4557715|NCT01260584|7388969|FG001|Period 1|Protocol Violation|0
4557716|NCT01260584|7388970|FG002|Period 1|Protocol Violation|1
4557717|NCT01260584|7388971|FG003|Period 1|Protocol Violation|1
4557718|NCT01260584|7388968|FG000|Period 1|Adverse Event|0
4557719|NCT01260584|7388969|FG001|Period 1|Adverse Event|0
4557720|NCT01260584|7388970|FG002|Period 1|Adverse Event|1
4557721|NCT01260584|7388971|FG003|Period 1|Adverse Event|0
4557722|NCT01260584|7388968|FG000|Period 2|Protocol Violation|0
4557723|NCT01260584|7388969|FG001|Period 2|Protocol Violation|2
4557724|NCT01260584|7388970|FG002|Period 2|Protocol Violation|3
4557725|NCT01260584|7388971|FG003|Period 2|Protocol Violation|1
4557726|NCT01260584|7388968|FG000|Period 2|Adverse Event|1
4557727|NCT01260584|7388969|FG001|Period 2|Adverse Event|0
4557728|NCT01260584|7388970|FG002|Period 2|Adverse Event|2
4557729|NCT01260584|7388971|FG003|Period 2|Adverse Event|0
4557730|NCT01260584|7388968|FG000|Period 2|Withdrawal by Subject|0
4557731|NCT01260584|7388969|FG001|Period 2|Withdrawal by Subject|1
4557732|NCT01260584|7388970|FG002|Period 2|Withdrawal by Subject|0
4557733|NCT01260584|7388971|FG003|Period 2|Withdrawal by Subject|0
4557734|NCT01260701|7389015|FG000|Overall Study|Adverse Event|9
4557735|NCT01260701|7389015|FG000|Overall Study|Withdrawal by Subject|2
4557736|NCT01260701|7389015|FG000|Overall Study|Progression|53
4557737|NCT01260701|7389015|FG000|Overall Study|Death|2
4557738|NCT01260701|7389015|FG000|Overall Study|Not protocol specified|3
4622763|NCT01804842|7485977|FG002|Overall Study|Adverse Event|0
4622764|NCT01804842|7485975|FG000|Overall Study|Lost to Follow-up|1
4622765|NCT01804842|7485976|FG001|Overall Study|Lost to Follow-up|0
4622766|NCT01804842|7485977|FG002|Overall Study|Lost to Follow-up|0
4622767|NCT01804842|7485975|FG000|Overall Study|Non-Compliance|1
4622768|NCT01804842|7485976|FG001|Overall Study|Non-Compliance|1
4622769|NCT01804842|7485977|FG002|Overall Study|Non-Compliance|0
4622770|NCT01804842|7485975|FG000|Overall Study|Personal Reason|0
4622771|NCT01804842|7485976|FG001|Overall Study|Personal Reason|0
4622772|NCT01804842|7485977|FG002|Overall Study|Personal Reason|1
4622773|NCT01804946|7485998|FG000|Overall Study|Protocol Violation|1
4622774|NCT01804946|7485999|FG001|Overall Study|Protocol Violation|0
4622775|NCT01804946|7485998|FG000|Overall Study|Adverse Event|0
4622776|NCT01804946|7485999|FG001|Overall Study|Adverse Event|1
4622777|NCT01804946|7485998|FG000|Overall Study|Insufficient data available|0
4622778|NCT01804946|7485999|FG001|Overall Study|Insufficient data available|1
4622779|NCT01804946|7485998|FG000|Overall Study|Do not meet inclusion criteria|1
4622780|NCT01804946|7485999|FG001|Overall Study|Do not meet inclusion criteria|2
4622781|NCT01805037|7486024|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0
4622782|NCT01805037|7486025|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2
4622783|NCT01805037|7486024|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0
4622784|NCT01805037|7486025|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2
4622785|NCT01805037|7486024|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0
4622786|NCT01805037|7486025|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1
4622787|NCT01805037|7486024|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0
4622788|NCT01805037|7486025|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1
4622789|NCT01805037|7486024|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0
4622790|NCT01805037|7486025|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10
4622791|NCT01805037|7486024|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0
4622792|NCT01805037|7486025|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1
4622793|NCT01805037|7486024|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0
4622794|NCT01805037|7486025|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1
4622795|NCT01805037|7486024|FG000|Follow Up (up to 3 Years)|Death|0
4622796|NCT01805037|7486025|FG001|Follow Up (up to 3 Years)|Death|2
4622797|NCT01805037|7486024|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0
4622798|NCT01805037|7486025|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3
4622799|NCT01805037|7486024|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0
4622800|NCT01805037|7486025|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1
4622801|NCT01805180|7486047|FG000|Lead-in Donor Phase|screen failure|1
4622802|NCT01805180|7486048|FG001|Lead-in Donor Phase|screen failure|0
4622803|NCT01805180|7486049|FG002|Lead-in Donor Phase|screen failure|0
4622804|NCT01806064|7486151|FG000|Overall Study|Randomized Not Enrolled|0
4622805|NCT01806064|7486152|FG001|Overall Study|Randomized Not Enrolled|0
4622806|NCT01806064|7486153|FG002|Overall Study|Randomized Not Enrolled|0
4622807|NCT01806064|7486154|FG003|Overall Study|Randomized Not Enrolled|1
4622808|NCT01806064|7486155|FG004|Overall Study|Randomized Not Enrolled|2
4622809|NCT01806168|7486174|FG000|Overall Study|Adverse Event|1
4622810|NCT01806168|7486175|FG001|Overall Study|Adverse Event|0
4557739|NCT01260701|7389015|FG000|Overall Study|Under review|1
4557740|NCT01260701|7389015|FG000|Overall Study|Ineligible|4
4557741|NCT01260701|7389015|FG000|Overall Study|Did not begin protocol therapy|1
4557742|NCT01260896|7389055|FG000|First Intervention|Withdrawn Due to Emesis|2
4622811|NCT01806168|7486176|FG002|Overall Study|Adverse Event|0
4557743|NCT01260896|7389056|FG001|First Intervention|Withdrawn Due to Emesis|0
4557744|NCT01260922|7389064|FG000|First Intervention|Withdrawal by Subject|0
4557745|NCT01260922|7389065|FG001|First Intervention|Withdrawal by Subject|1
4557746|NCT01260922|7389064|FG000|Washout of 28 Days|Withdrawal by Subject|4
4557747|NCT01260922|7389065|FG001|Washout of 28 Days|Withdrawal by Subject|2
4557748|NCT01260922|7389064|FG000|Second Intervention|Emesis|0
4557749|NCT01260922|7389065|FG001|Second Intervention|Emesis|2
4557750|NCT01260948|7389073|FG000|Washout of 28 Days|Withdrawal by Subject|1
4557751|NCT01260948|7389074|FG001|Washout of 28 Days|Withdrawal by Subject|3
4557752|NCT01260948|7389073|FG000|Second Intervention|Emesis|0
4557753|NCT01260948|7389074|FG001|Second Intervention|Emesis|1
4557754|NCT01261000|7389080|FG000|Overall Study|Screen failure|1
4557755|NCT01261325|7389092|FG000|Overall Study|Lack of Efficacy|1
4557756|NCT01261325|7389093|FG001|Overall Study|Lack of Efficacy|1
4557757|NCT01261325|7389094|FG002|Overall Study|Lack of Efficacy|0
4557758|NCT01261325|7389092|FG000|Overall Study|Withdrawal by Subject|2
4557759|NCT01261325|7389093|FG001|Overall Study|Withdrawal by Subject|2
4622812|NCT01806168|7486174|FG000|Overall Study|Withdrawal by Subject|0
4622813|NCT01806168|7486175|FG001|Overall Study|Withdrawal by Subject|1
4622814|NCT01806168|7486176|FG002|Overall Study|Withdrawal by Subject|2
4622815|NCT01806168|7486174|FG000|Overall Study|Protocol Violation|0
4622816|NCT01806168|7486175|FG001|Overall Study|Protocol Violation|0
4622817|NCT01806168|7486176|FG002|Overall Study|Protocol Violation|1
4622818|NCT01806298|7486197|FG000|Overall Study|Adverse Event|3
4622819|NCT01806298|7486197|FG000|Overall Study|Protocol Non-compliance|1
4622820|NCT01806298|7486197|FG000|Overall Study|Withdrawal by Subject|1
4622821|NCT01806298|7486197|FG000|Overall Study|Other|5
4622822|NCT01806389|7486201|FG000|Overall Study|Withdrawal by Subject|4
4622823|NCT01806506|7486217|FG000|Overall Study|Lost to Follow-up|2
4622824|NCT01806506|7486218|FG001|Overall Study|Lost to Follow-up|1
4622825|NCT01806545|7486226|FG000|Overall Study|Adverse Event|2
4622826|NCT01806545|7486227|FG001|Overall Study|Adverse Event|3
4622827|NCT01806545|7486226|FG000|Overall Study|Lost to Follow-up|1
4622828|NCT01806545|7486227|FG001|Overall Study|Lost to Follow-up|0
4622829|NCT01806545|7486226|FG000|Overall Study|Withdrawal by Subject|3
4622830|NCT01806545|7486227|FG001|Overall Study|Withdrawal by Subject|2
4622831|NCT01806584|7486239|FG000|Overall Study|Adverse Event|2
4622832|NCT01806584|7486240|FG001|Overall Study|Adverse Event|1
4622833|NCT01806584|7486239|FG000|Overall Study|Death|1
4622834|NCT01806584|7486240|FG001|Overall Study|Death|0
4622835|NCT01806584|7486239|FG000|Overall Study|Lost to Follow-up|0
4622836|NCT01806584|7486240|FG001|Overall Study|Lost to Follow-up|2
4622837|NCT01806584|7486239|FG000|Overall Study|Study terminated by sponsor|9
4622838|NCT01806584|7486240|FG001|Overall Study|Study terminated by sponsor|14
4622839|NCT01806584|7486239|FG000|Overall Study|Withdrawal by Subject|1
4622840|NCT01806584|7486240|FG001|Overall Study|Withdrawal by Subject|1
4622841|NCT01806584|7486239|FG000|Overall Study|Other unspecified|1
4622842|NCT01806584|7486240|FG001|Overall Study|Other unspecified|0
4622843|NCT01806597|7486249|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1
4622844|NCT01806597|7486250|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1
4622845|NCT01806597|7486251|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0
4622846|NCT01806597|7486252|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0
4622847|NCT01806597|7486253|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2
4622848|NCT01806597|7486254|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0
4622849|NCT01806597|7486249|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1
4622850|NCT01806597|7486250|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
4622851|NCT01806597|7486251|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
4622852|NCT01806597|7486252|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
4622853|NCT01806597|7486253|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1
4622854|NCT01806597|7486254|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
4622855|NCT01806597|7486249|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0
4622856|NCT01806597|7486250|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1
4622857|NCT01806597|7486251|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0
4622858|NCT01806597|7486252|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0
4622859|NCT01806597|7486253|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0
4622860|NCT01806597|7486254|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0
4622861|NCT01806597|7486249|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3
4622862|NCT01806597|7486250|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2
4622863|NCT01806597|7486251|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
4622864|NCT01806597|7486252|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
4622865|NCT01806597|7486253|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2
4622866|NCT01806597|7486254|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
4622867|NCT01806597|7486249|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0
4622868|NCT01806597|7486250|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1
4622869|NCT01806597|7486251|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0
4622870|NCT01806597|7486252|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0
4622871|NCT01806597|7486253|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0
4622872|NCT01806597|7486254|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0
4622873|NCT01806597|7486249|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9
4622874|NCT01806597|7486250|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6
4622875|NCT01806597|7486251|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4
4557760|NCT01261325|7389094|FG002|Overall Study|Withdrawal by Subject|4
4557761|NCT01261325|7389092|FG000|Overall Study|SAE, non-fatal|1
4557762|NCT01261325|7389093|FG001|Overall Study|SAE, non-fatal|5
4557763|NCT01261325|7389094|FG002|Overall Study|SAE, non-fatal|1
4557764|NCT01261325|7389092|FG000|Overall Study|AE, non-serious non-fatal|9
4557765|NCT01261325|7389093|FG001|Overall Study|AE, non-serious non-fatal|15
4557766|NCT01261325|7389094|FG002|Overall Study|AE, non-serious non-fatal|13
4557767|NCT01261325|7389092|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
4557768|NCT01261325|7389093|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
4557769|NCT01261325|7389094|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
4557770|NCT01261325|7389092|FG000|Overall Study|Non Compliance|2
4557771|NCT01261325|7389093|FG001|Overall Study|Non Compliance|0
4557772|NCT01261325|7389094|FG002|Overall Study|Non Compliance|0
4622876|NCT01806597|7486252|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3
4622877|NCT01806597|7486253|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1
4622878|NCT01806597|7486254|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0
4622879|NCT01806597|7486249|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12
4622880|NCT01806597|7486250|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5
4622881|NCT01806597|7486251|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3
4622882|NCT01806597|7486252|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1
4622883|NCT01806597|7486253|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0
4622884|NCT01806597|7486254|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0
4622885|NCT01806597|7486249|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2
4622886|NCT01806597|7486250|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
4622887|NCT01806597|7486251|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
4622888|NCT01806597|7486252|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
4622889|NCT01806597|7486253|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
4622890|NCT01806597|7486254|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
4622891|NCT01806597|7486249|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1
4622892|NCT01806597|7486250|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1
4622893|NCT01806597|7486251|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
4622894|NCT01806597|7486252|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
4622895|NCT01806597|7486253|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
4622896|NCT01806597|7486254|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
4622897|NCT01806597|7486249|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2
4622898|NCT01806597|7486250|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
4622899|NCT01806597|7486251|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
4622900|NCT01806597|7486252|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
4622901|NCT01806597|7486253|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
4622902|NCT01806597|7486254|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
4622903|NCT01806597|7486249|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
4622904|NCT01806597|7486250|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1
4622905|NCT01806597|7486251|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
4622906|NCT01806597|7486252|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1
4622907|NCT01806597|7486253|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
4622908|NCT01806597|7486254|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
4622909|NCT01806597|7486249|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10
4622910|NCT01806597|7486250|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5
4622911|NCT01806597|7486251|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6
4622912|NCT01806597|7486252|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5
4622913|NCT01806597|7486253|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0
4622914|NCT01806597|7486254|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0
4622915|NCT01806597|7486249|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2
4622916|NCT01806597|7486250|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2
4622917|NCT01806597|7486251|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1
4622918|NCT01806597|7486252|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1
4622919|NCT01806597|7486253|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0
4622920|NCT01806597|7486254|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0
4622921|NCT01806597|7486249|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1
4622922|NCT01806597|7486250|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0
4622923|NCT01806597|7486251|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0
4622924|NCT01806597|7486252|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0
4622925|NCT01806597|7486253|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0
4622926|NCT01806597|7486254|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0
4622927|NCT01806597|7486249|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
4622928|NCT01806597|7486250|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
4690733|NCT02563548|7600523|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0
4770417|NCT03740919|7746733|FG003|Treatment Period|Due to COVID-19 Pandemic|1
4557773|NCT01261325|7389092|FG000|Overall Study|Patient Randomized by Mistake|0
4557774|NCT01261325|7389093|FG001|Overall Study|Patient Randomized by Mistake|1
4592050|NCT01536418|7439266|FG000|Overall Study|Study closed/terminated|41
4557775|NCT01261325|7389094|FG002|Overall Study|Patient Randomized by Mistake|0
4557776|NCT01261325|7389092|FG000|Overall Study|Erroneously Randomized|1
4557777|NCT01261325|7389093|FG001|Overall Study|Erroneously Randomized|0
4557778|NCT01261325|7389094|FG002|Overall Study|Erroneously Randomized|0
4557779|NCT01261325|7389092|FG000|Overall Study|Screen Failure|1
4557780|NCT01261325|7389093|FG001|Overall Study|Screen Failure|0
4557781|NCT01261325|7389094|FG002|Overall Study|Screen Failure|0
4557782|NCT01261325|7389092|FG000|Overall Study|Randomized in Error|0
4557783|NCT01261325|7389093|FG001|Overall Study|Randomized in Error|0
4557784|NCT01261325|7389094|FG002|Overall Study|Randomized in Error|1
4557785|NCT01261325|7389092|FG000|Overall Study|Protocol Violation|0
4557786|NCT01261325|7389093|FG001|Overall Study|Protocol Violation|3
4557787|NCT01261325|7389094|FG002|Overall Study|Protocol Violation|1
4557788|NCT01261325|7389092|FG000|Overall Study|Lost to Follow-up|0
4557789|NCT01261325|7389093|FG001|Overall Study|Lost to Follow-up|1
4557790|NCT01261325|7389094|FG002|Overall Study|Lost to Follow-up|3
4557791|NCT01261325|7389092|FG000|Overall Study|AE, serious fatal|0
4557792|NCT01261325|7389093|FG001|Overall Study|AE, serious fatal|0
4557793|NCT01261325|7389094|FG002|Overall Study|AE, serious fatal|2
4557794|NCT01261338|7389107|FG000|Overall Study|Withdrawal by Subject|3
4557795|NCT01261338|7389108|FG001|Overall Study|Withdrawal by Subject|2
4557796|NCT01261390|7389118|FG000|Overall Study|Significant Concurrent Illness|1
4557797|NCT01261390|7389119|FG001|Overall Study|Significant Concurrent Illness|0
4557798|NCT01261390|7389120|FG002|Overall Study|Significant Concurrent Illness|1
4557799|NCT01261390|7389121|FG003|Overall Study|Significant Concurrent Illness|0
4557800|NCT01261390|7389118|FG000|Overall Study|Dissatisfaction with Treatment|2
4557801|NCT01261390|7389119|FG001|Overall Study|Dissatisfaction with Treatment|1
4557802|NCT01261390|7389120|FG002|Overall Study|Dissatisfaction with Treatment|1
4557803|NCT01261390|7389121|FG003|Overall Study|Dissatisfaction with Treatment|2
4557804|NCT01261390|7389118|FG000|Overall Study|Relocation|0
4557805|NCT01261390|7389119|FG001|Overall Study|Relocation|1
4557806|NCT01261390|7389120|FG002|Overall Study|Relocation|0
4557807|NCT01261390|7389121|FG003|Overall Study|Relocation|0
4557808|NCT01261390|7389118|FG000|Overall Study|Loss of Interest in the Study|3
4557809|NCT01261390|7389119|FG001|Overall Study|Loss of Interest in the Study|1
4557810|NCT01261390|7389120|FG002|Overall Study|Loss of Interest in the Study|0
4557811|NCT01261390|7389121|FG003|Overall Study|Loss of Interest in the Study|0
4557812|NCT01261390|7389118|FG000|Overall Study|Lost to Follow-up|1
4557813|NCT01261390|7389119|FG001|Overall Study|Lost to Follow-up|6
4557814|NCT01261390|7389120|FG002|Overall Study|Lost to Follow-up|5
4557815|NCT01261390|7389121|FG003|Overall Study|Lost to Follow-up|6
4557816|NCT01261611|7389156|FG000|Treatment Cycle 1|Withdrawal by Subject|3
4557817|NCT01261611|7389157|FG001|Treatment Cycle 1|Withdrawal by Subject|2
4557818|NCT01261611|7389158|FG002|Treatment Cycle 1|Withdrawal by Subject|0
4557819|NCT01261611|7389156|FG000|Treatment Cycle 1|Lost to Follow-up|1
4557820|NCT01261611|7389157|FG001|Treatment Cycle 1|Lost to Follow-up|0
4557821|NCT01261611|7389158|FG002|Treatment Cycle 1|Lost to Follow-up|0
4557822|NCT01261611|7389156|FG000|Treatment Cycle 1|Adverse Event|0
4557823|NCT01261611|7389157|FG001|Treatment Cycle 1|Adverse Event|1
4557824|NCT01261611|7389158|FG002|Treatment Cycle 1|Adverse Event|0
4557825|NCT01261611|7389156|FG000|Treatment Cycle 1|Protocol Violation|0
4557826|NCT01261611|7389157|FG001|Treatment Cycle 1|Protocol Violation|0
4557827|NCT01261611|7389158|FG002|Treatment Cycle 1|Protocol Violation|2
4557828|NCT01261611|7389156|FG000|Treatment Cycle 2|Completed study|4
4557829|NCT01261611|7389157|FG001|Treatment Cycle 2|Completed study|0
4557830|NCT01261611|7389158|FG002|Treatment Cycle 2|Completed study|0
4557831|NCT01261611|7389156|FG000|Treatment Cycle 2|Withdrawal by Subject|4
4557832|NCT01261611|7389157|FG001|Treatment Cycle 2|Withdrawal by Subject|0
4557833|NCT01261611|7389158|FG002|Treatment Cycle 2|Withdrawal by Subject|0
4557834|NCT01261611|7389156|FG000|Treatment Cycle 2|Adverse Event|1
4557835|NCT01261611|7389157|FG001|Treatment Cycle 2|Adverse Event|0
4557836|NCT01261611|7389158|FG002|Treatment Cycle 2|Adverse Event|0
4557837|NCT01261611|7389156|FG000|Treatment Cycle 2|Protocol Violation|2
4557838|NCT01261611|7389157|FG001|Treatment Cycle 2|Protocol Violation|0
4557839|NCT01261611|7389158|FG002|Treatment Cycle 2|Protocol Violation|0
4557840|NCT01261611|7389156|FG000|Treatment Cycle 2|Not otherwise specified|2
4557841|NCT01261611|7389157|FG001|Treatment Cycle 2|Not otherwise specified|0
4557842|NCT01261611|7389158|FG002|Treatment Cycle 2|Not otherwise specified|0
4557843|NCT01261611|7389156|FG000|Treatment Cycle 3|Completed study|24
4557844|NCT01261611|7389157|FG001|Treatment Cycle 3|Completed study|0
4557845|NCT01261611|7389158|FG002|Treatment Cycle 3|Completed study|0
4557846|NCT01261611|7389156|FG000|Treatment Cycle 3|Withdrawal by Subject|4
4557847|NCT01261611|7389157|FG001|Treatment Cycle 3|Withdrawal by Subject|0
4557848|NCT01261611|7389158|FG002|Treatment Cycle 3|Withdrawal by Subject|0
4557849|NCT01261611|7389156|FG000|Treatment Cycle 3|Adverse Event|1
4557850|NCT01261611|7389157|FG001|Treatment Cycle 3|Adverse Event|0
4557851|NCT01261611|7389158|FG002|Treatment Cycle 3|Adverse Event|0
4557852|NCT01261611|7389156|FG000|Treatment Cycle 3|Lost to Follow-up|1
4557853|NCT01261611|7389157|FG001|Treatment Cycle 3|Lost to Follow-up|0
4557854|NCT01261611|7389158|FG002|Treatment Cycle 3|Lost to Follow-up|0
4557855|NCT01261611|7389156|FG000|Treatment Cycle 4|Completed study|87
4557856|NCT01261611|7389157|FG001|Treatment Cycle 4|Completed study|0
4557857|NCT01261611|7389158|FG002|Treatment Cycle 4|Completed study|0
4557858|NCT01261611|7389156|FG000|Treatment Cycle 4|Withdrawal by Subject|3
4557859|NCT01261611|7389157|FG001|Treatment Cycle 4|Withdrawal by Subject|0
4557860|NCT01261611|7389158|FG002|Treatment Cycle 4|Withdrawal by Subject|0
4557861|NCT01261611|7389156|FG000|Treatment Cycle 4|Adverse Event|1
4557862|NCT01261611|7389157|FG001|Treatment Cycle 4|Adverse Event|0
4557863|NCT01261611|7389158|FG002|Treatment Cycle 4|Adverse Event|0
4557864|NCT01261611|7389156|FG000|Treatment Cycle 4|Lost to Follow-up|2
4557865|NCT01261611|7389157|FG001|Treatment Cycle 4|Lost to Follow-up|0
4557866|NCT01261611|7389158|FG002|Treatment Cycle 4|Lost to Follow-up|0
4557867|NCT01261611|7389156|FG000|Treatment Cycle 4|Not otherwise specified|3
4557868|NCT01261611|7389157|FG001|Treatment Cycle 4|Not otherwise specified|0
4557869|NCT01261611|7389158|FG002|Treatment Cycle 4|Not otherwise specified|0
4557870|NCT01261611|7389156|FG000|Treatment Cycle 5|Withdrawal by Subject|1
4557871|NCT01261611|7389157|FG001|Treatment Cycle 5|Withdrawal by Subject|0
4557872|NCT01261611|7389158|FG002|Treatment Cycle 5|Withdrawal by Subject|0
4557873|NCT01261611|7389156|FG000|Treatment Cycle 5|Adverse Event|1
4557874|NCT01261611|7389157|FG001|Treatment Cycle 5|Adverse Event|0
4557875|NCT01261611|7389158|FG002|Treatment Cycle 5|Adverse Event|0
4557876|NCT01261611|7389156|FG000|Treatment Cycle 5|Lost to Follow-up|1
4557877|NCT01261611|7389157|FG001|Treatment Cycle 5|Lost to Follow-up|0
4557878|NCT01261611|7389158|FG002|Treatment Cycle 5|Lost to Follow-up|0
4557879|NCT01261624|7389172|FG000|Week 0 to Week 12|Disease Progression|1
4557880|NCT01261624|7389173|FG001|Week 0 to Week 12|Disease Progression|1
4557881|NCT01261624|7389172|FG000|Week 0 to Week 12|Insufficient Response|0
4557882|NCT01261624|7389173|FG001|Week 0 to Week 12|Insufficient Response|2
4557883|NCT01261624|7389172|FG000|Week 13 to Week 24|Insufficient Response|0
4557884|NCT01261624|7389173|FG001|Week 13 to Week 24|Insufficient Response|1
4557885|NCT01261780|7389187|FG000|Overall Study|Withdrawal by Subject|1
4557886|NCT01261780|7389188|FG001|Overall Study|Withdrawal by Subject|0
4557887|NCT01261780|7389187|FG000|Overall Study|Event not related to subject|1
4557888|NCT01261780|7389188|FG001|Overall Study|Event not related to subject|2
4557889|NCT01261793|7389197|FG000|Overall Study|Lack of Efficacy|44
4557890|NCT01261793|7389198|FG001|Overall Study|Lack of Efficacy|37
4557891|NCT01261793|7389199|FG002|Overall Study|Lack of Efficacy|32
4557892|NCT01261793|7389197|FG000|Overall Study|Protocol Violation|3
4557893|NCT01261793|7389198|FG001|Overall Study|Protocol Violation|5
4557894|NCT01261793|7389199|FG002|Overall Study|Protocol Violation|6
4557895|NCT01261793|7389197|FG000|Overall Study|Lost to Follow-up|10
4557896|NCT01261793|7389198|FG001|Overall Study|Lost to Follow-up|3
4557897|NCT01261793|7389199|FG002|Overall Study|Lost to Follow-up|7
4557898|NCT01261793|7389197|FG000|Overall Study|Withdrawal by Subject|12
4557899|NCT01261793|7389198|FG001|Overall Study|Withdrawal by Subject|14
4557900|NCT01261793|7389199|FG002|Overall Study|Withdrawal by Subject|14
4557901|NCT01261793|7389197|FG000|Overall Study|Death|3
4557902|NCT01261793|7389198|FG001|Overall Study|Death|1
4557903|NCT01261793|7389199|FG002|Overall Study|Death|0
4557904|NCT01261793|7389197|FG000|Overall Study|Adverse Event|9
4557905|NCT01261793|7389198|FG001|Overall Study|Adverse Event|24
4557906|NCT01261793|7389199|FG002|Overall Study|Adverse Event|19
4557907|NCT01261793|7389197|FG000|Overall Study|Patient non-availability|1
4557908|NCT01261793|7389198|FG001|Overall Study|Patient non-availability|1
4557909|NCT01261793|7389199|FG002|Overall Study|Patient non-availability|1
4557910|NCT01261793|7389197|FG000|Overall Study|Suspected pregnancy|1
4557911|NCT01261793|7389198|FG001|Overall Study|Suspected pregnancy|1
4557912|NCT01261793|7389199|FG002|Overall Study|Suspected pregnancy|0
4557913|NCT01261793|7389197|FG000|Overall Study|Patient non-compliance|1
4557914|NCT01261793|7389198|FG001|Overall Study|Patient non-compliance|0
4557915|NCT01261793|7389199|FG002|Overall Study|Patient non-compliance|1
4557916|NCT01261793|7389197|FG000|Overall Study|Patient pregnant|1
4557917|NCT01261793|7389198|FG001|Overall Study|Patient pregnant|0
4557918|NCT01261793|7389199|FG002|Overall Study|Patient pregnant|0
4557919|NCT01261793|7389197|FG000|Overall Study|Outside the study area|0
4557920|NCT01261793|7389198|FG001|Overall Study|Outside the study area|2
4557921|NCT01261793|7389199|FG002|Overall Study|Outside the study area|1
4557922|NCT01261793|7389197|FG000|Overall Study|Lack of efficacy & patient not available|0
4557923|NCT01261793|7389198|FG001|Overall Study|Lack of efficacy & patient not available|1
4557924|NCT01261793|7389199|FG002|Overall Study|Lack of efficacy & patient not available|0
4557925|NCT01261793|7389197|FG000|Overall Study|Patient withdrew after cardiology visit|0
4557926|NCT01261793|7389198|FG001|Overall Study|Patient withdrew after cardiology visit|1
4557927|NCT01261793|7389199|FG002|Overall Study|Patient withdrew after cardiology visit|0
4557928|NCT01261793|7389197|FG000|Overall Study|Randomization error|0
4557929|NCT01261793|7389198|FG001|Overall Study|Randomization error|1
4557930|NCT01261793|7389199|FG002|Overall Study|Randomization error|0
4557931|NCT01261793|7389197|FG000|Overall Study|Patient unable to start IV line|0
4557932|NCT01261793|7389198|FG001|Overall Study|Patient unable to start IV line|0
4557933|NCT01261793|7389199|FG002|Overall Study|Patient unable to start IV line|1
4557934|NCT01261975|7389216|FG000|Overall Study|Surgical complication|1
4557935|NCT01262027|7389223|FG000|Overall Study|Adverse Event|1
4557936|NCT01262027|7389223|FG000|Overall Study|Withdrawal by Subject|3
4557937|NCT01262027|7389223|FG000|Overall Study|Protocol Violation|1
4557938|NCT01262092|7389229|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2
4557939|NCT01262092|7389230|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1
4557940|NCT01262092|7389229|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1
4557941|NCT01262092|7389230|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0
4557942|NCT01262092|7389229|FG000|Buprenorphine Taper|noncompliance - missed medication|1
4557943|NCT01262092|7389230|FG001|Buprenorphine Taper|noncompliance - missed medication|1
4557944|NCT01262092|7389229|FG000|Gabapentin Taper|noncompliance - missed medications|1
4557945|NCT01262092|7389230|FG001|Gabapentin Taper|noncompliance - missed medications|0
4557946|NCT01262287|7389269|FG000|Overall Study|Lost to Follow-up|2
4557947|NCT01262287|7389270|FG001|Overall Study|Lost to Follow-up|1
4557948|NCT01262352|7389282|FG000|Period 1|Illness after randomization|1
4557949|NCT01262352|7389283|FG001|Period 1|Illness after randomization|0
4557950|NCT01262352|7389282|FG000|Washout|Adverse Event|1
4557951|NCT01262352|7389283|FG001|Washout|Adverse Event|1
4557952|NCT01262352|7389282|FG000|Washout|Extended Washout|0
4557953|NCT01262352|7389283|FG001|Washout|Extended Washout|1
4557954|NCT01262365|7389292|FG000|Overall Study|Lack of Efficacy|35
4557955|NCT01262365|7389293|FG001|Overall Study|Lack of Efficacy|30
4557956|NCT01262365|7389294|FG002|Overall Study|Lack of Efficacy|47
4557957|NCT01262365|7389292|FG000|Overall Study|Protocol Violation|3
4557958|NCT01262365|7389293|FG001|Overall Study|Protocol Violation|1
4557959|NCT01262365|7389294|FG002|Overall Study|Protocol Violation|1
4557960|NCT01262365|7389292|FG000|Overall Study|Lost to Follow-up|3
4557961|NCT01262365|7389293|FG001|Overall Study|Lost to Follow-up|7
4557962|NCT01262365|7389294|FG002|Overall Study|Lost to Follow-up|6
4557963|NCT01262365|7389292|FG000|Overall Study|Withdrawal by Subject|17
4557964|NCT01262365|7389293|FG001|Overall Study|Withdrawal by Subject|22
4557965|NCT01262365|7389294|FG002|Overall Study|Withdrawal by Subject|22
4557966|NCT01262365|7389292|FG000|Overall Study|Death|1
4557967|NCT01262365|7389293|FG001|Overall Study|Death|2
4557968|NCT01262365|7389294|FG002|Overall Study|Death|1
4557969|NCT01262365|7389292|FG000|Overall Study|Adverse Event|26
4557970|NCT01262365|7389293|FG001|Overall Study|Adverse Event|16
4557971|NCT01262365|7389294|FG002|Overall Study|Adverse Event|11
4557972|NCT01262365|7389292|FG000|Overall Study|sponsor decision|1
4557973|NCT01262365|7389293|FG001|Overall Study|sponsor decision|1
4557974|NCT01262365|7389294|FG002|Overall Study|sponsor decision|0
4557975|NCT01262365|7389292|FG000|Overall Study|Randomization error|1
4557976|NCT01262365|7389293|FG001|Overall Study|Randomization error|0
4557977|NCT01262365|7389294|FG002|Overall Study|Randomization error|2
4557978|NCT01262365|7389292|FG000|Overall Study|Non-compliance|1
4557979|NCT01262365|7389293|FG001|Overall Study|Non-compliance|0
4557980|NCT01262365|7389294|FG002|Overall Study|Non-compliance|2
4557981|NCT01262365|7389292|FG000|Overall Study|Suspected pregnancy|1
4557982|NCT01262365|7389293|FG001|Overall Study|Suspected pregnancy|0
4557983|NCT01262365|7389294|FG002|Overall Study|Suspected pregnancy|0
4557984|NCT01262365|7389292|FG000|Overall Study|Patient pregnant|1
4557985|NCT01262365|7389293|FG001|Overall Study|Patient pregnant|0
4557986|NCT01262365|7389294|FG002|Overall Study|Patient pregnant|1
4557987|NCT01262365|7389292|FG000|Overall Study|Toxicity related to study drug|0
4557988|NCT01262365|7389293|FG001|Overall Study|Toxicity related to study drug|1
4557989|NCT01262365|7389294|FG002|Overall Study|Toxicity related to study drug|0
4557990|NCT01262365|7389292|FG000|Overall Study|Cannot tolerate the protocol|0
4557991|NCT01262365|7389293|FG001|Overall Study|Cannot tolerate the protocol|1
4557992|NCT01262365|7389294|FG002|Overall Study|Cannot tolerate the protocol|0
4557993|NCT01262365|7389292|FG000|Overall Study|Patient unavailable|0
4557994|NCT01262365|7389293|FG001|Overall Study|Patient unavailable|0
4557995|NCT01262365|7389294|FG002|Overall Study|Patient unavailable|1
4557996|NCT01262456|7389305|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6
4557997|NCT01262456|7389306|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8
4557998|NCT01262456|7389307|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9
4557999|NCT01262456|7389305|FG000|3-Month Double-Blind Period|Lost to Follow-up|4
4558000|NCT01262456|7389306|FG001|3-Month Double-Blind Period|Lost to Follow-up|5
4558001|NCT01262456|7389307|FG002|3-Month Double-Blind Period|Lost to Follow-up|3
4558002|NCT01262456|7389305|FG000|3-Month Double-Blind Period|Adverse Event|6
4558003|NCT01262456|7389306|FG001|3-Month Double-Blind Period|Adverse Event|4
4558004|NCT01262456|7389307|FG002|3-Month Double-Blind Period|Adverse Event|8
4558005|NCT01262456|7389305|FG000|3-Month Double-Blind Period|Protocol Violation|3
4558006|NCT01262456|7389306|FG001|3-Month Double-Blind Period|Protocol Violation|6
4558007|NCT01262456|7389307|FG002|3-Month Double-Blind Period|Protocol Violation|6
4558008|NCT01262456|7389305|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1
4558009|NCT01262456|7389306|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1
4558010|NCT01262456|7389307|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1
4558011|NCT01262456|7389305|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0
4558012|NCT01262456|7389306|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1
4558013|NCT01262456|7389307|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0
4558014|NCT01262456|7389305|FG000|1-Month Open-Label Extension Period|Adverse Event|2
4558015|NCT01262456|7389306|FG001|1-Month Open-Label Extension Period|Adverse Event|0
4558016|NCT01262456|7389307|FG002|1-Month Open-Label Extension Period|Adverse Event|2
4558017|NCT01262456|7389305|FG000|1-Month Open-Label Extension Period|Protocol Violation|1
4558018|NCT01262456|7389306|FG001|1-Month Open-Label Extension Period|Protocol Violation|0
4558019|NCT01262456|7389307|FG002|1-Month Open-Label Extension Period|Protocol Violation|2
4558020|NCT01262456|7389305|FG000|1-Month Open-Label Extension Period|Other Reason|0
4558021|NCT01262456|7389306|FG001|1-Month Open-Label Extension Period|Other Reason|1
4622929|NCT01806597|7486251|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
4622930|NCT01806597|7486252|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
4622931|NCT01806597|7486253|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
4622932|NCT01806597|7486254|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5
4622933|NCT01806597|7486249|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
4622934|NCT01806597|7486250|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
4622935|NCT01806597|7486251|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
4622936|NCT01806597|7486252|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
4622937|NCT01806597|7486253|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
4558022|NCT01262456|7389307|FG002|1-Month Open-Label Extension Period|Other Reason|0
4558023|NCT01262560|7389335|FG000|Overall Study|Protocol Violation|0
4558024|NCT01262560|7389336|FG001|Overall Study|Protocol Violation|1
4558025|NCT01262560|7389337|FG002|Overall Study|Protocol Violation|2
4558026|NCT01262573|7389347|FG000|Overall Study|Withdrawal by Subject|0
4558027|NCT01262573|7389348|FG001|Overall Study|Withdrawal by Subject|1
4558028|NCT01262638|7389369|FG000|Overall Study|Adverse Event|3
4558029|NCT01262638|7389370|FG001|Overall Study|Adverse Event|4
4558030|NCT01262638|7389371|FG002|Overall Study|Adverse Event|3
4558031|NCT01262638|7389372|FG003|Overall Study|Adverse Event|4
4558032|NCT01262638|7389369|FG000|Overall Study|Protocol Violation|1
4558033|NCT01262638|7389370|FG001|Overall Study|Protocol Violation|0
4558034|NCT01262638|7389371|FG002|Overall Study|Protocol Violation|0
4558035|NCT01262638|7389372|FG003|Overall Study|Protocol Violation|1
4558036|NCT01262638|7389369|FG000|Overall Study|Withdrawal by Subject|2
4558037|NCT01262638|7389370|FG001|Overall Study|Withdrawal by Subject|1
4558038|NCT01262638|7389371|FG002|Overall Study|Withdrawal by Subject|0
4558039|NCT01262638|7389372|FG003|Overall Study|Withdrawal by Subject|1
4558040|NCT01262638|7389369|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0
4558041|NCT01262638|7389370|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0
4558042|NCT01262638|7389371|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1
4558043|NCT01262638|7389372|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0
4558044|NCT01262638|7389369|FG000|Overall Study|Lost to Follow-up|1
4558045|NCT01262638|7389370|FG001|Overall Study|Lost to Follow-up|1
4558046|NCT01262638|7389371|FG002|Overall Study|Lost to Follow-up|1
4558047|NCT01262638|7389372|FG003|Overall Study|Lost to Follow-up|1
4558048|NCT01262638|7389369|FG000|Overall Study|Participant Went Out of Town|0
4558049|NCT01262638|7389370|FG001|Overall Study|Participant Went Out of Town|0
4558050|NCT01262638|7389371|FG002|Overall Study|Participant Went Out of Town|1
4558051|NCT01262638|7389372|FG003|Overall Study|Participant Went Out of Town|0
4558052|NCT01262651|7389387|FG000|Overall Study|Adverse Event|40
4558053|NCT01262651|7389388|FG001|Overall Study|Adverse Event|35
4558054|NCT01262651|7389387|FG000|Overall Study|Withdrawal by Subject|15
4558055|NCT01262651|7389388|FG001|Overall Study|Withdrawal by Subject|11
4558056|NCT01262651|7389387|FG000|Overall Study|Withdrawal by Investigator|2
4558057|NCT01262651|7389388|FG001|Overall Study|Withdrawal by Investigator|2
4558058|NCT01262651|7389387|FG000|Overall Study|Met Withdrawal Criteria|1
4558059|NCT01262651|7389388|FG001|Overall Study|Met Withdrawal Criteria|0
4558060|NCT01262677|7389397|FG000|Overall Study|Does not meet entrance criteria|0
4558061|NCT01262677|7389398|FG001|Overall Study|Does not meet entrance criteria|2
4558062|NCT01262677|7389399|FG002|Overall Study|Does not meet entrance criteria|0
4558063|NCT01262677|7389397|FG000|Overall Study|Insufficient clinical response|0
4558064|NCT01262677|7389398|FG001|Overall Study|Insufficient clinical response|0
4558065|NCT01262677|7389399|FG002|Overall Study|Insufficient clinical response|1
4558066|NCT01262677|7389397|FG000|Overall Study|Lost to Follow-up|1
4558067|NCT01262677|7389398|FG001|Overall Study|Lost to Follow-up|0
4558068|NCT01262677|7389399|FG002|Overall Study|Lost to Follow-up|2
4558069|NCT01262677|7389397|FG000|Overall Study|No longer willing to participate|3
4558070|NCT01262677|7389398|FG001|Overall Study|No longer willing to participate|3
4558071|NCT01262677|7389399|FG002|Overall Study|No longer willing to participate|2
4558072|NCT01262677|7389397|FG000|Overall Study|Reason not provided|2
4558073|NCT01262677|7389398|FG001|Overall Study|Reason not provided|1
4558074|NCT01262677|7389399|FG002|Overall Study|Reason not provided|3
4558075|NCT01262677|7389397|FG000|Overall Study|Protocol Violation|0
4558076|NCT01262677|7389398|FG001|Overall Study|Protocol Violation|1
4558077|NCT01262677|7389399|FG002|Overall Study|Protocol Violation|1
4558078|NCT01262677|7389397|FG000|Overall Study|Adverse Event (AE) related to study drug|3
4558079|NCT01262677|7389398|FG001|Overall Study|Adverse Event (AE) related to study drug|8
4558080|NCT01262677|7389399|FG002|Overall Study|Adverse Event (AE) related to study drug|3
4558081|NCT01262820|7389411|FG000|Overall Study|Adverse Event|5
4558082|NCT01262820|7389411|FG000|Overall Study|Lack of Efficacy|9
4558083|NCT01262820|7389411|FG000|Overall Study|Drug held for 21+ days|1
4558084|NCT01262872|7389432|FG000|Step 2|Death|0
4558085|NCT01262872|7389433|FG001|Step 2|Death|0
4690734|NCT02563548|7600524|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0
4558086|NCT01262872|7389434|FG002|Step 2|Death|0
4558087|NCT01262872|7389435|FG003|Step 2|Death|1
4558088|NCT01262872|7389436|FG004|Step 2|Death|0
4558089|NCT01262872|7389437|FG005|Step 2|Death|2
4558090|NCT01262872|7389438|FG006|Step 2|Death|2
4558091|NCT01262872|7389439|FG007|Step 2|Death|1
4558092|NCT01262872|7389432|FG000|Step 2|Protocol Violation|0
4558093|NCT01262872|7389433|FG001|Step 2|Protocol Violation|0
4558094|NCT01262872|7389434|FG002|Step 2|Protocol Violation|1
4558095|NCT01262872|7389435|FG003|Step 2|Protocol Violation|0
4558096|NCT01262872|7389436|FG004|Step 2|Protocol Violation|0
4558097|NCT01262872|7389437|FG005|Step 2|Protocol Violation|0
4558098|NCT01262872|7389438|FG006|Step 2|Protocol Violation|3
4558099|NCT01262872|7389439|FG007|Step 2|Protocol Violation|1
4558100|NCT01262872|7389432|FG000|Step 2|Withdrawal by Subject|0
4558101|NCT01262872|7389433|FG001|Step 2|Withdrawal by Subject|0
4558102|NCT01262872|7389434|FG002|Step 2|Withdrawal by Subject|4
4558103|NCT01262872|7389435|FG003|Step 2|Withdrawal by Subject|6
4558104|NCT01262872|7389436|FG004|Step 2|Withdrawal by Subject|3
4558105|NCT01262872|7389437|FG005|Step 2|Withdrawal by Subject|1
4558106|NCT01262872|7389438|FG006|Step 2|Withdrawal by Subject|2
4558107|NCT01262872|7389439|FG007|Step 2|Withdrawal by Subject|1
4558108|NCT01262872|7389432|FG000|Step 2|Migrated/moved from study area|0
4558109|NCT01262872|7389433|FG001|Step 2|Migrated/moved from study area|0
4558110|NCT01262872|7389434|FG002|Step 2|Migrated/moved from study area|4
4558111|NCT01262872|7389435|FG003|Step 2|Migrated/moved from study area|3
4558112|NCT01262872|7389436|FG004|Step 2|Migrated/moved from study area|2
4558113|NCT01262872|7389437|FG005|Step 2|Migrated/moved from study area|6
4558114|NCT01262872|7389438|FG006|Step 2|Migrated/moved from study area|2
4558115|NCT01262872|7389439|FG007|Step 2|Migrated/moved from study area|3
4558116|NCT01262898|7389477|FG000|Overall Study|Protocol Violation|1
4558117|NCT01262898|7389478|FG001|Overall Study|Protocol Violation|1
4558118|NCT01262898|7389479|FG002|Overall Study|Protocol Violation|0
4558119|NCT01262898|7389480|FG003|Overall Study|Protocol Violation|0
4558120|NCT01262898|7389477|FG000|Overall Study|Lost to Follow-up|1
4558121|NCT01262898|7389478|FG001|Overall Study|Lost to Follow-up|0
4558122|NCT01262898|7389479|FG002|Overall Study|Lost to Follow-up|0
4558123|NCT01262898|7389480|FG003|Overall Study|Lost to Follow-up|0
4558124|NCT01262898|7389477|FG000|Overall Study|Withdrawal by Subject|1
4558125|NCT01262898|7389478|FG001|Overall Study|Withdrawal by Subject|1
4558126|NCT01262898|7389479|FG002|Overall Study|Withdrawal by Subject|0
4558127|NCT01262898|7389480|FG003|Overall Study|Withdrawal by Subject|0
4558128|NCT01262976|7389499|FG000|Up to Month 2|Serious Adverse Event|0
4558129|NCT01262976|7389500|FG001|Up to Month 2|Serious Adverse Event|0
4558130|NCT01262976|7389501|FG002|Up to Month 2|Serious Adverse Event|1
4558131|NCT01262976|7389502|FG003|Up to Month 2|Serious Adverse Event|0
4558132|NCT01262976|7389503|FG004|Up to Month 2|Serious Adverse Event|0
4558133|NCT01262976|7389504|FG005|Up to Month 2|Serious Adverse Event|0
4558134|NCT01262976|7389499|FG000|Up to Month 2|Withdrawal by Subject|1
4622938|NCT01806597|7486254|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2
4622939|NCT01806597|7486249|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
4622940|NCT01806597|7486250|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
4622941|NCT01806597|7486251|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
4622942|NCT01806597|7486252|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
4622943|NCT01806597|7486253|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
4622944|NCT01806597|7486254|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2
4622945|NCT01806597|7486249|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
4622946|NCT01806597|7486250|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
4622947|NCT01806597|7486251|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
4622948|NCT01806597|7486252|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
4622949|NCT01806597|7486253|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
4622950|NCT01806597|7486254|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2
4622951|NCT01806597|7486249|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
4622952|NCT01806597|7486250|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
4622953|NCT01806597|7486251|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
4622954|NCT01806597|7486252|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
4622955|NCT01806597|7486253|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
4622956|NCT01806597|7486254|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1
4622957|NCT01806623|7486268|FG000|Overall Study|Withdrawal by Subject|1
4622958|NCT01806623|7486268|FG000|Overall Study|Adverse Event|1
4622959|NCT01806623|7486268|FG000|Overall Study|Did not meet the inclusion criteria|56
4622960|NCT01806662|7486272|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4
4622961|NCT01806662|7486273|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0
4558135|NCT01262976|7389500|FG001|Up to Month 2|Withdrawal by Subject|0
4558136|NCT01262976|7389501|FG002|Up to Month 2|Withdrawal by Subject|0
4558137|NCT01262976|7389502|FG003|Up to Month 2|Withdrawal by Subject|0
4558138|NCT01262976|7389503|FG004|Up to Month 2|Withdrawal by Subject|0
4558139|NCT01262976|7389504|FG005|Up to Month 2|Withdrawal by Subject|0
4558140|NCT01262976|7389499|FG000|Up to Month 2|Migrated/moved from study area|0
4558141|NCT01262976|7389500|FG001|Up to Month 2|Migrated/moved from study area|1
4558142|NCT01262976|7389501|FG002|Up to Month 2|Migrated/moved from study area|0
4558143|NCT01262976|7389502|FG003|Up to Month 2|Migrated/moved from study area|0
4558144|NCT01262976|7389503|FG004|Up to Month 2|Migrated/moved from study area|1
4558145|NCT01262976|7389504|FG005|Up to Month 2|Migrated/moved from study area|1
4558146|NCT01262976|7389499|FG000|Up to Month 2|Lost to Follow-up|1
4558147|NCT01262976|7389500|FG001|Up to Month 2|Lost to Follow-up|0
4558148|NCT01262976|7389501|FG002|Up to Month 2|Lost to Follow-up|0
4558149|NCT01262976|7389502|FG003|Up to Month 2|Lost to Follow-up|1
4558150|NCT01262976|7389503|FG004|Up to Month 2|Lost to Follow-up|1
4558151|NCT01262976|7389504|FG005|Up to Month 2|Lost to Follow-up|1
4558152|NCT01262976|7389499|FG000|Up to Month 2|Other|1
4558153|NCT01262976|7389500|FG001|Up to Month 2|Other|0
4558154|NCT01262976|7389501|FG002|Up to Month 2|Other|0
4558155|NCT01262976|7389502|FG003|Up to Month 2|Other|1
4558156|NCT01262976|7389503|FG004|Up to Month 2|Other|0
4558157|NCT01262976|7389504|FG005|Up to Month 2|Other|2
4558158|NCT01262976|7389499|FG000|Up to Month 7|Serious Adverse Event|0
4558159|NCT01262976|7389500|FG001|Up to Month 7|Serious Adverse Event|0
4558160|NCT01262976|7389501|FG002|Up to Month 7|Serious Adverse Event|2
4558161|NCT01262976|7389502|FG003|Up to Month 7|Serious Adverse Event|0
4558162|NCT01262976|7389503|FG004|Up to Month 7|Serious Adverse Event|0
4558163|NCT01262976|7389504|FG005|Up to Month 7|Serious Adverse Event|0
4558164|NCT01262976|7389499|FG000|Up to Month 7|Withdrawal by Subject|1
4558165|NCT01262976|7389500|FG001|Up to Month 7|Withdrawal by Subject|0
4558166|NCT01262976|7389501|FG002|Up to Month 7|Withdrawal by Subject|0
4558167|NCT01262976|7389502|FG003|Up to Month 7|Withdrawal by Subject|0
4558168|NCT01262976|7389503|FG004|Up to Month 7|Withdrawal by Subject|0
4558169|NCT01262976|7389504|FG005|Up to Month 7|Withdrawal by Subject|0
4558170|NCT01262976|7389499|FG000|Up to Month 7|Migrated/moved from study area|0
4558171|NCT01262976|7389500|FG001|Up to Month 7|Migrated/moved from study area|0
4558172|NCT01262976|7389501|FG002|Up to Month 7|Migrated/moved from study area|1
4558173|NCT01262976|7389502|FG003|Up to Month 7|Migrated/moved from study area|3
4558174|NCT01262976|7389503|FG004|Up to Month 7|Migrated/moved from study area|1
4558175|NCT01262976|7389504|FG005|Up to Month 7|Migrated/moved from study area|1
4558176|NCT01262976|7389499|FG000|Up to Month 7|Lost to Follow-up|1
4558177|NCT01262976|7389500|FG001|Up to Month 7|Lost to Follow-up|0
4558178|NCT01262976|7389501|FG002|Up to Month 7|Lost to Follow-up|1
4558179|NCT01262976|7389502|FG003|Up to Month 7|Lost to Follow-up|3
4558180|NCT01262976|7389503|FG004|Up to Month 7|Lost to Follow-up|1
4558181|NCT01262976|7389504|FG005|Up to Month 7|Lost to Follow-up|3
4558182|NCT01262976|7389499|FG000|Up to Month 7|Other|3
4558183|NCT01262976|7389500|FG001|Up to Month 7|Other|0
4558184|NCT01262976|7389501|FG002|Up to Month 7|Other|2
4558185|NCT01262976|7389502|FG003|Up to Month 7|Other|0
4558186|NCT01262976|7389503|FG004|Up to Month 7|Other|0
4558187|NCT01262976|7389504|FG005|Up to Month 7|Other|0
4558188|NCT01262976|7389499|FG000|Up to Year 1|Serious Adverse Event|0
4558189|NCT01262976|7389500|FG001|Up to Year 1|Serious Adverse Event|0
4558190|NCT01262976|7389501|FG002|Up to Year 1|Serious Adverse Event|2
4558191|NCT01262976|7389502|FG003|Up to Year 1|Serious Adverse Event|0
4558192|NCT01262976|7389503|FG004|Up to Year 1|Serious Adverse Event|0
4558193|NCT01262976|7389504|FG005|Up to Year 1|Serious Adverse Event|0
4558194|NCT01262976|7389499|FG000|Up to Year 1|Withdrawal by Subject|1
4558195|NCT01262976|7389500|FG001|Up to Year 1|Withdrawal by Subject|0
4558196|NCT01262976|7389501|FG002|Up to Year 1|Withdrawal by Subject|0
4558197|NCT01262976|7389502|FG003|Up to Year 1|Withdrawal by Subject|0
4558198|NCT01262976|7389503|FG004|Up to Year 1|Withdrawal by Subject|0
4558199|NCT01262976|7389504|FG005|Up to Year 1|Withdrawal by Subject|0
4558200|NCT01262976|7389499|FG000|Up to Year 1|Migrated/moved from study area|1
4558201|NCT01262976|7389500|FG001|Up to Year 1|Migrated/moved from study area|0
4558202|NCT01262976|7389501|FG002|Up to Year 1|Migrated/moved from study area|0
4558203|NCT01262976|7389502|FG003|Up to Year 1|Migrated/moved from study area|3
4558204|NCT01262976|7389503|FG004|Up to Year 1|Migrated/moved from study area|3
4558205|NCT01262976|7389504|FG005|Up to Year 1|Migrated/moved from study area|2
4558206|NCT01262976|7389499|FG000|Up to Year 1|Lost to Follow-up|4
4558207|NCT01262976|7389500|FG001|Up to Year 1|Lost to Follow-up|0
4558208|NCT01262976|7389501|FG002|Up to Year 1|Lost to Follow-up|0
4558209|NCT01262976|7389502|FG003|Up to Year 1|Lost to Follow-up|1
4558210|NCT01262976|7389503|FG004|Up to Year 1|Lost to Follow-up|6
4558211|NCT01262976|7389504|FG005|Up to Year 1|Lost to Follow-up|5
4558212|NCT01262976|7389499|FG000|Up to Year 1|Other|3
4558213|NCT01262976|7389500|FG001|Up to Year 1|Other|1
4558214|NCT01262976|7389501|FG002|Up to Year 1|Other|0
4558215|NCT01262976|7389502|FG003|Up to Year 1|Other|0
4558216|NCT01262976|7389503|FG004|Up to Year 1|Other|2
4558217|NCT01262976|7389504|FG005|Up to Year 1|Other|1
4558218|NCT01262976|7389499|FG000|Up to Year 1|Subjects with unknown completion status|0
4558219|NCT01262976|7389500|FG001|Up to Year 1|Subjects with unknown completion status|0
4558220|NCT01262976|7389501|FG002|Up to Year 1|Subjects with unknown completion status|1
4558221|NCT01262976|7389502|FG003|Up to Year 1|Subjects with unknown completion status|0
4558222|NCT01262976|7389503|FG004|Up to Year 1|Subjects with unknown completion status|0
4558223|NCT01262976|7389504|FG005|Up to Year 1|Subjects with unknown completion status|1
4558224|NCT01262976|7389499|FG000|Up to Year 2|Serious Adverse Event|0
4558225|NCT01262976|7389500|FG001|Up to Year 2|Serious Adverse Event|0
4558226|NCT01262976|7389501|FG002|Up to Year 2|Serious Adverse Event|2
4558227|NCT01262976|7389502|FG003|Up to Year 2|Serious Adverse Event|0
4558228|NCT01262976|7389503|FG004|Up to Year 2|Serious Adverse Event|0
4558229|NCT01262976|7389504|FG005|Up to Year 2|Serious Adverse Event|0
4558230|NCT01262976|7389499|FG000|Up to Year 2|Withdrawal by Subject|1
4558231|NCT01262976|7389500|FG001|Up to Year 2|Withdrawal by Subject|0
4558232|NCT01262976|7389501|FG002|Up to Year 2|Withdrawal by Subject|0
4558233|NCT01262976|7389502|FG003|Up to Year 2|Withdrawal by Subject|0
4558234|NCT01262976|7389503|FG004|Up to Year 2|Withdrawal by Subject|0
4558235|NCT01262976|7389504|FG005|Up to Year 2|Withdrawal by Subject|0
4558236|NCT01262976|7389499|FG000|Up to Year 2|Migrated/moved from study area|0
4558237|NCT01262976|7389500|FG001|Up to Year 2|Migrated/moved from study area|0
4558238|NCT01262976|7389501|FG002|Up to Year 2|Migrated/moved from study area|0
4558239|NCT01262976|7389502|FG003|Up to Year 2|Migrated/moved from study area|2
4558240|NCT01262976|7389503|FG004|Up to Year 2|Migrated/moved from study area|1
4558241|NCT01262976|7389504|FG005|Up to Year 2|Migrated/moved from study area|2
4558242|NCT01262976|7389499|FG000|Up to Year 2|Lost to Follow-up|1
4558243|NCT01262976|7389500|FG001|Up to Year 2|Lost to Follow-up|1
4558244|NCT01262976|7389501|FG002|Up to Year 2|Lost to Follow-up|2
4558245|NCT01262976|7389502|FG003|Up to Year 2|Lost to Follow-up|2
4558246|NCT01262976|7389503|FG004|Up to Year 2|Lost to Follow-up|3
4558247|NCT01262976|7389504|FG005|Up to Year 2|Lost to Follow-up|3
4558248|NCT01262976|7389499|FG000|Up to Year 2|Subjects with unknown completion status|0
4558249|NCT01262976|7389500|FG001|Up to Year 2|Subjects with unknown completion status|0
4558250|NCT01262976|7389501|FG002|Up to Year 2|Subjects with unknown completion status|1
4558251|NCT01262976|7389502|FG003|Up to Year 2|Subjects with unknown completion status|0
4558252|NCT01262976|7389503|FG004|Up to Year 2|Subjects with unknown completion status|0
4558253|NCT01262976|7389504|FG005|Up to Year 2|Subjects with unknown completion status|0
4558254|NCT01262976|7389499|FG000|Up to Year 2|Other|3
4558255|NCT01262976|7389500|FG001|Up to Year 2|Other|0
4558256|NCT01262976|7389501|FG002|Up to Year 2|Other|0
4558257|NCT01262976|7389502|FG003|Up to Year 2|Other|0
4558258|NCT01262976|7389503|FG004|Up to Year 2|Other|0
4558259|NCT01262976|7389504|FG005|Up to Year 2|Other|0
4558260|NCT01262976|7389499|FG000|Up to Year 3|Serious Adverse Event|0
4558261|NCT01262976|7389500|FG001|Up to Year 3|Serious Adverse Event|0
4558262|NCT01262976|7389501|FG002|Up to Year 3|Serious Adverse Event|2
4558263|NCT01262976|7389502|FG003|Up to Year 3|Serious Adverse Event|0
4558264|NCT01262976|7389503|FG004|Up to Year 3|Serious Adverse Event|0
4558265|NCT01262976|7389504|FG005|Up to Year 3|Serious Adverse Event|0
4558266|NCT01262976|7389499|FG000|Up to Year 3|Withdrawal by Subject|1
4558267|NCT01262976|7389500|FG001|Up to Year 3|Withdrawal by Subject|0
4558268|NCT01262976|7389501|FG002|Up to Year 3|Withdrawal by Subject|0
4558269|NCT01262976|7389502|FG003|Up to Year 3|Withdrawal by Subject|0
4558270|NCT01262976|7389503|FG004|Up to Year 3|Withdrawal by Subject|0
4558271|NCT01262976|7389504|FG005|Up to Year 3|Withdrawal by Subject|0
4558272|NCT01262976|7389499|FG000|Up to Year 3|Migrated/moved from study area|0
4558273|NCT01262976|7389500|FG001|Up to Year 3|Migrated/moved from study area|0
4558274|NCT01262976|7389501|FG002|Up to Year 3|Migrated/moved from study area|0
4558275|NCT01262976|7389502|FG003|Up to Year 3|Migrated/moved from study area|2
4558276|NCT01262976|7389503|FG004|Up to Year 3|Migrated/moved from study area|1
4558277|NCT01262976|7389504|FG005|Up to Year 3|Migrated/moved from study area|1
4558278|NCT01262976|7389499|FG000|Up to Year 3|Lost to Follow-up|2
4558279|NCT01262976|7389500|FG001|Up to Year 3|Lost to Follow-up|2
4558280|NCT01262976|7389501|FG002|Up to Year 3|Lost to Follow-up|4
4558281|NCT01262976|7389502|FG003|Up to Year 3|Lost to Follow-up|3
4558282|NCT01262976|7389503|FG004|Up to Year 3|Lost to Follow-up|1
4558283|NCT01262976|7389504|FG005|Up to Year 3|Lost to Follow-up|3
4558284|NCT01262976|7389499|FG000|Up to Year 3|Subjects with unknown completion status|0
4558285|NCT01262976|7389500|FG001|Up to Year 3|Subjects with unknown completion status|0
4558286|NCT01262976|7389501|FG002|Up to Year 3|Subjects with unknown completion status|1
4558287|NCT01262976|7389502|FG003|Up to Year 3|Subjects with unknown completion status|0
4558288|NCT01262976|7389503|FG004|Up to Year 3|Subjects with unknown completion status|0
4558289|NCT01262976|7389504|FG005|Up to Year 3|Subjects with unknown completion status|0
4558290|NCT01262976|7389499|FG000|Up to Year 3|Other|3
4558291|NCT01262976|7389500|FG001|Up to Year 3|Other|0
4558292|NCT01262976|7389501|FG002|Up to Year 3|Other|0
4558293|NCT01262976|7389502|FG003|Up to Year 3|Other|0
4558294|NCT01262976|7389503|FG004|Up to Year 3|Other|0
4558295|NCT01262976|7389504|FG005|Up to Year 3|Other|0
4558296|NCT01262989|7389519|FG000|Period 1|Lost to Follow-up|1
4558297|NCT01262989|7389520|FG001|Period 1|Lost to Follow-up|1
4558298|NCT01262989|7389519|FG000|Period 1|Intercurrent disease|0
4558299|NCT01262989|7389520|FG001|Period 1|Intercurrent disease|1
4558300|NCT01262989|7389519|FG000|Period 1|Positive answer for exclusion criteria|0
4558301|NCT01262989|7389520|FG001|Period 1|Positive answer for exclusion criteria|1
4558302|NCT01262989|7389519|FG000|Period 2|Intercurrent disease|0
4558303|NCT01262989|7389520|FG001|Period 2|Intercurrent disease|1
4558304|NCT01263015|7389528|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13
4558305|NCT01263015|7389529|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48
4558306|NCT01263015|7389528|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18
4558307|NCT01263015|7389529|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14
4558308|NCT01263015|7389528|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14
4558309|NCT01263015|7389529|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12
4558310|NCT01263015|7389528|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17
4558311|NCT01263015|7389529|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18
4558312|NCT01263015|7389528|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9
4558313|NCT01263015|7389529|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15
4558314|NCT01263015|7389528|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1
4558315|NCT01263015|7389529|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2
4558316|NCT01263015|7389528|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3
4558317|NCT01263015|7389529|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10
4558318|NCT01263015|7389528|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7
4558319|NCT01263015|7389529|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2
4558320|NCT01263015|7389528|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3
4558321|NCT01263015|7389529|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2
4558322|NCT01263015|7389528|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8
4558323|NCT01263015|7389529|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8
4558324|NCT01263015|7389528|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0
4558325|NCT01263015|7389529|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2
4558326|NCT01263015|7389528|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3
4558327|NCT01263015|7389529|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7
4558328|NCT01263054|7389537|FG000|Overall Study|Death|1
4558329|NCT01263054|7389538|FG001|Overall Study|Death|0
4558330|NCT01263054|7389537|FG000|Overall Study|Lost to Follow-up|2
4558331|NCT01263054|7389538|FG001|Overall Study|Lost to Follow-up|2
4558332|NCT01263054|7389537|FG000|Overall Study|Withdrawal by Subject|1
4558333|NCT01263054|7389538|FG001|Overall Study|Withdrawal by Subject|3
4558334|NCT01263054|7389537|FG000|Overall Study|Qualification Violation|1
4558335|NCT01263054|7389538|FG001|Overall Study|Qualification Violation|0
4558336|NCT01263054|7389537|FG000|Overall Study|Other|0
4558337|NCT01263054|7389538|FG001|Overall Study|Other|1
4558338|NCT01263093|7389546|FG000|Washout|Physician Decision|1
4558339|NCT01263093|7389547|FG001|Washout|Physician Decision|0
4558340|NCT01263093|7389546|FG000|Period 2|Adverse Event|1
4558341|NCT01263093|7389547|FG001|Period 2|Adverse Event|0
4558342|NCT01263106|7389554|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1
4558343|NCT01263106|7389555|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1
4558344|NCT01263119|7389564|FG000|Period 1|Protocol Violation|2
4558345|NCT01263119|7389564|FG000|Period 2|Adverse Event|2
4558346|NCT01263197|7389583|FG000|First Intervention (Period 1)|Adverse Event|0
4558347|NCT01263197|7389584|FG001|First Intervention (Period 1)|Adverse Event|0
4558348|NCT01263197|7389585|FG002|First Intervention (Period 1)|Adverse Event|0
4558349|NCT01263197|7389586|FG003|First Intervention (Period 1)|Adverse Event|0
4558350|NCT01263197|7389587|FG004|First Intervention (Period 1)|Adverse Event|0
4558351|NCT01263197|7389588|FG005|First Intervention (Period 1)|Adverse Event|1
4558352|NCT01263197|7389583|FG000|Washout Period 1|Protocol Violation|0
4558353|NCT01263197|7389584|FG001|Washout Period 1|Protocol Violation|0
4558354|NCT01263197|7389585|FG002|Washout Period 1|Protocol Violation|0
4558355|NCT01263197|7389586|FG003|Washout Period 1|Protocol Violation|0
4558356|NCT01263197|7389587|FG004|Washout Period 1|Protocol Violation|1
4558357|NCT01263197|7389588|FG005|Washout Period 1|Protocol Violation|0
4558358|NCT01263197|7389583|FG000|Washout Period 2|Physician Decision|0
4558359|NCT01263197|7389584|FG001|Washout Period 2|Physician Decision|0
4558360|NCT01263197|7389585|FG002|Washout Period 2|Physician Decision|0
4558361|NCT01263197|7389586|FG003|Washout Period 2|Physician Decision|0
4558362|NCT01263197|7389587|FG004|Washout Period 2|Physician Decision|0
4558363|NCT01263197|7389588|FG005|Washout Period 2|Physician Decision|1
4558364|NCT01263197|7389583|FG000|Washout Period 2|Protocol Violation|0
4558365|NCT01263197|7389584|FG001|Washout Period 2|Protocol Violation|0
4558366|NCT01263197|7389585|FG002|Washout Period 2|Protocol Violation|0
4558367|NCT01263197|7389586|FG003|Washout Period 2|Protocol Violation|1
4558368|NCT01263197|7389587|FG004|Washout Period 2|Protocol Violation|0
4622962|NCT01806662|7486272|FG000|First Intervention (Weeks 0-16)|Adverse Event|0
4622963|NCT01806662|7486273|FG001|First Intervention (Weeks 0-16)|Adverse Event|1
4622964|NCT01806662|7486272|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2
4622965|NCT01806662|7486273|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3
4622966|NCT01806662|7486272|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0
4622967|NCT01806662|7486273|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1
4558369|NCT01263197|7389588|FG005|Washout Period 2|Protocol Violation|0
4558370|NCT01263197|7389583|FG000|Third Intervention (Period 3)|Adverse Event|0
4558371|NCT01263197|7389584|FG001|Third Intervention (Period 3)|Adverse Event|1
4558372|NCT01263197|7389585|FG002|Third Intervention (Period 3)|Adverse Event|0
4558373|NCT01263197|7389586|FG003|Third Intervention (Period 3)|Adverse Event|0
4622968|NCT01806714|7486306|FG000|Overall Study|No functioning phone number|200
4558374|NCT01263197|7389587|FG004|Third Intervention (Period 3)|Adverse Event|0
4558375|NCT01263197|7389588|FG005|Third Intervention (Period 3)|Adverse Event|0
4558376|NCT01263223|7389602|FG000|Period 2|Withdrawal by Subject|0
4558377|NCT01263223|7389603|FG001|Period 2|Withdrawal by Subject|1
4558378|NCT01263223|7389602|FG000|7-day Follow-up|Withdrawal by Subject|0
4558379|NCT01263223|7389603|FG001|7-day Follow-up|Withdrawal by Subject|1
4558380|NCT01263223|7389602|FG000|7-day Follow-up|Lost to Follow-up|1
4558381|NCT01263223|7389603|FG001|7-day Follow-up|Lost to Follow-up|0
4558382|NCT01263444|7389660|FG000|Overall Study|Adverse Event|8
4558383|NCT01263444|7389660|FG000|Overall Study|Withdrawal by Subject|1
4558384|NCT01263444|7389660|FG000|Overall Study|Protocol Violation|1
4558385|NCT01263470|7389670|FG000|Overall Study|Adverse Event|2
4558386|NCT01263470|7389671|FG001|Overall Study|Adverse Event|2
4558387|NCT01263470|7389672|FG002|Overall Study|Adverse Event|1
4558388|NCT01263470|7389673|FG003|Overall Study|Adverse Event|1
4558389|NCT01263470|7389674|FG004|Overall Study|Adverse Event|2
4558390|NCT01263470|7389675|FG005|Overall Study|Adverse Event|2
4558391|NCT01263470|7389670|FG000|Overall Study|Protocol Violation|0
4558392|NCT01263470|7389671|FG001|Overall Study|Protocol Violation|1
4558393|NCT01263470|7389672|FG002|Overall Study|Protocol Violation|0
4558394|NCT01263470|7389673|FG003|Overall Study|Protocol Violation|0
4558395|NCT01263470|7389674|FG004|Overall Study|Protocol Violation|0
4558396|NCT01263470|7389675|FG005|Overall Study|Protocol Violation|1
4558397|NCT01263470|7389670|FG000|Overall Study|Withdrawal by Subject|0
4558398|NCT01263470|7389671|FG001|Overall Study|Withdrawal by Subject|1
4558399|NCT01263470|7389672|FG002|Overall Study|Withdrawal by Subject|1
4558400|NCT01263470|7389673|FG003|Overall Study|Withdrawal by Subject|2
4558401|NCT01263470|7389674|FG004|Overall Study|Withdrawal by Subject|0
4558402|NCT01263470|7389675|FG005|Overall Study|Withdrawal by Subject|2
4558403|NCT01263470|7389670|FG000|Overall Study|Lack of Efficacy|0
4558404|NCT01263470|7389671|FG001|Overall Study|Lack of Efficacy|0
4558405|NCT01263470|7389672|FG002|Overall Study|Lack of Efficacy|2
4558406|NCT01263470|7389673|FG003|Overall Study|Lack of Efficacy|0
4558407|NCT01263470|7389674|FG004|Overall Study|Lack of Efficacy|0
4558408|NCT01263470|7389675|FG005|Overall Study|Lack of Efficacy|0
4558409|NCT01263470|7389670|FG000|Overall Study|Participant Unavailability|0
4558410|NCT01263470|7389671|FG001|Overall Study|Participant Unavailability|1
4558411|NCT01263470|7389672|FG002|Overall Study|Participant Unavailability|0
4558412|NCT01263470|7389673|FG003|Overall Study|Participant Unavailability|0
4558413|NCT01263470|7389674|FG004|Overall Study|Participant Unavailability|0
4558414|NCT01263470|7389675|FG005|Overall Study|Participant Unavailability|0
4558415|NCT01263470|7389670|FG000|Overall Study|Study Drug Non-compliance|0
4558416|NCT01263470|7389671|FG001|Overall Study|Study Drug Non-compliance|0
4558417|NCT01263470|7389672|FG002|Overall Study|Study Drug Non-compliance|0
4558418|NCT01263470|7389673|FG003|Overall Study|Study Drug Non-compliance|0
4558419|NCT01263470|7389674|FG004|Overall Study|Study Drug Non-compliance|1
4558420|NCT01263470|7389675|FG005|Overall Study|Study Drug Non-compliance|0
4558421|NCT01263483|7389692|FG000|Overall Study|Adverse Event|4
4558422|NCT01263483|7389693|FG001|Overall Study|Adverse Event|0
4558423|NCT01263483|7389694|FG002|Overall Study|Adverse Event|3
4558424|NCT01263483|7389692|FG000|Overall Study|Withdrawal by Subject|1
4558425|NCT01263483|7389693|FG001|Overall Study|Withdrawal by Subject|0
4558426|NCT01263483|7389694|FG002|Overall Study|Withdrawal by Subject|0
4558427|NCT01263483|7389692|FG000|Overall Study|Lack of Efficacy|2
4558428|NCT01263483|7389693|FG001|Overall Study|Lack of Efficacy|0
4558429|NCT01263483|7389694|FG002|Overall Study|Lack of Efficacy|0
4558430|NCT01263483|7389692|FG000|Overall Study|Protocol Violation|0
4558431|NCT01263483|7389693|FG001|Overall Study|Protocol Violation|1
4558432|NCT01263483|7389694|FG002|Overall Study|Protocol Violation|1
4558433|NCT01263483|7389692|FG000|Overall Study|Participant Unavailability|0
4558434|NCT01263483|7389693|FG001|Overall Study|Participant Unavailability|1
4558435|NCT01263483|7389694|FG002|Overall Study|Participant Unavailability|1
4622969|NCT01806714|7486307|FG001|Overall Study|No functioning phone number|170
4622970|NCT01806740|7486313|FG000|Overall Study|Withdrawal by Subject|4
4622971|NCT01806740|7486313|FG000|Overall Study|Physician Decision|1
4622972|NCT01806740|7486313|FG000|Overall Study|Patient's refusal of treatment|1
4622973|NCT01806779|7486322|FG000|Overall Study|Physician Decision|2
4622974|NCT01806779|7486323|FG001|Overall Study|Physician Decision|0
4622975|NCT01806779|7486324|FG002|Overall Study|Physician Decision|1
4622976|NCT01806779|7486322|FG000|Overall Study|Lack of Efficacy|1
4622977|NCT01806779|7486323|FG001|Overall Study|Lack of Efficacy|1
4622978|NCT01806779|7486324|FG002|Overall Study|Lack of Efficacy|0
4622979|NCT01806779|7486322|FG000|Overall Study|Lost to Follow-up|19
4622980|NCT01806779|7486323|FG001|Overall Study|Lost to Follow-up|20
4622981|NCT01806779|7486324|FG002|Overall Study|Lost to Follow-up|0
4622982|NCT01806779|7486322|FG000|Overall Study|Withdrawal by Subject|20
4558436|NCT01263496|7389707|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1
4558437|NCT01263496|7389708|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0
4558438|NCT01263496|7389709|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0
4558439|NCT01263496|7389710|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0
4622983|NCT01806779|7486323|FG001|Overall Study|Withdrawal by Subject|23
4558440|NCT01263496|7389711|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0
4558441|NCT01263496|7389712|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0
4558442|NCT01263496|7389713|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0
4558443|NCT01263496|7389714|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0
4558444|NCT01263496|7389715|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0
4558445|NCT01263496|7389707|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0
4558446|NCT01263496|7389708|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0
4558447|NCT01263496|7389709|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0
4558448|NCT01263496|7389710|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1
4558449|NCT01263496|7389711|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2
4558450|NCT01263496|7389712|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0
4558451|NCT01263496|7389713|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0
4558452|NCT01263496|7389714|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0
4558453|NCT01263496|7389715|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0
4558454|NCT01263496|7389707|FG000|Entered - Long-Term Extension Study|Adverse Event|0
4558455|NCT01263496|7389708|FG001|Entered - Long-Term Extension Study|Adverse Event|5
4558456|NCT01263496|7389709|FG002|Entered - Long-Term Extension Study|Adverse Event|6
4558457|NCT01263496|7389710|FG003|Entered - Long-Term Extension Study|Adverse Event|3
4558458|NCT01263496|7389711|FG004|Entered - Long-Term Extension Study|Adverse Event|1
4558459|NCT01263496|7389712|FG005|Entered - Long-Term Extension Study|Adverse Event|0
4558460|NCT01263496|7389713|FG006|Entered - Long-Term Extension Study|Adverse Event|0
4558461|NCT01263496|7389714|FG007|Entered - Long-Term Extension Study|Adverse Event|0
4558462|NCT01263496|7389715|FG008|Entered - Long-Term Extension Study|Adverse Event|1
4558463|NCT01263496|7389707|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0
4558464|NCT01263496|7389708|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2
4558465|NCT01263496|7389709|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0
4558466|NCT01263496|7389710|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0
4558467|NCT01263496|7389711|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0
4558468|NCT01263496|7389712|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0
4558469|NCT01263496|7389713|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0
4558470|NCT01263496|7389714|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0
4558471|NCT01263496|7389715|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0
4558472|NCT01263496|7389707|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1
4558473|NCT01263496|7389708|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2
4558474|NCT01263496|7389709|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0
4558475|NCT01263496|7389710|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2
4558476|NCT01263496|7389711|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4
4558477|NCT01263496|7389712|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1
4558478|NCT01263496|7389713|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1
4558479|NCT01263496|7389714|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0
4558480|NCT01263496|7389715|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1
4558481|NCT01263496|7389707|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8
4558482|NCT01263496|7389708|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4
4558483|NCT01263496|7389709|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4
4558484|NCT01263496|7389710|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1
4558485|NCT01263496|7389711|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5
4558486|NCT01263496|7389712|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0
4558487|NCT01263496|7389713|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0
4558488|NCT01263496|7389714|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0
4558489|NCT01263496|7389715|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1
4558490|NCT01263496|7389707|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0
4558491|NCT01263496|7389708|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0
4558492|NCT01263496|7389709|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0
4558493|NCT01263496|7389710|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0
4558494|NCT01263496|7389711|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0
4558495|NCT01263496|7389712|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0
4558496|NCT01263496|7389713|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0
4558497|NCT01263496|7389714|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1
4558498|NCT01263496|7389715|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0
4558499|NCT01263509|7389729|FG000|Entered - Long-Term Extension Study|Adverse Event|5
4558500|NCT01263509|7389730|FG001|Entered - Long-Term Extension Study|Adverse Event|5
4558501|NCT01263509|7389731|FG002|Entered - Long-Term Extension Study|Adverse Event|4
4558502|NCT01263509|7389732|FG003|Entered - Long-Term Extension Study|Adverse Event|1
4558503|NCT01263509|7389729|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1
4558504|NCT01263509|7389730|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4
4558505|NCT01263509|7389731|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1
4558506|NCT01263509|7389732|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0
4558507|NCT01263509|7389729|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1
4558508|NCT01263509|7389730|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2
4558509|NCT01263509|7389731|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0
4558510|NCT01263509|7389732|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0
4558511|NCT01263509|7389729|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1
4558512|NCT01263509|7389730|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1
4558513|NCT01263509|7389731|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0
4558514|NCT01263509|7389732|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0
4558515|NCT01263509|7389729|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
4558516|NCT01263509|7389730|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
4558517|NCT01263509|7389731|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
4558518|NCT01263509|7389732|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1
4558519|NCT01263561|7389740|FG000|Overall Study|Death|1
4558520|NCT01263561|7389741|FG001|Overall Study|Death|2
4558521|NCT01263639|7389749|FG000|Overall Study|Lost to Follow-up|66
4558522|NCT01263639|7389750|FG001|Overall Study|Lost to Follow-up|70
4558523|NCT01263639|7389749|FG000|Overall Study|Exclusion =Admission greater than 7 days|7
4558524|NCT01263639|7389750|FG001|Overall Study|Exclusion =Admission greater than 7 days|9
4622984|NCT01806779|7486324|FG002|Overall Study|Withdrawal by Subject|22
4622985|NCT01806896|7486341|FG000|Overall Study|Adverse Event|2
4622986|NCT01806896|7486342|FG001|Overall Study|Adverse Event|0
4558525|NCT01263665|7389756|FG000|Overall Study|Withdrew Consent|1
4558526|NCT01263665|7389756|FG000|Overall Study|Lost to Follow-up|3
4558527|NCT01263665|7389756|FG000|Overall Study|Death|2
4558528|NCT01263665|7389756|FG000|Overall Study|Amputation above the ankle|1
4558529|NCT01263665|7389756|FG000|Overall Study|Surgical Bypass|2
4558530|NCT01263691|7389766|FG000|Overall Study|Lost to Follow-up|1
4558531|NCT01263691|7389767|FG001|Overall Study|Lost to Follow-up|0
4558532|NCT01263691|7389768|FG002|Overall Study|Lost to Follow-up|1
4558533|NCT01263691|7389769|FG003|Overall Study|Lost to Follow-up|1
4558534|NCT01263691|7389770|FG004|Overall Study|Lost to Follow-up|0
4558535|NCT01263691|7389771|FG005|Overall Study|Lost to Follow-up|0
4558536|NCT01263691|7389766|FG000|Overall Study|Withdrawal by Subject|1
4558537|NCT01263691|7389767|FG001|Overall Study|Withdrawal by Subject|0
4558538|NCT01263691|7389768|FG002|Overall Study|Withdrawal by Subject|0
4558539|NCT01263691|7389769|FG003|Overall Study|Withdrawal by Subject|0
4558540|NCT01263691|7389770|FG004|Overall Study|Withdrawal by Subject|0
4558541|NCT01263691|7389771|FG005|Overall Study|Withdrawal by Subject|0
4558542|NCT01263691|7389766|FG000|Overall Study|Adverse Event|1
4558543|NCT01263691|7389767|FG001|Overall Study|Adverse Event|0
4558544|NCT01263691|7389768|FG002|Overall Study|Adverse Event|0
4558545|NCT01263691|7389769|FG003|Overall Study|Adverse Event|0
4558546|NCT01263691|7389770|FG004|Overall Study|Adverse Event|0
4558547|NCT01263691|7389771|FG005|Overall Study|Adverse Event|0
4558548|NCT01263704|7389806|FG000|Overall Study|Progressive disease|18
4558549|NCT01263704|7389806|FG000|Overall Study|Adverse Event|3
4558550|NCT01263704|7389806|FG000|Overall Study|Death|2
4558551|NCT01263704|7389806|FG000|Overall Study|Patient withdrew consent|2
4558552|NCT01263704|7389806|FG000|Overall Study|Eligibility criteria not fulfilled|1
4558553|NCT01263704|7389806|FG000|Overall Study|Lost to Follow-up|1
4558554|NCT01263704|7389806|FG000|Overall Study|Colon metastases|1
4558555|NCT01263704|7389806|FG000|Overall Study|Principal Investigator (PI) decision|1
4558556|NCT01263782|7389823|FG000|Overall Study|Death|0
4558557|NCT01263782|7389824|FG001|Overall Study|Death|0
4558558|NCT01263782|7389825|FG002|Overall Study|Death|1
4558559|NCT01263782|7389826|FG003|Overall Study|Death|0
4558560|NCT01263782|7389823|FG000|Overall Study|Progressive disease|0
4558561|NCT01263782|7389824|FG001|Overall Study|Progressive disease|0
4558562|NCT01263782|7389825|FG002|Overall Study|Progressive disease|0
4558563|NCT01263782|7389826|FG003|Overall Study|Progressive disease|1
4558564|NCT01263782|7389823|FG000|Overall Study|Too early|0
4558565|NCT01263782|7389824|FG001|Overall Study|Too early|0
4558566|NCT01263782|7389825|FG002|Overall Study|Too early|1
4558567|NCT01263782|7389826|FG003|Overall Study|Too early|0
4558568|NCT01263782|7389823|FG000|Overall Study|Inevaluable|0
4558569|NCT01263782|7389824|FG001|Overall Study|Inevaluable|0
4558570|NCT01263782|7389825|FG002|Overall Study|Inevaluable|1
4558571|NCT01263782|7389826|FG003|Overall Study|Inevaluable|0
4558572|NCT01263873|7389838|FG000|Overall Study|One provider unable to complete numbers|1
4558573|NCT01263873|7389839|FG001|Overall Study|One provider unable to complete numbers|1
4558574|NCT01263925|7389847|FG000|Overall Study|Protocol Violation|1
4558575|NCT01263925|7389848|FG001|Overall Study|Protocol Violation|0
4558576|NCT01263925|7389847|FG000|Overall Study|Lack of Efficacy|0
4558577|NCT01263925|7389848|FG001|Overall Study|Lack of Efficacy|1
4558578|NCT01263925|7389847|FG000|Overall Study|Adverse Event|23
4558579|NCT01263925|7389848|FG001|Overall Study|Adverse Event|22
4558580|NCT01263925|7389847|FG000|Overall Study|Unsatisfactory Compliance of Subject|8
4558581|NCT01263925|7389848|FG001|Overall Study|Unsatisfactory Compliance of Subject|5
4558582|NCT01263925|7389847|FG000|Overall Study|Withdrawal by Subject|6
4558583|NCT01263925|7389848|FG001|Overall Study|Withdrawal by Subject|8
4558584|NCT01263925|7389847|FG000|Overall Study|Other|4
4558585|NCT01263925|7389848|FG001|Overall Study|Other|4
4558586|NCT01263925|7389847|FG000|Overall Study|Lost to Follow-up|3
4558587|NCT01263925|7389848|FG001|Overall Study|Lost to Follow-up|1
4558588|NCT01263925|7389847|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1
4558589|NCT01263925|7389848|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1
4558590|NCT01263925|7389847|FG000|Overall Study|AE/ Unsatisfactory Compliance|2
4558591|NCT01263925|7389848|FG001|Overall Study|AE/ Unsatisfactory Compliance|2
4558592|NCT01263925|7389847|FG000|Overall Study|AE/ Withdrawal|1
4558593|NCT01263925|7389848|FG001|Overall Study|AE/ Withdrawal|4
4558594|NCT01263925|7389847|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1
4622987|NCT01806896|7486341|FG000|Overall Study|Other|1
4558595|NCT01263925|7389848|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1
4558596|NCT01263925|7389847|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1
4558597|NCT01263925|7389848|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2
4622988|NCT01806896|7486342|FG001|Overall Study|Other|0
4558598|NCT01263925|7389847|FG000|Overall Study|Withdrawal/ Not specified|0
4558599|NCT01263925|7389848|FG001|Overall Study|Withdrawal/ Not specified|1
4558600|NCT01264016|7389859|FG000|Overall Study|Withdrawal by Subject|1
4558601|NCT01264016|7389859|FG000|Overall Study|Felt faint at sight of blood|1
4558602|NCT01264081|7389864|FG000|Participants Screened|Screening failures|30
4558603|NCT01264081|7389864|FG000|Started Treatment|Withdrawal by Subject|1
4558604|NCT01264081|7389864|FG000|Started Treatment|Not complete cycle 1 due to death|1
4558605|NCT01264380|7389868|FG000|Period C|Disease Progression|0
4558606|NCT01264380|7389869|FG001|Period C|Disease Progression|0
4558607|NCT01264380|7389870|FG002|Period C|Disease Progression|4
4558608|NCT01264380|7389868|FG000|Period C|Death|0
4558609|NCT01264380|7389869|FG001|Period C|Death|0
4558610|NCT01264380|7389870|FG002|Period C|Death|2
4558611|NCT01264380|7389868|FG000|Period C|Follow-up for survival status|0
4558612|NCT01264380|7389869|FG001|Period C|Follow-up for survival status|0
4558613|NCT01264380|7389870|FG002|Period C|Follow-up for survival status|6
4558614|NCT01264380|7389868|FG000|Period C|Withdrawal by Subject|0
4558615|NCT01264380|7389869|FG001|Period C|Withdrawal by Subject|0
4558616|NCT01264380|7389870|FG002|Period C|Withdrawal by Subject|1
4558617|NCT01264380|7389868|FG000|Period C|Adverse Event|0
4558618|NCT01264380|7389869|FG001|Period C|Adverse Event|0
4558619|NCT01264380|7389870|FG002|Period C|Adverse Event|1
4558620|NCT01264419|7389878|FG000|Overall Study|Lost to Follow-up|3
4558621|NCT01264718|7389918|FG000|Overall Study|Lost to Follow-up|3
4558622|NCT01264718|7389919|FG001|Overall Study|Lost to Follow-up|2
4558623|NCT01264718|7389918|FG000|Overall Study|Withdrawal by Subject|9
4558624|NCT01264718|7389919|FG001|Overall Study|Withdrawal by Subject|15
4558625|NCT01264718|7389918|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37
4558626|NCT01264718|7389919|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26
4558627|NCT01264770|7389931|FG000|Overall Study|Not reported|0
4558628|NCT01264770|7389932|FG001|Overall Study|Not reported|0
4558629|NCT01264770|7389933|FG002|Overall Study|Not reported|1
4558630|NCT01264770|7389934|FG003|Overall Study|Not reported|0
4558631|NCT01264770|7389935|FG004|Overall Study|Not reported|0
4558632|NCT01264770|7389936|FG005|Overall Study|Not reported|0
4558633|NCT01264770|7389931|FG000|Overall Study|e.g., change in circumstances|8
4558634|NCT01264770|7389932|FG001|Overall Study|e.g., change in circumstances|3
4558635|NCT01264770|7389933|FG002|Overall Study|e.g., change in circumstances|3
4558636|NCT01264770|7389934|FG003|Overall Study|e.g., change in circumstances|3
4558637|NCT01264770|7389935|FG004|Overall Study|e.g., change in circumstances|4
4558638|NCT01264770|7389936|FG005|Overall Study|e.g., change in circumstances|4
4558639|NCT01264770|7389931|FG000|Overall Study|Severe non-compliance to protocol|0
4558640|NCT01264770|7389932|FG001|Overall Study|Severe non-compliance to protocol|0
4558641|NCT01264770|7389933|FG002|Overall Study|Severe non-compliance to protocol|1
4558642|NCT01264770|7389934|FG003|Overall Study|Severe non-compliance to protocol|1
4558643|NCT01264770|7389935|FG004|Overall Study|Severe non-compliance to protocol|0
4558644|NCT01264770|7389936|FG005|Overall Study|Severe non-compliance to protocol|0
4558645|NCT01264770|7389931|FG000|Overall Study|Lack of therapeutic response|1
4558646|NCT01264770|7389932|FG001|Overall Study|Lack of therapeutic response|0
4558647|NCT01264770|7389933|FG002|Overall Study|Lack of therapeutic response|2
4558648|NCT01264770|7389934|FG003|Overall Study|Lack of therapeutic response|1
4558649|NCT01264770|7389935|FG004|Overall Study|Lack of therapeutic response|1
4558650|NCT01264770|7389936|FG005|Overall Study|Lack of therapeutic response|0
4558651|NCT01264770|7389931|FG000|Overall Study|Dev. of study specific discont. criteria|2
4558652|NCT01264770|7389932|FG001|Overall Study|Dev. of study specific discont. criteria|0
4558653|NCT01264770|7389933|FG002|Overall Study|Dev. of study specific discont. criteria|0
4558654|NCT01264770|7389934|FG003|Overall Study|Dev. of study specific discont. criteria|0
4558655|NCT01264770|7389935|FG004|Overall Study|Dev. of study specific discont. criteria|1
4558656|NCT01264770|7389936|FG005|Overall Study|Dev. of study specific discont. criteria|1
4558657|NCT01264770|7389931|FG000|Overall Study|Lost to Follow-up|0
4558658|NCT01264770|7389932|FG001|Overall Study|Lost to Follow-up|0
4558659|NCT01264770|7389933|FG002|Overall Study|Lost to Follow-up|1
4558660|NCT01264770|7389934|FG003|Overall Study|Lost to Follow-up|1
4558661|NCT01264770|7389935|FG004|Overall Study|Lost to Follow-up|0
4558662|NCT01264770|7389936|FG005|Overall Study|Lost to Follow-up|0
4558663|NCT01264770|7389931|FG000|Overall Study|Adverse Event|7
4558664|NCT01264770|7389932|FG001|Overall Study|Adverse Event|7
4558665|NCT01264770|7389933|FG002|Overall Study|Adverse Event|8
4558666|NCT01264770|7389934|FG003|Overall Study|Adverse Event|0
4558667|NCT01264770|7389935|FG004|Overall Study|Adverse Event|2
4558668|NCT01264770|7389936|FG005|Overall Study|Adverse Event|1
4558669|NCT01264887|7389956|FG000|Overall Study|Adverse Event|5
4558670|NCT01264887|7389956|FG000|Overall Study|Death|7
4558671|NCT01264887|7389956|FG000|Overall Study|Lack of Efficacy|5
4558672|NCT01264887|7389956|FG000|Overall Study|Physician Decision|4
4558673|NCT01264887|7389956|FG000|Overall Study|Withdrawal by Subject|6
4558674|NCT01264887|7389956|FG000|Overall Study|Sponsor Decision Administrative Reasons|2
4558675|NCT01264887|7389956|FG000|Overall Study|Other|2
4558676|NCT01264939|7389964|FG000|Overall Study|Adverse Event|1
4558677|NCT01264939|7389965|FG001|Overall Study|Adverse Event|3
4558678|NCT01264939|7389964|FG000|Overall Study|Lost to Follow-up|0
4558679|NCT01264939|7389965|FG001|Overall Study|Lost to Follow-up|3
4558680|NCT01264939|7389964|FG000|Overall Study|Physician Decision|1
4558681|NCT01264939|7389965|FG001|Overall Study|Physician Decision|1
4558682|NCT01264939|7389964|FG000|Overall Study|Patient/Guardian Decision|8
4558683|NCT01264939|7389965|FG001|Overall Study|Patient/Guardian Decision|10
4558684|NCT01264939|7389964|FG000|Overall Study|Disease Progression|8
4558685|NCT01264939|7389965|FG001|Overall Study|Disease Progression|11
4558686|NCT01265056|7389986|FG000|Initial Study Period|Withdrawal by Subject|1
4558687|NCT01265056|7389987|FG001|Initial Study Period|Withdrawal by Subject|1
4558688|NCT01265056|7389986|FG000|Initial Study Period|Withdrawal by Subject|1
4558689|NCT01265056|7389987|FG001|Initial Study Period|Withdrawal by Subject|1
4558690|NCT01265056|7389986|FG000|Follow up|Lost to Follow-up|7
4558691|NCT01265056|7389987|FG001|Follow up|Lost to Follow-up|3
4558692|NCT01265394|7389993|FG000|Overall Study|Subjects withdrawn|37
4558693|NCT01265420|7389998|FG000|Overall Study|Lost to Follow-up|1
4558694|NCT01265498|7390038|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31
4558695|NCT01265498|7390039|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33
4558696|NCT01265511|7390047|FG000|Overall Study|Lack of Efficacy|2
4558697|NCT01265511|7390048|FG001|Overall Study|Lack of Efficacy|1
4558698|NCT01265511|7390047|FG000|Overall Study|Met stopping rules|0
4558699|NCT01265511|7390048|FG001|Overall Study|Met stopping rules|2
4558700|NCT01265537|7390065|FG000|Overall Study|Adverse Event|2
4558701|NCT01265537|7390066|FG001|Overall Study|Adverse Event|1
4558702|NCT01265537|7390065|FG000|Overall Study|Physician Decision|0
4558703|NCT01265537|7390066|FG001|Overall Study|Physician Decision|1
4558704|NCT01265550|7390076|FG000|Pre Randomization|Withdrawal by Subject|0
4558705|NCT01265550|7390077|FG001|Pre Randomization|Withdrawal by Subject|0
4558706|NCT01265550|7390078|FG002|Pre Randomization|Withdrawal by Subject|0
4558707|NCT01265550|7390079|FG003|Pre Randomization|Withdrawal by Subject|70
4558708|NCT01265550|7390076|FG000|Pre Randomization|Technical Exclusions|0
4558709|NCT01265550|7390077|FG001|Pre Randomization|Technical Exclusions|0
4558710|NCT01265550|7390078|FG002|Pre Randomization|Technical Exclusions|0
4558711|NCT01265550|7390079|FG003|Pre Randomization|Technical Exclusions|54
4558712|NCT01265550|7390076|FG000|Pre Randomization|GERD, PPI-Responsive|0
4558713|NCT01265550|7390077|FG001|Pre Randomization|GERD, PPI-Responsive|0
4558714|NCT01265550|7390078|FG002|Pre Randomization|GERD, PPI-Responsive|0
4558715|NCT01265550|7390079|FG003|Pre Randomization|GERD, PPI-Responsive|42
4558716|NCT01265550|7390076|FG000|Pre Randomization|Non-GERD organic disorders|0
4558717|NCT01265550|7390077|FG001|Pre Randomization|Non-GERD organic disorders|0
4622989|NCT01807065|7486384|FG000|Overall Study|Receive no sip-T due to IV access|1
4622990|NCT01807065|7486385|FG001|Overall Study|Receive no sip-T due to IV access|1
4622991|NCT01807156|7486404|FG000|Overall Study|Physician Decision|1
4622992|NCT01807221|7486414|FG000|Overall Study|Progressive disease|1
4622993|NCT01807221|7486415|FG001|Overall Study|Progressive disease|0
4622994|NCT01807221|7486416|FG002|Overall Study|Progressive disease|1
4622995|NCT01807221|7486417|FG003|Overall Study|Progressive disease|0
4622996|NCT01807221|7486418|FG004|Overall Study|Progressive disease|0
4622997|NCT01807221|7486419|FG005|Overall Study|Progressive disease|0
4622998|NCT01807221|7486414|FG000|Overall Study|Death|7
4622999|NCT01807221|7486415|FG001|Overall Study|Death|9
4623000|NCT01807221|7486416|FG002|Overall Study|Death|4
4623001|NCT01807221|7486417|FG003|Overall Study|Death|2
4623002|NCT01807221|7486418|FG004|Overall Study|Death|1
4623003|NCT01807221|7486419|FG005|Overall Study|Death|6
4623004|NCT01807221|7486414|FG000|Overall Study|Physician Decision|2
4623005|NCT01807221|7486415|FG001|Overall Study|Physician Decision|1
4623006|NCT01807221|7486416|FG002|Overall Study|Physician Decision|0
4623007|NCT01807221|7486417|FG003|Overall Study|Physician Decision|0
4623008|NCT01807221|7486418|FG004|Overall Study|Physician Decision|0
4623009|NCT01807221|7486419|FG005|Overall Study|Physician Decision|0
4623010|NCT01807221|7486414|FG000|Overall Study|Adverse Event|33
4623011|NCT01807221|7486415|FG001|Overall Study|Adverse Event|22
4623012|NCT01807221|7486416|FG002|Overall Study|Adverse Event|26
4623013|NCT01807221|7486417|FG003|Overall Study|Adverse Event|25
4623014|NCT01807221|7486418|FG004|Overall Study|Adverse Event|18
4623015|NCT01807221|7486419|FG005|Overall Study|Adverse Event|21
4623016|NCT01807221|7486414|FG000|Overall Study|Protocol Violation|0
4558718|NCT01265550|7390078|FG002|Pre Randomization|Non-GERD organic disorders|0
4558719|NCT01265550|7390079|FG003|Pre Randomization|Non-GERD organic disorders|23
4558720|NCT01265550|7390076|FG000|Pre Randomization|Functional heartburn|0
4558721|NCT01265550|7390077|FG001|Pre Randomization|Functional heartburn|0
4558722|NCT01265550|7390078|FG002|Pre Randomization|Functional heartburn|0
4558723|NCT01265550|7390079|FG003|Pre Randomization|Functional heartburn|99
4558724|NCT01265563|7390098|FG000|Overall Study|Withdrawal by Subject|0
4558725|NCT01265563|7390099|FG001|Overall Study|Withdrawal by Subject|1
4558726|NCT01265563|7390100|FG002|Overall Study|Withdrawal by Subject|1
4558727|NCT01265563|7390101|FG003|Overall Study|Withdrawal by Subject|0
4558728|NCT01265563|7390102|FG004|Overall Study|Withdrawal by Subject|2
4558729|NCT01265615|7390123|FG000|Overall Study|Protocol Violation|2
4558730|NCT01265615|7390124|FG001|Overall Study|Protocol Violation|2
4558731|NCT01265615|7390125|FG002|Overall Study|Protocol Violation|4
4558732|NCT01265615|7390126|FG003|Overall Study|Protocol Violation|3
4558733|NCT01265719|7390147|FG000|Overall Study|Does not meet entrance criteria|0
4623017|NCT01807221|7486415|FG001|Overall Study|Protocol Violation|2
4623018|NCT01807221|7486416|FG002|Overall Study|Protocol Violation|1
4558734|NCT01265719|7390148|FG001|Overall Study|Does not meet entrance criteria|3
4558735|NCT01265719|7390147|FG000|Overall Study|Other reasons|2
4558736|NCT01265719|7390148|FG001|Overall Study|Other reasons|0
4558737|NCT01265719|7390147|FG000|Overall Study|Withdrawal by Subject|8
4558738|NCT01265719|7390148|FG001|Overall Study|Withdrawal by Subject|3
4558739|NCT01265719|7390147|FG000|Overall Study|Lost to Follow-up|2
4558740|NCT01265719|7390148|FG001|Overall Study|Lost to Follow-up|7
4558741|NCT01265719|7390147|FG000|Overall Study|Adverse Event|2
4558742|NCT01265719|7390148|FG001|Overall Study|Adverse Event|0
4558743|NCT01265797|7390156|FG000|Run-in Month|Withdrawal by Subject|0
4558744|NCT01265797|7390157|FG001|Run-in Month|Withdrawal by Subject|4
4558745|NCT01265797|7390156|FG000|Run-in Month|1st seizure during run-in month|0
4558746|NCT01265797|7390157|FG001|Run-in Month|1st seizure during run-in month|1
4558747|NCT01265797|7390156|FG000|Blinded Month|Lack of Efficacy|5
4558748|NCT01265797|7390157|FG001|Blinded Month|Lack of Efficacy|0
4558749|NCT01265797|7390156|FG000|Blinded Month|Lost to Follow-up|1
4558750|NCT01265797|7390157|FG001|Blinded Month|Lost to Follow-up|0
4558751|NCT01265797|7390156|FG000|Blinded Month|Protocol Violation|2
4558752|NCT01265797|7390157|FG001|Blinded Month|Protocol Violation|1
4558753|NCT01265797|7390156|FG000|Blinded Month|Adverse Event|2
4558754|NCT01265797|7390157|FG001|Blinded Month|Adverse Event|0
4558755|NCT01265797|7390156|FG000|Blinded Month|Diary data incomplete|0
4558756|NCT01265797|7390157|FG001|Blinded Month|Diary data incomplete|1
4558757|NCT01265797|7390156|FG000|Open Label Month|Lost to Follow-up|0
4558758|NCT01265797|7390157|FG001|Open Label Month|Lost to Follow-up|1
4592051|NCT01536418|7439267|FG001|Overall Study|Study closed/terminated|37
4592052|NCT01536418|7439266|FG000|Overall Study|Lack of Efficacy|10
4592053|NCT01536418|7439267|FG001|Overall Study|Lack of Efficacy|16
4592054|NCT01536418|7439266|FG000|Overall Study|Adverse Event|9
4592055|NCT01536418|7439267|FG001|Overall Study|Adverse Event|4
4592056|NCT01536418|7439266|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1
4592057|NCT01536418|7439267|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0
4592058|NCT01536418|7439266|FG000|Overall Study|Withdrawal by Subject|5
4592059|NCT01536418|7439267|FG001|Overall Study|Withdrawal by Subject|3
4592060|NCT01536535|7439287|FG000|Overall Study|Withdrawal by Subject|10
4592061|NCT01536535|7439288|FG001|Overall Study|Withdrawal by Subject|5
4592062|NCT01536535|7439287|FG000|Overall Study|Lost to Follow-up|4
4592063|NCT01536535|7439288|FG001|Overall Study|Lost to Follow-up|6
4592064|NCT01536535|7439287|FG000|Overall Study|Physician Decision|1
4592065|NCT01536535|7439288|FG001|Overall Study|Physician Decision|1
4592066|NCT01536535|7439287|FG000|Overall Study|Participant moved|0
4592067|NCT01536535|7439288|FG001|Overall Study|Participant moved|1
4592068|NCT01536561|7439295|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40
4592069|NCT01536561|7439295|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2
4592070|NCT01536561|7439295|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1
4592071|NCT01536561|7439295|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1
4592072|NCT01536561|7439295|FG000|Dosimetric and Therapeutic Treatment|Death|2
4592073|NCT01536561|7439295|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13
4592074|NCT01536574|7439304|FG000|Overall Study|Adverse Event|4
4592075|NCT01536574|7439305|FG001|Overall Study|Adverse Event|5
4592076|NCT01536574|7439304|FG000|Overall Study|Withdrawal by Subject|1
4592077|NCT01536574|7439305|FG001|Overall Study|Withdrawal by Subject|2
4592078|NCT01536574|7439304|FG000|Overall Study|Lack of Efficacy|1
4592079|NCT01536574|7439305|FG001|Overall Study|Lack of Efficacy|0
4592080|NCT01536587|7439311|FG000|Overall Study|Adverse Event|2
4592081|NCT01536704|7439315|FG000|Washout Period 1|Withdrawal by Subject|1
4592082|NCT01536704|7439316|FG001|Washout Period 1|Withdrawal by Subject|2
4592083|NCT01536704|7439317|FG002|Washout Period 1|Withdrawal by Subject|0
4592084|NCT01536704|7439318|FG003|Washout Period 1|Withdrawal by Subject|0
4592085|NCT01536704|7439315|FG000|Washout Period 2|Adverse Event|1
4592086|NCT01536704|7439316|FG001|Washout Period 2|Adverse Event|0
4592087|NCT01536704|7439317|FG002|Washout Period 2|Adverse Event|0
4592088|NCT01536704|7439318|FG003|Washout Period 2|Adverse Event|0
4592089|NCT01536704|7439315|FG000|Washout Period 2|Withdrawal by Subject|0
4592090|NCT01536704|7439316|FG001|Washout Period 2|Withdrawal by Subject|0
4592091|NCT01536704|7439317|FG002|Washout Period 2|Withdrawal by Subject|0
4592092|NCT01536704|7439318|FG003|Washout Period 2|Withdrawal by Subject|1
4592093|NCT01536704|7439315|FG000|Period 3|Adverse Event|0
4592094|NCT01536704|7439316|FG001|Period 3|Adverse Event|0
4592095|NCT01536704|7439317|FG002|Period 3|Adverse Event|0
4592096|NCT01536704|7439318|FG003|Period 3|Adverse Event|1
4592097|NCT01536704|7439315|FG000|Washout Period 3|Adverse Event|0
4592098|NCT01536704|7439316|FG001|Washout Period 3|Adverse Event|0
4592099|NCT01536704|7439317|FG002|Washout Period 3|Adverse Event|1
4592100|NCT01536704|7439318|FG003|Washout Period 3|Adverse Event|0
4592101|NCT01536795|7439334|FG000|Overall Study|Lost to Follow-up|0
4592102|NCT01536795|7439335|FG001|Overall Study|Lost to Follow-up|2
4592103|NCT01536795|7439334|FG000|Overall Study|Lack of Efficacy|1
4592104|NCT01536795|7439335|FG001|Overall Study|Lack of Efficacy|0
4592105|NCT01536860|7439341|FG000|Washout Period (3 Days)|Lost to Follow-up|1
4592106|NCT01536860|7439342|FG001|Washout Period (3 Days)|Lost to Follow-up|0
4592107|NCT01536860|7439343|FG002|Washout Period (3 Days)|Lost to Follow-up|0
4592108|NCT01536951|7439383|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0
4558759|NCT01265823|7390165|FG000|Overall Study|Unsatisfactory Response Efficacy|1
4558760|NCT01265823|7390165|FG000|Overall Study|Failure to Return|4
4558761|NCT01265823|7390165|FG000|Overall Study|Protocol Violation|1
4558762|NCT01265823|7390165|FG000|Overall Study|Participant Request|1
4558763|NCT01265875|7390173|FG000|Overall Study|Uncooperative/unreliable|1
4558764|NCT01265953|7390180|FG000|Overall Study|Non compliance|5
4558765|NCT01265953|7390181|FG001|Overall Study|Non compliance|3
4558766|NCT01265992|7390200|FG000|Overall Study|Lost to Follow-up|1
4558767|NCT01265992|7390200|FG000|Overall Study|Withdrawal by Subject|1
4558768|NCT01265992|7390200|FG000|Overall Study|Adverse Event|1
4558769|NCT01265992|7390200|FG000|Overall Study|Administrative reasons|2
4558770|NCT01265992|7390200|FG000|Overall Study|Stopped treatment|3
4558771|NCT01265992|7390200|FG000|Overall Study|Did not receive treatment|1
4558772|NCT01266018|7390204|FG000|Overall Study|Physician Decision|1
4558773|NCT01266018|7390205|FG001|Overall Study|Physician Decision|0
4558774|NCT01266018|7390204|FG000|Overall Study|Progressive disease|0
4558775|NCT01266018|7390205|FG001|Overall Study|Progressive disease|1
4558776|NCT01266070|7390211|FG000|Overall Study|Adverse Event|3
4558777|NCT01266070|7390211|FG000|Overall Study|Protocol Violation|1
4558778|NCT01266122|7390217|FG000|Overall Study|Lost to Follow-up|6
4558779|NCT01266122|7390218|FG001|Overall Study|Lost to Follow-up|6
4558780|NCT01266148|7390226|FG000|Overall Study|Adverse Event|2
4558781|NCT01266148|7390227|FG001|Overall Study|Adverse Event|0
4558782|NCT01266148|7390226|FG000|Overall Study|Ongoing rejection|1
4558783|NCT01266148|7390227|FG001|Overall Study|Ongoing rejection|0
4558784|NCT01266148|7390226|FG000|Overall Study|2 2R rejections|1
4558785|NCT01266148|7390227|FG001|Overall Study|2 2R rejections|0
4558786|NCT01266148|7390226|FG000|Overall Study|Death|2
4558787|NCT01266148|7390227|FG001|Overall Study|Death|3
4558788|NCT01266148|7390226|FG000|Overall Study|missing mGFR value + AE|1
4558789|NCT01266148|7390227|FG001|Overall Study|missing mGFR value + AE|0
4558790|NCT01266161|7390235|FG000|Overall Study|Ineligible|1
4558791|NCT01266161|7390236|FG001|Overall Study|Ineligible|0
4558792|NCT01266161|7390235|FG000|Overall Study|Lack of Efficacy|0
4558793|NCT01266161|7390236|FG001|Overall Study|Lack of Efficacy|1
4558794|NCT01266161|7390235|FG000|Overall Study|Vomited within 4 hours of dosing|3
4558795|NCT01266161|7390236|FG001|Overall Study|Vomited within 4 hours of dosing|0
4558796|NCT01266265|7390244|FG000|Overall Study|Death|95
4558797|NCT01266265|7390245|FG001|Overall Study|Death|73
4558798|NCT01266265|7390244|FG000|Overall Study|Lost to Follow-up|23
4558799|NCT01266265|7390245|FG001|Overall Study|Lost to Follow-up|28
4558800|NCT01266265|7390244|FG000|Overall Study|Withdrawal by Subject|13
4558801|NCT01266265|7390245|FG001|Overall Study|Withdrawal by Subject|11
4558802|NCT01266265|7390244|FG000|Overall Study|Respiratory-related adverse event|2
4558803|NCT01266265|7390245|FG001|Overall Study|Respiratory-related adverse event|1
4558804|NCT01266265|7390244|FG000|Overall Study|Transferred care to another provider|22
4558805|NCT01266265|7390245|FG001|Overall Study|Transferred care to another provider|28
4558806|NCT01266265|7390244|FG000|Overall Study|Stopped/changed PAH medication(s)|16
4558807|NCT01266265|7390245|FG001|Overall Study|Stopped/changed PAH medication(s)|9
4558808|NCT01266265|7390244|FG000|Overall Study|Enrolled in another clinical study|15
4558809|NCT01266265|7390245|FG001|Overall Study|Enrolled in another clinical study|26
4558810|NCT01266265|7390244|FG000|Overall Study|Non-compliance|8
4558811|NCT01266265|7390245|FG001|Overall Study|Non-compliance|5
4558812|NCT01266265|7390244|FG000|Overall Study|Lung transplant|6
4558813|NCT01266265|7390245|FG001|Overall Study|Lung transplant|5
4558814|NCT01266265|7390244|FG000|Overall Study|Site closed early|4
4558815|NCT01266265|7390245|FG001|Overall Study|Site closed early|3
4558816|NCT01266265|7390244|FG000|Overall Study|Clinical worsening|1
4558817|NCT01266265|7390245|FG001|Overall Study|Clinical worsening|1
4558818|NCT01266291|7390251|FG000|Overall Study|Adverse Event|1
4558819|NCT01266317|7390255|FG000|Overall Study|Withdrawal by Subject|2
4558820|NCT01266460|7390263|FG000|Overall Study|Adverse Event|3
4558821|NCT01266460|7390263|FG000|Overall Study|Withdrawal by Subject|5
4558822|NCT01266460|7390263|FG000|Overall Study|Disease Progression|18
4558823|NCT01266460|7390263|FG000|Overall Study|Not otherwise specified|8
4558824|NCT01266590|7390267|FG000|Overall Study|Adverse Event|3
4558825|NCT01266590|7390267|FG000|Overall Study|Lost to Follow-up|1
4558826|NCT01266590|7390267|FG000|Overall Study|Withdrawal by Subject|1
4558827|NCT01266590|7390267|FG000|Overall Study|Physician Decision|1
4558828|NCT01266603|7390274|FG000|Overall Study|Adverse Event|1
4558829|NCT01266603|7390274|FG000|Overall Study|Lack of Efficacy|14
4558830|NCT01266603|7390274|FG000|Overall Study|Withdrawal by Subject|1
4558831|NCT01266603|7390274|FG000|Overall Study|Failed screening; MAGE-A3 negative|26
4558832|NCT01266642|7390280|FG000|Overall Study|Protocol Violation|0
4558833|NCT01266642|7390281|FG001|Overall Study|Protocol Violation|1
4558834|NCT01266850|7390292|FG000|Overall Study|Lost to Follow-up|19
4558835|NCT01266850|7390293|FG001|Overall Study|Lost to Follow-up|19
4558836|NCT01266850|7390294|FG002|Overall Study|Lost to Follow-up|13
4558837|NCT01266850|7390295|FG003|Overall Study|Lost to Follow-up|13
4558838|NCT01266850|7390296|FG004|Overall Study|Lost to Follow-up|12
4558839|NCT01266850|7390292|FG000|Overall Study|Withdrawal by Subject|8
4558840|NCT01266850|7390293|FG001|Overall Study|Withdrawal by Subject|9
4558841|NCT01266850|7390294|FG002|Overall Study|Withdrawal by Subject|6
4558842|NCT01266850|7390295|FG003|Overall Study|Withdrawal by Subject|9
4558843|NCT01266850|7390296|FG004|Overall Study|Withdrawal by Subject|12
4558844|NCT01266850|7390292|FG000|Overall Study|Physician Decision|3
4558845|NCT01266850|7390293|FG001|Overall Study|Physician Decision|6
4558846|NCT01266850|7390294|FG002|Overall Study|Physician Decision|4
4558847|NCT01266850|7390295|FG003|Overall Study|Physician Decision|4
4558848|NCT01266850|7390296|FG004|Overall Study|Physician Decision|3
4558849|NCT01266850|7390292|FG000|Overall Study|Protocol Violation|0
4558850|NCT01266850|7390293|FG001|Overall Study|Protocol Violation|1
4558851|NCT01266850|7390294|FG002|Overall Study|Protocol Violation|0
4558852|NCT01266850|7390295|FG003|Overall Study|Protocol Violation|1
4558853|NCT01266850|7390296|FG004|Overall Study|Protocol Violation|2
4558854|NCT01266850|7390292|FG000|Overall Study|Adverse Event|0
4558855|NCT01266850|7390293|FG001|Overall Study|Adverse Event|0
4558856|NCT01266850|7390294|FG002|Overall Study|Adverse Event|0
4558857|NCT01266850|7390295|FG003|Overall Study|Adverse Event|0
4558858|NCT01266850|7390296|FG004|Overall Study|Adverse Event|1
4558859|NCT01266850|7390292|FG000|Overall Study|Site Closure|0
4558860|NCT01266850|7390293|FG001|Overall Study|Site Closure|1
4558861|NCT01266850|7390294|FG002|Overall Study|Site Closure|1
4558862|NCT01266850|7390295|FG003|Overall Study|Site Closure|1
4558863|NCT01266850|7390296|FG004|Overall Study|Site Closure|0
4558864|NCT01266876|7390313|FG000|Overall Study|Adverse Event|0
4558865|NCT01266876|7390314|FG001|Overall Study|Adverse Event|0
4558866|NCT01266876|7390315|FG002|Overall Study|Adverse Event|0
4558867|NCT01266876|7390316|FG003|Overall Study|Adverse Event|1
4558868|NCT01266876|7390317|FG004|Overall Study|Adverse Event|0
4558869|NCT01266902|7390331|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2
4558870|NCT01266902|7390332|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3
4558871|NCT01266902|7390333|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0
4558872|NCT01266902|7390331|FG000|Period 1 (Main Study)|Lost to Follow-up|5
4558873|NCT01266902|7390332|FG001|Period 1 (Main Study)|Lost to Follow-up|12
4558874|NCT01266902|7390333|FG002|Period 1 (Main Study)|Lost to Follow-up|0
4558875|NCT01266902|7390331|FG000|Period 1 (Main Study)|Lack of Efficacy|4
4558876|NCT01266902|7390332|FG001|Period 1 (Main Study)|Lack of Efficacy|2
4558877|NCT01266902|7390333|FG002|Period 1 (Main Study)|Lack of Efficacy|0
4558878|NCT01266902|7390331|FG000|Period 1 (Main Study)|Adverse Event|3
4558879|NCT01266902|7390332|FG001|Period 1 (Main Study)|Adverse Event|11
4558880|NCT01266902|7390333|FG002|Period 1 (Main Study)|Adverse Event|0
4558881|NCT01266902|7390331|FG000|Period 1 (Main Study)|Withdrawal by Subject|2
4558882|NCT01266902|7390332|FG001|Period 1 (Main Study)|Withdrawal by Subject|12
4558883|NCT01266902|7390333|FG002|Period 1 (Main Study)|Withdrawal by Subject|0
4558884|NCT01266902|7390331|FG000|Period 1 (Main Study)|Subject non-compliant|3
4558885|NCT01266902|7390332|FG001|Period 1 (Main Study)|Subject non-compliant|7
4558886|NCT01266902|7390333|FG002|Period 1 (Main Study)|Subject non-compliant|0
4558887|NCT01266902|7390331|FG000|Period 1 (Main Study)|Continued RPV treatment|11
4558888|NCT01266902|7390332|FG001|Period 1 (Main Study)|Continued RPV treatment|34
4558889|NCT01266902|7390333|FG002|Period 1 (Main Study)|Continued RPV treatment|0
4558890|NCT01266902|7390331|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0
4558891|NCT01266902|7390332|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0
4558892|NCT01266902|7390333|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1
4558893|NCT01266902|7390331|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0
4558894|NCT01266902|7390332|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0
4558895|NCT01266902|7390333|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1
4558896|NCT01266902|7390331|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0
4558897|NCT01266902|7390332|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0
4558898|NCT01266902|7390333|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6
4558899|NCT01266967|7390343|FG000|Overall Study|Death|69
4558900|NCT01266967|7390344|FG001|Overall Study|Death|61
4558901|NCT01266967|7390343|FG000|Overall Study|Study Closed/Terminated|15
4558902|NCT01266967|7390344|FG001|Overall Study|Study Closed/Terminated|17
4558903|NCT01266967|7390343|FG000|Overall Study|Lost to Follow-up|2
4558904|NCT01266967|7390344|FG001|Overall Study|Lost to Follow-up|1
4558905|NCT01266967|7390343|FG000|Overall Study|Physician Decision|0
4558906|NCT01266967|7390344|FG001|Overall Study|Physician Decision|1
4558907|NCT01266967|7390343|FG000|Overall Study|Withdrawal by Subject|3
4558908|NCT01266967|7390344|FG001|Overall Study|Withdrawal by Subject|3
4558909|NCT01266993|7390355|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5
4558910|NCT01266993|7390356|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1
4558911|NCT01266993|7390355|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0
4558912|NCT01266993|7390356|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1
4558913|NCT01267175|7390396|FG000|Overall Study|Withdrawal by Subject|1
4558914|NCT01267175|7390396|FG000|Overall Study|Lost to Follow-up|1
4558915|NCT01267201|7390400|FG000|First Intervention Period|Withdrawal by Subject|1
4558916|NCT01267201|7390401|FG001|First Intervention Period|Withdrawal by Subject|0
4558917|NCT01267201|7390402|FG002|First Intervention Period|Withdrawal by Subject|0
4558918|NCT01267201|7390403|FG003|First Intervention Period|Withdrawal by Subject|0
4558919|NCT01267201|7390404|FG004|First Intervention Period|Withdrawal by Subject|0
4558920|NCT01267201|7390405|FG005|First Intervention Period|Withdrawal by Subject|0
4558921|NCT01267201|7390400|FG000|Second Intervention Period|Withdrawal by Subject|0
4558922|NCT01267201|7390401|FG001|Second Intervention Period|Withdrawal by Subject|1
4558923|NCT01267201|7390402|FG002|Second Intervention Period|Withdrawal by Subject|0
4558924|NCT01267201|7390403|FG003|Second Intervention Period|Withdrawal by Subject|0
4558925|NCT01267201|7390404|FG004|Second Intervention Period|Withdrawal by Subject|0
4558926|NCT01267201|7390405|FG005|Second Intervention Period|Withdrawal by Subject|0
4558927|NCT01267253|7390438|FG000|Overall Study|Ineligible - required test not done|1
4558928|NCT01267253|7390438|FG000|Overall Study|Inevaluable-never received study treatme|2
4558929|NCT01267266|7390442|FG000|Enrollment Phase|Withdrawal by Subject|2
4558930|NCT01267266|7390443|FG001|Enrollment Phase|Withdrawal by Subject|0
4558931|NCT01267266|7390442|FG000|Lead-in Phase|Lack of Efficacy|20
4558932|NCT01267266|7390443|FG001|Lead-in Phase|Lack of Efficacy|0
4558933|NCT01267266|7390442|FG000|Lead-in Phase|Adverse Event|2
4558934|NCT01267266|7390443|FG001|Lead-in Phase|Adverse Event|0
4558935|NCT01267266|7390442|FG000|Lead-in Phase|Withdrawal by Subject|1
4558936|NCT01267266|7390443|FG001|Lead-in Phase|Withdrawal by Subject|0
4558937|NCT01267994|7390518|FG000|Overall Study|Adverse Event|2
4558938|NCT01268046|7390527|FG000|Overall Study|Withdrawal by Subject|1
4558939|NCT01268046|7390528|FG001|Overall Study|Withdrawal by Subject|0
4558940|NCT01268046|7390529|FG002|Overall Study|Withdrawal by Subject|0
4558941|NCT01268046|7390530|FG003|Overall Study|Withdrawal by Subject|1
4558942|NCT01268046|7390527|FG000|Overall Study|Lost to Follow-up|0
4558943|NCT01268046|7390528|FG001|Overall Study|Lost to Follow-up|0
4558944|NCT01268046|7390529|FG002|Overall Study|Lost to Follow-up|1
4558945|NCT01268046|7390530|FG003|Overall Study|Lost to Follow-up|0
4558946|NCT01268059|7390544|FG000|Overall Study|Lost to Follow-up|0
4558947|NCT01268059|7390545|FG001|Overall Study|Lost to Follow-up|1
4558948|NCT01268059|7390546|FG002|Overall Study|Lost to Follow-up|0
4558949|NCT01268059|7390547|FG003|Overall Study|Lost to Follow-up|0
4558950|NCT01268059|7390544|FG000|Overall Study|Withdrawal by Subject|7
4558951|NCT01268059|7390545|FG001|Overall Study|Withdrawal by Subject|4
4558952|NCT01268059|7390546|FG002|Overall Study|Withdrawal by Subject|0
4558953|NCT01268059|7390547|FG003|Overall Study|Withdrawal by Subject|0
4558954|NCT01268059|7390544|FG000|Overall Study|Death|20
4558955|NCT01268059|7390545|FG001|Overall Study|Death|30
4558956|NCT01268059|7390546|FG002|Overall Study|Death|3
4558957|NCT01268059|7390547|FG003|Overall Study|Death|5
4558958|NCT01268059|7390544|FG000|Overall Study|Progression of disease|1
4558959|NCT01268059|7390545|FG001|Overall Study|Progression of disease|0
4558960|NCT01268059|7390546|FG002|Overall Study|Progression of disease|0
4558961|NCT01268059|7390547|FG003|Overall Study|Progression of disease|0
4558962|NCT01268098|7390562|FG000|Overall Study|Adverse Event|1
4558963|NCT01268098|7390563|FG001|Overall Study|Adverse Event|0
4558964|NCT01268150|7390578|FG000|Treatment Phase|Progression of disease|18
4558965|NCT01268150|7390578|FG000|Treatment Phase|Adverse Event|3
4558966|NCT01268150|7390578|FG000|Treatment Phase|Withdrawal by Subject|3
4558967|NCT01268150|7390578|FG000|Treatment Phase|Other|4
4558968|NCT01268150|7390578|FG000|Extension Phase|Adverse Event|3
4558969|NCT01268150|7390578|FG000|Extension Phase|Disease progression|18
4558970|NCT01268150|7390578|FG000|Extension Phase|Other|6
4558971|NCT01268267|7390588|FG000|Overall Study|Protocol Violation|1
4558972|NCT01268293|7390593|FG000|Overall Study|Disease progression|7
4558973|NCT01268293|7390593|FG000|Overall Study|Adverse Event|1
4558974|NCT01268293|7390593|FG000|Overall Study|Subject choice|1
4558975|NCT01268306|7390597|FG000|Overall Study|Lost to Follow-up|1
4558976|NCT01268488|7390601|FG000|Overall Study|Adverse Event|3
4558977|NCT01268488|7390601|FG000|Overall Study|Physician Decision|2
4558978|NCT01268501|7390606|FG000|Overall Study|Lost to Follow-up|1
4558979|NCT01268501|7390606|FG000|Overall Study|Withdrawal by Subject|3
4558980|NCT01268501|7390606|FG000|Overall Study|Unacceptable Subjective Vision|3
4558981|NCT01268501|7390606|FG000|Overall Study|Handling Difficulties|2
4558982|NCT01268514|7390610|FG000|Overall Study|Adverse Event|20
4558983|NCT01268514|7390610|FG000|Overall Study|Death|8
4558984|NCT01268514|7390610|FG000|Overall Study|Lost to Follow-up|5
4558985|NCT01268514|7390610|FG000|Overall Study|Withdrawal by Subject|3
4558986|NCT01268514|7390610|FG000|Overall Study|Withdrawal by Surgeon|5
4558987|NCT01268566|7390642|FG000|Overall Study|Lost to Follow-up|1
4558988|NCT01268566|7390642|FG000|Overall Study|Withdrawal by Subject|12
4558989|NCT01268566|7390642|FG000|Overall Study|Death|30
4558990|NCT01268683|7390653|FG000|Overall Study|Lost to Follow-up|1
4558991|NCT01268683|7390653|FG000|Overall Study|Death|1
4558992|NCT01268891|7390659|FG000|Overall Study|Adverse Event|3
4558993|NCT01268891|7390660|FG001|Overall Study|Adverse Event|7
4558994|NCT01268891|7390659|FG000|Overall Study|Lack of Efficacy|1
4558995|NCT01268891|7390660|FG001|Overall Study|Lack of Efficacy|0
4558996|NCT01268891|7390659|FG000|Overall Study|Withdrawal of Consent|3
4558997|NCT01268891|7390660|FG001|Overall Study|Withdrawal of Consent|1
4558998|NCT01268891|7390659|FG000|Overall Study|Administrative or other reason(s)|1
4558999|NCT01268891|7390660|FG001|Overall Study|Administrative or other reason(s)|0
4559000|NCT01269125|7390701|FG000|Overall Study|Adverse Event|3
4559001|NCT01269125|7390702|FG001|Overall Study|Adverse Event|5
4559002|NCT01269125|7390703|FG002|Overall Study|Adverse Event|0
4559003|NCT01269125|7390701|FG000|Overall Study|Lost to Follow-up|4
4559004|NCT01269125|7390702|FG001|Overall Study|Lost to Follow-up|0
4559005|NCT01269125|7390703|FG002|Overall Study|Lost to Follow-up|0
4559006|NCT01269346|7390711|FG000|Treatment Phase|Disease progression|3
4559007|NCT01269346|7390711|FG000|Treatment Phase|Adverse Event|3
4559008|NCT01269346|7390711|FG000|Treatment Phase|Withdrawal by Subject|1
4559009|NCT01269346|7390711|FG000|Treatment Phase|Other|2
4559010|NCT01269346|7390711|FG000|Extension Phase|Adverse Event|6
4559011|NCT01269346|7390711|FG000|Extension Phase|Withdrawal by Subject|4
4559012|NCT01269346|7390711|FG000|Extension Phase|Disease progression|22
4559013|NCT01269346|7390711|FG000|Extension Phase|Physician decision or participant choice|9
4559014|NCT01269346|7390711|FG000|Extension Phase|Clinical progression|1
4559015|NCT01269346|7390711|FG000|Extension Phase|Started a prohibited con med|1
4559016|NCT01269385|7390725|FG000|Overall Study|Adverse Event|1
4559017|NCT01269385|7390726|FG001|Overall Study|Adverse Event|1
4559018|NCT01269385|7390727|FG002|Overall Study|Adverse Event|0
4559019|NCT01269385|7390728|FG003|Overall Study|Adverse Event|0
4559020|NCT01269918|7390764|FG000|Overall Study|Did not receive study drug|0
4559021|NCT01269918|7390765|FG001|Overall Study|Did not receive study drug|3
4559022|NCT01270139|7390783|FG000|Overall Study|Adverse Event|8
4559023|NCT01270139|7390784|FG001|Overall Study|Adverse Event|17
4559024|NCT01270139|7390785|FG002|Overall Study|Adverse Event|18
4559025|NCT01270139|7390783|FG000|Overall Study|Lost to Follow-up|10
4559026|NCT01270139|7390784|FG001|Overall Study|Lost to Follow-up|9
4559027|NCT01270139|7390785|FG002|Overall Study|Lost to Follow-up|2
4559028|NCT01270256|7390802|FG000|Overall Study|Withdrawal by Subject|1
4559029|NCT01270256|7390803|FG001|Overall Study|Withdrawal by Subject|0
4559030|NCT01270321|7390812|FG000|Overall Study|Death|3
4559031|NCT01270321|7390813|FG001|Overall Study|Death|1
4559032|NCT01270321|7390814|FG002|Overall Study|Death|4
4559033|NCT01270321|7390812|FG000|Overall Study|Adverse Event|7
4559034|NCT01270321|7390813|FG001|Overall Study|Adverse Event|9
4559035|NCT01270321|7390814|FG002|Overall Study|Adverse Event|5
4559036|NCT01270464|7390825|FG000|Overall Study|Protocol Violation|4
4559037|NCT01270464|7390826|FG001|Overall Study|Protocol Violation|3
4559038|NCT01270464|7390827|FG002|Overall Study|Protocol Violation|2
4559039|NCT01270464|7390825|FG000|Overall Study|Lack of Efficacy|2
4559040|NCT01270464|7390826|FG001|Overall Study|Lack of Efficacy|3
4559041|NCT01270464|7390827|FG002|Overall Study|Lack of Efficacy|1
4559042|NCT01270464|7390825|FG000|Overall Study|Adverse Event|9
4559043|NCT01270464|7390826|FG001|Overall Study|Adverse Event|1
4559044|NCT01270464|7390827|FG002|Overall Study|Adverse Event|7
4559045|NCT01270464|7390825|FG000|Overall Study|Withdrawal by Subject|2
4559046|NCT01270464|7390826|FG001|Overall Study|Withdrawal by Subject|1
4559047|NCT01270464|7390827|FG002|Overall Study|Withdrawal by Subject|4
4559048|NCT01270464|7390825|FG000|Overall Study|Lost to Follow-up|2
4559049|NCT01270464|7390826|FG001|Overall Study|Lost to Follow-up|3
4559050|NCT01270464|7390827|FG002|Overall Study|Lost to Follow-up|1
4559051|NCT01270464|7390825|FG000|Overall Study|Other|1
4559052|NCT01270464|7390826|FG001|Overall Study|Other|1
4559053|NCT01270464|7390827|FG002|Overall Study|Other|3
4559054|NCT01270503|7390835|FG000|Overall Study|Lost to Follow-up|1
4559055|NCT01270620|7390885|FG000|Overall Study|Withdrawal by Subject|1
4559056|NCT01270620|7390886|FG001|Overall Study|Withdrawal by Subject|3
4559057|NCT01270802|7390951|FG000|Overall Study|Withdrawal by Subject|1
4559058|NCT01270802|7390952|FG001|Overall Study|Withdrawal by Subject|0
4559059|NCT01270802|7390951|FG000|Overall Study|Adverse Event|1
4559060|NCT01270802|7390952|FG001|Overall Study|Adverse Event|0
4559061|NCT01270802|7390951|FG000|Overall Study|Lost to Follow-up|0
4559062|NCT01270802|7390952|FG001|Overall Study|Lost to Follow-up|1
4559063|NCT01270828|7390961|FG000|Pregabalin CR SB|Reason Unspecified|0
4559064|NCT01270828|7390962|FG001|Pregabalin CR SB|Reason Unspecified|0
4559065|NCT01270828|7390963|FG002|Pregabalin CR SB|Reason Unspecified|8
4559066|NCT01270828|7390961|FG000|Pregabalin CR SB|Enrolled but not treated|0
4559067|NCT01270828|7390962|FG001|Pregabalin CR SB|Enrolled but not treated|0
4559068|NCT01270828|7390963|FG002|Pregabalin CR SB|Enrolled but not treated|5
4559069|NCT01270828|7390961|FG000|Pregabalin CR SB|Related adverse event|0
4559070|NCT01270828|7390962|FG001|Pregabalin CR SB|Related adverse event|0
4559071|NCT01270828|7390963|FG002|Pregabalin CR SB|Related adverse event|46
4559072|NCT01270828|7390961|FG000|Pregabalin CR SB|Lack of Efficacy|0
4559073|NCT01270828|7390962|FG001|Pregabalin CR SB|Lack of Efficacy|0
4559074|NCT01270828|7390963|FG002|Pregabalin CR SB|Lack of Efficacy|32
4559075|NCT01270828|7390961|FG000|Pregabalin CR SB|Withdrawal by Subject|0
4559076|NCT01270828|7390962|FG001|Pregabalin CR SB|Withdrawal by Subject|0
4559077|NCT01270828|7390963|FG002|Pregabalin CR SB|Withdrawal by Subject|29
4559078|NCT01270828|7390961|FG000|Pregabalin CR SB|Lost to Follow-up|0
4559079|NCT01270828|7390962|FG001|Pregabalin CR SB|Lost to Follow-up|0
4559080|NCT01270828|7390963|FG002|Pregabalin CR SB|Lost to Follow-up|10
4559081|NCT01270828|7390961|FG000|Pregabalin CR SB|Unrelated AE|0
4559082|NCT01270828|7390962|FG001|Pregabalin CR SB|Unrelated AE|0
4559083|NCT01270828|7390963|FG002|Pregabalin CR SB|Unrelated AE|8
4559084|NCT01270828|7390961|FG000|Pregabalin CR SB|Protocol Violation|0
4559085|NCT01270828|7390962|FG001|Pregabalin CR SB|Protocol Violation|0
4559086|NCT01270828|7390963|FG002|Pregabalin CR SB|Protocol Violation|8
4559087|NCT01270828|7390961|FG000|Double Blind Phase|Death|0
4559088|NCT01270828|7390962|FG001|Double Blind Phase|Death|1
4559089|NCT01270828|7390963|FG002|Double Blind Phase|Death|0
4559090|NCT01270828|7390961|FG000|Double Blind Phase|Protocol Violation|0
4559091|NCT01270828|7390962|FG001|Double Blind Phase|Protocol Violation|1
4559092|NCT01270828|7390963|FG002|Double Blind Phase|Protocol Violation|0
4559093|NCT01270828|7390961|FG000|Double Blind Phase|Protocol and GCP non-compliance|4
4559094|NCT01270828|7390962|FG001|Double Blind Phase|Protocol and GCP non-compliance|3
4559095|NCT01270828|7390963|FG002|Double Blind Phase|Protocol and GCP non-compliance|0
4559096|NCT01270828|7390961|FG000|Double Blind Phase|Reason Unspecified|7
4559097|NCT01270828|7390962|FG001|Double Blind Phase|Reason Unspecified|4
4559098|NCT01270828|7390963|FG002|Double Blind Phase|Reason Unspecified|0
4559099|NCT01270828|7390961|FG000|Double Blind Phase|Withdrawal by Subject|6
4559100|NCT01270828|7390962|FG001|Double Blind Phase|Withdrawal by Subject|15
4559101|NCT01270828|7390963|FG002|Double Blind Phase|Withdrawal by Subject|0
4559102|NCT01270828|7390961|FG000|Double Blind Phase|Lost to Follow-up|1
4559103|NCT01270828|7390962|FG001|Double Blind Phase|Lost to Follow-up|2
4559104|NCT01270828|7390963|FG002|Double Blind Phase|Lost to Follow-up|0
4559105|NCT01270828|7390961|FG000|Double Blind Phase|Lack of Efficacy|2
4559106|NCT01270828|7390962|FG001|Double Blind Phase|Lack of Efficacy|11
4559107|NCT01270828|7390963|FG002|Double Blind Phase|Lack of Efficacy|0
4559108|NCT01270828|7390961|FG000|Double Blind Phase|Adverse event not related to study drug|1
4559109|NCT01270828|7390962|FG001|Double Blind Phase|Adverse event not related to study drug|1
4559110|NCT01270828|7390963|FG002|Double Blind Phase|Adverse event not related to study drug|0
4559111|NCT01270828|7390961|FG000|Double Blind Phase|Adverse event related to study drug|5
4559112|NCT01270828|7390962|FG001|Double Blind Phase|Adverse event related to study drug|7
4559113|NCT01270828|7390963|FG002|Double Blind Phase|Adverse event related to study drug|0
4559114|NCT01270841|7390975|FG000|Overall Study|Adverse Event|0
4559115|NCT01270841|7390976|FG001|Overall Study|Adverse Event|1
4559116|NCT01270841|7390977|FG002|Overall Study|Adverse Event|0
4559117|NCT01270841|7390978|FG003|Overall Study|Adverse Event|3
4559118|NCT01270841|7390975|FG000|Overall Study|Withdrawal by Subject|3
4559119|NCT01270841|7390976|FG001|Overall Study|Withdrawal by Subject|2
4559120|NCT01270841|7390977|FG002|Overall Study|Withdrawal by Subject|3
4559121|NCT01270841|7390978|FG003|Overall Study|Withdrawal by Subject|3
4559122|NCT01270841|7390975|FG000|Overall Study|Lost to Follow-up|3
4559123|NCT01270841|7390976|FG001|Overall Study|Lost to Follow-up|1
4559124|NCT01270841|7390977|FG002|Overall Study|Lost to Follow-up|4
4559125|NCT01270841|7390978|FG003|Overall Study|Lost to Follow-up|2
4559126|NCT01270841|7390975|FG000|Overall Study|Physician Decision|0
4559127|NCT01270841|7390976|FG001|Overall Study|Physician Decision|1
4559128|NCT01270841|7390977|FG002|Overall Study|Physician Decision|0
4559129|NCT01270841|7390978|FG003|Overall Study|Physician Decision|0
4559130|NCT01270841|7390975|FG000|Overall Study|Did not qualify|6
4559131|NCT01270841|7390976|FG001|Overall Study|Did not qualify|3
4559132|NCT01270841|7390977|FG002|Overall Study|Did not qualify|4
4559133|NCT01270841|7390978|FG003|Overall Study|Did not qualify|5
4559134|NCT01270841|7390975|FG000|Overall Study|Protocol Violation|1
4559135|NCT01270841|7390976|FG001|Overall Study|Protocol Violation|5
4559136|NCT01270841|7390977|FG002|Overall Study|Protocol Violation|0
4559137|NCT01270841|7390978|FG003|Overall Study|Protocol Violation|0
4559138|NCT01270841|7390975|FG000|Overall Study|Enrolled in error|0
4559139|NCT01270841|7390976|FG001|Overall Study|Enrolled in error|1
4559140|NCT01270841|7390977|FG002|Overall Study|Enrolled in error|0
4559141|NCT01270841|7390978|FG003|Overall Study|Enrolled in error|0
4559142|NCT01270880|7390997|FG000|Overall Study|Never rec'd treatment, but registered.|1
4559143|NCT01270958|7391001|FG000|Overall Study|Lost to Follow-up|2
4559144|NCT01270958|7391001|FG000|Overall Study|Did not meet inclusion criteria for age|2
4559145|NCT01270971|7391007|FG000|Overall Study|Withdrawal by Subject|24
4559146|NCT01270971|7391008|FG001|Overall Study|Withdrawal by Subject|11
4559147|NCT01270971|7391007|FG000|Overall Study|Lost to Follow-up|18
4559148|NCT01270971|7391008|FG001|Overall Study|Lost to Follow-up|5
4559149|NCT01270971|7391007|FG000|Overall Study|Adverse Event|1
4559150|NCT01270971|7391008|FG001|Overall Study|Adverse Event|2
4559151|NCT01270971|7391007|FG000|Overall Study|Non compliance|2
4559152|NCT01270971|7391008|FG001|Overall Study|Non compliance|2
4559153|NCT01270971|7391007|FG000|Overall Study|Non-specific|7
4559154|NCT01270971|7391008|FG001|Overall Study|Non-specific|3
4559155|NCT01271010|7391014|FG000|Overall Study|Reason not specified|11
4559156|NCT01271010|7391014|FG000|Overall Study|Start of new CLL therapy|1
4559157|NCT01271010|7391014|FG000|Overall Study|Protocol Violation|1
4559158|NCT01271010|7391014|FG000|Overall Study|Death|2
4559159|NCT01271010|7391014|FG000|Overall Study|Progression and relapse of disease|1
4559160|NCT01271010|7391014|FG000|Overall Study|Withdrawal by Subject|18
4559161|NCT01271010|7391014|FG000|Overall Study|Disease progression|27
4559162|NCT01271504|7391058|FG000|Overall Study|Death|7
4559163|NCT01271504|7391059|FG001|Overall Study|Death|6
4559164|NCT01271504|7391060|FG002|Overall Study|Death|32
4559165|NCT01271504|7391061|FG003|Overall Study|Death|32
4559166|NCT01271504|7391058|FG000|Overall Study|Lost to Follow-up|0
4559167|NCT01271504|7391059|FG001|Overall Study|Lost to Follow-up|1
4559168|NCT01271504|7391060|FG002|Overall Study|Lost to Follow-up|3
4559169|NCT01271504|7391061|FG003|Overall Study|Lost to Follow-up|1
4559170|NCT01271504|7391058|FG000|Overall Study|Protocol Violation|0
4559171|NCT01271504|7391059|FG001|Overall Study|Protocol Violation|0
4559172|NCT01271504|7391060|FG002|Overall Study|Protocol Violation|0
4559173|NCT01271504|7391061|FG003|Overall Study|Protocol Violation|2
4559174|NCT01271504|7391058|FG000|Overall Study|Administrative Reasons|0
4559175|NCT01271504|7391059|FG001|Overall Study|Administrative Reasons|0
4559176|NCT01271504|7391060|FG002|Overall Study|Administrative Reasons|6
4559177|NCT01271504|7391061|FG003|Overall Study|Administrative Reasons|5
4559178|NCT01271504|7391058|FG000|Overall Study|Withdrawal by Subject|0
4559179|NCT01271504|7391059|FG001|Overall Study|Withdrawal by Subject|0
4559180|NCT01271504|7391060|FG002|Overall Study|Withdrawal by Subject|1
4559181|NCT01271504|7391061|FG003|Overall Study|Withdrawal by Subject|3
4559182|NCT01271504|7391058|FG000|Overall Study|Other|0
4559183|NCT01271504|7391059|FG001|Overall Study|Other|1
4559184|NCT01271504|7391060|FG002|Overall Study|Other|2
4559185|NCT01271504|7391061|FG003|Overall Study|Other|0
4559186|NCT01271712|7391097|FG000|Double Blind Treatment|Death|2
4559187|NCT01271712|7391098|FG001|Double Blind Treatment|Death|0
4559188|NCT01271712|7391097|FG000|Double Blind Treatment|Lack of Efficacy|1
4559189|NCT01271712|7391098|FG001|Double Blind Treatment|Lack of Efficacy|0
4559190|NCT01271712|7391097|FG000|Double Blind Treatment|Adverse Event|9
4559191|NCT01271712|7391098|FG001|Double Blind Treatment|Adverse Event|4
4559192|NCT01271712|7391097|FG000|Double Blind Treatment|Progressive disease|23
4559193|NCT01271712|7391098|FG001|Double Blind Treatment|Progressive disease|3
4559194|NCT01271712|7391097|FG000|Double Blind Treatment|Withdrawal by Subject|4
4559195|NCT01271712|7391098|FG001|Double Blind Treatment|Withdrawal by Subject|1
4559196|NCT01271712|7391097|FG000|Double Blind Treatment|Non compliance with study drug|2
4559197|NCT01271712|7391098|FG001|Double Blind Treatment|Non compliance with study drug|0
4559198|NCT01271712|7391097|FG000|Double Blind Treatment|receive no study drug|1
4559199|NCT01271712|7391098|FG001|Double Blind Treatment|receive no study drug|0
4559200|NCT01271712|7391097|FG000|Open Label Treatment|Death|6
4559201|NCT01271712|7391098|FG001|Open Label Treatment|Death|5
4559202|NCT01271712|7391097|FG000|Open Label Treatment|Withdrawal by Subject|6
4559203|NCT01271712|7391098|FG001|Open Label Treatment|Withdrawal by Subject|11
4559204|NCT01271712|7391097|FG000|Open Label Treatment|Physician Decision|2
4559205|NCT01271712|7391098|FG001|Open Label Treatment|Physician Decision|0
4559206|NCT01271712|7391097|FG000|Open Label Treatment|Adverse Event|14
4559207|NCT01271712|7391098|FG001|Open Label Treatment|Adverse Event|8
4559208|NCT01271712|7391097|FG000|Open Label Treatment|Progressive disease|59
4559209|NCT01271712|7391098|FG001|Open Label Treatment|Progressive disease|32
4559210|NCT01271712|7391097|FG000|Open Label Treatment|transferred to rollover study|1
4559211|NCT01271712|7391098|FG001|Open Label Treatment|transferred to rollover study|0
4559212|NCT01271712|7391097|FG000|Open Label Treatment|Non-compliance with study drug|1
4559213|NCT01271712|7391098|FG001|Open Label Treatment|Non-compliance with study drug|0
4559214|NCT01271712|7391097|FG000|Open Label Treatment|Protocol Violation|0
4559215|NCT01271712|7391098|FG001|Open Label Treatment|Protocol Violation|1
4559216|NCT01271712|7391097|FG000|Open Label Treatment|Switching to other therapy|2
4559217|NCT01271712|7391098|FG001|Open Label Treatment|Switching to other therapy|1
4559218|NCT01271712|7391097|FG000|Safety Follow-up|Death|11
4559219|NCT01271712|7391098|FG001|Safety Follow-up|Death|7
4559220|NCT01271712|7391097|FG000|Safety Follow-up|Withdrawal by Subject|4
4559221|NCT01271712|7391098|FG001|Safety Follow-up|Withdrawal by Subject|2
4559222|NCT01271712|7391097|FG000|Safety Follow-up|Protocol Violation|1
4559223|NCT01271712|7391098|FG001|Safety Follow-up|Protocol Violation|1
4559224|NCT01271712|7391097|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3
4559225|NCT01271712|7391098|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4
4559226|NCT01271712|7391097|FG000|Safety Follow-up|No follow-up|1
4559227|NCT01271712|7391098|FG001|Safety Follow-up|No follow-up|1
4559228|NCT01271712|7391097|FG000|Safety Follow-up|Progressive disease|1
4559229|NCT01271712|7391098|FG001|Safety Follow-up|Progressive disease|0
4559230|NCT01271712|7391097|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15
4559231|NCT01271712|7391098|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6
4559232|NCT01271725|7391107|FG000|Part A|Progressive disease according to RECIST|8
4559233|NCT01271725|7391108|FG001|Part A|Progressive disease according to RECIST|0
4559234|NCT01271725|7391107|FG000|Part A|Clinical signs/symptoms of progression|2
4559235|NCT01271725|7391108|FG001|Part A|Clinical signs/symptoms of progression|0
4559236|NCT01271725|7391107|FG000|Part A|Other Adverse Event|8
4559237|NCT01271725|7391108|FG001|Part A|Other Adverse Event|0
4559238|NCT01271725|7391107|FG000|Part A|Lost to Follow-up|1
4559239|NCT01271725|7391108|FG001|Part A|Lost to Follow-up|0
4559240|NCT01271725|7391107|FG000|Part A|Withdrawal by Subject|12
4559241|NCT01271725|7391108|FG001|Part A|Withdrawal by Subject|0
4559242|NCT01271725|7391107|FG000|Part A|Other than specified|3
4559243|NCT01271725|7391108|FG001|Part A|Other than specified|0
4559244|NCT01271725|7391107|FG000|Part A|Protocol Violation|1
4559245|NCT01271725|7391108|FG001|Part A|Protocol Violation|0
4559246|NCT01271725|7391107|FG000|Part B|Other than specified|0
4559247|NCT01271725|7391108|FG001|Part B|Other than specified|2
4559248|NCT01271725|7391107|FG000|Part B|Clinical signs/symptoms of progression|0
4559249|NCT01271725|7391108|FG001|Part B|Clinical signs/symptoms of progression|2
4559250|NCT01271725|7391107|FG000|Part B|Other Adverse Event|0
4559251|NCT01271725|7391108|FG001|Part B|Other Adverse Event|1
4559252|NCT01271725|7391107|FG000|Part B|Protocol Violation|0
4559253|NCT01271725|7391108|FG001|Part B|Protocol Violation|1
4559254|NCT01271725|7391107|FG000|Part B|Withdrawal by Subject|0
4559255|NCT01271725|7391108|FG001|Part B|Withdrawal by Subject|6
4559256|NCT01271803|7391120|FG000|Overall Study|Progressive disease|0
4559257|NCT01271803|7391121|FG001|Overall Study|Progressive disease|0
4559258|NCT01271803|7391122|FG002|Overall Study|Progressive disease|2
4559259|NCT01271803|7391120|FG000|Overall Study|Death|53
4559260|NCT01271803|7391121|FG001|Overall Study|Death|34
4559261|NCT01271803|7391122|FG002|Overall Study|Death|0
4559262|NCT01271803|7391120|FG000|Overall Study|Withdrawal by Subject|1
4559263|NCT01271803|7391121|FG001|Overall Study|Withdrawal by Subject|5
4559264|NCT01271803|7391122|FG002|Overall Study|Withdrawal by Subject|0
4559265|NCT01271803|7391120|FG000|Overall Study|Lost to Follow-up|1
4559266|NCT01271803|7391121|FG001|Overall Study|Lost to Follow-up|0
4559267|NCT01271803|7391122|FG002|Overall Study|Lost to Follow-up|0
4592109|NCT01536951|7439384|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0
4592110|NCT01536951|7439385|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1
4592111|NCT01536951|7439386|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0
4592112|NCT01536951|7439387|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0
4592113|NCT01536951|7439388|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0
4592114|NCT01536951|7439389|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0
4592115|NCT01536951|7439390|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0
4592116|NCT01536951|7439391|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0
4592117|NCT01536951|7439383|FG000|Second Intervention and Washout Period 2|Adverse Event|0
4592118|NCT01536951|7439384|FG001|Second Intervention and Washout Period 2|Adverse Event|0
4592119|NCT01536951|7439385|FG002|Second Intervention and Washout Period 2|Adverse Event|0
4592120|NCT01536951|7439386|FG003|Second Intervention and Washout Period 2|Adverse Event|0
4592121|NCT01536951|7439387|FG004|Second Intervention and Washout Period 2|Adverse Event|0
4592122|NCT01536951|7439388|FG005|Second Intervention and Washout Period 2|Adverse Event|0
4592123|NCT01536951|7439389|FG006|Second Intervention and Washout Period 2|Adverse Event|0
4592124|NCT01536951|7439390|FG007|Second Intervention and Washout Period 2|Adverse Event|1
4592125|NCT01536951|7439391|FG008|Second Intervention and Washout Period 2|Adverse Event|0
4592126|NCT01537042|7439420|FG000|Overall Study|Adverse Event|0
4592127|NCT01537042|7439421|FG001|Overall Study|Adverse Event|2
4592128|NCT01537042|7439420|FG000|Overall Study|Lack of Efficacy|0
4592129|NCT01537042|7439421|FG001|Overall Study|Lack of Efficacy|1
4592130|NCT01537042|7439420|FG000|Overall Study|Protocol Violation|0
4592131|NCT01537042|7439421|FG001|Overall Study|Protocol Violation|1
4592132|NCT01537042|7439420|FG000|Overall Study|Other|0
4592133|NCT01537042|7439421|FG001|Overall Study|Other|1
4592134|NCT01537068|7439433|FG000|Overall Study|Lost to Follow-up|2
4592135|NCT01537068|7439434|FG001|Overall Study|Lost to Follow-up|1
4592136|NCT01537068|7439433|FG000|Overall Study|Adverse Event|0
4592137|NCT01537068|7439434|FG001|Overall Study|Adverse Event|1
4592138|NCT01537068|7439433|FG000|Overall Study|Withdrawal by Subject|1
4592139|NCT01537068|7439434|FG001|Overall Study|Withdrawal by Subject|1
4592140|NCT01537068|7439433|FG000|Overall Study|Lack of Efficacy|1
4592141|NCT01537068|7439434|FG001|Overall Study|Lack of Efficacy|0
4592142|NCT01537081|7439443|FG000|Overall Study|Adverse Event|5
4592143|NCT01537081|7439444|FG001|Overall Study|Adverse Event|2
4592144|NCT01537081|7439445|FG002|Overall Study|Adverse Event|2
4592145|NCT01537081|7439443|FG000|Overall Study|Lack of Efficacy|2
4592146|NCT01537081|7439444|FG001|Overall Study|Lack of Efficacy|1
4592147|NCT01537081|7439445|FG002|Overall Study|Lack of Efficacy|0
4592148|NCT01537081|7439443|FG000|Overall Study|Lost to Follow-up|17
4592149|NCT01537081|7439444|FG001|Overall Study|Lost to Follow-up|15
4592150|NCT01537081|7439445|FG002|Overall Study|Lost to Follow-up|9
4592151|NCT01537081|7439443|FG000|Overall Study|Protocol Violation|3
4592152|NCT01537081|7439444|FG001|Overall Study|Protocol Violation|2
4592153|NCT01537081|7439445|FG002|Overall Study|Protocol Violation|2
4592154|NCT01537081|7439443|FG000|Overall Study|Withdrawal by Subject|6
4592155|NCT01537081|7439444|FG001|Overall Study|Withdrawal by Subject|11
4592156|NCT01537081|7439445|FG002|Overall Study|Withdrawal by Subject|3
4592157|NCT01537081|7439443|FG000|Overall Study|Physician Decision|5
4592158|NCT01537081|7439444|FG001|Overall Study|Physician Decision|6
4592159|NCT01537081|7439445|FG002|Overall Study|Physician Decision|0
4592160|NCT01537081|7439443|FG000|Overall Study|Sponsor decision|0
4592161|NCT01537081|7439444|FG001|Overall Study|Sponsor decision|1
4592162|NCT01537081|7439445|FG002|Overall Study|Sponsor decision|0
4592163|NCT01537081|7439443|FG000|Overall Study|Assigned but never dosed|1
4592164|NCT01537081|7439444|FG001|Overall Study|Assigned but never dosed|0
4592165|NCT01537081|7439445|FG002|Overall Study|Assigned but never dosed|0
4592166|NCT01537120|7439454|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1
4592167|NCT01537120|7439454|FG000|3 Weeks Placebo|Withdrawal by Subject|1
4592168|NCT01537133|7439464|FG000|Overall Study|Withdrawal by Subject|2
4592169|NCT01537133|7439465|FG001|Overall Study|Withdrawal by Subject|0
4592170|NCT01537133|7439466|FG002|Overall Study|Withdrawal by Subject|0
4592171|NCT01537133|7439467|FG003|Overall Study|Withdrawal by Subject|0
4592172|NCT01537133|7439464|FG000|Overall Study|Lost to Follow-up|1
4592173|NCT01537133|7439465|FG001|Overall Study|Lost to Follow-up|0
4592174|NCT01537133|7439466|FG002|Overall Study|Lost to Follow-up|0
4592175|NCT01537133|7439467|FG003|Overall Study|Lost to Follow-up|0
4592176|NCT01537198|7439494|FG000|Overall Study|RSV infection|2
4592177|NCT01537198|7439494|FG000|Overall Study|Adverse Event|4
4592178|NCT01537198|7439494|FG000|Overall Study|No Further Visits to the Clinic|37
4592179|NCT01537198|7439494|FG000|Overall Study|Other|111
4592180|NCT01537211|7439500|FG000|Overall Study|Lost to Follow-up|0
4559268|NCT01271933|7391195|FG000|Single-Blind Phase|Lack of Efficacy|37
4559269|NCT01271933|7391196|FG001|Single-Blind Phase|Lack of Efficacy|0
4559270|NCT01271933|7391197|FG002|Single-Blind Phase|Lack of Efficacy|0
4559271|NCT01271933|7391195|FG000|Single-Blind Phase|Lost to Follow-up|10
4559272|NCT01271933|7391196|FG001|Single-Blind Phase|Lost to Follow-up|0
4559273|NCT01271933|7391197|FG002|Single-Blind Phase|Lost to Follow-up|0
4559274|NCT01271933|7391195|FG000|Single-Blind Phase|Withdrawal by Subject|15
4559275|NCT01271933|7391196|FG001|Single-Blind Phase|Withdrawal by Subject|0
4559276|NCT01271933|7391197|FG002|Single-Blind Phase|Withdrawal by Subject|0
4559277|NCT01271933|7391195|FG000|Single-Blind Phase|Protocol Violation|3
4559278|NCT01271933|7391196|FG001|Single-Blind Phase|Protocol Violation|0
4559279|NCT01271933|7391197|FG002|Single-Blind Phase|Protocol Violation|0
4559280|NCT01271933|7391195|FG000|Single-Blind Phase|Adverse Event|52
4559281|NCT01271933|7391196|FG001|Single-Blind Phase|Adverse Event|0
4559282|NCT01271933|7391197|FG002|Single-Blind Phase|Adverse Event|0
4559283|NCT01271933|7391195|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1
4559284|NCT01271933|7391196|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0
4559285|NCT01271933|7391197|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0
4559286|NCT01271933|7391195|FG000|Single-Blind Phase|(Protocol non-compliance)|2
4559287|NCT01271933|7391196|FG001|Single-Blind Phase|(Protocol non-compliance)|0
4559288|NCT01271933|7391197|FG002|Single-Blind Phase|(Protocol non-compliance)|0
4559289|NCT01271933|7391195|FG000|Single-Blind Phase|(Participant request-personal reason)|1
4559290|NCT01271933|7391196|FG001|Single-Blind Phase|(Participant request-personal reason)|0
4559291|NCT01271933|7391197|FG002|Single-Blind Phase|(Participant request-personal reason)|0
4559292|NCT01271933|7391195|FG000|Double-Blind Phase|Randomized but not treated|0
4559293|NCT01271933|7391196|FG001|Double-Blind Phase|Randomized but not treated|0
4559294|NCT01271933|7391197|FG002|Double-Blind Phase|Randomized but not treated|1
4559295|NCT01271933|7391195|FG000|Double-Blind Phase|Lack of Efficacy|0
4559296|NCT01271933|7391196|FG001|Double-Blind Phase|Lack of Efficacy|6
4559297|NCT01271933|7391197|FG002|Double-Blind Phase|Lack of Efficacy|9
4559298|NCT01271933|7391195|FG000|Double-Blind Phase|Lost to Follow-up|0
4559299|NCT01271933|7391196|FG001|Double-Blind Phase|Lost to Follow-up|1
4559300|NCT01271933|7391197|FG002|Double-Blind Phase|Lost to Follow-up|1
4559301|NCT01271933|7391195|FG000|Double-Blind Phase|Withdrawal by Subject|0
4559302|NCT01271933|7391196|FG001|Double-Blind Phase|Withdrawal by Subject|6
4559303|NCT01271933|7391197|FG002|Double-Blind Phase|Withdrawal by Subject|1
4559304|NCT01271933|7391195|FG000|Double-Blind Phase|Adverse Event|0
4559305|NCT01271933|7391196|FG001|Double-Blind Phase|Adverse Event|3
4559306|NCT01271933|7391197|FG002|Double-Blind Phase|Adverse Event|0
4559307|NCT01271933|7391195|FG000|Double-Blind Phase|Participant request-personal reason|0
4559308|NCT01271933|7391196|FG001|Double-Blind Phase|Participant request-personal reason|1
4559309|NCT01271933|7391197|FG002|Double-Blind Phase|Participant request-personal reason|0
4559310|NCT01272011|7391233|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0
4559311|NCT01272011|7391234|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2
4559312|NCT01272011|7391235|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0
4559313|NCT01272180|7391251|FG000|Overall Study|Adverse Event|0
4559314|NCT01272180|7391252|FG001|Overall Study|Adverse Event|0
4559315|NCT01272180|7391253|FG002|Overall Study|Adverse Event|1
4559316|NCT01272180|7391254|FG003|Overall Study|Adverse Event|0
4559317|NCT01272180|7391251|FG000|Overall Study|Withdrawal by Subject|2
4559318|NCT01272180|7391252|FG001|Overall Study|Withdrawal by Subject|6
4559319|NCT01272180|7391253|FG002|Overall Study|Withdrawal by Subject|3
4559320|NCT01272180|7391254|FG003|Overall Study|Withdrawal by Subject|2
4559321|NCT01272180|7391251|FG000|Overall Study|Lost to Follow-up|15
4559322|NCT01272180|7391252|FG001|Overall Study|Lost to Follow-up|14
4559323|NCT01272180|7391253|FG002|Overall Study|Lost to Follow-up|8
4559324|NCT01272180|7391254|FG003|Overall Study|Lost to Follow-up|10
4559325|NCT01272180|7391251|FG000|Overall Study|Inappropriate enrollment|0
4559326|NCT01272180|7391252|FG001|Overall Study|Inappropriate enrollment|0
4559327|NCT01272180|7391253|FG002|Overall Study|Inappropriate enrollment|1
4559328|NCT01272180|7391254|FG003|Overall Study|Inappropriate enrollment|1
4559329|NCT01272180|7391251|FG000|Overall Study|Protocol Violation|0
4559330|NCT01272180|7391252|FG001|Overall Study|Protocol Violation|1
4623019|NCT01807221|7486417|FG003|Overall Study|Protocol Violation|2
4623020|NCT01807221|7486418|FG004|Overall Study|Protocol Violation|0
4623021|NCT01807221|7486419|FG005|Overall Study|Protocol Violation|1
4623022|NCT01807221|7486414|FG000|Overall Study|Non-compliance|1
4623023|NCT01807221|7486415|FG001|Overall Study|Non-compliance|2
4623024|NCT01807221|7486416|FG002|Overall Study|Non-compliance|0
4623025|NCT01807221|7486417|FG003|Overall Study|Non-compliance|1
4623026|NCT01807221|7486418|FG004|Overall Study|Non-compliance|0
4623027|NCT01807221|7486419|FG005|Overall Study|Non-compliance|0
4623028|NCT01807221|7486414|FG000|Overall Study|Logistical difficulties|0
4559331|NCT01272180|7391253|FG002|Overall Study|Protocol Violation|0
4559332|NCT01272180|7391254|FG003|Overall Study|Protocol Violation|1
4559333|NCT01272193|7391270|FG000|Overall Study|Adverse Event|1
4559334|NCT01272193|7391271|FG001|Overall Study|Adverse Event|1
4559335|NCT01272193|7391270|FG000|Overall Study|Lack of Efficacy|0
4559336|NCT01272193|7391271|FG001|Overall Study|Lack of Efficacy|3
4559337|NCT01272193|7391270|FG000|Overall Study|Withdrawal Criteria|1
4559338|NCT01272193|7391271|FG001|Overall Study|Withdrawal Criteria|1
4559339|NCT01272193|7391270|FG000|Overall Study|Unclassified|8
4559340|NCT01272193|7391271|FG001|Overall Study|Unclassified|7
4559341|NCT01272219|7391281|FG000|Main Period: Week 0 to Week 56|Adverse Event|86
4559342|NCT01272219|7391282|FG001|Main Period: Week 0 to Week 56|Adverse Event|0
4559343|NCT01272219|7391283|FG002|Main Period: Week 0 to Week 56|Adverse Event|0
4559344|NCT01272219|7391284|FG003|Main Period: Week 0 to Week 56|Adverse Event|16
4559345|NCT01272219|7391285|FG004|Main Period: Week 0 to Week 56|Adverse Event|152
4559346|NCT01272219|7391286|FG005|Main Period: Week 0 to Week 56|Adverse Event|29
4559347|NCT01272219|7391281|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11
4559348|NCT01272219|7391282|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0
4559349|NCT01272219|7391283|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0
4559350|NCT01272219|7391284|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14
4559351|NCT01272219|7391285|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12
4559352|NCT01272219|7391286|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22
4559353|NCT01272219|7391281|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25
4559354|NCT01272219|7391282|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0
4559355|NCT01272219|7391283|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0
4559356|NCT01272219|7391284|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18
4559357|NCT01272219|7391285|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40
4559358|NCT01272219|7391286|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20
4559359|NCT01272219|7391281|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122
4559360|NCT01272219|7391282|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0
4559361|NCT01272219|7391283|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0
4559362|NCT01272219|7391284|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114
4559363|NCT01272219|7391285|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172
4559364|NCT01272219|7391286|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147
4559365|NCT01272219|7391281|FG000|Main Period: Week 0 to Week 56|Unclassified|36
4559366|NCT01272219|7391282|FG001|Main Period: Week 0 to Week 56|Unclassified|0
4559367|NCT01272219|7391283|FG002|Main Period: Week 0 to Week 56|Unclassified|0
4559368|NCT01272219|7391284|FG003|Main Period: Week 0 to Week 56|Unclassified|29
4559369|NCT01272219|7391285|FG004|Main Period: Week 0 to Week 56|Unclassified|42
4559370|NCT01272219|7391286|FG005|Main Period: Week 0 to Week 56|Unclassified|34
4559371|NCT01272219|7391281|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
4559372|NCT01272219|7391282|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1
4559373|NCT01272219|7391283|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1
4559374|NCT01272219|7391284|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2
4559375|NCT01272219|7391285|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
4559376|NCT01272219|7391286|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
4559377|NCT01272219|7391281|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
4559378|NCT01272219|7391282|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
4559379|NCT01272219|7391283|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
4559380|NCT01272219|7391284|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1
4559381|NCT01272219|7391285|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
4559382|NCT01272219|7391286|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
4559383|NCT01272219|7391281|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
4559384|NCT01272219|7391282|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1
4559385|NCT01272219|7391283|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
4559386|NCT01272219|7391284|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3
4559387|NCT01272219|7391285|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
4559388|NCT01272219|7391286|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
4559389|NCT01272219|7391281|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
4559390|NCT01272219|7391282|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6
4559391|NCT01272219|7391283|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4
4559392|NCT01272219|7391284|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7
4559393|NCT01272219|7391285|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
4559394|NCT01272219|7391286|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
4559395|NCT01272219|7391281|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0
4559396|NCT01272219|7391282|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1
4559397|NCT01272219|7391283|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2
4559398|NCT01272219|7391284|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2
4559399|NCT01272219|7391285|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0
4559400|NCT01272219|7391286|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0
4559401|NCT01272219|7391281|FG000|Main + Extension Period: Week 0-172|Adverse Event|0
4559402|NCT01272219|7391282|FG001|Main + Extension Period: Week 0-172|Adverse Event|0
4559403|NCT01272219|7391283|FG002|Main + Extension Period: Week 0-172|Adverse Event|0
4559404|NCT01272219|7391284|FG003|Main + Extension Period: Week 0-172|Adverse Event|0
4559405|NCT01272219|7391285|FG004|Main + Extension Period: Week 0-172|Adverse Event|191
4559406|NCT01272219|7391286|FG005|Main + Extension Period: Week 0-172|Adverse Event|43
4559407|NCT01272219|7391281|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0
4559408|NCT01272219|7391282|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0
4559409|NCT01272219|7391283|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0
4559410|NCT01272219|7391284|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0
4559411|NCT01272219|7391285|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29
4559412|NCT01272219|7391286|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36
4559413|NCT01272219|7391281|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0
4559414|NCT01272219|7391282|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0
4559415|NCT01272219|7391283|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0
4559416|NCT01272219|7391284|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0
4559417|NCT01272219|7391285|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76
4559418|NCT01272219|7391286|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36
4559419|NCT01272219|7391281|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0
4559420|NCT01272219|7391282|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0
4559421|NCT01272219|7391283|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0
4559422|NCT01272219|7391284|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0
4559423|NCT01272219|7391285|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364
4559424|NCT01272219|7391286|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256
4559425|NCT01272219|7391281|FG000|Main + Extension Period: Week 0-172|Missing reason|0
4559426|NCT01272219|7391282|FG001|Main + Extension Period: Week 0-172|Missing reason|0
4559427|NCT01272219|7391283|FG002|Main + Extension Period: Week 0-172|Missing reason|0
4559428|NCT01272219|7391284|FG003|Main + Extension Period: Week 0-172|Missing reason|0
4559429|NCT01272219|7391285|FG004|Main + Extension Period: Week 0-172|Missing reason|1
4559430|NCT01272219|7391286|FG005|Main + Extension Period: Week 0-172|Missing reason|0
4559431|NCT01272219|7391281|FG000|Main + Extension Period: Week 0-172|Unclassified|0
4559432|NCT01272219|7391282|FG001|Main + Extension Period: Week 0-172|Unclassified|0
4559433|NCT01272219|7391283|FG002|Main + Extension Period: Week 0-172|Unclassified|0
4559434|NCT01272219|7391284|FG003|Main + Extension Period: Week 0-172|Unclassified|0
4559435|NCT01272219|7391285|FG004|Main + Extension Period: Week 0-172|Unclassified|61
4559436|NCT01272219|7391286|FG005|Main + Extension Period: Week 0-172|Unclassified|51
4559437|NCT01272232|7391302|FG000|Weeks 0-56|Adverse Event|39
4559438|NCT01272232|7391303|FG001|Weeks 0-56|Adverse Event|18
4559439|NCT01272232|7391304|FG002|Weeks 0-56|Adverse Event|7
4559440|NCT01272232|7391302|FG000|Weeks 0-56|Lack of Efficacy|0
4559441|NCT01272232|7391303|FG001|Weeks 0-56|Lack of Efficacy|0
4559442|NCT01272232|7391304|FG002|Weeks 0-56|Lack of Efficacy|3
4559443|NCT01272232|7391302|FG000|Weeks 0-56|Protocol Violation|12
4559444|NCT01272232|7391303|FG001|Weeks 0-56|Protocol Violation|8
4559445|NCT01272232|7391304|FG002|Weeks 0-56|Protocol Violation|13
4559446|NCT01272232|7391302|FG000|Weeks 0-56|Withdrawal criteria|32
4559447|NCT01272232|7391303|FG001|Weeks 0-56|Withdrawal criteria|14
4559448|NCT01272232|7391304|FG002|Weeks 0-56|Withdrawal criteria|37
4559449|NCT01272232|7391302|FG000|Weeks 0-56|Unclassified|16
4559450|NCT01272232|7391303|FG001|Weeks 0-56|Unclassified|7
4559451|NCT01272232|7391304|FG002|Weeks 0-56|Unclassified|12
4559452|NCT01272232|7391302|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1
4559453|NCT01272232|7391303|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1
4559454|NCT01272232|7391304|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0
4559455|NCT01272232|7391302|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1
4559456|NCT01272232|7391303|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0
4559457|NCT01272232|7391304|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0
4559458|NCT01272232|7391302|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1
4559459|NCT01272232|7391303|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0
4559460|NCT01272232|7391304|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1
4559461|NCT01272232|7391302|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9
4559462|NCT01272232|7391303|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7
4559463|NCT01272232|7391304|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4
4559464|NCT01272232|7391302|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2
4559465|NCT01272232|7391303|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2
4559466|NCT01272232|7391304|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0
4559467|NCT01272635|7391343|FG000|Overall Study|Lost to Follow-up|31
4559468|NCT01272635|7391344|FG001|Overall Study|Lost to Follow-up|20
4559469|NCT01272635|7391345|FG002|Overall Study|Lost to Follow-up|31
4559470|NCT01272635|7391346|FG003|Overall Study|Lost to Follow-up|23
4559471|NCT01272661|7391357|FG000|Overall Study|lost to followup/case closed/ no birth|126
4559472|NCT01272661|7391358|FG001|Overall Study|lost to followup/case closed/ no birth|209
4559473|NCT01272661|7391359|FG002|Overall Study|lost to followup/case closed/ no birth|72
4559474|NCT01272804|7391373|FG000|Overall Study|Adverse Event|1
4559475|NCT01272804|7391374|FG001|Overall Study|Adverse Event|0
4559476|NCT01272804|7391375|FG002|Overall Study|Adverse Event|0
4559477|NCT01272804|7391376|FG003|Overall Study|Adverse Event|0
4559478|NCT01272804|7391377|FG004|Overall Study|Adverse Event|2
4559479|NCT01272804|7391378|FG005|Overall Study|Adverse Event|1
4559480|NCT01272869|7391403|FG000|Period 2 (14 Days)|Adverse Event|1
4559481|NCT01272869|7391404|FG001|Period 2 (14 Days)|Adverse Event|0
4559482|NCT01272908|7391414|FG000|Initial Treatment Period|Adverse Event|1
4559483|NCT01272908|7391414|FG000|Initial Treatment Period|Lack of Efficacy|5
4559484|NCT01272908|7391414|FG000|Initial Treatment Period|Protocol Violation|1
4559485|NCT01272908|7391414|FG000|Initial Treatment Period|Withdrawal by Subject|1
4559486|NCT01272908|7391414|FG000|Re-Treatment Period|Adverse Event|2
4559487|NCT01272908|7391414|FG000|Re-Treatment Period|Lack of Efficacy|3
4559488|NCT01272908|7391414|FG000|Re-Treatment Period|Withdrawal by Subject|1
4559489|NCT01272921|7391422|FG000|Overall Study|Protocol Violation|2
4559490|NCT01272921|7391423|FG001|Overall Study|Protocol Violation|1
4559491|NCT01272934|7391433|FG000|Overall Study|Adverse Event|0
4559492|NCT01272934|7391434|FG001|Overall Study|Adverse Event|1
4559493|NCT01272934|7391433|FG000|Overall Study|Abnormal Laboratory Value|0
4559494|NCT01272934|7391434|FG001|Overall Study|Abnormal Laboratory Value|1
4559495|NCT01272947|7391443|FG000|Overall Study|Abnormal Laboratory Value|2
4559496|NCT01272947|7391444|FG001|Overall Study|Abnormal Laboratory Value|2
4559497|NCT01273038|7391473|FG000|Second Intervention (14 Days)|Adverse Event|0
4559498|NCT01273038|7391474|FG001|Second Intervention (14 Days)|Adverse Event|1
4559499|NCT01273038|7391473|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0
4559500|NCT01273038|7391474|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1
4559501|NCT01273155|7391484|FG000|Overall Study|Off study trmt prior to end of C1/PD|2
4559502|NCT01273155|7391485|FG001|Overall Study|Off study trmt prior to end of C1/PD|3
4559503|NCT01273155|7391486|FG002|Overall Study|Off study trmt prior to end of C1/PD|8
4559504|NCT01273155|7391487|FG003|Overall Study|Off study trmt prior to end of C1/PD|0
4559505|NCT01273155|7391488|FG004|Overall Study|Off study trmt prior to end of C1/PD|0
4559506|NCT01273155|7391489|FG005|Overall Study|Off study trmt prior to end of C1/PD|2
4559507|NCT01273155|7391490|FG006|Overall Study|Off study trmt prior to end of C1/PD|3
4559508|NCT01273155|7391484|FG000|Overall Study|Change in liver function/no longer eval.|0
4559509|NCT01273155|7391485|FG001|Overall Study|Change in liver function/no longer eval.|1
4559510|NCT01273155|7391486|FG002|Overall Study|Change in liver function/no longer eval.|0
4559511|NCT01273155|7391487|FG003|Overall Study|Change in liver function/no longer eval.|0
4559512|NCT01273155|7391488|FG004|Overall Study|Change in liver function/no longer eval.|1
4559513|NCT01273155|7391489|FG005|Overall Study|Change in liver function/no longer eval.|0
4559514|NCT01273155|7391490|FG006|Overall Study|Change in liver function/no longer eval.|0
4559515|NCT01273155|7391484|FG000|Overall Study|Off study prior to C1/due to toxicity|0
4559516|NCT01273155|7391485|FG001|Overall Study|Off study prior to C1/due to toxicity|0
4559517|NCT01273155|7391486|FG002|Overall Study|Off study prior to C1/due to toxicity|2
4559518|NCT01273155|7391487|FG003|Overall Study|Off study prior to C1/due to toxicity|0
4559519|NCT01273155|7391488|FG004|Overall Study|Off study prior to C1/due to toxicity|0
4559520|NCT01273155|7391489|FG005|Overall Study|Off study prior to C1/due to toxicity|0
4559521|NCT01273155|7391490|FG006|Overall Study|Off study prior to C1/due to toxicity|1
4559522|NCT01273155|7391484|FG000|Overall Study|Died during Cycle 1|0
4559523|NCT01273155|7391485|FG001|Overall Study|Died during Cycle 1|0
4559524|NCT01273155|7391486|FG002|Overall Study|Died during Cycle 1|1
4559525|NCT01273155|7391487|FG003|Overall Study|Died during Cycle 1|1
4559526|NCT01273155|7391488|FG004|Overall Study|Died during Cycle 1|0
4559527|NCT01273155|7391489|FG005|Overall Study|Died during Cycle 1|2
4559528|NCT01273155|7391490|FG006|Overall Study|Died during Cycle 1|2
4559529|NCT01273155|7391484|FG000|Overall Study|Withdrew during C1/refused further trmt|0
4559530|NCT01273155|7391485|FG001|Overall Study|Withdrew during C1/refused further trmt|0
4559531|NCT01273155|7391486|FG002|Overall Study|Withdrew during C1/refused further trmt|1
4559532|NCT01273155|7391487|FG003|Overall Study|Withdrew during C1/refused further trmt|0
4559533|NCT01273155|7391488|FG004|Overall Study|Withdrew during C1/refused further trmt|1
4559534|NCT01273155|7391489|FG005|Overall Study|Withdrew during C1/refused further trmt|1
4559535|NCT01273155|7391490|FG006|Overall Study|Withdrew during C1/refused further trmt|0
4559536|NCT01273181|7391517|FG000|Phase I, Dose 1|Study termination|1
4559537|NCT01273181|7391518|FG001|Phase I, Dose 1|Study termination|0
4559538|NCT01273181|7391519|FG002|Phase I, Dose 1|Study termination|0
4559539|NCT01273181|7391520|FG003|Phase I, Dose 1|Study termination|0
4559540|NCT01273181|7391517|FG000|Phase I, Dose 2|Death during treatment|0
4559541|NCT01273181|7391518|FG001|Phase I, Dose 2|Death during treatment|1
4559542|NCT01273181|7391519|FG002|Phase I, Dose 2|Death during treatment|0
4559543|NCT01273181|7391520|FG003|Phase I, Dose 2|Death during treatment|0
4559544|NCT01273181|7391517|FG000|Phase 2, Dose 1|Study termination|0
4559545|NCT01273181|7391518|FG001|Phase 2, Dose 1|Study termination|0
4559546|NCT01273181|7391519|FG002|Phase 2, Dose 1|Study termination|1
4559547|NCT01273181|7391520|FG003|Phase 2, Dose 1|Study termination|0
4559548|NCT01273181|7391517|FG000|Phase 2, Dose 2|Death during treatment|0
4559549|NCT01273181|7391518|FG001|Phase 2, Dose 2|Death during treatment|0
4559550|NCT01273181|7391519|FG002|Phase 2, Dose 2|Death during treatment|0
4690735|NCT02563548|7600525|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2
4690736|NCT02563548|7600526|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1
4690737|NCT02563548|7600521|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
4690738|NCT02563548|7600522|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
4690739|NCT02563548|7600523|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
4690740|NCT02563548|7600524|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
4559551|NCT01273181|7391520|FG003|Phase 2, Dose 2|Death during treatment|1
4559552|NCT01273519|7391541|FG000|Overall Study|Adverse Event|3
4559553|NCT01273519|7391542|FG001|Overall Study|Adverse Event|0
4559554|NCT01273519|7391543|FG002|Overall Study|Adverse Event|0
4559555|NCT01273519|7391541|FG000|Overall Study|Lost to Follow-up|2
4559556|NCT01273519|7391542|FG001|Overall Study|Lost to Follow-up|1
4559557|NCT01273519|7391543|FG002|Overall Study|Lost to Follow-up|3
4559558|NCT01273519|7391541|FG000|Overall Study|Lack of Efficacy|8
4559559|NCT01273519|7391542|FG001|Overall Study|Lack of Efficacy|3
4559560|NCT01273519|7391543|FG002|Overall Study|Lack of Efficacy|4
4559561|NCT01273519|7391541|FG000|Overall Study|Other|6
4559562|NCT01273519|7391542|FG001|Overall Study|Other|1
4559563|NCT01273519|7391543|FG002|Overall Study|Other|1
4559564|NCT01273597|7391554|FG000|Overall Study|Adverse Event|5
4559565|NCT01273597|7391554|FG000|Overall Study|Underwent Kidney Transplantation|2
4559566|NCT01273597|7391554|FG000|Overall Study|Reason Not Reported|1
4559567|NCT01273623|7391558|FG000|Overall Study|did not meet IVUS criteria|29
4559568|NCT01273805|7391578|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10
4559569|NCT01273805|7391579|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10
4559570|NCT01273818|7391588|FG000|Overall Study|Physician Decision|13
4559571|NCT01273818|7391589|FG001|Overall Study|Physician Decision|2
4559572|NCT01273818|7391590|FG002|Overall Study|Physician Decision|9
4559573|NCT01273883|7391607|FG000|First Intervention|Adverse Event|2
4559574|NCT01273883|7391608|FG001|First Intervention|Adverse Event|1
4559575|NCT01273883|7391607|FG000|Second Intervention|Lost to Follow-up|1
4559576|NCT01273883|7391608|FG001|Second Intervention|Lost to Follow-up|1
4559577|NCT01273883|7391607|FG000|Second Intervention|Lack of Efficacy|1
4559578|NCT01273883|7391608|FG001|Second Intervention|Lack of Efficacy|0
4559579|NCT01274182|7391621|FG000|Overall Study|Unsatisfactory therapeutic effect|6
4559580|NCT01274182|7391622|FG001|Overall Study|Unsatisfactory therapeutic effect|3
4559581|NCT01274182|7391623|FG002|Overall Study|Unsatisfactory therapeutic effect|4
4559582|NCT01274182|7391621|FG000|Overall Study|Adverse Event|4
4559583|NCT01274182|7391622|FG001|Overall Study|Adverse Event|5
4559584|NCT01274182|7391623|FG002|Overall Study|Adverse Event|3
4559585|NCT01274182|7391621|FG000|Overall Study|Withdrawal by Subject|5
4559586|NCT01274182|7391622|FG001|Overall Study|Withdrawal by Subject|5
4559587|NCT01274182|7391623|FG002|Overall Study|Withdrawal by Subject|3
4559588|NCT01274182|7391621|FG000|Overall Study|Lost to Follow-up|2
4559589|NCT01274182|7391622|FG001|Overall Study|Lost to Follow-up|3
4559590|NCT01274182|7391623|FG002|Overall Study|Lost to Follow-up|1
4559591|NCT01274182|7391621|FG000|Overall Study|Protocol Violation|3
4559592|NCT01274182|7391622|FG001|Overall Study|Protocol Violation|2
4559593|NCT01274182|7391623|FG002|Overall Study|Protocol Violation|0
4559594|NCT01274182|7391621|FG000|Overall Study|Death|1
4559595|NCT01274182|7391622|FG001|Overall Study|Death|0
4559596|NCT01274182|7391623|FG002|Overall Study|Death|1
4559597|NCT01274338|7391641|FG000|Overall Study|Lack of Efficacy|72
4559598|NCT01274338|7391642|FG001|Overall Study|Lack of Efficacy|108
4559599|NCT01274338|7391643|FG002|Overall Study|Lack of Efficacy|116
4559600|NCT01274338|7391644|FG003|Overall Study|Lack of Efficacy|0
4559601|NCT01274338|7391645|FG004|Overall Study|Lack of Efficacy|0
4559602|NCT01274338|7391646|FG005|Overall Study|Lack of Efficacy|0
4559603|NCT01274338|7391641|FG000|Overall Study|Adverse Event|272
4559604|NCT01274338|7391642|FG001|Overall Study|Adverse Event|105
4559605|NCT01274338|7391643|FG002|Overall Study|Adverse Event|180
4559606|NCT01274338|7391644|FG003|Overall Study|Adverse Event|1
4559607|NCT01274338|7391645|FG004|Overall Study|Adverse Event|0
4559608|NCT01274338|7391646|FG005|Overall Study|Adverse Event|0
4559609|NCT01274338|7391641|FG000|Overall Study|Death|8
4559610|NCT01274338|7391642|FG001|Overall Study|Death|1
4559611|NCT01274338|7391643|FG002|Overall Study|Death|0
4559612|NCT01274338|7391644|FG003|Overall Study|Death|0
4559613|NCT01274338|7391645|FG004|Overall Study|Death|0
4559614|NCT01274338|7391646|FG005|Overall Study|Death|0
4559615|NCT01274338|7391641|FG000|Overall Study|Withdrawal by Subject|27
4559616|NCT01274338|7391642|FG001|Overall Study|Withdrawal by Subject|99
4559617|NCT01274338|7391643|FG002|Overall Study|Withdrawal by Subject|17
4559618|NCT01274338|7391644|FG003|Overall Study|Withdrawal by Subject|0
4559619|NCT01274338|7391645|FG004|Overall Study|Withdrawal by Subject|0
4559620|NCT01274338|7391646|FG005|Overall Study|Withdrawal by Subject|0
4559621|NCT01274338|7391641|FG000|Overall Study|Did not start treatment|8
4559622|NCT01274338|7391642|FG001|Overall Study|Did not start treatment|116
4559623|NCT01274338|7391643|FG002|Overall Study|Did not start treatment|7
4559624|NCT01274338|7391644|FG003|Overall Study|Did not start treatment|0
4559625|NCT01274338|7391645|FG004|Overall Study|Did not start treatment|0
4559626|NCT01274338|7391646|FG005|Overall Study|Did not start treatment|0
4559627|NCT01274338|7391641|FG000|Overall Study|Alternative therapy|0
4559628|NCT01274338|7391642|FG001|Overall Study|Alternative therapy|1
4559629|NCT01274338|7391643|FG002|Overall Study|Alternative therapy|0
4559630|NCT01274338|7391644|FG003|Overall Study|Alternative therapy|0
4559631|NCT01274338|7391645|FG004|Overall Study|Alternative therapy|0
4559632|NCT01274338|7391646|FG005|Overall Study|Alternative therapy|0
4559633|NCT01274338|7391641|FG000|Overall Study|Other complicating diseases|0
4559634|NCT01274338|7391642|FG001|Overall Study|Other complicating diseases|3
4559635|NCT01274338|7391643|FG002|Overall Study|Other complicating diseases|1
4559636|NCT01274338|7391644|FG003|Overall Study|Other complicating diseases|0
4559637|NCT01274338|7391645|FG004|Overall Study|Other complicating diseases|0
4559638|NCT01274338|7391646|FG005|Overall Study|Other complicating diseases|0
4559639|NCT01274338|7391641|FG000|Overall Study|Treatment arm was suspended due to toxicity|4
4559640|NCT01274338|7391642|FG001|Overall Study|Treatment arm was suspended due to toxicity|0
4559641|NCT01274338|7391643|FG002|Overall Study|Treatment arm was suspended due to toxicity|0
4559642|NCT01274338|7391644|FG003|Overall Study|Treatment arm was suspended due to toxicity|0
4559643|NCT01274338|7391645|FG004|Overall Study|Treatment arm was suspended due to toxicity|0
4559644|NCT01274338|7391646|FG005|Overall Study|Treatment arm was suspended due to toxicity|0
4559645|NCT01274338|7391641|FG000|Overall Study|Pregnancy|0
4559646|NCT01274338|7391642|FG001|Overall Study|Pregnancy|0
4559647|NCT01274338|7391643|FG002|Overall Study|Pregnancy|1
4559648|NCT01274338|7391644|FG003|Overall Study|Pregnancy|0
4559649|NCT01274338|7391645|FG004|Overall Study|Pregnancy|0
4559650|NCT01274338|7391646|FG005|Overall Study|Pregnancy|0
4559651|NCT01274338|7391641|FG000|Overall Study|Reason not reported|12
4559652|NCT01274338|7391642|FG001|Overall Study|Reason not reported|21
4559653|NCT01274338|7391643|FG002|Overall Study|Reason not reported|3
4559654|NCT01274338|7391644|FG003|Overall Study|Reason not reported|0
4559655|NCT01274338|7391645|FG004|Overall Study|Reason not reported|1
4559656|NCT01274338|7391646|FG005|Overall Study|Reason not reported|0
4559657|NCT01274351|7391659|FG000|Overall Study|Lost to Follow-up|1
4559658|NCT01274351|7391659|FG000|Overall Study|patient not compliant with the protocol|1
4559659|NCT01274351|7391659|FG000|Overall Study|Pregnancy|1
4559660|NCT01274351|7391659|FG000|Overall Study|Death|2
4559661|NCT01274351|7391659|FG000|Overall Study|Withdrawal by Subject|3
4559662|NCT01274351|7391659|FG000|Overall Study|Adverse Event|8
4559663|NCT01274351|7391659|FG000|Overall Study|progression of disease|3
4559664|NCT01274351|7391659|FG000|Overall Study|hospitalization|1
4559665|NCT01274637|7391686|FG000|Overall Study|Withdrawal by Subject|0
4559666|NCT01274637|7391687|FG001|Overall Study|Withdrawal by Subject|1
4559667|NCT01274637|7391686|FG000|Overall Study|Lost to Follow-up|0
4559668|NCT01274637|7391687|FG001|Overall Study|Lost to Follow-up|1
4559669|NCT01274715|7391693|FG000|Overall Study|Lost to Follow-up|1
4559670|NCT01274715|7391693|FG000|Overall Study|After consent, met exclusion criteria.|1
4559671|NCT01274715|7391693|FG000|Overall Study|After consent, met exclusion criteria.|1
4559672|NCT01274715|7391693|FG000|Overall Study|After consent, met exclusion criteria.|1
4559673|NCT01275066|7391713|FG000|Overall Study|Withdrawal by Subject|0
4559674|NCT01275066|7391714|FG001|Overall Study|Withdrawal by Subject|0
4559675|NCT01275066|7391715|FG002|Overall Study|Withdrawal by Subject|1
4559676|NCT01275066|7391713|FG000|Overall Study|Not Diagnosed w/ Disease|1
4559677|NCT01275066|7391714|FG001|Overall Study|Not Diagnosed w/ Disease|0
4559678|NCT01275066|7391715|FG002|Overall Study|Not Diagnosed w/ Disease|0
4559679|NCT01275131|7391731|FG000|Period 1|Withdrawal by Subject|1
4559680|NCT01275131|7391732|FG001|Period 1|Withdrawal by Subject|0
4559681|NCT01275131|7391733|FG002|Period 1|Withdrawal by Subject|3
4559682|NCT01275131|7391734|FG003|Period 1|Withdrawal by Subject|2
4559683|NCT01275131|7391731|FG000|Period 1|Physician Decision|1
4559684|NCT01275131|7391732|FG001|Period 1|Physician Decision|0
4559685|NCT01275131|7391733|FG002|Period 1|Physician Decision|0
4559686|NCT01275131|7391734|FG003|Period 1|Physician Decision|0
4559687|NCT01275131|7391731|FG000|Period 2 (Crossover)|Adverse Event|0
4559688|NCT01275131|7391732|FG001|Period 2 (Crossover)|Adverse Event|1
4559689|NCT01275131|7391733|FG002|Period 2 (Crossover)|Adverse Event|0
4559690|NCT01275131|7391734|FG003|Period 2 (Crossover)|Adverse Event|0
4559691|NCT01275131|7391731|FG000|Period 2 (Crossover)|Withdrawal by Subject|1
4559692|NCT01275131|7391732|FG001|Period 2 (Crossover)|Withdrawal by Subject|0
4559693|NCT01275131|7391733|FG002|Period 2 (Crossover)|Withdrawal by Subject|1
4559694|NCT01275131|7391734|FG003|Period 2 (Crossover)|Withdrawal by Subject|2
4559695|NCT01275144|7391752|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1
4559696|NCT01275144|7391753|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0
4559697|NCT01275170|7391769|FG000|Part 1: Period 1|Equipment malfunction before study drug|1
4559698|NCT01275170|7391770|FG001|Part 1: Period 1|Equipment malfunction before study drug|0
4559699|NCT01275170|7391771|FG002|Part 1: Period 1|Equipment malfunction before study drug|0
4559700|NCT01275170|7391772|FG003|Part 1: Period 1|Equipment malfunction before study drug|0
4559701|NCT01275170|7391773|FG004|Part 1: Period 1|Equipment malfunction before study drug|0
4559702|NCT01275170|7391774|FG005|Part 1: Period 1|Equipment malfunction before study drug|0
4559703|NCT01275170|7391775|FG006|Part 1: Period 1|Equipment malfunction before study drug|0
4559704|NCT01275170|7391776|FG007|Part 1: Period 1|Equipment malfunction before study drug|0
4559705|NCT01275196|7391811|FG000|Overall Study|Adverse Event|3
4559706|NCT01275196|7391812|FG001|Overall Study|Adverse Event|5
4559707|NCT01275196|7391811|FG000|Overall Study|Withdrawal by Subject|4
4559708|NCT01275196|7391812|FG001|Overall Study|Withdrawal by Subject|5
4559709|NCT01275196|7391811|FG000|Overall Study|Lost to Follow-up|1
4559710|NCT01275196|7391812|FG001|Overall Study|Lost to Follow-up|0
4559711|NCT01275196|7391811|FG000|Overall Study|Disease Progression|6
4559712|NCT01275196|7391812|FG001|Overall Study|Disease Progression|5
4559713|NCT01275196|7391811|FG000|Overall Study|Protocol Violation|1
4559714|NCT01275196|7391812|FG001|Overall Study|Protocol Violation|0
4559715|NCT01275196|7391811|FG000|Overall Study|Suboptimal response/treatment failure|5
4559716|NCT01275196|7391812|FG001|Overall Study|Suboptimal response/treatment failure|6
4559717|NCT01275222|7391826|FG000|Phase l by Treatment|Adverse Event|1
4559718|NCT01275222|7391827|FG001|Phase l by Treatment|Adverse Event|4
4559719|NCT01275222|7391828|FG002|Phase l by Treatment|Adverse Event|2
4559720|NCT01275222|7391829|FG003|Phase l by Treatment|Adverse Event|3
4559721|NCT01275222|7391830|FG004|Phase l by Treatment|Adverse Event|0
4559722|NCT01275222|7391831|FG005|Phase l by Treatment|Adverse Event|0
4559723|NCT01275222|7391826|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0
4559724|NCT01275222|7391827|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0
4559725|NCT01275222|7391828|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1
4559726|NCT01275222|7391829|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0
4559727|NCT01275222|7391830|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0
4623029|NCT01807221|7486415|FG001|Overall Study|Logistical difficulties|1
4559728|NCT01275222|7391831|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0
4559729|NCT01275222|7391826|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0
4559730|NCT01275222|7391827|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0
4559731|NCT01275222|7391828|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0
4559732|NCT01275222|7391829|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1
4559733|NCT01275222|7391830|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0
4559734|NCT01275222|7391831|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0
4559735|NCT01275222|7391826|FG000|Phase l by Treatment|Disease progression|12
4559736|NCT01275222|7391827|FG001|Phase l by Treatment|Disease progression|8
4559737|NCT01275222|7391828|FG002|Phase l by Treatment|Disease progression|2
4559738|NCT01275222|7391829|FG003|Phase l by Treatment|Disease progression|5
4559739|NCT01275222|7391830|FG004|Phase l by Treatment|Disease progression|0
4559740|NCT01275222|7391831|FG005|Phase l by Treatment|Disease progression|0
4559741|NCT01275222|7391826|FG000|Phase l by Treatment|Withdrawal by Subject|0
4559742|NCT01275222|7391827|FG001|Phase l by Treatment|Withdrawal by Subject|0
4559743|NCT01275222|7391828|FG002|Phase l by Treatment|Withdrawal by Subject|0
4559744|NCT01275222|7391829|FG003|Phase l by Treatment|Withdrawal by Subject|1
4559745|NCT01275222|7391830|FG004|Phase l by Treatment|Withdrawal by Subject|0
4559746|NCT01275222|7391831|FG005|Phase l by Treatment|Withdrawal by Subject|0
4559747|NCT01275222|7391826|FG000|Phase l by Treatment|Death|0
4559748|NCT01275222|7391827|FG001|Phase l by Treatment|Death|1
4559749|NCT01275222|7391828|FG002|Phase l by Treatment|Death|0
4559750|NCT01275222|7391829|FG003|Phase l by Treatment|Death|1
4559751|NCT01275222|7391830|FG004|Phase l by Treatment|Death|0
4559752|NCT01275222|7391831|FG005|Phase l by Treatment|Death|0
4559753|NCT01275222|7391826|FG000|Phase ll by Stratum|Adverse Event|0
4559754|NCT01275222|7391827|FG001|Phase ll by Stratum|Adverse Event|0
4559755|NCT01275222|7391828|FG002|Phase ll by Stratum|Adverse Event|0
4559756|NCT01275222|7391829|FG003|Phase ll by Stratum|Adverse Event|0
4559757|NCT01275222|7391830|FG004|Phase ll by Stratum|Adverse Event|2
4559758|NCT01275222|7391831|FG005|Phase ll by Stratum|Adverse Event|10
4559759|NCT01275222|7391826|FG000|Phase ll by Stratum|Abnormal laboratory values|0
4559760|NCT01275222|7391827|FG001|Phase ll by Stratum|Abnormal laboratory values|0
4559761|NCT01275222|7391828|FG002|Phase ll by Stratum|Abnormal laboratory values|0
4559762|NCT01275222|7391829|FG003|Phase ll by Stratum|Abnormal laboratory values|0
4559763|NCT01275222|7391830|FG004|Phase ll by Stratum|Abnormal laboratory values|0
4559764|NCT01275222|7391831|FG005|Phase ll by Stratum|Abnormal laboratory values|1
4559765|NCT01275222|7391826|FG000|Phase ll by Stratum|Disease progression|0
4559766|NCT01275222|7391827|FG001|Phase ll by Stratum|Disease progression|0
4559767|NCT01275222|7391828|FG002|Phase ll by Stratum|Disease progression|0
4559768|NCT01275222|7391829|FG003|Phase ll by Stratum|Disease progression|0
4559769|NCT01275222|7391830|FG004|Phase ll by Stratum|Disease progression|23
4559770|NCT01275222|7391831|FG005|Phase ll by Stratum|Disease progression|31
4559771|NCT01275222|7391826|FG000|Phase ll by Stratum|Withdrawal by Subject|0
4559772|NCT01275222|7391827|FG001|Phase ll by Stratum|Withdrawal by Subject|0
4559773|NCT01275222|7391828|FG002|Phase ll by Stratum|Withdrawal by Subject|0
4559774|NCT01275222|7391829|FG003|Phase ll by Stratum|Withdrawal by Subject|0
4559775|NCT01275222|7391830|FG004|Phase ll by Stratum|Withdrawal by Subject|2
4559776|NCT01275222|7391831|FG005|Phase ll by Stratum|Withdrawal by Subject|3
4559777|NCT01275222|7391826|FG000|Phase ll by Stratum|Death|0
4623030|NCT01807221|7486416|FG002|Overall Study|Logistical difficulties|0
4623031|NCT01807221|7486417|FG003|Overall Study|Logistical difficulties|0
4623032|NCT01807221|7486418|FG004|Overall Study|Logistical difficulties|1
4623033|NCT01807221|7486419|FG005|Overall Study|Logistical difficulties|0
4623034|NCT01807221|7486414|FG000|Overall Study|Withdrawal by Subject|33
4623035|NCT01807221|7486415|FG001|Overall Study|Withdrawal by Subject|15
4623036|NCT01807221|7486416|FG002|Overall Study|Withdrawal by Subject|8
4623037|NCT01807221|7486417|FG003|Overall Study|Withdrawal by Subject|14
4623038|NCT01807221|7486418|FG004|Overall Study|Withdrawal by Subject|16
4623039|NCT01807221|7486419|FG005|Overall Study|Withdrawal by Subject|13
4623040|NCT01807221|7486414|FG000|Overall Study|Sponsor decision|2
4623041|NCT01807221|7486415|FG001|Overall Study|Sponsor decision|0
4623042|NCT01807221|7486416|FG002|Overall Study|Sponsor decision|1
4559778|NCT01275222|7391827|FG001|Phase ll by Stratum|Death|0
4559779|NCT01275222|7391828|FG002|Phase ll by Stratum|Death|0
4559780|NCT01275222|7391829|FG003|Phase ll by Stratum|Death|0
4559781|NCT01275222|7391830|FG004|Phase ll by Stratum|Death|1
4559782|NCT01275222|7391831|FG005|Phase ll by Stratum|Death|1
4559783|NCT01275339|7391869|FG000|Overall Study|Referred for surgery for AS symptoms|1
4559784|NCT01275339|7391870|FG001|Overall Study|Referred for surgery for AS symptoms|0
4559785|NCT01275339|7391871|FG002|Overall Study|Referred for surgery for AS symptoms|0
4559786|NCT01275339|7391872|FG003|Overall Study|Referred for surgery for AS symptoms|0
4623043|NCT01807221|7486417|FG003|Overall Study|Sponsor decision|1
4559787|NCT01275339|7391869|FG000|Overall Study|Withdrawal by Subject|0
4559788|NCT01275339|7391870|FG001|Overall Study|Withdrawal by Subject|0
4559789|NCT01275339|7391871|FG002|Overall Study|Withdrawal by Subject|1
4559790|NCT01275339|7391872|FG003|Overall Study|Withdrawal by Subject|0
4559791|NCT01275430|7391899|FG000|Overall Study|Adverse Event|1
4559792|NCT01275430|7391899|FG000|Overall Study|No Contrast Injection|6
4559793|NCT01275430|7391899|FG000|Overall Study|Device Malfunction|1
4559794|NCT01275430|7391899|FG000|Overall Study|Inability to achieve maximum p-wave|1
4559795|NCT01275625|7391908|FG000|Overall Study|Death|1
4559796|NCT01275625|7391908|FG000|Overall Study|Lack of Efficacy|2
4559797|NCT01275625|7391908|FG000|Overall Study|Lost to Follow-up|1
4559798|NCT01275625|7391908|FG000|Overall Study|Withdrawal by Subject|3
4559799|NCT01275625|7391908|FG000|Overall Study|Protocol Violation|1
4559800|NCT01275625|7391908|FG000|Overall Study|Adverse Event|4
4559801|NCT01275625|7391908|FG000|Overall Study|Other|1
4559802|NCT01275755|7391918|FG000|Double-blind Treatment Period|Adverse Event|0
4559803|NCT01275755|7391919|FG001|Double-blind Treatment Period|Adverse Event|2
4559804|NCT01275755|7391918|FG000|Double-blind Treatment Period|Lost to Follow-up|1
4559805|NCT01275755|7391919|FG001|Double-blind Treatment Period|Lost to Follow-up|1
4559806|NCT01275755|7391918|FG000|Double-blind Treatment Period|Withdrawal by Subject|1
4559807|NCT01275755|7391919|FG001|Double-blind Treatment Period|Withdrawal by Subject|0
4559808|NCT01275755|7391918|FG000|Run-out Placebo Period|Lost to Follow-up|1
4559809|NCT01275755|7391919|FG001|Run-out Placebo Period|Lost to Follow-up|0
4559810|NCT01275833|7391927|FG000|Overall Study|Study terminated|1
4559811|NCT01275833|7391928|FG001|Overall Study|Study terminated|1
4559812|NCT01276041|7391934|FG000|Overall Study|Adverse Event|2
4559813|NCT01276041|7391934|FG000|Overall Study|Protocol Violation|1
4559814|NCT01276106|7391942|FG000|Overall Study|Adverse Event|3
4559815|NCT01276106|7391943|FG001|Overall Study|Adverse Event|3
4559816|NCT01276106|7391944|FG002|Overall Study|Adverse Event|11
4559817|NCT01276106|7391945|FG003|Overall Study|Adverse Event|3
4559818|NCT01276106|7391942|FG000|Overall Study|Withdrawal by Subject|6
4559819|NCT01276106|7391943|FG001|Overall Study|Withdrawal by Subject|3
4559820|NCT01276106|7391944|FG002|Overall Study|Withdrawal by Subject|1
4559821|NCT01276106|7391945|FG003|Overall Study|Withdrawal by Subject|6
4559822|NCT01276106|7391942|FG000|Overall Study|Lack of Efficacy|0
4559823|NCT01276106|7391943|FG001|Overall Study|Lack of Efficacy|1
4559824|NCT01276106|7391944|FG002|Overall Study|Lack of Efficacy|0
4559825|NCT01276106|7391945|FG003|Overall Study|Lack of Efficacy|1
4559826|NCT01276106|7391942|FG000|Overall Study|Lost to Follow-up|2
4559827|NCT01276106|7391943|FG001|Overall Study|Lost to Follow-up|1
4559828|NCT01276106|7391944|FG002|Overall Study|Lost to Follow-up|1
4559829|NCT01276106|7391945|FG003|Overall Study|Lost to Follow-up|0
4559830|NCT01276106|7391942|FG000|Overall Study|Physician Decision|0
4559831|NCT01276106|7391943|FG001|Overall Study|Physician Decision|0
4559832|NCT01276106|7391944|FG002|Overall Study|Physician Decision|1
4559833|NCT01276106|7391945|FG003|Overall Study|Physician Decision|1
4559834|NCT01276106|7391942|FG000|Overall Study|Protocol Violation|1
4559835|NCT01276106|7391943|FG001|Overall Study|Protocol Violation|1
4559836|NCT01276106|7391944|FG002|Overall Study|Protocol Violation|0
4559837|NCT01276106|7391945|FG003|Overall Study|Protocol Violation|2
4559838|NCT01276106|7391942|FG000|Overall Study|Insufficient therapeutic effects|0
4559839|NCT01276106|7391943|FG001|Overall Study|Insufficient therapeutic effects|0
4559840|NCT01276106|7391944|FG002|Overall Study|Insufficient therapeutic effects|2
4559841|NCT01276106|7391945|FG003|Overall Study|Insufficient therapeutic effects|0
4559842|NCT01276223|7391989|FG000|Overall Study|Adverse Event|7
4559843|NCT01276223|7391990|FG001|Overall Study|Adverse Event|4
4559844|NCT01276223|7391991|FG002|Overall Study|Adverse Event|1
4559845|NCT01276223|7391989|FG000|Overall Study|Lost to Follow-up|0
4559846|NCT01276223|7391990|FG001|Overall Study|Lost to Follow-up|0
4559847|NCT01276223|7391991|FG002|Overall Study|Lost to Follow-up|1
4559848|NCT01276223|7391989|FG000|Overall Study|Other|0
4559849|NCT01276223|7391990|FG001|Overall Study|Other|0
4559850|NCT01276223|7391991|FG002|Overall Study|Other|1
4559851|NCT01276223|7391989|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3
4559852|NCT01276223|7391990|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0
4559853|NCT01276223|7391991|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0
4559854|NCT01276223|7391989|FG000|Overall Study|Protocol Violation|1
4559855|NCT01276223|7391990|FG001|Overall Study|Protocol Violation|0
4559856|NCT01276223|7391991|FG002|Overall Study|Protocol Violation|0
4559857|NCT01276236|7391998|FG000|Overall Study|Lack of Efficacy|2
4559858|NCT01276236|7391998|FG000|Overall Study|Withdrawal by Subject|4
4559859|NCT01276288|7392002|FG000|Overall Study|Adverse Event|1
4559860|NCT01276288|7392003|FG001|Overall Study|Adverse Event|1
4559861|NCT01276288|7392004|FG002|Overall Study|Adverse Event|0
4559862|NCT01276288|7392005|FG003|Overall Study|Adverse Event|0
4559863|NCT01276288|7392002|FG000|Overall Study|not treated|1
4559864|NCT01276288|7392003|FG001|Overall Study|not treated|0
4559865|NCT01276288|7392004|FG002|Overall Study|not treated|0
4559866|NCT01276288|7392005|FG003|Overall Study|not treated|0
4559867|NCT01276327|7392054|FG000|Overall Study|Adverse Event|1
4559868|NCT01276327|7392055|FG001|Overall Study|Adverse Event|3
4559869|NCT01276327|7392054|FG000|Overall Study|Withdrawal by Subject|1
4559870|NCT01276327|7392055|FG001|Overall Study|Withdrawal by Subject|0
4559871|NCT01276353|7392063|FG000|Double-blind|Adverse Event|2
4559872|NCT01276353|7392064|FG001|Double-blind|Adverse Event|0
4559873|NCT01276353|7392063|FG000|Double-blind|Withdrawal by Subject|1
4559874|NCT01276353|7392064|FG001|Double-blind|Withdrawal by Subject|0
4559875|NCT01276353|7392063|FG000|Extension|Adverse Event|2
4559876|NCT01276353|7392064|FG001|Extension|Adverse Event|5
4559877|NCT01276353|7392063|FG000|Extension|Withdrawal by Subject|1
4559878|NCT01276353|7392064|FG001|Extension|Withdrawal by Subject|2
4559879|NCT01276353|7392063|FG000|Extension|Withdrawal of study drug 4 days in a row|3
4559880|NCT01276353|7392064|FG001|Extension|Withdrawal of study drug 4 days in a row|1
4559881|NCT01276353|7392063|FG000|Extension|Physician Decision|1
4559882|NCT01276353|7392064|FG001|Extension|Physician Decision|0
4559883|NCT01276353|7392063|FG000|Extension|Prohibited concomitant medications|0
4559884|NCT01276353|7392064|FG001|Extension|Prohibited concomitant medications|1
4559885|NCT01276379|7392076|FG000|Overall Study|Screening failure|40
4559886|NCT01276457|7392084|FG000|Core Study|Adverse Event|6
4559887|NCT01276457|7392085|FG001|Core Study|Adverse Event|3
4559888|NCT01276457|7392084|FG000|Core Study|Lost to Follow-up|1
4559889|NCT01276457|7392085|FG001|Core Study|Lost to Follow-up|2
4559890|NCT01276457|7392084|FG000|Core Study|Administrative problems|1
4559891|NCT01276457|7392085|FG001|Core Study|Administrative problems|1
4559892|NCT01276457|7392084|FG000|Core Study|Death|2
4559893|NCT01276457|7392085|FG001|Core Study|Death|2
4559894|NCT01276457|7392084|FG000|Core Study|Lack of Efficacy|3
4559895|NCT01276457|7392085|FG001|Core Study|Lack of Efficacy|12
4559896|NCT01276457|7392084|FG000|Extension Study|Lost to Follow-up|3
4559897|NCT01276457|7392085|FG001|Extension Study|Lost to Follow-up|0
4559898|NCT01276457|7392084|FG000|Extension Study|Death|0
4559899|NCT01276457|7392085|FG001|Extension Study|Death|1
4559900|NCT01276457|7392084|FG000|Extension Study|Lack of Efficacy|3
4559901|NCT01276457|7392085|FG001|Extension Study|Lack of Efficacy|1
4559902|NCT01276509|7392095|FG000|Overall Study|Adverse Event|9
4623044|NCT01807221|7486418|FG004|Overall Study|Sponsor decision|0
4623045|NCT01807221|7486419|FG005|Overall Study|Sponsor decision|0
4559903|NCT01276509|7392096|FG001|Overall Study|Adverse Event|8
4559904|NCT01276509|7392097|FG002|Overall Study|Adverse Event|4
4559905|NCT01276509|7392098|FG003|Overall Study|Adverse Event|3
4559906|NCT01276509|7392095|FG000|Overall Study|Lack of Efficacy|2
4559907|NCT01276509|7392096|FG001|Overall Study|Lack of Efficacy|1
4559908|NCT01276509|7392097|FG002|Overall Study|Lack of Efficacy|1
4559909|NCT01276509|7392098|FG003|Overall Study|Lack of Efficacy|2
4559910|NCT01276509|7392095|FG000|Overall Study|Pregnancy|1
4559911|NCT01276509|7392096|FG001|Overall Study|Pregnancy|0
4559912|NCT01276509|7392097|FG002|Overall Study|Pregnancy|0
4559913|NCT01276509|7392098|FG003|Overall Study|Pregnancy|0
4559914|NCT01276509|7392095|FG000|Overall Study|Withdrawal by Subject|1
4559915|NCT01276509|7392096|FG001|Overall Study|Withdrawal by Subject|2
4623046|NCT01807221|7486414|FG000|Overall Study|Lost to Follow-up|1
4623047|NCT01807221|7486415|FG001|Overall Study|Lost to Follow-up|0
4623048|NCT01807221|7486416|FG002|Overall Study|Lost to Follow-up|2
4623049|NCT01807221|7486417|FG003|Overall Study|Lost to Follow-up|1
4623050|NCT01807221|7486418|FG004|Overall Study|Lost to Follow-up|0
4623051|NCT01807221|7486419|FG005|Overall Study|Lost to Follow-up|0
4623052|NCT01807234|7486439|FG000|Overall Study|Lost to Follow-up|2
4623053|NCT01807234|7486440|FG001|Overall Study|Lost to Follow-up|5
4623054|NCT01807234|7486441|FG002|Overall Study|Lost to Follow-up|1
4623055|NCT01807234|7486442|FG003|Overall Study|Lost to Follow-up|1
4623056|NCT01807234|7486443|FG004|Overall Study|Lost to Follow-up|1
4623057|NCT01807234|7486444|FG005|Overall Study|Lost to Follow-up|2
4623058|NCT01807234|7486439|FG000|Overall Study|Withdrawal by Subject|3
4623059|NCT01807234|7486440|FG001|Overall Study|Withdrawal by Subject|1
4623060|NCT01807234|7486441|FG002|Overall Study|Withdrawal by Subject|1
4623061|NCT01807234|7486442|FG003|Overall Study|Withdrawal by Subject|1
4623062|NCT01807234|7486443|FG004|Overall Study|Withdrawal by Subject|2
4623063|NCT01807234|7486444|FG005|Overall Study|Withdrawal by Subject|1
4623064|NCT01807234|7486439|FG000|Overall Study|Lack of Efficacy|0
4623065|NCT01807234|7486440|FG001|Overall Study|Lack of Efficacy|0
4623066|NCT01807234|7486441|FG002|Overall Study|Lack of Efficacy|0
4623067|NCT01807234|7486442|FG003|Overall Study|Lack of Efficacy|0
4623068|NCT01807234|7486443|FG004|Overall Study|Lack of Efficacy|1
4623069|NCT01807234|7486444|FG005|Overall Study|Lack of Efficacy|1
4623070|NCT01807299|7486458|FG000|Overall Study|Protocol Violation|3
4623071|NCT01807299|7486459|FG001|Overall Study|Protocol Violation|1
4559916|NCT01276509|7392097|FG002|Overall Study|Withdrawal by Subject|0
4559917|NCT01276509|7392098|FG003|Overall Study|Withdrawal by Subject|0
4559918|NCT01276509|7392095|FG000|Overall Study|Other|0
4623072|NCT01807299|7486460|FG002|Overall Study|Protocol Violation|0
4623073|NCT01807299|7486461|FG003|Overall Study|Protocol Violation|2
4559919|NCT01276509|7392096|FG001|Overall Study|Other|1
4559920|NCT01276509|7392097|FG002|Overall Study|Other|0
4559921|NCT01276509|7392098|FG003|Overall Study|Other|0
4559922|NCT01276639|7392115|FG000|Week 0 to 16|Death|1
4623074|NCT01807520|7486478|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
4623075|NCT01807520|7486479|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1
4559923|NCT01276639|7392116|FG001|Week 0 to 16|Death|0
4559924|NCT01276639|7392117|FG002|Week 0 to 16|Death|0
4559925|NCT01276639|7392118|FG003|Week 0 to 16|Death|0
4559926|NCT01276639|7392119|FG004|Week 0 to 16|Death|0
4559927|NCT01276639|7392115|FG000|Week 0 to 16|Adverse Event|11
4559928|NCT01276639|7392116|FG001|Week 0 to 16|Adverse Event|8
4559929|NCT01276639|7392117|FG002|Week 0 to 16|Adverse Event|11
4559930|NCT01276639|7392118|FG003|Week 0 to 16|Adverse Event|0
4559931|NCT01276639|7392119|FG004|Week 0 to 16|Adverse Event|0
4559932|NCT01276639|7392115|FG000|Week 0 to 16|Lack of Efficacy|20
4559933|NCT01276639|7392116|FG001|Week 0 to 16|Lack of Efficacy|15
4559934|NCT01276639|7392117|FG002|Week 0 to 16|Lack of Efficacy|25
4623076|NCT01807520|7486480|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3
4623077|NCT01807520|7486481|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
4623078|NCT01807520|7486482|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
4623079|NCT01807520|7486483|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
4559935|NCT01276639|7392118|FG003|Week 0 to 16|Lack of Efficacy|0
4559936|NCT01276639|7392119|FG004|Week 0 to 16|Lack of Efficacy|0
4559937|NCT01276639|7392115|FG000|Week 0 to 16|Lost to Follow-up|3
4559938|NCT01276639|7392116|FG001|Week 0 to 16|Lost to Follow-up|5
4559939|NCT01276639|7392117|FG002|Week 0 to 16|Lost to Follow-up|3
4559940|NCT01276639|7392118|FG003|Week 0 to 16|Lost to Follow-up|0
4559941|NCT01276639|7392119|FG004|Week 0 to 16|Lost to Follow-up|0
4559942|NCT01276639|7392115|FG000|Week 0 to 16|Withdrawal by Subject|8
4559943|NCT01276639|7392116|FG001|Week 0 to 16|Withdrawal by Subject|5
4559944|NCT01276639|7392117|FG002|Week 0 to 16|Withdrawal by Subject|4
4559945|NCT01276639|7392118|FG003|Week 0 to 16|Withdrawal by Subject|0
4559946|NCT01276639|7392119|FG004|Week 0 to 16|Withdrawal by Subject|0
4559947|NCT01276639|7392115|FG000|Week 0 to 16|Other|7
4559948|NCT01276639|7392116|FG001|Week 0 to 16|Other|7
4559949|NCT01276639|7392117|FG002|Week 0 to 16|Other|2
4559950|NCT01276639|7392118|FG003|Week 0 to 16|Other|0
4559951|NCT01276639|7392119|FG004|Week 0 to 16|Other|0
4559952|NCT01276639|7392115|FG000|Week 0 to 16|Randomized, But Not Treated|0
4559953|NCT01276639|7392116|FG001|Week 0 to 16|Randomized, But Not Treated|1
4559954|NCT01276639|7392117|FG002|Week 0 to 16|Randomized, But Not Treated|0
4559955|NCT01276639|7392118|FG003|Week 0 to 16|Randomized, But Not Treated|0
4559956|NCT01276639|7392119|FG004|Week 0 to 16|Randomized, But Not Treated|0
4559957|NCT01276639|7392115|FG000|Week 16 to 52|Death|1
4559958|NCT01276639|7392116|FG001|Week 16 to 52|Death|0
4559959|NCT01276639|7392117|FG002|Week 16 to 52|Death|0
4559960|NCT01276639|7392118|FG003|Week 16 to 52|Death|0
4559961|NCT01276639|7392119|FG004|Week 16 to 52|Death|0
4559962|NCT01276639|7392115|FG000|Week 16 to 52|Adverse Event|10
4559963|NCT01276639|7392116|FG001|Week 16 to 52|Adverse Event|13
4559964|NCT01276639|7392117|FG002|Week 16 to 52|Adverse Event|0
4559965|NCT01276639|7392118|FG003|Week 16 to 52|Adverse Event|1
4559966|NCT01276639|7392119|FG004|Week 16 to 52|Adverse Event|3
4559967|NCT01276639|7392115|FG000|Week 16 to 52|Lack of Efficacy|99
4559968|NCT01276639|7392116|FG001|Week 16 to 52|Lack of Efficacy|71
4559969|NCT01276639|7392117|FG002|Week 16 to 52|Lack of Efficacy|0
4559970|NCT01276639|7392118|FG003|Week 16 to 52|Lack of Efficacy|14
4559971|NCT01276639|7392119|FG004|Week 16 to 52|Lack of Efficacy|13
4559972|NCT01276639|7392115|FG000|Week 16 to 52|Lost to Follow-up|3
4559973|NCT01276639|7392116|FG001|Week 16 to 52|Lost to Follow-up|1
4559974|NCT01276639|7392117|FG002|Week 16 to 52|Lost to Follow-up|0
4559975|NCT01276639|7392118|FG003|Week 16 to 52|Lost to Follow-up|0
4559976|NCT01276639|7392119|FG004|Week 16 to 52|Lost to Follow-up|1
4559977|NCT01276639|7392115|FG000|Week 16 to 52|Withdrawal by Subject|4
4559978|NCT01276639|7392116|FG001|Week 16 to 52|Withdrawal by Subject|4
4559979|NCT01276639|7392117|FG002|Week 16 to 52|Withdrawal by Subject|0
4559980|NCT01276639|7392118|FG003|Week 16 to 52|Withdrawal by Subject|0
4559981|NCT01276639|7392119|FG004|Week 16 to 52|Withdrawal by Subject|1
4559982|NCT01276639|7392115|FG000|Week 16 to 52|Other|10
4559983|NCT01276639|7392116|FG001|Week 16 to 52|Other|12
4559984|NCT01276639|7392117|FG002|Week 16 to 52|Other|0
4559985|NCT01276639|7392118|FG003|Week 16 to 52|Other|1
4559986|NCT01276639|7392119|FG004|Week 16 to 52|Other|3
4559987|NCT01276756|7392154|FG000|Overall Study|Lost to Follow-up|2
4559988|NCT01276756|7392155|FG001|Overall Study|Lost to Follow-up|0
4559989|NCT01276756|7392154|FG000|Overall Study|Adverse Event|3
4559990|NCT01276756|7392155|FG001|Overall Study|Adverse Event|2
4559991|NCT01276821|7392163|FG000|Overall Study|Protocol Violation|0
4559992|NCT01276821|7392164|FG001|Overall Study|Protocol Violation|1
4559993|NCT01276847|7392173|FG000|Overall Study|Withdrawal by Subject|1
4559994|NCT01276847|7392174|FG001|Overall Study|Withdrawal by Subject|0
4559995|NCT01276847|7392175|FG002|Overall Study|Withdrawal by Subject|0
4559996|NCT01277042|7392193|FG000|Overall Study|Adverse Event|4
4559997|NCT01277042|7392194|FG001|Overall Study|Adverse Event|3
4559998|NCT01277042|7392193|FG000|Overall Study|Lost to Follow-up|2
4559999|NCT01277042|7392194|FG001|Overall Study|Lost to Follow-up|2
4560000|NCT01277042|7392193|FG000|Overall Study|Withdrawal by Subject|2
4560001|NCT01277042|7392194|FG001|Overall Study|Withdrawal by Subject|0
4560002|NCT01277302|7392234|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0
4560003|NCT01277302|7392235|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0
4560004|NCT01277302|7392236|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8
4560005|NCT01277302|7392234|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0
4560006|NCT01277302|7392235|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0
4560007|NCT01277302|7392236|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2
4560008|NCT01277302|7392234|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0
4560009|NCT01277302|7392235|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0
4560010|NCT01277302|7392236|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1
4560011|NCT01277302|7392234|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0
4560012|NCT01277302|7392235|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0
4560013|NCT01277302|7392236|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1
4560014|NCT01277302|7392234|FG000|8-Month Alternate Dose Regimen Period|Death|0
4560015|NCT01277302|7392235|FG001|8-Month Alternate Dose Regimen Period|Death|1
4560016|NCT01277302|7392236|FG002|8-Month Alternate Dose Regimen Period|Death|0
4560017|NCT01277302|7392234|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1
4560018|NCT01277302|7392235|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1
4623080|NCT01807520|7486484|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
4560019|NCT01277302|7392236|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3
4560020|NCT01277302|7392234|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3
4560021|NCT01277302|7392235|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0
4560022|NCT01277302|7392236|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1
4560023|NCT01277302|7392234|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0
4560024|NCT01277302|7392235|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2
4560025|NCT01277302|7392236|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1
4560026|NCT01277302|7392234|FG000|8-Month Alternate Dose Regimen Period|Relocation|1
4560027|NCT01277302|7392235|FG001|8-Month Alternate Dose Regimen Period|Relocation|0
4560028|NCT01277302|7392236|FG002|8-Month Alternate Dose Regimen Period|Relocation|1
4560029|NCT01277510|7392272|FG000|Double-blind Phase|Non-compliance|0
4560030|NCT01277510|7392273|FG001|Double-blind Phase|Non-compliance|1
4560031|NCT01277510|7392272|FG000|Double-blind Phase|Adverse Event|1
4560032|NCT01277510|7392273|FG001|Double-blind Phase|Adverse Event|0
4560033|NCT01277510|7392272|FG000|Double-blind Phase|Withdrawal by Subject|2
4560034|NCT01277510|7392273|FG001|Double-blind Phase|Withdrawal by Subject|0
4560035|NCT01277510|7392272|FG000|Double-blind Phase|Administrative decision|7
4560036|NCT01277510|7392273|FG001|Double-blind Phase|Administrative decision|9
4560037|NCT01277510|7392272|FG000|Double-blind Phase|Death|0
4560038|NCT01277510|7392273|FG001|Double-blind Phase|Death|1
4560039|NCT01277510|7392272|FG000|Double-blind Phase|Protocol-specified criteria|2
4560040|NCT01277510|7392273|FG001|Double-blind Phase|Protocol-specified criteria|6
4560041|NCT01277510|7392272|FG000|Double-blind Phase|Other|1
4560042|NCT01277510|7392273|FG001|Double-blind Phase|Other|1
4560043|NCT01277510|7392272|FG000|Open-label Phase|Administrative decision|4
4560044|NCT01277510|7392273|FG001|Open-label Phase|Administrative decision|3
4560045|NCT01277510|7392272|FG000|Open-label Phase|Protocol-specified criteria|1
4560046|NCT01277510|7392273|FG001|Open-label Phase|Protocol-specified criteria|0
4560047|NCT01277510|7392272|FG000|Open-label Phase|Never received investigational product|2
4623081|NCT01807520|7486478|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1
4623082|NCT01807520|7486479|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
4623083|NCT01807520|7486480|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1
4623084|NCT01807520|7486481|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
4623085|NCT01807520|7486482|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
4623086|NCT01807520|7486483|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
4623087|NCT01807520|7486484|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
4623088|NCT01807520|7486478|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
4623089|NCT01807520|7486479|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
4623090|NCT01807520|7486480|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1
4623091|NCT01807520|7486481|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
4623092|NCT01807520|7486482|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
4623093|NCT01807520|7486483|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
4623094|NCT01807520|7486484|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
4623095|NCT01807520|7486478|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1
4623096|NCT01807520|7486479|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
4623097|NCT01807520|7486480|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
4623098|NCT01807520|7486481|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
4623099|NCT01807520|7486482|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
4623100|NCT01807520|7486483|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
4623101|NCT01807520|7486484|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
4623102|NCT01807520|7486478|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
4623103|NCT01807520|7486479|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
4623104|NCT01807520|7486480|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2
4623105|NCT01807520|7486481|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
4623106|NCT01807520|7486482|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
4623107|NCT01807520|7486483|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
4623108|NCT01807520|7486484|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
4623109|NCT01807520|7486478|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2
4623110|NCT01807520|7486479|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
4623111|NCT01807520|7486480|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
4560048|NCT01277510|7392273|FG001|Open-label Phase|Never received investigational product|0
4560049|NCT01277523|7392284|FG000|Overall Study|Adverse Event|1
4560050|NCT01277523|7392285|FG001|Overall Study|Adverse Event|0
4560051|NCT01277523|7392286|FG002|Overall Study|Adverse Event|0
4560052|NCT01277523|7392284|FG000|Overall Study|Protocol Violation|2
4560053|NCT01277523|7392285|FG001|Overall Study|Protocol Violation|0
4560054|NCT01277523|7392286|FG002|Overall Study|Protocol Violation|0
4560055|NCT01277523|7392284|FG000|Overall Study|Other Reason not Defined|0
4560056|NCT01277523|7392285|FG001|Overall Study|Other Reason not Defined|1
4560057|NCT01277523|7392286|FG002|Overall Study|Other Reason not Defined|0
4560058|NCT01277549|7392296|FG000|Overall Study|Failed to meet eligibility criteria|13
4560059|NCT01277549|7392297|FG001|Overall Study|Failed to meet eligibility criteria|9
4560060|NCT01277549|7392296|FG000|Overall Study|Withdrawal by Subject|1
4560061|NCT01277549|7392297|FG001|Overall Study|Withdrawal by Subject|3
4560062|NCT01277549|7392296|FG000|Overall Study|Protocol Violation|10
4560063|NCT01277549|7392297|FG001|Overall Study|Protocol Violation|1
4560064|NCT01277549|7392296|FG000|Overall Study|Physician Decision|2
4560065|NCT01277549|7392297|FG001|Overall Study|Physician Decision|1
4560066|NCT01277601|7392310|FG000|Overall Study|Adverse Event|5
4560067|NCT01277601|7392311|FG001|Overall Study|Adverse Event|3
4560068|NCT01277601|7392312|FG002|Overall Study|Adverse Event|0
4560069|NCT01277601|7392313|FG003|Overall Study|Adverse Event|7
4560070|NCT01277601|7392310|FG000|Overall Study|Withdrawal by Subject|18
4560071|NCT01277601|7392311|FG001|Overall Study|Withdrawal by Subject|21
4560072|NCT01277601|7392312|FG002|Overall Study|Withdrawal by Subject|8
4560073|NCT01277601|7392313|FG003|Overall Study|Withdrawal by Subject|17
4560074|NCT01277601|7392310|FG000|Overall Study|Lost to Follow-up|7
4560075|NCT01277601|7392311|FG001|Overall Study|Lost to Follow-up|9
4560076|NCT01277601|7392312|FG002|Overall Study|Lost to Follow-up|4
4560077|NCT01277601|7392313|FG003|Overall Study|Lost to Follow-up|2
4560078|NCT01277601|7392310|FG000|Overall Study|Physician Decision|3
4560079|NCT01277601|7392311|FG001|Overall Study|Physician Decision|5
4560080|NCT01277601|7392312|FG002|Overall Study|Physician Decision|1
4560081|NCT01277601|7392313|FG003|Overall Study|Physician Decision|6
4560082|NCT01277601|7392310|FG000|Overall Study|Pregnancy|2
4560083|NCT01277601|7392311|FG001|Overall Study|Pregnancy|2
4560084|NCT01277601|7392312|FG002|Overall Study|Pregnancy|4
4560085|NCT01277601|7392313|FG003|Overall Study|Pregnancy|1
4560086|NCT01277601|7392310|FG000|Overall Study|Noncompliance with Study Drug|1
4560087|NCT01277601|7392311|FG001|Overall Study|Noncompliance with Study Drug|3
4560088|NCT01277601|7392312|FG002|Overall Study|Noncompliance with Study Drug|2
4560089|NCT01277601|7392313|FG003|Overall Study|Noncompliance with Study Drug|0
4560090|NCT01277601|7392310|FG000|Overall Study|Subject Never Dosed with Study Drug|1
4560091|NCT01277601|7392311|FG001|Overall Study|Subject Never Dosed with Study Drug|2
4560092|NCT01277601|7392312|FG002|Overall Study|Subject Never Dosed with Study Drug|3
4560093|NCT01277601|7392313|FG003|Overall Study|Subject Never Dosed with Study Drug|1
4560094|NCT01277601|7392310|FG000|Overall Study|Protocol Violation|0
4560095|NCT01277601|7392311|FG001|Overall Study|Protocol Violation|2
4560096|NCT01277601|7392312|FG002|Overall Study|Protocol Violation|5
4560097|NCT01277601|7392313|FG003|Overall Study|Protocol Violation|0
4560098|NCT01277601|7392310|FG000|Overall Study|Subject Terminated from Study by Sponsor|0
4560099|NCT01277601|7392311|FG001|Overall Study|Subject Terminated from Study by Sponsor|1
4560100|NCT01277601|7392312|FG002|Overall Study|Subject Terminated from Study by Sponsor|0
4560101|NCT01277601|7392313|FG003|Overall Study|Subject Terminated from Study by Sponsor|2
4560102|NCT01277666|7392343|FG000|Overall Study|Adverse Event|26
4560103|NCT01277666|7392344|FG001|Overall Study|Adverse Event|25
4560104|NCT01277666|7392345|FG002|Overall Study|Adverse Event|20
4560105|NCT01277666|7392343|FG000|Overall Study|Lack of Efficacy|8
4560106|NCT01277666|7392344|FG001|Overall Study|Lack of Efficacy|20
4560107|NCT01277666|7392345|FG002|Overall Study|Lack of Efficacy|12
4560108|NCT01277666|7392343|FG000|Overall Study|Protocol Violation|2
4560109|NCT01277666|7392344|FG001|Overall Study|Protocol Violation|3
4560110|NCT01277666|7392345|FG002|Overall Study|Protocol Violation|2
4560111|NCT01277666|7392343|FG000|Overall Study|Protocol Defined Stopping criteria|1
4560112|NCT01277666|7392344|FG001|Overall Study|Protocol Defined Stopping criteria|2
4560113|NCT01277666|7392345|FG002|Overall Study|Protocol Defined Stopping criteria|6
4560114|NCT01277666|7392343|FG000|Overall Study|Lost to Follow-up|1
4560115|NCT01277666|7392344|FG001|Overall Study|Lost to Follow-up|1
4560116|NCT01277666|7392345|FG002|Overall Study|Lost to Follow-up|2
4560117|NCT01277666|7392343|FG000|Overall Study|Withdrawal by Subject|7
4623112|NCT01807520|7486481|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
4623113|NCT01807520|7486482|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
4623114|NCT01807520|7486483|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
4623115|NCT01807520|7486484|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
4560118|NCT01277666|7392344|FG001|Overall Study|Withdrawal by Subject|8
4560119|NCT01277666|7392345|FG002|Overall Study|Withdrawal by Subject|6
4560120|NCT01277666|7392343|FG000|Overall Study|Death|0
4560121|NCT01277666|7392344|FG001|Overall Study|Death|0
4560122|NCT01277666|7392345|FG002|Overall Study|Death|1
4560123|NCT01277718|7392353|FG000|Period 2 - Second Intervention|Protocol Violation|0
4560124|NCT01277718|7392354|FG001|Period 2 - Second Intervention|Protocol Violation|1
4560125|NCT01277718|7392353|FG000|Period 2 - Second Intervention|Physician Decision|0
4560126|NCT01277718|7392354|FG001|Period 2 - Second Intervention|Physician Decision|2
4560127|NCT01277744|7392362|FG000|Overall Study|Physician Decision|2
4560128|NCT01277757|7392366|FG000|Overall Study|Disease Progression|1
4560129|NCT01277757|7392366|FG000|Overall Study|Withdrawal by Subject|1
4592181|NCT01537211|7439501|FG001|Overall Study|Lost to Follow-up|1
4592182|NCT01537393|7439539|FG000|Overall Study|Exclude prior to study|32
4592183|NCT01537393|7439540|FG001|Overall Study|Exclude prior to study|44
4592184|NCT01537393|7439539|FG000|Overall Study|Death|20
4592185|NCT01537393|7439540|FG001|Overall Study|Death|32
4592186|NCT01537393|7439539|FG000|Overall Study|Withdrawal by Subject|18
4592187|NCT01537393|7439540|FG001|Overall Study|Withdrawal by Subject|17
4592188|NCT01537393|7439539|FG000|Overall Study|Lost to Follow-up|53
4592189|NCT01537393|7439540|FG001|Overall Study|Lost to Follow-up|48
4592190|NCT01537393|7439539|FG000|Overall Study|Failure - Regrafted|28
4592191|NCT01537393|7439540|FG001|Overall Study|Failure - Regrafted|43
4592192|NCT01537393|7439539|FG000|Overall Study|Failure - Not regrafted|2
4592193|NCT01537393|7439540|FG001|Overall Study|Failure - Not regrafted|6
4592194|NCT01537393|7439539|FG000|Overall Study|Censored (severe event unrelated to PT)|1
4592195|NCT01537393|7439540|FG001|Overall Study|Censored (severe event unrelated to PT)|1
4592196|NCT01537432|7439557|FG000|Overall Study|Lost to Follow-up|3
4592197|NCT01537432|7439558|FG001|Overall Study|Lost to Follow-up|1
4592198|NCT01537432|7439557|FG000|Overall Study|Withdrawal by Subject|0
4592199|NCT01537432|7439558|FG001|Overall Study|Withdrawal by Subject|1
4592200|NCT01537432|7439557|FG000|Overall Study|Administrative problems|1
4592201|NCT01537432|7439558|FG001|Overall Study|Administrative problems|0
4592202|NCT01537432|7439557|FG000|Overall Study|Adverse Event|1
4592203|NCT01537432|7439558|FG001|Overall Study|Adverse Event|0
4592204|NCT01537432|7439557|FG000|Overall Study|Unsatisfactory therapeutic effect|1
4592205|NCT01537432|7439558|FG001|Overall Study|Unsatisfactory therapeutic effect|0
4592206|NCT01537549|7439564|FG000|Overall Study|Lost to Follow-up|1
4592207|NCT01537549|7439564|FG000|Overall Study|Withdrawal by Subject|2
4592208|NCT01537783|7439599|FG000|Overall Study|Lost to Follow-up|11
4592209|NCT01537783|7439600|FG001|Overall Study|Lost to Follow-up|2
4592210|NCT01537887|7439619|FG000|Period 1|Physician Decision|0
4592211|NCT01537887|7439620|FG001|Period 1|Physician Decision|0
4592212|NCT01537887|7439621|FG002|Period 1|Physician Decision|0
4592213|NCT01537887|7439622|FG003|Period 1|Physician Decision|0
4592214|NCT01537887|7439623|FG004|Period 1|Physician Decision|1
4592215|NCT01537887|7439624|FG005|Period 1|Physician Decision|1
4592216|NCT01537887|7439619|FG000|Period 1|Did not receive treatment|0
4592217|NCT01537887|7439620|FG001|Period 1|Did not receive treatment|0
4592218|NCT01537887|7439621|FG002|Period 1|Did not receive treatment|1
4592219|NCT01537887|7439622|FG003|Period 1|Did not receive treatment|0
4592220|NCT01537887|7439623|FG004|Period 1|Did not receive treatment|0
4592221|NCT01537887|7439624|FG005|Period 1|Did not receive treatment|0
4592222|NCT01537887|7439619|FG000|Period 2|Withdrawal by Subject|0
4592223|NCT01537887|7439620|FG001|Period 2|Withdrawal by Subject|1
4592224|NCT01537887|7439621|FG002|Period 2|Withdrawal by Subject|0
4592225|NCT01537887|7439622|FG003|Period 2|Withdrawal by Subject|0
4592226|NCT01537887|7439623|FG004|Period 2|Withdrawal by Subject|0
4592227|NCT01537887|7439624|FG005|Period 2|Withdrawal by Subject|0
4592228|NCT01537887|7439619|FG000|Period 3|Adverse Event|0
4592229|NCT01537887|7439620|FG001|Period 3|Adverse Event|0
4592230|NCT01537887|7439621|FG002|Period 3|Adverse Event|1
4592231|NCT01537887|7439622|FG003|Period 3|Adverse Event|0
4592232|NCT01537887|7439623|FG004|Period 3|Adverse Event|0
4592233|NCT01537887|7439624|FG005|Period 3|Adverse Event|0
4592234|NCT01537887|7439619|FG000|Period 3|Withdrawal by Subject|0
4592235|NCT01537887|7439620|FG001|Period 3|Withdrawal by Subject|1
4592236|NCT01537887|7439621|FG002|Period 3|Withdrawal by Subject|0
4592237|NCT01537887|7439622|FG003|Period 3|Withdrawal by Subject|0
4592238|NCT01537887|7439623|FG004|Period 3|Withdrawal by Subject|0
4592239|NCT01537887|7439624|FG005|Period 3|Withdrawal by Subject|0
4592240|NCT01538199|7439652|FG000|Overall Study|Lost to Follow-up|1
4592241|NCT01538199|7439653|FG001|Overall Study|Lost to Follow-up|2
4592242|NCT01538199|7439654|FG002|Overall Study|Lost to Follow-up|1
4592243|NCT01538199|7439655|FG003|Overall Study|Lost to Follow-up|0
4592244|NCT01538199|7439652|FG000|Overall Study|participant did not have time|1
4592245|NCT01538199|7439653|FG001|Overall Study|participant did not have time|0
4592246|NCT01538199|7439654|FG002|Overall Study|participant did not have time|0
4592247|NCT01538199|7439655|FG003|Overall Study|participant did not have time|2
4592248|NCT01538199|7439652|FG000|Overall Study|Lack of Efficacy|0
4592249|NCT01538199|7439653|FG001|Overall Study|Lack of Efficacy|1
4592250|NCT01538199|7439654|FG002|Overall Study|Lack of Efficacy|0
4592251|NCT01538199|7439655|FG003|Overall Study|Lack of Efficacy|0
4592252|NCT01538472|7439672|FG000|Overall Study|Disease Progression|3
4592253|NCT01538472|7439672|FG000|Overall Study|Death|1
4592254|NCT01538628|7439687|FG000|Overall Study|Withdrawal by Subject|1
4592255|NCT01538628|7439688|FG001|Overall Study|Withdrawal by Subject|1
4592256|NCT01538628|7439687|FG000|Overall Study|Lost to Follow-up|0
4592257|NCT01538628|7439688|FG001|Overall Study|Lost to Follow-up|1
4592258|NCT01538719|7439697|FG000|Overall Study|Lost to Follow-up|2
4592259|NCT01538719|7439698|FG001|Overall Study|Lost to Follow-up|0
4592260|NCT01539083|7439727|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4
4592261|NCT01539083|7439728|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0
4592262|NCT01539083|7439729|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0
4592263|NCT01539083|7439727|FG000|Before Randomization (VCD Induction)|Adverse Event|14
4623116|NCT01807520|7486478|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7
4623117|NCT01807520|7486479|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4
4623118|NCT01807520|7486480|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0
4623119|NCT01807520|7486481|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0
4623120|NCT01807520|7486482|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2
4623121|NCT01807520|7486483|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0
4623122|NCT01807520|7486484|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0
4623123|NCT01807520|7486478|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
4623124|NCT01807520|7486479|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
4560130|NCT01277861|7392377|FG000|Overall Study|Physician Decision|2
4560131|NCT01277861|7392378|FG001|Overall Study|Physician Decision|2
4560132|NCT01277887|7392388|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1
4560133|NCT01277887|7392389|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0
4560134|NCT01277887|7392388|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2
4560135|NCT01277887|7392389|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0
4560136|NCT01277887|7392388|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3
4560137|NCT01277887|7392389|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5
4560138|NCT01278030|7392397|FG000|Overall Study|Withdrawal by Subject|8
4560139|NCT01278030|7392398|FG001|Overall Study|Withdrawal by Subject|4
4560140|NCT01278160|7392406|FG000|Overall Study|Adverse Event|1
4560141|NCT01278160|7392407|FG001|Overall Study|Adverse Event|1
4560142|NCT01278160|7392406|FG000|Overall Study|Lost to Follow-up|0
4560143|NCT01278160|7392407|FG001|Overall Study|Lost to Follow-up|1
4560144|NCT01278160|7392406|FG000|Overall Study|Withdrawal by Subject|3
4560145|NCT01278160|7392407|FG001|Overall Study|Withdrawal by Subject|2
4560146|NCT01278160|7392406|FG000|Overall Study|Unclassified|1
4560147|NCT01278160|7392407|FG001|Overall Study|Unclassified|2
4560148|NCT01278173|7392413|FG000|Overall Study|Lack of Efficacy|13
4560149|NCT01278173|7392413|FG000|Overall Study|Adverse Event|8
4560150|NCT01278173|7392413|FG000|Overall Study|Administrative or other reason|4
4560151|NCT01278173|7392413|FG000|Overall Study|Protocol Violation|1
4560152|NCT01278173|7392413|FG000|Overall Study|Withdrawal by Subject|1
4560153|NCT01278342|7392424|FG000|Overall Study|Physician Decision|0
4560154|NCT01278342|7392425|FG001|Overall Study|Physician Decision|1
4560155|NCT01278342|7392426|FG002|Overall Study|Physician Decision|0
4560156|NCT01278342|7392424|FG000|Overall Study|Lost to Follow-up|1
4560157|NCT01278342|7392425|FG001|Overall Study|Lost to Follow-up|0
4560158|NCT01278342|7392426|FG002|Overall Study|Lost to Follow-up|0
4560159|NCT01278342|7392424|FG000|Overall Study|Administrative problems|2
4560160|NCT01278342|7392425|FG001|Overall Study|Administrative problems|0
4560161|NCT01278342|7392426|FG002|Overall Study|Administrative problems|0
4560162|NCT01278342|7392424|FG000|Overall Study|Other|1
4560163|NCT01278342|7392425|FG001|Overall Study|Other|0
4560164|NCT01278342|7392426|FG002|Overall Study|Other|0
4560165|NCT01278394|7392434|FG000|Overall Study|Lost to Follow-up|1
4560166|NCT01278407|7392441|FG000|Confirmatory Phase|Adverse Event|5
4560167|NCT01278407|7392442|FG001|Confirmatory Phase|Adverse Event|10
4560168|NCT01278407|7392443|FG002|Confirmatory Phase|Adverse Event|1
4560169|NCT01278407|7392444|FG003|Confirmatory Phase|Adverse Event|0
4560170|NCT01278407|7392445|FG004|Confirmatory Phase|Adverse Event|0
4560171|NCT01278407|7392441|FG000|Confirmatory Phase|Participant's Choice|3
4560172|NCT01278407|7392442|FG001|Confirmatory Phase|Participant's Choice|5
4560173|NCT01278407|7392443|FG002|Confirmatory Phase|Participant's Choice|3
4560174|NCT01278407|7392444|FG003|Confirmatory Phase|Participant's Choice|0
4560175|NCT01278407|7392445|FG004|Confirmatory Phase|Participant's Choice|0
4560176|NCT01278407|7392441|FG000|Confirmatory Phase|Other|1
4560177|NCT01278407|7392442|FG001|Confirmatory Phase|Other|1
4560178|NCT01278407|7392443|FG002|Confirmatory Phase|Other|2
4560179|NCT01278407|7392444|FG003|Confirmatory Phase|Other|0
4560180|NCT01278407|7392445|FG004|Confirmatory Phase|Other|0
4560181|NCT01278407|7392441|FG000|Extension Phase|Adverse Event|0
4560182|NCT01278407|7392442|FG001|Extension Phase|Adverse Event|0
4560183|NCT01278407|7392443|FG002|Extension Phase|Adverse Event|0
4560184|NCT01278407|7392444|FG003|Extension Phase|Adverse Event|7
4560185|NCT01278407|7392445|FG004|Extension Phase|Adverse Event|16
4560186|NCT01278407|7392441|FG000|Extension Phase|Participant's Choice|0
4560187|NCT01278407|7392442|FG001|Extension Phase|Participant's Choice|0
4560188|NCT01278407|7392443|FG002|Extension Phase|Participant's Choice|0
4560189|NCT01278407|7392444|FG003|Extension Phase|Participant's Choice|4
4560190|NCT01278407|7392445|FG004|Extension Phase|Participant's Choice|11
4560191|NCT01278407|7392441|FG000|Extension Phase|Other|0
4560192|NCT01278407|7392442|FG001|Extension Phase|Other|0
4560193|NCT01278407|7392443|FG002|Extension Phase|Other|0
4560194|NCT01278407|7392444|FG003|Extension Phase|Other|1
4560195|NCT01278407|7392445|FG004|Extension Phase|Other|3
4560196|NCT01278615|7392459|FG000|Overall Study|Withdrawal by Subject|2
4560197|NCT01278745|7392465|FG000|Overall Study|Death|2
4560198|NCT01278745|7392466|FG001|Overall Study|Death|5
4560199|NCT01278745|7392467|FG002|Overall Study|Death|7
4560200|NCT01278745|7392468|FG003|Overall Study|Death|0
4560201|NCT01278745|7392465|FG000|Overall Study|Physician Decision|1
4560202|NCT01278745|7392466|FG001|Overall Study|Physician Decision|0
4560203|NCT01278745|7392467|FG002|Overall Study|Physician Decision|0
4560204|NCT01278745|7392468|FG003|Overall Study|Physician Decision|9
4623125|NCT01807520|7486480|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
4560205|NCT01278745|7392465|FG000|Overall Study|Withdrawal by Subject|1
4560206|NCT01278745|7392466|FG001|Overall Study|Withdrawal by Subject|1
4560207|NCT01278745|7392467|FG002|Overall Study|Withdrawal by Subject|5
4560208|NCT01278745|7392468|FG003|Overall Study|Withdrawal by Subject|1
4560209|NCT01278745|7392465|FG000|Overall Study|Sponsor Decision|1
4560210|NCT01278745|7392466|FG001|Overall Study|Sponsor Decision|0
4560211|NCT01278745|7392467|FG002|Overall Study|Sponsor Decision|62
4560212|NCT01278745|7392468|FG003|Overall Study|Sponsor Decision|6
4560213|NCT01278745|7392465|FG000|Overall Study|Ineligible|0
4560214|NCT01278745|7392466|FG001|Overall Study|Ineligible|0
4560215|NCT01278745|7392467|FG002|Overall Study|Ineligible|42
4560216|NCT01278745|7392468|FG003|Overall Study|Ineligible|61
4560217|NCT01278745|7392465|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0
4560218|NCT01278745|7392466|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0
4560219|NCT01278745|7392467|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5
4560220|NCT01278745|7392468|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1
4560221|NCT01278797|7392476|FG000|Period 1|Adverse Event|0
4560222|NCT01278797|7392477|FG001|Period 1|Adverse Event|1
4560223|NCT01278797|7392476|FG000|Period 1|Protocol Violation|1
4560224|NCT01278797|7392477|FG001|Period 1|Protocol Violation|0
4560225|NCT01278862|7392485|FG000|Overall Study|Lost to Follow-up|1
4560226|NCT01278862|7392486|FG001|Overall Study|Lost to Follow-up|1
4560227|NCT01279044|7392522|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0
4560228|NCT01279044|7392523|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3
4560229|NCT01279044|7392524|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2
4560230|NCT01279044|7392522|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0
4560231|NCT01279044|7392523|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8
4560232|NCT01279044|7392524|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0
4560233|NCT01279044|7392522|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0
4560234|NCT01279044|7392523|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0
4560235|NCT01279044|7392524|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1
4560236|NCT01279057|7392533|FG000|Overall Study|Adverse Event|1
4560237|NCT01279057|7392534|FG001|Overall Study|Adverse Event|0
4560238|NCT01279057|7392535|FG002|Overall Study|Adverse Event|1
4560239|NCT01279057|7392533|FG000|Overall Study|Insufficient therapeutic response|0
4560240|NCT01279057|7392534|FG001|Overall Study|Insufficient therapeutic response|0
4560241|NCT01279057|7392535|FG002|Overall Study|Insufficient therapeutic response|1
4560242|NCT01279057|7392533|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0
4560243|NCT01279057|7392534|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1
4560244|NCT01279057|7392535|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0
4560245|NCT01279057|7392533|FG000|Overall Study|Withdrew consent|2
4560246|NCT01279057|7392534|FG001|Overall Study|Withdrew consent|0
4560247|NCT01279057|7392535|FG002|Overall Study|Withdrew consent|1
4560248|NCT01279057|7392533|FG000|Overall Study|Pregnancy|0
4560249|NCT01279057|7392534|FG001|Overall Study|Pregnancy|1
4560250|NCT01279057|7392535|FG002|Overall Study|Pregnancy|0
4560251|NCT01279057|7392533|FG000|Overall Study|Other|3
4560252|NCT01279057|7392534|FG001|Overall Study|Other|3
4560253|NCT01279057|7392535|FG002|Overall Study|Other|0
4560254|NCT01279070|7392545|FG000|Overall Study|Withdrawal by Subject|2
4560255|NCT01279070|7392546|FG001|Overall Study|Withdrawal by Subject|3
4560256|NCT01279070|7392545|FG000|Overall Study|Acute exacerbation|3
4560257|NCT01279070|7392546|FG001|Overall Study|Acute exacerbation|1
4560258|NCT01279200|7392576|FG000|Overall Study|Withdrawal by Subject|1
4560259|NCT01279200|7392577|FG001|Overall Study|Withdrawal by Subject|3
4560260|NCT01279200|7392576|FG000|Overall Study|Patient withdrawal due to high cost|0
4560261|NCT01279200|7392577|FG001|Overall Study|Patient withdrawal due to high cost|1
4560262|NCT01279200|7392576|FG000|Overall Study|Inconvenience of ultrasound visit|0
4560263|NCT01279200|7392577|FG001|Overall Study|Inconvenience of ultrasound visit|1
4560264|NCT01279200|7392576|FG000|Overall Study|ultrasound screening failure|0
4560265|NCT01279200|7392577|FG001|Overall Study|ultrasound screening failure|1
4560266|NCT01279200|7392576|FG000|Overall Study|Lost to Follow-up|0
4560267|NCT01279200|7392577|FG001|Overall Study|Lost to Follow-up|1
4560268|NCT01279200|7392576|FG000|Overall Study|Adverse Event|1
4560269|NCT01279200|7392577|FG001|Overall Study|Adverse Event|0
4560270|NCT01279343|7392602|FG000|Overall Study|Did not receive treatment|2
4560271|NCT01279343|7392603|FG001|Overall Study|Did not receive treatment|6
4560272|NCT01279447|7392611|FG000|Overall Study|Lost to Follow-up|3
4560273|NCT01279447|7392612|FG001|Overall Study|Lost to Follow-up|1
4560274|NCT01279486|7392618|FG000|Overall Study|Lost to Follow-up|1
4560275|NCT01279681|7392633|FG000|Overall Study|Disease Progression|9
4560276|NCT01279681|7392634|FG001|Overall Study|Disease Progression|6
4560277|NCT01279681|7392633|FG000|Overall Study|Withdrawal by Subject|3
4560278|NCT01279681|7392634|FG001|Overall Study|Withdrawal by Subject|4
4560279|NCT01279681|7392633|FG000|Overall Study|Adverse Event|2
4560280|NCT01279681|7392634|FG001|Overall Study|Adverse Event|3
4560281|NCT01279681|7392633|FG000|Overall Study|Death|0
4560282|NCT01279681|7392634|FG001|Overall Study|Death|1
4560283|NCT01279681|7392633|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0
4560284|NCT01279681|7392634|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1
4560285|NCT01279681|7392633|FG000|Overall Study|Physician Decision|1
4560286|NCT01279681|7392634|FG001|Overall Study|Physician Decision|0
4560287|NCT01279681|7392633|FG000|Overall Study|Other Reason|0
4560288|NCT01279681|7392634|FG001|Overall Study|Other Reason|2
4560289|NCT01279850|7392640|FG000|Overall Study|Protocol Violation|50
4560290|NCT01279850|7392640|FG000|Overall Study|No Drug Administration Information|7
4560291|NCT01279850|7392640|FG000|Overall Study|No Visit After Treatment|34
4560292|NCT01279954|7392646|FG000|Overall Study|Lack of Efficacy|3
4560293|NCT01279954|7392647|FG001|Overall Study|Lack of Efficacy|4
4560294|NCT01280266|7392697|FG000|First Intervention (Week 1-4)|Adverse Event|1
4560295|NCT01280266|7392698|FG001|First Intervention (Week 1-4)|Adverse Event|0
4560296|NCT01280266|7392697|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0
4560297|NCT01280266|7392698|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2
4560298|NCT01280357|7392708|FG000|Overall Study|Excluded no internal monitoring|14
4560299|NCT01280357|7392708|FG000|Overall Study|IInsufficient data/No data supplied|12
4560300|NCT01280591|7392740|FG000|Overall Study|Withdrawal by Subject|0
4560301|NCT01280591|7392741|FG001|Overall Study|Withdrawal by Subject|0
4560302|NCT01280591|7392742|FG002|Overall Study|Withdrawal by Subject|0
4560303|NCT01280591|7392743|FG003|Overall Study|Withdrawal by Subject|2
4560304|NCT01280591|7392740|FG000|Overall Study|Does not meet exclusion #27 criteria|0
4560305|NCT01280591|7392741|FG001|Overall Study|Does not meet exclusion #27 criteria|0
4560306|NCT01280591|7392742|FG002|Overall Study|Does not meet exclusion #27 criteria|0
4560307|NCT01280591|7392743|FG003|Overall Study|Does not meet exclusion #27 criteria|1
4560308|NCT01280617|7392764|FG000|Overall Study|Adverse Event|0
4560309|NCT01280617|7392765|FG001|Overall Study|Adverse Event|1
4560310|NCT01280656|7392774|FG000|Overall Study|Adverse Event|1
4560311|NCT01280656|7392775|FG001|Overall Study|Adverse Event|14
4560312|NCT01280656|7392776|FG002|Overall Study|Adverse Event|13
4560313|NCT01280656|7392774|FG000|Overall Study|Lack of Efficacy|1
4560314|NCT01280656|7392775|FG001|Overall Study|Lack of Efficacy|22
4560315|NCT01280656|7392776|FG002|Overall Study|Lack of Efficacy|38
4560316|NCT01280656|7392774|FG000|Overall Study|Treatment shortening (RGT)|0
4560317|NCT01280656|7392775|FG001|Overall Study|Treatment shortening (RGT)|4
4560318|NCT01280656|7392776|FG002|Overall Study|Treatment shortening (RGT)|5
4560319|NCT01280656|7392774|FG000|Overall Study|Other|1
4560320|NCT01280656|7392775|FG001|Overall Study|Other|7
4560321|NCT01280656|7392776|FG002|Overall Study|Other|7
4560322|NCT01280721|7392805|FG000|Overall Study|Adverse Event|4
4560323|NCT01280721|7392805|FG000|Overall Study|Physician Decision|3
4560324|NCT01280721|7392805|FG000|Overall Study|Withdrawal by Subject|6
4560325|NCT01280721|7392805|FG000|Overall Study|eGFR under the withdrawal criteria|7
4560326|NCT01280721|7392805|FG000|Overall Study|No tolerability for the lowest dose|2
4560327|NCT01280812|7392823|FG000|Overall Study|Withdrawal by Subject|2
4560328|NCT01280812|7392824|FG001|Overall Study|Withdrawal by Subject|1
4560329|NCT01280812|7392825|FG002|Overall Study|Withdrawal by Subject|0
4560330|NCT01280812|7392823|FG000|Overall Study|Lost to Follow-up|1
4560331|NCT01280812|7392824|FG001|Overall Study|Lost to Follow-up|1
4560332|NCT01280812|7392825|FG002|Overall Study|Lost to Follow-up|1
4560333|NCT01280903|7392836|FG000|Overall Study|Lost to Follow-up|23
4560334|NCT01280903|7392837|FG001|Overall Study|Lost to Follow-up|16
4560335|NCT01280955|7392852|FG000|Overall Study|Death|2
4560336|NCT01280955|7392852|FG000|Overall Study|Withdrawal by Subject|1
4560337|NCT01280968|7392860|FG000|Overall Study|Lost to Follow-up|8
4560338|NCT01280968|7392861|FG001|Overall Study|Lost to Follow-up|2
4560339|NCT01280968|7392860|FG000|Overall Study|Unable to Follow Experimental Protocol|2
4560340|NCT01280968|7392861|FG001|Overall Study|Unable to Follow Experimental Protocol|0
4560341|NCT01280968|7392860|FG000|Overall Study|Commuting Problems|2
4560342|NCT01280968|7392861|FG001|Overall Study|Commuting Problems|0
4560343|NCT01280968|7392860|FG000|Overall Study|Anxiety|2
4560344|NCT01280968|7392861|FG001|Overall Study|Anxiety|0
4560345|NCT01280968|7392860|FG000|Overall Study|Adverse Event|1
4560346|NCT01280968|7392861|FG001|Overall Study|Adverse Event|0
4560347|NCT01280968|7392860|FG000|Overall Study|Scheduling Conflicts|1
4560348|NCT01280968|7392861|FG001|Overall Study|Scheduling Conflicts|1
4560349|NCT01280968|7392860|FG000|Overall Study|Pre-existing Neurological Condition|1
4560350|NCT01280968|7392861|FG001|Overall Study|Pre-existing Neurological Condition|0
4560351|NCT01280968|7392860|FG000|Overall Study|Unable to Smoke in Supine Position|1
4560352|NCT01280968|7392861|FG001|Overall Study|Unable to Smoke in Supine Position|0
4560353|NCT01280981|7392868|FG000|Overall Study|Withdrawal by Subject|11
4560354|NCT01280981|7392868|FG000|Overall Study|Protocol Violation|2
4560355|NCT01280981|7392868|FG000|Overall Study|Lack of Efficacy|13
4560356|NCT01280981|7392868|FG000|Overall Study|Lost to Follow-up|3
4560357|NCT01280981|7392868|FG000|Overall Study|Adverse Event|6
4560358|NCT01280981|7392868|FG000|Overall Study|Irregular or discontinued menses|3
4560359|NCT01280981|7392868|FG000|Overall Study|Failed to return|45
4560360|NCT01280981|7392868|FG000|Overall Study|Non-compliance with protocol|3
4560361|NCT01280981|7392868|FG000|Overall Study|Withdrawal of consent|3
4560362|NCT01280981|7392868|FG000|Overall Study|Elective surgery|2
4560363|NCT01280981|7392868|FG000|Overall Study|Study site closure|1
4560364|NCT01281137|7392883|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0
4560365|NCT01281137|7392884|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1
4592264|NCT01539083|7439728|FG001|Before Randomization (VCD Induction)|Adverse Event|0
4560366|NCT01281137|7392883|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4
4560367|NCT01281137|7392884|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9
4560368|NCT01281137|7392883|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0
4560369|NCT01281137|7392884|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5
4560370|NCT01281137|7392883|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1
4560371|NCT01281137|7392884|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0
4560372|NCT01281137|7392883|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1
4560373|NCT01281137|7392884|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2
4560374|NCT01281189|7392910|FG000|Overall Study|Adverse Event|7
4560375|NCT01281189|7392911|FG001|Overall Study|Adverse Event|9
4560376|NCT01281189|7392910|FG000|Overall Study|Lost to Follow-up|6
4560377|NCT01281189|7392911|FG001|Overall Study|Lost to Follow-up|4
4560378|NCT01281189|7392910|FG000|Overall Study|Withdrawal by Subject|21
4560379|NCT01281189|7392911|FG001|Overall Study|Withdrawal by Subject|24
4560380|NCT01281189|7392910|FG000|Overall Study|Physician Decision|2
4560381|NCT01281189|7392911|FG001|Overall Study|Physician Decision|3
4560382|NCT01281189|7392910|FG000|Overall Study|Death|103
4560383|NCT01281189|7392911|FG001|Overall Study|Death|91
4560384|NCT01281189|7392910|FG000|Overall Study|Other|8
4560385|NCT01281189|7392911|FG001|Overall Study|Other|12
4560386|NCT01281202|7392919|FG000|Overall Study|Adverse Event|2
4560387|NCT01281202|7392920|FG001|Overall Study|Adverse Event|0
4560388|NCT01281202|7392919|FG000|Overall Study|Withdrawal by Subject|2
4560389|NCT01281202|7392920|FG001|Overall Study|Withdrawal by Subject|2
4560390|NCT01281202|7392919|FG000|Overall Study|Protocol Violation|11
4560391|NCT01281202|7392920|FG001|Overall Study|Protocol Violation|10
4560392|NCT01281202|7392919|FG000|Overall Study|Administrative|2
4560393|NCT01281202|7392920|FG001|Overall Study|Administrative|8
4560394|NCT01281202|7392919|FG000|Overall Study|Lost to Follow-up|11
4560395|NCT01281202|7392920|FG001|Overall Study|Lost to Follow-up|13
4560396|NCT01281202|7392919|FG000|Overall Study|Incarceration|0
4560397|NCT01281202|7392920|FG001|Overall Study|Incarceration|3
4560398|NCT01281306|7392935|FG000|Overall Study|Lack of Efficacy|0
4560399|NCT01281306|7392936|FG001|Overall Study|Lack of Efficacy|1
4560400|NCT01281306|7392937|FG002|Overall Study|Lack of Efficacy|3
4560401|NCT01281306|7392938|FG003|Overall Study|Lack of Efficacy|0
4560402|NCT01281306|7392939|FG004|Overall Study|Lack of Efficacy|2
4560403|NCT01281306|7392940|FG005|Overall Study|Lack of Efficacy|0
4560404|NCT01281306|7392941|FG006|Overall Study|Lack of Efficacy|1
4560405|NCT01281306|7392935|FG000|Overall Study|Withdrawal by Subject|1
4560406|NCT01281306|7392936|FG001|Overall Study|Withdrawal by Subject|0
4560407|NCT01281306|7392937|FG002|Overall Study|Withdrawal by Subject|2
4560408|NCT01281306|7392938|FG003|Overall Study|Withdrawal by Subject|4
4560409|NCT01281306|7392939|FG004|Overall Study|Withdrawal by Subject|1
4560410|NCT01281306|7392940|FG005|Overall Study|Withdrawal by Subject|3
4560411|NCT01281306|7392941|FG006|Overall Study|Withdrawal by Subject|1
4560412|NCT01281306|7392935|FG000|Overall Study|Protocol deviation|0
4560413|NCT01281306|7392936|FG001|Overall Study|Protocol deviation|1
4560414|NCT01281306|7392937|FG002|Overall Study|Protocol deviation|1
4560415|NCT01281306|7392938|FG003|Overall Study|Protocol deviation|1
4560416|NCT01281306|7392939|FG004|Overall Study|Protocol deviation|1
4560417|NCT01281306|7392940|FG005|Overall Study|Protocol deviation|0
4560418|NCT01281306|7392941|FG006|Overall Study|Protocol deviation|0
4560419|NCT01281306|7392935|FG000|Overall Study|Condition no longer requires study drug|1
4560420|NCT01281306|7392936|FG001|Overall Study|Condition no longer requires study drug|0
4560421|NCT01281306|7392937|FG002|Overall Study|Condition no longer requires study drug|0
4560422|NCT01281306|7392938|FG003|Overall Study|Condition no longer requires study drug|0
4560423|NCT01281306|7392939|FG004|Overall Study|Condition no longer requires study drug|0
4560424|NCT01281306|7392940|FG005|Overall Study|Condition no longer requires study drug|1
4560425|NCT01281306|7392941|FG006|Overall Study|Condition no longer requires study drug|1
4560426|NCT01281306|7392935|FG000|Overall Study|Lost to Follow-up|1
4560427|NCT01281306|7392936|FG001|Overall Study|Lost to Follow-up|0
4560428|NCT01281306|7392937|FG002|Overall Study|Lost to Follow-up|0
4560429|NCT01281306|7392938|FG003|Overall Study|Lost to Follow-up|2
4560430|NCT01281306|7392939|FG004|Overall Study|Lost to Follow-up|0
4560431|NCT01281306|7392940|FG005|Overall Study|Lost to Follow-up|0
4560432|NCT01281306|7392941|FG006|Overall Study|Lost to Follow-up|1
4560433|NCT01281306|7392935|FG000|Overall Study|Death|1
4560434|NCT01281306|7392936|FG001|Overall Study|Death|0
4560435|NCT01281306|7392937|FG002|Overall Study|Death|0
4560436|NCT01281306|7392938|FG003|Overall Study|Death|0
4560437|NCT01281306|7392939|FG004|Overall Study|Death|0
4560438|NCT01281306|7392940|FG005|Overall Study|Death|0
4560439|NCT01281306|7392941|FG006|Overall Study|Death|0
4560440|NCT01281306|7392935|FG000|Overall Study|Adverse Event|3
4560441|NCT01281306|7392936|FG001|Overall Study|Adverse Event|2
4560442|NCT01281306|7392937|FG002|Overall Study|Adverse Event|2
4560443|NCT01281306|7392938|FG003|Overall Study|Adverse Event|3
4560444|NCT01281306|7392939|FG004|Overall Study|Adverse Event|5
4560445|NCT01281306|7392940|FG005|Overall Study|Adverse Event|3
4560446|NCT01281306|7392941|FG006|Overall Study|Adverse Event|3
4560447|NCT01281306|7392935|FG000|Overall Study|Randomized in error|1
4560448|NCT01281306|7392936|FG001|Overall Study|Randomized in error|0
4560449|NCT01281306|7392937|FG002|Overall Study|Randomized in error|0
4560450|NCT01281306|7392938|FG003|Overall Study|Randomized in error|1
4560451|NCT01281306|7392939|FG004|Overall Study|Randomized in error|0
4560452|NCT01281306|7392940|FG005|Overall Study|Randomized in error|0
4560453|NCT01281306|7392941|FG006|Overall Study|Randomized in error|0
4560454|NCT01281839|7392979|FG000|Overall Study|Lost to Follow-up|6
4560455|NCT01281839|7392980|FG001|Overall Study|Lost to Follow-up|3
4560456|NCT01281839|7392979|FG000|Overall Study|Withdrawal by Subject|4
4560457|NCT01281839|7392980|FG001|Overall Study|Withdrawal by Subject|10
4560458|NCT01281839|7392979|FG000|Overall Study|Reason not specified|0
4560459|NCT01281839|7392980|FG001|Overall Study|Reason not specified|1
4560460|NCT01281865|7392988|FG000|Overall Study|Adverse Event|1
4560461|NCT01281865|7392989|FG001|Overall Study|Adverse Event|1
4560462|NCT01281865|7392988|FG000|Overall Study|Withdrawal by Subject|1
4560463|NCT01281865|7392989|FG001|Overall Study|Withdrawal by Subject|0
4560464|NCT01281865|7392988|FG000|Overall Study|Lack of Efficacy|1
4560465|NCT01281865|7392989|FG001|Overall Study|Lack of Efficacy|0
4560466|NCT01281917|7392995|FG000|Overall Study|Withdrawal by Subject|1
4560467|NCT01281956|7392999|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1
4560468|NCT01281956|7393000|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0
4560469|NCT01281969|7393011|FG000|Overall Study|not randomized didn't meet criteria|0
4560470|NCT01281969|7393012|FG001|Overall Study|not randomized didn't meet criteria|0
4560471|NCT01281969|7393013|FG002|Overall Study|not randomized didn't meet criteria|7
4560472|NCT01281969|7393011|FG000|Overall Study|AE during LP prior to IVIG admin|1
4560473|NCT01281969|7393012|FG001|Overall Study|AE during LP prior to IVIG admin|0
4560474|NCT01281969|7393013|FG002|Overall Study|AE during LP prior to IVIG admin|3
4560475|NCT01281969|7393011|FG000|Overall Study|not randomized, child consent not given|0
4560476|NCT01281969|7393012|FG001|Overall Study|not randomized, child consent not given|0
4560477|NCT01281969|7393013|FG002|Overall Study|not randomized, child consent not given|2
4560478|NCT01282164|7393037|FG000|Overall Study|Lack of hypoglycemia during ITT|1
4560479|NCT01282164|7393038|FG001|Overall Study|Lack of hypoglycemia during ITT|0
4560480|NCT01282203|7393052|FG000|Overall Study|Adverse Event|1
4560481|NCT01282229|7393059|FG000|Overall Study|Protocol Violation|2
4560482|NCT01282294|7393086|FG000|Overall Study|Lost to Follow-up|14
4560483|NCT01282294|7393086|FG000|Overall Study|Screening failure|1
4560484|NCT01282294|7393086|FG000|Overall Study|Adverse Event|1
4560485|NCT01282294|7393086|FG000|Overall Study|Patient non-compliance|2
4560486|NCT01282294|7393086|FG000|Overall Study|Physician Decision|1
4560487|NCT01282372|7393090|FG000|Overall Study|Lack of Efficacy / Exacerbation|25
4560488|NCT01282372|7393090|FG000|Overall Study|Lost to Follow-up|23
4560489|NCT01282372|7393090|FG000|Overall Study|Withdrawal by Subject|11
4623126|NCT01807520|7486481|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1
4623127|NCT01807520|7486482|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
4623128|NCT01807520|7486483|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
4623129|NCT01807520|7486484|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
4623130|NCT01807520|7486478|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1
4623131|NCT01807520|7486479|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
4623132|NCT01807520|7486480|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
4623133|NCT01807520|7486481|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
4623134|NCT01807520|7486482|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
4623135|NCT01807520|7486483|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
4623136|NCT01807520|7486484|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
4623137|NCT01807520|7486478|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
4623138|NCT01807520|7486479|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2
4623139|NCT01807520|7486480|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
4623140|NCT01807520|7486481|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
4623141|NCT01807520|7486482|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
4560490|NCT01282372|7393090|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4
4560491|NCT01282372|7393090|FG000|Overall Study|Death|1
4560492|NCT01282372|7393090|FG000|Overall Study|Presence of AE, Lack of Efficacy|1
4560493|NCT01282372|7393090|FG000|Overall Study|Presence of AE, Regression of Symptoms|1
4560494|NCT01282372|7393090|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1
4560495|NCT01282372|7393090|FG000|Overall Study|Adverse Event|12
4560496|NCT01282424|7393101|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30
4560497|NCT01282424|7393101|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6
4560498|NCT01282424|7393101|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7
4560499|NCT01282424|7393101|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3
4560500|NCT01282424|7393101|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2
4560501|NCT01282424|7393101|FG000|Long-term Follow-up Period (5 Years)|Death|40
4560502|NCT01282424|7393101|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1
4560503|NCT01282424|7393101|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21
4560504|NCT01282463|7393108|FG000|Overall Study|Lost to Follow-up|1
4560505|NCT01282463|7393109|FG001|Overall Study|Lost to Follow-up|0
4560506|NCT01282463|7393110|FG002|Overall Study|Lost to Follow-up|0
4560507|NCT01282463|7393108|FG000|Overall Study|Withdrawal by Subject|6
4560508|NCT01282463|7393109|FG001|Overall Study|Withdrawal by Subject|2
4560509|NCT01282463|7393110|FG002|Overall Study|Withdrawal by Subject|3
4560510|NCT01282463|7393108|FG000|Overall Study|"Never Treated Death"|0
4560511|NCT01282463|7393109|FG001|Overall Study|"Never Treated Death"|1
4560512|NCT01282463|7393110|FG002|Overall Study|"Never Treated Death"|0
4560513|NCT01282463|7393108|FG000|Overall Study|"Never Treated PD"|0
4560514|NCT01282463|7393109|FG001|Overall Study|"Never Treated PD"|1
4560515|NCT01282463|7393110|FG002|Overall Study|"Never Treated PD"|0
4560516|NCT01282463|7393108|FG000|Overall Study|Protocol Violation|0
4560517|NCT01282463|7393109|FG001|Overall Study|Protocol Violation|0
4560518|NCT01282463|7393110|FG002|Overall Study|Protocol Violation|1
4560519|NCT01282463|7393108|FG000|Overall Study|Physician Decision|1
4560520|NCT01282463|7393109|FG001|Overall Study|Physician Decision|0
4560521|NCT01282463|7393110|FG002|Overall Study|Physician Decision|0
4560522|NCT01282476|7393126|FG000|Overall Study|Death|11
4560523|NCT01282801|7393140|FG000|Second Intervention|Emesis During Critical Breakfast|0
4560524|NCT01282801|7393141|FG001|Second Intervention|Emesis During Critical Breakfast|1
4560525|NCT01282814|7393149|FG000|First Intervention|Emesis During Dosing Interval|0
4560526|NCT01282814|7393150|FG001|First Intervention|Emesis During Dosing Interval|3
4560527|NCT01282814|7393149|FG000|Washout of 7 Days|Withdrawal by Subject|2
4560528|NCT01282814|7393150|FG001|Washout of 7 Days|Withdrawal by Subject|0
4560529|NCT01282866|7393156|FG000|Overall Study|Adverse Event|1
4560530|NCT01283009|7393162|FG000|Overall Study|Death|83
4560531|NCT01283009|7393163|FG001|Overall Study|Death|78
4560532|NCT01283009|7393162|FG000|Overall Study|Study ended early|23
4560533|NCT01283009|7393163|FG001|Overall Study|Study ended early|26
4560534|NCT01283009|7393162|FG000|Overall Study|Withdrawal by Subject|10
4560535|NCT01283009|7393163|FG001|Overall Study|Withdrawal by Subject|8
4560536|NCT01283009|7393162|FG000|Overall Study|Physician Decision|1
4560537|NCT01283009|7393163|FG001|Overall Study|Physician Decision|1
4560538|NCT01283009|7393162|FG000|Overall Study|Lost to Follow-up|1
4560539|NCT01283009|7393163|FG001|Overall Study|Lost to Follow-up|0
4560540|NCT01283009|7393162|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0
4560541|NCT01283009|7393163|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4
4560542|NCT01283035|7393174|FG000|Overall Study|Subject later found ineligible|1
4560543|NCT01283139|7393182|FG000|Overall Study|Lost to Follow-up|5
4560544|NCT01283139|7393183|FG001|Overall Study|Lost to Follow-up|2
4560545|NCT01283139|7393184|FG002|Overall Study|Lost to Follow-up|3
4560546|NCT01283139|7393185|FG003|Overall Study|Lost to Follow-up|1
4560547|NCT01283139|7393182|FG000|Overall Study|Withdrawal by Subject|8
4560548|NCT01283139|7393183|FG001|Overall Study|Withdrawal by Subject|8
4560549|NCT01283139|7393184|FG002|Overall Study|Withdrawal by Subject|6
4560550|NCT01283139|7393185|FG003|Overall Study|Withdrawal by Subject|8
4560551|NCT01283139|7393182|FG000|Overall Study|Death|2
4560552|NCT01283139|7393183|FG001|Overall Study|Death|0
4560553|NCT01283139|7393184|FG002|Overall Study|Death|2
4560554|NCT01283139|7393185|FG003|Overall Study|Death|2
4560555|NCT01283139|7393182|FG000|Overall Study|Lack of Efficacy|1
4560556|NCT01283139|7393183|FG001|Overall Study|Lack of Efficacy|2
4560557|NCT01283139|7393184|FG002|Overall Study|Lack of Efficacy|2
4560558|NCT01283139|7393185|FG003|Overall Study|Lack of Efficacy|1
4560559|NCT01283139|7393182|FG000|Overall Study|Early termination due to AE/SAE|1
4560560|NCT01283139|7393183|FG001|Overall Study|Early termination due to AE/SAE|1
4560561|NCT01283139|7393184|FG002|Overall Study|Early termination due to AE/SAE|0
4560562|NCT01283139|7393185|FG003|Overall Study|Early termination due to AE/SAE|0
4560563|NCT01283139|7393182|FG000|Overall Study|Participant's refusal to continue|0
4560564|NCT01283139|7393183|FG001|Overall Study|Participant's refusal to continue|3
4560565|NCT01283139|7393184|FG002|Overall Study|Participant's refusal to continue|1
4560566|NCT01283139|7393185|FG003|Overall Study|Participant's refusal to continue|1
4560567|NCT01283139|7393182|FG000|Overall Study|Pregnancy|0
4560568|NCT01283139|7393183|FG001|Overall Study|Pregnancy|1
4560569|NCT01283139|7393184|FG002|Overall Study|Pregnancy|1
4560570|NCT01283139|7393185|FG003|Overall Study|Pregnancy|0
4560571|NCT01283139|7393182|FG000|Overall Study|Missed follow-up visit|0
4560572|NCT01283139|7393183|FG001|Overall Study|Missed follow-up visit|1
4560573|NCT01283139|7393184|FG002|Overall Study|Missed follow-up visit|2
4560574|NCT01283139|7393185|FG003|Overall Study|Missed follow-up visit|2
4560575|NCT01283139|7393182|FG000|Overall Study|Participant randomized in error|0
4560576|NCT01283139|7393183|FG001|Overall Study|Participant randomized in error|0
4560577|NCT01283139|7393184|FG002|Overall Study|Participant randomized in error|1
4560578|NCT01283139|7393185|FG003|Overall Study|Participant randomized in error|0
4560579|NCT01283152|7393197|FG000|Overall Study|Discharged prior to 24 hr assessment|1
4560580|NCT01283152|7393198|FG001|Overall Study|Discharged prior to 24 hr assessment|0
4560581|NCT01283152|7393197|FG000|Overall Study|Refused HESA|1
4560582|NCT01283152|7393198|FG001|Overall Study|Refused HESA|0
4560583|NCT01283282|7393204|FG000|First Intervention (6 Weeks)|Physician Decision|0
4560584|NCT01283282|7393205|FG001|First Intervention (6 Weeks)|Physician Decision|1
4560585|NCT01283282|7393204|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2
4560586|NCT01283282|7393205|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3
4560587|NCT01283282|7393204|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1
4560588|NCT01283282|7393205|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0
4560589|NCT01283334|7393223|FG000|Overall Study|Withdrawal by Subject|1
4560590|NCT01283334|7393223|FG000|Overall Study|Inability to Swallow Everolimus Pills|1
4560591|NCT01283334|7393223|FG000|Overall Study|Adverse Event|4
4560592|NCT01283334|7393223|FG000|Overall Study|Physician Decision|1
4560593|NCT01283386|7393231|FG000|Overall Study|Death|2
4560594|NCT01283386|7393232|FG001|Overall Study|Death|0
4560595|NCT01283386|7393231|FG000|Overall Study|Withdrawal by Subject|2
4560596|NCT01283386|7393232|FG001|Overall Study|Withdrawal by Subject|1
4560597|NCT01283386|7393231|FG000|Overall Study|Relapse of underlying disease|1
4560598|NCT01283386|7393232|FG001|Overall Study|Relapse of underlying disease|3
4560599|NCT01283386|7393231|FG000|Overall Study|Progression of underlying disease|2
4560600|NCT01283386|7393232|FG001|Overall Study|Progression of underlying disease|7
4560601|NCT01283386|7393231|FG000|Overall Study|Reason not specified|1
4560602|NCT01283386|7393232|FG001|Overall Study|Reason not specified|0
4560603|NCT01283386|7393231|FG000|Overall Study|Protocol Violation|0
4560604|NCT01283386|7393232|FG001|Overall Study|Protocol Violation|1
4560605|NCT01283464|7393240|FG000|Overall Study|Lost to Follow-up|0
4560606|NCT01283464|7393241|FG001|Overall Study|Lost to Follow-up|1
4560607|NCT01283464|7393240|FG000|Overall Study|Withdrawal by Subject|1
4560608|NCT01283464|7393241|FG001|Overall Study|Withdrawal by Subject|0
4560609|NCT01283464|7393240|FG000|Overall Study|Physician Decision|1
4560610|NCT01283464|7393241|FG001|Overall Study|Physician Decision|0
4560611|NCT01283516|7393256|FG000|Overall Study|Adverse Event|0
4560612|NCT01283516|7393257|FG001|Overall Study|Adverse Event|0
4560613|NCT01283516|7393258|FG002|Overall Study|Adverse Event|0
4560614|NCT01283516|7393259|FG003|Overall Study|Adverse Event|0
4560615|NCT01283516|7393260|FG004|Overall Study|Adverse Event|0
4560616|NCT01283516|7393261|FG005|Overall Study|Adverse Event|0
4560617|NCT01283516|7393262|FG006|Overall Study|Adverse Event|2
4560618|NCT01283516|7393263|FG007|Overall Study|Adverse Event|0
4560619|NCT01283516|7393264|FG008|Overall Study|Adverse Event|28
4560620|NCT01283516|7393256|FG000|Overall Study|Death|0
4560621|NCT01283516|7393257|FG001|Overall Study|Death|0
4560622|NCT01283516|7393258|FG002|Overall Study|Death|0
4560623|NCT01283516|7393259|FG003|Overall Study|Death|0
4560624|NCT01283516|7393260|FG004|Overall Study|Death|0
4560625|NCT01283516|7393261|FG005|Overall Study|Death|1
4560626|NCT01283516|7393262|FG006|Overall Study|Death|0
4560627|NCT01283516|7393263|FG007|Overall Study|Death|1
4560628|NCT01283516|7393264|FG008|Overall Study|Death|12
4560629|NCT01283516|7393256|FG000|Overall Study|Disease Progression|2
4560630|NCT01283516|7393257|FG001|Overall Study|Disease Progression|2
4560631|NCT01283516|7393258|FG002|Overall Study|Disease Progression|3
4560632|NCT01283516|7393259|FG003|Overall Study|Disease Progression|3
4560633|NCT01283516|7393260|FG004|Overall Study|Disease Progression|13
4560634|NCT01283516|7393261|FG005|Overall Study|Disease Progression|8
4560635|NCT01283516|7393262|FG006|Overall Study|Disease Progression|6
4560636|NCT01283516|7393263|FG007|Overall Study|Disease Progression|3
4560637|NCT01283516|7393264|FG008|Overall Study|Disease Progression|139
4560638|NCT01283516|7393256|FG000|Overall Study|Withdrawal by Subject|0
4560639|NCT01283516|7393257|FG001|Overall Study|Withdrawal by Subject|0
4560640|NCT01283516|7393258|FG002|Overall Study|Withdrawal by Subject|0
4560641|NCT01283516|7393259|FG003|Overall Study|Withdrawal by Subject|0
4560642|NCT01283516|7393260|FG004|Overall Study|Withdrawal by Subject|1
4560643|NCT01283516|7393261|FG005|Overall Study|Withdrawal by Subject|0
4560644|NCT01283516|7393262|FG006|Overall Study|Withdrawal by Subject|1
4560645|NCT01283516|7393263|FG007|Overall Study|Withdrawal by Subject|0
4623142|NCT01807520|7486483|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
4623143|NCT01807520|7486484|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
4623144|NCT01807520|7486478|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4
4623145|NCT01807520|7486479|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
4623146|NCT01807520|7486480|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
4623147|NCT01807520|7486481|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1
4623148|NCT01807520|7486482|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
4623149|NCT01807520|7486483|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
4623150|NCT01807520|7486484|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
4623151|NCT01807520|7486478|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5
4623152|NCT01807520|7486479|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3
4560646|NCT01283516|7393264|FG008|Overall Study|Withdrawal by Subject|36
4560647|NCT01283516|7393256|FG000|Overall Study|Administrative problems|0
4560648|NCT01283516|7393257|FG001|Overall Study|Administrative problems|0
4560649|NCT01283516|7393258|FG002|Overall Study|Administrative problems|0
4560650|NCT01283516|7393259|FG003|Overall Study|Administrative problems|0
4560651|NCT01283516|7393260|FG004|Overall Study|Administrative problems|0
4560652|NCT01283516|7393261|FG005|Overall Study|Administrative problems|1
4560653|NCT01283516|7393262|FG006|Overall Study|Administrative problems|1
4560654|NCT01283516|7393263|FG007|Overall Study|Administrative problems|1
4560655|NCT01283516|7393264|FG008|Overall Study|Administrative problems|39
4560656|NCT01283516|7393256|FG000|Overall Study|Lost to Follow-up|0
4560657|NCT01283516|7393257|FG001|Overall Study|Lost to Follow-up|0
4560658|NCT01283516|7393258|FG002|Overall Study|Lost to Follow-up|0
4560659|NCT01283516|7393259|FG003|Overall Study|Lost to Follow-up|0
4560660|NCT01283516|7393260|FG004|Overall Study|Lost to Follow-up|0
4560661|NCT01283516|7393261|FG005|Overall Study|Lost to Follow-up|0
4560662|NCT01283516|7393262|FG006|Overall Study|Lost to Follow-up|0
4560663|NCT01283516|7393263|FG007|Overall Study|Lost to Follow-up|0
4560664|NCT01283516|7393264|FG008|Overall Study|Lost to Follow-up|1
4560665|NCT01283542|7393292|FG000|Main Phase|Acute or progressive vision loss|1
4560666|NCT01283542|7393292|FG000|Main Phase|Uncontrolled diabetes mellitus|1
4560667|NCT01283542|7393292|FG000|Main Phase|abnormal laboratory values|5
4560668|NCT01283542|7393292|FG000|Extension Phase|Physician Decision|1
4560669|NCT01283542|7393292|FG000|Extension Phase|Adverse Event|1
4560670|NCT01283542|7393292|FG000|Extension Phase|Administrative problems|1
4560671|NCT01283581|7393328|FG000|Overall Study|Lost to Follow-up|8
4560672|NCT01283581|7393329|FG001|Overall Study|Lost to Follow-up|6
4560673|NCT01283581|7393330|FG002|Overall Study|Lost to Follow-up|8
4560674|NCT01283581|7393328|FG000|Overall Study|Withdrawal by Subject|2
4560675|NCT01283581|7393329|FG001|Overall Study|Withdrawal by Subject|5
4560676|NCT01283581|7393330|FG002|Overall Study|Withdrawal by Subject|2
4560677|NCT01283581|7393328|FG000|Overall Study|Adverse Event|1
4560678|NCT01283581|7393329|FG001|Overall Study|Adverse Event|1
4560679|NCT01283581|7393330|FG002|Overall Study|Adverse Event|4
4560680|NCT01283581|7393328|FG000|Overall Study|Physician Decision|0
4560681|NCT01283581|7393329|FG001|Overall Study|Physician Decision|1
4560682|NCT01283581|7393330|FG002|Overall Study|Physician Decision|2
4560683|NCT01283581|7393328|FG000|Overall Study|Protocol Violation|0
4560684|NCT01283581|7393329|FG001|Overall Study|Protocol Violation|1
4560685|NCT01283581|7393330|FG002|Overall Study|Protocol Violation|2
4560686|NCT01283581|7393328|FG000|Overall Study|Noncompliance|1
4560687|NCT01283581|7393329|FG001|Overall Study|Noncompliance|0
4560688|NCT01283581|7393330|FG002|Overall Study|Noncompliance|0
4560689|NCT01283581|7393328|FG000|Overall Study|Investigator unblinded|0
4560690|NCT01283581|7393329|FG001|Overall Study|Investigator unblinded|0
4560691|NCT01283581|7393330|FG002|Overall Study|Investigator unblinded|1
4560692|NCT01283581|7393328|FG000|Overall Study|"Early termination"|0
4560693|NCT01283581|7393329|FG001|Overall Study|"Early termination"|0
4560694|NCT01283581|7393330|FG002|Overall Study|"Early termination"|1
4560695|NCT01283971|7393343|FG000|Overall Study|Adverse Event|3
4560696|NCT01283971|7393344|FG001|Overall Study|Adverse Event|5
4560697|NCT01283971|7393343|FG000|Overall Study|Insufficient therapeutic responses|3
4560698|NCT01283971|7393344|FG001|Overall Study|Insufficient therapeutic responses|3
4560699|NCT01283971|7393343|FG000|Overall Study|Protocol Violation|5
4560700|NCT01283971|7393344|FG001|Overall Study|Protocol Violation|1
4560701|NCT01283971|7393343|FG000|Overall Study|Refused treatment|3
4560702|NCT01283971|7393344|FG001|Overall Study|Refused treatment|1
4560703|NCT01283971|7393343|FG000|Overall Study|Failure to return|0
4560704|NCT01283971|7393344|FG001|Overall Study|Failure to return|1
4560705|NCT01283971|7393343|FG000|Overall Study|Administrative reasons|1
4560706|NCT01283971|7393344|FG001|Overall Study|Administrative reasons|1
4560707|NCT01284062|7393354|FG000|Overall Study|Adverse Event|4
4560708|NCT01284062|7393355|FG001|Overall Study|Adverse Event|5
4560709|NCT01284062|7393356|FG002|Overall Study|Adverse Event|0
4560710|NCT01284062|7393357|FG003|Overall Study|Adverse Event|5
4560711|NCT01284062|7393354|FG000|Overall Study|Lack of Efficacy|3
4560712|NCT01284062|7393355|FG001|Overall Study|Lack of Efficacy|2
4560713|NCT01284062|7393356|FG002|Overall Study|Lack of Efficacy|2
4560714|NCT01284062|7393357|FG003|Overall Study|Lack of Efficacy|1
4560715|NCT01284062|7393354|FG000|Overall Study|Medication error without adverse event|0
4560716|NCT01284062|7393355|FG001|Overall Study|Medication error without adverse event|0
4560717|NCT01284062|7393356|FG002|Overall Study|Medication error without adverse event|1
4560718|NCT01284062|7393357|FG003|Overall Study|Medication error without adverse event|0
4560719|NCT01284062|7393354|FG000|Overall Study|Protocol Violation|1
4560720|NCT01284062|7393355|FG001|Overall Study|Protocol Violation|0
4560721|NCT01284062|7393356|FG002|Overall Study|Protocol Violation|0
4560722|NCT01284062|7393357|FG003|Overall Study|Protocol Violation|2
4560723|NCT01284062|7393354|FG000|Overall Study|Withdrawal by Subject|3
4560724|NCT01284062|7393355|FG001|Overall Study|Withdrawal by Subject|1
4560725|NCT01284062|7393356|FG002|Overall Study|Withdrawal by Subject|2
4560726|NCT01284062|7393357|FG003|Overall Study|Withdrawal by Subject|5
4560727|NCT01284062|7393354|FG000|Overall Study|Other|0
4560728|NCT01284062|7393355|FG001|Overall Study|Other|0
4560729|NCT01284062|7393356|FG002|Overall Study|Other|0
4560730|NCT01284062|7393357|FG003|Overall Study|Other|1
4560731|NCT01284062|7393354|FG000|Overall Study|Site Closed|0
4560732|NCT01284062|7393355|FG001|Overall Study|Site Closed|0
4560733|NCT01284062|7393356|FG002|Overall Study|Site Closed|1
4560734|NCT01284062|7393357|FG003|Overall Study|Site Closed|0
4560735|NCT01284114|7393370|FG000|Overall Study|viral infection|1
4560736|NCT01284114|7393370|FG000|Overall Study|From the results of ALLTITUDE study|1
4560737|NCT01284114|7393370|FG000|Overall Study|Symptomatic hypotension|1
4560738|NCT01284114|7393370|FG000|Overall Study|dizziness|1
4560739|NCT01284127|7393375|FG000|Overall Study|Adverse Event|2
4560740|NCT01284127|7393375|FG000|Overall Study|Withdrawal by Subject|4
4560741|NCT01284127|7393375|FG000|Overall Study|Physician Decision|1
4560742|NCT01284140|7393381|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5
4560743|NCT01284140|7393382|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5
4560744|NCT01284140|7393381|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0
4560745|NCT01284140|7393382|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1
4592265|NCT01539083|7439729|FG002|Before Randomization (VCD Induction)|Adverse Event|0
4592266|NCT01539083|7439727|FG000|Before Randomization (VCD Induction)|Death|6
4592267|NCT01539083|7439728|FG001|Before Randomization (VCD Induction)|Death|0
4592268|NCT01539083|7439729|FG002|Before Randomization (VCD Induction)|Death|0
4592269|NCT01539083|7439727|FG000|Before Randomization (VCD Induction)|Protocol Violation|2
4592270|NCT01539083|7439728|FG001|Before Randomization (VCD Induction)|Protocol Violation|0
4592271|NCT01539083|7439729|FG002|Before Randomization (VCD Induction)|Protocol Violation|0
4592272|NCT01539083|7439727|FG000|Before Randomization (VCD Induction)|Physician Decision|14
4592273|NCT01539083|7439728|FG001|Before Randomization (VCD Induction)|Physician Decision|0
4592274|NCT01539083|7439729|FG002|Before Randomization (VCD Induction)|Physician Decision|0
4592275|NCT01539083|7439727|FG000|Before Randomization (VCD Induction)|Progressive Disease|8
4592276|NCT01539083|7439728|FG001|Before Randomization (VCD Induction)|Progressive Disease|0
4592277|NCT01539083|7439729|FG002|Before Randomization (VCD Induction)|Progressive Disease|0
4592278|NCT01539083|7439727|FG000|Before Randomization (VCD Induction)|Other|5
4592279|NCT01539083|7439728|FG001|Before Randomization (VCD Induction)|Other|0
4592280|NCT01539083|7439729|FG002|Before Randomization (VCD Induction)|Other|0
4592281|NCT01539083|7439727|FG000|After Randomization (TP and VTP)|Physician Decision|0
4592282|NCT01539083|7439728|FG001|After Randomization (TP and VTP)|Physician Decision|0
4592283|NCT01539083|7439729|FG002|After Randomization (TP and VTP)|Physician Decision|1
4592284|NCT01539083|7439727|FG000|After Randomization (TP and VTP)|Other|0
4592285|NCT01539083|7439728|FG001|After Randomization (TP and VTP)|Other|1
4592286|NCT01539083|7439729|FG002|After Randomization (TP and VTP)|Other|1
4592287|NCT01539083|7439727|FG000|After Randomization (TP and VTP)|Adverse Event|0
4592288|NCT01539083|7439728|FG001|After Randomization (TP and VTP)|Adverse Event|1
4592289|NCT01539083|7439729|FG002|After Randomization (TP and VTP)|Adverse Event|1
4592290|NCT01539083|7439727|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0
4592291|NCT01539083|7439728|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2
4592292|NCT01539083|7439729|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2
4592293|NCT01539083|7439727|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0
4592294|NCT01539083|7439728|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5
4592295|NCT01539083|7439729|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4
4592296|NCT01539083|7439727|FG000|After Randomization (TP and VTP)|Progressive Disease|0
4592297|NCT01539083|7439728|FG001|After Randomization (TP and VTP)|Progressive Disease|6
4592298|NCT01539083|7439729|FG002|After Randomization (TP and VTP)|Progressive Disease|3
4592299|NCT01539083|7439727|FG000|After Randomization (TP and VTP)|Death|0
4592300|NCT01539083|7439728|FG001|After Randomization (TP and VTP)|Death|6
4592301|NCT01539083|7439729|FG002|After Randomization (TP and VTP)|Death|11
4592302|NCT01539239|7439747|FG000|Overall Study|Death|5
4592303|NCT01539239|7439748|FG001|Overall Study|Death|5
4592304|NCT01539239|7439747|FG000|Overall Study|Lost to Follow-up|7
4592305|NCT01539239|7439748|FG001|Overall Study|Lost to Follow-up|12
4592306|NCT01539291|7439757|FG000|Study GS-US-312-0116|Adverse Event|9
4592307|NCT01539291|7439758|FG001|Study GS-US-312-0116|Adverse Event|0
4592308|NCT01539291|7439759|FG002|Study GS-US-312-0116|Adverse Event|0
4592309|NCT01539291|7439760|FG003|Study GS-US-312-0116|Adverse Event|0
4592310|NCT01539291|7439757|FG000|Study GS-US-312-0116|Physician Decision|1
4592311|NCT01539291|7439758|FG001|Study GS-US-312-0116|Physician Decision|0
4592312|NCT01539291|7439759|FG002|Study GS-US-312-0116|Physician Decision|0
4592313|NCT01539291|7439760|FG003|Study GS-US-312-0116|Physician Decision|0
4592314|NCT01539291|7439757|FG000|Study GS-US-312-0116|Withdrawal by Subject|12
4592315|NCT01539291|7439758|FG001|Study GS-US-312-0116|Withdrawal by Subject|0
4592316|NCT01539291|7439759|FG002|Study GS-US-312-0116|Withdrawal by Subject|0
4592317|NCT01539291|7439760|FG003|Study GS-US-312-0116|Withdrawal by Subject|0
4592318|NCT01539291|7439757|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2
4592319|NCT01539291|7439758|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0
4592320|NCT01539291|7439759|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0
4592321|NCT01539291|7439760|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0
4592322|NCT01539291|7439757|FG000|Study GS-US-312-0116|Other|1
4592323|NCT01539291|7439758|FG001|Study GS-US-312-0116|Other|0
4592324|NCT01539291|7439759|FG002|Study GS-US-312-0116|Other|0
4592325|NCT01539291|7439760|FG003|Study GS-US-312-0116|Other|0
4592326|NCT01539291|7439757|FG000|Study GS-US-312-0117|Adverse Event|22
4592327|NCT01539291|7439758|FG001|Study GS-US-312-0117|Adverse Event|1
4592328|NCT01539291|7439759|FG002|Study GS-US-312-0117|Adverse Event|9
4592329|NCT01539291|7439760|FG003|Study GS-US-312-0117|Adverse Event|12
4592330|NCT01539291|7439757|FG000|Study GS-US-312-0117|Physician Decision|9
4592331|NCT01539291|7439758|FG001|Study GS-US-312-0117|Physician Decision|0
4592332|NCT01539291|7439759|FG002|Study GS-US-312-0117|Physician Decision|6
4592333|NCT01539291|7439760|FG003|Study GS-US-312-0117|Physician Decision|4
4592334|NCT01539291|7439757|FG000|Study GS-US-312-0117|Withdrawal by Subject|5
4592335|NCT01539291|7439758|FG001|Study GS-US-312-0117|Withdrawal by Subject|0
4560746|NCT01284361|7393467|FG000|Overall Study|Withdrawal by Subject|1
4560747|NCT01284361|7393467|FG000|Overall Study|Protocol Violation|5
4560748|NCT01284361|7393467|FG000|Overall Study|Adverse Event|1
4560749|NCT01284361|7393467|FG000|Overall Study|Lost to Follow-up|2
4560750|NCT01284621|7393487|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
4560751|NCT01284621|7393488|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
4560752|NCT01284621|7393489|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
4560753|NCT01284621|7393490|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
4560754|NCT01284621|7393491|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1
4560755|NCT01284621|7393492|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
4560756|NCT01284634|7393506|FG000|Overall Study|Adverse Event|1
4560757|NCT01284634|7393507|FG001|Overall Study|Adverse Event|0
4560758|NCT01284634|7393508|FG002|Overall Study|Adverse Event|2
4560759|NCT01284634|7393509|FG003|Overall Study|Adverse Event|1
4560760|NCT01284959|7393522|FG000|Overall Study|Withdrawal by Subject|1
4560761|NCT01284959|7393523|FG001|Overall Study|Withdrawal by Subject|0
4560762|NCT01284959|7393524|FG002|Overall Study|Withdrawal by Subject|0
4560763|NCT01284959|7393522|FG000|Overall Study|Adverse Event|0
4560764|NCT01284959|7393523|FG001|Overall Study|Adverse Event|0
4560765|NCT01284959|7393524|FG002|Overall Study|Adverse Event|1
4560766|NCT01285310|7393553|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3
4560767|NCT01285310|7393554|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4
4560768|NCT01285310|7393555|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6
4560769|NCT01285310|7393556|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0
4560770|NCT01285310|7393557|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0
4560771|NCT01285310|7393553|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1
4560772|NCT01285310|7393554|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7
4560773|NCT01285310|7393555|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3
4560774|NCT01285310|7393556|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0
4560775|NCT01285310|7393557|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0
4560776|NCT01285310|7393553|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1
4560777|NCT01285310|7393554|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
4560778|NCT01285310|7393555|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2
4560779|NCT01285310|7393556|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
4560780|NCT01285310|7393557|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
4560781|NCT01285310|7393553|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3
4560782|NCT01285310|7393554|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3
4560783|NCT01285310|7393555|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2
4560784|NCT01285310|7393556|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0
4560785|NCT01285310|7393557|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0
4560786|NCT01285310|7393553|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
4560787|NCT01285310|7393554|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1
4560788|NCT01285310|7393555|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1
4560789|NCT01285310|7393556|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
4560790|NCT01285310|7393557|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
4560791|NCT01285310|7393553|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1
4560792|NCT01285310|7393554|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0
4560793|NCT01285310|7393555|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1
4560794|NCT01285310|7393556|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0
4560795|NCT01285310|7393557|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0
4560796|NCT01285310|7393553|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0
4560797|NCT01285310|7393554|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2
4560798|NCT01285310|7393555|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3
4560799|NCT01285310|7393556|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0
4560800|NCT01285310|7393557|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2
4560801|NCT01285310|7393553|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0
4560802|NCT01285310|7393554|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4
4560803|NCT01285310|7393555|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3
4560804|NCT01285310|7393556|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1
4560805|NCT01285310|7393557|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0
4560806|NCT01285310|7393553|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0
4560807|NCT01285310|7393554|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3
4560808|NCT01285310|7393555|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0
4560809|NCT01285310|7393556|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2
4560810|NCT01285310|7393557|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2
4560811|NCT01285310|7393553|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0
4560812|NCT01285310|7393554|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21
4560813|NCT01285310|7393555|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19
4560814|NCT01285310|7393556|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6
4560815|NCT01285310|7393557|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15
4560816|NCT01285310|7393553|FG000|Active Treatment Phase: Weeks 25-52|Other|0
4560817|NCT01285310|7393554|FG001|Active Treatment Phase: Weeks 25-52|Other|1
4623153|NCT01807520|7486480|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
4623154|NCT01807520|7486481|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
4623155|NCT01807520|7486482|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1
4623156|NCT01807520|7486483|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
4623157|NCT01807520|7486484|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
4623158|NCT01807520|7486478|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
4623159|NCT01807520|7486479|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
4623160|NCT01807520|7486480|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
4623161|NCT01807520|7486481|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
4623162|NCT01807520|7486482|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
4623163|NCT01807520|7486483|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
4623164|NCT01807520|7486484|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
4623165|NCT01807520|7486478|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5
4623166|NCT01807520|7486479|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6
4623167|NCT01807520|7486480|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
4623168|NCT01807520|7486481|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2
4623169|NCT01807520|7486482|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2
4623170|NCT01807520|7486483|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
4623171|NCT01807520|7486484|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
4623172|NCT01807520|7486478|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
4623173|NCT01807520|7486479|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
4623174|NCT01807520|7486480|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
4623175|NCT01807520|7486481|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
4623176|NCT01807520|7486482|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
4623177|NCT01807520|7486483|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1
4623178|NCT01807520|7486484|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
4623179|NCT01807520|7486478|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0
4560818|NCT01285310|7393555|FG002|Active Treatment Phase: Weeks 25-52|Other|0
4560819|NCT01285310|7393556|FG003|Active Treatment Phase: Weeks 25-52|Other|0
4560820|NCT01285310|7393557|FG004|Active Treatment Phase: Weeks 25-52|Other|0
4560821|NCT01285310|7393553|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0
4560822|NCT01285310|7393554|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1
4560823|NCT01285310|7393555|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1
4560824|NCT01285310|7393556|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1
4560825|NCT01285310|7393557|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0
4560826|NCT01285323|7393597|FG000|Overall Study|Adverse Event|9
4560827|NCT01285323|7393598|FG001|Overall Study|Adverse Event|8
4560828|NCT01285323|7393597|FG000|Overall Study|Lack of Efficacy|4
4560829|NCT01285323|7393598|FG001|Overall Study|Lack of Efficacy|2
4560830|NCT01285323|7393597|FG000|Overall Study|Withdrawal by Subject|15
4560831|NCT01285323|7393598|FG001|Overall Study|Withdrawal by Subject|11
4560832|NCT01285323|7393597|FG000|Overall Study|Protocol Violation|1
4560833|NCT01285323|7393598|FG001|Overall Study|Protocol Violation|2
4560834|NCT01285323|7393597|FG000|Overall Study|Non-compliance with study procedures|2
4560835|NCT01285323|7393598|FG001|Overall Study|Non-compliance with study procedures|3
4560836|NCT01285323|7393597|FG000|Overall Study|Lost to Follow-up|1
4560837|NCT01285323|7393598|FG001|Overall Study|Lost to Follow-up|1
4560838|NCT01285323|7393597|FG000|Overall Study|Other|1
4560839|NCT01285323|7393598|FG001|Overall Study|Other|3
4560840|NCT01285349|7393607|FG000|Overall Study|Lost to Follow-up|27
4560841|NCT01285349|7393608|FG001|Overall Study|Lost to Follow-up|20
4560842|NCT01285349|7393609|FG002|Overall Study|Lost to Follow-up|27
4560843|NCT01285401|7393620|FG000|Overall Study|Prematurely withdrawn from the study|17
4560844|NCT01285401|7393621|FG001|Overall Study|Prematurely withdrawn from the study|29
4560845|NCT01285492|7393641|FG000|Overall Study|Adverse Event|11
4560846|NCT01285492|7393642|FG001|Overall Study|Adverse Event|0
4560847|NCT01285492|7393641|FG000|Overall Study|Protocol Violation|3
4560848|NCT01285492|7393642|FG001|Overall Study|Protocol Violation|0
4560849|NCT01285492|7393641|FG000|Overall Study|Withdrawal by Subject|2
4560850|NCT01285492|7393642|FG001|Overall Study|Withdrawal by Subject|1
4560851|NCT01285492|7393641|FG000|Overall Study|Death|1
4623180|NCT01807520|7486479|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0
4623181|NCT01807520|7486480|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0
4623182|NCT01807520|7486481|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0
4623183|NCT01807520|7486482|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0
4623184|NCT01807520|7486483|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1
4623185|NCT01807520|7486484|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0
4623186|NCT01807520|7486478|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
4560852|NCT01285492|7393642|FG001|Overall Study|Death|0
4560853|NCT01285518|7393656|FG000|Overall Study|Lost to Follow-up|0
4560854|NCT01285518|7393657|FG001|Overall Study|Lost to Follow-up|0
4560855|NCT01285518|7393658|FG002|Overall Study|Lost to Follow-up|0
4623187|NCT01807520|7486479|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
4623188|NCT01807520|7486480|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
4623189|NCT01807520|7486481|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
4623190|NCT01807520|7486482|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
4560856|NCT01285518|7393659|FG003|Overall Study|Lost to Follow-up|0
4560857|NCT01285518|7393660|FG004|Overall Study|Lost to Follow-up|0
4560858|NCT01285518|7393661|FG005|Overall Study|Lost to Follow-up|1
4560859|NCT01285518|7393662|FG006|Overall Study|Lost to Follow-up|0
4560860|NCT01285518|7393663|FG007|Overall Study|Lost to Follow-up|0
4560861|NCT01285609|7393684|FG000|Randomized|Progressive Disease|41
4560862|NCT01285609|7393685|FG001|Randomized|Progressive Disease|61
4560863|NCT01285609|7393684|FG000|Randomized|Adverse Event Unrelated to Study Drug|18
4560864|NCT01285609|7393685|FG001|Randomized|Adverse Event Unrelated to Study Drug|18
4560865|NCT01285609|7393684|FG000|Randomized|Study Drug Toxicity|13
4560866|NCT01285609|7393685|FG001|Randomized|Study Drug Toxicity|14
4560867|NCT01285609|7393684|FG000|Randomized|Death|5
4560868|NCT01285609|7393685|FG001|Randomized|Death|7
4560869|NCT01285609|7393684|FG000|Randomized|Withdrawal by Subject|8
4560870|NCT01285609|7393685|FG001|Randomized|Withdrawal by Subject|11
4560871|NCT01285609|7393684|FG000|Randomized|Subject No Longer Met Study Criteria|1
4560872|NCT01285609|7393685|FG001|Randomized|Subject No Longer Met Study Criteria|1
4560873|NCT01285609|7393684|FG000|Randomized|Undisclosed Reasons|1
4560874|NCT01285609|7393685|FG001|Randomized|Undisclosed Reasons|0
4560875|NCT01285609|7393684|FG000|Randomized|Randomized but not Treated|4
4560876|NCT01285609|7393685|FG001|Randomized|Randomized but not Treated|4
4560877|NCT01285609|7393684|FG000|Treated With Blinded Therapy|Progressive Disease|223
4623191|NCT01807520|7486483|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2
4623192|NCT01807520|7486484|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1
4623193|NCT01807598|7486511|FG000|Overall Study|Withdrawal by Subject|4
4623194|NCT01807598|7486511|FG000|Overall Study|Adverse Event|1
4623195|NCT01807598|7486511|FG000|Overall Study|Other Physician Decision|1
4623196|NCT01807650|7486530|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13
4623197|NCT01807650|7486530|FG000|Overall Study|Adverse Event|5
4623198|NCT01807650|7486530|FG000|Overall Study|Other|2
4623199|NCT01807923|7486583|FG000|Overall Study|Adverse Event|2
4623200|NCT01807923|7486584|FG001|Overall Study|Adverse Event|1
4623201|NCT01807923|7486585|FG002|Overall Study|Adverse Event|2
4623202|NCT01807923|7486583|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0
4623203|NCT01807923|7486584|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3
4623204|NCT01807923|7486585|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2
4623205|NCT01807923|7486583|FG000|Overall Study|Physician Decision|0
4623206|NCT01807923|7486584|FG001|Overall Study|Physician Decision|0
4623207|NCT01807923|7486585|FG002|Overall Study|Physician Decision|1
4623208|NCT01807923|7486583|FG000|Overall Study|Not Eligible (Genotype)|0
4623209|NCT01807923|7486584|FG001|Overall Study|Not Eligible (Genotype)|0
4623210|NCT01807923|7486585|FG002|Overall Study|Not Eligible (Genotype)|1
4623211|NCT01807923|7486583|FG000|Overall Study|Randomized But Not Treated|3
4623212|NCT01807923|7486584|FG001|Overall Study|Randomized But Not Treated|2
4623213|NCT01807923|7486585|FG002|Overall Study|Randomized But Not Treated|5
4623214|NCT01807949|7486598|FG000|Overall Study|Adverse Event|1
4623215|NCT01807949|7486599|FG001|Overall Study|Adverse Event|2
4623216|NCT01807949|7486600|FG002|Overall Study|Adverse Event|2
4623217|NCT01807949|7486598|FG000|Overall Study|Withdrawal by Subject|1
4623218|NCT01807949|7486599|FG001|Overall Study|Withdrawal by Subject|2
4623219|NCT01807949|7486600|FG002|Overall Study|Withdrawal by Subject|2
4623220|NCT01807949|7486598|FG000|Overall Study|Non-Compliance|0
4623221|NCT01807949|7486599|FG001|Overall Study|Non-Compliance|0
4623222|NCT01807949|7486600|FG002|Overall Study|Non-Compliance|1
4623223|NCT01807949|7486598|FG000|Overall Study|Undefined|0
4623224|NCT01807949|7486599|FG001|Overall Study|Undefined|1
4623225|NCT01807949|7486600|FG002|Overall Study|Undefined|2
4623226|NCT01807949|7486598|FG000|Overall Study|Randomized But Not Treated|0
4623227|NCT01807949|7486599|FG001|Overall Study|Randomized But Not Treated|2
4623228|NCT01807949|7486600|FG002|Overall Study|Randomized But Not Treated|2
4623229|NCT01808066|7486610|FG000|Overall Study|Withdrawal by Subject|15
4623230|NCT01808092|7486617|FG000|Overall Study|Death|39
4623231|NCT01808092|7486618|FG001|Overall Study|Death|29
4623232|NCT01808092|7486617|FG000|Overall Study|Lost to Follow-up|3
4623233|NCT01808092|7486618|FG001|Overall Study|Lost to Follow-up|7
4623234|NCT01808092|7486617|FG000|Overall Study|Withdrawal by Subject|9
4623235|NCT01808092|7486618|FG001|Overall Study|Withdrawal by Subject|4
4623236|NCT01808092|7486617|FG000|Overall Study|Other Eligibility criteria|3
4623237|NCT01808092|7486618|FG001|Overall Study|Other Eligibility criteria|5
4623238|NCT01808118|7486624|FG000|Period 1|Adverse Event|15
4623239|NCT01808118|7486625|FG001|Period 1|Adverse Event|0
4623240|NCT01808118|7486626|FG002|Period 1|Adverse Event|0
4623241|NCT01808118|7486624|FG000|Period 1|Withdrew consent|24
4623242|NCT01808118|7486625|FG001|Period 1|Withdrew consent|0
4623243|NCT01808118|7486626|FG002|Period 1|Withdrew consent|0
4623244|NCT01808118|7486624|FG000|Period 1|Lost to Follow-up|9
4623245|NCT01808118|7486625|FG001|Period 1|Lost to Follow-up|0
4560878|NCT01285609|7393685|FG001|Treated With Blinded Therapy|Progressive Disease|305
4560879|NCT01285609|7393684|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87
4623246|NCT01808118|7486626|FG002|Period 1|Lost to Follow-up|0
4623247|NCT01808118|7486624|FG000|Period 1|Did not meet criteria for remission|303
4623248|NCT01808118|7486625|FG001|Period 1|Did not meet criteria for remission|0
4623249|NCT01808118|7486626|FG002|Period 1|Did not meet criteria for remission|0
4623250|NCT01808118|7486624|FG000|Period 1|Enrolled in error|7
4623251|NCT01808118|7486625|FG001|Period 1|Enrolled in error|0
4623252|NCT01808118|7486626|FG002|Period 1|Enrolled in error|0
4560880|NCT01285609|7393685|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14
4560881|NCT01285609|7393684|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36
4560882|NCT01285609|7393685|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14
4560883|NCT01285609|7393684|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20
4560884|NCT01285609|7393685|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7
4560885|NCT01285609|7393684|FG000|Treated With Blinded Therapy|Death|11
4560886|NCT01285609|7393685|FG001|Treated With Blinded Therapy|Death|3
4560887|NCT01285609|7393684|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2
4560888|NCT01285609|7393685|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4
4560889|NCT01285609|7393684|FG000|Treated With Blinded Therapy|Not Reported|0
4560890|NCT01285609|7393685|FG001|Treated With Blinded Therapy|Not Reported|2
4560891|NCT01285609|7393684|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1
4560892|NCT01285609|7393685|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2
4560893|NCT01285609|7393684|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1
4560894|NCT01285609|7393685|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0
4560895|NCT01285609|7393684|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1
4560896|NCT01285609|7393685|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3
4560897|NCT01285609|7393684|FG000|Treated With Blinded Therapy|Physician and Patient decision|1
4560898|NCT01285609|7393685|FG001|Treated With Blinded Therapy|Physician and Patient decision|3
4560899|NCT01285609|7393684|FG000|Treated With Blinded Therapy|Participant refused participation|1
4560900|NCT01285609|7393685|FG001|Treated With Blinded Therapy|Participant refused participation|0
4560901|NCT01285609|7393684|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1
4560902|NCT01285609|7393685|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0
4560903|NCT01285609|7393684|FG000|Treated With Blinded Therapy|Participant hospitalized|1
4560904|NCT01285609|7393685|FG001|Treated With Blinded Therapy|Participant hospitalized|0
4560905|NCT01285609|7393684|FG000|Treated With Blinded Therapy|Investigator's assessment|1
4560906|NCT01285609|7393685|FG001|Treated With Blinded Therapy|Investigator's assessment|0
4560907|NCT01285609|7393684|FG000|Treated With Blinded Therapy|PI decision to discontinue|0
4560908|NCT01285609|7393685|FG001|Treated With Blinded Therapy|PI decision to discontinue|1
4560909|NCT01285609|7393684|FG000|Treated With Blinded Therapy|Worsening of general condition|0
4560910|NCT01285609|7393685|FG001|Treated With Blinded Therapy|Worsening of general condition|1
4560911|NCT01285908|7393740|FG000|Baseline Measurement|unable to insert catheter|1
4560912|NCT01285908|7393741|FG001|Baseline Measurement|unable to insert catheter|0
4560913|NCT01285908|7393742|FG002|Baseline Measurement|unable to insert catheter|0
4560914|NCT01285908|7393740|FG000|Baseline Measurement|History of stroke, exclusion criteria|1
4560915|NCT01285908|7393741|FG001|Baseline Measurement|History of stroke, exclusion criteria|0
4560916|NCT01285908|7393742|FG002|Baseline Measurement|History of stroke, exclusion criteria|0
4560917|NCT01285908|7393740|FG000|Baseline Measurement|unable to tolerate procedure|1
4560918|NCT01285908|7393741|FG001|Baseline Measurement|unable to tolerate procedure|0
4560919|NCT01285908|7393742|FG002|Baseline Measurement|unable to tolerate procedure|0
4560920|NCT01285960|7393772|FG000|Overall Study|Withdrawal by Subject|2
4560921|NCT01285960|7393772|FG000|Overall Study|Lost to Follow-up|2
4560922|NCT01285960|7393772|FG000|Overall Study|2 subjects received less 10 sonications|2
4560923|NCT01286012|7393778|FG000|Overall Study|Adverse Event|3
4560924|NCT01286012|7393779|FG001|Overall Study|Adverse Event|3
4560925|NCT01286012|7393778|FG000|Overall Study|Death|2
4560926|NCT01286012|7393779|FG001|Overall Study|Death|3
4560927|NCT01286012|7393778|FG000|Overall Study|Protocol Violation|1
4560928|NCT01286012|7393779|FG001|Overall Study|Protocol Violation|1
4560929|NCT01286012|7393778|FG000|Overall Study|Withdrawal by Subject|4
4560930|NCT01286012|7393779|FG001|Overall Study|Withdrawal by Subject|4
4560931|NCT01286012|7393778|FG000|Overall Study|Physician Decision|2
4560932|NCT01286012|7393779|FG001|Overall Study|Physician Decision|0
4560933|NCT01286012|7393778|FG000|Overall Study|peritoneal dialysis, randomized in error|1
4560934|NCT01286012|7393779|FG001|Overall Study|peritoneal dialysis, randomized in error|3
4560935|NCT01286077|7393788|FG000|Overall Study|Adverse Event|2
4560936|NCT01286077|7393789|FG001|Overall Study|Adverse Event|0
4560937|NCT01286077|7393788|FG000|Overall Study|Death|1
4560938|NCT01286077|7393789|FG001|Overall Study|Death|0
4560939|NCT01286077|7393788|FG000|Overall Study|Protocol Violation|1
4560940|NCT01286077|7393789|FG001|Overall Study|Protocol Violation|1
4560941|NCT01286077|7393788|FG000|Overall Study|Withdrawal by Subject|0
4560942|NCT01286077|7393789|FG001|Overall Study|Withdrawal by Subject|2
4560943|NCT01286077|7393788|FG000|Overall Study|Intercurrent illness|1
4560944|NCT01286077|7393789|FG001|Overall Study|Intercurrent illness|0
4560945|NCT01286077|7393788|FG000|Overall Study|Non-compliance|1
4560946|NCT01286077|7393789|FG001|Overall Study|Non-compliance|0
4560947|NCT01286077|7393788|FG000|Overall Study|The subject starts with alternative MMY|0
4560948|NCT01286077|7393789|FG001|Overall Study|The subject starts with alternative MMY|3
4560949|NCT01286077|7393788|FG000|Overall Study|Patient's decision to stop treatment|3
4560950|NCT01286077|7393789|FG001|Overall Study|Patient's decision to stop treatment|0
4560951|NCT01286077|7393788|FG000|Overall Study|Progression of disease|0
4560952|NCT01286077|7393789|FG001|Overall Study|Progression of disease|1
4560953|NCT01286077|7393788|FG000|Overall Study|refill medication not received in time|1
4593849|NCT01555164|7442380|FG001|Overall Study|Investigator's Discretion|2
4560954|NCT01286077|7393789|FG001|Overall Study|refill medication not received in time|0
4560955|NCT01286129|7393797|FG000|Overall Study|Withdrawal by Subject|4
4560956|NCT01286129|7393798|FG001|Overall Study|Withdrawal by Subject|1
4560957|NCT01286129|7393797|FG000|Overall Study|Could not comply with study requirements|4
4560958|NCT01286129|7393798|FG001|Overall Study|Could not comply with study requirements|4
4560959|NCT01286168|7393806|FG000|Overall Study|Withdrawal by Subject|1
4560960|NCT01286168|7393806|FG000|Overall Study|Surgical Drains Fell Out at Home|2
4560961|NCT01286311|7393817|FG000|Overall Study|Physician did not want outreach sent|14
4560962|NCT01286311|7393818|FG001|Overall Study|Physician did not want outreach sent|0
4560963|NCT01286480|7393885|FG000|Overall Study|Withdrawal by Subject|5
4560964|NCT01286480|7393886|FG001|Overall Study|Withdrawal by Subject|3
4560965|NCT01286558|7393898|FG000|Overall Study|Adverse Event|1
4560966|NCT01286558|7393899|FG001|Overall Study|Adverse Event|1
4560967|NCT01286558|7393898|FG000|Overall Study|Withdrawal by Subject|0
4560968|NCT01286558|7393899|FG001|Overall Study|Withdrawal by Subject|1
4560969|NCT01286740|7393905|FG000|Overall Study|Enrolled but not treated|1
4560970|NCT01286740|7393905|FG000|Overall Study|Protocol Violation|1
4560971|NCT01286753|7393911|FG000|Overall Study|Adverse Event|7
4560972|NCT01286753|7393912|FG001|Overall Study|Adverse Event|6
4560973|NCT01286753|7393911|FG000|Overall Study|Progression|11
4560974|NCT01286753|7393912|FG001|Overall Study|Progression|13
4560975|NCT01286753|7393911|FG000|Overall Study|Refused Treatment|1
4560976|NCT01286753|7393912|FG001|Overall Study|Refused Treatment|0
4560977|NCT01286753|7393911|FG000|Overall Study|Withdrawal of Consent|0
4560978|NCT01286753|7393912|FG001|Overall Study|Withdrawal of Consent|2
4560979|NCT01286753|7393911|FG000|Overall Study|Discontinued to Join Extension Study|6
4560980|NCT01286753|7393912|FG001|Overall Study|Discontinued to Join Extension Study|4
4560981|NCT01286753|7393911|FG000|Overall Study|Participant to Receive Radiotherapy|1
4560982|NCT01286753|7393912|FG001|Overall Study|Participant to Receive Radiotherapy|0
4560983|NCT01286779|7393919|FG000|Overall Study|Withdrawal by Subject|9
4560984|NCT01286779|7393919|FG000|Overall Study|Protocol Violation|5
4560985|NCT01286779|7393919|FG000|Overall Study|Physician Decision|2
4560986|NCT01286779|7393919|FG000|Overall Study|Participant had scheduled surgery|1
4560987|NCT01286779|7393919|FG000|Overall Study|Participant moved to another country|1
4560988|NCT01286779|7393919|FG000|Overall Study|Discontinued by sponsor|1
4560989|NCT01286987|7393965|FG000|Part 1: Dose Escalation|Clinical Progression|1
4560990|NCT01286987|7393966|FG001|Part 1: Dose Escalation|Clinical Progression|1
4560991|NCT01286987|7393967|FG002|Part 1: Dose Escalation|Clinical Progression|0
4560992|NCT01286987|7393968|FG003|Part 1: Dose Escalation|Clinical Progression|1
4560993|NCT01286987|7393969|FG004|Part 1: Dose Escalation|Clinical Progression|1
4560994|NCT01286987|7393970|FG005|Part 1: Dose Escalation|Clinical Progression|1
4560995|NCT01286987|7393971|FG006|Part 1: Dose Escalation|Clinical Progression|0
4560996|NCT01286987|7393972|FG007|Part 1: Dose Escalation|Clinical Progression|2
4560997|NCT01286987|7393973|FG008|Part 1: Dose Escalation|Clinical Progression|1
4560998|NCT01286987|7393974|FG009|Part 1: Dose Escalation|Clinical Progression|0
4560999|NCT01286987|7393975|FG010|Part 1: Dose Escalation|Clinical Progression|0
4561000|NCT01286987|7393976|FG011|Part 1: Dose Escalation|Clinical Progression|0
4561001|NCT01286987|7393977|FG012|Part 1: Dose Escalation|Clinical Progression|0
4561002|NCT01286987|7393978|FG013|Part 1: Dose Escalation|Clinical Progression|0
4561003|NCT01286987|7393979|FG014|Part 1: Dose Escalation|Clinical Progression|0
4561004|NCT01286987|7393965|FG000|Part 1: Dose Escalation|Progressive Disease|2
4561005|NCT01286987|7393966|FG001|Part 1: Dose Escalation|Progressive Disease|2
4561006|NCT01286987|7393967|FG002|Part 1: Dose Escalation|Progressive Disease|3
4561007|NCT01286987|7393968|FG003|Part 1: Dose Escalation|Progressive Disease|2
4561008|NCT01286987|7393969|FG004|Part 1: Dose Escalation|Progressive Disease|1
4561009|NCT01286987|7393970|FG005|Part 1: Dose Escalation|Progressive Disease|5
4561010|NCT01286987|7393971|FG006|Part 1: Dose Escalation|Progressive Disease|5
4561011|NCT01286987|7393972|FG007|Part 1: Dose Escalation|Progressive Disease|3
4561012|NCT01286987|7393973|FG008|Part 1: Dose Escalation|Progressive Disease|5
4561013|NCT01286987|7393974|FG009|Part 1: Dose Escalation|Progressive Disease|0
4561014|NCT01286987|7393975|FG010|Part 1: Dose Escalation|Progressive Disease|0
4561015|NCT01286987|7393976|FG011|Part 1: Dose Escalation|Progressive Disease|0
4561016|NCT01286987|7393977|FG012|Part 1: Dose Escalation|Progressive Disease|0
4561017|NCT01286987|7393978|FG013|Part 1: Dose Escalation|Progressive Disease|0
4561018|NCT01286987|7393979|FG014|Part 1: Dose Escalation|Progressive Disease|0
4561019|NCT01286987|7393965|FG000|Part 1: Dose Escalation|Physician Decision|0
4561020|NCT01286987|7393966|FG001|Part 1: Dose Escalation|Physician Decision|0
4561021|NCT01286987|7393967|FG002|Part 1: Dose Escalation|Physician Decision|0
4623253|NCT01808118|7486624|FG000|Period 1|Did not meet inclusion criteria|3
4623254|NCT01808118|7486625|FG001|Period 1|Did not meet inclusion criteria|0
4623255|NCT01808118|7486626|FG002|Period 1|Did not meet inclusion criteria|0
4561022|NCT01286987|7393968|FG003|Part 1: Dose Escalation|Physician Decision|0
4561023|NCT01286987|7393969|FG004|Part 1: Dose Escalation|Physician Decision|1
4561024|NCT01286987|7393970|FG005|Part 1: Dose Escalation|Physician Decision|0
4561025|NCT01286987|7393971|FG006|Part 1: Dose Escalation|Physician Decision|0
4561026|NCT01286987|7393972|FG007|Part 1: Dose Escalation|Physician Decision|0
4561027|NCT01286987|7393973|FG008|Part 1: Dose Escalation|Physician Decision|0
4561028|NCT01286987|7393974|FG009|Part 1: Dose Escalation|Physician Decision|0
4561029|NCT01286987|7393975|FG010|Part 1: Dose Escalation|Physician Decision|0
4561030|NCT01286987|7393976|FG011|Part 1: Dose Escalation|Physician Decision|0
4561031|NCT01286987|7393977|FG012|Part 1: Dose Escalation|Physician Decision|0
4561032|NCT01286987|7393978|FG013|Part 1: Dose Escalation|Physician Decision|0
4561033|NCT01286987|7393979|FG014|Part 1: Dose Escalation|Physician Decision|0
4561034|NCT01286987|7393965|FG000|Part 2: Dose Expansion|Death|0
4561035|NCT01286987|7393966|FG001|Part 2: Dose Expansion|Death|0
4561036|NCT01286987|7393967|FG002|Part 2: Dose Expansion|Death|0
4561037|NCT01286987|7393968|FG003|Part 2: Dose Expansion|Death|0
4561038|NCT01286987|7393969|FG004|Part 2: Dose Expansion|Death|0
4561039|NCT01286987|7393970|FG005|Part 2: Dose Expansion|Death|0
4561040|NCT01286987|7393971|FG006|Part 2: Dose Expansion|Death|0
4561041|NCT01286987|7393972|FG007|Part 2: Dose Expansion|Death|0
4561042|NCT01286987|7393973|FG008|Part 2: Dose Expansion|Death|0
4561043|NCT01286987|7393974|FG009|Part 2: Dose Expansion|Death|0
4561044|NCT01286987|7393975|FG010|Part 2: Dose Expansion|Death|0
4561045|NCT01286987|7393976|FG011|Part 2: Dose Expansion|Death|0
4561046|NCT01286987|7393977|FG012|Part 2: Dose Expansion|Death|1
4561047|NCT01286987|7393978|FG013|Part 2: Dose Expansion|Death|1
4561048|NCT01286987|7393979|FG014|Part 2: Dose Expansion|Death|0
4561049|NCT01286987|7393965|FG000|Part 2: Dose Expansion|Physician Decision|0
4561050|NCT01286987|7393966|FG001|Part 2: Dose Expansion|Physician Decision|0
4561051|NCT01286987|7393967|FG002|Part 2: Dose Expansion|Physician Decision|0
4561052|NCT01286987|7393968|FG003|Part 2: Dose Expansion|Physician Decision|0
4561053|NCT01286987|7393969|FG004|Part 2: Dose Expansion|Physician Decision|0
4561054|NCT01286987|7393970|FG005|Part 2: Dose Expansion|Physician Decision|0
4561055|NCT01286987|7393971|FG006|Part 2: Dose Expansion|Physician Decision|0
4561056|NCT01286987|7393972|FG007|Part 2: Dose Expansion|Physician Decision|0
4561057|NCT01286987|7393973|FG008|Part 2: Dose Expansion|Physician Decision|0
4561058|NCT01286987|7393974|FG009|Part 2: Dose Expansion|Physician Decision|0
4561059|NCT01286987|7393975|FG010|Part 2: Dose Expansion|Physician Decision|1
4561060|NCT01286987|7393976|FG011|Part 2: Dose Expansion|Physician Decision|1
4561061|NCT01286987|7393977|FG012|Part 2: Dose Expansion|Physician Decision|0
4561062|NCT01286987|7393978|FG013|Part 2: Dose Expansion|Physician Decision|1
4561063|NCT01286987|7393979|FG014|Part 2: Dose Expansion|Physician Decision|0
4561064|NCT01286987|7393965|FG000|Part 2: Dose Expansion|Other|0
4561065|NCT01286987|7393966|FG001|Part 2: Dose Expansion|Other|0
4561066|NCT01286987|7393967|FG002|Part 2: Dose Expansion|Other|0
4561067|NCT01286987|7393968|FG003|Part 2: Dose Expansion|Other|0
4561068|NCT01286987|7393969|FG004|Part 2: Dose Expansion|Other|0
4561069|NCT01286987|7393970|FG005|Part 2: Dose Expansion|Other|0
4561070|NCT01286987|7393971|FG006|Part 2: Dose Expansion|Other|0
4561071|NCT01286987|7393972|FG007|Part 2: Dose Expansion|Other|0
4561072|NCT01286987|7393973|FG008|Part 2: Dose Expansion|Other|0
4561073|NCT01286987|7393974|FG009|Part 2: Dose Expansion|Other|0
4561074|NCT01286987|7393975|FG010|Part 2: Dose Expansion|Other|0
4561075|NCT01286987|7393976|FG011|Part 2: Dose Expansion|Other|0
4561076|NCT01286987|7393977|FG012|Part 2: Dose Expansion|Other|0
4561077|NCT01286987|7393978|FG013|Part 2: Dose Expansion|Other|1
4561078|NCT01286987|7393979|FG014|Part 2: Dose Expansion|Other|0
4561079|NCT01286987|7393965|FG000|Part 2: Dose Expansion|Progressive Disease|0
4561080|NCT01286987|7393966|FG001|Part 2: Dose Expansion|Progressive Disease|0
4561081|NCT01286987|7393967|FG002|Part 2: Dose Expansion|Progressive Disease|0
4561082|NCT01286987|7393968|FG003|Part 2: Dose Expansion|Progressive Disease|0
4561083|NCT01286987|7393969|FG004|Part 2: Dose Expansion|Progressive Disease|0
4561084|NCT01286987|7393970|FG005|Part 2: Dose Expansion|Progressive Disease|0
4561085|NCT01286987|7393971|FG006|Part 2: Dose Expansion|Progressive Disease|0
4561086|NCT01286987|7393972|FG007|Part 2: Dose Expansion|Progressive Disease|0
4561087|NCT01286987|7393973|FG008|Part 2: Dose Expansion|Progressive Disease|0
4561088|NCT01286987|7393974|FG009|Part 2: Dose Expansion|Progressive Disease|11
4561089|NCT01286987|7393975|FG010|Part 2: Dose Expansion|Progressive Disease|6
4561090|NCT01286987|7393976|FG011|Part 2: Dose Expansion|Progressive Disease|7
4561091|NCT01286987|7393977|FG012|Part 2: Dose Expansion|Progressive Disease|11
4561092|NCT01286987|7393978|FG013|Part 2: Dose Expansion|Progressive Disease|19
4561093|NCT01286987|7393979|FG014|Part 2: Dose Expansion|Progressive Disease|2
4561094|NCT01286987|7393965|FG000|Part 2: Dose Expansion|Clinical Progression|0
4561095|NCT01286987|7393966|FG001|Part 2: Dose Expansion|Clinical Progression|0
4561096|NCT01286987|7393967|FG002|Part 2: Dose Expansion|Clinical Progression|0
4561097|NCT01286987|7393968|FG003|Part 2: Dose Expansion|Clinical Progression|0
4561098|NCT01286987|7393969|FG004|Part 2: Dose Expansion|Clinical Progression|0
4561099|NCT01286987|7393970|FG005|Part 2: Dose Expansion|Clinical Progression|0
4561100|NCT01286987|7393971|FG006|Part 2: Dose Expansion|Clinical Progression|0
4561101|NCT01286987|7393972|FG007|Part 2: Dose Expansion|Clinical Progression|0
4561102|NCT01286987|7393973|FG008|Part 2: Dose Expansion|Clinical Progression|0
4561103|NCT01286987|7393974|FG009|Part 2: Dose Expansion|Clinical Progression|0
4561104|NCT01286987|7393975|FG010|Part 2: Dose Expansion|Clinical Progression|2
4561105|NCT01286987|7393976|FG011|Part 2: Dose Expansion|Clinical Progression|2
4561106|NCT01286987|7393977|FG012|Part 2: Dose Expansion|Clinical Progression|0
4561107|NCT01286987|7393978|FG013|Part 2: Dose Expansion|Clinical Progression|2
4561108|NCT01286987|7393979|FG014|Part 2: Dose Expansion|Clinical Progression|0
4561109|NCT01286987|7393965|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0
4561110|NCT01286987|7393966|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0
4561111|NCT01286987|7393967|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0
4561112|NCT01286987|7393968|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0
4561113|NCT01286987|7393969|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0
4561114|NCT01286987|7393970|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0
4561115|NCT01286987|7393971|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0
4561116|NCT01286987|7393972|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0
4561117|NCT01286987|7393973|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0
4561118|NCT01286987|7393974|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0
4561119|NCT01286987|7393975|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1
4561120|NCT01286987|7393976|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0
4561121|NCT01286987|7393977|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0
4561122|NCT01286987|7393978|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0
4561123|NCT01286987|7393979|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0
4561124|NCT01287013|7394023|FG000|Overall Study|Non-evaluable|3
4561125|NCT01287013|7394024|FG001|Overall Study|Non-evaluable|5
4561126|NCT01287013|7394025|FG002|Overall Study|Non-evaluable|21
4561127|NCT01287039|7394035|FG000|Overall Study|Noncompliance with study procedures|0
4561128|NCT01287039|7394036|FG001|Overall Study|Noncompliance with study procedures|1
4561129|NCT01287039|7394035|FG000|Overall Study|Change of location/residence|0
4561130|NCT01287039|7394036|FG001|Overall Study|Change of location/residence|3
4561131|NCT01287039|7394035|FG000|Overall Study|Elective surgery|0
4561132|NCT01287039|7394036|FG001|Overall Study|Elective surgery|1
4561133|NCT01287039|7394035|FG000|Overall Study|Protocol Violation|2
4561134|NCT01287039|7394036|FG001|Overall Study|Protocol Violation|3
4561135|NCT01287039|7394035|FG000|Overall Study|Excluded medication taken|1
4561136|NCT01287039|7394036|FG001|Overall Study|Excluded medication taken|0
4561137|NCT01287039|7394035|FG000|Overall Study|Noncompliance with study medication|0
4561138|NCT01287039|7394036|FG001|Overall Study|Noncompliance with study medication|1
4561139|NCT01287039|7394035|FG000|Overall Study|Problem with travel|0
4561140|NCT01287039|7394036|FG001|Overall Study|Problem with travel|1
4561141|NCT01287039|7394035|FG000|Overall Study|Death|1
4561142|NCT01287039|7394036|FG001|Overall Study|Death|0
4561143|NCT01287039|7394035|FG000|Overall Study|Change of residence|1
4561144|NCT01287039|7394036|FG001|Overall Study|Change of residence|0
4561145|NCT01287039|7394035|FG000|Overall Study|Adverse Event|7
4561146|NCT01287039|7394036|FG001|Overall Study|Adverse Event|4
4561147|NCT01287039|7394035|FG000|Overall Study|Withdrawal by Subject|14
4561148|NCT01287039|7394036|FG001|Overall Study|Withdrawal by Subject|11
4561149|NCT01287039|7394035|FG000|Overall Study|Lost to Follow-up|3
4561150|NCT01287039|7394036|FG001|Overall Study|Lost to Follow-up|2
4561151|NCT01287065|7394042|FG000|Treatment Period 1|Adverse Event|0
4561152|NCT01287065|7394043|FG001|Treatment Period 1|Adverse Event|0
4561153|NCT01287065|7394044|FG002|Treatment Period 1|Adverse Event|0
4623256|NCT01808118|7486624|FG000|Period 1|Non-conformance with inclusion criteria|3
4623257|NCT01808118|7486625|FG001|Period 1|Non-conformance with inclusion criteria|0
4623258|NCT01808118|7486626|FG002|Period 1|Non-conformance with inclusion criteria|0
4623259|NCT01808118|7486624|FG000|Period 1|Investigator decision: site closure|2
4623260|NCT01808118|7486625|FG001|Period 1|Investigator decision: site closure|0
4623261|NCT01808118|7486626|FG002|Period 1|Investigator decision: site closure|0
4623262|NCT01808118|7486624|FG000|Period 1|Non-compliance per sponsor|1
4623263|NCT01808118|7486625|FG001|Period 1|Non-compliance per sponsor|0
4623264|NCT01808118|7486626|FG002|Period 1|Non-compliance per sponsor|0
4690741|NCT02563548|7600525|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
4690742|NCT02563548|7600526|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2
4690743|NCT02563548|7600521|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
4690744|NCT02563548|7600522|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
4690745|NCT02563548|7600523|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
4690746|NCT02563548|7600524|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
4690747|NCT02563548|7600525|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
4690748|NCT02563548|7600526|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2
4690749|NCT02563548|7600521|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
4690750|NCT02563548|7600522|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
4690751|NCT02563548|7600523|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
4690752|NCT02563548|7600524|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
4690753|NCT02563548|7600525|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
4690754|NCT02563548|7600526|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1
4690755|NCT02563548|7600521|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
4561154|NCT01287065|7394045|FG003|Treatment Period 1|Adverse Event|0
4561155|NCT01287065|7394046|FG004|Treatment Period 1|Adverse Event|1
4561156|NCT01287065|7394047|FG005|Treatment Period 1|Adverse Event|0
4561157|NCT01287065|7394042|FG000|Treatment Period 1|Withdrawal by Subject|0
4561158|NCT01287065|7394043|FG001|Treatment Period 1|Withdrawal by Subject|0
4690756|NCT02563548|7600522|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
4690757|NCT02563548|7600523|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
4561159|NCT01287065|7394044|FG002|Treatment Period 1|Withdrawal by Subject|0
4561160|NCT01287065|7394045|FG003|Treatment Period 1|Withdrawal by Subject|0
4561161|NCT01287065|7394046|FG004|Treatment Period 1|Withdrawal by Subject|0
4690758|NCT02563548|7600524|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
4690759|NCT02563548|7600525|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1
4561162|NCT01287065|7394047|FG005|Treatment Period 1|Withdrawal by Subject|1
4561163|NCT01287104|7394068|FG000|Overall Study|Patient developed progressive disease|1
4561164|NCT01287104|7394069|FG001|Overall Study|Patient developed progressive disease|1
4561165|NCT01287104|7394070|FG002|Overall Study|Patient developed progressive disease|3
4561166|NCT01287104|7394071|FG003|Overall Study|Patient developed progressive disease|2
4561167|NCT01287104|7394068|FG000|Overall Study|Donor anaphylaxis|0
4561168|NCT01287104|7394069|FG001|Overall Study|Donor anaphylaxis|1
4561169|NCT01287104|7394070|FG002|Overall Study|Donor anaphylaxis|0
4561170|NCT01287104|7394071|FG003|Overall Study|Donor anaphylaxis|1
4561171|NCT01287104|7394068|FG000|Overall Study|Developed GVHD or complications of BMT|0
4561172|NCT01287104|7394069|FG001|Overall Study|Developed GVHD or complications of BMT|1
4561173|NCT01287104|7394070|FG002|Overall Study|Developed GVHD or complications of BMT|4
4561174|NCT01287104|7394071|FG003|Overall Study|Developed GVHD or complications of BMT|0
4561175|NCT01287104|7394068|FG000|Overall Study|Low donor chimerism|0
4561176|NCT01287104|7394069|FG001|Overall Study|Low donor chimerism|1
4561177|NCT01287104|7394070|FG002|Overall Study|Low donor chimerism|0
4561178|NCT01287104|7394071|FG003|Overall Study|Low donor chimerism|0
4561179|NCT01287104|7394068|FG000|Overall Study|NK cells did not meet release criteria|0
4561180|NCT01287104|7394069|FG001|Overall Study|NK cells did not meet release criteria|1
4561181|NCT01287104|7394070|FG002|Overall Study|NK cells did not meet release criteria|0
4561182|NCT01287104|7394071|FG003|Overall Study|NK cells did not meet release criteria|0
4561183|NCT01287117|7394092|FG000|Overall Study|Adverse Event|2
4561184|NCT01287117|7394093|FG001|Overall Study|Adverse Event|1
4561185|NCT01287117|7394094|FG002|Overall Study|Adverse Event|1
4561186|NCT01287117|7394095|FG003|Overall Study|Adverse Event|1
4561187|NCT01287117|7394092|FG000|Overall Study|Lost to Follow-up|1
4561188|NCT01287117|7394093|FG001|Overall Study|Lost to Follow-up|1
4561189|NCT01287117|7394094|FG002|Overall Study|Lost to Follow-up|0
4561190|NCT01287117|7394095|FG003|Overall Study|Lost to Follow-up|0
4561191|NCT01287117|7394092|FG000|Overall Study|Physician Decision|0
4561192|NCT01287117|7394093|FG001|Overall Study|Physician Decision|1
4561193|NCT01287117|7394094|FG002|Overall Study|Physician Decision|1
4561194|NCT01287117|7394095|FG003|Overall Study|Physician Decision|1
4561195|NCT01287117|7394092|FG000|Overall Study|Patient/Legal Guardian's Decision|2
4561196|NCT01287117|7394093|FG001|Overall Study|Patient/Legal Guardian's Decision|6
4561197|NCT01287117|7394094|FG002|Overall Study|Patient/Legal Guardian's Decision|8
4561198|NCT01287117|7394095|FG003|Overall Study|Patient/Legal Guardian's Decision|5
4561199|NCT01287117|7394092|FG000|Overall Study|Disease Progression|10
4561200|NCT01287117|7394093|FG001|Overall Study|Disease Progression|5
4561201|NCT01287117|7394094|FG002|Overall Study|Disease Progression|6
4561202|NCT01287117|7394095|FG003|Overall Study|Disease Progression|5
4561203|NCT01287195|7394105|FG000|Overall Study|Withdrawal by Subject|2
4561204|NCT01287221|7394122|FG000|Overall Study|Lack of Perceived Benefit|1
4561205|NCT01287221|7394123|FG001|Overall Study|Lack of Perceived Benefit|1
4561206|NCT01287221|7394122|FG000|Overall Study|Adverse Event|3
4561207|NCT01287221|7394123|FG001|Overall Study|Adverse Event|3
4561208|NCT01287221|7394122|FG000|Overall Study|Withdrawal by Subject|0
4561209|NCT01287221|7394123|FG001|Overall Study|Withdrawal by Subject|1
4561210|NCT01287364|7394131|FG000|Overall Study|Adverse Event|0
4561211|NCT01287364|7394132|FG001|Overall Study|Adverse Event|3
4561212|NCT01287364|7394131|FG000|Overall Study|Protocol Violation|5
4561213|NCT01287364|7394132|FG001|Overall Study|Protocol Violation|5
4561214|NCT01287364|7394131|FG000|Overall Study|Other Reason|4
4561215|NCT01287364|7394132|FG001|Overall Study|Other Reason|2
4561216|NCT01287403|7394164|FG000|1st Intervention (1 Day)|Adverse Event|1
4561217|NCT01287416|7394180|FG000|Pre-post Training|Withdrawal by Subject|17
4561218|NCT01287416|7394181|FG001|Pre-post Training|Withdrawal by Subject|24
4561219|NCT01287416|7394180|FG000|Pre-post Training|Lost to Follow-up|5
4561220|NCT01287416|7394181|FG001|Pre-post Training|Lost to Follow-up|1
4561221|NCT01287416|7394180|FG000|6 Month Follow-up|Lost to Follow-up|3
4561222|NCT01287416|7394181|FG001|6 Month Follow-up|Lost to Follow-up|2
4561223|NCT01287520|7394196|FG000|Overall Study|Adverse Event|2
4561224|NCT01287520|7394197|FG001|Overall Study|Adverse Event|2
4561225|NCT01287520|7394198|FG002|Overall Study|Adverse Event|2
4561226|NCT01287520|7394199|FG003|Overall Study|Adverse Event|1
4561227|NCT01287520|7394200|FG004|Overall Study|Adverse Event|1
4561228|NCT01287520|7394201|FG005|Overall Study|Adverse Event|2
4561229|NCT01287520|7394202|FG006|Overall Study|Adverse Event|0
4561230|NCT01287520|7394203|FG007|Overall Study|Adverse Event|2
4561231|NCT01287520|7394204|FG008|Overall Study|Adverse Event|0
4561232|NCT01287520|7394196|FG000|Overall Study|Physician Decision|1
4561233|NCT01287520|7394197|FG001|Overall Study|Physician Decision|1
4561234|NCT01287520|7394198|FG002|Overall Study|Physician Decision|2
4561235|NCT01287520|7394199|FG003|Overall Study|Physician Decision|0
4561236|NCT01287520|7394200|FG004|Overall Study|Physician Decision|1
4561237|NCT01287520|7394201|FG005|Overall Study|Physician Decision|1
4561238|NCT01287520|7394202|FG006|Overall Study|Physician Decision|0
4561239|NCT01287520|7394203|FG007|Overall Study|Physician Decision|1
4561240|NCT01287520|7394204|FG008|Overall Study|Physician Decision|0
4561241|NCT01287520|7394196|FG000|Overall Study|Progressive disease|0
4561242|NCT01287520|7394197|FG001|Overall Study|Progressive disease|4
4561243|NCT01287520|7394198|FG002|Overall Study|Progressive disease|1
4561244|NCT01287520|7394199|FG003|Overall Study|Progressive disease|6
4561245|NCT01287520|7394200|FG004|Overall Study|Progressive disease|1
4561246|NCT01287520|7394201|FG005|Overall Study|Progressive disease|0
4561247|NCT01287520|7394202|FG006|Overall Study|Progressive disease|2
4561248|NCT01287520|7394203|FG007|Overall Study|Progressive disease|2
4561249|NCT01287520|7394204|FG008|Overall Study|Progressive disease|4
4561250|NCT01287520|7394196|FG000|Overall Study|Withdrawal by Subject|0
4561251|NCT01287520|7394197|FG001|Overall Study|Withdrawal by Subject|0
4561252|NCT01287520|7394198|FG002|Overall Study|Withdrawal by Subject|0
4561253|NCT01287520|7394199|FG003|Overall Study|Withdrawal by Subject|0
4561254|NCT01287520|7394200|FG004|Overall Study|Withdrawal by Subject|0
4561255|NCT01287520|7394201|FG005|Overall Study|Withdrawal by Subject|1
4561256|NCT01287520|7394202|FG006|Overall Study|Withdrawal by Subject|0
4561257|NCT01287520|7394203|FG007|Overall Study|Withdrawal by Subject|0
4561258|NCT01287520|7394204|FG008|Overall Study|Withdrawal by Subject|1
4561259|NCT01287754|7394255|FG000|Overall Study|Death|2
4561260|NCT01287754|7394256|FG001|Overall Study|Death|12
4561261|NCT01287754|7394255|FG000|Overall Study|Lost to Follow-up|1
4561262|NCT01287754|7394256|FG001|Overall Study|Lost to Follow-up|6
4561263|NCT01287754|7394255|FG000|Overall Study|Protocol Violation|0
4561264|NCT01287754|7394256|FG001|Overall Study|Protocol Violation|3
4561265|NCT01287832|7394264|FG000|Overall Study|Adverse Event|1
4561266|NCT01287832|7394265|FG001|Overall Study|Adverse Event|0
4561267|NCT01287832|7394264|FG000|Overall Study|Death|0
4561268|NCT01287832|7394265|FG001|Overall Study|Death|1
4561269|NCT01287897|7394275|FG000|Overall Study|Adverse Event|5
4561270|NCT01287897|7394276|FG001|Overall Study|Adverse Event|3
4561271|NCT01287897|7394277|FG002|Overall Study|Adverse Event|6
4561272|NCT01287897|7394278|FG003|Overall Study|Adverse Event|4
4561273|NCT01287897|7394275|FG000|Overall Study|Lack of Efficacy|2
4561274|NCT01287897|7394276|FG001|Overall Study|Lack of Efficacy|0
4561275|NCT01287897|7394277|FG002|Overall Study|Lack of Efficacy|0
4561276|NCT01287897|7394278|FG003|Overall Study|Lack of Efficacy|0
4561277|NCT01287897|7394275|FG000|Overall Study|Protocol Violation|1
4561278|NCT01287897|7394276|FG001|Overall Study|Protocol Violation|1
4561279|NCT01287897|7394277|FG002|Overall Study|Protocol Violation|0
4561280|NCT01287897|7394278|FG003|Overall Study|Protocol Violation|1
4561281|NCT01287897|7394275|FG000|Overall Study|Lost to Follow-up|0
4561282|NCT01287897|7394276|FG001|Overall Study|Lost to Follow-up|0
4561283|NCT01287897|7394277|FG002|Overall Study|Lost to Follow-up|2
4561284|NCT01287897|7394278|FG003|Overall Study|Lost to Follow-up|0
4561285|NCT01287897|7394275|FG000|Overall Study|Withdrawal by Subject|1
4561286|NCT01287897|7394276|FG001|Overall Study|Withdrawal by Subject|5
4623265|NCT01808118|7486624|FG000|Period 1|Lack of Efficacy|1
4623266|NCT01808118|7486625|FG001|Period 1|Lack of Efficacy|0
4623267|NCT01808118|7486626|FG002|Period 1|Lack of Efficacy|0
4623268|NCT01808118|7486624|FG000|Period 2|Adverse Event|0
4623269|NCT01808118|7486625|FG001|Period 2|Adverse Event|4
4623270|NCT01808118|7486626|FG002|Period 2|Adverse Event|0
4623271|NCT01808118|7486624|FG000|Period 2|Withdrew consent|0
4623272|NCT01808118|7486625|FG001|Period 2|Withdrew consent|7
4623273|NCT01808118|7486626|FG002|Period 2|Withdrew consent|6
4623274|NCT01808118|7486624|FG000|Period 2|Lost to Follow-up|0
4623275|NCT01808118|7486625|FG001|Period 2|Lost to Follow-up|0
4623276|NCT01808118|7486626|FG002|Period 2|Lost to Follow-up|2
4623277|NCT01808118|7486624|FG000|Period 2|Investigator no longer conducting trials|0
4623278|NCT01808118|7486625|FG001|Period 2|Investigator no longer conducting trials|1
4623279|NCT01808118|7486626|FG002|Period 2|Investigator no longer conducting trials|0
4623280|NCT01808118|7486624|FG000|Period 2|Switched to other therapy|0
4623281|NCT01808118|7486625|FG001|Period 2|Switched to other therapy|1
4623282|NCT01808118|7486626|FG002|Period 2|Switched to other therapy|0
4623283|NCT01808144|7486642|FG000|Overall Study|Death|1
4623284|NCT01808144|7486643|FG001|Overall Study|Death|0
4623285|NCT01808144|7486642|FG000|Overall Study|Withdrawal by Subject|16
4623286|NCT01808144|7486643|FG001|Overall Study|Withdrawal by Subject|23
4623287|NCT01808144|7486642|FG000|Overall Study|Lost to Follow-up|6
4623288|NCT01808144|7486643|FG001|Overall Study|Lost to Follow-up|3
4623289|NCT01808144|7486642|FG000|Overall Study|Protocol Violation|6
4623290|NCT01808144|7486643|FG001|Overall Study|Protocol Violation|6
4623291|NCT01808144|7486642|FG000|Overall Study|Gout flare|0
4623292|NCT01808144|7486643|FG001|Overall Study|Gout flare|1
4623293|NCT01808144|7486642|FG000|Overall Study|Adverse Event|11
4623294|NCT01808144|7486643|FG001|Overall Study|Adverse Event|15
4623295|NCT01808196|7486649|FG000|Overall Study|Lost to Follow-up|1
4623296|NCT01808209|7486655|FG000|Overall Study|Lost to Follow-up|0
4561287|NCT01287897|7394277|FG002|Overall Study|Withdrawal by Subject|3
4561288|NCT01287897|7394278|FG003|Overall Study|Withdrawal by Subject|2
4561289|NCT01287897|7394275|FG000|Overall Study|Not consented properly|0
4561290|NCT01287897|7394276|FG001|Overall Study|Not consented properly|1
4561291|NCT01287897|7394277|FG002|Overall Study|Not consented properly|0
4561292|NCT01287897|7394278|FG003|Overall Study|Not consented properly|0
4561293|NCT01287897|7394275|FG000|Overall Study|Not meeting entrance criteria|1
4623297|NCT01808209|7486656|FG001|Overall Study|Lost to Follow-up|1
4561294|NCT01287897|7394276|FG001|Overall Study|Not meeting entrance criteria|1
4561295|NCT01287897|7394277|FG002|Overall Study|Not meeting entrance criteria|0
4561296|NCT01287897|7394278|FG003|Overall Study|Not meeting entrance criteria|0
4561297|NCT01287897|7394275|FG000|Overall Study|Other|1
4561298|NCT01287897|7394276|FG001|Overall Study|Other|0
4561299|NCT01287897|7394277|FG002|Overall Study|Other|1
4561300|NCT01287897|7394278|FG003|Overall Study|Other|0
4561301|NCT01288053|7394296|FG000|Overall Study|Death|1
4561302|NCT01288079|7394304|FG000|Overall Study|Withdrawal by Subject|2
4561303|NCT01288079|7394305|FG001|Overall Study|Withdrawal by Subject|4
4561304|NCT01288079|7394306|FG002|Overall Study|Withdrawal by Subject|1
4561305|NCT01288079|7394307|FG003|Overall Study|Withdrawal by Subject|0
4561306|NCT01288079|7394304|FG000|Overall Study|Adverse Event|2
4561307|NCT01288079|7394305|FG001|Overall Study|Adverse Event|1
4561308|NCT01288079|7394306|FG002|Overall Study|Adverse Event|2
4561309|NCT01288079|7394307|FG003|Overall Study|Adverse Event|3
4561310|NCT01288079|7394304|FG000|Overall Study|Severe Non-Compliance to Protocol|1
4561311|NCT01288079|7394305|FG001|Overall Study|Severe Non-Compliance to Protocol|3
4561312|NCT01288079|7394306|FG002|Overall Study|Severe Non-Compliance to Protocol|1
4561313|NCT01288079|7394307|FG003|Overall Study|Severe Non-Compliance to Protocol|3
4561314|NCT01288079|7394304|FG000|Overall Study|Condition under Investigation Worsened|0
4561315|NCT01288079|7394305|FG001|Overall Study|Condition under Investigation Worsened|0
4561316|NCT01288079|7394306|FG002|Overall Study|Condition under Investigation Worsened|0
4561317|NCT01288079|7394307|FG003|Overall Study|Condition under Investigation Worsened|1
4561318|NCT01288079|7394304|FG000|Overall Study|Lack of Efficacy|2
4561319|NCT01288079|7394305|FG001|Overall Study|Lack of Efficacy|2
4561320|NCT01288079|7394306|FG002|Overall Study|Lack of Efficacy|0
4561321|NCT01288079|7394307|FG003|Overall Study|Lack of Efficacy|2
4561322|NCT01288079|7394304|FG000|Overall Study|Study-Specific Withdrawal Criteria|1
4561323|NCT01288079|7394305|FG001|Overall Study|Study-Specific Withdrawal Criteria|1
4561324|NCT01288079|7394306|FG002|Overall Study|Study-Specific Withdrawal Criteria|0
4561325|NCT01288079|7394307|FG003|Overall Study|Study-Specific Withdrawal Criteria|0
4561326|NCT01288079|7394304|FG000|Overall Study|Lost to Follow-up|1
4561327|NCT01288079|7394305|FG001|Overall Study|Lost to Follow-up|1
4561328|NCT01288079|7394306|FG002|Overall Study|Lost to Follow-up|1
4561329|NCT01288079|7394307|FG003|Overall Study|Lost to Follow-up|0
4561330|NCT01288079|7394304|FG000|Overall Study|Other or Study Termination|11
4561331|NCT01288079|7394305|FG001|Overall Study|Other or Study Termination|15
4561332|NCT01288079|7394306|FG002|Overall Study|Other or Study Termination|14
4561333|NCT01288079|7394307|FG003|Overall Study|Other or Study Termination|8
4561334|NCT01288209|7394319|FG000|Overall Study|Withdrawal by Subject|1
4561335|NCT01288209|7394320|FG001|Overall Study|Withdrawal by Subject|3
4561336|NCT01288209|7394319|FG000|Overall Study|Other|1
4561337|NCT01288209|7394320|FG001|Overall Study|Other|0
4623298|NCT01808222|7486666|FG000|Overall Study|mpMR scan was not performed|1
4561338|NCT01288287|7394326|FG000|Overall Study|Lost to Follow-up|8
4561339|NCT01288287|7394326|FG000|Overall Study|Withdrawal by Subject|4
4561340|NCT01288287|7394326|FG000|Overall Study|Lack of Efficacy|13
4561341|NCT01288287|7394326|FG000|Overall Study|Other Reason|13
4561342|NCT01288287|7394326|FG000|Overall Study|Unknown Reason|1
4561343|NCT01288287|7394326|FG000|Overall Study|Unknown Status|7
4561344|NCT01288430|7394341|FG000|Part 1|Progressive disease|2
4561345|NCT01288430|7394342|FG001|Part 1|Progressive disease|1
4561346|NCT01288430|7394343|FG002|Part 1|Progressive disease|1
4623299|NCT01808248|7486672|FG000|Overall Study|Lack of Efficacy|3
4623300|NCT01808248|7486672|FG000|Overall Study|Withdrawal by Subject|1
4623301|NCT01808248|7486672|FG000|Overall Study|Lost to Follow-up|1
4623302|NCT01808313|7486678|FG000|Overall Study|Adverse Event|5
4623303|NCT01808313|7486678|FG000|Overall Study|Protocol Violation|2
4623304|NCT01808313|7486678|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1
4623305|NCT01808313|7486678|FG000|Overall Study|Lost to Follow-up|1
4623306|NCT01808313|7486678|FG000|Overall Study|Physician Decision|1
4623307|NCT01808339|7486686|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
4623308|NCT01808339|7486687|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
4623309|NCT01808339|7486688|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
4623310|NCT01808339|7486689|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1
4623311|NCT01808339|7486690|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2
4623312|NCT01808339|7486691|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1
4623313|NCT01808339|7486686|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
4623314|NCT01808339|7486687|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
4623315|NCT01808339|7486688|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
4623316|NCT01808339|7486689|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
4561347|NCT01288430|7394344|FG003|Part 1|Progressive disease|6
4561348|NCT01288430|7394345|FG004|Part 1|Progressive disease|2
4561349|NCT01288430|7394346|FG005|Part 1|Progressive disease|4
4561350|NCT01288430|7394347|FG006|Part 1|Progressive disease|2
4561351|NCT01288430|7394348|FG007|Part 1|Progressive disease|0
4561352|NCT01288430|7394349|FG008|Part 1|Progressive disease|0
4561353|NCT01288430|7394350|FG009|Part 1|Progressive disease|0
4561354|NCT01288430|7394341|FG000|Part 1|Clinical disease progression|0
4561355|NCT01288430|7394342|FG001|Part 1|Clinical disease progression|0
4561356|NCT01288430|7394343|FG002|Part 1|Clinical disease progression|1
4561357|NCT01288430|7394344|FG003|Part 1|Clinical disease progression|0
4561358|NCT01288430|7394345|FG004|Part 1|Clinical disease progression|0
4561359|NCT01288430|7394346|FG005|Part 1|Clinical disease progression|2
4561360|NCT01288430|7394347|FG006|Part 1|Clinical disease progression|2
4561361|NCT01288430|7394348|FG007|Part 1|Clinical disease progression|0
4561362|NCT01288430|7394349|FG008|Part 1|Clinical disease progression|0
4561363|NCT01288430|7394350|FG009|Part 1|Clinical disease progression|0
4561364|NCT01288430|7394341|FG000|Part 1|Death due to disease progression|0
4561365|NCT01288430|7394342|FG001|Part 1|Death due to disease progression|0
4561366|NCT01288430|7394343|FG002|Part 1|Death due to disease progression|0
4561367|NCT01288430|7394344|FG003|Part 1|Death due to disease progression|0
4561368|NCT01288430|7394345|FG004|Part 1|Death due to disease progression|1
4561369|NCT01288430|7394346|FG005|Part 1|Death due to disease progression|0
4561370|NCT01288430|7394347|FG006|Part 1|Death due to disease progression|0
4561371|NCT01288430|7394348|FG007|Part 1|Death due to disease progression|0
4561372|NCT01288430|7394349|FG008|Part 1|Death due to disease progression|0
4561373|NCT01288430|7394350|FG009|Part 1|Death due to disease progression|0
4623317|NCT01808339|7486690|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
4623318|NCT01808339|7486691|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
4623319|NCT01808339|7486686|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
4623320|NCT01808339|7486687|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
4623321|NCT01808339|7486688|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1
4623322|NCT01808339|7486689|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
4623323|NCT01808339|7486690|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
4623324|NCT01808339|7486691|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
4623325|NCT01808508|7486702|FG000|Overall Study|Lost to Follow-up|1
4623326|NCT01808508|7486703|FG001|Overall Study|Lost to Follow-up|0
4623327|NCT01808508|7486704|FG002|Overall Study|Lost to Follow-up|0
4623328|NCT01808534|7486712|FG000|Overall Study|Disease progression|3
4623329|NCT01808534|7486712|FG000|Overall Study|Physician Decision|1
4623330|NCT01808573|7486740|FG000|Overall Study|Death|212
4623331|NCT01808573|7486741|FG001|Overall Study|Death|240
4623332|NCT01808573|7486740|FG000|Overall Study|Withdrawal by Subject|12
4623333|NCT01808573|7486741|FG001|Overall Study|Withdrawal by Subject|10
4623334|NCT01808573|7486740|FG000|Overall Study|Lost to Follow-up|3
4623335|NCT01808573|7486741|FG001|Overall Study|Lost to Follow-up|0
4623336|NCT01808573|7486740|FG000|Overall Study|Discontinuation of study by sponsor|79
4623337|NCT01808573|7486741|FG001|Overall Study|Discontinuation of study by sponsor|64
4623338|NCT01808573|7486740|FG000|Overall Study|Randomized in Error|1
4623339|NCT01808573|7486741|FG001|Overall Study|Randomized in Error|0
4623340|NCT01808612|7486750|FG000|Treatment Period|Adverse Event|8
4623341|NCT01808612|7486751|FG001|Treatment Period|Adverse Event|4
4623342|NCT01808612|7486752|FG002|Treatment Period|Adverse Event|3
4623343|NCT01808612|7486750|FG000|Treatment Period|Lost to Follow-up|2
4623344|NCT01808612|7486751|FG001|Treatment Period|Lost to Follow-up|2
4623345|NCT01808612|7486752|FG002|Treatment Period|Lost to Follow-up|1
4623346|NCT01808612|7486750|FG000|Treatment Period|Protocol Violation|1
4623347|NCT01808612|7486751|FG001|Treatment Period|Protocol Violation|0
4623348|NCT01808612|7486752|FG002|Treatment Period|Protocol Violation|0
4623349|NCT01808612|7486750|FG000|Treatment Period|Withdrawal by Subject|1
4623350|NCT01808612|7486751|FG001|Treatment Period|Withdrawal by Subject|0
4623351|NCT01808612|7486752|FG002|Treatment Period|Withdrawal by Subject|4
4623352|NCT01808612|7486750|FG000|Treatment Period|Physician Decision|1
4623353|NCT01808612|7486751|FG001|Treatment Period|Physician Decision|0
4623354|NCT01808612|7486752|FG002|Treatment Period|Physician Decision|4
4623355|NCT01808612|7486750|FG000|Treatment Period|Sponsor Decision|1
4623356|NCT01808612|7486751|FG001|Treatment Period|Sponsor Decision|0
4623357|NCT01808612|7486752|FG002|Treatment Period|Sponsor Decision|0
4623358|NCT01808612|7486750|FG000|Treatment Period|Lack of Efficacy|1
4623359|NCT01808612|7486751|FG001|Treatment Period|Lack of Efficacy|1
4623360|NCT01808612|7486752|FG002|Treatment Period|Lack of Efficacy|2
4623361|NCT01808612|7486750|FG000|Discontinuation Period|Adverse Event|1
4623362|NCT01808612|7486751|FG001|Discontinuation Period|Adverse Event|0
4623363|NCT01808612|7486752|FG002|Discontinuation Period|Adverse Event|0
4623364|NCT01808612|7486750|FG000|Discontinuation Period|Physician Decision|1
4623365|NCT01808612|7486751|FG001|Discontinuation Period|Physician Decision|0
4623366|NCT01808612|7486752|FG002|Discontinuation Period|Physician Decision|0
4623367|NCT01808612|7486750|FG000|Discontinuation Period|Lost to Follow-up|0
4623368|NCT01808612|7486751|FG001|Discontinuation Period|Lost to Follow-up|1
4623369|NCT01808612|7486752|FG002|Discontinuation Period|Lost to Follow-up|0
4623370|NCT01808651|7486766|FG000|Study Period 1|Lost to Follow-up|1
4623371|NCT01808651|7486767|FG001|Study Period 1|Lost to Follow-up|3
4623372|NCT01808651|7486768|FG002|Study Period 1|Lost to Follow-up|0
4561374|NCT01288430|7394341|FG000|Part 1|Adverse Event|0
4623373|NCT01808651|7486766|FG000|Study Period 1|Protocol Violation|1
4623374|NCT01808651|7486767|FG001|Study Period 1|Protocol Violation|0
4623375|NCT01808651|7486768|FG002|Study Period 1|Protocol Violation|1
4623376|NCT01808651|7486766|FG000|Study Period 1|Physician Decision|3
4561375|NCT01288430|7394342|FG001|Part 1|Adverse Event|0
4561376|NCT01288430|7394343|FG002|Part 1|Adverse Event|3
4561377|NCT01288430|7394344|FG003|Part 1|Adverse Event|1
4561378|NCT01288430|7394345|FG004|Part 1|Adverse Event|0
4561379|NCT01288430|7394346|FG005|Part 1|Adverse Event|0
4561380|NCT01288430|7394347|FG006|Part 1|Adverse Event|2
4561381|NCT01288430|7394348|FG007|Part 1|Adverse Event|0
4561382|NCT01288430|7394349|FG008|Part 1|Adverse Event|0
4561383|NCT01288430|7394350|FG009|Part 1|Adverse Event|0
4561384|NCT01288430|7394341|FG000|Part 1|Other|0
4561385|NCT01288430|7394342|FG001|Part 1|Other|2
4561386|NCT01288430|7394343|FG002|Part 1|Other|0
4561387|NCT01288430|7394344|FG003|Part 1|Other|0
4561388|NCT01288430|7394345|FG004|Part 1|Other|0
4561389|NCT01288430|7394346|FG005|Part 1|Other|0
4561390|NCT01288430|7394347|FG006|Part 1|Other|1
4561391|NCT01288430|7394348|FG007|Part 1|Other|0
4561392|NCT01288430|7394349|FG008|Part 1|Other|0
4561393|NCT01288430|7394350|FG009|Part 1|Other|0
4561394|NCT01288430|7394341|FG000|Part 2|Progressive disease|0
4561395|NCT01288430|7394342|FG001|Part 2|Progressive disease|0
4561396|NCT01288430|7394343|FG002|Part 2|Progressive disease|0
4561397|NCT01288430|7394344|FG003|Part 2|Progressive disease|0
4561398|NCT01288430|7394345|FG004|Part 2|Progressive disease|0
4561399|NCT01288430|7394346|FG005|Part 2|Progressive disease|0
4561400|NCT01288430|7394347|FG006|Part 2|Progressive disease|0
4561401|NCT01288430|7394348|FG007|Part 2|Progressive disease|8
4561402|NCT01288430|7394349|FG008|Part 2|Progressive disease|7
4561403|NCT01288430|7394350|FG009|Part 2|Progressive disease|2
4561404|NCT01288430|7394341|FG000|Part 2|Clinical disease progression|0
4561405|NCT01288430|7394342|FG001|Part 2|Clinical disease progression|0
4561406|NCT01288430|7394343|FG002|Part 2|Clinical disease progression|0
4561407|NCT01288430|7394344|FG003|Part 2|Clinical disease progression|0
4561408|NCT01288430|7394345|FG004|Part 2|Clinical disease progression|0
4561409|NCT01288430|7394346|FG005|Part 2|Clinical disease progression|0
4561410|NCT01288430|7394347|FG006|Part 2|Clinical disease progression|0
4561411|NCT01288430|7394348|FG007|Part 2|Clinical disease progression|2
4561412|NCT01288430|7394349|FG008|Part 2|Clinical disease progression|0
4561413|NCT01288430|7394350|FG009|Part 2|Clinical disease progression|0
4561414|NCT01288430|7394341|FG000|Part 2|Withdrawal by Subject|0
4561415|NCT01288430|7394342|FG001|Part 2|Withdrawal by Subject|0
4561416|NCT01288430|7394343|FG002|Part 2|Withdrawal by Subject|0
4561417|NCT01288430|7394344|FG003|Part 2|Withdrawal by Subject|0
4561418|NCT01288430|7394345|FG004|Part 2|Withdrawal by Subject|0
4561419|NCT01288430|7394346|FG005|Part 2|Withdrawal by Subject|0
4561420|NCT01288430|7394347|FG006|Part 2|Withdrawal by Subject|0
4561421|NCT01288430|7394348|FG007|Part 2|Withdrawal by Subject|1
4561422|NCT01288430|7394349|FG008|Part 2|Withdrawal by Subject|4
4561423|NCT01288430|7394350|FG009|Part 2|Withdrawal by Subject|0
4561424|NCT01288430|7394341|FG000|Part 2|Adverse Event|0
4561425|NCT01288430|7394342|FG001|Part 2|Adverse Event|0
4561426|NCT01288430|7394343|FG002|Part 2|Adverse Event|0
4561427|NCT01288430|7394344|FG003|Part 2|Adverse Event|0
4561428|NCT01288430|7394345|FG004|Part 2|Adverse Event|0
4561429|NCT01288430|7394346|FG005|Part 2|Adverse Event|0
4561430|NCT01288430|7394347|FG006|Part 2|Adverse Event|0
4561431|NCT01288430|7394348|FG007|Part 2|Adverse Event|1
4561432|NCT01288430|7394349|FG008|Part 2|Adverse Event|1
4561433|NCT01288430|7394350|FG009|Part 2|Adverse Event|0
4561434|NCT01288430|7394341|FG000|Part 2|Other|0
4561435|NCT01288430|7394342|FG001|Part 2|Other|0
4561436|NCT01288430|7394343|FG002|Part 2|Other|0
4561437|NCT01288430|7394344|FG003|Part 2|Other|0
4561438|NCT01288430|7394345|FG004|Part 2|Other|0
4561439|NCT01288430|7394346|FG005|Part 2|Other|0
4561440|NCT01288430|7394347|FG006|Part 2|Other|0
4561441|NCT01288430|7394348|FG007|Part 2|Other|0
4561442|NCT01288430|7394349|FG008|Part 2|Other|0
4561443|NCT01288430|7394350|FG009|Part 2|Other|1
4561444|NCT01288443|7394383|FG000|Overall Study|Adverse Event|0
4561445|NCT01288443|7394384|FG001|Overall Study|Adverse Event|0
4561446|NCT01288443|7394385|FG002|Overall Study|Adverse Event|1
4561447|NCT01288443|7394386|FG003|Overall Study|Adverse Event|1
4561448|NCT01288443|7394387|FG004|Overall Study|Adverse Event|3
4561449|NCT01288443|7394388|FG005|Overall Study|Adverse Event|1
4561450|NCT01288443|7394383|FG000|Overall Study|Poor compliance to protocol|0
4561451|NCT01288443|7394384|FG001|Overall Study|Poor compliance to protocol|0
4561452|NCT01288443|7394385|FG002|Overall Study|Poor compliance to protocol|0
4561453|NCT01288443|7394386|FG003|Overall Study|Poor compliance to protocol|0
4561454|NCT01288443|7394387|FG004|Overall Study|Poor compliance to protocol|0
4561455|NCT01288443|7394388|FG005|Overall Study|Poor compliance to protocol|1
4561456|NCT01288443|7394383|FG000|Overall Study|Participant Moved|0
4561457|NCT01288443|7394384|FG001|Overall Study|Participant Moved|0
4561458|NCT01288443|7394385|FG002|Overall Study|Participant Moved|0
4561459|NCT01288443|7394386|FG003|Overall Study|Participant Moved|1
4561460|NCT01288443|7394387|FG004|Overall Study|Participant Moved|2
4561461|NCT01288443|7394388|FG005|Overall Study|Participant Moved|1
4561462|NCT01288443|7394383|FG000|Overall Study|Consent withdrawn by Participant|0
4561463|NCT01288443|7394384|FG001|Overall Study|Consent withdrawn by Participant|0
4561464|NCT01288443|7394385|FG002|Overall Study|Consent withdrawn by Participant|0
4561465|NCT01288443|7394386|FG003|Overall Study|Consent withdrawn by Participant|0
4561466|NCT01288443|7394387|FG004|Overall Study|Consent withdrawn by Participant|0
4561467|NCT01288443|7394388|FG005|Overall Study|Consent withdrawn by Participant|1
4561468|NCT01288443|7394383|FG000|Overall Study|Lost to Follow-up|0
4561469|NCT01288443|7394384|FG001|Overall Study|Lost to Follow-up|1
4561470|NCT01288443|7394385|FG002|Overall Study|Lost to Follow-up|0
4561471|NCT01288443|7394386|FG003|Overall Study|Lost to Follow-up|0
4561472|NCT01288443|7394387|FG004|Overall Study|Lost to Follow-up|0
4561473|NCT01288443|7394388|FG005|Overall Study|Lost to Follow-up|0
4561474|NCT01288443|7394383|FG000|Overall Study|Study drug auto-injector administration|0
4561475|NCT01288443|7394384|FG001|Overall Study|Study drug auto-injector administration|0
4561476|NCT01288443|7394385|FG002|Overall Study|Study drug auto-injector administration|0
4561477|NCT01288443|7394386|FG003|Overall Study|Study drug auto-injector administration|0
4561478|NCT01288443|7394387|FG004|Overall Study|Study drug auto-injector administration|1
4561479|NCT01288443|7394388|FG005|Overall Study|Study drug auto-injector administration|1
4561480|NCT01288443|7394383|FG000|Overall Study|Other than above|0
4561481|NCT01288443|7394384|FG001|Overall Study|Other than above|0
4561482|NCT01288443|7394385|FG002|Overall Study|Other than above|0
4561483|NCT01288443|7394386|FG003|Overall Study|Other than above|2
4561484|NCT01288443|7394387|FG004|Overall Study|Other than above|1
4561485|NCT01288443|7394388|FG005|Overall Study|Other than above|0
4561486|NCT01288469|7394405|FG000|Overall Study|Adverse Event|4
4561487|NCT01288469|7394406|FG001|Overall Study|Adverse Event|1
4561488|NCT01288469|7394407|FG002|Overall Study|Adverse Event|1
4561489|NCT01288469|7394405|FG000|Overall Study|Poor compliance to protocol|0
4561490|NCT01288469|7394406|FG001|Overall Study|Poor compliance to protocol|1
4561491|NCT01288469|7394407|FG002|Overall Study|Poor compliance to protocol|0
4561492|NCT01288469|7394405|FG000|Overall Study|Participant Moved|1
4561493|NCT01288469|7394406|FG001|Overall Study|Participant Moved|0
4561494|NCT01288469|7394407|FG002|Overall Study|Participant Moved|0
4561495|NCT01288469|7394405|FG000|Overall Study|Consent withdrawn by subject|1
4561496|NCT01288469|7394406|FG001|Overall Study|Consent withdrawn by subject|1
4561497|NCT01288469|7394407|FG002|Overall Study|Consent withdrawn by subject|1
4561498|NCT01288469|7394405|FG000|Overall Study|Exclusion criteria finally met|1
4561499|NCT01288469|7394406|FG001|Overall Study|Exclusion criteria finally met|0
4561500|NCT01288469|7394407|FG002|Overall Study|Exclusion criteria finally met|0
4561501|NCT01288612|7394431|FG000|Overall Study|Unable to contact|11
4561502|NCT01288612|7394432|FG001|Overall Study|Unable to contact|16
4561503|NCT01288612|7394433|FG002|Overall Study|Unable to contact|20
4561504|NCT01288612|7394431|FG000|Overall Study|Declined|78
4561505|NCT01288612|7394432|FG001|Overall Study|Declined|63
4561506|NCT01288612|7394433|FG002|Overall Study|Declined|62
4561507|NCT01288612|7394431|FG000|Overall Study|Unable to intubate|0
4561508|NCT01288612|7394432|FG001|Overall Study|Unable to intubate|3
4561509|NCT01288612|7394433|FG002|Overall Study|Unable to intubate|0
4561510|NCT01288729|7394443|FG000|Overall Study|Withdrawal by Subject|1
4561511|NCT01288729|7394444|FG001|Overall Study|Withdrawal by Subject|0
4561512|NCT01288911|7394499|FG000|Double-blind Period|Death|11
4561513|NCT01288911|7394500|FG001|Double-blind Period|Death|7
4561514|NCT01288911|7394499|FG000|Double-blind Period|Lost to Follow-up|0
4561515|NCT01288911|7394500|FG001|Double-blind Period|Lost to Follow-up|2
4561516|NCT01288911|7394499|FG000|Double-blind Period|Progressive Disease|75
4561517|NCT01288911|7394500|FG001|Double-blind Period|Progressive Disease|103
4561518|NCT01288911|7394499|FG000|Double-blind Period|Protocol Violation|1
4561519|NCT01288911|7394500|FG001|Double-blind Period|Protocol Violation|0
4561520|NCT01288911|7394499|FG000|Double-blind Period|Withdrawal by Subject|25
4561521|NCT01288911|7394500|FG001|Double-blind Period|Withdrawal by Subject|26
4561522|NCT01288911|7394499|FG000|Double-blind Period|Miscellaneous Reason|29
4561523|NCT01288911|7394500|FG001|Double-blind Period|Miscellaneous Reason|42
4561524|NCT01288911|7394499|FG000|Double-blind Period|Randomized but never received study drug|1
4561525|NCT01288911|7394500|FG001|Double-blind Period|Randomized but never received study drug|2
4561526|NCT01288911|7394499|FG000|Open-label Period (All Enzalutamide)|Death|0
4561527|NCT01288911|7394500|FG001|Open-label Period (All Enzalutamide)|Death|1
4561528|NCT01288911|7394499|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1
4561529|NCT01288911|7394500|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0
4561530|NCT01288911|7394499|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18
4561531|NCT01288911|7394500|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3
4561532|NCT01288911|7394499|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1
4561533|NCT01288911|7394500|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0
4561534|NCT01288911|7394499|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5
4561535|NCT01288911|7394500|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0
4561536|NCT01288911|7394499|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17
4561537|NCT01288911|7394500|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5
4561538|NCT01288937|7394511|FG000|Overall Study|Adverse Event|1
4561539|NCT01288937|7394512|FG001|Overall Study|Adverse Event|0
4561540|NCT01288976|7394521|FG000|Overall Study|Withdrawal by Subject|58
4561541|NCT01288976|7394522|FG001|Overall Study|Withdrawal by Subject|12
4561542|NCT01288976|7394523|FG002|Overall Study|Withdrawal by Subject|9
4561543|NCT01288976|7394521|FG000|Overall Study|Death|98
4561544|NCT01288976|7394522|FG001|Overall Study|Death|6
4561545|NCT01288976|7394523|FG002|Overall Study|Death|4
4561546|NCT01288976|7394521|FG000|Overall Study|Data unavailable|22
4561547|NCT01288976|7394522|FG001|Overall Study|Data unavailable|9
4561548|NCT01288976|7394523|FG002|Overall Study|Data unavailable|7
4561549|NCT01288989|7394534|FG000|Overall Study|Death|0
4561550|NCT01288989|7394535|FG001|Overall Study|Death|0
4561551|NCT01288989|7394536|FG002|Overall Study|Death|0
4561552|NCT01288989|7394537|FG003|Overall Study|Death|1
4561553|NCT01288989|7394538|FG004|Overall Study|Death|0
4561554|NCT01288989|7394534|FG000|Overall Study|Dose limiting toxicity|1
4561555|NCT01288989|7394535|FG001|Overall Study|Dose limiting toxicity|0
4561556|NCT01288989|7394536|FG002|Overall Study|Dose limiting toxicity|0
4561557|NCT01288989|7394537|FG003|Overall Study|Dose limiting toxicity|0
4561558|NCT01288989|7394538|FG004|Overall Study|Dose limiting toxicity|0
4561559|NCT01288989|7394534|FG000|Overall Study|Adverse Event|0
4561560|NCT01288989|7394535|FG001|Overall Study|Adverse Event|0
4561561|NCT01288989|7394536|FG002|Overall Study|Adverse Event|0
4561562|NCT01288989|7394537|FG003|Overall Study|Adverse Event|0
4561563|NCT01288989|7394538|FG004|Overall Study|Adverse Event|2
4561564|NCT01288989|7394534|FG000|Overall Study|Physician Decision|0
4561565|NCT01288989|7394535|FG001|Overall Study|Physician Decision|0
4561566|NCT01288989|7394536|FG002|Overall Study|Physician Decision|0
4561567|NCT01288989|7394537|FG003|Overall Study|Physician Decision|0
4561568|NCT01288989|7394538|FG004|Overall Study|Physician Decision|1
4561569|NCT01288989|7394534|FG000|Overall Study|Withdrawal by Subject|0
4561570|NCT01288989|7394535|FG001|Overall Study|Withdrawal by Subject|0
4561571|NCT01288989|7394536|FG002|Overall Study|Withdrawal by Subject|0
4561572|NCT01288989|7394537|FG003|Overall Study|Withdrawal by Subject|0
4561573|NCT01288989|7394538|FG004|Overall Study|Withdrawal by Subject|3
4561574|NCT01289015|7394558|FG000|Overall Study|Protocol Violation|12
4561575|NCT01289015|7394559|FG001|Overall Study|Protocol Violation|9
4561576|NCT01289015|7394558|FG000|Overall Study|Adverse Event|3
4561577|NCT01289015|7394559|FG001|Overall Study|Adverse Event|0
4561578|NCT01289015|7394558|FG000|Overall Study|Lost to Follow-up|33
4561579|NCT01289015|7394559|FG001|Overall Study|Lost to Follow-up|17
4561580|NCT01289015|7394558|FG000|Overall Study|Withdrawal by Subject|17
4561581|NCT01289015|7394559|FG001|Overall Study|Withdrawal by Subject|8
4561582|NCT01289015|7394558|FG000|Overall Study|Disease progression|1
4561583|NCT01289015|7394559|FG001|Overall Study|Disease progression|0
4561584|NCT01289015|7394558|FG000|Overall Study|Negative baseline culture and others|33
4561585|NCT01289015|7394559|FG001|Overall Study|Negative baseline culture and others|20
4561586|NCT01289028|7394565|FG000|Overall Study|Progressive Disease|49
4623377|NCT01808651|7486767|FG001|Study Period 1|Physician Decision|2
4623378|NCT01808651|7486768|FG002|Study Period 1|Physician Decision|0
4623379|NCT01808651|7486766|FG000|Study Period 1|Lack of Efficacy|2
4623380|NCT01808651|7486767|FG001|Study Period 1|Lack of Efficacy|1
4623381|NCT01808651|7486768|FG002|Study Period 1|Lack of Efficacy|0
4623382|NCT01808651|7486766|FG000|Study Period 1|Adverse Event|10
4623383|NCT01808651|7486767|FG001|Study Period 1|Adverse Event|4
4623384|NCT01808651|7486768|FG002|Study Period 1|Adverse Event|1
4623385|NCT01808651|7486766|FG000|Study Period 1|Participant Decision|9
4623386|NCT01808651|7486767|FG001|Study Period 1|Participant Decision|7
4623387|NCT01808651|7486768|FG002|Study Period 1|Participant Decision|3
4623388|NCT01808690|7486781|FG000|Overall Study|Withdrawal by Subject|1
4623389|NCT01808690|7486782|FG001|Overall Study|Withdrawal by Subject|2
4623390|NCT01809132|7486827|FG000|Overall Study|Withdrawal by Subject|0
4623391|NCT01809132|7486828|FG001|Overall Study|Withdrawal by Subject|0
4623392|NCT01809132|7486829|FG002|Overall Study|Withdrawal by Subject|1
4623393|NCT01809197|7486839|FG000|Overall Study|Lost to Follow-up|4
4623394|NCT01809197|7486840|FG001|Overall Study|Lost to Follow-up|2
4623395|NCT01809197|7486839|FG000|Overall Study|Adverse Event|2
4623396|NCT01809197|7486840|FG001|Overall Study|Adverse Event|3
4623397|NCT01809197|7486839|FG000|Overall Study|Failed slit lamp exam|1
4623398|NCT01809197|7486840|FG001|Overall Study|Failed slit lamp exam|0
4623399|NCT01809197|7486839|FG000|Overall Study|Non-Compliance|1
4623400|NCT01809197|7486840|FG001|Overall Study|Non-Compliance|1
4623401|NCT01809197|7486839|FG000|Overall Study|Decision Unrelated to an Adverse Event|1
4623402|NCT01809197|7486840|FG001|Overall Study|Decision Unrelated to an Adverse Event|0
4623403|NCT01809197|7486839|FG000|Overall Study|Withdrawal by Subject|1
4623404|NCT01809197|7486840|FG001|Overall Study|Withdrawal by Subject|1
4623405|NCT01809197|7486839|FG000|Overall Study|Product not available|0
4623406|NCT01809197|7486840|FG001|Overall Study|Product not available|1
4623407|NCT01809210|7486853|FG000|Overall Study|Withdrawal by Subject|0
4623408|NCT01809210|7486854|FG001|Overall Study|Withdrawal by Subject|0
4623409|NCT01809210|7486855|FG002|Overall Study|Withdrawal by Subject|1
4623410|NCT01809210|7486856|FG003|Overall Study|Withdrawal by Subject|1
4623411|NCT01809210|7486857|FG004|Overall Study|Withdrawal by Subject|1
4623412|NCT01809210|7486858|FG005|Overall Study|Withdrawal by Subject|0
4561587|NCT01289028|7394565|FG000|Overall Study|Adverse Event|14
4623413|NCT01809210|7486859|FG006|Overall Study|Withdrawal by Subject|4
4623414|NCT01809210|7486853|FG000|Overall Study|Death|1
4623415|NCT01809210|7486854|FG001|Overall Study|Death|1
4623416|NCT01809210|7486855|FG002|Overall Study|Death|2
4623417|NCT01809210|7486856|FG003|Overall Study|Death|0
4561588|NCT01289028|7394565|FG000|Overall Study|Withdrawal by Subject|6
4561589|NCT01289028|7394565|FG000|Overall Study|Death|4
4561590|NCT01289028|7394565|FG000|Overall Study|Lack of Efficacy|2
4561591|NCT01289028|7394565|FG000|Overall Study|No longer required|2
4561592|NCT01289028|7394565|FG000|Overall Study|Lost to Follow-up|2
4561593|NCT01289028|7394565|FG000|Overall Study|New Cancer Therapy|2
4561594|NCT01289028|7394565|FG000|Overall Study|Abnormal Lab Value|1
4561595|NCT01289028|7394565|FG000|Overall Study|Missing reason for discon|1
4561596|NCT01289041|7394571|FG000|Overall Study|Adverse Event|24
4561597|NCT01289041|7394571|FG000|Overall Study|Physician Decision|1
4561598|NCT01289041|7394571|FG000|Overall Study|Progressive Disease|41
4561599|NCT01289041|7394571|FG000|Overall Study|Withdrawal by Subject|3
4561600|NCT01289041|7394571|FG000|Overall Study|Death|1
4561601|NCT01289119|7394597|FG000|Overall Study|Adverse Event|2
4561602|NCT01289119|7394598|FG001|Overall Study|Adverse Event|1
4561603|NCT01289119|7394599|FG002|Overall Study|Adverse Event|0
4561604|NCT01289119|7394600|FG003|Overall Study|Adverse Event|2
4561605|NCT01289119|7394601|FG004|Overall Study|Adverse Event|1
4561606|NCT01289119|7394602|FG005|Overall Study|Adverse Event|0
4561607|NCT01289119|7394597|FG000|Overall Study|Major Protocol Deviation|2
4561608|NCT01289119|7394598|FG001|Overall Study|Major Protocol Deviation|1
4561609|NCT01289119|7394599|FG002|Overall Study|Major Protocol Deviation|3
4561610|NCT01289119|7394600|FG003|Overall Study|Major Protocol Deviation|0
4561611|NCT01289119|7394601|FG004|Overall Study|Major Protocol Deviation|2
4561612|NCT01289119|7394602|FG005|Overall Study|Major Protocol Deviation|1
4561613|NCT01289119|7394597|FG000|Overall Study|Lost to Follow-up|0
4561614|NCT01289119|7394598|FG001|Overall Study|Lost to Follow-up|3
4561615|NCT01289119|7394599|FG002|Overall Study|Lost to Follow-up|0
4561616|NCT01289119|7394600|FG003|Overall Study|Lost to Follow-up|0
4623418|NCT01809210|7486857|FG004|Overall Study|Death|1
4623419|NCT01809210|7486858|FG005|Overall Study|Death|3
4623420|NCT01809210|7486859|FG006|Overall Study|Death|1
4623421|NCT01809262|7486875|FG000|Period 1 (First Dose + Washout)|Adverse Event|0
4623422|NCT01809262|7486876|FG001|Period 1 (First Dose + Washout)|Adverse Event|0
4623423|NCT01809262|7486877|FG002|Period 1 (First Dose + Washout)|Adverse Event|0
4623424|NCT01809262|7486878|FG003|Period 1 (First Dose + Washout)|Adverse Event|0
4623425|NCT01809262|7486879|FG004|Period 1 (First Dose + Washout)|Adverse Event|1
4623426|NCT01809262|7486880|FG005|Period 1 (First Dose + Washout)|Adverse Event|0
4623427|NCT01809262|7486881|FG006|Period 1 (First Dose + Washout)|Adverse Event|0
4623428|NCT01809262|7486882|FG007|Period 1 (First Dose + Washout)|Adverse Event|0
4623429|NCT01809262|7486883|FG008|Period 1 (First Dose + Washout)|Adverse Event|0
4623430|NCT01809262|7486884|FG009|Period 1 (First Dose + Washout)|Adverse Event|0
4623431|NCT01809262|7486875|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0
4623432|NCT01809262|7486876|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1
4623433|NCT01809262|7486877|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0
4623434|NCT01809262|7486878|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0
4623435|NCT01809262|7486879|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0
4623436|NCT01809262|7486880|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0
4623437|NCT01809262|7486881|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0
4623438|NCT01809262|7486882|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0
4623439|NCT01809262|7486883|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0
4623440|NCT01809262|7486884|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0
4623441|NCT01809314|7486896|FG000|Overall Study|Withdrawal Prior to Treatment|1
4623442|NCT01809314|7486896|FG000|Overall Study|Adverse Event|6
4623443|NCT01809314|7486896|FG000|Overall Study|Insufficient Therapeutic Response|14
4623444|NCT01809314|7486896|FG000|Overall Study|Lost to Follow-up|724
4623445|NCT01809327|7486905|FG000|Overall Study|Lost to Follow-up|5
4623446|NCT01809327|7486906|FG001|Overall Study|Lost to Follow-up|2
4623447|NCT01809327|7486907|FG002|Overall Study|Lost to Follow-up|4
4623448|NCT01809327|7486908|FG003|Overall Study|Lost to Follow-up|2
4623449|NCT01809327|7486909|FG004|Overall Study|Lost to Follow-up|3
4623450|NCT01809327|7486905|FG000|Overall Study|Withdrawal by Subject|6
4623451|NCT01809327|7486906|FG001|Overall Study|Withdrawal by Subject|4
4623452|NCT01809327|7486907|FG002|Overall Study|Withdrawal by Subject|4
4623453|NCT01809327|7486908|FG003|Overall Study|Withdrawal by Subject|2
4623454|NCT01809327|7486909|FG004|Overall Study|Withdrawal by Subject|5
4623455|NCT01809327|7486905|FG000|Overall Study|Adverse Event|4
4623456|NCT01809327|7486906|FG001|Overall Study|Adverse Event|3
4623457|NCT01809327|7486907|FG002|Overall Study|Adverse Event|7
4623458|NCT01809327|7486908|FG003|Overall Study|Adverse Event|4
4623459|NCT01809327|7486909|FG004|Overall Study|Adverse Event|8
4623460|NCT01809327|7486905|FG000|Overall Study|Death|1
4623461|NCT01809327|7486906|FG001|Overall Study|Death|0
4623462|NCT01809327|7486907|FG002|Overall Study|Death|0
4623463|NCT01809327|7486908|FG003|Overall Study|Death|0
4623464|NCT01809327|7486909|FG004|Overall Study|Death|0
4623465|NCT01809327|7486905|FG000|Overall Study|Protocol Violation|0
4623466|NCT01809327|7486906|FG001|Overall Study|Protocol Violation|1
4561617|NCT01289119|7394601|FG004|Overall Study|Lost to Follow-up|0
4561618|NCT01289119|7394602|FG005|Overall Study|Lost to Follow-up|1
4561619|NCT01289119|7394597|FG000|Overall Study|Withdrawal by Subject|4
4561620|NCT01289119|7394598|FG001|Overall Study|Withdrawal by Subject|2
4561621|NCT01289119|7394599|FG002|Overall Study|Withdrawal by Subject|4
4623467|NCT01809327|7486907|FG002|Overall Study|Protocol Violation|0
4623468|NCT01809327|7486908|FG003|Overall Study|Protocol Violation|0
4623469|NCT01809327|7486909|FG004|Overall Study|Protocol Violation|0
4561622|NCT01289119|7394600|FG003|Overall Study|Withdrawal by Subject|3
4561623|NCT01289119|7394601|FG004|Overall Study|Withdrawal by Subject|1
4561624|NCT01289119|7394602|FG005|Overall Study|Withdrawal by Subject|1
4561625|NCT01289119|7394597|FG000|Overall Study|Pregnancy|0
4561626|NCT01289119|7394598|FG001|Overall Study|Pregnancy|1
4561627|NCT01289119|7394599|FG002|Overall Study|Pregnancy|0
4561628|NCT01289119|7394600|FG003|Overall Study|Pregnancy|0
4561629|NCT01289119|7394601|FG004|Overall Study|Pregnancy|0
4561630|NCT01289119|7394602|FG005|Overall Study|Pregnancy|0
4561631|NCT01289119|7394597|FG000|Overall Study|Lack of Efficacy|0
4561632|NCT01289119|7394598|FG001|Overall Study|Lack of Efficacy|1
4561633|NCT01289119|7394599|FG002|Overall Study|Lack of Efficacy|1
4561634|NCT01289119|7394600|FG003|Overall Study|Lack of Efficacy|1
4561635|NCT01289119|7394601|FG004|Overall Study|Lack of Efficacy|1
4561636|NCT01289119|7394602|FG005|Overall Study|Lack of Efficacy|1
4561637|NCT01289119|7394597|FG000|Overall Study|Other|1
4561638|NCT01289119|7394598|FG001|Overall Study|Other|0
4561639|NCT01289119|7394599|FG002|Overall Study|Other|1
4561640|NCT01289119|7394600|FG003|Overall Study|Other|0
4561641|NCT01289119|7394601|FG004|Overall Study|Other|0
4561642|NCT01289119|7394602|FG005|Overall Study|Other|0
4561643|NCT01289210|7394616|FG000|Overall Study|Adverse Event|1
4561644|NCT01289353|7394641|FG000|Overall Study|Lost to Follow-up|2
4561645|NCT01289418|7394661|FG000|Day 8 Survey|email address invalid|283
4561646|NCT01289418|7394661|FG000|Day 8 Survey|participants did not complete the survey|1935
4561647|NCT01289418|7394661|FG000|Day 29 Survey|email address invalid|283
4561648|NCT01289418|7394661|FG000|Day 29 Survey|participants did not complete the survey|2185
4561649|NCT01289574|7394729|FG000|Overall Study|Lack of Efficacy|4
4623470|NCT01809327|7486905|FG000|Overall Study|Physician Decision|1
4623471|NCT01809327|7486906|FG001|Overall Study|Physician Decision|1
4623472|NCT01809327|7486907|FG002|Overall Study|Physician Decision|0
4623473|NCT01809327|7486908|FG003|Overall Study|Physician Decision|0
4623474|NCT01809327|7486909|FG004|Overall Study|Physician Decision|0
4623475|NCT01809327|7486905|FG000|Overall Study|Pregnancy|1
4623476|NCT01809327|7486906|FG001|Overall Study|Pregnancy|0
4623477|NCT01809327|7486907|FG002|Overall Study|Pregnancy|0
4623478|NCT01809327|7486908|FG003|Overall Study|Pregnancy|0
4623479|NCT01809327|7486909|FG004|Overall Study|Pregnancy|0
4623480|NCT01809327|7486905|FG000|Overall Study|Other|14
4623481|NCT01809327|7486906|FG001|Overall Study|Other|15
4623482|NCT01809327|7486907|FG002|Overall Study|Other|7
4623483|NCT01809327|7486908|FG003|Overall Study|Other|4
4623484|NCT01809327|7486909|FG004|Overall Study|Other|9
4623485|NCT01810016|7486945|FG000|Overall Study|Progressive disease|1
4623486|NCT01810016|7486946|FG001|Overall Study|Progressive disease|1
4623487|NCT01810016|7486947|FG002|Overall Study|Progressive disease|0
4623488|NCT01810016|7486945|FG000|Overall Study|Death|0
4623489|NCT01810016|7486946|FG001|Overall Study|Death|0
4623490|NCT01810016|7486947|FG002|Overall Study|Death|1
4633107|NCT01908634|7503070|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5
4633108|NCT01908699|7503080|FG000|Overall Study|Adverse Event|8
4633109|NCT01908699|7503081|FG001|Overall Study|Adverse Event|12
4633110|NCT01908699|7503080|FG000|Overall Study|Lack of Efficacy|2
4633111|NCT01908699|7503081|FG001|Overall Study|Lack of Efficacy|2
4633112|NCT01908699|7503080|FG000|Overall Study|Lost to Follow-up|2
4633113|NCT01908699|7503081|FG001|Overall Study|Lost to Follow-up|4
4633114|NCT01908699|7503080|FG000|Overall Study|Physician Decision|8
4633115|NCT01908699|7503081|FG001|Overall Study|Physician Decision|8
4633116|NCT01908699|7503080|FG000|Overall Study|Withdrawal by Subject|15
4633117|NCT01908699|7503081|FG001|Overall Study|Withdrawal by Subject|10
4633118|NCT01908699|7503080|FG000|Overall Study|Pregnancy|0
4633119|NCT01908699|7503081|FG001|Overall Study|Pregnancy|1
4633120|NCT01908699|7503080|FG000|Overall Study|Randomized in Error|1
4633121|NCT01908699|7503081|FG001|Overall Study|Randomized in Error|0
4633122|NCT01908699|7503080|FG000|Overall Study|Death|9
4633123|NCT01908699|7503081|FG001|Overall Study|Death|12
4633124|NCT01908699|7503080|FG000|Overall Study|Progressive Disease|30
4633125|NCT01908699|7503081|FG001|Overall Study|Progressive Disease|29
4633388|NCT01911780|7503566|FG000|Double-blind Period (8 Weeks)|Adverse Event|1
4633389|NCT01911780|7503567|FG001|Double-blind Period (8 Weeks)|Adverse Event|2
4633390|NCT01911780|7503566|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1
4561650|NCT01289574|7394730|FG001|Overall Study|Lack of Efficacy|0
4561651|NCT01289574|7394731|FG002|Overall Study|Lack of Efficacy|1
4561652|NCT01289574|7394729|FG000|Overall Study|Lost to Follow-up|2
4633391|NCT01911780|7503567|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1
4633392|NCT01911780|7503566|FG000|Double-blind Period (8 Weeks)|Personal reason|1
4633393|NCT01911780|7503567|FG001|Double-blind Period (8 Weeks)|Personal reason|0
4633394|NCT01911780|7503566|FG000|Extension Period (52 Weeks)|Adverse Event|3
4633395|NCT01911780|7503567|FG001|Extension Period (52 Weeks)|Adverse Event|0
4561653|NCT01289574|7394730|FG001|Overall Study|Lost to Follow-up|0
4561654|NCT01289574|7394731|FG002|Overall Study|Lost to Follow-up|1
4561655|NCT01289574|7394729|FG000|Overall Study|Withdrawal by Subject|1
4561656|NCT01289574|7394730|FG001|Overall Study|Withdrawal by Subject|1
4561657|NCT01289574|7394731|FG002|Overall Study|Withdrawal by Subject|1
4633396|NCT01911780|7503566|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0
4633397|NCT01911780|7503567|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2
4633398|NCT01911780|7503566|FG000|Extension Period (52 Weeks)|Personal reason|1
4633399|NCT01911780|7503567|FG001|Extension Period (52 Weeks)|Personal reason|1
4561658|NCT01289574|7394729|FG000|Overall Study|Adverse Event|0
4561659|NCT01289574|7394730|FG001|Overall Study|Adverse Event|1
4561660|NCT01289574|7394731|FG002|Overall Study|Adverse Event|0
4561661|NCT01289574|7394729|FG000|Overall Study|Subject wanted alternate treatment|0
4561662|NCT01289574|7394730|FG001|Overall Study|Subject wanted alternate treatment|1
4561663|NCT01289574|7394731|FG002|Overall Study|Subject wanted alternate treatment|0
4561664|NCT01289639|7394743|FG000|Overall Study|Lost to Follow-up|1
4561665|NCT01289639|7394744|FG001|Overall Study|Lost to Follow-up|0
4561666|NCT01289639|7394745|FG002|Overall Study|Lost to Follow-up|0
4592336|NCT01539291|7439759|FG002|Study GS-US-312-0117|Withdrawal by Subject|6
4592337|NCT01539291|7439760|FG003|Study GS-US-312-0117|Withdrawal by Subject|4
4592338|NCT01539291|7439757|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3
4592339|NCT01539291|7439758|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0
4623491|NCT01810042|7486955|FG000|Overall Study|Lost to Follow-up|10
4623492|NCT01810263|7486961|FG000|Overall Study|Lost to Follow-up|8
4623493|NCT01810263|7486962|FG001|Overall Study|Lost to Follow-up|7
4623494|NCT01810380|7486980|FG000|Overall Study|Randomised not treated|2
4623495|NCT01810380|7486981|FG001|Overall Study|Randomised not treated|1
4623496|NCT01810380|7486982|FG002|Overall Study|Randomised not treated|1
4623497|NCT01810380|7486980|FG000|Overall Study|Adverse Event|11
4623498|NCT01810380|7486981|FG001|Overall Study|Adverse Event|14
4623499|NCT01810380|7486982|FG002|Overall Study|Adverse Event|4
4623500|NCT01810380|7486980|FG000|Overall Study|Lack of Efficacy|24
4623501|NCT01810380|7486981|FG001|Overall Study|Lack of Efficacy|10
4623502|NCT01810380|7486982|FG002|Overall Study|Lack of Efficacy|11
4623503|NCT01810380|7486980|FG000|Overall Study|Protocol Violation|1
4623504|NCT01810380|7486981|FG001|Overall Study|Protocol Violation|0
4623505|NCT01810380|7486982|FG002|Overall Study|Protocol Violation|1
4623506|NCT01810380|7486980|FG000|Overall Study|Withdrawal by Subject|6
4623507|NCT01810380|7486981|FG001|Overall Study|Withdrawal by Subject|0
4623508|NCT01810380|7486982|FG002|Overall Study|Withdrawal by Subject|6
4623509|NCT01810380|7486980|FG000|Overall Study|Administrative or other reasons|11
4623510|NCT01810380|7486981|FG001|Overall Study|Administrative or other reasons|13
4623511|NCT01810380|7486982|FG002|Overall Study|Administrative or other reasons|9
4623512|NCT01810432|7486990|FG000|Washout|Protocol Violation|0
4623513|NCT01810432|7486991|FG001|Washout|Protocol Violation|1
4623514|NCT01810432|7486990|FG000|Washout|Adverse Event|1
4623515|NCT01810432|7486991|FG001|Washout|Adverse Event|0
4623516|NCT01810432|7486990|FG000|Period 2|Withdrawal by Subject|2
4623517|NCT01810432|7486991|FG001|Period 2|Withdrawal by Subject|1
4623518|NCT01810432|7486990|FG000|Period 2|Physician Decision|1
4623519|NCT01810432|7486991|FG001|Period 2|Physician Decision|0
4623520|NCT01810432|7486990|FG000|Period 2|Lost to Follow-up|1
4623521|NCT01810432|7486991|FG001|Period 2|Lost to Follow-up|1
4623522|NCT01810783|7487010|FG000|Overall Study|Adverse Event|32
4623523|NCT01810783|7487010|FG000|Overall Study|Withdrawal by Subject|22
4623524|NCT01810783|7487010|FG000|Overall Study|Lack of Efficacy|12
4623525|NCT01810783|7487010|FG000|Overall Study|Lost to Follow-up|10
4623526|NCT01810783|7487010|FG000|Overall Study|Protocol Violation|5
4623527|NCT01810783|7487010|FG000|Overall Study|Non-compliance with IMP|4
4623528|NCT01810783|7487010|FG000|Overall Study|Adminstrative or other reason(s)|23
4623529|NCT01810783|7487010|FG000|Overall Study|Enrolled, not treated|1
4623530|NCT01810939|7487014|FG000|Part A Treatment Period|Non-compliance with Study Drug|1
4623531|NCT01810939|7487015|FG001|Part A Treatment Period|Non-compliance with Study Drug|0
4623532|NCT01810939|7487016|FG002|Part A Treatment Period|Non-compliance with Study Drug|0
4623533|NCT01810939|7487014|FG000|Part A Treatment Period|Protocol Violation|2
4623534|NCT01810939|7487015|FG001|Part A Treatment Period|Protocol Violation|0
4623535|NCT01810939|7487016|FG002|Part A Treatment Period|Protocol Violation|0
4623536|NCT01810939|7487014|FG000|Part A Treatment Period|Adverse Event|10
4623537|NCT01810939|7487015|FG001|Part A Treatment Period|Adverse Event|0
4623538|NCT01810939|7487016|FG002|Part A Treatment Period|Adverse Event|0
4623539|NCT01810939|7487014|FG000|Part A Treatment Period|Withdrawal by Subject|5
4623540|NCT01810939|7487015|FG001|Part A Treatment Period|Withdrawal by Subject|0
4623541|NCT01810939|7487016|FG002|Part A Treatment Period|Withdrawal by Subject|0
4623542|NCT01810939|7487014|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2
4623543|NCT01810939|7487015|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0
4623544|NCT01810939|7487016|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0
4623545|NCT01810939|7487014|FG000|Part A Treatment Period|Protocol-specified (High K+)|3
4623546|NCT01810939|7487015|FG001|Part A Treatment Period|Protocol-specified (High K+)|0
4623547|NCT01810939|7487016|FG002|Part A Treatment Period|Protocol-specified (High K+)|0
4623548|NCT01810939|7487014|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1
4623549|NCT01810939|7487015|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0
4623550|NCT01810939|7487016|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0
4623551|NCT01810939|7487014|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0
4623552|NCT01810939|7487015|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1
4623553|NCT01810939|7487016|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1
4623554|NCT01810939|7487014|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0
4592340|NCT01539291|7439759|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0
4592341|NCT01539291|7439760|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5
4561667|NCT01289678|7394762|FG000|Overall Study|Physician Decision|6
4561668|NCT01289782|7394768|FG000|Overall Study|Lost to Follow-up|14
4561669|NCT01289782|7394769|FG001|Overall Study|Lost to Follow-up|7
4561670|NCT01289782|7394768|FG000|Overall Study|Protocol Violation|1
4561671|NCT01289782|7394769|FG001|Overall Study|Protocol Violation|1
4561672|NCT01289782|7394768|FG000|Overall Study|Withdrawal by Subject|8
4561673|NCT01289782|7394769|FG001|Overall Study|Withdrawal by Subject|2
4561674|NCT01289782|7394768|FG000|Overall Study|Sponsor's Decision|1
4561675|NCT01289782|7394769|FG001|Overall Study|Sponsor's Decision|0
4561676|NCT01289782|7394768|FG000|Overall Study|Reason not specified|1
4561677|NCT01289782|7394769|FG001|Overall Study|Reason not specified|2
4561678|NCT01289821|7394775|FG000|Treatment Period|Withdrawal by Subject|1
4561679|NCT01289821|7394775|FG000|Treatment Period|Physician Decision|3
4561680|NCT01289821|7394775|FG000|Treatment Period|Adverse Event|4
4561681|NCT01289821|7394775|FG000|Treatment Period|Radiological Progression|43
4561682|NCT01289821|7394775|FG000|Treatment Period|Clinical Progression|2
4561683|NCT01289821|7394775|FG000|Treatment Period|Therapeutic procedure required|1
4561684|NCT01289821|7394775|FG000|Safety Follow-up Period|Withdrawal by Subject|1
4561685|NCT01289821|7394775|FG000|Safety Follow-up Period|Protocol Violation|3
4561686|NCT01289821|7394775|FG000|Safety Follow-up Period|Unspecified reason|1
4561687|NCT01289821|7394775|FG000|Survival Follow-up Period|Protocol Violation|1
4561688|NCT01289821|7394775|FG000|Survival Follow-up Period|Lost to Follow-up|1
4561689|NCT01289821|7394775|FG000|Survival Follow-up Period|Clinical endpoint reached|16
4561690|NCT01289847|7394779|FG000|Overall Study|Patient could not comply with visits|1
4561691|NCT01289990|7394815|FG000|Overall Study|Death|0
4561692|NCT01289990|7394816|FG001|Overall Study|Death|0
4561693|NCT01289990|7394817|FG002|Overall Study|Death|0
4561694|NCT01289990|7394818|FG003|Overall Study|Death|1
4561695|NCT01289990|7394819|FG004|Overall Study|Death|2
4561696|NCT01289990|7394820|FG005|Overall Study|Death|1
4623555|NCT01810939|7487015|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1
4623556|NCT01810939|7487016|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0
4623557|NCT01810939|7487014|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0
4623558|NCT01810939|7487015|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1
4623559|NCT01810939|7487016|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1
4623560|NCT01810939|7487014|FG000|Part B Placebo-Controlled Withdrawal|Death|0
4623561|NCT01810939|7487015|FG001|Part B Placebo-Controlled Withdrawal|Death|0
4623562|NCT01810939|7487016|FG002|Part B Placebo-Controlled Withdrawal|Death|1
4623563|NCT01810939|7487014|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0
4623564|NCT01810939|7487015|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0
4623565|NCT01810939|7487016|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1
4623566|NCT01810939|7487014|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0
4623567|NCT01810939|7487015|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1
4623568|NCT01810939|7487016|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1
4623569|NCT01810939|7487014|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0
4623570|NCT01810939|7487015|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1
4623571|NCT01810939|7487016|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2
4623572|NCT01810939|7487014|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0
4623573|NCT01810939|7487015|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2
4623574|NCT01810939|7487016|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14
4623575|NCT01810939|7487014|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0
4623576|NCT01810939|7487015|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2
4623577|NCT01810939|7487016|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1
4623578|NCT01810939|7487014|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0
4623579|NCT01810939|7487015|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1
4623580|NCT01810939|7487016|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0
4623581|NCT01811186|7487078|FG000|Overall Study|Adverse Event|54
4623582|NCT01811186|7487079|FG001|Overall Study|Adverse Event|38
4623583|NCT01811186|7487078|FG000|Overall Study|Protocol Violation|5
4623584|NCT01811186|7487079|FG001|Overall Study|Protocol Violation|6
4623585|NCT01811186|7487078|FG000|Overall Study|Withdrawal by Subject|5
4623586|NCT01811186|7487079|FG001|Overall Study|Withdrawal by Subject|10
4623587|NCT01811186|7487078|FG000|Overall Study|Lack of Efficacy|3
4623588|NCT01811186|7487079|FG001|Overall Study|Lack of Efficacy|6
4623589|NCT01811186|7487078|FG000|Overall Study|Lost to Follow-up|4
4623590|NCT01811186|7487079|FG001|Overall Study|Lost to Follow-up|2
4623591|NCT01811225|7487093|FG000|Treatment Period 1|Adverse Event|2
4623592|NCT01811225|7487094|FG001|Treatment Period 1|Adverse Event|3
4623593|NCT01811225|7487093|FG000|Treatment Period 1|Lost to Follow-up|12
4623594|NCT01811225|7487094|FG001|Treatment Period 1|Lost to Follow-up|8
4623595|NCT01811225|7487093|FG000|Treatment Period 1|transporation|1
4623596|NCT01811225|7487094|FG001|Treatment Period 1|transporation|0
4623597|NCT01811225|7487093|FG000|Treatment Period 1|unable to remain smoke free overnight|10
4623598|NCT01811225|7487094|FG001|Treatment Period 1|unable to remain smoke free overnight|6
4561697|NCT01289990|7394821|FG006|Overall Study|Death|0
4623599|NCT01811225|7487093|FG000|Treatment Period 2|Lost to Follow-up|1
4561698|NCT01289990|7394822|FG007|Overall Study|Death|0
4561699|NCT01289990|7394823|FG008|Overall Study|Death|0
4561700|NCT01289990|7394824|FG009|Overall Study|Death|0
4561701|NCT01289990|7394825|FG010|Overall Study|Death|0
4561702|NCT01289990|7394826|FG011|Overall Study|Death|1
4561703|NCT01289990|7394827|FG012|Overall Study|Death|0
4561704|NCT01289990|7394815|FG000|Overall Study|Lost to Follow-up|3
4561705|NCT01289990|7394816|FG001|Overall Study|Lost to Follow-up|2
4561706|NCT01289990|7394817|FG002|Overall Study|Lost to Follow-up|5
4561707|NCT01289990|7394818|FG003|Overall Study|Lost to Follow-up|5
4561708|NCT01289990|7394819|FG004|Overall Study|Lost to Follow-up|3
4561709|NCT01289990|7394820|FG005|Overall Study|Lost to Follow-up|4
4561710|NCT01289990|7394821|FG006|Overall Study|Lost to Follow-up|2
4561711|NCT01289990|7394822|FG007|Overall Study|Lost to Follow-up|2
4561712|NCT01289990|7394823|FG008|Overall Study|Lost to Follow-up|1
4561713|NCT01289990|7394824|FG009|Overall Study|Lost to Follow-up|4
4561714|NCT01289990|7394825|FG010|Overall Study|Lost to Follow-up|2
4561715|NCT01289990|7394826|FG011|Overall Study|Lost to Follow-up|1
4561716|NCT01289990|7394827|FG012|Overall Study|Lost to Follow-up|2
4561717|NCT01289990|7394815|FG000|Overall Study|Withdrawal by Subject|15
4561718|NCT01289990|7394816|FG001|Overall Study|Withdrawal by Subject|14
4561719|NCT01289990|7394817|FG002|Overall Study|Withdrawal by Subject|12
4561720|NCT01289990|7394818|FG003|Overall Study|Withdrawal by Subject|13
4561721|NCT01289990|7394819|FG004|Overall Study|Withdrawal by Subject|8
4561722|NCT01289990|7394820|FG005|Overall Study|Withdrawal by Subject|7
4561723|NCT01289990|7394821|FG006|Overall Study|Withdrawal by Subject|13
4561724|NCT01289990|7394822|FG007|Overall Study|Withdrawal by Subject|9
4561725|NCT01289990|7394823|FG008|Overall Study|Withdrawal by Subject|12
4561726|NCT01289990|7394824|FG009|Overall Study|Withdrawal by Subject|13
4561727|NCT01289990|7394825|FG010|Overall Study|Withdrawal by Subject|11
4561728|NCT01289990|7394826|FG011|Overall Study|Withdrawal by Subject|13
4561729|NCT01289990|7394827|FG012|Overall Study|Withdrawal by Subject|16
4561730|NCT01289990|7394815|FG000|Overall Study|discontinued in preceding trial|18
4561731|NCT01289990|7394816|FG001|Overall Study|discontinued in preceding trial|20
4561732|NCT01289990|7394817|FG002|Overall Study|discontinued in preceding trial|41
4561733|NCT01289990|7394818|FG003|Overall Study|discontinued in preceding trial|17
4561734|NCT01289990|7394819|FG004|Overall Study|discontinued in preceding trial|11
4561735|NCT01289990|7394820|FG005|Overall Study|discontinued in preceding trial|12
4561736|NCT01289990|7394821|FG006|Overall Study|discontinued in preceding trial|18
4561737|NCT01289990|7394822|FG007|Overall Study|discontinued in preceding trial|8
4561738|NCT01289990|7394823|FG008|Overall Study|discontinued in preceding trial|17
4561739|NCT01289990|7394824|FG009|Overall Study|discontinued in preceding trial|21
4561740|NCT01289990|7394825|FG010|Overall Study|discontinued in preceding trial|17
4561741|NCT01289990|7394826|FG011|Overall Study|discontinued in preceding trial|17
4561742|NCT01289990|7394827|FG012|Overall Study|discontinued in preceding trial|24
4561743|NCT01289990|7394815|FG000|Overall Study|did not continue in extension|41
4561744|NCT01289990|7394816|FG001|Overall Study|did not continue in extension|45
4561745|NCT01289990|7394817|FG002|Overall Study|did not continue in extension|51
4561746|NCT01289990|7394818|FG003|Overall Study|did not continue in extension|51
4561747|NCT01289990|7394819|FG004|Overall Study|did not continue in extension|48
4561748|NCT01289990|7394820|FG005|Overall Study|did not continue in extension|50
4623600|NCT01811225|7487094|FG001|Treatment Period 2|Lost to Follow-up|2
4623601|NCT01811225|7487093|FG000|Treatment Period 2|unable to remain smoke free overnight|3
4623602|NCT01811225|7487094|FG001|Treatment Period 2|unable to remain smoke free overnight|4
4623603|NCT01811238|7487100|FG000|Overall Study|Withdrawal by Subject|42
4623604|NCT01811238|7487100|FG000|Overall Study|Adverse Event|25
4623605|NCT01811238|7487100|FG000|Overall Study|Protocol Violation|4
4623606|NCT01811238|7487100|FG000|Overall Study|Lack of Efficacy|4
4623607|NCT01811238|7487100|FG000|Overall Study|subject refused study medication|6
4623608|NCT01811472|7487141|FG000|Overall Study|Adverse Event|1
4623609|NCT01811472|7487142|FG001|Overall Study|Adverse Event|0
4623610|NCT01811472|7487143|FG002|Overall Study|Adverse Event|4
4623611|NCT01811472|7487141|FG000|Overall Study|Lost to Follow-up|0
4623612|NCT01811472|7487142|FG001|Overall Study|Lost to Follow-up|0
4623613|NCT01811472|7487143|FG002|Overall Study|Lost to Follow-up|1
4623614|NCT01811472|7487141|FG000|Overall Study|Subject/guardian decision|1
4623615|NCT01811472|7487142|FG001|Overall Study|Subject/guardian decision|0
4623616|NCT01811472|7487143|FG002|Overall Study|Subject/guardian decision|0
4623617|NCT01811485|7487155|FG000|Overall Study|Adverse Event|1
4623618|NCT01811485|7487156|FG001|Overall Study|Adverse Event|3
4623619|NCT01811485|7487157|FG002|Overall Study|Adverse Event|2
4623620|NCT01811485|7487155|FG000|Overall Study|Unsatisfactory therapeutic effect|0
4623621|NCT01811485|7487156|FG001|Overall Study|Unsatisfactory therapeutic effect|0
4561749|NCT01289990|7394821|FG006|Overall Study|did not continue in extension|54
4561750|NCT01289990|7394822|FG007|Overall Study|did not continue in extension|36
4561751|NCT01289990|7394823|FG008|Overall Study|did not continue in extension|44
4623622|NCT01811485|7487157|FG002|Overall Study|Unsatisfactory therapeutic effect|3
4623623|NCT01811485|7487155|FG000|Overall Study|Administrative problems|1
4623624|NCT01811485|7487156|FG001|Overall Study|Administrative problems|0
4623625|NCT01811485|7487157|FG002|Overall Study|Administrative problems|0
4623626|NCT01811485|7487155|FG000|Overall Study|Protocol Deviation|0
4623627|NCT01811485|7487156|FG001|Overall Study|Protocol Deviation|1
4623628|NCT01811485|7487157|FG002|Overall Study|Protocol Deviation|0
4561752|NCT01289990|7394824|FG009|Overall Study|did not continue in extension|48
4561753|NCT01289990|7394825|FG010|Overall Study|did not continue in extension|45
4561754|NCT01289990|7394826|FG011|Overall Study|did not continue in extension|34
4561755|NCT01289990|7394827|FG012|Overall Study|did not continue in extension|56
4561756|NCT01289990|7394815|FG000|Overall Study|Not treated|0
4561757|NCT01289990|7394816|FG001|Overall Study|Not treated|0
4561758|NCT01289990|7394817|FG002|Overall Study|Not treated|0
4561759|NCT01289990|7394818|FG003|Overall Study|Not treated|0
4561760|NCT01289990|7394819|FG004|Overall Study|Not treated|0
4561761|NCT01289990|7394820|FG005|Overall Study|Not treated|0
4561762|NCT01289990|7394821|FG006|Overall Study|Not treated|1
4561763|NCT01289990|7394822|FG007|Overall Study|Not treated|0
4561764|NCT01289990|7394823|FG008|Overall Study|Not treated|1
4561765|NCT01289990|7394824|FG009|Overall Study|Not treated|0
4561766|NCT01289990|7394825|FG010|Overall Study|Not treated|1
4561767|NCT01289990|7394826|FG011|Overall Study|Not treated|2
4561768|NCT01289990|7394827|FG012|Overall Study|Not treated|0
4561769|NCT01290029|7394855|FG000|Overall Study|Other|2
4561770|NCT01290068|7394861|FG000|Overall Study|Adverse Event|1
4561771|NCT01290068|7394862|FG001|Overall Study|Adverse Event|3
4561772|NCT01290068|7394861|FG000|Overall Study|Lost to Follow-up|3
4561773|NCT01290068|7394862|FG001|Overall Study|Lost to Follow-up|0
4561774|NCT01290068|7394861|FG000|Overall Study|Withdrawal by subject prior to implant|0
4561775|NCT01290068|7394862|FG001|Overall Study|Withdrawal by subject prior to implant|2
4561776|NCT01290068|7394861|FG000|Overall Study|Other|3
4561777|NCT01290068|7394862|FG001|Overall Study|Other|1
4561778|NCT01290094|7394868|FG000|Overall Study|Withdrawal by Subject|1
4561779|NCT01290094|7394868|FG000|Overall Study|Lost to Follow-up|5
4561780|NCT01290224|7394872|FG000|Overall Study|Adverse Event|1
4561781|NCT01290224|7394872|FG000|Overall Study|Refused Further Treatment|4
4561782|NCT01290263|7394891|FG000|Overall Study|Adverse Event|0
4561783|NCT01290263|7394892|FG001|Overall Study|Adverse Event|0
4561784|NCT01290263|7394893|FG002|Overall Study|Adverse Event|0
4561785|NCT01290263|7394894|FG003|Overall Study|Adverse Event|1
4561786|NCT01290263|7394895|FG004|Overall Study|Adverse Event|1
4561787|NCT01290263|7394891|FG000|Overall Study|Lack of Efficacy|8
4561788|NCT01290263|7394892|FG001|Overall Study|Lack of Efficacy|2
4561789|NCT01290263|7394893|FG002|Overall Study|Lack of Efficacy|7
4561790|NCT01290263|7394894|FG003|Overall Study|Lack of Efficacy|24
4561791|NCT01290263|7394895|FG004|Overall Study|Lack of Efficacy|33
4561792|NCT01290263|7394891|FG000|Overall Study|Withdrawal by Subject|3
4561793|NCT01290263|7394892|FG001|Overall Study|Withdrawal by Subject|1
4561794|NCT01290263|7394893|FG002|Overall Study|Withdrawal by Subject|0
4561795|NCT01290263|7394894|FG003|Overall Study|Withdrawal by Subject|1
4561796|NCT01290263|7394895|FG004|Overall Study|Withdrawal by Subject|2
4561797|NCT01290263|7394891|FG000|Overall Study|Participant Non-Compliance|0
4561798|NCT01290263|7394892|FG001|Overall Study|Participant Non-Compliance|0
4561799|NCT01290263|7394893|FG002|Overall Study|Participant Non-Compliance|0
4561800|NCT01290263|7394894|FG003|Overall Study|Participant Non-Compliance|1
4561801|NCT01290263|7394895|FG004|Overall Study|Participant Non-Compliance|1
4561802|NCT01290315|7394907|FG000|Overall Study|Adverse Event|0
4561803|NCT01290315|7394908|FG001|Overall Study|Adverse Event|0
4561804|NCT01290315|7394909|FG002|Overall Study|Adverse Event|0
4561805|NCT01290315|7394910|FG003|Overall Study|Adverse Event|3
4561806|NCT01290315|7394907|FG000|Overall Study|Selection criteria/compliance|2
4561807|NCT01290315|7394908|FG001|Overall Study|Selection criteria/compliance|1
4561808|NCT01290315|7394909|FG002|Overall Study|Selection criteria/compliance|0
4561809|NCT01290315|7394910|FG003|Overall Study|Selection criteria/compliance|2
4561810|NCT01290315|7394907|FG000|Overall Study|Lost to Follow-up|0
4561811|NCT01290315|7394908|FG001|Overall Study|Lost to Follow-up|1
4561812|NCT01290315|7394909|FG002|Overall Study|Lost to Follow-up|0
4561813|NCT01290315|7394910|FG003|Overall Study|Lost to Follow-up|0
4561814|NCT01290315|7394907|FG000|Overall Study|Withdrawal by Subject|1
4561815|NCT01290315|7394908|FG001|Overall Study|Withdrawal by Subject|1
4561816|NCT01290315|7394909|FG002|Overall Study|Withdrawal by Subject|0
4561817|NCT01290315|7394910|FG003|Overall Study|Withdrawal by Subject|0
4561818|NCT01290341|7394921|FG000|Overall Study|Protocol Violation|7
4561819|NCT01290341|7394922|FG001|Overall Study|Protocol Violation|3
4561820|NCT01290341|7394921|FG000|Overall Study|Adverse Event|1
4561821|NCT01290341|7394922|FG001|Overall Study|Adverse Event|0
4561822|NCT01290341|7394921|FG000|Overall Study|Lost to Follow-up|21
4561823|NCT01290341|7394922|FG001|Overall Study|Lost to Follow-up|10
4561824|NCT01290341|7394921|FG000|Overall Study|Withdrawal by Subject|19
4561825|NCT01290341|7394922|FG001|Overall Study|Withdrawal by Subject|5
4561826|NCT01290341|7394921|FG000|Overall Study|Negative baseline culture and others|44
4561827|NCT01290341|7394922|FG001|Overall Study|Negative baseline culture and others|11
4561828|NCT01290523|7394945|FG000|Overall Study|Death|3
4561829|NCT01290601|7394958|FG000|Overall Study|Adverse Event|0
4561830|NCT01290601|7394959|FG001|Overall Study|Adverse Event|2
4561831|NCT01290601|7394960|FG002|Overall Study|Adverse Event|0
4561832|NCT01290601|7394961|FG003|Overall Study|Adverse Event|0
4561833|NCT01290601|7394958|FG000|Overall Study|Lack of Efficacy|2
4561834|NCT01290601|7394959|FG001|Overall Study|Lack of Efficacy|1
4561835|NCT01290601|7394960|FG002|Overall Study|Lack of Efficacy|0
4561836|NCT01290601|7394961|FG003|Overall Study|Lack of Efficacy|0
4561837|NCT01290601|7394958|FG000|Overall Study|Lost to Follow-up|7
4561838|NCT01290601|7394959|FG001|Overall Study|Lost to Follow-up|2
4561839|NCT01290601|7394960|FG002|Overall Study|Lost to Follow-up|0
4561840|NCT01290601|7394961|FG003|Overall Study|Lost to Follow-up|0
4561841|NCT01290601|7394958|FG000|Overall Study|Other|1
4561842|NCT01290601|7394959|FG001|Overall Study|Other|0
4561843|NCT01290601|7394960|FG002|Overall Study|Other|0
4561844|NCT01290601|7394961|FG003|Overall Study|Other|0
4561845|NCT01290601|7394958|FG000|Overall Study|Protocol Violation|1
4561846|NCT01290601|7394959|FG001|Overall Study|Protocol Violation|0
4561847|NCT01290601|7394960|FG002|Overall Study|Protocol Violation|0
4561848|NCT01290601|7394961|FG003|Overall Study|Protocol Violation|0
4561849|NCT01290666|7394998|FG000|Overall Study|Lost to Follow-up|11
4561850|NCT01290666|7394998|FG000|Overall Study|Withdrawal by Subject|23
4561851|NCT01290666|7394998|FG000|Overall Study|Early Termination of Study|4
4561852|NCT01290679|7395004|FG000|Overall Study|Adverse Event|2
4561853|NCT01290679|7395005|FG001|Overall Study|Adverse Event|0
4561854|NCT01290679|7395004|FG000|Overall Study|Lost to Follow-up|8
4561855|NCT01290679|7395005|FG001|Overall Study|Lost to Follow-up|10
4561856|NCT01290679|7395004|FG000|Overall Study|Protocol Violation|0
4561857|NCT01290679|7395005|FG001|Overall Study|Protocol Violation|1
4561858|NCT01290679|7395004|FG000|Overall Study|Withdrawal by Subject|6
4561859|NCT01290679|7395005|FG001|Overall Study|Withdrawal by Subject|5
4561860|NCT01290679|7395004|FG000|Overall Study|Subject Entered Another Trial|0
4561861|NCT01290679|7395005|FG001|Overall Study|Subject Entered Another Trial|5
4561862|NCT01290731|7395011|FG000|Overall Study|Withdrawal by Subject|1
4561863|NCT01290757|7395017|FG000|Overall Study|Adverse Event|1
4561864|NCT01290757|7395018|FG001|Overall Study|Adverse Event|0
4561865|NCT01290757|7395017|FG000|Overall Study|Protocol Violation|1
4561866|NCT01290757|7395018|FG001|Overall Study|Protocol Violation|1
4561867|NCT01290757|7395017|FG000|Overall Study|Other|0
4561868|NCT01290757|7395018|FG001|Overall Study|Other|1
4561869|NCT01290796|7395024|FG000|Overall Study|Lost to Follow-up|21
4561870|NCT01290796|7395024|FG000|Overall Study|Withdrawal by Subject|4
4561871|NCT01290796|7395024|FG000|Overall Study|Physician Decision|2
4561872|NCT01290796|7395024|FG000|Overall Study|Secondary Surgical Intervention|2
4561873|NCT01290796|7395024|FG000|Overall Study|Withdrawal by Sponsor|1
4561874|NCT01290887|7395040|FG000|Overall Study|Adverse Event|6
4561875|NCT01290887|7395041|FG001|Overall Study|Adverse Event|11
4561876|NCT01290887|7395040|FG000|Overall Study|Lack of Efficacy|4
4561877|NCT01290887|7395041|FG001|Overall Study|Lack of Efficacy|5
4561878|NCT01290887|7395040|FG000|Overall Study|Withdrawal by Subject|26
4561879|NCT01290887|7395041|FG001|Overall Study|Withdrawal by Subject|32
4561880|NCT01290887|7395040|FG000|Overall Study|Protocol Violation|2
4561881|NCT01290887|7395041|FG001|Overall Study|Protocol Violation|1
4561882|NCT01290887|7395040|FG000|Overall Study|Lost to Follow-up|4
4561883|NCT01290887|7395041|FG001|Overall Study|Lost to Follow-up|4
4561884|NCT01290887|7395040|FG000|Overall Study|Non-compliance to study procedures|0
4561885|NCT01290887|7395041|FG001|Overall Study|Non-compliance to study procedures|1
4561886|NCT01290887|7395040|FG000|Overall Study|Non-compliance to study medications|1
4561887|NCT01290887|7395041|FG001|Overall Study|Non-compliance to study medications|0
4561888|NCT01290887|7395040|FG000|Overall Study|Sponsor closure of study|420
4561889|NCT01290887|7395041|FG001|Overall Study|Sponsor closure of study|476
4561890|NCT01290887|7395040|FG000|Overall Study|Other|3
4561891|NCT01290887|7395041|FG001|Overall Study|Other|6
4561892|NCT01291017|7395067|FG000|Overall Study|Lost to Follow-up|2
4561893|NCT01291017|7395067|FG000|Overall Study|Withdrawal by Subject|3
4561894|NCT01291173|7395113|FG000|Overall Study|Adverse Event|0
4561895|NCT01291173|7395114|FG001|Overall Study|Adverse Event|3
4561896|NCT01291173|7395115|FG002|Overall Study|Adverse Event|1
4561897|NCT01291173|7395116|FG003|Overall Study|Adverse Event|3
4561898|NCT01291173|7395113|FG000|Overall Study|Protocol Violation|7
4561899|NCT01291173|7395114|FG001|Overall Study|Protocol Violation|2
4561900|NCT01291173|7395115|FG002|Overall Study|Protocol Violation|2
4561901|NCT01291173|7395116|FG003|Overall Study|Protocol Violation|5
4561902|NCT01291173|7395113|FG000|Overall Study|Withdrawal by Subject|6
4561903|NCT01291173|7395114|FG001|Overall Study|Withdrawal by Subject|4
4561904|NCT01291173|7395115|FG002|Overall Study|Withdrawal by Subject|4
4561905|NCT01291173|7395116|FG003|Overall Study|Withdrawal by Subject|2
4561906|NCT01291173|7395113|FG000|Overall Study|Lost to Follow-up|4
4623629|NCT01811563|7487170|FG000|Overall Study|Lost to Follow-up|5
4623630|NCT01811563|7487171|FG001|Overall Study|Lost to Follow-up|2
4561907|NCT01291173|7395114|FG001|Overall Study|Lost to Follow-up|6
4561908|NCT01291173|7395115|FG002|Overall Study|Lost to Follow-up|3
4561909|NCT01291173|7395116|FG003|Overall Study|Lost to Follow-up|2
4561910|NCT01291173|7395113|FG000|Overall Study|Unable to meet visit schedule|0
4561911|NCT01291173|7395114|FG001|Overall Study|Unable to meet visit schedule|0
4561912|NCT01291173|7395115|FG002|Overall Study|Unable to meet visit schedule|1
4561913|NCT01291173|7395116|FG003|Overall Study|Unable to meet visit schedule|0
4561914|NCT01291173|7395113|FG000|Overall Study|Lack of compliance|0
4561915|NCT01291173|7395114|FG001|Overall Study|Lack of compliance|0
4561916|NCT01291173|7395115|FG002|Overall Study|Lack of compliance|0
4561917|NCT01291173|7395116|FG003|Overall Study|Lack of compliance|1
4561918|NCT01291173|7395113|FG000|Overall Study|Subject was unblinded|0
4561919|NCT01291173|7395114|FG001|Overall Study|Subject was unblinded|0
4561920|NCT01291173|7395115|FG002|Overall Study|Subject was unblinded|1
4561921|NCT01291173|7395116|FG003|Overall Study|Subject was unblinded|0
4561922|NCT01291173|7395113|FG000|Overall Study|Excluded therapy|0
4561923|NCT01291173|7395114|FG001|Overall Study|Excluded therapy|0
4561924|NCT01291173|7395115|FG002|Overall Study|Excluded therapy|1
4561925|NCT01291173|7395116|FG003|Overall Study|Excluded therapy|0
4561926|NCT01291225|7395128|FG000|Overall Study|Lost to Follow-up|85
4561927|NCT01291225|7395129|FG001|Overall Study|Lost to Follow-up|39
4561928|NCT01291277|7395145|FG000|Overall Study|Death|2
4561929|NCT01291277|7395146|FG001|Overall Study|Death|2
4561930|NCT01291277|7395145|FG000|Overall Study|Lost to Follow-up|3
4561931|NCT01291277|7395146|FG001|Overall Study|Lost to Follow-up|1
4561932|NCT01292057|7395186|FG000|Overall Study|Protocol Violation|1
4561933|NCT01292057|7395187|FG001|Overall Study|Protocol Violation|1
4561934|NCT01292057|7395186|FG000|Overall Study|Lost to Follow-up|1
4561935|NCT01292057|7395187|FG001|Overall Study|Lost to Follow-up|1
4561936|NCT01292187|7395206|FG000|Overall Study|Adverse Event|10
4561937|NCT01292187|7395207|FG001|Overall Study|Adverse Event|5
4561938|NCT01292187|7395206|FG000|Overall Study|Withdrawal by Subject|6
4561939|NCT01292187|7395207|FG001|Overall Study|Withdrawal by Subject|5
4623631|NCT01811563|7487170|FG000|Overall Study|Incorrect Randomization procedure|0
4623632|NCT01811563|7487171|FG001|Overall Study|Incorrect Randomization procedure|1
4623633|NCT01811706|7487200|FG000|First Intervention ( 4 Weeks)|Adverse Event|1
4623634|NCT01811706|7487201|FG001|First Intervention ( 4 Weeks)|Adverse Event|0
4623635|NCT01811732|7487211|FG000|Overall Study|Lost to Follow-up|24
4623636|NCT01811732|7487212|FG001|Overall Study|Lost to Follow-up|30
4623637|NCT01811732|7487211|FG000|Overall Study|Withdrawal by Subject|16
4623638|NCT01811732|7487212|FG001|Overall Study|Withdrawal by Subject|10
4623639|NCT01811732|7487211|FG000|Overall Study|Adverse Event|3
4623640|NCT01811732|7487212|FG001|Overall Study|Adverse Event|9
4623641|NCT01811732|7487211|FG000|Overall Study|Lack of Efficacy|3
4623642|NCT01811732|7487212|FG001|Overall Study|Lack of Efficacy|1
4623643|NCT01811732|7487211|FG000|Overall Study|Non-compliance with study drug/procedure|3
4623644|NCT01811732|7487212|FG001|Overall Study|Non-compliance with study drug/procedure|3
4623645|NCT01811732|7487211|FG000|Overall Study|Physician Decision|2
4623646|NCT01811732|7487212|FG001|Overall Study|Physician Decision|0
4623647|NCT01811732|7487211|FG000|Overall Study|Death|1
4623648|NCT01811732|7487212|FG001|Overall Study|Death|1
4623649|NCT01811732|7487211|FG000|Overall Study|Insufficient venous access|0
4623650|NCT01811732|7487212|FG001|Overall Study|Insufficient venous access|1
4623651|NCT01811732|7487211|FG000|Overall Study|Protocol Violation|0
4623652|NCT01811732|7487212|FG001|Overall Study|Protocol Violation|1
4623653|NCT01811732|7487211|FG000|Overall Study|Subject incarcerated|1
4623654|NCT01811732|7487212|FG001|Overall Study|Subject incarcerated|2
4623655|NCT01811732|7487211|FG000|Overall Study|Admitted to another facility|1
4623656|NCT01811732|7487212|FG001|Overall Study|Admitted to another facility|0
4623657|NCT01811732|7487211|FG000|Overall Study|Correct study drug not available on site|1
4623658|NCT01811732|7487212|FG001|Overall Study|Correct study drug not available on site|0
4623659|NCT01811953|7487238|FG000|Overall Study|Adverse Event|0
4623660|NCT01811953|7487239|FG001|Overall Study|Adverse Event|0
4623661|NCT01811953|7487240|FG002|Overall Study|Adverse Event|0
4623662|NCT01811953|7487241|FG003|Overall Study|Adverse Event|1
4623663|NCT01811953|7487242|FG004|Overall Study|Adverse Event|0
4623664|NCT01811953|7487243|FG005|Overall Study|Adverse Event|1
4623665|NCT01811953|7487238|FG000|Overall Study|Protocol Violation|0
4623666|NCT01811953|7487239|FG001|Overall Study|Protocol Violation|0
4623667|NCT01811953|7487240|FG002|Overall Study|Protocol Violation|0
4623668|NCT01811953|7487241|FG003|Overall Study|Protocol Violation|0
4623669|NCT01811953|7487242|FG004|Overall Study|Protocol Violation|1
4623670|NCT01811953|7487243|FG005|Overall Study|Protocol Violation|0
4623671|NCT01812057|7487281|FG000|Overall Study|Protocol Violation|1
4623672|NCT01812057|7487282|FG001|Overall Study|Protocol Violation|0
4623673|NCT01812057|7487281|FG000|Overall Study|Physician Decision|1
4623674|NCT01812057|7487282|FG001|Overall Study|Physician Decision|0
4623675|NCT01812109|7487292|FG000|Overall Study|research personnel delay|16
4623676|NCT01812109|7487292|FG000|Overall Study|NIRS Unattainable|17
4623677|NCT01812655|7487308|FG000|Overall Study|Protocol Violation|1
4623678|NCT01812655|7487309|FG001|Overall Study|Protocol Violation|1
4623679|NCT01812655|7487310|FG002|Overall Study|Protocol Violation|0
4623680|NCT01812707|7487338|FG000|Overall Study|Adverse Event|0
4623681|NCT01812707|7487339|FG001|Overall Study|Adverse Event|0
4561940|NCT01292187|7395206|FG000|Overall Study|All other reasons|1
4561941|NCT01292187|7395207|FG001|Overall Study|All other reasons|3
4623682|NCT01812707|7487340|FG002|Overall Study|Adverse Event|0
4623683|NCT01812707|7487341|FG003|Overall Study|Adverse Event|2
4623684|NCT01812707|7487338|FG000|Overall Study|Poor compliance to protocol|1
4623685|NCT01812707|7487339|FG001|Overall Study|Poor compliance to protocol|0
4623686|NCT01812707|7487340|FG002|Overall Study|Poor compliance to protocol|0
4623687|NCT01812707|7487341|FG003|Overall Study|Poor compliance to protocol|0
4623688|NCT01812707|7487338|FG000|Overall Study|Consent withdrawn by participant|1
4623689|NCT01812707|7487339|FG001|Overall Study|Consent withdrawn by participant|0
4561942|NCT01292226|7395214|FG000|Overall Study|Adverse Event|5
4561943|NCT01292226|7395214|FG000|Overall Study|Death|1
4561944|NCT01292226|7395214|FG000|Overall Study|Graft loss|1
4561945|NCT01292226|7395214|FG000|Overall Study|Protocol Violation|3
4561946|NCT01292226|7395214|FG000|Overall Study|Withdrawal by Subject|1
4561947|NCT01292226|7395214|FG000|Overall Study|Other|2
4561948|NCT01292239|7395220|FG000|Overall Study|Other|1
4561949|NCT01292239|7395221|FG001|Overall Study|Other|1
4561950|NCT01292239|7395220|FG000|Overall Study|Withdrawal by Subject|3
4561951|NCT01292239|7395221|FG001|Overall Study|Withdrawal by Subject|6
4561952|NCT01292473|7395253|FG000|Overall Study|Adverse Event|1
4561953|NCT01292473|7395254|FG001|Overall Study|Adverse Event|0
4561954|NCT01292473|7395255|FG002|Overall Study|Adverse Event|1
4561955|NCT01292473|7395256|FG003|Overall Study|Adverse Event|1
4561956|NCT01292473|7395253|FG000|Overall Study|Lost to Follow-up|1
4561957|NCT01292473|7395254|FG001|Overall Study|Lost to Follow-up|1
4561958|NCT01292473|7395255|FG002|Overall Study|Lost to Follow-up|2
4561959|NCT01292473|7395256|FG003|Overall Study|Lost to Follow-up|2
4561960|NCT01292473|7395253|FG000|Overall Study|Withdrawal by Subject|3
4561961|NCT01292473|7395254|FG001|Overall Study|Withdrawal by Subject|4
4561962|NCT01292473|7395255|FG002|Overall Study|Withdrawal by Subject|3
4561963|NCT01292473|7395256|FG003|Overall Study|Withdrawal by Subject|3
4561964|NCT01292473|7395253|FG000|Overall Study|Physician Decision|0
4561965|NCT01292473|7395254|FG001|Overall Study|Physician Decision|1
4561966|NCT01292473|7395255|FG002|Overall Study|Physician Decision|0
4561967|NCT01292473|7395256|FG003|Overall Study|Physician Decision|0
4561968|NCT01292473|7395253|FG000|Overall Study|Disease Progression|0
4561969|NCT01292473|7395254|FG001|Overall Study|Disease Progression|1
4623690|NCT01812707|7487340|FG002|Overall Study|Consent withdrawn by participant|0
4623691|NCT01812707|7487341|FG003|Overall Study|Consent withdrawn by participant|0
4623692|NCT01812759|7487355|FG000|Overall Study|Physician Decision|0
4623693|NCT01812759|7487356|FG001|Overall Study|Physician Decision|0
4623694|NCT01812759|7487357|FG002|Overall Study|Physician Decision|1
4623695|NCT01812837|7487368|FG000|Overall Study|Lost to Follow-up|1
4623696|NCT01812837|7487369|FG001|Overall Study|Lost to Follow-up|1
4623697|NCT01812837|7487370|FG002|Overall Study|Lost to Follow-up|0
4623698|NCT01812837|7487368|FG000|Overall Study|Protocol Violation|1
4623699|NCT01812837|7487369|FG001|Overall Study|Protocol Violation|0
4623700|NCT01812837|7487370|FG002|Overall Study|Protocol Violation|0
4623701|NCT01813019|7487380|FG000|Overall Study|Adverse Event|0
4623702|NCT01813019|7487381|FG001|Overall Study|Adverse Event|3
4623703|NCT01813019|7487380|FG000|Overall Study|Withdrawal by Subject|3
4623704|NCT01813019|7487381|FG001|Overall Study|Withdrawal by Subject|2
4623705|NCT01813019|7487380|FG000|Overall Study|administrative problems|2
4623706|NCT01813019|7487381|FG001|Overall Study|administrative problems|0
4623707|NCT01813019|7487380|FG000|Overall Study|Protocol Deviation|2
4623708|NCT01813019|7487381|FG001|Overall Study|Protocol Deviation|1
4623709|NCT01813058|7487389|FG000|Overall Study|Withdrawal by Subject|5
4623710|NCT01813058|7487390|FG001|Overall Study|Withdrawal by Subject|4
4623711|NCT01813071|7487405|FG000|Overall Study|Protocol Violation|0
4623712|NCT01813071|7487406|FG001|Overall Study|Protocol Violation|0
4623713|NCT01813071|7487407|FG002|Overall Study|Protocol Violation|0
4623714|NCT01813071|7487408|FG003|Overall Study|Protocol Violation|0
4623715|NCT01813071|7487409|FG004|Overall Study|Protocol Violation|1
4623716|NCT01813071|7487410|FG005|Overall Study|Protocol Violation|4
4623717|NCT01813071|7487411|FG006|Overall Study|Protocol Violation|2
4623718|NCT01813071|7487412|FG007|Overall Study|Protocol Violation|4
4623719|NCT01813071|7487413|FG008|Overall Study|Protocol Violation|2
4623720|NCT01813071|7487405|FG000|Overall Study|Withdrawal by Subject|0
4623721|NCT01813071|7487406|FG001|Overall Study|Withdrawal by Subject|0
4623722|NCT01813071|7487407|FG002|Overall Study|Withdrawal by Subject|0
4623723|NCT01813071|7487408|FG003|Overall Study|Withdrawal by Subject|0
4623724|NCT01813071|7487409|FG004|Overall Study|Withdrawal by Subject|0
4623725|NCT01813071|7487410|FG005|Overall Study|Withdrawal by Subject|1
4623726|NCT01813071|7487411|FG006|Overall Study|Withdrawal by Subject|0
4623727|NCT01813071|7487412|FG007|Overall Study|Withdrawal by Subject|0
4623728|NCT01813071|7487413|FG008|Overall Study|Withdrawal by Subject|0
4623729|NCT01813071|7487405|FG000|Overall Study|Adverse Event|0
4623730|NCT01813071|7487406|FG001|Overall Study|Adverse Event|0
4623731|NCT01813071|7487407|FG002|Overall Study|Adverse Event|0
4623732|NCT01813071|7487408|FG003|Overall Study|Adverse Event|0
4623733|NCT01813071|7487409|FG004|Overall Study|Adverse Event|0
4623734|NCT01813071|7487410|FG005|Overall Study|Adverse Event|1
4623735|NCT01813071|7487411|FG006|Overall Study|Adverse Event|0
4623736|NCT01813071|7487412|FG007|Overall Study|Adverse Event|0
4623737|NCT01813071|7487413|FG008|Overall Study|Adverse Event|0
4623738|NCT01813071|7487405|FG000|Overall Study|Physician Decision|0
4623739|NCT01813071|7487406|FG001|Overall Study|Physician Decision|0
4623740|NCT01813071|7487407|FG002|Overall Study|Physician Decision|0
4623741|NCT01813071|7487408|FG003|Overall Study|Physician Decision|0
4623742|NCT01813071|7487409|FG004|Overall Study|Physician Decision|0
4623743|NCT01813071|7487410|FG005|Overall Study|Physician Decision|0
4561970|NCT01292473|7395255|FG002|Overall Study|Disease Progression|3
4561971|NCT01292473|7395256|FG003|Overall Study|Disease Progression|6
4561972|NCT01292486|7395270|FG000|Overall Study|Protocol Violation|2
4592342|NCT01539291|7439757|FG000|Study GS-US-312-0117|Other|2
4561973|NCT01292486|7395270|FG000|Overall Study|Did not meet screening criteria|2
4561974|NCT01292486|7395270|FG000|Overall Study|Adverse Event|1
4561975|NCT01292486|7395270|FG000|Overall Study|Physician Decision|1
4561976|NCT01292603|7395289|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0
4561977|NCT01292603|7395290|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0
4561978|NCT01292603|7395291|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0
4561979|NCT01292603|7395292|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4
4561980|NCT01292603|7395293|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0
4561981|NCT01292603|7395294|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0
4561982|NCT01292603|7395289|FG000|Part 1: Pilot Dose Selection Period|Death|0
4623744|NCT01813071|7487411|FG006|Overall Study|Physician Decision|1
4623745|NCT01813071|7487412|FG007|Overall Study|Physician Decision|0
4623746|NCT01813071|7487413|FG008|Overall Study|Physician Decision|0
4623747|NCT01813071|7487405|FG000|Overall Study|Met inc/exc criteria|0
4623748|NCT01813071|7487406|FG001|Overall Study|Met inc/exc criteria|0
4623749|NCT01813071|7487407|FG002|Overall Study|Met inc/exc criteria|0
4623750|NCT01813071|7487408|FG003|Overall Study|Met inc/exc criteria|0
4623751|NCT01813071|7487409|FG004|Overall Study|Met inc/exc criteria|0
4623752|NCT01813071|7487410|FG005|Overall Study|Met inc/exc criteria|1
4623753|NCT01813071|7487411|FG006|Overall Study|Met inc/exc criteria|0
4623754|NCT01813071|7487412|FG007|Overall Study|Met inc/exc criteria|1
4623755|NCT01813071|7487413|FG008|Overall Study|Met inc/exc criteria|1
4623756|NCT01813357|7487480|FG000|Overall Study|Lost to Follow-up|5
4623757|NCT01813357|7487481|FG001|Overall Study|Lost to Follow-up|6
4623758|NCT01813422|7487489|FG000|Overall Study|Withdrawal by Subject|14
4623759|NCT01813422|7487490|FG001|Overall Study|Withdrawal by Subject|8
4623760|NCT01813422|7487489|FG000|Overall Study|Death|2
4623761|NCT01813422|7487490|FG001|Overall Study|Death|3
4623762|NCT01813422|7487489|FG000|Overall Study|Sponsor Decision|2
4623763|NCT01813422|7487490|FG001|Overall Study|Sponsor Decision|1
4623764|NCT01813422|7487489|FG000|Overall Study|Lost to Follow-up|2
4623765|NCT01813422|7487490|FG001|Overall Study|Lost to Follow-up|4
4623766|NCT01813474|7487499|FG000|Overall Study|Withdrawal by Subject|0
4623767|NCT01813474|7487500|FG001|Overall Study|Withdrawal by Subject|0
4623768|NCT01813474|7487501|FG002|Overall Study|Withdrawal by Subject|1
4623769|NCT01813474|7487499|FG000|Overall Study|Adverse Event|1
4623770|NCT01813474|7487500|FG001|Overall Study|Adverse Event|1
4623771|NCT01813474|7487501|FG002|Overall Study|Adverse Event|0
4623772|NCT01813474|7487499|FG000|Overall Study|Lack of Efficacy|2
4623773|NCT01813474|7487500|FG001|Overall Study|Lack of Efficacy|6
4623774|NCT01813474|7487501|FG002|Overall Study|Lack of Efficacy|9
4623775|NCT01813474|7487499|FG000|Overall Study|Death|0
4623776|NCT01813474|7487500|FG001|Overall Study|Death|0
4623777|NCT01813474|7487501|FG002|Overall Study|Death|1
4623778|NCT01813721|7487510|FG000|Overall Study|Ineligibility determined|63
4623779|NCT01813721|7487510|FG000|Overall Study|Withdrawal by Subject|1
4623780|NCT01813890|7487539|FG000|Overall Study|Adverse Event|0
4623781|NCT01813890|7487540|FG001|Overall Study|Adverse Event|3
4623782|NCT01813890|7487541|FG002|Overall Study|Adverse Event|4
4623783|NCT01813890|7487539|FG000|Overall Study|Lack of Efficacy|9
4623784|NCT01813890|7487540|FG001|Overall Study|Lack of Efficacy|1
4623785|NCT01813890|7487541|FG002|Overall Study|Lack of Efficacy|2
4623786|NCT01814007|7487549|FG000|Overall Study|Withdrawal by Subject|1
4623787|NCT01814046|7487556|FG000|Drug Administration|Death due to complications of RSV|1
4623788|NCT01814046|7487557|FG001|Drug Administration|Death due to complications of RSV|0
4623789|NCT01814046|7487558|FG002|Drug Administration|Death due to complications of RSV|0
4623790|NCT01814072|7487597|FG000|Overall Study|Lost to Follow-up|2
4623791|NCT01814072|7487598|FG001|Overall Study|Lost to Follow-up|2
4623792|NCT01814072|7487599|FG002|Overall Study|Lost to Follow-up|2
4623793|NCT01814072|7487600|FG003|Overall Study|Lost to Follow-up|0
4623794|NCT01814072|7487601|FG004|Overall Study|Lost to Follow-up|2
4623795|NCT01814072|7487602|FG005|Overall Study|Lost to Follow-up|3
4623796|NCT01814072|7487603|FG006|Overall Study|Lost to Follow-up|3
4623797|NCT01814072|7487604|FG007|Overall Study|Lost to Follow-up|1
4623798|NCT01814072|7487605|FG008|Overall Study|Lost to Follow-up|2
4623799|NCT01814072|7487606|FG009|Overall Study|Lost to Follow-up|3
4623800|NCT01814072|7487607|FG010|Overall Study|Lost to Follow-up|1
4623801|NCT01814072|7487608|FG011|Overall Study|Lost to Follow-up|2
4623802|NCT01814072|7487609|FG012|Overall Study|Lost to Follow-up|2
4623803|NCT01814072|7487610|FG013|Overall Study|Lost to Follow-up|1
4623804|NCT01814072|7487611|FG014|Overall Study|Lost to Follow-up|2
4623805|NCT01814072|7487612|FG015|Overall Study|Lost to Follow-up|1
4623806|NCT01814072|7487613|FG016|Overall Study|Lost to Follow-up|3
4623807|NCT01814072|7487614|FG017|Overall Study|Lost to Follow-up|1
4623808|NCT01814072|7487615|FG018|Overall Study|Lost to Follow-up|3
4623809|NCT01814072|7487616|FG019|Overall Study|Lost to Follow-up|3
4623810|NCT01814072|7487617|FG020|Overall Study|Lost to Follow-up|2
4623811|NCT01814072|7487618|FG021|Overall Study|Lost to Follow-up|1
4623812|NCT01814072|7487619|FG022|Overall Study|Lost to Follow-up|3
4623813|NCT01814072|7487620|FG023|Overall Study|Lost to Follow-up|1
4623814|NCT01814072|7487621|FG024|Overall Study|Lost to Follow-up|4
4623815|NCT01814072|7487622|FG025|Overall Study|Lost to Follow-up|1
4623816|NCT01814072|7487623|FG026|Overall Study|Lost to Follow-up|1
4623817|NCT01814072|7487624|FG027|Overall Study|Lost to Follow-up|2
4623818|NCT01814072|7487625|FG028|Overall Study|Lost to Follow-up|3
4561983|NCT01292603|7395290|FG001|Part 1: Pilot Dose Selection Period|Death|0
4561984|NCT01292603|7395291|FG002|Part 1: Pilot Dose Selection Period|Death|0
4561985|NCT01292603|7395292|FG003|Part 1: Pilot Dose Selection Period|Death|1
4561986|NCT01292603|7395293|FG004|Part 1: Pilot Dose Selection Period|Death|0
4561987|NCT01292603|7395294|FG005|Part 1: Pilot Dose Selection Period|Death|0
4561988|NCT01292603|7395289|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0
4561989|NCT01292603|7395290|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0
4561990|NCT01292603|7395291|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0
4561991|NCT01292603|7395292|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2
4561992|NCT01292603|7395293|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0
4561993|NCT01292603|7395294|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0
4561994|NCT01292603|7395289|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
4561995|NCT01292603|7395290|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
4561996|NCT01292603|7395291|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
4561997|NCT01292603|7395292|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1
4561998|NCT01292603|7395293|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
4561999|NCT01292603|7395294|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
4562000|NCT01292603|7395289|FG000|Part 1: Regular Follow-Up Period|Death|3
4562001|NCT01292603|7395290|FG001|Part 1: Regular Follow-Up Period|Death|1
4562002|NCT01292603|7395291|FG002|Part 1: Regular Follow-Up Period|Death|3
4562003|NCT01292603|7395292|FG003|Part 1: Regular Follow-Up Period|Death|1
4562004|NCT01292603|7395293|FG004|Part 1: Regular Follow-Up Period|Death|0
4562005|NCT01292603|7395294|FG005|Part 1: Regular Follow-Up Period|Death|0
4562006|NCT01292603|7395289|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3
4562007|NCT01292603|7395290|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6
4562008|NCT01292603|7395291|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3
4562009|NCT01292603|7395292|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0
4562010|NCT01292603|7395293|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0
4562011|NCT01292603|7395294|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0
4562012|NCT01292603|7395289|FG000|Part 2: Dose Confirmation Period|Death|0
4562013|NCT01292603|7395290|FG001|Part 2: Dose Confirmation Period|Death|0
4562014|NCT01292603|7395291|FG002|Part 2: Dose Confirmation Period|Death|0
4562015|NCT01292603|7395292|FG003|Part 2: Dose Confirmation Period|Death|0
4562016|NCT01292603|7395293|FG004|Part 2: Dose Confirmation Period|Death|1
4562017|NCT01292603|7395294|FG005|Part 2: Dose Confirmation Period|Death|0
4562018|NCT01292603|7395289|FG000|Part 2: Dose Confirmation Period|Physician Decision|0
4562019|NCT01292603|7395290|FG001|Part 2: Dose Confirmation Period|Physician Decision|0
4562020|NCT01292603|7395291|FG002|Part 2: Dose Confirmation Period|Physician Decision|0
4562021|NCT01292603|7395292|FG003|Part 2: Dose Confirmation Period|Physician Decision|0
4562022|NCT01292603|7395293|FG004|Part 2: Dose Confirmation Period|Physician Decision|2
4562023|NCT01292603|7395294|FG005|Part 2: Dose Confirmation Period|Physician Decision|0
4562024|NCT01292603|7395289|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
4562025|NCT01292603|7395290|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
4562026|NCT01292603|7395291|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
4562027|NCT01292603|7395292|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
4562028|NCT01292603|7395293|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1
4562029|NCT01292603|7395294|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1
4562030|NCT01292603|7395289|FG000|Part 2: Dose Confirmation Period|Adverse Event|0
4562031|NCT01292603|7395290|FG001|Part 2: Dose Confirmation Period|Adverse Event|0
4562032|NCT01292603|7395291|FG002|Part 2: Dose Confirmation Period|Adverse Event|0
4562033|NCT01292603|7395292|FG003|Part 2: Dose Confirmation Period|Adverse Event|0
4562034|NCT01292603|7395293|FG004|Part 2: Dose Confirmation Period|Adverse Event|7
4562035|NCT01292603|7395294|FG005|Part 2: Dose Confirmation Period|Adverse Event|9
4562036|NCT01292603|7395289|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0
4562037|NCT01292603|7395290|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0
4562038|NCT01292603|7395291|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0
4562039|NCT01292603|7395292|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0
4562040|NCT01292603|7395293|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5
4562041|NCT01292603|7395294|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3
4562042|NCT01292603|7395289|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
4562043|NCT01292603|7395290|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
4562044|NCT01292603|7395291|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
4562045|NCT01292603|7395292|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
4562046|NCT01292603|7395293|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
4562047|NCT01292603|7395294|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2
4562048|NCT01292603|7395289|FG000|Part 2: Regular Follow-Up|Death|0
4562049|NCT01292603|7395290|FG001|Part 2: Regular Follow-Up|Death|0
4562050|NCT01292603|7395291|FG002|Part 2: Regular Follow-Up|Death|0
4562051|NCT01292603|7395292|FG003|Part 2: Regular Follow-Up|Death|0
4562052|NCT01292603|7395293|FG004|Part 2: Regular Follow-Up|Death|6
4562053|NCT01292603|7395294|FG005|Part 2: Regular Follow-Up|Death|3
4562054|NCT01292603|7395289|FG000|Part 2: Regular Follow-Up|Disease Progression|0
4562055|NCT01292603|7395290|FG001|Part 2: Regular Follow-Up|Disease Progression|0
4562056|NCT01292603|7395291|FG002|Part 2: Regular Follow-Up|Disease Progression|0
4562057|NCT01292603|7395292|FG003|Part 2: Regular Follow-Up|Disease Progression|0
4562058|NCT01292603|7395293|FG004|Part 2: Regular Follow-Up|Disease Progression|5
4562059|NCT01292603|7395294|FG005|Part 2: Regular Follow-Up|Disease Progression|5
4562060|NCT01292603|7395289|FG000|Part 2: Regular Follow-Up|Noncompliance|0
4562061|NCT01292603|7395290|FG001|Part 2: Regular Follow-Up|Noncompliance|0
4562062|NCT01292603|7395291|FG002|Part 2: Regular Follow-Up|Noncompliance|0
4562063|NCT01292603|7395292|FG003|Part 2: Regular Follow-Up|Noncompliance|0
4562064|NCT01292603|7395293|FG004|Part 2: Regular Follow-Up|Noncompliance|1
4562065|NCT01292603|7395294|FG005|Part 2: Regular Follow-Up|Noncompliance|0
4562066|NCT01292603|7395289|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0
4562067|NCT01292603|7395290|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0
4562068|NCT01292603|7395291|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0
4562069|NCT01292603|7395292|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0
4562070|NCT01292603|7395293|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0
4562071|NCT01292603|7395294|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1
4562072|NCT01292603|7395289|FG000|Part 2: Regular Follow-Up|Protocol Violation|0
4562073|NCT01292603|7395290|FG001|Part 2: Regular Follow-Up|Protocol Violation|0
4562074|NCT01292603|7395291|FG002|Part 2: Regular Follow-Up|Protocol Violation|0
4562075|NCT01292603|7395292|FG003|Part 2: Regular Follow-Up|Protocol Violation|0
4562076|NCT01292603|7395293|FG004|Part 2: Regular Follow-Up|Protocol Violation|2
4562077|NCT01292603|7395294|FG005|Part 2: Regular Follow-Up|Protocol Violation|0
4562078|NCT01292603|7395289|FG000|Part 2: Regular Follow-Up|Physician Decision|0
4562079|NCT01292603|7395290|FG001|Part 2: Regular Follow-Up|Physician Decision|0
4562080|NCT01292603|7395291|FG002|Part 2: Regular Follow-Up|Physician Decision|0
4562081|NCT01292603|7395292|FG003|Part 2: Regular Follow-Up|Physician Decision|0
4562082|NCT01292603|7395293|FG004|Part 2: Regular Follow-Up|Physician Decision|2
4562083|NCT01292603|7395294|FG005|Part 2: Regular Follow-Up|Physician Decision|0
4562084|NCT01292603|7395289|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0
4562085|NCT01292603|7395290|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0
4562086|NCT01292603|7395291|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0
4562087|NCT01292603|7395292|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0
4562088|NCT01292603|7395293|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1
4562089|NCT01292603|7395294|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1
4562090|NCT01292603|7395289|FG000|Part 2: Regular Follow-Up|Adverse Event|0
4562091|NCT01292603|7395290|FG001|Part 2: Regular Follow-Up|Adverse Event|0
4562092|NCT01292603|7395291|FG002|Part 2: Regular Follow-Up|Adverse Event|0
4562093|NCT01292603|7395292|FG003|Part 2: Regular Follow-Up|Adverse Event|0
4562094|NCT01292603|7395293|FG004|Part 2: Regular Follow-Up|Adverse Event|2
4562095|NCT01292603|7395294|FG005|Part 2: Regular Follow-Up|Adverse Event|2
4562096|NCT01292603|7395289|FG000|Overall Survival Status|Death|3
4562097|NCT01292603|7395290|FG001|Overall Survival Status|Death|1
4562098|NCT01292603|7395291|FG002|Overall Survival Status|Death|3
4562099|NCT01292603|7395292|FG003|Overall Survival Status|Death|1
4562100|NCT01292603|7395293|FG004|Overall Survival Status|Death|16
4562101|NCT01292603|7395294|FG005|Overall Survival Status|Death|10
4562102|NCT01292837|7395336|FG000|Overall Study|Adverse Event|1
4562103|NCT01292837|7395336|FG000|Overall Study|Further treatment determined|1
4562104|NCT01292876|7395340|FG000|Overall Study|Physician Decision|4
4562105|NCT01292928|7395346|FG000|Overall Study|Death|8
4562106|NCT01292928|7395346|FG000|Overall Study|Withdrawal by Subject|8
4562107|NCT01292928|7395346|FG000|Overall Study|Lost to Follow-up|6
4562108|NCT01292928|7395346|FG000|Overall Study|Physician Decision|2
4562109|NCT01293006|7395356|FG000|Period 2|Lost to Follow-up|1
4562110|NCT01293006|7395357|FG001|Period 2|Lost to Follow-up|0
4562111|NCT01293006|7395358|FG002|Period 2|Lost to Follow-up|0
4562112|NCT01293006|7395359|FG003|Period 2|Lost to Follow-up|0
4562113|NCT01293032|7395378|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
4562114|NCT01293032|7395379|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
4562115|NCT01293032|7395380|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5
4562116|NCT01293032|7395381|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
4562117|NCT01293032|7395378|FG000|Treatment|Adverse Event|0
4562118|NCT01293032|7395379|FG001|Treatment|Adverse Event|0
4562119|NCT01293032|7395380|FG002|Treatment|Adverse Event|1
4562120|NCT01293032|7395381|FG003|Treatment|Adverse Event|1
4562121|NCT01293032|7395378|FG000|Treatment|Withdrawal by Subject|2
4562122|NCT01293032|7395379|FG001|Treatment|Withdrawal by Subject|4
4562123|NCT01293032|7395380|FG002|Treatment|Withdrawal by Subject|0
4562124|NCT01293032|7395381|FG003|Treatment|Withdrawal by Subject|0
4562125|NCT01293032|7395378|FG000|Treatment|Disease Progression, relapse|0
4562126|NCT01293032|7395379|FG001|Treatment|Disease Progression, relapse|1
4562127|NCT01293032|7395380|FG002|Treatment|Disease Progression, relapse|0
4562128|NCT01293032|7395381|FG003|Treatment|Disease Progression, relapse|0
4562129|NCT01293084|7395388|FG000|Overall Study|Physician Decision|3
4562130|NCT01293084|7395388|FG000|Overall Study|Withdrawal by Subject|2
4562131|NCT01293240|7395394|FG000|Overall Study|Noncompliance|2
4562132|NCT01293539|7395408|FG000|Overall Study|Physician Decision|1
4562133|NCT01293695|7395414|FG000|Overall Study|Withdrawal by Subject|7
4562134|NCT01293695|7395415|FG001|Overall Study|Withdrawal by Subject|1
4562135|NCT01293695|7395414|FG000|Overall Study|Lost to Follow-up|8
4562136|NCT01293695|7395415|FG001|Overall Study|Lost to Follow-up|6
4562137|NCT01293968|7395430|FG000|Overall Study|non-cooperation|3
4562138|NCT01293968|7395431|FG001|Overall Study|non-cooperation|3
4562139|NCT01294150|7395452|FG000|Overall Study|Physician Decision|2
4562140|NCT01294150|7395453|FG001|Overall Study|Physician Decision|2
4562141|NCT01294358|7395518|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0
4562142|NCT01294358|7395519|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2
4562143|NCT01294358|7395520|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0
4562144|NCT01294358|7395521|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0
4562145|NCT01294358|7395522|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0
4562146|NCT01294358|7395518|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0
4562147|NCT01294358|7395519|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0
4562148|NCT01294358|7395520|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2
4562149|NCT01294358|7395521|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0
4562150|NCT01294358|7395522|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0
4562151|NCT01294358|7395518|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
4562152|NCT01294358|7395519|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
4562153|NCT01294358|7395520|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
4562154|NCT01294358|7395521|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1
4562155|NCT01294358|7395522|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
4562156|NCT01294358|7395518|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
4562157|NCT01294358|7395519|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
4562158|NCT01294358|7395520|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
4562159|NCT01294358|7395521|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
4562160|NCT01294358|7395522|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1
4562161|NCT01294371|7395539|FG000|Overall Study|Adverse Event|1
4562162|NCT01294371|7395539|FG000|Overall Study|Withdrawal by Subject|12
4562163|NCT01294371|7395539|FG000|Overall Study|Lost to Follow-up|6
4562164|NCT01294371|7395539|FG000|Overall Study|Administrative Reason|1
4562165|NCT01294371|7395539|FG000|Overall Study|Other|14
4562166|NCT01294397|7395559|FG000|Overall Study|Withdrawal by Subject|1
4562167|NCT01294397|7395559|FG000|Overall Study|Administrative Decision|1
4562168|NCT01294423|7395568|FG000|Overall Study|Adverse Event|1
4562169|NCT01294423|7395569|FG001|Overall Study|Adverse Event|2
4562170|NCT01294423|7395570|FG002|Overall Study|Adverse Event|3
4562171|NCT01294423|7395568|FG000|Overall Study|Withdrawal by Subject|1
4562172|NCT01294423|7395569|FG001|Overall Study|Withdrawal by Subject|2
4562173|NCT01294423|7395570|FG002|Overall Study|Withdrawal by Subject|2
4562174|NCT01294423|7395568|FG000|Overall Study|subject no longer meets study criteria|2
4562175|NCT01294423|7395569|FG001|Overall Study|subject no longer meets study criteria|5
4562176|NCT01294423|7395570|FG002|Overall Study|subject no longer meets study criteria|2
4562177|NCT01294423|7395568|FG000|Overall Study|poor/non-compliance|1
4562178|NCT01294423|7395569|FG001|Overall Study|poor/non-compliance|0
4562179|NCT01294423|7395570|FG002|Overall Study|poor/non-compliance|1
4562180|NCT01294436|7395580|FG000|Overall Study|Adverse Event|10
4562181|NCT01294436|7395581|FG001|Overall Study|Adverse Event|17
4562182|NCT01294436|7395580|FG000|Overall Study|Withdrawal by Subject|11
4562183|NCT01294436|7395581|FG001|Overall Study|Withdrawal by Subject|28
4562184|NCT01294436|7395580|FG000|Overall Study|subject no longer meets study criteria|5
4562185|NCT01294436|7395581|FG001|Overall Study|subject no longer meets study criteria|20
4562186|NCT01294436|7395580|FG000|Overall Study|poor/non-compliance|2
4562187|NCT01294436|7395581|FG001|Overall Study|poor/non-compliance|5
4562188|NCT01294449|7395589|FG000|Overall Study|Death|11
4562189|NCT01294449|7395590|FG001|Overall Study|Death|12
4562190|NCT01294449|7395589|FG000|Overall Study|Withdrawal by Subject|1
4562191|NCT01294449|7395590|FG001|Overall Study|Withdrawal by Subject|3
4623819|NCT01814072|7487626|FG029|Overall Study|Lost to Follow-up|3
4623820|NCT01814072|7487627|FG030|Overall Study|Lost to Follow-up|2
4623821|NCT01814072|7487628|FG031|Overall Study|Lost to Follow-up|0
4623822|NCT01814072|7487597|FG000|Overall Study|Withdrawal by Subject|2
4623823|NCT01814072|7487598|FG001|Overall Study|Withdrawal by Subject|0
4623824|NCT01814072|7487599|FG002|Overall Study|Withdrawal by Subject|1
4623825|NCT01814072|7487600|FG003|Overall Study|Withdrawal by Subject|0
4623826|NCT01814072|7487601|FG004|Overall Study|Withdrawal by Subject|2
4623827|NCT01814072|7487602|FG005|Overall Study|Withdrawal by Subject|3
4623828|NCT01814072|7487603|FG006|Overall Study|Withdrawal by Subject|1
4623829|NCT01814072|7487604|FG007|Overall Study|Withdrawal by Subject|0
4623830|NCT01814072|7487605|FG008|Overall Study|Withdrawal by Subject|1
4623831|NCT01814072|7487606|FG009|Overall Study|Withdrawal by Subject|2
4623832|NCT01814072|7487607|FG010|Overall Study|Withdrawal by Subject|0
4623833|NCT01814072|7487608|FG011|Overall Study|Withdrawal by Subject|0
4562192|NCT01294462|7395598|FG000|Overall Study|Lost to Follow-up|1
4562193|NCT01294462|7395599|FG001|Overall Study|Lost to Follow-up|0
4562194|NCT01294462|7395598|FG000|Overall Study|Withdrawal by Subject|65
4623834|NCT01814072|7487609|FG012|Overall Study|Withdrawal by Subject|1
4623835|NCT01814072|7487610|FG013|Overall Study|Withdrawal by Subject|1
4623836|NCT01814072|7487611|FG014|Overall Study|Withdrawal by Subject|1
4623837|NCT01814072|7487612|FG015|Overall Study|Withdrawal by Subject|1
4562195|NCT01294462|7395599|FG001|Overall Study|Withdrawal by Subject|63
4562196|NCT01294514|7395605|FG000|Overall Study|Excluded due to Arrhythmia|1
4562197|NCT01294553|7395613|FG000|Overall Study|Duplicated Participants|1
4562198|NCT01294553|7395613|FG000|Overall Study|Protocol Violation|268
4562199|NCT01294579|7395618|FG000|Overall Study|Disease progression|12
4562200|NCT01294579|7395618|FG000|Overall Study|Adverse Event|11
4562201|NCT01294579|7395618|FG000|Overall Study|Study closed/terminated|3
4562202|NCT01294579|7395618|FG000|Overall Study|Lost to Follow-up|1
4562203|NCT01294579|7395618|FG000|Overall Study|Physician Decision|3
4562204|NCT01294579|7395618|FG000|Overall Study|Withdrawal by Subject|5
4562205|NCT01294592|7395624|FG000|Overall Study|Adverse Event|28
4562206|NCT01294592|7395625|FG001|Overall Study|Adverse Event|13
4562207|NCT01294592|7395624|FG000|Overall Study|Lack of Efficacy|7
4562208|NCT01294592|7395625|FG001|Overall Study|Lack of Efficacy|5
4562209|NCT01294592|7395624|FG000|Overall Study|Protocol Violation|1
4562210|NCT01294592|7395625|FG001|Overall Study|Protocol Violation|7
4562211|NCT01294592|7395624|FG000|Overall Study|Lost to Follow-up|7
4562212|NCT01294592|7395625|FG001|Overall Study|Lost to Follow-up|9
4562213|NCT01294592|7395624|FG000|Overall Study|Physician Decision|6
4562214|NCT01294592|7395625|FG001|Overall Study|Physician Decision|11
4562215|NCT01294592|7395624|FG000|Overall Study|Withdrawal by Subject|28
4562216|NCT01294592|7395625|FG001|Overall Study|Withdrawal by Subject|28
4562217|NCT01294644|7395637|FG000|Overall Study|Adverse Event|2
4562218|NCT01294644|7395638|FG001|Overall Study|Adverse Event|0
4562219|NCT01294644|7395639|FG002|Overall Study|Adverse Event|1
4562220|NCT01294644|7395637|FG000|Overall Study|Withdrawal by Subject|3
4562221|NCT01294644|7395638|FG001|Overall Study|Withdrawal by Subject|7
4562222|NCT01294644|7395639|FG002|Overall Study|Withdrawal by Subject|4
4562223|NCT01294644|7395637|FG000|Overall Study|Lost to Follow-up|3
4562224|NCT01294644|7395638|FG001|Overall Study|Lost to Follow-up|2
4562225|NCT01294644|7395639|FG002|Overall Study|Lost to Follow-up|5
4562226|NCT01294644|7395637|FG000|Overall Study|Miscellaneous Reason|2
4562227|NCT01294644|7395638|FG001|Overall Study|Miscellaneous Reason|1
4562228|NCT01294644|7395639|FG002|Overall Study|Miscellaneous Reason|4
4562229|NCT01294683|7395649|FG000|Precrossover (Periods I/II)|Adverse Event|49
4562230|NCT01294683|7395650|FG001|Precrossover (Periods I/II)|Adverse Event|52
4562231|NCT01294683|7395649|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3
4562232|NCT01294683|7395650|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6
4562233|NCT01294683|7395649|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1
4562234|NCT01294683|7395650|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1
4562235|NCT01294683|7395649|FG000|Precrossover (Periods I/II)|Physician Decision|1
4562236|NCT01294683|7395650|FG001|Precrossover (Periods I/II)|Physician Decision|0
4562237|NCT01294683|7395649|FG000|Precrossover (Periods I/II)|Protocol Violation|5
4562238|NCT01294683|7395650|FG001|Precrossover (Periods I/II)|Protocol Violation|5
4562239|NCT01294683|7395649|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187
4562240|NCT01294683|7395650|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192
4562241|NCT01294683|7395649|FG000|Precrossover (Periods I/II)|Technical Problems|0
4562242|NCT01294683|7395650|FG001|Precrossover (Periods I/II)|Technical Problems|1
4562243|NCT01294683|7395649|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11
4562244|NCT01294683|7395650|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9
4562245|NCT01294683|7395649|FG000|Post Crossover (Period III)|Adverse Event|6
4562246|NCT01294683|7395650|FG001|Post Crossover (Period III)|Adverse Event|6
4562247|NCT01294683|7395649|FG000|Post Crossover (Period III)|Lost to Follow-up|1
4562248|NCT01294683|7395650|FG001|Post Crossover (Period III)|Lost to Follow-up|3
4562249|NCT01294683|7395649|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23
4562250|NCT01294683|7395650|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21
4562251|NCT01294683|7395649|FG000|Post Crossover (Period III)|Withdrawal by Subject|3
4562252|NCT01294683|7395650|FG001|Post Crossover (Period III)|Withdrawal by Subject|2
4562253|NCT01294787|7395683|FG000|Period 1|Adverse Event|0
4562254|NCT01294787|7395684|FG001|Period 1|Adverse Event|0
4562255|NCT01294787|7395685|FG002|Period 1|Adverse Event|0
4562256|NCT01294787|7395686|FG003|Period 1|Adverse Event|0
4562257|NCT01294787|7395687|FG004|Period 1|Adverse Event|1
4562258|NCT01294787|7395688|FG005|Period 1|Adverse Event|0
4562259|NCT01294787|7395683|FG000|Period 1|Withdrawal by Subject|0
4562260|NCT01294787|7395684|FG001|Period 1|Withdrawal by Subject|0
4562261|NCT01294787|7395685|FG002|Period 1|Withdrawal by Subject|0
4562262|NCT01294787|7395686|FG003|Period 1|Withdrawal by Subject|1
4562263|NCT01294787|7395687|FG004|Period 1|Withdrawal by Subject|1
4562264|NCT01294787|7395688|FG005|Period 1|Withdrawal by Subject|1
4562265|NCT01294787|7395683|FG000|Period 1|Administrative problem|0
4562266|NCT01294787|7395684|FG001|Period 1|Administrative problem|0
4562267|NCT01294787|7395685|FG002|Period 1|Administrative problem|1
4562268|NCT01294787|7395686|FG003|Period 1|Administrative problem|0
4562269|NCT01294787|7395687|FG004|Period 1|Administrative problem|0
4562270|NCT01294787|7395688|FG005|Period 1|Administrative problem|1
4562271|NCT01294787|7395683|FG000|Period 2|Adverse Event|0
4562272|NCT01294787|7395684|FG001|Period 2|Adverse Event|3
4562273|NCT01294787|7395685|FG002|Period 2|Adverse Event|0
4562274|NCT01294787|7395686|FG003|Period 2|Adverse Event|1
4562275|NCT01294787|7395687|FG004|Period 2|Adverse Event|0
4562276|NCT01294787|7395688|FG005|Period 2|Adverse Event|0
4562277|NCT01294787|7395683|FG000|Period 2|No longer needs study drug|0
4562278|NCT01294787|7395684|FG001|Period 2|No longer needs study drug|0
4562279|NCT01294787|7395685|FG002|Period 2|No longer needs study drug|0
4562280|NCT01294787|7395686|FG003|Period 2|No longer needs study drug|1
4562281|NCT01294787|7395687|FG004|Period 2|No longer needs study drug|0
4562282|NCT01294787|7395688|FG005|Period 2|No longer needs study drug|0
4562283|NCT01294787|7395683|FG000|Period 3|Adverse Event|0
4562284|NCT01294787|7395684|FG001|Period 3|Adverse Event|0
4562285|NCT01294787|7395685|FG002|Period 3|Adverse Event|0
4562286|NCT01294787|7395686|FG003|Period 3|Adverse Event|0
4562287|NCT01294787|7395687|FG004|Period 3|Adverse Event|1
4562288|NCT01294787|7395688|FG005|Period 3|Adverse Event|0
4562289|NCT01294800|7395703|FG000|Overall Study|Adverse Event|7
4562290|NCT01294800|7395704|FG001|Overall Study|Adverse Event|6
4562291|NCT01294800|7395705|FG002|Overall Study|Adverse Event|12
4562292|NCT01294800|7395706|FG003|Overall Study|Adverse Event|5
4562293|NCT01294800|7395703|FG000|Overall Study|Subject Withdrew Consent|2
4562294|NCT01294800|7395704|FG001|Overall Study|Subject Withdrew Consent|2
4562295|NCT01294800|7395705|FG002|Overall Study|Subject Withdrew Consent|2
4562296|NCT01294800|7395706|FG003|Overall Study|Subject Withdrew Consent|11
4562297|NCT01294800|7395703|FG000|Overall Study|Lost to Follow-up|0
4562298|NCT01294800|7395704|FG001|Overall Study|Lost to Follow-up|0
4562299|NCT01294800|7395705|FG002|Overall Study|Lost to Follow-up|1
4562300|NCT01294800|7395706|FG003|Overall Study|Lost to Follow-up|0
4562301|NCT01294800|7395703|FG000|Overall Study|Non-compliance With Protocol|0
4562302|NCT01294800|7395704|FG001|Overall Study|Non-compliance With Protocol|1
4562303|NCT01294800|7395705|FG002|Overall Study|Non-compliance With Protocol|1
4562304|NCT01294800|7395706|FG003|Overall Study|Non-compliance With Protocol|0
4562305|NCT01294800|7395703|FG000|Overall Study|Did Not Meet Protocol Eligibility|2
4562306|NCT01294800|7395704|FG001|Overall Study|Did Not Meet Protocol Eligibility|1
4562307|NCT01294800|7395705|FG002|Overall Study|Did Not Meet Protocol Eligibility|1
4562308|NCT01294800|7395706|FG003|Overall Study|Did Not Meet Protocol Eligibility|0
4562309|NCT01294917|7395716|FG000|Overall Study|Relocation|5
4562310|NCT01294917|7395716|FG000|Overall Study|Inconvenience|1
4562311|NCT01295034|7395724|FG000|Overall Study|Lost to Follow-up|5
4562312|NCT01295034|7395725|FG001|Overall Study|Lost to Follow-up|5
4592343|NCT01539291|7439758|FG001|Study GS-US-312-0117|Other|1
4592344|NCT01539291|7439759|FG002|Study GS-US-312-0117|Other|1
4592345|NCT01539291|7439760|FG003|Study GS-US-312-0117|Other|1
4592346|NCT01539317|7439779|FG000|Overall Study|Screening Error. Deleted from analysis.|1
4592347|NCT01539317|7439780|FG001|Overall Study|Screening Error. Deleted from analysis.|0
4592348|NCT01539512|7439791|FG000|Overall Study|Adverse Event|9
4592349|NCT01539512|7439792|FG001|Overall Study|Adverse Event|7
4592350|NCT01539512|7439791|FG000|Overall Study|Physician Decision|1
4592351|NCT01539512|7439792|FG001|Overall Study|Physician Decision|1
4592352|NCT01539512|7439791|FG000|Overall Study|Withdrawal by Subject|12
4592353|NCT01539512|7439792|FG001|Overall Study|Withdrawal by Subject|5
4592354|NCT01539512|7439791|FG000|Overall Study|Richter's Transformation|1
4592355|NCT01539512|7439792|FG001|Overall Study|Richter's Transformation|0
4592356|NCT01539525|7439801|FG000|Overall Study|Lost to Follow-up|19
4592357|NCT01539525|7439802|FG001|Overall Study|Lost to Follow-up|12
4592358|NCT01539525|7439803|FG002|Overall Study|Lost to Follow-up|11
4592359|NCT01539525|7439801|FG000|Overall Study|Withdrawal by Subject|0
4592360|NCT01539525|7439802|FG001|Overall Study|Withdrawal by Subject|3
4592361|NCT01539525|7439803|FG002|Overall Study|Withdrawal by Subject|2
4592362|NCT01539525|7439801|FG000|Overall Study|Protocol Violation|1
4592363|NCT01539525|7439802|FG001|Overall Study|Protocol Violation|1
4592364|NCT01539525|7439803|FG002|Overall Study|Protocol Violation|4
4592365|NCT01539538|7439816|FG000|Overall Study|Adverse Event|13
4592366|NCT01539538|7439817|FG001|Overall Study|Adverse Event|18
4592367|NCT01539538|7439816|FG000|Overall Study|Lack of Efficacy|13
4592368|NCT01539538|7439817|FG001|Overall Study|Lack of Efficacy|16
4592369|NCT01539538|7439816|FG000|Overall Study|Withdrawal by Subject|2
4592370|NCT01539538|7439817|FG001|Overall Study|Withdrawal by Subject|3
4592371|NCT01539538|7439816|FG000|Overall Study|PCA no longer required or PCA problem|3
4592372|NCT01539538|7439817|FG001|Overall Study|PCA no longer required or PCA problem|7
4592373|NCT01539642|7439825|FG000|Overall Study|Lack of Efficacy|20
4592374|NCT01539642|7439826|FG001|Overall Study|Lack of Efficacy|18
4592375|NCT01539642|7439825|FG000|Overall Study|Patient ready for early discharge|8
4592376|NCT01539642|7439826|FG001|Overall Study|Patient ready for early discharge|7
4592377|NCT01539642|7439825|FG000|Overall Study|Adverse Event|6
4592378|NCT01539642|7439826|FG001|Overall Study|Adverse Event|4
4592379|NCT01539642|7439825|FG000|Overall Study|Withdrawal by Subject|2
4592380|NCT01539642|7439826|FG001|Overall Study|Withdrawal by Subject|2
4592381|NCT01539759|7439841|FG000|Overall Study|Lost to Follow-up|6
4592382|NCT01539759|7439842|FG001|Overall Study|Lost to Follow-up|8
4592383|NCT01539837|7439851|FG000|Overall Study|reduce neutrophil level|0
4592384|NCT01539837|7439852|FG001|Overall Study|reduce neutrophil level|1
4592385|NCT01539837|7439853|FG002|Overall Study|reduce neutrophil level|1
4592386|NCT01539837|7439851|FG000|Overall Study|bad compliance|0
4592387|NCT01539837|7439852|FG001|Overall Study|bad compliance|0
4592388|NCT01539837|7439853|FG002|Overall Study|bad compliance|1
4770418|NCT03740919|7746730|FG000|Treatment Period|Failure of Inclusion Criteria|0
4592391|NCT01540474|7439958|FG000|Vaccination Period|Lost to Follow-up|0
4592392|NCT01540474|7439959|FG001|Vaccination Period|Lost to Follow-up|1
4562313|NCT01295281|7395752|FG000|First Intervention (7 Days)|Death|0
4562314|NCT01295281|7395753|FG001|First Intervention (7 Days)|Death|1
4562315|NCT01295320|7395759|FG000|Overall Study|Adverse Event|2
4562316|NCT01295320|7395759|FG000|Overall Study|Lost to Follow-up|4
4562317|NCT01295320|7395759|FG000|Overall Study|Withdrawal by Subject|2
4562318|NCT01295320|7395759|FG000|Overall Study|Subject was bedridden|1
4562319|NCT01295320|7395759|FG000|Overall Study|Unable to travel|1
4562320|NCT01295580|7395769|FG000|Overall Study|Protocol Violation|4
4562321|NCT01295580|7395770|FG001|Overall Study|Protocol Violation|2
4562322|NCT01295580|7395769|FG000|Overall Study|Withdrawal by Subject|1
4562323|NCT01295580|7395770|FG001|Overall Study|Withdrawal by Subject|4
4562324|NCT01295580|7395769|FG000|Overall Study|Adverse Event|2
4562325|NCT01295580|7395770|FG001|Overall Study|Adverse Event|1
4562326|NCT01295580|7395769|FG000|Overall Study|Lost to Follow-up|1
4562327|NCT01295580|7395770|FG001|Overall Study|Lost to Follow-up|0
4562328|NCT01295580|7395769|FG000|Overall Study|Lack of Efficacy|1
4562329|NCT01295580|7395770|FG001|Overall Study|Lack of Efficacy|0
4623838|NCT01814072|7487613|FG016|Overall Study|Withdrawal by Subject|0
4623839|NCT01814072|7487614|FG017|Overall Study|Withdrawal by Subject|0
4623840|NCT01814072|7487615|FG018|Overall Study|Withdrawal by Subject|0
4623841|NCT01814072|7487616|FG019|Overall Study|Withdrawal by Subject|2
4623842|NCT01814072|7487617|FG020|Overall Study|Withdrawal by Subject|0
4623843|NCT01814072|7487618|FG021|Overall Study|Withdrawal by Subject|0
4623844|NCT01814072|7487619|FG022|Overall Study|Withdrawal by Subject|1
4623845|NCT01814072|7487620|FG023|Overall Study|Withdrawal by Subject|0
4623846|NCT01814072|7487621|FG024|Overall Study|Withdrawal by Subject|2
4623847|NCT01814072|7487622|FG025|Overall Study|Withdrawal by Subject|1
4623848|NCT01814072|7487623|FG026|Overall Study|Withdrawal by Subject|1
4623849|NCT01814072|7487624|FG027|Overall Study|Withdrawal by Subject|2
4623850|NCT01814072|7487625|FG028|Overall Study|Withdrawal by Subject|1
4623851|NCT01814072|7487626|FG029|Overall Study|Withdrawal by Subject|0
4623852|NCT01814072|7487627|FG030|Overall Study|Withdrawal by Subject|0
4623853|NCT01814072|7487628|FG031|Overall Study|Withdrawal by Subject|0
4623854|NCT01814137|7487670|FG000|Overall Study|Adverse Event|0
4623855|NCT01814137|7487671|FG001|Overall Study|Adverse Event|1
4623856|NCT01814137|7487670|FG000|Overall Study|Withdrawal by Subject|2
4623857|NCT01814137|7487671|FG001|Overall Study|Withdrawal by Subject|2
4623858|NCT01814137|7487670|FG000|Overall Study|Physician Decision|1
4623859|NCT01814137|7487671|FG001|Overall Study|Physician Decision|1
4623860|NCT01814137|7487670|FG000|Overall Study|Unclassified|2
4623861|NCT01814137|7487671|FG001|Overall Study|Unclassified|1
4623862|NCT01814332|7487684|FG000|Overall Study|Adverse Event|8
4623863|NCT01814332|7487685|FG001|Overall Study|Adverse Event|3
4623864|NCT01814332|7487684|FG000|Overall Study|Withdrawal by Subject|3
4623865|NCT01814332|7487685|FG001|Overall Study|Withdrawal by Subject|8
4623866|NCT01814332|7487684|FG000|Overall Study|Protocol Violation|0
4623867|NCT01814332|7487685|FG001|Overall Study|Protocol Violation|4
4623868|NCT01814332|7487684|FG000|Overall Study|Lost to Follow-up|5
4623869|NCT01814332|7487685|FG001|Overall Study|Lost to Follow-up|1
4623870|NCT01814371|7487693|FG000|Overall Study|Lost to Follow-up|30
4623871|NCT01814371|7487694|FG001|Overall Study|Lost to Follow-up|27
4623872|NCT01814397|7487703|FG000|Overall Study|Adverse Event|7
4623873|NCT01814397|7487703|FG000|Overall Study|Withdrawal by Subject|7
4623874|NCT01814553|7487709|FG000|Overall Study|PD per clinical progression|6
4623875|NCT01814553|7487710|FG001|Overall Study|PD per clinical progression|8
4623876|NCT01814553|7487709|FG000|Overall Study|Other Adverse Event|4
4623877|NCT01814553|7487710|FG001|Overall Study|Other Adverse Event|5
4623878|NCT01814553|7487709|FG000|Overall Study|Withdrawal by Subject|1
4623879|NCT01814553|7487710|FG001|Overall Study|Withdrawal by Subject|1
4623880|NCT01814553|7487709|FG000|Overall Study|Other than stated|7
4623881|NCT01814553|7487710|FG001|Overall Study|Other than stated|8
4623882|NCT01814670|7487716|FG000|Overall Study|Protocol Violation|12
4623883|NCT01814696|7487722|FG000|Overall Study|Withdrawal by Subject|1
4623884|NCT01814696|7487723|FG001|Overall Study|Withdrawal by Subject|0
4623885|NCT01814696|7487722|FG000|Overall Study|Randomized to wrong group|1
4623886|NCT01814696|7487723|FG001|Overall Study|Randomized to wrong group|0
4623887|NCT01814748|7487731|FG000|Overall Study|Lost to Follow-up|1
4623888|NCT01814748|7487732|FG001|Overall Study|Lost to Follow-up|2
4623889|NCT01814748|7487731|FG000|Overall Study|Study site terminated by sponsor|1
4623890|NCT01814748|7487732|FG001|Overall Study|Study site terminated by sponsor|1
4623891|NCT01814748|7487731|FG000|Overall Study|Withdrawal by Subject|6
4623892|NCT01814748|7487732|FG001|Overall Study|Withdrawal by Subject|4
4623893|NCT01814761|7487740|FG000|Overall Study|Other Reasons|1
4623894|NCT01814761|7487741|FG001|Overall Study|Other Reasons|10
4562330|NCT01295580|7395769|FG000|Overall Study|Other: inconvenience|1
4562331|NCT01295580|7395770|FG001|Overall Study|Other: inconvenience|0
4623895|NCT01814761|7487740|FG000|Overall Study|Ocular Adverse Event|6
4623896|NCT01814761|7487741|FG001|Overall Study|Ocular Adverse Event|15
4623897|NCT01814761|7487740|FG000|Overall Study|Lost to Follow-up|1
4623898|NCT01814761|7487741|FG001|Overall Study|Lost to Follow-up|5
4623899|NCT01814800|7487762|FG000|Overall Study|Adverse Event|2
4623900|NCT01814800|7487762|FG000|Overall Study|Pregnancy|1
4562332|NCT01295580|7395769|FG000|Overall Study|Other: family objection|0
4623901|NCT01814800|7487762|FG000|Overall Study|Sponsor decision|1
4562333|NCT01295580|7395770|FG001|Overall Study|Other: family objection|1
4562334|NCT01295671|7395779|FG000|Overall Study|Lost to Follow-up|4
4562335|NCT01295671|7395780|FG001|Overall Study|Lost to Follow-up|6
4562336|NCT01295671|7395781|FG002|Overall Study|Lost to Follow-up|3
4562337|NCT01295671|7395779|FG000|Overall Study|Withdrawal by Subject|3
4562338|NCT01295671|7395780|FG001|Overall Study|Withdrawal by Subject|1
4562339|NCT01295671|7395781|FG002|Overall Study|Withdrawal by Subject|0
4562340|NCT01295814|7395800|FG000|Overall Study|Lack of Efficacy|0
4562341|NCT01295814|7395801|FG001|Overall Study|Lack of Efficacy|2
4562342|NCT01295814|7395800|FG000|Overall Study|Withdrawal by Subject|2
4562343|NCT01295814|7395801|FG001|Overall Study|Withdrawal by Subject|0
4562344|NCT01295827|7395819|FG000|Overall Study|Adverse Event|1
4562345|NCT01295827|7395820|FG001|Overall Study|Adverse Event|2
4562346|NCT01295827|7395821|FG002|Overall Study|Adverse Event|2
4562347|NCT01295827|7395822|FG003|Overall Study|Adverse Event|1
4562348|NCT01295827|7395823|FG004|Overall Study|Adverse Event|1
4562349|NCT01295827|7395824|FG005|Overall Study|Adverse Event|4
4562350|NCT01295827|7395825|FG006|Overall Study|Adverse Event|15
4562351|NCT01295827|7395826|FG007|Overall Study|Adverse Event|49
4562352|NCT01295827|7395827|FG008|Overall Study|Adverse Event|22
4562353|NCT01295827|7395828|FG009|Overall Study|Adverse Event|7
4562354|NCT01295827|7395829|FG010|Overall Study|Adverse Event|50
4562355|NCT01295827|7395830|FG011|Overall Study|Adverse Event|21
4623902|NCT01814800|7487762|FG000|Overall Study|Subject relocation|1
4623903|NCT01814878|7487781|FG000|Overall Study|Adverse Event|16
4623904|NCT01814878|7487782|FG001|Overall Study|Adverse Event|5
4623905|NCT01814878|7487781|FG000|Overall Study|Withdrawal by Subject|20
4623906|NCT01814878|7487782|FG001|Overall Study|Withdrawal by Subject|16
4623907|NCT01814878|7487781|FG000|Overall Study|Protocol Violation|5
4623908|NCT01814878|7487782|FG001|Overall Study|Protocol Violation|5
4623909|NCT01814878|7487781|FG000|Overall Study|Physician Decision|3
4623910|NCT01814878|7487782|FG001|Overall Study|Physician Decision|1
4623911|NCT01814878|7487781|FG000|Overall Study|Screening failure (drop-out)|0
4623912|NCT01814878|7487782|FG001|Overall Study|Screening failure (drop-out)|3
4623913|NCT01814878|7487781|FG000|Overall Study|Other|2
4623914|NCT01814878|7487782|FG001|Overall Study|Other|0
4623915|NCT01815099|7487794|FG000|Overall Study|Lack of Efficacy|1
4623916|NCT01815099|7487794|FG000|Overall Study|unable to attend study visits|1
4623917|NCT01815138|7487801|FG000|Overall Study|Withdrawal by Subject|0
4623918|NCT01815138|7487802|FG001|Overall Study|Withdrawal by Subject|1
4623919|NCT01815138|7487801|FG000|Overall Study|Physician Decision|8
4623920|NCT01815138|7487802|FG001|Overall Study|Physician Decision|5
4623921|NCT01815424|7487827|FG000|Week 0 to 16|Adverse Event|1
4623922|NCT01815424|7487828|FG001|Week 0 to 16|Adverse Event|3
4623923|NCT01815424|7487829|FG002|Week 0 to 16|Adverse Event|3
4623924|NCT01815424|7487830|FG003|Week 0 to 16|Adverse Event|0
4623925|NCT01815424|7487831|FG004|Week 0 to 16|Adverse Event|0
4623926|NCT01815424|7487827|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2
4623927|NCT01815424|7487828|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0
4623928|NCT01815424|7487829|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0
4623929|NCT01815424|7487830|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0
4623930|NCT01815424|7487831|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0
4623931|NCT01815424|7487827|FG000|Week 0 to 16|Lost to Follow-up|0
4623932|NCT01815424|7487828|FG001|Week 0 to 16|Lost to Follow-up|1
4623933|NCT01815424|7487829|FG002|Week 0 to 16|Lost to Follow-up|0
4623934|NCT01815424|7487830|FG003|Week 0 to 16|Lost to Follow-up|0
4623935|NCT01815424|7487831|FG004|Week 0 to 16|Lost to Follow-up|0
4623936|NCT01815424|7487827|FG000|Week 0 to 16|Withdrawal by Subject|0
4623937|NCT01815424|7487828|FG001|Week 0 to 16|Withdrawal by Subject|0
4623938|NCT01815424|7487829|FG002|Week 0 to 16|Withdrawal by Subject|1
4623939|NCT01815424|7487830|FG003|Week 0 to 16|Withdrawal by Subject|0
4623940|NCT01815424|7487831|FG004|Week 0 to 16|Withdrawal by Subject|0
4623941|NCT01815424|7487827|FG000|Week 0 to 16|Other|1
4623942|NCT01815424|7487828|FG001|Week 0 to 16|Other|0
4623943|NCT01815424|7487829|FG002|Week 0 to 16|Other|3
4623944|NCT01815424|7487830|FG003|Week 0 to 16|Other|0
4623945|NCT01815424|7487831|FG004|Week 0 to 16|Other|0
4623946|NCT01815424|7487827|FG000|Week 0 to 16|Protocol Violation|1
4623947|NCT01815424|7487828|FG001|Week 0 to 16|Protocol Violation|0
4623948|NCT01815424|7487829|FG002|Week 0 to 16|Protocol Violation|0
4623949|NCT01815424|7487830|FG003|Week 0 to 16|Protocol Violation|0
4623950|NCT01815424|7487831|FG004|Week 0 to 16|Protocol Violation|0
4623951|NCT01815424|7487827|FG000|Week 0 to 16|Insufficient Clinical Response|2
4623952|NCT01815424|7487828|FG001|Week 0 to 16|Insufficient Clinical Response|0
4623953|NCT01815424|7487829|FG002|Week 0 to 16|Insufficient Clinical Response|4
4623954|NCT01815424|7487830|FG003|Week 0 to 16|Insufficient Clinical Response|0
4623955|NCT01815424|7487831|FG004|Week 0 to 16|Insufficient Clinical Response|0
4623956|NCT01815424|7487827|FG000|Week 16 to 52|Other|0
4623957|NCT01815424|7487828|FG001|Week 16 to 52|Other|1
4623958|NCT01815424|7487829|FG002|Week 16 to 52|Other|0
4623959|NCT01815424|7487830|FG003|Week 16 to 52|Other|0
4623960|NCT01815424|7487831|FG004|Week 16 to 52|Other|0
4562356|NCT01295827|7395831|FG012|Overall Study|Adverse Event|0
4623961|NCT01815424|7487827|FG000|Week 16 to 52|Adverse Event|0
4623962|NCT01815424|7487828|FG001|Week 16 to 52|Adverse Event|0
4623963|NCT01815424|7487829|FG002|Week 16 to 52|Adverse Event|0
4562357|NCT01295827|7395832|FG013|Overall Study|Adverse Event|0
4562358|NCT01295827|7395833|FG014|Overall Study|Adverse Event|0
4562359|NCT01295827|7395819|FG000|Overall Study|Lost to Follow-up|0
4562360|NCT01295827|7395820|FG001|Overall Study|Lost to Follow-up|0
4562361|NCT01295827|7395821|FG002|Overall Study|Lost to Follow-up|3
4562362|NCT01295827|7395822|FG003|Overall Study|Lost to Follow-up|0
4562363|NCT01295827|7395823|FG004|Overall Study|Lost to Follow-up|1
4562364|NCT01295827|7395824|FG005|Overall Study|Lost to Follow-up|0
4562365|NCT01295827|7395825|FG006|Overall Study|Lost to Follow-up|4
4562366|NCT01295827|7395826|FG007|Overall Study|Lost to Follow-up|8
4562367|NCT01295827|7395827|FG008|Overall Study|Lost to Follow-up|7
4562368|NCT01295827|7395828|FG009|Overall Study|Lost to Follow-up|4
4562369|NCT01295827|7395829|FG010|Overall Study|Lost to Follow-up|7
4562370|NCT01295827|7395830|FG011|Overall Study|Lost to Follow-up|3
4562371|NCT01295827|7395831|FG012|Overall Study|Lost to Follow-up|0
4562372|NCT01295827|7395832|FG013|Overall Study|Lost to Follow-up|0
4562373|NCT01295827|7395833|FG014|Overall Study|Lost to Follow-up|0
4562374|NCT01295827|7395819|FG000|Overall Study|Not Reported|0
4562375|NCT01295827|7395820|FG001|Overall Study|Not Reported|0
4562376|NCT01295827|7395821|FG002|Overall Study|Not Reported|0
4562377|NCT01295827|7395822|FG003|Overall Study|Not Reported|1
4562378|NCT01295827|7395823|FG004|Overall Study|Not Reported|0
4562379|NCT01295827|7395824|FG005|Overall Study|Not Reported|0
4562380|NCT01295827|7395825|FG006|Overall Study|Not Reported|24
4562381|NCT01295827|7395826|FG007|Overall Study|Not Reported|58
4562382|NCT01295827|7395827|FG008|Overall Study|Not Reported|41
4562383|NCT01295827|7395828|FG009|Overall Study|Not Reported|2
4562384|NCT01295827|7395829|FG010|Overall Study|Not Reported|23
4562385|NCT01295827|7395830|FG011|Overall Study|Not Reported|13
4562386|NCT01295827|7395831|FG012|Overall Study|Not Reported|0
4562387|NCT01295827|7395832|FG013|Overall Study|Not Reported|0
4562388|NCT01295827|7395833|FG014|Overall Study|Not Reported|0
4562389|NCT01295827|7395819|FG000|Overall Study|Progressive Disease|2
4562390|NCT01295827|7395820|FG001|Overall Study|Progressive Disease|1
4562391|NCT01295827|7395821|FG002|Overall Study|Progressive Disease|5
4562392|NCT01295827|7395822|FG003|Overall Study|Progressive Disease|2
4562393|NCT01295827|7395823|FG004|Overall Study|Progressive Disease|0
4562394|NCT01295827|7395824|FG005|Overall Study|Progressive Disease|1
4562395|NCT01295827|7395825|FG006|Overall Study|Progressive Disease|87
4562396|NCT01295827|7395826|FG007|Overall Study|Progressive Disease|144
4562397|NCT01295827|7395827|FG008|Overall Study|Progressive Disease|85
4562398|NCT01295827|7395828|FG009|Overall Study|Progressive Disease|40
4562399|NCT01295827|7395829|FG010|Overall Study|Progressive Disease|175
4562400|NCT01295827|7395830|FG011|Overall Study|Progressive Disease|136
4562401|NCT01295827|7395831|FG012|Overall Study|Progressive Disease|0
4562402|NCT01295827|7395832|FG013|Overall Study|Progressive Disease|0
4562403|NCT01295827|7395833|FG014|Overall Study|Progressive Disease|0
4562404|NCT01295827|7395819|FG000|Overall Study|Screen Failure|0
4562405|NCT01295827|7395820|FG001|Overall Study|Screen Failure|0
4562406|NCT01295827|7395821|FG002|Overall Study|Screen Failure|0
4562407|NCT01295827|7395822|FG003|Overall Study|Screen Failure|0
4562408|NCT01295827|7395823|FG004|Overall Study|Screen Failure|0
4562409|NCT01295827|7395824|FG005|Overall Study|Screen Failure|0
4562410|NCT01295827|7395825|FG006|Overall Study|Screen Failure|2
4562411|NCT01295827|7395826|FG007|Overall Study|Screen Failure|2
4562412|NCT01295827|7395827|FG008|Overall Study|Screen Failure|2
4562413|NCT01295827|7395828|FG009|Overall Study|Screen Failure|0
4562414|NCT01295827|7395829|FG010|Overall Study|Screen Failure|1
4562415|NCT01295827|7395830|FG011|Overall Study|Screen Failure|0
4562416|NCT01295827|7395831|FG012|Overall Study|Screen Failure|0
4562417|NCT01295827|7395832|FG013|Overall Study|Screen Failure|0
4562418|NCT01295827|7395833|FG014|Overall Study|Screen Failure|0
4562419|NCT01295827|7395819|FG000|Overall Study|Withdrawal by Subject|1
4562420|NCT01295827|7395820|FG001|Overall Study|Withdrawal by Subject|0
4623964|NCT01815424|7487830|FG003|Week 16 to 52|Adverse Event|0
4623965|NCT01815424|7487831|FG004|Week 16 to 52|Adverse Event|1
4690760|NCT02563548|7600526|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
4690761|NCT02563561|7600549|FG000|Overall Study|Histology Other than Ta, G1-G2|3
4690762|NCT02563561|7600550|FG001|Overall Study|Histology Other than Ta, G1-G2|6
4690763|NCT02563561|7600551|FG002|Overall Study|Histology Other than Ta, G1-G2|6
4690764|NCT02563561|7600549|FG000|Overall Study|Withdrew of Consent|1
4690765|NCT02563561|7600550|FG001|Overall Study|Withdrew of Consent|1
4690766|NCT02563561|7600551|FG002|Overall Study|Withdrew of Consent|2
4562421|NCT01295827|7395821|FG002|Overall Study|Withdrawal by Subject|2
4562422|NCT01295827|7395822|FG003|Overall Study|Withdrawal by Subject|0
4562423|NCT01295827|7395823|FG004|Overall Study|Withdrawal by Subject|0
4562424|NCT01295827|7395824|FG005|Overall Study|Withdrawal by Subject|1
4562425|NCT01295827|7395825|FG006|Overall Study|Withdrawal by Subject|13
4562426|NCT01295827|7395826|FG007|Overall Study|Withdrawal by Subject|35
4562427|NCT01295827|7395827|FG008|Overall Study|Withdrawal by Subject|11
4562428|NCT01295827|7395828|FG009|Overall Study|Withdrawal by Subject|2
4562429|NCT01295827|7395829|FG010|Overall Study|Withdrawal by Subject|18
4562430|NCT01295827|7395830|FG011|Overall Study|Withdrawal by Subject|13
4562431|NCT01295827|7395831|FG012|Overall Study|Withdrawal by Subject|0
4562432|NCT01295827|7395832|FG013|Overall Study|Withdrawal by Subject|0
4623966|NCT01815424|7487827|FG000|Week 16 to 52|Insufficient Clinical Response|1
4562433|NCT01295827|7395833|FG014|Overall Study|Withdrawal by Subject|0
4562434|NCT01295827|7395819|FG000|Overall Study|Other|0
4562435|NCT01295827|7395820|FG001|Overall Study|Other|0
4623967|NCT01815424|7487828|FG001|Week 16 to 52|Insufficient Clinical Response|0
4623968|NCT01815424|7487829|FG002|Week 16 to 52|Insufficient Clinical Response|0
4623969|NCT01815424|7487830|FG003|Week 16 to 52|Insufficient Clinical Response|1
4623970|NCT01815424|7487831|FG004|Week 16 to 52|Insufficient Clinical Response|1
4623971|NCT01815424|7487827|FG000|Week 16 to 52|Lost to Follow-up|0
4623972|NCT01815424|7487828|FG001|Week 16 to 52|Lost to Follow-up|2
4623973|NCT01815424|7487829|FG002|Week 16 to 52|Lost to Follow-up|0
4623974|NCT01815424|7487830|FG003|Week 16 to 52|Lost to Follow-up|2
4623975|NCT01815424|7487831|FG004|Week 16 to 52|Lost to Follow-up|1
4623976|NCT01815424|7487827|FG000|Week 16 to 52|Withdrawal by Subject|1
4623977|NCT01815424|7487828|FG001|Week 16 to 52|Withdrawal by Subject|2
4623978|NCT01815424|7487829|FG002|Week 16 to 52|Withdrawal by Subject|0
4623979|NCT01815424|7487830|FG003|Week 16 to 52|Withdrawal by Subject|0
4623980|NCT01815424|7487831|FG004|Week 16 to 52|Withdrawal by Subject|0
4623981|NCT01815736|7487882|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11
4623982|NCT01815736|7487883|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17
4623983|NCT01815736|7487882|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10
4623984|NCT01815736|7487883|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9
4623985|NCT01815736|7487882|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11
4623986|NCT01815736|7487883|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2
4623987|NCT01815736|7487882|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7
4623988|NCT01815736|7487883|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4
4623989|NCT01815736|7487882|FG000|Randomized Treatment Phase-Up to Week 96|Death|4
4623990|NCT01815736|7487883|FG001|Randomized Treatment Phase-Up to Week 96|Death|0
4623991|NCT01815736|7487882|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1
4623992|NCT01815736|7487883|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0
4623993|NCT01815736|7487882|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1
4623994|NCT01815736|7487883|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0
4623995|NCT01815736|7487882|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4
4623996|NCT01815736|7487883|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3
4623997|NCT01815736|7487882|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31
4623998|NCT01815736|7487883|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15
4623999|NCT01815736|7487882|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13
4624000|NCT01815736|7487883|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9
4624001|NCT01815736|7487882|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5
4624002|NCT01815736|7487883|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1
4624003|NCT01815736|7487882|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1
4624004|NCT01815736|7487883|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1
4624005|NCT01815736|7487882|FG000|Extension Treatment Phase- After Week 96|Death|1
4624006|NCT01815736|7487883|FG001|Extension Treatment Phase- After Week 96|Death|0
4624007|NCT01815840|7487893|FG000|Overall Study|Missing|1
4624008|NCT01815840|7487894|FG001|Overall Study|Missing|0
4624009|NCT01815840|7487893|FG000|Overall Study|Withdrew Consent|31
4624010|NCT01815840|7487894|FG001|Overall Study|Withdrew Consent|30
4624011|NCT01815840|7487893|FG000|Overall Study|Administrative/Other|1
4624012|NCT01815840|7487894|FG001|Overall Study|Administrative/Other|3
4624013|NCT01815840|7487893|FG000|Overall Study|Adverse Event|10
4624014|NCT01815840|7487894|FG001|Overall Study|Adverse Event|16
4624015|NCT01815840|7487893|FG000|Overall Study|Death|2
4624016|NCT01815840|7487894|FG001|Overall Study|Death|2
4624017|NCT01815840|7487893|FG000|Overall Study|Disease progression|3
4624018|NCT01815840|7487894|FG001|Overall Study|Disease progression|2
4624019|NCT01815840|7487893|FG000|Overall Study|Investigators Decision|2
4624020|NCT01815840|7487894|FG001|Overall Study|Investigators Decision|3
4624021|NCT01815840|7487893|FG000|Overall Study|Lost to Follow-up|3
4624022|NCT01815840|7487894|FG001|Overall Study|Lost to Follow-up|6
4624023|NCT01815840|7487893|FG000|Overall Study|Refused Treatment|5
4624024|NCT01815840|7487894|FG001|Overall Study|Refused Treatment|1
4624025|NCT01815840|7487893|FG000|Overall Study|Sponsor Termination Treatment|1
4624026|NCT01815840|7487894|FG001|Overall Study|Sponsor Termination Treatment|0
4624027|NCT01815918|7487902|FG000|Overall Study|Patient samples not analyzable|3
4624028|NCT01815918|7487903|FG001|Overall Study|Patient samples not analyzable|4
4624029|NCT01815918|7487902|FG000|Overall Study|Lack of Efficacy|15
4624030|NCT01815918|7487903|FG001|Overall Study|Lack of Efficacy|15
4624031|NCT01816048|7487913|FG000|Overall Study|Adverse Event|1
4624032|NCT01816048|7487913|FG000|Overall Study|Death|1
4624033|NCT01816048|7487913|FG000|Overall Study|Withdrawal by Subject|1
4624034|NCT01816048|7487913|FG000|Overall Study|Disease Progression|3
4624035|NCT01816061|7487920|FG000|Overall Study|Lost to Follow-up|13
4624036|NCT01816061|7487921|FG001|Overall Study|Lost to Follow-up|24
4624037|NCT01816074|7487931|FG000|Phase 1|Time commitment issues|0
4624038|NCT01816074|7487932|FG001|Phase 1|Time commitment issues|0
4624039|NCT01816074|7487933|FG002|Phase 1|Time commitment issues|1
4624040|NCT01816074|7487934|FG003|Phase 1|Time commitment issues|0
4624041|NCT01816074|7487931|FG000|Phase 2|Time commitment Issues|0
4624042|NCT01816074|7487932|FG001|Phase 2|Time commitment Issues|2
4624043|NCT01816074|7487933|FG002|Phase 2|Time commitment Issues|0
4624044|NCT01816074|7487934|FG003|Phase 2|Time commitment Issues|0
4624045|NCT01816074|7487931|FG000|Phase 2|Unsatisfied with Randomization assignmen|1
4624046|NCT01816074|7487932|FG001|Phase 2|Unsatisfied with Randomization assignmen|0
4624047|NCT01816074|7487933|FG002|Phase 2|Unsatisfied with Randomization assignmen|0
4624048|NCT01816074|7487934|FG003|Phase 2|Unsatisfied with Randomization assignmen|0
4624049|NCT01816074|7487931|FG000|Phase 2|Physician Decision|0
4624050|NCT01816074|7487932|FG001|Phase 2|Physician Decision|0
4624051|NCT01816074|7487933|FG002|Phase 2|Physician Decision|0
4624052|NCT01816074|7487934|FG003|Phase 2|Physician Decision|1
4624053|NCT01816074|7487931|FG000|Phase 2|Withdrawal by Subject|1
4624054|NCT01816074|7487932|FG001|Phase 2|Withdrawal by Subject|0
4624055|NCT01816074|7487933|FG002|Phase 2|Withdrawal by Subject|0
4624056|NCT01816074|7487934|FG003|Phase 2|Withdrawal by Subject|0
4624057|NCT01816243|7487962|FG000|Overall Study|Adverse Event|6
4624058|NCT01816243|7487962|FG000|Overall Study|Lost to Follow-up|1
4624059|NCT01816243|7487962|FG000|Overall Study|Lack of Efficacy|1
4624060|NCT01816243|7487962|FG000|Overall Study|Not eligible for the study|1
4624061|NCT01816243|7487962|FG000|Overall Study|Amputation|3
4624062|NCT01816295|7487968|FG000|Double Blind Phase|Adverse Event|11
4624063|NCT01816295|7487969|FG001|Double Blind Phase|Adverse Event|8
4624064|NCT01816295|7487968|FG000|Double Blind Phase|Entry Criteria Not Met|0
4624065|NCT01816295|7487969|FG001|Double Blind Phase|Entry Criteria Not Met|2
4624066|NCT01816295|7487968|FG000|Double Blind Phase|Lost to Follow-up|3
4624067|NCT01816295|7487969|FG001|Double Blind Phase|Lost to Follow-up|5
4624068|NCT01816295|7487968|FG000|Double Blind Phase|Physician Decision|2
4624069|NCT01816295|7487969|FG001|Double Blind Phase|Physician Decision|2
4624070|NCT01816295|7487968|FG000|Double Blind Phase|Protocol Violation|17
4624071|NCT01816295|7487969|FG001|Double Blind Phase|Protocol Violation|11
4624072|NCT01816295|7487968|FG000|Double Blind Phase|Sponsor Decision|8
4624073|NCT01816295|7487969|FG001|Double Blind Phase|Sponsor Decision|8
4624074|NCT01816295|7487968|FG000|Double Blind Phase|Withdrawal by Subject|22
4624075|NCT01816295|7487969|FG001|Double Blind Phase|Withdrawal by Subject|20
4624076|NCT01816295|7487968|FG000|OLE Phase|Adverse Event|17
4624077|NCT01816295|7487969|FG001|OLE Phase|Adverse Event|15
4624078|NCT01816295|7487968|FG000|OLE Phase|Death|1
4624079|NCT01816295|7487969|FG001|OLE Phase|Death|0
4624080|NCT01816295|7487968|FG000|OLE Phase|Entry Criteria Not Met|3
4624081|NCT01816295|7487969|FG001|OLE Phase|Entry Criteria Not Met|5
4624082|NCT01816295|7487968|FG000|OLE Phase|Lost to Follow-up|5
4624083|NCT01816295|7487969|FG001|OLE Phase|Lost to Follow-up|5
4624084|NCT01816295|7487968|FG000|OLE Phase|Physician Decision|3
4624085|NCT01816295|7487969|FG001|OLE Phase|Physician Decision|1
4624086|NCT01816295|7487968|FG000|OLE Phase|Protocol Violation|4
4624087|NCT01816295|7487969|FG001|OLE Phase|Protocol Violation|4
4624088|NCT01816295|7487968|FG000|OLE Phase|Sponsor Decision|7
4624089|NCT01816295|7487969|FG001|OLE Phase|Sponsor Decision|9
4624090|NCT01816295|7487968|FG000|OLE Phase|Withdrawal by Subject|10
4624091|NCT01816295|7487969|FG001|OLE Phase|Withdrawal by Subject|10
4624092|NCT01816295|7487968|FG000|OLE Phase|Lack of Efficacy|3
4624093|NCT01816295|7487969|FG001|OLE Phase|Lack of Efficacy|7
4624094|NCT01816477|7487993|FG000|Overall Study|Withdrawal by Subject|13
4624095|NCT01816477|7487994|FG001|Overall Study|Withdrawal by Subject|1
4624096|NCT01816477|7487993|FG000|Overall Study|Unable to tolerate catheter placement|3
4624097|NCT01816477|7487994|FG001|Overall Study|Unable to tolerate catheter placement|0
4624098|NCT01816594|7488002|FG000|Overall Study|Local Progress|0
4624099|NCT01816594|7488003|FG001|Overall Study|Local Progress|2
4624100|NCT01816594|7488002|FG000|Overall Study|Adverse Event|9
4624101|NCT01816594|7488003|FG001|Overall Study|Adverse Event|0
4624102|NCT01816594|7488002|FG000|Overall Study|Withdrawal by Subject|1
4624103|NCT01816594|7488003|FG001|Overall Study|Withdrawal by Subject|0
4624104|NCT01816594|7488002|FG000|Overall Study|Physician Decision|1
4624105|NCT01816594|7488003|FG001|Overall Study|Physician Decision|0
4624106|NCT01816685|7488017|FG000|Overall Study|Lost to Follow-up|7
4624107|NCT01816685|7488018|FG001|Overall Study|Lost to Follow-up|9
4624108|NCT01816685|7488017|FG000|Overall Study|Surgery Cancelled|3
4624109|NCT01816685|7488018|FG001|Overall Study|Surgery Cancelled|2
4624110|NCT01816763|7488036|FG000|Overall Study|The main reason for an incomplete survey|4
4624111|NCT01816763|7488037|FG001|Overall Study|The main reason for an incomplete survey|15
4624112|NCT01816763|7488038|FG002|Overall Study|The main reason for an incomplete survey|11
4624113|NCT01816893|7488060|FG000|Washout Period|Withdrawal by Subject|2
4624114|NCT01816893|7488061|FG001|Washout Period|Withdrawal by Subject|0
4633126|NCT01908803|7503106|FG000|Overall Study|Adverse Event|1
4633127|NCT01908803|7503107|FG001|Overall Study|Adverse Event|0
4633128|NCT01908803|7503106|FG000|Overall Study|Physician Decision|0
4633129|NCT01908803|7503107|FG001|Overall Study|Physician Decision|1
4633130|NCT01908803|7503106|FG000|Overall Study|Withdrawal by Subject|1
4633131|NCT01908803|7503107|FG001|Overall Study|Withdrawal by Subject|0
4633132|NCT01908803|7503106|FG000|Overall Study|Randomization Error|1
4633133|NCT01908803|7503107|FG001|Overall Study|Randomization Error|0
4633134|NCT01908803|7503106|FG000|Overall Study|Adverse Event (pre-treatment)|1
4633135|NCT01908803|7503107|FG001|Overall Study|Adverse Event (pre-treatment)|0
4633136|NCT01908816|7503118|FG000|Overall Study|Subject's no longer requires study drug|0
4624115|NCT01816906|7488069|FG000|Six Months|Did Not Show Up for Baseline Measurement|7
4562436|NCT01295827|7395821|FG002|Overall Study|Other|0
4562437|NCT01295827|7395822|FG003|Overall Study|Other|0
4562438|NCT01295827|7395823|FG004|Overall Study|Other|0
4562439|NCT01295827|7395824|FG005|Overall Study|Other|0
4562440|NCT01295827|7395825|FG006|Overall Study|Other|1
4562441|NCT01295827|7395826|FG007|Overall Study|Other|1
4562442|NCT01295827|7395827|FG008|Overall Study|Other|1
4562443|NCT01295827|7395828|FG009|Overall Study|Other|0
4562444|NCT01295827|7395829|FG010|Overall Study|Other|2
4562445|NCT01295827|7395830|FG011|Overall Study|Other|0
4562446|NCT01295827|7395831|FG012|Overall Study|Other|0
4562447|NCT01295827|7395832|FG013|Overall Study|Other|0
4562448|NCT01295827|7395833|FG014|Overall Study|Other|0
4562449|NCT01295905|7395898|FG000|Overall Study|Did not meet inclusion criteria|1
4562450|NCT01295905|7395899|FG001|Overall Study|Did not meet inclusion criteria|0
4562451|NCT01295905|7395898|FG000|Overall Study|Met exclusion criteria|1
4562452|NCT01295905|7395899|FG001|Overall Study|Met exclusion criteria|0
4562453|NCT01296035|7395905|FG000|Overall Study|Withdrawal by Subject|1
4562454|NCT01296152|7395909|FG000|Overall Study|Unwilling to adhere to study requirement|1
4562455|NCT01296347|7395924|FG000|Allocation|Withdrawal by Subject|1
4562456|NCT01296347|7395925|FG001|Allocation|Withdrawal by Subject|2
4562457|NCT01296347|7395924|FG000|Allocation|Lack of Efficacy|1
4562458|NCT01296347|7395925|FG001|Allocation|Lack of Efficacy|2
4562459|NCT01296347|7395924|FG000|Allocation|not received infusion|1
4562460|NCT01296347|7395925|FG001|Allocation|not received infusion|0
4562461|NCT01296347|7395924|FG000|6 Week Follow up|Death|0
4562462|NCT01296347|7395925|FG001|6 Week Follow up|Death|1
4562463|NCT01296347|7395924|FG000|3 Month Follow up|Death|1
4562464|NCT01296347|7395925|FG001|3 Month Follow up|Death|0
4562465|NCT01296347|7395924|FG000|3 Month Follow up|Lost to Follow-up|0
4562466|NCT01296347|7395925|FG001|3 Month Follow up|Lost to Follow-up|1
4562467|NCT01296347|7395924|FG000|6 Month Follow up|Death|2
4562468|NCT01296347|7395925|FG001|6 Month Follow up|Death|1
4562469|NCT01296347|7395924|FG000|6 Month Follow up|Lost to Follow-up|0
4562470|NCT01296347|7395925|FG001|6 Month Follow up|Lost to Follow-up|1
4562471|NCT01296347|7395924|FG000|12 Month Follow up|Lost to Follow-up|3
4562472|NCT01296347|7395925|FG001|12 Month Follow up|Lost to Follow-up|1
4562473|NCT01296347|7395924|FG000|12 Month Follow up|Death|1
4562474|NCT01296347|7395925|FG001|12 Month Follow up|Death|1
4562475|NCT01296347|7395924|FG000|12 Month Follow up|Withdrawal by Subject|0
4562476|NCT01296347|7395925|FG001|12 Month Follow up|Withdrawal by Subject|1
4562477|NCT01296412|7395945|FG000|Overall Study|Adverse Event|8
4562478|NCT01296412|7395946|FG001|Overall Study|Adverse Event|29
4562479|NCT01296412|7395945|FG000|Overall Study|Lack of Efficacy|1
4562480|NCT01296412|7395946|FG001|Overall Study|Lack of Efficacy|0
4562481|NCT01296412|7395945|FG000|Overall Study|Lost to Follow-up|10
4562482|NCT01296412|7395946|FG001|Overall Study|Lost to Follow-up|7
4562483|NCT01296412|7395945|FG000|Overall Study|Non-compliance with study drug|1
4562484|NCT01296412|7395946|FG001|Overall Study|Non-compliance with study drug|2
4562485|NCT01296412|7395945|FG000|Overall Study|Other reason not specified|20
4562486|NCT01296412|7395946|FG001|Overall Study|Other reason not specified|15
4562487|NCT01296412|7395945|FG000|Overall Study|Physician Decision|1
4562488|NCT01296412|7395946|FG001|Overall Study|Physician Decision|3
4562489|NCT01296412|7395945|FG000|Overall Study|Pregnancy|0
4562490|NCT01296412|7395946|FG001|Overall Study|Pregnancy|1
4562491|NCT01296412|7395945|FG000|Overall Study|Withdrawal by Subject|10
4562492|NCT01296412|7395946|FG001|Overall Study|Withdrawal by Subject|13
4562493|NCT01296568|7395961|FG000|Continued Access Phase|Lost to Follow-up|1
4562494|NCT01296568|7395961|FG000|Continued Access Phase|Withdrawal by Subject|1
4562495|NCT01296568|7395961|FG000|Continued Access Phase|Disease Progression|1
4562496|NCT01296672|7395978|FG000|Overall Study|Lost to Follow-up|73
4562497|NCT01296672|7395979|FG001|Overall Study|Lost to Follow-up|18
4562498|NCT01296698|7395989|FG000|Overall Study|Adverse Event|1
4562499|NCT01296698|7395990|FG001|Overall Study|Adverse Event|0
4562500|NCT01296698|7395989|FG000|Overall Study|Death|1
4562501|NCT01296698|7395990|FG001|Overall Study|Death|0
4562502|NCT01296698|7395989|FG000|Overall Study|Lost to Follow-up|19
4562503|NCT01296698|7395990|FG001|Overall Study|Lost to Follow-up|1
4562504|NCT01296698|7395989|FG000|Overall Study|Withdrawal by Subject|12
4562505|NCT01296698|7395990|FG001|Overall Study|Withdrawal by Subject|0
4562506|NCT01296698|7395989|FG000|Overall Study|Difficulty Contacting Subject|2
4562507|NCT01296698|7395990|FG001|Overall Study|Difficulty Contacting Subject|0
4562508|NCT01296698|7395989|FG000|Overall Study|Study Terminated by Sponsor|209
4562509|NCT01296698|7395990|FG001|Overall Study|Study Terminated by Sponsor|12
4562510|NCT01296932|7396038|FG000|Overall Study|Dose limiting toxicity|0
4562511|NCT01296932|7396039|FG001|Overall Study|Dose limiting toxicity|0
4562512|NCT01296932|7396040|FG002|Overall Study|Dose limiting toxicity|0
4562513|NCT01296932|7396041|FG003|Overall Study|Dose limiting toxicity|0
4562514|NCT01296932|7396042|FG004|Overall Study|Dose limiting toxicity|0
4562515|NCT01296932|7396043|FG005|Overall Study|Dose limiting toxicity|0
4562516|NCT01296932|7396044|FG006|Overall Study|Dose limiting toxicity|1
4562517|NCT01296932|7396045|FG007|Overall Study|Dose limiting toxicity|0
4562518|NCT01296932|7396046|FG008|Overall Study|Dose limiting toxicity|1
4562519|NCT01296932|7396038|FG000|Overall Study|Progressive disease|2
4562520|NCT01296932|7396039|FG001|Overall Study|Progressive disease|0
4562521|NCT01296932|7396040|FG002|Overall Study|Progressive disease|1
4562522|NCT01296932|7396041|FG003|Overall Study|Progressive disease|1
4562523|NCT01296932|7396042|FG004|Overall Study|Progressive disease|2
4562524|NCT01296932|7396043|FG005|Overall Study|Progressive disease|3
4562525|NCT01296932|7396044|FG006|Overall Study|Progressive disease|1
4562526|NCT01296932|7396045|FG007|Overall Study|Progressive disease|0
4562527|NCT01296932|7396046|FG008|Overall Study|Progressive disease|0
4562528|NCT01296932|7396038|FG000|Overall Study|Withdrawal by Subject|0
4562529|NCT01296932|7396039|FG001|Overall Study|Withdrawal by Subject|0
4562530|NCT01296932|7396040|FG002|Overall Study|Withdrawal by Subject|1
4562531|NCT01296932|7396041|FG003|Overall Study|Withdrawal by Subject|1
4562532|NCT01296932|7396042|FG004|Overall Study|Withdrawal by Subject|0
4562533|NCT01296932|7396043|FG005|Overall Study|Withdrawal by Subject|0
4562534|NCT01296932|7396044|FG006|Overall Study|Withdrawal by Subject|3
4562535|NCT01296932|7396045|FG007|Overall Study|Withdrawal by Subject|0
4562536|NCT01296932|7396046|FG008|Overall Study|Withdrawal by Subject|0
4562537|NCT01296932|7396038|FG000|Overall Study|Adverse Event|1
4562538|NCT01296932|7396039|FG001|Overall Study|Adverse Event|1
4562539|NCT01296932|7396040|FG002|Overall Study|Adverse Event|1
4562540|NCT01296932|7396041|FG003|Overall Study|Adverse Event|2
4562541|NCT01296932|7396042|FG004|Overall Study|Adverse Event|1
4562542|NCT01296932|7396043|FG005|Overall Study|Adverse Event|0
4624116|NCT01816906|7488070|FG001|Six Months|Did Not Show Up for Baseline Measurement|6
4624117|NCT01816906|7488069|FG000|Six Months|Lost to Follow-up|14
4624118|NCT01816906|7488070|FG001|Six Months|Lost to Follow-up|16
4624119|NCT01816906|7488069|FG000|12 Months|Adverse Event|2
4624120|NCT01816906|7488070|FG001|12 Months|Adverse Event|2
4624121|NCT01816906|7488069|FG000|12 Months|Death|0
4562543|NCT01296932|7396044|FG006|Overall Study|Adverse Event|0
4562544|NCT01296932|7396045|FG007|Overall Study|Adverse Event|0
4562545|NCT01296932|7396046|FG008|Overall Study|Adverse Event|1
4562546|NCT01296932|7396038|FG000|Overall Study|Investigator decision|0
4562547|NCT01296932|7396039|FG001|Overall Study|Investigator decision|1
4562548|NCT01296932|7396040|FG002|Overall Study|Investigator decision|0
4562549|NCT01296932|7396041|FG003|Overall Study|Investigator decision|1
4562550|NCT01296932|7396042|FG004|Overall Study|Investigator decision|0
4562551|NCT01296932|7396043|FG005|Overall Study|Investigator decision|0
4562552|NCT01296932|7396044|FG006|Overall Study|Investigator decision|1
4562553|NCT01296932|7396045|FG007|Overall Study|Investigator decision|0
4562554|NCT01296932|7396046|FG008|Overall Study|Investigator decision|1
4562555|NCT01296932|7396038|FG000|Overall Study|No clinical benefit anymore|0
4562556|NCT01296932|7396039|FG001|Overall Study|No clinical benefit anymore|1
4562557|NCT01296932|7396040|FG002|Overall Study|No clinical benefit anymore|0
4562558|NCT01296932|7396041|FG003|Overall Study|No clinical benefit anymore|0
4562559|NCT01296932|7396042|FG004|Overall Study|No clinical benefit anymore|0
4562560|NCT01296932|7396043|FG005|Overall Study|No clinical benefit anymore|0
4562561|NCT01296932|7396044|FG006|Overall Study|No clinical benefit anymore|0
4562562|NCT01296932|7396045|FG007|Overall Study|No clinical benefit anymore|0
4562563|NCT01296932|7396046|FG008|Overall Study|No clinical benefit anymore|0
4562564|NCT01296932|7396038|FG000|Overall Study|Physician Decision|0
4562565|NCT01296932|7396039|FG001|Overall Study|Physician Decision|0
4562566|NCT01296932|7396040|FG002|Overall Study|Physician Decision|1
4562567|NCT01296932|7396041|FG003|Overall Study|Physician Decision|0
4562568|NCT01296932|7396042|FG004|Overall Study|Physician Decision|0
4562569|NCT01296932|7396043|FG005|Overall Study|Physician Decision|0
4562570|NCT01296932|7396044|FG006|Overall Study|Physician Decision|0
4562571|NCT01296932|7396045|FG007|Overall Study|Physician Decision|0
4562572|NCT01296932|7396046|FG008|Overall Study|Physician Decision|0
4562573|NCT01296932|7396038|FG000|Overall Study|IV problems, administration not possible|0
4562574|NCT01296932|7396039|FG001|Overall Study|IV problems, administration not possible|0
4562575|NCT01296932|7396040|FG002|Overall Study|IV problems, administration not possible|1
4562576|NCT01296932|7396041|FG003|Overall Study|IV problems, administration not possible|0
4562577|NCT01296932|7396042|FG004|Overall Study|IV problems, administration not possible|0
4562578|NCT01296932|7396043|FG005|Overall Study|IV problems, administration not possible|0
4562579|NCT01296932|7396044|FG006|Overall Study|IV problems, administration not possible|0
4562580|NCT01296932|7396045|FG007|Overall Study|IV problems, administration not possible|0
4562581|NCT01296932|7396046|FG008|Overall Study|IV problems, administration not possible|0
4562582|NCT01296932|7396038|FG000|Overall Study|per protocol|0
4562583|NCT01296932|7396039|FG001|Overall Study|per protocol|0
4562584|NCT01296932|7396040|FG002|Overall Study|per protocol|1
4562585|NCT01296932|7396041|FG003|Overall Study|per protocol|1
4562586|NCT01296932|7396042|FG004|Overall Study|per protocol|0
4624122|NCT01816906|7488070|FG001|12 Months|Death|2
4624123|NCT01816906|7488069|FG000|12 Months|Lost to Follow-up|2
4624124|NCT01816906|7488070|FG001|12 Months|Lost to Follow-up|1
4624125|NCT01816984|7488086|FG000|Overall Study|declining health status|1
4562587|NCT01296932|7396043|FG005|Overall Study|per protocol|0
4624126|NCT01817075|7488092|FG000|Overall Study|Adverse Event|7
4624127|NCT01817075|7488093|FG001|Overall Study|Adverse Event|5
4624128|NCT01817075|7488092|FG000|Overall Study|Physician Decision|9
4562588|NCT01296932|7396044|FG006|Overall Study|per protocol|0
4562589|NCT01296932|7396045|FG007|Overall Study|per protocol|0
4562590|NCT01296932|7396046|FG008|Overall Study|per protocol|0
4624129|NCT01817075|7488093|FG001|Overall Study|Physician Decision|12
4562591|NCT01296932|7396038|FG000|Overall Study|Low benefit and too many side effects|0
4562592|NCT01296932|7396039|FG001|Overall Study|Low benefit and too many side effects|0
4562593|NCT01296932|7396040|FG002|Overall Study|Low benefit and too many side effects|0
4562594|NCT01296932|7396041|FG003|Overall Study|Low benefit and too many side effects|0
4562595|NCT01296932|7396042|FG004|Overall Study|Low benefit and too many side effects|0
4562596|NCT01296932|7396043|FG005|Overall Study|Low benefit and too many side effects|0
4562597|NCT01296932|7396044|FG006|Overall Study|Low benefit and too many side effects|0
4562598|NCT01296932|7396045|FG007|Overall Study|Low benefit and too many side effects|1
4562599|NCT01296932|7396046|FG008|Overall Study|Low benefit and too many side effects|0
4562600|NCT01296932|7396038|FG000|Overall Study|No adequate treatment response|0
4562601|NCT01296932|7396039|FG001|Overall Study|No adequate treatment response|0
4562602|NCT01296932|7396040|FG002|Overall Study|No adequate treatment response|0
4562603|NCT01296932|7396041|FG003|Overall Study|No adequate treatment response|0
4562604|NCT01296932|7396042|FG004|Overall Study|No adequate treatment response|0
4562605|NCT01296932|7396043|FG005|Overall Study|No adequate treatment response|0
4562606|NCT01296932|7396044|FG006|Overall Study|No adequate treatment response|0
4562607|NCT01296932|7396045|FG007|Overall Study|No adequate treatment response|1
4562608|NCT01296932|7396046|FG008|Overall Study|No adequate treatment response|0
4562609|NCT01296932|7396038|FG000|Overall Study|Dosage already reduced, AE still present|0
4562610|NCT01296932|7396039|FG001|Overall Study|Dosage already reduced, AE still present|0
4562611|NCT01296932|7396040|FG002|Overall Study|Dosage already reduced, AE still present|0
4562612|NCT01296932|7396041|FG003|Overall Study|Dosage already reduced, AE still present|0
4562613|NCT01296932|7396042|FG004|Overall Study|Dosage already reduced, AE still present|0
4562614|NCT01296932|7396043|FG005|Overall Study|Dosage already reduced, AE still present|0
4562615|NCT01296932|7396044|FG006|Overall Study|Dosage already reduced, AE still present|0
4562616|NCT01296932|7396045|FG007|Overall Study|Dosage already reduced, AE still present|0
4562617|NCT01296932|7396046|FG008|Overall Study|Dosage already reduced, AE still present|1
4562618|NCT01297062|7396073|FG000|Overall Study|Adverse Event|2
4562619|NCT01297062|7396074|FG001|Overall Study|Adverse Event|0
4562620|NCT01297062|7396075|FG002|Overall Study|Adverse Event|1
4562621|NCT01297062|7396076|FG003|Overall Study|Adverse Event|0
4562622|NCT01297062|7396077|FG004|Overall Study|Adverse Event|0
4562623|NCT01297062|7396078|FG005|Overall Study|Adverse Event|0
4562624|NCT01297062|7396079|FG006|Overall Study|Adverse Event|0
4562625|NCT01297062|7396073|FG000|Overall Study|Physician Decision|1
4562626|NCT01297062|7396074|FG001|Overall Study|Physician Decision|0
4562627|NCT01297062|7396075|FG002|Overall Study|Physician Decision|1
4562628|NCT01297062|7396076|FG003|Overall Study|Physician Decision|0
4624130|NCT01817075|7488092|FG000|Overall Study|Withdrawal by Subject|31
4624131|NCT01817075|7488093|FG001|Overall Study|Withdrawal by Subject|15
4690767|NCT02563561|7600549|FG000|Overall Study|Lost to Follow-up|1
4690768|NCT02563561|7600550|FG001|Overall Study|Lost to Follow-up|1
4690769|NCT02563561|7600551|FG002|Overall Study|Lost to Follow-up|0
4690770|NCT02563561|7600549|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4
4690771|NCT02563561|7600550|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2
4690772|NCT02563561|7600551|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1
4690773|NCT02563561|7600549|FG000|Overall Study|Investigator Decision|3
4624132|NCT01817075|7488092|FG000|Overall Study|Received Sorafenib after enrollment|0
4624133|NCT01817075|7488093|FG001|Overall Study|Received Sorafenib after enrollment|1
4624134|NCT01817075|7488092|FG000|Overall Study|Ineligible|0
4624135|NCT01817075|7488093|FG001|Overall Study|Ineligible|2
4624136|NCT01817530|7488123|FG000|Overall Study|Exclusionary Medication Received|0
4624137|NCT01817530|7488124|FG001|Overall Study|Exclusionary Medication Received|0
4624138|NCT01817530|7488125|FG002|Overall Study|Exclusionary Medication Received|0
4624139|NCT01817530|7488126|FG003|Overall Study|Exclusionary Medication Received|0
4624140|NCT01817530|7488127|FG004|Overall Study|Exclusionary Medication Received|1
4624141|NCT01817530|7488128|FG005|Overall Study|Exclusionary Medication Received|0
4624142|NCT01817530|7488129|FG006|Overall Study|Exclusionary Medication Received|0
4624143|NCT01817530|7488130|FG007|Overall Study|Exclusionary Medication Received|0
4624144|NCT01817530|7488123|FG000|Overall Study|Adverse Event|6
4624145|NCT01817530|7488124|FG001|Overall Study|Adverse Event|3
4624146|NCT01817530|7488125|FG002|Overall Study|Adverse Event|2
4624147|NCT01817530|7488126|FG003|Overall Study|Adverse Event|5
4624148|NCT01817530|7488127|FG004|Overall Study|Adverse Event|0
4624149|NCT01817530|7488128|FG005|Overall Study|Adverse Event|10
4624150|NCT01817530|7488129|FG006|Overall Study|Adverse Event|5
4624151|NCT01817530|7488130|FG007|Overall Study|Adverse Event|8
4624152|NCT01817530|7488123|FG000|Overall Study|Subject Noncompliant|3
4624153|NCT01817530|7488124|FG001|Overall Study|Subject Noncompliant|1
4624154|NCT01817530|7488125|FG002|Overall Study|Subject Noncompliant|0
4624155|NCT01817530|7488126|FG003|Overall Study|Subject Noncompliant|4
4624156|NCT01817530|7488127|FG004|Overall Study|Subject Noncompliant|0
4624157|NCT01817530|7488128|FG005|Overall Study|Subject Noncompliant|1
4624158|NCT01817530|7488129|FG006|Overall Study|Subject Noncompliant|1
4624159|NCT01817530|7488130|FG007|Overall Study|Subject Noncompliant|1
4624160|NCT01817530|7488123|FG000|Overall Study|Lack of Efficacy|1
4690774|NCT02563561|7600550|FG001|Overall Study|Investigator Decision|4
4562629|NCT01297062|7396077|FG004|Overall Study|Physician Decision|0
4562630|NCT01297062|7396078|FG005|Overall Study|Physician Decision|0
4562631|NCT01297062|7396079|FG006|Overall Study|Physician Decision|6
4562632|NCT01297062|7396073|FG000|Overall Study|Protocol Violation|0
4562633|NCT01297062|7396074|FG001|Overall Study|Protocol Violation|0
4562634|NCT01297062|7396075|FG002|Overall Study|Protocol Violation|0
4562635|NCT01297062|7396076|FG003|Overall Study|Protocol Violation|0
4562636|NCT01297062|7396077|FG004|Overall Study|Protocol Violation|1
4562637|NCT01297062|7396078|FG005|Overall Study|Protocol Violation|0
4562638|NCT01297062|7396079|FG006|Overall Study|Protocol Violation|0
4562639|NCT01297062|7396073|FG000|Overall Study|Subject Decision|1
4562640|NCT01297062|7396074|FG001|Overall Study|Subject Decision|1
4562641|NCT01297062|7396075|FG002|Overall Study|Subject Decision|0
4562642|NCT01297062|7396076|FG003|Overall Study|Subject Decision|1
4562643|NCT01297062|7396077|FG004|Overall Study|Subject Decision|1
4562644|NCT01297062|7396078|FG005|Overall Study|Subject Decision|1
4562645|NCT01297062|7396079|FG006|Overall Study|Subject Decision|2
4562646|NCT01297244|7396089|FG000|Overall Study|Progressive disease|22
4562647|NCT01297244|7396090|FG001|Overall Study|Progressive disease|3
4562648|NCT01297244|7396089|FG000|Overall Study|Adverse Event|9
4562649|NCT01297244|7396090|FG001|Overall Study|Adverse Event|1
4562650|NCT01297244|7396089|FG000|Overall Study|Death|1
4562651|NCT01297244|7396090|FG001|Overall Study|Death|1
4562652|NCT01297244|7396089|FG000|Overall Study|Clinical progression|1
4562653|NCT01297244|7396090|FG001|Overall Study|Clinical progression|1
4562654|NCT01297244|7396089|FG000|Overall Study|Withdrawal by Subject|2
4562655|NCT01297244|7396090|FG001|Overall Study|Withdrawal by Subject|0
4562656|NCT01297270|7396105|FG000|Overall Study|Adverse Event|19
4562657|NCT01297270|7396106|FG001|Overall Study|Adverse Event|32
4562658|NCT01297270|7396107|FG002|Overall Study|Adverse Event|5
4562659|NCT01297270|7396105|FG000|Overall Study|Lack of Efficacy|15
4562660|NCT01297270|7396106|FG001|Overall Study|Lack of Efficacy|17
4562661|NCT01297270|7396107|FG002|Overall Study|Lack of Efficacy|15
4562662|NCT01297270|7396105|FG000|Overall Study|Lost to Follow-up|1
4562663|NCT01297270|7396106|FG001|Overall Study|Lost to Follow-up|2
4562664|NCT01297270|7396107|FG002|Overall Study|Lost to Follow-up|1
4562665|NCT01297270|7396105|FG000|Overall Study|Protocol Violation|0
4562666|NCT01297270|7396106|FG001|Overall Study|Protocol Violation|2
4562667|NCT01297270|7396107|FG002|Overall Study|Protocol Violation|0
4562668|NCT01297270|7396105|FG000|Overall Study|Withdrawal by Subject|7
4562669|NCT01297270|7396106|FG001|Overall Study|Withdrawal by Subject|15
4562670|NCT01297270|7396107|FG002|Overall Study|Withdrawal by Subject|7
4562671|NCT01297270|7396105|FG000|Overall Study|Other reason not defined above|3
4562672|NCT01297270|7396106|FG001|Overall Study|Other reason not defined above|3
4562673|NCT01297270|7396107|FG002|Overall Study|Other reason not defined above|1
4562674|NCT01297270|7396105|FG000|Overall Study|Not treated|0
4562675|NCT01297270|7396106|FG001|Overall Study|Not treated|1
4562676|NCT01297270|7396107|FG002|Overall Study|Not treated|0
4562677|NCT01297309|7396119|FG000|Overall Study|Eligibility failure|2
4562678|NCT01297309|7396119|FG000|Overall Study|Screen failure|2
4562679|NCT01297309|7396119|FG000|Overall Study|Withdrawal by Subject|5
4562680|NCT01297309|7396119|FG000|Overall Study|Adverse Event|1
4562681|NCT01297309|7396119|FG000|Overall Study|Investigator Decision|2
4562682|NCT01297309|7396119|FG000|Overall Study|Death|1
4562683|NCT01297309|7396119|FG000|Overall Study|Participant not entering extensionperiod|1
4562684|NCT01297322|7396125|FG000|Overall Study|Lost to Follow-up|1
4562685|NCT01297322|7396126|FG001|Overall Study|Lost to Follow-up|0
4562686|NCT01297322|7396125|FG000|Overall Study|Withdrawal by Subject|0
4562687|NCT01297322|7396126|FG001|Overall Study|Withdrawal by Subject|1
4562688|NCT01297322|7396125|FG000|Overall Study|Protocol Violation|0
4562689|NCT01297322|7396126|FG001|Overall Study|Protocol Violation|3
4562690|NCT01297465|7396151|FG000|Overall Study|Lack of Ovarian Response|1
4562691|NCT01297465|7396152|FG001|Overall Study|Lack of Ovarian Response|1
4562692|NCT01297465|7396151|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0
4562693|NCT01297465|7396152|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1
4562694|NCT01297465|7396151|FG000|Overall Study|No Oocytes Retrieved|1
4562695|NCT01297465|7396152|FG001|Overall Study|No Oocytes Retrieved|1
4562696|NCT01297465|7396151|FG000|Overall Study|Poor oocyte quality|0
4562697|NCT01297465|7396152|FG001|Overall Study|Poor oocyte quality|1
4562698|NCT01297465|7396151|FG000|Overall Study|No Fertilization|6
4562699|NCT01297465|7396152|FG001|Overall Study|No Fertilization|4
4562700|NCT01297465|7396151|FG000|Overall Study|All Embryos Discarded|0
4562701|NCT01297465|7396152|FG001|Overall Study|All Embryos Discarded|1
4562702|NCT01297465|7396151|FG000|Overall Study|Intention to Freeze all Embryos|0
4562703|NCT01297465|7396152|FG001|Overall Study|Intention to Freeze all Embryos|1
4562704|NCT01297491|7396160|FG000|Overall Study|Adverse Event|11
4562705|NCT01297491|7396161|FG001|Overall Study|Adverse Event|6
4562706|NCT01297491|7396160|FG000|Overall Study|Physician Decision|3
4562707|NCT01297491|7396161|FG001|Overall Study|Physician Decision|2
4562708|NCT01297491|7396160|FG000|Overall Study|Progressive disease|11
4562709|NCT01297491|7396161|FG001|Overall Study|Progressive disease|20
4562710|NCT01297491|7396160|FG000|Overall Study|Patient/Guardian decision|3
4562711|NCT01297491|7396161|FG001|Overall Study|Patient/Guardian decision|4
4562712|NCT01297491|7396160|FG000|Overall Study|Death|2
4562713|NCT01297491|7396161|FG001|Overall Study|Death|1
4562714|NCT01297504|7396167|FG000|Overall Study|Invalid Consent|1
4562715|NCT01297504|7396167|FG000|Overall Study|Received Palivizumab in Previous Season|1
4562716|NCT01297504|7396167|FG000|Overall Study|No Study Visits|4
4562717|NCT01297504|7396167|FG000|Overall Study|Death|3
4562718|NCT01297504|7396167|FG000|Overall Study|Lost to Follow-up|43
4562719|NCT01297504|7396167|FG000|Overall Study|Withdrawal by Subject|9
4562720|NCT01297504|7396167|FG000|Overall Study|Site Closure|3
4562721|NCT01297504|7396167|FG000|Overall Study|Protocol Violation|3
4562722|NCT01297517|7396178|FG000|Overall Study|Adverse Event|21
4562723|NCT01297517|7396179|FG001|Overall Study|Adverse Event|7
4562724|NCT01297517|7396180|FG002|Overall Study|Adverse Event|16
4562725|NCT01297517|7396178|FG000|Overall Study|Lost to Follow-up|1
4562726|NCT01297517|7396179|FG001|Overall Study|Lost to Follow-up|0
4562727|NCT01297517|7396180|FG002|Overall Study|Lost to Follow-up|1
4562728|NCT01297517|7396178|FG000|Overall Study|Patient Decision Unrelated to AE|2
4562729|NCT01297517|7396179|FG001|Overall Study|Patient Decision Unrelated to AE|3
4562730|NCT01297517|7396180|FG002|Overall Study|Patient Decision Unrelated to AE|7
4562731|NCT01297517|7396178|FG000|Overall Study|Noncompliance|1
4562732|NCT01297517|7396179|FG001|Overall Study|Noncompliance|0
4562733|NCT01297517|7396180|FG002|Overall Study|Noncompliance|0
4562734|NCT01297517|7396178|FG000|Overall Study|Protocol Violation|1
4562735|NCT01297517|7396179|FG001|Overall Study|Protocol Violation|1
4562736|NCT01297517|7396180|FG002|Overall Study|Protocol Violation|1
4562737|NCT01297517|7396178|FG000|Overall Study|Inadequate Control of IOP|1
4562738|NCT01297517|7396179|FG001|Overall Study|Inadequate Control of IOP|1
4562739|NCT01297517|7396180|FG002|Overall Study|Inadequate Control of IOP|2
4562740|NCT01297920|7396198|FG000|Overall Study|Adverse Event|42
4562741|NCT01297920|7396199|FG001|Overall Study|Adverse Event|10
4562742|NCT01297920|7396200|FG002|Overall Study|Adverse Event|38
4562743|NCT01297920|7396198|FG000|Overall Study|Patient Decision Unrelated to AE|6
4562744|NCT01297920|7396199|FG001|Overall Study|Patient Decision Unrelated to AE|5
4562745|NCT01297920|7396200|FG002|Overall Study|Patient Decision Unrelated to AE|2
4562746|NCT01297920|7396198|FG000|Overall Study|Noncompliance|1
4562747|NCT01297920|7396199|FG001|Overall Study|Noncompliance|0
4562748|NCT01297920|7396200|FG002|Overall Study|Noncompliance|0
4562749|NCT01297920|7396198|FG000|Overall Study|Protocol Violation|1
4562750|NCT01297920|7396199|FG001|Overall Study|Protocol Violation|3
4562751|NCT01297920|7396200|FG002|Overall Study|Protocol Violation|0
4562752|NCT01297920|7396198|FG000|Overall Study|Inadequate Control of IOP|7
4562753|NCT01297920|7396199|FG001|Overall Study|Inadequate Control of IOP|9
4562754|NCT01297920|7396200|FG002|Overall Study|Inadequate Control of IOP|17
4562755|NCT01297920|7396198|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1
4562756|NCT01297920|7396199|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0
4562757|NCT01297920|7396200|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0
4562758|NCT01297959|7396210|FG000|Overall Study|Adverse Event|0
4562759|NCT01297959|7396211|FG001|Overall Study|Adverse Event|1
4562760|NCT01297959|7396210|FG000|Overall Study|Protocol Violation|2
4562761|NCT01297959|7396211|FG001|Overall Study|Protocol Violation|1
4562762|NCT01297959|7396210|FG000|Overall Study|Withdrawal by Subject|5
4562763|NCT01297959|7396211|FG001|Overall Study|Withdrawal by Subject|4
4562764|NCT01297959|7396210|FG000|Overall Study|Physician Decision|0
4562765|NCT01297959|7396211|FG001|Overall Study|Physician Decision|1
4562766|NCT01297959|7396210|FG000|Overall Study|Unrelated medical illness / complication|0
4562767|NCT01297959|7396211|FG001|Overall Study|Unrelated medical illness / complication|2
4562768|NCT01297959|7396210|FG000|Overall Study|Other|13
4562769|NCT01297959|7396211|FG001|Overall Study|Other|7
4562770|NCT01298141|7396257|FG000|Overall Study|Adverse Event|3
4562771|NCT01298141|7396257|FG000|Overall Study|Refusal of Required Study Procedures|1
4562772|NCT01298141|7396257|FG000|Overall Study|Withdrawal by Subject|6
4562773|NCT01298141|7396257|FG000|Overall Study|Termination of Study by the Investigator|5
4562774|NCT01298141|7396257|FG000|Overall Study|Other|5
4562775|NCT01298141|7396257|FG000|Overall Study|Lost to Follow-up|1
4562776|NCT01298141|7396257|FG000|Overall Study|Death|6
4562777|NCT01298141|7396257|FG000|Overall Study|Not treated|4
4562778|NCT01298193|7396270|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2
4562779|NCT01298193|7396270|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16
4562780|NCT01298193|7396270|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9
4624161|NCT01817530|7488124|FG001|Overall Study|Lack of Efficacy|0
4624162|NCT01817530|7488125|FG002|Overall Study|Lack of Efficacy|0
4624163|NCT01817530|7488126|FG003|Overall Study|Lack of Efficacy|0
4624164|NCT01817530|7488127|FG004|Overall Study|Lack of Efficacy|0
4624165|NCT01817530|7488128|FG005|Overall Study|Lack of Efficacy|1
4624166|NCT01817530|7488129|FG006|Overall Study|Lack of Efficacy|0
4624167|NCT01817530|7488130|FG007|Overall Study|Lack of Efficacy|1
4624168|NCT01817530|7488123|FG000|Overall Study|Pregnancy|0
4624169|NCT01817530|7488124|FG001|Overall Study|Pregnancy|0
4624170|NCT01817530|7488125|FG002|Overall Study|Pregnancy|0
4624171|NCT01817530|7488126|FG003|Overall Study|Pregnancy|0
4624172|NCT01817530|7488127|FG004|Overall Study|Pregnancy|0
4624173|NCT01817530|7488128|FG005|Overall Study|Pregnancy|1
4624174|NCT01817530|7488129|FG006|Overall Study|Pregnancy|0
4624175|NCT01817530|7488130|FG007|Overall Study|Pregnancy|0
4624176|NCT01817530|7488123|FG000|Overall Study|Other|0
4624177|NCT01817530|7488124|FG001|Overall Study|Other|1
4624178|NCT01817530|7488125|FG002|Overall Study|Other|0
4624179|NCT01817530|7488126|FG003|Overall Study|Other|0
4562781|NCT01298193|7396270|FG000|Efficacy Phase (Second Cycle)|Death|1
4562782|NCT01298323|7396288|FG000|Overall Study|Adverse Event|2
4562783|NCT01298323|7396289|FG001|Overall Study|Adverse Event|4
4562784|NCT01298323|7396288|FG000|Overall Study|Death|11
4562785|NCT01298323|7396289|FG001|Overall Study|Death|16
4562786|NCT01298323|7396288|FG000|Overall Study|Lost to Follow-up|1
4562787|NCT01298323|7396289|FG001|Overall Study|Lost to Follow-up|0
4562788|NCT01298323|7396288|FG000|Overall Study|Withdrawal by Subject|6
4562789|NCT01298323|7396289|FG001|Overall Study|Withdrawal by Subject|3
4562790|NCT01298323|7396288|FG000|Overall Study|Protocol Violation|1
4562791|NCT01298323|7396289|FG001|Overall Study|Protocol Violation|0
4562792|NCT01298323|7396288|FG000|Overall Study|Other|10
4562793|NCT01298323|7396289|FG001|Overall Study|Other|9
4562794|NCT01298323|7396288|FG000|Overall Study|Ongoing|55
4562795|NCT01298323|7396289|FG001|Overall Study|Ongoing|55
4562796|NCT01298323|7396288|FG000|Overall Study|Eligibility criteria not fulfilled|0
4562797|NCT01298323|7396289|FG001|Overall Study|Eligibility criteria not fulfilled|1
4562798|NCT01298362|7396297|FG000|Overall Study|Did not provide 12month BMD measurements|38
4562799|NCT01298362|7396298|FG001|Overall Study|Did not provide 12month BMD measurements|43
4562800|NCT01298492|7396306|FG000|Overall Study|Death|2
4562801|NCT01298492|7396306|FG000|Overall Study|Insufficient Clinical Response|22
4562802|NCT01298492|7396306|FG000|Overall Study|Lost to Follow-up|12
4562803|NCT01298492|7396306|FG000|Overall Study|Withdrawal by Subject|47
4562804|NCT01298492|7396306|FG000|Overall Study|Other (Unspecified)|7
4562805|NCT01298492|7396306|FG000|Overall Study|Withdrawn Due to Pregnancy|1
4562806|NCT01298492|7396306|FG000|Overall Study|Protocol Violation|2
4562807|NCT01298492|7396306|FG000|Overall Study|Adverse Event(Related to Study Drug)|8
4562808|NCT01298492|7396306|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18
4562809|NCT01298518|7396313|FG000|Overall Study|Withdrawal by Subject|0
4562810|NCT01298518|7396314|FG001|Overall Study|Withdrawal by Subject|0
4562811|NCT01298518|7396315|FG002|Overall Study|Withdrawal by Subject|1
4562812|NCT01298531|7396325|FG000|Overall Study|Lack of Efficacy|0
4562813|NCT01298531|7396326|FG001|Overall Study|Lack of Efficacy|1
4562814|NCT01298531|7396325|FG000|Overall Study|Lost to Follow-up|2
4562815|NCT01298531|7396326|FG001|Overall Study|Lost to Follow-up|0
4562816|NCT01298531|7396325|FG000|Overall Study|Protocol Violation|1
4562817|NCT01298531|7396326|FG001|Overall Study|Protocol Violation|1
4562818|NCT01298531|7396325|FG000|Overall Study|Adverse Event|4
4562819|NCT01298531|7396326|FG001|Overall Study|Adverse Event|3
4562820|NCT01298531|7396325|FG000|Overall Study|Does not meet entrance criteria|0
4562821|NCT01298531|7396326|FG001|Overall Study|Does not meet entrance criteria|1
4562822|NCT01298531|7396325|FG000|Overall Study|Other|2
4562823|NCT01298531|7396326|FG001|Overall Study|Other|1
4562824|NCT01298570|7396341|FG000|Overall Study|Disease progression, relapse during acti|64
4562825|NCT01298570|7396342|FG001|Overall Study|Disease progression, relapse during acti|40
4562826|NCT01298570|7396341|FG000|Overall Study|Adverse Event|20
4562827|NCT01298570|7396342|FG001|Overall Study|Adverse Event|2
4562828|NCT01298570|7396341|FG000|Overall Study|Withdrawal by Subject|21
4562829|NCT01298570|7396342|FG001|Overall Study|Withdrawal by Subject|6
4562830|NCT01298570|7396341|FG000|Overall Study|Treatment delay > 4 weeks|4
4562831|NCT01298570|7396342|FG001|Overall Study|Treatment delay > 4 weeks|5
4562832|NCT01298570|7396341|FG000|Overall Study|Physician Decision|4
4562833|NCT01298570|7396342|FG001|Overall Study|Physician Decision|2
4562834|NCT01298570|7396341|FG000|Overall Study|Other complicating disease|2
4562835|NCT01298570|7396342|FG001|Overall Study|Other complicating disease|1
4562836|NCT01298570|7396341|FG000|Overall Study|Surgery|2
4562837|NCT01298570|7396342|FG001|Overall Study|Surgery|1
4562838|NCT01298570|7396341|FG000|Overall Study|Symptomatic progression/deterioration|3
4562839|NCT01298570|7396342|FG001|Overall Study|Symptomatic progression/deterioration|2
4562840|NCT01298570|7396341|FG000|Overall Study|Death|0
4562841|NCT01298570|7396342|FG001|Overall Study|Death|1
4562842|NCT01298570|7396341|FG000|Overall Study|Ineligibility|0
4562843|NCT01298570|7396342|FG001|Overall Study|Ineligibility|1
4562844|NCT01298596|7396350|FG000|Overall Study|Withdrawal by Subject|1
4562845|NCT01298596|7396351|FG001|Overall Study|Withdrawal by Subject|1
4562846|NCT01298596|7396350|FG000|Overall Study|Death|5
4562847|NCT01298596|7396351|FG001|Overall Study|Death|3
4562848|NCT01298596|7396350|FG000|Overall Study|Lost to Follow-up|6
4562849|NCT01298596|7396351|FG001|Overall Study|Lost to Follow-up|14
4562850|NCT01298596|7396350|FG000|Overall Study|Referred for further management|16
4562851|NCT01298596|7396351|FG001|Overall Study|Referred for further management|15
4562852|NCT01298648|7396357|FG000|Overall Study|Withdrawal by Subject|2
4562853|NCT01298648|7396357|FG000|Overall Study|Lost to Follow-up|21
4562854|NCT01298661|7396364|FG000|Overall Study|Withdrawal by Subject|2
4562855|NCT01298661|7396365|FG001|Overall Study|Withdrawal by Subject|0
4562856|NCT01298661|7396366|FG002|Overall Study|Withdrawal by Subject|2
4562857|NCT01298700|7396377|FG000|Overall Study|Adverse Event|50
4562858|NCT01298700|7396378|FG001|Overall Study|Adverse Event|51
4562859|NCT01298700|7396377|FG000|Overall Study|Lack of Efficacy|9
4562860|NCT01298700|7396378|FG001|Overall Study|Lack of Efficacy|14
4562861|NCT01298700|7396377|FG000|Overall Study|Lost to Follow-up|5
4562862|NCT01298700|7396378|FG001|Overall Study|Lost to Follow-up|2
4562863|NCT01298700|7396377|FG000|Overall Study|Withdrawal by Subject|12
4562864|NCT01298700|7396378|FG001|Overall Study|Withdrawal by Subject|9
4562865|NCT01298700|7396377|FG000|Overall Study|Protocol Violation|6
4562866|NCT01298700|7396378|FG001|Overall Study|Protocol Violation|4
4562867|NCT01298700|7396377|FG000|Overall Study|Other Miscellaneous Reasons|16
4562868|NCT01298700|7396378|FG001|Overall Study|Other Miscellaneous Reasons|15
4562869|NCT01298700|7396377|FG000|Overall Study|Did not Receive Study Drug|3
4562870|NCT01298700|7396378|FG001|Overall Study|Did not Receive Study Drug|5
4562871|NCT01298765|7396393|FG000|Titration Period|Adverse Event|26
4562872|NCT01298765|7396393|FG000|Titration Period|Death|1
4562873|NCT01298765|7396393|FG000|Titration Period|Lack of Efficacy|21
4562874|NCT01298765|7396393|FG000|Titration Period|Lost to Follow-up|9
4562875|NCT01298765|7396393|FG000|Titration Period|Physician Decision|1
4562876|NCT01298765|7396393|FG000|Titration Period|Withdrawal by Subject|10
4562877|NCT01298765|7396393|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8
4562878|NCT01298765|7396393|FG000|Long-Term Treatment Period|Adverse Event|19
4562879|NCT01298765|7396393|FG000|Long-Term Treatment Period|Lack of Efficacy|6
4562880|NCT01298765|7396393|FG000|Long-Term Treatment Period|Lost to Follow-up|8
4562881|NCT01298765|7396393|FG000|Long-Term Treatment Period|Withdrawal by Subject|19
4562882|NCT01298765|7396393|FG000|Long-Term Treatment Period|Physician Decision|1
4562883|NCT01298765|7396393|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46
4562884|NCT01298778|7396399|FG000|Overall Study|Lost to Follow-up|2
4562885|NCT01298778|7396400|FG001|Overall Study|Lost to Follow-up|3
4562886|NCT01298778|7396399|FG000|Overall Study|Incorrect use of VAS|1
4562887|NCT01298778|7396400|FG001|Overall Study|Incorrect use of VAS|0
4562888|NCT01298778|7396399|FG000|Overall Study|Withdrawal by Subject|0
4562889|NCT01298778|7396400|FG001|Overall Study|Withdrawal by Subject|1
4562890|NCT01298778|7396399|FG000|Overall Study|Protocol Violation|0
4562891|NCT01298778|7396400|FG001|Overall Study|Protocol Violation|1
4562892|NCT01298778|7396399|FG000|Overall Study|not meet inclusion/exclusion criteria|0
4562893|NCT01298778|7396400|FG001|Overall Study|not meet inclusion/exclusion criteria|1
4562894|NCT01298999|7396410|FG000|Overall Study|Physician Decision|0
4562895|NCT01298999|7396411|FG001|Overall Study|Physician Decision|1
4562896|NCT01298999|7396410|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3
4562897|NCT01298999|7396411|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0
4562898|NCT01299025|7396419|FG000|Overall Study|Withdrawal by Subject|2
4562899|NCT01299025|7396420|FG001|Overall Study|Withdrawal by Subject|1
4562900|NCT01299025|7396419|FG000|Overall Study|Lost to Follow-up|1
4562901|NCT01299025|7396420|FG001|Overall Study|Lost to Follow-up|0
4562902|NCT01299038|7396428|FG000|Overall Study|Withdrawal by Subject|1
4562903|NCT01299038|7396429|FG001|Overall Study|Withdrawal by Subject|0
4562904|NCT01299116|7396459|FG000|Overall Study|Lost to Follow-up|65
4562905|NCT01299116|7396460|FG001|Overall Study|Lost to Follow-up|9
4562906|NCT01299116|7396461|FG002|Overall Study|Lost to Follow-up|11
4562907|NCT01299272|7396472|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140
4562908|NCT01299272|7396473|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0
4562909|NCT01299272|7396474|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0
4562910|NCT01299272|7396475|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0
4562911|NCT01299272|7396472|FG000|Acute Open-label (OL) Period|Adverse Event|140
4562912|NCT01299272|7396473|FG001|Acute Open-label (OL) Period|Adverse Event|0
4562913|NCT01299272|7396474|FG002|Acute Open-label (OL) Period|Adverse Event|0
4562914|NCT01299272|7396475|FG003|Acute Open-label (OL) Period|Adverse Event|0
4562915|NCT01299272|7396472|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56
4562916|NCT01299272|7396473|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0
4562917|NCT01299272|7396474|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0
4562918|NCT01299272|7396475|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0
4562919|NCT01299272|7396472|FG000|Acute Open-label (OL) Period|Protocol Violation|36
4562920|NCT01299272|7396473|FG001|Acute Open-label (OL) Period|Protocol Violation|0
4562921|NCT01299272|7396474|FG002|Acute Open-label (OL) Period|Protocol Violation|0
4562922|NCT01299272|7396475|FG003|Acute Open-label (OL) Period|Protocol Violation|0
4562923|NCT01299272|7396472|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14
4562924|NCT01299272|7396473|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0
4562925|NCT01299272|7396474|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0
4562926|NCT01299272|7396475|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0
4562927|NCT01299272|7396472|FG000|Acute Open-label (OL) Period|Sponsor Decision|13
4562928|NCT01299272|7396473|FG001|Acute Open-label (OL) Period|Sponsor Decision|0
4562929|NCT01299272|7396474|FG002|Acute Open-label (OL) Period|Sponsor Decision|0
4562930|NCT01299272|7396475|FG003|Acute Open-label (OL) Period|Sponsor Decision|0
4562931|NCT01299272|7396472|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10
4562932|NCT01299272|7396473|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0
4562933|NCT01299272|7396474|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0
4562934|NCT01299272|7396475|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0
4562935|NCT01299272|7396472|FG000|Acute Open-label (OL) Period|Physician Decision|5
4562936|NCT01299272|7396473|FG001|Acute Open-label (OL) Period|Physician Decision|0
4562937|NCT01299272|7396474|FG002|Acute Open-label (OL) Period|Physician Decision|0
4562938|NCT01299272|7396475|FG003|Acute Open-label (OL) Period|Physician Decision|0
4562939|NCT01299272|7396472|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
4562940|NCT01299272|7396473|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80
4562941|NCT01299272|7396474|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
4562942|NCT01299272|7396475|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
4562943|NCT01299272|7396472|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0
4562944|NCT01299272|7396473|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44
4562945|NCT01299272|7396474|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0
4562946|NCT01299272|7396475|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0
4562947|NCT01299272|7396472|FG000|Stabilization Open-label (OL) Period|Adverse Event|0
4562948|NCT01299272|7396473|FG001|Stabilization Open-label (OL) Period|Adverse Event|42
4562949|NCT01299272|7396474|FG002|Stabilization Open-label (OL) Period|Adverse Event|0
4562950|NCT01299272|7396475|FG003|Stabilization Open-label (OL) Period|Adverse Event|0
4562951|NCT01299272|7396472|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
4562952|NCT01299272|7396473|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42
4562953|NCT01299272|7396474|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
4562954|NCT01299272|7396475|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
4562955|NCT01299272|7396472|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0
4562956|NCT01299272|7396473|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12
4562957|NCT01299272|7396474|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0
4562958|NCT01299272|7396475|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0
4562959|NCT01299272|7396472|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0
4562960|NCT01299272|7396473|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11
4562961|NCT01299272|7396474|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0
4562962|NCT01299272|7396475|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0
4562963|NCT01299272|7396472|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0
4562964|NCT01299272|7396473|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9
4562965|NCT01299272|7396474|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0
4562966|NCT01299272|7396475|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0
4562967|NCT01299272|7396472|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
4562968|NCT01299272|7396473|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6
4562969|NCT01299272|7396474|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
4562970|NCT01299272|7396475|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
4562971|NCT01299272|7396472|FG000|Stabilization Open-label (OL) Period|Physician Decision|0
4562972|NCT01299272|7396473|FG001|Stabilization Open-label (OL) Period|Physician Decision|3
4562973|NCT01299272|7396474|FG002|Stabilization Open-label (OL) Period|Physician Decision|0
4562974|NCT01299272|7396475|FG003|Stabilization Open-label (OL) Period|Physician Decision|0
4562975|NCT01299272|7396472|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0
4562976|NCT01299272|7396473|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0
4562977|NCT01299272|7396474|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22
4562978|NCT01299272|7396475|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15
4562979|NCT01299272|7396472|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0
4562980|NCT01299272|7396473|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0
4562981|NCT01299272|7396474|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20
4562982|NCT01299272|7396475|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10
4562983|NCT01299272|7396472|FG000|Double-blind (DB) Randomized Period|Adverse Event|0
4562984|NCT01299272|7396473|FG001|Double-blind (DB) Randomized Period|Adverse Event|0
4562985|NCT01299272|7396474|FG002|Double-blind (DB) Randomized Period|Adverse Event|8
4562986|NCT01299272|7396475|FG003|Double-blind (DB) Randomized Period|Adverse Event|9
4562987|NCT01299272|7396472|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0
4562988|NCT01299272|7396473|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0
4562989|NCT01299272|7396474|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8
4562990|NCT01299272|7396475|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7
4562991|NCT01299272|7396472|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0
4562992|NCT01299272|7396473|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0
4562993|NCT01299272|7396474|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5
4562994|NCT01299272|7396475|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5
4562995|NCT01299272|7396472|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0
4592393|NCT01540474|7439960|FG002|Vaccination Period|Lost to Follow-up|0
4624180|NCT01817530|7488127|FG004|Overall Study|Other|1
4624181|NCT01817530|7488128|FG005|Overall Study|Other|0
4690775|NCT02563561|7600551|FG002|Overall Study|Investigator Decision|2
4770419|NCT03740919|7746731|FG001|Treatment Period|Failure of Inclusion Criteria|0
4624182|NCT01817530|7488129|FG006|Overall Study|Other|5
4624183|NCT01817530|7488130|FG007|Overall Study|Other|0
4624184|NCT01817530|7488123|FG000|Overall Study|Surgery or Invasive Intervention|1
4624185|NCT01817530|7488124|FG001|Overall Study|Surgery or Invasive Intervention|0
4624186|NCT01817530|7488125|FG002|Overall Study|Surgery or Invasive Intervention|0
4624187|NCT01817530|7488126|FG003|Overall Study|Surgery or Invasive Intervention|0
4624188|NCT01817530|7488127|FG004|Overall Study|Surgery or Invasive Intervention|1
4624189|NCT01817530|7488128|FG005|Overall Study|Surgery or Invasive Intervention|1
4624190|NCT01817530|7488129|FG006|Overall Study|Surgery or Invasive Intervention|1
4624191|NCT01817530|7488130|FG007|Overall Study|Surgery or Invasive Intervention|0
4562996|NCT01299272|7396473|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0
4562997|NCT01299272|7396474|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4
4562998|NCT01299272|7396475|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10
4562999|NCT01299272|7396472|FG000|Double-blind (DB) Randomized Period|Physician Decision|0
4563000|NCT01299272|7396473|FG001|Double-blind (DB) Randomized Period|Physician Decision|0
4563001|NCT01299272|7396474|FG002|Double-blind (DB) Randomized Period|Physician Decision|2
4563002|NCT01299272|7396475|FG003|Double-blind (DB) Randomized Period|Physician Decision|1
4563003|NCT01299272|7396472|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0
4563004|NCT01299272|7396473|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0
4563005|NCT01299272|7396474|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1
4563006|NCT01299272|7396475|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1
4563007|NCT01299376|7396497|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1
4563008|NCT01299376|7396498|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2
4563009|NCT01299376|7396497|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0
4563010|NCT01299376|7396498|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1
4563011|NCT01299376|7396497|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0
4563012|NCT01299376|7396498|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1
4563013|NCT01299376|7396497|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4
4563014|NCT01299376|7396498|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7
4563015|NCT01299376|7396497|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1
4563016|NCT01299376|7396498|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0
4563017|NCT01299376|7396497|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1
4563018|NCT01299376|7396498|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1
4563019|NCT01299376|7396497|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2
4563020|NCT01299376|7396498|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1
4563021|NCT01299376|7396497|FG000|Extension (Weeks 9 to 52)|Adverse Event|2
4563022|NCT01299376|7396498|FG001|Extension (Weeks 9 to 52)|Adverse Event|3
4563023|NCT01299376|7396497|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1
4563024|NCT01299376|7396498|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2
4563025|NCT01299376|7396497|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4
4563026|NCT01299376|7396498|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9
4563027|NCT01299376|7396497|FG000|Extension (Weeks 9 to 52)|Physician Decision|1
4563028|NCT01299376|7396498|FG001|Extension (Weeks 9 to 52)|Physician Decision|0
4563029|NCT01299389|7396510|FG000|Double-blind|Adverse Event|45
4563030|NCT01299389|7396511|FG001|Double-blind|Adverse Event|27
4563031|NCT01299389|7396512|FG002|Double-blind|Adverse Event|0
4563032|NCT01299389|7396513|FG003|Double-blind|Adverse Event|0
4563033|NCT01299389|7396510|FG000|Double-blind|Lack of Efficacy|45
4563034|NCT01299389|7396511|FG001|Double-blind|Lack of Efficacy|21
4563035|NCT01299389|7396512|FG002|Double-blind|Lack of Efficacy|0
4563036|NCT01299389|7396513|FG003|Double-blind|Lack of Efficacy|0
4563037|NCT01299389|7396510|FG000|Double-blind|Lost to Follow-up|2
4563038|NCT01299389|7396511|FG001|Double-blind|Lost to Follow-up|1
4563039|NCT01299389|7396512|FG002|Double-blind|Lost to Follow-up|0
4563040|NCT01299389|7396513|FG003|Double-blind|Lost to Follow-up|0
4563041|NCT01299389|7396510|FG000|Double-blind|Withdrawal by Subject|16
4563042|NCT01299389|7396511|FG001|Double-blind|Withdrawal by Subject|13
4563043|NCT01299389|7396512|FG002|Double-blind|Withdrawal by Subject|0
4563044|NCT01299389|7396513|FG003|Double-blind|Withdrawal by Subject|0
4563045|NCT01299389|7396510|FG000|Double-blind|Other|1
4563046|NCT01299389|7396511|FG001|Double-blind|Other|1
4563047|NCT01299389|7396512|FG002|Double-blind|Other|0
4563048|NCT01299389|7396513|FG003|Double-blind|Other|0
4563049|NCT01299389|7396510|FG000|Double-blind|"fail to meet study population criteria"|0
4563050|NCT01299389|7396511|FG001|Double-blind|"fail to meet study population criteria"|1
4563051|NCT01299389|7396512|FG002|Double-blind|"fail to meet study population criteria"|0
4563052|NCT01299389|7396513|FG003|Double-blind|"fail to meet study population criteria"|0
4563053|NCT01299389|7396510|FG000|Post-observational|Other|0
4563054|NCT01299389|7396511|FG001|Post-observational|Other|0
4563055|NCT01299389|7396512|FG002|Post-observational|Other|12
4563056|NCT01299389|7396513|FG003|Post-observational|Other|6
4563057|NCT01299480|7396570|FG000|Overall Study|No longer willing to participate|19
4563058|NCT01299480|7396571|FG001|Overall Study|No longer willing to participate|17
4563059|NCT01299480|7396572|FG002|Overall Study|No longer willing to participate|14
4563060|NCT01299480|7396573|FG003|Overall Study|No longer willing to participate|13
4563061|NCT01299480|7396574|FG004|Overall Study|No longer willing to participate|10
4563062|NCT01299480|7396570|FG000|Overall Study|Protocol Violation|7
4563063|NCT01299480|7396571|FG001|Overall Study|Protocol Violation|5
4563064|NCT01299480|7396572|FG002|Overall Study|Protocol Violation|8
4563065|NCT01299480|7396573|FG003|Overall Study|Protocol Violation|1
4563066|NCT01299480|7396574|FG004|Overall Study|Protocol Violation|1
4563067|NCT01299480|7396570|FG000|Overall Study|Withdrawal by Subject|3
4563068|NCT01299480|7396571|FG001|Overall Study|Withdrawal by Subject|4
4563069|NCT01299480|7396572|FG002|Overall Study|Withdrawal by Subject|7
4563070|NCT01299480|7396573|FG003|Overall Study|Withdrawal by Subject|3
4624192|NCT01817530|7488123|FG000|Overall Study|Consent Withdrawn by Subject|3
4624193|NCT01817530|7488124|FG001|Overall Study|Consent Withdrawn by Subject|4
4624194|NCT01817530|7488125|FG002|Overall Study|Consent Withdrawn by Subject|7
4624195|NCT01817530|7488126|FG003|Overall Study|Consent Withdrawn by Subject|3
4624196|NCT01817530|7488127|FG004|Overall Study|Consent Withdrawn by Subject|5
4624197|NCT01817530|7488128|FG005|Overall Study|Consent Withdrawn by Subject|3
4624198|NCT01817530|7488129|FG006|Overall Study|Consent Withdrawn by Subject|3
4624199|NCT01817530|7488130|FG007|Overall Study|Consent Withdrawn by Subject|10
4563071|NCT01299480|7396574|FG004|Overall Study|Withdrawal by Subject|4
4563072|NCT01299480|7396570|FG000|Overall Study|Adverse Event|6
4563073|NCT01299480|7396571|FG001|Overall Study|Adverse Event|4
4563074|NCT01299480|7396572|FG002|Overall Study|Adverse Event|5
4563075|NCT01299480|7396573|FG003|Overall Study|Adverse Event|4
4563076|NCT01299480|7396574|FG004|Overall Study|Adverse Event|0
4563077|NCT01299480|7396570|FG000|Overall Study|Withdrawal due to pregnancy|0
4563078|NCT01299480|7396571|FG001|Overall Study|Withdrawal due to pregnancy|1
4563079|NCT01299480|7396572|FG002|Overall Study|Withdrawal due to pregnancy|1
4563080|NCT01299480|7396573|FG003|Overall Study|Withdrawal due to pregnancy|0
4563081|NCT01299480|7396574|FG004|Overall Study|Withdrawal due to pregnancy|0
4563082|NCT01299480|7396570|FG000|Overall Study|Physician Decision|1
4563083|NCT01299480|7396571|FG001|Overall Study|Physician Decision|1
4563084|NCT01299480|7396572|FG002|Overall Study|Physician Decision|0
4563085|NCT01299480|7396573|FG003|Overall Study|Physician Decision|2
4563086|NCT01299480|7396574|FG004|Overall Study|Physician Decision|0
4563087|NCT01299480|7396570|FG000|Overall Study|Lost to Follow-up|3
4563088|NCT01299480|7396571|FG001|Overall Study|Lost to Follow-up|1
4563089|NCT01299480|7396572|FG002|Overall Study|Lost to Follow-up|2
4563090|NCT01299480|7396573|FG003|Overall Study|Lost to Follow-up|1
4563091|NCT01299480|7396574|FG004|Overall Study|Lost to Follow-up|2
4563092|NCT01299480|7396570|FG000|Overall Study|Other|3
4563093|NCT01299480|7396571|FG001|Overall Study|Other|2
4563094|NCT01299480|7396572|FG002|Overall Study|Other|3
4563095|NCT01299480|7396573|FG003|Overall Study|Other|0
4563096|NCT01299480|7396574|FG004|Overall Study|Other|3
4563097|NCT01299480|7396570|FG000|Overall Study|Started, but not vaccinated|0
4563098|NCT01299480|7396571|FG001|Overall Study|Started, but not vaccinated|0
4563099|NCT01299480|7396572|FG002|Overall Study|Started, but not vaccinated|1
4563100|NCT01299480|7396573|FG003|Overall Study|Started, but not vaccinated|1
4563101|NCT01299480|7396574|FG004|Overall Study|Started, but not vaccinated|0
4563102|NCT01299571|7396587|FG000|Overall Study|Protocol Violation|107
4563103|NCT01299584|7396592|FG000|Overall Study|Protocol Violation|9
4563104|NCT01299727|7396616|FG000|Overall Study|Withdrawal by Subject|1
4563105|NCT01299727|7396617|FG001|Overall Study|Withdrawal by Subject|0
4563106|NCT01299727|7396618|FG002|Overall Study|Withdrawal by Subject|0
4563107|NCT01299727|7396616|FG000|Overall Study|Adverse Event|0
4563108|NCT01299727|7396617|FG001|Overall Study|Adverse Event|0
4563109|NCT01299727|7396618|FG002|Overall Study|Adverse Event|1
4563110|NCT01299727|7396616|FG000|Overall Study|Completed the Treatment Period|3
4563111|NCT01299727|7396617|FG001|Overall Study|Completed the Treatment Period|4
4563112|NCT01299727|7396618|FG002|Overall Study|Completed the Treatment Period|3
4563113|NCT01299766|7396628|FG000|Overall Study|Death|5
4563114|NCT01299766|7396629|FG001|Overall Study|Death|4
4563115|NCT01299766|7396628|FG000|Overall Study|Withdrawal by Subject|29
4563116|NCT01299766|7396629|FG001|Overall Study|Withdrawal by Subject|19
4563117|NCT01299805|7396637|FG000|Overall Study|Adverse Event|2
4563118|NCT01299805|7396638|FG001|Overall Study|Adverse Event|0
4563119|NCT01299896|7396646|FG000|Overall Study|Withdrawal by Subject|1
4563120|NCT01299896|7396647|FG001|Overall Study|Withdrawal by Subject|7
4563121|NCT01299896|7396646|FG000|Overall Study|Lost to Follow-up|0
4563122|NCT01299896|7396647|FG001|Overall Study|Lost to Follow-up|11
4563123|NCT01299909|7396656|FG000|Overall Study|Lost to Follow-up|22
4563124|NCT01299909|7396657|FG001|Overall Study|Lost to Follow-up|18
4563125|NCT01299909|7396658|FG002|Overall Study|Lost to Follow-up|17
4563126|NCT01299961|7396665|FG000|Overall Study|Adverse Event|3
4563127|NCT01299961|7396665|FG000|Overall Study|Lack of Efficacy|2
4563128|NCT01299961|7396665|FG000|Overall Study|Lost to Follow-up|1
4563129|NCT01300052|7396671|FG000|Overall Study|Adverse Event|3
4563130|NCT01300052|7396672|FG001|Overall Study|Adverse Event|0
4563131|NCT01300052|7396671|FG000|Overall Study|Withdrawal by Subject|2
4563132|NCT01300052|7396672|FG001|Overall Study|Withdrawal by Subject|2
4563133|NCT01300052|7396671|FG000|Overall Study|Protocol Violation|1
4563134|NCT01300052|7396672|FG001|Overall Study|Protocol Violation|1
4563135|NCT01300234|7396689|FG000|Overall Study|Adverse Event|1
4563136|NCT01300234|7396690|FG001|Overall Study|Adverse Event|1
4563137|NCT01300234|7396689|FG000|Overall Study|Protocol Violation|2
4563138|NCT01300234|7396690|FG001|Overall Study|Protocol Violation|3
4563139|NCT01300234|7396689|FG000|Overall Study|Withdrawal by Subject|5
4563140|NCT01300234|7396690|FG001|Overall Study|Withdrawal by Subject|9
4563141|NCT01300234|7396689|FG000|Overall Study|Lost to Follow-up|14
4563142|NCT01300234|7396690|FG001|Overall Study|Lost to Follow-up|12
4563143|NCT01300234|7396689|FG000|Overall Study|Pregnancy|2
4563144|NCT01300234|7396690|FG001|Overall Study|Pregnancy|1
4563145|NCT01300234|7396689|FG000|Overall Study|Participant reached stopping critera|2
4563146|NCT01300234|7396690|FG001|Overall Study|Participant reached stopping critera|0
4563147|NCT01300234|7396689|FG000|Overall Study|Participant stopped medication|1
4624200|NCT01817530|7488123|FG000|Overall Study|Lost to Follow-up|1
4563148|NCT01300234|7396690|FG001|Overall Study|Participant stopped medication|1
4563149|NCT01300234|7396689|FG000|Overall Study|Participant refused return to hospital|1
4563150|NCT01300234|7396690|FG001|Overall Study|Participant refused return to hospital|0
4563151|NCT01300247|7396709|FG000|Overall Study|Death|1
4563152|NCT01300247|7396710|FG001|Overall Study|Death|1
4563153|NCT01300247|7396709|FG000|Overall Study|Lost to Follow-up|2
4563154|NCT01300247|7396710|FG001|Overall Study|Lost to Follow-up|0
4563155|NCT01300247|7396709|FG000|Overall Study|Withdrawal by Subject|1
4563156|NCT01300247|7396710|FG001|Overall Study|Withdrawal by Subject|0
4563157|NCT01300247|7396709|FG000|Overall Study|Non-Compliance|0
4563158|NCT01300247|7396710|FG001|Overall Study|Non-Compliance|1
4563159|NCT01300260|7396718|FG000|Period 1 of Study: First Intervention|Adverse Event|0
4563160|NCT01300260|7396719|FG001|Period 1 of Study: First Intervention|Adverse Event|1
4563161|NCT01300260|7396718|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1
4563162|NCT01300260|7396719|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0
4563163|NCT01300260|7396718|FG000|Period 2 of Study: Second Intervention|Adverse Event|0
4563164|NCT01300260|7396719|FG001|Period 2 of Study: Second Intervention|Adverse Event|1
4563165|NCT01300286|7396736|FG000|Overall Study|did not get dosed|1
4563166|NCT01300338|7396743|FG000|Overall Study|Lost to Follow-up|5
4563167|NCT01300338|7396744|FG001|Overall Study|Lost to Follow-up|0
4563168|NCT01300351|7396752|FG000|Overall Study|Did not receive treatment|2
4563169|NCT01300351|7396753|FG001|Overall Study|Did not receive treatment|0
4563170|NCT01300351|7396752|FG000|Overall Study|Ongoing treatment at data cut-off|27
4563171|NCT01300351|7396753|FG001|Overall Study|Ongoing treatment at data cut-off|23
4563172|NCT01300351|7396752|FG000|Overall Study|Lost to Follow-up|0
4563173|NCT01300351|7396753|FG001|Overall Study|Lost to Follow-up|1
4563174|NCT01300351|7396752|FG000|Overall Study|Adverse Event|0
4563175|NCT01300351|7396753|FG001|Overall Study|Adverse Event|4
4563176|NCT01300351|7396752|FG000|Overall Study|Withdrawal by Subject|7
4563177|NCT01300351|7396753|FG001|Overall Study|Withdrawal by Subject|10
4563178|NCT01300455|7396761|FG000|Washout|Withdrawal by Subject|1
4563179|NCT01300455|7396762|FG001|Washout|Withdrawal by Subject|0
4563180|NCT01300546|7396770|FG000|Overall Study|Withdrawal by Subject|1
4563181|NCT01300546|7396771|FG001|Overall Study|Withdrawal by Subject|0
4563182|NCT01300546|7396770|FG000|Overall Study|Lost to Follow-up|0
4563183|NCT01300546|7396771|FG001|Overall Study|Lost to Follow-up|2
4563184|NCT01300546|7396770|FG000|Overall Study|Lack of Efficacy|0
4563185|NCT01300546|7396771|FG001|Overall Study|Lack of Efficacy|3
4563186|NCT01300546|7396770|FG000|Overall Study|Adverse Event|0
4563187|NCT01300546|7396771|FG001|Overall Study|Adverse Event|1
4563188|NCT01300572|7396786|FG000|Overall Study|HAMA + post dosimetry|1
4592394|NCT01540474|7439961|FG003|Vaccination Period|Lost to Follow-up|0
4592395|NCT01540487|7439974|FG000|Overall Study|Protocol Violation|1
4592396|NCT01540487|7439975|FG001|Overall Study|Protocol Violation|0
4593739|NCT01555125|7442332|FG001|Maintenance Period|Subject / guardian decision|2
4593740|NCT01555125|7442333|FG002|Maintenance Period|Subject / guardian decision|0
4593741|NCT01555125|7442334|FG003|Maintenance Period|Subject / guardian decision|0
4593742|NCT01555125|7442335|FG004|Maintenance Period|Subject / guardian decision|0
4593743|NCT01555125|7442331|FG000|Maintenance Period|Lost to Follow-up|2
4593744|NCT01555125|7442332|FG001|Maintenance Period|Lost to Follow-up|0
4593745|NCT01555125|7442333|FG002|Maintenance Period|Lost to Follow-up|0
4593746|NCT01555125|7442334|FG003|Maintenance Period|Lost to Follow-up|1
4593747|NCT01555125|7442335|FG004|Maintenance Period|Lost to Follow-up|0
4593748|NCT01555125|7442331|FG000|Maintenance Period|Lack of Efficacy|6
4593749|NCT01555125|7442332|FG001|Maintenance Period|Lack of Efficacy|1
4593750|NCT01555125|7442333|FG002|Maintenance Period|Lack of Efficacy|3
4593751|NCT01555125|7442334|FG003|Maintenance Period|Lack of Efficacy|0
4593752|NCT01555125|7442335|FG004|Maintenance Period|Lack of Efficacy|0
4593753|NCT01555125|7442331|FG000|Maintenance Period|Physician Decision|0
4593754|NCT01555125|7442332|FG001|Maintenance Period|Physician Decision|0
4593755|NCT01555125|7442333|FG002|Maintenance Period|Physician Decision|1
4593756|NCT01555125|7442334|FG003|Maintenance Period|Physician Decision|0
4593757|NCT01555125|7442335|FG004|Maintenance Period|Physician Decision|0
4593758|NCT01555125|7442331|FG000|Maintenance Period|Death|0
4593759|NCT01555125|7442332|FG001|Maintenance Period|Death|0
4593760|NCT01555125|7442333|FG002|Maintenance Period|Death|0
4593761|NCT01555125|7442334|FG003|Maintenance Period|Death|1
4593762|NCT01555125|7442335|FG004|Maintenance Period|Death|0
4593763|NCT01555125|7442331|FG000|Extension|Adverse Event|1
4593764|NCT01555125|7442332|FG001|Extension|Adverse Event|2
4593765|NCT01555125|7442333|FG002|Extension|Adverse Event|1
4593766|NCT01555125|7442334|FG003|Extension|Adverse Event|1
4593767|NCT01555125|7442335|FG004|Extension|Adverse Event|0
4593768|NCT01555125|7442331|FG000|Extension|Protocol deviation|1
4593769|NCT01555125|7442332|FG001|Extension|Protocol deviation|0
4593770|NCT01555125|7442333|FG002|Extension|Protocol deviation|0
4593771|NCT01555125|7442334|FG003|Extension|Protocol deviation|0
4593772|NCT01555125|7442335|FG004|Extension|Protocol deviation|0
4593773|NCT01555125|7442331|FG000|Extension|Lack of Efficacy|7
4593774|NCT01555125|7442332|FG001|Extension|Lack of Efficacy|6
4593775|NCT01555125|7442333|FG002|Extension|Lack of Efficacy|3
4593776|NCT01555125|7442334|FG003|Extension|Lack of Efficacy|0
4593777|NCT01555125|7442335|FG004|Extension|Lack of Efficacy|0
4563189|NCT01300650|7396796|FG000|Overall Study|Adverse Event|1
4563190|NCT01300728|7396803|FG000|Overall Study|Withdrawal by Subject|1
4563191|NCT01300728|7396804|FG001|Overall Study|Withdrawal by Subject|1
4563192|NCT01300728|7396803|FG000|Overall Study|Physician Decision|1
4563193|NCT01300728|7396804|FG001|Overall Study|Physician Decision|0
4563194|NCT01300741|7396810|FG000|Overall Study|Lens deposits|1
4563195|NCT01300741|7396810|FG000|Overall Study|Lost to Follow-up|1
4563196|NCT01300741|7396810|FG000|Overall Study|Discomfort|1
4563197|NCT01300767|7396816|FG000|Overall Study|Discomfort|2
4563198|NCT01300767|7396816|FG000|Overall Study|Biomicroscopy|1
4563199|NCT01300767|7396816|FG000|Overall Study|Unacceptable fit|1
4563200|NCT01300819|7396824|FG000|Overall Study|Adverse Event|9
4563201|NCT01300819|7396825|FG001|Overall Study|Adverse Event|27
4563202|NCT01300819|7396824|FG000|Overall Study|Lack of Efficacy|2
4563203|NCT01300819|7396825|FG001|Overall Study|Lack of Efficacy|1
4563204|NCT01300819|7396824|FG000|Overall Study|Withdrawal by Subject|10
4563205|NCT01300819|7396825|FG001|Overall Study|Withdrawal by Subject|12
4563206|NCT01300819|7396824|FG000|Overall Study|Patient was 1 month late for Visit 10|0
4563207|NCT01300819|7396825|FG001|Overall Study|Patient was 1 month late for Visit 10|1
4563208|NCT01300819|7396824|FG000|Overall Study|Refusal to down titrate study drug|0
4563209|NCT01300819|7396825|FG001|Overall Study|Refusal to down titrate study drug|1
4563210|NCT01300819|7396824|FG000|Overall Study|Administrative reason|0
4563211|NCT01300819|7396825|FG001|Overall Study|Administrative reason|1
4563212|NCT01300819|7396824|FG000|Overall Study|Safety follow up not done by mistake|0
4563213|NCT01300819|7396825|FG001|Overall Study|Safety follow up not done by mistake|1
4563214|NCT01300819|7396824|FG000|Overall Study|Follow up call was not done|1
4563215|NCT01300819|7396825|FG001|Overall Study|Follow up call was not done|0
4563216|NCT01300923|7396831|FG000|Overall Study|Physician Decision|0
4563217|NCT01300923|7396832|FG001|Overall Study|Physician Decision|2
4563218|NCT01301001|7396850|FG000|First Intervention|Lost to Follow-up|4
4563219|NCT01301001|7396851|FG001|First Intervention|Lost to Follow-up|4
4563220|NCT01301001|7396850|FG000|First Intervention|Withdrawal by Subject|1
4563221|NCT01301001|7396851|FG001|First Intervention|Withdrawal by Subject|4
4563222|NCT01301001|7396850|FG000|First Intervention|Adverse Event|5
4563223|NCT01301001|7396851|FG001|First Intervention|Adverse Event|0
4563224|NCT01301001|7396850|FG000|First Intervention|Protocol Violation|0
4563225|NCT01301001|7396851|FG001|First Intervention|Protocol Violation|1
4563226|NCT01301001|7396850|FG000|Second Intervention|Adverse Event|2
4563227|NCT01301001|7396851|FG001|Second Intervention|Adverse Event|0
4563228|NCT01301001|7396850|FG000|Second Intervention|Withdrawal by Subject|2
4563229|NCT01301001|7396851|FG001|Second Intervention|Withdrawal by Subject|0
4563230|NCT01301027|7396860|FG000|Overall Study|Physician Decision|2
4563231|NCT01301027|7396861|FG001|Overall Study|Physician Decision|0
4563232|NCT01301027|7396860|FG000|Overall Study|Withdrawal by Subject|2
4563233|NCT01301027|7396861|FG001|Overall Study|Withdrawal by Subject|3
4563234|NCT01301027|7396860|FG000|Overall Study|Adverse Event|0
4563235|NCT01301027|7396861|FG001|Overall Study|Adverse Event|2
4563236|NCT01301027|7396860|FG000|Overall Study|Fracture|1
4563237|NCT01301027|7396861|FG001|Overall Study|Fracture|3
4563238|NCT01301027|7396860|FG000|Overall Study|Transplant|0
4563239|NCT01301027|7396861|FG001|Overall Study|Transplant|2
4563240|NCT01301027|7396860|FG000|Overall Study|Volume Overload|3
4563241|NCT01301027|7396861|FG001|Overall Study|Volume Overload|0
4563242|NCT01301066|7396869|FG000|Overall Study|Lost to Follow-up|5
4563243|NCT01301066|7396870|FG001|Overall Study|Lost to Follow-up|11
4563244|NCT01301066|7396869|FG000|Overall Study|Protocol Violation|8
4563245|NCT01301066|7396870|FG001|Overall Study|Protocol Violation|7
4563246|NCT01301066|7396869|FG000|Overall Study|Withdrawal by Subject|4
4563247|NCT01301066|7396870|FG001|Overall Study|Withdrawal by Subject|9
4563248|NCT01301066|7396869|FG000|Overall Study|Adverse Event|6
4563249|NCT01301066|7396870|FG001|Overall Study|Adverse Event|6
4563250|NCT01301066|7396869|FG000|Overall Study|Sponsor Decision|2
4563251|NCT01301066|7396870|FG001|Overall Study|Sponsor Decision|1
4563252|NCT01301066|7396869|FG000|Overall Study|Physician Decision|0
4563253|NCT01301066|7396870|FG001|Overall Study|Physician Decision|1
4563254|NCT01301066|7396869|FG000|Overall Study|Other|2
4563255|NCT01301066|7396870|FG001|Overall Study|Other|0
4563256|NCT01301079|7396878|FG000|Overall Study|Lost to Follow-up|2
4563257|NCT01301079|7396879|FG001|Overall Study|Lost to Follow-up|2
4624201|NCT01817530|7488124|FG001|Overall Study|Lost to Follow-up|4
4563258|NCT01301092|7396892|FG000|Overall Study|Lost to Follow-up|0
4563259|NCT01301092|7396893|FG001|Overall Study|Lost to Follow-up|0
4563260|NCT01301092|7396894|FG002|Overall Study|Lost to Follow-up|1
4563261|NCT01301274|7396918|FG000|Overall Study|Physician Decision|2
4563262|NCT01301274|7396919|FG001|Overall Study|Physician Decision|1
4563263|NCT01301391|7396930|FG000|Overall Study|Death|13
4563264|NCT01301391|7396930|FG000|Overall Study|Lost to Follow-up|3
4563265|NCT01301391|7396930|FG000|Overall Study|Physician Decision|2
4563266|NCT01301391|7396930|FG000|Overall Study|Sponsor's decision|8
4563267|NCT01301456|7396946|FG000|Stage 1|Withdrawal by Subject|0
4563268|NCT01301456|7396947|FG001|Stage 1|Withdrawal by Subject|0
4563269|NCT01301456|7396948|FG002|Stage 1|Withdrawal by Subject|1
4563270|NCT01301456|7396949|FG003|Stage 1|Withdrawal by Subject|0
4563271|NCT01301456|7396950|FG004|Stage 1|Withdrawal by Subject|1
4563272|NCT01301456|7396951|FG005|Stage 1|Withdrawal by Subject|0
4563273|NCT01301456|7396952|FG006|Stage 1|Withdrawal by Subject|0
4624202|NCT01817530|7488125|FG002|Overall Study|Lost to Follow-up|2
4624203|NCT01817530|7488126|FG003|Overall Study|Lost to Follow-up|1
4624204|NCT01817530|7488127|FG004|Overall Study|Lost to Follow-up|3
4624205|NCT01817530|7488128|FG005|Overall Study|Lost to Follow-up|2
4624206|NCT01817530|7488129|FG006|Overall Study|Lost to Follow-up|8
4624207|NCT01817530|7488130|FG007|Overall Study|Lost to Follow-up|4
4624208|NCT01817582|7488151|FG000|Overall Study|Withdrawal by Subject|0
4624209|NCT01817582|7488152|FG001|Overall Study|Withdrawal by Subject|1
4624210|NCT01817582|7488153|FG002|Overall Study|Withdrawal by Subject|0
4624211|NCT01817582|7488151|FG000|Overall Study|Participant revealed masked treatment|1
4624212|NCT01817582|7488152|FG001|Overall Study|Participant revealed masked treatment|0
4624213|NCT01817582|7488153|FG002|Overall Study|Participant revealed masked treatment|0
4624214|NCT01817582|7488151|FG000|Overall Study|Randomized but exclusion criteria met|1
4624215|NCT01817582|7488152|FG001|Overall Study|Randomized but exclusion criteria met|0
4624216|NCT01817582|7488153|FG002|Overall Study|Randomized but exclusion criteria met|0
4624217|NCT01817725|7488170|FG000|Overall Study|Withdrawal by Subject|1
4624218|NCT01817764|7488176|FG000|Overall Study|Adverse Event|7
4563274|NCT01301456|7396953|FG007|Stage 1|Withdrawal by Subject|0
4563275|NCT01301456|7396954|FG008|Stage 1|Withdrawal by Subject|0
4563276|NCT01301456|7396955|FG009|Stage 1|Withdrawal by Subject|0
4563277|NCT01301456|7396956|FG010|Stage 1|Withdrawal by Subject|0
4563278|NCT01301456|7396957|FG011|Stage 1|Withdrawal by Subject|0
4563279|NCT01301456|7396946|FG000|Stage 1|Randomized but not treated|0
4563280|NCT01301456|7396947|FG001|Stage 1|Randomized but not treated|0
4563281|NCT01301456|7396948|FG002|Stage 1|Randomized but not treated|0
4563282|NCT01301456|7396949|FG003|Stage 1|Randomized but not treated|0
4563283|NCT01301456|7396950|FG004|Stage 1|Randomized but not treated|0
4563284|NCT01301456|7396951|FG005|Stage 1|Randomized but not treated|0
4563285|NCT01301456|7396952|FG006|Stage 1|Randomized but not treated|1
4563286|NCT01301456|7396953|FG007|Stage 1|Randomized but not treated|0
4563287|NCT01301456|7396954|FG008|Stage 1|Randomized but not treated|0
4563288|NCT01301456|7396955|FG009|Stage 1|Randomized but not treated|0
4563289|NCT01301456|7396956|FG010|Stage 1|Randomized but not treated|0
4563290|NCT01301456|7396957|FG011|Stage 1|Randomized but not treated|0
4563291|NCT01301456|7396946|FG000|Stage 2|Adverse Event|0
4563292|NCT01301456|7396947|FG001|Stage 2|Adverse Event|0
4563293|NCT01301456|7396948|FG002|Stage 2|Adverse Event|0
4563294|NCT01301456|7396949|FG003|Stage 2|Adverse Event|0
4563295|NCT01301456|7396950|FG004|Stage 2|Adverse Event|0
4563296|NCT01301456|7396951|FG005|Stage 2|Adverse Event|0
4563297|NCT01301456|7396952|FG006|Stage 2|Adverse Event|0
4563298|NCT01301456|7396953|FG007|Stage 2|Adverse Event|0
4563299|NCT01301456|7396954|FG008|Stage 2|Adverse Event|0
4563300|NCT01301456|7396955|FG009|Stage 2|Adverse Event|0
4563301|NCT01301456|7396956|FG010|Stage 2|Adverse Event|1
4563302|NCT01301456|7396957|FG011|Stage 2|Adverse Event|0
4563303|NCT01301508|7397003|FG000|Overall Study|Withdrawal by Subject|1
4563304|NCT01301508|7397004|FG001|Overall Study|Withdrawal by Subject|2
4563305|NCT01301508|7397003|FG000|Overall Study|Lost to Follow-up|0
4563306|NCT01301508|7397004|FG001|Overall Study|Lost to Follow-up|1
4563307|NCT01301625|7397010|FG000|Overall Study|Death|5
4563308|NCT01301625|7397010|FG000|Overall Study|Not Due|21
4563309|NCT01301625|7397010|FG000|Overall Study|Expected|8
4563310|NCT01301625|7397010|FG000|Overall Study|Lost to Follow-up|1
4563311|NCT01301729|7397014|FG000|Overall Study|Withdrawal by Subject|2
4563312|NCT01301729|7397014|FG000|Overall Study|Participant did not Return for Treatment|1
4563313|NCT01301729|7397014|FG000|Overall Study|Violated Selection Criteria|1
4563314|NCT01301833|7397031|FG000|Overall Study|Adverse Event|7
4563315|NCT01301833|7397032|FG001|Overall Study|Adverse Event|5
4563316|NCT01301833|7397033|FG002|Overall Study|Adverse Event|5
4563317|NCT01301833|7397034|FG003|Overall Study|Adverse Event|5
4563318|NCT01301833|7397031|FG000|Overall Study|Lack of Efficacy|1
4563319|NCT01301833|7397032|FG001|Overall Study|Lack of Efficacy|1
4563320|NCT01301833|7397033|FG002|Overall Study|Lack of Efficacy|0
4563321|NCT01301833|7397034|FG003|Overall Study|Lack of Efficacy|0
4563322|NCT01301833|7397031|FG000|Overall Study|Physician Decision|3
4563323|NCT01301833|7397032|FG001|Overall Study|Physician Decision|1
4563324|NCT01301833|7397033|FG002|Overall Study|Physician Decision|1
4563325|NCT01301833|7397034|FG003|Overall Study|Physician Decision|0
4563326|NCT01301833|7397031|FG000|Overall Study|Withdrawal by Subject|3
4563327|NCT01301833|7397032|FG001|Overall Study|Withdrawal by Subject|1
4563328|NCT01301833|7397033|FG002|Overall Study|Withdrawal by Subject|1
4563329|NCT01301833|7397034|FG003|Overall Study|Withdrawal by Subject|2
4563330|NCT01301833|7397031|FG000|Overall Study|Personal matter|1
4563331|NCT01301833|7397032|FG001|Overall Study|Personal matter|0
4563332|NCT01301833|7397033|FG002|Overall Study|Personal matter|0
4563333|NCT01301833|7397034|FG003|Overall Study|Personal matter|0
4563334|NCT01301950|7397046|FG000|Overall Study|Surgery was cancelled by patient|0
4563335|NCT01301950|7397047|FG001|Overall Study|Surgery was cancelled by patient|1
4563336|NCT01302041|7397053|FG000|Overall Study|Death|5
4563337|NCT01302041|7397053|FG000|Overall Study|Withdrawal by Subject|4
4563338|NCT01302041|7397053|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29
4624219|NCT01817764|7488177|FG001|Overall Study|Adverse Event|10
4563339|NCT01302041|7397053|FG000|Overall Study|Other-Miscellaneous Reason|2
4563340|NCT01302054|7397058|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4
4563341|NCT01302054|7397059|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0
4563342|NCT01302054|7397060|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0
4563343|NCT01302054|7397058|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17
4563344|NCT01302054|7397059|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0
4563345|NCT01302054|7397060|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0
4563346|NCT01302054|7397058|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16
4563347|NCT01302054|7397059|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0
4563348|NCT01302054|7397060|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0
4563349|NCT01302054|7397058|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8
4563350|NCT01302054|7397059|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0
4563351|NCT01302054|7397060|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0
4563352|NCT01302054|7397058|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13
4563353|NCT01302054|7397059|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0
4563354|NCT01302054|7397060|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0
4563355|NCT01302054|7397058|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314
4563356|NCT01302054|7397059|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0
4563357|NCT01302054|7397060|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0
4563358|NCT01302054|7397058|FG000|Tolterodine Open-Label Run-In Phase|Other|7
4563359|NCT01302054|7397059|FG001|Tolterodine Open-Label Run-In Phase|Other|0
4563360|NCT01302054|7397060|FG002|Tolterodine Open-Label Run-In Phase|Other|0
4563361|NCT01302054|7397058|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2
4563362|NCT01302054|7397059|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0
4563363|NCT01302054|7397060|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0
4624220|NCT01817764|7488176|FG000|Overall Study|Lack of Efficacy|9
4563364|NCT01302054|7397058|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0
4563365|NCT01302054|7397059|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2
4563366|NCT01302054|7397060|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4
4563367|NCT01302054|7397058|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0
4563368|NCT01302054|7397059|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2
4563369|NCT01302054|7397060|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1
4563370|NCT01302054|7397058|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0
4563371|NCT01302054|7397059|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6
4563372|NCT01302054|7397060|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14
4563373|NCT01302054|7397058|FG000|Double-Blind Treatment Phase|Protocol Violation|0
4563374|NCT01302054|7397059|FG001|Double-Blind Treatment Phase|Protocol Violation|3
4563375|NCT01302054|7397060|FG002|Double-Blind Treatment Phase|Protocol Violation|6
4563376|NCT01302054|7397058|FG000|Double-Blind Treatment Phase|Adverse Event|0
4563377|NCT01302054|7397059|FG001|Double-Blind Treatment Phase|Adverse Event|10
4563378|NCT01302054|7397060|FG002|Double-Blind Treatment Phase|Adverse Event|10
4563379|NCT01302054|7397058|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0
4563380|NCT01302054|7397059|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0
4563381|NCT01302054|7397060|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2
4563382|NCT01302054|7397058|FG000|Double-Blind Treatment Phase|Other|0
4563383|NCT01302054|7397059|FG001|Double-Blind Treatment Phase|Other|4
4563384|NCT01302054|7397060|FG002|Double-Blind Treatment Phase|Other|9
4563385|NCT01302067|7397072|FG000|Overall Study|Death|0
4563386|NCT01302067|7397073|FG001|Overall Study|Death|0
4563387|NCT01302067|7397074|FG002|Overall Study|Death|1
4563388|NCT01302067|7397072|FG000|Overall Study|Physician Decision|9
4563389|NCT01302067|7397073|FG001|Overall Study|Physician Decision|5
4563390|NCT01302067|7397074|FG002|Overall Study|Physician Decision|14
4624221|NCT01817764|7488177|FG001|Overall Study|Lack of Efficacy|7
4624222|NCT01817764|7488176|FG000|Overall Study|Protocol Violation|7
4624223|NCT01817764|7488177|FG001|Overall Study|Protocol Violation|5
4624224|NCT01817764|7488176|FG000|Overall Study|Lost to Follow-up|1
4624225|NCT01817764|7488177|FG001|Overall Study|Lost to Follow-up|4
4624226|NCT01817764|7488176|FG000|Overall Study|Withdrawal by Subject|10
4624227|NCT01817764|7488177|FG001|Overall Study|Withdrawal by Subject|12
4624228|NCT01817777|7488185|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3
4624229|NCT01817777|7488186|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0
4624230|NCT01817777|7488187|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0
4563391|NCT01302067|7397072|FG000|Overall Study|Lack of Efficacy|8
4563392|NCT01302067|7397073|FG001|Overall Study|Lack of Efficacy|4
4563393|NCT01302067|7397074|FG002|Overall Study|Lack of Efficacy|2
4563394|NCT01302067|7397072|FG000|Overall Study|Lost to Follow-up|9
4563395|NCT01302067|7397073|FG001|Overall Study|Lost to Follow-up|4
4563396|NCT01302067|7397074|FG002|Overall Study|Lost to Follow-up|15
4563397|NCT01302067|7397072|FG000|Overall Study|Withdrawal by Subject|13
4563398|NCT01302067|7397073|FG001|Overall Study|Withdrawal by Subject|6
4563399|NCT01302067|7397074|FG002|Overall Study|Withdrawal by Subject|10
4563400|NCT01302067|7397072|FG000|Overall Study|Other|1
4563401|NCT01302067|7397073|FG001|Overall Study|Other|1
4563402|NCT01302067|7397074|FG002|Overall Study|Other|3
4624231|NCT01817777|7488185|FG000|Observational Phase (8 Weeks)|Early Study Termination|2
4624232|NCT01817777|7488186|FG001|Observational Phase (8 Weeks)|Early Study Termination|0
4624233|NCT01817777|7488187|FG002|Observational Phase (8 Weeks)|Early Study Termination|0
4563403|NCT01302067|7397072|FG000|Overall Study|Protocol Violation|11
4563404|NCT01302067|7397073|FG001|Overall Study|Protocol Violation|0
4563405|NCT01302067|7397074|FG002|Overall Study|Protocol Violation|8
4563406|NCT01302067|7397072|FG000|Overall Study|Adverse Event|27
4563407|NCT01302067|7397073|FG001|Overall Study|Adverse Event|14
4563408|NCT01302067|7397074|FG002|Overall Study|Adverse Event|45
4563409|NCT01302080|7397085|FG000|Overall Study|Withdrew Consent|92
4563410|NCT01302080|7397086|FG001|Overall Study|Withdrew Consent|39
4563411|NCT01302080|7397085|FG000|Overall Study|Patient/Family Moved|28
4563412|NCT01302080|7397086|FG001|Overall Study|Patient/Family Moved|3
4563413|NCT01302080|7397085|FG000|Overall Study|Lost to Follow-up|192
4563414|NCT01302080|7397086|FG001|Overall Study|Lost to Follow-up|93
4563415|NCT01302080|7397085|FG000|Overall Study|Death|1
4563416|NCT01302080|7397086|FG001|Overall Study|Death|0
4563417|NCT01302080|7397085|FG000|Overall Study|Other|52
4563418|NCT01302080|7397086|FG001|Overall Study|Other|8
4563419|NCT01302080|7397085|FG000|Overall Study|Reason Missing For Discontinuation|1
4563420|NCT01302080|7397086|FG001|Overall Study|Reason Missing For Discontinuation|0
4563421|NCT01302119|7397118|FG000|Overall Study|Withdrawal by Subject|30
4563422|NCT01302119|7397119|FG001|Overall Study|Withdrawal by Subject|20
4563423|NCT01302119|7397118|FG000|Overall Study|Lost to Follow-up|10
4563424|NCT01302119|7397119|FG001|Overall Study|Lost to Follow-up|4
4563425|NCT01302119|7397118|FG000|Overall Study|Adverse Event|2
4563426|NCT01302119|7397119|FG001|Overall Study|Adverse Event|1
4563427|NCT01302119|7397118|FG000|Overall Study|Non-compliance|4
4563428|NCT01302119|7397119|FG001|Overall Study|Non-compliance|2
4563429|NCT01302119|7397118|FG000|Overall Study|Non-specific|4
4563430|NCT01302119|7397119|FG001|Overall Study|Non-specific|1
4563431|NCT01302366|7397125|FG000|Overall Study|patient choice or noncompliance|5
4563432|NCT01302392|7397146|FG000|Overall Study|Lost to Follow-up|1
4563433|NCT01302392|7397147|FG001|Overall Study|Lost to Follow-up|0
4563434|NCT01302392|7397146|FG000|Overall Study|Withdrawal by Subject|6
4563435|NCT01302392|7397147|FG001|Overall Study|Withdrawal by Subject|1
4563436|NCT01302418|7397153|FG000|Overall Study|Protocol Violation|9
4563437|NCT01302418|7397153|FG000|Overall Study|Non-evaluable|9
4563438|NCT01302548|7397174|FG000|Overall Study|Lost to Follow-up|2
4563439|NCT01302548|7397175|FG001|Overall Study|Lost to Follow-up|1
4563440|NCT01302691|7397183|FG000|Overall Study|Adverse Event|2
4563441|NCT01302691|7397184|FG001|Overall Study|Adverse Event|0
4563442|NCT01302691|7397183|FG000|Overall Study|Death|0
4563443|NCT01302691|7397184|FG001|Overall Study|Death|1
4563444|NCT01302691|7397183|FG000|Overall Study|Lost to Follow-up|1
4563445|NCT01302691|7397184|FG001|Overall Study|Lost to Follow-up|0
4563446|NCT01302691|7397183|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6
4563447|NCT01302691|7397184|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4
4563448|NCT01302691|7397183|FG000|Overall Study|Physician Decision|0
4563449|NCT01302691|7397184|FG001|Overall Study|Physician Decision|1
4563450|NCT01302691|7397183|FG000|Overall Study|Protocol Violation|1
4563451|NCT01302691|7397184|FG001|Overall Study|Protocol Violation|0
4563452|NCT01302834|7397224|FG000|Overall Study|Protocol Violation|17
4563453|NCT01302834|7397225|FG001|Overall Study|Protocol Violation|23
4563454|NCT01302834|7397224|FG000|Overall Study|HIV positive|1
4563455|NCT01302834|7397225|FG001|Overall Study|HIV positive|3
4563456|NCT01302899|7397237|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1
4563457|NCT01302899|7397238|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0
4563458|NCT01302899|7397237|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0
4563459|NCT01302899|7397238|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1
4563460|NCT01302938|7397250|FG000|Overall Study|Withdrawal by Subject|1
4563461|NCT01302938|7397251|FG001|Overall Study|Withdrawal by Subject|0
4563462|NCT01302938|7397250|FG000|Overall Study|Adverse Event|1
4563463|NCT01302938|7397251|FG001|Overall Study|Adverse Event|0
4563464|NCT01302964|7397260|FG000|Overall Study|Adverse Event|1
4563465|NCT01302964|7397261|FG001|Overall Study|Adverse Event|0
4563466|NCT01303159|7397276|FG000|Overall Study|Death|16
4563467|NCT01303159|7397276|FG000|Overall Study|Study Termination|7
4563468|NCT01303172|7397282|FG000|Overall Study|Physician Decision|9
4563469|NCT01303172|7397283|FG001|Overall Study|Physician Decision|6
4563470|NCT01303172|7397282|FG000|Overall Study|Adverse Event|5
4563471|NCT01303172|7397283|FG001|Overall Study|Adverse Event|2
4563472|NCT01303172|7397282|FG000|Overall Study|Withdrawal by Subject|4
4563473|NCT01303172|7397283|FG001|Overall Study|Withdrawal by Subject|2
4563474|NCT01303172|7397282|FG000|Overall Study|Death|20
4563475|NCT01303172|7397283|FG001|Overall Study|Death|7
4563476|NCT01303172|7397282|FG000|Overall Study|Lack of Efficacy|25
4563477|NCT01303172|7397283|FG001|Overall Study|Lack of Efficacy|17
4563478|NCT01303380|7397307|FG000|Overall Study|Lack of compliance to study procedures|1
4563479|NCT01303419|7397320|FG000|Overall Study|Discontinuation of study|60
4563480|NCT01303419|7397320|FG000|Overall Study|Did not complete both imaging methods|5
4563481|NCT01303419|7397320|FG000|Overall Study|Did not meet all I/E after screening|31
4563482|NCT01303445|7397324|FG000|First Intervention (7 Days)|Withdrawal by Subject|1
4563483|NCT01303445|7397325|FG001|First Intervention (7 Days)|Withdrawal by Subject|0
4563484|NCT01303445|7397324|FG000|Second Intervention (7 Days)|Adverse Event|0
4563485|NCT01303445|7397325|FG001|Second Intervention (7 Days)|Adverse Event|2
4563486|NCT01303445|7397324|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1
4563487|NCT01303445|7397325|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0
4563488|NCT01303445|7397324|FG000|Washout (14 Days)|Protocol Violation|1
4563489|NCT01303445|7397325|FG001|Washout (14 Days)|Protocol Violation|0
4624234|NCT01817777|7488185|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0
4624235|NCT01817777|7488186|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3
4624236|NCT01817777|7488187|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0
4624237|NCT01817777|7488185|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0
4624238|NCT01817777|7488186|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1
4624239|NCT01817777|7488187|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2
4624240|NCT01817777|7488185|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0
4624241|NCT01817777|7488186|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1
4624242|NCT01817777|7488187|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3
4624243|NCT01817790|7488195|FG000|Overall Study|Adverse Event|0
4624244|NCT01817790|7488196|FG001|Overall Study|Adverse Event|2
4624245|NCT01817790|7488195|FG000|Overall Study|Lost to Follow-up|0
4624246|NCT01817790|7488196|FG001|Overall Study|Lost to Follow-up|1
4624247|NCT01817790|7488195|FG000|Overall Study|Protocol Violation|2
4563490|NCT01303445|7397324|FG000|Washout (14 Days)|Lost to Follow-up|0
4563491|NCT01303445|7397325|FG001|Washout (14 Days)|Lost to Follow-up|2
4563492|NCT01303445|7397324|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1
4563493|NCT01303445|7397325|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0
4563494|NCT01303445|7397324|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0
4563495|NCT01303445|7397325|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1
4563496|NCT01303510|7397337|FG000|Overall Study|Lost to Follow-up|1
4563497|NCT01303510|7397338|FG001|Overall Study|Lost to Follow-up|0
4563498|NCT01303627|7397346|FG000|Overall Study|the failure while performing URS|0
4563499|NCT01303627|7397347|FG001|Overall Study|the failure while performing URS|1
4563500|NCT01303861|7397384|FG000|Overall Study|Lost to Follow-up|34
4563501|NCT01303861|7397385|FG001|Overall Study|Lost to Follow-up|14
4563502|NCT01303861|7397386|FG002|Overall Study|Lost to Follow-up|27
4563503|NCT01303861|7397387|FG003|Overall Study|Lost to Follow-up|31
4563504|NCT01303861|7397384|FG000|Overall Study|Lack of Efficacy|3
4563505|NCT01303861|7397385|FG001|Overall Study|Lack of Efficacy|2
4563506|NCT01303861|7397386|FG002|Overall Study|Lack of Efficacy|1
4563507|NCT01303861|7397387|FG003|Overall Study|Lack of Efficacy|0
4563508|NCT01303861|7397384|FG000|Overall Study|Withdrawal by Subject|16
4563509|NCT01303861|7397385|FG001|Overall Study|Withdrawal by Subject|8
4563510|NCT01303861|7397386|FG002|Overall Study|Withdrawal by Subject|8
4563511|NCT01303861|7397387|FG003|Overall Study|Withdrawal by Subject|23
4563512|NCT01303861|7397384|FG000|Overall Study|Adverse Event|4
4563513|NCT01303861|7397385|FG001|Overall Study|Adverse Event|1
4563514|NCT01303861|7397386|FG002|Overall Study|Adverse Event|0
4563515|NCT01303861|7397387|FG003|Overall Study|Adverse Event|5
4563516|NCT01303861|7397384|FG000|Overall Study|Pregnancy|1
4563517|NCT01303861|7397385|FG001|Overall Study|Pregnancy|0
4563518|NCT01303861|7397386|FG002|Overall Study|Pregnancy|0
4563519|NCT01303861|7397387|FG003|Overall Study|Pregnancy|0
4563520|NCT01303965|7397411|FG000|Overall Study|Adverse Event|1
4563521|NCT01303965|7397412|FG001|Overall Study|Adverse Event|1
4563522|NCT01303965|7397411|FG000|Overall Study|Death|0
4563523|NCT01303965|7397412|FG001|Overall Study|Death|3
4563524|NCT01303965|7397411|FG000|Overall Study|Withdrawal by Subject|1
4563525|NCT01303965|7397412|FG001|Overall Study|Withdrawal by Subject|0
4563526|NCT01303965|7397411|FG000|Overall Study|Disease Progression|1
4563527|NCT01303965|7397412|FG001|Overall Study|Disease Progression|6
4563528|NCT01304147|7397430|FG000|Second Intervention (7days)|Withdrawal by Subject|1
4563529|NCT01304147|7397431|FG001|Second Intervention (7days)|Withdrawal by Subject|1
4563530|NCT01304329|7397485|FG000|Third Intervention (3 Days)|Adverse Event|0
4563531|NCT01304329|7397486|FG001|Third Intervention (3 Days)|Adverse Event|1
4563532|NCT01304329|7397487|FG002|Third Intervention (3 Days)|Adverse Event|0
4563533|NCT01304329|7397488|FG003|Third Intervention (3 Days)|Adverse Event|0
4563534|NCT01304329|7397489|FG004|Third Intervention (3 Days)|Adverse Event|0
4563535|NCT01304329|7397490|FG005|Third Intervention (3 Days)|Adverse Event|0
4563536|NCT01304498|7397504|FG000|Overall Study|Adverse Event|1
4563537|NCT01304498|7397505|FG001|Overall Study|Adverse Event|1
4563538|NCT01304498|7397504|FG000|Overall Study|Withdrawal by Subject|2
4563539|NCT01304498|7397505|FG001|Overall Study|Withdrawal by Subject|3
4563540|NCT01304498|7397504|FG000|Overall Study|Protocol Violation|1
4563541|NCT01304498|7397505|FG001|Overall Study|Protocol Violation|0
4563542|NCT01304498|7397504|FG000|Overall Study|Lost to Follow-up|2
4563543|NCT01304498|7397505|FG001|Overall Study|Lost to Follow-up|1
4563544|NCT01304693|7397530|FG000|Overall Study|Adverse Event|0
4563545|NCT01304693|7397531|FG001|Overall Study|Adverse Event|0
4563546|NCT01304693|7397532|FG002|Overall Study|Adverse Event|0
4624248|NCT01817790|7488196|FG001|Overall Study|Protocol Violation|1
4624249|NCT01817790|7488195|FG000|Overall Study|Withdrawal by Subject|1
4624250|NCT01817790|7488196|FG001|Overall Study|Withdrawal by Subject|3
4563547|NCT01304693|7397533|FG003|Overall Study|Adverse Event|0
4563548|NCT01304693|7397534|FG004|Overall Study|Adverse Event|1
4563549|NCT01304693|7397530|FG000|Overall Study|Decision Unrelated to an Adverse Event|0
4563550|NCT01304693|7397531|FG001|Overall Study|Decision Unrelated to an Adverse Event|0
4563551|NCT01304693|7397532|FG002|Overall Study|Decision Unrelated to an Adverse Event|1
4563552|NCT01304693|7397533|FG003|Overall Study|Decision Unrelated to an Adverse Event|1
4563553|NCT01304693|7397534|FG004|Overall Study|Decision Unrelated to an Adverse Event|0
4563554|NCT01304706|7397546|FG000|Overall Study|Adverse Event|2
4563555|NCT01304706|7397546|FG000|Overall Study|Lack of Efficacy|1
4563556|NCT01304706|7397546|FG000|Overall Study|Death|3
4563557|NCT01304706|7397546|FG000|Overall Study|Withdrawal by Subject|3
4563558|NCT01304706|7397546|FG000|Overall Study|Lost to Follow-up|7
4563559|NCT01304706|7397546|FG000|Overall Study|Discontinued due to failed drug admin.|1
4563560|NCT01304940|7397552|FG000|Overall Study|not meet symptom severity requirement|3
4563561|NCT01304940|7397553|FG001|Overall Study|not meet symptom severity requirement|0
4563562|NCT01305044|7397567|FG000|Overall Study|Withdrawal by Subject|3
4563563|NCT01305044|7397568|FG001|Overall Study|Withdrawal by Subject|6
4563564|NCT01305200|7397577|FG000|Overall Study|Physician Decision|4
4563565|NCT01305200|7397578|FG001|Overall Study|Physician Decision|6
4563566|NCT01305200|7397579|FG002|Overall Study|Physician Decision|1
4563567|NCT01305200|7397577|FG000|Overall Study|Withdrawal by Subject|24
4563568|NCT01305200|7397578|FG001|Overall Study|Withdrawal by Subject|21
4563569|NCT01305200|7397579|FG002|Overall Study|Withdrawal by Subject|1
4563570|NCT01305200|7397577|FG000|Overall Study|Ineligible|1
4563571|NCT01305200|7397578|FG001|Overall Study|Ineligible|2
4563572|NCT01305200|7397579|FG002|Overall Study|Ineligible|1
4563573|NCT01305200|7397577|FG000|Overall Study|Death|0
4563574|NCT01305200|7397578|FG001|Overall Study|Death|2
4563575|NCT01305200|7397579|FG002|Overall Study|Death|0
4563576|NCT01305239|7397597|FG000|Overall Study|Adverse Event|22
4563577|NCT01305239|7397597|FG000|Overall Study|Exemestane taken prior to inclusion only|1
4563578|NCT01305408|7397634|FG000|Overall Study|Adverse Event|10
4563579|NCT01305408|7397635|FG001|Overall Study|Adverse Event|7
4563580|NCT01305408|7397634|FG000|Overall Study|Lack of Efficacy|3
4563581|NCT01305408|7397635|FG001|Overall Study|Lack of Efficacy|4
4563582|NCT01305408|7397634|FG000|Overall Study|Withdrawal by Subject|9
4563583|NCT01305408|7397635|FG001|Overall Study|Withdrawal by Subject|9
4563584|NCT01305408|7397634|FG000|Overall Study|Protocol Violation|4
4563585|NCT01305408|7397635|FG001|Overall Study|Protocol Violation|6
4563586|NCT01305408|7397634|FG000|Overall Study|Lost to Follow-up|5
4563587|NCT01305408|7397635|FG001|Overall Study|Lost to Follow-up|3
4563588|NCT01305408|7397634|FG000|Overall Study|Noncompliance with study medication|0
4563589|NCT01305408|7397635|FG001|Overall Study|Noncompliance with study medication|1
4563590|NCT01305408|7397634|FG000|Overall Study|Noncompliance with study procedures|0
4563591|NCT01305408|7397635|FG001|Overall Study|Noncompliance with study procedures|1
4563592|NCT01305408|7397634|FG000|Overall Study|Other|1
4563593|NCT01305408|7397635|FG001|Overall Study|Other|0
4563594|NCT01305564|7397645|FG000|Overall Study|Death|21
4563595|NCT01305564|7397645|FG000|Overall Study|Lost to Follow-up|12
4563596|NCT01305564|7397645|FG000|Overall Study|Withdrawal by Subject|1
4563597|NCT01305564|7397645|FG000|Overall Study|Physician Decision|3
4563598|NCT01305577|7397663|FG000|Overall Study|Adverse Event|2
4563599|NCT01305577|7397664|FG001|Overall Study|Adverse Event|2
4563600|NCT01305577|7397665|FG002|Overall Study|Adverse Event|1
4563601|NCT01305577|7397663|FG000|Overall Study|Withdrawal by Subject|7
4563602|NCT01305577|7397664|FG001|Overall Study|Withdrawal by Subject|5
4563603|NCT01305577|7397665|FG002|Overall Study|Withdrawal by Subject|6
4563604|NCT01305577|7397663|FG000|Overall Study|Lost to Follow-up|4
4563605|NCT01305577|7397664|FG001|Overall Study|Lost to Follow-up|3
4563606|NCT01305577|7397665|FG002|Overall Study|Lost to Follow-up|2
4563607|NCT01305577|7397663|FG000|Overall Study|Protocol Deviation|0
4563608|NCT01305577|7397664|FG001|Overall Study|Protocol Deviation|1
4563609|NCT01305577|7397665|FG002|Overall Study|Protocol Deviation|1
4563610|NCT01305941|7397696|FG000|Overall Study|Adverse Event|6
4563611|NCT01305941|7397696|FG000|Overall Study|Clinical decline|2
4563612|NCT01305941|7397696|FG000|Overall Study|Withdrawal by Subject|1
4563613|NCT01305941|7397696|FG000|Overall Study|Death|1
4563614|NCT01306032|7397706|FG000|First Intervention|Adverse Event|1
4563615|NCT01306032|7397707|FG001|First Intervention|Adverse Event|0
4563616|NCT01306032|7397708|FG002|First Intervention|Adverse Event|1
4563617|NCT01306032|7397709|FG003|First Intervention|Adverse Event|0
4563618|NCT01306032|7397710|FG004|First Intervention|Adverse Event|0
4563619|NCT01306032|7397711|FG005|First Intervention|Adverse Event|1
4563620|NCT01306032|7397706|FG000|First Intervention|Withdrawal by Subject|0
4563621|NCT01306032|7397707|FG001|First Intervention|Withdrawal by Subject|2
4563622|NCT01306032|7397708|FG002|First Intervention|Withdrawal by Subject|0
4563623|NCT01306032|7397709|FG003|First Intervention|Withdrawal by Subject|1
4563624|NCT01306032|7397710|FG004|First Intervention|Withdrawal by Subject|0
4563625|NCT01306032|7397711|FG005|First Intervention|Withdrawal by Subject|0
4563626|NCT01306032|7397706|FG000|First Intervention|Death|0
4563627|NCT01306032|7397707|FG001|First Intervention|Death|0
4563628|NCT01306032|7397708|FG002|First Intervention|Death|1
4563629|NCT01306032|7397709|FG003|First Intervention|Death|0
4563630|NCT01306032|7397710|FG004|First Intervention|Death|0
4563631|NCT01306032|7397711|FG005|First Intervention|Death|0
4563632|NCT01306032|7397706|FG000|First Intervention|Ineligible|0
4563633|NCT01306032|7397707|FG001|First Intervention|Ineligible|0
4563634|NCT01306032|7397708|FG002|First Intervention|Ineligible|0
4563635|NCT01306032|7397709|FG003|First Intervention|Ineligible|0
4563636|NCT01306032|7397710|FG004|First Intervention|Ineligible|0
4563637|NCT01306032|7397711|FG005|First Intervention|Ineligible|1
4563638|NCT01306032|7397706|FG000|First Intervention|Progressive disease|0
4563639|NCT01306032|7397707|FG001|First Intervention|Progressive disease|0
4563640|NCT01306032|7397708|FG002|First Intervention|Progressive disease|0
4563641|NCT01306032|7397709|FG003|First Intervention|Progressive disease|0
4563642|NCT01306032|7397710|FG004|First Intervention|Progressive disease|2
4563643|NCT01306032|7397711|FG005|First Intervention|Progressive disease|0
4563644|NCT01306032|7397706|FG000|Disease Progression/Crossover|Withdrawal by Subject|0
4563645|NCT01306032|7397707|FG001|Disease Progression/Crossover|Withdrawal by Subject|0
4563646|NCT01306032|7397708|FG002|Disease Progression/Crossover|Withdrawal by Subject|0
4563647|NCT01306032|7397709|FG003|Disease Progression/Crossover|Withdrawal by Subject|1
4563648|NCT01306032|7397710|FG004|Disease Progression/Crossover|Withdrawal by Subject|0
4563649|NCT01306032|7397711|FG005|Disease Progression/Crossover|Withdrawal by Subject|0
4563650|NCT01306032|7397706|FG000|Disease Progression/Crossover|other/symptomatic progression|0
4563651|NCT01306032|7397707|FG001|Disease Progression/Crossover|other/symptomatic progression|2
4563652|NCT01306032|7397708|FG002|Disease Progression/Crossover|other/symptomatic progression|0
4563653|NCT01306032|7397709|FG003|Disease Progression/Crossover|other/symptomatic progression|2
4563654|NCT01306032|7397710|FG004|Disease Progression/Crossover|other/symptomatic progression|0
4563655|NCT01306032|7397711|FG005|Disease Progression/Crossover|other/symptomatic progression|0
4563656|NCT01306058|7397737|FG000|Overall Study|Death|1
4563657|NCT01306058|7397737|FG000|Overall Study|Enrolled but did not get treatment|1
4563658|NCT01306162|7397745|FG000|Period 1|Adverse Event|0
4563659|NCT01306162|7397746|FG001|Period 1|Adverse Event|0
4563660|NCT01306162|7397747|FG002|Period 1|Adverse Event|0
4563661|NCT01306162|7397748|FG003|Period 1|Adverse Event|1
4563662|NCT01306162|7397745|FG000|Washout 1|Non-compliance to protocol|0
4563663|NCT01306162|7397746|FG001|Washout 1|Non-compliance to protocol|1
4563664|NCT01306162|7397747|FG002|Washout 1|Non-compliance to protocol|0
4563665|NCT01306162|7397748|FG003|Washout 1|Non-compliance to protocol|0
4563666|NCT01306201|7397767|FG000|Overall Study|Arrhythmia|4
4563667|NCT01306201|7397767|FG000|Overall Study|Files could not be processed|3
4563668|NCT01306201|7397767|FG000|Overall Study|Files unreadable|3
4563669|NCT01306214|7397778|FG000|Overall Study|Death|0
4563670|NCT01306214|7397779|FG001|Overall Study|Death|0
4563671|NCT01306214|7397780|FG002|Overall Study|Death|1
4563672|NCT01306214|7397778|FG000|Overall Study|Lost to Follow-up|3
4563673|NCT01306214|7397779|FG001|Overall Study|Lost to Follow-up|5
4563674|NCT01306214|7397780|FG002|Overall Study|Lost to Follow-up|4
4563675|NCT01306214|7397778|FG000|Overall Study|Withdrawal by Subject|24
4563676|NCT01306214|7397779|FG001|Overall Study|Withdrawal by Subject|22
4563677|NCT01306214|7397780|FG002|Overall Study|Withdrawal by Subject|16
4563678|NCT01306214|7397778|FG000|Overall Study|Not treated|1
4563679|NCT01306214|7397779|FG001|Overall Study|Not treated|1
4563680|NCT01306214|7397780|FG002|Overall Study|Not treated|1
4563681|NCT01306253|7397790|FG000|Overall Study|Lost to Follow-up|1
4563682|NCT01306253|7397791|FG001|Overall Study|Lost to Follow-up|1
4563683|NCT01306305|7397812|FG000|Overall Study|Lost to Follow-up|1
4563684|NCT01306305|7397813|FG001|Overall Study|Lost to Follow-up|0
4563685|NCT01306305|7397812|FG000|Overall Study|Withdrew consent|1
4563686|NCT01306305|7397813|FG001|Overall Study|Withdrew consent|0
4563687|NCT01306331|7397821|FG000|Overall Study|Adverse Event|28
4563688|NCT01306331|7397822|FG001|Overall Study|Adverse Event|25
4563689|NCT01306331|7397821|FG000|Overall Study|Lost to Follow-up|321
4563690|NCT01306331|7397822|FG001|Overall Study|Lost to Follow-up|323
4563691|NCT01306331|7397821|FG000|Overall Study|Physician Decision|26
4563692|NCT01306331|7397822|FG001|Overall Study|Physician Decision|22
4563693|NCT01306331|7397821|FG000|Overall Study|Pregnancy|136
4563694|NCT01306331|7397822|FG001|Overall Study|Pregnancy|151
4563695|NCT01306331|7397821|FG000|Overall Study|Protocol Violation|154
4563696|NCT01306331|7397822|FG001|Overall Study|Protocol Violation|124
4563697|NCT01306331|7397821|FG000|Overall Study|Withdrawal by Subject|163
4563698|NCT01306331|7397822|FG001|Overall Study|Withdrawal by Subject|152
4563699|NCT01306331|7397821|FG000|Overall Study|Not sexually active|29
4563700|NCT01306331|7397822|FG001|Overall Study|Not sexually active|28
4563701|NCT01306331|7397821|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10
4563702|NCT01306331|7397822|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20
4563703|NCT01306331|7397821|FG000|Overall Study|Other|34
4563704|NCT01306331|7397822|FG001|Overall Study|Other|32
4563705|NCT01306617|7397831|FG000|Overall Study|Adverse Event|1
4563706|NCT01306617|7397832|FG001|Overall Study|Adverse Event|0
4563707|NCT01306617|7397833|FG002|Overall Study|Adverse Event|0
4563708|NCT01306617|7397831|FG000|Overall Study|Virologic Failure|0
4563709|NCT01306617|7397832|FG001|Overall Study|Virologic Failure|0
4563710|NCT01306617|7397833|FG002|Overall Study|Virologic Failure|5
4563711|NCT01306617|7397831|FG000|Overall Study|Non-compliance|0
4563712|NCT01306617|7397832|FG001|Overall Study|Non-compliance|1
4563713|NCT01306617|7397833|FG002|Overall Study|Non-compliance|0
4563714|NCT01306643|7397841|FG000|Overall Study|Adverse Event|5
4563715|NCT01306643|7397841|FG000|Overall Study|Disease Progression|7
4563716|NCT01306643|7397841|FG000|Overall Study|Other: Change in Eligibility Status|1
4563717|NCT01306656|7397847|FG000|Overall Study|Lost to Follow-up|1
4563718|NCT01306656|7397848|FG001|Overall Study|Lost to Follow-up|0
4563719|NCT01306877|7397858|FG000|Overall Study|Lost to Follow-up|3
4563720|NCT01306877|7397859|FG001|Overall Study|Lost to Follow-up|3
4563721|NCT01306877|7397858|FG000|Overall Study|Physician Decision|0
4563722|NCT01306877|7397859|FG001|Overall Study|Physician Decision|1
4563723|NCT01306890|7397865|FG000|Overall Study|Adverse Event|2
4563724|NCT01306890|7397865|FG000|Overall Study|Death|1223
4563725|NCT01306890|7397865|FG000|Overall Study|Lost to Follow-up|58
4563726|NCT01306890|7397865|FG000|Overall Study|Withdrawal by Subject|88
4563727|NCT01306890|7397865|FG000|Overall Study|Unspecified reasons|104
4563728|NCT01306890|7397865|FG000|Overall Study|Study Termination|3
4563729|NCT01306890|7397865|FG000|Overall Study|No discontinuation documentation|41
4563730|NCT01306942|7397872|FG000|Phase I|Adverse Event|2
4563731|NCT01306942|7397873|FG001|Phase I|Adverse Event|2
4563732|NCT01306942|7397874|FG002|Phase I|Adverse Event|0
4563733|NCT01306942|7397875|FG003|Phase I|Adverse Event|0
4563734|NCT01306942|7397872|FG000|Phase I|Physician Decision|3
4563735|NCT01306942|7397873|FG001|Phase I|Physician Decision|1
4563736|NCT01306942|7397874|FG002|Phase I|Physician Decision|0
4563737|NCT01306942|7397875|FG003|Phase I|Physician Decision|0
4563738|NCT01306942|7397872|FG000|Phase II|Adverse Event|0
4563739|NCT01306942|7397873|FG001|Phase II|Adverse Event|0
4563740|NCT01306942|7397874|FG002|Phase II|Adverse Event|0
4563741|NCT01306942|7397875|FG003|Phase II|Adverse Event|6
4563742|NCT01306942|7397872|FG000|Phase II|Physician Decision|2
4563743|NCT01306942|7397873|FG001|Phase II|Physician Decision|0
4563744|NCT01306942|7397874|FG002|Phase II|Physician Decision|0
4563745|NCT01306942|7397875|FG003|Phase II|Physician Decision|5
4563746|NCT01306942|7397872|FG000|Phase II|Withdrawal by Subject|0
4563747|NCT01306942|7397873|FG001|Phase II|Withdrawal by Subject|0
4563748|NCT01306942|7397874|FG002|Phase II|Withdrawal by Subject|0
4563749|NCT01306942|7397875|FG003|Phase II|Withdrawal by Subject|2
4563750|NCT01306942|7397872|FG000|Phase II|Death|0
4563751|NCT01306942|7397873|FG001|Phase II|Death|0
4563752|NCT01306942|7397874|FG002|Phase II|Death|0
4563753|NCT01306942|7397875|FG003|Phase II|Death|1
4563754|NCT01306942|7397872|FG000|Phase II|Not finished treatment|0
4563755|NCT01306942|7397873|FG001|Phase II|Not finished treatment|0
4563756|NCT01306942|7397874|FG002|Phase II|Not finished treatment|0
4563757|NCT01306942|7397875|FG003|Phase II|Not finished treatment|1
4563758|NCT01306942|7397872|FG000|Phase II|Protocol Violation|0
4563759|NCT01306942|7397873|FG001|Phase II|Protocol Violation|0
4563760|NCT01306942|7397874|FG002|Phase II|Protocol Violation|0
4563761|NCT01306942|7397875|FG003|Phase II|Protocol Violation|1
4592397|NCT01540565|7439989|FG000|Overall Study|Ineligible|2
4592398|NCT01540838|7440059|FG000|Overall Study|Open nasogastric tube|9
4592399|NCT01540838|7440060|FG001|Overall Study|Open nasogastric tube|7
4592400|NCT01540838|7440059|FG000|Overall Study|Treatment doses missing|8
4592401|NCT01540838|7440060|FG001|Overall Study|Treatment doses missing|12
4592402|NCT01540838|7440059|FG000|Overall Study|Additional antibiotic treatment|1
4592403|NCT01540838|7440060|FG001|Overall Study|Additional antibiotic treatment|2
4592404|NCT01540838|7440059|FG000|Overall Study|Died before treatment initiation|1
4592405|NCT01540838|7440060|FG001|Overall Study|Died before treatment initiation|1
4592406|NCT01540838|7440059|FG000|Overall Study|Not BM. Other treatment|3
4592407|NCT01540838|7440060|FG001|Overall Study|Not BM. Other treatment|1
4592408|NCT01540851|7440068|FG000|Overall Study|Lost to Follow-up|14
4592409|NCT01540851|7440069|FG001|Overall Study|Lost to Follow-up|15
4592410|NCT01540851|7440068|FG000|Overall Study|Withdrawal by Subject|7
4592411|NCT01540851|7440069|FG001|Overall Study|Withdrawal by Subject|3
4592412|NCT01540981|7440079|FG000|Overall Study|Withdrawal by Subject|1
4592413|NCT01540981|7440080|FG001|Overall Study|Withdrawal by Subject|0
4624251|NCT01817790|7488195|FG000|Overall Study|Other: Could not attend appointment|1
4624252|NCT01817790|7488196|FG001|Overall Study|Other: Could not attend appointment|1
4624253|NCT01817959|7488238|FG000|Overall Study|Graft loss|1
4624254|NCT01817959|7488239|FG001|Overall Study|Graft loss|1
4624255|NCT01817959|7488238|FG000|Overall Study|forbidden medication|1
4624256|NCT01817959|7488239|FG001|Overall Study|forbidden medication|1
4624257|NCT01817959|7488238|FG000|Overall Study|Adverse Event|1
4624258|NCT01817959|7488239|FG001|Overall Study|Adverse Event|0
4624259|NCT01817959|7488238|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1
4624260|NCT01817959|7488239|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1
4624261|NCT01818141|7488256|FG000|Overall Study|Withdrawal by Subject|2
4624262|NCT01818141|7488257|FG001|Overall Study|Withdrawal by Subject|0
4624263|NCT01818141|7488256|FG000|Overall Study|No baseline C.diff colonies|1
4624264|NCT01818141|7488257|FG001|Overall Study|No baseline C.diff colonies|1
4624265|NCT01818141|7488256|FG000|Overall Study|Lost to Follow-up|0
4592414|NCT01541215|7440088|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6
4592415|NCT01541215|7440089|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8
4592416|NCT01541215|7440088|FG000|Treatment Period (52 Weeks)|Non-compliance|4
4592417|NCT01541215|7440089|FG001|Treatment Period (52 Weeks)|Non-compliance|4
4592418|NCT01541215|7440088|FG000|Treatment Period (52 Weeks)|Adverse Event|0
4592419|NCT01541215|7440089|FG001|Treatment Period (52 Weeks)|Adverse Event|1
4592420|NCT01541215|7440088|FG000|Treatment Period (52 Weeks)|Unclassified|0
4592421|NCT01541215|7440089|FG001|Treatment Period (52 Weeks)|Unclassified|3
4592422|NCT01541215|7440088|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1
4592423|NCT01541215|7440089|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0
4624266|NCT01818141|7488257|FG001|Overall Study|Lost to Follow-up|2
4592424|NCT01541215|7440088|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1
4592425|NCT01541215|7440089|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0
4563762|NCT01306968|7397891|FG000|Overall Study|Lost to Follow-up|1
4563763|NCT01306968|7397892|FG001|Overall Study|Lost to Follow-up|1
4563764|NCT01306968|7397893|FG002|Overall Study|Lost to Follow-up|0
4563765|NCT01306968|7397894|FG003|Overall Study|Lost to Follow-up|0
4563766|NCT01306968|7397891|FG000|Overall Study|Physician Decision|0
4563767|NCT01306968|7397892|FG001|Overall Study|Physician Decision|1
4563768|NCT01306968|7397893|FG002|Overall Study|Physician Decision|0
4563769|NCT01306968|7397894|FG003|Overall Study|Physician Decision|0
4563770|NCT01306968|7397891|FG000|Overall Study|Relocated and left active duty|0
4563771|NCT01306968|7397892|FG001|Overall Study|Relocated and left active duty|1
4563772|NCT01306968|7397893|FG002|Overall Study|Relocated and left active duty|1
4563773|NCT01306968|7397894|FG003|Overall Study|Relocated and left active duty|1
4563774|NCT01306968|7397891|FG000|Overall Study|Withdrew - time commitment|0
4563775|NCT01306968|7397892|FG001|Overall Study|Withdrew - time commitment|0
4563776|NCT01306968|7397893|FG002|Overall Study|Withdrew - time commitment|0
4563777|NCT01306968|7397894|FG003|Overall Study|Withdrew - time commitment|2
4563778|NCT01306968|7397891|FG000|Overall Study|Withdrew over privacy concerns|0
4563779|NCT01306968|7397892|FG001|Overall Study|Withdrew over privacy concerns|0
4563780|NCT01306968|7397893|FG002|Overall Study|Withdrew over privacy concerns|0
4563781|NCT01306968|7397894|FG003|Overall Study|Withdrew over privacy concerns|1
4563782|NCT01307020|7397925|FG000|Overall Study|Lost to Follow-up|0
4563783|NCT01307020|7397926|FG001|Overall Study|Lost to Follow-up|0
4563784|NCT01307020|7397927|FG002|Overall Study|Lost to Follow-up|1
4563785|NCT01307020|7397928|FG003|Overall Study|Lost to Follow-up|1
4563786|NCT01307020|7397929|FG004|Overall Study|Lost to Follow-up|0
4563787|NCT01307020|7397930|FG005|Overall Study|Lost to Follow-up|0
4563788|NCT01307020|7397931|FG006|Overall Study|Lost to Follow-up|1
4563789|NCT01307020|7397932|FG007|Overall Study|Lost to Follow-up|0
4563790|NCT01307020|7397933|FG008|Overall Study|Lost to Follow-up|0
4563791|NCT01307020|7397934|FG009|Overall Study|Lost to Follow-up|0
4563792|NCT01307020|7397925|FG000|Overall Study|Electronic data capture failure|0
4563793|NCT01307020|7397926|FG001|Overall Study|Electronic data capture failure|1
4563794|NCT01307020|7397927|FG002|Overall Study|Electronic data capture failure|0
4563795|NCT01307020|7397928|FG003|Overall Study|Electronic data capture failure|0
4563796|NCT01307020|7397929|FG004|Overall Study|Electronic data capture failure|0
4563797|NCT01307020|7397930|FG005|Overall Study|Electronic data capture failure|0
4563798|NCT01307020|7397931|FG006|Overall Study|Electronic data capture failure|0
4563799|NCT01307020|7397932|FG007|Overall Study|Electronic data capture failure|0
4563800|NCT01307020|7397933|FG008|Overall Study|Electronic data capture failure|0
4563801|NCT01307020|7397934|FG009|Overall Study|Electronic data capture failure|0
4563802|NCT01307111|7397972|FG000|IUD Insertion|Lost to Follow-up|2
4563803|NCT01307111|7397973|FG001|IUD Insertion|Lost to Follow-up|0
4563804|NCT01307111|7397972|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2
4563805|NCT01307111|7397973|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2
4563806|NCT01307267|7398002|FG000|Overall Study|Death|4
4563807|NCT01307267|7398003|FG001|Overall Study|Death|3
4563808|NCT01307267|7398004|FG002|Overall Study|Death|5
4563809|NCT01307267|7398005|FG003|Overall Study|Death|3
4563810|NCT01307267|7398006|FG004|Overall Study|Death|1
4563811|NCT01307267|7398007|FG005|Overall Study|Death|26
4563812|NCT01307267|7398008|FG006|Overall Study|Death|2
4563813|NCT01307267|7398009|FG007|Overall Study|Death|2
4563814|NCT01307267|7398010|FG008|Overall Study|Death|21
4563815|NCT01307267|7398011|FG009|Overall Study|Death|2
4563816|NCT01307267|7398012|FG010|Overall Study|Death|3
4563817|NCT01307267|7398013|FG011|Overall Study|Death|9
4563818|NCT01307267|7398014|FG012|Overall Study|Death|0
4563819|NCT01307267|7398015|FG013|Overall Study|Death|0
4563820|NCT01307267|7398016|FG014|Overall Study|Death|0
4563821|NCT01307267|7398017|FG015|Overall Study|Death|0
4563822|NCT01307267|7398018|FG016|Overall Study|Death|1
4563823|NCT01307267|7398019|FG017|Overall Study|Death|1
4563824|NCT01307267|7398020|FG018|Overall Study|Death|2
4563825|NCT01307267|7398021|FG019|Overall Study|Death|8
4563826|NCT01307267|7398022|FG020|Overall Study|Death|1
4563827|NCT01307267|7398023|FG021|Overall Study|Death|2
4563828|NCT01307267|7398024|FG022|Overall Study|Death|2
4563829|NCT01307267|7398002|FG000|Overall Study|Lost to Follow-up|0
4563830|NCT01307267|7398003|FG001|Overall Study|Lost to Follow-up|0
4563831|NCT01307267|7398004|FG002|Overall Study|Lost to Follow-up|0
4563832|NCT01307267|7398005|FG003|Overall Study|Lost to Follow-up|0
4563833|NCT01307267|7398006|FG004|Overall Study|Lost to Follow-up|0
4563834|NCT01307267|7398007|FG005|Overall Study|Lost to Follow-up|7
4563835|NCT01307267|7398008|FG006|Overall Study|Lost to Follow-up|0
4563836|NCT01307267|7398009|FG007|Overall Study|Lost to Follow-up|0
4563837|NCT01307267|7398010|FG008|Overall Study|Lost to Follow-up|1
4563838|NCT01307267|7398011|FG009|Overall Study|Lost to Follow-up|2
4563839|NCT01307267|7398012|FG010|Overall Study|Lost to Follow-up|1
4563840|NCT01307267|7398013|FG011|Overall Study|Lost to Follow-up|0
4563841|NCT01307267|7398014|FG012|Overall Study|Lost to Follow-up|0
4563842|NCT01307267|7398015|FG013|Overall Study|Lost to Follow-up|0
4563843|NCT01307267|7398016|FG014|Overall Study|Lost to Follow-up|0
4563844|NCT01307267|7398017|FG015|Overall Study|Lost to Follow-up|0
4563845|NCT01307267|7398018|FG016|Overall Study|Lost to Follow-up|0
4563846|NCT01307267|7398019|FG017|Overall Study|Lost to Follow-up|0
4563847|NCT01307267|7398020|FG018|Overall Study|Lost to Follow-up|0
4563848|NCT01307267|7398021|FG019|Overall Study|Lost to Follow-up|2
4563849|NCT01307267|7398022|FG020|Overall Study|Lost to Follow-up|0
4563850|NCT01307267|7398023|FG021|Overall Study|Lost to Follow-up|0
4563851|NCT01307267|7398024|FG022|Overall Study|Lost to Follow-up|0
4563852|NCT01307267|7398002|FG000|Overall Study|Withdrawal by Subject|0
4563853|NCT01307267|7398003|FG001|Overall Study|Withdrawal by Subject|0
4563854|NCT01307267|7398004|FG002|Overall Study|Withdrawal by Subject|0
4563855|NCT01307267|7398005|FG003|Overall Study|Withdrawal by Subject|0
4563856|NCT01307267|7398006|FG004|Overall Study|Withdrawal by Subject|0
4563857|NCT01307267|7398007|FG005|Overall Study|Withdrawal by Subject|1
4563858|NCT01307267|7398008|FG006|Overall Study|Withdrawal by Subject|0
4563859|NCT01307267|7398009|FG007|Overall Study|Withdrawal by Subject|1
4563860|NCT01307267|7398010|FG008|Overall Study|Withdrawal by Subject|5
4563861|NCT01307267|7398011|FG009|Overall Study|Withdrawal by Subject|1
4563862|NCT01307267|7398012|FG010|Overall Study|Withdrawal by Subject|1
4563863|NCT01307267|7398013|FG011|Overall Study|Withdrawal by Subject|1
4563864|NCT01307267|7398014|FG012|Overall Study|Withdrawal by Subject|0
4563865|NCT01307267|7398015|FG013|Overall Study|Withdrawal by Subject|0
4563866|NCT01307267|7398016|FG014|Overall Study|Withdrawal by Subject|0
4563867|NCT01307267|7398017|FG015|Overall Study|Withdrawal by Subject|0
4563868|NCT01307267|7398018|FG016|Overall Study|Withdrawal by Subject|0
4563869|NCT01307267|7398019|FG017|Overall Study|Withdrawal by Subject|0
4563870|NCT01307267|7398020|FG018|Overall Study|Withdrawal by Subject|0
4563871|NCT01307267|7398021|FG019|Overall Study|Withdrawal by Subject|3
4563872|NCT01307267|7398022|FG020|Overall Study|Withdrawal by Subject|0
4563873|NCT01307267|7398023|FG021|Overall Study|Withdrawal by Subject|0
4563874|NCT01307267|7398024|FG022|Overall Study|Withdrawal by Subject|0
4563875|NCT01307267|7398002|FG000|Overall Study|Other|0
4563876|NCT01307267|7398003|FG001|Overall Study|Other|0
4563877|NCT01307267|7398004|FG002|Overall Study|Other|0
4563878|NCT01307267|7398005|FG003|Overall Study|Other|0
4563879|NCT01307267|7398006|FG004|Overall Study|Other|0
4563880|NCT01307267|7398007|FG005|Overall Study|Other|7
4563881|NCT01307267|7398008|FG006|Overall Study|Other|0
4563882|NCT01307267|7398009|FG007|Overall Study|Other|1
4563883|NCT01307267|7398010|FG008|Overall Study|Other|3
4563884|NCT01307267|7398011|FG009|Overall Study|Other|0
4563885|NCT01307267|7398012|FG010|Overall Study|Other|1
4563886|NCT01307267|7398013|FG011|Overall Study|Other|1
4563887|NCT01307267|7398014|FG012|Overall Study|Other|1
4563888|NCT01307267|7398015|FG013|Overall Study|Other|0
4563889|NCT01307267|7398016|FG014|Overall Study|Other|2
4563890|NCT01307267|7398017|FG015|Overall Study|Other|1
4563891|NCT01307267|7398018|FG016|Overall Study|Other|0
4563892|NCT01307267|7398019|FG017|Overall Study|Other|0
4563893|NCT01307267|7398020|FG018|Overall Study|Other|0
4563894|NCT01307267|7398021|FG019|Overall Study|Other|19
4563895|NCT01307267|7398022|FG020|Overall Study|Other|2
4563896|NCT01307267|7398023|FG021|Overall Study|Other|3
4563897|NCT01307267|7398024|FG022|Overall Study|Other|2
4563898|NCT01307319|7398086|FG000|Overall Study|Adverse Event|2
4563899|NCT01307319|7398087|FG001|Overall Study|Adverse Event|2
4563900|NCT01307319|7398088|FG002|Overall Study|Adverse Event|1
4563901|NCT01307319|7398086|FG000|Overall Study|Lost to Follow-up|1
4563902|NCT01307319|7398087|FG001|Overall Study|Lost to Follow-up|0
4563903|NCT01307319|7398088|FG002|Overall Study|Lost to Follow-up|1
4563904|NCT01307319|7398086|FG000|Overall Study|Protocol Violation|1
4563905|NCT01307319|7398087|FG001|Overall Study|Protocol Violation|1
4563906|NCT01307319|7398088|FG002|Overall Study|Protocol Violation|0
4563907|NCT01307319|7398086|FG000|Overall Study|Withdrawal by Subject|0
4563908|NCT01307319|7398087|FG001|Overall Study|Withdrawal by Subject|1
4563909|NCT01307319|7398088|FG002|Overall Study|Withdrawal by Subject|2
4563910|NCT01307319|7398086|FG000|Overall Study|Other|0
4563911|NCT01307319|7398087|FG001|Overall Study|Other|4
4563912|NCT01307319|7398088|FG002|Overall Study|Other|3
4563913|NCT01307423|7398103|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
4563914|NCT01307423|7398104|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
4563915|NCT01307423|7398105|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6
4563916|NCT01307423|7398106|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
4563917|NCT01307423|7398107|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
4563918|NCT01307423|7398108|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
4563919|NCT01307423|7398109|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
4563920|NCT01307423|7398110|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
4563921|NCT01307423|7398111|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
4563922|NCT01307423|7398103|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1
4563923|NCT01307423|7398104|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
4563924|NCT01307423|7398105|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
4563925|NCT01307423|7398106|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
4563926|NCT01307423|7398107|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
4563927|NCT01307423|7398108|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
4563928|NCT01307423|7398109|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
4563929|NCT01307423|7398110|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
4563930|NCT01307423|7398111|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
4563931|NCT01307423|7398103|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8
4563932|NCT01307423|7398104|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
4563933|NCT01307423|7398105|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10
4563934|NCT01307423|7398106|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
4563935|NCT01307423|7398107|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
4563936|NCT01307423|7398108|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
4563937|NCT01307423|7398109|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
4563938|NCT01307423|7398110|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
4563939|NCT01307423|7398111|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
4563940|NCT01307423|7398103|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
4563941|NCT01307423|7398104|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
4563942|NCT01307423|7398105|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1
4563943|NCT01307423|7398106|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
4563944|NCT01307423|7398107|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
4563945|NCT01307423|7398108|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
4563946|NCT01307423|7398109|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
4563947|NCT01307423|7398110|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
4563948|NCT01307423|7398111|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
4563949|NCT01307423|7398103|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5
4563950|NCT01307423|7398104|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
4563951|NCT01307423|7398105|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2
4563952|NCT01307423|7398106|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
4563953|NCT01307423|7398107|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
4563954|NCT01307423|7398108|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
4563955|NCT01307423|7398109|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
4563956|NCT01307423|7398110|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
4563957|NCT01307423|7398111|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
4563958|NCT01307423|7398103|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
4563959|NCT01307423|7398104|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
4563960|NCT01307423|7398105|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
4563961|NCT01307423|7398106|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
4563962|NCT01307423|7398107|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
4563963|NCT01307423|7398108|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
4563964|NCT01307423|7398109|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
4563965|NCT01307423|7398110|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
4563966|NCT01307423|7398111|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
4563967|NCT01307423|7398103|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1
4563968|NCT01307423|7398104|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2
4563969|NCT01307423|7398105|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0
4563970|NCT01307423|7398106|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0
4563971|NCT01307423|7398107|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0
4563972|NCT01307423|7398108|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0
4563973|NCT01307423|7398109|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0
4563974|NCT01307423|7398110|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0
4563975|NCT01307423|7398111|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0
4563976|NCT01307423|7398103|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
4563977|NCT01307423|7398104|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1
4563978|NCT01307423|7398105|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1
4563979|NCT01307423|7398106|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
4563980|NCT01307423|7398107|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
4563981|NCT01307423|7398108|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
4563982|NCT01307423|7398109|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
4563983|NCT01307423|7398110|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
4563984|NCT01307423|7398111|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
4563985|NCT01307423|7398103|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0
4563986|NCT01307423|7398104|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3
4563987|NCT01307423|7398105|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2
4563988|NCT01307423|7398106|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2
4563989|NCT01307423|7398107|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2
4563990|NCT01307423|7398108|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0
4563991|NCT01307423|7398109|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0
4563992|NCT01307423|7398110|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0
4563993|NCT01307423|7398111|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0
4563994|NCT01307423|7398103|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
4563995|NCT01307423|7398104|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5
4563996|NCT01307423|7398105|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5
4563997|NCT01307423|7398106|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3
4563998|NCT01307423|7398107|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1
4563999|NCT01307423|7398108|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
4564000|NCT01307423|7398109|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
4564001|NCT01307423|7398110|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
4564002|NCT01307423|7398111|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
4564003|NCT01307423|7398103|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
4564004|NCT01307423|7398104|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
4564005|NCT01307423|7398105|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
4564006|NCT01307423|7398106|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
4564007|NCT01307423|7398107|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
4564008|NCT01307423|7398108|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1
4564009|NCT01307423|7398109|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
4564010|NCT01307423|7398110|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
4564011|NCT01307423|7398111|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
4564012|NCT01307423|7398103|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
4564013|NCT01307423|7398104|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11
4564014|NCT01307423|7398105|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2
4564015|NCT01307423|7398106|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
4564016|NCT01307423|7398107|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
4564017|NCT01307423|7398108|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1
4564018|NCT01307423|7398109|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1
4564019|NCT01307423|7398110|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
4564020|NCT01307423|7398111|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
4564021|NCT01307423|7398103|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
4564022|NCT01307423|7398104|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
4564023|NCT01307423|7398105|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
4564024|NCT01307423|7398106|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2
4564025|NCT01307423|7398107|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
4564026|NCT01307423|7398108|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
4564027|NCT01307423|7398109|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
4564028|NCT01307423|7398110|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
4564029|NCT01307423|7398111|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
4564030|NCT01307423|7398103|FG000|Active Treatment Phase (Week 25-52)|Other|0
4564031|NCT01307423|7398104|FG001|Active Treatment Phase (Week 25-52)|Other|0
4564032|NCT01307423|7398105|FG002|Active Treatment Phase (Week 25-52)|Other|0
4564033|NCT01307423|7398106|FG003|Active Treatment Phase (Week 25-52)|Other|1
4564034|NCT01307423|7398107|FG004|Active Treatment Phase (Week 25-52)|Other|0
4564035|NCT01307423|7398108|FG005|Active Treatment Phase (Week 25-52)|Other|0
4564036|NCT01307423|7398109|FG006|Active Treatment Phase (Week 25-52)|Other|0
4564037|NCT01307423|7398110|FG007|Active Treatment Phase (Week 25-52)|Other|0
4564038|NCT01307423|7398111|FG008|Active Treatment Phase (Week 25-52)|Other|0
4564039|NCT01307423|7398103|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0
4564040|NCT01307423|7398104|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0
4564041|NCT01307423|7398105|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0
4564042|NCT01307423|7398106|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0
4564043|NCT01307423|7398107|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0
4564044|NCT01307423|7398108|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1
4564045|NCT01307423|7398109|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0
4564046|NCT01307423|7398110|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0
4564047|NCT01307423|7398111|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0
4564048|NCT01307423|7398103|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0
4564049|NCT01307423|7398104|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2
4564050|NCT01307423|7398105|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7
4564051|NCT01307423|7398106|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0
4564052|NCT01307423|7398107|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0
4564053|NCT01307423|7398108|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0
4564054|NCT01307423|7398109|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0
4564055|NCT01307423|7398110|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1
4564056|NCT01307423|7398111|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1
4564057|NCT01307423|7398103|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
4564058|NCT01307423|7398104|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7
4624267|NCT01818258|7488279|FG000|Overall Study|Death|3
4624268|NCT01818258|7488280|FG001|Overall Study|Death|0
4624269|NCT01818258|7488279|FG000|Overall Study|Withdrawal by Subject|0
4624270|NCT01818258|7488280|FG001|Overall Study|Withdrawal by Subject|1
4624271|NCT01818258|7488279|FG000|Overall Study|Lost to Follow-up|0
4624272|NCT01818258|7488280|FG001|Overall Study|Lost to Follow-up|1
4624273|NCT01818258|7488279|FG000|Overall Study|Unable to Travel to Clinic|0
4624274|NCT01818258|7488280|FG001|Overall Study|Unable to Travel to Clinic|1
4624275|NCT01818284|7488289|FG000|Overall Study|Not eligible due to White Blood Counts|4
4624276|NCT01818284|7488290|FG001|Overall Study|Not eligible due to White Blood Counts|4
4624277|NCT01818284|7488289|FG000|Overall Study|Death|0
4624278|NCT01818284|7488290|FG001|Overall Study|Death|2
4624279|NCT01818297|7488297|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0
4624280|NCT01818297|7488298|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1
4624281|NCT01818297|7488297|FG000|Open Label Phase (3-12 Months)|Physician Decision|1
4624282|NCT01818297|7488298|FG001|Open Label Phase (3-12 Months)|Physician Decision|0
4624283|NCT01818297|7488297|FG000|Open Label Phase (3-12 Months)|Early study closure|17
4624284|NCT01818297|7488298|FG001|Open Label Phase (3-12 Months)|Early study closure|10
4624285|NCT01818336|7488304|FG000|Overall Study|Declined retest visit|0
4564059|NCT01307423|7398105|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5
4564060|NCT01307423|7398106|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
4564061|NCT01307423|7398107|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
4564062|NCT01307423|7398108|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
4564063|NCT01307423|7398109|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
4564064|NCT01307423|7398110|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4
4564065|NCT01307423|7398111|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3
4564066|NCT01307423|7398103|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
4564067|NCT01307423|7398104|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
4564068|NCT01307423|7398105|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1
4564069|NCT01307423|7398106|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
4564070|NCT01307423|7398107|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
4564071|NCT01307423|7398108|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
4564072|NCT01307423|7398109|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
4564073|NCT01307423|7398110|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
4564074|NCT01307423|7398111|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
4564075|NCT01307423|7398103|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
4564076|NCT01307423|7398104|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13
4564077|NCT01307423|7398105|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12
4564078|NCT01307423|7398106|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
4564079|NCT01307423|7398107|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
4564080|NCT01307423|7398108|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
4564081|NCT01307423|7398109|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
4564082|NCT01307423|7398110|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3
4564083|NCT01307423|7398111|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2
4564084|NCT01307423|7398103|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0
4564085|NCT01307423|7398104|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1
4564086|NCT01307423|7398105|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0
4564087|NCT01307423|7398106|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0
4564088|NCT01307423|7398107|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0
4564089|NCT01307423|7398108|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0
4564090|NCT01307423|7398109|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0
4564091|NCT01307423|7398110|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1
4564092|NCT01307423|7398111|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1
4564093|NCT01307423|7398103|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0
4564094|NCT01307423|7398104|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1
4564095|NCT01307423|7398105|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2
4564096|NCT01307423|7398106|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0
4564097|NCT01307423|7398107|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0
4564098|NCT01307423|7398108|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0
4564099|NCT01307423|7398109|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0
4564100|NCT01307423|7398110|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3
4564101|NCT01307423|7398111|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4
4564102|NCT01307423|7398103|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
4564103|NCT01307423|7398104|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
4564104|NCT01307423|7398105|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4
4564105|NCT01307423|7398106|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
4564106|NCT01307423|7398107|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
4564107|NCT01307423|7398108|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
4564108|NCT01307423|7398109|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
4564109|NCT01307423|7398110|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1
4564110|NCT01307423|7398111|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
4564111|NCT01307423|7398103|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
4564112|NCT01307423|7398104|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1
4564113|NCT01307423|7398105|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1
4564114|NCT01307423|7398106|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
4564115|NCT01307423|7398107|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
4564116|NCT01307423|7398108|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
4564117|NCT01307423|7398109|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
4564118|NCT01307423|7398110|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
4564119|NCT01307423|7398111|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
4564120|NCT01307423|7398103|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
4564121|NCT01307423|7398104|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2
4624286|NCT01818336|7488305|FG001|Overall Study|Declined retest visit|11
4564122|NCT01307423|7398105|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8
4564123|NCT01307423|7398106|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
4564124|NCT01307423|7398107|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
4564125|NCT01307423|7398108|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
4564126|NCT01307423|7398109|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
4564127|NCT01307423|7398110|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2
4564128|NCT01307423|7398111|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4
4624287|NCT01818336|7488304|FG000|Overall Study|Lost to Follow-up|0
4624288|NCT01818336|7488305|FG001|Overall Study|Lost to Follow-up|1
4624289|NCT01818492|7488331|FG000|Overall Study|Adverse Event|2
4624290|NCT01818492|7488331|FG000|Overall Study|Death|3
4624291|NCT01818492|7488331|FG000|Overall Study|Withdrawal by Subject|1
4624292|NCT01818492|7488331|FG000|Overall Study|Additional therapy when not allowed PP|4
4624293|NCT01818531|7488363|FG000|Overall Study|Withdrawn for case delay after block|1
4624294|NCT01818531|7488364|FG001|Overall Study|Withdrawn for case delay after block|0
4624295|NCT01818531|7488363|FG000|Overall Study|Withdrawn for long-acting opioid patch|0
4624296|NCT01818531|7488364|FG001|Overall Study|Withdrawn for long-acting opioid patch|1
4624297|NCT01818531|7488363|FG000|Overall Study|Withdrawn for failure to place block|0
4624298|NCT01818531|7488364|FG001|Overall Study|Withdrawn for failure to place block|1
4624299|NCT01818596|7488372|FG000|Overall Study|Enrolled but Not Treated|4
4624300|NCT01818596|7488373|FG001|Overall Study|Enrolled but Not Treated|0
4624301|NCT01818596|7488372|FG000|Overall Study|Adverse Event|7
4624302|NCT01818596|7488373|FG001|Overall Study|Adverse Event|0
4624303|NCT01818596|7488372|FG000|Overall Study|Death|3
4624304|NCT01818596|7488373|FG001|Overall Study|Death|0
4624305|NCT01818596|7488372|FG000|Overall Study|Investigator's Discretion|4
4624306|NCT01818596|7488373|FG001|Overall Study|Investigator's Discretion|0
4624307|NCT01818596|7488372|FG000|Overall Study|Protocol Violation|1
4624308|NCT01818596|7488373|FG001|Overall Study|Protocol Violation|0
4624309|NCT01818596|7488372|FG000|Overall Study|Withdrew Consent|5
4624310|NCT01818596|7488373|FG001|Overall Study|Withdrew Consent|0
4624311|NCT01818596|7488372|FG000|Overall Study|Lost to Follow-up|7
4624312|NCT01818596|7488373|FG001|Overall Study|Lost to Follow-up|0
4624313|NCT01818700|7488380|FG000|Overall Study|Adverse Event|67
4624314|NCT01818700|7488380|FG000|Overall Study|Lack of Efficacy|2
4690776|NCT02563561|7600549|FG000|Overall Study|Sponsor Decision|5
4690777|NCT02563561|7600550|FG001|Overall Study|Sponsor Decision|2
4690778|NCT02563561|7600551|FG002|Overall Study|Sponsor Decision|4
4690779|NCT02563561|7600549|FG000|Overall Study|Other|1
4690780|NCT02563561|7600550|FG001|Overall Study|Other|5
4690781|NCT02563561|7600551|FG002|Overall Study|Other|2
4690782|NCT02563899|7600587|FG000|Overall Study|Protocol Violation|1
4690783|NCT02563899|7600588|FG001|Overall Study|Protocol Violation|0
4690784|NCT02563899|7600589|FG002|Overall Study|Protocol Violation|0
4690785|NCT02563899|7600590|FG003|Overall Study|Protocol Violation|0
4690786|NCT02563899|7600587|FG000|Overall Study|Withdrawal by Subject|0
4690787|NCT02563899|7600588|FG001|Overall Study|Withdrawal by Subject|0
4690788|NCT02563899|7600589|FG002|Overall Study|Withdrawal by Subject|1
4690789|NCT02563899|7600590|FG003|Overall Study|Withdrawal by Subject|0
4624315|NCT01818700|7488380|FG000|Overall Study|Lost to Follow-up|5
4624316|NCT01818700|7488380|FG000|Overall Study|Withdrawal by Subject|27
4624317|NCT01818700|7488380|FG000|Overall Study|Protocol Violation|2
4624318|NCT01818700|7488380|FG000|Overall Study|Other|1
4624319|NCT01818726|7488388|FG000|Overall Study|Administrative reasons|5
4624320|NCT01818726|7488389|FG001|Overall Study|Administrative reasons|1
4624321|NCT01818726|7488388|FG000|Overall Study|Withdrawal by Subject|0
4624322|NCT01818726|7488389|FG001|Overall Study|Withdrawal by Subject|1
4624323|NCT01818726|7488388|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1
4624324|NCT01818726|7488389|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0
4624325|NCT01818752|7488402|FG000|Overall Study|Adverse Event|64
4624326|NCT01818752|7488403|FG001|Overall Study|Adverse Event|74
4624327|NCT01818752|7488402|FG000|Overall Study|Death|14
4624328|NCT01818752|7488403|FG001|Overall Study|Death|18
4624329|NCT01818752|7488402|FG000|Overall Study|Non-compliance|16
4624330|NCT01818752|7488403|FG001|Overall Study|Non-compliance|20
4624331|NCT01818752|7488402|FG000|Overall Study|Withdrawal by Subject|15
4624332|NCT01818752|7488403|FG001|Overall Study|Withdrawal by Subject|14
4624333|NCT01818752|7488402|FG000|Overall Study|Physician Decision|9
4624334|NCT01818752|7488403|FG001|Overall Study|Physician Decision|8
4624335|NCT01818752|7488402|FG000|Overall Study|Disease Progression|54
4624336|NCT01818752|7488403|FG001|Overall Study|Disease Progression|48
4624337|NCT01818752|7488402|FG000|Overall Study|Other|7
4624338|NCT01818752|7488403|FG001|Overall Study|Other|8
4624339|NCT01818752|7488402|FG000|Overall Study|Continuing Treatment|1
4624340|NCT01818752|7488403|FG001|Overall Study|Continuing Treatment|4
4624341|NCT01818752|7488402|FG000|Overall Study|Randomized but not Dosed|7
4624342|NCT01818752|7488403|FG001|Overall Study|Randomized but not Dosed|4
4624343|NCT01818765|7488409|FG000|Overall Study|Death|2
4624344|NCT01819129|7488425|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1
4690790|NCT02564042|7600638|FG000|Overall Study|Adverse Event|4
4690791|NCT02564042|7600639|FG001|Overall Study|Adverse Event|4
4690792|NCT02564042|7600640|FG002|Overall Study|Adverse Event|3
4690793|NCT02564042|7600641|FG003|Overall Study|Adverse Event|0
4564129|NCT01307423|7398103|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
4564130|NCT01307423|7398104|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2
4564131|NCT01307423|7398105|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3
4564132|NCT01307423|7398106|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
4564133|NCT01307423|7398107|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
4564134|NCT01307423|7398108|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
4564135|NCT01307423|7398109|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
4564136|NCT01307423|7398110|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1
4564137|NCT01307423|7398111|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1
4564138|NCT01307423|7398103|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0
4564139|NCT01307423|7398104|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1
4564140|NCT01307423|7398105|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0
4564141|NCT01307423|7398106|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0
4564142|NCT01307423|7398107|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0
4564143|NCT01307423|7398108|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0
4564144|NCT01307423|7398109|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0
4564145|NCT01307423|7398110|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1
4564146|NCT01307423|7398111|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0
4564147|NCT01307423|7398103|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0
4564148|NCT01307423|7398104|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2
4564149|NCT01307423|7398105|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0
4564150|NCT01307423|7398106|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0
4564151|NCT01307423|7398107|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0
4564152|NCT01307423|7398108|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0
4564153|NCT01307423|7398109|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0
4564154|NCT01307423|7398110|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0
4564155|NCT01307423|7398111|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0
4564156|NCT01307423|7398103|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
4564157|NCT01307423|7398104|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1
4564158|NCT01307423|7398105|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
4564159|NCT01307423|7398106|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
4564160|NCT01307423|7398107|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
4564161|NCT01307423|7398108|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
4564162|NCT01307423|7398109|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
4564163|NCT01307423|7398110|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
4564164|NCT01307423|7398111|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1
4564165|NCT01307423|7398103|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
4564166|NCT01307423|7398104|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5
4564167|NCT01307423|7398105|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4
4564168|NCT01307423|7398106|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
4564169|NCT01307423|7398107|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
4564170|NCT01307423|7398108|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
4564171|NCT01307423|7398109|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
4564172|NCT01307423|7398110|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1
4564173|NCT01307423|7398111|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4
4564174|NCT01307423|7398103|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
4564175|NCT01307423|7398104|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
4564176|NCT01307423|7398105|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1
4564177|NCT01307423|7398106|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
4564178|NCT01307423|7398107|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
4564179|NCT01307423|7398108|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
4564180|NCT01307423|7398109|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
4564181|NCT01307423|7398110|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
4564182|NCT01307423|7398111|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
4564183|NCT01307423|7398103|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0
4564184|NCT01307423|7398104|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0
4564185|NCT01307423|7398105|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0
4564186|NCT01307423|7398106|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0
4564187|NCT01307423|7398107|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0
4564188|NCT01307423|7398108|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0
4564189|NCT01307423|7398109|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0
4564190|NCT01307423|7398110|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1
4564191|NCT01307423|7398111|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0
4564192|NCT01307423|7398103|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0
4564193|NCT01307423|7398104|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1
4564194|NCT01307423|7398105|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1
4564195|NCT01307423|7398106|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0
4564196|NCT01307423|7398107|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0
4564197|NCT01307423|7398108|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0
4564198|NCT01307423|7398109|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0
4564199|NCT01307423|7398110|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0
4564200|NCT01307423|7398111|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1
4564201|NCT01307423|7398103|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
4564202|NCT01307423|7398104|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2
4564203|NCT01307423|7398105|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1
4564204|NCT01307423|7398106|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
4564205|NCT01307423|7398107|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
4564206|NCT01307423|7398108|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
4564207|NCT01307423|7398109|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
4564208|NCT01307423|7398110|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
4564209|NCT01307423|7398111|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
4564210|NCT01307423|7398103|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
4564211|NCT01307423|7398104|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6
4564212|NCT01307423|7398105|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2
4564213|NCT01307423|7398106|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
4564214|NCT01307423|7398107|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
4564215|NCT01307423|7398108|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
4564216|NCT01307423|7398109|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
4564217|NCT01307423|7398110|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
4564218|NCT01307423|7398111|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1
4564219|NCT01307423|7398103|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
4564220|NCT01307423|7398104|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1
4564221|NCT01307423|7398105|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
4564222|NCT01307423|7398106|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
4564223|NCT01307423|7398107|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
4564224|NCT01307423|7398108|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
4564225|NCT01307423|7398109|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
4564226|NCT01307423|7398110|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
4564227|NCT01307423|7398111|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
4564228|NCT01307423|7398103|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0
4564229|NCT01307423|7398104|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0
4564230|NCT01307423|7398105|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2
4564231|NCT01307423|7398106|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0
4564232|NCT01307423|7398107|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0
4564233|NCT01307423|7398108|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0
4564234|NCT01307423|7398109|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0
4564235|NCT01307423|7398110|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1
4564236|NCT01307423|7398111|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1
4564237|NCT01307449|7398147|FG000|Overall Study|Adverse Event|1
4564238|NCT01307449|7398148|FG001|Overall Study|Adverse Event|0
4564239|NCT01307449|7398149|FG002|Overall Study|Adverse Event|0
4564240|NCT01307449|7398150|FG003|Overall Study|Adverse Event|0
4564241|NCT01307501|7398164|FG000|Overall Study|Treatment Failure|1
4564242|NCT01307501|7398164|FG000|Overall Study|Death|20
4564243|NCT01307501|7398164|FG000|Overall Study|Lost to Follow-up|1
4564244|NCT01307501|7398164|FG000|Overall Study|Starting Hospice|1
4564245|NCT01307579|7398170|FG000|Overall Study|Death|3
4564246|NCT01307579|7398171|FG001|Overall Study|Death|6
4564247|NCT01307579|7398170|FG000|Overall Study|Physician Decision|26
4564248|NCT01307579|7398171|FG001|Overall Study|Physician Decision|29
4564249|NCT01307579|7398170|FG000|Overall Study|Withdrawal by Subject|7
4564250|NCT01307579|7398171|FG001|Overall Study|Withdrawal by Subject|3
4564251|NCT01307579|7398170|FG000|Overall Study|Institutional diagnosis of IFD|21
4564252|NCT01307579|7398171|FG001|Overall Study|Institutional diagnosis of IFD|36
4564253|NCT01307579|7398170|FG000|Overall Study|Begin conditioning for HSCT|42
4564254|NCT01307579|7398171|FG001|Overall Study|Begin conditioning for HSCT|44
4564255|NCT01307579|7398170|FG000|Overall Study|Refractory or relapsed AML|38
4564256|NCT01307579|7398171|FG001|Overall Study|Refractory or relapsed AML|23
4564257|NCT01307579|7398170|FG000|Overall Study|Ineligible|3
4564258|NCT01307579|7398171|FG001|Overall Study|Ineligible|4
4564259|NCT01307891|7398207|FG000|Overall Study|Progressive Disease|3
4564260|NCT01307891|7398208|FG001|Overall Study|Progressive Disease|1
4564261|NCT01308008|7398224|FG000|4 Weeks|Illness, disinterest, time|9
4564262|NCT01308008|7398225|FG001|4 Weeks|Illness, disinterest, time|2
4564263|NCT01308424|7398259|FG000|Baseline Eligibility|Screen Failures|71
4564264|NCT01308424|7398260|FG001|Baseline Eligibility|Screen Failures|0
4564265|NCT01308424|7398261|FG002|Baseline Eligibility|Screen Failures|0
4564266|NCT01308424|7398259|FG000|Randomization|Adverse Event|0
4564267|NCT01308424|7398260|FG001|Randomization|Adverse Event|1
4564268|NCT01308424|7398261|FG002|Randomization|Adverse Event|1
4564269|NCT01308424|7398259|FG000|Randomization|Lost to Follow-up|0
4564270|NCT01308424|7398260|FG001|Randomization|Lost to Follow-up|1
4564271|NCT01308424|7398261|FG002|Randomization|Lost to Follow-up|0
4564272|NCT01308424|7398259|FG000|Randomization|Physician Decision|0
4564273|NCT01308424|7398260|FG001|Randomization|Physician Decision|1
4564274|NCT01308424|7398261|FG002|Randomization|Physician Decision|1
4564275|NCT01308463|7398272|FG000|Overall Study|Study Discontinued|23
4564276|NCT01308463|7398272|FG000|Overall Study|Death|4
4564277|NCT01308463|7398272|FG000|Overall Study|Revision|2
4564278|NCT01308476|7398278|FG000|Overall Study|Lost to Follow-up|2
4564279|NCT01308476|7398279|FG001|Overall Study|Lost to Follow-up|2
4564280|NCT01308476|7398278|FG000|Overall Study|Other|1
4564281|NCT01308476|7398279|FG001|Overall Study|Other|0
4564282|NCT01308567|7398288|FG000|Overall Study|Lost to Follow-up|2
4564283|NCT01308567|7398289|FG001|Overall Study|Lost to Follow-up|4
4564284|NCT01308567|7398290|FG002|Overall Study|Lost to Follow-up|4
4564285|NCT01308580|7398300|FG000|Overall Study|Lost to Follow-up|12
4564286|NCT01308580|7398301|FG001|Overall Study|Lost to Follow-up|7
4564287|NCT01308736|7398321|FG000|Overall Study|Did not attend a single session|6
4564288|NCT01308736|7398322|FG001|Overall Study|Did not attend a single session|5
4564289|NCT01308749|7398330|FG000|Period 1: Double Blind Treatment|Adverse Event|1
4564290|NCT01308749|7398331|FG001|Period 1: Double Blind Treatment|Adverse Event|0
4564291|NCT01308749|7398330|FG000|Period 2: Open Label Treatment|Adverse Event|0
4564292|NCT01308749|7398331|FG001|Period 2: Open Label Treatment|Adverse Event|1
4564293|NCT01308749|7398330|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0
4564294|NCT01308749|7398331|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1
4564295|NCT01308762|7398354|FG000|Overall Study|Protocol Violation|0
4564296|NCT01308762|7398355|FG001|Overall Study|Protocol Violation|1
4564297|NCT01308762|7398356|FG002|Overall Study|Protocol Violation|0
4564298|NCT01308788|7398369|FG000|2-year Treatment|medication change by treating physician|4
4564299|NCT01308788|7398370|FG001|2-year Treatment|medication change by treating physician|11
4564300|NCT01308853|7398389|FG000|Overall Study|Adverse Event|1
4564301|NCT01308853|7398389|FG000|Overall Study|Lost to Follow-up|2
4564302|NCT01308853|7398389|FG000|Overall Study|Insertion of permanent implants|1
4564303|NCT01309100|7398397|FG000|Overall Study|Protocol Violation|1
4564304|NCT01309100|7398397|FG000|Overall Study|Positive Slit lamp finding|1
4564305|NCT01309165|7398406|FG000|Overall Study|Lost to Follow-up|4
4564306|NCT01309165|7398407|FG001|Overall Study|Lost to Follow-up|3
4564307|NCT01309165|7398406|FG000|Overall Study|Return to work|1
4564308|NCT01309165|7398407|FG001|Overall Study|Return to work|2
4564309|NCT01309165|7398406|FG000|Overall Study|Left country|0
4564310|NCT01309165|7398407|FG001|Overall Study|Left country|1
4564311|NCT01309165|7398406|FG000|Overall Study|No transportation|0
4564312|NCT01309165|7398407|FG001|Overall Study|No transportation|1
4564313|NCT01309165|7398406|FG000|Overall Study|Admitted to hospital for second stroke|1
4564314|NCT01309165|7398407|FG001|Overall Study|Admitted to hospital for second stroke|0
4564315|NCT01309204|7398416|FG000|Overall Study|Adverse Event|48
4564316|NCT01309204|7398417|FG001|Overall Study|Adverse Event|58
4564317|NCT01309204|7398416|FG000|Overall Study|Lost to Follow-up|2
4564318|NCT01309204|7398417|FG001|Overall Study|Lost to Follow-up|2
4564319|NCT01309204|7398416|FG000|Overall Study|Subject's decision unrelated to an AE|9
4564320|NCT01309204|7398417|FG001|Overall Study|Subject's decision unrelated to an AE|10
4564321|NCT01309204|7398416|FG000|Overall Study|Inadequate control of IOP|4
4564322|NCT01309204|7398417|FG001|Overall Study|Inadequate control of IOP|4
4564323|NCT01309204|7398416|FG000|Overall Study|Other|4
4564324|NCT01309204|7398417|FG001|Overall Study|Other|1
4564325|NCT01309243|7398425|FG000|Randomized Phase Through Week 96|Randomized but not treated|6
4564326|NCT01309243|7398426|FG001|Randomized Phase Through Week 96|Randomized but not treated|7
4564327|NCT01309243|7398425|FG000|Randomized Phase Through Week 96|Adverse Event|12
4564328|NCT01309243|7398426|FG001|Randomized Phase Through Week 96|Adverse Event|43
4564329|NCT01309243|7398425|FG000|Randomized Phase Through Week 96|Death|0
4564330|NCT01309243|7398426|FG001|Randomized Phase Through Week 96|Death|1
4564331|NCT01309243|7398425|FG000|Randomized Phase Through Week 96|Pregnancy|2
4564332|NCT01309243|7398426|FG001|Randomized Phase Through Week 96|Pregnancy|0
4564333|NCT01309243|7398425|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16
4564334|NCT01309243|7398426|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4
4564335|NCT01309243|7398425|FG000|Randomized Phase Through Week 96|Investigators Discretion|3
4564336|NCT01309243|7398426|FG001|Randomized Phase Through Week 96|Investigators Discretion|6
4564337|NCT01309243|7398425|FG000|Randomized Phase Through Week 96|Withdrew Consent|12
4564338|NCT01309243|7398426|FG001|Randomized Phase Through Week 96|Withdrew Consent|18
4564339|NCT01309243|7398425|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23
4564340|NCT01309243|7398426|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22
4564341|NCT01309243|7398425|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9
4564342|NCT01309243|7398426|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7
4564343|NCT01309243|7398425|FG000|Randomized Phase Through Week 96|Protocol Violation|1
4564344|NCT01309243|7398426|FG001|Randomized Phase Through Week 96|Protocol Violation|1
4564345|NCT01309243|7398425|FG000|Extension Phase|Lost to Follow-up|6
4564346|NCT01309243|7398426|FG001|Extension Phase|Lost to Follow-up|0
4564347|NCT01309269|7398432|FG000|Overall Study|Adverse Event|56
4564348|NCT01309269|7398432|FG000|Overall Study|Withdrawal by Subject|25
4564349|NCT01309269|7398432|FG000|Overall Study|Lack of Acceptance|15
4564350|NCT01309269|7398432|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119
4564351|NCT01309269|7398432|FG000|Overall Study|Kidney Transplant|25
4564352|NCT01309269|7398432|FG000|Overall Study|Administrative Problems|141
4564353|NCT01309269|7398432|FG000|Overall Study|Other|256
4564354|NCT01309269|7398432|FG000|Overall Study|Other|1
4564355|NCT01309269|7398432|FG000|Overall Study|Study Completion Data Not Recorded|95
4564356|NCT01309269|7398432|FG000|Overall Study|Enrolled but not Treated|107
4564357|NCT01309282|7398436|FG000|Overall Study|Lost to Follow-up|1
4564358|NCT01309308|7398442|FG000|Overall Study|Lost to Follow-up|6
4564359|NCT01309308|7398443|FG001|Overall Study|Lost to Follow-up|4
4564360|NCT01309386|7398464|FG000|Overall Study|Other|2
4564361|NCT01309386|7398465|FG001|Overall Study|Other|0
4564362|NCT01309386|7398464|FG000|Overall Study|Withdrawal by Subject|2
4564363|NCT01309386|7398465|FG001|Overall Study|Withdrawal by Subject|0
4564364|NCT01309386|7398464|FG000|Overall Study|Progressive disease|9
4564365|NCT01309386|7398465|FG001|Overall Study|Progressive disease|11
4564366|NCT01309386|7398464|FG000|Overall Study|Physician Decision|1
4564367|NCT01309386|7398465|FG001|Overall Study|Physician Decision|1
4564368|NCT01309386|7398464|FG000|Overall Study|Lack of Efficacy|3
4564369|NCT01309386|7398465|FG001|Overall Study|Lack of Efficacy|1
4564370|NCT01309386|7398464|FG000|Overall Study|Adverse Event|5
4564371|NCT01309386|7398465|FG001|Overall Study|Adverse Event|8
4564372|NCT01309659|7398493|FG000|Overall Study|Protocol Violation|0
4564373|NCT01309659|7398494|FG001|Overall Study|Protocol Violation|1
4564374|NCT01309737|7398503|FG000|Week 0 to 16|Death|1
4564375|NCT01309737|7398504|FG001|Week 0 to 16|Death|0
4564376|NCT01309737|7398505|FG002|Week 0 to 16|Death|1
4564377|NCT01309737|7398506|FG003|Week 0 to 16|Death|0
4564378|NCT01309737|7398507|FG004|Week 0 to 16|Death|0
4564379|NCT01309737|7398503|FG000|Week 0 to 16|Adverse Event|11
4564380|NCT01309737|7398504|FG001|Week 0 to 16|Adverse Event|10
4564381|NCT01309737|7398505|FG002|Week 0 to 16|Adverse Event|5
4564382|NCT01309737|7398506|FG003|Week 0 to 16|Adverse Event|0
4564383|NCT01309737|7398507|FG004|Week 0 to 16|Adverse Event|0
4564384|NCT01309737|7398503|FG000|Week 0 to 16|Lack of Efficacy|15
4564385|NCT01309737|7398504|FG001|Week 0 to 16|Lack of Efficacy|2
4564386|NCT01309737|7398505|FG002|Week 0 to 16|Lack of Efficacy|24
4564387|NCT01309737|7398506|FG003|Week 0 to 16|Lack of Efficacy|0
4564388|NCT01309737|7398507|FG004|Week 0 to 16|Lack of Efficacy|0
4564389|NCT01309737|7398503|FG000|Week 0 to 16|Lost to Follow-up|7
4564390|NCT01309737|7398504|FG001|Week 0 to 16|Lost to Follow-up|8
4564391|NCT01309737|7398505|FG002|Week 0 to 16|Lost to Follow-up|3
4564392|NCT01309737|7398506|FG003|Week 0 to 16|Lost to Follow-up|0
4564393|NCT01309737|7398507|FG004|Week 0 to 16|Lost to Follow-up|0
4564394|NCT01309737|7398503|FG000|Week 0 to 16|Withdrawal by Subject|7
4564395|NCT01309737|7398504|FG001|Week 0 to 16|Withdrawal by Subject|6
4564396|NCT01309737|7398505|FG002|Week 0 to 16|Withdrawal by Subject|7
4564397|NCT01309737|7398506|FG003|Week 0 to 16|Withdrawal by Subject|0
4564398|NCT01309737|7398507|FG004|Week 0 to 16|Withdrawal by Subject|0
4564399|NCT01309737|7398503|FG000|Week 0 to 16|Other|10
4564400|NCT01309737|7398504|FG001|Week 0 to 16|Other|14
4564401|NCT01309737|7398505|FG002|Week 0 to 16|Other|4
4564402|NCT01309737|7398506|FG003|Week 0 to 16|Other|0
4564403|NCT01309737|7398507|FG004|Week 0 to 16|Other|0
4564404|NCT01309737|7398503|FG000|Week 0 to 16|Randomized, but not treated|1
4564405|NCT01309737|7398504|FG001|Week 0 to 16|Randomized, but not treated|0
4564406|NCT01309737|7398505|FG002|Week 0 to 16|Randomized, but not treated|0
4564407|NCT01309737|7398506|FG003|Week 0 to 16|Randomized, but not treated|0
4564408|NCT01309737|7398507|FG004|Week 0 to 16|Randomized, but not treated|0
4564409|NCT01309737|7398503|FG000|Week 16 to 52|Death|0
4564410|NCT01309737|7398504|FG001|Week 16 to 52|Death|0
4564411|NCT01309737|7398505|FG002|Week 16 to 52|Death|0
4564412|NCT01309737|7398506|FG003|Week 16 to 52|Death|0
4564413|NCT01309737|7398507|FG004|Week 16 to 52|Death|1
4564414|NCT01309737|7398503|FG000|Week 16 to 52|Adverse Event|7
4564415|NCT01309737|7398504|FG001|Week 16 to 52|Adverse Event|7
4564416|NCT01309737|7398505|FG002|Week 16 to 52|Adverse Event|0
4564417|NCT01309737|7398506|FG003|Week 16 to 52|Adverse Event|6
4564418|NCT01309737|7398507|FG004|Week 16 to 52|Adverse Event|5
4564419|NCT01309737|7398503|FG000|Week 16 to 52|Lack of Efficacy|107
4564420|NCT01309737|7398504|FG001|Week 16 to 52|Lack of Efficacy|76
4564421|NCT01309737|7398505|FG002|Week 16 to 52|Lack of Efficacy|0
4564422|NCT01309737|7398506|FG003|Week 16 to 52|Lack of Efficacy|25
4564423|NCT01309737|7398507|FG004|Week 16 to 52|Lack of Efficacy|21
4564424|NCT01309737|7398503|FG000|Week 16 to 52|Lost to Follow-up|4
4564425|NCT01309737|7398504|FG001|Week 16 to 52|Lost to Follow-up|2
4564426|NCT01309737|7398505|FG002|Week 16 to 52|Lost to Follow-up|0
4564427|NCT01309737|7398506|FG003|Week 16 to 52|Lost to Follow-up|1
4564428|NCT01309737|7398507|FG004|Week 16 to 52|Lost to Follow-up|4
4564429|NCT01309737|7398503|FG000|Week 16 to 52|Withdrawal by Subject|5
4564430|NCT01309737|7398504|FG001|Week 16 to 52|Withdrawal by Subject|6
4564431|NCT01309737|7398505|FG002|Week 16 to 52|Withdrawal by Subject|0
4564432|NCT01309737|7398506|FG003|Week 16 to 52|Withdrawal by Subject|0
4564433|NCT01309737|7398507|FG004|Week 16 to 52|Withdrawal by Subject|2
4564434|NCT01309737|7398503|FG000|Week 16 to 52|Other|10
4564435|NCT01309737|7398504|FG001|Week 16 to 52|Other|12
4564436|NCT01309737|7398505|FG002|Week 16 to 52|Other|0
4564437|NCT01309737|7398506|FG003|Week 16 to 52|Other|2
4564438|NCT01309737|7398507|FG004|Week 16 to 52|Other|0
4564439|NCT01309828|7398541|FG000|Overall Study|Adverse Event|10
4564440|NCT01309828|7398542|FG001|Overall Study|Adverse Event|11
4564441|NCT01309828|7398541|FG000|Overall Study|Voluntary Withdrawal|5
4564442|NCT01309828|7398542|FG001|Overall Study|Voluntary Withdrawal|4
4564443|NCT01309828|7398541|FG000|Overall Study|Major Protocol Deviation|0
4564444|NCT01309828|7398542|FG001|Overall Study|Major Protocol Deviation|1
4564445|NCT01309828|7398541|FG000|Overall Study|Other|1
4564446|NCT01309828|7398542|FG001|Overall Study|Other|0
4564447|NCT01309841|7398551|FG000|Overall Study|Other|0
4564448|NCT01309841|7398552|FG001|Overall Study|Other|1
4564449|NCT01309841|7398553|FG002|Overall Study|Other|1
4564450|NCT01309841|7398551|FG000|Overall Study|Lost to Follow-up|7
4564451|NCT01309841|7398552|FG001|Overall Study|Lost to Follow-up|6
4564452|NCT01309841|7398553|FG002|Overall Study|Lost to Follow-up|4
4564453|NCT01309841|7398551|FG000|Overall Study|Study-Specific Withdrawal Criteria|3
4624345|NCT01819129|7488426|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0
4624346|NCT01819129|7488425|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1
4624347|NCT01819129|7488426|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0
4564454|NCT01309841|7398552|FG001|Overall Study|Study-Specific Withdrawal Criteria|1
4564455|NCT01309841|7398553|FG002|Overall Study|Study-Specific Withdrawal Criteria|2
4624348|NCT01819129|7488425|FG000|Overall Study|Other, Subject moved out of the country|0
4624349|NCT01819129|7488426|FG001|Overall Study|Other, Subject moved out of the country|1
4624350|NCT01819129|7488425|FG000|Overall Study|Withdrawal by Subject|15
4624351|NCT01819129|7488426|FG001|Overall Study|Withdrawal by Subject|15
4624352|NCT01819129|7488425|FG000|Overall Study|Lost to Follow-up|5
4624353|NCT01819129|7488426|FG001|Overall Study|Lost to Follow-up|2
4564456|NCT01309841|7398551|FG000|Overall Study|Lack of Efficacy|0
4564457|NCT01309841|7398552|FG001|Overall Study|Lack of Efficacy|0
4564458|NCT01309841|7398553|FG002|Overall Study|Lack of Efficacy|2
4564459|NCT01309841|7398551|FG000|Overall Study|Adverse Event|9
4564460|NCT01309841|7398552|FG001|Overall Study|Adverse Event|22
4564461|NCT01309841|7398553|FG002|Overall Study|Adverse Event|11
4564462|NCT01309841|7398551|FG000|Overall Study|Death|1
4564463|NCT01309841|7398552|FG001|Overall Study|Death|0
4564464|NCT01309841|7398553|FG002|Overall Study|Death|0
4564465|NCT01309841|7398551|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0
4564466|NCT01309841|7398552|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0
4564467|NCT01309841|7398553|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1
4564468|NCT01309841|7398551|FG000|Overall Study|Withdrawal by Subject|17
4624354|NCT01819129|7488425|FG000|Overall Study|Lack of Efficacy|0
4624355|NCT01819129|7488426|FG001|Overall Study|Lack of Efficacy|1
4624356|NCT01819129|7488425|FG000|Overall Study|Adverse Event|1
4624357|NCT01819129|7488426|FG001|Overall Study|Adverse Event|4
4624358|NCT01819129|7488425|FG000|Overall Study|Death|1
4624359|NCT01819129|7488426|FG001|Overall Study|Death|1
4624360|NCT01819129|7488425|FG000|Overall Study|Withdrawal Criteria|20
4624361|NCT01819129|7488426|FG001|Overall Study|Withdrawal Criteria|15
4624362|NCT01819194|7488432|FG000|Overall Study|Loss of study articles|2
4624363|NCT01819272|7488446|FG000|Overall Study|Adverse Event|1
4624364|NCT01819272|7488447|FG001|Overall Study|Adverse Event|0
4624365|NCT01819272|7488448|FG002|Overall Study|Adverse Event|0
4624366|NCT01819272|7488449|FG003|Overall Study|Adverse Event|2
4624367|NCT01819272|7488450|FG004|Overall Study|Adverse Event|0
4624368|NCT01819272|7488451|FG005|Overall Study|Adverse Event|0
4624369|NCT01819272|7488446|FG000|Overall Study|Lost to Follow-up|3
4624370|NCT01819272|7488447|FG001|Overall Study|Lost to Follow-up|0
4624371|NCT01819272|7488448|FG002|Overall Study|Lost to Follow-up|1
4624372|NCT01819272|7488449|FG003|Overall Study|Lost to Follow-up|0
4624373|NCT01819272|7488450|FG004|Overall Study|Lost to Follow-up|0
4624374|NCT01819272|7488451|FG005|Overall Study|Lost to Follow-up|3
4624375|NCT01819272|7488446|FG000|Overall Study|Protocol Violation|0
4624376|NCT01819272|7488447|FG001|Overall Study|Protocol Violation|0
4624377|NCT01819272|7488448|FG002|Overall Study|Protocol Violation|0
4624378|NCT01819272|7488449|FG003|Overall Study|Protocol Violation|1
4624379|NCT01819272|7488450|FG004|Overall Study|Protocol Violation|2
4624380|NCT01819272|7488451|FG005|Overall Study|Protocol Violation|3
4624381|NCT01819272|7488446|FG000|Overall Study|Physician Decision|0
4624382|NCT01819272|7488447|FG001|Overall Study|Physician Decision|1
4624383|NCT01819272|7488448|FG002|Overall Study|Physician Decision|0
4624384|NCT01819272|7488449|FG003|Overall Study|Physician Decision|0
4624385|NCT01819272|7488450|FG004|Overall Study|Physician Decision|0
4624386|NCT01819272|7488451|FG005|Overall Study|Physician Decision|0
4624387|NCT01819272|7488446|FG000|Overall Study|Withdrawal of Consent|0
4624388|NCT01819272|7488447|FG001|Overall Study|Withdrawal of Consent|1
4624389|NCT01819272|7488448|FG002|Overall Study|Withdrawal of Consent|2
4624390|NCT01819272|7488449|FG003|Overall Study|Withdrawal of Consent|1
4624391|NCT01819272|7488450|FG004|Overall Study|Withdrawal of Consent|0
4624392|NCT01819272|7488451|FG005|Overall Study|Withdrawal of Consent|1
4624393|NCT01819272|7488446|FG000|Overall Study|Loss of Glucose Control|2
4624394|NCT01819272|7488447|FG001|Overall Study|Loss of Glucose Control|1
4624395|NCT01819272|7488448|FG002|Overall Study|Loss of Glucose Control|0
4624396|NCT01819272|7488449|FG003|Overall Study|Loss of Glucose Control|1
4624397|NCT01819272|7488450|FG004|Overall Study|Loss of Glucose Control|2
4624398|NCT01819272|7488451|FG005|Overall Study|Loss of Glucose Control|0
4624399|NCT01819506|7488493|FG000|Overall Study|Physician Decision|5
4624400|NCT01819506|7488494|FG001|Overall Study|Physician Decision|2
4624401|NCT01819506|7488493|FG000|Overall Study|Withdrawal by Subject|3
4564469|NCT01309841|7398552|FG001|Overall Study|Withdrawal by Subject|6
4624402|NCT01819506|7488494|FG001|Overall Study|Withdrawal by Subject|3
4624403|NCT01819727|7488506|FG000|Overall Study|Adverse Event|8
4624404|NCT01819727|7488507|FG001|Overall Study|Adverse Event|9
4624405|NCT01819727|7488506|FG000|Overall Study|Death|1
4564470|NCT01309841|7398553|FG002|Overall Study|Withdrawal by Subject|13
4564471|NCT01309841|7398551|FG000|Overall Study|Did Not Receive Treatment|2
4564472|NCT01309841|7398552|FG001|Overall Study|Did Not Receive Treatment|0
4564473|NCT01309841|7398553|FG002|Overall Study|Did Not Receive Treatment|1
4564474|NCT01309841|7398551|FG000|Overall Study|Severe non-compliance with protocol|0
4564475|NCT01309841|7398552|FG001|Overall Study|Severe non-compliance with protocol|5
4564476|NCT01309841|7398553|FG002|Overall Study|Severe non-compliance with protocol|2
4564477|NCT01309893|7398575|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1
4564478|NCT01309893|7398576|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0
4564479|NCT01309893|7398575|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0
4564480|NCT01309893|7398576|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1
4564481|NCT01309919|7398591|FG000|Overall Study|Did not receive a postpartum IUD|17
4564482|NCT01309919|7398592|FG001|Overall Study|Did not receive a postpartum IUD|48
4564483|NCT01309997|7398600|FG000|Overall Study|Adverse Event|1
4564484|NCT01309997|7398601|FG001|Overall Study|Adverse Event|0
4564485|NCT01309997|7398600|FG000|Overall Study|Death|1
4564486|NCT01309997|7398601|FG001|Overall Study|Death|3
4564487|NCT01309997|7398600|FG000|Overall Study|Lack of Efficacy|2
4564488|NCT01309997|7398601|FG001|Overall Study|Lack of Efficacy|2
4564489|NCT01309997|7398600|FG000|Overall Study|Withdrawal by Subject|1
4564490|NCT01309997|7398601|FG001|Overall Study|Withdrawal by Subject|1
4564491|NCT01310036|7398618|FG000|Overall Study|Administrative/other|10
4564492|NCT01310036|7398618|FG000|Overall Study|Withdrew Consent|11
4564493|NCT01310036|7398618|FG000|Overall Study|Refused Treatment/Did not Cooperate|4
4564494|NCT01310036|7398618|FG000|Overall Study|Progression of Disease|164
4564495|NCT01310036|7398618|FG000|Overall Study|Death|1
4564496|NCT01310036|7398618|FG000|Overall Study|Adverse event or intercurrent illness|12
4564497|NCT01310075|7398624|FG000|Overall Study|Lost to Follow-up|1
4564498|NCT01310075|7398625|FG001|Overall Study|Lost to Follow-up|0
4564499|NCT01310075|7398624|FG000|Overall Study|Physician Decision|10
4564500|NCT01310075|7398625|FG001|Overall Study|Physician Decision|7
4564501|NCT01310075|7398624|FG000|Overall Study|Protocol Violation|2
4564502|NCT01310075|7398625|FG001|Overall Study|Protocol Violation|2
4564503|NCT01310075|7398624|FG000|Overall Study|Withdrawal by Subject|1
4564504|NCT01310075|7398625|FG001|Overall Study|Withdrawal by Subject|1
4564505|NCT01310127|7398633|FG000|Overall Study|Protocol Violation|1
4564506|NCT01310127|7398634|FG001|Overall Study|Protocol Violation|1
4564507|NCT01310127|7398633|FG000|Overall Study|advanced psc cataract outlier|1
4564508|NCT01310127|7398634|FG001|Overall Study|advanced psc cataract outlier|0
4564509|NCT01310413|7398675|FG000|Day 0 to Day 385|Withdrawal by Subject|5
4564510|NCT01310413|7398676|FG001|Day 0 to Day 385|Withdrawal by Subject|2
4564511|NCT01310413|7398677|FG002|Day 0 to Day 385|Withdrawal by Subject|0
4564512|NCT01310413|7398678|FG003|Day 0 to Day 385|Withdrawal by Subject|2
4564513|NCT01310413|7398679|FG004|Day 0 to Day 385|Withdrawal by Subject|1
4564514|NCT01310413|7398680|FG005|Day 0 to Day 385|Withdrawal by Subject|1
4564515|NCT01310413|7398681|FG006|Day 0 to Day 385|Withdrawal by Subject|0
4564516|NCT01310413|7398675|FG000|Day 0 to Day 385|Lost to Follow-up|18
4564517|NCT01310413|7398676|FG001|Day 0 to Day 385|Lost to Follow-up|3
4690794|NCT02564042|7600642|FG004|Overall Study|Adverse Event|0
4690795|NCT02564042|7600643|FG005|Overall Study|Adverse Event|1
4690796|NCT02564042|7600638|FG000|Overall Study|Lost to Follow-up|1
4690797|NCT02564042|7600639|FG001|Overall Study|Lost to Follow-up|1
4690798|NCT02564042|7600640|FG002|Overall Study|Lost to Follow-up|1
4690799|NCT02564042|7600641|FG003|Overall Study|Lost to Follow-up|0
4690800|NCT02564042|7600642|FG004|Overall Study|Lost to Follow-up|1
4690801|NCT02564042|7600643|FG005|Overall Study|Lost to Follow-up|1
4564518|NCT01310413|7398677|FG002|Day 0 to Day 385|Lost to Follow-up|3
4564519|NCT01310413|7398678|FG003|Day 0 to Day 385|Lost to Follow-up|5
4564520|NCT01310413|7398679|FG004|Day 0 to Day 385|Lost to Follow-up|1
4564521|NCT01310413|7398680|FG005|Day 0 to Day 385|Lost to Follow-up|2
4564522|NCT01310413|7398681|FG006|Day 0 to Day 385|Lost to Follow-up|0
4564523|NCT01310413|7398675|FG000|Day 0 to Day 385|Migrated/moved from study area|3
4564524|NCT01310413|7398676|FG001|Day 0 to Day 385|Migrated/moved from study area|3
4564525|NCT01310413|7398677|FG002|Day 0 to Day 385|Migrated/moved from study area|1
4564526|NCT01310413|7398678|FG003|Day 0 to Day 385|Migrated/moved from study area|1
4564527|NCT01310413|7398679|FG004|Day 0 to Day 385|Migrated/moved from study area|1
4564528|NCT01310413|7398680|FG005|Day 0 to Day 385|Migrated/moved from study area|0
4564529|NCT01310413|7398681|FG006|Day 0 to Day 385|Migrated/moved from study area|0
4564530|NCT01310413|7398675|FG000|Day 0 to Day 385|Other|1
4564531|NCT01310413|7398676|FG001|Day 0 to Day 385|Other|0
4564532|NCT01310413|7398677|FG002|Day 0 to Day 385|Other|3
4564533|NCT01310413|7398678|FG003|Day 0 to Day 385|Other|0
4564534|NCT01310413|7398679|FG004|Day 0 to Day 385|Other|0
4564535|NCT01310413|7398680|FG005|Day 0 to Day 385|Other|0
4564536|NCT01310413|7398681|FG006|Day 0 to Day 385|Other|0
4564537|NCT01310413|7398675|FG000|From Day U0 to Day U385|Withdrawal by Subject|0
4564538|NCT01310413|7398676|FG001|From Day U0 to Day U385|Withdrawal by Subject|0
4564539|NCT01310413|7398677|FG002|From Day U0 to Day U385|Withdrawal by Subject|0
4564540|NCT01310413|7398678|FG003|From Day U0 to Day U385|Withdrawal by Subject|0
4564541|NCT01310413|7398679|FG004|From Day U0 to Day U385|Withdrawal by Subject|0
4690802|NCT02564042|7600638|FG000|Overall Study|Physician Decision|1
4690803|NCT02564042|7600639|FG001|Overall Study|Physician Decision|0
4690804|NCT02564042|7600640|FG002|Overall Study|Physician Decision|0
4690805|NCT02564042|7600641|FG003|Overall Study|Physician Decision|1
4690806|NCT02564042|7600642|FG004|Overall Study|Physician Decision|0
4690807|NCT02564042|7600643|FG005|Overall Study|Physician Decision|0
4690808|NCT02564042|7600638|FG000|Overall Study|Withdrawal by Subject|5
4690809|NCT02564042|7600639|FG001|Overall Study|Withdrawal by Subject|3
4690810|NCT02564042|7600640|FG002|Overall Study|Withdrawal by Subject|2
4690811|NCT02564042|7600641|FG003|Overall Study|Withdrawal by Subject|2
4690812|NCT02564042|7600642|FG004|Overall Study|Withdrawal by Subject|10
4690813|NCT02564042|7600643|FG005|Overall Study|Withdrawal by Subject|12
4690814|NCT02564055|7600663|FG000|Overall Study|Adverse Event|1
4690815|NCT02564055|7600664|FG001|Overall Study|Adverse Event|0
4690816|NCT02564055|7600665|FG002|Overall Study|Adverse Event|4
4690817|NCT02564055|7600666|FG003|Overall Study|Adverse Event|1
4690818|NCT02564055|7600667|FG004|Overall Study|Adverse Event|4
4690819|NCT02564055|7600668|FG005|Overall Study|Adverse Event|1
4690820|NCT02564055|7600663|FG000|Overall Study|Protocol Violation|1
4690821|NCT02564055|7600664|FG001|Overall Study|Protocol Violation|0
4690822|NCT02564055|7600665|FG002|Overall Study|Protocol Violation|0
4690823|NCT02564055|7600666|FG003|Overall Study|Protocol Violation|0
4690824|NCT02564055|7600667|FG004|Overall Study|Protocol Violation|0
4690825|NCT02564055|7600668|FG005|Overall Study|Protocol Violation|0
4690826|NCT02564055|7600663|FG000|Overall Study|Reached stopping criteria|0
4690827|NCT02564055|7600664|FG001|Overall Study|Reached stopping criteria|0
4690828|NCT02564055|7600665|FG002|Overall Study|Reached stopping criteria|0
4564542|NCT01310413|7398680|FG005|From Day U0 to Day U385|Withdrawal by Subject|0
4564543|NCT01310413|7398681|FG006|From Day U0 to Day U385|Withdrawal by Subject|1
4564544|NCT01310413|7398675|FG000|From Day U0 to Day U385|Lost to Follow-up|0
4564545|NCT01310413|7398676|FG001|From Day U0 to Day U385|Lost to Follow-up|0
4564546|NCT01310413|7398677|FG002|From Day U0 to Day U385|Lost to Follow-up|0
4564547|NCT01310413|7398678|FG003|From Day U0 to Day U385|Lost to Follow-up|0
4564548|NCT01310413|7398679|FG004|From Day U0 to Day U385|Lost to Follow-up|0
4564549|NCT01310413|7398680|FG005|From Day U0 to Day U385|Lost to Follow-up|0
4564550|NCT01310413|7398681|FG006|From Day U0 to Day U385|Lost to Follow-up|2
4564551|NCT01310699|7398721|FG000|Overall Study|Patients did not complete tandem.|4
4564552|NCT01310699|7398722|FG001|Overall Study|Patients did not complete tandem.|6
4564553|NCT01310777|7398733|FG000|Overall Study|Adverse Event|23
4564554|NCT01310777|7398734|FG001|Overall Study|Adverse Event|1
4564555|NCT01310777|7398735|FG002|Overall Study|Adverse Event|15
4564556|NCT01310777|7398733|FG000|Overall Study|Lost to Follow-up|0
4564557|NCT01310777|7398734|FG001|Overall Study|Lost to Follow-up|4
4564558|NCT01310777|7398735|FG002|Overall Study|Lost to Follow-up|1
4564559|NCT01310777|7398733|FG000|Overall Study|Patient's Decision Unrelated to AE|1
4564560|NCT01310777|7398734|FG001|Overall Study|Patient's Decision Unrelated to AE|1
4564561|NCT01310777|7398735|FG002|Overall Study|Patient's Decision Unrelated to AE|2
4564562|NCT01310777|7398733|FG000|Overall Study|Inadequate Control of IOP|5
4564563|NCT01310777|7398734|FG001|Overall Study|Inadequate Control of IOP|7
4564564|NCT01310777|7398735|FG002|Overall Study|Inadequate Control of IOP|10
4564565|NCT01310777|7398733|FG000|Overall Study|Other|4
4564566|NCT01310777|7398734|FG001|Overall Study|Other|1
4564567|NCT01310777|7398735|FG002|Overall Study|Other|2
4564568|NCT01310868|7398752|FG000|Overall Study|Do not have histologically confirmed GBM|13
4564569|NCT01311024|7398758|FG000|Overall Study|Protocol Violation|35
4564570|NCT01311024|7398759|FG001|Overall Study|Protocol Violation|22
4564571|NCT01311505|7398785|FG000|First Intervention Period|Protocol Violation|0
4564572|NCT01311505|7398786|FG001|First Intervention Period|Protocol Violation|1
4564573|NCT01311557|7398797|FG000|Overall Study|Serious adverse event|0
4564574|NCT01311557|7398798|FG001|Overall Study|Serious adverse event|1
4564575|NCT01311557|7398797|FG000|Overall Study|Protocol Violation|4
4564576|NCT01311557|7398798|FG001|Overall Study|Protocol Violation|2
4564577|NCT01311557|7398797|FG000|Overall Study|Lost to Follow-up|0
4564578|NCT01311557|7398798|FG001|Overall Study|Lost to Follow-up|1
4564579|NCT01311557|7398797|FG000|Overall Study|Withdrawal by Subject|1
4564580|NCT01311557|7398798|FG001|Overall Study|Withdrawal by Subject|2
4564581|NCT01311648|7398807|FG000|Main Study|Protocol Violation|0
4564582|NCT01311648|7398808|FG001|Main Study|Protocol Violation|1
4564583|NCT01311648|7398807|FG000|Main Study|Adverse Event|0
4564584|NCT01311648|7398808|FG001|Main Study|Adverse Event|1
4564585|NCT01311648|7398807|FG000|Main Study|Inhibitor management|0
4564586|NCT01311648|7398808|FG001|Main Study|Inhibitor management|17
4564587|NCT01311648|7398807|FG000|Main Study|Withdrawal by Subject|0
4564588|NCT01311648|7398808|FG001|Main Study|Withdrawal by Subject|2
4564589|NCT01311648|7398807|FG000|Extension Study|Physician Decision|0
4564590|NCT01311648|7398808|FG001|Extension Study|Physician Decision|1
4564591|NCT01311648|7398807|FG000|Extension Study|ITI therapy with marketed product|0
4564592|NCT01311648|7398808|FG001|Extension Study|ITI therapy with marketed product|1
4564593|NCT01311648|7398807|FG000|Extension Study|Incorrect visit planning|0
4564594|NCT01311648|7398808|FG001|Extension Study|Incorrect visit planning|1
4690829|NCT02564055|7600666|FG003|Overall Study|Reached stopping criteria|0
4690830|NCT02564055|7600667|FG004|Overall Study|Reached stopping criteria|0
4690831|NCT02564055|7600668|FG005|Overall Study|Reached stopping criteria|1
4690832|NCT02564055|7600663|FG000|Overall Study|Lost to Follow-up|0
4690833|NCT02564055|7600664|FG001|Overall Study|Lost to Follow-up|1
4690834|NCT02564055|7600665|FG002|Overall Study|Lost to Follow-up|4
4564595|NCT01311648|7398807|FG000|Extension Study|Family's decision|0
4564596|NCT01311648|7398808|FG001|Extension Study|Family's decision|1
4564597|NCT01311648|7398807|FG000|Extension Study|Failure of ITI therapy|0
4564598|NCT01311648|7398808|FG001|Extension Study|Failure of ITI therapy|3
4564599|NCT01311648|7398807|FG000|Extension Study|Long travel|0
4564600|NCT01311648|7398808|FG001|Extension Study|Long travel|1
4564601|NCT01311648|7398807|FG000|Extension Study|Diagnosed with von Willebrand disease|1
4564602|NCT01311648|7398808|FG001|Extension Study|Diagnosed with von Willebrand disease|0
4564603|NCT01311648|7398807|FG000|Extension Study|Withdrawal by Subject|0
4564604|NCT01311648|7398808|FG001|Extension Study|Withdrawal by Subject|1
4564605|NCT01311648|7398807|FG000|Extension Study|Inhibitor management|0
4564606|NCT01311648|7398808|FG001|Extension Study|Inhibitor management|2
4564607|NCT01311661|7398821|FG000|Overall Study|Adverse Event|2
4564608|NCT01311661|7398821|FG000|Overall Study|Protocol Violation|3
4564609|NCT01311661|7398821|FG000|Overall Study|Withdrawal by Subject|2
4564610|NCT01312129|7398875|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0
4564611|NCT01312129|7398876|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1
4564612|NCT01312467|7398930|FG000|Overall Study|Adverse Event|4
4564613|NCT01312467|7398930|FG000|Overall Study|Lost to Follow-up|1
4564614|NCT01312467|7398930|FG000|Overall Study|Withdrawal by Subject|2
4564615|NCT01312467|7398930|FG000|Overall Study|Deported to country of origin|1
4564616|NCT01312467|7398930|FG000|Overall Study|Another medical condition|1
4564617|NCT01312467|7398930|FG000|Overall Study|Ineligible|4
4564618|NCT01312779|7398962|FG000|Overall Study|Withdrawal by Subject|2
4564619|NCT01312779|7398962|FG000|Overall Study|Death|3
4624406|NCT01819727|7488507|FG001|Overall Study|Death|0
4624407|NCT01819727|7488506|FG000|Overall Study|Lost to Follow-up|1
4624408|NCT01819727|7488507|FG001|Overall Study|Lost to Follow-up|1
4624409|NCT01819727|7488506|FG000|Overall Study|Physician Decision|3
4624410|NCT01819727|7488507|FG001|Overall Study|Physician Decision|2
4624411|NCT01819727|7488506|FG000|Overall Study|Pregnancy|1
4624412|NCT01819727|7488507|FG001|Overall Study|Pregnancy|0
4624413|NCT01819727|7488506|FG000|Overall Study|Protocol Violation|0
4624414|NCT01819727|7488507|FG001|Overall Study|Protocol Violation|2
4624415|NCT01819727|7488506|FG000|Overall Study|Study Terminated by Sponsor|0
4624416|NCT01819727|7488507|FG001|Overall Study|Study Terminated by Sponsor|1
4624417|NCT01819727|7488506|FG000|Overall Study|Withdrawal by Subject|6
4624418|NCT01819727|7488507|FG001|Overall Study|Withdrawal by Subject|11
4624419|NCT01819727|7488506|FG000|Overall Study|Unable to demostrate ability self-inject|0
4624420|NCT01819727|7488507|FG001|Overall Study|Unable to demostrate ability self-inject|1
4624421|NCT01819727|7488506|FG000|Overall Study|Quit due to lack of health benifits|0
4624422|NCT01819727|7488507|FG001|Overall Study|Quit due to lack of health benifits|1
4624423|NCT01820260|7488556|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
4624424|NCT01820260|7488557|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
4690835|NCT02564055|7600666|FG003|Overall Study|Lost to Follow-up|2
4690836|NCT02564055|7600667|FG004|Overall Study|Lost to Follow-up|1
4624425|NCT01820260|7488558|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
4624426|NCT01820260|7488559|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
4624427|NCT01820260|7488560|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
4624428|NCT01820260|7488561|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
4624429|NCT01820260|7488562|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1
4624430|NCT01820260|7488563|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
4624431|NCT01820260|7488564|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
4624432|NCT01820260|7488565|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
4624433|NCT01820260|7488566|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
4624434|NCT01820260|7488567|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
4624435|NCT01820260|7488568|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
4624436|NCT01820260|7488569|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0
4624437|NCT01820260|7488556|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0
4624438|NCT01820260|7488557|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0
4624439|NCT01820260|7488558|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0
4624440|NCT01820260|7488559|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0
4624441|NCT01820260|7488560|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0
4624442|NCT01820260|7488561|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0
4624443|NCT01820260|7488562|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0
4624444|NCT01820260|7488563|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0
4624445|NCT01820260|7488564|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0
4624446|NCT01820260|7488565|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1
4624447|NCT01820260|7488566|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0
4624448|NCT01820260|7488567|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0
4624449|NCT01820260|7488568|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0
4624450|NCT01820260|7488569|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0
4624451|NCT01820364|7488605|FG000|Part I: LGX818|Death|1
4624452|NCT01820364|7488606|FG001|Part I: LGX818|Death|0
4690837|NCT02564055|7600668|FG005|Overall Study|Lost to Follow-up|0
4564620|NCT01312779|7398962|FG000|Overall Study|Not Implanted with Device|27
4564621|NCT01312909|7399002|FG000|Overall Study|Randomized but not treated|1
4564622|NCT01312909|7399003|FG001|Overall Study|Randomized but not treated|3
4564623|NCT01312909|7399004|FG002|Overall Study|Randomized but not treated|1
4564624|NCT01312909|7399002|FG000|Overall Study|Adverse Event|1
4564625|NCT01312909|7399003|FG001|Overall Study|Adverse Event|0
4564626|NCT01312909|7399004|FG002|Overall Study|Adverse Event|3
4564627|NCT01312909|7399002|FG000|Overall Study|Protocol Violation|2
4564628|NCT01312909|7399003|FG001|Overall Study|Protocol Violation|0
4564629|NCT01312909|7399004|FG002|Overall Study|Protocol Violation|2
4564630|NCT01312909|7399002|FG000|Overall Study|Other|9
4564631|NCT01312909|7399003|FG001|Overall Study|Other|6
4564632|NCT01312909|7399004|FG002|Overall Study|Other|11
4564633|NCT01312909|7399002|FG000|Overall Study|Withdrawal by Subject|8
4564634|NCT01312909|7399003|FG001|Overall Study|Withdrawal by Subject|10
4564635|NCT01312909|7399004|FG002|Overall Study|Withdrawal by Subject|7
4564636|NCT01312909|7399002|FG000|Overall Study|Lost to Follow-up|21
4564637|NCT01312909|7399003|FG001|Overall Study|Lost to Follow-up|17
4564638|NCT01312909|7399004|FG002|Overall Study|Lost to Follow-up|20
4564639|NCT01312909|7399002|FG000|Overall Study|Insufficient clinical response|0
4564640|NCT01312909|7399003|FG001|Overall Study|Insufficient clinical response|0
4564641|NCT01312909|7399004|FG002|Overall Study|Insufficient clinical response|1
4564642|NCT01312909|7399002|FG000|Overall Study|Entrance criteria not met|0
4564643|NCT01312909|7399003|FG001|Overall Study|Entrance criteria not met|0
4564644|NCT01312909|7399004|FG002|Overall Study|Entrance criteria not met|2
4564645|NCT01312961|7399021|FG000|Overall Study|Adverse Event|3
4564646|NCT01312961|7399022|FG001|Overall Study|Adverse Event|3
4564647|NCT01312961|7399021|FG000|Overall Study|Lack of Efficacy|11
4564648|NCT01312961|7399022|FG001|Overall Study|Lack of Efficacy|1
4564649|NCT01312961|7399021|FG000|Overall Study|Poor compliance to protocol|1
4564650|NCT01312961|7399022|FG001|Overall Study|Poor compliance to protocol|0
4564651|NCT01312961|7399021|FG000|Overall Study|Other than specified above|2
4564652|NCT01312961|7399022|FG001|Overall Study|Other than specified above|3
4564653|NCT01313039|7399029|FG000|Overall Study|Physician Decision|1
4564654|NCT01313039|7399029|FG000|Overall Study|Adverse Event|1
4564655|NCT01313078|7399033|FG000|Overall Study|Death|1
4564656|NCT01313078|7399033|FG000|Overall Study|Discontinued study drug|1
4564657|NCT01313078|7399033|FG000|Overall Study|Withdrawal by Subject|1
4564658|NCT01313117|7399037|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1
4564659|NCT01313117|7399037|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1
4592426|NCT01541254|7440099|FG000|Overall Study|Withdrawal by Subject|1
4592427|NCT01541254|7440099|FG000|Overall Study|excluded - metal allergy|1
4592428|NCT01541254|7440099|FG000|Overall Study|enrolled after study closed|1
4592429|NCT01541254|7440099|FG000|Overall Study|GI bleed prior to procedure|1
4592430|NCT01541254|7440099|FG000|Overall Study|stent not required|1
4592431|NCT01541254|7440099|FG000|Overall Study|alternate stent used|1
4592432|NCT01541371|7440108|FG000|Overall Study|Withdrawal by Subject|14
4592433|NCT01541371|7440108|FG000|Overall Study|Lost to Follow-up|21
4592434|NCT01541371|7440108|FG000|Overall Study|Adverse Event|15
4592435|NCT01541371|7440108|FG000|Overall Study|Lack of Efficacy|12
4592436|NCT01541371|7440108|FG000|Overall Study|Protocol Violation|6
4592437|NCT01541371|7440108|FG000|Overall Study|Study medication non-compliance|3
4592438|NCT01541371|7440108|FG000|Overall Study|Other|6
4592439|NCT01541644|7440138|FG000|Overall Study|Withdrawal by Subject|3
4592440|NCT01541748|7440151|FG000|Overall Study|Lost to Follow-up|17
4592441|NCT01541748|7440151|FG000|Overall Study|Moved out of state|1
4592442|NCT01541748|7440151|FG000|Overall Study|Withdrawal by Subject|7
4592443|NCT01541748|7440151|FG000|Overall Study|Screen failure|5
4592444|NCT01541748|7440151|FG000|Overall Study|Did not receive study device|1
4592445|NCT01541826|7440167|FG000|Overall Study|Lost to Follow-up|2
4592446|NCT01541826|7440168|FG001|Overall Study|Lost to Follow-up|3
4592447|NCT01541826|7440169|FG002|Overall Study|Lost to Follow-up|0
4592448|NCT01541826|7440167|FG000|Overall Study|Withdrawal by Subject|2
4592449|NCT01541826|7440168|FG001|Overall Study|Withdrawal by Subject|0
4592450|NCT01541826|7440169|FG002|Overall Study|Withdrawal by Subject|0
4592451|NCT01541865|7440177|FG000|Overall Study|Lost to Follow-up|11
4592452|NCT01541865|7440177|FG000|Overall Study|Withdrawal by Subject|9
4592453|NCT01541865|7440177|FG000|Overall Study|Adverse Event|1
4592454|NCT01541865|7440177|FG000|Overall Study|Protocol Violation|1
4592455|NCT01541917|7440195|FG000|Overall Study|Lost to Follow-up|2
4592456|NCT01541917|7440196|FG001|Overall Study|Lost to Follow-up|2
4592457|NCT01541917|7440195|FG000|Overall Study|Withdrawal by Subject|13
4592458|NCT01541917|7440196|FG001|Overall Study|Withdrawal by Subject|7
4592459|NCT01541930|7440205|FG000|Overall Study|Withdrawal by Subject|1
4592460|NCT01541969|7440222|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0
4592461|NCT01541969|7440223|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1
4592462|NCT01541969|7440222|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1
4592463|NCT01541969|7440223|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1
4592464|NCT01541969|7440222|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2
4592465|NCT01541969|7440223|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0
4592466|NCT01541969|7440222|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1
4592467|NCT01541969|7440223|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0
4592468|NCT01541969|7440222|FG000|Double-blind (0-12 Weeks)|Adverse Event|2
4592469|NCT01541969|7440223|FG001|Double-blind (0-12 Weeks)|Adverse Event|0
4564660|NCT01313182|7399044|FG000|Overall Study|Protocol Violation|66
4564661|NCT01313182|7399045|FG001|Overall Study|Protocol Violation|92
4564662|NCT01313208|7399053|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3
4564663|NCT01313208|7399054|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2
4564664|NCT01313208|7399053|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1
4564665|NCT01313208|7399054|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2
4564666|NCT01313208|7399053|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0
4564667|NCT01313208|7399054|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1
4564668|NCT01313208|7399053|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1
4564669|NCT01313208|7399054|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0
4564670|NCT01313208|7399053|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1
4564671|NCT01313208|7399054|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0
4564672|NCT01313208|7399053|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3
4564673|NCT01313208|7399054|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1
4564674|NCT01313208|7399053|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0
4564675|NCT01313208|7399054|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2
4564676|NCT01313208|7399053|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1
4564677|NCT01313208|7399054|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0
4564678|NCT01313208|7399053|FG000|Open-label Phase (Weeks 13 - 24)|Other|2
4564679|NCT01313208|7399054|FG001|Open-label Phase (Weeks 13 - 24)|Other|0
4564680|NCT01313221|7399065|FG000|Overall Study|Protocol Violation|0
4564681|NCT01313221|7399066|FG001|Overall Study|Protocol Violation|1
4564682|NCT01313221|7399067|FG002|Overall Study|Protocol Violation|1
4564683|NCT01313221|7399065|FG000|Overall Study|Non-compliance|3
4564684|NCT01313221|7399066|FG001|Overall Study|Non-compliance|0
4564685|NCT01313221|7399067|FG002|Overall Study|Non-compliance|2
4564686|NCT01313221|7399065|FG000|Overall Study|Withdrawal by Subject|2
4564687|NCT01313221|7399066|FG001|Overall Study|Withdrawal by Subject|3
4564688|NCT01313221|7399067|FG002|Overall Study|Withdrawal by Subject|5
4564689|NCT01313221|7399065|FG000|Overall Study|Requirement for alternative therapy|0
4564690|NCT01313221|7399066|FG001|Overall Study|Requirement for alternative therapy|1
4564691|NCT01313221|7399067|FG002|Overall Study|Requirement for alternative therapy|1
4564692|NCT01313221|7399065|FG000|Overall Study|Lost to Follow-up|6
4564693|NCT01313221|7399066|FG001|Overall Study|Lost to Follow-up|3
4564694|NCT01313221|7399067|FG002|Overall Study|Lost to Follow-up|1
4624453|NCT01820364|7488605|FG000|Part I: LGX818|Administrative Problems|3
4624454|NCT01820364|7488606|FG001|Part I: LGX818|Administrative Problems|0
4624455|NCT01820364|7488605|FG000|Part I: LGX818|Adverse Event|6
4624456|NCT01820364|7488606|FG001|Part I: LGX818|Adverse Event|0
4624457|NCT01820364|7488605|FG000|Part I: LGX818|Disease Progression|4
4624458|NCT01820364|7488606|FG001|Part I: LGX818|Disease Progression|0
4624459|NCT01820364|7488605|FG000|Part II: LGX818 + MEK162|Study Termination|0
4624460|NCT01820364|7488606|FG001|Part II: LGX818 + MEK162|Study Termination|1
4624461|NCT01820559|7488628|FG000|Overall Study|Adverse Event|4
4624462|NCT01820559|7488629|FG001|Overall Study|Adverse Event|6
4624463|NCT01820559|7488630|FG002|Overall Study|Adverse Event|13
4624464|NCT01820559|7488628|FG000|Overall Study|Withdrawal by Subject|1
4624465|NCT01820559|7488629|FG001|Overall Study|Withdrawal by Subject|2
4624466|NCT01820559|7488630|FG002|Overall Study|Withdrawal by Subject|5
4624467|NCT01820559|7488628|FG000|Overall Study|Protocol Violation|2
4624468|NCT01820559|7488629|FG001|Overall Study|Protocol Violation|1
4624469|NCT01820559|7488630|FG002|Overall Study|Protocol Violation|3
4690838|NCT02564055|7600663|FG000|Overall Study|Physician Decision|0
4690839|NCT02564055|7600664|FG001|Overall Study|Physician Decision|0
4564695|NCT01313221|7399065|FG000|Overall Study|Other|1
4564696|NCT01313221|7399066|FG001|Overall Study|Other|0
4564697|NCT01313221|7399067|FG002|Overall Study|Other|0
4564698|NCT01313221|7399065|FG000|Overall Study|Adverse Event|0
4564699|NCT01313221|7399066|FG001|Overall Study|Adverse Event|0
4564700|NCT01313221|7399067|FG002|Overall Study|Adverse Event|7
4564701|NCT01313221|7399065|FG000|Overall Study|Disease progression|0
4564702|NCT01313221|7399066|FG001|Overall Study|Disease progression|0
4564703|NCT01313221|7399067|FG002|Overall Study|Disease progression|2
4564704|NCT01313221|7399065|FG000|Overall Study|Physician Decision|0
4564705|NCT01313221|7399066|FG001|Overall Study|Physician Decision|0
4564706|NCT01313221|7399067|FG002|Overall Study|Physician Decision|2
4564707|NCT01313221|7399065|FG000|Overall Study|Pregnancy|0
4564708|NCT01313221|7399066|FG001|Overall Study|Pregnancy|0
4564709|NCT01313221|7399067|FG002|Overall Study|Pregnancy|2
4564710|NCT01313286|7399075|FG000|Period 1|Withdrawal by Subject|2
4564711|NCT01313286|7399076|FG001|Period 1|Withdrawal by Subject|0
4564712|NCT01313299|7399085|FG000|Overall Study|Adverse Event|3
4564713|NCT01313299|7399086|FG001|Overall Study|Adverse Event|1
4564714|NCT01313299|7399087|FG002|Overall Study|Adverse Event|1
4564715|NCT01313299|7399085|FG000|Overall Study|Lost to Follow-up|1
4564716|NCT01313299|7399086|FG001|Overall Study|Lost to Follow-up|0
4690840|NCT02564055|7600665|FG002|Overall Study|Physician Decision|1
4690841|NCT02564055|7600666|FG003|Overall Study|Physician Decision|0
4564717|NCT01313299|7399087|FG002|Overall Study|Lost to Follow-up|0
4564718|NCT01313299|7399085|FG000|Overall Study|Protocol Violation|2
4564719|NCT01313299|7399086|FG001|Overall Study|Protocol Violation|0
4564720|NCT01313299|7399087|FG002|Overall Study|Protocol Violation|0
4564721|NCT01313299|7399085|FG000|Overall Study|Withdrawal by Subject|1
4564722|NCT01313299|7399086|FG001|Overall Study|Withdrawal by Subject|0
4564723|NCT01313299|7399087|FG002|Overall Study|Withdrawal by Subject|2
4564724|NCT01313299|7399085|FG000|Overall Study|Family reason and moved out of state|0
4564725|NCT01313299|7399086|FG001|Overall Study|Family reason and moved out of state|2
4564726|NCT01313299|7399087|FG002|Overall Study|Family reason and moved out of state|0
4564727|NCT01313299|7399085|FG000|Overall Study|Lack of subject compliance|0
4564728|NCT01313299|7399086|FG001|Overall Study|Lack of subject compliance|0
4564729|NCT01313299|7399087|FG002|Overall Study|Lack of subject compliance|1
4564730|NCT01313312|7399095|FG000|Overall Study|Adverse Event|5
4564731|NCT01313312|7399095|FG000|Overall Study|Withdrawal by Subject|18
4564732|NCT01313312|7399095|FG000|Overall Study|Lack of Efficacy|3
4564733|NCT01313312|7399095|FG000|Overall Study|Investigator Decision|1
4564734|NCT01313312|7399095|FG000|Overall Study|Observational Phase|1
4564735|NCT01313312|7399095|FG000|Overall Study|Subject Withdrawn Early in Error|4
4564736|NCT01313312|7399095|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4
4564737|NCT01313559|7399125|FG000|Overall Study|Withdrawal by Subject|1
4564738|NCT01313559|7399126|FG001|Overall Study|Withdrawal by Subject|2
4564739|NCT01313559|7399125|FG000|Overall Study|Disease progression|1
4564740|NCT01313559|7399126|FG001|Overall Study|Disease progression|0
4564741|NCT01313559|7399125|FG000|Overall Study|Rising PSA|2
4564742|NCT01313559|7399126|FG001|Overall Study|Rising PSA|0
4564743|NCT01313624|7399134|FG000|Double-Blind Phase|Adverse Event|27
4564744|NCT01313624|7399135|FG001|Double-Blind Phase|Adverse Event|4
4564745|NCT01313624|7399134|FG000|Double-Blind Phase|Withdrawal by Subject|9
4564746|NCT01313624|7399135|FG001|Double-Blind Phase|Withdrawal by Subject|4
4564747|NCT01313624|7399134|FG000|Double-Blind Phase|Lost to Follow-up|0
4564748|NCT01313624|7399135|FG001|Double-Blind Phase|Lost to Follow-up|2
4564749|NCT01313624|7399134|FG000|Double-Blind Phase|Physician Decision|1
4564750|NCT01313624|7399135|FG001|Double-Blind Phase|Physician Decision|0
4564751|NCT01313624|7399134|FG000|Double-Blind Phase|Lack of Efficacy|1
4564752|NCT01313624|7399135|FG001|Double-Blind Phase|Lack of Efficacy|0
4564753|NCT01313624|7399134|FG000|Open-Label Phase|Adverse Event|1
4564754|NCT01313624|7399135|FG001|Open-Label Phase|Adverse Event|10
4564755|NCT01313624|7399134|FG000|Open-Label Phase|Withdrawal by Subject|2
4564756|NCT01313624|7399135|FG001|Open-Label Phase|Withdrawal by Subject|2
4564757|NCT01313624|7399134|FG000|Open-Label Phase|Lost to Follow-up|1
4564758|NCT01313624|7399135|FG001|Open-Label Phase|Lost to Follow-up|1
4564759|NCT01313637|7399147|FG000|Overall Study|Adverse Event|17
4564760|NCT01313637|7399148|FG001|Overall Study|Adverse Event|24
4564761|NCT01313637|7399149|FG002|Overall Study|Adverse Event|25
4564762|NCT01313637|7399150|FG003|Overall Study|Adverse Event|18
4564763|NCT01313637|7399147|FG000|Overall Study|Lack of Efficacy|44
4564764|NCT01313637|7399148|FG001|Overall Study|Lack of Efficacy|38
4564765|NCT01313637|7399149|FG002|Overall Study|Lack of Efficacy|37
4564766|NCT01313637|7399150|FG003|Overall Study|Lack of Efficacy|24
4564767|NCT01313637|7399147|FG000|Overall Study|Protocol Violation|4
4564768|NCT01313637|7399148|FG001|Overall Study|Protocol Violation|3
4564769|NCT01313637|7399149|FG002|Overall Study|Protocol Violation|11
4564770|NCT01313637|7399150|FG003|Overall Study|Protocol Violation|5
4564771|NCT01313637|7399147|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16
4564772|NCT01313637|7399148|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15
4564773|NCT01313637|7399149|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14
4564774|NCT01313637|7399150|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13
4564775|NCT01313637|7399147|FG000|Overall Study|Lost to Follow-up|0
4564776|NCT01313637|7399148|FG001|Overall Study|Lost to Follow-up|2
4564777|NCT01313637|7399149|FG002|Overall Study|Lost to Follow-up|1
4564778|NCT01313637|7399150|FG003|Overall Study|Lost to Follow-up|3
4564779|NCT01313637|7399147|FG000|Overall Study|Withdrawal by Subject|11
4564780|NCT01313637|7399148|FG001|Overall Study|Withdrawal by Subject|13
4564781|NCT01313637|7399149|FG002|Overall Study|Withdrawal by Subject|18
4564782|NCT01313637|7399150|FG003|Overall Study|Withdrawal by Subject|15
4564783|NCT01313650|7399164|FG000|Overall Study|Adverse Event|9
4564784|NCT01313650|7399165|FG001|Overall Study|Adverse Event|34
4564785|NCT01313650|7399166|FG002|Overall Study|Adverse Event|24
4564786|NCT01313650|7399167|FG003|Overall Study|Adverse Event|23
4564787|NCT01313650|7399164|FG000|Overall Study|Lack of Efficacy|37
4564788|NCT01313650|7399165|FG001|Overall Study|Lack of Efficacy|20
4564789|NCT01313650|7399166|FG002|Overall Study|Lack of Efficacy|32
4564790|NCT01313650|7399167|FG003|Overall Study|Lack of Efficacy|20
4564791|NCT01313650|7399164|FG000|Overall Study|Lost to Follow-up|1
4564792|NCT01313650|7399165|FG001|Overall Study|Lost to Follow-up|0
4564793|NCT01313650|7399166|FG002|Overall Study|Lost to Follow-up|3
4564794|NCT01313650|7399167|FG003|Overall Study|Lost to Follow-up|2
4564795|NCT01313650|7399164|FG000|Overall Study|Withdrawal by Subject|16
4564796|NCT01313650|7399165|FG001|Overall Study|Withdrawal by Subject|20
4564797|NCT01313650|7399166|FG002|Overall Study|Withdrawal by Subject|15
4564798|NCT01313650|7399167|FG003|Overall Study|Withdrawal by Subject|15
4564799|NCT01313650|7399164|FG000|Overall Study|Protocol Violation|4
4564800|NCT01313650|7399165|FG001|Overall Study|Protocol Violation|7
4564801|NCT01313650|7399166|FG002|Overall Study|Protocol Violation|5
4564802|NCT01313650|7399167|FG003|Overall Study|Protocol Violation|6
4564803|NCT01313650|7399164|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9
4564804|NCT01313650|7399165|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13
4564805|NCT01313650|7399166|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24
4564806|NCT01313650|7399167|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15
4564807|NCT01313663|7399179|FG000|Overall Study|Study Closed/Terminated|2
4564808|NCT01313663|7399180|FG001|Overall Study|Study Closed/Terminated|4
4564809|NCT01313663|7399179|FG000|Overall Study|Lost to Follow-up|0
4564810|NCT01313663|7399180|FG001|Overall Study|Lost to Follow-up|1
4564811|NCT01313663|7399179|FG000|Overall Study|Physician Decision|0
4564812|NCT01313663|7399180|FG001|Overall Study|Physician Decision|2
4564813|NCT01313663|7399179|FG000|Overall Study|Withdrawal by Subject|2
4564814|NCT01313663|7399180|FG001|Overall Study|Withdrawal by Subject|1
4564815|NCT01313676|7399190|FG000|Overall Study|Adverse Event|395
4564816|NCT01313676|7399191|FG001|Overall Study|Adverse Event|365
4564817|NCT01313676|7399192|FG002|Overall Study|Adverse Event|372
4564818|NCT01313676|7399193|FG003|Overall Study|Adverse Event|333
4564819|NCT01313676|7399190|FG000|Overall Study|Lack of Efficacy|98
4564820|NCT01313676|7399191|FG001|Overall Study|Lack of Efficacy|90
4564821|NCT01313676|7399192|FG002|Overall Study|Lack of Efficacy|65
4564822|NCT01313676|7399193|FG003|Overall Study|Lack of Efficacy|46
4564823|NCT01313676|7399190|FG000|Overall Study|Protocol Violation|37
4564824|NCT01313676|7399191|FG001|Overall Study|Protocol Violation|44
4564825|NCT01313676|7399192|FG002|Overall Study|Protocol Violation|46
4564826|NCT01313676|7399193|FG003|Overall Study|Protocol Violation|44
4624470|NCT01820559|7488628|FG000|Overall Study|Subject's non-compliance|1
4624471|NCT01820559|7488629|FG001|Overall Study|Subject's non-compliance|0
4624472|NCT01820559|7488630|FG002|Overall Study|Subject's non-compliance|2
4624473|NCT01820559|7488628|FG000|Overall Study|Lost to Follow-up|3
4624474|NCT01820559|7488629|FG001|Overall Study|Lost to Follow-up|2
4624475|NCT01820559|7488630|FG002|Overall Study|Lost to Follow-up|2
4624476|NCT01820559|7488628|FG000|Overall Study|At sponsor request|0
4624477|NCT01820559|7488629|FG001|Overall Study|At sponsor request|0
4564827|NCT01313676|7399190|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3
4564828|NCT01313676|7399191|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4
4564829|NCT01313676|7399192|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2
4564830|NCT01313676|7399193|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11
4564831|NCT01313676|7399190|FG000|Overall Study|Study Closed/terminated|7
4564832|NCT01313676|7399191|FG001|Overall Study|Study Closed/terminated|6
4564833|NCT01313676|7399192|FG002|Overall Study|Study Closed/terminated|9
4564834|NCT01313676|7399193|FG003|Overall Study|Study Closed/terminated|9
4564835|NCT01313676|7399190|FG000|Overall Study|Lost to Follow-up|0
4564836|NCT01313676|7399191|FG001|Overall Study|Lost to Follow-up|0
4564837|NCT01313676|7399192|FG002|Overall Study|Lost to Follow-up|1
4564838|NCT01313676|7399193|FG003|Overall Study|Lost to Follow-up|0
4564839|NCT01313676|7399190|FG000|Overall Study|Physician Decision|53
4564840|NCT01313676|7399191|FG001|Overall Study|Physician Decision|64
4564841|NCT01313676|7399192|FG002|Overall Study|Physician Decision|62
4564842|NCT01313676|7399193|FG003|Overall Study|Physician Decision|48
4564843|NCT01313676|7399190|FG000|Overall Study|Decision by Participant or Proxy|643
4564844|NCT01313676|7399191|FG001|Overall Study|Decision by Participant or Proxy|527
4564845|NCT01313676|7399192|FG002|Overall Study|Decision by Participant or Proxy|515
4564846|NCT01313676|7399193|FG003|Overall Study|Decision by Participant or Proxy|492
4564847|NCT01313676|7399190|FG000|Overall Study|Sponsor Terminated Study Treatment|1
4564848|NCT01313676|7399191|FG001|Overall Study|Sponsor Terminated Study Treatment|1
4564849|NCT01313676|7399192|FG002|Overall Study|Sponsor Terminated Study Treatment|0
4564850|NCT01313676|7399193|FG003|Overall Study|Sponsor Terminated Study Treatment|1
4564851|NCT01313676|7399190|FG000|Overall Study|Investigator Site Closed|12
4564852|NCT01313676|7399191|FG001|Overall Study|Investigator Site Closed|11
4564853|NCT01313676|7399192|FG002|Overall Study|Investigator Site Closed|15
4564854|NCT01313676|7399193|FG003|Overall Study|Investigator Site Closed|10
4564855|NCT01313676|7399190|FG000|Overall Study|Missing|1
4564856|NCT01313676|7399191|FG001|Overall Study|Missing|1
4564857|NCT01313676|7399192|FG002|Overall Study|Missing|1
4564858|NCT01313676|7399193|FG003|Overall Study|Missing|0
4564859|NCT01313728|7399204|FG000|Informed Consent to Baseline|Withdrawal by Subject|1
4564860|NCT01313767|7399211|FG000|Overall Study|Adverse Event|1
4564861|NCT01313767|7399212|FG001|Overall Study|Adverse Event|0
4564862|NCT01313767|7399211|FG000|Overall Study|Lost to Follow-up|1
4564863|NCT01313767|7399212|FG001|Overall Study|Lost to Follow-up|0
4564864|NCT01313767|7399211|FG000|Overall Study|Withdrawal by Subject|2
4564865|NCT01313767|7399212|FG001|Overall Study|Withdrawal by Subject|1
4564866|NCT01313767|7399211|FG000|Overall Study|Protocol Violation|3
4564867|NCT01313767|7399212|FG001|Overall Study|Protocol Violation|1
4564868|NCT01313780|7399220|FG000|Overall Study|Lack of Efficacy|4
4564869|NCT01313780|7399221|FG001|Overall Study|Lack of Efficacy|2
4564870|NCT01313780|7399220|FG000|Overall Study|Adverse Event|6
4564871|NCT01313780|7399221|FG001|Overall Study|Adverse Event|11
4564872|NCT01313780|7399220|FG000|Overall Study|Withdrawal by Subject|2
4564873|NCT01313780|7399221|FG001|Overall Study|Withdrawal by Subject|8
4564874|NCT01313780|7399220|FG000|Overall Study|Protocol Violation|10
4564875|NCT01313780|7399221|FG001|Overall Study|Protocol Violation|4
4564876|NCT01313780|7399220|FG000|Overall Study|missing data|3
4564877|NCT01313780|7399221|FG001|Overall Study|missing data|3
4564878|NCT01313858|7399230|FG000|Overall Study|Premature Treatment Termination|251
4624478|NCT01820559|7488630|FG002|Overall Study|At sponsor request|1
4564879|NCT01313858|7399231|FG001|Overall Study|Premature Treatment Termination|219
4564880|NCT01313858|7399232|FG002|Overall Study|Premature Treatment Termination|191
4564881|NCT01313858|7399230|FG000|Overall Study|Lost to Follow-up|35
4564882|NCT01313858|7399231|FG001|Overall Study|Lost to Follow-up|51
4564883|NCT01313858|7399232|FG002|Overall Study|Lost to Follow-up|47
4564884|NCT01313884|7399238|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1
4564885|NCT01314105|7399293|FG000|Overall Study|Progressive Disease|6
4564886|NCT01314105|7399294|FG001|Overall Study|Progressive Disease|10
4564887|NCT01314105|7399293|FG000|Overall Study|Refused to continue taking medication|0
4564888|NCT01314105|7399294|FG001|Overall Study|Refused to continue taking medication|1
4564889|NCT01314105|7399293|FG000|Overall Study|Other Adverse Event|1
4564890|NCT01314105|7399294|FG001|Overall Study|Other Adverse Event|1
4564891|NCT01314261|7399306|FG000|Overall Study|Adverse Event|1
4564892|NCT01314261|7399307|FG001|Overall Study|Adverse Event|0
4564893|NCT01314261|7399308|FG002|Overall Study|Adverse Event|0
4564894|NCT01314261|7399309|FG003|Overall Study|Adverse Event|0
4564895|NCT01314261|7399306|FG000|Overall Study|Withdrawal by Subject|0
4564896|NCT01314261|7399307|FG001|Overall Study|Withdrawal by Subject|3
4564897|NCT01314261|7399308|FG002|Overall Study|Withdrawal by Subject|1
4564898|NCT01314261|7399309|FG003|Overall Study|Withdrawal by Subject|0
4564899|NCT01314261|7399306|FG000|Overall Study|Lost to Follow-up|1
4564900|NCT01314261|7399307|FG001|Overall Study|Lost to Follow-up|0
4564901|NCT01314261|7399308|FG002|Overall Study|Lost to Follow-up|2
4564902|NCT01314261|7399309|FG003|Overall Study|Lost to Follow-up|2
4564903|NCT01314261|7399306|FG000|Overall Study|Virologic Failure|0
4564904|NCT01314261|7399307|FG001|Overall Study|Virologic Failure|1
4564905|NCT01314261|7399308|FG002|Overall Study|Virologic Failure|0
4564906|NCT01314261|7399309|FG003|Overall Study|Virologic Failure|1
4564907|NCT01314443|7399338|FG000|Overall Study|Withdrawal by Subject|2
4564908|NCT01314443|7399339|FG001|Overall Study|Withdrawal by Subject|1
4564909|NCT01314443|7399340|FG002|Overall Study|Withdrawal by Subject|1
4564910|NCT01314443|7399341|FG003|Overall Study|Withdrawal by Subject|1
4564911|NCT01314443|7399338|FG000|Overall Study|Protocol Violation|2
4564912|NCT01314443|7399339|FG001|Overall Study|Protocol Violation|2
4564913|NCT01314443|7399340|FG002|Overall Study|Protocol Violation|1
4564914|NCT01314443|7399341|FG003|Overall Study|Protocol Violation|1
4564915|NCT01314703|7399351|FG000|Overall Study|screen failure and closed enrollment|8
4564916|NCT01314716|7399358|FG000|Double-Blind Phase|Randomized but not treated|1
4564917|NCT01314716|7399359|FG001|Double-Blind Phase|Randomized but not treated|1
4564918|NCT01314716|7399358|FG000|Double-Blind Phase|Adverse Event|10
4564919|NCT01314716|7399359|FG001|Double-Blind Phase|Adverse Event|4
4624479|NCT01820559|7488628|FG000|Overall Study|Lack of Efficacy|3
4624480|NCT01820559|7488629|FG001|Overall Study|Lack of Efficacy|2
4624481|NCT01820559|7488630|FG002|Overall Study|Lack of Efficacy|3
4624482|NCT01820572|7488640|FG000|Randomization|Not Treated|2
4624483|NCT01820572|7488641|FG001|Randomization|Not Treated|1
4624484|NCT01820572|7488640|FG000|Treatment Period|Adverse Event|12
4624485|NCT01820572|7488641|FG001|Treatment Period|Adverse Event|7
4624486|NCT01820572|7488640|FG000|Treatment Period|Death|3
4624487|NCT01820572|7488641|FG001|Treatment Period|Death|3
4624488|NCT01820572|7488640|FG000|Treatment Period|Lack of Efficacy|1
4624489|NCT01820572|7488641|FG001|Treatment Period|Lack of Efficacy|0
4624490|NCT01820572|7488640|FG000|Treatment Period|poor/non compliance|0
4624491|NCT01820572|7488641|FG001|Treatment Period|poor/non compliance|3
4624492|NCT01820572|7488640|FG000|Treatment Period|request to discontinue|6
4624493|NCT01820572|7488641|FG001|Treatment Period|request to discontinue|11
4624494|NCT01820572|7488640|FG000|Treatment Period|No longer meets study criteria|3
4624495|NCT01820572|7488641|FG001|Treatment Period|No longer meets study criteria|10
4624496|NCT01820572|7488640|FG000|Treatment Period|withdrew consent|1
4624497|NCT01820572|7488641|FG001|Treatment Period|withdrew consent|2
4624498|NCT01820585|7488651|FG000|Overall Study|Adverse Event|9
4624499|NCT01820585|7488652|FG001|Overall Study|Adverse Event|13
4624500|NCT01820585|7488653|FG002|Overall Study|Adverse Event|23
4624501|NCT01820585|7488654|FG003|Overall Study|Adverse Event|34
4624502|NCT01820585|7488651|FG000|Overall Study|Lack of Efficacy|9
4624503|NCT01820585|7488652|FG001|Overall Study|Lack of Efficacy|7
4624504|NCT01820585|7488653|FG002|Overall Study|Lack of Efficacy|5
4624505|NCT01820585|7488654|FG003|Overall Study|Lack of Efficacy|1
4624506|NCT01820585|7488651|FG000|Overall Study|Withdrawal by Subject|3
4624507|NCT01820585|7488652|FG001|Overall Study|Withdrawal by Subject|7
4624508|NCT01820585|7488653|FG002|Overall Study|Withdrawal by Subject|3
4624509|NCT01820585|7488654|FG003|Overall Study|Withdrawal by Subject|8
4624510|NCT01820585|7488651|FG000|Overall Study|Lost to Follow-up|3
4624511|NCT01820585|7488652|FG001|Overall Study|Lost to Follow-up|3
4624512|NCT01820585|7488653|FG002|Overall Study|Lost to Follow-up|0
4624513|NCT01820585|7488654|FG003|Overall Study|Lost to Follow-up|3
4624514|NCT01820585|7488651|FG000|Overall Study|Protocol Violation|3
4624515|NCT01820585|7488652|FG001|Overall Study|Protocol Violation|1
4624516|NCT01820585|7488653|FG002|Overall Study|Protocol Violation|1
4564920|NCT01314716|7399358|FG000|Double-Blind Phase|Withdrawal by Subject|5
4624517|NCT01820585|7488654|FG003|Overall Study|Protocol Violation|1
4624518|NCT01820585|7488651|FG000|Overall Study|Subject non-compliance|0
4624519|NCT01820585|7488652|FG001|Overall Study|Subject non-compliance|0
4624520|NCT01820585|7488653|FG002|Overall Study|Subject non-compliance|1
4624521|NCT01820585|7488654|FG003|Overall Study|Subject non-compliance|2
4564921|NCT01314716|7399359|FG001|Double-Blind Phase|Withdrawal by Subject|6
4564922|NCT01314716|7399358|FG000|Double-Blind Phase|Lost to Follow-up|0
4564923|NCT01314716|7399359|FG001|Double-Blind Phase|Lost to Follow-up|1
4564924|NCT01314716|7399358|FG000|Double-Blind Phase|Sponsor request|1
4564925|NCT01314716|7399359|FG001|Double-Blind Phase|Sponsor request|2
4564926|NCT01314716|7399358|FG000|Double-Blind Phase|Physician Decision|0
4564927|NCT01314716|7399359|FG001|Double-Blind Phase|Physician Decision|1
4564928|NCT01314716|7399358|FG000|Open-Label Phase|Adverse Event|4
4564929|NCT01314716|7399359|FG001|Open-Label Phase|Adverse Event|6
4564930|NCT01314716|7399358|FG000|Open-Label Phase|Withdrawal by Subject|1
4564931|NCT01314716|7399359|FG001|Open-Label Phase|Withdrawal by Subject|2
4564932|NCT01314716|7399358|FG000|Open-Label Phase|Physician Decision|5
4564933|NCT01314716|7399359|FG001|Open-Label Phase|Physician Decision|4
4564934|NCT01314872|7399389|FG000|Treatment Period 1|Protocol Violation|2
4564935|NCT01314872|7399390|FG001|Treatment Period 1|Protocol Violation|1
4564936|NCT01314872|7399391|FG002|Treatment Period 1|Protocol Violation|1
4564937|NCT01314872|7399392|FG003|Treatment Period 1|Protocol Violation|0
4564938|NCT01314872|7399393|FG004|Treatment Period 1|Protocol Violation|1
4564939|NCT01314872|7399394|FG005|Treatment Period 1|Protocol Violation|0
4564940|NCT01314872|7399395|FG006|Treatment Period 1|Protocol Violation|0
4564941|NCT01314872|7399396|FG007|Treatment Period 1|Protocol Violation|0
4564942|NCT01314872|7399397|FG008|Treatment Period 1|Protocol Violation|0
4564943|NCT01314872|7399398|FG009|Treatment Period 1|Protocol Violation|1
4564944|NCT01314872|7399399|FG010|Treatment Period 1|Protocol Violation|1
4564945|NCT01314872|7399400|FG011|Treatment Period 1|Protocol Violation|0
4564946|NCT01314872|7399401|FG012|Treatment Period 1|Protocol Violation|0
4564947|NCT01314872|7399402|FG013|Treatment Period 1|Protocol Violation|0
4564948|NCT01314872|7399403|FG014|Treatment Period 1|Protocol Violation|0
4564949|NCT01314872|7399389|FG000|Treatment Period 1|Physician Decision|0
4564950|NCT01314872|7399390|FG001|Treatment Period 1|Physician Decision|1
4564951|NCT01314872|7399391|FG002|Treatment Period 1|Physician Decision|0
4564952|NCT01314872|7399392|FG003|Treatment Period 1|Physician Decision|1
4564953|NCT01314872|7399393|FG004|Treatment Period 1|Physician Decision|0
4564954|NCT01314872|7399394|FG005|Treatment Period 1|Physician Decision|0
4564955|NCT01314872|7399395|FG006|Treatment Period 1|Physician Decision|0
4564956|NCT01314872|7399396|FG007|Treatment Period 1|Physician Decision|0
4564957|NCT01314872|7399397|FG008|Treatment Period 1|Physician Decision|0
4564958|NCT01314872|7399398|FG009|Treatment Period 1|Physician Decision|1
4564959|NCT01314872|7399399|FG010|Treatment Period 1|Physician Decision|0
4564960|NCT01314872|7399400|FG011|Treatment Period 1|Physician Decision|0
4564961|NCT01314872|7399401|FG012|Treatment Period 1|Physician Decision|0
4564962|NCT01314872|7399402|FG013|Treatment Period 1|Physician Decision|0
4564963|NCT01314872|7399403|FG014|Treatment Period 1|Physician Decision|0
4564964|NCT01314872|7399389|FG000|Treatment Period 1|Lack of Efficacy|1
4564965|NCT01314872|7399390|FG001|Treatment Period 1|Lack of Efficacy|0
4564966|NCT01314872|7399391|FG002|Treatment Period 1|Lack of Efficacy|0
4564967|NCT01314872|7399392|FG003|Treatment Period 1|Lack of Efficacy|0
4564968|NCT01314872|7399393|FG004|Treatment Period 1|Lack of Efficacy|0
4564969|NCT01314872|7399394|FG005|Treatment Period 1|Lack of Efficacy|1
4564970|NCT01314872|7399395|FG006|Treatment Period 1|Lack of Efficacy|0
4564971|NCT01314872|7399396|FG007|Treatment Period 1|Lack of Efficacy|2
4564972|NCT01314872|7399397|FG008|Treatment Period 1|Lack of Efficacy|0
4564973|NCT01314872|7399398|FG009|Treatment Period 1|Lack of Efficacy|0
4564974|NCT01314872|7399399|FG010|Treatment Period 1|Lack of Efficacy|0
4564975|NCT01314872|7399400|FG011|Treatment Period 1|Lack of Efficacy|0
4564976|NCT01314872|7399401|FG012|Treatment Period 1|Lack of Efficacy|0
4564977|NCT01314872|7399402|FG013|Treatment Period 1|Lack of Efficacy|0
4564978|NCT01314872|7399403|FG014|Treatment Period 1|Lack of Efficacy|0
4564979|NCT01314872|7399389|FG000|Treatment Period 1|Adverse event, non-fatal|4
4564980|NCT01314872|7399390|FG001|Treatment Period 1|Adverse event, non-fatal|2
4624522|NCT01820585|7488651|FG000|Overall Study|at sponsor request|0
4624523|NCT01820585|7488652|FG001|Overall Study|at sponsor request|0
4624524|NCT01820585|7488653|FG002|Overall Study|at sponsor request|1
4624525|NCT01820585|7488654|FG003|Overall Study|at sponsor request|0
4624526|NCT01820585|7488651|FG000|Overall Study|Pregnancy|0
4624527|NCT01820585|7488652|FG001|Overall Study|Pregnancy|1
4624528|NCT01820585|7488653|FG002|Overall Study|Pregnancy|0
4624529|NCT01820585|7488654|FG003|Overall Study|Pregnancy|0
4624530|NCT01820637|7488664|FG000|Overall Study|Death|2
4624531|NCT01820637|7488664|FG000|Overall Study|Withdrawal by Subject|1
4624532|NCT01821118|7488678|FG000|Overall Study|Death|0
4624533|NCT01821118|7488679|FG001|Overall Study|Death|1
4624534|NCT01821391|7488733|FG000|Overall Study|Adverse Event|1
4624535|NCT01821391|7488734|FG001|Overall Study|Adverse Event|0
4624536|NCT01821560|7488757|FG000|Overall Study|Lost to Follow-up|5
4624537|NCT01821560|7488758|FG001|Overall Study|Lost to Follow-up|5
4624538|NCT01821560|7488757|FG000|Overall Study|Withdrawal by Subject|1
4624539|NCT01821560|7488758|FG001|Overall Study|Withdrawal by Subject|1
4624540|NCT01821560|7488757|FG000|Overall Study|Protocol Violation|0
4624541|NCT01821560|7488758|FG001|Overall Study|Protocol Violation|1
4624542|NCT01821625|7488764|FG000|Overall Study|Withdrawal by Subject|2
4624543|NCT01821625|7488764|FG000|Overall Study|Lack of Efficacy|2
4624544|NCT01821625|7488764|FG000|Overall Study|Adverse Event|1
4624545|NCT01821625|7488764|FG000|Overall Study|Medical contraindication|1
4624546|NCT01821729|7488768|FG000|Overall Study|Withdrawal by Subject|1
4624547|NCT01821807|7488774|FG000|Overall Study|Lost to Follow-up|3
4624548|NCT01821807|7488775|FG001|Overall Study|Lost to Follow-up|1
4624549|NCT01821937|7488783|FG000|Overall Study|Adverse Event|0
4624550|NCT01821937|7488784|FG001|Overall Study|Adverse Event|3
4624551|NCT01822132|7488798|FG000|Overall Study|Lost to Follow-up|4
4624552|NCT01822132|7488799|FG001|Overall Study|Lost to Follow-up|2
4624553|NCT01822223|7488817|FG000|Overall Study|Death|0
4624554|NCT01822223|7488818|FG001|Overall Study|Death|1
4624555|NCT01822353|7488839|FG000|Overall Study|Adverse Event|1
4624556|NCT01822353|7488840|FG001|Overall Study|Adverse Event|3
4624557|NCT01822353|7488841|FG002|Overall Study|Adverse Event|1
4624558|NCT01822353|7488839|FG000|Overall Study|Pregnancy|0
4624559|NCT01822353|7488840|FG001|Overall Study|Pregnancy|1
4624560|NCT01822353|7488841|FG002|Overall Study|Pregnancy|0
4624561|NCT01822353|7488839|FG000|Overall Study|Withdrawal by Subject|3
4624562|NCT01822353|7488840|FG001|Overall Study|Withdrawal by Subject|1
4624563|NCT01822353|7488841|FG002|Overall Study|Withdrawal by Subject|0
4624564|NCT01822366|7488856|FG000|Overall Study|Lost to Follow-up|5
4624565|NCT01822366|7488857|FG001|Overall Study|Lost to Follow-up|1
4624566|NCT01822366|7488858|FG002|Overall Study|Lost to Follow-up|5
4624567|NCT01822366|7488859|FG003|Overall Study|Lost to Follow-up|1
4624568|NCT01822366|7488856|FG000|Overall Study|Withdrawal by Subject|0
4624569|NCT01822366|7488857|FG001|Overall Study|Withdrawal by Subject|6
4624570|NCT01822366|7488858|FG002|Overall Study|Withdrawal by Subject|0
4624571|NCT01822366|7488859|FG003|Overall Study|Withdrawal by Subject|6
4624572|NCT01822366|7488856|FG000|Overall Study|Partial Intervention Completion|0
4624573|NCT01822366|7488857|FG001|Overall Study|Partial Intervention Completion|15
4624574|NCT01822366|7488858|FG002|Overall Study|Partial Intervention Completion|0
4624575|NCT01822366|7488859|FG003|Overall Study|Partial Intervention Completion|15
4624576|NCT01822496|7488900|FG000|Overall Study|Protocol Violation|2
4624577|NCT01822496|7488901|FG001|Overall Study|Protocol Violation|2
4624578|NCT01822496|7488902|FG002|Overall Study|Protocol Violation|0
4624579|NCT01822496|7488903|FG003|Overall Study|Protocol Violation|1
4624580|NCT01822496|7488900|FG000|Overall Study|Withdrawal by Subject|0
4624581|NCT01822496|7488901|FG001|Overall Study|Withdrawal by Subject|0
4624582|NCT01822496|7488902|FG002|Overall Study|Withdrawal by Subject|0
4624583|NCT01822496|7488903|FG003|Overall Study|Withdrawal by Subject|3
4624584|NCT01822535|7488915|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2
4624585|NCT01822535|7488916|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0
4624586|NCT01822535|7488915|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4
4624587|NCT01822535|7488916|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2
4624588|NCT01822535|7488915|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1
4624589|NCT01822535|7488916|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0
4624590|NCT01822561|7488934|FG000|Overall Study|Withdrawal by Subject|2
4624591|NCT01822587|7488958|FG000|Overall Study|Lost to Follow-up|7
4624592|NCT01822587|7488959|FG001|Overall Study|Lost to Follow-up|9
4624593|NCT01822587|7488960|FG002|Overall Study|Lost to Follow-up|12
4624594|NCT01822587|7488958|FG000|Overall Study|Physician Decision|9
4624595|NCT01822587|7488959|FG001|Overall Study|Physician Decision|6
4624596|NCT01822587|7488960|FG002|Overall Study|Physician Decision|6
4624597|NCT01822665|7488968|FG000|Overall Study|Adverse Event|3
4624598|NCT01822665|7488968|FG000|Overall Study|Other Reason|5
4624599|NCT01822678|7488989|FG000|Overall Study|Withdrawal by Subject|5
4624600|NCT01822678|7488990|FG001|Overall Study|Withdrawal by Subject|4
4624601|NCT01822678|7488991|FG002|Overall Study|Withdrawal by Subject|4
4624602|NCT01822678|7488989|FG000|Overall Study|Adverse Event|4
4564981|NCT01314872|7399391|FG002|Treatment Period 1|Adverse event, non-fatal|3
4564982|NCT01314872|7399392|FG003|Treatment Period 1|Adverse event, non-fatal|2
4564983|NCT01314872|7399393|FG004|Treatment Period 1|Adverse event, non-fatal|2
4564984|NCT01314872|7399394|FG005|Treatment Period 1|Adverse event, non-fatal|4
4564985|NCT01314872|7399395|FG006|Treatment Period 1|Adverse event, non-fatal|4
4564986|NCT01314872|7399396|FG007|Treatment Period 1|Adverse event, non-fatal|2
4564987|NCT01314872|7399397|FG008|Treatment Period 1|Adverse event, non-fatal|3
4564988|NCT01314872|7399398|FG009|Treatment Period 1|Adverse event, non-fatal|0
4564989|NCT01314872|7399399|FG010|Treatment Period 1|Adverse event, non-fatal|1
4624603|NCT01822678|7488990|FG001|Overall Study|Adverse Event|3
4624604|NCT01822678|7488991|FG002|Overall Study|Adverse Event|1
4624605|NCT01822678|7488989|FG000|Overall Study|Lack of Efficacy|3
4624606|NCT01822678|7488990|FG001|Overall Study|Lack of Efficacy|6
4624607|NCT01822678|7488991|FG002|Overall Study|Lack of Efficacy|5
4624608|NCT01822678|7488989|FG000|Overall Study|Lost to Follow-up|0
4624609|NCT01822678|7488990|FG001|Overall Study|Lost to Follow-up|2
4624610|NCT01822678|7488991|FG002|Overall Study|Lost to Follow-up|1
4624611|NCT01822691|7488999|FG000|Overall Study|Withdrawal by Subject|2
4624612|NCT01822756|7489008|FG000|Overall Study|Adverse Event|0
4624613|NCT01822756|7489009|FG001|Overall Study|Adverse Event|0
4624614|NCT01822756|7489010|FG002|Overall Study|Adverse Event|0
4624615|NCT01822756|7489011|FG003|Overall Study|Adverse Event|2
4624616|NCT01822756|7489012|FG004|Overall Study|Adverse Event|0
4624617|NCT01822756|7489008|FG000|Overall Study|Disease progression|11
4624618|NCT01822756|7489009|FG001|Overall Study|Disease progression|1
4624619|NCT01822756|7489010|FG002|Overall Study|Disease progression|7
4624620|NCT01822756|7489011|FG003|Overall Study|Disease progression|2
4624621|NCT01822756|7489012|FG004|Overall Study|Disease progression|6
4624622|NCT01822756|7489008|FG000|Overall Study|Death|2
4624623|NCT01822756|7489009|FG001|Overall Study|Death|2
4624624|NCT01822756|7489010|FG002|Overall Study|Death|1
4624625|NCT01822756|7489011|FG003|Overall Study|Death|0
4624626|NCT01822756|7489012|FG004|Overall Study|Death|0
4624627|NCT01822756|7489008|FG000|Overall Study|Lost to Follow-up|1
4624628|NCT01822756|7489009|FG001|Overall Study|Lost to Follow-up|0
4624629|NCT01822756|7489010|FG002|Overall Study|Lost to Follow-up|1
4624630|NCT01822756|7489011|FG003|Overall Study|Lost to Follow-up|0
4624631|NCT01822756|7489012|FG004|Overall Study|Lost to Follow-up|1
4624632|NCT01822756|7489008|FG000|Overall Study|Physician Decision|0
4624633|NCT01822756|7489009|FG001|Overall Study|Physician Decision|1
4624634|NCT01822756|7489010|FG002|Overall Study|Physician Decision|0
4564990|NCT01314872|7399400|FG011|Treatment Period 1|Adverse event, non-fatal|0
4564991|NCT01314872|7399401|FG012|Treatment Period 1|Adverse event, non-fatal|0
4564992|NCT01314872|7399402|FG013|Treatment Period 1|Adverse event, non-fatal|0
4564993|NCT01314872|7399403|FG014|Treatment Period 1|Adverse event, non-fatal|0
4564994|NCT01314872|7399389|FG000|Treatment Period 1|Withdrawal by Subject|3
4564995|NCT01314872|7399390|FG001|Treatment Period 1|Withdrawal by Subject|1
4564996|NCT01314872|7399391|FG002|Treatment Period 1|Withdrawal by Subject|0
4564997|NCT01314872|7399392|FG003|Treatment Period 1|Withdrawal by Subject|2
4564998|NCT01314872|7399393|FG004|Treatment Period 1|Withdrawal by Subject|3
4564999|NCT01314872|7399394|FG005|Treatment Period 1|Withdrawal by Subject|1
4565000|NCT01314872|7399395|FG006|Treatment Period 1|Withdrawal by Subject|3
4565001|NCT01314872|7399396|FG007|Treatment Period 1|Withdrawal by Subject|2
4565002|NCT01314872|7399397|FG008|Treatment Period 1|Withdrawal by Subject|2
4565003|NCT01314872|7399398|FG009|Treatment Period 1|Withdrawal by Subject|2
4565004|NCT01314872|7399399|FG010|Treatment Period 1|Withdrawal by Subject|1
4565005|NCT01314872|7399400|FG011|Treatment Period 1|Withdrawal by Subject|0
4565006|NCT01314872|7399401|FG012|Treatment Period 1|Withdrawal by Subject|0
4565007|NCT01314872|7399402|FG013|Treatment Period 1|Withdrawal by Subject|0
4565008|NCT01314872|7399403|FG014|Treatment Period 1|Withdrawal by Subject|0
4565009|NCT01314872|7399389|FG000|Treatment Period 1|Lost to Follow-up|0
4565010|NCT01314872|7399390|FG001|Treatment Period 1|Lost to Follow-up|1
4565011|NCT01314872|7399391|FG002|Treatment Period 1|Lost to Follow-up|2
4565012|NCT01314872|7399392|FG003|Treatment Period 1|Lost to Follow-up|2
4565013|NCT01314872|7399393|FG004|Treatment Period 1|Lost to Follow-up|1
4565014|NCT01314872|7399394|FG005|Treatment Period 1|Lost to Follow-up|1
4565015|NCT01314872|7399395|FG006|Treatment Period 1|Lost to Follow-up|1
4565016|NCT01314872|7399396|FG007|Treatment Period 1|Lost to Follow-up|1
4565017|NCT01314872|7399397|FG008|Treatment Period 1|Lost to Follow-up|1
4565018|NCT01314872|7399398|FG009|Treatment Period 1|Lost to Follow-up|0
4565019|NCT01314872|7399399|FG010|Treatment Period 1|Lost to Follow-up|0
4565020|NCT01314872|7399400|FG011|Treatment Period 1|Lost to Follow-up|0
4565021|NCT01314872|7399401|FG012|Treatment Period 1|Lost to Follow-up|0
4565022|NCT01314872|7399402|FG013|Treatment Period 1|Lost to Follow-up|0
4565023|NCT01314872|7399403|FG014|Treatment Period 1|Lost to Follow-up|0
4565024|NCT01314872|7399389|FG000|Period 2|Protocol Violation|0
4565025|NCT01314872|7399390|FG001|Period 2|Protocol Violation|0
4565026|NCT01314872|7399391|FG002|Period 2|Protocol Violation|0
4565027|NCT01314872|7399392|FG003|Period 2|Protocol Violation|0
4565028|NCT01314872|7399393|FG004|Period 2|Protocol Violation|0
4565029|NCT01314872|7399394|FG005|Period 2|Protocol Violation|0
4565030|NCT01314872|7399395|FG006|Period 2|Protocol Violation|0
4565031|NCT01314872|7399396|FG007|Period 2|Protocol Violation|0
4565032|NCT01314872|7399397|FG008|Period 2|Protocol Violation|0
4565033|NCT01314872|7399398|FG009|Period 2|Protocol Violation|0
4565034|NCT01314872|7399399|FG010|Period 2|Protocol Violation|0
4565035|NCT01314872|7399400|FG011|Period 2|Protocol Violation|3
4565036|NCT01314872|7399401|FG012|Period 2|Protocol Violation|3
4565037|NCT01314872|7399402|FG013|Period 2|Protocol Violation|2
4565038|NCT01314872|7399403|FG014|Period 2|Protocol Violation|0
4565039|NCT01314872|7399389|FG000|Period 2|Non-compliance with study drug|0
4565040|NCT01314872|7399390|FG001|Period 2|Non-compliance with study drug|0
4565041|NCT01314872|7399391|FG002|Period 2|Non-compliance with study drug|0
4565042|NCT01314872|7399392|FG003|Period 2|Non-compliance with study drug|0
4565043|NCT01314872|7399393|FG004|Period 2|Non-compliance with study drug|0
4565044|NCT01314872|7399394|FG005|Period 2|Non-compliance with study drug|0
4565045|NCT01314872|7399395|FG006|Period 2|Non-compliance with study drug|0
4565046|NCT01314872|7399396|FG007|Period 2|Non-compliance with study drug|0
4565047|NCT01314872|7399397|FG008|Period 2|Non-compliance with study drug|0
4565048|NCT01314872|7399398|FG009|Period 2|Non-compliance with study drug|0
4565049|NCT01314872|7399399|FG010|Period 2|Non-compliance with study drug|0
4565050|NCT01314872|7399400|FG011|Period 2|Non-compliance with study drug|3
4565051|NCT01314872|7399401|FG012|Period 2|Non-compliance with study drug|3
4624635|NCT01822756|7489011|FG003|Overall Study|Physician Decision|0
4624636|NCT01822756|7489012|FG004|Overall Study|Physician Decision|0
4624637|NCT01822756|7489008|FG000|Overall Study|disease progression & patient preference|2
4624638|NCT01822756|7489009|FG001|Overall Study|disease progression & patient preference|0
4624639|NCT01822756|7489010|FG002|Overall Study|disease progression & patient preference|1
4565052|NCT01314872|7399402|FG013|Period 2|Non-compliance with study drug|1
4565053|NCT01314872|7399403|FG014|Period 2|Non-compliance with study drug|2
4565054|NCT01314872|7399389|FG000|Period 2|Lack of Efficacy|0
4565055|NCT01314872|7399390|FG001|Period 2|Lack of Efficacy|0
4565056|NCT01314872|7399391|FG002|Period 2|Lack of Efficacy|0
4565057|NCT01314872|7399392|FG003|Period 2|Lack of Efficacy|0
4565058|NCT01314872|7399393|FG004|Period 2|Lack of Efficacy|0
4565059|NCT01314872|7399394|FG005|Period 2|Lack of Efficacy|0
4565060|NCT01314872|7399395|FG006|Period 2|Lack of Efficacy|0
4565061|NCT01314872|7399396|FG007|Period 2|Lack of Efficacy|0
4565062|NCT01314872|7399397|FG008|Period 2|Lack of Efficacy|0
4565063|NCT01314872|7399398|FG009|Period 2|Lack of Efficacy|0
4565064|NCT01314872|7399399|FG010|Period 2|Lack of Efficacy|0
4565065|NCT01314872|7399400|FG011|Period 2|Lack of Efficacy|7
4565066|NCT01314872|7399401|FG012|Period 2|Lack of Efficacy|12
4565067|NCT01314872|7399402|FG013|Period 2|Lack of Efficacy|9
4565068|NCT01314872|7399403|FG014|Period 2|Lack of Efficacy|2
4565069|NCT01314872|7399389|FG000|Period 2|Pregnancy|0
4565070|NCT01314872|7399390|FG001|Period 2|Pregnancy|0
4565071|NCT01314872|7399391|FG002|Period 2|Pregnancy|0
4565072|NCT01314872|7399392|FG003|Period 2|Pregnancy|0
4565073|NCT01314872|7399393|FG004|Period 2|Pregnancy|0
4565074|NCT01314872|7399394|FG005|Period 2|Pregnancy|0
4565075|NCT01314872|7399395|FG006|Period 2|Pregnancy|0
4565076|NCT01314872|7399396|FG007|Period 2|Pregnancy|0
4565077|NCT01314872|7399397|FG008|Period 2|Pregnancy|0
4565078|NCT01314872|7399398|FG009|Period 2|Pregnancy|0
4565079|NCT01314872|7399399|FG010|Period 2|Pregnancy|0
4565080|NCT01314872|7399400|FG011|Period 2|Pregnancy|0
4565081|NCT01314872|7399401|FG012|Period 2|Pregnancy|0
4565082|NCT01314872|7399402|FG013|Period 2|Pregnancy|0
4565083|NCT01314872|7399403|FG014|Period 2|Pregnancy|1
4565084|NCT01314872|7399389|FG000|Period 2|Study terminated by Sponsor|0
4565085|NCT01314872|7399390|FG001|Period 2|Study terminated by Sponsor|0
4565086|NCT01314872|7399391|FG002|Period 2|Study terminated by Sponsor|0
4565087|NCT01314872|7399392|FG003|Period 2|Study terminated by Sponsor|0
4565088|NCT01314872|7399393|FG004|Period 2|Study terminated by Sponsor|0
4565089|NCT01314872|7399394|FG005|Period 2|Study terminated by Sponsor|0
4565090|NCT01314872|7399395|FG006|Period 2|Study terminated by Sponsor|0
4565091|NCT01314872|7399396|FG007|Period 2|Study terminated by Sponsor|0
4565092|NCT01314872|7399397|FG008|Period 2|Study terminated by Sponsor|0
4565093|NCT01314872|7399398|FG009|Period 2|Study terminated by Sponsor|0
4565094|NCT01314872|7399399|FG010|Period 2|Study terminated by Sponsor|0
4565095|NCT01314872|7399400|FG011|Period 2|Study terminated by Sponsor|2
4565096|NCT01314872|7399401|FG012|Period 2|Study terminated by Sponsor|2
4565097|NCT01314872|7399402|FG013|Period 2|Study terminated by Sponsor|3
4565098|NCT01314872|7399403|FG014|Period 2|Study terminated by Sponsor|0
4565099|NCT01314872|7399389|FG000|Period 2|Adverse event, non-fatal|0
4565100|NCT01314872|7399390|FG001|Period 2|Adverse event, non-fatal|0
4565101|NCT01314872|7399391|FG002|Period 2|Adverse event, non-fatal|0
4565102|NCT01314872|7399392|FG003|Period 2|Adverse event, non-fatal|0
4565103|NCT01314872|7399393|FG004|Period 2|Adverse event, non-fatal|0
4565104|NCT01314872|7399394|FG005|Period 2|Adverse event, non-fatal|0
4565105|NCT01314872|7399395|FG006|Period 2|Adverse event, non-fatal|0
4565106|NCT01314872|7399396|FG007|Period 2|Adverse event, non-fatal|0
4565107|NCT01314872|7399397|FG008|Period 2|Adverse event, non-fatal|0
4565108|NCT01314872|7399398|FG009|Period 2|Adverse event, non-fatal|0
4565109|NCT01314872|7399399|FG010|Period 2|Adverse event, non-fatal|0
4565110|NCT01314872|7399400|FG011|Period 2|Adverse event, non-fatal|13
4565111|NCT01314872|7399401|FG012|Period 2|Adverse event, non-fatal|16
4565112|NCT01314872|7399402|FG013|Period 2|Adverse event, non-fatal|24
4565113|NCT01314872|7399403|FG014|Period 2|Adverse event, non-fatal|9
4565114|NCT01314872|7399389|FG000|Period 2|Withdrawal by Subject|0
4565115|NCT01314872|7399390|FG001|Period 2|Withdrawal by Subject|0
4565116|NCT01314872|7399391|FG002|Period 2|Withdrawal by Subject|0
4565117|NCT01314872|7399392|FG003|Period 2|Withdrawal by Subject|0
4565118|NCT01314872|7399393|FG004|Period 2|Withdrawal by Subject|0
4565119|NCT01314872|7399394|FG005|Period 2|Withdrawal by Subject|0
4565120|NCT01314872|7399395|FG006|Period 2|Withdrawal by Subject|0
4565121|NCT01314872|7399396|FG007|Period 2|Withdrawal by Subject|0
4565122|NCT01314872|7399397|FG008|Period 2|Withdrawal by Subject|0
4565123|NCT01314872|7399398|FG009|Period 2|Withdrawal by Subject|0
4565124|NCT01314872|7399399|FG010|Period 2|Withdrawal by Subject|0
4565125|NCT01314872|7399400|FG011|Period 2|Withdrawal by Subject|14
4565126|NCT01314872|7399401|FG012|Period 2|Withdrawal by Subject|17
4565127|NCT01314872|7399402|FG013|Period 2|Withdrawal by Subject|12
4565128|NCT01314872|7399403|FG014|Period 2|Withdrawal by Subject|4
4565129|NCT01314872|7399389|FG000|Period 2|Lost to Follow-up|0
4565130|NCT01314872|7399390|FG001|Period 2|Lost to Follow-up|0
4565131|NCT01314872|7399391|FG002|Period 2|Lost to Follow-up|0
4565132|NCT01314872|7399392|FG003|Period 2|Lost to Follow-up|0
4565133|NCT01314872|7399393|FG004|Period 2|Lost to Follow-up|0
4565134|NCT01314872|7399394|FG005|Period 2|Lost to Follow-up|0
4565135|NCT01314872|7399395|FG006|Period 2|Lost to Follow-up|0
4565136|NCT01314872|7399396|FG007|Period 2|Lost to Follow-up|0
4565137|NCT01314872|7399397|FG008|Period 2|Lost to Follow-up|0
4565138|NCT01314872|7399398|FG009|Period 2|Lost to Follow-up|0
4565139|NCT01314872|7399399|FG010|Period 2|Lost to Follow-up|0
4565140|NCT01314872|7399400|FG011|Period 2|Lost to Follow-up|6
4565141|NCT01314872|7399401|FG012|Period 2|Lost to Follow-up|7
4565142|NCT01314872|7399402|FG013|Period 2|Lost to Follow-up|2
4565143|NCT01314872|7399403|FG014|Period 2|Lost to Follow-up|6
4565144|NCT01314911|7399437|FG000|Overall Study|Lost to Follow-up|3
4565145|NCT01314911|7399438|FG001|Overall Study|Lost to Follow-up|2
4565146|NCT01314911|7399437|FG000|Overall Study|Withdrawal by Subject|1
4565147|NCT01314911|7399438|FG001|Overall Study|Withdrawal by Subject|3
4565148|NCT01314911|7399437|FG000|Overall Study|Received Non-randomized Study Drug|0
4565149|NCT01314911|7399438|FG001|Overall Study|Received Non-randomized Study Drug|1
4565150|NCT01314911|7399437|FG000|Overall Study|Never Started Treatment|1
4565151|NCT01314911|7399438|FG001|Overall Study|Never Started Treatment|0
4565152|NCT01315028|7399459|FG000|Overall Study|Lost to Follow-up|1
4565153|NCT01315028|7399460|FG001|Overall Study|Lost to Follow-up|0
4565154|NCT01315028|7399459|FG000|Overall Study|Death|0
4565155|NCT01315028|7399460|FG001|Overall Study|Death|1
4565156|NCT01315132|7399466|FG000|Overall Study|not treated due to disease progression|1
4565157|NCT01315236|7399490|FG000|Double-blind Phase|Death|1
4565158|NCT01315236|7399491|FG001|Double-blind Phase|Death|0
4565159|NCT01315236|7399490|FG000|Double-blind Phase|Adverse Event|1
4565160|NCT01315236|7399491|FG001|Double-blind Phase|Adverse Event|0
4565161|NCT01315236|7399490|FG000|Double-blind Phase|Withdrawal of Consent|1
4565162|NCT01315236|7399491|FG001|Double-blind Phase|Withdrawal of Consent|0
4565163|NCT01315236|7399490|FG000|Double-blind Phase|Lost to Follow-up|1
4565164|NCT01315236|7399491|FG001|Double-blind Phase|Lost to Follow-up|0
4565165|NCT01315236|7399490|FG000|Open-label Phase|Death|1
4565166|NCT01315236|7399491|FG001|Open-label Phase|Death|0
4565167|NCT01315236|7399490|FG000|Open-label Phase|Adverse Event|0
4565168|NCT01315236|7399491|FG001|Open-label Phase|Adverse Event|1
4565169|NCT01315236|7399490|FG000|Open-label Phase|Other|0
4565170|NCT01315236|7399491|FG001|Open-label Phase|Other|1
4565171|NCT01315236|7399490|FG000|12-Month Follow-up Period|Death|0
4565172|NCT01315236|7399491|FG001|12-Month Follow-up Period|Death|1
4565173|NCT01315236|7399490|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1
4565174|NCT01315236|7399491|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0
4565175|NCT01315249|7399501|FG000|Overall Study|Adverse Event|22
4565176|NCT01315249|7399502|FG001|Overall Study|Adverse Event|26
4565177|NCT01315249|7399501|FG000|Overall Study|Withdrawal by Subject|11
4565178|NCT01315249|7399502|FG001|Overall Study|Withdrawal by Subject|10
4565179|NCT01315249|7399501|FG000|Overall Study|Protocol Violation|8
4565180|NCT01315249|7399502|FG001|Overall Study|Protocol Violation|5
4565181|NCT01315249|7399501|FG000|Overall Study|Abnormal test results|1
4565182|NCT01315249|7399502|FG001|Overall Study|Abnormal test results|2
4565183|NCT01315249|7399501|FG000|Overall Study|Administrative problems|1
4565184|NCT01315249|7399502|FG001|Overall Study|Administrative problems|0
4565185|NCT01315249|7399501|FG000|Overall Study|inability to use device|1
4565186|NCT01315249|7399502|FG001|Overall Study|inability to use device|0
4565187|NCT01315249|7399501|FG000|Overall Study|Lack of Efficacy|0
4565188|NCT01315249|7399502|FG001|Overall Study|Lack of Efficacy|1
4565189|NCT01315249|7399501|FG000|Overall Study|Lost to Follow-up|0
4565190|NCT01315249|7399502|FG001|Overall Study|Lost to Follow-up|2
4565191|NCT01315249|7399501|FG000|Overall Study|Death|0
4565192|NCT01315249|7399502|FG001|Overall Study|Death|1
4565193|NCT01315678|7399530|FG000|Overall Study|Withdrawal by Subject|7
4565194|NCT01315678|7399531|FG001|Overall Study|Withdrawal by Subject|3
4565195|NCT01315678|7399530|FG000|Overall Study|Adverse Event|3
4565196|NCT01315678|7399531|FG001|Overall Study|Adverse Event|1
4565197|NCT01315678|7399530|FG000|Overall Study|Lost to Follow-up|1
4565198|NCT01315678|7399531|FG001|Overall Study|Lost to Follow-up|0
4565199|NCT01315678|7399530|FG000|Overall Study|similar reason to those listed above|3
4565200|NCT01315678|7399531|FG001|Overall Study|similar reason to those listed above|2
4565201|NCT01315847|7399541|FG000|Part I, Period 1|Reached maximum number of arterial lines|3
4565202|NCT01315847|7399542|FG001|Part I, Period 1|Reached maximum number of arterial lines|0
4565203|NCT01315847|7399541|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0
4565204|NCT01315847|7399542|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1
4565205|NCT01316055|7399560|FG000|Overall Study|Lost to Follow-up|1
4565206|NCT01316055|7399561|FG001|Overall Study|Lost to Follow-up|0
4565207|NCT01316055|7399562|FG002|Overall Study|Lost to Follow-up|0
4565208|NCT01316224|7399582|FG000|Overall Study|Protocol Violation|3
4565209|NCT01316224|7399582|FG000|Overall Study|Adverse Event|3
4565210|NCT01316224|7399582|FG000|Overall Study|Lack of Efficacy|1
4565211|NCT01316224|7399582|FG000|Overall Study|Withdrawal by Subject|1
4565212|NCT01316224|7399582|FG000|Overall Study|Adverse Event With Treatment Failure|1
4565213|NCT01316224|7399582|FG000|Overall Study|Other|1
4565214|NCT01316276|7399597|FG000|Overall Study|Death|1
4565215|NCT01316276|7399597|FG000|Overall Study|Adverse Event|19
4565216|NCT01316276|7399597|FG000|Overall Study|Withdrawal of consent|24
4565217|NCT01316276|7399597|FG000|Overall Study|Lost to Follow-up|1
4565218|NCT01316276|7399597|FG000|Overall Study|Other|22
4565219|NCT01316380|7399649|FG000|Overall Study|Adverse Event|0
4565220|NCT01316380|7399650|FG001|Overall Study|Adverse Event|2
4565221|NCT01316380|7399651|FG002|Overall Study|Adverse Event|1
4565222|NCT01316380|7399649|FG000|Overall Study|Protocol Violation|0
4565223|NCT01316380|7399650|FG001|Overall Study|Protocol Violation|0
4565224|NCT01316380|7399651|FG002|Overall Study|Protocol Violation|1
4565225|NCT01316380|7399649|FG000|Overall Study|Withdrawal by Subject|1
4565226|NCT01316380|7399650|FG001|Overall Study|Withdrawal by Subject|2
4565227|NCT01316380|7399651|FG002|Overall Study|Withdrawal by Subject|0
4565228|NCT01316380|7399649|FG000|Overall Study|Other|0
4565229|NCT01316380|7399650|FG001|Overall Study|Other|1
4565230|NCT01316380|7399651|FG002|Overall Study|Other|1
4565231|NCT01316380|7399649|FG000|Overall Study|Not treated|1
4565232|NCT01316380|7399650|FG001|Overall Study|Not treated|0
4565233|NCT01316380|7399651|FG002|Overall Study|Not treated|0
4565234|NCT01316419|7399659|FG000|Overall Study|Not treated|103
4565235|NCT01316419|7399659|FG000|Overall Study|Violated inclusion/exclusion criterion|143
4565236|NCT01316419|7399659|FG000|Overall Study|Lost to Follow-up|19
4565237|NCT01316575|7399674|FG000|Overall Study|Withdrawal by Subject|2
4565238|NCT01316575|7399675|FG001|Overall Study|Withdrawal by Subject|0
4565239|NCT01316575|7399674|FG000|Overall Study|Required alternate treatment|0
4565240|NCT01316575|7399675|FG001|Overall Study|Required alternate treatment|1
4565241|NCT01316614|7399681|FG000|Overall Study|No solid lesion and FNA not indicated|25
4565242|NCT01316614|7399681|FG000|Overall Study|Cytology slides not available for review|4
4565243|NCT01316614|7399681|FG000|Overall Study|Cystic lesion|5
4565244|NCT01316614|7399681|FG000|Overall Study|Inadequate number of passes|2
4565245|NCT01316614|7399681|FG000|Overall Study|Medically unstable|1
4565246|NCT01316692|7399686|FG000|Overall Study|Adverse Event|5
4565247|NCT01316692|7399686|FG000|Overall Study|Disease Progression|7
4565248|NCT01316887|7399704|FG000|Overall Study|Adverse Event|13
4565249|NCT01316887|7399705|FG001|Overall Study|Adverse Event|21
4565250|NCT01316887|7399706|FG002|Overall Study|Adverse Event|17
4565251|NCT01316887|7399704|FG000|Overall Study|Lack of Efficacy|9
4565252|NCT01316887|7399705|FG001|Overall Study|Lack of Efficacy|3
4565253|NCT01316887|7399706|FG002|Overall Study|Lack of Efficacy|1
4565254|NCT01316887|7399704|FG000|Overall Study|Protocol Violation|2
4565255|NCT01316887|7399705|FG001|Overall Study|Protocol Violation|6
4565256|NCT01316887|7399706|FG002|Overall Study|Protocol Violation|6
4565257|NCT01316887|7399704|FG000|Overall Study|Protocol-defined Stopping Criteria|8
4565258|NCT01316887|7399705|FG001|Overall Study|Protocol-defined Stopping Criteria|37
4565259|NCT01316887|7399706|FG002|Overall Study|Protocol-defined Stopping Criteria|36
4565260|NCT01316887|7399704|FG000|Overall Study|Study Closed/Terminated|2
4565261|NCT01316887|7399705|FG001|Overall Study|Study Closed/Terminated|4
4565262|NCT01316887|7399706|FG002|Overall Study|Study Closed/Terminated|3
4565263|NCT01316887|7399704|FG000|Overall Study|Lost to Follow-up|1
4565264|NCT01316887|7399705|FG001|Overall Study|Lost to Follow-up|7
4565265|NCT01316887|7399706|FG002|Overall Study|Lost to Follow-up|5
4565266|NCT01316887|7399704|FG000|Overall Study|Withdrawal by Subject|8
4565267|NCT01316887|7399705|FG001|Overall Study|Withdrawal by Subject|16
4565268|NCT01316887|7399706|FG002|Overall Study|Withdrawal by Subject|15
4565269|NCT01316900|7399719|FG000|Overall Study|Adverse Event|10
4565270|NCT01316900|7399720|FG001|Overall Study|Adverse Event|10
4565271|NCT01316900|7399721|FG002|Overall Study|Adverse Event|15
4565272|NCT01316900|7399722|FG003|Overall Study|Adverse Event|9
4565273|NCT01316900|7399719|FG000|Overall Study|Lack of Efficacy|17
4565274|NCT01316900|7399720|FG001|Overall Study|Lack of Efficacy|9
4565275|NCT01316900|7399721|FG002|Overall Study|Lack of Efficacy|5
4565276|NCT01316900|7399722|FG003|Overall Study|Lack of Efficacy|7
4565277|NCT01316900|7399719|FG000|Overall Study|Protocol Violation|7
4565278|NCT01316900|7399720|FG001|Overall Study|Protocol Violation|1
4565279|NCT01316900|7399721|FG002|Overall Study|Protocol Violation|4
4565280|NCT01316900|7399722|FG003|Overall Study|Protocol Violation|0
4565281|NCT01316900|7399719|FG000|Overall Study|Protocol-defined Stopping Criteria|2
4565282|NCT01316900|7399720|FG001|Overall Study|Protocol-defined Stopping Criteria|3
4565283|NCT01316900|7399721|FG002|Overall Study|Protocol-defined Stopping Criteria|10
4565284|NCT01316900|7399722|FG003|Overall Study|Protocol-defined Stopping Criteria|5
4565285|NCT01316900|7399719|FG000|Overall Study|Lost to Follow-up|1
4565286|NCT01316900|7399720|FG001|Overall Study|Lost to Follow-up|0
4565287|NCT01316900|7399721|FG002|Overall Study|Lost to Follow-up|1
4565288|NCT01316900|7399722|FG003|Overall Study|Lost to Follow-up|1
4565289|NCT01316900|7399719|FG000|Overall Study|Withdrawal by Subject|7
4565290|NCT01316900|7399720|FG001|Overall Study|Withdrawal by Subject|8
4565291|NCT01316900|7399721|FG002|Overall Study|Withdrawal by Subject|6
4565292|NCT01316900|7399722|FG003|Overall Study|Withdrawal by Subject|9
4565293|NCT01316913|7399736|FG000|Overall Study|Adverse Event|17
4565294|NCT01316913|7399737|FG001|Overall Study|Adverse Event|20
4565295|NCT01316913|7399738|FG002|Overall Study|Adverse Event|15
4565296|NCT01316913|7399739|FG003|Overall Study|Adverse Event|11
4565297|NCT01316913|7399736|FG000|Overall Study|Lack of Efficacy|22
4565298|NCT01316913|7399737|FG001|Overall Study|Lack of Efficacy|12
4565299|NCT01316913|7399738|FG002|Overall Study|Lack of Efficacy|9
4565300|NCT01316913|7399739|FG003|Overall Study|Lack of Efficacy|13
4565301|NCT01316913|7399736|FG000|Overall Study|Protocol Violation|1
4565302|NCT01316913|7399737|FG001|Overall Study|Protocol Violation|4
4565303|NCT01316913|7399738|FG002|Overall Study|Protocol Violation|4
4565304|NCT01316913|7399739|FG003|Overall Study|Protocol Violation|1
4565305|NCT01316913|7399736|FG000|Overall Study|Protocol-defined Stopping Criteria|7
4565306|NCT01316913|7399737|FG001|Overall Study|Protocol-defined Stopping Criteria|8
4565307|NCT01316913|7399738|FG002|Overall Study|Protocol-defined Stopping Criteria|11
4565308|NCT01316913|7399739|FG003|Overall Study|Protocol-defined Stopping Criteria|6
4565309|NCT01316913|7399736|FG000|Overall Study|Lost to Follow-up|0
4565310|NCT01316913|7399737|FG001|Overall Study|Lost to Follow-up|1
4565311|NCT01316913|7399738|FG002|Overall Study|Lost to Follow-up|0
4565312|NCT01316913|7399739|FG003|Overall Study|Lost to Follow-up|2
4565313|NCT01316913|7399736|FG000|Overall Study|Withdrawal by Subject|10
4565314|NCT01316913|7399737|FG001|Overall Study|Withdrawal by Subject|9
4565315|NCT01316913|7399738|FG002|Overall Study|Withdrawal by Subject|10
4565316|NCT01316913|7399739|FG003|Overall Study|Withdrawal by Subject|6
4565317|NCT01316939|7399761|FG000|Overall Study|Study closed/terminated|26
4565318|NCT01316939|7399762|FG001|Overall Study|Study closed/terminated|25
4565319|NCT01316939|7399763|FG002|Overall Study|Study closed/terminated|23
4565320|NCT01316939|7399761|FG000|Overall Study|Lack of Efficacy|24
4565321|NCT01316939|7399762|FG001|Overall Study|Lack of Efficacy|25
4565322|NCT01316939|7399763|FG002|Overall Study|Lack of Efficacy|25
4565323|NCT01316939|7399761|FG000|Overall Study|Adverse Event|9
4565324|NCT01316939|7399762|FG001|Overall Study|Adverse Event|12
4565325|NCT01316939|7399763|FG002|Overall Study|Adverse Event|11
4565326|NCT01316939|7399761|FG000|Overall Study|Withdrawal by Subject|1
4565327|NCT01316939|7399762|FG001|Overall Study|Withdrawal by Subject|3
4565328|NCT01316939|7399763|FG002|Overall Study|Withdrawal by Subject|6
4565329|NCT01316939|7399761|FG000|Overall Study|Physician Decision|2
4565330|NCT01316939|7399762|FG001|Overall Study|Physician Decision|2
4565331|NCT01316939|7399763|FG002|Overall Study|Physician Decision|1
4565332|NCT01316939|7399761|FG000|Overall Study|Lost to Follow-up|0
4565333|NCT01316939|7399762|FG001|Overall Study|Lost to Follow-up|0
4565334|NCT01316939|7399763|FG002|Overall Study|Lost to Follow-up|2
4565335|NCT01316939|7399761|FG000|Overall Study|Met Liver chemistry stopping criteria|1
4565336|NCT01316939|7399762|FG001|Overall Study|Met Liver chemistry stopping criteria|0
4565337|NCT01316939|7399763|FG002|Overall Study|Met Liver chemistry stopping criteria|1
4565338|NCT01316939|7399761|FG000|Overall Study|Protocol Violation|0
4565339|NCT01316939|7399762|FG001|Overall Study|Protocol Violation|1
4565340|NCT01316939|7399763|FG002|Overall Study|Protocol Violation|0
4565341|NCT01317004|7399773|FG000|Overall Study|Withdrawal by Subject|1
4565342|NCT01317004|7399774|FG001|Overall Study|Withdrawal by Subject|4
4565343|NCT01317004|7399773|FG000|Overall Study|Protocol Violation|0
4565344|NCT01317004|7399774|FG001|Overall Study|Protocol Violation|2
4565345|NCT01317004|7399773|FG000|Overall Study|Adverse Event|3
4565346|NCT01317004|7399774|FG001|Overall Study|Adverse Event|3
4565347|NCT01317160|7399800|FG000|Overall Study|Incorrect inclusion|1
4565348|NCT01317160|7399801|FG001|Overall Study|Incorrect inclusion|1
4565349|NCT01317160|7399800|FG000|Overall Study|Lost to Follow-up|3
4565350|NCT01317160|7399801|FG001|Overall Study|Lost to Follow-up|3
4565351|NCT01317160|7399800|FG000|Overall Study|Withdrawal by Subject|0
4565352|NCT01317160|7399801|FG001|Overall Study|Withdrawal by Subject|2
4565353|NCT01317199|7399811|FG000|Dose-escalation Phase 1|Physician Decision|5
4565354|NCT01317199|7399812|FG001|Dose-escalation Phase 1|Physician Decision|0
4565355|NCT01317199|7399813|FG002|Dose-escalation Phase 1|Physician Decision|0
4565356|NCT01317199|7399814|FG003|Dose-escalation Phase 1|Physician Decision|0
4565357|NCT01317199|7399811|FG000|Dose-escalation Phase 1|Disease progression|1
4565358|NCT01317199|7399812|FG001|Dose-escalation Phase 1|Disease progression|0
4565359|NCT01317199|7399813|FG002|Dose-escalation Phase 1|Disease progression|0
4565360|NCT01317199|7399814|FG003|Dose-escalation Phase 1|Disease progression|0
4565361|NCT01317199|7399811|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1
4565362|NCT01317199|7399812|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0
4565363|NCT01317199|7399813|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0
4565364|NCT01317199|7399814|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0
4565365|NCT01317199|7399811|FG000|Randomized Phase 2|Disease progression|0
4565366|NCT01317199|7399812|FG001|Randomized Phase 2|Disease progression|3
4565367|NCT01317199|7399813|FG002|Randomized Phase 2|Disease progression|7
4565368|NCT01317199|7399814|FG003|Randomized Phase 2|Disease progression|5
4565369|NCT01317199|7399811|FG000|Randomized Phase 2|Withdrawal by Subject|0
4565370|NCT01317199|7399812|FG001|Randomized Phase 2|Withdrawal by Subject|3
4565371|NCT01317199|7399813|FG002|Randomized Phase 2|Withdrawal by Subject|5
4565372|NCT01317199|7399814|FG003|Randomized Phase 2|Withdrawal by Subject|4
4565373|NCT01317199|7399811|FG000|Randomized Phase 2|Adverse Event|0
4565374|NCT01317199|7399812|FG001|Randomized Phase 2|Adverse Event|0
4565375|NCT01317199|7399813|FG002|Randomized Phase 2|Adverse Event|0
4565376|NCT01317199|7399814|FG003|Randomized Phase 2|Adverse Event|1
4565377|NCT01317199|7399811|FG000|Randomized Phase 2|Comorbidities|0
4565378|NCT01317199|7399812|FG001|Randomized Phase 2|Comorbidities|2
4565379|NCT01317199|7399813|FG002|Randomized Phase 2|Comorbidities|2
4565380|NCT01317199|7399814|FG003|Randomized Phase 2|Comorbidities|2
4565381|NCT01317199|7399811|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0
4565382|NCT01317199|7399812|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2
4565383|NCT01317199|7399813|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5
4565384|NCT01317199|7399814|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2
4565385|NCT01317199|7399811|FG000|Randomized Phase 2|Disenrolled before treatment|0
4565386|NCT01317199|7399812|FG001|Randomized Phase 2|Disenrolled before treatment|1
4565387|NCT01317199|7399813|FG002|Randomized Phase 2|Disenrolled before treatment|1
4565388|NCT01317199|7399814|FG003|Randomized Phase 2|Disenrolled before treatment|2
4565389|NCT01317199|7399811|FG000|Randomized Phase 2|Patient stopped taking study drug|0
4565390|NCT01317199|7399812|FG001|Randomized Phase 2|Patient stopped taking study drug|0
4565391|NCT01317199|7399813|FG002|Randomized Phase 2|Patient stopped taking study drug|0
4565392|NCT01317199|7399814|FG003|Randomized Phase 2|Patient stopped taking study drug|1
4565393|NCT01317199|7399811|FG000|Randomized Phase 2|Patient transferred to other facility|0
4565394|NCT01317199|7399812|FG001|Randomized Phase 2|Patient transferred to other facility|0
4565395|NCT01317199|7399813|FG002|Randomized Phase 2|Patient transferred to other facility|1
4565396|NCT01317199|7399814|FG003|Randomized Phase 2|Patient transferred to other facility|0
4565397|NCT01317277|7399833|FG000|Overall Study|Lost to Follow-up|3
4565398|NCT01317277|7399834|FG001|Overall Study|Lost to Follow-up|1
4565399|NCT01317277|7399833|FG000|Overall Study|Lost MEMS|1
4565400|NCT01317277|7399834|FG001|Overall Study|Lost MEMS|1
4565401|NCT01317277|7399833|FG000|Overall Study|Unable to comply with intervention|1
4565402|NCT01317277|7399834|FG001|Overall Study|Unable to comply with intervention|0
4565403|NCT01317277|7399833|FG000|Overall Study|Withdrawal by Subject|1
4565404|NCT01317277|7399834|FG001|Overall Study|Withdrawal by Subject|0
4565405|NCT01317277|7399833|FG000|Overall Study|Adverse Event|1
4565406|NCT01317277|7399834|FG001|Overall Study|Adverse Event|0
4565407|NCT01317472|7399842|FG000|Overall Study|Withdrawal by Subject|1
4565408|NCT01317472|7399843|FG001|Overall Study|Withdrawal by Subject|0
4565409|NCT01317472|7399842|FG000|Overall Study|Unrelated hospitalization|1
4565410|NCT01317472|7399843|FG001|Overall Study|Unrelated hospitalization|0
4565411|NCT01317550|7399853|FG000|Overall Study|Withdrawal by Subject|1
4565412|NCT01317550|7399854|FG001|Overall Study|Withdrawal by Subject|0
4565413|NCT01317550|7399855|FG002|Overall Study|Withdrawal by Subject|0
4565414|NCT01317550|7399856|FG003|Overall Study|Withdrawal by Subject|0
4565415|NCT01317550|7399853|FG000|Overall Study|Lack of compliance study med|1
4565416|NCT01317550|7399854|FG001|Overall Study|Lack of compliance study med|0
4565417|NCT01317550|7399855|FG002|Overall Study|Lack of compliance study med|0
4565418|NCT01317550|7399856|FG003|Overall Study|Lack of compliance study med|0
4565419|NCT01317615|7399866|FG000|Overall Study|Disease progression|25
4565420|NCT01317615|7399866|FG000|Overall Study|New cancer therapy|5
4565421|NCT01317615|7399866|FG000|Overall Study|Death|6
4565422|NCT01317615|7399866|FG000|Overall Study|Withdrawal by Subject|5
4565423|NCT01317615|7399866|FG000|Overall Study|Abnormal laboratory value(s)|1
4565424|NCT01317615|7399866|FG000|Overall Study|Adverse Event|7
4565425|NCT01317641|7399879|FG000|Overall Study|Not treated|0
4565426|NCT01317641|7399880|FG001|Overall Study|Not treated|0
4565427|NCT01317641|7399881|FG002|Overall Study|Not treated|0
4565428|NCT01317641|7399882|FG003|Overall Study|Not treated|0
4565429|NCT01317641|7399883|FG004|Overall Study|Not treated|0
4565430|NCT01317641|7399884|FG005|Overall Study|Not treated|0
4565431|NCT01317641|7399885|FG006|Overall Study|Not treated|0
4565432|NCT01317641|7399886|FG007|Overall Study|Not treated|1
4565433|NCT01317641|7399887|FG008|Overall Study|Not treated|1
4565434|NCT01317641|7399879|FG000|Overall Study|Adverse Event|0
4565435|NCT01317641|7399880|FG001|Overall Study|Adverse Event|1
4565436|NCT01317641|7399881|FG002|Overall Study|Adverse Event|0
4565437|NCT01317641|7399882|FG003|Overall Study|Adverse Event|1
4565438|NCT01317641|7399883|FG004|Overall Study|Adverse Event|0
4565439|NCT01317641|7399884|FG005|Overall Study|Adverse Event|0
4565440|NCT01317641|7399885|FG006|Overall Study|Adverse Event|2
4565441|NCT01317641|7399886|FG007|Overall Study|Adverse Event|1
4565442|NCT01317641|7399887|FG008|Overall Study|Adverse Event|0
4565443|NCT01317641|7399879|FG000|Overall Study|Protocol Violation|1
4565444|NCT01317641|7399880|FG001|Overall Study|Protocol Violation|0
4565445|NCT01317641|7399881|FG002|Overall Study|Protocol Violation|0
4565446|NCT01317641|7399882|FG003|Overall Study|Protocol Violation|0
4565447|NCT01317641|7399883|FG004|Overall Study|Protocol Violation|0
4565448|NCT01317641|7399884|FG005|Overall Study|Protocol Violation|0
4565449|NCT01317641|7399885|FG006|Overall Study|Protocol Violation|0
4565450|NCT01317641|7399886|FG007|Overall Study|Protocol Violation|0
4565451|NCT01317641|7399887|FG008|Overall Study|Protocol Violation|0
4565452|NCT01317641|7399879|FG000|Overall Study|Disease progression|0
4565453|NCT01317641|7399880|FG001|Overall Study|Disease progression|0
4565454|NCT01317641|7399881|FG002|Overall Study|Disease progression|0
4565455|NCT01317641|7399882|FG003|Overall Study|Disease progression|0
4565456|NCT01317641|7399883|FG004|Overall Study|Disease progression|0
4565457|NCT01317641|7399884|FG005|Overall Study|Disease progression|0
4565458|NCT01317641|7399885|FG006|Overall Study|Disease progression|0
4565459|NCT01317641|7399886|FG007|Overall Study|Disease progression|3
4565460|NCT01317641|7399887|FG008|Overall Study|Disease progression|4
4565461|NCT01317641|7399879|FG000|Overall Study|Withdrawal by Subject|0
4565462|NCT01317641|7399880|FG001|Overall Study|Withdrawal by Subject|0
4565463|NCT01317641|7399881|FG002|Overall Study|Withdrawal by Subject|0
4565464|NCT01317641|7399882|FG003|Overall Study|Withdrawal by Subject|0
4565465|NCT01317641|7399883|FG004|Overall Study|Withdrawal by Subject|0
4565466|NCT01317641|7399884|FG005|Overall Study|Withdrawal by Subject|0
4565467|NCT01317641|7399885|FG006|Overall Study|Withdrawal by Subject|1
4565468|NCT01317641|7399886|FG007|Overall Study|Withdrawal by Subject|0
4565469|NCT01317641|7399887|FG008|Overall Study|Withdrawal by Subject|0
4565470|NCT01317797|7399939|FG000|Overall Study|Other|0
4565471|NCT01317797|7399940|FG001|Overall Study|Other|1
4565472|NCT01317797|7399941|FG002|Overall Study|Other|0
4565473|NCT01317797|7399939|FG000|Overall Study|Withdrawal of Patient|0
4565474|NCT01317797|7399940|FG001|Overall Study|Withdrawal of Patient|0
4565475|NCT01317797|7399941|FG002|Overall Study|Withdrawal of Patient|1
4565476|NCT01317940|7399964|FG000|Overall Study|Death|1
4565477|NCT01317940|7399965|FG001|Overall Study|Death|0
4565478|NCT01317940|7399966|FG002|Overall Study|Death|1
4565479|NCT01317940|7399967|FG003|Overall Study|Death|0
4565480|NCT01317940|7399968|FG004|Overall Study|Death|0
4565481|NCT01317940|7399969|FG005|Overall Study|Death|0
4565482|NCT01317940|7399964|FG000|Overall Study|Lost to Follow-up|0
4565483|NCT01317940|7399965|FG001|Overall Study|Lost to Follow-up|0
4565484|NCT01317940|7399966|FG002|Overall Study|Lost to Follow-up|1
4565485|NCT01317940|7399967|FG003|Overall Study|Lost to Follow-up|1
4565486|NCT01317940|7399968|FG004|Overall Study|Lost to Follow-up|1
4565487|NCT01317940|7399969|FG005|Overall Study|Lost to Follow-up|0
4565488|NCT01317940|7399964|FG000|Overall Study|Change in therapy plan|0
4565489|NCT01317940|7399965|FG001|Overall Study|Change in therapy plan|0
4565490|NCT01317940|7399966|FG002|Overall Study|Change in therapy plan|3
4565491|NCT01317940|7399967|FG003|Overall Study|Change in therapy plan|0
4565492|NCT01317940|7399968|FG004|Overall Study|Change in therapy plan|0
4565493|NCT01317940|7399969|FG005|Overall Study|Change in therapy plan|0
4565494|NCT01318070|7399996|FG000|Overall Study|Adverse Event|1
4565495|NCT01318070|7399997|FG001|Overall Study|Adverse Event|1
4565496|NCT01318070|7399998|FG002|Overall Study|Adverse Event|5
4565497|NCT01318070|7399996|FG000|Overall Study|Withdrawal by Subject|0
4565498|NCT01318070|7399997|FG001|Overall Study|Withdrawal by Subject|1
4565499|NCT01318070|7399998|FG002|Overall Study|Withdrawal by Subject|1
4565500|NCT01318070|7399996|FG000|Overall Study|Lack of Efficacy|0
4565501|NCT01318070|7399997|FG001|Overall Study|Lack of Efficacy|0
4565502|NCT01318070|7399998|FG002|Overall Study|Lack of Efficacy|1
4565503|NCT01318070|7399996|FG000|Overall Study|Principal Investigator Discretion|1
4565504|NCT01318070|7399997|FG001|Overall Study|Principal Investigator Discretion|0
4565505|NCT01318070|7399998|FG002|Overall Study|Principal Investigator Discretion|0
4565506|NCT01318083|7400009|FG000|Overall Study|Adverse Event|4
4565507|NCT01318083|7400010|FG001|Overall Study|Adverse Event|1
4565508|NCT01318083|7400011|FG002|Overall Study|Adverse Event|2
4565509|NCT01318083|7400009|FG000|Overall Study|Withdrawal by Subject|1
4565510|NCT01318083|7400010|FG001|Overall Study|Withdrawal by Subject|0
4565511|NCT01318083|7400011|FG002|Overall Study|Withdrawal by Subject|2
4565512|NCT01318083|7400009|FG000|Overall Study|Lack of Efficacy|0
4565513|NCT01318083|7400010|FG001|Overall Study|Lack of Efficacy|0
4565514|NCT01318083|7400011|FG002|Overall Study|Lack of Efficacy|1
4565515|NCT01318083|7400009|FG000|Overall Study|Treatment Complications|1
4565516|NCT01318083|7400010|FG001|Overall Study|Treatment Complications|0
4565517|NCT01318083|7400011|FG002|Overall Study|Treatment Complications|0
4565518|NCT01318083|7400009|FG000|Overall Study|Lack of Study Medication Compliance|0
4565519|NCT01318083|7400010|FG001|Overall Study|Lack of Study Medication Compliance|1
4565520|NCT01318083|7400011|FG002|Overall Study|Lack of Study Medication Compliance|0
4565521|NCT01318109|7400022|FG000|Overall Study|Adverse Event|0
4565522|NCT01318109|7400023|FG001|Overall Study|Adverse Event|2
4565523|NCT01318109|7400024|FG002|Overall Study|Adverse Event|0
4565524|NCT01318109|7400022|FG000|Overall Study|Withdrawal by Subject|1
4565525|NCT01318109|7400023|FG001|Overall Study|Withdrawal by Subject|0
4565526|NCT01318109|7400024|FG002|Overall Study|Withdrawal by Subject|0
4565527|NCT01318109|7400022|FG000|Overall Study|Schedule Conflict|0
4565528|NCT01318109|7400023|FG001|Overall Study|Schedule Conflict|1
4565529|NCT01318109|7400024|FG002|Overall Study|Schedule Conflict|0
4565530|NCT01318122|7400034|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0
4565531|NCT01318122|7400035|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0
4565532|NCT01318122|7400036|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2
4565533|NCT01318122|7400037|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1
4565534|NCT01318122|7400034|FG000|Enrolled - Long-Term Extension Study|Other|1
4565535|NCT01318122|7400035|FG001|Enrolled - Long-Term Extension Study|Other|0
4565536|NCT01318122|7400036|FG002|Enrolled - Long-Term Extension Study|Other|0
4565537|NCT01318122|7400037|FG003|Enrolled - Long-Term Extension Study|Other|0
4565538|NCT01318122|7400034|FG000|Entered - Long-Term Extension Study|Adverse Event|6
4565539|NCT01318122|7400035|FG001|Entered - Long-Term Extension Study|Adverse Event|6
4565540|NCT01318122|7400036|FG002|Entered - Long-Term Extension Study|Adverse Event|2
4565541|NCT01318122|7400037|FG003|Entered - Long-Term Extension Study|Adverse Event|4
4565542|NCT01318122|7400034|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1
4565543|NCT01318122|7400035|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0
4565544|NCT01318122|7400036|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0
4565545|NCT01318122|7400037|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0
4565546|NCT01318122|7400034|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2
4565547|NCT01318122|7400035|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3
4565548|NCT01318122|7400036|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1
4565549|NCT01318122|7400037|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0
4565550|NCT01318122|7400034|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0
4565551|NCT01318122|7400035|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2
4565552|NCT01318122|7400036|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3
4565553|NCT01318122|7400037|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0
4565554|NCT01318135|7400047|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1
4565555|NCT01318135|7400048|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0
4565556|NCT01318135|7400049|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0
4565557|NCT01318135|7400050|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0
4565558|NCT01318135|7400051|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0
4565559|NCT01318135|7400052|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0
4565560|NCT01318135|7400053|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0
4565561|NCT01318135|7400054|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0
4565562|NCT01318135|7400047|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1
4565563|NCT01318135|7400048|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0
4565564|NCT01318135|7400049|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0
4565565|NCT01318135|7400050|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0
4565566|NCT01318135|7400051|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0
4565567|NCT01318135|7400052|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0
4565568|NCT01318135|7400053|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0
4565569|NCT01318135|7400054|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0
4565570|NCT01318135|7400047|FG000|Entered - Long-Term Extension Study|Adverse Event|9
4565571|NCT01318135|7400048|FG001|Entered - Long-Term Extension Study|Adverse Event|3
4565572|NCT01318135|7400049|FG002|Entered - Long-Term Extension Study|Adverse Event|4
4565573|NCT01318135|7400050|FG003|Entered - Long-Term Extension Study|Adverse Event|3
4565574|NCT01318135|7400051|FG004|Entered - Long-Term Extension Study|Adverse Event|4
4565575|NCT01318135|7400052|FG005|Entered - Long-Term Extension Study|Adverse Event|2
4565576|NCT01318135|7400053|FG006|Entered - Long-Term Extension Study|Adverse Event|0
4565577|NCT01318135|7400054|FG007|Entered - Long-Term Extension Study|Adverse Event|0
4565578|NCT01318135|7400047|FG000|Entered - Long-Term Extension Study|Protocol Violation|1
4565579|NCT01318135|7400048|FG001|Entered - Long-Term Extension Study|Protocol Violation|1
4565580|NCT01318135|7400049|FG002|Entered - Long-Term Extension Study|Protocol Violation|0
4565581|NCT01318135|7400050|FG003|Entered - Long-Term Extension Study|Protocol Violation|0
4565582|NCT01318135|7400051|FG004|Entered - Long-Term Extension Study|Protocol Violation|1
4565583|NCT01318135|7400052|FG005|Entered - Long-Term Extension Study|Protocol Violation|0
4565584|NCT01318135|7400053|FG006|Entered - Long-Term Extension Study|Protocol Violation|0
4565585|NCT01318135|7400054|FG007|Entered - Long-Term Extension Study|Protocol Violation|0
4565586|NCT01318135|7400047|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2
4565587|NCT01318135|7400048|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2
4565588|NCT01318135|7400049|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2
4565589|NCT01318135|7400050|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1
4565590|NCT01318135|7400051|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2
4565591|NCT01318135|7400052|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0
4565592|NCT01318135|7400053|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0
4565593|NCT01318135|7400054|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1
4565594|NCT01318135|7400047|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5
4565595|NCT01318135|7400048|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7
4565596|NCT01318135|7400049|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2
4565597|NCT01318135|7400050|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3
4565598|NCT01318135|7400051|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2
4565599|NCT01318135|7400052|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2
4565600|NCT01318135|7400053|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1
4565601|NCT01318135|7400054|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1
4565602|NCT01318135|7400047|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0
4565603|NCT01318135|7400048|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0
4565604|NCT01318135|7400049|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0
4565605|NCT01318135|7400050|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0
4565606|NCT01318135|7400051|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0
4565607|NCT01318135|7400052|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0
4565608|NCT01318135|7400053|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0
4565609|NCT01318135|7400054|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1
4565610|NCT01318382|7400091|FG000|Overall Study|Physician Decision|2
4565611|NCT01318382|7400091|FG000|Overall Study|Device Malfunction|10
4565612|NCT01318382|7400091|FG000|Overall Study|Protocol Violation|1
4565613|NCT01318499|7400103|FG000|Overall Study|Adverse Event|16
4565614|NCT01318499|7400104|FG001|Overall Study|Adverse Event|11
4565615|NCT01318499|7400105|FG002|Overall Study|Adverse Event|6
4565616|NCT01318499|7400103|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1
4565617|NCT01318499|7400104|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1
4565618|NCT01318499|7400105|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2
4565619|NCT01318499|7400103|FG000|Overall Study|Noncompliance|2
4565620|NCT01318499|7400104|FG001|Overall Study|Noncompliance|3
4565621|NCT01318499|7400105|FG002|Overall Study|Noncompliance|0
4565622|NCT01318499|7400103|FG000|Overall Study|Treatment Failure|19
4565623|NCT01318499|7400104|FG001|Overall Study|Treatment Failure|19
4565624|NCT01318499|7400105|FG002|Overall Study|Treatment Failure|101
4565625|NCT01318499|7400103|FG000|Overall Study|Protocol Violation|2
4565626|NCT01318499|7400104|FG001|Overall Study|Protocol Violation|4
4565627|NCT01318499|7400105|FG002|Overall Study|Protocol Violation|2
4565628|NCT01318499|7400103|FG000|Overall Study|Patient Did Not Use Study Medication|18
4565629|NCT01318499|7400104|FG001|Overall Study|Patient Did Not Use Study Medication|28
4565630|NCT01318499|7400105|FG002|Overall Study|Patient Did Not Use Study Medication|14
4565631|NCT01318499|7400103|FG000|Overall Study|Other|7
4565632|NCT01318499|7400104|FG001|Overall Study|Other|10
4565633|NCT01318499|7400105|FG002|Overall Study|Other|22
4565634|NCT01318512|7400115|FG000|Maintenance Period (6 Months)|Death|2
4565635|NCT01318512|7400115|FG000|Maintenance Period (6 Months)|Protocol Violation|9
4565636|NCT01318811|7400165|FG000|Overall Study|Physician Decision|1
4565637|NCT01318811|7400166|FG001|Overall Study|Physician Decision|1
4565638|NCT01318811|7400165|FG000|Overall Study|CRRT stopped for head CT|0
4565639|NCT01318811|7400166|FG001|Overall Study|CRRT stopped for head CT|1
4565640|NCT01318811|7400165|FG000|Overall Study|Death|0
4565641|NCT01318811|7400166|FG001|Overall Study|Death|1
4565642|NCT01318811|7400165|FG000|Overall Study|CRRT stopped for head MRI|0
4565643|NCT01318811|7400166|FG001|Overall Study|CRRT stopped for head MRI|1
4565644|NCT01318876|7400172|FG000|Day 8 Survey|email address invalid|96
4565645|NCT01318876|7400172|FG000|Day 8 Survey|survey not completed-don't know why|1724
4565646|NCT01318876|7400172|FG000|Day 29 Survey|survey not completed-don't know why|1825
4592470|NCT01541969|7440222|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1
4592471|NCT01541969|7440223|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1
4592472|NCT01541969|7440222|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1
4592473|NCT01541969|7440223|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0
4592474|NCT01541969|7440222|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1
4592475|NCT01541969|7440223|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1
4592476|NCT01541969|7440222|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6
4592477|NCT01541969|7440223|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8
4592478|NCT01541969|7440222|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2
4592479|NCT01541969|7440223|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3
4592480|NCT01542034|7440234|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20
4592481|NCT01542034|7440235|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12
4592482|NCT01542034|7440234|FG000|Overall Study|Administrative decision|0
4592483|NCT01542034|7440235|FG001|Overall Study|Administrative decision|3
4592484|NCT01542034|7440234|FG000|Overall Study|Subject Noncompliance|1
4592485|NCT01542034|7440235|FG001|Overall Study|Subject Noncompliance|0
4592486|NCT01542034|7440234|FG000|Overall Study|Adverse Event|2
4592487|NCT01542034|7440235|FG001|Overall Study|Adverse Event|2
4592488|NCT01542034|7440234|FG000|Overall Study|Lost to Follow-up|7
4592489|NCT01542034|7440235|FG001|Overall Study|Lost to Follow-up|6
4592490|NCT01542528|7440299|FG000|Overall Study|Lost to Follow-up|2
4592491|NCT01542528|7440300|FG001|Overall Study|Lost to Follow-up|1
4592492|NCT01542528|7440299|FG000|Overall Study|Physician Decision|1
4592493|NCT01542528|7440300|FG001|Overall Study|Physician Decision|0
4592494|NCT01542528|7440299|FG000|Overall Study|Withdrawal by Subject|9
4592495|NCT01542528|7440300|FG001|Overall Study|Withdrawal by Subject|6
4592496|NCT01542632|7440321|FG000|Overall Study|Withdrawal of Consent|0
4592497|NCT01542632|7440322|FG001|Overall Study|Withdrawal of Consent|0
4592498|NCT01542632|7440323|FG002|Overall Study|Withdrawal of Consent|0
4592499|NCT01542632|7440324|FG003|Overall Study|Withdrawal of Consent|2
4592500|NCT01542632|7440325|FG004|Overall Study|Withdrawal of Consent|3
4592501|NCT01542632|7440326|FG005|Overall Study|Withdrawal of Consent|0
4592502|NCT01542632|7440321|FG000|Overall Study|Adverse Event|0
4592503|NCT01542632|7440322|FG001|Overall Study|Adverse Event|0
4592504|NCT01542632|7440323|FG002|Overall Study|Adverse Event|1
4592505|NCT01542632|7440324|FG003|Overall Study|Adverse Event|0
4592506|NCT01542632|7440325|FG004|Overall Study|Adverse Event|0
4592507|NCT01542632|7440326|FG005|Overall Study|Adverse Event|0
4592508|NCT01542632|7440321|FG000|Overall Study|Lost to Follow-up|0
4592509|NCT01542632|7440322|FG001|Overall Study|Lost to Follow-up|1
4592510|NCT01542632|7440323|FG002|Overall Study|Lost to Follow-up|0
4592511|NCT01542632|7440324|FG003|Overall Study|Lost to Follow-up|0
4592512|NCT01542632|7440325|FG004|Overall Study|Lost to Follow-up|0
4592513|NCT01542632|7440326|FG005|Overall Study|Lost to Follow-up|0
4592514|NCT01542632|7440321|FG000|Overall Study|Sponsor/Investigator Decision|0
4592515|NCT01542632|7440322|FG001|Overall Study|Sponsor/Investigator Decision|0
4592516|NCT01542632|7440323|FG002|Overall Study|Sponsor/Investigator Decision|0
4592517|NCT01542632|7440324|FG003|Overall Study|Sponsor/Investigator Decision|0
4592518|NCT01542632|7440325|FG004|Overall Study|Sponsor/Investigator Decision|1
4592519|NCT01542632|7440326|FG005|Overall Study|Sponsor/Investigator Decision|0
4592520|NCT01542788|7440364|FG000|Overall Study|Randomized but Not Treated|2
4592521|NCT01542788|7440365|FG001|Overall Study|Randomized but Not Treated|0
4592522|NCT01542788|7440364|FG000|Overall Study|Lack of Efficacy|41
4592523|NCT01542788|7440365|FG001|Overall Study|Lack of Efficacy|71
4592524|NCT01542788|7440364|FG000|Overall Study|Lost to Follow-up|5
4592525|NCT01542788|7440365|FG001|Overall Study|Lost to Follow-up|0
4592526|NCT01542788|7440364|FG000|Overall Study|Death|3
4592527|NCT01542788|7440365|FG001|Overall Study|Death|0
4592528|NCT01542788|7440364|FG000|Overall Study|Protocol Violation|2
4592529|NCT01542788|7440365|FG001|Overall Study|Protocol Violation|0
4624640|NCT01822756|7489011|FG003|Overall Study|disease progression & patient preference|0
4624641|NCT01822756|7489012|FG004|Overall Study|disease progression & patient preference|0
4624642|NCT01822821|7489026|FG000|Overall Study|Eligible surgery cancelled|1
4624643|NCT01822821|7489027|FG001|Overall Study|Eligible surgery cancelled|1
4624644|NCT01822821|7489026|FG000|Overall Study|Other reasons|1
4624645|NCT01822821|7489027|FG001|Overall Study|Other reasons|0
4624646|NCT01822899|7489039|FG000|Overall Study|Adverse Event|6
4624647|NCT01822899|7489040|FG001|Overall Study|Adverse Event|5
4624648|NCT01822899|7489039|FG000|Overall Study|Lack of Efficacy|6
4565647|NCT01318902|7400180|FG000|Overall Study|Symptomatic Deterioration|0
4565648|NCT01318902|7400181|FG001|Overall Study|Symptomatic Deterioration|1
4565649|NCT01318902|7400182|FG002|Overall Study|Symptomatic Deterioration|1
4565650|NCT01318902|7400183|FG003|Overall Study|Symptomatic Deterioration|2
4565651|NCT01318902|7400180|FG000|Overall Study|Withdrawal by Patient|0
4565652|NCT01318902|7400181|FG001|Overall Study|Withdrawal by Patient|1
4565653|NCT01318902|7400182|FG002|Overall Study|Withdrawal by Patient|0
4565654|NCT01318902|7400183|FG003|Overall Study|Withdrawal by Patient|3
4565655|NCT01318902|7400180|FG000|Overall Study|Unsatisfactory Therapeutic Response|1
4565656|NCT01318902|7400181|FG001|Overall Study|Unsatisfactory Therapeutic Response|0
4565657|NCT01318902|7400182|FG002|Overall Study|Unsatisfactory Therapeutic Response|0
4565658|NCT01318902|7400183|FG003|Overall Study|Unsatisfactory Therapeutic Response|1
4565659|NCT01318902|7400180|FG000|Overall Study|Adverse Event|0
4565660|NCT01318902|7400181|FG001|Overall Study|Adverse Event|1
4565661|NCT01318902|7400182|FG002|Overall Study|Adverse Event|0
4565662|NCT01318902|7400183|FG003|Overall Study|Adverse Event|0
4565663|NCT01318902|7400180|FG000|Overall Study|Terminated by Sponsor|0
4565664|NCT01318902|7400181|FG001|Overall Study|Terminated by Sponsor|0
4565665|NCT01318902|7400182|FG002|Overall Study|Terminated by Sponsor|1
4565666|NCT01318902|7400183|FG003|Overall Study|Terminated by Sponsor|0
4565667|NCT01318915|7400195|FG000|Overall Study|Lost to Follow-up|1
4565668|NCT01319383|7400223|FG000|Overall Study|No ex vivo or in vivo response|4
4565669|NCT01319383|7400224|FG001|Overall Study|No ex vivo or in vivo response|0
4565670|NCT01319383|7400223|FG000|Overall Study|Physician Decision|3
4565671|NCT01319383|7400224|FG001|Overall Study|Physician Decision|0
4565672|NCT01319383|7400223|FG000|Overall Study|Lack of Efficacy|5
4565673|NCT01319383|7400224|FG001|Overall Study|Lack of Efficacy|9
4565674|NCT01319383|7400223|FG000|Overall Study|No in vivo response to interval doses|0
4565675|NCT01319383|7400224|FG001|Overall Study|No in vivo response to interval doses|1
4565676|NCT01319422|7400247|FG000|Overall Study|Withdrawal by Subject|1
4565677|NCT01319422|7400248|FG001|Overall Study|Withdrawal by Subject|0
4565678|NCT01319721|7400285|FG000|Overall Study|Lost to Follow-up|1
4565679|NCT01319721|7400286|FG001|Overall Study|Lost to Follow-up|6
4565680|NCT01319877|7400337|FG000|Overall Study|Lost to Follow-up|100
4565681|NCT01319877|7400338|FG001|Overall Study|Lost to Follow-up|37
4565682|NCT01319877|7400337|FG000|Overall Study|Physician Decision|2
4565683|NCT01319877|7400338|FG001|Overall Study|Physician Decision|0
4565684|NCT01319877|7400337|FG000|Overall Study|Disease Progression|2
4565685|NCT01319877|7400338|FG001|Overall Study|Disease Progression|2
4565686|NCT01319877|7400337|FG000|Overall Study|Withdrawal by Subject|0
4565687|NCT01319877|7400338|FG001|Overall Study|Withdrawal by Subject|1
4565688|NCT01319877|7400337|FG000|Overall Study|Reason Not Specified|4
4565689|NCT01319877|7400338|FG001|Overall Study|Reason Not Specified|5
4565690|NCT01319929|7400345|FG000|First Treatment Period (4 Weeks)|Adverse Event|2
4565691|NCT01319929|7400346|FG001|First Treatment Period (4 Weeks)|Adverse Event|0
4565692|NCT01319929|7400345|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1
4565693|NCT01319929|7400346|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1
4565694|NCT01319929|7400345|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0
4565695|NCT01319929|7400346|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1
4565696|NCT01319929|7400345|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1
4565697|NCT01319929|7400346|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0
4565698|NCT01319929|7400345|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0
4565699|NCT01319929|7400346|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1
4565700|NCT01319994|7400355|FG000|Overall Study|Protocol Violation|7
4565701|NCT01319994|7400356|FG001|Overall Study|Protocol Violation|6
4565702|NCT01320033|7400365|FG000|Overall Study|Lack of Efficacy|0
4565703|NCT01320033|7400366|FG001|Overall Study|Lack of Efficacy|0
4565704|NCT01320033|7400367|FG002|Overall Study|Lack of Efficacy|1
4565705|NCT01320033|7400365|FG000|Overall Study|Adverse Event|9
4565706|NCT01320033|7400366|FG001|Overall Study|Adverse Event|7
4565707|NCT01320033|7400367|FG002|Overall Study|Adverse Event|8
4565708|NCT01320033|7400365|FG000|Overall Study|Withdrawal by Subject|22
4565709|NCT01320033|7400366|FG001|Overall Study|Withdrawal by Subject|23
4565710|NCT01320033|7400367|FG002|Overall Study|Withdrawal by Subject|23
4565711|NCT01320033|7400365|FG000|Overall Study|Protocol Violation|3
4565712|NCT01320033|7400366|FG001|Overall Study|Protocol Violation|5
4565713|NCT01320033|7400367|FG002|Overall Study|Protocol Violation|3
4565714|NCT01320033|7400365|FG000|Overall Study|Lost to Follow-up|22
4565715|NCT01320033|7400366|FG001|Overall Study|Lost to Follow-up|26
4565716|NCT01320033|7400367|FG002|Overall Study|Lost to Follow-up|17
4565717|NCT01320033|7400365|FG000|Overall Study|Other|2
4565718|NCT01320033|7400366|FG001|Overall Study|Other|3
4565719|NCT01320033|7400367|FG002|Overall Study|Other|1
4565720|NCT01320085|7400378|FG000|Overall Study|Treatment Ongoing|0
4565721|NCT01320085|7400379|FG001|Overall Study|Treatment Ongoing|13
4565722|NCT01320085|7400380|FG002|Overall Study|Treatment Ongoing|2
4565723|NCT01320085|7400378|FG000|Overall Study|Disease Progression|26
4565724|NCT01320085|7400379|FG001|Overall Study|Disease Progression|86
4565725|NCT01320085|7400380|FG002|Overall Study|Disease Progression|16
4565726|NCT01320085|7400378|FG000|Overall Study|Adverse Event|12
4565727|NCT01320085|7400379|FG001|Overall Study|Adverse Event|14
4565728|NCT01320085|7400380|FG002|Overall Study|Adverse Event|5
4565729|NCT01320085|7400378|FG000|Overall Study|Withdrawal by Subject|2
4565730|NCT01320085|7400379|FG001|Overall Study|Withdrawal by Subject|4
4565731|NCT01320085|7400380|FG002|Overall Study|Withdrawal by Subject|1
4565732|NCT01320085|7400378|FG000|Overall Study|Protocol Deviation|1
4565733|NCT01320085|7400379|FG001|Overall Study|Protocol Deviation|0
4565734|NCT01320085|7400380|FG002|Overall Study|Protocol Deviation|1
4565735|NCT01320150|7400399|FG000|Overall Study|Protocol Violation|15
4565736|NCT01320150|7400399|FG000|Overall Study|Withdrawal by Subject|5
4565737|NCT01320150|7400399|FG000|Overall Study|Death|2
4565738|NCT01320150|7400399|FG000|Overall Study|Lost to Follow-up|44
4565739|NCT01320202|7400405|FG000|Overall Study|Adverse Event|5
4565740|NCT01320202|7400406|FG001|Overall Study|Adverse Event|5
4565741|NCT01320202|7400405|FG000|Overall Study|Death|5
4565742|NCT01320202|7400406|FG001|Overall Study|Death|3
4565743|NCT01320202|7400405|FG000|Overall Study|Lost to Follow-up|1
4565744|NCT01320202|7400406|FG001|Overall Study|Lost to Follow-up|0
4565745|NCT01320202|7400405|FG000|Overall Study|Physician Decision|3
4565746|NCT01320202|7400406|FG001|Overall Study|Physician Decision|1
4565747|NCT01320202|7400405|FG000|Overall Study|Protocol Violation|2
4565748|NCT01320202|7400406|FG001|Overall Study|Protocol Violation|1
4565749|NCT01320202|7400405|FG000|Overall Study|Withdrawal by Subject|10
4565750|NCT01320202|7400406|FG001|Overall Study|Withdrawal by Subject|3
4565751|NCT01320202|7400405|FG000|Overall Study|non-protocol change to ESA or IV iron|17
4565752|NCT01320202|7400406|FG001|Overall Study|non-protocol change to ESA or IV iron|20
4565753|NCT01320202|7400405|FG000|Overall Study|kidney transplant|1
4565754|NCT01320202|7400406|FG001|Overall Study|kidney transplant|2
4565755|NCT01320202|7400405|FG000|Overall Study|blood transfusion|1
4565756|NCT01320202|7400406|FG001|Overall Study|blood transfusion|7
4565757|NCT01320202|7400405|FG000|Overall Study|moved/changed dialysis|5
4565758|NCT01320202|7400406|FG001|Overall Study|moved/changed dialysis|2
4565759|NCT01320202|7400405|FG000|Overall Study|sponsor request|2
4565760|NCT01320202|7400406|FG001|Overall Study|sponsor request|0
4565761|NCT01320202|7400405|FG000|Overall Study|ineligible|3
4565762|NCT01320202|7400406|FG001|Overall Study|ineligible|0
4565763|NCT01320202|7400405|FG000|Overall Study|regained renal function|1
4565764|NCT01320202|7400406|FG001|Overall Study|regained renal function|0
4565765|NCT01320293|7400415|FG000|Overall Study|Lack of Efficacy|1
4565766|NCT01320293|7400415|FG000|Overall Study|Adverse Event|1
4565767|NCT01320722|7400441|FG000|Overall Study|Did not Receive Intervention|3
4565768|NCT01320722|7400442|FG001|Overall Study|Did not Receive Intervention|2
4565769|NCT01320722|7400443|FG002|Overall Study|Did not Receive Intervention|1
4565770|NCT01320722|7400444|FG003|Overall Study|Did not Receive Intervention|1
4565771|NCT01320722|7400445|FG004|Overall Study|Did not Receive Intervention|2
4565772|NCT01320722|7400441|FG000|Overall Study|Lost to Follow-up|0
4565773|NCT01320722|7400442|FG001|Overall Study|Lost to Follow-up|1
4565774|NCT01320722|7400443|FG002|Overall Study|Lost to Follow-up|0
4565775|NCT01320722|7400444|FG003|Overall Study|Lost to Follow-up|1
4565776|NCT01320722|7400445|FG004|Overall Study|Lost to Follow-up|3
4565777|NCT01320722|7400441|FG000|Overall Study|Not Available for the 8 Week Visit|0
4565778|NCT01320722|7400442|FG001|Overall Study|Not Available for the 8 Week Visit|3
4565779|NCT01320722|7400443|FG002|Overall Study|Not Available for the 8 Week Visit|0
4565780|NCT01320722|7400444|FG003|Overall Study|Not Available for the 8 Week Visit|0
4565781|NCT01320722|7400445|FG004|Overall Study|Not Available for the 8 Week Visit|0
4565782|NCT01320722|7400441|FG000|Overall Study|Participant Developed a Rash|0
4565783|NCT01320722|7400442|FG001|Overall Study|Participant Developed a Rash|0
4565784|NCT01320722|7400443|FG002|Overall Study|Participant Developed a Rash|2
4565785|NCT01320722|7400444|FG003|Overall Study|Participant Developed a Rash|1
4565786|NCT01320722|7400445|FG004|Overall Study|Participant Developed a Rash|1
4565787|NCT01320722|7400441|FG000|Overall Study|Non-compliant with Medication|0
4565788|NCT01320722|7400442|FG001|Overall Study|Non-compliant with Medication|0
4565789|NCT01320722|7400443|FG002|Overall Study|Non-compliant with Medication|1
4565790|NCT01320722|7400444|FG003|Overall Study|Non-compliant with Medication|0
4565791|NCT01320722|7400445|FG004|Overall Study|Non-compliant with Medication|0
4565792|NCT01320722|7400441|FG000|Overall Study|Adverse Event|0
4565793|NCT01320722|7400442|FG001|Overall Study|Adverse Event|0
4565794|NCT01320722|7400443|FG002|Overall Study|Adverse Event|3
4565795|NCT01320722|7400444|FG003|Overall Study|Adverse Event|6
4565796|NCT01320722|7400445|FG004|Overall Study|Adverse Event|0
4565797|NCT01320722|7400441|FG000|Overall Study|Not Compliant with Study Procedures|0
4565798|NCT01320722|7400442|FG001|Overall Study|Not Compliant with Study Procedures|0
4565799|NCT01320722|7400443|FG002|Overall Study|Not Compliant with Study Procedures|0
4565800|NCT01320722|7400444|FG003|Overall Study|Not Compliant with Study Procedures|4
4565801|NCT01320722|7400445|FG004|Overall Study|Not Compliant with Study Procedures|0
4565802|NCT01320722|7400441|FG000|Overall Study|Pregnancy|0
4565803|NCT01320722|7400442|FG001|Overall Study|Pregnancy|0
4565804|NCT01320722|7400443|FG002|Overall Study|Pregnancy|0
4565805|NCT01320722|7400444|FG003|Overall Study|Pregnancy|1
4624649|NCT01822899|7489040|FG001|Overall Study|Lack of Efficacy|3
4624650|NCT01822899|7489039|FG000|Overall Study|Protocol Violation|6
4624651|NCT01822899|7489040|FG001|Overall Study|Protocol Violation|3
4624652|NCT01822899|7489039|FG000|Overall Study|Lost to Follow-up|1
4565806|NCT01320722|7400445|FG004|Overall Study|Pregnancy|0
4565807|NCT01320722|7400441|FG000|Overall Study|Started an Exclusionary Medication|0
4565808|NCT01320722|7400442|FG001|Overall Study|Started an Exclusionary Medication|0
4565809|NCT01320722|7400443|FG002|Overall Study|Started an Exclusionary Medication|0
4565810|NCT01320722|7400444|FG003|Overall Study|Started an Exclusionary Medication|0
4565811|NCT01320722|7400445|FG004|Overall Study|Started an Exclusionary Medication|1
4565812|NCT01320722|7400441|FG000|Overall Study|Withdrew due to Health Condition|0
4565813|NCT01320722|7400442|FG001|Overall Study|Withdrew due to Health Condition|0
4565814|NCT01320722|7400443|FG002|Overall Study|Withdrew due to Health Condition|0
4565815|NCT01320722|7400444|FG003|Overall Study|Withdrew due to Health Condition|0
4565816|NCT01320722|7400445|FG004|Overall Study|Withdrew due to Health Condition|1
4565817|NCT01320735|7400460|FG000|Overall Study|Adverse Event|3
4565818|NCT01320735|7400460|FG000|Overall Study|Withdrawal by Subject|3
4565819|NCT01320735|7400460|FG000|Overall Study|Lost to Follow-up|13
4565820|NCT01320735|7400460|FG000|Overall Study|Administrative Reason|6
4565821|NCT01320735|7400460|FG000|Overall Study|Progression/Hormone-Refractory Pca|55
4565822|NCT01320735|7400460|FG000|Overall Study|Protocol Violation|1
4565823|NCT01320735|7400460|FG000|Overall Study|Other|1
4565824|NCT01320735|7400460|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7
4565825|NCT01320735|7400460|FG000|Overall Study|Investigator Unable to be Contacted|17
4565826|NCT01320943|7400481|FG000|Overall Study|Lost to Follow-up|1
4565827|NCT01320943|7400482|FG001|Overall Study|Lost to Follow-up|0
4565828|NCT01320943|7400481|FG000|Overall Study|Physician Decision|0
4565829|NCT01320943|7400482|FG001|Overall Study|Physician Decision|1
4565830|NCT01320943|7400481|FG000|Overall Study|Randomized but not Treated|0
4565831|NCT01320943|7400482|FG001|Overall Study|Randomized but not Treated|1
4565832|NCT01321073|7400495|FG000|Overall Study|Did not attempt implant|4
4565833|NCT01321073|7400495|FG000|Overall Study|Death|3
4565834|NCT01321606|7400545|FG000|Overall Study|Lost to Follow-up|0
4565835|NCT01321606|7400546|FG001|Overall Study|Lost to Follow-up|0
4565836|NCT01321606|7400547|FG002|Overall Study|Lost to Follow-up|0
4565837|NCT01321606|7400548|FG003|Overall Study|Lost to Follow-up|1
4565838|NCT01321710|7400561|FG000|Overall Study|Lost to Follow-up|4
4565839|NCT01321710|7400562|FG001|Overall Study|Lost to Follow-up|5
4565840|NCT01321710|7400563|FG002|Overall Study|Lost to Follow-up|0
4565841|NCT01321723|7400576|FG000|Overall Study|Adverse Event|3
4565842|NCT01321723|7400577|FG001|Overall Study|Adverse Event|5
4565843|NCT01321723|7400578|FG002|Overall Study|Adverse Event|2
4565844|NCT01321723|7400576|FG000|Overall Study|Withdrawal by Subject|2
4565845|NCT01321723|7400577|FG001|Overall Study|Withdrawal by Subject|0
4565846|NCT01321723|7400578|FG002|Overall Study|Withdrawal by Subject|2
4565847|NCT01321749|7400588|FG000|Overall Study|Lost to Follow-up|4
4565848|NCT01321749|7400589|FG001|Overall Study|Lost to Follow-up|11
4565849|NCT01321749|7400588|FG000|Overall Study|Protocol Violation|4
4565850|NCT01321749|7400589|FG001|Overall Study|Protocol Violation|7
4565851|NCT01321749|7400588|FG000|Overall Study|Withdrawal by Subject|5
4565852|NCT01321749|7400589|FG001|Overall Study|Withdrawal by Subject|4
4624653|NCT01822899|7489040|FG001|Overall Study|Lost to Follow-up|0
4624654|NCT01822899|7489039|FG000|Overall Study|Withdrawal by Subject|5
4624655|NCT01822899|7489040|FG001|Overall Study|Withdrawal by Subject|7
4565853|NCT01321879|7400595|FG000|Overall Study|Lack of Efficacy|5
4624656|NCT01822925|7489050|FG000|Overall Study|Adverse Event|1
4624657|NCT01822925|7489051|FG001|Overall Study|Adverse Event|1
4565854|NCT01321879|7400595|FG000|Overall Study|Adverse Event|5
4565855|NCT01321879|7400595|FG000|Overall Study|Death|3
4565856|NCT01321879|7400595|FG000|Overall Study|Withdrawal by Subject|1
4565857|NCT01322009|7400601|FG000|Overall Study|Death|0
4565858|NCT01322009|7400602|FG001|Overall Study|Death|1
4565859|NCT01322009|7400601|FG000|Overall Study|Adverse Event|0
4565860|NCT01322009|7400602|FG001|Overall Study|Adverse Event|1
4565861|NCT01322009|7400601|FG000|Overall Study|ng tube discontinued|0
4565862|NCT01322009|7400602|FG001|Overall Study|ng tube discontinued|1
4565863|NCT01322347|7400628|FG000|Overall Study|Adverse Event|7
4565864|NCT01322347|7400629|FG001|Overall Study|Adverse Event|2
4565865|NCT01322347|7400628|FG000|Overall Study|Death|5
4565866|NCT01322347|7400629|FG001|Overall Study|Death|3
4565867|NCT01322347|7400628|FG000|Overall Study|Physician Decision|2
4565868|NCT01322347|7400629|FG001|Overall Study|Physician Decision|1
4565869|NCT01322347|7400628|FG000|Overall Study|Protocol Violation|5
4565870|NCT01322347|7400629|FG001|Overall Study|Protocol Violation|2
4565871|NCT01322347|7400628|FG000|Overall Study|Withdrawal by Subject|1
4565872|NCT01322347|7400629|FG001|Overall Study|Withdrawal by Subject|4
4565873|NCT01322347|7400628|FG000|Overall Study|non-protocol change to ESA or IV iron|14
4565874|NCT01322347|7400629|FG001|Overall Study|non-protocol change to ESA or IV iron|6
4565875|NCT01322347|7400628|FG000|Overall Study|blood transfusion|5
4565876|NCT01322347|7400629|FG001|Overall Study|blood transfusion|5
4565877|NCT01322347|7400628|FG000|Overall Study|sponsor decision|1
4565878|NCT01322347|7400629|FG001|Overall Study|sponsor decision|3
4565879|NCT01322347|7400628|FG000|Overall Study|ineligible|6
4565880|NCT01322347|7400629|FG001|Overall Study|ineligible|3
4565881|NCT01322347|7400628|FG000|Overall Study|kidney transplant|3
4565882|NCT01322347|7400629|FG001|Overall Study|kidney transplant|1
4565883|NCT01322347|7400628|FG000|Overall Study|study drug withheld > 12 wks|0
4565884|NCT01322347|7400629|FG001|Overall Study|study drug withheld > 12 wks|1
4565885|NCT01322347|7400628|FG000|Overall Study|moved/changed dialysis|2
4565886|NCT01322347|7400629|FG001|Overall Study|moved/changed dialysis|4
4565887|NCT01322386|7400643|FG000|Overall Study|Protocol Violation|0
4565888|NCT01322386|7400644|FG001|Overall Study|Protocol Violation|1
4565889|NCT01322386|7400643|FG000|Overall Study|Physician Decision|0
4565890|NCT01322386|7400644|FG001|Overall Study|Physician Decision|1
4565891|NCT01322490|7400655|FG000|Treatment Period|Adverse Event|12
4565892|NCT01322490|7400656|FG001|Treatment Period|Adverse Event|18
4565893|NCT01322490|7400657|FG002|Treatment Period|Adverse Event|15
4565894|NCT01322490|7400655|FG000|Treatment Period|Death|5
4565895|NCT01322490|7400656|FG001|Treatment Period|Death|7
4565896|NCT01322490|7400657|FG002|Treatment Period|Death|3
4565897|NCT01322490|7400655|FG000|Treatment Period|Lack of Efficacy|89
4565898|NCT01322490|7400656|FG001|Treatment Period|Lack of Efficacy|100
4565899|NCT01322490|7400657|FG002|Treatment Period|Lack of Efficacy|112
4565900|NCT01322490|7400655|FG000|Treatment Period|Physician Decision|0
4565901|NCT01322490|7400656|FG001|Treatment Period|Physician Decision|2
4565902|NCT01322490|7400657|FG002|Treatment Period|Physician Decision|1
4565903|NCT01322490|7400655|FG000|Treatment Period|Protocol Violation|7
4565904|NCT01322490|7400656|FG001|Treatment Period|Protocol Violation|5
4565905|NCT01322490|7400657|FG002|Treatment Period|Protocol Violation|4
4565906|NCT01322490|7400655|FG000|Treatment Period|Withdrawal by Subject|14
4565907|NCT01322490|7400656|FG001|Treatment Period|Withdrawal by Subject|16
4565908|NCT01322490|7400657|FG002|Treatment Period|Withdrawal by Subject|11
4565909|NCT01322490|7400655|FG000|Treatment Period|Non-compliance with study drug|0
4565910|NCT01322490|7400656|FG001|Treatment Period|Non-compliance with study drug|0
4565911|NCT01322490|7400657|FG002|Treatment Period|Non-compliance with study drug|1
4565912|NCT01322490|7400655|FG000|Treatment Period|Other per report|2
4565913|NCT01322490|7400656|FG001|Treatment Period|Other per report|2
4565914|NCT01322490|7400657|FG002|Treatment Period|Other per report|1
4565915|NCT01322490|7400655|FG000|Treatment Period|Randomized but Not Treated|3
4565916|NCT01322490|7400656|FG001|Treatment Period|Randomized but Not Treated|3
4565917|NCT01322490|7400657|FG002|Treatment Period|Randomized but Not Treated|5
4565918|NCT01322490|7400655|FG000|Long Term Follow-up Period|Death|235
4565919|NCT01322490|7400656|FG001|Long Term Follow-up Period|Death|239
4565920|NCT01322490|7400657|FG002|Long Term Follow-up Period|Death|236
4565921|NCT01322490|7400655|FG000|Long Term Follow-up Period|Lost to Follow-up|2
4565922|NCT01322490|7400656|FG001|Long Term Follow-up Period|Lost to Follow-up|2
4565923|NCT01322490|7400657|FG002|Long Term Follow-up Period|Lost to Follow-up|3
4565924|NCT01322490|7400655|FG000|Long Term Follow-up Period|Withdrawal by Subject|9
4565925|NCT01322490|7400656|FG001|Long Term Follow-up Period|Withdrawal by Subject|6
4565926|NCT01322490|7400657|FG002|Long Term Follow-up Period|Withdrawal by Subject|6
4565927|NCT01322490|7400655|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160
4565928|NCT01322490|7400656|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158
4565929|NCT01322490|7400657|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165
4565930|NCT01322490|7400655|FG000|Long Term Follow-up Period|Other per report|3
4624658|NCT01822925|7489052|FG002|Overall Study|Adverse Event|1
4624659|NCT01822925|7489053|FG003|Overall Study|Adverse Event|1
4624660|NCT01822925|7489050|FG000|Overall Study|Lost to Follow-up|0
4624661|NCT01822925|7489051|FG001|Overall Study|Lost to Follow-up|1
4624662|NCT01822925|7489052|FG002|Overall Study|Lost to Follow-up|0
4624663|NCT01822925|7489053|FG003|Overall Study|Lost to Follow-up|0
4624664|NCT01822925|7489050|FG000|Overall Study|Protocol Violation|1
4624665|NCT01822925|7489051|FG001|Overall Study|Protocol Violation|0
4624666|NCT01822925|7489052|FG002|Overall Study|Protocol Violation|0
4624667|NCT01822925|7489053|FG003|Overall Study|Protocol Violation|1
4624668|NCT01822925|7489050|FG000|Overall Study|Withdrawal by Subject|2
4624669|NCT01822925|7489051|FG001|Overall Study|Withdrawal by Subject|0
4624670|NCT01822925|7489052|FG002|Overall Study|Withdrawal by Subject|2
4624671|NCT01822925|7489053|FG003|Overall Study|Withdrawal by Subject|2
4624672|NCT01822925|7489050|FG000|Overall Study|Taking prohibited medication|2
4624673|NCT01822925|7489051|FG001|Overall Study|Taking prohibited medication|0
4624674|NCT01822925|7489052|FG002|Overall Study|Taking prohibited medication|0
4624675|NCT01822925|7489053|FG003|Overall Study|Taking prohibited medication|1
4624676|NCT01823107|7489063|FG000|Overall Study|Withdrawal by Subject|1
4624677|NCT01823146|7489069|FG000|Overall Study|Withdrawal by Subject|0
4624678|NCT01823146|7489070|FG001|Overall Study|Withdrawal by Subject|1
4624679|NCT01823146|7489069|FG000|Overall Study|Lost to Follow-up|2
4565931|NCT01322490|7400656|FG001|Long Term Follow-up Period|Other per report|2
4565932|NCT01322490|7400657|FG002|Long Term Follow-up Period|Other per report|2
4565933|NCT01322490|7400655|FG000|Long Term Follow-up Period|Unknown/Missing|0
4565934|NCT01322490|7400656|FG001|Long Term Follow-up Period|Unknown/Missing|1
4565935|NCT01322490|7400657|FG002|Long Term Follow-up Period|Unknown/Missing|1
4565936|NCT01323192|7400773|FG000|Overall Study|Adverse Event|6
4565937|NCT01323192|7400774|FG001|Overall Study|Adverse Event|1
4565938|NCT01323192|7400773|FG000|Overall Study|Withdrawal by Subject|3
4565939|NCT01323192|7400774|FG001|Overall Study|Withdrawal by Subject|1
4565940|NCT01323192|7400773|FG000|Overall Study|Noncompliance with study medication|0
4565941|NCT01323192|7400774|FG001|Overall Study|Noncompliance with study medication|3
4565942|NCT01323192|7400773|FG000|Overall Study|Nonmedical reasons|0
4565943|NCT01323192|7400774|FG001|Overall Study|Nonmedical reasons|1
4565944|NCT01323270|7400782|FG000|Overall Study|Withdrawal by Subject|19
4565945|NCT01323270|7400783|FG001|Overall Study|Withdrawal by Subject|10
4565946|NCT01323270|7400782|FG000|Overall Study|Protocol Violation|9
4565947|NCT01323270|7400783|FG001|Overall Study|Protocol Violation|7
4565948|NCT01323270|7400782|FG000|Overall Study|Lost to Follow-up|4
4565949|NCT01323270|7400783|FG001|Overall Study|Lost to Follow-up|6
4565950|NCT01323270|7400782|FG000|Overall Study|Adverse Event|8
4565951|NCT01323270|7400783|FG001|Overall Study|Adverse Event|0
4565952|NCT01323270|7400782|FG000|Overall Study|Other|0
4565953|NCT01323270|7400783|FG001|Overall Study|Other|3
4565954|NCT01323270|7400782|FG000|Overall Study|Physician Decision|0
4565955|NCT01323270|7400783|FG001|Overall Study|Physician Decision|2
4565956|NCT01323270|7400782|FG000|Overall Study|Not eligible|1
4565957|NCT01323270|7400783|FG001|Overall Study|Not eligible|1
4565958|NCT01323270|7400782|FG000|Overall Study|Death|1
4565959|NCT01323270|7400783|FG001|Overall Study|Death|0
4565960|NCT01323270|7400782|FG000|Overall Study|Randomized, but not vaccinated|1
4565961|NCT01323270|7400783|FG001|Overall Study|Randomized, but not vaccinated|0
4565962|NCT01323387|7400790|FG000|Overall Study|Withdrawal by Subject|41
4565963|NCT01323387|7400790|FG000|Overall Study|Radiographic Data Unavailable|1
4565964|NCT01323387|7400790|FG000|Overall Study|Revision|14
4565965|NCT01323387|7400790|FG000|Overall Study|Protocol Violation|12
4565966|NCT01323387|7400790|FG000|Overall Study|Randomized but Never Treated|16
4565967|NCT01323478|7400796|FG000|Overall Study|Adverse Event|7
4565968|NCT01323478|7400796|FG000|Overall Study|Lack of Efficacy|4
4565969|NCT01323478|7400796|FG000|Overall Study|Non-compliance With Study Product|3
4565970|NCT01323478|7400796|FG000|Overall Study|Protocol Violation|1
4565971|NCT01323478|7400796|FG000|Overall Study|Withdrawal of Consent|1
4565972|NCT01323478|7400796|FG000|Overall Study|Administrative or Other Reasons|8
4565973|NCT01323530|7400811|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2
4565974|NCT01323530|7400812|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0
4565975|NCT01323530|7400813|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0
4565976|NCT01323530|7400814|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0
4565977|NCT01323530|7400815|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0
4565978|NCT01323530|7400816|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2
4565979|NCT01323530|7400817|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0
4565980|NCT01323530|7400811|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1
4565981|NCT01323530|7400812|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1
4565982|NCT01323530|7400813|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1
4565983|NCT01323530|7400814|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0
4565984|NCT01323530|7400815|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2
4565985|NCT01323530|7400816|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0
4565986|NCT01323530|7400817|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0
4565987|NCT01323530|7400811|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0
4565988|NCT01323530|7400812|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1
4565989|NCT01323530|7400813|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0
4565990|NCT01323530|7400814|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0
4565991|NCT01323530|7400815|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1
4565992|NCT01323530|7400816|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1
4565993|NCT01323530|7400817|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0
4565994|NCT01323530|7400811|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0
4565995|NCT01323530|7400812|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0
4565996|NCT01323530|7400813|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0
4565997|NCT01323530|7400814|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0
4565998|NCT01323530|7400815|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0
4565999|NCT01323530|7400816|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0
4566000|NCT01323530|7400817|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2
4566001|NCT01323530|7400811|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0
4566002|NCT01323530|7400812|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0
4566003|NCT01323530|7400813|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0
4566004|NCT01323530|7400814|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0
4566005|NCT01323530|7400815|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0
4566006|NCT01323530|7400816|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0
4566007|NCT01323530|7400817|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3
4566008|NCT01323530|7400811|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0
4566009|NCT01323530|7400812|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0
4566010|NCT01323530|7400813|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0
4566011|NCT01323530|7400814|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0
4566012|NCT01323530|7400815|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0
4566013|NCT01323530|7400816|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0
4566014|NCT01323530|7400817|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8
4566015|NCT01323530|7400811|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0
4566016|NCT01323530|7400812|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0
4566017|NCT01323530|7400813|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0
4566018|NCT01323530|7400814|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0
4566019|NCT01323530|7400815|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0
4566020|NCT01323530|7400816|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0
4566021|NCT01323530|7400817|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3
4566022|NCT01323530|7400811|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0
4566023|NCT01323530|7400812|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0
4566024|NCT01323530|7400813|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0
4566025|NCT01323530|7400814|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0
4566026|NCT01323530|7400815|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0
4566027|NCT01323530|7400816|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0
4566028|NCT01323530|7400817|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1
4566029|NCT01323582|7400836|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2
4566030|NCT01323582|7400837|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2
4566031|NCT01323582|7400836|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0
4566032|NCT01323582|7400837|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1
4566033|NCT01323582|7400836|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0
4566034|NCT01323582|7400837|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1
4566035|NCT01323621|7400858|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121
4566036|NCT01323621|7400859|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0
4566037|NCT01323621|7400860|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0
4566038|NCT01323621|7400858|FG000|2-week, Single-blind Run In Period|Physician Decision|7
4566039|NCT01323621|7400859|FG001|2-week, Single-blind Run In Period|Physician Decision|0
4566040|NCT01323621|7400860|FG002|2-week, Single-blind Run In Period|Physician Decision|0
4566041|NCT01323621|7400858|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12
4566042|NCT01323621|7400859|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0
4566043|NCT01323621|7400860|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0
4566044|NCT01323621|7400858|FG000|2-week, Single-blind Run In Period|Protocol Violation|1
4566045|NCT01323621|7400859|FG001|2-week, Single-blind Run In Period|Protocol Violation|0
4566046|NCT01323621|7400860|FG002|2-week, Single-blind Run In Period|Protocol Violation|0
4566047|NCT01323621|7400858|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1
4566048|NCT01323621|7400859|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0
4566049|NCT01323621|7400860|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0
4566050|NCT01323621|7400858|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86
4566051|NCT01323621|7400859|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0
4566052|NCT01323621|7400860|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0
4566053|NCT01323621|7400858|FG000|12-week, Double-blind Treatment Period|Adverse Event|0
4566054|NCT01323621|7400859|FG001|12-week, Double-blind Treatment Period|Adverse Event|1
4566055|NCT01323621|7400860|FG002|12-week, Double-blind Treatment Period|Adverse Event|5
4566056|NCT01323621|7400858|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0
4566057|NCT01323621|7400859|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2
4566058|NCT01323621|7400860|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6
4566059|NCT01323621|7400858|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0
4566060|NCT01323621|7400859|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4
4566061|NCT01323621|7400860|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4
4566062|NCT01323621|7400858|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0
4566063|NCT01323621|7400859|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1
4566064|NCT01323621|7400860|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0
4566065|NCT01323621|7400858|FG000|12-week, Double-blind Treatment Period|Physician Decision|0
4566066|NCT01323621|7400859|FG001|12-week, Double-blind Treatment Period|Physician Decision|2
4566067|NCT01323621|7400860|FG002|12-week, Double-blind Treatment Period|Physician Decision|1
4566068|NCT01323621|7400858|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0
4566069|NCT01323621|7400859|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5
4566070|NCT01323621|7400860|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4
4566071|NCT01323634|7400868|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125
4566072|NCT01323634|7400869|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0
4566073|NCT01323634|7400870|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0
4566074|NCT01323634|7400868|FG000|2-week Run-in Period|Continuation Criteria not Met|73
4566075|NCT01323634|7400869|FG001|2-week Run-in Period|Continuation Criteria not Met|0
4566076|NCT01323634|7400870|FG002|2-week Run-in Period|Continuation Criteria not Met|0
4566077|NCT01323634|7400868|FG000|2-week Run-in Period|Withdrawal by Subject|7
4566078|NCT01323634|7400869|FG001|2-week Run-in Period|Withdrawal by Subject|0
4566079|NCT01323634|7400870|FG002|2-week Run-in Period|Withdrawal by Subject|0
4566080|NCT01323634|7400868|FG000|2-week Run-in Period|Physician Decision|5
4566081|NCT01323634|7400869|FG001|2-week Run-in Period|Physician Decision|0
4566082|NCT01323634|7400870|FG002|2-week Run-in Period|Physician Decision|0
4566083|NCT01323634|7400868|FG000|2-week Run-in Period|Protocol Violation|1
4566084|NCT01323634|7400869|FG001|2-week Run-in Period|Protocol Violation|0
4566085|NCT01323634|7400870|FG002|2-week Run-in Period|Protocol Violation|0
4566086|NCT01323634|7400868|FG000|2-week Run-in Period|Adverse Event|1
4566087|NCT01323634|7400869|FG001|2-week Run-in Period|Adverse Event|0
4566088|NCT01323634|7400870|FG002|2-week Run-in Period|Adverse Event|0
4566089|NCT01323634|7400868|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0
4566090|NCT01323634|7400869|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8
4566091|NCT01323634|7400870|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4
4566092|NCT01323634|7400868|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
4566093|NCT01323634|7400869|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
4566094|NCT01323634|7400870|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2
4566095|NCT01323634|7400868|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0
4566096|NCT01323634|7400869|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6
4566097|NCT01323634|7400870|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7
4566098|NCT01323634|7400868|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
4566099|NCT01323634|7400869|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
4566100|NCT01323634|7400870|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
4566101|NCT01323634|7400868|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0
4566102|NCT01323634|7400869|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2
4566103|NCT01323634|7400870|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3
4566104|NCT01323634|7400868|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
4566105|NCT01323634|7400869|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7
4566106|NCT01323634|7400870|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4
4566107|NCT01323634|7400868|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0
4566108|NCT01323634|7400869|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1
4566109|NCT01323634|7400870|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1
4566110|NCT01323647|7400878|FG000|Overall Study|Migrated/moved from study area|2
4566111|NCT01323647|7400879|FG001|Overall Study|Migrated/moved from study area|0
4566112|NCT01323647|7400878|FG000|Overall Study|Withdrawal by Subject|5
4566113|NCT01323647|7400879|FG001|Overall Study|Withdrawal by Subject|0
4566114|NCT01323647|7400878|FG000|Overall Study|Lost to Follow-up|2
4566115|NCT01323647|7400879|FG001|Overall Study|Lost to Follow-up|0
4566116|NCT01323660|7400885|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6
4566117|NCT01323660|7400886|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1
4566118|NCT01323660|7400887|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1
4566119|NCT01323660|7400888|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3
4566120|NCT01323660|7400889|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3
4566121|NCT01323660|7400890|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4
4566122|NCT01323660|7400885|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
4566123|NCT01323660|7400886|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0
4566124|NCT01323660|7400887|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2
4566125|NCT01323660|7400888|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0
4566126|NCT01323660|7400889|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
4566127|NCT01323660|7400890|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3
4566128|NCT01323660|7400885|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2
4566129|NCT01323660|7400886|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0
4566130|NCT01323660|7400887|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1
4566131|NCT01323660|7400888|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1
4566132|NCT01323660|7400889|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1
4566133|NCT01323660|7400890|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2
4566134|NCT01323660|7400885|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
4566135|NCT01323660|7400886|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
4566136|NCT01323660|7400887|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
4566137|NCT01323660|7400888|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
4566138|NCT01323660|7400889|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1
4566139|NCT01323660|7400890|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
4566140|NCT01323660|7400885|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
4566141|NCT01323660|7400886|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
4566142|NCT01323660|7400887|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
4566143|NCT01323660|7400888|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
4566144|NCT01323660|7400889|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
4566145|NCT01323660|7400890|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
4566146|NCT01323660|7400885|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5
4566147|NCT01323660|7400886|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
4566148|NCT01323660|7400887|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
4566149|NCT01323660|7400888|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
4566150|NCT01323660|7400889|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3
4566151|NCT01323660|7400890|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
4566152|NCT01323660|7400885|FG000|Washout Period (14 Days)|Adverse Event|0
4566153|NCT01323660|7400886|FG001|Washout Period (14 Days)|Adverse Event|0
4566154|NCT01323660|7400887|FG002|Washout Period (14 Days)|Adverse Event|0
4566155|NCT01323660|7400888|FG003|Washout Period (14 Days)|Adverse Event|0
4566156|NCT01323660|7400889|FG004|Washout Period (14 Days)|Adverse Event|1
4566157|NCT01323660|7400890|FG005|Washout Period (14 Days)|Adverse Event|0
4566158|NCT01323660|7400885|FG000|Washout Period (14 Days)|Lack of Efficacy|0
4566159|NCT01323660|7400886|FG001|Washout Period (14 Days)|Lack of Efficacy|0
4566160|NCT01323660|7400887|FG002|Washout Period (14 Days)|Lack of Efficacy|1
4566161|NCT01323660|7400888|FG003|Washout Period (14 Days)|Lack of Efficacy|3
4566162|NCT01323660|7400889|FG004|Washout Period (14 Days)|Lack of Efficacy|2
4566163|NCT01323660|7400890|FG005|Washout Period (14 Days)|Lack of Efficacy|2
4566164|NCT01323660|7400885|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1
4566165|NCT01323660|7400886|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0
4566166|NCT01323660|7400887|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0
4566167|NCT01323660|7400888|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1
4566168|NCT01323660|7400889|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1
4566169|NCT01323660|7400890|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2
4566170|NCT01323660|7400885|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9
4566171|NCT01323660|7400886|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
4566172|NCT01323660|7400887|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
4566173|NCT01323660|7400888|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
4566174|NCT01323660|7400889|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
4566175|NCT01323660|7400890|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3
4566176|NCT01323660|7400885|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
4566177|NCT01323660|7400886|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
4566178|NCT01323660|7400887|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
4566179|NCT01323660|7400888|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
4566180|NCT01323660|7400889|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
4566181|NCT01323660|7400890|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1
4566182|NCT01323660|7400885|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
4566183|NCT01323660|7400886|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
4566184|NCT01323660|7400887|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
4566185|NCT01323660|7400888|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
4566186|NCT01323660|7400889|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
4566187|NCT01323660|7400890|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
4566188|NCT01323660|7400885|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
4566189|NCT01323660|7400886|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
4566190|NCT01323660|7400887|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
4566191|NCT01323660|7400888|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
4566192|NCT01323660|7400889|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2
4566193|NCT01323660|7400890|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
4566194|NCT01323673|7400906|FG000|Overall Study|Adverse Event|0
4566195|NCT01323673|7400907|FG001|Overall Study|Adverse Event|1
4566196|NCT01323673|7400906|FG000|Overall Study|Lost to Follow-up|0
4566197|NCT01323673|7400907|FG001|Overall Study|Lost to Follow-up|1
4566198|NCT01323673|7400906|FG000|Overall Study|Protocol Violation|1
4566199|NCT01323673|7400907|FG001|Overall Study|Protocol Violation|0
4566200|NCT01323673|7400906|FG000|Overall Study|Withdrawal by Subject|2
4566201|NCT01323673|7400907|FG001|Overall Study|Withdrawal by Subject|3
4566202|NCT01323790|7400927|FG000|Overall Study|Other|3
4566203|NCT01323790|7400928|FG001|Overall Study|Other|2
4566204|NCT01323790|7400929|FG002|Overall Study|Other|1
4566205|NCT01323790|7400927|FG000|Overall Study|Lost to Follow-up|11
4624680|NCT01823146|7489070|FG001|Overall Study|Lost to Follow-up|1
4624681|NCT01823224|7489078|FG000|Overall Study|Lost to Follow-up|5
4624682|NCT01823224|7489079|FG001|Overall Study|Lost to Follow-up|6
4624683|NCT01823224|7489078|FG000|Overall Study|didn't qualify|1
4624684|NCT01823224|7489079|FG001|Overall Study|didn't qualify|2
4624685|NCT01823224|7489078|FG000|Overall Study|pharmacy error|0
4566206|NCT01323790|7400928|FG001|Overall Study|Lost to Follow-up|9
4566207|NCT01323790|7400929|FG002|Overall Study|Lost to Follow-up|9
4566208|NCT01323790|7400927|FG000|Overall Study|Study-Specific Withdrawal Criteria|0
4566209|NCT01323790|7400928|FG001|Overall Study|Study-Specific Withdrawal Criteria|3
4566210|NCT01323790|7400929|FG002|Overall Study|Study-Specific Withdrawal Criteria|3
4566211|NCT01323790|7400927|FG000|Overall Study|Lack of Efficacy|3
4566212|NCT01323790|7400928|FG001|Overall Study|Lack of Efficacy|0
4566213|NCT01323790|7400929|FG002|Overall Study|Lack of Efficacy|3
4566214|NCT01323790|7400927|FG000|Overall Study|Adverse Event|11
4566215|NCT01323790|7400928|FG001|Overall Study|Adverse Event|24
4566216|NCT01323790|7400929|FG002|Overall Study|Adverse Event|12
4566217|NCT01323790|7400927|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0
4566218|NCT01323790|7400928|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0
4566219|NCT01323790|7400929|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1
4566220|NCT01323790|7400927|FG000|Overall Study|Withdrawal by Subject|23
4566221|NCT01323790|7400928|FG001|Overall Study|Withdrawal by Subject|20
4566222|NCT01323790|7400929|FG002|Overall Study|Withdrawal by Subject|13
4566223|NCT01323790|7400927|FG000|Overall Study|Did Not Receive Treatment|2
4566224|NCT01323790|7400928|FG001|Overall Study|Did Not Receive Treatment|0
4566225|NCT01323790|7400929|FG002|Overall Study|Did Not Receive Treatment|1
4566226|NCT01323790|7400927|FG000|Overall Study|Severe non-compliance with protocol|2
4566227|NCT01323790|7400928|FG001|Overall Study|Severe non-compliance with protocol|2
4624686|NCT01823224|7489079|FG001|Overall Study|pharmacy error|1
4566228|NCT01323790|7400929|FG002|Overall Study|Severe non-compliance with protocol|2
4566229|NCT01323920|7400958|FG000|Overall Study|Death|5
4566230|NCT01323920|7400958|FG000|Overall Study|Withdrawal by Subject|1
4566231|NCT01323946|7400965|FG000|Overall Study|Lost to Follow-up|0
4566232|NCT01323946|7400966|FG001|Overall Study|Lost to Follow-up|1
4566233|NCT01323946|7400967|FG002|Overall Study|Lost to Follow-up|0
4566234|NCT01323946|7400965|FG000|Overall Study|Parents refused the last blood draw|1
4566235|NCT01323946|7400966|FG001|Overall Study|Parents refused the last blood draw|0
4566236|NCT01323946|7400967|FG002|Overall Study|Parents refused the last blood draw|0
4566237|NCT01323946|7400965|FG000|Overall Study|Withdrawal by Subject|2
4566238|NCT01323946|7400966|FG001|Overall Study|Withdrawal by Subject|2
4566239|NCT01323946|7400967|FG002|Overall Study|Withdrawal by Subject|0
4566240|NCT01323972|7400994|FG000|Overall Study|Withdrawal by Subject|1
4566241|NCT01323972|7400995|FG001|Overall Study|Withdrawal by Subject|0
4566242|NCT01323972|7400996|FG002|Overall Study|Withdrawal by Subject|1
4566243|NCT01323972|7400997|FG003|Overall Study|Withdrawal by Subject|0
4566244|NCT01323972|7400994|FG000|Overall Study|Migrated/moved from study area|1
4566245|NCT01323972|7400995|FG001|Overall Study|Migrated/moved from study area|2
4566246|NCT01323972|7400996|FG002|Overall Study|Migrated/moved from study area|0
4566247|NCT01323972|7400997|FG003|Overall Study|Migrated/moved from study area|0
4566248|NCT01323972|7400994|FG000|Overall Study|Lost to Follow-up|0
4566249|NCT01323972|7400995|FG001|Overall Study|Lost to Follow-up|1
4566250|NCT01323972|7400996|FG002|Overall Study|Lost to Follow-up|1
4566251|NCT01323972|7400997|FG003|Overall Study|Lost to Follow-up|1
4566252|NCT01324024|7401030|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2
4566253|NCT01324024|7401031|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1
4566254|NCT01324102|7401043|FG000|Overall Study|illness|1
4566255|NCT01324102|7401044|FG001|Overall Study|illness|6
4566256|NCT01324141|7401066|FG000|Overall Study|Declined to participate before treatment started|1
4566257|NCT01324141|7401066|FG000|Overall Study|Disease progression on study|1
4566258|NCT01324232|7401084|FG000|Overall Study|Protocol Violation|0
4566259|NCT01324232|7401085|FG001|Overall Study|Protocol Violation|0
4566260|NCT01324232|7401086|FG002|Overall Study|Protocol Violation|0
4566261|NCT01324232|7401087|FG003|Overall Study|Protocol Violation|2
4624687|NCT01823224|7489078|FG000|Overall Study|missed med dose|0
4624688|NCT01823224|7489079|FG001|Overall Study|missed med dose|1
4624689|NCT01823224|7489078|FG000|Overall Study|Withdrawal by Subject|0
4624690|NCT01823224|7489079|FG001|Overall Study|Withdrawal by Subject|1
4624691|NCT01823289|7489087|FG000|Overall Study|Lost to Follow-up|5
4624692|NCT01823289|7489087|FG000|Overall Study|Adverse Event|5
4624693|NCT01823289|7489087|FG000|Overall Study|Lack of Efficacy|1
4624694|NCT01823289|7489087|FG000|Overall Study|Physician Decision|9
4624695|NCT01823289|7489087|FG000|Overall Study|Administered contraindicated medicine|1
4624696|NCT01823289|7489087|FG000|Overall Study|Transaminase increased more than 3 times|1
4624697|NCT01823289|7489087|FG000|Overall Study|Drug affected efficacy and safety|1
4624698|NCT01823289|7489087|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1
4624699|NCT01823328|7489093|FG000|Overall Study|Withdrawal by Subject|8
4624700|NCT01823328|7489094|FG001|Overall Study|Withdrawal by Subject|6
4624701|NCT01823341|7489100|FG000|Overall Study|Failed run-in|7
4624702|NCT01823341|7489100|FG000|Overall Study|Withdrawal by Subject|7
4624703|NCT01823341|7489100|FG000|Overall Study|Adverse Event|1
4633137|NCT01908816|7503119|FG001|Overall Study|Subject's no longer requires study drug|0
4633138|NCT01908816|7503120|FG002|Overall Study|Subject's no longer requires study drug|0
4633139|NCT01908816|7503121|FG003|Overall Study|Subject's no longer requires study drug|1
4633140|NCT01908816|7503118|FG000|Overall Study|Protocol deviation|1
4633141|NCT01908816|7503119|FG001|Overall Study|Protocol deviation|2
4633142|NCT01908816|7503120|FG002|Overall Study|Protocol deviation|1
4633143|NCT01908816|7503121|FG003|Overall Study|Protocol deviation|1
4633144|NCT01908816|7503118|FG000|Overall Study|Withdrawal by Subject|0
4633145|NCT01908816|7503119|FG001|Overall Study|Withdrawal by Subject|4
4633146|NCT01908816|7503120|FG002|Overall Study|Withdrawal by Subject|2
4633147|NCT01908816|7503121|FG003|Overall Study|Withdrawal by Subject|2
4633148|NCT01908816|7503118|FG000|Overall Study|Lost to Follow-up|3
4633149|NCT01908816|7503119|FG001|Overall Study|Lost to Follow-up|5
4633150|NCT01908816|7503120|FG002|Overall Study|Lost to Follow-up|4
4633151|NCT01908816|7503121|FG003|Overall Study|Lost to Follow-up|2
4633152|NCT01908816|7503118|FG000|Overall Study|Death|1
4566262|NCT01324232|7401084|FG000|Overall Study|Missing|0
4566263|NCT01324232|7401085|FG001|Overall Study|Missing|0
4566264|NCT01324232|7401086|FG002|Overall Study|Missing|1
4566265|NCT01324232|7401087|FG003|Overall Study|Missing|0
4566266|NCT01324232|7401084|FG000|Overall Study|Participant's Personal Reason/Decision|0
4566267|NCT01324232|7401085|FG001|Overall Study|Participant's Personal Reason/Decision|1
4566268|NCT01324232|7401086|FG002|Overall Study|Participant's Personal Reason/Decision|0
4566269|NCT01324232|7401087|FG003|Overall Study|Participant's Personal Reason/Decision|0
4566270|NCT01324232|7401084|FG000|Overall Study|Lack of Efficacy|2
4633153|NCT01908816|7503119|FG001|Overall Study|Death|0
4633154|NCT01908816|7503120|FG002|Overall Study|Death|7
4633155|NCT01908816|7503121|FG003|Overall Study|Death|1
4633156|NCT01908816|7503118|FG000|Overall Study|Unsatisfactory therapeutic effect|1
4633157|NCT01908816|7503119|FG001|Overall Study|Unsatisfactory therapeutic effect|13
4633158|NCT01908816|7503120|FG002|Overall Study|Unsatisfactory therapeutic effect|1
4566271|NCT01324232|7401085|FG001|Overall Study|Lack of Efficacy|1
4566272|NCT01324232|7401086|FG002|Overall Study|Lack of Efficacy|2
4566273|NCT01324232|7401087|FG003|Overall Study|Lack of Efficacy|2
4566274|NCT01324232|7401084|FG000|Overall Study|Participant Refused Medication|0
4566275|NCT01324232|7401085|FG001|Overall Study|Participant Refused Medication|1
4566276|NCT01324232|7401086|FG002|Overall Study|Participant Refused Medication|0
4566277|NCT01324232|7401087|FG003|Overall Study|Participant Refused Medication|0
4566278|NCT01324232|7401084|FG000|Overall Study|Intercurrent illness|0
4566279|NCT01324232|7401085|FG001|Overall Study|Intercurrent illness|0
4566280|NCT01324232|7401086|FG002|Overall Study|Intercurrent illness|0
4566281|NCT01324232|7401087|FG003|Overall Study|Intercurrent illness|1
4566282|NCT01324232|7401084|FG000|Overall Study|Adverse Event|2
4566283|NCT01324232|7401085|FG001|Overall Study|Adverse Event|5
4566284|NCT01324232|7401086|FG002|Overall Study|Adverse Event|6
4566285|NCT01324232|7401087|FG003|Overall Study|Adverse Event|6
4566286|NCT01324232|7401084|FG000|Overall Study|Withdrawal by Subject|0
4566287|NCT01324232|7401085|FG001|Overall Study|Withdrawal by Subject|3
4566288|NCT01324232|7401086|FG002|Overall Study|Withdrawal by Subject|4
4566289|NCT01324232|7401087|FG003|Overall Study|Withdrawal by Subject|0
4566290|NCT01324232|7401084|FG000|Overall Study|Lost to Follow-up|1
4566291|NCT01324232|7401085|FG001|Overall Study|Lost to Follow-up|0
4566292|NCT01324232|7401086|FG002|Overall Study|Lost to Follow-up|0
4566293|NCT01324232|7401087|FG003|Overall Study|Lost to Follow-up|0
4566294|NCT01324271|7401102|FG000|Overall Study|Lost to Follow-up|3
4566295|NCT01324271|7401103|FG001|Overall Study|Lost to Follow-up|0
4566296|NCT01324271|7401102|FG000|Overall Study|Physician Decision|1
4566297|NCT01324271|7401103|FG001|Overall Study|Physician Decision|0
4624704|NCT01823536|7489129|FG000|Overall Study|Lost to Follow-up|1
4624705|NCT01823536|7489130|FG001|Overall Study|Lost to Follow-up|0
4624706|NCT01823536|7489131|FG002|Overall Study|Lost to Follow-up|0
4624707|NCT01823536|7489132|FG003|Overall Study|Lost to Follow-up|1
4624708|NCT01823536|7489133|FG004|Overall Study|Lost to Follow-up|1
4624709|NCT01823536|7489134|FG005|Overall Study|Lost to Follow-up|0
4624710|NCT01823536|7489129|FG000|Overall Study|Protocol Violation|0
4624711|NCT01823536|7489130|FG001|Overall Study|Protocol Violation|1
4624712|NCT01823536|7489131|FG002|Overall Study|Protocol Violation|0
4624713|NCT01823536|7489132|FG003|Overall Study|Protocol Violation|0
4624714|NCT01823536|7489133|FG004|Overall Study|Protocol Violation|0
4624715|NCT01823536|7489134|FG005|Overall Study|Protocol Violation|0
4624716|NCT01823536|7489129|FG000|Overall Study|Withdrawal by Subject|1
4624717|NCT01823536|7489130|FG001|Overall Study|Withdrawal by Subject|1
4624718|NCT01823536|7489131|FG002|Overall Study|Withdrawal by Subject|0
4624719|NCT01823536|7489132|FG003|Overall Study|Withdrawal by Subject|0
4624720|NCT01823536|7489133|FG004|Overall Study|Withdrawal by Subject|0
4624721|NCT01823536|7489134|FG005|Overall Study|Withdrawal by Subject|0
4624722|NCT01823536|7489129|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0
4624723|NCT01823536|7489130|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0
4624724|NCT01823536|7489131|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1
4624725|NCT01823536|7489132|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0
4624726|NCT01823536|7489133|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0
4624727|NCT01823536|7489134|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0
4624728|NCT01823536|7489129|FG000|Overall Study|Met exclusion criterion No 6|0
4624729|NCT01823536|7489130|FG001|Overall Study|Met exclusion criterion No 6|0
4624730|NCT01823536|7489131|FG002|Overall Study|Met exclusion criterion No 6|0
4624731|NCT01823536|7489132|FG003|Overall Study|Met exclusion criterion No 6|1
4624732|NCT01823536|7489133|FG004|Overall Study|Met exclusion criterion No 6|0
4624733|NCT01823536|7489134|FG005|Overall Study|Met exclusion criterion No 6|0
4624734|NCT01823536|7489129|FG000|Overall Study|Subject moved out of the state|0
4624735|NCT01823536|7489130|FG001|Overall Study|Subject moved out of the state|0
4624736|NCT01823536|7489131|FG002|Overall Study|Subject moved out of the state|0
4624737|NCT01823536|7489132|FG003|Overall Study|Subject moved out of the state|0
4624738|NCT01823536|7489133|FG004|Overall Study|Subject moved out of the state|1
4624739|NCT01823536|7489134|FG005|Overall Study|Subject moved out of the state|0
4624740|NCT01823679|7489185|FG000|Overall Study|Death|1
4624741|NCT01823835|7489205|FG000|Overall Study|Adverse Event|0
4624742|NCT01823835|7489206|FG001|Overall Study|Adverse Event|0
4624743|NCT01823835|7489207|FG002|Overall Study|Adverse Event|0
4566298|NCT01324310|7401109|FG000|Overall Study|Adverse Event|1
4566299|NCT01324310|7401109|FG000|Overall Study|Disease Progression|1
4566300|NCT01324323|7401115|FG000|Overall Study|Withdrawal by Subject|1
4566301|NCT01324349|7401129|FG000|Overall Study|Death|1
4566302|NCT01324349|7401130|FG001|Overall Study|Death|1
4624744|NCT01823835|7489208|FG003|Overall Study|Adverse Event|0
4624745|NCT01823835|7489209|FG004|Overall Study|Adverse Event|1
4624746|NCT01823835|7489210|FG005|Overall Study|Adverse Event|0
4624747|NCT01823835|7489211|FG006|Overall Study|Adverse Event|1
4624748|NCT01823835|7489212|FG007|Overall Study|Adverse Event|0
4624749|NCT01823835|7489213|FG008|Overall Study|Adverse Event|0
4624750|NCT01823835|7489214|FG009|Overall Study|Adverse Event|0
4624751|NCT01823835|7489215|FG010|Overall Study|Adverse Event|1
4624752|NCT01823835|7489216|FG011|Overall Study|Adverse Event|2
4624753|NCT01823835|7489217|FG012|Overall Study|Adverse Event|0
4624754|NCT01823835|7489218|FG013|Overall Study|Adverse Event|0
4566303|NCT01324349|7401129|FG000|Overall Study|Withdrawal by Subject|0
4566304|NCT01324349|7401130|FG001|Overall Study|Withdrawal by Subject|1
4566305|NCT01324388|7401139|FG000|Part 1 of Study|Adverse Event|2
4566306|NCT01324388|7401140|FG001|Part 1 of Study|Adverse Event|0
4566307|NCT01324388|7401141|FG002|Part 1 of Study|Adverse Event|0
4566308|NCT01324388|7401142|FG003|Part 1 of Study|Adverse Event|0
4566309|NCT01324388|7401139|FG000|Part 1 of Study|Protocol Violation|1
4566310|NCT01324388|7401140|FG001|Part 1 of Study|Protocol Violation|2
4566311|NCT01324388|7401141|FG002|Part 1 of Study|Protocol Violation|0
4566312|NCT01324388|7401142|FG003|Part 1 of Study|Protocol Violation|0
4566313|NCT01324388|7401139|FG000|Part 1 of Study|Physician Decision|1
4566314|NCT01324388|7401140|FG001|Part 1 of Study|Physician Decision|0
4566315|NCT01324388|7401141|FG002|Part 1 of Study|Physician Decision|0
4566316|NCT01324388|7401142|FG003|Part 1 of Study|Physician Decision|0
4566317|NCT01324388|7401139|FG000|Part 2 of Study: First Intervention|Protocol Violation|0
4566318|NCT01324388|7401140|FG001|Part 2 of Study: First Intervention|Protocol Violation|0
4566319|NCT01324388|7401141|FG002|Part 2 of Study: First Intervention|Protocol Violation|0
4566320|NCT01324388|7401142|FG003|Part 2 of Study: First Intervention|Protocol Violation|1
4566321|NCT01324388|7401139|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
4566322|NCT01324388|7401140|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
4566323|NCT01324388|7401141|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1
4566324|NCT01324388|7401142|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
4566325|NCT01324401|7401156|FG000|Overall Study|Withdrawn before any treatment|0
4566326|NCT01324401|7401157|FG001|Overall Study|Withdrawn before any treatment|3
4566327|NCT01324401|7401156|FG000|Overall Study|Adverse Event|1
4566328|NCT01324401|7401157|FG001|Overall Study|Adverse Event|3
4566329|NCT01324440|7401165|FG000|Overall Study|Subject moved|0
4624755|NCT01823835|7489219|FG014|Overall Study|Adverse Event|0
4624756|NCT01823835|7489205|FG000|Overall Study|Physician Decision|0
4624757|NCT01823835|7489206|FG001|Overall Study|Physician Decision|0
4624758|NCT01823835|7489207|FG002|Overall Study|Physician Decision|0
4624759|NCT01823835|7489208|FG003|Overall Study|Physician Decision|0
4624760|NCT01823835|7489209|FG004|Overall Study|Physician Decision|0
4624761|NCT01823835|7489210|FG005|Overall Study|Physician Decision|0
4624762|NCT01823835|7489211|FG006|Overall Study|Physician Decision|0
4624763|NCT01823835|7489212|FG007|Overall Study|Physician Decision|0
4624764|NCT01823835|7489213|FG008|Overall Study|Physician Decision|0
4624765|NCT01823835|7489214|FG009|Overall Study|Physician Decision|0
4624766|NCT01823835|7489215|FG010|Overall Study|Physician Decision|0
4624767|NCT01823835|7489216|FG011|Overall Study|Physician Decision|2
4624768|NCT01823835|7489217|FG012|Overall Study|Physician Decision|0
4624769|NCT01823835|7489218|FG013|Overall Study|Physician Decision|0
4624770|NCT01823835|7489219|FG014|Overall Study|Physician Decision|0
4624771|NCT01823835|7489205|FG000|Overall Study|Progressive Disease|3
4624772|NCT01823835|7489206|FG001|Overall Study|Progressive Disease|4
4624773|NCT01823835|7489207|FG002|Overall Study|Progressive Disease|3
4624774|NCT01823835|7489208|FG003|Overall Study|Progressive Disease|6
4624775|NCT01823835|7489209|FG004|Overall Study|Progressive Disease|4
4624776|NCT01823835|7489210|FG005|Overall Study|Progressive Disease|6
4624777|NCT01823835|7489211|FG006|Overall Study|Progressive Disease|5
4624778|NCT01823835|7489212|FG007|Overall Study|Progressive Disease|3
4624779|NCT01823835|7489213|FG008|Overall Study|Progressive Disease|3
4624780|NCT01823835|7489214|FG009|Overall Study|Progressive Disease|18
4624781|NCT01823835|7489215|FG010|Overall Study|Progressive Disease|8
4624782|NCT01823835|7489216|FG011|Overall Study|Progressive Disease|46
4624783|NCT01823835|7489217|FG012|Overall Study|Progressive Disease|18
4624784|NCT01823835|7489218|FG013|Overall Study|Progressive Disease|4
4624785|NCT01823835|7489219|FG014|Overall Study|Progressive Disease|6
4624786|NCT01823835|7489205|FG000|Overall Study|Study Termination|0
4624787|NCT01823835|7489206|FG001|Overall Study|Study Termination|0
4624788|NCT01823835|7489207|FG002|Overall Study|Study Termination|0
4624789|NCT01823835|7489208|FG003|Overall Study|Study Termination|0
4624790|NCT01823835|7489209|FG004|Overall Study|Study Termination|1
4624791|NCT01823835|7489210|FG005|Overall Study|Study Termination|0
4624792|NCT01823835|7489211|FG006|Overall Study|Study Termination|0
4566330|NCT01324440|7401166|FG001|Overall Study|Subject moved|1
4566331|NCT01324570|7401196|FG000|Overall Study|Adverse Event|4
4566332|NCT01324570|7401197|FG001|Overall Study|Adverse Event|7
4566333|NCT01324570|7401196|FG000|Overall Study|Withdrawal by Subject|0
4566334|NCT01324570|7401197|FG001|Overall Study|Withdrawal by Subject|3
4624793|NCT01823835|7489212|FG007|Overall Study|Study Termination|0
4690842|NCT02564055|7600667|FG004|Overall Study|Physician Decision|0
4624794|NCT01823835|7489213|FG008|Overall Study|Study Termination|0
4624795|NCT01823835|7489214|FG009|Overall Study|Study Termination|0
4624796|NCT01823835|7489215|FG010|Overall Study|Study Termination|0
4624797|NCT01823835|7489216|FG011|Overall Study|Study Termination|1
4624798|NCT01823835|7489217|FG012|Overall Study|Study Termination|0
4624799|NCT01823835|7489218|FG013|Overall Study|Study Termination|0
4624800|NCT01823835|7489219|FG014|Overall Study|Study Termination|0
4624801|NCT01823835|7489205|FG000|Overall Study|Withdrawal by Subject|0
4624802|NCT01823835|7489206|FG001|Overall Study|Withdrawal by Subject|0
4624803|NCT01823835|7489207|FG002|Overall Study|Withdrawal by Subject|1
4624804|NCT01823835|7489208|FG003|Overall Study|Withdrawal by Subject|0
4624805|NCT01823835|7489209|FG004|Overall Study|Withdrawal by Subject|0
4566335|NCT01324570|7401196|FG000|Overall Study|Lack of Efficacy|0
4566336|NCT01324570|7401197|FG001|Overall Study|Lack of Efficacy|1
4566337|NCT01324570|7401196|FG000|Overall Study|Confirmed or suspected diversion|0
4566338|NCT01324570|7401197|FG001|Overall Study|Confirmed or suspected diversion|1
4566339|NCT01324570|7401196|FG000|Overall Study|Administrative|0
4566340|NCT01324570|7401197|FG001|Overall Study|Administrative|2
4566341|NCT01324622|7401207|FG000|Overall Study|Lost to Follow-up|7
4566342|NCT01324622|7401208|FG001|Overall Study|Lost to Follow-up|7
4566343|NCT01324622|7401207|FG000|Overall Study|Death|1
4566344|NCT01324622|7401208|FG001|Overall Study|Death|0
4566345|NCT01324622|7401207|FG000|Overall Study|Lack of Efficacy|1
4566346|NCT01324622|7401208|FG001|Overall Study|Lack of Efficacy|0
4566347|NCT01324830|7401260|FG000|Overall Study|Progressive Disease|3
4566348|NCT01324830|7401261|FG001|Overall Study|Progressive Disease|2
4566349|NCT01324830|7401262|FG002|Overall Study|Progressive Disease|3
4566350|NCT01324830|7401263|FG003|Overall Study|Progressive Disease|3
4566351|NCT01324830|7401264|FG004|Overall Study|Progressive Disease|6
4566352|NCT01324830|7401265|FG005|Overall Study|Progressive Disease|6
4566353|NCT01324830|7401266|FG006|Overall Study|Progressive Disease|3
4566354|NCT01324830|7401267|FG007|Overall Study|Progressive Disease|3
4566355|NCT01324830|7401268|FG008|Overall Study|Progressive Disease|3
4566356|NCT01324830|7401269|FG009|Overall Study|Progressive Disease|6
4566357|NCT01324830|7401270|FG010|Overall Study|Progressive Disease|2
4566358|NCT01324830|7401271|FG011|Overall Study|Progressive Disease|1
4566359|NCT01324830|7401272|FG012|Overall Study|Progressive Disease|1
4566360|NCT01324830|7401273|FG013|Overall Study|Progressive Disease|1
4566361|NCT01324830|7401274|FG014|Overall Study|Progressive Disease|1
4566362|NCT01324830|7401275|FG015|Overall Study|Progressive Disease|3
4566363|NCT01324830|7401276|FG016|Overall Study|Progressive Disease|2
4566364|NCT01324830|7401277|FG017|Overall Study|Progressive Disease|3
4566365|NCT01324830|7401278|FG018|Overall Study|Progressive Disease|4
4566366|NCT01324830|7401260|FG000|Overall Study|Dose limiting toxicity|0
4566367|NCT01324830|7401261|FG001|Overall Study|Dose limiting toxicity|0
4566368|NCT01324830|7401262|FG002|Overall Study|Dose limiting toxicity|0
4566369|NCT01324830|7401263|FG003|Overall Study|Dose limiting toxicity|0
4566370|NCT01324830|7401264|FG004|Overall Study|Dose limiting toxicity|1
4624806|NCT01823835|7489210|FG005|Overall Study|Withdrawal by Subject|0
4624807|NCT01823835|7489211|FG006|Overall Study|Withdrawal by Subject|0
4624808|NCT01823835|7489212|FG007|Overall Study|Withdrawal by Subject|0
4624809|NCT01823835|7489213|FG008|Overall Study|Withdrawal by Subject|0
4624810|NCT01823835|7489214|FG009|Overall Study|Withdrawal by Subject|1
4624811|NCT01823835|7489215|FG010|Overall Study|Withdrawal by Subject|1
4624812|NCT01823835|7489216|FG011|Overall Study|Withdrawal by Subject|2
4624813|NCT01823835|7489217|FG012|Overall Study|Withdrawal by Subject|1
4624814|NCT01823835|7489218|FG013|Overall Study|Withdrawal by Subject|0
4624815|NCT01823835|7489219|FG014|Overall Study|Withdrawal by Subject|0
4624816|NCT01823991|7489270|FG000|Overall Study|Withdrawal by Subject|8
4624817|NCT01823991|7489271|FG001|Overall Study|Withdrawal by Subject|5
4624818|NCT01824290|7489300|FG000|Period 1: Double Blind|Entry Criteria Not Met|1
4624819|NCT01824290|7489301|FG001|Period 1: Double Blind|Entry Criteria Not Met|0
4624820|NCT01824290|7489302|FG002|Period 1: Double Blind|Entry Criteria Not Met|0
4624821|NCT01824290|7489303|FG003|Period 1: Double Blind|Entry Criteria Not Met|0
4624822|NCT01824290|7489300|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1
4624823|NCT01824290|7489301|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1
4624824|NCT01824290|7489302|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0
4624825|NCT01824290|7489303|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0
4624826|NCT01824290|7489300|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1
4624827|NCT01824290|7489301|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1
4624828|NCT01824290|7489302|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0
4624829|NCT01824290|7489303|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0
4624830|NCT01824290|7489300|FG000|Period 2: Open-Label Treatment|Adverse Event|0
4624831|NCT01824290|7489301|FG001|Period 2: Open-Label Treatment|Adverse Event|0
4624832|NCT01824290|7489302|FG002|Period 2: Open-Label Treatment|Adverse Event|0
4624833|NCT01824290|7489303|FG003|Period 2: Open-Label Treatment|Adverse Event|1
4624834|NCT01824290|7489300|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0
4624835|NCT01824290|7489301|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0
4624836|NCT01824290|7489302|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1
4624837|NCT01824290|7489303|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1
4624838|NCT01824290|7489300|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0
4624839|NCT01824290|7489301|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0
4566371|NCT01324830|7401265|FG005|Overall Study|Dose limiting toxicity|0
4566372|NCT01324830|7401266|FG006|Overall Study|Dose limiting toxicity|0
4566373|NCT01324830|7401267|FG007|Overall Study|Dose limiting toxicity|0
4566374|NCT01324830|7401268|FG008|Overall Study|Dose limiting toxicity|0
4566375|NCT01324830|7401269|FG009|Overall Study|Dose limiting toxicity|0
4566376|NCT01324830|7401270|FG010|Overall Study|Dose limiting toxicity|0
4566377|NCT01324830|7401271|FG011|Overall Study|Dose limiting toxicity|0
4566378|NCT01324830|7401272|FG012|Overall Study|Dose limiting toxicity|0
4624840|NCT01824290|7489302|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2
4624841|NCT01824290|7489303|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1
4566379|NCT01324830|7401273|FG013|Overall Study|Dose limiting toxicity|0
4566380|NCT01324830|7401274|FG014|Overall Study|Dose limiting toxicity|0
4566381|NCT01324830|7401275|FG015|Overall Study|Dose limiting toxicity|0
4566382|NCT01324830|7401276|FG016|Overall Study|Dose limiting toxicity|1
4566383|NCT01324830|7401277|FG017|Overall Study|Dose limiting toxicity|1
4566384|NCT01324830|7401278|FG018|Overall Study|Dose limiting toxicity|1
4566385|NCT01324830|7401260|FG000|Overall Study|Reason not mentioned above|0
4566386|NCT01324830|7401261|FG001|Overall Study|Reason not mentioned above|0
4566387|NCT01324830|7401262|FG002|Overall Study|Reason not mentioned above|0
4566388|NCT01324830|7401263|FG003|Overall Study|Reason not mentioned above|0
4566389|NCT01324830|7401264|FG004|Overall Study|Reason not mentioned above|0
4566390|NCT01324830|7401265|FG005|Overall Study|Reason not mentioned above|0
4566391|NCT01324830|7401266|FG006|Overall Study|Reason not mentioned above|0
4566392|NCT01324830|7401267|FG007|Overall Study|Reason not mentioned above|0
4566393|NCT01324830|7401268|FG008|Overall Study|Reason not mentioned above|0
4566394|NCT01324830|7401269|FG009|Overall Study|Reason not mentioned above|0
4566395|NCT01324830|7401270|FG010|Overall Study|Reason not mentioned above|0
4566396|NCT01324830|7401271|FG011|Overall Study|Reason not mentioned above|0
4566397|NCT01324830|7401272|FG012|Overall Study|Reason not mentioned above|0
4566398|NCT01324830|7401273|FG013|Overall Study|Reason not mentioned above|0
4566399|NCT01324830|7401274|FG014|Overall Study|Reason not mentioned above|0
4566400|NCT01324830|7401275|FG015|Overall Study|Reason not mentioned above|0
4566401|NCT01324830|7401276|FG016|Overall Study|Reason not mentioned above|0
4566402|NCT01324830|7401277|FG017|Overall Study|Reason not mentioned above|1
4566403|NCT01324830|7401278|FG018|Overall Study|Reason not mentioned above|0
4566404|NCT01324830|7401260|FG000|Overall Study|Adverse Event, serious fatal|0
4566405|NCT01324830|7401261|FG001|Overall Study|Adverse Event, serious fatal|1
4566406|NCT01324830|7401262|FG002|Overall Study|Adverse Event, serious fatal|0
4566407|NCT01324830|7401263|FG003|Overall Study|Adverse Event, serious fatal|0
4566408|NCT01324830|7401264|FG004|Overall Study|Adverse Event, serious fatal|0
4566409|NCT01324830|7401265|FG005|Overall Study|Adverse Event, serious fatal|0
4566410|NCT01324830|7401266|FG006|Overall Study|Adverse Event, serious fatal|0
4566411|NCT01324830|7401267|FG007|Overall Study|Adverse Event, serious fatal|0
4566412|NCT01324830|7401268|FG008|Overall Study|Adverse Event, serious fatal|0
4566413|NCT01324830|7401269|FG009|Overall Study|Adverse Event, serious fatal|0
4566414|NCT01324830|7401270|FG010|Overall Study|Adverse Event, serious fatal|0
4566415|NCT01324830|7401271|FG011|Overall Study|Adverse Event, serious fatal|0
4566416|NCT01324830|7401272|FG012|Overall Study|Adverse Event, serious fatal|0
4624842|NCT01824303|7489317|FG000|Randomized Study|Withdrawal by Subject|1
4624843|NCT01824303|7489318|FG001|Randomized Study|Withdrawal by Subject|1
4624844|NCT01824303|7489317|FG000|Randomized Study|Other Miscellaneous Reasons|1
4624845|NCT01824303|7489318|FG001|Randomized Study|Other Miscellaneous Reasons|0
4624846|NCT01824342|7489328|FG000|Overall Study|Withdrawal by Subject|0
4624847|NCT01824342|7489329|FG001|Overall Study|Withdrawal by Subject|3
4624848|NCT01824342|7489328|FG000|Overall Study|Adverse Event|1
4624849|NCT01824342|7489329|FG001|Overall Study|Adverse Event|1
4624850|NCT01824342|7489328|FG000|Overall Study|Disease Progression|1
4624851|NCT01824342|7489329|FG001|Overall Study|Disease Progression|1
4624852|NCT01824342|7489328|FG000|Overall Study|Physician Decision|5
4624853|NCT01824342|7489329|FG001|Overall Study|Physician Decision|0
4624854|NCT01824342|7489328|FG000|Overall Study|Death|2
4624855|NCT01824342|7489329|FG001|Overall Study|Death|0
4624856|NCT01824355|7489335|FG000|Overall Study|Adverse Event|2
4624857|NCT01824355|7489335|FG000|Overall Study|unevaluable reference method results per|1
4624858|NCT01824394|7489342|FG000|Overall Study|Early Termination|1
4624859|NCT01824394|7489343|FG001|Overall Study|Early Termination|1
4624860|NCT01824394|7489344|FG002|Overall Study|Early Termination|3
4624861|NCT01824394|7489342|FG000|Overall Study|Withdrawn due to Study Termination|91
4624862|NCT01824394|7489343|FG001|Overall Study|Withdrawn due to Study Termination|83
4624863|NCT01824394|7489344|FG002|Overall Study|Withdrawn due to Study Termination|41
4624864|NCT01824394|7489342|FG000|Overall Study|Lost to Follow-up|0
4624865|NCT01824394|7489343|FG001|Overall Study|Lost to Follow-up|9
4624866|NCT01824394|7489344|FG002|Overall Study|Lost to Follow-up|3
4624867|NCT01824394|7489342|FG000|Overall Study|Death|3
4624868|NCT01824394|7489343|FG001|Overall Study|Death|2
4624869|NCT01824394|7489344|FG002|Overall Study|Death|4
4624870|NCT01824394|7489342|FG000|Overall Study|Discontinued Subjects|1
4624871|NCT01824394|7489343|FG001|Overall Study|Discontinued Subjects|1
4624872|NCT01824394|7489344|FG002|Overall Study|Discontinued Subjects|2
4624873|NCT01824394|7489342|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23
4624874|NCT01824394|7489343|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20
4624875|NCT01824394|7489344|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21
4624876|NCT01824472|7489359|FG000|Overall Study|Lost to Follow-up|0
4624877|NCT01824472|7489360|FG001|Overall Study|Lost to Follow-up|0
4624878|NCT01824472|7489361|FG002|Overall Study|Lost to Follow-up|1
4566417|NCT01324830|7401273|FG013|Overall Study|Adverse Event, serious fatal|0
4566418|NCT01324830|7401274|FG014|Overall Study|Adverse Event, serious fatal|0
4566419|NCT01324830|7401275|FG015|Overall Study|Adverse Event, serious fatal|0
4566420|NCT01324830|7401276|FG016|Overall Study|Adverse Event, serious fatal|0
4566421|NCT01324830|7401277|FG017|Overall Study|Adverse Event, serious fatal|0
4624879|NCT01824472|7489359|FG000|Overall Study|Withdrawal by Subject|1
4566422|NCT01324830|7401278|FG018|Overall Study|Adverse Event, serious fatal|0
4566423|NCT01324830|7401260|FG000|Overall Study|Adverse Event, non-fatal|0
4566424|NCT01324830|7401261|FG001|Overall Study|Adverse Event, non-fatal|0
4566425|NCT01324830|7401262|FG002|Overall Study|Adverse Event, non-fatal|0
4566426|NCT01324830|7401263|FG003|Overall Study|Adverse Event, non-fatal|0
4566427|NCT01324830|7401264|FG004|Overall Study|Adverse Event, non-fatal|0
4566428|NCT01324830|7401265|FG005|Overall Study|Adverse Event, non-fatal|0
4566429|NCT01324830|7401266|FG006|Overall Study|Adverse Event, non-fatal|0
4566430|NCT01324830|7401267|FG007|Overall Study|Adverse Event, non-fatal|0
4566431|NCT01324830|7401268|FG008|Overall Study|Adverse Event, non-fatal|2
4566432|NCT01324830|7401269|FG009|Overall Study|Adverse Event, non-fatal|0
4566433|NCT01324830|7401270|FG010|Overall Study|Adverse Event, non-fatal|1
4566434|NCT01324830|7401271|FG011|Overall Study|Adverse Event, non-fatal|0
4566435|NCT01324830|7401272|FG012|Overall Study|Adverse Event, non-fatal|0
4566436|NCT01324830|7401273|FG013|Overall Study|Adverse Event, non-fatal|0
4566437|NCT01324830|7401274|FG014|Overall Study|Adverse Event, non-fatal|0
4566438|NCT01324830|7401275|FG015|Overall Study|Adverse Event, non-fatal|0
4624880|NCT01824472|7489360|FG001|Overall Study|Withdrawal by Subject|5
4624881|NCT01824472|7489361|FG002|Overall Study|Withdrawal by Subject|3
4624882|NCT01824472|7489359|FG000|Overall Study|Ineligible post randomization&screening|0
4624883|NCT01824472|7489360|FG001|Overall Study|Ineligible post randomization&screening|2
4624884|NCT01824472|7489361|FG002|Overall Study|Ineligible post randomization&screening|0
4624885|NCT01824498|7489375|FG000|Washout (8 Weeks)|Withdrawal by Subject|2
4624886|NCT01824498|7489376|FG001|Washout (8 Weeks)|Withdrawal by Subject|0
4624887|NCT01824498|7489377|FG002|Washout (8 Weeks)|Withdrawal by Subject|2
4624888|NCT01824498|7489378|FG003|Washout (8 Weeks)|Withdrawal by Subject|1
4624889|NCT01824498|7489379|FG004|Washout (8 Weeks)|Withdrawal by Subject|1
4624890|NCT01824498|7489380|FG005|Washout (8 Weeks)|Withdrawal by Subject|0
4624891|NCT01824576|7489388|FG000|Overall Study|Device deficiency|2
4624892|NCT01824602|7489413|FG000|Overall Study|Withdrawal by Subject|0
4624893|NCT01824602|7489414|FG001|Overall Study|Withdrawal by Subject|0
4624894|NCT01824602|7489415|FG002|Overall Study|Withdrawal by Subject|1
4624895|NCT01824602|7489416|FG003|Overall Study|Withdrawal by Subject|2
4624896|NCT01824602|7489413|FG000|Overall Study|Patient non-compliance|0
4624897|NCT01824602|7489414|FG001|Overall Study|Patient non-compliance|0
4624898|NCT01824602|7489415|FG002|Overall Study|Patient non-compliance|1
4624899|NCT01824602|7489416|FG003|Overall Study|Patient non-compliance|0
4624900|NCT01824602|7489413|FG000|Overall Study|Adverse Event|1
4624901|NCT01824602|7489414|FG001|Overall Study|Adverse Event|0
4624902|NCT01824602|7489415|FG002|Overall Study|Adverse Event|2
4624903|NCT01824602|7489416|FG003|Overall Study|Adverse Event|2
4624904|NCT01824602|7489413|FG000|Overall Study|Treatment failure|0
4624905|NCT01824602|7489414|FG001|Overall Study|Treatment failure|0
4624906|NCT01824602|7489415|FG002|Overall Study|Treatment failure|0
4624907|NCT01824602|7489416|FG003|Overall Study|Treatment failure|1
4624908|NCT01824693|7489429|FG000|Overall Study|Death|0
4624909|NCT01824693|7489430|FG001|Overall Study|Death|1
4624910|NCT01824693|7489431|FG002|Overall Study|Death|0
4624911|NCT01824693|7489429|FG000|Overall Study|Physician Decision|1
4624912|NCT01824693|7489430|FG001|Overall Study|Physician Decision|1
4624913|NCT01824693|7489431|FG002|Overall Study|Physician Decision|1
4624914|NCT01824693|7489429|FG000|Overall Study|Withdrawal by Subject|0
4624915|NCT01824693|7489430|FG001|Overall Study|Withdrawal by Subject|0
4624916|NCT01824693|7489431|FG002|Overall Study|Withdrawal by Subject|1
4624917|NCT01824693|7489429|FG000|Overall Study|Progressive Disease|0
4624918|NCT01824693|7489430|FG001|Overall Study|Progressive Disease|5
4624919|NCT01824693|7489431|FG002|Overall Study|Progressive Disease|0
4624920|NCT01824693|7489429|FG000|Overall Study|Ineligible|0
4624921|NCT01824693|7489430|FG001|Overall Study|Ineligible|0
4624922|NCT01824693|7489431|FG002|Overall Study|Ineligible|3
4624923|NCT01824693|7489429|FG000|Overall Study|No Transplant Planned|0
4624924|NCT01824693|7489430|FG001|Overall Study|No Transplant Planned|0
4624925|NCT01824693|7489431|FG002|Overall Study|No Transplant Planned|10
4624926|NCT01824823|7489440|FG000|Overall Study|Lack of Efficacy|1
4624927|NCT01824823|7489441|FG001|Overall Study|Lack of Efficacy|1
4624928|NCT01824823|7489440|FG000|Overall Study|Off-treatment reason not submitted|1
4624929|NCT01824823|7489441|FG001|Overall Study|Off-treatment reason not submitted|0
4624930|NCT01824979|7489456|FG000|Overall Study|Withdrawal by Subject|5
4624931|NCT01824979|7489457|FG001|Overall Study|Withdrawal by Subject|0
4624932|NCT01824979|7489456|FG000|Overall Study|Physician Decision|2
4624933|NCT01824979|7489457|FG001|Overall Study|Physician Decision|0
4624934|NCT01824979|7489456|FG000|Overall Study|Protocol Violation|6
4624935|NCT01824979|7489457|FG001|Overall Study|Protocol Violation|13
4624936|NCT01825200|7489490|FG000|Overall Study|Lost to Follow-up|5
4624937|NCT01825200|7489491|FG001|Overall Study|Lost to Follow-up|6
4624938|NCT01825200|7489490|FG000|Overall Study|Withdrawal by Subject|0
4624939|NCT01825200|7489491|FG001|Overall Study|Withdrawal by Subject|1
4624940|NCT01825577|7489523|FG000|Overall Study|Physician Decision|2
4566439|NCT01324830|7401276|FG016|Overall Study|Adverse Event, non-fatal|0
4566440|NCT01324830|7401277|FG017|Overall Study|Adverse Event, non-fatal|1
4566441|NCT01324830|7401278|FG018|Overall Study|Adverse Event, non-fatal|0
4566442|NCT01324830|7401260|FG000|Overall Study|Withdrawal by Subject|0
4624941|NCT01825577|7489523|FG000|Overall Study|Withdrawal by Subject|1
4566443|NCT01324830|7401261|FG001|Overall Study|Withdrawal by Subject|0
4566444|NCT01324830|7401262|FG002|Overall Study|Withdrawal by Subject|0
4566445|NCT01324830|7401263|FG003|Overall Study|Withdrawal by Subject|0
4566446|NCT01324830|7401264|FG004|Overall Study|Withdrawal by Subject|0
4566447|NCT01324830|7401265|FG005|Overall Study|Withdrawal by Subject|1
4566448|NCT01324830|7401266|FG006|Overall Study|Withdrawal by Subject|0
4566449|NCT01324830|7401267|FG007|Overall Study|Withdrawal by Subject|0
4566450|NCT01324830|7401268|FG008|Overall Study|Withdrawal by Subject|0
4566451|NCT01324830|7401269|FG009|Overall Study|Withdrawal by Subject|0
4566452|NCT01324830|7401270|FG010|Overall Study|Withdrawal by Subject|1
4566453|NCT01324830|7401271|FG011|Overall Study|Withdrawal by Subject|0
4566454|NCT01324830|7401272|FG012|Overall Study|Withdrawal by Subject|0
4566455|NCT01324830|7401273|FG013|Overall Study|Withdrawal by Subject|0
4566456|NCT01324830|7401274|FG014|Overall Study|Withdrawal by Subject|0
4566457|NCT01324830|7401275|FG015|Overall Study|Withdrawal by Subject|0
4566458|NCT01324830|7401276|FG016|Overall Study|Withdrawal by Subject|0
4566459|NCT01324830|7401277|FG017|Overall Study|Withdrawal by Subject|0
4566460|NCT01324830|7401278|FG018|Overall Study|Withdrawal by Subject|1
4592530|NCT01542788|7440364|FG000|Overall Study|Physician Decision|1
4592531|NCT01542788|7440365|FG001|Overall Study|Physician Decision|0
4592532|NCT01542788|7440364|FG000|Overall Study|Withdrawal by Subject|1
4592533|NCT01542788|7440365|FG001|Overall Study|Withdrawal by Subject|0
4592534|NCT01543087|7440407|FG000|Stage 1 (48 Months)|Lost to Follow-up|3
4592535|NCT01543087|7440408|FG001|Stage 1 (48 Months)|Lost to Follow-up|4
4592536|NCT01543087|7440409|FG002|Stage 1 (48 Months)|Lost to Follow-up|12
4592537|NCT01543087|7440410|FG003|Stage 1 (48 Months)|Lost to Follow-up|0
4592538|NCT01543087|7440411|FG004|Stage 1 (48 Months)|Lost to Follow-up|0
4592539|NCT01543087|7440412|FG005|Stage 1 (48 Months)|Lost to Follow-up|0
4592540|NCT01543087|7440407|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1
4592541|NCT01543087|7440408|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0
4592542|NCT01543087|7440409|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1
4592543|NCT01543087|7440410|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2
4592544|NCT01543087|7440411|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0
4624942|NCT01825577|7489523|FG000|Overall Study|Withdrawn by family members|2
4624943|NCT01825577|7489523|FG000|Overall Study|Lack of Efficacy|3
4624944|NCT01825785|7489543|FG000|Overall Study|Adverse Event|0
4624945|NCT01825785|7489544|FG001|Overall Study|Adverse Event|0
4624946|NCT01825785|7489545|FG002|Overall Study|Adverse Event|0
4624947|NCT01825785|7489546|FG003|Overall Study|Adverse Event|0
4624948|NCT01825785|7489547|FG004|Overall Study|Adverse Event|1
4624949|NCT01825785|7489548|FG005|Overall Study|Adverse Event|0
4624950|NCT01825785|7489549|FG006|Overall Study|Adverse Event|0
4624951|NCT01825785|7489543|FG000|Overall Study|Withdrawal by Subject|0
4624952|NCT01825785|7489544|FG001|Overall Study|Withdrawal by Subject|0
4624953|NCT01825785|7489545|FG002|Overall Study|Withdrawal by Subject|0
4624954|NCT01825785|7489546|FG003|Overall Study|Withdrawal by Subject|0
4624955|NCT01825785|7489547|FG004|Overall Study|Withdrawal by Subject|1
4624956|NCT01825785|7489548|FG005|Overall Study|Withdrawal by Subject|1
4624957|NCT01825785|7489549|FG006|Overall Study|Withdrawal by Subject|0
4624958|NCT01825798|7489573|FG000|Overall Study|Adverse Event|1
4624959|NCT01825798|7489574|FG001|Overall Study|Adverse Event|5
4624960|NCT01825798|7489573|FG000|Overall Study|Lost to Follow-up|1
4624961|NCT01825798|7489574|FG001|Overall Study|Lost to Follow-up|0
4624962|NCT01825837|7489584|FG000|PART I|Withdrawal by Subject|0
4624963|NCT01825837|7489585|FG001|PART I|Withdrawal by Subject|0
4624964|NCT01825837|7489586|FG002|PART I|Withdrawal by Subject|0
4624965|NCT01825837|7489587|FG003|PART I|Withdrawal by Subject|6
4624966|NCT01825837|7489584|FG000|PART I|Patient non-compliance|0
4624967|NCT01825837|7489585|FG001|PART I|Patient non-compliance|0
4624968|NCT01825837|7489586|FG002|PART I|Patient non-compliance|0
4624969|NCT01825837|7489587|FG003|PART I|Patient non-compliance|1
4624970|NCT01825837|7489584|FG000|PART I|Treatment failure|0
4624971|NCT01825837|7489585|FG001|PART I|Treatment failure|0
4624972|NCT01825837|7489586|FG002|PART I|Treatment failure|0
4624973|NCT01825837|7489587|FG003|PART I|Treatment failure|7
4624974|NCT01825837|7489584|FG000|PART I|reason unspecified|0
4624975|NCT01825837|7489585|FG001|PART I|reason unspecified|0
4624976|NCT01825837|7489586|FG002|PART I|reason unspecified|0
4624977|NCT01825837|7489587|FG003|PART I|reason unspecified|3
4624978|NCT01825837|7489584|FG000|PART II|Withdrawal by Subject|3
4624979|NCT01825837|7489585|FG001|PART II|Withdrawal by Subject|3
4624980|NCT01825837|7489586|FG002|PART II|Withdrawal by Subject|7
4624981|NCT01825837|7489587|FG003|PART II|Withdrawal by Subject|0
4624982|NCT01825837|7489584|FG000|PART II|Patient non-compliance|5
4624983|NCT01825837|7489585|FG001|PART II|Patient non-compliance|2
4624984|NCT01825837|7489586|FG002|PART II|Patient non-compliance|4
4592545|NCT01543087|7440412|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0
4592546|NCT01543087|7440407|FG000|Stage 1 (48 Months)|No longer willing to participate|5
4592547|NCT01543087|7440408|FG001|Stage 1 (48 Months)|No longer willing to participate|3
4592548|NCT01543087|7440409|FG002|Stage 1 (48 Months)|No longer willing to participate|18
4624985|NCT01825837|7489587|FG003|PART II|Patient non-compliance|0
4624986|NCT01825837|7489584|FG000|PART II|Adverse Event|3
4624987|NCT01825837|7489585|FG001|PART II|Adverse Event|3
4624988|NCT01825837|7489586|FG002|PART II|Adverse Event|1
4566461|NCT01324947|7401335|FG000|Overall Study|Adverse Event|7
4566462|NCT01324947|7401335|FG000|Overall Study|Death|10
4566463|NCT01324947|7401335|FG000|Overall Study|Other|3
4566464|NCT01324947|7401335|FG000|Overall Study|Progressive Disease|50
4566465|NCT01324947|7401335|FG000|Overall Study|Withdrawal by Subject|3
4566466|NCT01324947|7401335|FG000|Overall Study|1 discontinued before starting drug|1
4566467|NCT01324999|7401341|FG000|Overall Study|Adverse Event|3
4566468|NCT01324999|7401341|FG000|Overall Study|Withdrawal by Subject|2
4566469|NCT01325207|7401360|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
4566470|NCT01325207|7401361|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
4566471|NCT01325207|7401362|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
4566472|NCT01325207|7401363|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
4566473|NCT01325207|7401364|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2
4566474|NCT01325207|7401365|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
4566475|NCT01325207|7401360|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1
4566476|NCT01325207|7401361|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1
4566477|NCT01325207|7401362|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0
4566478|NCT01325207|7401363|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0
4566479|NCT01325207|7401364|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2
4566480|NCT01325207|7401365|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5
4566481|NCT01325207|7401360|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
4566482|NCT01325207|7401361|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
4566483|NCT01325207|7401362|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
4566484|NCT01325207|7401363|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
4566485|NCT01325207|7401364|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0
4566486|NCT01325207|7401365|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4
4566487|NCT01325207|7401360|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
4566488|NCT01325207|7401361|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1
4566489|NCT01325207|7401362|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
4566490|NCT01325207|7401363|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
4566491|NCT01325207|7401364|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
4566492|NCT01325207|7401365|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
4566493|NCT01325207|7401360|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
4566494|NCT01325207|7401361|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
4566495|NCT01325207|7401362|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
4566496|NCT01325207|7401363|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
4566497|NCT01325207|7401364|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
4566498|NCT01325207|7401365|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1
4566499|NCT01325207|7401360|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
4566500|NCT01325207|7401361|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
4566501|NCT01325207|7401362|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
4566502|NCT01325207|7401363|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
4566503|NCT01325207|7401364|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
4566504|NCT01325207|7401365|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1
4566505|NCT01325207|7401360|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
4566506|NCT01325207|7401361|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
4566507|NCT01325207|7401362|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
4566508|NCT01325207|7401363|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
4566509|NCT01325207|7401364|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1
4593778|NCT01555125|7442331|FG000|Extension|Lost to Follow-up|2
4624989|NCT01825837|7489587|FG003|PART II|Adverse Event|0
4624990|NCT01825837|7489584|FG000|PART II|Treatment failure|6
4624991|NCT01825837|7489585|FG001|PART II|Treatment failure|4
4624992|NCT01825837|7489586|FG002|PART II|Treatment failure|5
4624993|NCT01825837|7489587|FG003|PART II|Treatment failure|0
4624994|NCT01825837|7489584|FG000|PART II|reason unspecified|2
4624995|NCT01825837|7489585|FG001|PART II|reason unspecified|2
4624996|NCT01825837|7489586|FG002|PART II|reason unspecified|2
4624997|NCT01825837|7489587|FG003|PART II|reason unspecified|0
4624998|NCT01825876|7489595|FG000|Period 2|Withdrawal by Subject|0
4624999|NCT01825876|7489596|FG001|Period 2|Withdrawal by Subject|1
4625000|NCT01825941|7489616|FG000|Overall Study|Lost to Follow-up|4
4625001|NCT01825941|7489617|FG001|Overall Study|Lost to Follow-up|1
4625002|NCT01826201|7489623|FG000|Overall Study|Non compliance with protocol|4
4625003|NCT01826214|7489631|FG000|Overall Study|Adverse Event|7
4625004|NCT01826214|7489632|FG001|Overall Study|Adverse Event|6
4625005|NCT01826214|7489631|FG000|Overall Study|Death|3
4625006|NCT01826214|7489632|FG001|Overall Study|Death|1
4625007|NCT01826214|7489631|FG000|Overall Study|Lost to Follow-up|1
4625008|NCT01826214|7489632|FG001|Overall Study|Lost to Follow-up|0
4625009|NCT01826214|7489631|FG000|Overall Study|Physician Decision|0
4625010|NCT01826214|7489632|FG001|Overall Study|Physician Decision|2
4625011|NCT01826214|7489631|FG000|Overall Study|Progressive disease|22
4625012|NCT01826214|7489632|FG001|Overall Study|Progressive disease|21
4625013|NCT01826214|7489631|FG000|Overall Study|Study terminated by Sponsor|0
4566510|NCT01325207|7401365|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
4566511|NCT01325337|7401394|FG000|Overall Study|Adverse Event|0
4566512|NCT01325337|7401395|FG001|Overall Study|Adverse Event|2
4566513|NCT01325337|7401396|FG002|Overall Study|Adverse Event|2
4566514|NCT01325337|7401397|FG003|Overall Study|Adverse Event|1
4566515|NCT01325337|7401398|FG004|Overall Study|Adverse Event|2
4566516|NCT01325337|7401394|FG000|Overall Study|Lost to Follow-up|2
4566517|NCT01325337|7401395|FG001|Overall Study|Lost to Follow-up|2
4566518|NCT01325337|7401396|FG002|Overall Study|Lost to Follow-up|2
4566519|NCT01325337|7401397|FG003|Overall Study|Lost to Follow-up|1
4566520|NCT01325337|7401398|FG004|Overall Study|Lost to Follow-up|2
4566521|NCT01325337|7401394|FG000|Overall Study|Personal Reasons|2
4566522|NCT01325337|7401395|FG001|Overall Study|Personal Reasons|5
4566523|NCT01325337|7401396|FG002|Overall Study|Personal Reasons|4
4566524|NCT01325337|7401397|FG003|Overall Study|Personal Reasons|8
4566525|NCT01325337|7401398|FG004|Overall Study|Personal Reasons|3
4566526|NCT01325337|7401394|FG000|Overall Study|Withdrawal by Subject|1
4566527|NCT01325337|7401395|FG001|Overall Study|Withdrawal by Subject|0
4566528|NCT01325337|7401396|FG002|Overall Study|Withdrawal by Subject|1
4566529|NCT01325337|7401397|FG003|Overall Study|Withdrawal by Subject|0
4566530|NCT01325337|7401398|FG004|Overall Study|Withdrawal by Subject|1
4566531|NCT01325350|7401415|FG000|Overall Study|Adverse Event|3
4566532|NCT01325350|7401416|FG001|Overall Study|Adverse Event|3
4566533|NCT01325350|7401417|FG002|Overall Study|Adverse Event|3
4566534|NCT01325350|7401418|FG003|Overall Study|Adverse Event|1
4566535|NCT01325350|7401419|FG004|Overall Study|Adverse Event|2
4566536|NCT01325350|7401415|FG000|Overall Study|Pregnancy|0
4566537|NCT01325350|7401416|FG001|Overall Study|Pregnancy|0
4566538|NCT01325350|7401417|FG002|Overall Study|Pregnancy|1
4566539|NCT01325350|7401418|FG003|Overall Study|Pregnancy|0
4566540|NCT01325350|7401419|FG004|Overall Study|Pregnancy|1
4566541|NCT01325350|7401415|FG000|Overall Study|Lost to Follow-up|1
4566542|NCT01325350|7401416|FG001|Overall Study|Lost to Follow-up|0
4566543|NCT01325350|7401417|FG002|Overall Study|Lost to Follow-up|5
4566544|NCT01325350|7401418|FG003|Overall Study|Lost to Follow-up|1
4566545|NCT01325350|7401419|FG004|Overall Study|Lost to Follow-up|5
4566546|NCT01325350|7401415|FG000|Overall Study|Personal Reasons|2
4566547|NCT01325350|7401416|FG001|Overall Study|Personal Reasons|1
4566548|NCT01325350|7401417|FG002|Overall Study|Personal Reasons|6
4566549|NCT01325350|7401418|FG003|Overall Study|Personal Reasons|5
4566550|NCT01325350|7401419|FG004|Overall Study|Personal Reasons|3
4566551|NCT01325350|7401415|FG000|Overall Study|Protocol Violation|0
4566552|NCT01325350|7401416|FG001|Overall Study|Protocol Violation|0
4566553|NCT01325350|7401417|FG002|Overall Study|Protocol Violation|0
4566554|NCT01325350|7401418|FG003|Overall Study|Protocol Violation|1
4566555|NCT01325350|7401419|FG004|Overall Study|Protocol Violation|0
4566556|NCT01325350|7401415|FG000|Overall Study|Withdrawal by Subject|0
4566557|NCT01325350|7401416|FG001|Overall Study|Withdrawal by Subject|0
4566558|NCT01325350|7401417|FG002|Overall Study|Withdrawal by Subject|1
4566559|NCT01325350|7401418|FG003|Overall Study|Withdrawal by Subject|1
4566560|NCT01325350|7401419|FG004|Overall Study|Withdrawal by Subject|0
4566561|NCT01325350|7401415|FG000|Overall Study|Did Not Receive Treatment|0
4566562|NCT01325350|7401416|FG001|Overall Study|Did Not Receive Treatment|1
4625014|NCT01826214|7489632|FG001|Overall Study|Study terminated by Sponsor|1
4625015|NCT01826214|7489631|FG000|Overall Study|Subject/guardian decision|2
4625016|NCT01826214|7489632|FG001|Overall Study|Subject/guardian decision|3
4625017|NCT01826370|7489642|FG000|Overall Study|Protocol Violation|6
4625018|NCT01826370|7489642|FG000|Overall Study|Lost to Follow-up|12
4625019|NCT01826370|7489642|FG000|Overall Study|Other reason not defined above|2
4625020|NCT01826422|7489648|FG000|Overall Study|Withdrawal by Subject|1
4625021|NCT01826422|7489649|FG001|Overall Study|Withdrawal by Subject|3
4625022|NCT01826448|7489657|FG000|Overall Study|Adverse Event|1
4625023|NCT01826448|7489658|FG001|Overall Study|Adverse Event|3
4625024|NCT01826448|7489657|FG000|Overall Study|Disease progression|2
4625025|NCT01826448|7489658|FG001|Overall Study|Disease progression|4
4625026|NCT01826448|7489657|FG000|Overall Study|Withdrawal by Subject|1
4625027|NCT01826448|7489658|FG001|Overall Study|Withdrawal by Subject|0
4625028|NCT01826448|7489657|FG000|Overall Study|Physician Decision|0
4625029|NCT01826448|7489658|FG001|Overall Study|Physician Decision|1
4625030|NCT01826448|7489657|FG000|Overall Study|2 active cancers|0
4625031|NCT01826448|7489658|FG001|Overall Study|2 active cancers|1
4625032|NCT01826487|7489666|FG000|Overall Study|Adverse Event|1
4625033|NCT01826487|7489667|FG001|Overall Study|Adverse Event|1
4625034|NCT01826487|7489666|FG000|Overall Study|Lost to Follow-up|1
4566563|NCT01325350|7401417|FG002|Overall Study|Did Not Receive Treatment|1
4566564|NCT01325350|7401418|FG003|Overall Study|Did Not Receive Treatment|0
4566565|NCT01325350|7401419|FG004|Overall Study|Did Not Receive Treatment|1
4566566|NCT01325428|7401431|FG000|Part A|Progressive disease according to RECIST|9
4566567|NCT01325428|7401431|FG000|Part A|Clinical signs, symptoms of progression|2
4566568|NCT01325428|7401431|FG000|Part A|Other adverse event|1
4566569|NCT01325428|7401431|FG000|Part A|Refused continue taking trial medication|2
4566570|NCT01325428|7401431|FG000|Part A|Other reason not defined above|2
4625035|NCT01826487|7489667|FG001|Overall Study|Lost to Follow-up|0
4625036|NCT01826487|7489666|FG000|Overall Study|Withdrawal by Subject|1
4625037|NCT01826487|7489667|FG001|Overall Study|Withdrawal by Subject|3
4566571|NCT01325428|7401431|FG000|Part B|Refused continue taking trial medication|2
4566572|NCT01325428|7401431|FG000|Part B|Other reason not defined above|1
4566573|NCT01325493|7401442|FG000|Overall Study|Protocol Violation|0
4566574|NCT01325493|7401443|FG001|Overall Study|Protocol Violation|1
4566575|NCT01325493|7401442|FG000|Overall Study|loss of neuromonitoring signals|0
4566576|NCT01325493|7401443|FG001|Overall Study|loss of neuromonitoring signals|2
4566577|NCT01325493|7401442|FG000|Overall Study|Allergy|1
4566578|NCT01325493|7401443|FG001|Overall Study|Allergy|0
4566579|NCT01325532|7401451|FG000|Overall Study|Withdrawal by Subject|2
4566580|NCT01325532|7401452|FG001|Overall Study|Withdrawal by Subject|0
4566581|NCT01325584|7401458|FG000|Overall Study|Death|1
4566582|NCT01325623|7401462|FG000|Overall Study|Withdrawal by Subject|3
4566583|NCT01325701|7401501|FG000|Overall Study|Adverse Event|12
4566584|NCT01325701|7401502|FG001|Overall Study|Adverse Event|0
4566585|NCT01325701|7401501|FG000|Overall Study|Protocol Violation|1
4566586|NCT01325701|7401502|FG001|Overall Study|Protocol Violation|0
4566587|NCT01325701|7401501|FG000|Overall Study|Physician Decision|2
4566588|NCT01325701|7401502|FG001|Overall Study|Physician Decision|2
4566589|NCT01325701|7401501|FG000|Overall Study|Withdrawal by Subject|2
4566590|NCT01325701|7401502|FG001|Overall Study|Withdrawal by Subject|1
4566591|NCT01325701|7401501|FG000|Overall Study|Rollerover Extension Study|4
4566592|NCT01325701|7401502|FG001|Overall Study|Rollerover Extension Study|0
4566593|NCT01326026|7401539|FG000|Overall Study|Adverse Event|4
4566594|NCT01326026|7401540|FG001|Overall Study|Adverse Event|3
4566595|NCT01326026|7401539|FG000|Overall Study|Withdrawal Criteria|5
4566596|NCT01326026|7401540|FG001|Overall Study|Withdrawal Criteria|7
4566597|NCT01326026|7401539|FG000|Overall Study|Other|3
4566598|NCT01326026|7401540|FG001|Overall Study|Other|3
4566599|NCT01326481|7401546|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1
4566600|NCT01326533|7401554|FG000|Overall Study|Lost to Follow-up|2
4566601|NCT01326533|7401555|FG001|Overall Study|Lost to Follow-up|0
4566602|NCT01326533|7401554|FG000|Overall Study|Withdrawal by Subject|1
4566603|NCT01326533|7401555|FG001|Overall Study|Withdrawal by Subject|0
4566604|NCT01326533|7401554|FG000|Overall Study|Adverse Event|1
4566605|NCT01326533|7401555|FG001|Overall Study|Adverse Event|0
4566606|NCT01326546|7401563|FG000|Overall Study|Lost to Follow-up|8
4566607|NCT01326546|7401564|FG001|Overall Study|Lost to Follow-up|7
4566608|NCT01326546|7401563|FG000|Overall Study|Protocol Violation|3
4566609|NCT01326546|7401564|FG001|Overall Study|Protocol Violation|4
4566610|NCT01326546|7401563|FG000|Overall Study|Pregnancy|0
4566611|NCT01326546|7401564|FG001|Overall Study|Pregnancy|1
4625038|NCT01826487|7489666|FG000|Overall Study|Protocol Violation|1
4625039|NCT01826487|7489667|FG001|Overall Study|Protocol Violation|1
4625040|NCT01826604|7489688|FG000|Overall Study|Lost to Follow-up|8
4625041|NCT01826604|7489689|FG001|Overall Study|Lost to Follow-up|9
4625042|NCT01826825|7489708|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0
4625043|NCT01826825|7489709|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2
4625044|NCT01826981|7489741|FG000|Overall Study|Lack of Efficacy|0
4625045|NCT01826981|7489742|FG001|Overall Study|Lack of Efficacy|1
4625046|NCT01826981|7489743|FG002|Overall Study|Lack of Efficacy|0
4625047|NCT01826981|7489744|FG003|Overall Study|Lack of Efficacy|0
4625048|NCT01826981|7489745|FG004|Overall Study|Lack of Efficacy|5
4625049|NCT01826981|7489746|FG005|Overall Study|Lack of Efficacy|0
4625050|NCT01826981|7489747|FG006|Overall Study|Lack of Efficacy|0
4625051|NCT01826981|7489748|FG007|Overall Study|Lack of Efficacy|8
4625052|NCT01826981|7489749|FG008|Overall Study|Lack of Efficacy|7
4625053|NCT01826981|7489750|FG009|Overall Study|Lack of Efficacy|0
4625054|NCT01826981|7489751|FG010|Overall Study|Lack of Efficacy|1
4625055|NCT01826981|7489752|FG011|Overall Study|Lack of Efficacy|0
4625056|NCT01826981|7489753|FG012|Overall Study|Lack of Efficacy|0
4625057|NCT01826981|7489754|FG013|Overall Study|Lack of Efficacy|3
4625058|NCT01826981|7489755|FG014|Overall Study|Lack of Efficacy|0
4625059|NCT01826981|7489741|FG000|Overall Study|Lost to Follow-up|0
4625060|NCT01826981|7489742|FG001|Overall Study|Lost to Follow-up|0
4625061|NCT01826981|7489743|FG002|Overall Study|Lost to Follow-up|0
4625062|NCT01826981|7489744|FG003|Overall Study|Lost to Follow-up|0
4625063|NCT01826981|7489745|FG004|Overall Study|Lost to Follow-up|1
4625064|NCT01826981|7489746|FG005|Overall Study|Lost to Follow-up|1
4625065|NCT01826981|7489747|FG006|Overall Study|Lost to Follow-up|0
4625066|NCT01826981|7489748|FG007|Overall Study|Lost to Follow-up|1
4625067|NCT01826981|7489749|FG008|Overall Study|Lost to Follow-up|0
4625068|NCT01826981|7489750|FG009|Overall Study|Lost to Follow-up|1
4566612|NCT01326546|7401563|FG000|Overall Study|Adverse Event|1
4566613|NCT01326546|7401564|FG001|Overall Study|Adverse Event|0
4566614|NCT01326546|7401563|FG000|Overall Study|Withdrawal by Subject|5
4566615|NCT01326546|7401564|FG001|Overall Study|Withdrawal by Subject|1
4566616|NCT01326702|7401577|FG000|Overall Study|Other|1
4566617|NCT01326702|7401578|FG001|Overall Study|Other|0
4566618|NCT01326702|7401579|FG002|Overall Study|Other|0
4566619|NCT01326702|7401580|FG003|Overall Study|Other|0
4625069|NCT01826981|7489751|FG010|Overall Study|Lost to Follow-up|1
4625070|NCT01826981|7489752|FG011|Overall Study|Lost to Follow-up|1
4625071|NCT01826981|7489753|FG012|Overall Study|Lost to Follow-up|1
4625072|NCT01826981|7489754|FG013|Overall Study|Lost to Follow-up|0
4625073|NCT01826981|7489755|FG014|Overall Study|Lost to Follow-up|0
4625074|NCT01826981|7489741|FG000|Overall Study|Withdrew Consent|0
4566620|NCT01326702|7401581|FG004|Overall Study|Other|0
4566621|NCT01326702|7401582|FG005|Overall Study|Other|1
4566622|NCT01326702|7401583|FG006|Overall Study|Other|0
4566623|NCT01326702|7401577|FG000|Overall Study|progressive disease|1
4566624|NCT01326702|7401578|FG001|Overall Study|progressive disease|1
4566625|NCT01326702|7401579|FG002|Overall Study|progressive disease|3
4566626|NCT01326702|7401580|FG003|Overall Study|progressive disease|1
4566627|NCT01326702|7401581|FG004|Overall Study|progressive disease|3
4566628|NCT01326702|7401582|FG005|Overall Study|progressive disease|2
4566629|NCT01326702|7401583|FG006|Overall Study|progressive disease|3
4566630|NCT01326702|7401577|FG000|Overall Study|Death|0
4566631|NCT01326702|7401578|FG001|Overall Study|Death|1
4566632|NCT01326702|7401579|FG002|Overall Study|Death|0
4566633|NCT01326702|7401580|FG003|Overall Study|Death|0
4566634|NCT01326702|7401581|FG004|Overall Study|Death|0
4566635|NCT01326702|7401582|FG005|Overall Study|Death|0
4566636|NCT01326702|7401583|FG006|Overall Study|Death|0
4566637|NCT01326702|7401577|FG000|Overall Study|Adverse Event|0
4566638|NCT01326702|7401578|FG001|Overall Study|Adverse Event|0
4566639|NCT01326702|7401579|FG002|Overall Study|Adverse Event|1
4566640|NCT01326702|7401580|FG003|Overall Study|Adverse Event|1
4566641|NCT01326702|7401581|FG004|Overall Study|Adverse Event|0
4566642|NCT01326702|7401582|FG005|Overall Study|Adverse Event|3
4566643|NCT01326702|7401583|FG006|Overall Study|Adverse Event|1
4566644|NCT01326702|7401577|FG000|Overall Study|Withdrawal by Subject|0
4566645|NCT01326702|7401578|FG001|Overall Study|Withdrawal by Subject|0
4566646|NCT01326702|7401579|FG002|Overall Study|Withdrawal by Subject|1
4566647|NCT01326702|7401580|FG003|Overall Study|Withdrawal by Subject|0
4566648|NCT01326702|7401581|FG004|Overall Study|Withdrawal by Subject|1
4566649|NCT01326702|7401582|FG005|Overall Study|Withdrawal by Subject|1
4566650|NCT01326702|7401583|FG006|Overall Study|Withdrawal by Subject|3
4566651|NCT01326702|7401577|FG000|Overall Study|Not Treated|0
4566652|NCT01326702|7401578|FG001|Overall Study|Not Treated|0
4625075|NCT01826981|7489742|FG001|Overall Study|Withdrew Consent|0
4625076|NCT01826981|7489743|FG002|Overall Study|Withdrew Consent|0
4625077|NCT01826981|7489744|FG003|Overall Study|Withdrew Consent|0
4625078|NCT01826981|7489745|FG004|Overall Study|Withdrew Consent|0
4625079|NCT01826981|7489746|FG005|Overall Study|Withdrew Consent|0
4625080|NCT01826981|7489747|FG006|Overall Study|Withdrew Consent|1
4625081|NCT01826981|7489748|FG007|Overall Study|Withdrew Consent|1
4625082|NCT01826981|7489749|FG008|Overall Study|Withdrew Consent|0
4625083|NCT01826981|7489750|FG009|Overall Study|Withdrew Consent|0
4625084|NCT01826981|7489751|FG010|Overall Study|Withdrew Consent|0
4625085|NCT01826981|7489752|FG011|Overall Study|Withdrew Consent|1
4625086|NCT01826981|7489753|FG012|Overall Study|Withdrew Consent|0
4625087|NCT01826981|7489754|FG013|Overall Study|Withdrew Consent|1
4625088|NCT01826981|7489755|FG014|Overall Study|Withdrew Consent|0
4625089|NCT01826981|7489741|FG000|Overall Study|Adverse Event|0
4625090|NCT01826981|7489742|FG001|Overall Study|Adverse Event|0
4625091|NCT01826981|7489743|FG002|Overall Study|Adverse Event|0
4625092|NCT01826981|7489744|FG003|Overall Study|Adverse Event|0
4625093|NCT01826981|7489745|FG004|Overall Study|Adverse Event|1
4625094|NCT01826981|7489746|FG005|Overall Study|Adverse Event|0
4625095|NCT01826981|7489747|FG006|Overall Study|Adverse Event|0
4625096|NCT01826981|7489748|FG007|Overall Study|Adverse Event|0
4625097|NCT01826981|7489749|FG008|Overall Study|Adverse Event|0
4625098|NCT01826981|7489750|FG009|Overall Study|Adverse Event|0
4625099|NCT01826981|7489751|FG010|Overall Study|Adverse Event|0
4625100|NCT01826981|7489752|FG011|Overall Study|Adverse Event|0
4625101|NCT01826981|7489753|FG012|Overall Study|Adverse Event|0
4625102|NCT01826981|7489754|FG013|Overall Study|Adverse Event|0
4625103|NCT01826981|7489755|FG014|Overall Study|Adverse Event|0
4625104|NCT01826981|7489741|FG000|Overall Study|Upper G-I Haemorrhage|0
4625105|NCT01826981|7489742|FG001|Overall Study|Upper G-I Haemorrhage|0
4625106|NCT01826981|7489743|FG002|Overall Study|Upper G-I Haemorrhage|0
4625107|NCT01826981|7489744|FG003|Overall Study|Upper G-I Haemorrhage|0
4625108|NCT01826981|7489745|FG004|Overall Study|Upper G-I Haemorrhage|0
4625109|NCT01826981|7489746|FG005|Overall Study|Upper G-I Haemorrhage|0
4625110|NCT01826981|7489747|FG006|Overall Study|Upper G-I Haemorrhage|0
4625111|NCT01826981|7489748|FG007|Overall Study|Upper G-I Haemorrhage|0
4625112|NCT01826981|7489749|FG008|Overall Study|Upper G-I Haemorrhage|0
4566653|NCT01326702|7401579|FG002|Overall Study|Not Treated|0
4566654|NCT01326702|7401580|FG003|Overall Study|Not Treated|1
4566655|NCT01326702|7401581|FG004|Overall Study|Not Treated|0
4566656|NCT01326702|7401582|FG005|Overall Study|Not Treated|1
4566657|NCT01326702|7401583|FG006|Overall Study|Not Treated|0
4566658|NCT01326728|7401604|FG000|Overall Study|Death|13
4566659|NCT01326728|7401605|FG001|Overall Study|Death|0
4566660|NCT01326728|7401604|FG000|Overall Study|Early closure of study|34
4566661|NCT01326728|7401605|FG001|Overall Study|Early closure of study|9
4566662|NCT01326910|7401629|FG000|Overall Study|Withdrawal by Subject|3
4625113|NCT01826981|7489750|FG009|Overall Study|Upper G-I Haemorrhage|0
4625114|NCT01826981|7489751|FG010|Overall Study|Upper G-I Haemorrhage|0
4625115|NCT01826981|7489752|FG011|Overall Study|Upper G-I Haemorrhage|0
4625116|NCT01826981|7489753|FG012|Overall Study|Upper G-I Haemorrhage|0
4625117|NCT01826981|7489754|FG013|Overall Study|Upper G-I Haemorrhage|1
4625118|NCT01826981|7489755|FG014|Overall Study|Upper G-I Haemorrhage|0
4633400|NCT01911819|7503580|FG000|Overall Study|Adverse Event|0
4566663|NCT01326910|7401630|FG001|Overall Study|Withdrawal by Subject|2
4566664|NCT01326910|7401629|FG000|Overall Study|Protocol Violation|1
4566665|NCT01326910|7401630|FG001|Overall Study|Protocol Violation|1
4566666|NCT01326962|7401636|FG000|Overall Study|Adverse Event|1
4566667|NCT01326962|7401636|FG000|Overall Study|Withdrawal by Subject|1
4566668|NCT01326962|7401636|FG000|Overall Study|Lost to Follow-up|3
4566669|NCT01326962|7401636|FG000|Overall Study|Other|2
4566670|NCT01327053|7401642|FG000|Overall Study|Adverse Event|23
4566671|NCT01327053|7401643|FG001|Overall Study|Adverse Event|57
4566672|NCT01327053|7401642|FG000|Overall Study|Patient/guardian decision|11
4566673|NCT01327053|7401643|FG001|Overall Study|Patient/guardian decision|35
4566674|NCT01327053|7401642|FG000|Overall Study|Physician Decision|10
4566675|NCT01327053|7401643|FG001|Overall Study|Physician Decision|14
4566676|NCT01327053|7401642|FG000|Overall Study|Death|1
4566677|NCT01327053|7401643|FG001|Overall Study|Death|5
4566678|NCT01327053|7401642|FG000|Overall Study|Lost to Follow-up|2
4566679|NCT01327053|7401643|FG001|Overall Study|Lost to Follow-up|4
4566680|NCT01327053|7401642|FG000|Overall Study|Non-compliance with study treatment|0
4566681|NCT01327053|7401643|FG001|Overall Study|Non-compliance with study treatment|5
4566682|NCT01327053|7401642|FG000|Overall Study|Study terminated by Sponsor|1
4566683|NCT01327053|7401643|FG001|Overall Study|Study terminated by Sponsor|3
4566684|NCT01327053|7401642|FG000|Overall Study|Progressive disease|31
4566685|NCT01327053|7401643|FG001|Overall Study|Progressive disease|26
4566686|NCT01327053|7401642|FG000|Overall Study|Protocol Violation|0
4566687|NCT01327053|7401643|FG001|Overall Study|Protocol Violation|1
4566688|NCT01327053|7401642|FG000|Overall Study|Untreated|0
4566689|NCT01327053|7401643|FG001|Overall Study|Untreated|1
4566690|NCT01327300|7401672|FG000|Washout (3 Weeks)|Withdrawal by Subject|1
4566691|NCT01327300|7401673|FG001|Washout (3 Weeks)|Withdrawal by Subject|0
4566692|NCT01327339|7401706|FG000|Overall Study|Protocol Violation|8
4566693|NCT01327482|7401710|FG000|Overall Study|Adverse Event|1
4566694|NCT01327495|7401720|FG000|Overall Study|Adverse Event|2
4566695|NCT01327495|7401721|FG001|Overall Study|Adverse Event|1
4566696|NCT01327495|7401722|FG002|Overall Study|Adverse Event|1
4566697|NCT01327495|7401723|FG003|Overall Study|Adverse Event|0
4566698|NCT01327495|7401724|FG004|Overall Study|Adverse Event|0
4566699|NCT01327495|7401725|FG005|Overall Study|Adverse Event|2
4566700|NCT01327495|7401720|FG000|Overall Study|Withdrawal by Subject|0
4566701|NCT01327495|7401721|FG001|Overall Study|Withdrawal by Subject|1
4566702|NCT01327495|7401722|FG002|Overall Study|Withdrawal by Subject|1
4566703|NCT01327495|7401723|FG003|Overall Study|Withdrawal by Subject|0
4566704|NCT01327495|7401724|FG004|Overall Study|Withdrawal by Subject|1
4566705|NCT01327495|7401725|FG005|Overall Study|Withdrawal by Subject|0
4566706|NCT01327495|7401720|FG000|Overall Study|Physician Decision|0
4566707|NCT01327495|7401721|FG001|Overall Study|Physician Decision|0
4566708|NCT01327495|7401722|FG002|Overall Study|Physician Decision|0
4566709|NCT01327495|7401723|FG003|Overall Study|Physician Decision|0
4566710|NCT01327495|7401724|FG004|Overall Study|Physician Decision|2
4566711|NCT01327495|7401725|FG005|Overall Study|Physician Decision|0
4566712|NCT01327547|7401756|FG000|Overall Study|Adverse Event|4
4625119|NCT01826981|7489741|FG000|Overall Study|Enrolled/Randomized but Not Treated|0
4625120|NCT01826981|7489742|FG001|Overall Study|Enrolled/Randomized but Not Treated|0
4625121|NCT01826981|7489743|FG002|Overall Study|Enrolled/Randomized but Not Treated|0
4625122|NCT01826981|7489744|FG003|Overall Study|Enrolled/Randomized but Not Treated|0
4625123|NCT01826981|7489745|FG004|Overall Study|Enrolled/Randomized but Not Treated|0
4625124|NCT01826981|7489746|FG005|Overall Study|Enrolled/Randomized but Not Treated|0
4566713|NCT01327547|7401757|FG001|Overall Study|Adverse Event|1
4566714|NCT01327547|7401756|FG000|Overall Study|Death|1
4566715|NCT01327547|7401757|FG001|Overall Study|Death|2
4566716|NCT01327547|7401756|FG000|Overall Study|Lost to Follow-up|6
4566717|NCT01327547|7401757|FG001|Overall Study|Lost to Follow-up|6
4566718|NCT01327547|7401756|FG000|Overall Study|Non-Compliance With Study Treatment|0
4566719|NCT01327547|7401757|FG001|Overall Study|Non-Compliance With Study Treatment|2
4566720|NCT01327547|7401756|FG000|Overall Study|Withdrawal by Subject|3
4566721|NCT01327547|7401757|FG001|Overall Study|Withdrawal by Subject|7
4566722|NCT01327547|7401756|FG000|Overall Study|Does Not Meet Entrance Criteria|2
4566723|NCT01327547|7401757|FG001|Overall Study|Does Not Meet Entrance Criteria|2
4566724|NCT01327547|7401756|FG000|Overall Study|Protocol Violation|1
4625125|NCT01826981|7489747|FG006|Overall Study|Enrolled/Randomized but Not Treated|0
4625126|NCT01826981|7489748|FG007|Overall Study|Enrolled/Randomized but Not Treated|1
4625127|NCT01826981|7489749|FG008|Overall Study|Enrolled/Randomized but Not Treated|0
4625128|NCT01826981|7489750|FG009|Overall Study|Enrolled/Randomized but Not Treated|0
4625129|NCT01826981|7489751|FG010|Overall Study|Enrolled/Randomized but Not Treated|0
4625130|NCT01826981|7489752|FG011|Overall Study|Enrolled/Randomized but Not Treated|0
4625131|NCT01826981|7489753|FG012|Overall Study|Enrolled/Randomized but Not Treated|0
4566725|NCT01327547|7401757|FG001|Overall Study|Protocol Violation|0
4566726|NCT01327547|7401756|FG000|Overall Study|Non-compliance due to alcohol intake|0
4566727|NCT01327547|7401757|FG001|Overall Study|Non-compliance due to alcohol intake|1
4566728|NCT01327547|7401756|FG000|Overall Study|Required prohibited medication|2
4566729|NCT01327547|7401757|FG001|Overall Study|Required prohibited medication|0
4566730|NCT01327547|7401756|FG000|Overall Study|Non-compliance with study procedures|1
4566731|NCT01327547|7401757|FG001|Overall Study|Non-compliance with study procedures|0
4593779|NCT01555125|7442332|FG001|Extension|Lost to Follow-up|1
4566732|NCT01327547|7401756|FG000|Overall Study|By investigator in subject's interest|0
4566733|NCT01327547|7401757|FG001|Overall Study|By investigator in subject's interest|1
4566734|NCT01327573|7401774|FG000|Overall Study|Physician Decision|3
4566735|NCT01327573|7401775|FG001|Overall Study|Physician Decision|1
4566736|NCT01327599|7401782|FG000|Overall Study|Adverse Event|1
4566737|NCT01327599|7401782|FG000|Overall Study|Could Not Attend Visit|1
4566738|NCT01327599|7401782|FG000|Overall Study|Withdrawal of Consent|1
4566739|NCT01327612|7401793|FG000|Overall Study|Withdrawal by Subject|0
4566740|NCT01327612|7401794|FG001|Overall Study|Withdrawal by Subject|0
4566741|NCT01327612|7401795|FG002|Overall Study|Withdrawal by Subject|0
4566742|NCT01327612|7401796|FG003|Overall Study|Withdrawal by Subject|0
4566743|NCT01327612|7401797|FG004|Overall Study|Withdrawal by Subject|0
4566744|NCT01327612|7401798|FG005|Overall Study|Withdrawal by Subject|1
4566745|NCT01327612|7401799|FG006|Overall Study|Withdrawal by Subject|0
4566746|NCT01327612|7401793|FG000|Overall Study|Disease Progression|1
4566747|NCT01327612|7401794|FG001|Overall Study|Disease Progression|1
4566748|NCT01327612|7401795|FG002|Overall Study|Disease Progression|1
4566749|NCT01327612|7401796|FG003|Overall Study|Disease Progression|0
4566750|NCT01327612|7401797|FG004|Overall Study|Disease Progression|1
4566751|NCT01327612|7401798|FG005|Overall Study|Disease Progression|2
4566752|NCT01327612|7401799|FG006|Overall Study|Disease Progression|2
4566753|NCT01327612|7401793|FG000|Overall Study|Administrative Decision|0
4566754|NCT01327612|7401794|FG001|Overall Study|Administrative Decision|0
4566755|NCT01327612|7401795|FG002|Overall Study|Administrative Decision|0
4566756|NCT01327612|7401796|FG003|Overall Study|Administrative Decision|1
4566757|NCT01327612|7401797|FG004|Overall Study|Administrative Decision|0
4566758|NCT01327612|7401798|FG005|Overall Study|Administrative Decision|0
4566759|NCT01327612|7401799|FG006|Overall Study|Administrative Decision|0
4566760|NCT01327612|7401793|FG000|Overall Study|Death|0
4566761|NCT01327612|7401794|FG001|Overall Study|Death|0
4566762|NCT01327612|7401795|FG002|Overall Study|Death|0
4566763|NCT01327612|7401796|FG003|Overall Study|Death|0
4566764|NCT01327612|7401797|FG004|Overall Study|Death|1
4566765|NCT01327612|7401798|FG005|Overall Study|Death|0
4566766|NCT01327612|7401799|FG006|Overall Study|Death|0
4566767|NCT01327651|7401825|FG000|Self-administered Dosing Period|Lost to Follow-up|3
4566768|NCT01327651|7401826|FG001|Self-administered Dosing Period|Lost to Follow-up|2
4566769|NCT01327651|7401827|FG002|Self-administered Dosing Period|Lost to Follow-up|4
4566770|NCT01327651|7401828|FG003|Self-administered Dosing Period|Lost to Follow-up|2
4566771|NCT01327651|7401829|FG004|Self-administered Dosing Period|Lost to Follow-up|3
4566772|NCT01327651|7401830|FG005|Self-administered Dosing Period|Lost to Follow-up|0
4625132|NCT01826981|7489754|FG013|Overall Study|Enrolled/Randomized but Not Treated|0
4625133|NCT01826981|7489755|FG014|Overall Study|Enrolled/Randomized but Not Treated|0
4625134|NCT01827046|7489793|FG000|Overall Study|Lost to Follow-up|1
4625135|NCT01827046|7489794|FG001|Overall Study|Lost to Follow-up|5
4625136|NCT01827046|7489793|FG000|Overall Study|Withdrawal by Subject|0
4625137|NCT01827046|7489794|FG001|Overall Study|Withdrawal by Subject|4
4625138|NCT01827163|7489800|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2
4625139|NCT01827163|7489800|FG000|Overall Study|Adverse Event|9
4625140|NCT01827254|7489804|FG000|Overall Study|Death|10
4625141|NCT01827254|7489804|FG000|Overall Study|Case report form not completed|4
4625142|NCT01827254|7489804|FG000|Overall Study|Invalidated centre|3
4625143|NCT01827254|7489804|FG000|Overall Study|Discontinued prior initiation: sunitinib|1
4625144|NCT01827254|7489804|FG000|Overall Study|Did not complete re-challenge|1
4625145|NCT01827254|7489804|FG000|Overall Study|Disease progression|36
4625146|NCT01827254|7489804|FG000|Overall Study|Intolerance to treatment|4
4625147|NCT01827267|7489814|FG000|Overall Study|Did not receive study drug|1
4625148|NCT01827267|7489815|FG001|Overall Study|Did not receive study drug|1
4625149|NCT01827267|7489814|FG000|Overall Study|Physician Decision|1
4625150|NCT01827267|7489815|FG001|Overall Study|Physician Decision|0
4625151|NCT01827267|7489814|FG000|Overall Study|Disease Progression|1
4625152|NCT01827267|7489815|FG001|Overall Study|Disease Progression|1
4625153|NCT01827267|7489814|FG000|Overall Study|Sponsor Discontinued Study|2
4625154|NCT01827267|7489815|FG001|Overall Study|Sponsor Discontinued Study|8
4625155|NCT01827267|7489814|FG000|Overall Study|Still on study|0
4625156|NCT01827267|7489815|FG001|Overall Study|Still on study|2
4625157|NCT01827319|7489831|FG000|Overall Study|Lost to Follow-up|3
4690843|NCT02564055|7600668|FG005|Overall Study|Physician Decision|0
4690844|NCT02564055|7600663|FG000|Overall Study|Withdrawal by Subject|4
4690845|NCT02564055|7600664|FG001|Overall Study|Withdrawal by Subject|4
4690846|NCT02564055|7600665|FG002|Overall Study|Withdrawal by Subject|3
4690847|NCT02564055|7600666|FG003|Overall Study|Withdrawal by Subject|3
4690848|NCT02564055|7600667|FG004|Overall Study|Withdrawal by Subject|10
4690849|NCT02564055|7600668|FG005|Overall Study|Withdrawal by Subject|10
4690850|NCT02564120|7600687|FG000|Overall Study|Did not return release forms|160
4690851|NCT02564120|7600687|FG000|Overall Study|Death|58
4566773|NCT01327651|7401831|FG006|Self-administered Dosing Period|Lost to Follow-up|8
4566774|NCT01327651|7401832|FG007|Self-administered Dosing Period|Lost to Follow-up|9
4566775|NCT01327651|7401833|FG008|Self-administered Dosing Period|Lost to Follow-up|10
4566776|NCT01327651|7401825|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1
4566777|NCT01327651|7401826|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0
4566778|NCT01327651|7401827|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0
4566779|NCT01327651|7401828|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0
4566780|NCT01327651|7401829|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0
4566781|NCT01327651|7401830|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0
4566782|NCT01327651|7401831|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0
4566783|NCT01327651|7401832|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0
4566784|NCT01327651|7401833|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0
4566785|NCT01327651|7401825|FG000|Self-administered Dosing Period|Withdrawal by Subject|0
4566786|NCT01327651|7401826|FG001|Self-administered Dosing Period|Withdrawal by Subject|1
4566787|NCT01327651|7401827|FG002|Self-administered Dosing Period|Withdrawal by Subject|0
4566788|NCT01327651|7401828|FG003|Self-administered Dosing Period|Withdrawal by Subject|1
4566789|NCT01327651|7401829|FG004|Self-administered Dosing Period|Withdrawal by Subject|0
4566790|NCT01327651|7401830|FG005|Self-administered Dosing Period|Withdrawal by Subject|0
4566791|NCT01327651|7401831|FG006|Self-administered Dosing Period|Withdrawal by Subject|2
4566792|NCT01327651|7401832|FG007|Self-administered Dosing Period|Withdrawal by Subject|1
4566793|NCT01327651|7401833|FG008|Self-administered Dosing Period|Withdrawal by Subject|1
4566794|NCT01327651|7401825|FG000|Post Study Follow-up|Lost to Follow-up|0
4566795|NCT01327651|7401826|FG001|Post Study Follow-up|Lost to Follow-up|1
4566796|NCT01327651|7401827|FG002|Post Study Follow-up|Lost to Follow-up|1
4566797|NCT01327651|7401828|FG003|Post Study Follow-up|Lost to Follow-up|0
4566798|NCT01327651|7401829|FG004|Post Study Follow-up|Lost to Follow-up|0
4566799|NCT01327651|7401830|FG005|Post Study Follow-up|Lost to Follow-up|0
4566800|NCT01327651|7401831|FG006|Post Study Follow-up|Lost to Follow-up|4
4566801|NCT01327651|7401832|FG007|Post Study Follow-up|Lost to Follow-up|1
4566802|NCT01327651|7401833|FG008|Post Study Follow-up|Lost to Follow-up|2
4566803|NCT01327703|7401883|FG000|Second Treatment Period|Adverse Event|1
4566804|NCT01327703|7401884|FG001|Second Treatment Period|Adverse Event|1
4566805|NCT01327703|7401883|FG000|Second Treatment Period|Protocol Violation|0
4566806|NCT01327703|7401884|FG001|Second Treatment Period|Protocol Violation|1
4566807|NCT01327846|7401897|FG000|Core Phase|Subject decision (vital status: missing)|1
4566808|NCT01327846|7401898|FG001|Core Phase|Subject decision (vital status: missing)|2
4566809|NCT01327846|7401899|FG002|Core Phase|Subject decision (vital status: missing)|2
4566810|NCT01327846|7401900|FG003|Core Phase|Subject decision (vital status: missing)|1
4566811|NCT01327846|7401897|FG000|Core Phase|Subject decision (vital stat: unkn)|0
4566812|NCT01327846|7401898|FG001|Core Phase|Subject decision (vital stat: unkn)|0
4566813|NCT01327846|7401899|FG002|Core Phase|Subject decision (vital stat: unkn)|3
4566814|NCT01327846|7401900|FG003|Core Phase|Subject decision (vital stat: unkn)|3
4566815|NCT01327846|7401897|FG000|Core Phase|Subject decision (vital stat: dead)|1
4566816|NCT01327846|7401898|FG001|Core Phase|Subject decision (vital stat: dead)|3
4566817|NCT01327846|7401899|FG002|Core Phase|Subject decision (vital stat: dead)|4
4566818|NCT01327846|7401900|FG003|Core Phase|Subject decision (vital stat: dead)|4
4566819|NCT01327846|7401897|FG000|Core Phase|Subject decision (vital stat: alive)|23
4566820|NCT01327846|7401898|FG001|Core Phase|Subject decision (vital stat: alive)|24
4566821|NCT01327846|7401899|FG002|Core Phase|Subject decision (vital stat: alive)|13
4566822|NCT01327846|7401900|FG003|Core Phase|Subject decision (vital stat: alive)|20
4566823|NCT01327846|7401897|FG000|Core Phase|Lost to Follow-up|3
4566824|NCT01327846|7401898|FG001|Core Phase|Lost to Follow-up|3
4566825|NCT01327846|7401899|FG002|Core Phase|Lost to Follow-up|4
4625158|NCT01827332|7489837|FG000|Overall Study|Lost to Follow-up|2
4625159|NCT01827332|7489838|FG001|Overall Study|Lost to Follow-up|1
4625160|NCT01827371|7489857|FG000|Overall Study|Adverse Event|0
4625161|NCT01827371|7489858|FG001|Overall Study|Adverse Event|0
4625162|NCT01827371|7489859|FG002|Overall Study|Adverse Event|4
4625163|NCT01827371|7489860|FG003|Overall Study|Adverse Event|2
4625164|NCT01827371|7489857|FG000|Overall Study|Lost to Follow-up|0
4625165|NCT01827371|7489858|FG001|Overall Study|Lost to Follow-up|2
4625166|NCT01827371|7489859|FG002|Overall Study|Lost to Follow-up|0
4625167|NCT01827371|7489860|FG003|Overall Study|Lost to Follow-up|4
4625168|NCT01827371|7489857|FG000|Overall Study|Protocol Violation|1
4625169|NCT01827371|7489858|FG001|Overall Study|Protocol Violation|0
4625170|NCT01827371|7489859|FG002|Overall Study|Protocol Violation|0
4625171|NCT01827371|7489860|FG003|Overall Study|Protocol Violation|0
4625172|NCT01827371|7489857|FG000|Overall Study|Withdrawal by Subject|1
4625173|NCT01827371|7489858|FG001|Overall Study|Withdrawal by Subject|2
4625174|NCT01827371|7489859|FG002|Overall Study|Withdrawal by Subject|2
4625175|NCT01827371|7489860|FG003|Overall Study|Withdrawal by Subject|3
4625176|NCT01827371|7489857|FG000|Overall Study|Physician Decision|0
4625177|NCT01827371|7489858|FG001|Overall Study|Physician Decision|1
4625178|NCT01827371|7489859|FG002|Overall Study|Physician Decision|0
4625179|NCT01827371|7489860|FG003|Overall Study|Physician Decision|1
4625180|NCT01827371|7489857|FG000|Overall Study|Temporary study halt to vaccinations|11
4625181|NCT01827371|7489858|FG001|Overall Study|Temporary study halt to vaccinations|2
4625182|NCT01827371|7489859|FG002|Overall Study|Temporary study halt to vaccinations|5
4625183|NCT01827371|7489860|FG003|Overall Study|Temporary study halt to vaccinations|13
4625184|NCT01827592|7489902|FG000|Overall Study|Adverse Event|11
4625185|NCT01827592|7489903|FG001|Overall Study|Adverse Event|9
4625186|NCT01827592|7489904|FG002|Overall Study|Adverse Event|2
4625187|NCT01827592|7489902|FG000|Overall Study|Physician Decision|0
4625188|NCT01827592|7489903|FG001|Overall Study|Physician Decision|2
4566826|NCT01327846|7401900|FG003|Core Phase|Lost to Follow-up|5
4566827|NCT01327846|7401897|FG000|Extension Phase|Study terminated by sponsor|1073
4566828|NCT01327846|7401898|FG001|Extension Phase|Study terminated by sponsor|1124
4566829|NCT01327846|7401899|FG002|Extension Phase|Study terminated by sponsor|1067
4566830|NCT01327846|7401900|FG003|Extension Phase|Study terminated by sponsor|1660
4566831|NCT01327846|7401897|FG000|Extension Phase|Withdrawal by Subject|20
4566832|NCT01327846|7401898|FG001|Extension Phase|Withdrawal by Subject|13
4566833|NCT01327846|7401899|FG002|Extension Phase|Withdrawal by Subject|19
4566834|NCT01327846|7401900|FG003|Extension Phase|Withdrawal by Subject|37
4566835|NCT01327846|7401897|FG000|Extension Phase|Lost to Follow-up|4
4566836|NCT01327846|7401898|FG001|Extension Phase|Lost to Follow-up|3
4566837|NCT01327846|7401899|FG002|Extension Phase|Lost to Follow-up|4
4566838|NCT01327846|7401900|FG003|Extension Phase|Lost to Follow-up|7
4566839|NCT01327846|7401897|FG000|Extension Phase|Technical Problems|2
4566840|NCT01327846|7401898|FG001|Extension Phase|Technical Problems|4
4566841|NCT01327846|7401899|FG002|Extension Phase|Technical Problems|2
4566842|NCT01327846|7401900|FG003|Extension Phase|Technical Problems|2
4566843|NCT01327885|7401913|FG000|Overall Study|Disease progression-according to RECIST|173
4566844|NCT01327885|7401914|FG001|Overall Study|Disease progression-according to RECIST|165
4566845|NCT01327885|7401913|FG000|Overall Study|Clinical progression|24
4566846|NCT01327885|7401914|FG001|Overall Study|Clinical progression|27
4566847|NCT01327885|7401913|FG000|Overall Study|Adverse Event|14
4566848|NCT01327885|7401914|FG001|Overall Study|Adverse Event|10
4566849|NCT01327885|7401913|FG000|Overall Study|Subject choice|5
4566850|NCT01327885|7401914|FG001|Overall Study|Subject choice|10
4566851|NCT01327885|7401913|FG000|Overall Study|Other|8
4625189|NCT01827592|7489904|FG002|Overall Study|Physician Decision|1
4625190|NCT01827592|7489902|FG000|Overall Study|Protocol Violation|2
4625191|NCT01827592|7489903|FG001|Overall Study|Protocol Violation|1
4625192|NCT01827592|7489904|FG002|Overall Study|Protocol Violation|0
4625193|NCT01827592|7489902|FG000|Overall Study|Lost to Follow-up|1
4625194|NCT01827592|7489903|FG001|Overall Study|Lost to Follow-up|2
4625195|NCT01827592|7489904|FG002|Overall Study|Lost to Follow-up|2
4625196|NCT01827592|7489902|FG000|Overall Study|Withdrawal by Subject|12
4625197|NCT01827592|7489903|FG001|Overall Study|Withdrawal by Subject|11
4625198|NCT01827592|7489904|FG002|Overall Study|Withdrawal by Subject|11
4625199|NCT01827592|7489902|FG000|Overall Study|Patient's substantial non-compliance|1
4625200|NCT01827592|7489903|FG001|Overall Study|Patient's substantial non-compliance|1
4625201|NCT01827592|7489904|FG002|Overall Study|Patient's substantial non-compliance|6
4625202|NCT01827592|7489902|FG000|Overall Study|Trial terminated by Sponsor|47
4625203|NCT01827592|7489903|FG001|Overall Study|Trial terminated by Sponsor|53
4625204|NCT01827592|7489904|FG002|Overall Study|Trial terminated by Sponsor|51
4625205|NCT01827592|7489902|FG000|Overall Study|Others|0
4625206|NCT01827592|7489903|FG001|Overall Study|Others|1
4625207|NCT01827592|7489904|FG002|Overall Study|Others|3
4625208|NCT01827670|7489914|FG000|Overall Study|Withdrawal of Consent|3
4625209|NCT01827670|7489915|FG001|Overall Study|Withdrawal of Consent|2
4625210|NCT01827670|7489914|FG000|Overall Study|Lost to Follow-up|0
4625211|NCT01827670|7489915|FG001|Overall Study|Lost to Follow-up|1
4625212|NCT01827839|7489938|FG000|Overall Study|Adverse Event|1
4625213|NCT01827839|7489938|FG000|Overall Study|Consent Withdrawal|2
4625214|NCT01827943|7489962|FG000|Overall Study|Protocol Violation|8
4625215|NCT01827943|7489962|FG000|Overall Study|Never treated because of an rapid progression|1
4625216|NCT01828034|7489970|FG000|Overall Study|Withdrawal by Subject|0
4625217|NCT01828034|7489971|FG001|Overall Study|Withdrawal by Subject|0
4625218|NCT01828034|7489972|FG002|Overall Study|Withdrawal by Subject|0
4625219|NCT01828034|7489973|FG003|Overall Study|Withdrawal by Subject|1
4625220|NCT01828073|7489982|FG000|Overall Study|Lost to Follow-up|1
4625221|NCT01828073|7489983|FG001|Overall Study|Lost to Follow-up|2
4625222|NCT01828281|7490027|FG000|Overall Study|Withdrawal by Subject|1
4625223|NCT01828281|7490028|FG001|Overall Study|Withdrawal by Subject|0
4625224|NCT01828567|7490059|FG000|Overall Study|Lost to Follow-up|27
4625225|NCT01828567|7490060|FG001|Overall Study|Lost to Follow-up|9
4625226|NCT01828567|7490059|FG000|Overall Study|Excluded - did not meet criteria|4
4625227|NCT01828567|7490060|FG001|Overall Study|Excluded - did not meet criteria|1
4625228|NCT01829048|7490096|FG000|Overall Study|Withdrawal by Subject|0
4625229|NCT01829048|7490097|FG001|Overall Study|Withdrawal by Subject|0
4625230|NCT01829048|7490098|FG002|Overall Study|Withdrawal by Subject|0
4625231|NCT01829048|7490099|FG003|Overall Study|Withdrawal by Subject|2
4625232|NCT01829048|7490100|FG004|Overall Study|Withdrawal by Subject|0
4625233|NCT01829113|7490115|FG000|Overall Study|Disease Progression|37
4625234|NCT01829113|7490116|FG001|Overall Study|Disease Progression|48
4625235|NCT01829113|7490115|FG000|Overall Study|Adverse Event|14
4625236|NCT01829113|7490116|FG001|Overall Study|Adverse Event|10
4625237|NCT01829113|7490115|FG000|Overall Study|Withdrawal by Subject|17
4625238|NCT01829113|7490116|FG001|Overall Study|Withdrawal by Subject|10
4566852|NCT01327885|7401914|FG001|Overall Study|Other|6
4625239|NCT01829113|7490115|FG000|Overall Study|Death|4
4625240|NCT01829113|7490116|FG001|Overall Study|Death|6
4625241|NCT01829113|7490115|FG000|Overall Study|Sponsor Decision|1
4625242|NCT01829113|7490116|FG001|Overall Study|Sponsor Decision|1
4625243|NCT01829113|7490115|FG000|Overall Study|No Study Treatment Received|3
4625244|NCT01829113|7490116|FG001|Overall Study|No Study Treatment Received|2
4566853|NCT01327885|7401913|FG000|Overall Study|Withdrawal of consent from study|3
4566854|NCT01327885|7401914|FG001|Overall Study|Withdrawal of consent from study|4
4566855|NCT01327885|7401913|FG000|Overall Study|Not treated|1
4566856|NCT01327885|7401914|FG001|Overall Study|Not treated|1
4566857|NCT01327885|7401913|FG000|Overall Study|Administrative decision|0
4566858|NCT01327885|7401914|FG001|Overall Study|Administrative decision|1
4566859|NCT01328002|7401942|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66
4566860|NCT01328002|7401943|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0
4566861|NCT01328002|7401942|FG000|Open-Label Period|Adverse Event|8
4566862|NCT01328002|7401943|FG001|Open-Label Period|Adverse Event|0
4566863|NCT01328002|7401942|FG000|Open-Label Period|Lack of Efficacy|3
4566864|NCT01328002|7401943|FG001|Open-Label Period|Lack of Efficacy|0
4566865|NCT01328002|7401942|FG000|Open-Label Period|Protocol Violation|2
4566866|NCT01328002|7401943|FG001|Open-Label Period|Protocol Violation|0
4566867|NCT01328002|7401942|FG000|Open-Label Period|Withdrawal by Subject|9
4566868|NCT01328002|7401943|FG001|Open-Label Period|Withdrawal by Subject|0
4566869|NCT01328002|7401942|FG000|Open-Label Period|Lost to Follow-up|6
4566870|NCT01328002|7401943|FG001|Open-Label Period|Lost to Follow-up|0
4566871|NCT01328002|7401942|FG000|Open-Label Period|Other Reason|2
4566872|NCT01328002|7401943|FG001|Open-Label Period|Other Reason|0
4566873|NCT01328002|7401942|FG000|Double-Blind Period|Adverse Event|1
4566874|NCT01328002|7401943|FG001|Double-Blind Period|Adverse Event|0
4566875|NCT01328002|7401942|FG000|Double-Blind Period|Lack of Efficacy|1
4566876|NCT01328002|7401943|FG001|Double-Blind Period|Lack of Efficacy|0
4566877|NCT01328041|7401950|FG000|Overall Study|Adverse Event|7
4566878|NCT01328041|7401950|FG000|Overall Study|Lack of Efficacy|27
4566879|NCT01328041|7401950|FG000|Overall Study|Protocol Violation|7
4566880|NCT01328041|7401950|FG000|Overall Study|Lost to Follow-up|7
4566881|NCT01328041|7401950|FG000|Overall Study|Physician Decision|2
4566882|NCT01328041|7401950|FG000|Overall Study|Withdrawal by Subject|7
4566883|NCT01328054|7401954|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0
4566884|NCT01328054|7401955|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2
4566885|NCT01328054|7401954|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0
4566886|NCT01328054|7401955|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1
4566887|NCT01328054|7401954|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0
4566888|NCT01328054|7401955|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2
4566889|NCT01328080|7401967|FG000|Overall Study|Lost to Follow-up|5
4566890|NCT01328249|7401986|FG000|Overall Study|Adverse Event|3
4566891|NCT01328249|7401987|FG001|Overall Study|Adverse Event|0
4566892|NCT01328249|7401986|FG000|Overall Study|Disease progression|1
4566893|NCT01328249|7401987|FG001|Overall Study|Disease progression|0
4566894|NCT01328249|7401986|FG000|Overall Study|Withdrawal by Subject|1
4566895|NCT01328249|7401987|FG001|Overall Study|Withdrawal by Subject|1
4566896|NCT01328249|7401986|FG000|Overall Study|Moved before end of treatment visit|1
4566897|NCT01328249|7401987|FG001|Overall Study|Moved before end of treatment visit|0
4566898|NCT01328249|7401986|FG000|Overall Study|Subject choice|1
4566899|NCT01328249|7401987|FG001|Overall Study|Subject choice|1
4566900|NCT01328249|7401986|FG000|Overall Study|Protocol Violation|0
4566901|NCT01328249|7401987|FG001|Overall Study|Protocol Violation|1
4566902|NCT01328366|7401995|FG000|Overall Study|Death|1
4566903|NCT01328366|7401995|FG000|Overall Study|Withdrawal by Subject|2
4566904|NCT01328366|7401995|FG000|Overall Study|Lost to Follow-up|7
4566905|NCT01328431|7402023|FG000|Baseline|Protocol Violation|0
4566906|NCT01328431|7402024|FG001|Baseline|Protocol Violation|2
4566907|NCT01328431|7402023|FG000|1 Month (1M)|Lost to Follow-up|55
4566908|NCT01328431|7402024|FG001|1 Month (1M)|Lost to Follow-up|58
4566909|NCT01328431|7402023|FG000|3 Month (3M)|Death|2
4566910|NCT01328431|7402024|FG001|3 Month (3M)|Death|2
4566911|NCT01328431|7402023|FG000|3 Month (3M)|Lost to Follow-up|75
4566912|NCT01328431|7402024|FG001|3 Month (3M)|Lost to Follow-up|70
4566913|NCT01328431|7402023|FG000|12 Month (12M)|Death|2
4566914|NCT01328431|7402024|FG001|12 Month (12M)|Death|6
4566915|NCT01328431|7402023|FG000|12 Month (12M)|Lost to Follow-up|82
4566916|NCT01328431|7402024|FG001|12 Month (12M)|Lost to Follow-up|91
4566917|NCT01328444|7402030|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3
4566918|NCT01328444|7402031|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1
4566919|NCT01328444|7402032|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1
4566920|NCT01328444|7402033|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3
4566921|NCT01328444|7402034|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5
4566922|NCT01328444|7402035|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2
4566923|NCT01328444|7402030|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
4566924|NCT01328444|7402031|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
4566925|NCT01328444|7402032|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
4566926|NCT01328444|7402033|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
4566927|NCT01328444|7402034|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
4566928|NCT01328444|7402035|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2
4566929|NCT01328444|7402030|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0
4566930|NCT01328444|7402031|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0
4566931|NCT01328444|7402032|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0
4566932|NCT01328444|7402033|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1
4566933|NCT01328444|7402034|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0
4625245|NCT01829113|7490115|FG000|Overall Study|Physician Decision|1
4625246|NCT01829113|7490116|FG001|Overall Study|Physician Decision|1
4625247|NCT01829165|7490126|FG000|Overall Study|Did not complete intervention|2
4625248|NCT01829165|7490127|FG001|Overall Study|Did not complete intervention|0
4625249|NCT01829191|7490135|FG000|Overall Study|Relocation|0
4625250|NCT01829191|7490136|FG001|Overall Study|Relocation|1
4625251|NCT01829191|7490135|FG000|Overall Study|Lens discomfort|0
4625252|NCT01829191|7490136|FG001|Overall Study|Lens discomfort|3
4625253|NCT01829191|7490135|FG000|Overall Study|Lens handling difficulty|1
4625254|NCT01829191|7490136|FG001|Overall Study|Lens handling difficulty|4
4625255|NCT01829191|7490135|FG000|Overall Study|Protocol Violation|4
4625256|NCT01829191|7490136|FG001|Overall Study|Protocol Violation|1
4625257|NCT01829191|7490135|FG000|Overall Study|Withdrawal by Subject|2
4625258|NCT01829191|7490136|FG001|Overall Study|Withdrawal by Subject|3
4625259|NCT01829191|7490135|FG000|Overall Study|Lost to Follow-up|0
4625260|NCT01829191|7490136|FG001|Overall Study|Lost to Follow-up|1
4625261|NCT01829191|7490135|FG000|Overall Study|Subject was fit for ortho - k|0
4625262|NCT01829191|7490136|FG001|Overall Study|Subject was fit for ortho - k|1
4625263|NCT01829230|7490147|FG000|Overall Study|Protocol Violation|0
4566934|NCT01328444|7402035|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1
4566935|NCT01328444|7402030|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
4566936|NCT01328444|7402031|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1
4566937|NCT01328444|7402032|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
4566938|NCT01328444|7402033|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
4566939|NCT01328444|7402034|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2
4566940|NCT01328444|7402035|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
4566941|NCT01328444|7402030|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2
4566942|NCT01328444|7402031|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
4566943|NCT01328444|7402032|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
4566944|NCT01328444|7402033|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
4566945|NCT01328444|7402034|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
4566946|NCT01328444|7402035|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
4566947|NCT01328444|7402030|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
4566948|NCT01328444|7402031|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2
4566949|NCT01328444|7402032|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
4566950|NCT01328444|7402033|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2
4566951|NCT01328444|7402034|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
4566952|NCT01328444|7402035|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
4566953|NCT01328444|7402030|FG000|Washout Period (14 Days)|Adverse Event|1
4566954|NCT01328444|7402031|FG001|Washout Period (14 Days)|Adverse Event|1
4566955|NCT01328444|7402032|FG002|Washout Period (14 Days)|Adverse Event|0
4566956|NCT01328444|7402033|FG003|Washout Period (14 Days)|Adverse Event|1
4566957|NCT01328444|7402034|FG004|Washout Period (14 Days)|Adverse Event|1
4566958|NCT01328444|7402035|FG005|Washout Period (14 Days)|Adverse Event|2
4566959|NCT01328444|7402030|FG000|Washout Period (14 Days)|Lack of Efficacy|0
4566960|NCT01328444|7402031|FG001|Washout Period (14 Days)|Lack of Efficacy|0
4566961|NCT01328444|7402032|FG002|Washout Period (14 Days)|Lack of Efficacy|0
4566962|NCT01328444|7402033|FG003|Washout Period (14 Days)|Lack of Efficacy|0
4566963|NCT01328444|7402034|FG004|Washout Period (14 Days)|Lack of Efficacy|0
4566964|NCT01328444|7402035|FG005|Washout Period (14 Days)|Lack of Efficacy|1
4566965|NCT01328444|7402030|FG000|Washout Period (14 Days)|Withdrawal by Subject|0
4566966|NCT01328444|7402031|FG001|Washout Period (14 Days)|Withdrawal by Subject|0
4566967|NCT01328444|7402032|FG002|Washout Period (14 Days)|Withdrawal by Subject|0
4566968|NCT01328444|7402033|FG003|Washout Period (14 Days)|Withdrawal by Subject|0
4566969|NCT01328444|7402034|FG004|Washout Period (14 Days)|Withdrawal by Subject|0
4566970|NCT01328444|7402035|FG005|Washout Period (14 Days)|Withdrawal by Subject|1
4566971|NCT01328444|7402030|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5
4566972|NCT01328444|7402031|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0
4566973|NCT01328444|7402032|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1
4566974|NCT01328444|7402033|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1
4566975|NCT01328444|7402034|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1
4566976|NCT01328444|7402035|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0
4566977|NCT01328444|7402030|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5
4566978|NCT01328444|7402031|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
4566979|NCT01328444|7402032|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
4566980|NCT01328444|7402033|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
4566981|NCT01328444|7402034|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3
4566982|NCT01328444|7402035|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4
4566983|NCT01328444|7402030|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1
4566984|NCT01328444|7402031|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0
4566985|NCT01328444|7402032|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0
4566986|NCT01328444|7402033|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0
4566987|NCT01328444|7402034|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1
4566988|NCT01328444|7402035|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0
4566989|NCT01328444|7402030|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
4625264|NCT01829230|7490148|FG001|Overall Study|Protocol Violation|2
4566990|NCT01328444|7402031|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
4566991|NCT01328444|7402032|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
4566992|NCT01328444|7402033|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1
4566993|NCT01328444|7402034|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1
4566994|NCT01328444|7402035|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
4566995|NCT01328444|7402030|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
4566996|NCT01328444|7402031|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
4566997|NCT01328444|7402032|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
4566998|NCT01328444|7402033|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
4566999|NCT01328444|7402034|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
4567000|NCT01328444|7402035|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2
4567001|NCT01328444|7402030|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
4567002|NCT01328444|7402031|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
4567003|NCT01328444|7402032|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
4567004|NCT01328444|7402033|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
4567005|NCT01328444|7402034|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
4567006|NCT01328444|7402035|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
4567007|NCT01328496|7402051|FG000|Overall Study|Significant Change in Health Status|1
4567008|NCT01328496|7402052|FG001|Overall Study|Significant Change in Health Status|0
4567009|NCT01328535|7402061|FG000|Overall Study|Ineligible|1
4567010|NCT01328548|7402069|FG000|Overall Study|Death|3
4567011|NCT01328548|7402070|FG001|Overall Study|Death|0
4567012|NCT01328548|7402069|FG000|Overall Study|Protocol Violation|1
4567013|NCT01328548|7402070|FG001|Overall Study|Protocol Violation|0
4567014|NCT01328574|7402076|FG000|Overall Study|Refused further treatment|1
4567015|NCT01328717|7402085|FG000|Overall Study|Adverse Event|1
4567016|NCT01328756|7402098|FG000|Overall Study|Protocol Violation|4
4567017|NCT01328756|7402098|FG000|Overall Study|Adverse Event|39
4567018|NCT01328756|7402098|FG000|Overall Study|Lack of Efficacy|5
4567019|NCT01328756|7402098|FG000|Overall Study|Withdrawal by Subject|41
4567020|NCT01328756|7402098|FG000|Overall Study|Lost to Follow-up|5
4567021|NCT01328756|7402098|FG000|Overall Study|Other|29
4567022|NCT01328951|7402132|FG000|Overall Study|Disease Progression|17
4567023|NCT01328951|7402133|FG001|Overall Study|Disease Progression|14
4567024|NCT01328951|7402132|FG000|Overall Study|Adverse Event|2
4567025|NCT01328951|7402133|FG001|Overall Study|Adverse Event|0
4567026|NCT01328951|7402132|FG000|Overall Study|Death|243
4567027|NCT01328951|7402133|FG001|Overall Study|Death|258
4567028|NCT01328951|7402132|FG000|Overall Study|Lost to Follow-up|6
4567029|NCT01328951|7402133|FG001|Overall Study|Lost to Follow-up|7
4567030|NCT01328951|7402132|FG000|Overall Study|Withdrawal by Subject|6
4567031|NCT01328951|7402133|FG001|Overall Study|Withdrawal by Subject|6
4567032|NCT01328951|7402132|FG000|Overall Study|Study Closed by the Sponsor|36
4567033|NCT01328951|7402133|FG001|Overall Study|Study Closed by the Sponsor|31
4567034|NCT01328951|7402132|FG000|Overall Study|Other|11
4567035|NCT01328951|7402133|FG001|Overall Study|Other|6
4567036|NCT01329029|7402158|FG000|Overall Study|Withdrawal by Subject|117
4567037|NCT01329029|7402159|FG001|Overall Study|Withdrawal by Subject|87
4625265|NCT01829230|7490147|FG000|Overall Study|Withdrawal by Subject|0
4625266|NCT01829230|7490148|FG001|Overall Study|Withdrawal by Subject|1
4625267|NCT01829230|7490147|FG000|Overall Study|Lost to Follow-up|1
4625268|NCT01829230|7490148|FG001|Overall Study|Lost to Follow-up|1
4625269|NCT01829243|7490154|FG000|First Intervention|Screen Failure|4
4625270|NCT01829243|7490155|FG001|First Intervention|Screen Failure|2
4625271|NCT01829295|7490165|FG000|6-12 Months|Did not want to switch antimetabolites|0
4625272|NCT01829295|7490166|FG001|6-12 Months|Did not want to switch antimetabolites|0
4625273|NCT01829295|7490167|FG002|6-12 Months|Did not want to switch antimetabolites|9
4625274|NCT01829295|7490168|FG003|6-12 Months|Did not want to switch antimetabolites|11
4625275|NCT01829295|7490165|FG000|6-12 Months|Adverse Event|0
4625276|NCT01829295|7490166|FG001|6-12 Months|Adverse Event|0
4625277|NCT01829295|7490167|FG002|6-12 Months|Adverse Event|3
4625278|NCT01829295|7490168|FG003|6-12 Months|Adverse Event|2
4625279|NCT01829295|7490165|FG000|6-12 Months|Lost to Follow-up|2
4625280|NCT01829295|7490166|FG001|6-12 Months|Lost to Follow-up|0
4625281|NCT01829295|7490167|FG002|6-12 Months|Lost to Follow-up|0
4625282|NCT01829295|7490168|FG003|6-12 Months|Lost to Follow-up|0
4625283|NCT01829295|7490165|FG000|6-12 Months|Withdrawal by Subject|2
4625284|NCT01829295|7490166|FG001|6-12 Months|Withdrawal by Subject|2
4625285|NCT01829295|7490167|FG002|6-12 Months|Withdrawal by Subject|0
4625286|NCT01829295|7490168|FG003|6-12 Months|Withdrawal by Subject|0
4625287|NCT01829347|7490180|FG000|VTI-210|Death|5
4625288|NCT01829347|7490181|FG001|VTI-210|Death|3
4625289|NCT01829347|7490180|FG000|VTI-210|Withdrawal by Subject|1
4625290|NCT01829347|7490181|FG001|VTI-210|Withdrawal by Subject|0
4625291|NCT01829347|7490180|FG000|VTI-210E|Death|2
4567038|NCT01329029|7402158|FG000|Overall Study|Adverse Event|82
4567039|NCT01329029|7402159|FG001|Overall Study|Adverse Event|29
4567040|NCT01329029|7402158|FG000|Overall Study|Death|16
4567041|NCT01329029|7402159|FG001|Overall Study|Death|19
4567042|NCT01329029|7402158|FG000|Overall Study|Other|14
4625292|NCT01829347|7490181|FG001|VTI-210E|Death|1
4625293|NCT01829347|7490180|FG000|VTI-210E|Study terminated prematurely|1
4625294|NCT01829347|7490181|FG001|VTI-210E|Study terminated prematurely|5
4567043|NCT01329029|7402159|FG001|Overall Study|Other|20
4567044|NCT01329029|7402158|FG000|Overall Study|COPD Exacerbation|11
4625295|NCT01829360|7490191|FG000|Overall Study|Protocol Violation|0
4625296|NCT01829360|7490192|FG001|Overall Study|Protocol Violation|0
4625297|NCT01829360|7490193|FG002|Overall Study|Protocol Violation|1
4625298|NCT01829360|7490194|FG003|Overall Study|Protocol Violation|0
4625299|NCT01829425|7490221|FG000|Overall Study|Withdrawal by Subject|4
4625300|NCT01829425|7490222|FG001|Overall Study|Withdrawal by Subject|3
4625301|NCT01829425|7490221|FG000|Overall Study|Lost to Follow-up|2
4625302|NCT01829425|7490222|FG001|Overall Study|Lost to Follow-up|1
4625303|NCT01829464|7490231|FG000|Overall Study|Adverse Event|1
4625304|NCT01829464|7490232|FG001|Overall Study|Adverse Event|0
4625305|NCT01829464|7490233|FG002|Overall Study|Adverse Event|0
4625306|NCT01829464|7490231|FG000|Overall Study|Lost to Follow-up|0
4625307|NCT01829464|7490232|FG001|Overall Study|Lost to Follow-up|0
4625308|NCT01829464|7490233|FG002|Overall Study|Lost to Follow-up|1
4625309|NCT01829464|7490231|FG000|Overall Study|Withdrawal by Subject|2
4625310|NCT01829464|7490232|FG001|Overall Study|Withdrawal by Subject|0
4625311|NCT01829464|7490233|FG002|Overall Study|Withdrawal by Subject|0
4625312|NCT01829464|7490231|FG000|Overall Study|Study terminated by sponsor|25
4625313|NCT01829464|7490232|FG001|Overall Study|Study terminated by sponsor|28
4625314|NCT01829464|7490233|FG002|Overall Study|Study terminated by sponsor|25
4625315|NCT01829464|7490231|FG000|Overall Study|Lack of Efficacy|0
4625316|NCT01829464|7490232|FG001|Overall Study|Lack of Efficacy|1
4625317|NCT01829464|7490233|FG002|Overall Study|Lack of Efficacy|0
4625318|NCT01830127|7490266|FG000|Overall Study|Adverse Event|1
4625319|NCT01830127|7490267|FG001|Overall Study|Adverse Event|6
4625320|NCT01830127|7490266|FG000|Overall Study|Lack of Efficacy|3
4625321|NCT01830127|7490267|FG001|Overall Study|Lack of Efficacy|0
4625322|NCT01830127|7490266|FG000|Overall Study|Withdrawal by Subject|1
4625323|NCT01830127|7490267|FG001|Overall Study|Withdrawal by Subject|1
4625324|NCT01830127|7490266|FG000|Overall Study|Other reason not defined above|0
4625325|NCT01830127|7490267|FG001|Overall Study|Other reason not defined above|2
4625326|NCT01830543|7490313|FG000|Overall Study|Subject Decision|19
4625327|NCT01830543|7490314|FG001|Overall Study|Subject Decision|21
4625328|NCT01830543|7490315|FG002|Overall Study|Subject Decision|57
4625329|NCT01830543|7490313|FG000|Overall Study|Adverse Event|91
4625330|NCT01830543|7490314|FG001|Overall Study|Adverse Event|77
4625331|NCT01830543|7490315|FG002|Overall Study|Adverse Event|76
4625332|NCT01830543|7490313|FG000|Overall Study|Death|20
4625333|NCT01830543|7490314|FG001|Overall Study|Death|22
4625334|NCT01830543|7490315|FG002|Overall Study|Death|22
4625335|NCT01830543|7490313|FG000|Overall Study|Protocol Violation|3
4625336|NCT01830543|7490314|FG001|Overall Study|Protocol Violation|7
4625337|NCT01830543|7490315|FG002|Overall Study|Protocol Violation|7
4625338|NCT01830543|7490313|FG000|Overall Study|Physician Decision|11
4625339|NCT01830543|7490314|FG001|Overall Study|Physician Decision|5
4625340|NCT01830543|7490315|FG002|Overall Study|Physician Decision|12
4625341|NCT01830543|7490313|FG000|Overall Study|Withdrawal by consent|3
4625342|NCT01830543|7490314|FG001|Overall Study|Withdrawal by consent|3
4625343|NCT01830543|7490315|FG002|Overall Study|Withdrawal by consent|3
4625344|NCT01830543|7490313|FG000|Overall Study|Other|12
4625345|NCT01830543|7490314|FG001|Overall Study|Other|17
4625346|NCT01830543|7490315|FG002|Overall Study|Other|37
4633159|NCT01908816|7503121|FG003|Overall Study|Unsatisfactory therapeutic effect|0
4633160|NCT01908816|7503118|FG000|Overall Study|Early termination|87
4633161|NCT01908816|7503119|FG001|Overall Study|Early termination|60
4633162|NCT01908816|7503120|FG002|Overall Study|Early termination|43
4633163|NCT01908816|7503121|FG003|Overall Study|Early termination|28
4633164|NCT01908829|7503137|FG000|Overall Study|Adverse Event|13
4633165|NCT01908829|7503138|FG001|Overall Study|Adverse Event|11
4633166|NCT01908829|7503139|FG002|Overall Study|Adverse Event|13
4633167|NCT01908829|7503137|FG000|Overall Study|Lost to Follow-up|4
4633168|NCT01908829|7503138|FG001|Overall Study|Lost to Follow-up|2
4633169|NCT01908829|7503139|FG002|Overall Study|Lost to Follow-up|1
4633170|NCT01908829|7503137|FG000|Overall Study|Randomized no double-blind drug received|1
4633171|NCT01908829|7503138|FG001|Overall Study|Randomized no double-blind drug received|0
4633172|NCT01908829|7503139|FG002|Overall Study|Randomized no double-blind drug received|1
4633173|NCT01908829|7503137|FG000|Overall Study|Discontinued (no EoT page)|2
4633174|NCT01908829|7503138|FG001|Overall Study|Discontinued (no EoT page)|0
4633175|NCT01908829|7503139|FG002|Overall Study|Discontinued (no EoT page)|0
4633176|NCT01908829|7503137|FG000|Overall Study|Miscellaneous|0
4633177|NCT01908829|7503138|FG001|Overall Study|Miscellaneous|2
4633178|NCT01908829|7503139|FG002|Overall Study|Miscellaneous|0
4633179|NCT01908829|7503137|FG000|Overall Study|Protocol Violation|2
4633180|NCT01908829|7503138|FG001|Overall Study|Protocol Violation|2
4633181|NCT01908829|7503139|FG002|Overall Study|Protocol Violation|0
4633182|NCT01908829|7503137|FG000|Overall Study|Lack of Efficacy|1
4633183|NCT01908829|7503138|FG001|Overall Study|Lack of Efficacy|3
4567045|NCT01329029|7402159|FG001|Overall Study|COPD Exacerbation|18
4633184|NCT01908829|7503139|FG002|Overall Study|Lack of Efficacy|2
4633185|NCT01908829|7503137|FG000|Overall Study|Withdrawal by Subject|26
4633186|NCT01908829|7503138|FG001|Overall Study|Withdrawal by Subject|29
4633187|NCT01908829|7503139|FG002|Overall Study|Withdrawal by Subject|22
4633188|NCT01908907|7503158|FG000|Overall Study|Physician Decision|1
4633189|NCT01908907|7503159|FG001|Overall Study|Physician Decision|0
4567046|NCT01329029|7402158|FG000|Overall Study|Physician Decision|16
4567047|NCT01329029|7402159|FG001|Overall Study|Physician Decision|13
4567048|NCT01329029|7402158|FG000|Overall Study|Lost to Follow-up|8
4567049|NCT01329029|7402159|FG001|Overall Study|Lost to Follow-up|5
4567050|NCT01329029|7402158|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5
4567051|NCT01329029|7402159|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1
4567052|NCT01329263|7402190|FG000|Overall Study|Lost to Follow-up|4
4567053|NCT01329263|7402191|FG001|Overall Study|Lost to Follow-up|21
4567054|NCT01329263|7402190|FG000|Overall Study|Withdrawal by Subject|1
4567055|NCT01329263|7402191|FG001|Overall Study|Withdrawal by Subject|2
4567056|NCT01329328|7402202|FG000|Overall Study|Withdrawal by Subject|2
4567057|NCT01329328|7402203|FG001|Overall Study|Withdrawal by Subject|4
4567058|NCT01329328|7402204|FG002|Overall Study|Withdrawal by Subject|3
4567059|NCT01329419|7402216|FG000|Overall Study|Protocol Violation|235
4567060|NCT01329562|7402223|FG000|Overall Study|Protocol Violation|5
4567061|NCT01329562|7402224|FG001|Overall Study|Protocol Violation|3
4567062|NCT01329562|7402223|FG000|Overall Study|Lost to Follow-up|1
4567063|NCT01329562|7402224|FG001|Overall Study|Lost to Follow-up|1
4567064|NCT01329562|7402223|FG000|Overall Study|Subject withdrew due to personal issues.|3
4567065|NCT01329562|7402224|FG001|Overall Study|Subject withdrew due to personal issues.|2
4567066|NCT01329562|7402223|FG000|Overall Study|Physician Decision|0
4567067|NCT01329562|7402224|FG001|Overall Study|Physician Decision|1
4567068|NCT01329900|7402245|FG000|Overall Study|Elevated creatinine/renal function|1
4567069|NCT01329939|7402253|FG000|Overall Study|Lost to Follow-up|3
4567070|NCT01329939|7402254|FG001|Overall Study|Lost to Follow-up|0
4567071|NCT01329939|7402255|FG002|Overall Study|Lost to Follow-up|1
4567072|NCT01329939|7402256|FG003|Overall Study|Lost to Follow-up|2
4567073|NCT01329939|7402253|FG000|Overall Study|Withdrawal by Subject|0
4567074|NCT01329939|7402254|FG001|Overall Study|Withdrawal by Subject|1
4567075|NCT01329939|7402255|FG002|Overall Study|Withdrawal by Subject|0
4567076|NCT01329939|7402256|FG003|Overall Study|Withdrawal by Subject|0
4567077|NCT01329939|7402253|FG000|Overall Study|Adverse Event|0
4567078|NCT01329939|7402254|FG001|Overall Study|Adverse Event|0
4567079|NCT01329939|7402255|FG002|Overall Study|Adverse Event|0
4567080|NCT01329939|7402256|FG003|Overall Study|Adverse Event|3
4567081|NCT01329978|7402269|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1
4567082|NCT01329978|7402270|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2
4567083|NCT01329978|7402271|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
4567084|NCT01329978|7402272|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
4567085|NCT01329978|7402273|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
4567086|NCT01329978|7402269|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2
4625347|NCT01830595|7490323|FG000|First Period|Withdrawal by Subject|1
4625348|NCT01830595|7490324|FG001|First Period|Withdrawal by Subject|3
4625349|NCT01830595|7490323|FG000|Washout|Withdrawal by Subject|2
4625350|NCT01830595|7490324|FG001|Washout|Withdrawal by Subject|2
4625351|NCT01830816|7490351|FG000|Overall Study|Progressive Disease|12
4625352|NCT01830816|7490352|FG001|Overall Study|Progressive Disease|7
4625353|NCT01830816|7490353|FG002|Overall Study|Progressive Disease|7
4625354|NCT01830816|7490351|FG000|Overall Study|Adverse Event|3
4625355|NCT01830816|7490352|FG001|Overall Study|Adverse Event|4
4625356|NCT01830816|7490353|FG002|Overall Study|Adverse Event|0
4625357|NCT01830816|7490351|FG000|Overall Study|Study Terminated by Sponsor|1
4625358|NCT01830816|7490352|FG001|Overall Study|Study Terminated by Sponsor|1
4625359|NCT01830816|7490353|FG002|Overall Study|Study Terminated by Sponsor|0
4625360|NCT01830816|7490351|FG000|Overall Study|Withdrawal by Subject|1
4625361|NCT01830816|7490352|FG001|Overall Study|Withdrawal by Subject|1
4625362|NCT01830816|7490353|FG002|Overall Study|Withdrawal by Subject|0
4625363|NCT01830816|7490351|FG000|Overall Study|Lost to Follow-up|0
4625364|NCT01830816|7490352|FG001|Overall Study|Lost to Follow-up|1
4625365|NCT01830816|7490353|FG002|Overall Study|Lost to Follow-up|0
4625366|NCT01830816|7490351|FG000|Overall Study|Symptomatic Deterioration|1
4625367|NCT01830816|7490352|FG001|Overall Study|Symptomatic Deterioration|0
4625368|NCT01830816|7490353|FG002|Overall Study|Symptomatic Deterioration|0
4625369|NCT01830816|7490351|FG000|Overall Study|Reason not Specified|2
4625370|NCT01830816|7490352|FG001|Overall Study|Reason not Specified|0
4625371|NCT01830816|7490353|FG002|Overall Study|Reason not Specified|0
4625372|NCT01830855|7490377|FG000|Overall Study|Other|7
4625373|NCT01830855|7490378|FG001|Overall Study|Other|1
4625374|NCT01830855|7490379|FG002|Overall Study|Other|4
4625375|NCT01830855|7490380|FG003|Overall Study|Other|4
4625376|NCT01830855|7490377|FG000|Overall Study|Medication error without associated AE|1
4625377|NCT01830855|7490378|FG001|Overall Study|Medication error without associated AE|0
4625378|NCT01830855|7490379|FG002|Overall Study|Medication error without associated AE|0
4625379|NCT01830855|7490380|FG003|Overall Study|Medication error without associated AE|1
4625380|NCT01830855|7490377|FG000|Overall Study|Pregnancy|3
4625381|NCT01830855|7490378|FG001|Overall Study|Pregnancy|1
4625382|NCT01830855|7490379|FG002|Overall Study|Pregnancy|2
4567087|NCT01329978|7402270|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8
4567088|NCT01329978|7402271|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2
4567089|NCT01329978|7402272|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0
4567090|NCT01329978|7402273|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0
4625383|NCT01830855|7490380|FG003|Overall Study|Pregnancy|1
4567091|NCT01329978|7402269|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1
4567092|NCT01329978|7402270|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1
4567093|NCT01329978|7402271|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3
4567094|NCT01329978|7402272|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0
4567095|NCT01329978|7402273|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0
4567096|NCT01329978|7402269|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
4567097|NCT01329978|7402270|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1
4567098|NCT01329978|7402271|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
4567099|NCT01329978|7402272|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
4567100|NCT01329978|7402273|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
4567101|NCT01329978|7402269|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
4567102|NCT01329978|7402270|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1
4567103|NCT01329978|7402271|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
4567104|NCT01329978|7402272|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
4567105|NCT01329978|7402273|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
4567106|NCT01329978|7402269|FG000|Rerandomization Treatment Period|Lost to Follow-up|0
4567107|NCT01329978|7402270|FG001|Rerandomization Treatment Period|Lost to Follow-up|0
4567108|NCT01329978|7402271|FG002|Rerandomization Treatment Period|Lost to Follow-up|0
4567109|NCT01329978|7402272|FG003|Rerandomization Treatment Period|Lost to Follow-up|5
4567110|NCT01329978|7402273|FG004|Rerandomization Treatment Period|Lost to Follow-up|3
4567111|NCT01329978|7402269|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0
4567112|NCT01329978|7402270|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0
4567113|NCT01329978|7402271|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0
4567114|NCT01329978|7402272|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0
4567115|NCT01329978|7402273|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1
4567116|NCT01330017|7402290|FG000|Overall Study|Adverse Event|0
4567117|NCT01330017|7402291|FG001|Overall Study|Adverse Event|1
4625384|NCT01830855|7490377|FG000|Overall Study|No longer meets eligibility criteria|11
4625385|NCT01830855|7490378|FG001|Overall Study|No longer meets eligibility criteria|2
4625386|NCT01830855|7490379|FG002|Overall Study|No longer meets eligibility criteria|3
4625387|NCT01830855|7490380|FG003|Overall Study|No longer meets eligibility criteria|5
4625388|NCT01830855|7490377|FG000|Overall Study|Adverse Event|11
4625389|NCT01830855|7490378|FG001|Overall Study|Adverse Event|5
4625390|NCT01830855|7490379|FG002|Overall Study|Adverse Event|6
4625391|NCT01830855|7490380|FG003|Overall Study|Adverse Event|3
4625392|NCT01830855|7490377|FG000|Overall Study|Protocol deviation|10
4625393|NCT01830855|7490378|FG001|Overall Study|Protocol deviation|5
4625394|NCT01830855|7490379|FG002|Overall Study|Protocol deviation|6
4625395|NCT01830855|7490380|FG003|Overall Study|Protocol deviation|6
4625396|NCT01830855|7490377|FG000|Overall Study|Withdrawal by Subject|33
4625397|NCT01830855|7490378|FG001|Overall Study|Withdrawal by Subject|14
4625398|NCT01830855|7490379|FG002|Overall Study|Withdrawal by Subject|10
4625399|NCT01830855|7490380|FG003|Overall Study|Withdrawal by Subject|12
4625400|NCT01830855|7490377|FG000|Overall Study|No longer willing to participate|32
4625401|NCT01830855|7490378|FG001|Overall Study|No longer willing to participate|13
4625402|NCT01830855|7490379|FG002|Overall Study|No longer willing to participate|12
4625403|NCT01830855|7490380|FG003|Overall Study|No longer willing to participate|17
4625404|NCT01830855|7490377|FG000|Overall Study|Lost to Follow-up|47
4625405|NCT01830855|7490378|FG001|Overall Study|Lost to Follow-up|20
4625406|NCT01830855|7490379|FG002|Overall Study|Lost to Follow-up|23
4625407|NCT01830855|7490380|FG003|Overall Study|Lost to Follow-up|33
4625408|NCT01830881|7490397|FG000|Overall Study|Changed decision to have an abortion|0
4625409|NCT01830881|7490398|FG001|Overall Study|Changed decision to have an abortion|1
4625410|NCT01830920|7490411|FG000|Overall Study|Adverse Event|1
4625411|NCT01830920|7490412|FG001|Overall Study|Adverse Event|0
4625412|NCT01830920|7490413|FG002|Overall Study|Adverse Event|1
4625413|NCT01830920|7490414|FG003|Overall Study|Adverse Event|0
4625414|NCT01830920|7490415|FG004|Overall Study|Adverse Event|0
4625415|NCT01830920|7490411|FG000|Overall Study|Withdrawal by Subject|2
4625416|NCT01830920|7490412|FG001|Overall Study|Withdrawal by Subject|2
4625417|NCT01830920|7490413|FG002|Overall Study|Withdrawal by Subject|1
4625418|NCT01830920|7490414|FG003|Overall Study|Withdrawal by Subject|7
4625419|NCT01830920|7490415|FG004|Overall Study|Withdrawal by Subject|1
4625420|NCT01830920|7490411|FG000|Overall Study|Death|3
4625421|NCT01830920|7490412|FG001|Overall Study|Death|3
4625422|NCT01830920|7490413|FG002|Overall Study|Death|5
4625423|NCT01830920|7490414|FG003|Overall Study|Death|4
4625424|NCT01830920|7490415|FG004|Overall Study|Death|4
4625425|NCT01830920|7490411|FG000|Overall Study|Other|15
4625426|NCT01830920|7490412|FG001|Overall Study|Other|1
4625427|NCT01830920|7490413|FG002|Overall Study|Other|1
4625428|NCT01830920|7490414|FG003|Overall Study|Other|5
4625429|NCT01830920|7490415|FG004|Overall Study|Other|3
4625430|NCT01830972|7490438|FG000|Part II|Withdrawal by Subject|2
4625431|NCT01830972|7490439|FG001|Part II|Withdrawal by Subject|2
4625432|NCT01830972|7490438|FG000|Part III|Withdrawal by Subject|1
4625433|NCT01830972|7490439|FG001|Part III|Withdrawal by Subject|0
4625434|NCT01830972|7490438|FG000|Part III|Noncompliance|1
4567118|NCT01330017|7402292|FG002|Overall Study|Adverse Event|1
4567119|NCT01330017|7402293|FG003|Overall Study|Adverse Event|4
4567120|NCT01330017|7402294|FG004|Overall Study|Adverse Event|0
4567121|NCT01330017|7402290|FG000|Overall Study|Withdrawal by Subject|0
4567122|NCT01330017|7402291|FG001|Overall Study|Withdrawal by Subject|0
4567123|NCT01330017|7402292|FG002|Overall Study|Withdrawal by Subject|1
4567124|NCT01330017|7402293|FG003|Overall Study|Withdrawal by Subject|0
4567125|NCT01330017|7402294|FG004|Overall Study|Withdrawal by Subject|1
4567126|NCT01330017|7402290|FG000|Overall Study|Lost to Follow-up|0
4567127|NCT01330017|7402291|FG001|Overall Study|Lost to Follow-up|0
4567128|NCT01330017|7402292|FG002|Overall Study|Lost to Follow-up|1
4567129|NCT01330017|7402293|FG003|Overall Study|Lost to Follow-up|0
4567130|NCT01330017|7402294|FG004|Overall Study|Lost to Follow-up|0
4567131|NCT01330017|7402290|FG000|Overall Study|Protocol Violation|0
4567132|NCT01330017|7402291|FG001|Overall Study|Protocol Violation|0
4567133|NCT01330017|7402292|FG002|Overall Study|Protocol Violation|0
4567134|NCT01330017|7402293|FG003|Overall Study|Protocol Violation|1
4567135|NCT01330017|7402294|FG004|Overall Study|Protocol Violation|0
4567136|NCT01330017|7402290|FG000|Overall Study|Unknown Reason|5
4567137|NCT01330017|7402291|FG001|Overall Study|Unknown Reason|3
4567138|NCT01330017|7402292|FG002|Overall Study|Unknown Reason|5
4567139|NCT01330017|7402293|FG003|Overall Study|Unknown Reason|7
4567140|NCT01330017|7402294|FG004|Overall Study|Unknown Reason|2
4567141|NCT01330030|7402308|FG000|Overall Study|Lost to Follow-up|16
4567142|NCT01330030|7402309|FG001|Overall Study|Lost to Follow-up|17
4567143|NCT01330108|7402324|FG000|Overall Study|Withdrawal by Subject|4
4567144|NCT01330303|7402341|FG000|Period 1|Adverse Event|1
4567145|NCT01330303|7402342|FG001|Period 1|Adverse Event|0
4567146|NCT01330303|7402341|FG000|Period 1|Protocol Violation|0
4567147|NCT01330303|7402342|FG001|Period 1|Protocol Violation|1
4567148|NCT01330303|7402341|FG000|Period 1|Withdrawal by Subject|0
4567149|NCT01330303|7402342|FG001|Period 1|Withdrawal by Subject|1
4567150|NCT01330316|7402351|FG000|Overall Study|Adverse Event|2
4567151|NCT01330316|7402352|FG001|Overall Study|Adverse Event|2
4567152|NCT01330316|7402351|FG000|Overall Study|Lack of Efficacy|0
4567153|NCT01330316|7402352|FG001|Overall Study|Lack of Efficacy|10
4567154|NCT01330316|7402351|FG000|Overall Study|Lost to Follow-up|0
4567155|NCT01330316|7402352|FG001|Overall Study|Lost to Follow-up|1
4567156|NCT01330316|7402351|FG000|Overall Study|Withdrawal by Subject|0
4567157|NCT01330316|7402352|FG001|Overall Study|Withdrawal by Subject|1
4567158|NCT01330316|7402351|FG000|Overall Study|other than above|0
4567159|NCT01330316|7402352|FG001|Overall Study|other than above|1
4567160|NCT01330381|7402369|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5
4567161|NCT01330381|7402370|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4
4567162|NCT01330381|7402371|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0
4567163|NCT01330381|7402369|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2
4567164|NCT01330381|7402370|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1
4567165|NCT01330381|7402371|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0
4567166|NCT01330381|7402369|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1
4567167|NCT01330381|7402370|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1
4567168|NCT01330381|7402371|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0
4625435|NCT01830972|7490439|FG001|Part III|Noncompliance|0
4625436|NCT01830972|7490438|FG000|Part IV|Withdrawal by Subject|2
4625437|NCT01830972|7490439|FG001|Part IV|Withdrawal by Subject|1
4625438|NCT01830972|7490438|FG000|Part IV|Non-Compliance|1
4625439|NCT01830972|7490439|FG001|Part IV|Non-Compliance|0
4625440|NCT01831089|7490461|FG000|Cohort I: Dose Level 1|Progressive disease|3
4625441|NCT01831089|7490462|FG001|Cohort I: Dose Level 1|Progressive disease|0
4625442|NCT01831089|7490463|FG002|Cohort I: Dose Level 1|Progressive disease|0
4625443|NCT01831089|7490464|FG003|Cohort I: Dose Level 1|Progressive disease|0
4625444|NCT01831089|7490465|FG004|Cohort I: Dose Level 1|Progressive disease|0
4625445|NCT01831089|7490466|FG005|Cohort I: Dose Level 1|Progressive disease|0
4625446|NCT01831089|7490461|FG000|Cohort II: Dose Level 2|Progressive disease|0
4625447|NCT01831089|7490462|FG001|Cohort II: Dose Level 2|Progressive disease|2
4625448|NCT01831089|7490463|FG002|Cohort II: Dose Level 2|Progressive disease|0
4625449|NCT01831089|7490464|FG003|Cohort II: Dose Level 2|Progressive disease|0
4625450|NCT01831089|7490465|FG004|Cohort II: Dose Level 2|Progressive disease|0
4625451|NCT01831089|7490466|FG005|Cohort II: Dose Level 2|Progressive disease|0
4625452|NCT01831089|7490461|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0
4625453|NCT01831089|7490462|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1
4625454|NCT01831089|7490463|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0
4625455|NCT01831089|7490464|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0
4625456|NCT01831089|7490465|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0
4625457|NCT01831089|7490466|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0
4625458|NCT01831089|7490461|FG000|Cohort III: Dose Level 3|Progressive disease|0
4625459|NCT01831089|7490462|FG001|Cohort III: Dose Level 3|Progressive disease|0
4625460|NCT01831089|7490463|FG002|Cohort III: Dose Level 3|Progressive disease|3
4567169|NCT01330381|7402369|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1
4567170|NCT01330381|7402370|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0
4567171|NCT01330381|7402371|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0
4567172|NCT01330381|7402369|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1
4567173|NCT01330381|7402370|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0
4567174|NCT01330381|7402371|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0
4593780|NCT01555125|7442333|FG002|Extension|Lost to Follow-up|2
4625461|NCT01831089|7490464|FG003|Cohort III: Dose Level 3|Progressive disease|0
4625462|NCT01831089|7490465|FG004|Cohort III: Dose Level 3|Progressive disease|0
4625463|NCT01831089|7490466|FG005|Cohort III: Dose Level 3|Progressive disease|0
4625464|NCT01831089|7490461|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0
4625465|NCT01831089|7490462|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0
4625466|NCT01831089|7490463|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1
4625467|NCT01831089|7490464|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0
4625468|NCT01831089|7490465|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0
4625469|NCT01831089|7490466|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0
4625470|NCT01831089|7490461|FG000|Cohort III: Dose Level 3|Adverse Event|0
4625471|NCT01831089|7490462|FG001|Cohort III: Dose Level 3|Adverse Event|0
4625472|NCT01831089|7490463|FG002|Cohort III: Dose Level 3|Adverse Event|1
4625473|NCT01831089|7490464|FG003|Cohort III: Dose Level 3|Adverse Event|0
4625474|NCT01831089|7490465|FG004|Cohort III: Dose Level 3|Adverse Event|0
4625475|NCT01831089|7490466|FG005|Cohort III: Dose Level 3|Adverse Event|0
4625476|NCT01831089|7490461|FG000|Cohort III: Dose Level 3|Global end of study|0
4625477|NCT01831089|7490462|FG001|Cohort III: Dose Level 3|Global end of study|0
4625478|NCT01831089|7490463|FG002|Cohort III: Dose Level 3|Global end of study|1
4625479|NCT01831089|7490464|FG003|Cohort III: Dose Level 3|Global end of study|0
4625480|NCT01831089|7490465|FG004|Cohort III: Dose Level 3|Global end of study|0
4625481|NCT01831089|7490466|FG005|Cohort III: Dose Level 3|Global end of study|0
4625482|NCT01831089|7490461|FG000|Cohort IV: Dose Level 4|Progressive disease|0
4625483|NCT01831089|7490462|FG001|Cohort IV: Dose Level 4|Progressive disease|0
4625484|NCT01831089|7490463|FG002|Cohort IV: Dose Level 4|Progressive disease|0
4625485|NCT01831089|7490464|FG003|Cohort IV: Dose Level 4|Progressive disease|6
4625486|NCT01831089|7490465|FG004|Cohort IV: Dose Level 4|Progressive disease|0
4625487|NCT01831089|7490466|FG005|Cohort IV: Dose Level 4|Progressive disease|0
4625488|NCT01831089|7490461|FG000|Cohort V: Dose Level 5|Progressive disease|0
4625489|NCT01831089|7490462|FG001|Cohort V: Dose Level 5|Progressive disease|0
4625490|NCT01831089|7490463|FG002|Cohort V: Dose Level 5|Progressive disease|0
4625491|NCT01831089|7490464|FG003|Cohort V: Dose Level 5|Progressive disease|0
4625492|NCT01831089|7490465|FG004|Cohort V: Dose Level 5|Progressive disease|30
4625493|NCT01831089|7490466|FG005|Cohort V: Dose Level 5|Progressive disease|0
4625494|NCT01831089|7490461|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0
4625495|NCT01831089|7490462|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0
4625496|NCT01831089|7490463|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0
4625497|NCT01831089|7490464|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0
4625498|NCT01831089|7490465|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3
4625499|NCT01831089|7490466|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0
4625500|NCT01831089|7490461|FG000|Cohort V: Dose Level 5|Death|0
4625501|NCT01831089|7490462|FG001|Cohort V: Dose Level 5|Death|0
4625502|NCT01831089|7490463|FG002|Cohort V: Dose Level 5|Death|0
4625503|NCT01831089|7490464|FG003|Cohort V: Dose Level 5|Death|0
4625504|NCT01831089|7490465|FG004|Cohort V: Dose Level 5|Death|1
4625505|NCT01831089|7490466|FG005|Cohort V: Dose Level 5|Death|0
4625506|NCT01831089|7490461|FG000|Cohort V: Dose Level 5|Global end of study|0
4625507|NCT01831089|7490462|FG001|Cohort V: Dose Level 5|Global end of study|0
4625508|NCT01831089|7490463|FG002|Cohort V: Dose Level 5|Global end of study|0
4625509|NCT01831089|7490464|FG003|Cohort V: Dose Level 5|Global end of study|0
4625510|NCT01831089|7490465|FG004|Cohort V: Dose Level 5|Global end of study|2
4625511|NCT01831089|7490466|FG005|Cohort V: Dose Level 5|Global end of study|0
4625512|NCT01831089|7490461|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0
4625513|NCT01831089|7490462|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0
4625514|NCT01831089|7490463|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0
4625515|NCT01831089|7490464|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0
4625516|NCT01831089|7490465|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1
4625517|NCT01831089|7490466|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0
4625518|NCT01831089|7490461|FG000|Cohort B: Arm B|Progressive disease|0
4625519|NCT01831089|7490462|FG001|Cohort B: Arm B|Progressive disease|0
4625520|NCT01831089|7490463|FG002|Cohort B: Arm B|Progressive disease|0
4625521|NCT01831089|7490464|FG003|Cohort B: Arm B|Progressive disease|0
4625522|NCT01831089|7490465|FG004|Cohort B: Arm B|Progressive disease|0
4625523|NCT01831089|7490466|FG005|Cohort B: Arm B|Progressive disease|8
4625524|NCT01831089|7490461|FG000|Cohort B: Arm B|Physician Decision|0
4625525|NCT01831089|7490462|FG001|Cohort B: Arm B|Physician Decision|0
4625526|NCT01831089|7490463|FG002|Cohort B: Arm B|Physician Decision|0
4625527|NCT01831089|7490464|FG003|Cohort B: Arm B|Physician Decision|0
4625528|NCT01831089|7490465|FG004|Cohort B: Arm B|Physician Decision|0
4625529|NCT01831089|7490466|FG005|Cohort B: Arm B|Physician Decision|2
4625530|NCT01831089|7490461|FG000|Cohort B: Arm B|Never treated|0
4625531|NCT01831089|7490462|FG001|Cohort B: Arm B|Never treated|0
4625532|NCT01831089|7490463|FG002|Cohort B: Arm B|Never treated|0
4625533|NCT01831089|7490464|FG003|Cohort B: Arm B|Never treated|0
4567175|NCT01330381|7402369|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1
4567176|NCT01330381|7402370|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1
4567177|NCT01330381|7402371|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0
4567178|NCT01330381|7402369|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7
4567179|NCT01330381|7402370|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0
4567180|NCT01330381|7402371|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16
4567181|NCT01330381|7402369|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2
4567182|NCT01330381|7402370|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0
4567183|NCT01330381|7402371|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0
4567184|NCT01330381|7402369|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1
4567185|NCT01330381|7402370|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0
4567186|NCT01330381|7402371|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1
4567187|NCT01330381|7402369|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0
4567188|NCT01330381|7402370|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0
4567189|NCT01330381|7402371|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1
4567190|NCT01330433|7402395|FG000|Overall Study|Death|1
4567191|NCT01330433|7402396|FG001|Overall Study|Death|3
4567192|NCT01330433|7402395|FG000|Overall Study|Lost to Follow-up|1
4567193|NCT01330433|7402396|FG001|Overall Study|Lost to Follow-up|0
4567194|NCT01330459|7402404|FG000|Overall Study|Physician Decision|0
4567195|NCT01330459|7402405|FG001|Overall Study|Physician Decision|2
4567196|NCT01330628|7402415|FG000|Overall Study|Death|2
4567197|NCT01330628|7402416|FG001|Overall Study|Death|3
4567198|NCT01330628|7402415|FG000|Overall Study|Lost to Follow-up|5
4567199|NCT01330628|7402416|FG001|Overall Study|Lost to Follow-up|6
4567200|NCT01330628|7402415|FG000|Overall Study|Adverse Event|44
4567201|NCT01330628|7402416|FG001|Overall Study|Adverse Event|25
4567202|NCT01330628|7402415|FG000|Overall Study|Withdrawn|18
4567203|NCT01330628|7402416|FG001|Overall Study|Withdrawn|6
4567204|NCT01330628|7402415|FG000|Overall Study|Didn't receive study treatment|1
4567205|NCT01330628|7402416|FG001|Overall Study|Didn't receive study treatment|0
4567206|NCT01330914|7402422|FG000|Overall Study|Withdrawal by Subject|4
4567207|NCT01330914|7402422|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3
4592549|NCT01543087|7440410|FG003|Stage 1 (48 Months)|No longer willing to participate|6
4592550|NCT01543087|7440411|FG004|Stage 1 (48 Months)|No longer willing to participate|3
4592551|NCT01543087|7440412|FG005|Stage 1 (48 Months)|No longer willing to participate|0
4592552|NCT01543087|7440407|FG000|Stage 1 (48 Months)|Other than specified|5
4592553|NCT01543087|7440408|FG001|Stage 1 (48 Months)|Other than specified|0
4592554|NCT01543087|7440409|FG002|Stage 1 (48 Months)|Other than specified|9
4592555|NCT01543087|7440410|FG003|Stage 1 (48 Months)|Other than specified|0
4592556|NCT01543087|7440411|FG004|Stage 1 (48 Months)|Other than specified|0
4592557|NCT01543087|7440412|FG005|Stage 1 (48 Months)|Other than specified|0
4592558|NCT01543087|7440407|FG000|Stage 1 (48 Months)|Protocol Violation|0
4592559|NCT01543087|7440408|FG001|Stage 1 (48 Months)|Protocol Violation|3
4592560|NCT01543087|7440409|FG002|Stage 1 (48 Months)|Protocol Violation|0
4592561|NCT01543087|7440410|FG003|Stage 1 (48 Months)|Protocol Violation|0
4592562|NCT01543087|7440411|FG004|Stage 1 (48 Months)|Protocol Violation|0
4592563|NCT01543087|7440412|FG005|Stage 1 (48 Months)|Protocol Violation|0
4592564|NCT01543087|7440407|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0
4592565|NCT01543087|7440408|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1
4592566|NCT01543087|7440409|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0
4592567|NCT01543087|7440410|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0
4592568|NCT01543087|7440411|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2
4592569|NCT01543087|7440412|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0
4592570|NCT01543087|7440407|FG000|Booster Stage (26 Months)|Lost to Follow-up|0
4592571|NCT01543087|7440408|FG001|Booster Stage (26 Months)|Lost to Follow-up|0
4592572|NCT01543087|7440409|FG002|Booster Stage (26 Months)|Lost to Follow-up|1
4592573|NCT01543087|7440410|FG003|Booster Stage (26 Months)|Lost to Follow-up|0
4592574|NCT01543087|7440411|FG004|Booster Stage (26 Months)|Lost to Follow-up|0
4592575|NCT01543087|7440412|FG005|Booster Stage (26 Months)|Lost to Follow-up|0
4592576|NCT01543152|7440453|FG000|Overall Study|Withdrawal by Subject|0
4592577|NCT01543152|7440454|FG001|Overall Study|Withdrawal by Subject|2
4592578|NCT01543152|7440455|FG002|Overall Study|Withdrawal by Subject|0
4592579|NCT01543152|7440456|FG003|Overall Study|Withdrawal by Subject|0
4592580|NCT01543152|7440457|FG004|Overall Study|Withdrawal by Subject|0
4592581|NCT01543204|7440481|FG000|Overall Study|Non-compliance|1
4592582|NCT01543204|7440481|FG000|Overall Study|Adverse Event|1
4592583|NCT01543204|7440481|FG000|Overall Study|Withdrawal by Subject|4
4592584|NCT01543204|7440481|FG000|Overall Study|Requirement for Alternative Therapy|1
4592585|NCT01543204|7440481|FG000|Overall Study|Lost to Follow-up|1
4592586|NCT01543490|7440491|FG000|Overall Study|Adverse Event|4
4592587|NCT01543490|7440492|FG001|Overall Study|Adverse Event|0
4592588|NCT01543490|7440491|FG000|Overall Study|Physician Decision|1
4592589|NCT01543490|7440492|FG001|Overall Study|Physician Decision|0
4592590|NCT01543490|7440491|FG000|Overall Study|Lack of Efficacy|3
4592591|NCT01543490|7440492|FG001|Overall Study|Lack of Efficacy|3
4592592|NCT01543490|7440491|FG000|Overall Study|Lost to Follow-up|5
4592593|NCT01543490|7440492|FG001|Overall Study|Lost to Follow-up|0
4567208|NCT01331005|7402458|FG000|Overall Study|Lost to Follow-up|2
4567209|NCT01331005|7402459|FG001|Overall Study|Lost to Follow-up|1
4567210|NCT01331005|7402458|FG000|Overall Study|Withdrawal by Subject|2
4567211|NCT01331005|7402459|FG001|Overall Study|Withdrawal by Subject|3
4567212|NCT01331109|7402474|FG000|Overall Study|Adverse Event|6
4567213|NCT01331109|7402474|FG000|Overall Study|Lack of Efficacy|2
4567214|NCT01331109|7402474|FG000|Overall Study|Protocol Violation|3
4567215|NCT01331109|7402474|FG000|Overall Study|Withdrawal by Subject|7
4567216|NCT01331109|7402474|FG000|Overall Study|Lost to Follow-up|1
4567217|NCT01331109|7402474|FG000|Overall Study|Study Terminated by Sponsor|38
4567218|NCT01331161|7402480|FG000|Overall Study|Physician Decision|1
4567219|NCT01331161|7402481|FG001|Overall Study|Physician Decision|0
4567220|NCT01331161|7402480|FG000|Overall Study|Lost to Follow-up|0
4567221|NCT01331161|7402481|FG001|Overall Study|Lost to Follow-up|1
4567222|NCT01331161|7402480|FG000|Overall Study|Pregnancy|0
4567223|NCT01331161|7402481|FG001|Overall Study|Pregnancy|1
4567224|NCT01331239|7402500|FG000|Part II: Core Study|Adverse Event|0
4567225|NCT01331239|7402501|FG001|Part II: Core Study|Adverse Event|3
4567226|NCT01331239|7402502|FG002|Part II: Core Study|Adverse Event|0
4567227|NCT01331239|7402500|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0
4567228|NCT01331239|7402501|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2
4567229|NCT01331239|7402502|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1
4567230|NCT01331239|7402500|FG000|Part II: Core Study|Withdrawal by Subject|0
4567231|NCT01331239|7402501|FG001|Part II: Core Study|Withdrawal by Subject|2
4567232|NCT01331239|7402502|FG002|Part II: Core Study|Withdrawal by Subject|0
4567233|NCT01331239|7402500|FG000|Part II: Core Study|Administrative problems|0
4567234|NCT01331239|7402501|FG001|Part II: Core Study|Administrative problems|1
4567235|NCT01331239|7402502|FG002|Part II: Core Study|Administrative problems|0
4567236|NCT01331291|7402520|FG000|Overall Study|Lack of Efficacy|2
4567237|NCT01331291|7402521|FG001|Overall Study|Lack of Efficacy|8
4567238|NCT01331291|7402520|FG000|Overall Study|Death|0
4567239|NCT01331291|7402521|FG001|Overall Study|Death|1
4567240|NCT01331681|7402543|FG000|Overall Study|Adverse Event|10
4567241|NCT01331681|7402544|FG001|Overall Study|Adverse Event|13
4567242|NCT01331681|7402545|FG002|Overall Study|Adverse Event|10
4567243|NCT01331681|7402543|FG000|Overall Study|Death|6
4567244|NCT01331681|7402544|FG001|Overall Study|Death|6
4567245|NCT01331681|7402545|FG002|Overall Study|Death|2
4567246|NCT01331681|7402543|FG000|Overall Study|Lack of Efficacy|0
4567247|NCT01331681|7402544|FG001|Overall Study|Lack of Efficacy|1
4567248|NCT01331681|7402545|FG002|Overall Study|Lack of Efficacy|0
4567249|NCT01331681|7402543|FG000|Overall Study|Withdrawal by Subject|12
4567250|NCT01331681|7402544|FG001|Overall Study|Withdrawal by Subject|8
4567251|NCT01331681|7402545|FG002|Overall Study|Withdrawal by Subject|15
4567252|NCT01331681|7402543|FG000|Overall Study|Protocol Violation|1
4567253|NCT01331681|7402544|FG001|Overall Study|Protocol Violation|1
4567254|NCT01331681|7402545|FG002|Overall Study|Protocol Violation|0
4567255|NCT01331681|7402543|FG000|Overall Study|Lost to Follow-up|2
4567256|NCT01331681|7402544|FG001|Overall Study|Lost to Follow-up|4
4567257|NCT01331681|7402545|FG002|Overall Study|Lost to Follow-up|1
4567258|NCT01331681|7402543|FG000|Overall Study|Physician Decision|2
4567259|NCT01331681|7402544|FG001|Overall Study|Physician Decision|0
4567260|NCT01331681|7402545|FG002|Overall Study|Physician Decision|4
4567261|NCT01331681|7402543|FG000|Overall Study|Therapeutic procedure required|1
4567262|NCT01331681|7402544|FG001|Overall Study|Therapeutic procedure required|0
4567263|NCT01331681|7402545|FG002|Overall Study|Therapeutic procedure required|0
4567264|NCT01331681|7402543|FG000|Overall Study|Sponsor decision|1
4567265|NCT01331681|7402544|FG001|Overall Study|Sponsor decision|1
4567266|NCT01331681|7402545|FG002|Overall Study|Sponsor decision|0
4567267|NCT01331681|7402543|FG000|Overall Study|Switching to other therapy|0
4567268|NCT01331681|7402544|FG001|Overall Study|Switching to other therapy|0
4567269|NCT01331681|7402545|FG002|Overall Study|Switching to other therapy|1
4567270|NCT01331681|7402543|FG000|Overall Study|Not Received Study Treatment|0
4567271|NCT01331681|7402544|FG001|Overall Study|Not Received Study Treatment|0
4567272|NCT01331681|7402545|FG002|Overall Study|Not Received Study Treatment|2
4567273|NCT01331824|7402578|FG000|Overall Study|Adverse Event|2
4567274|NCT01331824|7402578|FG000|Overall Study|Death|1
4567275|NCT01331824|7402578|FG000|Overall Study|Disease Progression|9
4567276|NCT01331824|7402578|FG000|Overall Study|Withdrawal by Subject|1
4567277|NCT01331837|7402584|FG000|Overall Study|Death|30
4567278|NCT01331837|7402585|FG001|Overall Study|Death|34
4567279|NCT01331837|7402584|FG000|Overall Study|Lost to Follow-up|3
4567280|NCT01331837|7402585|FG001|Overall Study|Lost to Follow-up|1
4567281|NCT01331837|7402584|FG000|Overall Study|Info not recorded|10
4567282|NCT01331837|7402585|FG001|Overall Study|Info not recorded|16
4567283|NCT01331837|7402584|FG000|Overall Study|Withdrawal by Subject|13
4567284|NCT01331837|7402585|FG001|Overall Study|Withdrawal by Subject|16
4567285|NCT01332019|7402593|FG000|Overall Study|Was Not Dosed|1
4567286|NCT01332019|7402594|FG001|Overall Study|Was Not Dosed|0
4567287|NCT01332019|7402593|FG000|Overall Study|Other|16
4567288|NCT01332019|7402594|FG001|Overall Study|Other|18
4567289|NCT01332019|7402593|FG000|Overall Study|Death|2
4567290|NCT01332019|7402594|FG001|Overall Study|Death|1
4567291|NCT01332019|7402593|FG000|Overall Study|Physician Decision|4
4567292|NCT01332019|7402594|FG001|Overall Study|Physician Decision|3
4567293|NCT01332019|7402593|FG000|Overall Study|Withdrawal by Subject|73
4567294|NCT01332019|7402594|FG001|Overall Study|Withdrawal by Subject|71
4567295|NCT01332019|7402593|FG000|Overall Study|Lost to Follow-up|4
4567296|NCT01332019|7402594|FG001|Overall Study|Lost to Follow-up|7
4567297|NCT01332019|7402593|FG000|Overall Study|Adverse Event|13
4567298|NCT01332019|7402594|FG001|Overall Study|Adverse Event|22
4567299|NCT01332149|7402616|FG000|Overall Study|Adverse Event|11
4567300|NCT01332149|7402617|FG001|Overall Study|Adverse Event|9
4567301|NCT01332149|7402616|FG000|Overall Study|Other unspecified|5
4567302|NCT01332149|7402617|FG001|Overall Study|Other unspecified|7
4567303|NCT01332149|7402616|FG000|Overall Study|Protocol Violation|1
4567304|NCT01332149|7402617|FG001|Overall Study|Protocol Violation|3
4567305|NCT01332149|7402616|FG000|Overall Study|Withdrawal by Subject|4
4567306|NCT01332149|7402617|FG001|Overall Study|Withdrawal by Subject|5
4567307|NCT01332149|7402616|FG000|Overall Study|Lost to Follow-up|1
4567308|NCT01332149|7402617|FG001|Overall Study|Lost to Follow-up|1
4567309|NCT01332149|7402616|FG000|Overall Study|Insufficient clinical response|4
4567310|NCT01332149|7402617|FG001|Overall Study|Insufficient clinical response|7
4567311|NCT01332149|7402616|FG000|Overall Study|Did not meet entrance criteria|3
4567312|NCT01332149|7402617|FG001|Overall Study|Did not meet entrance criteria|4
4567313|NCT01332149|7402616|FG000|Overall Study|Randomized but not treated|1
4567314|NCT01332149|7402617|FG001|Overall Study|Randomized but not treated|2
4567315|NCT01332227|7402642|FG000|Overall Study|Adverse Event|4
4567316|NCT01332227|7402643|FG001|Overall Study|Adverse Event|1
4567317|NCT01332227|7402642|FG000|Overall Study|Withdrawal by Subject|5
4567318|NCT01332227|7402643|FG001|Overall Study|Withdrawal by Subject|1
4567319|NCT01332227|7402642|FG000|Overall Study|Lost to Follow-up|2
4567320|NCT01332227|7402643|FG001|Overall Study|Lost to Follow-up|0
4567321|NCT01332227|7402642|FG000|Overall Study|Lack of Efficacy|3
4567322|NCT01332227|7402643|FG001|Overall Study|Lack of Efficacy|1
4567323|NCT01332227|7402642|FG000|Overall Study|Poor compliance/noncompliance|1
4567324|NCT01332227|7402643|FG001|Overall Study|Poor compliance/noncompliance|1
4567325|NCT01332227|7402642|FG000|Overall Study|Patient moved from area|1
4567326|NCT01332227|7402643|FG001|Overall Study|Patient moved from area|0
4567327|NCT01332227|7402642|FG000|Overall Study|Patient began prohibited medication|0
4567328|NCT01332227|7402643|FG001|Overall Study|Patient began prohibited medication|1
4567329|NCT01332292|7402658|FG000|Treatment Period 1 (14 Days)|Adverse Event|1
4567330|NCT01332292|7402659|FG001|Treatment Period 1 (14 Days)|Adverse Event|0
4567331|NCT01332292|7402658|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1
4625534|NCT01831089|7490465|FG004|Cohort B: Arm B|Never treated|0
4625535|NCT01831089|7490466|FG005|Cohort B: Arm B|Never treated|2
4625536|NCT01831089|7490461|FG000|Cohort B: Arm B|Adverse Event|0
4625537|NCT01831089|7490462|FG001|Cohort B: Arm B|Adverse Event|0
4625538|NCT01831089|7490463|FG002|Cohort B: Arm B|Adverse Event|0
4625539|NCT01831089|7490464|FG003|Cohort B: Arm B|Adverse Event|0
4625540|NCT01831089|7490465|FG004|Cohort B: Arm B|Adverse Event|0
4625541|NCT01831089|7490466|FG005|Cohort B: Arm B|Adverse Event|1
4625542|NCT01831089|7490461|FG000|Cohort B: Arm B|Global end of study|0
4625543|NCT01831089|7490462|FG001|Cohort B: Arm B|Global end of study|0
4625544|NCT01831089|7490463|FG002|Cohort B: Arm B|Global end of study|0
4625545|NCT01831089|7490464|FG003|Cohort B: Arm B|Global end of study|0
4625546|NCT01831089|7490465|FG004|Cohort B: Arm B|Global end of study|0
4625547|NCT01831089|7490466|FG005|Cohort B: Arm B|Global end of study|1
4625548|NCT01831258|7490507|FG000|Overall Study|Withdrawal by Subject|2
4625549|NCT01831258|7490508|FG001|Overall Study|Withdrawal by Subject|1
4625550|NCT01831258|7490507|FG000|Overall Study|Lost to Follow-up|3
4625551|NCT01831258|7490508|FG001|Overall Study|Lost to Follow-up|2
4625552|NCT01831427|7490527|FG000|Overall Study|Adverse Event|0
4625553|NCT01831427|7490528|FG001|Overall Study|Adverse Event|1
4625554|NCT01831427|7490529|FG002|Overall Study|Adverse Event|0
4625555|NCT01831427|7490530|FG003|Overall Study|Adverse Event|0
4567332|NCT01332292|7402659|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1
4567333|NCT01332292|7402658|FG000|Treatment Period 2 (14 Days)|Physician Decision|1
4567334|NCT01332292|7402659|FG001|Treatment Period 2 (14 Days)|Physician Decision|1
4567335|NCT01332305|7402672|FG000|Overall Study|Adverse Event|1
4567336|NCT01332305|7402673|FG001|Overall Study|Adverse Event|4
4567337|NCT01332305|7402674|FG002|Overall Study|Adverse Event|6
4567338|NCT01332305|7402675|FG003|Overall Study|Adverse Event|3
4567339|NCT01332305|7402676|FG004|Overall Study|Adverse Event|5
4567340|NCT01332305|7402672|FG000|Overall Study|Withdrawal by Subject|6
4625556|NCT01831427|7490531|FG004|Overall Study|Adverse Event|0
4625557|NCT01831427|7490532|FG005|Overall Study|Adverse Event|1
4625558|NCT01831427|7490533|FG006|Overall Study|Adverse Event|0
4625559|NCT01831427|7490534|FG007|Overall Study|Adverse Event|1
4625560|NCT01831427|7490535|FG008|Overall Study|Adverse Event|0
4625561|NCT01831427|7490536|FG009|Overall Study|Adverse Event|0
4567341|NCT01332305|7402673|FG001|Overall Study|Withdrawal by Subject|5
4567342|NCT01332305|7402674|FG002|Overall Study|Withdrawal by Subject|4
4567343|NCT01332305|7402675|FG003|Overall Study|Withdrawal by Subject|1
4567344|NCT01332305|7402676|FG004|Overall Study|Withdrawal by Subject|0
4567345|NCT01332305|7402672|FG000|Overall Study|Lost to Follow-up|0
4567346|NCT01332305|7402673|FG001|Overall Study|Lost to Follow-up|2
4567347|NCT01332305|7402674|FG002|Overall Study|Lost to Follow-up|3
4567348|NCT01332305|7402675|FG003|Overall Study|Lost to Follow-up|2
4567349|NCT01332305|7402676|FG004|Overall Study|Lost to Follow-up|3
4567350|NCT01332305|7402672|FG000|Overall Study|Protocol Violation|1
4625562|NCT01831427|7490537|FG010|Overall Study|Adverse Event|2
4625563|NCT01831427|7490527|FG000|Overall Study|Investigator's Discretion|0
4625564|NCT01831427|7490528|FG001|Overall Study|Investigator's Discretion|0
4625565|NCT01831427|7490529|FG002|Overall Study|Investigator's Discretion|0
4625566|NCT01831427|7490530|FG003|Overall Study|Investigator's Discretion|1
4625567|NCT01831427|7490531|FG004|Overall Study|Investigator's Discretion|0
4625568|NCT01831427|7490532|FG005|Overall Study|Investigator's Discretion|0
4625569|NCT01831427|7490533|FG006|Overall Study|Investigator's Discretion|0
4625570|NCT01831427|7490534|FG007|Overall Study|Investigator's Discretion|0
4625571|NCT01831427|7490535|FG008|Overall Study|Investigator's Discretion|0
4625572|NCT01831427|7490536|FG009|Overall Study|Investigator's Discretion|0
4625573|NCT01831427|7490537|FG010|Overall Study|Investigator's Discretion|0
4625574|NCT01831427|7490527|FG000|Overall Study|Withdrew Consent|0
4625575|NCT01831427|7490528|FG001|Overall Study|Withdrew Consent|0
4625576|NCT01831427|7490529|FG002|Overall Study|Withdrew Consent|0
4625577|NCT01831427|7490530|FG003|Overall Study|Withdrew Consent|0
4625578|NCT01831427|7490531|FG004|Overall Study|Withdrew Consent|0
4625579|NCT01831427|7490532|FG005|Overall Study|Withdrew Consent|0
4625580|NCT01831427|7490533|FG006|Overall Study|Withdrew Consent|2
4625581|NCT01831427|7490534|FG007|Overall Study|Withdrew Consent|0
4625582|NCT01831427|7490535|FG008|Overall Study|Withdrew Consent|0
4625583|NCT01831427|7490536|FG009|Overall Study|Withdrew Consent|1
4625584|NCT01831427|7490537|FG010|Overall Study|Withdrew Consent|1
4625585|NCT01831466|7490584|FG000|Overall Study|Protocol Violation|1
4625586|NCT01831466|7490585|FG001|Overall Study|Protocol Violation|1
4625587|NCT01831466|7490586|FG002|Overall Study|Protocol Violation|2
4625588|NCT01831466|7490587|FG003|Overall Study|Protocol Violation|0
4625589|NCT01831466|7490588|FG004|Overall Study|Protocol Violation|0
4625590|NCT01831466|7490589|FG005|Overall Study|Protocol Violation|1
4625591|NCT01831466|7490590|FG006|Overall Study|Protocol Violation|0
4625592|NCT01831466|7490591|FG007|Overall Study|Protocol Violation|0
4625593|NCT01831466|7490592|FG008|Overall Study|Protocol Violation|0
4625594|NCT01831466|7490593|FG009|Overall Study|Protocol Violation|0
4625595|NCT01831466|7490594|FG010|Overall Study|Protocol Violation|0
4625596|NCT01831466|7490595|FG011|Overall Study|Protocol Violation|0
4625597|NCT01831466|7490584|FG000|Overall Study|Other|2
4625598|NCT01831466|7490585|FG001|Overall Study|Other|3
4625599|NCT01831466|7490586|FG002|Overall Study|Other|2
4625600|NCT01831466|7490587|FG003|Overall Study|Other|2
4625601|NCT01831466|7490588|FG004|Overall Study|Other|2
4625602|NCT01831466|7490589|FG005|Overall Study|Other|1
4625603|NCT01831466|7490590|FG006|Overall Study|Other|0
4625604|NCT01831466|7490591|FG007|Overall Study|Other|0
4625605|NCT01831466|7490592|FG008|Overall Study|Other|0
4625606|NCT01831466|7490593|FG009|Overall Study|Other|0
4625607|NCT01831466|7490594|FG010|Overall Study|Other|0
4625608|NCT01831466|7490595|FG011|Overall Study|Other|0
4625609|NCT01831466|7490584|FG000|Overall Study|Non-compliance with study treatment|2
4625610|NCT01831466|7490585|FG001|Overall Study|Non-compliance with study treatment|1
4625611|NCT01831466|7490586|FG002|Overall Study|Non-compliance with study treatment|1
4625612|NCT01831466|7490587|FG003|Overall Study|Non-compliance with study treatment|0
4625613|NCT01831466|7490588|FG004|Overall Study|Non-compliance with study treatment|0
4625614|NCT01831466|7490589|FG005|Overall Study|Non-compliance with study treatment|1
4625615|NCT01831466|7490590|FG006|Overall Study|Non-compliance with study treatment|0
4625616|NCT01831466|7490591|FG007|Overall Study|Non-compliance with study treatment|0
4625617|NCT01831466|7490592|FG008|Overall Study|Non-compliance with study treatment|0
4625618|NCT01831466|7490593|FG009|Overall Study|Non-compliance with study treatment|0
4567351|NCT01332305|7402673|FG001|Overall Study|Protocol Violation|2
4625619|NCT01831466|7490594|FG010|Overall Study|Non-compliance with study treatment|0
4625620|NCT01831466|7490595|FG011|Overall Study|Non-compliance with study treatment|0
4625621|NCT01831466|7490584|FG000|Overall Study|Death|0
4625622|NCT01831466|7490585|FG001|Overall Study|Death|1
4625623|NCT01831466|7490586|FG002|Overall Study|Death|0
4625624|NCT01831466|7490587|FG003|Overall Study|Death|0
4625625|NCT01831466|7490588|FG004|Overall Study|Death|0
4625626|NCT01831466|7490589|FG005|Overall Study|Death|0
4567352|NCT01332305|7402674|FG002|Overall Study|Protocol Violation|1
4625627|NCT01831466|7490590|FG006|Overall Study|Death|0
4625628|NCT01831466|7490591|FG007|Overall Study|Death|0
4625629|NCT01831466|7490592|FG008|Overall Study|Death|0
4625630|NCT01831466|7490593|FG009|Overall Study|Death|0
4625631|NCT01831466|7490594|FG010|Overall Study|Death|0
4625632|NCT01831466|7490595|FG011|Overall Study|Death|0
4625633|NCT01831466|7490584|FG000|Overall Study|Withdrawal by Subject|6
4625634|NCT01831466|7490585|FG001|Overall Study|Withdrawal by Subject|3
4625635|NCT01831466|7490586|FG002|Overall Study|Withdrawal by Subject|3
4625636|NCT01831466|7490587|FG003|Overall Study|Withdrawal by Subject|3
4625637|NCT01831466|7490588|FG004|Overall Study|Withdrawal by Subject|3
4625638|NCT01831466|7490589|FG005|Overall Study|Withdrawal by Subject|5
4625639|NCT01831466|7490590|FG006|Overall Study|Withdrawal by Subject|0
4625640|NCT01831466|7490591|FG007|Overall Study|Withdrawal by Subject|0
4625641|NCT01831466|7490592|FG008|Overall Study|Withdrawal by Subject|0
4625642|NCT01831466|7490593|FG009|Overall Study|Withdrawal by Subject|1
4625643|NCT01831466|7490594|FG010|Overall Study|Withdrawal by Subject|0
4567353|NCT01332305|7402675|FG003|Overall Study|Protocol Violation|0
4567354|NCT01332305|7402676|FG004|Overall Study|Protocol Violation|3
4567355|NCT01332305|7402672|FG000|Overall Study|Withdrawal by Sponsor|1
4567356|NCT01332305|7402673|FG001|Overall Study|Withdrawal by Sponsor|0
4567357|NCT01332305|7402674|FG002|Overall Study|Withdrawal by Sponsor|0
4567358|NCT01332305|7402675|FG003|Overall Study|Withdrawal by Sponsor|1
4567359|NCT01332305|7402676|FG004|Overall Study|Withdrawal by Sponsor|1
4567360|NCT01332305|7402672|FG000|Overall Study|Treatment Failure|1
4567361|NCT01332305|7402673|FG001|Overall Study|Treatment Failure|1
4567362|NCT01332305|7402674|FG002|Overall Study|Treatment Failure|0
4567363|NCT01332305|7402675|FG003|Overall Study|Treatment Failure|0
4567364|NCT01332305|7402676|FG004|Overall Study|Treatment Failure|0
4567365|NCT01332305|7402672|FG000|Overall Study|Physician Decision|0
4567366|NCT01332305|7402673|FG001|Overall Study|Physician Decision|0
4567367|NCT01332305|7402674|FG002|Overall Study|Physician Decision|0
4567368|NCT01332305|7402675|FG003|Overall Study|Physician Decision|1
4567369|NCT01332305|7402676|FG004|Overall Study|Physician Decision|0
4567370|NCT01332318|7402692|FG000|Overall Study|Adverse Event|0
4567371|NCT01332318|7402693|FG001|Overall Study|Adverse Event|3
4567372|NCT01332318|7402694|FG002|Overall Study|Adverse Event|0
4567373|NCT01332318|7402695|FG003|Overall Study|Adverse Event|0
4567374|NCT01332318|7402692|FG000|Overall Study|Withdrawal by Subject|1
4567375|NCT01332318|7402693|FG001|Overall Study|Withdrawal by Subject|1
4567376|NCT01332318|7402694|FG002|Overall Study|Withdrawal by Subject|0
4567377|NCT01332318|7402695|FG003|Overall Study|Withdrawal by Subject|1
4567378|NCT01332318|7402692|FG000|Overall Study|Protocol Violation|1
4567379|NCT01332318|7402693|FG001|Overall Study|Protocol Violation|0
4567380|NCT01332318|7402694|FG002|Overall Study|Protocol Violation|1
4567381|NCT01332318|7402695|FG003|Overall Study|Protocol Violation|1
4567382|NCT01332331|7402708|FG000|Overall Study|Lost to Follow-up|0
4567383|NCT01332331|7402709|FG001|Overall Study|Lost to Follow-up|1
4567384|NCT01332331|7402708|FG000|Overall Study|Adverse Event|1
4567385|NCT01332331|7402709|FG001|Overall Study|Adverse Event|1
4567386|NCT01332331|7402708|FG000|Overall Study|Physician Decision|1
4567387|NCT01332331|7402709|FG001|Overall Study|Physician Decision|0
4567388|NCT01332630|7402781|FG000|Overall Study|Withdrawal by Subject|3
4567389|NCT01332851|7402791|FG000|Overall Study|Withdrawal by Subject|4
4567390|NCT01332851|7402792|FG001|Overall Study|Withdrawal by Subject|2
4567391|NCT01332851|7402791|FG000|Overall Study|Lost to Follow-up|7
4567392|NCT01332851|7402792|FG001|Overall Study|Lost to Follow-up|11
4567393|NCT01332994|7402809|FG000|Overall Study|Adverse Event|34
4567394|NCT01332994|7402809|FG000|Overall Study|Death|1
4567395|NCT01332994|7402809|FG000|Overall Study|Lack of Efficacy|1
4567396|NCT01332994|7402809|FG000|Overall Study|Lost to Follow-up|4
4567397|NCT01332994|7402809|FG000|Overall Study|Protocol Violation|6
4567398|NCT01332994|7402809|FG000|Overall Study|Withdrawal by Subject|15
4567399|NCT01332994|7402809|FG000|Overall Study|Administrative Problem|2
4567400|NCT01332994|7402809|FG000|Overall Study|Other|8
4567401|NCT01333033|7402815|FG000|Overall Study|Ineligible|0
4567402|NCT01333033|7402816|FG001|Overall Study|Ineligible|0
4567403|NCT01333033|7402817|FG002|Overall Study|Ineligible|0
4567404|NCT01333033|7402818|FG003|Overall Study|Ineligible|0
4567405|NCT01333033|7402819|FG004|Overall Study|Ineligible|6
4567406|NCT01333033|7402820|FG005|Overall Study|Ineligible|8
4567407|NCT01333033|7402815|FG000|Overall Study|Withdrawal by Subject|0
4567408|NCT01333033|7402816|FG001|Overall Study|Withdrawal by Subject|0
4567409|NCT01333033|7402817|FG002|Overall Study|Withdrawal by Subject|0
4567410|NCT01333033|7402818|FG003|Overall Study|Withdrawal by Subject|0
4567411|NCT01333033|7402819|FG004|Overall Study|Withdrawal by Subject|4
4567412|NCT01333033|7402820|FG005|Overall Study|Withdrawal by Subject|2
4567413|NCT01333033|7402815|FG000|Overall Study|PET inevaluable|0
4567414|NCT01333033|7402816|FG001|Overall Study|PET inevaluable|0
4567415|NCT01333033|7402817|FG002|Overall Study|PET inevaluable|0
4567416|NCT01333033|7402818|FG003|Overall Study|PET inevaluable|0
4567417|NCT01333033|7402819|FG004|Overall Study|PET inevaluable|2
4567418|NCT01333033|7402820|FG005|Overall Study|PET inevaluable|4
4567419|NCT01333033|7402815|FG000|Overall Study|Adverse Event|0
4567420|NCT01333033|7402816|FG001|Overall Study|Adverse Event|0
4567421|NCT01333033|7402817|FG002|Overall Study|Adverse Event|0
4567422|NCT01333033|7402818|FG003|Overall Study|Adverse Event|0
4567423|NCT01333033|7402819|FG004|Overall Study|Adverse Event|2
4567424|NCT01333033|7402820|FG005|Overall Study|Adverse Event|1
4567425|NCT01333033|7402815|FG000|Overall Study|Progression|0
4567426|NCT01333033|7402816|FG001|Overall Study|Progression|0
4567427|NCT01333033|7402817|FG002|Overall Study|Progression|0
4567428|NCT01333033|7402818|FG003|Overall Study|Progression|0
4567429|NCT01333033|7402819|FG004|Overall Study|Progression|0
4567430|NCT01333033|7402820|FG005|Overall Study|Progression|1
4567431|NCT01333033|7402815|FG000|Overall Study|MD Decision|0
4567432|NCT01333033|7402816|FG001|Overall Study|MD Decision|0
4567433|NCT01333033|7402817|FG002|Overall Study|MD Decision|0
4567434|NCT01333033|7402818|FG003|Overall Study|MD Decision|0
4567435|NCT01333033|7402819|FG004|Overall Study|MD Decision|0
4567436|NCT01333033|7402820|FG005|Overall Study|MD Decision|2
4567437|NCT01333059|7402840|FG000|Overall Study|Physician Decision|3
4567438|NCT01333059|7402841|FG001|Overall Study|Physician Decision|3
4567439|NCT01333059|7402840|FG000|Overall Study|Protocol Violation|3
4567440|NCT01333059|7402841|FG001|Overall Study|Protocol Violation|0
4567441|NCT01333072|7402851|FG000|Overall Study|Lost to Follow-up|3
4567442|NCT01333072|7402852|FG001|Overall Study|Lost to Follow-up|0
4567443|NCT01333072|7402851|FG000|Overall Study|Adverse Event|2
4567444|NCT01333072|7402852|FG001|Overall Study|Adverse Event|4
4567445|NCT01333072|7402851|FG000|Overall Study|Physician Decision|1
4567446|NCT01333072|7402852|FG001|Overall Study|Physician Decision|0
4567447|NCT01333111|7402867|FG000|Overall Study|patient undergoing major surgery|0
4567448|NCT01333111|7402868|FG001|Overall Study|patient undergoing major surgery|2
4567449|NCT01333111|7402869|FG002|Overall Study|patient undergoing major surgery|0
4567450|NCT01333111|7402867|FG000|Overall Study|personal reasons|0
4567451|NCT01333111|7402868|FG001|Overall Study|personal reasons|0
4567452|NCT01333111|7402869|FG002|Overall Study|personal reasons|1
4567453|NCT01333111|7402867|FG000|Overall Study|unclassified|1
4567454|NCT01333111|7402868|FG001|Overall Study|unclassified|0
4567455|NCT01333111|7402869|FG002|Overall Study|unclassified|0
4567456|NCT01333111|7402867|FG000|Overall Study|withdrawal criteria|0
4567457|NCT01333111|7402868|FG001|Overall Study|withdrawal criteria|1
4567458|NCT01333111|7402869|FG002|Overall Study|withdrawal criteria|0
4567459|NCT01333111|7402867|FG000|Overall Study|Non-compliance|1
4567460|NCT01333111|7402868|FG001|Overall Study|Non-compliance|0
4567461|NCT01333111|7402869|FG002|Overall Study|Non-compliance|0
4567462|NCT01333111|7402867|FG000|Overall Study|Ineffective therapy|0
4567463|NCT01333111|7402868|FG001|Overall Study|Ineffective therapy|0
4567464|NCT01333111|7402869|FG002|Overall Study|Ineffective therapy|1
4567465|NCT01333189|7402879|FG000|Overall Study|Time constraints|1
4567466|NCT01333189|7402880|FG001|Overall Study|Time constraints|0
4567467|NCT01333189|7402879|FG000|Overall Study|Adverse Event|1
4567468|NCT01333189|7402880|FG001|Overall Study|Adverse Event|0
4567469|NCT01333189|7402879|FG000|Overall Study|Transportation difficulties|0
4567470|NCT01333189|7402880|FG001|Overall Study|Transportation difficulties|1
4567471|NCT01333189|7402879|FG000|Overall Study|Moved from region|0
4567472|NCT01333189|7402880|FG001|Overall Study|Moved from region|1
4567473|NCT01333397|7402891|FG000|Overall Study|Lost to Follow-up|1
4567474|NCT01333397|7402892|FG001|Overall Study|Lost to Follow-up|0
4567475|NCT01333397|7402893|FG002|Overall Study|Lost to Follow-up|0
4567476|NCT01333397|7402894|FG003|Overall Study|Lost to Follow-up|1
4567477|NCT01333397|7402895|FG004|Overall Study|Lost to Follow-up|0
4567478|NCT01333475|7402918|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1
4567479|NCT01333475|7402919|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0
4567480|NCT01333475|7402918|FG000|Overall Study|Toxicity|1
4567481|NCT01333475|7402919|FG001|Overall Study|Toxicity|3
4567482|NCT01333501|7402942|FG000|Overall Study|Adverse Event|3
4567483|NCT01333501|7402943|FG001|Overall Study|Adverse Event|1
4567484|NCT01333501|7402942|FG000|Overall Study|Abnormal laboratory value|2
4567485|NCT01333501|7402943|FG001|Overall Study|Abnormal laboratory value|1
4567486|NCT01333501|7402942|FG000|Overall Study|Unsatisfactory therapeutic effect|1
4567487|NCT01333501|7402943|FG001|Overall Study|Unsatisfactory therapeutic effect|7
4567488|NCT01333501|7402942|FG000|Overall Study|Withdrawn consent|3
4567489|NCT01333501|7402943|FG001|Overall Study|Withdrawn consent|12
4567490|NCT01333722|7402969|FG000|Overall Study|Lack of Efficacy|0
4567491|NCT01333722|7402970|FG001|Overall Study|Lack of Efficacy|2
4567492|NCT01333722|7402969|FG000|Overall Study|Withdrawal by Subject|0
4567493|NCT01333722|7402970|FG001|Overall Study|Withdrawal by Subject|1
4567494|NCT01333865|7402982|FG000|Overall Study|Adverse Event|2
4567495|NCT01333943|7402988|FG000|Overall Study|Known neuropathy|1
4567496|NCT01333943|7402989|FG001|Overall Study|Known neuropathy|0
4567497|NCT01333956|7402999|FG000|Overall Study|Lost to Follow-up|1
4567498|NCT01333956|7403000|FG001|Overall Study|Lost to Follow-up|2
4567499|NCT01333956|7403001|FG002|Overall Study|Lost to Follow-up|0
4567500|NCT01333956|7403002|FG003|Overall Study|Lost to Follow-up|1
4567501|NCT01333956|7402999|FG000|Overall Study|Unable to complete study procedure|1
4567502|NCT01333956|7403000|FG001|Overall Study|Unable to complete study procedure|0
4567503|NCT01333956|7403001|FG002|Overall Study|Unable to complete study procedure|0
4567504|NCT01333956|7403002|FG003|Overall Study|Unable to complete study procedure|1
4567505|NCT01333956|7402999|FG000|Overall Study|Withdrawal by Subject|0
4567506|NCT01333956|7403000|FG001|Overall Study|Withdrawal by Subject|2
4567507|NCT01333956|7403001|FG002|Overall Study|Withdrawal by Subject|1
4567508|NCT01333956|7403002|FG003|Overall Study|Withdrawal by Subject|0
4567509|NCT01334125|7403019|FG000|Overall Study|Lost to Follow-up|3
4567510|NCT01334125|7403020|FG001|Overall Study|Lost to Follow-up|3
4567511|NCT01334515|7403047|FG000|Overall Study|Adverse Event|1
4567512|NCT01334515|7403048|FG001|Overall Study|Adverse Event|6
4567513|NCT01334515|7403047|FG000|Overall Study|Death|1
4567514|NCT01334515|7403048|FG001|Overall Study|Death|0
4567515|NCT01334515|7403047|FG000|Overall Study|Lack of Efficacy|8
4567516|NCT01334515|7403048|FG001|Overall Study|Lack of Efficacy|21
4567517|NCT01334515|7403047|FG000|Overall Study|Physician Decision|1
4567518|NCT01334515|7403048|FG001|Overall Study|Physician Decision|1
4567519|NCT01334515|7403047|FG000|Overall Study|Withdrawal by Subject|1
4567520|NCT01334515|7403048|FG001|Overall Study|Withdrawal by Subject|1
4567521|NCT01334554|7403056|FG000|Overall Study|Adverse Event|4
4567522|NCT01334554|7403057|FG001|Overall Study|Adverse Event|2
4567523|NCT01334710|7403065|FG000|Overall Study|Trial was terminated|3
4567524|NCT01334866|7403099|FG000|Overall Study|Withdrawal by Subject|10
4567525|NCT01334866|7403099|FG000|Overall Study|Lost to Follow-up|3
4567526|NCT01334866|7403099|FG000|Overall Study|Physician Decision|3
4567527|NCT01334866|7403099|FG000|Overall Study|medically necessary prior to procedure|2
4567528|NCT01334866|7403099|FG000|Overall Study|medically necessary post-procedure|1
4567529|NCT01334918|7403107|FG000|Overall Study|Did not receive study drug|6
4567530|NCT01334918|7403108|FG001|Overall Study|Did not receive study drug|0
4567531|NCT01334918|7403107|FG000|Overall Study|Adverse Event|2
4567532|NCT01334918|7403108|FG001|Overall Study|Adverse Event|0
4567533|NCT01334918|7403107|FG000|Overall Study|Withdrawal by Subject|0
4567534|NCT01334918|7403108|FG001|Overall Study|Withdrawal by Subject|1
4567535|NCT01335009|7403141|FG000|Overall Study|Too ill to travel to study sites|1
4567536|NCT01335009|7403142|FG001|Overall Study|Too ill to travel to study sites|0
4567537|NCT01335009|7403141|FG000|Overall Study|Death|28
4625644|NCT01831466|7490595|FG011|Overall Study|Withdrawal by Subject|1
4625645|NCT01831466|7490584|FG000|Overall Study|Lost to Follow-up|0
4625646|NCT01831466|7490585|FG001|Overall Study|Lost to Follow-up|1
4625647|NCT01831466|7490586|FG002|Overall Study|Lost to Follow-up|4
4625648|NCT01831466|7490587|FG003|Overall Study|Lost to Follow-up|2
4625649|NCT01831466|7490588|FG004|Overall Study|Lost to Follow-up|0
4625650|NCT01831466|7490589|FG005|Overall Study|Lost to Follow-up|3
4567538|NCT01335009|7403142|FG001|Overall Study|Death|32
4567539|NCT01335009|7403141|FG000|Overall Study|Withdrawal by Subject|1
4567540|NCT01335009|7403142|FG001|Overall Study|Withdrawal by Subject|1
4567541|NCT01335009|7403141|FG000|Overall Study|Lost to Follow-up|1
4567542|NCT01335009|7403142|FG001|Overall Study|Lost to Follow-up|0
4567543|NCT01335464|7403204|FG000|Overall Study|Adverse Event|15
4567544|NCT01335464|7403205|FG001|Overall Study|Adverse Event|25
4567545|NCT01335464|7403204|FG000|Overall Study|Non compliant with protocol|2
4567546|NCT01335464|7403205|FG001|Overall Study|Non compliant with protocol|0
4567547|NCT01335464|7403204|FG000|Overall Study|Consent withdrawn, not due to AE|12
4567548|NCT01335464|7403205|FG001|Overall Study|Consent withdrawn, not due to AE|23
4567549|NCT01335464|7403204|FG000|Overall Study|Not treated|2
4567550|NCT01335464|7403205|FG001|Overall Study|Not treated|0
4567551|NCT01335464|7403204|FG000|Overall Study|Reason other than those stated above|1
4567552|NCT01335464|7403205|FG001|Overall Study|Reason other than those stated above|1
4567553|NCT01335477|7403213|FG000|Overall Study|Adverse Event|30
4567554|NCT01335477|7403214|FG001|Overall Study|Adverse Event|42
4567555|NCT01335477|7403213|FG000|Overall Study|Non compliant with protocol|0
4567556|NCT01335477|7403214|FG001|Overall Study|Non compliant with protocol|2
4567557|NCT01335477|7403213|FG000|Overall Study|Lost to Follow-up|1
4567558|NCT01335477|7403214|FG001|Overall Study|Lost to Follow-up|2
4567559|NCT01335477|7403213|FG000|Overall Study|Consent withdrawn, not due to AE|7
4567560|NCT01335477|7403214|FG001|Overall Study|Consent withdrawn, not due to AE|9
4567561|NCT01335477|7403213|FG000|Overall Study|Not treated|1
4567562|NCT01335477|7403214|FG001|Overall Study|Not treated|2
4567563|NCT01335477|7403213|FG000|Overall Study|Reason other than those stated above|2
4567564|NCT01335477|7403214|FG001|Overall Study|Reason other than those stated above|2
4567565|NCT01335698|7403238|FG000|Treatment Stage 1|Lack of Efficacy|3
4567566|NCT01335698|7403239|FG001|Treatment Stage 1|Lack of Efficacy|1
4567567|NCT01335698|7403240|FG002|Treatment Stage 1|Lack of Efficacy|3
4567568|NCT01335698|7403241|FG003|Treatment Stage 1|Lack of Efficacy|3
4567569|NCT01335698|7403242|FG004|Treatment Stage 1|Lack of Efficacy|1
4567570|NCT01335698|7403238|FG000|Treatment Stage 1|Adverse Event|1
4567571|NCT01335698|7403239|FG001|Treatment Stage 1|Adverse Event|2
4567572|NCT01335698|7403240|FG002|Treatment Stage 1|Adverse Event|2
4567573|NCT01335698|7403241|FG003|Treatment Stage 1|Adverse Event|1
4567574|NCT01335698|7403242|FG004|Treatment Stage 1|Adverse Event|1
4567575|NCT01335698|7403238|FG000|Treatment Stage 1|Withdrawal by Subject|1
4567576|NCT01335698|7403239|FG001|Treatment Stage 1|Withdrawal by Subject|2
4567577|NCT01335698|7403240|FG002|Treatment Stage 1|Withdrawal by Subject|0
4567578|NCT01335698|7403241|FG003|Treatment Stage 1|Withdrawal by Subject|1
4567579|NCT01335698|7403242|FG004|Treatment Stage 1|Withdrawal by Subject|0
4567580|NCT01335698|7403238|FG000|Treatment Stage 1|Lost to Follow-up|1
4567581|NCT01335698|7403239|FG001|Treatment Stage 1|Lost to Follow-up|1
4567582|NCT01335698|7403240|FG002|Treatment Stage 1|Lost to Follow-up|0
4567583|NCT01335698|7403241|FG003|Treatment Stage 1|Lost to Follow-up|0
4567584|NCT01335698|7403242|FG004|Treatment Stage 1|Lost to Follow-up|0
4567585|NCT01335698|7403238|FG000|Treatment Stage 1|Poor compliance/noncompliance|0
4567586|NCT01335698|7403239|FG001|Treatment Stage 1|Poor compliance/noncompliance|1
4567587|NCT01335698|7403240|FG002|Treatment Stage 1|Poor compliance/noncompliance|0
4567588|NCT01335698|7403241|FG003|Treatment Stage 1|Poor compliance/noncompliance|2
4567589|NCT01335698|7403242|FG004|Treatment Stage 1|Poor compliance/noncompliance|0
4567590|NCT01335698|7403238|FG000|Treatment Stage 1|No longer meets study criteria|1
4567591|NCT01335698|7403239|FG001|Treatment Stage 1|No longer meets study criteria|1
4567592|NCT01335698|7403240|FG002|Treatment Stage 1|No longer meets study criteria|0
4567593|NCT01335698|7403241|FG003|Treatment Stage 1|No longer meets study criteria|1
4567594|NCT01335698|7403242|FG004|Treatment Stage 1|No longer meets study criteria|0
4567595|NCT01335698|7403238|FG000|Treatment Stage 1|Other|1
4567596|NCT01335698|7403239|FG001|Treatment Stage 1|Other|0
4625651|NCT01831466|7490590|FG006|Overall Study|Lost to Follow-up|0
4567597|NCT01335698|7403240|FG002|Treatment Stage 1|Other|0
4625652|NCT01831466|7490591|FG007|Overall Study|Lost to Follow-up|0
4625653|NCT01831466|7490592|FG008|Overall Study|Lost to Follow-up|0
4567598|NCT01335698|7403241|FG003|Treatment Stage 1|Other|1
4567599|NCT01335698|7403242|FG004|Treatment Stage 1|Other|0
4567600|NCT01335698|7403238|FG000|Treatment Stage 2|Lack of Efficacy|2
4567601|NCT01335698|7403239|FG001|Treatment Stage 2|Lack of Efficacy|1
4567602|NCT01335698|7403240|FG002|Treatment Stage 2|Lack of Efficacy|3
4567603|NCT01335698|7403241|FG003|Treatment Stage 2|Lack of Efficacy|1
4567604|NCT01335698|7403242|FG004|Treatment Stage 2|Lack of Efficacy|0
4567605|NCT01335698|7403238|FG000|Treatment Stage 2|Adverse Event|2
4567606|NCT01335698|7403239|FG001|Treatment Stage 2|Adverse Event|0
4567607|NCT01335698|7403240|FG002|Treatment Stage 2|Adverse Event|0
4567608|NCT01335698|7403241|FG003|Treatment Stage 2|Adverse Event|3
4567609|NCT01335698|7403242|FG004|Treatment Stage 2|Adverse Event|0
4567610|NCT01335698|7403238|FG000|Treatment Stage 2|Withdrawal by Subject|3
4567611|NCT01335698|7403239|FG001|Treatment Stage 2|Withdrawal by Subject|1
4567612|NCT01335698|7403240|FG002|Treatment Stage 2|Withdrawal by Subject|1
4567613|NCT01335698|7403241|FG003|Treatment Stage 2|Withdrawal by Subject|0
4567614|NCT01335698|7403242|FG004|Treatment Stage 2|Withdrawal by Subject|0
4567615|NCT01335698|7403238|FG000|Treatment Stage 2|Poor compliance/noncompliance|1
4567616|NCT01335698|7403239|FG001|Treatment Stage 2|Poor compliance/noncompliance|0
4567617|NCT01335698|7403240|FG002|Treatment Stage 2|Poor compliance/noncompliance|1
4567618|NCT01335698|7403241|FG003|Treatment Stage 2|Poor compliance/noncompliance|3
4567619|NCT01335698|7403242|FG004|Treatment Stage 2|Poor compliance/noncompliance|1
4567620|NCT01335698|7403238|FG000|Treatment Stage 2|Lost to Follow-up|1
4567621|NCT01335698|7403239|FG001|Treatment Stage 2|Lost to Follow-up|0
4567622|NCT01335698|7403240|FG002|Treatment Stage 2|Lost to Follow-up|0
4567623|NCT01335698|7403241|FG003|Treatment Stage 2|Lost to Follow-up|0
4567624|NCT01335698|7403242|FG004|Treatment Stage 2|Lost to Follow-up|0
4567625|NCT01335698|7403238|FG000|Treatment Stage 2|Capsules received at state hospital|1
4567626|NCT01335698|7403239|FG001|Treatment Stage 2|Capsules received at state hospital|0
4567627|NCT01335698|7403240|FG002|Treatment Stage 2|Capsules received at state hospital|0
4567628|NCT01335698|7403241|FG003|Treatment Stage 2|Capsules received at state hospital|0
4567629|NCT01335698|7403242|FG004|Treatment Stage 2|Capsules received at state hospital|0
4567630|NCT01335698|7403238|FG000|Treatment Stage 2|Subject no longer meets study criteria|0
4567631|NCT01335698|7403239|FG001|Treatment Stage 2|Subject no longer meets study criteria|0
4567632|NCT01335698|7403240|FG002|Treatment Stage 2|Subject no longer meets study criteria|0
4567633|NCT01335698|7403241|FG003|Treatment Stage 2|Subject no longer meets study criteria|1
4567634|NCT01335698|7403242|FG004|Treatment Stage 2|Subject no longer meets study criteria|0
4567635|NCT01335698|7403238|FG000|Treatment Stage 2|Switched to another formulation|1
4567636|NCT01335698|7403239|FG001|Treatment Stage 2|Switched to another formulation|1
4567637|NCT01335698|7403240|FG002|Treatment Stage 2|Switched to another formulation|0
4567638|NCT01335698|7403241|FG003|Treatment Stage 2|Switched to another formulation|0
4567639|NCT01335698|7403242|FG004|Treatment Stage 2|Switched to another formulation|0
4567640|NCT01335971|7403314|FG000|Overall Study|Withdrawal by Subject|1
4567641|NCT01335971|7403315|FG001|Overall Study|Withdrawal by Subject|0
4567642|NCT01335971|7403316|FG002|Overall Study|Withdrawal by Subject|0
4567643|NCT01335971|7403314|FG000|Overall Study|Did not complete bronchoscopy|1
4567644|NCT01335971|7403315|FG001|Overall Study|Did not complete bronchoscopy|1
4567645|NCT01335971|7403316|FG002|Overall Study|Did not complete bronchoscopy|1
4567646|NCT01336023|7403327|FG000|Week 0 to Week 26|Adverse Event|8
4567647|NCT01336023|7403328|FG001|Week 0 to Week 26|Adverse Event|10
4567648|NCT01336023|7403329|FG002|Week 0 to Week 26|Adverse Event|24
4567649|NCT01336023|7403327|FG000|Week 0 to Week 26|Lack of Efficacy|0
4567650|NCT01336023|7403328|FG001|Week 0 to Week 26|Lack of Efficacy|1
4567651|NCT01336023|7403329|FG002|Week 0 to Week 26|Lack of Efficacy|0
4567652|NCT01336023|7403327|FG000|Week 0 to Week 26|Protocol Violation|1
4567653|NCT01336023|7403328|FG001|Week 0 to Week 26|Protocol Violation|2
4567654|NCT01336023|7403329|FG002|Week 0 to Week 26|Protocol Violation|0
4567655|NCT01336023|7403327|FG000|Week 0 to Week 26|Withdrawal Criteria|34
4567656|NCT01336023|7403328|FG001|Week 0 to Week 26|Withdrawal Criteria|69
4567657|NCT01336023|7403329|FG002|Week 0 to Week 26|Withdrawal Criteria|40
4567658|NCT01336023|7403327|FG000|Week 0 to Week 26|Unclassified|5
4567659|NCT01336023|7403328|FG001|Week 0 to Week 26|Unclassified|16
4567660|NCT01336023|7403329|FG002|Week 0 to Week 26|Unclassified|9
4567661|NCT01336023|7403327|FG000|Week 27 to 52|Adverse Event|1
4567662|NCT01336023|7403328|FG001|Week 27 to 52|Adverse Event|5
4567663|NCT01336023|7403329|FG002|Week 27 to 52|Adverse Event|2
4567664|NCT01336023|7403327|FG000|Week 27 to 52|Protocol Violation|0
4567665|NCT01336023|7403328|FG001|Week 27 to 52|Protocol Violation|2
4567666|NCT01336023|7403329|FG002|Week 27 to 52|Protocol Violation|1
4567667|NCT01336023|7403327|FG000|Week 27 to 52|Withdrawal Criteria|14
4567668|NCT01336023|7403328|FG001|Week 27 to 52|Withdrawal Criteria|19
4567669|NCT01336023|7403329|FG002|Week 27 to 52|Withdrawal Criteria|16
4567670|NCT01336023|7403327|FG000|Week 27 to 52|Unclassified|13
4567671|NCT01336023|7403328|FG001|Week 27 to 52|Unclassified|18
4567672|NCT01336023|7403329|FG002|Week 27 to 52|Unclassified|9
4567673|NCT01336205|7403348|FG000|Overall Study|Other|22
4567674|NCT01336205|7403349|FG001|Overall Study|Other|9
4567675|NCT01336205|7403348|FG000|Overall Study|Lost to Follow-up|40
4567676|NCT01336205|7403349|FG001|Overall Study|Lost to Follow-up|20
4567677|NCT01336205|7403348|FG000|Overall Study|Study-Specific Withdrawal Criteria|16
4567678|NCT01336205|7403349|FG001|Overall Study|Study-Specific Withdrawal Criteria|7
4567679|NCT01336205|7403348|FG000|Overall Study|Lack of Efficacy|4
4567680|NCT01336205|7403349|FG001|Overall Study|Lack of Efficacy|0
4567681|NCT01336205|7403348|FG000|Overall Study|Severe noncompliance with protocol|9
4567682|NCT01336205|7403349|FG001|Overall Study|Severe noncompliance with protocol|2
4567683|NCT01336205|7403348|FG000|Overall Study|Adverse Event|56
4567684|NCT01336205|7403349|FG001|Overall Study|Adverse Event|6
4567685|NCT01336205|7403348|FG000|Overall Study|Death|1
4567686|NCT01336205|7403349|FG001|Overall Study|Death|1
4567687|NCT01336205|7403348|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9
4567688|NCT01336205|7403349|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6
4567689|NCT01336205|7403348|FG000|Overall Study|Withdrawal by Subject|72
4567690|NCT01336205|7403349|FG001|Overall Study|Withdrawal by Subject|38
4567691|NCT01336205|7403348|FG000|Overall Study|Did not receive treatment|4
4567692|NCT01336205|7403349|FG001|Overall Study|Did not receive treatment|0
4567693|NCT01336569|7403375|FG000|Overall Study|Lost to Follow-up|4
4567694|NCT01336608|7403382|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102
4567695|NCT01336608|7403383|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
4567696|NCT01336608|7403384|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
4567697|NCT01336608|7403385|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
4567698|NCT01336608|7403382|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9
4567699|NCT01336608|7403383|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
4567700|NCT01336608|7403384|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
4567701|NCT01336608|7403385|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
4567702|NCT01336608|7403382|FG000|2-week, Single-blind Run-In Period|Adverse Event|1
4567703|NCT01336608|7403383|FG001|2-week, Single-blind Run-In Period|Adverse Event|0
4567704|NCT01336608|7403384|FG002|2-week, Single-blind Run-In Period|Adverse Event|0
4567705|NCT01336608|7403385|FG003|2-week, Single-blind Run-In Period|Adverse Event|0
4567706|NCT01336608|7403382|FG000|2-week, Single-blind Run-In Period|Physician Decision|1
4567707|NCT01336608|7403383|FG001|2-week, Single-blind Run-In Period|Physician Decision|0
4567708|NCT01336608|7403384|FG002|2-week, Single-blind Run-In Period|Physician Decision|0
4567709|NCT01336608|7403385|FG003|2-week, Single-blind Run-In Period|Physician Decision|0
4567710|NCT01336608|7403382|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2
4567711|NCT01336608|7403383|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0
4567712|NCT01336608|7403384|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0
4567713|NCT01336608|7403385|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0
4567714|NCT01336608|7403382|FG000|24-week, Double-blind Treatment Period|Adverse Event|0
4567715|NCT01336608|7403383|FG001|24-week, Double-blind Treatment Period|Adverse Event|8
4567716|NCT01336608|7403384|FG002|24-week, Double-blind Treatment Period|Adverse Event|6
4567717|NCT01336608|7403385|FG003|24-week, Double-blind Treatment Period|Adverse Event|7
4567718|NCT01336608|7403382|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
4567719|NCT01336608|7403383|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
4567720|NCT01336608|7403384|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
4567721|NCT01336608|7403385|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
4567722|NCT01336608|7403382|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
4567723|NCT01336608|7403383|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
4567724|NCT01336608|7403384|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
4567725|NCT01336608|7403385|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6
4567726|NCT01336608|7403382|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0
4567727|NCT01336608|7403383|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4
4567728|NCT01336608|7403384|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3
4567729|NCT01336608|7403385|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3
4567730|NCT01336608|7403382|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0
4567731|NCT01336608|7403383|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4
4567732|NCT01336608|7403384|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3
4567733|NCT01336608|7403385|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6
4567734|NCT01336608|7403382|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0
4567735|NCT01336608|7403383|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3
4567736|NCT01336608|7403384|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0
4567737|NCT01336608|7403385|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0
4567738|NCT01336608|7403382|FG000|24-week, Double-blind Treatment Period|Physician Decision|0
4567739|NCT01336608|7403383|FG001|24-week, Double-blind Treatment Period|Physician Decision|3
4567740|NCT01336608|7403384|FG002|24-week, Double-blind Treatment Period|Physician Decision|1
4567741|NCT01336608|7403385|FG003|24-week, Double-blind Treatment Period|Physician Decision|1
4567742|NCT01336608|7403382|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
4567743|NCT01336608|7403383|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
4567744|NCT01336608|7403384|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4
4567745|NCT01336608|7403385|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1
4567746|NCT01336647|7403396|FG000|Overall Study|Lost to Follow-up|4
4567747|NCT01336647|7403397|FG001|Overall Study|Lost to Follow-up|1
4567748|NCT01336647|7403398|FG002|Overall Study|Lost to Follow-up|3
4567749|NCT01336712|7403408|FG000|Overall Study|Death|2
4567750|NCT01336712|7403408|FG000|Overall Study|Lack of Efficacy|1
4567751|NCT01336738|7403417|FG000|Overall Study|Adverse Event|0
4567752|NCT01336738|7403418|FG001|Overall Study|Adverse Event|3
4567753|NCT01336738|7403419|FG002|Overall Study|Adverse Event|2
4567754|NCT01336738|7403420|FG003|Overall Study|Adverse Event|1
4567755|NCT01336738|7403421|FG004|Overall Study|Adverse Event|3
4567756|NCT01336738|7403417|FG000|Overall Study|Lost to Follow-up|2
4567757|NCT01336738|7403418|FG001|Overall Study|Lost to Follow-up|1
4567758|NCT01336738|7403419|FG002|Overall Study|Lost to Follow-up|2
4567759|NCT01336738|7403420|FG003|Overall Study|Lost to Follow-up|2
4567760|NCT01336738|7403421|FG004|Overall Study|Lost to Follow-up|2
4567761|NCT01336738|7403417|FG000|Overall Study|Did not meet entrance criteria|0
4567762|NCT01336738|7403418|FG001|Overall Study|Did not meet entrance criteria|1
4567763|NCT01336738|7403419|FG002|Overall Study|Did not meet entrance criteria|0
4567764|NCT01336738|7403420|FG003|Overall Study|Did not meet entrance criteria|0
4567765|NCT01336738|7403421|FG004|Overall Study|Did not meet entrance criteria|0
4567766|NCT01336738|7403417|FG000|Overall Study|Protocol Violation|0
4567767|NCT01336738|7403418|FG001|Overall Study|Protocol Violation|1
4567768|NCT01336738|7403419|FG002|Overall Study|Protocol Violation|0
4567769|NCT01336738|7403420|FG003|Overall Study|Protocol Violation|0
4567770|NCT01336738|7403421|FG004|Overall Study|Protocol Violation|0
4567771|NCT01336738|7403417|FG000|Overall Study|Withdrawal by Subject|2
4567772|NCT01336738|7403418|FG001|Overall Study|Withdrawal by Subject|0
4567773|NCT01336738|7403419|FG002|Overall Study|Withdrawal by Subject|2
4567774|NCT01336738|7403420|FG003|Overall Study|Withdrawal by Subject|1
4567775|NCT01336738|7403421|FG004|Overall Study|Withdrawal by Subject|1
4567776|NCT01336738|7403417|FG000|Overall Study|Other|3
4567777|NCT01336738|7403418|FG001|Overall Study|Other|3
4567778|NCT01336738|7403419|FG002|Overall Study|Other|2
4567779|NCT01336738|7403420|FG003|Overall Study|Other|3
4567780|NCT01336738|7403421|FG004|Overall Study|Other|4
4567781|NCT01336764|7403435|FG000|Overall Study|Withdrawal by Subject|5
4567782|NCT01336764|7403436|FG001|Overall Study|Withdrawal by Subject|5
4567783|NCT01336894|7403456|FG000|Follow-up|Study terminated prematurely|2
4567784|NCT01336894|7403457|FG001|Follow-up|Study terminated prematurely|7
4567785|NCT01336972|7403487|FG000|Overall Study|Adverse Event|1
4567786|NCT01336972|7403488|FG001|Overall Study|Adverse Event|1
4567787|NCT01336972|7403489|FG002|Overall Study|Adverse Event|0
4567788|NCT01337050|7403501|FG000|Overall Study|Death|0
4567789|NCT01337050|7403502|FG001|Overall Study|Death|0
4567790|NCT01337050|7403503|FG002|Overall Study|Death|4
4567791|NCT01337050|7403501|FG000|Overall Study|Other|4
4567792|NCT01337050|7403502|FG001|Overall Study|Other|6
4567793|NCT01337050|7403503|FG002|Overall Study|Other|8
4567794|NCT01337050|7403501|FG000|Overall Study|Participants refused further follow-up|0
4567795|NCT01337050|7403502|FG001|Overall Study|Participants refused further follow-up|7
4567796|NCT01337050|7403503|FG002|Overall Study|Participants refused further follow-up|7
4592594|NCT01543490|7440491|FG000|Overall Study|Withdrawal by Subject|2
4592595|NCT01543490|7440492|FG001|Overall Study|Withdrawal by Subject|0
4592596|NCT01543490|7440491|FG000|Overall Study|Other-Various Administrative Reasons|1
4592597|NCT01543490|7440492|FG001|Overall Study|Other-Various Administrative Reasons|2
4592598|NCT01543503|7440500|FG000|Overall Study|Lost to Follow-up|32
4592599|NCT01543503|7440501|FG001|Overall Study|Lost to Follow-up|36
4592600|NCT01543503|7440500|FG000|Overall Study|Adverse Event|9
4592601|NCT01543503|7440501|FG001|Overall Study|Adverse Event|13
4592602|NCT01543503|7440500|FG000|Overall Study|Lack of Efficacy|4
4592603|NCT01543503|7440501|FG001|Overall Study|Lack of Efficacy|16
4592604|NCT01543503|7440500|FG000|Overall Study|Participant withdrew informed consent|8
4592605|NCT01543503|7440501|FG001|Overall Study|Participant withdrew informed consent|10
4592606|NCT01543503|7440500|FG000|Overall Study|Change of jobs|0
4592607|NCT01543503|7440501|FG001|Overall Study|Change of jobs|1
4592608|NCT01543503|7440500|FG000|Overall Study|Intolerance to the biologic treatment|0
4592609|NCT01543503|7440501|FG001|Overall Study|Intolerance to the biologic treatment|1
4592610|NCT01543503|7440500|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1
4592611|NCT01543503|7440501|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0
4592612|NCT01543503|7440500|FG000|Overall Study|Participant did not complete last visit|0
4592613|NCT01543503|7440501|FG001|Overall Study|Participant did not complete last visit|2
4592614|NCT01543503|7440500|FG000|Overall Study|Refused to continue treatment|7
4592615|NCT01543503|7440501|FG001|Overall Study|Refused to continue treatment|0
4592616|NCT01543503|7440500|FG000|Overall Study|Incorrect medication received|1
4592617|NCT01543503|7440501|FG001|Overall Study|Incorrect medication received|0
4592618|NCT01543503|7440500|FG000|Overall Study|Participant moved to another city|2
4592619|NCT01543503|7440501|FG001|Overall Study|Participant moved to another city|0
4592620|NCT01543503|7440500|FG000|Overall Study|Participant will not return for visits|0
4592621|NCT01543503|7440501|FG001|Overall Study|Participant will not return for visits|2
4592622|NCT01543503|7440500|FG000|Overall Study|Participant transferred to another city|1
4592623|NCT01543503|7440501|FG001|Overall Study|Participant transferred to another city|0
4592624|NCT01543503|7440500|FG000|Overall Study|Participant moved to Scotland|1
4592625|NCT01543503|7440501|FG001|Overall Study|Participant moved to Scotland|0
4592626|NCT01543503|7440500|FG000|Overall Study|Participant decision to stop treatment|1
4567797|NCT01337089|7403516|FG000|Overall Study|Adverse Event|237
4567798|NCT01337089|7403516|FG000|Overall Study|Withdrawal by Subject|129
4567799|NCT01337089|7403516|FG000|Overall Study|Withdrawal by Investigator|33
4567800|NCT01337089|7403516|FG000|Overall Study|Met Withdrawal Criteria|3
4567801|NCT01337089|7403516|FG000|Overall Study|Lost to Follow-up|2
4567802|NCT01337115|7403522|FG000|Overall Study|Protocol Violation|2
4567803|NCT01337115|7403523|FG001|Overall Study|Protocol Violation|0
4567804|NCT01337167|7403533|FG000|Infant Series|Adverse Event|1
4567805|NCT01337167|7403534|FG001|Infant Series|Adverse Event|1
4567806|NCT01337167|7403533|FG000|Infant Series|Death|1
4567807|NCT01337167|7403534|FG001|Infant Series|Death|1
4567808|NCT01337167|7403533|FG000|Infant Series|Lost to Follow-up|13
4567809|NCT01337167|7403534|FG001|Infant Series|Lost to Follow-up|7
4567810|NCT01337167|7403533|FG000|Infant Series|Non-compliance with study drug|2
4567811|NCT01337167|7403534|FG001|Infant Series|Non-compliance with study drug|1
4567812|NCT01337167|7403533|FG000|Infant Series|Physician Decision|3
4567813|NCT01337167|7403534|FG001|Infant Series|Physician Decision|1
4567814|NCT01337167|7403533|FG000|Infant Series|Protocol Violation|22
4567815|NCT01337167|7403534|FG001|Infant Series|Protocol Violation|9
4567816|NCT01337167|7403533|FG000|Infant Series|Withdrawal by Subject|15
4567817|NCT01337167|7403534|FG001|Infant Series|Withdrawal by Subject|4
4567818|NCT01337167|7403533|FG000|Infant Series|Randomized but not vaccinated|5
4567819|NCT01337167|7403534|FG001|Infant Series|Randomized but not vaccinated|3
4567820|NCT01337167|7403533|FG000|Interim Period|Lost to Follow-up|51
4567821|NCT01337167|7403534|FG001|Interim Period|Lost to Follow-up|23
4567822|NCT01337167|7403533|FG000|Interim Period|Non-compliance with study drug|1
4567823|NCT01337167|7403534|FG001|Interim Period|Non-compliance with study drug|0
4567824|NCT01337167|7403533|FG000|Interim Period|Physician Decision|6
4567825|NCT01337167|7403534|FG001|Interim Period|Physician Decision|3
4567826|NCT01337167|7403533|FG000|Interim Period|Protocol Violation|5
4567827|NCT01337167|7403534|FG001|Interim Period|Protocol Violation|3
4567828|NCT01337167|7403533|FG000|Interim Period|Withdrawal by Subject|18
4567829|NCT01337167|7403534|FG001|Interim Period|Withdrawal by Subject|10
4567830|NCT01337167|7403533|FG000|Interim Period|Other protocol criterion not met|0
4567831|NCT01337167|7403534|FG001|Interim Period|Other protocol criterion not met|1
4567832|NCT01337167|7403533|FG000|Toddler Vaccinations|Lost to Follow-up|11
4567833|NCT01337167|7403534|FG001|Toddler Vaccinations|Lost to Follow-up|12
4567834|NCT01337167|7403533|FG000|Toddler Vaccinations|Protocol Violation|0
4567835|NCT01337167|7403534|FG001|Toddler Vaccinations|Protocol Violation|1
4567836|NCT01337167|7403533|FG000|Toddler Vaccinations|Withdrawal by Subject|3
4567837|NCT01337167|7403534|FG001|Toddler Vaccinations|Withdrawal by Subject|0
4567838|NCT01337297|7403542|FG000|Overall Study|They entered to single anodal tDCS|4
4567839|NCT01337297|7403543|FG001|Overall Study|They entered to single anodal tDCS|3
4567840|NCT01337297|7403542|FG000|Overall Study|Lost to Follow-up|1
4567841|NCT01337297|7403543|FG001|Overall Study|Lost to Follow-up|3
4567842|NCT01337596|7403567|FG000|Overall Study|Withdrawal by Subject|0
4567843|NCT01337596|7403568|FG001|Overall Study|Withdrawal by Subject|0
4567844|NCT01337596|7403569|FG002|Overall Study|Withdrawal by Subject|0
4567845|NCT01337596|7403570|FG003|Overall Study|Withdrawal by Subject|0
4567846|NCT01337596|7403571|FG004|Overall Study|Withdrawal by Subject|2
4567847|NCT01337596|7403572|FG005|Overall Study|Withdrawal by Subject|0
4567848|NCT01337596|7403573|FG006|Overall Study|Withdrawal by Subject|0
4567849|NCT01337596|7403574|FG007|Overall Study|Withdrawal by Subject|0
4567850|NCT01337596|7403575|FG008|Overall Study|Withdrawal by Subject|0
4567851|NCT01337635|7403600|FG000|Overall Study|Lost to Follow-up|0
4567852|NCT01337635|7403601|FG001|Overall Study|Lost to Follow-up|1
4567853|NCT01337674|7403609|FG000|Treatment Period 1|Adverse Event|0
4567854|NCT01337674|7403610|FG001|Treatment Period 1|Adverse Event|1
4567855|NCT01337674|7403611|FG002|Treatment Period 1|Adverse Event|0
4567856|NCT01337674|7403612|FG003|Treatment Period 1|Adverse Event|0
4567857|NCT01337674|7403609|FG000|Treatment Period 1|Discontinued due to blood draws|0
4567858|NCT01337674|7403610|FG001|Treatment Period 1|Discontinued due to blood draws|0
4567859|NCT01337674|7403611|FG002|Treatment Period 1|Discontinued due to blood draws|0
4567860|NCT01337674|7403612|FG003|Treatment Period 1|Discontinued due to blood draws|1
4567861|NCT01337674|7403609|FG000|Treatment Period 2|Withdrawal by Subject|0
4567862|NCT01337674|7403610|FG001|Treatment Period 2|Withdrawal by Subject|0
4567863|NCT01337674|7403611|FG002|Treatment Period 2|Withdrawal by Subject|1
4567864|NCT01337674|7403612|FG003|Treatment Period 2|Withdrawal by Subject|0
4567865|NCT01337960|7403655|FG000|Overall Study|Lost to Follow-up|1
4567866|NCT01337960|7403656|FG001|Overall Study|Lost to Follow-up|0
4567867|NCT01337960|7403657|FG002|Overall Study|Lost to Follow-up|0
4567868|NCT01337960|7403655|FG000|Overall Study|Withdrawal by Subject|1
4567869|NCT01337960|7403656|FG001|Overall Study|Withdrawal by Subject|0
4567870|NCT01337960|7403657|FG002|Overall Study|Withdrawal by Subject|0
4567871|NCT01337973|7403668|FG000|Overall Study|Lost to Follow-up|2
4567872|NCT01337973|7403669|FG001|Overall Study|Lost to Follow-up|4
4567873|NCT01337973|7403670|FG002|Overall Study|Lost to Follow-up|3
4567874|NCT01337973|7403668|FG000|Overall Study|Death|1
4567875|NCT01337973|7403669|FG001|Overall Study|Death|2
4567876|NCT01337973|7403670|FG002|Overall Study|Death|1
4567877|NCT01337973|7403668|FG000|Overall Study|Withdrawal by Subject|10
4567878|NCT01337973|7403669|FG001|Overall Study|Withdrawal by Subject|8
4567879|NCT01337973|7403670|FG002|Overall Study|Withdrawal by Subject|4
4567880|NCT01337973|7403668|FG000|Overall Study|missing data on primary outcome|3
4567881|NCT01337973|7403669|FG001|Overall Study|missing data on primary outcome|1
4567882|NCT01337973|7403670|FG002|Overall Study|missing data on primary outcome|3
4567883|NCT01337986|7403680|FG000|Overall Study|Adverse Event|2
4567884|NCT01337986|7403681|FG001|Overall Study|Adverse Event|2
4567885|NCT01337986|7403680|FG000|Overall Study|Lost to Follow-up|1
4567886|NCT01337986|7403681|FG001|Overall Study|Lost to Follow-up|0
4567887|NCT01337986|7403680|FG000|Overall Study|Protocol Violation|0
4567888|NCT01337986|7403681|FG001|Overall Study|Protocol Violation|3
4567889|NCT01338012|7403703|FG000|Overall Study|Death|4
4567890|NCT01338012|7403703|FG000|Overall Study|Study terminated|4
4567891|NCT01338025|7403709|FG000|Overall Study|Unexpected closure of study|10
4567892|NCT01338025|7403710|FG001|Overall Study|Unexpected closure of study|9
4567893|NCT01338025|7403709|FG000|Overall Study|Withdrawal by Subject|0
4567894|NCT01338025|7403710|FG001|Overall Study|Withdrawal by Subject|2
4567895|NCT01338025|7403709|FG000|Overall Study|Found ineligible after starting|1
4567896|NCT01338025|7403710|FG001|Overall Study|Found ineligible after starting|0
4567897|NCT01338298|7403718|FG000|Overall Study|Withdrawal by Subject|1
4567898|NCT01338298|7403719|FG001|Overall Study|Withdrawal by Subject|1
4567899|NCT01338298|7403718|FG000|Overall Study|Abdominal Pain and scheduled surgery|0
4567900|NCT01338298|7403719|FG001|Overall Study|Abdominal Pain and scheduled surgery|1
4567901|NCT01338298|7403718|FG000|Overall Study|Administrative error|0
4567902|NCT01338298|7403719|FG001|Overall Study|Administrative error|1
4567903|NCT01338298|7403718|FG000|Overall Study|Positive symptom worsening|1
4567904|NCT01338298|7403719|FG001|Overall Study|Positive symptom worsening|0
4567905|NCT01338298|7403718|FG000|Overall Study|Depressive symptoms and nausea|1
4567906|NCT01338298|7403719|FG001|Overall Study|Depressive symptoms and nausea|0
4567907|NCT01338298|7403718|FG000|Overall Study|Non-adherence|1
4567908|NCT01338298|7403719|FG001|Overall Study|Non-adherence|0
4567909|NCT01338415|7403727|FG000|Core + Extension|Adverse Event|8
4567910|NCT01338415|7403728|FG001|Core + Extension|Adverse Event|6
4567911|NCT01338415|7403729|FG002|Core + Extension|Adverse Event|0
4567912|NCT01338415|7403727|FG000|Core + Extension|Withdrawal by Subject|1
4567913|NCT01338415|7403728|FG001|Core + Extension|Withdrawal by Subject|1
4567914|NCT01338415|7403729|FG002|Core + Extension|Withdrawal by Subject|0
4567915|NCT01338415|7403727|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0
4567916|NCT01338415|7403728|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2
4567917|NCT01338415|7403729|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0
4567918|NCT01338415|7403727|FG000|Core + Extension|Other (administrative reason)|1
4567919|NCT01338415|7403728|FG001|Core + Extension|Other (administrative reason)|0
4567920|NCT01338415|7403729|FG002|Core + Extension|Other (administrative reason)|0
4567921|NCT01338415|7403727|FG000|Exceptional Use Treatment Period|Administrative decision|0
4567922|NCT01338415|7403728|FG001|Exceptional Use Treatment Period|Administrative decision|0
4567923|NCT01338415|7403729|FG002|Exceptional Use Treatment Period|Administrative decision|1
4567924|NCT01338415|7403727|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0
4567925|NCT01338415|7403728|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0
4567926|NCT01338415|7403729|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3
4567927|NCT01338415|7403727|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0
4567928|NCT01338415|7403728|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0
4567929|NCT01338415|7403729|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1
4567930|NCT01338415|7403727|FG000|Exceptional Use Treatment Period|Death|0
4567931|NCT01338415|7403728|FG001|Exceptional Use Treatment Period|Death|0
4567932|NCT01338415|7403729|FG002|Exceptional Use Treatment Period|Death|1
4567933|NCT01338493|7403737|FG000|Enrolled|Withdrawal by Subject|1
4567934|NCT01338493|7403737|FG000|Enrolled|Patient not implanted|4
4567935|NCT01338493|7403737|FG000|Discharge|Death|1
4567936|NCT01338493|7403737|FG000|Discharge|Missed visit|1
4567937|NCT01338493|7403737|FG000|6 Months Follow up|Lost to Follow-up|11
4567938|NCT01338493|7403737|FG000|6 Months Follow up|Missed visit|8
4567939|NCT01338493|7403737|FG000|12 Months Follow up|Lost to Follow-up|9
4567940|NCT01338610|7403757|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1
4567941|NCT01338610|7403758|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1
4567942|NCT01338610|7403759|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0
4567943|NCT01338610|7403757|FG000|Overall Study|Protocol Violation|1
4567944|NCT01338610|7403758|FG001|Overall Study|Protocol Violation|0
4567945|NCT01338610|7403759|FG002|Overall Study|Protocol Violation|1
4567946|NCT01338610|7403757|FG000|Overall Study|Adverse Event|3
4567947|NCT01338610|7403758|FG001|Overall Study|Adverse Event|0
4567948|NCT01338610|7403759|FG002|Overall Study|Adverse Event|0
4567949|NCT01338792|7403775|FG000|Overall Study|Adverse Event|2
4567950|NCT01338792|7403775|FG000|Overall Study|Death|1
4567951|NCT01338792|7403775|FG000|Overall Study|Withdrawal by Subject|1
4567952|NCT01338818|7403779|FG000|Overall Study|Adverse Event|8
4567953|NCT01338818|7403779|FG000|Overall Study|Lack of Efficacy|5
4567954|NCT01338818|7403779|FG000|Overall Study|no longer require study drug|1
4567955|NCT01338818|7403779|FG000|Overall Study|Withdrawal by Subject|11
4567956|NCT01338818|7403779|FG000|Overall Study|Lost to Follow-up|4
4567957|NCT01338818|7403779|FG000|Overall Study|Administrative problems|3
4567958|NCT01338818|7403779|FG000|Overall Study|Protocol Deviation|4
4567959|NCT01338870|7403793|FG000|Overall Study|Lost to Follow-up|0
4567960|NCT01338870|7403794|FG001|Overall Study|Lost to Follow-up|0
4567961|NCT01338870|7403795|FG002|Overall Study|Lost to Follow-up|1
4567962|NCT01338870|7403796|FG003|Overall Study|Lost to Follow-up|0
4567963|NCT01338870|7403797|FG004|Overall Study|Lost to Follow-up|1
4567964|NCT01338870|7403798|FG005|Overall Study|Lost to Follow-up|0
4567965|NCT01338870|7403793|FG000|Overall Study|Withdrawal by Subject|2
4567966|NCT01338870|7403794|FG001|Overall Study|Withdrawal by Subject|3
4567967|NCT01338870|7403795|FG002|Overall Study|Withdrawal by Subject|4
4567968|NCT01338870|7403796|FG003|Overall Study|Withdrawal by Subject|0
4567969|NCT01338870|7403797|FG004|Overall Study|Withdrawal by Subject|0
4567970|NCT01338870|7403798|FG005|Overall Study|Withdrawal by Subject|2
4567971|NCT01338870|7403793|FG000|Overall Study|Other|3
4567972|NCT01338870|7403794|FG001|Overall Study|Other|3
4567973|NCT01338870|7403795|FG002|Overall Study|Other|3
4567974|NCT01338870|7403796|FG003|Overall Study|Other|2
4567975|NCT01338870|7403797|FG004|Overall Study|Other|0
4567976|NCT01338870|7403798|FG005|Overall Study|Other|2
4567977|NCT01338870|7403793|FG000|Overall Study|Protocol Violation|0
4567978|NCT01338870|7403794|FG001|Overall Study|Protocol Violation|2
4567979|NCT01338870|7403795|FG002|Overall Study|Protocol Violation|2
4567980|NCT01338870|7403796|FG003|Overall Study|Protocol Violation|2
4567981|NCT01338870|7403797|FG004|Overall Study|Protocol Violation|1
4567982|NCT01338870|7403798|FG005|Overall Study|Protocol Violation|1
4567983|NCT01338870|7403793|FG000|Overall Study|Adverse Event|4
4567984|NCT01338870|7403794|FG001|Overall Study|Adverse Event|4
4567985|NCT01338870|7403795|FG002|Overall Study|Adverse Event|1
4567986|NCT01338870|7403796|FG003|Overall Study|Adverse Event|5
4567987|NCT01338870|7403797|FG004|Overall Study|Adverse Event|4
4567988|NCT01338870|7403798|FG005|Overall Study|Adverse Event|1
4567989|NCT01338987|7403817|FG000|Overall Study|enrolled on new protocol|0
4567990|NCT01338987|7403818|FG001|Overall Study|enrolled on new protocol|0
4567991|NCT01338987|7403819|FG002|Overall Study|enrolled on new protocol|1
4567992|NCT01338987|7403820|FG003|Overall Study|enrolled on new protocol|0
4567993|NCT01338987|7403821|FG004|Overall Study|enrolled on new protocol|0
4567994|NCT01338987|7403817|FG000|Overall Study|Disease progression on study|2
4567995|NCT01338987|7403818|FG001|Overall Study|Disease progression on study|1
4567996|NCT01338987|7403819|FG002|Overall Study|Disease progression on study|1
4567997|NCT01338987|7403820|FG003|Overall Study|Disease progression on study|0
4567998|NCT01338987|7403821|FG004|Overall Study|Disease progression on study|0
4567999|NCT01339000|7403837|FG000|Overall Study|study closed due to lack of drug supply|1
4568000|NCT01339000|7403838|FG001|Overall Study|study closed due to lack of drug supply|0
4568001|NCT01339052|7403853|FG000|Overall Study|Disease progression|13
4568002|NCT01339052|7403854|FG001|Overall Study|Disease progression|46
4568003|NCT01339052|7403853|FG000|Overall Study|Adverse Event|1
4568004|NCT01339052|7403854|FG001|Overall Study|Adverse Event|1
4568005|NCT01339052|7403853|FG000|Overall Study|Withdrawal by Subject|0
4568006|NCT01339052|7403854|FG001|Overall Study|Withdrawal by Subject|3
4568007|NCT01339052|7403853|FG000|Overall Study|Physician Decision|1
4568008|NCT01339052|7403854|FG001|Overall Study|Physician Decision|0
4568009|NCT01339273|7403892|FG000|Overall Study|Lost to Follow-up|8
4568010|NCT01339273|7403893|FG001|Overall Study|Lost to Follow-up|8
4568011|NCT01339390|7403910|FG000|Overall Study|Death|32
4568012|NCT01339390|7403911|FG001|Overall Study|Death|29
4568013|NCT01339390|7403910|FG000|Overall Study|Lost to Follow-up|125
4568014|NCT01339390|7403911|FG001|Overall Study|Lost to Follow-up|127
4568015|NCT01339429|7403930|FG000|Overall Study|Withdrawal by Subject|1
4568016|NCT01339429|7403930|FG000|Overall Study|Physician Decision|3
4568017|NCT01339559|7403934|FG000|Overall Study|Adverse Event|92
4568018|NCT01339559|7403934|FG000|Overall Study|Death|5
4568019|NCT01339559|7403934|FG000|Overall Study|Lack of Efficacy|164
4568020|NCT01339559|7403934|FG000|Overall Study|Lost to Follow-up|22
4568021|NCT01339559|7403934|FG000|Overall Study|Subject choice|89
4568022|NCT01339559|7403934|FG000|Overall Study|Protocol Violation|15
4568023|NCT01339559|7403934|FG000|Overall Study|Study closure at site|1
4568024|NCT01339559|7403934|FG000|Overall Study|Incarcerated|2
4568025|NCT01339559|7403934|FG000|Overall Study|Epilepsy surgery|1
4568026|NCT01339559|7403934|FG000|Overall Study|Pregnancy planned|2
4568027|NCT01339559|7403934|FG000|Overall Study|Left the country|1
4568028|NCT01339559|7403934|FG000|Overall Study|Investigator decision|2
4568029|NCT01339559|7403934|FG000|Overall Study|Patient didn't wish to continue|1
4568030|NCT01339559|7403934|FG000|Overall Study|PI decision|1
4568031|NCT01339832|7403939|FG000|Overall Study|Lost to Follow-up|3
4568032|NCT01339832|7403939|FG000|Overall Study|Death|11
4568033|NCT01339897|7403958|FG000|Overall Study|Adverse Event|1
4568034|NCT01339897|7403959|FG001|Overall Study|Adverse Event|0
4568035|NCT01339897|7403960|FG002|Overall Study|Adverse Event|0
4568036|NCT01339897|7403961|FG003|Overall Study|Adverse Event|1
4568037|NCT01339910|7403975|FG000|Overall Study|Withdrawal by Subject|1
4568038|NCT01339910|7403976|FG001|Overall Study|Withdrawal by Subject|0
4568039|NCT01339910|7403975|FG000|Overall Study|Physician Decision|1
4568040|NCT01339910|7403976|FG001|Overall Study|Physician Decision|0
4568041|NCT01339910|7403975|FG000|Overall Study|Disease relapse|1
4568042|NCT01339910|7403976|FG001|Overall Study|Disease relapse|4
4568043|NCT01339923|7403989|FG000|Overall Study|Adverse Event|1
4568044|NCT01339923|7403990|FG001|Overall Study|Adverse Event|1
4568045|NCT01339923|7403991|FG002|Overall Study|Adverse Event|1
4568046|NCT01339923|7403992|FG003|Overall Study|Adverse Event|0
4568047|NCT01339923|7403993|FG004|Overall Study|Adverse Event|0
4568048|NCT01339923|7403994|FG005|Overall Study|Adverse Event|0
4568049|NCT01339923|7403995|FG006|Overall Study|Adverse Event|1
4568050|NCT01339923|7403989|FG000|Overall Study|Inappropriate Enrollment|1
4568051|NCT01339923|7403990|FG001|Overall Study|Inappropriate Enrollment|0
4568052|NCT01339923|7403991|FG002|Overall Study|Inappropriate Enrollment|0
4568053|NCT01339923|7403992|FG003|Overall Study|Inappropriate Enrollment|0
4568054|NCT01339923|7403993|FG004|Overall Study|Inappropriate Enrollment|0
4568055|NCT01339923|7403994|FG005|Overall Study|Inappropriate Enrollment|1
4568056|NCT01339923|7403995|FG006|Overall Study|Inappropriate Enrollment|0
4568057|NCT01339923|7403989|FG000|Overall Study|Lost to Follow-up|4
4568058|NCT01339923|7403990|FG001|Overall Study|Lost to Follow-up|4
4568059|NCT01339923|7403991|FG002|Overall Study|Lost to Follow-up|0
4568060|NCT01339923|7403992|FG003|Overall Study|Lost to Follow-up|3
4568061|NCT01339923|7403993|FG004|Overall Study|Lost to Follow-up|1
4568062|NCT01339923|7403994|FG005|Overall Study|Lost to Follow-up|1
4568063|NCT01339923|7403995|FG006|Overall Study|Lost to Follow-up|5
4568064|NCT01339923|7403989|FG000|Overall Study|Protocol Violation|0
4568065|NCT01339923|7403990|FG001|Overall Study|Protocol Violation|0
4568066|NCT01339923|7403991|FG002|Overall Study|Protocol Violation|0
4568067|NCT01339923|7403992|FG003|Overall Study|Protocol Violation|0
4568068|NCT01339923|7403993|FG004|Overall Study|Protocol Violation|0
4568069|NCT01339923|7403994|FG005|Overall Study|Protocol Violation|3
4568070|NCT01339923|7403995|FG006|Overall Study|Protocol Violation|1
4568071|NCT01339923|7403989|FG000|Overall Study|Unable to Classify|1
4568072|NCT01339923|7403990|FG001|Overall Study|Unable to Classify|0
4568073|NCT01339923|7403991|FG002|Overall Study|Unable to Classify|1
4568074|NCT01339923|7403992|FG003|Overall Study|Unable to Classify|0
4568075|NCT01339923|7403993|FG004|Overall Study|Unable to Classify|0
4568076|NCT01339923|7403994|FG005|Overall Study|Unable to Classify|1
4568077|NCT01339923|7403995|FG006|Overall Study|Unable to Classify|5
4568078|NCT01339923|7403989|FG000|Overall Study|Withdrawal by Subject|7
4625654|NCT01831466|7490593|FG009|Overall Study|Lost to Follow-up|1
4625655|NCT01831466|7490594|FG010|Overall Study|Lost to Follow-up|0
4625656|NCT01831466|7490595|FG011|Overall Study|Lost to Follow-up|1
4625657|NCT01831466|7490584|FG000|Overall Study|Lack of Efficacy|5
4625658|NCT01831466|7490585|FG001|Overall Study|Lack of Efficacy|8
4625659|NCT01831466|7490586|FG002|Overall Study|Lack of Efficacy|7
4625660|NCT01831466|7490587|FG003|Overall Study|Lack of Efficacy|6
4625661|NCT01831466|7490588|FG004|Overall Study|Lack of Efficacy|9
4568079|NCT01339923|7403990|FG001|Overall Study|Withdrawal by Subject|11
4568080|NCT01339923|7403991|FG002|Overall Study|Withdrawal by Subject|6
4568081|NCT01339923|7403992|FG003|Overall Study|Withdrawal by Subject|1
4568082|NCT01339923|7403993|FG004|Overall Study|Withdrawal by Subject|4
4568083|NCT01339923|7403994|FG005|Overall Study|Withdrawal by Subject|3
4568084|NCT01339923|7403995|FG006|Overall Study|Withdrawal by Subject|2
4568085|NCT01340014|7404030|FG000|Period 1, First 7 Days|Adverse Event|1
4568086|NCT01340014|7404031|FG001|Period 1, First 7 Days|Adverse Event|0
4568087|NCT01340014|7404030|FG000|Period 1, First 7 Days|Personal Reasons|1
4568088|NCT01340014|7404031|FG001|Period 1, First 7 Days|Personal Reasons|0
4568089|NCT01340014|7404030|FG000|Period 2, Second 7 Days|Adverse Event|0
4568090|NCT01340014|7404031|FG001|Period 2, Second 7 Days|Adverse Event|1
4568091|NCT01340027|7404049|FG000|Overall Study|Randomized but Never Received Study Drug|0
4568092|NCT01340027|7404050|FG001|Overall Study|Randomized but Never Received Study Drug|0
4568093|NCT01340027|7404051|FG002|Overall Study|Randomized but Never Received Study Drug|1
4568094|NCT01340027|7404052|FG003|Overall Study|Randomized but Never Received Study Drug|0
4568095|NCT01340027|7404053|FG004|Overall Study|Randomized but Never Received Study Drug|0
4568096|NCT01340027|7404054|FG005|Overall Study|Randomized but Never Received Study Drug|0
4568097|NCT01340027|7404055|FG006|Overall Study|Randomized but Never Received Study Drug|0
4568098|NCT01340027|7404056|FG007|Overall Study|Randomized but Never Received Study Drug|0
4568099|NCT01340027|7404057|FG008|Overall Study|Randomized but Never Received Study Drug|0
4568100|NCT01340027|7404058|FG009|Overall Study|Randomized but Never Received Study Drug|0
4568101|NCT01340027|7404059|FG010|Overall Study|Randomized but Never Received Study Drug|0
4568102|NCT01340027|7404060|FG011|Overall Study|Randomized but Never Received Study Drug|0
4568103|NCT01340027|7404049|FG000|Overall Study|Adverse Event|0
4568104|NCT01340027|7404050|FG001|Overall Study|Adverse Event|1
4568105|NCT01340027|7404051|FG002|Overall Study|Adverse Event|2
4568106|NCT01340027|7404052|FG003|Overall Study|Adverse Event|0
4568107|NCT01340027|7404053|FG004|Overall Study|Adverse Event|1
4568108|NCT01340027|7404054|FG005|Overall Study|Adverse Event|2
4568109|NCT01340027|7404055|FG006|Overall Study|Adverse Event|2
4568110|NCT01340027|7404056|FG007|Overall Study|Adverse Event|1
4568111|NCT01340027|7404057|FG008|Overall Study|Adverse Event|4
4568112|NCT01340027|7404058|FG009|Overall Study|Adverse Event|1
4568113|NCT01340027|7404059|FG010|Overall Study|Adverse Event|1
4568114|NCT01340027|7404060|FG011|Overall Study|Adverse Event|3
4625662|NCT01831466|7490589|FG005|Overall Study|Lack of Efficacy|8
4625663|NCT01831466|7490590|FG006|Overall Study|Lack of Efficacy|1
4568115|NCT01340027|7404049|FG000|Overall Study|Lack of Efficacy|0
4568116|NCT01340027|7404050|FG001|Overall Study|Lack of Efficacy|0
4625664|NCT01831466|7490591|FG007|Overall Study|Lack of Efficacy|1
4568117|NCT01340027|7404051|FG002|Overall Study|Lack of Efficacy|0
4568118|NCT01340027|7404052|FG003|Overall Study|Lack of Efficacy|0
4568119|NCT01340027|7404053|FG004|Overall Study|Lack of Efficacy|0
4568120|NCT01340027|7404054|FG005|Overall Study|Lack of Efficacy|0
4568121|NCT01340027|7404055|FG006|Overall Study|Lack of Efficacy|1
4568122|NCT01340027|7404056|FG007|Overall Study|Lack of Efficacy|1
4568123|NCT01340027|7404057|FG008|Overall Study|Lack of Efficacy|1
4568124|NCT01340027|7404058|FG009|Overall Study|Lack of Efficacy|0
4568125|NCT01340027|7404059|FG010|Overall Study|Lack of Efficacy|0
4568126|NCT01340027|7404060|FG011|Overall Study|Lack of Efficacy|0
4568127|NCT01340027|7404049|FG000|Overall Study|Lost to Follow-up|0
4568128|NCT01340027|7404050|FG001|Overall Study|Lost to Follow-up|1
4568129|NCT01340027|7404051|FG002|Overall Study|Lost to Follow-up|0
4568130|NCT01340027|7404052|FG003|Overall Study|Lost to Follow-up|0
4568131|NCT01340027|7404053|FG004|Overall Study|Lost to Follow-up|0
4568132|NCT01340027|7404054|FG005|Overall Study|Lost to Follow-up|0
4568133|NCT01340027|7404055|FG006|Overall Study|Lost to Follow-up|1
4568134|NCT01340027|7404056|FG007|Overall Study|Lost to Follow-up|0
4568135|NCT01340027|7404057|FG008|Overall Study|Lost to Follow-up|0
4568136|NCT01340027|7404058|FG009|Overall Study|Lost to Follow-up|1
4568137|NCT01340027|7404059|FG010|Overall Study|Lost to Follow-up|0
4568138|NCT01340027|7404060|FG011|Overall Study|Lost to Follow-up|0
4568139|NCT01340027|7404049|FG000|Overall Study|Protocol Violation|1
4568140|NCT01340027|7404050|FG001|Overall Study|Protocol Violation|2
4568141|NCT01340027|7404051|FG002|Overall Study|Protocol Violation|0
4568142|NCT01340027|7404052|FG003|Overall Study|Protocol Violation|0
4568143|NCT01340027|7404053|FG004|Overall Study|Protocol Violation|6
4568144|NCT01340027|7404054|FG005|Overall Study|Protocol Violation|0
4568145|NCT01340027|7404055|FG006|Overall Study|Protocol Violation|0
4568146|NCT01340027|7404056|FG007|Overall Study|Protocol Violation|1
4568147|NCT01340027|7404057|FG008|Overall Study|Protocol Violation|2
4568148|NCT01340027|7404058|FG009|Overall Study|Protocol Violation|2
4568149|NCT01340027|7404059|FG010|Overall Study|Protocol Violation|0
4568150|NCT01340027|7404060|FG011|Overall Study|Protocol Violation|0
4568151|NCT01340027|7404049|FG000|Overall Study|Withdrawal by Subject|4
4568152|NCT01340027|7404050|FG001|Overall Study|Withdrawal by Subject|3
4568153|NCT01340027|7404051|FG002|Overall Study|Withdrawal by Subject|1
4568154|NCT01340027|7404052|FG003|Overall Study|Withdrawal by Subject|3
4568155|NCT01340027|7404053|FG004|Overall Study|Withdrawal by Subject|3
4568156|NCT01340027|7404054|FG005|Overall Study|Withdrawal by Subject|2
4568157|NCT01340027|7404055|FG006|Overall Study|Withdrawal by Subject|3
4568158|NCT01340027|7404056|FG007|Overall Study|Withdrawal by Subject|4
4568159|NCT01340027|7404057|FG008|Overall Study|Withdrawal by Subject|1
4568160|NCT01340027|7404058|FG009|Overall Study|Withdrawal by Subject|2
4568161|NCT01340027|7404059|FG010|Overall Study|Withdrawal by Subject|0
4568162|NCT01340027|7404060|FG011|Overall Study|Withdrawal by Subject|1
4568163|NCT01340027|7404049|FG000|Overall Study|Miscellaneous|0
4568164|NCT01340027|7404050|FG001|Overall Study|Miscellaneous|0
4568165|NCT01340027|7404051|FG002|Overall Study|Miscellaneous|0
4568166|NCT01340027|7404052|FG003|Overall Study|Miscellaneous|1
4568167|NCT01340027|7404053|FG004|Overall Study|Miscellaneous|0
4568168|NCT01340027|7404054|FG005|Overall Study|Miscellaneous|0
4568169|NCT01340027|7404055|FG006|Overall Study|Miscellaneous|0
4568170|NCT01340027|7404056|FG007|Overall Study|Miscellaneous|0
4568171|NCT01340027|7404057|FG008|Overall Study|Miscellaneous|0
4568172|NCT01340027|7404058|FG009|Overall Study|Miscellaneous|0
4568173|NCT01340027|7404059|FG010|Overall Study|Miscellaneous|1
4568174|NCT01340027|7404060|FG011|Overall Study|Miscellaneous|0
4568175|NCT01340066|7404105|FG000|Placebo Run in Period|Screen Failures|27
4568176|NCT01340066|7404106|FG001|Placebo Run in Period|Screen Failures|0
4568177|NCT01340066|7404107|FG002|Placebo Run in Period|Screen Failures|0
4568178|NCT01340066|7404105|FG000|5 Week Double Blind Randomization Period|Adverse Event|0
4568179|NCT01340066|7404106|FG001|5 Week Double Blind Randomization Period|Adverse Event|2
4568180|NCT01340066|7404107|FG002|5 Week Double Blind Randomization Period|Adverse Event|2
4568181|NCT01340066|7404105|FG000|5 Week Double Blind Randomization Period|Physician Decision|0
4568182|NCT01340066|7404106|FG001|5 Week Double Blind Randomization Period|Physician Decision|1
4568183|NCT01340066|7404107|FG002|5 Week Double Blind Randomization Period|Physician Decision|0
4568184|NCT01340066|7404105|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0
4568185|NCT01340066|7404106|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2
4568186|NCT01340066|7404107|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1
4568187|NCT01340196|7404123|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2
4568188|NCT01340209|7404135|FG000|Overall Study|Adverse Event|1
4568189|NCT01340209|7404136|FG001|Overall Study|Adverse Event|1
4568190|NCT01340209|7404137|FG002|Overall Study|Adverse Event|2
4568191|NCT01340209|7404135|FG000|Overall Study|Protocol Violation|1
4568192|NCT01340209|7404136|FG001|Overall Study|Protocol Violation|2
4568193|NCT01340209|7404137|FG002|Overall Study|Protocol Violation|1
4568194|NCT01340209|7404135|FG000|Overall Study|Withdrawal by Subject|0
4568195|NCT01340209|7404136|FG001|Overall Study|Withdrawal by Subject|0
4568196|NCT01340209|7404137|FG002|Overall Study|Withdrawal by Subject|1
4568197|NCT01340209|7404135|FG000|Overall Study|Other reason not defined above|3
4568198|NCT01340209|7404136|FG001|Overall Study|Other reason not defined above|5
4568199|NCT01340209|7404137|FG002|Overall Study|Other reason not defined above|4
4568200|NCT01340300|7404149|FG000|Overall Study|Lost to Follow-up|3
4568201|NCT01340300|7404150|FG001|Overall Study|Lost to Follow-up|0
4568202|NCT01340300|7404151|FG002|Overall Study|Lost to Follow-up|5
4568203|NCT01340300|7404152|FG003|Overall Study|Lost to Follow-up|10
4568204|NCT01340300|7404149|FG000|Overall Study|Withdrawal by Subject|5
4568205|NCT01340300|7404150|FG001|Overall Study|Withdrawal by Subject|6
4568206|NCT01340300|7404151|FG002|Overall Study|Withdrawal by Subject|6
4568207|NCT01340300|7404152|FG003|Overall Study|Withdrawal by Subject|3
4568208|NCT01340300|7404149|FG000|Overall Study|Adverse Event|1
4568209|NCT01340300|7404150|FG001|Overall Study|Adverse Event|0
4568210|NCT01340300|7404151|FG002|Overall Study|Adverse Event|4
4568211|NCT01340300|7404152|FG003|Overall Study|Adverse Event|0
4568212|NCT01340300|7404149|FG000|Overall Study|Physician Decision|0
4568213|NCT01340300|7404150|FG001|Overall Study|Physician Decision|1
4568214|NCT01340300|7404151|FG002|Overall Study|Physician Decision|0
4568215|NCT01340300|7404152|FG003|Overall Study|Physician Decision|0
4568216|NCT01340300|7404149|FG000|Overall Study|Unrelated sickness|0
4568217|NCT01340300|7404150|FG001|Overall Study|Unrelated sickness|2
4568218|NCT01340300|7404151|FG002|Overall Study|Unrelated sickness|0
4568219|NCT01340300|7404152|FG003|Overall Study|Unrelated sickness|1
4568220|NCT01340482|7404165|FG000|Overall Study|Adverse Event|2
4568221|NCT01340482|7404166|FG001|Overall Study|Adverse Event|0
4568222|NCT01340482|7404167|FG002|Overall Study|Adverse Event|0
4568223|NCT01340495|7404177|FG000|Overall Study|Withdrawal by Subject|1
4568224|NCT01340625|7404197|FG000|First Intervention|Adverse Event|1
4568225|NCT01340625|7404198|FG001|First Intervention|Adverse Event|0
4568226|NCT01340625|7404197|FG000|Washout Period of 28 Days|Withdrawal by Subject|1
4568227|NCT01340625|7404198|FG001|Washout Period of 28 Days|Withdrawal by Subject|0
4568228|NCT01340651|7404204|FG000|Overall Study|Adverse Event|3
4568229|NCT01340651|7404204|FG000|Overall Study|Consent Withdrawn|2
4568230|NCT01340651|7404204|FG000|Overall Study|Commercial Supply per Sponsor|12
4568231|NCT01340664|7404213|FG000|Overall Study|Adverse Event|0
4568232|NCT01340664|7404214|FG001|Overall Study|Adverse Event|1
4568233|NCT01340664|7404215|FG002|Overall Study|Adverse Event|7
4568234|NCT01340664|7404213|FG000|Overall Study|Lost to Follow-up|2
4568235|NCT01340664|7404214|FG001|Overall Study|Lost to Follow-up|0
4568236|NCT01340664|7404215|FG002|Overall Study|Lost to Follow-up|2
4568237|NCT01340664|7404213|FG000|Overall Study|Withdrawal by Subject|2
4568238|NCT01340664|7404214|FG001|Overall Study|Withdrawal by Subject|4
4568239|NCT01340664|7404215|FG002|Overall Study|Withdrawal by Subject|0
4568240|NCT01340664|7404213|FG000|Overall Study|Glycemic withdrawal criteria|2
4568241|NCT01340664|7404214|FG001|Overall Study|Glycemic withdrawal criteria|0
4568242|NCT01340664|7404215|FG002|Overall Study|Glycemic withdrawal criteria|0
4568243|NCT01340664|7404213|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0
4568244|NCT01340664|7404214|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1
4568245|NCT01340664|7404215|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2
4568246|NCT01340664|7404213|FG000|Overall Study|Other|1
4568247|NCT01340664|7404214|FG001|Overall Study|Other|2
4568248|NCT01340664|7404215|FG002|Overall Study|Other|2
4568249|NCT01340768|7404225|FG000|Overall Study|Lost to Follow-up|10
4568250|NCT01340768|7404226|FG001|Overall Study|Lost to Follow-up|4
4568251|NCT01340768|7404225|FG000|Overall Study|Withdrawal by Subject|5
4568252|NCT01340768|7404226|FG001|Overall Study|Withdrawal by Subject|1
4568253|NCT01340768|7404225|FG000|Overall Study|Other|2
4568254|NCT01340768|7404226|FG001|Overall Study|Other|0
4568255|NCT01340794|7404234|FG000|Overall Study|Withdrawal by Subject|0
4568256|NCT01340794|7404235|FG001|Overall Study|Withdrawal by Subject|1
4568257|NCT01340872|7404245|FG000|Double-blind Phase|Adverse Event|6
4568258|NCT01340872|7404246|FG001|Double-blind Phase|Adverse Event|4
4568259|NCT01340872|7404247|FG002|Double-blind Phase|Adverse Event|0
4568260|NCT01340872|7404248|FG003|Double-blind Phase|Adverse Event|0
4568261|NCT01340872|7404245|FG000|Double-blind Phase|Withdrawal by Subject|3
4568262|NCT01340872|7404246|FG001|Double-blind Phase|Withdrawal by Subject|5
4568263|NCT01340872|7404247|FG002|Double-blind Phase|Withdrawal by Subject|0
4568264|NCT01340872|7404248|FG003|Double-blind Phase|Withdrawal by Subject|0
4568265|NCT01340872|7404245|FG000|Double-blind Phase|Lost to Follow-up|0
4568266|NCT01340872|7404246|FG001|Double-blind Phase|Lost to Follow-up|1
4568267|NCT01340872|7404247|FG002|Double-blind Phase|Lost to Follow-up|0
4568268|NCT01340872|7404248|FG003|Double-blind Phase|Lost to Follow-up|0
4568269|NCT01340872|7404245|FG000|Double-blind Phase|Protocol Violation|0
4568270|NCT01340872|7404246|FG001|Double-blind Phase|Protocol Violation|1
4568271|NCT01340872|7404247|FG002|Double-blind Phase|Protocol Violation|0
4568272|NCT01340872|7404248|FG003|Double-blind Phase|Protocol Violation|0
4568273|NCT01340872|7404245|FG000|Open-label Phase|Physician Decision|0
4568274|NCT01340872|7404246|FG001|Open-label Phase|Physician Decision|0
4568275|NCT01340872|7404247|FG002|Open-label Phase|Physician Decision|2
4568276|NCT01340872|7404248|FG003|Open-label Phase|Physician Decision|1
4568277|NCT01340872|7404245|FG000|Open-label Phase|Pregnancy|0
4568278|NCT01340872|7404246|FG001|Open-label Phase|Pregnancy|0
4568279|NCT01340872|7404247|FG002|Open-label Phase|Pregnancy|1
4568280|NCT01340872|7404248|FG003|Open-label Phase|Pregnancy|0
4568281|NCT01340872|7404245|FG000|Open-label Phase|Adverse Event|0
4568282|NCT01340872|7404246|FG001|Open-label Phase|Adverse Event|0
4568283|NCT01340872|7404247|FG002|Open-label Phase|Adverse Event|8
4568284|NCT01340872|7404248|FG003|Open-label Phase|Adverse Event|4
4568285|NCT01340872|7404245|FG000|Open-label Phase|Withdrawal by Subject|0
4568286|NCT01340872|7404246|FG001|Open-label Phase|Withdrawal by Subject|0
4568287|NCT01340872|7404247|FG002|Open-label Phase|Withdrawal by Subject|1
4568288|NCT01340872|7404248|FG003|Open-label Phase|Withdrawal by Subject|6
4568289|NCT01340872|7404245|FG000|Open-label Phase|Worsening of IBD|0
4568290|NCT01340872|7404246|FG001|Open-label Phase|Worsening of IBD|0
4568291|NCT01340872|7404247|FG002|Open-label Phase|Worsening of IBD|1
4568292|NCT01340872|7404248|FG003|Open-label Phase|Worsening of IBD|0
4568293|NCT01340898|7404263|FG000|Primary Phase|Serious Adverse Events|0
4568294|NCT01340898|7404264|FG001|Primary Phase|Serious Adverse Events|0
4568295|NCT01340898|7404265|FG002|Primary Phase|Serious Adverse Events|1
4568296|NCT01340898|7404263|FG000|Primary Phase|Withdrawal by Subject|8
4568297|NCT01340898|7404264|FG001|Primary Phase|Withdrawal by Subject|7
4625665|NCT01831466|7490592|FG008|Overall Study|Lack of Efficacy|2
4625666|NCT01831466|7490593|FG009|Overall Study|Lack of Efficacy|2
4625667|NCT01831466|7490594|FG010|Overall Study|Lack of Efficacy|2
4625668|NCT01831466|7490595|FG011|Overall Study|Lack of Efficacy|0
4625669|NCT01831466|7490584|FG000|Overall Study|Adverse Event|0
4625670|NCT01831466|7490585|FG001|Overall Study|Adverse Event|0
4625671|NCT01831466|7490586|FG002|Overall Study|Adverse Event|4
4625672|NCT01831466|7490587|FG003|Overall Study|Adverse Event|6
4568298|NCT01340898|7404265|FG002|Primary Phase|Withdrawal by Subject|5
4568299|NCT01340898|7404263|FG000|Primary Phase|Migrated/moved from study area|4
4568300|NCT01340898|7404264|FG001|Primary Phase|Migrated/moved from study area|1
4568301|NCT01340898|7404265|FG002|Primary Phase|Migrated/moved from study area|0
4568302|NCT01340898|7404263|FG000|Primary Phase|Lost to Follow-up|4
4568303|NCT01340898|7404264|FG001|Primary Phase|Lost to Follow-up|1
4568304|NCT01340898|7404265|FG002|Primary Phase|Lost to Follow-up|0
4568305|NCT01340898|7404263|FG000|Booster Phase|Withdrawal by Subject|3
4568306|NCT01340898|7404264|FG001|Booster Phase|Withdrawal by Subject|0
4568307|NCT01340898|7404265|FG002|Booster Phase|Withdrawal by Subject|4
4568308|NCT01340898|7404263|FG000|Booster Phase|Migrated/moved from study area|3
4568309|NCT01340898|7404264|FG001|Booster Phase|Migrated/moved from study area|0
4568310|NCT01340898|7404265|FG002|Booster Phase|Migrated/moved from study area|0
4568311|NCT01340898|7404263|FG000|Booster Phase|Lost to Follow-up|4
4568312|NCT01340898|7404264|FG001|Booster Phase|Lost to Follow-up|2
4568313|NCT01340898|7404265|FG002|Booster Phase|Lost to Follow-up|3
4568314|NCT01340937|7404279|FG000|Period 1: Infant Series|Other protocol criterion not met|0
4568315|NCT01340937|7404280|FG001|Period 1: Infant Series|Other protocol criterion not met|1
4568316|NCT01340937|7404281|FG002|Period 1: Infant Series|Other protocol criterion not met|1
4568317|NCT01340937|7404282|FG003|Period 1: Infant Series|Other protocol criterion not met|0
4568318|NCT01340937|7404279|FG000|Period 1: Infant Series|Adverse Event|0
4568319|NCT01340937|7404280|FG001|Period 1: Infant Series|Adverse Event|1
4568320|NCT01340937|7404281|FG002|Period 1: Infant Series|Adverse Event|4
4568321|NCT01340937|7404282|FG003|Period 1: Infant Series|Adverse Event|0
4568322|NCT01340937|7404279|FG000|Period 1: Infant Series|Death|2
4568323|NCT01340937|7404280|FG001|Period 1: Infant Series|Death|0
4568324|NCT01340937|7404281|FG002|Period 1: Infant Series|Death|2
4568325|NCT01340937|7404282|FG003|Period 1: Infant Series|Death|0
4568326|NCT01340937|7404279|FG000|Period 1: Infant Series|Lost to Follow-up|20
4568327|NCT01340937|7404280|FG001|Period 1: Infant Series|Lost to Follow-up|14
4568328|NCT01340937|7404281|FG002|Period 1: Infant Series|Lost to Follow-up|12
4568329|NCT01340937|7404282|FG003|Period 1: Infant Series|Lost to Follow-up|13
4568330|NCT01340937|7404279|FG000|Period 1: Infant Series|Physician Decision|2
4568331|NCT01340937|7404280|FG001|Period 1: Infant Series|Physician Decision|3
4568332|NCT01340937|7404281|FG002|Period 1: Infant Series|Physician Decision|1
4568333|NCT01340937|7404282|FG003|Period 1: Infant Series|Physician Decision|0
4568334|NCT01340937|7404279|FG000|Period 1: Infant Series|Protocol Violation|1
4568335|NCT01340937|7404280|FG001|Period 1: Infant Series|Protocol Violation|4
4568336|NCT01340937|7404281|FG002|Period 1: Infant Series|Protocol Violation|4
4568337|NCT01340937|7404282|FG003|Period 1: Infant Series|Protocol Violation|3
4568338|NCT01340937|7404279|FG000|Period 1: Infant Series|Withdrawal by Subject|33
4568339|NCT01340937|7404280|FG001|Period 1: Infant Series|Withdrawal by Subject|32
4568340|NCT01340937|7404281|FG002|Period 1: Infant Series|Withdrawal by Subject|30
4568341|NCT01340937|7404282|FG003|Period 1: Infant Series|Withdrawal by Subject|15
4568342|NCT01340937|7404279|FG000|Period 1: Infant Series|Randomized but not vaccinated|0
4568343|NCT01340937|7404280|FG001|Period 1: Infant Series|Randomized but not vaccinated|5
4568344|NCT01340937|7404281|FG002|Period 1: Infant Series|Randomized but not vaccinated|2
4568345|NCT01340937|7404282|FG003|Period 1: Infant Series|Randomized but not vaccinated|1
4568346|NCT01340937|7404279|FG000|Period 2: Interim Period|Withdrawal by Subject|28
4568347|NCT01340937|7404280|FG001|Period 2: Interim Period|Withdrawal by Subject|23
4568348|NCT01340937|7404281|FG002|Period 2: Interim Period|Withdrawal by Subject|17
4568349|NCT01340937|7404282|FG003|Period 2: Interim Period|Withdrawal by Subject|12
4568350|NCT01340937|7404279|FG000|Period 2: Interim Period|Adverse Event|1
4568351|NCT01340937|7404280|FG001|Period 2: Interim Period|Adverse Event|0
4568352|NCT01340937|7404281|FG002|Period 2: Interim Period|Adverse Event|1
4568353|NCT01340937|7404282|FG003|Period 2: Interim Period|Adverse Event|0
4625673|NCT01831466|7490588|FG004|Overall Study|Adverse Event|3
4625674|NCT01831466|7490589|FG005|Overall Study|Adverse Event|7
4568354|NCT01340937|7404279|FG000|Period 2: Interim Period|Lost to Follow-up|29
4568355|NCT01340937|7404280|FG001|Period 2: Interim Period|Lost to Follow-up|48
4568356|NCT01340937|7404281|FG002|Period 2: Interim Period|Lost to Follow-up|53
4568357|NCT01340937|7404282|FG003|Period 2: Interim Period|Lost to Follow-up|23
4568358|NCT01340937|7404279|FG000|Period 2: Interim Period|Physician Decision|0
4568359|NCT01340937|7404280|FG001|Period 2: Interim Period|Physician Decision|1
4568360|NCT01340937|7404281|FG002|Period 2: Interim Period|Physician Decision|1
4568361|NCT01340937|7404282|FG003|Period 2: Interim Period|Physician Decision|0
4568362|NCT01340937|7404279|FG000|Period 2: Interim Period|Protocol Violation|5
4568363|NCT01340937|7404280|FG001|Period 2: Interim Period|Protocol Violation|3
4568364|NCT01340937|7404281|FG002|Period 2: Interim Period|Protocol Violation|6
4568365|NCT01340937|7404282|FG003|Period 2: Interim Period|Protocol Violation|3
4568366|NCT01340937|7404279|FG000|Period 2: Interim Period|Technical problems|4
4568367|NCT01340937|7404280|FG001|Period 2: Interim Period|Technical problems|4
4568368|NCT01340937|7404281|FG002|Period 2: Interim Period|Technical problems|6
4568369|NCT01340937|7404282|FG003|Period 2: Interim Period|Technical problems|3
4568370|NCT01340937|7404279|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2
4568371|NCT01340937|7404280|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2
4568372|NCT01340937|7404281|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1
4568373|NCT01340937|7404282|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1
4568374|NCT01340937|7404279|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6
4568375|NCT01340937|7404280|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14
4568376|NCT01340937|7404281|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7
4568377|NCT01340937|7404282|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8
4568378|NCT01340937|7404279|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0
4568379|NCT01340937|7404280|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0
4568380|NCT01340937|7404281|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0
4568381|NCT01340937|7404282|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1
4568382|NCT01340937|7404279|FG000|Period 3: Toddler Vaccinations|Technical problem|1
4568383|NCT01340937|7404280|FG001|Period 3: Toddler Vaccinations|Technical problem|1
4568384|NCT01340937|7404281|FG002|Period 3: Toddler Vaccinations|Technical problem|1
4568385|NCT01340937|7404282|FG003|Period 3: Toddler Vaccinations|Technical problem|0
4568386|NCT01340976|7404304|FG000|Overall Study|Physician Decision|2
4568387|NCT01340976|7404305|FG001|Overall Study|Physician Decision|0
4568388|NCT01340976|7404306|FG002|Overall Study|Physician Decision|1
4568389|NCT01340976|7404307|FG003|Overall Study|Physician Decision|1
4568390|NCT01340976|7404308|FG004|Overall Study|Physician Decision|1
4568391|NCT01340976|7404309|FG005|Overall Study|Physician Decision|0
4568392|NCT01340976|7404304|FG000|Overall Study|Death|0
4568393|NCT01340976|7404305|FG001|Overall Study|Death|1
4568394|NCT01340976|7404306|FG002|Overall Study|Death|0
4568395|NCT01340976|7404307|FG003|Overall Study|Death|0
4568396|NCT01340976|7404308|FG004|Overall Study|Death|0
4568397|NCT01340976|7404309|FG005|Overall Study|Death|0
4568398|NCT01340976|7404304|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1
4568399|NCT01340976|7404305|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0
4568400|NCT01340976|7404306|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0
4568401|NCT01340976|7404307|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0
4568402|NCT01340976|7404308|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0
4568403|NCT01340976|7404309|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0
4568404|NCT01340976|7404304|FG000|Overall Study|Withdrawal by Subject|0
4568405|NCT01340976|7404305|FG001|Overall Study|Withdrawal by Subject|0
4568406|NCT01340976|7404306|FG002|Overall Study|Withdrawal by Subject|0
4568407|NCT01340976|7404307|FG003|Overall Study|Withdrawal by Subject|1
4568408|NCT01340976|7404308|FG004|Overall Study|Withdrawal by Subject|1
4568409|NCT01340976|7404309|FG005|Overall Study|Withdrawal by Subject|0
4568410|NCT01340976|7404304|FG000|Overall Study|Other anemia treatment|1
4568411|NCT01340976|7404305|FG001|Overall Study|Other anemia treatment|0
4568412|NCT01340976|7404306|FG002|Overall Study|Other anemia treatment|2
4568413|NCT01340976|7404307|FG003|Overall Study|Other anemia treatment|1
4568414|NCT01340976|7404308|FG004|Overall Study|Other anemia treatment|0
4568415|NCT01340976|7404309|FG005|Overall Study|Other anemia treatment|1
4568416|NCT01340976|7404304|FG000|Overall Study|Adverse Event|0
4568417|NCT01340976|7404305|FG001|Overall Study|Adverse Event|1
4568418|NCT01340976|7404306|FG002|Overall Study|Adverse Event|0
4568419|NCT01340976|7404307|FG003|Overall Study|Adverse Event|0
4568420|NCT01340976|7404308|FG004|Overall Study|Adverse Event|0
4568421|NCT01340976|7404309|FG005|Overall Study|Adverse Event|0
4568422|NCT01341457|7404350|FG000|Overall Study|Adverse Event|2
4568423|NCT01341457|7404351|FG001|Overall Study|Adverse Event|0
4568424|NCT01341470|7404364|FG000|Overall Study|Sponsor decision|0
4568425|NCT01341470|7404365|FG001|Overall Study|Sponsor decision|0
4568426|NCT01341470|7404366|FG002|Overall Study|Sponsor decision|1
4568427|NCT01341470|7404367|FG003|Overall Study|Sponsor decision|1
4568428|NCT01341470|7404368|FG004|Overall Study|Sponsor decision|0
4568429|NCT01341470|7404369|FG005|Overall Study|Sponsor decision|1
4568430|NCT01341639|7404387|FG000|Infant Series|Protocol Violation|1
4568431|NCT01341639|7404388|FG001|Infant Series|Protocol Violation|0
4568432|NCT01341639|7404387|FG000|Infant Series|Not Vaccinated|0
4568433|NCT01341639|7404388|FG001|Infant Series|Not Vaccinated|1
4568434|NCT01341639|7404387|FG000|Infant Series|Adverse Event|0
4568435|NCT01341639|7404388|FG001|Infant Series|Adverse Event|5
4568436|NCT01341639|7404387|FG000|Infant Series|Withdrawal by Subject|11
4568437|NCT01341639|7404388|FG001|Infant Series|Withdrawal by Subject|8
4568438|NCT01341639|7404387|FG000|Infant Series|Lost to Follow-up|0
4568439|NCT01341639|7404388|FG001|Infant Series|Lost to Follow-up|2
4568440|NCT01341639|7404387|FG000|Infant Series|Site 0048 Participants|17
4568441|NCT01341639|7404388|FG001|Infant Series|Site 0048 Participants|16
4568442|NCT01341639|7404387|FG000|Interim Period|Withdrawal by Subject|6
4568443|NCT01341639|7404388|FG001|Interim Period|Withdrawal by Subject|7
4568444|NCT01341639|7404387|FG000|Interim Period|Lost to Follow-up|2
4568445|NCT01341639|7404388|FG001|Interim Period|Lost to Follow-up|0
4568446|NCT01341639|7404387|FG000|Interim Period|Physician Decision|0
4568447|NCT01341639|7404388|FG001|Interim Period|Physician Decision|1
4568448|NCT01341639|7404387|FG000|Interim Period|Protocol Violation|0
4568449|NCT01341639|7404388|FG001|Interim Period|Protocol Violation|1
4568450|NCT01341639|7404387|FG000|Post-Treatment|Withdrawal by Subject|0
4568451|NCT01341639|7404388|FG001|Post-Treatment|Withdrawal by Subject|1
4568452|NCT01341639|7404387|FG000|Post-Treatment|Adverse Event|0
4568453|NCT01341639|7404388|FG001|Post-Treatment|Adverse Event|2
4568454|NCT01341652|7404396|FG000|Overall Study|Incorrect Random Assignment|0
4568455|NCT01341652|7404397|FG001|Overall Study|Incorrect Random Assignment|1
4568456|NCT01341652|7404396|FG000|Overall Study|ineligible; presence metastatic disease|0
4568457|NCT01341652|7404397|FG001|Overall Study|ineligible; presence metastatic disease|1
4568458|NCT01341782|7404416|FG000|Overall Study|Adverse Event|1
4568459|NCT01341782|7404417|FG001|Overall Study|Adverse Event|1
4568460|NCT01341782|7404416|FG000|Overall Study|Withdrawal by Subject|6
4568461|NCT01341782|7404417|FG001|Overall Study|Withdrawal by Subject|5
4568462|NCT01341782|7404416|FG000|Overall Study|Missed 3 consecutive doses|0
4568463|NCT01341782|7404417|FG001|Overall Study|Missed 3 consecutive doses|4
4568464|NCT01341782|7404416|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0
4568465|NCT01341782|7404417|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1
4568466|NCT01341782|7404416|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3
4568467|NCT01341782|7404417|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3
4568468|NCT01341782|7404416|FG000|Overall Study|Other|5
4568469|NCT01341782|7404417|FG001|Overall Study|Other|0
4568470|NCT01341990|7404438|FG000|Overall Study|Adverse Event|0
4568471|NCT01341990|7404439|FG001|Overall Study|Adverse Event|1
4568472|NCT01341990|7404438|FG000|Overall Study|Torn Study Lens|1
4568473|NCT01341990|7404439|FG001|Overall Study|Torn Study Lens|0
4568474|NCT01341990|7404438|FG000|Overall Study|Withdrawal by Subject|2
4568475|NCT01341990|7404439|FG001|Overall Study|Withdrawal by Subject|0
4568476|NCT01342081|7404457|FG000|Overall Study|Did not receive allocated intervention|0
4568477|NCT01342081|7404458|FG001|Overall Study|Did not receive allocated intervention|0
4568478|NCT01342081|7404459|FG002|Overall Study|Did not receive allocated intervention|1
4568479|NCT01342081|7404457|FG000|Overall Study|Adverse Event|1
4568480|NCT01342081|7404458|FG001|Overall Study|Adverse Event|0
4568481|NCT01342081|7404459|FG002|Overall Study|Adverse Event|0
4568482|NCT01342081|7404457|FG000|Overall Study|Physician Decision|0
4568483|NCT01342081|7404458|FG001|Overall Study|Physician Decision|1
4568484|NCT01342081|7404459|FG002|Overall Study|Physician Decision|0
4568485|NCT01342081|7404457|FG000|Overall Study|Withdrawal by Subject|1
4568486|NCT01342081|7404458|FG001|Overall Study|Withdrawal by Subject|1
4568487|NCT01342081|7404459|FG002|Overall Study|Withdrawal by Subject|0
4568488|NCT01342094|7404469|FG000|Overall Study|Adverse Event|5
4568489|NCT01342094|7404470|FG001|Overall Study|Adverse Event|0
4568490|NCT01342094|7404469|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0
4568491|NCT01342094|7404470|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1
4568492|NCT01342094|7404469|FG000|Overall Study|Withdrawal by Subject|0
4568493|NCT01342094|7404470|FG001|Overall Study|Withdrawal by Subject|2
4568494|NCT01342211|7404495|FG000|Overall Study|Lost to Follow-up|0
4568495|NCT01342211|7404496|FG001|Overall Study|Lost to Follow-up|0
4568496|NCT01342211|7404497|FG002|Overall Study|Lost to Follow-up|0
4568497|NCT01342211|7404498|FG003|Overall Study|Lost to Follow-up|1
4568498|NCT01342211|7404499|FG004|Overall Study|Lost to Follow-up|0
4568499|NCT01342211|7404495|FG000|Overall Study|Adverse Event|0
4625675|NCT01831466|7490590|FG006|Overall Study|Adverse Event|0
4625676|NCT01831466|7490591|FG007|Overall Study|Adverse Event|1
4568500|NCT01342211|7404496|FG001|Overall Study|Adverse Event|0
4568501|NCT01342211|7404497|FG002|Overall Study|Adverse Event|0
4568502|NCT01342211|7404498|FG003|Overall Study|Adverse Event|0
4568503|NCT01342211|7404499|FG004|Overall Study|Adverse Event|1
4568504|NCT01342211|7404495|FG000|Overall Study|Withdrawal by Subject|0
4568505|NCT01342211|7404496|FG001|Overall Study|Withdrawal by Subject|0
4568506|NCT01342211|7404497|FG002|Overall Study|Withdrawal by Subject|0
4568507|NCT01342211|7404498|FG003|Overall Study|Withdrawal by Subject|1
4568508|NCT01342211|7404499|FG004|Overall Study|Withdrawal by Subject|0
4568509|NCT01342211|7404495|FG000|Overall Study|Randomized, but not Treated|0
4568510|NCT01342211|7404496|FG001|Overall Study|Randomized, but not Treated|2
4568511|NCT01342211|7404497|FG002|Overall Study|Randomized, but not Treated|0
4568512|NCT01342211|7404498|FG003|Overall Study|Randomized, but not Treated|0
4568513|NCT01342211|7404499|FG004|Overall Study|Randomized, but not Treated|1
4568514|NCT01342341|7404517|FG000|Overall Study|Lost to Follow-up|4
4568515|NCT01342341|7404518|FG001|Overall Study|Lost to Follow-up|4
4568516|NCT01342367|7404526|FG000|Overall Study|Death|1
4568517|NCT01342367|7404527|FG001|Overall Study|Death|0
4568518|NCT01342367|7404526|FG000|Overall Study|Withdrawal by Subject|1
4568519|NCT01342367|7404527|FG001|Overall Study|Withdrawal by Subject|2
4568520|NCT01342445|7404535|FG000|Overall Study|Experienced side effects|0
4568521|NCT01342445|7404536|FG001|Overall Study|Experienced side effects|2
4568522|NCT01342484|7404581|FG000|Overall Study|Other Reasons|1
4568523|NCT01342484|7404582|FG001|Overall Study|Other Reasons|0
4568524|NCT01342484|7404583|FG002|Overall Study|Other Reasons|0
4568525|NCT01342484|7404581|FG000|Overall Study|Protocol Violation|0
4568526|NCT01342484|7404582|FG001|Overall Study|Protocol Violation|0
4568527|NCT01342484|7404583|FG002|Overall Study|Protocol Violation|1
4568528|NCT01342484|7404581|FG000|Overall Study|Withdrawal by Subject|1
4568529|NCT01342484|7404582|FG001|Overall Study|Withdrawal by Subject|0
4568530|NCT01342484|7404583|FG002|Overall Study|Withdrawal by Subject|0
4568531|NCT01342510|7404595|FG000|Overall Study|Protocol Violation|12
4568532|NCT01342510|7404596|FG001|Overall Study|Protocol Violation|6
4568533|NCT01342510|7404597|FG002|Overall Study|Protocol Violation|13
4568534|NCT01342510|7404598|FG003|Overall Study|Protocol Violation|11
4568535|NCT01342640|7404697|FG000|Overall Study|Adverse Event|3
4568536|NCT01342640|7404697|FG000|Overall Study|Protocol Violation|16
4568537|NCT01342640|7404697|FG000|Overall Study|Lost to Follow-up|21
4568538|NCT01342640|7404697|FG000|Overall Study|Other|1
4568539|NCT01342796|7404720|FG000|Overall Study|Withdrawal by Subject|2
4568540|NCT01342796|7404721|FG001|Overall Study|Withdrawal by Subject|0
4568541|NCT01342796|7404720|FG000|Overall Study|Lost to Follow-up|0
4568542|NCT01342796|7404721|FG001|Overall Study|Lost to Follow-up|3
4568543|NCT01342796|7404720|FG000|Overall Study|Inappropriate enrollment|1
4568544|NCT01342796|7404721|FG001|Overall Study|Inappropriate enrollment|0
4568545|NCT01342887|7404727|FG000|Overall Study|Death|2
4592627|NCT01543503|7440501|FG001|Overall Study|Participant decision to stop treatment|0
4592628|NCT01543503|7440500|FG000|Overall Study|Investigator did not wish to participate|1
4592629|NCT01543503|7440501|FG001|Overall Study|Investigator did not wish to participate|1
4592630|NCT01543503|7440500|FG000|Overall Study|Participant recruited after closing date|0
4592631|NCT01543503|7440501|FG001|Overall Study|Participant recruited after closing date|1
4592632|NCT01543503|7440500|FG000|Overall Study|Site stopped participation|5
4592633|NCT01543503|7440501|FG001|Overall Study|Site stopped participation|1
4592634|NCT01543503|7440500|FG000|Overall Study|Participant did not attend a visit|1
4592635|NCT01543503|7440501|FG001|Overall Study|Participant did not attend a visit|0
4592636|NCT01543503|7440500|FG000|Overall Study|Moved to other rheumatologic site|0
4592637|NCT01543503|7440501|FG001|Overall Study|Moved to other rheumatologic site|1
4592638|NCT01543503|7440500|FG000|Overall Study|Participant consented to another study|0
4592639|NCT01543503|7440501|FG001|Overall Study|Participant consented to another study|2
4592640|NCT01543503|7440500|FG000|Overall Study|Participant went to United States|1
4592641|NCT01543503|7440501|FG001|Overall Study|Participant went to United States|0
4592642|NCT01543503|7440500|FG000|Overall Study|Screen failure|1
4592643|NCT01543503|7440501|FG001|Overall Study|Screen failure|0
4592644|NCT01543685|7440527|FG000|Overall Study|Lack of Efficacy|1
4592645|NCT01543685|7440528|FG001|Overall Study|Lack of Efficacy|2
4592646|NCT01543685|7440529|FG002|Overall Study|Lack of Efficacy|2
4592647|NCT01543685|7440530|FG003|Overall Study|Lack of Efficacy|0
4592648|NCT01543685|7440531|FG004|Overall Study|Lack of Efficacy|2
4592649|NCT01543685|7440527|FG000|Overall Study|Adverse Event|2
4592650|NCT01543685|7440528|FG001|Overall Study|Adverse Event|1
4592651|NCT01543685|7440529|FG002|Overall Study|Adverse Event|0
4592652|NCT01543685|7440530|FG003|Overall Study|Adverse Event|0
4592653|NCT01543685|7440531|FG004|Overall Study|Adverse Event|2
4592654|NCT01543776|7440545|FG000|Overall Study|Withdrawal by Subject|2
4592655|NCT01543776|7440546|FG001|Overall Study|Withdrawal by Subject|2
4592656|NCT01543828|7440554|FG000|Treatment 2|Lost to Follow-up|1
4592657|NCT01543828|7440555|FG001|Treatment 2|Lost to Follow-up|0
4592658|NCT01543958|7440563|FG000|Overall Study|Loss to follow-up|3
4592659|NCT01543958|7440563|FG000|Overall Study|ART initiation|1
4592660|NCT01544114|7440593|FG000|Overall Study|Withdrawal by Subject|0
4592661|NCT01544114|7440594|FG001|Overall Study|Withdrawal by Subject|0
4592662|NCT01544114|7440595|FG002|Overall Study|Withdrawal by Subject|3
4592663|NCT01544114|7440593|FG000|Overall Study|Lost to Follow-up|0
4592664|NCT01544114|7440594|FG001|Overall Study|Lost to Follow-up|2
4592665|NCT01544114|7440595|FG002|Overall Study|Lost to Follow-up|0
4592666|NCT01544114|7440593|FG000|Overall Study|Adverse Event|1
4592667|NCT01544114|7440594|FG001|Overall Study|Adverse Event|1
4592668|NCT01544114|7440595|FG002|Overall Study|Adverse Event|2
4592669|NCT01544114|7440593|FG000|Overall Study|Protocol Violation|0
4592670|NCT01544114|7440594|FG001|Overall Study|Protocol Violation|1
4592671|NCT01544114|7440595|FG002|Overall Study|Protocol Violation|0
4592672|NCT01544153|7440609|FG000|Overall Study|Under 18|0
4592673|NCT01544153|7440610|FG001|Overall Study|Under 18|1
4592674|NCT01544153|7440611|FG002|Overall Study|Under 18|0
4592675|NCT01544153|7440612|FG003|Overall Study|Under 18|0
4592676|NCT01544153|7440609|FG000|Overall Study|Non-smoker|0
4568546|NCT01342913|7404733|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66
4568547|NCT01342913|7404734|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
4568548|NCT01342913|7404735|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
4568549|NCT01342913|7404733|FG000|2-week Run-in Period|Physician Decision|6
4568550|NCT01342913|7404734|FG001|2-week Run-in Period|Physician Decision|0
4568551|NCT01342913|7404735|FG002|2-week Run-in Period|Physician Decision|0
4568552|NCT01342913|7404733|FG000|2-week Run-in Period|Withdrawal by Subject|7
4568553|NCT01342913|7404734|FG001|2-week Run-in Period|Withdrawal by Subject|0
4568554|NCT01342913|7404735|FG002|2-week Run-in Period|Withdrawal by Subject|0
4568555|NCT01342913|7404733|FG000|2-week Run-in Period|Adverse Event|2
4568556|NCT01342913|7404734|FG001|2-week Run-in Period|Adverse Event|0
4568557|NCT01342913|7404735|FG002|2-week Run-in Period|Adverse Event|0
4568558|NCT01342913|7404733|FG000|2-week Run-in Period|Protocol Violation|5
4568559|NCT01342913|7404734|FG001|2-week Run-in Period|Protocol Violation|0
4568560|NCT01342913|7404735|FG002|2-week Run-in Period|Protocol Violation|0
4568561|NCT01342913|7404733|FG000|2-week Run-in Period|Continuation Criteria Not Met|88
4568562|NCT01342913|7404734|FG001|2-week Run-in Period|Continuation Criteria Not Met|0
4568563|NCT01342913|7404735|FG002|2-week Run-in Period|Continuation Criteria Not Met|0
4568564|NCT01342913|7404733|FG000|Double-Blind Treatment Period|Adverse Event|0
4568565|NCT01342913|7404734|FG001|Double-Blind Treatment Period|Adverse Event|3
4568566|NCT01342913|7404735|FG002|Double-Blind Treatment Period|Adverse Event|6
4568567|NCT01342913|7404733|FG000|Double-Blind Treatment Period|Lack of Efficacy|0
4568568|NCT01342913|7404734|FG001|Double-Blind Treatment Period|Lack of Efficacy|2
4568569|NCT01342913|7404735|FG002|Double-Blind Treatment Period|Lack of Efficacy|3
4568570|NCT01342913|7404733|FG000|Double-Blind Treatment Period|Protocol Violation|0
4568571|NCT01342913|7404734|FG001|Double-Blind Treatment Period|Protocol Violation|6
4568572|NCT01342913|7404735|FG002|Double-Blind Treatment Period|Protocol Violation|9
4568573|NCT01342913|7404733|FG000|Double-Blind Treatment Period|Lost to Follow-up|0
4568574|NCT01342913|7404734|FG001|Double-Blind Treatment Period|Lost to Follow-up|1
4568575|NCT01342913|7404735|FG002|Double-Blind Treatment Period|Lost to Follow-up|3
4568576|NCT01342913|7404733|FG000|Double-Blind Treatment Period|Physician Decision|0
4568577|NCT01342913|7404734|FG001|Double-Blind Treatment Period|Physician Decision|2
4568578|NCT01342913|7404735|FG002|Double-Blind Treatment Period|Physician Decision|0
4568579|NCT01342913|7404733|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0
4568580|NCT01342913|7404734|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2
4568581|NCT01342913|7404735|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2
4568582|NCT01342926|7404745|FG000|Overall Study|Adverse Event|5
4568583|NCT01342926|7404746|FG001|Overall Study|Adverse Event|8
4568584|NCT01342926|7404747|FG002|Overall Study|Adverse Event|10
4568585|NCT01342926|7404748|FG003|Overall Study|Adverse Event|7
4568586|NCT01342926|7404745|FG000|Overall Study|Lost to Follow-up|0
4568587|NCT01342926|7404746|FG001|Overall Study|Lost to Follow-up|1
4568588|NCT01342926|7404747|FG002|Overall Study|Lost to Follow-up|1
4568589|NCT01342926|7404748|FG003|Overall Study|Lost to Follow-up|0
4568590|NCT01342926|7404745|FG000|Overall Study|Investigator Discretion|2
4568591|NCT01342926|7404746|FG001|Overall Study|Investigator Discretion|2
4568592|NCT01342926|7404747|FG002|Overall Study|Investigator Discretion|0
4568593|NCT01342926|7404748|FG003|Overall Study|Investigator Discretion|0
4568594|NCT01342926|7404745|FG000|Overall Study|Withdrawal by Subject|2
4568595|NCT01342926|7404746|FG001|Overall Study|Withdrawal by Subject|4
4568596|NCT01342926|7404747|FG002|Overall Study|Withdrawal by Subject|3
4568597|NCT01342926|7404748|FG003|Overall Study|Withdrawal by Subject|5
4568598|NCT01342965|7404760|FG000|Overall Study|Death|58
4568599|NCT01342965|7404761|FG001|Overall Study|Death|57
4568600|NCT01342965|7404760|FG000|Overall Study|Lost to Follow-up|5
4568601|NCT01342965|7404761|FG001|Overall Study|Lost to Follow-up|3
4568602|NCT01342965|7404760|FG000|Overall Study|Other Reasons- Unspecified|44
4568603|NCT01342965|7404761|FG001|Overall Study|Other Reasons- Unspecified|38
4568604|NCT01342965|7404760|FG000|Overall Study|Withdrawal by Subject|2
4568605|NCT01342965|7404761|FG001|Overall Study|Withdrawal by Subject|9
4568606|NCT01343043|7404784|FG000|Overall Study|Disease progression before treatment|1
4568607|NCT01343043|7404785|FG001|Overall Study|Disease progression before treatment|0
4568608|NCT01343043|7404786|FG002|Overall Study|Disease progression before treatment|0
4568609|NCT01343043|7404787|FG003|Overall Study|Disease progression before treatment|0
4568610|NCT01343043|7404784|FG000|Overall Study|Withdrawal by Subject|1
4568611|NCT01343043|7404785|FG001|Overall Study|Withdrawal by Subject|0
4568612|NCT01343043|7404786|FG002|Overall Study|Withdrawal by Subject|0
4568613|NCT01343043|7404787|FG003|Overall Study|Withdrawal by Subject|0
4568614|NCT01343043|7404784|FG000|Overall Study|Death|1
4568615|NCT01343043|7404785|FG001|Overall Study|Death|1
4568616|NCT01343043|7404786|FG002|Overall Study|Death|0
4568617|NCT01343043|7404787|FG003|Overall Study|Death|1
4568618|NCT01343056|7404804|FG000|Overall Study|Lost to Follow-up|7
4568619|NCT01343056|7404805|FG001|Overall Study|Lost to Follow-up|5
4568620|NCT01343056|7404806|FG002|Overall Study|Lost to Follow-up|3
4568621|NCT01343056|7404807|FG003|Overall Study|Lost to Follow-up|9
4568622|NCT01343082|7404821|FG000|The run-in Period|Not meeting criteria|3
4568623|NCT01343082|7404822|FG001|The run-in Period|Not meeting criteria|4
4568624|NCT01343082|7404823|FG002|The run-in Period|Not meeting criteria|5
4592677|NCT01544153|7440610|FG001|Overall Study|Non-smoker|0
4568625|NCT01343082|7404821|FG000|Treatment Period , Switched to DE-111|Adverse Event|1
4568626|NCT01343082|7404822|FG001|Treatment Period , Switched to DE-111|Adverse Event|4
4568627|NCT01343082|7404823|FG002|Treatment Period , Switched to DE-111|Adverse Event|3
4568628|NCT01343082|7404821|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0
4568629|NCT01343082|7404822|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1
4568630|NCT01343082|7404823|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2
4568631|NCT01343082|7404821|FG000|Treatment Period , Switched to DE-111|Physician Decision|0
4568632|NCT01343082|7404822|FG001|Treatment Period , Switched to DE-111|Physician Decision|2
4568633|NCT01343082|7404823|FG002|Treatment Period , Switched to DE-111|Physician Decision|2
4568634|NCT01343082|7404821|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4
4568635|NCT01343082|7404822|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2
4568636|NCT01343082|7404823|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5
4568637|NCT01343277|7404861|FG000|Overall Study|Other|3
4568638|NCT01343277|7404862|FG001|Overall Study|Other|3
4568639|NCT01343277|7404861|FG000|Overall Study|Withdrawal by Subject|18
4568640|NCT01343277|7404862|FG001|Overall Study|Withdrawal by Subject|13
4568641|NCT01343277|7404861|FG000|Overall Study|Physician Decision|1
4568642|NCT01343277|7404862|FG001|Overall Study|Physician Decision|2
4568643|NCT01343277|7404861|FG000|Overall Study|Death|10
4568644|NCT01343277|7404862|FG001|Overall Study|Death|1
4568645|NCT01343277|7404861|FG000|Overall Study|Adverse Event|67
4568646|NCT01343277|7404862|FG001|Overall Study|Adverse Event|13
4568647|NCT01343277|7404861|FG000|Overall Study|Disease progression|270
4568648|NCT01343277|7404862|FG001|Overall Study|Disease progression|138
4568649|NCT01343277|7404861|FG000|Overall Study|Randomized not treated|6
4568650|NCT01343277|7404862|FG001|Overall Study|Randomized not treated|21
4568651|NCT01343277|7404861|FG000|Overall Study|Treatment ongoing|8
4568652|NCT01343277|7404862|FG001|Overall Study|Treatment ongoing|2
4568653|NCT01343277|7404861|FG000|Overall Study|Subsequent anticancer therapy|1
4568654|NCT01343277|7404862|FG001|Overall Study|Subsequent anticancer therapy|0
4568655|NCT01343368|7404870|FG000|Overall Study|Death|1
4568656|NCT01343368|7404871|FG001|Overall Study|Death|0
4568657|NCT01343368|7404870|FG000|Overall Study|Lost to Follow-up|1
4568658|NCT01343368|7404871|FG001|Overall Study|Lost to Follow-up|0
4568659|NCT01343407|7404877|FG000|Second Treatment Period (Part 2)|Adverse Event|0
4568660|NCT01343407|7404878|FG001|Second Treatment Period (Part 2)|Adverse Event|0
4568661|NCT01343407|7404879|FG002|Second Treatment Period (Part 2)|Adverse Event|1
4568662|NCT01343407|7404880|FG003|Second Treatment Period (Part 2)|Adverse Event|0
4568663|NCT01343407|7404881|FG004|Second Treatment Period (Part 2)|Adverse Event|0
4568664|NCT01343407|7404882|FG005|Second Treatment Period (Part 2)|Adverse Event|0
4568665|NCT01343407|7404877|FG000|Second Washout (Part 2)|Withdrawal by Subject|0
4568666|NCT01343407|7404878|FG001|Second Washout (Part 2)|Withdrawal by Subject|0
4568667|NCT01343407|7404879|FG002|Second Washout (Part 2)|Withdrawal by Subject|1
4568668|NCT01343407|7404880|FG003|Second Washout (Part 2)|Withdrawal by Subject|0
4568669|NCT01343407|7404881|FG004|Second Washout (Part 2)|Withdrawal by Subject|0
4568670|NCT01343407|7404882|FG005|Second Washout (Part 2)|Withdrawal by Subject|0
4568671|NCT01343693|7404908|FG000|Overall Study|Lost to Follow-up|9
4568672|NCT01343823|7404916|FG000|Overall Study|Study Terminated|1
4568673|NCT01343823|7404917|FG001|Overall Study|Study Terminated|0
4568674|NCT01343823|7404918|FG002|Overall Study|Study Terminated|0
4568675|NCT01343823|7404919|FG003|Overall Study|Study Terminated|1
4568676|NCT01343823|7404916|FG000|Overall Study|Withdrawal by Subject|1
4568677|NCT01343823|7404917|FG001|Overall Study|Withdrawal by Subject|0
4568678|NCT01343823|7404918|FG002|Overall Study|Withdrawal by Subject|0
4568679|NCT01343823|7404919|FG003|Overall Study|Withdrawal by Subject|0
4568680|NCT01343888|7404932|FG000|Overall Study|Adverse Event|12
4568681|NCT01343888|7404933|FG001|Overall Study|Adverse Event|22
4568682|NCT01343888|7404934|FG002|Overall Study|Adverse Event|5
4568683|NCT01343888|7404932|FG000|Overall Study|Lack of Efficacy|9
4568684|NCT01343888|7404933|FG001|Overall Study|Lack of Efficacy|9
4568685|NCT01343888|7404934|FG002|Overall Study|Lack of Efficacy|13
4568686|NCT01343888|7404932|FG000|Overall Study|Lost to Follow-up|0
4568687|NCT01343888|7404933|FG001|Overall Study|Lost to Follow-up|2
4568688|NCT01343888|7404934|FG002|Overall Study|Lost to Follow-up|1
4568689|NCT01343888|7404932|FG000|Overall Study|Protocol Violation|0
4568690|NCT01343888|7404933|FG001|Overall Study|Protocol Violation|2
4568691|NCT01343888|7404934|FG002|Overall Study|Protocol Violation|0
4568692|NCT01343888|7404932|FG000|Overall Study|Withdrawal by Subject|4
4568693|NCT01343888|7404933|FG001|Overall Study|Withdrawal by Subject|4
4568694|NCT01343888|7404934|FG002|Overall Study|Withdrawal by Subject|2
4568695|NCT01343888|7404932|FG000|Overall Study|other than stated above|0
4568696|NCT01343888|7404933|FG001|Overall Study|other than stated above|0
4568697|NCT01343888|7404934|FG002|Overall Study|other than stated above|1
4568698|NCT01343901|7404942|FG000|Overall Study|Death|85
4568699|NCT01343901|7404942|FG000|Overall Study|Physician Decision|4
4568700|NCT01343901|7404942|FG000|Overall Study|Lost to Follow-up|12
4568701|NCT01343901|7404942|FG000|Overall Study|Management by another medical team|11
4568702|NCT01343901|7404942|FG000|Overall Study|Participant decision|1
4568703|NCT01344057|7404946|FG000|Overall Study|Premature Withdrawal|1
4568704|NCT01344161|7404952|FG000|Overall Study|Lost to Follow-up|4
4568705|NCT01344161|7404953|FG001|Overall Study|Lost to Follow-up|1
4568706|NCT01344161|7404952|FG000|Overall Study|Pregnancy|0
4568707|NCT01344161|7404953|FG001|Overall Study|Pregnancy|1
4568708|NCT01344161|7404952|FG000|Overall Study|Protocol Violation|1
4568709|NCT01344161|7404953|FG001|Overall Study|Protocol Violation|1
4568710|NCT01344226|7404959|FG000|Overall Study|Protocol Violation|2
4568711|NCT01344226|7404959|FG000|Overall Study|Withdrawal by Subject|3
4568712|NCT01344226|7404959|FG000|Overall Study|Lack of Efficacy|3
4568713|NCT01344356|7404965|FG000|Overall Study|Physician Decision|0
4568714|NCT01344356|7404966|FG001|Overall Study|Physician Decision|3
4568715|NCT01344356|7404965|FG000|Overall Study|Lost to Follow-up|0
4568716|NCT01344356|7404966|FG001|Overall Study|Lost to Follow-up|6
4568717|NCT01344369|7404976|FG000|Washout of 28 Days|Withdrawal by Subject|1
4568718|NCT01344369|7404977|FG001|Washout of 28 Days|Withdrawal by Subject|0
4568719|NCT01344369|7404976|FG000|Washout of 28 Days|Physician Decision|0
4568720|NCT01344369|7404977|FG001|Washout of 28 Days|Physician Decision|1
4568721|NCT01344369|7404976|FG000|Second Intervention|Emesis within 2 x Tmax|0
4568722|NCT01344369|7404977|FG001|Second Intervention|Emesis within 2 x Tmax|1
4568723|NCT01344447|7404983|FG000|Overall Study|Adverse Event|1
4568724|NCT01344447|7404983|FG000|Overall Study|Protocol Violation|1
4568725|NCT01344447|7404983|FG000|Overall Study|Withdrawal by Subject|1
4568726|NCT01344447|7404983|FG000|Overall Study|The contrast was not seen|1
4568727|NCT01344447|7404983|FG000|Overall Study|Physician Decision|1
4568728|NCT01344447|7404983|FG000|Overall Study|MRA unsuccessful|1
4568729|NCT01344447|7404983|FG000|Overall Study|Bolus tracking failed|1
4568730|NCT01344447|7404983|FG000|Overall Study|Error of power injector|1
4568731|NCT01344460|7404991|FG000|Overall Study|Withdrawal by Subject|1
4568732|NCT01344460|7404991|FG000|Overall Study|Lost to Follow-up|2
4568733|NCT01344538|7405001|FG000|Overall Study|Adverse Event|1
4568734|NCT01344538|7405002|FG001|Overall Study|Adverse Event|1
4568735|NCT01344538|7405001|FG000|Overall Study|Lost to Follow-up|1
4568736|NCT01344538|7405002|FG001|Overall Study|Lost to Follow-up|0
4568737|NCT01344629|7405019|FG000|Crossover Period 2|Withdrawal by Subject|0
4568738|NCT01344629|7405020|FG001|Crossover Period 2|Withdrawal by Subject|1
4568739|NCT01344759|7405028|FG000|Overall Study|Patients failed to reach sedation level|0
4568740|NCT01344759|7405029|FG001|Overall Study|Patients failed to reach sedation level|2
4568741|NCT01344824|7405041|FG000|Overall Study|Adverse Event|15
4568742|NCT01344824|7405041|FG000|Overall Study|Withdrawal by Subject|6
4568743|NCT01344824|7405041|FG000|Overall Study|Other complicating disease|1
4568744|NCT01344824|7405041|FG000|Overall Study|Progression|15
4568745|NCT01344876|7405046|FG000|Overall Study|Adverse Event|0
4568746|NCT01344876|7405047|FG001|Overall Study|Adverse Event|0
4568747|NCT01344876|7405048|FG002|Overall Study|Adverse Event|0
4568748|NCT01344876|7405049|FG003|Overall Study|Adverse Event|0
4568749|NCT01344876|7405050|FG004|Overall Study|Adverse Event|1
4568750|NCT01344876|7405046|FG000|Overall Study|Withdrawal by Subject|0
4568751|NCT01344876|7405047|FG001|Overall Study|Withdrawal by Subject|0
4568752|NCT01344876|7405048|FG002|Overall Study|Withdrawal by Subject|1
4568753|NCT01344876|7405049|FG003|Overall Study|Withdrawal by Subject|0
4568754|NCT01344876|7405050|FG004|Overall Study|Withdrawal by Subject|0
4568755|NCT01344876|7405046|FG000|Overall Study|Definite progression of primary disease|1
4568756|NCT01344876|7405047|FG001|Overall Study|Definite progression of primary disease|0
4568757|NCT01344876|7405048|FG002|Overall Study|Definite progression of primary disease|0
4568758|NCT01344876|7405049|FG003|Overall Study|Definite progression of primary disease|3
4568759|NCT01344876|7405050|FG004|Overall Study|Definite progression of primary disease|0
4568760|NCT01345019|7405065|FG000|Blinded Treatment Phase|Death|147
4568761|NCT01345019|7405066|FG001|Blinded Treatment Phase|Death|137
4568762|NCT01345019|7405065|FG000|Blinded Treatment Phase|Withdrawal by Subject|103
4568763|NCT01345019|7405066|FG001|Blinded Treatment Phase|Withdrawal by Subject|112
4568764|NCT01345019|7405065|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21
4568765|NCT01345019|7405066|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9
4568766|NCT01345019|7405065|FG000|Blinded Treatment Phase|Disease Progression|12
4568767|NCT01345019|7405066|FG001|Blinded Treatment Phase|Disease Progression|10
4568768|NCT01345019|7405065|FG000|Blinded Treatment Phase|Adverse Event|6
4568769|NCT01345019|7405066|FG001|Blinded Treatment Phase|Adverse Event|13
4568770|NCT01345019|7405065|FG000|Blinded Treatment Phase|Administrative Decision|10
4568771|NCT01345019|7405066|FG001|Blinded Treatment Phase|Administrative Decision|8
4568772|NCT01345019|7405065|FG000|Blinded Treatment Phase|Noncompliance|5
4568773|NCT01345019|7405066|FG001|Blinded Treatment Phase|Noncompliance|3
4568774|NCT01345019|7405065|FG000|Blinded Treatment Phase|Ineligibility Determined|1
4568775|NCT01345019|7405066|FG001|Blinded Treatment Phase|Ineligibility Determined|6
4568776|NCT01345019|7405065|FG000|Blinded Treatment Phase|Protocol Deviation|5
4568777|NCT01345019|7405066|FG001|Blinded Treatment Phase|Protocol Deviation|0
4568778|NCT01345019|7405065|FG000|Blinded Treatment Phase|Other, Not Specified|2
4568779|NCT01345019|7405066|FG001|Blinded Treatment Phase|Other, Not Specified|3
4568780|NCT01345019|7405065|FG000|Blinded Treatment Phase|Lost to Follow-up|6
4568781|NCT01345019|7405066|FG001|Blinded Treatment Phase|Lost to Follow-up|3
4568782|NCT01345019|7405065|FG000|Open Label Treatment Phase|Death|49
4568783|NCT01345019|7405066|FG001|Open Label Treatment Phase|Death|48
4568784|NCT01345019|7405065|FG000|Open Label Treatment Phase|Withdrawal by Subject|49
4568785|NCT01345019|7405066|FG001|Open Label Treatment Phase|Withdrawal by Subject|47
4568786|NCT01345019|7405065|FG000|Open Label Treatment Phase|Adverse Event|30
4568787|NCT01345019|7405066|FG001|Open Label Treatment Phase|Adverse Event|51
4568788|NCT01345019|7405065|FG000|Open Label Treatment Phase|Administrative Decision|30
4568789|NCT01345019|7405066|FG001|Open Label Treatment Phase|Administrative Decision|15
4568790|NCT01345019|7405065|FG000|Open Label Treatment Phase|Disease Progression|17
4568791|NCT01345019|7405066|FG001|Open Label Treatment Phase|Disease Progression|18
4568792|NCT01345019|7405065|FG000|Open Label Treatment Phase|Noncompliance|5
4568793|NCT01345019|7405066|FG001|Open Label Treatment Phase|Noncompliance|4
4568794|NCT01345019|7405065|FG000|Open Label Treatment Phase|Lost to Follow-up|1
4568795|NCT01345019|7405066|FG001|Open Label Treatment Phase|Lost to Follow-up|2
4568796|NCT01345019|7405065|FG000|Open Label Treatment Phase|Pregnancy|1
4568797|NCT01345019|7405066|FG001|Open Label Treatment Phase|Pregnancy|0
4568798|NCT01345019|7405065|FG000|Open Label Treatment Phase|Other, Not Specified|9
4568799|NCT01345019|7405066|FG001|Open Label Treatment Phase|Other, Not Specified|7
4568800|NCT01345019|7405065|FG000|Open Label Treatment Phase|Protocol Violation|0
4568801|NCT01345019|7405066|FG001|Open Label Treatment Phase|Protocol Violation|1
4568802|NCT01345058|7405076|FG000|Overall Study|Withdrawal by Subject|1
4568803|NCT01345058|7405077|FG001|Overall Study|Withdrawal by Subject|0
4568804|NCT01345058|7405076|FG000|Overall Study|Participant Reported Increase in Events|1
4568805|NCT01345058|7405077|FG001|Overall Study|Participant Reported Increase in Events|0
4568806|NCT01345058|7405076|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1
4568807|NCT01345058|7405077|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0
4568808|NCT01345058|7405076|FG000|Overall Study|Participant Stopped Taking Study Drug|1
4568809|NCT01345058|7405077|FG001|Overall Study|Participant Stopped Taking Study Drug|0
4568810|NCT01345058|7405076|FG000|Overall Study|Participant No-Show at Multiple Visits|1
4568811|NCT01345058|7405077|FG001|Overall Study|Participant No-Show at Multiple Visits|0
4568812|NCT01345123|7405086|FG000|Overall Study|participants no longer with health plan|79
4568813|NCT01345123|7405087|FG001|Overall Study|participants no longer with health plan|85
4568814|NCT01345123|7405088|FG002|Overall Study|participants no longer with health plan|88
4568815|NCT01345162|7405099|FG000|Overall Study|Protocol Violation|2
4568816|NCT01345162|7405100|FG001|Overall Study|Protocol Violation|4
4568817|NCT01345188|7405106|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2
4568818|NCT01345188|7405106|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1
4568819|NCT01345253|7405115|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22
4568820|NCT01345253|7405116|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27
4568821|NCT01345253|7405115|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11
4568822|NCT01345253|7405116|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7
4568823|NCT01345253|7405115|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1
4568824|NCT01345253|7405116|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5
4568825|NCT01345253|7405115|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6
4568826|NCT01345253|7405116|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1
4568827|NCT01345253|7405115|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3
4568828|NCT01345253|7405116|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8
4568829|NCT01345253|7405115|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4
4568830|NCT01345253|7405116|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12
4568831|NCT01345253|7405115|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9
4568832|NCT01345253|7405116|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19
4568833|NCT01345253|7405115|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7
4568834|NCT01345253|7405116|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18
4568835|NCT01345253|7405115|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0
4568836|NCT01345253|7405116|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1
4568837|NCT01345253|7405115|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3
4568838|NCT01345253|7405116|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7
4568839|NCT01345253|7405115|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2
4568840|NCT01345253|7405116|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5
4568841|NCT01345253|7405115|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4
4568842|NCT01345253|7405116|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6
4568843|NCT01345253|7405115|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11
4568844|NCT01345253|7405116|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24
4568845|NCT01345253|7405115|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37
4568846|NCT01345253|7405116|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82
4568847|NCT01345253|7405115|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1
4568848|NCT01345253|7405116|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1
4568849|NCT01345292|7405127|FG000|Overall Study|Withdrawal by Subject|2
4568850|NCT01345292|7405128|FG001|Overall Study|Withdrawal by Subject|0
4568851|NCT01345292|7405129|FG002|Overall Study|Withdrawal by Subject|1
4568852|NCT01345318|7405137|FG000|Overall Study|Adverse Event|16
4568853|NCT01345318|7405137|FG000|Overall Study|Lack of Efficacy|17
4568854|NCT01345318|7405137|FG000|Overall Study|Lost to Follow-up|2
4568855|NCT01345318|7405137|FG000|Overall Study|Protocol Violation|1
4568856|NCT01345318|7405137|FG000|Overall Study|Withdrawal by Subject|41
4568857|NCT01345318|7405137|FG000|Overall Study|Other|3
4568858|NCT01345591|7405146|FG000|Overall Study|Lost to Follow-up|1
4568859|NCT01345630|7405157|FG000|Overall Study|Adverse Event|22
4568860|NCT01345630|7405158|FG001|Overall Study|Adverse Event|23
4568861|NCT01345630|7405157|FG000|Overall Study|Lost to Follow-up|17
4568862|NCT01345630|7405158|FG001|Overall Study|Lost to Follow-up|16
4568863|NCT01345630|7405157|FG000|Overall Study|Protocol Violation|4
4568864|NCT01345630|7405158|FG001|Overall Study|Protocol Violation|1
4568865|NCT01345630|7405157|FG000|Overall Study|Medication error without associated AE|0
4568866|NCT01345630|7405158|FG001|Overall Study|Medication error without associated AE|1
4568867|NCT01345630|7405157|FG000|Overall Study|Study terminated by sponsor|254
4568868|NCT01345630|7405158|FG001|Overall Study|Study terminated by sponsor|285
4568869|NCT01345630|7405157|FG000|Overall Study|Other reasons|6
4568870|NCT01345630|7405158|FG001|Overall Study|Other reasons|8
4568871|NCT01345630|7405157|FG000|Overall Study|Withdrawn due to pregnancy|1
4568872|NCT01345630|7405158|FG001|Overall Study|Withdrawn due to pregnancy|2
4568873|NCT01345630|7405157|FG000|Overall Study|No longer willing to participate|9
4568874|NCT01345630|7405158|FG001|Overall Study|No longer willing to participate|12
4568875|NCT01345630|7405157|FG000|Overall Study|Insufficient clinical response|48
4568876|NCT01345630|7405158|FG001|Overall Study|Insufficient clinical response|11
4568877|NCT01345669|7405170|FG000|Overall Study|Primary tumour recurrence|53
4568878|NCT01345669|7405171|FG001|Overall Study|Primary tumour recurrence|32
4568879|NCT01345669|7405170|FG000|Overall Study|Second primary tumour|4
4568880|NCT01345669|7405171|FG001|Overall Study|Second primary tumour|3
4568881|NCT01345669|7405170|FG000|Overall Study|Adverse Event|63
4568882|NCT01345669|7405171|FG001|Overall Study|Adverse Event|9
4568883|NCT01345669|7405170|FG000|Overall Study|Protocol Violation|3
4568884|NCT01345669|7405171|FG001|Overall Study|Protocol Violation|1
4568885|NCT01345669|7405170|FG000|Overall Study|Lost to Follow-up|1
4568886|NCT01345669|7405171|FG001|Overall Study|Lost to Follow-up|1
4568887|NCT01345669|7405170|FG000|Overall Study|Withdrawal by Subject|52
4568888|NCT01345669|7405171|FG001|Overall Study|Withdrawal by Subject|13
4568889|NCT01345669|7405170|FG000|Overall Study|Other Reasons|111
4568890|NCT01345669|7405171|FG001|Overall Study|Other Reasons|60
4568891|NCT01345682|7405179|FG000|Overall Study|Progressive disease per RECIST|226
4568892|NCT01345682|7405180|FG001|Overall Study|Progressive disease per RECIST|93
4568893|NCT01345682|7405179|FG000|Overall Study|Worsening of underlying cancer disease|23
4568894|NCT01345682|7405180|FG001|Overall Study|Worsening of underlying cancer disease|12
4568895|NCT01345682|7405179|FG000|Overall Study|Adverse Event|51
4568896|NCT01345682|7405180|FG001|Overall Study|Adverse Event|41
4568897|NCT01345682|7405179|FG000|Overall Study|Non-compliance with protocol|0
4568898|NCT01345682|7405180|FG001|Overall Study|Non-compliance with protocol|1
4568899|NCT01345682|7405179|FG000|Overall Study|Lost to Follow-up|0
4568900|NCT01345682|7405180|FG001|Overall Study|Lost to Follow-up|1
4568901|NCT01345682|7405179|FG000|Overall Study|Refused to continue trial medication|16
4568902|NCT01345682|7405180|FG001|Overall Study|Refused to continue trial medication|9
4568903|NCT01345682|7405179|FG000|Overall Study|Not treated|2
4568904|NCT01345682|7405180|FG001|Overall Study|Not treated|1
4568905|NCT01345682|7405179|FG000|Overall Study|Reason other than those specified above|4
4568906|NCT01345682|7405180|FG001|Overall Study|Reason other than those specified above|3
4568907|NCT01345929|7405205|FG000|Overall Study|Withdrawal by Subject|9
4568908|NCT01345929|7405206|FG001|Overall Study|Withdrawal by Subject|8
4568909|NCT01345929|7405205|FG000|Overall Study|Lost to Follow-up|9
4568910|NCT01345929|7405206|FG001|Overall Study|Lost to Follow-up|9
4568911|NCT01345929|7405205|FG000|Overall Study|Adverse Event|0
4568912|NCT01345929|7405206|FG001|Overall Study|Adverse Event|1
4568913|NCT01345929|7405205|FG000|Overall Study|Didn't meet eligibility criteria|2
4568914|NCT01345929|7405206|FG001|Overall Study|Didn't meet eligibility criteria|0
4568915|NCT01345929|7405205|FG000|Overall Study|40,000 CFU/ML|1
4568916|NCT01345929|7405206|FG001|Overall Study|40,000 CFU/ML|0
4568917|NCT01345929|7405205|FG000|Overall Study|Patient withdrawal|0
4568918|NCT01345929|7405206|FG001|Overall Study|Patient withdrawal|1
4568919|NCT01346059|7405214|FG000|Overall Study|Withdrawal by Subject|1
4568920|NCT01346059|7405215|FG001|Overall Study|Withdrawal by Subject|0
4568921|NCT01346176|7405237|FG000|Recruited|Protocol Violation|1
4568922|NCT01346176|7405238|FG001|Recruited|Protocol Violation|0
4568923|NCT01346176|7405239|FG002|Recruited|Protocol Violation|0
4568924|NCT01346176|7405237|FG000|Completed Advance Directive|Death|3
4568925|NCT01346176|7405238|FG001|Completed Advance Directive|Death|2
4568926|NCT01346176|7405239|FG002|Completed Advance Directive|Death|2
4568927|NCT01346176|7405237|FG000|Completed Advance Directive|Became Ineligible|3
4568928|NCT01346176|7405238|FG001|Completed Advance Directive|Became Ineligible|0
4568929|NCT01346176|7405239|FG002|Completed Advance Directive|Became Ineligible|1
4568930|NCT01346176|7405237|FG000|Completed Advance Directive|Other reason did not complete AD|7
4568931|NCT01346176|7405238|FG001|Completed Advance Directive|Other reason did not complete AD|12
4568932|NCT01346176|7405239|FG002|Completed Advance Directive|Other reason did not complete AD|7
4568933|NCT01346176|7405237|FG000|Completed Satisfaction Survey|Death|3
4568934|NCT01346176|7405238|FG001|Completed Satisfaction Survey|Death|0
4568935|NCT01346176|7405239|FG002|Completed Satisfaction Survey|Death|2
4568936|NCT01346176|7405237|FG000|Completed Satisfaction Survey|Lost to Follow-up|3
4568937|NCT01346176|7405238|FG001|Completed Satisfaction Survey|Lost to Follow-up|4
4568938|NCT01346176|7405239|FG002|Completed Satisfaction Survey|Lost to Follow-up|4
4568939|NCT01346189|7405251|FG000|Overall Study|Withdrawal by Subject|7
4568940|NCT01346189|7405252|FG001|Overall Study|Withdrawal by Subject|5
4568941|NCT01346189|7405253|FG002|Overall Study|Withdrawal by Subject|3
4568942|NCT01346189|7405254|FG003|Overall Study|Withdrawal by Subject|5
4568943|NCT01346189|7405251|FG000|Overall Study|Physician Decision|4
4568944|NCT01346189|7405252|FG001|Overall Study|Physician Decision|0
4568945|NCT01346189|7405253|FG002|Overall Study|Physician Decision|0
4568946|NCT01346189|7405254|FG003|Overall Study|Physician Decision|0
4625677|NCT01831466|7490592|FG008|Overall Study|Adverse Event|1
4625678|NCT01831466|7490593|FG009|Overall Study|Adverse Event|1
4625679|NCT01831466|7490594|FG010|Overall Study|Adverse Event|0
4625680|NCT01831466|7490595|FG011|Overall Study|Adverse Event|2
4625681|NCT01831544|7490615|FG000|Overall Study|Death|1
4625682|NCT01831544|7490615|FG000|Overall Study|Still on original MVAD device|2
4625683|NCT01831726|7490619|FG000|Overall Study|Adverse Event|16
4625684|NCT01831726|7490619|FG000|Overall Study|Death|7
4625685|NCT01831726|7490619|FG000|Overall Study|Disease Progression|49
4625686|NCT01831726|7490619|FG000|Overall Study|Physician Decision|1
4625687|NCT01831726|7490619|FG000|Overall Study|Subject/guardian decision|7
4625688|NCT01831765|7490626|FG000|Overall Study|Lack of Efficacy|1
4625689|NCT01831765|7490627|FG001|Overall Study|Lack of Efficacy|0
4625690|NCT01831765|7490628|FG002|Overall Study|Lack of Efficacy|0
4625691|NCT01831765|7490626|FG000|Overall Study|Other, sponsor withdrew subject|0
4625692|NCT01831765|7490627|FG001|Overall Study|Other, sponsor withdrew subject|1
4625693|NCT01831765|7490628|FG002|Overall Study|Other, sponsor withdrew subject|0
4625694|NCT01831765|7490626|FG000|Overall Study|Pregnancy|1
4625695|NCT01831765|7490627|FG001|Overall Study|Pregnancy|1
4625696|NCT01831765|7490628|FG002|Overall Study|Pregnancy|2
4625697|NCT01831765|7490626|FG000|Overall Study|Death|0
4625698|NCT01831765|7490627|FG001|Overall Study|Death|1
4625699|NCT01831765|7490628|FG002|Overall Study|Death|1
4625700|NCT01831765|7490626|FG000|Overall Study|Other, site closed|1
4625701|NCT01831765|7490627|FG001|Overall Study|Other, site closed|1
4625702|NCT01831765|7490628|FG002|Overall Study|Other, site closed|0
4625703|NCT01831765|7490626|FG000|Overall Study|Adverse Event|5
4625704|NCT01831765|7490627|FG001|Overall Study|Adverse Event|3
4625705|NCT01831765|7490628|FG002|Overall Study|Adverse Event|3
4625706|NCT01831765|7490626|FG000|Overall Study|Withdrawal by Subject|22
4625707|NCT01831765|7490627|FG001|Overall Study|Withdrawal by Subject|7
4625708|NCT01831765|7490628|FG002|Overall Study|Withdrawal by Subject|17
4625709|NCT01831765|7490626|FG000|Overall Study|Withdrawal criteria|12
4625710|NCT01831765|7490627|FG001|Overall Study|Withdrawal criteria|10
4625711|NCT01831765|7490628|FG002|Overall Study|Withdrawal criteria|16
4625712|NCT01831765|7490626|FG000|Overall Study|Lost to Follow-up|2
4625713|NCT01831765|7490627|FG001|Overall Study|Lost to Follow-up|3
4625714|NCT01831765|7490628|FG002|Overall Study|Lost to Follow-up|3
4625715|NCT01831791|7490638|FG000|Overall Study|Withdrawal by Subject|10
4568947|NCT01346189|7405251|FG000|Overall Study|Moved|3
4568948|NCT01346189|7405252|FG001|Overall Study|Moved|0
4568949|NCT01346189|7405253|FG002|Overall Study|Moved|4
4568950|NCT01346189|7405254|FG003|Overall Study|Moved|0
4568951|NCT01346189|7405251|FG000|Overall Study|Other|2
4568952|NCT01346189|7405252|FG001|Overall Study|Other|4
4568953|NCT01346189|7405253|FG002|Overall Study|Other|7
4568954|NCT01346189|7405254|FG003|Overall Study|Other|3
4568955|NCT01346189|7405251|FG000|Overall Study|Death|0
4568956|NCT01346189|7405252|FG001|Overall Study|Death|3
4568957|NCT01346189|7405253|FG002|Overall Study|Death|0
4568958|NCT01346189|7405254|FG003|Overall Study|Death|0
4568959|NCT01346189|7405251|FG000|Overall Study|Non-health system primary care physician|0
4568960|NCT01346189|7405252|FG001|Overall Study|Non-health system primary care physician|5
4568961|NCT01346189|7405253|FG002|Overall Study|Non-health system primary care physician|0
4568962|NCT01346189|7405254|FG003|Overall Study|Non-health system primary care physician|0
4568963|NCT01346189|7405251|FG000|Overall Study|Travel|0
4568964|NCT01346189|7405252|FG001|Overall Study|Travel|0
4568965|NCT01346189|7405253|FG002|Overall Study|Travel|0
4568966|NCT01346189|7405254|FG003|Overall Study|Travel|3
4625716|NCT01831804|7490651|FG000|Overall Study|Adverse Event|0
4625717|NCT01831804|7490652|FG001|Overall Study|Adverse Event|0
4625718|NCT01831804|7490653|FG002|Overall Study|Adverse Event|0
4625719|NCT01831804|7490654|FG003|Overall Study|Adverse Event|0
4625720|NCT01831804|7490655|FG004|Overall Study|Adverse Event|0
4625721|NCT01831804|7490656|FG005|Overall Study|Adverse Event|0
4625722|NCT01831804|7490657|FG006|Overall Study|Adverse Event|1
4625723|NCT01831804|7490658|FG007|Overall Study|Adverse Event|0
4625724|NCT01831804|7490659|FG008|Overall Study|Adverse Event|1
4625725|NCT01831804|7490651|FG000|Overall Study|Protocol Violation|0
4625726|NCT01831804|7490652|FG001|Overall Study|Protocol Violation|0
4625727|NCT01831804|7490653|FG002|Overall Study|Protocol Violation|2
4568967|NCT01346293|7405275|FG000|Overall Study|Protocol Violation|30
4568968|NCT01346293|7405276|FG001|Overall Study|Protocol Violation|9
4625728|NCT01831804|7490654|FG003|Overall Study|Protocol Violation|0
4625729|NCT01831804|7490655|FG004|Overall Study|Protocol Violation|0
4625730|NCT01831804|7490656|FG005|Overall Study|Protocol Violation|0
4625731|NCT01831804|7490657|FG006|Overall Study|Protocol Violation|0
4625732|NCT01831804|7490658|FG007|Overall Study|Protocol Violation|0
4625733|NCT01831804|7490659|FG008|Overall Study|Protocol Violation|0
4625734|NCT01831804|7490651|FG000|Overall Study|Protocol defined stopping criteria|1
4625735|NCT01831804|7490652|FG001|Overall Study|Protocol defined stopping criteria|1
4633190|NCT01908907|7503158|FG000|Overall Study|Protocol Violation|1
4568969|NCT01346293|7405275|FG000|Overall Study|Lost to Follow-up|21
4568970|NCT01346293|7405276|FG001|Overall Study|Lost to Follow-up|8
4568971|NCT01346293|7405275|FG000|Overall Study|Withdrawal by Subject|15
4568972|NCT01346293|7405276|FG001|Overall Study|Withdrawal by Subject|4
4568973|NCT01346293|7405275|FG000|Overall Study|Other|1
4568974|NCT01346293|7405276|FG001|Overall Study|Other|0
4568975|NCT01346371|7405286|FG000|Overall Study|Lost to Follow-up|2
4568976|NCT01346371|7405287|FG001|Overall Study|Lost to Follow-up|0
4568977|NCT01346410|7405302|FG000|Overall Study|Death|1
4568978|NCT01346475|7405308|FG000|First Intervention|Lost to Follow-up|4
4568979|NCT01346475|7405309|FG001|First Intervention|Lost to Follow-up|3
4568980|NCT01346501|7405321|FG000|Overall Study|Initiated Other Biological Agents|3
4568981|NCT01346501|7405322|FG001|Overall Study|Initiated Other Biological Agents|1
4568982|NCT01346501|7405321|FG000|Overall Study|Other|8
4568983|NCT01346501|7405322|FG001|Overall Study|Other|12
4568984|NCT01346514|7405332|FG000|Overall Study|Lost to Follow-up|19
4568985|NCT01346514|7405333|FG001|Overall Study|Lost to Follow-up|30
4568986|NCT01346514|7405332|FG000|Overall Study|Withdrawal by Subject|7
4568987|NCT01346514|7405333|FG001|Overall Study|Withdrawal by Subject|3
4568988|NCT01346514|7405332|FG000|Overall Study|Death|3
4568989|NCT01346514|7405333|FG001|Overall Study|Death|4
4568990|NCT01346540|7405343|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3
4568991|NCT01346540|7405344|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8
4568992|NCT01346540|7405343|FG000|Overall Study|Adverse Event|0
4568993|NCT01346540|7405344|FG001|Overall Study|Adverse Event|4
4568994|NCT01346592|7405354|FG000|Overall Study|Lost to Follow-up|62
4568995|NCT01346592|7405355|FG001|Overall Study|Lost to Follow-up|29
4568996|NCT01346592|7405356|FG002|Overall Study|Lost to Follow-up|29
4568997|NCT01346592|7405354|FG000|Overall Study|Protocol Violation|2
4568998|NCT01346592|7405355|FG001|Overall Study|Protocol Violation|1
4568999|NCT01346592|7405356|FG002|Overall Study|Protocol Violation|0
4569000|NCT01346592|7405354|FG000|Overall Study|Death|1
4569001|NCT01346592|7405355|FG001|Overall Study|Death|3
4569002|NCT01346592|7405356|FG002|Overall Study|Death|4
4569003|NCT01346592|7405354|FG000|Overall Study|Adverse Event|0
4569004|NCT01346592|7405355|FG001|Overall Study|Adverse Event|1
4569005|NCT01346592|7405356|FG002|Overall Study|Adverse Event|0
4569006|NCT01346592|7405354|FG000|Overall Study|Withdrawal by Subject|77
4569007|NCT01346592|7405355|FG001|Overall Study|Withdrawal by Subject|51
4569008|NCT01346592|7405356|FG002|Overall Study|Withdrawal by Subject|38
4569009|NCT01346592|7405354|FG000|Overall Study|Inappropriate enrollment|3
4569010|NCT01346592|7405355|FG001|Overall Study|Inappropriate enrollment|1
4569011|NCT01346592|7405356|FG002|Overall Study|Inappropriate enrollment|1
4569012|NCT01346592|7405354|FG000|Overall Study|Administrative reason|1
4569013|NCT01346592|7405355|FG001|Overall Study|Administrative reason|0
4569014|NCT01346592|7405356|FG002|Overall Study|Administrative reason|0
4569015|NCT01346592|7405354|FG000|Overall Study|Unable to Classify|7
4569016|NCT01346592|7405355|FG001|Overall Study|Unable to Classify|3
4569017|NCT01346592|7405356|FG002|Overall Study|Unable to Classify|6
4569018|NCT01346696|7405385|FG000|Overall Study|Death|1
4569019|NCT01346774|7405391|FG000|Overall Study|Did not take a single dose|6
4569020|NCT01346774|7405392|FG001|Overall Study|Did not take a single dose|4
4569021|NCT01346774|7405391|FG000|Overall Study|Lost to Follow-up|3
4569022|NCT01346774|7405392|FG001|Overall Study|Lost to Follow-up|4
4569023|NCT01346774|7405391|FG000|Overall Study|Withdrawal by Subject|1
4569024|NCT01346774|7405392|FG001|Overall Study|Withdrawal by Subject|4
4569025|NCT01346774|7405391|FG000|Overall Study|Protocol Violation|2
4569026|NCT01346774|7405392|FG001|Overall Study|Protocol Violation|3
4569027|NCT01346774|7405391|FG000|Overall Study|Adverse Event|1
4569028|NCT01346774|7405392|FG001|Overall Study|Adverse Event|2
4569029|NCT01346969|7405420|FG000|Overall Study|Withdrawal by Subject|0
4569030|NCT01346969|7405421|FG001|Overall Study|Withdrawal by Subject|0
4569031|NCT01346969|7405422|FG002|Overall Study|Withdrawal by Subject|1
4569032|NCT01346969|7405423|FG003|Overall Study|Withdrawal by Subject|0
4569033|NCT01346969|7405420|FG000|Overall Study|Lost to Follow-up|1
4569034|NCT01346969|7405421|FG001|Overall Study|Lost to Follow-up|0
4569035|NCT01346969|7405422|FG002|Overall Study|Lost to Follow-up|2
4569036|NCT01346969|7405423|FG003|Overall Study|Lost to Follow-up|0
4569037|NCT01346969|7405420|FG000|Overall Study|Physician Decision|0
4569038|NCT01346969|7405421|FG001|Overall Study|Physician Decision|0
4569039|NCT01346969|7405422|FG002|Overall Study|Physician Decision|0
4569040|NCT01346969|7405423|FG003|Overall Study|Physician Decision|1
4569041|NCT01346969|7405420|FG000|Overall Study|Randomized but not treated|1
4569042|NCT01346969|7405421|FG001|Overall Study|Randomized but not treated|0
4569043|NCT01346969|7405422|FG002|Overall Study|Randomized but not treated|0
4569044|NCT01346969|7405423|FG003|Overall Study|Randomized but not treated|0
4569045|NCT01347073|7405460|FG000|Overall Study|Adverse Event|1
4569046|NCT01347073|7405460|FG000|Overall Study|Liver Transplant|1
4569047|NCT01347086|7405480|FG000|Overall Study|failed screening visit|0
4569048|NCT01347086|7405481|FG001|Overall Study|failed screening visit|0
4569049|NCT01347086|7405482|FG002|Overall Study|failed screening visit|1
4569050|NCT01347086|7405483|FG003|Overall Study|failed screening visit|0
4569051|NCT01347086|7405484|FG004|Overall Study|failed screening visit|0
4569052|NCT01347086|7405485|FG005|Overall Study|failed screening visit|0
4569053|NCT01347086|7405486|FG006|Overall Study|failed screening visit|1
4569054|NCT01347086|7405487|FG007|Overall Study|failed screening visit|1
4569055|NCT01347086|7405488|FG008|Overall Study|failed screening visit|0
4569056|NCT01347086|7405489|FG009|Overall Study|failed screening visit|1
4569057|NCT01347112|7405523|FG000|Overall Study|Withdrawal by Subject|1
4569058|NCT01347112|7405524|FG001|Overall Study|Withdrawal by Subject|7
4569059|NCT01347112|7405523|FG000|Overall Study|Lost to Follow-up|3
4569060|NCT01347112|7405524|FG001|Overall Study|Lost to Follow-up|5
4569061|NCT01347307|7405540|FG000|Overall Study|Death|0
4569062|NCT01347307|7405541|FG001|Overall Study|Death|4
4569063|NCT01347307|7405540|FG000|Overall Study|Physician Decision|0
4569064|NCT01347307|7405541|FG001|Overall Study|Physician Decision|1
4569065|NCT01347554|7405567|FG000|Overall Study|Lack of Efficacy|7
4569066|NCT01347554|7405568|FG001|Overall Study|Lack of Efficacy|11
4569067|NCT01347580|7405576|FG000|Overall Study|Withdrawal by Subject|13
4569068|NCT01347580|7405577|FG001|Overall Study|Withdrawal by Subject|23
4569069|NCT01347580|7405576|FG000|Overall Study|Death|30
4569070|NCT01347580|7405577|FG001|Overall Study|Death|19
4569071|NCT01347580|7405576|FG000|Overall Study|Protocol Violation|10
4569072|NCT01347580|7405577|FG001|Overall Study|Protocol Violation|7
4569073|NCT01347580|7405576|FG000|Overall Study|Lost to Follow-up|3
4569074|NCT01347580|7405577|FG001|Overall Study|Lost to Follow-up|1
4569075|NCT01347580|7405576|FG000|Overall Study|Had other reason|9
4569076|NCT01347580|7405577|FG001|Overall Study|Had other reason|6
4569077|NCT01347710|7405583|FG000|Overall Study|Withdrawal by Subject|2
4569078|NCT01347710|7405583|FG000|Overall Study|Adverse Event|4
4569079|NCT01347710|7405583|FG000|Overall Study|Angio or SPECT not completed|18
4569080|NCT01347710|7405583|FG000|Overall Study|issue with vitals prior to dosing|1
4569081|NCT01347710|7405583|FG000|Overall Study|Lost to Follow-up|1
4569082|NCT01347710|7405583|FG000|Overall Study|Physician Decision|2
4569083|NCT01347710|7405583|FG000|Overall Study|Other|3
4569084|NCT01347762|7405595|FG000|Overall Study|Lost to Follow-up|0
4569085|NCT01347762|7405596|FG001|Overall Study|Lost to Follow-up|1
4569086|NCT01347762|7405597|FG002|Overall Study|Lost to Follow-up|6
4569087|NCT01347762|7405598|FG003|Overall Study|Lost to Follow-up|5
4569088|NCT01347762|7405595|FG000|Overall Study|Withdrawal by Subject|4
4569089|NCT01347762|7405596|FG001|Overall Study|Withdrawal by Subject|1
4569090|NCT01347762|7405597|FG002|Overall Study|Withdrawal by Subject|3
4569091|NCT01347762|7405598|FG003|Overall Study|Withdrawal by Subject|3
4569092|NCT01347866|7405635|FG000|Overall Study|Death|0
4569093|NCT01347866|7405636|FG001|Overall Study|Death|0
4569094|NCT01347866|7405637|FG002|Overall Study|Death|0
4569095|NCT01347866|7405638|FG003|Overall Study|Death|1
4569096|NCT01347866|7405639|FG004|Overall Study|Death|2
4569097|NCT01347866|7405640|FG005|Overall Study|Death|2
4569098|NCT01347866|7405641|FG006|Overall Study|Death|1
4569099|NCT01347866|7405642|FG007|Overall Study|Death|0
4569100|NCT01347866|7405643|FG008|Overall Study|Death|4
4569101|NCT01347866|7405644|FG009|Overall Study|Death|1
4569102|NCT01347866|7405645|FG010|Overall Study|Death|3
4569103|NCT01347866|7405646|FG011|Overall Study|Death|1
4569104|NCT01347866|7405647|FG012|Overall Study|Death|2
4569105|NCT01347866|7405648|FG013|Overall Study|Death|0
4569106|NCT01347866|7405649|FG014|Overall Study|Death|0
4569107|NCT01347866|7405650|FG015|Overall Study|Death|1
4569108|NCT01347866|7405651|FG016|Overall Study|Death|0
4569109|NCT01347866|7405635|FG000|Overall Study|Lost to Follow-up|0
4569110|NCT01347866|7405636|FG001|Overall Study|Lost to Follow-up|0
4569111|NCT01347866|7405637|FG002|Overall Study|Lost to Follow-up|0
4569112|NCT01347866|7405638|FG003|Overall Study|Lost to Follow-up|0
4569113|NCT01347866|7405639|FG004|Overall Study|Lost to Follow-up|0
4569114|NCT01347866|7405640|FG005|Overall Study|Lost to Follow-up|0
4569115|NCT01347866|7405641|FG006|Overall Study|Lost to Follow-up|0
4569116|NCT01347866|7405642|FG007|Overall Study|Lost to Follow-up|1
4569117|NCT01347866|7405643|FG008|Overall Study|Lost to Follow-up|1
4569118|NCT01347866|7405644|FG009|Overall Study|Lost to Follow-up|0
4569119|NCT01347866|7405645|FG010|Overall Study|Lost to Follow-up|0
4569120|NCT01347866|7405646|FG011|Overall Study|Lost to Follow-up|0
4569121|NCT01347866|7405647|FG012|Overall Study|Lost to Follow-up|0
4569122|NCT01347866|7405648|FG013|Overall Study|Lost to Follow-up|0
4569123|NCT01347866|7405649|FG014|Overall Study|Lost to Follow-up|0
4569124|NCT01347866|7405650|FG015|Overall Study|Lost to Follow-up|0
4569125|NCT01347866|7405651|FG016|Overall Study|Lost to Follow-up|0
4569126|NCT01347866|7405635|FG000|Overall Study|Other|3
4569127|NCT01347866|7405636|FG001|Overall Study|Other|1
4569128|NCT01347866|7405637|FG002|Overall Study|Other|1
4569129|NCT01347866|7405638|FG003|Overall Study|Other|4
4569130|NCT01347866|7405639|FG004|Overall Study|Other|5
4569131|NCT01347866|7405640|FG005|Overall Study|Other|0
4569132|NCT01347866|7405641|FG006|Overall Study|Other|5
4569133|NCT01347866|7405642|FG007|Overall Study|Other|3
4569134|NCT01347866|7405643|FG008|Overall Study|Other|22
4569135|NCT01347866|7405644|FG009|Overall Study|Other|5
4569136|NCT01347866|7405645|FG010|Overall Study|Other|0
4569137|NCT01347866|7405646|FG011|Overall Study|Other|3
4569138|NCT01347866|7405647|FG012|Overall Study|Other|4
4569139|NCT01347866|7405648|FG013|Overall Study|Other|4
4569140|NCT01347866|7405649|FG014|Overall Study|Other|2
4569141|NCT01347866|7405650|FG015|Overall Study|Other|3
4569142|NCT01347866|7405651|FG016|Overall Study|Other|0
4569143|NCT01347866|7405635|FG000|Overall Study|Subject refused further follow-up|2
4569144|NCT01347866|7405636|FG001|Overall Study|Subject refused further follow-up|0
4569145|NCT01347866|7405637|FG002|Overall Study|Subject refused further follow-up|0
4569146|NCT01347866|7405638|FG003|Overall Study|Subject refused further follow-up|2
4569147|NCT01347866|7405639|FG004|Overall Study|Subject refused further follow-up|0
4569148|NCT01347866|7405640|FG005|Overall Study|Subject refused further follow-up|1
4569149|NCT01347866|7405641|FG006|Overall Study|Subject refused further follow-up|0
4569150|NCT01347866|7405642|FG007|Overall Study|Subject refused further follow-up|0
4569151|NCT01347866|7405643|FG008|Overall Study|Subject refused further follow-up|4
4569152|NCT01347866|7405644|FG009|Overall Study|Subject refused further follow-up|1
4569153|NCT01347866|7405645|FG010|Overall Study|Subject refused further follow-up|0
4569154|NCT01347866|7405646|FG011|Overall Study|Subject refused further follow-up|0
4569155|NCT01347866|7405647|FG012|Overall Study|Subject refused further follow-up|1
4569156|NCT01347866|7405648|FG013|Overall Study|Subject refused further follow-up|3
4569157|NCT01347866|7405649|FG014|Overall Study|Subject refused further follow-up|1
4569158|NCT01347866|7405650|FG015|Overall Study|Subject refused further follow-up|0
4569159|NCT01347866|7405651|FG016|Overall Study|Subject refused further follow-up|2
4569160|NCT01347879|7405724|FG000|Overall Study|Adverse Event|0
4569161|NCT01347879|7405725|FG001|Overall Study|Adverse Event|12
4569162|NCT01347879|7405724|FG000|Overall Study|Lost to Follow-up|2
4569163|NCT01347879|7405725|FG001|Overall Study|Lost to Follow-up|0
4569164|NCT01347879|7405724|FG000|Overall Study|Withdrawal by Subject|3
4569165|NCT01347879|7405725|FG001|Overall Study|Withdrawal by Subject|2
4569166|NCT01347879|7405724|FG000|Overall Study|Other|2
4569167|NCT01347879|7405725|FG001|Overall Study|Other|3
4569168|NCT01347931|7405731|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1
4569169|NCT01348087|7405737|FG000|Overall Study|Unsatisfactory therapeutic effect|35
4569170|NCT01348087|7405737|FG000|Overall Study|Administrative problems|79
4569171|NCT01348087|7405737|FG000|Overall Study|protocol deviation|1
4569172|NCT01348087|7405737|FG000|Overall Study|Lost to Follow-up|1
4569173|NCT01348087|7405737|FG000|Overall Study|Subject withdrew consent|7
4569174|NCT01348087|7405737|FG000|Overall Study|Adverse Event|25
4569175|NCT01348100|7405758|FG000|Overall Study|Subject Withdrew Consent|0
4569176|NCT01348100|7405759|FG001|Overall Study|Subject Withdrew Consent|0
4569177|NCT01348100|7405760|FG002|Overall Study|Subject Withdrew Consent|2
4569178|NCT01348100|7405761|FG003|Overall Study|Subject Withdrew Consent|0
4569179|NCT01348100|7405762|FG004|Overall Study|Subject Withdrew Consent|1
4569180|NCT01348100|7405763|FG005|Overall Study|Subject Withdrew Consent|0
4569181|NCT01348100|7405764|FG006|Overall Study|Subject Withdrew Consent|1
4569182|NCT01348100|7405758|FG000|Overall Study|Protocol Deviation|0
4569183|NCT01348100|7405759|FG001|Overall Study|Protocol Deviation|0
4569184|NCT01348100|7405760|FG002|Overall Study|Protocol Deviation|0
4569185|NCT01348100|7405761|FG003|Overall Study|Protocol Deviation|1
4569186|NCT01348100|7405762|FG004|Overall Study|Protocol Deviation|0
4569187|NCT01348100|7405763|FG005|Overall Study|Protocol Deviation|0
4569188|NCT01348100|7405764|FG006|Overall Study|Protocol Deviation|0
4569189|NCT01348100|7405758|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0
4569190|NCT01348100|7405759|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0
4569191|NCT01348100|7405760|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0
4569192|NCT01348100|7405761|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0
4569193|NCT01348100|7405762|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0
4569194|NCT01348100|7405763|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1
4569195|NCT01348100|7405764|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0
4569196|NCT01348100|7405758|FG000|Overall Study|Lost to Follow-up|0
4569197|NCT01348100|7405759|FG001|Overall Study|Lost to Follow-up|0
4569198|NCT01348100|7405760|FG002|Overall Study|Lost to Follow-up|0
4569199|NCT01348100|7405761|FG003|Overall Study|Lost to Follow-up|0
4569200|NCT01348100|7405762|FG004|Overall Study|Lost to Follow-up|0
4569201|NCT01348100|7405763|FG005|Overall Study|Lost to Follow-up|0
4569202|NCT01348100|7405764|FG006|Overall Study|Lost to Follow-up|1
4569203|NCT01348100|7405758|FG000|Overall Study|Administrative Problems|0
4569204|NCT01348100|7405759|FG001|Overall Study|Administrative Problems|0
4569205|NCT01348100|7405760|FG002|Overall Study|Administrative Problems|0
4569206|NCT01348100|7405761|FG003|Overall Study|Administrative Problems|0
4569207|NCT01348100|7405762|FG004|Overall Study|Administrative Problems|0
4569208|NCT01348100|7405763|FG005|Overall Study|Administrative Problems|1
4569209|NCT01348100|7405764|FG006|Overall Study|Administrative Problems|1
4569210|NCT01348139|7405785|FG000|Period 1|Adverse Event|1
4569211|NCT01348139|7405786|FG001|Period 1|Adverse Event|0
4569212|NCT01348139|7405787|FG002|Period 1|Adverse Event|0
4569213|NCT01348139|7405788|FG003|Period 1|Adverse Event|0
4569214|NCT01348139|7405789|FG004|Period 1|Adverse Event|0
4569215|NCT01348139|7405790|FG005|Period 1|Adverse Event|0
4569216|NCT01348165|7405811|FG000|Overall Study|Adverse Event|0
4569217|NCT01348165|7405812|FG001|Overall Study|Adverse Event|0
4569218|NCT01348165|7405813|FG002|Overall Study|Adverse Event|0
4569219|NCT01348165|7405814|FG003|Overall Study|Adverse Event|0
4569220|NCT01348165|7405815|FG004|Overall Study|Adverse Event|0
4569221|NCT01348165|7405816|FG005|Overall Study|Adverse Event|0
4569222|NCT01348165|7405817|FG006|Overall Study|Adverse Event|1
4569223|NCT01348347|7405840|FG000|Overall Study|Withdrawal by Subject|1
4569224|NCT01348347|7405841|FG001|Overall Study|Withdrawal by Subject|1
4569225|NCT01348347|7405842|FG002|Overall Study|Withdrawal by Subject|1
4569226|NCT01348347|7405840|FG000|Overall Study|Progressive disease|2
4569227|NCT01348347|7405841|FG001|Overall Study|Progressive disease|5
4569228|NCT01348347|7405842|FG002|Overall Study|Progressive disease|5
4569229|NCT01348425|7405853|FG000|Overall Study|Imaging was not taken.|1
4569230|NCT01348425|7405854|FG001|Overall Study|Imaging was not taken.|1
4569231|NCT01348490|7405859|FG000|Overall Study|Death|1
4569232|NCT01348490|7405859|FG000|Overall Study|Adverse Event|3
4569233|NCT01348490|7405859|FG000|Overall Study|Consent withdrawn|7
4569234|NCT01348490|7405859|FG000|Overall Study|Disease progression|3
4569235|NCT01348490|7405859|FG000|Overall Study|Lost to Follow-up|1
4569236|NCT01348490|7405859|FG000|Overall Study|Termination of clinical trial by sponsor|1
4569237|NCT01348490|7405859|FG000|Overall Study|Other Unspecified|8
4569238|NCT01348542|7405882|FG000|Overall Study|Withdrawal by Subject|3
4569239|NCT01348542|7405883|FG001|Overall Study|Withdrawal by Subject|0
4569240|NCT01348698|7405902|FG000|Overall Study|Does not meet lesion size criteria|1
4569241|NCT01348698|7405902|FG000|Overall Study|Death|3
4569242|NCT01348698|7405902|FG000|Overall Study|PI decision to close study|68
4569243|NCT01348763|7405906|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1
4569244|NCT01348763|7405906|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1
4569245|NCT01348776|7405910|FG000|Overall Study|Lost to Follow-up|3
4569246|NCT01348789|7405923|FG000|Overall Study|Protocol Violation|2
4569247|NCT01348789|7405923|FG000|Overall Study|Withdrawal by Subject|2
4592678|NCT01544153|7440611|FG002|Overall Study|Non-smoker|1
4592679|NCT01544153|7440612|FG003|Overall Study|Non-smoker|0
4592680|NCT01544179|7440631|FG000|Overall Study|Death|50
4592681|NCT01544179|7440632|FG001|Overall Study|Death|37
4592682|NCT01544179|7440631|FG000|Overall Study|Lost to Follow-up|0
4592683|NCT01544179|7440632|FG001|Overall Study|Lost to Follow-up|1
4592684|NCT01544179|7440631|FG000|Overall Study|Adverse Event|0
4592685|NCT01544179|7440632|FG001|Overall Study|Adverse Event|1
4592686|NCT01544179|7440631|FG000|Overall Study|Withdrawal by Subject|12
4592687|NCT01544179|7440632|FG001|Overall Study|Withdrawal by Subject|7
4592688|NCT01544179|7440631|FG000|Overall Study|Eligibility criteria not fulfilled|1
4592689|NCT01544179|7440632|FG001|Overall Study|Eligibility criteria not fulfilled|0
4592690|NCT01544309|7440640|FG000|Overall Study|Withdrawal by Subject|12
4592691|NCT01544309|7440641|FG001|Overall Study|Withdrawal by Subject|7
4592692|NCT01544309|7440640|FG000|Overall Study|Protocol Violation|2
4592693|NCT01544309|7440641|FG001|Overall Study|Protocol Violation|1
4592694|NCT01544309|7440640|FG000|Overall Study|Physician Decision|4
4592695|NCT01544309|7440641|FG001|Overall Study|Physician Decision|1
4592696|NCT01544309|7440640|FG000|Overall Study|Not performed pre-dose examination|1
4592697|NCT01544309|7440641|FG001|Overall Study|Not performed pre-dose examination|2
4592698|NCT01544309|7440640|FG000|Overall Study|Administered prohibit prior medication|1
4592699|NCT01544309|7440641|FG001|Overall Study|Administered prohibit prior medication|0
4592700|NCT01544335|7440649|FG000|Overall Study|Lost to Follow-up|27
4592701|NCT01544335|7440649|FG000|Overall Study|Death|4
4592702|NCT01544335|7440649|FG000|Overall Study|Disease progression|3
4592703|NCT01544335|7440649|FG000|Overall Study|Baseline Measurements not Available|19
4592704|NCT01544348|7440661|FG000|Overall Study|Lost to Follow-up|1
4592705|NCT01544348|7440662|FG001|Overall Study|Lost to Follow-up|0
4592706|NCT01544348|7440663|FG002|Overall Study|Lost to Follow-up|0
4592707|NCT01544348|7440664|FG003|Overall Study|Lost to Follow-up|0
4592708|NCT01544348|7440665|FG004|Overall Study|Lost to Follow-up|0
4592709|NCT01544348|7440666|FG005|Overall Study|Lost to Follow-up|0
4592710|NCT01544348|7440667|FG006|Overall Study|Lost to Follow-up|1
4592711|NCT01544348|7440668|FG007|Overall Study|Lost to Follow-up|0
4592712|NCT01544348|7440661|FG000|Overall Study|Withdrawal by Subject|1
4592713|NCT01544348|7440662|FG001|Overall Study|Withdrawal by Subject|0
4592714|NCT01544348|7440663|FG002|Overall Study|Withdrawal by Subject|0
4592715|NCT01544348|7440664|FG003|Overall Study|Withdrawal by Subject|0
4592716|NCT01544348|7440665|FG004|Overall Study|Withdrawal by Subject|1
4592717|NCT01544348|7440666|FG005|Overall Study|Withdrawal by Subject|2
4592718|NCT01544348|7440667|FG006|Overall Study|Withdrawal by Subject|1
4592719|NCT01544348|7440668|FG007|Overall Study|Withdrawal by Subject|0
4592720|NCT01544348|7440661|FG000|Overall Study|Physician Decision|0
4592721|NCT01544348|7440662|FG001|Overall Study|Physician Decision|0
4592722|NCT01544348|7440663|FG002|Overall Study|Physician Decision|0
4592723|NCT01544348|7440664|FG003|Overall Study|Physician Decision|0
4592724|NCT01544348|7440665|FG004|Overall Study|Physician Decision|0
4592725|NCT01544348|7440666|FG005|Overall Study|Physician Decision|1
4592726|NCT01544348|7440667|FG006|Overall Study|Physician Decision|0
4592727|NCT01544348|7440668|FG007|Overall Study|Physician Decision|0
4592728|NCT01544478|7440714|FG000|Overall Study|Adverse Event|1
4592729|NCT01544478|7440714|FG000|Overall Study|Death|1
4592730|NCT01544478|7440714|FG000|Overall Study|Lost to Follow-up|48
4592731|NCT01544478|7440714|FG000|Overall Study|Physician Decision|15
4592732|NCT01544478|7440714|FG000|Overall Study|Pregnancy|1
4592733|NCT01544478|7440714|FG000|Overall Study|Withdrawal by Subject|52
4592734|NCT01544491|7440720|FG000|Overall Study|Withdrawal by Subject|3
4592735|NCT01544491|7440721|FG001|Overall Study|Withdrawal by Subject|2
4592736|NCT01544491|7440720|FG000|Overall Study|Lost to Follow-up|0
4592737|NCT01544491|7440721|FG001|Overall Study|Lost to Follow-up|1
4592738|NCT01544491|7440720|FG000|Overall Study|administrative problems|2
4592739|NCT01544491|7440721|FG001|Overall Study|administrative problems|0
4592740|NCT01544582|7440730|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1
4569248|NCT01348828|7405934|FG000|Overall Study|Death|20
4569249|NCT01348828|7405934|FG000|Overall Study|Withdrawals/Lost to Follow-up|10
4569250|NCT01348828|7405934|FG000|Overall Study|Conversion|2
4569251|NCT01348828|7405934|FG000|Overall Study|missed visit|1
4569252|NCT01348854|7405940|FG000|Overall Study|Lost to Follow-up|2
4569253|NCT01348854|7405941|FG001|Overall Study|Lost to Follow-up|1
4569254|NCT01348854|7405940|FG000|Overall Study|Withdrawal by Subject|1
4569255|NCT01348854|7405941|FG001|Overall Study|Withdrawal by Subject|0
4569256|NCT01349036|7405949|FG000|Overall Study|Disease progression|13
4569257|NCT01349036|7405950|FG001|Overall Study|Disease progression|22
4569258|NCT01349036|7405949|FG000|Overall Study|Other|1
4569259|NCT01349036|7405950|FG001|Overall Study|Other|0
4569260|NCT01349036|7405949|FG000|Overall Study|Withdrawal by Subject|0
4569261|NCT01349036|7405950|FG001|Overall Study|Withdrawal by Subject|2
4569262|NCT01349049|7405969|FG000|Overall Study|Disease progression|3
4569263|NCT01349049|7405970|FG001|Overall Study|Disease progression|5
4569264|NCT01349049|7405971|FG002|Overall Study|Disease progression|3
4569265|NCT01349049|7405972|FG003|Overall Study|Disease progression|2
4569266|NCT01349049|7405973|FG004|Overall Study|Disease progression|2
4569267|NCT01349049|7405974|FG005|Overall Study|Disease progression|2
4569268|NCT01349049|7405975|FG006|Overall Study|Disease progression|3
4569269|NCT01349049|7405976|FG007|Overall Study|Disease progression|2
4569270|NCT01349049|7405977|FG008|Overall Study|Disease progression|33
4569271|NCT01349049|7405969|FG000|Overall Study|Adverse Event|0
4569272|NCT01349049|7405970|FG001|Overall Study|Adverse Event|1
4569273|NCT01349049|7405971|FG002|Overall Study|Adverse Event|0
4569274|NCT01349049|7405972|FG003|Overall Study|Adverse Event|0
4569275|NCT01349049|7405973|FG004|Overall Study|Adverse Event|0
4569276|NCT01349049|7405974|FG005|Overall Study|Adverse Event|3
4569277|NCT01349049|7405975|FG006|Overall Study|Adverse Event|1
4569278|NCT01349049|7405976|FG007|Overall Study|Adverse Event|0
4569279|NCT01349049|7405977|FG008|Overall Study|Adverse Event|4
4569280|NCT01349049|7405969|FG000|Overall Study|Physician Decision|0
4569281|NCT01349049|7405970|FG001|Overall Study|Physician Decision|1
4569282|NCT01349049|7405971|FG002|Overall Study|Physician Decision|0
4569283|NCT01349049|7405972|FG003|Overall Study|Physician Decision|0
4569284|NCT01349049|7405973|FG004|Overall Study|Physician Decision|0
4569285|NCT01349049|7405974|FG005|Overall Study|Physician Decision|0
4569286|NCT01349049|7405975|FG006|Overall Study|Physician Decision|0
4569287|NCT01349049|7405976|FG007|Overall Study|Physician Decision|0
4569288|NCT01349049|7405977|FG008|Overall Study|Physician Decision|2
4569289|NCT01349049|7405969|FG000|Overall Study|Protocol Violation|0
4569290|NCT01349049|7405970|FG001|Overall Study|Protocol Violation|0
4569291|NCT01349049|7405971|FG002|Overall Study|Protocol Violation|0
4569292|NCT01349049|7405972|FG003|Overall Study|Protocol Violation|0
4569293|NCT01349049|7405973|FG004|Overall Study|Protocol Violation|0
4569294|NCT01349049|7405974|FG005|Overall Study|Protocol Violation|0
4569295|NCT01349049|7405975|FG006|Overall Study|Protocol Violation|0
4569296|NCT01349049|7405976|FG007|Overall Study|Protocol Violation|0
4569297|NCT01349049|7405977|FG008|Overall Study|Protocol Violation|1
4569298|NCT01349049|7405969|FG000|Overall Study|Hematopoietic stem cell transplant|0
4569299|NCT01349049|7405970|FG001|Overall Study|Hematopoietic stem cell transplant|0
4569300|NCT01349049|7405971|FG002|Overall Study|Hematopoietic stem cell transplant|0
4569301|NCT01349049|7405972|FG003|Overall Study|Hematopoietic stem cell transplant|0
4569302|NCT01349049|7405973|FG004|Overall Study|Hematopoietic stem cell transplant|1
4569303|NCT01349049|7405974|FG005|Overall Study|Hematopoietic stem cell transplant|0
4569304|NCT01349049|7405975|FG006|Overall Study|Hematopoietic stem cell transplant|1
4569305|NCT01349049|7405976|FG007|Overall Study|Hematopoietic stem cell transplant|1
4569306|NCT01349049|7405977|FG008|Overall Study|Hematopoietic stem cell transplant|0
4569307|NCT01349049|7405969|FG000|Overall Study|Other|0
4569308|NCT01349049|7405970|FG001|Overall Study|Other|0
4569309|NCT01349049|7405971|FG002|Overall Study|Other|0
4569310|NCT01349049|7405972|FG003|Overall Study|Other|0
4569311|NCT01349049|7405973|FG004|Overall Study|Other|0
4569312|NCT01349049|7405974|FG005|Overall Study|Other|1
4569313|NCT01349049|7405975|FG006|Overall Study|Other|0
4569314|NCT01349049|7405976|FG007|Overall Study|Other|0
4569315|NCT01349049|7405977|FG008|Overall Study|Other|4
4569316|NCT01349049|7405969|FG000|Overall Study|Death|0
4569317|NCT01349049|7405970|FG001|Overall Study|Death|0
4569318|NCT01349049|7405971|FG002|Overall Study|Death|0
4569319|NCT01349049|7405972|FG003|Overall Study|Death|0
4569320|NCT01349049|7405973|FG004|Overall Study|Death|0
4569321|NCT01349049|7405974|FG005|Overall Study|Death|0
4569322|NCT01349049|7405975|FG006|Overall Study|Death|0
4569323|NCT01349049|7405976|FG007|Overall Study|Death|1
4569324|NCT01349049|7405977|FG008|Overall Study|Death|5
4569325|NCT01349049|7405969|FG000|Overall Study|Non-compliance|0
4569326|NCT01349049|7405970|FG001|Overall Study|Non-compliance|0
4569327|NCT01349049|7405971|FG002|Overall Study|Non-compliance|0
4569328|NCT01349049|7405972|FG003|Overall Study|Non-compliance|1
4569329|NCT01349049|7405973|FG004|Overall Study|Non-compliance|0
4569330|NCT01349049|7405974|FG005|Overall Study|Non-compliance|0
4569331|NCT01349049|7405975|FG006|Overall Study|Non-compliance|0
4569332|NCT01349049|7405976|FG007|Overall Study|Non-compliance|0
4569333|NCT01349049|7405977|FG008|Overall Study|Non-compliance|0
4569334|NCT01349049|7405969|FG000|Overall Study|Withdrawal by Subject|0
4569335|NCT01349049|7405970|FG001|Overall Study|Withdrawal by Subject|0
4569336|NCT01349049|7405971|FG002|Overall Study|Withdrawal by Subject|0
4569337|NCT01349049|7405972|FG003|Overall Study|Withdrawal by Subject|0
4569338|NCT01349049|7405973|FG004|Overall Study|Withdrawal by Subject|0
4569339|NCT01349049|7405974|FG005|Overall Study|Withdrawal by Subject|0
4569340|NCT01349049|7405975|FG006|Overall Study|Withdrawal by Subject|0
4569341|NCT01349049|7405976|FG007|Overall Study|Withdrawal by Subject|0
4569342|NCT01349049|7405977|FG008|Overall Study|Withdrawal by Subject|6
4569343|NCT01349192|7406026|FG000|Overall Study|Protocol Violation|0
4569344|NCT01349192|7406027|FG001|Overall Study|Protocol Violation|1
4569345|NCT01349192|7406026|FG000|Overall Study|Withdrawal by Subject|0
4569346|NCT01349192|7406027|FG001|Overall Study|Withdrawal by Subject|2
4569347|NCT01349192|7406026|FG000|Overall Study|Lost to Follow-up|1
4569348|NCT01349192|7406027|FG001|Overall Study|Lost to Follow-up|3
4569349|NCT01349192|7406026|FG000|Overall Study|Failure to adhere to Protocol|2
4569350|NCT01349192|7406027|FG001|Overall Study|Failure to adhere to Protocol|0
4569351|NCT01349465|7406041|FG000|Overall Study|Adverse Event|1
4569352|NCT01349465|7406042|FG001|Overall Study|Adverse Event|0
4569353|NCT01349465|7406041|FG000|Overall Study|Death|3
4569354|NCT01349465|7406042|FG001|Overall Study|Death|0
4569355|NCT01349465|7406041|FG000|Overall Study|Lost to Follow-up|10
4569356|NCT01349465|7406042|FG001|Overall Study|Lost to Follow-up|1
4569357|NCT01349465|7406041|FG000|Overall Study|Withdrawal by Subject|4
4569358|NCT01349465|7406042|FG001|Overall Study|Withdrawal by Subject|2
4569359|NCT01349465|7406041|FG000|Overall Study|Subject Ineligible To Continue The Trial|0
4569360|NCT01349465|7406042|FG001|Overall Study|Subject Ineligible To Continue The Trial|19
4569361|NCT01349569|7406059|FG000|Overall Study|Lack of Efficacy|4
4569362|NCT01349660|7406069|FG000|Overall Study|Still Receiving Study Treatment|0
4569363|NCT01349660|7406070|FG001|Overall Study|Still Receiving Study Treatment|0
4569364|NCT01349660|7406071|FG002|Overall Study|Still Receiving Study Treatment|1
4569365|NCT01349660|7406069|FG000|Overall Study|Disease Progression|2
4569366|NCT01349660|7406070|FG001|Overall Study|Disease Progression|4
4569367|NCT01349660|7406071|FG002|Overall Study|Disease Progression|50
4569368|NCT01349660|7406069|FG000|Overall Study|Adverse Event|1
4569369|NCT01349660|7406070|FG001|Overall Study|Adverse Event|1
4569370|NCT01349660|7406071|FG002|Overall Study|Adverse Event|12
4569371|NCT01349660|7406069|FG000|Overall Study|Withdrawal by Subject|2
4569372|NCT01349660|7406070|FG001|Overall Study|Withdrawal by Subject|0
4569373|NCT01349660|7406071|FG002|Overall Study|Withdrawal by Subject|9
4569374|NCT01349660|7406069|FG000|Overall Study|Death|1
4569375|NCT01349660|7406070|FG001|Overall Study|Death|1
4569376|NCT01349660|7406071|FG002|Overall Study|Death|0
4569377|NCT01349660|7406069|FG000|Overall Study|Non-Permitted Interventions|0
4569378|NCT01349660|7406070|FG001|Overall Study|Non-Permitted Interventions|0
4569379|NCT01349660|7406071|FG002|Overall Study|Non-Permitted Interventions|2
4569380|NCT01349660|7406069|FG000|Overall Study|Study Compliance|0
4569381|NCT01349660|7406070|FG001|Overall Study|Study Compliance|0
4569382|NCT01349660|7406071|FG002|Overall Study|Study Compliance|1
4569383|NCT01349660|7406069|FG000|Overall Study|Declining Performance Status|0
4569384|NCT01349660|7406070|FG001|Overall Study|Declining Performance Status|0
4569385|NCT01349660|7406071|FG002|Overall Study|Declining Performance Status|1
4569386|NCT01349673|7406086|FG000|Overall Study|Progression Of Disease Past 40 cm|1
4569387|NCT01349673|7406086|FG000|Overall Study|No Longer Qualified For Study|1
4569388|NCT01349673|7406086|FG000|Overall Study|Site Closure|10
4569389|NCT01349673|7406086|FG000|Overall Study|Withdrawal by Subject|21
4569390|NCT01349673|7406086|FG000|Overall Study|Lost to Follow-up|6
4569391|NCT01349673|7406086|FG000|Overall Study|Adverse Event|17
4569392|NCT01349673|7406086|FG000|Overall Study|Study Terminated By Sponsor|50
4569393|NCT01349673|7406086|FG000|Overall Study|Lack of Efficacy|8
4569394|NCT01349790|7406090|FG000|Overall Study|Investigator Judgement|3
4569395|NCT01349790|7406090|FG000|Overall Study|Death|2
4569396|NCT01349790|7406090|FG000|Overall Study|Withdrawal by Patient|2
4569397|NCT01349790|7406090|FG000|Overall Study|Adverse Event|1
4569398|NCT01349790|7406090|FG000|Overall Study|Lost to Follow-up|1
4569399|NCT01349803|7406098|FG000|Overall Study|Adverse Event|0
4569400|NCT01349803|7406099|FG001|Overall Study|Adverse Event|0
4569401|NCT01349803|7406100|FG002|Overall Study|Adverse Event|0
4569402|NCT01349803|7406101|FG003|Overall Study|Adverse Event|2
4569403|NCT01349803|7406098|FG000|Overall Study|Withdrawal by Subject|1
4569404|NCT01349803|7406099|FG001|Overall Study|Withdrawal by Subject|0
4569405|NCT01349803|7406100|FG002|Overall Study|Withdrawal by Subject|0
4569406|NCT01349803|7406101|FG003|Overall Study|Withdrawal by Subject|0
4569407|NCT01349803|7406098|FG000|Overall Study|Protocol-specified criteria|0
4569408|NCT01349803|7406099|FG001|Overall Study|Protocol-specified criteria|1
4569409|NCT01349803|7406100|FG002|Overall Study|Protocol-specified criteria|3
4569410|NCT01349803|7406101|FG003|Overall Study|Protocol-specified criteria|0
4569411|NCT01349816|7406119|FG000|Overall Study|Withdrawal by Subject|4
4569412|NCT01349816|7406119|FG000|Overall Study|Physician Decision|1
4569413|NCT01349816|7406119|FG000|Overall Study|Adverse Event|14
4569414|NCT01349816|7406119|FG000|Overall Study|Lost to Follow-up|2
4569415|NCT01349816|7406119|FG000|Overall Study|Protocol Violation|1
4569416|NCT01349816|7406119|FG000|Overall Study|Protocol-specified criteria|8
4569417|NCT01349829|7406135|FG000|Overall Study|Lost to Follow-up|4
4569418|NCT01349829|7406136|FG001|Overall Study|Lost to Follow-up|8
4569419|NCT01349829|7406135|FG000|Overall Study|Consent withdrawal|3
4569420|NCT01349829|7406136|FG001|Overall Study|Consent withdrawal|8
4569421|NCT01349829|7406135|FG000|Overall Study|Migrated/moved|2
4569422|NCT01349829|7406136|FG001|Overall Study|Migrated/moved|7
4569423|NCT01350102|7406167|FG000|Overall Study|Adverse Event|0
4569424|NCT01350102|7406168|FG001|Overall Study|Adverse Event|0
4569425|NCT01350102|7406169|FG002|Overall Study|Adverse Event|1
4569426|NCT01350102|7406170|FG003|Overall Study|Adverse Event|0
4569427|NCT01350115|7406182|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0
4569428|NCT01350115|7406183|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1
4569429|NCT01350115|7406182|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0
4569430|NCT01350115|7406183|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1
4569431|NCT01350115|7406182|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1
4569432|NCT01350115|7406183|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0
4569433|NCT01350128|7406191|FG000|Overall Study|Withdrawal by Subject|3
4569434|NCT01350128|7406191|FG000|Overall Study|Protocol discontinuation criteria|8
4569435|NCT01350128|7406191|FG000|Overall Study|Physician Decision|1
4569436|NCT01350128|7406191|FG000|Overall Study|Lost to Follow-up|2
4569437|NCT01350141|7406208|FG000|Overall Study|Lost to Follow-up|1
4569438|NCT01350141|7406209|FG001|Overall Study|Lost to Follow-up|0
4569439|NCT01350141|7406210|FG002|Overall Study|Lost to Follow-up|1
4569440|NCT01350141|7406208|FG000|Overall Study|Withdrawal by Subject|1
4569441|NCT01350141|7406209|FG001|Overall Study|Withdrawal by Subject|0
4569442|NCT01350141|7406210|FG002|Overall Study|Withdrawal by Subject|0
4569443|NCT01350141|7406208|FG000|Overall Study|Randomized but not treated|1
4569444|NCT01350141|7406209|FG001|Overall Study|Randomized but not treated|0
4569445|NCT01350141|7406210|FG002|Overall Study|Randomized but not treated|0
4569446|NCT01350271|7406227|FG000|Overall Study|Lost to Follow-up|21
4569447|NCT01350271|7406228|FG001|Overall Study|Lost to Follow-up|17
4569448|NCT01350271|7406229|FG002|Overall Study|Lost to Follow-up|26
4569449|NCT01350336|7406240|FG000|Overall Study|Lost to Follow-up|31
4569450|NCT01350336|7406240|FG000|Overall Study|Withdrawal by Subject|14
4569451|NCT01350336|7406240|FG000|Overall Study|Physician Decision|8
4569452|NCT01350336|7406240|FG000|Overall Study|Death|4
4569453|NCT01350414|7406306|FG000|Overall Study|Lost to Follow-up|13
4569454|NCT01350414|7406306|FG000|Overall Study|Withdrawal by Subject|4
4569455|NCT01350414|7406306|FG000|Overall Study|Physician Decision|2
4569456|NCT01350492|7406338|FG000|Intervention|Lost to Follow-up|2
4569457|NCT01350492|7406339|FG001|Intervention|Lost to Follow-up|5
4569458|NCT01350492|7406338|FG000|Intervention|Withdrawal by Subject|3
4569459|NCT01350492|7406339|FG001|Intervention|Withdrawal by Subject|1
4569460|NCT01350492|7406338|FG000|Post Intervention Follow-Up|Lost to Follow-up|6
4569461|NCT01350492|7406339|FG001|Post Intervention Follow-Up|Lost to Follow-up|1
4569462|NCT01350492|7406338|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0
4569463|NCT01350492|7406339|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1
4569464|NCT01350505|7406345|FG000|Overall Study|Lost to Follow-up|4
4569465|NCT01350544|7406351|FG000|Overall Study|Administrative Withdrawal|0
4569466|NCT01350544|7406352|FG001|Overall Study|Administrative Withdrawal|1
4569467|NCT01350544|7406351|FG000|Overall Study|Death|1
4569468|NCT01350544|7406352|FG001|Overall Study|Death|2
4569469|NCT01350544|7406351|FG000|Overall Study|Moved out of LA County|2
4569470|NCT01350544|7406352|FG001|Overall Study|Moved out of LA County|2
4569471|NCT01350544|7406351|FG000|Overall Study|Medical Issues|1
4569472|NCT01350544|7406352|FG001|Overall Study|Medical Issues|1
4569473|NCT01350544|7406351|FG000|Overall Study|Withdrawal by Subject|0
4569474|NCT01350544|7406352|FG001|Overall Study|Withdrawal by Subject|1
4569475|NCT01350544|7406351|FG000|Overall Study|Incarceration|1
4569476|NCT01350544|7406352|FG001|Overall Study|Incarceration|0
4569477|NCT01350544|7406351|FG000|Overall Study|Lost to Follow-up|18
4569478|NCT01350544|7406352|FG001|Overall Study|Lost to Follow-up|15
4569479|NCT01350804|7406362|FG000|Core Study|Withdrawal by Subject|11
4569480|NCT01350804|7406363|FG001|Core Study|Withdrawal by Subject|17
4569481|NCT01350804|7406364|FG002|Core Study|Withdrawal by Subject|16
4569482|NCT01350804|7406365|FG003|Core Study|Withdrawal by Subject|7
4569483|NCT01350804|7406362|FG000|Core Study|Study terminated by Sponsor|0
4569484|NCT01350804|7406363|FG001|Core Study|Study terminated by Sponsor|0
4569485|NCT01350804|7406364|FG002|Core Study|Study terminated by Sponsor|0
4569486|NCT01350804|7406365|FG003|Core Study|Study terminated by Sponsor|2
4569487|NCT01350804|7406362|FG000|Core Study|Protocol deviation|1
4569488|NCT01350804|7406363|FG001|Core Study|Protocol deviation|0
4569489|NCT01350804|7406364|FG002|Core Study|Protocol deviation|1
4569490|NCT01350804|7406365|FG003|Core Study|Protocol deviation|0
4569491|NCT01350804|7406362|FG000|Core Study|Physician Decision|1
4569492|NCT01350804|7406363|FG001|Core Study|Physician Decision|0
4569493|NCT01350804|7406364|FG002|Core Study|Physician Decision|1
4569494|NCT01350804|7406365|FG003|Core Study|Physician Decision|3
4569495|NCT01350804|7406362|FG000|Core Study|Lost to Follow-up|3
4569496|NCT01350804|7406363|FG001|Core Study|Lost to Follow-up|0
4569497|NCT01350804|7406364|FG002|Core Study|Lost to Follow-up|2
4569498|NCT01350804|7406365|FG003|Core Study|Lost to Follow-up|1
4569499|NCT01350804|7406362|FG000|Core Study|Lack of Efficacy|16
4569500|NCT01350804|7406363|FG001|Core Study|Lack of Efficacy|19
4569501|NCT01350804|7406364|FG002|Core Study|Lack of Efficacy|18
4569502|NCT01350804|7406365|FG003|Core Study|Lack of Efficacy|5
4569503|NCT01350804|7406362|FG000|Core Study|Death|1
4569504|NCT01350804|7406363|FG001|Core Study|Death|1
4569505|NCT01350804|7406364|FG002|Core Study|Death|1
4569506|NCT01350804|7406365|FG003|Core Study|Death|0
4569507|NCT01350804|7406362|FG000|Core Study|Adverse Event|8
4569508|NCT01350804|7406363|FG001|Core Study|Adverse Event|10
4569509|NCT01350804|7406364|FG002|Core Study|Adverse Event|8
4569510|NCT01350804|7406365|FG003|Core Study|Adverse Event|8
4569511|NCT01350804|7406362|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5
4569512|NCT01350804|7406363|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6
4569513|NCT01350804|7406364|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4
4569514|NCT01350804|7406365|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3
4569515|NCT01350804|7406362|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67
4569516|NCT01350804|7406363|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67
4569517|NCT01350804|7406364|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64
4569518|NCT01350804|7406365|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16
4569519|NCT01350804|7406362|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1
4569520|NCT01350804|7406363|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0
4569521|NCT01350804|7406364|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2
4569522|NCT01350804|7406365|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0
4569523|NCT01350804|7406362|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
4569524|NCT01350804|7406363|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1
4569525|NCT01350804|7406364|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
4569526|NCT01350804|7406365|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
4569527|NCT01350804|7406362|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4
4569528|NCT01350804|7406363|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4
4569529|NCT01350804|7406364|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0
4569530|NCT01350804|7406365|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1
4569531|NCT01350804|7406362|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3
4569532|NCT01350804|7406363|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1
4569533|NCT01350804|7406364|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2
4569534|NCT01350804|7406365|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3
4569535|NCT01350973|7406392|FG000|Overall Study|Adverse Event|4
4569536|NCT01350973|7406393|FG001|Overall Study|Adverse Event|7
4569537|NCT01350973|7406394|FG002|Overall Study|Adverse Event|7
4569538|NCT01350973|7406392|FG000|Overall Study|Voluntary Withdrawal|2
4569539|NCT01350973|7406393|FG001|Overall Study|Voluntary Withdrawal|1
4569540|NCT01350973|7406394|FG002|Overall Study|Voluntary Withdrawal|1
4569541|NCT01350999|7406405|FG000|Overall Study|Adverse Event|4
4569542|NCT01350999|7406406|FG001|Overall Study|Adverse Event|9
4569543|NCT01350999|7406407|FG002|Overall Study|Adverse Event|10
4569544|NCT01350999|7406405|FG000|Overall Study|Voluntary withdrawal|3
4569545|NCT01350999|7406406|FG001|Overall Study|Voluntary withdrawal|4
4569546|NCT01350999|7406407|FG002|Overall Study|Voluntary withdrawal|6
4569547|NCT01350999|7406405|FG000|Overall Study|Difficulty Making it to Study Visit|1
4569548|NCT01350999|7406406|FG001|Overall Study|Difficulty Making it to Study Visit|1
4569549|NCT01350999|7406407|FG002|Overall Study|Difficulty Making it to Study Visit|5
4569550|NCT01351025|7406417|FG000|Week 0 - 20|Lost to Follow-up|2
4569551|NCT01351025|7406418|FG001|Week 0 - 20|Lost to Follow-up|1
4569552|NCT01351025|7406417|FG000|Week 0 - 20|Withdrawal by Subject|1
4569553|NCT01351025|7406418|FG001|Week 0 - 20|Withdrawal by Subject|0
4569554|NCT01351025|7406417|FG000|Week 24 - 44|Lost to Follow-up|0
4569555|NCT01351025|7406418|FG001|Week 24 - 44|Lost to Follow-up|2
4569556|NCT01351025|7406417|FG000|Week 24 - 44|Site closed|0
4569557|NCT01351025|7406418|FG001|Week 24 - 44|Site closed|1
4569558|NCT01351025|7406417|FG000|Week 24 - 44|unable to get to clinic|1
4569559|NCT01351025|7406418|FG001|Week 24 - 44|unable to get to clinic|1
4569560|NCT01351350|7406471|FG000|Overall Study|Disease Progression|5
4569561|NCT01351350|7406472|FG001|Overall Study|Disease Progression|13
4569562|NCT01351350|7406473|FG002|Overall Study|Disease Progression|6
4569563|NCT01351350|7406474|FG003|Overall Study|Disease Progression|8
4569564|NCT01351350|7406475|FG004|Overall Study|Disease Progression|5
4569565|NCT01351350|7406471|FG000|Overall Study|Adverse Event|1
4569566|NCT01351350|7406472|FG001|Overall Study|Adverse Event|10
4569567|NCT01351350|7406473|FG002|Overall Study|Adverse Event|1
4569568|NCT01351350|7406474|FG003|Overall Study|Adverse Event|2
4569569|NCT01351350|7406475|FG004|Overall Study|Adverse Event|0
4569570|NCT01351350|7406471|FG000|Overall Study|Participant Decision|2
4569571|NCT01351350|7406472|FG001|Overall Study|Participant Decision|6
4569572|NCT01351350|7406473|FG002|Overall Study|Participant Decision|3
4569573|NCT01351350|7406474|FG003|Overall Study|Participant Decision|3
4569574|NCT01351350|7406475|FG004|Overall Study|Participant Decision|2
4569575|NCT01351350|7406471|FG000|Overall Study|Enrolled but not Treated|0
4569576|NCT01351350|7406472|FG001|Overall Study|Enrolled but not Treated|0
4569577|NCT01351350|7406473|FG002|Overall Study|Enrolled but not Treated|1
4569578|NCT01351350|7406474|FG003|Overall Study|Enrolled but not Treated|0
4569579|NCT01351350|7406475|FG004|Overall Study|Enrolled but not Treated|0
4569580|NCT01351415|7406511|FG000|Overall Study|Withdrawal by Subject|15
4569581|NCT01351415|7406512|FG001|Overall Study|Withdrawal by Subject|17
4569582|NCT01351415|7406511|FG000|Overall Study|Trial termination by the Sponsor|28
4569583|NCT01351415|7406512|FG001|Overall Study|Trial termination by the Sponsor|19
4569584|NCT01351415|7406511|FG000|Overall Study|Lost to Follow-up|5
4569585|NCT01351415|7406512|FG001|Overall Study|Lost to Follow-up|7
4569586|NCT01351415|7406511|FG000|Overall Study|Death|190
4569587|NCT01351415|7406512|FG001|Overall Study|Death|187
4569588|NCT01351415|7406511|FG000|Overall Study|Physician Decision|2
4569589|NCT01351415|7406512|FG001|Overall Study|Physician Decision|3
4569590|NCT01351415|7406511|FG000|Overall Study|Reason unknown|0
4569591|NCT01351415|7406512|FG001|Overall Study|Reason unknown|2
4569592|NCT01351415|7406511|FG000|Overall Study|Never Started|5
4569593|NCT01351415|7406512|FG001|Overall Study|Never Started|5
4569594|NCT01351623|7406530|FG000|Overall Study|Protocol Violation|2
4569595|NCT01351623|7406530|FG000|Overall Study|Adverse Event|4
4569596|NCT01351623|7406530|FG000|Overall Study|Withdrawal by Subject|1
4569597|NCT01351623|7406530|FG000|Overall Study|Death|2
4569598|NCT01352117|7406598|FG000|Overall Study|Death|15
4569599|NCT01352117|7406599|FG001|Overall Study|Death|16
4569600|NCT01352117|7406598|FG000|Overall Study|Withdrawal by Subject|1
4569601|NCT01352117|7406599|FG001|Overall Study|Withdrawal by Subject|0
4569602|NCT01352117|7406598|FG000|Overall Study|Lost to Follow-up|2
4569603|NCT01352117|7406599|FG001|Overall Study|Lost to Follow-up|7
4569604|NCT01352117|7406598|FG000|Overall Study|Non-adherent to study requirements|1
4569605|NCT01352117|7406599|FG001|Overall Study|Non-adherent to study requirements|1
4569606|NCT01352117|7406598|FG000|Overall Study|Did not initiate study treatment|1
4569607|NCT01352117|7406599|FG001|Overall Study|Did not initiate study treatment|0
4569608|NCT01352117|7406598|FG000|Overall Study|Ineligible (no KS diagnosis)|1
4569609|NCT01352117|7406599|FG001|Overall Study|Ineligible (no KS diagnosis)|0
4569610|NCT01352221|7406621|FG000|Double-blind Phase|Adverse Event|6
4569611|NCT01352221|7406622|FG001|Double-blind Phase|Adverse Event|4
4569612|NCT01352221|7406623|FG002|Double-blind Phase|Adverse Event|0
4569613|NCT01352221|7406624|FG003|Double-blind Phase|Adverse Event|0
4569614|NCT01352221|7406621|FG000|Double-blind Phase|Withdrawal by Subject|3
4569615|NCT01352221|7406622|FG001|Double-blind Phase|Withdrawal by Subject|5
4569616|NCT01352221|7406623|FG002|Double-blind Phase|Withdrawal by Subject|0
4569617|NCT01352221|7406624|FG003|Double-blind Phase|Withdrawal by Subject|0
4569618|NCT01352221|7406621|FG000|Double-blind Phase|Lost to Follow-up|0
4569619|NCT01352221|7406622|FG001|Double-blind Phase|Lost to Follow-up|1
4569620|NCT01352221|7406623|FG002|Double-blind Phase|Lost to Follow-up|0
4569621|NCT01352221|7406624|FG003|Double-blind Phase|Lost to Follow-up|0
4569622|NCT01352221|7406621|FG000|Double-blind Phase|Protocol Violation|0
4569623|NCT01352221|7406622|FG001|Double-blind Phase|Protocol Violation|1
4569624|NCT01352221|7406623|FG002|Double-blind Phase|Protocol Violation|0
4569625|NCT01352221|7406624|FG003|Double-blind Phase|Protocol Violation|0
4569626|NCT01352221|7406621|FG000|Open-label Phase|Physician Decision|0
4569627|NCT01352221|7406622|FG001|Open-label Phase|Physician Decision|0
4569628|NCT01352221|7406623|FG002|Open-label Phase|Physician Decision|2
4569629|NCT01352221|7406624|FG003|Open-label Phase|Physician Decision|1
4569630|NCT01352221|7406621|FG000|Open-label Phase|Pregnancy|0
4569631|NCT01352221|7406622|FG001|Open-label Phase|Pregnancy|0
4569632|NCT01352221|7406623|FG002|Open-label Phase|Pregnancy|1
4569633|NCT01352221|7406624|FG003|Open-label Phase|Pregnancy|0
4569634|NCT01352221|7406621|FG000|Open-label Phase|Adverse Event|0
4569635|NCT01352221|7406622|FG001|Open-label Phase|Adverse Event|0
4569636|NCT01352221|7406623|FG002|Open-label Phase|Adverse Event|8
4569637|NCT01352221|7406624|FG003|Open-label Phase|Adverse Event|4
4569638|NCT01352221|7406621|FG000|Open-label Phase|Withdrawal by Subject|0
4569639|NCT01352221|7406622|FG001|Open-label Phase|Withdrawal by Subject|0
4569640|NCT01352221|7406623|FG002|Open-label Phase|Withdrawal by Subject|1
4569641|NCT01352221|7406624|FG003|Open-label Phase|Withdrawal by Subject|6
4569642|NCT01352221|7406621|FG000|Open-label Phase|Worsening of IBD|0
4569643|NCT01352221|7406622|FG001|Open-label Phase|Worsening of IBD|0
4569644|NCT01352221|7406623|FG002|Open-label Phase|Worsening of IBD|1
4569645|NCT01352221|7406624|FG003|Open-label Phase|Worsening of IBD|0
4569646|NCT01352507|7406656|FG000|Treatment Period 1|Adverse Event|3
4569647|NCT01352507|7406657|FG001|Treatment Period 1|Adverse Event|0
4569648|NCT01352507|7406656|FG000|Treatment Period 1|Lost to Follow-up|3
4569649|NCT01352507|7406657|FG001|Treatment Period 1|Lost to Follow-up|4
4569650|NCT01352507|7406656|FG000|Treatment Period 1|Withdrawal by Subject|7
4569651|NCT01352507|7406657|FG001|Treatment Period 1|Withdrawal by Subject|5
4569652|NCT01352507|7406656|FG000|Treatment Period 1|Physician Decision|1
4569653|NCT01352507|7406657|FG001|Treatment Period 1|Physician Decision|0
4569654|NCT01352507|7406656|FG000|Washout Period|Withdrawal by Subject|0
4569655|NCT01352507|7406657|FG001|Washout Period|Withdrawal by Subject|1
4569656|NCT01352507|7406656|FG000|Treatment Period 2|Entry Criteria Not Met|1
4569657|NCT01352507|7406657|FG001|Treatment Period 2|Entry Criteria Not Met|0
4569658|NCT01352507|7406656|FG000|Treatment Period 2|Withdrawal by Subject|4
4569659|NCT01352507|7406657|FG001|Treatment Period 2|Withdrawal by Subject|3
4569660|NCT01352507|7406656|FG000|Treatment Period 2|Lack of Efficacy|1
4569661|NCT01352507|7406657|FG001|Treatment Period 2|Lack of Efficacy|0
4569662|NCT01352585|7406675|FG000|Overall Study|Adverse Event|2
4569663|NCT01352585|7406676|FG001|Overall Study|Adverse Event|1
4569664|NCT01352585|7406675|FG000|Overall Study|Lost to Follow-up|1
4569665|NCT01352585|7406676|FG001|Overall Study|Lost to Follow-up|0
4569666|NCT01352585|7406675|FG000|Overall Study|Other|5
4569667|NCT01352585|7406676|FG001|Overall Study|Other|2
4569668|NCT01352715|7406706|FG000|Overall Study|Death|3
4569669|NCT01352715|7406707|FG001|Overall Study|Death|3
4569670|NCT01352715|7406706|FG000|Overall Study|Lost to Follow-up|5
4569671|NCT01352715|7406707|FG001|Overall Study|Lost to Follow-up|7
4569672|NCT01352715|7406706|FG000|Overall Study|Withdrawal by Subject|4
4625736|NCT01831804|7490653|FG002|Overall Study|Protocol defined stopping criteria|3
4625737|NCT01831804|7490654|FG003|Overall Study|Protocol defined stopping criteria|0
4625738|NCT01831804|7490655|FG004|Overall Study|Protocol defined stopping criteria|1
4625739|NCT01831804|7490656|FG005|Overall Study|Protocol defined stopping criteria|0
4625740|NCT01831804|7490657|FG006|Overall Study|Protocol defined stopping criteria|0
4625741|NCT01831804|7490658|FG007|Overall Study|Protocol defined stopping criteria|0
4625742|NCT01831804|7490659|FG008|Overall Study|Protocol defined stopping criteria|0
4625743|NCT01831804|7490651|FG000|Overall Study|Lost to Follow-up|0
4569673|NCT01352715|7406707|FG001|Overall Study|Withdrawal by Subject|8
4569674|NCT01352715|7406706|FG000|Overall Study|site closure|16
4569675|NCT01352715|7406707|FG001|Overall Study|site closure|15
4569676|NCT01352715|7406706|FG000|Overall Study|no final visit in closeout period|15
4569677|NCT01352715|7406707|FG001|Overall Study|no final visit in closeout period|12
4569678|NCT01352715|7406706|FG000|Overall Study|major ineligibility|2
4569679|NCT01352715|7406707|FG001|Overall Study|major ineligibility|1
4569680|NCT01352741|7406713|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4
4569681|NCT01352741|7406714|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0
4569682|NCT01352741|7406713|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19
4569683|NCT01352741|7406714|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0
4569684|NCT01352741|7406713|FG000|Open-label Tapentadol Titration Period|Adverse Event|34
4569685|NCT01352741|7406714|FG001|Open-label Tapentadol Titration Period|Adverse Event|0
4569686|NCT01352741|7406713|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7
4569687|NCT01352741|7406714|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0
4569688|NCT01352741|7406713|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5
4569689|NCT01352741|7406714|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0
4569690|NCT01352741|7406713|FG000|Open-label Tapentadol Titration Period|Other|4
4569691|NCT01352741|7406714|FG001|Open-label Tapentadol Titration Period|Other|0
4569692|NCT01352741|7406713|FG000|Double-blind Comparative Period|Protocol Violation|2
4569693|NCT01352741|7406714|FG001|Double-blind Comparative Period|Protocol Violation|0
4569694|NCT01352741|7406713|FG000|Double-blind Comparative Period|Lack of Efficacy|0
4569695|NCT01352741|7406714|FG001|Double-blind Comparative Period|Lack of Efficacy|3
4569696|NCT01352741|7406713|FG000|Double-blind Comparative Period|Adverse Event|16
4569697|NCT01352741|7406714|FG001|Double-blind Comparative Period|Adverse Event|17
4569698|NCT01352741|7406713|FG000|Double-blind Comparative Period|Lost to Follow-up|1
4569699|NCT01352741|7406714|FG001|Double-blind Comparative Period|Lost to Follow-up|0
4569700|NCT01352741|7406713|FG000|Double-blind Comparative Period|Death|0
4569701|NCT01352741|7406714|FG001|Double-blind Comparative Period|Death|1
4569702|NCT01352741|7406713|FG000|Double-blind Comparative Period|Withdrawal of consent|8
4569703|NCT01352741|7406714|FG001|Double-blind Comparative Period|Withdrawal of consent|3
4569704|NCT01352741|7406713|FG000|Double-blind Comparative Period|Other|1
4569705|NCT01352741|7406714|FG001|Double-blind Comparative Period|Other|2
4569706|NCT01352741|7406713|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4
4569707|NCT01352741|7406714|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0
4569708|NCT01352741|7406713|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1
4569709|NCT01352741|7406714|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0
4569710|NCT01352741|7406713|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2
4569711|NCT01352741|7406714|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0
4569712|NCT01352741|7406713|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1
4569713|NCT01352741|7406714|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0
4569714|NCT01352793|7406736|FG000|Overall Study|Lost to Follow-up|289
4569715|NCT01352793|7406737|FG001|Overall Study|Lost to Follow-up|125
4569716|NCT01352793|7406736|FG000|Overall Study|Withdrawal by Subject|120
4569717|NCT01352793|7406737|FG001|Overall Study|Withdrawal by Subject|55
4569718|NCT01352793|7406736|FG000|Overall Study|Protocol Violation|44
4569719|NCT01352793|7406737|FG001|Overall Study|Protocol Violation|23
4569720|NCT01352793|7406736|FG000|Overall Study|Adverse Event|44
4569721|NCT01352793|7406737|FG001|Overall Study|Adverse Event|10
4569722|NCT01352793|7406736|FG000|Overall Study|Physician Decision|1
4569723|NCT01352793|7406737|FG001|Overall Study|Physician Decision|0
4569724|NCT01352793|7406736|FG000|Overall Study|Pregnancy|26
4569725|NCT01352793|7406737|FG001|Overall Study|Pregnancy|8
4569726|NCT01352793|7406736|FG000|Overall Study|Other|25
4569727|NCT01352793|7406737|FG001|Overall Study|Other|7
4569728|NCT01352793|7406736|FG000|Overall Study|Medication error|2
4569729|NCT01352793|7406737|FG001|Overall Study|Medication error|2
4569730|NCT01352793|7406736|FG000|Overall Study|Death|1
4569731|NCT01352793|7406737|FG001|Overall Study|Death|0
4569732|NCT01352793|7406736|FG000|Overall Study|Randomized but not vaccinated|8
4569733|NCT01352793|7406737|FG001|Overall Study|Randomized but not vaccinated|0
4569734|NCT01352793|7406736|FG000|Overall Study|No longer meets eligibility criteria|25
4569735|NCT01352793|7406737|FG001|Overall Study|No longer meets eligibility criteria|15
4569736|NCT01352845|7406745|FG000|Overall Study|Lost to Follow-up|313
4569737|NCT01352845|7406746|FG001|Overall Study|Lost to Follow-up|92
4569738|NCT01352845|7406745|FG000|Overall Study|No Longer Willing to Participate|205
4625744|NCT01831804|7490652|FG001|Overall Study|Lost to Follow-up|0
4569739|NCT01352845|7406746|FG001|Overall Study|No Longer Willing to Participate|58
4569740|NCT01352845|7406745|FG000|Overall Study|Withdrawal by Subject|48
4569741|NCT01352845|7406746|FG001|Overall Study|Withdrawal by Subject|16
4569742|NCT01352845|7406745|FG000|Overall Study|No Longer Meets Eligibility Criteria|24
4569743|NCT01352845|7406746|FG001|Overall Study|No Longer Meets Eligibility Criteria|11
4569744|NCT01352845|7406745|FG000|Overall Study|Pregnancy|27
4569745|NCT01352845|7406746|FG001|Overall Study|Pregnancy|7
4569746|NCT01352845|7406745|FG000|Overall Study|Adverse Event|22
4569747|NCT01352845|7406746|FG001|Overall Study|Adverse Event|6
4569748|NCT01352845|7406745|FG000|Overall Study|Other|17
4569749|NCT01352845|7406746|FG001|Overall Study|Other|7
4569750|NCT01352845|7406745|FG000|Overall Study|Protocol Violation|12
4569751|NCT01352845|7406746|FG001|Overall Study|Protocol Violation|6
4569752|NCT01352845|7406745|FG000|Overall Study|Death|3
4569753|NCT01352845|7406746|FG001|Overall Study|Death|0
4569754|NCT01353222|7406785|FG000|Overall Study|Death|30
4569755|NCT01353222|7406786|FG001|Overall Study|Death|30
4569756|NCT01353222|7406785|FG000|Overall Study|Withdrawal by Subject|8
4569757|NCT01353222|7406786|FG001|Overall Study|Withdrawal by Subject|5
4569758|NCT01353222|7406785|FG000|Overall Study|Study Terminated|31
4569759|NCT01353222|7406786|FG001|Overall Study|Study Terminated|37
4569760|NCT01353222|7406785|FG000|Overall Study|Site closed research department|1
4569761|NCT01353222|7406786|FG001|Overall Study|Site closed research department|0
4569762|NCT01353274|7406792|FG000|Overall Study|No case report form (CRF) collected|28
4569763|NCT01353508|7406809|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0
4569764|NCT01353508|7406810|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0
4569765|NCT01353508|7406811|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0
4569766|NCT01353508|7406812|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1
4569767|NCT01353508|7406809|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1
4569768|NCT01353508|7406810|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
4569769|NCT01353508|7406811|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
4569770|NCT01353508|7406812|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
4569771|NCT01353586|7406824|FG000|Overall Study|Procedure terminated prior to ablation|3
4569772|NCT01353586|7406825|FG001|Overall Study|Procedure terminated prior to ablation|0
4569773|NCT01353586|7406824|FG000|Overall Study|Never had insertion of study catheter|4
4569774|NCT01353586|7406825|FG001|Overall Study|Never had insertion of study catheter|1
4569775|NCT01353586|7406824|FG000|Overall Study|Neurological exam not done|0
4569776|NCT01353586|7406825|FG001|Overall Study|Neurological exam not done|1
4569777|NCT01353664|7406834|FG000|Overall Study|Other|3
4569778|NCT01353664|7406834|FG000|Overall Study|Disease Progression|16
4569779|NCT01353703|7406840|FG000|Overall Study|Migrated/moved from study area|1
4569780|NCT01353703|7406841|FG001|Overall Study|Migrated/moved from study area|0
4569781|NCT01353859|7406849|FG000|Overall Study|Adverse Event|3
4569782|NCT01353859|7406849|FG000|Overall Study|Lack of Efficacy|1
4569783|NCT01353898|7406859|FG000|Overall Study|Study site terminated|0
4569784|NCT01353898|7406860|FG001|Overall Study|Study site terminated|0
4569785|NCT01353898|7406861|FG002|Overall Study|Study site terminated|0
4569786|NCT01353898|7406862|FG003|Overall Study|Study site terminated|0
4569787|NCT01353898|7406863|FG004|Overall Study|Study site terminated|0
4569788|NCT01353898|7406864|FG005|Overall Study|Study site terminated|1
4569789|NCT01353911|7406886|FG000|Overall Study|Lost to Follow-up|2
4569790|NCT01353911|7406887|FG001|Overall Study|Lost to Follow-up|6
4569791|NCT01353911|7406888|FG002|Overall Study|Lost to Follow-up|4
4569792|NCT01353911|7406889|FG003|Overall Study|Lost to Follow-up|0
4569793|NCT01353911|7406890|FG004|Overall Study|Lost to Follow-up|4
4569794|NCT01353911|7406891|FG005|Overall Study|Lost to Follow-up|4
4569795|NCT01353911|7406892|FG006|Overall Study|Lost to Follow-up|3
4569796|NCT01353911|7406893|FG007|Overall Study|Lost to Follow-up|6
4569797|NCT01353911|7406886|FG000|Overall Study|Withdrawal by Subject|2
4569798|NCT01353911|7406887|FG001|Overall Study|Withdrawal by Subject|3
4569799|NCT01353911|7406888|FG002|Overall Study|Withdrawal by Subject|4
4569800|NCT01353911|7406889|FG003|Overall Study|Withdrawal by Subject|2
4569801|NCT01353911|7406890|FG004|Overall Study|Withdrawal by Subject|2
4569802|NCT01353911|7406891|FG005|Overall Study|Withdrawal by Subject|3
4569803|NCT01353911|7406892|FG006|Overall Study|Withdrawal by Subject|3
4569804|NCT01353911|7406893|FG007|Overall Study|Withdrawal by Subject|9
4569805|NCT01353911|7406886|FG000|Overall Study|Status Not Recorded|4
4569806|NCT01353911|7406887|FG001|Overall Study|Status Not Recorded|0
4569807|NCT01353911|7406888|FG002|Overall Study|Status Not Recorded|1
4569808|NCT01353911|7406889|FG003|Overall Study|Status Not Recorded|0
4569809|NCT01353911|7406890|FG004|Overall Study|Status Not Recorded|0
4569810|NCT01353911|7406891|FG005|Overall Study|Status Not Recorded|0
4569811|NCT01353911|7406892|FG006|Overall Study|Status Not Recorded|0
4569812|NCT01353911|7406893|FG007|Overall Study|Status Not Recorded|0
4569813|NCT01353963|7406911|FG000|Overall Study|Adverse Event|2
4592741|NCT01544582|7440731|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0
4592742|NCT01544582|7440732|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0
4592743|NCT01544582|7440733|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0
4592744|NCT01544582|7440730|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33
4592745|NCT01544582|7440731|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0
4593781|NCT01555125|7442334|FG003|Extension|Lost to Follow-up|0
4569814|NCT01354028|7406933|FG000|Overall Study|Physician Decision|0
4569815|NCT01354028|7406934|FG001|Overall Study|Physician Decision|2
4569816|NCT01354028|7406933|FG000|Overall Study|Discharged before study start|2
4569817|NCT01354028|7406934|FG001|Overall Study|Discharged before study start|2
4569818|NCT01354028|7406933|FG000|Overall Study|No quiet alert state|0
4569819|NCT01354028|7406934|FG001|Overall Study|No quiet alert state|1
4569820|NCT01354106|7406946|FG000|Overall Study|Withdrawal by Subject|2
4569821|NCT01354132|7406954|FG000|Randomization|Physician Decision|1
4569822|NCT01354132|7406955|FG001|Randomization|Physician Decision|0
4569823|NCT01354132|7406954|FG000|Randomization|Withdrawal by Subject|0
4569824|NCT01354132|7406955|FG001|Randomization|Withdrawal by Subject|1
4569825|NCT01354132|7406954|FG000|Double Blind (Visits 1-7)|Adverse Event|1
4569826|NCT01354132|7406955|FG001|Double Blind (Visits 1-7)|Adverse Event|0
4569827|NCT01354132|7406954|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8
4569828|NCT01354132|7406955|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11
4569829|NCT01354132|7406954|FG000|1 Month Post Study Medication|Withdrawal by Subject|1
4569830|NCT01354132|7406955|FG001|1 Month Post Study Medication|Withdrawal by Subject|3
4569831|NCT01354223|7406982|FG000|Overall Study|Withdrawal by Subject|3
4569832|NCT01354223|7406983|FG001|Overall Study|Withdrawal by Subject|1
4569833|NCT01354314|7406993|FG000|Overall Study|Lost to Follow-up|1
4569834|NCT01354314|7406994|FG001|Overall Study|Lost to Follow-up|0
4569835|NCT01354314|7406995|FG002|Overall Study|Lost to Follow-up|1
4569836|NCT01354314|7406996|FG003|Overall Study|Lost to Follow-up|1
4569837|NCT01354314|7406993|FG000|Overall Study|Withdrawal by Subject|0
4569838|NCT01354314|7406994|FG001|Overall Study|Withdrawal by Subject|0
4569839|NCT01354314|7406995|FG002|Overall Study|Withdrawal by Subject|1
4569840|NCT01354314|7406996|FG003|Overall Study|Withdrawal by Subject|0
4569841|NCT01354314|7406993|FG000|Overall Study|Adverse Event|0
4569842|NCT01354314|7406994|FG001|Overall Study|Adverse Event|0
4569843|NCT01354314|7406995|FG002|Overall Study|Adverse Event|0
4569844|NCT01354314|7406996|FG003|Overall Study|Adverse Event|1
4569845|NCT01354314|7406993|FG000|Overall Study|Protocol Violation|1
4569846|NCT01354314|7406994|FG001|Overall Study|Protocol Violation|1
4569847|NCT01354314|7406995|FG002|Overall Study|Protocol Violation|0
4569848|NCT01354314|7406996|FG003|Overall Study|Protocol Violation|0
4569849|NCT01354314|7406993|FG000|Overall Study|Less than 90% Adherence|4
4569850|NCT01354314|7406994|FG001|Overall Study|Less than 90% Adherence|2
4569851|NCT01354314|7406995|FG002|Overall Study|Less than 90% Adherence|6
4569852|NCT01354314|7406996|FG003|Overall Study|Less than 90% Adherence|4
4569853|NCT01354353|7407014|FG000|Overall Study|Adverse Event|1
4569854|NCT01354353|7407015|FG001|Overall Study|Adverse Event|0
4569855|NCT01354353|7407016|FG002|Overall Study|Adverse Event|0
4569856|NCT01354353|7407017|FG003|Overall Study|Adverse Event|4
4569857|NCT01354353|7407018|FG004|Overall Study|Adverse Event|0
4569858|NCT01354353|7407019|FG005|Overall Study|Adverse Event|5
4569859|NCT01354353|7407014|FG000|Overall Study|Entry Criteria Not Met|0
4569860|NCT01354353|7407015|FG001|Overall Study|Entry Criteria Not Met|0
4569861|NCT01354353|7407016|FG002|Overall Study|Entry Criteria Not Met|0
4569862|NCT01354353|7407017|FG003|Overall Study|Entry Criteria Not Met|1
4569863|NCT01354353|7407018|FG004|Overall Study|Entry Criteria Not Met|1
4569864|NCT01354353|7407019|FG005|Overall Study|Entry Criteria Not Met|0
4569865|NCT01354353|7407014|FG000|Overall Study|Physician Decision|0
4569866|NCT01354353|7407015|FG001|Overall Study|Physician Decision|1
4569867|NCT01354353|7407016|FG002|Overall Study|Physician Decision|1
4569868|NCT01354353|7407017|FG003|Overall Study|Physician Decision|0
4569869|NCT01354353|7407018|FG004|Overall Study|Physician Decision|0
4569870|NCT01354353|7407019|FG005|Overall Study|Physician Decision|0
4569871|NCT01354353|7407014|FG000|Overall Study|Withdrawal by Subject|2
4569872|NCT01354353|7407015|FG001|Overall Study|Withdrawal by Subject|0
4569873|NCT01354353|7407016|FG002|Overall Study|Withdrawal by Subject|1
4569874|NCT01354353|7407017|FG003|Overall Study|Withdrawal by Subject|0
4569875|NCT01354353|7407018|FG004|Overall Study|Withdrawal by Subject|0
4569876|NCT01354353|7407019|FG005|Overall Study|Withdrawal by Subject|1
4569877|NCT01354496|7407053|FG000|Period 1|Adverse Event|0
4569878|NCT01354496|7407054|FG001|Period 1|Adverse Event|0
4569879|NCT01354496|7407055|FG002|Period 1|Adverse Event|1
4569880|NCT01354496|7407056|FG003|Period 1|Adverse Event|0
4569881|NCT01354496|7407057|FG004|Period 1|Adverse Event|0
4569882|NCT01354496|7407058|FG005|Period 1|Adverse Event|0
4569883|NCT01354496|7407053|FG000|Period 1|Physician Decision|0
4569884|NCT01354496|7407054|FG001|Period 1|Physician Decision|0
4569885|NCT01354496|7407055|FG002|Period 1|Physician Decision|1
4569886|NCT01354496|7407056|FG003|Period 1|Physician Decision|0
4569887|NCT01354496|7407057|FG004|Period 1|Physician Decision|0
4569888|NCT01354496|7407058|FG005|Period 1|Physician Decision|0
4569889|NCT01354496|7407053|FG000|Period 2|Adverse Event|0
4569890|NCT01354496|7407054|FG001|Period 2|Adverse Event|0
4569891|NCT01354496|7407055|FG002|Period 2|Adverse Event|0
4569892|NCT01354496|7407056|FG003|Period 2|Adverse Event|1
4569893|NCT01354496|7407057|FG004|Period 2|Adverse Event|0
4569894|NCT01354496|7407058|FG005|Period 2|Adverse Event|0
4569895|NCT01354496|7407053|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0
4569896|NCT01354496|7407054|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1
4569897|NCT01354496|7407055|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0
4569898|NCT01354496|7407056|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1
4569899|NCT01354496|7407057|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0
4569900|NCT01354496|7407058|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0
4569901|NCT01354899|7407102|FG000|Overall Study|discharge from the hospital|2
4569902|NCT01354899|7407102|FG000|Overall Study|Protocol Violation|1
4569903|NCT01354938|7407106|FG000|Overall Study|Lost to Follow-up|1
4569904|NCT01354964|7407112|FG000|Overall Study|Lost to Follow-up|2
4569905|NCT01354964|7407113|FG001|Overall Study|Lost to Follow-up|0
4569906|NCT01354964|7407112|FG000|Overall Study|IV access issues|1
4569907|NCT01354964|7407113|FG001|Overall Study|IV access issues|1
4569908|NCT01354964|7407112|FG000|Overall Study|Physician Decision|1
4569909|NCT01354964|7407113|FG001|Overall Study|Physician Decision|0
4592746|NCT01544582|7440732|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0
4592747|NCT01544582|7440733|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0
4592748|NCT01544582|7440730|FG000|Analysis Population|Participant Refuses to Continue Study|0
4592749|NCT01544582|7440731|FG001|Analysis Population|Participant Refuses to Continue Study|15
4592750|NCT01544582|7440732|FG002|Analysis Population|Participant Refuses to Continue Study|17
4592751|NCT01544582|7440733|FG003|Analysis Population|Participant Refuses to Continue Study|4
4592752|NCT01544582|7440730|FG000|Analysis Population|Physician Decision|0
4592753|NCT01544582|7440731|FG001|Analysis Population|Physician Decision|13
4592754|NCT01544582|7440732|FG002|Analysis Population|Physician Decision|10
4592755|NCT01544582|7440733|FG003|Analysis Population|Physician Decision|9
4592756|NCT01544582|7440730|FG000|Analysis Population|Safety Reason|0
4592757|NCT01544582|7440731|FG001|Analysis Population|Safety Reason|33
4625745|NCT01831804|7490653|FG002|Overall Study|Lost to Follow-up|1
4625746|NCT01831804|7490654|FG003|Overall Study|Lost to Follow-up|0
4625747|NCT01831804|7490655|FG004|Overall Study|Lost to Follow-up|0
4625748|NCT01831804|7490656|FG005|Overall Study|Lost to Follow-up|0
4625749|NCT01831804|7490657|FG006|Overall Study|Lost to Follow-up|0
4625750|NCT01831804|7490658|FG007|Overall Study|Lost to Follow-up|0
4625751|NCT01831804|7490659|FG008|Overall Study|Lost to Follow-up|1
4625752|NCT01831804|7490651|FG000|Overall Study|Investigator discretion|0
4625753|NCT01831804|7490652|FG001|Overall Study|Investigator discretion|0
4625754|NCT01831804|7490653|FG002|Overall Study|Investigator discretion|0
4625755|NCT01831804|7490654|FG003|Overall Study|Investigator discretion|0
4625756|NCT01831804|7490655|FG004|Overall Study|Investigator discretion|1
4625757|NCT01831804|7490656|FG005|Overall Study|Investigator discretion|0
4625758|NCT01831804|7490657|FG006|Overall Study|Investigator discretion|0
4625759|NCT01831804|7490658|FG007|Overall Study|Investigator discretion|1
4625760|NCT01831804|7490659|FG008|Overall Study|Investigator discretion|0
4625761|NCT01831804|7490651|FG000|Overall Study|Withdrew Consent|0
4625762|NCT01831804|7490652|FG001|Overall Study|Withdrew Consent|1
4625763|NCT01831804|7490653|FG002|Overall Study|Withdrew Consent|0
4625764|NCT01831804|7490654|FG003|Overall Study|Withdrew Consent|0
4625765|NCT01831804|7490655|FG004|Overall Study|Withdrew Consent|0
4625766|NCT01831804|7490656|FG005|Overall Study|Withdrew Consent|0
4625767|NCT01831804|7490657|FG006|Overall Study|Withdrew Consent|0
4625768|NCT01831804|7490658|FG007|Overall Study|Withdrew Consent|2
4625769|NCT01831804|7490659|FG008|Overall Study|Withdrew Consent|0
4625770|NCT01831817|7490692|FG000|Overall Study|Lost to Follow-up|1
4625771|NCT01831817|7490693|FG001|Overall Study|Lost to Follow-up|0
4625772|NCT01831817|7490694|FG002|Overall Study|Lost to Follow-up|0
4592758|NCT01544582|7440732|FG002|Analysis Population|Safety Reason|31
4592759|NCT01544582|7440733|FG003|Analysis Population|Safety Reason|8
4592760|NCT01544582|7440730|FG000|Analysis Population|Effectiveness Reason|0
4592761|NCT01544582|7440731|FG001|Analysis Population|Effectiveness Reason|48
4592762|NCT01544582|7440732|FG002|Analysis Population|Effectiveness Reason|29
4592763|NCT01544582|7440733|FG003|Analysis Population|Effectiveness Reason|12
4592764|NCT01544582|7440730|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0
4592765|NCT01544582|7440731|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0
4592766|NCT01544582|7440732|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0
4592767|NCT01544582|7440733|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1
4592768|NCT01544582|7440730|FG000|Analysis Population|Lost to Follow-up|0
4592769|NCT01544582|7440731|FG001|Analysis Population|Lost to Follow-up|6
4592770|NCT01544582|7440732|FG002|Analysis Population|Lost to Follow-up|6
4592771|NCT01544582|7440733|FG003|Analysis Population|Lost to Follow-up|5
4592772|NCT01544582|7440730|FG000|Analysis Population|Bad Tolerance to Treatment|0
4592773|NCT01544582|7440731|FG001|Analysis Population|Bad Tolerance to Treatment|0
4592774|NCT01544582|7440732|FG002|Analysis Population|Bad Tolerance to Treatment|2
4592775|NCT01544582|7440733|FG003|Analysis Population|Bad Tolerance to Treatment|0
4592776|NCT01544582|7440730|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0
4592777|NCT01544582|7440731|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0
4592778|NCT01544582|7440732|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3
4592779|NCT01544582|7440733|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0
4592780|NCT01544582|7440730|FG000|Analysis Population|Intolerance|0
4592781|NCT01544582|7440731|FG001|Analysis Population|Intolerance|1
4592782|NCT01544582|7440732|FG002|Analysis Population|Intolerance|0
4625773|NCT01831817|7490695|FG003|Overall Study|Lost to Follow-up|0
4625774|NCT01831817|7490692|FG000|Overall Study|Withdrawl of Consent|3
4625775|NCT01831817|7490693|FG001|Overall Study|Withdrawl of Consent|0
4625776|NCT01831817|7490694|FG002|Overall Study|Withdrawl of Consent|0
4625777|NCT01831817|7490695|FG003|Overall Study|Withdrawl of Consent|0
4569910|NCT01355068|7407125|FG000|First Intervention Period|Adverse Event|0
4569911|NCT01355068|7407126|FG001|First Intervention Period|Adverse Event|1
4569912|NCT01355068|7407125|FG000|First Intervention Period|Withdrawal by Subject|0
4569913|NCT01355068|7407126|FG001|First Intervention Period|Withdrawal by Subject|1
4569914|NCT01355081|7407135|FG000|Overall Study|Pretreatment Event or Adverse Event|3
4569915|NCT01355081|7407136|FG001|Overall Study|Pretreatment Event or Adverse Event|4
4569916|NCT01355081|7407137|FG002|Overall Study|Pretreatment Event or Adverse Event|6
4569917|NCT01355081|7407135|FG000|Overall Study|Major Protocol Deviation|0
4569918|NCT01355081|7407136|FG001|Overall Study|Major Protocol Deviation|1
4569919|NCT01355081|7407137|FG002|Overall Study|Major Protocol Deviation|0
4569920|NCT01355081|7407135|FG000|Overall Study|Lost to Follow-up|0
4569921|NCT01355081|7407136|FG001|Overall Study|Lost to Follow-up|0
4569922|NCT01355081|7407137|FG002|Overall Study|Lost to Follow-up|1
4569923|NCT01355081|7407135|FG000|Overall Study|Withdrawal of Consent|2
4569924|NCT01355081|7407136|FG001|Overall Study|Withdrawal of Consent|3
4569925|NCT01355081|7407137|FG002|Overall Study|Withdrawal of Consent|3
4569926|NCT01355081|7407135|FG000|Overall Study|Lack of Efficacy|2
4569927|NCT01355081|7407136|FG001|Overall Study|Lack of Efficacy|1
4569928|NCT01355081|7407137|FG002|Overall Study|Lack of Efficacy|1
4569929|NCT01355081|7407135|FG000|Overall Study|Non Compliance with Study Medication|0
4569930|NCT01355081|7407136|FG001|Overall Study|Non Compliance with Study Medication|1
4569931|NCT01355081|7407137|FG002|Overall Study|Non Compliance with Study Medication|0
4569932|NCT01355159|7407147|FG000|Overall Study|Withdrew consent|39
4569933|NCT01355159|7407148|FG001|Overall Study|Withdrew consent|47
4569934|NCT01355159|7407147|FG000|Overall Study|No primary outcome data|17
4569935|NCT01355159|7407148|FG001|Overall Study|No primary outcome data|11
4569936|NCT01355159|7407147|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22
4569937|NCT01355159|7407148|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15
4569938|NCT01355159|7407147|FG000|Overall Study|Early intrauterine fetal death|6
4569939|NCT01355159|7407148|FG001|Overall Study|Early intrauterine fetal death|6
4569940|NCT01355289|7407183|FG000|Core Study|Adverse Event, Non-Fatal|1
4569941|NCT01355289|7407184|FG001|Core Study|Adverse Event, Non-Fatal|0
4569942|NCT01355289|7407185|FG002|Core Study|Adverse Event, Non-Fatal|0
4569943|NCT01355289|7407186|FG003|Core Study|Adverse Event, Non-Fatal|0
4569944|NCT01355289|7407187|FG004|Core Study|Adverse Event, Non-Fatal|0
4569945|NCT01355289|7407183|FG000|Core Study|Inadequate Therapeutic Effect|0
4569946|NCT01355289|7407184|FG001|Core Study|Inadequate Therapeutic Effect|0
4569947|NCT01355289|7407185|FG002|Core Study|Inadequate Therapeutic Effect|0
4569948|NCT01355289|7407186|FG003|Core Study|Inadequate Therapeutic Effect|1
4569949|NCT01355289|7407187|FG004|Core Study|Inadequate Therapeutic Effect|0
4569950|NCT01355289|7407183|FG000|Core Study|Other|0
4569951|NCT01355289|7407184|FG001|Core Study|Other|0
4569952|NCT01355289|7407185|FG002|Core Study|Other|0
4569953|NCT01355289|7407186|FG003|Core Study|Other|1
4569954|NCT01355289|7407187|FG004|Core Study|Other|0
4569955|NCT01355289|7407183|FG000|Open Label Extension|Adverse Event, Non-Fatal|0
4569956|NCT01355289|7407184|FG001|Open Label Extension|Adverse Event, Non-Fatal|0
4569957|NCT01355289|7407185|FG002|Open Label Extension|Adverse Event, Non-Fatal|0
4569958|NCT01355289|7407186|FG003|Open Label Extension|Adverse Event, Non-Fatal|0
4569959|NCT01355289|7407187|FG004|Open Label Extension|Adverse Event, Non-Fatal|1
4569960|NCT01355289|7407183|FG000|Open Label Extension|Lost to Follow-up|0
4569961|NCT01355289|7407184|FG001|Open Label Extension|Lost to Follow-up|0
4569962|NCT01355289|7407185|FG002|Open Label Extension|Lost to Follow-up|0
4569963|NCT01355289|7407186|FG003|Open Label Extension|Lost to Follow-up|0
4569964|NCT01355289|7407187|FG004|Open Label Extension|Lost to Follow-up|1
4569965|NCT01355289|7407183|FG000|Open Label Extension|Inadequate Therapeutic Effect|0
4569966|NCT01355289|7407184|FG001|Open Label Extension|Inadequate Therapeutic Effect|0
4569967|NCT01355289|7407185|FG002|Open Label Extension|Inadequate Therapeutic Effect|0
4569968|NCT01355289|7407186|FG003|Open Label Extension|Inadequate Therapeutic Effect|0
4569969|NCT01355289|7407187|FG004|Open Label Extension|Inadequate Therapeutic Effect|29
4569970|NCT01355289|7407183|FG000|Open Label Extension|Other|0
4569971|NCT01355289|7407184|FG001|Open Label Extension|Other|0
4569972|NCT01355289|7407185|FG002|Open Label Extension|Other|0
4569973|NCT01355289|7407186|FG003|Open Label Extension|Other|0
4569974|NCT01355289|7407187|FG004|Open Label Extension|Other|3
4569975|NCT01355302|7407200|FG000|Phase 1b|Death|4
4569976|NCT01355302|7407201|FG001|Phase 1b|Death|0
4569977|NCT01355302|7407202|FG002|Phase 1b|Death|0
4569978|NCT01355302|7407200|FG000|Phase 1b|Study terminated by sponsor|2
4569979|NCT01355302|7407201|FG001|Phase 1b|Study terminated by sponsor|0
4569980|NCT01355302|7407202|FG002|Phase 1b|Study terminated by sponsor|0
4569981|NCT01355497|7407243|FG000|Overall Study|Death|19
4569982|NCT01355497|7407244|FG001|Overall Study|Death|18
4569983|NCT01355497|7407243|FG000|Overall Study|Lost to Follow-up|3
4569984|NCT01355497|7407244|FG001|Overall Study|Lost to Follow-up|0
4569985|NCT01355497|7407243|FG000|Overall Study|Protocol Violation|0
4569986|NCT01355497|7407244|FG001|Overall Study|Protocol Violation|1
4569987|NCT01355497|7407243|FG000|Overall Study|other-not provided|9
4569988|NCT01355497|7407244|FG001|Overall Study|other-not provided|4
4569989|NCT01355497|7407243|FG000|Overall Study|Withdrawal by Subject|12
4569990|NCT01355497|7407244|FG001|Overall Study|Withdrawal by Subject|20
4569991|NCT01355497|7407243|FG000|Overall Study|noncompliance|1
4569992|NCT01355497|7407244|FG001|Overall Study|noncompliance|2
4569993|NCT01355497|7407243|FG000|Overall Study|progressive disease|11
4569994|NCT01355497|7407244|FG001|Overall Study|progressive disease|8
4569995|NCT01355497|7407243|FG000|Overall Study|Adverse Event|11
4569996|NCT01355497|7407244|FG001|Overall Study|Adverse Event|10
4569997|NCT01355523|7407252|FG000|Overall Study|Withdrawal by Subject|1
4569998|NCT01355523|7407253|FG001|Overall Study|Withdrawal by Subject|4
4569999|NCT01355523|7407252|FG000|Overall Study|Lost to Follow-up|0
4570000|NCT01355523|7407253|FG001|Overall Study|Lost to Follow-up|2
4570001|NCT01355523|7407252|FG000|Overall Study|Protocol Violation|0
4570002|NCT01355523|7407253|FG001|Overall Study|Protocol Violation|2
4570003|NCT01355523|7407252|FG000|Overall Study|Adverse Event|0
4570004|NCT01355523|7407253|FG001|Overall Study|Adverse Event|2
4570005|NCT01355575|7407259|FG000|Overall Study|Withdrawal by Subject|2
4570006|NCT01355627|7407286|FG000|Overall Study|Request By the Patient to Discontinue|5
4570007|NCT01355627|7407287|FG001|Overall Study|Request By the Patient to Discontinue|7
4570008|NCT01355627|7407286|FG000|Overall Study|Lost to Follow-up|8
4570009|NCT01355627|7407287|FG001|Overall Study|Lost to Follow-up|7
4570010|NCT01355627|7407286|FG000|Overall Study|Fatal Adverse Event|19
4570011|NCT01355627|7407287|FG001|Overall Study|Fatal Adverse Event|23
4570012|NCT01355627|7407286|FG000|Overall Study|Other|1
4570013|NCT01355627|7407287|FG001|Overall Study|Other|1
4570014|NCT01356407|7407331|FG000|Overall Study|Lost to Follow-up|2
4570015|NCT01356407|7407332|FG001|Overall Study|Lost to Follow-up|0
4570016|NCT01356407|7407331|FG000|Overall Study|Patient Withdrew Consent|2
4570017|NCT01356407|7407332|FG001|Overall Study|Patient Withdrew Consent|1
4570018|NCT01356407|7407331|FG000|Overall Study|Could not afford IMP administration|0
4570019|NCT01356407|7407332|FG001|Overall Study|Could not afford IMP administration|1
4570020|NCT01356407|7407331|FG000|Overall Study|Not complete Endoscopy|2
4570021|NCT01356407|7407332|FG001|Overall Study|Not complete Endoscopy|2
4570022|NCT01356589|7407369|FG000|Overall Study|Enrolled, but not treated|3
4570023|NCT01356589|7407369|FG000|Overall Study|Dose data not recorded|2
4570024|NCT01356602|7407376|FG000|Overall Study|Protocol Deviation|0
4570025|NCT01356602|7407377|FG001|Overall Study|Protocol Deviation|1
4570026|NCT01356602|7407378|FG002|Overall Study|Protocol Deviation|1
4570027|NCT01356602|7407376|FG000|Overall Study|Administrative Problems|1
4570028|NCT01356602|7407377|FG001|Overall Study|Administrative Problems|4
4570029|NCT01356602|7407378|FG002|Overall Study|Administrative Problems|5
4570030|NCT01356602|7407376|FG000|Overall Study|Lost to Follow-up|4
4570031|NCT01356602|7407377|FG001|Overall Study|Lost to Follow-up|5
4570032|NCT01356602|7407378|FG002|Overall Study|Lost to Follow-up|6
4570033|NCT01356602|7407376|FG000|Overall Study|Withdrawal by Subject|4
4570034|NCT01356602|7407377|FG001|Overall Study|Withdrawal by Subject|3
4570035|NCT01356602|7407378|FG002|Overall Study|Withdrawal by Subject|7
4570036|NCT01356602|7407376|FG000|Overall Study|Lack of Efficacy|0
4570037|NCT01356602|7407377|FG001|Overall Study|Lack of Efficacy|1
4570038|NCT01356602|7407378|FG002|Overall Study|Lack of Efficacy|4
4570039|NCT01356602|7407376|FG000|Overall Study|Adverse Event|0
4570040|NCT01356602|7407377|FG001|Overall Study|Adverse Event|1
4570041|NCT01356602|7407378|FG002|Overall Study|Adverse Event|1
4570042|NCT01356940|7407392|FG000|First Intervention (28 Days)|Adverse Event|1
4570043|NCT01356940|7407393|FG001|First Intervention (28 Days)|Adverse Event|0
4570044|NCT01356940|7407392|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1
4570045|NCT01356940|7407393|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0
4570046|NCT01356966|7407403|FG000|Overall Study|Withdrawal by Subject|1
4570047|NCT01356966|7407404|FG001|Overall Study|Withdrawal by Subject|2
4570048|NCT01356966|7407403|FG000|Overall Study|Physician Decision|1
4570049|NCT01356966|7407404|FG001|Overall Study|Physician Decision|0
4570050|NCT01357161|7407430|FG000|Part 1 (Open Label Run-in)|Death|5
4570051|NCT01357161|7407431|FG001|Part 1 (Open Label Run-in)|Death|0
4570052|NCT01357161|7407432|FG002|Part 1 (Open Label Run-in)|Death|0
4570053|NCT01357161|7407430|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3
4570054|NCT01357161|7407431|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0
4570055|NCT01357161|7407432|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0
4570056|NCT01357161|7407430|FG000|Part 1 (Open Label Run-in)|Physician Decision|1
4570057|NCT01357161|7407431|FG001|Part 1 (Open Label Run-in)|Physician Decision|0
4570058|NCT01357161|7407432|FG002|Part 1 (Open Label Run-in)|Physician Decision|0
4570059|NCT01357161|7407430|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5
4570060|NCT01357161|7407431|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0
4570061|NCT01357161|7407432|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0
4570062|NCT01357161|7407430|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1
4570063|NCT01357161|7407431|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0
4570064|NCT01357161|7407432|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0
4570065|NCT01357161|7407430|FG000|Part 2 (Double-Blind Comparison)|Death|0
4570066|NCT01357161|7407431|FG001|Part 2 (Double-Blind Comparison)|Death|22
4570067|NCT01357161|7407432|FG002|Part 2 (Double-Blind Comparison)|Death|19
4570068|NCT01357161|7407430|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0
4570069|NCT01357161|7407431|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1
4570070|NCT01357161|7407432|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6
4570071|NCT01357161|7407430|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0
4570072|NCT01357161|7407431|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1
4570073|NCT01357161|7407432|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4
4570074|NCT01357161|7407430|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0
4570075|NCT01357161|7407431|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1
4570076|NCT01357161|7407432|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3
4570077|NCT01357161|7407430|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0
4570078|NCT01357161|7407431|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29
4570079|NCT01357161|7407432|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26
4570080|NCT01357161|7407430|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0
4570081|NCT01357161|7407431|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5
4570082|NCT01357161|7407432|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4
4570083|NCT01357239|7407444|FG000|Stratum: All Patients|Adverse Event|0
4570084|NCT01357239|7407445|FG001|Stratum: All Patients|Adverse Event|0
4570085|NCT01357239|7407446|FG002|Stratum: All Patients|Adverse Event|1
4570086|NCT01357239|7407447|FG003|Stratum: All Patients|Adverse Event|1
4570087|NCT01357239|7407444|FG000|Stratum: All Patients|Subject withdrew consent|0
4570088|NCT01357239|7407445|FG001|Stratum: All Patients|Subject withdrew consent|0
4570089|NCT01357239|7407446|FG002|Stratum: All Patients|Subject withdrew consent|1
4570090|NCT01357239|7407447|FG003|Stratum: All Patients|Subject withdrew consent|1
4570091|NCT01357239|7407444|FG000|Stratum I: Fully-Methylated|Adverse Event|0
4570092|NCT01357239|7407445|FG001|Stratum I: Fully-Methylated|Adverse Event|0
4570093|NCT01357239|7407446|FG002|Stratum I: Fully-Methylated|Adverse Event|1
4570094|NCT01357239|7407447|FG003|Stratum I: Fully-Methylated|Adverse Event|0
4570095|NCT01357239|7407444|FG000|Stratum II: Partially-Methylated|Adverse Event|0
4570096|NCT01357239|7407445|FG001|Stratum II: Partially-Methylated|Adverse Event|0
4570097|NCT01357239|7407446|FG002|Stratum II: Partially-Methylated|Adverse Event|0
4570098|NCT01357239|7407447|FG003|Stratum II: Partially-Methylated|Adverse Event|1
4570099|NCT01357239|7407444|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0
4570100|NCT01357239|7407445|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0
4570101|NCT01357239|7407446|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1
4570102|NCT01357239|7407447|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1
4570103|NCT01357551|7407494|FG000|Overall Study|Withdrawal by Subject|6
4570104|NCT01357551|7407495|FG001|Overall Study|Withdrawal by Subject|4
4570105|NCT01357551|7407494|FG000|Overall Study|Death|0
4570106|NCT01357551|7407495|FG001|Overall Study|Death|1
4570107|NCT01357551|7407494|FG000|Overall Study|Lost to Follow-up|16
4570108|NCT01357551|7407495|FG001|Overall Study|Lost to Follow-up|6
4570109|NCT01357577|7407517|FG000|Overall Study|Lost to Follow-up|20
4570110|NCT01357577|7407518|FG001|Overall Study|Lost to Follow-up|16
4570111|NCT01357577|7407517|FG000|Overall Study|Withdrawal by Subject|16
4570112|NCT01357577|7407518|FG001|Overall Study|Withdrawal by Subject|8
4570113|NCT01357577|7407517|FG000|Overall Study|look at data in database?|1
4570114|NCT01357577|7407518|FG001|Overall Study|look at data in database?|2
4570115|NCT01357616|7407527|FG000|Overall Study|Adverse Event|1
4570116|NCT01357616|7407528|FG001|Overall Study|Adverse Event|1
4570117|NCT01357616|7407527|FG000|Overall Study|Lost to Follow-up|4
4570118|NCT01357616|7407528|FG001|Overall Study|Lost to Follow-up|3
4570119|NCT01357616|7407527|FG000|Overall Study|Protocol Violation|0
4570120|NCT01357616|7407528|FG001|Overall Study|Protocol Violation|2
4570121|NCT01357616|7407527|FG000|Overall Study|Inadequate Control of IOP|1
4570122|NCT01357616|7407528|FG001|Overall Study|Inadequate Control of IOP|2
4570123|NCT01357616|7407527|FG000|Overall Study|Decision Unrelated to Adverse Event|3
4570124|NCT01357616|7407528|FG001|Overall Study|Decision Unrelated to Adverse Event|1
4570125|NCT01357616|7407527|FG000|Overall Study|Withdrawal by Subject|1
4570126|NCT01357616|7407528|FG001|Overall Study|Withdrawal by Subject|0
4570127|NCT01357655|7407536|FG000|Overall Study|Administrative Reason by Sponsor|45
4570128|NCT01357655|7407537|FG001|Overall Study|Administrative Reason by Sponsor|0
4570129|NCT01357655|7407536|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3
4570130|NCT01357655|7407537|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0
4570131|NCT01357655|7407536|FG000|Overall Study|Disease Progression|1
4570132|NCT01357655|7407537|FG001|Overall Study|Disease Progression|0
4570133|NCT01357655|7407536|FG000|Overall Study|Lost to Follow-up|2
4570134|NCT01357655|7407537|FG001|Overall Study|Lost to Follow-up|0
4570135|NCT01357655|7407536|FG000|Overall Study|Maximum Clinical Benefit|2
4570136|NCT01357655|7407537|FG001|Overall Study|Maximum Clinical Benefit|0
4570137|NCT01357655|7407536|FG000|Overall Study|Reason Unspecified|1
4570138|NCT01357655|7407537|FG001|Overall Study|Reason Unspecified|0
4570139|NCT01357655|7407536|FG000|Overall Study|Study Drug Toxicity|11
4570140|NCT01357655|7407537|FG001|Overall Study|Study Drug Toxicity|0
4570141|NCT01357655|7407536|FG000|Overall Study|Subject Withdrew Consent|1
4570142|NCT01357655|7407537|FG001|Overall Study|Subject Withdrew Consent|0
4570143|NCT01357850|7407555|FG000|Overall Study|Lost to Follow-up|1
4570144|NCT01357850|7407556|FG001|Overall Study|Lost to Follow-up|0
4570145|NCT01357850|7407557|FG002|Overall Study|Lost to Follow-up|0
4570146|NCT01357850|7407558|FG003|Overall Study|Lost to Follow-up|0
4570147|NCT01357889|7407571|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2
4570148|NCT01357889|7407572|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1
4570149|NCT01357889|7407571|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1
4570150|NCT01357889|7407572|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1
4570151|NCT01357889|7407571|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1
4625778|NCT01831856|7490707|FG000|Overall Study|Adverse Event|5
4625779|NCT01831856|7490708|FG001|Overall Study|Adverse Event|8
4625780|NCT01831856|7490707|FG000|Overall Study|Lack of Efficacy|13
4625781|NCT01831856|7490708|FG001|Overall Study|Lack of Efficacy|11
4625782|NCT01831856|7490707|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16
4625783|NCT01831856|7490708|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18
4625784|NCT01832038|7490745|FG000|Overall Study|Death|5
4625785|NCT01832038|7490745|FG000|Overall Study|Adverse Event|50
4625786|NCT01832038|7490745|FG000|Overall Study|Lack of Efficacy|81
4625787|NCT01832038|7490745|FG000|Overall Study|Protocol Violation|7
4625788|NCT01832038|7490745|FG000|Overall Study|Lost to Follow-up|10
4625789|NCT01832038|7490745|FG000|Overall Study|Withdrawal by Subject|49
4625790|NCT01832038|7490745|FG000|Overall Study|Visit non-compliance|2
4625791|NCT01832038|7490745|FG000|Overall Study|Subject refused to return visit|2
4625792|NCT01832038|7490745|FG000|Overall Study|Not convenient to come back to site|2
4625793|NCT01832038|7490745|FG000|Overall Study|Participant was asked to quit|5
4625794|NCT01832038|7490745|FG000|Overall Study|Back home|1
4625795|NCT01832038|7490745|FG000|Overall Study|Pregnancy|1
4625796|NCT01832038|7490745|FG000|Overall Study|Low compliance|3
4625797|NCT01832038|7490745|FG000|Overall Study|Prohibit procedure|2
4625798|NCT01832038|7490745|FG000|Overall Study|Not possible to visit the hospital|1
4625799|NCT01832038|7490745|FG000|Overall Study|Changes of implementation system|3
4625800|NCT01832038|7490745|FG000|Overall Study|Plan to pregnancy|7
4625801|NCT01832038|7490745|FG000|Overall Study|Bad mood and has suicidal thought|1
4625802|NCT01832038|7490745|FG000|Overall Study|Prohibited concomitant medication|1
4625803|NCT01832038|7490745|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1
4570152|NCT01357889|7407572|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0
4570153|NCT01357889|7407571|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2
4570154|NCT01357889|7407572|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2
4570155|NCT01357889|7407571|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0
4570156|NCT01357889|7407572|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2
4570157|NCT01357889|7407571|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0
4570158|NCT01357889|7407572|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2
4570159|NCT01357889|7407571|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5
4570160|NCT01357889|7407572|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2
4570161|NCT01357889|7407571|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2
4570162|NCT01357889|7407572|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1
4570163|NCT01357889|7407571|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7
4570164|NCT01357889|7407572|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7
4570165|NCT01357889|7407571|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1
4570166|NCT01357889|7407572|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0
4570167|NCT01357889|7407571|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0
4570168|NCT01357889|7407572|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4
4570169|NCT01357889|7407571|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1
4570170|NCT01357889|7407572|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0
4570171|NCT01357889|7407571|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1
4570172|NCT01357889|7407572|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0
4570173|NCT01357915|7407582|FG000|Overall Study|Lost to Follow-up|3
4570174|NCT01357915|7407583|FG001|Overall Study|Lost to Follow-up|0
4570175|NCT01357980|7407593|FG000|Overall Study|Lack of Efficacy|0
4570176|NCT01357980|7407594|FG001|Overall Study|Lack of Efficacy|1
4570177|NCT01357980|7407595|FG002|Overall Study|Lack of Efficacy|0
4570178|NCT01357980|7407596|FG003|Overall Study|Lack of Efficacy|0
4570179|NCT01357980|7407593|FG000|Overall Study|Consent withdrawn|0
4570180|NCT01357980|7407594|FG001|Overall Study|Consent withdrawn|0
4570181|NCT01357980|7407595|FG002|Overall Study|Consent withdrawn|1
4570182|NCT01357980|7407596|FG003|Overall Study|Consent withdrawn|0
4570183|NCT01358175|7407609|FG000|Overall Study|Death|1
4570184|NCT01358175|7407610|FG001|Overall Study|Death|0
4570185|NCT01358175|7407611|FG002|Overall Study|Death|1
4570186|NCT01358175|7407609|FG000|Overall Study|Withdrawal by Subject|9
4570187|NCT01358175|7407610|FG001|Overall Study|Withdrawal by Subject|5
4570188|NCT01358175|7407611|FG002|Overall Study|Withdrawal by Subject|10
4570189|NCT01358175|7407609|FG000|Overall Study|Technical issues|0
4570190|NCT01358175|7407610|FG001|Overall Study|Technical issues|1
4570191|NCT01358175|7407611|FG002|Overall Study|Technical issues|0
4570192|NCT01358175|7407609|FG000|Overall Study|Pregnancy|0
4625804|NCT01832038|7490745|FG000|Overall Study|Subject considered the efficacy was poor|1
4625805|NCT01832155|7490781|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1
4625806|NCT01832155|7490782|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0
4625807|NCT01832155|7490781|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1
4625808|NCT01832155|7490782|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0
4625809|NCT01832402|7490805|FG000|Overall Study|Lost to Follow-up|2
4625810|NCT01832402|7490806|FG001|Overall Study|Lost to Follow-up|0
4625811|NCT01832402|7490805|FG000|Overall Study|Withdrawal by Subject|3
4625812|NCT01832402|7490806|FG001|Overall Study|Withdrawal by Subject|3
4625813|NCT01832402|7490805|FG000|Overall Study|Declining Performance status|2
4625814|NCT01832402|7490806|FG001|Overall Study|Declining Performance status|1
4570193|NCT01358175|7407610|FG001|Overall Study|Pregnancy|1
4570194|NCT01358175|7407611|FG002|Overall Study|Pregnancy|0
4570195|NCT01358175|7407609|FG000|Overall Study|Physician Decision|1
4570196|NCT01358175|7407610|FG001|Overall Study|Physician Decision|0
4570197|NCT01358175|7407611|FG002|Overall Study|Physician Decision|0
4570198|NCT01358175|7407609|FG000|Overall Study|Non Compliance with Study Treatment|0
4570199|NCT01358175|7407610|FG001|Overall Study|Non Compliance with Study Treatment|1
4570200|NCT01358175|7407611|FG002|Overall Study|Non Compliance with Study Treatment|1
4570201|NCT01358175|7407609|FG000|Overall Study|Lost to Follow-up|1
4570202|NCT01358175|7407610|FG001|Overall Study|Lost to Follow-up|1
4570203|NCT01358175|7407611|FG002|Overall Study|Lost to Follow-up|3
4570204|NCT01358175|7407609|FG000|Overall Study|Lack of Efficacy|3
4570205|NCT01358175|7407610|FG001|Overall Study|Lack of Efficacy|8
4570206|NCT01358175|7407611|FG002|Overall Study|Lack of Efficacy|6
4570207|NCT01358175|7407609|FG000|Overall Study|Adverse Event|6
4570208|NCT01358175|7407610|FG001|Overall Study|Adverse Event|11
4570209|NCT01358175|7407611|FG002|Overall Study|Adverse Event|11
4570210|NCT01358331|7407643|FG000|Overall Study|Lost to Follow-up|0
4570211|NCT01358331|7407644|FG001|Overall Study|Lost to Follow-up|0
4570212|NCT01358331|7407645|FG002|Overall Study|Lost to Follow-up|0
4570213|NCT01358331|7407646|FG003|Overall Study|Lost to Follow-up|1
4570214|NCT01358331|7407647|FG004|Overall Study|Lost to Follow-up|0
4570215|NCT01358331|7407648|FG005|Overall Study|Lost to Follow-up|0
4570216|NCT01358331|7407643|FG000|Overall Study|Withdrawal by Subject|0
4570217|NCT01358331|7407644|FG001|Overall Study|Withdrawal by Subject|0
4570218|NCT01358331|7407645|FG002|Overall Study|Withdrawal by Subject|0
4570219|NCT01358331|7407646|FG003|Overall Study|Withdrawal by Subject|1
4570220|NCT01358331|7407647|FG004|Overall Study|Withdrawal by Subject|1
4570221|NCT01358331|7407648|FG005|Overall Study|Withdrawal by Subject|1
4570222|NCT01358331|7407643|FG000|Overall Study|Adverse Events|1
4570223|NCT01358331|7407644|FG001|Overall Study|Adverse Events|1
4570224|NCT01358331|7407645|FG002|Overall Study|Adverse Events|1
4570225|NCT01358331|7407646|FG003|Overall Study|Adverse Events|0
4570226|NCT01358331|7407647|FG004|Overall Study|Adverse Events|1
4570227|NCT01358331|7407648|FG005|Overall Study|Adverse Events|5
4570228|NCT01358331|7407643|FG000|Overall Study|Symptomatic Deterioration|0
4570229|NCT01358331|7407644|FG001|Overall Study|Symptomatic Deterioration|0
4625815|NCT01832480|7490818|FG000|Overall Study|Lost to Follow-up|33
4625816|NCT01832480|7490819|FG001|Overall Study|Lost to Follow-up|30
4625817|NCT01832480|7490818|FG000|Overall Study|Withdrawal by Subject|0
4625818|NCT01832480|7490819|FG001|Overall Study|Withdrawal by Subject|2
4625819|NCT01832480|7490818|FG000|Overall Study|post randomization ineligible|8
4625820|NCT01832480|7490819|FG001|Overall Study|post randomization ineligible|10
4625821|NCT01832493|7490825|FG000|Overall Study|Physician Decision|2
4625822|NCT01832493|7490825|FG000|Overall Study|Protocol Violation|4
4625823|NCT01832493|7490825|FG000|Overall Study|Unable to place LV lead|2
4625824|NCT01832532|7490849|FG000|Overall Study|Withdrawal by Subject|5
4625825|NCT01832532|7490850|FG001|Overall Study|Withdrawal by Subject|2
4625826|NCT01832727|7490869|FG000|Overall Study|Adverse Event|4
4625827|NCT01832727|7490870|FG001|Overall Study|Adverse Event|6
4625828|NCT01832727|7490871|FG002|Overall Study|Adverse Event|1
4625829|NCT01832727|7490872|FG003|Overall Study|Adverse Event|0
4625830|NCT01832727|7490873|FG004|Overall Study|Adverse Event|1
4625831|NCT01832727|7490874|FG005|Overall Study|Adverse Event|1
4625832|NCT01832727|7490875|FG006|Overall Study|Adverse Event|2
4625833|NCT01832727|7490876|FG007|Overall Study|Adverse Event|1
4625834|NCT01832727|7490877|FG008|Overall Study|Adverse Event|9
4625835|NCT01832727|7490869|FG000|Overall Study|Disease progression|3
4625836|NCT01832727|7490870|FG001|Overall Study|Disease progression|0
4625837|NCT01832727|7490871|FG002|Overall Study|Disease progression|2
4625838|NCT01832727|7490872|FG003|Overall Study|Disease progression|1
4625839|NCT01832727|7490873|FG004|Overall Study|Disease progression|3
4625840|NCT01832727|7490874|FG005|Overall Study|Disease progression|3
4625841|NCT01832727|7490875|FG006|Overall Study|Disease progression|6
4625842|NCT01832727|7490876|FG007|Overall Study|Disease progression|2
4625843|NCT01832727|7490877|FG008|Overall Study|Disease progression|7
4625844|NCT01832727|7490869|FG000|Overall Study|Lost to Follow-up|0
4625845|NCT01832727|7490870|FG001|Overall Study|Lost to Follow-up|0
4570230|NCT01358331|7407645|FG002|Overall Study|Symptomatic Deterioration|0
4570231|NCT01358331|7407646|FG003|Overall Study|Symptomatic Deterioration|0
4570232|NCT01358331|7407647|FG004|Overall Study|Symptomatic Deterioration|1
4570233|NCT01358331|7407648|FG005|Overall Study|Symptomatic Deterioration|0
4570234|NCT01358331|7407643|FG000|Overall Study|Participants did not wish to continue|0
4570235|NCT01358331|7407644|FG001|Overall Study|Participants did not wish to continue|0
4570236|NCT01358331|7407645|FG002|Overall Study|Participants did not wish to continue|0
4570237|NCT01358331|7407646|FG003|Overall Study|Participants did not wish to continue|0
4570238|NCT01358331|7407647|FG004|Overall Study|Participants did not wish to continue|1
4570239|NCT01358331|7407648|FG005|Overall Study|Participants did not wish to continue|0
4570240|NCT01358331|7407643|FG000|Overall Study|Progress of disease under investigation|1
4570241|NCT01358331|7407644|FG001|Overall Study|Progress of disease under investigation|2
4570242|NCT01358331|7407645|FG002|Overall Study|Progress of disease under investigation|3
4570243|NCT01358331|7407646|FG003|Overall Study|Progress of disease under investigation|1
4570244|NCT01358331|7407647|FG004|Overall Study|Progress of disease under investigation|3
4625846|NCT01832727|7490871|FG002|Overall Study|Lost to Follow-up|0
4570245|NCT01358331|7407648|FG005|Overall Study|Progress of disease under investigation|0
4570246|NCT01358357|7407664|FG000|Open Label Phase|Adverse Event|0
4570247|NCT01358357|7407665|FG001|Open Label Phase|Adverse Event|0
4570248|NCT01358357|7407666|FG002|Open Label Phase|Adverse Event|59
4570249|NCT01358357|7407664|FG000|Open Label Phase|Lack of Efficacy|0
4570250|NCT01358357|7407665|FG001|Open Label Phase|Lack of Efficacy|0
4570251|NCT01358357|7407666|FG002|Open Label Phase|Lack of Efficacy|107
4570252|NCT01358357|7407664|FG000|Open Label Phase|Lost to Follow-up|0
4570253|NCT01358357|7407665|FG001|Open Label Phase|Lost to Follow-up|0
4570254|NCT01358357|7407666|FG002|Open Label Phase|Lost to Follow-up|76
4570255|NCT01358357|7407664|FG000|Open Label Phase|Protocol Violation|0
4570256|NCT01358357|7407665|FG001|Open Label Phase|Protocol Violation|0
4570257|NCT01358357|7407666|FG002|Open Label Phase|Protocol Violation|45
4570258|NCT01358357|7407664|FG000|Open Label Phase|Withdrawal by Subject|0
4570259|NCT01358357|7407665|FG001|Open Label Phase|Withdrawal by Subject|0
4570260|NCT01358357|7407666|FG002|Open Label Phase|Withdrawal by Subject|112
4570261|NCT01358357|7407664|FG000|Open Label Phase|Did not meet criteria for DB phase|0
4570262|NCT01358357|7407665|FG001|Open Label Phase|Did not meet criteria for DB phase|0
4570263|NCT01358357|7407666|FG002|Open Label Phase|Did not meet criteria for DB phase|16
4570264|NCT01358357|7407664|FG000|Open Label Phase|Terminated at study completion|0
4570265|NCT01358357|7407665|FG001|Open Label Phase|Terminated at study completion|0
4570266|NCT01358357|7407666|FG002|Open Label Phase|Terminated at study completion|5
4570267|NCT01358357|7407664|FG000|Open Label Phase|Mood episode|0
4570268|NCT01358357|7407665|FG001|Open Label Phase|Mood episode|0
4570269|NCT01358357|7407666|FG002|Open Label Phase|Mood episode|42
4570270|NCT01358357|7407664|FG000|Double-Blind Phase|Adverse Event|8
4570271|NCT01358357|7407665|FG001|Double-Blind Phase|Adverse Event|5
4570272|NCT01358357|7407666|FG002|Double-Blind Phase|Adverse Event|0
4570273|NCT01358357|7407664|FG000|Double-Blind Phase|Lost to Follow-up|5
4570274|NCT01358357|7407665|FG001|Double-Blind Phase|Lost to Follow-up|7
4570275|NCT01358357|7407666|FG002|Double-Blind Phase|Lost to Follow-up|0
4570276|NCT01358357|7407664|FG000|Double-Blind Phase|Protocol Violation|1
4570277|NCT01358357|7407665|FG001|Double-Blind Phase|Protocol Violation|11
4570278|NCT01358357|7407666|FG002|Double-Blind Phase|Protocol Violation|0
4570279|NCT01358357|7407664|FG000|Double-Blind Phase|Protocol Violation|16
4570280|NCT01358357|7407665|FG001|Double-Blind Phase|Protocol Violation|12
4570281|NCT01358357|7407666|FG002|Double-Blind Phase|Protocol Violation|0
4570282|NCT01358357|7407664|FG000|Double-Blind Phase|Terminated at study completion|2
4570283|NCT01358357|7407665|FG001|Double-Blind Phase|Terminated at study completion|0
4570284|NCT01358357|7407666|FG002|Double-Blind Phase|Terminated at study completion|0
4570285|NCT01358357|7407664|FG000|Double-Blind Phase|Recurrence of mood event|48
4570286|NCT01358357|7407665|FG001|Double-Blind Phase|Recurrence of mood event|64
4570287|NCT01358357|7407666|FG002|Double-Blind Phase|Recurrence of mood event|0
4570288|NCT01358357|7407664|FG000|Double-Blind Phase|Administrative|0
4570289|NCT01358357|7407665|FG001|Double-Blind Phase|Administrative|1
4570290|NCT01358357|7407666|FG002|Double-Blind Phase|Administrative|0
4570291|NCT01358526|7407675|FG000|Open-label Titration Period|Adverse Event|95
4570292|NCT01358526|7407676|FG001|Open-label Titration Period|Adverse Event|0
4570293|NCT01358526|7407677|FG002|Open-label Titration Period|Adverse Event|0
4570294|NCT01358526|7407675|FG000|Open-label Titration Period|Withdrawal by Subject|65
4570295|NCT01358526|7407676|FG001|Open-label Titration Period|Withdrawal by Subject|0
4570296|NCT01358526|7407677|FG002|Open-label Titration Period|Withdrawal by Subject|0
4570297|NCT01358526|7407675|FG000|Open-label Titration Period|Lost to Follow-up|25
4570298|NCT01358526|7407676|FG001|Open-label Titration Period|Lost to Follow-up|0
4570299|NCT01358526|7407677|FG002|Open-label Titration Period|Lost to Follow-up|0
4570300|NCT01358526|7407675|FG000|Open-label Titration Period|Lack of Efficacy|107
4570301|NCT01358526|7407676|FG001|Open-label Titration Period|Lack of Efficacy|0
4570302|NCT01358526|7407677|FG002|Open-label Titration Period|Lack of Efficacy|0
4570303|NCT01358526|7407675|FG000|Open-label Titration Period|Confirmed or suspected diversion|16
4570304|NCT01358526|7407676|FG001|Open-label Titration Period|Confirmed or suspected diversion|0
4570305|NCT01358526|7407677|FG002|Open-label Titration Period|Confirmed or suspected diversion|0
4570306|NCT01358526|7407675|FG000|Open-label Titration Period|Administrative|8
4570307|NCT01358526|7407676|FG001|Open-label Titration Period|Administrative|0
4570308|NCT01358526|7407677|FG002|Open-label Titration Period|Administrative|0
4570309|NCT01358526|7407675|FG000|Open-label Titration Period|Did not qualify|178
4570310|NCT01358526|7407676|FG001|Open-label Titration Period|Did not qualify|0
4570311|NCT01358526|7407677|FG002|Open-label Titration Period|Did not qualify|0
4570312|NCT01358526|7407675|FG000|Double-blind Phase|Adverse Event|0
4570313|NCT01358526|7407676|FG001|Double-blind Phase|Adverse Event|24
4570314|NCT01358526|7407677|FG002|Double-blind Phase|Adverse Event|23
4570315|NCT01358526|7407675|FG000|Double-blind Phase|Withdrawal by Subject|0
4570316|NCT01358526|7407676|FG001|Double-blind Phase|Withdrawal by Subject|10
4570317|NCT01358526|7407677|FG002|Double-blind Phase|Withdrawal by Subject|8
4570318|NCT01358526|7407675|FG000|Double-blind Phase|Lost to Follow-up|0
4570319|NCT01358526|7407676|FG001|Double-blind Phase|Lost to Follow-up|4
4570320|NCT01358526|7407677|FG002|Double-blind Phase|Lost to Follow-up|1
4570321|NCT01358526|7407675|FG000|Double-blind Phase|Lack of Efficacy|0
4570322|NCT01358526|7407676|FG001|Double-blind Phase|Lack of Efficacy|31
4570323|NCT01358526|7407677|FG002|Double-blind Phase|Lack of Efficacy|73
4570324|NCT01358526|7407675|FG000|Double-blind Phase|Confirmed or suspected diversion|0
4570325|NCT01358526|7407676|FG001|Double-blind Phase|Confirmed or suspected diversion|5
4570326|NCT01358526|7407677|FG002|Double-blind Phase|Confirmed or suspected diversion|6
4570327|NCT01358526|7407675|FG000|Double-blind Phase|Administrative|0
4570328|NCT01358526|7407676|FG001|Double-blind Phase|Administrative|6
4570329|NCT01358526|7407677|FG002|Double-blind Phase|Administrative|10
4570330|NCT01358578|7407688|FG000|Induction Period|Adverse Event|2
4570331|NCT01358578|7407689|FG001|Induction Period|Adverse Event|4
4570332|NCT01358578|7407690|FG002|Induction Period|Adverse Event|2
4570333|NCT01358578|7407691|FG003|Induction Period|Adverse Event|6
4570334|NCT01358578|7407692|FG004|Induction Period|Adverse Event|0
4570335|NCT01358578|7407693|FG005|Induction Period|Adverse Event|0
4570336|NCT01358578|7407688|FG000|Induction Period|Lack of Efficacy|0
4570337|NCT01358578|7407689|FG001|Induction Period|Lack of Efficacy|0
4570338|NCT01358578|7407690|FG002|Induction Period|Lack of Efficacy|9
4570339|NCT01358578|7407691|FG003|Induction Period|Lack of Efficacy|1
4570340|NCT01358578|7407692|FG004|Induction Period|Lack of Efficacy|0
4570341|NCT01358578|7407693|FG005|Induction Period|Lack of Efficacy|0
4570342|NCT01358578|7407688|FG000|Induction Period|Lost to Follow-up|0
4570343|NCT01358578|7407689|FG001|Induction Period|Lost to Follow-up|0
4570344|NCT01358578|7407690|FG002|Induction Period|Lost to Follow-up|1
4570345|NCT01358578|7407691|FG003|Induction Period|Lost to Follow-up|4
4570346|NCT01358578|7407692|FG004|Induction Period|Lost to Follow-up|0
4570347|NCT01358578|7407693|FG005|Induction Period|Lost to Follow-up|0
4570348|NCT01358578|7407688|FG000|Induction Period|Physician Decision|2
4570349|NCT01358578|7407689|FG001|Induction Period|Physician Decision|1
4570350|NCT01358578|7407690|FG002|Induction Period|Physician Decision|2
4570351|NCT01358578|7407691|FG003|Induction Period|Physician Decision|0
4570352|NCT01358578|7407692|FG004|Induction Period|Physician Decision|0
4570353|NCT01358578|7407693|FG005|Induction Period|Physician Decision|0
4570354|NCT01358578|7407688|FG000|Induction Period|Protocol Deviation|3
4570355|NCT01358578|7407689|FG001|Induction Period|Protocol Deviation|5
4570356|NCT01358578|7407690|FG002|Induction Period|Protocol Deviation|0
4570357|NCT01358578|7407691|FG003|Induction Period|Protocol Deviation|3
4570358|NCT01358578|7407692|FG004|Induction Period|Protocol Deviation|0
4570359|NCT01358578|7407693|FG005|Induction Period|Protocol Deviation|0
4570360|NCT01358578|7407688|FG000|Induction Period|technical problems|0
4570361|NCT01358578|7407689|FG001|Induction Period|technical problems|0
4570362|NCT01358578|7407690|FG002|Induction Period|technical problems|1
4570363|NCT01358578|7407691|FG003|Induction Period|technical problems|1
4570364|NCT01358578|7407692|FG004|Induction Period|technical problems|0
4570365|NCT01358578|7407693|FG005|Induction Period|technical problems|0
4570366|NCT01358578|7407688|FG000|Induction Period|Withdrawal by Subject|5
4570367|NCT01358578|7407689|FG001|Induction Period|Withdrawal by Subject|5
4570368|NCT01358578|7407690|FG002|Induction Period|Withdrawal by Subject|10
4570369|NCT01358578|7407691|FG003|Induction Period|Withdrawal by Subject|6
4570370|NCT01358578|7407692|FG004|Induction Period|Withdrawal by Subject|0
4570371|NCT01358578|7407693|FG005|Induction Period|Withdrawal by Subject|0
4570372|NCT01358578|7407688|FG000|Maintenance Period|Adverse Event|2
4570373|NCT01358578|7407689|FG001|Maintenance Period|Adverse Event|7
4570374|NCT01358578|7407690|FG002|Maintenance Period|Adverse Event|0
4570375|NCT01358578|7407691|FG003|Maintenance Period|Adverse Event|6
4570376|NCT01358578|7407692|FG004|Maintenance Period|Adverse Event|4
4570377|NCT01358578|7407693|FG005|Maintenance Period|Adverse Event|3
4570378|NCT01358578|7407688|FG000|Maintenance Period|Lack of Efficacy|10
4570379|NCT01358578|7407689|FG001|Maintenance Period|Lack of Efficacy|2
4570380|NCT01358578|7407690|FG002|Maintenance Period|Lack of Efficacy|0
4570381|NCT01358578|7407691|FG003|Maintenance Period|Lack of Efficacy|11
4570382|NCT01358578|7407692|FG004|Maintenance Period|Lack of Efficacy|3
4570383|NCT01358578|7407693|FG005|Maintenance Period|Lack of Efficacy|0
4570384|NCT01358578|7407688|FG000|Maintenance Period|Lost to Follow-up|4
4570385|NCT01358578|7407689|FG001|Maintenance Period|Lost to Follow-up|0
4570386|NCT01358578|7407690|FG002|Maintenance Period|Lost to Follow-up|0
4570387|NCT01358578|7407691|FG003|Maintenance Period|Lost to Follow-up|5
4570388|NCT01358578|7407692|FG004|Maintenance Period|Lost to Follow-up|1
4570389|NCT01358578|7407693|FG005|Maintenance Period|Lost to Follow-up|1
4570390|NCT01358578|7407688|FG000|Maintenance Period|Non-compliance with study treatment|3
4570391|NCT01358578|7407689|FG001|Maintenance Period|Non-compliance with study treatment|1
4570392|NCT01358578|7407690|FG002|Maintenance Period|Non-compliance with study treatment|0
4570393|NCT01358578|7407691|FG003|Maintenance Period|Non-compliance with study treatment|2
4570394|NCT01358578|7407692|FG004|Maintenance Period|Non-compliance with study treatment|1
4570395|NCT01358578|7407693|FG005|Maintenance Period|Non-compliance with study treatment|2
4570396|NCT01358578|7407688|FG000|Maintenance Period|Physician Decision|0
4570397|NCT01358578|7407689|FG001|Maintenance Period|Physician Decision|1
4570398|NCT01358578|7407690|FG002|Maintenance Period|Physician Decision|0
4570399|NCT01358578|7407691|FG003|Maintenance Period|Physician Decision|1
4570400|NCT01358578|7407692|FG004|Maintenance Period|Physician Decision|0
4570401|NCT01358578|7407693|FG005|Maintenance Period|Physician Decision|0
4570402|NCT01358578|7407688|FG000|Maintenance Period|Pregnancy|1
4570403|NCT01358578|7407689|FG001|Maintenance Period|Pregnancy|0
4570404|NCT01358578|7407690|FG002|Maintenance Period|Pregnancy|0
4570405|NCT01358578|7407691|FG003|Maintenance Period|Pregnancy|0
4570406|NCT01358578|7407692|FG004|Maintenance Period|Pregnancy|0
4570407|NCT01358578|7407693|FG005|Maintenance Period|Pregnancy|0
4570408|NCT01358578|7407688|FG000|Maintenance Period|Protocol deviation|7
4570409|NCT01358578|7407689|FG001|Maintenance Period|Protocol deviation|4
4570410|NCT01358578|7407690|FG002|Maintenance Period|Protocol deviation|0
4570411|NCT01358578|7407691|FG003|Maintenance Period|Protocol deviation|2
4570412|NCT01358578|7407692|FG004|Maintenance Period|Protocol deviation|2
4570413|NCT01358578|7407693|FG005|Maintenance Period|Protocol deviation|2
4570414|NCT01358578|7407688|FG000|Maintenance Period|Withdrawal by Subject|12
4570415|NCT01358578|7407689|FG001|Maintenance Period|Withdrawal by Subject|7
4570416|NCT01358578|7407690|FG002|Maintenance Period|Withdrawal by Subject|2
4570417|NCT01358578|7407691|FG003|Maintenance Period|Withdrawal by Subject|15
4570418|NCT01358578|7407692|FG004|Maintenance Period|Withdrawal by Subject|6
4570419|NCT01358578|7407693|FG005|Maintenance Period|Withdrawal by Subject|3
4570420|NCT01358578|7407688|FG000|Follow-up Period|Adverse Event|1
4570421|NCT01358578|7407689|FG001|Follow-up Period|Adverse Event|1
4570422|NCT01358578|7407690|FG002|Follow-up Period|Adverse Event|0
4570423|NCT01358578|7407691|FG003|Follow-up Period|Adverse Event|0
4570424|NCT01358578|7407692|FG004|Follow-up Period|Adverse Event|0
4570425|NCT01358578|7407693|FG005|Follow-up Period|Adverse Event|0
4570426|NCT01358578|7407688|FG000|Follow-up Period|Lack of Efficacy|3
4570427|NCT01358578|7407689|FG001|Follow-up Period|Lack of Efficacy|0
4570428|NCT01358578|7407690|FG002|Follow-up Period|Lack of Efficacy|4
4570429|NCT01358578|7407691|FG003|Follow-up Period|Lack of Efficacy|1
4570430|NCT01358578|7407692|FG004|Follow-up Period|Lack of Efficacy|0
4570431|NCT01358578|7407693|FG005|Follow-up Period|Lack of Efficacy|0
4570432|NCT01358578|7407688|FG000|Follow-up Period|Lost to Follow-up|0
4570433|NCT01358578|7407689|FG001|Follow-up Period|Lost to Follow-up|1
4570434|NCT01358578|7407690|FG002|Follow-up Period|Lost to Follow-up|0
4570435|NCT01358578|7407691|FG003|Follow-up Period|Lost to Follow-up|4
4570436|NCT01358578|7407692|FG004|Follow-up Period|Lost to Follow-up|0
4570437|NCT01358578|7407693|FG005|Follow-up Period|Lost to Follow-up|0
4570438|NCT01358578|7407688|FG000|Follow-up Period|non- compliance with study treatment|1
4570439|NCT01358578|7407689|FG001|Follow-up Period|non- compliance with study treatment|0
4570440|NCT01358578|7407690|FG002|Follow-up Period|non- compliance with study treatment|0
4570441|NCT01358578|7407691|FG003|Follow-up Period|non- compliance with study treatment|0
4570442|NCT01358578|7407692|FG004|Follow-up Period|non- compliance with study treatment|0
4570443|NCT01358578|7407693|FG005|Follow-up Period|non- compliance with study treatment|0
4570444|NCT01358578|7407688|FG000|Follow-up Period|Pregnancy|1
4570445|NCT01358578|7407689|FG001|Follow-up Period|Pregnancy|0
4570446|NCT01358578|7407690|FG002|Follow-up Period|Pregnancy|0
4570447|NCT01358578|7407691|FG003|Follow-up Period|Pregnancy|0
4570448|NCT01358578|7407692|FG004|Follow-up Period|Pregnancy|0
4570449|NCT01358578|7407693|FG005|Follow-up Period|Pregnancy|0
4570450|NCT01358578|7407688|FG000|Follow-up Period|Withdrawal by Subject|3
4570451|NCT01358578|7407689|FG001|Follow-up Period|Withdrawal by Subject|3
4570452|NCT01358578|7407690|FG002|Follow-up Period|Withdrawal by Subject|1
4570453|NCT01358578|7407691|FG003|Follow-up Period|Withdrawal by Subject|12
4570454|NCT01358578|7407692|FG004|Follow-up Period|Withdrawal by Subject|0
4570455|NCT01358578|7407693|FG005|Follow-up Period|Withdrawal by Subject|0
4570456|NCT01358578|7407688|FG000|Follow-up Period|Physician Decision|1
4570457|NCT01358578|7407689|FG001|Follow-up Period|Physician Decision|1
4570458|NCT01358578|7407690|FG002|Follow-up Period|Physician Decision|0
4570459|NCT01358578|7407691|FG003|Follow-up Period|Physician Decision|2
4570460|NCT01358578|7407692|FG004|Follow-up Period|Physician Decision|0
4570461|NCT01358578|7407693|FG005|Follow-up Period|Physician Decision|0
4570462|NCT01358708|7407723|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2
4570463|NCT01358708|7407724|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0
4570464|NCT01358708|7407723|FG000|Double-Blind Treatment Phase|Protocol Violation|1
4570465|NCT01358708|7407724|FG001|Double-Blind Treatment Phase|Protocol Violation|0
4570466|NCT01358721|7407738|FG000|Overall Study|Withdrawal by Subject|0
4570467|NCT01358721|7407739|FG001|Overall Study|Withdrawal by Subject|0
4570468|NCT01358721|7407740|FG002|Overall Study|Withdrawal by Subject|0
4570469|NCT01358721|7407741|FG003|Overall Study|Withdrawal by Subject|1
4570470|NCT01358721|7407738|FG000|Overall Study|Death|0
4570471|NCT01358721|7407739|FG001|Overall Study|Death|2
4570472|NCT01358721|7407740|FG002|Overall Study|Death|0
4570473|NCT01358721|7407741|FG003|Overall Study|Death|0
4570474|NCT01358721|7407738|FG000|Overall Study|Study Drug Toxicity|1
4570475|NCT01358721|7407739|FG001|Overall Study|Study Drug Toxicity|3
4570476|NCT01358721|7407740|FG002|Overall Study|Study Drug Toxicity|4
4570477|NCT01358721|7407741|FG003|Overall Study|Study Drug Toxicity|5
4570478|NCT01358721|7407738|FG000|Overall Study|SUBJ request to discontinue study TRT|0
4570479|NCT01358721|7407739|FG001|Overall Study|SUBJ request to discontinue study TRT|0
4570480|NCT01358721|7407740|FG002|Overall Study|SUBJ request to discontinue study TRT|0
4570481|NCT01358721|7407741|FG003|Overall Study|SUBJ request to discontinue study TRT|1
4570482|NCT01358721|7407738|FG000|Overall Study|Subject No Longer Meets Study Criteria|0
4570483|NCT01358721|7407739|FG001|Overall Study|Subject No Longer Meets Study Criteria|2
4570484|NCT01358721|7407740|FG002|Overall Study|Subject No Longer Meets Study Criteria|0
4570485|NCT01358721|7407741|FG003|Overall Study|Subject No Longer Meets Study Criteria|1
4570486|NCT01358721|7407738|FG000|Overall Study|Adverse Event related to study drug|1
4570487|NCT01358721|7407739|FG001|Overall Study|Adverse Event related to study drug|0
4570488|NCT01358721|7407740|FG002|Overall Study|Adverse Event related to study drug|0
4570489|NCT01358721|7407741|FG003|Overall Study|Adverse Event related to study drug|1
4570490|NCT01358721|7407738|FG000|Overall Study|Disease Progression|19
4570491|NCT01358721|7407739|FG001|Overall Study|Disease Progression|15
4570492|NCT01358721|7407740|FG002|Overall Study|Disease Progression|17
4570493|NCT01358721|7407741|FG003|Overall Study|Disease Progression|15
4570494|NCT01358721|7407738|FG000|Overall Study|Out of State/Unmet Criteria|0
4570495|NCT01358721|7407739|FG001|Overall Study|Out of State/Unmet Criteria|0
4570496|NCT01358721|7407740|FG002|Overall Study|Out of State/Unmet Criteria|1
4570497|NCT01358721|7407741|FG003|Overall Study|Out of State/Unmet Criteria|0
4570498|NCT01358734|7407754|FG000|Overall Study|Adverse Event|4
4570499|NCT01358734|7407755|FG001|Overall Study|Adverse Event|7
4570500|NCT01358734|7407756|FG002|Overall Study|Adverse Event|3
4570501|NCT01358734|7407754|FG000|Overall Study|Lack of Efficacy|0
4570502|NCT01358734|7407755|FG001|Overall Study|Lack of Efficacy|1
4570503|NCT01358734|7407756|FG002|Overall Study|Lack of Efficacy|3
4570504|NCT01358734|7407754|FG000|Overall Study|Withdrawal by Subject|1
4570505|NCT01358734|7407755|FG001|Overall Study|Withdrawal by Subject|6
4570506|NCT01358734|7407756|FG002|Overall Study|Withdrawal by Subject|3
4570507|NCT01358734|7407754|FG000|Overall Study|Death|3
4570508|NCT01358734|7407755|FG001|Overall Study|Death|7
4570509|NCT01358734|7407756|FG002|Overall Study|Death|2
4570510|NCT01358734|7407754|FG000|Overall Study|Progressive Disease|5
4570511|NCT01358734|7407755|FG001|Overall Study|Progressive Disease|13
4570512|NCT01358734|7407756|FG002|Overall Study|Progressive Disease|16
4570513|NCT01358734|7407754|FG000|Overall Study|Non-compliance with study drug|0
4570514|NCT01358734|7407755|FG001|Overall Study|Non-compliance with study drug|0
4570515|NCT01358734|7407756|FG002|Overall Study|Non-compliance with study drug|1
4570516|NCT01358734|7407754|FG000|Overall Study|Other|2
4570517|NCT01358734|7407755|FG001|Overall Study|Other|5
4570518|NCT01358734|7407756|FG002|Overall Study|Other|4
4570519|NCT01358734|7407754|FG000|Overall Study|Protocol Violation|0
4570520|NCT01358734|7407755|FG001|Overall Study|Protocol Violation|0
4570521|NCT01358734|7407756|FG002|Overall Study|Protocol Violation|2
4570522|NCT01358760|7407767|FG000|Overall Study|Adverse Event|3
4570523|NCT01358760|7407768|FG001|Overall Study|Adverse Event|4
4570524|NCT01358760|7407769|FG002|Overall Study|Adverse Event|3
4570525|NCT01358760|7407767|FG000|Overall Study|Lost to Follow-up|1
4570526|NCT01358760|7407768|FG001|Overall Study|Lost to Follow-up|1
4570527|NCT01358760|7407769|FG002|Overall Study|Lost to Follow-up|3
4570528|NCT01358760|7407767|FG000|Overall Study|Withdrawal by Subject|5
4570529|NCT01358760|7407768|FG001|Overall Study|Withdrawal by Subject|3
4570530|NCT01358760|7407769|FG002|Overall Study|Withdrawal by Subject|2
4570531|NCT01358760|7407767|FG000|Overall Study|Physician Decision|1
4570532|NCT01358760|7407768|FG001|Overall Study|Physician Decision|0
4570533|NCT01358760|7407769|FG002|Overall Study|Physician Decision|1
4570534|NCT01358760|7407767|FG000|Overall Study|Entry criteria not met/Non-compliance|12
4570535|NCT01358760|7407768|FG001|Overall Study|Entry criteria not met/Non-compliance|12
4570536|NCT01358760|7407769|FG002|Overall Study|Entry criteria not met/Non-compliance|16
4570537|NCT01358825|7407779|FG000|Overall Study|Blood sample not drawn|0
4570538|NCT01358825|7407780|FG001|Overall Study|Blood sample not drawn|1
4570539|NCT01358864|7407794|FG000|Overall Study|Adverse Event|0
4570540|NCT01358864|7407795|FG001|Overall Study|Adverse Event|6
4570541|NCT01358864|7407796|FG002|Overall Study|Adverse Event|9
4570542|NCT01358864|7407797|FG003|Overall Study|Adverse Event|0
4570543|NCT01358864|7407798|FG004|Overall Study|Adverse Event|4
4570544|NCT01358864|7407799|FG005|Overall Study|Adverse Event|8
4570545|NCT01358864|7407800|FG006|Overall Study|Adverse Event|12
4570546|NCT01358864|7407801|FG007|Overall Study|Adverse Event|7
4570547|NCT01358864|7407794|FG000|Overall Study|Lack of Efficacy|26
4570548|NCT01358864|7407795|FG001|Overall Study|Lack of Efficacy|3
4570549|NCT01358864|7407796|FG002|Overall Study|Lack of Efficacy|4
4570550|NCT01358864|7407797|FG003|Overall Study|Lack of Efficacy|19
4570551|NCT01358864|7407798|FG004|Overall Study|Lack of Efficacy|7
4570552|NCT01358864|7407799|FG005|Overall Study|Lack of Efficacy|4
4570553|NCT01358864|7407800|FG006|Overall Study|Lack of Efficacy|49
4570554|NCT01358864|7407801|FG007|Overall Study|Lack of Efficacy|44
4570555|NCT01358864|7407794|FG000|Overall Study|Lost to Follow-up|0
4570556|NCT01358864|7407795|FG001|Overall Study|Lost to Follow-up|0
4570557|NCT01358864|7407796|FG002|Overall Study|Lost to Follow-up|1
4570558|NCT01358864|7407797|FG003|Overall Study|Lost to Follow-up|0
4570559|NCT01358864|7407798|FG004|Overall Study|Lost to Follow-up|0
4570560|NCT01358864|7407799|FG005|Overall Study|Lost to Follow-up|0
4570561|NCT01358864|7407800|FG006|Overall Study|Lost to Follow-up|0
4570562|NCT01358864|7407801|FG007|Overall Study|Lost to Follow-up|1
4570563|NCT01358864|7407794|FG000|Overall Study|Withdrawal by Subject|3
4570564|NCT01358864|7407795|FG001|Overall Study|Withdrawal by Subject|4
4570565|NCT01358864|7407796|FG002|Overall Study|Withdrawal by Subject|2
4570566|NCT01358864|7407797|FG003|Overall Study|Withdrawal by Subject|0
4570567|NCT01358864|7407798|FG004|Overall Study|Withdrawal by Subject|0
4570568|NCT01358864|7407799|FG005|Overall Study|Withdrawal by Subject|1
4570569|NCT01358864|7407800|FG006|Overall Study|Withdrawal by Subject|1
4570570|NCT01358864|7407801|FG007|Overall Study|Withdrawal by Subject|3
4570571|NCT01358864|7407794|FG000|Overall Study|Other reason not defined above|2
4570572|NCT01358864|7407795|FG001|Overall Study|Other reason not defined above|0
4570573|NCT01358864|7407796|FG002|Overall Study|Other reason not defined above|0
4570574|NCT01358864|7407797|FG003|Overall Study|Other reason not defined above|0
4570575|NCT01358864|7407798|FG004|Overall Study|Other reason not defined above|0
4570576|NCT01358864|7407799|FG005|Overall Study|Other reason not defined above|0
4570577|NCT01358864|7407800|FG006|Overall Study|Other reason not defined above|2
4570578|NCT01358864|7407801|FG007|Overall Study|Other reason not defined above|0
4570579|NCT01358864|7407794|FG000|Overall Study|Not treated|0
4570580|NCT01358864|7407795|FG001|Overall Study|Not treated|0
4570581|NCT01358864|7407796|FG002|Overall Study|Not treated|0
4570582|NCT01358864|7407797|FG003|Overall Study|Not treated|0
4570583|NCT01358864|7407798|FG004|Overall Study|Not treated|0
4570584|NCT01358864|7407799|FG005|Overall Study|Not treated|0
4570585|NCT01358864|7407800|FG006|Overall Study|Not treated|1
4570586|NCT01358864|7407801|FG007|Overall Study|Not treated|0
4570587|NCT01358968|7407821|FG000|Period 2|Adverse Event|0
4570588|NCT01358968|7407822|FG001|Period 2|Adverse Event|1
4570589|NCT01358968|7407823|FG002|Period 2|Adverse Event|0
4570590|NCT01358968|7407824|FG003|Period 2|Adverse Event|0
4570591|NCT01358968|7407821|FG000|Continued Access Phase|Progression of Disease|0
4570592|NCT01358968|7407822|FG001|Continued Access Phase|Progression of Disease|0
4570593|NCT01358968|7407823|FG002|Continued Access Phase|Progression of Disease|8
4570594|NCT01358968|7407824|FG003|Continued Access Phase|Progression of Disease|4
4570595|NCT01358968|7407821|FG000|Continued Access Phase|Protocol Violation|0
4570596|NCT01358968|7407822|FG001|Continued Access Phase|Protocol Violation|0
4570597|NCT01358968|7407823|FG002|Continued Access Phase|Protocol Violation|0
4570598|NCT01358968|7407824|FG003|Continued Access Phase|Protocol Violation|2
4570599|NCT01358968|7407821|FG000|Continued Access Phase|Withdrawal by Subject|0
4570600|NCT01358968|7407822|FG001|Continued Access Phase|Withdrawal by Subject|0
4570601|NCT01358968|7407823|FG002|Continued Access Phase|Withdrawal by Subject|3
4570602|NCT01358968|7407824|FG003|Continued Access Phase|Withdrawal by Subject|0
4570603|NCT01358968|7407821|FG000|Continued Access Phase|Death|0
4570604|NCT01358968|7407822|FG001|Continued Access Phase|Death|0
4570605|NCT01358968|7407823|FG002|Continued Access Phase|Death|1
4570606|NCT01358968|7407824|FG003|Continued Access Phase|Death|1
4570607|NCT01358981|7407841|FG000|Period 1|Withdrawal by Subject|0
4570608|NCT01358981|7407842|FG001|Period 1|Withdrawal by Subject|0
4570609|NCT01358981|7407843|FG002|Period 1|Withdrawal by Subject|0
4570610|NCT01358981|7407844|FG003|Period 1|Withdrawal by Subject|1
4570611|NCT01358981|7407845|FG004|Period 1|Withdrawal by Subject|0
4570612|NCT01358981|7407846|FG005|Period 1|Withdrawal by Subject|0
4570613|NCT01358981|7407847|FG006|Period 1|Withdrawal by Subject|0
4570614|NCT01359046|7407879|FG000|Overall Study|Did not receive allocated intervention|6
4570615|NCT01359046|7407880|FG001|Overall Study|Did not receive allocated intervention|6
4570616|NCT01359046|7407879|FG000|Overall Study|Physician Decision|1
4570617|NCT01359046|7407880|FG001|Overall Study|Physician Decision|11
4570618|NCT01359150|7407894|FG000|Overall Study|Lack of Efficacy|1
4570619|NCT01359150|7407895|FG001|Overall Study|Lack of Efficacy|1
4570620|NCT01359150|7407894|FG000|Overall Study|Withdrawal by Subject|1
4570621|NCT01359150|7407895|FG001|Overall Study|Withdrawal by Subject|1
4570622|NCT01359150|7407894|FG000|Overall Study|Adverse Event|4
4570623|NCT01359150|7407895|FG001|Overall Study|Adverse Event|3
4570624|NCT01359150|7407894|FG000|Overall Study|Other|1
4570625|NCT01359150|7407895|FG001|Overall Study|Other|0
4570626|NCT01359449|7407921|FG000|Overall Study|Lost to Follow-up|1
4570627|NCT01359449|7407922|FG001|Overall Study|Lost to Follow-up|0
4570628|NCT01359449|7407921|FG000|Overall Study|Protocol Violation|0
4570629|NCT01359449|7407922|FG001|Overall Study|Protocol Violation|2
4570630|NCT01359449|7407921|FG000|Overall Study|Withdrawal by Subject|3
4570631|NCT01359449|7407922|FG001|Overall Study|Withdrawal by Subject|2
4570632|NCT01359592|7407928|FG000|Initial Registration|Adverse Event|1
4570633|NCT01359592|7407929|FG001|Initial Registration|Adverse Event|0
4570634|NCT01359592|7407930|FG002|Initial Registration|Adverse Event|0
4570635|NCT01359592|7407931|FG003|Initial Registration|Adverse Event|0
4570636|NCT01359592|7407928|FG000|Initial Registration|Death|1
4570637|NCT01359592|7407929|FG001|Initial Registration|Death|0
4570638|NCT01359592|7407930|FG002|Initial Registration|Death|0
4570639|NCT01359592|7407931|FG003|Initial Registration|Death|0
4570640|NCT01359592|7407928|FG000|Initial Registration|Other reason not protocol specified|1
4570641|NCT01359592|7407929|FG001|Initial Registration|Other reason not protocol specified|0
4570642|NCT01359592|7407930|FG002|Initial Registration|Other reason not protocol specified|0
4570643|NCT01359592|7407931|FG003|Initial Registration|Other reason not protocol specified|0
4570644|NCT01359592|7407928|FG000|Initial Registration|Ineligible|26
4570645|NCT01359592|7407929|FG001|Initial Registration|Ineligible|0
4570646|NCT01359592|7407930|FG002|Initial Registration|Ineligible|0
4570647|NCT01359592|7407931|FG003|Initial Registration|Ineligible|0
4570648|NCT01359592|7407928|FG000|PET-Directed Therapy|Adverse Event|0
4570649|NCT01359592|7407929|FG001|PET-Directed Therapy|Adverse Event|0
4570650|NCT01359592|7407930|FG002|PET-Directed Therapy|Adverse Event|1
4570651|NCT01359592|7407931|FG003|PET-Directed Therapy|Adverse Event|0
4570652|NCT01359592|7407928|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0
4570653|NCT01359592|7407929|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0
4570654|NCT01359592|7407930|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1
4570655|NCT01359592|7407931|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0
4570656|NCT01359592|7407928|FG000|PET-Directed Therapy|Ineligible|0
4570657|NCT01359592|7407929|FG001|PET-Directed Therapy|Ineligible|0
4570658|NCT01359592|7407930|FG002|PET-Directed Therapy|Ineligible|24
4570659|NCT01359592|7407931|FG003|PET-Directed Therapy|Ineligible|0
4570660|NCT01359644|7407956|FG000|Treatment Period|Lack of Efficacy|0
4570661|NCT01359644|7407957|FG001|Treatment Period|Lack of Efficacy|1
4570662|NCT01359644|7407958|FG002|Treatment Period|Lack of Efficacy|0
4570663|NCT01359644|7407959|FG003|Treatment Period|Lack of Efficacy|0
4570664|NCT01359644|7407960|FG004|Treatment Period|Lack of Efficacy|0
4570665|NCT01359644|7407961|FG005|Treatment Period|Lack of Efficacy|0
4570666|NCT01359644|7407962|FG006|Treatment Period|Lack of Efficacy|0
4570667|NCT01359644|7407963|FG007|Treatment Period|Lack of Efficacy|0
4570668|NCT01359644|7407964|FG008|Treatment Period|Lack of Efficacy|0
4570669|NCT01359644|7407965|FG009|Treatment Period|Lack of Efficacy|0
4570670|NCT01359644|7407956|FG000|Treatment Period|Adverse Event|0
4570671|NCT01359644|7407957|FG001|Treatment Period|Adverse Event|0
4570672|NCT01359644|7407958|FG002|Treatment Period|Adverse Event|1
4570673|NCT01359644|7407959|FG003|Treatment Period|Adverse Event|0
4570674|NCT01359644|7407960|FG004|Treatment Period|Adverse Event|0
4570675|NCT01359644|7407961|FG005|Treatment Period|Adverse Event|1
4570676|NCT01359644|7407962|FG006|Treatment Period|Adverse Event|0
4570677|NCT01359644|7407963|FG007|Treatment Period|Adverse Event|0
4570678|NCT01359644|7407964|FG008|Treatment Period|Adverse Event|0
4570679|NCT01359644|7407965|FG009|Treatment Period|Adverse Event|0
4570680|NCT01359644|7407956|FG000|Treatment Period|Lost to Follow-up|0
4570681|NCT01359644|7407957|FG001|Treatment Period|Lost to Follow-up|0
4570682|NCT01359644|7407958|FG002|Treatment Period|Lost to Follow-up|0
4570683|NCT01359644|7407959|FG003|Treatment Period|Lost to Follow-up|0
4570684|NCT01359644|7407960|FG004|Treatment Period|Lost to Follow-up|0
4570685|NCT01359644|7407961|FG005|Treatment Period|Lost to Follow-up|1
4570686|NCT01359644|7407962|FG006|Treatment Period|Lost to Follow-up|0
4570687|NCT01359644|7407963|FG007|Treatment Period|Lost to Follow-up|0
4570688|NCT01359644|7407964|FG008|Treatment Period|Lost to Follow-up|0
4570689|NCT01359644|7407965|FG009|Treatment Period|Lost to Follow-up|0
4570690|NCT01359644|7407956|FG000|Follow-up Period|Withdrawal by Subject|0
4570691|NCT01359644|7407957|FG001|Follow-up Period|Withdrawal by Subject|0
4570692|NCT01359644|7407958|FG002|Follow-up Period|Withdrawal by Subject|0
4570693|NCT01359644|7407959|FG003|Follow-up Period|Withdrawal by Subject|0
4570694|NCT01359644|7407960|FG004|Follow-up Period|Withdrawal by Subject|0
4570695|NCT01359644|7407961|FG005|Follow-up Period|Withdrawal by Subject|1
4570696|NCT01359644|7407962|FG006|Follow-up Period|Withdrawal by Subject|0
4570697|NCT01359644|7407963|FG007|Follow-up Period|Withdrawal by Subject|0
4570698|NCT01359644|7407964|FG008|Follow-up Period|Withdrawal by Subject|0
4570699|NCT01359644|7407965|FG009|Follow-up Period|Withdrawal by Subject|0
4570700|NCT01359644|7407956|FG000|Follow-up Period|Lost to Follow-up|0
4570701|NCT01359644|7407957|FG001|Follow-up Period|Lost to Follow-up|0
4570702|NCT01359644|7407958|FG002|Follow-up Period|Lost to Follow-up|0
4570703|NCT01359644|7407959|FG003|Follow-up Period|Lost to Follow-up|0
4570704|NCT01359644|7407960|FG004|Follow-up Period|Lost to Follow-up|0
4570705|NCT01359644|7407961|FG005|Follow-up Period|Lost to Follow-up|0
4570706|NCT01359644|7407962|FG006|Follow-up Period|Lost to Follow-up|1
4570707|NCT01359644|7407963|FG007|Follow-up Period|Lost to Follow-up|2
4570708|NCT01359644|7407964|FG008|Follow-up Period|Lost to Follow-up|0
4570709|NCT01359644|7407965|FG009|Follow-up Period|Lost to Follow-up|0
4570710|NCT01359904|7408024|FG000|Overall Study|Withdrawal by Subject|1
4570711|NCT01359904|7408025|FG001|Overall Study|Withdrawal by Subject|0
4570712|NCT01359943|7408034|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1
4570713|NCT01359943|7408035|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0
4570714|NCT01359943|7408036|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0
4570715|NCT01359943|7408034|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1
4570716|NCT01359943|7408035|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2
4570717|NCT01359943|7408036|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0
4570718|NCT01359943|7408034|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0
4570719|NCT01359943|7408035|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2
4570720|NCT01359943|7408036|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0
4570721|NCT01359943|7408034|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1
4570722|NCT01359943|7408035|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0
4570723|NCT01359943|7408036|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0
4570724|NCT01359943|7408034|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1
4570725|NCT01359943|7408035|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3
4570726|NCT01359943|7408036|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4
4570727|NCT01359943|7408034|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0
4570728|NCT01359943|7408035|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1
4570729|NCT01359943|7408036|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0
4570730|NCT01359943|7408034|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
4570731|NCT01359943|7408035|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
4570732|NCT01359943|7408036|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
4570733|NCT01359943|7408034|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0
4625847|NCT01832727|7490872|FG003|Overall Study|Lost to Follow-up|1
4625848|NCT01832727|7490873|FG004|Overall Study|Lost to Follow-up|0
4625849|NCT01832727|7490874|FG005|Overall Study|Lost to Follow-up|0
4625850|NCT01832727|7490875|FG006|Overall Study|Lost to Follow-up|0
4625851|NCT01832727|7490876|FG007|Overall Study|Lost to Follow-up|0
4625852|NCT01832727|7490877|FG008|Overall Study|Lost to Follow-up|0
4625853|NCT01832727|7490869|FG000|Overall Study|Physician Decision|1
4625854|NCT01832727|7490870|FG001|Overall Study|Physician Decision|0
4625855|NCT01832727|7490871|FG002|Overall Study|Physician Decision|0
4625856|NCT01832727|7490872|FG003|Overall Study|Physician Decision|1
4625857|NCT01832727|7490873|FG004|Overall Study|Physician Decision|0
4570734|NCT01359943|7408035|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1
4570735|NCT01359943|7408036|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0
4570736|NCT01359943|7408034|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3
4570737|NCT01359943|7408035|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5
4625858|NCT01832727|7490874|FG005|Overall Study|Physician Decision|1
4625859|NCT01832727|7490875|FG006|Overall Study|Physician Decision|0
4570738|NCT01359943|7408036|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1
4570739|NCT01359943|7408034|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1
4570740|NCT01359943|7408035|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5
4570741|NCT01359943|7408036|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4
4570742|NCT01359943|7408034|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1
4570743|NCT01359943|7408035|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0
4570744|NCT01359943|7408036|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0
4570745|NCT01359943|7408034|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0
4570746|NCT01359943|7408035|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1
4570747|NCT01359943|7408036|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0
4570748|NCT01359943|7408034|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
4570749|NCT01359943|7408035|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
4570750|NCT01359943|7408036|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
4570751|NCT01359943|7408034|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0
4570752|NCT01359943|7408035|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1
4570753|NCT01359943|7408036|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0
4570754|NCT01359943|7408034|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3
4570755|NCT01359943|7408035|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5
4570756|NCT01359943|7408036|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1
4570757|NCT01359956|7408050|FG000|Overall Study|Death|61
4570758|NCT01359956|7408051|FG001|Overall Study|Death|64
4570759|NCT01359956|7408052|FG002|Overall Study|Death|67
4570760|NCT01359956|7408053|FG003|Overall Study|Death|58
4570761|NCT01360021|7408066|FG000|Overall Study|Eligibility criteria + other|2
4570762|NCT01360021|7408067|FG001|Overall Study|Eligibility criteria + other|1
4570763|NCT01360021|7408068|FG002|Overall Study|Eligibility criteria + other|1
4570764|NCT01360021|7408066|FG000|Overall Study|Protocol Violation|0
4570765|NCT01360021|7408067|FG001|Overall Study|Protocol Violation|0
4570766|NCT01360021|7408068|FG002|Overall Study|Protocol Violation|1
4570767|NCT01360021|7408066|FG000|Overall Study|Withdrawal by Subject|4
4570768|NCT01360021|7408067|FG001|Overall Study|Withdrawal by Subject|0
4570769|NCT01360021|7408068|FG002|Overall Study|Withdrawal by Subject|2
4570770|NCT01360021|7408066|FG000|Overall Study|Adverse Event|2
4570771|NCT01360021|7408067|FG001|Overall Study|Adverse Event|3
4570772|NCT01360021|7408068|FG002|Overall Study|Adverse Event|3
4570773|NCT01360398|7408085|FG000|Overall Study|Withdrawal by Subject|14
4570774|NCT01360398|7408085|FG000|Overall Study|Other|7
4570775|NCT01360398|7408085|FG000|Overall Study|Migrated/moved from study area|1
4570776|NCT01360554|7408101|FG000|Overall Study|Death|359
4570777|NCT01360554|7408102|FG001|Overall Study|Death|371
4570778|NCT01360554|7408101|FG000|Overall Study|Lost to Follow-up|4
4570779|NCT01360554|7408102|FG001|Overall Study|Lost to Follow-up|4
4570780|NCT01360554|7408101|FG000|Overall Study|Withdrawal by Subject|23
4570781|NCT01360554|7408102|FG001|Overall Study|Withdrawal by Subject|24
4570782|NCT01360554|7408101|FG000|Overall Study|Study terminated by sponsor|49
4570783|NCT01360554|7408102|FG001|Overall Study|Study terminated by sponsor|37
4570784|NCT01360554|7408101|FG000|Overall Study|Other, not specified|1
4570785|NCT01360554|7408102|FG001|Overall Study|Other, not specified|0
4570786|NCT01360554|7408101|FG000|Overall Study|Randomized but not treated.|3
4570787|NCT01360554|7408102|FG001|Overall Study|Randomized but not treated.|3
4570788|NCT01360632|7408111|FG000|Phase A (8 Weeks)|Lost to Follow-up|27
4570789|NCT01360632|7408112|FG001|Phase A (8 Weeks)|Lost to Follow-up|0
4570790|NCT01360632|7408113|FG002|Phase A (8 Weeks)|Lost to Follow-up|0
4570791|NCT01360632|7408114|FG003|Phase A (8 Weeks)|Lost to Follow-up|0
4570792|NCT01360632|7408115|FG004|Phase A (8 Weeks)|Lost to Follow-up|0
4570793|NCT01360632|7408111|FG000|Phase A (8 Weeks)|Adverse Event|60
4625860|NCT01832727|7490876|FG007|Overall Study|Physician Decision|0
4570794|NCT01360632|7408112|FG001|Phase A (8 Weeks)|Adverse Event|0
4570795|NCT01360632|7408113|FG002|Phase A (8 Weeks)|Adverse Event|0
4570796|NCT01360632|7408114|FG003|Phase A (8 Weeks)|Adverse Event|0
4570797|NCT01360632|7408115|FG004|Phase A (8 Weeks)|Adverse Event|0
4570798|NCT01360632|7408111|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45
4570799|NCT01360632|7408112|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0
4570800|NCT01360632|7408113|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0
4625861|NCT01832727|7490877|FG008|Overall Study|Physician Decision|0
4570801|NCT01360632|7408114|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0
4570802|NCT01360632|7408115|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0
4570803|NCT01360632|7408111|FG000|Phase A (8 Weeks)|Physician Decision|10
4570804|NCT01360632|7408112|FG001|Phase A (8 Weeks)|Physician Decision|0
4570805|NCT01360632|7408113|FG002|Phase A (8 Weeks)|Physician Decision|0
4570806|NCT01360632|7408114|FG003|Phase A (8 Weeks)|Physician Decision|0
4570807|NCT01360632|7408115|FG004|Phase A (8 Weeks)|Physician Decision|0
4570808|NCT01360632|7408111|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74
4570809|NCT01360632|7408112|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0
4570810|NCT01360632|7408113|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0
4570811|NCT01360632|7408114|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0
4570812|NCT01360632|7408115|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0
4570813|NCT01360632|7408111|FG000|Phase A (8 Weeks)|Protocol Deviation|39
4570814|NCT01360632|7408112|FG001|Phase A (8 Weeks)|Protocol Deviation|0
4570815|NCT01360632|7408113|FG002|Phase A (8 Weeks)|Protocol Deviation|0
4570816|NCT01360632|7408114|FG003|Phase A (8 Weeks)|Protocol Deviation|0
4570817|NCT01360632|7408115|FG004|Phase A (8 Weeks)|Protocol Deviation|0
4570818|NCT01360632|7408111|FG000|Phase B (6 Weeks)|Lost to Follow-up|0
4570819|NCT01360632|7408112|FG001|Phase B (6 Weeks)|Lost to Follow-up|1
4570820|NCT01360632|7408113|FG002|Phase B (6 Weeks)|Lost to Follow-up|1
4570821|NCT01360632|7408114|FG003|Phase B (6 Weeks)|Lost to Follow-up|0
4570822|NCT01360632|7408115|FG004|Phase B (6 Weeks)|Lost to Follow-up|0
4570823|NCT01360632|7408111|FG000|Phase B (6 Weeks)|Adverse Event|0
4570824|NCT01360632|7408112|FG001|Phase B (6 Weeks)|Adverse Event|3
4570825|NCT01360632|7408113|FG002|Phase B (6 Weeks)|Adverse Event|9
4570826|NCT01360632|7408114|FG003|Phase B (6 Weeks)|Adverse Event|3
4570827|NCT01360632|7408115|FG004|Phase B (6 Weeks)|Adverse Event|0
4570828|NCT01360632|7408111|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0
4570829|NCT01360632|7408112|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0
4570830|NCT01360632|7408113|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2
4570831|NCT01360632|7408114|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1
4570832|NCT01360632|7408115|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0
4570833|NCT01360632|7408111|FG000|Phase B (6 Weeks)|Physician Decision|0
4570834|NCT01360632|7408112|FG001|Phase B (6 Weeks)|Physician Decision|0
4570835|NCT01360632|7408113|FG002|Phase B (6 Weeks)|Physician Decision|0
4570836|NCT01360632|7408114|FG003|Phase B (6 Weeks)|Physician Decision|1
4570837|NCT01360632|7408115|FG004|Phase B (6 Weeks)|Physician Decision|0
4570838|NCT01360632|7408111|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0
4570839|NCT01360632|7408112|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4
4570840|NCT01360632|7408113|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4
4570841|NCT01360632|7408114|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7
4570842|NCT01360632|7408115|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0
4570843|NCT01360632|7408111|FG000|Phase B (6 Weeks)|Protocol Deviation|0
4570844|NCT01360632|7408112|FG001|Phase B (6 Weeks)|Protocol Deviation|1
4570845|NCT01360632|7408113|FG002|Phase B (6 Weeks)|Protocol Deviation|4
4570846|NCT01360632|7408114|FG003|Phase B (6 Weeks)|Protocol Deviation|1
4570847|NCT01360632|7408115|FG004|Phase B (6 Weeks)|Protocol Deviation|0
4570848|NCT01360632|7408111|FG000|Phase B (6 Weeks)|Lack of Efficacy|0
4570849|NCT01360632|7408112|FG001|Phase B (6 Weeks)|Lack of Efficacy|1
4570850|NCT01360632|7408113|FG002|Phase B (6 Weeks)|Lack of Efficacy|0
4570851|NCT01360632|7408114|FG003|Phase B (6 Weeks)|Lack of Efficacy|0
4570852|NCT01360632|7408115|FG004|Phase B (6 Weeks)|Lack of Efficacy|0
4570853|NCT01360632|7408111|FG000|Phase A+|Lost to Follow-up|0
4570854|NCT01360632|7408112|FG001|Phase A+|Lost to Follow-up|0
4570855|NCT01360632|7408113|FG002|Phase A+|Lost to Follow-up|0
4570856|NCT01360632|7408114|FG003|Phase A+|Lost to Follow-up|0
4570857|NCT01360632|7408115|FG004|Phase A+|Lost to Follow-up|2
4570858|NCT01360632|7408111|FG000|Phase A+|Adverse Event|0
4570859|NCT01360632|7408112|FG001|Phase A+|Adverse Event|0
4570860|NCT01360632|7408113|FG002|Phase A+|Adverse Event|0
4570861|NCT01360632|7408114|FG003|Phase A+|Adverse Event|0
4570862|NCT01360632|7408115|FG004|Phase A+|Adverse Event|2
4570863|NCT01360632|7408111|FG000|Phase A+|Met Withdrawal Criteria|0
4570864|NCT01360632|7408112|FG001|Phase A+|Met Withdrawal Criteria|0
4570865|NCT01360632|7408113|FG002|Phase A+|Met Withdrawal Criteria|0
4570866|NCT01360632|7408114|FG003|Phase A+|Met Withdrawal Criteria|0
4570867|NCT01360632|7408115|FG004|Phase A+|Met Withdrawal Criteria|7
4570868|NCT01360632|7408111|FG000|Phase A+|Physician Decision|0
4570869|NCT01360632|7408112|FG001|Phase A+|Physician Decision|0
4570870|NCT01360632|7408113|FG002|Phase A+|Physician Decision|0
4570871|NCT01360632|7408114|FG003|Phase A+|Physician Decision|0
4570872|NCT01360632|7408115|FG004|Phase A+|Physician Decision|3
4570873|NCT01360632|7408111|FG000|Phase A+|Withdrawal by Subject|0
4570874|NCT01360632|7408112|FG001|Phase A+|Withdrawal by Subject|0
4570875|NCT01360632|7408113|FG002|Phase A+|Withdrawal by Subject|0
4570876|NCT01360632|7408114|FG003|Phase A+|Withdrawal by Subject|0
4570877|NCT01360632|7408115|FG004|Phase A+|Withdrawal by Subject|8
4570878|NCT01360632|7408111|FG000|Phase A+|Protocol Deviation|0
4570879|NCT01360632|7408112|FG001|Phase A+|Protocol Deviation|0
4570880|NCT01360632|7408113|FG002|Phase A+|Protocol Deviation|0
4570881|NCT01360632|7408114|FG003|Phase A+|Protocol Deviation|0
4570882|NCT01360632|7408115|FG004|Phase A+|Protocol Deviation|3
4570883|NCT01360645|7408125|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16
4570884|NCT01360645|7408126|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
4570885|NCT01360645|7408127|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
4570886|NCT01360645|7408128|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
4570887|NCT01360645|7408125|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19
4570888|NCT01360645|7408126|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
4570889|NCT01360645|7408127|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
4570890|NCT01360645|7408128|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
4570891|NCT01360645|7408125|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16
4570892|NCT01360645|7408126|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
4570893|NCT01360645|7408127|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
4570894|NCT01360645|7408128|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
4570895|NCT01360645|7408125|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34
4570896|NCT01360645|7408126|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
4570897|NCT01360645|7408127|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
4570898|NCT01360645|7408128|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
4570899|NCT01360645|7408125|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24
4570900|NCT01360645|7408126|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
4570901|NCT01360645|7408127|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
4570902|NCT01360645|7408128|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
4570903|NCT01360645|7408125|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5
4570904|NCT01360645|7408126|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
4570905|NCT01360645|7408127|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
4570906|NCT01360645|7408128|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
4570907|NCT01360645|7408125|FG000|Phase B (6 Weeks)|Lost to Follow-up|0
4570908|NCT01360645|7408126|FG001|Phase B (6 Weeks)|Lost to Follow-up|1
4570909|NCT01360645|7408127|FG002|Phase B (6 Weeks)|Lost to Follow-up|0
4570910|NCT01360645|7408128|FG003|Phase B (6 Weeks)|Lost to Follow-up|0
4570911|NCT01360645|7408125|FG000|Phase B (6 Weeks)|Adverse Event|0
4570912|NCT01360645|7408126|FG001|Phase B (6 Weeks)|Adverse Event|6
4570913|NCT01360645|7408127|FG002|Phase B (6 Weeks)|Adverse Event|0
4570914|NCT01360645|7408128|FG003|Phase B (6 Weeks)|Adverse Event|0
4570915|NCT01360645|7408125|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0
4570916|NCT01360645|7408126|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3
4570917|NCT01360645|7408127|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2
4570918|NCT01360645|7408128|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0
4570919|NCT01360645|7408125|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0
4570920|NCT01360645|7408126|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3
4570921|NCT01360645|7408127|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8
4570922|NCT01360645|7408128|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0
4570923|NCT01360645|7408125|FG000|Phase B (6 Weeks)|Protocol Deviation|0
4570924|NCT01360645|7408126|FG001|Phase B (6 Weeks)|Protocol Deviation|1
4570925|NCT01360645|7408127|FG002|Phase B (6 Weeks)|Protocol Deviation|3
4570926|NCT01360645|7408128|FG003|Phase B (6 Weeks)|Protocol Deviation|0
4570927|NCT01360645|7408125|FG000|Phase A+|Lost to Follow-up|0
4570928|NCT01360645|7408126|FG001|Phase A+|Lost to Follow-up|0
4570929|NCT01360645|7408127|FG002|Phase A+|Lost to Follow-up|0
4570930|NCT01360645|7408128|FG003|Phase A+|Lost to Follow-up|7
4570931|NCT01360645|7408125|FG000|Phase A+|Adverse Event|0
4570932|NCT01360645|7408126|FG001|Phase A+|Adverse Event|0
4570933|NCT01360645|7408127|FG002|Phase A+|Adverse Event|0
4570934|NCT01360645|7408128|FG003|Phase A+|Adverse Event|2
4570935|NCT01360645|7408125|FG000|Phase A+|Met Withdrawal Criteria|0
4570936|NCT01360645|7408126|FG001|Phase A+|Met Withdrawal Criteria|0
4570937|NCT01360645|7408127|FG002|Phase A+|Met Withdrawal Criteria|0
4570938|NCT01360645|7408128|FG003|Phase A+|Met Withdrawal Criteria|4
4570939|NCT01360645|7408125|FG000|Phase A+|Physician Decision|0
4570940|NCT01360645|7408126|FG001|Phase A+|Physician Decision|0
4570941|NCT01360645|7408127|FG002|Phase A+|Physician Decision|0
4570942|NCT01360645|7408128|FG003|Phase A+|Physician Decision|2
4570943|NCT01360645|7408125|FG000|Phase A+|Withdrawal by Subject|0
4570944|NCT01360645|7408126|FG001|Phase A+|Withdrawal by Subject|0
4570945|NCT01360645|7408127|FG002|Phase A+|Withdrawal by Subject|0
4570946|NCT01360645|7408128|FG003|Phase A+|Withdrawal by Subject|5
4570947|NCT01360645|7408125|FG000|Phase A+|Protocol Deviation|0
4570948|NCT01360645|7408126|FG001|Phase A+|Protocol Deviation|0
4570949|NCT01360645|7408127|FG002|Phase A+|Protocol Deviation|0
4570950|NCT01360645|7408128|FG003|Phase A+|Protocol Deviation|4
4570951|NCT01360762|7408134|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7
4570952|NCT01360762|7408134|FG000|Main Study Period (12-month Treatment)|Death|5
4570953|NCT01360762|7408134|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1
4570954|NCT01360762|7408134|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15
4570955|NCT01360762|7408134|FG000|Main Study Period (12-month Treatment)|Discontinuation|1
4570956|NCT01360762|7408134|FG000|Whole Study Period|Lost to Follow-up|10
4570957|NCT01360762|7408134|FG000|Whole Study Period|Death|7
4570958|NCT01360762|7408134|FG000|Whole Study Period|Patient relapsed|18
4570959|NCT01360762|7408134|FG000|Whole Study Period|Discontinuation of study drug for safety|1
4570960|NCT01360840|7408141|FG000|Overall Study|Ongoing at data cut-off|10
4570961|NCT01360840|7408142|FG001|Overall Study|Ongoing at data cut-off|10
4570962|NCT01360840|7408143|FG002|Overall Study|Ongoing at data cut-off|9
4570963|NCT01360866|7408157|FG000|Overall Study|Lost to Follow-up|11
4570964|NCT01360866|7408158|FG001|Overall Study|Lost to Follow-up|28
4570965|NCT01360866|7408159|FG002|Overall Study|Lost to Follow-up|41
4570966|NCT01360866|7408160|FG003|Overall Study|Lost to Follow-up|0
4570967|NCT01360866|7408157|FG000|Overall Study|Adverse Event|56
4570968|NCT01360866|7408158|FG001|Overall Study|Adverse Event|61
4570969|NCT01360866|7408159|FG002|Overall Study|Adverse Event|134
4570970|NCT01360866|7408160|FG003|Overall Study|Adverse Event|6
4570971|NCT01360866|7408157|FG000|Overall Study|Paticipant met withdrawal criteria|11
4570972|NCT01360866|7408158|FG001|Overall Study|Paticipant met withdrawal criteria|28
4570973|NCT01360866|7408159|FG002|Overall Study|Paticipant met withdrawal criteria|54
4570974|NCT01360866|7408160|FG003|Overall Study|Paticipant met withdrawal criteria|0
4570975|NCT01360866|7408157|FG000|Overall Study|Withdrawn by Investigator|9
4570976|NCT01360866|7408158|FG001|Overall Study|Withdrawn by Investigator|8
4570977|NCT01360866|7408159|FG002|Overall Study|Withdrawn by Investigator|31
4570978|NCT01360866|7408160|FG003|Overall Study|Withdrawn by Investigator|2
4570979|NCT01360866|7408157|FG000|Overall Study|Withdrawal by participant|79
4570980|NCT01360866|7408158|FG001|Overall Study|Withdrawal by participant|89
4570981|NCT01360866|7408159|FG002|Overall Study|Withdrawal by participant|168
4570982|NCT01360866|7408160|FG003|Overall Study|Withdrawal by participant|8
4570983|NCT01360866|7408157|FG000|Overall Study|Protocol Deviation|25
4570984|NCT01360866|7408158|FG001|Overall Study|Protocol Deviation|33
4570985|NCT01360866|7408159|FG002|Overall Study|Protocol Deviation|61
4570986|NCT01360866|7408160|FG003|Overall Study|Protocol Deviation|2
4570987|NCT01360866|7408157|FG000|Overall Study|Lack of Efficacy|30
4570988|NCT01360866|7408158|FG001|Overall Study|Lack of Efficacy|40
4570989|NCT01360866|7408159|FG002|Overall Study|Lack of Efficacy|30
4570990|NCT01360866|7408160|FG003|Overall Study|Lack of Efficacy|4
4570991|NCT01360996|7408173|FG000|Overall Study|Withdrawal by Subject|4
4570992|NCT01360996|7408174|FG001|Overall Study|Withdrawal by Subject|3
4570993|NCT01360996|7408175|FG002|Overall Study|Withdrawal by Subject|2
4570994|NCT01360996|7408173|FG000|Overall Study|Noncompliant|2
4570995|NCT01360996|7408174|FG001|Overall Study|Noncompliant|0
4570996|NCT01360996|7408175|FG002|Overall Study|Noncompliant|0
4570997|NCT01361009|7408182|FG000|Overall Study|Protocol Violation|116
4570998|NCT01361126|7408210|FG000|Overall Study|Sponsor decision|0
4570999|NCT01361126|7408211|FG001|Overall Study|Sponsor decision|2
4571000|NCT01361178|7408220|FG000|Overall Study|Death|13
4571001|NCT01361178|7408221|FG001|Overall Study|Death|0
4571002|NCT01361308|7408235|FG000|Overall Study|Withdrawal by Subject|9
4571003|NCT01361308|7408236|FG001|Overall Study|Withdrawal by Subject|13
4571004|NCT01361308|7408235|FG000|Overall Study|Physician Decision|3
4571005|NCT01361308|7408236|FG001|Overall Study|Physician Decision|3
4571006|NCT01361308|7408235|FG000|Overall Study|Lack of Efficacy|2
4571007|NCT01361308|7408236|FG001|Overall Study|Lack of Efficacy|0
4571008|NCT01361308|7408235|FG000|Overall Study|Protocol Violation|1
4571009|NCT01361308|7408236|FG001|Overall Study|Protocol Violation|0
4571010|NCT01361308|7408235|FG000|Overall Study|Lost to Follow-up|5
4571011|NCT01361308|7408236|FG001|Overall Study|Lost to Follow-up|4
4571012|NCT01361308|7408235|FG000|Overall Study|Adverse Event|8
4571013|NCT01361308|7408236|FG001|Overall Study|Adverse Event|4
4571014|NCT01361308|7408235|FG000|Overall Study|Eligibility Criteria Not Met|2
4571015|NCT01361308|7408236|FG001|Overall Study|Eligibility Criteria Not Met|3
4571016|NCT01361308|7408235|FG000|Overall Study|Failed C-SSRS|5
4571017|NCT01361308|7408236|FG001|Overall Study|Failed C-SSRS|2
4571018|NCT01361308|7408235|FG000|Overall Study|Other|0
4571019|NCT01361308|7408236|FG001|Overall Study|Other|1
4571020|NCT01361464|7408242|FG000|Overall Study|Death|1
4571021|NCT01361464|7408242|FG000|Overall Study|Withdrawal by Subject|2
4571022|NCT01361568|7408252|FG000|Overall Study|Adverse Event|0
4571023|NCT01361568|7408253|FG001|Overall Study|Adverse Event|0
4571024|NCT01361568|7408254|FG002|Overall Study|Adverse Event|0
4571025|NCT01361568|7408255|FG003|Overall Study|Adverse Event|0
4571026|NCT01361568|7408256|FG004|Overall Study|Adverse Event|1
4571027|NCT01361568|7408257|FG005|Overall Study|Adverse Event|0
4571028|NCT01361568|7408252|FG000|Overall Study|Physician Decision|0
4571029|NCT01361568|7408253|FG001|Overall Study|Physician Decision|0
4571030|NCT01361568|7408254|FG002|Overall Study|Physician Decision|0
4571031|NCT01361568|7408255|FG003|Overall Study|Physician Decision|0
4571032|NCT01361568|7408256|FG004|Overall Study|Physician Decision|0
4571033|NCT01361568|7408257|FG005|Overall Study|Physician Decision|1
4571034|NCT01361568|7408252|FG000|Overall Study|Withdrawal by Subject|2
4571035|NCT01361568|7408253|FG001|Overall Study|Withdrawal by Subject|1
4571036|NCT01361568|7408254|FG002|Overall Study|Withdrawal by Subject|0
4571037|NCT01361568|7408255|FG003|Overall Study|Withdrawal by Subject|0
4571038|NCT01361568|7408256|FG004|Overall Study|Withdrawal by Subject|0
4571039|NCT01361568|7408257|FG005|Overall Study|Withdrawal by Subject|1
4571040|NCT01361594|7408274|FG000|Overall Study|Withdrawal by Subject|1
4571041|NCT01361594|7408275|FG001|Overall Study|Withdrawal by Subject|2
4571042|NCT01361607|7408283|FG000|Overall Study|Adverse Event|38
4571043|NCT01361607|7408284|FG001|Overall Study|Adverse Event|29
4571044|NCT01361607|7408283|FG000|Overall Study|Withdrawal by Subject|19
4571045|NCT01361607|7408284|FG001|Overall Study|Withdrawal by Subject|8
4571046|NCT01361607|7408283|FG000|Overall Study|Withdrawal by Investigator|5
4571047|NCT01361607|7408284|FG001|Overall Study|Withdrawal by Investigator|3
4571048|NCT01361607|7408283|FG000|Overall Study|Lost to Follow-up|1
4571049|NCT01361607|7408284|FG001|Overall Study|Lost to Follow-up|0
4571050|NCT01361607|7408283|FG000|Overall Study|Met Withdrawal Criteria|1
4571051|NCT01361607|7408284|FG001|Overall Study|Met Withdrawal Criteria|1
4571052|NCT01361711|7408306|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1
4571053|NCT01361711|7408306|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1
4571054|NCT01361711|7408306|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7
4571055|NCT01361711|7408306|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2
4571056|NCT01361711|7408306|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1
4571057|NCT01361711|7408306|FG000|Completed Week 18 of Treatment|Complete Remission|2
4571058|NCT01361711|7408306|FG000|Completed Week 18 of Treatment|Other|9
4571059|NCT01361711|7408306|FG000|10 Year Follow-up|Still in follow-up|22
4571060|NCT01361711|7408306|FG000|10 Year Follow-up|Death|7
4571061|NCT01361711|7408306|FG000|10 Year Follow-up|Developed new cancer|1
4571062|NCT01361711|7408306|FG000|10 Year Follow-up|Lost to Follow-up|2
4571063|NCT01361711|7408306|FG000|10 Year Follow-up|New treatment started|6
4571064|NCT01361711|7408306|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11
4571065|NCT01361711|7408306|FG000|10 Year Follow-up|Progressive Disease|1
4592783|NCT01544582|7440733|FG003|Analysis Population|Intolerance|0
4592784|NCT01544582|7440730|FG000|Analysis Population|Liver Transplantation|0
4592785|NCT01544582|7440731|FG001|Analysis Population|Liver Transplantation|0
4592786|NCT01544582|7440732|FG002|Analysis Population|Liver Transplantation|1
4592787|NCT01544582|7440733|FG003|Analysis Population|Liver Transplantation|0
4592788|NCT01544582|7440730|FG000|Analysis Population|No Social Insurance|0
4592789|NCT01544582|7440731|FG001|Analysis Population|No Social Insurance|0
4592790|NCT01544582|7440732|FG002|Analysis Population|No Social Insurance|1
4592791|NCT01544582|7440733|FG003|Analysis Population|No Social Insurance|0
4592792|NCT01544582|7440730|FG000|Analysis Population|Poor Adherence|0
4592793|NCT01544582|7440731|FG001|Analysis Population|Poor Adherence|0
4592794|NCT01544582|7440732|FG002|Analysis Population|Poor Adherence|1
4592795|NCT01544582|7440733|FG003|Analysis Population|Poor Adherence|0
4592796|NCT01544582|7440730|FG000|Analysis Population|Poor Participant Compliance|0
4592797|NCT01544582|7440731|FG001|Analysis Population|Poor Participant Compliance|1
4592798|NCT01544582|7440732|FG002|Analysis Population|Poor Participant Compliance|0
4592799|NCT01544582|7440733|FG003|Analysis Population|Poor Participant Compliance|0
4592800|NCT01544582|7440730|FG000|Analysis Population|Programmed Surgery|0
4592801|NCT01544582|7440731|FG001|Analysis Population|Programmed Surgery|1
4592802|NCT01544582|7440732|FG002|Analysis Population|Programmed Surgery|0
4592803|NCT01544582|7440733|FG003|Analysis Population|Programmed Surgery|0
4592804|NCT01544582|7440730|FG000|Analysis Population|Participant in Jail|0
4592805|NCT01544582|7440731|FG001|Analysis Population|Participant in Jail|0
4592806|NCT01544582|7440732|FG002|Analysis Population|Participant in Jail|1
4592807|NCT01544582|7440733|FG003|Analysis Population|Participant in Jail|0
4592808|NCT01544595|7440752|FG000|Status at Week 68|Adverse Event|3
4592809|NCT01544595|7440753|FG001|Status at Week 68|Adverse Event|2
4592810|NCT01544595|7440754|FG002|Status at Week 68|Adverse Event|1
4592811|NCT01544595|7440755|FG003|Status at Week 68|Adverse Event|0
4592812|NCT01544595|7440756|FG004|Status at Week 68|Adverse Event|0
4592813|NCT01544595|7440757|FG005|Status at Week 68|Adverse Event|0
4592814|NCT01544595|7440752|FG000|Status at Week 68|Lack of Efficacy|1
4592815|NCT01544595|7440753|FG001|Status at Week 68|Lack of Efficacy|0
4592816|NCT01544595|7440754|FG002|Status at Week 68|Lack of Efficacy|0
4592817|NCT01544595|7440755|FG003|Status at Week 68|Lack of Efficacy|0
4592818|NCT01544595|7440756|FG004|Status at Week 68|Lack of Efficacy|0
4592819|NCT01544595|7440757|FG005|Status at Week 68|Lack of Efficacy|0
4592820|NCT01544595|7440752|FG000|Status at Week 68|Lost to Follow-up|1
4592821|NCT01544595|7440753|FG001|Status at Week 68|Lost to Follow-up|1
4592822|NCT01544595|7440754|FG002|Status at Week 68|Lost to Follow-up|0
4592823|NCT01544595|7440755|FG003|Status at Week 68|Lost to Follow-up|0
4592824|NCT01544595|7440756|FG004|Status at Week 68|Lost to Follow-up|0
4592825|NCT01544595|7440757|FG005|Status at Week 68|Lost to Follow-up|0
4592826|NCT01544595|7440752|FG000|Status at Week 68|Non-compliance with study treatment|1
4625862|NCT01832727|7490869|FG000|Overall Study|Withdrawal by Subject|1
4625863|NCT01832727|7490870|FG001|Overall Study|Withdrawal by Subject|1
4625864|NCT01832727|7490871|FG002|Overall Study|Withdrawal by Subject|0
4625865|NCT01832727|7490872|FG003|Overall Study|Withdrawal by Subject|1
4625866|NCT01832727|7490873|FG004|Overall Study|Withdrawal by Subject|0
4625867|NCT01832727|7490874|FG005|Overall Study|Withdrawal by Subject|1
4625868|NCT01832727|7490875|FG006|Overall Study|Withdrawal by Subject|0
4625869|NCT01832727|7490876|FG007|Overall Study|Withdrawal by Subject|2
4592827|NCT01544595|7440753|FG001|Status at Week 68|Non-compliance with study treatment|0
4592828|NCT01544595|7440754|FG002|Status at Week 68|Non-compliance with study treatment|0
4592829|NCT01544595|7440755|FG003|Status at Week 68|Non-compliance with study treatment|1
4592830|NCT01544595|7440756|FG004|Status at Week 68|Non-compliance with study treatment|0
4592831|NCT01544595|7440757|FG005|Status at Week 68|Non-compliance with study treatment|0
4592832|NCT01544595|7440752|FG000|Status at Week 68|Protocol Violation|2
4592833|NCT01544595|7440753|FG001|Status at Week 68|Protocol Violation|0
4592834|NCT01544595|7440754|FG002|Status at Week 68|Protocol Violation|1
4571066|NCT01361919|7408324|FG000|Overall Study|technical issues|10
4571067|NCT01361919|7408325|FG001|Overall Study|technical issues|12
4571068|NCT01361919|7408326|FG002|Overall Study|technical issues|10
4571069|NCT01362049|7408338|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3
4571070|NCT01362049|7408339|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3
4571071|NCT01362049|7408340|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2
4571072|NCT01362049|7408341|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1
4571073|NCT01362049|7408338|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5
4571074|NCT01362049|7408339|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3
4571075|NCT01362049|7408340|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2
4571076|NCT01362049|7408341|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3
4571077|NCT01362062|7408357|FG000|Overall Study|Adverse Event|1
4571078|NCT01362062|7408358|FG001|Overall Study|Adverse Event|0
4571079|NCT01362062|7408357|FG000|Overall Study|Lost to Follow-up|11
4571080|NCT01362062|7408358|FG001|Overall Study|Lost to Follow-up|0
4571081|NCT01362062|7408357|FG000|Overall Study|Withdrawal by Subject|2
4571082|NCT01362062|7408358|FG001|Overall Study|Withdrawal by Subject|0
4571083|NCT01362062|7408357|FG000|Overall Study|Non-compliant participant|2
4571084|NCT01362062|7408358|FG001|Overall Study|Non-compliant participant|0
4571085|NCT01362062|7408357|FG000|Overall Study|Detected with Spondylo-arthritis|1
4571086|NCT01362062|7408358|FG001|Overall Study|Detected with Spondylo-arthritis|0
4571087|NCT01362062|7408357|FG000|Overall Study|Had significant improvement|9
4571088|NCT01362062|7408358|FG001|Overall Study|Had significant improvement|0
4571089|NCT01362140|7408374|FG000|Overall Study|Noncompliance|1
4571090|NCT01362140|7408375|FG001|Overall Study|Noncompliance|0
4571091|NCT01362140|7408374|FG000|Overall Study|Adverse Event|2
4571092|NCT01362140|7408375|FG001|Overall Study|Adverse Event|2
4571093|NCT01362140|7408374|FG000|Overall Study|Withdrawal by Subject|3
4571094|NCT01362140|7408375|FG001|Overall Study|Withdrawal by Subject|3
4571095|NCT01362140|7408374|FG000|Overall Study|Administrative Decision|0
4571096|NCT01362140|7408375|FG001|Overall Study|Administrative Decision|1
4571097|NCT01362140|7408374|FG000|Overall Study|Death|2
4571098|NCT01362140|7408375|FG001|Overall Study|Death|1
4571099|NCT01362140|7408374|FG000|Overall Study|Other|1
4571100|NCT01362140|7408375|FG001|Overall Study|Other|1
4571101|NCT01362140|7408374|FG000|Overall Study|Protocol-specified Criteria|1
4571102|NCT01362140|7408375|FG001|Overall Study|Protocol-specified Criteria|2
4571103|NCT01362140|7408374|FG000|Overall Study|Discontinued Without Receiving Treatment|0
4571104|NCT01362140|7408375|FG001|Overall Study|Discontinued Without Receiving Treatment|1
4571105|NCT01362244|7408396|FG000|Overall Study|Adverse Event|3
4571106|NCT01362244|7408397|FG001|Overall Study|Adverse Event|5
4571107|NCT01362244|7408396|FG000|Overall Study|Lack of Efficacy|5
4571108|NCT01362244|7408397|FG001|Overall Study|Lack of Efficacy|11
4571109|NCT01362244|7408396|FG000|Overall Study|Lost to Follow-up|0
4571110|NCT01362244|7408397|FG001|Overall Study|Lost to Follow-up|2
4571111|NCT01362244|7408396|FG000|Overall Study|Protocol Violation|5
4571112|NCT01362244|7408397|FG001|Overall Study|Protocol Violation|1
4571113|NCT01362244|7408396|FG000|Overall Study|Withdrawal by Subject|2
4571114|NCT01362244|7408397|FG001|Overall Study|Withdrawal by Subject|1
4571115|NCT01362244|7408396|FG000|Overall Study|Did not Meet Continuation Criteria|17
4571116|NCT01362244|7408397|FG001|Overall Study|Did not Meet Continuation Criteria|11
4571117|NCT01362244|7408396|FG000|Overall Study|Protocol Defined Stopping Criteria|0
4571118|NCT01362244|7408397|FG001|Overall Study|Protocol Defined Stopping Criteria|1
4571119|NCT01362270|7408405|FG000|Overall Study|Withdrawal by Subject|1
4571120|NCT01362270|7408406|FG001|Overall Study|Withdrawal by Subject|0
4571121|NCT01362270|7408405|FG000|Overall Study|Met exclusion criteria after 1st session|0
4625870|NCT01832727|7490877|FG008|Overall Study|Withdrawal by Subject|1
4625871|NCT01832727|7490869|FG000|Overall Study|Study terminated by sponsor|0
4625872|NCT01832727|7490870|FG001|Overall Study|Study terminated by sponsor|0
4625873|NCT01832727|7490871|FG002|Overall Study|Study terminated by sponsor|0
4625874|NCT01832727|7490872|FG003|Overall Study|Study terminated by sponsor|0
4625875|NCT01832727|7490873|FG004|Overall Study|Study terminated by sponsor|0
4625876|NCT01832727|7490874|FG005|Overall Study|Study terminated by sponsor|0
4625877|NCT01832727|7490875|FG006|Overall Study|Study terminated by sponsor|0
4625878|NCT01832727|7490876|FG007|Overall Study|Study terminated by sponsor|1
4625879|NCT01832727|7490877|FG008|Overall Study|Study terminated by sponsor|1
4625880|NCT01832766|7490920|FG000|Washout|Lost to Follow-up|0
4625881|NCT01832766|7490921|FG001|Washout|Lost to Follow-up|1
4625882|NCT01832818|7490927|FG000|Overall Study|Lost to Follow-up|6
4625883|NCT01833065|7490959|FG000|Overall Study|Adverse Event|6
4571122|NCT01362270|7408406|FG001|Overall Study|Met exclusion criteria after 1st session|1
4571123|NCT01362270|7408405|FG000|Overall Study|Met excl. criteria before 1st session|1
4571124|NCT01362270|7408406|FG001|Overall Study|Met excl. criteria before 1st session|1
4571125|NCT01362296|7408414|FG000|Randomized Phase (RP)|PD including Death due to PD|56
4571126|NCT01362296|7408415|FG001|Randomized Phase (RP)|PD including Death due to PD|28
4571127|NCT01362296|7408416|FG002|Randomized Phase (RP)|PD including Death due to PD|0
4571128|NCT01362296|7408417|FG003|Randomized Phase (RP)|PD including Death due to PD|0
4571129|NCT01362296|7408414|FG000|Randomized Phase (RP)|Physician Decision|1
4571130|NCT01362296|7408415|FG001|Randomized Phase (RP)|Physician Decision|9
4571131|NCT01362296|7408416|FG002|Randomized Phase (RP)|Physician Decision|0
4571132|NCT01362296|7408417|FG003|Randomized Phase (RP)|Physician Decision|0
4571133|NCT01362296|7408414|FG000|Randomized Phase (RP)|Withdrawal by Subject|2
4571134|NCT01362296|7408415|FG001|Randomized Phase (RP)|Withdrawal by Subject|1
4571135|NCT01362296|7408416|FG002|Randomized Phase (RP)|Withdrawal by Subject|0
4571136|NCT01362296|7408417|FG003|Randomized Phase (RP)|Withdrawal by Subject|0
4571137|NCT01362296|7408414|FG000|Randomized Phase (RP)|Adverse Event|20
4571138|NCT01362296|7408415|FG001|Randomized Phase (RP)|Adverse Event|4
4571139|NCT01362296|7408416|FG002|Randomized Phase (RP)|Adverse Event|0
4571140|NCT01362296|7408417|FG003|Randomized Phase (RP)|Adverse Event|0
4571141|NCT01362296|7408414|FG000|Randomized Phase (RP)|Study Closed/Terminated|8
4571142|NCT01362296|7408415|FG001|Randomized Phase (RP)|Study Closed/Terminated|1
4571143|NCT01362296|7408416|FG002|Randomized Phase (RP)|Study Closed/Terminated|0
4571144|NCT01362296|7408417|FG003|Randomized Phase (RP)|Study Closed/Terminated|0
4571145|NCT01362296|7408414|FG000|Crossover Phase|PD including Death due to PD|0
4571146|NCT01362296|7408415|FG001|Crossover Phase|PD including Death due to PD|0
4571147|NCT01362296|7408416|FG002|Crossover Phase|PD including Death due to PD|16
4571148|NCT01362296|7408417|FG003|Crossover Phase|PD including Death due to PD|1
4571149|NCT01362296|7408414|FG000|Crossover Phase|Withdrawal by Subject|0
4571150|NCT01362296|7408415|FG001|Crossover Phase|Withdrawal by Subject|0
4571151|NCT01362296|7408416|FG002|Crossover Phase|Withdrawal by Subject|2
4571152|NCT01362296|7408417|FG003|Crossover Phase|Withdrawal by Subject|1
4571153|NCT01362296|7408414|FG000|Crossover Phase|Adverse Event|0
4571154|NCT01362296|7408415|FG001|Crossover Phase|Adverse Event|0
4571155|NCT01362296|7408416|FG002|Crossover Phase|Adverse Event|4
4625884|NCT01833065|7490960|FG001|Overall Study|Adverse Event|1
4625885|NCT01833065|7490961|FG002|Overall Study|Adverse Event|0
4625886|NCT01833065|7490962|FG003|Overall Study|Adverse Event|2
4625887|NCT01833065|7490963|FG004|Overall Study|Adverse Event|3
4625888|NCT01833065|7490959|FG000|Overall Study|Protocol Violation|1
4625889|NCT01833065|7490960|FG001|Overall Study|Protocol Violation|0
4625890|NCT01833065|7490961|FG002|Overall Study|Protocol Violation|0
4625891|NCT01833065|7490962|FG003|Overall Study|Protocol Violation|0
4625892|NCT01833065|7490963|FG004|Overall Study|Protocol Violation|2
4625893|NCT01833065|7490959|FG000|Overall Study|Lost to Follow-up|1
4625894|NCT01833065|7490960|FG001|Overall Study|Lost to Follow-up|0
4625895|NCT01833065|7490961|FG002|Overall Study|Lost to Follow-up|0
4625896|NCT01833065|7490962|FG003|Overall Study|Lost to Follow-up|0
4625897|NCT01833065|7490963|FG004|Overall Study|Lost to Follow-up|3
4625898|NCT01833065|7490959|FG000|Overall Study|Withdrawal by Subject|6
4625899|NCT01833065|7490960|FG001|Overall Study|Withdrawal by Subject|2
4625900|NCT01833065|7490961|FG002|Overall Study|Withdrawal by Subject|4
4625901|NCT01833065|7490962|FG003|Overall Study|Withdrawal by Subject|3
4625902|NCT01833065|7490963|FG004|Overall Study|Withdrawal by Subject|11
4625903|NCT01833065|7490959|FG000|Overall Study|Subject's substantial non-compliance|0
4625904|NCT01833065|7490960|FG001|Overall Study|Subject's substantial non-compliance|1
4625905|NCT01833065|7490961|FG002|Overall Study|Subject's substantial non-compliance|0
4625906|NCT01833065|7490962|FG003|Overall Study|Subject's substantial non-compliance|0
4625907|NCT01833065|7490963|FG004|Overall Study|Subject's substantial non-compliance|0
4625908|NCT01833065|7490959|FG000|Overall Study|Trial terminated by sponsor|8
4625909|NCT01833065|7490960|FG001|Overall Study|Trial terminated by sponsor|8
4625910|NCT01833065|7490961|FG002|Overall Study|Trial terminated by sponsor|7
4625911|NCT01833065|7490962|FG003|Overall Study|Trial terminated by sponsor|3
4625912|NCT01833065|7490963|FG004|Overall Study|Trial terminated by sponsor|13
4625913|NCT01833065|7490959|FG000|Overall Study|Others|2
4625914|NCT01833065|7490960|FG001|Overall Study|Others|1
4625915|NCT01833065|7490961|FG002|Overall Study|Others|1
4625916|NCT01833065|7490962|FG003|Overall Study|Others|1
4625917|NCT01833065|7490963|FG004|Overall Study|Others|4
4625918|NCT01833143|7490995|FG000|Overall Study|Not Treated|1
4625919|NCT01833169|7490999|FG000|Overall Study|Disease Progression|99
4625920|NCT01833169|7490999|FG000|Overall Study|Adverse Event|33
4625921|NCT01833169|7490999|FG000|Overall Study|Withdrawal by Subject|9
4625922|NCT01833169|7490999|FG000|Overall Study|Death|3
4625923|NCT01833169|7490999|FG000|Overall Study|Physician Decision|2
4625924|NCT01833455|7491014|FG000|Overall Study|Withdrawal by Subject|1
4625925|NCT01833455|7491015|FG001|Overall Study|Withdrawal by Subject|0
4625926|NCT01833494|7491046|FG000|Overall Study|Adverse Event|24
4625927|NCT01833494|7491046|FG000|Overall Study|Physician Decision|6
4625928|NCT01833494|7491046|FG000|Overall Study|Withdrawal by Subject|6
4625929|NCT01833494|7491046|FG000|Overall Study|Decrease in serum phosphorus|4
4625930|NCT01833494|7491046|FG000|Overall Study|Decrease in serum calcium|4
4625931|NCT01833494|7491046|FG000|Overall Study|Increase in serum ferritin|1
4625932|NCT01833520|7491052|FG000|Overall Study|Lack of Efficacy|3
4625933|NCT01833520|7491053|FG001|Overall Study|Lack of Efficacy|3
4571156|NCT01362296|7408417|FG003|Crossover Phase|Adverse Event|0
4571157|NCT01362296|7408414|FG000|Crossover Phase|Study Closed/Terminated|0
4571158|NCT01362296|7408415|FG001|Crossover Phase|Study Closed/Terminated|0
4571159|NCT01362296|7408416|FG002|Crossover Phase|Study Closed/Terminated|1
4625934|NCT01833520|7491054|FG002|Overall Study|Lack of Efficacy|8
4625935|NCT01833520|7491055|FG003|Overall Study|Lack of Efficacy|3
4625936|NCT01833533|7491069|FG000|Overall Study|Adverse Event|0
4625937|NCT01833533|7491070|FG001|Overall Study|Adverse Event|1
4625938|NCT01833533|7491069|FG000|Overall Study|Lost to Follow-up|4
4625939|NCT01833533|7491070|FG001|Overall Study|Lost to Follow-up|9
4571160|NCT01362296|7408417|FG003|Crossover Phase|Study Closed/Terminated|0
4571161|NCT01362322|7408429|FG000|Overall Study|Withdrawal by Subject|3
4571162|NCT01362322|7408430|FG001|Overall Study|Withdrawal by Subject|1
4571163|NCT01362322|7408429|FG000|Overall Study|Lost to Follow-up|2
4571164|NCT01362322|7408430|FG001|Overall Study|Lost to Follow-up|6
4571165|NCT01362348|7408436|FG000|Overall Study|Protocol-defined stopping criteria|9
4571166|NCT01362348|7408436|FG000|Overall Study|Study closed/terminated|5
4571167|NCT01362439|7408440|FG000|Overall Study|Adverse Event|1
4571168|NCT01362439|7408440|FG000|Overall Study|Lack of Efficacy|3
4571169|NCT01362439|7408440|FG000|Overall Study|Lost to Follow-up|2
4571170|NCT01362439|7408440|FG000|Overall Study|Study medication non-compliant|1
4571171|NCT01362439|7408440|FG000|Overall Study|Participant who withdrew consent|8
4571172|NCT01362491|7408448|FG000|Overall Study|Ineligible|1
4571173|NCT01362491|7408449|FG001|Overall Study|Ineligible|0
4571174|NCT01362491|7408450|FG002|Overall Study|Ineligible|0
4571175|NCT01362517|7408459|FG000|Overall Study|Protocol Violation|1
4571176|NCT01362517|7408459|FG000|Overall Study|Lost to Follow-up|1
4571177|NCT01362530|7408468|FG000|Base Study (Cycle 1)|Adverse Event|2
4571178|NCT01362530|7408469|FG001|Base Study (Cycle 1)|Adverse Event|0
4571179|NCT01362530|7408468|FG000|Base Study (Cycle 1)|Physician Decision|0
4571180|NCT01362530|7408469|FG001|Base Study (Cycle 1)|Physician Decision|1
4571181|NCT01362530|7408468|FG000|Base Study (Cycle 1)|Protocol Violation|2
4571182|NCT01362530|7408469|FG001|Base Study (Cycle 1)|Protocol Violation|0
4571183|NCT01362530|7408468|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1
4571184|NCT01362530|7408469|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2
4571185|NCT01362530|7408468|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2
4571186|NCT01362530|7408469|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0
4571187|NCT01362530|7408468|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51
4571188|NCT01362530|7408469|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0
4571189|NCT01362530|7408468|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25
4625940|NCT01833533|7491069|FG000|Overall Study|To Enter an Extension Study|0
4625941|NCT01833533|7491070|FG001|Overall Study|To Enter an Extension Study|4
4625942|NCT01833533|7491069|FG000|Overall Study|Other|2
4625943|NCT01833533|7491070|FG001|Overall Study|Other|7
4625944|NCT01833832|7491111|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1
4625945|NCT01833897|7491119|FG000|Overall Study|Lack of Efficacy|1
4625946|NCT01834222|7491153|FG000|Overall Study|Not meet inclusion/exclusion criteria|1
4625947|NCT01834274|7491168|FG000|Overall Study|Study Termination|41
4625948|NCT01834274|7491169|FG001|Overall Study|Study Termination|38
4625949|NCT01834274|7491168|FG000|Overall Study|Withdrawal by Subject|1
4625950|NCT01834274|7491169|FG001|Overall Study|Withdrawal by Subject|1
4625951|NCT01834274|7491168|FG000|Overall Study|Lost to Follow-up|3
4625952|NCT01834274|7491169|FG001|Overall Study|Lost to Follow-up|1
4625953|NCT01834274|7491168|FG000|Overall Study|Other|2
4625954|NCT01834274|7491169|FG001|Overall Study|Other|1
4625955|NCT01834586|7491193|FG000|Overall Study|Adverse Event|1
4625956|NCT01834729|7491216|FG000|Overall Study|Did not return bowel diaries|0
4625957|NCT01834729|7491217|FG001|Overall Study|Did not return bowel diaries|0
4625958|NCT01834729|7491218|FG002|Overall Study|Did not return bowel diaries|3
4625959|NCT01834729|7491219|FG003|Overall Study|Did not return bowel diaries|0
4625960|NCT01834729|7491216|FG000|Overall Study|Withdrawal by Subject|1
4625961|NCT01834729|7491217|FG001|Overall Study|Withdrawal by Subject|1
4625962|NCT01834729|7491218|FG002|Overall Study|Withdrawal by Subject|0
4625963|NCT01834729|7491219|FG003|Overall Study|Withdrawal by Subject|0
4625964|NCT01834729|7491216|FG000|Overall Study|Adverse Event|0
4625965|NCT01834729|7491217|FG001|Overall Study|Adverse Event|0
4625966|NCT01834729|7491218|FG002|Overall Study|Adverse Event|0
4625967|NCT01834729|7491219|FG003|Overall Study|Adverse Event|2
4625968|NCT01835015|7491235|FG000|Overall Study|Adverse Event|0
4625969|NCT01835015|7491236|FG001|Overall Study|Adverse Event|0
4625970|NCT01835015|7491237|FG002|Overall Study|Adverse Event|1
4625971|NCT01835015|7491238|FG003|Overall Study|Adverse Event|0
4625972|NCT01835015|7491239|FG004|Overall Study|Adverse Event|0
4625973|NCT01835132|7491252|FG000|Initial Phase|Insufficient Therapeutic Response|2
4625974|NCT01835158|7491258|FG000|Overall Study|Withdrawal by Subject|1
4625975|NCT01835158|7491259|FG001|Overall Study|Withdrawal by Subject|6
4625976|NCT01835223|7491267|FG000|Overall Study|Adverse Event|1
4625977|NCT01835223|7491268|FG001|Overall Study|Adverse Event|0
4625978|NCT01835223|7491267|FG000|Overall Study|Withdrawal by Subject|2
4625979|NCT01835223|7491268|FG001|Overall Study|Withdrawal by Subject|0
4625980|NCT01835223|7491267|FG000|Overall Study|Disease progression|2
4625981|NCT01835223|7491268|FG001|Overall Study|Disease progression|1
4625982|NCT01835223|7491267|FG000|Overall Study|Became Inelligible|4
4571190|NCT01362530|7408469|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0
4571191|NCT01362530|7408468|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4
4571192|NCT01362530|7408469|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0
4571193|NCT01362530|7408468|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1
4571194|NCT01362530|7408469|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0
4571195|NCT01362530|7408468|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1
4625983|NCT01835223|7491268|FG001|Overall Study|Became Inelligible|0
4625984|NCT01835431|7491296|FG000|Overall Study|Adverse Event|1
4571196|NCT01362530|7408469|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0
4571197|NCT01362530|7408468|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19
4571198|NCT01362530|7408469|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0
4571199|NCT01362530|7408468|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4
4571200|NCT01362530|7408469|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0
4571201|NCT01362530|7408468|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18
4571202|NCT01362530|7408469|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0
4571203|NCT01362608|7408478|FG000|Overall Study|Protocol Violation|0
4571204|NCT01362608|7408479|FG001|Overall Study|Protocol Violation|1
4571205|NCT01362608|7408478|FG000|Overall Study|Lost to Follow-up|3
4571206|NCT01362608|7408479|FG001|Overall Study|Lost to Follow-up|1
4571207|NCT01362608|7408478|FG000|Overall Study|Withdrawal by Subject|1
4571208|NCT01362608|7408479|FG001|Overall Study|Withdrawal by Subject|2
4571209|NCT01362608|7408478|FG000|Overall Study|Lack of Efficacy|0
4571210|NCT01362608|7408479|FG001|Overall Study|Lack of Efficacy|2
4571211|NCT01362608|7408478|FG000|Overall Study|Adverse Event|0
4571212|NCT01362608|7408479|FG001|Overall Study|Adverse Event|2
4571213|NCT01362790|7408504|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1
4571214|NCT01362790|7408505|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
4571215|NCT01362790|7408506|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
4571216|NCT01362790|7408507|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
4571217|NCT01362790|7408508|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
4571218|NCT01362790|7408509|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
4571219|NCT01362790|7408510|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
4571220|NCT01362790|7408504|FG000|Pilot Phase & Phase 2|Adverse Event|0
4571221|NCT01362790|7408505|FG001|Pilot Phase & Phase 2|Adverse Event|1
4571222|NCT01362790|7408506|FG002|Pilot Phase & Phase 2|Adverse Event|0
4571223|NCT01362790|7408507|FG003|Pilot Phase & Phase 2|Adverse Event|1
4571224|NCT01362790|7408508|FG004|Pilot Phase & Phase 2|Adverse Event|0
4571225|NCT01362790|7408509|FG005|Pilot Phase & Phase 2|Adverse Event|2
4571226|NCT01362790|7408510|FG006|Pilot Phase & Phase 2|Adverse Event|0
4571227|NCT01362790|7408504|FG000|Pilot Phase & Phase 2|Physician Decision|0
4571228|NCT01362790|7408505|FG001|Pilot Phase & Phase 2|Physician Decision|0
4571229|NCT01362790|7408506|FG002|Pilot Phase & Phase 2|Physician Decision|0
4571230|NCT01362790|7408507|FG003|Pilot Phase & Phase 2|Physician Decision|1
4571231|NCT01362790|7408508|FG004|Pilot Phase & Phase 2|Physician Decision|0
4571232|NCT01362790|7408509|FG005|Pilot Phase & Phase 2|Physician Decision|0
4571233|NCT01362790|7408510|FG006|Pilot Phase & Phase 2|Physician Decision|0
4571234|NCT01362790|7408504|FG000|Pilot Phase & Phase 2|Developed antibodies|7
4571235|NCT01362790|7408505|FG001|Pilot Phase & Phase 2|Developed antibodies|2
4571236|NCT01362790|7408506|FG002|Pilot Phase & Phase 2|Developed antibodies|3
4571237|NCT01362790|7408507|FG003|Pilot Phase & Phase 2|Developed antibodies|8
4571238|NCT01362790|7408508|FG004|Pilot Phase & Phase 2|Developed antibodies|0
4571239|NCT01362790|7408509|FG005|Pilot Phase & Phase 2|Developed antibodies|0
4571240|NCT01362790|7408510|FG006|Pilot Phase & Phase 2|Developed antibodies|0
4571241|NCT01362790|7408504|FG000|Pilot Phase & Phase 2|Refused further treatment|0
4571242|NCT01362790|7408505|FG001|Pilot Phase & Phase 2|Refused further treatment|1
4571243|NCT01362790|7408506|FG002|Pilot Phase & Phase 2|Refused further treatment|0
4571244|NCT01362790|7408507|FG003|Pilot Phase & Phase 2|Refused further treatment|0
4571245|NCT01362790|7408508|FG004|Pilot Phase & Phase 2|Refused further treatment|0
4571246|NCT01362790|7408509|FG005|Pilot Phase & Phase 2|Refused further treatment|0
4571247|NCT01362790|7408510|FG006|Pilot Phase & Phase 2|Refused further treatment|0
4571248|NCT01362790|7408504|FG000|Pilot Phase & Phase 2|Progressive disease|1
4571249|NCT01362790|7408505|FG001|Pilot Phase & Phase 2|Progressive disease|2
4571250|NCT01362790|7408506|FG002|Pilot Phase & Phase 2|Progressive disease|2
4571251|NCT01362790|7408507|FG003|Pilot Phase & Phase 2|Progressive disease|3
4571252|NCT01362790|7408508|FG004|Pilot Phase & Phase 2|Progressive disease|0
4571253|NCT01362790|7408509|FG005|Pilot Phase & Phase 2|Progressive disease|2
4571254|NCT01362790|7408510|FG006|Pilot Phase & Phase 2|Progressive disease|0
4571255|NCT01362790|7408504|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1
4571256|NCT01362790|7408505|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
4571257|NCT01362790|7408506|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
4571258|NCT01362790|7408507|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
4571259|NCT01362790|7408508|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
4571260|NCT01362790|7408509|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
4571261|NCT01362790|7408510|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
4571262|NCT01362790|7408504|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
4571263|NCT01362790|7408505|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2
4571264|NCT01362790|7408506|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
4571265|NCT01362790|7408507|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
4571266|NCT01362790|7408508|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
4571267|NCT01362790|7408509|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
4571268|NCT01362790|7408510|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
4571269|NCT01362790|7408504|FG000|Pilot Phase & Phase 2|Death on study|0
4571270|NCT01362790|7408505|FG001|Pilot Phase & Phase 2|Death on study|0
4571271|NCT01362790|7408506|FG002|Pilot Phase & Phase 2|Death on study|0
4571272|NCT01362790|7408507|FG003|Pilot Phase & Phase 2|Death on study|1
4571273|NCT01362790|7408508|FG004|Pilot Phase & Phase 2|Death on study|0
4571274|NCT01362790|7408509|FG005|Pilot Phase & Phase 2|Death on study|0
4571275|NCT01362790|7408510|FG006|Pilot Phase & Phase 2|Death on study|0
4571276|NCT01362790|7408504|FG000|Dose De-escalation of Regimen A|Adverse Event|0
4571277|NCT01362790|7408505|FG001|Dose De-escalation of Regimen A|Adverse Event|0
4571278|NCT01362790|7408506|FG002|Dose De-escalation of Regimen A|Adverse Event|0
4571279|NCT01362790|7408507|FG003|Dose De-escalation of Regimen A|Adverse Event|0
4571280|NCT01362790|7408508|FG004|Dose De-escalation of Regimen A|Adverse Event|1
4571281|NCT01362790|7408509|FG005|Dose De-escalation of Regimen A|Adverse Event|0
4571282|NCT01362790|7408510|FG006|Dose De-escalation of Regimen A|Adverse Event|0
4571283|NCT01362790|7408504|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0
4571284|NCT01362790|7408505|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0
4571285|NCT01362790|7408506|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0
4571286|NCT01362790|7408507|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0
4571287|NCT01362790|7408508|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3
4571288|NCT01362790|7408509|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0
4571289|NCT01362790|7408510|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0
4571290|NCT01362790|7408504|FG000|Dose De-escalation of Regimen A|Progressive disease|0
4571291|NCT01362790|7408505|FG001|Dose De-escalation of Regimen A|Progressive disease|0
4571292|NCT01362790|7408506|FG002|Dose De-escalation of Regimen A|Progressive disease|0
4571293|NCT01362790|7408507|FG003|Dose De-escalation of Regimen A|Progressive disease|0
4571294|NCT01362790|7408508|FG004|Dose De-escalation of Regimen A|Progressive disease|2
4571295|NCT01362790|7408509|FG005|Dose De-escalation of Regimen A|Progressive disease|0
4571296|NCT01362790|7408510|FG006|Dose De-escalation of Regimen A|Progressive disease|0
4571297|NCT01363011|7408562|FG000|Main Study|Adverse Event|2
4571298|NCT01363011|7408563|FG001|Main Study|Adverse Event|3
4571299|NCT01363011|7408562|FG000|Main Study|Investigator's Discretion|1
4571300|NCT01363011|7408563|FG001|Main Study|Investigator's Discretion|1
4571301|NCT01363011|7408562|FG000|Main Study|Withdrew Consent|1
4571302|NCT01363011|7408563|FG001|Main Study|Withdrew Consent|4
4571303|NCT01363011|7408562|FG000|Main Study|Protocol Violation|0
4571304|NCT01363011|7408563|FG001|Main Study|Protocol Violation|1
4571305|NCT01363011|7408562|FG000|Extension Phase|Adverse Event|1
4571306|NCT01363011|7408563|FG001|Extension Phase|Adverse Event|1
4571307|NCT01363011|7408562|FG000|Extension Phase|Lack of Efficacy|0
4571308|NCT01363011|7408563|FG001|Extension Phase|Lack of Efficacy|1
4571309|NCT01363011|7408562|FG000|Extension Phase|Investigator's Discretion|2
4571310|NCT01363011|7408563|FG001|Extension Phase|Investigator's Discretion|2
4571311|NCT01363011|7408562|FG000|Extension Phase|Withdrew Consent|0
4571312|NCT01363011|7408563|FG001|Extension Phase|Withdrew Consent|1
4571313|NCT01363011|7408562|FG000|Extension Phase|Lost to Follow-up|0
4571314|NCT01363011|7408563|FG001|Extension Phase|Lost to Follow-up|2
4571315|NCT01363011|7408562|FG000|Extension Phase|Rolled Over to Another Gilead Study|2
4571316|NCT01363011|7408563|FG001|Extension Phase|Rolled Over to Another Gilead Study|1
4571317|NCT01363076|7408577|FG000|Overall Study|Withdrawal by Subject|0
4571318|NCT01363076|7408578|FG001|Overall Study|Withdrawal by Subject|1
4571319|NCT01363297|7408602|FG000|Overall Study|Other|0
4571320|NCT01363297|7408603|FG001|Overall Study|Other|0
4571321|NCT01363297|7408604|FG002|Overall Study|Other|0
4571322|NCT01363297|7408605|FG003|Overall Study|Other|0
4571323|NCT01363297|7408606|FG004|Overall Study|Other|1
4571324|NCT01363297|7408602|FG000|Overall Study|Death|3
4571325|NCT01363297|7408603|FG001|Overall Study|Death|6
4571326|NCT01363297|7408604|FG002|Overall Study|Death|6
4571327|NCT01363297|7408605|FG003|Overall Study|Death|10
4571328|NCT01363297|7408606|FG004|Overall Study|Death|30
4571329|NCT01363349|7408625|FG000|Overall Study|Adverse Event|6
4571330|NCT01363349|7408626|FG001|Overall Study|Adverse Event|7
4571331|NCT01363349|7408625|FG000|Overall Study|Lack of Efficacy|3
4625985|NCT01835431|7491297|FG001|Overall Study|Adverse Event|0
4625986|NCT01835431|7491296|FG000|Overall Study|other|0
4625987|NCT01835431|7491297|FG001|Overall Study|other|2
4625988|NCT01835431|7491296|FG000|Overall Study|Withdrawal by Subject|6
4625989|NCT01835431|7491297|FG001|Overall Study|Withdrawal by Subject|10
4625990|NCT01835431|7491296|FG000|Overall Study|Protocol Violation|1
4625991|NCT01835431|7491297|FG001|Overall Study|Protocol Violation|0
4625992|NCT01835470|7491303|FG000|Long Term Treatment Period|Subject Request to Discontinue|1
4625993|NCT01835470|7491303|FG000|Long Term Treatment Period|Lack of Efficacy|3
4625994|NCT01835548|7491314|FG000|Dose Optimization Period|Adverse Event|0
4625995|NCT01835548|7491315|FG001|Dose Optimization Period|Adverse Event|0
4625996|NCT01835548|7491316|FG002|Dose Optimization Period|Adverse Event|1
4625997|NCT01835548|7491314|FG000|Dose Optimization Period|Withdrawal by Subject|0
4625998|NCT01835548|7491315|FG001|Dose Optimization Period|Withdrawal by Subject|0
4625999|NCT01835548|7491316|FG002|Dose Optimization Period|Withdrawal by Subject|1
4571332|NCT01363349|7408626|FG001|Overall Study|Lack of Efficacy|10
4571333|NCT01363349|7408625|FG000|Overall Study|Non compliance/Protocol deviations|2
4571334|NCT01363349|7408626|FG001|Overall Study|Non compliance/Protocol deviations|2
4571335|NCT01363349|7408625|FG000|Overall Study|Withdrawal by Subject|14
4571336|NCT01363349|7408626|FG001|Overall Study|Withdrawal by Subject|6
4571337|NCT01363349|7408625|FG000|Overall Study|Lost to Follow-up|5
4571338|NCT01363349|7408626|FG001|Overall Study|Lost to Follow-up|6
4571339|NCT01363349|7408625|FG000|Overall Study|Not reported|36
4571340|NCT01363349|7408626|FG001|Overall Study|Not reported|37
4571341|NCT01363349|7408625|FG000|Overall Study|missing|1
4571342|NCT01363349|7408626|FG001|Overall Study|missing|2
4571343|NCT01363440|7408648|FG000|Overall Study|Adverse Event|5
4571344|NCT01363440|7408649|FG001|Overall Study|Adverse Event|4
4571345|NCT01363440|7408650|FG002|Overall Study|Adverse Event|4
4571346|NCT01363440|7408648|FG000|Overall Study|Death|3
4571347|NCT01363440|7408649|FG001|Overall Study|Death|7
4571348|NCT01363440|7408650|FG002|Overall Study|Death|5
4571349|NCT01363440|7408648|FG000|Overall Study|Withdrawal by Subject|9
4571350|NCT01363440|7408649|FG001|Overall Study|Withdrawal by Subject|11
4571351|NCT01363440|7408650|FG002|Overall Study|Withdrawal by Subject|11
4571352|NCT01363440|7408648|FG000|Overall Study|Lost to Follow-up|2
4571353|NCT01363440|7408649|FG001|Overall Study|Lost to Follow-up|4
4571354|NCT01363440|7408650|FG002|Overall Study|Lost to Follow-up|5
4571355|NCT01363440|7408648|FG000|Overall Study|Other|4
4571356|NCT01363440|7408649|FG001|Overall Study|Other|5
4571357|NCT01363440|7408650|FG002|Overall Study|Other|2
4571358|NCT01363661|7408678|FG000|Overall Study|Adverse Event|9
4571359|NCT01363661|7408679|FG001|Overall Study|Adverse Event|2
4571360|NCT01363661|7408678|FG000|Overall Study|Withdrawal by Subject|1
4571361|NCT01363661|7408679|FG001|Overall Study|Withdrawal by Subject|1
4571362|NCT01363661|7408678|FG000|Overall Study|Protocol Violation|1
4571363|NCT01363661|7408679|FG001|Overall Study|Protocol Violation|0
4571364|NCT01363661|7408678|FG000|Overall Study|Lost to Follow-up|3
4571365|NCT01363661|7408679|FG001|Overall Study|Lost to Follow-up|1
4571366|NCT01363700|7408688|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0
4571367|NCT01363700|7408689|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1
4571368|NCT01363700|7408690|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0
4571369|NCT01363700|7408691|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0
4571370|NCT01363700|7408692|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0
4571371|NCT01363713|7408703|FG000|Overall Study|Adverse Event|1
4571372|NCT01363713|7408703|FG000|Overall Study|Protocol Violation|3
4571373|NCT01363713|7408703|FG000|Overall Study|Withdrawal by Subject|2
4571374|NCT01363765|7408709|FG000|Overall Study|non-diagnostic|2621
4571375|NCT01363765|7408710|FG001|Overall Study|non-diagnostic|1124
4571376|NCT01363765|7408709|FG000|Overall Study|duplicate records|736
4571377|NCT01363765|7408710|FG001|Overall Study|duplicate records|3177
4571378|NCT01363765|7408709|FG000|Overall Study|non-resident|156
4571379|NCT01363765|7408710|FG001|Overall Study|non-resident|76
4571380|NCT01363765|7408709|FG000|Overall Study|age not recorded (used for cross-linkage|117
4571381|NCT01363765|7408710|FG001|Overall Study|age not recorded (used for cross-linkage|354
4571382|NCT01363765|7408709|FG000|Overall Study|smear during intervention|2170
4571383|NCT01363765|7408710|FG001|Overall Study|smear during intervention|0
4571384|NCT01363908|7408725|FG000|Chronic Dosing (CD) Phase|Adverse Event|1
4571385|NCT01363908|7408726|FG001|Chronic Dosing (CD) Phase|Adverse Event|1
4571386|NCT01363908|7408725|FG000|Chronic Dosing (CD) Phase|Patient decision|0
4571387|NCT01363908|7408726|FG001|Chronic Dosing (CD) Phase|Patient decision|1
4571388|NCT01363908|7408725|FG000|Chronic Dosing (CD) Phase|Physician Decision|0
4571389|NCT01363908|7408726|FG001|Chronic Dosing (CD) Phase|Physician Decision|1
4571390|NCT01363908|7408725|FG000|Chronic Dosing (CD) Phase|Early study termination|9
4571391|NCT01363908|7408726|FG001|Chronic Dosing (CD) Phase|Early study termination|3
4571392|NCT01363986|7408732|FG000|Overall Study|Disease progression|1
4571393|NCT01364233|7408763|FG000|Overall Study|Lost to Follow-up|1
4571394|NCT01364298|7408778|FG000|Overall Study|Adverse Event|3
4571395|NCT01364298|7408779|FG001|Overall Study|Adverse Event|4
4571396|NCT01364298|7408778|FG000|Overall Study|Lack of adherence to treatment|1
4571397|NCT01364298|7408779|FG001|Overall Study|Lack of adherence to treatment|3
4571398|NCT01364298|7408778|FG000|Overall Study|Lack of Efficacy|1
4571399|NCT01364298|7408779|FG001|Overall Study|Lack of Efficacy|0
4571400|NCT01364298|7408778|FG000|Overall Study|Lost to Follow-up|5
4571401|NCT01364298|7408779|FG001|Overall Study|Lost to Follow-up|10
4571402|NCT01364298|7408778|FG000|Overall Study|Withdrawal by Subject|3
4571403|NCT01364298|7408779|FG001|Overall Study|Withdrawal by Subject|3
4571404|NCT01364298|7408778|FG000|Overall Study|Other|1
4571405|NCT01364298|7408779|FG001|Overall Study|Other|3
4571406|NCT01364389|7408788|FG000|Overall Study|Withdrawal by Subject|0
4571407|NCT01364389|7408789|FG001|Overall Study|Withdrawal by Subject|1
4571408|NCT01364389|7408790|FG002|Overall Study|Withdrawal by Subject|0
4571409|NCT01364389|7408788|FG000|Overall Study|Protocol deviation|0
4571410|NCT01364389|7408789|FG001|Overall Study|Protocol deviation|0
4571411|NCT01364389|7408790|FG002|Overall Study|Protocol deviation|1
4571412|NCT01364389|7408788|FG000|Overall Study|Administrative problems|1
4571413|NCT01364389|7408789|FG001|Overall Study|Administrative problems|0
4571414|NCT01364389|7408790|FG002|Overall Study|Administrative problems|0
4571415|NCT01364389|7408788|FG000|Overall Study|Adverse Event|1
4571416|NCT01364389|7408789|FG001|Overall Study|Adverse Event|0
4571417|NCT01364389|7408790|FG002|Overall Study|Adverse Event|0
4571418|NCT01364428|7408800|FG000|Overall Study|Adverse Event|1
4571419|NCT01364428|7408801|FG001|Overall Study|Adverse Event|2
4571420|NCT01364428|7408800|FG000|Overall Study|Protocol Violation|2
4571421|NCT01364428|7408801|FG001|Overall Study|Protocol Violation|0
4571422|NCT01364428|7408800|FG000|Overall Study|Withdrawal Criteria|14
4571423|NCT01364428|7408801|FG001|Overall Study|Withdrawal Criteria|10
4571424|NCT01364428|7408800|FG000|Overall Study|Other|3
4571425|NCT01364428|7408801|FG001|Overall Study|Other|3
4571426|NCT01364467|7408809|FG000|Overall Study|Lost to Follow-up|1
4571427|NCT01364467|7408810|FG001|Overall Study|Lost to Follow-up|2
4571428|NCT01364649|7408860|FG000|Overall Study|Pretreatment Event or Adverse Event|20
4571429|NCT01364649|7408861|FG001|Overall Study|Pretreatment Event or Adverse Event|14
4571430|NCT01364649|7408860|FG000|Overall Study|Lack of Efficacy|6
4571431|NCT01364649|7408861|FG001|Overall Study|Lack of Efficacy|0
4571432|NCT01364649|7408860|FG000|Overall Study|Non-compliance with Investigational Drug|1
4571433|NCT01364649|7408861|FG001|Overall Study|Non-compliance with Investigational Drug|0
4571434|NCT01364649|7408860|FG000|Overall Study|Protocol Deviations|4
4571435|NCT01364649|7408861|FG001|Overall Study|Protocol Deviations|8
4571436|NCT01364649|7408860|FG000|Overall Study|Withdrawal of Consent|9
4571437|NCT01364649|7408861|FG001|Overall Study|Withdrawal of Consent|7
4571438|NCT01364649|7408860|FG000|Overall Study|Lost to Follow-up|12
4571439|NCT01364649|7408861|FG001|Overall Study|Lost to Follow-up|13
4571440|NCT01364649|7408860|FG000|Overall Study|Other|4
4571441|NCT01364649|7408861|FG001|Overall Study|Other|1
4571442|NCT01364727|7408867|FG000|Overall Study|Not Eligible|2
4571443|NCT01364870|7408881|FG000|Overall Study|Withdrawal by Subject|13
4571444|NCT01364870|7408882|FG001|Overall Study|Withdrawal by Subject|24
4571445|NCT01364870|7408883|FG002|Overall Study|Withdrawal by Subject|10
4571446|NCT01364870|7408881|FG000|Overall Study|Adverse Event|8
4571447|NCT01364870|7408882|FG001|Overall Study|Adverse Event|6
4571448|NCT01364870|7408883|FG002|Overall Study|Adverse Event|4
4571449|NCT01364870|7408881|FG000|Overall Study|Protocol Violation|1
4571450|NCT01364870|7408882|FG001|Overall Study|Protocol Violation|0
4571451|NCT01364870|7408883|FG002|Overall Study|Protocol Violation|0
4571452|NCT01364922|7408898|FG000|Open-label (OL) Period|Adverse Event|7
4571453|NCT01364922|7408899|FG001|Open-label (OL) Period|Adverse Event|0
4571454|NCT01364922|7408900|FG002|Open-label (OL) Period|Adverse Event|0
4571455|NCT01364922|7408898|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6
4571456|NCT01364922|7408899|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0
4571457|NCT01364922|7408900|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0
4571458|NCT01364922|7408898|FG000|Open-label (OL) Period|Withdrawal by Subject|4
4571459|NCT01364922|7408899|FG001|Open-label (OL) Period|Withdrawal by Subject|0
4571460|NCT01364922|7408900|FG002|Open-label (OL) Period|Withdrawal by Subject|0
4571461|NCT01364922|7408898|FG000|Open-label (OL) Period|Lack of Efficacy|3
4571462|NCT01364922|7408899|FG001|Open-label (OL) Period|Lack of Efficacy|0
4571463|NCT01364922|7408900|FG002|Open-label (OL) Period|Lack of Efficacy|0
4571464|NCT01364922|7408898|FG000|Open-label (OL) Period|Lost to Follow-up|1
4571465|NCT01364922|7408899|FG001|Open-label (OL) Period|Lost to Follow-up|0
4571466|NCT01364922|7408900|FG002|Open-label (OL) Period|Lost to Follow-up|0
4571467|NCT01364922|7408898|FG000|Open-label (OL) Period|Other, Unspecified|1
4571468|NCT01364922|7408899|FG001|Open-label (OL) Period|Other, Unspecified|0
4571469|NCT01364922|7408900|FG002|Open-label (OL) Period|Other, Unspecified|0
4571470|NCT01364922|7408898|FG000|Double-Blind (DB) Period|Lack of Efficacy|0
4571471|NCT01364922|7408899|FG001|Double-Blind (DB) Period|Lack of Efficacy|3
4571472|NCT01364922|7408900|FG002|Double-Blind (DB) Period|Lack of Efficacy|4
4690852|NCT02564120|7600687|FG000|Overall Study|Withdrawal by Subject|204
4690853|NCT02564120|7600687|FG000|Overall Study|Other medical condition|24
4690854|NCT02564198|7600704|FG000|Overall Study|Withdrawal by Subject|2
4690855|NCT02564198|7600705|FG001|Overall Study|Withdrawal by Subject|4
4690856|NCT02564198|7600706|FG002|Overall Study|Withdrawal by Subject|0
4690857|NCT02564198|7600704|FG000|Overall Study|Adverse Event|0
4770420|NCT03740919|7746732|FG002|Treatment Period|Failure of Inclusion Criteria|1
4571473|NCT01364922|7408898|FG000|Double-Blind (DB) Period|Subject Noncompliant|0
4571474|NCT01364922|7408899|FG001|Double-Blind (DB) Period|Subject Noncompliant|1
4571475|NCT01364922|7408900|FG002|Double-Blind (DB) Period|Subject Noncompliant|0
4571476|NCT01364922|7408898|FG000|Double-Blind (DB) Period|Adverse Event|0
4571477|NCT01364922|7408899|FG001|Double-Blind (DB) Period|Adverse Event|0
4571478|NCT01364922|7408900|FG002|Double-Blind (DB) Period|Adverse Event|1
4571479|NCT01364922|7408898|FG000|Double-Blind (DB) Period|Other, Unspecified|0
4571480|NCT01364922|7408899|FG001|Double-Blind (DB) Period|Other, Unspecified|1
4571481|NCT01364922|7408900|FG002|Double-Blind (DB) Period|Other, Unspecified|0
4571482|NCT01365039|7408909|FG000|Overall Study|Study related symptoms and complaints|1
4571483|NCT01365039|7408910|FG001|Overall Study|Study related symptoms and complaints|0
4571484|NCT01365052|7408919|FG000|Overall Study|Adverse Event|4
4571485|NCT01365052|7408920|FG001|Overall Study|Adverse Event|4
4571486|NCT01365091|7408930|FG000|Period 1|Adverse Event|1
4571487|NCT01365091|7408931|FG001|Period 1|Adverse Event|0
4571488|NCT01365091|7408932|FG002|Period 1|Adverse Event|2
4571489|NCT01365091|7408933|FG003|Period 1|Adverse Event|3
4571490|NCT01365091|7408930|FG000|Period 1|Positive test result for drugs of abuse|1
4571491|NCT01365091|7408931|FG001|Period 1|Positive test result for drugs of abuse|0
4571492|NCT01365091|7408932|FG002|Period 1|Positive test result for drugs of abuse|0
4571493|NCT01365091|7408933|FG003|Period 1|Positive test result for drugs of abuse|0
4690858|NCT02564198|7600705|FG001|Overall Study|Adverse Event|1
4571494|NCT01365091|7408930|FG000|Period 1|No longer met study criteria|0
4571495|NCT01365091|7408931|FG001|Period 1|No longer met study criteria|1
4571496|NCT01365091|7408932|FG002|Period 1|No longer met study criteria|0
4571497|NCT01365091|7408933|FG003|Period 1|No longer met study criteria|0
4571498|NCT01365091|7408930|FG000|Period 1|Withdrawal by Subject|0
4571499|NCT01365091|7408931|FG001|Period 1|Withdrawal by Subject|1
4571500|NCT01365091|7408932|FG002|Period 1|Withdrawal by Subject|0
4571501|NCT01365091|7408933|FG003|Period 1|Withdrawal by Subject|0
4571502|NCT01365091|7408930|FG000|Period 1|Personal reasons|0
4571503|NCT01365091|7408931|FG001|Period 1|Personal reasons|0
4571504|NCT01365091|7408932|FG002|Period 1|Personal reasons|1
4571505|NCT01365091|7408933|FG003|Period 1|Personal reasons|0
4571506|NCT01365091|7408930|FG000|Period 2|Withdrawal by Subject|1
4571507|NCT01365091|7408931|FG001|Period 2|Withdrawal by Subject|0
4571508|NCT01365091|7408932|FG002|Period 2|Withdrawal by Subject|0
4571509|NCT01365091|7408933|FG003|Period 2|Withdrawal by Subject|0
4571510|NCT01365091|7408930|FG000|Period 2|Adverse Event|0
4571511|NCT01365091|7408931|FG001|Period 2|Adverse Event|0
4571512|NCT01365091|7408932|FG002|Period 2|Adverse Event|1
4571513|NCT01365091|7408933|FG003|Period 2|Adverse Event|0
4571514|NCT01365130|7408957|FG000|Overall Study|Progression/worsening of Dx prior to txt|2
4571515|NCT01365273|7408963|FG000|Overall Study|Lost to Follow-up|1
4571516|NCT01365273|7408964|FG001|Overall Study|Lost to Follow-up|0
4571517|NCT01365273|7408963|FG000|Overall Study|Protocol Violation|0
4571518|NCT01365273|7408964|FG001|Overall Study|Protocol Violation|1
4626000|NCT01835548|7491314|FG000|Double-Blind Treatment Period|Adverse Event|0
4626001|NCT01835548|7491315|FG001|Double-Blind Treatment Period|Adverse Event|1
4626002|NCT01835548|7491316|FG002|Double-Blind Treatment Period|Adverse Event|0
4626003|NCT01835548|7491314|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0
4626004|NCT01835548|7491315|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1
4626005|NCT01835548|7491316|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0
4626006|NCT01835587|7491332|FG000|Overall Study|Disease Recurrence or Relapse|0
4626007|NCT01835587|7491333|FG001|Overall Study|Disease Recurrence or Relapse|3
4626008|NCT01835587|7491334|FG002|Overall Study|Disease Recurrence or Relapse|0
4626009|NCT01835587|7491335|FG003|Overall Study|Disease Recurrence or Relapse|3
4626010|NCT01835587|7491332|FG000|Overall Study|Withdrawal by Subject|2
4626011|NCT01835587|7491333|FG001|Overall Study|Withdrawal by Subject|0
4626012|NCT01835587|7491334|FG002|Overall Study|Withdrawal by Subject|0
4626013|NCT01835587|7491335|FG003|Overall Study|Withdrawal by Subject|3
4626014|NCT01835587|7491332|FG000|Overall Study|Adverse Event|0
4626015|NCT01835587|7491333|FG001|Overall Study|Adverse Event|0
4626016|NCT01835587|7491334|FG002|Overall Study|Adverse Event|2
4626017|NCT01835587|7491335|FG003|Overall Study|Adverse Event|2
4626018|NCT01835587|7491332|FG000|Overall Study|Death|0
4626019|NCT01835587|7491333|FG001|Overall Study|Death|0
4626020|NCT01835587|7491334|FG002|Overall Study|Death|0
4626021|NCT01835587|7491335|FG003|Overall Study|Death|1
4626022|NCT01835587|7491332|FG000|Overall Study|Miscellaneous|0
4626023|NCT01835587|7491333|FG001|Overall Study|Miscellaneous|1
4626024|NCT01835587|7491334|FG002|Overall Study|Miscellaneous|0
4626025|NCT01835587|7491335|FG003|Overall Study|Miscellaneous|0
4626026|NCT01835899|7491379|FG000|Overall Study|Adverse Event|0
4626027|NCT01835899|7491380|FG001|Overall Study|Adverse Event|0
4626028|NCT01835899|7491381|FG002|Overall Study|Adverse Event|1
4626029|NCT01835899|7491379|FG000|Overall Study|Other than stated above|0
4626030|NCT01835899|7491380|FG001|Overall Study|Other than stated above|1
4626031|NCT01835899|7491381|FG002|Overall Study|Other than stated above|0
4626032|NCT01836198|7491446|FG000|Part A, Period 2|Protocol Violation|0
4626033|NCT01836198|7491447|FG001|Part A, Period 2|Protocol Violation|1
4626034|NCT01836198|7491448|FG002|Part A, Period 2|Protocol Violation|0
4626035|NCT01836276|7491466|FG000|Overall Study|Lost to Follow-up|28
4626036|NCT01836276|7491467|FG001|Overall Study|Lost to Follow-up|51
4626037|NCT01836458|7491486|FG000|Overall Study|Unsatisfactory therapeutic effect|3
4626038|NCT01836458|7491487|FG001|Overall Study|Unsatisfactory therapeutic effect|2
4626039|NCT01836458|7491488|FG002|Overall Study|Unsatisfactory therapeutic effect|5
4626040|NCT01836458|7491489|FG003|Overall Study|Unsatisfactory therapeutic effect|6
4626041|NCT01836471|7491504|FG000|Overall Study|Pregnancy|1
4626042|NCT01836471|7491505|FG001|Overall Study|Pregnancy|0
4626043|NCT01836471|7491506|FG002|Overall Study|Pregnancy|0
4626044|NCT01836471|7491507|FG003|Overall Study|Pregnancy|0
4626045|NCT01836471|7491508|FG004|Overall Study|Pregnancy|0
4626046|NCT01836471|7491504|FG000|Overall Study|Withdrawal by Subject|3
4626047|NCT01836471|7491505|FG001|Overall Study|Withdrawal by Subject|4
4626048|NCT01836471|7491506|FG002|Overall Study|Withdrawal by Subject|1
4626049|NCT01836471|7491507|FG003|Overall Study|Withdrawal by Subject|0
4626050|NCT01836471|7491508|FG004|Overall Study|Withdrawal by Subject|2
4626051|NCT01836471|7491504|FG000|Overall Study|Physician Decision|0
4626052|NCT01836471|7491505|FG001|Overall Study|Physician Decision|1
4626053|NCT01836471|7491506|FG002|Overall Study|Physician Decision|0
4626054|NCT01836471|7491507|FG003|Overall Study|Physician Decision|0
4571519|NCT01365273|7408963|FG000|Overall Study|Physician Decision|1
4571520|NCT01365273|7408964|FG001|Overall Study|Physician Decision|0
4571521|NCT01365455|7408973|FG000|Induction Period|Adverse Event|5
4571522|NCT01365455|7408974|FG001|Induction Period|Adverse Event|3
4571523|NCT01365455|7408975|FG002|Induction Period|Adverse Event|4
4571524|NCT01365455|7408976|FG003|Induction Period|Adverse Event|0
4571525|NCT01365455|7408977|FG004|Induction Period|Adverse Event|0
4571526|NCT01365455|7408973|FG000|Induction Period|Lack of Efficacy|1
4571527|NCT01365455|7408974|FG001|Induction Period|Lack of Efficacy|1
4571528|NCT01365455|7408975|FG002|Induction Period|Lack of Efficacy|0
4571529|NCT01365455|7408976|FG003|Induction Period|Lack of Efficacy|0
4571530|NCT01365455|7408977|FG004|Induction Period|Lack of Efficacy|0
4571531|NCT01365455|7408973|FG000|Induction Period|Pregnancy|0
4571532|NCT01365455|7408974|FG001|Induction Period|Pregnancy|1
4571533|NCT01365455|7408975|FG002|Induction Period|Pregnancy|0
4571534|NCT01365455|7408976|FG003|Induction Period|Pregnancy|0
4571535|NCT01365455|7408977|FG004|Induction Period|Pregnancy|0
4571536|NCT01365455|7408973|FG000|Induction Period|Protocol deviation|0
4571537|NCT01365455|7408974|FG001|Induction Period|Protocol deviation|1
4571538|NCT01365455|7408975|FG002|Induction Period|Protocol deviation|1
4571539|NCT01365455|7408976|FG003|Induction Period|Protocol deviation|0
4571540|NCT01365455|7408977|FG004|Induction Period|Protocol deviation|0
4571541|NCT01365455|7408973|FG000|Induction Period|Subject/guardian decision|9
4571542|NCT01365455|7408974|FG001|Induction Period|Subject/guardian decision|1
4571543|NCT01365455|7408975|FG002|Induction Period|Subject/guardian decision|8
4571544|NCT01365455|7408976|FG003|Induction Period|Subject/guardian decision|0
4571545|NCT01365455|7408977|FG004|Induction Period|Subject/guardian decision|0
4571546|NCT01365455|7408973|FG000|Induction Period|Lost to Follow-up|0
4571547|NCT01365455|7408974|FG001|Induction Period|Lost to Follow-up|0
4571548|NCT01365455|7408975|FG002|Induction Period|Lost to Follow-up|3
4571549|NCT01365455|7408976|FG003|Induction Period|Lost to Follow-up|0
4571550|NCT01365455|7408977|FG004|Induction Period|Lost to Follow-up|0
4571551|NCT01365455|7408973|FG000|Maintenance Period|Adverse Event|12
4571552|NCT01365455|7408974|FG001|Maintenance Period|Adverse Event|5
4571553|NCT01365455|7408975|FG002|Maintenance Period|Adverse Event|1
4571554|NCT01365455|7408976|FG003|Maintenance Period|Adverse Event|2
4571555|NCT01365455|7408977|FG004|Maintenance Period|Adverse Event|4
4571556|NCT01365455|7408973|FG000|Maintenance Period|Lack of Efficacy|10
4571557|NCT01365455|7408974|FG001|Maintenance Period|Lack of Efficacy|2
4571558|NCT01365455|7408975|FG002|Maintenance Period|Lack of Efficacy|0
4571559|NCT01365455|7408976|FG003|Maintenance Period|Lack of Efficacy|2
4571560|NCT01365455|7408977|FG004|Maintenance Period|Lack of Efficacy|2
4571561|NCT01365455|7408973|FG000|Maintenance Period|Lost to Follow-up|2
4571562|NCT01365455|7408974|FG001|Maintenance Period|Lost to Follow-up|4
4571563|NCT01365455|7408975|FG002|Maintenance Period|Lost to Follow-up|0
4571564|NCT01365455|7408976|FG003|Maintenance Period|Lost to Follow-up|0
4571565|NCT01365455|7408977|FG004|Maintenance Period|Lost to Follow-up|3
4571566|NCT01365455|7408973|FG000|Maintenance Period|Non-compliance with study treatment|0
4571567|NCT01365455|7408974|FG001|Maintenance Period|Non-compliance with study treatment|0
4571568|NCT01365455|7408975|FG002|Maintenance Period|Non-compliance with study treatment|0
4571569|NCT01365455|7408976|FG003|Maintenance Period|Non-compliance with study treatment|1
4571570|NCT01365455|7408977|FG004|Maintenance Period|Non-compliance with study treatment|0
4571571|NCT01365455|7408973|FG000|Maintenance Period|Physician Decision|0
4571572|NCT01365455|7408974|FG001|Maintenance Period|Physician Decision|1
4571573|NCT01365455|7408975|FG002|Maintenance Period|Physician Decision|0
4571574|NCT01365455|7408976|FG003|Maintenance Period|Physician Decision|0
4571575|NCT01365455|7408977|FG004|Maintenance Period|Physician Decision|1
4571576|NCT01365455|7408973|FG000|Maintenance Period|Pregnancy|0
4571577|NCT01365455|7408974|FG001|Maintenance Period|Pregnancy|4
4571578|NCT01365455|7408975|FG002|Maintenance Period|Pregnancy|0
4571579|NCT01365455|7408976|FG003|Maintenance Period|Pregnancy|0
4571580|NCT01365455|7408977|FG004|Maintenance Period|Pregnancy|2
4571581|NCT01365455|7408973|FG000|Maintenance Period|Protocol deviation|1
4571582|NCT01365455|7408974|FG001|Maintenance Period|Protocol deviation|1
4571583|NCT01365455|7408975|FG002|Maintenance Period|Protocol deviation|0
4571584|NCT01365455|7408976|FG003|Maintenance Period|Protocol deviation|0
4571585|NCT01365455|7408977|FG004|Maintenance Period|Protocol deviation|0
4571586|NCT01365455|7408973|FG000|Maintenance Period|Subject/guardian decision|4
4571587|NCT01365455|7408974|FG001|Maintenance Period|Subject/guardian decision|6
4571588|NCT01365455|7408975|FG002|Maintenance Period|Subject/guardian decision|2
4571589|NCT01365455|7408976|FG003|Maintenance Period|Subject/guardian decision|4
4571590|NCT01365455|7408977|FG004|Maintenance Period|Subject/guardian decision|1
4571591|NCT01365468|7408997|FG000|Overall Study|Physician Decision|1
4571592|NCT01365468|7408998|FG001|Overall Study|Physician Decision|0
4571593|NCT01365468|7408997|FG000|Overall Study|Disease progression|1
4571594|NCT01365468|7408998|FG001|Overall Study|Disease progression|0
4571595|NCT01365468|7408997|FG000|Overall Study|Lost to Follow-up|2
4626055|NCT01836471|7491508|FG004|Overall Study|Physician Decision|0
4626056|NCT01836471|7491504|FG000|Overall Study|Lost to Follow-up|0
4626057|NCT01836471|7491505|FG001|Overall Study|Lost to Follow-up|0
4626058|NCT01836471|7491506|FG002|Overall Study|Lost to Follow-up|0
4626059|NCT01836471|7491507|FG003|Overall Study|Lost to Follow-up|1
4626060|NCT01836471|7491508|FG004|Overall Study|Lost to Follow-up|1
4571596|NCT01365468|7408998|FG001|Overall Study|Lost to Follow-up|0
4571597|NCT01365481|7409009|FG000|Overall Study|Adverse Event|6
4571598|NCT01365481|7409010|FG001|Overall Study|Adverse Event|9
4571599|NCT01365481|7409011|FG002|Overall Study|Adverse Event|0
4571600|NCT01365481|7409012|FG003|Overall Study|Adverse Event|2
4571601|NCT01365481|7409009|FG000|Overall Study|Withdrawal by Subject|0
4571602|NCT01365481|7409010|FG001|Overall Study|Withdrawal by Subject|2
4571603|NCT01365481|7409011|FG002|Overall Study|Withdrawal by Subject|1
4571604|NCT01365481|7409012|FG003|Overall Study|Withdrawal by Subject|1
4571605|NCT01365481|7409009|FG000|Overall Study|Lost to Follow-up|1
4571606|NCT01365481|7409010|FG001|Overall Study|Lost to Follow-up|1
4571607|NCT01365481|7409011|FG002|Overall Study|Lost to Follow-up|2
4571608|NCT01365481|7409012|FG003|Overall Study|Lost to Follow-up|3
4571609|NCT01365481|7409009|FG000|Overall Study|Abnormal laboratory value(s)|0
4571610|NCT01365481|7409010|FG001|Overall Study|Abnormal laboratory value(s)|1
4571611|NCT01365481|7409011|FG002|Overall Study|Abnormal laboratory value(s)|0
4571612|NCT01365481|7409012|FG003|Overall Study|Abnormal laboratory value(s)|0
4571613|NCT01365481|7409009|FG000|Overall Study|Administrative problems|0
4571614|NCT01365481|7409010|FG001|Overall Study|Administrative problems|1
4626061|NCT01836471|7491504|FG000|Overall Study|Adverse Event|6
4626062|NCT01836471|7491505|FG001|Overall Study|Adverse Event|3
4626063|NCT01836471|7491506|FG002|Overall Study|Adverse Event|1
4626064|NCT01836471|7491507|FG003|Overall Study|Adverse Event|1
4626065|NCT01836471|7491508|FG004|Overall Study|Adverse Event|2
4626066|NCT01836471|7491504|FG000|Overall Study|Non compliance with tx|1
4626067|NCT01836471|7491505|FG001|Overall Study|Non compliance with tx|1
4626068|NCT01836471|7491506|FG002|Overall Study|Non compliance with tx|0
4626069|NCT01836471|7491507|FG003|Overall Study|Non compliance with tx|0
4626070|NCT01836471|7491508|FG004|Overall Study|Non compliance with tx|0
4626071|NCT01836523|7491525|FG000|Overall Study|Adverse Event|15
4626072|NCT01836523|7491526|FG001|Overall Study|Adverse Event|41
4626073|NCT01836523|7491527|FG002|Overall Study|Adverse Event|49
4626074|NCT01836523|7491528|FG003|Overall Study|Adverse Event|14
4626075|NCT01836523|7491525|FG000|Overall Study|Protocol Violation|6
4626076|NCT01836523|7491526|FG001|Overall Study|Protocol Violation|3
4626077|NCT01836523|7491527|FG002|Overall Study|Protocol Violation|2
4626078|NCT01836523|7491528|FG003|Overall Study|Protocol Violation|4
4626079|NCT01836523|7491525|FG000|Overall Study|Met Withdrawal Criteria|13
4626080|NCT01836523|7491526|FG001|Overall Study|Met Withdrawal Criteria|13
4626081|NCT01836523|7491527|FG002|Overall Study|Met Withdrawal Criteria|21
4626082|NCT01836523|7491528|FG003|Overall Study|Met Withdrawal Criteria|27
4626083|NCT01836523|7491525|FG000|Overall Study|Unclassified|17
4626084|NCT01836523|7491526|FG001|Overall Study|Unclassified|28
4626085|NCT01836523|7491527|FG002|Overall Study|Unclassified|19
4626086|NCT01836523|7491528|FG003|Overall Study|Unclassified|29
4633191|NCT01908907|7503159|FG001|Overall Study|Protocol Violation|0
4633192|NCT01909336|7503211|FG000|Overall Study|Lost to Follow-up|4
4633193|NCT01909336|7503212|FG001|Overall Study|Lost to Follow-up|2
4633194|NCT01909336|7503213|FG002|Overall Study|Lost to Follow-up|2
4633195|NCT01909336|7503211|FG000|Overall Study|Physician Decision|0
4633196|NCT01909336|7503212|FG001|Overall Study|Physician Decision|1
4633197|NCT01909336|7503213|FG002|Overall Study|Physician Decision|1
4633198|NCT01909466|7503221|FG000|Overall Study|Lost to Follow-up|5
4633199|NCT01909466|7503222|FG001|Overall Study|Lost to Follow-up|7
4633200|NCT01909466|7503221|FG000|Overall Study|Adverse Event|3
4633201|NCT01909466|7503222|FG001|Overall Study|Adverse Event|4
4633202|NCT01909466|7503221|FG000|Overall Study|Met Withdrawal Criteria|0
4633203|NCT01909466|7503222|FG001|Overall Study|Met Withdrawal Criteria|3
4633204|NCT01909466|7503221|FG000|Overall Study|Physician Decision|2
4633205|NCT01909466|7503222|FG001|Overall Study|Physician Decision|0
4633206|NCT01909466|7503221|FG000|Overall Study|Withdrawal by Subject|11
4633207|NCT01909466|7503222|FG001|Overall Study|Withdrawal by Subject|9
4633208|NCT01909466|7503221|FG000|Overall Study|Lack of Efficacy|1
4633209|NCT01909466|7503222|FG001|Overall Study|Lack of Efficacy|0
4633210|NCT01909674|7503228|FG000|Overall Study|Withdrawal by Subject|5
4633211|NCT01909674|7503229|FG001|Overall Study|Withdrawal by Subject|2
4633212|NCT01909778|7503260|FG000|Overall Study|failed screening|1
4633213|NCT01909791|7503269|FG000|Overall Study|Death|9
4633214|NCT01909791|7503270|FG001|Overall Study|Death|8
4633215|NCT01909791|7503271|FG002|Overall Study|Death|4
4633216|NCT01909791|7503269|FG000|Overall Study|Withdrawal by Subject|5
4633217|NCT01909791|7503270|FG001|Overall Study|Withdrawal by Subject|9
4633218|NCT01909791|7503271|FG002|Overall Study|Withdrawal by Subject|13
4633219|NCT01909791|7503269|FG000|Overall Study|Lost to Follow-up|5
4571615|NCT01365481|7409011|FG002|Overall Study|Administrative problems|0
4633220|NCT01909791|7503270|FG001|Overall Study|Lost to Follow-up|11
4633221|NCT01909791|7503271|FG002|Overall Study|Lost to Follow-up|10
4633222|NCT01909791|7503269|FG000|Overall Study|Missed Visit|2
4633223|NCT01909791|7503270|FG001|Overall Study|Missed Visit|0
4633224|NCT01909791|7503271|FG002|Overall Study|Missed Visit|1
4633225|NCT01909804|7503296|FG000|Overall Study|Randomized but Never Treated|0
4633226|NCT01909804|7503297|FG001|Overall Study|Randomized but Never Treated|0
4633227|NCT01909804|7503298|FG002|Overall Study|Randomized but Never Treated|0
4633228|NCT01909804|7503299|FG003|Overall Study|Randomized but Never Treated|0
4633229|NCT01909804|7503300|FG004|Overall Study|Randomized but Never Treated|0
4633230|NCT01909804|7503301|FG005|Overall Study|Randomized but Never Treated|0
4571616|NCT01365481|7409012|FG003|Overall Study|Administrative problems|0
4633231|NCT01909804|7503302|FG006|Overall Study|Randomized but Never Treated|1
4571617|NCT01365481|7409009|FG000|Overall Study|Protocol deviation|0
4571618|NCT01365481|7409010|FG001|Overall Study|Protocol deviation|1
4571619|NCT01365481|7409011|FG002|Overall Study|Protocol deviation|0
4571620|NCT01365481|7409012|FG003|Overall Study|Protocol deviation|1
4571621|NCT01365481|7409009|FG000|Overall Study|Unsatisfactory therapeutic effect|0
4571622|NCT01365481|7409010|FG001|Overall Study|Unsatisfactory therapeutic effect|0
4571623|NCT01365481|7409011|FG002|Overall Study|Unsatisfactory therapeutic effect|1
4571624|NCT01365481|7409012|FG003|Overall Study|Unsatisfactory therapeutic effect|0
4571625|NCT01365494|7409024|FG000|Overall Study|Adverse Event|1
4571626|NCT01365494|7409025|FG001|Overall Study|Adverse Event|0
4571627|NCT01365494|7409024|FG000|Overall Study|Withdrawal by Subject|0
4571628|NCT01365494|7409025|FG001|Overall Study|Withdrawal by Subject|1
4571629|NCT01365494|7409024|FG000|Overall Study|Lost to Follow-up|1
4571630|NCT01365494|7409025|FG001|Overall Study|Lost to Follow-up|2
4571631|NCT01365507|7409034|FG000|Overall Study|Withdrawal Criteria|8
4571632|NCT01365507|7409035|FG001|Overall Study|Withdrawal Criteria|5
4571633|NCT01365507|7409034|FG000|Overall Study|Unclassified|1
4571634|NCT01365507|7409035|FG001|Overall Study|Unclassified|4
4571635|NCT01365546|7409041|FG000|Overall Study|Withdrawal by Subject|1
4571636|NCT01365546|7409041|FG000|Overall Study|Screen failure|9
4571637|NCT01365546|7409041|FG000|Overall Study|Study termination|1
4571638|NCT01365910|7409109|FG000|Overall Study|Withdrawal by Subject|7
4571639|NCT01365910|7409109|FG000|Overall Study|disease progression|18
4571640|NCT01365910|7409109|FG000|Overall Study|Adverse Event|3
4571641|NCT01365910|7409109|FG000|Overall Study|other complicating disease|1
4571642|NCT01365910|7409109|FG000|Overall Study|pt did not get tx, nausea/vomiting|1
4571643|NCT01366209|7409124|FG000|Overall Study|Adverse Event|6
4571644|NCT01366209|7409125|FG001|Overall Study|Adverse Event|7
4571645|NCT01366209|7409124|FG000|Overall Study|Withdrawal by Subject|4
4571646|NCT01366209|7409125|FG001|Overall Study|Withdrawal by Subject|4
4571647|NCT01366209|7409124|FG000|Overall Study|Death|12
4571648|NCT01366209|7409125|FG001|Overall Study|Death|19
4571649|NCT01366209|7409124|FG000|Overall Study|Lung transplantation|6
4571650|NCT01366209|7409125|FG001|Overall Study|Lung transplantation|1
4571651|NCT01366209|7409124|FG000|Overall Study|Lost to Follow-up|2
4571652|NCT01366209|7409125|FG001|Overall Study|Lost to Follow-up|1
4571653|NCT01366209|7409124|FG000|Overall Study|Physician Decision|1
4571654|NCT01366209|7409125|FG001|Overall Study|Physician Decision|0
4571655|NCT01366209|7409124|FG000|Overall Study|Sponsors decision|0
4571656|NCT01366209|7409125|FG001|Overall Study|Sponsors decision|1
4571657|NCT01366209|7409124|FG000|Overall Study|Withdrew consent|4
4571658|NCT01366209|7409125|FG001|Overall Study|Withdrew consent|3
4571659|NCT01366443|7409136|FG000|Overall Study|Lost to Follow-up|2
4571660|NCT01366443|7409136|FG000|Overall Study|Under 18 yo|1
4571661|NCT01366521|7409162|FG000|Overall Study|Adverse Event|1
4571662|NCT01366521|7409163|FG001|Overall Study|Adverse Event|0
4571663|NCT01366521|7409164|FG002|Overall Study|Adverse Event|0
4571664|NCT01366521|7409165|FG003|Overall Study|Adverse Event|0
4571665|NCT01366521|7409162|FG000|Overall Study|Protocol Violation|0
4571666|NCT01366521|7409163|FG001|Overall Study|Protocol Violation|0
4571667|NCT01366521|7409164|FG002|Overall Study|Protocol Violation|1
4571668|NCT01366521|7409165|FG003|Overall Study|Protocol Violation|0
4571669|NCT01366521|7409162|FG000|Overall Study|Physician Decision|0
4571670|NCT01366521|7409163|FG001|Overall Study|Physician Decision|0
4571671|NCT01366521|7409164|FG002|Overall Study|Physician Decision|1
4571672|NCT01366521|7409165|FG003|Overall Study|Physician Decision|0
4571673|NCT01366521|7409162|FG000|Overall Study|Withdrawal by Subject|0
4571674|NCT01366521|7409163|FG001|Overall Study|Withdrawal by Subject|1
4571675|NCT01366521|7409164|FG002|Overall Study|Withdrawal by Subject|0
4571676|NCT01366521|7409165|FG003|Overall Study|Withdrawal by Subject|0
4571677|NCT01366534|7409180|FG000|Overall Study|Lost to Follow-up|1
4571678|NCT01366534|7409181|FG001|Overall Study|Lost to Follow-up|0
4571679|NCT01366534|7409182|FG002|Overall Study|Lost to Follow-up|0
4571680|NCT01366534|7409180|FG000|Overall Study|Migrated|1
4571681|NCT01366534|7409181|FG001|Overall Study|Migrated|1
4571682|NCT01366534|7409182|FG002|Overall Study|Migrated|0
4571683|NCT01366534|7409180|FG000|Overall Study|Declined challenged|0
4571684|NCT01366534|7409181|FG001|Overall Study|Declined challenged|1
4571685|NCT01366534|7409182|FG002|Overall Study|Declined challenged|0
4571686|NCT01366638|7409193|FG000|Overall Study|Withdrawal by Subject|0
4571687|NCT01366638|7409194|FG001|Overall Study|Withdrawal by Subject|0
4571688|NCT01366638|7409195|FG002|Overall Study|Withdrawal by Subject|6
4571689|NCT01366638|7409193|FG000|Overall Study|Other|1
4571690|NCT01366638|7409194|FG001|Overall Study|Other|0
4571691|NCT01366638|7409195|FG002|Overall Study|Other|0
4571692|NCT01366846|7409207|FG000|Overall Study|Withdrawal by Subject|2
4571693|NCT01366846|7409208|FG001|Overall Study|Withdrawal by Subject|0
4571694|NCT01366846|7409209|FG002|Overall Study|Withdrawal by Subject|0
4571695|NCT01366846|7409210|FG003|Overall Study|Withdrawal by Subject|0
4571696|NCT01366846|7409207|FG000|Overall Study|Communication Difficulties|1
4571697|NCT01366846|7409208|FG001|Overall Study|Communication Difficulties|4
4571698|NCT01366846|7409209|FG002|Overall Study|Communication Difficulties|0
4571699|NCT01366846|7409210|FG003|Overall Study|Communication Difficulties|1
4571700|NCT01366846|7409207|FG000|Overall Study|Scheduling Conflicts|0
4571701|NCT01366846|7409208|FG001|Overall Study|Scheduling Conflicts|0
4571702|NCT01366846|7409209|FG002|Overall Study|Scheduling Conflicts|1
4571703|NCT01366846|7409210|FG003|Overall Study|Scheduling Conflicts|0
4571704|NCT01367119|7409253|FG000|Overall Study|Adverse Event|1
4571705|NCT01367119|7409254|FG001|Overall Study|Adverse Event|0
4571706|NCT01367119|7409253|FG000|Overall Study|Withdrawal by Subject|1
4571707|NCT01367119|7409254|FG001|Overall Study|Withdrawal by Subject|1
4571708|NCT01367158|7409271|FG000|Overall Study|Withdrew consent|0
4571709|NCT01367158|7409272|FG001|Overall Study|Withdrew consent|2
4571710|NCT01367158|7409273|FG002|Overall Study|Withdrew consent|1
4571711|NCT01367158|7409274|FG003|Overall Study|Withdrew consent|0
4571712|NCT01367158|7409275|FG004|Overall Study|Withdrew consent|2
4571713|NCT01367158|7409276|FG005|Overall Study|Withdrew consent|0
4571714|NCT01367158|7409277|FG006|Overall Study|Withdrew consent|0
4571715|NCT01367158|7409278|FG007|Overall Study|Withdrew consent|1
4571716|NCT01367158|7409279|FG008|Overall Study|Withdrew consent|0
4571717|NCT01367158|7409280|FG009|Overall Study|Withdrew consent|0
4571718|NCT01367158|7409281|FG010|Overall Study|Withdrew consent|0
4571719|NCT01367158|7409271|FG000|Overall Study|Lost to Follow-up|0
4571720|NCT01367158|7409272|FG001|Overall Study|Lost to Follow-up|0
4571721|NCT01367158|7409273|FG002|Overall Study|Lost to Follow-up|0
4571722|NCT01367158|7409274|FG003|Overall Study|Lost to Follow-up|1
4571723|NCT01367158|7409275|FG004|Overall Study|Lost to Follow-up|0
4571724|NCT01367158|7409276|FG005|Overall Study|Lost to Follow-up|2
4571725|NCT01367158|7409277|FG006|Overall Study|Lost to Follow-up|0
4571726|NCT01367158|7409278|FG007|Overall Study|Lost to Follow-up|1
4571727|NCT01367158|7409279|FG008|Overall Study|Lost to Follow-up|0
4571728|NCT01367158|7409280|FG009|Overall Study|Lost to Follow-up|0
4571729|NCT01367158|7409281|FG010|Overall Study|Lost to Follow-up|1
4571730|NCT01367158|7409271|FG000|Overall Study|Protocol Violation|0
4571731|NCT01367158|7409272|FG001|Overall Study|Protocol Violation|1
4571732|NCT01367158|7409273|FG002|Overall Study|Protocol Violation|0
4571733|NCT01367158|7409274|FG003|Overall Study|Protocol Violation|0
4571734|NCT01367158|7409275|FG004|Overall Study|Protocol Violation|0
4571735|NCT01367158|7409276|FG005|Overall Study|Protocol Violation|0
4571736|NCT01367158|7409277|FG006|Overall Study|Protocol Violation|0
4571737|NCT01367158|7409278|FG007|Overall Study|Protocol Violation|0
4571738|NCT01367158|7409279|FG008|Overall Study|Protocol Violation|0
4571739|NCT01367158|7409280|FG009|Overall Study|Protocol Violation|0
4571740|NCT01367158|7409281|FG010|Overall Study|Protocol Violation|0
4571741|NCT01367236|7409318|FG000|Overall Study|Withdrawal by Subject|3
4571742|NCT01367236|7409319|FG001|Overall Study|Withdrawal by Subject|1
4571743|NCT01367249|7409327|FG000|Overall Study|Withdrawal by Subject|6
4571744|NCT01367249|7409328|FG001|Overall Study|Withdrawal by Subject|6
4571745|NCT01367249|7409327|FG000|Overall Study|Other|3
4571746|NCT01367249|7409328|FG001|Overall Study|Other|10
4571747|NCT01367275|7409338|FG000|Overall Study|Ineligible|1
4571748|NCT01367275|7409338|FG000|Overall Study|Disease Progression|2
4571749|NCT01367457|7409374|FG000|Overall Study|Death|2
4571750|NCT01367457|7409375|FG001|Overall Study|Death|0
4571751|NCT01367457|7409376|FG002|Overall Study|Death|0
4571752|NCT01367457|7409374|FG000|Overall Study|Investigator's decision|2
4571753|NCT01367457|7409375|FG001|Overall Study|Investigator's decision|0
4571754|NCT01367457|7409376|FG002|Overall Study|Investigator's decision|0
4571755|NCT01367457|7409374|FG000|Overall Study|Clinical decline (CD)|2
4571756|NCT01367457|7409375|FG001|Overall Study|Clinical decline (CD)|0
4571757|NCT01367457|7409376|FG002|Overall Study|Clinical decline (CD)|0
4571758|NCT01367457|7409374|FG000|Overall Study|Progression and death|8
4571759|NCT01367457|7409375|FG001|Overall Study|Progression and death|0
4571760|NCT01367457|7409376|FG002|Overall Study|Progression and death|0
4571761|NCT01367457|7409374|FG000|Overall Study|Toxicity|16
4571762|NCT01367457|7409375|FG001|Overall Study|Toxicity|0
4571763|NCT01367457|7409376|FG002|Overall Study|Toxicity|0
4571764|NCT01367457|7409374|FG000|Overall Study|Progression|137
4571765|NCT01367457|7409375|FG001|Overall Study|Progression|0
4571766|NCT01367457|7409376|FG002|Overall Study|Progression|0
4571767|NCT01367457|7409374|FG000|Overall Study|Patient asks for rest + slow progression|1
4571768|NCT01367457|7409375|FG001|Overall Study|Patient asks for rest + slow progression|0
4571769|NCT01367457|7409376|FG002|Overall Study|Patient asks for rest + slow progression|0
4571770|NCT01367457|7409374|FG000|Overall Study|Investigator's opinion, stable disease|1
4571771|NCT01367457|7409375|FG001|Overall Study|Investigator's opinion, stable disease|0
4571772|NCT01367457|7409376|FG002|Overall Study|Investigator's opinion, stable disease|0
4571773|NCT01367457|7409374|FG000|Overall Study|Bleeding from cavernous haemangioma|1
4571774|NCT01367457|7409375|FG001|Overall Study|Bleeding from cavernous haemangioma|0
4571775|NCT01367457|7409376|FG002|Overall Study|Bleeding from cavernous haemangioma|0
4571776|NCT01367457|7409374|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1
4571777|NCT01367457|7409375|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0
4571778|NCT01367457|7409376|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0
4571779|NCT01367457|7409374|FG000|Overall Study|low grade toxicities + stable disease|1
4571780|NCT01367457|7409375|FG001|Overall Study|low grade toxicities + stable disease|0
4571781|NCT01367457|7409376|FG002|Overall Study|low grade toxicities + stable disease|0
4571782|NCT01367457|7409374|FG000|Overall Study|Choledocolithiasis and pancreatitis|1
4571783|NCT01367457|7409375|FG001|Overall Study|Choledocolithiasis and pancreatitis|0
4571784|NCT01367457|7409376|FG002|Overall Study|Choledocolithiasis and pancreatitis|0
4571785|NCT01367457|7409374|FG000|Overall Study|Withdrawal by Subject|1
4571786|NCT01367457|7409375|FG001|Overall Study|Withdrawal by Subject|0
4571787|NCT01367457|7409376|FG002|Overall Study|Withdrawal by Subject|0
4571788|NCT01367457|7409374|FG000|Overall Study|CD, associated leukaemia|1
4571789|NCT01367457|7409375|FG001|Overall Study|CD, associated leukaemia|0
4571790|NCT01367457|7409376|FG002|Overall Study|CD, associated leukaemia|0
4571791|NCT01367457|7409374|FG000|Overall Study|Uncontrolled pain|1
4571792|NCT01367457|7409375|FG001|Overall Study|Uncontrolled pain|0
4571793|NCT01367457|7409376|FG002|Overall Study|Uncontrolled pain|0
4571794|NCT01367457|7409374|FG000|Overall Study|Overall status worsens to grade 4|1
4571795|NCT01367457|7409375|FG001|Overall Study|Overall status worsens to grade 4|0
4571796|NCT01367457|7409376|FG002|Overall Study|Overall status worsens to grade 4|0
4571797|NCT01367457|7409374|FG000|Overall Study|Stabilisation + frequent infections|1
4571798|NCT01367457|7409375|FG001|Overall Study|Stabilisation + frequent infections|0
4571799|NCT01367457|7409376|FG002|Overall Study|Stabilisation + frequent infections|0
4571800|NCT01367457|7409374|FG000|Overall Study|No clinical benefit|1
4571801|NCT01367457|7409375|FG001|Overall Study|No clinical benefit|0
4571802|NCT01367457|7409376|FG002|Overall Study|No clinical benefit|0
4571803|NCT01367457|7409374|FG000|Overall Study|Intestinal obstruction with necrosis|1
4571804|NCT01367457|7409375|FG001|Overall Study|Intestinal obstruction with necrosis|0
4571805|NCT01367457|7409376|FG002|Overall Study|Intestinal obstruction with necrosis|0
4571806|NCT01367457|7409374|FG000|Overall Study|Overall decline|1
4571807|NCT01367457|7409375|FG001|Overall Study|Overall decline|0
4571808|NCT01367457|7409376|FG002|Overall Study|Overall decline|0
4571809|NCT01367457|7409374|FG000|Overall Study|Rejection of treatment|1
4571810|NCT01367457|7409375|FG001|Overall Study|Rejection of treatment|0
4571811|NCT01367457|7409376|FG002|Overall Study|Rejection of treatment|0
4571812|NCT01367457|7409374|FG000|Overall Study|Lost to Follow-up|1
4571813|NCT01367457|7409375|FG001|Overall Study|Lost to Follow-up|0
4571814|NCT01367457|7409376|FG002|Overall Study|Lost to Follow-up|0
4571815|NCT01367457|7409374|FG000|Overall Study|Death from septic shock|1
4571816|NCT01367457|7409375|FG001|Overall Study|Death from septic shock|0
4571817|NCT01367457|7409376|FG002|Overall Study|Death from septic shock|0
4571818|NCT01367457|7409374|FG000|Overall Study|CD, Suspected disease progression (DP)|1
4571819|NCT01367457|7409375|FG001|Overall Study|CD, Suspected disease progression (DP)|0
4571820|NCT01367457|7409376|FG002|Overall Study|CD, Suspected disease progression (DP)|0
4571821|NCT01367457|7409374|FG000|Overall Study|Patient's Wish|1
4571822|NCT01367457|7409375|FG001|Overall Study|Patient's Wish|0
4571823|NCT01367457|7409376|FG002|Overall Study|Patient's Wish|0
4571824|NCT01367457|7409374|FG000|Overall Study|Palliative. Overall decline|1
4571825|NCT01367457|7409375|FG001|Overall Study|Palliative. Overall decline|0
4571826|NCT01367457|7409376|FG002|Overall Study|Palliative. Overall decline|0
4571827|NCT01367457|7409374|FG000|Overall Study|Suspected DP/suspected active infection|1
4571828|NCT01367457|7409375|FG001|Overall Study|Suspected DP/suspected active infection|0
4571829|NCT01367457|7409376|FG002|Overall Study|Suspected DP/suspected active infection|0
4571830|NCT01367665|7409386|FG000|Overall Study|Death|102
4571831|NCT01367665|7409387|FG001|Overall Study|Death|19
4571832|NCT01367665|7409386|FG000|Overall Study|Lost to Follow-up|222
4571833|NCT01367665|7409387|FG001|Overall Study|Lost to Follow-up|22
4571834|NCT01367665|7409386|FG000|Overall Study|Not Done|118
4571835|NCT01367665|7409387|FG001|Overall Study|Not Done|14
4592835|NCT01544595|7440755|FG003|Status at Week 68|Protocol Violation|1
4592836|NCT01544595|7440756|FG004|Status at Week 68|Protocol Violation|0
4592837|NCT01544595|7440757|FG005|Status at Week 68|Protocol Violation|0
4592838|NCT01544595|7440752|FG000|Status at Week 68|Technical problems|1
4592839|NCT01544595|7440753|FG001|Status at Week 68|Technical problems|0
4592840|NCT01544595|7440754|FG002|Status at Week 68|Technical problems|0
4592841|NCT01544595|7440755|FG003|Status at Week 68|Technical problems|1
4592842|NCT01544595|7440756|FG004|Status at Week 68|Technical problems|0
4592843|NCT01544595|7440757|FG005|Status at Week 68|Technical problems|0
4592844|NCT01544595|7440752|FG000|Status at Week 68|Withdrawal by Subject|0
4592845|NCT01544595|7440753|FG001|Status at Week 68|Withdrawal by Subject|1
4592846|NCT01544595|7440754|FG002|Status at Week 68|Withdrawal by Subject|1
4592847|NCT01544595|7440755|FG003|Status at Week 68|Withdrawal by Subject|2
4592848|NCT01544595|7440756|FG004|Status at Week 68|Withdrawal by Subject|0
4592849|NCT01544595|7440757|FG005|Status at Week 68|Withdrawal by Subject|0
4592850|NCT01544595|7440752|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30
4592851|NCT01544595|7440753|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13
4592852|NCT01544595|7440754|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60
4592853|NCT01544595|7440755|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46
4592854|NCT01544595|7440756|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0
4592855|NCT01544595|7440757|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0
4592856|NCT01544595|7440752|FG000|Status at Week 156|Withdrawal by Subject|9
4592857|NCT01544595|7440753|FG001|Status at Week 156|Withdrawal by Subject|10
4592858|NCT01544595|7440754|FG002|Status at Week 156|Withdrawal by Subject|4
4592859|NCT01544595|7440755|FG003|Status at Week 156|Withdrawal by Subject|9
4592860|NCT01544595|7440756|FG004|Status at Week 156|Withdrawal by Subject|20
4592861|NCT01544595|7440757|FG005|Status at Week 156|Withdrawal by Subject|6
4592862|NCT01544595|7440752|FG000|Status at Week 156|Adverse Event|9
4592863|NCT01544595|7440753|FG001|Status at Week 156|Adverse Event|11
4592864|NCT01544595|7440754|FG002|Status at Week 156|Adverse Event|1
4571836|NCT01367704|7409396|FG000|Overall Study|Lost to Follow-up|47
4571837|NCT01367704|7409397|FG001|Overall Study|Lost to Follow-up|161
4571838|NCT01367834|7409405|FG000|Overall Study|Withdrawal by Subject|2
4571839|NCT01367834|7409406|FG001|Overall Study|Withdrawal by Subject|2
4571840|NCT01367834|7409405|FG000|Overall Study|Study was ended.|0
4571841|NCT01367834|7409406|FG001|Overall Study|Study was ended.|1
4571842|NCT01367847|7409414|FG000|Overall Study|Withdrawal by Subject|2
4571843|NCT01367847|7409415|FG001|Overall Study|Withdrawal by Subject|2
4571844|NCT01367886|7409431|FG000|Overall Study|Lost to Follow-up|4
4571845|NCT01367886|7409431|FG000|Overall Study|Lack of Efficacy|2
4571846|NCT01367886|7409431|FG000|Overall Study|Death|1
4571847|NCT01368042|7409436|FG000|Overall Study|Death|14
4571848|NCT01368042|7409436|FG000|Overall Study|Protocol Violation|11
4571849|NCT01368042|7409436|FG000|Overall Study|Lost to Follow-up|4
4571850|NCT01368042|7409436|FG000|Overall Study|Transplanted|1
4571851|NCT01368081|7409453|FG000|Overall Study|Adverse Event|4
4571852|NCT01368081|7409454|FG001|Overall Study|Adverse Event|4
4571853|NCT01368081|7409455|FG002|Overall Study|Adverse Event|3
4571854|NCT01368081|7409456|FG003|Overall Study|Adverse Event|2
4571855|NCT01368081|7409457|FG004|Overall Study|Adverse Event|2
4571856|NCT01368081|7409458|FG005|Overall Study|Adverse Event|5
4571857|NCT01368081|7409459|FG006|Overall Study|Adverse Event|6
4571858|NCT01368081|7409460|FG007|Overall Study|Adverse Event|2
4571859|NCT01368081|7409461|FG008|Overall Study|Adverse Event|3
4571860|NCT01368081|7409462|FG009|Overall Study|Adverse Event|5
4571861|NCT01368081|7409463|FG010|Overall Study|Adverse Event|6
4571862|NCT01368081|7409464|FG011|Overall Study|Adverse Event|1
4571863|NCT01368081|7409465|FG012|Overall Study|Adverse Event|3
4571864|NCT01368081|7409453|FG000|Overall Study|Lack of Efficacy|0
4571865|NCT01368081|7409454|FG001|Overall Study|Lack of Efficacy|1
4571866|NCT01368081|7409455|FG002|Overall Study|Lack of Efficacy|0
4571867|NCT01368081|7409456|FG003|Overall Study|Lack of Efficacy|1
4571868|NCT01368081|7409457|FG004|Overall Study|Lack of Efficacy|0
4571869|NCT01368081|7409458|FG005|Overall Study|Lack of Efficacy|0
4571870|NCT01368081|7409459|FG006|Overall Study|Lack of Efficacy|0
4571871|NCT01368081|7409460|FG007|Overall Study|Lack of Efficacy|2
4571872|NCT01368081|7409461|FG008|Overall Study|Lack of Efficacy|0
4571873|NCT01368081|7409462|FG009|Overall Study|Lack of Efficacy|0
4571874|NCT01368081|7409463|FG010|Overall Study|Lack of Efficacy|0
4571875|NCT01368081|7409464|FG011|Overall Study|Lack of Efficacy|0
4571876|NCT01368081|7409465|FG012|Overall Study|Lack of Efficacy|0
4571877|NCT01368081|7409453|FG000|Overall Study|Protocol Violation|0
4571878|NCT01368081|7409454|FG001|Overall Study|Protocol Violation|0
4571879|NCT01368081|7409455|FG002|Overall Study|Protocol Violation|0
4626087|NCT01836549|7491544|FG000|Overall Study|Did not receive study drug|0
4626088|NCT01836549|7491545|FG001|Overall Study|Did not receive study drug|0
4626089|NCT01836549|7491546|FG002|Overall Study|Did not receive study drug|1
4626090|NCT01836549|7491547|FG003|Overall Study|Did not receive study drug|0
4626091|NCT01836549|7491548|FG004|Overall Study|Did not receive study drug|0
4626092|NCT01836549|7491549|FG005|Overall Study|Did not receive study drug|0
4626093|NCT01836549|7491550|FG006|Overall Study|Did not receive study drug|0
4626094|NCT01836549|7491544|FG000|Overall Study|Patient declared ineligible|0
4626095|NCT01836549|7491545|FG001|Overall Study|Patient declared ineligible|0
4626096|NCT01836549|7491546|FG002|Overall Study|Patient declared ineligible|0
4626097|NCT01836549|7491547|FG003|Overall Study|Patient declared ineligible|1
4626098|NCT01836549|7491548|FG004|Overall Study|Patient declared ineligible|0
4626099|NCT01836549|7491549|FG005|Overall Study|Patient declared ineligible|0
4626100|NCT01836549|7491550|FG006|Overall Study|Patient declared ineligible|0
4626101|NCT01836549|7491544|FG000|Overall Study|Patient inevaluable to start therapy|0
4626102|NCT01836549|7491545|FG001|Overall Study|Patient inevaluable to start therapy|0
4626103|NCT01836549|7491546|FG002|Overall Study|Patient inevaluable to start therapy|0
4626104|NCT01836549|7491547|FG003|Overall Study|Patient inevaluable to start therapy|0
4626105|NCT01836549|7491548|FG004|Overall Study|Patient inevaluable to start therapy|0
4626106|NCT01836549|7491549|FG005|Overall Study|Patient inevaluable to start therapy|0
4626107|NCT01836549|7491550|FG006|Overall Study|Patient inevaluable to start therapy|1
4626108|NCT01837680|7491608|FG000|Overall Study|Lost to Follow-up|2
4571880|NCT01368081|7409456|FG003|Overall Study|Protocol Violation|0
4571881|NCT01368081|7409457|FG004|Overall Study|Protocol Violation|0
4571882|NCT01368081|7409458|FG005|Overall Study|Protocol Violation|1
4571883|NCT01368081|7409459|FG006|Overall Study|Protocol Violation|0
4571884|NCT01368081|7409460|FG007|Overall Study|Protocol Violation|1
4571885|NCT01368081|7409461|FG008|Overall Study|Protocol Violation|0
4571886|NCT01368081|7409462|FG009|Overall Study|Protocol Violation|0
4571887|NCT01368081|7409463|FG010|Overall Study|Protocol Violation|0
4571888|NCT01368081|7409464|FG011|Overall Study|Protocol Violation|0
4571889|NCT01368081|7409465|FG012|Overall Study|Protocol Violation|0
4571890|NCT01368081|7409453|FG000|Overall Study|Lost to Follow-up|0
4571891|NCT01368081|7409454|FG001|Overall Study|Lost to Follow-up|0
4571892|NCT01368081|7409455|FG002|Overall Study|Lost to Follow-up|0
4571893|NCT01368081|7409456|FG003|Overall Study|Lost to Follow-up|0
4626109|NCT01837680|7491609|FG001|Overall Study|Lost to Follow-up|2
4626110|NCT01837680|7491608|FG000|Overall Study|lack of insurance|0
4626111|NCT01837680|7491609|FG001|Overall Study|lack of insurance|2
4571894|NCT01368081|7409457|FG004|Overall Study|Lost to Follow-up|0
4571895|NCT01368081|7409458|FG005|Overall Study|Lost to Follow-up|0
4571896|NCT01368081|7409459|FG006|Overall Study|Lost to Follow-up|0
4571897|NCT01368081|7409460|FG007|Overall Study|Lost to Follow-up|0
4571898|NCT01368081|7409461|FG008|Overall Study|Lost to Follow-up|0
4571899|NCT01368081|7409462|FG009|Overall Study|Lost to Follow-up|0
4571900|NCT01368081|7409463|FG010|Overall Study|Lost to Follow-up|0
4571901|NCT01368081|7409464|FG011|Overall Study|Lost to Follow-up|0
4571902|NCT01368081|7409465|FG012|Overall Study|Lost to Follow-up|1
4571903|NCT01368081|7409453|FG000|Overall Study|Withdrawal by Subject|4
4571904|NCT01368081|7409454|FG001|Overall Study|Withdrawal by Subject|4
4571905|NCT01368081|7409455|FG002|Overall Study|Withdrawal by Subject|1
4571906|NCT01368081|7409456|FG003|Overall Study|Withdrawal by Subject|1
4571907|NCT01368081|7409457|FG004|Overall Study|Withdrawal by Subject|0
4571908|NCT01368081|7409458|FG005|Overall Study|Withdrawal by Subject|3
4571909|NCT01368081|7409459|FG006|Overall Study|Withdrawal by Subject|4
4571910|NCT01368081|7409460|FG007|Overall Study|Withdrawal by Subject|2
4571911|NCT01368081|7409461|FG008|Overall Study|Withdrawal by Subject|5
4571912|NCT01368081|7409462|FG009|Overall Study|Withdrawal by Subject|4
4571913|NCT01368081|7409463|FG010|Overall Study|Withdrawal by Subject|3
4571914|NCT01368081|7409464|FG011|Overall Study|Withdrawal by Subject|2
4571915|NCT01368081|7409465|FG012|Overall Study|Withdrawal by Subject|0
4571916|NCT01368081|7409453|FG000|Overall Study|Other reason not defined above|2
4571917|NCT01368081|7409454|FG001|Overall Study|Other reason not defined above|0
4571918|NCT01368081|7409455|FG002|Overall Study|Other reason not defined above|0
4571919|NCT01368081|7409456|FG003|Overall Study|Other reason not defined above|1
4571920|NCT01368081|7409457|FG004|Overall Study|Other reason not defined above|0
4571921|NCT01368081|7409458|FG005|Overall Study|Other reason not defined above|1
4571922|NCT01368081|7409459|FG006|Overall Study|Other reason not defined above|2
4571923|NCT01368081|7409460|FG007|Overall Study|Other reason not defined above|0
4571924|NCT01368081|7409461|FG008|Overall Study|Other reason not defined above|0
4571925|NCT01368081|7409462|FG009|Overall Study|Other reason not defined above|1
4571926|NCT01368081|7409463|FG010|Overall Study|Other reason not defined above|0
4571927|NCT01368081|7409464|FG011|Overall Study|Other reason not defined above|0
4571928|NCT01368081|7409465|FG012|Overall Study|Other reason not defined above|3
4571929|NCT01368211|7409495|FG000|Second Platelets Transfusion|No need for additional transfusion|1
4571930|NCT01368211|7409496|FG001|Second Platelets Transfusion|No need for additional transfusion|2
4571931|NCT01368276|7409517|FG000|Overall Study|Death|1
4571932|NCT01368276|7409518|FG001|Overall Study|Death|10
4571933|NCT01368406|7409526|FG000|Overall Study|Lost to Follow-up|8
4571934|NCT01368406|7409527|FG001|Overall Study|Lost to Follow-up|4
4571935|NCT01368406|7409526|FG000|Overall Study|Withdrawal by Subject|8
4571936|NCT01368406|7409527|FG001|Overall Study|Withdrawal by Subject|4
4571937|NCT01368406|7409526|FG000|Overall Study|relapse of the disease|3
4571938|NCT01368406|7409527|FG001|Overall Study|relapse of the disease|2
4571939|NCT01368406|7409526|FG000|Overall Study|started working|2
4571940|NCT01368406|7409527|FG001|Overall Study|started working|3
4571941|NCT01368432|7409535|FG000|Overall Study|Lost to Follow-up|0
4571942|NCT01368432|7409536|FG001|Overall Study|Lost to Follow-up|1
4571943|NCT01368497|7409556|FG000|Overall Study|Lost to Follow-up|2
4571944|NCT01368536|7409563|FG000|Overall Study|Adverse Event|5
4571945|NCT01368536|7409564|FG001|Overall Study|Adverse Event|6
4571946|NCT01368536|7409565|FG002|Overall Study|Adverse Event|8
4571947|NCT01368536|7409563|FG000|Overall Study|Abnormal laboratory value(s)|0
4571948|NCT01368536|7409564|FG001|Overall Study|Abnormal laboratory value(s)|1
4571949|NCT01368536|7409565|FG002|Overall Study|Abnormal laboratory value(s)|2
4571950|NCT01368536|7409563|FG000|Overall Study|Abnormal test procedure result(s)|0
4571951|NCT01368536|7409564|FG001|Overall Study|Abnormal test procedure result(s)|0
4571952|NCT01368536|7409565|FG002|Overall Study|Abnormal test procedure result(s)|1
4571953|NCT01368536|7409563|FG000|Overall Study|Unsatisfactory therapeutic effect|7
4571954|NCT01368536|7409564|FG001|Overall Study|Unsatisfactory therapeutic effect|2
4571955|NCT01368536|7409565|FG002|Overall Study|Unsatisfactory therapeutic effect|2
4571956|NCT01368536|7409563|FG000|Overall Study|No longer required study medication|0
4571957|NCT01368536|7409564|FG001|Overall Study|No longer required study medication|0
4571958|NCT01368536|7409565|FG002|Overall Study|No longer required study medication|1
4571959|NCT01368536|7409563|FG000|Overall Study|Withdrawal by Subject|2
4571960|NCT01368536|7409564|FG001|Overall Study|Withdrawal by Subject|5
4571961|NCT01368536|7409565|FG002|Overall Study|Withdrawal by Subject|4
4571962|NCT01368536|7409563|FG000|Overall Study|Lost to Follow-up|3
4571963|NCT01368536|7409564|FG001|Overall Study|Lost to Follow-up|3
4571964|NCT01368536|7409565|FG002|Overall Study|Lost to Follow-up|5
4571965|NCT01368536|7409563|FG000|Overall Study|Administrative problems|34
4571966|NCT01368536|7409564|FG001|Overall Study|Administrative problems|39
4571967|NCT01368536|7409565|FG002|Overall Study|Administrative problems|35
4571968|NCT01368536|7409563|FG000|Overall Study|Protocol deviation|0
4571969|NCT01368536|7409564|FG001|Overall Study|Protocol deviation|3
4571970|NCT01368536|7409565|FG002|Overall Study|Protocol deviation|1
4571971|NCT01368562|7409574|FG000|Overall Study|Adverse Event|1
4571972|NCT01368562|7409574|FG000|Overall Study|Disease progression|1
4571973|NCT01368562|7409574|FG000|Overall Study|Lost to Follow-up|1
4571974|NCT01368562|7409574|FG000|Overall Study|Death|6
4571975|NCT01368562|7409574|FG000|Overall Study|Unresponsive to treatment|5
4571976|NCT01368562|7409574|FG000|Overall Study|Other|3
4571977|NCT01368562|7409574|FG000|Overall Study|Other than specified|2
4571978|NCT01368614|7409578|FG000|Screening Period|Screen Failure|58
4571979|NCT01368614|7409579|FG001|Screening Period|Screen Failure|0
4571980|NCT01368614|7409580|FG002|Screening Period|Screen Failure|0
4571981|NCT01368614|7409581|FG003|Screening Period|Screen Failure|0
4571982|NCT01368614|7409578|FG000|Study Period|Withdrawal by Subject|0
4571983|NCT01368614|7409579|FG001|Study Period|Withdrawal by Subject|1
4571984|NCT01368614|7409580|FG002|Study Period|Withdrawal by Subject|1
4571985|NCT01368614|7409581|FG003|Study Period|Withdrawal by Subject|3
4571986|NCT01368614|7409578|FG000|Study Period|Lost to Follow-up|0
4571987|NCT01368614|7409579|FG001|Study Period|Lost to Follow-up|0
4571988|NCT01368614|7409580|FG002|Study Period|Lost to Follow-up|1
4571989|NCT01368614|7409581|FG003|Study Period|Lost to Follow-up|0
4571990|NCT01368835|7409616|FG000|Overall Study|Inclusion criteria/photography quality|22
4571991|NCT01368835|7409616|FG000|Overall Study|Lost to Follow-up|11
4571992|NCT01368900|7409668|FG000|Overall Study|Lost to Follow-up|7
4571993|NCT01368965|7409674|FG000|Overall Study|Lost to Follow-up|12
4571994|NCT01369069|7409686|FG000|Overall Study|Lost to Follow-up|8
4571995|NCT01369069|7409687|FG001|Overall Study|Lost to Follow-up|9
4571996|NCT01369069|7409686|FG000|Overall Study|Withdrawal by Subject|9
4571997|NCT01369069|7409687|FG001|Overall Study|Withdrawal by Subject|7
4571998|NCT01369199|7409698|FG000|Overall Study|Withdrawal by Subject|1
4571999|NCT01369199|7409698|FG000|Overall Study|Lost to Follow-up|2
4572000|NCT01369225|7409708|FG000|Overall Study|Withdrawal by Subject|1
4572001|NCT01369225|7409709|FG001|Overall Study|Withdrawal by Subject|0
4572002|NCT01369225|7409710|FG002|Overall Study|Withdrawal by Subject|2
4572003|NCT01369225|7409711|FG003|Overall Study|Withdrawal by Subject|1
4572004|NCT01369225|7409712|FG004|Overall Study|Withdrawal by Subject|0
4572005|NCT01369225|7409713|FG005|Overall Study|Withdrawal by Subject|0
4572006|NCT01369225|7409708|FG000|Overall Study|Does Not Meet Entrance Criteria|0
4572007|NCT01369225|7409709|FG001|Overall Study|Does Not Meet Entrance Criteria|0
4572008|NCT01369225|7409710|FG002|Overall Study|Does Not Meet Entrance Criteria|1
4572009|NCT01369225|7409711|FG003|Overall Study|Does Not Meet Entrance Criteria|0
4572010|NCT01369225|7409712|FG004|Overall Study|Does Not Meet Entrance Criteria|0
4572011|NCT01369225|7409713|FG005|Overall Study|Does Not Meet Entrance Criteria|0
4572012|NCT01369225|7409708|FG000|Overall Study|Other|1
4572013|NCT01369225|7409709|FG001|Overall Study|Other|0
4572014|NCT01369225|7409710|FG002|Overall Study|Other|0
4572015|NCT01369225|7409711|FG003|Overall Study|Other|0
4572016|NCT01369225|7409712|FG004|Overall Study|Other|1
4572017|NCT01369225|7409713|FG005|Overall Study|Other|0
4572018|NCT01369225|7409708|FG000|Overall Study|Adverse Event|0
4572019|NCT01369225|7409709|FG001|Overall Study|Adverse Event|0
4572020|NCT01369225|7409710|FG002|Overall Study|Adverse Event|0
4572021|NCT01369225|7409711|FG003|Overall Study|Adverse Event|1
4572022|NCT01369225|7409712|FG004|Overall Study|Adverse Event|1
4572023|NCT01369225|7409713|FG005|Overall Study|Adverse Event|0
4572024|NCT01369329|7409730|FG000|Overall Study|Withdrawal by Subject|8
4572025|NCT01369329|7409731|FG001|Overall Study|Withdrawal by Subject|6
4572026|NCT01369329|7409732|FG002|Overall Study|Withdrawal by Subject|10
4572027|NCT01369329|7409730|FG000|Overall Study|Lost to Follow-up|2
4572028|NCT01369329|7409731|FG001|Overall Study|Lost to Follow-up|2
4572029|NCT01369329|7409732|FG002|Overall Study|Lost to Follow-up|2
4572030|NCT01369329|7409730|FG000|Overall Study|Other|2
4572031|NCT01369329|7409731|FG001|Overall Study|Other|3
4572032|NCT01369329|7409732|FG002|Overall Study|Other|2
4572033|NCT01369342|7409743|FG000|Overall Study|Withdrawal by Subject|7
4572034|NCT01369342|7409744|FG001|Overall Study|Withdrawal by Subject|7
4572035|NCT01369342|7409745|FG002|Overall Study|Withdrawal by Subject|2
4572036|NCT01369342|7409743|FG000|Overall Study|Lost to Follow-up|5
4572037|NCT01369342|7409744|FG001|Overall Study|Lost to Follow-up|2
4572038|NCT01369342|7409745|FG002|Overall Study|Lost to Follow-up|1
4572039|NCT01369342|7409743|FG000|Overall Study|Not Treated|1
4572040|NCT01369342|7409744|FG001|Overall Study|Not Treated|0
4572041|NCT01369342|7409745|FG002|Overall Study|Not Treated|0
4572042|NCT01369355|7409759|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9
4572043|NCT01369355|7409760|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12
4572044|NCT01369355|7409761|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6
4572045|NCT01369355|7409762|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7
4572046|NCT01369355|7409763|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14
4572047|NCT01369355|7409764|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25
4572048|NCT01369355|7409765|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0
4572049|NCT01369355|7409766|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0
4572050|NCT01369355|7409767|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0
4572051|NCT01369355|7409759|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15
4572052|NCT01369355|7409760|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14
4572053|NCT01369355|7409761|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15
4572054|NCT01369355|7409762|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15
4572055|NCT01369355|7409763|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126
4572056|NCT01369355|7409764|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217
4572057|NCT01369355|7409765|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0
4572058|NCT01369355|7409766|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0
4572059|NCT01369355|7409767|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0
4626112|NCT01837680|7491608|FG000|Overall Study|allergic reaction|6
4626113|NCT01837680|7491609|FG001|Overall Study|allergic reaction|0
4572060|NCT01369355|7409759|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
4572061|NCT01369355|7409760|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1
4572062|NCT01369355|7409761|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1
4572063|NCT01369355|7409762|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
4572064|NCT01369355|7409763|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
4572065|NCT01369355|7409764|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2
4572066|NCT01369355|7409765|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
4572067|NCT01369355|7409766|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
4572068|NCT01369355|7409767|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
4572069|NCT01369355|7409759|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1
4572070|NCT01369355|7409760|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0
4572071|NCT01369355|7409761|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1
4572072|NCT01369355|7409762|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2
4572073|NCT01369355|7409763|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5
4572074|NCT01369355|7409764|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6
4572075|NCT01369355|7409765|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0
4572076|NCT01369355|7409766|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0
4572077|NCT01369355|7409767|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0
4572078|NCT01369355|7409759|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6
4572079|NCT01369355|7409760|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2
4572080|NCT01369355|7409761|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7
4572081|NCT01369355|7409762|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6
4572082|NCT01369355|7409763|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8
4572083|NCT01369355|7409764|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22
4572084|NCT01369355|7409765|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0
4572085|NCT01369355|7409766|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0
4572086|NCT01369355|7409767|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0
4572087|NCT01369355|7409759|FG000|Week 0 - Week 44 (Maintenance)|Other|0
4572088|NCT01369355|7409760|FG001|Week 0 - Week 44 (Maintenance)|Other|0
4572089|NCT01369355|7409761|FG002|Week 0 - Week 44 (Maintenance)|Other|1
4572090|NCT01369355|7409762|FG003|Week 0 - Week 44 (Maintenance)|Other|0
4572091|NCT01369355|7409763|FG004|Week 0 - Week 44 (Maintenance)|Other|1
4572092|NCT01369355|7409764|FG005|Week 0 - Week 44 (Maintenance)|Other|0
4572093|NCT01369355|7409765|FG006|Week 0 - Week 44 (Maintenance)|Other|0
4572094|NCT01369355|7409766|FG007|Week 0 - Week 44 (Maintenance)|Other|0
4572095|NCT01369355|7409767|FG008|Week 0 - Week 44 (Maintenance)|Other|0
4572096|NCT01369355|7409759|FG000|Long-term Extension (Week 44-272)|Adverse Event|0
4572097|NCT01369355|7409760|FG001|Long-term Extension (Week 44-272)|Adverse Event|0
4572098|NCT01369355|7409761|FG002|Long-term Extension (Week 44-272)|Adverse Event|0
4572099|NCT01369355|7409762|FG003|Long-term Extension (Week 44-272)|Adverse Event|0
4572100|NCT01369355|7409763|FG004|Long-term Extension (Week 44-272)|Adverse Event|0
4572101|NCT01369355|7409764|FG005|Long-term Extension (Week 44-272)|Adverse Event|0
4572102|NCT01369355|7409765|FG006|Long-term Extension (Week 44-272)|Adverse Event|15
4572103|NCT01369355|7409766|FG007|Long-term Extension (Week 44-272)|Adverse Event|29
4572104|NCT01369355|7409767|FG008|Long-term Extension (Week 44-272)|Adverse Event|53
4572105|NCT01369355|7409759|FG000|Long-term Extension (Week 44-272)|Death|0
4572106|NCT01369355|7409760|FG001|Long-term Extension (Week 44-272)|Death|0
4572107|NCT01369355|7409761|FG002|Long-term Extension (Week 44-272)|Death|0
4572108|NCT01369355|7409762|FG003|Long-term Extension (Week 44-272)|Death|0
4572109|NCT01369355|7409763|FG004|Long-term Extension (Week 44-272)|Death|0
4572110|NCT01369355|7409764|FG005|Long-term Extension (Week 44-272)|Death|0
4572111|NCT01369355|7409765|FG006|Long-term Extension (Week 44-272)|Death|0
4572112|NCT01369355|7409766|FG007|Long-term Extension (Week 44-272)|Death|1
4572113|NCT01369355|7409767|FG008|Long-term Extension (Week 44-272)|Death|3
4572114|NCT01369355|7409759|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0
4572115|NCT01369355|7409760|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0
4572116|NCT01369355|7409761|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0
4572117|NCT01369355|7409762|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0
4572118|NCT01369355|7409763|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0
4572119|NCT01369355|7409764|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0
4572120|NCT01369355|7409765|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12
4572121|NCT01369355|7409766|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26
4572122|NCT01369355|7409767|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29
4572123|NCT01369355|7409759|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0
4572124|NCT01369355|7409760|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0
4572125|NCT01369355|7409761|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0
4572126|NCT01369355|7409762|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0
4572127|NCT01369355|7409763|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0
4572128|NCT01369355|7409764|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0
4572129|NCT01369355|7409765|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0
4572130|NCT01369355|7409766|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1
4626114|NCT01837680|7491608|FG000|Overall Study|switched to oral hypoglycemic or diet|2
4572131|NCT01369355|7409767|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2
4572132|NCT01369355|7409759|FG000|Long-term Extension (Week 44-272)|Physician Decision|0
4572133|NCT01369355|7409760|FG001|Long-term Extension (Week 44-272)|Physician Decision|0
4572134|NCT01369355|7409761|FG002|Long-term Extension (Week 44-272)|Physician Decision|0
4572135|NCT01369355|7409762|FG003|Long-term Extension (Week 44-272)|Physician Decision|0
4572136|NCT01369355|7409763|FG004|Long-term Extension (Week 44-272)|Physician Decision|0
4572137|NCT01369355|7409764|FG005|Long-term Extension (Week 44-272)|Physician Decision|0
4572138|NCT01369355|7409765|FG006|Long-term Extension (Week 44-272)|Physician Decision|1
4572139|NCT01369355|7409766|FG007|Long-term Extension (Week 44-272)|Physician Decision|5
4572140|NCT01369355|7409767|FG008|Long-term Extension (Week 44-272)|Physician Decision|11
4572141|NCT01369355|7409759|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0
4572142|NCT01369355|7409760|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0
4572143|NCT01369355|7409761|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0
4572144|NCT01369355|7409762|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0
4572145|NCT01369355|7409763|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0
4572146|NCT01369355|7409764|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0
4572147|NCT01369355|7409765|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1
4572148|NCT01369355|7409766|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5
4572149|NCT01369355|7409767|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9
4572150|NCT01369355|7409759|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
4572151|NCT01369355|7409760|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
4572152|NCT01369355|7409761|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
4572153|NCT01369355|7409762|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
4572154|NCT01369355|7409763|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
4572155|NCT01369355|7409764|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
4572156|NCT01369355|7409765|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12
4572157|NCT01369355|7409766|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30
4572158|NCT01369355|7409767|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47
4572159|NCT01369355|7409759|FG000|Long-term Extension (Week 44-272)|Other|0
4572160|NCT01369355|7409760|FG001|Long-term Extension (Week 44-272)|Other|0
4572161|NCT01369355|7409761|FG002|Long-term Extension (Week 44-272)|Other|0
4572162|NCT01369355|7409762|FG003|Long-term Extension (Week 44-272)|Other|0
4572163|NCT01369355|7409763|FG004|Long-term Extension (Week 44-272)|Other|0
4572164|NCT01369355|7409764|FG005|Long-term Extension (Week 44-272)|Other|0
4572165|NCT01369355|7409765|FG006|Long-term Extension (Week 44-272)|Other|110
4572166|NCT01369355|7409766|FG007|Long-term Extension (Week 44-272)|Other|9
4572167|NCT01369355|7409767|FG008|Long-term Extension (Week 44-272)|Other|17
4572168|NCT01369433|7409786|FG000|Overall Study|Adverse Event|31
4572169|NCT01369433|7409787|FG001|Overall Study|Adverse Event|1
4572170|NCT01369433|7409786|FG000|Overall Study|Required significant surgical procedure|1
4572171|NCT01369433|7409787|FG001|Overall Study|Required significant surgical procedure|0
4572172|NCT01369433|7409786|FG000|Overall Study|Non-compliance|1
4572173|NCT01369433|7409787|FG001|Overall Study|Non-compliance|0
4572174|NCT01369433|7409786|FG000|Overall Study|Withdrawal by Subject|5
4572175|NCT01369433|7409787|FG001|Overall Study|Withdrawal by Subject|2
4572176|NCT01369433|7409786|FG000|Overall Study|Study terminated by Sponsor|67
4572177|NCT01369433|7409787|FG001|Overall Study|Study terminated by Sponsor|0
4572178|NCT01369433|7409786|FG000|Overall Study|Lost to Follow-up|1
4572179|NCT01369433|7409787|FG001|Overall Study|Lost to Follow-up|0
4572180|NCT01369433|7409786|FG000|Overall Study|Death|5
4572181|NCT01369433|7409787|FG001|Overall Study|Death|0
4572182|NCT01369433|7409786|FG000|Overall Study|Investigator discretion|6
4572183|NCT01369433|7409787|FG001|Overall Study|Investigator discretion|1
4572184|NCT01369433|7409786|FG000|Overall Study|Progressive Disease|92
4572185|NCT01369433|7409787|FG001|Overall Study|Progressive Disease|12
4572186|NCT01369485|7409795|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7
4572187|NCT01369485|7409796|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5
4572188|NCT01369485|7409795|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12
4572189|NCT01369485|7409796|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8
4572190|NCT01369485|7409795|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2
4572191|NCT01369485|7409796|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4
4572192|NCT01369485|7409795|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2
4572193|NCT01369485|7409796|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0
4572194|NCT01369485|7409795|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11
4572195|NCT01369485|7409796|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9
4572196|NCT01369485|7409795|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2
4572197|NCT01369485|7409796|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3
4572198|NCT01369485|7409795|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3
4572199|NCT01369485|7409796|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4
4572200|NCT01369485|7409795|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17
4572201|NCT01369485|7409796|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20
4572202|NCT01369485|7409795|FG000|Open Label Phase (Week 12 to Month 12)|Death|0
4572203|NCT01369485|7409796|FG001|Open Label Phase (Week 12 to Month 12)|Death|1
4572204|NCT01369485|7409795|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0
4572205|NCT01369485|7409796|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3
4572206|NCT01369498|7409814|FG000|Overall Study|Lack of Efficacy|9
4572207|NCT01369498|7409815|FG001|Overall Study|Lack of Efficacy|9
4572208|NCT01369498|7409816|FG002|Overall Study|Lack of Efficacy|1
4572209|NCT01369498|7409817|FG003|Overall Study|Lack of Efficacy|3
4572210|NCT01369498|7409814|FG000|Overall Study|Adverse Event|1
4572211|NCT01369498|7409815|FG001|Overall Study|Adverse Event|2
4572212|NCT01369498|7409816|FG002|Overall Study|Adverse Event|0
4572213|NCT01369498|7409817|FG003|Overall Study|Adverse Event|1
4572214|NCT01369498|7409814|FG000|Overall Study|Withdrawal of Consent|0
4572215|NCT01369498|7409815|FG001|Overall Study|Withdrawal of Consent|1
4572216|NCT01369498|7409816|FG002|Overall Study|Withdrawal of Consent|1
4572217|NCT01369498|7409817|FG003|Overall Study|Withdrawal of Consent|1
4572218|NCT01369498|7409814|FG000|Overall Study|Death|0
4572219|NCT01369498|7409815|FG001|Overall Study|Death|0
4572220|NCT01369498|7409816|FG002|Overall Study|Death|1
4572221|NCT01369498|7409817|FG003|Overall Study|Death|0
4572222|NCT01369498|7409814|FG000|Overall Study|Investigator's Discretion|1
4572223|NCT01369498|7409815|FG001|Overall Study|Investigator's Discretion|0
4572224|NCT01369498|7409816|FG002|Overall Study|Investigator's Discretion|1
4572225|NCT01369498|7409817|FG003|Overall Study|Investigator's Discretion|3
4572226|NCT01369498|7409814|FG000|Overall Study|Unknown Reason|1
4572227|NCT01369498|7409815|FG001|Overall Study|Unknown Reason|0
4572228|NCT01369498|7409816|FG002|Overall Study|Unknown Reason|11
4572229|NCT01369498|7409817|FG003|Overall Study|Unknown Reason|6
4572230|NCT01369498|7409814|FG000|Overall Study|Disease Progression|0
4572231|NCT01369498|7409815|FG001|Overall Study|Disease Progression|0
4572232|NCT01369498|7409816|FG002|Overall Study|Disease Progression|0
4572233|NCT01369498|7409817|FG003|Overall Study|Disease Progression|1
4572234|NCT01369511|7409832|FG000|Overall Study|Adverse Event|1
4572235|NCT01369511|7409833|FG001|Overall Study|Adverse Event|1
4572236|NCT01369511|7409834|FG002|Overall Study|Adverse Event|5
4572237|NCT01369511|7409835|FG003|Overall Study|Adverse Event|0
4572238|NCT01369511|7409832|FG000|Overall Study|Entry criteria not met|2
4572239|NCT01369511|7409833|FG001|Overall Study|Entry criteria not met|0
4572240|NCT01369511|7409834|FG002|Overall Study|Entry criteria not met|0
4572241|NCT01369511|7409835|FG003|Overall Study|Entry criteria not met|1
4572242|NCT01369511|7409832|FG000|Overall Study|Lost to Follow-up|0
4572243|NCT01369511|7409833|FG001|Overall Study|Lost to Follow-up|1
4572244|NCT01369511|7409834|FG002|Overall Study|Lost to Follow-up|1
4572245|NCT01369511|7409835|FG003|Overall Study|Lost to Follow-up|2
4572246|NCT01369511|7409832|FG000|Overall Study|Protocol Violation|0
4572247|NCT01369511|7409833|FG001|Overall Study|Protocol Violation|1
4572248|NCT01369511|7409834|FG002|Overall Study|Protocol Violation|0
4572249|NCT01369511|7409835|FG003|Overall Study|Protocol Violation|2
4572250|NCT01369511|7409832|FG000|Overall Study|Physician Decision|3
4572251|NCT01369511|7409833|FG001|Overall Study|Physician Decision|4
4572252|NCT01369511|7409834|FG002|Overall Study|Physician Decision|0
4572253|NCT01369511|7409835|FG003|Overall Study|Physician Decision|0
4572254|NCT01369511|7409832|FG000|Overall Study|Sponsor decision|2
4572255|NCT01369511|7409833|FG001|Overall Study|Sponsor decision|0
4572256|NCT01369511|7409834|FG002|Overall Study|Sponsor decision|1
4572257|NCT01369511|7409835|FG003|Overall Study|Sponsor decision|0
4572258|NCT01369511|7409832|FG000|Overall Study|Withdrawal by Subject|5
4572259|NCT01369511|7409833|FG001|Overall Study|Withdrawal by Subject|6
4572260|NCT01369511|7409834|FG002|Overall Study|Withdrawal by Subject|4
4572261|NCT01369511|7409835|FG003|Overall Study|Withdrawal by Subject|6
4572262|NCT01369615|7409847|FG000|Overall Study|Withdrawal by Subject|0
4572263|NCT01369615|7409848|FG001|Overall Study|Withdrawal by Subject|1
4572264|NCT01369615|7409847|FG000|Overall Study|Lost to Follow-up|0
4572265|NCT01369615|7409848|FG001|Overall Study|Lost to Follow-up|1
4572266|NCT01369680|7409858|FG000|Overall Study|Lost to Follow-up|0
4572267|NCT01369680|7409859|FG001|Overall Study|Lost to Follow-up|0
4572268|NCT01369680|7409860|FG002|Overall Study|Lost to Follow-up|1
4572269|NCT01369680|7409861|FG003|Overall Study|Lost to Follow-up|2
4572270|NCT01369784|7409920|FG000|Overall Study|Protocol Violation|12
4572271|NCT01369849|7409927|FG000|Overall Study|Ineligible prior to treatment|0
4572272|NCT01369849|7409928|FG001|Overall Study|Ineligible prior to treatment|0
4572273|NCT01369849|7409929|FG002|Overall Study|Ineligible prior to treatment|1
4572274|NCT01369849|7409927|FG000|Overall Study|Ineligible after receiving treatment|0
4572275|NCT01369849|7409928|FG001|Overall Study|Ineligible after receiving treatment|1
4572276|NCT01369849|7409929|FG002|Overall Study|Ineligible after receiving treatment|0
4572277|NCT01370005|7409964|FG000|Overall Study|Not treated|1
4572278|NCT01370005|7409965|FG001|Overall Study|Not treated|0
4572279|NCT01370005|7409966|FG002|Overall Study|Not treated|0
4572280|NCT01370005|7409964|FG000|Overall Study|Adverse Event|5
4572281|NCT01370005|7409965|FG001|Overall Study|Adverse Event|5
4572282|NCT01370005|7409966|FG002|Overall Study|Adverse Event|6
4572283|NCT01370005|7409964|FG000|Overall Study|Lack of Efficacy|1
4572284|NCT01370005|7409965|FG001|Overall Study|Lack of Efficacy|0
4572285|NCT01370005|7409966|FG002|Overall Study|Lack of Efficacy|0
4572286|NCT01370005|7409964|FG000|Overall Study|Non compliant with protocol|0
4572287|NCT01370005|7409965|FG001|Overall Study|Non compliant with protocol|1
4572288|NCT01370005|7409966|FG002|Overall Study|Non compliant with protocol|2
4572289|NCT01370005|7409964|FG000|Overall Study|Lost to Follow-up|1
4572290|NCT01370005|7409965|FG001|Overall Study|Lost to Follow-up|1
4572291|NCT01370005|7409966|FG002|Overall Study|Lost to Follow-up|1
4572292|NCT01370005|7409964|FG000|Overall Study|Patient refusal to continue,not due toAE|5
4572293|NCT01370005|7409965|FG001|Overall Study|Patient refusal to continue,not due toAE|4
4572294|NCT01370005|7409966|FG002|Overall Study|Patient refusal to continue,not due toAE|0
4572295|NCT01370005|7409964|FG000|Overall Study|Other reason not defined above|3
4572296|NCT01370005|7409965|FG001|Overall Study|Other reason not defined above|0
4572297|NCT01370005|7409966|FG002|Overall Study|Other reason not defined above|2
4572298|NCT01370018|7409974|FG000|Overall Study|Did not meet criteria for analysis|1
4572299|NCT01370083|7409980|FG000|Overall Study|Lost to Follow-up|2
4572300|NCT01370083|7409981|FG001|Overall Study|Lost to Follow-up|0
4572301|NCT01370083|7409980|FG000|Overall Study|Adverse Event|0
4572302|NCT01370083|7409981|FG001|Overall Study|Adverse Event|1
4572303|NCT01370213|7410007|FG000|Overall Study|Early Death|1
4572304|NCT01370213|7410008|FG001|Overall Study|Early Death|0
4572305|NCT01370213|7410009|FG002|Overall Study|Early Death|0
4572306|NCT01370213|7410007|FG000|Overall Study|Not evaluable|0
4572307|NCT01370213|7410008|FG001|Overall Study|Not evaluable|2
4572308|NCT01370213|7410009|FG002|Overall Study|Not evaluable|0
4572309|NCT01370265|7410016|FG000|First Intervention|Adverse Event|1
4572310|NCT01370265|7410017|FG001|First Intervention|Adverse Event|1
4572311|NCT01370317|7410026|FG000|Overall Study|Participant withdrew consent|1
4572312|NCT01370317|7410027|FG001|Overall Study|Participant withdrew consent|0
4572313|NCT01370317|7410026|FG000|Overall Study|Protocol deviation|0
4572314|NCT01370317|7410027|FG001|Overall Study|Protocol deviation|1
4572315|NCT01370356|7410035|FG000|Overall Study|Death|1
4572316|NCT01370356|7410036|FG001|Overall Study|Death|0
4572317|NCT01370356|7410035|FG000|Overall Study|Lack of Efficacy|6
4572318|NCT01370356|7410036|FG001|Overall Study|Lack of Efficacy|28
4572319|NCT01370356|7410035|FG000|Overall Study|Lost to Follow-up|76
4572320|NCT01370356|7410036|FG001|Overall Study|Lost to Follow-up|81
4572321|NCT01370356|7410035|FG000|Overall Study|Withdrawal by Subject|54
4626115|NCT01837680|7491609|FG001|Overall Study|switched to oral hypoglycemic or diet|4
4626116|NCT01837719|7491615|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1
4626117|NCT01837719|7491615|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1
4626118|NCT01837797|7491633|FG000|Period 1|Adverse Event|9
4626119|NCT01837797|7491634|FG001|Period 1|Adverse Event|0
4626120|NCT01837797|7491635|FG002|Period 1|Adverse Event|0
4626121|NCT01837797|7491636|FG003|Period 1|Adverse Event|0
4626122|NCT01837797|7491637|FG004|Period 1|Adverse Event|0
4626123|NCT01837797|7491633|FG000|Period 1|Withdrawal by Subject|6
4626124|NCT01837797|7491634|FG001|Period 1|Withdrawal by Subject|0
4626125|NCT01837797|7491635|FG002|Period 1|Withdrawal by Subject|0
4626126|NCT01837797|7491636|FG003|Period 1|Withdrawal by Subject|0
4626127|NCT01837797|7491637|FG004|Period 1|Withdrawal by Subject|0
4626128|NCT01837797|7491633|FG000|Period 1|Administrative reasons|76
4626129|NCT01837797|7491634|FG001|Period 1|Administrative reasons|0
4626130|NCT01837797|7491635|FG002|Period 1|Administrative reasons|0
4626131|NCT01837797|7491636|FG003|Period 1|Administrative reasons|0
4626132|NCT01837797|7491637|FG004|Period 1|Administrative reasons|0
4626133|NCT01837797|7491633|FG000|Period 1|Withdrawal of consent before treatment|1
4626134|NCT01837797|7491634|FG001|Period 1|Withdrawal of consent before treatment|0
4626135|NCT01837797|7491635|FG002|Period 1|Withdrawal of consent before treatment|0
4626136|NCT01837797|7491636|FG003|Period 1|Withdrawal of consent before treatment|0
4626137|NCT01837797|7491637|FG004|Period 1|Withdrawal of consent before treatment|0
4626138|NCT01837797|7491633|FG000|Period 1|Other|10
4626139|NCT01837797|7491634|FG001|Period 1|Other|0
4626140|NCT01837797|7491635|FG002|Period 1|Other|0
4626141|NCT01837797|7491636|FG003|Period 1|Other|0
4626142|NCT01837797|7491637|FG004|Period 1|Other|0
4626143|NCT01837797|7491633|FG000|Period 2|Administrative or other reasons|0
4626144|NCT01837797|7491634|FG001|Period 2|Administrative or other reasons|5
4626145|NCT01837797|7491635|FG002|Period 2|Administrative or other reasons|2
4626146|NCT01837797|7491636|FG003|Period 2|Administrative or other reasons|4
4626147|NCT01837797|7491637|FG004|Period 2|Administrative or other reasons|0
4626148|NCT01837797|7491633|FG000|Period 2|Adverse Event|0
4626149|NCT01837797|7491634|FG001|Period 2|Adverse Event|0
4626150|NCT01837797|7491635|FG002|Period 2|Adverse Event|0
4626151|NCT01837797|7491636|FG003|Period 2|Adverse Event|1
4626152|NCT01837797|7491637|FG004|Period 2|Adverse Event|0
4626153|NCT01837797|7491633|FG000|Period 3|Adverse Event|0
4626154|NCT01837797|7491634|FG001|Period 3|Adverse Event|0
4626155|NCT01837797|7491635|FG002|Period 3|Adverse Event|0
4626156|NCT01837797|7491636|FG003|Period 3|Adverse Event|0
4626157|NCT01837797|7491637|FG004|Period 3|Adverse Event|1
4626158|NCT01837797|7491633|FG000|Period 3|Administrative reasons|0
4626159|NCT01837797|7491634|FG001|Period 3|Administrative reasons|0
4626160|NCT01837797|7491635|FG002|Period 3|Administrative reasons|0
4626161|NCT01837797|7491636|FG003|Period 3|Administrative reasons|0
4626162|NCT01837797|7491637|FG004|Period 3|Administrative reasons|20
4626163|NCT01837797|7491633|FG000|Period 3|Other|0
4572322|NCT01370356|7410036|FG001|Overall Study|Withdrawal by Subject|59
4572323|NCT01370356|7410035|FG000|Overall Study|Reason not specified|39
4626164|NCT01837797|7491634|FG001|Period 3|Other|0
4626165|NCT01837797|7491635|FG002|Period 3|Other|0
4626166|NCT01837797|7491636|FG003|Period 3|Other|0
4626167|NCT01837797|7491637|FG004|Period 3|Other|2
4572324|NCT01370356|7410036|FG001|Overall Study|Reason not specified|43
4572325|NCT01370356|7410035|FG000|Overall Study|Protocol Violation|3
4572326|NCT01370356|7410036|FG001|Overall Study|Protocol Violation|3
4572327|NCT01370356|7410035|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12
4572328|NCT01370356|7410036|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9
4572329|NCT01370356|7410035|FG000|Overall Study|AE Not Related to Study Drug|1
4572330|NCT01370356|7410036|FG001|Overall Study|AE Not Related to Study Drug|4
4572331|NCT01370408|7410055|FG000|Overall Study|treatment failure|9
4572332|NCT01370499|7410071|FG000|Overall Study|Adverse Event|38
4572333|NCT01370499|7410072|FG001|Overall Study|Adverse Event|12
4572334|NCT01370499|7410071|FG000|Overall Study|Lack of Efficacy|4
4572335|NCT01370499|7410072|FG001|Overall Study|Lack of Efficacy|2
4572336|NCT01370499|7410071|FG000|Overall Study|Lost to Follow-up|2
4572337|NCT01370499|7410072|FG001|Overall Study|Lost to Follow-up|1
4572338|NCT01370499|7410071|FG000|Overall Study|Physician Decision|3
4572339|NCT01370499|7410072|FG001|Overall Study|Physician Decision|3
4572340|NCT01370499|7410071|FG000|Overall Study|Protocol Violation|5
4572341|NCT01370499|7410072|FG001|Overall Study|Protocol Violation|4
4572342|NCT01370499|7410071|FG000|Overall Study|Withdrawal by Subject|18
4572343|NCT01370499|7410072|FG001|Overall Study|Withdrawal by Subject|7
4572344|NCT01370499|7410071|FG000|Overall Study|Sponsor Decision|41
4572345|NCT01370499|7410072|FG001|Overall Study|Sponsor Decision|15
4572346|NCT01370525|7410082|FG000|Overall Study|Voluntary Discontinuation by Subject|2
4572347|NCT01370525|7410083|FG001|Overall Study|Voluntary Discontinuation by Subject|3
4572348|NCT01370525|7410082|FG000|Overall Study|Eligibility criteria not fulfilled|2
4572349|NCT01370525|7410083|FG001|Overall Study|Eligibility criteria not fulfilled|0
4572350|NCT01370525|7410082|FG000|Overall Study|Adverse Event|0
4572351|NCT01370525|7410083|FG001|Overall Study|Adverse Event|1
4572352|NCT01370525|7410082|FG000|Overall Study|Protocol Violation|2
4572353|NCT01370525|7410083|FG001|Overall Study|Protocol Violation|1
4572354|NCT01370525|7410082|FG000|Overall Study|Lost to follow up|2
4572355|NCT01370525|7410083|FG001|Overall Study|Lost to follow up|6
4572356|NCT01370538|7410091|FG000|Overall Study|Voluntary Discontinuation by Subject|3
4572357|NCT01370538|7410092|FG001|Overall Study|Voluntary Discontinuation by Subject|2
4572358|NCT01370538|7410091|FG000|Overall Study|Eligibility criteria not fulfilled|0
4572359|NCT01370538|7410092|FG001|Overall Study|Eligibility criteria not fulfilled|1
4572360|NCT01370538|7410091|FG000|Overall Study|Adverse Event|1
4572361|NCT01370538|7410092|FG001|Overall Study|Adverse Event|0
4572362|NCT01370538|7410091|FG000|Overall Study|Protocol Violation|8
4572363|NCT01370538|7410092|FG001|Overall Study|Protocol Violation|5
4572364|NCT01370538|7410091|FG000|Overall Study|Development of study specific withdrawal|1
4572365|NCT01370538|7410092|FG001|Overall Study|Development of study specific withdrawal|1
4572366|NCT01370538|7410091|FG000|Overall Study|Lost to follow up|6
4572367|NCT01370538|7410092|FG001|Overall Study|Lost to follow up|10
4572368|NCT01370616|7410104|FG000|Overall Study|Adverse Event|11
4572369|NCT01370616|7410105|FG001|Overall Study|Adverse Event|16
4572370|NCT01370616|7410104|FG000|Overall Study|Death|1
4572371|NCT01370616|7410105|FG001|Overall Study|Death|0
4572372|NCT01370616|7410104|FG000|Overall Study|Lack of Efficacy|6
4572373|NCT01370616|7410105|FG001|Overall Study|Lack of Efficacy|2
4572374|NCT01370616|7410104|FG000|Overall Study|Lost to Follow-up|0
4572375|NCT01370616|7410105|FG001|Overall Study|Lost to Follow-up|3
4572376|NCT01370616|7410104|FG000|Overall Study|Physician Decision|6
4572377|NCT01370616|7410105|FG001|Overall Study|Physician Decision|6
4572378|NCT01370616|7410104|FG000|Overall Study|Progressive Disease|0
4572379|NCT01370616|7410105|FG001|Overall Study|Progressive Disease|1
4572380|NCT01370616|7410104|FG000|Overall Study|Recovery|1
4626168|NCT01837823|7491645|FG000|Overall Study|Lost to Follow-up|6
4626169|NCT01837966|7491668|FG000|Overall Study|Withdrawal by Subject|2
4626170|NCT01837966|7491669|FG001|Overall Study|Withdrawal by Subject|1
4626171|NCT01838044|7491677|FG000|Overall Study|Adverse Event|4
4626172|NCT01838044|7491678|FG001|Overall Study|Adverse Event|6
4626173|NCT01838044|7491677|FG000|Overall Study|Protocol Violation|3
4626174|NCT01838044|7491678|FG001|Overall Study|Protocol Violation|3
4626175|NCT01838044|7491677|FG000|Overall Study|Withdrawal by Subject|0
4626176|NCT01838044|7491678|FG001|Overall Study|Withdrawal by Subject|2
4626177|NCT01838044|7491677|FG000|Overall Study|Insufficient clinical response|1
4626178|NCT01838044|7491678|FG001|Overall Study|Insufficient clinical response|2
4626179|NCT01838044|7491677|FG000|Overall Study|Medication error without associated AE|0
4626180|NCT01838044|7491678|FG001|Overall Study|Medication error without associated AE|1
4626181|NCT01838044|7491677|FG000|Overall Study|Lost to Follow-up|0
4626182|NCT01838044|7491678|FG001|Overall Study|Lost to Follow-up|2
4572381|NCT01370616|7410105|FG001|Overall Study|Recovery|0
4572382|NCT01370616|7410104|FG000|Overall Study|Technical Problems|3
4572383|NCT01370616|7410105|FG001|Overall Study|Technical Problems|5
4572384|NCT01370616|7410104|FG000|Overall Study|Withdrawal by Subject|34
4572385|NCT01370616|7410105|FG001|Overall Study|Withdrawal by Subject|34
4572386|NCT01370642|7410118|FG000|Overall Study|Adverse Event|2
4572387|NCT01370642|7410119|FG001|Overall Study|Adverse Event|1
4572388|NCT01370642|7410120|FG002|Overall Study|Adverse Event|1
4572389|NCT01370642|7410118|FG000|Overall Study|Detectable HCV RNA|0
4572390|NCT01370642|7410119|FG001|Overall Study|Detectable HCV RNA|0
4572391|NCT01370642|7410120|FG002|Overall Study|Detectable HCV RNA|22
4572392|NCT01370642|7410118|FG000|Overall Study|Lost to Follow-up|0
4572393|NCT01370642|7410119|FG001|Overall Study|Lost to Follow-up|0
4572394|NCT01370642|7410120|FG002|Overall Study|Lost to Follow-up|1
4572395|NCT01370642|7410118|FG000|Overall Study|Physician Decision|4
4572396|NCT01370642|7410119|FG001|Overall Study|Physician Decision|1
4572397|NCT01370642|7410120|FG002|Overall Study|Physician Decision|2
4572398|NCT01370642|7410118|FG000|Overall Study|Withdrawal by Subject|2
4572399|NCT01370642|7410119|FG001|Overall Study|Withdrawal by Subject|4
4572400|NCT01370642|7410120|FG002|Overall Study|Withdrawal by Subject|3
4572401|NCT01370655|7410140|FG000|Period 1|Adverse Event|2
4572402|NCT01370655|7410141|FG001|Period 1|Adverse Event|0
4572403|NCT01370655|7410142|FG002|Period 1|Adverse Event|0
4572404|NCT01370655|7410143|FG003|Period 1|Adverse Event|0
4572405|NCT01370655|7410144|FG004|Period 1|Adverse Event|0
4572406|NCT01370655|7410145|FG005|Period 1|Adverse Event|0
4572407|NCT01370655|7410146|FG006|Period 1|Adverse Event|1
4572408|NCT01370655|7410147|FG007|Period 1|Adverse Event|0
4572409|NCT01370655|7410148|FG008|Period 1|Adverse Event|0
4572410|NCT01370655|7410149|FG009|Period 1|Adverse Event|0
4572411|NCT01370655|7410150|FG010|Period 1|Adverse Event|0
4572412|NCT01370655|7410151|FG011|Period 1|Adverse Event|0
4572413|NCT01370655|7410140|FG000|Period 2|Adverse Event|0
4572414|NCT01370655|7410141|FG001|Period 2|Adverse Event|0
4572415|NCT01370655|7410142|FG002|Period 2|Adverse Event|1
4572416|NCT01370655|7410143|FG003|Period 2|Adverse Event|0
4572417|NCT01370655|7410144|FG004|Period 2|Adverse Event|1
4572418|NCT01370655|7410145|FG005|Period 2|Adverse Event|0
4572419|NCT01370655|7410146|FG006|Period 2|Adverse Event|0
4572420|NCT01370655|7410147|FG007|Period 2|Adverse Event|1
4572421|NCT01370655|7410148|FG008|Period 2|Adverse Event|0
4572422|NCT01370655|7410149|FG009|Period 2|Adverse Event|0
4572423|NCT01370655|7410150|FG010|Period 2|Adverse Event|0
4572424|NCT01370655|7410151|FG011|Period 2|Adverse Event|0
4572425|NCT01370655|7410140|FG000|Period 2|met protocol specified stopping criteria|0
4572426|NCT01370655|7410141|FG001|Period 2|met protocol specified stopping criteria|0
4572427|NCT01370655|7410142|FG002|Period 2|met protocol specified stopping criteria|1
4572428|NCT01370655|7410143|FG003|Period 2|met protocol specified stopping criteria|0
4572429|NCT01370655|7410144|FG004|Period 2|met protocol specified stopping criteria|0
4572430|NCT01370655|7410145|FG005|Period 2|met protocol specified stopping criteria|0
4572431|NCT01370655|7410146|FG006|Period 2|met protocol specified stopping criteria|1
4572432|NCT01370655|7410147|FG007|Period 2|met protocol specified stopping criteria|0
4572433|NCT01370655|7410148|FG008|Period 2|met protocol specified stopping criteria|1
4572434|NCT01370655|7410149|FG009|Period 2|met protocol specified stopping criteria|0
4572435|NCT01370655|7410150|FG010|Period 2|met protocol specified stopping criteria|1
4572436|NCT01370655|7410151|FG011|Period 2|met protocol specified stopping criteria|0
4572437|NCT01370655|7410140|FG000|Period 2|Withdrawal by Subject|0
4572438|NCT01370655|7410141|FG001|Period 2|Withdrawal by Subject|0
4572439|NCT01370655|7410142|FG002|Period 2|Withdrawal by Subject|0
4572440|NCT01370655|7410143|FG003|Period 2|Withdrawal by Subject|0
4572441|NCT01370655|7410144|FG004|Period 2|Withdrawal by Subject|0
4572442|NCT01370655|7410145|FG005|Period 2|Withdrawal by Subject|0
4626183|NCT01838200|7491687|FG000|Overall Study|Adverse Event|0
4626184|NCT01838200|7491688|FG001|Overall Study|Adverse Event|2
4626185|NCT01838200|7491687|FG000|Overall Study|Progressive disease|3
4626186|NCT01838200|7491688|FG001|Overall Study|Progressive disease|0
4626187|NCT01838213|7491696|FG000|Overall Study|Ineligible|166
4626188|NCT01838213|7491697|FG001|Overall Study|Ineligible|191
4626189|NCT01838447|7491732|FG000|Overall Study|Change in surgical plan|1
4626190|NCT01838447|7491733|FG001|Overall Study|Change in surgical plan|2
4626191|NCT01838447|7491732|FG000|Overall Study|Withdrawal by Subject|1
4626192|NCT01838447|7491733|FG001|Overall Study|Withdrawal by Subject|1
4626193|NCT01838499|7491741|FG000|Overall Study|Protocol Violation|0
4626194|NCT01838499|7491742|FG001|Overall Study|Protocol Violation|1
4626195|NCT01838499|7491741|FG000|Overall Study|Lost to Follow-up|2
4626196|NCT01838499|7491742|FG001|Overall Study|Lost to Follow-up|4
4626197|NCT01838499|7491741|FG000|Overall Study|Lack of Efficacy|1
4626198|NCT01838499|7491742|FG001|Overall Study|Lack of Efficacy|2
4626199|NCT01838499|7491741|FG000|Overall Study|Adverse Event|2
4626200|NCT01838499|7491742|FG001|Overall Study|Adverse Event|1
4626201|NCT01838499|7491741|FG000|Overall Study|Withdrawal by Subject|19
4626202|NCT01838499|7491742|FG001|Overall Study|Withdrawal by Subject|9
4626203|NCT01838551|7491748|FG000|Overall Study|Adverse Event|16
4572443|NCT01370655|7410146|FG006|Period 2|Withdrawal by Subject|0
4572444|NCT01370655|7410147|FG007|Period 2|Withdrawal by Subject|0
4572445|NCT01370655|7410148|FG008|Period 2|Withdrawal by Subject|1
4626204|NCT01838551|7491748|FG000|Overall Study|Death|1
4626205|NCT01838551|7491748|FG000|Overall Study|Lack of Efficacy|10
4626206|NCT01838551|7491748|FG000|Overall Study|Physician Decision|4
4626207|NCT01838551|7491748|FG000|Overall Study|Withdrawal by Subject|10
4626208|NCT01838551|7491748|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7
4626209|NCT01838590|7491756|FG000|Overall Study|Lack of Efficacy|12
4572446|NCT01370655|7410149|FG009|Period 2|Withdrawal by Subject|0
4572447|NCT01370655|7410150|FG010|Period 2|Withdrawal by Subject|0
4572448|NCT01370655|7410151|FG011|Period 2|Withdrawal by Subject|0
4572449|NCT01370694|7410161|FG000|Overall Study|Switched to rituximab|4
4626210|NCT01838590|7491757|FG001|Overall Study|Lack of Efficacy|4
4626211|NCT01838590|7491756|FG000|Overall Study|Lost to Follow-up|0
4626212|NCT01838590|7491757|FG001|Overall Study|Lost to Follow-up|1
4572450|NCT01370694|7410161|FG000|Overall Study|Progressive disease|2
4572451|NCT01370733|7410167|FG000|Overall Study|Withdrawal by Subject|8
4572452|NCT01370733|7410168|FG001|Overall Study|Withdrawal by Subject|8
4572453|NCT01370733|7410167|FG000|Overall Study|Lost to Follow-up|3
4572454|NCT01370733|7410168|FG001|Overall Study|Lost to Follow-up|0
4572455|NCT01370733|7410167|FG000|Overall Study|Adverse Event|2
4572456|NCT01370733|7410168|FG001|Overall Study|Adverse Event|4
4572457|NCT01370733|7410167|FG000|Overall Study|Lack of Efficacy|3
4572458|NCT01370733|7410168|FG001|Overall Study|Lack of Efficacy|5
4572459|NCT01370733|7410167|FG000|Overall Study|Physician Decision|0
4572460|NCT01370733|7410168|FG001|Overall Study|Physician Decision|2
4572461|NCT01370733|7410167|FG000|Overall Study|Protocol Violation|1
4572462|NCT01370733|7410168|FG001|Overall Study|Protocol Violation|3
4572463|NCT01370863|7410189|FG000|Overall Study|Adverse Event|1
4572464|NCT01370863|7410190|FG001|Overall Study|Adverse Event|1
4572465|NCT01370863|7410189|FG000|Overall Study|Did not want second pH/MII monitoring|1
4572466|NCT01370863|7410190|FG001|Overall Study|Did not want second pH/MII monitoring|1
4572467|NCT01370863|7410189|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0
4572468|NCT01370863|7410190|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1
4572469|NCT01371006|7410198|FG000|Overall Study|Adverse Event|1
4572470|NCT01371006|7410199|FG001|Overall Study|Adverse Event|0
4572471|NCT01371539|7410245|FG000|Period One: One Week|Lost to Follow-up|0
4572472|NCT01371539|7410246|FG001|Period One: One Week|Lost to Follow-up|1
4572473|NCT01371539|7410245|FG000|Period Two: One Week|Lost to Follow-up|0
4572474|NCT01371539|7410246|FG001|Period Two: One Week|Lost to Follow-up|1
4572475|NCT01371539|7410245|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0
4572476|NCT01371539|7410246|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1
4572477|NCT01371539|7410245|FG000|Period Two: One Week|Time/job conflict|0
4572478|NCT01371539|7410246|FG001|Period Two: One Week|Time/job conflict|1
4572479|NCT01371552|7410252|FG000|Part 1, First 3 Days|Inconvenience|0
4572480|NCT01371552|7410253|FG001|Part 1, First 3 Days|Inconvenience|0
4572481|NCT01371552|7410254|FG002|Part 1, First 3 Days|Inconvenience|1
4572482|NCT01371552|7410255|FG003|Part 1, First 3 Days|Inconvenience|0
4572483|NCT01371552|7410256|FG004|Part 1, First 3 Days|Inconvenience|0
4572484|NCT01371552|7410257|FG005|Part 1, First 3 Days|Inconvenience|0
4572485|NCT01371565|7410266|FG000|Overall Study|Withdrawal by Subject|1
4572486|NCT01371565|7410266|FG000|Overall Study|Death|1
4572487|NCT01371565|7410266|FG000|Overall Study|Resection of neuroendocrine tumor|1
4572488|NCT01371643|7410272|FG000|Overall Study|Withdrawal by Subject|3
4572489|NCT01371643|7410273|FG001|Overall Study|Withdrawal by Subject|0
4572490|NCT01371656|7410281|FG000|Overall Study|Death|7
4572491|NCT01371656|7410282|FG001|Overall Study|Death|4
4572492|NCT01371656|7410281|FG000|Overall Study|Physician Decision|46
4572493|NCT01371656|7410282|FG001|Overall Study|Physician Decision|7
4572494|NCT01371656|7410281|FG000|Overall Study|Withdrawal by Subject|7
4572495|NCT01371656|7410282|FG001|Overall Study|Withdrawal by Subject|0
4572496|NCT01371656|7410281|FG000|Overall Study|Ineligible|4
4572497|NCT01371656|7410282|FG001|Overall Study|Ineligible|3
4572498|NCT01371708|7410291|FG000|Overall Study|Insufficient clinical response|3
4572499|NCT01371708|7410292|FG001|Overall Study|Insufficient clinical response|2
4572500|NCT01371708|7410293|FG002|Overall Study|Insufficient clinical response|0
4572501|NCT01371708|7410291|FG000|Overall Study|Lost to Follow-up|5
4572502|NCT01371708|7410292|FG001|Overall Study|Lost to Follow-up|9
4572503|NCT01371708|7410293|FG002|Overall Study|Lost to Follow-up|7
4572504|NCT01371708|7410291|FG000|Overall Study|Protocol Violation|2
4572505|NCT01371708|7410292|FG001|Overall Study|Protocol Violation|1
4572506|NCT01371708|7410293|FG002|Overall Study|Protocol Violation|2
4572507|NCT01371708|7410291|FG000|Overall Study|No longer willing to participate|7
4572508|NCT01371708|7410292|FG001|Overall Study|No longer willing to participate|7
4572509|NCT01371708|7410293|FG002|Overall Study|No longer willing to participate|13
4572510|NCT01371708|7410291|FG000|Overall Study|Medication error/not related to AE|0
4572511|NCT01371708|7410292|FG001|Overall Study|Medication error/not related to AE|1
4572512|NCT01371708|7410293|FG002|Overall Study|Medication error/not related to AE|0
4572513|NCT01371708|7410291|FG000|Overall Study|Other|3
4572514|NCT01371708|7410292|FG001|Overall Study|Other|2
4572515|NCT01371708|7410293|FG002|Overall Study|Other|4
4572516|NCT01371708|7410291|FG000|Overall Study|Adverse Event|5
4572517|NCT01371708|7410292|FG001|Overall Study|Adverse Event|8
4572518|NCT01371708|7410293|FG002|Overall Study|Adverse Event|12
4572519|NCT01371708|7410291|FG000|Overall Study|Started but did not receive treatment|1
4572520|NCT01371708|7410292|FG001|Overall Study|Started but did not receive treatment|0
4572521|NCT01371708|7410293|FG002|Overall Study|Started but did not receive treatment|1
4572522|NCT01371721|7410306|FG000|Overall Study|Adverse Event|5
4572523|NCT01371721|7410307|FG001|Overall Study|Adverse Event|4
4572524|NCT01371721|7410308|FG002|Overall Study|Adverse Event|5
4572525|NCT01371721|7410306|FG000|Overall Study|Protocol Violation|6
4572526|NCT01371721|7410307|FG001|Overall Study|Protocol Violation|4
4572527|NCT01371721|7410308|FG002|Overall Study|Protocol Violation|5
4572528|NCT01371721|7410306|FG000|Overall Study|Lost to Follow-up|8
4572529|NCT01371721|7410307|FG001|Overall Study|Lost to Follow-up|2
4572530|NCT01371721|7410308|FG002|Overall Study|Lost to Follow-up|6
4572531|NCT01371721|7410306|FG000|Overall Study|Withdrawal by Subject|5
4572532|NCT01371721|7410307|FG001|Overall Study|Withdrawal by Subject|7
4572533|NCT01371721|7410308|FG002|Overall Study|Withdrawal by Subject|11
4572534|NCT01371721|7410306|FG000|Overall Study|Other|2
4572535|NCT01371721|7410307|FG001|Overall Study|Other|3
4572536|NCT01371721|7410308|FG002|Overall Study|Other|0
4572537|NCT01371721|7410306|FG000|Overall Study|Lack of Efficacy|2
4572538|NCT01371721|7410307|FG001|Overall Study|Lack of Efficacy|4
4572539|NCT01371721|7410308|FG002|Overall Study|Lack of Efficacy|3
4572540|NCT01371721|7410306|FG000|Overall Study|Randomized but not treated|1
4572541|NCT01371721|7410307|FG001|Overall Study|Randomized but not treated|0
4572542|NCT01371721|7410308|FG002|Overall Study|Randomized but not treated|0
4572543|NCT01371734|7410321|FG000|Overall Study|Other|2
4572544|NCT01371734|7410322|FG001|Overall Study|Other|1
4572545|NCT01371734|7410323|FG002|Overall Study|Other|2
4572546|NCT01371734|7410321|FG000|Overall Study|Withdrawal by Subject|3
4572547|NCT01371734|7410322|FG001|Overall Study|Withdrawal by Subject|4
4572548|NCT01371734|7410323|FG002|Overall Study|Withdrawal by Subject|9
4572549|NCT01371734|7410321|FG000|Overall Study|Lost to Follow-up|5
4572550|NCT01371734|7410322|FG001|Overall Study|Lost to Follow-up|3
4572551|NCT01371734|7410323|FG002|Overall Study|Lost to Follow-up|1
4572552|NCT01371734|7410321|FG000|Overall Study|Protocol Violation|3
4572553|NCT01371734|7410322|FG001|Overall Study|Protocol Violation|1
4572554|NCT01371734|7410323|FG002|Overall Study|Protocol Violation|2
4572555|NCT01371734|7410321|FG000|Overall Study|Adverse Event|8
4572556|NCT01371734|7410322|FG001|Overall Study|Adverse Event|8
4572557|NCT01371734|7410323|FG002|Overall Study|Adverse Event|3
4572558|NCT01371734|7410321|FG000|Overall Study|Lack of Efficacy|2
4572559|NCT01371734|7410322|FG001|Overall Study|Lack of Efficacy|2
4572560|NCT01371734|7410323|FG002|Overall Study|Lack of Efficacy|0
4572561|NCT01371747|7410337|FG000|Overall Study|Adverse Event|4
4572562|NCT01371747|7410338|FG001|Overall Study|Adverse Event|2
4572563|NCT01371747|7410339|FG002|Overall Study|Adverse Event|7
4572564|NCT01371747|7410340|FG003|Overall Study|Adverse Event|2
4572565|NCT01371747|7410341|FG004|Overall Study|Adverse Event|2
4572566|NCT01371747|7410342|FG005|Overall Study|Adverse Event|2
4572567|NCT01371747|7410337|FG000|Overall Study|Death|1
4572568|NCT01371747|7410338|FG001|Overall Study|Death|0
4572569|NCT01371747|7410339|FG002|Overall Study|Death|4
4572570|NCT01371747|7410340|FG003|Overall Study|Death|1
4572571|NCT01371747|7410341|FG004|Overall Study|Death|2
4572572|NCT01371747|7410342|FG005|Overall Study|Death|0
4572573|NCT01371747|7410337|FG000|Overall Study|Abnormal Renal Function|0
4572574|NCT01371747|7410338|FG001|Overall Study|Abnormal Renal Function|2
4572575|NCT01371747|7410339|FG002|Overall Study|Abnormal Renal Function|0
4572576|NCT01371747|7410340|FG003|Overall Study|Abnormal Renal Function|1
4572577|NCT01371747|7410341|FG004|Overall Study|Abnormal Renal Function|0
4572578|NCT01371747|7410342|FG005|Overall Study|Abnormal Renal Function|1
4572579|NCT01371747|7410337|FG000|Overall Study|High Serum Potassium Results|1
4572580|NCT01371747|7410338|FG001|Overall Study|High Serum Potassium Results|1
4572581|NCT01371747|7410339|FG002|Overall Study|High Serum Potassium Results|1
4572582|NCT01371747|7410340|FG003|Overall Study|High Serum Potassium Results|2
4572583|NCT01371747|7410341|FG004|Overall Study|High Serum Potassium Results|0
4572584|NCT01371747|7410342|FG005|Overall Study|High Serum Potassium Results|2
4572585|NCT01371747|7410337|FG000|Overall Study|Low Serum Potassium Results|1
4572586|NCT01371747|7410338|FG001|Overall Study|Low Serum Potassium Results|1
4572587|NCT01371747|7410339|FG002|Overall Study|Low Serum Potassium Results|1
4572588|NCT01371747|7410340|FG003|Overall Study|Low Serum Potassium Results|1
4572589|NCT01371747|7410341|FG004|Overall Study|Low Serum Potassium Results|0
4572590|NCT01371747|7410342|FG005|Overall Study|Low Serum Potassium Results|3
4572591|NCT01371747|7410337|FG000|Overall Study|Protocol Violation|0
4572592|NCT01371747|7410338|FG001|Overall Study|Protocol Violation|0
4572593|NCT01371747|7410339|FG002|Overall Study|Protocol Violation|1
4572594|NCT01371747|7410340|FG003|Overall Study|Protocol Violation|0
4572595|NCT01371747|7410341|FG004|Overall Study|Protocol Violation|0
4572596|NCT01371747|7410342|FG005|Overall Study|Protocol Violation|0
4572597|NCT01371747|7410337|FG000|Overall Study|Non-Compliance|3
4572598|NCT01371747|7410338|FG001|Overall Study|Non-Compliance|4
4572599|NCT01371747|7410339|FG002|Overall Study|Non-Compliance|3
4572600|NCT01371747|7410340|FG003|Overall Study|Non-Compliance|0
4572601|NCT01371747|7410341|FG004|Overall Study|Non-Compliance|0
4572602|NCT01371747|7410342|FG005|Overall Study|Non-Compliance|1
4572603|NCT01371747|7410337|FG000|Overall Study|Physician Decision|0
4572604|NCT01371747|7410338|FG001|Overall Study|Physician Decision|0
4572605|NCT01371747|7410339|FG002|Overall Study|Physician Decision|0
4572606|NCT01371747|7410340|FG003|Overall Study|Physician Decision|0
4572607|NCT01371747|7410341|FG004|Overall Study|Physician Decision|1
4572608|NCT01371747|7410342|FG005|Overall Study|Physician Decision|0
4572609|NCT01371747|7410337|FG000|Overall Study|Withdrawal by Subject|6
4572610|NCT01371747|7410338|FG001|Overall Study|Withdrawal by Subject|12
4572611|NCT01371747|7410339|FG002|Overall Study|Withdrawal by Subject|5
4572612|NCT01371747|7410340|FG003|Overall Study|Withdrawal by Subject|2
4572613|NCT01371747|7410341|FG004|Overall Study|Withdrawal by Subject|2
4572614|NCT01371747|7410342|FG005|Overall Study|Withdrawal by Subject|4
4572615|NCT01371747|7410337|FG000|Overall Study|Other Reasons|2
4572616|NCT01371747|7410338|FG001|Overall Study|Other Reasons|1
4572617|NCT01371747|7410339|FG002|Overall Study|Other Reasons|2
4572618|NCT01371747|7410340|FG003|Overall Study|Other Reasons|0
4572619|NCT01371747|7410341|FG004|Overall Study|Other Reasons|0
4572620|NCT01371747|7410342|FG005|Overall Study|Other Reasons|1
4572621|NCT01371825|7410366|FG000|Overall Study|Death|4
4572622|NCT01371838|7410372|FG000|Overall Study|Withdrawal by Subject|27
4626213|NCT01838616|7491769|FG000|Titration Period|Adverse Event|18
4626214|NCT01838616|7491770|FG001|Titration Period|Adverse Event|48
4626215|NCT01838616|7491769|FG000|Titration Period|Lack of Efficacy|5
4626216|NCT01838616|7491770|FG001|Titration Period|Lack of Efficacy|12
4626217|NCT01838616|7491769|FG000|Titration Period|Withdrawal by Subject|5
4626218|NCT01838616|7491770|FG001|Titration Period|Withdrawal by Subject|5
4572623|NCT01371838|7410373|FG001|Overall Study|Withdrawal by Subject|33
4572624|NCT01371838|7410372|FG000|Overall Study|Lost to Follow-up|10
4626219|NCT01838616|7491769|FG000|Titration Period|Technical problems|1
4626220|NCT01838616|7491770|FG001|Titration Period|Technical problems|0
4626221|NCT01838616|7491769|FG000|Titration Period|Other|1
4626222|NCT01838616|7491770|FG001|Titration Period|Other|0
4626223|NCT01838616|7491769|FG000|Titration Period|Protocol Violation|0
4626224|NCT01838616|7491770|FG001|Titration Period|Protocol Violation|1
4626225|NCT01838616|7491769|FG000|Continuation Period|Lack of Efficacy|3
4626226|NCT01838616|7491770|FG001|Continuation Period|Lack of Efficacy|5
4626227|NCT01838616|7491769|FG000|Continuation Period|Adverse Event|8
4626228|NCT01838616|7491770|FG001|Continuation Period|Adverse Event|4
4626229|NCT01838616|7491769|FG000|Continuation Period|Protocol Violation|2
4626230|NCT01838616|7491770|FG001|Continuation Period|Protocol Violation|0
4626231|NCT01838616|7491769|FG000|Continuation Period|Lost to Follow-up|1
4626232|NCT01838616|7491770|FG001|Continuation Period|Lost to Follow-up|0
4626233|NCT01838616|7491769|FG000|Continuation Period|Withdrawal by Subject|0
4626234|NCT01838616|7491770|FG001|Continuation Period|Withdrawal by Subject|4
4626235|NCT01838616|7491769|FG000|Continuation Period|Technical problems|0
4626236|NCT01838616|7491770|FG001|Continuation Period|Technical problems|1
4626237|NCT01838616|7491769|FG000|Pick-up Arm|Lack of Efficacy|4
4626238|NCT01838616|7491770|FG001|Pick-up Arm|Lack of Efficacy|0
4626239|NCT01838616|7491769|FG000|Pick-up Arm|Adverse Event|9
4626240|NCT01838616|7491770|FG001|Pick-up Arm|Adverse Event|0
4626241|NCT01838616|7491769|FG000|Pick-up Arm|Withdrawal by Subject|1
4626242|NCT01838616|7491770|FG001|Pick-up Arm|Withdrawal by Subject|0
4626243|NCT01838616|7491769|FG000|Pick-up Arm|Technical problems|1
4626244|NCT01838616|7491770|FG001|Pick-up Arm|Technical problems|0
4626245|NCT01838642|7491781|FG000|Overall Study|Died on study|1
4626246|NCT01838681|7491790|FG000|Period A|Adverse Event|39
4626247|NCT01838681|7491791|FG001|Period A|Adverse Event|0
4626248|NCT01838681|7491792|FG002|Period A|Adverse Event|0
4626249|NCT01838681|7491793|FG003|Period A|Adverse Event|0
4626250|NCT01838681|7491790|FG000|Period A|Lack of Efficacy|21
4626251|NCT01838681|7491791|FG001|Period A|Lack of Efficacy|0
4626252|NCT01838681|7491792|FG002|Period A|Lack of Efficacy|0
4626253|NCT01838681|7491793|FG003|Period A|Lack of Efficacy|0
4626254|NCT01838681|7491790|FG000|Period A|Early response|148
4626255|NCT01838681|7491791|FG001|Period A|Early response|0
4626256|NCT01838681|7491792|FG002|Period A|Early response|0
4626257|NCT01838681|7491793|FG003|Period A|Early response|0
4626258|NCT01838681|7491790|FG000|Period A|Withdrawal by Subject|70
4626259|NCT01838681|7491791|FG001|Period A|Withdrawal by Subject|0
4626260|NCT01838681|7491792|FG002|Period A|Withdrawal by Subject|0
4626261|NCT01838681|7491793|FG003|Period A|Withdrawal by Subject|0
4626262|NCT01838681|7491790|FG000|Period A|Protocol Violation|16
4626263|NCT01838681|7491791|FG001|Period A|Protocol Violation|0
4626264|NCT01838681|7491792|FG002|Period A|Protocol Violation|0
4626265|NCT01838681|7491793|FG003|Period A|Protocol Violation|0
4626266|NCT01838681|7491790|FG000|Period A|Non-compliance with IMP|6
4626267|NCT01838681|7491791|FG001|Period A|Non-compliance with IMP|0
4626268|NCT01838681|7491792|FG002|Period A|Non-compliance with IMP|0
4626269|NCT01838681|7491793|FG003|Period A|Non-compliance with IMP|0
4626270|NCT01838681|7491790|FG000|Period A|Lost to Follow-up|4
4626271|NCT01838681|7491791|FG001|Period A|Lost to Follow-up|0
4626272|NCT01838681|7491792|FG002|Period A|Lost to Follow-up|0
4626273|NCT01838681|7491793|FG003|Period A|Lost to Follow-up|0
4626274|NCT01838681|7491790|FG000|Period A|Withdrawal before treatment|4
4626275|NCT01838681|7491791|FG001|Period A|Withdrawal before treatment|0
4626276|NCT01838681|7491792|FG002|Period A|Withdrawal before treatment|0
4626277|NCT01838681|7491793|FG003|Period A|Withdrawal before treatment|0
4626278|NCT01838681|7491790|FG000|Period A|Administrative or other reasons|17
4626279|NCT01838681|7491791|FG001|Period A|Administrative or other reasons|0
4626280|NCT01838681|7491792|FG002|Period A|Administrative or other reasons|0
4626281|NCT01838681|7491793|FG003|Period A|Administrative or other reasons|0
4626282|NCT01838681|7491790|FG000|Period B/A+|Adverse Event|0
4626283|NCT01838681|7491791|FG001|Period B/A+|Adverse Event|13
4572625|NCT01371838|7410373|FG001|Overall Study|Lost to Follow-up|20
4626284|NCT01838681|7491792|FG002|Period B/A+|Adverse Event|27
4626285|NCT01838681|7491793|FG003|Period B/A+|Adverse Event|16
4572626|NCT01371838|7410372|FG000|Overall Study|Death|3
4626286|NCT01838681|7491790|FG000|Period B/A+|Lack of Efficacy|0
4626287|NCT01838681|7491791|FG001|Period B/A+|Lack of Efficacy|9
4626288|NCT01838681|7491792|FG002|Period B/A+|Lack of Efficacy|11
4626289|NCT01838681|7491793|FG003|Period B/A+|Lack of Efficacy|6
4626290|NCT01838681|7491790|FG000|Period B/A+|Withdrawal by Subject|0
4626291|NCT01838681|7491791|FG001|Period B/A+|Withdrawal by Subject|28
4626292|NCT01838681|7491792|FG002|Period B/A+|Withdrawal by Subject|35
4572627|NCT01371838|7410373|FG001|Overall Study|Death|4
4572628|NCT01371838|7410372|FG000|Overall Study|Protocol Violation|3
4572629|NCT01371838|7410373|FG001|Overall Study|Protocol Violation|0
4572630|NCT01371838|7410372|FG000|Overall Study|Investigator Decision|3
4572631|NCT01371838|7410373|FG001|Overall Study|Investigator Decision|8
4572632|NCT01371838|7410372|FG000|Overall Study|Last follow-up visit not conducted|2
4572633|NCT01371838|7410373|FG001|Overall Study|Last follow-up visit not conducted|0
4572634|NCT01371838|7410372|FG000|Overall Study|Lack of therapeutic response|0
4572635|NCT01371838|7410373|FG001|Overall Study|Lack of therapeutic response|1
4572636|NCT01371838|7410372|FG000|Overall Study|Surgery|1
4572637|NCT01371838|7410373|FG001|Overall Study|Surgery|0
4572638|NCT01371851|7410381|FG000|Overall Study|Lost to Follow-up|5
4572639|NCT01371851|7410382|FG001|Overall Study|Lost to Follow-up|8
4572640|NCT01371851|7410381|FG000|Overall Study|was arrested and put in jail|0
4572641|NCT01371851|7410382|FG001|Overall Study|was arrested and put in jail|1
4572642|NCT01371851|7410381|FG000|Overall Study|non study related adverse event|1
4572643|NCT01371851|7410382|FG001|Overall Study|non study related adverse event|0
4572644|NCT01371851|7410381|FG000|Overall Study|Blood Pressure outside study parameters|2
4572645|NCT01371851|7410382|FG001|Overall Study|Blood Pressure outside study parameters|0
4572646|NCT01371877|7410390|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0
4572647|NCT01371877|7410391|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4
4572648|NCT01371994|7410399|FG000|Overall Study|Adverse Event|3
4572649|NCT01371994|7410400|FG001|Overall Study|Adverse Event|6
4572650|NCT01371994|7410399|FG000|Overall Study|Lack of Efficacy|3
4572651|NCT01371994|7410400|FG001|Overall Study|Lack of Efficacy|0
4572652|NCT01371994|7410399|FG000|Overall Study|Withdrawal by Subject|13
4572653|NCT01371994|7410400|FG001|Overall Study|Withdrawal by Subject|7
4572654|NCT01371994|7410399|FG000|Overall Study|Lost to Follow-up|1
4572655|NCT01371994|7410400|FG001|Overall Study|Lost to Follow-up|1
4572656|NCT01371994|7410399|FG000|Overall Study|Protocol Violation|24
4572657|NCT01371994|7410400|FG001|Overall Study|Protocol Violation|17
4572658|NCT01371994|7410399|FG000|Overall Study|Randomized but Never Received Study Drug|6
4572659|NCT01371994|7410400|FG001|Overall Study|Randomized but Never Received Study Drug|6
4572660|NCT01371994|7410399|FG000|Overall Study|Physician Decision|1
4572661|NCT01371994|7410400|FG001|Overall Study|Physician Decision|1
4572662|NCT01371994|7410399|FG000|Overall Study|Miscellaneous Reasons|6
4572663|NCT01371994|7410400|FG001|Overall Study|Miscellaneous Reasons|4
4572664|NCT01372085|7410416|FG000|Washout Period 2|Physician Decision|0
4572665|NCT01372085|7410417|FG001|Washout Period 2|Physician Decision|0
4572666|NCT01372085|7410418|FG002|Washout Period 2|Physician Decision|0
4572667|NCT01372085|7410419|FG003|Washout Period 2|Physician Decision|0
4572668|NCT01372085|7410420|FG004|Washout Period 2|Physician Decision|1
4572669|NCT01372085|7410421|FG005|Washout Period 2|Physician Decision|0
4572670|NCT01372085|7410422|FG006|Washout Period 2|Physician Decision|0
4572671|NCT01372085|7410423|FG007|Washout Period 2|Physician Decision|0
4572672|NCT01372085|7410424|FG008|Washout Period 2|Physician Decision|0
4626293|NCT01838681|7491793|FG003|Period B/A+|Withdrawal by Subject|47
4572673|NCT01372085|7410425|FG009|Washout Period 2|Physician Decision|0
4572674|NCT01372085|7410416|FG000|Washout Period 3|Withdrawal by Subject|0
4572675|NCT01372085|7410417|FG001|Washout Period 3|Withdrawal by Subject|0
4572676|NCT01372085|7410418|FG002|Washout Period 3|Withdrawal by Subject|0
4572677|NCT01372085|7410419|FG003|Washout Period 3|Withdrawal by Subject|0
4572678|NCT01372085|7410420|FG004|Washout Period 3|Withdrawal by Subject|0
4572679|NCT01372085|7410421|FG005|Washout Period 3|Withdrawal by Subject|2
4572680|NCT01372085|7410422|FG006|Washout Period 3|Withdrawal by Subject|0
4572681|NCT01372085|7410423|FG007|Washout Period 3|Withdrawal by Subject|0
4572682|NCT01372085|7410424|FG008|Washout Period 3|Withdrawal by Subject|0
4572683|NCT01372085|7410425|FG009|Washout Period 3|Withdrawal by Subject|0
4572684|NCT01372150|7410452|FG000|Overall Study|Lack of Efficacy|3
4572685|NCT01372150|7410453|FG001|Overall Study|Lack of Efficacy|0
4572686|NCT01372150|7410454|FG002|Overall Study|Lack of Efficacy|1
4572687|NCT01372150|7410452|FG000|Overall Study|Lost to Follow-up|4
4572688|NCT01372150|7410453|FG001|Overall Study|Lost to Follow-up|5
4572689|NCT01372150|7410454|FG002|Overall Study|Lost to Follow-up|6
4572690|NCT01372150|7410452|FG000|Overall Study|Protocol Violation|1
4572691|NCT01372150|7410453|FG001|Overall Study|Protocol Violation|0
4572692|NCT01372150|7410454|FG002|Overall Study|Protocol Violation|3
4572693|NCT01372150|7410452|FG000|Overall Study|Withdrawal by Subject|2
4572694|NCT01372150|7410453|FG001|Overall Study|Withdrawal by Subject|7
4572695|NCT01372150|7410454|FG002|Overall Study|Withdrawal by Subject|2
4572696|NCT01372150|7410452|FG000|Overall Study|Other|1
4572697|NCT01372150|7410453|FG001|Overall Study|Other|0
4572698|NCT01372150|7410454|FG002|Overall Study|Other|2
4572699|NCT01372150|7410452|FG000|Overall Study|Adverse Event|2
4572700|NCT01372150|7410453|FG001|Overall Study|Adverse Event|1
4572701|NCT01372150|7410454|FG002|Overall Study|Adverse Event|2
4572702|NCT01372150|7410452|FG000|Overall Study|Randomized but not treated|0
4572703|NCT01372150|7410453|FG001|Overall Study|Randomized but not treated|1
4572704|NCT01372150|7410454|FG002|Overall Study|Randomized but not treated|0
4572705|NCT01372384|7410489|FG000|Overall Study|Progression of disease|3
4572706|NCT01372410|7410493|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1
4572707|NCT01372410|7410494|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1
4572708|NCT01372410|7410495|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0
4572709|NCT01372410|7410496|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0
4572710|NCT01372410|7410497|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1
4572711|NCT01372410|7410498|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0
4572712|NCT01372410|7410499|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0
4572713|NCT01372410|7410500|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0
4572714|NCT01372410|7410493|FG000|Treatment Period 1 (7 Days)|Adverse Event|0
4572715|NCT01372410|7410494|FG001|Treatment Period 1 (7 Days)|Adverse Event|1
4572716|NCT01372410|7410495|FG002|Treatment Period 1 (7 Days)|Adverse Event|0
4572717|NCT01372410|7410496|FG003|Treatment Period 1 (7 Days)|Adverse Event|0
4572718|NCT01372410|7410497|FG004|Treatment Period 1 (7 Days)|Adverse Event|0
4572719|NCT01372410|7410498|FG005|Treatment Period 1 (7 Days)|Adverse Event|0
4572720|NCT01372410|7410499|FG006|Treatment Period 1 (7 Days)|Adverse Event|1
4572721|NCT01372410|7410500|FG007|Treatment Period 1 (7 Days)|Adverse Event|0
4572722|NCT01372410|7410493|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0
4572723|NCT01372410|7410494|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0
4572724|NCT01372410|7410495|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0
4572725|NCT01372410|7410496|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0
4572726|NCT01372410|7410497|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1
4572727|NCT01372410|7410498|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0
4572728|NCT01372410|7410499|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0
4572729|NCT01372410|7410500|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0
4572730|NCT01372410|7410493|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
4572731|NCT01372410|7410494|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
4626294|NCT01838681|7491790|FG000|Period B/A+|Protocol Violation|0
4626295|NCT01838681|7491791|FG001|Period B/A+|Protocol Violation|1
4626296|NCT01838681|7491792|FG002|Period B/A+|Protocol Violation|4
4626297|NCT01838681|7491793|FG003|Period B/A+|Protocol Violation|6
4626298|NCT01838681|7491790|FG000|Period B/A+|Non-compliance with IMP|0
4626299|NCT01838681|7491791|FG001|Period B/A+|Non-compliance with IMP|2
4626300|NCT01838681|7491792|FG002|Period B/A+|Non-compliance with IMP|3
4626301|NCT01838681|7491793|FG003|Period B/A+|Non-compliance with IMP|3
4626302|NCT01838681|7491790|FG000|Period B/A+|Lost to Follow-up|0
4626303|NCT01838681|7491791|FG001|Period B/A+|Lost to Follow-up|2
4626304|NCT01838681|7491792|FG002|Period B/A+|Lost to Follow-up|5
4626305|NCT01838681|7491793|FG003|Period B/A+|Lost to Follow-up|11
4626306|NCT01838681|7491790|FG000|Period B/A+|Withdrawal before treatment|0
4626307|NCT01838681|7491791|FG001|Period B/A+|Withdrawal before treatment|1
4626308|NCT01838681|7491792|FG002|Period B/A+|Withdrawal before treatment|0
4626309|NCT01838681|7491793|FG003|Period B/A+|Withdrawal before treatment|0
4626310|NCT01838681|7491790|FG000|Period B/A+|Administrative or other reasons|0
4626311|NCT01838681|7491791|FG001|Period B/A+|Administrative or other reasons|6
4626312|NCT01838681|7491792|FG002|Period B/A+|Administrative or other reasons|10
4626313|NCT01838681|7491793|FG003|Period B/A+|Administrative or other reasons|28
4626314|NCT01838694|7491801|FG000|Overall Study|Adverse Event|0
4626315|NCT01838694|7491802|FG001|Overall Study|Adverse Event|1
4626316|NCT01838876|7491824|FG000|Overall Study|Adverse Event|49
4626317|NCT01838876|7491824|FG000|Overall Study|Insufficient Therapeutic Response|10
4626318|NCT01838876|7491824|FG000|Overall Study|Protocol Violation|34
4626319|NCT01838876|7491824|FG000|Overall Study|Withdrawal of Consent|33
4626320|NCT01838876|7491824|FG000|Overall Study|Lost to Follow-up|21
4626321|NCT01838876|7491824|FG000|Overall Study|Study or Site Terminated by Sponsor|1
4626322|NCT01838876|7491824|FG000|Overall Study|Reason not Specified|7
4626323|NCT01838876|7491824|FG000|Overall Study|Did not meet eligibility criteria|78
4626324|NCT01838941|7491830|FG000|Overall Study|Adverse Event|1
4626325|NCT01838941|7491830|FG000|Overall Study|Withdrawal by Subject|1
4626326|NCT01839188|7491861|FG000|Overall Study|Withdrawal by Subject|1
4690859|NCT02564198|7600706|FG002|Overall Study|Adverse Event|0
4690860|NCT02564211|7600716|FG000|Overall Study|Adverse Event|4
4690861|NCT02564471|7600739|FG000|Overall Study|Adverse Event|1
4690862|NCT02564471|7600740|FG001|Overall Study|Adverse Event|0
4690863|NCT02564471|7600741|FG002|Overall Study|Adverse Event|0
4690864|NCT02564471|7600742|FG003|Overall Study|Adverse Event|0
4690865|NCT02564471|7600739|FG000|Overall Study|Withdrawal by Subject|2
4690866|NCT02564471|7600740|FG001|Overall Study|Withdrawal by Subject|1
4690867|NCT02564471|7600741|FG002|Overall Study|Withdrawal by Subject|3
4690868|NCT02564471|7600742|FG003|Overall Study|Withdrawal by Subject|0
4690869|NCT02564471|7600739|FG000|Overall Study|Lost to Follow-up|0
4690870|NCT02564471|7600740|FG001|Overall Study|Lost to Follow-up|2
4690871|NCT02564471|7600741|FG002|Overall Study|Lost to Follow-up|0
4690872|NCT02564471|7600742|FG003|Overall Study|Lost to Follow-up|0
4690873|NCT02564718|7600763|FG000|Overall Study|Withdrew from treatment|0
4690874|NCT02564718|7600764|FG001|Overall Study|Withdrew from treatment|1
4690875|NCT02564887|7600772|FG000|Overall Study|Lost to Follow-up|6
4690876|NCT02564887|7600773|FG001|Overall Study|Lost to Follow-up|0
4572732|NCT01372410|7410495|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
4572733|NCT01372410|7410496|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
4626327|NCT01839279|7491873|FG000|Overall Study|Adverse Event|4
4626328|NCT01839279|7491874|FG001|Overall Study|Adverse Event|1
4626329|NCT01839279|7491875|FG002|Overall Study|Adverse Event|1
4626330|NCT01839279|7491873|FG000|Overall Study|Withdrawal by Subject|4
4572734|NCT01372410|7410497|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
4572735|NCT01372410|7410498|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
4572736|NCT01372410|7410499|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1
4572737|NCT01372410|7410500|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
4572738|NCT01372410|7410493|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1
4572739|NCT01372410|7410494|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
4572740|NCT01372410|7410495|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
4572741|NCT01372410|7410496|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
4572742|NCT01372410|7410497|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
4572743|NCT01372410|7410498|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
4572744|NCT01372410|7410499|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
4572745|NCT01372410|7410500|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1
4572746|NCT01372410|7410493|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0
4572747|NCT01372410|7410494|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0
4572748|NCT01372410|7410495|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0
4572749|NCT01372410|7410496|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0
4572750|NCT01372410|7410497|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1
4572751|NCT01372410|7410498|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0
4572752|NCT01372410|7410499|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0
4572753|NCT01372410|7410500|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0
4690877|NCT02564952|7600790|FG000|Overall Study|Adverse Event|6
4690878|NCT02564952|7600790|FG000|Overall Study|Lost to Follow-up|1
4690879|NCT02564952|7600790|FG000|Overall Study|Participant Withdrawn by Investigator|1
4690880|NCT02564952|7600790|FG000|Overall Study|Withdrawal by Subject|1
4690881|NCT02564952|7600790|FG000|Overall Study|Low Efficacy|1
4690882|NCT02564952|7600790|FG000|Overall Study|Participant Met Withdrawal Criteria|1
4690883|NCT02565108|7600796|FG000|Overall Study|Adverse Event|1
4690884|NCT02565108|7600797|FG001|Overall Study|Adverse Event|0
4690885|NCT02565108|7600796|FG000|Overall Study|Withdrew Consent|1
4690886|NCT02565108|7600797|FG001|Overall Study|Withdrew Consent|0
4690887|NCT02565147|7600805|FG000|Overall Study|Withdrawal by Subject|5
4690888|NCT02565147|7600806|FG001|Overall Study|Withdrawal by Subject|1
4690889|NCT02565147|7600805|FG000|Overall Study|Lost to Follow-up|0
4690890|NCT02565147|7600806|FG001|Overall Study|Lost to Follow-up|1
4690891|NCT02565147|7600805|FG000|Overall Study|Death|1
4690892|NCT02565147|7600806|FG001|Overall Study|Death|1
4690893|NCT02565186|7600814|FG000|Overall Study|Adverse Event|113
4690894|NCT02565186|7600815|FG001|Overall Study|Adverse Event|148
4690895|NCT02565186|7600814|FG000|Overall Study|Lost to Follow-up|102
4690896|NCT02565186|7600815|FG001|Overall Study|Lost to Follow-up|93
4690897|NCT02565186|7600814|FG000|Overall Study|Non-Compliance|57
4690898|NCT02565186|7600815|FG001|Overall Study|Non-Compliance|55
4690899|NCT02565186|7600814|FG000|Overall Study|Withdrawal by Subject|229
4690900|NCT02565186|7600815|FG001|Overall Study|Withdrawal by Subject|214
4690901|NCT02565186|7600814|FG000|Overall Study|Physician Decision|18
4690902|NCT02565186|7600815|FG001|Overall Study|Physician Decision|16
4690903|NCT02565186|7600814|FG000|Overall Study|Sponsor Request|5
4690904|NCT02565186|7600815|FG001|Overall Study|Sponsor Request|9
4690905|NCT02565186|7600814|FG000|Overall Study|Missing|1
4690906|NCT02565186|7600815|FG001|Overall Study|Missing|0
4690907|NCT02565186|7600814|FG000|Overall Study|Did Not Receive Study Drug|55
4690908|NCT02565186|7600815|FG001|Overall Study|Did Not Receive Study Drug|86
4690909|NCT02565381|7600824|FG000|Overall Study|Lost to Follow-up|1
4690910|NCT02565381|7600825|FG001|Overall Study|Lost to Follow-up|0
4690911|NCT02565381|7600826|FG002|Overall Study|Lost to Follow-up|1
4690912|NCT02565511|7600847|FG000|Overall Study|Study terminated by Sponsor|35
4690913|NCT02565511|7600848|FG001|Overall Study|Study terminated by Sponsor|22
4690914|NCT02565511|7600849|FG002|Overall Study|Study terminated by Sponsor|235
4690915|NCT02565511|7600850|FG003|Overall Study|Study terminated by Sponsor|156
4690916|NCT02565511|7600847|FG000|Overall Study|Withdrawal by Subject|3
4690917|NCT02565511|7600848|FG001|Overall Study|Withdrawal by Subject|0
4690918|NCT02565511|7600849|FG002|Overall Study|Withdrawal by Subject|12
4690919|NCT02565511|7600850|FG003|Overall Study|Withdrawal by Subject|5
4690920|NCT02565511|7600847|FG000|Overall Study|Adverse Event|0
4690921|NCT02565511|7600848|FG001|Overall Study|Adverse Event|0
4690922|NCT02565511|7600849|FG002|Overall Study|Adverse Event|1
4690923|NCT02565511|7600850|FG003|Overall Study|Adverse Event|1
4690924|NCT02565511|7600847|FG000|Overall Study|Lost to Follow-up|4
4690925|NCT02565511|7600848|FG001|Overall Study|Lost to Follow-up|1
4690926|NCT02565511|7600849|FG002|Overall Study|Lost to Follow-up|0
4690927|NCT02565511|7600850|FG003|Overall Study|Lost to Follow-up|1
4690928|NCT02565511|7600847|FG000|Overall Study|Physician Decision|0
4690929|NCT02565511|7600848|FG001|Overall Study|Physician Decision|0
4690930|NCT02565511|7600849|FG002|Overall Study|Physician Decision|0
4690931|NCT02565511|7600850|FG003|Overall Study|Physician Decision|1
4690932|NCT02565511|7600847|FG000|Overall Study|Protocol deviation|0
4690933|NCT02565511|7600848|FG001|Overall Study|Protocol deviation|0
4690934|NCT02565511|7600849|FG002|Overall Study|Protocol deviation|3
4690935|NCT02565511|7600850|FG003|Overall Study|Protocol deviation|0
4690936|NCT02565576|7600862|FG000|Overall Study|abnormal lab value|2
4690937|NCT02565576|7600863|FG001|Overall Study|abnormal lab value|0
4572754|NCT01372410|7410493|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
4572755|NCT01372410|7410494|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
4572756|NCT01372410|7410495|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
4572757|NCT01372410|7410496|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
4572758|NCT01372410|7410497|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
4572759|NCT01372410|7410498|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
4572760|NCT01372410|7410499|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
4572761|NCT01372410|7410500|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
4572762|NCT01372410|7410493|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
4690938|NCT02565576|7600862|FG000|Overall Study|subject / guardian decision|1
4690939|NCT02565576|7600863|FG001|Overall Study|subject / guardian decision|3
4690940|NCT02565576|7600862|FG000|Overall Study|Lost to Follow-up|1
4690941|NCT02565576|7600863|FG001|Overall Study|Lost to Follow-up|0
4690942|NCT02565576|7600862|FG000|Overall Study|Death|0
4690943|NCT02565576|7600863|FG001|Overall Study|Death|2
4690944|NCT02565576|7600862|FG000|Overall Study|Adverse Event|1
4690945|NCT02565576|7600863|FG001|Overall Study|Adverse Event|0
4690946|NCT02565615|7600874|FG000|Overall Study|Death|0
4690947|NCT02565615|7600875|FG001|Overall Study|Death|1
4690948|NCT02565615|7600876|FG002|Overall Study|Death|0
4690949|NCT02565615|7600877|FG003|Overall Study|Death|0
4690950|NCT02565615|7600878|FG004|Overall Study|Death|4
4690951|NCT02565615|7600874|FG000|Overall Study|Not willing to participate in study|2
4690952|NCT02565615|7600875|FG001|Overall Study|Not willing to participate in study|21
4690953|NCT02565615|7600876|FG002|Overall Study|Not willing to participate in study|0
4690954|NCT02565615|7600877|FG003|Overall Study|Not willing to participate in study|1
4690955|NCT02565615|7600878|FG004|Overall Study|Not willing to participate in study|169
4690956|NCT02565615|7600874|FG000|Overall Study|Lost to Follow-up|0
4690957|NCT02565615|7600875|FG001|Overall Study|Lost to Follow-up|4
4690958|NCT02565615|7600876|FG002|Overall Study|Lost to Follow-up|0
4690959|NCT02565615|7600877|FG003|Overall Study|Lost to Follow-up|1
4690960|NCT02565615|7600878|FG004|Overall Study|Lost to Follow-up|765
4690961|NCT02565615|7600874|FG000|Overall Study|Not meeting eligibility criteria|0
4690962|NCT02565615|7600875|FG001|Overall Study|Not meeting eligibility criteria|7
4690963|NCT02565615|7600876|FG002|Overall Study|Not meeting eligibility criteria|0
4690964|NCT02565615|7600877|FG003|Overall Study|Not meeting eligibility criteria|0
4690965|NCT02565615|7600878|FG004|Overall Study|Not meeting eligibility criteria|25
4690966|NCT02565615|7600874|FG000|Overall Study|Reason not defined|0
4690967|NCT02565615|7600875|FG001|Overall Study|Reason not defined|2
4690968|NCT02565615|7600876|FG002|Overall Study|Reason not defined|0
4690969|NCT02565615|7600877|FG003|Overall Study|Reason not defined|1
4690970|NCT02565615|7600878|FG004|Overall Study|Reason not defined|62
4690971|NCT02565615|7600874|FG000|Overall Study|Adverse Event|1
4690972|NCT02565615|7600875|FG001|Overall Study|Adverse Event|1
4690973|NCT02565615|7600876|FG002|Overall Study|Adverse Event|0
4690974|NCT02565615|7600877|FG003|Overall Study|Adverse Event|0
4690975|NCT02565615|7600878|FG004|Overall Study|Adverse Event|9
4690976|NCT02565615|7600874|FG000|Overall Study|Untreated|0
4690977|NCT02565615|7600875|FG001|Overall Study|Untreated|0
4690978|NCT02565615|7600876|FG002|Overall Study|Untreated|0
4690979|NCT02565615|7600877|FG003|Overall Study|Untreated|0
4690980|NCT02565615|7600878|FG004|Overall Study|Untreated|567
4690981|NCT02565706|7600903|FG000|Overall Study|Withdrawal by Subject|5
4690982|NCT02565706|7600904|FG001|Overall Study|Withdrawal by Subject|7
4690983|NCT02565706|7600905|FG002|Overall Study|Withdrawal by Subject|7
4690984|NCT02565706|7600906|FG003|Overall Study|Withdrawal by Subject|11
4690985|NCT02565706|7600903|FG000|Overall Study|Lost to Follow-up|72
4690986|NCT02565706|7600904|FG001|Overall Study|Lost to Follow-up|75
4690987|NCT02565706|7600905|FG002|Overall Study|Lost to Follow-up|82
4690988|NCT02565706|7600906|FG003|Overall Study|Lost to Follow-up|74
4690989|NCT02565784|7600921|FG000|First Treatment|Adverse Event|1
4690990|NCT02565784|7600921|FG000|First Treatment|Withdrawal by Subject|1
4690991|NCT02565784|7600921|FG000|Second Treatment|Withdrawal by Subject|2
4690992|NCT02565810|7600929|FG000|Overall Study|Withdrawal by Subject|1
4690993|NCT02565914|7600952|FG000|Overall Study|Adverse Event|17
4690994|NCT02565914|7600952|FG000|Overall Study|Withdrawal of consent (not due to AE)|25
4690995|NCT02565914|7600952|FG000|Overall Study|Lost to Follow-up|12
4690996|NCT02565914|7600952|FG000|Overall Study|Death (not treatment emergent)|1
4690997|NCT02565914|7600952|FG000|Overall Study|Other noncompliance|6
4690998|NCT02565914|7600952|FG000|Overall Study|Physician Decision|6
4690999|NCT02565914|7600952|FG000|Overall Study|Parent study termination by sponsor|1
4691000|NCT02565914|7600952|FG000|Overall Study|Commercial drug available|5
4691001|NCT02565914|7600952|FG000|Overall Study|Other|18
4691002|NCT02565914|7600952|FG000|Overall Study|Enrolled, but did not receive study drug|2
4691003|NCT02566005|7600966|FG000|Overall Study|vaginal bleeding|0
4691004|NCT02566005|7600967|FG001|Overall Study|vaginal bleeding|1
4691005|NCT02566005|7600966|FG000|Overall Study|received foley|8
4691006|NCT02566005|7600967|FG001|Overall Study|received foley|0
4691007|NCT02566005|7600966|FG000|Overall Study|did not receive foley|0
4691008|NCT02566005|7600967|FG001|Overall Study|did not receive foley|1
4691009|NCT02566005|7600966|FG000|Overall Study|labor after randomization|0
4691010|NCT02566005|7600967|FG001|Overall Study|labor after randomization|4
4572763|NCT01372410|7410494|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
4572764|NCT01372410|7410495|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
4572765|NCT01372410|7410496|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
4572766|NCT01372410|7410497|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
4572767|NCT01372410|7410498|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
4572768|NCT01372410|7410499|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
4572769|NCT01372410|7410500|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1
4572770|NCT01372410|7410493|FG000|Treatment Period 3 (7 Days)|Adverse Event|0
4572771|NCT01372410|7410494|FG001|Treatment Period 3 (7 Days)|Adverse Event|0
4572772|NCT01372410|7410495|FG002|Treatment Period 3 (7 Days)|Adverse Event|1
4572773|NCT01372410|7410496|FG003|Treatment Period 3 (7 Days)|Adverse Event|0
4572774|NCT01372410|7410497|FG004|Treatment Period 3 (7 Days)|Adverse Event|0
4572775|NCT01372410|7410498|FG005|Treatment Period 3 (7 Days)|Adverse Event|0
4572776|NCT01372410|7410499|FG006|Treatment Period 3 (7 Days)|Adverse Event|0
4572777|NCT01372410|7410500|FG007|Treatment Period 3 (7 Days)|Adverse Event|0
4572778|NCT01372410|7410493|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0
4572779|NCT01372410|7410494|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0
4572780|NCT01372410|7410495|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0
4572781|NCT01372410|7410496|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0
4572782|NCT01372410|7410497|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0
4572783|NCT01372410|7410498|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1
4572784|NCT01372410|7410499|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0
4572785|NCT01372410|7410500|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0
4572786|NCT01372501|7410529|FG000|Overall Study|Adverse Event|4
4572787|NCT01372501|7410529|FG000|Overall Study|Device migration|1
4572788|NCT01372605|7410536|FG000|Overall Study|Death|1
4572789|NCT01372605|7410537|FG001|Overall Study|Death|2
4572790|NCT01372605|7410536|FG000|Overall Study|Lost to Follow-up|2
4691011|NCT02566031|7600975|FG000|Overall Study|Patient/guardian decision|14
4691012|NCT02566031|7600976|FG001|Overall Study|Patient/guardian decision|7
4691013|NCT02566031|7600975|FG000|Overall Study|Protocol deviation|2
4691014|NCT02566031|7600976|FG001|Overall Study|Protocol deviation|3
4691015|NCT02566031|7600975|FG000|Overall Study|Adverse Event|3
4691016|NCT02566031|7600976|FG001|Overall Study|Adverse Event|1
4691017|NCT02566031|7600975|FG000|Overall Study|Lost to Follow-up|1
4691018|NCT02566031|7600976|FG001|Overall Study|Lost to Follow-up|1
4691019|NCT02566109|7601010|FG000|Overall Study|Withdrawal by Subject|1
4734821|NCT03505593|7682042|FG000|Overall Study|Unable to pass through esophagus|1
4734822|NCT03505593|7682042|FG000|Overall Study|Obstruction by Endotracheal tube|1
4734823|NCT03506425|7682068|FG000|Overall Study|Adverse Event|1
4734824|NCT03506425|7682069|FG001|Overall Study|Adverse Event|3
4734825|NCT03506425|7682070|FG002|Overall Study|Adverse Event|0
4734826|NCT03506425|7682068|FG000|Overall Study|Death|1
4734827|NCT03506425|7682069|FG001|Overall Study|Death|0
4734828|NCT03506425|7682070|FG002|Overall Study|Death|0
4734829|NCT03506425|7682068|FG000|Overall Study|Withdrawal by Subject|0
4734830|NCT03506425|7682069|FG001|Overall Study|Withdrawal by Subject|0
4734831|NCT03506425|7682070|FG002|Overall Study|Withdrawal by Subject|1
4734832|NCT03506477|7682081|FG000|Overall Study|Withdrawal by Subject|1
4734833|NCT03506477|7682082|FG001|Overall Study|Withdrawal by Subject|0
4734834|NCT03508050|7682123|FG000|Overall Study|Pleural adhesions|1
4734835|NCT03508050|7682124|FG001|Overall Study|Pleural adhesions|0
4734836|NCT03508050|7682123|FG000|Overall Study|Mucus plug|1
4734837|NCT03508050|7682124|FG001|Overall Study|Mucus plug|0
4734838|NCT03508050|7682123|FG000|Overall Study|Negative biopsy, surgery cancelled|3
4734839|NCT03508050|7682124|FG001|Overall Study|Negative biopsy, surgery cancelled|1
4734840|NCT03508050|7682123|FG000|Overall Study|Sustained desaturation|0
4734841|NCT03508050|7682124|FG001|Overall Study|Sustained desaturation|1
4734842|NCT03508609|7682131|FG000|Overall Study|Withdrawal by Subject|1
4734843|NCT03508830|7682152|FG000|Overall Study|Withdrawal by Subject|3
4734844|NCT03508830|7682153|FG001|Overall Study|Withdrawal by Subject|4
4734845|NCT03508830|7682152|FG000|Overall Study|Physician Decision|2
4734846|NCT03508830|7682153|FG001|Overall Study|Physician Decision|2
4734847|NCT03508843|7682159|FG000|Overall Study|Withdrawal by Subject|1
4734848|NCT03508843|7682159|FG000|Overall Study|technical difficulties|2
4734849|NCT03509350|7682165|FG000|Overall Study|Withdrawal by Subject|0
4734850|NCT03509350|7682166|FG001|Overall Study|Withdrawal by Subject|2
4572791|NCT01372605|7410537|FG001|Overall Study|Lost to Follow-up|1
4572792|NCT01372605|7410536|FG000|Overall Study|Withdrawal by Subject|4
4734851|NCT03509675|7682174|FG000|First Intervention (7 Days)|Lost to Follow-up|3
4734852|NCT03509675|7682175|FG001|First Intervention (7 Days)|Lost to Follow-up|3
4734853|NCT03509675|7682174|FG000|First Intervention (7 Days)|Lack of Efficacy|2
4734854|NCT03509675|7682175|FG001|First Intervention (7 Days)|Lack of Efficacy|1
4734855|NCT03509675|7682174|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1
4734856|NCT03509675|7682175|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0
4734857|NCT03509675|7682174|FG000|Second Intervention )7 Days)|Lost Rinse B|1
4734858|NCT03509675|7682175|FG001|Second Intervention )7 Days)|Lost Rinse B|0
4734859|NCT03509948|7682196|FG000|Overall Study|Protocol Violation|0
4734860|NCT03509948|7682197|FG001|Overall Study|Protocol Violation|1
4572793|NCT01372605|7410537|FG001|Overall Study|Withdrawal by Subject|7
4572794|NCT01372605|7410536|FG000|Overall Study|Moved|3
4572795|NCT01372605|7410537|FG001|Overall Study|Moved|0
4572796|NCT01372605|7410536|FG000|Overall Study|Changed medical home|2
4572797|NCT01372605|7410537|FG001|Overall Study|Changed medical home|0
4572798|NCT01372748|7410545|FG000|Overall Study|Lost to Follow-up|16
4572799|NCT01372748|7410546|FG001|Overall Study|Lost to Follow-up|34
4572800|NCT01372748|7410545|FG000|Overall Study|Withdrawal by Subject|7
4572801|NCT01372748|7410546|FG001|Overall Study|Withdrawal by Subject|5
4572802|NCT01372774|7410554|FG000|Overall Study|Withdrawal prior to treatment|4
4572803|NCT01372774|7410555|FG001|Overall Study|Withdrawal prior to treatment|5
4572804|NCT01372878|7410567|FG000|Overall Study|Withdrawal by Subject|63
4572805|NCT01372878|7410567|FG000|Overall Study|Protocol Violation|17
4572806|NCT01372878|7410567|FG000|Overall Study|incomplete study procedure|104
4572807|NCT01372995|7410574|FG000|Overall Study|Spouse withdrew participant from study|0
4572808|NCT01372995|7410575|FG001|Overall Study|Spouse withdrew participant from study|1
4572809|NCT01372995|7410576|FG002|Overall Study|Spouse withdrew participant from study|0
4572810|NCT01372995|7410574|FG000|Overall Study|Physician Decision|0
4572811|NCT01372995|7410575|FG001|Overall Study|Physician Decision|0
4572812|NCT01372995|7410576|FG002|Overall Study|Physician Decision|1
4572813|NCT01373164|7410589|FG000|Overall Study|Lost to Follow-up|0
4572814|NCT01373164|7410590|FG001|Overall Study|Lost to Follow-up|0
4572815|NCT01373164|7410591|FG002|Overall Study|Lost to Follow-up|1
4572816|NCT01373164|7410592|FG003|Overall Study|Lost to Follow-up|2
4572817|NCT01373164|7410593|FG004|Overall Study|Lost to Follow-up|0
4572818|NCT01373164|7410589|FG000|Overall Study|Withdrawal by Subject|0
4572819|NCT01373164|7410590|FG001|Overall Study|Withdrawal by Subject|1
4572820|NCT01373164|7410591|FG002|Overall Study|Withdrawal by Subject|0
4572821|NCT01373164|7410592|FG003|Overall Study|Withdrawal by Subject|10
4572822|NCT01373164|7410593|FG004|Overall Study|Withdrawal by Subject|2
4592865|NCT01544595|7440755|FG003|Status at Week 156|Adverse Event|3
4592866|NCT01544595|7440756|FG004|Status at Week 156|Adverse Event|4
4592867|NCT01544595|7440757|FG005|Status at Week 156|Adverse Event|2
4691020|NCT02566525|7601061|FG000|Overall Study|Protocol Violation|3
4691021|NCT02566525|7601062|FG001|Overall Study|Protocol Violation|5
4691022|NCT02566577|7601072|FG000|Overall Study|Withdrawal by Subject|1
4691023|NCT02566577|7601073|FG001|Overall Study|Withdrawal by Subject|1
4691024|NCT02566577|7601072|FG000|Overall Study|Equipment failure|1
4691025|NCT02566577|7601073|FG001|Overall Study|Equipment failure|1
4691026|NCT02566577|7601072|FG000|Overall Study|Physical limitation|1
4691027|NCT02566577|7601073|FG001|Overall Study|Physical limitation|0
4691028|NCT02566759|7601107|FG000|All Parts|Withdrawal by Subject|0
4691029|NCT02566759|7601108|FG001|All Parts|Withdrawal by Subject|1
4691030|NCT02566759|7601109|FG002|All Parts|Withdrawal by Subject|0
4691031|NCT02566759|7601110|FG003|All Parts|Withdrawal by Subject|0
4691032|NCT02566759|7601111|FG004|All Parts|Withdrawal by Subject|0
4691033|NCT02566759|7601112|FG005|All Parts|Withdrawal by Subject|0
4691034|NCT02566759|7601113|FG006|All Parts|Withdrawal by Subject|0
4691035|NCT02566759|7601114|FG007|All Parts|Withdrawal by Subject|0
4691036|NCT02566759|7601115|FG008|All Parts|Withdrawal by Subject|0
4691037|NCT02566759|7601116|FG009|All Parts|Withdrawal by Subject|0
4691038|NCT02566759|7601117|FG010|All Parts|Withdrawal by Subject|0
4691039|NCT02566759|7601118|FG011|All Parts|Withdrawal by Subject|0
4592868|NCT01544595|7440752|FG000|Status at Week 156|Lost to Follow-up|4
4691040|NCT02566759|7601119|FG012|All Parts|Withdrawal by Subject|0
4691041|NCT02566759|7601120|FG013|All Parts|Withdrawal by Subject|0
4691042|NCT02566759|7601121|FG014|All Parts|Withdrawal by Subject|0
4691043|NCT02566759|7601122|FG015|All Parts|Withdrawal by Subject|0
4691044|NCT02566759|7601123|FG016|All Parts|Withdrawal by Subject|0
4691045|NCT02566759|7601107|FG000|All Parts|Adverse Event|0
4691046|NCT02566759|7601108|FG001|All Parts|Adverse Event|0
4691047|NCT02566759|7601109|FG002|All Parts|Adverse Event|0
4691048|NCT02566759|7601110|FG003|All Parts|Adverse Event|0
4691049|NCT02566759|7601111|FG004|All Parts|Adverse Event|0
4691050|NCT02566759|7601112|FG005|All Parts|Adverse Event|0
4691051|NCT02566759|7601113|FG006|All Parts|Adverse Event|0
4691052|NCT02566759|7601114|FG007|All Parts|Adverse Event|0
4691053|NCT02566759|7601115|FG008|All Parts|Adverse Event|0
4691054|NCT02566759|7601116|FG009|All Parts|Adverse Event|0
4691055|NCT02566759|7601117|FG010|All Parts|Adverse Event|0
4691056|NCT02566759|7601118|FG011|All Parts|Adverse Event|0
4691057|NCT02566759|7601119|FG012|All Parts|Adverse Event|1
4691058|NCT02566759|7601120|FG013|All Parts|Adverse Event|3
4691059|NCT02566759|7601121|FG014|All Parts|Adverse Event|0
4691060|NCT02566759|7601122|FG015|All Parts|Adverse Event|0
4691061|NCT02566759|7601123|FG016|All Parts|Adverse Event|0
4592869|NCT01544595|7440753|FG001|Status at Week 156|Lost to Follow-up|4
4691062|NCT02566759|7601107|FG000|All Parts|Other|0
4691063|NCT02566759|7601108|FG001|All Parts|Other|0
4691064|NCT02566759|7601109|FG002|All Parts|Other|0
4592870|NCT01544595|7440754|FG002|Status at Week 156|Lost to Follow-up|0
4592871|NCT01544595|7440755|FG003|Status at Week 156|Lost to Follow-up|1
4592872|NCT01544595|7440756|FG004|Status at Week 156|Lost to Follow-up|4
4691065|NCT02566759|7601110|FG003|All Parts|Other|0
4691066|NCT02566759|7601111|FG004|All Parts|Other|0
4691067|NCT02566759|7601112|FG005|All Parts|Other|0
4691068|NCT02566759|7601113|FG006|All Parts|Other|0
4691069|NCT02566759|7601114|FG007|All Parts|Other|0
4691070|NCT02566759|7601115|FG008|All Parts|Other|0
4691071|NCT02566759|7601116|FG009|All Parts|Other|0
4691072|NCT02566759|7601117|FG010|All Parts|Other|0
4691073|NCT02566759|7601118|FG011|All Parts|Other|0
4572823|NCT01373229|7410608|FG000|Overall Study|Death|3
4572824|NCT01373229|7410608|FG000|Overall Study|Physician Decision|3
4572825|NCT01373294|7410620|FG000|Overall Study|Adverse Event|1
4572826|NCT01373294|7410621|FG001|Overall Study|Adverse Event|0
4572827|NCT01373346|7410627|FG000|Overall Study|Death|1
4572828|NCT01373918|7410675|FG000|Overall Study|Physician Decision|0
4572829|NCT01373918|7410676|FG001|Overall Study|Physician Decision|1
4572830|NCT01373931|7410684|FG000|Lead-in Period|Adverse Event|2
4572831|NCT01373931|7410685|FG001|Lead-in Period|Adverse Event|0
4691074|NCT02566759|7601119|FG012|All Parts|Other|0
4691075|NCT02566759|7601120|FG013|All Parts|Other|2
4691076|NCT02566759|7601121|FG014|All Parts|Other|0
4691077|NCT02566759|7601122|FG015|All Parts|Other|0
4691078|NCT02566759|7601123|FG016|All Parts|Other|0
4691079|NCT02566759|7601107|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
4691080|NCT02566759|7601108|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
4691081|NCT02566759|7601109|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
4691082|NCT02566759|7601110|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
4691083|NCT02566759|7601111|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
4691084|NCT02566759|7601112|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
4691085|NCT02566759|7601113|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
4691086|NCT02566759|7601114|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
4691087|NCT02566759|7601115|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
4691088|NCT02566759|7601116|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
4691089|NCT02566759|7601117|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
4691090|NCT02566759|7601118|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
4691091|NCT02566759|7601119|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
4691092|NCT02566759|7601120|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
4691093|NCT02566759|7601121|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
4691094|NCT02566759|7601122|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
4691095|NCT02566759|7601123|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1
4691096|NCT02566785|7601184|FG000|Overall Study|Lost to Follow-up|0
4691097|NCT02566785|7601185|FG001|Overall Study|Lost to Follow-up|2
4691098|NCT02566785|7601184|FG000|Overall Study|Worsening condition|1
4691099|NCT02566785|7601185|FG001|Overall Study|Worsening condition|1
4691100|NCT02566889|7601193|FG000|Overall Study|Withdrawal by Subject|3
4691101|NCT02566889|7601194|FG001|Overall Study|Withdrawal by Subject|1
4691102|NCT02566889|7601193|FG000|Overall Study|Adverse Event|4
4691103|NCT02566889|7601194|FG001|Overall Study|Adverse Event|2
4691104|NCT02566889|7601193|FG000|Overall Study|Other|6
4691105|NCT02566889|7601194|FG001|Overall Study|Other|2
4691106|NCT02566902|7601201|FG000|Overall Study|Protocol Violation|2
4691107|NCT02566902|7601202|FG001|Overall Study|Protocol Violation|1
4691108|NCT02566993|7601210|FG000|Overall Study|Randomized but not treated|5
4691109|NCT02566993|7601211|FG001|Overall Study|Randomized but not treated|16
4691110|NCT02566993|7601210|FG000|Overall Study|Progressive disease|213
4691111|NCT02566993|7601211|FG001|Overall Study|Progressive disease|152
4691112|NCT02566993|7601210|FG000|Overall Study|Withdrawal by Subject|12
4691113|NCT02566993|7601211|FG001|Overall Study|Withdrawal by Subject|28
4691114|NCT02566993|7601210|FG000|Overall Study|Death|17
4691115|NCT02566993|7601211|FG001|Overall Study|Death|23
4691116|NCT02566993|7601210|FG000|Overall Study|Physician Decision|10
4691117|NCT02566993|7601211|FG001|Overall Study|Physician Decision|17
4691118|NCT02566993|7601210|FG000|Overall Study|Study drug-related adverse event|20
4691119|NCT02566993|7601211|FG001|Overall Study|Study drug-related adverse event|41
4691120|NCT02566993|7601210|FG000|Overall Study|Non study drug-related adverse event|9
4691121|NCT02566993|7601211|FG001|Overall Study|Non study drug-related adverse event|9
4691122|NCT02566993|7601210|FG000|Overall Study|Symptomatic deterioration|9
4691123|NCT02566993|7601211|FG001|Overall Study|Symptomatic deterioration|16
4691124|NCT02566993|7601210|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9
4691125|NCT02566993|7601211|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1
4691126|NCT02566993|7601210|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1
4691127|NCT02566993|7601211|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1
4691128|NCT02566993|7601210|FG000|Overall Study|Screening failure|2
4691129|NCT02566993|7601211|FG001|Overall Study|Screening failure|0
4691130|NCT02566993|7601210|FG000|Overall Study|Lost to Follow-up|0
4691131|NCT02566993|7601211|FG001|Overall Study|Lost to Follow-up|1
4691132|NCT02566993|7601210|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0
4691133|NCT02566993|7601211|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1
4691134|NCT02567188|7601219|FG000|Overall Study|Death|10
4691135|NCT02567188|7601219|FG000|Overall Study|Terminated Mircera Treatment|9
4691136|NCT02567188|7601219|FG000|Overall Study|Lost to Follow-up|5
4691137|NCT02567188|7601219|FG000|Overall Study|Adverse Event|1
4691138|NCT02567188|7601219|FG000|Overall Study|Withdrawal by Subject|1
4572832|NCT01373931|7410684|FG000|Period 1|Adverse Event|2
4572833|NCT01373931|7410685|FG001|Period 1|Adverse Event|0
4572834|NCT01373931|7410684|FG000|Period 1|Withdrawal by Subject|0
4572835|NCT01373931|7410685|FG001|Period 1|Withdrawal by Subject|2
4572836|NCT01374087|7410694|FG000|Overall Study|Adverse Event|1
4572837|NCT01374087|7410695|FG001|Overall Study|Adverse Event|0
4572838|NCT01374087|7410694|FG000|Overall Study|Disease progression|2
4572839|NCT01374087|7410695|FG001|Overall Study|Disease progression|2
4572840|NCT01374087|7410694|FG000|Overall Study|Study discontinued|13
4572841|NCT01374087|7410695|FG001|Overall Study|Study discontinued|13
4572842|NCT01374178|7410701|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1
4572843|NCT01374178|7410702|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0
4572844|NCT01374178|7410701|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2
4572845|NCT01374178|7410702|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0
4572846|NCT01374217|7410708|FG000|Overall Study|Lack of Efficacy|13
4572847|NCT01374269|7410714|FG000|Overall Study|Withdrawal by Subject|4
4572848|NCT01374269|7410715|FG001|Overall Study|Withdrawal by Subject|0
4572849|NCT01374269|7410714|FG000|Overall Study|Lost to Follow-up|1
4572850|NCT01374269|7410715|FG001|Overall Study|Lost to Follow-up|3
4572851|NCT01374269|7410714|FG000|Overall Study|closed research|1
4572852|NCT01374269|7410715|FG001|Overall Study|closed research|2
4572853|NCT01374425|7410723|FG000|Overall Study|Radiographic Disease Progression|86
4572854|NCT01374425|7410724|FG001|Overall Study|Radiographic Disease Progression|81
4572855|NCT01374425|7410723|FG000|Overall Study|Clinical Disease Progression|9
4572856|NCT01374425|7410724|FG001|Overall Study|Clinical Disease Progression|6
4572857|NCT01374425|7410723|FG000|Overall Study|Adverse Event|29
4572858|NCT01374425|7410724|FG001|Overall Study|Adverse Event|18
4572859|NCT01374425|7410723|FG000|Overall Study|Death (Progression of Disease)|1
4572860|NCT01374425|7410724|FG001|Overall Study|Death (Progression of Disease)|0
4572861|NCT01374425|7410723|FG000|Overall Study|Death (Adverse Event)|2
4572862|NCT01374425|7410724|FG001|Overall Study|Death (Adverse Event)|4
4572863|NCT01374425|7410723|FG000|Overall Study|Withdrawal by Subject|6
4691139|NCT02567188|7601219|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1
4691140|NCT02567188|7601219|FG000|Overall Study|Moved and Changed Clinic|1
4691141|NCT02567188|7601219|FG000|Overall Study|Started Hemodialysis|2
4691142|NCT02567188|7601219|FG000|Overall Study|Protocol Violation|5
4691143|NCT02567227|7601226|FG000|9 Weeks|Adverse Event|5
4691144|NCT02567227|7601227|FG001|9 Weeks|Adverse Event|5
4691145|NCT02567227|7601226|FG000|9 Weeks|Withdrawal by Subject|18
4691146|NCT02567227|7601227|FG001|9 Weeks|Withdrawal by Subject|8
4691147|NCT02567227|7601226|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11
4691148|NCT02567227|7601227|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11
4691149|NCT02567227|7601226|FG000|6 Month|Death|2
4691150|NCT02567227|7601227|FG001|6 Month|Death|0
4691151|NCT02567227|7601226|FG000|6 Month|Lost to Follow-up|43
4691152|NCT02567227|7601227|FG001|6 Month|Lost to Follow-up|40
4691153|NCT02567227|7601226|FG000|12 Months|Lost to Follow-up|31
4691154|NCT02567227|7601227|FG001|12 Months|Lost to Follow-up|32
4691155|NCT02567227|7601226|FG000|12 Months|Death|0
4691156|NCT02567227|7601227|FG001|12 Months|Death|2
4691157|NCT02567266|7601236|FG000|Overall Study|Withdrawal by Subject|10
4691158|NCT02567266|7601237|FG001|Overall Study|Withdrawal by Subject|7
4691159|NCT02567266|7601238|FG002|Overall Study|Withdrawal by Subject|6
4691160|NCT02567266|7601236|FG000|Overall Study|Lost to Follow-up|13
4691161|NCT02567266|7601237|FG001|Overall Study|Lost to Follow-up|8
4691162|NCT02567266|7601238|FG002|Overall Study|Lost to Follow-up|10
4691163|NCT02567552|7601248|FG000|Overall Study|Adverse Event|0
4691164|NCT02567552|7601249|FG001|Overall Study|Adverse Event|1
4691165|NCT02567656|7601261|FG000|Overall Study|Premature discontinuation due to PD|1
4691166|NCT02567656|7601262|FG001|Overall Study|Premature discontinuation due to PD|1
4691167|NCT02567656|7601263|FG002|Overall Study|Premature discontinuation due to PD|2
4691168|NCT02567656|7601264|FG003|Overall Study|Premature discontinuation due to PD|0
4691169|NCT02567656|7601265|FG004|Overall Study|Premature discontinuation due to PD|0
4691170|NCT02567656|7601266|FG005|Overall Study|Premature discontinuation due to PD|0
4691171|NCT02567708|7601280|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0
4691172|NCT02567708|7601281|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2
4691173|NCT02567708|7601280|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0
4691174|NCT02567708|7601281|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1
4691175|NCT02567708|7601280|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2
4691176|NCT02567708|7601281|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0
4691177|NCT02567708|7601280|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0
4691178|NCT02567708|7601281|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3
4691179|NCT02568046|7601297|FG000|Overall Study|Adverse Event|0
4691180|NCT02568046|7601298|FG001|Overall Study|Adverse Event|1
4691181|NCT02568046|7601297|FG000|Overall Study|Death|2
4691182|NCT02568046|7601298|FG001|Overall Study|Death|0
4691183|NCT02568046|7601297|FG000|Overall Study|Progressive Disease|1
4691184|NCT02568046|7601298|FG001|Overall Study|Progressive Disease|0
4691185|NCT02568046|7601297|FG000|Overall Study|Withdrawal by Subject|2
4691186|NCT02568046|7601298|FG001|Overall Study|Withdrawal by Subject|1
4691187|NCT02568046|7601297|FG000|Overall Study|Other Events|0
4691188|NCT02568046|7601298|FG001|Overall Study|Other Events|1
4691189|NCT02568072|7601304|FG000|Overall Study|Unavailable for appointment|23
4572864|NCT01374425|7410724|FG001|Overall Study|Withdrawal by Subject|7
4572865|NCT01374425|7410723|FG000|Overall Study|Refused Treatment|10
4572866|NCT01374425|7410724|FG001|Overall Study|Refused Treatment|24
4572867|NCT01374425|7410723|FG000|Overall Study|Protocol Violation|2
4572868|NCT01374425|7410724|FG001|Overall Study|Protocol Violation|3
4572869|NCT01374425|7410723|FG000|Overall Study|Sponsor Decision|0
4572870|NCT01374425|7410724|FG001|Overall Study|Sponsor Decision|1
4572871|NCT01374425|7410723|FG000|Overall Study|Lost to Follow-up|2
4572872|NCT01374425|7410724|FG001|Overall Study|Lost to Follow-up|1
4572873|NCT01374425|7410723|FG000|Overall Study|Other|41
4572874|NCT01374425|7410724|FG001|Overall Study|Other|43
4572875|NCT01374451|7410762|FG000|Overall Study|Administrative problems|1
4572876|NCT01374451|7410763|FG001|Overall Study|Administrative problems|0
4572877|NCT01374568|7410775|FG000|Overall Study|Lab unable to analyze BTM|0
4572878|NCT01374568|7410776|FG001|Overall Study|Lab unable to analyze BTM|2
4572879|NCT01374906|7410790|FG000|Overall Study|Abnormal laboratory value(s)|0
4572880|NCT01374906|7410791|FG001|Overall Study|Abnormal laboratory value(s)|3
4572881|NCT01374906|7410790|FG000|Overall Study|Administrative problems|2
4572882|NCT01374906|7410791|FG001|Overall Study|Administrative problems|2
4572883|NCT01374906|7410790|FG000|Overall Study|Adverse Event|10
4572884|NCT01374906|7410791|FG001|Overall Study|Adverse Event|11
4572885|NCT01374906|7410790|FG000|Overall Study|Death|0
4572886|NCT01374906|7410791|FG001|Overall Study|Death|2
4572887|NCT01374906|7410790|FG000|Overall Study|Protocol Violation|2
4572888|NCT01374906|7410791|FG001|Overall Study|Protocol Violation|2
4572889|NCT01374906|7410790|FG000|Overall Study|Withdrawal by Subject|15
4572890|NCT01374906|7410791|FG001|Overall Study|Withdrawal by Subject|9
4572891|NCT01374906|7410790|FG000|Overall Study|Unsatisfactory therapeutic effect|11
4572892|NCT01374906|7410791|FG001|Overall Study|Unsatisfactory therapeutic effect|19
4572893|NCT01374919|7410801|FG000|Overall Study|Withdrawal by Subject|2
4572894|NCT01374971|7410805|FG000|Overall Study|Withdrawal by Subject|1
4572895|NCT01375010|7410811|FG000|Overall Study|Lost to Follow-up|8
4572896|NCT01375010|7410812|FG001|Overall Study|Lost to Follow-up|2
4572897|NCT01375010|7410811|FG000|Overall Study|Withdrawal by Subject|4
4572898|NCT01375010|7410812|FG001|Overall Study|Withdrawal by Subject|2
4572899|NCT01375049|7410818|FG000|Overall Study|Adverse Event|2
4572900|NCT01375049|7410818|FG000|Overall Study|Lost to Follow-up|1
4572901|NCT01375049|7410818|FG000|Overall Study|Withdrawal by Subject|2
4572902|NCT01375049|7410818|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45
4572903|NCT01375075|7410832|FG000|Overall Study|Adverse Event|0
4572904|NCT01375075|7410833|FG001|Overall Study|Adverse Event|0
4572905|NCT01375075|7410834|FG002|Overall Study|Adverse Event|3
4572906|NCT01375075|7410835|FG003|Overall Study|Adverse Event|1
4572907|NCT01375075|7410836|FG004|Overall Study|Adverse Event|0
4572908|NCT01375075|7410837|FG005|Overall Study|Adverse Event|1
4572909|NCT01375075|7410832|FG000|Overall Study|Entry Criterion Not Met|1
4572910|NCT01375075|7410833|FG001|Overall Study|Entry Criterion Not Met|0
4572911|NCT01375075|7410834|FG002|Overall Study|Entry Criterion Not Met|0
4572912|NCT01375075|7410835|FG003|Overall Study|Entry Criterion Not Met|0
4572913|NCT01375075|7410836|FG004|Overall Study|Entry Criterion Not Met|0
4572914|NCT01375075|7410837|FG005|Overall Study|Entry Criterion Not Met|1
4572915|NCT01375075|7410832|FG000|Overall Study|Withdrawal by Subject|0
4572916|NCT01375075|7410833|FG001|Overall Study|Withdrawal by Subject|1
4572917|NCT01375075|7410834|FG002|Overall Study|Withdrawal by Subject|0
4572918|NCT01375075|7410835|FG003|Overall Study|Withdrawal by Subject|0
4572919|NCT01375075|7410836|FG004|Overall Study|Withdrawal by Subject|0
4572920|NCT01375075|7410837|FG005|Overall Study|Withdrawal by Subject|1
4572921|NCT01375205|7410886|FG000|Overall Study|Lost to Follow-up|15
4572922|NCT01375205|7410887|FG001|Overall Study|Lost to Follow-up|12
4572923|NCT01375205|7410886|FG000|Overall Study|Withdrawal by Subject|6
4572924|NCT01375205|7410887|FG001|Overall Study|Withdrawal by Subject|1
4572925|NCT01375374|7410893|FG000|Overall Study|Adverse Event|1
4572926|NCT01375608|7410913|FG000|Overall Study|Withdrawal by Subject|2
4572927|NCT01375673|7410929|FG000|Overall Study|Withdrawal by Subject|0
4572928|NCT01375673|7410930|FG001|Overall Study|Withdrawal by Subject|1
4572929|NCT01375751|7410939|FG000|Overall Study|Other|0
4572930|NCT01375751|7410940|FG001|Overall Study|Other|1
4572931|NCT01375751|7410941|FG002|Overall Study|Other|0
4572932|NCT01375764|7410954|FG000|Overall Study|Lost to Follow-up|0
4572933|NCT01375764|7410955|FG001|Overall Study|Lost to Follow-up|1
4572934|NCT01375764|7410956|FG002|Overall Study|Lost to Follow-up|0
4572935|NCT01375764|7410957|FG003|Overall Study|Lost to Follow-up|0
4572936|NCT01375764|7410958|FG004|Overall Study|Lost to Follow-up|0
4691190|NCT02568072|7601304|FG000|Overall Study|Unable to contact|3
4572937|NCT01375764|7410954|FG000|Overall Study|Withdrawal by Subject|2
4572938|NCT01375764|7410955|FG001|Overall Study|Withdrawal by Subject|0
4572939|NCT01375764|7410956|FG002|Overall Study|Withdrawal by Subject|0
4572940|NCT01375764|7410957|FG003|Overall Study|Withdrawal by Subject|0
4572941|NCT01375764|7410958|FG004|Overall Study|Withdrawal by Subject|1
4572942|NCT01375764|7410954|FG000|Overall Study|Other|0
4572943|NCT01375764|7410955|FG001|Overall Study|Other|0
4572944|NCT01375764|7410956|FG002|Overall Study|Other|0
4572945|NCT01375764|7410957|FG003|Overall Study|Other|1
4572946|NCT01375764|7410958|FG004|Overall Study|Other|0
4572947|NCT01375777|7410979|FG000|Overall Study|Withdrawal by Subject|0
4572948|NCT01375777|7410980|FG001|Overall Study|Withdrawal by Subject|2
4572949|NCT01375777|7410981|FG002|Overall Study|Withdrawal by Subject|1
4572950|NCT01375777|7410982|FG003|Overall Study|Withdrawal by Subject|0
4572951|NCT01375777|7410983|FG004|Overall Study|Withdrawal by Subject|1
4572952|NCT01375777|7410984|FG005|Overall Study|Withdrawal by Subject|1
4572953|NCT01375777|7410985|FG006|Overall Study|Withdrawal by Subject|1
4572954|NCT01375777|7410986|FG007|Overall Study|Withdrawal by Subject|2
4572955|NCT01375777|7410987|FG008|Overall Study|Withdrawal by Subject|1
4572956|NCT01375777|7410979|FG000|Overall Study|Lost to Follow-up|1
4572957|NCT01375777|7410980|FG001|Overall Study|Lost to Follow-up|0
4572958|NCT01375777|7410981|FG002|Overall Study|Lost to Follow-up|0
4572959|NCT01375777|7410982|FG003|Overall Study|Lost to Follow-up|0
4572960|NCT01375777|7410983|FG004|Overall Study|Lost to Follow-up|0
4572961|NCT01375777|7410984|FG005|Overall Study|Lost to Follow-up|0
4572962|NCT01375777|7410985|FG006|Overall Study|Lost to Follow-up|1
4572963|NCT01375777|7410986|FG007|Overall Study|Lost to Follow-up|0
4572964|NCT01375777|7410987|FG008|Overall Study|Lost to Follow-up|0
4572965|NCT01375777|7410979|FG000|Overall Study|Other|1
4572966|NCT01375777|7410980|FG001|Overall Study|Other|1
4572967|NCT01375777|7410981|FG002|Overall Study|Other|0
4572968|NCT01375777|7410982|FG003|Overall Study|Other|0
4572969|NCT01375777|7410983|FG004|Overall Study|Other|0
4572970|NCT01375777|7410984|FG005|Overall Study|Other|0
4572971|NCT01375777|7410985|FG006|Overall Study|Other|0
4691191|NCT02568072|7601304|FG000|Overall Study|Diagnosis of Long QT Syndrome|1
4691192|NCT02568072|7601304|FG000|Overall Study|Withdrawal by Subject|1
4691193|NCT02568072|7601304|FG000|Overall Study|Sustained injury, marathon not run|24
4691194|NCT02568254|7601309|FG000|Period 2|Adverse Event|0
4691195|NCT02568254|7601310|FG001|Period 2|Adverse Event|0
4691196|NCT02568254|7601311|FG002|Period 2|Adverse Event|1
4691197|NCT02568254|7601312|FG003|Period 2|Adverse Event|0
4691198|NCT02568254|7601313|FG004|Period 2|Adverse Event|0
4691199|NCT02568254|7601314|FG005|Period 2|Adverse Event|0
4691200|NCT02568254|7601309|FG000|Period 3|Unstatisfactory Lens fitting|0
4691201|NCT02568254|7601310|FG001|Period 3|Unstatisfactory Lens fitting|0
4691202|NCT02568254|7601311|FG002|Period 3|Unstatisfactory Lens fitting|0
4691203|NCT02568254|7601312|FG003|Period 3|Unstatisfactory Lens fitting|0
4691204|NCT02568254|7601313|FG004|Period 3|Unstatisfactory Lens fitting|1
4691205|NCT02568254|7601314|FG005|Period 3|Unstatisfactory Lens fitting|0
4691206|NCT02568384|7601326|FG000|Overall Study|Mobile devices incompatible with App|2
4691207|NCT02568397|7601330|FG000|Period 2|Withdrawal by Subject|0
4691208|NCT02568397|7601331|FG001|Period 2|Withdrawal by Subject|1
4691209|NCT02568397|7601330|FG000|Period 2|Physician Decision|0
4691210|NCT02568397|7601331|FG001|Period 2|Physician Decision|1
4572972|NCT01375777|7410986|FG007|Overall Study|Other|0
4572973|NCT01375777|7410987|FG008|Overall Study|Other|1
4572974|NCT01376037|7411018|FG000|Overall Study|Lost to Follow-up|0
4572975|NCT01376037|7411019|FG001|Overall Study|Lost to Follow-up|2
4572976|NCT01376089|7411036|FG000|Overall Study|Patient received no contrast media|3
4572977|NCT01376089|7411037|FG001|Overall Study|Patient received no contrast media|4
4572978|NCT01376167|7411050|FG000|Overall Study|Lost to Follow-up|2
4572979|NCT01376167|7411051|FG001|Overall Study|Lost to Follow-up|4
4572980|NCT01376167|7411052|FG002|Overall Study|Lost to Follow-up|2
4572981|NCT01376167|7411050|FG000|Overall Study|Physician Decision|1
4572982|NCT01376167|7411051|FG001|Overall Study|Physician Decision|1
4572983|NCT01376167|7411052|FG002|Overall Study|Physician Decision|0
4572984|NCT01376167|7411050|FG000|Overall Study|Withdrawal by Subject|1
4691211|NCT02568475|7601348|FG000|Overall Study|Lost to Follow-up|40
4691212|NCT02568475|7601349|FG001|Overall Study|Lost to Follow-up|39
4691213|NCT02568475|7601348|FG000|Overall Study|Withdrawal by Subject|2
4691214|NCT02568475|7601349|FG001|Overall Study|Withdrawal by Subject|0
4691215|NCT02568475|7601348|FG000|Overall Study|Discharged home|4
4691216|NCT02568475|7601349|FG001|Overall Study|Discharged home|4
4691217|NCT02568475|7601348|FG000|Overall Study|Short-term: Discharge location unknown|4
4691218|NCT02568475|7601349|FG001|Overall Study|Short-term: Discharge location unknown|0
4691219|NCT02568475|7601348|FG000|Overall Study|Transferred to another facility|1
4691220|NCT02568475|7601349|FG001|Overall Study|Transferred to another facility|0
4691221|NCT02568683|7601368|FG000|Overall Study|Death|0
4691222|NCT02568683|7601369|FG001|Overall Study|Death|2
4691223|NCT02568683|7601368|FG000|Overall Study|Withdrew Consent|1
4691224|NCT02568683|7601369|FG001|Overall Study|Withdrew Consent|0
4691225|NCT02568683|7601368|FG000|Overall Study|Study Terminated By Sponsor|5
4691226|NCT02568683|7601369|FG001|Overall Study|Study Terminated By Sponsor|2
4691227|NCT02569398|7601397|FG000|Overall Study|Adverse Event|0
4691228|NCT02569398|7601398|FG001|Overall Study|Adverse Event|1
4691229|NCT02569398|7601399|FG002|Overall Study|Adverse Event|6
4691230|NCT02569398|7601397|FG000|Overall Study|Withdrawal by Subject|43
4691231|NCT02569398|7601398|FG001|Overall Study|Withdrawal by Subject|43
4691232|NCT02569398|7601399|FG002|Overall Study|Withdrawal by Subject|30
4691233|NCT02569398|7601397|FG000|Overall Study|Study terminated by sponsor|130
4691234|NCT02569398|7601398|FG001|Overall Study|Study terminated by sponsor|131
4691235|NCT02569398|7601399|FG002|Overall Study|Study terminated by sponsor|134
4572985|NCT01376167|7411051|FG001|Overall Study|Withdrawal by Subject|5
4572986|NCT01376167|7411052|FG002|Overall Study|Withdrawal by Subject|4
4572987|NCT01376245|7411067|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66
4572988|NCT01376245|7411068|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
4572989|NCT01376245|7411069|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
4592873|NCT01544595|7440757|FG005|Status at Week 156|Lost to Follow-up|1
4572990|NCT01376245|7411070|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
4572991|NCT01376245|7411071|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
4572992|NCT01376245|7411067|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4
4572993|NCT01376245|7411068|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
4572994|NCT01376245|7411069|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
4572995|NCT01376245|7411070|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
4572996|NCT01376245|7411071|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
4572997|NCT01376245|7411067|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1
4572998|NCT01376245|7411068|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
4572999|NCT01376245|7411069|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
4573000|NCT01376245|7411070|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
4573001|NCT01376245|7411071|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
4573002|NCT01376245|7411067|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2
4573003|NCT01376245|7411068|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
4573004|NCT01376245|7411069|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
4573005|NCT01376245|7411070|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
4573006|NCT01376245|7411071|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
4573007|NCT01376245|7411067|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28
4573008|NCT01376245|7411068|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
4573009|NCT01376245|7411069|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
4573010|NCT01376245|7411070|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
4573011|NCT01376245|7411071|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
4573012|NCT01376245|7411067|FG000|24-week, Double-blind Treatment Period|Adverse Event|0
4573013|NCT01376245|7411068|FG001|24-week, Double-blind Treatment Period|Adverse Event|16
4573014|NCT01376245|7411069|FG002|24-week, Double-blind Treatment Period|Adverse Event|7
4573015|NCT01376245|7411070|FG003|24-week, Double-blind Treatment Period|Adverse Event|8
4573016|NCT01376245|7411071|FG004|24-week, Double-blind Treatment Period|Adverse Event|18
4573017|NCT01376245|7411067|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0
4573018|NCT01376245|7411068|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4
4573019|NCT01376245|7411069|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5
4573020|NCT01376245|7411070|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4
4573021|NCT01376245|7411071|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3
4573022|NCT01376245|7411067|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0
4573023|NCT01376245|7411068|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2
4573024|NCT01376245|7411069|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0
4573025|NCT01376245|7411070|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2
4573026|NCT01376245|7411071|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1
4573027|NCT01376245|7411067|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
4593782|NCT01555125|7442335|FG004|Extension|Lost to Follow-up|0
4691236|NCT02569398|7601397|FG000|Overall Study|Other|12
4691237|NCT02569398|7601398|FG001|Overall Study|Other|14
4691238|NCT02569398|7601399|FG002|Overall Study|Other|13
4691239|NCT02569437|7601418|FG000|Overall Study|Lost to Follow-up|12
4691240|NCT02569437|7601419|FG001|Overall Study|Lost to Follow-up|14
4691241|NCT02569710|7601452|FG000|Overall Study|Adverse Event|1
4691242|NCT02569710|7601453|FG001|Overall Study|Adverse Event|0
4691243|NCT02569710|7601454|FG002|Overall Study|Adverse Event|0
4691244|NCT02569710|7601455|FG003|Overall Study|Adverse Event|0
4691245|NCT02569710|7601456|FG004|Overall Study|Adverse Event|0
4691246|NCT02569710|7601457|FG005|Overall Study|Adverse Event|0
4691247|NCT02569710|7601458|FG006|Overall Study|Adverse Event|0
4691248|NCT02569710|7601459|FG007|Overall Study|Adverse Event|0
4691249|NCT02569710|7601460|FG008|Overall Study|Adverse Event|0
4691250|NCT02569710|7601461|FG009|Overall Study|Adverse Event|0
4691251|NCT02569710|7601452|FG000|Overall Study|Lost to Follow-up|0
4691252|NCT02569710|7601453|FG001|Overall Study|Lost to Follow-up|0
4691253|NCT02569710|7601454|FG002|Overall Study|Lost to Follow-up|0
4691254|NCT02569710|7601455|FG003|Overall Study|Lost to Follow-up|0
4691255|NCT02569710|7601456|FG004|Overall Study|Lost to Follow-up|0
4691256|NCT02569710|7601457|FG005|Overall Study|Lost to Follow-up|0
4691257|NCT02569710|7601458|FG006|Overall Study|Lost to Follow-up|1
4691258|NCT02569710|7601459|FG007|Overall Study|Lost to Follow-up|0
4691259|NCT02569710|7601460|FG008|Overall Study|Lost to Follow-up|1
4691260|NCT02569710|7601461|FG009|Overall Study|Lost to Follow-up|0
4691261|NCT02569710|7601452|FG000|Overall Study|Virologic failure|0
4691262|NCT02569710|7601453|FG001|Overall Study|Virologic failure|0
4691263|NCT02569710|7601454|FG002|Overall Study|Virologic failure|0
4691264|NCT02569710|7601455|FG003|Overall Study|Virologic failure|0
4691265|NCT02569710|7601456|FG004|Overall Study|Virologic failure|1
4691266|NCT02569710|7601457|FG005|Overall Study|Virologic failure|0
4691267|NCT02569710|7601458|FG006|Overall Study|Virologic failure|1
4691268|NCT02569710|7601459|FG007|Overall Study|Virologic failure|0
4691269|NCT02569710|7601460|FG008|Overall Study|Virologic failure|0
4691270|NCT02569710|7601461|FG009|Overall Study|Virologic failure|0
4691271|NCT02569710|7601452|FG000|Overall Study|Withdrawal by Subject|0
4691272|NCT02569710|7601453|FG001|Overall Study|Withdrawal by Subject|0
4573028|NCT01376245|7411068|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2
4573029|NCT01376245|7411069|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3
4573030|NCT01376245|7411070|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1
4573031|NCT01376245|7411071|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
4573032|NCT01376245|7411067|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0
4573033|NCT01376245|7411068|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2
4573034|NCT01376245|7411069|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0
4573035|NCT01376245|7411070|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1
4573036|NCT01376245|7411071|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1
4573037|NCT01376245|7411067|FG000|24-week, Double-blind Treatment Period|Physician Decision|0
4573038|NCT01376245|7411068|FG001|24-week, Double-blind Treatment Period|Physician Decision|0
4573039|NCT01376245|7411069|FG002|24-week, Double-blind Treatment Period|Physician Decision|1
4691273|NCT02569710|7601454|FG002|Overall Study|Withdrawal by Subject|0
4691274|NCT02569710|7601455|FG003|Overall Study|Withdrawal by Subject|0
4691275|NCT02569710|7601456|FG004|Overall Study|Withdrawal by Subject|0
4691276|NCT02569710|7601457|FG005|Overall Study|Withdrawal by Subject|1
4691277|NCT02569710|7601458|FG006|Overall Study|Withdrawal by Subject|0
4691278|NCT02569710|7601459|FG007|Overall Study|Withdrawal by Subject|0
4691279|NCT02569710|7601460|FG008|Overall Study|Withdrawal by Subject|0
4691280|NCT02569710|7601461|FG009|Overall Study|Withdrawal by Subject|0
4691281|NCT02569801|7601500|FG000|Overall Study|Withdrawal by Subject|9
4691282|NCT02569801|7601501|FG001|Overall Study|Withdrawal by Subject|9
4691283|NCT02569801|7601500|FG000|Overall Study|Sponsor Decision|13
4691284|NCT02569801|7601501|FG001|Overall Study|Sponsor Decision|14
4691285|NCT02569801|7601500|FG000|Overall Study|Progressive Disease|2
4691286|NCT02569801|7601501|FG001|Overall Study|Progressive Disease|7
4691287|NCT02569801|7601500|FG000|Overall Study|Lost to Follow-up|0
4691288|NCT02569801|7601501|FG001|Overall Study|Lost to Follow-up|1
4691289|NCT02569801|7601500|FG000|Overall Study|Death|12
4691290|NCT02569801|7601501|FG001|Overall Study|Death|4
4691291|NCT02569853|7601509|FG000|Overall Study|Adverse Event|2
4691292|NCT02569853|7601510|FG001|Overall Study|Adverse Event|0
4691293|NCT02569853|7601509|FG000|Overall Study|Withdrawal by Subject|3
4691294|NCT02569853|7601510|FG001|Overall Study|Withdrawal by Subject|2
4691295|NCT02569853|7601509|FG000|Overall Study|Lost to Follow-up|3
4691296|NCT02569853|7601510|FG001|Overall Study|Lost to Follow-up|3
4691297|NCT02569853|7601509|FG000|Overall Study|Protocol Violation|1
4691298|NCT02569853|7601510|FG001|Overall Study|Protocol Violation|1
4691299|NCT02569853|7601509|FG000|Overall Study|Did not experience migraine attack|10
4691300|NCT02569853|7601510|FG001|Overall Study|Did not experience migraine attack|7
4691301|NCT02569853|7601509|FG000|Overall Study|Physician Decision|1
4691302|NCT02569853|7601510|FG001|Overall Study|Physician Decision|1
4691303|NCT02569996|7601525|FG000|Overall Study|Adverse Event|6
4691304|NCT02569996|7601525|FG000|Overall Study|Physician Decision|3
4691305|NCT02569996|7601525|FG000|Overall Study|Progression of the disease|18
4691306|NCT02569996|7601525|FG000|Overall Study|New anti-lymphoma treatment|1
4691307|NCT02569996|7601525|FG000|Overall Study|Non-compliance|9
4691308|NCT02569996|7601525|FG000|Overall Study|Withdrawal by Subject|5
4691309|NCT02569996|7601525|FG000|Overall Study|Lost to Follow-up|5
4691310|NCT02569996|7601525|FG000|Overall Study|Complete remission|7
4691311|NCT02569996|7601525|FG000|Overall Study|Unknown reason|1
4691312|NCT02570074|7601540|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1
4691313|NCT02570074|7601541|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0
4691314|NCT02570126|7601561|FG000|Overall Study|Lost to Follow-up|2
4691315|NCT02570126|7601562|FG001|Overall Study|Lost to Follow-up|0
4691316|NCT02570126|7601561|FG000|Overall Study|Unable To Arrange Visit 3|1
4691317|NCT02570126|7601562|FG001|Overall Study|Unable To Arrange Visit 3|0
4691318|NCT02570126|7601561|FG000|Overall Study|Violation Of Procedures GSK|0
4691319|NCT02570126|7601562|FG001|Overall Study|Violation Of Procedures GSK|1
4691320|NCT02570126|7601561|FG000|Overall Study|Protocol Violation|0
4691321|NCT02570126|7601562|FG001|Overall Study|Protocol Violation|1
4691322|NCT02570126|7601561|FG000|Overall Study|Withdrawal by Subject|3
4691323|NCT02570126|7601562|FG001|Overall Study|Withdrawal by Subject|7
4691324|NCT02570152|7601577|FG000|Overall Study|Protocol Violation|2
4691325|NCT02570152|7601577|FG000|Overall Study|Migrated/moved from study area|13
4691326|NCT02570165|7601588|FG000|Overall Study|Adverse Event|1
4691327|NCT02570165|7601589|FG001|Overall Study|Adverse Event|0
4691328|NCT02570165|7601590|FG002|Overall Study|Adverse Event|2
4691329|NCT02570165|7601591|FG003|Overall Study|Adverse Event|0
4691330|NCT02570165|7601592|FG004|Overall Study|Adverse Event|0
4691331|NCT02570165|7601593|FG005|Overall Study|Adverse Event|0
4691332|NCT02570165|7601594|FG006|Overall Study|Adverse Event|0
4691333|NCT02570165|7601588|FG000|Overall Study|Lack of Efficacy|0
4691334|NCT02570165|7601589|FG001|Overall Study|Lack of Efficacy|1
4691335|NCT02570165|7601590|FG002|Overall Study|Lack of Efficacy|0
4691336|NCT02570165|7601591|FG003|Overall Study|Lack of Efficacy|0
4691337|NCT02570165|7601592|FG004|Overall Study|Lack of Efficacy|4
4691338|NCT02570165|7601593|FG005|Overall Study|Lack of Efficacy|0
4691339|NCT02570165|7601594|FG006|Overall Study|Lack of Efficacy|0
4691340|NCT02570165|7601588|FG000|Overall Study|Par. Reached Stopping Criteria|1
4691341|NCT02570165|7601589|FG001|Overall Study|Par. Reached Stopping Criteria|1
4573040|NCT01376245|7411070|FG003|24-week, Double-blind Treatment Period|Physician Decision|1
4573041|NCT01376245|7411071|FG004|24-week, Double-blind Treatment Period|Physician Decision|0
4573042|NCT01376245|7411067|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
4573043|NCT01376245|7411068|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6
4573044|NCT01376245|7411069|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
4573045|NCT01376245|7411070|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6
4573046|NCT01376245|7411071|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3
4573047|NCT01376310|7411092|FG000|Overall Study|Study closed/terminated|1
4573048|NCT01376310|7411093|FG001|Overall Study|Study closed/terminated|2
4573049|NCT01376310|7411092|FG000|Overall Study|Withdrawal by Subject|8
4573050|NCT01376310|7411093|FG001|Overall Study|Withdrawal by Subject|2
4573051|NCT01376310|7411092|FG000|Overall Study|Physician Decision|26
4573052|NCT01376310|7411093|FG001|Overall Study|Physician Decision|7
4573053|NCT01376310|7411092|FG000|Overall Study|Lost to Follow-up|1
4573054|NCT01376310|7411093|FG001|Overall Study|Lost to Follow-up|0
4573055|NCT01376349|7411102|FG000|Raondomized Treatment|Withdrawal by Subject|10
4573056|NCT01376349|7411103|FG001|Raondomized Treatment|Withdrawal by Subject|16
4573057|NCT01376349|7411104|FG002|Raondomized Treatment|Withdrawal by Subject|13
4573058|NCT01376349|7411102|FG000|Raondomized Treatment|Adverse Event|13
4573059|NCT01376349|7411103|FG001|Raondomized Treatment|Adverse Event|17
4573060|NCT01376349|7411104|FG002|Raondomized Treatment|Adverse Event|14
4573061|NCT01376349|7411102|FG000|Raondomized Treatment|Unkown|1
4573062|NCT01376349|7411103|FG001|Raondomized Treatment|Unkown|2
4573063|NCT01376349|7411104|FG002|Raondomized Treatment|Unkown|1
4573064|NCT01376349|7411102|FG000|Raondomized Treatment|Alternative Treatment|0
4573065|NCT01376349|7411103|FG001|Raondomized Treatment|Alternative Treatment|0
4573066|NCT01376349|7411104|FG002|Raondomized Treatment|Alternative Treatment|1
4573067|NCT01376388|7411117|FG000|Overall Study|Adverse Event|13
4573068|NCT01376388|7411117|FG000|Overall Study|Lack of Efficacy|2
4573069|NCT01376388|7411117|FG000|Overall Study|Withdrawal by Subject|3
4573070|NCT01376700|7411142|FG000|Overall Study|Sponsor terminated study early|8
4573071|NCT01376700|7411142|FG000|Overall Study|Low or high titer inhibitor|8
4691342|NCT02570165|7601590|FG002|Overall Study|Par. Reached Stopping Criteria|0
4691343|NCT02570165|7601591|FG003|Overall Study|Par. Reached Stopping Criteria|2
4691344|NCT02570165|7601592|FG004|Overall Study|Par. Reached Stopping Criteria|1
4691345|NCT02570165|7601593|FG005|Overall Study|Par. Reached Stopping Criteria|1
4691346|NCT02570165|7601594|FG006|Overall Study|Par. Reached Stopping Criteria|0
4691347|NCT02570165|7601588|FG000|Overall Study|Lost to Follow-up|0
4573072|NCT01376804|7411149|FG000|Treatment Period|Withdrawal by Subject|1
4573073|NCT01376804|7411149|FG000|Treatment Period|Adverse Event|6
4573074|NCT01376804|7411149|FG000|Treatment Period|Patient did not receive study drug|1
4573075|NCT01376908|7411155|FG000|Overall Study|Protocol Violation|1
4573076|NCT01376908|7411156|FG001|Overall Study|Protocol Violation|1
4573077|NCT01376908|7411155|FG000|Overall Study|Withdrawal by Subject|1
4573078|NCT01376908|7411156|FG001|Overall Study|Withdrawal by Subject|2
4573079|NCT01377012|7411172|FG000|Core Study|Study terminated by Sponsor|47
4573080|NCT01377012|7411173|FG001|Core Study|Study terminated by Sponsor|54
4573081|NCT01377012|7411174|FG002|Core Study|Study terminated by Sponsor|46
4573082|NCT01377012|7411172|FG000|Core Study|Technical problems|1
4573083|NCT01377012|7411173|FG001|Core Study|Technical problems|0
4573084|NCT01377012|7411174|FG002|Core Study|Technical problems|0
4691348|NCT02570165|7601589|FG001|Overall Study|Lost to Follow-up|0
4691349|NCT02570165|7601590|FG002|Overall Study|Lost to Follow-up|1
4691350|NCT02570165|7601591|FG003|Overall Study|Lost to Follow-up|1
4691351|NCT02570165|7601592|FG004|Overall Study|Lost to Follow-up|0
4691352|NCT02570165|7601593|FG005|Overall Study|Lost to Follow-up|0
4691353|NCT02570165|7601594|FG006|Overall Study|Lost to Follow-up|0
4691354|NCT02570165|7601588|FG000|Overall Study|Physician Decision|0
4691355|NCT02570165|7601589|FG001|Overall Study|Physician Decision|1
4691356|NCT02570165|7601590|FG002|Overall Study|Physician Decision|0
4691357|NCT02570165|7601591|FG003|Overall Study|Physician Decision|0
4691358|NCT02570165|7601592|FG004|Overall Study|Physician Decision|0
4691359|NCT02570165|7601593|FG005|Overall Study|Physician Decision|0
4691360|NCT02570165|7601594|FG006|Overall Study|Physician Decision|0
4691361|NCT02570165|7601588|FG000|Overall Study|Withdrawal by Subject|0
4691362|NCT02570165|7601589|FG001|Overall Study|Withdrawal by Subject|0
4691363|NCT02570165|7601590|FG002|Overall Study|Withdrawal by Subject|0
4691364|NCT02570165|7601591|FG003|Overall Study|Withdrawal by Subject|2
4691365|NCT02570165|7601592|FG004|Overall Study|Withdrawal by Subject|1
4691366|NCT02570165|7601593|FG005|Overall Study|Withdrawal by Subject|0
4691367|NCT02570165|7601594|FG006|Overall Study|Withdrawal by Subject|0
4573085|NCT01377012|7411172|FG000|Core Study|Withdrawal by Subject|15
4573086|NCT01377012|7411173|FG001|Core Study|Withdrawal by Subject|23
4573087|NCT01377012|7411174|FG002|Core Study|Withdrawal by Subject|18
4573088|NCT01377012|7411172|FG000|Core Study|Protocol Violation|7
4573089|NCT01377012|7411173|FG001|Core Study|Protocol Violation|3
4573090|NCT01377012|7411174|FG002|Core Study|Protocol Violation|2
4573091|NCT01377012|7411172|FG000|Core Study|Pregnancy|0
4691368|NCT02570165|7601588|FG000|Overall Study|Par. did not Meet Continuation Criteria|0
4691369|NCT02570165|7601589|FG001|Overall Study|Par. did not Meet Continuation Criteria|0
4691370|NCT02570165|7601590|FG002|Overall Study|Par. did not Meet Continuation Criteria|0
4573092|NCT01377012|7411173|FG001|Core Study|Pregnancy|0
4691371|NCT02570165|7601591|FG003|Overall Study|Par. did not Meet Continuation Criteria|0
4691372|NCT02570165|7601592|FG004|Overall Study|Par. did not Meet Continuation Criteria|0
4691373|NCT02570165|7601593|FG005|Overall Study|Par. did not Meet Continuation Criteria|1
4691374|NCT02570165|7601594|FG006|Overall Study|Par. did not Meet Continuation Criteria|0
4691375|NCT02570165|7601588|FG000|Overall Study|Withdrawal Request by GSK|0
4691376|NCT02570165|7601589|FG001|Overall Study|Withdrawal Request by GSK|0
4573093|NCT01377012|7411174|FG002|Core Study|Pregnancy|1
4573094|NCT01377012|7411172|FG000|Core Study|Physician Decision|5
4573095|NCT01377012|7411173|FG001|Core Study|Physician Decision|4
4573096|NCT01377012|7411174|FG002|Core Study|Physician Decision|10
4573097|NCT01377012|7411172|FG000|Core Study|Non-Compliant with study treatment|0
4573098|NCT01377012|7411173|FG001|Core Study|Non-Compliant with study treatment|0
4573099|NCT01377012|7411174|FG002|Core Study|Non-Compliant with study treatment|1
4573100|NCT01377012|7411172|FG000|Core Study|No Longer require treatment|0
4573101|NCT01377012|7411173|FG001|Core Study|No Longer require treatment|0
4573102|NCT01377012|7411174|FG002|Core Study|No Longer require treatment|1
4573103|NCT01377012|7411172|FG000|Core Study|Lost to Follow-up|7
4573104|NCT01377012|7411173|FG001|Core Study|Lost to Follow-up|5
4573105|NCT01377012|7411174|FG002|Core Study|Lost to Follow-up|4
4573106|NCT01377012|7411172|FG000|Core Study|Lack of Efficacy|41
4573107|NCT01377012|7411173|FG001|Core Study|Lack of Efficacy|28
4573108|NCT01377012|7411174|FG002|Core Study|Lack of Efficacy|37
4573109|NCT01377012|7411172|FG000|Core Study|Death|1
4573110|NCT01377012|7411173|FG001|Core Study|Death|1
4573111|NCT01377012|7411174|FG002|Core Study|Death|1
4573112|NCT01377012|7411172|FG000|Core Study|Adverse Event|10
4573113|NCT01377012|7411173|FG001|Core Study|Adverse Event|14
4573114|NCT01377012|7411174|FG002|Core Study|Adverse Event|13
4573115|NCT01377012|7411172|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3
4573116|NCT01377012|7411173|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0
4573117|NCT01377012|7411174|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0
4573118|NCT01377012|7411172|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52
4573119|NCT01377012|7411173|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69
4573120|NCT01377012|7411174|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63
4573121|NCT01377012|7411172|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1
4573122|NCT01377012|7411173|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0
4573123|NCT01377012|7411174|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3
4573124|NCT01377012|7411172|FG000|Extension Study, Weeks 104-260|Physician Decision|1
4573125|NCT01377012|7411173|FG001|Extension Study, Weeks 104-260|Physician Decision|0
4573126|NCT01377012|7411174|FG002|Extension Study, Weeks 104-260|Physician Decision|0
4573127|NCT01377012|7411172|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0
4573128|NCT01377012|7411173|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0
4573129|NCT01377012|7411174|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1
4573130|NCT01377012|7411172|FG000|Extension Study, Weeks 104-260|Adverse Event|0
4573131|NCT01377012|7411173|FG001|Extension Study, Weeks 104-260|Adverse Event|2
4573132|NCT01377012|7411174|FG002|Extension Study, Weeks 104-260|Adverse Event|1
4573133|NCT01377194|7411185|FG000|Overall Study|Adverse Event|3
4573134|NCT01377194|7411186|FG001|Overall Study|Adverse Event|12
4573135|NCT01377194|7411187|FG002|Overall Study|Adverse Event|19
4573136|NCT01377194|7411185|FG000|Overall Study|Lack of Efficacy|3
4573137|NCT01377194|7411186|FG001|Overall Study|Lack of Efficacy|3
4573138|NCT01377194|7411187|FG002|Overall Study|Lack of Efficacy|3
4573139|NCT01377194|7411185|FG000|Overall Study|Protocol Violation|4
4691377|NCT02570165|7601590|FG002|Overall Study|Withdrawal Request by GSK|2
4691378|NCT02570165|7601591|FG003|Overall Study|Withdrawal Request by GSK|0
4691379|NCT02570165|7601592|FG004|Overall Study|Withdrawal Request by GSK|0
4691380|NCT02570165|7601593|FG005|Overall Study|Withdrawal Request by GSK|0
4691381|NCT02570165|7601594|FG006|Overall Study|Withdrawal Request by GSK|0
4691382|NCT02570711|7601633|FG000|Overall Study|Death|1
4691383|NCT02570711|7601634|FG001|Overall Study|Death|0
4691384|NCT02570711|7601633|FG000|Overall Study|Early Termination of Study by Sponsor|0
4691385|NCT02570711|7601634|FG001|Overall Study|Early Termination of Study by Sponsor|2
4691386|NCT02570750|7601642|FG000|Overall Study|Inclusion/exclusion criteria deviation|1
4691387|NCT02570750|7601643|FG001|Overall Study|Inclusion/exclusion criteria deviation|0
4691388|NCT02570750|7601642|FG000|Overall Study|Protocol deviation|4
4691389|NCT02570750|7601643|FG001|Overall Study|Protocol deviation|2
4691390|NCT02570750|7601642|FG000|Overall Study|Withdrawal by Subject|5
4691391|NCT02570750|7601643|FG001|Overall Study|Withdrawal by Subject|0
4691392|NCT02570750|7601642|FG000|Overall Study|Lost to Follow-up|2
4691393|NCT02570750|7601643|FG001|Overall Study|Lost to Follow-up|2
4691394|NCT02570750|7601642|FG000|Overall Study|Adverse Event|2
4691395|NCT02570750|7601643|FG001|Overall Study|Adverse Event|1
4691396|NCT02571049|7601649|FG000|Screening|Did not meet entry criteria|2
4691397|NCT02571049|7601650|FG001|Screening|Did not meet entry criteria|2
4691398|NCT02571049|7601649|FG000|Randomization|No migraine attack|0
4691399|NCT02571049|7601650|FG001|Randomization|No migraine attack|1
4573140|NCT01377194|7411186|FG001|Overall Study|Protocol Violation|10
4691400|NCT02571049|7601649|FG000|Randomization|Adverse Event|0
4691401|NCT02571049|7601650|FG001|Randomization|Adverse Event|1
4573141|NCT01377194|7411187|FG002|Overall Study|Protocol Violation|6
4573142|NCT01377194|7411185|FG000|Overall Study|Withdrawal by Subject|8
4573143|NCT01377194|7411186|FG001|Overall Study|Withdrawal by Subject|10
4573144|NCT01377194|7411187|FG002|Overall Study|Withdrawal by Subject|7
4573145|NCT01377194|7411185|FG000|Overall Study|Lost to Follow-up|14
4573146|NCT01377194|7411186|FG001|Overall Study|Lost to Follow-up|8
4573147|NCT01377194|7411187|FG002|Overall Study|Lost to Follow-up|11
4573148|NCT01377233|7411203|FG000|Open-label|Adverse Event|1
4573149|NCT01377233|7411204|FG001|Open-label|Adverse Event|0
4573150|NCT01377233|7411205|FG002|Open-label|Adverse Event|0
4573151|NCT01377233|7411206|FG003|Open-label|Adverse Event|0
4573152|NCT01377233|7411207|FG004|Open-label|Adverse Event|0
4573153|NCT01377233|7411203|FG000|Open-label|Withdrawal by Subject|3
4573154|NCT01377233|7411204|FG001|Open-label|Withdrawal by Subject|0
4573155|NCT01377233|7411205|FG002|Open-label|Withdrawal by Subject|0
4691402|NCT02571075|7601658|FG000|Overall Study|Lost to Follow-up|20
4691403|NCT02571075|7601659|FG001|Overall Study|Lost to Follow-up|24
4691404|NCT02571244|7601689|FG000|Overall Study|Lost to Follow-up|0
4691405|NCT02571244|7601690|FG001|Overall Study|Lost to Follow-up|1
4691406|NCT02571244|7601689|FG000|Overall Study|Unable to reach out post discharge|3
4691407|NCT02571244|7601690|FG001|Overall Study|Unable to reach out post discharge|0
4691408|NCT02571452|7601710|FG000|Overall Study Treatment|Protocol Violation|0
4691409|NCT02571452|7601711|FG001|Overall Study Treatment|Protocol Violation|1
4691410|NCT02571452|7601710|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4
4691411|NCT02571452|7601711|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0
4691412|NCT02571452|7601710|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1
4691413|NCT02571452|7601711|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0
4691414|NCT02571777|7601727|FG000|Overall Study|Subject/guardian decision|34
4691415|NCT02571777|7601728|FG001|Overall Study|Subject/guardian decision|26
4691416|NCT02571777|7601729|FG002|Overall Study|Subject/guardian decision|26
4691417|NCT02571777|7601730|FG003|Overall Study|Subject/guardian decision|25
4691418|NCT02571777|7601731|FG004|Overall Study|Subject/guardian decision|27
4691419|NCT02571777|7601727|FG000|Overall Study|Protocol Deviation|2
4691420|NCT02571777|7601728|FG001|Overall Study|Protocol Deviation|3
4691421|NCT02571777|7601729|FG002|Overall Study|Protocol Deviation|4
4691422|NCT02571777|7601730|FG003|Overall Study|Protocol Deviation|8
4691423|NCT02571777|7601731|FG004|Overall Study|Protocol Deviation|4
4691424|NCT02571777|7601727|FG000|Overall Study|Death|1
4691425|NCT02571777|7601728|FG001|Overall Study|Death|1
4691426|NCT02571777|7601729|FG002|Overall Study|Death|4
4691427|NCT02571777|7601730|FG003|Overall Study|Death|0
4691428|NCT02571777|7601731|FG004|Overall Study|Death|0
4691429|NCT02571777|7601727|FG000|Overall Study|Lost to Follow-up|1
4691430|NCT02571777|7601728|FG001|Overall Study|Lost to Follow-up|1
4691431|NCT02571777|7601729|FG002|Overall Study|Lost to Follow-up|2
4691432|NCT02571777|7601730|FG003|Overall Study|Lost to Follow-up|0
4691433|NCT02571777|7601731|FG004|Overall Study|Lost to Follow-up|1
4691434|NCT02571777|7601727|FG000|Overall Study|Physician Decision|1
4691435|NCT02571777|7601728|FG001|Overall Study|Physician Decision|7
4691436|NCT02571777|7601729|FG002|Overall Study|Physician Decision|5
4691437|NCT02571777|7601730|FG003|Overall Study|Physician Decision|2
4691438|NCT02571777|7601731|FG004|Overall Study|Physician Decision|4
4691439|NCT02571777|7601727|FG000|Overall Study|Pregnancy|0
4691440|NCT02571777|7601728|FG001|Overall Study|Pregnancy|0
4691441|NCT02571777|7601729|FG002|Overall Study|Pregnancy|0
4691442|NCT02571777|7601730|FG003|Overall Study|Pregnancy|2
4691443|NCT02571777|7601731|FG004|Overall Study|Pregnancy|0
4691444|NCT02571972|7601743|FG000|Overall Study|Protocol Violation|2
4691445|NCT02571972|7601743|FG000|Overall Study|Withdrawal by Subject|2
4691446|NCT02572076|7601747|FG000|Overall Study|Protocol Violation|1
4691447|NCT02572167|7601754|FG000|Overall Study|In follow up|6
4691448|NCT02572167|7601755|FG001|Overall Study|In follow up|48
4691449|NCT02572167|7601756|FG002|Overall Study|In follow up|27
4691450|NCT02572167|7601754|FG000|Overall Study|Withdrawal by Subject|0
4691451|NCT02572167|7601755|FG001|Overall Study|Withdrawal by Subject|3
4691452|NCT02572167|7601756|FG002|Overall Study|Withdrawal by Subject|1
4691453|NCT02572167|7601754|FG000|Overall Study|Lost to Follow-up|0
4691454|NCT02572167|7601755|FG001|Overall Study|Lost to Follow-up|2
4691455|NCT02572167|7601756|FG002|Overall Study|Lost to Follow-up|1
4691456|NCT02572167|7601754|FG000|Overall Study|Death|0
4691457|NCT02572167|7601755|FG001|Overall Study|Death|3
4691458|NCT02572167|7601756|FG002|Overall Study|Death|1
4691459|NCT02572167|7601754|FG000|Overall Study|Did not meet inclusion criteria|0
4691460|NCT02572167|7601755|FG001|Overall Study|Did not meet inclusion criteria|0
4691461|NCT02572167|7601756|FG002|Overall Study|Did not meet inclusion criteria|1
4691462|NCT02572388|7601768|FG000|Overall Study|Withdrawal by Subject|1
4691463|NCT02572388|7601769|FG001|Overall Study|Withdrawal by Subject|1
4691464|NCT02572388|7601770|FG002|Overall Study|Withdrawal by Subject|2
4691465|NCT02572388|7601771|FG003|Overall Study|Withdrawal by Subject|2
4691466|NCT02572401|7601785|FG000|Overall Study|Lost to Follow-up|5
4573156|NCT01377233|7411206|FG003|Open-label|Withdrawal by Subject|0
4573157|NCT01377233|7411207|FG004|Open-label|Withdrawal by Subject|0
4691467|NCT02572401|7601786|FG001|Overall Study|Lost to Follow-up|8
4691468|NCT02572401|7601787|FG002|Overall Study|Lost to Follow-up|9
4691469|NCT02572401|7601788|FG003|Overall Study|Lost to Follow-up|9
4691470|NCT02572401|7601785|FG000|Overall Study|Death|0
4691471|NCT02572401|7601786|FG001|Overall Study|Death|0
4691472|NCT02572401|7601787|FG002|Overall Study|Death|0
4573158|NCT01377233|7411203|FG000|Double-blind|Adverse Event|0
4573159|NCT01377233|7411204|FG001|Double-blind|Adverse Event|1
4573160|NCT01377233|7411205|FG002|Double-blind|Adverse Event|2
4573161|NCT01377233|7411206|FG003|Double-blind|Adverse Event|2
4573162|NCT01377233|7411207|FG004|Double-blind|Adverse Event|0
4573163|NCT01377233|7411203|FG000|Double-blind|Protocol Violation|0
4573164|NCT01377233|7411204|FG001|Double-blind|Protocol Violation|0
4573165|NCT01377233|7411205|FG002|Double-blind|Protocol Violation|0
4573166|NCT01377233|7411206|FG003|Double-blind|Protocol Violation|0
4573167|NCT01377233|7411207|FG004|Double-blind|Protocol Violation|1
4573168|NCT01377233|7411203|FG000|Double-blind|Withdrawal by Subject|0
4573169|NCT01377233|7411204|FG001|Double-blind|Withdrawal by Subject|0
4573170|NCT01377233|7411205|FG002|Double-blind|Withdrawal by Subject|0
4573171|NCT01377233|7411206|FG003|Double-blind|Withdrawal by Subject|1
4573172|NCT01377233|7411207|FG004|Double-blind|Withdrawal by Subject|0
4573173|NCT01377233|7411203|FG000|Double-blind|Administrative or other|0
4573174|NCT01377233|7411204|FG001|Double-blind|Administrative or other|0
4573175|NCT01377233|7411205|FG002|Double-blind|Administrative or other|0
4573176|NCT01377233|7411206|FG003|Double-blind|Administrative or other|1
4573177|NCT01377233|7411207|FG004|Double-blind|Administrative or other|1
4573178|NCT01377389|7411223|FG000|Overall Study|Withdrawal by Subject|1
4573179|NCT01377389|7411223|FG000|Overall Study|Screen failure|2
4573180|NCT01377480|7411246|FG000|Overall Study|Protocol Violation|0
4573181|NCT01377480|7411247|FG001|Overall Study|Protocol Violation|0
4573182|NCT01377480|7411248|FG002|Overall Study|Protocol Violation|0
4573183|NCT01377480|7411249|FG003|Overall Study|Protocol Violation|4
4573184|NCT01377480|7411246|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0
4573185|NCT01377480|7411247|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1
4573186|NCT01377480|7411248|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1
4573187|NCT01377480|7411249|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0
4573188|NCT01377480|7411246|FG000|Overall Study|Withdrawal by Subject|0
4573189|NCT01377480|7411247|FG001|Overall Study|Withdrawal by Subject|0
4573190|NCT01377480|7411248|FG002|Overall Study|Withdrawal by Subject|1
4573191|NCT01377480|7411249|FG003|Overall Study|Withdrawal by Subject|0
4573192|NCT01377480|7411246|FG000|Overall Study|Serious adverse event|0
4573193|NCT01377480|7411247|FG001|Overall Study|Serious adverse event|0
4573194|NCT01377480|7411248|FG002|Overall Study|Serious adverse event|1
4573195|NCT01377480|7411249|FG003|Overall Study|Serious adverse event|1
4573196|NCT01377480|7411246|FG000|Overall Study|Other|0
4573197|NCT01377480|7411247|FG001|Overall Study|Other|0
4573198|NCT01377480|7411248|FG002|Overall Study|Other|7
4573199|NCT01377480|7411249|FG003|Overall Study|Other|6
4573200|NCT01377844|7411304|FG000|Overall Study|Withdrawal by Subject|25
4573201|NCT01377844|7411305|FG001|Overall Study|Withdrawal by Subject|28
4573202|NCT01377844|7411304|FG000|Overall Study|Protocol Violation|2
4573203|NCT01377844|7411305|FG001|Overall Study|Protocol Violation|3
4573204|NCT01377844|7411304|FG000|Overall Study|Adverse Event|3
4573205|NCT01377844|7411305|FG001|Overall Study|Adverse Event|0
4573206|NCT01377844|7411304|FG000|Overall Study|Physician Decision|6
4573207|NCT01377844|7411305|FG001|Overall Study|Physician Decision|3
4573208|NCT01377844|7411304|FG000|Overall Study|Study terminated by Sponsor|0
4573209|NCT01377844|7411305|FG001|Overall Study|Study terminated by Sponsor|1
4573210|NCT01377922|7411314|FG000|Overall Study|rescue tx after part 2, entered part 4|1
4573211|NCT01377922|7411315|FG001|Overall Study|rescue tx after part 2, entered part 4|0
4573212|NCT01377987|7411321|FG000|Washout (7 Days)|Withdrawal by Subject|1
4573213|NCT01377987|7411322|FG001|Washout (7 Days)|Withdrawal by Subject|1
4573214|NCT01378104|7411334|FG000|Overall Study|Adverse Event|8
4573215|NCT01378104|7411335|FG001|Overall Study|Adverse Event|8
4573216|NCT01378104|7411334|FG000|Overall Study|Lack of Efficacy|7
4573217|NCT01378104|7411335|FG001|Overall Study|Lack of Efficacy|5
4573218|NCT01378104|7411334|FG000|Overall Study|Withdrawal by Subject|12
4573219|NCT01378104|7411335|FG001|Overall Study|Withdrawal by Subject|13
4573220|NCT01378117|7411346|FG000|Overall Study|withdrawal|2
4573221|NCT01378117|7411347|FG001|Overall Study|withdrawal|1
4573222|NCT01378117|7411348|FG002|Overall Study|withdrawal|2
4573223|NCT01378117|7411346|FG000|Overall Study|discharged before med given|2
4573224|NCT01378117|7411347|FG001|Overall Study|discharged before med given|0
4573225|NCT01378117|7411348|FG002|Overall Study|discharged before med given|1
4573226|NCT01378195|7411363|FG000|Overall Study|Lost to Follow-up|29
4573227|NCT01378195|7411364|FG001|Overall Study|Lost to Follow-up|18
4573228|NCT01378325|7411424|FG000|Overall Study|Protocol Violation|0
4573229|NCT01378325|7411425|FG001|Overall Study|Protocol Violation|1
4573230|NCT01378429|7411455|FG000|Overall Study|Noncompliance with study drug|1
4573231|NCT01378429|7411456|FG001|Overall Study|Noncompliance with study drug|0
4573232|NCT01378858|7411474|FG000|Overall Study|Withdrawal by Subject|4
4573233|NCT01378858|7411475|FG001|Overall Study|Withdrawal by Subject|4
4573234|NCT01378962|7411481|FG000|Overall Study|Death|14
4573235|NCT01378962|7411481|FG000|Overall Study|Lost to Follow-up|1
4573236|NCT01378962|7411481|FG000|Overall Study|Other|2
4573237|NCT01378975|7411487|FG000|Overall Study|Death|77
4573238|NCT01378975|7411488|FG001|Overall Study|Death|46
4573239|NCT01378975|7411487|FG000|Overall Study|Investigator Request|1
4573240|NCT01378975|7411488|FG001|Overall Study|Investigator Request|0
4573241|NCT01378975|7411487|FG000|Overall Study|Lost to Follow-up|4
4573242|NCT01378975|7411488|FG001|Overall Study|Lost to Follow-up|1
4573243|NCT01378975|7411487|FG000|Overall Study|Withdrew Consent|4
4573244|NCT01378975|7411488|FG001|Overall Study|Withdrew Consent|3
4573245|NCT01379508|7411523|FG000|Treatment to Week 104|Adverse Event|2
4573246|NCT01379508|7411524|FG001|Treatment to Week 104|Adverse Event|0
4573247|NCT01379508|7411525|FG002|Treatment to Week 104|Adverse Event|5
4573248|NCT01379508|7411526|FG003|Treatment to Week 104|Adverse Event|0
4573249|NCT01379508|7411523|FG000|Treatment to Week 104|Abnormal lab value|1
4573250|NCT01379508|7411524|FG001|Treatment to Week 104|Abnormal lab value|0
4573251|NCT01379508|7411525|FG002|Treatment to Week 104|Abnormal lab value|0
4573252|NCT01379508|7411526|FG003|Treatment to Week 104|Abnormal lab value|0
4573253|NCT01379508|7411523|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1
4573254|NCT01379508|7411524|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0
4573255|NCT01379508|7411525|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0
4573256|NCT01379508|7411526|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0
4573257|NCT01379508|7411523|FG000|Treatment to Week 104|Withdrawal by Subject|6
4573258|NCT01379508|7411524|FG001|Treatment to Week 104|Withdrawal by Subject|1
4573259|NCT01379508|7411525|FG002|Treatment to Week 104|Withdrawal by Subject|4
4573260|NCT01379508|7411526|FG003|Treatment to Week 104|Withdrawal by Subject|0
4573261|NCT01379508|7411523|FG000|Treatment to Week 104|Lost to Follow-up|5
4573262|NCT01379508|7411524|FG001|Treatment to Week 104|Lost to Follow-up|0
4573263|NCT01379508|7411525|FG002|Treatment to Week 104|Lost to Follow-up|3
4573264|NCT01379508|7411526|FG003|Treatment to Week 104|Lost to Follow-up|0
4573265|NCT01379508|7411523|FG000|Treatment to Week 104|Administrative problems|3
4573266|NCT01379508|7411524|FG001|Treatment to Week 104|Administrative problems|1
4573267|NCT01379508|7411525|FG002|Treatment to Week 104|Administrative problems|0
4573268|NCT01379508|7411526|FG003|Treatment to Week 104|Administrative problems|0
4573269|NCT01379508|7411523|FG000|Treatment to Week 104|Protocol Violation|1
4573270|NCT01379508|7411524|FG001|Treatment to Week 104|Protocol Violation|1
4573271|NCT01379508|7411525|FG002|Treatment to Week 104|Protocol Violation|1
4573272|NCT01379508|7411526|FG003|Treatment to Week 104|Protocol Violation|0
4573273|NCT01379508|7411523|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8
4573274|NCT01379508|7411524|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1
4573275|NCT01379508|7411525|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8
4573276|NCT01379508|7411526|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0
4573277|NCT01379508|7411523|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6
4573278|NCT01379508|7411524|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1
4573279|NCT01379508|7411525|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5
4573280|NCT01379508|7411526|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0
4573281|NCT01379508|7411523|FG000|Extension Period Weeks 109-156|Administrative problems|3
4573282|NCT01379508|7411524|FG001|Extension Period Weeks 109-156|Administrative problems|0
4573283|NCT01379508|7411525|FG002|Extension Period Weeks 109-156|Administrative problems|1
4573284|NCT01379508|7411526|FG003|Extension Period Weeks 109-156|Administrative problems|0
4573285|NCT01379508|7411523|FG000|Extension Period Weeks 109-156|Protocol Violation|2
4573286|NCT01379508|7411524|FG001|Extension Period Weeks 109-156|Protocol Violation|1
4573287|NCT01379508|7411525|FG002|Extension Period Weeks 109-156|Protocol Violation|0
4573288|NCT01379508|7411526|FG003|Extension Period Weeks 109-156|Protocol Violation|0
4573289|NCT01379521|7411542|FG000|Overall Study -Treatment Period|Adverse Event|3
4573290|NCT01379521|7411543|FG001|Overall Study -Treatment Period|Adverse Event|0
4573291|NCT01379521|7411542|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0
4573292|NCT01379521|7411543|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1
4573293|NCT01379521|7411542|FG000|Overall Study -Treatment Period|Disease Progression|23
4573294|NCT01379521|7411543|FG001|Overall Study -Treatment Period|Disease Progression|22
4573295|NCT01379521|7411542|FG000|Overall Study -Treatment Period|New Cancer Therapy|1
4573296|NCT01379521|7411543|FG001|Overall Study -Treatment Period|New Cancer Therapy|0
4573297|NCT01379521|7411542|FG000|Overall Study -Treatment Period|Protocol Deviation|0
4573298|NCT01379521|7411543|FG001|Overall Study -Treatment Period|Protocol Deviation|2
4573299|NCT01379521|7411542|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3
4573300|NCT01379521|7411543|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0
4573301|NCT01379521|7411542|FG000|Overall Study -Treatment Period|Administrative Problems|1
4573302|NCT01379521|7411543|FG001|Overall Study -Treatment Period|Administrative Problems|0
4573303|NCT01379521|7411542|FG000|Overall Study -Treatment Period|Death|2
4573304|NCT01379521|7411543|FG001|Overall Study -Treatment Period|Death|1
4573305|NCT01379521|7411542|FG000|Post-Treatment Evaluations|Disease Progression|22
4573306|NCT01379521|7411543|FG001|Post-Treatment Evaluations|Disease Progression|20
4573307|NCT01379521|7411542|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2
4573308|NCT01379521|7411543|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1
4573309|NCT01379521|7411542|FG000|Post-Treatment Evaluations|Death|1
4573310|NCT01379521|7411543|FG001|Post-Treatment Evaluations|Death|0
4573311|NCT01379534|7411551|FG000|Treatment Phase|Withdrawal by Subject|2
4573312|NCT01379534|7411552|FG001|Treatment Phase|Withdrawal by Subject|2
4573313|NCT01379534|7411551|FG000|Treatment Phase|Progressive disease|13
4573314|NCT01379534|7411552|FG001|Treatment Phase|Progressive disease|22
4573315|NCT01379534|7411551|FG000|Treatment Phase|Adverse Event|7
4573316|NCT01379534|7411552|FG001|Treatment Phase|Adverse Event|7
4593783|NCT01555125|7442331|FG000|Extension|Study terminated by sponsor|32
4573317|NCT01379534|7411551|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0
4573318|NCT01379534|7411552|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1
4573319|NCT01379534|7411551|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3
4573320|NCT01379534|7411552|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0
4573321|NCT01379534|7411551|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0
4573322|NCT01379534|7411552|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1
4691473|NCT02572401|7601788|FG003|Overall Study|Death|1
4691474|NCT02572570|7601807|FG000|Overall Study|Study Terminated|27
4573323|NCT01379534|7411551|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1
4573324|NCT01379534|7411552|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0
4573325|NCT01379573|7411558|FG000|Overall Study|Lost to Follow-up|1
4573326|NCT01379573|7411558|FG000|Overall Study|Screen Failure|10
4573327|NCT01379703|7411589|FG000|Study Start Through 9 Months|Lost to Follow-up|2
4573328|NCT01379703|7411590|FG001|Study Start Through 9 Months|Lost to Follow-up|61
4573329|NCT01379703|7411591|FG002|Study Start Through 9 Months|Lost to Follow-up|104
4573330|NCT01379703|7411589|FG000|Study Start Through 9 Months|Adverse Event|0
4573331|NCT01379703|7411590|FG001|Study Start Through 9 Months|Adverse Event|14
4573332|NCT01379703|7411591|FG002|Study Start Through 9 Months|Adverse Event|10
4573333|NCT01379703|7411589|FG000|Study Start Through 9 Months|Withdrawal by Subject|0
4573334|NCT01379703|7411590|FG001|Study Start Through 9 Months|Withdrawal by Subject|6
4573335|NCT01379703|7411591|FG002|Study Start Through 9 Months|Withdrawal by Subject|1
4573336|NCT01379703|7411589|FG000|Study Start Through 9 Months|Treatment Failure|0
4573337|NCT01379703|7411590|FG001|Study Start Through 9 Months|Treatment Failure|2
4573338|NCT01379703|7411591|FG002|Study Start Through 9 Months|Treatment Failure|2
4573339|NCT01379703|7411589|FG000|Study Start Through 9 Months|Patient Noncompliance|0
4573340|NCT01379703|7411590|FG001|Study Start Through 9 Months|Patient Noncompliance|0
4573341|NCT01379703|7411591|FG002|Study Start Through 9 Months|Patient Noncompliance|1
4573342|NCT01379703|7411589|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0
4573343|NCT01379703|7411590|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4
4573344|NCT01379703|7411591|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0
4573345|NCT01379703|7411589|FG000|Study Start Through 9 Months|Medication not available|0
4573346|NCT01379703|7411590|FG001|Study Start Through 9 Months|Medication not available|2
4573347|NCT01379703|7411591|FG002|Study Start Through 9 Months|Medication not available|1
4573348|NCT01379703|7411589|FG000|Study Start Through 9 Months|Poor general condition|0
4573349|NCT01379703|7411590|FG001|Study Start Through 9 Months|Poor general condition|1
4573350|NCT01379703|7411591|FG002|Study Start Through 9 Months|Poor general condition|0
4573351|NCT01379703|7411589|FG000|Study Start Through 9 Months|Increased triglycerides|0
4573352|NCT01379703|7411590|FG001|Study Start Through 9 Months|Increased triglycerides|1
4573353|NCT01379703|7411591|FG002|Study Start Through 9 Months|Increased triglycerides|0
4573354|NCT01379703|7411589|FG000|Study Start Through 9 Months|Reason unknown|2
4573355|NCT01379703|7411590|FG001|Study Start Through 9 Months|Reason unknown|31
4573356|NCT01379703|7411591|FG002|Study Start Through 9 Months|Reason unknown|24
4573357|NCT01379703|7411589|FG000|9 Months Through 18 Months|Lost to Follow-up|0
4573358|NCT01379703|7411590|FG001|9 Months Through 18 Months|Lost to Follow-up|178
4573359|NCT01379703|7411591|FG002|9 Months Through 18 Months|Lost to Follow-up|0
4573360|NCT01379703|7411589|FG000|9 Months Through 18 Months|Withdrawal by Subject|0
4573361|NCT01379703|7411590|FG001|9 Months Through 18 Months|Withdrawal by Subject|11
4573362|NCT01379703|7411591|FG002|9 Months Through 18 Months|Withdrawal by Subject|0
4573363|NCT01379703|7411589|FG000|9 Months Through 18 Months|Adverse Event|0
4573364|NCT01379703|7411590|FG001|9 Months Through 18 Months|Adverse Event|6
4573365|NCT01379703|7411591|FG002|9 Months Through 18 Months|Adverse Event|0
4573366|NCT01379703|7411589|FG000|9 Months Through 18 Months|Treatment failure|0
4573367|NCT01379703|7411590|FG001|9 Months Through 18 Months|Treatment failure|5
4573368|NCT01379703|7411591|FG002|9 Months Through 18 Months|Treatment failure|0
4573369|NCT01379703|7411589|FG000|9 Months Through 18 Months|Patient Noncompliance|0
4573370|NCT01379703|7411590|FG001|9 Months Through 18 Months|Patient Noncompliance|4
4573371|NCT01379703|7411591|FG002|9 Months Through 18 Months|Patient Noncompliance|0
4573372|NCT01379703|7411589|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0
4573373|NCT01379703|7411590|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2
4573374|NCT01379703|7411591|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0
4573375|NCT01379703|7411589|FG000|9 Months Through 18 Months|Fatigue|0
4573376|NCT01379703|7411590|FG001|9 Months Through 18 Months|Fatigue|1
4573377|NCT01379703|7411591|FG002|9 Months Through 18 Months|Fatigue|0
4573378|NCT01379703|7411589|FG000|9 Months Through 18 Months|Reason Unknown|0
4573379|NCT01379703|7411590|FG001|9 Months Through 18 Months|Reason Unknown|23
4573380|NCT01379703|7411591|FG002|9 Months Through 18 Months|Reason Unknown|0
4573381|NCT01379768|7411603|FG000|Overall Study|Adverse Event|1
4573382|NCT01379768|7411604|FG001|Overall Study|Adverse Event|1
4573383|NCT01379768|7411605|FG002|Overall Study|Adverse Event|0
4573384|NCT01379768|7411603|FG000|Overall Study|Lost to Follow-up|2
4573385|NCT01379768|7411604|FG001|Overall Study|Lost to Follow-up|0
4573386|NCT01379768|7411605|FG002|Overall Study|Lost to Follow-up|0
4573387|NCT01379937|7411629|FG000|Overall Study|Protocol Violation|0
4573388|NCT01379937|7411630|FG001|Overall Study|Protocol Violation|0
4573389|NCT01379937|7411631|FG002|Overall Study|Protocol Violation|0
4573390|NCT01379937|7411632|FG003|Overall Study|Protocol Violation|1
4573391|NCT01379937|7411629|FG000|Overall Study|Consent withdrawal|0
4573392|NCT01379937|7411630|FG001|Overall Study|Consent withdrawal|1
4573393|NCT01379937|7411631|FG002|Overall Study|Consent withdrawal|0
4573394|NCT01379937|7411632|FG003|Overall Study|Consent withdrawal|0
4573395|NCT01379937|7411629|FG000|Overall Study|Lost to Follow-up|1
4573396|NCT01379937|7411630|FG001|Overall Study|Lost to Follow-up|2
4573397|NCT01379937|7411631|FG002|Overall Study|Lost to Follow-up|2
4573398|NCT01379937|7411632|FG003|Overall Study|Lost to Follow-up|0
4573399|NCT01380080|7411653|FG000|Overall Study|Death|36
4573400|NCT01380080|7411654|FG001|Overall Study|Death|44
4573401|NCT01380080|7411653|FG000|Overall Study|Site is closing|28
4691475|NCT02572817|7601837|FG000|Overall Study|Death|6
4691476|NCT02572817|7601838|FG001|Overall Study|Death|3
4691477|NCT02572817|7601837|FG000|Overall Study|Lost to Follow-up|3
4691478|NCT02572817|7601838|FG001|Overall Study|Lost to Follow-up|3
4691479|NCT02573012|7601846|FG000|Overall Study|Adverse Event|5
4691480|NCT02573012|7601847|FG001|Overall Study|Adverse Event|5
4573402|NCT01380080|7411654|FG001|Overall Study|Site is closing|31
4573403|NCT01380080|7411653|FG000|Overall Study|Not able to get to clinic|7
4573404|NCT01380080|7411654|FG001|Overall Study|Not able to get to clinic|1
4573405|NCT01380080|7411653|FG000|Overall Study|Not willing to adhere to requirements|6
4573406|NCT01380080|7411654|FG001|Overall Study|Not willing to adhere to requirements|2
4573407|NCT01380080|7411653|FG000|Overall Study|Withdrawal by Subject|5
4573408|NCT01380080|7411654|FG001|Overall Study|Withdrawal by Subject|2
4573409|NCT01380080|7411653|FG000|Overall Study|Lost to Follow-up|3
4573410|NCT01380080|7411654|FG001|Overall Study|Lost to Follow-up|3
4573411|NCT01380093|7411660|FG000|Naloxone Challenge Phase|Screen failures|21
4573412|NCT01380093|7411661|FG001|Naloxone Challenge Phase|Screen failures|0
4573413|NCT01380093|7411662|FG002|Naloxone Challenge Phase|Screen failures|0
4573414|NCT01380093|7411663|FG003|Naloxone Challenge Phase|Screen failures|0
4573415|NCT01380093|7411664|FG004|Naloxone Challenge Phase|Screen failures|0
4573416|NCT01380093|7411665|FG005|Naloxone Challenge Phase|Screen failures|0
4573417|NCT01380093|7411666|FG006|Naloxone Challenge Phase|Screen failures|0
4573418|NCT01380093|7411667|FG007|Naloxone Challenge Phase|Screen failures|0
4573419|NCT01380093|7411668|FG008|Naloxone Challenge Phase|Screen failures|0
4573420|NCT01380093|7411660|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0
4573421|NCT01380093|7411661|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1
4573422|NCT01380093|7411662|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0
4573423|NCT01380093|7411663|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0
4573424|NCT01380093|7411664|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0
4573425|NCT01380093|7411665|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0
4573426|NCT01380093|7411666|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0
4573427|NCT01380093|7411667|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0
4573428|NCT01380093|7411668|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0
4573429|NCT01380093|7411660|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0
4573430|NCT01380093|7411661|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3
4573431|NCT01380093|7411662|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1
4573432|NCT01380093|7411663|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0
4573433|NCT01380093|7411664|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0
4573434|NCT01380093|7411665|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0
4573435|NCT01380093|7411666|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0
4573436|NCT01380093|7411667|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0
4573437|NCT01380093|7411668|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0
4573438|NCT01380093|7411660|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
4573439|NCT01380093|7411661|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1
4573440|NCT01380093|7411662|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
4573441|NCT01380093|7411663|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
4573442|NCT01380093|7411664|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
4573443|NCT01380093|7411665|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
4573444|NCT01380093|7411666|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
4573445|NCT01380093|7411667|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
4573446|NCT01380093|7411668|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
4573447|NCT01380093|7411660|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0
4573448|NCT01380093|7411661|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4
4573449|NCT01380093|7411662|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9
4573450|NCT01380093|7411663|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0
4573451|NCT01380093|7411664|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0
4573452|NCT01380093|7411665|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0
4573453|NCT01380093|7411666|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0
4573454|NCT01380093|7411667|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0
4573455|NCT01380093|7411668|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0
4573456|NCT01380093|7411660|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
4573457|NCT01380093|7411661|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1
4573458|NCT01380093|7411662|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1
4573459|NCT01380093|7411663|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
4573460|NCT01380093|7411664|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
4573461|NCT01380093|7411665|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
4573462|NCT01380093|7411666|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
4573463|NCT01380093|7411667|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
4573464|NCT01380093|7411668|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
4573465|NCT01380093|7411660|FG000|Drug Discrimination Phase: Day 2|Backup participant|0
4573466|NCT01380093|7411661|FG001|Drug Discrimination Phase: Day 2|Backup participant|0
4573467|NCT01380093|7411662|FG002|Drug Discrimination Phase: Day 2|Backup participant|1
4573468|NCT01380093|7411663|FG003|Drug Discrimination Phase: Day 2|Backup participant|0
4573469|NCT01380093|7411664|FG004|Drug Discrimination Phase: Day 2|Backup participant|0
4573470|NCT01380093|7411665|FG005|Drug Discrimination Phase: Day 2|Backup participant|0
4573471|NCT01380093|7411666|FG006|Drug Discrimination Phase: Day 2|Backup participant|0
4573472|NCT01380093|7411667|FG007|Drug Discrimination Phase: Day 2|Backup participant|0
4573473|NCT01380093|7411668|FG008|Drug Discrimination Phase: Day 2|Backup participant|0
4573474|NCT01380093|7411660|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0
4573475|NCT01380093|7411661|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0
4573476|NCT01380093|7411662|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1
4573477|NCT01380093|7411663|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0
4573478|NCT01380093|7411664|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0
4573479|NCT01380093|7411665|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0
4573480|NCT01380093|7411666|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0
4573481|NCT01380093|7411667|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0
4691481|NCT02573012|7601846|FG000|Overall Study|Lack of Efficacy|5
4691482|NCT02573012|7601847|FG001|Overall Study|Lack of Efficacy|4
4691483|NCT02573012|7601846|FG000|Overall Study|Non-compliance|1
4691484|NCT02573012|7601847|FG001|Overall Study|Non-compliance|2
4691485|NCT02573012|7601846|FG000|Overall Study|Withdrawal by Subject|2
4691486|NCT02573012|7601847|FG001|Overall Study|Withdrawal by Subject|2
4691487|NCT02573012|7601846|FG000|Overall Study|Study Ended per Protocol|1
4691488|NCT02573012|7601847|FG001|Overall Study|Study Ended per Protocol|0
4691489|NCT02573012|7601846|FG000|Overall Study|Physician Decision|1
4691490|NCT02573012|7601847|FG001|Overall Study|Physician Decision|2
4691491|NCT02573155|7601855|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0
4691492|NCT02573155|7601856|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1
4573482|NCT01380093|7411668|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0
4573483|NCT01380093|7411660|FG000|Treatment Phase: Second Intervention|Other|0
4573484|NCT01380093|7411661|FG001|Treatment Phase: Second Intervention|Other|0
4573485|NCT01380093|7411662|FG002|Treatment Phase: Second Intervention|Other|0
4573486|NCT01380093|7411663|FG003|Treatment Phase: Second Intervention|Other|1
4573487|NCT01380093|7411664|FG004|Treatment Phase: Second Intervention|Other|0
4573488|NCT01380093|7411665|FG005|Treatment Phase: Second Intervention|Other|0
4573489|NCT01380093|7411666|FG006|Treatment Phase: Second Intervention|Other|0
4573490|NCT01380093|7411667|FG007|Treatment Phase: Second Intervention|Other|0
4573491|NCT01380093|7411668|FG008|Treatment Phase: Second Intervention|Other|0
4573492|NCT01380093|7411660|FG000|Treatment Phase: Third Intervention|Non-compliance|0
4573493|NCT01380093|7411661|FG001|Treatment Phase: Third Intervention|Non-compliance|0
4573494|NCT01380093|7411662|FG002|Treatment Phase: Third Intervention|Non-compliance|0
4573495|NCT01380093|7411663|FG003|Treatment Phase: Third Intervention|Non-compliance|0
4573496|NCT01380093|7411664|FG004|Treatment Phase: Third Intervention|Non-compliance|0
4573497|NCT01380093|7411665|FG005|Treatment Phase: Third Intervention|Non-compliance|0
4573498|NCT01380093|7411666|FG006|Treatment Phase: Third Intervention|Non-compliance|0
4573499|NCT01380093|7411667|FG007|Treatment Phase: Third Intervention|Non-compliance|0
4573500|NCT01380093|7411668|FG008|Treatment Phase: Third Intervention|Non-compliance|1
4573501|NCT01380093|7411660|FG000|Treatment Phase: Third Intervention|Other|0
4573502|NCT01380093|7411661|FG001|Treatment Phase: Third Intervention|Other|0
4573503|NCT01380093|7411662|FG002|Treatment Phase: Third Intervention|Other|0
4573504|NCT01380093|7411663|FG003|Treatment Phase: Third Intervention|Other|0
4573505|NCT01380093|7411664|FG004|Treatment Phase: Third Intervention|Other|0
4573506|NCT01380093|7411665|FG005|Treatment Phase: Third Intervention|Other|0
4573507|NCT01380093|7411666|FG006|Treatment Phase: Third Intervention|Other|0
4573508|NCT01380093|7411667|FG007|Treatment Phase: Third Intervention|Other|0
4573509|NCT01380093|7411668|FG008|Treatment Phase: Third Intervention|Other|1
4573510|NCT01380145|7411691|FG000|Overall Study|Progressive disease|4
4592874|NCT01544595|7440752|FG000|Status at Week 156|Non-compliance with study treatement|0
4592875|NCT01544595|7440753|FG001|Status at Week 156|Non-compliance with study treatement|1
4592876|NCT01544595|7440754|FG002|Status at Week 156|Non-compliance with study treatement|0
4592877|NCT01544595|7440755|FG003|Status at Week 156|Non-compliance with study treatement|1
4592878|NCT01544595|7440756|FG004|Status at Week 156|Non-compliance with study treatement|0
4592879|NCT01544595|7440757|FG005|Status at Week 156|Non-compliance with study treatement|1
4592880|NCT01544595|7440752|FG000|Status at Week 156|Physician Decision|0
4592881|NCT01544595|7440753|FG001|Status at Week 156|Physician Decision|3
4592882|NCT01544595|7440754|FG002|Status at Week 156|Physician Decision|1
4691493|NCT02573155|7601855|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0
4691494|NCT02573155|7601856|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1
4573511|NCT01380184|7411697|FG000|Part 1 (19 Days)|Adverse Event|1
4573512|NCT01380184|7411697|FG000|Part 2|Adverse Event|5
4573513|NCT01380184|7411697|FG000|Part 2|Disease Progression|8
4573514|NCT01380184|7411697|FG000|Part 2|Lost to Follow-up|1
4573515|NCT01380327|7411713|FG000|Overall Study|Lost to Follow-up|0
4573516|NCT01380327|7411714|FG001|Overall Study|Lost to Follow-up|1
4573517|NCT01380327|7411715|FG002|Overall Study|Lost to Follow-up|1
4573518|NCT01380327|7411713|FG000|Overall Study|Protocol Violation|3
4573519|NCT01380327|7411714|FG001|Overall Study|Protocol Violation|2
4573520|NCT01380327|7411715|FG002|Overall Study|Protocol Violation|3
4573521|NCT01380327|7411713|FG000|Overall Study|Withdrawal by Subject|0
4573522|NCT01380327|7411714|FG001|Overall Study|Withdrawal by Subject|0
4573523|NCT01380327|7411715|FG002|Overall Study|Withdrawal by Subject|1
4573524|NCT01380327|7411713|FG000|Overall Study|Housing situation precluded ability to k|0
4573525|NCT01380327|7411714|FG001|Overall Study|Housing situation precluded ability to k|0
4573526|NCT01380327|7411715|FG002|Overall Study|Housing situation precluded ability to k|1
4573527|NCT01380327|7411713|FG000|Overall Study|Questionable onset of epilepsy|0
4573528|NCT01380327|7411714|FG001|Overall Study|Questionable onset of epilepsy|0
4573529|NCT01380327|7411715|FG002|Overall Study|Questionable onset of epilepsy|1
4573530|NCT01380379|7411728|FG000|Overall Study|Pregnancy|1
4573531|NCT01380535|7411734|FG000|Overall Study|Adverse Event|3
4573532|NCT01380535|7411735|FG001|Overall Study|Adverse Event|3
4573533|NCT01380535|7411734|FG000|Overall Study|Death|3
4573534|NCT01380535|7411735|FG001|Overall Study|Death|0
4573535|NCT01380535|7411734|FG000|Overall Study|Study site closed|0
4573536|NCT01380535|7411735|FG001|Overall Study|Study site closed|5
4573537|NCT01380535|7411734|FG000|Overall Study|Withdrawal by Subject|1
4573538|NCT01380535|7411735|FG001|Overall Study|Withdrawal by Subject|2
4573539|NCT01380535|7411734|FG000|Overall Study|Protocol Violation|0
4573540|NCT01380535|7411735|FG001|Overall Study|Protocol Violation|2
4573541|NCT01380535|7411734|FG000|Overall Study|Lack of Efficacy|0
4573542|NCT01380535|7411735|FG001|Overall Study|Lack of Efficacy|3
4573543|NCT01380691|7411750|FG000|Washout (7 Days)|Protocol Violation|0
4691495|NCT02573155|7601855|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0
4691496|NCT02573155|7601856|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3
4691497|NCT02573155|7601855|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1
4691498|NCT02573155|7601856|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0
4691499|NCT02573155|7601855|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0
4691500|NCT02573155|7601856|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2
4691501|NCT02573155|7601855|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0
4691502|NCT02573155|7601856|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1
4691503|NCT02573155|7601855|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0
4691504|NCT02573155|7601856|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1
4691505|NCT02573155|7601855|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0
4691506|NCT02573155|7601856|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1
4691507|NCT02573246|7601896|FG000|Overall Study|Lost to Follow-up|2
4691508|NCT02573246|7601897|FG001|Overall Study|Lost to Follow-up|0
4691509|NCT02573246|7601898|FG002|Overall Study|Lost to Follow-up|0
4691510|NCT02573246|7601899|FG003|Overall Study|Lost to Follow-up|0
4691511|NCT02573246|7601900|FG004|Overall Study|Lost to Follow-up|1
4691512|NCT02573246|7601896|FG000|Overall Study|Withdrawal by Subject|0
4691513|NCT02573246|7601897|FG001|Overall Study|Withdrawal by Subject|0
4691514|NCT02573246|7601898|FG002|Overall Study|Withdrawal by Subject|0
4573544|NCT01380691|7411751|FG001|Washout (7 Days)|Protocol Violation|0
4573545|NCT01380691|7411752|FG002|Washout (7 Days)|Protocol Violation|0
4573546|NCT01380691|7411753|FG003|Washout (7 Days)|Protocol Violation|1
4573547|NCT01380691|7411750|FG000|Washout (7 Days)|Withdrawal by Subject|0
4573548|NCT01380691|7411751|FG001|Washout (7 Days)|Withdrawal by Subject|0
4573549|NCT01380691|7411752|FG002|Washout (7 Days)|Withdrawal by Subject|1
4573550|NCT01380691|7411753|FG003|Washout (7 Days)|Withdrawal by Subject|0
4573551|NCT01380730|7411772|FG000|Overall Study|Death|0
4573552|NCT01380730|7411773|FG001|Overall Study|Death|0
4573553|NCT01380730|7411774|FG002|Overall Study|Death|0
4573554|NCT01380730|7411775|FG003|Overall Study|Death|0
4573555|NCT01380730|7411776|FG004|Overall Study|Death|1
4573556|NCT01380730|7411777|FG005|Overall Study|Death|0
4573557|NCT01380730|7411778|FG006|Overall Study|Death|0
4573558|NCT01380730|7411779|FG007|Overall Study|Death|0
4573559|NCT01380769|7411816|FG000|Overall Study|Withdrawal by Subject|7
4573560|NCT01380769|7411817|FG001|Overall Study|Withdrawal by Subject|11
4573561|NCT01380769|7411816|FG000|Overall Study|Physician Decision|1
4573562|NCT01380769|7411817|FG001|Overall Study|Physician Decision|1
4573563|NCT01380769|7411816|FG000|Overall Study|Adverse Event|1
4573564|NCT01380769|7411817|FG001|Overall Study|Adverse Event|1
4573565|NCT01380769|7411816|FG000|Overall Study|Protocol Violation|0
4573566|NCT01380769|7411817|FG001|Overall Study|Protocol Violation|1
4691515|NCT02573246|7601899|FG003|Overall Study|Withdrawal by Subject|0
4691516|NCT02573246|7601900|FG004|Overall Study|Withdrawal by Subject|1
4573567|NCT01380782|7411825|FG000|Overall Study|Adverse Event|0
4573568|NCT01380782|7411826|FG001|Overall Study|Adverse Event|1
4573569|NCT01380782|7411827|FG002|Overall Study|Adverse Event|0
4573570|NCT01380782|7411828|FG003|Overall Study|Adverse Event|0
4573571|NCT01380782|7411825|FG000|Overall Study|Death|1
4573572|NCT01380782|7411826|FG001|Overall Study|Death|0
4573573|NCT01380782|7411827|FG002|Overall Study|Death|0
4573574|NCT01380782|7411828|FG003|Overall Study|Death|0
4573575|NCT01380782|7411825|FG000|Overall Study|Lack of Efficacy|10
4573576|NCT01380782|7411826|FG001|Overall Study|Lack of Efficacy|9
4573577|NCT01380782|7411827|FG002|Overall Study|Lack of Efficacy|10
4573578|NCT01380782|7411828|FG003|Overall Study|Lack of Efficacy|3
4573579|NCT01380782|7411825|FG000|Overall Study|Physician Decision|1
4573580|NCT01380782|7411826|FG001|Overall Study|Physician Decision|0
4573581|NCT01380782|7411827|FG002|Overall Study|Physician Decision|0
4573582|NCT01380782|7411828|FG003|Overall Study|Physician Decision|0
4573583|NCT01380782|7411825|FG000|Overall Study|Withdrawal by Subject|0
4573584|NCT01380782|7411826|FG001|Overall Study|Withdrawal by Subject|0
4573585|NCT01380782|7411827|FG002|Overall Study|Withdrawal by Subject|1
4573586|NCT01380782|7411828|FG003|Overall Study|Withdrawal by Subject|1
4573587|NCT01380834|7411842|FG000|Overall Study|Physician Decision|1
4573588|NCT01380834|7411843|FG001|Overall Study|Physician Decision|0
4573589|NCT01380990|7411864|FG000|Overall Study|Treatment Failure|1
4573590|NCT01380990|7411865|FG001|Overall Study|Treatment Failure|0
4573591|NCT01380990|7411864|FG000|Overall Study|Death|0
4573592|NCT01380990|7411865|FG001|Overall Study|Death|1
4573593|NCT01381016|7411877|FG000|Overall Study|Lost to Follow-up|1
4573594|NCT01381016|7411878|FG001|Overall Study|Lost to Follow-up|1
4573595|NCT01381016|7411877|FG000|Overall Study|Screen Failure|2
4573596|NCT01381016|7411878|FG001|Overall Study|Screen Failure|2
4573597|NCT01381016|7411877|FG000|Overall Study|Withdrawal by Subject|0
4573598|NCT01381016|7411878|FG001|Overall Study|Withdrawal by Subject|1
4573599|NCT01381016|7411877|FG000|Overall Study|Physician Decision|0
4573600|NCT01381016|7411878|FG001|Overall Study|Physician Decision|2
4573601|NCT01381068|7411888|FG000|Overall Study|Death|1
4573602|NCT01381068|7411889|FG001|Overall Study|Death|0
4573603|NCT01381549|7411929|FG000|Overall Study|Ineligible: No organisms isolated|0
4573604|NCT01381549|7411930|FG001|Overall Study|Ineligible: No organisms isolated|0
4573605|NCT01381549|7411931|FG002|Overall Study|Ineligible: No organisms isolated|1
4573606|NCT01381562|7411943|FG000|Overall Study|Adverse Event|0
4573607|NCT01381562|7411944|FG001|Overall Study|Adverse Event|1
4573608|NCT01381562|7411945|FG002|Overall Study|Adverse Event|0
4573609|NCT01381575|7411956|FG000|Overall Study|Serious Adverse Event|1
4573610|NCT01381575|7411957|FG001|Overall Study|Serious Adverse Event|0
4573611|NCT01381575|7411958|FG002|Overall Study|Serious Adverse Event|0
4573612|NCT01381575|7411956|FG000|Overall Study|Non-Serious Adverse Event|0
4573613|NCT01381575|7411957|FG001|Overall Study|Non-Serious Adverse Event|0
4573614|NCT01381575|7411958|FG002|Overall Study|Non-Serious Adverse Event|1
4573615|NCT01381575|7411956|FG000|Overall Study|Protocol Violation|0
4573616|NCT01381575|7411957|FG001|Overall Study|Protocol Violation|1
4573617|NCT01381575|7411958|FG002|Overall Study|Protocol Violation|1
4573618|NCT01381575|7411956|FG000|Overall Study|Withdrawal by Subject|15
4573619|NCT01381575|7411957|FG001|Overall Study|Withdrawal by Subject|9
4573620|NCT01381575|7411958|FG002|Overall Study|Withdrawal by Subject|7
4573621|NCT01381575|7411956|FG000|Overall Study|Migrated/moved from study area|2
4573622|NCT01381575|7411957|FG001|Overall Study|Migrated/moved from study area|12
4573623|NCT01381575|7411958|FG002|Overall Study|Migrated/moved from study area|2
4573624|NCT01381575|7411956|FG000|Overall Study|Lost to Follow-up|8
4573625|NCT01381575|7411957|FG001|Overall Study|Lost to Follow-up|17
4573626|NCT01381575|7411958|FG002|Overall Study|Lost to Follow-up|9
4573627|NCT01381692|7411969|FG000|Overall Study|Adverse Event|1
4573628|NCT01381692|7411970|FG001|Overall Study|Adverse Event|0
4573629|NCT01381692|7411971|FG002|Overall Study|Adverse Event|0
4573630|NCT01381692|7411972|FG003|Overall Study|Adverse Event|0
4573631|NCT01381692|7411973|FG004|Overall Study|Adverse Event|0
4573632|NCT01381692|7411974|FG005|Overall Study|Adverse Event|0
4573633|NCT01381718|7411984|FG000|Overall Study|Withdrawal by Subject|2
4573634|NCT01381718|7411985|FG001|Overall Study|Withdrawal by Subject|5
4573635|NCT01381718|7411984|FG000|Overall Study|Lost to Follow-up|3
4573636|NCT01381718|7411985|FG001|Overall Study|Lost to Follow-up|5
4573637|NCT01381718|7411984|FG000|Overall Study|Toxicity, side effects or complications related to study|0
4573638|NCT01381718|7411985|FG001|Overall Study|Toxicity, side effects or complications related to study|3
4573639|NCT01381874|7411998|FG000|Overall Study|Lost to Follow-up|1
4573640|NCT01381874|7411999|FG001|Overall Study|Lost to Follow-up|1
4573641|NCT01381874|7412000|FG002|Overall Study|Lost to Follow-up|0
4573642|NCT01381874|7411998|FG000|Overall Study|Withdrawal by Subject|9
4573643|NCT01381874|7411999|FG001|Overall Study|Withdrawal by Subject|10
4573644|NCT01381874|7412000|FG002|Overall Study|Withdrawal by Subject|9
4573645|NCT01381874|7411998|FG000|Overall Study|Other|67
4573646|NCT01381874|7411999|FG001|Overall Study|Other|52
4573647|NCT01381874|7412000|FG002|Overall Study|Other|67
4573648|NCT01381900|7412011|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2
4573649|NCT01381900|7412012|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0
4573650|NCT01381900|7412013|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0
4573651|NCT01381900|7412011|FG000|Overall Study|Adverse Event|4
4573652|NCT01381900|7412012|FG001|Overall Study|Adverse Event|6
4573653|NCT01381900|7412013|FG002|Overall Study|Adverse Event|7
4573654|NCT01381900|7412011|FG000|Overall Study|Noncompliance with study drug|0
4573655|NCT01381900|7412012|FG001|Overall Study|Noncompliance with study drug|0
4573656|NCT01381900|7412013|FG002|Overall Study|Noncompliance with study drug|1
4573657|NCT01381900|7412011|FG000|Overall Study|Physician Decision|0
4573658|NCT01381900|7412012|FG001|Overall Study|Physician Decision|1
4573659|NCT01381900|7412013|FG002|Overall Study|Physician Decision|1
4573660|NCT01381900|7412011|FG000|Overall Study|Protocol Violation|0
4573661|NCT01381900|7412012|FG001|Overall Study|Protocol Violation|1
4573662|NCT01381900|7412013|FG002|Overall Study|Protocol Violation|1
4573663|NCT01381900|7412011|FG000|Overall Study|Withdrawal by Subject|0
4573664|NCT01381900|7412012|FG001|Overall Study|Withdrawal by Subject|0
4573665|NCT01381900|7412013|FG002|Overall Study|Withdrawal by Subject|1
4573666|NCT01381900|7412011|FG000|Overall Study|Early withdraw|3
4573667|NCT01381900|7412012|FG001|Overall Study|Early withdraw|1
4573668|NCT01381900|7412013|FG002|Overall Study|Early withdraw|1
4573669|NCT01381926|7412023|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2
4573670|NCT01381926|7412024|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0
4573671|NCT01381926|7412023|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0
4573672|NCT01381926|7412024|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1
4573673|NCT01382212|7412060|FG000|Overall Study|Kidney transplant|1
4573674|NCT01382212|7412060|FG000|Overall Study|Withdrew consent|1
4573675|NCT01382225|7412066|FG000|Overall Study|Adverse Event|3
4573676|NCT01382225|7412067|FG001|Overall Study|Adverse Event|2
4573677|NCT01382225|7412066|FG000|Overall Study|Protocol Violation|2
4573678|NCT01382225|7412067|FG001|Overall Study|Protocol Violation|1
4573679|NCT01382225|7412066|FG000|Overall Study|Subject Withdrew Consent|5
4573680|NCT01382225|7412067|FG001|Overall Study|Subject Withdrew Consent|2
4573681|NCT01382225|7412066|FG000|Overall Study|Other|4
4573682|NCT01382225|7412067|FG001|Overall Study|Other|2
4573683|NCT01382251|7412075|FG000|Overall Study|Surgeries cancelled or delayed|16
4573684|NCT01382251|7412076|FG001|Overall Study|Surgeries cancelled or delayed|16
4573685|NCT01382251|7412075|FG000|Overall Study|Lost to Follow-up|4
4573686|NCT01382251|7412076|FG001|Overall Study|Lost to Follow-up|4
4573687|NCT01382251|7412075|FG000|Overall Study|Contacted after study closed|1
4573688|NCT01382251|7412076|FG001|Overall Study|Contacted after study closed|1
4573689|NCT01382446|7412092|FG000|Overall Study|Withdrawal by Subject|0
4573690|NCT01382446|7412093|FG001|Overall Study|Withdrawal by Subject|1
4573691|NCT01382446|7412092|FG000|Overall Study|Removal from Mechanical Ventilation|3
4573692|NCT01382446|7412093|FG001|Overall Study|Removal from Mechanical Ventilation|3
4573693|NCT01382602|7412101|FG000|Overall Study|Protocol Violation|0
4573694|NCT01382602|7412102|FG001|Overall Study|Protocol Violation|3
4573695|NCT01382602|7412101|FG000|Overall Study|Withdrawal by Subject|0
4573696|NCT01382602|7412102|FG001|Overall Study|Withdrawal by Subject|1
4573697|NCT01382940|7412134|FG000|Overall Study|Adverse Event|19
4573698|NCT01382940|7412134|FG000|Overall Study|Lost to Follow-up|4
4573699|NCT01382940|7412134|FG000|Overall Study|Physician Decision|7
4573700|NCT01382940|7412134|FG000|Overall Study|Withdrawal by Subject|23
4573701|NCT01382940|7412134|FG000|Overall Study|Protocol Violation|20
4573702|NCT01383018|7412147|FG000|Overall Study|Adverse Event|14
4573703|NCT01383018|7412147|FG000|Overall Study|Death|10
4573704|NCT01383018|7412147|FG000|Overall Study|Lost to Follow-up|5
4573705|NCT01383018|7412147|FG000|Overall Study|Physician Decision|5
4573706|NCT01383018|7412147|FG000|Overall Study|Withdrawal by Subject|9
4573707|NCT01383018|7412147|FG000|Overall Study|Subject not implanted|76
4573708|NCT01383018|7412147|FG000|Overall Study|Missed Visit|247
4573709|NCT01383018|7412147|FG000|Overall Study|Site closed early-not compliance related|7
4573710|NCT01383018|7412147|FG000|Overall Study|Patient moved away from site|1
4573711|NCT01383018|7412147|FG000|Overall Study|Subject Incarcerated|1
4573712|NCT01383096|7412164|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
4573713|NCT01383096|7412165|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
4573714|NCT01383096|7412166|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1
4573715|NCT01383096|7412164|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
4573716|NCT01383096|7412165|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
4573717|NCT01383096|7412166|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
4573718|NCT01383096|7412164|FG000|Third Intervention (8 Days)|Elevated AST|0
4573719|NCT01383096|7412165|FG001|Third Intervention (8 Days)|Elevated AST|1
4573720|NCT01383096|7412166|FG002|Third Intervention (8 Days)|Elevated AST|0
4573721|NCT01383096|7412164|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1
4573722|NCT01383096|7412165|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3
4573723|NCT01383096|7412166|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
4573724|NCT01383096|7412164|FG000|Third Intervention (8 Days)|Adverse Event|1
4573725|NCT01383096|7412165|FG001|Third Intervention (8 Days)|Adverse Event|0
4573726|NCT01383096|7412166|FG002|Third Intervention (8 Days)|Adverse Event|0
4573727|NCT01383096|7412164|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1
4573728|NCT01383096|7412165|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0
4573729|NCT01383096|7412166|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0
4573730|NCT01383096|7412164|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1
4573731|NCT01383096|7412165|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0
4573732|NCT01383096|7412166|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0
4573733|NCT01383096|7412164|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
4573734|NCT01383096|7412165|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
4573735|NCT01383096|7412166|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
4573736|NCT01383096|7412164|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1
4573737|NCT01383096|7412165|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0
4573738|NCT01383096|7412166|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0
4573739|NCT01383096|7412164|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1
4573740|NCT01383096|7412165|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0
4573741|NCT01383096|7412166|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0
4573742|NCT01383096|7412164|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1
4573743|NCT01383096|7412165|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0
4573744|NCT01383096|7412166|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0
4573745|NCT01383161|7412205|FG000|Overall Study|Adverse Event|5
4573746|NCT01383161|7412206|FG001|Overall Study|Adverse Event|1
4573747|NCT01383161|7412205|FG000|Overall Study|Withdrawal by Subject|0
4691517|NCT02573246|7601896|FG000|Overall Study|Physician Decision|1
4691518|NCT02573246|7601897|FG001|Overall Study|Physician Decision|1
4691519|NCT02573246|7601898|FG002|Overall Study|Physician Decision|3
4691520|NCT02573246|7601899|FG003|Overall Study|Physician Decision|2
4691521|NCT02573246|7601900|FG004|Overall Study|Physician Decision|2
4691522|NCT02573311|7601919|FG000|Disposition for Part 1|Withdrawal by Subject|7
4691523|NCT02573311|7601920|FG001|Disposition for Part 1|Withdrawal by Subject|3
4691524|NCT02573311|7601919|FG000|Disposition for Part 2|Physician Decision|25
4691525|NCT02573311|7601920|FG001|Disposition for Part 2|Physician Decision|7
4691526|NCT02573311|7601919|FG000|Disposition for Part 2|Adverse Event|36
4691527|NCT02573311|7601920|FG001|Disposition for Part 2|Adverse Event|5
4691528|NCT02573311|7601919|FG000|Disposition for Part 2|Lost to Follow-up|76
4691529|NCT02573311|7601920|FG001|Disposition for Part 2|Lost to Follow-up|7
4691530|NCT02573311|7601919|FG000|Disposition for Part 2|Withdrawal by Subject|60
4691531|NCT02573311|7601920|FG001|Disposition for Part 2|Withdrawal by Subject|3
4573748|NCT01383161|7412206|FG001|Overall Study|Withdrawal by Subject|2
4573749|NCT01383161|7412205|FG000|Overall Study|Lack of Efficacy|0
4573750|NCT01383161|7412206|FG001|Overall Study|Lack of Efficacy|1
4573751|NCT01383174|7412214|FG000|3 Month Assessment|Death|0
4573752|NCT01383174|7412215|FG001|3 Month Assessment|Death|1
4573753|NCT01383174|7412214|FG000|3 Month Assessment|Lost to Follow-up|2
4573754|NCT01383174|7412215|FG001|3 Month Assessment|Lost to Follow-up|0
4573755|NCT01383174|7412214|FG000|3 Month Assessment|Refused to complete|4
4573756|NCT01383174|7412215|FG001|3 Month Assessment|Refused to complete|0
4573757|NCT01383174|7412214|FG000|6 Month Assessment|Lost to Follow-up|1
4573758|NCT01383174|7412215|FG001|6 Month Assessment|Lost to Follow-up|1
4573759|NCT01383174|7412214|FG000|6 Month Assessment|Refused to complete|4
4573760|NCT01383174|7412215|FG001|6 Month Assessment|Refused to complete|0
4573761|NCT01383317|7412241|FG000|Overall Study|Lost to Follow-up|2
4573762|NCT01383317|7412242|FG001|Overall Study|Lost to Follow-up|1
4573763|NCT01383317|7412241|FG000|Overall Study|Death|1
4573764|NCT01383317|7412242|FG001|Overall Study|Death|0
4573765|NCT01383317|7412241|FG000|Overall Study|Adverse Event|0
4573766|NCT01383317|7412242|FG001|Overall Study|Adverse Event|1
4573767|NCT01383356|7412248|FG000|Period 1|Adverse Event|5
4573768|NCT01383356|7412249|FG001|Period 1|Adverse Event|3
4573769|NCT01383356|7412248|FG000|Period 1|Non-compliance|3
4573770|NCT01383356|7412249|FG001|Period 1|Non-compliance|0
4573771|NCT01383356|7412248|FG000|Period 1|Out of Range Mid-study-Test|0
4573772|NCT01383356|7412249|FG001|Period 1|Out of Range Mid-study-Test|1
4573773|NCT01383356|7412248|FG000|Period 1|Personal|0
4573774|NCT01383356|7412249|FG001|Period 1|Personal|2
4573775|NCT01383486|7412263|FG000|Overall Study|Lost to Follow-up|10
4573776|NCT01383486|7412263|FG000|Overall Study|Incomplete information for analysis|2
4573777|NCT01383486|7412263|FG000|Overall Study|Did not take any product|6
4573778|NCT01383499|7412268|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1
4573779|NCT01383499|7412269|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0
4573780|NCT01383499|7412270|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0
4573781|NCT01383499|7412271|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0
4573782|NCT01383707|7412297|FG000|Overall Study|Consent withdrawal|6
4573783|NCT01383707|7412297|FG000|Overall Study|Death|19
4573784|NCT01383707|7412297|FG000|Overall Study|Other|8
4573785|NCT01383707|7412297|FG000|Overall Study|Sponsor's decision|2
4573786|NCT01383707|7412297|FG000|Overall Study|Adverse Event|14
4573787|NCT01383707|7412297|FG000|Overall Study|Progressive disease|23
4573788|NCT01383928|7412317|FG000|Overall Study|Initiation of ASCT|2
4573789|NCT01383928|7412318|FG001|Overall Study|Initiation of ASCT|1
4573790|NCT01383928|7412319|FG002|Overall Study|Initiation of ASCT|18
4573791|NCT01383928|7412317|FG000|Overall Study|Adverse Event|1
4573792|NCT01383928|7412318|FG001|Overall Study|Adverse Event|2
4573793|NCT01383928|7412319|FG002|Overall Study|Adverse Event|8
4573794|NCT01383928|7412317|FG000|Overall Study|Other|1
4691532|NCT02573311|7601919|FG000|Disposition for Part 2|Investigator decision|0
4573795|NCT01383928|7412318|FG001|Overall Study|Other|3
4573796|NCT01383928|7412319|FG002|Overall Study|Other|4
4573797|NCT01383928|7412317|FG000|Overall Study|Progressive Disease|1
4573798|NCT01383928|7412318|FG001|Overall Study|Progressive Disease|1
4573799|NCT01383928|7412319|FG002|Overall Study|Progressive Disease|5
4573800|NCT01383928|7412317|FG000|Overall Study|Withdrawal by Subject|0
4573801|NCT01383928|7412318|FG001|Overall Study|Withdrawal by Subject|0
4573802|NCT01383928|7412319|FG002|Overall Study|Withdrawal by Subject|4
4573803|NCT01383928|7412317|FG000|Overall Study|Unsatisfactory Therapeutic Response|0
4573804|NCT01383928|7412318|FG001|Overall Study|Unsatisfactory Therapeutic Response|0
4573805|NCT01383928|7412319|FG002|Overall Study|Unsatisfactory Therapeutic Response|1
4573806|NCT01383954|7412329|FG000|Overall Study|Lack of Efficacy|2
4573807|NCT01383954|7412329|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2
4573808|NCT01383954|7412329|FG000|Overall Study|Adverse Event|1
4573809|NCT01383954|7412329|FG000|Overall Study|Reason Not Specified|9
4691533|NCT02573311|7601920|FG001|Disposition for Part 2|Investigator decision|1
4691534|NCT02573311|7601919|FG000|Disposition for Part 2|Other than specified above|13
4770421|NCT03740919|7746733|FG003|Treatment Period|Failure of Inclusion Criteria|0
4573810|NCT01383993|7412336|FG000|Overall Study|Adverse Event|1
4573811|NCT01383993|7412337|FG001|Overall Study|Adverse Event|1
4573812|NCT01383993|7412338|FG002|Overall Study|Adverse Event|0
4573813|NCT01383993|7412336|FG000|Overall Study|Withdrawal by Subject|0
4573814|NCT01383993|7412337|FG001|Overall Study|Withdrawal by Subject|0
4573815|NCT01383993|7412338|FG002|Overall Study|Withdrawal by Subject|1
4573816|NCT01383993|7412336|FG000|Overall Study|Marketed voriconazole in post-therapy|2
4573817|NCT01383993|7412337|FG001|Overall Study|Marketed voriconazole in post-therapy|0
4573818|NCT01383993|7412338|FG002|Overall Study|Marketed voriconazole in post-therapy|0
4573819|NCT01384019|7412349|FG000|Overall Study|Withdrawal by Subject|3
4573820|NCT01384019|7412350|FG001|Overall Study|Withdrawal by Subject|0
4573821|NCT01384019|7412349|FG000|Overall Study|Death|1
4573822|NCT01384019|7412350|FG001|Overall Study|Death|0
4573823|NCT01384019|7412349|FG000|Overall Study|MRI refusal|6
4573824|NCT01384019|7412350|FG001|Overall Study|MRI refusal|6
4573825|NCT01384292|7412359|FG000|Part B|Severe non-compliance to protocol|1
4573826|NCT01384292|7412360|FG001|Part B|Severe non-compliance to protocol|0
4573827|NCT01384292|7412361|FG002|Part B|Severe non-compliance to protocol|0
4573828|NCT01384734|7412398|FG000|Overall Study|Adverse Event|0
4573829|NCT01384734|7412399|FG001|Overall Study|Adverse Event|3
4573830|NCT01384734|7412400|FG002|Overall Study|Adverse Event|0
4573831|NCT01384734|7412401|FG003|Overall Study|Adverse Event|2
4573832|NCT01384734|7412402|FG004|Overall Study|Adverse Event|7
4573833|NCT01384734|7412398|FG000|Overall Study|Death|1
4573834|NCT01384734|7412399|FG001|Overall Study|Death|0
4573835|NCT01384734|7412400|FG002|Overall Study|Death|1
4573836|NCT01384734|7412401|FG003|Overall Study|Death|0
4573837|NCT01384734|7412402|FG004|Overall Study|Death|0
4573838|NCT01384734|7412398|FG000|Overall Study|Continuation criteria not met|0
4573839|NCT01384734|7412399|FG001|Overall Study|Continuation criteria not met|0
4573840|NCT01384734|7412400|FG002|Overall Study|Continuation criteria not met|1
4573841|NCT01384734|7412401|FG003|Overall Study|Continuation criteria not met|1
4573842|NCT01384734|7412402|FG004|Overall Study|Continuation criteria not met|0
4573843|NCT01384734|7412398|FG000|Overall Study|Lack of Efficacy|3
4573844|NCT01384734|7412399|FG001|Overall Study|Lack of Efficacy|7
4573845|NCT01384734|7412400|FG002|Overall Study|Lack of Efficacy|4
4573846|NCT01384734|7412401|FG003|Overall Study|Lack of Efficacy|4
4573847|NCT01384734|7412402|FG004|Overall Study|Lack of Efficacy|2
4573848|NCT01384734|7412398|FG000|Overall Study|Lost to Follow-up|5
4573849|NCT01384734|7412399|FG001|Overall Study|Lost to Follow-up|3
4573850|NCT01384734|7412400|FG002|Overall Study|Lost to Follow-up|3
4573851|NCT01384734|7412401|FG003|Overall Study|Lost to Follow-up|8
4573852|NCT01384734|7412402|FG004|Overall Study|Lost to Follow-up|5
4573853|NCT01384734|7412398|FG000|Overall Study|Non-compliance with study drug|1
4573854|NCT01384734|7412399|FG001|Overall Study|Non-compliance with study drug|2
4573855|NCT01384734|7412400|FG002|Overall Study|Non-compliance with study drug|6
4573856|NCT01384734|7412401|FG003|Overall Study|Non-compliance with study drug|0
4573857|NCT01384734|7412402|FG004|Overall Study|Non-compliance with study drug|2
4573858|NCT01384734|7412398|FG000|Overall Study|Pregnancy|0
4573859|NCT01384734|7412399|FG001|Overall Study|Pregnancy|1
4573860|NCT01384734|7412400|FG002|Overall Study|Pregnancy|0
4573861|NCT01384734|7412401|FG003|Overall Study|Pregnancy|0
4573862|NCT01384734|7412402|FG004|Overall Study|Pregnancy|1
4573863|NCT01384734|7412398|FG000|Overall Study|Sponsor terminated|0
4573864|NCT01384734|7412399|FG001|Overall Study|Sponsor terminated|0
4573865|NCT01384734|7412400|FG002|Overall Study|Sponsor terminated|0
4573866|NCT01384734|7412401|FG003|Overall Study|Sponsor terminated|0
4573867|NCT01384734|7412402|FG004|Overall Study|Sponsor terminated|1
4573868|NCT01384734|7412398|FG000|Overall Study|Withdrawal by Subject|5
4573869|NCT01384734|7412399|FG001|Overall Study|Withdrawal by Subject|5
4573870|NCT01384734|7412400|FG002|Overall Study|Withdrawal by Subject|6
4573871|NCT01384734|7412401|FG003|Overall Study|Withdrawal by Subject|7
4573872|NCT01384734|7412402|FG004|Overall Study|Withdrawal by Subject|9
4573873|NCT01384734|7412398|FG000|Overall Study|Investigator relocating|0
4573874|NCT01384734|7412399|FG001|Overall Study|Investigator relocating|2
4573875|NCT01384734|7412400|FG002|Overall Study|Investigator relocating|0
4573876|NCT01384734|7412401|FG003|Overall Study|Investigator relocating|3
4573877|NCT01384734|7412402|FG004|Overall Study|Investigator relocating|1
4573878|NCT01384734|7412398|FG000|Overall Study|Unable to come back for visit|1
4573879|NCT01384734|7412399|FG001|Overall Study|Unable to come back for visit|0
4691535|NCT02573311|7601920|FG001|Disposition for Part 2|Other than specified above|3
4691536|NCT02573350|7601928|FG000|Overall Study|Lost to Follow-up|2
4573880|NCT01384734|7412400|FG002|Overall Study|Unable to come back for visit|1
4573881|NCT01384734|7412401|FG003|Overall Study|Unable to come back for visit|1
4573882|NCT01384734|7412402|FG004|Overall Study|Unable to come back for visit|0
4573883|NCT01384734|7412398|FG000|Overall Study|Prison|0
4573884|NCT01384734|7412399|FG001|Overall Study|Prison|0
4573885|NCT01384734|7412400|FG002|Overall Study|Prison|1
4573886|NCT01384734|7412401|FG003|Overall Study|Prison|0
4573887|NCT01384734|7412402|FG004|Overall Study|Prison|0
4573888|NCT01384734|7412398|FG000|Overall Study|As per Exclusion criteria|0
4573889|NCT01384734|7412399|FG001|Overall Study|As per Exclusion criteria|1
4573890|NCT01384734|7412400|FG002|Overall Study|As per Exclusion criteria|0
4573891|NCT01384734|7412401|FG003|Overall Study|As per Exclusion criteria|0
4573892|NCT01384734|7412402|FG004|Overall Study|As per Exclusion criteria|0
4573893|NCT01384734|7412398|FG000|Overall Study|Missed End of treatment visit|0
4573894|NCT01384734|7412399|FG001|Overall Study|Missed End of treatment visit|0
4573895|NCT01384734|7412400|FG002|Overall Study|Missed End of treatment visit|0
4573896|NCT01384734|7412401|FG003|Overall Study|Missed End of treatment visit|1
4573897|NCT01384734|7412402|FG004|Overall Study|Missed End of treatment visit|0
4573898|NCT01384734|7412398|FG000|Overall Study|Adhesion problem|0
4573899|NCT01384734|7412399|FG001|Overall Study|Adhesion problem|0
4573900|NCT01384734|7412400|FG002|Overall Study|Adhesion problem|0
4573901|NCT01384734|7412401|FG003|Overall Study|Adhesion problem|1
4573902|NCT01384734|7412402|FG004|Overall Study|Adhesion problem|0
4573903|NCT01384734|7412398|FG000|Overall Study|Early termination|0
4573904|NCT01384734|7412399|FG001|Overall Study|Early termination|0
4573905|NCT01384734|7412400|FG002|Overall Study|Early termination|0
4573906|NCT01384734|7412401|FG003|Overall Study|Early termination|0
4573907|NCT01384734|7412402|FG004|Overall Study|Early termination|1
4573908|NCT01384734|7412398|FG000|Overall Study|Physician Decision|1
4573909|NCT01384734|7412399|FG001|Overall Study|Physician Decision|0
4573910|NCT01384734|7412400|FG002|Overall Study|Physician Decision|0
4573911|NCT01384734|7412401|FG003|Overall Study|Physician Decision|0
4573912|NCT01384734|7412402|FG004|Overall Study|Physician Decision|0
4573913|NCT01384760|7412413|FG000|Overall Study|Lost to Follow-up|0
4573914|NCT01384760|7412414|FG001|Overall Study|Lost to Follow-up|6
4573915|NCT01384760|7412413|FG000|Overall Study|Protocol Violation|16
4573916|NCT01384760|7412414|FG001|Overall Study|Protocol Violation|0
4573917|NCT01384877|7412422|FG000|Treatment 2|Lost to Follow-up|2
4573918|NCT01384877|7412423|FG001|Treatment 2|Lost to Follow-up|2
4573919|NCT01385098|7412429|FG000|Overall Study|Adverse Event|10
4573920|NCT01385098|7412429|FG000|Overall Study|Lost to Follow-up|4
4573921|NCT01385202|7412472|FG000|Overall Study|Lost to Follow-up|6
4573922|NCT01385202|7412472|FG000|Overall Study|Not Eligible|11
4573923|NCT01385202|7412472|FG000|Overall Study|Withdrawn|1
4573924|NCT01385371|7412488|FG000|Overall Study|Adverse Event|54
4573925|NCT01385371|7412489|FG001|Overall Study|Adverse Event|19
4573926|NCT01385371|7412488|FG000|Overall Study|Lost to Follow-up|16
4573927|NCT01385371|7412489|FG001|Overall Study|Lost to Follow-up|16
4573928|NCT01385371|7412488|FG000|Overall Study|Withdrawal by Subject|52
4573929|NCT01385371|7412489|FG001|Overall Study|Withdrawal by Subject|39
4573930|NCT01385371|7412488|FG000|Overall Study|Protocol Violation|25
4573931|NCT01385371|7412489|FG001|Overall Study|Protocol Violation|21
4573932|NCT01385371|7412488|FG000|Overall Study|Administrative|2
4573933|NCT01385371|7412489|FG001|Overall Study|Administrative|2
4573934|NCT01385566|7412501|FG000|Overall Study|Lost to Follow-up|1
4573935|NCT01385566|7412502|FG001|Overall Study|Lost to Follow-up|0
4573936|NCT01385566|7412503|FG002|Overall Study|Lost to Follow-up|0
4573937|NCT01385566|7412504|FG003|Overall Study|Lost to Follow-up|0
4573938|NCT01385566|7412505|FG004|Overall Study|Lost to Follow-up|0
4573939|NCT01385566|7412506|FG005|Overall Study|Lost to Follow-up|0
4573940|NCT01385566|7412501|FG000|Overall Study|Withdrawal by Subject|0
4573941|NCT01385566|7412502|FG001|Overall Study|Withdrawal by Subject|0
4573942|NCT01385566|7412503|FG002|Overall Study|Withdrawal by Subject|0
4573943|NCT01385566|7412504|FG003|Overall Study|Withdrawal by Subject|1
4573944|NCT01385566|7412505|FG004|Overall Study|Withdrawal by Subject|0
4573945|NCT01385566|7412506|FG005|Overall Study|Withdrawal by Subject|0
4573946|NCT01385748|7412551|FG000|Overall Study|Withdrawal by Subject|7
4573947|NCT01385748|7412552|FG001|Overall Study|Withdrawal by Subject|4
4573948|NCT01385748|7412553|FG002|Overall Study|Withdrawal by Subject|5
4573949|NCT01385748|7412551|FG000|Overall Study|Noncompliance|3
4573950|NCT01385748|7412552|FG001|Overall Study|Noncompliance|1
4573951|NCT01385748|7412553|FG002|Overall Study|Noncompliance|6
4573952|NCT01385748|7412551|FG000|Overall Study|Other|1
4573953|NCT01385748|7412552|FG001|Overall Study|Other|7
4573954|NCT01385748|7412553|FG002|Overall Study|Other|1
4573955|NCT01385748|7412551|FG000|Overall Study|Adverse Event|4
4573956|NCT01385748|7412552|FG001|Overall Study|Adverse Event|2
4573957|NCT01385748|7412553|FG002|Overall Study|Adverse Event|1
4573958|NCT01385995|7412567|FG000|Period 1, 2 Months|Physician Decision|1
4573959|NCT01385995|7412568|FG001|Period 1, 2 Months|Physician Decision|0
4573960|NCT01386008|7412576|FG000|Overall Study|exited w/o incident /study discontinued|17
4573961|NCT01386008|7412576|FG000|Overall Study|Adverse Event|3
4573962|NCT01386554|7412587|FG000|Overall Study|Lost to Follow-up|0
4573963|NCT01386554|7412588|FG001|Overall Study|Lost to Follow-up|0
4573964|NCT01386554|7412589|FG002|Overall Study|Lost to Follow-up|1
4573965|NCT01386554|7412587|FG000|Overall Study|Adverse Event|2
4573966|NCT01386554|7412588|FG001|Overall Study|Adverse Event|5
4573967|NCT01386554|7412589|FG002|Overall Study|Adverse Event|2
4573968|NCT01386554|7412587|FG000|Overall Study|Progressive disease|1
4573969|NCT01386554|7412588|FG001|Overall Study|Progressive disease|2
4573970|NCT01386554|7412589|FG002|Overall Study|Progressive disease|2
4573971|NCT01386554|7412587|FG000|Overall Study|Administration of live vaccines|0
4573972|NCT01386554|7412588|FG001|Overall Study|Administration of live vaccines|1
4573973|NCT01386554|7412589|FG002|Overall Study|Administration of live vaccines|0
4573974|NCT01386554|7412587|FG000|Overall Study|Investigator discretion|0
4573975|NCT01386554|7412588|FG001|Overall Study|Investigator discretion|0
4573976|NCT01386554|7412589|FG002|Overall Study|Investigator discretion|1
4573977|NCT01386554|7412587|FG000|Overall Study|Reason not collected|0
4573978|NCT01386554|7412588|FG001|Overall Study|Reason not collected|1
4573979|NCT01386554|7412589|FG002|Overall Study|Reason not collected|0
4573980|NCT01386606|7412603|FG000|Overall Study|Adverse Event|0
4573981|NCT01386606|7412604|FG001|Overall Study|Adverse Event|1
4573982|NCT01386606|7412605|FG002|Overall Study|Adverse Event|0
4573983|NCT01386606|7412606|FG003|Overall Study|Adverse Event|0
4573984|NCT01386606|7412603|FG000|Overall Study|Withdrawal by Subject|0
4573985|NCT01386606|7412604|FG001|Overall Study|Withdrawal by Subject|1
4573986|NCT01386606|7412605|FG002|Overall Study|Withdrawal by Subject|1
4573987|NCT01386606|7412606|FG003|Overall Study|Withdrawal by Subject|0
4573988|NCT01386606|7412603|FG000|Overall Study|Protocol Violation|1
4573989|NCT01386606|7412604|FG001|Overall Study|Protocol Violation|0
4573990|NCT01386606|7412605|FG002|Overall Study|Protocol Violation|1
4573991|NCT01386606|7412606|FG003|Overall Study|Protocol Violation|1
4573992|NCT01386606|7412603|FG000|Overall Study|Lost to Follow-up|2
4573993|NCT01386606|7412604|FG001|Overall Study|Lost to Follow-up|0
4573994|NCT01386606|7412605|FG002|Overall Study|Lost to Follow-up|0
4573995|NCT01386606|7412606|FG003|Overall Study|Lost to Follow-up|0
4573996|NCT01386606|7412603|FG000|Overall Study|Subject incarcerated|0
4573997|NCT01386606|7412604|FG001|Overall Study|Subject incarcerated|1
4573998|NCT01386606|7412605|FG002|Overall Study|Subject incarcerated|0
4573999|NCT01386606|7412606|FG003|Overall Study|Subject incarcerated|0
4574000|NCT01386606|7412603|FG000|Overall Study|Unable to draw PK|1
4574001|NCT01386606|7412604|FG001|Overall Study|Unable to draw PK|0
4574002|NCT01386606|7412605|FG002|Overall Study|Unable to draw PK|0
4574003|NCT01386606|7412606|FG003|Overall Study|Unable to draw PK|0
4574004|NCT01386606|7412603|FG000|Overall Study|T levels too high|0
4574005|NCT01386606|7412604|FG001|Overall Study|T levels too high|1
4574006|NCT01386606|7412605|FG002|Overall Study|T levels too high|1
4574007|NCT01386606|7412606|FG003|Overall Study|T levels too high|0
4574008|NCT01386645|7412632|FG000|Overall Study|Physician Decision|0
4574009|NCT01386645|7412633|FG001|Overall Study|Physician Decision|0
4574010|NCT01386645|7412634|FG002|Overall Study|Physician Decision|1
4574011|NCT01386645|7412632|FG000|Overall Study|Withdrawal by Subject|0
4574012|NCT01386645|7412633|FG001|Overall Study|Withdrawal by Subject|1
4574013|NCT01386645|7412634|FG002|Overall Study|Withdrawal by Subject|1
4574014|NCT01386788|7412642|FG000|Overall Study|Lost to Follow-up|2
4574015|NCT01386944|7412646|FG000|Overall Study|Adverse Event|26
4574016|NCT01386944|7412646|FG000|Overall Study|Lack of Efficacy|14
4574017|NCT01386944|7412646|FG000|Overall Study|Lost to Follow-up|8
4574018|NCT01386944|7412646|FG000|Overall Study|Unspecified reason|8
4574019|NCT01386970|7412652|FG000|Overall Study|Withdrawal by Subject|0
4574020|NCT01386970|7412653|FG001|Overall Study|Withdrawal by Subject|1
4574021|NCT01386970|7412652|FG000|Overall Study|Adverse Event|4
4574022|NCT01386970|7412653|FG001|Overall Study|Adverse Event|1
4574023|NCT01387022|7412672|FG000|Overall Study|Death|1
4574024|NCT01387022|7412673|FG001|Overall Study|Death|1
4574025|NCT01387022|7412672|FG000|Overall Study|Lost to Follow-up|0
4574026|NCT01387022|7412673|FG001|Overall Study|Lost to Follow-up|3
4574027|NCT01387074|7412679|FG000|Overall Study|Lost to Follow-up|7
4574028|NCT01387074|7412679|FG000|Overall Study|Lack of Efficacy|1
4574029|NCT01387230|7412705|FG000|Overall Study|Adverse Event|0
4574030|NCT01387230|7412706|FG001|Overall Study|Adverse Event|1
4574031|NCT01387230|7412707|FG002|Overall Study|Adverse Event|3
4574032|NCT01387230|7412705|FG000|Overall Study|Lack of Efficacy|8
4574033|NCT01387230|7412706|FG001|Overall Study|Lack of Efficacy|5
4574034|NCT01387230|7412707|FG002|Overall Study|Lack of Efficacy|4
4574035|NCT01387230|7412705|FG000|Overall Study|Protocol-defined Stopping Criteria|6
4574036|NCT01387230|7412706|FG001|Overall Study|Protocol-defined Stopping Criteria|0
4574037|NCT01387230|7412707|FG002|Overall Study|Protocol-defined Stopping Criteria|5
4574038|NCT01387230|7412705|FG000|Overall Study|Lost to Follow-up|0
4574039|NCT01387230|7412706|FG001|Overall Study|Lost to Follow-up|0
4574040|NCT01387230|7412707|FG002|Overall Study|Lost to Follow-up|1
4574041|NCT01387230|7412705|FG000|Overall Study|Withdrawal by Subject|4
4574042|NCT01387230|7412706|FG001|Overall Study|Withdrawal by Subject|1
4574043|NCT01387230|7412707|FG002|Overall Study|Withdrawal by Subject|0
4574044|NCT01387269|7412717|FG000|Overall Study|Death|38
4574045|NCT01387269|7412718|FG001|Overall Study|Death|20
4574046|NCT01387269|7412717|FG000|Overall Study|Other|8
4574047|NCT01387269|7412718|FG001|Overall Study|Other|7
4574048|NCT01387269|7412717|FG000|Overall Study|Unrelated AE|12
4574049|NCT01387269|7412718|FG001|Overall Study|Unrelated AE|3
4574050|NCT01387269|7412717|FG000|Overall Study|Withdrawal by patient|32
4574051|NCT01387269|7412718|FG001|Overall Study|Withdrawal by patient|10
4574052|NCT01387269|7412717|FG000|Overall Study|Study drug-related AE|1
4574053|NCT01387269|7412718|FG001|Overall Study|Study drug-related AE|0
4574054|NCT01387269|7412717|FG000|Overall Study|Lost to Follow-up|1
4574055|NCT01387269|7412718|FG001|Overall Study|Lost to Follow-up|0
4574056|NCT01387282|7412726|FG000|Overall Study|Death|47
4574057|NCT01387282|7412727|FG001|Overall Study|Death|16
4574058|NCT01387282|7412726|FG000|Overall Study|Other|5
4574059|NCT01387282|7412727|FG001|Overall Study|Other|1
4574060|NCT01387282|7412726|FG000|Overall Study|Unrelated AE|6
4574061|NCT01387282|7412727|FG001|Overall Study|Unrelated AE|4
4574062|NCT01387282|7412726|FG000|Overall Study|Withdrawal by patient|33
4574063|NCT01387282|7412727|FG001|Overall Study|Withdrawal by patient|23
4574064|NCT01387282|7412726|FG000|Overall Study|Study drug-related AE|2
4574065|NCT01387282|7412727|FG001|Overall Study|Study drug-related AE|2
4574066|NCT01387282|7412726|FG000|Overall Study|Lost to Follow-up|4
4574067|NCT01387282|7412727|FG001|Overall Study|Lost to Follow-up|1
4574068|NCT01387347|7412735|FG000|Overall Study|Lost to Follow-up|2
4574069|NCT01387347|7412736|FG001|Overall Study|Lost to Follow-up|1
4592883|NCT01544595|7440755|FG003|Status at Week 156|Physician Decision|0
4592884|NCT01544595|7440756|FG004|Status at Week 156|Physician Decision|0
4592885|NCT01544595|7440757|FG005|Status at Week 156|Physician Decision|0
4592886|NCT01544595|7440752|FG000|Status at Week 156|Pregnancy|2
4592887|NCT01544595|7440753|FG001|Status at Week 156|Pregnancy|3
4592888|NCT01544595|7440754|FG002|Status at Week 156|Pregnancy|0
4592889|NCT01544595|7440755|FG003|Status at Week 156|Pregnancy|0
4592890|NCT01544595|7440756|FG004|Status at Week 156|Pregnancy|0
4592891|NCT01544595|7440757|FG005|Status at Week 156|Pregnancy|0
4592892|NCT01544595|7440752|FG000|Status at Week 156|Protocol Violation|3
4592893|NCT01544595|7440753|FG001|Status at Week 156|Protocol Violation|1
4592894|NCT01544595|7440754|FG002|Status at Week 156|Protocol Violation|2
4592895|NCT01544595|7440755|FG003|Status at Week 156|Protocol Violation|2
4592896|NCT01544595|7440756|FG004|Status at Week 156|Protocol Violation|0
4592897|NCT01544595|7440757|FG005|Status at Week 156|Protocol Violation|0
4592898|NCT01544595|7440752|FG000|Status at Week 156|Technical problems|3
4592899|NCT01544595|7440753|FG001|Status at Week 156|Technical problems|1
4592900|NCT01544595|7440754|FG002|Status at Week 156|Technical problems|0
4592901|NCT01544595|7440755|FG003|Status at Week 156|Technical problems|1
4592902|NCT01544595|7440756|FG004|Status at Week 156|Technical problems|0
4592903|NCT01544595|7440757|FG005|Status at Week 156|Technical problems|0
4592904|NCT01544595|7440752|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86
4592905|NCT01544595|7440753|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44
4592906|NCT01544595|7440754|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131
4592907|NCT01544595|7440755|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145
4592908|NCT01544595|7440756|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0
4592909|NCT01544595|7440757|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0
4592910|NCT01544595|7440752|FG000|Status at Week 156|Lack of Efficacy|1
4592911|NCT01544595|7440753|FG001|Status at Week 156|Lack of Efficacy|0
4592912|NCT01544595|7440754|FG002|Status at Week 156|Lack of Efficacy|1
4592913|NCT01544595|7440755|FG003|Status at Week 156|Lack of Efficacy|4
4592914|NCT01544595|7440756|FG004|Status at Week 156|Lack of Efficacy|10
4592915|NCT01544595|7440757|FG005|Status at Week 156|Lack of Efficacy|5
4592916|NCT01544920|7440777|FG000|Overall Study|Adverse Event|0
4592917|NCT01544920|7440778|FG001|Overall Study|Adverse Event|3
4592918|NCT01544920|7440777|FG000|Overall Study|Death|0
4592919|NCT01544920|7440778|FG001|Overall Study|Death|1
4592920|NCT01544920|7440777|FG000|Overall Study|Lost to Follow-up|11
4592921|NCT01544920|7440778|FG001|Overall Study|Lost to Follow-up|12
4592922|NCT01544920|7440777|FG000|Overall Study|Protocol Violation|0
4592923|NCT01544920|7440778|FG001|Overall Study|Protocol Violation|2
4592924|NCT01544920|7440777|FG000|Overall Study|Physician Decision|4
4592925|NCT01544920|7440778|FG001|Overall Study|Physician Decision|1
4592926|NCT01544920|7440777|FG000|Overall Study|Withdrawal by Subject|4
4592927|NCT01544920|7440778|FG001|Overall Study|Withdrawal by Subject|4
4592928|NCT01545076|7440795|FG000|IgPro10 Restabilization Period|Adverse Event|4
4592929|NCT01545076|7440796|FG001|IgPro10 Restabilization Period|Adverse Event|0
4592930|NCT01545076|7440797|FG002|IgPro10 Restabilization Period|Adverse Event|0
4592931|NCT01545076|7440798|FG003|IgPro10 Restabilization Period|Adverse Event|0
4592932|NCT01545076|7440799|FG004|IgPro10 Restabilization Period|Adverse Event|0
4592933|NCT01545076|7440795|FG000|IgPro10 Restabilization Period|Physician Decision|2
4592934|NCT01545076|7440796|FG001|IgPro10 Restabilization Period|Physician Decision|0
4592935|NCT01545076|7440797|FG002|IgPro10 Restabilization Period|Physician Decision|0
4592936|NCT01545076|7440798|FG003|IgPro10 Restabilization Period|Physician Decision|0
4592937|NCT01545076|7440799|FG004|IgPro10 Restabilization Period|Physician Decision|0
4592938|NCT01545076|7440795|FG000|IgPro10 Restabilization Period|Protocol Violation|1
4592939|NCT01545076|7440796|FG001|IgPro10 Restabilization Period|Protocol Violation|0
4592940|NCT01545076|7440797|FG002|IgPro10 Restabilization Period|Protocol Violation|0
4592941|NCT01545076|7440798|FG003|IgPro10 Restabilization Period|Protocol Violation|0
4592942|NCT01545076|7440799|FG004|IgPro10 Restabilization Period|Protocol Violation|0
4592943|NCT01545076|7440795|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22
4574070|NCT01387516|7412759|FG000|Overall Study|Lost to Follow-up|4
4574071|NCT01387516|7412760|FG001|Overall Study|Lost to Follow-up|4
4574072|NCT01387516|7412761|FG002|Overall Study|Lost to Follow-up|2
4574073|NCT01387516|7412762|FG003|Overall Study|Lost to Follow-up|3
4574074|NCT01387516|7412759|FG000|Overall Study|Withdrawal by Subject|1
4574075|NCT01387516|7412760|FG001|Overall Study|Withdrawal by Subject|1
4574076|NCT01387516|7412761|FG002|Overall Study|Withdrawal by Subject|2
4574077|NCT01387516|7412762|FG003|Overall Study|Withdrawal by Subject|0
4574078|NCT01387516|7412759|FG000|Overall Study|Death|0
4574079|NCT01387516|7412760|FG001|Overall Study|Death|0
4574080|NCT01387516|7412761|FG002|Overall Study|Death|0
4574081|NCT01387516|7412762|FG003|Overall Study|Death|1
4574082|NCT01387542|7412772|FG000|Overall Study|Adverse Event|3
4574083|NCT01387542|7412772|FG000|Overall Study|Withdrawal by Subject|1
4574084|NCT01387542|7412772|FG000|Overall Study|Changed diagnosis|1
4574085|NCT01387542|7412772|FG000|Overall Study|Insufficient response|1
4574086|NCT01387542|7412772|FG000|Overall Study|Non-compliant|1
4574087|NCT01387542|7412772|FG000|Overall Study|Lost to Follow-up|1
4574088|NCT01387594|7412791|FG000|Overall Study|Withdrawal by Subject|0
4574089|NCT01387594|7412792|FG001|Overall Study|Withdrawal by Subject|2
4574090|NCT01387594|7412791|FG000|Overall Study|Lost to Follow-up|0
4574091|NCT01387594|7412792|FG001|Overall Study|Lost to Follow-up|1
4574092|NCT01387607|7412803|FG000|Overall Study|Adverse Event|23
4574093|NCT01387607|7412804|FG001|Overall Study|Adverse Event|11
4574094|NCT01387607|7412803|FG000|Overall Study|Lack of Efficacy|8
4574095|NCT01387607|7412804|FG001|Overall Study|Lack of Efficacy|6
4574096|NCT01387607|7412803|FG000|Overall Study|Lost to Follow-up|2
4574097|NCT01387607|7412804|FG001|Overall Study|Lost to Follow-up|1
4574098|NCT01387607|7412803|FG000|Overall Study|No longer meets eligibility criteria|0
4574099|NCT01387607|7412804|FG001|Overall Study|No longer meets eligibility criteria|1
4574100|NCT01387607|7412803|FG000|Overall Study|Protocol Violation|1
4574101|NCT01387607|7412804|FG001|Overall Study|Protocol Violation|5
4574102|NCT01387607|7412803|FG000|Overall Study|Withdrawal by Subject|13
4574103|NCT01387607|7412804|FG001|Overall Study|Withdrawal by Subject|14
4574104|NCT01387607|7412803|FG000|Overall Study|Other|1
4574105|NCT01387607|7412804|FG001|Overall Study|Other|1
4574106|NCT01387607|7412803|FG000|Overall Study|Randomized, not treated|3
4574107|NCT01387607|7412804|FG001|Overall Study|Randomized, not treated|6
4574108|NCT01387737|7412838|FG000|Overall Study|Adverse Event|20
4574109|NCT01387737|7412839|FG001|Overall Study|Adverse Event|30
4574110|NCT01387737|7412838|FG000|Overall Study|Lack of Efficacy|1
4574111|NCT01387737|7412839|FG001|Overall Study|Lack of Efficacy|0
4574112|NCT01387737|7412838|FG000|Overall Study|Physician Decision|3
4574113|NCT01387737|7412839|FG001|Overall Study|Physician Decision|10
4574114|NCT01387737|7412838|FG000|Overall Study|Withdrawal by Subject|27
4574115|NCT01387737|7412839|FG001|Overall Study|Withdrawal by Subject|31
4574116|NCT01387737|7412838|FG000|Overall Study|Clearly not eligible for the study|1
4574117|NCT01387737|7412839|FG001|Overall Study|Clearly not eligible for the study|3
4574118|NCT01387789|7412845|FG000|Overall Study|Adverse Event|5
4574119|NCT01387789|7412845|FG000|Overall Study|Lack of Efficacy|2
4574120|NCT01387789|7412845|FG000|Overall Study|Lost to Follow-up|1
4574121|NCT01387932|7412860|FG000|Randomized and Treated|Physician Decision|3
4574122|NCT01387932|7412861|FG001|Randomized and Treated|Physician Decision|2
4574123|NCT01387932|7412860|FG000|Randomized and Treated|Withdrawal by Subject|4
4574124|NCT01387932|7412861|FG001|Randomized and Treated|Withdrawal by Subject|2
4574125|NCT01387932|7412860|FG000|Survival Follow-up|Liver Transplant|24
4574126|NCT01387932|7412861|FG001|Survival Follow-up|Liver Transplant|28
4574127|NCT01387932|7412860|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52
4574128|NCT01387932|7412861|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53
4574129|NCT01387932|7412860|FG000|Survival Follow-up|Withdrawal by Subject|2
4574130|NCT01387932|7412861|FG001|Survival Follow-up|Withdrawal by Subject|4
4574131|NCT01387932|7412860|FG000|Survival Follow-up|Lost to Follow-up|6
4574132|NCT01387932|7412861|FG001|Survival Follow-up|Lost to Follow-up|5
4574133|NCT01388166|7412869|FG000|Overall Study|Adverse Event|16
4574134|NCT01388166|7412869|FG000|Overall Study|Lost to Follow-up|30
4574135|NCT01388166|7412869|FG000|Overall Study|Others than specified above|13
4574136|NCT01388335|7412873|FG000|Period 1|Progressive Disease|1
4574137|NCT01388335|7412873|FG000|Period 2|Progressive Disease|2
4574138|NCT01388335|7412873|FG000|Period 2|Sponsor Decision|1
4574139|NCT01388335|7412873|FG000|Safety Extension|Progressive Disease|7
4574140|NCT01388361|7412888|FG000|Overall Study|Adverse Event|0
4574141|NCT01388361|7412889|FG001|Overall Study|Adverse Event|5
4574142|NCT01388361|7412890|FG002|Overall Study|Adverse Event|1
4574143|NCT01388361|7412888|FG000|Overall Study|Protocol Violation|0
4574144|NCT01388361|7412889|FG001|Overall Study|Protocol Violation|0
4574145|NCT01388361|7412890|FG002|Overall Study|Protocol Violation|2
4574146|NCT01388361|7412888|FG000|Overall Study|Withdrawal criteria|12
4574147|NCT01388361|7412889|FG001|Overall Study|Withdrawal criteria|7
4574148|NCT01388361|7412890|FG002|Overall Study|Withdrawal criteria|10
4574149|NCT01388361|7412888|FG000|Overall Study|Unclassified|0
4574150|NCT01388361|7412889|FG001|Overall Study|Unclassified|0
4574151|NCT01388361|7412890|FG002|Overall Study|Unclassified|1
4574152|NCT01388478|7412898|FG000|Overall Study|Adverse Event|4
4574153|NCT01388478|7412898|FG000|Overall Study|Withdrawal by Subject|1
4574154|NCT01388530|7412902|FG000|Overall Study|Lost to Follow-up|5
4574155|NCT01388543|7412908|FG000|Day 14|Adverse Event|1
4574156|NCT01388543|7412909|FG001|Day 14|Adverse Event|4
4574157|NCT01388647|7412917|FG000|Overall Study|Adverse Event|1
4574158|NCT01388647|7412918|FG001|Overall Study|Adverse Event|2
4574159|NCT01388790|7412929|FG000|Overall Study|Ongoing at data cut-off date|8
4574160|NCT01388816|7412937|FG000|Overall Study|Adverse Event|0
4574161|NCT01388816|7412938|FG001|Overall Study|Adverse Event|2
4574162|NCT01388816|7412939|FG002|Overall Study|Adverse Event|0
4574163|NCT01388816|7412940|FG003|Overall Study|Adverse Event|0
4574164|NCT01388816|7412937|FG000|Overall Study|Lost to Follow-up|0
4574165|NCT01388816|7412938|FG001|Overall Study|Lost to Follow-up|1
4574166|NCT01388816|7412939|FG002|Overall Study|Lost to Follow-up|0
4574167|NCT01388816|7412940|FG003|Overall Study|Lost to Follow-up|0
4574168|NCT01388816|7412937|FG000|Overall Study|Withdrawal by Subject|2
4574169|NCT01388816|7412938|FG001|Overall Study|Withdrawal by Subject|1
4574170|NCT01388816|7412939|FG002|Overall Study|Withdrawal by Subject|1
4574171|NCT01388816|7412940|FG003|Overall Study|Withdrawal by Subject|0
4574172|NCT01388816|7412937|FG000|Overall Study|Protocol Violation|0
4574173|NCT01388816|7412938|FG001|Overall Study|Protocol Violation|0
4574174|NCT01388816|7412939|FG002|Overall Study|Protocol Violation|2
4574175|NCT01388816|7412940|FG003|Overall Study|Protocol Violation|0
4574176|NCT01388907|7412955|FG000|Overall Study|Adverse Event|2
4574177|NCT01388907|7412956|FG001|Overall Study|Adverse Event|0
4574178|NCT01388985|7412975|FG000|Overall Study|Death|0
4574179|NCT01388985|7412976|FG001|Overall Study|Death|1
4574180|NCT01388985|7412975|FG000|Overall Study|Lost to Follow-up|30
4574181|NCT01388985|7412976|FG001|Overall Study|Lost to Follow-up|30
4574182|NCT01388985|7412975|FG000|Overall Study|Withdrawal by Subject|13
4574183|NCT01388985|7412976|FG001|Overall Study|Withdrawal by Subject|4
4574184|NCT01388985|7412975|FG000|Overall Study|Subject unavailable|1
4574185|NCT01388985|7412976|FG001|Overall Study|Subject unavailable|1
4574186|NCT01388985|7412975|FG000|Overall Study|Other (no reason)|0
4574187|NCT01388985|7412976|FG001|Overall Study|Other (no reason)|1
4574188|NCT01388985|7412975|FG000|Overall Study|Error of nurse|5
4574189|NCT01388985|7412976|FG001|Overall Study|Error of nurse|1
4574190|NCT01389102|7412992|FG000|Overall Study|Adverse Event|1
4574191|NCT01389102|7412993|FG001|Overall Study|Adverse Event|3
4574192|NCT01389102|7412994|FG002|Overall Study|Adverse Event|2
4574193|NCT01389102|7412995|FG003|Overall Study|Adverse Event|2
4574194|NCT01389102|7412996|FG004|Overall Study|Adverse Event|2
4574195|NCT01389102|7412997|FG005|Overall Study|Adverse Event|2
4574196|NCT01389102|7412992|FG000|Overall Study|Hurricane Katrina|4
4574197|NCT01389102|7412993|FG001|Overall Study|Hurricane Katrina|2
4574198|NCT01389102|7412994|FG002|Overall Study|Hurricane Katrina|3
4574199|NCT01389102|7412995|FG003|Overall Study|Hurricane Katrina|0
4574200|NCT01389102|7412996|FG004|Overall Study|Hurricane Katrina|3
4574201|NCT01389102|7412997|FG005|Overall Study|Hurricane Katrina|1
4574202|NCT01389102|7412992|FG000|Overall Study|Lost to Follow-up|4
4574203|NCT01389102|7412993|FG001|Overall Study|Lost to Follow-up|1
4574204|NCT01389102|7412994|FG002|Overall Study|Lost to Follow-up|1
4574205|NCT01389102|7412995|FG003|Overall Study|Lost to Follow-up|2
4574206|NCT01389102|7412996|FG004|Overall Study|Lost to Follow-up|4
4574207|NCT01389102|7412997|FG005|Overall Study|Lost to Follow-up|1
4574208|NCT01389102|7412992|FG000|Overall Study|Protocol Violation|0
4574209|NCT01389102|7412993|FG001|Overall Study|Protocol Violation|0
4574210|NCT01389102|7412994|FG002|Overall Study|Protocol Violation|3
4574211|NCT01389102|7412995|FG003|Overall Study|Protocol Violation|0
4574212|NCT01389102|7412996|FG004|Overall Study|Protocol Violation|1
4574213|NCT01389102|7412997|FG005|Overall Study|Protocol Violation|1
4574214|NCT01389102|7412992|FG000|Overall Study|Withdrawal by Subject|7
4574215|NCT01389102|7412993|FG001|Overall Study|Withdrawal by Subject|4
4574216|NCT01389102|7412994|FG002|Overall Study|Withdrawal by Subject|9
4574217|NCT01389102|7412995|FG003|Overall Study|Withdrawal by Subject|2
4574218|NCT01389102|7412996|FG004|Overall Study|Withdrawal by Subject|3
4574219|NCT01389102|7412997|FG005|Overall Study|Withdrawal by Subject|3
4574220|NCT01389102|7412992|FG000|Overall Study|Subject Traveling Out of Country|0
4574221|NCT01389102|7412993|FG001|Overall Study|Subject Traveling Out of Country|0
4574222|NCT01389102|7412994|FG002|Overall Study|Subject Traveling Out of Country|0
4574223|NCT01389102|7412995|FG003|Overall Study|Subject Traveling Out of Country|1
4574224|NCT01389102|7412996|FG004|Overall Study|Subject Traveling Out of Country|0
4574225|NCT01389102|7412997|FG005|Overall Study|Subject Traveling Out of Country|0
4574226|NCT01389102|7412992|FG000|Overall Study|Subject Moved|2
4574227|NCT01389102|7412993|FG001|Overall Study|Subject Moved|0
4574228|NCT01389102|7412994|FG002|Overall Study|Subject Moved|1
4574229|NCT01389102|7412995|FG003|Overall Study|Subject Moved|0
4574230|NCT01389102|7412996|FG004|Overall Study|Subject Moved|0
4574231|NCT01389102|7412997|FG005|Overall Study|Subject Moved|0
4574232|NCT01389102|7412992|FG000|Overall Study|Unavailable due to husband's illness|0
4574233|NCT01389102|7412993|FG001|Overall Study|Unavailable due to husband's illness|1
4574234|NCT01389102|7412994|FG002|Overall Study|Unavailable due to husband's illness|0
4574235|NCT01389102|7412995|FG003|Overall Study|Unavailable due to husband's illness|0
4574236|NCT01389102|7412996|FG004|Overall Study|Unavailable due to husband's illness|0
4574237|NCT01389102|7412997|FG005|Overall Study|Unavailable due to husband's illness|0
4574238|NCT01389102|7412992|FG000|Overall Study|Investigator Judgement|0
4574239|NCT01389102|7412993|FG001|Overall Study|Investigator Judgement|1
4574240|NCT01389102|7412994|FG002|Overall Study|Investigator Judgement|0
4574241|NCT01389102|7412995|FG003|Overall Study|Investigator Judgement|0
4574242|NCT01389102|7412996|FG004|Overall Study|Investigator Judgement|0
4574243|NCT01389102|7412997|FG005|Overall Study|Investigator Judgement|0
4574244|NCT01389128|7413019|FG000|Overall Study|Fetal distress|1
4574245|NCT01389128|7413020|FG001|Overall Study|Fetal distress|0
4574246|NCT01389128|7413019|FG000|Overall Study|Cervix dilation stop|1
4574247|NCT01389128|7413020|FG001|Overall Study|Cervix dilation stop|2
4691537|NCT02573350|7601929|FG001|Overall Study|Lost to Follow-up|1
4691538|NCT02573350|7601928|FG000|Overall Study|Adverse Event|3
4691539|NCT02573350|7601929|FG001|Overall Study|Adverse Event|4
4691540|NCT02573350|7601928|FG000|Overall Study|Subject met Withdrawal Criteria|1
4691541|NCT02573350|7601929|FG001|Overall Study|Subject met Withdrawal Criteria|1
4691542|NCT02573350|7601928|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3
4691543|NCT02573350|7601929|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1
4691544|NCT02573350|7601928|FG000|Overall Study|Subject withdrew consent to participate|6
4691545|NCT02573350|7601929|FG001|Overall Study|Subject withdrew consent to participate|1
4691546|NCT02573350|7601928|FG000|Overall Study|Protocol Deviation|1
4691547|NCT02573350|7601929|FG001|Overall Study|Protocol Deviation|1
4691548|NCT02573467|7601951|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0
4691549|NCT02573467|7601952|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0
4691550|NCT02573467|7601953|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1
4691551|NCT02573467|7601954|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0
4691552|NCT02573467|7601951|FG000|Double-blind Treatment Epoch|Adverse Event|1
4691553|NCT02573467|7601952|FG001|Double-blind Treatment Epoch|Adverse Event|0
4691554|NCT02573467|7601953|FG002|Double-blind Treatment Epoch|Adverse Event|1
4691555|NCT02573467|7601954|FG003|Double-blind Treatment Epoch|Adverse Event|0
4691556|NCT02573467|7601951|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2
4574248|NCT01389128|7413019|FG000|Overall Study|Rapid labor evolution|3
4574249|NCT01389128|7413020|FG001|Overall Study|Rapid labor evolution|2
4574250|NCT01389128|7413019|FG000|Overall Study|Intolerance to procedure|0
4574251|NCT01389128|7413020|FG001|Overall Study|Intolerance to procedure|2
4574252|NCT01389232|7413030|FG000|Overall Study|Had scaffold removed|15
4574253|NCT01389232|7413030|FG000|Overall Study|Personal reasons|2
4574254|NCT01389232|7413030|FG000|Overall Study|Adverse Event|1
4574255|NCT01389232|7413030|FG000|Overall Study|Death|1
4691557|NCT02573467|7601952|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1
4691558|NCT02573467|7601953|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1
4691559|NCT02573467|7601954|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0
4574256|NCT01389245|7413044|FG000|Overall Study|Protocol Violation|10
4574257|NCT01389245|7413044|FG000|Overall Study|Lost to Follow-up|3
4574258|NCT01389245|7413044|FG000|Overall Study|Withdrawal by Subject|2
4574259|NCT01389258|7413048|FG000|Overall Study|Lost to Follow-up|5
4574260|NCT01389323|7413065|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41
4574261|NCT01389323|7413065|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24
4574262|NCT01389323|7413065|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6
4574263|NCT01389323|7413065|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7
4574264|NCT01389323|7413065|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10
4574265|NCT01389323|7413065|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5
4574266|NCT01389323|7413065|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2
4574267|NCT01389323|7413065|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10
4574268|NCT01389323|7413065|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22
4574269|NCT01389323|7413065|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2
4574270|NCT01389323|7413065|FG000|Follow-up Period (up to 48 Weeks)|Other|3
4574271|NCT01389596|7413079|FG000|Overall Study|Protocol Violation|3
4574272|NCT01389596|7413080|FG001|Overall Study|Protocol Violation|4
4574273|NCT01389596|7413081|FG002|Overall Study|Protocol Violation|3
4574274|NCT01389596|7413079|FG000|Overall Study|Withdrawal by Subject|1
4574275|NCT01389596|7413080|FG001|Overall Study|Withdrawal by Subject|2
4574276|NCT01389596|7413081|FG002|Overall Study|Withdrawal by Subject|2
4574277|NCT01389596|7413079|FG000|Overall Study|Insufficient Clinical Response|3
4574278|NCT01389596|7413080|FG001|Overall Study|Insufficient Clinical Response|4
4574279|NCT01389596|7413081|FG002|Overall Study|Insufficient Clinical Response|5
4574280|NCT01389596|7413079|FG000|Overall Study|Adverse Event|1
4574281|NCT01389596|7413080|FG001|Overall Study|Adverse Event|4
4574282|NCT01389596|7413081|FG002|Overall Study|Adverse Event|0
4574283|NCT01389596|7413079|FG000|Overall Study|Death|0
4574284|NCT01389596|7413080|FG001|Overall Study|Death|1
4574285|NCT01389596|7413081|FG002|Overall Study|Death|0
4574286|NCT01389596|7413079|FG000|Overall Study|Other Unspecified|2
4574287|NCT01389596|7413080|FG001|Overall Study|Other Unspecified|1
4574288|NCT01389596|7413081|FG002|Overall Study|Other Unspecified|0
4574289|NCT01389752|7413089|FG000|Study Period 1|Sponsor decision|0
4574290|NCT01389752|7413090|FG001|Study Period 1|Sponsor decision|2
4574291|NCT01389752|7413089|FG000|Study Period 2|Sponsor decision|1
4574292|NCT01389752|7413090|FG001|Study Period 2|Sponsor decision|0
4574293|NCT01389882|7413115|FG000|Overall Study|Respiratory rate > 80/min during study|1
4574294|NCT01389882|7413116|FG001|Overall Study|Respiratory rate > 80/min during study|3
4574295|NCT01389882|7413115|FG000|Overall Study|Withdrawal by Subject|0
4574296|NCT01389882|7413116|FG001|Overall Study|Withdrawal by Subject|1
4574297|NCT01389973|7413122|FG000|Overall Study|Lost to Follow-up|1
4574298|NCT01389973|7413122|FG000|Overall Study|Trial Stopped by Sponsor|9
4574299|NCT01389973|7413122|FG000|Overall Study|Other|10
4574300|NCT01390038|7413126|FG000|Overall Study|Death|1
4574301|NCT01390038|7413126|FG000|Overall Study|Lost to Follow-up|1
4574302|NCT01390038|7413126|FG000|Overall Study|Withdrawal by Subject|4
4574303|NCT01390038|7413126|FG000|Overall Study|Simpliciti System Removal|2
4574304|NCT01390220|7413148|FG000|Test Dose Phase|Adverse Event|17
4574305|NCT01390220|7413149|FG001|Test Dose Phase|Adverse Event|0
4574306|NCT01390220|7413150|FG002|Test Dose Phase|Adverse Event|0
4574307|NCT01390220|7413148|FG000|Test Dose Phase|Withdrawal by Subject|8
4574308|NCT01390220|7413149|FG001|Test Dose Phase|Withdrawal by Subject|0
4574309|NCT01390220|7413150|FG002|Test Dose Phase|Withdrawal by Subject|0
4574310|NCT01390220|7413148|FG000|Test Dose Phase|Lost to Follow-up|2
4574311|NCT01390220|7413149|FG001|Test Dose Phase|Lost to Follow-up|0
4574312|NCT01390220|7413150|FG002|Test Dose Phase|Lost to Follow-up|0
4574313|NCT01390220|7413148|FG000|Test Dose Phase|Protocol Violation|8
4574314|NCT01390220|7413149|FG001|Test Dose Phase|Protocol Violation|0
4574315|NCT01390220|7413150|FG002|Test Dose Phase|Protocol Violation|0
4574316|NCT01390220|7413148|FG000|Test Dose Phase|No treated seizure cluster episode|37
4574317|NCT01390220|7413149|FG001|Test Dose Phase|No treated seizure cluster episode|0
4574318|NCT01390220|7413150|FG002|Test Dose Phase|No treated seizure cluster episode|0
4574319|NCT01390220|7413148|FG000|Test Dose Phase|Study/Site closure|6
4574320|NCT01390220|7413149|FG001|Test Dose Phase|Study/Site closure|0
4574321|NCT01390220|7413150|FG002|Test Dose Phase|Study/Site closure|0
4574322|NCT01390220|7413148|FG000|Test Dose Phase|Caregiver no longer available|5
4574323|NCT01390220|7413149|FG001|Test Dose Phase|Caregiver no longer available|0
4574324|NCT01390220|7413150|FG002|Test Dose Phase|Caregiver no longer available|0
4574325|NCT01390220|7413148|FG000|Test Dose Phase|Noncompliance|2
4574326|NCT01390220|7413149|FG001|Test Dose Phase|Noncompliance|0
4574327|NCT01390220|7413150|FG002|Test Dose Phase|Noncompliance|0
4574328|NCT01390220|7413148|FG000|Test Dose Phase|Logistical|6
4574329|NCT01390220|7413149|FG001|Test Dose Phase|Logistical|0
4574330|NCT01390220|7413150|FG002|Test Dose Phase|Logistical|0
4574331|NCT01390220|7413148|FG000|Comparative Phase|Withdrawal by Subject|0
4574332|NCT01390220|7413149|FG001|Comparative Phase|Withdrawal by Subject|1
4574333|NCT01390220|7413150|FG002|Comparative Phase|Withdrawal by Subject|0
4574334|NCT01390272|7413189|FG000|Overall Study|Death|3
4574335|NCT01390272|7413190|FG001|Overall Study|Death|2
4574336|NCT01390272|7413189|FG000|Overall Study|Withdrawal by Subject|9
4574337|NCT01390272|7413190|FG001|Overall Study|Withdrawal by Subject|5
4574338|NCT01390272|7413189|FG000|Overall Study|Patient moved, no longer eligible|5
4574339|NCT01390272|7413190|FG001|Overall Study|Patient moved, no longer eligible|8
4574340|NCT01390298|7413196|FG000|Overall Study|Death|1
4574341|NCT01390298|7413196|FG000|Overall Study|long term ICU admission|1
4574342|NCT01390298|7413196|FG000|Overall Study|Withdrawal by Subject|14
4574343|NCT01390298|7413196|FG000|Overall Study|Lost to Follow-up|7
4574344|NCT01390298|7413196|FG000|Overall Study|Surgery cancelled|1
4574345|NCT01390389|7413202|FG000|Overall Study|Withdrawal by Subject|2
4574346|NCT01390389|7413203|FG001|Overall Study|Withdrawal by Subject|0
4574347|NCT01390389|7413202|FG000|Overall Study|Screen Fail|2
4574348|NCT01390389|7413203|FG001|Overall Study|Screen Fail|1
4574349|NCT01390402|7413213|FG000|Overall Study|Death|1
4574350|NCT01390402|7413213|FG000|Overall Study|Disease Progression|4
4574351|NCT01390428|7413223|FG000|Overall Study|Elective Surgery|0
4574352|NCT01390428|7413224|FG001|Overall Study|Elective Surgery|0
4574353|NCT01390428|7413225|FG002|Overall Study|Elective Surgery|0
4574354|NCT01390428|7413226|FG003|Overall Study|Elective Surgery|0
4574355|NCT01390428|7413227|FG004|Overall Study|Elective Surgery|1
4574356|NCT01390428|7413228|FG005|Overall Study|Elective Surgery|0
4574357|NCT01390428|7413223|FG000|Overall Study|Withdrawal by Subject|0
4574358|NCT01390428|7413224|FG001|Overall Study|Withdrawal by Subject|0
4574359|NCT01390428|7413225|FG002|Overall Study|Withdrawal by Subject|1
4574360|NCT01390428|7413226|FG003|Overall Study|Withdrawal by Subject|0
4574361|NCT01390428|7413227|FG004|Overall Study|Withdrawal by Subject|0
4574362|NCT01390428|7413228|FG005|Overall Study|Withdrawal by Subject|0
4574363|NCT01390441|7413247|FG000|Treatment Period|Protocol Violation|0
4574364|NCT01390441|7413248|FG001|Treatment Period|Protocol Violation|1
4574365|NCT01390441|7413249|FG002|Treatment Period|Protocol Violation|0
4574366|NCT01390441|7413250|FG003|Treatment Period|Protocol Violation|0
4574367|NCT01390441|7413251|FG004|Treatment Period|Protocol Violation|0
4574368|NCT01390441|7413247|FG000|Treatment Period|Physician Decision|0
4574369|NCT01390441|7413248|FG001|Treatment Period|Physician Decision|0
4574370|NCT01390441|7413249|FG002|Treatment Period|Physician Decision|0
4574371|NCT01390441|7413250|FG003|Treatment Period|Physician Decision|1
4574372|NCT01390441|7413251|FG004|Treatment Period|Physician Decision|0
4574373|NCT01390441|7413247|FG000|Treatment Period|Lack of Efficacy|0
4574374|NCT01390441|7413248|FG001|Treatment Period|Lack of Efficacy|0
4574375|NCT01390441|7413249|FG002|Treatment Period|Lack of Efficacy|0
4574376|NCT01390441|7413250|FG003|Treatment Period|Lack of Efficacy|0
4574377|NCT01390441|7413251|FG004|Treatment Period|Lack of Efficacy|1
4574378|NCT01390441|7413247|FG000|Treatment Period|Unknown due to early stopping of study|0
4574379|NCT01390441|7413248|FG001|Treatment Period|Unknown due to early stopping of study|0
4574380|NCT01390441|7413249|FG002|Treatment Period|Unknown due to early stopping of study|8
4574381|NCT01390441|7413250|FG003|Treatment Period|Unknown due to early stopping of study|11
4574382|NCT01390441|7413251|FG004|Treatment Period|Unknown due to early stopping of study|7
4574383|NCT01390441|7413247|FG000|Treatment Period|Adverse Event|0
4574384|NCT01390441|7413248|FG001|Treatment Period|Adverse Event|0
4574385|NCT01390441|7413249|FG002|Treatment Period|Adverse Event|1
4574386|NCT01390441|7413250|FG003|Treatment Period|Adverse Event|1
4574387|NCT01390441|7413251|FG004|Treatment Period|Adverse Event|2
4574388|NCT01390441|7413247|FG000|Treatment Period|Withdrawal by Subject|0
4574389|NCT01390441|7413248|FG001|Treatment Period|Withdrawal by Subject|0
4574390|NCT01390441|7413249|FG002|Treatment Period|Withdrawal by Subject|1
4574391|NCT01390441|7413250|FG003|Treatment Period|Withdrawal by Subject|0
4574392|NCT01390441|7413251|FG004|Treatment Period|Withdrawal by Subject|1
4574393|NCT01390441|7413247|FG000|Treatment Period|Lost to Follow-up|1
4574394|NCT01390441|7413248|FG001|Treatment Period|Lost to Follow-up|0
4574395|NCT01390441|7413249|FG002|Treatment Period|Lost to Follow-up|0
4574396|NCT01390441|7413250|FG003|Treatment Period|Lost to Follow-up|0
4574397|NCT01390441|7413251|FG004|Treatment Period|Lost to Follow-up|0
4574398|NCT01390441|7413247|FG000|Extension Period|Protocol Violation|3
4574399|NCT01390441|7413248|FG001|Extension Period|Protocol Violation|1
4574400|NCT01390441|7413249|FG002|Extension Period|Protocol Violation|0
4574401|NCT01390441|7413250|FG003|Extension Period|Protocol Violation|1
4574402|NCT01390441|7413251|FG004|Extension Period|Protocol Violation|0
4574403|NCT01390584|7413291|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0
4574404|NCT01390584|7413292|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0
4574405|NCT01390584|7413293|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1
4574406|NCT01390649|7413302|FG000|Overall Study|Physician Decision|1
4574407|NCT01390779|7413306|FG000|Overall Study|Physician Decision|1
4574408|NCT01390844|7413443|FG000|Treatment Phase|Adverse Event|12
4574409|NCT01390844|7413444|FG001|Treatment Phase|Adverse Event|2
4574410|NCT01390844|7413445|FG002|Treatment Phase|Adverse Event|3
4574411|NCT01390844|7413446|FG003|Treatment Phase|Adverse Event|2
4574412|NCT01390844|7413443|FG000|Treatment Phase|Treatment Failure|23
4574413|NCT01390844|7413444|FG001|Treatment Phase|Treatment Failure|25
4574414|NCT01390844|7413445|FG002|Treatment Phase|Treatment Failure|10
4574415|NCT01390844|7413446|FG003|Treatment Phase|Treatment Failure|13
4574416|NCT01390844|7413443|FG000|Treatment Phase|Non-Medical Reasons|5
4574417|NCT01390844|7413444|FG001|Treatment Phase|Non-Medical Reasons|1
4574418|NCT01390844|7413445|FG002|Treatment Phase|Non-Medical Reasons|8
4574419|NCT01390844|7413446|FG003|Treatment Phase|Non-Medical Reasons|1
4574420|NCT01390844|7413443|FG000|Treatment Phase|Non-GCP Compliant|0
4574421|NCT01390844|7413444|FG001|Treatment Phase|Non-GCP Compliant|0
4574422|NCT01390844|7413445|FG002|Treatment Phase|Non-GCP Compliant|10
4574423|NCT01390844|7413446|FG003|Treatment Phase|Non-GCP Compliant|3
4574424|NCT01390844|7413443|FG000|Follow-Up Phase|Non-Medical Reasons|1
4574425|NCT01390844|7413444|FG001|Follow-Up Phase|Non-Medical Reasons|1
4574426|NCT01390844|7413445|FG002|Follow-Up Phase|Non-Medical Reasons|1
4574427|NCT01390844|7413446|FG003|Follow-Up Phase|Non-Medical Reasons|0
4574428|NCT01390857|7413456|FG000|Overall Study|Protocol Violation|2
4574429|NCT01390857|7413456|FG000|Overall Study|Lost to Follow-up|1
4574430|NCT01390857|7413456|FG000|Overall Study|No Visit after the First Visit|7
4574431|NCT01390948|7413496|FG000|Overall Study|End of Study|1
4574432|NCT01390948|7413497|FG001|Overall Study|End of Study|0
4574433|NCT01390948|7413498|FG002|Overall Study|End of Study|0
4574434|NCT01390948|7413496|FG000|Overall Study|Withdrew consent|2
4574435|NCT01390948|7413497|FG001|Overall Study|Withdrew consent|2
4574436|NCT01390948|7413498|FG002|Overall Study|Withdrew consent|0
4574437|NCT01390948|7413496|FG000|Overall Study|Progressive Disease|2
4574438|NCT01390948|7413497|FG001|Overall Study|Progressive Disease|5
4574439|NCT01390948|7413498|FG002|Overall Study|Progressive Disease|0
4574440|NCT01390948|7413496|FG000|Overall Study|Death during follow-up|10
4574441|NCT01390948|7413497|FG001|Overall Study|Death during follow-up|11
4574442|NCT01390948|7413498|FG002|Overall Study|Death during follow-up|1
4574443|NCT01391000|7413507|FG000|Overall Study|Lost to Follow-up|2
4574444|NCT01391000|7413508|FG001|Overall Study|Lost to Follow-up|0
4574445|NCT01391130|7413525|FG000|Overall Study|Withdrawal by Subject|3
4574446|NCT01391130|7413526|FG001|Overall Study|Withdrawal by Subject|2
4574447|NCT01391130|7413525|FG000|Overall Study|Physician Decision|2
4574448|NCT01391130|7413526|FG001|Overall Study|Physician Decision|3
4574449|NCT01391130|7413525|FG000|Overall Study|Did not Receive Drug|1
4574450|NCT01391130|7413526|FG001|Overall Study|Did not Receive Drug|1
4574451|NCT01391507|7413603|FG000|Overall Study|Death|0
4574452|NCT01391507|7413604|FG001|Overall Study|Death|0
4574453|NCT01391507|7413605|FG002|Overall Study|Death|0
4574454|NCT01391507|7413606|FG003|Overall Study|Death|1
4574455|NCT01391507|7413603|FG000|Overall Study|Adverse Event|1
4574456|NCT01391507|7413604|FG001|Overall Study|Adverse Event|1
4574457|NCT01391507|7413605|FG002|Overall Study|Adverse Event|2
4574458|NCT01391507|7413606|FG003|Overall Study|Adverse Event|2
4574459|NCT01391507|7413603|FG000|Overall Study|Withdrawal by Subject|1
4574460|NCT01391507|7413604|FG001|Overall Study|Withdrawal by Subject|2
4574461|NCT01391507|7413605|FG002|Overall Study|Withdrawal by Subject|1
4574462|NCT01391507|7413606|FG003|Overall Study|Withdrawal by Subject|1
4574463|NCT01391507|7413603|FG000|Overall Study|Lack of Efficacy|0
4574464|NCT01391507|7413604|FG001|Overall Study|Lack of Efficacy|0
4574465|NCT01391507|7413605|FG002|Overall Study|Lack of Efficacy|0
4574466|NCT01391507|7413606|FG003|Overall Study|Lack of Efficacy|1
4574467|NCT01391507|7413603|FG000|Overall Study|Protocol Violation|2
4574468|NCT01391507|7413604|FG001|Overall Study|Protocol Violation|1
4574469|NCT01391507|7413605|FG002|Overall Study|Protocol Violation|1
4574470|NCT01391507|7413606|FG003|Overall Study|Protocol Violation|2
4574471|NCT01391546|7413618|FG000|Overall Study|History of Herpes Zoster (HZ)|1
4574472|NCT01391546|7413619|FG001|Overall Study|History of Herpes Zoster (HZ)|0
4574473|NCT01391663|7413641|FG000|Overall Study|Withdrawal by Subject|0
4574474|NCT01391663|7413642|FG001|Overall Study|Withdrawal by Subject|0
4574475|NCT01391663|7413643|FG002|Overall Study|Withdrawal by Subject|1
4574476|NCT01391663|7413644|FG003|Overall Study|Withdrawal by Subject|0
4574477|NCT01391793|7413656|FG000|Overall Study|Ineligible|3
4574478|NCT01391793|7413657|FG001|Overall Study|Ineligible|0
4574479|NCT01391793|7413656|FG000|Overall Study|Urine Culture Negative or Indeterminate|71
4574480|NCT01391793|7413657|FG001|Overall Study|Urine Culture Negative or Indeterminate|87
4574481|NCT01391793|7413656|FG000|Overall Study|No DMSA|73
4574482|NCT01391793|7413657|FG001|Overall Study|No DMSA|57
4574483|NCT01391819|7413663|FG000|Overall Study|Withdrawal by Subject|56
4574484|NCT01391819|7413663|FG000|Overall Study|Migrated/moved from study area|82
4574485|NCT01391819|7413663|FG000|Overall Study|Lost to Follow-up|252
4574486|NCT01391819|7413663|FG000|Overall Study|Death|3
4574487|NCT01391819|7413663|FG000|Overall Study|Other|9
4574488|NCT01391832|7413672|FG000|Overall Study|Withdrawal by Subject|21
4574489|NCT01391832|7413673|FG001|Overall Study|Withdrawal by Subject|22
4574490|NCT01391832|7413672|FG000|Overall Study|Lost to Follow-up|0
4574491|NCT01391832|7413673|FG001|Overall Study|Lost to Follow-up|1
4574492|NCT01392183|7413699|FG000|First Drug Administration|Adverse Event|3
4574493|NCT01392183|7413700|FG001|First Drug Administration|Adverse Event|2
4574494|NCT01392183|7413699|FG000|First Drug Administration|Death|1
4574495|NCT01392183|7413700|FG001|First Drug Administration|Death|0
4574496|NCT01392183|7413699|FG000|First Drug Administration|Withdrawal by Subject|10
4574497|NCT01392183|7413700|FG001|First Drug Administration|Withdrawal by Subject|17
4574498|NCT01392300|7413710|FG000|Main Period (MP)|Predefined discontinuation criteria|2
4574499|NCT01392300|7413711|FG001|Main Period (MP)|Predefined discontinuation criteria|3
4574500|NCT01392300|7413712|FG002|Main Period (MP)|Predefined discontinuation criteria|0
4574501|NCT01392300|7413710|FG000|Main Period (MP)|Withdrawal by Subject|5
4574502|NCT01392300|7413711|FG001|Main Period (MP)|Withdrawal by Subject|1
4574503|NCT01392300|7413712|FG002|Main Period (MP)|Withdrawal by Subject|0
4574504|NCT01392300|7413710|FG000|Main Period (MP)|Lost to Follow-up|3
4574505|NCT01392300|7413711|FG001|Main Period (MP)|Lost to Follow-up|3
4574506|NCT01392300|7413712|FG002|Main Period (MP)|Lost to Follow-up|0
4574507|NCT01392300|7413710|FG000|Main Period (MP)|Non-compliance|1
4574508|NCT01392300|7413711|FG001|Main Period (MP)|Non-compliance|0
4574509|NCT01392300|7413712|FG002|Main Period (MP)|Non-compliance|0
4574510|NCT01392300|7413710|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0
4574511|NCT01392300|7413711|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0
4574512|NCT01392300|7413712|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13
4574513|NCT01392300|7413710|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0
4574514|NCT01392300|7413711|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0
4574515|NCT01392300|7413712|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3
4574516|NCT01392300|7413710|FG000|Open Label Extension (OLEX) Period|Non-compliance|0
4574517|NCT01392300|7413711|FG001|Open Label Extension (OLEX) Period|Non-compliance|0
4574518|NCT01392300|7413712|FG002|Open Label Extension (OLEX) Period|Non-compliance|1
4574519|NCT01392300|7413710|FG000|Open Label Extension (OLEX) Period|Death|0
4574520|NCT01392300|7413711|FG001|Open Label Extension (OLEX) Period|Death|0
4574521|NCT01392300|7413712|FG002|Open Label Extension (OLEX) Period|Death|4
4574522|NCT01392300|7413710|FG000|Open Label Extension (OLEX) Period|Adverse Event|0
4574523|NCT01392300|7413711|FG001|Open Label Extension (OLEX) Period|Adverse Event|0
4574524|NCT01392300|7413712|FG002|Open Label Extension (OLEX) Period|Adverse Event|7
4574525|NCT01392300|7413710|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0
4574526|NCT01392300|7413711|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0
4574527|NCT01392300|7413712|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17
4574528|NCT01392300|7413710|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0
4574529|NCT01392300|7413711|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0
4574530|NCT01392300|7413712|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6
4574531|NCT01392326|7413722|FG000|Overall Study|Death|2
4574532|NCT01392326|7413723|FG001|Overall Study|Death|0
4574533|NCT01392326|7413724|FG002|Overall Study|Death|0
4574534|NCT01392326|7413722|FG000|Overall Study|Withdrawal by Subject|12
4574535|NCT01392326|7413723|FG001|Overall Study|Withdrawal by Subject|11
4574536|NCT01392326|7413724|FG002|Overall Study|Withdrawal by Subject|15
4574537|NCT01392326|7413722|FG000|Overall Study|Protocol Violation|2
4574538|NCT01392326|7413723|FG001|Overall Study|Protocol Violation|0
4574539|NCT01392326|7413724|FG002|Overall Study|Protocol Violation|0
4574540|NCT01392326|7413722|FG000|Overall Study|Pregnancy|0
4574541|NCT01392326|7413723|FG001|Overall Study|Pregnancy|0
4574542|NCT01392326|7413724|FG002|Overall Study|Pregnancy|1
4574543|NCT01392326|7413722|FG000|Overall Study|Physician Decision|7
4574544|NCT01392326|7413723|FG001|Overall Study|Physician Decision|5
4574545|NCT01392326|7413724|FG002|Overall Study|Physician Decision|2
4574546|NCT01392326|7413722|FG000|Overall Study|Lost to Follow-up|1
4574547|NCT01392326|7413723|FG001|Overall Study|Lost to Follow-up|3
4574548|NCT01392326|7413724|FG002|Overall Study|Lost to Follow-up|4
4574549|NCT01392326|7413722|FG000|Overall Study|Lack of Efficacy|14
4574550|NCT01392326|7413723|FG001|Overall Study|Lack of Efficacy|10
4574551|NCT01392326|7413724|FG002|Overall Study|Lack of Efficacy|15
4574552|NCT01392326|7413722|FG000|Overall Study|Adverse Event|9
4574553|NCT01392326|7413723|FG001|Overall Study|Adverse Event|6
4574554|NCT01392326|7413724|FG002|Overall Study|Adverse Event|11
4574555|NCT01392378|7413737|FG000|Infant Series|Adverse Event|0
4574556|NCT01392378|7413738|FG001|Infant Series|Adverse Event|0
4574557|NCT01392378|7413739|FG002|Infant Series|Adverse Event|0
4574558|NCT01392378|7413740|FG003|Infant Series|Adverse Event|1
4574559|NCT01392378|7413741|FG004|Infant Series|Adverse Event|0
4574560|NCT01392378|7413737|FG000|Infant Series|Lost to Follow-up|0
4574561|NCT01392378|7413738|FG001|Infant Series|Lost to Follow-up|0
4574562|NCT01392378|7413739|FG002|Infant Series|Lost to Follow-up|0
4574563|NCT01392378|7413740|FG003|Infant Series|Lost to Follow-up|1
4574564|NCT01392378|7413741|FG004|Infant Series|Lost to Follow-up|0
4574565|NCT01392378|7413737|FG000|Infant Series|Protocol Violation|0
4574566|NCT01392378|7413738|FG001|Infant Series|Protocol Violation|1
4574567|NCT01392378|7413739|FG002|Infant Series|Protocol Violation|0
4574568|NCT01392378|7413740|FG003|Infant Series|Protocol Violation|0
4574569|NCT01392378|7413741|FG004|Infant Series|Protocol Violation|0
4574570|NCT01392378|7413737|FG000|Infant Series|Withdrawal by Parent|4
4574571|NCT01392378|7413738|FG001|Infant Series|Withdrawal by Parent|1
4574572|NCT01392378|7413739|FG002|Infant Series|Withdrawal by Parent|0
4574573|NCT01392378|7413740|FG003|Infant Series|Withdrawal by Parent|0
4574574|NCT01392378|7413741|FG004|Infant Series|Withdrawal by Parent|0
4574575|NCT01392378|7413737|FG000|After Infant Series|Lost to Follow-up|0
4574576|NCT01392378|7413738|FG001|After Infant Series|Lost to Follow-up|0
4574577|NCT01392378|7413739|FG002|After Infant Series|Lost to Follow-up|1
4574578|NCT01392378|7413740|FG003|After Infant Series|Lost to Follow-up|0
4574579|NCT01392378|7413741|FG004|After Infant Series|Lost to Follow-up|0
4574580|NCT01392378|7413737|FG000|After Infant Series|Withdrawal by Parent|0
4574581|NCT01392378|7413738|FG001|After Infant Series|Withdrawal by Parent|1
4574582|NCT01392378|7413739|FG002|After Infant Series|Withdrawal by Parent|1
4574583|NCT01392378|7413740|FG003|After Infant Series|Withdrawal by Parent|0
4574584|NCT01392378|7413741|FG004|After Infant Series|Withdrawal by Parent|1
4574585|NCT01392378|7413737|FG000|Toddler Dose|Lost to Follow-up|0
4574586|NCT01392378|7413738|FG001|Toddler Dose|Lost to Follow-up|0
4574587|NCT01392378|7413739|FG002|Toddler Dose|Lost to Follow-up|0
4574588|NCT01392378|7413740|FG003|Toddler Dose|Lost to Follow-up|1
4574589|NCT01392378|7413741|FG004|Toddler Dose|Lost to Follow-up|0
4574590|NCT01392378|7413737|FG000|Toddler Dose|Withdrawal by Parent|0
4574591|NCT01392378|7413738|FG001|Toddler Dose|Withdrawal by Parent|1
4574592|NCT01392378|7413739|FG002|Toddler Dose|Withdrawal by Parent|0
4574593|NCT01392378|7413740|FG003|Toddler Dose|Withdrawal by Parent|1
4574594|NCT01392378|7413741|FG004|Toddler Dose|Withdrawal by Parent|1
4574595|NCT01392443|7413763|FG000|Overall Study|Disease progression|30
4574596|NCT01392443|7413763|FG000|Overall Study|Adverse Event|24
4574597|NCT01392443|7413763|FG000|Overall Study|Death|7
4574598|NCT01392443|7413763|FG000|Overall Study|Withdrawal by Subject|5
4574599|NCT01392443|7413763|FG000|Overall Study|Lost to Follow-up|1
4574600|NCT01392443|7413763|FG000|Overall Study|Protocol Violation|1
4574601|NCT01392469|7413767|FG000|Overall Study|Adverse Event|2
4574602|NCT01392469|7413767|FG000|Overall Study|Withdrawal by Subject|1
4574603|NCT01392469|7413767|FG000|Overall Study|Protocol Violation|1
4574604|NCT01392495|7413782|FG000|Overall Study|Death|3
4574605|NCT01392495|7413782|FG000|Overall Study|Administrative problems|8
4574606|NCT01392495|7413782|FG000|Overall Study|Withdrawal by Subject|2
4574607|NCT01392495|7413782|FG000|Overall Study|Adverse Event|3
4574608|NCT01392547|7413788|FG000|Overall Study|Adverse Event|2
4574609|NCT01392547|7413788|FG000|Overall Study|Non-compliance|2
4574610|NCT01392547|7413788|FG000|Overall Study|Withdrawal criteria|3
4574611|NCT01392547|7413788|FG000|Overall Study|Unclassified|1
4574612|NCT01392560|7413794|FG000|Overall Study|Adverse Event|2
4574613|NCT01392560|7413794|FG000|Overall Study|not entered|8
4574614|NCT01392560|7413794|FG000|Overall Study|discontinued during placebo run-in|2
4574615|NCT01392573|7413802|FG000|Overall Study|Adverse Event|1
4574616|NCT01392573|7413803|FG001|Overall Study|Adverse Event|3
4574617|NCT01392573|7413802|FG000|Overall Study|Lack of Efficacy|1
4574618|NCT01392573|7413803|FG001|Overall Study|Lack of Efficacy|2
4574619|NCT01392573|7413802|FG000|Overall Study|Protocol Violation|0
4574620|NCT01392573|7413803|FG001|Overall Study|Protocol Violation|2
4574621|NCT01392573|7413802|FG000|Overall Study|Withdrawal Criteria|13
4574622|NCT01392573|7413803|FG001|Overall Study|Withdrawal Criteria|15
4574623|NCT01392573|7413802|FG000|Overall Study|Site closure|8
4574624|NCT01392573|7413803|FG001|Overall Study|Site closure|7
4574625|NCT01392573|7413802|FG000|Overall Study|Unclassified|9
4574626|NCT01392573|7413803|FG001|Overall Study|Unclassified|6
4574627|NCT01392677|7413820|FG000|Overall Study|Adverse Event|3
4574628|NCT01392677|7413821|FG001|Overall Study|Adverse Event|1
4574629|NCT01392677|7413820|FG000|Overall Study|Withdrawal by Subject|0
4574630|NCT01392677|7413821|FG001|Overall Study|Withdrawal by Subject|2
4574631|NCT01392677|7413820|FG000|Overall Study|Incorrect enrollment|2
4574632|NCT01392677|7413821|FG001|Overall Study|Incorrect enrollment|3
4574633|NCT01392677|7413820|FG000|Overall Study|Other reason|3
4574634|NCT01392677|7413821|FG001|Overall Study|Other reason|2
4574635|NCT01392742|7413839|FG000|Overall Study|Premature study termination|42
4574636|NCT01392742|7413839|FG000|Overall Study|Failure to return|35
4574637|NCT01392742|7413839|FG000|Overall Study|No treatment/no cooperation/withdrew|12
4574638|NCT01392742|7413839|FG000|Overall Study|Lost to Follow-up|34
4574639|NCT01392742|7413839|FG000|Overall Study|Insufficient therapeutic response (ITR)|30
4574640|NCT01392742|7413839|FG000|Overall Study|ITR and Protocol deviation|1
4574641|NCT01392742|7413839|FG000|Overall Study|Adverse event/intercurrent illness|17
4574642|NCT01392742|7413839|FG000|Overall Study|Protocol Violation|14
4574643|NCT01392742|7413839|FG000|Overall Study|Other|3
4574644|NCT01392742|7413839|FG000|Overall Study|Missing information|13
4574645|NCT01392963|7413853|FG000|Week 0 (First Intervention)|Lost to Follow-up|0
4574646|NCT01392963|7413854|FG001|Week 0 (First Intervention)|Lost to Follow-up|1
4574647|NCT01392963|7413853|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0
4574648|NCT01392963|7413854|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1
4574649|NCT01392963|7413853|FG000|Week 24 Follow-up|Lost to Follow-up|2
4574650|NCT01392963|7413854|FG001|Week 24 Follow-up|Lost to Follow-up|0
4574651|NCT01393106|7413867|FG000|Overall Study|Adverse Event|3
4574652|NCT01393106|7413867|FG000|Overall Study|Withdrawal by Subject|1
4574653|NCT01393106|7413867|FG000|Overall Study|Lack of Efficacy|1
4574654|NCT01393158|7413884|FG000|Overall Study|Adverse Event|1
4574655|NCT01393158|7413885|FG001|Overall Study|Adverse Event|0
4574656|NCT01393301|7413899|FG000|Overall Study|Lost to Follow-up|5
4574657|NCT01393301|7413900|FG001|Overall Study|Lost to Follow-up|3
4574658|NCT01393301|7413899|FG000|Overall Study|Withdrawal by Subject|2
4574659|NCT01393301|7413900|FG001|Overall Study|Withdrawal by Subject|0
4574660|NCT01393301|7413899|FG000|Overall Study|Completed <7 sessions (intervention)|2
4574661|NCT01393301|7413900|FG001|Overall Study|Completed <7 sessions (intervention)|0
4592944|NCT01545076|7440796|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
4592945|NCT01545076|7440797|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
4592946|NCT01545076|7440798|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
4592947|NCT01545076|7440799|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
4592948|NCT01545076|7440795|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7
4592949|NCT01545076|7440796|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0
4592950|NCT01545076|7440797|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0
4592951|NCT01545076|7440798|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0
4592952|NCT01545076|7440799|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0
4592953|NCT01545076|7440795|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
4592954|NCT01545076|7440796|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
4592955|NCT01545076|7440797|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
4592956|NCT01545076|7440798|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1
4592957|NCT01545076|7440799|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
4592958|NCT01545076|7440795|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0
4592959|NCT01545076|7440796|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10
4592960|NCT01545076|7440797|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18
4592961|NCT01545076|7440798|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32
4592962|NCT01545076|7440799|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0
4592963|NCT01545076|7440795|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0
4592964|NCT01545076|7440796|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1
4592965|NCT01545076|7440797|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1
4592966|NCT01545076|7440798|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0
4592967|NCT01545076|7440799|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0
4592968|NCT01545076|7440795|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0
4592969|NCT01545076|7440796|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8
4592970|NCT01545076|7440797|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2
4592971|NCT01545076|7440798|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3
4592972|NCT01545076|7440799|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0
4592973|NCT01545375|7440861|FG000|Overall Study|Adverse Event|2
4592974|NCT01545375|7440862|FG001|Overall Study|Adverse Event|1
4592975|NCT01545375|7440861|FG000|Overall Study|Lost to Follow-up|34
4592976|NCT01545375|7440862|FG001|Overall Study|Lost to Follow-up|31
4592977|NCT01545375|7440861|FG000|Overall Study|Protocol Violation|3
4592978|NCT01545375|7440862|FG001|Overall Study|Protocol Violation|3
4592979|NCT01545375|7440861|FG000|Overall Study|Withdrawal by Subject|58
4592980|NCT01545375|7440862|FG001|Overall Study|Withdrawal by Subject|55
4592981|NCT01545388|7440871|FG000|Overall Study|Adverse Event|2
4592982|NCT01545388|7440872|FG001|Overall Study|Adverse Event|4
4592983|NCT01545388|7440873|FG002|Overall Study|Adverse Event|1
4592984|NCT01545388|7440871|FG000|Overall Study|Lack of Efficacy|3
4574662|NCT01393405|7413915|FG000|Induction Period (week1-16)|Lack of Efficacy|70
4574663|NCT01393405|7413916|FG001|Induction Period (week1-16)|Lack of Efficacy|0
4574664|NCT01393405|7413917|FG002|Induction Period (week1-16)|Lack of Efficacy|0
4574665|NCT01393405|7413915|FG000|Induction Period (week1-16)|Adverse Event|16
4574666|NCT01393405|7413916|FG001|Induction Period (week1-16)|Adverse Event|0
4574667|NCT01393405|7413917|FG002|Induction Period (week1-16)|Adverse Event|0
4574668|NCT01393405|7413915|FG000|Induction Period (week1-16)|Withdrawal by Subject|9
4574669|NCT01393405|7413916|FG001|Induction Period (week1-16)|Withdrawal by Subject|0
4574670|NCT01393405|7413917|FG002|Induction Period (week1-16)|Withdrawal by Subject|0
4574671|NCT01393405|7413915|FG000|Maintenance Period Week|Lack of Efficacy|0
4574672|NCT01393405|7413916|FG001|Maintenance Period Week|Lack of Efficacy|22
4574673|NCT01393405|7413917|FG002|Maintenance Period Week|Lack of Efficacy|22
4574674|NCT01393405|7413915|FG000|Maintenance Period Week|Adverse Event|0
4574675|NCT01393405|7413916|FG001|Maintenance Period Week|Adverse Event|5
4574676|NCT01393405|7413917|FG002|Maintenance Period Week|Adverse Event|2
4574677|NCT01393405|7413915|FG000|Maintenance Period Week|Withdrawal by Subject|0
4574678|NCT01393405|7413916|FG001|Maintenance Period Week|Withdrawal by Subject|1
4574679|NCT01393405|7413917|FG002|Maintenance Period Week|Withdrawal by Subject|0
4574680|NCT01393405|7413915|FG000|Maintenance Period Week|Lost to Follow-up|0
4574681|NCT01393405|7413916|FG001|Maintenance Period Week|Lost to Follow-up|1
4574682|NCT01393405|7413917|FG002|Maintenance Period Week|Lost to Follow-up|0
4574683|NCT01393444|7413927|FG000|Overall Study|Withdrawal by Subject|1
4574684|NCT01393444|7413927|FG000|Overall Study|Determined ineligible during screening.|2
4574685|NCT01393600|7413948|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
4574686|NCT01393600|7413949|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1
4574687|NCT01393600|7413950|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
4574688|NCT01393600|7413951|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
4574689|NCT01393600|7413948|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
4574690|NCT01393600|7413949|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
4574691|NCT01393600|7413950|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1
4574692|NCT01393600|7413951|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
4574693|NCT01393600|7413948|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
4574694|NCT01393600|7413949|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
4574695|NCT01393600|7413950|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
4574696|NCT01393600|7413951|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1
4574697|NCT01393600|7413948|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
4574698|NCT01393600|7413949|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
4574699|NCT01393600|7413950|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
4574700|NCT01393600|7413951|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1
4574701|NCT01393600|7413948|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
4574702|NCT01393600|7413949|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
4574703|NCT01393600|7413950|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1
4574704|NCT01393600|7413951|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
4574705|NCT01393600|7413948|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
4574706|NCT01393600|7413949|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
4574707|NCT01393600|7413950|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1
4574708|NCT01393600|7413951|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
4574709|NCT01393600|7413948|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
4574710|NCT01393600|7413949|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
4574711|NCT01393600|7413950|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1
4574712|NCT01393600|7413951|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
4574713|NCT01393613|7413967|FG000|Overall Study|Adverse Event|11
4574714|NCT01393613|7413968|FG001|Overall Study|Adverse Event|11
4574715|NCT01393613|7413969|FG002|Overall Study|Adverse Event|13
4574716|NCT01393613|7413970|FG003|Overall Study|Adverse Event|22
4574717|NCT01393613|7413967|FG000|Overall Study|Participant Met Withdrawal Criteria|0
4574718|NCT01393613|7413968|FG001|Overall Study|Participant Met Withdrawal Criteria|0
4574719|NCT01393613|7413969|FG002|Overall Study|Participant Met Withdrawal Criteria|2
4574720|NCT01393613|7413970|FG003|Overall Study|Participant Met Withdrawal Criteria|1
4574721|NCT01393613|7413967|FG000|Overall Study|Physician Decision|2
4574722|NCT01393613|7413968|FG001|Overall Study|Physician Decision|0
4574723|NCT01393613|7413969|FG002|Overall Study|Physician Decision|0
4574724|NCT01393613|7413970|FG003|Overall Study|Physician Decision|1
4574725|NCT01393613|7413967|FG000|Overall Study|Withdrawal by Subject|15
4574726|NCT01393613|7413968|FG001|Overall Study|Withdrawal by Subject|25
4574727|NCT01393613|7413969|FG002|Overall Study|Withdrawal by Subject|23
4574728|NCT01393613|7413970|FG003|Overall Study|Withdrawal by Subject|21
4574729|NCT01393613|7413967|FG000|Overall Study|Protocol Deviation|2
4574730|NCT01393613|7413968|FG001|Overall Study|Protocol Deviation|1
4574731|NCT01393613|7413969|FG002|Overall Study|Protocol Deviation|0
4574732|NCT01393613|7413970|FG003|Overall Study|Protocol Deviation|0
4574733|NCT01393613|7413967|FG000|Overall Study|Lack of Efficacy|9
4574734|NCT01393613|7413968|FG001|Overall Study|Lack of Efficacy|20
4574735|NCT01393613|7413969|FG002|Overall Study|Lack of Efficacy|16
4574736|NCT01393613|7413970|FG003|Overall Study|Lack of Efficacy|21
4574737|NCT01393626|7413986|FG000|Overall Study|Adverse Event|2
4574738|NCT01393626|7413987|FG001|Overall Study|Adverse Event|1
4574739|NCT01393626|7413988|FG002|Overall Study|Adverse Event|5
4574740|NCT01393626|7413989|FG003|Overall Study|Adverse Event|0
4574741|NCT01393626|7413986|FG000|Overall Study|Did not meet entrance criteria|1
4574742|NCT01393626|7413987|FG001|Overall Study|Did not meet entrance criteria|0
4574743|NCT01393626|7413988|FG002|Overall Study|Did not meet entrance criteria|0
4574744|NCT01393626|7413989|FG003|Overall Study|Did not meet entrance criteria|0
4574745|NCT01393626|7413986|FG000|Overall Study|Lack of Efficacy|6
4574746|NCT01393626|7413987|FG001|Overall Study|Lack of Efficacy|6
4574747|NCT01393626|7413988|FG002|Overall Study|Lack of Efficacy|4
4574748|NCT01393626|7413989|FG003|Overall Study|Lack of Efficacy|1
4574749|NCT01393626|7413986|FG000|Overall Study|Lost to Follow-up|1
4574750|NCT01393626|7413987|FG001|Overall Study|Lost to Follow-up|1
4574751|NCT01393626|7413988|FG002|Overall Study|Lost to Follow-up|1
4574752|NCT01393626|7413989|FG003|Overall Study|Lost to Follow-up|0
4574753|NCT01393626|7413986|FG000|Overall Study|Withdrawal by Subject|6
4574754|NCT01393626|7413987|FG001|Overall Study|Withdrawal by Subject|4
4574755|NCT01393626|7413988|FG002|Overall Study|Withdrawal by Subject|0
4574756|NCT01393626|7413989|FG003|Overall Study|Withdrawal by Subject|0
4574757|NCT01393626|7413986|FG000|Overall Study|Other|1
4574758|NCT01393626|7413987|FG001|Overall Study|Other|0
4574759|NCT01393626|7413988|FG002|Overall Study|Other|0
4574760|NCT01393626|7413989|FG003|Overall Study|Other|0
4574761|NCT01393626|7413986|FG000|Overall Study|Protocol Violation|1
4574762|NCT01393626|7413987|FG001|Overall Study|Protocol Violation|0
4574763|NCT01393626|7413988|FG002|Overall Study|Protocol Violation|2
4574764|NCT01393626|7413989|FG003|Overall Study|Protocol Violation|0
4574765|NCT01393730|7414026|FG000|Overall Study|Withdrawal by Subject|3
4574766|NCT01393730|7414026|FG000|Overall Study|Other|2
4574767|NCT01393730|7414026|FG000|Overall Study|Adverse Event|1
4574768|NCT01393743|7414032|FG000|Core Study|Adverse Event|5
4574769|NCT01393743|7414033|FG001|Core Study|Adverse Event|9
4574770|NCT01393743|7414034|FG002|Core Study|Adverse Event|0
4574771|NCT01393743|7414032|FG000|Core Study|Lost to Follow-up|1
4574772|NCT01393743|7414033|FG001|Core Study|Lost to Follow-up|1
4574773|NCT01393743|7414034|FG002|Core Study|Lost to Follow-up|0
4574774|NCT01393743|7414032|FG000|Core Study|Participant's Choice|2
4574775|NCT01393743|7414033|FG001|Core Study|Participant's Choice|3
4574776|NCT01393743|7414034|FG002|Core Study|Participant's Choice|0
4574777|NCT01393743|7414032|FG000|Core Study|Inadequate therapeutic effect|2
4574778|NCT01393743|7414033|FG001|Core Study|Inadequate therapeutic effect|0
4574779|NCT01393743|7414034|FG002|Core Study|Inadequate therapeutic effect|0
4574780|NCT01393743|7414032|FG000|Extension Phase|Adverse Event|0
4574781|NCT01393743|7414033|FG001|Extension Phase|Adverse Event|0
4574782|NCT01393743|7414034|FG002|Extension Phase|Adverse Event|12
4574783|NCT01393743|7414032|FG000|Extension Phase|Lost to Follow-up|0
4574784|NCT01393743|7414033|FG001|Extension Phase|Lost to Follow-up|0
4574785|NCT01393743|7414034|FG002|Extension Phase|Lost to Follow-up|2
4574786|NCT01393743|7414032|FG000|Extension Phase|Participant choice|0
4574787|NCT01393743|7414033|FG001|Extension Phase|Participant choice|0
4574788|NCT01393743|7414034|FG002|Extension Phase|Participant choice|16
4574789|NCT01393743|7414032|FG000|Extension Phase|Inadequate therapeutic effect|0
4574790|NCT01393743|7414033|FG001|Extension Phase|Inadequate therapeutic effect|0
4574791|NCT01393743|7414034|FG002|Extension Phase|Inadequate therapeutic effect|7
4574792|NCT01393743|7414032|FG000|Extension Phase|Withdrawal by Subject|0
4574793|NCT01393743|7414033|FG001|Extension Phase|Withdrawal by Subject|0
4574794|NCT01393743|7414034|FG002|Extension Phase|Withdrawal by Subject|8
4574795|NCT01393743|7414032|FG000|Extension Phase|Pregnancy|0
4574796|NCT01393743|7414033|FG001|Extension Phase|Pregnancy|0
4574797|NCT01393743|7414034|FG002|Extension Phase|Pregnancy|1
4574798|NCT01393743|7414032|FG000|Extension Phase|Other|0
4574799|NCT01393743|7414033|FG001|Extension Phase|Other|0
4574800|NCT01393743|7414034|FG002|Extension Phase|Other|14
4574801|NCT01393821|7414047|FG000|Overall Study|Cancel|1
4574802|NCT01393821|7414048|FG001|Overall Study|Cancel|1
4574803|NCT01393821|7414047|FG000|Overall Study|not evaluable for primary endpoint|4
4574804|NCT01393821|7414048|FG001|Overall Study|not evaluable for primary endpoint|2
4574805|NCT01393899|7414057|FG000|Overall Study|Study terminated by sponsor|1
4574806|NCT01393899|7414058|FG001|Overall Study|Study terminated by sponsor|0
4574807|NCT01393899|7414059|FG002|Overall Study|Study terminated by sponsor|1
4574808|NCT01393899|7414057|FG000|Overall Study|Other|1
4574809|NCT01393899|7414058|FG001|Overall Study|Other|0
4574810|NCT01393899|7414059|FG002|Overall Study|Other|0
4574811|NCT01393899|7414057|FG000|Overall Study|Withdrawal by Subject|2
4574812|NCT01393899|7414058|FG001|Overall Study|Withdrawal by Subject|2
4574813|NCT01393899|7414059|FG002|Overall Study|Withdrawal by Subject|1
4574814|NCT01393899|7414057|FG000|Overall Study|Lost to Follow-up|0
4574815|NCT01393899|7414058|FG001|Overall Study|Lost to Follow-up|0
4574816|NCT01393899|7414059|FG002|Overall Study|Lost to Follow-up|1
4574817|NCT01393899|7414057|FG000|Overall Study|Does not meet entrance criteria|1
4574818|NCT01393899|7414058|FG001|Overall Study|Does not meet entrance criteria|0
4574819|NCT01393899|7414059|FG002|Overall Study|Does not meet entrance criteria|1
4574820|NCT01393899|7414057|FG000|Overall Study|Lack of Efficacy|26
4574821|NCT01393899|7414058|FG001|Overall Study|Lack of Efficacy|21
4574822|NCT01393899|7414059|FG002|Overall Study|Lack of Efficacy|16
4574823|NCT01393899|7414057|FG000|Overall Study|Adverse Event|1
4574824|NCT01393899|7414058|FG001|Overall Study|Adverse Event|5
4574825|NCT01393899|7414059|FG002|Overall Study|Adverse Event|3
4574826|NCT01393964|7414072|FG000|Overall Study|Disease Progression|4
4574827|NCT01393964|7414073|FG001|Overall Study|Disease Progression|3
4574828|NCT01393964|7414074|FG002|Overall Study|Disease Progression|5
4574829|NCT01393964|7414072|FG000|Overall Study|Study drug toxicity|1
4574830|NCT01393964|7414073|FG001|Overall Study|Study drug toxicity|0
4574831|NCT01393964|7414074|FG002|Overall Study|Study drug toxicity|0
4574832|NCT01393964|7414072|FG000|Overall Study|Withdrawal by Subject|0
4574833|NCT01393964|7414073|FG001|Overall Study|Withdrawal by Subject|0
4574834|NCT01393964|7414074|FG002|Overall Study|Withdrawal by Subject|1
4574835|NCT01393964|7414072|FG000|Overall Study|Adverse event unrelated to study drug|0
4574836|NCT01393964|7414073|FG001|Overall Study|Adverse event unrelated to study drug|3
4574837|NCT01393964|7414074|FG002|Overall Study|Adverse event unrelated to study drug|0
4574838|NCT01393964|7414072|FG000|Overall Study|Subject request stop study treatment|0
4574839|NCT01393964|7414073|FG001|Overall Study|Subject request stop study treatment|1
4574840|NCT01393964|7414074|FG002|Overall Study|Subject request stop study treatment|0
4574841|NCT01393964|7414072|FG000|Overall Study|Subject decided to move to transplant|1
4574842|NCT01393964|7414073|FG001|Overall Study|Subject decided to move to transplant|0
4574843|NCT01393964|7414074|FG002|Overall Study|Subject decided to move to transplant|0
4574844|NCT01393964|7414072|FG000|Overall Study|Subject switched to commercial supply|1
4574845|NCT01393964|7414073|FG001|Overall Study|Subject switched to commercial supply|0
4574846|NCT01393964|7414074|FG002|Overall Study|Subject switched to commercial supply|2
4574847|NCT01393964|7414072|FG000|Overall Study|Subject plateaued in terms of effect|1
4574848|NCT01393964|7414073|FG001|Overall Study|Subject plateaued in terms of effect|0
4574849|NCT01393964|7414074|FG002|Overall Study|Subject plateaued in terms of effect|0
4574850|NCT01393964|7414072|FG000|Overall Study|Investigator removed subject from study|0
4574851|NCT01393964|7414073|FG001|Overall Study|Investigator removed subject from study|1
4574852|NCT01393964|7414074|FG002|Overall Study|Investigator removed subject from study|0
4574853|NCT01393964|7414072|FG000|Overall Study|Subject converted to roll-over study|0
4574854|NCT01393964|7414073|FG001|Overall Study|Subject converted to roll-over study|1
4574855|NCT01393964|7414074|FG002|Overall Study|Subject converted to roll-over study|0
4574856|NCT01393964|7414072|FG000|Overall Study|Subject to receive non-protocol therapy|0
4574857|NCT01393964|7414073|FG001|Overall Study|Subject to receive non-protocol therapy|0
4574858|NCT01393964|7414074|FG002|Overall Study|Subject to receive non-protocol therapy|1
4574859|NCT01393990|7414106|FG000|Overall Study|Adverse Event|0
4574860|NCT01393990|7414107|FG001|Overall Study|Adverse Event|0
4574861|NCT01393990|7414108|FG002|Overall Study|Adverse Event|0
4574862|NCT01393990|7414109|FG003|Overall Study|Adverse Event|0
4574863|NCT01393990|7414110|FG004|Overall Study|Adverse Event|0
4574864|NCT01393990|7414111|FG005|Overall Study|Adverse Event|0
4574865|NCT01393990|7414112|FG006|Overall Study|Adverse Event|0
4574866|NCT01393990|7414113|FG007|Overall Study|Adverse Event|0
4574867|NCT01393990|7414114|FG008|Overall Study|Adverse Event|0
4574868|NCT01393990|7414115|FG009|Overall Study|Adverse Event|0
4574869|NCT01393990|7414116|FG010|Overall Study|Adverse Event|0
4574870|NCT01393990|7414117|FG011|Overall Study|Adverse Event|0
4574871|NCT01393990|7414118|FG012|Overall Study|Adverse Event|0
4574872|NCT01393990|7414119|FG013|Overall Study|Adverse Event|0
4574873|NCT01393990|7414120|FG014|Overall Study|Adverse Event|1
4574874|NCT01393990|7414121|FG015|Overall Study|Adverse Event|1
4574875|NCT01393990|7414122|FG016|Overall Study|Adverse Event|0
4574876|NCT01393990|7414123|FG017|Overall Study|Adverse Event|0
4574877|NCT01393990|7414106|FG000|Overall Study|Progressive Disease|1
4574878|NCT01393990|7414107|FG001|Overall Study|Progressive Disease|0
4574879|NCT01393990|7414108|FG002|Overall Study|Progressive Disease|0
4574880|NCT01393990|7414109|FG003|Overall Study|Progressive Disease|1
4574881|NCT01393990|7414110|FG004|Overall Study|Progressive Disease|1
4574882|NCT01393990|7414111|FG005|Overall Study|Progressive Disease|1
4574883|NCT01393990|7414112|FG006|Overall Study|Progressive Disease|1
4574884|NCT01393990|7414113|FG007|Overall Study|Progressive Disease|1
4574885|NCT01393990|7414114|FG008|Overall Study|Progressive Disease|3
4574886|NCT01393990|7414115|FG009|Overall Study|Progressive Disease|1
4574887|NCT01393990|7414116|FG010|Overall Study|Progressive Disease|0
4574888|NCT01393990|7414117|FG011|Overall Study|Progressive Disease|0
4574889|NCT01393990|7414118|FG012|Overall Study|Progressive Disease|0
4574890|NCT01393990|7414119|FG013|Overall Study|Progressive Disease|1
4574891|NCT01393990|7414120|FG014|Overall Study|Progressive Disease|6
4574892|NCT01393990|7414121|FG015|Overall Study|Progressive Disease|1
4626331|NCT01839279|7491874|FG001|Overall Study|Withdrawal by Subject|1
4574893|NCT01393990|7414122|FG016|Overall Study|Progressive Disease|0
4574894|NCT01393990|7414123|FG017|Overall Study|Progressive Disease|0
4574895|NCT01393990|7414106|FG000|Overall Study|Death|0
4574896|NCT01393990|7414107|FG001|Overall Study|Death|0
4574897|NCT01393990|7414108|FG002|Overall Study|Death|0
4574898|NCT01393990|7414109|FG003|Overall Study|Death|0
4574899|NCT01393990|7414110|FG004|Overall Study|Death|1
4574900|NCT01393990|7414111|FG005|Overall Study|Death|0
4574901|NCT01393990|7414112|FG006|Overall Study|Death|0
4574902|NCT01393990|7414113|FG007|Overall Study|Death|0
4574903|NCT01393990|7414114|FG008|Overall Study|Death|0
4574904|NCT01393990|7414115|FG009|Overall Study|Death|0
4574905|NCT01393990|7414116|FG010|Overall Study|Death|0
4574906|NCT01393990|7414117|FG011|Overall Study|Death|0
4574907|NCT01393990|7414118|FG012|Overall Study|Death|0
4574908|NCT01393990|7414119|FG013|Overall Study|Death|1
4574909|NCT01393990|7414120|FG014|Overall Study|Death|1
4574910|NCT01393990|7414121|FG015|Overall Study|Death|0
4574911|NCT01393990|7414122|FG016|Overall Study|Death|0
4574912|NCT01393990|7414123|FG017|Overall Study|Death|0
4574913|NCT01393990|7414106|FG000|Overall Study|Withdrawal by Subject|0
4574914|NCT01393990|7414107|FG001|Overall Study|Withdrawal by Subject|0
4574915|NCT01393990|7414108|FG002|Overall Study|Withdrawal by Subject|0
4574916|NCT01393990|7414109|FG003|Overall Study|Withdrawal by Subject|0
4574917|NCT01393990|7414110|FG004|Overall Study|Withdrawal by Subject|0
4574918|NCT01393990|7414111|FG005|Overall Study|Withdrawal by Subject|0
4574919|NCT01393990|7414112|FG006|Overall Study|Withdrawal by Subject|0
4574920|NCT01393990|7414113|FG007|Overall Study|Withdrawal by Subject|0
4574921|NCT01393990|7414114|FG008|Overall Study|Withdrawal by Subject|0
4574922|NCT01393990|7414115|FG009|Overall Study|Withdrawal by Subject|0
4574923|NCT01393990|7414116|FG010|Overall Study|Withdrawal by Subject|0
4574924|NCT01393990|7414117|FG011|Overall Study|Withdrawal by Subject|0
4574925|NCT01393990|7414118|FG012|Overall Study|Withdrawal by Subject|0
4574926|NCT01393990|7414119|FG013|Overall Study|Withdrawal by Subject|0
4574927|NCT01393990|7414120|FG014|Overall Study|Withdrawal by Subject|1
4574928|NCT01393990|7414121|FG015|Overall Study|Withdrawal by Subject|1
4574929|NCT01393990|7414122|FG016|Overall Study|Withdrawal by Subject|0
4574930|NCT01393990|7414123|FG017|Overall Study|Withdrawal by Subject|0
4574931|NCT01394185|7414231|FG000|Overall Study|Withdrawal by Subject|2
4574932|NCT01394185|7414232|FG001|Overall Study|Withdrawal by Subject|0
4574933|NCT01394185|7414233|FG002|Overall Study|Withdrawal by Subject|0
4574934|NCT01394185|7414234|FG003|Overall Study|Withdrawal by Subject|0
4574935|NCT01394185|7414235|FG004|Overall Study|Withdrawal by Subject|1
4574936|NCT01394185|7414236|FG005|Overall Study|Withdrawal by Subject|0
4574937|NCT01394185|7414231|FG000|Overall Study|Change in protocol|3
4574938|NCT01394185|7414232|FG001|Overall Study|Change in protocol|0
4574939|NCT01394185|7414233|FG002|Overall Study|Change in protocol|0
4574940|NCT01394185|7414234|FG003|Overall Study|Change in protocol|0
4574941|NCT01394185|7414235|FG004|Overall Study|Change in protocol|3
4574942|NCT01394185|7414236|FG005|Overall Study|Change in protocol|0
4574943|NCT01394185|7414231|FG000|Overall Study|Protocol Violation|1
4574944|NCT01394185|7414232|FG001|Overall Study|Protocol Violation|0
4574945|NCT01394185|7414233|FG002|Overall Study|Protocol Violation|0
4574946|NCT01394185|7414234|FG003|Overall Study|Protocol Violation|1
4574947|NCT01394185|7414235|FG004|Overall Study|Protocol Violation|0
4574948|NCT01394185|7414236|FG005|Overall Study|Protocol Violation|1
4574949|NCT01394250|7414246|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14
4574950|NCT01394250|7414247|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13
4574951|NCT01394250|7414246|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6
4574952|NCT01394250|7414247|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11
4574953|NCT01394276|7414253|FG000|Overall Study|Related Adverse event (AEs)|15
4574954|NCT01394276|7414253|FG000|Overall Study|Not related AEs|9
4574955|NCT01394276|7414253|FG000|Overall Study|Remission of disease|2
4574956|NCT01394276|7414253|FG000|Overall Study|Insufficient therapeutic effect|17
4574957|NCT01394276|7414253|FG000|Overall Study|Insufficient compliance|9
4574958|NCT01394276|7414253|FG000|Overall Study|Lost to Follow-up|5
4574959|NCT01394276|7414253|FG000|Overall Study|Participant moved to another site|1
4574960|NCT01394276|7414253|FG000|Overall Study|Pregnancy|1
4574961|NCT01394276|7414253|FG000|Overall Study|unavailability of drug at the Hospital|2
4574962|NCT01394276|7414253|FG000|Overall Study|Symptoms of concurrent diseases|1
4574963|NCT01394523|7414269|FG000|Overall Study|Unable to place block|1
4574964|NCT01394523|7414270|FG001|Overall Study|Unable to place block|0
4574965|NCT01394523|7414271|FG002|Overall Study|Unable to place block|0
4574966|NCT01394627|7414288|FG000|First Intervention (1 Day)|poor intravenous access|0
4574967|NCT01394627|7414289|FG001|First Intervention (1 Day)|poor intravenous access|1
4574968|NCT01394627|7414288|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1
4574969|NCT01394627|7414289|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0
4574970|NCT01394718|7414316|FG000|Overall Study|Met protocol-specific stopping criteria|2
4574971|NCT01394718|7414317|FG001|Overall Study|Met protocol-specific stopping criteria|1
4574972|NCT01394939|7414327|FG000|Overall Study|Adverse Event|1
4574973|NCT01394939|7414328|FG001|Overall Study|Adverse Event|3
4574974|NCT01394939|7414329|FG002|Overall Study|Adverse Event|0
4574975|NCT01394939|7414330|FG003|Overall Study|Adverse Event|2
4574976|NCT01394939|7414327|FG000|Overall Study|Death|0
4574977|NCT01394939|7414328|FG001|Overall Study|Death|2
4574978|NCT01394939|7414329|FG002|Overall Study|Death|0
4574979|NCT01394939|7414330|FG003|Overall Study|Death|0
4574980|NCT01394939|7414327|FG000|Overall Study|Physician Decision|0
4574981|NCT01394939|7414328|FG001|Overall Study|Physician Decision|1
4574982|NCT01394939|7414329|FG002|Overall Study|Physician Decision|0
4574983|NCT01394939|7414330|FG003|Overall Study|Physician Decision|0
4574984|NCT01394939|7414327|FG000|Overall Study|Withdrawal by Subject|0
4574985|NCT01394939|7414328|FG001|Overall Study|Withdrawal by Subject|2
4574986|NCT01394939|7414329|FG002|Overall Study|Withdrawal by Subject|0
4574987|NCT01394939|7414330|FG003|Overall Study|Withdrawal by Subject|2
4574988|NCT01394939|7414327|FG000|Overall Study|Others|0
4574989|NCT01394939|7414328|FG001|Overall Study|Others|2
4574990|NCT01394939|7414329|FG002|Overall Study|Others|0
4574991|NCT01394939|7414330|FG003|Overall Study|Others|3
4574992|NCT01394952|7414342|FG000|Overall Study|Lost to Follow-up|0
4574993|NCT01394952|7414343|FG001|Overall Study|Lost to Follow-up|5
4574994|NCT01394952|7414342|FG000|Overall Study|Withdrawal by Subject|10
4574995|NCT01394952|7414343|FG001|Overall Study|Withdrawal by Subject|5
4574996|NCT01394952|7414342|FG000|Overall Study|Physician Decision|2
4574997|NCT01394952|7414343|FG001|Overall Study|Physician Decision|0
4574998|NCT01394952|7414342|FG000|Overall Study|Sponsor Decision|5
4574999|NCT01394952|7414343|FG001|Overall Study|Sponsor Decision|7
4575000|NCT01394978|7414352|FG000|Overall Study|Withdrawal by Subject|2
4575001|NCT01394978|7414353|FG001|Overall Study|Withdrawal by Subject|4
4575002|NCT01394978|7414352|FG000|Overall Study|Lost to Follow-up|13
4575003|NCT01394978|7414353|FG001|Overall Study|Lost to Follow-up|20
4575004|NCT01394978|7414352|FG000|Overall Study|Death|6
4575005|NCT01394978|7414353|FG001|Overall Study|Death|7
4575006|NCT01394991|7414362|FG000|Overall Study|Adverse Event|0
4575007|NCT01394991|7414363|FG001|Overall Study|Adverse Event|4
4575008|NCT01394991|7414362|FG000|Overall Study|Lack of Efficacy|5
4575009|NCT01394991|7414363|FG001|Overall Study|Lack of Efficacy|7
4575010|NCT01394991|7414362|FG000|Overall Study|Lost to Follow-up|6
4575011|NCT01394991|7414363|FG001|Overall Study|Lost to Follow-up|8
4575012|NCT01394991|7414362|FG000|Overall Study|Physician Decision|1
4575013|NCT01394991|7414363|FG001|Overall Study|Physician Decision|3
4575014|NCT01394991|7414362|FG000|Overall Study|Protocol Violation|1
4575015|NCT01394991|7414363|FG001|Overall Study|Protocol Violation|1
4575016|NCT01394991|7414362|FG000|Overall Study|Withdrawal by Subject|20
4575017|NCT01394991|7414363|FG001|Overall Study|Withdrawal by Subject|17
4575018|NCT01394991|7414362|FG000|Overall Study|Chemotherapy Termination|10
4575019|NCT01394991|7414363|FG001|Overall Study|Chemotherapy Termination|15
4575020|NCT01394991|7414362|FG000|Overall Study|Disease Progression|7
4575021|NCT01394991|7414363|FG001|Overall Study|Disease Progression|7
4575022|NCT01394991|7414362|FG000|Overall Study|Prematurely Termination of Trial|9
4575023|NCT01394991|7414363|FG001|Overall Study|Prematurely Termination of Trial|10
4575024|NCT01395017|7414371|FG000|Overall Study|Lost to Follow-up|1
4575025|NCT01395017|7414372|FG001|Overall Study|Lost to Follow-up|0
4575026|NCT01395017|7414371|FG000|Overall Study|Adverse Event|26
4575027|NCT01395017|7414372|FG001|Overall Study|Adverse Event|12
4575028|NCT01395017|7414371|FG000|Overall Study|Physician Decision|11
4575029|NCT01395017|7414372|FG001|Overall Study|Physician Decision|15
4575030|NCT01395017|7414371|FG000|Overall Study|Withdrawal by Subject|14
4575031|NCT01395017|7414372|FG001|Overall Study|Withdrawal by Subject|8
4575032|NCT01395017|7414371|FG000|Overall Study|Protocol deviation|1
4575033|NCT01395017|7414372|FG001|Overall Study|Protocol deviation|2
4575034|NCT01395017|7414371|FG000|Overall Study|Death|4
4575035|NCT01395017|7414372|FG001|Overall Study|Death|3
4575036|NCT01395017|7414371|FG000|Overall Study|Disease progression|42
4575037|NCT01395017|7414372|FG001|Overall Study|Disease progression|58
4575038|NCT01395017|7414371|FG000|Overall Study|Sponsor discontinued study|1
4575039|NCT01395017|7414372|FG001|Overall Study|Sponsor discontinued study|4
4575040|NCT01395030|7414379|FG000|Overall Study|Did not complete FCH PET/CT|7
4575041|NCT01395316|7414401|FG000|Overall Study|Lost to Follow-up|2
4575042|NCT01395316|7414401|FG000|Overall Study|poor MRI quality|1
4575043|NCT01395368|7414421|FG000|Overall Study|Physician Decision|14
4575044|NCT01395368|7414421|FG000|Overall Study|Withdrawal by Subject|2
4575045|NCT01395394|7414428|FG000|Baseline Study Visit|Protocol Violation|1
4575046|NCT01395394|7414429|FG001|Baseline Study Visit|Protocol Violation|0
4575047|NCT01395394|7414430|FG002|Baseline Study Visit|Protocol Violation|0
4575048|NCT01395524|7414441|FG000|Overall Study|Non-compliance with study schedule|1
4575049|NCT01395524|7414442|FG001|Overall Study|Non-compliance with study schedule|0
4575050|NCT01395524|7414443|FG002|Overall Study|Non-compliance with study schedule|1
4575051|NCT01395524|7414441|FG000|Overall Study|Lost to Follow-up|3
4575052|NCT01395524|7414442|FG001|Overall Study|Lost to Follow-up|1
4575053|NCT01395524|7414443|FG002|Overall Study|Lost to Follow-up|1
4575054|NCT01395524|7414441|FG000|Overall Study|Study-Specific Withdrawal Criteria|1
4575055|NCT01395524|7414442|FG001|Overall Study|Study-Specific Withdrawal Criteria|2
4575056|NCT01395524|7414443|FG002|Overall Study|Study-Specific Withdrawal Criteria|0
4575057|NCT01395524|7414441|FG000|Overall Study|Severe noncompliance with protocol|1
4575058|NCT01395524|7414442|FG001|Overall Study|Severe noncompliance with protocol|0
4575059|NCT01395524|7414443|FG002|Overall Study|Severe noncompliance with protocol|0
4575060|NCT01395524|7414441|FG000|Overall Study|Adverse Event|4
4575061|NCT01395524|7414442|FG001|Overall Study|Adverse Event|4
4575062|NCT01395524|7414443|FG002|Overall Study|Adverse Event|3
4575063|NCT01395524|7414441|FG000|Overall Study|Death|1
4575064|NCT01395524|7414442|FG001|Overall Study|Death|0
4575065|NCT01395524|7414443|FG002|Overall Study|Death|0
4575066|NCT01395524|7414441|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2
4575067|NCT01395524|7414442|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0
4575068|NCT01395524|7414443|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0
4575069|NCT01395524|7414441|FG000|Overall Study|Withdrawal by Subject|4
4575070|NCT01395524|7414442|FG001|Overall Study|Withdrawal by Subject|8
4575071|NCT01395524|7414443|FG002|Overall Study|Withdrawal by Subject|8
4575072|NCT01395524|7414441|FG000|Overall Study|Did not receive treatment|1
4575073|NCT01395524|7414442|FG001|Overall Study|Did not receive treatment|1
4575074|NCT01395524|7414443|FG002|Overall Study|Did not receive treatment|3
4575075|NCT01395524|7414441|FG000|Overall Study|Subject had spinal surgery|0
4575076|NCT01395524|7414442|FG001|Overall Study|Subject had spinal surgery|0
4575077|NCT01395524|7414443|FG002|Overall Study|Subject had spinal surgery|1
4575078|NCT01395758|7414457|FG000|Open-label Treatment Period|Withdrawal by Subject|4
4575079|NCT01395758|7414458|FG001|Open-label Treatment Period|Withdrawal by Subject|0
4575080|NCT01395758|7414459|FG002|Open-label Treatment Period|Withdrawal by Subject|0
4575081|NCT01395784|7414466|FG000|Overall Study|Lost to Follow-up|7
4575082|NCT01395784|7414466|FG000|Overall Study|Withdrawal by Subject|3
4575083|NCT01395784|7414466|FG000|Overall Study|Physician Decision|5
4575084|NCT01395810|7414505|FG000|Overall Study|Adverse Event|0
4575085|NCT01395810|7414506|FG001|Overall Study|Adverse Event|1
4575086|NCT01395810|7414507|FG002|Overall Study|Adverse Event|0
4575087|NCT01395810|7414508|FG003|Overall Study|Adverse Event|0
4575088|NCT01395810|7414505|FG000|Overall Study|Lack of Efficacy|0
4575089|NCT01395810|7414506|FG001|Overall Study|Lack of Efficacy|1
4575090|NCT01395810|7414507|FG002|Overall Study|Lack of Efficacy|0
4575091|NCT01395810|7414508|FG003|Overall Study|Lack of Efficacy|0
4575092|NCT01395810|7414505|FG000|Overall Study|Withdrawal criteria|0
4575093|NCT01395810|7414506|FG001|Overall Study|Withdrawal criteria|2
4575094|NCT01395810|7414507|FG002|Overall Study|Withdrawal criteria|0
4575095|NCT01395810|7414508|FG003|Overall Study|Withdrawal criteria|0
4575096|NCT01395810|7414505|FG000|Overall Study|Unclassified|2
4575097|NCT01395810|7414506|FG001|Overall Study|Unclassified|0
4691560|NCT02573467|7601951|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50
4691561|NCT02573467|7601952|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51
4691562|NCT02573467|7601953|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48
4691563|NCT02573467|7601954|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55
4691564|NCT02573467|7601951|FG000|Post-treatment Follow up Epoch|Death|1
4691565|NCT02573467|7601952|FG001|Post-treatment Follow up Epoch|Death|1
4691566|NCT02573467|7601953|FG002|Post-treatment Follow up Epoch|Death|0
4575098|NCT01395810|7414507|FG002|Overall Study|Unclassified|0
4575099|NCT01395810|7414508|FG003|Overall Study|Unclassified|0
4575100|NCT01395823|7414521|FG000|Overall Study|Death|4
4575101|NCT01395823|7414522|FG001|Overall Study|Death|4
4575102|NCT01395823|7414521|FG000|Overall Study|Physician Decision|3
4575103|NCT01395823|7414522|FG001|Overall Study|Physician Decision|1
4575104|NCT01395823|7414521|FG000|Overall Study|Lost to Follow-up|1
4575105|NCT01395823|7414522|FG001|Overall Study|Lost to Follow-up|0
4575106|NCT01395823|7414521|FG000|Overall Study|Transplant|1
4575107|NCT01395823|7414522|FG001|Overall Study|Transplant|0
4575108|NCT01395823|7414521|FG000|Overall Study|GI symptoms|1
4575109|NCT01395823|7414522|FG001|Overall Study|GI symptoms|0
4575110|NCT01395823|7414521|FG000|Overall Study|Withdrawal by Subject|5
4575111|NCT01395823|7414522|FG001|Overall Study|Withdrawal by Subject|4
4575112|NCT01395888|7414530|FG000|2-week Run-in Period|Adverse Event|2
4575113|NCT01395888|7414531|FG001|2-week Run-in Period|Adverse Event|0
4575114|NCT01395888|7414532|FG002|2-week Run-in Period|Adverse Event|0
4575115|NCT01395888|7414530|FG000|2-week Run-in Period|Continuation Criteria Not Met|13
4575116|NCT01395888|7414531|FG001|2-week Run-in Period|Continuation Criteria Not Met|0
4575117|NCT01395888|7414532|FG002|2-week Run-in Period|Continuation Criteria Not Met|0
4575118|NCT01395888|7414530|FG000|2-week Run-in Period|Lost to Follow-up|1
4575119|NCT01395888|7414531|FG001|2-week Run-in Period|Lost to Follow-up|0
4575120|NCT01395888|7414532|FG002|2-week Run-in Period|Lost to Follow-up|0
4575121|NCT01395888|7414530|FG000|2-week Run-in Period|Protocol Violation|2
4575122|NCT01395888|7414531|FG001|2-week Run-in Period|Protocol Violation|0
4575123|NCT01395888|7414532|FG002|2-week Run-in Period|Protocol Violation|0
4575124|NCT01395888|7414530|FG000|2-week Run-in Period|Withdrawal by Subject|4
4575125|NCT01395888|7414531|FG001|2-week Run-in Period|Withdrawal by Subject|0
4575126|NCT01395888|7414532|FG002|2-week Run-in Period|Withdrawal by Subject|0
4575127|NCT01395888|7414530|FG000|Treatment Period (TP)|Adverse Event|0
4575128|NCT01395888|7414531|FG001|Treatment Period (TP)|Adverse Event|7
4575129|NCT01395888|7414532|FG002|Treatment Period (TP)|Adverse Event|6
4691567|NCT02573467|7601954|FG003|Post-treatment Follow up Epoch|Death|1
4575130|NCT01395888|7414530|FG000|Treatment Period (TP)|Lack of Efficacy|0
4575131|NCT01395888|7414531|FG001|Treatment Period (TP)|Lack of Efficacy|4
4575132|NCT01395888|7414532|FG002|Treatment Period (TP)|Lack of Efficacy|3
4575133|NCT01395888|7414530|FG000|Treatment Period (TP)|Protocol Violation|0
4575134|NCT01395888|7414531|FG001|Treatment Period (TP)|Protocol Violation|1
4575135|NCT01395888|7414532|FG002|Treatment Period (TP)|Protocol Violation|5
4575136|NCT01395888|7414530|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0
4575137|NCT01395888|7414531|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1
4575138|NCT01395888|7414532|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0
4575139|NCT01395888|7414530|FG000|Treatment Period (TP)|Withdrawal by Subject|0
4575140|NCT01395888|7414531|FG001|Treatment Period (TP)|Withdrawal by Subject|2
4575141|NCT01395888|7414532|FG002|Treatment Period (TP)|Withdrawal by Subject|3
4575142|NCT01395901|7414540|FG000|Overall Study|Lost to Follow-up|4
4575143|NCT01395901|7414541|FG001|Overall Study|Lost to Follow-up|0
4575144|NCT01395901|7414540|FG000|Overall Study|Randomized but not received study drug|5
4575145|NCT01395901|7414541|FG001|Overall Study|Randomized but not received study drug|4
4575146|NCT01395901|7414540|FG000|Overall Study|Adverse Event|0
4575147|NCT01395901|7414541|FG001|Overall Study|Adverse Event|1
4575148|NCT01395901|7414540|FG000|Overall Study|Withdrawal of consent|1
4575149|NCT01395901|7414541|FG001|Overall Study|Withdrawal of consent|0
4575150|NCT01395914|7414549|FG000|Overall Study|Unrelated to study drug AE|6
4575151|NCT01395914|7414550|FG001|Overall Study|Unrelated to study drug AE|1
4575152|NCT01395914|7414549|FG000|Overall Study|Death|23
4575153|NCT01395914|7414550|FG001|Overall Study|Death|17
4575154|NCT01395914|7414549|FG000|Overall Study|Other|9
4575155|NCT01395914|7414550|FG001|Overall Study|Other|3
4575156|NCT01395914|7414549|FG000|Overall Study|Withdrawal by patient|27
4575157|NCT01395914|7414550|FG001|Overall Study|Withdrawal by patient|14
4575158|NCT01395914|7414549|FG000|Overall Study|Study drug-related AE|1
4575159|NCT01395914|7414550|FG001|Overall Study|Study drug-related AE|0
4691568|NCT02573467|7601951|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5
4691569|NCT02573467|7601952|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4
4691570|NCT02573467|7601953|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9
4691571|NCT02573467|7601954|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2
4691572|NCT02573467|7601951|FG000|Post-treatment Follow up Epoch|Technical problems|0
4691573|NCT02573467|7601952|FG001|Post-treatment Follow up Epoch|Technical problems|0
4691574|NCT02573467|7601953|FG002|Post-treatment Follow up Epoch|Technical problems|1
4691575|NCT02573467|7601954|FG003|Post-treatment Follow up Epoch|Technical problems|0
4691576|NCT02573493|7601969|FG000|Overall Study|Determined to not be eligible after enrollment|0
4691577|NCT02573493|7601970|FG001|Overall Study|Determined to not be eligible after enrollment|0
4691578|NCT02573493|7601971|FG002|Overall Study|Determined to not be eligible after enrollment|0
4691579|NCT02573493|7601972|FG003|Overall Study|Determined to not be eligible after enrollment|1
4691580|NCT02573870|7602007|FG000|Overall Study|Adverse Event|0
4691581|NCT02573870|7602008|FG001|Overall Study|Adverse Event|2
4691582|NCT02573870|7602007|FG000|Overall Study|Lack of Efficacy|0
4691583|NCT02573870|7602008|FG001|Overall Study|Lack of Efficacy|1
4691584|NCT02573870|7602007|FG000|Overall Study|Other: Reached defined stopping criteria|0
4691585|NCT02573870|7602008|FG001|Overall Study|Other: Reached defined stopping criteria|1
4691586|NCT02573870|7602007|FG000|Overall Study|Lost to Follow-up|0
4691587|NCT02573870|7602008|FG001|Overall Study|Lost to Follow-up|1
4691588|NCT02573870|7602007|FG000|Overall Study|Other: Fail to Meet Visit|0
4691589|NCT02573870|7602008|FG001|Overall Study|Other: Fail to Meet Visit|2
4691590|NCT02573883|7602016|FG000|Six Month Follow Up|Lost to Follow-up|1
4691591|NCT02573883|7602017|FG001|Six Month Follow Up|Lost to Follow-up|0
4691592|NCT02573883|7602018|FG002|Six Month Follow Up|Lost to Follow-up|0
4691593|NCT02573883|7602019|FG003|Six Month Follow Up|Lost to Follow-up|0
4691594|NCT02573883|7602016|FG000|One Year Follow Up|Lost to Follow-up|2
4691595|NCT02573883|7602017|FG001|One Year Follow Up|Lost to Follow-up|1
4575160|NCT01395914|7414549|FG000|Overall Study|Lost to Follow-up|6
4575161|NCT01395914|7414550|FG001|Overall Study|Lost to Follow-up|2
4575162|NCT01396005|7414571|FG000|Overall Study|Withdrawal by Subject|0
4575163|NCT01396005|7414572|FG001|Overall Study|Withdrawal by Subject|1
4575164|NCT01396005|7414571|FG000|Overall Study|Non-compliance with protocol|0
4575165|NCT01396005|7414572|FG001|Overall Study|Non-compliance with protocol|1
4575166|NCT01396057|7414591|FG000|Overall Study|Adverse Event|2
4575167|NCT01396057|7414592|FG001|Overall Study|Adverse Event|6
4575168|NCT01396057|7414591|FG000|Overall Study|Unsatisfactory therapeutic effect|2
4575169|NCT01396057|7414592|FG001|Overall Study|Unsatisfactory therapeutic effect|6
4575170|NCT01396057|7414591|FG000|Overall Study|Protocol deviation|4
4575171|NCT01396057|7414592|FG001|Overall Study|Protocol deviation|4
4575172|NCT01396057|7414591|FG000|Overall Study|Consent withdrawn|3
4575173|NCT01396057|7414592|FG001|Overall Study|Consent withdrawn|2
4575174|NCT01396070|7414598|FG000|Overall Study|Withdrawal by Subject|2
4575175|NCT01396070|7414598|FG000|Overall Study|Death|2
4575176|NCT01396070|7414598|FG000|Overall Study|Adverse Event|8
4575177|NCT01396070|7414598|FG000|Overall Study|Physician Decision|3
4575178|NCT01396070|7414598|FG000|Overall Study|Lack of Efficacy|4
4575179|NCT01396083|7414605|FG000|Overall Study|Adverse Event|2
4575180|NCT01396083|7414606|FG001|Overall Study|Adverse Event|28
4575181|NCT01396083|7414605|FG000|Overall Study|Unsatisfactory therapeutic effect|2
4575182|NCT01396083|7414606|FG001|Overall Study|Unsatisfactory therapeutic effect|13
4575183|NCT01396083|7414605|FG000|Overall Study|Consent withdrawn|4
4691596|NCT02573883|7602018|FG002|One Year Follow Up|Lost to Follow-up|0
4575184|NCT01396083|7414606|FG001|Overall Study|Consent withdrawn|5
4575185|NCT01396083|7414605|FG000|Overall Study|Protocol deviation(s)|0
4575186|NCT01396083|7414606|FG001|Overall Study|Protocol deviation(s)|1
4575187|NCT01396083|7414605|FG000|Overall Study|Abnormal laboratory value(s)|1
4575188|NCT01396083|7414606|FG001|Overall Study|Abnormal laboratory value(s)|0
4575189|NCT01396083|7414605|FG000|Overall Study|Administrative problems|1
4575190|NCT01396083|7414606|FG001|Overall Study|Administrative problems|0
4575191|NCT01396083|7414605|FG000|Overall Study|Lost to Follow-up|1
4575192|NCT01396083|7414606|FG001|Overall Study|Lost to Follow-up|0
4575193|NCT01396148|7414612|FG000|Overall Study|Patient Decision|1
4575194|NCT01396161|7414625|FG000|Overall Study|Withdrawal by Subject|0
4575195|NCT01396161|7414626|FG001|Overall Study|Withdrawal by Subject|0
4575196|NCT01396161|7414627|FG002|Overall Study|Withdrawal by Subject|0
4575197|NCT01396161|7414628|FG003|Overall Study|Withdrawal by Subject|0
4575198|NCT01396161|7414629|FG004|Overall Study|Withdrawal by Subject|1
4575199|NCT01396161|7414630|FG005|Overall Study|Withdrawal by Subject|0
4575200|NCT01396161|7414631|FG006|Overall Study|Withdrawal by Subject|0
4575201|NCT01396161|7414625|FG000|Overall Study|Other|0
4575202|NCT01396161|7414626|FG001|Overall Study|Other|0
4575203|NCT01396161|7414627|FG002|Overall Study|Other|0
4575204|NCT01396161|7414628|FG003|Overall Study|Other|0
4575205|NCT01396161|7414629|FG004|Overall Study|Other|0
4575206|NCT01396161|7414630|FG005|Overall Study|Other|0
4575207|NCT01396161|7414631|FG006|Overall Study|Other|1
4575208|NCT01396187|7414657|FG000|Overall Study|Adverse Event|0
4575209|NCT01396187|7414658|FG001|Overall Study|Adverse Event|1
4575210|NCT01396187|7414659|FG002|Overall Study|Adverse Event|0
4575211|NCT01396187|7414660|FG003|Overall Study|Adverse Event|0
4575212|NCT01396187|7414661|FG004|Overall Study|Adverse Event|0
4575213|NCT01396187|7414657|FG000|Overall Study|Withdrawal by Subject|0
4575214|NCT01396187|7414658|FG001|Overall Study|Withdrawal by Subject|1
4575215|NCT01396187|7414659|FG002|Overall Study|Withdrawal by Subject|1
4575216|NCT01396187|7414660|FG003|Overall Study|Withdrawal by Subject|0
4575217|NCT01396187|7414661|FG004|Overall Study|Withdrawal by Subject|0
4575218|NCT01396187|7414657|FG000|Overall Study|Other|1
4575219|NCT01396187|7414658|FG001|Overall Study|Other|1
4575220|NCT01396187|7414659|FG002|Overall Study|Other|0
4575221|NCT01396187|7414660|FG003|Overall Study|Other|0
4575222|NCT01396187|7414661|FG004|Overall Study|Other|1
4575223|NCT01396265|7414709|FG000|Rifa+Afatinib|Withdrawal by Subject|1
4575224|NCT01396317|7414717|FG000|Overall Study|Adverse Event|1
4575225|NCT01396317|7414718|FG001|Overall Study|Adverse Event|0
4575226|NCT01396395|7414733|FG000|Overall Study|Withdrawal by Subject|10
4575227|NCT01396395|7414734|FG001|Overall Study|Withdrawal by Subject|12
4575228|NCT01396395|7414733|FG000|Overall Study|Protocol Violation|3
4575229|NCT01396395|7414734|FG001|Overall Study|Protocol Violation|1
4575230|NCT01396395|7414733|FG000|Overall Study|Adverse Event|10
4575231|NCT01396395|7414734|FG001|Overall Study|Adverse Event|2
4575232|NCT01396395|7414733|FG000|Overall Study|Lost to Follow-up|17
4575233|NCT01396395|7414734|FG001|Overall Study|Lost to Follow-up|11
4575234|NCT01396395|7414733|FG000|Overall Study|Other|0
4575235|NCT01396395|7414734|FG001|Overall Study|Other|1
4575236|NCT01396421|7414746|FG000|Overall Study|Lost to Follow-up|0
4575237|NCT01396421|7414747|FG001|Overall Study|Lost to Follow-up|0
4575238|NCT01396421|7414748|FG002|Overall Study|Lost to Follow-up|0
4575239|NCT01396421|7414749|FG003|Overall Study|Lost to Follow-up|1
4575240|NCT01396421|7414746|FG000|Overall Study|Adverse Event|17
4575241|NCT01396421|7414747|FG001|Overall Study|Adverse Event|15
4575242|NCT01396421|7414748|FG002|Overall Study|Adverse Event|12
4575243|NCT01396421|7414749|FG003|Overall Study|Adverse Event|32
4575244|NCT01396421|7414746|FG000|Overall Study|Participant Met Withdrawal Criteria|1
4575245|NCT01396421|7414747|FG001|Overall Study|Participant Met Withdrawal Criteria|0
4575246|NCT01396421|7414748|FG002|Overall Study|Participant Met Withdrawal Criteria|1
4575247|NCT01396421|7414749|FG003|Overall Study|Participant Met Withdrawal Criteria|0
4575248|NCT01396421|7414746|FG000|Overall Study|Physician Decision|1
4575249|NCT01396421|7414747|FG001|Overall Study|Physician Decision|1
4575250|NCT01396421|7414748|FG002|Overall Study|Physician Decision|0
4575251|NCT01396421|7414749|FG003|Overall Study|Physician Decision|3
4575252|NCT01396421|7414746|FG000|Overall Study|Withdrawal by Subject|31
4575253|NCT01396421|7414747|FG001|Overall Study|Withdrawal by Subject|24
4575254|NCT01396421|7414748|FG002|Overall Study|Withdrawal by Subject|13
4691597|NCT02573883|7602019|FG003|One Year Follow Up|Lost to Follow-up|0
4691598|NCT02573948|7602034|FG000|Longitudinal Cohort|Death|9
4691599|NCT02573948|7602034|FG000|Longitudinal Cohort|Lost to Follow-up|22
4691600|NCT02573948|7602034|FG000|Longitudinal Cohort|Incarcerated|25
4691601|NCT02574078|7602054|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0
4691602|NCT02574078|7602055|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0
4575255|NCT01396421|7414749|FG003|Overall Study|Withdrawal by Subject|21
4575256|NCT01396421|7414746|FG000|Overall Study|Protocol Deviation|2
4575257|NCT01396421|7414747|FG001|Overall Study|Protocol Deviation|1
4575258|NCT01396421|7414748|FG002|Overall Study|Protocol Deviation|1
4575259|NCT01396421|7414749|FG003|Overall Study|Protocol Deviation|0
4575260|NCT01396421|7414746|FG000|Overall Study|Lack of Efficacy|7
4575261|NCT01396421|7414747|FG001|Overall Study|Lack of Efficacy|17
4575262|NCT01396421|7414748|FG002|Overall Study|Lack of Efficacy|7
4575263|NCT01396421|7414749|FG003|Overall Study|Lack of Efficacy|18
4575264|NCT01396434|7414776|FG000|Overall Study|Lost to Follow-up|1
4575265|NCT01396434|7414777|FG001|Overall Study|Lost to Follow-up|0
4575266|NCT01396434|7414778|FG002|Overall Study|Lost to Follow-up|0
4575267|NCT01396434|7414776|FG000|Overall Study|Other|10
4575268|NCT01396434|7414777|FG001|Overall Study|Other|0
4575269|NCT01396434|7414778|FG002|Overall Study|Other|0
4575270|NCT01396447|7414790|FG000|Overall Study|Did Not Receive Treatment|3
4575271|NCT01396447|7414791|FG001|Overall Study|Did Not Receive Treatment|2
4575272|NCT01396447|7414792|FG002|Overall Study|Did Not Receive Treatment|1
4575273|NCT01396447|7414793|FG003|Overall Study|Did Not Receive Treatment|0
4575274|NCT01396447|7414790|FG000|Overall Study|Adverse Event|15
4575275|NCT01396447|7414791|FG001|Overall Study|Adverse Event|12
4575276|NCT01396447|7414792|FG002|Overall Study|Adverse Event|12
4575277|NCT01396447|7414793|FG003|Overall Study|Adverse Event|17
4575278|NCT01396447|7414790|FG000|Overall Study|Insufficient Therapeutic Response|5
4575279|NCT01396447|7414791|FG001|Overall Study|Insufficient Therapeutic Response|5
4575280|NCT01396447|7414792|FG002|Overall Study|Insufficient Therapeutic Response|2
4575281|NCT01396447|7414793|FG003|Overall Study|Insufficient Therapeutic Response|4
4575282|NCT01396447|7414790|FG000|Overall Study|Protocol Violation|5
4575283|NCT01396447|7414791|FG001|Overall Study|Protocol Violation|2
4575284|NCT01396447|7414792|FG002|Overall Study|Protocol Violation|3
4575285|NCT01396447|7414793|FG003|Overall Study|Protocol Violation|7
4575286|NCT01396447|7414790|FG000|Overall Study|Withdrawal of Consent|11
4575287|NCT01396447|7414791|FG001|Overall Study|Withdrawal of Consent|9
4575288|NCT01396447|7414792|FG002|Overall Study|Withdrawal of Consent|4
4575289|NCT01396447|7414793|FG003|Overall Study|Withdrawal of Consent|15
4691603|NCT02574078|7602056|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0
4691604|NCT02574078|7602057|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0
4691605|NCT02574078|7602058|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0
4691606|NCT02574078|7602059|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1
4691607|NCT02574078|7602060|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2
4691608|NCT02574078|7602061|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0
4691609|NCT02574078|7602062|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1
4691610|NCT02574078|7602063|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0
4691611|NCT02574078|7602064|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0
4691612|NCT02574078|7602065|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0
4691613|NCT02574078|7602066|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0
4691614|NCT02574078|7602054|FG000|Pre-Treatment Period|Participant withdrew consent|0
4691615|NCT02574078|7602055|FG001|Pre-Treatment Period|Participant withdrew consent|0
4691616|NCT02574078|7602056|FG002|Pre-Treatment Period|Participant withdrew consent|0
4691617|NCT02574078|7602057|FG003|Pre-Treatment Period|Participant withdrew consent|0
4575290|NCT01396447|7414790|FG000|Overall Study|Lost to Follow-up|4
4575291|NCT01396447|7414791|FG001|Overall Study|Lost to Follow-up|8
4575292|NCT01396447|7414792|FG002|Overall Study|Lost to Follow-up|7
4575293|NCT01396447|7414793|FG003|Overall Study|Lost to Follow-up|9
4575294|NCT01396447|7414790|FG000|Overall Study|Other Miscellaneous Reasons|0
4575295|NCT01396447|7414791|FG001|Overall Study|Other Miscellaneous Reasons|2
4575296|NCT01396447|7414792|FG002|Overall Study|Other Miscellaneous Reasons|1
4575297|NCT01396447|7414793|FG003|Overall Study|Other Miscellaneous Reasons|0
4575298|NCT01396512|7414818|FG000|Overall Study|Withdrawal by Subject|0
4575299|NCT01396512|7414819|FG001|Overall Study|Withdrawal by Subject|1
4575300|NCT01396525|7414825|FG000|Overall Study|Withdrawal by Subject|8
4575301|NCT01396525|7414825|FG000|Overall Study|Death|14
4575302|NCT01396525|7414825|FG000|Overall Study|Lost to Follow-up|4
4575303|NCT01397084|7414849|FG000|Overall Study|Severe Non-Compliance to Protocol|1
4575304|NCT01397084|7414849|FG000|Overall Study|Protocol Violation|2
4575305|NCT01397084|7414849|FG000|Overall Study|Adverse Event|2
4575306|NCT01397084|7414849|FG000|Overall Study|Withdrawal by Subject|1
4575307|NCT01397084|7414849|FG000|Overall Study|Lost to Follow-up|1
4575308|NCT01397084|7414849|FG000|Overall Study|Used other proton pump inhibitor|1
4575309|NCT01397253|7414855|FG000|Overall Study|Reviewed by only 1 pharmacist|126
4575310|NCT01397253|7414856|FG001|Overall Study|Reviewed by only 1 pharmacist|149
4575311|NCT01397409|7414872|FG000|Stage 2|Adverse Event|0
4575312|NCT01397409|7414873|FG001|Stage 2|Adverse Event|0
4575313|NCT01397409|7414874|FG002|Stage 2|Adverse Event|0
4575314|NCT01397409|7414875|FG003|Stage 2|Adverse Event|0
4575315|NCT01397409|7414876|FG004|Stage 2|Adverse Event|6
4575316|NCT01397409|7414877|FG005|Stage 2|Adverse Event|3
4575317|NCT01397409|7414878|FG006|Stage 2|Adverse Event|0
4575318|NCT01397409|7414879|FG007|Stage 2|Adverse Event|0
4575319|NCT01397409|7414880|FG008|Stage 2|Adverse Event|0
4575320|NCT01397409|7414881|FG009|Stage 2|Adverse Event|0
4575321|NCT01397409|7414872|FG000|Stage 2|Personal Reasons|0
4575322|NCT01397409|7414873|FG001|Stage 2|Personal Reasons|0
4575323|NCT01397409|7414874|FG002|Stage 2|Personal Reasons|0
4575324|NCT01397409|7414875|FG003|Stage 2|Personal Reasons|0
4575325|NCT01397409|7414876|FG004|Stage 2|Personal Reasons|1
4575326|NCT01397409|7414877|FG005|Stage 2|Personal Reasons|0
4575327|NCT01397409|7414878|FG006|Stage 2|Personal Reasons|0
4575328|NCT01397409|7414879|FG007|Stage 2|Personal Reasons|0
4575329|NCT01397409|7414880|FG008|Stage 2|Personal Reasons|0
4575330|NCT01397409|7414881|FG009|Stage 2|Personal Reasons|0
4575331|NCT01397409|7414872|FG000|Stage 2|Other Miscellaneous Reasons|0
4575332|NCT01397409|7414873|FG001|Stage 2|Other Miscellaneous Reasons|0
4575333|NCT01397409|7414874|FG002|Stage 2|Other Miscellaneous Reasons|0
4575334|NCT01397409|7414875|FG003|Stage 2|Other Miscellaneous Reasons|0
4575335|NCT01397409|7414876|FG004|Stage 2|Other Miscellaneous Reasons|1
4575336|NCT01397409|7414877|FG005|Stage 2|Other Miscellaneous Reasons|1
4575337|NCT01397409|7414878|FG006|Stage 2|Other Miscellaneous Reasons|0
4575338|NCT01397409|7414879|FG007|Stage 2|Other Miscellaneous Reasons|0
4575339|NCT01397409|7414880|FG008|Stage 2|Other Miscellaneous Reasons|0
4575340|NCT01397409|7414881|FG009|Stage 2|Other Miscellaneous Reasons|0
4575341|NCT01397409|7414872|FG000|Stage 3|Adverse Event|0
4575342|NCT01397409|7414873|FG001|Stage 3|Adverse Event|0
4575343|NCT01397409|7414874|FG002|Stage 3|Adverse Event|0
4575344|NCT01397409|7414875|FG003|Stage 3|Adverse Event|0
4575345|NCT01397409|7414876|FG004|Stage 3|Adverse Event|0
4575346|NCT01397409|7414877|FG005|Stage 3|Adverse Event|0
4575347|NCT01397409|7414878|FG006|Stage 3|Adverse Event|0
4575348|NCT01397409|7414879|FG007|Stage 3|Adverse Event|1
4575349|NCT01397409|7414880|FG008|Stage 3|Adverse Event|0
4575350|NCT01397409|7414881|FG009|Stage 3|Adverse Event|0
4575351|NCT01397409|7414872|FG000|Stage 3|Other Miscellaneous Reasons|0
4575352|NCT01397409|7414873|FG001|Stage 3|Other Miscellaneous Reasons|0
4575353|NCT01397409|7414874|FG002|Stage 3|Other Miscellaneous Reasons|0
4575354|NCT01397409|7414875|FG003|Stage 3|Other Miscellaneous Reasons|0
4575355|NCT01397409|7414876|FG004|Stage 3|Other Miscellaneous Reasons|0
4575356|NCT01397409|7414877|FG005|Stage 3|Other Miscellaneous Reasons|0
4575357|NCT01397409|7414878|FG006|Stage 3|Other Miscellaneous Reasons|0
4575358|NCT01397409|7414879|FG007|Stage 3|Other Miscellaneous Reasons|1
4575359|NCT01397409|7414880|FG008|Stage 3|Other Miscellaneous Reasons|0
4575360|NCT01397409|7414881|FG009|Stage 3|Other Miscellaneous Reasons|0
4575361|NCT01397422|7414908|FG000|Overall Study|Adverse Event|0
4575362|NCT01397422|7414909|FG001|Overall Study|Adverse Event|3
4575363|NCT01397422|7414910|FG002|Overall Study|Adverse Event|3
4575364|NCT01397422|7414911|FG003|Overall Study|Adverse Event|8
4575365|NCT01397422|7414908|FG000|Overall Study|Withdrawal by Subject|1
4575366|NCT01397422|7414909|FG001|Overall Study|Withdrawal by Subject|0
4575367|NCT01397422|7414910|FG002|Overall Study|Withdrawal by Subject|0
4575368|NCT01397422|7414911|FG003|Overall Study|Withdrawal by Subject|0
4575369|NCT01397422|7414908|FG000|Overall Study|Increased bradykinesia related to PD|1
4575370|NCT01397422|7414909|FG001|Overall Study|Increased bradykinesia related to PD|0
4575371|NCT01397422|7414910|FG002|Overall Study|Increased bradykinesia related to PD|0
4575372|NCT01397422|7414911|FG003|Overall Study|Increased bradykinesia related to PD|0
4575373|NCT01397448|7414926|FG000|Overall Study|Adverse Event|4
4575374|NCT01397448|7414927|FG001|Overall Study|Adverse Event|4
4575375|NCT01397448|7414928|FG002|Overall Study|Adverse Event|6
4575376|NCT01397448|7414926|FG000|Overall Study|Withdrawal by Subject|4
4575377|NCT01397448|7414927|FG001|Overall Study|Withdrawal by Subject|4
4575378|NCT01397448|7414928|FG002|Overall Study|Withdrawal by Subject|3
4575379|NCT01397448|7414926|FG000|Overall Study|Lack of Efficacy|2
4575380|NCT01397448|7414927|FG001|Overall Study|Lack of Efficacy|0
4575381|NCT01397448|7414928|FG002|Overall Study|Lack of Efficacy|5
4575382|NCT01397448|7414926|FG000|Overall Study|Other|8
4575383|NCT01397448|7414927|FG001|Overall Study|Other|7
4575384|NCT01397448|7414928|FG002|Overall Study|Other|4
4575385|NCT01397461|7414939|FG000|Overall Study|Withdrawal by Subject|2
4575386|NCT01397461|7414940|FG001|Overall Study|Withdrawal by Subject|1
4575387|NCT01397461|7414941|FG002|Overall Study|Withdrawal by Subject|0
4575388|NCT01397461|7414939|FG000|Overall Study|Lost to Follow-up|0
4575389|NCT01397461|7414940|FG001|Overall Study|Lost to Follow-up|2
4575390|NCT01397461|7414941|FG002|Overall Study|Lost to Follow-up|1
4575391|NCT01397461|7414939|FG000|Overall Study|Lack of Efficacy|0
4575392|NCT01397461|7414940|FG001|Overall Study|Lack of Efficacy|3
4575393|NCT01397461|7414941|FG002|Overall Study|Lack of Efficacy|0
4575394|NCT01397461|7414939|FG000|Overall Study|Not treated|0
4575395|NCT01397461|7414940|FG001|Overall Study|Not treated|0
4575396|NCT01397461|7414941|FG002|Overall Study|Not treated|1
4575397|NCT01397747|7414981|FG000|Overall Study|Multitarget DNA test excluded|689
4575398|NCT01397747|7414981|FG000|Overall Study|Colonoscopy excluded|304
4575399|NCT01397747|7414981|FG000|Overall Study|FIT excluded|34
4575400|NCT01397786|7414989|FG000|Phase A|Lost to Follow-up|0
4575401|NCT01397786|7414990|FG001|Phase A|Lost to Follow-up|0
4575402|NCT01397786|7414991|FG002|Phase A|Lost to Follow-up|6
4575403|NCT01397786|7414989|FG000|Phase A|Adverse Event|0
4575404|NCT01397786|7414990|FG001|Phase A|Adverse Event|0
4575405|NCT01397786|7414991|FG002|Phase A|Adverse Event|8
4575406|NCT01397786|7414989|FG000|Phase A|Subject Met Withdrawal Criteria|0
4575407|NCT01397786|7414990|FG001|Phase A|Subject Met Withdrawal Criteria|0
4575408|NCT01397786|7414991|FG002|Phase A|Subject Met Withdrawal Criteria|7
4575409|NCT01397786|7414989|FG000|Phase A|Physician Decision|0
4575410|NCT01397786|7414990|FG001|Phase A|Physician Decision|0
4575411|NCT01397786|7414991|FG002|Phase A|Physician Decision|1
4575412|NCT01397786|7414989|FG000|Phase A|Withdrawal by Subject|0
4575413|NCT01397786|7414990|FG001|Phase A|Withdrawal by Subject|0
4575414|NCT01397786|7414991|FG002|Phase A|Withdrawal by Subject|5
4575415|NCT01397786|7414989|FG000|Phase A|Lack of Efficacy|0
4575416|NCT01397786|7414990|FG001|Phase A|Lack of Efficacy|0
4575417|NCT01397786|7414991|FG002|Phase A|Lack of Efficacy|1
4575418|NCT01397786|7414989|FG000|Phase B|Lost to Follow-up|22
4575419|NCT01397786|7414990|FG001|Phase B|Lost to Follow-up|12
4575420|NCT01397786|7414991|FG002|Phase B|Lost to Follow-up|22
4575421|NCT01397786|7414989|FG000|Phase B|Adverse Event|109
4575422|NCT01397786|7414990|FG001|Phase B|Adverse Event|23
4575423|NCT01397786|7414991|FG002|Phase B|Adverse Event|27
4575424|NCT01397786|7414989|FG000|Phase B|Subject Met Withdrawal Criteria|38
4575425|NCT01397786|7414990|FG001|Phase B|Subject Met Withdrawal Criteria|5
4575426|NCT01397786|7414991|FG002|Phase B|Subject Met Withdrawal Criteria|38
4575427|NCT01397786|7414989|FG000|Phase B|Physician Decision|9
4575428|NCT01397786|7414990|FG001|Phase B|Physician Decision|1
4575429|NCT01397786|7414991|FG002|Phase B|Physician Decision|3
4575430|NCT01397786|7414989|FG000|Phase B|Withdrawal by Subject|102
4575431|NCT01397786|7414990|FG001|Phase B|Withdrawal by Subject|45
4575432|NCT01397786|7414991|FG002|Phase B|Withdrawal by Subject|30
4575433|NCT01397786|7414989|FG000|Phase B|Protocol Deviation|1
4575434|NCT01397786|7414990|FG001|Phase B|Protocol Deviation|2
4575435|NCT01397786|7414991|FG002|Phase B|Protocol Deviation|4
4575436|NCT01397786|7414989|FG000|Phase B|Lack of Efficacy|22
4575437|NCT01397786|7414990|FG001|Phase B|Lack of Efficacy|7
4575438|NCT01397786|7414991|FG002|Phase B|Lack of Efficacy|14
4575439|NCT01397825|7415007|FG000|Overall Study|Progressive Disease|10
4575440|NCT01397825|7415008|FG001|Overall Study|Progressive Disease|3
4575441|NCT01397825|7415009|FG002|Overall Study|Progressive Disease|11
4575442|NCT01397825|7415010|FG003|Overall Study|Progressive Disease|1
4575443|NCT01397825|7415011|FG004|Overall Study|Progressive Disease|0
4575444|NCT01397825|7415007|FG000|Overall Study|Symptomatic Deterioration|2
4575445|NCT01397825|7415008|FG001|Overall Study|Symptomatic Deterioration|0
4575446|NCT01397825|7415009|FG002|Overall Study|Symptomatic Deterioration|4
4575447|NCT01397825|7415010|FG003|Overall Study|Symptomatic Deterioration|0
4575448|NCT01397825|7415011|FG004|Overall Study|Symptomatic Deterioration|0
4575449|NCT01397825|7415007|FG000|Overall Study|Adverse Event|0
4575450|NCT01397825|7415008|FG001|Overall Study|Adverse Event|1
4575451|NCT01397825|7415009|FG002|Overall Study|Adverse Event|5
4575452|NCT01397825|7415010|FG003|Overall Study|Adverse Event|1
4575453|NCT01397825|7415011|FG004|Overall Study|Adverse Event|0
4575454|NCT01397825|7415007|FG000|Overall Study|Withdrawal by Subject|1
4575455|NCT01397825|7415008|FG001|Overall Study|Withdrawal by Subject|0
4575456|NCT01397825|7415009|FG002|Overall Study|Withdrawal by Subject|5
4575457|NCT01397825|7415010|FG003|Overall Study|Withdrawal by Subject|1
4575458|NCT01397825|7415011|FG004|Overall Study|Withdrawal by Subject|0
4575459|NCT01397890|7415036|FG000|Overall Study|Withdrawal by Subject|7
4575460|NCT01397890|7415037|FG001|Overall Study|Withdrawal by Subject|11
4575461|NCT01397890|7415036|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7
4575462|NCT01397890|7415037|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6
4575463|NCT01397890|7415036|FG000|Overall Study|Death|2
4575464|NCT01397890|7415037|FG001|Overall Study|Death|3
4575465|NCT01397890|7415036|FG000|Overall Study|Lost to Follow-up|1
4575466|NCT01397890|7415037|FG001|Overall Study|Lost to Follow-up|4
4575467|NCT01397890|7415036|FG000|Overall Study|Condition under Investigation Worsened|1
4575468|NCT01397890|7415037|FG001|Overall Study|Condition under Investigation Worsened|3
4575469|NCT01397890|7415036|FG000|Overall Study|Adverse Event|1
4575470|NCT01397890|7415037|FG001|Overall Study|Adverse Event|2
4575471|NCT01397890|7415036|FG000|Overall Study|Severe Non-Compliance to Protocol|2
4575472|NCT01397890|7415037|FG001|Overall Study|Severe Non-Compliance to Protocol|1
4575473|NCT01397890|7415036|FG000|Overall Study|Others|2
4575474|NCT01397890|7415037|FG001|Overall Study|Others|1
4575475|NCT01398176|7415058|FG000|Overall Study|Lost to Follow-up|1
4575476|NCT01398176|7415059|FG001|Overall Study|Lost to Follow-up|3
4575477|NCT01398176|7415058|FG000|Overall Study|Physician Decision|2
4575478|NCT01398176|7415059|FG001|Overall Study|Physician Decision|3
4575479|NCT01398358|7415077|FG000|Overall Study|Lost to Follow-up|11
4575480|NCT01398358|7415078|FG001|Overall Study|Lost to Follow-up|21
4575481|NCT01398358|7415079|FG002|Overall Study|Lost to Follow-up|18
4575482|NCT01398358|7415077|FG000|Overall Study|Withdrawal by Subject|3
4575483|NCT01398358|7415078|FG001|Overall Study|Withdrawal by Subject|2
4575484|NCT01398358|7415079|FG002|Overall Study|Withdrawal by Subject|2
4575485|NCT01398358|7415077|FG000|Overall Study|no longer eligible|1
4691618|NCT02574078|7602058|FG004|Pre-Treatment Period|Participant withdrew consent|0
4691619|NCT02574078|7602059|FG005|Pre-Treatment Period|Participant withdrew consent|0
4691620|NCT02574078|7602060|FG006|Pre-Treatment Period|Participant withdrew consent|0
4691621|NCT02574078|7602061|FG007|Pre-Treatment Period|Participant withdrew consent|3
4691622|NCT02574078|7602062|FG008|Pre-Treatment Period|Participant withdrew consent|0
4691623|NCT02574078|7602063|FG009|Pre-Treatment Period|Participant withdrew consent|0
4691624|NCT02574078|7602064|FG010|Pre-Treatment Period|Participant withdrew consent|2
4691625|NCT02574078|7602065|FG011|Pre-Treatment Period|Participant withdrew consent|0
4691626|NCT02574078|7602066|FG012|Pre-Treatment Period|Participant withdrew consent|0
4691627|NCT02574078|7602054|FG000|Pre-Treatment Period|Other reasons|0
4691628|NCT02574078|7602055|FG001|Pre-Treatment Period|Other reasons|0
4691629|NCT02574078|7602056|FG002|Pre-Treatment Period|Other reasons|0
4691630|NCT02574078|7602057|FG003|Pre-Treatment Period|Other reasons|0
4691631|NCT02574078|7602058|FG004|Pre-Treatment Period|Other reasons|0
4691632|NCT02574078|7602059|FG005|Pre-Treatment Period|Other reasons|0
4575486|NCT01398358|7415078|FG001|Overall Study|no longer eligible|0
4575487|NCT01398358|7415079|FG002|Overall Study|no longer eligible|1
4575488|NCT01398410|7415089|FG000|Overall Study|Adverse Event|12
4575489|NCT01398410|7415090|FG001|Overall Study|Adverse Event|16
4575490|NCT01398410|7415089|FG000|Overall Study|Participants Choice|8
4575491|NCT01398410|7415090|FG001|Overall Study|Participants Choice|11
4575492|NCT01398410|7415089|FG000|Overall Study|Inadequate Therapeutic Effect|2
4575493|NCT01398410|7415090|FG001|Overall Study|Inadequate Therapeutic Effect|0
4575494|NCT01398410|7415089|FG000|Overall Study|Other|36
4575495|NCT01398410|7415090|FG001|Overall Study|Other|29
4575496|NCT01398514|7415111|FG000|Overall Study|Adverse Event|1
4575497|NCT01398514|7415112|FG001|Overall Study|Adverse Event|0
4575498|NCT01398514|7415111|FG000|Overall Study|Non-compliance with study procedures|2
4575499|NCT01398514|7415112|FG001|Overall Study|Non-compliance with study procedures|0
4575500|NCT01398514|7415111|FG000|Overall Study|Physiologic non-responsiveness|1
4575501|NCT01398514|7415112|FG001|Overall Study|Physiologic non-responsiveness|3
4575502|NCT01398514|7415111|FG000|Overall Study|Failure to show a conditioned response|4
4575503|NCT01398514|7415112|FG001|Overall Study|Failure to show a conditioned response|3
4575504|NCT01398787|7415124|FG000|Overall Study|Adverse Event|1
4575505|NCT01398956|7415143|FG000|Overall Study|Withdrawal by Subject|4
4575506|NCT01398956|7415143|FG000|Overall Study|AE, non-serious non-fatal|4
4575507|NCT01398956|7415143|FG000|Overall Study|Withdrawal Criteria No.3|1
4575508|NCT01398956|7415143|FG000|Overall Study|Subject moved a long distance|1
4592985|NCT01545388|7440872|FG001|Overall Study|Lack of Efficacy|2
4592986|NCT01545388|7440873|FG002|Overall Study|Lack of Efficacy|5
4592987|NCT01545388|7440871|FG000|Overall Study|Participant moved or relocated|1
4592988|NCT01545388|7440872|FG001|Overall Study|Participant moved or relocated|0
4592989|NCT01545388|7440873|FG002|Overall Study|Participant moved or relocated|0
4592990|NCT01545388|7440871|FG000|Overall Study|Withdrawal by Subject|1
4592991|NCT01545388|7440872|FG001|Overall Study|Withdrawal by Subject|4
4592992|NCT01545388|7440873|FG002|Overall Study|Withdrawal by Subject|2
4592993|NCT01545388|7440871|FG000|Overall Study|Other|1
4592994|NCT01545388|7440872|FG001|Overall Study|Other|1
4592995|NCT01545388|7440873|FG002|Overall Study|Other|0
4592996|NCT01545817|7440977|FG000|Pazopanib|Disease progression|51
4592997|NCT01545817|7440978|FG001|Pazopanib|Disease progression|0
4592998|NCT01545817|7440977|FG000|Pazopanib|Adverse Event|19
4592999|NCT01545817|7440978|FG001|Pazopanib|Adverse Event|0
4593000|NCT01545817|7440977|FG000|Pazopanib|Other reason|4
4593001|NCT01545817|7440978|FG001|Pazopanib|Other reason|0
4593002|NCT01545817|7440977|FG000|Everolimus|Other reason|0
4593003|NCT01545817|7440978|FG001|Everolimus|Other reason|7
4593004|NCT01545817|7440977|FG000|Everolimus|Disease progression|0
4593005|NCT01545817|7440978|FG001|Everolimus|Disease progression|25
4593006|NCT01545817|7440977|FG000|Everolimus|Adverse Event|0
4593007|NCT01545817|7440978|FG001|Everolimus|Adverse Event|6
4593008|NCT01545934|7441004|FG000|Overall Study|Withdrawal by Subject|4
4593009|NCT01545934|7441005|FG001|Overall Study|Withdrawal by Subject|3
4593010|NCT01545934|7441004|FG000|Overall Study|Lost to Follow-up|1
4593011|NCT01545934|7441005|FG001|Overall Study|Lost to Follow-up|0
4593012|NCT01546038|7441018|FG000|Overall Study|Death|15
4593013|NCT01546038|7441019|FG001|Overall Study|Death|6
4593014|NCT01546038|7441020|FG002|Overall Study|Death|4
4593015|NCT01546038|7441021|FG003|Overall Study|Death|2
4593016|NCT01546038|7441022|FG004|Overall Study|Death|9
4593017|NCT01546038|7441023|FG005|Overall Study|Death|3
4593018|NCT01546038|7441024|FG006|Overall Study|Death|46
4593019|NCT01546038|7441025|FG007|Overall Study|Death|76
4593020|NCT01546038|7441026|FG008|Overall Study|Death|39
4593021|NCT01546038|7441018|FG000|Overall Study|Lost to Follow-up|0
4593022|NCT01546038|7441019|FG001|Overall Study|Lost to Follow-up|0
4593023|NCT01546038|7441020|FG002|Overall Study|Lost to Follow-up|0
4593024|NCT01546038|7441021|FG003|Overall Study|Lost to Follow-up|0
4593025|NCT01546038|7441022|FG004|Overall Study|Lost to Follow-up|1
4593026|NCT01546038|7441023|FG005|Overall Study|Lost to Follow-up|0
4593027|NCT01546038|7441024|FG006|Overall Study|Lost to Follow-up|2
4593028|NCT01546038|7441025|FG007|Overall Study|Lost to Follow-up|1
4593029|NCT01546038|7441026|FG008|Overall Study|Lost to Follow-up|0
4593030|NCT01546038|7441018|FG000|Overall Study|Withdrawal by Subject|1
4593031|NCT01546038|7441019|FG001|Overall Study|Withdrawal by Subject|0
4593032|NCT01546038|7441020|FG002|Overall Study|Withdrawal by Subject|0
4593033|NCT01546038|7441021|FG003|Overall Study|Withdrawal by Subject|1
4593034|NCT01546038|7441022|FG004|Overall Study|Withdrawal by Subject|0
4593035|NCT01546038|7441023|FG005|Overall Study|Withdrawal by Subject|1
4593036|NCT01546038|7441024|FG006|Overall Study|Withdrawal by Subject|3
4593037|NCT01546038|7441025|FG007|Overall Study|Withdrawal by Subject|3
4593038|NCT01546038|7441026|FG008|Overall Study|Withdrawal by Subject|1
4593039|NCT01546038|7441018|FG000|Overall Study|: Randomized, not treated|0
4593040|NCT01546038|7441019|FG001|Overall Study|: Randomized, not treated|0
4593041|NCT01546038|7441020|FG002|Overall Study|: Randomized, not treated|0
4593042|NCT01546038|7441021|FG003|Overall Study|: Randomized, not treated|0
4593043|NCT01546038|7441022|FG004|Overall Study|: Randomized, not treated|0
4593044|NCT01546038|7441023|FG005|Overall Study|: Randomized, not treated|0
4593045|NCT01546038|7441024|FG006|Overall Study|: Randomized, not treated|2
4593046|NCT01546038|7441025|FG007|Overall Study|: Randomized, not treated|4
4593047|NCT01546038|7441026|FG008|Overall Study|: Randomized, not treated|3
4593048|NCT01546142|7441078|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15
4593049|NCT01546142|7441079|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15
4593050|NCT01546142|7441078|FG000|Overall Study|Subject Noncompliance|1
4593051|NCT01546142|7441079|FG001|Overall Study|Subject Noncompliance|1
4593052|NCT01546142|7441078|FG000|Overall Study|Adverse Event|6
4593053|NCT01546142|7441079|FG001|Overall Study|Adverse Event|3
4691633|NCT02574078|7602060|FG006|Pre-Treatment Period|Other reasons|2
4691634|NCT02574078|7602061|FG007|Pre-Treatment Period|Other reasons|0
4691635|NCT02574078|7602062|FG008|Pre-Treatment Period|Other reasons|0
4691636|NCT02574078|7602063|FG009|Pre-Treatment Period|Other reasons|0
4691637|NCT02574078|7602064|FG010|Pre-Treatment Period|Other reasons|2
4691638|NCT02574078|7602065|FG011|Pre-Treatment Period|Other reasons|0
4575509|NCT01399047|7415172|FG000|Overall Study|Withdrawal by Subject|0
4575510|NCT01399047|7415173|FG001|Overall Study|Withdrawal by Subject|1
4575511|NCT01399099|7415181|FG000|Overall Study|Lost to Follow-up|11
4575512|NCT01399099|7415181|FG000|Overall Study|Physician Decision|1
4575513|NCT01399099|7415181|FG000|Overall Study|Protocol Violation|1
4575514|NCT01399099|7415181|FG000|Overall Study|Skin Irritation|13
4575515|NCT01399099|7415181|FG000|Overall Study|Infection|1
4575516|NCT01399099|7415181|FG000|Overall Study|Miscellaneous|4
4575517|NCT01399125|7415188|FG000|Overall Study|Adverse Event|32
4575518|NCT01399125|7415189|FG001|Overall Study|Adverse Event|30
4575519|NCT01399125|7415188|FG000|Overall Study|Abnormal Lab values|0
4575520|NCT01399125|7415189|FG001|Overall Study|Abnormal Lab values|1
4575521|NCT01399125|7415188|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0
4575522|NCT01399125|7415189|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4
4575523|NCT01399125|7415188|FG000|Overall Study|Withdrawal by Subject|5
4575524|NCT01399125|7415189|FG001|Overall Study|Withdrawal by Subject|8
4575525|NCT01399125|7415188|FG000|Overall Study|Lost to Follow-up|2
4575526|NCT01399125|7415189|FG001|Overall Study|Lost to Follow-up|3
4575527|NCT01399125|7415188|FG000|Overall Study|Administrative Problems|7
4575528|NCT01399125|7415189|FG001|Overall Study|Administrative Problems|11
4575529|NCT01399125|7415188|FG000|Overall Study|Death|0
4575530|NCT01399125|7415189|FG001|Overall Study|Death|1
4575531|NCT01399125|7415188|FG000|Overall Study|Protocol Deviation|5
4575532|NCT01399125|7415189|FG001|Overall Study|Protocol Deviation|2
4575533|NCT01399190|7415195|FG000|Overall Study|Not Eligible for Final Analysis|5
4691639|NCT02574078|7602066|FG012|Pre-Treatment Period|Other reasons|0
4691640|NCT02574078|7602054|FG000|Pre-Treatment Period|Poor/non-compliance|0
4691641|NCT02574078|7602055|FG001|Pre-Treatment Period|Poor/non-compliance|0
4691642|NCT02574078|7602056|FG002|Pre-Treatment Period|Poor/non-compliance|0
4691643|NCT02574078|7602057|FG003|Pre-Treatment Period|Poor/non-compliance|0
4691644|NCT02574078|7602058|FG004|Pre-Treatment Period|Poor/non-compliance|0
4691645|NCT02574078|7602059|FG005|Pre-Treatment Period|Poor/non-compliance|0
4691646|NCT02574078|7602060|FG006|Pre-Treatment Period|Poor/non-compliance|0
4691647|NCT02574078|7602061|FG007|Pre-Treatment Period|Poor/non-compliance|0
4691648|NCT02574078|7602062|FG008|Pre-Treatment Period|Poor/non-compliance|0
4691649|NCT02574078|7602063|FG009|Pre-Treatment Period|Poor/non-compliance|0
4691650|NCT02574078|7602064|FG010|Pre-Treatment Period|Poor/non-compliance|0
4691651|NCT02574078|7602065|FG011|Pre-Treatment Period|Poor/non-compliance|1
4691652|NCT02574078|7602066|FG012|Pre-Treatment Period|Poor/non-compliance|0
4691653|NCT02574078|7602054|FG000|Treatment Period|Disease progression|6
4691654|NCT02574078|7602055|FG001|Treatment Period|Disease progression|4
4691655|NCT02574078|7602056|FG002|Treatment Period|Disease progression|7
4691656|NCT02574078|7602057|FG003|Treatment Period|Disease progression|18
4691657|NCT02574078|7602058|FG004|Treatment Period|Disease progression|16
4691658|NCT02574078|7602059|FG005|Treatment Period|Disease progression|26
4691659|NCT02574078|7602060|FG006|Treatment Period|Disease progression|5
4691660|NCT02574078|7602061|FG007|Treatment Period|Disease progression|9
4691661|NCT02574078|7602062|FG008|Treatment Period|Disease progression|8
4691662|NCT02574078|7602063|FG009|Treatment Period|Disease progression|5
4691663|NCT02574078|7602064|FG010|Treatment Period|Disease progression|20
4691664|NCT02574078|7602065|FG011|Treatment Period|Disease progression|29
4691665|NCT02574078|7602066|FG012|Treatment Period|Disease progression|2
4691666|NCT02574078|7602054|FG000|Treatment Period|Study drug toxicity|1
4691667|NCT02574078|7602055|FG001|Treatment Period|Study drug toxicity|1
4691668|NCT02574078|7602056|FG002|Treatment Period|Study drug toxicity|0
4691669|NCT02574078|7602057|FG003|Treatment Period|Study drug toxicity|5
4691670|NCT02574078|7602058|FG004|Treatment Period|Study drug toxicity|3
4691671|NCT02574078|7602059|FG005|Treatment Period|Study drug toxicity|1
4691672|NCT02574078|7602060|FG006|Treatment Period|Study drug toxicity|2
4691673|NCT02574078|7602061|FG007|Treatment Period|Study drug toxicity|0
4691674|NCT02574078|7602062|FG008|Treatment Period|Study drug toxicity|2
4691675|NCT02574078|7602063|FG009|Treatment Period|Study drug toxicity|1
4691676|NCT02574078|7602064|FG010|Treatment Period|Study drug toxicity|16
4691677|NCT02574078|7602065|FG011|Treatment Period|Study drug toxicity|2
4575534|NCT01399190|7415195|FG000|Overall Study|Adverse Event|8
4575535|NCT01399190|7415195|FG000|Overall Study|Participant's Request|5
4575536|NCT01399190|7415195|FG000|Overall Study|Physician Decision|2
4575537|NCT01399372|7415216|FG000|Overall Study|Protocol Violation|3
4575538|NCT01399372|7415217|FG001|Overall Study|Protocol Violation|1
4691678|NCT02574078|7602066|FG012|Treatment Period|Study drug toxicity|4
4575539|NCT01399593|7415225|FG000|Overall Study|Physician Decision|1
4575540|NCT01399593|7415226|FG001|Overall Study|Physician Decision|0
4691679|NCT02574078|7602054|FG000|Treatment Period|Death|2
4691680|NCT02574078|7602055|FG001|Treatment Period|Death|0
4691681|NCT02574078|7602056|FG002|Treatment Period|Death|0
4691682|NCT02574078|7602057|FG003|Treatment Period|Death|0
4691683|NCT02574078|7602058|FG004|Treatment Period|Death|1
4691684|NCT02574078|7602059|FG005|Treatment Period|Death|1
4575541|NCT01399593|7415225|FG000|Overall Study|Adverse Event|1
4575542|NCT01399593|7415226|FG001|Overall Study|Adverse Event|0
4575543|NCT01399593|7415225|FG000|Overall Study|Death|1
4575544|NCT01399593|7415226|FG001|Overall Study|Death|1
4575545|NCT01399593|7415225|FG000|Overall Study|Transplantectomy|0
4575546|NCT01399593|7415226|FG001|Overall Study|Transplantectomy|1
4575547|NCT01399619|7415234|FG000|Overall Study|Adverse Event|10
4575548|NCT01399619|7415235|FG001|Overall Study|Adverse Event|0
4575549|NCT01399619|7415236|FG002|Overall Study|Adverse Event|4
4575550|NCT01399619|7415237|FG003|Overall Study|Adverse Event|10
4575551|NCT01399619|7415234|FG000|Overall Study|Lack of Efficacy|9
4575552|NCT01399619|7415235|FG001|Overall Study|Lack of Efficacy|0
4575553|NCT01399619|7415236|FG002|Overall Study|Lack of Efficacy|5
4575554|NCT01399619|7415237|FG003|Overall Study|Lack of Efficacy|0
4575555|NCT01399619|7415234|FG000|Overall Study|Withdrawal by Subject|6
4575556|NCT01399619|7415235|FG001|Overall Study|Withdrawal by Subject|0
4575557|NCT01399619|7415236|FG002|Overall Study|Withdrawal by Subject|3
4575558|NCT01399619|7415237|FG003|Overall Study|Withdrawal by Subject|4
4575559|NCT01399619|7415234|FG000|Overall Study|Protocol Violation|0
4575560|NCT01399619|7415235|FG001|Overall Study|Protocol Violation|0
4575561|NCT01399619|7415236|FG002|Overall Study|Protocol Violation|0
4575562|NCT01399619|7415237|FG003|Overall Study|Protocol Violation|1
4575563|NCT01399619|7415234|FG000|Overall Study|Not treated|0
4575564|NCT01399619|7415235|FG001|Overall Study|Not treated|0
4575565|NCT01399619|7415236|FG002|Overall Study|Not treated|0
4575566|NCT01399619|7415237|FG003|Overall Study|Not treated|2
4575567|NCT01399697|7415255|FG000|Overall Study|Adverse Event|13
4575568|NCT01399697|7415256|FG001|Overall Study|Adverse Event|3
4575569|NCT01399697|7415257|FG002|Overall Study|Adverse Event|1
4575570|NCT01399697|7415255|FG000|Overall Study|Lost to Follow-up|2
4575571|NCT01399697|7415256|FG001|Overall Study|Lost to Follow-up|0
4575572|NCT01399697|7415257|FG002|Overall Study|Lost to Follow-up|0
4575573|NCT01399697|7415255|FG000|Overall Study|Withdrawal by Subject|8
4575574|NCT01399697|7415256|FG001|Overall Study|Withdrawal by Subject|0
4575575|NCT01399697|7415257|FG002|Overall Study|Withdrawal by Subject|0
4575576|NCT01399697|7415255|FG000|Overall Study|Investigator Decisión|1
4575577|NCT01399697|7415256|FG001|Overall Study|Investigator Decisión|0
4575578|NCT01399697|7415257|FG002|Overall Study|Investigator Decisión|2
4575579|NCT01399697|7415255|FG000|Overall Study|Lack of Efficacy|9
4575580|NCT01399697|7415256|FG001|Overall Study|Lack of Efficacy|0
4575581|NCT01399697|7415257|FG002|Overall Study|Lack of Efficacy|1
4575582|NCT01399697|7415255|FG000|Overall Study|Protocol Violation|2
4575583|NCT01399697|7415256|FG001|Overall Study|Protocol Violation|0
4575584|NCT01399697|7415257|FG002|Overall Study|Protocol Violation|0
4575585|NCT01399697|7415255|FG000|Overall Study|Non-Compliant|1
4575586|NCT01399697|7415256|FG001|Overall Study|Non-Compliant|0
4575587|NCT01399697|7415257|FG002|Overall Study|Non-Compliant|0
4575588|NCT01399697|7415255|FG000|Overall Study|Inclusion Error|2
4575589|NCT01399697|7415256|FG001|Overall Study|Inclusion Error|0
4575590|NCT01399697|7415257|FG002|Overall Study|Inclusion Error|0
4575591|NCT01399697|7415255|FG000|Overall Study|Positive result for hepatitis B|1
4575592|NCT01399697|7415256|FG001|Overall Study|Positive result for hepatitis B|0
4575593|NCT01399697|7415257|FG002|Overall Study|Positive result for hepatitis B|0
4575594|NCT01399697|7415255|FG000|Overall Study|Clinical RA remission|1
4575595|NCT01399697|7415256|FG001|Overall Study|Clinical RA remission|0
4575596|NCT01399697|7415257|FG002|Overall Study|Clinical RA remission|0
4575597|NCT01399697|7415255|FG000|Overall Study|Sponsor Decision|1
4575598|NCT01399697|7415256|FG001|Overall Study|Sponsor Decision|0
4575599|NCT01399697|7415257|FG002|Overall Study|Sponsor Decision|0
4575600|NCT01399723|7415270|FG000|Overall Study|Lost to Follow-up|0
4575601|NCT01399723|7415271|FG001|Overall Study|Lost to Follow-up|1
4575602|NCT01399736|7415280|FG000|Overall Study|Withdrawal by Subject|4
4575603|NCT01399736|7415281|FG001|Overall Study|Withdrawal by Subject|2
4575604|NCT01399736|7415280|FG000|Overall Study|Lost to Follow-up|0
4575605|NCT01399736|7415281|FG001|Overall Study|Lost to Follow-up|2
4575606|NCT01399788|7415295|FG000|First Intervention Period|Adverse Event|1
4575607|NCT01399788|7415296|FG001|First Intervention Period|Adverse Event|0
4575608|NCT01399905|7415322|FG000|Overall Study|Withdrawal by Subject|1
4575609|NCT01399905|7415323|FG001|Overall Study|Withdrawal by Subject|1
4575610|NCT01400113|7415336|FG000|Overall Study|Withdrawal by Subject|1
4575611|NCT01400113|7415337|FG001|Overall Study|Withdrawal by Subject|1
4575612|NCT01400139|7415343|FG000|HYD Core Study|Adverse Event|210
4575613|NCT01400139|7415343|FG000|HYD Core Study|Lack of Efficacy|59
4575614|NCT01400139|7415343|FG000|HYD Core Study|Withdrawal by Subject|114
4575615|NCT01400139|7415343|FG000|HYD Core Study|Lost to Follow-up|39
4575616|NCT01400139|7415343|FG000|HYD Core Study|Confirmed or suspected diversion|20
4575617|NCT01400139|7415343|FG000|HYD Core Study|Administrative|56
4575618|NCT01400139|7415343|FG000|HYD Core Study|Did not qualify for Maintenance Period|14
4575619|NCT01400139|7415343|FG000|HYD Extension Period|Adverse Event|8
4575620|NCT01400139|7415343|FG000|HYD Extension Period|Withdrawal by Subject|5
4575621|NCT01400139|7415343|FG000|HYD Extension Period|Administrative|10
4575622|NCT01400243|7415351|FG000|Overall Study|Protocol Violation|8
4575623|NCT01400243|7415352|FG001|Overall Study|Protocol Violation|11
4575624|NCT01400412|7415362|FG000|Overall Study|Lost to Follow-up|4
4575625|NCT01400412|7415363|FG001|Overall Study|Lost to Follow-up|7
4575626|NCT01400412|7415362|FG000|Overall Study|Withdrawal by Subject|3
4575627|NCT01400412|7415363|FG001|Overall Study|Withdrawal by Subject|4
4575628|NCT01400412|7415362|FG000|Overall Study|Unable to complete|3
4575629|NCT01400412|7415363|FG001|Overall Study|Unable to complete|3
4575630|NCT01400412|7415362|FG000|Overall Study|Never started study treatment|0
4575631|NCT01400412|7415363|FG001|Overall Study|Never started study treatment|3
4575632|NCT01400425|7415371|FG000|Overall Study|Withdrawal by Subject|10
4575633|NCT01400451|7415380|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2
4575634|NCT01400451|7415381|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1
4575635|NCT01400451|7415382|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1
4575636|NCT01400451|7415380|FG000|Combination Treatment (or Intended)|Drug Toxicity|0
4575637|NCT01400451|7415381|FG001|Combination Treatment (or Intended)|Drug Toxicity|1
4575638|NCT01400451|7415382|FG002|Combination Treatment (or Intended)|Drug Toxicity|0
4575639|NCT01400451|7415380|FG000|Combination Treatment (or Intended)|Adverse Event|1
4575640|NCT01400451|7415381|FG001|Combination Treatment (or Intended)|Adverse Event|0
4575641|NCT01400451|7415382|FG002|Combination Treatment (or Intended)|Adverse Event|0
4575642|NCT01400451|7415380|FG000|Combination Treatment (or Intended)|Disease Progression|3
4575643|NCT01400451|7415381|FG001|Combination Treatment (or Intended)|Disease Progression|1
4575644|NCT01400451|7415382|FG002|Combination Treatment (or Intended)|Disease Progression|1
4575645|NCT01400451|7415380|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0
4575646|NCT01400451|7415381|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1
4575647|NCT01400451|7415382|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0
4575648|NCT01400503|7415404|FG000|Overall Study|Withdrawal by Subject|1
4575649|NCT01400503|7415404|FG000|Overall Study|Study Terminated by Sponsor|58
4575650|NCT01400503|7415404|FG000|Overall Study|Other|1
4575651|NCT01400516|7415410|FG000|Primary Trial|Withdrawal by Subject|0
4575652|NCT01400516|7415411|FG001|Primary Trial|Withdrawal by Subject|2
4575653|NCT01400698|7415421|FG000|Overall Study|Lost to Follow-up|2
4575654|NCT01400698|7415422|FG001|Overall Study|Lost to Follow-up|5
4575655|NCT01400698|7415423|FG002|Overall Study|Lost to Follow-up|2
4575656|NCT01400698|7415424|FG003|Overall Study|Lost to Follow-up|1
4575657|NCT01400698|7415425|FG004|Overall Study|Lost to Follow-up|4
4575658|NCT01400698|7415426|FG005|Overall Study|Lost to Follow-up|3
4575659|NCT01400698|7415421|FG000|Overall Study|Withdrawal by Subject|8
4575660|NCT01400698|7415422|FG001|Overall Study|Withdrawal by Subject|2
4575661|NCT01400698|7415423|FG002|Overall Study|Withdrawal by Subject|0
4575662|NCT01400698|7415424|FG003|Overall Study|Withdrawal by Subject|4
4575663|NCT01400698|7415425|FG004|Overall Study|Withdrawal by Subject|1
4575664|NCT01400698|7415426|FG005|Overall Study|Withdrawal by Subject|3
4575665|NCT01400698|7415421|FG000|Overall Study|Protocol Violation|0
4575666|NCT01400698|7415422|FG001|Overall Study|Protocol Violation|1
4575667|NCT01400698|7415423|FG002|Overall Study|Protocol Violation|0
4575668|NCT01400698|7415424|FG003|Overall Study|Protocol Violation|0
4575669|NCT01400698|7415425|FG004|Overall Study|Protocol Violation|1
4691685|NCT02574078|7602060|FG006|Treatment Period|Death|1
4691686|NCT02574078|7602061|FG007|Treatment Period|Death|1
4691687|NCT02574078|7602062|FG008|Treatment Period|Death|7
4691688|NCT02574078|7602063|FG009|Treatment Period|Death|1
4691689|NCT02574078|7602064|FG010|Treatment Period|Death|0
4691690|NCT02574078|7602065|FG011|Treatment Period|Death|2
4691691|NCT02574078|7602066|FG012|Treatment Period|Death|1
4691692|NCT02574078|7602054|FG000|Treatment Period|Adverse event unrelated to drug|0
4575670|NCT01400698|7415426|FG005|Overall Study|Protocol Violation|0
4575671|NCT01400698|7415421|FG000|Overall Study|Non-compliance|0
4575672|NCT01400698|7415422|FG001|Overall Study|Non-compliance|1
4575673|NCT01400698|7415423|FG002|Overall Study|Non-compliance|0
4575674|NCT01400698|7415424|FG003|Overall Study|Non-compliance|1
4575675|NCT01400698|7415425|FG004|Overall Study|Non-compliance|0
4575676|NCT01400698|7415426|FG005|Overall Study|Non-compliance|0
4575677|NCT01400698|7415421|FG000|Overall Study|Adverse Event|1
4575678|NCT01400698|7415422|FG001|Overall Study|Adverse Event|0
4575679|NCT01400698|7415423|FG002|Overall Study|Adverse Event|0
4575680|NCT01400698|7415424|FG003|Overall Study|Adverse Event|0
4575681|NCT01400698|7415425|FG004|Overall Study|Adverse Event|0
4575682|NCT01400698|7415426|FG005|Overall Study|Adverse Event|0
4575683|NCT01400698|7415421|FG000|Overall Study|Other|4
4575684|NCT01400698|7415422|FG001|Overall Study|Other|2
4575685|NCT01400698|7415423|FG002|Overall Study|Other|0
4575686|NCT01400698|7415424|FG003|Overall Study|Other|2
4575687|NCT01400698|7415425|FG004|Overall Study|Other|1
4691693|NCT02574078|7602055|FG001|Treatment Period|Adverse event unrelated to drug|0
4575688|NCT01400698|7415426|FG005|Overall Study|Other|0
4575689|NCT01400815|7415438|FG000|Overall Study|Adverse Event|3
4575690|NCT01400815|7415439|FG001|Overall Study|Adverse Event|0
4575691|NCT01400815|7415438|FG000|Overall Study|Death|0
4691694|NCT02574078|7602056|FG002|Treatment Period|Adverse event unrelated to drug|1
4575692|NCT01400815|7415439|FG001|Overall Study|Death|1
4575693|NCT01400815|7415438|FG000|Overall Study|Lost to Follow-up|18
4575694|NCT01400815|7415439|FG001|Overall Study|Lost to Follow-up|11
4575695|NCT01400815|7415438|FG000|Overall Study|Protocol Violation|0
4575696|NCT01400815|7415439|FG001|Overall Study|Protocol Violation|1
4575697|NCT01400815|7415438|FG000|Overall Study|Physician Decision|1
4575698|NCT01400815|7415439|FG001|Overall Study|Physician Decision|0
4575699|NCT01400815|7415438|FG000|Overall Study|Withdrawal by Subject|15
4575700|NCT01400815|7415439|FG001|Overall Study|Withdrawal by Subject|8
4575701|NCT01400815|7415438|FG000|Overall Study|Subject in jail|1
4575702|NCT01400815|7415439|FG001|Overall Study|Subject in jail|0
4575703|NCT01400841|7415445|FG000|Initial Study Phase (6 Months)|Death|1
4575704|NCT01400841|7415445|FG000|Extended Study Phase (2 Years)|Adverse Event|2
4575705|NCT01400893|7415455|FG000|Overall Study|Death|27
4575706|NCT01400893|7415456|FG001|Overall Study|Death|21
4575707|NCT01400893|7415455|FG000|Overall Study|Lost to Follow-up|0
4575708|NCT01400893|7415456|FG001|Overall Study|Lost to Follow-up|6
4575709|NCT01400919|7415477|FG000|Overall Study|Withdrawal by Subject|4
4575710|NCT01400919|7415477|FG000|Overall Study|Lost to Follow-up|2
4575711|NCT01400919|7415477|FG000|Overall Study|Missed visit|2
4575712|NCT01400932|7415483|FG000|Overall Study|Adverse Event|10
4575713|NCT01400932|7415484|FG001|Overall Study|Adverse Event|5
4575714|NCT01400932|7415483|FG000|Overall Study|Lack of Efficacy|0
4575715|NCT01400932|7415484|FG001|Overall Study|Lack of Efficacy|3
4575716|NCT01400932|7415483|FG000|Overall Study|Withdrawal by Subject|2
4575717|NCT01400932|7415484|FG001|Overall Study|Withdrawal by Subject|6
4575718|NCT01400932|7415483|FG000|Overall Study|Lost to Follow-up|1
4575719|NCT01400932|7415484|FG001|Overall Study|Lost to Follow-up|0
4575720|NCT01400932|7415483|FG000|Overall Study|Protocol Deviation|0
4575721|NCT01400932|7415484|FG001|Overall Study|Protocol Deviation|1
4575722|NCT01400932|7415483|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1
4575723|NCT01400932|7415484|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0
4575724|NCT01400958|7415492|FG000|Overall Study|Physician Decision|0
4575725|NCT01400958|7415493|FG001|Overall Study|Physician Decision|1
4575726|NCT01400958|7415492|FG000|Overall Study|Withdrawal by Subject|0
4575727|NCT01400958|7415493|FG001|Overall Study|Withdrawal by Subject|1
4575728|NCT01400958|7415492|FG000|Overall Study|Adverse Event|1
4691695|NCT02574078|7602057|FG003|Treatment Period|Adverse event unrelated to drug|0
4575729|NCT01400958|7415493|FG001|Overall Study|Adverse Event|0
4575730|NCT01400971|7415499|FG000|Overall Study|Death|82
4575731|NCT01400971|7415499|FG000|Overall Study|Lost to Follow-up|196
4575732|NCT01400971|7415499|FG000|Overall Study|Lost to follow up + Subject Decision|2
4575733|NCT01400971|7415499|FG000|Overall Study|Physician Decision|57
4575734|NCT01400971|7415499|FG000|Overall Study|Withdrawal by Subject|158
4575735|NCT01400971|7415499|FG000|Overall Study|Other|422
4575736|NCT01401010|7415505|FG000|Overall Study|Could not interpret assay results|1
4575737|NCT01401010|7415506|FG001|Overall Study|Could not interpret assay results|0
4575738|NCT01401062|7415525|FG000|Overall Study|Death|9
4575739|NCT01401062|7415526|FG001|Overall Study|Death|7
4575740|NCT01401062|7415525|FG000|Overall Study|Physician Decision|1
4575741|NCT01401062|7415526|FG001|Overall Study|Physician Decision|0
4575742|NCT01401062|7415525|FG000|Overall Study|Withdrawal by Subject|1
4575743|NCT01401062|7415526|FG001|Overall Study|Withdrawal by Subject|1
4575744|NCT01401153|7415543|FG000|First Test Day|Learning disabilities; illness|1
4575745|NCT01401153|7415544|FG001|First Test Day|Learning disabilities; illness|10
4575746|NCT01401153|7415543|FG000|Second Test Day|illness|0
4575747|NCT01401153|7415544|FG001|Second Test Day|illness|5
4575748|NCT01401283|7415592|FG000|Overall Study|surgery cancelled|5
4575749|NCT01401283|7415593|FG001|Overall Study|surgery cancelled|8
4575750|NCT01401283|7415592|FG000|Overall Study|preoperative arrhythmia|5
4575751|NCT01401283|7415593|FG001|Overall Study|preoperative arrhythmia|0
4575752|NCT01401283|7415592|FG000|Overall Study|no central venous access|0
4575753|NCT01401283|7415593|FG001|Overall Study|no central venous access|1
4575754|NCT01401283|7415592|FG000|Overall Study|suspicion of malignant hyperthermia|0
4575755|NCT01401283|7415593|FG001|Overall Study|suspicion of malignant hyperthermia|1
4575756|NCT01401322|7415599|FG000|Overall Study|Withdrawal by Subject|1
4575757|NCT01401322|7415599|FG000|Overall Study|Physician Decision|1
4575758|NCT01401361|7415603|FG000|Overall Study|Withdrawal by Subject|16
4575759|NCT01401361|7415603|FG000|Overall Study|Lack of Efficacy|6
4575760|NCT01401361|7415603|FG000|Overall Study|Physician Decision|1
4575761|NCT01401361|7415603|FG000|Overall Study|Lost to Follow-up|3
4575762|NCT01401361|7415603|FG000|Overall Study|Subject/family decision post procedure|2
4575763|NCT01401452|7415607|FG000|Overall Study|Adverse reaction|9
4575764|NCT01401452|7415607|FG000|Overall Study|Lost to Follow-up|12
4575765|NCT01401452|7415607|FG000|Overall Study|Lack of Efficacy|30
4575766|NCT01401452|7415607|FG000|Overall Study|Participant developed breast cancer|1
4575767|NCT01401452|7415607|FG000|Overall Study|Tx stopped due to financial reasons|1
4575768|NCT01401452|7415607|FG000|Overall Study|Tx stopped by psychiatrist|1
4575769|NCT01401452|7415607|FG000|Overall Study|No more visits within the 36 wk followup|4
4575770|NCT01401452|7415607|FG000|Overall Study|Subject did not come to follow up visits|2
4734861|NCT03510182|7682207|FG000|Overall Study|Withdrawal by Subject|2
4575771|NCT01401452|7415607|FG000|Overall Study|Subject didn't return for routine visits|1
4575772|NCT01401452|7415607|FG000|Overall Study|Subject moved to another city|1
4575773|NCT01401452|7415607|FG000|Overall Study|Subject's wife wants to get pregnant|1
4575774|NCT01401452|7415607|FG000|Overall Study|Psoriatic arthritis|1
4575775|NCT01401452|7415607|FG000|Overall Study|Participant stopped Tx|2
4575776|NCT01401452|7415607|FG000|Overall Study|Discontinuation for personal reasons|1
4575777|NCT01401452|7415607|FG000|Overall Study|Treatment failure|1
4575778|NCT01401452|7415607|FG000|Overall Study|Unsatisfactory output|1
4575779|NCT01401452|7415607|FG000|Overall Study|Subject withdrew because of Tx success|1
4575780|NCT01401452|7415607|FG000|Overall Study|Subject chose to discontinue treatment|1
4575781|NCT01401452|7415607|FG000|Overall Study|Participant withdrew consent|1
4575782|NCT01401465|7415613|FG000|Treatment Period 1|Adverse Event|4
4575783|NCT01401465|7415614|FG001|Treatment Period 1|Adverse Event|1
4575784|NCT01401465|7415613|FG000|Treatment Period 1|Pregnancy|0
4575785|NCT01401465|7415614|FG001|Treatment Period 1|Pregnancy|1
4575786|NCT01401465|7415613|FG000|Treatment Period 1|Protocol Violation|5
4575787|NCT01401465|7415614|FG001|Treatment Period 1|Protocol Violation|0
4575788|NCT01401465|7415613|FG000|Treatment Period 1|Withdrawal by Subject|1
4575789|NCT01401465|7415614|FG001|Treatment Period 1|Withdrawal by Subject|4
4575790|NCT01401465|7415613|FG000|Treatment Period 1|Non-Compliance to Study Drug|1
4575791|NCT01401465|7415614|FG001|Treatment Period 1|Non-Compliance to Study Drug|0
4575792|NCT01401465|7415613|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3
4575793|NCT01401465|7415614|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9
4575794|NCT01401465|7415613|FG000|Treatment Period 1|Scheduling Difficulties|1
4575795|NCT01401465|7415614|FG001|Treatment Period 1|Scheduling Difficulties|1
4575796|NCT01401465|7415613|FG000|Treatment Period 2|Lost to Follow-up|0
4575797|NCT01401465|7415614|FG001|Treatment Period 2|Lost to Follow-up|1
4575798|NCT01401465|7415613|FG000|Treatment Period 2|Withdrawal by Subject|0
4575799|NCT01401465|7415614|FG001|Treatment Period 2|Withdrawal by Subject|1
4575800|NCT01401478|7415623|FG000|Overall Study|Study drug not available|6
4575801|NCT01401478|7415623|FG000|Overall Study|Adverse Event|5
4575802|NCT01401478|7415623|FG000|Overall Study|Hyperphosphatemia|5
4575803|NCT01401478|7415623|FG000|Overall Study|Lost to Follow-up|5
4691696|NCT02574078|7602058|FG004|Treatment Period|Adverse event unrelated to drug|2
4691697|NCT02574078|7602059|FG005|Treatment Period|Adverse event unrelated to drug|3
4691698|NCT02574078|7602060|FG006|Treatment Period|Adverse event unrelated to drug|0
4691699|NCT02574078|7602061|FG007|Treatment Period|Adverse event unrelated to drug|0
4691700|NCT02574078|7602062|FG008|Treatment Period|Adverse event unrelated to drug|1
4691701|NCT02574078|7602063|FG009|Treatment Period|Adverse event unrelated to drug|2
4575804|NCT01401478|7415623|FG000|Overall Study|Kidney transplantation|3
4575805|NCT01401478|7415623|FG000|Overall Study|Withdrawal by Subject|3
4575806|NCT01401478|7415623|FG000|Overall Study|Blood samples not available|1
4575807|NCT01401478|7415623|FG000|Overall Study|Hyperphosphatemia and adverse event|1
4575808|NCT01401478|7415623|FG000|Overall Study|Low intact parathyroid hormone|1
4575809|NCT01401478|7415623|FG000|Overall Study|Serious adverse event|1
4575810|NCT01401530|7415643|FG000|Overall Study|Disease Progression|1
4575811|NCT01401530|7415644|FG001|Overall Study|Disease Progression|2
4575812|NCT01401530|7415645|FG002|Overall Study|Disease Progression|1
4575813|NCT01401530|7415643|FG000|Overall Study|Adverse Event|1
4575814|NCT01401530|7415644|FG001|Overall Study|Adverse Event|1
4575815|NCT01401530|7415645|FG002|Overall Study|Adverse Event|1
4575816|NCT01401530|7415643|FG000|Overall Study|Participant Choice|1
4575817|NCT01401530|7415644|FG001|Overall Study|Participant Choice|2
4575818|NCT01401530|7415645|FG002|Overall Study|Participant Choice|1
4575819|NCT01401530|7415643|FG000|Overall Study|Physician Decision|0
4575820|NCT01401530|7415644|FG001|Overall Study|Physician Decision|1
4575821|NCT01401530|7415645|FG002|Overall Study|Physician Decision|0
4575822|NCT01401647|7415697|FG000|Overall Study|Withdrawal by Subject|1
4575823|NCT01401647|7415698|FG001|Overall Study|Withdrawal by Subject|5
4575824|NCT01401647|7415699|FG002|Overall Study|Withdrawal by Subject|2
4575825|NCT01401647|7415697|FG000|Overall Study|Lost to Follow-up|3
4575826|NCT01401647|7415698|FG001|Overall Study|Lost to Follow-up|3
4575827|NCT01401647|7415699|FG002|Overall Study|Lost to Follow-up|1
4575828|NCT01401842|7415713|FG000|Overall Study|Withdrawal by Subject|3
4575829|NCT01401842|7415714|FG001|Overall Study|Withdrawal by Subject|2
4575830|NCT01401842|7415713|FG000|Overall Study|academic reason|4
4575831|NCT01401842|7415714|FG001|Overall Study|academic reason|1
4575832|NCT01401842|7415713|FG000|Overall Study|changed companies|20
4575833|NCT01401842|7415714|FG001|Overall Study|changed companies|34
4575834|NCT01401842|7415713|FG000|Overall Study|discharged from US Army|3
4575835|NCT01401842|7415714|FG001|Overall Study|discharged from US Army|4
4575836|NCT01401842|7415713|FG000|Overall Study|invalid follow-up strength data|1
4575837|NCT01401842|7415714|FG001|Overall Study|invalid follow-up strength data|4
4691702|NCT02574078|7602064|FG010|Treatment Period|Adverse event unrelated to drug|4
4575838|NCT01401842|7415713|FG000|Overall Study|on profile|9
4575839|NCT01401842|7415714|FG001|Overall Study|on profile|5
4575840|NCT01401842|7415713|FG000|Overall Study|other/unknown|28
4575841|NCT01401842|7415714|FG001|Overall Study|other/unknown|17
4575842|NCT01401959|7415734|FG000|Enrolled|Withdrawal by Subject|1
4575843|NCT01401959|7415735|FG001|Enrolled|Withdrawal by Subject|0
4691703|NCT02574078|7602065|FG011|Treatment Period|Adverse event unrelated to drug|1
4575844|NCT01401959|7415736|FG002|Enrolled|Withdrawal by Subject|0
4575845|NCT01401959|7415734|FG000|Treated|Disease Progression|2
4575846|NCT01401959|7415735|FG001|Treated|Disease Progression|2
4575847|NCT01401959|7415736|FG002|Treated|Disease Progression|1
4575848|NCT01401959|7415734|FG000|Treated|Adverse Event|4
4575849|NCT01401959|7415735|FG001|Treated|Adverse Event|3
4575850|NCT01401959|7415736|FG002|Treated|Adverse Event|2
4575851|NCT01401959|7415734|FG000|Treated|Withdrawal by Subject|1
4575852|NCT01401959|7415735|FG001|Treated|Withdrawal by Subject|2
4575853|NCT01401959|7415736|FG002|Treated|Withdrawal by Subject|2
4575854|NCT01401959|7415734|FG000|Treated|Protocol Violation|0
4575855|NCT01401959|7415735|FG001|Treated|Protocol Violation|1
4575856|NCT01401959|7415736|FG002|Treated|Protocol Violation|0
4575857|NCT01402011|7415749|FG000|Delayed Treatment Period|Withdrawal by Subject|1
4575858|NCT01402011|7415750|FG001|Delayed Treatment Period|Withdrawal by Subject|0
4575859|NCT01402011|7415751|FG002|Delayed Treatment Period|Withdrawal by Subject|0
4575860|NCT01402011|7415749|FG000|Active Treatment Period|Withdrawal by Subject|1
4575861|NCT01402011|7415750|FG001|Active Treatment Period|Withdrawal by Subject|3
4575862|NCT01402011|7415751|FG002|Active Treatment Period|Withdrawal by Subject|0
4575863|NCT01402011|7415749|FG000|Nine Month Follow-up|Withdrawal by Subject|0
4575864|NCT01402011|7415750|FG001|Nine Month Follow-up|Withdrawal by Subject|1
4575865|NCT01402011|7415751|FG002|Nine Month Follow-up|Withdrawal by Subject|0
4575866|NCT01402063|7415773|FG000|Overall Study|Withdrawal by Subject|3
4575867|NCT01402063|7415774|FG001|Overall Study|Withdrawal by Subject|3
4575868|NCT01402102|7415782|FG000|Overall Study|Protocol Violation|1
4575869|NCT01402102|7415783|FG001|Overall Study|Protocol Violation|0
4575870|NCT01402102|7415782|FG000|Overall Study|Insufficiency of compliance|1
4575871|NCT01402102|7415783|FG001|Overall Study|Insufficiency of compliance|1
4575872|NCT01402102|7415782|FG000|Overall Study|Withdrawal by Subject|0
4575873|NCT01402102|7415783|FG001|Overall Study|Withdrawal by Subject|2
4575874|NCT01402284|7415819|FG000|Overall Study|Withdrawal consent|2
4575875|NCT01402284|7415819|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1
4575876|NCT01402284|7415819|FG000|Overall Study|Physician Decision|1
4575877|NCT01402284|7415819|FG000|Overall Study|Disease progression on study|10
4575878|NCT01402492|7415860|FG000|Overall Study|Withdrawal by Subject|17
4575879|NCT01402492|7415861|FG001|Overall Study|Withdrawal by Subject|11
4575880|NCT01402492|7415862|FG002|Overall Study|Withdrawal by Subject|11
4575881|NCT01402492|7415860|FG000|Overall Study|Adverse Event|2
4575882|NCT01402492|7415861|FG001|Overall Study|Adverse Event|3
4575883|NCT01402492|7415862|FG002|Overall Study|Adverse Event|4
4575884|NCT01402492|7415860|FG000|Overall Study|Physician Decision|0
4575885|NCT01402492|7415861|FG001|Overall Study|Physician Decision|3
4575886|NCT01402492|7415862|FG002|Overall Study|Physician Decision|0
4575887|NCT01402492|7415860|FG000|Overall Study|Incarcerated (N=3)|2
4575888|NCT01402492|7415861|FG001|Overall Study|Incarcerated (N=3)|0
4575889|NCT01402492|7415862|FG002|Overall Study|Incarcerated (N=3)|1
4575890|NCT01402544|7415870|FG000|Overall Study|Withdrawal by Subject|6
4575891|NCT01402570|7415874|FG000|Overall Study|Adverse Event|1
4575892|NCT01402700|7415879|FG000|Overall Study|Death|3
4575893|NCT01402700|7415879|FG000|Overall Study|Withdrawal by Subject|3
4575894|NCT01402700|7415879|FG000|Overall Study|Missed Visit|1
4575895|NCT01402817|7415883|FG000|Overall Study|Withdrawal by Subject|3
4575896|NCT01402817|7415883|FG000|Overall Study|Study Suspended by FDA|8
4575897|NCT01402869|7415891|FG000|Overall Study|Required Tooth Extraction|0
4575898|NCT01402869|7415892|FG001|Overall Study|Required Tooth Extraction|0
4575899|NCT01402869|7415893|FG002|Overall Study|Required Tooth Extraction|1
4575900|NCT01402908|7415903|FG000|Overall Study|Withdrawal by Subject|30
4575901|NCT01402908|7415904|FG001|Overall Study|Withdrawal by Subject|17
4575902|NCT01402908|7415903|FG000|Overall Study|Lost to Follow-up|3
4575903|NCT01402908|7415904|FG001|Overall Study|Lost to Follow-up|1
4575904|NCT01402908|7415903|FG000|Overall Study|Physician Decision|1
4575905|NCT01402908|7415904|FG001|Overall Study|Physician Decision|0
4575906|NCT01402947|7415912|FG000|First Intervention|Adverse Event|0
4575907|NCT01402947|7415913|FG001|First Intervention|Adverse Event|1
4575908|NCT01402986|7415923|FG000|Overall Study|Withdrawal by Subject|7
4575909|NCT01402986|7415924|FG001|Overall Study|Withdrawal by Subject|10
4575910|NCT01402986|7415925|FG002|Overall Study|Withdrawal by Subject|7
4575911|NCT01402986|7415926|FG003|Overall Study|Withdrawal by Subject|13
4575912|NCT01402986|7415923|FG000|Overall Study|Death|0
4575913|NCT01402986|7415924|FG001|Overall Study|Death|0
4575914|NCT01402986|7415925|FG002|Overall Study|Death|0
4575915|NCT01402986|7415926|FG003|Overall Study|Death|2
4575916|NCT01402986|7415923|FG000|Overall Study|Lost to Follow-up|0
4575917|NCT01402986|7415924|FG001|Overall Study|Lost to Follow-up|0
4575918|NCT01402986|7415925|FG002|Overall Study|Lost to Follow-up|0
4575919|NCT01402986|7415926|FG003|Overall Study|Lost to Follow-up|1
4575920|NCT01402986|7415923|FG000|Overall Study|Other|2
4575921|NCT01402986|7415924|FG001|Overall Study|Other|5
4575922|NCT01402986|7415925|FG002|Overall Study|Other|1
4575923|NCT01402986|7415926|FG003|Overall Study|Other|6
4575924|NCT01403051|7415938|FG000|Overall Study|Protocol Violation|2
4575925|NCT01403051|7415939|FG001|Overall Study|Protocol Violation|0
4575926|NCT01403051|7415938|FG000|Overall Study|Death|1
4575927|NCT01403051|7415939|FG001|Overall Study|Death|0
4575928|NCT01403051|7415938|FG000|Overall Study|Withdrawal by Subject|2
4575929|NCT01403051|7415939|FG001|Overall Study|Withdrawal by Subject|1
4575930|NCT01403051|7415938|FG000|Overall Study|Lost to Follow-up|5
4575931|NCT01403051|7415939|FG001|Overall Study|Lost to Follow-up|5
4575932|NCT01403064|7415950|FG000|Overall Study|Death|0
4575933|NCT01403064|7415951|FG001|Overall Study|Death|0
4575934|NCT01403064|7415952|FG002|Overall Study|Death|1
4575935|NCT01403064|7415953|FG003|Overall Study|Death|1
4575936|NCT01403064|7415950|FG000|Overall Study|Withdrawal by Subject|0
4575937|NCT01403064|7415951|FG001|Overall Study|Withdrawal by Subject|0
4575938|NCT01403064|7415952|FG002|Overall Study|Withdrawal by Subject|1
4575939|NCT01403064|7415953|FG003|Overall Study|Withdrawal by Subject|1
4575940|NCT01403064|7415950|FG000|Overall Study|Other|1
4575941|NCT01403064|7415951|FG001|Overall Study|Other|0
4575942|NCT01403064|7415952|FG002|Overall Study|Other|2
4575943|NCT01403064|7415953|FG003|Overall Study|Other|1
4575944|NCT01403116|7415974|FG000|Overall Study|Adverse Event|7
4575945|NCT01403116|7415975|FG001|Overall Study|Adverse Event|4
4575946|NCT01403116|7415974|FG000|Overall Study|Lost to Follow-up|7
4575947|NCT01403116|7415975|FG001|Overall Study|Lost to Follow-up|5
4575948|NCT01403116|7415974|FG000|Overall Study|Withdrawal by Subject|12
4575949|NCT01403116|7415975|FG001|Overall Study|Withdrawal by Subject|15
4575950|NCT01403116|7415974|FG000|Overall Study|Non-compliance of study drug|3
4575951|NCT01403116|7415975|FG001|Overall Study|Non-compliance of study drug|0
4575952|NCT01403116|7415974|FG000|Overall Study|Protocol Violation|0
4575953|NCT01403116|7415975|FG001|Overall Study|Protocol Violation|1
4575954|NCT01403116|7415974|FG000|Overall Study|undisclosed Hx of Prostate Ca|1
4575955|NCT01403116|7415975|FG001|Overall Study|undisclosed Hx of Prostate Ca|0
4575956|NCT01403116|7415974|FG000|Overall Study|Hct >54%|2
4575957|NCT01403116|7415975|FG001|Overall Study|Hct >54%|0
4575958|NCT01403116|7415974|FG000|Overall Study|unable to keep appointments|0
4575959|NCT01403116|7415975|FG001|Overall Study|unable to keep appointments|2
4575960|NCT01403610|7416015|FG000|Overall Study|Withdrawal by Subject|2
4575961|NCT01403610|7416016|FG001|Overall Study|Withdrawal by Subject|0
4575962|NCT01403610|7416017|FG002|Overall Study|Withdrawal by Subject|0
4575963|NCT01403610|7416018|FG003|Overall Study|Withdrawal by Subject|0
4575964|NCT01403610|7416015|FG000|Overall Study|Didn't recover from surgery sufficiently|0
4575965|NCT01403610|7416016|FG001|Overall Study|Didn't recover from surgery sufficiently|3
4575966|NCT01403610|7416017|FG002|Overall Study|Didn't recover from surgery sufficiently|0
4575967|NCT01403610|7416018|FG003|Overall Study|Didn't recover from surgery sufficiently|0
4575968|NCT01403805|7416030|FG000|Overall Study|Withdrawal by Subject|0
4575969|NCT01403805|7416031|FG001|Overall Study|Withdrawal by Subject|4
4575970|NCT01403805|7416030|FG000|Overall Study|Lost to Follow-up|0
4575971|NCT01403805|7416031|FG001|Overall Study|Lost to Follow-up|2
4575972|NCT01403805|7416030|FG000|Overall Study|Death|0
4575973|NCT01403805|7416031|FG001|Overall Study|Death|1
4575974|NCT01403987|7416044|FG000|Overall Study|Residents forgot their secret PIN|18
4575975|NCT01403987|7416045|FG001|Overall Study|Residents forgot their secret PIN|17
4575976|NCT01403987|7416046|FG002|Overall Study|Residents forgot their secret PIN|18
4575977|NCT01404208|7416110|FG000|Overall Study|Discontinued|3
4575978|NCT01404208|7416111|FG001|Overall Study|Discontinued|0
4575979|NCT01404234|7416117|FG000|Overall Study|Withdrawal by Subject|2
4575980|NCT01404325|7416132|FG000|Overall Study|Lost to Follow-up|1
4575981|NCT01404325|7416133|FG001|Overall Study|Lost to Follow-up|0
4575982|NCT01404325|7416132|FG000|Overall Study|Death|2
4575983|NCT01404325|7416133|FG001|Overall Study|Death|0
4575984|NCT01404325|7416132|FG000|Overall Study|Graft loss/Retransplantation|1
4575985|NCT01404325|7416133|FG001|Overall Study|Graft loss/Retransplantation|0
4575986|NCT01404325|7416132|FG000|Overall Study|non-specified reason|0
4575987|NCT01404325|7416133|FG001|Overall Study|non-specified reason|2
4593054|NCT01546142|7441078|FG000|Overall Study|Lost to Follow-up|20
4593055|NCT01546142|7441079|FG001|Overall Study|Lost to Follow-up|15
4593056|NCT01546142|7441078|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1
4593057|NCT01546142|7441079|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0
4593058|NCT01546142|7441078|FG000|Overall Study|Subject Randomized but Not Treated|1
4593059|NCT01546142|7441079|FG001|Overall Study|Subject Randomized but Not Treated|0
4593060|NCT01546155|7441085|FG000|Overall Study|could not tolerate long scan duration|3
4593061|NCT01546168|7441091|FG000|Overall Study|Lost to Follow-up|1
4593062|NCT01546168|7441092|FG001|Overall Study|Lost to Follow-up|0
4593063|NCT01546168|7441091|FG000|Overall Study|Withdrawal by Subject|1
4593064|NCT01546168|7441092|FG001|Overall Study|Withdrawal by Subject|0
4593065|NCT01546168|7441091|FG000|Overall Study|ineligible after signing consent|2
4593066|NCT01546168|7441092|FG001|Overall Study|ineligible after signing consent|0
4593067|NCT01546519|7441132|FG000|Overall Study|Adverse Event|0
4593068|NCT01546519|7441133|FG001|Overall Study|Adverse Event|0
4593069|NCT01546519|7441134|FG002|Overall Study|Adverse Event|1
4593070|NCT01546519|7441135|FG003|Overall Study|Adverse Event|1
4593071|NCT01546519|7441132|FG000|Overall Study|Death|0
4593072|NCT01546519|7441133|FG001|Overall Study|Death|1
4593073|NCT01546519|7441134|FG002|Overall Study|Death|3
4593074|NCT01546519|7441135|FG003|Overall Study|Death|1
4593075|NCT01546519|7441132|FG000|Overall Study|related to disease progression|2
4593076|NCT01546519|7441133|FG001|Overall Study|related to disease progression|2
4593077|NCT01546519|7441134|FG002|Overall Study|related to disease progression|2
4575988|NCT01404949|7416209|FG000|Overall Study|Not Treated|1
4575989|NCT01404988|7416216|FG000|Overall Study|Death|2
4575990|NCT01404988|7416217|FG001|Overall Study|Death|0
4575991|NCT01404988|7416218|FG002|Overall Study|Death|2
4575992|NCT01404988|7416216|FG000|Overall Study|Adverse Event|1
4575993|NCT01404988|7416217|FG001|Overall Study|Adverse Event|0
4575994|NCT01404988|7416218|FG002|Overall Study|Adverse Event|0
4575995|NCT01404988|7416216|FG000|Overall Study|Withdrawal by Subject|2
4691704|NCT02574078|7602066|FG012|Treatment Period|Adverse event unrelated to drug|0
4691705|NCT02574078|7602054|FG000|Treatment Period|Administrative reason by Sponsor|0
4691706|NCT02574078|7602055|FG001|Treatment Period|Administrative reason by Sponsor|1
4691707|NCT02574078|7602056|FG002|Treatment Period|Administrative reason by Sponsor|0
4691708|NCT02574078|7602057|FG003|Treatment Period|Administrative reason by Sponsor|0
4691709|NCT02574078|7602058|FG004|Treatment Period|Administrative reason by Sponsor|0
4691710|NCT02574078|7602059|FG005|Treatment Period|Administrative reason by Sponsor|0
4691711|NCT02574078|7602060|FG006|Treatment Period|Administrative reason by Sponsor|1
4575996|NCT01404988|7416217|FG001|Overall Study|Withdrawal by Subject|2
4575997|NCT01404988|7416218|FG002|Overall Study|Withdrawal by Subject|0
4575998|NCT01404988|7416216|FG000|Overall Study|Lost to Follow-up|1
4575999|NCT01404988|7416217|FG001|Overall Study|Lost to Follow-up|2
4576000|NCT01404988|7416218|FG002|Overall Study|Lost to Follow-up|1
4576001|NCT01405027|7416231|FG000|Overall Study|Withdrawn consent|3
4576002|NCT01405027|7416232|FG001|Overall Study|Withdrawn consent|0
4576003|NCT01405027|7416231|FG000|Overall Study|Lost to Follow-up|16
4576004|NCT01405027|7416232|FG001|Overall Study|Lost to Follow-up|24
4576005|NCT01405027|7416231|FG000|Overall Study|Investigator judgement|0
4576006|NCT01405027|7416232|FG001|Overall Study|Investigator judgement|2
4576007|NCT01405027|7416231|FG000|Overall Study|Death|1
4576008|NCT01405027|7416232|FG001|Overall Study|Death|0
4576009|NCT01405027|7416231|FG000|Overall Study|Other or Unknown|12
4576010|NCT01405027|7416232|FG001|Overall Study|Other or Unknown|25
4576011|NCT01405053|7416242|FG000|Overall Study|Adverse Event|3
4576012|NCT01405053|7416243|FG001|Overall Study|Adverse Event|0
4576013|NCT01405053|7416242|FG000|Overall Study|Lost to Follow-up|0
4576014|NCT01405053|7416243|FG001|Overall Study|Lost to Follow-up|1
4576015|NCT01405053|7416242|FG000|Overall Study|Participant choice|2
4576016|NCT01405053|7416243|FG001|Overall Study|Participant choice|1
4576017|NCT01405053|7416242|FG000|Overall Study|Inadequate therapeutic effect|2
4576018|NCT01405053|7416243|FG001|Overall Study|Inadequate therapeutic effect|1
4576019|NCT01405053|7416242|FG000|Overall Study|Withdrawal by Subject|3
4576020|NCT01405053|7416243|FG001|Overall Study|Withdrawal by Subject|4
4576021|NCT01405053|7416242|FG000|Overall Study|Other|0
4576022|NCT01405053|7416243|FG001|Overall Study|Other|1
4576023|NCT01405196|7416253|FG000|Overall Study|Study Terminated by Sponsor|0
4576024|NCT01405196|7416254|FG001|Overall Study|Study Terminated by Sponsor|0
4576025|NCT01405196|7416255|FG002|Overall Study|Study Terminated by Sponsor|9
4576026|NCT01405196|7416256|FG003|Overall Study|Study Terminated by Sponsor|0
4576027|NCT01405196|7416253|FG000|Overall Study|Other|2
4576028|NCT01405196|7416254|FG001|Overall Study|Other|2
4576029|NCT01405196|7416255|FG002|Overall Study|Other|5
4576030|NCT01405196|7416256|FG003|Overall Study|Other|0
4576031|NCT01405196|7416253|FG000|Overall Study|Withdrawal by Subject|4
4576032|NCT01405196|7416254|FG001|Overall Study|Withdrawal by Subject|6
4576033|NCT01405196|7416255|FG002|Overall Study|Withdrawal by Subject|3
4576034|NCT01405196|7416256|FG003|Overall Study|Withdrawal by Subject|6
4576035|NCT01405196|7416253|FG000|Overall Study|Adverse Event|2
4576036|NCT01405196|7416254|FG001|Overall Study|Adverse Event|2
4576037|NCT01405196|7416255|FG002|Overall Study|Adverse Event|0
4576038|NCT01405196|7416256|FG003|Overall Study|Adverse Event|2
4576039|NCT01405196|7416253|FG000|Overall Study|Death|1
4576040|NCT01405196|7416254|FG001|Overall Study|Death|0
4576041|NCT01405196|7416255|FG002|Overall Study|Death|3
4576042|NCT01405196|7416256|FG003|Overall Study|Death|0
4576043|NCT01405196|7416253|FG000|Overall Study|Lost to Follow-up|2
4691712|NCT02574078|7602061|FG007|Treatment Period|Administrative reason by Sponsor|0
4691713|NCT02574078|7602062|FG008|Treatment Period|Administrative reason by Sponsor|0
4576044|NCT01405196|7416254|FG001|Overall Study|Lost to Follow-up|2
4576045|NCT01405196|7416255|FG002|Overall Study|Lost to Follow-up|3
4576046|NCT01405196|7416256|FG003|Overall Study|Lost to Follow-up|1
4576047|NCT01405456|7416277|FG000|Overall Study|Lost to Follow-up|2
4576048|NCT01405456|7416278|FG001|Overall Study|Lost to Follow-up|1
4576049|NCT01405456|7416277|FG000|Overall Study|Physician Decision|1
4576050|NCT01405456|7416278|FG001|Overall Study|Physician Decision|0
4576051|NCT01405508|7416293|FG000|Overall Study|AE, non-serious non-fatal|1
4576052|NCT01405508|7416294|FG001|Overall Study|AE, non-serious non-fatal|1
4576053|NCT01405508|7416295|FG002|Overall Study|AE, non-serious non-fatal|0
4576054|NCT01405508|7416296|FG003|Overall Study|AE, non-serious non-fatal|0
4576055|NCT01405560|7416306|FG000|Overall Study|Physician Decision|1
4576056|NCT01405742|7416310|FG000|Overall Study|Lost to Follow-up|1
4576057|NCT01405742|7416311|FG001|Overall Study|Lost to Follow-up|0
4576058|NCT01405768|7416319|FG000|Overall Study|Didn't complete questionnaire correctly|4
4576059|NCT01405768|7416320|FG001|Overall Study|Didn't complete questionnaire correctly|0
4576060|NCT01405820|7416338|FG000|Randomized Treatment Period|Adverse Event|3
4576061|NCT01405820|7416339|FG001|Randomized Treatment Period|Adverse Event|3
4576062|NCT01405820|7416340|FG002|Randomized Treatment Period|Adverse Event|3
4576063|NCT01405820|7416341|FG003|Randomized Treatment Period|Adverse Event|0
4576064|NCT01405820|7416342|FG004|Randomized Treatment Period|Adverse Event|2
4576065|NCT01405820|7416343|FG005|Randomized Treatment Period|Adverse Event|1
4576066|NCT01405820|7416338|FG000|Randomized Treatment Period|Withdrawal by Subject|6
4576067|NCT01405820|7416339|FG001|Randomized Treatment Period|Withdrawal by Subject|2
4576068|NCT01405820|7416340|FG002|Randomized Treatment Period|Withdrawal by Subject|2
4576069|NCT01405820|7416341|FG003|Randomized Treatment Period|Withdrawal by Subject|2
4576070|NCT01405820|7416342|FG004|Randomized Treatment Period|Withdrawal by Subject|0
4576071|NCT01405820|7416343|FG005|Randomized Treatment Period|Withdrawal by Subject|0
4576072|NCT01405820|7416338|FG000|Randomized Treatment Period|Other|2
4576073|NCT01405820|7416339|FG001|Randomized Treatment Period|Other|2
4576074|NCT01405820|7416340|FG002|Randomized Treatment Period|Other|1
4576075|NCT01405820|7416341|FG003|Randomized Treatment Period|Other|1
4576076|NCT01405820|7416342|FG004|Randomized Treatment Period|Other|0
4576077|NCT01405820|7416343|FG005|Randomized Treatment Period|Other|0
4576078|NCT01405820|7416338|FG000|Randomized Treatment Period|Physician Decision|0
4576079|NCT01405820|7416339|FG001|Randomized Treatment Period|Physician Decision|2
4576080|NCT01405820|7416340|FG002|Randomized Treatment Period|Physician Decision|1
4576081|NCT01405820|7416341|FG003|Randomized Treatment Period|Physician Decision|0
4576082|NCT01405820|7416342|FG004|Randomized Treatment Period|Physician Decision|0
4576083|NCT01405820|7416343|FG005|Randomized Treatment Period|Physician Decision|0
4576084|NCT01405820|7416338|FG000|Randomized Treatment Period|Rescue|0
4576085|NCT01405820|7416339|FG001|Randomized Treatment Period|Rescue|1
4576086|NCT01405820|7416340|FG002|Randomized Treatment Period|Rescue|13
4576087|NCT01405820|7416341|FG003|Randomized Treatment Period|Rescue|10
4576088|NCT01405820|7416342|FG004|Randomized Treatment Period|Rescue|8
4576089|NCT01405820|7416343|FG005|Randomized Treatment Period|Rescue|8
4576090|NCT01405820|7416338|FG000|Randomized Treatment Period|Incorrect Study Treatment|0
4576091|NCT01405820|7416339|FG001|Randomized Treatment Period|Incorrect Study Treatment|0
4576092|NCT01405820|7416340|FG002|Randomized Treatment Period|Incorrect Study Treatment|3
4576093|NCT01405820|7416341|FG003|Randomized Treatment Period|Incorrect Study Treatment|0
4576094|NCT01405820|7416342|FG004|Randomized Treatment Period|Incorrect Study Treatment|2
4576095|NCT01405820|7416343|FG005|Randomized Treatment Period|Incorrect Study Treatment|0
4576096|NCT01405820|7416338|FG000|Randomized Treatment Period|Treatment Arm Closed|0
4576097|NCT01405820|7416339|FG001|Randomized Treatment Period|Treatment Arm Closed|0
4576098|NCT01405820|7416340|FG002|Randomized Treatment Period|Treatment Arm Closed|20
4576099|NCT01405820|7416341|FG003|Randomized Treatment Period|Treatment Arm Closed|36
4576100|NCT01405820|7416342|FG004|Randomized Treatment Period|Treatment Arm Closed|33
4576101|NCT01405820|7416343|FG005|Randomized Treatment Period|Treatment Arm Closed|28
4576102|NCT01405820|7416338|FG000|Randomized Treatment Period|Death|0
4576103|NCT01405820|7416339|FG001|Randomized Treatment Period|Death|0
4576104|NCT01405820|7416340|FG002|Randomized Treatment Period|Death|0
4576105|NCT01405820|7416341|FG003|Randomized Treatment Period|Death|1
4576106|NCT01405820|7416342|FG004|Randomized Treatment Period|Death|0
4576107|NCT01405820|7416343|FG005|Randomized Treatment Period|Death|0
4576108|NCT01405820|7416338|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0
4576109|NCT01405820|7416339|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0
4576110|NCT01405820|7416340|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0
4576111|NCT01405820|7416341|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1
4576112|NCT01405820|7416342|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0
4576113|NCT01405820|7416343|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0
4576114|NCT01405820|7416338|FG000|Open-Label Treatment Period|Withdrawal by Subject|3
4576115|NCT01405820|7416339|FG001|Open-Label Treatment Period|Withdrawal by Subject|1
4576116|NCT01405820|7416340|FG002|Open-Label Treatment Period|Withdrawal by Subject|1
4576117|NCT01405820|7416341|FG003|Open-Label Treatment Period|Withdrawal by Subject|1
4576118|NCT01405820|7416342|FG004|Open-Label Treatment Period|Withdrawal by Subject|0
4576119|NCT01405820|7416343|FG005|Open-Label Treatment Period|Withdrawal by Subject|1
4576120|NCT01405820|7416338|FG000|Open-Label Treatment Period|Other|1
4576121|NCT01405820|7416339|FG001|Open-Label Treatment Period|Other|1
4576122|NCT01405820|7416340|FG002|Open-Label Treatment Period|Other|1
4576123|NCT01405820|7416341|FG003|Open-Label Treatment Period|Other|1
4576124|NCT01405820|7416342|FG004|Open-Label Treatment Period|Other|1
4576125|NCT01405820|7416343|FG005|Open-Label Treatment Period|Other|1
4576126|NCT01405820|7416338|FG000|Open-Label Treatment Period|Physician Decision|0
4576127|NCT01405820|7416339|FG001|Open-Label Treatment Period|Physician Decision|0
4576128|NCT01405820|7416340|FG002|Open-Label Treatment Period|Physician Decision|1
4576129|NCT01405820|7416341|FG003|Open-Label Treatment Period|Physician Decision|2
4576130|NCT01405820|7416342|FG004|Open-Label Treatment Period|Physician Decision|1
4576131|NCT01405820|7416343|FG005|Open-Label Treatment Period|Physician Decision|0
4576132|NCT01405820|7416338|FG000|Open-Label Treatment Period|Adverse Event|0
4576133|NCT01405820|7416339|FG001|Open-Label Treatment Period|Adverse Event|0
4576134|NCT01405820|7416340|FG002|Open-Label Treatment Period|Adverse Event|0
4576135|NCT01405820|7416341|FG003|Open-Label Treatment Period|Adverse Event|1
4576136|NCT01405820|7416342|FG004|Open-Label Treatment Period|Adverse Event|0
4576137|NCT01405820|7416343|FG005|Open-Label Treatment Period|Adverse Event|0
4576138|NCT01405898|7416365|FG000|Overall Study|Withdrawal by Subject|2
4576139|NCT01405898|7416366|FG001|Overall Study|Withdrawal by Subject|2
4576140|NCT01405911|7416375|FG000|Overall Study|Pre-treatment lab AE|0
4576141|NCT01405911|7416376|FG001|Overall Study|Pre-treatment lab AE|1
4576142|NCT01405911|7416377|FG002|Overall Study|Pre-treatment lab AE|0
4576143|NCT01405911|7416375|FG000|Overall Study|Lost to Follow-up|0
4576144|NCT01405911|7416376|FG001|Overall Study|Lost to Follow-up|1
4576145|NCT01405911|7416377|FG002|Overall Study|Lost to Follow-up|0
4576146|NCT01405911|7416375|FG000|Overall Study|Protocol Violation|1
4576147|NCT01405911|7416376|FG001|Overall Study|Protocol Violation|0
4576148|NCT01405911|7416377|FG002|Overall Study|Protocol Violation|0
4576149|NCT01405911|7416375|FG000|Overall Study|Withdrawal by Subject|3
4576150|NCT01405911|7416376|FG001|Overall Study|Withdrawal by Subject|1
4576151|NCT01405911|7416377|FG002|Overall Study|Withdrawal by Subject|1
4576152|NCT01405924|7416385|FG000|Overall Study|Protocol Violation|8
4576153|NCT01405924|7416385|FG000|Overall Study|Missing/Incomplete Data|2
4576154|NCT01405950|7416402|FG000|Overall Study|Withdrawal by Subject|1
4576155|NCT01405950|7416403|FG001|Overall Study|Withdrawal by Subject|0
4576156|NCT01405950|7416404|FG002|Overall Study|Withdrawal by Subject|0
4576157|NCT01405950|7416405|FG003|Overall Study|Withdrawal by Subject|0
4576158|NCT01406015|7416415|FG000|Overall Study|Withdrawal by Subject|3
4576159|NCT01406015|7416416|FG001|Overall Study|Withdrawal by Subject|3
4576160|NCT01406574|7416452|FG000|Overall Study|Adverse Event|0
4576161|NCT01406574|7416453|FG001|Overall Study|Adverse Event|0
4576162|NCT01406574|7416454|FG002|Overall Study|Adverse Event|1
4576163|NCT01406574|7416455|FG003|Overall Study|Adverse Event|3
4576164|NCT01406574|7416452|FG000|Overall Study|Physician Decision|0
4576165|NCT01406574|7416453|FG001|Overall Study|Physician Decision|0
4576166|NCT01406574|7416454|FG002|Overall Study|Physician Decision|0
4576167|NCT01406574|7416455|FG003|Overall Study|Physician Decision|1
4576168|NCT01406574|7416452|FG000|Overall Study|Withdrawal by Subject|0
4576169|NCT01406574|7416453|FG001|Overall Study|Withdrawal by Subject|1
4576170|NCT01406574|7416454|FG002|Overall Study|Withdrawal by Subject|0
4576171|NCT01406574|7416455|FG003|Overall Study|Withdrawal by Subject|0
4576172|NCT01406574|7416452|FG000|Overall Study|Definite progression of primary disease|1
4576173|NCT01406574|7416453|FG001|Overall Study|Definite progression of primary disease|0
4576174|NCT01406574|7416454|FG002|Overall Study|Definite progression of primary disease|0
4576175|NCT01406574|7416455|FG003|Overall Study|Definite progression of primary disease|0
4576176|NCT01406652|7416468|FG000|Overall Study|Lost-to-follow-up|3
4576177|NCT01406652|7416469|FG001|Overall Study|Lost-to-follow-up|4
4576178|NCT01406652|7416468|FG000|Overall Study|Withdrawal by Subject|2
4576179|NCT01406652|7416469|FG001|Overall Study|Withdrawal by Subject|2
4576180|NCT01406652|7416468|FG000|Overall Study|Insufficient follow-up|5
4576181|NCT01406652|7416469|FG001|Overall Study|Insufficient follow-up|4
4576182|NCT01406652|7416468|FG000|Overall Study|Infection not sure|10
4576183|NCT01406652|7416469|FG001|Overall Study|Infection not sure|10
4576184|NCT01406717|7416479|FG000|Overall Study|Subject non-compliance|4
4576185|NCT01406717|7416480|FG001|Overall Study|Subject non-compliance|3
4576186|NCT01406717|7416479|FG000|Overall Study|Protocol Violation|5
4576187|NCT01406717|7416480|FG001|Overall Study|Protocol Violation|1
4576188|NCT01406717|7416479|FG000|Overall Study|Lost to Follow-up|14
4576189|NCT01406717|7416480|FG001|Overall Study|Lost to Follow-up|8
4576190|NCT01406717|7416479|FG000|Overall Study|Withdrawal by Subject|19
4576191|NCT01406717|7416480|FG001|Overall Study|Withdrawal by Subject|15
4576192|NCT01406717|7416479|FG000|Overall Study|Adverse Event|1
4576193|NCT01406717|7416480|FG001|Overall Study|Adverse Event|2
4576194|NCT01406717|7416479|FG000|Overall Study|Lack of Efficacy|0
4576195|NCT01406717|7416480|FG001|Overall Study|Lack of Efficacy|1
4576196|NCT01406717|7416479|FG000|Overall Study|Non-completion of visit activity|0
4576197|NCT01406717|7416480|FG001|Overall Study|Non-completion of visit activity|1
4576198|NCT01406795|7416496|FG000|Overall Study|Withdrawal by Subject|1
4576199|NCT01406873|7416502|FG000|Overall Study|Withdrawal by Subject|1
4576200|NCT01406873|7416503|FG001|Overall Study|Withdrawal by Subject|1
4576201|NCT01406938|7416521|FG000|Induction Period|Subject/guardian decision|6
4576202|NCT01406938|7416522|FG001|Induction Period|Subject/guardian decision|8
4576203|NCT01406938|7416523|FG002|Induction Period|Subject/guardian decision|0
4576204|NCT01406938|7416524|FG003|Induction Period|Subject/guardian decision|0
4576205|NCT01406938|7416525|FG004|Induction Period|Subject/guardian decision|0
4576206|NCT01406938|7416526|FG005|Induction Period|Subject/guardian decision|0
4576207|NCT01406938|7416521|FG000|Induction Period|Protocol deviation|1
4576208|NCT01406938|7416522|FG001|Induction Period|Protocol deviation|0
4576209|NCT01406938|7416523|FG002|Induction Period|Protocol deviation|0
4576210|NCT01406938|7416524|FG003|Induction Period|Protocol deviation|0
4576211|NCT01406938|7416525|FG004|Induction Period|Protocol deviation|0
4576212|NCT01406938|7416526|FG005|Induction Period|Protocol deviation|0
4576213|NCT01406938|7416521|FG000|Induction Period|Adverse Event|8
4576214|NCT01406938|7416522|FG001|Induction Period|Adverse Event|9
4576215|NCT01406938|7416523|FG002|Induction Period|Adverse Event|0
4576216|NCT01406938|7416524|FG003|Induction Period|Adverse Event|0
4576217|NCT01406938|7416525|FG004|Induction Period|Adverse Event|0
4576218|NCT01406938|7416526|FG005|Induction Period|Adverse Event|0
4576219|NCT01406938|7416521|FG000|Induction Period|Lack of Efficacy|1
4576220|NCT01406938|7416522|FG001|Induction Period|Lack of Efficacy|0
4576221|NCT01406938|7416523|FG002|Induction Period|Lack of Efficacy|0
4576222|NCT01406938|7416524|FG003|Induction Period|Lack of Efficacy|0
4576223|NCT01406938|7416525|FG004|Induction Period|Lack of Efficacy|0
4576224|NCT01406938|7416526|FG005|Induction Period|Lack of Efficacy|0
4576225|NCT01406938|7416521|FG000|Induction Period|Lost to Follow-up|2
4576226|NCT01406938|7416522|FG001|Induction Period|Lost to Follow-up|3
4576227|NCT01406938|7416523|FG002|Induction Period|Lost to Follow-up|0
4576228|NCT01406938|7416524|FG003|Induction Period|Lost to Follow-up|0
4576229|NCT01406938|7416525|FG004|Induction Period|Lost to Follow-up|0
4576230|NCT01406938|7416526|FG005|Induction Period|Lost to Follow-up|0
4576231|NCT01406938|7416521|FG000|Maintenance Period|Adverse Event|0
4576232|NCT01406938|7416522|FG001|Maintenance Period|Adverse Event|0
4576233|NCT01406938|7416523|FG002|Maintenance Period|Adverse Event|2
4576234|NCT01406938|7416524|FG003|Maintenance Period|Adverse Event|8
4576235|NCT01406938|7416525|FG004|Maintenance Period|Adverse Event|4
4576236|NCT01406938|7416526|FG005|Maintenance Period|Adverse Event|2
4576237|NCT01406938|7416521|FG000|Maintenance Period|Death|0
4576238|NCT01406938|7416522|FG001|Maintenance Period|Death|0
4576239|NCT01406938|7416523|FG002|Maintenance Period|Death|0
4576240|NCT01406938|7416524|FG003|Maintenance Period|Death|0
4576241|NCT01406938|7416525|FG004|Maintenance Period|Death|1
4576242|NCT01406938|7416526|FG005|Maintenance Period|Death|0
4576243|NCT01406938|7416521|FG000|Maintenance Period|Subject/guardian decision|0
4576244|NCT01406938|7416522|FG001|Maintenance Period|Subject/guardian decision|0
4576245|NCT01406938|7416523|FG002|Maintenance Period|Subject/guardian decision|11
4576246|NCT01406938|7416524|FG003|Maintenance Period|Subject/guardian decision|7
4576247|NCT01406938|7416525|FG004|Maintenance Period|Subject/guardian decision|10
4576248|NCT01406938|7416526|FG005|Maintenance Period|Subject/guardian decision|7
4576249|NCT01406938|7416521|FG000|Maintenance Period|Protocol Violation|0
4576250|NCT01406938|7416522|FG001|Maintenance Period|Protocol Violation|0
4576251|NCT01406938|7416523|FG002|Maintenance Period|Protocol Violation|2
4576252|NCT01406938|7416524|FG003|Maintenance Period|Protocol Violation|2
4576253|NCT01406938|7416525|FG004|Maintenance Period|Protocol Violation|2
4576254|NCT01406938|7416526|FG005|Maintenance Period|Protocol Violation|2
4576255|NCT01406938|7416521|FG000|Maintenance Period|Pregnancy|0
4576256|NCT01406938|7416522|FG001|Maintenance Period|Pregnancy|0
4576257|NCT01406938|7416523|FG002|Maintenance Period|Pregnancy|0
4576258|NCT01406938|7416524|FG003|Maintenance Period|Pregnancy|0
4576259|NCT01406938|7416525|FG004|Maintenance Period|Pregnancy|1
4576260|NCT01406938|7416526|FG005|Maintenance Period|Pregnancy|0
4576261|NCT01406938|7416521|FG000|Maintenance Period|Lost to Follow-up|0
4576262|NCT01406938|7416522|FG001|Maintenance Period|Lost to Follow-up|0
4576263|NCT01406938|7416523|FG002|Maintenance Period|Lost to Follow-up|0
4576264|NCT01406938|7416524|FG003|Maintenance Period|Lost to Follow-up|0
4576265|NCT01406938|7416525|FG004|Maintenance Period|Lost to Follow-up|4
4576266|NCT01406938|7416526|FG005|Maintenance Period|Lost to Follow-up|0
4576267|NCT01406938|7416521|FG000|Maintenance Period|Lack of Efficacy|0
4576268|NCT01406938|7416522|FG001|Maintenance Period|Lack of Efficacy|0
4576269|NCT01406938|7416523|FG002|Maintenance Period|Lack of Efficacy|2
4576270|NCT01406938|7416524|FG003|Maintenance Period|Lack of Efficacy|1
4576271|NCT01406938|7416525|FG004|Maintenance Period|Lack of Efficacy|3
4576272|NCT01406938|7416526|FG005|Maintenance Period|Lack of Efficacy|5
4576273|NCT01406938|7416521|FG000|Follow up|Lack of Efficacy|3
4576274|NCT01406938|7416522|FG001|Follow up|Lack of Efficacy|2
4576275|NCT01406938|7416523|FG002|Follow up|Lack of Efficacy|1
4576276|NCT01406938|7416524|FG003|Follow up|Lack of Efficacy|0
4576277|NCT01406938|7416525|FG004|Follow up|Lack of Efficacy|0
4576278|NCT01406938|7416526|FG005|Follow up|Lack of Efficacy|0
4576279|NCT01406938|7416521|FG000|Follow up|Patient/guardian decision|4
4576280|NCT01406938|7416522|FG001|Follow up|Patient/guardian decision|2
4576281|NCT01406938|7416523|FG002|Follow up|Patient/guardian decision|4
4576282|NCT01406938|7416524|FG003|Follow up|Patient/guardian decision|2
4576283|NCT01406938|7416525|FG004|Follow up|Patient/guardian decision|4
4576284|NCT01406938|7416526|FG005|Follow up|Patient/guardian decision|1
4576285|NCT01406938|7416521|FG000|Follow up|Protocol Violation|0
4576286|NCT01406938|7416522|FG001|Follow up|Protocol Violation|0
4576287|NCT01406938|7416523|FG002|Follow up|Protocol Violation|1
4576288|NCT01406938|7416524|FG003|Follow up|Protocol Violation|0
4576289|NCT01406938|7416525|FG004|Follow up|Protocol Violation|0
4576290|NCT01406938|7416526|FG005|Follow up|Protocol Violation|0
4576291|NCT01406938|7416521|FG000|Follow up|Physician Decision|0
4576292|NCT01406938|7416522|FG001|Follow up|Physician Decision|0
4576293|NCT01406938|7416523|FG002|Follow up|Physician Decision|2
4576294|NCT01406938|7416524|FG003|Follow up|Physician Decision|0
4576295|NCT01406938|7416525|FG004|Follow up|Physician Decision|3
4576296|NCT01406938|7416526|FG005|Follow up|Physician Decision|1
4576297|NCT01406938|7416521|FG000|Follow up|Lost to Follow-up|1
4576298|NCT01406938|7416522|FG001|Follow up|Lost to Follow-up|1
4576299|NCT01406938|7416523|FG002|Follow up|Lost to Follow-up|0
4576300|NCT01406938|7416524|FG003|Follow up|Lost to Follow-up|1
4576301|NCT01406938|7416525|FG004|Follow up|Lost to Follow-up|2
4576302|NCT01406938|7416526|FG005|Follow up|Lost to Follow-up|1
4576303|NCT01407276|7416590|FG000|Overall Study|Withdrawal by Subject|0
4576304|NCT01407276|7416591|FG001|Overall Study|Withdrawal by Subject|0
4576305|NCT01407276|7416592|FG002|Overall Study|Withdrawal by Subject|0
4576306|NCT01407276|7416593|FG003|Overall Study|Withdrawal by Subject|0
4576307|NCT01407276|7416594|FG004|Overall Study|Withdrawal by Subject|0
4576308|NCT01407276|7416595|FG005|Overall Study|Withdrawal by Subject|0
4576309|NCT01407276|7416596|FG006|Overall Study|Withdrawal by Subject|0
4576310|NCT01407276|7416597|FG007|Overall Study|Withdrawal by Subject|1
4576311|NCT01407354|7416622|FG000|First Intervention|Withdrawal by Subject|0
4576312|NCT01407354|7416623|FG001|First Intervention|Withdrawal by Subject|2
4576313|NCT01407354|7416622|FG000|First Intervention|Adverse Event|1
4576314|NCT01407354|7416623|FG001|First Intervention|Adverse Event|0
4576315|NCT01407354|7416622|FG000|First Intervention|Physician Decision|1
4576316|NCT01407354|7416623|FG001|First Intervention|Physician Decision|0
4576317|NCT01407367|7416632|FG000|Overall Study|Death|24
4576318|NCT01407367|7416633|FG001|Overall Study|Death|32
4576319|NCT01407367|7416632|FG000|Overall Study|Renal Replacement Therapy (RRT)|12
4576320|NCT01407367|7416633|FG001|Overall Study|Renal Replacement Therapy (RRT)|29
4576321|NCT01407367|7416632|FG000|Overall Study|Withdrawal by Subject|4
4576322|NCT01407367|7416633|FG001|Overall Study|Withdrawal by Subject|15
4576323|NCT01407367|7416632|FG000|Overall Study|Lost to Follow-up|0
4576324|NCT01407367|7416633|FG001|Overall Study|Lost to Follow-up|2
4576325|NCT01407926|7416657|FG000|Overall Study|Lost to Follow-up|55
4576326|NCT01408030|7416675|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1
4576327|NCT01408030|7416676|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0
4576328|NCT01408030|7416677|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1
4576329|NCT01408030|7416678|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0
4576330|NCT01408030|7416675|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2
4576331|NCT01408030|7416676|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6
4576332|NCT01408030|7416677|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0
4576333|NCT01408030|7416678|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3
4576334|NCT01408030|7416675|FG000|Treatment Phase (on Drug)|Protocol Violation|0
4576335|NCT01408030|7416676|FG001|Treatment Phase (on Drug)|Protocol Violation|1
4576336|NCT01408030|7416677|FG002|Treatment Phase (on Drug)|Protocol Violation|0
4576337|NCT01408030|7416678|FG003|Treatment Phase (on Drug)|Protocol Violation|0
4576338|NCT01408030|7416675|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0
4576339|NCT01408030|7416676|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2
4576340|NCT01408030|7416677|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2
4576341|NCT01408030|7416678|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0
4576342|NCT01408030|7416675|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3
4576343|NCT01408030|7416676|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2
4576344|NCT01408030|7416677|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1
4576345|NCT01408030|7416678|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3
4576346|NCT01408030|7416675|FG000|Observation Phase (Off Drug)|Physician Decision|0
4576347|NCT01408030|7416676|FG001|Observation Phase (Off Drug)|Physician Decision|1
4576348|NCT01408030|7416677|FG002|Observation Phase (Off Drug)|Physician Decision|2
4576349|NCT01408030|7416678|FG003|Observation Phase (Off Drug)|Physician Decision|0
4576350|NCT01408030|7416675|FG000|Observation Phase (Off Drug)|Other|1
4576351|NCT01408030|7416676|FG001|Observation Phase (Off Drug)|Other|1
4576352|NCT01408030|7416677|FG002|Observation Phase (Off Drug)|Other|1
4576353|NCT01408030|7416678|FG003|Observation Phase (Off Drug)|Other|1
4576354|NCT01408043|7416688|FG000|Overall Study|unable to collect cells|1
4576355|NCT01408147|7416694|FG000|Overall Study|Withdrawal by Subject|0
4576356|NCT01408147|7416695|FG001|Overall Study|Withdrawal by Subject|1
4576357|NCT01408277|7416703|FG000|Overall Study|Adverse Event|3
4576358|NCT01408277|7416704|FG001|Overall Study|Adverse Event|4
4576359|NCT01408277|7416703|FG000|Overall Study|Lost to Follow-up|1
4576360|NCT01408277|7416704|FG001|Overall Study|Lost to Follow-up|0
4576361|NCT01408277|7416703|FG000|Overall Study|Withdrawal by Subject|2
4576362|NCT01408277|7416704|FG001|Overall Study|Withdrawal by Subject|0
4576363|NCT01408277|7416703|FG000|Overall Study|Protocol Violation|2
4576364|NCT01408277|7416704|FG001|Overall Study|Protocol Violation|0
4576365|NCT01408303|7416713|FG000|Overall Study|Adverse Event|3
4576366|NCT01408303|7416714|FG001|Overall Study|Adverse Event|7
4576367|NCT01408303|7416715|FG002|Overall Study|Adverse Event|2
4576368|NCT01408303|7416713|FG000|Overall Study|Lost to Follow-up|0
4576369|NCT01408303|7416714|FG001|Overall Study|Lost to Follow-up|1
4576370|NCT01408303|7416715|FG002|Overall Study|Lost to Follow-up|2
4576371|NCT01408303|7416713|FG000|Overall Study|Withdrawal by Subject|2
4576372|NCT01408303|7416714|FG001|Overall Study|Withdrawal by Subject|3
4576373|NCT01408303|7416715|FG002|Overall Study|Withdrawal by Subject|1
4576374|NCT01408303|7416713|FG000|Overall Study|Protocol Violation|0
4576375|NCT01408303|7416714|FG001|Overall Study|Protocol Violation|1
4576376|NCT01408303|7416715|FG002|Overall Study|Protocol Violation|0
4576377|NCT01408303|7416713|FG000|Overall Study|Noncompliance|1
4576378|NCT01408303|7416714|FG001|Overall Study|Noncompliance|0
4576379|NCT01408303|7416715|FG002|Overall Study|Noncompliance|1
4576380|NCT01408459|7416734|FG000|Overall Study|Withdrawal by Subject|1
4576381|NCT01408459|7416735|FG001|Overall Study|Withdrawal by Subject|1
4576382|NCT01408485|7416742|FG000|Overall Study|Withdrawal by Subject|21
4576383|NCT01408537|7416746|FG000|Overall Study|Withdrawal by Subject|2
4576384|NCT01408537|7416746|FG000|Overall Study|Protocol Violation|3
4576385|NCT01408537|7416746|FG000|Overall Study|Lost to Follow-up|3
4576386|NCT01408563|7416761|FG000|Overall Study|Ineligible after consent/ registration|2
4576387|NCT01408576|7416768|FG000|Overall Study|Lack of Efficacy|17
4576388|NCT01408576|7416769|FG001|Overall Study|Lack of Efficacy|30
4576389|NCT01408576|7416770|FG002|Overall Study|Lack of Efficacy|48
4576390|NCT01408576|7416768|FG000|Overall Study|Protocol Violation|1
4576391|NCT01408576|7416769|FG001|Overall Study|Protocol Violation|2
4576392|NCT01408576|7416770|FG002|Overall Study|Protocol Violation|2
4576393|NCT01408576|7416768|FG000|Overall Study|Lost to Follow-up|10
4576394|NCT01408576|7416769|FG001|Overall Study|Lost to Follow-up|9
4576395|NCT01408576|7416770|FG002|Overall Study|Lost to Follow-up|17
4576396|NCT01408576|7416768|FG000|Overall Study|Withdrawal by Subject|34
4576397|NCT01408576|7416769|FG001|Overall Study|Withdrawal by Subject|60
4576398|NCT01408576|7416770|FG002|Overall Study|Withdrawal by Subject|66
4576399|NCT01408576|7416768|FG000|Overall Study|Sponsor terminated study|89
4576400|NCT01408576|7416769|FG001|Overall Study|Sponsor terminated study|333
4576401|NCT01408576|7416770|FG002|Overall Study|Sponsor terminated study|330
4576402|NCT01408576|7416768|FG000|Overall Study|AE, serious fatal|4
4576403|NCT01408576|7416769|FG001|Overall Study|AE, serious fatal|4
4576404|NCT01408576|7416770|FG002|Overall Study|AE, serious fatal|1
4576405|NCT01408576|7416768|FG000|Overall Study|SAE, non-fatal|11
4576406|NCT01408576|7416769|FG001|Overall Study|SAE, non-fatal|23
4576407|NCT01408576|7416770|FG002|Overall Study|SAE, non-fatal|14
4576408|NCT01408576|7416768|FG000|Overall Study|AE, non-serious non-fatal|12
4576409|NCT01408576|7416769|FG001|Overall Study|AE, non-serious non-fatal|19
4576410|NCT01408576|7416770|FG002|Overall Study|AE, non-serious non-fatal|11
4576411|NCT01408576|7416768|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
4576412|NCT01408576|7416769|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
4576413|NCT01408576|7416770|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
4576414|NCT01408576|7416768|FG000|Overall Study|AE, unknown type|0
4576415|NCT01408576|7416769|FG001|Overall Study|AE, unknown type|1
4576416|NCT01408576|7416770|FG002|Overall Study|AE, unknown type|0
4576417|NCT01408576|7416768|FG000|Overall Study|Other|10
4576418|NCT01408576|7416769|FG001|Overall Study|Other|16
4576419|NCT01408576|7416770|FG002|Overall Study|Other|18
4576420|NCT01408628|7416790|FG000|Consented|Withdrawal by Subject|12
4576421|NCT01408628|7416790|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3
4576422|NCT01408628|7416790|FG000|Completed 6 Month Follow-Up|Protocol Violation|6
4576423|NCT01408628|7416790|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5
4576424|NCT01408706|7416797|FG000|Overall Study|Physician Decision|1
4576425|NCT01408706|7416798|FG001|Overall Study|Physician Decision|0
4576426|NCT01408732|7416855|FG000|Overall Study|Withdrawal by Subject|2
4576427|NCT01408732|7416856|FG001|Overall Study|Withdrawal by Subject|2
4576428|NCT01408888|7416867|FG000|First Intervention|Adverse Event|0
4576429|NCT01408888|7416868|FG001|First Intervention|Adverse Event|1
4576430|NCT01408888|7416867|FG000|First Intervention|Withdrawal by Subject|0
4576431|NCT01408888|7416868|FG001|First Intervention|Withdrawal by Subject|2
4576432|NCT01408888|7416867|FG000|Second Intervention|Withdrawal by Subject|1
4576433|NCT01408888|7416868|FG001|Second Intervention|Withdrawal by Subject|0
4576434|NCT01408888|7416867|FG000|Second Intervention|Adverse Event|1
4576435|NCT01408888|7416868|FG001|Second Intervention|Adverse Event|0
4576436|NCT01408901|7416888|FG000|6-Week Follow-Up|Lost to Follow-up|2
4576437|NCT01408901|7416889|FG001|6-Week Follow-Up|Lost to Follow-up|1
4576438|NCT01408901|7416890|FG002|6-Week Follow-Up|Lost to Follow-up|3
4576439|NCT01408901|7416891|FG003|6-Week Follow-Up|Lost to Follow-up|2
4576440|NCT01408901|7416888|FG000|6-Week Follow-Up|Death|1
4576441|NCT01408901|7416889|FG001|6-Week Follow-Up|Death|0
4576442|NCT01408901|7416890|FG002|6-Week Follow-Up|Death|0
4576443|NCT01408901|7416891|FG003|6-Week Follow-Up|Death|0
4576444|NCT01408901|7416888|FG000|6-Week Follow-Up|Cancelled visit|0
4576445|NCT01408901|7416889|FG001|6-Week Follow-Up|Cancelled visit|1
4576446|NCT01408901|7416890|FG002|6-Week Follow-Up|Cancelled visit|0
4576447|NCT01408901|7416891|FG003|6-Week Follow-Up|Cancelled visit|2
4576448|NCT01408901|7416888|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0
4576449|NCT01408901|7416889|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0
4576450|NCT01408901|7416890|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0
4576451|NCT01408901|7416891|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2
4576452|NCT01408901|7416888|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1
4576453|NCT01408901|7416889|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0
4576454|NCT01408901|7416890|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0
4576455|NCT01408901|7416891|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0
4576456|NCT01408901|7416888|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0
4576457|NCT01408901|7416889|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2
4576458|NCT01408901|7416890|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0
4576459|NCT01408901|7416891|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1
4576460|NCT01408901|7416888|FG000|26-Week Follow-Up|Lost to Follow-up|1
4576461|NCT01408901|7416889|FG001|26-Week Follow-Up|Lost to Follow-up|1
4576462|NCT01408901|7416890|FG002|26-Week Follow-Up|Lost to Follow-up|0
4576463|NCT01408901|7416891|FG003|26-Week Follow-Up|Lost to Follow-up|1
4576464|NCT01408901|7416888|FG000|26-Week Follow-Up|Death|0
4576465|NCT01408901|7416889|FG001|26-Week Follow-Up|Death|1
4576466|NCT01408901|7416890|FG002|26-Week Follow-Up|Death|0
4576467|NCT01408901|7416891|FG003|26-Week Follow-Up|Death|0
4576468|NCT01408914|7416906|FG000|Overall Study|Could not complete tx in protocol period|5
4576469|NCT01408914|7416907|FG001|Overall Study|Could not complete tx in protocol period|5
4576470|NCT01408914|7416908|FG002|Overall Study|Could not complete tx in protocol period|6
4576471|NCT01408914|7416906|FG000|Overall Study|Lost to Follow-up|4
4576472|NCT01408914|7416907|FG001|Overall Study|Lost to Follow-up|1
4576473|NCT01408914|7416908|FG002|Overall Study|Lost to Follow-up|2
4576474|NCT01408914|7416906|FG000|Overall Study|Physician Decision|1
4576475|NCT01408914|7416907|FG001|Overall Study|Physician Decision|1
4576476|NCT01408914|7416908|FG002|Overall Study|Physician Decision|0
4576477|NCT01408914|7416906|FG000|Overall Study|Withdrawal by Subject|1
4576478|NCT01408914|7416907|FG001|Overall Study|Withdrawal by Subject|0
4576479|NCT01408914|7416908|FG002|Overall Study|Withdrawal by Subject|1
4576480|NCT01408914|7416906|FG000|Overall Study|Moved out of study jurisdiction|1
4576481|NCT01408914|7416907|FG001|Overall Study|Moved out of study jurisdiction|1
4576482|NCT01408914|7416908|FG002|Overall Study|Moved out of study jurisdiction|0
4576483|NCT01408914|7416906|FG000|Overall Study|Late exclusion|0
4576484|NCT01408914|7416907|FG001|Overall Study|Late exclusion|3
4576485|NCT01408914|7416908|FG002|Overall Study|Late exclusion|3
4576486|NCT01408914|7416906|FG000|Overall Study|Change in local TB/HIV norms|0
4576487|NCT01408914|7416907|FG001|Overall Study|Change in local TB/HIV norms|1
4576488|NCT01408914|7416908|FG002|Overall Study|Change in local TB/HIV norms|1
4576489|NCT01409382|7416961|FG000|Overall Study|Lost to Follow-up|1
4576490|NCT01409382|7416962|FG001|Overall Study|Lost to Follow-up|1
4576491|NCT01409382|7416961|FG000|Overall Study|Protocol Violation|0
4576492|NCT01409382|7416962|FG001|Overall Study|Protocol Violation|3
4576493|NCT01409382|7416961|FG000|Overall Study|Multiple pregnancy|2
4576494|NCT01409382|7416962|FG001|Overall Study|Multiple pregnancy|4
4576495|NCT01409382|7416961|FG000|Overall Study|Still pregnant when study ended|13
4576496|NCT01409382|7416962|FG001|Overall Study|Still pregnant when study ended|2
4576497|NCT01409382|7416961|FG000|Overall Study|Did not manage to get pregnant|64
4576498|NCT01409382|7416962|FG001|Overall Study|Did not manage to get pregnant|70
4576499|NCT01409382|7416961|FG000|Overall Study|Had a 2nd trimester loss after accident|1
4576500|NCT01409382|7416962|FG001|Overall Study|Had a 2nd trimester loss after accident|0
4576501|NCT01409434|7416972|FG000|Overall Study|Protocol Violation|4
4576502|NCT01409564|7416978|FG000|Overall Study|low medication compliance|4
4576503|NCT01409564|7416979|FG001|Overall Study|low medication compliance|3
4576504|NCT01409564|7416978|FG000|Overall Study|brain abnormalities found in T1 MR|1
4576505|NCT01409564|7416979|FG001|Overall Study|brain abnormalities found in T1 MR|2
4576506|NCT01409707|7416992|FG000|Overall Study|Withdrawal by Subject|5
4576507|NCT01409707|7416993|FG001|Overall Study|Withdrawal by Subject|17
4576508|NCT01409707|7416994|FG002|Overall Study|Withdrawal by Subject|16
4576509|NCT01409811|7417001|FG000|Overall Study|Insurance denial|1
4576510|NCT01409837|7417007|FG000|Overall Study|Withdrawal by Subject|2
4576511|NCT01409837|7417008|FG001|Overall Study|Withdrawal by Subject|1
4576512|NCT01409837|7417007|FG000|Overall Study|Lost to Follow-up|1
4576513|NCT01409837|7417008|FG001|Overall Study|Lost to Follow-up|0
4576514|NCT01409837|7417007|FG000|Overall Study|Physician Decision|0
4576515|NCT01409837|7417008|FG001|Overall Study|Physician Decision|1
4576516|NCT01409915|7417018|FG000|Overall Study|Adverse Event|0
4576517|NCT01409915|7417019|FG001|Overall Study|Adverse Event|2
4576518|NCT01409915|7417018|FG000|Overall Study|Withdrawal by Subject|0
4576519|NCT01409915|7417019|FG001|Overall Study|Withdrawal by Subject|1
4576520|NCT01409915|7417018|FG000|Overall Study|Protocol Violation|1
4576521|NCT01409915|7417019|FG001|Overall Study|Protocol Violation|0
4576522|NCT01409928|7417025|FG000|Overall Study|Physician Decision|12
4576523|NCT01409993|7417031|FG000|Overall Study|Adverse Event|4
4576524|NCT01409993|7417032|FG001|Overall Study|Adverse Event|4
4576525|NCT01409993|7417033|FG002|Overall Study|Adverse Event|3
4576526|NCT01409993|7417034|FG003|Overall Study|Adverse Event|1
4576527|NCT01409993|7417031|FG000|Overall Study|Withdrawal by Subject|0
4576528|NCT01409993|7417032|FG001|Overall Study|Withdrawal by Subject|0
4576529|NCT01409993|7417033|FG002|Overall Study|Withdrawal by Subject|0
4576530|NCT01409993|7417034|FG003|Overall Study|Withdrawal by Subject|4
4576531|NCT01409993|7417031|FG000|Overall Study|Lost to Follow-up|0
4576532|NCT01409993|7417032|FG001|Overall Study|Lost to Follow-up|1
4576533|NCT01409993|7417033|FG002|Overall Study|Lost to Follow-up|0
4576534|NCT01409993|7417034|FG003|Overall Study|Lost to Follow-up|0
4576535|NCT01410110|7417079|FG000|Overall Study|Withdrawal by Subject|4
4576536|NCT01410110|7417080|FG001|Overall Study|Withdrawal by Subject|2
4576537|NCT01410227|7417086|FG000|Overall Study|Adverse Event|1
4576538|NCT01410227|7417087|FG001|Overall Study|Adverse Event|0
4576539|NCT01410227|7417088|FG002|Overall Study|Adverse Event|0
4576540|NCT01410227|7417089|FG003|Overall Study|Adverse Event|0
4576541|NCT01410227|7417086|FG000|Overall Study|Withdrawal by Subject|3
4576542|NCT01410227|7417087|FG001|Overall Study|Withdrawal by Subject|0
4576543|NCT01410227|7417088|FG002|Overall Study|Withdrawal by Subject|1
4576544|NCT01410227|7417089|FG003|Overall Study|Withdrawal by Subject|0
4576545|NCT01410227|7417086|FG000|Overall Study|Pregnancy|0
4576546|NCT01410227|7417087|FG001|Overall Study|Pregnancy|0
4576547|NCT01410227|7417088|FG002|Overall Study|Pregnancy|0
4576548|NCT01410227|7417089|FG003|Overall Study|Pregnancy|1
4576549|NCT01410227|7417086|FG000|Overall Study|Met Excl. Criteria After Starting Study|0
4576550|NCT01410227|7417087|FG001|Overall Study|Met Excl. Criteria After Starting Study|0
4576551|NCT01410227|7417088|FG002|Overall Study|Met Excl. Criteria After Starting Study|1
4576552|NCT01410227|7417089|FG003|Overall Study|Met Excl. Criteria After Starting Study|0
4576553|NCT01410240|7417102|FG000|Overall Study|Physician Decision|0
4576554|NCT01410240|7417103|FG001|Overall Study|Physician Decision|0
4576555|NCT01410240|7417104|FG002|Overall Study|Physician Decision|1
4576556|NCT01410240|7417102|FG000|Overall Study|Missed week 6 assessments|1
4576557|NCT01410240|7417103|FG001|Overall Study|Missed week 6 assessments|1
4576558|NCT01410240|7417104|FG002|Overall Study|Missed week 6 assessments|1
4576559|NCT01410357|7417121|FG000|Overall Study|Death|2
4576560|NCT01410357|7417122|FG001|Overall Study|Death|1
4576561|NCT01410357|7417121|FG000|Overall Study|Withdrawal by Subject|1
4576562|NCT01410357|7417122|FG001|Overall Study|Withdrawal by Subject|2
4576563|NCT01410357|7417121|FG000|Overall Study|Lost to Follow-up|23
4576564|NCT01410357|7417122|FG001|Overall Study|Lost to Follow-up|21
4576565|NCT01410448|7417141|FG000|Overall Study|No conversion to everolimus|0
4576566|NCT01410448|7417142|FG001|Overall Study|No conversion to everolimus|24
4576567|NCT01410448|7417141|FG000|Overall Study|Graft loss|4
4576568|NCT01410448|7417142|FG001|Overall Study|Graft loss|1
4576569|NCT01410448|7417141|FG000|Overall Study|Administrative issues|2
4576570|NCT01410448|7417142|FG001|Overall Study|Administrative issues|1
4576571|NCT01410448|7417141|FG000|Overall Study|Lost to Follow-up|1
4576572|NCT01410448|7417142|FG001|Overall Study|Lost to Follow-up|0
4576573|NCT01410448|7417141|FG000|Overall Study|Withdrawal by Subject|3
4576574|NCT01410448|7417142|FG001|Overall Study|Withdrawal by Subject|2
4576575|NCT01410448|7417141|FG000|Overall Study|Protocol Violation|0
4576576|NCT01410448|7417142|FG001|Overall Study|Protocol Violation|4
4576577|NCT01410448|7417141|FG000|Overall Study|Death|2
4576578|NCT01410448|7417142|FG001|Overall Study|Death|3
4576579|NCT01410474|7417150|FG000|Overall Study|Withdrawal by Subject|0
4576580|NCT01410474|7417151|FG001|Overall Study|Withdrawal by Subject|1
4576581|NCT01410604|7417180|FG000|Overall Study|Adverse Event|2
4576582|NCT01410604|7417181|FG001|Overall Study|Adverse Event|1
4576583|NCT01410604|7417180|FG000|Overall Study|Lost to Follow-up|1
4576584|NCT01410604|7417181|FG001|Overall Study|Lost to Follow-up|0
4576585|NCT01410604|7417180|FG000|Overall Study|Physician Decision|0
4576586|NCT01410604|7417181|FG001|Overall Study|Physician Decision|1
4576587|NCT01411085|7417204|FG000|Overall Study|Physician Decision|1
4576588|NCT01411085|7417204|FG000|Overall Study|Protocol Violation|1
4576589|NCT01411085|7417204|FG000|Overall Study|Adverse Event|1
4576590|NCT01411215|7417225|FG000|Overall Study|Adverse Event|1
4576591|NCT01411215|7417226|FG001|Overall Study|Adverse Event|2
4576592|NCT01411215|7417225|FG000|Overall Study|Lack of Efficacy|2
4576593|NCT01411215|7417226|FG001|Overall Study|Lack of Efficacy|4
4576594|NCT01411215|7417225|FG000|Overall Study|Lost to Follow-up|12
4576595|NCT01411215|7417226|FG001|Overall Study|Lost to Follow-up|18
4576596|NCT01411215|7417225|FG000|Overall Study|Did not meet entrance criteria|0
4576597|NCT01411215|7417226|FG001|Overall Study|Did not meet entrance criteria|1
4576598|NCT01411215|7417225|FG000|Overall Study|Study terminated by sponsor|2
4576599|NCT01411215|7417226|FG001|Overall Study|Study terminated by sponsor|15
4576600|NCT01411215|7417225|FG000|Overall Study|Protocol Violation|3
4576601|NCT01411215|7417226|FG001|Overall Study|Protocol Violation|5
4576602|NCT01411215|7417225|FG000|Overall Study|Withdrawal by Subject|34
4576603|NCT01411215|7417226|FG001|Overall Study|Withdrawal by Subject|21
4576604|NCT01411215|7417225|FG000|Overall Study|Other|12
4576605|NCT01411215|7417226|FG001|Overall Study|Other|17
4576606|NCT01411215|7417225|FG000|Overall Study|Screen failure|0
4576607|NCT01411215|7417226|FG001|Overall Study|Screen failure|1
4576608|NCT01411228|7417235|FG000|Overall Study|Lost to Follow-up|0
4576609|NCT01411228|7417236|FG001|Overall Study|Lost to Follow-up|0
4576610|NCT01411228|7417237|FG002|Overall Study|Lost to Follow-up|1
4576611|NCT01411228|7417235|FG000|Overall Study|Withdrawal by Subject|1
4576612|NCT01411228|7417236|FG001|Overall Study|Withdrawal by Subject|0
4576613|NCT01411228|7417237|FG002|Overall Study|Withdrawal by Subject|0
4576614|NCT01411319|7417245|FG000|Overall Study|Lost to Follow-up|1
4593078|NCT01546519|7441135|FG003|Overall Study|related to disease progression|1
4593079|NCT01546519|7441132|FG000|Overall Study|Physician Decision|6
4593080|NCT01546519|7441133|FG001|Overall Study|Physician Decision|5
4593081|NCT01546519|7441134|FG002|Overall Study|Physician Decision|2
4593082|NCT01546519|7441135|FG003|Overall Study|Physician Decision|3
4593083|NCT01546519|7441132|FG000|Overall Study|Withdrawal by Subject|1
4593084|NCT01546519|7441133|FG001|Overall Study|Withdrawal by Subject|0
4593085|NCT01546519|7441134|FG002|Overall Study|Withdrawal by Subject|0
4593086|NCT01546519|7441135|FG003|Overall Study|Withdrawal by Subject|0
4593087|NCT01546623|7441151|FG000|Overall Study|Adverse Event|2
4593088|NCT01546623|7441152|FG001|Overall Study|Adverse Event|3
4593089|NCT01546623|7441151|FG000|Overall Study|Major Protocol Deviation|1
4593090|NCT01546623|7441152|FG001|Overall Study|Major Protocol Deviation|1
4593091|NCT01546623|7441151|FG000|Overall Study|High Prostate specific antigen|2
4593092|NCT01546623|7441152|FG001|Overall Study|High Prostate specific antigen|1
4593093|NCT01546623|7441151|FG000|Overall Study|Did Not Receive Study Drug|1
4593094|NCT01546623|7441152|FG001|Overall Study|Did Not Receive Study Drug|1
4593095|NCT01546649|7441169|FG000|Overall Study|Adverse Event|4
4593096|NCT01546649|7441170|FG001|Overall Study|Adverse Event|5
4593097|NCT01546649|7441169|FG000|Overall Study|Protocol Violation|1
4593098|NCT01546649|7441170|FG001|Overall Study|Protocol Violation|0
4593099|NCT01546649|7441169|FG000|Overall Study|Lack of Efficacy|1
4593100|NCT01546649|7441170|FG001|Overall Study|Lack of Efficacy|0
4593101|NCT01546649|7441169|FG000|Overall Study|Recurrence|1
4593102|NCT01546649|7441170|FG001|Overall Study|Recurrence|1
4593784|NCT01555125|7442332|FG001|Extension|Study terminated by sponsor|33
4576615|NCT01411774|7417298|FG000|Overall Study|Withdrawal by Subject|0
4576616|NCT01411774|7417299|FG001|Overall Study|Withdrawal by Subject|3
4576617|NCT01411839|7417307|FG000|Overall Study|Lost to Follow-up|4
4576618|NCT01411839|7417308|FG001|Overall Study|Lost to Follow-up|3
4576619|NCT01411852|7417316|FG000|Prehospital Intervention Phase|No qualifying SBP|5
4576620|NCT01411852|7417317|FG001|Prehospital Intervention Phase|No qualifying SBP|4
4576621|NCT01411852|7417316|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2
4576622|NCT01411852|7417317|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2
4576623|NCT01411852|7417316|FG000|Prehospital Intervention Phase|Found to be under age|0
4576624|NCT01411852|7417317|FG001|Prehospital Intervention Phase|Found to be under age|1
4576625|NCT01411852|7417316|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5
4576626|NCT01411852|7417317|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0
4576627|NCT01411852|7417316|FG000|Hospital Intervention Phase|Severe head injury|5
4576628|NCT01411852|7417317|FG001|Hospital Intervention Phase|Severe head injury|4
4576629|NCT01411852|7417316|FG000|Hospital Intervention Phase|No qualifying SBP|5
4576630|NCT01411852|7417317|FG001|Hospital Intervention Phase|No qualifying SBP|1
4576631|NCT01411852|7417316|FG000|Hospital Intervention Phase|Miscommunication error|1
4576632|NCT01411852|7417317|FG001|Hospital Intervention Phase|Miscommunication error|2
4576633|NCT01411852|7417316|FG000|Hospital Intervention Phase|CPR administered|3
4576634|NCT01411852|7417317|FG001|Hospital Intervention Phase|CPR administered|1
4576635|NCT01411852|7417316|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4
4576636|NCT01411852|7417317|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1
4576637|NCT01411852|7417316|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0
4576638|NCT01411852|7417317|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2
4576639|NCT01411852|7417316|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0
4576640|NCT01411852|7417317|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1
4576641|NCT01411852|7417316|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0
4576642|NCT01411852|7417317|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4
4576643|NCT01411852|7417316|FG000|Hospital Intervention Phase|Other ineligible|2
4576644|NCT01411852|7417317|FG001|Hospital Intervention Phase|Other ineligible|2
4576645|NCT01411852|7417316|FG000|Hospital Intervention Phase|Spinal cord injury|2
4576646|NCT01411852|7417317|FG001|Hospital Intervention Phase|Spinal cord injury|0
4576647|NCT01411852|7417316|FG000|Hospital Intervention Phase|Withdrawal by Subject|1
4576648|NCT01411852|7417317|FG001|Hospital Intervention Phase|Withdrawal by Subject|0
4576649|NCT01411852|7417316|FG000|Hospital Intervention Phase|Vascular access failed|1
4576650|NCT01411852|7417317|FG001|Hospital Intervention Phase|Vascular access failed|0
4576651|NCT01411891|7417327|FG000|Overall Study|Catheter dislodgement or loss to follow-|3
4576652|NCT01411891|7417328|FG001|Overall Study|Catheter dislodgement or loss to follow-|2
4576653|NCT01411917|7417336|FG000|Overall Study|Patient did not undergo scheduled surger|0
4576654|NCT01411917|7417337|FG001|Overall Study|Patient did not undergo scheduled surger|1
4576655|NCT01411995|7417345|FG000|Overall Study|Failed IUD insertion|0
4576656|NCT01411995|7417346|FG001|Overall Study|Failed IUD insertion|1
4576657|NCT01412021|7417352|FG000|Overall Study|Case Report Forms Not Retrieved|7
4576658|NCT01412021|7417352|FG000|Overall Study|Treatment Prior to Approval|3
4576659|NCT01412021|7417352|FG000|Overall Study|Transferred to Other Hospital|9
4576660|NCT01412060|7417356|FG000|Open-label Run-in Period (RIP)|Adverse Event|86
4576661|NCT01412060|7417357|FG001|Open-label Run-in Period (RIP)|Adverse Event|0
4576662|NCT01412060|7417358|FG002|Open-label Run-in Period (RIP)|Adverse Event|0
4576663|NCT01412060|7417356|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66
4576664|NCT01412060|7417357|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0
4576665|NCT01412060|7417358|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0
4576666|NCT01412060|7417356|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27
4576667|NCT01412060|7417357|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0
4576668|NCT01412060|7417358|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0
4576669|NCT01412060|7417356|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117
4576670|NCT01412060|7417357|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0
4576671|NCT01412060|7417358|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0
4576672|NCT01412060|7417356|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32
4576673|NCT01412060|7417357|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0
4576674|NCT01412060|7417358|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0
4576675|NCT01412060|7417356|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19
4576676|NCT01412060|7417357|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0
4576677|NCT01412060|7417358|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0
4576678|NCT01412060|7417356|FG000|Period Between RIP and SP|Adverse Event|4
4576679|NCT01412060|7417357|FG001|Period Between RIP and SP|Adverse Event|0
4576680|NCT01412060|7417358|FG002|Period Between RIP and SP|Adverse Event|0
4576681|NCT01412060|7417356|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19
4576682|NCT01412060|7417357|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0
4576683|NCT01412060|7417358|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0
4576684|NCT01412060|7417356|FG000|Period Between RIP and SP|Protocol Violation|2
4576685|NCT01412060|7417357|FG001|Period Between RIP and SP|Protocol Violation|0
4576686|NCT01412060|7417358|FG002|Period Between RIP and SP|Protocol Violation|0
4576687|NCT01412060|7417356|FG000|Period Between RIP and SP|Withdrawal of Consent|1
4576688|NCT01412060|7417357|FG001|Period Between RIP and SP|Withdrawal of Consent|0
4576689|NCT01412060|7417358|FG002|Period Between RIP and SP|Withdrawal of Consent|0
4576690|NCT01412060|7417356|FG000|Period Between RIP and SP|Lost to Follow-up|5
4576691|NCT01412060|7417357|FG001|Period Between RIP and SP|Lost to Follow-up|0
4576692|NCT01412060|7417358|FG002|Period Between RIP and SP|Lost to Follow-up|0
4576693|NCT01412060|7417356|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23
4576694|NCT01412060|7417357|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0
4576695|NCT01412060|7417358|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0
4576696|NCT01412060|7417356|FG000|Open-label Stabilization Period (SP)|Adverse Event|9
4576697|NCT01412060|7417357|FG001|Open-label Stabilization Period (SP)|Adverse Event|0
4576698|NCT01412060|7417358|FG002|Open-label Stabilization Period (SP)|Adverse Event|0
4576699|NCT01412060|7417356|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9
4576700|NCT01412060|7417357|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0
4576701|NCT01412060|7417358|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0
4576702|NCT01412060|7417356|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14
4576703|NCT01412060|7417357|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0
4576704|NCT01412060|7417358|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0
4576705|NCT01412060|7417356|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40
4576706|NCT01412060|7417357|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0
4576707|NCT01412060|7417358|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0
4576708|NCT01412060|7417356|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9
4576709|NCT01412060|7417357|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0
4576710|NCT01412060|7417358|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0
4576711|NCT01412060|7417356|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19
4576712|NCT01412060|7417357|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0
4576713|NCT01412060|7417358|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0
4576714|NCT01412060|7417356|FG000|Period Between SP and DBP|Protocol Violation|2
4576715|NCT01412060|7417357|FG001|Period Between SP and DBP|Protocol Violation|0
4576716|NCT01412060|7417358|FG002|Period Between SP and DBP|Protocol Violation|0
4576717|NCT01412060|7417356|FG000|Period Between SP and DBP|Withdrawal of Consent|2
4576718|NCT01412060|7417357|FG001|Period Between SP and DBP|Withdrawal of Consent|0
4576719|NCT01412060|7417358|FG002|Period Between SP and DBP|Withdrawal of Consent|0
4576720|NCT01412060|7417356|FG000|Period Between SP and DBP|Lost to Follow-up|1
4576721|NCT01412060|7417357|FG001|Period Between SP and DBP|Lost to Follow-up|0
4576722|NCT01412060|7417358|FG002|Period Between SP and DBP|Lost to Follow-up|0
4576723|NCT01412060|7417356|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4
4576724|NCT01412060|7417357|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0
4576725|NCT01412060|7417358|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0
4576726|NCT01412060|7417356|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55
4576727|NCT01412060|7417357|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0
4576728|NCT01412060|7417358|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0
4576729|NCT01412060|7417356|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0
4576730|NCT01412060|7417357|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5
4576731|NCT01412060|7417358|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6
4576732|NCT01412060|7417356|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0
4576733|NCT01412060|7417357|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4
4576734|NCT01412060|7417358|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5
4576735|NCT01412060|7417356|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0
4576736|NCT01412060|7417357|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10
4576737|NCT01412060|7417358|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15
4576738|NCT01412060|7417356|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0
4576739|NCT01412060|7417357|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6
4576740|NCT01412060|7417358|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5
4576741|NCT01412060|7417356|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0
4576742|NCT01412060|7417357|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11
4576743|NCT01412060|7417358|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27
4576744|NCT01412060|7417356|FG000|Double-blind Treatment Phase (DBP)|Relapse|0
4576745|NCT01412060|7417357|FG001|Double-blind Treatment Phase (DBP)|Relapse|47
4576746|NCT01412060|7417358|FG002|Double-blind Treatment Phase (DBP)|Relapse|25
4576747|NCT01412151|7417372|FG000|Week 0 - 306 - Treatment Period|Death|1
4576748|NCT01412151|7417372|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1
4576749|NCT01412151|7417372|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3
4576750|NCT01412151|7417372|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2
4576751|NCT01412229|7417382|FG000|Overall Study|Physician Decision|1
4576752|NCT01412424|7417413|FG000|Core Treatment Period|Treatment Failure|24
4576753|NCT01412424|7417413|FG000|Core Treatment Period|Adverse Event|21
4576754|NCT01412424|7417413|FG000|Core Treatment Period|Patient Request|5
4576755|NCT01412424|7417413|FG000|Core Treatment Period|Lost to Follow-up|2
4576756|NCT01412424|7417413|FG000|Core Treatment Period|Sponsor Request|1
4576757|NCT01412424|7417413|FG000|Extension Treatment Period|Adverse Event|2
4576758|NCT01412424|7417413|FG000|Extension Treatment Period|Treatment Failure|2
4576759|NCT01412424|7417413|FG000|Extension Treatment Period|Patient Request|2
4576760|NCT01412801|7417454|FG000|Overall Study|Death|0
4576761|NCT01412801|7417455|FG001|Overall Study|Death|1
4576762|NCT01412801|7417456|FG002|Overall Study|Death|0
4576763|NCT01412801|7417457|FG003|Overall Study|Death|4
4576764|NCT01412801|7417458|FG004|Overall Study|Death|2
4576765|NCT01412801|7417459|FG005|Overall Study|Death|2
4576766|NCT01412801|7417454|FG000|Overall Study|Lost to Follow-up|1
4691714|NCT02574078|7602063|FG009|Treatment Period|Administrative reason by Sponsor|0
4691715|NCT02574078|7602064|FG010|Treatment Period|Administrative reason by Sponsor|0
4576767|NCT01412801|7417455|FG001|Overall Study|Lost to Follow-up|2
4576768|NCT01412801|7417456|FG002|Overall Study|Lost to Follow-up|4
4576769|NCT01412801|7417457|FG003|Overall Study|Lost to Follow-up|0
4576770|NCT01412801|7417458|FG004|Overall Study|Lost to Follow-up|1
4576771|NCT01412801|7417459|FG005|Overall Study|Lost to Follow-up|1
4576772|NCT01412801|7417454|FG000|Overall Study|Withdrawal by Subject|3
4576773|NCT01412801|7417455|FG001|Overall Study|Withdrawal by Subject|2
4576774|NCT01412801|7417456|FG002|Overall Study|Withdrawal by Subject|1
4576775|NCT01412801|7417457|FG003|Overall Study|Withdrawal by Subject|0
4576776|NCT01412801|7417458|FG004|Overall Study|Withdrawal by Subject|0
4576777|NCT01412801|7417459|FG005|Overall Study|Withdrawal by Subject|0
4576778|NCT01412801|7417454|FG000|Overall Study|Relocated to another area|0
4576779|NCT01412801|7417455|FG001|Overall Study|Relocated to another area|0
4576780|NCT01412801|7417456|FG002|Overall Study|Relocated to another area|2
4576781|NCT01412801|7417457|FG003|Overall Study|Relocated to another area|0
4576782|NCT01412801|7417458|FG004|Overall Study|Relocated to another area|0
4576783|NCT01412801|7417459|FG005|Overall Study|Relocated to another area|0
4576784|NCT01412879|7417493|FG000|Initial Registration (Induction Therapy)|Adverse Event|5
4576785|NCT01412879|7417494|FG001|Initial Registration (Induction Therapy)|Adverse Event|3
4576786|NCT01412879|7417495|FG002|Initial Registration (Induction Therapy)|Adverse Event|0
4576787|NCT01412879|7417493|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1
4576788|NCT01412879|7417494|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3
4576789|NCT01412879|7417495|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0
4576790|NCT01412879|7417493|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0
4691716|NCT02574078|7602065|FG011|Treatment Period|Administrative reason by Sponsor|0
4691717|NCT02574078|7602066|FG012|Treatment Period|Administrative reason by Sponsor|3
4691718|NCT02574078|7602054|FG000|Treatment Period|Other reasons|1
4691719|NCT02574078|7602055|FG001|Treatment Period|Other reasons|0
4691720|NCT02574078|7602056|FG002|Treatment Period|Other reasons|1
4691721|NCT02574078|7602057|FG003|Treatment Period|Other reasons|3
4576791|NCT01412879|7417494|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1
4576792|NCT01412879|7417495|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0
4576793|NCT01412879|7417493|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6
4576794|NCT01412879|7417494|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1
4576795|NCT01412879|7417495|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0
4576796|NCT01412879|7417493|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1
4576797|NCT01412879|7417494|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0
4576798|NCT01412879|7417495|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0
4576799|NCT01412944|7417517|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
4576800|NCT01412944|7417518|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
4576801|NCT01412944|7417519|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1
4576802|NCT01412944|7417520|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
4576803|NCT01412944|7417521|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
4576804|NCT01412944|7417522|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
4576805|NCT01412944|7417517|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
4576806|NCT01412944|7417518|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
4576807|NCT01412944|7417519|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
4576808|NCT01412944|7417520|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
4576809|NCT01412944|7417521|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
4576810|NCT01412944|7417522|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1
4576811|NCT01412944|7417517|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
4576812|NCT01412944|7417518|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
4576813|NCT01412944|7417519|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
4576814|NCT01412944|7417520|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
4576815|NCT01412944|7417521|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
4576816|NCT01412944|7417522|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1
4576817|NCT01412944|7417517|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1
4576818|NCT01412944|7417518|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0
4576819|NCT01412944|7417519|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0
4576820|NCT01412944|7417520|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0
4593785|NCT01555125|7442333|FG002|Extension|Study terminated by sponsor|16
4576821|NCT01412944|7417521|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0
4576822|NCT01412944|7417522|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0
4576823|NCT01412944|7417517|FG000|IV: Per CAIN457A2307|Protocol deviation|0
4576824|NCT01412944|7417518|FG001|IV: Per CAIN457A2307|Protocol deviation|1
4576825|NCT01412944|7417519|FG002|IV: Per CAIN457A2307|Protocol deviation|0
4576826|NCT01412944|7417520|FG003|IV: Per CAIN457A2307|Protocol deviation|0
4576827|NCT01412944|7417521|FG004|IV: Per CAIN457A2307|Protocol deviation|0
4576828|NCT01412944|7417522|FG005|IV: Per CAIN457A2307|Protocol deviation|0
4576829|NCT01412944|7417517|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0
4576830|NCT01412944|7417518|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1
4576831|NCT01412944|7417519|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0
4576832|NCT01412944|7417520|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0
4576833|NCT01412944|7417521|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0
4576834|NCT01412944|7417522|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0
4576835|NCT01412944|7417517|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0
4576836|NCT01412944|7417518|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0
4576837|NCT01412944|7417519|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1
4576838|NCT01412944|7417520|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1
4576839|NCT01412944|7417521|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1
4576840|NCT01412944|7417522|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0
4576841|NCT01412944|7417517|FG000|Entire: IV + Maintenance|Adverse Event|0
4576842|NCT01412944|7417518|FG001|Entire: IV + Maintenance|Adverse Event|0
4576843|NCT01412944|7417519|FG002|Entire: IV + Maintenance|Adverse Event|0
4576844|NCT01412944|7417520|FG003|Entire: IV + Maintenance|Adverse Event|0
4576845|NCT01412944|7417521|FG004|Entire: IV + Maintenance|Adverse Event|1
4576846|NCT01412944|7417522|FG005|Entire: IV + Maintenance|Adverse Event|0
4576847|NCT01412944|7417517|FG000|Entire: IV + Maintenance|Protocol deviation|0
4576848|NCT01412944|7417518|FG001|Entire: IV + Maintenance|Protocol deviation|0
4576849|NCT01412944|7417519|FG002|Entire: IV + Maintenance|Protocol deviation|0
4576850|NCT01412944|7417520|FG003|Entire: IV + Maintenance|Protocol deviation|0
4576851|NCT01412944|7417521|FG004|Entire: IV + Maintenance|Protocol deviation|0
4576852|NCT01412944|7417522|FG005|Entire: IV + Maintenance|Protocol deviation|1
4576853|NCT01412944|7417517|FG000|Entire: IV + Maintenance|Lost to Follow-up|0
4576854|NCT01412944|7417518|FG001|Entire: IV + Maintenance|Lost to Follow-up|0
4576855|NCT01412944|7417519|FG002|Entire: IV + Maintenance|Lost to Follow-up|0
4576856|NCT01412944|7417520|FG003|Entire: IV + Maintenance|Lost to Follow-up|0
4576857|NCT01412944|7417521|FG004|Entire: IV + Maintenance|Lost to Follow-up|0
4576858|NCT01412944|7417522|FG005|Entire: IV + Maintenance|Lost to Follow-up|1
4576859|NCT01412944|7417517|FG000|Entire: IV + Maintenance|Lack of Efficacy|0
4576860|NCT01412944|7417518|FG001|Entire: IV + Maintenance|Lack of Efficacy|0
4576861|NCT01412944|7417519|FG002|Entire: IV + Maintenance|Lack of Efficacy|0
4576862|NCT01412944|7417520|FG003|Entire: IV + Maintenance|Lack of Efficacy|0
4576863|NCT01412944|7417521|FG004|Entire: IV + Maintenance|Lack of Efficacy|1
4576864|NCT01412944|7417522|FG005|Entire: IV + Maintenance|Lack of Efficacy|0
4576865|NCT01412944|7417517|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2
4576866|NCT01412944|7417518|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1
4576867|NCT01412944|7417519|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0
4576868|NCT01412944|7417520|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0
4576869|NCT01412944|7417521|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0
4576870|NCT01412944|7417522|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0
4576871|NCT01412944|7417517|FG000|Entire: IV + Maintenance|Protocol deviation|0
4691722|NCT02574078|7602058|FG004|Treatment Period|Other reasons|3
4691723|NCT02574078|7602059|FG005|Treatment Period|Other reasons|1
4691724|NCT02574078|7602060|FG006|Treatment Period|Other reasons|2
4691725|NCT02574078|7602061|FG007|Treatment Period|Other reasons|1
4691726|NCT02574078|7602062|FG008|Treatment Period|Other reasons|3
4691727|NCT02574078|7602063|FG009|Treatment Period|Other reasons|1
4691728|NCT02574078|7602064|FG010|Treatment Period|Other reasons|1
4691729|NCT02574078|7602065|FG011|Treatment Period|Other reasons|3
4691730|NCT02574078|7602066|FG012|Treatment Period|Other reasons|1
4691731|NCT02574078|7602054|FG000|Treatment Period|Participant request to stop drug|0
4691732|NCT02574078|7602055|FG001|Treatment Period|Participant request to stop drug|0
4691733|NCT02574078|7602056|FG002|Treatment Period|Participant request to stop drug|0
4691734|NCT02574078|7602057|FG003|Treatment Period|Participant request to stop drug|2
4691735|NCT02574078|7602058|FG004|Treatment Period|Participant request to stop drug|4
4576872|NCT01412944|7417518|FG001|Entire: IV + Maintenance|Protocol deviation|1
4576873|NCT01412944|7417519|FG002|Entire: IV + Maintenance|Protocol deviation|0
4576874|NCT01412944|7417520|FG003|Entire: IV + Maintenance|Protocol deviation|0
4576875|NCT01412944|7417521|FG004|Entire: IV + Maintenance|Protocol deviation|0
4576876|NCT01412944|7417522|FG005|Entire: IV + Maintenance|Protocol deviation|0
4576877|NCT01412944|7417517|FG000|Entire: IV + Maintenance|Lost to Follow-up|0
4576878|NCT01412944|7417518|FG001|Entire: IV + Maintenance|Lost to Follow-up|1
4576879|NCT01412944|7417519|FG002|Entire: IV + Maintenance|Lost to Follow-up|0
4576880|NCT01412944|7417520|FG003|Entire: IV + Maintenance|Lost to Follow-up|0
4576881|NCT01412944|7417521|FG004|Entire: IV + Maintenance|Lost to Follow-up|0
4691736|NCT02574078|7602059|FG005|Treatment Period|Participant request to stop drug|0
4691737|NCT02574078|7602060|FG006|Treatment Period|Participant request to stop drug|1
4691738|NCT02574078|7602061|FG007|Treatment Period|Participant request to stop drug|0
4576882|NCT01412944|7417522|FG005|Entire: IV + Maintenance|Lost to Follow-up|0
4576883|NCT01412944|7417517|FG000|Entire: IV + Maintenance|Lack of Efficacy|0
4576884|NCT01412944|7417518|FG001|Entire: IV + Maintenance|Lack of Efficacy|1
4576885|NCT01412944|7417519|FG002|Entire: IV + Maintenance|Lack of Efficacy|0
4576886|NCT01412944|7417520|FG003|Entire: IV + Maintenance|Lack of Efficacy|0
4576887|NCT01412944|7417521|FG004|Entire: IV + Maintenance|Lack of Efficacy|0
4576888|NCT01412944|7417522|FG005|Entire: IV + Maintenance|Lack of Efficacy|0
4576889|NCT01412944|7417517|FG000|Entire: IV + Maintenance|Adverse Event|0
4576890|NCT01412944|7417518|FG001|Entire: IV + Maintenance|Adverse Event|1
4576891|NCT01412944|7417519|FG002|Entire: IV + Maintenance|Adverse Event|0
4576892|NCT01412944|7417520|FG003|Entire: IV + Maintenance|Adverse Event|0
4576893|NCT01412944|7417521|FG004|Entire: IV + Maintenance|Adverse Event|0
4576894|NCT01412944|7417522|FG005|Entire: IV + Maintenance|Adverse Event|0
4576895|NCT01412957|7417540|FG000|Overall Study|Withdrawal by Subject|6
4576896|NCT01412957|7417541|FG001|Overall Study|Withdrawal by Subject|22
4576897|NCT01412957|7417540|FG000|Overall Study|Lost to Follow-up|7
4576898|NCT01412957|7417541|FG001|Overall Study|Lost to Follow-up|2
4576899|NCT01412957|7417540|FG000|Overall Study|Death|136
4576900|NCT01412957|7417541|FG001|Overall Study|Death|133
4576901|NCT01412983|7417547|FG000|1st Period|Ineligible|0
4576902|NCT01412983|7417548|FG001|1st Period|Ineligible|1
4576903|NCT01412983|7417547|FG000|1st Period|Positive slit lamp finding|0
4576904|NCT01412983|7417548|FG001|1st Period|Positive slit lamp finding|1
4576905|NCT01412983|7417547|FG000|1st Period|Unacceptable lens movement|0
4576906|NCT01412983|7417548|FG001|1st Period|Unacceptable lens movement|1
4576907|NCT01412983|7417547|FG000|1st Period|Inability to maintain wear|0
4576908|NCT01412983|7417548|FG001|1st Period|Inability to maintain wear|1
4576909|NCT01413178|7417566|FG000|Overall Study|Toxicity|1
4576910|NCT01413178|7417567|FG001|Overall Study|Toxicity|0
4576911|NCT01413178|7417566|FG000|Overall Study|Ineligible|0
4576912|NCT01413178|7417567|FG001|Overall Study|Ineligible|2
4576913|NCT01413191|7417573|FG000|Overall Study|Lost to Follow-up|5
4576914|NCT01413191|7417573|FG000|Overall Study|Disease Progression|5
4576915|NCT01413191|7417573|FG000|Overall Study|Death|1
4576916|NCT01413204|7417580|FG000|Overall Study|Adverse Event|1
4576917|NCT01413204|7417581|FG001|Overall Study|Adverse Event|2
4576918|NCT01413204|7417582|FG002|Overall Study|Adverse Event|2
4576919|NCT01413204|7417580|FG000|Overall Study|Physician Decision|3
4576920|NCT01413204|7417581|FG001|Overall Study|Physician Decision|0
4576921|NCT01413204|7417582|FG002|Overall Study|Physician Decision|2
4576922|NCT01413204|7417580|FG000|Overall Study|Withdrawal by Subject|1
4576923|NCT01413204|7417581|FG001|Overall Study|Withdrawal by Subject|4
4576924|NCT01413204|7417582|FG002|Overall Study|Withdrawal by Subject|4
4576925|NCT01413204|7417580|FG000|Overall Study|Clearly not eligible for the study|0
4576926|NCT01413204|7417581|FG001|Overall Study|Clearly not eligible for the study|0
4576927|NCT01413204|7417582|FG002|Overall Study|Clearly not eligible for the study|1
4576928|NCT01413204|7417580|FG000|Overall Study|Fasting plasma glucose level increased|1
4576929|NCT01413204|7417581|FG001|Overall Study|Fasting plasma glucose level increased|0
4576930|NCT01413204|7417582|FG002|Overall Study|Fasting plasma glucose level increased|10
4576931|NCT01413360|7417590|FG000|Overall Study|Lost to Follow-up|2
4576932|NCT01413360|7417590|FG000|Overall Study|Adverse Event|1
4576933|NCT01413503|7417594|FG000|Overall Study|Lost to Follow-up|1
4576934|NCT01413542|7417609|FG000|Overall Study|Physician Decision|1
4576935|NCT01413542|7417610|FG001|Overall Study|Physician Decision|0
4576936|NCT01413542|7417611|FG002|Overall Study|Physician Decision|3
4576937|NCT01413542|7417612|FG003|Overall Study|Physician Decision|0
4576938|NCT01413542|7417609|FG000|Overall Study|Adverse Event|0
4576939|NCT01413542|7417610|FG001|Overall Study|Adverse Event|0
4576940|NCT01413542|7417611|FG002|Overall Study|Adverse Event|0
4576941|NCT01413542|7417612|FG003|Overall Study|Adverse Event|1
4576942|NCT01413958|7417644|FG000|Overall Study|Lost to Follow-up|0
4576943|NCT01413958|7417645|FG001|Overall Study|Lost to Follow-up|1
4576944|NCT01414075|7417688|FG000|Overall Study|Adverse Event|1
4576945|NCT01414075|7417689|FG001|Overall Study|Adverse Event|0
4576946|NCT01414075|7417690|FG002|Overall Study|Adverse Event|1
4576947|NCT01414075|7417691|FG003|Overall Study|Adverse Event|0
4576948|NCT01414075|7417688|FG000|Overall Study|Death|1
4576949|NCT01414075|7417689|FG001|Overall Study|Death|0
4576950|NCT01414075|7417690|FG002|Overall Study|Death|0
4576951|NCT01414075|7417691|FG003|Overall Study|Death|1
4576952|NCT01414075|7417688|FG000|Overall Study|Withdrawal by Subject|0
4576953|NCT01414075|7417689|FG001|Overall Study|Withdrawal by Subject|0
4576954|NCT01414075|7417690|FG002|Overall Study|Withdrawal by Subject|0
4576955|NCT01414075|7417691|FG003|Overall Study|Withdrawal by Subject|1
4576956|NCT01414075|7417688|FG000|Overall Study|Other than specified|1
4576957|NCT01414075|7417689|FG001|Overall Study|Other than specified|0
4576958|NCT01414075|7417690|FG002|Overall Study|Other than specified|1
4576959|NCT01414075|7417691|FG003|Overall Study|Other than specified|0
4576960|NCT01414114|7417701|FG000|Overall Study|Adverse Event|2
4576961|NCT01414114|7417701|FG000|Overall Study|Withdrawal by Subject|1
4576962|NCT01414114|7417701|FG000|Overall Study|Other|2
4576963|NCT01414205|7417726|FG000|Overall Study|Death|5
4576964|NCT01414205|7417727|FG001|Overall Study|Death|1
4576965|NCT01414205|7417726|FG000|Overall Study|Lost to Follow-up|1
4576966|NCT01414205|7417727|FG001|Overall Study|Lost to Follow-up|4
4576967|NCT01414205|7417726|FG000|Overall Study|Physician Decision|0
4576968|NCT01414205|7417727|FG001|Overall Study|Physician Decision|1
4576969|NCT01414205|7417726|FG000|Overall Study|Randomized but not Treated|1
4576970|NCT01414205|7417727|FG001|Overall Study|Randomized but not Treated|1
4576971|NCT01414257|7417742|FG000|Overall Study|No Visit After First Day of Treatment|12
4576972|NCT01414257|7417742|FG000|Overall Study|Protocol Violation|10
4576973|NCT01414738|7417782|FG000|Overall Study|Death|26
4576974|NCT01414738|7417782|FG000|Overall Study|Refused testing|5
4576975|NCT01414738|7417782|FG000|Overall Study|Lost to Follow-up|2
4576976|NCT01414738|7417782|FG000|Overall Study|Refused, disease progression|8
4576977|NCT01414738|7417782|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3
4576978|NCT01414855|7417786|FG000|Overall Study|Death|17
4576979|NCT01414855|7417786|FG000|Overall Study|Lost to Follow-up|5
4576980|NCT01414855|7417786|FG000|Overall Study|Withdrawal by Subject|7
4576981|NCT01415349|7417794|FG000|Treatment Period 1|Adverse Event|0
4576982|NCT01415349|7417795|FG001|Treatment Period 1|Adverse Event|1
4576983|NCT01415349|7417794|FG000|Treatment Period 1|Withdrawal by Subject|0
4576984|NCT01415349|7417795|FG001|Treatment Period 1|Withdrawal by Subject|1
4576985|NCT01415401|7417801|FG000|Overall Study|Adverse Event|5
4576986|NCT01415401|7417801|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1
4576987|NCT01415401|7417801|FG000|Overall Study|Terminated by Sponsor|1
4576988|NCT01415440|7417827|FG000|Overall Study|Lost to Follow-up|0
4576989|NCT01415440|7417828|FG001|Overall Study|Lost to Follow-up|1
4576990|NCT01415440|7417829|FG002|Overall Study|Lost to Follow-up|2
4576991|NCT01415440|7417827|FG000|Overall Study|Physician Decision|3
4576992|NCT01415440|7417828|FG001|Overall Study|Physician Decision|0
4576993|NCT01415440|7417829|FG002|Overall Study|Physician Decision|0
4576994|NCT01415440|7417827|FG000|Overall Study|Withdrawal by Subject|1
4576995|NCT01415440|7417828|FG001|Overall Study|Withdrawal by Subject|0
4576996|NCT01415440|7417829|FG002|Overall Study|Withdrawal by Subject|0
4576997|NCT01415518|7417842|FG000|Overall Study|Withdrawal by Subject|2
4576998|NCT01415518|7417843|FG001|Overall Study|Withdrawal by Subject|12
4576999|NCT01415518|7417842|FG000|Overall Study|Protocol Violation|6
4577000|NCT01415518|7417843|FG001|Overall Study|Protocol Violation|8
4577001|NCT01415518|7417842|FG000|Overall Study|Lost to Follow-up|3
4577002|NCT01415518|7417843|FG001|Overall Study|Lost to Follow-up|5
4577003|NCT01415518|7417842|FG000|Overall Study|Adverse Event|3
4577004|NCT01415518|7417843|FG001|Overall Study|Adverse Event|4
4577005|NCT01415518|7417842|FG000|Overall Study|Death|1
4577006|NCT01415518|7417843|FG001|Overall Study|Death|1
4577007|NCT01415518|7417842|FG000|Overall Study|Condition under Investigation Worsened|1
4577008|NCT01415518|7417843|FG001|Overall Study|Condition under Investigation Worsened|1
4577009|NCT01415531|7417851|FG000|Overall Study|Adverse Event|7
4577010|NCT01415531|7417852|FG001|Overall Study|Adverse Event|10
4577011|NCT01415531|7417851|FG000|Overall Study|Lack of Efficacy|3
4577012|NCT01415531|7417852|FG001|Overall Study|Lack of Efficacy|2
4577013|NCT01415531|7417851|FG000|Overall Study|Protocol Violation|0
4577014|NCT01415531|7417852|FG001|Overall Study|Protocol Violation|1
4577015|NCT01415531|7417851|FG000|Overall Study|Withdrawal by Subject|5
4577016|NCT01415531|7417852|FG001|Overall Study|Withdrawal by Subject|4
4577017|NCT01415531|7417851|FG000|Overall Study|Lost to Follow-up|6
4577018|NCT01415531|7417852|FG001|Overall Study|Lost to Follow-up|14
4577019|NCT01415531|7417851|FG000|Overall Study|Lack of Compliance|1
4577020|NCT01415531|7417852|FG001|Overall Study|Lack of Compliance|4
4577021|NCT01415531|7417851|FG000|Overall Study|Other Reasons|3
4577022|NCT01415531|7417852|FG001|Overall Study|Other Reasons|2
4577023|NCT01415908|7417869|FG000|Overall Study|Withdrawal by Subject|1
4577024|NCT01415908|7417870|FG001|Overall Study|Withdrawal by Subject|0
4577025|NCT01415921|7417878|FG000|Overall Study|Adverse Event|0
4577026|NCT01415921|7417879|FG001|Overall Study|Adverse Event|1
4577027|NCT01415921|7417878|FG000|Overall Study|Physician Decision|1
4577028|NCT01415921|7417879|FG001|Overall Study|Physician Decision|1
4577029|NCT01415921|7417878|FG000|Overall Study|Withdrawal by Subject|0
4577030|NCT01415921|7417879|FG001|Overall Study|Withdrawal by Subject|1
4577031|NCT01415921|7417878|FG000|Overall Study|Other|2
4577032|NCT01415921|7417879|FG001|Overall Study|Other|0
4577033|NCT01416142|7417916|FG000|PureVision2 HD|Inability to maintain lens wear|0
4577034|NCT01416142|7417917|FG001|PureVision2 HD|Inability to maintain lens wear|0
4577035|NCT01416142|7417918|FG002|PureVision2 HD|Inability to maintain lens wear|1
4577036|NCT01416155|7417926|FG000|Overall Study|Adverse Event|8
4577037|NCT01416155|7417926|FG000|Overall Study|Positive for anti-BG00002 antibodies|2
4577038|NCT01416155|7417926|FG000|Overall Study|Withdrawal by Subject|33
4577039|NCT01416155|7417926|FG000|Overall Study|Investigator decision|8
4577040|NCT01416155|7417926|FG000|Overall Study|Other|7
4577041|NCT01416181|7417932|FG000|Part 1|Other|10
4577042|NCT01416181|7417933|FG001|Part 1|Other|24
4577043|NCT01416181|7417932|FG000|Part 1|Death|0
4577044|NCT01416181|7417933|FG001|Part 1|Death|1
4577045|NCT01416181|7417932|FG000|Part 1|Investigator Decision|7
4577046|NCT01416181|7417933|FG001|Part 1|Investigator Decision|6
4577047|NCT01416181|7417932|FG000|Part 1|Withdrawal by Subject|74
4577048|NCT01416181|7417933|FG001|Part 1|Withdrawal by Subject|48
4577049|NCT01416181|7417932|FG000|Part 1|Lack of Efficacy|16
4577050|NCT01416181|7417933|FG001|Part 1|Lack of Efficacy|8
4577051|NCT01416181|7417932|FG000|Part 1|Lost to Follow-up|1
4577052|NCT01416181|7417933|FG001|Part 1|Lost to Follow-up|1
4577053|NCT01416181|7417932|FG000|Part 1|Adverse Event|15
4577054|NCT01416181|7417933|FG001|Part 1|Adverse Event|18
4577055|NCT01416181|7417932|FG000|Part 1|Ongoing in Follow-Up|14
4577056|NCT01416181|7417933|FG001|Part 1|Ongoing in Follow-Up|8
4577057|NCT01416181|7417932|FG000|Part 2|Adverse Event|11
4577058|NCT01416181|7417933|FG001|Part 2|Adverse Event|4
4577059|NCT01416181|7417932|FG000|Part 2|Other|234
4577060|NCT01416181|7417933|FG001|Part 2|Other|267
4577061|NCT01416181|7417932|FG000|Part 2|Investigator Decision|6
4577062|NCT01416181|7417933|FG001|Part 2|Investigator Decision|7
4577063|NCT01416181|7417932|FG000|Part 2|Withdrawal by Subject|14
4577064|NCT01416181|7417933|FG001|Part 2|Withdrawal by Subject|5
4577065|NCT01416181|7417932|FG000|Part 2|Lack of Efficacy|4
4577066|NCT01416181|7417933|FG001|Part 2|Lack of Efficacy|1
4577067|NCT01416181|7417932|FG000|Part 2|Lost to Follow-up|2
4577068|NCT01416181|7417933|FG001|Part 2|Lost to Follow-up|2
4577069|NCT01416389|7417956|FG000|Overall Study|Lost to Follow-up|1
4577070|NCT01416389|7417957|FG001|Overall Study|Lost to Follow-up|0
4577071|NCT01416389|7417956|FG000|Overall Study|Started New Therapy|2
4577072|NCT01416389|7417957|FG001|Overall Study|Started New Therapy|0
4577073|NCT01416441|7417965|FG000|Overall Study|Lost to Follow-up|5
4577074|NCT01416441|7417965|FG000|Overall Study|Adverse Event|6
4577075|NCT01416441|7417965|FG000|Overall Study|Sponsor Discontinued Trial Site|43
4577076|NCT01416441|7417965|FG000|Overall Study|Subject Met Withdrawal Criteria|10
4577077|NCT01416441|7417965|FG000|Overall Study|Investigator Withdrew Subject|2
4577078|NCT01416441|7417965|FG000|Overall Study|Subject Withdrew Consent|12
4577079|NCT01416441|7417965|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3
4577080|NCT01416571|7417969|FG000|Overall Study|Lost to Follow-up|2
4577081|NCT01416610|7417992|FG000|Overall Study|Adverse Event|4
4577082|NCT01416610|7417992|FG000|Overall Study|Adverse Event -Patient decision|3
4577083|NCT01416610|7417992|FG000|Overall Study|Lack of Efficacy|4
4577084|NCT01416610|7417992|FG000|Overall Study|No reason given|5
4577085|NCT01416610|7417992|FG000|Overall Study|Withdrawal by Subject|13
4577086|NCT01416610|7417992|FG000|Overall Study|Lost to Follow-up|7
4577087|NCT01416610|7417992|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7
4577088|NCT01416805|7418011|FG000|Overall Study|Lost to Follow-up|4
4577089|NCT01416805|7418012|FG001|Overall Study|Lost to Follow-up|4
4577090|NCT01417000|7418024|FG000|Overall Study|Death|59
4577091|NCT01417000|7418025|FG001|Overall Study|Death|28
4577092|NCT01417000|7418024|FG000|Overall Study|Lost to Follow-up|1
4577093|NCT01417000|7418025|FG001|Overall Study|Lost to Follow-up|0
4577094|NCT01417000|7418024|FG000|Overall Study|Study Terminated by Sponsor|1
4577095|NCT01417000|7418025|FG001|Overall Study|Study Terminated by Sponsor|1
4577096|NCT01417078|7418040|FG000|Overall Study|Withdrawal by Subject|1
4577097|NCT01417104|7418048|FG000|Overall Study|Withdrawal by Subject|5
4577098|NCT01417104|7418049|FG001|Overall Study|Withdrawal by Subject|1
4577099|NCT01417104|7418048|FG000|Overall Study|Failure to make contact|0
4577100|NCT01417104|7418049|FG001|Overall Study|Failure to make contact|1
4577101|NCT01417104|7418048|FG000|Overall Study|Adverse Event|1
4577102|NCT01417104|7418049|FG001|Overall Study|Adverse Event|0
4577103|NCT01417156|7418055|FG000|Overall Study|Adverse Event|12
4577104|NCT01417156|7418055|FG000|Overall Study|Protocol Violation|2
4577105|NCT01417195|7418061|FG000|Overall Study|Stimulation failure|1
4577106|NCT01417195|7418062|FG001|Overall Study|Stimulation failure|0
4577107|NCT01417195|7418061|FG000|Overall Study|No embryos for transfer|0
4577108|NCT01417195|7418062|FG001|Overall Study|No embryos for transfer|1
4577109|NCT01417195|7418061|FG000|Overall Study|No transfer due to risk of OHSS|1
4577110|NCT01417195|7418062|FG001|Overall Study|No transfer due to risk of OHSS|0
4577111|NCT01417195|7418061|FG000|Overall Study|No transfer due to elevated progesterone|1
4577112|NCT01417195|7418062|FG001|Overall Study|No transfer due to elevated progesterone|0
4577113|NCT01417234|7418069|FG000|Overall Study|Subject non-compliant|3
4577114|NCT01417481|7418108|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0
4577115|NCT01417481|7418109|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2
4577116|NCT01418209|7418149|FG000|Overall Study|Withdrawal by Subject|1
4577117|NCT01418209|7418150|FG001|Overall Study|Withdrawal by Subject|0
4577118|NCT01418209|7418151|FG002|Overall Study|Withdrawal by Subject|1
4577119|NCT01418209|7418149|FG000|Overall Study|Did not provide hot flash diary data|1
4577120|NCT01418209|7418150|FG001|Overall Study|Did not provide hot flash diary data|3
4577121|NCT01418209|7418151|FG002|Overall Study|Did not provide hot flash diary data|3
4577122|NCT01418339|7418161|FG000|Overall Study|Adverse Event|5
4577123|NCT01418339|7418162|FG001|Overall Study|Adverse Event|2
4577124|NCT01418339|7418161|FG000|Overall Study|Subject Withdrew Consent|1
4577125|NCT01418339|7418162|FG001|Overall Study|Subject Withdrew Consent|2
4577126|NCT01418339|7418161|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6
4577127|NCT01418339|7418162|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6
4577128|NCT01418352|7418172|FG000|Overall Study|Lost to Follow-up|2
4577129|NCT01418352|7418173|FG001|Overall Study|Lost to Follow-up|0
4577130|NCT01418352|7418174|FG002|Overall Study|Lost to Follow-up|0
4577131|NCT01418352|7418175|FG003|Overall Study|Lost to Follow-up|0
4577132|NCT01418352|7418172|FG000|Overall Study|Adverse Event|0
4577133|NCT01418352|7418173|FG001|Overall Study|Adverse Event|1
4577134|NCT01418352|7418174|FG002|Overall Study|Adverse Event|0
4577135|NCT01418352|7418175|FG003|Overall Study|Adverse Event|0
4593786|NCT01555125|7442334|FG003|Extension|Study terminated by sponsor|20
4577136|NCT01418352|7418172|FG000|Overall Study|Sponsor Discontinued Trial Site|0
4577137|NCT01418352|7418173|FG001|Overall Study|Sponsor Discontinued Trial Site|2
4577138|NCT01418352|7418174|FG002|Overall Study|Sponsor Discontinued Trial Site|2
4577139|NCT01418352|7418175|FG003|Overall Study|Sponsor Discontinued Trial Site|2
4577140|NCT01418352|7418172|FG000|Overall Study|Subject Withdrew Consent|0
4577141|NCT01418352|7418173|FG001|Overall Study|Subject Withdrew Consent|1
4577142|NCT01418352|7418174|FG002|Overall Study|Subject Withdrew Consent|2
4577143|NCT01418352|7418175|FG003|Overall Study|Subject Withdrew Consent|1
4577144|NCT01418352|7418172|FG000|Overall Study|Protocol Deviation|0
4577145|NCT01418352|7418173|FG001|Overall Study|Protocol Deviation|0
4577146|NCT01418352|7418174|FG002|Overall Study|Protocol Deviation|1
4577147|NCT01418352|7418175|FG003|Overall Study|Protocol Deviation|0
4577148|NCT01418352|7418172|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1
4577149|NCT01418352|7418173|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0
4577150|NCT01418352|7418174|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0
4577151|NCT01418352|7418175|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0
4577152|NCT01418365|7418187|FG000|First Intervention|Withdrawal by Subject|0
4691739|NCT02574078|7602062|FG008|Treatment Period|Participant request to stop drug|3
4577153|NCT01418365|7418188|FG001|First Intervention|Withdrawal by Subject|1
4577154|NCT01418365|7418187|FG000|First Intervention|Non-compliance|1
4577155|NCT01418365|7418188|FG001|First Intervention|Non-compliance|0
4577156|NCT01418365|7418187|FG000|Second Intervention|Withdrawal by Subject|0
4577157|NCT01418365|7418188|FG001|Second Intervention|Withdrawal by Subject|1
4577158|NCT01418378|7418196|FG000|Overall Study|Death|1
4577159|NCT01418378|7418197|FG001|Overall Study|Death|2
4577160|NCT01418378|7418196|FG000|Overall Study|Physician Decision|0
4577161|NCT01418378|7418197|FG001|Overall Study|Physician Decision|1
4577162|NCT01418378|7418196|FG000|Overall Study|ligament imbalance|0
4577163|NCT01418378|7418197|FG001|Overall Study|ligament imbalance|1
4577164|NCT01418378|7418196|FG000|Overall Study|developed chronic myopathy|0
4577165|NCT01418378|7418197|FG001|Overall Study|developed chronic myopathy|1
4577166|NCT01418937|7418219|FG000|Overall Study|Lost to Follow-up|5
4577167|NCT01418937|7418219|FG000|Overall Study|Protocol Violation|1
4577168|NCT01418937|7418219|FG000|Overall Study|Pregnancy|1
4577169|NCT01418937|7418219|FG000|Overall Study|Withdrawal by Subject|1
4577170|NCT01419015|7418223|FG000|Overall Study|Death|2
4577171|NCT01419080|7418231|FG000|Overall Study|Withdrawal by Subject|75
4577172|NCT01419080|7418231|FG000|Overall Study|Death|30
4577173|NCT01419080|7418231|FG000|Overall Study|Lost to Follow-up|23
4577174|NCT01419080|7418231|FG000|Overall Study|Too Ill|3
4593103|NCT01546649|7441169|FG000|Overall Study|Discovery of secondary cancer|0
4593104|NCT01546649|7441170|FG001|Overall Study|Discovery of secondary cancer|1
4593105|NCT01546649|7441169|FG000|Overall Study|Withdrawal by Subject|1
4691740|NCT02574078|7602063|FG009|Treatment Period|Participant request to stop drug|2
4691741|NCT02574078|7602064|FG010|Treatment Period|Participant request to stop drug|2
4691742|NCT02574078|7602065|FG011|Treatment Period|Participant request to stop drug|4
4691743|NCT02574078|7602066|FG012|Treatment Period|Participant request to stop drug|1
4691744|NCT02574078|7602054|FG000|Treatment Period|Participant withdrew consent|0
4691745|NCT02574078|7602055|FG001|Treatment Period|Participant withdrew consent|0
4691746|NCT02574078|7602056|FG002|Treatment Period|Participant withdrew consent|0
4691747|NCT02574078|7602057|FG003|Treatment Period|Participant withdrew consent|0
4691748|NCT02574078|7602058|FG004|Treatment Period|Participant withdrew consent|1
4593106|NCT01546649|7441170|FG001|Overall Study|Withdrawal by Subject|2
4593107|NCT01546688|7441187|FG000|Overall Study|Adverse Event|0
4593108|NCT01546688|7441188|FG001|Overall Study|Adverse Event|4
4593109|NCT01546688|7441187|FG000|Overall Study|Withdrawal by Subject|2
4593110|NCT01546688|7441188|FG001|Overall Study|Withdrawal by Subject|1
4593111|NCT01546688|7441187|FG000|Overall Study|Lack of Efficacy|1
4593112|NCT01546688|7441188|FG001|Overall Study|Lack of Efficacy|0
4593113|NCT01546857|7441196|FG000|Overall Study|Withdrawal by Subject|2
4593114|NCT01546857|7441197|FG001|Overall Study|Withdrawal by Subject|3
4593115|NCT01546922|7441204|FG000|First Period of 10 Weeks|Protocol Violation|3
4593116|NCT01546922|7441205|FG001|First Period of 10 Weeks|Protocol Violation|1
4593117|NCT01546922|7441204|FG000|First Period of 10 Weeks|Withdrawal by Subject|1
4593118|NCT01546922|7441205|FG001|First Period of 10 Weeks|Withdrawal by Subject|1
4593119|NCT01546922|7441204|FG000|First Period of 10 Weeks|Investigator's judgment|1
4593120|NCT01546922|7441205|FG001|First Period of 10 Weeks|Investigator's judgment|0
4593121|NCT01546922|7441204|FG000|Second Period of 10 Weeks|Protocol Violation|3
4593122|NCT01546922|7441205|FG001|Second Period of 10 Weeks|Protocol Violation|1
4593123|NCT01546922|7441204|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0
4593124|NCT01546922|7441205|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2
4593125|NCT01547130|7441222|FG000|Overall Study|Lost to Follow-up|9
4593126|NCT01547130|7441223|FG001|Overall Study|Lost to Follow-up|5
4593127|NCT01547286|7441246|FG000|Overall Study|Did not meet all eligibility criteria|1
4593128|NCT01547286|7441246|FG000|Overall Study|Physician Decision|1
4593787|NCT01555125|7442335|FG004|Extension|Study terminated by sponsor|0
4593788|NCT01555125|7442331|FG000|Extension|Subject/guardian decision|1
4593789|NCT01555125|7442332|FG001|Extension|Subject/guardian decision|9
4593790|NCT01555125|7442333|FG002|Extension|Subject/guardian decision|1
4593791|NCT01555125|7442334|FG003|Extension|Subject/guardian decision|0
4577175|NCT01419184|7418243|FG000|Overall Study|Site data not available|3
4577176|NCT01419184|7418244|FG001|Overall Study|Site data not available|2
4577177|NCT01419184|7418243|FG000|Overall Study|No IRLOS-No in-patient end date reported|3
4577178|NCT01419184|7418244|FG001|Overall Study|No IRLOS-No in-patient end date reported|6
4577179|NCT01419184|7418243|FG000|Overall Study|No IRLOS-randomized, not treated|2
4577180|NCT01419184|7418244|FG001|Overall Study|No IRLOS-randomized, not treated|4
4577181|NCT01419184|7418243|FG000|Overall Study|No IRLOS-non trial antibiotic used|1
4577182|NCT01419184|7418244|FG001|Overall Study|No IRLOS-non trial antibiotic used|2
4577183|NCT01419184|7418243|FG000|Overall Study|No IRLOS-No adverse event treatment date|0
4577184|NCT01419184|7418244|FG001|Overall Study|No IRLOS-No adverse event treatment date|1
4577185|NCT01419184|7418243|FG000|Overall Study|Participant randomized, not treated|1
4577186|NCT01419184|7418244|FG001|Overall Study|Participant randomized, not treated|0
4577187|NCT01419197|7418252|FG000|Overall Study|Death|247
4577188|NCT01419197|7418253|FG001|Overall Study|Death|122
4577189|NCT01419197|7418252|FG000|Overall Study|Physician Decision|4
4577190|NCT01419197|7418253|FG001|Overall Study|Physician Decision|4
4577191|NCT01419197|7418252|FG000|Overall Study|Non-compliance|3
4577192|NCT01419197|7418253|FG001|Overall Study|Non-compliance|1
4577193|NCT01419197|7418252|FG000|Overall Study|Withdrawal by Subject|33
4577194|NCT01419197|7418253|FG001|Overall Study|Withdrawal by Subject|32
4577195|NCT01419197|7418252|FG000|Overall Study|Study Completed by Sponsor|103
4577196|NCT01419197|7418253|FG001|Overall Study|Study Completed by Sponsor|34
4577197|NCT01419197|7418252|FG000|Overall Study|Reason Not Specified|0
4577198|NCT01419197|7418253|FG001|Overall Study|Reason Not Specified|1
4577199|NCT01419197|7418252|FG000|Overall Study|Lost to Follow-up|14
4577200|NCT01419197|7418253|FG001|Overall Study|Lost to Follow-up|4
4577201|NCT01419236|7418262|FG000|Overall Study|Adverse Event|1
4577202|NCT01419236|7418263|FG001|Overall Study|Adverse Event|0
4577203|NCT01419236|7418262|FG000|Overall Study|Lack of Efficacy|0
4577204|NCT01419236|7418263|FG001|Overall Study|Lack of Efficacy|1
4577205|NCT01419236|7418262|FG000|Overall Study|Lost to Follow-up|1
4577206|NCT01419236|7418263|FG001|Overall Study|Lost to Follow-up|0
4577207|NCT01419236|7418262|FG000|Overall Study|Physician Decision|1
4577208|NCT01419236|7418263|FG001|Overall Study|Physician Decision|0
4577209|NCT01419236|7418262|FG000|Overall Study|Withdrawal by Subject|1
4577210|NCT01419236|7418263|FG001|Overall Study|Withdrawal by Subject|4
4577211|NCT01419236|7418262|FG000|Overall Study|Entry Criteria Not Met|1
4577212|NCT01419236|7418263|FG001|Overall Study|Entry Criteria Not Met|0
4577213|NCT01419314|7418285|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3
4577214|NCT01419314|7418286|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1
4577215|NCT01419314|7418285|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3
4577216|NCT01419314|7418286|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0
4577217|NCT01419314|7418285|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1
4577218|NCT01419314|7418286|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2
4577219|NCT01419535|7418298|FG000|Overall Study|could not maintain iv line|1
4691749|NCT02574078|7602059|FG005|Treatment Period|Participant withdrew consent|1
4691750|NCT02574078|7602060|FG006|Treatment Period|Participant withdrew consent|0
4691751|NCT02574078|7602061|FG007|Treatment Period|Participant withdrew consent|1
4691752|NCT02574078|7602062|FG008|Treatment Period|Participant withdrew consent|0
4691753|NCT02574078|7602063|FG009|Treatment Period|Participant withdrew consent|2
4691754|NCT02574078|7602064|FG010|Treatment Period|Participant withdrew consent|1
4691755|NCT02574078|7602065|FG011|Treatment Period|Participant withdrew consent|4
4691756|NCT02574078|7602066|FG012|Treatment Period|Participant withdrew consent|1
4691757|NCT02574078|7602054|FG000|Treatment Period|Participant no longer meets criteria|0
4691758|NCT02574078|7602055|FG001|Treatment Period|Participant no longer meets criteria|0
4691759|NCT02574078|7602056|FG002|Treatment Period|Participant no longer meets criteria|0
4691760|NCT02574078|7602057|FG003|Treatment Period|Participant no longer meets criteria|0
4691761|NCT02574078|7602058|FG004|Treatment Period|Participant no longer meets criteria|1
4691762|NCT02574078|7602059|FG005|Treatment Period|Participant no longer meets criteria|0
4691763|NCT02574078|7602060|FG006|Treatment Period|Participant no longer meets criteria|0
4691764|NCT02574078|7602061|FG007|Treatment Period|Participant no longer meets criteria|0
4691765|NCT02574078|7602062|FG008|Treatment Period|Participant no longer meets criteria|0
4691766|NCT02574078|7602063|FG009|Treatment Period|Participant no longer meets criteria|1
4691767|NCT02574078|7602064|FG010|Treatment Period|Participant no longer meets criteria|1
4691768|NCT02574078|7602065|FG011|Treatment Period|Participant no longer meets criteria|1
4691769|NCT02574078|7602066|FG012|Treatment Period|Participant no longer meets criteria|0
4691770|NCT02574078|7602054|FG000|Treatment Period|Lost to Follow-up|0
4691771|NCT02574078|7602055|FG001|Treatment Period|Lost to Follow-up|0
4691772|NCT02574078|7602056|FG002|Treatment Period|Lost to Follow-up|0
4691773|NCT02574078|7602057|FG003|Treatment Period|Lost to Follow-up|0
4577220|NCT01419535|7418299|FG001|Overall Study|could not maintain iv line|1
4577221|NCT01419535|7418298|FG000|Overall Study|Withdrawal by Subject|0
4577222|NCT01419535|7418299|FG001|Overall Study|Withdrawal by Subject|1
4577223|NCT01419626|7418308|FG000|Overall Study|Protocol Violation|3
4577224|NCT01419626|7418309|FG001|Overall Study|Protocol Violation|2
4577225|NCT01419626|7418310|FG002|Overall Study|Protocol Violation|2
4577226|NCT01419626|7418308|FG000|Overall Study|Withdrawal by Subject|1
4577227|NCT01419626|7418309|FG001|Overall Study|Withdrawal by Subject|0
4577228|NCT01419626|7418310|FG002|Overall Study|Withdrawal by Subject|0
4577229|NCT01419626|7418308|FG000|Overall Study|Lost to Follow-up|0
4577230|NCT01419626|7418309|FG001|Overall Study|Lost to Follow-up|1
4577231|NCT01419626|7418310|FG002|Overall Study|Lost to Follow-up|1
4577232|NCT01419665|7418324|FG000|Combination Treatment|Adverse Event|7
4577233|NCT01419665|7418325|FG001|Combination Treatment|Adverse Event|10
4577234|NCT01419665|7418324|FG000|Combination Treatment|Physician Decision|5
4577235|NCT01419665|7418325|FG001|Combination Treatment|Physician Decision|8
4577236|NCT01419665|7418324|FG000|Combination Treatment|Protocol Violation|6
4577237|NCT01419665|7418325|FG001|Combination Treatment|Protocol Violation|2
4577238|NCT01419665|7418324|FG000|Combination Treatment|disease progression|10
4577239|NCT01419665|7418325|FG001|Combination Treatment|disease progression|9
4577240|NCT01419665|7418324|FG000|Combination Treatment|Death|5
4577241|NCT01419665|7418325|FG001|Combination Treatment|Death|7
4577242|NCT01419665|7418324|FG000|Combination Treatment|administrative problems|0
4577243|NCT01419665|7418325|FG001|Combination Treatment|administrative problems|1
4577244|NCT01419665|7418324|FG000|Combination Treatment|Withdrawal by Subject|5
4577245|NCT01419665|7418325|FG001|Combination Treatment|Withdrawal by Subject|4
4577246|NCT01419665|7418324|FG000|Maintenance Treatment and/or Follow up|switch to open label|44
4577247|NCT01419665|7418325|FG001|Maintenance Treatment and/or Follow up|switch to open label|39
4577248|NCT01419665|7418324|FG000|Maintenance Treatment and/or Follow up|administrative problems|0
4577249|NCT01419665|7418325|FG001|Maintenance Treatment and/or Follow up|administrative problems|6
4577250|NCT01419665|7418324|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6
4577251|NCT01419665|7418325|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6
4577252|NCT01419665|7418324|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1
4577253|NCT01419665|7418325|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1
4577254|NCT01419665|7418324|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5
4577255|NCT01419665|7418325|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2
4577256|NCT01419665|7418324|FG000|Maintenance Treatment and/or Follow up|disease progression|53
4577257|NCT01419665|7418325|FG001|Maintenance Treatment and/or Follow up|disease progression|37
4577258|NCT01419665|7418324|FG000|Maintenance Treatment and/or Follow up|Death|1
4577259|NCT01419665|7418325|FG001|Maintenance Treatment and/or Follow up|Death|2
4577260|NCT01419665|7418324|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11
4577261|NCT01419665|7418325|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7
4577262|NCT01419665|7418324|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1
4577263|NCT01419665|7418325|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2
4577264|NCT01419665|7418324|FG000|Open Label Phase|Death|1
4577265|NCT01419665|7418325|FG001|Open Label Phase|Death|0
4577266|NCT01419665|7418324|FG000|Open Label Phase|disease progression|0
4577267|NCT01419665|7418325|FG001|Open Label Phase|disease progression|1
4577268|NCT01419717|7418333|FG000|Overall Study|Protocol-specified Criteria|62
4577269|NCT01419717|7418333|FG000|Overall Study|Adverse Event|19
4577270|NCT01419717|7418333|FG000|Overall Study|Death|17
4577271|NCT01419717|7418333|FG000|Overall Study|Withdrawal by Subject|10
4577272|NCT01419717|7418333|FG000|Overall Study|Disease Progression|9
4577273|NCT01419717|7418333|FG000|Overall Study|Other|4
4577274|NCT01419717|7418333|FG000|Overall Study|Lost to Follow-up|2
4577275|NCT01419717|7418333|FG000|Overall Study|Administrative Decision|1
4577276|NCT01419717|7418333|FG000|Overall Study|Noncompliance|1
4577277|NCT01419769|7418337|FG000|Overall Study|Did not receive the AXIOS stent|3
4577278|NCT01419769|7418337|FG000|Overall Study|Not evaluable due to pigtail stents|1
4577279|NCT01420068|7418372|FG000|Overall Study|Administrative problems|1
4577280|NCT01420068|7418373|FG001|Overall Study|Administrative problems|3
4577281|NCT01420068|7418372|FG000|Overall Study|Withdrawal by Subject|1
4577282|NCT01420068|7418373|FG001|Overall Study|Withdrawal by Subject|2
4577283|NCT01420081|7418388|FG000|Overall Study|Death|1
4577284|NCT01420081|7418389|FG001|Overall Study|Death|0
4577285|NCT01420081|7418390|FG002|Overall Study|Death|8
4577286|NCT01420081|7418391|FG003|Overall Study|Death|0
4577287|NCT01420081|7418392|FG004|Overall Study|Death|7
4577288|NCT01420081|7418393|FG005|Overall Study|Death|12
4577289|NCT01420081|7418394|FG006|Overall Study|Death|0
4577290|NCT01420081|7418395|FG007|Overall Study|Death|1
4577291|NCT01420081|7418396|FG008|Overall Study|Death|1
4577292|NCT01420081|7418388|FG000|Overall Study|Lost to Follow-up|0
4577293|NCT01420081|7418389|FG001|Overall Study|Lost to Follow-up|0
4577294|NCT01420081|7418390|FG002|Overall Study|Lost to Follow-up|0
4577295|NCT01420081|7418391|FG003|Overall Study|Lost to Follow-up|0
4577296|NCT01420081|7418392|FG004|Overall Study|Lost to Follow-up|1
4577297|NCT01420081|7418393|FG005|Overall Study|Lost to Follow-up|1
4577298|NCT01420081|7418394|FG006|Overall Study|Lost to Follow-up|0
4577299|NCT01420081|7418395|FG007|Overall Study|Lost to Follow-up|0
4577300|NCT01420081|7418396|FG008|Overall Study|Lost to Follow-up|0
4577301|NCT01420081|7418388|FG000|Overall Study|Study Terminated by Sponsor|2
4577302|NCT01420081|7418389|FG001|Overall Study|Study Terminated by Sponsor|1
4577303|NCT01420081|7418390|FG002|Overall Study|Study Terminated by Sponsor|1
4577304|NCT01420081|7418391|FG003|Overall Study|Study Terminated by Sponsor|3
4577305|NCT01420081|7418392|FG004|Overall Study|Study Terminated by Sponsor|11
4577306|NCT01420081|7418393|FG005|Overall Study|Study Terminated by Sponsor|7
4577307|NCT01420081|7418394|FG006|Overall Study|Study Terminated by Sponsor|3
4577308|NCT01420081|7418395|FG007|Overall Study|Study Terminated by Sponsor|2
4577309|NCT01420081|7418396|FG008|Overall Study|Study Terminated by Sponsor|2
4577310|NCT01420081|7418388|FG000|Overall Study|Subject Refused Futher Follow-up|0
4577311|NCT01420081|7418389|FG001|Overall Study|Subject Refused Futher Follow-up|0
4577312|NCT01420081|7418390|FG002|Overall Study|Subject Refused Futher Follow-up|1
4577313|NCT01420081|7418391|FG003|Overall Study|Subject Refused Futher Follow-up|0
4577314|NCT01420081|7418392|FG004|Overall Study|Subject Refused Futher Follow-up|1
4577315|NCT01420081|7418393|FG005|Overall Study|Subject Refused Futher Follow-up|0
4577316|NCT01420081|7418394|FG006|Overall Study|Subject Refused Futher Follow-up|0
4577317|NCT01420081|7418395|FG007|Overall Study|Subject Refused Futher Follow-up|0
4577318|NCT01420081|7418396|FG008|Overall Study|Subject Refused Futher Follow-up|0
4577319|NCT01420081|7418388|FG000|Overall Study|Other Reasons|0
4577320|NCT01420081|7418389|FG001|Overall Study|Other Reasons|0
4577321|NCT01420081|7418390|FG002|Overall Study|Other Reasons|1
4577322|NCT01420081|7418391|FG003|Overall Study|Other Reasons|0
4577323|NCT01420081|7418392|FG004|Overall Study|Other Reasons|0
4577324|NCT01420081|7418393|FG005|Overall Study|Other Reasons|0
4577325|NCT01420081|7418394|FG006|Overall Study|Other Reasons|0
4577326|NCT01420081|7418395|FG007|Overall Study|Other Reasons|0
4577327|NCT01420081|7418396|FG008|Overall Study|Other Reasons|0
4577328|NCT01420536|7418427|FG000|Period 1 (30 Days)|Withdrawal by Subject|3
4577329|NCT01420536|7418428|FG001|Period 1 (30 Days)|Withdrawal by Subject|0
4577330|NCT01420549|7418438|FG000|Overall Study|Adverse Event|1
4577331|NCT01420549|7418439|FG001|Overall Study|Adverse Event|1
4577332|NCT01420549|7418438|FG000|Overall Study|Lost to Follow-up|2
4577333|NCT01420549|7418439|FG001|Overall Study|Lost to Follow-up|2
4577334|NCT01420549|7418438|FG000|Overall Study|Protocol Violation|0
4577335|NCT01420549|7418439|FG001|Overall Study|Protocol Violation|1
4577336|NCT01420549|7418438|FG000|Overall Study|Non-adherence to medication|4
4577337|NCT01420549|7418439|FG001|Overall Study|Non-adherence to medication|1
4577338|NCT01420627|7418445|FG000|EZN-2279 Treatment Period|Adverse Event|1
4577339|NCT01420679|7418472|FG000|Overall Study|Disease Progression|3
4577340|NCT01420679|7418473|FG001|Overall Study|Disease Progression|2
4577341|NCT01420679|7418472|FG000|Overall Study|Adverse Event|4
4577342|NCT01420679|7418473|FG001|Overall Study|Adverse Event|0
4577343|NCT01420679|7418472|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1
4577344|NCT01420679|7418473|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0
4577345|NCT01420679|7418472|FG000|Overall Study|Patient Decision|1
4577346|NCT01420679|7418473|FG001|Overall Study|Patient Decision|0
4577347|NCT01420679|7418472|FG000|Overall Study|Investigator Decision|1
4577348|NCT01420679|7418473|FG001|Overall Study|Investigator Decision|2
4577349|NCT01420679|7418472|FG000|Overall Study|Sponsor Decision|3
4577350|NCT01420679|7418473|FG001|Overall Study|Sponsor Decision|3
4577351|NCT01420679|7418472|FG000|Overall Study|Other|1
4577352|NCT01420679|7418473|FG001|Overall Study|Other|0
4577353|NCT01421017|7418495|FG000|Overall Study|Withdrawal by Subject|2
4577354|NCT01421017|7418496|FG001|Overall Study|Withdrawal by Subject|0
4577355|NCT01421017|7418497|FG002|Overall Study|Withdrawal by Subject|0
4577356|NCT01421017|7418495|FG000|Overall Study|POD|0
4577357|NCT01421017|7418496|FG001|Overall Study|POD|6
4577358|NCT01421017|7418497|FG002|Overall Study|POD|3
4577359|NCT01421134|7418507|FG000|Overall Study|Adverse Event|3
4577360|NCT01421134|7418508|FG001|Overall Study|Adverse Event|5
4577361|NCT01421134|7418507|FG000|Overall Study|Lack of Efficacy|2
4577362|NCT01421134|7418508|FG001|Overall Study|Lack of Efficacy|4
4577363|NCT01421134|7418507|FG000|Overall Study|Protocol Violation|0
4577364|NCT01421134|7418508|FG001|Overall Study|Protocol Violation|3
4577365|NCT01421134|7418507|FG000|Overall Study|Withdrawal by Subject|1
4577366|NCT01421134|7418508|FG001|Overall Study|Withdrawal by Subject|1
4577367|NCT01421134|7418507|FG000|Overall Study|Administrative|0
4577368|NCT01421134|7418508|FG001|Overall Study|Administrative|1
4577369|NCT01421134|7418507|FG000|Overall Study|Lost to Follow-up|1
4577370|NCT01421134|7418508|FG001|Overall Study|Lost to Follow-up|1
4577371|NCT01421147|7418516|FG000|Treatment Period|Adverse Event|2
4577372|NCT01421147|7418517|FG001|Treatment Period|Adverse Event|3
4577373|NCT01421147|7418516|FG000|Treatment Period|Lost to Follow-up|2
4577374|NCT01421147|7418517|FG001|Treatment Period|Lost to Follow-up|1
4577375|NCT01421147|7418516|FG000|Treatment Period|Physician Decision|2
4577376|NCT01421147|7418517|FG001|Treatment Period|Physician Decision|2
4577377|NCT01421147|7418516|FG000|Treatment Period|Withdrawal by Subject|10
4577378|NCT01421147|7418517|FG001|Treatment Period|Withdrawal by Subject|5
4577379|NCT01421147|7418516|FG000|Extension Period|Adverse Event|0
4577380|NCT01421147|7418517|FG001|Extension Period|Adverse Event|2
4577381|NCT01421147|7418516|FG000|Extension Period|Death|0
4577382|NCT01421147|7418517|FG001|Extension Period|Death|1
4577383|NCT01421147|7418516|FG000|Extension Period|Lost to Follow-up|2
4577384|NCT01421147|7418517|FG001|Extension Period|Lost to Follow-up|5
4577385|NCT01421147|7418516|FG000|Extension Period|Physician Decision|1
4577386|NCT01421147|7418517|FG001|Extension Period|Physician Decision|0
4577387|NCT01421147|7418516|FG000|Extension Period|Withdrawal by Subject|5
4577388|NCT01421147|7418517|FG001|Extension Period|Withdrawal by Subject|3
4577389|NCT01421225|7418552|FG000|Overall Study|Withdrawal by Subject|0
4577390|NCT01421225|7418553|FG001|Overall Study|Withdrawal by Subject|1
4577391|NCT01421277|7418562|FG000|Overall Study|Lack of qualifying event|0
4577392|NCT01421277|7418563|FG001|Overall Study|Lack of qualifying event|61
4691774|NCT02574078|7602058|FG004|Treatment Period|Lost to Follow-up|0
4691775|NCT02574078|7602059|FG005|Treatment Period|Lost to Follow-up|0
4691776|NCT02574078|7602060|FG006|Treatment Period|Lost to Follow-up|0
4691777|NCT02574078|7602061|FG007|Treatment Period|Lost to Follow-up|0
4691778|NCT02574078|7602062|FG008|Treatment Period|Lost to Follow-up|0
4691779|NCT02574078|7602063|FG009|Treatment Period|Lost to Follow-up|1
4691780|NCT02574078|7602064|FG010|Treatment Period|Lost to Follow-up|0
4691781|NCT02574078|7602065|FG011|Treatment Period|Lost to Follow-up|1
4691782|NCT02574078|7602066|FG012|Treatment Period|Lost to Follow-up|0
4691783|NCT02574078|7602054|FG000|Treatment Period|Maximum clinical benefit|0
4691784|NCT02574078|7602055|FG001|Treatment Period|Maximum clinical benefit|0
4691785|NCT02574078|7602056|FG002|Treatment Period|Maximum clinical benefit|0
4691786|NCT02574078|7602057|FG003|Treatment Period|Maximum clinical benefit|0
4691787|NCT02574078|7602058|FG004|Treatment Period|Maximum clinical benefit|0
4691788|NCT02574078|7602059|FG005|Treatment Period|Maximum clinical benefit|0
4691789|NCT02574078|7602060|FG006|Treatment Period|Maximum clinical benefit|0
4691790|NCT02574078|7602061|FG007|Treatment Period|Maximum clinical benefit|0
4691791|NCT02574078|7602062|FG008|Treatment Period|Maximum clinical benefit|0
4691792|NCT02574078|7602063|FG009|Treatment Period|Maximum clinical benefit|1
4691793|NCT02574078|7602064|FG010|Treatment Period|Maximum clinical benefit|0
4691794|NCT02574078|7602065|FG011|Treatment Period|Maximum clinical benefit|0
4691795|NCT02574078|7602066|FG012|Treatment Period|Maximum clinical benefit|0
4691796|NCT02574247|7602100|FG000|Overall Study|Withdrawal by Subject|1
4691797|NCT02574247|7602101|FG001|Overall Study|Withdrawal by Subject|0
4691798|NCT02574247|7602102|FG002|Overall Study|Withdrawal by Subject|0
4691799|NCT02574247|7602100|FG000|Overall Study|Did not meet inclusion criteria|4
4691800|NCT02574247|7602101|FG001|Overall Study|Did not meet inclusion criteria|3
4691801|NCT02574247|7602102|FG002|Overall Study|Did not meet inclusion criteria|5
4691802|NCT02574260|7602112|FG000|Overall Study|Disease Progression|1
4691803|NCT02574312|7602118|FG000|3 Months Follow-up|Withdrawal by Subject|1
4691804|NCT02574312|7602119|FG001|3 Months Follow-up|Withdrawal by Subject|0
4691805|NCT02574520|7602129|FG000|Overall Study|Not dosed|2
4691806|NCT02574520|7602130|FG001|Overall Study|Not dosed|0
4577393|NCT01421277|7418562|FG000|Overall Study|Incomplete baseline data|0
4577394|NCT01421277|7418563|FG001|Overall Study|Incomplete baseline data|31
4577395|NCT01421303|7418569|FG000|Overall Study|Lost to Follow-up|13
4577396|NCT01421303|7418569|FG000|Overall Study|Non compliance with study procedure|1
4577397|NCT01421303|7418569|FG000|Overall Study|Other|7
4577398|NCT01421303|7418569|FG000|Overall Study|Withdrawal by Subject|1
4577399|NCT01421342|7418576|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49
4577400|NCT01421342|7418577|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28
4577401|NCT01421342|7418578|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13
4577402|NCT01421342|7418576|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53
4577403|NCT01421342|7418577|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38
4577404|NCT01421342|7418578|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27
4577405|NCT01421342|7418576|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23
4577406|NCT01421342|7418577|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20
4577407|NCT01421342|7418578|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13
4577408|NCT01421342|7418576|FG000|Acute Treatment Phase (12 Weeks)|Death|0
4577409|NCT01421342|7418577|FG001|Acute Treatment Phase (12 Weeks)|Death|0
4577410|NCT01421342|7418578|FG002|Acute Treatment Phase (12 Weeks)|Death|3
4577411|NCT01421342|7418576|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6
4577412|NCT01421342|7418577|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18
4577413|NCT01421342|7418578|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21
4577414|NCT01421342|7418576|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15
4577415|NCT01421342|7418577|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7
4691807|NCT02574520|7602131|FG002|Overall Study|Not dosed|5
4691808|NCT02574520|7602132|FG003|Overall Study|Not dosed|4
4691809|NCT02574520|7602129|FG000|Overall Study|Adverse Event|0
4691810|NCT02574520|7602130|FG001|Overall Study|Adverse Event|0
4691811|NCT02574520|7602131|FG002|Overall Study|Adverse Event|0
4691812|NCT02574520|7602132|FG003|Overall Study|Adverse Event|1
4577416|NCT01421342|7418578|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13
4577417|NCT01421342|7418576|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3
4577418|NCT01421342|7418577|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2
4577419|NCT01421342|7418578|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4
4577420|NCT01421342|7418576|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1
4577421|NCT01421342|7418577|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6
4577422|NCT01421342|7418578|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1
4577423|NCT01421342|7418576|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8
4691813|NCT02574520|7602129|FG000|Overall Study|Withdrawal by Subject|0
4691814|NCT02574520|7602130|FG001|Overall Study|Withdrawal by Subject|0
4691815|NCT02574520|7602131|FG002|Overall Study|Withdrawal by Subject|0
4577424|NCT01421342|7418577|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9
4577425|NCT01421342|7418578|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4
4577426|NCT01421342|7418576|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111
4577427|NCT01421342|7418577|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93
4577428|NCT01421342|7418578|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88
4577429|NCT01421342|7418576|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7
4577430|NCT01421342|7418577|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10
4577431|NCT01421342|7418578|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12
4577432|NCT01421342|7418576|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4
4577433|NCT01421342|7418577|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3
4577434|NCT01421342|7418578|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6
4577435|NCT01421342|7418576|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13
4577436|NCT01421342|7418577|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4
4577437|NCT01421342|7418578|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11
4577438|NCT01421342|7418576|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4
4577439|NCT01421342|7418577|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3
4577440|NCT01421342|7418578|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3
4577441|NCT01421342|7418576|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5
4577442|NCT01421342|7418577|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4
4577443|NCT01421342|7418578|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5
4577444|NCT01421342|7418576|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1
4577445|NCT01421342|7418577|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0
4577446|NCT01421342|7418578|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2
4577447|NCT01421342|7418576|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1
4577448|NCT01421342|7418577|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5
4577449|NCT01421342|7418578|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5
4577450|NCT01421342|7418576|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3
4577451|NCT01421342|7418577|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3
4577452|NCT01421342|7418578|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4
4577453|NCT01421342|7418576|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0
4577454|NCT01421342|7418577|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0
4577455|NCT01421342|7418578|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2
4577456|NCT01421342|7418576|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11
4577457|NCT01421342|7418577|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5
4577458|NCT01421342|7418578|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11
4577459|NCT01421342|7418576|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0
4577460|NCT01421342|7418577|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6
4577461|NCT01421342|7418578|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11
4577462|NCT01421342|7418576|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7
4577463|NCT01421342|7418577|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6
4577464|NCT01421342|7418578|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4
4577465|NCT01421342|7418576|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4
4577466|NCT01421342|7418577|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11
4577467|NCT01421342|7418578|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9
4577468|NCT01421342|7418576|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3
4577469|NCT01421342|7418577|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8
4577470|NCT01421342|7418578|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4
4577471|NCT01421342|7418576|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15
4577472|NCT01421342|7418577|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20
4577473|NCT01421342|7418578|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14
4577474|NCT01421342|7418576|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4
4577475|NCT01421342|7418577|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1
4577476|NCT01421342|7418578|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3
4577477|NCT01421342|7418576|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
4577478|NCT01421342|7418577|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
4577479|NCT01421342|7418578|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
4577480|NCT01421342|7418576|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6
4577481|NCT01421342|7418577|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0
4577482|NCT01421342|7418578|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7
4577483|NCT01421459|7418592|FG000|Overall Study|Adverse Event|6
4577484|NCT01421459|7418593|FG001|Overall Study|Adverse Event|10
4577485|NCT01421459|7418592|FG000|Overall Study|Death|1
4577486|NCT01421459|7418593|FG001|Overall Study|Death|1
4577487|NCT01421459|7418592|FG000|Overall Study|Lack of Efficacy|1
4577488|NCT01421459|7418593|FG001|Overall Study|Lack of Efficacy|2
4577489|NCT01421459|7418592|FG000|Overall Study|Lost to Follow-up|8
4577490|NCT01421459|7418593|FG001|Overall Study|Lost to Follow-up|9
4577491|NCT01421459|7418592|FG000|Overall Study|Physician Decision|9
4577492|NCT01421459|7418593|FG001|Overall Study|Physician Decision|9
4577493|NCT01421459|7418592|FG000|Overall Study|Protocol Violation|8
4577494|NCT01421459|7418593|FG001|Overall Study|Protocol Violation|5
4577495|NCT01421459|7418592|FG000|Overall Study|Withdrawal by Subject|12
4577496|NCT01421459|7418593|FG001|Overall Study|Withdrawal by Subject|16
4577497|NCT01421511|7418627|FG000|Overall Study|Lost to Follow-up|11
4577498|NCT01421511|7418628|FG001|Overall Study|Lost to Follow-up|14
4577499|NCT01421511|7418627|FG000|Overall Study|Randomized but didn't receive study drug|1
4577500|NCT01421511|7418628|FG001|Overall Study|Randomized but didn't receive study drug|7
4577501|NCT01421511|7418627|FG000|Overall Study|Physician Decision|0
4577502|NCT01421511|7418628|FG001|Overall Study|Physician Decision|1
4577503|NCT01421511|7418627|FG000|Overall Study|Withdrawal by Subject|6
4577504|NCT01421511|7418628|FG001|Overall Study|Withdrawal by Subject|5
4577505|NCT01421511|7418627|FG000|Overall Study|Death|1
4577506|NCT01421511|7418628|FG001|Overall Study|Death|1
4577507|NCT01421641|7418642|FG000|Overall Study|Protocol Violation|2
4577508|NCT01421641|7418643|FG001|Overall Study|Protocol Violation|2
4577509|NCT01421667|7418662|FG000|Overall Study|Withdrawal by Subject|0
4577510|NCT01421667|7418663|FG001|Overall Study|Withdrawal by Subject|1
4577511|NCT01421667|7418664|FG002|Overall Study|Withdrawal by Subject|2
4577512|NCT01421667|7418665|FG003|Overall Study|Withdrawal by Subject|1
4577513|NCT01421667|7418662|FG000|Overall Study|Lost to Follow-up|0
4577514|NCT01421667|7418663|FG001|Overall Study|Lost to Follow-up|1
4577515|NCT01421667|7418664|FG002|Overall Study|Lost to Follow-up|0
4577516|NCT01421667|7418665|FG003|Overall Study|Lost to Follow-up|0
4577517|NCT01421719|7418683|FG000|Overall Study|Withdrawal by Subject|4
4577518|NCT01422187|7418727|FG000|Overall Study|Personal reason|1
4577519|NCT01422187|7418728|FG001|Overall Study|Personal reason|0
4577520|NCT01422187|7418729|FG002|Overall Study|Personal reason|0
4577521|NCT01422187|7418727|FG000|Overall Study|Lost to Follow-up|0
4577522|NCT01422187|7418728|FG001|Overall Study|Lost to Follow-up|1
4577523|NCT01422187|7418729|FG002|Overall Study|Lost to Follow-up|0
4577524|NCT01422213|7418751|FG000|Overall Study|Adverse Event|8
4577525|NCT01422213|7418752|FG001|Overall Study|Adverse Event|7
4577526|NCT01422213|7418753|FG002|Overall Study|Adverse Event|11
4577527|NCT01422213|7418751|FG000|Overall Study|Lack of Efficacy|10
4577528|NCT01422213|7418752|FG001|Overall Study|Lack of Efficacy|2
4577529|NCT01422213|7418753|FG002|Overall Study|Lack of Efficacy|2
4577530|NCT01422213|7418751|FG000|Overall Study|Non-compliance with study drug|0
4577531|NCT01422213|7418752|FG001|Overall Study|Non-compliance with study drug|1
4577532|NCT01422213|7418753|FG002|Overall Study|Non-compliance with study drug|0
4577533|NCT01422213|7418751|FG000|Overall Study|Protocol Violation|0
4577534|NCT01422213|7418752|FG001|Overall Study|Protocol Violation|2
4577535|NCT01422213|7418753|FG002|Overall Study|Protocol Violation|4
4577536|NCT01422213|7418751|FG000|Overall Study|Withdrawal of Consent|7
4577537|NCT01422213|7418752|FG001|Overall Study|Withdrawal of Consent|3
4577538|NCT01422213|7418753|FG002|Overall Study|Withdrawal of Consent|5
4577539|NCT01422213|7418751|FG000|Overall Study|Lost to Follow-up|3
4577540|NCT01422213|7418752|FG001|Overall Study|Lost to Follow-up|3
4577541|NCT01422213|7418753|FG002|Overall Study|Lost to Follow-up|5
4577542|NCT01422213|7418751|FG000|Overall Study|Administrative or Other Reason(s)|5
4577543|NCT01422213|7418752|FG001|Overall Study|Administrative or Other Reason(s)|4
4577544|NCT01422213|7418753|FG002|Overall Study|Administrative or Other Reason(s)|2
4577545|NCT01422239|7418772|FG000|Overall Study|Lost to Follow-up|4
4577546|NCT01422239|7418773|FG001|Overall Study|Lost to Follow-up|3
4577547|NCT01422304|7418781|FG000|Overall Study|Adverse Event|0
4577548|NCT01422304|7418782|FG001|Overall Study|Adverse Event|1
4577549|NCT01422304|7418781|FG000|Overall Study|Lost to Follow-up|14
4577550|NCT01422304|7418782|FG001|Overall Study|Lost to Follow-up|20
4577551|NCT01422304|7418781|FG000|Overall Study|Never Entered Follow-up|2
4577552|NCT01422304|7418782|FG001|Overall Study|Never Entered Follow-up|1
4577553|NCT01422304|7418781|FG000|Overall Study|Protocol Violation|1
4577554|NCT01422304|7418782|FG001|Overall Study|Protocol Violation|0
4577555|NCT01422304|7418781|FG000|Overall Study|Withdrawal by Subject|4
4577556|NCT01422304|7418782|FG001|Overall Study|Withdrawal by Subject|2
4577557|NCT01422304|7418781|FG000|Overall Study|Did Not Meet Protocol Eligibility|0
4577558|NCT01422304|7418782|FG001|Overall Study|Did Not Meet Protocol Eligibility|2
4577559|NCT01422304|7418781|FG000|Overall Study|Not Treated|3
4577560|NCT01422304|7418782|FG001|Overall Study|Not Treated|11
4577561|NCT01422382|7418797|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1
4577562|NCT01422408|7418801|FG000|Overall Study|Adverse Event|1
4577563|NCT01422408|7418801|FG000|Overall Study|Withdrawal by Subject|3
4577564|NCT01422538|7418821|FG000|Overall Study|Lost to Follow-up|0
4577565|NCT01422538|7418822|FG001|Overall Study|Lost to Follow-up|1
4577566|NCT01422538|7418823|FG002|Overall Study|Lost to Follow-up|1
4577567|NCT01422538|7418821|FG000|Overall Study|Missed visit|0
4577568|NCT01422538|7418822|FG001|Overall Study|Missed visit|1
4577569|NCT01422538|7418823|FG002|Overall Study|Missed visit|1
4577570|NCT01422720|7418832|FG000|Overall Study|Adverse Event|16
4577571|NCT01422720|7418832|FG000|Overall Study|Lack of Efficacy|1
4577572|NCT01422720|7418832|FG000|Overall Study|Withdrawal by Subject|4
4577573|NCT01422720|7418832|FG000|Overall Study|Ineligibility|1
4577574|NCT01422824|7418840|FG000|Overall Study|Case record form not evaluated|1
4577575|NCT01422824|7418840|FG000|Overall Study|Lost to Follow-up|37
4577576|NCT01422850|7418844|FG000|Overall Study|Physician Decision|3
4577577|NCT01422876|7418860|FG000|Week 24|Lost to Follow-up|1
4577578|NCT01422876|7418861|FG001|Week 24|Lost to Follow-up|1
4577579|NCT01422876|7418862|FG002|Week 24|Lost to Follow-up|2
4577580|NCT01422876|7418863|FG003|Week 24|Lost to Follow-up|4
4577581|NCT01422876|7418864|FG004|Week 24|Lost to Follow-up|2
4577582|NCT01422876|7418865|FG005|Week 24|Lost to Follow-up|0
4577583|NCT01422876|7418866|FG006|Week 24|Lost to Follow-up|1
4577584|NCT01422876|7418867|FG007|Week 24|Lost to Follow-up|3
4577585|NCT01422876|7418868|FG008|Week 24|Lost to Follow-up|3
4577586|NCT01422876|7418869|FG009|Week 24|Lost to Follow-up|4
4577587|NCT01422876|7418860|FG000|Week 24|Consent withdrawn|5
4577588|NCT01422876|7418861|FG001|Week 24|Consent withdrawn|1
4577589|NCT01422876|7418862|FG002|Week 24|Consent withdrawn|3
4577590|NCT01422876|7418863|FG003|Week 24|Consent withdrawn|4
4577591|NCT01422876|7418864|FG004|Week 24|Consent withdrawn|5
4577592|NCT01422876|7418865|FG005|Week 24|Consent withdrawn|6
4577593|NCT01422876|7418866|FG006|Week 24|Consent withdrawn|5
4577594|NCT01422876|7418867|FG007|Week 24|Consent withdrawn|4
4577595|NCT01422876|7418868|FG008|Week 24|Consent withdrawn|3
4577596|NCT01422876|7418869|FG009|Week 24|Consent withdrawn|6
4577597|NCT01422876|7418860|FG000|Week 24|Death|0
4577598|NCT01422876|7418861|FG001|Week 24|Death|1
4577599|NCT01422876|7418862|FG002|Week 24|Death|0
4577600|NCT01422876|7418863|FG003|Week 24|Death|0
4577601|NCT01422876|7418864|FG004|Week 24|Death|0
4577602|NCT01422876|7418865|FG005|Week 24|Death|0
4577603|NCT01422876|7418866|FG006|Week 24|Death|0
4577604|NCT01422876|7418867|FG007|Week 24|Death|0
4577605|NCT01422876|7418868|FG008|Week 24|Death|0
4577606|NCT01422876|7418869|FG009|Week 24|Death|0
4577607|NCT01422876|7418860|FG000|Week 52|Lost to Follow-up|3
4577608|NCT01422876|7418861|FG001|Week 52|Lost to Follow-up|5
4577609|NCT01422876|7418862|FG002|Week 52|Lost to Follow-up|7
4577610|NCT01422876|7418863|FG003|Week 52|Lost to Follow-up|5
4577611|NCT01422876|7418864|FG004|Week 52|Lost to Follow-up|8
4577612|NCT01422876|7418865|FG005|Week 52|Lost to Follow-up|5
4577613|NCT01422876|7418866|FG006|Week 52|Lost to Follow-up|5
4577614|NCT01422876|7418867|FG007|Week 52|Lost to Follow-up|8
4577615|NCT01422876|7418868|FG008|Week 52|Lost to Follow-up|7
4577616|NCT01422876|7418869|FG009|Week 52|Lost to Follow-up|8
4577617|NCT01422876|7418860|FG000|Week 52|Consent withdrawn|9
4577618|NCT01422876|7418861|FG001|Week 52|Consent withdrawn|4
4577619|NCT01422876|7418862|FG002|Week 52|Consent withdrawn|6
4577620|NCT01422876|7418863|FG003|Week 52|Consent withdrawn|12
4577621|NCT01422876|7418864|FG004|Week 52|Consent withdrawn|7
4577622|NCT01422876|7418865|FG005|Week 52|Consent withdrawn|12
4577623|NCT01422876|7418866|FG006|Week 52|Consent withdrawn|10
4577624|NCT01422876|7418867|FG007|Week 52|Consent withdrawn|12
4577625|NCT01422876|7418868|FG008|Week 52|Consent withdrawn|13
4577626|NCT01422876|7418869|FG009|Week 52|Consent withdrawn|9
4577627|NCT01422876|7418860|FG000|Week 52|Death|0
4577628|NCT01422876|7418861|FG001|Week 52|Death|1
4577629|NCT01422876|7418862|FG002|Week 52|Death|0
4577630|NCT01422876|7418863|FG003|Week 52|Death|1
4577631|NCT01422876|7418864|FG004|Week 52|Death|0
4577632|NCT01422876|7418865|FG005|Week 52|Death|0
4577633|NCT01422876|7418866|FG006|Week 52|Death|1
4577634|NCT01422876|7418867|FG007|Week 52|Death|3
4577635|NCT01422876|7418868|FG008|Week 52|Death|1
4577636|NCT01422876|7418869|FG009|Week 52|Death|0
4577637|NCT01422889|7418887|FG000|Overall Study|No Data Entered for Study Stent|9
4577638|NCT01422915|7418891|FG000|Overall Study|Adverse Event|1
4577639|NCT01423084|7418898|FG000|Overall Study|Adverse Event|0
4577640|NCT01423084|7418899|FG001|Overall Study|Adverse Event|1
4577641|NCT01423084|7418898|FG000|Overall Study|Withdrawal by Subject|2
4577642|NCT01423084|7418899|FG001|Overall Study|Withdrawal by Subject|3
4577643|NCT01423253|7418915|FG000|Overall Study|Adverse Event|2
4577644|NCT01423253|7418915|FG000|Overall Study|Lack of Efficacy|2
4577645|NCT01423253|7418915|FG000|Overall Study|Lost to Follow-up|1
4577646|NCT01423253|7418915|FG000|Overall Study|Protocol Violation|2
4577647|NCT01423253|7418915|FG000|Overall Study|Withdrawal by Subject|2
4577648|NCT01423604|7418922|FG000|Safety Run-In|Adverse Event|3
4577649|NCT01423604|7418923|FG001|Safety Run-In|Adverse Event|0
4577650|NCT01423604|7418922|FG000|Safety Run-In|Death|1
4577651|NCT01423604|7418923|FG001|Safety Run-In|Death|0
4577652|NCT01423604|7418922|FG000|Safety Run-In|Physician Decision|1
4577653|NCT01423604|7418923|FG001|Safety Run-In|Physician Decision|0
4577654|NCT01423604|7418922|FG000|Safety Run-In|Disease progression|3
4577655|NCT01423604|7418923|FG001|Safety Run-In|Disease progression|0
4577656|NCT01423604|7418922|FG000|Safety Run-In|Patient decision|1
4577657|NCT01423604|7418923|FG001|Safety Run-In|Patient decision|0
4577658|NCT01423604|7418922|FG000|Randomized|Adverse Event|4
4577659|NCT01423604|7418923|FG001|Randomized|Adverse Event|10
4577660|NCT01423604|7418922|FG000|Randomized|Death|1
4577661|NCT01423604|7418923|FG001|Randomized|Death|0
4577662|NCT01423604|7418922|FG000|Randomized|Physician Decision|16
4577663|NCT01423604|7418923|FG001|Randomized|Physician Decision|13
4577664|NCT01423604|7418922|FG000|Randomized|Other - unspecified|37
4577665|NCT01423604|7418923|FG001|Randomized|Other - unspecified|31
4577666|NCT01423604|7418922|FG000|Randomized|Patient decision|5
4577667|NCT01423604|7418923|FG001|Randomized|Patient decision|9
4577668|NCT01423617|7418932|FG000|Overall Study|Lost to Follow-up|0
4577669|NCT01423617|7418933|FG001|Overall Study|Lost to Follow-up|1
4577670|NCT01423812|7418957|FG000|Overall Study|Lost to Follow-up|2
4577671|NCT01423812|7418958|FG001|Overall Study|Lost to Follow-up|2
4577672|NCT01423812|7418957|FG000|Overall Study|Withdrawal by Subject|1
4577673|NCT01423812|7418958|FG001|Overall Study|Withdrawal by Subject|2
4577674|NCT01423916|7418969|FG000|Overall Study|Adverse Event|5
4577675|NCT01423916|7418970|FG001|Overall Study|Adverse Event|9
4577676|NCT01423916|7418971|FG002|Overall Study|Adverse Event|2
4577677|NCT01423916|7418969|FG000|Overall Study|Met Withdrawal Criteria|1
4577678|NCT01423916|7418970|FG001|Overall Study|Met Withdrawal Criteria|1
4577679|NCT01423916|7418971|FG002|Overall Study|Met Withdrawal Criteria|1
4577680|NCT01423916|7418969|FG000|Overall Study|Physician Decision|1
4577681|NCT01423916|7418970|FG001|Overall Study|Physician Decision|0
4577682|NCT01423916|7418971|FG002|Overall Study|Physician Decision|1
4577683|NCT01423916|7418969|FG000|Overall Study|Withdrawal by Subject|3
4577684|NCT01423916|7418970|FG001|Overall Study|Withdrawal by Subject|10
4577685|NCT01423916|7418971|FG002|Overall Study|Withdrawal by Subject|3
4577686|NCT01423916|7418969|FG000|Overall Study|Protocol Deviation|1
4577687|NCT01423916|7418970|FG001|Overall Study|Protocol Deviation|0
4577688|NCT01423916|7418971|FG002|Overall Study|Protocol Deviation|0
4577689|NCT01424189|7419009|FG000|Overall Study|Adverse Event|1
4577690|NCT01424189|7419010|FG001|Overall Study|Adverse Event|0
4577691|NCT01424189|7419009|FG000|Overall Study|Lost to Follow-up|4
4577692|NCT01424189|7419010|FG001|Overall Study|Lost to Follow-up|1
4577693|NCT01424189|7419009|FG000|Overall Study|Withdrawal by Subject|4
4577694|NCT01424189|7419010|FG001|Overall Study|Withdrawal by Subject|4
4577695|NCT01424189|7419009|FG000|Overall Study|Subject moved|1
4577696|NCT01424189|7419010|FG001|Overall Study|Subject moved|0
4577697|NCT01424189|7419009|FG000|Overall Study|Death|3
4577698|NCT01424189|7419010|FG001|Overall Study|Death|1
4577699|NCT01424228|7419027|FG000|Overall Study|Withdrawal by Subject|27
4577700|NCT01424228|7419028|FG001|Overall Study|Withdrawal by Subject|11
4577701|NCT01424228|7419027|FG000|Overall Study|Adverse Event|10
4577702|NCT01424228|7419028|FG001|Overall Study|Adverse Event|14
4577703|NCT01424228|7419027|FG000|Overall Study|Sponsor's decision|9
4577704|NCT01424228|7419028|FG001|Overall Study|Sponsor's decision|12
4577705|NCT01424228|7419027|FG000|Overall Study|Lack of Efficacy|5
4577706|NCT01424228|7419028|FG001|Overall Study|Lack of Efficacy|7
4577707|NCT01424228|7419027|FG000|Overall Study|inclusion/exclusion criteria not met|2
4577708|NCT01424228|7419028|FG001|Overall Study|inclusion/exclusion criteria not met|2
4577709|NCT01424228|7419027|FG000|Overall Study|Non-compliance|2
4577710|NCT01424228|7419028|FG001|Overall Study|Non-compliance|0
4577711|NCT01424228|7419027|FG000|Overall Study|Worsening of symptoms|1
4577712|NCT01424228|7419028|FG001|Overall Study|Worsening of symptoms|0
4577713|NCT01424228|7419027|FG000|Overall Study|Unplanned journey|0
4577714|NCT01424228|7419028|FG001|Overall Study|Unplanned journey|1
4577715|NCT01424306|7419038|FG000|Overall Study|Protocol Violation|0
4577716|NCT01424306|7419039|FG001|Overall Study|Protocol Violation|0
4577717|NCT01424306|7419040|FG002|Overall Study|Protocol Violation|0
4577718|NCT01424306|7419041|FG003|Overall Study|Protocol Violation|0
4577719|NCT01424306|7419042|FG004|Overall Study|Protocol Violation|1
4577720|NCT01424306|7419043|FG005|Overall Study|Protocol Violation|0
4577721|NCT01424397|7419087|FG000|Period-2 (8 Days)|Withdrawal by Subject|0
4577722|NCT01424397|7419088|FG001|Period-2 (8 Days)|Withdrawal by Subject|0
4577723|NCT01424397|7419089|FG002|Period-2 (8 Days)|Withdrawal by Subject|1
4577724|NCT01424397|7419090|FG003|Period-2 (8 Days)|Withdrawal by Subject|0
4577725|NCT01424397|7419091|FG004|Period-2 (8 Days)|Withdrawal by Subject|0
4577726|NCT01424397|7419092|FG005|Period-2 (8 Days)|Withdrawal by Subject|0
4577727|NCT01424397|7419093|FG006|Period-2 (8 Days)|Withdrawal by Subject|0
4577728|NCT01424397|7419094|FG007|Period-2 (8 Days)|Withdrawal by Subject|0
4577729|NCT01424397|7419095|FG008|Period-2 (8 Days)|Withdrawal by Subject|0
4577730|NCT01424397|7419096|FG009|Period-2 (8 Days)|Withdrawal by Subject|0
4577731|NCT01424397|7419097|FG010|Period-2 (8 Days)|Withdrawal by Subject|0
4577732|NCT01424397|7419098|FG011|Period-2 (8 Days)|Withdrawal by Subject|0
4577733|NCT01424501|7419118|FG000|Overall Study|Withdrawal by Subject|1
4577734|NCT01424501|7419119|FG001|Overall Study|Withdrawal by Subject|0
4577735|NCT01424501|7419120|FG002|Overall Study|Withdrawal by Subject|1
4577736|NCT01424501|7419121|FG003|Overall Study|Withdrawal by Subject|0
4577737|NCT01424501|7419122|FG004|Overall Study|Withdrawal by Subject|0
4577738|NCT01424501|7419123|FG005|Overall Study|Withdrawal by Subject|0
4577739|NCT01424501|7419118|FG000|Overall Study|Lost to Follow-up|0
4577740|NCT01424501|7419119|FG001|Overall Study|Lost to Follow-up|1
4577741|NCT01424501|7419120|FG002|Overall Study|Lost to Follow-up|1
4577742|NCT01424501|7419121|FG003|Overall Study|Lost to Follow-up|0
4577743|NCT01424501|7419122|FG004|Overall Study|Lost to Follow-up|0
4577744|NCT01424501|7419123|FG005|Overall Study|Lost to Follow-up|0
4577745|NCT01424514|7419138|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1
4577746|NCT01424514|7419139|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1
4577747|NCT01424514|7419138|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1
4577748|NCT01424514|7419139|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0
4577749|NCT01424566|7419150|FG000|Single-blind Treatment|Adverse Event|71
4577750|NCT01424566|7419151|FG001|Single-blind Treatment|Adverse Event|0
4577751|NCT01424566|7419152|FG002|Single-blind Treatment|Adverse Event|0
4577752|NCT01424566|7419150|FG000|Single-blind Treatment|Withdrawal by Subject|16
4577753|NCT01424566|7419151|FG001|Single-blind Treatment|Withdrawal by Subject|0
4577754|NCT01424566|7419152|FG002|Single-blind Treatment|Withdrawal by Subject|0
4577755|NCT01424566|7419150|FG000|Single-blind Treatment|Withdrawal by Investigator|2
4577756|NCT01424566|7419151|FG001|Single-blind Treatment|Withdrawal by Investigator|0
4577757|NCT01424566|7419152|FG002|Single-blind Treatment|Withdrawal by Investigator|0
4577758|NCT01424566|7419150|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108
4577759|NCT01424566|7419151|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0
4577760|NCT01424566|7419152|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0
4577761|NCT01424566|7419150|FG000|Single-blind Treatment|Met Exclusion Criteria|1
4577762|NCT01424566|7419151|FG001|Single-blind Treatment|Met Exclusion Criteria|0
4577763|NCT01424566|7419152|FG002|Single-blind Treatment|Met Exclusion Criteria|0
4577764|NCT01424566|7419150|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2
4577765|NCT01424566|7419151|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0
4577766|NCT01424566|7419152|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0
4577767|NCT01424566|7419150|FG000|Double-blind Treatment|Adverse Event|0
4577768|NCT01424566|7419151|FG001|Double-blind Treatment|Adverse Event|21
4577769|NCT01424566|7419152|FG002|Double-blind Treatment|Adverse Event|13
4577770|NCT01424566|7419150|FG000|Double-blind Treatment|Withdrawal by Subject|0
4577771|NCT01424566|7419151|FG001|Double-blind Treatment|Withdrawal by Subject|2
4577772|NCT01424566|7419152|FG002|Double-blind Treatment|Withdrawal by Subject|0
4577773|NCT01424566|7419150|FG000|Double-blind Treatment|Withdrawal by Investigator|0
4691816|NCT02574520|7602132|FG003|Overall Study|Withdrawal by Subject|1
4691817|NCT02574520|7602129|FG000|Overall Study|Other|0
4691818|NCT02574520|7602130|FG001|Overall Study|Other|0
4691819|NCT02574520|7602131|FG002|Overall Study|Other|0
4691820|NCT02574520|7602132|FG003|Overall Study|Other|2
4691821|NCT02574637|7602156|FG000|Double-blind Period|Adverse Event|1
4691822|NCT02574637|7602157|FG001|Double-blind Period|Adverse Event|0
4691823|NCT02574637|7602158|FG002|Double-blind Period|Adverse Event|0
4691824|NCT02574637|7602159|FG003|Double-blind Period|Adverse Event|0
4691825|NCT02574637|7602160|FG004|Double-blind Period|Adverse Event|0
4691826|NCT02574637|7602161|FG005|Double-blind Period|Adverse Event|0
4691827|NCT02574637|7602162|FG006|Double-blind Period|Adverse Event|0
4691828|NCT02574637|7602163|FG007|Double-blind Period|Adverse Event|0
4691829|NCT02574637|7602164|FG008|Double-blind Period|Adverse Event|0
4691830|NCT02574637|7602165|FG009|Double-blind Period|Adverse Event|0
4691831|NCT02574637|7602156|FG000|Double-blind Period|Lack of Efficacy|0
4691832|NCT02574637|7602157|FG001|Double-blind Period|Lack of Efficacy|0
4691833|NCT02574637|7602158|FG002|Double-blind Period|Lack of Efficacy|2
4691834|NCT02574637|7602159|FG003|Double-blind Period|Lack of Efficacy|0
4691835|NCT02574637|7602160|FG004|Double-blind Period|Lack of Efficacy|0
4691836|NCT02574637|7602161|FG005|Double-blind Period|Lack of Efficacy|0
4691837|NCT02574637|7602162|FG006|Double-blind Period|Lack of Efficacy|0
4691838|NCT02574637|7602163|FG007|Double-blind Period|Lack of Efficacy|0
4691839|NCT02574637|7602164|FG008|Double-blind Period|Lack of Efficacy|0
4691840|NCT02574637|7602165|FG009|Double-blind Period|Lack of Efficacy|0
4691841|NCT02574637|7602156|FG000|Double-blind Period|Protocol Deviation|1
4691842|NCT02574637|7602157|FG001|Double-blind Period|Protocol Deviation|0
4691843|NCT02574637|7602158|FG002|Double-blind Period|Protocol Deviation|0
4691844|NCT02574637|7602159|FG003|Double-blind Period|Protocol Deviation|0
4691845|NCT02574637|7602160|FG004|Double-blind Period|Protocol Deviation|0
4691846|NCT02574637|7602161|FG005|Double-blind Period|Protocol Deviation|0
4691847|NCT02574637|7602162|FG006|Double-blind Period|Protocol Deviation|0
4691848|NCT02574637|7602163|FG007|Double-blind Period|Protocol Deviation|0
4691849|NCT02574637|7602164|FG008|Double-blind Period|Protocol Deviation|0
4691850|NCT02574637|7602165|FG009|Double-blind Period|Protocol Deviation|0
4691851|NCT02574637|7602156|FG000|Double-blind Period|Non-Compliance With Study Drug|0
4691852|NCT02574637|7602157|FG001|Double-blind Period|Non-Compliance With Study Drug|0
4691853|NCT02574637|7602158|FG002|Double-blind Period|Non-Compliance With Study Drug|0
4691854|NCT02574637|7602159|FG003|Double-blind Period|Non-Compliance With Study Drug|1
4691855|NCT02574637|7602160|FG004|Double-blind Period|Non-Compliance With Study Drug|0
4691856|NCT02574637|7602161|FG005|Double-blind Period|Non-Compliance With Study Drug|0
4691857|NCT02574637|7602162|FG006|Double-blind Period|Non-Compliance With Study Drug|0
4691858|NCT02574637|7602163|FG007|Double-blind Period|Non-Compliance With Study Drug|0
4691859|NCT02574637|7602164|FG008|Double-blind Period|Non-Compliance With Study Drug|0
4691860|NCT02574637|7602165|FG009|Double-blind Period|Non-Compliance With Study Drug|0
4691861|NCT02574637|7602156|FG000|Double-blind Period|Study Terminated By Sponsor|1
4691862|NCT02574637|7602157|FG001|Double-blind Period|Study Terminated By Sponsor|1
4691863|NCT02574637|7602158|FG002|Double-blind Period|Study Terminated By Sponsor|5
4691864|NCT02574637|7602159|FG003|Double-blind Period|Study Terminated By Sponsor|2
4691865|NCT02574637|7602160|FG004|Double-blind Period|Study Terminated By Sponsor|2
4691866|NCT02574637|7602161|FG005|Double-blind Period|Study Terminated By Sponsor|0
4691867|NCT02574637|7602162|FG006|Double-blind Period|Study Terminated By Sponsor|0
4691868|NCT02574637|7602163|FG007|Double-blind Period|Study Terminated By Sponsor|0
4691869|NCT02574637|7602164|FG008|Double-blind Period|Study Terminated By Sponsor|0
4691870|NCT02574637|7602165|FG009|Double-blind Period|Study Terminated By Sponsor|0
4691871|NCT02574637|7602156|FG000|Double-blind Period|Reason Not Specified|0
4691872|NCT02574637|7602157|FG001|Double-blind Period|Reason Not Specified|0
4691873|NCT02574637|7602158|FG002|Double-blind Period|Reason Not Specified|0
4691874|NCT02574637|7602159|FG003|Double-blind Period|Reason Not Specified|1
4691875|NCT02574637|7602160|FG004|Double-blind Period|Reason Not Specified|0
4691876|NCT02574637|7602161|FG005|Double-blind Period|Reason Not Specified|0
4691877|NCT02574637|7602162|FG006|Double-blind Period|Reason Not Specified|0
4691878|NCT02574637|7602163|FG007|Double-blind Period|Reason Not Specified|0
4577774|NCT01424566|7419151|FG001|Double-blind Treatment|Withdrawal by Investigator|1
4577775|NCT01424566|7419152|FG002|Double-blind Treatment|Withdrawal by Investigator|1
4691879|NCT02574637|7602164|FG008|Double-blind Period|Reason Not Specified|0
4577776|NCT01424566|7419150|FG000|Double-blind Treatment|Lack of Efficacy|0
4577777|NCT01424566|7419151|FG001|Double-blind Treatment|Lack of Efficacy|1
4577778|NCT01424566|7419152|FG002|Double-blind Treatment|Lack of Efficacy|1
4577779|NCT01424644|7419161|FG000|Overall Study|Adverse Event|2
4577780|NCT01424644|7419162|FG001|Overall Study|Adverse Event|0
4577781|NCT01424644|7419161|FG000|Overall Study|Withdrawal by Subject|9
4577782|NCT01424644|7419162|FG001|Overall Study|Withdrawal by Subject|12
4577783|NCT01424644|7419161|FG000|Overall Study|Lost to Follow-up|16
4577784|NCT01424644|7419162|FG001|Overall Study|Lost to Follow-up|12
4577785|NCT01424644|7419161|FG000|Overall Study|Protocol Violation|4
4577786|NCT01424644|7419162|FG001|Overall Study|Protocol Violation|3
4577787|NCT01424644|7419161|FG000|Overall Study|Administrative Reason|1
4577788|NCT01424644|7419162|FG001|Overall Study|Administrative Reason|0
4577789|NCT01424644|7419161|FG000|Overall Study|Unable to Classify|1
4577790|NCT01424644|7419162|FG001|Overall Study|Unable to Classify|0
4577791|NCT01424670|7419170|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2
4577792|NCT01424670|7419171|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2
4577793|NCT01424670|7419170|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0
4577794|NCT01424670|7419171|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1
4577795|NCT01424670|7419170|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2
4577796|NCT01424670|7419171|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1
4577797|NCT01424670|7419170|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2
4577798|NCT01424670|7419171|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3
4577799|NCT01424670|7419170|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13
4691880|NCT02574637|7602165|FG009|Double-blind Period|Reason Not Specified|0
4691881|NCT02574637|7602156|FG000|Open-label (OL) Period|Adverse Event|0
4577800|NCT01424670|7419171|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7
4577801|NCT01424670|7419170|FG000|Continuation Period|Adverse Event|13
4577802|NCT01424670|7419171|FG001|Continuation Period|Adverse Event|5
4577803|NCT01424670|7419170|FG000|Continuation Period|Lost to Follow-up|2
4577804|NCT01424670|7419171|FG001|Continuation Period|Lost to Follow-up|0
4577805|NCT01424670|7419170|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1
4577806|NCT01424670|7419171|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1
4577807|NCT01424670|7419170|FG000|Continuation Period|Physician Decision|5
4770422|NCT03740919|7746730|FG000|Treatment Period|Not Completing Diary|0
4577808|NCT01424670|7419171|FG001|Continuation Period|Physician Decision|4
4577809|NCT01424670|7419170|FG000|Continuation Period|Withdrawal by Subject|13
4577810|NCT01424670|7419171|FG001|Continuation Period|Withdrawal by Subject|4
4577811|NCT01424722|7419179|FG000|Overall Study|Sponsor terminated investigation|2258
4577812|NCT01424813|7419185|FG000|Overall Study|Withdrawal by Subject|3
4577813|NCT01424813|7419186|FG001|Overall Study|Withdrawal by Subject|0
4577814|NCT01424813|7419185|FG000|Overall Study|Protocol Violation|1
4577815|NCT01424813|7419186|FG001|Overall Study|Protocol Violation|0
4577816|NCT01424813|7419185|FG000|Overall Study|Other|1
4577817|NCT01424813|7419186|FG001|Overall Study|Other|2
4577818|NCT01424930|7419194|FG000|Overall Study|Adverse Event|0
4577819|NCT01424930|7419195|FG001|Overall Study|Adverse Event|1
4577820|NCT01424930|7419194|FG000|Overall Study|Death|1
4577821|NCT01424930|7419195|FG001|Overall Study|Death|0
4577822|NCT01424930|7419194|FG000|Overall Study|Progressive Disease|3
4577823|NCT01424930|7419195|FG001|Overall Study|Progressive Disease|6
4577824|NCT01424930|7419194|FG000|Overall Study|Screen Failure|0
4577825|NCT01424930|7419195|FG001|Overall Study|Screen Failure|1
4577826|NCT01424930|7419194|FG000|Overall Study|Reason not specified|0
4577827|NCT01424930|7419195|FG001|Overall Study|Reason not specified|6
4577828|NCT01425190|7419213|FG000|Overall Study|Full dose not consumed.|1
4577829|NCT01425190|7419214|FG001|Overall Study|Full dose not consumed.|0
4577830|NCT01425190|7419215|FG002|Overall Study|Full dose not consumed.|0
4577831|NCT01425203|7419225|FG000|Treatment Phase|DC during PR Lead-in Phase|3
4577832|NCT01425203|7419226|FG001|Treatment Phase|DC during PR Lead-in Phase|1
4577833|NCT01425203|7419227|FG002|Treatment Phase|DC during PR Lead-in Phase|0
4577834|NCT01425203|7419225|FG000|Treatment Phase|Failure at futility timepoint|8
4577835|NCT01425203|7419226|FG001|Treatment Phase|Failure at futility timepoint|27
4577836|NCT01425203|7419227|FG002|Treatment Phase|Failure at futility timepoint|0
4577837|NCT01425203|7419225|FG000|Treatment Phase|Other virologic failure criteria|5
4577838|NCT01425203|7419226|FG001|Treatment Phase|Other virologic failure criteria|3
4577839|NCT01425203|7419227|FG002|Treatment Phase|Other virologic failure criteria|0
4577840|NCT01425203|7419225|FG000|Treatment Phase|Unidentified reasons|11
4577841|NCT01425203|7419226|FG001|Treatment Phase|Unidentified reasons|5
4577842|NCT01425203|7419227|FG002|Treatment Phase|Unidentified reasons|0
4577843|NCT01425203|7419225|FG000|Treatment Phase|Did not receive treatment|0
4577844|NCT01425203|7419226|FG001|Treatment Phase|Did not receive treatment|1
4577845|NCT01425203|7419227|FG002|Treatment Phase|Did not receive treatment|0
4577846|NCT01425203|7419225|FG000|Crossover Phase|Failure at futility timepoint|0
4577847|NCT01425203|7419226|FG001|Crossover Phase|Failure at futility timepoint|0
4577848|NCT01425203|7419227|FG002|Crossover Phase|Failure at futility timepoint|3
4577849|NCT01425203|7419225|FG000|Crossover Phase|Other virologic failure criteria|0
4577850|NCT01425203|7419226|FG001|Crossover Phase|Other virologic failure criteria|0
4577851|NCT01425203|7419227|FG002|Crossover Phase|Other virologic failure criteria|3
4691882|NCT02574637|7602157|FG001|Open-label (OL) Period|Adverse Event|0
4577852|NCT01425268|7419245|FG000|Overall Study|Withdrawal by Subject|2
4577853|NCT01425268|7419246|FG001|Overall Study|Withdrawal by Subject|0
4577854|NCT01425268|7419245|FG000|Overall Study|Sponsor Decision|5
4577855|NCT01425268|7419246|FG001|Overall Study|Sponsor Decision|0
4577856|NCT01425268|7419245|FG000|Overall Study|Physician Decision|1
4577857|NCT01425268|7419246|FG001|Overall Study|Physician Decision|0
4577858|NCT01425281|7419254|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1
4577859|NCT01425281|7419255|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0
4577860|NCT01425281|7419254|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3
4577861|NCT01425281|7419255|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0
4577862|NCT01425281|7419254|FG000|At 180-day Clinical Follow-up|Death|0
4577863|NCT01425281|7419255|FG001|At 180-day Clinical Follow-up|Death|1
4577864|NCT01425281|7419254|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1
4577865|NCT01425281|7419255|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1
4577866|NCT01425281|7419254|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1
4577867|NCT01425281|7419255|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0
4577868|NCT01425281|7419254|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2
4577869|NCT01425281|7419255|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1
4577870|NCT01425281|7419254|FG000|At 2-year Clinical Follow-up|Death|2
4577871|NCT01425281|7419255|FG001|At 2-year Clinical Follow-up|Death|0
4577872|NCT01425281|7419254|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1
4577873|NCT01425281|7419255|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0
4577874|NCT01425281|7419254|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1
4577875|NCT01425281|7419255|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0
4577876|NCT01425281|7419254|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3
4577877|NCT01425281|7419255|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3
4577878|NCT01425281|7419254|FG000|At 3-year Clinical Follow-up|Death|2
4577879|NCT01425281|7419255|FG001|At 3-year Clinical Follow-up|Death|3
4577880|NCT01425281|7419254|FG000|At 4-year Clinical Follow-up|Death|7
4577881|NCT01425281|7419255|FG001|At 4-year Clinical Follow-up|Death|3
4577882|NCT01425281|7419254|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3
4577883|NCT01425281|7419255|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2
4577884|NCT01425281|7419254|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10
4577885|NCT01425281|7419255|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10
4577886|NCT01425281|7419254|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6
4577887|NCT01425281|7419255|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5
4577888|NCT01425281|7419254|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4
4577889|NCT01425281|7419255|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1
4577890|NCT01425281|7419254|FG000|At 5-year Clinical Follow-up|Death|2
4577891|NCT01425281|7419255|FG001|At 5-year Clinical Follow-up|Death|0
4577892|NCT01425281|7419254|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2
4577893|NCT01425281|7419255|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1
4577894|NCT01425281|7419254|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19
4577895|NCT01425281|7419255|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7
4577896|NCT01425281|7419254|FG000|At 5-year Clinical Follow-up|Refused/terminated|9
4577897|NCT01425281|7419255|FG001|At 5-year Clinical Follow-up|Refused/terminated|3
4577898|NCT01425359|7419275|FG000|Overall Study|Randomized but Not Treated|2
4577899|NCT01425359|7419276|FG001|Overall Study|Randomized but Not Treated|3
4577900|NCT01425359|7419275|FG000|Overall Study|Adverse Event|9
4577901|NCT01425359|7419276|FG001|Overall Study|Adverse Event|8
4577902|NCT01425359|7419275|FG000|Overall Study|Revascularization|0
4577903|NCT01425359|7419276|FG001|Overall Study|Revascularization|1
4577904|NCT01425359|7419275|FG000|Overall Study|Death|0
4577905|NCT01425359|7419276|FG001|Overall Study|Death|1
4577906|NCT01425359|7419275|FG000|Overall Study|Unsatisfactory Response|1
4577907|NCT01425359|7419276|FG001|Overall Study|Unsatisfactory Response|0
4577908|NCT01425359|7419275|FG000|Overall Study|Protocol Violation|1
4577909|NCT01425359|7419276|FG001|Overall Study|Protocol Violation|2
4577910|NCT01425359|7419275|FG000|Overall Study|Subject Withdrew Consent|1
4577911|NCT01425359|7419276|FG001|Overall Study|Subject Withdrew Consent|2
4577912|NCT01425359|7419275|FG000|Overall Study|Investigator's Discretion|2
4577913|NCT01425359|7419276|FG001|Overall Study|Investigator's Discretion|0
4577914|NCT01425359|7419275|FG000|Overall Study|Did Not Meet Qualifying Criteria|3
4577915|NCT01425359|7419276|FG001|Overall Study|Did Not Meet Qualifying Criteria|5
4577916|NCT01425463|7419285|FG000|Overall Study|Adverse Event|5
4577917|NCT01425463|7419286|FG001|Overall Study|Adverse Event|7
4577918|NCT01425463|7419285|FG000|Overall Study|Lack of Efficacy|1
4577919|NCT01425463|7419286|FG001|Overall Study|Lack of Efficacy|1
4577920|NCT01425463|7419285|FG000|Overall Study|Protocol Violation|2
4577921|NCT01425463|7419286|FG001|Overall Study|Protocol Violation|2
4577922|NCT01425463|7419285|FG000|Overall Study|Lost to Follow-up|5
4577923|NCT01425463|7419286|FG001|Overall Study|Lost to Follow-up|2
4577924|NCT01425463|7419285|FG000|Overall Study|Withdrawal by Subject|7
4577925|NCT01425463|7419286|FG001|Overall Study|Withdrawal by Subject|5
4577926|NCT01425463|7419285|FG000|Overall Study|Unknown Reason|4
4577927|NCT01425463|7419286|FG001|Overall Study|Unknown Reason|7
4577928|NCT01425528|7419294|FG000|Overall Study|Withdrawal by Subject|1
4577929|NCT01425528|7419295|FG001|Overall Study|Withdrawal by Subject|1
4593129|NCT01547299|7441253|FG000|Overall Study|Withdrawal by Subject|2
4593130|NCT01547299|7441254|FG001|Overall Study|Withdrawal by Subject|2
4593131|NCT01547390|7441262|FG000|Overall Study|Withdrawal by Subject|10
4593132|NCT01547390|7441263|FG001|Overall Study|Withdrawal by Subject|7
4593133|NCT01547390|7441262|FG000|Overall Study|termination of pregnancy|0
4593134|NCT01547390|7441263|FG001|Overall Study|termination of pregnancy|1
4593135|NCT01547390|7441262|FG000|Overall Study|Lost to Follow-up|0
4593136|NCT01547390|7441263|FG001|Overall Study|Lost to Follow-up|2
4593137|NCT01547390|7441262|FG000|Overall Study|Adverse Event|3
4593138|NCT01547390|7441263|FG001|Overall Study|Adverse Event|0
4593139|NCT01547598|7441271|FG000|Overall Study|Withdrew consent|1
4593140|NCT01547598|7441272|FG001|Overall Study|Withdrew consent|1
4593141|NCT01547598|7441271|FG000|Overall Study|Lost to Follow-up|1
4593142|NCT01547598|7441272|FG001|Overall Study|Lost to Follow-up|1
4593143|NCT01547598|7441271|FG000|Overall Study|Adverse Event|1
4593144|NCT01547598|7441272|FG001|Overall Study|Adverse Event|1
4593145|NCT01547598|7441271|FG000|Overall Study|Protocol Violation|1
4593146|NCT01547598|7441272|FG001|Overall Study|Protocol Violation|1
4593147|NCT01547598|7441271|FG000|Overall Study|Other Miscellaneous Reasons|2
4593148|NCT01547598|7441272|FG001|Overall Study|Other Miscellaneous Reasons|1
4593149|NCT01547780|7441297|FG000|Baseline PET Scan|Physician Decision|1
4593150|NCT01547780|7441298|FG001|Baseline PET Scan|Physician Decision|0
4593151|NCT01547780|7441299|FG002|Baseline PET Scan|Physician Decision|1
4593152|NCT01547780|7441300|FG003|Baseline PET Scan|Physician Decision|0
4593153|NCT01547780|7441297|FG000|Baseline PET Scan|Withdrawal by Subject|2
4593154|NCT01547780|7441298|FG001|Baseline PET Scan|Withdrawal by Subject|0
4593155|NCT01547780|7441299|FG002|Baseline PET Scan|Withdrawal by Subject|1
4593156|NCT01547780|7441300|FG003|Baseline PET Scan|Withdrawal by Subject|0
4593157|NCT01548287|7441328|FG000|Screening|No reason provided|0
4593158|NCT01548287|7441329|FG001|Screening|No reason provided|0
4593159|NCT01548287|7441330|FG002|Screening|No reason provided|0
4593160|NCT01548287|7441331|FG003|Screening|No reason provided|0
4593161|NCT01548287|7441332|FG004|Screening|No reason provided|9
4593162|NCT01548287|7441328|FG000|Screening|Did not meet eligibility criteria|0
4593163|NCT01548287|7441329|FG001|Screening|Did not meet eligibility criteria|0
4593164|NCT01548287|7441330|FG002|Screening|Did not meet eligibility criteria|0
4593165|NCT01548287|7441331|FG003|Screening|Did not meet eligibility criteria|0
4593166|NCT01548287|7441332|FG004|Screening|Did not meet eligibility criteria|74
4593167|NCT01548287|7441328|FG000|Randomized Period|Did not meet inclusion criteria|0
4593168|NCT01548287|7441329|FG001|Randomized Period|Did not meet inclusion criteria|0
4593169|NCT01548287|7441330|FG002|Randomized Period|Did not meet inclusion criteria|2
4593170|NCT01548287|7441331|FG003|Randomized Period|Did not meet inclusion criteria|0
4593171|NCT01548287|7441332|FG004|Randomized Period|Did not meet inclusion criteria|0
4593172|NCT01548287|7441328|FG000|Randomized Period|Adverse Event|0
4593173|NCT01548287|7441329|FG001|Randomized Period|Adverse Event|2
4593174|NCT01548287|7441330|FG002|Randomized Period|Adverse Event|5
4593175|NCT01548287|7441331|FG003|Randomized Period|Adverse Event|0
4593176|NCT01548287|7441332|FG004|Randomized Period|Adverse Event|0
4593177|NCT01548404|7441353|FG000|Overall Study|Adverse Event|3
4593178|NCT01548404|7441354|FG001|Overall Study|Adverse Event|1
4593179|NCT01548404|7441353|FG000|Overall Study|Physician Decision|2
4593180|NCT01548404|7441354|FG001|Overall Study|Physician Decision|1
4593181|NCT01548404|7441353|FG000|Overall Study|Inadequate response to study treatment|23
4593182|NCT01548404|7441354|FG001|Overall Study|Inadequate response to study treatment|7
4593183|NCT01548404|7441353|FG000|Overall Study|Lost to Follow-up|2
4593184|NCT01548404|7441354|FG001|Overall Study|Lost to Follow-up|0
4593185|NCT01548404|7441353|FG000|Overall Study|Withdrawal by Subject|0
4593186|NCT01548404|7441354|FG001|Overall Study|Withdrawal by Subject|3
4593187|NCT01548404|7441353|FG000|Overall Study|Other than specified above|0
4593188|NCT01548404|7441354|FG001|Overall Study|Other than specified above|2
4593189|NCT01548417|7441363|FG000|Overall Study|Withdrawal by Subject|0
4593190|NCT01548417|7441364|FG001|Overall Study|Withdrawal by Subject|2
4691883|NCT02574637|7602158|FG002|Open-label (OL) Period|Adverse Event|0
4691884|NCT02574637|7602159|FG003|Open-label (OL) Period|Adverse Event|0
4691885|NCT02574637|7602160|FG004|Open-label (OL) Period|Adverse Event|0
4691886|NCT02574637|7602161|FG005|Open-label (OL) Period|Adverse Event|0
4691887|NCT02574637|7602162|FG006|Open-label (OL) Period|Adverse Event|0
4691888|NCT02574637|7602163|FG007|Open-label (OL) Period|Adverse Event|0
4691889|NCT02574637|7602164|FG008|Open-label (OL) Period|Adverse Event|1
4593191|NCT01548573|7441370|FG000|Overall Study|Death|3
4593192|NCT01548573|7441370|FG000|Overall Study|Withdrawal by Subject|2
4593193|NCT01548599|7441377|FG000|Overall Study|Lost to Follow-up|0
4593194|NCT01548599|7441378|FG001|Overall Study|Lost to Follow-up|1
4593195|NCT01548599|7441377|FG000|Overall Study|Withdrawal by Subject|4
4593196|NCT01548599|7441378|FG001|Overall Study|Withdrawal by Subject|0
4593197|NCT01548599|7441377|FG000|Overall Study|Death|2
4593198|NCT01548599|7441378|FG001|Overall Study|Death|1
4593199|NCT01548638|7441387|FG000|Overall Study|Protocol Violation|3
4593200|NCT01548638|7441387|FG000|Overall Study|Withdrawal by Subject|1
4691890|NCT02574637|7602165|FG009|Open-label (OL) Period|Adverse Event|0
4593201|NCT01548768|7441427|FG000|Overall Study|Withdrawal by Subject|0
4593202|NCT01548768|7441428|FG001|Overall Study|Withdrawal by Subject|2
4577930|NCT01425632|7419304|FG000|Overall Study|Adverse Event|0
4577931|NCT01425632|7419305|FG001|Overall Study|Adverse Event|1
4577932|NCT01425632|7419306|FG002|Overall Study|Adverse Event|1
4577933|NCT01425632|7419304|FG000|Overall Study|Physician Decision|1
4577934|NCT01425632|7419305|FG001|Overall Study|Physician Decision|0
4577935|NCT01425632|7419306|FG002|Overall Study|Physician Decision|0
4577936|NCT01425632|7419304|FG000|Overall Study|Protocol Violation|0
4577937|NCT01425632|7419305|FG001|Overall Study|Protocol Violation|0
4577938|NCT01425632|7419306|FG002|Overall Study|Protocol Violation|2
4577939|NCT01425632|7419304|FG000|Overall Study|Withdrawal by Subject|0
4577940|NCT01425632|7419305|FG001|Overall Study|Withdrawal by Subject|0
4577941|NCT01425632|7419306|FG002|Overall Study|Withdrawal by Subject|1
4577942|NCT01425723|7419316|FG000|Overall Study|Lack of Efficacy|0
4577943|NCT01425723|7419317|FG001|Overall Study|Lack of Efficacy|1
4577944|NCT01425723|7419316|FG000|Overall Study|Withdrawal by Subject|1
4577945|NCT01425723|7419317|FG001|Overall Study|Withdrawal by Subject|4
4577946|NCT01425723|7419316|FG000|Overall Study|Lost to Follow-up|0
4577947|NCT01425723|7419317|FG001|Overall Study|Lost to Follow-up|3
4577948|NCT01425723|7419316|FG000|Overall Study|Physician Decision|2
4577949|NCT01425723|7419317|FG001|Overall Study|Physician Decision|0
4577950|NCT01425723|7419316|FG000|Overall Study|Other|1
4577951|NCT01425723|7419317|FG001|Overall Study|Other|10
4577952|NCT01425749|7419334|FG000|Overall Study|progression of melanoma|0
4577953|NCT01425749|7419335|FG001|Overall Study|progression of melanoma|1
4577954|NCT01425801|7419344|FG000|Period 1|Withdrawal by Subject|0
4577955|NCT01425801|7419345|FG001|Period 1|Withdrawal by Subject|0
4577956|NCT01425801|7419346|FG002|Period 1|Withdrawal by Subject|0
4577957|NCT01425801|7419347|FG003|Period 1|Withdrawal by Subject|0
4577958|NCT01425801|7419348|FG004|Period 1|Withdrawal by Subject|1
4577959|NCT01425801|7419349|FG005|Period 1|Withdrawal by Subject|0
4577960|NCT01425801|7419344|FG000|Period 2|Withdrawal by Subject|0
4577961|NCT01425801|7419345|FG001|Period 2|Withdrawal by Subject|0
4577962|NCT01425801|7419346|FG002|Period 2|Withdrawal by Subject|0
4577963|NCT01425801|7419347|FG003|Period 2|Withdrawal by Subject|0
4577964|NCT01425801|7419348|FG004|Period 2|Withdrawal by Subject|1
4577965|NCT01425801|7419349|FG005|Period 2|Withdrawal by Subject|0
4577966|NCT01425801|7419344|FG000|Period 3|Stability criteria not fullfilled|0
4577967|NCT01425801|7419345|FG001|Period 3|Stability criteria not fullfilled|0
4577968|NCT01425801|7419346|FG002|Period 3|Stability criteria not fullfilled|1
4577969|NCT01425801|7419347|FG003|Period 3|Stability criteria not fullfilled|0
4577970|NCT01425801|7419348|FG004|Period 3|Stability criteria not fullfilled|0
4577971|NCT01425801|7419349|FG005|Period 3|Stability criteria not fullfilled|0
4577972|NCT01425801|7419344|FG000|Period 4|Not able to maintain visit schedule|0
4577973|NCT01425801|7419345|FG001|Period 4|Not able to maintain visit schedule|0
4577974|NCT01425801|7419346|FG002|Period 4|Not able to maintain visit schedule|1
4577975|NCT01425801|7419347|FG003|Period 4|Not able to maintain visit schedule|0
4577976|NCT01425801|7419348|FG004|Period 4|Not able to maintain visit schedule|0
4577977|NCT01425801|7419349|FG005|Period 4|Not able to maintain visit schedule|0
4577978|NCT01425814|7419363|FG000|Period 1|Stability criteria not fulfilled|0
4577979|NCT01425814|7419364|FG001|Period 1|Stability criteria not fulfilled|1
4577980|NCT01425814|7419365|FG002|Period 1|Stability criteria not fulfilled|0
4577981|NCT01425814|7419366|FG003|Period 1|Stability criteria not fulfilled|0
4577982|NCT01425814|7419367|FG004|Period 1|Stability criteria not fulfilled|0
4577983|NCT01425814|7419368|FG005|Period 1|Stability criteria not fulfilled|0
4577984|NCT01425814|7419363|FG000|Period 2|Stability criteria not fulfilled|0
4577985|NCT01425814|7419364|FG001|Period 2|Stability criteria not fulfilled|1
4577986|NCT01425814|7419365|FG002|Period 2|Stability criteria not fulfilled|0
4577987|NCT01425814|7419366|FG003|Period 2|Stability criteria not fulfilled|0
4577988|NCT01425814|7419367|FG004|Period 2|Stability criteria not fulfilled|0
4577989|NCT01425814|7419368|FG005|Period 2|Stability criteria not fulfilled|0
4577990|NCT01425814|7419363|FG000|Period 3|Adverse Event|0
4577991|NCT01425814|7419364|FG001|Period 3|Adverse Event|0
4577992|NCT01425814|7419365|FG002|Period 3|Adverse Event|0
4577993|NCT01425814|7419366|FG003|Period 3|Adverse Event|0
4577994|NCT01425814|7419367|FG004|Period 3|Adverse Event|0
4577995|NCT01425814|7419368|FG005|Period 3|Adverse Event|1
4577996|NCT01425814|7419363|FG000|Period 4|Adverse Event|1
4577997|NCT01425814|7419364|FG001|Period 4|Adverse Event|0
4577998|NCT01425814|7419365|FG002|Period 4|Adverse Event|1
4577999|NCT01425814|7419366|FG003|Period 4|Adverse Event|0
4578000|NCT01425814|7419367|FG004|Period 4|Adverse Event|0
4578001|NCT01425814|7419368|FG005|Period 4|Adverse Event|0
4578002|NCT01425814|7419363|FG000|Period 5|Stability criteria not fulfilled|0
4578003|NCT01425814|7419364|FG001|Period 5|Stability criteria not fulfilled|0
4578004|NCT01425814|7419365|FG002|Period 5|Stability criteria not fulfilled|1
4578005|NCT01425814|7419366|FG003|Period 5|Stability criteria not fulfilled|0
4578006|NCT01425814|7419367|FG004|Period 5|Stability criteria not fulfilled|0
4578007|NCT01425814|7419368|FG005|Period 5|Stability criteria not fulfilled|1
4578008|NCT01426009|7419396|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1
4578009|NCT01426009|7419396|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1
4578010|NCT01426009|7419396|FG000|Washout 1|Withdrawal by Subject|1
4578011|NCT01426009|7419396|FG000|Washout 1|Personal Reasons|1
4578012|NCT01426009|7419396|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4
4578013|NCT01426009|7419396|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1
4578014|NCT01426009|7419396|FG000|Washout 2|electrive surgery|1
4578015|NCT01426009|7419396|FG000|Washout 3|personal reasons|1
4578016|NCT01426009|7419396|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1
4578017|NCT01426009|7419396|FG000|Washout 4|Lost to Follow-up|1
4578018|NCT01426217|7419418|FG000|Overall Study|lost sample|8
4578019|NCT01426217|7419419|FG001|Overall Study|lost sample|14
4578020|NCT01426269|7419433|FG000|Period 1: 12 Weeks|Adverse Event|5
4578021|NCT01426269|7419434|FG001|Period 1: 12 Weeks|Adverse Event|0
4578022|NCT01426269|7419435|FG002|Period 1: 12 Weeks|Adverse Event|0
4578023|NCT01426269|7419433|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22
4578024|NCT01426269|7419434|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0
4578025|NCT01426269|7419435|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0
4578026|NCT01426269|7419433|FG000|Period 1: 12 Weeks|Protocol Violation|5
4691891|NCT02574637|7602156|FG000|Open-label (OL) Period|Withdrawal by Subject|0
4691892|NCT02574637|7602157|FG001|Open-label (OL) Period|Withdrawal by Subject|0
4691893|NCT02574637|7602158|FG002|Open-label (OL) Period|Withdrawal by Subject|0
4691894|NCT02574637|7602159|FG003|Open-label (OL) Period|Withdrawal by Subject|0
4691895|NCT02574637|7602160|FG004|Open-label (OL) Period|Withdrawal by Subject|0
4691896|NCT02574637|7602161|FG005|Open-label (OL) Period|Withdrawal by Subject|1
4691897|NCT02574637|7602162|FG006|Open-label (OL) Period|Withdrawal by Subject|0
4691898|NCT02574637|7602163|FG007|Open-label (OL) Period|Withdrawal by Subject|0
4578027|NCT01426269|7419434|FG001|Period 1: 12 Weeks|Protocol Violation|0
4578028|NCT01426269|7419435|FG002|Period 1: 12 Weeks|Protocol Violation|0
4578029|NCT01426269|7419433|FG000|Period 1: 12 Weeks|Lost to Follow-up|22
4578030|NCT01426269|7419434|FG001|Period 1: 12 Weeks|Lost to Follow-up|0
4578031|NCT01426269|7419435|FG002|Period 1: 12 Weeks|Lost to Follow-up|0
4578032|NCT01426269|7419433|FG000|Period 1: 12 Weeks|Pregnancy|1
4578033|NCT01426269|7419434|FG001|Period 1: 12 Weeks|Pregnancy|0
4578034|NCT01426269|7419435|FG002|Period 1: 12 Weeks|Pregnancy|0
4578035|NCT01426269|7419433|FG000|Eligibility for Period 2, Randomization|Did not qualify|42
4578036|NCT01426269|7419434|FG001|Eligibility for Period 2, Randomization|Did not qualify|0
4578037|NCT01426269|7419435|FG002|Eligibility for Period 2, Randomization|Did not qualify|0
4578038|NCT01426269|7419433|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8
4578039|NCT01426269|7419434|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0
4578040|NCT01426269|7419435|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0
4578041|NCT01426269|7419433|FG000|Period 2: 40 Weeks|Adverse Event|0
4578042|NCT01426269|7419434|FG001|Period 2: 40 Weeks|Adverse Event|1
4578043|NCT01426269|7419435|FG002|Period 2: 40 Weeks|Adverse Event|2
4578044|NCT01426269|7419433|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0
4578045|NCT01426269|7419434|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9
4578046|NCT01426269|7419435|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11
4578047|NCT01426269|7419433|FG000|Period 2: 40 Weeks|Protocol Violation|0
4578048|NCT01426269|7419434|FG001|Period 2: 40 Weeks|Protocol Violation|5
4578049|NCT01426269|7419435|FG002|Period 2: 40 Weeks|Protocol Violation|5
4578050|NCT01426269|7419433|FG000|Period 2: 40 Weeks|Lost to Follow-up|0
4578051|NCT01426269|7419434|FG001|Period 2: 40 Weeks|Lost to Follow-up|8
4578052|NCT01426269|7419435|FG002|Period 2: 40 Weeks|Lost to Follow-up|6
4578053|NCT01426269|7419433|FG000|Period 2: 40 Weeks|Site closed|0
4578054|NCT01426269|7419434|FG001|Period 2: 40 Weeks|Site closed|6
4578055|NCT01426269|7419435|FG002|Period 2: 40 Weeks|Site closed|5
4578056|NCT01426269|7419433|FG000|Period 2: 40 Weeks|Relapsed|0
4578057|NCT01426269|7419434|FG001|Period 2: 40 Weeks|Relapsed|9
4578058|NCT01426269|7419435|FG002|Period 2: 40 Weeks|Relapsed|18
4578059|NCT01426347|7419448|FG000|Overall Study|Lost to Follow-up|0
4578060|NCT01426347|7419449|FG001|Overall Study|Lost to Follow-up|3
4578061|NCT01426347|7419448|FG000|Overall Study|Protocol Violation|2
4578062|NCT01426347|7419449|FG001|Overall Study|Protocol Violation|0
4578063|NCT01426347|7419448|FG000|Overall Study|Withdrawal by Subject|5
4578064|NCT01426347|7419449|FG001|Overall Study|Withdrawal by Subject|0
4578065|NCT01426373|7419464|FG000|Overall Study|Adverse Event|6
4578066|NCT01426373|7419464|FG000|Overall Study|Lost to Follow-up|14
4578067|NCT01426373|7419464|FG000|Overall Study|Participant Convenience|10
4578068|NCT01426373|7419464|FG000|Overall Study|Miscellaneous Reasons|4
4578069|NCT01426386|7419476|FG000|Overall Study|Adverse Event|0
4578070|NCT01426386|7419477|FG001|Overall Study|Adverse Event|1
4578071|NCT01426386|7419478|FG002|Overall Study|Adverse Event|0
4578072|NCT01426386|7419479|FG003|Overall Study|Adverse Event|0
4578073|NCT01426386|7419480|FG004|Overall Study|Adverse Event|0
4578074|NCT01426386|7419481|FG005|Overall Study|Adverse Event|0
4578075|NCT01426386|7419476|FG000|Overall Study|Did not attend scheduled visit|1
4578076|NCT01426386|7419477|FG001|Overall Study|Did not attend scheduled visit|4
4578077|NCT01426386|7419478|FG002|Overall Study|Did not attend scheduled visit|0
4578078|NCT01426386|7419479|FG003|Overall Study|Did not attend scheduled visit|0
4578079|NCT01426386|7419480|FG004|Overall Study|Did not attend scheduled visit|2
4578080|NCT01426386|7419481|FG005|Overall Study|Did not attend scheduled visit|1
4578081|NCT01426386|7419476|FG000|Overall Study|Poor response|2
4578082|NCT01426386|7419477|FG001|Overall Study|Poor response|1
4578083|NCT01426386|7419478|FG002|Overall Study|Poor response|2
4578084|NCT01426386|7419479|FG003|Overall Study|Poor response|0
4578085|NCT01426386|7419480|FG004|Overall Study|Poor response|1
4578086|NCT01426386|7419481|FG005|Overall Study|Poor response|0
4691899|NCT02574637|7602164|FG008|Open-label (OL) Period|Withdrawal by Subject|0
4578087|NCT01426386|7419476|FG000|Overall Study|Personal reasons|0
4578088|NCT01426386|7419477|FG001|Overall Study|Personal reasons|0
4578089|NCT01426386|7419478|FG002|Overall Study|Personal reasons|0
4578090|NCT01426386|7419479|FG003|Overall Study|Personal reasons|0
4578091|NCT01426386|7419480|FG004|Overall Study|Personal reasons|1
4578092|NCT01426386|7419481|FG005|Overall Study|Personal reasons|0
4578093|NCT01426412|7419504|FG000|Overall Study|Withdrawal by Subject|1
4578094|NCT01426412|7419505|FG001|Overall Study|Withdrawal by Subject|0
4578095|NCT01426412|7419506|FG002|Overall Study|Withdrawal by Subject|0
4578096|NCT01426412|7419507|FG003|Overall Study|Withdrawal by Subject|0
4578097|NCT01426412|7419508|FG004|Overall Study|Withdrawal by Subject|1
4578098|NCT01426412|7419509|FG005|Overall Study|Withdrawal by Subject|0
4578099|NCT01426412|7419510|FG006|Overall Study|Withdrawal by Subject|0
4578100|NCT01426412|7419511|FG007|Overall Study|Withdrawal by Subject|3
4578101|NCT01426412|7419512|FG008|Overall Study|Withdrawal by Subject|1
4578102|NCT01426425|7419543|FG000|Overall Study|Exited prior to EP study|22
4578103|NCT01426425|7419543|FG000|Overall Study|Inclusion/exclusion criteria not met|151
4578104|NCT01426425|7419543|FG000|Overall Study|Met inclusion/exclusion, not treated|2
4578105|NCT01426438|7419550|FG000|Overall Study|Lost to Follow-up|1
4578106|NCT01426438|7419551|FG001|Overall Study|Lost to Follow-up|3
4578107|NCT01426438|7419550|FG000|Overall Study|Off study Treatment|9
4578108|NCT01426438|7419551|FG001|Overall Study|Off study Treatment|3
4578109|NCT01426438|7419550|FG000|Overall Study|Poor scan quality|3
4578110|NCT01426438|7419551|FG001|Overall Study|Poor scan quality|2
4578111|NCT01426438|7419550|FG000|Overall Study|Missed Scan|2
4578112|NCT01426438|7419551|FG001|Overall Study|Missed Scan|2
4578113|NCT01426789|7419581|FG000|Part 1|Protocol deviation|0
4578114|NCT01426789|7419582|FG001|Part 1|Protocol deviation|1
4578115|NCT01426789|7419583|FG002|Part 1|Protocol deviation|0
4578116|NCT01426789|7419584|FG003|Part 1|Protocol deviation|0
4578117|NCT01426789|7419585|FG004|Part 1|Protocol deviation|0
4578118|NCT01426789|7419586|FG005|Part 1|Protocol deviation|0
4578119|NCT01426789|7419581|FG000|Part 1|Lost to Follow-up|1
4578120|NCT01426789|7419582|FG001|Part 1|Lost to Follow-up|2
4578121|NCT01426789|7419583|FG002|Part 1|Lost to Follow-up|0
4578122|NCT01426789|7419584|FG003|Part 1|Lost to Follow-up|0
4578123|NCT01426789|7419585|FG004|Part 1|Lost to Follow-up|0
4578124|NCT01426789|7419586|FG005|Part 1|Lost to Follow-up|0
4578125|NCT01426789|7419581|FG000|Part 1|Lack of Efficacy|2
4578126|NCT01426789|7419582|FG001|Part 1|Lack of Efficacy|1
4578127|NCT01426789|7419583|FG002|Part 1|Lack of Efficacy|0
4578128|NCT01426789|7419584|FG003|Part 1|Lack of Efficacy|0
4578129|NCT01426789|7419585|FG004|Part 1|Lack of Efficacy|0
4578130|NCT01426789|7419586|FG005|Part 1|Lack of Efficacy|0
4578131|NCT01426789|7419581|FG000|Part 1|Adverse Event|3
4578132|NCT01426789|7419582|FG001|Part 1|Adverse Event|0
4578133|NCT01426789|7419583|FG002|Part 1|Adverse Event|0
4578134|NCT01426789|7419584|FG003|Part 1|Adverse Event|0
4578135|NCT01426789|7419585|FG004|Part 1|Adverse Event|0
4578136|NCT01426789|7419586|FG005|Part 1|Adverse Event|0
4578137|NCT01426789|7419581|FG000|Part 2|Protocol deviation|0
4578138|NCT01426789|7419582|FG001|Part 2|Protocol deviation|0
4578139|NCT01426789|7419583|FG002|Part 2|Protocol deviation|1
4578140|NCT01426789|7419584|FG003|Part 2|Protocol deviation|0
4578141|NCT01426789|7419585|FG004|Part 2|Protocol deviation|0
4578142|NCT01426789|7419586|FG005|Part 2|Protocol deviation|0
4578143|NCT01426789|7419581|FG000|Part 2|Death|0
4578144|NCT01426789|7419582|FG001|Part 2|Death|0
4578145|NCT01426789|7419583|FG002|Part 2|Death|1
4578146|NCT01426789|7419584|FG003|Part 2|Death|0
4578147|NCT01426789|7419585|FG004|Part 2|Death|1
4578148|NCT01426789|7419586|FG005|Part 2|Death|0
4578149|NCT01426789|7419581|FG000|Part 2|Administrative problems|0
4578150|NCT01426789|7419582|FG001|Part 2|Administrative problems|0
4578151|NCT01426789|7419583|FG002|Part 2|Administrative problems|2
4578152|NCT01426789|7419584|FG003|Part 2|Administrative problems|0
4578153|NCT01426789|7419585|FG004|Part 2|Administrative problems|1
4578154|NCT01426789|7419586|FG005|Part 2|Administrative problems|0
4578155|NCT01426789|7419581|FG000|Part 2|Lost to Follow-up|0
4578156|NCT01426789|7419582|FG001|Part 2|Lost to Follow-up|0
4578157|NCT01426789|7419583|FG002|Part 2|Lost to Follow-up|4
4578158|NCT01426789|7419584|FG003|Part 2|Lost to Follow-up|0
4578159|NCT01426789|7419585|FG004|Part 2|Lost to Follow-up|1
4578160|NCT01426789|7419586|FG005|Part 2|Lost to Follow-up|0
4578161|NCT01426789|7419581|FG000|Part 2|Withdrawal by Subject|0
4578162|NCT01426789|7419582|FG001|Part 2|Withdrawal by Subject|0
4578163|NCT01426789|7419583|FG002|Part 2|Withdrawal by Subject|0
4578164|NCT01426789|7419584|FG003|Part 2|Withdrawal by Subject|1
4578165|NCT01426789|7419585|FG004|Part 2|Withdrawal by Subject|2
4578166|NCT01426789|7419586|FG005|Part 2|Withdrawal by Subject|0
4578167|NCT01426789|7419581|FG000|Part 2|Lack of Efficacy|0
4578168|NCT01426789|7419582|FG001|Part 2|Lack of Efficacy|0
4578169|NCT01426789|7419583|FG002|Part 2|Lack of Efficacy|5
4578170|NCT01426789|7419584|FG003|Part 2|Lack of Efficacy|0
4578171|NCT01426789|7419585|FG004|Part 2|Lack of Efficacy|2
4578172|NCT01426789|7419586|FG005|Part 2|Lack of Efficacy|0
4578173|NCT01426789|7419581|FG000|Part 2|Adverse Event|0
4578174|NCT01426789|7419582|FG001|Part 2|Adverse Event|0
4578175|NCT01426789|7419583|FG002|Part 2|Adverse Event|2
4578176|NCT01426789|7419584|FG003|Part 2|Adverse Event|0
4578177|NCT01426789|7419585|FG004|Part 2|Adverse Event|1
4578178|NCT01426789|7419586|FG005|Part 2|Adverse Event|0
4578179|NCT01426854|7419605|FG000|Overall Study|Adverse Event|1
4578180|NCT01426854|7419606|FG001|Overall Study|Adverse Event|5
4578181|NCT01426854|7419605|FG000|Overall Study|Subject Decision Unrelated to AE|5
4578182|NCT01426854|7419606|FG001|Overall Study|Subject Decision Unrelated to AE|6
4578183|NCT01426854|7419605|FG000|Overall Study|Lost to Follow-up|3
4578184|NCT01426854|7419606|FG001|Overall Study|Lost to Follow-up|0
4578185|NCT01426854|7419605|FG000|Overall Study|Noncompliance|0
4578186|NCT01426854|7419606|FG001|Overall Study|Noncompliance|1
4578187|NCT01426854|7419605|FG000|Overall Study|Treatment Failure|0
4578188|NCT01426854|7419606|FG001|Overall Study|Treatment Failure|16
4578189|NCT01426854|7419605|FG000|Overall Study|Protocol Deviation|0
4578190|NCT01426854|7419606|FG001|Overall Study|Protocol Deviation|1
4578191|NCT01426854|7419605|FG000|Overall Study|Other|3
4578192|NCT01426854|7419606|FG001|Overall Study|Other|2
4578193|NCT01426958|7419625|FG000|Overall Study|Adverse Event|2
4578194|NCT01427309|7419646|FG000|Overall Study|Lost to Follow-up|130
4578195|NCT01427309|7419647|FG001|Overall Study|Lost to Follow-up|145
4578196|NCT01427309|7419648|FG002|Overall Study|Lost to Follow-up|122
4578197|NCT01427309|7419649|FG003|Overall Study|Lost to Follow-up|135
4578198|NCT01427309|7419646|FG000|Overall Study|Protocol Violation|42
4578199|NCT01427309|7419647|FG001|Overall Study|Protocol Violation|69
4578200|NCT01427309|7419648|FG002|Overall Study|Protocol Violation|125
4578201|NCT01427309|7419649|FG003|Overall Study|Protocol Violation|124
4578202|NCT01427309|7419646|FG000|Overall Study|Adverse Event|0
4578203|NCT01427309|7419647|FG001|Overall Study|Adverse Event|0
4578204|NCT01427309|7419648|FG002|Overall Study|Adverse Event|3
4578205|NCT01427309|7419649|FG003|Overall Study|Adverse Event|1
4578206|NCT01427309|7419646|FG000|Overall Study|Serious adverse event|52
4578207|NCT01427309|7419647|FG001|Overall Study|Serious adverse event|45
4578208|NCT01427309|7419648|FG002|Overall Study|Serious adverse event|50
4578209|NCT01427309|7419649|FG003|Overall Study|Serious adverse event|61
4578210|NCT01427309|7419646|FG000|Overall Study|Withdrawal by Subject|148
4578211|NCT01427309|7419647|FG001|Overall Study|Withdrawal by Subject|148
4578212|NCT01427309|7419648|FG002|Overall Study|Withdrawal by Subject|61
4578213|NCT01427309|7419649|FG003|Overall Study|Withdrawal by Subject|55
4578214|NCT01427608|7419706|FG000|Overall Study|Death|1
4578215|NCT01427608|7419707|FG001|Overall Study|Death|0
4578216|NCT01427608|7419706|FG000|Overall Study|Withdrawal by Subject|7
4578217|NCT01427608|7419707|FG001|Overall Study|Withdrawal by Subject|3
4578218|NCT01427608|7419706|FG000|Overall Study|Relapsed-all cause|13
4578219|NCT01427608|7419707|FG001|Overall Study|Relapsed-all cause|34
4691900|NCT02574637|7602165|FG009|Open-label (OL) Period|Withdrawal by Subject|1
4578220|NCT01427608|7419706|FG000|Overall Study|Events not attributed to study meds|0
4578221|NCT01427608|7419707|FG001|Overall Study|Events not attributed to study meds|1
4578222|NCT01427738|7419717|FG000|Overall Study|Death|12
4578223|NCT01427738|7419718|FG001|Overall Study|Death|9
4578224|NCT01427738|7419717|FG000|Overall Study|Severe debilitation, unable to continue|0
4578225|NCT01427738|7419718|FG001|Overall Study|Severe debilitation, unable to continue|1
4578226|NCT01427738|7419717|FG000|Overall Study|Subject unable to get to clinic|5
4578227|NCT01427738|7419718|FG001|Overall Study|Subject unable to get to clinic|2
4578228|NCT01427738|7419717|FG000|Overall Study|Withdrawal by Subject|0
4578229|NCT01427738|7419718|FG001|Overall Study|Withdrawal by Subject|2
4578230|NCT01427738|7419717|FG000|Overall Study|Subject not willing to adhere to reqs|1
4578231|NCT01427738|7419718|FG001|Overall Study|Subject not willing to adhere to reqs|2
4578232|NCT01427738|7419717|FG000|Overall Study|Lost to Follow-up|1
4578233|NCT01427738|7419718|FG001|Overall Study|Lost to Follow-up|5
4578234|NCT01427751|7419726|FG000|Overall Study|Adverse Event|18
4578235|NCT01427751|7419727|FG001|Overall Study|Adverse Event|2
4578236|NCT01427751|7419726|FG000|Overall Study|No further treatment benefit expected|5
4691901|NCT02574637|7602156|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0
4691902|NCT02574637|7602157|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0
4691903|NCT02574637|7602158|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0
4691904|NCT02574637|7602159|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0
4691905|NCT02574637|7602160|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0
4691906|NCT02574637|7602161|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1
4691907|NCT02574637|7602162|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2
4691908|NCT02574637|7602163|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1
4691909|NCT02574637|7602164|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1
4691910|NCT02574637|7602165|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0
4691911|NCT02574845|7602196|FG000|Overall Study|Consent withdrawn further participation|0
4691912|NCT02574845|7602197|FG001|Overall Study|Consent withdrawn further participation|0
4691913|NCT02574845|7602198|FG002|Overall Study|Consent withdrawn further participation|0
4691914|NCT02574845|7602199|FG003|Overall Study|Consent withdrawn further participation|0
4691915|NCT02574845|7602200|FG004|Overall Study|Consent withdrawn further participation|1
4578237|NCT01427751|7419727|FG001|Overall Study|No further treatment benefit expected|1
4578238|NCT01427751|7419726|FG000|Overall Study|Lost to Follow-up|3
4578239|NCT01427751|7419727|FG001|Overall Study|Lost to Follow-up|1
4578240|NCT01427751|7419726|FG000|Overall Study|Withdrawal of consent|2
4578241|NCT01427751|7419727|FG001|Overall Study|Withdrawal of consent|2
4578242|NCT01427751|7419726|FG000|Overall Study|Protocol Violation|6
4578243|NCT01427751|7419727|FG001|Overall Study|Protocol Violation|4
4578244|NCT01427751|7419726|FG000|Overall Study|Death|2
4578245|NCT01427751|7419727|FG001|Overall Study|Death|0
4578246|NCT01427751|7419726|FG000|Overall Study|Other miscellaneous reasons|6
4578247|NCT01427751|7419727|FG001|Overall Study|Other miscellaneous reasons|4
4578248|NCT01427803|7419735|FG000|Overall Study|Lost to Follow-up|32
4578249|NCT01427803|7419736|FG001|Overall Study|Lost to Follow-up|26
4578250|NCT01427803|7419735|FG000|Overall Study|Withdrawal by Subject|20
4578251|NCT01427803|7419736|FG001|Overall Study|Withdrawal by Subject|0
4578252|NCT01427803|7419735|FG000|Overall Study|Unable to complete full treatment period|6
4578253|NCT01427803|7419736|FG001|Overall Study|Unable to complete full treatment period|0
4578254|NCT01427803|7419735|FG000|Overall Study|Protocol Violation|1
4578255|NCT01427803|7419736|FG001|Overall Study|Protocol Violation|0
4578256|NCT01427803|7419735|FG000|Overall Study|Physician Decision|3
4578257|NCT01427803|7419736|FG001|Overall Study|Physician Decision|0
4578258|NCT01427803|7419735|FG000|Overall Study|did not take product|1
4578259|NCT01427803|7419736|FG001|Overall Study|did not take product|0
4578260|NCT01427907|7419746|FG000|Overall Study|Withdrawal by Subject|3
4578261|NCT01427907|7419747|FG001|Overall Study|Withdrawal by Subject|4
4578262|NCT01427920|7419755|FG000|Overall Study|Adverse Event|1
4578263|NCT01427920|7419756|FG001|Overall Study|Adverse Event|2
4578264|NCT01427920|7419755|FG000|Overall Study|Lack of Efficacy|1
4578265|NCT01427920|7419756|FG001|Overall Study|Lack of Efficacy|0
4578266|NCT01427920|7419755|FG000|Overall Study|Protocol Violation|1
4578267|NCT01427920|7419756|FG001|Overall Study|Protocol Violation|3
4578268|NCT01427920|7419755|FG000|Overall Study|Withdrawal Criteria|4
4578269|NCT01427920|7419756|FG001|Overall Study|Withdrawal Criteria|4
4578270|NCT01427920|7419755|FG000|Overall Study|Unclassified|2
4578271|NCT01427920|7419756|FG001|Overall Study|Unclassified|8
4578272|NCT01427933|7419764|FG000|Overall Study|Withdrawal by Subject|5
4578273|NCT01427933|7419765|FG001|Overall Study|Withdrawal by Subject|8
4578274|NCT01427933|7419764|FG000|Overall Study|Lost to Follow-up|1
4691916|NCT02574845|7602201|FG005|Overall Study|Consent withdrawn further participation|0
4691917|NCT02574845|7602196|FG000|Overall Study|Adverse Event|0
4691918|NCT02574845|7602197|FG001|Overall Study|Adverse Event|1
4691919|NCT02574845|7602198|FG002|Overall Study|Adverse Event|0
4691920|NCT02574845|7602199|FG003|Overall Study|Adverse Event|0
4691921|NCT02574845|7602200|FG004|Overall Study|Adverse Event|0
4691922|NCT02574845|7602201|FG005|Overall Study|Adverse Event|1
4734862|NCT03510273|7682225|FG000|Overall Study|Withdrawal by Subject|2
4734863|NCT03510273|7682225|FG000|Overall Study|Care outside study, ineligible to cont.|3
4734864|NCT03510273|7682225|FG000|Overall Study|Moved away from study area|4
4734865|NCT03510455|7682233|FG000|Overall Study|Physician Decision|1
4734866|NCT03510663|7682266|FG000|Overall Study|Withdrawal by Subject|0
4734867|NCT03510663|7682267|FG001|Overall Study|Withdrawal by Subject|1
4734868|NCT03510663|7682268|FG002|Overall Study|Withdrawal by Subject|0
4734869|NCT03510663|7682269|FG003|Overall Study|Withdrawal by Subject|0
4734870|NCT03510663|7682270|FG004|Overall Study|Withdrawal by Subject|0
4734871|NCT03510663|7682271|FG005|Overall Study|Withdrawal by Subject|0
4734872|NCT03510663|7682272|FG006|Overall Study|Withdrawal by Subject|0
4734873|NCT03510663|7682273|FG007|Overall Study|Withdrawal by Subject|0
4734874|NCT03510715|7682285|FG000|Overall Study|Adverse Event|1
4734875|NCT03510715|7682286|FG001|Overall Study|Adverse Event|0
4734876|NCT03510910|7682295|FG000|Overall Study|Incomplete Survey|2
4734877|NCT03510910|7682296|FG001|Overall Study|Incomplete Survey|3
4734878|NCT03511053|7682311|FG000|Overall Study|Withdrawal by Subject|1
4734879|NCT03511105|7682317|FG000|Overall Study|Adverse Event|1
4734880|NCT03511105|7682318|FG001|Overall Study|Adverse Event|0
4734881|NCT03511105|7682317|FG000|Overall Study|Withdrew consent|1
4734882|NCT03511105|7682318|FG001|Overall Study|Withdrew consent|0
4734883|NCT03511326|7682325|FG000|Overall Study|Withdrawal by Subject|1
4734884|NCT03511378|7682331|FG000|Overall Study|Withdrawal by Subject|2
4734885|NCT03511378|7682332|FG001|Overall Study|Withdrawal by Subject|2
4734886|NCT03511378|7682331|FG000|Overall Study|Patient not coming or schedule visit|1
4734887|NCT03511378|7682332|FG001|Overall Study|Patient not coming or schedule visit|0
4734888|NCT03512028|7682369|FG000|Overall Study|Withdrawal by Subject|2
4734889|NCT03512028|7682370|FG001|Overall Study|Withdrawal by Subject|0
4734890|NCT03512028|7682369|FG000|Overall Study|Protocol Violation|2
4734891|NCT03512028|7682370|FG001|Overall Study|Protocol Violation|0
4734892|NCT03512288|7682399|FG000|Overall Study|Adverse Event|1
4734893|NCT03512288|7682400|FG001|Overall Study|Adverse Event|0
4734894|NCT03512288|7682399|FG000|Overall Study|Lost to Follow-up|12
4734895|NCT03512288|7682400|FG001|Overall Study|Lost to Follow-up|15
4734896|NCT03512288|7682399|FG000|Overall Study|Physician Decision|0
4734897|NCT03512288|7682400|FG001|Overall Study|Physician Decision|2
4734898|NCT03512288|7682399|FG000|Overall Study|Protocol Violation|6
4734899|NCT03512288|7682400|FG001|Overall Study|Protocol Violation|4
4734900|NCT03512288|7682399|FG000|Overall Study|Medication error without associated adverse event|1
4734901|NCT03512288|7682400|FG001|Overall Study|Medication error without associated adverse event|0
4734902|NCT03512288|7682399|FG000|Overall Study|No longer met eligibility criteria|5
4578275|NCT01427933|7419765|FG001|Overall Study|Lost to Follow-up|5
4578276|NCT01427933|7419764|FG000|Overall Study|Other|1
4578277|NCT01427933|7419765|FG001|Overall Study|Other|0
4578278|NCT01427933|7419764|FG000|Overall Study|Investigator's Decision|1
4578279|NCT01427933|7419765|FG001|Overall Study|Investigator's Decision|0
4578280|NCT01427972|7419784|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0
4578281|NCT01427972|7419785|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0
4578282|NCT01427972|7419786|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0
4578283|NCT01427972|7419787|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0
4578284|NCT01427972|7419788|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0
4578285|NCT01427972|7419789|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0
4578286|NCT01427972|7419790|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0
4578287|NCT01427972|7419791|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1
4578288|NCT01427972|7419792|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0
4578289|NCT01427972|7419793|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0
4578290|NCT01427972|7419794|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0
4578291|NCT01427972|7419795|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0
4578292|NCT01427972|7419784|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0
4578293|NCT01427972|7419785|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0
4578294|NCT01427972|7419786|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0
4578295|NCT01427972|7419787|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0
4578296|NCT01427972|7419788|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0
4578297|NCT01427972|7419789|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2
4578298|NCT01427972|7419790|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0
4578299|NCT01427972|7419791|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0
4578300|NCT01427972|7419792|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0
4578301|NCT01427972|7419793|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0
4578302|NCT01427972|7419794|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0
4578303|NCT01427972|7419795|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0
4578304|NCT01427972|7419784|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
4578305|NCT01427972|7419785|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1
4578306|NCT01427972|7419786|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
4578307|NCT01427972|7419787|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
4578308|NCT01427972|7419788|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
4578309|NCT01427972|7419789|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
4578310|NCT01427972|7419790|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
4578311|NCT01427972|7419791|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
4578312|NCT01427972|7419792|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
4578313|NCT01427972|7419793|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
4578314|NCT01427972|7419794|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
4578315|NCT01427972|7419795|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
4578316|NCT01428063|7419828|FG000|Overall Study|Lack of Efficacy|8
4578317|NCT01428063|7419829|FG001|Overall Study|Lack of Efficacy|4
4578318|NCT01428063|7419830|FG002|Overall Study|Lack of Efficacy|1
4578319|NCT01428063|7419828|FG000|Overall Study|Adverse Event|2
4578320|NCT01428063|7419829|FG001|Overall Study|Adverse Event|3
4578321|NCT01428063|7419830|FG002|Overall Study|Adverse Event|0
4578322|NCT01428063|7419828|FG000|Overall Study|Lost to Follow-up|0
4578323|NCT01428063|7419829|FG001|Overall Study|Lost to Follow-up|2
4578324|NCT01428063|7419830|FG002|Overall Study|Lost to Follow-up|0
4578325|NCT01428063|7419828|FG000|Overall Study|No longer meets study criteria|0
4578326|NCT01428063|7419829|FG001|Overall Study|No longer meets study criteria|1
4578327|NCT01428063|7419830|FG002|Overall Study|No longer meets study criteria|0
4578328|NCT01428076|7419851|FG000|Overall Study|Adverse Event|0
4578329|NCT01428076|7419852|FG001|Overall Study|Adverse Event|1
4578330|NCT01428115|7419860|FG000|Overall Study|Lack of Efficacy|3
4578331|NCT01428115|7419860|FG000|Overall Study|Lost to Follow-up|10
4578332|NCT01428115|7419860|FG000|Overall Study|Pregnancy|1
4578333|NCT01428115|7419860|FG000|Overall Study|Protocol Violation|3
4578334|NCT01428115|7419860|FG000|Overall Study|Withdrawal by Subject|4
4578335|NCT01428128|7419865|FG000|Overall Study|Withdrawal by Subject|4
4578336|NCT01428128|7419865|FG000|Overall Study|Screen failure by p53|10
4578337|NCT01428128|7419865|FG000|Overall Study|Received Neulasta in one cycle|2
4578338|NCT01428128|7419865|FG000|Overall Study|Adverse Event|1
4578339|NCT01428193|7419870|FG000|Overall Study|Physician Decision|1
4578340|NCT01428193|7419870|FG000|Overall Study|Elevated screening liver enzymes|1
4578341|NCT01428219|7419874|FG000|Overall Study|25 patients enrolled, 3 were not treated|3
4578342|NCT01428258|7419884|FG000|Intervention 1|Withdrawal by Subject|2
4578343|NCT01428258|7419885|FG001|Intervention 1|Withdrawal by Subject|0
4578344|NCT01428453|7419913|FG000|Overall Study|Adverse Event|2
4578345|NCT01428453|7419914|FG001|Overall Study|Adverse Event|7
4578346|NCT01428453|7419913|FG000|Overall Study|Protocol Violation|1
4578347|NCT01428453|7419914|FG001|Overall Study|Protocol Violation|0
4578348|NCT01428453|7419913|FG000|Overall Study|Lost to Follow-up|0
4578349|NCT01428453|7419914|FG001|Overall Study|Lost to Follow-up|1
4578350|NCT01428453|7419913|FG000|Overall Study|Withdrawal by Subject|3
4578351|NCT01428453|7419914|FG001|Overall Study|Withdrawal by Subject|1
4578352|NCT01428583|7419922|FG000|Overall Study|Adverse Event|75
4578353|NCT01428583|7419922|FG000|Overall Study|Withdrawal by Subject|51
4578354|NCT01428583|7419922|FG000|Overall Study|Lack of Efficacy|37
4578355|NCT01428583|7419922|FG000|Overall Study|Lost to Follow-up|17
4578356|NCT01428583|7419922|FG000|Overall Study|Death|1
4578357|NCT01428583|7419922|FG000|Overall Study|Pregnancy|1
4578358|NCT01428583|7419922|FG000|Overall Study|Protocol Violation|1
4578359|NCT01428583|7419922|FG000|Overall Study|Physician Decision|12
4578360|NCT01428583|7419922|FG000|Overall Study|Non-compliant|25
4578361|NCT01428583|7419922|FG000|Overall Study|Confirmed positive urine drug test|8
4578362|NCT01428583|7419922|FG000|Overall Study|Sponsor's request|3
4578363|NCT01428583|7419922|FG000|Overall Study|Other|6
4578364|NCT01428661|7419929|FG000|Double-Masked Phase|Protocol Violation|9
4578365|NCT01428661|7419930|FG001|Double-Masked Phase|Protocol Violation|4
4578366|NCT01428661|7419931|FG002|Double-Masked Phase|Protocol Violation|0
4578367|NCT01428661|7419929|FG000|Double-Masked Phase|Adverse Event|13
4578368|NCT01428661|7419930|FG001|Double-Masked Phase|Adverse Event|4
4578369|NCT01428661|7419931|FG002|Double-Masked Phase|Adverse Event|0
4578370|NCT01428661|7419929|FG000|Double-Masked Phase|Lost to Follow-up|14
4578371|NCT01428661|7419930|FG001|Double-Masked Phase|Lost to Follow-up|14
4578372|NCT01428661|7419931|FG002|Double-Masked Phase|Lost to Follow-up|0
4578373|NCT01428661|7419929|FG000|Double-Masked Phase|Withdrawal by Subject|18
4578374|NCT01428661|7419930|FG001|Double-Masked Phase|Withdrawal by Subject|20
4578375|NCT01428661|7419931|FG002|Double-Masked Phase|Withdrawal by Subject|0
4578376|NCT01428661|7419929|FG000|Double-Masked Phase|Lack of Efficacy|2
4578377|NCT01428661|7419930|FG001|Double-Masked Phase|Lack of Efficacy|1
4578378|NCT01428661|7419931|FG002|Double-Masked Phase|Lack of Efficacy|0
4578379|NCT01428661|7419929|FG000|Double-Masked Phase|*Various|1
4578380|NCT01428661|7419930|FG001|Double-Masked Phase|*Various|6
4578381|NCT01428661|7419931|FG002|Double-Masked Phase|*Various|0
4578382|NCT01428661|7419929|FG000|Open Label Extension|Protocol Violation|0
4578383|NCT01428661|7419930|FG001|Open Label Extension|Protocol Violation|0
4578384|NCT01428661|7419931|FG002|Open Label Extension|Protocol Violation|9
4578385|NCT01428661|7419929|FG000|Open Label Extension|Adverse Event|0
4578386|NCT01428661|7419930|FG001|Open Label Extension|Adverse Event|0
4578387|NCT01428661|7419931|FG002|Open Label Extension|Adverse Event|15
4691923|NCT02575079|7602221|FG000|Overall Study|Death|3
4691924|NCT02575079|7602222|FG001|Overall Study|Death|0
4691925|NCT02575079|7602221|FG000|Overall Study|Withdrawal by Subject|3
4691926|NCT02575079|7602222|FG001|Overall Study|Withdrawal by Subject|0
4691927|NCT02575807|7602236|FG000|Overall Study|Death|8
4691928|NCT02575807|7602237|FG001|Overall Study|Death|3
4691929|NCT02575807|7602238|FG002|Overall Study|Death|7
4691930|NCT02575807|7602239|FG003|Overall Study|Death|0
4691931|NCT02575807|7602240|FG004|Overall Study|Death|1
4691932|NCT02575807|7602236|FG000|Overall Study|Study terminated by Sponsor|0
4691933|NCT02575807|7602237|FG001|Overall Study|Study terminated by Sponsor|1
4691934|NCT02575807|7602238|FG002|Overall Study|Study terminated by Sponsor|7
4691935|NCT02575807|7602239|FG003|Overall Study|Study terminated by Sponsor|0
4691936|NCT02575807|7602240|FG004|Overall Study|Study terminated by Sponsor|1
4691937|NCT02575807|7602236|FG000|Overall Study|Terminated due to FDA clinical hold|1
4691938|NCT02575807|7602237|FG001|Overall Study|Terminated due to FDA clinical hold|0
4691939|NCT02575807|7602238|FG002|Overall Study|Terminated due to FDA clinical hold|0
4691940|NCT02575807|7602239|FG003|Overall Study|Terminated due to FDA clinical hold|0
4691941|NCT02575807|7602240|FG004|Overall Study|Terminated due to FDA clinical hold|0
4691942|NCT02575807|7602236|FG000|Overall Study|Terminated due to physician decision|0
4691943|NCT02575807|7602237|FG001|Overall Study|Terminated due to physician decision|0
4691944|NCT02575807|7602238|FG002|Overall Study|Terminated due to physician decision|1
4691945|NCT02575807|7602239|FG003|Overall Study|Terminated due to physician decision|0
4691946|NCT02575807|7602240|FG004|Overall Study|Terminated due to physician decision|0
4691947|NCT02575807|7602236|FG000|Overall Study|Subject ineligible - medical implant|0
4691948|NCT02575807|7602237|FG001|Overall Study|Subject ineligible - medical implant|0
4691949|NCT02575807|7602238|FG002|Overall Study|Subject ineligible - medical implant|0
4691950|NCT02575807|7602239|FG003|Overall Study|Subject ineligible - medical implant|1
4691951|NCT02575807|7602240|FG004|Overall Study|Subject ineligible - medical implant|0
4691952|NCT02575807|7602236|FG000|Overall Study|Withdrawal by Subject|0
4691953|NCT02575807|7602237|FG001|Overall Study|Withdrawal by Subject|0
4691954|NCT02575807|7602238|FG002|Overall Study|Withdrawal by Subject|1
4691955|NCT02575807|7602239|FG003|Overall Study|Withdrawal by Subject|1
4691956|NCT02575807|7602240|FG004|Overall Study|Withdrawal by Subject|2
4691957|NCT02575833|7602256|FG000|Overall Study|Withdrawal by Subject|0
4691958|NCT02575833|7602257|FG001|Overall Study|Withdrawal by Subject|1
4691959|NCT02575833|7602256|FG000|Overall Study|Lost to Follow-up|1
4691960|NCT02575833|7602257|FG001|Overall Study|Lost to Follow-up|0
4691961|NCT02575911|7602263|FG000|Overall Study|Lost to Follow-up|1
4691962|NCT02575950|7602275|FG000|Overall Study|Withdrawal by Subject|0
4691963|NCT02575950|7602276|FG001|Overall Study|Withdrawal by Subject|0
4691964|NCT02575950|7602277|FG002|Overall Study|Withdrawal by Subject|0
4691965|NCT02575950|7602278|FG003|Overall Study|Withdrawal by Subject|2
4691966|NCT02575950|7602275|FG000|Overall Study|Lost to Follow-up|0
4691967|NCT02575950|7602276|FG001|Overall Study|Lost to Follow-up|1
4578388|NCT01428661|7419929|FG000|Open Label Extension|Lost to Follow-up|0
4578389|NCT01428661|7419930|FG001|Open Label Extension|Lost to Follow-up|0
4578390|NCT01428661|7419931|FG002|Open Label Extension|Lost to Follow-up|38
4578391|NCT01428661|7419929|FG000|Open Label Extension|Withdrawal by Subject|0
4578392|NCT01428661|7419930|FG001|Open Label Extension|Withdrawal by Subject|0
4578393|NCT01428661|7419931|FG002|Open Label Extension|Withdrawal by Subject|49
4578394|NCT01428661|7419929|FG000|Open Label Extension|Lack of Efficacy|0
4578395|NCT01428661|7419930|FG001|Open Label Extension|Lack of Efficacy|0
4578396|NCT01428661|7419931|FG002|Open Label Extension|Lack of Efficacy|24
4578397|NCT01428661|7419929|FG000|Open Label Extension|**Various|0
4578398|NCT01428661|7419930|FG001|Open Label Extension|**Various|0
4578399|NCT01428661|7419931|FG002|Open Label Extension|**Various|185
4578400|NCT01428713|7419939|FG000|Overall Study|Non-compliance|2
4578401|NCT01428713|7419940|FG001|Overall Study|Non-compliance|2
4578402|NCT01428713|7419939|FG000|Overall Study|Withdrawal by Subject|1
4578403|NCT01428713|7419940|FG001|Overall Study|Withdrawal by Subject|1
4578404|NCT01428713|7419939|FG000|Overall Study|Adverse Event|0
4578405|NCT01428713|7419940|FG001|Overall Study|Adverse Event|2
4578406|NCT01428882|7419952|FG000|Overall Study|Lack of Efficacy|2
4578407|NCT01428882|7419953|FG001|Overall Study|Lack of Efficacy|7
4578408|NCT01428882|7419952|FG000|Overall Study|Protocol Violation|4
4578409|NCT01428882|7419953|FG001|Overall Study|Protocol Violation|3
4578410|NCT01429051|7419959|FG000|Titration Phase|Death|1
4578411|NCT01429051|7419959|FG000|Titration Phase|Withdrawal by Subject|7
4578412|NCT01429051|7419959|FG000|Titration Phase|Physician Decision|1
4578413|NCT01429051|7419959|FG000|Titration Phase|Unsuccessful titration at any dose|1
4578414|NCT01429051|7419959|FG000|Titration Phase|Less than 3 BTP episodes per week|2
4578415|NCT01429051|7419959|FG000|Efficacy Phase|Adverse Event|1
4578416|NCT01429051|7419959|FG000|Efficacy Phase|Death|1
4578417|NCT01429051|7419959|FG000|Tolerability Phase|Death|5
4578418|NCT01429051|7419959|FG000|Tolerability Phase|Adverse Event|2
4578419|NCT01429051|7419959|FG000|Tolerability Phase|Withdrawal by Subject|5
4578420|NCT01429051|7419959|FG000|Tolerability Phase|Physician Decision|1
4578421|NCT01429051|7419959|FG000|Tolerability Phase|Other|2
4578422|NCT01429077|7419989|FG000|Overall Study|Lost to Follow-up|0
4578423|NCT01429077|7419990|FG001|Overall Study|Lost to Follow-up|3
4578424|NCT01429285|7420019|FG000|Overall Study|Protocol Violation|9
4578425|NCT01429285|7420020|FG001|Overall Study|Protocol Violation|4
4578426|NCT01429285|7420019|FG000|Overall Study|Missing Data|5
4578427|NCT01429285|7420020|FG001|Overall Study|Missing Data|3
4578428|NCT01429285|7420019|FG000|Overall Study|Erroneously Enrolled Twice|8
4578429|NCT01429285|7420020|FG001|Overall Study|Erroneously Enrolled Twice|2
4578430|NCT01429298|7420028|FG000|Overall Study|Protocol Violation|4
4578431|NCT01429298|7420029|FG001|Overall Study|Protocol Violation|6
4578432|NCT01429441|7420046|FG000|Overall Study|Adverse Event|5
4578433|NCT01429441|7420047|FG001|Overall Study|Adverse Event|1
4578434|NCT01429441|7420046|FG000|Overall Study|Death|0
4578435|NCT01429441|7420047|FG001|Overall Study|Death|2
4578436|NCT01429441|7420046|FG000|Overall Study|Lost to Follow-up|5
4578437|NCT01429441|7420047|FG001|Overall Study|Lost to Follow-up|2
4578438|NCT01429441|7420046|FG000|Overall Study|Physician Decision|1
4578439|NCT01429441|7420047|FG001|Overall Study|Physician Decision|0
4578440|NCT01429441|7420046|FG000|Overall Study|Withdrawal by Subject|27
4578441|NCT01429441|7420047|FG001|Overall Study|Withdrawal by Subject|18
4578442|NCT01429584|7420078|FG000|Overall Study|Withdrawal by Subject|1
4578443|NCT01429584|7420079|FG001|Overall Study|Withdrawal by Subject|0
4578444|NCT01429584|7420078|FG000|Overall Study|Protocol Violation|0
4578445|NCT01429584|7420079|FG001|Overall Study|Protocol Violation|1
4578446|NCT01429623|7420087|FG000|Overall Study|Death|1
4578447|NCT01429623|7420088|FG001|Overall Study|Death|0
4578448|NCT01429623|7420087|FG000|Overall Study|Adverse Event|7
4691968|NCT02575950|7602277|FG002|Overall Study|Lost to Follow-up|0
4691969|NCT02575950|7602278|FG003|Overall Study|Lost to Follow-up|3
4734903|NCT03512288|7682400|FG001|Overall Study|No longer met eligibility criteria|2
4734904|NCT03512288|7682399|FG000|Overall Study|Withdrawal by parent/guardian|14
4734905|NCT03512288|7682400|FG001|Overall Study|Withdrawal by parent/guardian|18
4734906|NCT03512288|7682399|FG000|Overall Study|Other|1
4734907|NCT03512288|7682400|FG001|Overall Study|Other|1
4734908|NCT03512288|7682399|FG000|Overall Study|Randomized but not treated|1
4734909|NCT03512288|7682400|FG001|Overall Study|Randomized but not treated|1
4734910|NCT03512353|7682406|FG000|Overall Study|Sponsor Decision|3
4734911|NCT03512353|7682406|FG000|Overall Study|Death|1
4734912|NCT03513588|7682426|FG000|Overall Study|Lost to Follow-up|0
4734913|NCT03513588|7682427|FG001|Overall Study|Lost to Follow-up|1
4734914|NCT03513588|7682428|FG002|Overall Study|Lost to Follow-up|1
4734915|NCT03513588|7682426|FG000|Overall Study|Study dosing paused by sponsor|1
4734916|NCT03513588|7682427|FG001|Overall Study|Study dosing paused by sponsor|1
4734917|NCT03513588|7682428|FG002|Overall Study|Study dosing paused by sponsor|0
4578449|NCT01429623|7420088|FG001|Overall Study|Adverse Event|14
4578450|NCT01429623|7420087|FG000|Overall Study|Withdrawal by Subject|19
4734918|NCT03513588|7682426|FG000|Overall Study|Death|0
4734919|NCT03513588|7682427|FG001|Overall Study|Death|0
4578451|NCT01429623|7420088|FG001|Overall Study|Withdrawal by Subject|13
4578452|NCT01429623|7420087|FG000|Overall Study|Physician Decision|2
4578453|NCT01429623|7420088|FG001|Overall Study|Physician Decision|3
4578454|NCT01429623|7420087|FG000|Overall Study|Protocol Violation|3
4578455|NCT01429623|7420088|FG001|Overall Study|Protocol Violation|2
4578456|NCT01429623|7420087|FG000|Overall Study|Assorted|1
4578457|NCT01429623|7420088|FG001|Overall Study|Assorted|2
4578458|NCT01429623|7420087|FG000|Overall Study|Conversion to Alzheimer's disease|14
4578459|NCT01429623|7420088|FG001|Overall Study|Conversion to Alzheimer's disease|21
4578460|NCT01429623|7420087|FG000|Overall Study|No post baseline data|4
4578461|NCT01429623|7420088|FG001|Overall Study|No post baseline data|4
4578462|NCT01429792|7420094|FG000|Overall Study|Other Reasons|67
4578463|NCT01429792|7420094|FG000|Overall Study|Unknown Disposition|94
4578464|NCT01429792|7420094|FG000|Overall Study|Negative HCV-RNA at Week 4|1
4578465|NCT01429792|7420094|FG000|Overall Study|Negative HCV-RNA at Week 12|4
4578466|NCT01429792|7420094|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32
4578467|NCT01429792|7420094|FG000|Overall Study|Positive HCV-RNA at Week 24|50
4578468|NCT01429792|7420094|FG000|Overall Study|Withdrawal by Subject|70
4578469|NCT01429792|7420094|FG000|Overall Study|Lost to Follow-up|88
4578470|NCT01430104|7420129|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1
4578471|NCT01430130|7420136|FG000|Overall Study|Lost to Follow-up|1
4578472|NCT01430130|7420136|FG000|Overall Study|Infection on Control Side of Incision|1
4578473|NCT01430403|7420184|FG000|Overall Study|Lost to Follow-up|5
4578474|NCT01430403|7420185|FG001|Overall Study|Lost to Follow-up|5
4578475|NCT01430403|7420186|FG002|Overall Study|Lost to Follow-up|3
4578476|NCT01430403|7420184|FG000|Overall Study|Physician Decision|1
4578477|NCT01430403|7420185|FG001|Overall Study|Physician Decision|0
4578478|NCT01430403|7420186|FG002|Overall Study|Physician Decision|0
4578479|NCT01430403|7420184|FG000|Overall Study|Protocol Violation|2
4578480|NCT01430403|7420185|FG001|Overall Study|Protocol Violation|3
4578481|NCT01430403|7420186|FG002|Overall Study|Protocol Violation|2
4578482|NCT01430403|7420184|FG000|Overall Study|Withdrawal by Subject|9
4578483|NCT01430403|7420185|FG001|Overall Study|Withdrawal by Subject|1
4578484|NCT01430403|7420186|FG002|Overall Study|Withdrawal by Subject|3
4578485|NCT01430442|7420207|FG000|Overall Study|Subject Withdrew Consent|3
4578486|NCT01430442|7420208|FG001|Overall Study|Subject Withdrew Consent|0
4691970|NCT02576054|7602290|FG000|Overall Study|Withdrawal by Subject|1
4691971|NCT02576067|7602298|FG000|Overall Study|Death|0
4691972|NCT02576067|7602299|FG001|Overall Study|Death|1
4691973|NCT02576067|7602298|FG000|Overall Study|Lack of Efficacy|1
4691974|NCT02576067|7602299|FG001|Overall Study|Lack of Efficacy|0
4691975|NCT02576067|7602298|FG000|Overall Study|Lost to Follow-up|11
4691976|NCT02576067|7602299|FG001|Overall Study|Lost to Follow-up|0
4691977|NCT02576067|7602298|FG000|Overall Study|Withdrawal by Subject|11
4691978|NCT02576067|7602299|FG001|Overall Study|Withdrawal by Subject|2
4691979|NCT02576067|7602298|FG000|Overall Study|study closure of main CIRT trial)|0
4691980|NCT02576067|7602299|FG001|Overall Study|study closure of main CIRT trial)|8
4691981|NCT02576067|7602298|FG000|Overall Study|not randomized, failed run-in|7
4691982|NCT02576067|7602299|FG001|Overall Study|not randomized, failed run-in|0
4691983|NCT02576067|7602298|FG000|Overall Study|screen failure/ re-enrolled|0
4691984|NCT02576067|7602299|FG001|Overall Study|screen failure/ re-enrolled|25
4691985|NCT02576067|7602298|FG000|Overall Study|Physician Decision|4
4691986|NCT02576067|7602299|FG001|Overall Study|Physician Decision|0
4691987|NCT02576145|7602307|FG000|Overall Study|Adverse Event|1
4691988|NCT02576145|7602308|FG001|Overall Study|Adverse Event|0
4691989|NCT02576145|7602307|FG000|Overall Study|Withdrawal by Subject|1
4691990|NCT02576145|7602308|FG001|Overall Study|Withdrawal by Subject|0
4691991|NCT02576145|7602307|FG000|Overall Study|Acute rejection|1
4691992|NCT02576145|7602308|FG001|Overall Study|Acute rejection|0
4691993|NCT02576145|7602307|FG000|Overall Study|Tetanus Titers Decreased|0
4691994|NCT02576145|7602308|FG001|Overall Study|Tetanus Titers Decreased|1
4691995|NCT02576509|7602325|FG000|Pre-Treatment Period|Participant request to stop therapy|0
4691996|NCT02576509|7602326|FG001|Pre-Treatment Period|Participant request to stop therapy|2
4691997|NCT02576509|7602325|FG000|Pre-Treatment Period|Participant withdrew consent|1
4691998|NCT02576509|7602326|FG001|Pre-Treatment Period|Participant withdrew consent|5
4691999|NCT02576509|7602325|FG000|Pre-Treatment Period|Participant no longer meets criteria|3
4692000|NCT02576509|7602326|FG001|Pre-Treatment Period|Participant no longer meets criteria|2
4692001|NCT02576509|7602325|FG000|Treatment Period|Disease progression|245
4692002|NCT02576509|7602326|FG001|Treatment Period|Disease progression|240
4692003|NCT02576509|7602325|FG000|Treatment Period|Study drug toxicity|32
4692004|NCT02576509|7602326|FG001|Treatment Period|Study drug toxicity|41
4692005|NCT02576509|7602325|FG000|Treatment Period|Death|1
4692006|NCT02576509|7602326|FG001|Treatment Period|Death|1
4692007|NCT02576509|7602325|FG000|Treatment Period|Adverse event unrelated to study drug|37
4692008|NCT02576509|7602326|FG001|Treatment Period|Adverse event unrelated to study drug|40
4692009|NCT02576509|7602325|FG000|Treatment Period|Participant request to stop treatment|8
4692010|NCT02576509|7602326|FG001|Treatment Period|Participant request to stop treatment|17
4692011|NCT02576509|7602325|FG000|Treatment Period|Participant withdrew consent|2
4692012|NCT02576509|7602326|FG001|Treatment Period|Participant withdrew consent|7
4692013|NCT02576509|7602325|FG000|Treatment Period|Lost to Follow-up|0
4692014|NCT02576509|7602326|FG001|Treatment Period|Lost to Follow-up|1
4692015|NCT02576509|7602325|FG000|Treatment Period|Maximum clinical benefit|1
4692016|NCT02576509|7602326|FG001|Treatment Period|Maximum clinical benefit|0
4692017|NCT02576509|7602325|FG000|Treatment Period|Poor/non-compliance|0
4692018|NCT02576509|7602326|FG001|Treatment Period|Poor/non-compliance|1
4692019|NCT02576509|7602325|FG000|Treatment Period|Participant no longer meets criteria|1
4692020|NCT02576509|7602326|FG001|Treatment Period|Participant no longer meets criteria|0
4578487|NCT01430442|7420209|FG002|Overall Study|Subject Withdrew Consent|1
4578488|NCT01430442|7420210|FG003|Overall Study|Subject Withdrew Consent|0
4578489|NCT01430442|7420211|FG004|Overall Study|Subject Withdrew Consent|2
4578490|NCT01430442|7420212|FG005|Overall Study|Subject Withdrew Consent|1
4578491|NCT01430442|7420213|FG006|Overall Study|Subject Withdrew Consent|5
4578492|NCT01430442|7420214|FG007|Overall Study|Subject Withdrew Consent|2
4578493|NCT01430442|7420207|FG000|Overall Study|Lost to Follow-up|2
4578494|NCT01430442|7420208|FG001|Overall Study|Lost to Follow-up|0
4578495|NCT01430442|7420209|FG002|Overall Study|Lost to Follow-up|1
4578496|NCT01430442|7420210|FG003|Overall Study|Lost to Follow-up|2
4578497|NCT01430442|7420211|FG004|Overall Study|Lost to Follow-up|2
4578498|NCT01430442|7420212|FG005|Overall Study|Lost to Follow-up|1
4578499|NCT01430442|7420213|FG006|Overall Study|Lost to Follow-up|5
4578500|NCT01430442|7420214|FG007|Overall Study|Lost to Follow-up|1
4578501|NCT01430442|7420207|FG000|Overall Study|Pregnancy|1
4578502|NCT01430442|7420208|FG001|Overall Study|Pregnancy|0
4578503|NCT01430442|7420209|FG002|Overall Study|Pregnancy|0
4578504|NCT01430442|7420210|FG003|Overall Study|Pregnancy|0
4578505|NCT01430442|7420211|FG004|Overall Study|Pregnancy|0
4578506|NCT01430442|7420212|FG005|Overall Study|Pregnancy|1
4578507|NCT01430442|7420213|FG006|Overall Study|Pregnancy|0
4578508|NCT01430442|7420214|FG007|Overall Study|Pregnancy|0
4578509|NCT01430442|7420207|FG000|Overall Study|Patient No Longer Meets Study Criteria|7
4578510|NCT01430442|7420208|FG001|Overall Study|Patient No Longer Meets Study Criteria|6
4578511|NCT01430442|7420209|FG002|Overall Study|Patient No Longer Meets Study Criteria|3
4578512|NCT01430442|7420210|FG003|Overall Study|Patient No Longer Meets Study Criteria|2
4578513|NCT01430442|7420211|FG004|Overall Study|Patient No Longer Meets Study Criteria|5
4578514|NCT01430442|7420212|FG005|Overall Study|Patient No Longer Meets Study Criteria|5
4578515|NCT01430442|7420213|FG006|Overall Study|Patient No Longer Meets Study Criteria|9
4578516|NCT01430442|7420214|FG007|Overall Study|Patient No Longer Meets Study Criteria|6
4578517|NCT01430455|7420232|FG000|Overall Study|Withdrawal by Subject|1
4578518|NCT01430455|7420232|FG000|Overall Study|Switched to follow-up phase|1
4578519|NCT01430468|7420238|FG000|Overall Study|Physician Decision|2
4578520|NCT01430468|7420239|FG001|Overall Study|Physician Decision|1
4578521|NCT01430468|7420238|FG000|Overall Study|Withdrawal by Subject|5
4578522|NCT01430468|7420239|FG001|Overall Study|Withdrawal by Subject|5
4578523|NCT01430559|7420247|FG000|Overall Study|Adverse Event|7
4578524|NCT01430559|7420248|FG001|Overall Study|Adverse Event|3
4578525|NCT01430559|7420247|FG000|Overall Study|Entry criteria not met|1
4578526|NCT01430559|7420248|FG001|Overall Study|Entry criteria not met|1
4578527|NCT01430559|7420247|FG000|Overall Study|Lost to Follow-up|1
4578528|NCT01430559|7420248|FG001|Overall Study|Lost to Follow-up|0
4578529|NCT01430559|7420247|FG000|Overall Study|Medication error|1
4578530|NCT01430559|7420248|FG001|Overall Study|Medication error|0
4578531|NCT01430559|7420247|FG000|Overall Study|Withdrawal by Subject|3
4578532|NCT01430559|7420248|FG001|Overall Study|Withdrawal by Subject|2
4578533|NCT01430559|7420247|FG000|Overall Study|Protocol Violation|1
4578534|NCT01430559|7420248|FG001|Overall Study|Protocol Violation|0
4578535|NCT01430559|7420247|FG000|Overall Study|Other|3
4578536|NCT01430559|7420248|FG001|Overall Study|Other|3
4578537|NCT01430559|7420247|FG000|Overall Study|Randomized, Not Treated|3
4692021|NCT02576509|7602325|FG000|Treatment Period|Other reason|2
4692022|NCT02576509|7602326|FG001|Treatment Period|Other reason|7
4692023|NCT02576509|7602325|FG000|Follow-up Period|Death|41
4692024|NCT02576509|7602326|FG001|Follow-up Period|Death|35
4692025|NCT02576509|7602325|FG000|Follow-up Period|Participant withdrew consent|7
4692026|NCT02576509|7602326|FG001|Follow-up Period|Participant withdrew consent|14
4692027|NCT02576509|7602325|FG000|Follow-up Period|Lost to Follow-up|0
4692028|NCT02576509|7602326|FG001|Follow-up Period|Lost to Follow-up|1
4692029|NCT02576509|7602325|FG000|Follow-up Period|Other reason|1
4692030|NCT02576509|7602326|FG001|Follow-up Period|Other reason|2
4692031|NCT02576535|7602332|FG000|Overall Study|Withdrawal by Subject|2
4692032|NCT02576587|7602338|FG000|Baseline|Equipment failure|0
4692033|NCT02576587|7602339|FG001|Baseline|Equipment failure|1
4692034|NCT02576587|7602338|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25
4692035|NCT02576587|7602339|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0
4692036|NCT02576587|7602338|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92
4692037|NCT02576587|7602339|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0
4692038|NCT02576587|7602338|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0
4692039|NCT02576587|7602339|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155
4692040|NCT02576639|7602352|FG000|Overall Study|Withdrawal by Subject|1
4692041|NCT02576639|7602353|FG001|Overall Study|Withdrawal by Subject|2
4692042|NCT02576639|7602354|FG002|Overall Study|Withdrawal by Subject|1
4692043|NCT02576639|7602355|FG003|Overall Study|Withdrawal by Subject|0
4692044|NCT02576639|7602356|FG004|Overall Study|Withdrawal by Subject|1
4692045|NCT02576639|7602352|FG000|Overall Study|Adverse Event|1
4692046|NCT02576639|7602353|FG001|Overall Study|Adverse Event|0
4692047|NCT02576639|7602354|FG002|Overall Study|Adverse Event|1
4692048|NCT02576639|7602355|FG003|Overall Study|Adverse Event|1
4692049|NCT02576639|7602356|FG004|Overall Study|Adverse Event|2
4692050|NCT02576639|7602352|FG000|Overall Study|Physician Decision|0
4692051|NCT02576639|7602353|FG001|Overall Study|Physician Decision|0
4692052|NCT02576639|7602354|FG002|Overall Study|Physician Decision|0
4578538|NCT01430559|7420248|FG001|Overall Study|Randomized, Not Treated|3
4578539|NCT01430585|7420259|FG000|Overall Study|Death|1
4578540|NCT01430585|7420259|FG000|Overall Study|Objective Progression or Relapse|3
4578541|NCT01430585|7420259|FG000|Overall Study|Study Terminated by Sponsor|3
4578542|NCT01430585|7420259|FG000|Overall Study|Other|7
4578543|NCT01430611|7420271|FG000|Overall Study|Adverse Event|0
4578544|NCT01430611|7420272|FG001|Overall Study|Adverse Event|1
4578545|NCT01430611|7420271|FG000|Overall Study|Protocol Violation|1
4578546|NCT01430611|7420272|FG001|Overall Study|Protocol Violation|0
4578547|NCT01430611|7420271|FG000|Overall Study|Lost to Follow-up|1
4578548|NCT01430611|7420272|FG001|Overall Study|Lost to Follow-up|0
4578549|NCT01430611|7420271|FG000|Overall Study|Withdrawal by Subject|15
4578550|NCT01430611|7420272|FG001|Overall Study|Withdrawal by Subject|14
4578551|NCT01430624|7420281|FG000|Overall Study|Lost to Follow-up|23
4578552|NCT01430624|7420282|FG001|Overall Study|Lost to Follow-up|29
4578553|NCT01430624|7420283|FG002|Overall Study|Lost to Follow-up|27
4578554|NCT01430624|7420281|FG000|Overall Study|technical or eligibility|5
4692053|NCT02576639|7602355|FG003|Overall Study|Physician Decision|0
4692054|NCT02576639|7602356|FG004|Overall Study|Physician Decision|1
4692055|NCT02576652|7602372|FG000|Overall Study|Withdrawal by Subject|2
4692056|NCT02576678|7602379|FG000|Overall Study|Adverse Event|0
4692057|NCT02576678|7602380|FG001|Overall Study|Adverse Event|0
4692058|NCT02576678|7602381|FG002|Overall Study|Adverse Event|2
4692059|NCT02576678|7602379|FG000|Overall Study|Withdrawal by Subject|3
4692060|NCT02576678|7602380|FG001|Overall Study|Withdrawal by Subject|1
4692061|NCT02576678|7602381|FG002|Overall Study|Withdrawal by Subject|2
4692062|NCT02576678|7602379|FG000|Overall Study|Lost to Follow-up|0
4692063|NCT02576678|7602380|FG001|Overall Study|Lost to Follow-up|0
4692064|NCT02576678|7602381|FG002|Overall Study|Lost to Follow-up|1
4692065|NCT02576678|7602379|FG000|Overall Study|Miscellaneous|2
4692066|NCT02576678|7602380|FG001|Overall Study|Miscellaneous|0
4692067|NCT02576678|7602381|FG002|Overall Study|Miscellaneous|0
4692068|NCT02576938|7602402|FG000|Overall Study|Adverse Event|5
4692069|NCT02576938|7602403|FG001|Overall Study|Adverse Event|3
4692070|NCT02576938|7602404|FG002|Overall Study|Adverse Event|6
4692071|NCT02576938|7602402|FG000|Overall Study|Protocol Violation|1
4692072|NCT02576938|7602403|FG001|Overall Study|Protocol Violation|1
4692073|NCT02576938|7602404|FG002|Overall Study|Protocol Violation|1
4692074|NCT02576938|7602402|FG000|Overall Study|Withdrawal by Subject|3
4692075|NCT02576938|7602403|FG001|Overall Study|Withdrawal by Subject|2
4692076|NCT02576938|7602404|FG002|Overall Study|Withdrawal by Subject|4
4692077|NCT02576938|7602402|FG000|Overall Study|Lack of Efficacy|9
4692078|NCT02576938|7602403|FG001|Overall Study|Lack of Efficacy|4
4692079|NCT02576938|7602404|FG002|Overall Study|Lack of Efficacy|0
4692080|NCT02576938|7602402|FG000|Overall Study|Lost to Follow-up|2
4692081|NCT02576938|7602403|FG001|Overall Study|Lost to Follow-up|0
4692082|NCT02576938|7602404|FG002|Overall Study|Lost to Follow-up|1
4692083|NCT02576938|7602402|FG000|Overall Study|Physician Decision|0
4692084|NCT02576938|7602403|FG001|Overall Study|Physician Decision|1
4692085|NCT02576938|7602404|FG002|Overall Study|Physician Decision|0
4692086|NCT02576938|7602402|FG000|Overall Study|Met Exclusion Criteria|0
4692087|NCT02576938|7602403|FG001|Overall Study|Met Exclusion Criteria|1
4692088|NCT02576938|7602404|FG002|Overall Study|Met Exclusion Criteria|0
4692089|NCT02576951|7602418|FG000|Overall Study|Lost to Follow-up|0
4692090|NCT02576951|7602419|FG001|Overall Study|Lost to Follow-up|0
4692091|NCT02576951|7602420|FG002|Overall Study|Lost to Follow-up|2
4692092|NCT02576951|7602421|FG003|Overall Study|Lost to Follow-up|2
4692093|NCT02576951|7602418|FG000|Overall Study|Withdrawal by Subject|1
4692094|NCT02576951|7602419|FG001|Overall Study|Withdrawal by Subject|0
4692095|NCT02576951|7602420|FG002|Overall Study|Withdrawal by Subject|0
4692096|NCT02576951|7602421|FG003|Overall Study|Withdrawal by Subject|2
4692097|NCT02576951|7602418|FG000|Overall Study|Protocol Violation|0
4692098|NCT02576951|7602419|FG001|Overall Study|Protocol Violation|0
4692099|NCT02576951|7602420|FG002|Overall Study|Protocol Violation|0
4692100|NCT02576951|7602421|FG003|Overall Study|Protocol Violation|1
4692101|NCT02576977|7602435|FG000|Overall Study|Adverse Event|13
4692102|NCT02576977|7602436|FG001|Overall Study|Adverse Event|2
4692103|NCT02576977|7602435|FG000|Overall Study|Death|73
4692104|NCT02576977|7602436|FG001|Overall Study|Death|60
4692105|NCT02576977|7602435|FG000|Overall Study|Screen failure|1
4692106|NCT02576977|7602436|FG001|Overall Study|Screen failure|0
4692107|NCT02576977|7602435|FG000|Overall Study|Study Terminated at Selected Sites|27
4692108|NCT02576977|7602436|FG001|Overall Study|Study Terminated at Selected Sites|50
4692109|NCT02576977|7602435|FG000|Overall Study|Withdrawal by Subject|11
4692110|NCT02576977|7602436|FG001|Overall Study|Withdrawal by Subject|11
4692111|NCT02576977|7602435|FG000|Overall Study|Final Disposition Unknown|0
4692112|NCT02576977|7602436|FG001|Overall Study|Final Disposition Unknown|1
4692113|NCT02576977|7602435|FG000|Overall Study|Lost to Follow-up|1
4692114|NCT02576977|7602436|FG001|Overall Study|Lost to Follow-up|0
4692115|NCT02576977|7602435|FG000|Overall Study|Progressive Disease|0
4692116|NCT02576977|7602436|FG001|Overall Study|Progressive Disease|1
4692117|NCT02576990|7602444|FG000|Overall Study|Death|29
4692118|NCT02576990|7602445|FG001|Overall Study|Death|18
4692119|NCT02576990|7602444|FG000|Overall Study|Physician Decision|1
4692120|NCT02576990|7602445|FG001|Overall Study|Physician Decision|0
4692121|NCT02576990|7602444|FG000|Overall Study|Screen failure|2
4692122|NCT02576990|7602445|FG001|Overall Study|Screen failure|0
4692123|NCT02576990|7602444|FG000|Overall Study|Sponsor's decision|24
4692124|NCT02576990|7602445|FG001|Overall Study|Sponsor's decision|4
4578555|NCT01430624|7420282|FG001|Overall Study|technical or eligibility|5
4578556|NCT01430624|7420283|FG002|Overall Study|technical or eligibility|2
4578557|NCT01430754|7420315|FG000|Run-In Phase|Circadian Period Ineligible|24
4578558|NCT01430754|7420316|FG001|Run-In Phase|Circadian Period Ineligible|0
4578559|NCT01430754|7420315|FG000|Run-In Phase|Protocol Violation|6
4578560|NCT01430754|7420316|FG001|Run-In Phase|Protocol Violation|0
4578561|NCT01430754|7420315|FG000|Run-In Phase|Adverse Event|2
4578562|NCT01430754|7420316|FG001|Run-In Phase|Adverse Event|0
4578563|NCT01430754|7420315|FG000|Run-In Phase|Other|2
4578564|NCT01430754|7420316|FG001|Run-In Phase|Other|0
4578565|NCT01430754|7420315|FG000|Run-In Phase|Withdrawal by Subject|2
4578566|NCT01430754|7420316|FG001|Run-In Phase|Withdrawal by Subject|0
4578567|NCT01430754|7420315|FG000|Run-In Phase|Lost to Follow-up|1
4578568|NCT01430754|7420316|FG001|Run-In Phase|Lost to Follow-up|0
4578569|NCT01431079|7420344|FG000|Overall Study|Lost to Follow-up|35
4578570|NCT01431079|7420345|FG001|Overall Study|Lost to Follow-up|39
4578571|NCT01431144|7420390|FG000|Overall Study|Implant mobility and removal|2
4578572|NCT01431144|7420391|FG001|Overall Study|Implant mobility and removal|0
4578573|NCT01431274|7420430|FG000|Overall Study|Adverse Event|51
4578574|NCT01431274|7420431|FG001|Overall Study|Adverse Event|37
4578575|NCT01431274|7420432|FG002|Overall Study|Adverse Event|43
4578576|NCT01431274|7420433|FG003|Overall Study|Adverse Event|30
4578577|NCT01431274|7420434|FG004|Overall Study|Adverse Event|37
4578578|NCT01431274|7420430|FG000|Overall Study|Consent withdrawn not due to AE|29
4578579|NCT01431274|7420431|FG001|Overall Study|Consent withdrawn not due to AE|20
4578580|NCT01431274|7420432|FG002|Overall Study|Consent withdrawn not due to AE|17
4578581|NCT01431274|7420433|FG003|Overall Study|Consent withdrawn not due to AE|20
4578582|NCT01431274|7420434|FG004|Overall Study|Consent withdrawn not due to AE|11
4578583|NCT01431274|7420430|FG000|Overall Study|Non compliant with protocol|5
4578584|NCT01431274|7420431|FG001|Overall Study|Non compliant with protocol|8
4578585|NCT01431274|7420432|FG002|Overall Study|Non compliant with protocol|4
4578586|NCT01431274|7420433|FG003|Overall Study|Non compliant with protocol|4
4578587|NCT01431274|7420434|FG004|Overall Study|Non compliant with protocol|4
4578588|NCT01431274|7420430|FG000|Overall Study|Lost to Follow-up|6
4578589|NCT01431274|7420431|FG001|Overall Study|Lost to Follow-up|7
4578590|NCT01431274|7420432|FG002|Overall Study|Lost to Follow-up|1
4692125|NCT02576990|7602444|FG000|Overall Study|Withdrawal by Subject|0
4692126|NCT02576990|7602445|FG001|Overall Study|Withdrawal by Subject|2
4692127|NCT02577003|7602453|FG000|Overall Study|Adverse Event|2
4692128|NCT02577003|7602454|FG001|Overall Study|Adverse Event|4
4692129|NCT02577003|7602453|FG000|Overall Study|Withdrawal by Subject|0
4692130|NCT02577003|7602454|FG001|Overall Study|Withdrawal by Subject|1
4692131|NCT02577016|7602462|FG000|Overall Study|Adverse Event|2
4692132|NCT02577016|7602463|FG001|Overall Study|Adverse Event|1
4692133|NCT02577016|7602462|FG000|Overall Study|Physician Decision|0
4692134|NCT02577016|7602463|FG001|Overall Study|Physician Decision|1
4692135|NCT02577029|7602477|FG000|Overall Study|Adverse Event|1
4692136|NCT02577029|7602478|FG001|Overall Study|Adverse Event|0
4692137|NCT02577029|7602479|FG002|Overall Study|Adverse Event|2
4692138|NCT02577029|7602480|FG003|Overall Study|Adverse Event|0
4692139|NCT02577029|7602481|FG004|Overall Study|Adverse Event|1
4692140|NCT02577029|7602482|FG005|Overall Study|Adverse Event|0
4692141|NCT02577029|7602483|FG006|Overall Study|Adverse Event|0
4692142|NCT02577029|7602484|FG007|Overall Study|Adverse Event|0
4692143|NCT02577029|7602477|FG000|Overall Study|Withdrawal by Subject|0
4692144|NCT02577029|7602478|FG001|Overall Study|Withdrawal by Subject|0
4692145|NCT02577029|7602479|FG002|Overall Study|Withdrawal by Subject|0
4692146|NCT02577029|7602480|FG003|Overall Study|Withdrawal by Subject|0
4692147|NCT02577029|7602481|FG004|Overall Study|Withdrawal by Subject|0
4692148|NCT02577029|7602482|FG005|Overall Study|Withdrawal by Subject|1
4692149|NCT02577029|7602483|FG006|Overall Study|Withdrawal by Subject|0
4692150|NCT02577029|7602484|FG007|Overall Study|Withdrawal by Subject|0
4692151|NCT02577029|7602477|FG000|Overall Study|Sponsor Termination of the Study|9
4692152|NCT02577029|7602478|FG001|Overall Study|Sponsor Termination of the Study|2
4692153|NCT02577029|7602479|FG002|Overall Study|Sponsor Termination of the Study|5
4692154|NCT02577029|7602480|FG003|Overall Study|Sponsor Termination of the Study|12
4692155|NCT02577029|7602481|FG004|Overall Study|Sponsor Termination of the Study|10
4692156|NCT02577029|7602482|FG005|Overall Study|Sponsor Termination of the Study|12
4692157|NCT02577029|7602483|FG006|Overall Study|Sponsor Termination of the Study|12
4692158|NCT02577029|7602484|FG007|Overall Study|Sponsor Termination of the Study|12
4692159|NCT02577107|7602514|FG000|Overall Study|Protocol deviation|0
4692160|NCT02577107|7602515|FG001|Overall Study|Protocol deviation|1
4692161|NCT02577146|7602521|FG000|Overall Study|Lost to Follow-up|8
4578591|NCT01431274|7420433|FG003|Overall Study|Lost to Follow-up|4
4578592|NCT01431274|7420434|FG004|Overall Study|Lost to Follow-up|0
4578593|NCT01431274|7420430|FG000|Overall Study|Other reason not stated above|6
4692162|NCT02577146|7602521|FG000|Overall Study|Physician Decision|3
4692163|NCT02577146|7602521|FG000|Overall Study|Screen Failure|17
4692164|NCT02577315|7602527|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
4692165|NCT02577315|7602528|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
4692166|NCT02577718|7602580|FG000|Overall Study|Death|6
4692167|NCT02577718|7602580|FG000|Overall Study|Withdrawal by Subject|2
4578594|NCT01431274|7420431|FG001|Overall Study|Other reason not stated above|5
4578595|NCT01431274|7420432|FG002|Overall Study|Other reason not stated above|7
4578596|NCT01431274|7420433|FG003|Overall Study|Other reason not stated above|2
4578597|NCT01431274|7420434|FG004|Overall Study|Other reason not stated above|4
4578598|NCT01431287|7420451|FG000|Overall Study|not treated|0
4578599|NCT01431287|7420452|FG001|Overall Study|not treated|0
4578600|NCT01431287|7420453|FG002|Overall Study|not treated|1
4578601|NCT01431287|7420454|FG003|Overall Study|not treated|0
4578602|NCT01431287|7420455|FG004|Overall Study|not treated|0
4578603|NCT01431287|7420451|FG000|Overall Study|Adverse Event|59
4578604|NCT01431287|7420452|FG001|Overall Study|Adverse Event|57
4578605|NCT01431287|7420453|FG002|Overall Study|Adverse Event|53
4578606|NCT01431287|7420454|FG003|Overall Study|Adverse Event|33
4578607|NCT01431287|7420455|FG004|Overall Study|Adverse Event|41
4578608|NCT01431287|7420451|FG000|Overall Study|Non compliant with protocol|6
4578609|NCT01431287|7420452|FG001|Overall Study|Non compliant with protocol|6
4578610|NCT01431287|7420453|FG002|Overall Study|Non compliant with protocol|5
4578611|NCT01431287|7420454|FG003|Overall Study|Non compliant with protocol|6
4578612|NCT01431287|7420455|FG004|Overall Study|Non compliant with protocol|5
4578613|NCT01431287|7420451|FG000|Overall Study|Lost to Follow-up|0
4578614|NCT01431287|7420452|FG001|Overall Study|Lost to Follow-up|3
4578615|NCT01431287|7420453|FG002|Overall Study|Lost to Follow-up|2
4692168|NCT02577887|7602595|FG000|Overall Study|Death|93
4692169|NCT02577887|7602595|FG000|Overall Study|Protocol Violation|125
4692170|NCT02577887|7602595|FG000|Overall Study|Withdrawal by Subject|80
4692171|NCT02578186|7602634|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4
4578616|NCT01431287|7420454|FG003|Overall Study|Lost to Follow-up|3
4578617|NCT01431287|7420455|FG004|Overall Study|Lost to Follow-up|1
4578618|NCT01431287|7420451|FG000|Overall Study|Consent withdrawn not due to AE|29
4578619|NCT01431287|7420452|FG001|Overall Study|Consent withdrawn not due to AE|30
4578620|NCT01431287|7420453|FG002|Overall Study|Consent withdrawn not due to AE|34
4578621|NCT01431287|7420454|FG003|Overall Study|Consent withdrawn not due to AE|19
4578622|NCT01431287|7420455|FG004|Overall Study|Consent withdrawn not due to AE|29
4578623|NCT01431287|7420451|FG000|Overall Study|not stated above|4
4692172|NCT02578186|7602635|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4
4692173|NCT02578186|7602634|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1
4692174|NCT02578186|7602635|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1
4692175|NCT02578316|7602649|FG000|Extension Phase|Progression of disease|6
4692176|NCT02578706|7602660|FG000|Overall Study|Withdrawal by Subject|1
4692177|NCT02578706|7602661|FG001|Overall Study|Withdrawal by Subject|0
4692178|NCT02578706|7602662|FG002|Overall Study|Withdrawal by Subject|0
4692179|NCT02578706|7602660|FG000|Overall Study|Lost to Follow-up|0
4692180|NCT02578706|7602661|FG001|Overall Study|Lost to Follow-up|4
4692181|NCT02578706|7602662|FG002|Overall Study|Lost to Follow-up|0
4692182|NCT02578706|7602660|FG000|Overall Study|Physician Decision|0
4692183|NCT02578706|7602661|FG001|Overall Study|Physician Decision|1
4692184|NCT02578706|7602662|FG002|Overall Study|Physician Decision|0
4692185|NCT02578862|7602682|FG000|Overall Study|Withdrawal by Subject|0
4692186|NCT02578862|7602683|FG001|Overall Study|Withdrawal by Subject|1
4692187|NCT02578862|7602682|FG000|Overall Study|Unplanned unilateral procedure|0
4692188|NCT02578862|7602683|FG001|Overall Study|Unplanned unilateral procedure|1
4692189|NCT02578940|7602698|FG000|Overall Study|Screening failure|5
4692190|NCT02578940|7602698|FG000|Overall Study|Lost to Follow-up|1
4692191|NCT02578992|7602706|FG000|Overall Study|equipment not available or malfunction|3
4692192|NCT02578992|7602707|FG001|Overall Study|equipment not available or malfunction|3
4692193|NCT02579382|7602750|FG000|Main Study Phase|Lost to Follow-up|0
4692194|NCT02579382|7602751|FG001|Main Study Phase|Lost to Follow-up|0
4692195|NCT02579382|7602752|FG002|Main Study Phase|Lost to Follow-up|2
4692196|NCT02579382|7602753|FG003|Main Study Phase|Lost to Follow-up|0
4692197|NCT02579382|7602750|FG000|Main Study Phase|Withdrew Consent|0
4692198|NCT02579382|7602751|FG001|Main Study Phase|Withdrew Consent|0
4692199|NCT02579382|7602752|FG002|Main Study Phase|Withdrew Consent|0
4692200|NCT02579382|7602753|FG003|Main Study Phase|Withdrew Consent|2
4692201|NCT02579382|7602750|FG000|Main Study Phase|Lack of Efficacy|0
4692202|NCT02579382|7602751|FG001|Main Study Phase|Lack of Efficacy|0
4692203|NCT02579382|7602752|FG002|Main Study Phase|Lack of Efficacy|0
4692204|NCT02579382|7602753|FG003|Main Study Phase|Lack of Efficacy|1
4692205|NCT02579382|7602750|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0
4692206|NCT02579382|7602751|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3
4692207|NCT02579382|7602752|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1
4692208|NCT02579382|7602753|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4
4692209|NCT02579382|7602750|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1
4692210|NCT02579382|7602751|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0
4578624|NCT01431287|7420452|FG001|Overall Study|not stated above|2
4578625|NCT01431287|7420453|FG002|Overall Study|not stated above|2
4692211|NCT02579382|7602752|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2
4692212|NCT02579382|7602753|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0
4692213|NCT02579382|7602750|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0
4578626|NCT01431287|7420454|FG003|Overall Study|not stated above|2
4578627|NCT01431287|7420455|FG004|Overall Study|not stated above|1
4593203|NCT01548768|7441429|FG002|Overall Study|Withdrawal by Subject|1
4692214|NCT02579382|7602751|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1
4578628|NCT01431521|7420517|FG000|Overall Study|Withdrawal by Subject|0
4578629|NCT01431521|7420518|FG001|Overall Study|Withdrawal by Subject|0
4578630|NCT01431521|7420519|FG002|Overall Study|Withdrawal by Subject|1
4578631|NCT01431521|7420520|FG003|Overall Study|Withdrawal by Subject|0
4578632|NCT01431534|7420532|FG000|Treatment Phase|Adverse Event|0
4578633|NCT01431534|7420533|FG001|Treatment Phase|Adverse Event|0
4578634|NCT01431534|7420534|FG002|Treatment Phase|Adverse Event|1
4578635|NCT01431534|7420532|FG000|Treatment Phase|Progressive Disease|4
4578636|NCT01431534|7420533|FG001|Treatment Phase|Progressive Disease|3
4578637|NCT01431534|7420534|FG002|Treatment Phase|Progressive Disease|10
4578638|NCT01431638|7420549|FG000|Overall Study|Adverse Event|1
4578639|NCT01431638|7420550|FG001|Overall Study|Adverse Event|3
4692215|NCT02579382|7602752|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1
4692216|NCT02579382|7602753|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1
4692217|NCT02579382|7602750|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0
4692218|NCT02579382|7602751|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1
4692219|NCT02579382|7602752|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0
4692220|NCT02579382|7602753|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0
4692221|NCT02579382|7602750|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0
4692222|NCT02579382|7602751|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1
4692223|NCT02579382|7602752|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0
4692224|NCT02579382|7602753|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0
4692225|NCT02579382|7602750|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0
4692226|NCT02579382|7602751|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1
4692227|NCT02579382|7602752|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0
4692228|NCT02579382|7602753|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0
4692229|NCT02579603|7602790|FG000|Overall Study|Not treated|1
4692230|NCT02579603|7602791|FG001|Overall Study|Not treated|0
4692231|NCT02579603|7602790|FG000|Overall Study|Adverse Event|2
4692232|NCT02579603|7602791|FG001|Overall Study|Adverse Event|2
4692233|NCT02579603|7602790|FG000|Overall Study|Other than stated|1
4692234|NCT02579603|7602791|FG001|Overall Study|Other than stated|0
4692235|NCT02579616|7602798|FG000|Overall Study|Participants did not receive treatment|3
4692236|NCT02579629|7602805|FG000|Overall Study|Withdrawal by Subject|0
4692237|NCT02579629|7602806|FG001|Overall Study|Withdrawal by Subject|1
4692238|NCT02579629|7602807|FG002|Overall Study|Withdrawal by Subject|0
4692239|NCT02579629|7602805|FG000|Overall Study|Screen Failure|2
4692240|NCT02579629|7602806|FG001|Overall Study|Screen Failure|0
4692241|NCT02579629|7602807|FG002|Overall Study|Screen Failure|2
4692242|NCT02579759|7602818|FG000|Overall Study|Protocol Violation|2
4692243|NCT02579759|7602819|FG001|Overall Study|Protocol Violation|0
4692244|NCT02579759|7602820|FG002|Overall Study|Protocol Violation|0
4692245|NCT02579759|7602818|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0
4692246|NCT02579759|7602819|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1
4692247|NCT02579759|7602820|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0
4692248|NCT02579759|7602818|FG000|Overall Study|BfArM hold|13
4692249|NCT02579759|7602819|FG001|Overall Study|BfArM hold|12
4692250|NCT02579759|7602820|FG002|Overall Study|BfArM hold|12
4692251|NCT02579759|7602818|FG000|Overall Study|Sponsor stopped Dose 2|0
4692252|NCT02579759|7602819|FG001|Overall Study|Sponsor stopped Dose 2|41
4692253|NCT02579759|7602820|FG002|Overall Study|Sponsor stopped Dose 2|0
4692254|NCT02579759|7602818|FG000|Overall Study|Non compliance|0
4692255|NCT02579759|7602819|FG001|Overall Study|Non compliance|1
4692256|NCT02579759|7602820|FG002|Overall Study|Non compliance|0
4692257|NCT02579759|7602818|FG000|Overall Study|Pregnancy|0
4692258|NCT02579759|7602819|FG001|Overall Study|Pregnancy|1
4692259|NCT02579759|7602820|FG002|Overall Study|Pregnancy|0
4692260|NCT02579759|7602818|FG000|Overall Study|Inclusion/exclusion criteria|0
4692261|NCT02579759|7602819|FG001|Overall Study|Inclusion/exclusion criteria|0
4692262|NCT02579759|7602820|FG002|Overall Study|Inclusion/exclusion criteria|1
4692263|NCT02579759|7602818|FG000|Overall Study|Adverse Event|4
4692264|NCT02579759|7602819|FG001|Overall Study|Adverse Event|3
4692265|NCT02579759|7602820|FG002|Overall Study|Adverse Event|1
4692266|NCT02579759|7602818|FG000|Overall Study|Withdrawal by Subject|3
4692267|NCT02579759|7602819|FG001|Overall Study|Withdrawal by Subject|3
4692268|NCT02579759|7602820|FG002|Overall Study|Withdrawal by Subject|5
4692269|NCT02579759|7602818|FG000|Overall Study|Lost to Follow-up|2
4692270|NCT02579759|7602819|FG001|Overall Study|Lost to Follow-up|2
4578640|NCT01431638|7420551|FG002|Overall Study|Adverse Event|1
4578641|NCT01431638|7420549|FG000|Overall Study|Unsatisfactory therapeutic effect|2
4578642|NCT01431638|7420550|FG001|Overall Study|Unsatisfactory therapeutic effect|2
4578643|NCT01431638|7420551|FG002|Overall Study|Unsatisfactory therapeutic effect|4
4578644|NCT01431638|7420549|FG000|Overall Study|Participants condition no longer requires study drug|0
4692271|NCT02579759|7602820|FG002|Overall Study|Lost to Follow-up|2
4692272|NCT02579772|7602830|FG000|Overall Study|Withdrawal by Subject|0
4692273|NCT02579772|7602831|FG001|Overall Study|Withdrawal by Subject|1
4692274|NCT02579772|7602830|FG000|Overall Study|Usage of additional antioxidants|1
4692275|NCT02579772|7602831|FG001|Overall Study|Usage of additional antioxidants|0
4692276|NCT02579772|7602830|FG000|Overall Study|flu-like illness, orthopedic trauma|1
4692277|NCT02579772|7602831|FG001|Overall Study|flu-like illness, orthopedic trauma|1
4578645|NCT01431638|7420550|FG001|Overall Study|Participants condition no longer requires study drug|1
4578646|NCT01431638|7420551|FG002|Overall Study|Participants condition no longer requires study drug|0
4578647|NCT01431638|7420549|FG000|Overall Study|Participant withdrew consent|14
4578648|NCT01431638|7420550|FG001|Overall Study|Participant withdrew consent|5
4578649|NCT01431638|7420551|FG002|Overall Study|Participant withdrew consent|8
4578650|NCT01431638|7420549|FG000|Overall Study|Lost to Follow-up|7
4578651|NCT01431638|7420550|FG001|Overall Study|Lost to Follow-up|9
4578652|NCT01431638|7420551|FG002|Overall Study|Lost to Follow-up|7
4578653|NCT01431638|7420549|FG000|Overall Study|Administrative problems|1
4578654|NCT01431638|7420550|FG001|Overall Study|Administrative problems|4
4578655|NCT01431638|7420551|FG002|Overall Study|Administrative problems|6
4578656|NCT01431638|7420549|FG000|Overall Study|Death|1
4578657|NCT01431638|7420550|FG001|Overall Study|Death|0
4578658|NCT01431638|7420551|FG002|Overall Study|Death|0
4578659|NCT01431638|7420549|FG000|Overall Study|Protocol deviation|1
4578660|NCT01431638|7420550|FG001|Overall Study|Protocol deviation|1
4578661|NCT01431638|7420551|FG002|Overall Study|Protocol deviation|4
4578662|NCT01431638|7420549|FG000|Overall Study|Participants Did not enter extension study from core study|39
4578663|NCT01431638|7420550|FG001|Overall Study|Participants Did not enter extension study from core study|46
4578664|NCT01431638|7420551|FG002|Overall Study|Participants Did not enter extension study from core study|32
4578665|NCT01431716|7420563|FG000|Overall Study|Withdrawal of consent|1
4578666|NCT01431950|7420609|FG000|Overall Study|Study Site Closed/Terminated|7
4578667|NCT01431950|7420610|FG001|Overall Study|Study Site Closed/Terminated|3
4578668|NCT01431950|7420609|FG000|Overall Study|Withdrawal by Subject|4
4578669|NCT01431950|7420610|FG001|Overall Study|Withdrawal by Subject|3
4578670|NCT01431950|7420609|FG000|Overall Study|Protocol Violation|2
4578671|NCT01431950|7420610|FG001|Overall Study|Protocol Violation|3
4578672|NCT01431950|7420609|FG000|Overall Study|Adverse Event|2
4578673|NCT01431950|7420610|FG001|Overall Study|Adverse Event|2
4578674|NCT01431950|7420609|FG000|Overall Study|Physician Decision|2
4578675|NCT01431950|7420610|FG001|Overall Study|Physician Decision|1
4692278|NCT02579863|7602843|FG000|Overall Study|Final Disposition Unknown|2
4692279|NCT02579863|7602844|FG001|Overall Study|Final Disposition Unknown|1
4692280|NCT02579863|7602843|FG000|Overall Study|Adverse Event|18
4692281|NCT02579863|7602844|FG001|Overall Study|Adverse Event|11
4692282|NCT02579863|7602843|FG000|Overall Study|Death|31
4692283|NCT02579863|7602844|FG001|Overall Study|Death|29
4692284|NCT02579863|7602843|FG000|Overall Study|Lost to Follow-up|2
4692285|NCT02579863|7602844|FG001|Overall Study|Lost to Follow-up|1
4692286|NCT02579863|7602843|FG000|Overall Study|Physician Decision|1
4692287|NCT02579863|7602844|FG001|Overall Study|Physician Decision|2
4692288|NCT02579863|7602843|FG000|Overall Study|Screen Failure|0
4692289|NCT02579863|7602844|FG001|Overall Study|Screen Failure|2
4692290|NCT02579863|7602843|FG000|Overall Study|Study Terminated at Selected Sites|82
4692291|NCT02579863|7602844|FG001|Overall Study|Study Terminated at Selected Sites|88
4692292|NCT02579863|7602843|FG000|Overall Study|Withdrawal by Subject|20
4692293|NCT02579863|7602844|FG001|Overall Study|Withdrawal by Subject|20
4692294|NCT02579928|7602870|FG000|Overall Study|Withdrawal by Subject|1
4692295|NCT02579928|7602871|FG001|Overall Study|Withdrawal by Subject|0
4692296|NCT02580240|7602899|FG000|Overall Study|Physician Decision|2
4692297|NCT02580240|7602900|FG001|Overall Study|Physician Decision|0
4692298|NCT02580357|7602913|FG000|Overall Study|Lost to Follow-up|2
4692299|NCT02580357|7602914|FG001|Overall Study|Lost to Follow-up|0
4692300|NCT02580357|7602915|FG002|Overall Study|Lost to Follow-up|0
4692301|NCT02580357|7602913|FG000|Overall Study|Protocol Violation|1
4692302|NCT02580357|7602914|FG001|Overall Study|Protocol Violation|0
4692303|NCT02580357|7602915|FG002|Overall Study|Protocol Violation|0
4692304|NCT02580591|7602927|FG000|Overall Study|Adverse Event|0
4692305|NCT02580591|7602928|FG001|Overall Study|Adverse Event|1
4692306|NCT02580591|7602929|FG002|Overall Study|Adverse Event|2
4692307|NCT02580591|7602930|FG003|Overall Study|Adverse Event|5
4692308|NCT02580591|7602927|FG000|Overall Study|Protocol Violation|3
4692309|NCT02580591|7602928|FG001|Overall Study|Protocol Violation|2
4692310|NCT02580591|7602929|FG002|Overall Study|Protocol Violation|1
4692311|NCT02580591|7602930|FG003|Overall Study|Protocol Violation|1
4692312|NCT02580591|7602927|FG000|Overall Study|Lost to Follow-up|5
4692313|NCT02580591|7602928|FG001|Overall Study|Lost to Follow-up|3
4692314|NCT02580591|7602929|FG002|Overall Study|Lost to Follow-up|3
4692315|NCT02580591|7602930|FG003|Overall Study|Lost to Follow-up|1
4692316|NCT02580591|7602927|FG000|Overall Study|Withdrawal by Subject|6
4578676|NCT01431950|7420609|FG000|Overall Study|Lack of Efficacy|2
4578677|NCT01431950|7420610|FG001|Overall Study|Lack of Efficacy|1
4578678|NCT01431950|7420609|FG000|Overall Study|Lost to Follow-up|0
4578679|NCT01431950|7420610|FG001|Overall Study|Lost to Follow-up|1
4692317|NCT02580591|7602928|FG001|Overall Study|Withdrawal by Subject|1
4692318|NCT02580591|7602929|FG002|Overall Study|Withdrawal by Subject|2
4692319|NCT02580591|7602930|FG003|Overall Study|Withdrawal by Subject|3
4692320|NCT02580591|7602927|FG000|Overall Study|Not treated|1
4692321|NCT02580591|7602928|FG001|Overall Study|Not treated|1
4692322|NCT02580591|7602929|FG002|Overall Study|Not treated|0
4692323|NCT02580591|7602930|FG003|Overall Study|Not treated|0
4692324|NCT02580591|7602927|FG000|Overall Study|Other than specified|3
4692325|NCT02580591|7602928|FG001|Overall Study|Other than specified|2
4692326|NCT02580591|7602929|FG002|Overall Study|Other than specified|5
4578680|NCT01431950|7420609|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0
4578681|NCT01431950|7420610|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1
4578682|NCT01431963|7420616|FG000|Overall Study|Adverse Event|18
4578683|NCT01431963|7420616|FG000|Overall Study|Lack of Efficacy|7
4578684|NCT01431963|7420616|FG000|Overall Study|Protocol Violation|1
4578685|NCT01431963|7420616|FG000|Overall Study|Protocol-defined Stopping Criteria|2
4578686|NCT01431963|7420616|FG000|Overall Study|Physician Decision|4
4578687|NCT01431963|7420616|FG000|Overall Study|Withdrawal by Subject|3
4578688|NCT01431976|7420620|FG000|Overall Study|Adverse Event|6
4578689|NCT01431976|7420620|FG000|Overall Study|Lack of Efficacy|2
4578690|NCT01431976|7420620|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4
4578691|NCT01431976|7420620|FG000|Overall Study|Physician Decision|1
4578692|NCT01431976|7420620|FG000|Overall Study|Withdrawal by Subject|1
4578693|NCT01432171|7420646|FG000|Overall Study|Death|1
4578694|NCT01432171|7420647|FG001|Overall Study|Death|2
4578695|NCT01432171|7420646|FG000|Overall Study|Lost to Follow-up|6
4578696|NCT01432171|7420647|FG001|Overall Study|Lost to Follow-up|5
4692327|NCT02580591|7602930|FG003|Overall Study|Other than specified|2
4692328|NCT02580877|7602946|FG000|Overall Study|Withdrawal by Subject|1
4692329|NCT02580877|7602947|FG001|Overall Study|Withdrawal by Subject|3
4692330|NCT02580877|7602946|FG000|Overall Study|Adverse Event|0
4692331|NCT02580877|7602947|FG001|Overall Study|Adverse Event|1
4692332|NCT02581163|7602963|FG000|Overall Study|Failure to return|15
4692333|NCT02581163|7602963|FG000|Overall Study|Insufficient virological response|3
4692334|NCT02581163|7602963|FG000|Overall Study|Withdrew consent|1
4692335|NCT02581163|7602963|FG000|Overall Study|Death|1
4692336|NCT02581163|7602963|FG000|Overall Study|Other, not specified|9
4692337|NCT02581189|7602970|FG000|Overall Study|Failure to return|36
4692338|NCT02581189|7602970|FG000|Overall Study|Withdrew consent|5
4692339|NCT02581189|7602970|FG000|Overall Study|Death|3
4692340|NCT02581189|7602970|FG000|Overall Study|Insufficient virological response|2
4770423|NCT03740919|7746731|FG001|Treatment Period|Not Completing Diary|0
4578697|NCT01432171|7420646|FG000|Overall Study|Withdrawal by Subject|3
4578698|NCT01432171|7420647|FG001|Overall Study|Withdrawal by Subject|1
4692341|NCT02581189|7602970|FG000|Overall Study|Other, not specified|7
4692342|NCT02581202|7602977|FG000|Overall Study|Lack of Efficacy|2
4692343|NCT02581202|7602977|FG000|Overall Study|Withdrawal by Subject|4
4692344|NCT02581202|7602977|FG000|Overall Study|Lost to Follow-up|5
4692345|NCT02581202|7602977|FG000|Overall Study|Pregnancy|3
4692346|NCT02581345|7602984|FG000|Part 1: up to Week 16|Adverse Event|3
4692347|NCT02581345|7602985|FG001|Part 1: up to Week 16|Adverse Event|8
4692348|NCT02581345|7602986|FG002|Part 1: up to Week 16|Adverse Event|0
4692349|NCT02581345|7602987|FG003|Part 1: up to Week 16|Adverse Event|0
4692350|NCT02581345|7602984|FG000|Part 1: up to Week 16|Physician Decision|2
4692351|NCT02581345|7602985|FG001|Part 1: up to Week 16|Physician Decision|4
4692352|NCT02581345|7602986|FG002|Part 1: up to Week 16|Physician Decision|0
4692353|NCT02581345|7602987|FG003|Part 1: up to Week 16|Physician Decision|0
4692354|NCT02581345|7602984|FG000|Part 1: up to Week 16|Withdrawal by Subject|4
4692355|NCT02581345|7602985|FG001|Part 1: up to Week 16|Withdrawal by Subject|7
4692356|NCT02581345|7602986|FG002|Part 1: up to Week 16|Withdrawal by Subject|0
4692357|NCT02581345|7602987|FG003|Part 1: up to Week 16|Withdrawal by Subject|0
4692358|NCT02581345|7602984|FG000|Part 1: up to Week 16|Lost to Follow-up|2
4692359|NCT02581345|7602985|FG001|Part 1: up to Week 16|Lost to Follow-up|0
4692360|NCT02581345|7602986|FG002|Part 1: up to Week 16|Lost to Follow-up|0
4692361|NCT02581345|7602987|FG003|Part 1: up to Week 16|Lost to Follow-up|0
4692362|NCT02581345|7602984|FG000|Part 1: up to Week 16|Unspecified Reason|3
4692363|NCT02581345|7602985|FG001|Part 1: up to Week 16|Unspecified Reason|3
4692364|NCT02581345|7602986|FG002|Part 1: up to Week 16|Unspecified Reason|0
4692365|NCT02581345|7602987|FG003|Part 1: up to Week 16|Unspecified Reason|0
4692366|NCT02581345|7602984|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1
4692367|NCT02581345|7602985|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1
4692368|NCT02581345|7602986|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0
4692369|NCT02581345|7602987|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0
4692370|NCT02581345|7602984|FG000|Part 2: Week 17 to Week 47|Adverse Event|5
4692371|NCT02581345|7602985|FG001|Part 2: Week 17 to Week 47|Adverse Event|0
4692372|NCT02581345|7602986|FG002|Part 2: Week 17 to Week 47|Adverse Event|2
4692373|NCT02581345|7602987|FG003|Part 2: Week 17 to Week 47|Adverse Event|2
4692374|NCT02581345|7602984|FG000|Part 2: Week 17 to Week 47|Physician Decision|3
4692375|NCT02581345|7602985|FG001|Part 2: Week 17 to Week 47|Physician Decision|0
4692376|NCT02581345|7602986|FG002|Part 2: Week 17 to Week 47|Physician Decision|2
4578699|NCT01432171|7420646|FG000|Overall Study|Noncompliance|2
4578700|NCT01432171|7420647|FG001|Overall Study|Noncompliance|3
4578701|NCT01432171|7420646|FG000|Overall Study|Insurance denial trial coverage|1
4692377|NCT02581345|7602987|FG003|Part 2: Week 17 to Week 47|Physician Decision|1
4692378|NCT02581345|7602984|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9
4692379|NCT02581345|7602985|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0
4692380|NCT02581345|7602986|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7
4692381|NCT02581345|7602987|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5
4692382|NCT02581345|7602984|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8
4692383|NCT02581345|7602985|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0
4734920|NCT03513588|7682428|FG002|Overall Study|Death|1
4578702|NCT01432171|7420647|FG001|Overall Study|Insurance denial trial coverage|0
4578703|NCT01432171|7420646|FG000|Overall Study|Patient moved to palliative care|1
4578704|NCT01432171|7420647|FG001|Overall Study|Patient moved to palliative care|0
4578705|NCT01432262|7420671|FG000|Overall Study|Withdrawal by Subject|2
4578706|NCT01432262|7420672|FG001|Overall Study|Withdrawal by Subject|1
4578707|NCT01432275|7420678|FG000|First BG Meter System (7 Days)|Adverse Event|0
4578708|NCT01432275|7420679|FG001|First BG Meter System (7 Days)|Adverse Event|2
4578709|NCT01432275|7420678|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0
4578710|NCT01432275|7420679|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1
4578711|NCT01432275|7420678|FG000|Second BG Meter System (7 Days)|Adverse Event|1
4578712|NCT01432275|7420679|FG001|Second BG Meter System (7 Days)|Adverse Event|1
4692384|NCT02581345|7602986|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3
4692385|NCT02581345|7602987|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2
4692386|NCT02581345|7602984|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2
4692387|NCT02581345|7602985|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0
4692388|NCT02581345|7602986|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0
4692389|NCT02581345|7602987|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1
4692390|NCT02581345|7602984|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2
4692391|NCT02581345|7602985|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0
4692392|NCT02581345|7602986|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1
4692393|NCT02581345|7602987|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1
4692394|NCT02581410|7603015|FG000|Vaccination Phase|Adverse Event|2
4692395|NCT02581410|7603016|FG001|Vaccination Phase|Adverse Event|1
4692396|NCT02581410|7603015|FG000|Vaccination Phase|Withdrawal by Subject|0
4692397|NCT02581410|7603016|FG001|Vaccination Phase|Withdrawal by Subject|1
4692398|NCT02581410|7603015|FG000|Vaccination Phase|Migrated/moved from study area|0
4692399|NCT02581410|7603016|FG001|Vaccination Phase|Migrated/moved from study area|1
4692400|NCT02581410|7603015|FG000|End of Study Phase|Adverse Event|4
4692401|NCT02581410|7603016|FG001|End of Study Phase|Adverse Event|3
4692402|NCT02581410|7603015|FG000|End of Study Phase|Withdrawal by Subject|1
4692403|NCT02581410|7603016|FG001|End of Study Phase|Withdrawal by Subject|2
4692404|NCT02581410|7603015|FG000|End of Study Phase|Migrated/moved from study area|0
4692405|NCT02581410|7603016|FG001|End of Study Phase|Migrated/moved from study area|3
4692406|NCT02581410|7603015|FG000|End of Study Phase|Lost to Follow-up|0
4692407|NCT02581410|7603016|FG001|End of Study Phase|Lost to Follow-up|2
4692408|NCT02581410|7603015|FG000|End of Study Phase|Other-transfer of subject not completed|0
4692409|NCT02581410|7603016|FG001|End of Study Phase|Other-transfer of subject not completed|1
4692410|NCT02581488|7603034|FG000|Overall Study|Adverse Event|6
4692411|NCT02581488|7603035|FG001|Overall Study|Adverse Event|7
4692412|NCT02581488|7603034|FG000|Overall Study|Lost to Follow-up|1
4692413|NCT02581488|7603035|FG001|Overall Study|Lost to Follow-up|0
4578713|NCT01432275|7420678|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1
4578714|NCT01432275|7420679|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0
4578715|NCT01432275|7420678|FG000|Second BG Meter System (7 Days)|Physician Decision|0
4578716|NCT01432275|7420679|FG001|Second BG Meter System (7 Days)|Physician Decision|1
4578717|NCT01432275|7420678|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0
4578718|NCT01432275|7420679|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1
4578719|NCT01432275|7420678|FG000|ADC With Calculator (10 Days)|Physician Decision|1
4578720|NCT01432275|7420679|FG001|ADC With Calculator (10 Days)|Physician Decision|1
4578721|NCT01432275|7420678|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2
4578722|NCT01432275|7420679|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0
4578723|NCT01432275|7420678|FG000|ADC With Calculator (10 Days)|Protocol Violation|0
4578724|NCT01432275|7420679|FG001|ADC With Calculator (10 Days)|Protocol Violation|1
4578725|NCT01432327|7420689|FG000|Posttest 3 Months|depression|3
4578726|NCT01432327|7420690|FG001|Posttest 3 Months|depression|0
4578727|NCT01432327|7420691|FG002|Posttest 3 Months|depression|0
4578728|NCT01432327|7420692|FG003|Posttest 3 Months|depression|0
4578729|NCT01432327|7420689|FG000|Posttest 3 Months|Lost to Follow-up|1
4578730|NCT01432327|7420690|FG001|Posttest 3 Months|Lost to Follow-up|0
4578731|NCT01432327|7420691|FG002|Posttest 3 Months|Lost to Follow-up|2
4578732|NCT01432327|7420692|FG003|Posttest 3 Months|Lost to Follow-up|1
4578733|NCT01432327|7420689|FG000|Posttest 3 Months|Allergic reaction|0
4578734|NCT01432327|7420690|FG001|Posttest 3 Months|Allergic reaction|2
4578735|NCT01432327|7420691|FG002|Posttest 3 Months|Allergic reaction|0
4578736|NCT01432327|7420692|FG003|Posttest 3 Months|Allergic reaction|0
4578737|NCT01432327|7420689|FG000|Posttest 6 Months|Lost to Follow-up|0
4578738|NCT01432327|7420690|FG001|Posttest 6 Months|Lost to Follow-up|0
4578739|NCT01432327|7420691|FG002|Posttest 6 Months|Lost to Follow-up|3
4578740|NCT01432327|7420692|FG003|Posttest 6 Months|Lost to Follow-up|2
4578741|NCT01432327|7420689|FG000|Posttest 6 Months|Allergic reaction|0
4578742|NCT01432327|7420690|FG001|Posttest 6 Months|Allergic reaction|0
4692414|NCT02581488|7603034|FG000|Overall Study|Withdrawal by Subject|1
4692415|NCT02581488|7603035|FG001|Overall Study|Withdrawal by Subject|0
4692416|NCT02581488|7603034|FG000|Overall Study|Non-Compliance|1
4692417|NCT02581488|7603035|FG001|Overall Study|Non-Compliance|0
4692418|NCT02581488|7603034|FG000|Overall Study|Protocol Violation|0
4692419|NCT02581488|7603035|FG001|Overall Study|Protocol Violation|4
4578743|NCT01432327|7420691|FG002|Posttest 6 Months|Allergic reaction|1
4578744|NCT01432327|7420692|FG003|Posttest 6 Months|Allergic reaction|0
4578745|NCT01432327|7420689|FG000|Posttest 6 Months|Withdrawal by Subject|0
4578746|NCT01432327|7420690|FG001|Posttest 6 Months|Withdrawal by Subject|0
4578747|NCT01432327|7420691|FG002|Posttest 6 Months|Withdrawal by Subject|1
4578748|NCT01432327|7420692|FG003|Posttest 6 Months|Withdrawal by Subject|0
4578749|NCT01432327|7420689|FG000|Posttest 1 Year|Measurement have to take place in future|24
4578750|NCT01432327|7420690|FG001|Posttest 1 Year|Measurement have to take place in future|28
4578751|NCT01432327|7420691|FG002|Posttest 1 Year|Measurement have to take place in future|15
4578752|NCT01432327|7420692|FG003|Posttest 1 Year|Measurement have to take place in future|20
4578753|NCT01432327|7420689|FG000|Posttest 1 Year|Lost to Follow-up|0
4578754|NCT01432327|7420690|FG001|Posttest 1 Year|Lost to Follow-up|0
4578755|NCT01432327|7420691|FG002|Posttest 1 Year|Lost to Follow-up|4
4578756|NCT01432327|7420692|FG003|Posttest 1 Year|Lost to Follow-up|2
4578757|NCT01432327|7420689|FG000|Posttest 1 Year|Allergic reaction|0
4578758|NCT01432327|7420690|FG001|Posttest 1 Year|Allergic reaction|0
4578759|NCT01432327|7420691|FG002|Posttest 1 Year|Allergic reaction|1
4578760|NCT01432327|7420692|FG003|Posttest 1 Year|Allergic reaction|1
4578761|NCT01432366|7420702|FG000|Overall Study|Non-Responder|7
4578762|NCT01432366|7420702|FG000|Overall Study|Adverse Event|8
4578763|NCT01432366|7420702|FG000|Overall Study|Withdrawal Due to Non-Compliance|3
4578764|NCT01432366|7420702|FG000|Overall Study|Pregnancy|1
4578765|NCT01432366|7420702|FG000|Overall Study|Lost to Follow-up|13
4578766|NCT01432366|7420702|FG000|Overall Study|Lack of Efficacy|1
4578767|NCT01432366|7420702|FG000|Overall Study|Site Closed|20
4578768|NCT01432366|7420702|FG000|Overall Study|Investigator Forget to Complete Visits|1
4578769|NCT01432366|7420702|FG000|Overall Study|Other|14
4578770|NCT01432444|7420719|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10
4578771|NCT01432444|7420720|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0
4578772|NCT01432444|7420721|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0
4578773|NCT01432444|7420719|FG000|Tolerability/Cross-titration Phase|Adverse Event|16
4578774|NCT01432444|7420720|FG001|Tolerability/Cross-titration Phase|Adverse Event|0
4578775|NCT01432444|7420721|FG002|Tolerability/Cross-titration Phase|Adverse Event|0
4578776|NCT01432444|7420719|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5
4578777|NCT01432444|7420720|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0
4578778|NCT01432444|7420721|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0
4578779|NCT01432444|7420719|FG000|Tolerability/Cross-titration Phase|Physician Decision|8
4578780|NCT01432444|7420720|FG001|Tolerability/Cross-titration Phase|Physician Decision|0
4578781|NCT01432444|7420721|FG002|Tolerability/Cross-titration Phase|Physician Decision|0
4578782|NCT01432444|7420719|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15
4578783|NCT01432444|7420720|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0
4578784|NCT01432444|7420721|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0
4578785|NCT01432444|7420719|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1
4578786|NCT01432444|7420720|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0
4578787|NCT01432444|7420721|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0
4578788|NCT01432444|7420719|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5
4578789|NCT01432444|7420720|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0
4578790|NCT01432444|7420721|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0
4578791|NCT01432444|7420719|FG000|Treatment Phase|Lost to Follow-up|0
4578792|NCT01432444|7420720|FG001|Treatment Phase|Lost to Follow-up|33
4578793|NCT01432444|7420721|FG002|Treatment Phase|Lost to Follow-up|0
4578794|NCT01432444|7420719|FG000|Treatment Phase|Adverse Event|0
4578795|NCT01432444|7420720|FG001|Treatment Phase|Adverse Event|37
4578796|NCT01432444|7420721|FG002|Treatment Phase|Adverse Event|0
4578797|NCT01432444|7420719|FG000|Treatment Phase|Met Withdrawal Criteria|0
4578798|NCT01432444|7420720|FG001|Treatment Phase|Met Withdrawal Criteria|11
4578799|NCT01432444|7420721|FG002|Treatment Phase|Met Withdrawal Criteria|0
4578800|NCT01432444|7420719|FG000|Treatment Phase|Physician Decision|0
4578801|NCT01432444|7420720|FG001|Treatment Phase|Physician Decision|5
4578802|NCT01432444|7420721|FG002|Treatment Phase|Physician Decision|0
4578803|NCT01432444|7420719|FG000|Treatment Phase|Withdrawal by Subject|0
4578804|NCT01432444|7420720|FG001|Treatment Phase|Withdrawal by Subject|41
4578805|NCT01432444|7420721|FG002|Treatment Phase|Withdrawal by Subject|0
4578806|NCT01432444|7420719|FG000|Treatment Phase|Protocol Deviation|0
4578807|NCT01432444|7420720|FG001|Treatment Phase|Protocol Deviation|3
4692420|NCT02581891|7603063|FG000|Overall Study|Adverse Event|4
4692421|NCT02581891|7603064|FG001|Overall Study|Adverse Event|6
4692422|NCT02581891|7603063|FG000|Overall Study|Death|3
4692423|NCT02581891|7603064|FG001|Overall Study|Death|4
4692424|NCT02581891|7603063|FG000|Overall Study|Lost to Follow-up|1
4692425|NCT02581891|7603064|FG001|Overall Study|Lost to Follow-up|2
4692426|NCT02581891|7603063|FG000|Overall Study|Physician Decision|0
4578808|NCT01432444|7420721|FG002|Treatment Phase|Protocol Deviation|0
4578809|NCT01432444|7420719|FG000|Treatment Phase|Lack of Efficacy|0
4578810|NCT01432444|7420720|FG001|Treatment Phase|Lack of Efficacy|10
4578811|NCT01432444|7420721|FG002|Treatment Phase|Lack of Efficacy|0
4578812|NCT01432444|7420719|FG000|Extension Phase|Lost to Follow-up|0
4692427|NCT02581891|7603064|FG001|Overall Study|Physician Decision|1
4692428|NCT02581891|7603063|FG000|Overall Study|Withdrawal by Subject|4
4692429|NCT02581891|7603064|FG001|Overall Study|Withdrawal by Subject|5
4578813|NCT01432444|7420720|FG001|Extension Phase|Lost to Follow-up|0
4578814|NCT01432444|7420721|FG002|Extension Phase|Lost to Follow-up|17
4578815|NCT01432444|7420719|FG000|Extension Phase|Adverse Event|0
4578816|NCT01432444|7420720|FG001|Extension Phase|Adverse Event|0
4578817|NCT01432444|7420721|FG002|Extension Phase|Adverse Event|10
4578818|NCT01432444|7420719|FG000|Extension Phase|Sponsor Discontinued Trial|0
4578819|NCT01432444|7420720|FG001|Extension Phase|Sponsor Discontinued Trial|0
4578820|NCT01432444|7420721|FG002|Extension Phase|Sponsor Discontinued Trial|7
4578821|NCT01432444|7420719|FG000|Extension Phase|Met Withdrawal Criteria|0
4578822|NCT01432444|7420720|FG001|Extension Phase|Met Withdrawal Criteria|0
4578823|NCT01432444|7420721|FG002|Extension Phase|Met Withdrawal Criteria|144
4578824|NCT01432444|7420719|FG000|Extension Phase|Physician Decision|0
4578825|NCT01432444|7420720|FG001|Extension Phase|Physician Decision|0
4578826|NCT01432444|7420721|FG002|Extension Phase|Physician Decision|1
4578827|NCT01432444|7420719|FG000|Extension Phase|Withdrawal by Subject|0
4578828|NCT01432444|7420720|FG001|Extension Phase|Withdrawal by Subject|0
4578829|NCT01432444|7420721|FG002|Extension Phase|Withdrawal by Subject|13
4578830|NCT01432457|7420729|FG000|Overall Study|Adverse Event|7
4578831|NCT01432457|7420730|FG001|Overall Study|Adverse Event|10
4578832|NCT01432457|7420731|FG002|Overall Study|Adverse Event|16
4578833|NCT01432457|7420729|FG000|Overall Study|Lack of Efficacy|2
4578834|NCT01432457|7420730|FG001|Overall Study|Lack of Efficacy|1
4578835|NCT01432457|7420731|FG002|Overall Study|Lack of Efficacy|1
4578836|NCT01432457|7420729|FG000|Overall Study|Lost to Follow-up|11
4578837|NCT01432457|7420730|FG001|Overall Study|Lost to Follow-up|15
4578838|NCT01432457|7420731|FG002|Overall Study|Lost to Follow-up|20
4578839|NCT01432457|7420729|FG000|Overall Study|Protocol Violation|3
4578840|NCT01432457|7420730|FG001|Overall Study|Protocol Violation|2
4578841|NCT01432457|7420731|FG002|Overall Study|Protocol Violation|6
4578842|NCT01432457|7420729|FG000|Overall Study|Withdrawal by Subject|6
4578843|NCT01432457|7420730|FG001|Overall Study|Withdrawal by Subject|11
4578844|NCT01432457|7420731|FG002|Overall Study|Withdrawal by Subject|9
4578845|NCT01432457|7420729|FG000|Overall Study|Reasons not defined|2
4578846|NCT01432457|7420730|FG001|Overall Study|Reasons not defined|3
4578847|NCT01432457|7420731|FG002|Overall Study|Reasons not defined|4
4578848|NCT01432457|7420729|FG000|Overall Study|Did not take study drug|6
4578849|NCT01432457|7420730|FG001|Overall Study|Did not take study drug|6
4578850|NCT01432457|7420731|FG002|Overall Study|Did not take study drug|3
4578851|NCT01432574|7420756|FG000|Overall Study|Moved|2
4578852|NCT01432574|7420756|FG000|Overall Study|Not interested|1
4578853|NCT01432600|7420765|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0
4578854|NCT01432600|7420766|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1
4578855|NCT01432600|7420767|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1
4578856|NCT01432626|7420777|FG000|Overall Study|LV function recovered|2
4578857|NCT01432626|7420777|FG000|Overall Study|Withdrawal by Subject|2
4578858|NCT01432626|7420777|FG000|Overall Study|Only 1 image competed|2
4578859|NCT01432626|7420777|FG000|Overall Study|Imaging agent not available|1
4578860|NCT01432730|7420781|FG000|Period 1|Adverse Event|2
4578861|NCT01432730|7420782|FG001|Period 1|Adverse Event|0
4578862|NCT01432730|7420781|FG000|Period 2|Adverse Event|0
4578863|NCT01432730|7420782|FG001|Period 2|Adverse Event|4
4578864|NCT01432756|7420792|FG000|Overall Study|Lost to Follow-up|1
4578865|NCT01432756|7420793|FG001|Overall Study|Lost to Follow-up|0
4578866|NCT01432756|7420794|FG002|Overall Study|Lost to Follow-up|2
4578867|NCT01432756|7420795|FG003|Overall Study|Lost to Follow-up|1
4578868|NCT01432938|7420813|FG000|First Intervention|Protocol Violation|1
4578869|NCT01432938|7420814|FG001|First Intervention|Protocol Violation|0
4578870|NCT01432938|7420813|FG000|First Intervention|Physician Decision|1
4578871|NCT01432938|7420814|FG001|First Intervention|Physician Decision|0
4578872|NCT01432938|7420813|FG000|Second Intervention|Adverse Event|1
4578873|NCT01432938|7420814|FG001|Second Intervention|Adverse Event|0
4578874|NCT01432951|7420821|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1
4578875|NCT01433055|7420836|FG000|Overall Study|Diagnosed with cancer unrelated to study|1
4578876|NCT01433055|7420837|FG001|Overall Study|Diagnosed with cancer unrelated to study|0
4578877|NCT01433055|7420836|FG000|Overall Study|Severely elevated triglycerides at entry|1
4578878|NCT01433055|7420837|FG001|Overall Study|Severely elevated triglycerides at entry|0
4578879|NCT01433159|7420864|FG000|Overall Study|Adverse Event|1
4578880|NCT01433159|7420865|FG001|Overall Study|Adverse Event|0
4578881|NCT01433159|7420864|FG000|Overall Study|Physician Decision|1
4578882|NCT01433159|7420865|FG001|Overall Study|Physician Decision|0
4578883|NCT01433159|7420864|FG000|Overall Study|Protocol Violation|0
4578884|NCT01433159|7420865|FG001|Overall Study|Protocol Violation|1
4578885|NCT01433172|7420874|FG000|Overall Study|Withdrawal by Subject|0
4578886|NCT01433172|7420875|FG001|Overall Study|Withdrawal by Subject|1
4578887|NCT01433172|7420876|FG002|Overall Study|Withdrawal by Subject|0
4578888|NCT01433172|7420874|FG000|Overall Study|Disease Progression|0
4578889|NCT01433172|7420875|FG001|Overall Study|Disease Progression|0
4578890|NCT01433172|7420876|FG002|Overall Study|Disease Progression|1
4578891|NCT01433172|7420874|FG000|Overall Study|Death|0
4578892|NCT01433172|7420875|FG001|Overall Study|Death|2
4578893|NCT01433172|7420876|FG002|Overall Study|Death|0
4578894|NCT01433250|7420886|FG000|Overall Study|Protocol Violation|0
4578895|NCT01433250|7420887|FG001|Overall Study|Protocol Violation|1
4578896|NCT01433250|7420886|FG000|Overall Study|Withdrawal by Subject|3
4578897|NCT01433250|7420887|FG001|Overall Study|Withdrawal by Subject|2
4578898|NCT01433263|7420895|FG000|Overall Study|Adverse Event|3
4578899|NCT01433263|7420896|FG001|Overall Study|Adverse Event|1
4692430|NCT02581891|7603063|FG000|Overall Study|Other Reasons|3
4692431|NCT02581891|7603064|FG001|Overall Study|Other Reasons|1
4692432|NCT02581891|7603063|FG000|Overall Study|Discontinued during followup|1
4692433|NCT02581891|7603064|FG001|Overall Study|Discontinued during followup|0
4692434|NCT02581995|7603071|FG000|Overall Study|Unspecified other|3
4692435|NCT02581995|7603071|FG000|Overall Study|Adverse Event|6
4692436|NCT02581995|7603071|FG000|Overall Study|Lost to Follow-up|5
4692437|NCT02581995|7603071|FG000|Overall Study|Withdrawal by participant|12
4692438|NCT02581995|7603071|FG000|Overall Study|Physician Decision|1
4692439|NCT02581995|7603071|FG000|Overall Study|Death|4
4692440|NCT02582242|7603091|FG000|Overall Study|Adverse Event|4
4692441|NCT02582242|7603092|FG001|Overall Study|Adverse Event|3
4692442|NCT02582242|7603091|FG000|Overall Study|Protocol Violation|3
4692443|NCT02582242|7603092|FG001|Overall Study|Protocol Violation|1
4692444|NCT02582242|7603091|FG000|Overall Study|Lost to Follow-up|0
4692445|NCT02582242|7603092|FG001|Overall Study|Lost to Follow-up|1
4692446|NCT02582242|7603091|FG000|Overall Study|Withdrawal by Subject|11
4692447|NCT02582242|7603092|FG001|Overall Study|Withdrawal by Subject|11
4692448|NCT02582242|7603091|FG000|Overall Study|Unclassified|2
4692449|NCT02582242|7603092|FG001|Overall Study|Unclassified|1
4692450|NCT02582255|7603100|FG000|Overall Study|Protocol Violation|0
4692451|NCT02582255|7603101|FG001|Overall Study|Protocol Violation|3
4692452|NCT02582515|7603110|FG000|Overall Study|Withdrawal by Subject|0
4692453|NCT02582515|7603111|FG001|Overall Study|Withdrawal by Subject|1
4692454|NCT02582632|7603117|FG000|Overall Study|Other|1
4464919|NCT00606684|7255972|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
4464920|NCT00606684|7255973|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
4464921|NCT00606684|7255974|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
4464922|NCT00606684|7255975|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
4464923|NCT00606684|7255969|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32
4464924|NCT00606684|7255970|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
4692455|NCT02582658|7603121|FG000|Overall Study|Failure to Return|10
4692456|NCT02582658|7603121|FG000|Overall Study|Insufficient Virological Response|2
4692457|NCT02582658|7603121|FG000|Overall Study|Withdrawn Consent|1
4692458|NCT02582658|7603121|FG000|Overall Study|Death|1
4692459|NCT02582658|7603121|FG000|Overall Study|Not further specified|11
4692460|NCT02582671|7603125|FG000|Overall Study|Failure to return|1
4692461|NCT02582671|7603125|FG000|Overall Study|Other, not specified|1
4692462|NCT02582684|7603130|FG000|Overall Study|Unable to contact subject/parent|4
4692463|NCT02582684|7603130|FG000|Overall Study|Subject not able to get to clinic|10
4692464|NCT02582684|7603130|FG000|Overall Study|Subject withdrew consent|1
4692465|NCT02582684|7603130|FG000|Overall Study|Found to be ineligible after enrollment|2
4692466|NCT02582814|7603136|FG000|Overall Study|Study-specific withdrawal criteria|1
4692467|NCT02582814|7603137|FG001|Overall Study|Study-specific withdrawal criteria|0
4692468|NCT02582814|7603136|FG000|Overall Study|Withdrawal by Subject|4
4692469|NCT02582814|7603137|FG001|Overall Study|Withdrawal by Subject|3
4692470|NCT02582814|7603136|FG000|Overall Study|Adverse Event|4
4692471|NCT02582814|7603137|FG001|Overall Study|Adverse Event|4
4692472|NCT02582866|7603158|FG000|Overall Study|Death|1
4692473|NCT02582866|7603158|FG000|Overall Study|Lack of Efficacy|2
4692474|NCT02582866|7603158|FG000|Overall Study|Lost to Follow-up|2
4692475|NCT02582866|7603158|FG000|Overall Study|Withdrawal by Subject|7
4692476|NCT02582866|7603158|FG000|Overall Study|Investigator decision|5
4692477|NCT02582866|7603158|FG000|Overall Study|Participant wants to get pregnant|1
4692478|NCT02582866|7603158|FG000|Overall Study|Pregnancy|2
4692479|NCT02582866|7603158|FG000|Overall Study|Sponsor decision|1
4692480|NCT02582866|7603158|FG000|Overall Study|Withdrawal due to personal reasons|1
4692481|NCT02582983|7603166|FG000|Overall Study|Death|3
4692482|NCT02582983|7603166|FG000|Overall Study|Withdrawal by Subject|2
4692483|NCT02582983|7603166|FG000|Overall Study|Adverse Event|1
4692484|NCT02583256|7603178|FG000|Overall Study|Withdrawal by Subject|0
4692485|NCT02583256|7603179|FG001|Overall Study|Withdrawal by Subject|1
4692486|NCT02583256|7603180|FG002|Overall Study|Withdrawal by Subject|1
4464925|NCT00606684|7255971|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
4692487|NCT02583256|7603181|FG003|Overall Study|Withdrawal by Subject|0
4692488|NCT02583256|7603178|FG000|Overall Study|Lost to Follow-up|1
4692489|NCT02583256|7603179|FG001|Overall Study|Lost to Follow-up|1
4692490|NCT02583256|7603180|FG002|Overall Study|Lost to Follow-up|0
4692491|NCT02583256|7603181|FG003|Overall Study|Lost to Follow-up|1
4692492|NCT02583256|7603178|FG000|Overall Study|Administrative/Other|2
4692493|NCT02583256|7603179|FG001|Overall Study|Administrative/Other|0
4692494|NCT02583256|7603180|FG002|Overall Study|Administrative/Other|1
4692495|NCT02583256|7603181|FG003|Overall Study|Administrative/Other|2
4692496|NCT02583399|7603202|FG000|Overall Study|Able to be discharged|3
4692497|NCT02583399|7603202|FG000|Overall Study|Wanted to use a restricted medication|3
4692498|NCT02583425|7603206|FG000|Screening|Did not meet entry criteria|12
4692499|NCT02583425|7603206|FG000|Baseline|Did not meet continued criteria|5
4692500|NCT02583425|7603206|FG000|Treatment Period|Adverse Event|1
4692501|NCT02583477|7603213|FG000|Overall Study|Adverse Event|0
4578900|NCT01433263|7420895|FG000|Overall Study|Death|5
4578901|NCT01433263|7420896|FG001|Overall Study|Death|3
4578902|NCT01433263|7420895|FG000|Overall Study|Lost to Follow-up|0
4578903|NCT01433263|7420896|FG001|Overall Study|Lost to Follow-up|1
4578904|NCT01433263|7420895|FG000|Overall Study|Protocol Deviation|1
4578905|NCT01433263|7420896|FG001|Overall Study|Protocol Deviation|0
4578906|NCT01433263|7420895|FG000|Overall Study|Withdrawal by Subject|10
4578907|NCT01433263|7420896|FG001|Overall Study|Withdrawal by Subject|7
4578908|NCT01433354|7420905|FG000|Overall Study|Adverse Event|6
4578909|NCT01433354|7420905|FG000|Overall Study|Lost to Follow-up|1
4578910|NCT01433354|7420905|FG000|Overall Study|Administrative problems|90
4578911|NCT01433354|7420905|FG000|Overall Study|Protocol Violation|2
4578912|NCT01433354|7420905|FG000|Overall Study|Lack of Efficacy|17
4578913|NCT01433354|7420905|FG000|Overall Study|Subject Withdrew Consent|3
4578914|NCT01433549|7420919|FG000|Phase 2: Second Study Product|Adverse Event|0
4578915|NCT01433549|7420920|FG001|Phase 2: Second Study Product|Adverse Event|1
4578916|NCT01433978|7420953|FG000|Core Study|Adverse Event, Non-Fatal|0
4578917|NCT01433978|7420954|FG001|Core Study|Adverse Event, Non-Fatal|1
4578918|NCT01433978|7420955|FG002|Core Study|Adverse Event, Non-Fatal|0
4578919|NCT01433978|7420953|FG000|Core Study|Lack of Efficacy|5
4578920|NCT01433978|7420954|FG001|Core Study|Lack of Efficacy|1
4578921|NCT01433978|7420955|FG002|Core Study|Lack of Efficacy|0
4578922|NCT01433978|7420953|FG000|Core Study|Study Terminated by Sponsor|6
4578923|NCT01433978|7420954|FG001|Core Study|Study Terminated by Sponsor|9
4578924|NCT01433978|7420955|FG002|Core Study|Study Terminated by Sponsor|0
4578925|NCT01433978|7420953|FG000|Extension Phase|Adverse Event, Non-Fatal|0
4578926|NCT01433978|7420954|FG001|Extension Phase|Adverse Event, Non-Fatal|0
4578927|NCT01433978|7420955|FG002|Extension Phase|Adverse Event, Non-Fatal|1
4578928|NCT01433978|7420953|FG000|Extension Phase|Lack of Efficacy|0
4578929|NCT01433978|7420954|FG001|Extension Phase|Lack of Efficacy|0
4578930|NCT01433978|7420955|FG002|Extension Phase|Lack of Efficacy|1
4578931|NCT01433978|7420953|FG000|Extension Phase|Study Terminated by Sponsor|0
4692502|NCT02583477|7603214|FG001|Overall Study|Adverse Event|2
4692503|NCT02583477|7603213|FG000|Overall Study|Death|1
4692504|NCT02583477|7603214|FG001|Overall Study|Death|16
4692505|NCT02583477|7603213|FG000|Overall Study|Study terminated|2
4692506|NCT02583477|7603214|FG001|Overall Study|Study terminated|2
4692507|NCT02583711|7603224|FG000|Overall Study|Withdrawal by Subject|0
4692508|NCT02583711|7603225|FG001|Overall Study|Withdrawal by Subject|10
4692509|NCT02583711|7603226|FG002|Overall Study|Withdrawal by Subject|0
4734921|NCT03514641|7682480|FG000|603A: 0-12 Week Study Period|Protocol Violation|3
4734922|NCT03514641|7682481|FG001|603A: 0-12 Week Study Period|Protocol Violation|3
4734923|NCT03514641|7682482|FG002|603A: 0-12 Week Study Period|Protocol Violation|0
4734924|NCT03514641|7682483|FG003|603A: 0-12 Week Study Period|Protocol Violation|0
4734925|NCT03514641|7682480|FG000|603A: 0-12 Week Study Period|Adverse Event|5
4734926|NCT03514641|7682481|FG001|603A: 0-12 Week Study Period|Adverse Event|2
4734927|NCT03514641|7682482|FG002|603A: 0-12 Week Study Period|Adverse Event|0
4734928|NCT03514641|7682483|FG003|603A: 0-12 Week Study Period|Adverse Event|0
4734929|NCT03514641|7682480|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7
4734930|NCT03514641|7682481|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5
4734931|NCT03514641|7682482|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0
4734932|NCT03514641|7682483|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0
4734933|NCT03514641|7682480|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10
4734934|NCT03514641|7682481|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9
4734935|NCT03514641|7682482|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0
4734936|NCT03514641|7682483|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0
4734937|NCT03514641|7682480|FG000|603A: 0-12 Week Study Period|Physician Decision|1
4734938|NCT03514641|7682481|FG001|603A: 0-12 Week Study Period|Physician Decision|0
4734939|NCT03514641|7682482|FG002|603A: 0-12 Week Study Period|Physician Decision|0
4734940|NCT03514641|7682483|FG003|603A: 0-12 Week Study Period|Physician Decision|0
4734941|NCT03514641|7682480|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1
4734942|NCT03514641|7682481|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0
4734943|NCT03514641|7682482|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0
4734944|NCT03514641|7682483|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0
4734945|NCT03514641|7682480|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0
4734946|NCT03514641|7682481|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1
4734947|NCT03514641|7682482|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0
4734948|NCT03514641|7682483|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0
4734949|NCT03514641|7682480|FG000|603B: 24-36 Week Study Period|Protocol Violation|0
4734950|NCT03514641|7682481|FG001|603B: 24-36 Week Study Period|Protocol Violation|0
4578932|NCT01433978|7420954|FG001|Extension Phase|Study Terminated by Sponsor|0
4578933|NCT01433978|7420955|FG002|Extension Phase|Study Terminated by Sponsor|4
4578934|NCT01433991|7420966|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2
4578935|NCT01433991|7420967|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0
4578936|NCT01433991|7420968|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0
4734951|NCT03514641|7682482|FG002|603B: 24-36 Week Study Period|Protocol Violation|0
4734952|NCT03514641|7682483|FG003|603B: 24-36 Week Study Period|Protocol Violation|2
4734953|NCT03514641|7682480|FG000|603B: 24-36 Week Study Period|Adverse Event|0
4578937|NCT01433991|7420969|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0
4578938|NCT01433991|7420966|FG000|Treatment Phase (Combination Agent)|Adverse Event|1
4578939|NCT01433991|7420967|FG001|Treatment Phase (Combination Agent)|Adverse Event|0
4578940|NCT01433991|7420968|FG002|Treatment Phase (Combination Agent)|Adverse Event|3
4578941|NCT01433991|7420969|FG003|Treatment Phase (Combination Agent)|Adverse Event|1
4578942|NCT01433991|7420966|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0
4578943|NCT01433991|7420967|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0
4578944|NCT01433991|7420968|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0
4578945|NCT01433991|7420969|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1
4578946|NCT01433991|7420966|FG000|Treatment Phase (Combination Agent)|Participant Choice|0
4692510|NCT02584257|7603240|FG000|Period 1|Withdrawal by Subject|0
4578947|NCT01433991|7420967|FG001|Treatment Phase (Combination Agent)|Participant Choice|0
4578948|NCT01433991|7420968|FG002|Treatment Phase (Combination Agent)|Participant Choice|0
4578949|NCT01433991|7420969|FG003|Treatment Phase (Combination Agent)|Participant Choice|1
4578950|NCT01433991|7420966|FG000|Treatment Phase (Combination Agent)|Clinical progression|0
4578951|NCT01433991|7420967|FG001|Treatment Phase (Combination Agent)|Clinical progression|1
4578952|NCT01433991|7420968|FG002|Treatment Phase (Combination Agent)|Clinical progression|2
4578953|NCT01433991|7420969|FG003|Treatment Phase (Combination Agent)|Clinical progression|3
4578954|NCT01433991|7420966|FG000|Treatment Phase (Combination Agent)|Progressive disease|1
4578955|NCT01433991|7420967|FG001|Treatment Phase (Combination Agent)|Progressive disease|0
4578956|NCT01433991|7420968|FG002|Treatment Phase (Combination Agent)|Progressive disease|0
4578957|NCT01433991|7420969|FG003|Treatment Phase (Combination Agent)|Progressive disease|0
4578958|NCT01433991|7420966|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0
4578959|NCT01433991|7420967|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0
4578960|NCT01433991|7420968|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1
4578961|NCT01433991|7420969|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0
4578962|NCT01434290|7421017|FG000|Overall Study|Protocol Violation|6
4578963|NCT01434290|7421018|FG001|Overall Study|Protocol Violation|3
4578964|NCT01434290|7421017|FG000|Overall Study|No protocol treatment|2
4578965|NCT01434290|7421018|FG001|Overall Study|No protocol treatment|4
4578966|NCT01434654|7421044|FG000|Overall Study|Withdrawal by Subject|1
4578967|NCT01434654|7421045|FG001|Overall Study|Withdrawal by Subject|0
4578968|NCT01434654|7421044|FG000|Overall Study|Lost to Follow-up|1
4692511|NCT02584257|7603241|FG001|Period 1|Withdrawal by Subject|0
4692512|NCT02584257|7603242|FG002|Period 1|Withdrawal by Subject|0
4692513|NCT02584257|7603243|FG003|Period 1|Withdrawal by Subject|0
4692514|NCT02584257|7603244|FG004|Period 1|Withdrawal by Subject|0
4692515|NCT02584257|7603245|FG005|Period 1|Withdrawal by Subject|0
4692516|NCT02584257|7603246|FG006|Period 1|Withdrawal by Subject|1
4692517|NCT02584257|7603247|FG007|Period 1|Withdrawal by Subject|0
4692518|NCT02584257|7603248|FG008|Period 1|Withdrawal by Subject|0
4692519|NCT02584257|7603240|FG000|Period 2|Physician Decision|1
4692520|NCT02584257|7603241|FG001|Period 2|Physician Decision|0
4692521|NCT02584257|7603242|FG002|Period 2|Physician Decision|0
4692522|NCT02584257|7603243|FG003|Period 2|Physician Decision|0
4692523|NCT02584257|7603244|FG004|Period 2|Physician Decision|0
4692524|NCT02584257|7603245|FG005|Period 2|Physician Decision|0
4692525|NCT02584257|7603246|FG006|Period 2|Physician Decision|0
4692526|NCT02584257|7603247|FG007|Period 2|Physician Decision|0
4692527|NCT02584257|7603248|FG008|Period 2|Physician Decision|0
4692528|NCT02584257|7603240|FG000|Period 2|Adverse Event|0
4692529|NCT02584257|7603241|FG001|Period 2|Adverse Event|1
4692530|NCT02584257|7603242|FG002|Period 2|Adverse Event|0
4692531|NCT02584257|7603243|FG003|Period 2|Adverse Event|0
4692532|NCT02584257|7603244|FG004|Period 2|Adverse Event|0
4692533|NCT02584257|7603245|FG005|Period 2|Adverse Event|0
4692534|NCT02584257|7603246|FG006|Period 2|Adverse Event|0
4692535|NCT02584257|7603247|FG007|Period 2|Adverse Event|0
4692536|NCT02584257|7603248|FG008|Period 2|Adverse Event|0
4692537|NCT02584452|7603262|FG000|Overall Study|Physician Decision|1
4578969|NCT01434654|7421045|FG001|Overall Study|Lost to Follow-up|0
4578970|NCT01434667|7421055|FG000|Overall Study|Lost to Follow-up|5
4578971|NCT01434667|7421056|FG001|Overall Study|Lost to Follow-up|10
4578972|NCT01434680|7421066|FG000|Overall Study|Withdrawal by Subject|1
4578973|NCT01434680|7421067|FG001|Overall Study|Withdrawal by Subject|0
4578974|NCT01434680|7421068|FG002|Overall Study|Withdrawal by Subject|2
4578975|NCT01434680|7421069|FG003|Overall Study|Withdrawal by Subject|0
4578976|NCT01434680|7421066|FG000|Overall Study|Lost to Follow-up|1
4578977|NCT01434680|7421067|FG001|Overall Study|Lost to Follow-up|1
4578978|NCT01434680|7421068|FG002|Overall Study|Lost to Follow-up|0
4578979|NCT01434680|7421069|FG003|Overall Study|Lost to Follow-up|0
4578980|NCT01434680|7421066|FG000|Overall Study|Protocol Violation|1
4578981|NCT01434680|7421067|FG001|Overall Study|Protocol Violation|1
4578982|NCT01434680|7421068|FG002|Overall Study|Protocol Violation|0
4692538|NCT02584452|7603263|FG001|Overall Study|Physician Decision|1
4692539|NCT02584452|7603262|FG000|Overall Study|Lost to Follow-up|1
4692540|NCT02584452|7603263|FG001|Overall Study|Lost to Follow-up|1
4692541|NCT02584504|7603273|FG000|Double-blind Treatment|Participant withdrew consent|0
4692542|NCT02584504|7603274|FG001|Double-blind Treatment|Participant withdrew consent|0
4692543|NCT02584504|7603275|FG002|Double-blind Treatment|Participant withdrew consent|1
4578983|NCT01434680|7421069|FG003|Overall Study|Protocol Violation|0
4578984|NCT01434693|7421083|FG000|Overall Study|Adverse Event|1
4578985|NCT01434693|7421084|FG001|Overall Study|Adverse Event|0
4578986|NCT01434693|7421085|FG002|Overall Study|Adverse Event|0
4578987|NCT01434693|7421086|FG003|Overall Study|Adverse Event|0
4578988|NCT01434693|7421083|FG000|Overall Study|Withdrawal by Subject|1
4578989|NCT01434693|7421084|FG001|Overall Study|Withdrawal by Subject|0
4578990|NCT01434693|7421085|FG002|Overall Study|Withdrawal by Subject|1
4578991|NCT01434693|7421086|FG003|Overall Study|Withdrawal by Subject|1
4578992|NCT01434693|7421083|FG000|Overall Study|Lost to Follow-up|1
4578993|NCT01434693|7421084|FG001|Overall Study|Lost to Follow-up|0
4578994|NCT01434693|7421085|FG002|Overall Study|Lost to Follow-up|0
4578995|NCT01434693|7421086|FG003|Overall Study|Lost to Follow-up|0
4578996|NCT01434810|7421098|FG000|Overall Study|Did not receive treatment|11
4578997|NCT01434810|7421099|FG001|Overall Study|Did not receive treatment|3
4578998|NCT01434810|7421098|FG000|Overall Study|Missing data/received <5hr phototherapy|12
4578999|NCT01434810|7421099|FG001|Overall Study|Missing data/received <5hr phototherapy|7
4579000|NCT01434823|7421107|FG000|Overall Study|Incomplete data in medical record|4
4579001|NCT01434823|7421108|FG001|Overall Study|Incomplete data in medical record|7
4579002|NCT01435018|7421118|FG000|Overall Study|Death|37
4579003|NCT01435018|7421119|FG001|Overall Study|Death|18
4579004|NCT01435018|7421120|FG002|Overall Study|Death|25
4692544|NCT02584504|7603273|FG000|Double-blind Treatment|Adverse Event|0
4692545|NCT02584504|7603274|FG001|Double-blind Treatment|Adverse Event|1
4692546|NCT02584504|7603275|FG002|Double-blind Treatment|Adverse Event|0
4692547|NCT02584504|7603273|FG000|Double-blind Treatment|Family Matter|0
4692548|NCT02584504|7603274|FG001|Double-blind Treatment|Family Matter|1
4692549|NCT02584504|7603275|FG002|Double-blind Treatment|Family Matter|0
4692550|NCT02584504|7603273|FG000|Open-label Treatment|Participant withdrew consent|0
4692551|NCT02584504|7603274|FG001|Open-label Treatment|Participant withdrew consent|0
4692552|NCT02584504|7603275|FG002|Open-label Treatment|Participant withdrew consent|4
4692553|NCT02584504|7603273|FG000|Open-label Treatment|Adverse Event|2
4692554|NCT02584504|7603274|FG001|Open-label Treatment|Adverse Event|2
4692555|NCT02584504|7603275|FG002|Open-label Treatment|Adverse Event|3
4692556|NCT02584504|7603273|FG000|Open-label Treatment|Physician Decision|0
4692557|NCT02584504|7603274|FG001|Open-label Treatment|Physician Decision|1
4692558|NCT02584504|7603275|FG002|Open-label Treatment|Physician Decision|0
4692559|NCT02584504|7603273|FG000|Open-label Treatment|Entered but not treated|0
4692560|NCT02584504|7603274|FG001|Open-label Treatment|Entered but not treated|1
4692561|NCT02584504|7603275|FG002|Open-label Treatment|Entered but not treated|1
4692562|NCT02584660|7603293|FG000|Overall Study|Adverse Event|4
4692563|NCT02584660|7603294|FG001|Overall Study|Adverse Event|0
4692564|NCT02584660|7603293|FG000|Overall Study|Lost to Follow-up|3
4692565|NCT02584660|7603294|FG001|Overall Study|Lost to Follow-up|4
4692566|NCT02584660|7603293|FG000|Overall Study|Protocol Violation|0
4692567|NCT02584660|7603294|FG001|Overall Study|Protocol Violation|1
4692568|NCT02584660|7603293|FG000|Overall Study|Withdrawal by Subject|0
4692569|NCT02584660|7603294|FG001|Overall Study|Withdrawal by Subject|2
4692570|NCT02584660|7603293|FG000|Overall Study|Other|0
4692571|NCT02584660|7603294|FG001|Overall Study|Other|1
4692572|NCT02584855|7603336|FG000|Open-Label Treatment Period|Lack of Efficacy|61
4692573|NCT02584855|7603337|FG001|Open-Label Treatment Period|Lack of Efficacy|0
4692574|NCT02584855|7603338|FG002|Open-Label Treatment Period|Lack of Efficacy|0
4692575|NCT02584855|7603339|FG003|Open-Label Treatment Period|Lack of Efficacy|0
4692576|NCT02584855|7603340|FG004|Open-Label Treatment Period|Lack of Efficacy|0
4692577|NCT02584855|7603341|FG005|Open-Label Treatment Period|Lack of Efficacy|0
4692578|NCT02584855|7603336|FG000|Open-Label Treatment Period|Withdrawal by Subject|21
4692579|NCT02584855|7603337|FG001|Open-Label Treatment Period|Withdrawal by Subject|0
4692580|NCT02584855|7603338|FG002|Open-Label Treatment Period|Withdrawal by Subject|0
4692581|NCT02584855|7603339|FG003|Open-Label Treatment Period|Withdrawal by Subject|0
4692582|NCT02584855|7603340|FG004|Open-Label Treatment Period|Withdrawal by Subject|0
4692583|NCT02584855|7603341|FG005|Open-Label Treatment Period|Withdrawal by Subject|0
4692584|NCT02584855|7603336|FG000|Open-Label Treatment Period|Adverse Event|14
4692585|NCT02584855|7603337|FG001|Open-Label Treatment Period|Adverse Event|0
4692586|NCT02584855|7603338|FG002|Open-Label Treatment Period|Adverse Event|0
4692587|NCT02584855|7603339|FG003|Open-Label Treatment Period|Adverse Event|0
4692588|NCT02584855|7603340|FG004|Open-Label Treatment Period|Adverse Event|0
4692589|NCT02584855|7603341|FG005|Open-Label Treatment Period|Adverse Event|0
4692590|NCT02584855|7603336|FG000|Open-Label Treatment Period|Death|2
4692591|NCT02584855|7603337|FG001|Open-Label Treatment Period|Death|0
4692592|NCT02584855|7603338|FG002|Open-Label Treatment Period|Death|0
4692593|NCT02584855|7603339|FG003|Open-Label Treatment Period|Death|0
4692594|NCT02584855|7603340|FG004|Open-Label Treatment Period|Death|0
4579005|NCT01435018|7421118|FG000|Overall Study|Site is closing|4
4579006|NCT01435018|7421119|FG001|Overall Study|Site is closing|9
4579007|NCT01435018|7421120|FG002|Overall Study|Site is closing|7
4692595|NCT02584855|7603341|FG005|Open-Label Treatment Period|Death|0
4692596|NCT02584855|7603336|FG000|Open-Label Treatment Period|Lost to Follow-up|1
4692597|NCT02584855|7603337|FG001|Open-Label Treatment Period|Lost to Follow-up|0
4692598|NCT02584855|7603338|FG002|Open-Label Treatment Period|Lost to Follow-up|0
4692599|NCT02584855|7603339|FG003|Open-Label Treatment Period|Lost to Follow-up|0
4579008|NCT01435018|7421118|FG000|Overall Study|Withdrew consent|0
4579009|NCT01435018|7421119|FG001|Overall Study|Withdrew consent|3
4579010|NCT01435018|7421120|FG002|Overall Study|Withdrew consent|1
4579011|NCT01435018|7421118|FG000|Overall Study|Not willing to adhere to requirements|0
4579012|NCT01435018|7421119|FG001|Overall Study|Not willing to adhere to requirements|2
4579013|NCT01435018|7421120|FG002|Overall Study|Not willing to adhere to requirements|3
4579014|NCT01435018|7421118|FG000|Overall Study|Not able to get to clinic|2
4579015|NCT01435018|7421119|FG001|Overall Study|Not able to get to clinic|0
4579016|NCT01435018|7421120|FG002|Overall Study|Not able to get to clinic|2
4579017|NCT01435018|7421118|FG000|Overall Study|Severe debilitation, unable to continue|0
4579018|NCT01435018|7421119|FG001|Overall Study|Severe debilitation, unable to continue|0
4579019|NCT01435018|7421120|FG002|Overall Study|Severe debilitation, unable to continue|1
4579020|NCT01435018|7421118|FG000|Overall Study|Unable to contact participant/parent|1
4579021|NCT01435018|7421119|FG001|Overall Study|Unable to contact participant/parent|1
4579022|NCT01435018|7421120|FG002|Overall Study|Unable to contact participant/parent|1
4579023|NCT01435018|7421118|FG000|Overall Study|Enrollment Violation|0
4579024|NCT01435018|7421119|FG001|Overall Study|Enrollment Violation|1
4579025|NCT01435018|7421120|FG002|Overall Study|Enrollment Violation|0
4579026|NCT01435018|7421118|FG000|Overall Study|Never started chemotherapy|3
4579027|NCT01435018|7421119|FG001|Overall Study|Never started chemotherapy|0
4579028|NCT01435018|7421120|FG002|Overall Study|Never started chemotherapy|1
4579029|NCT01435031|7421130|FG000|ITT at 1 Month|Withdrawal by Subject|1
4579030|NCT01435031|7421130|FG000|ITT at 1 Month|Death|1
4579031|NCT01435031|7421130|FG000|ITT at 1 Month|Lost to Follow-up|4
4579032|NCT01435031|7421130|FG000|ITT at 6 Months|Death|2
4579033|NCT01435031|7421130|FG000|ITT at 6 Months|Lost to Follow-up|3
4579034|NCT01435031|7421130|FG000|ITT at 1 Year|Death|1
4692600|NCT02584855|7603340|FG004|Open-Label Treatment Period|Lost to Follow-up|0
4692601|NCT02584855|7603341|FG005|Open-Label Treatment Period|Lost to Follow-up|0
4692602|NCT02584855|7603336|FG000|Open-Label Treatment Period|Protocol Violation|1
4692603|NCT02584855|7603337|FG001|Open-Label Treatment Period|Protocol Violation|0
4692604|NCT02584855|7603338|FG002|Open-Label Treatment Period|Protocol Violation|0
4692605|NCT02584855|7603339|FG003|Open-Label Treatment Period|Protocol Violation|0
4692606|NCT02584855|7603340|FG004|Open-Label Treatment Period|Protocol Violation|0
4692607|NCT02584855|7603341|FG005|Open-Label Treatment Period|Protocol Violation|0
4692608|NCT02584855|7603336|FG000|Open-Label Treatment Period|No PI Available|2
4692609|NCT02584855|7603337|FG001|Open-Label Treatment Period|No PI Available|0
4692610|NCT02584855|7603338|FG002|Open-Label Treatment Period|No PI Available|0
4692611|NCT02584855|7603339|FG003|Open-Label Treatment Period|No PI Available|0
4692612|NCT02584855|7603340|FG004|Open-Label Treatment Period|No PI Available|0
4692613|NCT02584855|7603341|FG005|Open-Label Treatment Period|No PI Available|0
4692614|NCT02584855|7603336|FG000|Open-Label Treatment Period|Sponsor Decision|1
4692615|NCT02584855|7603337|FG001|Open-Label Treatment Period|Sponsor Decision|0
4692616|NCT02584855|7603338|FG002|Open-Label Treatment Period|Sponsor Decision|0
4692617|NCT02584855|7603339|FG003|Open-Label Treatment Period|Sponsor Decision|0
4692618|NCT02584855|7603340|FG004|Open-Label Treatment Period|Sponsor Decision|0
4692619|NCT02584855|7603341|FG005|Open-Label Treatment Period|Sponsor Decision|0
4692620|NCT02584855|7603336|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0
4692621|NCT02584855|7603337|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0
4692622|NCT02584855|7603338|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2
4692623|NCT02584855|7603339|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0
4692624|NCT02584855|7603340|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0
4692625|NCT02584855|7603341|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0
4692626|NCT02584855|7603336|FG000|Double-Blind Withdrawal Period|Adverse Event|0
4692627|NCT02584855|7603337|FG001|Double-Blind Withdrawal Period|Adverse Event|4
4692628|NCT02584855|7603338|FG002|Double-Blind Withdrawal Period|Adverse Event|0
4692629|NCT02584855|7603339|FG003|Double-Blind Withdrawal Period|Adverse Event|1
4692630|NCT02584855|7603340|FG004|Double-Blind Withdrawal Period|Adverse Event|0
4692631|NCT02584855|7603341|FG005|Double-Blind Withdrawal Period|Adverse Event|0
4692632|NCT02584855|7603336|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0
4692633|NCT02584855|7603337|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10
4692634|NCT02584855|7603338|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0
4692635|NCT02584855|7603339|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0
4692636|NCT02584855|7603340|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0
4692637|NCT02584855|7603341|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0
4692638|NCT02584855|7603336|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
4692639|NCT02584855|7603337|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1
4692640|NCT02584855|7603338|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
4692641|NCT02584855|7603339|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
4692642|NCT02584855|7603340|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
4692643|NCT02584855|7603341|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
4692644|NCT02584855|7603336|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0
4579035|NCT01435031|7421130|FG000|ITT at 1 Year|Withdrawal by Subject|2
4579036|NCT01435031|7421130|FG000|ITT at 1 Year|Lost to Follow-up|6
4579037|NCT01435031|7421130|FG000|ITT at 2 Years|Death|7
4579038|NCT01435031|7421130|FG000|ITT at 2 Years|Withdrawal by Subject|2
4579039|NCT01435031|7421130|FG000|ITT at 2 Years|Lost to Follow-up|4
4579040|NCT01435031|7421130|FG000|ITT at 3 Years|Death|5
4579041|NCT01435031|7421130|FG000|ITT at 3 Years|Withdrawal by Subject|2
4579042|NCT01435031|7421130|FG000|ITT at 3 Years|Lost to Follow-up|4
4579043|NCT01435031|7421130|FG000|ITT at 4 Years|Death|4
4579044|NCT01435031|7421130|FG000|ITT at 4 Years|Withdrawal by Subject|2
4579045|NCT01435031|7421130|FG000|ITT at 4 Years|Lost to Follow-up|1
4579046|NCT01435122|7421134|FG000|Overall Study|Early withdrawal due to toxicity|8
4579047|NCT01435265|7421144|FG000|Overall Study|Lost to Follow-up|0
4579048|NCT01435265|7421145|FG001|Overall Study|Lost to Follow-up|1
4579049|NCT01435356|7421162|FG000|Overall Study|Adverse Event|2
4579050|NCT01435356|7421163|FG001|Overall Study|Adverse Event|0
4579051|NCT01435356|7421162|FG000|Overall Study|Disease progression/recurrence|17
4579052|NCT01435356|7421163|FG001|Overall Study|Disease progression/recurrence|10
4579053|NCT01435356|7421162|FG000|Overall Study|Protocol Violation|0
4579054|NCT01435356|7421163|FG001|Overall Study|Protocol Violation|1
4579055|NCT01435356|7421162|FG000|Overall Study|Study Discontinuation, amendment 4|5
4579056|NCT01435356|7421163|FG001|Overall Study|Study Discontinuation, amendment 4|11
4579057|NCT01435356|7421162|FG000|Overall Study|Withdrawal by Subject|1
4579058|NCT01435356|7421163|FG001|Overall Study|Withdrawal by Subject|1
4579059|NCT01435356|7421162|FG000|Overall Study|Facial palsy|1
4579060|NCT01435356|7421163|FG001|Overall Study|Facial palsy|0
4579061|NCT01435356|7421162|FG000|Overall Study|IC withdrawal due to study cancellation|1
4579062|NCT01435356|7421163|FG001|Overall Study|IC withdrawal due to study cancellation|0
4579063|NCT01435356|7421162|FG000|Overall Study|Physician Decision|1
4579064|NCT01435356|7421163|FG001|Overall Study|Physician Decision|0
4579065|NCT01435356|7421162|FG000|Overall Study|Patient decision|3
4579066|NCT01435356|7421163|FG001|Overall Study|Patient decision|0
4579067|NCT01435356|7421162|FG000|Overall Study|Patient moved to another city|1
4579068|NCT01435356|7421163|FG001|Overall Study|Patient moved to another city|1
4579069|NCT01435382|7421173|FG000|Overall Study|Lost to Follow-up|1
4579070|NCT01435382|7421174|FG001|Overall Study|Lost to Follow-up|0
4579071|NCT01435382|7421175|FG002|Overall Study|Lost to Follow-up|1
4579072|NCT01435382|7421176|FG003|Overall Study|Lost to Follow-up|0
4579073|NCT01435382|7421173|FG000|Overall Study|Withdrawal by Subject|0
4579074|NCT01435382|7421174|FG001|Overall Study|Withdrawal by Subject|2
4579075|NCT01435382|7421175|FG002|Overall Study|Withdrawal by Subject|0
4579076|NCT01435382|7421176|FG003|Overall Study|Withdrawal by Subject|1
4579077|NCT01435460|7421194|FG000|Overall Study|Adverse Event|2
4579078|NCT01435460|7421195|FG001|Overall Study|Adverse Event|1
4579079|NCT01435460|7421194|FG000|Overall Study|Lost to Follow-up|6
4579080|NCT01435460|7421195|FG001|Overall Study|Lost to Follow-up|1
4579081|NCT01435460|7421194|FG000|Overall Study|Withdrawal by Subject|1
4579082|NCT01435460|7421195|FG001|Overall Study|Withdrawal by Subject|3
4579083|NCT01435460|7421194|FG000|Overall Study|Protocol Violation|0
4579084|NCT01435460|7421195|FG001|Overall Study|Protocol Violation|1
4579085|NCT01435460|7421194|FG000|Overall Study|Did not meet eligibility criteria|2
4579086|NCT01435460|7421195|FG001|Overall Study|Did not meet eligibility criteria|0
4579087|NCT01435577|7421212|FG000|Overall Study|Adverse Event|10
4579088|NCT01435577|7421213|FG001|Overall Study|Adverse Event|0
4579089|NCT01435577|7421212|FG000|Overall Study|Lack of Efficacy|7
4579090|NCT01435577|7421213|FG001|Overall Study|Lack of Efficacy|51
4579091|NCT01435577|7421212|FG000|Overall Study|Alternative treatment started|0
4579092|NCT01435577|7421213|FG001|Overall Study|Alternative treatment started|1
4579093|NCT01435616|7421234|FG000|Overall Study|Adverse Event|39
4579094|NCT01435616|7421235|FG001|Overall Study|Adverse Event|21
4579095|NCT01435616|7421234|FG000|Overall Study|Death|7
4579096|NCT01435616|7421235|FG001|Overall Study|Death|2
4579097|NCT01435616|7421234|FG000|Overall Study|Lost to Follow-up|22
4579098|NCT01435616|7421235|FG001|Overall Study|Lost to Follow-up|13
4579099|NCT01435616|7421234|FG000|Overall Study|Protocol Violation|16
4579100|NCT01435616|7421235|FG001|Overall Study|Protocol Violation|13
4579101|NCT01435616|7421234|FG000|Overall Study|Withdrawal by Subject|66
4579102|NCT01435616|7421235|FG001|Overall Study|Withdrawal by Subject|24
4579103|NCT01435616|7421234|FG000|Overall Study|Physician Decision|20
4579104|NCT01435616|7421235|FG001|Overall Study|Physician Decision|7
4579105|NCT01435616|7421234|FG000|Overall Study|Sponsor Decision|1
4579106|NCT01435616|7421235|FG001|Overall Study|Sponsor Decision|0
4579107|NCT01435655|7421243|FG000|Overall Study|Death|2
4692645|NCT02584855|7603337|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0
4579108|NCT01435655|7421243|FG000|Overall Study|Other|1
4579109|NCT01435759|7421252|FG000|Antidepressant Lead-in Phase|Adverse Event|40
4579110|NCT01435759|7421253|FG001|Antidepressant Lead-in Phase|Adverse Event|0
4579111|NCT01435759|7421254|FG002|Antidepressant Lead-in Phase|Adverse Event|0
4579112|NCT01435759|7421255|FG003|Antidepressant Lead-in Phase|Adverse Event|0
4579113|NCT01435759|7421256|FG004|Antidepressant Lead-in Phase|Adverse Event|0
4579114|NCT01435759|7421257|FG005|Antidepressant Lead-in Phase|Adverse Event|0
4579115|NCT01435759|7421252|FG000|Antidepressant Lead-in Phase|Protocol Violation|16
4579116|NCT01435759|7421253|FG001|Antidepressant Lead-in Phase|Protocol Violation|0
4579117|NCT01435759|7421254|FG002|Antidepressant Lead-in Phase|Protocol Violation|0
4579118|NCT01435759|7421255|FG003|Antidepressant Lead-in Phase|Protocol Violation|0
4579119|NCT01435759|7421256|FG004|Antidepressant Lead-in Phase|Protocol Violation|0
4579120|NCT01435759|7421257|FG005|Antidepressant Lead-in Phase|Protocol Violation|0
4579121|NCT01435759|7421252|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74
4579122|NCT01435759|7421253|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0
4579123|NCT01435759|7421254|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0
4579124|NCT01435759|7421255|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0
4579125|NCT01435759|7421256|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0
4579126|NCT01435759|7421257|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0
4579127|NCT01435759|7421252|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83
4579128|NCT01435759|7421253|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0
4579129|NCT01435759|7421254|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0
4579130|NCT01435759|7421255|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0
4579131|NCT01435759|7421256|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0
4579132|NCT01435759|7421257|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0
4579133|NCT01435759|7421252|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10
4579134|NCT01435759|7421253|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
4579135|NCT01435759|7421254|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
4579136|NCT01435759|7421255|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
4579137|NCT01435759|7421256|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
4579138|NCT01435759|7421257|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
4579139|NCT01435759|7421252|FG000|Antidepressant Lead-in Phase|Other|119
4579140|NCT01435759|7421253|FG001|Antidepressant Lead-in Phase|Other|0
4579141|NCT01435759|7421254|FG002|Antidepressant Lead-in Phase|Other|0
4579142|NCT01435759|7421255|FG003|Antidepressant Lead-in Phase|Other|0
4579143|NCT01435759|7421256|FG004|Antidepressant Lead-in Phase|Other|0
4579144|NCT01435759|7421257|FG005|Antidepressant Lead-in Phase|Other|0
4579145|NCT01435759|7421252|FG000|Double-blind Phase|Adverse Event|7
4579146|NCT01435759|7421253|FG001|Double-blind Phase|Adverse Event|0
4579147|NCT01435759|7421254|FG002|Double-blind Phase|Adverse Event|1
4579148|NCT01435759|7421255|FG003|Double-blind Phase|Adverse Event|1
4579149|NCT01435759|7421256|FG004|Double-blind Phase|Adverse Event|1
4579150|NCT01435759|7421257|FG005|Double-blind Phase|Adverse Event|3
4579151|NCT01435759|7421252|FG000|Double-blind Phase|Protocol Violation|2
4579152|NCT01435759|7421253|FG001|Double-blind Phase|Protocol Violation|0
4579153|NCT01435759|7421254|FG002|Double-blind Phase|Protocol Violation|1
4579154|NCT01435759|7421255|FG003|Double-blind Phase|Protocol Violation|2
4579155|NCT01435759|7421256|FG004|Double-blind Phase|Protocol Violation|0
4579156|NCT01435759|7421257|FG005|Double-blind Phase|Protocol Violation|1
4579157|NCT01435759|7421252|FG000|Double-blind Phase|Withdrawal by Subject|17
4579158|NCT01435759|7421253|FG001|Double-blind Phase|Withdrawal by Subject|4
4579159|NCT01435759|7421254|FG002|Double-blind Phase|Withdrawal by Subject|3
4579160|NCT01435759|7421255|FG003|Double-blind Phase|Withdrawal by Subject|4
4579161|NCT01435759|7421256|FG004|Double-blind Phase|Withdrawal by Subject|2
4579162|NCT01435759|7421257|FG005|Double-blind Phase|Withdrawal by Subject|2
4579163|NCT01435759|7421252|FG000|Double-blind Phase|Lost to Follow-up|31
4579164|NCT01435759|7421253|FG001|Double-blind Phase|Lost to Follow-up|1
4579165|NCT01435759|7421254|FG002|Double-blind Phase|Lost to Follow-up|2
4579166|NCT01435759|7421255|FG003|Double-blind Phase|Lost to Follow-up|0
4579167|NCT01435759|7421256|FG004|Double-blind Phase|Lost to Follow-up|3
4579168|NCT01435759|7421257|FG005|Double-blind Phase|Lost to Follow-up|3
4579169|NCT01435759|7421252|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1
4579170|NCT01435759|7421253|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
4579171|NCT01435759|7421254|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
4579172|NCT01435759|7421255|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
4579173|NCT01435759|7421256|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3
4579174|NCT01435759|7421257|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
4579175|NCT01435759|7421252|FG000|Double-blind Phase|Other|8
4579176|NCT01435759|7421253|FG001|Double-blind Phase|Other|2
4579177|NCT01435759|7421254|FG002|Double-blind Phase|Other|0
4579178|NCT01435759|7421255|FG003|Double-blind Phase|Other|2
4579179|NCT01435759|7421256|FG004|Double-blind Phase|Other|0
4692646|NCT02584855|7603338|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0
4692647|NCT02584855|7603339|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0
4692648|NCT02584855|7603340|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7
4692649|NCT02584855|7603341|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0
4692650|NCT02584855|7603336|FG000|Post Treatment Follow-up Period|Protocol Violation|0
4692651|NCT02584855|7603337|FG001|Post Treatment Follow-up Period|Protocol Violation|0
4692652|NCT02584855|7603338|FG002|Post Treatment Follow-up Period|Protocol Violation|0
4692653|NCT02584855|7603339|FG003|Post Treatment Follow-up Period|Protocol Violation|0
4692654|NCT02584855|7603340|FG004|Post Treatment Follow-up Period|Protocol Violation|1
4692655|NCT02584855|7603341|FG005|Post Treatment Follow-up Period|Protocol Violation|0
4692656|NCT02584959|7603366|FG000|Period 1|Withdrawn from study|3
4692657|NCT02584959|7603367|FG001|Period 1|Withdrawn from study|4
4579180|NCT01435759|7421257|FG005|Double-blind Phase|Other|0
4579181|NCT01435772|7421272|FG000|Overall Study|Adverse Event|1
4579182|NCT01435772|7421273|FG001|Overall Study|Adverse Event|0
4579183|NCT01435772|7421274|FG002|Overall Study|Adverse Event|2
4579184|NCT01435772|7421272|FG000|Overall Study|Withdrawal by Subject|0
4579185|NCT01435772|7421273|FG001|Overall Study|Withdrawal by Subject|1
4579186|NCT01435772|7421274|FG002|Overall Study|Withdrawal by Subject|3
4579187|NCT01435772|7421272|FG000|Overall Study|Other - study termination|2
4579188|NCT01435772|7421273|FG001|Overall Study|Other - study termination|2
4579189|NCT01435772|7421274|FG002|Overall Study|Other - study termination|10
4579190|NCT01435798|7421283|FG000|Overall Study|Withdrawal by Subject|1
4579191|NCT01435928|7421302|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83
4579192|NCT01435928|7421303|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0
4579193|NCT01435928|7421304|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0
4579194|NCT01435928|7421302|FG000|Open Label Phase - up to 24 Weeks|Death|1
4579195|NCT01435928|7421303|FG001|Open Label Phase - up to 24 Weeks|Death|0
4579196|NCT01435928|7421304|FG002|Open Label Phase - up to 24 Weeks|Death|0
4579197|NCT01435928|7421302|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46
4579198|NCT01435928|7421303|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0
4579199|NCT01435928|7421304|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0
4579200|NCT01435928|7421302|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60
4579201|NCT01435928|7421303|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0
4579202|NCT01435928|7421304|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0
4579203|NCT01435928|7421302|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39
4579204|NCT01435928|7421303|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0
4579205|NCT01435928|7421304|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0
4579206|NCT01435928|7421302|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96
4579207|NCT01435928|7421303|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0
4579208|NCT01435928|7421304|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0
4579209|NCT01435928|7421302|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44
4579210|NCT01435928|7421303|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0
4579211|NCT01435928|7421304|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0
4579212|NCT01435928|7421302|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6
4579213|NCT01435928|7421303|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0
4579214|NCT01435928|7421304|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0
4579215|NCT01435928|7421302|FG000|Open Label Phase - up to 24 Weeks|Administrative|14
4579216|NCT01435928|7421303|FG001|Open Label Phase - up to 24 Weeks|Administrative|0
4579217|NCT01435928|7421304|FG002|Open Label Phase - up to 24 Weeks|Administrative|0
4579218|NCT01435928|7421302|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0
4579219|NCT01435928|7421303|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3
4579220|NCT01435928|7421304|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1
4579221|NCT01435928|7421302|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0
4579222|NCT01435928|7421303|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2
4579223|NCT01435928|7421304|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5
4579224|NCT01435928|7421302|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0
4579225|NCT01435928|7421303|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11
4579226|NCT01435928|7421304|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4
4579227|NCT01435928|7421302|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0
4579228|NCT01435928|7421303|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5
4579229|NCT01435928|7421304|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12
4579230|NCT01435928|7421302|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0
4579231|NCT01435928|7421303|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47
4579232|NCT01435928|7421304|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39
4579233|NCT01435928|7421302|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0
4579234|NCT01435928|7421303|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43
4579235|NCT01435928|7421304|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58
4579236|NCT01435928|7421302|FG000|Double Blind Phase - 28 Weeks|Administrative|0
4579237|NCT01435928|7421303|FG001|Double Blind Phase - 28 Weeks|Administrative|5
4579238|NCT01435928|7421304|FG002|Double Blind Phase - 28 Weeks|Administrative|2
4579239|NCT01436071|7421332|FG000|Overall Study|Adverse Event|1
4579240|NCT01436071|7421333|FG001|Overall Study|Adverse Event|0
4579241|NCT01436071|7421332|FG000|Overall Study|Lack of Efficacy|16
4579242|NCT01436071|7421333|FG001|Overall Study|Lack of Efficacy|7
4579243|NCT01436071|7421332|FG000|Overall Study|Protocol Violation|0
4579244|NCT01436071|7421333|FG001|Overall Study|Protocol Violation|1
4579245|NCT01436071|7421332|FG000|Overall Study|Lost to Follow-up|3
4579246|NCT01436071|7421333|FG001|Overall Study|Lost to Follow-up|1
4579247|NCT01436071|7421332|FG000|Overall Study|Physician Decision|1
4692658|NCT02584959|7603368|FG002|Period 1|Withdrawn from study|0
4692659|NCT02584959|7603366|FG000|Period 2|Withdrawn from study|6
4692660|NCT02584959|7603367|FG001|Period 2|Withdrawn from study|1
4692661|NCT02584959|7603368|FG002|Period 2|Withdrawn from study|2
4692662|NCT02585713|7603414|FG000|Overall Study|Withdrew prior to treatment|2
4692663|NCT02585713|7603415|FG001|Overall Study|Withdrew prior to treatment|7
4692664|NCT02585713|7603414|FG000|Overall Study|Other|3
4692665|NCT02585713|7603415|FG001|Overall Study|Other|1
4692666|NCT02585778|7603425|FG000|Overall Study|Adverse Event|17
4692667|NCT02585778|7603426|FG001|Overall Study|Adverse Event|4
4692668|NCT02585778|7603425|FG000|Overall Study|Participant did not wish to continue|9
4692669|NCT02585778|7603426|FG001|Overall Study|Participant did not wish to continue|4
4579248|NCT01436071|7421333|FG001|Overall Study|Physician Decision|0
4579249|NCT01436071|7421332|FG000|Overall Study|Withdrawal by Subject|2
4579250|NCT01436071|7421333|FG001|Overall Study|Withdrawal by Subject|2
4579251|NCT01436071|7421332|FG000|Overall Study|Did Not Receive Trial Medication|3
4579252|NCT01436071|7421333|FG001|Overall Study|Did Not Receive Trial Medication|3
4579253|NCT01436110|7421342|FG000|Overall Study|Lack of Efficacy|23
4579254|NCT01436110|7421343|FG001|Overall Study|Lack of Efficacy|14
4579255|NCT01436110|7421344|FG002|Overall Study|Lack of Efficacy|9
4579256|NCT01436110|7421342|FG000|Overall Study|Withdrawal by Subject|6
4579257|NCT01436110|7421343|FG001|Overall Study|Withdrawal by Subject|8
4579258|NCT01436110|7421344|FG002|Overall Study|Withdrawal by Subject|4
4579259|NCT01436110|7421342|FG000|Overall Study|Adverse Event|2
4579260|NCT01436110|7421343|FG001|Overall Study|Adverse Event|1
4579261|NCT01436110|7421344|FG002|Overall Study|Adverse Event|2
4579262|NCT01436110|7421342|FG000|Overall Study|Physician Decision|3
4579263|NCT01436110|7421343|FG001|Overall Study|Physician Decision|1
4692670|NCT02585778|7603425|FG000|Overall Study|Poor compliance to study protocol|0
4692671|NCT02585778|7603426|FG001|Overall Study|Poor compliance to study protocol|2
4692672|NCT02585778|7603425|FG000|Overall Study|Death|0
4692673|NCT02585778|7603426|FG001|Overall Study|Death|1
4692674|NCT02585778|7603425|FG000|Overall Study|Randomized but not treated|1
4692675|NCT02585778|7603426|FG001|Overall Study|Randomized but not treated|2
4692676|NCT02585778|7603425|FG000|Overall Study|Other than specified above|6
4692677|NCT02585778|7603426|FG001|Overall Study|Other than specified above|2
4692678|NCT02585830|7603436|FG000|Overall Study|Withdrawal by Subject|3
4692679|NCT02585934|7603463|FG000|Overall Study|Lost to Follow-up|2
4692680|NCT02585934|7603464|FG001|Overall Study|Lost to Follow-up|2
4692681|NCT02585934|7603463|FG000|Overall Study|Protocol Violation|14
4692682|NCT02585934|7603464|FG001|Overall Study|Protocol Violation|11
4692683|NCT02585934|7603463|FG000|Overall Study|Adverse Event|21
4692684|NCT02585934|7603464|FG001|Overall Study|Adverse Event|22
4692685|NCT02585934|7603463|FG000|Overall Study|Physician Decision|3
4692686|NCT02585934|7603464|FG001|Overall Study|Physician Decision|2
4692687|NCT02585934|7603463|FG000|Overall Study|Withdrawal by Subject|7
4692688|NCT02585934|7603464|FG001|Overall Study|Withdrawal by Subject|21
4692689|NCT02585934|7603463|FG000|Overall Study|Lack of Efficacy|2
4692690|NCT02585934|7603464|FG001|Overall Study|Lack of Efficacy|1
4692691|NCT02585934|7603463|FG000|Overall Study|Death|2
4692692|NCT02585934|7603464|FG001|Overall Study|Death|0
4692693|NCT02585934|7603463|FG000|Overall Study|Caregiver Withdrew Consent|7
4692694|NCT02585934|7603464|FG001|Overall Study|Caregiver Withdrew Consent|7
4692695|NCT02585934|7603463|FG000|Overall Study|Sponsor Termination|1
4692696|NCT02585934|7603464|FG001|Overall Study|Sponsor Termination|2
4692697|NCT02585934|7603463|FG000|Overall Study|Another Reason|10
4692698|NCT02585934|7603464|FG001|Overall Study|Another Reason|5
4692699|NCT02585960|7603478|FG000|PK/Safety Assessment Period|Physician Decision|0
4692700|NCT02585960|7603479|FG001|PK/Safety Assessment Period|Physician Decision|1
4692701|NCT02585960|7603480|FG002|PK/Safety Assessment Period|Physician Decision|0
4692702|NCT02585960|7603478|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1
4692703|NCT02585960|7603479|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2
4692704|NCT02585960|7603480|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5
4692705|NCT02585960|7603478|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0
4692706|NCT02585960|7603479|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2
4692707|NCT02585960|7603480|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0
4692708|NCT02585960|7603478|FG000|PK/Safety Assessment Period|Other|4
4692709|NCT02585960|7603479|FG001|PK/Safety Assessment Period|Other|4
4692710|NCT02585960|7603480|FG002|PK/Safety Assessment Period|Other|0
4692711|NCT02585960|7603478|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0
4692712|NCT02585960|7603479|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1
4692713|NCT02585960|7603480|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0
4692714|NCT02585960|7603478|FG000|PK/Safety Assessment Period|Screen Failure|0
4692715|NCT02585960|7603479|FG001|PK/Safety Assessment Period|Screen Failure|0
4692716|NCT02585960|7603480|FG002|PK/Safety Assessment Period|Screen Failure|1
4692717|NCT02585960|7603478|FG000|Prophylactic Treatment Period|Major protocol deviation|0
4692718|NCT02585960|7603479|FG001|Prophylactic Treatment Period|Major protocol deviation|4
4692719|NCT02585960|7603480|FG002|Prophylactic Treatment Period|Major protocol deviation|0
4692720|NCT02585960|7603478|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0
4692721|NCT02585960|7603479|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1
4692722|NCT02585960|7603480|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0
4692723|NCT02585999|7603491|FG000|Overall Study|Lost to Follow-up|1
4692724|NCT02585999|7603491|FG000|Overall Study|Protocol Violation|1
4692725|NCT02586012|7603496|FG000|Overall Study|Withdrawal by Subject|1
4692726|NCT02586012|7603497|FG001|Overall Study|Withdrawal by Subject|1
4692727|NCT02586012|7603498|FG002|Overall Study|Withdrawal by Subject|0
4692728|NCT02586012|7603499|FG003|Overall Study|Withdrawal by Subject|1
4692729|NCT02586012|7603500|FG004|Overall Study|Withdrawal by Subject|0
4692730|NCT02586012|7603501|FG005|Overall Study|Withdrawal by Subject|2
4692731|NCT02586012|7603496|FG000|Overall Study|Protocol Violation|0
4692732|NCT02586012|7603497|FG001|Overall Study|Protocol Violation|0
4692733|NCT02586012|7603498|FG002|Overall Study|Protocol Violation|0
4692734|NCT02586012|7603499|FG003|Overall Study|Protocol Violation|0
4579264|NCT01436110|7421344|FG002|Overall Study|Physician Decision|1
4579265|NCT01436110|7421342|FG000|Overall Study|Lost to Follow-up|1
4579266|NCT01436110|7421343|FG001|Overall Study|Lost to Follow-up|1
4579267|NCT01436110|7421344|FG002|Overall Study|Lost to Follow-up|3
4579268|NCT01436110|7421342|FG000|Overall Study|Protocol Violation|3
4579269|NCT01436110|7421343|FG001|Overall Study|Protocol Violation|1
4579270|NCT01436110|7421344|FG002|Overall Study|Protocol Violation|1
4579271|NCT01436110|7421342|FG000|Overall Study|Did Not Receive Trial Medication|1
4579272|NCT01436110|7421343|FG001|Overall Study|Did Not Receive Trial Medication|0
4579273|NCT01436110|7421344|FG002|Overall Study|Did Not Receive Trial Medication|3
4579274|NCT01436149|7421354|FG000|Antidepressant Lead-in Phase|Adverse Event|39
4579275|NCT01436149|7421355|FG001|Antidepressant Lead-in Phase|Adverse Event|0
4579276|NCT01436149|7421356|FG002|Antidepressant Lead-in Phase|Adverse Event|0
4579277|NCT01436149|7421354|FG000|Antidepressant Lead-in Phase|Protocol Violation|29
4579278|NCT01436149|7421355|FG001|Antidepressant Lead-in Phase|Protocol Violation|0
4579279|NCT01436149|7421356|FG002|Antidepressant Lead-in Phase|Protocol Violation|0
4579280|NCT01436149|7421354|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61
4579281|NCT01436149|7421355|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0
4579282|NCT01436149|7421356|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0
4579283|NCT01436149|7421354|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96
4579284|NCT01436149|7421355|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0
4579285|NCT01436149|7421356|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0
4579286|NCT01436149|7421354|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22
4579287|NCT01436149|7421355|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0
4579288|NCT01436149|7421356|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0
4692735|NCT02586012|7603500|FG004|Overall Study|Protocol Violation|0
4692736|NCT02586012|7603501|FG005|Overall Study|Protocol Violation|1
4692737|NCT02586012|7603496|FG000|Overall Study|study terminated|0
4692738|NCT02586012|7603497|FG001|Overall Study|study terminated|2
4692739|NCT02586012|7603498|FG002|Overall Study|study terminated|1
4692740|NCT02586012|7603499|FG003|Overall Study|study terminated|1
4692741|NCT02586012|7603500|FG004|Overall Study|study terminated|1
4692742|NCT02586012|7603501|FG005|Overall Study|study terminated|0
4692743|NCT02586064|7603512|FG000|Overall Study|Other Obligations|6
4692744|NCT02586064|7603513|FG001|Overall Study|Other Obligations|6
4692745|NCT02586064|7603512|FG000|Overall Study|Other|3
4692746|NCT02586064|7603513|FG001|Overall Study|Other|7
4692747|NCT02586064|7603512|FG000|Overall Study|Never Started|3
4692748|NCT02586064|7603513|FG001|Overall Study|Never Started|3
4692749|NCT02586064|7603512|FG000|Overall Study|Lost Interest|1
4692750|NCT02586064|7603513|FG001|Overall Study|Lost Interest|4
4692751|NCT02586064|7603512|FG000|Overall Study|Miscellaneous Life Issues|0
4692752|NCT02586064|7603513|FG001|Overall Study|Miscellaneous Life Issues|5
4692753|NCT02586064|7603512|FG000|Overall Study|Infrequent Attendance|2
4692754|NCT02586064|7603513|FG001|Overall Study|Infrequent Attendance|1
4692755|NCT02586064|7603512|FG000|Overall Study|Timed Out|2
4692756|NCT02586064|7603513|FG001|Overall Study|Timed Out|0
4692757|NCT02586064|7603512|FG000|Overall Study|AUD relapse|0
4692758|NCT02586064|7603513|FG001|Overall Study|AUD relapse|2
4692759|NCT02586064|7603512|FG000|Overall Study|Legal Issue|1
4692760|NCT02586064|7603513|FG001|Overall Study|Legal Issue|0
4692761|NCT02586077|7603522|FG000|Overall Study|Withdrawal by Subject|1
4692762|NCT02586077|7603522|FG000|Overall Study|Physician Decision|4
4692763|NCT02586077|7603522|FG000|Overall Study|Lost to Follow-up|3
4692764|NCT02586155|7603529|FG000|Overall Study|Adverse Event|2
4692765|NCT02586155|7603530|FG001|Overall Study|Adverse Event|3
4692766|NCT02586155|7603529|FG000|Overall Study|Withdrawal by Subject|31
4692767|NCT02586155|7603530|FG001|Overall Study|Withdrawal by Subject|24
4692768|NCT02586155|7603529|FG000|Overall Study|Lost to Follow-up|7
4692769|NCT02586155|7603530|FG001|Overall Study|Lost to Follow-up|13
4692770|NCT02586155|7603529|FG000|Overall Study|Death|61
4692771|NCT02586155|7603530|FG001|Overall Study|Death|72
4692772|NCT02586155|7603529|FG000|Overall Study|Other reasons|26
4692773|NCT02586155|7603530|FG001|Overall Study|Other reasons|15
4692774|NCT02586233|7603543|FG000|Overall Study|Randomized but did not receive treatment|0
4692775|NCT02586233|7603544|FG001|Overall Study|Randomized but did not receive treatment|1
4692776|NCT02586233|7603545|FG002|Overall Study|Randomized but did not receive treatment|0
4692777|NCT02586233|7603546|FG003|Overall Study|Randomized but did not receive treatment|0
4692778|NCT02586233|7603547|FG004|Overall Study|Randomized but did not receive treatment|0
4692779|NCT02586233|7603548|FG005|Overall Study|Randomized but did not receive treatment|2
4692780|NCT02586233|7603549|FG006|Overall Study|Randomized but did not receive treatment|2
4692781|NCT02586233|7603543|FG000|Overall Study|Death|0
4692782|NCT02586233|7603544|FG001|Overall Study|Death|1
4692783|NCT02586233|7603545|FG002|Overall Study|Death|0
4692784|NCT02586233|7603546|FG003|Overall Study|Death|0
4692785|NCT02586233|7603547|FG004|Overall Study|Death|2
4579289|NCT01436149|7421354|FG000|Antidepressant Lead-in Phase|Other|119
4692786|NCT02586233|7603548|FG005|Overall Study|Death|0
4692787|NCT02586233|7603549|FG006|Overall Study|Death|0
4692788|NCT02586415|7603571|FG000|Overall Study|Death|13
4692789|NCT02586415|7603572|FG001|Overall Study|Death|23
4692790|NCT02586415|7603571|FG000|Overall Study|Lost to Follow-up|1
4692791|NCT02586415|7603572|FG001|Overall Study|Lost to Follow-up|2
4579290|NCT01436149|7421355|FG001|Antidepressant Lead-in Phase|Other|0
4579291|NCT01436149|7421356|FG002|Antidepressant Lead-in Phase|Other|0
4579292|NCT01436149|7421354|FG000|Randomized Phase|Adverse Event|9
4579293|NCT01436149|7421355|FG001|Randomized Phase|Adverse Event|10
4579294|NCT01436149|7421356|FG002|Randomized Phase|Adverse Event|11
4579295|NCT01436149|7421354|FG000|Randomized Phase|Protocol Violation|4
4579296|NCT01436149|7421355|FG001|Randomized Phase|Protocol Violation|5
4579297|NCT01436149|7421356|FG002|Randomized Phase|Protocol Violation|0
4579298|NCT01436149|7421354|FG000|Randomized Phase|Withdrawal by Subject|16
4579299|NCT01436149|7421355|FG001|Randomized Phase|Withdrawal by Subject|10
4579300|NCT01436149|7421356|FG002|Randomized Phase|Withdrawal by Subject|10
4579301|NCT01436149|7421354|FG000|Randomized Phase|Lost to Follow-up|34
4579302|NCT01436149|7421355|FG001|Randomized Phase|Lost to Follow-up|5
4579303|NCT01436149|7421356|FG002|Randomized Phase|Lost to Follow-up|6
4579304|NCT01436149|7421354|FG000|Randomized Phase|Lack of Efficacy|0
4579305|NCT01436149|7421355|FG001|Randomized Phase|Lack of Efficacy|0
4579306|NCT01436149|7421356|FG002|Randomized Phase|Lack of Efficacy|1
4579307|NCT01436149|7421354|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2
4579308|NCT01436149|7421355|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3
4579309|NCT01436149|7421356|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3
4579310|NCT01436149|7421354|FG000|Randomized Phase|Other|12
4579311|NCT01436149|7421355|FG001|Randomized Phase|Other|5
4579312|NCT01436149|7421356|FG002|Randomized Phase|Other|11
4579313|NCT01436162|7421364|FG000|Single-blind Lead-in Phase|Adverse Event|26
4692792|NCT02586493|7603579|FG000|Overall Study|Adverse Event|4
4692793|NCT02586493|7603579|FG000|Overall Study|Protocol Violation|6
4692794|NCT02586493|7603579|FG000|Overall Study|Lost to Follow-up|1
4692795|NCT02586493|7603579|FG000|Overall Study|Withdrawal by Subject|1
4692796|NCT02586506|7603583|FG000|Overall Study|Protocol Violation|6
4692797|NCT02586506|7603583|FG000|Overall Study|Lost to Follow-up|1
4692798|NCT02586506|7603583|FG000|Overall Study|Other Reason|2
4692799|NCT02586727|7603589|FG000|Overall Study|Lost to Follow-up|1
4692800|NCT02586727|7603590|FG001|Overall Study|Lost to Follow-up|0
4692801|NCT02586805|7603600|FG000|Overall Study|Withdrawal by Subject|3
4692802|NCT02586805|7603601|FG001|Overall Study|Withdrawal by Subject|1
4692803|NCT02586805|7603602|FG002|Overall Study|Withdrawal by Subject|1
4692804|NCT02586805|7603603|FG003|Overall Study|Withdrawal by Subject|2
4692805|NCT02586805|7603600|FG000|Overall Study|Adverse Event|2
4692806|NCT02586805|7603601|FG001|Overall Study|Adverse Event|0
4692807|NCT02586805|7603602|FG002|Overall Study|Adverse Event|1
4692808|NCT02586805|7603603|FG003|Overall Study|Adverse Event|0
4692809|NCT02586805|7603600|FG000|Overall Study|Lost to Follow-up|0
4692810|NCT02586805|7603601|FG001|Overall Study|Lost to Follow-up|0
4692811|NCT02586805|7603602|FG002|Overall Study|Lost to Follow-up|1
4692812|NCT02586805|7603603|FG003|Overall Study|Lost to Follow-up|0
4692813|NCT02586805|7603600|FG000|Overall Study|Physician Decision|1
4692814|NCT02586805|7603601|FG001|Overall Study|Physician Decision|0
4692815|NCT02586805|7603602|FG002|Overall Study|Physician Decision|0
4692816|NCT02586805|7603603|FG003|Overall Study|Physician Decision|0
4692817|NCT02587065|7603637|FG000|Overall Study|Adverse Event|14
4692818|NCT02587065|7603637|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5
4692819|NCT02587065|7603637|FG000|Overall Study|Non-adherence to the Protocol|3
4692820|NCT02587065|7603637|FG000|Overall Study|Discontinuation of Study Medication|2
4692821|NCT02587065|7603637|FG000|Overall Study|Reason not Specified|3
4692822|NCT02587143|7603652|FG000|Overall Study|Adverse Event|1
4692823|NCT02587143|7603653|FG001|Overall Study|Adverse Event|0
4692824|NCT02587221|7603661|FG000|Overall Study|Adverse Event|3
4692825|NCT02587221|7603662|FG001|Overall Study|Adverse Event|3
4692826|NCT02587221|7603661|FG000|Overall Study|Death|33
4692827|NCT02587221|7603662|FG001|Overall Study|Death|34
4692828|NCT02587221|7603661|FG000|Overall Study|Withdrawal by Subject|66
4692829|NCT02587221|7603662|FG001|Overall Study|Withdrawal by Subject|61
4692830|NCT02587221|7603661|FG000|Overall Study|Lost to Follow-up|21
4692831|NCT02587221|7603662|FG001|Overall Study|Lost to Follow-up|19
4692832|NCT02587221|7603661|FG000|Overall Study|Protocol Violation|6
4692833|NCT02587221|7603662|FG001|Overall Study|Protocol Violation|5
4692834|NCT02587221|7603661|FG000|Overall Study|Other Reason or Unspecified|2
4692835|NCT02587221|7603662|FG001|Overall Study|Other Reason or Unspecified|1
4692836|NCT02587234|7603670|FG000|Overall Study|Withdrawal by Subject|1
4692837|NCT02587234|7603671|FG001|Overall Study|Withdrawal by Subject|1
4692838|NCT02587234|7603670|FG000|Overall Study|Lost to Follow-up|0
4692839|NCT02587234|7603671|FG001|Overall Study|Lost to Follow-up|2
4579314|NCT01436162|7421365|FG001|Single-blind Lead-in Phase|Adverse Event|0
4579315|NCT01436162|7421366|FG002|Single-blind Lead-in Phase|Adverse Event|0
4692840|NCT02587819|7603686|FG000|Overall Study|Adverse Event|1
4692841|NCT02587819|7603686|FG000|Overall Study|Lost to Follow-up|1
4692842|NCT02587962|7603696|FG000|Overall Study|Adverse Event|0
4692843|NCT02587962|7603697|FG001|Overall Study|Adverse Event|0
4692844|NCT02587962|7603698|FG002|Overall Study|Adverse Event|1
4692845|NCT02587962|7603699|FG003|Overall Study|Adverse Event|0
4692846|NCT02587962|7603700|FG004|Overall Study|Adverse Event|0
4692847|NCT02587962|7603696|FG000|Overall Study|Withdrawal by Subject|0
4692848|NCT02587962|7603697|FG001|Overall Study|Withdrawal by Subject|0
4692849|NCT02587962|7603698|FG002|Overall Study|Withdrawal by Subject|1
4692850|NCT02587962|7603699|FG003|Overall Study|Withdrawal by Subject|1
4579316|NCT01436162|7421364|FG000|Single-blind Lead-in Phase|Protocol Violation|24
4579317|NCT01436162|7421365|FG001|Single-blind Lead-in Phase|Protocol Violation|0
4579318|NCT01436162|7421366|FG002|Single-blind Lead-in Phase|Protocol Violation|0
4579319|NCT01436162|7421364|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69
4579320|NCT01436162|7421365|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0
4579321|NCT01436162|7421366|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0
4579322|NCT01436162|7421364|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43
4579323|NCT01436162|7421365|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0
4579324|NCT01436162|7421366|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0
4579325|NCT01436162|7421364|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13
4579326|NCT01436162|7421365|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
4579327|NCT01436162|7421366|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
4579328|NCT01436162|7421364|FG000|Single-blind Lead-in Phase|Other|107
4579329|NCT01436162|7421365|FG001|Single-blind Lead-in Phase|Other|0
4579330|NCT01436162|7421366|FG002|Single-blind Lead-in Phase|Other|0
4579331|NCT01436162|7421364|FG000|Randomized Phase|Adverse Event|1
4692851|NCT02587962|7603700|FG004|Overall Study|Withdrawal by Subject|4
4692852|NCT02587962|7603696|FG000|Overall Study|Radiological progression|2
4692853|NCT02587962|7603697|FG001|Overall Study|Radiological progression|2
4692854|NCT02587962|7603698|FG002|Overall Study|Radiological progression|2
4692855|NCT02587962|7603699|FG003|Overall Study|Radiological progression|5
4692856|NCT02587962|7603700|FG004|Overall Study|Radiological progression|10
4692857|NCT02587962|7603696|FG000|Overall Study|Clinical progression|0
4692858|NCT02587962|7603697|FG001|Overall Study|Clinical progression|1
4692859|NCT02587962|7603698|FG002|Overall Study|Clinical progression|2
4692860|NCT02587962|7603699|FG003|Overall Study|Clinical progression|0
4692861|NCT02587962|7603700|FG004|Overall Study|Clinical progression|1
4692862|NCT02588092|7603725|FG000|Overall Study|Death|4
4692863|NCT02588092|7603726|FG001|Overall Study|Death|3
4692864|NCT02588092|7603727|FG002|Overall Study|Death|3
4692865|NCT02588092|7603728|FG003|Overall Study|Death|3
4692866|NCT02588092|7603729|FG004|Overall Study|Death|2
4692867|NCT02588092|7603730|FG005|Overall Study|Death|2
4692868|NCT02588092|7603731|FG006|Overall Study|Death|2
4692869|NCT02588092|7603732|FG007|Overall Study|Death|1
4692870|NCT02588092|7603733|FG008|Overall Study|Death|5
4692871|NCT02588092|7603734|FG009|Overall Study|Death|2
4692872|NCT02588092|7603725|FG000|Overall Study|Withdrawal by Subject|0
4692873|NCT02588092|7603726|FG001|Overall Study|Withdrawal by Subject|0
4692874|NCT02588092|7603727|FG002|Overall Study|Withdrawal by Subject|0
4692875|NCT02588092|7603728|FG003|Overall Study|Withdrawal by Subject|0
4692876|NCT02588092|7603729|FG004|Overall Study|Withdrawal by Subject|0
4692877|NCT02588092|7603730|FG005|Overall Study|Withdrawal by Subject|1
4692878|NCT02588092|7603731|FG006|Overall Study|Withdrawal by Subject|1
4692879|NCT02588092|7603732|FG007|Overall Study|Withdrawal by Subject|2
4692880|NCT02588092|7603733|FG008|Overall Study|Withdrawal by Subject|0
4692881|NCT02588092|7603734|FG009|Overall Study|Withdrawal by Subject|0
4692882|NCT02588092|7603725|FG000|Overall Study|Started Another Treatment|0
4692883|NCT02588092|7603726|FG001|Overall Study|Started Another Treatment|0
4692884|NCT02588092|7603727|FG002|Overall Study|Started Another Treatment|0
4692885|NCT02588092|7603728|FG003|Overall Study|Started Another Treatment|0
4692886|NCT02588092|7603729|FG004|Overall Study|Started Another Treatment|1
4692887|NCT02588092|7603730|FG005|Overall Study|Started Another Treatment|0
4692888|NCT02588092|7603731|FG006|Overall Study|Started Another Treatment|0
4692889|NCT02588092|7603732|FG007|Overall Study|Started Another Treatment|1
4692890|NCT02588092|7603733|FG008|Overall Study|Started Another Treatment|0
4770424|NCT03740919|7746732|FG002|Treatment Period|Not Completing Diary|1
4770425|NCT03740919|7746733|FG003|Treatment Period|Not Completing Diary|0
4770426|NCT03740919|7746730|FG000|Treatment Period|Insulin Painful to Participant|0
4770427|NCT03740919|7746731|FG001|Treatment Period|Insulin Painful to Participant|0
4692891|NCT02588092|7603734|FG009|Overall Study|Started Another Treatment|0
4692892|NCT02588092|7603725|FG000|Overall Study|Sponsor Decision|0
4770428|NCT03740919|7746732|FG002|Treatment Period|Insulin Painful to Participant|1
4770429|NCT03740919|7746733|FG003|Treatment Period|Insulin Painful to Participant|0
4770430|NCT03647488|7746767|FG000|Overall Study|Progressive disease|10
4770431|NCT03647488|7746768|FG001|Overall Study|Progressive disease|0
4770432|NCT03647488|7746769|FG002|Overall Study|Progressive disease|0
4770433|NCT03647488|7746767|FG000|Overall Study|Adverse Event|5
4770434|NCT03647488|7746768|FG001|Overall Study|Adverse Event|0
4770435|NCT03647488|7746769|FG002|Overall Study|Adverse Event|0
4770436|NCT03647488|7746767|FG000|Overall Study|Clinical progression|2
4770437|NCT03647488|7746768|FG001|Overall Study|Clinical progression|0
4770438|NCT03647488|7746769|FG002|Overall Study|Clinical progression|0
4770439|NCT03647488|7746767|FG000|Overall Study|Participant refused to take investigational product|1
4770440|NCT03647488|7746768|FG001|Overall Study|Participant refused to take investigational product|0
4770441|NCT03647488|7746769|FG002|Overall Study|Participant refused to take investigational product|0
4770442|NCT03614923|7746778|FG000|Overall Study|Withdrawal by Subject|2
4770443|NCT03614923|7746779|FG001|Overall Study|Withdrawal by Subject|1
4770444|NCT03614923|7746780|FG002|Overall Study|Withdrawal by Subject|1
4770445|NCT03614923|7746778|FG000|Overall Study|Adverse Event|0
4770446|NCT03614923|7746779|FG001|Overall Study|Adverse Event|2
4579332|NCT01436162|7421365|FG001|Randomized Phase|Adverse Event|5
4579333|NCT01436162|7421366|FG002|Randomized Phase|Adverse Event|6
4579334|NCT01436162|7421364|FG000|Randomized Phase|Protocol Violation|4
4579335|NCT01436162|7421365|FG001|Randomized Phase|Protocol Violation|4
4579336|NCT01436162|7421366|FG002|Randomized Phase|Protocol Violation|2
4579337|NCT01436162|7421364|FG000|Randomized Phase|Withdrawal by Subject|16
4579338|NCT01436162|7421365|FG001|Randomized Phase|Withdrawal by Subject|9
4579339|NCT01436162|7421366|FG002|Randomized Phase|Withdrawal by Subject|8
4579340|NCT01436162|7421364|FG000|Randomized Phase|Lost to Follow-up|17
4579341|NCT01436162|7421365|FG001|Randomized Phase|Lost to Follow-up|5
4579342|NCT01436162|7421366|FG002|Randomized Phase|Lost to Follow-up|4
4579343|NCT01436162|7421364|FG000|Randomized Phase|Lack of Efficacy|0
4579344|NCT01436162|7421365|FG001|Randomized Phase|Lack of Efficacy|1
4579345|NCT01436162|7421366|FG002|Randomized Phase|Lack of Efficacy|1
4579346|NCT01436162|7421364|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4
4579347|NCT01436162|7421365|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2
4579348|NCT01436162|7421366|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0
4579349|NCT01436162|7421364|FG000|Randomized Phase|Other|2
4579350|NCT01436162|7421365|FG001|Randomized Phase|Other|5
4579351|NCT01436162|7421366|FG002|Randomized Phase|Other|4
4579352|NCT01436175|7421374|FG000|Overall Study|Adverse Event|111
4579353|NCT01436175|7421374|FG000|Overall Study|Protocol Violation|49
4579354|NCT01436175|7421374|FG000|Overall Study|Withdrawal by Subject|108
4579355|NCT01436175|7421374|FG000|Overall Study|Lost to Follow-up|89
4579356|NCT01436175|7421374|FG000|Overall Study|Lack of Efficacy|24
4579357|NCT01436175|7421374|FG000|Overall Study|Met blood pressure or pulse withdrawal|63
4579358|NCT01436175|7421374|FG000|Overall Study|Other|826
4579359|NCT01436201|7421379|FG000|Overall Study|Adverse Event|2
4579360|NCT01436201|7421379|FG000|Overall Study|Withdrawal by Subject|1
4579361|NCT01436201|7421379|FG000|Overall Study|Protocol Violation|1
4579362|NCT01436305|7421408|FG000|Overall Study|Death|1
4579363|NCT01436305|7421409|FG001|Overall Study|Death|0
4579364|NCT01436305|7421410|FG002|Overall Study|Death|0
4579365|NCT01436305|7421408|FG000|Overall Study|Lost to Follow-up|0
4579366|NCT01436305|7421409|FG001|Overall Study|Lost to Follow-up|1
4579367|NCT01436305|7421410|FG002|Overall Study|Lost to Follow-up|0
4579368|NCT01436305|7421408|FG000|Overall Study|Withdrawal by Subject|1
4579369|NCT01436305|7421409|FG001|Overall Study|Withdrawal by Subject|3
4579370|NCT01436305|7421410|FG002|Overall Study|Withdrawal by Subject|0
4579371|NCT01436357|7421420|FG000|Overall Study|Death|5
4579372|NCT01436357|7421421|FG001|Overall Study|Death|1
4579373|NCT01436357|7421420|FG000|Overall Study|Enrolled but not vaccinated|1
4579374|NCT01436357|7421421|FG001|Overall Study|Enrolled but not vaccinated|1
4579375|NCT01436357|7421420|FG000|Overall Study|Incarceration|18
4579376|NCT01436357|7421421|FG001|Overall Study|Incarceration|20
4579377|NCT01436357|7421420|FG000|Overall Study|Lost to Follow-up|67
4579378|NCT01436357|7421421|FG001|Overall Study|Lost to Follow-up|61
4579379|NCT01436357|7421420|FG000|Overall Study|Protocol Violation|1
4579380|NCT01436357|7421421|FG001|Overall Study|Protocol Violation|0
4579381|NCT01436357|7421420|FG000|Overall Study|Withdrawal by Subject|26
4579382|NCT01436357|7421421|FG001|Overall Study|Withdrawal by Subject|38
4579383|NCT01436357|7421420|FG000|Overall Study|Physician Decision|3
4579384|NCT01436357|7421421|FG001|Overall Study|Physician Decision|4
4579385|NCT01436357|7421420|FG000|Overall Study|Moved out of area|1
4579386|NCT01436357|7421421|FG001|Overall Study|Moved out of area|2
4579387|NCT01436357|7421420|FG000|Overall Study|Subject in rehab|0
4579388|NCT01436357|7421421|FG001|Overall Study|Subject in rehab|1
4579389|NCT01436370|7421435|FG000|Overall Study|Lost to Follow-up|0
4579390|NCT01436370|7421436|FG001|Overall Study|Lost to Follow-up|0
4579391|NCT01436370|7421437|FG002|Overall Study|Lost to Follow-up|0
4579392|NCT01436370|7421438|FG003|Overall Study|Lost to Follow-up|0
4579393|NCT01436370|7421439|FG004|Overall Study|Lost to Follow-up|1
4579394|NCT01436370|7421440|FG005|Overall Study|Lost to Follow-up|0
4579395|NCT01436370|7421441|FG006|Overall Study|Lost to Follow-up|0
4579396|NCT01436370|7421442|FG007|Overall Study|Lost to Follow-up|0
4579397|NCT01436500|7421474|FG000|Overall Study|Death|1
4579398|NCT01436500|7421475|FG001|Overall Study|Death|0
4579399|NCT01436500|7421476|FG002|Overall Study|Death|0
4579400|NCT01436500|7421477|FG003|Overall Study|Death|0
4579401|NCT01436500|7421478|FG004|Overall Study|Death|0
4579402|NCT01436500|7421474|FG000|Overall Study|Adverse Event|0
4579403|NCT01436500|7421475|FG001|Overall Study|Adverse Event|2
4579404|NCT01436500|7421476|FG002|Overall Study|Adverse Event|2
4579405|NCT01436500|7421477|FG003|Overall Study|Adverse Event|0
4579406|NCT01436500|7421478|FG004|Overall Study|Adverse Event|1
4579407|NCT01436500|7421474|FG000|Overall Study|Withdrawal by Subject|0
4579408|NCT01436500|7421475|FG001|Overall Study|Withdrawal by Subject|0
4579409|NCT01436500|7421476|FG002|Overall Study|Withdrawal by Subject|2
4579410|NCT01436500|7421477|FG003|Overall Study|Withdrawal by Subject|0
4579411|NCT01436500|7421478|FG004|Overall Study|Withdrawal by Subject|2
4579412|NCT01436500|7421474|FG000|Overall Study|Physician Decision|0
4579413|NCT01436500|7421475|FG001|Overall Study|Physician Decision|0
4579414|NCT01436500|7421476|FG002|Overall Study|Physician Decision|1
4579415|NCT01436500|7421477|FG003|Overall Study|Physician Decision|0
4579416|NCT01436500|7421478|FG004|Overall Study|Physician Decision|0
4579417|NCT01436500|7421474|FG000|Overall Study|liver transplant|1
4579418|NCT01436500|7421475|FG001|Overall Study|liver transplant|0
4579419|NCT01436500|7421476|FG002|Overall Study|liver transplant|0
4579420|NCT01436500|7421477|FG003|Overall Study|liver transplant|0
4579421|NCT01436500|7421478|FG004|Overall Study|liver transplant|0
4579422|NCT01436500|7421474|FG000|Overall Study|initiation of dialysis|0
4579423|NCT01436500|7421475|FG001|Overall Study|initiation of dialysis|0
4579424|NCT01436500|7421476|FG002|Overall Study|initiation of dialysis|0
4579425|NCT01436500|7421477|FG003|Overall Study|initiation of dialysis|0
4579426|NCT01436500|7421478|FG004|Overall Study|initiation of dialysis|1
4579427|NCT01436500|7421474|FG000|Overall Study|discontinued study drug|1
4579428|NCT01436500|7421475|FG001|Overall Study|discontinued study drug|0
4579429|NCT01436500|7421476|FG002|Overall Study|discontinued study drug|0
4579430|NCT01436500|7421477|FG003|Overall Study|discontinued study drug|0
4579431|NCT01436500|7421478|FG004|Overall Study|discontinued study drug|0
4579432|NCT01436500|7421474|FG000|Overall Study|Other|0
4579433|NCT01436500|7421475|FG001|Overall Study|Other|1
4579434|NCT01436500|7421476|FG002|Overall Study|Other|0
4579435|NCT01436500|7421477|FG003|Overall Study|Other|1
4579436|NCT01436500|7421478|FG004|Overall Study|Other|0
4593204|NCT01548768|7441430|FG003|Overall Study|Withdrawal by Subject|0
4593205|NCT01548768|7441427|FG000|Overall Study|Physician Decision|1
4593206|NCT01548768|7441428|FG001|Overall Study|Physician Decision|0
4593207|NCT01548768|7441429|FG002|Overall Study|Physician Decision|0
4593208|NCT01548768|7441430|FG003|Overall Study|Physician Decision|0
4593209|NCT01548768|7441427|FG000|Overall Study|Adverse Event|0
4593210|NCT01548768|7441428|FG001|Overall Study|Adverse Event|0
4593211|NCT01548768|7441429|FG002|Overall Study|Adverse Event|0
4593212|NCT01548768|7441430|FG003|Overall Study|Adverse Event|1
4593213|NCT01548768|7441427|FG000|Overall Study|Non-Compliance|0
4593214|NCT01548768|7441428|FG001|Overall Study|Non-Compliance|0
4593215|NCT01548768|7441429|FG002|Overall Study|Non-Compliance|0
4593216|NCT01548768|7441430|FG003|Overall Study|Non-Compliance|3
4593217|NCT01549002|7441456|FG000|Overall Study|Excessive pain|0
4593218|NCT01549002|7441457|FG001|Overall Study|Excessive pain|2
4593219|NCT01549002|7441456|FG000|Overall Study|Moderate sedation required|0
4593220|NCT01549002|7441457|FG001|Overall Study|Moderate sedation required|2
4593221|NCT01549041|7441465|FG000|Overall Study|Lack of Efficacy|2
4593222|NCT01549041|7441466|FG001|Overall Study|Lack of Efficacy|4
4593223|NCT01549041|7441465|FG000|Overall Study|Adverse Event|0
4593224|NCT01549041|7441466|FG001|Overall Study|Adverse Event|4
4593225|NCT01549275|7441483|FG000|Overall Study|Lost to Follow-up|1
4593226|NCT01549275|7441484|FG001|Overall Study|Lost to Follow-up|0
4593227|NCT01549392|7441518|FG000|Overall Study|Withdrawal by Subject|1
4593228|NCT01549392|7441519|FG001|Overall Study|Withdrawal by Subject|0
4593229|NCT01549613|7441547|FG000|Overall Study|Lost to Follow-up|11
4593230|NCT01549613|7441548|FG001|Overall Study|Lost to Follow-up|11
4692893|NCT02588092|7603726|FG001|Overall Study|Sponsor Decision|0
4692894|NCT02588092|7603727|FG002|Overall Study|Sponsor Decision|0
4692895|NCT02588092|7603728|FG003|Overall Study|Sponsor Decision|0
4692896|NCT02588092|7603729|FG004|Overall Study|Sponsor Decision|0
4692897|NCT02588092|7603730|FG005|Overall Study|Sponsor Decision|0
4692898|NCT02588092|7603731|FG006|Overall Study|Sponsor Decision|0
4692899|NCT02588092|7603732|FG007|Overall Study|Sponsor Decision|0
4692900|NCT02588092|7603733|FG008|Overall Study|Sponsor Decision|1
4692901|NCT02588092|7603734|FG009|Overall Study|Sponsor Decision|1
4734954|NCT03514641|7682481|FG001|603B: 24-36 Week Study Period|Adverse Event|0
4734955|NCT03514641|7682482|FG002|603B: 24-36 Week Study Period|Adverse Event|3
4734956|NCT03514641|7682483|FG003|603B: 24-36 Week Study Period|Adverse Event|1
4734957|NCT03514641|7682480|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0
4734958|NCT03514641|7682481|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0
4734959|NCT03514641|7682482|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2
4734960|NCT03514641|7682483|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3
4734961|NCT03514641|7682480|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0
4734962|NCT03514641|7682481|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0
4734963|NCT03514641|7682482|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6
4734964|NCT03514641|7682483|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6
4734965|NCT03514641|7682480|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0
4593231|NCT01549652|7441557|FG000|Overall Study|Did Not Receive Allocated Intervention|0
4593232|NCT01549652|7441558|FG001|Overall Study|Did Not Receive Allocated Intervention|0
4593233|NCT01549652|7441559|FG002|Overall Study|Did Not Receive Allocated Intervention|2
4593234|NCT01549652|7441560|FG003|Overall Study|Did Not Receive Allocated Intervention|0
4593235|NCT01549652|7441557|FG000|Overall Study|Study Drug Titration Failure|5
4593236|NCT01549652|7441558|FG001|Overall Study|Study Drug Titration Failure|6
4593237|NCT01549652|7441559|FG002|Overall Study|Study Drug Titration Failure|0
4593238|NCT01549652|7441560|FG003|Overall Study|Study Drug Titration Failure|0
4593239|NCT01549652|7441557|FG000|Overall Study|Withdrawal Effect|0
4593240|NCT01549652|7441558|FG001|Overall Study|Withdrawal Effect|2
4593241|NCT01549652|7441559|FG002|Overall Study|Withdrawal Effect|0
4593242|NCT01549652|7441560|FG003|Overall Study|Withdrawal Effect|0
4734966|NCT03514641|7682481|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0
4579437|NCT01436643|7421503|FG000|2-week Pre-treatment|Abnormal test result|0
4579438|NCT01436643|7421504|FG001|2-week Pre-treatment|Abnormal test result|0
4579439|NCT01436643|7421505|FG002|2-week Pre-treatment|Abnormal test result|0
4579440|NCT01436643|7421506|FG003|2-week Pre-treatment|Abnormal test result|1
4579441|NCT01436643|7421503|FG000|2-week Pre-treatment|Adverse Event|0
4579442|NCT01436643|7421504|FG001|2-week Pre-treatment|Adverse Event|0
4579443|NCT01436643|7421505|FG002|2-week Pre-treatment|Adverse Event|0
4579444|NCT01436643|7421506|FG003|2-week Pre-treatment|Adverse Event|5
4579445|NCT01436643|7421503|FG000|2-week Pre-treatment|Protocol Violation|0
4579446|NCT01436643|7421504|FG001|2-week Pre-treatment|Protocol Violation|0
4579447|NCT01436643|7421505|FG002|2-week Pre-treatment|Protocol Violation|0
4579448|NCT01436643|7421506|FG003|2-week Pre-treatment|Protocol Violation|4
4579449|NCT01436643|7421503|FG000|Core Phase (16 Weeks)|Adverse Event|0
4579450|NCT01436643|7421504|FG001|Core Phase (16 Weeks)|Adverse Event|3
4579451|NCT01436643|7421505|FG002|Core Phase (16 Weeks)|Adverse Event|1
4579452|NCT01436643|7421506|FG003|Core Phase (16 Weeks)|Adverse Event|0
4579453|NCT01436643|7421503|FG000|Core Phase (16 Weeks)|Abnormal Test result|0
4579454|NCT01436643|7421504|FG001|Core Phase (16 Weeks)|Abnormal Test result|0
4579455|NCT01436643|7421505|FG002|Core Phase (16 Weeks)|Abnormal Test result|1
4579456|NCT01436643|7421506|FG003|Core Phase (16 Weeks)|Abnormal Test result|0
4579457|NCT01436643|7421503|FG000|Core Phase (16 Weeks)|Protocol Violation|1
4579458|NCT01436643|7421504|FG001|Core Phase (16 Weeks)|Protocol Violation|1
4579459|NCT01436643|7421505|FG002|Core Phase (16 Weeks)|Protocol Violation|1
4579460|NCT01436643|7421506|FG003|Core Phase (16 Weeks)|Protocol Violation|0
4579461|NCT01437267|7421547|FG000|Overall Study|Withdrawal by Subject|0
4579462|NCT01437267|7421548|FG001|Overall Study|Withdrawal by Subject|0
4579463|NCT01437267|7421549|FG002|Overall Study|Withdrawal by Subject|0
4579464|NCT01437267|7421550|FG003|Overall Study|Withdrawal by Subject|1
4579465|NCT01437267|7421551|FG004|Overall Study|Withdrawal by Subject|0
4579466|NCT01437267|7421552|FG005|Overall Study|Withdrawal by Subject|0
4579467|NCT01437267|7421547|FG000|Overall Study|Protocol Violation|0
4579468|NCT01437267|7421548|FG001|Overall Study|Protocol Violation|1
4579469|NCT01437267|7421549|FG002|Overall Study|Protocol Violation|0
4579470|NCT01437267|7421550|FG003|Overall Study|Protocol Violation|0
4579471|NCT01437267|7421551|FG004|Overall Study|Protocol Violation|0
4579472|NCT01437267|7421552|FG005|Overall Study|Protocol Violation|0
4579473|NCT01437319|7421566|FG000|Phase I|Lost to Follow-up|2
4579474|NCT01437319|7421567|FG001|Phase I|Lost to Follow-up|0
4579475|NCT01437319|7421568|FG002|Phase I|Lost to Follow-up|0
4579476|NCT01437319|7421566|FG000|Phase I|Protocol Violation|1
4579477|NCT01437319|7421567|FG001|Phase I|Protocol Violation|0
4579478|NCT01437319|7421568|FG002|Phase I|Protocol Violation|0
4579479|NCT01437319|7421566|FG000|Phase I|Study related symptoms/complaints|27
4579480|NCT01437319|7421567|FG001|Phase I|Study related symptoms/complaints|0
4579481|NCT01437319|7421568|FG002|Phase I|Study related symptoms/complaints|0
4579482|NCT01437319|7421566|FG000|Phase I|Withdrawal by Subject|25
4579483|NCT01437319|7421567|FG001|Phase I|Withdrawal by Subject|0
4579484|NCT01437319|7421568|FG002|Phase I|Withdrawal by Subject|0
4579485|NCT01437319|7421566|FG000|Phase II|Withdrawal by Subject|0
4579486|NCT01437319|7421567|FG001|Phase II|Withdrawal by Subject|8
4579487|NCT01437319|7421568|FG002|Phase II|Withdrawal by Subject|16
4579488|NCT01437319|7421566|FG000|Phase II|Lost to Follow-up|0
4579489|NCT01437319|7421567|FG001|Phase II|Lost to Follow-up|7
4579490|NCT01437319|7421568|FG002|Phase II|Lost to Follow-up|2
4579491|NCT01437319|7421566|FG000|Phase II|Study related symptoms/complaints|0
4579492|NCT01437319|7421567|FG001|Phase II|Study related symptoms/complaints|28
4579493|NCT01437319|7421568|FG002|Phase II|Study related symptoms/complaints|19
4579494|NCT01437319|7421566|FG000|Phase II|Protocol Violation|0
4579495|NCT01437319|7421567|FG001|Phase II|Protocol Violation|1
4579496|NCT01437319|7421568|FG002|Phase II|Protocol Violation|0
4579497|NCT01437397|7421582|FG000|Overall Study|Lost to Follow-up|9
4579498|NCT01437397|7421583|FG001|Overall Study|Lost to Follow-up|4
4579499|NCT01437397|7421584|FG002|Overall Study|Lost to Follow-up|2
4579500|NCT01437397|7421585|FG003|Overall Study|Lost to Follow-up|4
4579501|NCT01437397|7421586|FG004|Overall Study|Lost to Follow-up|5
4579502|NCT01437397|7421582|FG000|Overall Study|Withdrawal by Subject|11
4579503|NCT01437397|7421583|FG001|Overall Study|Withdrawal by Subject|12
4579504|NCT01437397|7421584|FG002|Overall Study|Withdrawal by Subject|24
4579505|NCT01437397|7421585|FG003|Overall Study|Withdrawal by Subject|11
4579506|NCT01437397|7421586|FG004|Overall Study|Withdrawal by Subject|22
4579507|NCT01437397|7421582|FG000|Overall Study|Protocol Violation|10
4579508|NCT01437397|7421583|FG001|Overall Study|Protocol Violation|12
4579509|NCT01437397|7421584|FG002|Overall Study|Protocol Violation|13
4579510|NCT01437397|7421585|FG003|Overall Study|Protocol Violation|21
4579511|NCT01437397|7421586|FG004|Overall Study|Protocol Violation|19
4579512|NCT01437397|7421582|FG000|Overall Study|Lack of Efficacy|5
4579513|NCT01437397|7421583|FG001|Overall Study|Lack of Efficacy|4
4579514|NCT01437397|7421584|FG002|Overall Study|Lack of Efficacy|8
4579515|NCT01437397|7421585|FG003|Overall Study|Lack of Efficacy|10
4579516|NCT01437397|7421586|FG004|Overall Study|Lack of Efficacy|20
4579517|NCT01437397|7421582|FG000|Overall Study|Adverse Event|21
4579518|NCT01437397|7421583|FG001|Overall Study|Adverse Event|22
4579519|NCT01437397|7421584|FG002|Overall Study|Adverse Event|16
4579520|NCT01437397|7421585|FG003|Overall Study|Adverse Event|14
4579521|NCT01437397|7421586|FG004|Overall Study|Adverse Event|21
4579522|NCT01437397|7421582|FG000|Overall Study|Site termination/COPD exacerbation/other|10
4579523|NCT01437397|7421583|FG001|Overall Study|Site termination/COPD exacerbation/other|8
4579524|NCT01437397|7421584|FG002|Overall Study|Site termination/COPD exacerbation/other|9
4579525|NCT01437397|7421585|FG003|Overall Study|Site termination/COPD exacerbation/other|9
4579526|NCT01437397|7421586|FG004|Overall Study|Site termination/COPD exacerbation/other|14
4579527|NCT01437540|7421622|FG000|Overall Study|Not listed below|7
4579528|NCT01437540|7421623|FG001|Overall Study|Not listed below|6
4579529|NCT01437540|7421622|FG000|Overall Study|COPD exacerbation|13
4579530|NCT01437540|7421623|FG001|Overall Study|COPD exacerbation|3
4579531|NCT01437540|7421622|FG000|Overall Study|Lost to Follow-up|3
4579532|NCT01437540|7421623|FG001|Overall Study|Lost to Follow-up|5
4579533|NCT01437540|7421622|FG000|Overall Study|Lack of Efficacy|23
4579534|NCT01437540|7421623|FG001|Overall Study|Lack of Efficacy|11
4579535|NCT01437540|7421622|FG000|Overall Study|Protocol Violation|24
4579536|NCT01437540|7421623|FG001|Overall Study|Protocol Violation|12
4579537|NCT01437540|7421622|FG000|Overall Study|Adverse Event|26
4579538|NCT01437540|7421623|FG001|Overall Study|Adverse Event|13
4579539|NCT01437540|7421622|FG000|Overall Study|Withdrawal by Subject|31
4579540|NCT01437540|7421623|FG001|Overall Study|Withdrawal by Subject|15
4579541|NCT01437878|7421645|FG000|Overall Study|Withdrawal by Subject|1
4579542|NCT01437878|7421646|FG001|Overall Study|Withdrawal by Subject|0
4579543|NCT01437943|7421654|FG000|Overall Study|Aliskiren trials terminated by Novartis|4
4579544|NCT01437943|7421655|FG001|Overall Study|Aliskiren trials terminated by Novartis|2
4579545|NCT01437943|7421654|FG000|Overall Study|Subject expressed pregnancy plans|1
4579546|NCT01437943|7421655|FG001|Overall Study|Subject expressed pregnancy plans|0
4579547|NCT01437943|7421654|FG000|Overall Study|Adverse Event|2
4579548|NCT01437943|7421655|FG001|Overall Study|Adverse Event|0
4579549|NCT01437995|7421664|FG000|Overall Study|Lost to Follow-up|11
4579550|NCT01437995|7421665|FG001|Overall Study|Lost to Follow-up|18
4579551|NCT01437995|7421666|FG002|Overall Study|Lost to Follow-up|20
4579552|NCT01438060|7421685|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7
4579553|NCT01438060|7421686|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9
4579554|NCT01438060|7421685|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6
4579555|NCT01438060|7421686|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3
4579556|NCT01438060|7421685|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3
4579557|NCT01438060|7421686|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4
4579558|NCT01438060|7421685|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1
4579559|NCT01438060|7421686|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0
4579560|NCT01438060|7421685|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0
4579561|NCT01438060|7421686|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2
4579562|NCT01438060|7421685|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1
4579563|NCT01438060|7421686|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0
4579564|NCT01438060|7421685|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15
4579565|NCT01438060|7421686|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16
4579566|NCT01438060|7421685|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8
4579567|NCT01438060|7421686|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8
4579568|NCT01438060|7421685|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3
4579569|NCT01438060|7421686|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5
4579570|NCT01438060|7421685|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1
4579571|NCT01438060|7421686|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0
4579572|NCT01438060|7421685|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2
4579573|NCT01438060|7421686|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0
4579574|NCT01438060|7421685|FG000|Extension Phase: Week 10 to Week 130|Death|22
4579575|NCT01438060|7421686|FG001|Extension Phase: Week 10 to Week 130|Death|12
4579576|NCT01438060|7421685|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7
4579577|NCT01438060|7421686|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15
4579578|NCT01438060|7421685|FG000|On Study Beyond Week 140|Adverse Event|0
4579579|NCT01438060|7421686|FG001|On Study Beyond Week 140|Adverse Event|2
4579580|NCT01438060|7421685|FG000|On Study Beyond Week 140|Lack of Efficacy|0
4579581|NCT01438060|7421686|FG001|On Study Beyond Week 140|Lack of Efficacy|1
4579582|NCT01438060|7421685|FG000|On Study Beyond Week 140|Withdrawal by Subject|0
4579583|NCT01438060|7421686|FG001|On Study Beyond Week 140|Withdrawal by Subject|1
4579584|NCT01438060|7421685|FG000|On Study Beyond Week 140|Death|0
4579585|NCT01438060|7421686|FG001|On Study Beyond Week 140|Death|1
4579586|NCT01438060|7421685|FG000|On Study Beyond Week 140|Other Reason|0
4579587|NCT01438060|7421686|FG001|On Study Beyond Week 140|Other Reason|3
4579588|NCT01438151|7421697|FG000|Overall Study|study terminated|8
4579589|NCT01438177|7421701|FG000|Overall Study|Withdrawal by Subject|1
4579590|NCT01438177|7421701|FG000|Overall Study|Initiation of new therapy|1
4579591|NCT01438294|7421711|FG000|Overall Study|Lost to Follow-up|3
4579592|NCT01438294|7421712|FG001|Overall Study|Lost to Follow-up|7
4579593|NCT01438307|7421720|FG000|Overall Study|Death|1
4579594|NCT01438307|7421721|FG001|Overall Study|Death|1
4579595|NCT01438411|7421727|FG000|Overall Study|Adverse Event|8
4579596|NCT01438411|7421727|FG000|Overall Study|Lost to Follow-up|1
4579597|NCT01438411|7421727|FG000|Overall Study|Lack of Efficacy|1
4579598|NCT01438411|7421727|FG000|Overall Study|Withdrawal by Subject|3
4579599|NCT01438424|7421731|FG000|Overall Study|Continuing treatment|29
4579600|NCT01438424|7421731|FG000|Overall Study|Minimal virologic response|95
4579601|NCT01438424|7421731|FG000|Overall Study|Not identified|55
4579602|NCT01438424|7421731|FG000|Overall Study|Withdrawal by Subject|104
4579603|NCT01438424|7421731|FG000|Overall Study|Progression of chronic hepatitis B|22
4579604|NCT01438424|7421731|FG000|Overall Study|Death|22
4579605|NCT01438424|7421731|FG000|Overall Study|Adverse Event|17
4579606|NCT01438424|7421731|FG000|Overall Study|Lost to Follow-up|17
4579607|NCT01438424|7421731|FG000|Overall Study|Abnormal laboratory test result|14
4579608|NCT01438424|7421731|FG000|Overall Study|Need for drug prohibited by protocol|14
4579609|NCT01438424|7421731|FG000|Overall Study|Pregnancy|7
4579610|NCT01438424|7421731|FG000|Overall Study|No longer met inclusion criteria|1
4579611|NCT01438424|7421731|FG000|Overall Study|Participant noncompliance|20
4579612|NCT01438476|7421747|FG000|Overall Study|Protocol Violation|1
4579613|NCT01438476|7421748|FG001|Overall Study|Protocol Violation|0
4579614|NCT01438476|7421747|FG000|Overall Study|Withdrawal by Subject|1
4579615|NCT01438476|7421748|FG001|Overall Study|Withdrawal by Subject|0
4579616|NCT01438476|7421747|FG000|Overall Study|No Surgery- Disease|8
4579617|NCT01438476|7421748|FG001|Overall Study|No Surgery- Disease|10
4579618|NCT01438476|7421747|FG000|Overall Study|Communication barrier|0
4579619|NCT01438476|7421748|FG001|Overall Study|Communication barrier|1
4579620|NCT01438489|7421757|FG000|Overall Study|Lost to Follow-up|4
4579621|NCT01438489|7421758|FG001|Overall Study|Lost to Follow-up|2
4579622|NCT01438489|7421759|FG002|Overall Study|Lost to Follow-up|2
4579623|NCT01438489|7421757|FG000|Overall Study|Withdrawal by Subject|11
4579624|NCT01438489|7421758|FG001|Overall Study|Withdrawal by Subject|3
4579625|NCT01438489|7421759|FG002|Overall Study|Withdrawal by Subject|8
4579626|NCT01438489|7421757|FG000|Overall Study|Death|0
4579627|NCT01438489|7421758|FG001|Overall Study|Death|0
4579628|NCT01438489|7421759|FG002|Overall Study|Death|1
4579629|NCT01438489|7421757|FG000|Overall Study|Sponsor decision|4
4579630|NCT01438489|7421758|FG001|Overall Study|Sponsor decision|1
4579631|NCT01438489|7421759|FG002|Overall Study|Sponsor decision|4
4579632|NCT01438489|7421757|FG000|Overall Study|Subject choice/Subject moved|2
4579633|NCT01438489|7421758|FG001|Overall Study|Subject choice/Subject moved|1
4579634|NCT01438489|7421759|FG002|Overall Study|Subject choice/Subject moved|1
4579635|NCT01438489|7421757|FG000|Overall Study|Investigator decision|0
4579636|NCT01438489|7421758|FG001|Overall Study|Investigator decision|1
4579637|NCT01438489|7421759|FG002|Overall Study|Investigator decision|0
4579638|NCT01438489|7421757|FG000|Overall Study|AE/SAEs|2
4579639|NCT01438489|7421758|FG001|Overall Study|AE/SAEs|1
4579640|NCT01438489|7421759|FG002|Overall Study|AE/SAEs|1
4579641|NCT01438489|7421757|FG000|Overall Study|Received prohibited medication|1
4579642|NCT01438489|7421758|FG001|Overall Study|Received prohibited medication|0
4579643|NCT01438489|7421759|FG002|Overall Study|Received prohibited medication|0
4579644|NCT01438489|7421757|FG000|Overall Study|Did not complete all 3 follow-up visits|2
4579645|NCT01438489|7421758|FG001|Overall Study|Did not complete all 3 follow-up visits|5
4579646|NCT01438489|7421759|FG002|Overall Study|Did not complete all 3 follow-up visits|2
4579647|NCT01438489|7421757|FG000|Overall Study|Inadequate venous access|0
4579648|NCT01438489|7421758|FG001|Overall Study|Inadequate venous access|2
4579649|NCT01438489|7421759|FG002|Overall Study|Inadequate venous access|0
4579650|NCT01438541|7421769|FG000|Overall Study|Physician Decision|1
4579651|NCT01438541|7421769|FG000|Overall Study|Withdrawal by Subject|1
4579652|NCT01438541|7421769|FG000|Overall Study|discharge from the hospital|5
4579653|NCT01438814|7421781|FG000|Overall Study|Adverse Event|3
4579654|NCT01438814|7421782|FG001|Overall Study|Adverse Event|3
4579655|NCT01438814|7421781|FG000|Overall Study|Protocol Violation|1
4579656|NCT01438814|7421782|FG001|Overall Study|Protocol Violation|2
4579657|NCT01438814|7421781|FG000|Overall Study|Lost to Follow-up|4
4579658|NCT01438814|7421782|FG001|Overall Study|Lost to Follow-up|3
4579659|NCT01438814|7421781|FG000|Overall Study|Withdrawal by Subject|4
4579660|NCT01438814|7421782|FG001|Overall Study|Withdrawal by Subject|2
4579661|NCT01438814|7421781|FG000|Overall Study|Other|2
4579662|NCT01438814|7421782|FG001|Overall Study|Other|4
4579663|NCT01438840|7421790|FG000|Core Study|Adverse Event|0
4579664|NCT01438840|7421791|FG001|Core Study|Adverse Event|3
4579665|NCT01438840|7421792|FG002|Core Study|Adverse Event|0
4579666|NCT01438840|7421790|FG000|Core Study|Lack of Efficacy|15
4579667|NCT01438840|7421791|FG001|Core Study|Lack of Efficacy|7
4579668|NCT01438840|7421792|FG002|Core Study|Lack of Efficacy|0
4579669|NCT01438840|7421790|FG000|Core Study|Withdrawal of consent|1
4579670|NCT01438840|7421791|FG001|Core Study|Withdrawal of consent|0
4579671|NCT01438840|7421792|FG002|Core Study|Withdrawal of consent|0
4579672|NCT01438840|7421790|FG000|Extension Phase|Adverse Event|0
4579673|NCT01438840|7421791|FG001|Extension Phase|Adverse Event|0
4579674|NCT01438840|7421792|FG002|Extension Phase|Adverse Event|3
4579675|NCT01438840|7421790|FG000|Extension Phase|Lost to Follow-up|0
4579676|NCT01438840|7421791|FG001|Extension Phase|Lost to Follow-up|0
4579677|NCT01438840|7421792|FG002|Extension Phase|Lost to Follow-up|1
4579678|NCT01438840|7421790|FG000|Extension Phase|Withdrawal by Subject|0
4579679|NCT01438840|7421791|FG001|Extension Phase|Withdrawal by Subject|0
4579680|NCT01438840|7421792|FG002|Extension Phase|Withdrawal by Subject|3
4579681|NCT01438840|7421790|FG000|Extension Phase|Lack of Efficacy|0
4579682|NCT01438840|7421791|FG001|Extension Phase|Lack of Efficacy|0
4579683|NCT01438840|7421792|FG002|Extension Phase|Lack of Efficacy|2
4579684|NCT01438840|7421790|FG000|Extension Phase|Other|0
4579685|NCT01438840|7421791|FG001|Extension Phase|Other|0
4579686|NCT01438840|7421792|FG002|Extension Phase|Other|1
4579687|NCT01438957|7421804|FG000|Overall Study|Physician Decision|1
4579688|NCT01438957|7421805|FG001|Overall Study|Physician Decision|1
4579689|NCT01438957|7421806|FG002|Overall Study|Physician Decision|0
4579690|NCT01438957|7421807|FG003|Overall Study|Physician Decision|1
4579691|NCT01438957|7421808|FG004|Overall Study|Physician Decision|0
4579692|NCT01438996|7421823|FG000|Overall Study|Not meeting Inclusion Criteria|4
4579693|NCT01438996|7421824|FG001|Overall Study|Not meeting Inclusion Criteria|1
4579694|NCT01438996|7421825|FG002|Overall Study|Not meeting Inclusion Criteria|0
4579695|NCT01439009|7421835|FG000|Overall Study|Physician Decision|5
4579696|NCT01439009|7421836|FG001|Overall Study|Physician Decision|3
4579697|NCT01439009|7421835|FG000|Overall Study|Protocol Violation|2
4579698|NCT01439009|7421836|FG001|Overall Study|Protocol Violation|0
4579699|NCT01439009|7421835|FG000|Overall Study|Deviation of exclusion criteria|1
4579700|NCT01439009|7421836|FG001|Overall Study|Deviation of exclusion criteria|0
4579701|NCT01439074|7421848|FG000|Overall Study|Lost to Follow-up|3
4579702|NCT01439074|7421849|FG001|Overall Study|Lost to Follow-up|4
4579703|NCT01439074|7421848|FG000|Overall Study|Subject shedding|1
4579704|NCT01439074|7421849|FG001|Overall Study|Subject shedding|0
4579705|NCT01439074|7421848|FG000|Overall Study|Withdrawal by Subject|1
4579706|NCT01439074|7421849|FG001|Overall Study|Withdrawal by Subject|5
4579707|NCT01439074|7421848|FG000|Overall Study|Other|4
4579708|NCT01439074|7421849|FG001|Overall Study|Other|4
4579709|NCT01439126|7421861|FG000|Overall Study|Adverse Event|2
4579710|NCT01439126|7421862|FG001|Overall Study|Adverse Event|0
4579711|NCT01439126|7421861|FG000|Overall Study|Withdrawal by Subject|5
4579712|NCT01439126|7421862|FG001|Overall Study|Withdrawal by Subject|21
4579713|NCT01439126|7421861|FG000|Overall Study|Protocol Violation|6
4579714|NCT01439126|7421862|FG001|Overall Study|Protocol Violation|4
4579715|NCT01439126|7421861|FG000|Overall Study|Lost to Follow-up|6
4579716|NCT01439126|7421862|FG001|Overall Study|Lost to Follow-up|3
4579717|NCT01439126|7421861|FG000|Overall Study|Other-Use of prohibited treatment|0
4579718|NCT01439126|7421862|FG001|Overall Study|Other-Use of prohibited treatment|2
4579719|NCT01439126|7421861|FG000|Overall Study|Other-Miscellaneous|12
4579720|NCT01439126|7421862|FG001|Overall Study|Other-Miscellaneous|12
4770447|NCT03614923|7746780|FG002|Overall Study|Adverse Event|1
4770448|NCT03614923|7746778|FG000|Overall Study|Lost to Follow-up|1
4770449|NCT03614923|7746779|FG001|Overall Study|Lost to Follow-up|0
4770450|NCT03614923|7746780|FG002|Overall Study|Lost to Follow-up|1
4770451|NCT03614923|7746778|FG000|Overall Study|Lack of Efficacy|2
4770452|NCT03614923|7746779|FG001|Overall Study|Lack of Efficacy|0
4579727|NCT01439204|7421879|FG000|Overall Study|Withdrawal by Subject|0
4579728|NCT01439204|7421880|FG001|Overall Study|Withdrawal by Subject|1
4579729|NCT01439204|7421879|FG000|Overall Study|Lost to Follow-up|0
4579730|NCT01439204|7421880|FG001|Overall Study|Lost to Follow-up|2
4579731|NCT01439204|7421879|FG000|Overall Study|No longer meets study criteria|1
4579732|NCT01439204|7421880|FG001|Overall Study|No longer meets study criteria|0
4579733|NCT01439204|7421879|FG000|Overall Study|poor/non-compliance|3
4579734|NCT01439204|7421880|FG001|Overall Study|poor/non-compliance|0
4579735|NCT01439282|7421888|FG000|Overall Study|Adverse Event|5
4579736|NCT01439282|7421889|FG001|Overall Study|Adverse Event|0
4579737|NCT01439282|7421888|FG000|Overall Study|Withdrawal by Subject|2
4579738|NCT01439282|7421889|FG001|Overall Study|Withdrawal by Subject|0
4579739|NCT01439282|7421888|FG000|Overall Study|Other|1
4579740|NCT01439282|7421889|FG001|Overall Study|Other|1
4579741|NCT01439360|7421898|FG000|Overall Study|Adverse Event|4
4579742|NCT01439360|7421899|FG001|Overall Study|Adverse Event|16
4579743|NCT01439360|7421898|FG000|Overall Study|Lost to Follow-up|43
4579744|NCT01439360|7421899|FG001|Overall Study|Lost to Follow-up|58
4579745|NCT01439360|7421898|FG000|Overall Study|Others|10
4579746|NCT01439360|7421899|FG001|Overall Study|Others|5
4579747|NCT01439360|7421898|FG000|Overall Study|Protocol Violation|1
4579748|NCT01439360|7421899|FG001|Overall Study|Protocol Violation|0
4579749|NCT01439360|7421898|FG000|Overall Study|Withdrawal by Subject|140
4579750|NCT01439360|7421899|FG001|Overall Study|Withdrawal by Subject|129
4579751|NCT01439373|7421907|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0
4579752|NCT01439373|7421908|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1
4579753|NCT01439373|7421907|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2
4579754|NCT01439373|7421908|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0
4579755|NCT01439555|7421918|FG000|Overall Study|Protocol Violation|1
4579756|NCT01439568|7421924|FG000|Overall Study|Lost to Follow-up|1
4579757|NCT01439568|7421925|FG001|Overall Study|Lost to Follow-up|0
4579758|NCT01439568|7421924|FG000|Overall Study|Withdrawal by Subject|2
4579759|NCT01439568|7421925|FG001|Overall Study|Withdrawal by Subject|2
4579760|NCT01439711|7421956|FG000|Overall Study|Ineligible|13
4579761|NCT01439711|7421956|FG000|Overall Study|Cancel|3
4579762|NCT01439711|7421956|FG000|Overall Study|Progression Prior to Beginning Tx|1
4579763|NCT01439711|7421956|FG000|Overall Study|Adverse Event|5
4579764|NCT01439711|7421956|FG000|Overall Study|Withdrawal by Subject|3
4579765|NCT01439711|7421956|FG000|Overall Study|Progression During Active Tx|3
4579766|NCT01439711|7421956|FG000|Overall Study|Noncompliance|3
4579767|NCT01439711|7421956|FG000|Overall Study|No MRI|9
4579768|NCT01439724|7421962|FG000|Overall Study|missing consultation|9
4579769|NCT01439724|7421963|FG001|Overall Study|missing consultation|8
4579770|NCT01439867|7421989|FG000|Overall Study|Non-compliance|0
4579771|NCT01439867|7421990|FG001|Overall Study|Non-compliance|1
4579772|NCT01439867|7421989|FG000|Overall Study|Withdrawal by Subject|1
4579773|NCT01439867|7421990|FG001|Overall Study|Withdrawal by Subject|2
4579774|NCT01439867|7421989|FG000|Overall Study|Administrative Decision|4
4579775|NCT01439867|7421990|FG001|Overall Study|Administrative Decision|5
4579776|NCT01439867|7421989|FG000|Overall Study|Protocol-specified Criteria|1
4579777|NCT01439867|7421990|FG001|Overall Study|Protocol-specified Criteria|0
4579778|NCT01439880|7422000|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24
4579779|NCT01439880|7422001|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38
4579780|NCT01439880|7422000|FG000|SOC-controlled Period (Year 1)|Death|2
4579781|NCT01439880|7422001|FG001|SOC-controlled Period (Year 1)|Death|1
4579782|NCT01439880|7422000|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0
4579783|NCT01439880|7422001|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1
4579784|NCT01439880|7422000|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10
4579785|NCT01439880|7422001|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5
4579786|NCT01439880|7422000|FG000|SOC-controlled Period (Year 1)|Other|8
4579787|NCT01439880|7422001|FG001|SOC-controlled Period (Year 1)|Other|13
4579788|NCT01439880|7422000|FG000|SOC-controlled Period (Year 1)|Reason Missing|0
4579789|NCT01439880|7422001|FG001|SOC-controlled Period (Year 1)|Reason Missing|2
4579790|NCT01439880|7422000|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21
4579791|NCT01439880|7422001|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30
4579792|NCT01439880|7422000|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30
4579793|NCT01439880|7422001|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66
4579794|NCT01439880|7422000|FG000|All-IP Period (Years 2 to 5)|Death|3
4579795|NCT01439880|7422001|FG001|All-IP Period (Years 2 to 5)|Death|13
4579796|NCT01439880|7422000|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1
4579797|NCT01439880|7422001|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0
4579798|NCT01439880|7422000|FG000|All-IP Period (Years 2 to 5)|Other|14
4579799|NCT01439880|7422001|FG001|All-IP Period (Years 2 to 5)|Other|31
4579800|NCT01439880|7422000|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1
4579801|NCT01439880|7422001|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0
4579802|NCT01439945|7422021|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3
4579803|NCT01439945|7422022|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3
4579804|NCT01439945|7422023|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3
4579805|NCT01439945|7422024|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1
4579806|NCT01439945|7422021|FG000|Double-Blind Treatment Phase|Ineligible|1
4579807|NCT01439945|7422022|FG001|Double-Blind Treatment Phase|Ineligible|2
4579808|NCT01439945|7422023|FG002|Double-Blind Treatment Phase|Ineligible|0
4579809|NCT01439945|7422024|FG003|Double-Blind Treatment Phase|Ineligible|1
4579810|NCT01439971|7422040|FG000|Overall Study|Required number in cohort dosed|0
4579811|NCT01439971|7422041|FG001|Overall Study|Required number in cohort dosed|1
4579812|NCT01439971|7422042|FG002|Overall Study|Required number in cohort dosed|2
4579813|NCT01439971|7422043|FG003|Overall Study|Required number in cohort dosed|0
4579814|NCT01439971|7422044|FG004|Overall Study|Required number in cohort dosed|1
4579815|NCT01440049|7422056|FG000|Overall Study|Adverse Event|5
4579816|NCT01440101|7422063|FG000|Overall Study|Adverse Event|2
4579817|NCT01440101|7422064|FG001|Overall Study|Adverse Event|0
4579818|NCT01440101|7422065|FG002|Overall Study|Adverse Event|0
4579819|NCT01440101|7422063|FG000|Overall Study|Withdrawal by Subject|0
4579820|NCT01440101|7422064|FG001|Overall Study|Withdrawal by Subject|3
4579821|NCT01440101|7422065|FG002|Overall Study|Withdrawal by Subject|1
4579822|NCT01440101|7422063|FG000|Overall Study|Other|0
4579823|NCT01440101|7422064|FG001|Overall Study|Other|1
4579824|NCT01440101|7422065|FG002|Overall Study|Other|0
4579825|NCT01440283|7422074|FG000|Overall Study|Death|3
4579826|NCT01440283|7422074|FG000|Overall Study|Withdrawal by Subject|4
4579827|NCT01440283|7422074|FG000|Overall Study|Physician Decision|3
4579828|NCT01440322|7422086|FG000|Overall Study|Discomfort|2
4579829|NCT01440322|7422087|FG001|Overall Study|Discomfort|0
4579830|NCT01440322|7422086|FG000|Overall Study|Biomicroscopy|1
4579831|NCT01440322|7422087|FG001|Overall Study|Biomicroscopy|0
4579832|NCT01440322|7422086|FG000|Overall Study|Symptoms and Problems|1
4579833|NCT01440322|7422087|FG001|Overall Study|Symptoms and Problems|0
4579834|NCT01440322|7422086|FG000|Overall Study|Unacceptable Subjective Vision|1
4579835|NCT01440322|7422087|FG001|Overall Study|Unacceptable Subjective Vision|0
4579836|NCT01440322|7422086|FG000|Overall Study|Other Product Related|1
4579837|NCT01440322|7422087|FG001|Overall Study|Other Product Related|0
4579838|NCT01440322|7422086|FG000|Overall Study|Unrelated Medical Problem|0
4579839|NCT01440322|7422087|FG001|Overall Study|Unrelated Medical Problem|1
4579840|NCT01440322|7422086|FG000|Overall Study|Other Non-Product Related|1
4579841|NCT01440322|7422087|FG001|Overall Study|Other Non-Product Related|0
4579842|NCT01440374|7422096|FG000|Part 1: Open-label Phase|Adverse Event|5
4579843|NCT01440374|7422097|FG001|Part 1: Open-label Phase|Adverse Event|0
4579844|NCT01440374|7422098|FG002|Part 1: Open-label Phase|Adverse Event|0
4579845|NCT01440374|7422099|FG003|Part 1: Open-label Phase|Adverse Event|0
4579846|NCT01440374|7422096|FG000|Part 1: Open-label Phase|Physician Decision|1
4579847|NCT01440374|7422097|FG001|Part 1: Open-label Phase|Physician Decision|0
4579848|NCT01440374|7422098|FG002|Part 1: Open-label Phase|Physician Decision|0
4579849|NCT01440374|7422099|FG003|Part 1: Open-label Phase|Physician Decision|0
4579850|NCT01440374|7422096|FG000|Part 2; Double-blind Phase|Physician Decision|0
4579851|NCT01440374|7422097|FG001|Part 2; Double-blind Phase|Physician Decision|8
4579852|NCT01440374|7422098|FG002|Part 2; Double-blind Phase|Physician Decision|17
4579853|NCT01440374|7422099|FG003|Part 2; Double-blind Phase|Physician Decision|0
4579854|NCT01440374|7422096|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0
4579855|NCT01440374|7422097|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4
4579856|NCT01440374|7422098|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5
4579857|NCT01440374|7422099|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0
4579858|NCT01440374|7422096|FG000|Part 2; Double-blind Phase|Protocol Violation|0
4579859|NCT01440374|7422097|FG001|Part 2; Double-blind Phase|Protocol Violation|0
4579860|NCT01440374|7422098|FG002|Part 2; Double-blind Phase|Protocol Violation|1
4579861|NCT01440374|7422099|FG003|Part 2; Double-blind Phase|Protocol Violation|0
4579862|NCT01440374|7422096|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0
4579863|NCT01440374|7422097|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1
4579864|NCT01440374|7422098|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0
4579865|NCT01440374|7422099|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0
4579866|NCT01440374|7422096|FG000|Part 2; Double-blind Phase|Adverse Event|0
4579867|NCT01440374|7422097|FG001|Part 2; Double-blind Phase|Adverse Event|7
4579868|NCT01440374|7422098|FG002|Part 2; Double-blind Phase|Adverse Event|31
4579869|NCT01440374|7422099|FG003|Part 2; Double-blind Phase|Adverse Event|0
4579870|NCT01440374|7422096|FG000|Part 2; Double-blind Phase|Not treated|0
4579871|NCT01440374|7422097|FG001|Part 2; Double-blind Phase|Not treated|0
4579872|NCT01440374|7422098|FG002|Part 2; Double-blind Phase|Not treated|1
4579873|NCT01440374|7422099|FG003|Part 2; Double-blind Phase|Not treated|0
4579874|NCT01440374|7422096|FG000|Part 3: Extension|Withdrawal by Subject|0
4579875|NCT01440374|7422097|FG001|Part 3: Extension|Withdrawal by Subject|0
4579876|NCT01440374|7422098|FG002|Part 3: Extension|Withdrawal by Subject|0
4579877|NCT01440374|7422099|FG003|Part 3: Extension|Withdrawal by Subject|5
4579878|NCT01440374|7422096|FG000|Part 3: Extension|Adverse Event|0
4579879|NCT01440374|7422097|FG001|Part 3: Extension|Adverse Event|0
4579880|NCT01440374|7422098|FG002|Part 3: Extension|Adverse Event|0
4579881|NCT01440374|7422099|FG003|Part 3: Extension|Adverse Event|13
4579882|NCT01440374|7422096|FG000|Part 3: Extension|Physician Decision|0
4579883|NCT01440374|7422097|FG001|Part 3: Extension|Physician Decision|0
4579884|NCT01440374|7422098|FG002|Part 3: Extension|Physician Decision|0
4579885|NCT01440374|7422099|FG003|Part 3: Extension|Physician Decision|14
4579886|NCT01440569|7422139|FG000|Main Study|Enrolled but not treated|1
4579887|NCT01440569|7422140|FG001|Main Study|Enrolled but not treated|0
4579888|NCT01440569|7422139|FG000|Main Study|Adverse Event|9
4579889|NCT01440569|7422140|FG001|Main Study|Adverse Event|0
4579890|NCT01440569|7422139|FG000|Main Study|Pregnancy|1
4579891|NCT01440569|7422140|FG001|Main Study|Pregnancy|0
4579892|NCT01440569|7422139|FG000|Main Study|Investigator's Discretion|1
4579893|NCT01440569|7422140|FG001|Main Study|Investigator's Discretion|1
4579894|NCT01440569|7422139|FG000|Main Study|Withdrew Consent|7
4579895|NCT01440569|7422140|FG001|Main Study|Withdrew Consent|1
4579896|NCT01440569|7422139|FG000|Main Study|Lost to Follow-up|13
4579897|NCT01440569|7422140|FG001|Main Study|Lost to Follow-up|2
4579898|NCT01440569|7422139|FG000|Main Study|Subject Non-Compliance|3
4579899|NCT01440569|7422140|FG001|Main Study|Subject Non-Compliance|0
4579900|NCT01440569|7422139|FG000|Main Study|Protocol Violation|1
4579901|NCT01440569|7422140|FG001|Main Study|Protocol Violation|0
4579902|NCT01440569|7422139|FG000|Open-Label Rollover Phase|Adverse Event|3
4579903|NCT01440569|7422140|FG001|Open-Label Rollover Phase|Adverse Event|0
4579904|NCT01440569|7422139|FG000|Open-Label Rollover Phase|Pregnancy|1
4579905|NCT01440569|7422140|FG001|Open-Label Rollover Phase|Pregnancy|0
4579906|NCT01440569|7422139|FG000|Open-Label Rollover Phase|Lack of Efficacy|2
4579907|NCT01440569|7422140|FG001|Open-Label Rollover Phase|Lack of Efficacy|0
4579908|NCT01440569|7422139|FG000|Open-Label Rollover Phase|Investigator's Discretion|3
4579909|NCT01440569|7422140|FG001|Open-Label Rollover Phase|Investigator's Discretion|1
4579910|NCT01440569|7422139|FG000|Open-Label Rollover Phase|Withdrew Consent|11
4579911|NCT01440569|7422140|FG001|Open-Label Rollover Phase|Withdrew Consent|1
4579912|NCT01440569|7422139|FG000|Open-Label Rollover Phase|Lost to Follow-up|26
4579913|NCT01440569|7422140|FG001|Open-Label Rollover Phase|Lost to Follow-up|3
4579914|NCT01440569|7422139|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1
4579915|NCT01440569|7422140|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1
4579916|NCT01440647|7422157|FG000|Overall Study|Death|2
4579917|NCT01440647|7422158|FG001|Overall Study|Death|3
4579918|NCT01440803|7422192|FG000|Overall Study|Met study stopping rule|2
4579919|NCT01440803|7422193|FG001|Overall Study|Met study stopping rule|1
4579920|NCT01440803|7422192|FG000|Overall Study|Lost to Follow-up|0
4579921|NCT01440803|7422193|FG001|Overall Study|Lost to Follow-up|2
4579922|NCT01440803|7422192|FG000|Overall Study|Withdrawal by Subject|0
4579923|NCT01440803|7422193|FG001|Overall Study|Withdrawal by Subject|1
4579924|NCT01440816|7422202|FG000|Overall Study|Disease Progression|0
4579925|NCT01440816|7422203|FG001|Overall Study|Disease Progression|9
4579926|NCT01440816|7422202|FG000|Overall Study|To Be Seen By Local Oncologist|1
4579927|NCT01440816|7422203|FG001|Overall Study|To Be Seen By Local Oncologist|2
4579928|NCT01440881|7422213|FG000|Overall Study|Death|0
4579929|NCT01440881|7422214|FG001|Overall Study|Death|1
4579930|NCT01440946|7422236|FG000|Overall Study|Lost to Follow-up|1
4579931|NCT01440946|7422237|FG001|Overall Study|Lost to Follow-up|1
4579932|NCT01440946|7422236|FG000|Overall Study|Physician Decision|1
4579933|NCT01440946|7422237|FG001|Overall Study|Physician Decision|0
4579934|NCT01440972|7422250|FG000|Overall Study|Withdrawal by Subject|3
4579935|NCT01440972|7422251|FG001|Overall Study|Withdrawal by Subject|2
4579936|NCT01441063|7422261|FG000|Tocilizumab Alone|Required AZT/VGC addition|3
4579937|NCT01441063|7422261|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1
4579938|NCT01441102|7422272|FG000|Overall Study|Adverse Event|1
4579939|NCT01441102|7422272|FG000|Overall Study|Withdrawal by Subject|2
4579940|NCT01441180|7422279|FG000|Overall Study|Lost to Follow-up|1
4579941|NCT01441180|7422280|FG001|Overall Study|Lost to Follow-up|1
4579942|NCT01441180|7422281|FG002|Overall Study|Lost to Follow-up|1
4579943|NCT01441180|7422279|FG000|Overall Study|Discontinued|0
4579944|NCT01441180|7422280|FG001|Overall Study|Discontinued|0
4579945|NCT01441180|7422281|FG002|Overall Study|Discontinued|2
4579946|NCT01441414|7422335|FG000|Overall Study|Participant died|9
4579947|NCT01441414|7422335|FG000|Overall Study|Other reasons|3
4579948|NCT01441414|7422335|FG000|Overall Study|Study terminated by sponsor|2
4579949|NCT01441414|7422335|FG000|Overall Study|Subject refused further follow-up|1
4579950|NCT01441440|7422354|FG000|Overall Study|Death|1
4579951|NCT01441440|7422355|FG001|Overall Study|Death|0
4579952|NCT01441440|7422356|FG002|Overall Study|Death|1
4579953|NCT01441440|7422354|FG000|Overall Study|Adverse Event|2
4579954|NCT01441440|7422355|FG001|Overall Study|Adverse Event|9
4579955|NCT01441440|7422356|FG002|Overall Study|Adverse Event|9
4579956|NCT01441440|7422354|FG000|Overall Study|Lost to Follow-up|0
4579957|NCT01441440|7422355|FG001|Overall Study|Lost to Follow-up|2
4579958|NCT01441440|7422356|FG002|Overall Study|Lost to Follow-up|1
4579959|NCT01441440|7422354|FG000|Overall Study|Withdrawal by Subject|11
4579960|NCT01441440|7422355|FG001|Overall Study|Withdrawal by Subject|9
4579961|NCT01441440|7422356|FG002|Overall Study|Withdrawal by Subject|9
4579962|NCT01441440|7422354|FG000|Overall Study|Pregnancy|1
4579963|NCT01441440|7422355|FG001|Overall Study|Pregnancy|0
4579964|NCT01441440|7422356|FG002|Overall Study|Pregnancy|0
4579965|NCT01441440|7422354|FG000|Overall Study|Lack of Efficacy|1
4579966|NCT01441440|7422355|FG001|Overall Study|Lack of Efficacy|0
4579967|NCT01441440|7422356|FG002|Overall Study|Lack of Efficacy|1
4579968|NCT01441440|7422354|FG000|Overall Study|Moving|0
4579969|NCT01441440|7422355|FG001|Overall Study|Moving|1
4579970|NCT01441440|7422356|FG002|Overall Study|Moving|1
4579971|NCT01441440|7422354|FG000|Overall Study|Work-related matter|0
4579972|NCT01441440|7422355|FG001|Overall Study|Work-related matter|1
4579973|NCT01441440|7422356|FG002|Overall Study|Work-related matter|0
4579974|NCT01441440|7422354|FG000|Overall Study|Difficllty in keeping the schedule|1
4579975|NCT01441440|7422355|FG001|Overall Study|Difficllty in keeping the schedule|1
4579976|NCT01441440|7422356|FG002|Overall Study|Difficllty in keeping the schedule|0
4579977|NCT01441596|7422397|FG000|Overall Study|Other reason not defined below|0
4579978|NCT01441596|7422398|FG001|Overall Study|Other reason not defined below|2
4579979|NCT01441596|7422399|FG002|Overall Study|Other reason not defined below|1
4579980|NCT01441596|7422397|FG000|Overall Study|Withdrawal by Subject|4
4579981|NCT01441596|7422398|FG001|Overall Study|Withdrawal by Subject|0
4579982|NCT01441596|7422399|FG002|Overall Study|Withdrawal by Subject|2
4579983|NCT01441596|7422397|FG000|Overall Study|Not treated|0
4579984|NCT01441596|7422398|FG001|Overall Study|Not treated|1
4579985|NCT01441596|7422399|FG002|Overall Study|Not treated|1
4579986|NCT01441635|7422417|FG000|Overall Study|Adverse Event|4
4579987|NCT01441635|7422418|FG001|Overall Study|Adverse Event|3
4579988|NCT01441635|7422419|FG002|Overall Study|Adverse Event|1
4579989|NCT01441635|7422420|FG003|Overall Study|Adverse Event|5
4579990|NCT01441635|7422421|FG004|Overall Study|Adverse Event|1
4579991|NCT01441635|7422422|FG005|Overall Study|Adverse Event|2
4579992|NCT01441635|7422423|FG006|Overall Study|Adverse Event|2
4579993|NCT01441635|7422424|FG007|Overall Study|Adverse Event|2
4579994|NCT01441635|7422425|FG008|Overall Study|Adverse Event|1
4579995|NCT01441635|7422426|FG009|Overall Study|Adverse Event|0
4579996|NCT01441635|7422417|FG000|Overall Study|Withdrawal by Subject|1
4579997|NCT01441635|7422418|FG001|Overall Study|Withdrawal by Subject|1
4579998|NCT01441635|7422419|FG002|Overall Study|Withdrawal by Subject|0
4692902|NCT04960228|7603762|FG000|Overall Study|Withdrawal by Subject|216
4692903|NCT04960228|7603763|FG001|Overall Study|Withdrawal by Subject|35
4579999|NCT01441635|7422420|FG003|Overall Study|Withdrawal by Subject|1
4580000|NCT01441635|7422421|FG004|Overall Study|Withdrawal by Subject|0
4580001|NCT01441635|7422422|FG005|Overall Study|Withdrawal by Subject|0
4580002|NCT01441635|7422423|FG006|Overall Study|Withdrawal by Subject|2
4580003|NCT01441635|7422424|FG007|Overall Study|Withdrawal by Subject|0
4580004|NCT01441635|7422425|FG008|Overall Study|Withdrawal by Subject|1
4580005|NCT01441635|7422426|FG009|Overall Study|Withdrawal by Subject|1
4580006|NCT01441635|7422417|FG000|Overall Study|Lost to Follow-up|0
4580007|NCT01441635|7422418|FG001|Overall Study|Lost to Follow-up|1
4580008|NCT01441635|7422419|FG002|Overall Study|Lost to Follow-up|1
4580009|NCT01441635|7422420|FG003|Overall Study|Lost to Follow-up|1
4580010|NCT01441635|7422421|FG004|Overall Study|Lost to Follow-up|1
4580011|NCT01441635|7422422|FG005|Overall Study|Lost to Follow-up|3
4580012|NCT01441635|7422423|FG006|Overall Study|Lost to Follow-up|1
4580013|NCT01441635|7422424|FG007|Overall Study|Lost to Follow-up|1
4580014|NCT01441635|7422425|FG008|Overall Study|Lost to Follow-up|0
4580015|NCT01441635|7422426|FG009|Overall Study|Lost to Follow-up|1
4580016|NCT01441635|7422417|FG000|Overall Study|Noncompliance|0
4580017|NCT01441635|7422418|FG001|Overall Study|Noncompliance|1
4580018|NCT01441635|7422419|FG002|Overall Study|Noncompliance|0
4580019|NCT01441635|7422420|FG003|Overall Study|Noncompliance|0
4580020|NCT01441635|7422421|FG004|Overall Study|Noncompliance|0
4580021|NCT01441635|7422422|FG005|Overall Study|Noncompliance|0
4580022|NCT01441635|7422423|FG006|Overall Study|Noncompliance|1
4580023|NCT01441635|7422424|FG007|Overall Study|Noncompliance|0
4580024|NCT01441635|7422425|FG008|Overall Study|Noncompliance|0
4580025|NCT01441635|7422426|FG009|Overall Study|Noncompliance|0
4580026|NCT01441635|7422417|FG000|Overall Study|Surgery or Invasive Intervention|0
4580027|NCT01441635|7422418|FG001|Overall Study|Surgery or Invasive Intervention|0
4580028|NCT01441635|7422419|FG002|Overall Study|Surgery or Invasive Intervention|1
4580029|NCT01441635|7422420|FG003|Overall Study|Surgery or Invasive Intervention|0
4580030|NCT01441635|7422421|FG004|Overall Study|Surgery or Invasive Intervention|0
4580031|NCT01441635|7422422|FG005|Overall Study|Surgery or Invasive Intervention|0
4580032|NCT01441635|7422423|FG006|Overall Study|Surgery or Invasive Intervention|0
4580033|NCT01441635|7422424|FG007|Overall Study|Surgery or Invasive Intervention|0
4580034|NCT01441635|7422425|FG008|Overall Study|Surgery or Invasive Intervention|0
4580035|NCT01441635|7422426|FG009|Overall Study|Surgery or Invasive Intervention|0
4580036|NCT01441635|7422417|FG000|Overall Study|Received Exclusionary Medication|1
4580037|NCT01441635|7422418|FG001|Overall Study|Received Exclusionary Medication|0
4580038|NCT01441635|7422419|FG002|Overall Study|Received Exclusionary Medication|0
4580039|NCT01441635|7422420|FG003|Overall Study|Received Exclusionary Medication|0
4580040|NCT01441635|7422421|FG004|Overall Study|Received Exclusionary Medication|0
4580041|NCT01441635|7422422|FG005|Overall Study|Received Exclusionary Medication|0
4580042|NCT01441635|7422423|FG006|Overall Study|Received Exclusionary Medication|0
4580043|NCT01441635|7422424|FG007|Overall Study|Received Exclusionary Medication|0
4580044|NCT01441635|7422425|FG008|Overall Study|Received Exclusionary Medication|0
4580045|NCT01441635|7422426|FG009|Overall Study|Received Exclusionary Medication|0
4580046|NCT01441635|7422417|FG000|Overall Study|Other|0
4580047|NCT01441635|7422418|FG001|Overall Study|Other|0
4580048|NCT01441635|7422419|FG002|Overall Study|Other|0
4580049|NCT01441635|7422420|FG003|Overall Study|Other|0
4580050|NCT01441635|7422421|FG004|Overall Study|Other|0
4580051|NCT01441635|7422422|FG005|Overall Study|Other|0
4580052|NCT01441635|7422423|FG006|Overall Study|Other|0
4580053|NCT01441635|7422424|FG007|Overall Study|Other|1
4580054|NCT01441635|7422425|FG008|Overall Study|Other|0
4580055|NCT01441635|7422426|FG009|Overall Study|Other|0
4580056|NCT01441765|7422450|FG000|Overall Study|Death|1
4580057|NCT01441765|7422451|FG001|Overall Study|Death|0
4580058|NCT01441960|7422470|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6
4580059|NCT01441960|7422471|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5
4580060|NCT01441960|7422470|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1
4580061|NCT01441960|7422471|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1
4580062|NCT01441960|7422470|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1
4580063|NCT01441960|7422471|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0
4580064|NCT01441973|7422483|FG000|Overall Study|Disease progression|8
4580065|NCT01441973|7422484|FG001|Overall Study|Disease progression|6
4580066|NCT01441973|7422483|FG000|Overall Study|Adverse event unrelated to study drug|3
4580067|NCT01441973|7422484|FG001|Overall Study|Adverse event unrelated to study drug|2
4580068|NCT01441973|7422483|FG000|Overall Study|Participant request to discontinue|1
4580069|NCT01441973|7422484|FG001|Overall Study|Participant request to discontinue|1
4580070|NCT01441973|7422483|FG000|Overall Study|Poor compliance/noncompliance|0
4580071|NCT01441973|7422484|FG001|Overall Study|Poor compliance/noncompliance|1
4580072|NCT01441973|7422483|FG000|Overall Study|Administrative reason by sponsor|3
4580073|NCT01441973|7422484|FG001|Overall Study|Administrative reason by sponsor|5
4580074|NCT01441973|7422483|FG000|Overall Study|Participant withdrew consent|0
4580075|NCT01441973|7422484|FG001|Overall Study|Participant withdrew consent|1
4580076|NCT01442038|7422493|FG000|Overall Study|Death|35
4580077|NCT01442038|7422494|FG001|Overall Study|Death|29
4580078|NCT01442038|7422493|FG000|Overall Study|Investigator-Initiated Early Closure|44
4580079|NCT01442038|7422494|FG001|Overall Study|Investigator-Initiated Early Closure|43
4580080|NCT01442038|7422493|FG000|Overall Study|Participant Withdrew Consent|137
4580081|NCT01442038|7422494|FG001|Overall Study|Participant Withdrew Consent|102
4580082|NCT01442038|7422493|FG000|Overall Study|Lost to Follow-up|37
4580083|NCT01442038|7422494|FG001|Overall Study|Lost to Follow-up|51
4580084|NCT01442038|7422493|FG000|Overall Study|Adverse Event|26
4580085|NCT01442038|7422494|FG001|Overall Study|Adverse Event|15
4580086|NCT01442038|7422493|FG000|Overall Study|Protocol Deviation|9
4580087|NCT01442038|7422494|FG001|Overall Study|Protocol Deviation|20
4580088|NCT01442038|7422493|FG000|Overall Study|Investigator's Discretion|13
4580089|NCT01442038|7422494|FG001|Overall Study|Investigator's Discretion|16
4580090|NCT01442038|7422493|FG000|Overall Study|Study Terminated By Sponsor|2
4580091|NCT01442038|7422494|FG001|Overall Study|Study Terminated By Sponsor|3
4580092|NCT01442064|7422506|FG000|Overall Study|Adverse Event|2
4580093|NCT01442064|7422507|FG001|Overall Study|Adverse Event|2
4580094|NCT01442064|7422508|FG002|Overall Study|Adverse Event|2
4580095|NCT01442064|7422509|FG003|Overall Study|Adverse Event|1
4580096|NCT01442064|7422510|FG004|Overall Study|Adverse Event|2
4580097|NCT01442064|7422511|FG005|Overall Study|Adverse Event|0
4580098|NCT01442064|7422506|FG000|Overall Study|Death|0
4580099|NCT01442064|7422507|FG001|Overall Study|Death|1
4580100|NCT01442064|7422508|FG002|Overall Study|Death|3
4580101|NCT01442064|7422509|FG003|Overall Study|Death|3
4580102|NCT01442064|7422510|FG004|Overall Study|Death|1
4580103|NCT01442064|7422511|FG005|Overall Study|Death|3
4580104|NCT01442064|7422506|FG000|Overall Study|Lost to Follow-up|5
4580105|NCT01442064|7422507|FG001|Overall Study|Lost to Follow-up|5
4580106|NCT01442064|7422508|FG002|Overall Study|Lost to Follow-up|1
4580107|NCT01442064|7422509|FG003|Overall Study|Lost to Follow-up|1
4580108|NCT01442064|7422510|FG004|Overall Study|Lost to Follow-up|3
4580109|NCT01442064|7422511|FG005|Overall Study|Lost to Follow-up|3
4580110|NCT01442064|7422506|FG000|Overall Study|Physician Decision|1
4580111|NCT01442064|7422507|FG001|Overall Study|Physician Decision|1
4580112|NCT01442064|7422508|FG002|Overall Study|Physician Decision|2
4580113|NCT01442064|7422509|FG003|Overall Study|Physician Decision|3
4580114|NCT01442064|7422510|FG004|Overall Study|Physician Decision|3
4580115|NCT01442064|7422511|FG005|Overall Study|Physician Decision|1
4580116|NCT01442064|7422506|FG000|Overall Study|Withdrawal by Subject|6
4580117|NCT01442064|7422507|FG001|Overall Study|Withdrawal by Subject|3
4580118|NCT01442064|7422508|FG002|Overall Study|Withdrawal by Subject|2
4580119|NCT01442064|7422509|FG003|Overall Study|Withdrawal by Subject|2
4580120|NCT01442064|7422510|FG004|Overall Study|Withdrawal by Subject|2
4580121|NCT01442064|7422511|FG005|Overall Study|Withdrawal by Subject|1
4580122|NCT01442064|7422506|FG000|Overall Study|Sponsor decision|82
4580123|NCT01442064|7422507|FG001|Overall Study|Sponsor decision|88
4580124|NCT01442064|7422508|FG002|Overall Study|Sponsor decision|92
4580125|NCT01442064|7422509|FG003|Overall Study|Sponsor decision|88
4580126|NCT01442064|7422510|FG004|Overall Study|Sponsor decision|95
4580127|NCT01442064|7422511|FG005|Overall Study|Sponsor decision|87
4580128|NCT01442064|7422506|FG000|Overall Study|Subject non-compliance|0
4580129|NCT01442064|7422507|FG001|Overall Study|Subject non-compliance|0
4580130|NCT01442064|7422508|FG002|Overall Study|Subject non-compliance|0
4580131|NCT01442064|7422509|FG003|Overall Study|Subject non-compliance|0
4580132|NCT01442064|7422510|FG004|Overall Study|Subject non-compliance|0
4580133|NCT01442064|7422511|FG005|Overall Study|Subject non-compliance|2
4580134|NCT01442064|7422506|FG000|Overall Study|Condition mandated other intervention|1
4580135|NCT01442064|7422507|FG001|Overall Study|Condition mandated other intervention|1
4580136|NCT01442064|7422508|FG002|Overall Study|Condition mandated other intervention|2
4580137|NCT01442064|7422509|FG003|Overall Study|Condition mandated other intervention|0
4580138|NCT01442064|7422510|FG004|Overall Study|Condition mandated other intervention|0
4580139|NCT01442064|7422511|FG005|Overall Study|Condition mandated other intervention|2
4580140|NCT01442103|7422528|FG000|Overall Study|Lost to Follow-up|2
4580141|NCT01442155|7422541|FG000|Overall Study|Complete remission|35
4580142|NCT01442155|7422541|FG000|Overall Study|Recurrence|26
4580143|NCT01442155|7422541|FG000|Overall Study|Adverse Event|2
4580144|NCT01442155|7422541|FG000|Overall Study|Lost to Follow-up|2
4593243|NCT01549652|7441557|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5
4593244|NCT01549652|7441558|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1
4593245|NCT01549652|7441559|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0
4593246|NCT01549652|7441560|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0
4593247|NCT01549652|7441557|FG000|Overall Study|Problem with Infusion|1
4593248|NCT01549652|7441558|FG001|Overall Study|Problem with Infusion|0
4593249|NCT01549652|7441559|FG002|Overall Study|Problem with Infusion|0
4593250|NCT01549652|7441560|FG003|Overall Study|Problem with Infusion|0
4593251|NCT01549652|7441557|FG000|Overall Study|Titration Non-Compliance|1
4593252|NCT01549652|7441558|FG001|Overall Study|Titration Non-Compliance|3
4593253|NCT01549652|7441559|FG002|Overall Study|Titration Non-Compliance|4
4593254|NCT01549652|7441560|FG003|Overall Study|Titration Non-Compliance|5
4593255|NCT01549652|7441557|FG000|Overall Study|Titration Side Effects|0
4593256|NCT01549652|7441558|FG001|Overall Study|Titration Side Effects|0
4593257|NCT01549652|7441559|FG002|Overall Study|Titration Side Effects|6
4593258|NCT01549652|7441560|FG003|Overall Study|Titration Side Effects|3
4593259|NCT01549652|7441557|FG000|Overall Study|Withdrawal by Subject|0
4593260|NCT01549652|7441558|FG001|Overall Study|Withdrawal by Subject|0
4593261|NCT01549652|7441559|FG002|Overall Study|Withdrawal by Subject|5
4593262|NCT01549652|7441560|FG003|Overall Study|Withdrawal by Subject|3
4593263|NCT01549860|7441568|FG000|Overall Study|Withdrawal by Subject|1
4593264|NCT01549860|7441569|FG001|Overall Study|Withdrawal by Subject|0
4593265|NCT01549860|7441568|FG000|Overall Study|Physician Decision|1
4593266|NCT01549860|7441569|FG001|Overall Study|Physician Decision|1
4593267|NCT01549873|7441577|FG000|Overall Study|Physician Decision|0
4593268|NCT01549873|7441578|FG001|Overall Study|Physician Decision|1
4593269|NCT01549886|7441586|FG000|Overall Study|Sponsor's decision|2
4593270|NCT01549886|7441587|FG001|Overall Study|Sponsor's decision|3
4593271|NCT01549951|7441604|FG000|Overall Study|Adverse Event|15
4593272|NCT01549951|7441604|FG000|Overall Study|Withdrawal by Subject|2
4593273|NCT01549951|7441604|FG000|Overall Study|Unsatisfactory therapeutic response|1
4593274|NCT01549951|7441604|FG000|Overall Study|Progressive disease|29
4580145|NCT01442181|7422547|FG000|Overall Study|patient refused surgery|1
4580146|NCT01442181|7422548|FG001|Overall Study|patient refused surgery|0
4580147|NCT01442181|7422547|FG000|Overall Study|no insurance for surgery|1
4580148|NCT01442181|7422548|FG001|Overall Study|no insurance for surgery|0
4580149|NCT01442181|7422547|FG000|Overall Study|low ejection factor|0
4580150|NCT01442181|7422548|FG001|Overall Study|low ejection factor|1
4580151|NCT01442181|7422547|FG000|Overall Study|Lost to Follow-up|1
4580152|NCT01442181|7422548|FG001|Overall Study|Lost to Follow-up|1
4580153|NCT01442181|7422547|FG000|Overall Study|patient in an additional study|1
4580154|NCT01442181|7422548|FG001|Overall Study|patient in an additional study|0
4580155|NCT01442181|7422547|FG000|Overall Study|atrial fibrillation not noted|0
4580156|NCT01442181|7422548|FG001|Overall Study|atrial fibrillation not noted|1
4580157|NCT01442376|7422558|FG000|Overall Study|Adverse Event|0
4580158|NCT01442376|7422559|FG001|Overall Study|Adverse Event|3
4580159|NCT01442376|7422560|FG002|Overall Study|Adverse Event|2
4580160|NCT01442376|7422558|FG000|Overall Study|Death|0
4580161|NCT01442376|7422559|FG001|Overall Study|Death|1
4580162|NCT01442376|7422560|FG002|Overall Study|Death|1
4580163|NCT01442376|7422558|FG000|Overall Study|Withdrawal of consent|0
4580164|NCT01442376|7422559|FG001|Overall Study|Withdrawal of consent|0
4580165|NCT01442376|7422560|FG002|Overall Study|Withdrawal of consent|1
4580166|NCT01442376|7422558|FG000|Overall Study|Patients not treated|2
4580167|NCT01442376|7422559|FG001|Overall Study|Patients not treated|3
4580168|NCT01442376|7422560|FG002|Overall Study|Patients not treated|1
4580169|NCT01442376|7422558|FG000|Overall Study|Not eligible for subsequent cycles|1
4580170|NCT01442376|7422559|FG001|Overall Study|Not eligible for subsequent cycles|2
4580171|NCT01442376|7422560|FG002|Overall Study|Not eligible for subsequent cycles|0
4580172|NCT01442493|7422570|FG000|Overall Study|withdrawn from study|3
4580173|NCT01442493|7422571|FG001|Overall Study|withdrawn from study|2
4580174|NCT01442675|7422577|FG000|Overall Study|Protocol Violation|6
4580175|NCT01442675|7422577|FG000|Overall Study|Lost to Follow-up|2
4580176|NCT01442675|7422577|FG000|Overall Study|Withdrawal by Subject|4
4580177|NCT01442688|7422584|FG000|First Intervention|Withdrawal by Subject|1
4580178|NCT01442688|7422585|FG001|First Intervention|Withdrawal by Subject|0
4580179|NCT01442688|7422584|FG000|First Intervention|subject incarcerated|1
4580180|NCT01442688|7422585|FG001|First Intervention|subject incarcerated|0
4580181|NCT01442688|7422584|FG000|Second Intervention|Adverse Event|1
4580182|NCT01442688|7422585|FG001|Second Intervention|Adverse Event|0
4580183|NCT01442714|7422591|FG000|Overall Study|Death|11
4580184|NCT01442714|7422591|FG000|Overall Study|Withdrawal by Subject|1
4580185|NCT01442779|7422597|FG000|Overall Study|Withdrawal by Subject|3
4580186|NCT01442779|7422597|FG000|Overall Study|Death|3
4580187|NCT01442779|7422597|FG000|Overall Study|Non-compliance|1
4580188|NCT01443026|7422612|FG000|Overall Study|Physician Decision|1
4580189|NCT01443026|7422613|FG001|Overall Study|Physician Decision|0
4580190|NCT01443026|7422612|FG000|Overall Study|Death|0
4580191|NCT01443026|7422613|FG001|Overall Study|Death|1
4580192|NCT01443026|7422612|FG000|Overall Study|Withdrawal by Subject|0
4580193|NCT01443026|7422613|FG001|Overall Study|Withdrawal by Subject|3
4580194|NCT01443026|7422612|FG000|Overall Study|Lost to Follow-up|2
4580195|NCT01443026|7422613|FG001|Overall Study|Lost to Follow-up|1
4580196|NCT01443078|7422619|FG000|Overall Study|Responded to neoadjuvant platinum txt|27
4580197|NCT01443078|7422619|FG000|Overall Study|Withdrawal by Subject|1
4580198|NCT01443078|7422619|FG000|Overall Study|Patient had brain mets|1
4580199|NCT01443130|7422629|FG000|Overall Study|Lost to Follow-up|44
4580200|NCT01443130|7422630|FG001|Overall Study|Lost to Follow-up|42
4580201|NCT01443130|7422631|FG002|Overall Study|Lost to Follow-up|50
4580202|NCT01443130|7422632|FG003|Overall Study|Lost to Follow-up|23
4580203|NCT01443130|7422633|FG004|Overall Study|Lost to Follow-up|25
4580204|NCT01443130|7422634|FG005|Overall Study|Lost to Follow-up|21
4580205|NCT01443130|7422629|FG000|Overall Study|Death|0
4580206|NCT01443130|7422630|FG001|Overall Study|Death|1
4580207|NCT01443130|7422631|FG002|Overall Study|Death|0
4580208|NCT01443130|7422632|FG003|Overall Study|Death|7
4580209|NCT01443130|7422633|FG004|Overall Study|Death|10
4580210|NCT01443130|7422634|FG005|Overall Study|Death|8
4580211|NCT01443130|7422629|FG000|Overall Study|Adverse Event|2
4580212|NCT01443130|7422630|FG001|Overall Study|Adverse Event|1
4580213|NCT01443130|7422631|FG002|Overall Study|Adverse Event|1
4580214|NCT01443130|7422632|FG003|Overall Study|Adverse Event|0
4580215|NCT01443130|7422633|FG004|Overall Study|Adverse Event|0
4580216|NCT01443130|7422634|FG005|Overall Study|Adverse Event|0
4580217|NCT01443130|7422629|FG000|Overall Study|Protocol Violation|2
4580218|NCT01443130|7422630|FG001|Overall Study|Protocol Violation|1
4580219|NCT01443130|7422631|FG002|Overall Study|Protocol Violation|3
4580220|NCT01443130|7422632|FG003|Overall Study|Protocol Violation|2
4580221|NCT01443130|7422633|FG004|Overall Study|Protocol Violation|2
4580222|NCT01443130|7422634|FG005|Overall Study|Protocol Violation|3
4580223|NCT01443130|7422629|FG000|Overall Study|Withdrawal by Subject|15
4580224|NCT01443130|7422630|FG001|Overall Study|Withdrawal by Subject|14
4580225|NCT01443130|7422631|FG002|Overall Study|Withdrawal by Subject|12
4580226|NCT01443130|7422632|FG003|Overall Study|Withdrawal by Subject|7
4580227|NCT01443130|7422633|FG004|Overall Study|Withdrawal by Subject|7
4580228|NCT01443130|7422634|FG005|Overall Study|Withdrawal by Subject|2
4580229|NCT01443130|7422629|FG000|Overall Study|Death of Subject's Infant|5
4580230|NCT01443130|7422630|FG001|Overall Study|Death of Subject's Infant|10
4580231|NCT01443130|7422631|FG002|Overall Study|Death of Subject's Infant|11
4580232|NCT01443130|7422632|FG003|Overall Study|Death of Subject's Infant|0
4580233|NCT01443130|7422633|FG004|Overall Study|Death of Subject's Infant|0
4580234|NCT01443130|7422634|FG005|Overall Study|Death of Subject's Infant|0
4580235|NCT01443364|7422648|FG000|Overall Study|Lack of Efficacy|14
4580236|NCT01443364|7422648|FG000|Overall Study|Lost to Follow-up|3
4580237|NCT01443364|7422648|FG000|Overall Study|Withdrawal by Subject|5
4580238|NCT01443364|7422648|FG000|Overall Study|Other Reason|4
4580239|NCT01443364|7422648|FG000|Overall Study|SAE, non-fatal|6
4580240|NCT01443364|7422648|FG000|Overall Study|AE, non-serious non-fatal|8
4580241|NCT01443364|7422648|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
4580242|NCT01443403|7422656|FG000|Overall Study|Adverse Event|1
4580243|NCT01443403|7422657|FG001|Overall Study|Adverse Event|1
4580244|NCT01443403|7422658|FG002|Overall Study|Adverse Event|4
4580245|NCT01443403|7422659|FG003|Overall Study|Adverse Event|5
4580246|NCT01443403|7422656|FG000|Overall Study|Withdrawal by Subject|0
4580247|NCT01443403|7422657|FG001|Overall Study|Withdrawal by Subject|1
4580248|NCT01443403|7422658|FG002|Overall Study|Withdrawal by Subject|2
4580249|NCT01443403|7422659|FG003|Overall Study|Withdrawal by Subject|1
4580250|NCT01443403|7422656|FG000|Overall Study|Lost to Follow-up|0
4580251|NCT01443403|7422657|FG001|Overall Study|Lost to Follow-up|0
4580252|NCT01443403|7422658|FG002|Overall Study|Lost to Follow-up|0
4580253|NCT01443403|7422659|FG003|Overall Study|Lost to Follow-up|1
4580254|NCT01443403|7422656|FG000|Overall Study|Protocol Violation|2
4580255|NCT01443403|7422657|FG001|Overall Study|Protocol Violation|1
4580256|NCT01443403|7422658|FG002|Overall Study|Protocol Violation|1
4580257|NCT01443403|7422659|FG003|Overall Study|Protocol Violation|1
4580258|NCT01443403|7422656|FG000|Overall Study|Use of Prohibited Treatment|2
4580259|NCT01443403|7422657|FG001|Overall Study|Use of Prohibited Treatment|3
4580260|NCT01443403|7422658|FG002|Overall Study|Use of Prohibited Treatment|0
4580261|NCT01443403|7422659|FG003|Overall Study|Use of Prohibited Treatment|0
4580262|NCT01443403|7422656|FG000|Overall Study|Other - Miscellaneous|1
4580263|NCT01443403|7422657|FG001|Overall Study|Other - Miscellaneous|0
4580264|NCT01443403|7422658|FG002|Overall Study|Other - Miscellaneous|0
4580265|NCT01443403|7422659|FG003|Overall Study|Other - Miscellaneous|1
4580266|NCT01443845|7422702|FG000|Overall Study|Protocol Violation|43
4580267|NCT01443845|7422703|FG001|Overall Study|Protocol Violation|45
4580268|NCT01443845|7422702|FG000|Overall Study|Other reasons, such as COPD exacerbation|44
4580269|NCT01443845|7422703|FG001|Overall Study|Other reasons, such as COPD exacerbation|44
4580270|NCT01443845|7422702|FG000|Overall Study|Deterioration in pulmonary function|1
4580271|NCT01443845|7422703|FG001|Overall Study|Deterioration in pulmonary function|4
4580272|NCT01443845|7422702|FG000|Overall Study|Lack of Efficacy|10
4580273|NCT01443845|7422703|FG001|Overall Study|Lack of Efficacy|5
4580274|NCT01443845|7422702|FG000|Overall Study|Adverse Event|64
4580275|NCT01443845|7422703|FG001|Overall Study|Adverse Event|138
4580276|NCT01443845|7422702|FG000|Overall Study|Withdrawal by Subject|63
4580277|NCT01443845|7422703|FG001|Overall Study|Withdrawal by Subject|67
4580278|NCT01443845|7422702|FG000|Overall Study|Military Conflict - Site Terminated|20
4580279|NCT01443845|7422703|FG001|Overall Study|Military Conflict - Site Terminated|21
4580280|NCT01443845|7422702|FG000|Overall Study|Lost to Follow-up|9
4580281|NCT01443845|7422703|FG001|Overall Study|Lost to Follow-up|13
4580282|NCT01443858|7422712|FG000|Overall Study|Withdrawal by Subject|9
4580283|NCT01443858|7422713|FG001|Overall Study|Withdrawal by Subject|8
4580284|NCT01443858|7422714|FG002|Overall Study|Withdrawal by Subject|5
4580285|NCT01443858|7422712|FG000|Overall Study|Lack of Efficacy|1
4580286|NCT01443858|7422713|FG001|Overall Study|Lack of Efficacy|0
4580287|NCT01443858|7422714|FG002|Overall Study|Lack of Efficacy|0
4580288|NCT01443858|7422712|FG000|Overall Study|Lost to Follow-up|5
4580289|NCT01443858|7422713|FG001|Overall Study|Lost to Follow-up|5
4580290|NCT01443858|7422714|FG002|Overall Study|Lost to Follow-up|2
4580291|NCT01444027|7422725|FG000|Overall Study|Withdrawal by Subject|4
4580292|NCT01444027|7422726|FG001|Overall Study|Withdrawal by Subject|10
4580293|NCT01444027|7422727|FG002|Overall Study|Withdrawal by Subject|24
4580294|NCT01444027|7422725|FG000|Overall Study|Lost to Follow-up|26
4580295|NCT01444027|7422726|FG001|Overall Study|Lost to Follow-up|20
4580296|NCT01444027|7422727|FG002|Overall Study|Lost to Follow-up|14
4580297|NCT01444300|7422751|FG000|Overall Study|Adverse Event|4
4580298|NCT01444300|7422752|FG001|Overall Study|Adverse Event|0
4580299|NCT01444378|7422759|FG000|Overall Study|Lost to Follow-up|1
4580300|NCT01444378|7422759|FG000|Overall Study|Withdrawal by Subject|1
4580301|NCT01444378|7422759|FG000|Overall Study|Death|3
4580302|NCT01444378|7422759|FG000|Overall Study|Administrative Closure Of The Study|2
4580303|NCT01444378|7422759|FG000|Overall Study|Missed Visits|10
4580304|NCT01444391|7422766|FG000|Overall Study|Death|1
4580305|NCT01444417|7422772|FG000|Overall Study|Ineligibility Determined|0
4580306|NCT01444417|7422773|FG001|Overall Study|Ineligibility Determined|1
4580307|NCT01444417|7422772|FG000|Overall Study|Withdrawal by Subject|2
4580308|NCT01444417|7422773|FG001|Overall Study|Withdrawal by Subject|0
4580309|NCT01444430|7422781|FG000|Overall Study|Withdrawal by Subject|53
4580310|NCT01444430|7422782|FG001|Overall Study|Withdrawal by Subject|72
4580311|NCT01444430|7422781|FG000|Overall Study|Death|6
4580312|NCT01444430|7422782|FG001|Overall Study|Death|8
4580313|NCT01444430|7422781|FG000|Overall Study|Lost to Follow-up|2
4580314|NCT01444430|7422782|FG001|Overall Study|Lost to Follow-up|0
4580315|NCT01444430|7422781|FG000|Overall Study|CRF termination module not completed.|0
4580316|NCT01444430|7422782|FG001|Overall Study|CRF termination module not completed.|1
4580317|NCT01444456|7422788|FG000|Overall Study|Withdrawal by Subject|21
4580318|NCT01444456|7422788|FG000|Overall Study|Physician Decision|9
4580319|NCT01444456|7422788|FG000|Overall Study|Lost to Follow-up|37
4580320|NCT01444456|7422788|FG000|Overall Study|Death|73
4580321|NCT01444456|7422788|FG000|Overall Study|Ineligibility determined|23
4580322|NCT01444456|7422788|FG000|Overall Study|Other|18
4580323|NCT01444456|7422788|FG000|Overall Study|Not treated|104
4580324|NCT01444651|7422794|FG000|Overall Study|Adverse Event|3
4580325|NCT01444651|7422795|FG001|Overall Study|Adverse Event|2
4580326|NCT01444651|7422794|FG000|Overall Study|Lost to Follow-up|5
4580327|NCT01444651|7422795|FG001|Overall Study|Lost to Follow-up|5
4580328|NCT01444651|7422794|FG000|Overall Study|Non-fasting|2
4580329|NCT01444651|7422795|FG001|Overall Study|Non-fasting|1
4580330|NCT01444651|7422794|FG000|Overall Study|Missing data|1
4580331|NCT01444651|7422795|FG001|Overall Study|Missing data|1
4580332|NCT01444742|7422805|FG000|Overall Study|Death|1
4580333|NCT01444781|7422812|FG000|Overall Study|Lost to Follow-up|0
4580334|NCT01444781|7422813|FG001|Overall Study|Lost to Follow-up|3
4580335|NCT01444781|7422814|FG002|Overall Study|Lost to Follow-up|1
4580336|NCT01444781|7422812|FG000|Overall Study|Withdrawal by Subject|3
4580337|NCT01444781|7422813|FG001|Overall Study|Withdrawal by Subject|1
4580338|NCT01444781|7422814|FG002|Overall Study|Withdrawal by Subject|2
4580339|NCT01444898|7422829|FG000|Overall Study|Withdrawal by Subject|1
4580340|NCT01445080|7422869|FG000|Overall Study|Adverse Event|5
4580341|NCT01445080|7422870|FG001|Overall Study|Adverse Event|3
4580342|NCT01445080|7422871|FG002|Overall Study|Adverse Event|11
4580343|NCT01445080|7422872|FG003|Overall Study|Adverse Event|6
4580344|NCT01445080|7422873|FG004|Overall Study|Adverse Event|2
4580345|NCT01445080|7422874|FG005|Overall Study|Adverse Event|3
4580346|NCT01445080|7422875|FG006|Overall Study|Adverse Event|0
4580347|NCT01445080|7422876|FG007|Overall Study|Adverse Event|3
4580348|NCT01445080|7422877|FG008|Overall Study|Adverse Event|10
4580349|NCT01445080|7422869|FG000|Overall Study|Physician Decision|0
4580350|NCT01445080|7422870|FG001|Overall Study|Physician Decision|0
4580351|NCT01445080|7422871|FG002|Overall Study|Physician Decision|1
4580352|NCT01445080|7422872|FG003|Overall Study|Physician Decision|0
4580353|NCT01445080|7422873|FG004|Overall Study|Physician Decision|0
4580354|NCT01445080|7422874|FG005|Overall Study|Physician Decision|3
4580355|NCT01445080|7422875|FG006|Overall Study|Physician Decision|2
4580356|NCT01445080|7422876|FG007|Overall Study|Physician Decision|2
4580357|NCT01445080|7422877|FG008|Overall Study|Physician Decision|0
4580358|NCT01445080|7422869|FG000|Overall Study|Withdrawal by Subject|1
4580359|NCT01445080|7422870|FG001|Overall Study|Withdrawal by Subject|0
4580360|NCT01445080|7422871|FG002|Overall Study|Withdrawal by Subject|0
4580361|NCT01445080|7422872|FG003|Overall Study|Withdrawal by Subject|1
4580362|NCT01445080|7422873|FG004|Overall Study|Withdrawal by Subject|0
4580363|NCT01445080|7422874|FG005|Overall Study|Withdrawal by Subject|0
4580364|NCT01445080|7422875|FG006|Overall Study|Withdrawal by Subject|0
4580365|NCT01445080|7422876|FG007|Overall Study|Withdrawal by Subject|0
4580366|NCT01445080|7422877|FG008|Overall Study|Withdrawal by Subject|2
4580367|NCT01445080|7422869|FG000|Overall Study|Ineligible/Inevaluable|1
4580368|NCT01445080|7422870|FG001|Overall Study|Ineligible/Inevaluable|2
4580369|NCT01445080|7422871|FG002|Overall Study|Ineligible/Inevaluable|0
4580370|NCT01445080|7422872|FG003|Overall Study|Ineligible/Inevaluable|1
4580371|NCT01445080|7422873|FG004|Overall Study|Ineligible/Inevaluable|2
4580372|NCT01445080|7422874|FG005|Overall Study|Ineligible/Inevaluable|3
4580373|NCT01445080|7422875|FG006|Overall Study|Ineligible/Inevaluable|0
4580374|NCT01445080|7422876|FG007|Overall Study|Ineligible/Inevaluable|0
4580375|NCT01445080|7422877|FG008|Overall Study|Ineligible/Inevaluable|6
4580376|NCT01445171|7422912|FG000|Overall Study|Lost to Follow-up|11
4580377|NCT01445171|7422912|FG000|Overall Study|Withdrawal by Subject|16
4580378|NCT01445171|7422912|FG000|Overall Study|Death|51
4580379|NCT01445171|7422912|FG000|Overall Study|Subjects declined to return for followup|9
4580380|NCT01445171|7422912|FG000|Overall Study|Consented but did not receive device|8
4580381|NCT01445301|7422921|FG000|Overall Study|Adverse Event|15
4580382|NCT01445301|7422922|FG001|Overall Study|Adverse Event|25
4580383|NCT01445301|7422923|FG002|Overall Study|Adverse Event|4
4580384|NCT01445301|7422921|FG000|Overall Study|Lack of Efficacy|0
4580385|NCT01445301|7422922|FG001|Overall Study|Lack of Efficacy|1
4580386|NCT01445301|7422923|FG002|Overall Study|Lack of Efficacy|0
4580387|NCT01445301|7422921|FG000|Overall Study|Protocol Violation|1
4580388|NCT01445301|7422922|FG001|Overall Study|Protocol Violation|0
4580389|NCT01445301|7422923|FG002|Overall Study|Protocol Violation|0
4580390|NCT01445301|7422921|FG000|Overall Study|Protocol-Defined Stopping Criteria|0
4580391|NCT01445301|7422922|FG001|Overall Study|Protocol-Defined Stopping Criteria|1
4580392|NCT01445301|7422923|FG002|Overall Study|Protocol-Defined Stopping Criteria|1
4580393|NCT01445301|7422921|FG000|Overall Study|Physician Decision|0
4580394|NCT01445301|7422922|FG001|Overall Study|Physician Decision|2
4626332|NCT01839279|7491875|FG002|Overall Study|Withdrawal by Subject|1
4626333|NCT01839279|7491873|FG000|Overall Study|Classified as 'Other'|5
4580395|NCT01445301|7422923|FG002|Overall Study|Physician Decision|0
4580396|NCT01445301|7422921|FG000|Overall Study|Withdrawal by Subject|5
4580397|NCT01445301|7422922|FG001|Overall Study|Withdrawal by Subject|6
4580398|NCT01445301|7422923|FG002|Overall Study|Withdrawal by Subject|4
4580399|NCT01445535|7422935|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0
4580400|NCT01445535|7422936|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0
4580401|NCT01445535|7422937|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0
4580402|NCT01445535|7422938|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1
4580403|NCT01445535|7422935|FG000|Overall Study|Disease progression|1
4580404|NCT01445535|7422936|FG001|Overall Study|Disease progression|0
4580405|NCT01445535|7422937|FG002|Overall Study|Disease progression|1
4580406|NCT01445535|7422938|FG003|Overall Study|Disease progression|0
4580407|NCT01445535|7422935|FG000|Overall Study|PI discretion|0
4580408|NCT01445535|7422936|FG001|Overall Study|PI discretion|0
4580409|NCT01445535|7422937|FG002|Overall Study|PI discretion|0
4580410|NCT01445535|7422938|FG003|Overall Study|PI discretion|1
4580411|NCT01445548|7422949|FG000|Overall Study|Adverse Event|1
4580412|NCT01445613|7422953|FG000|30-day Follow-up|Withdrawal by Subject|6
4580413|NCT01445613|7422953|FG000|30-day Follow-up|Physician Decision|3
4580414|NCT01445613|7422953|FG000|30-day Follow-up|Missed visit|23
4580415|NCT01445613|7422953|FG000|30-day Follow-up|Death|3
4580416|NCT01445613|7422953|FG000|1-year Follow-up|Withdrawal by Subject|12
4580417|NCT01445613|7422953|FG000|1-year Follow-up|Missed visit|29
4580418|NCT01445613|7422953|FG000|1-year Follow-up|Lost to Follow-up|2
4580419|NCT01445613|7422953|FG000|1-year Follow-up|Death|30
4580420|NCT01445613|7422953|FG000|1-year Follow-up|Physician Decision|2
4580421|NCT01445613|7422953|FG000|1-year Follow-up|Received a non-study stent|2
4580422|NCT01445652|7422969|FG000|Overall Study|Not comfortable in lenses|5
4580423|NCT01445652|7422970|FG001|Overall Study|Not comfortable in lenses|0
4580424|NCT01445652|7422969|FG000|Overall Study|Failed to attend scheduled visit|2
4580425|NCT01445652|7422970|FG001|Overall Study|Failed to attend scheduled visit|3
4580426|NCT01445652|7422969|FG000|Overall Study|Failed teach session|2
4580427|NCT01445652|7422970|FG001|Overall Study|Failed teach session|0
4580428|NCT01445652|7422969|FG000|Overall Study|Adverse Event|1
4580429|NCT01445652|7422970|FG001|Overall Study|Adverse Event|0
4580430|NCT01445678|7422978|FG000|Overall Study|Adverse Event|12
4580431|NCT01445678|7422979|FG001|Overall Study|Adverse Event|8
4580432|NCT01445678|7422978|FG000|Overall Study|Lack of Efficacy|0
4580433|NCT01445678|7422979|FG001|Overall Study|Lack of Efficacy|2
4580434|NCT01445678|7422978|FG000|Overall Study|Lost to Follow-up|8
4580435|NCT01445678|7422979|FG001|Overall Study|Lost to Follow-up|5
4580436|NCT01445678|7422978|FG000|Overall Study|Protocol Violation|1
4580437|NCT01445678|7422979|FG001|Overall Study|Protocol Violation|1
4580438|NCT01445678|7422978|FG000|Overall Study|Withdrawal by Subject|9
4580439|NCT01445678|7422979|FG001|Overall Study|Withdrawal by Subject|5
4580440|NCT01445730|7422985|FG000|Overall Study|Adverse Event|1
4580441|NCT01445730|7422985|FG000|Overall Study|For the advice of a dentist|1
4580442|NCT01445730|7422985|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9
4580443|NCT01445769|7422989|FG000|Overall Study|Consent Withdrawn|2
4580444|NCT01445769|7422989|FG000|Overall Study|Disease Progression|1
4580445|NCT01445769|7422989|FG000|Overall Study|Lost to Follow-up|5
4580446|NCT01445847|7423006|FG000|Overall Study|Protocol Violation|13
4580447|NCT01445847|7423007|FG001|Overall Study|Protocol Violation|14
4580448|NCT01445847|7423006|FG000|Overall Study|Missed Data|1
4580449|NCT01445847|7423007|FG001|Overall Study|Missed Data|0
4580450|NCT01445886|7423017|FG000|Overall Study|Lost to Follow-up|2
4580451|NCT01445886|7423017|FG000|Overall Study|Protocol Violation|3
4580452|NCT01445951|7423026|FG000|Overall Study|Adverse Event|16
4580453|NCT01445951|7423027|FG001|Overall Study|Adverse Event|9
4580454|NCT01445951|7423028|FG002|Overall Study|Adverse Event|0
4580455|NCT01445951|7423026|FG000|Overall Study|Protocol Violation|2
4580456|NCT01445951|7423027|FG001|Overall Study|Protocol Violation|2
4580457|NCT01445951|7423028|FG002|Overall Study|Protocol Violation|2
4580458|NCT01445951|7423026|FG000|Overall Study|Withdrawal by Subject|21
4580459|NCT01445951|7423027|FG001|Overall Study|Withdrawal by Subject|16
4580460|NCT01445951|7423028|FG002|Overall Study|Withdrawal by Subject|8
4580461|NCT01445951|7423026|FG000|Overall Study|Physician Decision|3
4580462|NCT01445951|7423027|FG001|Overall Study|Physician Decision|1
4580463|NCT01445951|7423028|FG002|Overall Study|Physician Decision|0
4580464|NCT01445951|7423026|FG000|Overall Study|Lost to Follow-up|1
4580465|NCT01445951|7423027|FG001|Overall Study|Lost to Follow-up|2
4580466|NCT01445951|7423028|FG002|Overall Study|Lost to Follow-up|4
4580467|NCT01445951|7423026|FG000|Overall Study|Pregnancy|0
4580468|NCT01445951|7423027|FG001|Overall Study|Pregnancy|1
4580469|NCT01445951|7423028|FG002|Overall Study|Pregnancy|4
4580470|NCT01445951|7423026|FG000|Overall Study|Death|0
4580471|NCT01445951|7423027|FG001|Overall Study|Death|0
4580472|NCT01445951|7423028|FG002|Overall Study|Death|1
4580473|NCT01445951|7423026|FG000|Overall Study|Non-compliance with study drug|1
4580474|NCT01445951|7423027|FG001|Overall Study|Non-compliance with study drug|2
4580475|NCT01445951|7423028|FG002|Overall Study|Non-compliance with study drug|0
4580476|NCT01445951|7423026|FG000|Overall Study|Non-compliance with protocol|0
4580477|NCT01445951|7423027|FG001|Overall Study|Non-compliance with protocol|1
4580478|NCT01445951|7423028|FG002|Overall Study|Non-compliance with protocol|0
4580479|NCT01445951|7423026|FG000|Overall Study|Sponsor decision - subject travel|0
4580480|NCT01445951|7423027|FG001|Overall Study|Sponsor decision - subject travel|1
4580481|NCT01445951|7423028|FG002|Overall Study|Sponsor decision - subject travel|0
4580482|NCT01445951|7423026|FG000|Overall Study|Cough|0
4580483|NCT01445951|7423027|FG001|Overall Study|Cough|1
4580484|NCT01445951|7423028|FG002|Overall Study|Cough|0
4580485|NCT01446003|7423036|FG000|Period 1|Protocol Violation|2
4580486|NCT01446003|7423037|FG001|Period 1|Protocol Violation|0
4580487|NCT01446003|7423036|FG000|Period 2|Adverse Event|1
4580488|NCT01446003|7423037|FG001|Period 2|Adverse Event|0
4580489|NCT01446042|7423046|FG000|Overall Study|Withdrawal by Subject|12
4580490|NCT01446042|7423047|FG001|Overall Study|Withdrawal by Subject|2
4580491|NCT01446042|7423048|FG002|Overall Study|Withdrawal by Subject|4
4580492|NCT01446042|7423046|FG000|Overall Study|Adverse Event|1
4580493|NCT01446042|7423047|FG001|Overall Study|Adverse Event|0
4580494|NCT01446042|7423048|FG002|Overall Study|Adverse Event|4
4580495|NCT01446042|7423046|FG000|Overall Study|Lost to Follow-up|5
4580496|NCT01446042|7423047|FG001|Overall Study|Lost to Follow-up|0
4580497|NCT01446042|7423048|FG002|Overall Study|Lost to Follow-up|0
4580498|NCT01446042|7423046|FG000|Overall Study|Other reasons|2
4580499|NCT01446042|7423047|FG001|Overall Study|Other reasons|1
4580500|NCT01446042|7423048|FG002|Overall Study|Other reasons|1
4580501|NCT01446159|7423060|FG000|Overall Study|Withdrawal by Subject|1
4580502|NCT01446159|7423061|FG001|Overall Study|Withdrawal by Subject|0
4580503|NCT01446159|7423062|FG002|Overall Study|Withdrawal by Subject|14
4580504|NCT01446159|7423063|FG003|Overall Study|Withdrawal by Subject|11
4580505|NCT01446159|7423060|FG000|Overall Study|Lost to Follow-up|0
4580506|NCT01446159|7423061|FG001|Overall Study|Lost to Follow-up|0
4580507|NCT01446159|7423062|FG002|Overall Study|Lost to Follow-up|1
4580508|NCT01446159|7423063|FG003|Overall Study|Lost to Follow-up|2
4580509|NCT01446159|7423060|FG000|Overall Study|Death|2
4580510|NCT01446159|7423061|FG001|Overall Study|Death|3
4580511|NCT01446159|7423062|FG002|Overall Study|Death|43
4580512|NCT01446159|7423063|FG003|Overall Study|Death|36
4580513|NCT01446159|7423060|FG000|Overall Study|Other|0
4580514|NCT01446159|7423061|FG001|Overall Study|Other|0
4580515|NCT01446159|7423062|FG002|Overall Study|Other|13
4580516|NCT01446159|7423063|FG003|Overall Study|Other|13
4580517|NCT01446237|7423075|FG000|Overall Study|Adverse Event|1
4580518|NCT01446237|7423075|FG000|Overall Study|Lost to Follow-up|2
4580519|NCT01446237|7423075|FG000|Overall Study|Withdrawal by Subject|7
4580520|NCT01446289|7423083|FG000|Overall Study|Withdrawal by Subject|1
4580521|NCT01446289|7423084|FG001|Overall Study|Withdrawal by Subject|0
4580522|NCT01446289|7423085|FG002|Overall Study|Withdrawal by Subject|1
4580523|NCT01446289|7423086|FG003|Overall Study|Withdrawal by Subject|0
4580524|NCT01446419|7423100|FG000|Overall Study|Death|1
4580525|NCT01446419|7423101|FG001|Overall Study|Death|0
4580526|NCT01446419|7423100|FG000|Overall Study|Withdrawal by Subject|1
4580527|NCT01446419|7423101|FG001|Overall Study|Withdrawal by Subject|1
4580528|NCT01446419|7423100|FG000|Overall Study|Terminated per protocol|3
4580529|NCT01446419|7423101|FG001|Overall Study|Terminated per protocol|0
4580530|NCT01446809|7423133|FG000|Overall Study|Adverse Event|0
4580531|NCT01446809|7423134|FG001|Overall Study|Adverse Event|0
4580532|NCT01446809|7423135|FG002|Overall Study|Adverse Event|1
4580533|NCT01446809|7423133|FG000|Overall Study|Failure to complete study procedures|0
4580534|NCT01446809|7423134|FG001|Overall Study|Failure to complete study procedures|0
4580535|NCT01446809|7423135|FG002|Overall Study|Failure to complete study procedures|1
4580536|NCT01446874|7423147|FG000|Overall Study|Not eligible|1
4580537|NCT01446874|7423148|FG001|Overall Study|Not eligible|0
4580538|NCT01446874|7423149|FG002|Overall Study|Not eligible|0
4580539|NCT01446874|7423147|FG000|Overall Study|No surgery/No qualifying surgery|1
4580540|NCT01446874|7423148|FG001|Overall Study|No surgery/No qualifying surgery|0
4580541|NCT01446874|7423149|FG002|Overall Study|No surgery/No qualifying surgery|12
4580542|NCT01446874|7423147|FG000|Overall Study|Non-compliance|0
4580543|NCT01446874|7423148|FG001|Overall Study|Non-compliance|4
4580544|NCT01446874|7423149|FG002|Overall Study|Non-compliance|0
4580545|NCT01446874|7423147|FG000|Overall Study|Antibiotics for pre-op infection|0
4580546|NCT01446874|7423148|FG001|Overall Study|Antibiotics for pre-op infection|0
4580547|NCT01446874|7423149|FG002|Overall Study|Antibiotics for pre-op infection|2
4580548|NCT01446874|7423147|FG000|Overall Study|Withdrawal by Subject|0
4692904|NCT04960228|7603762|FG000|Overall Study|Failed attention check|69
4692905|NCT04960228|7603763|FG001|Overall Study|Failed attention check|148
4692906|NCT04960228|7603762|FG000|Overall Study|Flagged for response quality by Dynata|3
4692907|NCT04960228|7603763|FG001|Overall Study|Flagged for response quality by Dynata|3
4734967|NCT03514641|7682482|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3
4734968|NCT03514641|7682483|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3
4734969|NCT03515824|7682516|FG000|Overall Study|Death|3
4734970|NCT03515824|7682517|FG001|Overall Study|Death|2
4734971|NCT03515824|7682518|FG002|Overall Study|Death|6
4580549|NCT01446874|7423148|FG001|Overall Study|Withdrawal by Subject|0
4580550|NCT01446874|7423149|FG002|Overall Study|Withdrawal by Subject|4
4580551|NCT01446913|7423160|FG000|Overall Study|Significant illness|1
4580552|NCT01446913|7423161|FG001|Overall Study|Significant illness|1
4580553|NCT01446913|7423162|FG002|Overall Study|Significant illness|1
4734972|NCT03515824|7682519|FG003|Overall Study|Death|0
4734973|NCT03515824|7682516|FG000|Overall Study|Lost to Follow-up|0
4734974|NCT03515824|7682517|FG001|Overall Study|Lost to Follow-up|1
4580554|NCT01446913|7423160|FG000|Overall Study|Withdrawal by Subject|5
4580555|NCT01446913|7423161|FG001|Overall Study|Withdrawal by Subject|3
4580556|NCT01446913|7423162|FG002|Overall Study|Withdrawal by Subject|5
4580557|NCT01446913|7423160|FG000|Overall Study|Physician Decision|0
4580558|NCT01446913|7423161|FG001|Overall Study|Physician Decision|0
4580559|NCT01446913|7423162|FG002|Overall Study|Physician Decision|2
4580560|NCT01446913|7423160|FG000|Overall Study|Lost to Follow-up|3
4580561|NCT01446913|7423161|FG001|Overall Study|Lost to Follow-up|5
4580562|NCT01446913|7423162|FG002|Overall Study|Lost to Follow-up|3
4580563|NCT01446965|7423178|FG000|Randominization|One site was dismissed due to IRB irregularity|30
4580564|NCT01446965|7423179|FG001|Randominization|One site was dismissed due to IRB irregularity|16
4580565|NCT01446965|7423178|FG000|Participants Followed and Analyzed|Lost to Follow-up|10
4580566|NCT01446965|7423179|FG001|Participants Followed and Analyzed|Lost to Follow-up|12
4580567|NCT01447407|7423248|FG000|Overall Study|Withdrawal by Subject|2
4580568|NCT01447407|7423249|FG001|Overall Study|Withdrawal by Subject|0
4692908|NCT03922477|7603769|FG000|Overall Study|Death|9
4692909|NCT03922477|7603769|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1
4692910|NCT03922477|7603769|FG000|Overall Study|Physician Decision|1
4580569|NCT01447407|7423250|FG002|Overall Study|Withdrawal by Subject|0
4580570|NCT01447407|7423251|FG003|Overall Study|Withdrawal by Subject|1
4580571|NCT01447407|7423248|FG000|Overall Study|Physician Decision|0
4580572|NCT01447407|7423249|FG001|Overall Study|Physician Decision|0
4580573|NCT01447407|7423250|FG002|Overall Study|Physician Decision|1
4580574|NCT01447407|7423251|FG003|Overall Study|Physician Decision|1
4580575|NCT01447420|7423264|FG000|Overall Study|Adverse Event|2
4580576|NCT01447420|7423265|FG001|Overall Study|Adverse Event|4
4580577|NCT01447420|7423266|FG002|Overall Study|Adverse Event|2
4580578|NCT01447420|7423264|FG000|Overall Study|Protocol Violation|3
4580579|NCT01447420|7423265|FG001|Overall Study|Protocol Violation|3
4580580|NCT01447420|7423266|FG002|Overall Study|Protocol Violation|0
4580581|NCT01447420|7423264|FG000|Overall Study|Withdrawal by Subject|4
4580582|NCT01447420|7423265|FG001|Overall Study|Withdrawal by Subject|1
4580583|NCT01447420|7423266|FG002|Overall Study|Withdrawal by Subject|0
4580584|NCT01447420|7423264|FG000|Overall Study|Lack of Efficacy|1
4580585|NCT01447420|7423265|FG001|Overall Study|Lack of Efficacy|19
4580586|NCT01447420|7423266|FG002|Overall Study|Lack of Efficacy|8
4580587|NCT01447433|7423275|FG000|Overall Study|Lost to Follow-up|0
4580588|NCT01447433|7423276|FG001|Overall Study|Lost to Follow-up|2
4580589|NCT01447433|7423275|FG000|Overall Study|Withdrawal by Subject|3
4580590|NCT01447433|7423276|FG001|Overall Study|Withdrawal by Subject|3
4580591|NCT01447433|7423275|FG000|Overall Study|Protocol Violation|1
4580592|NCT01447433|7423276|FG001|Overall Study|Protocol Violation|1
4580593|NCT01447446|7423288|FG000|Overall Study|Death|6
4580594|NCT01447446|7423289|FG001|Overall Study|Death|3
4580595|NCT01447446|7423290|FG002|Overall Study|Death|2
4692911|NCT03922477|7603769|FG000|Overall Study|Withdrawal by Subject|2
4692919|NCT03091192|7603789|FG001|Overall Study|Study terminated by sponsor|14
4580596|NCT01447446|7423291|FG003|Overall Study|Death|1
4580597|NCT01447446|7423292|FG004|Overall Study|Death|7
4580598|NCT01447446|7423293|FG005|Overall Study|Death|0
4580599|NCT01447446|7423288|FG000|Overall Study|Adverse Event|3
4580600|NCT01447446|7423289|FG001|Overall Study|Adverse Event|0
4580601|NCT01447446|7423290|FG002|Overall Study|Adverse Event|1
4580602|NCT01447446|7423291|FG003|Overall Study|Adverse Event|0
4580603|NCT01447446|7423292|FG004|Overall Study|Adverse Event|2
4580604|NCT01447446|7423293|FG005|Overall Study|Adverse Event|0
4580605|NCT01447446|7423288|FG000|Overall Study|Failure to Return/Consent Withdrawn|357
4580606|NCT01447446|7423289|FG001|Overall Study|Failure to Return/Consent Withdrawn|78
4580607|NCT01447446|7423290|FG002|Overall Study|Failure to Return/Consent Withdrawn|31
4580608|NCT01447446|7423291|FG003|Overall Study|Failure to Return/Consent Withdrawn|7
4580609|NCT01447446|7423292|FG004|Overall Study|Failure to Return/Consent Withdrawn|69
4580610|NCT01447446|7423293|FG005|Overall Study|Failure to Return/Consent Withdrawn|9
4580611|NCT01447446|7423288|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300
4580612|NCT01447446|7423289|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71
4580613|NCT01447446|7423290|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52
4692920|NCT03091192|7603788|FG000|Overall Study|Death|9
4692921|NCT03091192|7603789|FG001|Overall Study|Death|13
4692922|NCT03091192|7603788|FG000|Overall Study|Withdrawal by Subject|2
4692923|NCT03091192|7603789|FG001|Overall Study|Withdrawal by Subject|0
4692924|NCT03091192|7603788|FG000|Overall Study|Lost to Follow-up|1
4580614|NCT01447446|7423291|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21
4580615|NCT01447446|7423292|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92
4580616|NCT01447446|7423293|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14
4580617|NCT01447446|7423288|FG000|Overall Study|Administrative/Other|34
4580618|NCT01447446|7423289|FG001|Overall Study|Administrative/Other|9
4580619|NCT01447446|7423290|FG002|Overall Study|Administrative/Other|10
4580620|NCT01447446|7423291|FG003|Overall Study|Administrative/Other|2
4580621|NCT01447446|7423292|FG004|Overall Study|Administrative/Other|33
4580622|NCT01447446|7423293|FG005|Overall Study|Administrative/Other|4
4692925|NCT03091192|7603789|FG001|Overall Study|Lost to Follow-up|0
4734975|NCT03515824|7682518|FG002|Overall Study|Lost to Follow-up|1
4734976|NCT03515824|7682519|FG003|Overall Study|Lost to Follow-up|0
4580623|NCT01447446|7423288|FG000|Overall Study|SVR12 Assessment|13
4580624|NCT01447446|7423289|FG001|Overall Study|SVR12 Assessment|1
4580625|NCT01447446|7423290|FG002|Overall Study|SVR12 Assessment|2
4580626|NCT01447446|7423291|FG003|Overall Study|SVR12 Assessment|1
4580627|NCT01447446|7423292|FG004|Overall Study|SVR12 Assessment|5
4580628|NCT01447446|7423293|FG005|Overall Study|SVR12 Assessment|5
4692912|NCT03688074|7603775|FG000|Overall Study|Adverse Event|0
4692913|NCT03688074|7603776|FG001|Overall Study|Adverse Event|1
4692914|NCT03688074|7603775|FG000|Overall Study|Other|1
4692915|NCT03688074|7603776|FG001|Overall Study|Other|0
4692916|NCT03342001|7603782|FG000|Overall Study|Adverse Event|1
4580629|NCT01447446|7423288|FG000|Overall Study|New Treatment Started|8
4580630|NCT01447446|7423289|FG001|Overall Study|New Treatment Started|2
4580631|NCT01447446|7423290|FG002|Overall Study|New Treatment Started|1
4580632|NCT01447446|7423291|FG003|Overall Study|New Treatment Started|0
4580633|NCT01447446|7423292|FG004|Overall Study|New Treatment Started|2
4580634|NCT01447446|7423293|FG005|Overall Study|New Treatment Started|0
4580635|NCT01447446|7423288|FG000|Overall Study|Reason not Specified|1
4580636|NCT01447446|7423289|FG001|Overall Study|Reason not Specified|1
4580637|NCT01447446|7423290|FG002|Overall Study|Reason not Specified|1
4580638|NCT01447446|7423291|FG003|Overall Study|Reason not Specified|1
4580639|NCT01447446|7423292|FG004|Overall Study|Reason not Specified|1
4580640|NCT01447446|7423293|FG005|Overall Study|Reason not Specified|0
4580641|NCT01447576|7423334|FG000|Overall Study|Lost to Follow-up|52
4580642|NCT01447576|7423334|FG000|Overall Study|Adverse Event|127
4580643|NCT01447576|7423334|FG000|Overall Study|Participant met withdrawal criteria|40
4580644|NCT01447576|7423334|FG000|Overall Study|Withdrawal by Subject|100
4580645|NCT01447576|7423334|FG000|Overall Study|Protocol deviation|83
4580646|NCT01447576|7423334|FG000|Overall Study|Lack of Efficacy|68
4580647|NCT01447576|7423334|FG000|Overall Study|Physician Decision|6
4580648|NCT01447719|7423351|FG000|Overall Study|Image acquisition failure|2
4580649|NCT01447719|7423351|FG000|Overall Study|Invalid image or not imaged|3
4580650|NCT01447719|7423351|FG000|Overall Study|Subject still living at end of study|79
4580651|NCT01447719|7423351|FG000|Overall Study|Withdrawal by Subject|2
4580652|NCT01447719|7423351|FG000|Overall Study|Family withdrew autopsy consent|7
4580653|NCT01447927|7423392|FG000|Overall Study|Adverse Event|4
4580654|NCT01447927|7423393|FG001|Overall Study|Adverse Event|3
4580655|NCT01447927|7423392|FG000|Overall Study|Withdrawal by Subject|1
4580656|NCT01447927|7423393|FG001|Overall Study|Withdrawal by Subject|0
4580657|NCT01448044|7423401|FG000|Treatment Period|Adverse Event|4
4580658|NCT01448044|7423402|FG001|Treatment Period|Adverse Event|3
4580659|NCT01448044|7423401|FG000|Treatment Period|Lack of Efficacy|5
4580660|NCT01448044|7423402|FG001|Treatment Period|Lack of Efficacy|12
4580661|NCT01448044|7423401|FG000|Treatment Period|Subject requested discontinue study drug|1
4580662|NCT01448044|7423402|FG001|Treatment Period|Subject requested discontinue study drug|0
4580663|NCT01448044|7423401|FG000|Treatment Period|Completed 24 weeks treatment period only|8
4580664|NCT01448044|7423402|FG001|Treatment Period|Completed 24 weeks treatment period only|0
4580665|NCT01448044|7423401|FG000|Treatment Period|Participant does not meet study criteria|1
4580666|NCT01448044|7423402|FG001|Treatment Period|Participant does not meet study criteria|0
4580667|NCT01448044|7423401|FG000|Treatment Period|Lost to Follow-up|2
4580668|NCT01448044|7423402|FG001|Treatment Period|Lost to Follow-up|1
4580669|NCT01448044|7423401|FG000|Treatment Period|Other reason|2
4580670|NCT01448044|7423402|FG001|Treatment Period|Other reason|0
4580671|NCT01448044|7423401|FG000|Follow Up Period|Withdrawal by Subject|1
4580672|NCT01448044|7423402|FG001|Follow Up Period|Withdrawal by Subject|1
4580673|NCT01448044|7423401|FG000|Follow Up Period|Lost to Follow-up|6
4580674|NCT01448044|7423402|FG001|Follow Up Period|Lost to Follow-up|2
4580675|NCT01448044|7423401|FG000|Follow Up Period|Other|5
4580676|NCT01448044|7423402|FG001|Follow Up Period|Other|11
4580677|NCT01448057|7423410|FG000|Overall Study|Protocol Violation|3
4580678|NCT01448057|7423411|FG001|Overall Study|Protocol Violation|2
4580679|NCT01448057|7423410|FG000|Overall Study|Lost to Follow-up|3
4580680|NCT01448057|7423411|FG001|Overall Study|Lost to Follow-up|0
4580681|NCT01448057|7423410|FG000|Overall Study|Adverse Event|0
4580682|NCT01448057|7423411|FG001|Overall Study|Adverse Event|2
4580683|NCT01448057|7423410|FG000|Overall Study|Withdrawal by Subject|2
4580684|NCT01448057|7423411|FG001|Overall Study|Withdrawal by Subject|0
4580685|NCT01448213|7423419|FG000|Overall Study|Lost to Follow-up|12
4580686|NCT01448213|7423420|FG001|Overall Study|Lost to Follow-up|10
4580687|NCT01448213|7423419|FG000|Overall Study|Adverse Event|4
4580688|NCT01448213|7423420|FG001|Overall Study|Adverse Event|10
4580689|NCT01448213|7423419|FG000|Overall Study|Protocol Violation|1
4580690|NCT01448213|7423420|FG001|Overall Study|Protocol Violation|2
4580691|NCT01448616|7423465|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3
4580692|NCT01448616|7423466|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0
4580693|NCT01448616|7423467|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0
4580694|NCT01448616|7423468|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0
4580695|NCT01448616|7423465|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6
4580696|NCT01448616|7423466|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0
4580697|NCT01448616|7423467|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0
4692917|NCT03342001|7603782|FG000|Overall Study|Lost to Follow-up|1
4692918|NCT03091192|7603788|FG000|Overall Study|Study terminated by sponsor|21
4580698|NCT01448616|7423468|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0
4580699|NCT01448616|7423465|FG000|Study Drug (Treatment Phase)|Adverse Event|0
4580700|NCT01448616|7423466|FG001|Study Drug (Treatment Phase)|Adverse Event|1
4580701|NCT01448616|7423467|FG002|Study Drug (Treatment Phase)|Adverse Event|1
4580702|NCT01448616|7423468|FG003|Study Drug (Treatment Phase)|Adverse Event|0
4580703|NCT01448616|7423465|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0
4580704|NCT01448616|7423466|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0
4580705|NCT01448616|7423467|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1
4580706|NCT01448616|7423468|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2
4580707|NCT01448616|7423465|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0
4580708|NCT01448616|7423466|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1
4580709|NCT01448616|7423467|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2
4580710|NCT01448616|7423468|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2
4580711|NCT01448707|7423483|FG000|Overall Study|Adverse Event|3
4580712|NCT01448707|7423484|FG001|Overall Study|Adverse Event|1
4580713|NCT01448707|7423483|FG000|Overall Study|Lost to Follow-up|2
4580714|NCT01448707|7423484|FG001|Overall Study|Lost to Follow-up|6
4580715|NCT01448707|7423483|FG000|Overall Study|Withdrawal by Subject|6
4580716|NCT01448707|7423484|FG001|Overall Study|Withdrawal by Subject|7
4580717|NCT01448707|7423483|FG000|Overall Study|Other|7
4580718|NCT01448707|7423484|FG001|Overall Study|Other|4
4580719|NCT01448824|7423498|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
4580720|NCT01448824|7423499|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
4580721|NCT01448824|7423500|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
4580722|NCT01448824|7423501|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
4580723|NCT01448824|7423502|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
4580724|NCT01448824|7423503|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
4580725|NCT01448824|7423504|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1
4580726|NCT01448824|7423505|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
4580727|NCT01448824|7423498|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
4580728|NCT01448824|7423499|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
4580729|NCT01448824|7423500|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
4580730|NCT01448824|7423501|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1
4580731|NCT01448824|7423502|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2
4580732|NCT01448824|7423503|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1
4580733|NCT01448824|7423504|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
4580734|NCT01448824|7423505|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
4580735|NCT01448824|7423498|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
4580736|NCT01448824|7423499|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
4580737|NCT01448824|7423500|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
4580738|NCT01448824|7423501|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
4580739|NCT01448824|7423502|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
4580740|NCT01448824|7423503|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1
4580741|NCT01448824|7423504|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
4580742|NCT01448824|7423505|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
4580743|NCT01448824|7423498|FG000|Part 1: Washout Period|Lost to Follow-up|1
4580744|NCT01448824|7423499|FG001|Part 1: Washout Period|Lost to Follow-up|0
4580745|NCT01448824|7423500|FG002|Part 1: Washout Period|Lost to Follow-up|0
4580746|NCT01448824|7423501|FG003|Part 1: Washout Period|Lost to Follow-up|0
4580747|NCT01448824|7423502|FG004|Part 1: Washout Period|Lost to Follow-up|0
4580748|NCT01448824|7423503|FG005|Part 1: Washout Period|Lost to Follow-up|0
4580749|NCT01448824|7423504|FG006|Part 1: Washout Period|Lost to Follow-up|0
4580750|NCT01448824|7423505|FG007|Part 1: Washout Period|Lost to Follow-up|0
4580751|NCT01448824|7423498|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
4580752|NCT01448824|7423499|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
4580753|NCT01448824|7423500|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
4580754|NCT01448824|7423501|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
4580755|NCT01448824|7423502|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
4580756|NCT01448824|7423503|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
4580757|NCT01448824|7423504|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
4580758|NCT01448824|7423505|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1
4580759|NCT01448824|7423498|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
4580760|NCT01448824|7423499|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
4580761|NCT01448824|7423500|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
4580762|NCT01448824|7423501|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
4580763|NCT01448824|7423502|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
4580764|NCT01448824|7423503|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
4580765|NCT01448824|7423504|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
4580766|NCT01448824|7423505|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1
4580767|NCT01448824|7423498|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
4580768|NCT01448824|7423499|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
4580769|NCT01448824|7423500|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
4580770|NCT01448824|7423501|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
4580771|NCT01448824|7423502|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
4580772|NCT01448824|7423503|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
4580773|NCT01448824|7423504|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
4580774|NCT01448824|7423505|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1
4580775|NCT01448824|7423498|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
4580776|NCT01448824|7423499|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
4580777|NCT01448824|7423500|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
4580778|NCT01448824|7423501|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
4580779|NCT01448824|7423502|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
4580780|NCT01448824|7423503|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
4580781|NCT01448824|7423504|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
4580782|NCT01448824|7423505|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1
4580783|NCT01448850|7423535|FG000|Overall Study|Death|3
4580784|NCT01448850|7423536|FG001|Overall Study|Death|6
4580785|NCT01448850|7423535|FG000|Overall Study|Withdrawal by Subject|13
4580786|NCT01448850|7423536|FG001|Overall Study|Withdrawal by Subject|21
4580787|NCT01448850|7423535|FG000|Overall Study|Lost to Follow-up|3
4580788|NCT01448850|7423536|FG001|Overall Study|Lost to Follow-up|1
4580789|NCT01448850|7423535|FG000|Overall Study|Other|15
4580790|NCT01448850|7423536|FG001|Overall Study|Other|12
4580791|NCT01449006|7423545|FG000|Overall Study|Lost to Follow-up|1
4580792|NCT01449006|7423546|FG001|Overall Study|Lost to Follow-up|0
4580793|NCT01449006|7423545|FG000|Overall Study|Withdrawal by Subject|1
4580794|NCT01449006|7423546|FG001|Overall Study|Withdrawal by Subject|0
4580795|NCT01449006|7423545|FG000|Overall Study|Protocol Violation|1
4580796|NCT01449006|7423546|FG001|Overall Study|Protocol Violation|0
4580797|NCT01449279|7423560|FG000|Overall Study|Lack of Efficacy|5
4580798|NCT01449279|7423560|FG000|Overall Study|Toxicity|2
4580799|NCT01449370|7423593|FG000|Overall Study|Disease Progression|5
4580800|NCT01449370|7423594|FG001|Overall Study|Disease Progression|4
4580801|NCT01449370|7423595|FG002|Overall Study|Disease Progression|8
4580802|NCT01449370|7423596|FG003|Overall Study|Disease Progression|3
4580803|NCT01449370|7423597|FG004|Overall Study|Disease Progression|3
4580804|NCT01449370|7423598|FG005|Overall Study|Disease Progression|3
4580805|NCT01449370|7423599|FG006|Overall Study|Disease Progression|3
4580806|NCT01449370|7423600|FG007|Overall Study|Disease Progression|2
4580807|NCT01449370|7423601|FG008|Overall Study|Disease Progression|9
4580808|NCT01449370|7423602|FG009|Overall Study|Disease Progression|1
4580809|NCT01449370|7423603|FG010|Overall Study|Disease Progression|3
4580810|NCT01449370|7423604|FG011|Overall Study|Disease Progression|3
4580811|NCT01449370|7423605|FG012|Overall Study|Disease Progression|2
4580812|NCT01449370|7423606|FG013|Overall Study|Disease Progression|8
4580813|NCT01449370|7423607|FG014|Overall Study|Disease Progression|3
4580814|NCT01449370|7423608|FG015|Overall Study|Disease Progression|1
4580815|NCT01449370|7423609|FG016|Overall Study|Disease Progression|4
4580816|NCT01449370|7423610|FG017|Overall Study|Disease Progression|3
4580817|NCT01449370|7423611|FG018|Overall Study|Disease Progression|1
4580818|NCT01449370|7423612|FG019|Overall Study|Disease Progression|2
4580819|NCT01449370|7423613|FG020|Overall Study|Disease Progression|5
4580820|NCT01449370|7423614|FG021|Overall Study|Disease Progression|2
4580821|NCT01449370|7423615|FG022|Overall Study|Disease Progression|3
4580822|NCT01449370|7423616|FG023|Overall Study|Disease Progression|7
4580823|NCT01449370|7423617|FG024|Overall Study|Disease Progression|3
4580824|NCT01449370|7423593|FG000|Overall Study|Adverse Event|1
4580825|NCT01449370|7423594|FG001|Overall Study|Adverse Event|2
4580826|NCT01449370|7423595|FG002|Overall Study|Adverse Event|0
4580827|NCT01449370|7423596|FG003|Overall Study|Adverse Event|1
4580828|NCT01449370|7423597|FG004|Overall Study|Adverse Event|0
4580829|NCT01449370|7423598|FG005|Overall Study|Adverse Event|0
4580830|NCT01449370|7423599|FG006|Overall Study|Adverse Event|0
4580831|NCT01449370|7423600|FG007|Overall Study|Adverse Event|0
4580832|NCT01449370|7423601|FG008|Overall Study|Adverse Event|1
4580833|NCT01449370|7423602|FG009|Overall Study|Adverse Event|1
4580834|NCT01449370|7423603|FG010|Overall Study|Adverse Event|0
4580835|NCT01449370|7423604|FG011|Overall Study|Adverse Event|0
4580836|NCT01449370|7423605|FG012|Overall Study|Adverse Event|0
4580837|NCT01449370|7423606|FG013|Overall Study|Adverse Event|2
4580838|NCT01449370|7423607|FG014|Overall Study|Adverse Event|0
4580839|NCT01449370|7423608|FG015|Overall Study|Adverse Event|1
4580840|NCT01449370|7423609|FG016|Overall Study|Adverse Event|0
4580841|NCT01449370|7423610|FG017|Overall Study|Adverse Event|0
4580842|NCT01449370|7423611|FG018|Overall Study|Adverse Event|1
4580843|NCT01449370|7423612|FG019|Overall Study|Adverse Event|1
4580844|NCT01449370|7423613|FG020|Overall Study|Adverse Event|0
4580845|NCT01449370|7423614|FG021|Overall Study|Adverse Event|1
4580846|NCT01449370|7423615|FG022|Overall Study|Adverse Event|0
4580847|NCT01449370|7423616|FG023|Overall Study|Adverse Event|1
4580848|NCT01449370|7423617|FG024|Overall Study|Adverse Event|3
4580849|NCT01449370|7423593|FG000|Overall Study|Participant Decision|0
4580850|NCT01449370|7423594|FG001|Overall Study|Participant Decision|0
4580851|NCT01449370|7423595|FG002|Overall Study|Participant Decision|0
4580852|NCT01449370|7423596|FG003|Overall Study|Participant Decision|0
4580853|NCT01449370|7423597|FG004|Overall Study|Participant Decision|0
4580854|NCT01449370|7423598|FG005|Overall Study|Participant Decision|0
4580855|NCT01449370|7423599|FG006|Overall Study|Participant Decision|0
4580856|NCT01449370|7423600|FG007|Overall Study|Participant Decision|1
4580857|NCT01449370|7423601|FG008|Overall Study|Participant Decision|1
4580858|NCT01449370|7423602|FG009|Overall Study|Participant Decision|0
4580859|NCT01449370|7423603|FG010|Overall Study|Participant Decision|0
4580860|NCT01449370|7423604|FG011|Overall Study|Participant Decision|0
4580861|NCT01449370|7423605|FG012|Overall Study|Participant Decision|1
4580862|NCT01449370|7423606|FG013|Overall Study|Participant Decision|1
4580863|NCT01449370|7423607|FG014|Overall Study|Participant Decision|0
4580864|NCT01449370|7423608|FG015|Overall Study|Participant Decision|1
4580865|NCT01449370|7423609|FG016|Overall Study|Participant Decision|3
4580866|NCT01449370|7423610|FG017|Overall Study|Participant Decision|0
4580867|NCT01449370|7423611|FG018|Overall Study|Participant Decision|1
4580868|NCT01449370|7423612|FG019|Overall Study|Participant Decision|0
4580869|NCT01449370|7423613|FG020|Overall Study|Participant Decision|0
4580870|NCT01449370|7423614|FG021|Overall Study|Participant Decision|1
4580871|NCT01449370|7423615|FG022|Overall Study|Participant Decision|0
4580872|NCT01449370|7423616|FG023|Overall Study|Participant Decision|0
4580873|NCT01449370|7423617|FG024|Overall Study|Participant Decision|1
4580874|NCT01449370|7423593|FG000|Overall Study|Lost to Follow-up|0
4580875|NCT01449370|7423594|FG001|Overall Study|Lost to Follow-up|0
4580876|NCT01449370|7423595|FG002|Overall Study|Lost to Follow-up|0
4580877|NCT01449370|7423596|FG003|Overall Study|Lost to Follow-up|0
4580878|NCT01449370|7423597|FG004|Overall Study|Lost to Follow-up|0
4580879|NCT01449370|7423598|FG005|Overall Study|Lost to Follow-up|0
4580880|NCT01449370|7423599|FG006|Overall Study|Lost to Follow-up|0
4580881|NCT01449370|7423600|FG007|Overall Study|Lost to Follow-up|0
4580882|NCT01449370|7423601|FG008|Overall Study|Lost to Follow-up|0
4580883|NCT01449370|7423602|FG009|Overall Study|Lost to Follow-up|0
4580884|NCT01449370|7423603|FG010|Overall Study|Lost to Follow-up|0
4580885|NCT01449370|7423604|FG011|Overall Study|Lost to Follow-up|0
4580886|NCT01449370|7423605|FG012|Overall Study|Lost to Follow-up|0
4580887|NCT01449370|7423606|FG013|Overall Study|Lost to Follow-up|0
4580888|NCT01449370|7423607|FG014|Overall Study|Lost to Follow-up|0
4580889|NCT01449370|7423608|FG015|Overall Study|Lost to Follow-up|0
4580890|NCT01449370|7423609|FG016|Overall Study|Lost to Follow-up|0
4580891|NCT01449370|7423610|FG017|Overall Study|Lost to Follow-up|0
4580892|NCT01449370|7423611|FG018|Overall Study|Lost to Follow-up|0
4580893|NCT01449370|7423612|FG019|Overall Study|Lost to Follow-up|0
4580894|NCT01449370|7423613|FG020|Overall Study|Lost to Follow-up|1
4580895|NCT01449370|7423614|FG021|Overall Study|Lost to Follow-up|0
4580896|NCT01449370|7423615|FG022|Overall Study|Lost to Follow-up|0
4580897|NCT01449370|7423616|FG023|Overall Study|Lost to Follow-up|0
4580898|NCT01449370|7423617|FG024|Overall Study|Lost to Follow-up|0
4580899|NCT01449370|7423593|FG000|Overall Study|Other|0
4580900|NCT01449370|7423594|FG001|Overall Study|Other|0
4580901|NCT01449370|7423595|FG002|Overall Study|Other|0
4580902|NCT01449370|7423596|FG003|Overall Study|Other|0
4580903|NCT01449370|7423597|FG004|Overall Study|Other|0
4580904|NCT01449370|7423598|FG005|Overall Study|Other|0
4580905|NCT01449370|7423599|FG006|Overall Study|Other|0
4580906|NCT01449370|7423600|FG007|Overall Study|Other|0
4580907|NCT01449370|7423601|FG008|Overall Study|Other|1
4580908|NCT01449370|7423602|FG009|Overall Study|Other|1
4580909|NCT01449370|7423603|FG010|Overall Study|Other|0
4580910|NCT01449370|7423604|FG011|Overall Study|Other|0
4580911|NCT01449370|7423605|FG012|Overall Study|Other|0
4580912|NCT01449370|7423606|FG013|Overall Study|Other|0
4580913|NCT01449370|7423607|FG014|Overall Study|Other|0
4580914|NCT01449370|7423608|FG015|Overall Study|Other|0
4580915|NCT01449370|7423609|FG016|Overall Study|Other|0
4580916|NCT01449370|7423610|FG017|Overall Study|Other|0
4580917|NCT01449370|7423611|FG018|Overall Study|Other|0
4580918|NCT01449370|7423612|FG019|Overall Study|Other|0
4580919|NCT01449370|7423613|FG020|Overall Study|Other|0
4580920|NCT01449370|7423614|FG021|Overall Study|Other|0
4580921|NCT01449370|7423615|FG022|Overall Study|Other|1
4580922|NCT01449370|7423616|FG023|Overall Study|Other|1
4580923|NCT01449370|7423617|FG024|Overall Study|Other|0
4580924|NCT01449370|7423593|FG000|Overall Study|Medication Prohibited by Protocol|0
4580925|NCT01449370|7423594|FG001|Overall Study|Medication Prohibited by Protocol|0
4580926|NCT01449370|7423595|FG002|Overall Study|Medication Prohibited by Protocol|0
4580927|NCT01449370|7423596|FG003|Overall Study|Medication Prohibited by Protocol|0
4580928|NCT01449370|7423597|FG004|Overall Study|Medication Prohibited by Protocol|0
4580929|NCT01449370|7423598|FG005|Overall Study|Medication Prohibited by Protocol|0
4580930|NCT01449370|7423599|FG006|Overall Study|Medication Prohibited by Protocol|0
4580931|NCT01449370|7423600|FG007|Overall Study|Medication Prohibited by Protocol|0
4580932|NCT01449370|7423601|FG008|Overall Study|Medication Prohibited by Protocol|0
4580933|NCT01449370|7423602|FG009|Overall Study|Medication Prohibited by Protocol|0
4580934|NCT01449370|7423603|FG010|Overall Study|Medication Prohibited by Protocol|0
4580935|NCT01449370|7423604|FG011|Overall Study|Medication Prohibited by Protocol|0
4580936|NCT01449370|7423605|FG012|Overall Study|Medication Prohibited by Protocol|0
4580937|NCT01449370|7423606|FG013|Overall Study|Medication Prohibited by Protocol|0
4580938|NCT01449370|7423607|FG014|Overall Study|Medication Prohibited by Protocol|0
4580939|NCT01449370|7423608|FG015|Overall Study|Medication Prohibited by Protocol|0
4580940|NCT01449370|7423609|FG016|Overall Study|Medication Prohibited by Protocol|0
4580941|NCT01449370|7423610|FG017|Overall Study|Medication Prohibited by Protocol|0
4580942|NCT01449370|7423611|FG018|Overall Study|Medication Prohibited by Protocol|0
4580943|NCT01449370|7423612|FG019|Overall Study|Medication Prohibited by Protocol|0
4580944|NCT01449370|7423613|FG020|Overall Study|Medication Prohibited by Protocol|0
4580945|NCT01449370|7423614|FG021|Overall Study|Medication Prohibited by Protocol|0
4580946|NCT01449370|7423615|FG022|Overall Study|Medication Prohibited by Protocol|0
4580947|NCT01449370|7423616|FG023|Overall Study|Medication Prohibited by Protocol|1
4580948|NCT01449370|7423617|FG024|Overall Study|Medication Prohibited by Protocol|0
4580949|NCT01449370|7423593|FG000|Overall Study|Death|0
4580950|NCT01449370|7423594|FG001|Overall Study|Death|0
4580951|NCT01449370|7423595|FG002|Overall Study|Death|0
4580952|NCT01449370|7423596|FG003|Overall Study|Death|0
4580953|NCT01449370|7423597|FG004|Overall Study|Death|0
4580954|NCT01449370|7423598|FG005|Overall Study|Death|0
4580955|NCT01449370|7423599|FG006|Overall Study|Death|0
4580956|NCT01449370|7423600|FG007|Overall Study|Death|0
4580957|NCT01449370|7423601|FG008|Overall Study|Death|0
4580958|NCT01449370|7423602|FG009|Overall Study|Death|0
4580959|NCT01449370|7423603|FG010|Overall Study|Death|0
4580960|NCT01449370|7423604|FG011|Overall Study|Death|0
4580961|NCT01449370|7423605|FG012|Overall Study|Death|0
4580962|NCT01449370|7423606|FG013|Overall Study|Death|0
4580963|NCT01449370|7423607|FG014|Overall Study|Death|0
4580964|NCT01449370|7423608|FG015|Overall Study|Death|0
4580965|NCT01449370|7423609|FG016|Overall Study|Death|0
4580966|NCT01449370|7423610|FG017|Overall Study|Death|0
4580967|NCT01449370|7423611|FG018|Overall Study|Death|0
4580968|NCT01449370|7423612|FG019|Overall Study|Death|0
4580969|NCT01449370|7423613|FG020|Overall Study|Death|0
4580970|NCT01449370|7423614|FG021|Overall Study|Death|0
4580971|NCT01449370|7423615|FG022|Overall Study|Death|0
4580972|NCT01449370|7423616|FG023|Overall Study|Death|0
4580973|NCT01449370|7423617|FG024|Overall Study|Death|1
4580974|NCT01449461|7423696|FG000|Overall Study|Adverse Event|0
4580975|NCT01449461|7423697|FG001|Overall Study|Adverse Event|3
4580976|NCT01449461|7423698|FG002|Overall Study|Adverse Event|2
4580977|NCT01449461|7423699|FG003|Overall Study|Adverse Event|3
4580978|NCT01449461|7423700|FG004|Overall Study|Adverse Event|4
4580979|NCT01449461|7423701|FG005|Overall Study|Adverse Event|4
4580980|NCT01449461|7423696|FG000|Overall Study|Death|0
4580981|NCT01449461|7423697|FG001|Overall Study|Death|2
4580982|NCT01449461|7423698|FG002|Overall Study|Death|0
4580983|NCT01449461|7423699|FG003|Overall Study|Death|0
4580984|NCT01449461|7423700|FG004|Overall Study|Death|7
4580985|NCT01449461|7423701|FG005|Overall Study|Death|1
4580986|NCT01449461|7423696|FG000|Overall Study|Physician Decision|0
4580987|NCT01449461|7423697|FG001|Overall Study|Physician Decision|1
4580988|NCT01449461|7423698|FG002|Overall Study|Physician Decision|0
4580989|NCT01449461|7423699|FG003|Overall Study|Physician Decision|4
4580990|NCT01449461|7423700|FG004|Overall Study|Physician Decision|1
4580991|NCT01449461|7423701|FG005|Overall Study|Physician Decision|0
4580992|NCT01449461|7423696|FG000|Overall Study|Documented Progressive Disease|4
4580993|NCT01449461|7423697|FG001|Overall Study|Documented Progressive Disease|7
4580994|NCT01449461|7423698|FG002|Overall Study|Documented Progressive Disease|14
4580995|NCT01449461|7423699|FG003|Overall Study|Documented Progressive Disease|15
4580996|NCT01449461|7423700|FG004|Overall Study|Documented Progressive Disease|24
4580997|NCT01449461|7423701|FG005|Overall Study|Documented Progressive Disease|5
4580998|NCT01449461|7423696|FG000|Overall Study|Clinical Progressive Disease|2
4580999|NCT01449461|7423697|FG001|Overall Study|Clinical Progressive Disease|2
4581000|NCT01449461|7423698|FG002|Overall Study|Clinical Progressive Disease|0
4581001|NCT01449461|7423699|FG003|Overall Study|Clinical Progressive Disease|3
4581002|NCT01449461|7423700|FG004|Overall Study|Clinical Progressive Disease|4
4581003|NCT01449461|7423701|FG005|Overall Study|Clinical Progressive Disease|2
4581004|NCT01449461|7423696|FG000|Overall Study|Protocol Violation|0
4581005|NCT01449461|7423697|FG001|Overall Study|Protocol Violation|0
4581006|NCT01449461|7423698|FG002|Overall Study|Protocol Violation|0
4581007|NCT01449461|7423699|FG003|Overall Study|Protocol Violation|1
4581008|NCT01449461|7423700|FG004|Overall Study|Protocol Violation|0
4581009|NCT01449461|7423701|FG005|Overall Study|Protocol Violation|0
4581010|NCT01449461|7423696|FG000|Overall Study|Site Terminated by Sponsor|0
4581011|NCT01449461|7423697|FG001|Overall Study|Site Terminated by Sponsor|1
4581012|NCT01449461|7423698|FG002|Overall Study|Site Terminated by Sponsor|2
4581013|NCT01449461|7423699|FG003|Overall Study|Site Terminated by Sponsor|3
4581014|NCT01449461|7423700|FG004|Overall Study|Site Terminated by Sponsor|4
4581015|NCT01449461|7423701|FG005|Overall Study|Site Terminated by Sponsor|1
4581016|NCT01449461|7423696|FG000|Overall Study|Withdrawal by Subject|0
4581017|NCT01449461|7423697|FG001|Overall Study|Withdrawal by Subject|1
4581018|NCT01449461|7423698|FG002|Overall Study|Withdrawal by Subject|0
4581019|NCT01449461|7423699|FG003|Overall Study|Withdrawal by Subject|0
4581020|NCT01449461|7423700|FG004|Overall Study|Withdrawal by Subject|2
4581021|NCT01449461|7423701|FG005|Overall Study|Withdrawal by Subject|1
4581022|NCT01449461|7423696|FG000|Overall Study|Reason not Specified|0
4581023|NCT01449461|7423697|FG001|Overall Study|Reason not Specified|1
4581024|NCT01449461|7423698|FG002|Overall Study|Reason not Specified|0
4581025|NCT01449461|7423699|FG003|Overall Study|Reason not Specified|3
4581026|NCT01449461|7423700|FG004|Overall Study|Reason not Specified|2
4581027|NCT01449461|7423701|FG005|Overall Study|Reason not Specified|1
4581028|NCT01449526|7423735|FG000|Overall Study|Lost to Follow-up|1
4581029|NCT01449526|7423736|FG001|Overall Study|Lost to Follow-up|2
4581030|NCT01449526|7423735|FG000|Overall Study|Withdrawal by Subject|1
4581031|NCT01449526|7423736|FG001|Overall Study|Withdrawal by Subject|1
4581032|NCT01449526|7423735|FG000|Overall Study|Symptoms/complaints|0
4581033|NCT01449526|7423736|FG001|Overall Study|Symptoms/complaints|1
4581034|NCT01449526|7423735|FG000|Overall Study|Lack of Motivation|0
4581035|NCT01449526|7423736|FG001|Overall Study|Lack of Motivation|1
4581036|NCT01449526|7423735|FG000|Overall Study|Cannot maintain visits|0
4581037|NCT01449526|7423736|FG001|Overall Study|Cannot maintain visits|1
4581038|NCT01449539|7423742|FG000|Overall Study|Withdrawal by Subject|3
4581039|NCT01449539|7423742|FG000|Overall Study|Toxicity not study related|1
4581040|NCT01449630|7423755|FG000|Period 1|Physician Decision|1
4581041|NCT01449630|7423756|FG001|Period 1|Physician Decision|0
4581042|NCT01449630|7423757|FG002|Period 1|Physician Decision|0
4581043|NCT01449630|7423758|FG003|Period 1|Physician Decision|1
4581044|NCT01449630|7423759|FG004|Period 1|Physician Decision|0
4581045|NCT01449630|7423760|FG005|Period 1|Physician Decision|0
4581046|NCT01449630|7423761|FG006|Period 1|Physician Decision|0
4581047|NCT01449630|7423762|FG007|Period 1|Physician Decision|0
4581048|NCT01449630|7423763|FG008|Period 1|Physician Decision|0
4581049|NCT01449630|7423755|FG000|Period 1|Sponsor Decision|0
4581050|NCT01449630|7423756|FG001|Period 1|Sponsor Decision|0
4581051|NCT01449630|7423757|FG002|Period 1|Sponsor Decision|0
4581052|NCT01449630|7423758|FG003|Period 1|Sponsor Decision|0
4581053|NCT01449630|7423759|FG004|Period 1|Sponsor Decision|0
4581054|NCT01449630|7423760|FG005|Period 1|Sponsor Decision|1
4581055|NCT01449630|7423761|FG006|Period 1|Sponsor Decision|0
4581056|NCT01449630|7423762|FG007|Period 1|Sponsor Decision|0
4581057|NCT01449630|7423763|FG008|Period 1|Sponsor Decision|0
4581058|NCT01449630|7423755|FG000|Period 2|Sponsor Decision|0
4581059|NCT01449630|7423756|FG001|Period 2|Sponsor Decision|0
4581060|NCT01449630|7423757|FG002|Period 2|Sponsor Decision|0
4581061|NCT01449630|7423758|FG003|Period 2|Sponsor Decision|0
4581062|NCT01449630|7423759|FG004|Period 2|Sponsor Decision|0
4581063|NCT01449630|7423760|FG005|Period 2|Sponsor Decision|0
4581064|NCT01449630|7423761|FG006|Period 2|Sponsor Decision|1
4581065|NCT01449630|7423762|FG007|Period 2|Sponsor Decision|0
4581066|NCT01449630|7423763|FG008|Period 2|Sponsor Decision|0
4593275|NCT01549951|7441604|FG000|Overall Study|Symptomatic deterioration|1
4593276|NCT01549951|7441604|FG000|Overall Study|Other|2
4593277|NCT01549964|7441612|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50
4593278|NCT01549964|7441613|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104
4593279|NCT01549964|7441614|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104
4593280|NCT01549964|7441615|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105
4593281|NCT01549964|7441612|FG000|24-Week Treatment Period|Voluntary Withdrawal|6
4593282|NCT01549964|7441613|FG001|24-Week Treatment Period|Voluntary Withdrawal|3
4593283|NCT01549964|7441614|FG002|24-Week Treatment Period|Voluntary Withdrawal|3
4593284|NCT01549964|7441615|FG003|24-Week Treatment Period|Voluntary Withdrawal|8
4593285|NCT01549964|7441612|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1
4593286|NCT01549964|7441613|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
4593287|NCT01549964|7441614|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
4593288|NCT01549964|7441615|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
4593289|NCT01549964|7441612|FG000|24-Week Treatment Period|Lost to Follow-up|1
4593290|NCT01549964|7441613|FG001|24-Week Treatment Period|Lost to Follow-up|0
4593291|NCT01549964|7441614|FG002|24-Week Treatment Period|Lost to Follow-up|1
4593292|NCT01549964|7441615|FG003|24-Week Treatment Period|Lost to Follow-up|2
4593293|NCT01549964|7441612|FG000|24-Week Treatment Period|Lack of Efficacy|1
4593294|NCT01549964|7441613|FG001|24-Week Treatment Period|Lack of Efficacy|0
4593295|NCT01549964|7441614|FG002|24-Week Treatment Period|Lack of Efficacy|1
4593296|NCT01549964|7441615|FG003|24-Week Treatment Period|Lack of Efficacy|1
4593297|NCT01549964|7441612|FG000|24-Week Treatment Period|Other|1
4593298|NCT01549964|7441613|FG001|24-Week Treatment Period|Other|0
4593299|NCT01549964|7441614|FG002|24-Week Treatment Period|Other|1
4593300|NCT01549964|7441615|FG003|24-Week Treatment Period|Other|0
4593301|NCT01549964|7441612|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
4593302|NCT01549964|7441613|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
4593303|NCT01549964|7441614|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1
4593304|NCT01549964|7441615|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
4593305|NCT01549964|7441612|FG000|24-Week Treatment Period|Randomized but Not Treated|0
4593306|NCT01549964|7441613|FG001|24-Week Treatment Period|Randomized but Not Treated|0
4593307|NCT01549964|7441614|FG002|24-Week Treatment Period|Randomized but Not Treated|0
4593308|NCT01549964|7441615|FG003|24-Week Treatment Period|Randomized but Not Treated|1
4593309|NCT01549964|7441612|FG000|24-Week Treatment Period|Completion Status Unknown|1
4593310|NCT01549964|7441613|FG001|24-Week Treatment Period|Completion Status Unknown|0
4593311|NCT01549964|7441614|FG002|24-Week Treatment Period|Completion Status Unknown|1
4593312|NCT01549964|7441615|FG003|24-Week Treatment Period|Completion Status Unknown|0
4581067|NCT01449682|7423787|FG000|Overall Study|Death|0
4581068|NCT01449682|7423788|FG001|Overall Study|Death|1
4581069|NCT01449682|7423787|FG000|Overall Study|Adverse Event|1
4581070|NCT01449682|7423788|FG001|Overall Study|Adverse Event|0
4581071|NCT01449708|7423796|FG000|Overall Study|Protocol Violation|0
4581072|NCT01449708|7423797|FG001|Overall Study|Protocol Violation|1
4581073|NCT01449708|7423796|FG000|Overall Study|surgical complication|1
4581074|NCT01449708|7423797|FG001|Overall Study|surgical complication|2
4581075|NCT01449708|7423796|FG000|Overall Study|respiratory failure|1
4581076|NCT01449708|7423797|FG001|Overall Study|respiratory failure|0
4581077|NCT01449721|7423808|FG000|Overall Study|Physician Decision|0
4581078|NCT01449721|7423809|FG001|Overall Study|Physician Decision|1
4581079|NCT01449721|7423808|FG000|Overall Study|Physician Decision|0
4581080|NCT01449721|7423809|FG001|Overall Study|Physician Decision|1
4581081|NCT01449812|7423831|FG000|Overall Study|Migrated/moved from study area|1
4581082|NCT01449812|7423832|FG001|Overall Study|Migrated/moved from study area|0
4581083|NCT01449812|7423833|FG002|Overall Study|Migrated/moved from study area|0
4581084|NCT01449812|7423831|FG000|Overall Study|Withdrawal by Subject|0
4581085|NCT01449812|7423832|FG001|Overall Study|Withdrawal by Subject|0
4581086|NCT01449812|7423833|FG002|Overall Study|Withdrawal by Subject|1
4581087|NCT01449812|7423831|FG000|Overall Study|Lost to Follow-up|1
4581088|NCT01449812|7423832|FG001|Overall Study|Lost to Follow-up|0
4581089|NCT01449812|7423833|FG002|Overall Study|Lost to Follow-up|0
4581090|NCT01449929|7423847|FG000|Randomization Phase 96 Week|Adverse Event|5
4581091|NCT01449929|7423848|FG001|Randomization Phase 96 Week|Adverse Event|13
4581092|NCT01449929|7423849|FG002|Randomization Phase 96 Week|Adverse Event|0
4581093|NCT01449929|7423847|FG000|Randomization Phase 96 Week|Lack of Efficacy|3
4581094|NCT01449929|7423848|FG001|Randomization Phase 96 Week|Lack of Efficacy|4
4581095|NCT01449929|7423849|FG002|Randomization Phase 96 Week|Lack of Efficacy|0
4581096|NCT01449929|7423847|FG000|Randomization Phase 96 Week|Protocol Violation|5
4581097|NCT01449929|7423848|FG001|Randomization Phase 96 Week|Protocol Violation|6
4581098|NCT01449929|7423849|FG002|Randomization Phase 96 Week|Protocol Violation|0
4581099|NCT01449929|7423847|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1
4581100|NCT01449929|7423848|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0
4581101|NCT01449929|7423849|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0
4581102|NCT01449929|7423847|FG000|Randomization Phase 96 Week|Lost to Follow-up|15
4581103|NCT01449929|7423848|FG001|Randomization Phase 96 Week|Lost to Follow-up|18
4581104|NCT01449929|7423849|FG002|Randomization Phase 96 Week|Lost to Follow-up|0
4581105|NCT01449929|7423847|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2
4581106|NCT01449929|7423848|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8
4581107|NCT01449929|7423849|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0
4581108|NCT01449929|7423847|FG000|Randomization Phase 96 Week|Physician Decision|2
4581109|NCT01449929|7423848|FG001|Randomization Phase 96 Week|Physician Decision|3
4581110|NCT01449929|7423849|FG002|Randomization Phase 96 Week|Physician Decision|0
4581111|NCT01449929|7423847|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0
4581112|NCT01449929|7423848|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1
4581113|NCT01449929|7423849|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0
4581114|NCT01449929|7423847|FG000|Extension Phase Approximately 3 Years|Adverse Event|0
4581115|NCT01449929|7423848|FG001|Extension Phase Approximately 3 Years|Adverse Event|0
4581116|NCT01449929|7423849|FG002|Extension Phase Approximately 3 Years|Adverse Event|2
4581117|NCT01449929|7423847|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0
4581118|NCT01449929|7423848|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0
4581119|NCT01449929|7423849|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2
4581120|NCT01449929|7423847|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0
4581121|NCT01449929|7423848|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0
4581122|NCT01449929|7423849|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4
4581123|NCT01449955|7423861|FG000|Overall Study|Withdrawal by Subject|1
4581124|NCT01449955|7423862|FG001|Overall Study|Withdrawal by Subject|2
4581125|NCT01450007|7423878|FG000|Overall Study|Late exclusion before treatment|2
4581126|NCT01450007|7423879|FG001|Overall Study|Late exclusion before treatment|3
4581127|NCT01450007|7423880|FG002|Overall Study|Late exclusion before treatment|2
4581128|NCT01450007|7423878|FG000|Overall Study|Protocol Violation|0
4581129|NCT01450007|7423879|FG001|Overall Study|Protocol Violation|1
4581130|NCT01450007|7423880|FG002|Overall Study|Protocol Violation|1
4581131|NCT01450007|7423878|FG000|Overall Study|Adverse Event|0
4581132|NCT01450007|7423879|FG001|Overall Study|Adverse Event|1
4581133|NCT01450007|7423880|FG002|Overall Study|Adverse Event|0
4581134|NCT01450098|7423890|FG000|Period 3|Protocol Violation|0
4581135|NCT01450098|7423891|FG001|Period 3|Protocol Violation|1
4581136|NCT01450098|7423890|FG000|Period 3|Withdrawal by Subject|0
4581137|NCT01450098|7423891|FG001|Period 3|Withdrawal by Subject|2
4581138|NCT01450137|7423906|FG000|Up to Week 12|Adverse Event|2
4581139|NCT01450137|7423907|FG001|Up to Week 12|Adverse Event|1
4581140|NCT01450137|7423906|FG000|Up to Week 12|Withdrawal by Subject|0
4581141|NCT01450137|7423907|FG001|Up to Week 12|Withdrawal by Subject|2
4581142|NCT01450137|7423906|FG000|Week 12 to Study End|Death|0
4581143|NCT01450137|7423907|FG001|Week 12 to Study End|Death|1
4581144|NCT01450137|7423906|FG000|Week 12 to Study End|Withdrawal by Subject|0
4581145|NCT01450137|7423907|FG001|Week 12 to Study End|Withdrawal by Subject|1
4581146|NCT01450540|7423952|FG000|Overall Study|Withdrawal by Subject|19
4581147|NCT01450540|7423953|FG001|Overall Study|Withdrawal by Subject|13
4581148|NCT01450540|7423952|FG000|Overall Study|protocol deviation|3
4581149|NCT01450540|7423953|FG001|Overall Study|protocol deviation|23
4581150|NCT01450631|7423963|FG000|Overall Study|Lost to Follow-up|2
4581151|NCT01450631|7423964|FG001|Overall Study|Lost to Follow-up|4
4581152|NCT01450631|7423963|FG000|Overall Study|Withdrawal by Subject|1
4581153|NCT01450631|7423964|FG001|Overall Study|Withdrawal by Subject|0
4581154|NCT01450683|7423970|FG000|Overall Study|Adverse Event|2
4581155|NCT01450696|7423976|FG000|Overall Study|Never Treated|1
4581156|NCT01450696|7423977|FG001|Overall Study|Never Treated|1
4581157|NCT01450696|7423976|FG000|Overall Study|Death|77
4581158|NCT01450696|7423977|FG001|Overall Study|Death|84
4581159|NCT01450696|7423976|FG000|Overall Study|Lost to Follow-up|3
4581160|NCT01450696|7423977|FG001|Overall Study|Lost to Follow-up|3
4581161|NCT01450696|7423976|FG000|Overall Study|Non-Compliance|1
4581162|NCT01450696|7423977|FG001|Overall Study|Non-Compliance|0
4581163|NCT01450696|7423976|FG000|Overall Study|Withdrawal by Subject|13
4581164|NCT01450696|7423977|FG001|Overall Study|Withdrawal by Subject|2
4581165|NCT01450696|7423976|FG000|Overall Study|Study Terminated by Sponsor|53
4581166|NCT01450696|7423977|FG001|Overall Study|Study Terminated by Sponsor|58
4581167|NCT01450761|7423985|FG000|Randomization|Subject no longer meets study criteria|1
4581168|NCT01450761|7423986|FG001|Randomization|Subject no longer meets study criteria|2
4581169|NCT01450761|7423985|FG000|Randomization|Withdrawal by Subject|2
4581170|NCT01450761|7423986|FG001|Randomization|Withdrawal by Subject|0
4581171|NCT01450761|7423985|FG000|Randomization|Disease progression|0
4581172|NCT01450761|7423986|FG001|Randomization|Disease progression|2
4581173|NCT01450761|7423985|FG000|Randomization|Adverse Event unrelated to study drug|1
4581174|NCT01450761|7423986|FG001|Randomization|Adverse Event unrelated to study drug|0
4581175|NCT01450761|7423985|FG000|Randomization|Other|0
4581176|NCT01450761|7423986|FG001|Randomization|Other|1
4581177|NCT01450761|7423985|FG000|Lead-in Chemotherapy|Disease progression|33
4581178|NCT01450761|7423986|FG001|Lead-in Chemotherapy|Disease progression|32
4581179|NCT01450761|7423985|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21
4581180|NCT01450761|7423986|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19
4581181|NCT01450761|7423985|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14
4581182|NCT01450761|7423986|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12
4581183|NCT01450761|7423985|FG000|Lead-in Chemotherapy|Study drug toxicity|6
4581184|NCT01450761|7423986|FG001|Lead-in Chemotherapy|Study drug toxicity|10
4581185|NCT01450761|7423985|FG000|Lead-in Chemotherapy|No longer meets study criteria|3
4581186|NCT01450761|7423986|FG001|Lead-in Chemotherapy|No longer meets study criteria|7
4581187|NCT01450761|7423985|FG000|Lead-in Chemotherapy|Death|3
4581188|NCT01450761|7423986|FG001|Lead-in Chemotherapy|Death|3
4581189|NCT01450761|7423985|FG000|Lead-in Chemotherapy|Other|2
4581190|NCT01450761|7423986|FG001|Lead-in Chemotherapy|Other|2
4581191|NCT01450761|7423985|FG000|Lead-in Chemotherapy|Lost to Follow-up|2
4581192|NCT01450761|7423986|FG001|Lead-in Chemotherapy|Lost to Follow-up|0
4581193|NCT01450761|7423985|FG000|Treatment With Blinded Study Therapy|Disease progression|318
4581194|NCT01450761|7423986|FG001|Treatment With Blinded Study Therapy|Disease progression|415
4581195|NCT01450761|7423985|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87
4581196|NCT01450761|7423986|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9
4581197|NCT01450761|7423985|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27
4581198|NCT01450761|7423986|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19
4581199|NCT01450761|7423985|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15
4581200|NCT01450761|7423986|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8
4581201|NCT01450761|7423985|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12
4581202|NCT01450761|7423986|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5
4581203|NCT01450761|7423985|FG000|Treatment With Blinded Study Therapy|Death|5
4581204|NCT01450761|7423986|FG001|Treatment With Blinded Study Therapy|Death|6
4581205|NCT01450761|7423985|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5
4581206|NCT01450761|7423986|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4
4581207|NCT01450761|7423985|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2
4581208|NCT01450761|7423986|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1
4581209|NCT01450761|7423985|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1
4581210|NCT01450761|7423986|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2
4581211|NCT01450761|7423985|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1
4581212|NCT01450761|7423986|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2
4581213|NCT01450761|7423985|FG000|Treatment With Blinded Study Therapy|Not reported|2
4581214|NCT01450761|7423986|FG001|Treatment With Blinded Study Therapy|Not reported|2
4581215|NCT01450761|7423985|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1
4581216|NCT01450761|7423986|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0
4581217|NCT01450761|7423985|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2
4581218|NCT01450761|7423986|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3
4581219|NCT01450800|7424003|FG000|Overall Study|Protocol Violation|1
4581220|NCT01450800|7424004|FG001|Overall Study|Protocol Violation|3
4581221|NCT01450813|7424016|FG000|Overall Study|Physician Decision|1
4581222|NCT01450813|7424017|FG001|Overall Study|Physician Decision|1
4581223|NCT01450813|7424018|FG002|Overall Study|Physician Decision|0
4581224|NCT01450813|7424019|FG003|Overall Study|Physician Decision|3
4581225|NCT01450943|7424043|FG000|Overall Study|Screen failure, loss to follow-up|2
4581226|NCT01450943|7424044|FG001|Overall Study|Screen failure, loss to follow-up|7
4581227|NCT01450943|7424045|FG002|Overall Study|Screen failure, loss to follow-up|6
4581228|NCT01451164|7424061|FG000|Overall Study|Adverse Event|19
4581229|NCT01451164|7424062|FG001|Overall Study|Adverse Event|12
4581230|NCT01451164|7424063|FG002|Overall Study|Adverse Event|18
4581231|NCT01451164|7424064|FG003|Overall Study|Adverse Event|21
4581232|NCT01451164|7424061|FG000|Overall Study|Withdrawal Criteria|1
4581233|NCT01451164|7424062|FG001|Overall Study|Withdrawal Criteria|1
4581234|NCT01451164|7424063|FG002|Overall Study|Withdrawal Criteria|1
4581235|NCT01451164|7424064|FG003|Overall Study|Withdrawal Criteria|1
4581236|NCT01451164|7424061|FG000|Overall Study|Physician Decision|2
4581237|NCT01451164|7424062|FG001|Overall Study|Physician Decision|0
4581238|NCT01451164|7424063|FG002|Overall Study|Physician Decision|1
4581239|NCT01451164|7424064|FG003|Overall Study|Physician Decision|0
4581240|NCT01451164|7424061|FG000|Overall Study|Withdrawal by Subject|14
4581241|NCT01451164|7424062|FG001|Overall Study|Withdrawal by Subject|11
4581242|NCT01451164|7424063|FG002|Overall Study|Withdrawal by Subject|16
4581243|NCT01451164|7424064|FG003|Overall Study|Withdrawal by Subject|17
4581244|NCT01451164|7424061|FG000|Overall Study|Protocol Violation|0
4581245|NCT01451164|7424062|FG001|Overall Study|Protocol Violation|1
4581246|NCT01451164|7424063|FG002|Overall Study|Protocol Violation|0
4581247|NCT01451164|7424064|FG003|Overall Study|Protocol Violation|0
4581248|NCT01451164|7424061|FG000|Overall Study|Lack of Efficacy|7
4581249|NCT01451164|7424062|FG001|Overall Study|Lack of Efficacy|9
4581250|NCT01451164|7424063|FG002|Overall Study|Lack of Efficacy|9
4581251|NCT01451164|7424064|FG003|Overall Study|Lack of Efficacy|7
4581252|NCT01451203|7424076|FG000|Double-blind Treatment Period|Did not receive treatment|1
4581253|NCT01451203|7424077|FG001|Double-blind Treatment Period|Did not receive treatment|2
4581254|NCT01451203|7424076|FG000|Double-blind Treatment Period|Consent Withdrawn|3
4581255|NCT01451203|7424077|FG001|Double-blind Treatment Period|Consent Withdrawn|2
4581256|NCT01451203|7424076|FG000|Double-blind Treatment Period|Lack of Efficacy|71
4581257|NCT01451203|7424077|FG001|Double-blind Treatment Period|Lack of Efficacy|36
4581258|NCT01451203|7424076|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0
4581259|NCT01451203|7424077|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1
4581260|NCT01451203|7424076|FG000|Double-blind Treatment Period|Adverse Event|6
4581261|NCT01451203|7424077|FG001|Double-blind Treatment Period|Adverse Event|9
4581262|NCT01451203|7424076|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1
4581263|NCT01451203|7424077|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0
4581264|NCT01451203|7424076|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1
4581265|NCT01451203|7424077|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0
4581266|NCT01451203|7424076|FG000|Double-blind Treatment Period|Investigator decision|2
4581267|NCT01451203|7424077|FG001|Double-blind Treatment Period|Investigator decision|0
4581268|NCT01451203|7424076|FG000|Post-treatment Period|Consent withdrawn|2
4581269|NCT01451203|7424077|FG001|Post-treatment Period|Consent withdrawn|4
4581270|NCT01451203|7424076|FG000|Post-treatment Period|Lack of Efficacy|12
4581271|NCT01451203|7424077|FG001|Post-treatment Period|Lack of Efficacy|28
4581272|NCT01451203|7424076|FG000|Post-treatment Period|Adverse Event|0
4581273|NCT01451203|7424077|FG001|Post-treatment Period|Adverse Event|1
4581274|NCT01451203|7424076|FG000|Post-treatment Period|Investigator decision|0
4581275|NCT01451203|7424077|FG001|Post-treatment Period|Investigator decision|1
4581276|NCT01451398|7424093|FG000|Overall Study|Adverse Event|7
4581277|NCT01451398|7424094|FG001|Overall Study|Adverse Event|9
4581278|NCT01451398|7424093|FG000|Overall Study|Protocol Violation|1
4581279|NCT01451398|7424094|FG001|Overall Study|Protocol Violation|2
4581280|NCT01451398|7424093|FG000|Overall Study|Physician Decision|1
4581281|NCT01451398|7424094|FG001|Overall Study|Physician Decision|1
4581282|NCT01451398|7424093|FG000|Overall Study|Withdrawal by Subject|10
4581283|NCT01451398|7424094|FG001|Overall Study|Withdrawal by Subject|14
4581284|NCT01451398|7424093|FG000|Overall Study|Lost to Follow-up|6
4581285|NCT01451398|7424094|FG001|Overall Study|Lost to Follow-up|4
4581286|NCT01451398|7424093|FG000|Overall Study|Non-compliance with study drug|1
4581287|NCT01451398|7424094|FG001|Overall Study|Non-compliance with study drug|3
4581288|NCT01451398|7424093|FG000|Overall Study|Non-compliance with protocol|1
4581289|NCT01451398|7424094|FG001|Overall Study|Non-compliance with protocol|1
4581290|NCT01451398|7424093|FG000|Overall Study|Moved out of country|0
4581291|NCT01451398|7424094|FG001|Overall Study|Moved out of country|1
4581292|NCT01451398|7424093|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0
4581293|NCT01451398|7424094|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1
4581294|NCT01451398|7424093|FG000|Overall Study|Lack of Efficacy|0
4581295|NCT01451398|7424094|FG001|Overall Study|Lack of Efficacy|1
4581296|NCT01451424|7424113|FG000|Overall Study|Withdrawal by Subject|1
4581297|NCT01451424|7424114|FG001|Overall Study|Withdrawal by Subject|1
4581298|NCT01451424|7424115|FG002|Overall Study|Withdrawal by Subject|0
4581299|NCT01451424|7424116|FG003|Overall Study|Withdrawal by Subject|2
4581300|NCT01451424|7424113|FG000|Overall Study|Lost to Follow-up|0
4581301|NCT01451424|7424114|FG001|Overall Study|Lost to Follow-up|1
4581302|NCT01451424|7424115|FG002|Overall Study|Lost to Follow-up|0
4581303|NCT01451424|7424116|FG003|Overall Study|Lost to Follow-up|1
4581304|NCT01451424|7424113|FG000|Overall Study|Physician Decision|0
4581305|NCT01451424|7424114|FG001|Overall Study|Physician Decision|0
4581306|NCT01451424|7424115|FG002|Overall Study|Physician Decision|1
4581307|NCT01451424|7424116|FG003|Overall Study|Physician Decision|1
4581308|NCT01451424|7424113|FG000|Overall Study|Adverse Event|0
4581309|NCT01451424|7424114|FG001|Overall Study|Adverse Event|0
4581310|NCT01451424|7424115|FG002|Overall Study|Adverse Event|0
4581311|NCT01451424|7424116|FG003|Overall Study|Adverse Event|1
4581312|NCT01451437|7424140|FG000|Overall Study|Adverse Event|0
4581313|NCT01451437|7424141|FG001|Overall Study|Adverse Event|0
4581314|NCT01451437|7424142|FG002|Overall Study|Adverse Event|0
4581315|NCT01451437|7424143|FG003|Overall Study|Adverse Event|0
4581316|NCT01451437|7424144|FG004|Overall Study|Adverse Event|0
4581317|NCT01451437|7424145|FG005|Overall Study|Adverse Event|1
4581318|NCT01451437|7424146|FG006|Overall Study|Adverse Event|1
4581319|NCT01451437|7424147|FG007|Overall Study|Adverse Event|2
4581320|NCT01451437|7424148|FG008|Overall Study|Adverse Event|1
4581321|NCT01451437|7424140|FG000|Overall Study|Physician Decision|1
4581322|NCT01451437|7424141|FG001|Overall Study|Physician Decision|1
4581323|NCT01451437|7424142|FG002|Overall Study|Physician Decision|2
4581324|NCT01451437|7424143|FG003|Overall Study|Physician Decision|0
4581325|NCT01451437|7424144|FG004|Overall Study|Physician Decision|0
4581326|NCT01451437|7424145|FG005|Overall Study|Physician Decision|0
4581327|NCT01451437|7424146|FG006|Overall Study|Physician Decision|0
4581328|NCT01451437|7424147|FG007|Overall Study|Physician Decision|0
4581329|NCT01451437|7424148|FG008|Overall Study|Physician Decision|0
4581330|NCT01451437|7424140|FG000|Overall Study|Disease Progression|0
4581331|NCT01451437|7424141|FG001|Overall Study|Disease Progression|0
4581332|NCT01451437|7424142|FG002|Overall Study|Disease Progression|1
4581333|NCT01451437|7424143|FG003|Overall Study|Disease Progression|1
4581334|NCT01451437|7424144|FG004|Overall Study|Disease Progression|3
4581335|NCT01451437|7424145|FG005|Overall Study|Disease Progression|2
4581336|NCT01451437|7424146|FG006|Overall Study|Disease Progression|3
4581337|NCT01451437|7424147|FG007|Overall Study|Disease Progression|1
4581338|NCT01451437|7424148|FG008|Overall Study|Disease Progression|3
4581339|NCT01451437|7424140|FG000|Overall Study|Protocol Violation|0
4581340|NCT01451437|7424141|FG001|Overall Study|Protocol Violation|0
4581341|NCT01451437|7424142|FG002|Overall Study|Protocol Violation|0
4581342|NCT01451437|7424143|FG003|Overall Study|Protocol Violation|0
4581343|NCT01451437|7424144|FG004|Overall Study|Protocol Violation|0
4581344|NCT01451437|7424145|FG005|Overall Study|Protocol Violation|0
4581345|NCT01451437|7424146|FG006|Overall Study|Protocol Violation|1
4581346|NCT01451437|7424147|FG007|Overall Study|Protocol Violation|0
4581347|NCT01451437|7424148|FG008|Overall Study|Protocol Violation|0
4581348|NCT01451437|7424140|FG000|Overall Study|Withdrawal by Subject|0
4581349|NCT01451437|7424141|FG001|Overall Study|Withdrawal by Subject|0
4581350|NCT01451437|7424142|FG002|Overall Study|Withdrawal by Subject|0
4581351|NCT01451437|7424143|FG003|Overall Study|Withdrawal by Subject|0
4581352|NCT01451437|7424144|FG004|Overall Study|Withdrawal by Subject|1
4581353|NCT01451437|7424145|FG005|Overall Study|Withdrawal by Subject|0
4581354|NCT01451437|7424146|FG006|Overall Study|Withdrawal by Subject|1
4581355|NCT01451437|7424147|FG007|Overall Study|Withdrawal by Subject|0
4581356|NCT01451437|7424148|FG008|Overall Study|Withdrawal by Subject|0
4581357|NCT01451541|7424189|FG000|Overall Study|Adverse Event|4
4581358|NCT01451541|7424190|FG001|Overall Study|Adverse Event|3
4581359|NCT01451541|7424191|FG002|Overall Study|Adverse Event|6
4581360|NCT01451541|7424189|FG000|Overall Study|Lack of Efficacy|2
4581361|NCT01451541|7424190|FG001|Overall Study|Lack of Efficacy|0
4581362|NCT01451541|7424191|FG002|Overall Study|Lack of Efficacy|0
4581363|NCT01451541|7424189|FG000|Overall Study|Lost to Follow-up|4
4581364|NCT01451541|7424190|FG001|Overall Study|Lost to Follow-up|4
4581365|NCT01451541|7424191|FG002|Overall Study|Lost to Follow-up|7
4581366|NCT01451541|7424189|FG000|Overall Study|Withdrawal by Subject|15
4581367|NCT01451541|7424190|FG001|Overall Study|Withdrawal by Subject|8
4581368|NCT01451541|7424191|FG002|Overall Study|Withdrawal by Subject|6
4581369|NCT01451541|7424189|FG000|Overall Study|randomization error, noncompliance|11
4581370|NCT01451541|7424190|FG001|Overall Study|randomization error, noncompliance|10
4581371|NCT01451541|7424191|FG002|Overall Study|randomization error, noncompliance|8
4581372|NCT01451554|7424203|FG000|Overall Study|Withdrawal by Subject|14
4581373|NCT01451554|7424204|FG001|Overall Study|Withdrawal by Subject|9
4581374|NCT01451606|7424212|FG000|Overall Study|Withdrawal by Subject|4
4581375|NCT01451606|7424213|FG001|Overall Study|Withdrawal by Subject|3
4581376|NCT01451645|7424257|FG000|Overall Study|Protocol Violation|1
4581377|NCT01451645|7424258|FG001|Overall Study|Protocol Violation|0
4581378|NCT01451645|7424257|FG000|Overall Study|Adverse Event|0
4581379|NCT01451645|7424258|FG001|Overall Study|Adverse Event|3
4581380|NCT01451645|7424257|FG000|Overall Study|Withdrawal by Subject|4
4581381|NCT01451645|7424258|FG001|Overall Study|Withdrawal by Subject|2
4581382|NCT01451645|7424257|FG000|Overall Study|Lost to Follow-up|4
4581383|NCT01451645|7424258|FG001|Overall Study|Lost to Follow-up|3
4581384|NCT01451749|7424266|FG000|Overall Study|Protocol Violation|14
4581385|NCT01451749|7424267|FG001|Overall Study|Protocol Violation|7
4581386|NCT01451749|7424266|FG000|Overall Study|Lost to Follow-up|15
4581387|NCT01451749|7424267|FG001|Overall Study|Lost to Follow-up|5
4581388|NCT01451749|7424266|FG000|Overall Study|Meet the exclusion criteria,and|1
4581389|NCT01451749|7424267|FG001|Overall Study|Meet the exclusion criteria,and|1
4581390|NCT01451749|7424266|FG000|Overall Study|Adverse Event|2
4581391|NCT01451749|7424267|FG001|Overall Study|Adverse Event|0
4581392|NCT01451749|7424266|FG000|Overall Study|Withdrawal by Subject|0
4581393|NCT01451749|7424267|FG001|Overall Study|Withdrawal by Subject|1
4581394|NCT01451762|7424278|FG000|Overall Study|Lost to Follow-up|3
4581395|NCT01451762|7424279|FG001|Overall Study|Lost to Follow-up|6
4581396|NCT01451762|7424280|FG002|Overall Study|Lost to Follow-up|6
4581397|NCT01451814|7424303|FG000|Overall Study|Withdrawal by Subject|1
4581398|NCT01451814|7424304|FG001|Overall Study|Withdrawal by Subject|1
4581399|NCT01451814|7424303|FG000|Overall Study|Lost to Follow-up|5
4581400|NCT01451814|7424304|FG001|Overall Study|Lost to Follow-up|4
4581401|NCT01451827|7424314|FG000|Overall Study|Adverse Event|2
4581402|NCT01451827|7424315|FG001|Overall Study|Adverse Event|0
4581403|NCT01451827|7424316|FG002|Overall Study|Adverse Event|1
4581404|NCT01451827|7424317|FG003|Overall Study|Adverse Event|1
4581405|NCT01451827|7424314|FG000|Overall Study|Protocol deviation|1
4581406|NCT01451827|7424315|FG001|Overall Study|Protocol deviation|0
4581407|NCT01451827|7424316|FG002|Overall Study|Protocol deviation|0
4581408|NCT01451827|7424317|FG003|Overall Study|Protocol deviation|0
4581409|NCT01451827|7424314|FG000|Overall Study|Lost to Follow-up|0
4581410|NCT01451827|7424315|FG001|Overall Study|Lost to Follow-up|3
4581411|NCT01451827|7424316|FG002|Overall Study|Lost to Follow-up|0
4581412|NCT01451827|7424317|FG003|Overall Study|Lost to Follow-up|2
4581413|NCT01451827|7424314|FG000|Overall Study|Participant met withdrawal criteria|0
4581414|NCT01451827|7424315|FG001|Overall Study|Participant met withdrawal criteria|2
4581415|NCT01451827|7424316|FG002|Overall Study|Participant met withdrawal criteria|0
4581416|NCT01451827|7424317|FG003|Overall Study|Participant met withdrawal criteria|0
4581417|NCT01451827|7424314|FG000|Overall Study|Withdrawal by Subject|0
4581418|NCT01451827|7424315|FG001|Overall Study|Withdrawal by Subject|0
4581419|NCT01451827|7424316|FG002|Overall Study|Withdrawal by Subject|1
4581420|NCT01451827|7424317|FG003|Overall Study|Withdrawal by Subject|1
4581421|NCT01451931|7424330|FG000|Overall Study|Lost to Follow-up|17
4581422|NCT01451931|7424331|FG001|Overall Study|Lost to Follow-up|36
4581423|NCT01451931|7424332|FG002|Overall Study|Lost to Follow-up|21
4581424|NCT01451931|7424330|FG000|Overall Study|Withdrawal by Subject|16
4581425|NCT01451931|7424331|FG001|Overall Study|Withdrawal by Subject|22
4581426|NCT01451931|7424332|FG002|Overall Study|Withdrawal by Subject|22
4581427|NCT01452347|7424407|FG000|Overall Study|Adverse Event|2
4581428|NCT01452347|7424408|FG001|Overall Study|Adverse Event|1
4581429|NCT01452347|7424407|FG000|Overall Study|Non compliance protocol|2
4581430|NCT01452347|7424408|FG001|Overall Study|Non compliance protocol|0
4581431|NCT01452347|7424407|FG000|Overall Study|Lost to Follow-up|2
4581432|NCT01452347|7424408|FG001|Overall Study|Lost to Follow-up|0
4581433|NCT01452347|7424407|FG000|Overall Study|Withdrawal by Subject|3
4581434|NCT01452347|7424408|FG001|Overall Study|Withdrawal by Subject|3
4581435|NCT01452347|7424407|FG000|Overall Study|Not treated|6
4581436|NCT01452347|7424408|FG001|Overall Study|Not treated|3
4581437|NCT01452347|7424407|FG000|Overall Study|Other reason not defined above|2
4581438|NCT01452347|7424408|FG001|Overall Study|Other reason not defined above|0
4581439|NCT01452412|7424418|FG000|Overall Study|Withdrawal by Subject|15
4581440|NCT01452412|7424419|FG001|Overall Study|Withdrawal by Subject|11
4581441|NCT01452412|7424418|FG000|Overall Study|Adverse Event|4
4581442|NCT01452412|7424419|FG001|Overall Study|Adverse Event|3
4581443|NCT01452412|7424418|FG000|Overall Study|Lost to Follow-up|5
4581444|NCT01452412|7424419|FG001|Overall Study|Lost to Follow-up|3
4581445|NCT01452412|7424418|FG000|Overall Study|Death|1
4581446|NCT01452412|7424419|FG001|Overall Study|Death|0
4581447|NCT01452412|7424418|FG000|Overall Study|Initiated dialysis|1
4581448|NCT01452412|7424419|FG001|Overall Study|Initiated dialysis|0
4581449|NCT01452412|7424418|FG000|Overall Study|Other|2
4581450|NCT01452412|7424419|FG001|Overall Study|Other|0
4581451|NCT01452529|7424432|FG000|Run-in Period|Adverse Event|96
4581452|NCT01452529|7424433|FG001|Run-in Period|Adverse Event|0
4581453|NCT01452529|7424434|FG002|Run-in Period|Adverse Event|0
4581454|NCT01452529|7424432|FG000|Run-in Period|Withdrawal by Subject|49
4581455|NCT01452529|7424433|FG001|Run-in Period|Withdrawal by Subject|0
4581456|NCT01452529|7424434|FG002|Run-in Period|Withdrawal by Subject|0
4581457|NCT01452529|7424432|FG000|Run-in Period|Lost to Follow-up|19
4581458|NCT01452529|7424433|FG001|Run-in Period|Lost to Follow-up|0
4581459|NCT01452529|7424434|FG002|Run-in Period|Lost to Follow-up|0
4581460|NCT01452529|7424432|FG000|Run-in Period|Lack of Efficacy|46
4581461|NCT01452529|7424433|FG001|Run-in Period|Lack of Efficacy|0
4581462|NCT01452529|7424434|FG002|Run-in Period|Lack of Efficacy|0
4581463|NCT01452529|7424432|FG000|Run-in Period|Confirmed or suspected diversion|23
4581464|NCT01452529|7424433|FG001|Run-in Period|Confirmed or suspected diversion|0
4581465|NCT01452529|7424434|FG002|Run-in Period|Confirmed or suspected diversion|0
4581466|NCT01452529|7424432|FG000|Run-in Period|Administrative|21
4581467|NCT01452529|7424433|FG001|Run-in Period|Administrative|0
4581468|NCT01452529|7424434|FG002|Run-in Period|Administrative|0
4581469|NCT01452529|7424432|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59
4581470|NCT01452529|7424433|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0
4581471|NCT01452529|7424434|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0
4581472|NCT01452529|7424432|FG000|Double-blind (DB) Period|Adverse Event|0
4581473|NCT01452529|7424433|FG001|Double-blind (DB) Period|Adverse Event|18
4581474|NCT01452529|7424434|FG002|Double-blind (DB) Period|Adverse Event|11
4581475|NCT01452529|7424432|FG000|Double-blind (DB) Period|Withdrawal by Subject|0
4581476|NCT01452529|7424433|FG001|Double-blind (DB) Period|Withdrawal by Subject|15
4581477|NCT01452529|7424434|FG002|Double-blind (DB) Period|Withdrawal by Subject|14
4581478|NCT01452529|7424432|FG000|Double-blind (DB) Period|Lost to Follow-up|0
4581479|NCT01452529|7424433|FG001|Double-blind (DB) Period|Lost to Follow-up|5
4581480|NCT01452529|7424434|FG002|Double-blind (DB) Period|Lost to Follow-up|3
4581481|NCT01452529|7424432|FG000|Double-blind (DB) Period|Lack of Efficacy|0
4581482|NCT01452529|7424433|FG001|Double-blind (DB) Period|Lack of Efficacy|16
4581483|NCT01452529|7424434|FG002|Double-blind (DB) Period|Lack of Efficacy|44
4581484|NCT01452529|7424432|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0
4581485|NCT01452529|7424433|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2
4581486|NCT01452529|7424434|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3
4581487|NCT01452529|7424432|FG000|Double-blind (DB) Period|Administrative|0
4581488|NCT01452529|7424433|FG001|Double-blind (DB) Period|Administrative|11
4581489|NCT01452529|7424434|FG002|Double-blind (DB) Period|Administrative|7
4581490|NCT01452789|7424443|FG000|Overall Study|Withdrawal by Subject|3
4581491|NCT01452789|7424444|FG001|Overall Study|Withdrawal by Subject|2
4581492|NCT01452919|7424450|FG000|Open-Label Treatment|Adverse Event|5
4581493|NCT01452919|7424451|FG001|Open-Label Treatment|Adverse Event|0
4581494|NCT01452919|7424452|FG002|Open-Label Treatment|Adverse Event|0
4581495|NCT01452919|7424450|FG000|Open-Label Treatment|Lost to Follow-up|4
4581496|NCT01452919|7424451|FG001|Open-Label Treatment|Lost to Follow-up|0
4581497|NCT01452919|7424452|FG002|Open-Label Treatment|Lost to Follow-up|0
4581498|NCT01452919|7424450|FG000|Open-Label Treatment|Perceived lack of efficacy|3
4581499|NCT01452919|7424451|FG001|Open-Label Treatment|Perceived lack of efficacy|0
4581500|NCT01452919|7424452|FG002|Open-Label Treatment|Perceived lack of efficacy|0
4581501|NCT01452919|7424450|FG000|Open-Label Treatment|Protocol Violation|4
4581502|NCT01452919|7424451|FG001|Open-Label Treatment|Protocol Violation|0
4581503|NCT01452919|7424452|FG002|Open-Label Treatment|Protocol Violation|0
4581504|NCT01452919|7424450|FG000|Open-Label Treatment|Sponsor Decision|1
4581505|NCT01452919|7424451|FG001|Open-Label Treatment|Sponsor Decision|0
4581506|NCT01452919|7424452|FG002|Open-Label Treatment|Sponsor Decision|0
4581507|NCT01452919|7424450|FG000|Open-Label Treatment|Withdrawal by Subject|2
4581508|NCT01452919|7424451|FG001|Open-Label Treatment|Withdrawal by Subject|0
4581509|NCT01452919|7424452|FG002|Open-Label Treatment|Withdrawal by Subject|0
4581510|NCT01452919|7424450|FG000|Open-Label Treatment|Subject is moving or has moved|1
4581511|NCT01452919|7424451|FG001|Open-Label Treatment|Subject is moving or has moved|0
4581512|NCT01452919|7424452|FG002|Open-Label Treatment|Subject is moving or has moved|0
4581513|NCT01452919|7424450|FG000|Randomization Treatment|Adverse Event|0
4581514|NCT01452919|7424451|FG001|Randomization Treatment|Adverse Event|0
4581515|NCT01452919|7424452|FG002|Randomization Treatment|Adverse Event|2
4581516|NCT01452919|7424450|FG000|Randomization Treatment|Sponsor Decision|0
4581517|NCT01452919|7424451|FG001|Randomization Treatment|Sponsor Decision|1
4581518|NCT01452919|7424452|FG002|Randomization Treatment|Sponsor Decision|0
4581519|NCT01452919|7424450|FG000|Randomization Treatment|Withdrawal by Subject|0
4581520|NCT01452919|7424451|FG001|Randomization Treatment|Withdrawal by Subject|1
4581521|NCT01452919|7424452|FG002|Randomization Treatment|Withdrawal by Subject|0
4581522|NCT01452919|7424450|FG000|Randomization Treatment|Subject is moving or has moved|0
4581523|NCT01452919|7424451|FG001|Randomization Treatment|Subject is moving or has moved|1
4581524|NCT01452919|7424452|FG002|Randomization Treatment|Subject is moving or has moved|0
4581525|NCT01453023|7424462|FG000|Treatment Period (TP) 1|Protocol Violation|1
4581526|NCT01453023|7424463|FG001|Treatment Period (TP) 1|Protocol Violation|0
4581527|NCT01453023|7424462|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0
4581528|NCT01453023|7424463|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1
4581529|NCT01453023|7424462|FG000|Treatment Period 2|Protocol Violation|0
4581530|NCT01453023|7424463|FG001|Treatment Period 2|Protocol Violation|1
4581531|NCT01453036|7424472|FG000|Overall Study|Lost to Follow-up|26
4581532|NCT01453036|7424473|FG001|Overall Study|Lost to Follow-up|115
4581533|NCT01453036|7424474|FG002|Overall Study|Lost to Follow-up|31
4581534|NCT01453049|7424484|FG000|Overall Study|Protocol Violation|2
4581535|NCT01453049|7424485|FG001|Overall Study|Protocol Violation|5
4581536|NCT01453049|7424484|FG000|Overall Study|Lost to Follow-up|2
4581537|NCT01453049|7424485|FG001|Overall Study|Lost to Follow-up|1
4581538|NCT01453049|7424484|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35
4581539|NCT01453049|7424485|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36
4581540|NCT01453049|7424484|FG000|Overall Study|Withdrawal by Subject|1
4581541|NCT01453049|7424485|FG001|Overall Study|Withdrawal by Subject|0
4581542|NCT01453049|7424484|FG000|Overall Study|Randomized in Error|1
4581543|NCT01453049|7424485|FG001|Overall Study|Randomized in Error|0
4581544|NCT01453153|7424503|FG000|Overall Study|Physician Decision|0
4581545|NCT01453153|7424504|FG001|Overall Study|Physician Decision|0
4581546|NCT01453153|7424505|FG002|Overall Study|Physician Decision|1
4581547|NCT01453153|7424503|FG000|Overall Study|Progressive Disease|3
4581548|NCT01453153|7424504|FG001|Overall Study|Progressive Disease|2
4581549|NCT01453153|7424505|FG002|Overall Study|Progressive Disease|16
4581550|NCT01453153|7424503|FG000|Overall Study|Withdrawal by Subject|0
4581551|NCT01453153|7424504|FG001|Overall Study|Withdrawal by Subject|1
4581552|NCT01453153|7424505|FG002|Overall Study|Withdrawal by Subject|2
4581553|NCT01453153|7424503|FG000|Overall Study|Adverse Event|1
4581554|NCT01453153|7424504|FG001|Overall Study|Adverse Event|1
4581555|NCT01453153|7424505|FG002|Overall Study|Adverse Event|1
4581556|NCT01453205|7424533|FG000|Overall Study|Lost to Follow-up|3
4692926|NCT02859558|7603809|FG000|Step 1|Not Eligible|0
4692927|NCT02859558|7603810|FG001|Step 1|Not Eligible|0
4581557|NCT01453205|7424534|FG001|Overall Study|Lost to Follow-up|0
4581558|NCT01453205|7424535|FG002|Overall Study|Lost to Follow-up|1
4581559|NCT01453205|7424533|FG000|Overall Study|Withdrawal by Subject|8
4581560|NCT01453205|7424534|FG001|Overall Study|Withdrawal by Subject|3
4581561|NCT01453205|7424535|FG002|Overall Study|Withdrawal by Subject|0
4581562|NCT01453205|7424533|FG000|Overall Study|Death|24
4581563|NCT01453205|7424534|FG001|Overall Study|Death|22
4581564|NCT01453205|7424535|FG002|Overall Study|Death|18
4581565|NCT01453205|7424533|FG000|Overall Study|Other|45
4581566|NCT01453205|7424534|FG001|Overall Study|Other|27
4581567|NCT01453205|7424535|FG002|Overall Study|Other|35
4581568|NCT01453296|7424546|FG000|Treatment Period 1|Adverse Event|0
4581569|NCT01453296|7424547|FG001|Treatment Period 1|Adverse Event|1
4581570|NCT01453296|7424546|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1
4581571|NCT01453296|7424547|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0
4581572|NCT01453296|7424546|FG000|Treatment Period 2|Adverse Event|1
4581573|NCT01453296|7424547|FG001|Treatment Period 2|Adverse Event|0
4581574|NCT01453296|7424546|FG000|Treatment Period 2|Withdrawal by Subject|1
4581575|NCT01453296|7424547|FG001|Treatment Period 2|Withdrawal by Subject|0
4581576|NCT01453348|7424556|FG000|Overall Study|Death|0
4581577|NCT01453348|7424557|FG001|Overall Study|Death|0
4581578|NCT01453348|7424558|FG002|Overall Study|Death|1
4581579|NCT01453348|7424556|FG000|Overall Study|Withdrawal by Subject|0
4581580|NCT01453348|7424557|FG001|Overall Study|Withdrawal by Subject|1
4581581|NCT01453348|7424558|FG002|Overall Study|Withdrawal by Subject|0
4581582|NCT01453348|7424556|FG000|Overall Study|Protocol Violation|1
4581583|NCT01453348|7424557|FG001|Overall Study|Protocol Violation|0
4581584|NCT01453348|7424558|FG002|Overall Study|Protocol Violation|0
4581585|NCT01453361|7424569|FG000|Overall Study|Disease Progression|6
4581586|NCT01453361|7424569|FG000|Overall Study|Screen-Failures|10
4581587|NCT01453374|7424573|FG000|Overall Study|Adverse Event|7
4581588|NCT01453374|7424573|FG000|Overall Study|Lack of Efficacy|1
4581589|NCT01453374|7424573|FG000|Overall Study|Lost to Follow-up|3
4581590|NCT01453374|7424573|FG000|Overall Study|Withdrawal by Subject|5
4581591|NCT01453374|7424573|FG000|Overall Study|Incarcerated|2
4581592|NCT01453439|7424611|FG000|Treatment Phase|Withdrawal by Subject|13
4581593|NCT01453439|7424612|FG001|Treatment Phase|Withdrawal by Subject|10
4581594|NCT01453439|7424611|FG000|Treatment Phase|Suicidal Ideation|2
4581595|NCT01453439|7424612|FG001|Treatment Phase|Suicidal Ideation|0
4581596|NCT01453439|7424611|FG000|Treatment Phase|Need for higher level of care|1
4692928|NCT02859558|7603811|FG002|Step 1|Not Eligible|0
4692929|NCT02859558|7603812|FG003|Step 1|Not Eligible|0
4692930|NCT02859558|7603813|FG004|Step 1|Not Eligible|3
4692931|NCT02859558|7603809|FG000|Step 1|Lost to Follow-up|1
4692932|NCT02859558|7603810|FG001|Step 1|Lost to Follow-up|3
4692933|NCT02859558|7603811|FG002|Step 1|Lost to Follow-up|3
4692934|NCT02859558|7603812|FG003|Step 1|Lost to Follow-up|0
4692935|NCT02859558|7603813|FG004|Step 1|Lost to Follow-up|0
4692936|NCT02859558|7603809|FG000|Step 1|Did Not Return to Clinic|2
4692937|NCT02859558|7603810|FG001|Step 1|Did Not Return to Clinic|3
4692938|NCT02859558|7603811|FG002|Step 1|Did Not Return to Clinic|4
4692939|NCT02859558|7603812|FG003|Step 1|Did Not Return to Clinic|0
4692940|NCT02859558|7603813|FG004|Step 1|Did Not Return to Clinic|0
4692941|NCT02859558|7603809|FG000|Step 1|Moved|0
4692942|NCT02859558|7603810|FG001|Step 1|Moved|1
4692943|NCT02859558|7603811|FG002|Step 1|Moved|1
4692944|NCT02859558|7603812|FG003|Step 1|Moved|0
4692945|NCT02859558|7603813|FG004|Step 1|Moved|0
4692946|NCT02859558|7603809|FG000|Step 1|Withdrawal By Participant|1
4692947|NCT02859558|7603810|FG001|Step 1|Withdrawal By Participant|2
4692948|NCT02859558|7603811|FG002|Step 1|Withdrawal By Participant|1
4692949|NCT02859558|7603812|FG003|Step 1|Withdrawal By Participant|0
4692950|NCT02859558|7603813|FG004|Step 1|Withdrawal By Participant|0
4692951|NCT02859558|7603809|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1
4581597|NCT01453439|7424612|FG001|Treatment Phase|Need for higher level of care|1
4581598|NCT01453439|7424611|FG000|Treatment Phase|Therapist conflict of interest|1
4581599|NCT01453439|7424612|FG001|Treatment Phase|Therapist conflict of interest|0
4581600|NCT01453439|7424611|FG000|Follow-up|Withdrawal by Subject|0
4581601|NCT01453439|7424612|FG001|Follow-up|Withdrawal by Subject|1
4581602|NCT01453439|7424611|FG000|Follow-up|Lost to Follow-up|5
4692952|NCT02859558|7603810|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0
4692953|NCT02859558|7603811|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0
4692954|NCT02859558|7603812|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0
4692955|NCT02859558|7603813|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0
4692956|NCT02859558|7603809|FG000|Step 1|Incarceration|0
4692957|NCT02859558|7603810|FG001|Step 1|Incarceration|1
4692958|NCT02859558|7603811|FG002|Step 1|Incarceration|0
4692959|NCT02859558|7603812|FG003|Step 1|Incarceration|0
4692960|NCT02859558|7603813|FG004|Step 1|Incarceration|0
4581603|NCT01453439|7424612|FG001|Follow-up|Lost to Follow-up|10
4581604|NCT01453595|7424634|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2
4581605|NCT01453595|7424635|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1
4581606|NCT01453595|7424636|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2
4581607|NCT01453725|7424644|FG000|Overall Study|Adverse Event|3
4581608|NCT01453725|7424645|FG001|Overall Study|Adverse Event|3
4581609|NCT01453725|7424644|FG000|Overall Study|Lost to Follow-up|4
4581610|NCT01453725|7424645|FG001|Overall Study|Lost to Follow-up|0
4581611|NCT01453725|7424644|FG000|Overall Study|Non-compliance With Protocol|1
4581612|NCT01453725|7424645|FG001|Overall Study|Non-compliance With Protocol|2
4581613|NCT01453725|7424644|FG000|Overall Study|Protocol Violation|1
4581614|NCT01453725|7424645|FG001|Overall Study|Protocol Violation|0
4581615|NCT01453725|7424644|FG000|Overall Study|Withdrawal by Subject|2
4581616|NCT01453725|7424645|FG001|Overall Study|Withdrawal by Subject|3
4581617|NCT01453725|7424644|FG000|Overall Study|Pregnancy Wish|0
4581618|NCT01453725|7424645|FG001|Overall Study|Pregnancy Wish|2
4581619|NCT01453725|7424644|FG000|Overall Study|Pregnancy|1
4581620|NCT01453725|7424645|FG001|Overall Study|Pregnancy|0
4581621|NCT01453725|7424644|FG000|Overall Study|Physician Decision|1
4581622|NCT01453725|7424645|FG001|Overall Study|Physician Decision|1
4581623|NCT01453855|7424655|FG000|Overall Study|Adverse Event|3
4581624|NCT01453855|7424656|FG001|Overall Study|Adverse Event|4
4581625|NCT01453855|7424655|FG000|Overall Study|Lost to Follow-up|2
4581626|NCT01453855|7424656|FG001|Overall Study|Lost to Follow-up|1
4581627|NCT01453855|7424655|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3
4581628|NCT01453855|7424656|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3
4581629|NCT01453855|7424655|FG000|Overall Study|Noncompliance|1
4581630|NCT01453855|7424656|FG001|Overall Study|Noncompliance|0
4581631|NCT01453855|7424655|FG000|Overall Study|Inadequate Control of IOP|1
4581632|NCT01453855|7424656|FG001|Overall Study|Inadequate Control of IOP|5
4581633|NCT01453855|7424655|FG000|Overall Study|Other|0
4581634|NCT01453855|7424656|FG001|Overall Study|Other|1
4581635|NCT01453998|7424674|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1
4581636|NCT01453998|7424675|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0
4581637|NCT01453998|7424676|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0
4581638|NCT01454063|7424689|FG000|Randomized|Adverse Event|1
4581639|NCT01454063|7424690|FG001|Randomized|Adverse Event|1
4581640|NCT01454063|7424689|FG000|Randomized|Protocol Violation|0
4581641|NCT01454063|7424690|FG001|Randomized|Protocol Violation|1
4581642|NCT01454076|7424701|FG000|Overall Study|Other|2
4581643|NCT01454076|7424702|FG001|Overall Study|Other|0
4581644|NCT01454076|7424703|FG002|Overall Study|Other|0
4581645|NCT01454076|7424704|FG003|Overall Study|Other|1
4581646|NCT01454076|7424705|FG004|Overall Study|Other|2
4581647|NCT01454076|7424701|FG000|Overall Study|Withdrawal by Subject|3
4581648|NCT01454076|7424702|FG001|Overall Study|Withdrawal by Subject|4
4581649|NCT01454076|7424703|FG002|Overall Study|Withdrawal by Subject|2
4581650|NCT01454076|7424704|FG003|Overall Study|Withdrawal by Subject|1
4581651|NCT01454076|7424705|FG004|Overall Study|Withdrawal by Subject|2
4581652|NCT01454076|7424701|FG000|Overall Study|Adverse Event|8
4581653|NCT01454076|7424702|FG001|Overall Study|Adverse Event|2
4581654|NCT01454076|7424703|FG002|Overall Study|Adverse Event|7
4581655|NCT01454076|7424704|FG003|Overall Study|Adverse Event|0
4581656|NCT01454076|7424705|FG004|Overall Study|Adverse Event|2
4581657|NCT01454102|7424742|FG000|Overall Study|Continuing in the treatment period|0
4581658|NCT01454102|7424743|FG001|Overall Study|Continuing in the treatment period|0
4581659|NCT01454102|7424744|FG002|Overall Study|Continuing in the treatment period|0
4581660|NCT01454102|7424745|FG003|Overall Study|Continuing in the treatment period|0
4581661|NCT01454102|7424746|FG004|Overall Study|Continuing in the treatment period|3
4581662|NCT01454102|7424747|FG005|Overall Study|Continuing in the treatment period|3
4581663|NCT01454102|7424748|FG006|Overall Study|Continuing in the treatment period|2
4581664|NCT01454102|7424749|FG007|Overall Study|Continuing in the treatment period|0
4581665|NCT01454102|7424750|FG008|Overall Study|Continuing in the treatment period|1
4581666|NCT01454102|7424751|FG009|Overall Study|Continuing in the treatment period|0
4581667|NCT01454102|7424752|FG010|Overall Study|Continuing in the treatment period|0
4581668|NCT01454102|7424753|FG011|Overall Study|Continuing in the treatment period|4
4581669|NCT01454102|7424754|FG012|Overall Study|Continuing in the treatment period|7
4581670|NCT01454102|7424755|FG013|Overall Study|Continuing in the treatment period|4
4581671|NCT01454102|7424756|FG014|Overall Study|Continuing in the treatment period|3
4581672|NCT01454102|7424757|FG015|Overall Study|Continuing in the treatment period|1
4581673|NCT01454284|7424800|FG000|Overall Study|Adverse Event|20
4581674|NCT01454284|7424801|FG001|Overall Study|Adverse Event|7
4581675|NCT01454284|7424800|FG000|Overall Study|Death|0
4581676|NCT01454284|7424801|FG001|Overall Study|Death|3
4581677|NCT01454284|7424800|FG000|Overall Study|Lost to Follow-up|13
4581678|NCT01454284|7424801|FG001|Overall Study|Lost to Follow-up|8
4581679|NCT01454284|7424800|FG000|Overall Study|Protocol Violation|9
4581680|NCT01454284|7424801|FG001|Overall Study|Protocol Violation|6
4581681|NCT01454284|7424800|FG000|Overall Study|Withdrawal by Subject|58
4581682|NCT01454284|7424801|FG001|Overall Study|Withdrawal by Subject|36
4581683|NCT01454284|7424800|FG000|Overall Study|Physician Decision|16
4581684|NCT01454284|7424801|FG001|Overall Study|Physician Decision|11
4581685|NCT01454284|7424800|FG000|Overall Study|Sponsor Decision|0
4581686|NCT01454284|7424801|FG001|Overall Study|Sponsor Decision|2
4581687|NCT01454401|7424818|FG000|Overall Study|Death|1
4581688|NCT01454401|7424818|FG000|Overall Study|hospitalised|1
4581689|NCT01454401|7424818|FG000|Overall Study|osteomyelitis|2
4581690|NCT01454401|7424818|FG000|Overall Study|non-adherence|1
4581691|NCT01454531|7424847|FG000|Overall Study|Adverse Event|14
4581692|NCT01454531|7424847|FG000|Overall Study|Withdrawal by Subject|5
4581693|NCT01454531|7424847|FG000|Overall Study|Lost to Follow-up|1
4581694|NCT01454531|7424847|FG000|Overall Study|Physician Decision|1
4581695|NCT01454531|7424847|FG000|Overall Study|Delay in IMP administration|1
4581696|NCT01454531|7424847|FG000|Overall Study|Other|1
4581697|NCT01454570|7424851|FG000|Overall Study|Withdrawal by Subject|2
4581698|NCT01454570|7424851|FG000|Overall Study|Screen Failure|7
4581699|NCT01454583|7424858|FG000|1st Year|Lost to Follow-up|1057
4581700|NCT01454583|7424859|FG001|1st Year|Lost to Follow-up|318
4581701|NCT01454583|7424860|FG002|1st Year|Lost to Follow-up|180
4581702|NCT01454583|7424858|FG000|2nd Year|Lost to Follow-up|3965
4581703|NCT01454583|7424859|FG001|2nd Year|Lost to Follow-up|1049
4581704|NCT01454583|7424860|FG002|2nd Year|Lost to Follow-up|737
4581705|NCT01454583|7424858|FG000|3rd Year|Lost to Follow-up|1959
4581706|NCT01454583|7424859|FG001|3rd Year|Lost to Follow-up|512
4581707|NCT01454583|7424860|FG002|3rd Year|Lost to Follow-up|297
4581708|NCT01454596|7424880|FG000|Overall Study|Death|0
4581709|NCT01454596|7424881|FG001|Overall Study|Death|0
4581710|NCT01454596|7424882|FG002|Overall Study|Death|0
4581711|NCT01454596|7424883|FG003|Overall Study|Death|0
4581712|NCT01454596|7424884|FG004|Overall Study|Death|0
4581713|NCT01454596|7424885|FG005|Overall Study|Death|0
4581714|NCT01454596|7424886|FG006|Overall Study|Death|0
4581715|NCT01454596|7424887|FG007|Overall Study|Death|0
4581716|NCT01454596|7424888|FG008|Overall Study|Death|0
4581717|NCT01454596|7424889|FG009|Overall Study|Death|1
4581718|NCT01454596|7424890|FG010|Overall Study|Death|1
4581719|NCT01454596|7424891|FG011|Overall Study|Death|0
4581720|NCT01454726|7424919|FG000|Overall Study|Withdrawal by Subject|0
4581721|NCT01454726|7424920|FG001|Overall Study|Withdrawal by Subject|1
4581722|NCT01454739|7424928|FG000|Overall Study|Protocol Violation|2
4581723|NCT01454739|7424929|FG001|Overall Study|Protocol Violation|3
4581724|NCT01454739|7424928|FG000|Overall Study|Withdrawal by Subject|2
4581725|NCT01454739|7424929|FG001|Overall Study|Withdrawal by Subject|6
4581726|NCT01454739|7424928|FG000|Overall Study|Other|3
4581727|NCT01454739|7424929|FG001|Overall Study|Other|5
4581728|NCT01454739|7424928|FG000|Overall Study|Physician Decision|0
4581729|NCT01454739|7424929|FG001|Overall Study|Physician Decision|5
4581730|NCT01454739|7424928|FG000|Overall Study|Lost to Follow-up|0
4581731|NCT01454739|7424929|FG001|Overall Study|Lost to Follow-up|1
4581732|NCT01454739|7424928|FG000|Overall Study|Adverse Event|0
4581733|NCT01454739|7424929|FG001|Overall Study|Adverse Event|1
4581734|NCT01454778|7424942|FG000|Overall Study|Lost to Follow-up|2
4581735|NCT01454778|7424942|FG000|Overall Study|Death|1
4581736|NCT01454830|7424959|FG000|Overall Study|Withdrawal by Subject|4
4581737|NCT01454830|7424960|FG001|Overall Study|Withdrawal by Subject|4
4581738|NCT01454830|7424959|FG000|Overall Study|Post-allocation Exclude- AHI<10|18
4581739|NCT01454830|7424960|FG001|Overall Study|Post-allocation Exclude- AHI<10|12
4581740|NCT01454830|7424959|FG000|Overall Study|Post-allocation Exclude-refused PAP|0
4581741|NCT01454830|7424960|FG001|Overall Study|Post-allocation Exclude-refused PAP|2
4581742|NCT01454830|7424959|FG000|Overall Study|Post-allocation Exclude-other treatment|6
4581743|NCT01454830|7424960|FG001|Overall Study|Post-allocation Exclude-other treatment|7
4581744|NCT01454830|7424959|FG000|Overall Study|Withdrawal - no polysomnography|3
4581745|NCT01454830|7424960|FG001|Overall Study|Withdrawal - no polysomnography|2
4581746|NCT01454934|7424968|FG000|Overall Study|Clinical progression|28
4581747|NCT01454934|7424969|FG001|Overall Study|Clinical progression|25
4581748|NCT01454934|7424968|FG000|Overall Study|Other|6
4581749|NCT01454934|7424969|FG001|Overall Study|Other|17
4581750|NCT01454934|7424968|FG000|Overall Study|Adverse Event|28
4581751|NCT01454934|7424969|FG001|Overall Study|Adverse Event|24
4581752|NCT01454934|7424968|FG000|Overall Study|Withdrawn consent|2
4581753|NCT01454934|7424969|FG001|Overall Study|Withdrawn consent|5
4581754|NCT01454934|7424968|FG000|Overall Study|Withdrawal by Subject|11
4447934|NCT00492856|7233153|FG001|Post-consolidation|Withdrawal by Subject|4
4447935|NCT00492856|7233154|FG002|Post-consolidation|Withdrawal by Subject|0
4447936|NCT00492856|7233155|FG003|Post-consolidation|Withdrawal by Subject|0
4447937|NCT00492856|7233152|FG000|Post-consolidation|Death|0
4581755|NCT01454934|7424969|FG001|Overall Study|Withdrawal by Subject|15
4581756|NCT01454934|7424968|FG000|Overall Study|Disease progression|194
4581757|NCT01454934|7424969|FG001|Overall Study|Disease progression|181
4581758|NCT01454934|7424968|FG000|Overall Study|Lost to Follow-up|0
4581759|NCT01454934|7424969|FG001|Overall Study|Lost to Follow-up|1
4581760|NCT01454934|7424968|FG000|Overall Study|Not treated|1
4581761|NCT01454934|7424969|FG001|Overall Study|Not treated|2
4581762|NCT01455012|7425010|FG000|Overall Study|Adverse Event|0
4581763|NCT01455012|7425011|FG001|Overall Study|Adverse Event|2
4581764|NCT01455012|7425010|FG000|Overall Study|Lack of Efficacy|6
4581765|NCT01455012|7425011|FG001|Overall Study|Lack of Efficacy|1
4581766|NCT01455012|7425010|FG000|Overall Study|Withdrawal by Subject|3
4581767|NCT01455012|7425011|FG001|Overall Study|Withdrawal by Subject|1
4581768|NCT01455012|7425010|FG000|Overall Study|Unknown reason|2
4581769|NCT01455012|7425011|FG001|Overall Study|Unknown reason|0
4593313|NCT01549964|7441612|FG000|80-Week Extension Period|Pregnancy|0
4593314|NCT01549964|7441613|FG001|80-Week Extension Period|Pregnancy|0
4593315|NCT01549964|7441614|FG002|80-Week Extension Period|Pregnancy|1
4593316|NCT01549964|7441615|FG003|80-Week Extension Period|Pregnancy|0
4593317|NCT01549964|7441612|FG000|80-Week Extension Period|Study Terminated by Sponsor|65
4593318|NCT01549964|7441613|FG001|80-Week Extension Period|Study Terminated by Sponsor|137
4593319|NCT01549964|7441614|FG002|80-Week Extension Period|Study Terminated by Sponsor|132
4593320|NCT01549964|7441615|FG003|80-Week Extension Period|Study Terminated by Sponsor|132
4593321|NCT01549964|7441612|FG000|80-Week Extension Period|Voluntary Withdrawal|0
4593322|NCT01549964|7441613|FG001|80-Week Extension Period|Voluntary Withdrawal|1
4593323|NCT01549964|7441614|FG002|80-Week Extension Period|Voluntary Withdrawal|4
4593324|NCT01549964|7441615|FG003|80-Week Extension Period|Voluntary Withdrawal|2
4593325|NCT01549964|7441612|FG000|80-Week Extension Period|Lost to Follow-up|1
4593326|NCT01549964|7441613|FG001|80-Week Extension Period|Lost to Follow-up|0
4593327|NCT01549964|7441614|FG002|80-Week Extension Period|Lost to Follow-up|2
4593328|NCT01549964|7441615|FG003|80-Week Extension Period|Lost to Follow-up|1
4593329|NCT01549964|7441612|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0
4593330|NCT01549964|7441613|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0
4593331|NCT01549964|7441614|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1
4593332|NCT01549964|7441615|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2
4593333|NCT01550744|7441689|FG000|Open-Label|Lost to Follow-up|7
4593334|NCT01550744|7441690|FG001|Open-Label|Lost to Follow-up|0
4593335|NCT01550744|7441691|FG002|Open-Label|Lost to Follow-up|0
4593336|NCT01550744|7441689|FG000|Open-Label|Withdrawal by Subject|13
4593337|NCT01550744|7441690|FG001|Open-Label|Withdrawal by Subject|0
4593338|NCT01550744|7441691|FG002|Open-Label|Withdrawal by Subject|0
4593339|NCT01550744|7441689|FG000|Open-Label|Adverse Event|11
4593340|NCT01550744|7441690|FG001|Open-Label|Adverse Event|0
4593341|NCT01550744|7441691|FG002|Open-Label|Adverse Event|0
4593342|NCT01550744|7441689|FG000|Open-Label|Lack of Efficacy|4
4593343|NCT01550744|7441690|FG001|Open-Label|Lack of Efficacy|0
4593344|NCT01550744|7441691|FG002|Open-Label|Lack of Efficacy|0
4593345|NCT01550744|7441689|FG000|Open-Label|Protocol Violation|4
4593346|NCT01550744|7441690|FG001|Open-Label|Protocol Violation|0
4593347|NCT01550744|7441691|FG002|Open-Label|Protocol Violation|0
4593348|NCT01550744|7441689|FG000|Open-Label|Not all 3 study drug injections received|2
4593349|NCT01550744|7441690|FG001|Open-Label|Not all 3 study drug injections received|0
4593350|NCT01550744|7441691|FG002|Open-Label|Not all 3 study drug injections received|0
4593351|NCT01550744|7441689|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58
4593352|NCT01550744|7441690|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0
4593353|NCT01550744|7441691|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0
4593354|NCT01550744|7441689|FG000|Open-Label|Other|1
4593355|NCT01550744|7441690|FG001|Open-Label|Other|0
4593356|NCT01550744|7441691|FG002|Open-Label|Other|0
4593357|NCT01550744|7441689|FG000|Double-Blind|Lost to Follow-up|0
4593358|NCT01550744|7441690|FG001|Double-Blind|Lost to Follow-up|6
4593359|NCT01550744|7441691|FG002|Double-Blind|Lost to Follow-up|12
4593360|NCT01550744|7441689|FG000|Double-Blind|Withdrawal by Subject|0
4593361|NCT01550744|7441690|FG001|Double-Blind|Withdrawal by Subject|2
4593362|NCT01550744|7441691|FG002|Double-Blind|Withdrawal by Subject|15
4447938|NCT00492856|7233153|FG001|Post-consolidation|Death|1
4581770|NCT01455194|7425028|FG000|Overall Study|Screen Failure|20
4581771|NCT01455194|7425029|FG001|Overall Study|Screen Failure|0
4581772|NCT01455194|7425030|FG002|Overall Study|Screen Failure|0
4581773|NCT01455194|7425031|FG003|Overall Study|Screen Failure|0
4692961|NCT02859558|7603809|FG000|Step 1|Non-Adherence to Study Drug|2
4692962|NCT02859558|7603810|FG001|Step 1|Non-Adherence to Study Drug|0
4692963|NCT02859558|7603811|FG002|Step 1|Non-Adherence to Study Drug|1
4692964|NCT02859558|7603812|FG003|Step 1|Non-Adherence to Study Drug|0
4692965|NCT02859558|7603813|FG004|Step 1|Non-Adherence to Study Drug|0
4692966|NCT02859558|7603809|FG000|Step 1|Non-Adherence to Study Requirements|3
4581774|NCT01455194|7425028|FG000|Overall Study|Randomisation Failure|90
4581775|NCT01455194|7425029|FG001|Overall Study|Randomisation Failure|0
4581776|NCT01455194|7425030|FG002|Overall Study|Randomisation Failure|0
4581777|NCT01455194|7425031|FG003|Overall Study|Randomisation Failure|0
4581778|NCT01455194|7425028|FG000|Overall Study|Deterioration in asthma|12
4581779|NCT01455194|7425029|FG001|Overall Study|Deterioration in asthma|6
4581780|NCT01455194|7425030|FG002|Overall Study|Deterioration in asthma|14
4581781|NCT01455194|7425031|FG003|Overall Study|Deterioration in asthma|9
4581782|NCT01455194|7425028|FG000|Overall Study|Adverse Event|1
4581783|NCT01455194|7425029|FG001|Overall Study|Adverse Event|1
4581784|NCT01455194|7425030|FG002|Overall Study|Adverse Event|1
4581785|NCT01455194|7425031|FG003|Overall Study|Adverse Event|3
4581786|NCT01455194|7425028|FG000|Overall Study|Withdrawal by Subject|21
4581787|NCT01455194|7425029|FG001|Overall Study|Withdrawal by Subject|16
4581788|NCT01455194|7425030|FG002|Overall Study|Withdrawal by Subject|12
4581789|NCT01455194|7425031|FG003|Overall Study|Withdrawal by Subject|9
4581790|NCT01455194|7425028|FG000|Overall Study|Lost to Follow-up|2
4581791|NCT01455194|7425029|FG001|Overall Study|Lost to Follow-up|0
4581792|NCT01455194|7425030|FG002|Overall Study|Lost to Follow-up|1
4581793|NCT01455194|7425031|FG003|Overall Study|Lost to Follow-up|1
4581794|NCT01455194|7425028|FG000|Overall Study|Pregnancy|0
4581795|NCT01455194|7425029|FG001|Overall Study|Pregnancy|1
4581796|NCT01455194|7425030|FG002|Overall Study|Pregnancy|1
4581797|NCT01455194|7425031|FG003|Overall Study|Pregnancy|0
4581798|NCT01455194|7425028|FG000|Overall Study|Discontinuation criterion fulfilled|3
4581799|NCT01455194|7425029|FG001|Overall Study|Discontinuation criterion fulfilled|2
4581800|NCT01455194|7425030|FG002|Overall Study|Discontinuation criterion fulfilled|0
4581801|NCT01455194|7425031|FG003|Overall Study|Discontinuation criterion fulfilled|2
4581802|NCT01455194|7425028|FG000|Overall Study|Miscellaneous|4
4581803|NCT01455194|7425029|FG001|Overall Study|Miscellaneous|5
4581804|NCT01455194|7425030|FG002|Overall Study|Miscellaneous|1
4581805|NCT01455194|7425031|FG003|Overall Study|Miscellaneous|4
4581806|NCT01455220|7425044|FG000|Overall Study|screen fail|30
4581807|NCT01455415|7425053|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9
4581808|NCT01455415|7425054|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6
4581809|NCT01455415|7425053|FG000|Period 1|Lost To Follow-up Related to Study Drug|3
4581810|NCT01455415|7425054|FG001|Period 1|Lost To Follow-up Related to Study Drug|3
4581811|NCT01455415|7425053|FG000|Period 1|Drug Error not Associated to AE|0
4581812|NCT01455415|7425054|FG001|Period 1|Drug Error not Associated to AE|1
4581813|NCT01455415|7425053|FG000|Period 1|AE Not Related to Study Drug|2
4581814|NCT01455415|7425054|FG001|Period 1|AE Not Related to Study Drug|6
4581815|NCT01455415|7425053|FG000|Period 1|Withdrawal by Subject|4
4581816|NCT01455415|7425054|FG001|Period 1|Withdrawal by Subject|5
4581817|NCT01455415|7425053|FG000|Period 1|Unspecified Reason|1
4581818|NCT01455415|7425054|FG001|Period 1|Unspecified Reason|1
4581819|NCT01455415|7425053|FG000|Period 1|Protocol Violation|0
4581820|NCT01455415|7425054|FG001|Period 1|Protocol Violation|2
4581821|NCT01455415|7425053|FG000|Washout|AE Related to Study Drug|2
4581822|NCT01455415|7425054|FG001|Washout|AE Related to Study Drug|0
4581823|NCT01455415|7425053|FG000|Washout|Lost to Follow-up|1
4581824|NCT01455415|7425054|FG001|Washout|Lost to Follow-up|0
4581825|NCT01455415|7425053|FG000|Washout|Drug Error not Associated to AE|2
4581826|NCT01455415|7425054|FG001|Washout|Drug Error not Associated to AE|1
4581827|NCT01455415|7425053|FG000|Washout|AE Not Related to Study Drug|2
4581828|NCT01455415|7425054|FG001|Washout|AE Not Related to Study Drug|3
4581829|NCT01455415|7425053|FG000|Washout|Unspecified Reason|1
4581830|NCT01455415|7425054|FG001|Washout|Unspecified Reason|2
4581831|NCT01455415|7425053|FG000|Washout|Protocol Violation|0
4581832|NCT01455415|7425054|FG001|Washout|Protocol Violation|1
4581833|NCT01455415|7425053|FG000|Period 2|AE Related to Study Drug|1
4581834|NCT01455415|7425054|FG001|Period 2|AE Related to Study Drug|2
4581835|NCT01455415|7425053|FG000|Period 2|Lost to Follow-up|2
4581836|NCT01455415|7425054|FG001|Period 2|Lost to Follow-up|1
4581837|NCT01455415|7425053|FG000|Period 2|AE Not Related to Study Drug|2
4581838|NCT01455415|7425054|FG001|Period 2|AE Not Related to Study Drug|1
4581839|NCT01455415|7425053|FG000|Period 2|Lack of Efficacy|2
4581840|NCT01455415|7425054|FG001|Period 2|Lack of Efficacy|0
4581841|NCT01455415|7425053|FG000|Period 2|Withdrawal by Subject|2
4581842|NCT01455415|7425054|FG001|Period 2|Withdrawal by Subject|3
4581843|NCT01455415|7425053|FG000|Period 2|Unspecified Reason|2
4581844|NCT01455415|7425054|FG001|Period 2|Unspecified Reason|3
4581845|NCT01455415|7425053|FG000|Period 2|Protocol Violation|2
4581846|NCT01455415|7425054|FG001|Period 2|Protocol Violation|0
4581847|NCT01455415|7425053|FG000|Follow-up|AE Related to Study Drug|0
4692967|NCT02859558|7603810|FG001|Step 1|Non-Adherence to Study Requirements|1
4581848|NCT01455415|7425054|FG001|Follow-up|AE Related to Study Drug|1
4581849|NCT01455415|7425053|FG000|Follow-up|Lack of Efficacy|0
4581850|NCT01455415|7425054|FG001|Follow-up|Lack of Efficacy|1
4581851|NCT01455415|7425053|FG000|Follow-up|Withdrawal by Subject|2
4581852|NCT01455415|7425054|FG001|Follow-up|Withdrawal by Subject|0
4581853|NCT01455415|7425053|FG000|Follow-up|Unspecified Reason|1
4581854|NCT01455415|7425054|FG001|Follow-up|Unspecified Reason|0
4581855|NCT01455428|7425062|FG000|Overall Study|Protocol Violation|2
4581856|NCT01455428|7425063|FG001|Overall Study|Protocol Violation|1
4581857|NCT01455428|7425062|FG000|Overall Study|Adverse Event|6
4581858|NCT01455428|7425063|FG001|Overall Study|Adverse Event|2
4581859|NCT01455428|7425062|FG000|Overall Study|Lost to Follow-up|1
4581860|NCT01455428|7425063|FG001|Overall Study|Lost to Follow-up|1
4581861|NCT01455428|7425062|FG000|Overall Study|Withdrawal by Subject|2
4581862|NCT01455428|7425063|FG001|Overall Study|Withdrawal by Subject|5
4581863|NCT01455428|7425062|FG000|Overall Study|Did not meet entrance criteria|0
4581864|NCT01455428|7425063|FG001|Overall Study|Did not meet entrance criteria|2
4581865|NCT01455428|7425062|FG000|Overall Study|Insufficient clinical response|0
4581866|NCT01455428|7425063|FG001|Overall Study|Insufficient clinical response|2
4581867|NCT01455428|7425062|FG000|Overall Study|Did not receive treatment|1
4581868|NCT01455428|7425063|FG001|Overall Study|Did not receive treatment|1
4581869|NCT01455428|7425062|FG000|Overall Study|Other|2
4581870|NCT01455428|7425063|FG001|Overall Study|Other|4
4581871|NCT01456039|7425106|FG000|Phase 1 (First Step)|Disease Progression|1
4581872|NCT01456039|7425107|FG001|Phase 1 (First Step)|Disease Progression|1
4581873|NCT01456039|7425108|FG002|Phase 1 (First Step)|Disease Progression|0
4581874|NCT01456039|7425106|FG000|Phase 1 (First Step)|Withdrawal by Subject|1
4581875|NCT01456039|7425107|FG001|Phase 1 (First Step)|Withdrawal by Subject|2
4581876|NCT01456039|7425108|FG002|Phase 1 (First Step)|Withdrawal by Subject|0
4581877|NCT01456039|7425106|FG000|Phase 1 (First Step)|Adverse Event|0
4581878|NCT01456039|7425107|FG001|Phase 1 (First Step)|Adverse Event|3
4581879|NCT01456039|7425108|FG002|Phase 1 (First Step)|Adverse Event|0
4581880|NCT01456039|7425106|FG000|Phase 1 (First Step)|Other|0
4581881|NCT01456039|7425107|FG001|Phase 1 (First Step)|Other|1
4581882|NCT01456039|7425108|FG002|Phase 1 (First Step)|Other|0
4581883|NCT01456039|7425106|FG000|Phase 2 (Second Step)|Disease Progression|0
4581884|NCT01456039|7425107|FG001|Phase 2 (Second Step)|Disease Progression|0
4581885|NCT01456039|7425108|FG002|Phase 2 (Second Step)|Disease Progression|17
4581886|NCT01456039|7425106|FG000|Phase 2 (Second Step)|Adverse Event|0
4581887|NCT01456039|7425107|FG001|Phase 2 (Second Step)|Adverse Event|0
4581888|NCT01456039|7425108|FG002|Phase 2 (Second Step)|Adverse Event|10
4581889|NCT01456039|7425106|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0
4581890|NCT01456039|7425107|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0
4581891|NCT01456039|7425108|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4
4581892|NCT01456039|7425106|FG000|Phase 2 (Second Step)|Protocol Violation|0
4581893|NCT01456039|7425107|FG001|Phase 2 (Second Step)|Protocol Violation|0
4581894|NCT01456039|7425108|FG002|Phase 2 (Second Step)|Protocol Violation|1
4581895|NCT01456039|7425106|FG000|Phase 2 (Second Step)|Other|0
4581896|NCT01456039|7425107|FG001|Phase 2 (Second Step)|Other|0
4581897|NCT01456039|7425108|FG002|Phase 2 (Second Step)|Other|1
4581898|NCT01456052|7425127|FG000|Overall Study|Adverse Event|1
4581899|NCT01456052|7425128|FG001|Overall Study|Adverse Event|1
4581900|NCT01456052|7425129|FG002|Overall Study|Adverse Event|2
4581901|NCT01456052|7425127|FG000|Overall Study|Consent withdrawn|0
4581902|NCT01456052|7425128|FG001|Overall Study|Consent withdrawn|2
4581903|NCT01456052|7425129|FG002|Overall Study|Consent withdrawn|1
4581904|NCT01456052|7425127|FG000|Overall Study|Protocol Violation|0
4581905|NCT01456052|7425128|FG001|Overall Study|Protocol Violation|1
4581906|NCT01456052|7425129|FG002|Overall Study|Protocol Violation|0
4581907|NCT01456052|7425127|FG000|Overall Study|Physician Decision|1
4581908|NCT01456052|7425128|FG001|Overall Study|Physician Decision|0
4581909|NCT01456052|7425129|FG002|Overall Study|Physician Decision|1
4581910|NCT01456052|7425127|FG000|Overall Study|Treatment Failure|0
4581911|NCT01456052|7425128|FG001|Overall Study|Treatment Failure|1
4581912|NCT01456052|7425129|FG002|Overall Study|Treatment Failure|1
4581913|NCT01456130|7425138|FG000|Overall Study|Adverse Event|4
4581914|NCT01456130|7425138|FG000|Overall Study|Voluntary Withdrawal|1
4581915|NCT01456130|7425138|FG000|Overall Study|Lack of Efficacy|4
4581916|NCT01456130|7425138|FG000|Overall Study|Other|1
4581917|NCT01456169|7425149|FG000|Overall Study|Adverse Event|1
4581918|NCT01456169|7425150|FG001|Overall Study|Adverse Event|2
4581919|NCT01456169|7425151|FG002|Overall Study|Adverse Event|7
4581920|NCT01456169|7425149|FG000|Overall Study|Major Protocol Deviation|3
4581921|NCT01456169|7425150|FG001|Overall Study|Major Protocol Deviation|2
4581922|NCT01456169|7425151|FG002|Overall Study|Major Protocol Deviation|3
4581923|NCT01456169|7425149|FG000|Overall Study|Voluntary Withdrawal|3
4581924|NCT01456169|7425150|FG001|Overall Study|Voluntary Withdrawal|0
4581925|NCT01456169|7425151|FG002|Overall Study|Voluntary Withdrawal|2
4581926|NCT01456169|7425149|FG000|Overall Study|Lack of Efficacy|2
4581927|NCT01456169|7425150|FG001|Overall Study|Lack of Efficacy|0
4581928|NCT01456169|7425151|FG002|Overall Study|Lack of Efficacy|0
4581929|NCT01456169|7425149|FG000|Overall Study|Other|1
4581930|NCT01456169|7425150|FG001|Overall Study|Other|1
4581931|NCT01456169|7425151|FG002|Overall Study|Other|0
4581932|NCT01456195|7425163|FG000|Overall Study|Pretreatment Event/Adverse Event|1
4581933|NCT01456195|7425164|FG001|Overall Study|Pretreatment Event/Adverse Event|4
4581934|NCT01456195|7425165|FG002|Overall Study|Pretreatment Event/Adverse Event|1
4581935|NCT01456195|7425163|FG000|Overall Study|Lost to Follow-up|3
4581936|NCT01456195|7425164|FG001|Overall Study|Lost to Follow-up|1
4581937|NCT01456195|7425165|FG002|Overall Study|Lost to Follow-up|3
4581938|NCT01456195|7425163|FG000|Overall Study|Voluntary Withdrawal|5
4581939|NCT01456195|7425164|FG001|Overall Study|Voluntary Withdrawal|3
4581940|NCT01456195|7425165|FG002|Overall Study|Voluntary Withdrawal|7
4581941|NCT01456195|7425163|FG000|Overall Study|Lack of Efficacy|0
4581942|NCT01456195|7425164|FG001|Overall Study|Lack of Efficacy|1
4581943|NCT01456195|7425165|FG002|Overall Study|Lack of Efficacy|0
4581944|NCT01456195|7425163|FG000|Overall Study|Other Reasons|2
4581945|NCT01456195|7425164|FG001|Overall Study|Other Reasons|1
4581946|NCT01456195|7425165|FG002|Overall Study|Other Reasons|3
4581947|NCT01456221|7425175|FG000|Overall Study|Withdrawal by Subject|56
4581948|NCT01456221|7425176|FG001|Overall Study|Withdrawal by Subject|49
4581949|NCT01456221|7425175|FG000|Overall Study|Lost to Follow-up|1
4581950|NCT01456221|7425176|FG001|Overall Study|Lost to Follow-up|4
4581951|NCT01456221|7425175|FG000|Overall Study|Received medication|3
4581952|NCT01456221|7425176|FG001|Overall Study|Received medication|2
4581953|NCT01456221|7425175|FG000|Overall Study|Incomplete data|4
4581954|NCT01456221|7425176|FG001|Overall Study|Incomplete data|2
4581955|NCT01456780|7425207|FG000|Overall Study|Lost to Follow-up|3
4581956|NCT01456780|7425208|FG001|Overall Study|Lost to Follow-up|3
4581957|NCT01456780|7425209|FG002|Overall Study|Lost to Follow-up|0
4581958|NCT01456897|7425219|FG000|Overall Study|Adverse Event|19
4581959|NCT01456897|7425220|FG001|Overall Study|Adverse Event|22
4581960|NCT01456897|7425219|FG000|Overall Study|Protocol Violation|3
4581961|NCT01456897|7425220|FG001|Overall Study|Protocol Violation|4
4581962|NCT01456897|7425219|FG000|Overall Study|Physician Decision|5
4581963|NCT01456897|7425220|FG001|Overall Study|Physician Decision|3
4581964|NCT01456897|7425219|FG000|Overall Study|Withdrawal by Subject|44
4581965|NCT01456897|7425220|FG001|Overall Study|Withdrawal by Subject|17
4581966|NCT01456897|7425219|FG000|Overall Study|Lack of Efficacy|4
4581967|NCT01456897|7425220|FG001|Overall Study|Lack of Efficacy|11
4581968|NCT01456936|7425230|FG000|Overall Study|Other reason|41
4581969|NCT01456936|7425231|FG001|Overall Study|Other reason|30
4581970|NCT01456936|7425232|FG002|Overall Study|Other reason|36
4581971|NCT01456936|7425233|FG003|Overall Study|Other reason|33
4581972|NCT01456936|7425230|FG000|Overall Study|No longer meets eligibility criteria|4
4581973|NCT01456936|7425231|FG001|Overall Study|No longer meets eligibility criteria|8
4581974|NCT01456936|7425232|FG002|Overall Study|No longer meets eligibility criteria|6
4581975|NCT01456936|7425233|FG003|Overall Study|No longer meets eligibility criteria|5
4581976|NCT01456936|7425230|FG000|Overall Study|Protocol Violation|4
4581977|NCT01456936|7425231|FG001|Overall Study|Protocol Violation|2
4581978|NCT01456936|7425232|FG002|Overall Study|Protocol Violation|5
4581979|NCT01456936|7425233|FG003|Overall Study|Protocol Violation|5
4581980|NCT01456936|7425230|FG000|Overall Study|Pregnancy|1
4581981|NCT01456936|7425231|FG001|Overall Study|Pregnancy|0
4581982|NCT01456936|7425232|FG002|Overall Study|Pregnancy|0
4581983|NCT01456936|7425233|FG003|Overall Study|Pregnancy|1
4581984|NCT01456936|7425230|FG000|Overall Study|Insufficient clinical response|4
4581985|NCT01456936|7425231|FG001|Overall Study|Insufficient clinical response|4
4581986|NCT01456936|7425232|FG002|Overall Study|Insufficient clinical response|14
4581987|NCT01456936|7425233|FG003|Overall Study|Insufficient clinical response|13
4581988|NCT01456936|7425230|FG000|Overall Study|No longer willing to participate|195
4581989|NCT01456936|7425231|FG001|Overall Study|No longer willing to participate|218
4581990|NCT01456936|7425232|FG002|Overall Study|No longer willing to participate|224
4581991|NCT01456936|7425233|FG003|Overall Study|No longer willing to participate|248
4581992|NCT01456936|7425230|FG000|Overall Study|Lost to Follow-up|135
4581993|NCT01456936|7425231|FG001|Overall Study|Lost to Follow-up|126
4581994|NCT01456936|7425232|FG002|Overall Study|Lost to Follow-up|144
4581995|NCT01456936|7425233|FG003|Overall Study|Lost to Follow-up|127
4581996|NCT01456936|7425230|FG000|Overall Study|Medication error|0
4581997|NCT01456936|7425231|FG001|Overall Study|Medication error|1
4581998|NCT01456936|7425232|FG002|Overall Study|Medication error|0
4581999|NCT01456936|7425233|FG003|Overall Study|Medication error|1
4582000|NCT01456936|7425230|FG000|Overall Study|Adverse event (study drug)|25
4582001|NCT01456936|7425231|FG001|Overall Study|Adverse event (study drug)|21
4582002|NCT01456936|7425232|FG002|Overall Study|Adverse event (study drug)|26
4582003|NCT01456936|7425233|FG003|Overall Study|Adverse event (study drug)|17
4582004|NCT01456936|7425230|FG000|Overall Study|Adverse event (study drug unrelated)|9
4582005|NCT01456936|7425231|FG001|Overall Study|Adverse event (study drug unrelated)|7
4582006|NCT01456936|7425232|FG002|Overall Study|Adverse event (study drug unrelated)|9
4582007|NCT01456936|7425233|FG003|Overall Study|Adverse event (study drug unrelated)|9
4582008|NCT01456936|7425230|FG000|Overall Study|Death|0
4582009|NCT01456936|7425231|FG001|Overall Study|Death|3
4582010|NCT01456936|7425232|FG002|Overall Study|Death|1
4582011|NCT01456936|7425233|FG003|Overall Study|Death|3
4582012|NCT01456936|7425230|FG000|Overall Study|Randomized but not treated|21
4582013|NCT01456936|7425231|FG001|Overall Study|Randomized but not treated|28
4582014|NCT01456936|7425232|FG002|Overall Study|Randomized but not treated|16
4582015|NCT01456936|7425233|FG003|Overall Study|Randomized but not treated|21
4582016|NCT01456949|7425243|FG000|Enrollment|PI death- incomplete data|6
4582017|NCT01456949|7425243|FG000|Enrollment|Death|1
4582018|NCT01456949|7425243|FG000|Enrollment|I/E criteria not met prior to procedure|13
4582019|NCT01456949|7425243|FG000|Enrollment|Physician Decision|10
4582020|NCT01456949|7425243|FG000|Enrollment|Withdrawal by Subject|7
4582021|NCT01456949|7425243|FG000|Study Cryoablation Procedure & Follow-up|Death|5
4582022|NCT01456949|7425243|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23
4582023|NCT01456949|7425243|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11
4582024|NCT01456949|7425243|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1
4582025|NCT01456949|7425243|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10
4582026|NCT01456949|7425243|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2
4582027|NCT01456949|7425243|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6
4582028|NCT01456949|7425243|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4
4582029|NCT01456962|7425249|FG000|Overall Study|Lost to Follow-up|2
4582030|NCT01456962|7425250|FG001|Overall Study|Lost to Follow-up|1
4582031|NCT01457014|7425256|FG000|First Night|Didn't meet inclusion/exclusion criteria|37
4582032|NCT01457014|7425257|FG001|First Night|Didn't meet inclusion/exclusion criteria|0
4582033|NCT01457014|7425258|FG002|First Night|Didn't meet inclusion/exclusion criteria|0
4582034|NCT01457014|7425259|FG003|First Night|Didn't meet inclusion/exclusion criteria|0
4582035|NCT01457014|7425256|FG000|First Night|Withdrawal by Subject|3
4582036|NCT01457014|7425257|FG001|First Night|Withdrawal by Subject|0
4582037|NCT01457014|7425258|FG002|First Night|Withdrawal by Subject|0
4582038|NCT01457014|7425259|FG003|First Night|Withdrawal by Subject|0
4582039|NCT01457118|7425271|FG000|Overall Study|Adverse Event|1
4582040|NCT01457118|7425272|FG001|Overall Study|Adverse Event|0
4582041|NCT01457118|7425273|FG002|Overall Study|Adverse Event|0
4582042|NCT01457118|7425274|FG003|Overall Study|Adverse Event|1
4582043|NCT01457118|7425271|FG000|Overall Study|Clinical Progression|0
4582044|NCT01457118|7425272|FG001|Overall Study|Clinical Progression|1
4582045|NCT01457118|7425273|FG002|Overall Study|Clinical Progression|0
4582046|NCT01457118|7425274|FG003|Overall Study|Clinical Progression|1
4582047|NCT01457118|7425271|FG000|Overall Study|Physician Decision|2
4582048|NCT01457118|7425272|FG001|Overall Study|Physician Decision|0
4582049|NCT01457118|7425273|FG002|Overall Study|Physician Decision|0
4582050|NCT01457118|7425274|FG003|Overall Study|Physician Decision|0
4582051|NCT01457118|7425271|FG000|Overall Study|Progressive Disease by RECIST|12
4582052|NCT01457118|7425272|FG001|Overall Study|Progressive Disease by RECIST|3
4582053|NCT01457118|7425273|FG002|Overall Study|Progressive Disease by RECIST|1
4582054|NCT01457118|7425274|FG003|Overall Study|Progressive Disease by RECIST|0
4582055|NCT01457118|7425271|FG000|Overall Study|Withdrawal by Subject|5
4582056|NCT01457118|7425272|FG001|Overall Study|Withdrawal by Subject|0
4582057|NCT01457118|7425273|FG002|Overall Study|Withdrawal by Subject|0
4582058|NCT01457118|7425274|FG003|Overall Study|Withdrawal by Subject|0
4582059|NCT01457339|7425292|FG000|Period 3 (100 mg)|Adverse Event|0
4582060|NCT01457339|7425293|FG001|Period 3 (100 mg)|Adverse Event|1
4582061|NCT01457339|7425292|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0
4582062|NCT01457339|7425293|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1
4582063|NCT01457339|7425292|FG000|Period 6 (250 mg)|Family Emergency|1
4582064|NCT01457339|7425293|FG001|Period 6 (250 mg)|Family Emergency|0
4582065|NCT01457339|7425292|FG000|Period 6 (250 mg)|Personal appointment|0
4582066|NCT01457339|7425293|FG001|Period 6 (250 mg)|Personal appointment|1
4582067|NCT01457352|7425318|FG000|Period 1|Adverse Event|2
4582068|NCT01457352|7425319|FG001|Period 1|Adverse Event|0
4582069|NCT01457352|7425318|FG000|Period 1|Withdrawal by Subject|2
4582070|NCT01457352|7425319|FG001|Period 1|Withdrawal by Subject|0
4582071|NCT01457352|7425318|FG000|Period 1|Physician Decision|2
4582072|NCT01457352|7425319|FG001|Period 1|Physician Decision|0
4582073|NCT01457352|7425318|FG000|Period 1|MS related disease progression|1
4582074|NCT01457352|7425319|FG001|Period 1|MS related disease progression|0
4582075|NCT01457352|7425318|FG000|Period 1|Withdrawn|1
4582076|NCT01457352|7425319|FG001|Period 1|Withdrawn|0
4582077|NCT01457352|7425318|FG000|Period 1|withdrew per sponsor|1
4582078|NCT01457352|7425319|FG001|Period 1|withdrew per sponsor|0
4582079|NCT01457352|7425318|FG000|Period 1|Protocol Violation|4
4582080|NCT01457352|7425319|FG001|Period 1|Protocol Violation|0
4582081|NCT01457352|7425318|FG000|Period 1|Did not meet eligibility criteria|3
4582082|NCT01457352|7425319|FG001|Period 1|Did not meet eligibility criteria|0
4582083|NCT01457352|7425318|FG000|Period 2|Withdrawal by Subject|23
4582084|NCT01457352|7425319|FG001|Period 2|Withdrawal by Subject|0
4692968|NCT02859558|7603811|FG002|Step 1|Non-Adherence to Study Requirements|0
4692969|NCT02859558|7603812|FG003|Step 1|Non-Adherence to Study Requirements|0
4692970|NCT02859558|7603813|FG004|Step 1|Non-Adherence to Study Requirements|0
4692971|NCT02859558|7603809|FG000|Step 1|Virologic Failure|2
4692972|NCT02859558|7603810|FG001|Step 1|Virologic Failure|1
4692973|NCT02859558|7603811|FG002|Step 1|Virologic Failure|1
4692974|NCT02859558|7603812|FG003|Step 1|Virologic Failure|0
4692975|NCT02859558|7603813|FG004|Step 1|Virologic Failure|0
4582085|NCT01457352|7425318|FG000|Period 2|Adverse Event|22
4582086|NCT01457352|7425319|FG001|Period 2|Adverse Event|0
4582087|NCT01457352|7425318|FG000|Period 2|no analysis|10
4582088|NCT01457352|7425319|FG001|Period 2|no analysis|0
4582089|NCT01457352|7425318|FG000|Period 2|Lack of Efficacy|8
4582090|NCT01457352|7425319|FG001|Period 2|Lack of Efficacy|0
4582091|NCT01457352|7425318|FG000|Period 2|Protocol Violation|4
4582092|NCT01457352|7425319|FG001|Period 2|Protocol Violation|0
4582093|NCT01457352|7425318|FG000|Period 2|Sponsor's withdrawal|7
4582094|NCT01457352|7425319|FG001|Period 2|Sponsor's withdrawal|0
4582095|NCT01457352|7425318|FG000|Period 2|Lost to Follow-up|1
4582096|NCT01457352|7425319|FG001|Period 2|Lost to Follow-up|0
4582097|NCT01457352|7425318|FG000|Period 2|dose change|1
4692976|NCT02859558|7603809|FG000|Step 2|Active On Study|23
4692977|NCT02859558|7603810|FG001|Step 2|Active On Study|38
4692978|NCT02859558|7603811|FG002|Step 2|Active On Study|20
4692979|NCT02859558|7603812|FG003|Step 2|Active On Study|0
4692980|NCT02859558|7603813|FG004|Step 2|Active On Study|0
4692981|NCT02859558|7603809|FG000|Step 2|Did Not Return to Clinic|2
4692982|NCT02859558|7603810|FG001|Step 2|Did Not Return to Clinic|0
4582098|NCT01457352|7425319|FG001|Period 2|dose change|0
4582099|NCT01457352|7425318|FG000|Period 2|Physician Decision|1
4582100|NCT01457352|7425319|FG001|Period 2|Physician Decision|0
4582101|NCT01457352|7425318|FG000|Period 2|Did not meet eligibility criteria|3
4582102|NCT01457352|7425319|FG001|Period 2|Did not meet eligibility criteria|0
4582103|NCT01457352|7425318|FG000|Period 3|Adverse Event|1
4582104|NCT01457352|7425319|FG001|Period 3|Adverse Event|1
4582105|NCT01457352|7425318|FG000|Period 3|Withdrawal by Subject|0
4582106|NCT01457352|7425319|FG001|Period 3|Withdrawal by Subject|2
4582107|NCT01457352|7425318|FG000|Period 3|incorrect treatment|0
4582108|NCT01457352|7425319|FG001|Period 3|incorrect treatment|1
4582109|NCT01457352|7425318|FG000|Period 3|Sponsor's withdrawal|0
4582110|NCT01457352|7425319|FG001|Period 3|Sponsor's withdrawal|1
4582111|NCT01457703|7425373|FG000|Overall Study|Screen Failure|5
4582112|NCT01457703|7425374|FG001|Overall Study|Screen Failure|7
4582113|NCT01457703|7425373|FG000|Overall Study|Withdrawal by Subject|1
4582114|NCT01457703|7425374|FG001|Overall Study|Withdrawal by Subject|4
4582115|NCT01457846|7425384|FG000|Overall Study|Death before treatment|1
4582116|NCT01457846|7425385|FG001|Overall Study|Death before treatment|2
4582117|NCT01457846|7425384|FG000|Overall Study|Did not receive treatment|0
4582118|NCT01457846|7425385|FG001|Overall Study|Did not receive treatment|1
4582119|NCT01457846|7425384|FG000|Overall Study|Death|27
4582120|NCT01457846|7425385|FG001|Overall Study|Death|16
4582121|NCT01457846|7425384|FG000|Overall Study|Unclassified reason for not completed|11
4582122|NCT01457846|7425385|FG001|Overall Study|Unclassified reason for not completed|10
4582123|NCT01457846|7425384|FG000|Overall Study|Withdrawal by Subject|1
4582124|NCT01457846|7425385|FG001|Overall Study|Withdrawal by Subject|1
4582125|NCT01457846|7425384|FG000|Overall Study|Lost to Follow-up|1
4582126|NCT01457846|7425385|FG001|Overall Study|Lost to Follow-up|0
4582127|NCT01457924|7425400|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0
4582128|NCT01457924|7425401|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4
4582129|NCT01457924|7425402|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1
4582130|NCT01457924|7425403|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0
4582131|NCT01457924|7425404|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2
4582132|NCT01457924|7425400|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0
4582133|NCT01457924|7425401|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0
4582134|NCT01457924|7425402|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0
4582135|NCT01457924|7425403|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0
4582136|NCT01457924|7425404|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1
4582137|NCT01457924|7425400|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1
4582138|NCT01457924|7425401|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
4582139|NCT01457924|7425402|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
4582140|NCT01457924|7425403|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
4582141|NCT01457924|7425404|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
4582142|NCT01457924|7425400|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1
4582143|NCT01457924|7425401|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0
4582144|NCT01457924|7425402|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1
4582145|NCT01457924|7425403|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0
4582146|NCT01457924|7425404|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0
4582147|NCT01457924|7425400|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
4582148|NCT01457924|7425401|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
4582149|NCT01457924|7425402|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
4582150|NCT01457924|7425403|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1
4582151|NCT01457924|7425404|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1
4582152|NCT01457924|7425400|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1
4582153|NCT01457924|7425401|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1
4582154|NCT01457924|7425402|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0
4582155|NCT01457924|7425403|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0
4692983|NCT02859558|7603811|FG002|Step 2|Did Not Return to Clinic|0
4692984|NCT02859558|7603812|FG003|Step 2|Did Not Return to Clinic|0
4692985|NCT02859558|7603813|FG004|Step 2|Did Not Return to Clinic|0
4582156|NCT01457924|7425404|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2
4582157|NCT01457924|7425400|FG000|FUP (Weeks 24-48)|Adverse Event|0
4582158|NCT01457924|7425401|FG001|FUP (Weeks 24-48)|Adverse Event|0
4582159|NCT01457924|7425402|FG002|FUP (Weeks 24-48)|Adverse Event|1
4582160|NCT01457924|7425403|FG003|FUP (Weeks 24-48)|Adverse Event|0
4582161|NCT01457924|7425404|FG004|FUP (Weeks 24-48)|Adverse Event|0
4582162|NCT01457924|7425400|FG000|FUP (Weeks 24-48)|Physician Decision|1
4582163|NCT01457924|7425401|FG001|FUP (Weeks 24-48)|Physician Decision|0
4582164|NCT01457924|7425402|FG002|FUP (Weeks 24-48)|Physician Decision|1
4582165|NCT01457924|7425403|FG003|FUP (Weeks 24-48)|Physician Decision|0
4582166|NCT01457924|7425404|FG004|FUP (Weeks 24-48)|Physician Decision|0
4582167|NCT01457924|7425400|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0
4582168|NCT01457924|7425401|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0
4582169|NCT01457924|7425402|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0
4582170|NCT01457924|7425403|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1
4692986|NCT02859558|7603809|FG000|Step 2|Unexpected Closure of Site|0
4692987|NCT02859558|7603810|FG001|Step 2|Unexpected Closure of Site|1
4692988|NCT02859558|7603811|FG002|Step 2|Unexpected Closure of Site|1
4692989|NCT02859558|7603812|FG003|Step 2|Unexpected Closure of Site|0
4692990|NCT02859558|7603813|FG004|Step 2|Unexpected Closure of Site|0
4582171|NCT01457924|7425404|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0
4582172|NCT01457924|7425400|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2
4582173|NCT01457924|7425401|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1
4582174|NCT01457924|7425402|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0
4582175|NCT01457924|7425403|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0
4582176|NCT01457924|7425404|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2
4582177|NCT01457924|7425400|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1
4582178|NCT01457924|7425401|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
4582179|NCT01457924|7425402|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1
4582180|NCT01457924|7425403|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
4582181|NCT01457924|7425404|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
4582182|NCT01457924|7425400|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3
4582183|NCT01457924|7425401|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4
4582184|NCT01457924|7425402|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2
4582185|NCT01457924|7425403|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3
4582186|NCT01457924|7425404|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5
4582187|NCT01457924|7425400|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
4582188|NCT01457924|7425401|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0
4582189|NCT01457924|7425402|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
4582190|NCT01457924|7425403|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2
4582191|NCT01457924|7425404|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
4582192|NCT01457950|7425418|FG000|Double-Blind Phase|Continuation Criteria Not Met|1
4582193|NCT01457950|7425419|FG001|Double-Blind Phase|Continuation Criteria Not Met|0
4582194|NCT01457950|7425420|FG002|Double-Blind Phase|Continuation Criteria Not Met|0
4582195|NCT01457950|7425421|FG003|Double-Blind Phase|Continuation Criteria Not Met|0
4582196|NCT01457950|7425418|FG000|Double-Blind Phase|Protocol Violation|2
4582197|NCT01457950|7425419|FG001|Double-Blind Phase|Protocol Violation|1
4582198|NCT01457950|7425420|FG002|Double-Blind Phase|Protocol Violation|0
4582199|NCT01457950|7425421|FG003|Double-Blind Phase|Protocol Violation|0
4582200|NCT01457950|7425418|FG000|Double-Blind Phase|Withdrawal by Subject|6
4582201|NCT01457950|7425419|FG001|Double-Blind Phase|Withdrawal by Subject|2
4582202|NCT01457950|7425420|FG002|Double-Blind Phase|Withdrawal by Subject|0
4582203|NCT01457950|7425421|FG003|Double-Blind Phase|Withdrawal by Subject|0
4582204|NCT01457950|7425418|FG000|Open-Label Phase|Adverse Event|0
4582205|NCT01457950|7425419|FG001|Open-Label Phase|Adverse Event|0
4582206|NCT01457950|7425420|FG002|Open-Label Phase|Adverse Event|0
4582207|NCT01457950|7425421|FG003|Open-Label Phase|Adverse Event|1
4582208|NCT01457950|7425418|FG000|Open-Label Phase|Protocol Violation|0
4582209|NCT01457950|7425419|FG001|Open-Label Phase|Protocol Violation|0
4582210|NCT01457950|7425420|FG002|Open-Label Phase|Protocol Violation|0
4582211|NCT01457950|7425421|FG003|Open-Label Phase|Protocol Violation|1
4582212|NCT01457950|7425418|FG000|Open-Label Phase|Withdrawal by Subject|0
4582213|NCT01457950|7425419|FG001|Open-Label Phase|Withdrawal by Subject|0
4582214|NCT01457950|7425420|FG002|Open-Label Phase|Withdrawal by Subject|2
4582215|NCT01457950|7425421|FG003|Open-Label Phase|Withdrawal by Subject|0
4582216|NCT01458106|7425434|FG000|Overall Study|Withdrawal by Subject|2
4582217|NCT01458106|7425435|FG001|Overall Study|Withdrawal by Subject|0
4582218|NCT01458106|7425434|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1
4582219|NCT01458106|7425435|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0
4582220|NCT01458106|7425434|FG000|Overall Study|Withdrawn Per Protocol|0
4582221|NCT01458106|7425435|FG001|Overall Study|Withdrawn Per Protocol|1
4582222|NCT01458119|7425444|FG000|Overall Study|Physician Decision|4
4582223|NCT01458119|7425444|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1
4582224|NCT01458119|7425444|FG000|Overall Study|Pregnancy|1
4582225|NCT01458119|7425444|FG000|Overall Study|Death|2
4582226|NCT01458119|7425444|FG000|Overall Study|Adverse Event|1
4582227|NCT01458119|7425444|FG000|Overall Study|Consent Withdrawn by Participant|8
4692991|NCT02818920|7603823|FG000|Overall Study|Unresectable|4
4692992|NCT02818920|7603823|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1
4582228|NCT01458119|7425444|FG000|Overall Study|Non-compliance With Study Drug|3
4582229|NCT01458132|7425451|FG000|Overall Study|Other|15
4582230|NCT01458132|7425452|FG001|Overall Study|Other|3
4582231|NCT01458171|7425458|FG000|Overall Study|Adverse Event|1
4582232|NCT01458210|7425464|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2
4582233|NCT01458210|7425464|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2
4582234|NCT01458210|7425464|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2
4582235|NCT01458210|7425464|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1
4582236|NCT01458249|7425473|FG000|Overall Study|Not treated|1
4582237|NCT01458249|7425473|FG000|Overall Study|Adverse Event|4
4582238|NCT01458249|7425473|FG000|Overall Study|Other|2
4582239|NCT01458249|7425473|FG000|Overall Study|Ongoing|1
4582240|NCT01458275|7425481|FG000|Overall Study|Adverse Event|3
4582241|NCT01458275|7425482|FG001|Overall Study|Adverse Event|4
4582242|NCT01458275|7425483|FG002|Overall Study|Adverse Event|1
4582243|NCT01458275|7425481|FG000|Overall Study|Lost to Follow-up|3
4582244|NCT01458275|7425482|FG001|Overall Study|Lost to Follow-up|2
4582245|NCT01458275|7425483|FG002|Overall Study|Lost to Follow-up|5
4582246|NCT01458275|7425481|FG000|Overall Study|Protocol Violation|5
4582247|NCT01458275|7425482|FG001|Overall Study|Protocol Violation|5
4582248|NCT01458275|7425483|FG002|Overall Study|Protocol Violation|2
4582249|NCT01458275|7425481|FG000|Overall Study|Withdrawal by Subject|3
4582250|NCT01458275|7425482|FG001|Overall Study|Withdrawal by Subject|2
4582251|NCT01458275|7425483|FG002|Overall Study|Withdrawal by Subject|1
4582252|NCT01458366|7425508|FG000|Period 1: 70mg/m^2|Physician Decision|2
4582253|NCT01458366|7425509|FG001|Period 1: 70mg/m^2|Physician Decision|0
4582254|NCT01458366|7425510|FG002|Period 1: 70mg/m^2|Physician Decision|0
4582255|NCT01458366|7425511|FG003|Period 1: 70mg/m^2|Physician Decision|0
4582256|NCT01458366|7425512|FG004|Period 1: 70mg/m^2|Physician Decision|0
4582257|NCT01458366|7425508|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0
4582258|NCT01458366|7425509|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0
4582259|NCT01458366|7425510|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0
4582260|NCT01458366|7425511|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0
4582261|NCT01458366|7425512|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1
4582262|NCT01458392|7425523|FG000|Overall Study|Death|2
4582263|NCT01458392|7425524|FG001|Overall Study|Death|11
4582264|NCT01458392|7425525|FG002|Overall Study|Death|22
4582265|NCT01458392|7425523|FG000|Overall Study|At the discretion of the sponsor|0
4582266|NCT01458392|7425524|FG001|Overall Study|At the discretion of the sponsor|2
4582267|NCT01458392|7425525|FG002|Overall Study|At the discretion of the sponsor|7
4582268|NCT01458392|7425523|FG000|Overall Study|Patient unwilling to comply with protoco|0
4582269|NCT01458392|7425524|FG001|Overall Study|Patient unwilling to comply with protoco|0
4582270|NCT01458392|7425525|FG002|Overall Study|Patient unwilling to comply with protoco|2
4582271|NCT01458522|7425556|FG000|Overall Study|Withdrawal by Subject|2
4582272|NCT01458522|7425557|FG001|Overall Study|Withdrawal by Subject|2
4582273|NCT01458522|7425556|FG000|Overall Study|Physician Decision|1
4582274|NCT01458522|7425557|FG001|Overall Study|Physician Decision|9
4582275|NCT01458535|7425575|FG000|Overall Study|Other|0
4582276|NCT01458535|7425576|FG001|Overall Study|Other|0
4582277|NCT01458535|7425577|FG002|Overall Study|Other|0
4582278|NCT01458535|7425578|FG003|Overall Study|Other|0
4582279|NCT01458535|7425579|FG004|Overall Study|Other|1
4582280|NCT01458535|7425580|FG005|Overall Study|Other|1
4582281|NCT01458535|7425575|FG000|Overall Study|Withdrawal by Subject|0
4582282|NCT01458535|7425576|FG001|Overall Study|Withdrawal by Subject|0
4582283|NCT01458535|7425577|FG002|Overall Study|Withdrawal by Subject|2
4582284|NCT01458535|7425578|FG003|Overall Study|Withdrawal by Subject|0
4582285|NCT01458535|7425579|FG004|Overall Study|Withdrawal by Subject|1
4582286|NCT01458535|7425580|FG005|Overall Study|Withdrawal by Subject|1
4582287|NCT01458535|7425575|FG000|Overall Study|Lost to Follow-up|0
4582288|NCT01458535|7425576|FG001|Overall Study|Lost to Follow-up|2
4582289|NCT01458535|7425577|FG002|Overall Study|Lost to Follow-up|0
4582290|NCT01458535|7425578|FG003|Overall Study|Lost to Follow-up|3
4582291|NCT01458535|7425579|FG004|Overall Study|Lost to Follow-up|2
4582292|NCT01458535|7425580|FG005|Overall Study|Lost to Follow-up|2
4582293|NCT01458535|7425575|FG000|Overall Study|Adverse Event|0
4582294|NCT01458535|7425576|FG001|Overall Study|Adverse Event|0
4582295|NCT01458535|7425577|FG002|Overall Study|Adverse Event|0
4582296|NCT01458535|7425578|FG003|Overall Study|Adverse Event|1
4582297|NCT01458535|7425579|FG004|Overall Study|Adverse Event|0
4582298|NCT01458535|7425580|FG005|Overall Study|Adverse Event|0
4582299|NCT01458574|7425636|FG000|Overall Study|Adverse Event|5
4582300|NCT01458574|7425637|FG001|Overall Study|Adverse Event|9
4582301|NCT01458574|7425638|FG002|Overall Study|Adverse Event|7
4582302|NCT01458574|7425636|FG000|Overall Study|Lack of Efficacy|70
4582303|NCT01458574|7425637|FG001|Overall Study|Lack of Efficacy|53
4582304|NCT01458574|7425638|FG002|Overall Study|Lack of Efficacy|132
4582305|NCT01458574|7425636|FG000|Overall Study|Lost to Follow-up|3
4582306|NCT01458574|7425637|FG001|Overall Study|Lost to Follow-up|2
4582307|NCT01458574|7425638|FG002|Overall Study|Lost to Follow-up|1
4582308|NCT01458574|7425636|FG000|Overall Study|Pregnancy|1
4582309|NCT01458574|7425637|FG001|Overall Study|Pregnancy|1
4582310|NCT01458574|7425638|FG002|Overall Study|Pregnancy|0
4582311|NCT01458574|7425636|FG000|Overall Study|Protocol Violation|0
4582312|NCT01458574|7425637|FG001|Overall Study|Protocol Violation|1
4582313|NCT01458574|7425638|FG002|Overall Study|Protocol Violation|0
4582314|NCT01458574|7425636|FG000|Overall Study|Withdrawal by Subject|6
4582315|NCT01458574|7425637|FG001|Overall Study|Withdrawal by Subject|3
4582316|NCT01458574|7425638|FG002|Overall Study|Withdrawal by Subject|5
4582317|NCT01458574|7425636|FG000|Overall Study|Other|2
4582318|NCT01458574|7425637|FG001|Overall Study|Other|1
4582319|NCT01458574|7425638|FG002|Overall Study|Other|0
4582320|NCT01458574|7425636|FG000|Overall Study|Randomized but not treated|0
4582321|NCT01458574|7425637|FG001|Overall Study|Randomized but not treated|1
4582322|NCT01458574|7425638|FG002|Overall Study|Randomized but not treated|0
4582323|NCT01458587|7425648|FG000|Overall Study|Withdrawal by Subject|1
4582324|NCT01458587|7425649|FG001|Overall Study|Withdrawal by Subject|0
4582325|NCT01458639|7425657|FG000|Overall Study|Physician Decision|4
4582326|NCT01458639|7425657|FG000|Overall Study|Equipment issue|1
4582327|NCT01458639|7425657|FG000|Overall Study|Inability to obtain subject blood sample|1
4582328|NCT01458951|7425664|FG000|Overall Study|Other|1
4582329|NCT01458951|7425665|FG001|Overall Study|Other|0
4582330|NCT01458951|7425666|FG002|Overall Study|Other|0
4582331|NCT01458951|7425664|FG000|Overall Study|Protocol Violation|5
4582332|NCT01458951|7425665|FG001|Overall Study|Protocol Violation|1
4582333|NCT01458951|7425666|FG002|Overall Study|Protocol Violation|0
4582334|NCT01458951|7425664|FG000|Overall Study|Withdrawal by Subject|2
4582335|NCT01458951|7425665|FG001|Overall Study|Withdrawal by Subject|0
4582336|NCT01458951|7425666|FG002|Overall Study|Withdrawal by Subject|2
4582337|NCT01458951|7425664|FG000|Overall Study|Adverse Event|7
4582338|NCT01458951|7425665|FG001|Overall Study|Adverse Event|0
4582339|NCT01458951|7425666|FG002|Overall Study|Adverse Event|2
4582340|NCT01458951|7425664|FG000|Overall Study|Insufficient Clinical Response|17
4582341|NCT01458951|7425665|FG001|Overall Study|Insufficient Clinical Response|0
4582342|NCT01458951|7425666|FG002|Overall Study|Insufficient Clinical Response|11
4582343|NCT01459016|7425684|FG000|Overall Study|Withdrawal by Subject|11
4582344|NCT01459016|7425684|FG000|Overall Study|Amendment Discontinuation Criteria|4
4582345|NCT01459068|7425690|FG000|Overall Study|Withdrawal by Subject|8
4582346|NCT01459068|7425691|FG001|Overall Study|Withdrawal by Subject|18
4582347|NCT01459068|7425690|FG000|Overall Study|Lost to Follow-up|31
4582348|NCT01459068|7425691|FG001|Overall Study|Lost to Follow-up|15
4582349|NCT01459068|7425690|FG000|Overall Study|Death|0
4582350|NCT01459068|7425691|FG001|Overall Study|Death|1
4582351|NCT01459614|7425716|FG000|Overall Study|Adverse Event|1
4582352|NCT01459614|7425717|FG001|Overall Study|Adverse Event|0
4582353|NCT01459718|7425807|FG000|Overall Study|Physician Decision|1
4582354|NCT01459718|7425807|FG000|Overall Study|Lost to Follow-up|1
4582355|NCT01459718|7425807|FG000|Overall Study|Adverse Event|1
4582356|NCT01459783|7425813|FG000|Baseline to 6 Months|Death|1
4582357|NCT01459783|7425814|FG001|Baseline to 6 Months|Death|0
4582358|NCT01459783|7425813|FG000|Baseline to 6 Months|Withdrawal by Subject|12
4582359|NCT01459783|7425814|FG001|Baseline to 6 Months|Withdrawal by Subject|6
4582360|NCT01459783|7425813|FG000|Baseline to 6 Months|Lost to Follow-up|19
4582361|NCT01459783|7425814|FG001|Baseline to 6 Months|Lost to Follow-up|14
4582362|NCT01459783|7425813|FG000|6 Months to 12 Months|Death|0
4582363|NCT01459783|7425814|FG001|6 Months to 12 Months|Death|1
4582364|NCT01459783|7425813|FG000|6 Months to 12 Months|Withdrawal by Subject|6
4582365|NCT01459783|7425814|FG001|6 Months to 12 Months|Withdrawal by Subject|5
4582366|NCT01459783|7425813|FG000|6 Months to 12 Months|Lost to Follow-up|2
4582367|NCT01459783|7425814|FG001|6 Months to 12 Months|Lost to Follow-up|7
4582368|NCT01459783|7425813|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11
4582369|NCT01459783|7425814|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17
4582370|NCT01459796|7425822|FG000|Overall Study|Non compliance with protocol|2
4582371|NCT01459796|7425823|FG001|Overall Study|Non compliance with protocol|4
4582372|NCT01459796|7425822|FG000|Overall Study|Adverse Event|5
4582373|NCT01459796|7425823|FG001|Overall Study|Adverse Event|5
4582374|NCT01459796|7425822|FG000|Overall Study|Withdrawal by Subject|6
4582375|NCT01459796|7425823|FG001|Overall Study|Withdrawal by Subject|3
4582376|NCT01459796|7425822|FG000|Overall Study|Lost to Follow-up|5
4582377|NCT01459796|7425823|FG001|Overall Study|Lost to Follow-up|4
4582378|NCT01459796|7425822|FG000|Overall Study|Reason unspecified|1
4582379|NCT01459796|7425823|FG001|Overall Study|Reason unspecified|2
4582380|NCT01459796|7425822|FG000|Overall Study|Decision by the sponsor|75
4582381|NCT01459796|7425823|FG001|Overall Study|Decision by the sponsor|108
4582382|NCT01459913|7425833|FG000|Overall Study|Adverse Event|0
4582383|NCT01459913|7425834|FG001|Overall Study|Adverse Event|0
4582384|NCT01459913|7425835|FG002|Overall Study|Adverse Event|0
4582385|NCT01459913|7425836|FG003|Overall Study|Adverse Event|3
4582386|NCT01459913|7425833|FG000|Overall Study|Withdrawal by Subject|4
4582387|NCT01459913|7425834|FG001|Overall Study|Withdrawal by Subject|0
4582388|NCT01459913|7425835|FG002|Overall Study|Withdrawal by Subject|0
4582389|NCT01459913|7425836|FG003|Overall Study|Withdrawal by Subject|5
4582390|NCT01459913|7425833|FG000|Overall Study|Lost to Follow-up|7
4582391|NCT01459913|7425834|FG001|Overall Study|Lost to Follow-up|4
4582392|NCT01459913|7425835|FG002|Overall Study|Lost to Follow-up|1
4582393|NCT01459913|7425836|FG003|Overall Study|Lost to Follow-up|8
4582394|NCT01459913|7425833|FG000|Overall Study|Death|0
4582395|NCT01459913|7425834|FG001|Overall Study|Death|0
4582396|NCT01459913|7425835|FG002|Overall Study|Death|0
4582397|NCT01459913|7425836|FG003|Overall Study|Death|1
4582398|NCT01459913|7425833|FG000|Overall Study|Non- Compliance|0
4582399|NCT01459913|7425834|FG001|Overall Study|Non- Compliance|0
4582400|NCT01459913|7425835|FG002|Overall Study|Non- Compliance|0
4582401|NCT01459913|7425836|FG003|Overall Study|Non- Compliance|3
4582402|NCT01459913|7425833|FG000|Overall Study|Physician Decision|0
4582403|NCT01459913|7425834|FG001|Overall Study|Physician Decision|1
4582404|NCT01459913|7425835|FG002|Overall Study|Physician Decision|0
4582405|NCT01459913|7425836|FG003|Overall Study|Physician Decision|0
4582406|NCT01459913|7425833|FG000|Overall Study|Study Terminated by Sponsor|30
4582407|NCT01459913|7425834|FG001|Overall Study|Study Terminated by Sponsor|15
4582408|NCT01459913|7425835|FG002|Overall Study|Study Terminated by Sponsor|9
4582409|NCT01459913|7425836|FG003|Overall Study|Study Terminated by Sponsor|11
4582410|NCT01459913|7425833|FG000|Overall Study|Other|0
4582411|NCT01459913|7425834|FG001|Overall Study|Other|0
4582412|NCT01459913|7425835|FG002|Overall Study|Other|3
4582413|NCT01459913|7425836|FG003|Overall Study|Other|1
4582414|NCT01459913|7425833|FG000|Overall Study|Did Not Meet Inclusion Criteria|0
4582415|NCT01459913|7425834|FG001|Overall Study|Did Not Meet Inclusion Criteria|0
4582416|NCT01459913|7425835|FG002|Overall Study|Did Not Meet Inclusion Criteria|0
4582417|NCT01459913|7425836|FG003|Overall Study|Did Not Meet Inclusion Criteria|1
4582418|NCT01460290|7425853|FG000|Overall Study|Adverse Event|3
4582419|NCT01460290|7425853|FG000|Overall Study|Elevated liver function|1
4582420|NCT01460342|7425869|FG000|Overall Study|Adverse Event|5
4582421|NCT01460342|7425870|FG001|Overall Study|Adverse Event|4
4582422|NCT01460342|7425869|FG000|Overall Study|Lost to Follow-up|1
4582423|NCT01460342|7425870|FG001|Overall Study|Lost to Follow-up|2
4582424|NCT01460342|7425869|FG000|Overall Study|Protocol Violation|0
4582425|NCT01460342|7425870|FG001|Overall Study|Protocol Violation|1
4582426|NCT01460342|7425869|FG000|Overall Study|Withdrawal by Subject|3
4582427|NCT01460342|7425870|FG001|Overall Study|Withdrawal by Subject|4
4582428|NCT01460342|7425869|FG000|Overall Study|Physician Decision|1
4582429|NCT01460342|7425870|FG001|Overall Study|Physician Decision|3
4582430|NCT01460342|7425869|FG000|Overall Study|Lack of Efficacy|1
4582431|NCT01460342|7425870|FG001|Overall Study|Lack of Efficacy|0
4582432|NCT01460368|7425878|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0
4582433|NCT01460368|7425879|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0
4582434|NCT01460368|7425880|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0
4582435|NCT01460368|7425881|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0
4582436|NCT01460368|7425882|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1
4582437|NCT01460368|7425883|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0
4582438|NCT01460368|7425884|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0
4582439|NCT01460368|7425878|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
4582440|NCT01460368|7425879|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1
4582441|NCT01460368|7425880|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
4582442|NCT01460368|7425881|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
4582443|NCT01460368|7425882|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
4582444|NCT01460368|7425883|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
4582445|NCT01460368|7425884|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1
4582446|NCT01460368|7425878|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
4582447|NCT01460368|7425879|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1
4582448|NCT01460368|7425880|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
4582449|NCT01460368|7425881|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
4582450|NCT01460368|7425882|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
4582451|NCT01460368|7425883|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
4582452|NCT01460368|7425884|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
4582453|NCT01460368|7425878|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0
4582454|NCT01460368|7425879|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0
4582455|NCT01460368|7425880|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1
4582456|NCT01460368|7425881|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0
4582457|NCT01460368|7425882|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0
4582458|NCT01460368|7425883|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0
4582459|NCT01460368|7425884|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0
4582460|NCT01460368|7425878|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
4582461|NCT01460368|7425879|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
4582462|NCT01460368|7425880|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1
4582463|NCT01460368|7425881|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1
4582464|NCT01460368|7425882|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
4582465|NCT01460368|7425883|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1
4582466|NCT01460368|7425884|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
4582467|NCT01460381|7425895|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1
4582468|NCT01460381|7425896|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0
4582469|NCT01460407|7425904|FG000|Period 2: Day 6 to Day 14|Adverse Event|0
4582470|NCT01460407|7425905|FG001|Period 2: Day 6 to Day 14|Adverse Event|1
4582471|NCT01460446|7425914|FG000|Overall Study|Non-compliance|2
4582472|NCT01460446|7425915|FG001|Overall Study|Non-compliance|9
4582473|NCT01460446|7425914|FG000|Overall Study|Consent Withdrawn|0
4582474|NCT01460446|7425915|FG001|Overall Study|Consent Withdrawn|4
4582475|NCT01460446|7425914|FG000|Overall Study|Non-compliance & Consent Withdrawn|1
4582476|NCT01460446|7425915|FG001|Overall Study|Non-compliance & Consent Withdrawn|3
4582477|NCT01460446|7425914|FG000|Overall Study|Surgery/Illness|1
4582478|NCT01460446|7425915|FG001|Overall Study|Surgery/Illness|1
4582479|NCT01460446|7425914|FG000|Overall Study|Pregnancy|1
4582480|NCT01460446|7425915|FG001|Overall Study|Pregnancy|0
4582481|NCT01460446|7425914|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0
4582482|NCT01460446|7425915|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3
4582483|NCT01460628|7425922|FG000|Overall Study|Adverse Event|3
4582484|NCT01460628|7425922|FG000|Overall Study|Withdrawal by Subject|2
4582485|NCT01460719|7425926|FG000|Overall Study|Adverse Event|1
4582486|NCT01460719|7425926|FG000|Overall Study|Withdrawal by Subject|1
4582487|NCT01460901|7425940|FG000|Overall Study|Withdrawal by Subject|2
4582488|NCT01461005|7425959|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1
4582489|NCT01461044|7425966|FG000|Overall Study|Death|58
4582490|NCT01461044|7425967|FG001|Overall Study|Death|35
4582491|NCT01461044|7425966|FG000|Overall Study|Lost to Follow-up|12
4582492|NCT01461044|7425967|FG001|Overall Study|Lost to Follow-up|5
4582493|NCT01461057|7425978|FG000|Overall Study|Death|10
4582494|NCT01461057|7425979|FG001|Overall Study|Death|9
4582495|NCT01461057|7425978|FG000|Overall Study|Withdrawal by Subject|2
4582496|NCT01461057|7425979|FG001|Overall Study|Withdrawal by Subject|3
4582497|NCT01461057|7425978|FG000|Overall Study|Physician Decision|0
4582498|NCT01461057|7425979|FG001|Overall Study|Physician Decision|2
4582499|NCT01461057|7425978|FG000|Overall Study|Adverse Event|0
4582500|NCT01461057|7425979|FG001|Overall Study|Adverse Event|1
4582501|NCT01461057|7425978|FG000|Overall Study|Progression of Disease|1
4582502|NCT01461057|7425979|FG001|Overall Study|Progression of Disease|0
4582503|NCT01461057|7425978|FG000|Overall Study|Study Terminated by Sponsor|2
4582504|NCT01461057|7425979|FG001|Overall Study|Study Terminated by Sponsor|0
4582505|NCT01461096|7425987|FG000|Overall Study|Death|3
4582506|NCT01461096|7425988|FG001|Overall Study|Death|6
4582507|NCT01461096|7425987|FG000|Overall Study|Severe debilitation, unable to continue|1
4582508|NCT01461096|7425988|FG001|Overall Study|Severe debilitation, unable to continue|1
4582509|NCT01461096|7425987|FG000|Overall Study|Subj not able to get to clinic|15
4582510|NCT01461096|7425988|FG001|Overall Study|Subj not able to get to clinic|13
4582511|NCT01461096|7425987|FG000|Overall Study|Site is closing|27
4582512|NCT01461096|7425988|FG001|Overall Study|Site is closing|30
4582513|NCT01461096|7425987|FG000|Overall Study|Withdrawal by Subject|5
4582514|NCT01461096|7425988|FG001|Overall Study|Withdrawal by Subject|3
4582515|NCT01461096|7425987|FG000|Overall Study|Subj not willing to adhere to reqs|3
4582516|NCT01461096|7425988|FG001|Overall Study|Subj not willing to adhere to reqs|4
4582517|NCT01461096|7425987|FG000|Overall Study|Lost to Follow-up|8
4582518|NCT01461096|7425988|FG001|Overall Study|Lost to Follow-up|4
4582519|NCT01461369|7425998|FG000|Overall Study|Lack of Efficacy|2
4582520|NCT01461369|7425999|FG001|Overall Study|Lack of Efficacy|0
4582521|NCT01461369|7426000|FG002|Overall Study|Lack of Efficacy|6
4582522|NCT01461369|7425998|FG000|Overall Study|Lost to Follow-up|0
4582523|NCT01461369|7425999|FG001|Overall Study|Lost to Follow-up|0
4582524|NCT01461369|7426000|FG002|Overall Study|Lost to Follow-up|3
4582525|NCT01461369|7425998|FG000|Overall Study|Adverse Event|9
4582526|NCT01461369|7425999|FG001|Overall Study|Adverse Event|12
4582527|NCT01461369|7426000|FG002|Overall Study|Adverse Event|4
4582528|NCT01461369|7425998|FG000|Overall Study|Protocol Violation|1
4582529|NCT01461369|7425999|FG001|Overall Study|Protocol Violation|2
4582530|NCT01461369|7426000|FG002|Overall Study|Protocol Violation|2
4582531|NCT01461369|7425998|FG000|Overall Study|Withdrawal by Subject|1
4582532|NCT01461369|7425999|FG001|Overall Study|Withdrawal by Subject|3
4582533|NCT01461369|7426000|FG002|Overall Study|Withdrawal by Subject|2
4582534|NCT01461538|7426031|FG000|Overall Study|Death|15
4582535|NCT01461538|7426032|FG001|Overall Study|Death|6
4582536|NCT01461538|7426033|FG002|Overall Study|Death|2
4582537|NCT01461538|7426031|FG000|Overall Study|Study Stopped by Sponsor|2
4582538|NCT01461538|7426032|FG001|Overall Study|Study Stopped by Sponsor|1
4582539|NCT01461538|7426033|FG002|Overall Study|Study Stopped by Sponsor|0
4582540|NCT01461538|7426031|FG000|Overall Study|Withdrawal by Subject|1
4582541|NCT01461538|7426032|FG001|Overall Study|Withdrawal by Subject|1
4582542|NCT01461538|7426033|FG002|Overall Study|Withdrawal by Subject|0
4582543|NCT01461551|7426046|FG000|Overall Study|Physician Decision|2
4582544|NCT01461551|7426047|FG001|Overall Study|Physician Decision|1
4582545|NCT01461551|7426048|FG002|Overall Study|Physician Decision|2
4582546|NCT01461707|7426072|FG000|Overall Study|Withdrawal by Subject|1
4582547|NCT01461707|7426073|FG001|Overall Study|Withdrawal by Subject|0
4582548|NCT01461811|7426090|FG000|Overall Study|Adverse Event|2
4582549|NCT01461811|7426091|FG001|Overall Study|Adverse Event|1
4582550|NCT01461811|7426090|FG000|Overall Study|Subject decision unrelated to an AE|1
4582551|NCT01461811|7426091|FG001|Overall Study|Subject decision unrelated to an AE|1
4582552|NCT01461811|7426090|FG000|Overall Study|Noncompliance|1
4582553|NCT01461811|7426091|FG001|Overall Study|Noncompliance|1
4582554|NCT01461928|7426121|FG000|Induction (up to 8 Months)|Adverse Event|76
4582555|NCT01461928|7426122|FG001|Induction (up to 8 Months)|Adverse Event|0
4582556|NCT01461928|7426123|FG002|Induction (up to 8 Months)|Adverse Event|0
4582557|NCT01461928|7426121|FG000|Induction (up to 8 Months)|Death|3
4582558|NCT01461928|7426122|FG001|Induction (up to 8 Months)|Death|0
4582559|NCT01461928|7426123|FG002|Induction (up to 8 Months)|Death|0
4582560|NCT01461928|7426121|FG000|Induction (up to 8 Months)|Lost to Follow-up|5
4582561|NCT01461928|7426122|FG001|Induction (up to 8 Months)|Lost to Follow-up|0
4582562|NCT01461928|7426123|FG002|Induction (up to 8 Months)|Lost to Follow-up|0
4582563|NCT01461928|7426121|FG000|Induction (up to 8 Months)|Physician Decision|9
4582564|NCT01461928|7426122|FG001|Induction (up to 8 Months)|Physician Decision|0
4582565|NCT01461928|7426123|FG002|Induction (up to 8 Months)|Physician Decision|0
4582566|NCT01461928|7426121|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18
4582567|NCT01461928|7426122|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0
4582568|NCT01461928|7426123|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0
4582569|NCT01461928|7426121|FG000|Induction (up to 8 Months)|Disease progression|45
4582570|NCT01461928|7426122|FG001|Induction (up to 8 Months)|Disease progression|0
4582571|NCT01461928|7426123|FG002|Induction (up to 8 Months)|Disease progression|0
4582572|NCT01461928|7426121|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10
4582573|NCT01461928|7426122|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0
4582574|NCT01461928|7426123|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0
4582575|NCT01461928|7426121|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11
4582576|NCT01461928|7426122|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0
4582577|NCT01461928|7426123|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0
4582578|NCT01461928|7426121|FG000|Induction (up to 8 Months)|Not responding to treatment|11
4582579|NCT01461928|7426122|FG001|Induction (up to 8 Months)|Not responding to treatment|0
4582580|NCT01461928|7426123|FG002|Induction (up to 8 Months)|Not responding to treatment|0
4582581|NCT01461928|7426121|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1
4582582|NCT01461928|7426122|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0
4582583|NCT01461928|7426123|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0
4582584|NCT01461928|7426121|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1
4582585|NCT01461928|7426122|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0
4582586|NCT01461928|7426123|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0
4582587|NCT01461928|7426121|FG000|Induction (up to 8 Months)|Sponsor decision|1
4582588|NCT01461928|7426122|FG001|Induction (up to 8 Months)|Sponsor decision|0
4582589|NCT01461928|7426123|FG002|Induction (up to 8 Months)|Sponsor decision|0
4582590|NCT01461928|7426121|FG000|Induction (up to 8 Months)|Protocol deviation|2
4582591|NCT01461928|7426122|FG001|Induction (up to 8 Months)|Protocol deviation|0
4582592|NCT01461928|7426123|FG002|Induction (up to 8 Months)|Protocol deviation|0
4582593|NCT01461928|7426121|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1
4582594|NCT01461928|7426122|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0
4582595|NCT01461928|7426123|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0
4582596|NCT01461928|7426121|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1
4582597|NCT01461928|7426122|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0
4582598|NCT01461928|7426123|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0
4582599|NCT01461928|7426121|FG000|Induction (up to 8 Months)|Promotor request|1
4582600|NCT01461928|7426122|FG001|Induction (up to 8 Months)|Promotor request|0
4582601|NCT01461928|7426123|FG002|Induction (up to 8 Months)|Promotor request|0
4582602|NCT01461928|7426121|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1
4582603|NCT01461928|7426122|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0
4692993|NCT02818920|7603823|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8
4692994|NCT02818920|7603823|FG000|Overall Study|Adverse Event|3
4582604|NCT01461928|7426123|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0
4582605|NCT01461928|7426121|FG000|Induction (up to 8 Months)|Medical advisor request|1
4582606|NCT01461928|7426122|FG001|Induction (up to 8 Months)|Medical advisor request|0
4582607|NCT01461928|7426123|FG002|Induction (up to 8 Months)|Medical advisor request|0
4582608|NCT01461928|7426121|FG000|Maintenance I (24 Months)|Death|3
4582609|NCT01461928|7426122|FG001|Maintenance I (24 Months)|Death|0
4582610|NCT01461928|7426123|FG002|Maintenance I (24 Months)|Death|0
4582611|NCT01461928|7426121|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32
4582612|NCT01461928|7426122|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0
4582613|NCT01461928|7426123|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0
4582614|NCT01461928|7426121|FG000|Maintenance I (24 Months)|Lost to Follow-up|2
4582615|NCT01461928|7426122|FG001|Maintenance I (24 Months)|Lost to Follow-up|0
4582616|NCT01461928|7426123|FG002|Maintenance I (24 Months)|Lost to Follow-up|0
4582617|NCT01461928|7426121|FG000|Maintenance I (24 Months)|Diseases progression|91
4582618|NCT01461928|7426122|FG001|Maintenance I (24 Months)|Diseases progression|0
4582619|NCT01461928|7426123|FG002|Maintenance I (24 Months)|Diseases progression|0
4582620|NCT01461928|7426121|FG000|Maintenance I (24 Months)|Adverse Event|70
4582621|NCT01461928|7426122|FG001|Maintenance I (24 Months)|Adverse Event|0
4582622|NCT01461928|7426123|FG002|Maintenance I (24 Months)|Adverse Event|0
4582623|NCT01461928|7426121|FG000|Maintenance I (24 Months)|Physician Decision|9
4582624|NCT01461928|7426122|FG001|Maintenance I (24 Months)|Physician Decision|0
4582625|NCT01461928|7426123|FG002|Maintenance I (24 Months)|Physician Decision|0
4582626|NCT01461928|7426121|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2
4582627|NCT01461928|7426122|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0
4582628|NCT01461928|7426123|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0
4582629|NCT01461928|7426121|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2
4582630|NCT01461928|7426122|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0
4582631|NCT01461928|7426123|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0
4582632|NCT01461928|7426121|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1
4582633|NCT01461928|7426122|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0
4582634|NCT01461928|7426123|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0
4582635|NCT01461928|7426121|FG000|Maintenance I (24 Months)|Not compliant|1
4582636|NCT01461928|7426122|FG001|Maintenance I (24 Months)|Not compliant|0
4582637|NCT01461928|7426123|FG002|Maintenance I (24 Months)|Not compliant|0
4582638|NCT01461928|7426121|FG000|Maintenance I (24 Months)|Did not meet criteria|5
4582639|NCT01461928|7426122|FG001|Maintenance I (24 Months)|Did not meet criteria|0
4582640|NCT01461928|7426123|FG002|Maintenance I (24 Months)|Did not meet criteria|0
4582641|NCT01461928|7426121|FG000|Maintenance II (15 Months)|Adverse Event|0
4582642|NCT01461928|7426122|FG001|Maintenance II (15 Months)|Adverse Event|2
4582643|NCT01461928|7426123|FG002|Maintenance II (15 Months)|Adverse Event|0
4582644|NCT01461928|7426121|FG000|Maintenance II (15 Months)|Death|0
4582645|NCT01461928|7426122|FG001|Maintenance II (15 Months)|Death|10
4582646|NCT01461928|7426123|FG002|Maintenance II (15 Months)|Death|8
4582647|NCT01461928|7426121|FG000|Maintenance II (15 Months)|Physician Decision|0
4582648|NCT01461928|7426122|FG001|Maintenance II (15 Months)|Physician Decision|0
4582649|NCT01461928|7426123|FG002|Maintenance II (15 Months)|Physician Decision|4
4582650|NCT01461928|7426121|FG000|Maintenance II (15 Months)|Lost to Follow-up|0
4582651|NCT01461928|7426122|FG001|Maintenance II (15 Months)|Lost to Follow-up|1
4582652|NCT01461928|7426123|FG002|Maintenance II (15 Months)|Lost to Follow-up|0
4582653|NCT01461928|7426121|FG000|Maintenance II (15 Months)|Moved to another town|0
4582654|NCT01461928|7426122|FG001|Maintenance II (15 Months)|Moved to another town|1
4582655|NCT01461928|7426123|FG002|Maintenance II (15 Months)|Moved to another town|0
4582656|NCT01461928|7426121|FG000|Maintenance II (15 Months)|Disease progression|0
4582657|NCT01461928|7426122|FG001|Maintenance II (15 Months)|Disease progression|0
4582658|NCT01461928|7426123|FG002|Maintenance II (15 Months)|Disease progression|3
4582659|NCT01461928|7426121|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0
4582660|NCT01461928|7426122|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9
4582661|NCT01461928|7426123|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8
4582662|NCT01461928|7426121|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0
4582663|NCT01461928|7426122|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0
4593363|NCT01550744|7441689|FG000|Double-Blind|Adverse Event|0
4692995|NCT02818920|7603823|FG000|Overall Study|Developed Other Disease|1
4692996|NCT02818920|7603823|FG000|Overall Study|Refused Further Treatment|1
4692997|NCT02481310|7603830|FG000|Follow up|Still in follow up|0
4692998|NCT02481310|7603831|FG001|Follow up|Still in follow up|3
4692999|NCT02481310|7603832|FG002|Follow up|Still in follow up|0
4693000|NCT02343952|7603836|FG000|Study Treatment|Disease Progression|23
4693001|NCT02343952|7603836|FG000|Study Treatment|Death|3
4693002|NCT02343952|7603836|FG000|Study Treatment|Adverse Event|19
4693003|NCT02343952|7603836|FG000|Study Treatment|Withdrawal by Subject|7
4693004|NCT02343952|7603836|FG000|Study Treatment|other complicating Diseases|1
4693005|NCT02343952|7603836|FG000|Follow up|Withdrawal by Subject|3
4693006|NCT02343952|7603836|FG000|Follow up|Death|33
4693007|NCT02343952|7603836|FG000|Follow up|Patient does not meet eligibility for study.|1
4693008|NCT02343952|7603836|FG000|Follow up|Research department closed by the practice.|5
4693009|NCT02343952|7603836|FG000|Follow up|Patient went home to Russia|1
4693010|NCT02343952|7603836|FG000|Follow up|Disease Progression|1
4693011|NCT02343952|7603836|FG000|Follow up|study terminated|1
4693012|NCT02326155|7603842|FG000|Overall Study|Adverse Event|21
4693013|NCT02326155|7603843|FG001|Overall Study|Adverse Event|5
4693014|NCT02326155|7603842|FG000|Overall Study|Death|3
4693015|NCT02326155|7603843|FG001|Overall Study|Death|0
4693016|NCT02326155|7603842|FG000|Overall Study|Lack of Efficacy|49
4693017|NCT02326155|7603843|FG001|Overall Study|Lack of Efficacy|5
4693018|NCT02326155|7603842|FG000|Overall Study|Lost to Follow-up|14
4693019|NCT02326155|7603843|FG001|Overall Study|Lost to Follow-up|3
4693020|NCT02326155|7603842|FG000|Overall Study|Protocol Violation|2
4693021|NCT02326155|7603843|FG001|Overall Study|Protocol Violation|0
4693022|NCT02326155|7603842|FG000|Overall Study|Withdrawal by Subject|34
4693023|NCT02326155|7603843|FG001|Overall Study|Withdrawal by Subject|11
4693024|NCT02326155|7603842|FG000|Overall Study|Disease progression|37
4693025|NCT02326155|7603843|FG001|Overall Study|Disease progression|4
4693026|NCT02326155|7603842|FG000|Overall Study|Study close|188
4693027|NCT02326155|7603843|FG001|Overall Study|Study close|21
4693028|NCT02326155|7603842|FG000|Overall Study|except for study close|46
4693029|NCT02326155|7603843|FG001|Overall Study|except for study close|13
4693030|NCT02304367|7603849|FG000|Overall Study|Lack of Response to Bruosumab|1
4693031|NCT02304367|7603849|FG000|Overall Study|Sponsor Decision|3
4693032|NCT02304367|7603849|FG000|Overall Study|Death|2
4693033|NCT02304367|7603849|FG000|Overall Study|Physician Decision|1
4693034|NCT02304367|7603849|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1
4582664|NCT01461928|7426123|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1
4582665|NCT01461928|7426121|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0
4582666|NCT01461928|7426122|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0
4582667|NCT01461928|7426123|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1
4582668|NCT01461928|7426121|FG000|Maintenance II (15 Months)|Withdrew informed consent|0
4582669|NCT01461928|7426122|FG001|Maintenance II (15 Months)|Withdrew informed consent|0
4582670|NCT01461928|7426123|FG002|Maintenance II (15 Months)|Withdrew informed consent|1
4582671|NCT01461928|7426121|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0
4582672|NCT01461928|7426122|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0
4582673|NCT01461928|7426123|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1
4582674|NCT01461980|7426137|FG000|Overall Study|Other|9
4582675|NCT01461980|7426138|FG001|Overall Study|Other|8
4582676|NCT01461980|7426139|FG002|Overall Study|Other|6
4582677|NCT01461980|7426137|FG000|Overall Study|Medication error|7
4582678|NCT01461980|7426138|FG001|Overall Study|Medication error|5
4582679|NCT01461980|7426139|FG002|Overall Study|Medication error|6
4582680|NCT01461980|7426137|FG000|Overall Study|Adverse Event|12
4582681|NCT01461980|7426138|FG001|Overall Study|Adverse Event|5
4582682|NCT01461980|7426139|FG002|Overall Study|Adverse Event|6
4582683|NCT01461980|7426137|FG000|Overall Study|Protocol Violation|12
4582684|NCT01461980|7426138|FG001|Overall Study|Protocol Violation|19
4582685|NCT01461980|7426139|FG002|Overall Study|Protocol Violation|16
4582686|NCT01461980|7426137|FG000|Overall Study|No longer meets eligibility criteria|18
4582687|NCT01461980|7426138|FG001|Overall Study|No longer meets eligibility criteria|9
4582688|NCT01461980|7426139|FG002|Overall Study|No longer meets eligibility criteria|19
4582689|NCT01461980|7426137|FG000|Overall Study|Lost to Follow-up|52
4582690|NCT01461980|7426138|FG001|Overall Study|Lost to Follow-up|53
4582691|NCT01461980|7426139|FG002|Overall Study|Lost to Follow-up|51
4582692|NCT01461980|7426137|FG000|Overall Study|No longer willing to participate|52
4582693|NCT01461980|7426138|FG001|Overall Study|No longer willing to participate|38
4693035|NCT02588261|7603871|FG000|Overall Study|Study Terminated by Sponsor|157
4693036|NCT02588261|7603872|FG001|Overall Study|Study Terminated by Sponsor|142
4693037|NCT02588261|7603871|FG000|Overall Study|Protocol Deviation|1
4693038|NCT02588261|7603872|FG001|Overall Study|Protocol Deviation|0
4693039|NCT02588261|7603871|FG000|Overall Study|Death|1
4693040|NCT02588261|7603872|FG001|Overall Study|Death|2
4693041|NCT02588261|7603871|FG000|Overall Study|Withdrawal by Subject|12
4693042|NCT02588261|7603872|FG001|Overall Study|Withdrawal by Subject|8
4693043|NCT02588261|7603871|FG000|Overall Study|Noncompliance with Study Drug|0
4693044|NCT02588261|7603872|FG001|Overall Study|Noncompliance with Study Drug|1
4693045|NCT02588261|7603871|FG000|Overall Study|Miscellaneous|5
4693046|NCT02588261|7603872|FG001|Overall Study|Miscellaneous|4
4693047|NCT02588261|7603871|FG000|Overall Study|Progressive Disease|61
4693048|NCT02588261|7603872|FG001|Overall Study|Progressive Disease|82
4693049|NCT02588261|7603871|FG000|Overall Study|Adverse Event|29
4693050|NCT02588261|7603872|FG001|Overall Study|Adverse Event|24
4693051|NCT02588261|7603871|FG000|Overall Study|Lost to Follow-up|1
4693052|NCT02588261|7603872|FG001|Overall Study|Lost to Follow-up|0
4693053|NCT02588339|7603878|FG000|Overall Study|Withdrawal by Subject|1
4693054|NCT02588339|7603878|FG000|Overall Study|GVHD Progression prior to treatment|2
4693055|NCT02588612|7603911|FG000|Overall Study|Physician Decision|1
4693056|NCT02588612|7603911|FG000|Overall Study|Leukapheresis did not yield enough cells|1
4693057|NCT02588612|7603911|FG000|Overall Study|Failed eligibility prior to chemotherapy|2
4693058|NCT02588612|7603911|FG000|Overall Study|Death prior to T-cell infusion|1
4693059|NCT02588664|7603917|FG000|Overall Study|Death|56
4693060|NCT02588664|7603918|FG001|Overall Study|Death|55
4693061|NCT02588664|7603917|FG000|Overall Study|Lost to Follow-up|1305
4693062|NCT02588664|7603918|FG001|Overall Study|Lost to Follow-up|990
4693063|NCT02588833|7603926|FG000|Part 1|Withdrawal by Subject|1
4693064|NCT02588833|7603927|FG001|Part 1|Withdrawal by Subject|0
4693065|NCT02588833|7603926|FG000|Part 2A|Physician Decision|0
4693066|NCT02588833|7603927|FG001|Part 2A|Physician Decision|1
4693067|NCT02588833|7603926|FG000|Part 2A|Withdrawal by Subject|0
4693068|NCT02588833|7603927|FG001|Part 2A|Withdrawal by Subject|1
4693069|NCT02588833|7603926|FG000|Part 2B|Adverse Event|0
4693070|NCT02588833|7603927|FG001|Part 2B|Adverse Event|1
4693071|NCT02588833|7603926|FG000|Part 2C|Adverse Event|0
4693072|NCT02588833|7603927|FG001|Part 2C|Adverse Event|1
4693073|NCT02588833|7603926|FG000|Part 2C|Withdrawal by Subject|0
4582694|NCT01461980|7426139|FG002|Overall Study|No longer willing to participate|54
4693074|NCT02588833|7603927|FG001|Part 2C|Withdrawal by Subject|1
4693075|NCT02588833|7603926|FG000|Part 3 (Safety Follow-up)|Other|0
4693076|NCT02588833|7603927|FG001|Part 3 (Safety Follow-up)|Other|2
4693077|NCT02589405|7603967|FG000|Overall Study|Adverse Event|3
4693078|NCT02589405|7603967|FG000|Overall Study|Withdrawal by Subject|1
4693079|NCT02589626|7603973|FG000|Overall Study|Other than the reason specified|1
4693080|NCT02589626|7603974|FG001|Overall Study|Other than the reason specified|0
4693081|NCT02589626|7603973|FG000|Overall Study|Withdrawal by Subject|1
4693082|NCT02589626|7603974|FG001|Overall Study|Withdrawal by Subject|1
4693083|NCT02589626|7603973|FG000|Overall Study|Adverse Event|1
4693084|NCT02589626|7603974|FG001|Overall Study|Adverse Event|1
4693085|NCT02589639|7603983|FG000|Overall Study|Lost to Follow-up|1
4582695|NCT01461980|7426137|FG000|Overall Study|Randomized but not vaccinated|4
4582696|NCT01461980|7426138|FG001|Overall Study|Randomized but not vaccinated|8
4582697|NCT01461980|7426139|FG002|Overall Study|Randomized but not vaccinated|7
4582698|NCT01461993|7426151|FG000|Overall Study|Withdrawal by Subject|60
4582699|NCT01461993|7426152|FG001|Overall Study|Withdrawal by Subject|53
4582700|NCT01461993|7426153|FG002|Overall Study|Withdrawal by Subject|16
4582701|NCT01461993|7426151|FG000|Overall Study|Lost to Follow-up|44
4582702|NCT01461993|7426152|FG001|Overall Study|Lost to Follow-up|48
4582703|NCT01461993|7426153|FG002|Overall Study|Lost to Follow-up|22
4582704|NCT01461993|7426151|FG000|Overall Study|Protocol Violation|10
4582705|NCT01461993|7426152|FG001|Overall Study|Protocol Violation|9
4582706|NCT01461993|7426153|FG002|Overall Study|Protocol Violation|7
4582707|NCT01461993|7426151|FG000|Overall Study|Adverse Event|9
4582708|NCT01461993|7426152|FG001|Overall Study|Adverse Event|11
4582709|NCT01461993|7426153|FG002|Overall Study|Adverse Event|3
4582710|NCT01461993|7426151|FG000|Overall Study|No longer met eligibility criteria|13
4582711|NCT01461993|7426152|FG001|Overall Study|No longer met eligibility criteria|18
4582712|NCT01461993|7426153|FG002|Overall Study|No longer met eligibility criteria|10
4582713|NCT01461993|7426151|FG000|Overall Study|Did not meet entrance criteria|2
4582714|NCT01461993|7426152|FG001|Overall Study|Did not meet entrance criteria|3
4582715|NCT01461993|7426153|FG002|Overall Study|Did not meet entrance criteria|0
4582716|NCT01461993|7426151|FG000|Overall Study|Other|13
4582717|NCT01461993|7426152|FG001|Overall Study|Other|15
4582718|NCT01461993|7426153|FG002|Overall Study|Other|6
4582719|NCT01462045|7426165|FG000|Overall Study|Family matter|0
4582720|NCT01462045|7426166|FG001|Overall Study|Family matter|1
4582721|NCT01462045|7426167|FG002|Overall Study|Family matter|0
4593364|NCT01550744|7441690|FG001|Double-Blind|Adverse Event|4
4593365|NCT01550744|7441691|FG002|Double-Blind|Adverse Event|15
4593366|NCT01550744|7441689|FG000|Double-Blind|Death|0
4593367|NCT01550744|7441690|FG001|Double-Blind|Death|1
4593368|NCT01550744|7441691|FG002|Double-Blind|Death|0
4593369|NCT01550744|7441689|FG000|Double-Blind|Lack of Efficacy|0
4593370|NCT01550744|7441690|FG001|Double-Blind|Lack of Efficacy|2
4593371|NCT01550744|7441691|FG002|Double-Blind|Lack of Efficacy|8
4593372|NCT01550744|7441689|FG000|Double-Blind|Protocol Violation|0
4593373|NCT01550744|7441690|FG001|Double-Blind|Protocol Violation|0
4593374|NCT01550744|7441691|FG002|Double-Blind|Protocol Violation|4
4593375|NCT01550744|7441689|FG000|Double-Blind|Pregnancy|0
4593376|NCT01550744|7441690|FG001|Double-Blind|Pregnancy|0
4593377|NCT01550744|7441691|FG002|Double-Blind|Pregnancy|3
4593378|NCT01550744|7441689|FG000|Double-Blind|Other|0
4593379|NCT01550744|7441690|FG001|Double-Blind|Other|2
4593380|NCT01550744|7441691|FG002|Double-Blind|Other|10
4593381|NCT01550757|7441702|FG000|Overall Study|Lost to Follow-up|21
4593382|NCT01550757|7441703|FG001|Overall Study|Lost to Follow-up|14
4593383|NCT01550757|7441704|FG002|Overall Study|Lost to Follow-up|42
4593384|NCT01550757|7441705|FG003|Overall Study|Lost to Follow-up|53
4593385|NCT01550757|7441702|FG000|Overall Study|Withdrawal by Subject|2
4593386|NCT01550757|7441703|FG001|Overall Study|Withdrawal by Subject|0
4593387|NCT01550757|7441704|FG002|Overall Study|Withdrawal by Subject|3
4593388|NCT01550757|7441705|FG003|Overall Study|Withdrawal by Subject|1
4593389|NCT01550965|7441728|FG000|Overall Study|Adverse Event|26
4593390|NCT01550965|7441728|FG000|Overall Study|Withdrawal by Subject|10
4593391|NCT01550965|7441728|FG000|Overall Study|Lost to Follow-up|2
4593392|NCT01550965|7441728|FG000|Overall Study|Lack of Efficacy|59
4593393|NCT01550965|7441728|FG000|Overall Study|Other|13
4593394|NCT01551173|7441752|FG000|Overall Study|Withdrawal by Subject|11
4593395|NCT01551173|7441753|FG001|Overall Study|Withdrawal by Subject|16
4593396|NCT01551173|7441752|FG000|Overall Study|Adverse Event|7
4593397|NCT01551173|7441753|FG001|Overall Study|Adverse Event|6
4593398|NCT01551173|7441752|FG000|Overall Study|Lost to Follow-up|5
4593399|NCT01551173|7441753|FG001|Overall Study|Lost to Follow-up|7
4593400|NCT01551173|7441752|FG000|Overall Study|Other|5
4593401|NCT01551173|7441753|FG001|Overall Study|Other|3
4593402|NCT01551212|7441775|FG000|Overall Study|Graft loss/Retransplantation|0
4593403|NCT01551212|7441776|FG001|Overall Study|Graft loss/Retransplantation|1
4593404|NCT01551212|7441775|FG000|Overall Study|Administrative problems|1
4593405|NCT01551212|7441776|FG001|Overall Study|Administrative problems|2
4593406|NCT01551212|7441775|FG000|Overall Study|Lost to Follow-up|0
4593407|NCT01551212|7441776|FG001|Overall Study|Lost to Follow-up|1
4593408|NCT01551212|7441775|FG000|Overall Study|Protocol Violation|0
4593409|NCT01551212|7441776|FG001|Overall Study|Protocol Violation|1
4593410|NCT01551212|7441775|FG000|Overall Study|Withdrawal by Subject|0
4593411|NCT01551212|7441776|FG001|Overall Study|Withdrawal by Subject|7
4593412|NCT01551212|7441775|FG000|Overall Study|Death|2
4593413|NCT01551212|7441776|FG001|Overall Study|Death|4
4593414|NCT01551212|7441775|FG000|Overall Study|Never Received Study Treatment|2
4593415|NCT01551212|7441776|FG001|Overall Study|Never Received Study Treatment|4
4593416|NCT01551303|7441793|FG000|Overall Study|failed awareness check on vision test|4
4593417|NCT01551303|7441794|FG001|Overall Study|failed awareness check on vision test|7
4593418|NCT01551355|7441806|FG000|Overall Study|Lost to Follow-up|51
4593419|NCT01551355|7441807|FG001|Overall Study|Lost to Follow-up|49
4593420|NCT01551355|7441808|FG002|Overall Study|Lost to Follow-up|34
4593421|NCT01551355|7441809|FG003|Overall Study|Lost to Follow-up|24
4593422|NCT01551355|7441810|FG004|Overall Study|Lost to Follow-up|9
4582722|NCT01462084|7426175|FG000|Overall Study|Withdrawal by Subject|1
4582723|NCT01462084|7426176|FG001|Overall Study|Withdrawal by Subject|0
4582724|NCT01462084|7426175|FG000|Overall Study|Protocol Violation|1
4582725|NCT01462084|7426176|FG001|Overall Study|Protocol Violation|1
4582726|NCT01462110|7426185|FG000|Overall Study|Adverse Event|1
4582727|NCT01462110|7426186|FG001|Overall Study|Adverse Event|0
4582728|NCT01462162|7426192|FG000|Overall Study|Adverse Event|5
4582729|NCT01462162|7426192|FG000|Overall Study|Lack of Efficacy|4
4582730|NCT01462162|7426192|FG000|Overall Study|Abnormal laboratory parameters|1
4582731|NCT01462162|7426192|FG000|Overall Study|Other|2
4582732|NCT01462227|7426199|FG000|Second Assignment|Lost to Follow-up|1
4582733|NCT01462227|7426200|FG001|Second Assignment|Lost to Follow-up|0
4582734|NCT01462227|7426201|FG002|Second Assignment|Lost to Follow-up|0
4582735|NCT01462227|7426202|FG003|Second Assignment|Lost to Follow-up|0
4582736|NCT01462227|7426199|FG000|Second Assignment|Protocol Violation|0
4582737|NCT01462227|7426200|FG001|Second Assignment|Protocol Violation|1
4582738|NCT01462227|7426201|FG002|Second Assignment|Protocol Violation|1
4582739|NCT01462227|7426202|FG003|Second Assignment|Protocol Violation|0
4582740|NCT01462266|7426216|FG000|Overall Study|Adverse Event|7
4582741|NCT01462266|7426217|FG001|Overall Study|Adverse Event|6
4582742|NCT01462266|7426216|FG000|Overall Study|Death|2
4582743|NCT01462266|7426217|FG001|Overall Study|Death|1
4582744|NCT01462266|7426216|FG000|Overall Study|Lack of Efficacy|0
4582745|NCT01462266|7426217|FG001|Overall Study|Lack of Efficacy|2
4582746|NCT01462266|7426216|FG000|Overall Study|Lost to Follow-up|4
4582747|NCT01462266|7426217|FG001|Overall Study|Lost to Follow-up|3
4582748|NCT01462266|7426216|FG000|Overall Study|Non-compliance with study drug|3
4582749|NCT01462266|7426217|FG001|Overall Study|Non-compliance with study drug|0
4582750|NCT01462266|7426216|FG000|Overall Study|Creatinine and eGFR, excluded medication|8
4582751|NCT01462266|7426217|FG001|Overall Study|Creatinine and eGFR, excluded medication|4
4582752|NCT01462266|7426216|FG000|Overall Study|Physician Decision|2
4582753|NCT01462266|7426217|FG001|Overall Study|Physician Decision|5
4582754|NCT01462266|7426216|FG000|Overall Study|Protocol Violation|1
4582755|NCT01462266|7426217|FG001|Overall Study|Protocol Violation|3
4582756|NCT01462266|7426216|FG000|Overall Study|Withdrawal by Subject|7
4582757|NCT01462266|7426217|FG001|Overall Study|Withdrawal by Subject|2
4582758|NCT01462266|7426216|FG000|Overall Study|Screen failure|1
4582759|NCT01462266|7426217|FG001|Overall Study|Screen failure|1
4582760|NCT01462318|7426254|FG000|Main Study / TP-DI Study|Other|2
4582761|NCT01462318|7426255|FG001|Main Study / TP-DI Study|Other|0
4582762|NCT01462318|7426256|FG002|Main Study / TP-DI Study|Other|0
4582763|NCT01462318|7426254|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2
4582764|NCT01462318|7426255|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0
4582765|NCT01462318|7426256|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0
4582766|NCT01462318|7426254|FG000|Main Study / TP-DI Study|Adverse Event|4
4582767|NCT01462318|7426255|FG001|Main Study / TP-DI Study|Adverse Event|0
4582768|NCT01462318|7426256|FG002|Main Study / TP-DI Study|Adverse Event|0
4582769|NCT01462318|7426254|FG000|Extension Phase|Lost to Follow-up|0
4582770|NCT01462318|7426255|FG001|Extension Phase|Lost to Follow-up|0
4582771|NCT01462318|7426256|FG002|Extension Phase|Lost to Follow-up|1
4582772|NCT01462318|7426254|FG000|Extension Phase|Other|0
4582773|NCT01462318|7426255|FG001|Extension Phase|Other|0
4582774|NCT01462318|7426256|FG002|Extension Phase|Other|1
4582775|NCT01462318|7426254|FG000|Extension Phase|Disease Progression|0
4582776|NCT01462318|7426255|FG001|Extension Phase|Disease Progression|0
4582777|NCT01462318|7426256|FG002|Extension Phase|Disease Progression|1
4582778|NCT01462318|7426254|FG000|Extension Phase|Withdrawal by Subject|0
4582779|NCT01462318|7426255|FG001|Extension Phase|Withdrawal by Subject|0
4582780|NCT01462318|7426256|FG002|Extension Phase|Withdrawal by Subject|15
4582781|NCT01462318|7426254|FG000|Extension Phase|Investigator Decision|0
4582782|NCT01462318|7426255|FG001|Extension Phase|Investigator Decision|0
4582783|NCT01462318|7426256|FG002|Extension Phase|Investigator Decision|5
4582784|NCT01462318|7426254|FG000|Extension Phase|Adverse Event|0
4582785|NCT01462318|7426255|FG001|Extension Phase|Adverse Event|0
4582786|NCT01462318|7426256|FG002|Extension Phase|Adverse Event|22
4582787|NCT01462344|7426263|FG000|Overall Study|Withdrawal by Subject|245
4582788|NCT01462344|7426264|FG001|Overall Study|Withdrawal by Subject|226
4582789|NCT01462344|7426263|FG000|Overall Study|Adverse Event|24
4582790|NCT01462344|7426264|FG001|Overall Study|Adverse Event|23
4582791|NCT01462344|7426263|FG000|Overall Study|Asthma Exacerbation|34
4582792|NCT01462344|7426264|FG001|Overall Study|Asthma Exacerbation|35
4693086|NCT02589639|7603984|FG001|Overall Study|Lost to Follow-up|0
4582793|NCT01462344|7426263|FG000|Overall Study|Lack of Efficacy|5
4582794|NCT01462344|7426264|FG001|Overall Study|Lack of Efficacy|6
4582795|NCT01462344|7426263|FG000|Overall Study|Protocol Violation|68
4582796|NCT01462344|7426264|FG001|Overall Study|Protocol Violation|53
4582797|NCT01462344|7426263|FG000|Overall Study|Lost to Follow-up|7
4582798|NCT01462344|7426264|FG001|Overall Study|Lost to Follow-up|7
4582799|NCT01462357|7426273|FG000|Overall Study|Death|0
4582800|NCT01462357|7426274|FG001|Overall Study|Death|0
4582801|NCT01462357|7426275|FG002|Overall Study|Death|1
4582802|NCT01462357|7426273|FG000|Overall Study|Withdrawal by Subject|3
4582803|NCT01462357|7426274|FG001|Overall Study|Withdrawal by Subject|11
4582804|NCT01462357|7426275|FG002|Overall Study|Withdrawal by Subject|3
4582805|NCT01462357|7426273|FG000|Overall Study|Migrated/moved from study area|2
4582806|NCT01462357|7426274|FG001|Overall Study|Migrated/moved from study area|3
4582807|NCT01462357|7426275|FG002|Overall Study|Migrated/moved from study area|1
4582808|NCT01462357|7426273|FG000|Overall Study|Lost to Follow-up|3
4582809|NCT01462357|7426274|FG001|Overall Study|Lost to Follow-up|5
4582810|NCT01462357|7426275|FG002|Overall Study|Lost to Follow-up|7
4582811|NCT01462435|7426287|FG000|Overall Study|Lack of Efficacy|1
4582812|NCT01462435|7426288|FG001|Overall Study|Lack of Efficacy|0
4582813|NCT01462435|7426289|FG002|Overall Study|Lack of Efficacy|0
4582814|NCT01462435|7426290|FG003|Overall Study|Lack of Efficacy|3
4582815|NCT01462435|7426287|FG000|Overall Study|Physician Decision|0
4582816|NCT01462435|7426288|FG001|Overall Study|Physician Decision|0
4582817|NCT01462435|7426289|FG002|Overall Study|Physician Decision|1
4582818|NCT01462435|7426290|FG003|Overall Study|Physician Decision|0
4582819|NCT01462435|7426287|FG000|Overall Study|Withdrawal by Subject|0
4582820|NCT01462435|7426288|FG001|Overall Study|Withdrawal by Subject|0
4582821|NCT01462435|7426289|FG002|Overall Study|Withdrawal by Subject|0
4582822|NCT01462435|7426290|FG003|Overall Study|Withdrawal by Subject|1
4582823|NCT01462435|7426287|FG000|Overall Study|Lost to Follow-up|0
4582824|NCT01462435|7426288|FG001|Overall Study|Lost to Follow-up|0
4582825|NCT01462435|7426289|FG002|Overall Study|Lost to Follow-up|0
4582826|NCT01462435|7426290|FG003|Overall Study|Lost to Follow-up|1
4582827|NCT01462695|7426306|FG000|Overall Study|Adverse Event|1
4582828|NCT01462695|7426307|FG001|Overall Study|Adverse Event|1
4582829|NCT01462695|7426306|FG000|Overall Study|Death|2
4582830|NCT01462695|7426307|FG001|Overall Study|Death|0
4582831|NCT01462695|7426306|FG000|Overall Study|Lack of Efficacy|6
4582832|NCT01462695|7426307|FG001|Overall Study|Lack of Efficacy|12
4582833|NCT01462695|7426306|FG000|Overall Study|Physician Decision|5
4582834|NCT01462695|7426307|FG001|Overall Study|Physician Decision|0
4582835|NCT01462695|7426306|FG000|Overall Study|Withdrawal by Subject|2
4582836|NCT01462695|7426307|FG001|Overall Study|Withdrawal by Subject|0
4582837|NCT01462695|7426306|FG000|Overall Study|Inevaluable (did not receive study drug)|1
4582838|NCT01462695|7426307|FG001|Overall Study|Inevaluable (did not receive study drug)|0
4582839|NCT01462929|7426334|FG000|Overall Study|Adverse Event|3
4582840|NCT01462929|7426335|FG001|Overall Study|Adverse Event|3
4582841|NCT01462929|7426336|FG002|Overall Study|Adverse Event|4
4582842|NCT01462929|7426334|FG000|Overall Study|Withdrawal by Subject|2
4582843|NCT01462929|7426335|FG001|Overall Study|Withdrawal by Subject|1
4582844|NCT01462929|7426336|FG002|Overall Study|Withdrawal by Subject|0
4582845|NCT01462929|7426334|FG000|Overall Study|Lack of Efficacy|0
4582846|NCT01462929|7426335|FG001|Overall Study|Lack of Efficacy|0
4582847|NCT01462929|7426336|FG002|Overall Study|Lack of Efficacy|1
4582848|NCT01462942|7426349|FG000|Overall Study|Adverse Event|7
4582849|NCT01462942|7426350|FG001|Overall Study|Adverse Event|12
4582850|NCT01462942|7426351|FG002|Overall Study|Adverse Event|10
4582851|NCT01462942|7426352|FG003|Overall Study|Adverse Event|11
4582852|NCT01462942|7426353|FG004|Overall Study|Adverse Event|11
4582853|NCT01462942|7426349|FG000|Overall Study|Other, including COPD exacerbation|3
4582854|NCT01462942|7426350|FG001|Overall Study|Other, including COPD exacerbation|5
4582855|NCT01462942|7426351|FG002|Overall Study|Other, including COPD exacerbation|2
4582856|NCT01462942|7426352|FG003|Overall Study|Other, including COPD exacerbation|8
4582857|NCT01462942|7426353|FG004|Overall Study|Other, including COPD exacerbation|5
4582858|NCT01462942|7426349|FG000|Overall Study|Withdrawal by Subject|14
4582859|NCT01462942|7426350|FG001|Overall Study|Withdrawal by Subject|10
4582860|NCT01462942|7426351|FG002|Overall Study|Withdrawal by Subject|14
4582861|NCT01462942|7426352|FG003|Overall Study|Withdrawal by Subject|16
4582862|NCT01462942|7426353|FG004|Overall Study|Withdrawal by Subject|19
4582863|NCT01462942|7426349|FG000|Overall Study|Lack of Efficacy|6
4582864|NCT01462942|7426350|FG001|Overall Study|Lack of Efficacy|0
4582865|NCT01462942|7426351|FG002|Overall Study|Lack of Efficacy|4
4582866|NCT01462942|7426352|FG003|Overall Study|Lack of Efficacy|5
4582867|NCT01462942|7426353|FG004|Overall Study|Lack of Efficacy|3
4582868|NCT01462942|7426349|FG000|Overall Study|Lost to Follow-up|0
4582869|NCT01462942|7426350|FG001|Overall Study|Lost to Follow-up|1
4582870|NCT01462942|7426351|FG002|Overall Study|Lost to Follow-up|1
4582871|NCT01462942|7426352|FG003|Overall Study|Lost to Follow-up|1
4582872|NCT01462942|7426353|FG004|Overall Study|Lost to Follow-up|1
4582873|NCT01462942|7426349|FG000|Overall Study|Protocol Violation|4
4582874|NCT01462942|7426350|FG001|Overall Study|Protocol Violation|6
4582875|NCT01462942|7426351|FG002|Overall Study|Protocol Violation|9
4582876|NCT01462942|7426352|FG003|Overall Study|Protocol Violation|9
4582877|NCT01462942|7426353|FG004|Overall Study|Protocol Violation|6
4582878|NCT01463007|7426365|FG000|Overall Study|Physician Decision|1
4582879|NCT01463033|7426372|FG000|Overall Study|Lost to Follow-up|4
4582880|NCT01463033|7426373|FG001|Overall Study|Lost to Follow-up|4
4582881|NCT01463033|7426372|FG000|Overall Study|Death|3
4582882|NCT01463033|7426373|FG001|Overall Study|Death|2
4582883|NCT01463098|7426394|FG000|Part A (11 Days)|Participant Choice|2
4582884|NCT01463098|7426395|FG001|Part A (11 Days)|Participant Choice|0
4582885|NCT01463098|7426396|FG002|Part A (11 Days)|Participant Choice|0
4582886|NCT01463098|7426397|FG003|Part A (11 Days)|Participant Choice|0
4582887|NCT01463098|7426398|FG004|Part A (11 Days)|Participant Choice|0
4582888|NCT01463098|7426399|FG005|Part A (11 Days)|Participant Choice|0
4582889|NCT01463098|7426400|FG006|Part A (11 Days)|Participant Choice|0
4582890|NCT01463098|7426401|FG007|Part A (11 Days)|Participant Choice|0
4582891|NCT01463098|7426402|FG008|Part A (11 Days)|Participant Choice|1
4582892|NCT01463098|7426403|FG009|Part A (11 Days)|Participant Choice|0
4582893|NCT01463098|7426404|FG010|Part A (11 Days)|Participant Choice|0
4582894|NCT01463098|7426405|FG011|Part A (11 Days)|Participant Choice|0
4582895|NCT01463098|7426406|FG012|Part A (11 Days)|Participant Choice|0
4693087|NCT02589639|7603985|FG002|Overall Study|Lost to Follow-up|0
4693088|NCT02589639|7603983|FG000|Overall Study|Protocol Violation|1
4693089|NCT02589639|7603984|FG001|Overall Study|Protocol Violation|0
4693090|NCT02589639|7603985|FG002|Overall Study|Protocol Violation|0
4693091|NCT02589639|7603983|FG000|Overall Study|Patient withdrawal, not due to AE|3
4693092|NCT02589639|7603984|FG001|Overall Study|Patient withdrawal, not due to AE|0
4693093|NCT02589639|7603985|FG002|Overall Study|Patient withdrawal, not due to AE|0
4693094|NCT02589639|7603983|FG000|Overall Study|Adverse Event|4
4693095|NCT02589639|7603984|FG001|Overall Study|Adverse Event|5
4693096|NCT02589639|7603985|FG002|Overall Study|Adverse Event|3
4582896|NCT01463098|7426407|FG013|Part A (11 Days)|Participant Choice|0
4582897|NCT01463098|7426394|FG000|Part A (11 Days)|Lost to Follow-up|0
4582898|NCT01463098|7426395|FG001|Part A (11 Days)|Lost to Follow-up|0
4582899|NCT01463098|7426396|FG002|Part A (11 Days)|Lost to Follow-up|0
4582900|NCT01463098|7426397|FG003|Part A (11 Days)|Lost to Follow-up|0
4582901|NCT01463098|7426398|FG004|Part A (11 Days)|Lost to Follow-up|1
4582902|NCT01463098|7426399|FG005|Part A (11 Days)|Lost to Follow-up|0
4582903|NCT01463098|7426400|FG006|Part A (11 Days)|Lost to Follow-up|0
4582904|NCT01463098|7426401|FG007|Part A (11 Days)|Lost to Follow-up|0
4582905|NCT01463098|7426402|FG008|Part A (11 Days)|Lost to Follow-up|0
4582906|NCT01463098|7426403|FG009|Part A (11 Days)|Lost to Follow-up|0
4582907|NCT01463098|7426404|FG010|Part A (11 Days)|Lost to Follow-up|0
4582908|NCT01463098|7426405|FG011|Part A (11 Days)|Lost to Follow-up|0
4582909|NCT01463098|7426406|FG012|Part A (11 Days)|Lost to Follow-up|0
4582910|NCT01463098|7426407|FG013|Part A (11 Days)|Lost to Follow-up|0
4582911|NCT01463098|7426394|FG000|Part B (11 Days)|Participant Choice|0
4582912|NCT01463098|7426395|FG001|Part B (11 Days)|Participant Choice|0
4582913|NCT01463098|7426396|FG002|Part B (11 Days)|Participant Choice|0
4582914|NCT01463098|7426397|FG003|Part B (11 Days)|Participant Choice|0
4582915|NCT01463098|7426398|FG004|Part B (11 Days)|Participant Choice|0
4582916|NCT01463098|7426399|FG005|Part B (11 Days)|Participant Choice|0
4582917|NCT01463098|7426400|FG006|Part B (11 Days)|Participant Choice|0
4582918|NCT01463098|7426401|FG007|Part B (11 Days)|Participant Choice|0
4582919|NCT01463098|7426402|FG008|Part B (11 Days)|Participant Choice|0
4582920|NCT01463098|7426403|FG009|Part B (11 Days)|Participant Choice|0
4582921|NCT01463098|7426404|FG010|Part B (11 Days)|Participant Choice|0
4582922|NCT01463098|7426405|FG011|Part B (11 Days)|Participant Choice|1
4582923|NCT01463098|7426406|FG012|Part B (11 Days)|Participant Choice|0
4582924|NCT01463098|7426407|FG013|Part B (11 Days)|Participant Choice|0
4582925|NCT01463111|7426456|FG000|Overall Study|Withdrawal by Subject|2
4582926|NCT01463111|7426456|FG000|Overall Study|Lost to Follow-up|5
4582927|NCT01463111|7426456|FG000|Overall Study|Physician Decision|2
4582928|NCT01463306|7426489|FG000|Overall Study|Adverse Event|6
4582929|NCT01463306|7426490|FG001|Overall Study|Adverse Event|9
4582930|NCT01463306|7426491|FG002|Overall Study|Adverse Event|3
4582931|NCT01463306|7426489|FG000|Overall Study|Death|3
4582932|NCT01463306|7426490|FG001|Overall Study|Death|3
4582933|NCT01463306|7426491|FG002|Overall Study|Death|0
4582934|NCT01463306|7426489|FG000|Overall Study|Lack of Efficacy|22
4582935|NCT01463306|7426490|FG001|Overall Study|Lack of Efficacy|16
4582936|NCT01463306|7426491|FG002|Overall Study|Lack of Efficacy|1
4582937|NCT01463306|7426489|FG000|Overall Study|Lost to Follow-up|5
4582938|NCT01463306|7426490|FG001|Overall Study|Lost to Follow-up|2
4582939|NCT01463306|7426491|FG002|Overall Study|Lost to Follow-up|0
4582940|NCT01463306|7426489|FG000|Overall Study|Protocol Violation|4
4582941|NCT01463306|7426490|FG001|Overall Study|Protocol Violation|0
4582942|NCT01463306|7426491|FG002|Overall Study|Protocol Violation|0
4582943|NCT01463306|7426489|FG000|Overall Study|Withdrawal by Subject|19
4582944|NCT01463306|7426490|FG001|Overall Study|Withdrawal by Subject|9
4582945|NCT01463306|7426491|FG002|Overall Study|Withdrawal by Subject|1
4582946|NCT01463306|7426489|FG000|Overall Study|Other|26
4693097|NCT02589639|7603983|FG000|Overall Study|Other reason than specified above|1
4693098|NCT02589639|7603984|FG001|Overall Study|Other reason than specified above|2
4693099|NCT02589639|7603985|FG002|Overall Study|Other reason than specified above|1
4693100|NCT02589639|7603983|FG000|Overall Study|Not Treated|0
4693101|NCT02589639|7603984|FG001|Overall Study|Not Treated|3
4693102|NCT02589639|7603985|FG002|Overall Study|Not Treated|0
4693103|NCT02589665|7603997|FG000|Induction Period|Did not receive drug|0
4693104|NCT02589665|7603998|FG001|Induction Period|Did not receive drug|0
4693105|NCT02589665|7603999|FG002|Induction Period|Did not receive drug|0
4582947|NCT01463306|7426490|FG001|Overall Study|Other|13
4582948|NCT01463306|7426491|FG002|Overall Study|Other|0
4582949|NCT01463306|7426489|FG000|Overall Study|Approval expiry at site|1
4582950|NCT01463306|7426490|FG001|Overall Study|Approval expiry at site|0
4582951|NCT01463306|7426491|FG002|Overall Study|Approval expiry at site|0
4582952|NCT01463527|7426516|FG000|Overall Study|Protocol Violation|1
4582953|NCT01463527|7426517|FG001|Overall Study|Protocol Violation|1
4693106|NCT02589665|7604000|FG003|Induction Period|Did not receive drug|1
4693107|NCT02589665|7604001|FG004|Induction Period|Did not receive drug|0
4582954|NCT01463527|7426516|FG000|Overall Study|Crying >20% of sedation|5
4582955|NCT01463527|7426517|FG001|Overall Study|Crying >20% of sedation|6
4582956|NCT01463631|7426527|FG000|Overall Study|Withdrawal by Subject|0
4582957|NCT01463631|7426528|FG001|Overall Study|Withdrawal by Subject|0
4582958|NCT01463631|7426529|FG002|Overall Study|Withdrawal by Subject|0
4582959|NCT01463631|7426530|FG003|Overall Study|Withdrawal by Subject|1
4582960|NCT01463631|7426527|FG000|Overall Study|Death|0
4582961|NCT01463631|7426528|FG001|Overall Study|Death|0
4582962|NCT01463631|7426529|FG002|Overall Study|Death|1
4582963|NCT01463631|7426530|FG003|Overall Study|Death|0
4582964|NCT01463631|7426527|FG000|Overall Study|Progressive Disease|0
4582965|NCT01463631|7426528|FG001|Overall Study|Progressive Disease|0
4582966|NCT01463631|7426529|FG002|Overall Study|Progressive Disease|0
4582967|NCT01463631|7426530|FG003|Overall Study|Progressive Disease|5
4582968|NCT01463683|7426545|FG000|Overall Study|Adverse Event|2
4582969|NCT01463683|7426546|FG001|Overall Study|Adverse Event|0
4582970|NCT01463683|7426547|FG002|Overall Study|Adverse Event|0
4582971|NCT01463683|7426545|FG000|Overall Study|Lost to Follow-up|10
4582972|NCT01463683|7426546|FG001|Overall Study|Lost to Follow-up|9
4582973|NCT01463683|7426547|FG002|Overall Study|Lost to Follow-up|7
4582974|NCT01463683|7426545|FG000|Overall Study|Physician Decision|0
4582975|NCT01463683|7426546|FG001|Overall Study|Physician Decision|3
4582976|NCT01463683|7426547|FG002|Overall Study|Physician Decision|1
4582977|NCT01463683|7426545|FG000|Overall Study|Pregnancy|2
4582978|NCT01463683|7426546|FG001|Overall Study|Pregnancy|2
4582979|NCT01463683|7426547|FG002|Overall Study|Pregnancy|1
4582980|NCT01463683|7426545|FG000|Overall Study|Withdrawal by Subject|5
4582981|NCT01463683|7426546|FG001|Overall Study|Withdrawal by Subject|17
4582982|NCT01463683|7426547|FG002|Overall Study|Withdrawal by Subject|2
4582983|NCT01463696|7426563|FG000|Overall Study|Adverse Event|0
4582984|NCT01463696|7426564|FG001|Overall Study|Adverse Event|1
4582985|NCT01463696|7426565|FG002|Overall Study|Adverse Event|0
4582986|NCT01463696|7426566|FG003|Overall Study|Adverse Event|2
4582987|NCT01463696|7426567|FG004|Overall Study|Adverse Event|0
4582988|NCT01463696|7426568|FG005|Overall Study|Adverse Event|1
4582989|NCT01463696|7426569|FG006|Overall Study|Adverse Event|3
4582990|NCT01463696|7426570|FG007|Overall Study|Adverse Event|2
4582991|NCT01463696|7426563|FG000|Overall Study|Lost to Follow-up|0
4582992|NCT01463696|7426564|FG001|Overall Study|Lost to Follow-up|0
4582993|NCT01463696|7426565|FG002|Overall Study|Lost to Follow-up|1
4582994|NCT01463696|7426566|FG003|Overall Study|Lost to Follow-up|0
4582995|NCT01463696|7426567|FG004|Overall Study|Lost to Follow-up|0
4582996|NCT01463696|7426568|FG005|Overall Study|Lost to Follow-up|0
4582997|NCT01463696|7426569|FG006|Overall Study|Lost to Follow-up|0
4582998|NCT01463696|7426570|FG007|Overall Study|Lost to Follow-up|0
4582999|NCT01463696|7426563|FG000|Overall Study|Progressive Disease|0
4583000|NCT01463696|7426564|FG001|Overall Study|Progressive Disease|1
4583001|NCT01463696|7426565|FG002|Overall Study|Progressive Disease|0
4583002|NCT01463696|7426566|FG003|Overall Study|Progressive Disease|1
4583003|NCT01463696|7426567|FG004|Overall Study|Progressive Disease|0
4583004|NCT01463696|7426568|FG005|Overall Study|Progressive Disease|1
4583005|NCT01463696|7426569|FG006|Overall Study|Progressive Disease|4
4583006|NCT01463696|7426570|FG007|Overall Study|Progressive Disease|2
4583007|NCT01463696|7426563|FG000|Overall Study|Withdrawal by Subject|0
4583008|NCT01463696|7426564|FG001|Overall Study|Withdrawal by Subject|0
4583009|NCT01463696|7426565|FG002|Overall Study|Withdrawal by Subject|0
4583010|NCT01463696|7426566|FG003|Overall Study|Withdrawal by Subject|1
4583011|NCT01463696|7426567|FG004|Overall Study|Withdrawal by Subject|1
4583012|NCT01463696|7426568|FG005|Overall Study|Withdrawal by Subject|1
4583013|NCT01463696|7426569|FG006|Overall Study|Withdrawal by Subject|2
4583014|NCT01463696|7426570|FG007|Overall Study|Withdrawal by Subject|0
4583015|NCT01463696|7426563|FG000|Overall Study|Not Treated|0
4583016|NCT01463696|7426564|FG001|Overall Study|Not Treated|0
4583017|NCT01463696|7426565|FG002|Overall Study|Not Treated|0
4583018|NCT01463696|7426566|FG003|Overall Study|Not Treated|0
4583019|NCT01463696|7426567|FG004|Overall Study|Not Treated|0
4583020|NCT01463696|7426568|FG005|Overall Study|Not Treated|0
4583021|NCT01463696|7426569|FG006|Overall Study|Not Treated|1
4583022|NCT01463696|7426570|FG007|Overall Study|Not Treated|0
4583023|NCT01463878|7426590|FG000|Overall Study|no longer met criteria for tube feed|2
4583024|NCT01463878|7426591|FG001|Overall Study|no longer met criteria for tube feed|2
4583025|NCT01463982|7426601|FG000|Overall Study|Withdrawal by Subject|0
4583026|NCT01463982|7426602|FG001|Overall Study|Withdrawal by Subject|1
4583027|NCT01463982|7426603|FG002|Overall Study|Withdrawal by Subject|1
4583028|NCT01463982|7426604|FG003|Overall Study|Withdrawal by Subject|0
4583029|NCT01463982|7426601|FG000|Overall Study|Treatment delay over 5 week|0
4583030|NCT01463982|7426602|FG001|Overall Study|Treatment delay over 5 week|0
4583031|NCT01463982|7426603|FG002|Overall Study|Treatment delay over 5 week|1
4583032|NCT01463982|7426604|FG003|Overall Study|Treatment delay over 5 week|0
4583033|NCT01464021|7426614|FG000|Overall Study|Withdrawal by Subject|13
4583034|NCT01464021|7426614|FG000|Overall Study|Lost to Follow-up|1
4583035|NCT01464021|7426614|FG000|Overall Study|Lack of Efficacy|1
4583036|NCT01464021|7426614|FG000|Overall Study|various|11
4583037|NCT01464255|7426638|FG000|Overall Study|unresolve corneal staining|0
4583038|NCT01464255|7426639|FG001|Overall Study|unresolve corneal staining|1
4583039|NCT01464307|7426648|FG000|Main Period|Death|0
4583040|NCT01464307|7426649|FG001|Main Period|Death|1
4583041|NCT01464307|7426648|FG000|Main Period|Adverse Event|6
4583042|NCT01464307|7426649|FG001|Main Period|Adverse Event|1
4583043|NCT01464307|7426648|FG000|Main Period|Lack of Efficacy|2
4583044|NCT01464307|7426649|FG001|Main Period|Lack of Efficacy|0
4583045|NCT01464307|7426648|FG000|Main Period|Withdrawal by Subject|5
4583046|NCT01464307|7426649|FG001|Main Period|Withdrawal by Subject|2
4583047|NCT01464307|7426648|FG000|Main Period|Predefined discontinuation criteria|2
4583048|NCT01464307|7426649|FG001|Main Period|Predefined discontinuation criteria|1
4583049|NCT01464307|7426648|FG000|Open-Label Extension Period|Adverse Event|15
4583050|NCT01464307|7426649|FG001|Open-Label Extension Period|Adverse Event|0
4583051|NCT01464307|7426648|FG000|Open-Label Extension Period|Withdrawal by Subject|14
4583052|NCT01464307|7426649|FG001|Open-Label Extension Period|Withdrawal by Subject|0
4583053|NCT01464307|7426648|FG000|Open-Label Extension Period|Lack of Efficacy|5
4583054|NCT01464307|7426649|FG001|Open-Label Extension Period|Lack of Efficacy|0
4583055|NCT01464307|7426648|FG000|Open-Label Extension Period|Death|1
4583056|NCT01464307|7426649|FG001|Open-Label Extension Period|Death|0
4583057|NCT01464307|7426648|FG000|Open-Label Extension Period|Lost to Follow-up|1
4583058|NCT01464307|7426649|FG001|Open-Label Extension Period|Lost to Follow-up|0
4583059|NCT01464307|7426648|FG000|Open-Label Extension Period|Non-compliance|9
4583060|NCT01464307|7426649|FG001|Open-Label Extension Period|Non-compliance|0
4583061|NCT01464307|7426648|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6
4583062|NCT01464307|7426649|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0
4583063|NCT01464333|7426656|FG000|Overall Study|Adverse Event|34
4583064|NCT01464333|7426656|FG000|Overall Study|Lack of Efficacy|72
4583065|NCT01464333|7426656|FG000|Overall Study|Withdrawal by Subject|11
4583066|NCT01464333|7426656|FG000|Overall Study|Other|4
4583067|NCT01464333|7426656|FG000|Overall Study|No Hospital Visit|42
4583068|NCT01464346|7426660|FG000|Overall Study|Withdrawal by Subject|0
4583069|NCT01464346|7426661|FG001|Overall Study|Withdrawal by Subject|0
4583070|NCT01464346|7426662|FG002|Overall Study|Withdrawal by Subject|1
4583071|NCT01464424|7426674|FG000|Period 1, First 6 Weeks|Adverse Event|0
4583072|NCT01464424|7426675|FG001|Period 1, First 6 Weeks|Adverse Event|1
4583073|NCT01464619|7426683|FG000|Overall Study|Lost to Follow-up|3
4583074|NCT01464619|7426684|FG001|Overall Study|Lost to Follow-up|4
4583075|NCT01464788|7426715|FG000|Overall Study|Lost to Follow-up|0
4583076|NCT01464788|7426716|FG001|Overall Study|Lost to Follow-up|1
4583077|NCT01464788|7426717|FG002|Overall Study|Lost to Follow-up|0
4583078|NCT01464788|7426715|FG000|Overall Study|Patient had hemorrhage after tPA started|0
4583079|NCT01464788|7426716|FG001|Overall Study|Patient had hemorrhage after tPA started|1
4583080|NCT01464788|7426717|FG002|Overall Study|Patient had hemorrhage after tPA started|0
4583081|NCT01464827|7426741|FG000|Overall Study|Adverse Event|0
4583082|NCT01464827|7426742|FG001|Overall Study|Adverse Event|0
4583083|NCT01464827|7426743|FG002|Overall Study|Adverse Event|0
4583084|NCT01464827|7426744|FG003|Overall Study|Adverse Event|0
4583085|NCT01464827|7426745|FG004|Overall Study|Adverse Event|0
4583086|NCT01464827|7426746|FG005|Overall Study|Adverse Event|0
4583087|NCT01464827|7426747|FG006|Overall Study|Adverse Event|0
4583088|NCT01464827|7426748|FG007|Overall Study|Adverse Event|0
4583089|NCT01464827|7426749|FG008|Overall Study|Adverse Event|0
4583090|NCT01464827|7426750|FG009|Overall Study|Adverse Event|0
4583091|NCT01464827|7426751|FG010|Overall Study|Adverse Event|0
4583092|NCT01464827|7426752|FG011|Overall Study|Adverse Event|0
4583093|NCT01464827|7426753|FG012|Overall Study|Adverse Event|1
4583094|NCT01464827|7426754|FG013|Overall Study|Adverse Event|0
4583095|NCT01464827|7426741|FG000|Overall Study|Withdrawal by Subject|1
4583096|NCT01464827|7426742|FG001|Overall Study|Withdrawal by Subject|0
4583097|NCT01464827|7426743|FG002|Overall Study|Withdrawal by Subject|0
4583098|NCT01464827|7426744|FG003|Overall Study|Withdrawal by Subject|0
4583099|NCT01464827|7426745|FG004|Overall Study|Withdrawal by Subject|1
4583100|NCT01464827|7426746|FG005|Overall Study|Withdrawal by Subject|0
4583101|NCT01464827|7426747|FG006|Overall Study|Withdrawal by Subject|0
4583102|NCT01464827|7426748|FG007|Overall Study|Withdrawal by Subject|1
4583103|NCT01464827|7426749|FG008|Overall Study|Withdrawal by Subject|0
4583104|NCT01464827|7426750|FG009|Overall Study|Withdrawal by Subject|0
4583105|NCT01464827|7426751|FG010|Overall Study|Withdrawal by Subject|0
4583106|NCT01464827|7426752|FG011|Overall Study|Withdrawal by Subject|0
4583107|NCT01464827|7426753|FG012|Overall Study|Withdrawal by Subject|0
4583108|NCT01464827|7426754|FG013|Overall Study|Withdrawal by Subject|0
4583109|NCT01464827|7426741|FG000|Overall Study|Lost to Follow-up|0
4583110|NCT01464827|7426742|FG001|Overall Study|Lost to Follow-up|2
4583111|NCT01464827|7426743|FG002|Overall Study|Lost to Follow-up|0
4583112|NCT01464827|7426744|FG003|Overall Study|Lost to Follow-up|2
4583113|NCT01464827|7426745|FG004|Overall Study|Lost to Follow-up|3
4583114|NCT01464827|7426746|FG005|Overall Study|Lost to Follow-up|1
4583115|NCT01464827|7426747|FG006|Overall Study|Lost to Follow-up|2
4583116|NCT01464827|7426748|FG007|Overall Study|Lost to Follow-up|2
4583117|NCT01464827|7426749|FG008|Overall Study|Lost to Follow-up|0
4583118|NCT01464827|7426750|FG009|Overall Study|Lost to Follow-up|0
4583119|NCT01464827|7426751|FG010|Overall Study|Lost to Follow-up|0
4583120|NCT01464827|7426752|FG011|Overall Study|Lost to Follow-up|1
4583121|NCT01464827|7426753|FG012|Overall Study|Lost to Follow-up|0
4583122|NCT01464827|7426754|FG013|Overall Study|Lost to Follow-up|1
4583123|NCT01464827|7426741|FG000|Overall Study|Other|2
4583124|NCT01464827|7426742|FG001|Overall Study|Other|3
4583125|NCT01464827|7426743|FG002|Overall Study|Other|0
4583126|NCT01464827|7426744|FG003|Overall Study|Other|2
4583127|NCT01464827|7426745|FG004|Overall Study|Other|3
4583128|NCT01464827|7426746|FG005|Overall Study|Other|0
4583129|NCT01464827|7426747|FG006|Overall Study|Other|1
4583130|NCT01464827|7426748|FG007|Overall Study|Other|0
4583131|NCT01464827|7426749|FG008|Overall Study|Other|3
4583132|NCT01464827|7426750|FG009|Overall Study|Other|1
4583133|NCT01464827|7426751|FG010|Overall Study|Other|2
4583134|NCT01464827|7426752|FG011|Overall Study|Other|0
4583135|NCT01464827|7426753|FG012|Overall Study|Other|1
4583136|NCT01464827|7426754|FG013|Overall Study|Other|0
4583137|NCT01464827|7426741|FG000|Overall Study|Not Treated|0
4583138|NCT01464827|7426742|FG001|Overall Study|Not Treated|2
4583139|NCT01464827|7426743|FG002|Overall Study|Not Treated|0
4583140|NCT01464827|7426744|FG003|Overall Study|Not Treated|0
4583141|NCT01464827|7426745|FG004|Overall Study|Not Treated|1
4583142|NCT01464827|7426746|FG005|Overall Study|Not Treated|0
4583143|NCT01464827|7426747|FG006|Overall Study|Not Treated|1
4583144|NCT01464827|7426748|FG007|Overall Study|Not Treated|0
4583145|NCT01464827|7426749|FG008|Overall Study|Not Treated|0
4583146|NCT01464827|7426750|FG009|Overall Study|Not Treated|2
4583147|NCT01464827|7426751|FG010|Overall Study|Not Treated|0
4583148|NCT01464827|7426752|FG011|Overall Study|Not Treated|1
4583149|NCT01464827|7426753|FG012|Overall Study|Not Treated|0
4583150|NCT01464827|7426754|FG013|Overall Study|Not Treated|2
4583151|NCT01464879|7426808|FG000|Overall Study|Physician Decision|1
4583152|NCT01464879|7426808|FG000|Overall Study|Non-compliance|1
4583153|NCT01464931|7426820|FG000|Overall Study|Withdrawal by Subject|1
4583154|NCT01464931|7426821|FG001|Overall Study|Withdrawal by Subject|0
4583155|NCT01465022|7426843|FG000|Overall Study|Lost to Follow-up|15
4583156|NCT01465022|7426844|FG001|Overall Study|Lost to Follow-up|14
4583157|NCT01465022|7426845|FG002|Overall Study|Lost to Follow-up|0
4583158|NCT01465022|7426843|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8
4583159|NCT01465022|7426844|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9
4583160|NCT01465022|7426845|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0
4583161|NCT01465022|7426843|FG000|Overall Study|Not Randomized|0
4583162|NCT01465022|7426844|FG001|Overall Study|Not Randomized|0
4583163|NCT01465022|7426845|FG002|Overall Study|Not Randomized|70
4583164|NCT01465178|7426866|FG000|Overall Study|Withdrawal by Subject|1
4583165|NCT01465178|7426867|FG001|Overall Study|Withdrawal by Subject|0
4583166|NCT01465191|7426876|FG000|Overall Study|Protocol Violation|6
4583167|NCT01465191|7426877|FG001|Overall Study|Protocol Violation|3
4583168|NCT01465191|7426878|FG002|Overall Study|Protocol Violation|3
4583169|NCT01465191|7426876|FG000|Overall Study|Lost to Follow-up|3
4583170|NCT01465191|7426877|FG001|Overall Study|Lost to Follow-up|6
4583171|NCT01465191|7426878|FG002|Overall Study|Lost to Follow-up|4
4583172|NCT01465334|7426891|FG000|Overall Study|Disease Progression|1
4583173|NCT01465334|7426892|FG001|Overall Study|Disease Progression|0
4583174|NCT01465334|7426891|FG000|Overall Study|Adverse Event|1
4583175|NCT01465334|7426892|FG001|Overall Study|Adverse Event|0
4583176|NCT01465334|7426891|FG000|Overall Study|Richter's transformation|0
4583177|NCT01465334|7426892|FG001|Overall Study|Richter's transformation|3
4583178|NCT01465334|7426891|FG000|Overall Study|Refractory Disease|0
4583179|NCT01465334|7426892|FG001|Overall Study|Refractory Disease|3
4583180|NCT01465347|7426898|FG000|Overall Study|Withdrawal by Subject|1
4583181|NCT01465347|7426899|FG001|Overall Study|Withdrawal by Subject|1
4583182|NCT01465347|7426898|FG000|Overall Study|Physician Decision|0
4583183|NCT01465347|7426899|FG001|Overall Study|Physician Decision|1
4583184|NCT01465347|7426898|FG000|Overall Study|Admitted to hospice|0
4583185|NCT01465347|7426899|FG001|Overall Study|Admitted to hospice|1
4583186|NCT01465386|7426908|FG000|Overall Study|Lack of Efficacy|3
4583187|NCT01465386|7426908|FG000|Overall Study|Adverse Event|1
4583188|NCT01465464|7426931|FG000|Overall Study|Adverse Event|96
4583189|NCT01465464|7426932|FG001|Overall Study|Adverse Event|49
4583190|NCT01465464|7426931|FG000|Overall Study|Lack of Efficacy|139
4583191|NCT01465464|7426932|FG001|Overall Study|Lack of Efficacy|190
4583192|NCT01465464|7426931|FG000|Overall Study|Physician Decision|13
4583193|NCT01465464|7426932|FG001|Overall Study|Physician Decision|5
4583194|NCT01465464|7426931|FG000|Overall Study|Protocol Violation|1
4583195|NCT01465464|7426932|FG001|Overall Study|Protocol Violation|1
4583196|NCT01465464|7426931|FG000|Overall Study|Withdrawal by Subject|46
4583197|NCT01465464|7426932|FG001|Overall Study|Withdrawal by Subject|30
4583198|NCT01465464|7426931|FG000|Overall Study|Other|9
4583199|NCT01465464|7426932|FG001|Overall Study|Other|3
4583200|NCT01465464|7426931|FG000|Overall Study|Ongoing treatment at cutoff date|140
4583201|NCT01465464|7426932|FG001|Overall Study|Ongoing treatment at cutoff date|166
4583202|NCT01465659|7426942|FG000|Completed 1 Cycle of Treatment|Death|0
4583203|NCT01465659|7426943|FG001|Completed 1 Cycle of Treatment|Death|1
4583204|NCT01465659|7426944|FG002|Completed 1 Cycle of Treatment|Death|0
4583205|NCT01465659|7426945|FG003|Completed 1 Cycle of Treatment|Death|0
4583206|NCT01465659|7426942|FG000|Completed 1 Cycle of Treatment|Adverse Event|0
4583207|NCT01465659|7426943|FG001|Completed 1 Cycle of Treatment|Adverse Event|0
4583208|NCT01465659|7426944|FG002|Completed 1 Cycle of Treatment|Adverse Event|0
4583209|NCT01465659|7426945|FG003|Completed 1 Cycle of Treatment|Adverse Event|1
4583210|NCT01465659|7426942|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1
4583211|NCT01465659|7426943|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0
4583212|NCT01465659|7426944|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1
4583213|NCT01465659|7426945|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1
4583214|NCT01465659|7426942|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1
4583215|NCT01465659|7426943|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0
4583216|NCT01465659|7426944|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1
4583217|NCT01465659|7426945|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0
4583218|NCT01465659|7426942|FG000|Completed Follow for 1 Year|Death|6
4583219|NCT01465659|7426943|FG001|Completed Follow for 1 Year|Death|3
4583220|NCT01465659|7426944|FG002|Completed Follow for 1 Year|Death|2
4583221|NCT01465659|7426945|FG003|Completed Follow for 1 Year|Death|4
4583222|NCT01465763|7426961|FG000|Overall Study|Withdrawal by Subject|4
4583223|NCT01465763|7426962|FG001|Overall Study|Withdrawal by Subject|0
4583224|NCT01465763|7426963|FG002|Overall Study|Withdrawal by Subject|1
4583225|NCT01465763|7426961|FG000|Overall Study|Insufficient Clinical Response|11
4583226|NCT01465763|7426962|FG001|Overall Study|Insufficient Clinical Response|0
4583227|NCT01465763|7426963|FG002|Overall Study|Insufficient Clinical Response|1
4583228|NCT01465763|7426961|FG000|Overall Study|Adverse Event|9
4583229|NCT01465763|7426962|FG001|Overall Study|Adverse Event|0
4583230|NCT01465763|7426963|FG002|Overall Study|Adverse Event|1
4583231|NCT01465763|7426961|FG000|Overall Study|Other|2
4583232|NCT01465763|7426962|FG001|Overall Study|Other|0
4583233|NCT01465763|7426963|FG002|Overall Study|Other|0
4583234|NCT01465763|7426961|FG000|Overall Study|Protocol Violation|4
4583235|NCT01465763|7426962|FG001|Overall Study|Protocol Violation|1
4583236|NCT01465763|7426963|FG002|Overall Study|Protocol Violation|1
4583237|NCT01465763|7426961|FG000|Overall Study|Death|1
4583238|NCT01465763|7426962|FG001|Overall Study|Death|0
4583239|NCT01465763|7426963|FG002|Overall Study|Death|0
4583240|NCT01465802|7426975|FG000|Overall Study|Study terminated by sponsor|1
4583241|NCT01465802|7426976|FG001|Overall Study|Study terminated by sponsor|0
4583242|NCT01465802|7426977|FG002|Overall Study|Study terminated by sponsor|0
4583243|NCT01465802|7426978|FG003|Overall Study|Study terminated by sponsor|1
4583244|NCT01465802|7426979|FG004|Overall Study|Study terminated by sponsor|7
4583245|NCT01465802|7426975|FG000|Overall Study|Withdrawal by Subject|7
4583246|NCT01465802|7426976|FG001|Overall Study|Withdrawal by Subject|7
4583247|NCT01465802|7426977|FG002|Overall Study|Withdrawal by Subject|0
4583248|NCT01465802|7426978|FG003|Overall Study|Withdrawal by Subject|8
4583249|NCT01465802|7426979|FG004|Overall Study|Withdrawal by Subject|1
4583250|NCT01465802|7426975|FG000|Overall Study|Lost to Follow-up|1
4583251|NCT01465802|7426976|FG001|Overall Study|Lost to Follow-up|1
4583252|NCT01465802|7426977|FG002|Overall Study|Lost to Follow-up|0
4583253|NCT01465802|7426978|FG003|Overall Study|Lost to Follow-up|0
4583254|NCT01465802|7426979|FG004|Overall Study|Lost to Follow-up|0
4583255|NCT01465802|7426975|FG000|Overall Study|Reason not specified|9
4583256|NCT01465802|7426976|FG001|Overall Study|Reason not specified|4
4583257|NCT01465802|7426977|FG002|Overall Study|Reason not specified|0
4583258|NCT01465802|7426978|FG003|Overall Study|Reason not specified|10
4583259|NCT01465802|7426979|FG004|Overall Study|Reason not specified|2
4583260|NCT01465802|7426975|FG000|Overall Study|Death|15
4583261|NCT01465802|7426976|FG001|Overall Study|Death|12
4583262|NCT01465802|7426977|FG002|Overall Study|Death|0
4583263|NCT01465802|7426978|FG003|Overall Study|Death|10
4583264|NCT01465802|7426979|FG004|Overall Study|Death|2
4583265|NCT01465958|7426997|FG000|Run-in Phase|Protocol Violation|1
4583266|NCT01465958|7426998|FG001|Run-in Phase|Protocol Violation|0
4583267|NCT01465958|7426997|FG000|Subcutaneous (SC) Phase|Adverse Event|0
4583268|NCT01465958|7426998|FG001|Subcutaneous (SC) Phase|Adverse Event|1
4583269|NCT01465997|7427007|FG000|Overall Study|Adverse Event|12
4583270|NCT01465997|7427008|FG001|Overall Study|Adverse Event|22
4583271|NCT01465997|7427007|FG000|Overall Study|Lack of Efficacy|13
4583272|NCT01465997|7427008|FG001|Overall Study|Lack of Efficacy|1
4583273|NCT01465997|7427007|FG000|Overall Study|Protocol Violation|1
4583274|NCT01465997|7427008|FG001|Overall Study|Protocol Violation|4
4583275|NCT01465997|7427007|FG000|Overall Study|Lost to Follow-up|6
4583276|NCT01465997|7427008|FG001|Overall Study|Lost to Follow-up|9
4583277|NCT01465997|7427007|FG000|Overall Study|Withdrawal by Subject|32
4583278|NCT01465997|7427008|FG001|Overall Study|Withdrawal by Subject|35
4583279|NCT01465997|7427007|FG000|Overall Study|investigator's decision|1
4583280|NCT01465997|7427008|FG001|Overall Study|investigator's decision|1
4583281|NCT01465997|7427007|FG000|Overall Study|Death|0
4583282|NCT01465997|7427008|FG001|Overall Study|Death|1
4583283|NCT01465997|7427007|FG000|Overall Study|sponsor's decision|1
4583284|NCT01465997|7427008|FG001|Overall Study|sponsor's decision|1
4583285|NCT01465997|7427007|FG000|Overall Study|subject withdrew consent|1
4583286|NCT01465997|7427008|FG001|Overall Study|subject withdrew consent|0
4583287|NCT01465997|7427007|FG000|Overall Study|local lab unblinded site|1
4583288|NCT01465997|7427008|FG001|Overall Study|local lab unblinded site|0
4583289|NCT01465997|7427007|FG000|Overall Study|withdrew before follow-up|0
4583290|NCT01465997|7427008|FG001|Overall Study|withdrew before follow-up|13
4583291|NCT01465997|7427007|FG000|Overall Study|decision by site staff|0
4583292|NCT01465997|7427008|FG001|Overall Study|decision by site staff|1
4583293|NCT01465997|7427007|FG000|Overall Study|subject left participation SP0993|0
4593423|NCT01551355|7441811|FG005|Overall Study|Lost to Follow-up|6
4583294|NCT01465997|7427008|FG001|Overall Study|subject left participation SP0993|1
4583295|NCT01466062|7427016|FG000|Overall Study|Adverse Event|1
4583296|NCT01466062|7427016|FG000|Overall Study|Withdrawal by Subject|1
4583297|NCT01466153|7427036|FG000|Overall Study|Disease Progression|2
4583298|NCT01466153|7427037|FG001|Overall Study|Disease Progression|2
4583299|NCT01466153|7427038|FG002|Overall Study|Disease Progression|0
4583300|NCT01466153|7427036|FG000|Overall Study|Adverse Event|14
4583301|NCT01466153|7427037|FG001|Overall Study|Adverse Event|13
4583302|NCT01466153|7427038|FG002|Overall Study|Adverse Event|17
4583303|NCT01466153|7427036|FG000|Overall Study|Withdrawal of Consent|2
4583304|NCT01466153|7427037|FG001|Overall Study|Withdrawal of Consent|0
4583305|NCT01466153|7427038|FG002|Overall Study|Withdrawal of Consent|0
4583306|NCT01466153|7427036|FG000|Overall Study|Investigator Discretion|3
4583307|NCT01466153|7427037|FG001|Overall Study|Investigator Discretion|2
4583308|NCT01466153|7427038|FG002|Overall Study|Investigator Discretion|2
4583309|NCT01466153|7427036|FG000|Overall Study|Randomized-Not Treated|2
4583310|NCT01466153|7427037|FG001|Overall Study|Randomized-Not Treated|3
4583311|NCT01466153|7427038|FG002|Overall Study|Randomized-Not Treated|4
4583312|NCT01466153|7427036|FG000|Overall Study|Other-Unspecified|6
4583313|NCT01466153|7427037|FG001|Overall Study|Other-Unspecified|4
4583314|NCT01466153|7427038|FG002|Overall Study|Other-Unspecified|2
4583315|NCT01466166|7427048|FG000|Overall Study|Death|1
4583316|NCT01466166|7427048|FG000|Overall Study|Lost to Follow-up|7
4583317|NCT01466166|7427048|FG000|Overall Study|Infusion Reaction (IR)|27
4583318|NCT01466166|7427048|FG000|Overall Study|Adverse Event (Other than IR)|11
4583319|NCT01466166|7427048|FG000|Overall Study|Elevated Serum Uric Acid|78
4583320|NCT01466166|7427048|FG000|Overall Study|Withdrawal by Subject|13
4583321|NCT01466166|7427048|FG000|Overall Study|Sponsor Decision|4
4583322|NCT01466166|7427048|FG000|Overall Study|Protocol Violation/Noncompliance|2
4583323|NCT01466166|7427048|FG000|Overall Study|Other|20
4583324|NCT01466179|7427052|FG000|Overall Study|Ongoing in core study|2
4583325|NCT01466179|7427052|FG000|Overall Study|Physician Decision|46
4583326|NCT01466179|7427052|FG000|Overall Study|Progressive disease|43
4583327|NCT01466179|7427052|FG000|Overall Study|Adverse Event|32
4583328|NCT01466179|7427052|FG000|Overall Study|Disease relapse|23
4583329|NCT01466179|7427052|FG000|Overall Study|Lack of Efficacy|14
4583330|NCT01466179|7427052|FG000|Overall Study|Death|7
4583331|NCT01466179|7427052|FG000|Overall Study|Withdrawal by Subject|7
4583332|NCT01466179|7427052|FG000|Overall Study|Protocol Violation|2
4583333|NCT01466179|7427052|FG000|Overall Study|Other|3
4583334|NCT01466192|7427059|FG000|Overall Study|Physician Decision|1
4583335|NCT01466192|7427059|FG000|Overall Study|Withdrawal by Subject|3
4583336|NCT01466270|7427065|FG000|Overall Study|Withdrawal by Subject|4
4583337|NCT01466270|7427066|FG001|Overall Study|Withdrawal by Subject|1
4583338|NCT01466270|7427065|FG000|Overall Study|Physician Decision|1
4583339|NCT01466270|7427066|FG001|Overall Study|Physician Decision|0
4583340|NCT01466270|7427065|FG000|Overall Study|Lost to Follow-up|1
4583341|NCT01466270|7427066|FG001|Overall Study|Lost to Follow-up|3
4583342|NCT01466270|7427065|FG000|Overall Study|Progression|1
4583343|NCT01466270|7427066|FG001|Overall Study|Progression|0
4583344|NCT01466270|7427065|FG000|Overall Study|Toxicity|4
4583345|NCT01466270|7427066|FG001|Overall Study|Toxicity|1
4583346|NCT01466270|7427065|FG000|Overall Study|Multiple|1
4583347|NCT01466270|7427066|FG001|Overall Study|Multiple|1
4583348|NCT01466348|7427074|FG000|Period I - First Intervention|Withdrawal by Subject|0
4583349|NCT01466348|7427075|FG001|Period I - First Intervention|Withdrawal by Subject|1
4583350|NCT01466387|7427111|FG000|Overall Study|Adverse Event|0
4583351|NCT01466387|7427112|FG001|Overall Study|Adverse Event|0
4583352|NCT01466387|7427113|FG002|Overall Study|Adverse Event|1
4583353|NCT01466387|7427114|FG003|Overall Study|Adverse Event|1
4583354|NCT01466387|7427115|FG004|Overall Study|Adverse Event|0
4583355|NCT01466387|7427116|FG005|Overall Study|Adverse Event|0
4583356|NCT01466387|7427111|FG000|Overall Study|Lost to Follow-up|0
4583357|NCT01466387|7427112|FG001|Overall Study|Lost to Follow-up|0
4583358|NCT01466387|7427113|FG002|Overall Study|Lost to Follow-up|0
4583359|NCT01466387|7427114|FG003|Overall Study|Lost to Follow-up|0
4583360|NCT01466387|7427115|FG004|Overall Study|Lost to Follow-up|0
4583361|NCT01466387|7427116|FG005|Overall Study|Lost to Follow-up|1
4583362|NCT01466387|7427111|FG000|Overall Study|Protocol Violation|1
4583363|NCT01466387|7427112|FG001|Overall Study|Protocol Violation|0
4583364|NCT01466387|7427113|FG002|Overall Study|Protocol Violation|0
4583365|NCT01466387|7427114|FG003|Overall Study|Protocol Violation|1
4583366|NCT01466387|7427115|FG004|Overall Study|Protocol Violation|0
4583367|NCT01466387|7427116|FG005|Overall Study|Protocol Violation|0
4583368|NCT01466491|7427143|FG000|Overall Study|Protocol Violation|0
4583369|NCT01466491|7427144|FG001|Overall Study|Protocol Violation|3
4583370|NCT01466491|7427145|FG002|Overall Study|Protocol Violation|2
4583371|NCT01466491|7427146|FG003|Overall Study|Protocol Violation|0
4583372|NCT01466491|7427143|FG000|Overall Study|Missing Data|0
4583373|NCT01466491|7427144|FG001|Overall Study|Missing Data|0
4583374|NCT01466491|7427145|FG002|Overall Study|Missing Data|1
4583375|NCT01466491|7427146|FG003|Overall Study|Missing Data|0
4583376|NCT01466595|7427158|FG000|Overall Study|Withdrawal by Subject|0
4583377|NCT01466595|7427159|FG001|Overall Study|Withdrawal by Subject|1
4583378|NCT01466660|7427167|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120
4583379|NCT01466660|7427168|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127
4583380|NCT01466660|7427167|FG000|Overall Study|Worsening of underlying cancer disease|5
4583381|NCT01466660|7427168|FG001|Overall Study|Worsening of underlying cancer disease|2
4583382|NCT01466660|7427167|FG000|Overall Study|Other adverse event|19
4583383|NCT01466660|7427168|FG001|Overall Study|Other adverse event|18
4583384|NCT01466660|7427167|FG000|Overall Study|Protocol Violation|2
4583385|NCT01466660|7427168|FG001|Overall Study|Protocol Violation|1
4583386|NCT01466660|7427167|FG000|Overall Study|Refused continuation of trial medication|4
4583387|NCT01466660|7427168|FG001|Overall Study|Refused continuation of trial medication|3
4583388|NCT01466660|7427167|FG000|Overall Study|Other reason not defined above|10
4583389|NCT01466660|7427168|FG001|Overall Study|Other reason not defined above|8
4583390|NCT01466673|7427176|FG000|Overall Study|Non-compliance with study treatment|2
4583391|NCT01466673|7427177|FG001|Overall Study|Non-compliance with study treatment|0
4583392|NCT01466673|7427176|FG000|Overall Study|Lost to Follow-up|3
4583393|NCT01466673|7427177|FG001|Overall Study|Lost to Follow-up|5
4583394|NCT01466673|7427176|FG000|Overall Study|Adverse Event|2
4583395|NCT01466673|7427177|FG001|Overall Study|Adverse Event|1
4583396|NCT01466790|7427211|FG000|Overall Study|Adverse Event|1
4583397|NCT01466790|7427212|FG001|Overall Study|Adverse Event|0
4583398|NCT01466790|7427213|FG002|Overall Study|Adverse Event|0
4583399|NCT01466790|7427214|FG003|Overall Study|Adverse Event|0
4583400|NCT01466790|7427215|FG004|Overall Study|Adverse Event|2
4583401|NCT01466790|7427216|FG005|Overall Study|Adverse Event|0
4583402|NCT01466790|7427217|FG006|Overall Study|Adverse Event|0
4583403|NCT01466790|7427218|FG007|Overall Study|Adverse Event|0
4583404|NCT01466790|7427211|FG000|Overall Study|Lost to Follow-up|2
4583405|NCT01466790|7427212|FG001|Overall Study|Lost to Follow-up|0
4583406|NCT01466790|7427213|FG002|Overall Study|Lost to Follow-up|0
4583407|NCT01466790|7427214|FG003|Overall Study|Lost to Follow-up|0
4583408|NCT01466790|7427215|FG004|Overall Study|Lost to Follow-up|0
4583409|NCT01466790|7427216|FG005|Overall Study|Lost to Follow-up|0
4583410|NCT01466790|7427217|FG006|Overall Study|Lost to Follow-up|0
4583411|NCT01466790|7427218|FG007|Overall Study|Lost to Follow-up|0
4583412|NCT01466790|7427211|FG000|Overall Study|Withdrawal by Subject|1
4583413|NCT01466790|7427212|FG001|Overall Study|Withdrawal by Subject|1
4583414|NCT01466790|7427213|FG002|Overall Study|Withdrawal by Subject|0
4583415|NCT01466790|7427214|FG003|Overall Study|Withdrawal by Subject|0
4583416|NCT01466790|7427215|FG004|Overall Study|Withdrawal by Subject|1
4583417|NCT01466790|7427216|FG005|Overall Study|Withdrawal by Subject|0
4583418|NCT01466790|7427217|FG006|Overall Study|Withdrawal by Subject|1
4583419|NCT01466790|7427218|FG007|Overall Study|Withdrawal by Subject|1
4583420|NCT01466881|7427232|FG000|Overall Study|Ineligible|5
4583421|NCT01466881|7427232|FG000|Overall Study|Adverse Event|6
4583422|NCT01466881|7427232|FG000|Overall Study|Progression/relapse|20
4583423|NCT01466881|7427232|FG000|Overall Study|Death|4
4583424|NCT01466881|7427232|FG000|Overall Study|Other reason not protocol specified|5
4583425|NCT01467076|7427275|FG000|Overall Study|Lost to Follow-up|1
4583426|NCT01467076|7427276|FG001|Overall Study|Lost to Follow-up|0
4583427|NCT01467076|7427277|FG002|Overall Study|Lost to Follow-up|0
4583428|NCT01467271|7427285|FG000|Overall Study|Death|84
4583429|NCT01467271|7427285|FG000|Overall Study|Lost to Follow-up|83
4583430|NCT01467271|7427285|FG000|Overall Study|Retraction of patient's consent|21
4583431|NCT01467271|7427285|FG000|Overall Study|Other reason|14
4583432|NCT01467427|7427291|FG000|Overall Study|Withdrawal by Subject|1
4583433|NCT01467427|7427292|FG001|Overall Study|Withdrawal by Subject|0
4583434|NCT01467427|7427291|FG000|Overall Study|Entered extension phase|11
4583435|NCT01467427|7427292|FG001|Overall Study|Entered extension phase|11
4583436|NCT01467427|7427291|FG000|Overall Study|Not continuing in extension phase|0
4583437|NCT01467427|7427292|FG001|Overall Study|Not continuing in extension phase|2
4583438|NCT01467466|7427302|FG000|Overall Study|Withdrawal by Subject|15
4583439|NCT01467466|7427303|FG001|Overall Study|Withdrawal by Subject|18
4583440|NCT01467466|7427304|FG002|Overall Study|Withdrawal by Subject|13
4583441|NCT01467466|7427305|FG003|Overall Study|Withdrawal by Subject|11
4583442|NCT01467466|7427302|FG000|Overall Study|Revoked Consent Prior To Procedure|10
4583443|NCT01467466|7427303|FG001|Overall Study|Revoked Consent Prior To Procedure|9
4583444|NCT01467466|7427304|FG002|Overall Study|Revoked Consent Prior To Procedure|15
4583445|NCT01467466|7427305|FG003|Overall Study|Revoked Consent Prior To Procedure|5
4583446|NCT01467466|7427302|FG000|Overall Study|Procedure Cancelled|46
4583447|NCT01467466|7427303|FG001|Overall Study|Procedure Cancelled|45
4583448|NCT01467466|7427304|FG002|Overall Study|Procedure Cancelled|25
4583449|NCT01467466|7427305|FG003|Overall Study|Procedure Cancelled|29
4583450|NCT01467466|7427302|FG000|Overall Study|No Endpoint Blood Draw|38
4583451|NCT01467466|7427303|FG001|Overall Study|No Endpoint Blood Draw|32
4583452|NCT01467466|7427304|FG002|Overall Study|No Endpoint Blood Draw|51
4583453|NCT01467466|7427305|FG003|Overall Study|No Endpoint Blood Draw|43
4583454|NCT01467479|7427318|FG000|Overall Study|No Study Medication|1
4583455|NCT01467479|7427319|FG001|Overall Study|No Study Medication|0
4583456|NCT01467479|7427320|FG002|Overall Study|No Study Medication|2
4583457|NCT01467479|7427318|FG000|Overall Study|Adverse Event|1
4583458|NCT01467479|7427319|FG001|Overall Study|Adverse Event|2
4583459|NCT01467479|7427320|FG002|Overall Study|Adverse Event|0
4583460|NCT01467479|7427318|FG000|Overall Study|Death|0
4583461|NCT01467479|7427319|FG001|Overall Study|Death|0
4583462|NCT01467479|7427320|FG002|Overall Study|Death|1
4583463|NCT01467479|7427318|FG000|Overall Study|Lost to Follow-up|2
4583464|NCT01467479|7427319|FG001|Overall Study|Lost to Follow-up|5
4583465|NCT01467479|7427320|FG002|Overall Study|Lost to Follow-up|3
4583466|NCT01467479|7427318|FG000|Overall Study|Withdrawal of Consent|3
4583467|NCT01467479|7427319|FG001|Overall Study|Withdrawal of Consent|7
4583468|NCT01467479|7427320|FG002|Overall Study|Withdrawal of Consent|7
4583469|NCT01467479|7427318|FG000|Overall Study|Study Terminated by Sponsor|1
4583470|NCT01467479|7427319|FG001|Overall Study|Study Terminated by Sponsor|3
4583471|NCT01467479|7427320|FG002|Overall Study|Study Terminated by Sponsor|3
4583472|NCT01467479|7427318|FG000|Overall Study|Other|1
4583473|NCT01467479|7427319|FG001|Overall Study|Other|0
4583474|NCT01467479|7427320|FG002|Overall Study|Other|0
4583475|NCT01467492|7427331|FG000|Overall Study|Withdrawal by Subject|6
4583476|NCT01467492|7427332|FG001|Overall Study|Withdrawal by Subject|4
4583477|NCT01467492|7427331|FG000|Overall Study|Study Terminated by Sponsor|6
4583478|NCT01467492|7427332|FG001|Overall Study|Study Terminated by Sponsor|4
4583479|NCT01467492|7427331|FG000|Overall Study|Adverse Event|4
4583480|NCT01467492|7427332|FG001|Overall Study|Adverse Event|3
4583481|NCT01467492|7427331|FG000|Overall Study|Lost to Follow-up|3
4583482|NCT01467492|7427332|FG001|Overall Study|Lost to Follow-up|2
4583483|NCT01467492|7427331|FG000|Overall Study|Undefined|2
4583484|NCT01467492|7427332|FG001|Overall Study|Undefined|0
4583485|NCT01467492|7427331|FG000|Overall Study|Enrolled But Not Treated|1
4583486|NCT01467492|7427332|FG001|Overall Study|Enrolled But Not Treated|0
4583487|NCT01467505|7427341|FG000|Overall Study|Adverse Event|1
4583488|NCT01467505|7427342|FG001|Overall Study|Adverse Event|0
4583489|NCT01467505|7427341|FG000|Overall Study|Withdrawal by Subject|4
4583490|NCT01467505|7427342|FG001|Overall Study|Withdrawal by Subject|0
4583491|NCT01467505|7427341|FG000|Overall Study|Study Terminated by Sponsor|28
4583492|NCT01467505|7427342|FG001|Overall Study|Study Terminated by Sponsor|3
4583493|NCT01467570|7427359|FG000|Overall Study|Lost to Follow-up|8
4583494|NCT01467570|7427360|FG001|Overall Study|Lost to Follow-up|9
4593424|NCT01551420|7441821|FG000|In-laboratory (Part A)|Lost to Follow-up|2
4593425|NCT01551420|7441822|FG001|In-laboratory (Part A)|Lost to Follow-up|1
4593426|NCT01551420|7441821|FG000|In-laboratory (Part A)|Withdrawal by Subject|2
4593427|NCT01551420|7441822|FG001|In-laboratory (Part A)|Withdrawal by Subject|0
4593428|NCT01551420|7441821|FG000|In-laboratory (Part A)|Scheduling conflict|2
4593429|NCT01551420|7441822|FG001|In-laboratory (Part A)|Scheduling conflict|1
4593430|NCT01551420|7441821|FG000|Screened for Part B Eligibility|Declined participation|8
4593431|NCT01551420|7441822|FG001|Screened for Part B Eligibility|Declined participation|1
4593432|NCT01551420|7441821|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1
4593433|NCT01551420|7441822|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2
4593434|NCT01551420|7441821|FG000|Home Use (Part B)|Withdrawal by Subject|6
4593435|NCT01551420|7441822|FG001|Home Use (Part B)|Withdrawal by Subject|0
4593436|NCT01551420|7441821|FG000|Home Use (Part B)|Withdrawal by staff|0
4593437|NCT01551420|7441822|FG001|Home Use (Part B)|Withdrawal by staff|1
4593438|NCT01551693|7441839|FG000|Overall Study|Disease Progression|1
4593439|NCT01551693|7441840|FG001|Overall Study|Disease Progression|0
4593440|NCT01551693|7441839|FG000|Overall Study|Adverse Event|0
4593441|NCT01551693|7441840|FG001|Overall Study|Adverse Event|1
4593442|NCT01551693|7441839|FG000|Overall Study|Withdrawal by Subject|0
4593443|NCT01551693|7441840|FG001|Overall Study|Withdrawal by Subject|1
4593444|NCT01551745|7441846|FG000|Overall Study|Withdrawal by Subject|1
4593445|NCT01551745|7441846|FG000|Overall Study|Disease Progression|2
4593446|NCT01551758|7441852|FG000|Overall Study|Adverse Event|29
4593447|NCT01551758|7441853|FG001|Overall Study|Adverse Event|43
4593448|NCT01551758|7441852|FG000|Overall Study|Lack of Efficacy|0
4593449|NCT01551758|7441853|FG001|Overall Study|Lack of Efficacy|1
4593450|NCT01551758|7441852|FG000|Overall Study|Protocol Violation|5
4593451|NCT01551758|7441853|FG001|Overall Study|Protocol Violation|6
4593452|NCT01551758|7441852|FG000|Overall Study|Met Protocol-defined stopping criteria|8
4593453|NCT01551758|7441853|FG001|Overall Study|Met Protocol-defined stopping criteria|10
4593454|NCT01551758|7441852|FG000|Overall Study|Lost to Follow-up|29
4593455|NCT01551758|7441853|FG001|Overall Study|Lost to Follow-up|25
4593456|NCT01551758|7441852|FG000|Overall Study|Physician Decision|9
4593457|NCT01551758|7441853|FG001|Overall Study|Physician Decision|3
4593458|NCT01551758|7441852|FG000|Overall Study|Withdrawal by Subject|14
4593459|NCT01551758|7441853|FG001|Overall Study|Withdrawal by Subject|17
4593460|NCT01552057|7441881|FG000|Overall Study|Adverse Event|14
4593461|NCT01552057|7441882|FG001|Overall Study|Adverse Event|15
4593462|NCT01552057|7441881|FG000|Overall Study|Lack of Efficacy|8
4593463|NCT01552057|7441882|FG001|Overall Study|Lack of Efficacy|23
4593464|NCT01552057|7441881|FG000|Overall Study|Withdrawal by Subject|5
4593465|NCT01552057|7441882|FG001|Overall Study|Withdrawal by Subject|8
4593466|NCT01552057|7441881|FG000|Overall Study|Entry Criteria Not Met|2
4593467|NCT01552057|7441882|FG001|Overall Study|Entry Criteria Not Met|2
4593468|NCT01552057|7441881|FG000|Overall Study|Physician Decision|1
4593469|NCT01552057|7441882|FG001|Overall Study|Physician Decision|0
4593470|NCT01552369|7441917|FG000|Overall Study|Did not consent to extended follow up|8
4593471|NCT01552369|7441918|FG001|Overall Study|Did not consent to extended follow up|9
4593472|NCT01552408|7441928|FG000|Overall Study|Lost to Follow-up|2
4593473|NCT01552408|7441929|FG001|Overall Study|Lost to Follow-up|0
4593474|NCT01552408|7441928|FG000|Overall Study|Relocation|0
4593475|NCT01552408|7441929|FG001|Overall Study|Relocation|1
4583495|NCT01467583|7427371|FG000|Overall Study|Death|1
4583496|NCT01467583|7427372|FG001|Overall Study|Death|1
4583497|NCT01467583|7427373|FG002|Overall Study|Death|0
4583498|NCT01467583|7427371|FG000|Overall Study|Withdrawal by Subject|1
4583499|NCT01467583|7427372|FG001|Overall Study|Withdrawal by Subject|0
4583500|NCT01467583|7427373|FG002|Overall Study|Withdrawal by Subject|0
4583501|NCT01467583|7427371|FG000|Overall Study|Protocol Violation|0
4583502|NCT01467583|7427372|FG001|Overall Study|Protocol Violation|0
4583503|NCT01467583|7427373|FG002|Overall Study|Protocol Violation|2
4583504|NCT01467661|7427384|FG000|Overall Study|Adverse Event|16
4583505|NCT01467661|7427384|FG000|Overall Study|Withdrawal by Subject|1
4583506|NCT01467661|7427384|FG000|Overall Study|Lack of Efficacy|3
4583507|NCT01467661|7427384|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1
4583508|NCT01467700|7427394|FG000|Overall Study|Pretreatment Event or Adverse Event|6
4583509|NCT01467700|7427395|FG001|Overall Study|Pretreatment Event or Adverse Event|4
4583510|NCT01467700|7427396|FG002|Overall Study|Pretreatment Event or Adverse Event|2
4583511|NCT01467700|7427397|FG003|Overall Study|Pretreatment Event or Adverse Event|3
4583512|NCT01467700|7427394|FG000|Overall Study|Major Protocol Deviation|3
4583513|NCT01467700|7427395|FG001|Overall Study|Major Protocol Deviation|3
4583514|NCT01467700|7427396|FG002|Overall Study|Major Protocol Deviation|2
4583515|NCT01467700|7427397|FG003|Overall Study|Major Protocol Deviation|3
4583516|NCT01467700|7427394|FG000|Overall Study|Lost to Follow-up|6
4583517|NCT01467700|7427395|FG001|Overall Study|Lost to Follow-up|5
4583518|NCT01467700|7427396|FG002|Overall Study|Lost to Follow-up|2
4583519|NCT01467700|7427397|FG003|Overall Study|Lost to Follow-up|3
4583520|NCT01467700|7427394|FG000|Overall Study|Voluntary Withdrawal|5
4583521|NCT01467700|7427395|FG001|Overall Study|Voluntary Withdrawal|7
4583522|NCT01467700|7427396|FG002|Overall Study|Voluntary Withdrawal|6
4583523|NCT01467700|7427397|FG003|Overall Study|Voluntary Withdrawal|2
4583524|NCT01467700|7427394|FG000|Overall Study|Study Termination|6
4583525|NCT01467700|7427395|FG001|Overall Study|Study Termination|5
4583526|NCT01467700|7427396|FG002|Overall Study|Study Termination|10
4583527|NCT01467700|7427397|FG003|Overall Study|Study Termination|7
4583528|NCT01467700|7427394|FG000|Overall Study|Pregnancy|0
4583529|NCT01467700|7427395|FG001|Overall Study|Pregnancy|1
4583530|NCT01467700|7427396|FG002|Overall Study|Pregnancy|1
4583531|NCT01467700|7427397|FG003|Overall Study|Pregnancy|0
4583532|NCT01467700|7427394|FG000|Overall Study|Lack of Efficacy|2
4583533|NCT01467700|7427395|FG001|Overall Study|Lack of Efficacy|0
4583534|NCT01467700|7427396|FG002|Overall Study|Lack of Efficacy|2
4583535|NCT01467700|7427397|FG003|Overall Study|Lack of Efficacy|1
4583536|NCT01467700|7427394|FG000|Overall Study|Reason not Specified|1
4583537|NCT01467700|7427395|FG001|Overall Study|Reason not Specified|3
4583538|NCT01467700|7427396|FG002|Overall Study|Reason not Specified|2
4583539|NCT01467700|7427397|FG003|Overall Study|Reason not Specified|8
4583540|NCT01467713|7427411|FG000|Overall Study|Pretreatment Event or Adverse Event|9
4583541|NCT01467713|7427412|FG001|Overall Study|Pretreatment Event or Adverse Event|4
4583542|NCT01467713|7427413|FG002|Overall Study|Pretreatment Event or Adverse Event|6
4583543|NCT01467713|7427414|FG003|Overall Study|Pretreatment Event or Adverse Event|5
4583544|NCT01467713|7427411|FG000|Overall Study|Major Protocol Deviation|2
4583545|NCT01467713|7427412|FG001|Overall Study|Major Protocol Deviation|4
4583546|NCT01467713|7427413|FG002|Overall Study|Major Protocol Deviation|4
4583547|NCT01467713|7427414|FG003|Overall Study|Major Protocol Deviation|1
4583548|NCT01467713|7427411|FG000|Overall Study|Lost to Follow-up|9
4583549|NCT01467713|7427412|FG001|Overall Study|Lost to Follow-up|12
4583550|NCT01467713|7427413|FG002|Overall Study|Lost to Follow-up|6
4583551|NCT01467713|7427414|FG003|Overall Study|Lost to Follow-up|9
4583552|NCT01467713|7427411|FG000|Overall Study|Voluntary Withdrawal|18
4583553|NCT01467713|7427412|FG001|Overall Study|Voluntary Withdrawal|14
4583554|NCT01467713|7427413|FG002|Overall Study|Voluntary Withdrawal|21
4583555|NCT01467713|7427414|FG003|Overall Study|Voluntary Withdrawal|20
4583556|NCT01467713|7427411|FG000|Overall Study|Study Termination|23
4583557|NCT01467713|7427412|FG001|Overall Study|Study Termination|33
4583558|NCT01467713|7427413|FG002|Overall Study|Study Termination|28
4583559|NCT01467713|7427414|FG003|Overall Study|Study Termination|29
4583560|NCT01467713|7427411|FG000|Overall Study|Pregnancy|0
4583561|NCT01467713|7427412|FG001|Overall Study|Pregnancy|1
4583562|NCT01467713|7427413|FG002|Overall Study|Pregnancy|1
4583563|NCT01467713|7427414|FG003|Overall Study|Pregnancy|3
4583564|NCT01467713|7427411|FG000|Overall Study|Relapse|35
4583565|NCT01467713|7427412|FG001|Overall Study|Relapse|25
4583566|NCT01467713|7427413|FG002|Overall Study|Relapse|28
4583567|NCT01467713|7427414|FG003|Overall Study|Relapse|35
4583568|NCT01467713|7427411|FG000|Overall Study|Reason not Specified|6
4583569|NCT01467713|7427412|FG001|Overall Study|Reason not Specified|11
4583570|NCT01467713|7427413|FG002|Overall Study|Reason not Specified|8
4583571|NCT01467713|7427414|FG003|Overall Study|Reason not Specified|7
4583572|NCT01467960|7427458|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0
4583573|NCT01467960|7427459|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0
4583574|NCT01467960|7427460|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0
4583575|NCT01467960|7427461|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30
4583576|NCT01467960|7427462|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30
4583577|NCT01467960|7427463|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30
4583578|NCT01468077|7427497|FG000|Overall Study|Adverse Event|2
4583579|NCT01468077|7427498|FG001|Overall Study|Adverse Event|2
4583580|NCT01468077|7427497|FG000|Overall Study|Lack of Efficacy|1
4583581|NCT01468077|7427498|FG001|Overall Study|Lack of Efficacy|1
4583582|NCT01468077|7427497|FG000|Overall Study|Physician Decision|1
4583583|NCT01468077|7427498|FG001|Overall Study|Physician Decision|0
4583584|NCT01468181|7427509|FG000|Overall Study|Adverse Event|8
4583585|NCT01468181|7427510|FG001|Overall Study|Adverse Event|1
4583586|NCT01468181|7427511|FG002|Overall Study|Adverse Event|6
4583587|NCT01468181|7427512|FG003|Overall Study|Adverse Event|2
4583588|NCT01468181|7427513|FG004|Overall Study|Adverse Event|2
4583589|NCT01468181|7427509|FG000|Overall Study|Protocol Violation|2
4583590|NCT01468181|7427510|FG001|Overall Study|Protocol Violation|0
4583591|NCT01468181|7427511|FG002|Overall Study|Protocol Violation|1
4583592|NCT01468181|7427512|FG003|Overall Study|Protocol Violation|0
4583593|NCT01468181|7427513|FG004|Overall Study|Protocol Violation|1
4583594|NCT01468181|7427509|FG000|Overall Study|Physician Decision|0
4583595|NCT01468181|7427510|FG001|Overall Study|Physician Decision|0
4583596|NCT01468181|7427511|FG002|Overall Study|Physician Decision|0
4583597|NCT01468181|7427512|FG003|Overall Study|Physician Decision|1
4583598|NCT01468181|7427513|FG004|Overall Study|Physician Decision|1
4583599|NCT01468181|7427509|FG000|Overall Study|Lost to Follow-up|0
4583600|NCT01468181|7427510|FG001|Overall Study|Lost to Follow-up|0
4583601|NCT01468181|7427511|FG002|Overall Study|Lost to Follow-up|1
4583602|NCT01468181|7427512|FG003|Overall Study|Lost to Follow-up|0
4583603|NCT01468181|7427513|FG004|Overall Study|Lost to Follow-up|1
4583604|NCT01468181|7427509|FG000|Overall Study|Withdrawal by Subject|0
4583605|NCT01468181|7427510|FG001|Overall Study|Withdrawal by Subject|1
4583606|NCT01468181|7427511|FG002|Overall Study|Withdrawal by Subject|0
4583607|NCT01468181|7427512|FG003|Overall Study|Withdrawal by Subject|0
4583608|NCT01468181|7427513|FG004|Overall Study|Withdrawal by Subject|0
4583609|NCT01468207|7427527|FG000|Treatment Period 1|Adverse Event|1
4583610|NCT01468207|7427528|FG001|Treatment Period 1|Adverse Event|0
4583611|NCT01468207|7427529|FG002|Treatment Period 1|Adverse Event|0
4583612|NCT01468207|7427530|FG003|Treatment Period 1|Adverse Event|0
4583613|NCT01468207|7427531|FG004|Treatment Period 1|Adverse Event|0
4583614|NCT01468207|7427532|FG005|Treatment Period 1|Adverse Event|0
4583615|NCT01468207|7427527|FG000|Treatment Period 1|Protocol Violation|1
4583616|NCT01468207|7427528|FG001|Treatment Period 1|Protocol Violation|1
4583617|NCT01468207|7427529|FG002|Treatment Period 1|Protocol Violation|0
4583618|NCT01468207|7427530|FG003|Treatment Period 1|Protocol Violation|0
4583619|NCT01468207|7427531|FG004|Treatment Period 1|Protocol Violation|0
4583620|NCT01468207|7427532|FG005|Treatment Period 1|Protocol Violation|0
4583621|NCT01468207|7427527|FG000|Treatment Period 1|Withdrawal by Subject|5
4583622|NCT01468207|7427528|FG001|Treatment Period 1|Withdrawal by Subject|4
4583623|NCT01468207|7427529|FG002|Treatment Period 1|Withdrawal by Subject|0
4583624|NCT01468207|7427530|FG003|Treatment Period 1|Withdrawal by Subject|0
4583625|NCT01468207|7427531|FG004|Treatment Period 1|Withdrawal by Subject|0
4583626|NCT01468207|7427532|FG005|Treatment Period 1|Withdrawal by Subject|0
4583627|NCT01468207|7427527|FG000|Treatment Period 1|Lost to Follow-up|2
4583628|NCT01468207|7427528|FG001|Treatment Period 1|Lost to Follow-up|1
4583629|NCT01468207|7427529|FG002|Treatment Period 1|Lost to Follow-up|0
4583630|NCT01468207|7427530|FG003|Treatment Period 1|Lost to Follow-up|0
4583631|NCT01468207|7427531|FG004|Treatment Period 1|Lost to Follow-up|0
4583632|NCT01468207|7427532|FG005|Treatment Period 1|Lost to Follow-up|0
4583633|NCT01468207|7427527|FG000|Treatment Period 1|Other|0
4583634|NCT01468207|7427528|FG001|Treatment Period 1|Other|2
4583635|NCT01468207|7427529|FG002|Treatment Period 1|Other|0
4583636|NCT01468207|7427530|FG003|Treatment Period 1|Other|0
4583637|NCT01468207|7427531|FG004|Treatment Period 1|Other|0
4583638|NCT01468207|7427532|FG005|Treatment Period 1|Other|0
4583639|NCT01468207|7427527|FG000|Treatment Period 2|Adverse Event|0
4583640|NCT01468207|7427528|FG001|Treatment Period 2|Adverse Event|0
4583641|NCT01468207|7427529|FG002|Treatment Period 2|Adverse Event|6
4583642|NCT01468207|7427530|FG003|Treatment Period 2|Adverse Event|1
4583643|NCT01468207|7427531|FG004|Treatment Period 2|Adverse Event|2
4583644|NCT01468207|7427532|FG005|Treatment Period 2|Adverse Event|1
4583645|NCT01468207|7427527|FG000|Treatment Period 2|Lack of Efficacy|0
4583646|NCT01468207|7427528|FG001|Treatment Period 2|Lack of Efficacy|0
4583647|NCT01468207|7427529|FG002|Treatment Period 2|Lack of Efficacy|1
4583648|NCT01468207|7427530|FG003|Treatment Period 2|Lack of Efficacy|1
4583649|NCT01468207|7427531|FG004|Treatment Period 2|Lack of Efficacy|0
4583650|NCT01468207|7427532|FG005|Treatment Period 2|Lack of Efficacy|2
4583651|NCT01468207|7427527|FG000|Treatment Period 2|Withdrawal by Subject|0
4583652|NCT01468207|7427528|FG001|Treatment Period 2|Withdrawal by Subject|0
4583653|NCT01468207|7427529|FG002|Treatment Period 2|Withdrawal by Subject|5
4583654|NCT01468207|7427530|FG003|Treatment Period 2|Withdrawal by Subject|0
4583655|NCT01468207|7427531|FG004|Treatment Period 2|Withdrawal by Subject|0
4583656|NCT01468207|7427532|FG005|Treatment Period 2|Withdrawal by Subject|2
4583657|NCT01468207|7427527|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0
4583658|NCT01468207|7427528|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0
4583659|NCT01468207|7427529|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30
4583660|NCT01468207|7427530|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23
4583661|NCT01468207|7427531|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18
4583662|NCT01468207|7427532|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13
4583663|NCT01468207|7427527|FG000|Treatment Period 2|Lost to Follow-up|0
4583664|NCT01468207|7427528|FG001|Treatment Period 2|Lost to Follow-up|0
4583665|NCT01468207|7427529|FG002|Treatment Period 2|Lost to Follow-up|5
4583666|NCT01468207|7427530|FG003|Treatment Period 2|Lost to Follow-up|1
4583667|NCT01468207|7427531|FG004|Treatment Period 2|Lost to Follow-up|0
4583668|NCT01468207|7427532|FG005|Treatment Period 2|Lost to Follow-up|0
4583669|NCT01468207|7427527|FG000|Treatment Period 2|Other|0
4583670|NCT01468207|7427528|FG001|Treatment Period 2|Other|0
4583671|NCT01468207|7427529|FG002|Treatment Period 2|Other|5
4583672|NCT01468207|7427530|FG003|Treatment Period 2|Other|1
4583673|NCT01468207|7427531|FG004|Treatment Period 2|Other|1
4583674|NCT01468207|7427532|FG005|Treatment Period 2|Other|2
4583675|NCT01468233|7427552|FG000|Treatment Period 1|Adverse Event|5
4583676|NCT01468233|7427553|FG001|Treatment Period 1|Adverse Event|3
4583677|NCT01468233|7427554|FG002|Treatment Period 1|Adverse Event|0
4583678|NCT01468233|7427555|FG003|Treatment Period 1|Adverse Event|0
4583679|NCT01468233|7427556|FG004|Treatment Period 1|Adverse Event|0
4583680|NCT01468233|7427557|FG005|Treatment Period 1|Adverse Event|0
4583681|NCT01468233|7427552|FG000|Treatment Period 1|Withdrawal by Subject|3
4583682|NCT01468233|7427553|FG001|Treatment Period 1|Withdrawal by Subject|4
4583683|NCT01468233|7427554|FG002|Treatment Period 1|Withdrawal by Subject|0
4583684|NCT01468233|7427555|FG003|Treatment Period 1|Withdrawal by Subject|0
4583685|NCT01468233|7427556|FG004|Treatment Period 1|Withdrawal by Subject|0
4583686|NCT01468233|7427557|FG005|Treatment Period 1|Withdrawal by Subject|0
4583687|NCT01468233|7427552|FG000|Treatment Period 1|Lost to Follow-up|3
4583688|NCT01468233|7427553|FG001|Treatment Period 1|Lost to Follow-up|0
4583689|NCT01468233|7427554|FG002|Treatment Period 1|Lost to Follow-up|0
4583690|NCT01468233|7427555|FG003|Treatment Period 1|Lost to Follow-up|0
4583691|NCT01468233|7427556|FG004|Treatment Period 1|Lost to Follow-up|0
4583692|NCT01468233|7427557|FG005|Treatment Period 1|Lost to Follow-up|0
4583693|NCT01468233|7427552|FG000|Treatment Period 1|Other|1
4583694|NCT01468233|7427553|FG001|Treatment Period 1|Other|1
4583695|NCT01468233|7427554|FG002|Treatment Period 1|Other|0
4583696|NCT01468233|7427555|FG003|Treatment Period 1|Other|0
4583697|NCT01468233|7427556|FG004|Treatment Period 1|Other|0
4583698|NCT01468233|7427557|FG005|Treatment Period 1|Other|0
4583699|NCT01468233|7427552|FG000|Treatment Period 2|Adverse Event|0
4583700|NCT01468233|7427553|FG001|Treatment Period 2|Adverse Event|0
4583701|NCT01468233|7427554|FG002|Treatment Period 2|Adverse Event|3
4583702|NCT01468233|7427555|FG003|Treatment Period 2|Adverse Event|0
4583703|NCT01468233|7427556|FG004|Treatment Period 2|Adverse Event|2
4583704|NCT01468233|7427557|FG005|Treatment Period 2|Adverse Event|1
4583705|NCT01468233|7427552|FG000|Treatment Period 2|Lack of Efficacy|0
4583706|NCT01468233|7427553|FG001|Treatment Period 2|Lack of Efficacy|0
4583707|NCT01468233|7427554|FG002|Treatment Period 2|Lack of Efficacy|9
4583708|NCT01468233|7427555|FG003|Treatment Period 2|Lack of Efficacy|2
4583709|NCT01468233|7427556|FG004|Treatment Period 2|Lack of Efficacy|0
4583710|NCT01468233|7427557|FG005|Treatment Period 2|Lack of Efficacy|1
4583711|NCT01468233|7427552|FG000|Treatment Period 2|Withdrawal by Subject|0
4583712|NCT01468233|7427553|FG001|Treatment Period 2|Withdrawal by Subject|0
4583713|NCT01468233|7427554|FG002|Treatment Period 2|Withdrawal by Subject|9
4583714|NCT01468233|7427555|FG003|Treatment Period 2|Withdrawal by Subject|1
4583715|NCT01468233|7427556|FG004|Treatment Period 2|Withdrawal by Subject|1
4583716|NCT01468233|7427557|FG005|Treatment Period 2|Withdrawal by Subject|1
4583717|NCT01468233|7427552|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0
4583718|NCT01468233|7427553|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0
4583719|NCT01468233|7427554|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84
4583720|NCT01468233|7427555|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25
4583721|NCT01468233|7427556|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22
4583722|NCT01468233|7427557|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20
4583723|NCT01468233|7427552|FG000|Treatment Period 2|Lost to Follow-up|0
4583724|NCT01468233|7427553|FG001|Treatment Period 2|Lost to Follow-up|0
4583725|NCT01468233|7427554|FG002|Treatment Period 2|Lost to Follow-up|3
4583726|NCT01468233|7427555|FG003|Treatment Period 2|Lost to Follow-up|0
4583727|NCT01468233|7427556|FG004|Treatment Period 2|Lost to Follow-up|2
4583728|NCT01468233|7427557|FG005|Treatment Period 2|Lost to Follow-up|0
4583729|NCT01468233|7427552|FG000|Treatment Period 2|Other|0
4583730|NCT01468233|7427553|FG001|Treatment Period 2|Other|0
4583731|NCT01468233|7427554|FG002|Treatment Period 2|Other|3
4583732|NCT01468233|7427555|FG003|Treatment Period 2|Other|0
4583733|NCT01468233|7427556|FG004|Treatment Period 2|Other|1
4583734|NCT01468233|7427557|FG005|Treatment Period 2|Other|0
4583735|NCT01468311|7427575|FG000|Overall Study|mobilization failure|1
4583736|NCT01468311|7427575|FG000|Overall Study|Withdrawal by Subject|1
4583737|NCT01468454|7427600|FG000|Overall Study|Did not have surgery after PET|9
4583738|NCT01468597|7427621|FG000|Overall Study|Found ineligible|17
4583739|NCT01468597|7427621|FG000|Overall Study|concomitant valves|12
4583740|NCT01468597|7427621|FG000|Overall Study|off-pump CABG|1
4583741|NCT01468597|7427621|FG000|Overall Study|no platelet function data|5
4583742|NCT01468701|7427651|FG000|Overall Study|Not eligible|91
4583743|NCT01468701|7427652|FG001|Overall Study|Not eligible|140
4583744|NCT01468701|7427653|FG002|Overall Study|Not eligible|29
4583745|NCT01468701|7427654|FG003|Overall Study|Not eligible|12
4583746|NCT01468701|7427655|FG004|Overall Study|Not eligible|22
4583747|NCT01468701|7427656|FG005|Overall Study|Not eligible|2
4583748|NCT01468701|7427657|FG006|Overall Study|Not eligible|39
4583749|NCT01468701|7427658|FG007|Overall Study|Not eligible|1
4583750|NCT01468701|7427659|FG008|Overall Study|Not eligible|40
4583751|NCT01468701|7427660|FG009|Overall Study|Not eligible|126
4583752|NCT01468701|7427661|FG010|Overall Study|Not eligible|39
4583753|NCT01468701|7427662|FG011|Overall Study|Not eligible|33
4583754|NCT01468701|7427663|FG012|Overall Study|Not eligible|1
4583755|NCT01468701|7427664|FG013|Overall Study|Not eligible|19
4583756|NCT01468701|7427665|FG014|Overall Study|Not eligible|1
4583757|NCT01468701|7427666|FG015|Overall Study|Not eligible|32
4583758|NCT01468701|7427667|FG016|Overall Study|Not eligible|0
4583759|NCT01468701|7427651|FG000|Overall Study|Lost to Follow-up|306
4583760|NCT01468701|7427652|FG001|Overall Study|Lost to Follow-up|0
4583761|NCT01468701|7427653|FG002|Overall Study|Lost to Follow-up|0
4583762|NCT01468701|7427654|FG003|Overall Study|Lost to Follow-up|0
4583763|NCT01468701|7427655|FG004|Overall Study|Lost to Follow-up|0
4583764|NCT01468701|7427656|FG005|Overall Study|Lost to Follow-up|0
4583765|NCT01468701|7427657|FG006|Overall Study|Lost to Follow-up|0
4583766|NCT01468701|7427658|FG007|Overall Study|Lost to Follow-up|0
4583767|NCT01468701|7427659|FG008|Overall Study|Lost to Follow-up|215
4583768|NCT01468701|7427660|FG009|Overall Study|Lost to Follow-up|309
4583769|NCT01468701|7427661|FG010|Overall Study|Lost to Follow-up|224
4583770|NCT01468701|7427662|FG011|Overall Study|Lost to Follow-up|212
4583771|NCT01468701|7427663|FG012|Overall Study|Lost to Follow-up|11
4583772|NCT01468701|7427664|FG013|Overall Study|Lost to Follow-up|164
4583773|NCT01468701|7427665|FG014|Overall Study|Lost to Follow-up|17
4583774|NCT01468701|7427666|FG015|Overall Study|Lost to Follow-up|127
4583775|NCT01468701|7427667|FG016|Overall Study|Lost to Follow-up|1
4583776|NCT01468701|7427651|FG000|Overall Study|Withdrawal by Subject|165
4583777|NCT01468701|7427652|FG001|Overall Study|Withdrawal by Subject|0
4583778|NCT01468701|7427653|FG002|Overall Study|Withdrawal by Subject|0
4583779|NCT01468701|7427654|FG003|Overall Study|Withdrawal by Subject|0
4583780|NCT01468701|7427655|FG004|Overall Study|Withdrawal by Subject|0
4583781|NCT01468701|7427656|FG005|Overall Study|Withdrawal by Subject|0
4583782|NCT01468701|7427657|FG006|Overall Study|Withdrawal by Subject|0
4583783|NCT01468701|7427658|FG007|Overall Study|Withdrawal by Subject|0
4583784|NCT01468701|7427659|FG008|Overall Study|Withdrawal by Subject|83
4583785|NCT01468701|7427660|FG009|Overall Study|Withdrawal by Subject|88
4583786|NCT01468701|7427661|FG010|Overall Study|Withdrawal by Subject|100
4583787|NCT01468701|7427662|FG011|Overall Study|Withdrawal by Subject|114
4583788|NCT01468701|7427663|FG012|Overall Study|Withdrawal by Subject|9
4583789|NCT01468701|7427664|FG013|Overall Study|Withdrawal by Subject|47
4583790|NCT01468701|7427665|FG014|Overall Study|Withdrawal by Subject|6
4583791|NCT01468701|7427666|FG015|Overall Study|Withdrawal by Subject|31
4583792|NCT01468701|7427667|FG016|Overall Study|Withdrawal by Subject|0
4583793|NCT01468701|7427651|FG000|Overall Study|Other reasons than listed|437
4583794|NCT01468701|7427652|FG001|Overall Study|Other reasons than listed|0
4583795|NCT01468701|7427653|FG002|Overall Study|Other reasons than listed|0
4583796|NCT01468701|7427654|FG003|Overall Study|Other reasons than listed|0
4583797|NCT01468701|7427655|FG004|Overall Study|Other reasons than listed|0
4583798|NCT01468701|7427656|FG005|Overall Study|Other reasons than listed|0
4583799|NCT01468701|7427657|FG006|Overall Study|Other reasons than listed|0
4583800|NCT01468701|7427658|FG007|Overall Study|Other reasons than listed|0
4583801|NCT01468701|7427659|FG008|Overall Study|Other reasons than listed|318
4583802|NCT01468701|7427660|FG009|Overall Study|Other reasons than listed|658
4583803|NCT01468701|7427661|FG010|Overall Study|Other reasons than listed|433
4583804|NCT01468701|7427662|FG011|Overall Study|Other reasons than listed|504
4583805|NCT01468701|7427663|FG012|Overall Study|Other reasons than listed|28
4583806|NCT01468701|7427664|FG013|Overall Study|Other reasons than listed|239
4583807|NCT01468701|7427665|FG014|Overall Study|Other reasons than listed|39
4583808|NCT01468701|7427666|FG015|Overall Study|Other reasons than listed|172
4583809|NCT01468701|7427667|FG016|Overall Study|Other reasons than listed|0
4583810|NCT01468701|7427651|FG000|Overall Study|No end of study case report form|0
4583811|NCT01468701|7427652|FG001|Overall Study|No end of study case report form|0
4583812|NCT01468701|7427653|FG002|Overall Study|No end of study case report form|0
4583813|NCT01468701|7427654|FG003|Overall Study|No end of study case report form|0
4583814|NCT01468701|7427655|FG004|Overall Study|No end of study case report form|0
4583815|NCT01468701|7427656|FG005|Overall Study|No end of study case report form|0
4583816|NCT01468701|7427657|FG006|Overall Study|No end of study case report form|0
4583817|NCT01468701|7427658|FG007|Overall Study|No end of study case report form|0
4583818|NCT01468701|7427659|FG008|Overall Study|No end of study case report form|4
4583819|NCT01468701|7427660|FG009|Overall Study|No end of study case report form|1
4583820|NCT01468701|7427661|FG010|Overall Study|No end of study case report form|2
4583821|NCT01468701|7427662|FG011|Overall Study|No end of study case report form|3
4583822|NCT01468701|7427663|FG012|Overall Study|No end of study case report form|0
4583823|NCT01468701|7427664|FG013|Overall Study|No end of study case report form|1
4583824|NCT01468701|7427665|FG014|Overall Study|No end of study case report form|0
4583825|NCT01468701|7427666|FG015|Overall Study|No end of study case report form|0
4583826|NCT01468701|7427667|FG016|Overall Study|No end of study case report form|0
4583827|NCT01468701|7427651|FG000|Overall Study|Not being followed up|0
4583828|NCT01468701|7427652|FG001|Overall Study|Not being followed up|4963
4583829|NCT01468701|7427653|FG002|Overall Study|Not being followed up|1755
4583830|NCT01468701|7427654|FG003|Overall Study|Not being followed up|703
4583831|NCT01468701|7427655|FG004|Overall Study|Not being followed up|1714
4583832|NCT01468701|7427656|FG005|Overall Study|Not being followed up|126
4583833|NCT01468701|7427657|FG006|Overall Study|Not being followed up|1170
4583834|NCT01468701|7427658|FG007|Overall Study|Not being followed up|4
4583835|NCT01468701|7427659|FG008|Overall Study|Not being followed up|0
4583836|NCT01468701|7427660|FG009|Overall Study|Not being followed up|0
4583837|NCT01468701|7427661|FG010|Overall Study|Not being followed up|0
4583838|NCT01468701|7427662|FG011|Overall Study|Not being followed up|0
4583839|NCT01468701|7427663|FG012|Overall Study|Not being followed up|0
4583840|NCT01468701|7427664|FG013|Overall Study|Not being followed up|0
4583841|NCT01468701|7427665|FG014|Overall Study|Not being followed up|0
4583842|NCT01468701|7427666|FG015|Overall Study|Not being followed up|0
4583843|NCT01468701|7427667|FG016|Overall Study|Not being followed up|0
4583844|NCT01468818|7427680|FG000|Overall Study|Death during treatment|2
4583845|NCT01468844|7427686|FG000|Overall Study|Adverse Event|1
4583846|NCT01468844|7427687|FG001|Overall Study|Adverse Event|0
4583847|NCT01468844|7427686|FG000|Overall Study|Withdrawal by Subject|1
4583848|NCT01468844|7427687|FG001|Overall Study|Withdrawal by Subject|0
4583849|NCT01468909|7427698|FG000|Overall Study|Never Treated|2
4583850|NCT01468909|7427699|FG001|Overall Study|Never Treated|2
4583851|NCT01468987|7427711|FG000|Overall Study|Adverse Event|12
4583852|NCT01468987|7427712|FG001|Overall Study|Adverse Event|9
4583853|NCT01468987|7427711|FG000|Overall Study|Death|4
4583854|NCT01468987|7427712|FG001|Overall Study|Death|1
4583855|NCT01468987|7427711|FG000|Overall Study|Lost to Follow-up|10
4583856|NCT01468987|7427712|FG001|Overall Study|Lost to Follow-up|5
4583857|NCT01468987|7427711|FG000|Overall Study|Protocol Violation|8
4583858|NCT01468987|7427712|FG001|Overall Study|Protocol Violation|2
4583859|NCT01468987|7427711|FG000|Overall Study|Withdrawal by Subject|28
4583860|NCT01468987|7427712|FG001|Overall Study|Withdrawal by Subject|28
4583861|NCT01468987|7427711|FG000|Overall Study|Physician Decision|8
4583862|NCT01468987|7427712|FG001|Overall Study|Physician Decision|15
4583863|NCT01468987|7427711|FG000|Overall Study|Sponsor Decision|1
4583864|NCT01468987|7427712|FG001|Overall Study|Sponsor Decision|0
4583865|NCT01469000|7427722|FG000|Overall Study|Withdrawal by Subject|16
4583866|NCT01469000|7427723|FG001|Overall Study|Withdrawal by Subject|3
4583867|NCT01469000|7427722|FG000|Overall Study|Sponsor Decision|4
4583868|NCT01469000|7427723|FG001|Overall Study|Sponsor Decision|1
4583869|NCT01469013|7427734|FG000|Part A (Treatment Period)|Adverse Event|1
4583870|NCT01469013|7427735|FG001|Part A (Treatment Period)|Adverse Event|0
4583871|NCT01469013|7427736|FG002|Part A (Treatment Period)|Adverse Event|0
4583872|NCT01469013|7427737|FG003|Part A (Treatment Period)|Adverse Event|0
4583873|NCT01469013|7427738|FG004|Part A (Treatment Period)|Adverse Event|1
4583874|NCT01469013|7427739|FG005|Part A (Treatment Period)|Adverse Event|0
4583875|NCT01469013|7427740|FG006|Part A (Treatment Period)|Adverse Event|0
4583876|NCT01469013|7427741|FG007|Part A (Treatment Period)|Adverse Event|0
4583877|NCT01469013|7427742|FG008|Part A (Treatment Period)|Adverse Event|0
4583878|NCT01469013|7427743|FG009|Part A (Treatment Period)|Adverse Event|0
4583879|NCT01469013|7427744|FG010|Part A (Treatment Period)|Adverse Event|0
4583880|NCT01469013|7427745|FG011|Part A (Treatment Period)|Adverse Event|0
4583881|NCT01469013|7427746|FG012|Part A (Treatment Period)|Adverse Event|0
4583882|NCT01469013|7427734|FG000|Part A (Treatment Period)|Withdrawal by Subject|0
4583883|NCT01469013|7427735|FG001|Part A (Treatment Period)|Withdrawal by Subject|0
4583884|NCT01469013|7427736|FG002|Part A (Treatment Period)|Withdrawal by Subject|1
4583885|NCT01469013|7427737|FG003|Part A (Treatment Period)|Withdrawal by Subject|0
4583886|NCT01469013|7427738|FG004|Part A (Treatment Period)|Withdrawal by Subject|0
4583887|NCT01469013|7427739|FG005|Part A (Treatment Period)|Withdrawal by Subject|0
4583888|NCT01469013|7427740|FG006|Part A (Treatment Period)|Withdrawal by Subject|0
4583889|NCT01469013|7427741|FG007|Part A (Treatment Period)|Withdrawal by Subject|0
4583890|NCT01469013|7427742|FG008|Part A (Treatment Period)|Withdrawal by Subject|0
4583891|NCT01469013|7427743|FG009|Part A (Treatment Period)|Withdrawal by Subject|0
4583892|NCT01469013|7427744|FG010|Part A (Treatment Period)|Withdrawal by Subject|0
4583893|NCT01469013|7427745|FG011|Part A (Treatment Period)|Withdrawal by Subject|0
4583894|NCT01469013|7427746|FG012|Part A (Treatment Period)|Withdrawal by Subject|0
4583895|NCT01469013|7427734|FG000|Part B (Extension Period)|Adverse Event|0
4583896|NCT01469013|7427735|FG001|Part B (Extension Period)|Adverse Event|0
4583897|NCT01469013|7427736|FG002|Part B (Extension Period)|Adverse Event|0
4583898|NCT01469013|7427737|FG003|Part B (Extension Period)|Adverse Event|0
4583899|NCT01469013|7427738|FG004|Part B (Extension Period)|Adverse Event|0
4583900|NCT01469013|7427739|FG005|Part B (Extension Period)|Adverse Event|2
4583901|NCT01469013|7427740|FG006|Part B (Extension Period)|Adverse Event|5
4583902|NCT01469013|7427741|FG007|Part B (Extension Period)|Adverse Event|5
4583903|NCT01469013|7427742|FG008|Part B (Extension Period)|Adverse Event|3
4693108|NCT02589665|7604002|FG005|Induction Period|Did not receive drug|0
4693109|NCT02589665|7604003|FG006|Induction Period|Did not receive drug|0
4693110|NCT02589665|7604004|FG007|Induction Period|Did not receive drug|0
4693111|NCT02589665|7604005|FG008|Induction Period|Did not receive drug|0
4583904|NCT01469013|7427743|FG009|Part B (Extension Period)|Adverse Event|3
4693112|NCT02589665|7604006|FG009|Induction Period|Did not receive drug|0
4693113|NCT02589665|7603997|FG000|Induction Period|Adverse Event|3
4583905|NCT01469013|7427744|FG010|Part B (Extension Period)|Adverse Event|1
4583906|NCT01469013|7427745|FG011|Part B (Extension Period)|Adverse Event|6
4583907|NCT01469013|7427746|FG012|Part B (Extension Period)|Adverse Event|3
4583908|NCT01469013|7427734|FG000|Part B (Extension Period)|Withdrawal by Subject|0
4583909|NCT01469013|7427735|FG001|Part B (Extension Period)|Withdrawal by Subject|0
4583910|NCT01469013|7427736|FG002|Part B (Extension Period)|Withdrawal by Subject|0
4583911|NCT01469013|7427737|FG003|Part B (Extension Period)|Withdrawal by Subject|0
4583912|NCT01469013|7427738|FG004|Part B (Extension Period)|Withdrawal by Subject|0
4583913|NCT01469013|7427739|FG005|Part B (Extension Period)|Withdrawal by Subject|0
4583914|NCT01469013|7427740|FG006|Part B (Extension Period)|Withdrawal by Subject|0
4583915|NCT01469013|7427741|FG007|Part B (Extension Period)|Withdrawal by Subject|0
4583916|NCT01469013|7427742|FG008|Part B (Extension Period)|Withdrawal by Subject|1
4583917|NCT01469013|7427743|FG009|Part B (Extension Period)|Withdrawal by Subject|0
4583918|NCT01469013|7427744|FG010|Part B (Extension Period)|Withdrawal by Subject|1
4583919|NCT01469013|7427745|FG011|Part B (Extension Period)|Withdrawal by Subject|0
4583920|NCT01469013|7427746|FG012|Part B (Extension Period)|Withdrawal by Subject|3
4583921|NCT01469052|7427792|FG000|Overall Study|Adverse Event|2
4583922|NCT01469052|7427793|FG001|Overall Study|Adverse Event|3
4583923|NCT01469052|7427794|FG002|Overall Study|Adverse Event|0
4583924|NCT01469052|7427795|FG003|Overall Study|Adverse Event|2
4583925|NCT01469052|7427796|FG004|Overall Study|Adverse Event|0
4583926|NCT01469052|7427797|FG005|Overall Study|Adverse Event|1
4583927|NCT01469052|7427792|FG000|Overall Study|Progressive disease|3
4583928|NCT01469052|7427793|FG001|Overall Study|Progressive disease|0
4583929|NCT01469052|7427794|FG002|Overall Study|Progressive disease|5
4583930|NCT01469052|7427795|FG003|Overall Study|Progressive disease|3
4583931|NCT01469052|7427796|FG004|Overall Study|Progressive disease|7
4583932|NCT01469052|7427797|FG005|Overall Study|Progressive disease|2
4583933|NCT01469052|7427792|FG000|Overall Study|Lack of Efficacy|0
4583934|NCT01469052|7427793|FG001|Overall Study|Lack of Efficacy|0
4583935|NCT01469052|7427794|FG002|Overall Study|Lack of Efficacy|0
4583936|NCT01469052|7427795|FG003|Overall Study|Lack of Efficacy|0
4583937|NCT01469052|7427796|FG004|Overall Study|Lack of Efficacy|0
4583938|NCT01469052|7427797|FG005|Overall Study|Lack of Efficacy|2
4583939|NCT01469052|7427792|FG000|Overall Study|Moved to rollover protocol|1
4583940|NCT01469052|7427793|FG001|Overall Study|Moved to rollover protocol|0
4583941|NCT01469052|7427794|FG002|Overall Study|Moved to rollover protocol|1
4583942|NCT01469052|7427795|FG003|Overall Study|Moved to rollover protocol|0
4583943|NCT01469052|7427796|FG004|Overall Study|Moved to rollover protocol|0
4583944|NCT01469052|7427797|FG005|Overall Study|Moved to rollover protocol|1
4583945|NCT01469052|7427792|FG000|Overall Study|Other|0
4583946|NCT01469052|7427793|FG001|Overall Study|Other|1
4583947|NCT01469052|7427794|FG002|Overall Study|Other|0
4583948|NCT01469052|7427795|FG003|Overall Study|Other|0
4693114|NCT02589665|7603998|FG001|Induction Period|Adverse Event|0
4693115|NCT02589665|7603999|FG002|Induction Period|Adverse Event|2
4693116|NCT02589665|7604000|FG003|Induction Period|Adverse Event|2
4693117|NCT02589665|7604001|FG004|Induction Period|Adverse Event|0
4583949|NCT01469052|7427796|FG004|Overall Study|Other|1
4583950|NCT01469052|7427797|FG005|Overall Study|Other|0
4583951|NCT01469065|7427814|FG000|Overall Study|Lack of Efficacy|0
4583952|NCT01469065|7427815|FG001|Overall Study|Lack of Efficacy|0
4583953|NCT01469065|7427816|FG002|Overall Study|Lack of Efficacy|0
4583954|NCT01469065|7427817|FG003|Overall Study|Lack of Efficacy|0
4583955|NCT01469065|7427818|FG004|Overall Study|Lack of Efficacy|1
4583956|NCT01469065|7427814|FG000|Overall Study|Other|0
4583957|NCT01469065|7427815|FG001|Overall Study|Other|1
4583958|NCT01469065|7427816|FG002|Overall Study|Other|0
4583959|NCT01469065|7427817|FG003|Overall Study|Other|0
4583960|NCT01469065|7427818|FG004|Overall Study|Other|0
4583961|NCT01469182|7427836|FG000|Overall Study|Adverse Event|21
4583962|NCT01469182|7427837|FG001|Overall Study|Adverse Event|3
4583963|NCT01469182|7427836|FG000|Overall Study|Lost to Follow-up|3
4583964|NCT01469182|7427837|FG001|Overall Study|Lost to Follow-up|0
4583965|NCT01469182|7427836|FG000|Overall Study|Withdrawal by Subject|4
4583966|NCT01469182|7427837|FG001|Overall Study|Withdrawal by Subject|1
4583967|NCT01469182|7427836|FG000|Overall Study|Protocol Violation|4
4583968|NCT01469182|7427837|FG001|Overall Study|Protocol Violation|2
4583969|NCT01469182|7427836|FG000|Overall Study|Did not meet Protocol Eligibility|3
4583970|NCT01469182|7427837|FG001|Overall Study|Did not meet Protocol Eligibility|0
4583971|NCT01469221|7427845|FG000|Double Blind Phase|Protocol Violation|1
4583972|NCT01469221|7427846|FG001|Double Blind Phase|Protocol Violation|0
4583973|NCT01469221|7427847|FG002|Double Blind Phase|Protocol Violation|0
4583974|NCT01469221|7427845|FG000|Double Blind Phase|Physician Decision|1
4583975|NCT01469221|7427846|FG001|Double Blind Phase|Physician Decision|1
4583976|NCT01469221|7427847|FG002|Double Blind Phase|Physician Decision|0
4583977|NCT01469221|7427845|FG000|Double Blind Phase|Sponsor Terminate Study|12
4583978|NCT01469221|7427846|FG001|Double Blind Phase|Sponsor Terminate Study|16
4583979|NCT01469221|7427847|FG002|Double Blind Phase|Sponsor Terminate Study|0
4583980|NCT01469364|7427867|FG000|Overall Study|Adverse Event|1
4583981|NCT01469364|7427867|FG000|Overall Study|Withdrawal by Subject|1
4583982|NCT01469377|7427874|FG000|Overall Study|Protocol Deviation|7
4583983|NCT01469377|7427875|FG001|Overall Study|Protocol Deviation|10
4583984|NCT01469377|7427876|FG002|Overall Study|Protocol Deviation|10
4583985|NCT01469377|7427874|FG000|Overall Study|Lost to Follow-up|3
4583986|NCT01469377|7427875|FG001|Overall Study|Lost to Follow-up|2
4583987|NCT01469377|7427876|FG002|Overall Study|Lost to Follow-up|5
4583988|NCT01469377|7427874|FG000|Overall Study|Withdrawal of Consent|12
4583989|NCT01469377|7427875|FG001|Overall Study|Withdrawal of Consent|14
4583990|NCT01469377|7427876|FG002|Overall Study|Withdrawal of Consent|15
4583991|NCT01469377|7427874|FG000|Overall Study|Adverse Event|8
4583992|NCT01469377|7427875|FG001|Overall Study|Adverse Event|18
4583993|NCT01469377|7427876|FG002|Overall Study|Adverse Event|36
4583994|NCT01469377|7427874|FG000|Overall Study|Insufficient Therapeutic Response|3
4583995|NCT01469377|7427875|FG001|Overall Study|Insufficient Therapeutic Response|4
4583996|NCT01469377|7427876|FG002|Overall Study|Insufficient Therapeutic Response|0
4583997|NCT01469377|7427874|FG000|Overall Study|Other Miscellaneous Reasons|2
4583998|NCT01469377|7427875|FG001|Overall Study|Other Miscellaneous Reasons|0
4583999|NCT01469377|7427876|FG002|Overall Study|Other Miscellaneous Reasons|0
4584000|NCT01469546|7427884|FG000|Received 5 mg Dose|Adverse Event|13
4584001|NCT01469546|7427884|FG000|Received 5 mg Dose|Death|2
4584002|NCT01469546|7427884|FG000|Received 5 mg Dose|Protocol Violation|2
4584003|NCT01469546|7427884|FG000|Received 5 mg Dose|Progressive Disease|3
4584004|NCT01469546|7427884|FG000|Received 5 mg Dose|Physician Decision|3
4584005|NCT01469637|7427901|FG000|First Intervention|Unacceptable behavior|0
4584006|NCT01469637|7427902|FG001|First Intervention|Unacceptable behavior|1
4584007|NCT01469637|7427901|FG000|Second Intervention|Incarcerated|1
4584008|NCT01469637|7427902|FG001|Second Intervention|Incarcerated|0
4584009|NCT01469819|7427916|FG000|Overall Study|Withdrawal by Subject|1
4584010|NCT01469819|7427916|FG000|Overall Study|Did not meet inclusionary criteria|2
4584011|NCT01469819|7427916|FG000|Overall Study|Could not swallow SmartPill|2
4584012|NCT01469819|7427916|FG000|Overall Study|Technical malfunction of SmartPill data|3
4584013|NCT01470001|7427928|FG000|Overall Study|Lost to Follow-up|1
4584014|NCT01470001|7427929|FG001|Overall Study|Lost to Follow-up|1
4584015|NCT01470001|7427928|FG000|Overall Study|Physician Decision|2
4584016|NCT01470001|7427929|FG001|Overall Study|Physician Decision|0
4584017|NCT01470001|7427928|FG000|Overall Study|Withdrawal by Subject|2
4584018|NCT01470001|7427929|FG001|Overall Study|Withdrawal by Subject|1
4584019|NCT01470144|7427970|FG000|Overall Study|Adverse Event|2
4584020|NCT01470144|7427970|FG000|Overall Study|Death|1
4584021|NCT01470144|7427970|FG000|Overall Study|Lung transplant|6
4584022|NCT01470144|7427970|FG000|Overall Study|Patient's and investigator's decision|1
4584023|NCT01470248|7427999|FG000|Overall Study|Withdrawal by Subject|1
4584024|NCT01470417|7428005|FG000|Overall Study|Disease progression|0
4584025|NCT01470417|7428006|FG001|Overall Study|Disease progression|2
4584026|NCT01470469|7428014|FG000|Overall Study|Withdrawal by Subject|4
4584027|NCT01470469|7428015|FG001|Overall Study|Withdrawal by Subject|6
4584028|NCT01470469|7428014|FG000|Overall Study|Lack of Efficacy|1
4584029|NCT01470469|7428015|FG001|Overall Study|Lack of Efficacy|7
4584030|NCT01470469|7428014|FG000|Overall Study|Adverse Event|0
4584031|NCT01470469|7428015|FG001|Overall Study|Adverse Event|7
4584032|NCT01470469|7428014|FG000|Overall Study|Lost to Follow-up|2
4584033|NCT01470469|7428015|FG001|Overall Study|Lost to Follow-up|2
4584034|NCT01470469|7428014|FG000|Overall Study|Protocol Violation|1
4584035|NCT01470469|7428015|FG001|Overall Study|Protocol Violation|1
4584036|NCT01470469|7428014|FG000|Overall Study|Other|2
4584037|NCT01470469|7428015|FG001|Overall Study|Other|1
4584038|NCT01470599|7428023|FG000|Overall Study|Did not meet entrance criteria|1
4584039|NCT01470599|7428024|FG001|Overall Study|Did not meet entrance criteria|0
4584040|NCT01470599|7428023|FG000|Overall Study|Lost to Follow-up|2
4584041|NCT01470599|7428024|FG001|Overall Study|Lost to Follow-up|1
4584042|NCT01470599|7428023|FG000|Overall Study|Withdrawal by Subject|3
4584043|NCT01470599|7428024|FG001|Overall Study|Withdrawal by Subject|4
4584044|NCT01470599|7428023|FG000|Overall Study|Other|1
4584045|NCT01470599|7428024|FG001|Overall Study|Other|0
4584046|NCT01470599|7428023|FG000|Overall Study|Protocol Violation|3
4584047|NCT01470599|7428024|FG001|Overall Study|Protocol Violation|1
4584048|NCT01470599|7428023|FG000|Overall Study|Adverse event related to study drug|2
4584049|NCT01470599|7428024|FG001|Overall Study|Adverse event related to study drug|5
4584050|NCT01470599|7428023|FG000|Overall Study|Insufficient clinical response|6
4584051|NCT01470599|7428024|FG001|Overall Study|Insufficient clinical response|27
4584052|NCT01470599|7428023|FG000|Overall Study|Adverse event not related to study drug|1
4584053|NCT01470599|7428024|FG001|Overall Study|Adverse event not related to study drug|5
4584054|NCT01470612|7428032|FG000|Overall Study|Adverse Event|20
4584055|NCT01470612|7428033|FG001|Overall Study|Adverse Event|80
4584056|NCT01470612|7428032|FG000|Overall Study|Death|0
4584057|NCT01470612|7428033|FG001|Overall Study|Death|1
4584058|NCT01470612|7428032|FG000|Overall Study|Lack of Efficacy|20
4584059|NCT01470612|7428033|FG001|Overall Study|Lack of Efficacy|326
4584060|NCT01470612|7428032|FG000|Overall Study|Lost to Follow-up|2
4584061|NCT01470612|7428033|FG001|Overall Study|Lost to Follow-up|5
4584062|NCT01470612|7428032|FG000|Overall Study|Did not meet entrance criteria|0
4584063|NCT01470612|7428033|FG001|Overall Study|Did not meet entrance criteria|1
4584064|NCT01470612|7428032|FG000|Overall Study|Pregnancy|2
4584065|NCT01470612|7428033|FG001|Overall Study|Pregnancy|10
4584066|NCT01470612|7428032|FG000|Overall Study|Protocol Violation|2
4584067|NCT01470612|7428033|FG001|Overall Study|Protocol Violation|7
4584068|NCT01470612|7428032|FG000|Overall Study|Withdrawal by Subject|24
4584069|NCT01470612|7428033|FG001|Overall Study|Withdrawal by Subject|79
4584070|NCT01470612|7428032|FG000|Overall Study|Other|14
4584071|NCT01470612|7428033|FG001|Overall Study|Other|156
4584072|NCT01470989|7428069|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103
4584073|NCT01470989|7428070|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136
4584074|NCT01470989|7428069|FG000|Overall Study|Adverse Event|2
4584075|NCT01470989|7428070|FG001|Overall Study|Adverse Event|5
4584076|NCT01470989|7428069|FG000|Overall Study|Abnormal laboratory value|1
4584077|NCT01470989|7428070|FG001|Overall Study|Abnormal laboratory value|1
4584078|NCT01470989|7428069|FG000|Overall Study|Unsatisfactory therapeutic effect|0
4584079|NCT01470989|7428070|FG001|Overall Study|Unsatisfactory therapeutic effect|6
4584080|NCT01470989|7428069|FG000|Overall Study|Withdrawal by Subject|19
4584081|NCT01470989|7428070|FG001|Overall Study|Withdrawal by Subject|17
4584082|NCT01470989|7428069|FG000|Overall Study|Lost to Follow-up|18
4584083|NCT01470989|7428070|FG001|Overall Study|Lost to Follow-up|13
4584084|NCT01470989|7428069|FG000|Overall Study|Administrative problems|2
4584085|NCT01470989|7428070|FG001|Overall Study|Administrative problems|4
4584086|NCT01470989|7428069|FG000|Overall Study|Death|2
4584087|NCT01470989|7428070|FG001|Overall Study|Death|2
4584088|NCT01470989|7428069|FG000|Overall Study|Protocol deviation|1
4584089|NCT01470989|7428070|FG001|Overall Study|Protocol deviation|2
4584090|NCT01471015|7428081|FG000|Overall Study|Death|0
4584091|NCT01471015|7428082|FG001|Overall Study|Death|1
4584092|NCT01471015|7428083|FG002|Overall Study|Death|1
4584093|NCT01471028|7428093|FG000|VTI-208|Adverse Event|39
4584094|NCT01471028|7428094|FG001|VTI-208|Adverse Event|41
4584095|NCT01471028|7428093|FG000|VTI-208|Withdrawal by Subject|0
4584096|NCT01471028|7428094|FG001|VTI-208|Withdrawal by Subject|2
4584097|NCT01471028|7428093|FG000|VTI-208|Lost to Follow-up|1
4584098|NCT01471028|7428094|FG001|VTI-208|Lost to Follow-up|1
4584099|NCT01471028|7428093|FG000|VTI-208E|Death|7
4584100|NCT01471028|7428094|FG001|VTI-208E|Death|10
4584101|NCT01471028|7428093|FG000|VTI-208E|Withdrawal by Subject|1
4584102|NCT01471028|7428094|FG001|VTI-208E|Withdrawal by Subject|0
4584103|NCT01471028|7428093|FG000|VTI-208E|Lost to Follow-up|0
4584104|NCT01471028|7428094|FG001|VTI-208E|Lost to Follow-up|2
4584105|NCT01471054|7428109|FG000|Overall Study|Study terminated prematurely|4
4584106|NCT01471054|7428110|FG001|Overall Study|Study terminated prematurely|0
4584107|NCT01471093|7428128|FG000|Overall Study|Adverse Event|1
4584108|NCT01471093|7428129|FG001|Overall Study|Adverse Event|0
4584109|NCT01471093|7428130|FG002|Overall Study|Adverse Event|0
4584110|NCT01471093|7428131|FG003|Overall Study|Adverse Event|0
4584111|NCT01471171|7428137|FG000|Treatment Period 1|Adverse Event|4
4584112|NCT01471171|7428138|FG001|Treatment Period 1|Adverse Event|1
4584113|NCT01471171|7428137|FG000|Treatment Period 2|Adverse Event|1
4584114|NCT01471171|7428138|FG001|Treatment Period 2|Adverse Event|0
4584115|NCT01471197|7428146|FG000|Overall Study|Disease Progression|4
4584116|NCT01471197|7428147|FG001|Overall Study|Disease Progression|2
4693118|NCT02589665|7604002|FG005|Induction Period|Adverse Event|0
4693119|NCT02589665|7604003|FG006|Induction Period|Adverse Event|0
4693120|NCT02589665|7604004|FG007|Induction Period|Adverse Event|0
4693121|NCT02589665|7604005|FG008|Induction Period|Adverse Event|0
4693122|NCT02589665|7604006|FG009|Induction Period|Adverse Event|0
4693123|NCT02589665|7603997|FG000|Induction Period|Withdrawal by Subject|0
4693124|NCT02589665|7603998|FG001|Induction Period|Withdrawal by Subject|1
4693125|NCT02589665|7603999|FG002|Induction Period|Withdrawal by Subject|0
4693126|NCT02589665|7604000|FG003|Induction Period|Withdrawal by Subject|1
4693127|NCT02589665|7604001|FG004|Induction Period|Withdrawal by Subject|0
4693128|NCT02589665|7604002|FG005|Induction Period|Withdrawal by Subject|0
4693129|NCT02589665|7604003|FG006|Induction Period|Withdrawal by Subject|0
4693130|NCT02589665|7604004|FG007|Induction Period|Withdrawal by Subject|0
4693131|NCT02589665|7604005|FG008|Induction Period|Withdrawal by Subject|0
4693132|NCT02589665|7604006|FG009|Induction Period|Withdrawal by Subject|0
4693133|NCT02589665|7603997|FG000|Induction Period|Protocol Violation|0
4693134|NCT02589665|7603998|FG001|Induction Period|Protocol Violation|1
4693135|NCT02589665|7603999|FG002|Induction Period|Protocol Violation|0
4693136|NCT02589665|7604000|FG003|Induction Period|Protocol Violation|0
4693137|NCT02589665|7604001|FG004|Induction Period|Protocol Violation|0
4693138|NCT02589665|7604002|FG005|Induction Period|Protocol Violation|0
4693139|NCT02589665|7604003|FG006|Induction Period|Protocol Violation|0
4693140|NCT02589665|7604004|FG007|Induction Period|Protocol Violation|0
4693141|NCT02589665|7604005|FG008|Induction Period|Protocol Violation|0
4693142|NCT02589665|7604006|FG009|Induction Period|Protocol Violation|0
4693143|NCT02589665|7603997|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
4693144|NCT02589665|7603998|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
4693145|NCT02589665|7603999|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
4584117|NCT01471197|7428146|FG000|Overall Study|Death|1
4584118|NCT01471197|7428147|FG001|Overall Study|Death|0
4584119|NCT01471197|7428146|FG000|Overall Study|Study Drug Toxicity|1
4584120|NCT01471197|7428147|FG001|Overall Study|Study Drug Toxicity|0
4584121|NCT01471353|7428153|FG000|Overall Study|remain on study|3
4693146|NCT02589665|7604000|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
4693147|NCT02589665|7604001|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7
4693148|NCT02589665|7604002|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41
4584122|NCT01471379|7428160|FG000|Overall Study|Adverse Event|1
4584123|NCT01471379|7428161|FG001|Overall Study|Adverse Event|0
4584124|NCT01471379|7428162|FG002|Overall Study|Adverse Event|0
4584125|NCT01471379|7428160|FG000|Overall Study|Study terminated|0
4584126|NCT01471379|7428161|FG001|Overall Study|Study terminated|1
4584127|NCT01471379|7428162|FG002|Overall Study|Study terminated|0
4584128|NCT01471522|7428182|FG000|Overall Study|Withdrawal by Subject|28
4584129|NCT01471522|7428183|FG001|Overall Study|Withdrawal by Subject|22
4584130|NCT01471522|7428182|FG000|Overall Study|Lost to Follow-up|36
4584131|NCT01471522|7428183|FG001|Overall Study|Lost to Follow-up|26
4584132|NCT01471574|7428194|FG000|Treatment Period|Lack of Efficacy|12
4584133|NCT01471574|7428195|FG001|Treatment Period|Lack of Efficacy|4
4584134|NCT01471574|7428196|FG002|Treatment Period|Lack of Efficacy|14
4584135|NCT01471574|7428197|FG003|Treatment Period|Lack of Efficacy|1
4584136|NCT01471574|7428194|FG000|Treatment Period|Adverse Event|7
4584137|NCT01471574|7428195|FG001|Treatment Period|Adverse Event|3
4584138|NCT01471574|7428196|FG002|Treatment Period|Adverse Event|6
4584139|NCT01471574|7428197|FG003|Treatment Period|Adverse Event|1
4584140|NCT01471574|7428194|FG000|Treatment Period|Withdrawal by Subject|5
4584141|NCT01471574|7428195|FG001|Treatment Period|Withdrawal by Subject|1
4584142|NCT01471574|7428196|FG002|Treatment Period|Withdrawal by Subject|1
4584143|NCT01471574|7428197|FG003|Treatment Period|Withdrawal by Subject|0
4584144|NCT01471574|7428194|FG000|Treatment Period|Patient Requested Discontinue Study drug|4
4584145|NCT01471574|7428195|FG001|Treatment Period|Patient Requested Discontinue Study drug|0
4584146|NCT01471574|7428196|FG002|Treatment Period|Patient Requested Discontinue Study drug|1
4584147|NCT01471574|7428197|FG003|Treatment Period|Patient Requested Discontinue Study drug|1
4584148|NCT01471574|7428194|FG000|Treatment Period|Lost to Follow-up|1
4584149|NCT01471574|7428195|FG001|Treatment Period|Lost to Follow-up|2
4584150|NCT01471574|7428196|FG002|Treatment Period|Lost to Follow-up|2
4584151|NCT01471574|7428197|FG003|Treatment Period|Lost to Follow-up|0
4584152|NCT01471574|7428194|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1
4584153|NCT01471574|7428195|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0
4584154|NCT01471574|7428196|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0
4584155|NCT01471574|7428197|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0
4584156|NCT01471574|7428194|FG000|Treatment Period|Other|1
4584157|NCT01471574|7428195|FG001|Treatment Period|Other|0
4584158|NCT01471574|7428196|FG002|Treatment Period|Other|0
4584159|NCT01471574|7428197|FG003|Treatment Period|Other|0
4584160|NCT01471574|7428194|FG000|Follow-up Period|Withdrawal by Subject|3
4584161|NCT01471574|7428195|FG001|Follow-up Period|Withdrawal by Subject|0
4584162|NCT01471574|7428196|FG002|Follow-up Period|Withdrawal by Subject|3
4584163|NCT01471574|7428197|FG003|Follow-up Period|Withdrawal by Subject|1
4584164|NCT01471574|7428194|FG000|Follow-up Period|Lost to Follow-up|4
4584165|NCT01471574|7428195|FG001|Follow-up Period|Lost to Follow-up|1
4584166|NCT01471574|7428196|FG002|Follow-up Period|Lost to Follow-up|3
4584167|NCT01471574|7428197|FG003|Follow-up Period|Lost to Follow-up|2
4584168|NCT01471574|7428194|FG000|Follow-up Period|Death|0
4584169|NCT01471574|7428195|FG001|Follow-up Period|Death|0
4584170|NCT01471574|7428196|FG002|Follow-up Period|Death|1
4584171|NCT01471574|7428197|FG003|Follow-up Period|Death|0
4584172|NCT01471574|7428194|FG000|Follow-up Period|Follow-up no longer required|0
4584173|NCT01471574|7428195|FG001|Follow-up Period|Follow-up no longer required|1
4584174|NCT01471574|7428196|FG002|Follow-up Period|Follow-up no longer required|0
4584175|NCT01471574|7428197|FG003|Follow-up Period|Follow-up no longer required|0
4584176|NCT01471691|7428223|FG000|Overall Study|Lack of Efficacy|0
4584177|NCT01471691|7428224|FG001|Overall Study|Lack of Efficacy|1
4584178|NCT01471782|7428236|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2
4584179|NCT01471782|7428237|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2
4584180|NCT01471782|7428238|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1
4584181|NCT01471782|7428239|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0
4693149|NCT02589665|7604003|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39
4693150|NCT02589665|7604004|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
4584182|NCT01471782|7428240|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5
4584183|NCT01471782|7428241|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3
4584184|NCT01471782|7428236|FG000|Overall Study|Lack of Efficacy|1
4584185|NCT01471782|7428237|FG001|Overall Study|Lack of Efficacy|2
4584186|NCT01471782|7428238|FG002|Overall Study|Lack of Efficacy|1
4584187|NCT01471782|7428239|FG003|Overall Study|Lack of Efficacy|1
4584188|NCT01471782|7428240|FG004|Overall Study|Lack of Efficacy|5
4734977|NCT03515824|7682516|FG000|Overall Study|Study terminated by sponsor|0
4584189|NCT01471782|7428241|FG005|Overall Study|Lack of Efficacy|18
4584190|NCT01471782|7428236|FG000|Overall Study|Adverse Event|1
4584191|NCT01471782|7428237|FG001|Overall Study|Adverse Event|1
4584192|NCT01471782|7428238|FG002|Overall Study|Adverse Event|2
4584193|NCT01471782|7428239|FG003|Overall Study|Adverse Event|2
4584194|NCT01471782|7428240|FG004|Overall Study|Adverse Event|3
4584195|NCT01471782|7428241|FG005|Overall Study|Adverse Event|1
4584196|NCT01471782|7428236|FG000|Overall Study|Other|0
4584197|NCT01471782|7428237|FG001|Overall Study|Other|0
4584198|NCT01471782|7428238|FG002|Overall Study|Other|1
4584199|NCT01471782|7428239|FG003|Overall Study|Other|1
4584200|NCT01471782|7428240|FG004|Overall Study|Other|6
4584201|NCT01471782|7428241|FG005|Overall Study|Other|5
4584202|NCT01471782|7428236|FG000|Overall Study|Change of Chemotherapy|1
4584203|NCT01471782|7428237|FG001|Overall Study|Change of Chemotherapy|1
4584204|NCT01471782|7428238|FG002|Overall Study|Change of Chemotherapy|0
4584205|NCT01471782|7428239|FG003|Overall Study|Change of Chemotherapy|0
4584206|NCT01471782|7428240|FG004|Overall Study|Change of Chemotherapy|1
4584207|NCT01471782|7428241|FG005|Overall Study|Change of Chemotherapy|4
4584208|NCT01471782|7428236|FG000|Overall Study|Disease Relapse|0
4584209|NCT01471782|7428237|FG001|Overall Study|Disease Relapse|0
4584210|NCT01471782|7428238|FG002|Overall Study|Disease Relapse|0
4584211|NCT01471782|7428239|FG003|Overall Study|Disease Relapse|1
4584212|NCT01471782|7428240|FG004|Overall Study|Disease Relapse|2
4584213|NCT01471782|7428241|FG005|Overall Study|Disease Relapse|1
4584214|NCT01471782|7428236|FG000|Overall Study|Physician Decision|0
4584215|NCT01471782|7428237|FG001|Overall Study|Physician Decision|0
4584216|NCT01471782|7428238|FG002|Overall Study|Physician Decision|0
4584217|NCT01471782|7428239|FG003|Overall Study|Physician Decision|0
4584218|NCT01471782|7428240|FG004|Overall Study|Physician Decision|3
4584219|NCT01471782|7428241|FG005|Overall Study|Physician Decision|8
4584220|NCT01471782|7428236|FG000|Overall Study|Withdrawal by Parent/Guardian|0
4584221|NCT01471782|7428237|FG001|Overall Study|Withdrawal by Parent/Guardian|0
4584222|NCT01471782|7428238|FG002|Overall Study|Withdrawal by Parent/Guardian|0
4584223|NCT01471782|7428239|FG003|Overall Study|Withdrawal by Parent/Guardian|0
4584224|NCT01471782|7428240|FG004|Overall Study|Withdrawal by Parent/Guardian|1
4584225|NCT01471782|7428241|FG005|Overall Study|Withdrawal by Parent/Guardian|0
4584226|NCT01471782|7428236|FG000|Overall Study|Death|0
4584227|NCT01471782|7428237|FG001|Overall Study|Death|0
4584228|NCT01471782|7428238|FG002|Overall Study|Death|0
4584229|NCT01471782|7428239|FG003|Overall Study|Death|0
4584230|NCT01471782|7428240|FG004|Overall Study|Death|0
4584231|NCT01471782|7428241|FG005|Overall Study|Death|1
4584232|NCT01472185|7428268|FG000|Overall Study|Randomized but Not Treated|0
4584233|NCT01472185|7428269|FG001|Overall Study|Randomized but Not Treated|1
4584234|NCT01472185|7428268|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3
4584235|NCT01472185|7428269|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10
4584236|NCT01472185|7428268|FG000|Overall Study|Hyperglycemia|5
4584237|NCT01472185|7428269|FG001|Overall Study|Hyperglycemia|2
4584238|NCT01472185|7428268|FG000|Overall Study|Investigator's Discretion|3
4584239|NCT01472185|7428269|FG001|Overall Study|Investigator's Discretion|1
4584240|NCT01472185|7428268|FG000|Overall Study|Lost to Follow-up|4
4584241|NCT01472185|7428269|FG001|Overall Study|Lost to Follow-up|1
4584242|NCT01472185|7428268|FG000|Overall Study|Protocol Violation|5
4584243|NCT01472185|7428269|FG001|Overall Study|Protocol Violation|1
4584244|NCT01472185|7428268|FG000|Overall Study|Subject Noncompliance|8
4584245|NCT01472185|7428269|FG001|Overall Study|Subject Noncompliance|15
4584246|NCT01472185|7428268|FG000|Overall Study|Subject Withdrew Consent|6
4584247|NCT01472185|7428269|FG001|Overall Study|Subject Withdrew Consent|3
4584248|NCT01472289|7428275|FG000|Overall Study|Death|2
4584249|NCT01472341|7428279|FG000|Overall Study|Started insulin therapy|55
4584250|NCT01472341|7428279|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92
4584251|NCT01472341|7428279|FG000|Overall Study|Withdrawal by Subject|39
4584252|NCT01472341|7428279|FG000|Overall Study|Lost to Follow-up|52
4584253|NCT01472341|7428279|FG000|Overall Study|Laboratory parameters unavailable|25
4584254|NCT01472341|7428279|FG000|Overall Study|Death|9
4584255|NCT01472380|7428283|FG000|Efavirenz Alone|Withdrawal by Subject|1
4584256|NCT01472380|7428283|FG000|1 Day Period Between Dosing|Protocol Violation|1
4584257|NCT01472757|7428334|FG000|Overall Study|Withdrawal by Subject|1
4584258|NCT01472757|7428335|FG001|Overall Study|Withdrawal by Subject|2
4584259|NCT01472757|7428336|FG002|Overall Study|Withdrawal by Subject|2
4584260|NCT01472757|7428337|FG003|Overall Study|Withdrawal by Subject|0
4584261|NCT01472757|7428334|FG000|Overall Study|Asthma exacerbation|4
4584262|NCT01472757|7428335|FG001|Overall Study|Asthma exacerbation|1
4584263|NCT01472757|7428336|FG002|Overall Study|Asthma exacerbation|2
4584264|NCT01472757|7428337|FG003|Overall Study|Asthma exacerbation|1
4584265|NCT01472757|7428334|FG000|Overall Study|Treatment period withdrawal criteria met|21
4584266|NCT01472757|7428335|FG001|Overall Study|Treatment period withdrawal criteria met|8
4584267|NCT01472757|7428336|FG002|Overall Study|Treatment period withdrawal criteria met|9
4584268|NCT01472757|7428337|FG003|Overall Study|Treatment period withdrawal criteria met|12
4584269|NCT01472757|7428334|FG000|Overall Study|Protocol Violation|3
4584270|NCT01472757|7428335|FG001|Overall Study|Protocol Violation|2
4584271|NCT01472757|7428336|FG002|Overall Study|Protocol Violation|4
4584272|NCT01472757|7428337|FG003|Overall Study|Protocol Violation|4
4584273|NCT01472757|7428334|FG000|Overall Study|Other reasons|1
4584274|NCT01472757|7428335|FG001|Overall Study|Other reasons|0
4584275|NCT01472757|7428336|FG002|Overall Study|Other reasons|2
4584276|NCT01472757|7428337|FG003|Overall Study|Other reasons|2
4584277|NCT01472835|7428358|FG000|Overall Study|Lost to Follow-up|2
4584278|NCT01472835|7428359|FG001|Overall Study|Lost to Follow-up|0
4584279|NCT01472939|7428376|FG000|Overall Study|Adverse Event|3
4584280|NCT01472939|7428377|FG001|Overall Study|Adverse Event|7
4584281|NCT01472939|7428378|FG002|Overall Study|Adverse Event|7
4584282|NCT01472939|7428379|FG003|Overall Study|Adverse Event|14
4584283|NCT01472939|7428376|FG000|Overall Study|Lack of Efficacy|1
4584284|NCT01472939|7428377|FG001|Overall Study|Lack of Efficacy|0
4584285|NCT01472939|7428378|FG002|Overall Study|Lack of Efficacy|0
4584286|NCT01472939|7428379|FG003|Overall Study|Lack of Efficacy|1
4584287|NCT01472939|7428376|FG000|Overall Study|Lost to Follow-up|3
4584288|NCT01472939|7428377|FG001|Overall Study|Lost to Follow-up|0
4584289|NCT01472939|7428378|FG002|Overall Study|Lost to Follow-up|2
4584290|NCT01472939|7428379|FG003|Overall Study|Lost to Follow-up|0
4584291|NCT01472939|7428376|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0
4584292|NCT01472939|7428377|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0
4584293|NCT01472939|7428378|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1
4584294|NCT01472939|7428379|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0
4584295|NCT01472939|7428376|FG000|Overall Study|Prohibited Medication|0
4584296|NCT01472939|7428377|FG001|Overall Study|Prohibited Medication|1
4584297|NCT01472939|7428378|FG002|Overall Study|Prohibited Medication|0
4584298|NCT01472939|7428379|FG003|Overall Study|Prohibited Medication|0
4584299|NCT01472939|7428376|FG000|Overall Study|Withdrawal By PI|1
4584300|NCT01472939|7428377|FG001|Overall Study|Withdrawal By PI|0
4584301|NCT01472939|7428378|FG002|Overall Study|Withdrawal By PI|0
4584302|NCT01472939|7428379|FG003|Overall Study|Withdrawal By PI|0
4584303|NCT01472939|7428376|FG000|Overall Study|Protocol Violation|3
4584304|NCT01472939|7428377|FG001|Overall Study|Protocol Violation|3
4584305|NCT01472939|7428378|FG002|Overall Study|Protocol Violation|0
4584306|NCT01472939|7428379|FG003|Overall Study|Protocol Violation|1
4584307|NCT01472939|7428376|FG000|Overall Study|Withdrawal by Subject|9
4584308|NCT01472939|7428377|FG001|Overall Study|Withdrawal by Subject|3
4584309|NCT01472939|7428378|FG002|Overall Study|Withdrawal by Subject|1
4584310|NCT01472939|7428379|FG003|Overall Study|Withdrawal by Subject|4
4584311|NCT01472965|7428394|FG000|Overall Study|Withdrawal by Subject|1
4584312|NCT01472965|7428395|FG001|Overall Study|Withdrawal by Subject|0
4584313|NCT01473355|7428407|FG000|Overall Study|Protocol Violation|2
4584314|NCT01473355|7428407|FG000|Overall Study|Adverse Event|2
4584315|NCT01473355|7428407|FG000|Overall Study|Lost to Follow-up|2
4584316|NCT01473381|7428448|FG000|Overall Study|Adverse Event|8
4584317|NCT01473381|7428449|FG001|Overall Study|Adverse Event|20
4584318|NCT01473381|7428450|FG002|Overall Study|Adverse Event|25
4584319|NCT01473381|7428451|FG003|Overall Study|Adverse Event|17
4584320|NCT01473381|7428448|FG000|Overall Study|Insufficient Therapeutic Response|10
4584321|NCT01473381|7428449|FG001|Overall Study|Insufficient Therapeutic Response|1
4584322|NCT01473381|7428450|FG002|Overall Study|Insufficient Therapeutic Response|2
4584323|NCT01473381|7428451|FG003|Overall Study|Insufficient Therapeutic Response|3
4584324|NCT01473381|7428448|FG000|Overall Study|Protocol Violation|17
4584325|NCT01473381|7428449|FG001|Overall Study|Protocol Violation|23
4584326|NCT01473381|7428450|FG002|Overall Study|Protocol Violation|19
4584327|NCT01473381|7428451|FG003|Overall Study|Protocol Violation|17
4584328|NCT01473381|7428448|FG000|Overall Study|Withdrawal of Consent|20
4584329|NCT01473381|7428449|FG001|Overall Study|Withdrawal of Consent|21
4584330|NCT01473381|7428450|FG002|Overall Study|Withdrawal of Consent|20
4584331|NCT01473381|7428451|FG003|Overall Study|Withdrawal of Consent|26
4584332|NCT01473381|7428448|FG000|Overall Study|Lost to Follow-up|25
4584333|NCT01473381|7428449|FG001|Overall Study|Lost to Follow-up|28
4584334|NCT01473381|7428450|FG002|Overall Study|Lost to Follow-up|35
4584335|NCT01473381|7428451|FG003|Overall Study|Lost to Follow-up|23
4584336|NCT01473381|7428448|FG000|Overall Study|Other Reasons|0
4584337|NCT01473381|7428449|FG001|Overall Study|Other Reasons|0
4584338|NCT01473381|7428450|FG002|Overall Study|Other Reasons|1
4584339|NCT01473381|7428451|FG003|Overall Study|Other Reasons|3
4584340|NCT01473394|7428464|FG000|Overall Study|Adverse Event|13
4584341|NCT01473394|7428465|FG001|Overall Study|Adverse Event|16
4584342|NCT01473394|7428464|FG000|Overall Study|Insufficient Therapeutic Response|4
4584343|NCT01473394|7428465|FG001|Overall Study|Insufficient Therapeutic Response|1
4584344|NCT01473394|7428464|FG000|Overall Study|Protocol Violation|7
4584345|NCT01473394|7428465|FG001|Overall Study|Protocol Violation|5
4584346|NCT01473394|7428464|FG000|Overall Study|Withdrew Consent|12
4584347|NCT01473394|7428465|FG001|Overall Study|Withdrew Consent|10
4584348|NCT01473394|7428464|FG000|Overall Study|Lost to Follow-up|9
4584349|NCT01473394|7428465|FG001|Overall Study|Lost to Follow-up|11
4584350|NCT01473407|7428473|FG000|Overall Study|Physician Decision|1
4584351|NCT01473407|7428474|FG001|Overall Study|Physician Decision|4
4584352|NCT01473407|7428473|FG000|Overall Study|Lost to Follow-up|10
4584353|NCT01473407|7428474|FG001|Overall Study|Lost to Follow-up|4
4584354|NCT01473407|7428473|FG000|Overall Study|Adverse Event|8
4584355|NCT01473407|7428474|FG001|Overall Study|Adverse Event|8
4584356|NCT01473407|7428473|FG000|Overall Study|Randomization Error|3
4584357|NCT01473407|7428474|FG001|Overall Study|Randomization Error|1
4584358|NCT01473407|7428473|FG000|Overall Study|Withdrawal by Subject|4
4584359|NCT01473407|7428474|FG001|Overall Study|Withdrawal by Subject|7
4584360|NCT01473407|7428473|FG000|Overall Study|Kidney Transplant|7
4584361|NCT01473407|7428474|FG001|Overall Study|Kidney Transplant|6
4584362|NCT01473407|7428473|FG000|Overall Study|Vacation/Travel|1
4584363|NCT01473407|7428474|FG001|Overall Study|Vacation/Travel|1
4584364|NCT01473407|7428473|FG000|Overall Study|Elevated Hemoglobin|1
4584365|NCT01473407|7428474|FG001|Overall Study|Elevated Hemoglobin|0
4584366|NCT01473407|7428473|FG000|Overall Study|Patient Received Aranesp|1
4584367|NCT01473407|7428474|FG001|Overall Study|Patient Received Aranesp|0
4584368|NCT01473407|7428473|FG000|Overall Study|Patient Lost Green Card Status|1
4584369|NCT01473407|7428474|FG001|Overall Study|Patient Lost Green Card Status|0
4584370|NCT01473407|7428473|FG000|Overall Study|Temperature Excursion|2
4584371|NCT01473407|7428474|FG001|Overall Study|Temperature Excursion|3
4584372|NCT01473407|7428473|FG000|Overall Study|Transfer to Another Facility/Unit|4
4584373|NCT01473407|7428474|FG001|Overall Study|Transfer to Another Facility/Unit|3
4584374|NCT01473407|7428473|FG000|Overall Study|Sponsor's Decision|10
4584375|NCT01473407|7428474|FG001|Overall Study|Sponsor's Decision|10
4584376|NCT01473407|7428473|FG000|Overall Study|Site Closure|1
4584377|NCT01473407|7428474|FG001|Overall Study|Site Closure|0
4584378|NCT01473420|7428482|FG000|Titration Period (18 Weeks)|Adverse Event|4
4584379|NCT01473420|7428483|FG001|Titration Period (18 Weeks)|Adverse Event|6
4584380|NCT01473420|7428482|FG000|Titration Period (18 Weeks)|Did not meet criteria|32
4584381|NCT01473420|7428483|FG001|Titration Period (18 Weeks)|Did not meet criteria|32
4584382|NCT01473420|7428482|FG000|Maintenance Period (16 Weeks)|Adverse Event|3
4584383|NCT01473420|7428483|FG001|Maintenance Period (16 Weeks)|Adverse Event|2
4584384|NCT01473420|7428482|FG000|Maintenance Period (16 Weeks)|Physician Decision|1
4584385|NCT01473420|7428483|FG001|Maintenance Period (16 Weeks)|Physician Decision|2
4584386|NCT01473420|7428482|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0
4584387|NCT01473420|7428483|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2
4584388|NCT01473420|7428482|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3
4584389|NCT01473420|7428483|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1
4584390|NCT01473420|7428482|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1
4584391|NCT01473420|7428483|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2
4584392|NCT01473420|7428482|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4
4584393|NCT01473420|7428483|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6
4584394|NCT01473420|7428482|FG000|Maintenance Period (16 Weeks)|Site closure|3
4584395|NCT01473420|7428483|FG001|Maintenance Period (16 Weeks)|Site closure|1
4584396|NCT01473420|7428482|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1
4584397|NCT01473420|7428483|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0
4584398|NCT01473420|7428482|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0
4584399|NCT01473420|7428483|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1
4584400|NCT01473420|7428482|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1
4693151|NCT02589665|7604005|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
4693152|NCT02589665|7604006|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
4693153|NCT02589665|7603997|FG000|Maintenance Period|Withdrawal by Subject|0
4693154|NCT02589665|7603998|FG001|Maintenance Period|Withdrawal by Subject|0
4693155|NCT02589665|7603999|FG002|Maintenance Period|Withdrawal by Subject|0
4693156|NCT02589665|7604000|FG003|Maintenance Period|Withdrawal by Subject|0
4693157|NCT02589665|7604001|FG004|Maintenance Period|Withdrawal by Subject|4
4693158|NCT02589665|7604002|FG005|Maintenance Period|Withdrawal by Subject|2
4693159|NCT02589665|7604003|FG006|Maintenance Period|Withdrawal by Subject|4
4693160|NCT02589665|7604004|FG007|Maintenance Period|Withdrawal by Subject|0
4693161|NCT02589665|7604005|FG008|Maintenance Period|Withdrawal by Subject|0
4693162|NCT02589665|7604006|FG009|Maintenance Period|Withdrawal by Subject|0
4693163|NCT02589665|7603997|FG000|Maintenance Period|Lack of Efficacy|0
4693164|NCT02589665|7603998|FG001|Maintenance Period|Lack of Efficacy|0
4693165|NCT02589665|7603999|FG002|Maintenance Period|Lack of Efficacy|0
4693166|NCT02589665|7604000|FG003|Maintenance Period|Lack of Efficacy|0
4693167|NCT02589665|7604001|FG004|Maintenance Period|Lack of Efficacy|2
4693168|NCT02589665|7604002|FG005|Maintenance Period|Lack of Efficacy|1
4693169|NCT02589665|7604003|FG006|Maintenance Period|Lack of Efficacy|0
4693170|NCT02589665|7604004|FG007|Maintenance Period|Lack of Efficacy|0
4693171|NCT02589665|7604005|FG008|Maintenance Period|Lack of Efficacy|0
4693172|NCT02589665|7604006|FG009|Maintenance Period|Lack of Efficacy|0
4693173|NCT02589665|7603997|FG000|Maintenance Period|Adverse Event|0
4693174|NCT02589665|7603998|FG001|Maintenance Period|Adverse Event|0
4693175|NCT02589665|7603999|FG002|Maintenance Period|Adverse Event|0
4693176|NCT02589665|7604000|FG003|Maintenance Period|Adverse Event|0
4693177|NCT02589665|7604001|FG004|Maintenance Period|Adverse Event|0
4693178|NCT02589665|7604002|FG005|Maintenance Period|Adverse Event|0
4693179|NCT02589665|7604003|FG006|Maintenance Period|Adverse Event|2
4693180|NCT02589665|7604004|FG007|Maintenance Period|Adverse Event|0
4693181|NCT02589665|7604005|FG008|Maintenance Period|Adverse Event|0
4693182|NCT02589665|7604006|FG009|Maintenance Period|Adverse Event|0
4693183|NCT02589665|7603997|FG000|Maintenance Period|Lost to Follow-up|0
4693184|NCT02589665|7603998|FG001|Maintenance Period|Lost to Follow-up|0
4693185|NCT02589665|7603999|FG002|Maintenance Period|Lost to Follow-up|0
4693186|NCT02589665|7604000|FG003|Maintenance Period|Lost to Follow-up|0
4693187|NCT02589665|7604001|FG004|Maintenance Period|Lost to Follow-up|0
4693188|NCT02589665|7604002|FG005|Maintenance Period|Lost to Follow-up|1
4693189|NCT02589665|7604003|FG006|Maintenance Period|Lost to Follow-up|0
4693190|NCT02589665|7604004|FG007|Maintenance Period|Lost to Follow-up|0
4693191|NCT02589665|7604005|FG008|Maintenance Period|Lost to Follow-up|0
4693192|NCT02589665|7604006|FG009|Maintenance Period|Lost to Follow-up|0
4693193|NCT02589665|7603997|FG000|Maintenance Period|Physician Decision|0
4693194|NCT02589665|7603998|FG001|Maintenance Period|Physician Decision|0
4693195|NCT02589665|7603999|FG002|Maintenance Period|Physician Decision|0
4693196|NCT02589665|7604000|FG003|Maintenance Period|Physician Decision|0
4693197|NCT02589665|7604001|FG004|Maintenance Period|Physician Decision|0
4693198|NCT02589665|7604002|FG005|Maintenance Period|Physician Decision|1
4693199|NCT02589665|7604003|FG006|Maintenance Period|Physician Decision|0
4693200|NCT02589665|7604004|FG007|Maintenance Period|Physician Decision|0
4693201|NCT02589665|7604005|FG008|Maintenance Period|Physician Decision|0
4693202|NCT02589665|7604006|FG009|Maintenance Period|Physician Decision|0
4693203|NCT02589665|7603997|FG000|Maintenance Period|Reason Not Collected|0
4693204|NCT02589665|7603998|FG001|Maintenance Period|Reason Not Collected|0
4693205|NCT02589665|7603999|FG002|Maintenance Period|Reason Not Collected|0
4693206|NCT02589665|7604000|FG003|Maintenance Period|Reason Not Collected|0
4693207|NCT02589665|7604001|FG004|Maintenance Period|Reason Not Collected|0
4693208|NCT02589665|7604002|FG005|Maintenance Period|Reason Not Collected|1
4693209|NCT02589665|7604003|FG006|Maintenance Period|Reason Not Collected|1
4693210|NCT02589665|7604004|FG007|Maintenance Period|Reason Not Collected|0
4693211|NCT02589665|7604005|FG008|Maintenance Period|Reason Not Collected|0
4693212|NCT02589665|7604006|FG009|Maintenance Period|Reason Not Collected|0
4693213|NCT02589665|7603997|FG000|Induction Extension Period|Adverse Event|0
4693214|NCT02589665|7603998|FG001|Induction Extension Period|Adverse Event|0
4693215|NCT02589665|7603999|FG002|Induction Extension Period|Adverse Event|0
4693216|NCT02589665|7604000|FG003|Induction Extension Period|Adverse Event|0
4693217|NCT02589665|7604001|FG004|Induction Extension Period|Adverse Event|0
4584401|NCT01473420|7428483|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0
4584402|NCT01473420|7428482|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1
4584403|NCT01473420|7428483|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0
4584404|NCT01473524|7428498|FG000|DB Phase|Adverse Event|4
4584405|NCT01473524|7428499|FG001|DB Phase|Adverse Event|8
4584406|NCT01473524|7428500|FG002|DB Phase|Adverse Event|2
4584407|NCT01473524|7428501|FG003|DB Phase|Adverse Event|0
4584408|NCT01473524|7428502|FG004|DB Phase|Adverse Event|0
4584409|NCT01473524|7428503|FG005|DB Phase|Adverse Event|0
4584410|NCT01473524|7428498|FG000|DB Phase|Death|1
4584411|NCT01473524|7428499|FG001|DB Phase|Death|0
4584412|NCT01473524|7428500|FG002|DB Phase|Death|0
4584413|NCT01473524|7428501|FG003|DB Phase|Death|0
4584414|NCT01473524|7428502|FG004|DB Phase|Death|0
4584415|NCT01473524|7428503|FG005|DB Phase|Death|0
4584416|NCT01473524|7428498|FG000|DB Phase|Withdrawal by Subject|2
4584417|NCT01473524|7428499|FG001|DB Phase|Withdrawal by Subject|1
4584418|NCT01473524|7428500|FG002|DB Phase|Withdrawal by Subject|1
4584419|NCT01473524|7428501|FG003|DB Phase|Withdrawal by Subject|0
4584420|NCT01473524|7428502|FG004|DB Phase|Withdrawal by Subject|0
4584421|NCT01473524|7428503|FG005|DB Phase|Withdrawal by Subject|0
4584422|NCT01473524|7428498|FG000|LTSE Phase|Withdrawal by Subject|0
4584423|NCT01473524|7428499|FG001|LTSE Phase|Withdrawal by Subject|0
4584424|NCT01473524|7428500|FG002|LTSE Phase|Withdrawal by Subject|0
4584425|NCT01473524|7428501|FG003|LTSE Phase|Withdrawal by Subject|3
4584426|NCT01473524|7428502|FG004|LTSE Phase|Withdrawal by Subject|3
4584427|NCT01473524|7428503|FG005|LTSE Phase|Withdrawal by Subject|6
4584428|NCT01473524|7428498|FG000|LTSE Phase|Death|0
4584429|NCT01473524|7428499|FG001|LTSE Phase|Death|0
4584430|NCT01473524|7428500|FG002|LTSE Phase|Death|0
4584431|NCT01473524|7428501|FG003|LTSE Phase|Death|0
4584432|NCT01473524|7428502|FG004|LTSE Phase|Death|1
4584433|NCT01473524|7428503|FG005|LTSE Phase|Death|0
4584434|NCT01473524|7428498|FG000|LTSE Phase|Adverse Event of Pruritus|0
4584435|NCT01473524|7428499|FG001|LTSE Phase|Adverse Event of Pruritus|0
4584436|NCT01473524|7428500|FG002|LTSE Phase|Adverse Event of Pruritus|0
4584437|NCT01473524|7428501|FG003|LTSE Phase|Adverse Event of Pruritus|1
4584438|NCT01473524|7428502|FG004|LTSE Phase|Adverse Event of Pruritus|5
4584439|NCT01473524|7428503|FG005|LTSE Phase|Adverse Event of Pruritus|2
4584440|NCT01473524|7428498|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0
4584441|NCT01473524|7428499|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0
4584442|NCT01473524|7428500|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0
4584443|NCT01473524|7428501|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2
4584444|NCT01473524|7428502|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4
4584445|NCT01473524|7428503|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6
4584446|NCT01473524|7428498|FG000|LTSE Phase|Lost to Follow-up|0
4584447|NCT01473524|7428499|FG001|LTSE Phase|Lost to Follow-up|0
4584448|NCT01473524|7428500|FG002|LTSE Phase|Lost to Follow-up|0
4693218|NCT02589665|7604002|FG005|Induction Extension Period|Adverse Event|0
4693219|NCT02589665|7604003|FG006|Induction Extension Period|Adverse Event|0
4693220|NCT02589665|7604004|FG007|Induction Extension Period|Adverse Event|0
4693221|NCT02589665|7604005|FG008|Induction Extension Period|Adverse Event|4
4693222|NCT02589665|7604006|FG009|Induction Extension Period|Adverse Event|0
4693223|NCT02589665|7603997|FG000|Induction Extension Period|Lack of Efficacy|0
4584449|NCT01473524|7428501|FG003|LTSE Phase|Lost to Follow-up|1
4584450|NCT01473524|7428502|FG004|LTSE Phase|Lost to Follow-up|3
4584451|NCT01473524|7428503|FG005|LTSE Phase|Lost to Follow-up|2
4584452|NCT01473524|7428498|FG000|LTSE Phase|Principal Investigator Decision|0
4584453|NCT01473524|7428499|FG001|LTSE Phase|Principal Investigator Decision|0
4584454|NCT01473524|7428500|FG002|LTSE Phase|Principal Investigator Decision|0
4584455|NCT01473524|7428501|FG003|LTSE Phase|Principal Investigator Decision|1
4584456|NCT01473524|7428502|FG004|LTSE Phase|Principal Investigator Decision|1
4584457|NCT01473524|7428503|FG005|LTSE Phase|Principal Investigator Decision|3
4584458|NCT01473524|7428498|FG000|LTSE Phase|Liver Transplantation|0
4584459|NCT01473524|7428499|FG001|LTSE Phase|Liver Transplantation|0
4584460|NCT01473524|7428500|FG002|LTSE Phase|Liver Transplantation|0
4584461|NCT01473524|7428501|FG003|LTSE Phase|Liver Transplantation|0
4584462|NCT01473524|7428502|FG004|LTSE Phase|Liver Transplantation|0
4584463|NCT01473524|7428503|FG005|LTSE Phase|Liver Transplantation|1
4584464|NCT01473524|7428498|FG000|LTSE Phase|Pregnancy|0
4584465|NCT01473524|7428499|FG001|LTSE Phase|Pregnancy|0
4584466|NCT01473524|7428500|FG002|LTSE Phase|Pregnancy|0
4584467|NCT01473524|7428501|FG003|LTSE Phase|Pregnancy|1
4584468|NCT01473524|7428502|FG004|LTSE Phase|Pregnancy|0
4584469|NCT01473524|7428503|FG005|LTSE Phase|Pregnancy|0
4584470|NCT01473524|7428498|FG000|LTSE Phase|Protocol Violation|0
4584471|NCT01473524|7428499|FG001|LTSE Phase|Protocol Violation|0
4584472|NCT01473524|7428500|FG002|LTSE Phase|Protocol Violation|0
4584473|NCT01473524|7428501|FG003|LTSE Phase|Protocol Violation|0
4584474|NCT01473524|7428502|FG004|LTSE Phase|Protocol Violation|0
4584475|NCT01473524|7428503|FG005|LTSE Phase|Protocol Violation|1
4584476|NCT01473563|7428525|FG000|Overall Study|Lost to FU post tx discontinuation|1
4584477|NCT01473589|7428531|FG000|Overall Study|Adverse Event|1
4584478|NCT01473589|7428532|FG001|Overall Study|Adverse Event|1
4584479|NCT01473589|7428531|FG000|Overall Study|Death|2
4584480|NCT01473589|7428532|FG001|Overall Study|Death|0
4584481|NCT01473589|7428531|FG000|Overall Study|Lost to Follow-up|2
4584482|NCT01473589|7428532|FG001|Overall Study|Lost to Follow-up|2
4584483|NCT01473589|7428531|FG000|Overall Study|Protocol Violation|1
4584484|NCT01473589|7428532|FG001|Overall Study|Protocol Violation|0
4584485|NCT01473589|7428531|FG000|Overall Study|Withdrawal by Subject|5
4584486|NCT01473589|7428532|FG001|Overall Study|Withdrawal by Subject|11
4584487|NCT01473589|7428531|FG000|Overall Study|Physician Decision|0
4584488|NCT01473589|7428532|FG001|Overall Study|Physician Decision|1
4584489|NCT01473589|7428531|FG000|Overall Study|Entry criteria not met|0
4584490|NCT01473589|7428532|FG001|Overall Study|Entry criteria not met|1
4593476|NCT01552408|7441928|FG000|Overall Study|Withdrawal by Subject|2
4593477|NCT01552408|7441929|FG001|Overall Study|Withdrawal by Subject|1
4593478|NCT01552603|7441936|FG000|Overall Study|Physician Decision|1
4593479|NCT01552681|7441942|FG000|Overall Study|Withdrawal by Subject|4
4593480|NCT01552681|7441943|FG001|Overall Study|Withdrawal by Subject|0
4593481|NCT01552681|7441942|FG000|Overall Study|Physician Decision|1
4593482|NCT01552681|7441943|FG001|Overall Study|Physician Decision|0
4593483|NCT01552681|7441942|FG000|Overall Study|Subject moved away|0
4593484|NCT01552681|7441943|FG001|Overall Study|Subject moved away|1
4593485|NCT01552694|7441951|FG000|Overall Study|Lost to Follow-up|0
4593486|NCT01552694|7441952|FG001|Overall Study|Lost to Follow-up|1
4593487|NCT01552694|7441951|FG000|Overall Study|Protocol Violation|0
4593488|NCT01552694|7441952|FG001|Overall Study|Protocol Violation|1
4593489|NCT01552772|7441958|FG000|Overall Study|Lost to Follow-up|2
4593490|NCT01552772|7441958|FG000|Overall Study|Adverse Event|1
4593491|NCT01552772|7441958|FG000|Overall Study|Protocol Deviation|1
4593492|NCT01552902|7441990|FG000|Overall Study|Adverse Event|1
4593493|NCT01552902|7441991|FG001|Overall Study|Adverse Event|15
4593494|NCT01552902|7441992|FG002|Overall Study|Adverse Event|14
4593495|NCT01552902|7441990|FG000|Overall Study|Protocol Violation|3
4593496|NCT01552902|7441991|FG001|Overall Study|Protocol Violation|3
4593497|NCT01552902|7441992|FG002|Overall Study|Protocol Violation|3
4593498|NCT01552902|7441990|FG000|Overall Study|Lack of Efficacy|4
4693224|NCT02589665|7603998|FG001|Induction Extension Period|Lack of Efficacy|0
4693225|NCT02589665|7603999|FG002|Induction Extension Period|Lack of Efficacy|0
4693226|NCT02589665|7604000|FG003|Induction Extension Period|Lack of Efficacy|0
4693227|NCT02589665|7604001|FG004|Induction Extension Period|Lack of Efficacy|0
4693228|NCT02589665|7604002|FG005|Induction Extension Period|Lack of Efficacy|0
4693229|NCT02589665|7604003|FG006|Induction Extension Period|Lack of Efficacy|0
4693230|NCT02589665|7604004|FG007|Induction Extension Period|Lack of Efficacy|0
4693231|NCT02589665|7604005|FG008|Induction Extension Period|Lack of Efficacy|3
4693232|NCT02589665|7604006|FG009|Induction Extension Period|Lack of Efficacy|0
4693233|NCT02589665|7603997|FG000|Induction Extension Period|Withdrawal by Subject|0
4693234|NCT02589665|7603998|FG001|Induction Extension Period|Withdrawal by Subject|0
4693235|NCT02589665|7603999|FG002|Induction Extension Period|Withdrawal by Subject|0
4693236|NCT02589665|7604000|FG003|Induction Extension Period|Withdrawal by Subject|0
4693237|NCT02589665|7604001|FG004|Induction Extension Period|Withdrawal by Subject|0
4693238|NCT02589665|7604002|FG005|Induction Extension Period|Withdrawal by Subject|0
4693239|NCT02589665|7604003|FG006|Induction Extension Period|Withdrawal by Subject|0
4693240|NCT02589665|7604004|FG007|Induction Extension Period|Withdrawal by Subject|2
4693241|NCT02589665|7604005|FG008|Induction Extension Period|Withdrawal by Subject|3
4693242|NCT02589665|7604006|FG009|Induction Extension Period|Withdrawal by Subject|0
4593499|NCT01552902|7441991|FG001|Overall Study|Lack of Efficacy|3
4593500|NCT01552902|7441992|FG002|Overall Study|Lack of Efficacy|1
4593501|NCT01552902|7441990|FG000|Overall Study|Withdrawal by Subject|1
4593502|NCT01552902|7441991|FG001|Overall Study|Withdrawal by Subject|9
4593503|NCT01552902|7441992|FG002|Overall Study|Withdrawal by Subject|6
4593504|NCT01552902|7441990|FG000|Overall Study|Lost to Follow-up|1
4593505|NCT01552902|7441991|FG001|Overall Study|Lost to Follow-up|3
4593506|NCT01552902|7441992|FG002|Overall Study|Lost to Follow-up|6
4593507|NCT01552902|7441990|FG000|Overall Study|Other|3
4584491|NCT01473602|7428542|FG000|Overall Study|Adverse Event|1
4584492|NCT01473602|7428543|FG001|Overall Study|Adverse Event|2
4584493|NCT01473602|7428542|FG000|Overall Study|Death|0
4584494|NCT01473602|7428543|FG001|Overall Study|Death|1
4584495|NCT01473602|7428542|FG000|Overall Study|Lost to Follow-up|1
4584496|NCT01473602|7428543|FG001|Overall Study|Lost to Follow-up|1
4584497|NCT01473602|7428542|FG000|Overall Study|Withdrawal by Subject|5
4584498|NCT01473602|7428543|FG001|Overall Study|Withdrawal by Subject|4
4584499|NCT01473602|7428542|FG000|Overall Study|Physician Decision|1
4584500|NCT01473602|7428543|FG001|Overall Study|Physician Decision|0
4584501|NCT01473758|7428562|FG000|Cycle 1|Adverse Event|10
4584502|NCT01473758|7428563|FG001|Cycle 1|Adverse Event|2
4584503|NCT01473758|7428564|FG002|Cycle 1|Adverse Event|0
4584504|NCT01473758|7428565|FG003|Cycle 1|Adverse Event|0
4584505|NCT01473758|7428562|FG000|Cycle 1|Withdrawal by Subject|1
4584506|NCT01473758|7428563|FG001|Cycle 1|Withdrawal by Subject|1
4584507|NCT01473758|7428564|FG002|Cycle 1|Withdrawal by Subject|0
4584508|NCT01473758|7428565|FG003|Cycle 1|Withdrawal by Subject|0
4584509|NCT01473758|7428562|FG000|Cycle 2|Adverse Event|0
4584510|NCT01473758|7428563|FG001|Cycle 2|Adverse Event|0
4584511|NCT01473758|7428564|FG002|Cycle 2|Adverse Event|5
4584512|NCT01473758|7428565|FG003|Cycle 2|Adverse Event|0
4584513|NCT01473836|7428573|FG000|Overall Study|Adverse Event|4
4584514|NCT01473836|7428573|FG000|Overall Study|Lack of Efficacy|1
4584515|NCT01473836|7428573|FG000|Overall Study|Does not meet entrance criteria|1
4584516|NCT01473940|7428581|FG000|Induction Therapy|Death|0
4584517|NCT01473940|7428582|FG001|Induction Therapy|Death|0
4584518|NCT01473940|7428583|FG002|Induction Therapy|Death|1
4584519|NCT01473940|7428584|FG003|Induction Therapy|Death|1
4584520|NCT01473940|7428581|FG000|Induction Therapy|Progressive Disease|0
4584521|NCT01473940|7428582|FG001|Induction Therapy|Progressive Disease|1
4584522|NCT01473940|7428583|FG002|Induction Therapy|Progressive Disease|1
4584523|NCT01473940|7428584|FG003|Induction Therapy|Progressive Disease|0
4584524|NCT01473940|7428581|FG000|Maintenance Therapy|Progressive Disease|1
4584525|NCT01473940|7428582|FG001|Maintenance Therapy|Progressive Disease|2
4584526|NCT01473940|7428583|FG002|Maintenance Therapy|Progressive Disease|1
4584527|NCT01473940|7428584|FG003|Maintenance Therapy|Progressive Disease|4
4584528|NCT01473953|7428602|FG000|Overall Study|Other|1
4584529|NCT01473953|7428603|FG001|Overall Study|Other|0
4584530|NCT01473953|7428604|FG002|Overall Study|Other|0
4584531|NCT01473953|7428605|FG003|Overall Study|Other|0
4584532|NCT01473953|7428606|FG004|Overall Study|Other|0
4584533|NCT01474018|7428632|FG000|Overall Study|Lost to Follow-up|0
4584534|NCT01474018|7428633|FG001|Overall Study|Lost to Follow-up|1
4584535|NCT01474018|7428632|FG000|Overall Study|Withdrawal by Subject|0
4584536|NCT01474018|7428633|FG001|Overall Study|Withdrawal by Subject|2
4584537|NCT01474239|7428691|FG000|Overall Study|Disease Progression|37
4584538|NCT01474239|7428692|FG001|Overall Study|Disease Progression|25
4584539|NCT01474239|7428691|FG000|Overall Study|Adverse Event|12
4584540|NCT01474239|7428692|FG001|Overall Study|Adverse Event|3
4584541|NCT01474239|7428691|FG000|Overall Study|Withdrawal by Subject|1
4584542|NCT01474239|7428692|FG001|Overall Study|Withdrawal by Subject|2
4584543|NCT01474239|7428691|FG000|Overall Study|Death|1
4584544|NCT01474239|7428692|FG001|Overall Study|Death|1
4584545|NCT01474239|7428691|FG000|Overall Study|Clinical Disease Progression|7
4584546|NCT01474239|7428692|FG001|Overall Study|Clinical Disease Progression|1
4584547|NCT01474239|7428691|FG000|Overall Study|Withdrawal for Economic Reason|1
4584548|NCT01474239|7428692|FG001|Overall Study|Withdrawal for Economic Reason|0
4584549|NCT01474291|7428700|FG000|Overall Study|Not Evaluable for Efficacy|26
4584550|NCT01474291|7428700|FG000|Overall Study|Lack of Treatment Efficacy|88
4584551|NCT01474291|7428700|FG000|Overall Study|Adverse Event|53
4584552|NCT01474291|7428700|FG000|Overall Study|Lost to Follow-up|29
4584553|NCT01474291|7428700|FG000|Overall Study|Patient No Longer Wanted to Participate|12
4584554|NCT01474291|7428700|FG000|Overall Study|No Reason Reported|10
4584555|NCT01474291|7428700|FG000|Overall Study|Death|2
4584556|NCT01474317|7428707|FG000|Overall Study|Adverse Event|1
4584557|NCT01474317|7428707|FG000|Overall Study|Subject ineligible for study|1
4584558|NCT01474434|7428715|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0
4584559|NCT01474434|7428716|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0
4584560|NCT01474434|7428717|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1
4584561|NCT01474434|7428718|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1
4584562|NCT01474434|7428715|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
4584563|NCT01474434|7428716|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
4584564|NCT01474434|7428717|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
4584565|NCT01474434|7428718|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1
4584566|NCT01474434|7428715|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1
4584567|NCT01474434|7428716|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
4584568|NCT01474434|7428717|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
4584569|NCT01474434|7428718|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
4584570|NCT01474486|7428732|FG000|Overall Study|Death|2
4584571|NCT01474486|7428732|FG000|Overall Study|Withdrawal by Subject|4
4584572|NCT01474486|7428732|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2
4584573|NCT01474512|7428743|FG000|Induction Period|Adverse Event|6
4584574|NCT01474512|7428744|FG001|Induction Period|Adverse Event|10
4584575|NCT01474512|7428745|FG002|Induction Period|Adverse Event|10
4584576|NCT01474512|7428746|FG003|Induction Period|Adverse Event|0
4584577|NCT01474512|7428747|FG004|Induction Period|Adverse Event|0
4584578|NCT01474512|7428748|FG005|Induction Period|Adverse Event|0
4584579|NCT01474512|7428749|FG006|Induction Period|Adverse Event|0
4584580|NCT01474512|7428750|FG007|Induction Period|Adverse Event|0
4584581|NCT01474512|7428751|FG008|Induction Period|Adverse Event|0
4584582|NCT01474512|7428752|FG009|Induction Period|Adverse Event|0
4584583|NCT01474512|7428753|FG010|Induction Period|Adverse Event|0
4584584|NCT01474512|7428754|FG011|Induction Period|Adverse Event|0
4584585|NCT01474512|7428755|FG012|Induction Period|Adverse Event|0
4584586|NCT01474512|7428756|FG013|Induction Period|Adverse Event|0
4584587|NCT01474512|7428757|FG014|Induction Period|Adverse Event|0
4584588|NCT01474512|7428758|FG015|Induction Period|Adverse Event|0
4584589|NCT01474512|7428759|FG016|Induction Period|Adverse Event|0
4584590|NCT01474512|7428760|FG017|Induction Period|Adverse Event|0
4584591|NCT01474512|7428743|FG000|Induction Period|Lack of Efficacy|7
4584592|NCT01474512|7428744|FG001|Induction Period|Lack of Efficacy|1
4584593|NCT01474512|7428745|FG002|Induction Period|Lack of Efficacy|0
4584594|NCT01474512|7428746|FG003|Induction Period|Lack of Efficacy|0
4584595|NCT01474512|7428747|FG004|Induction Period|Lack of Efficacy|0
4584596|NCT01474512|7428748|FG005|Induction Period|Lack of Efficacy|0
4584597|NCT01474512|7428749|FG006|Induction Period|Lack of Efficacy|0
4584598|NCT01474512|7428750|FG007|Induction Period|Lack of Efficacy|0
4584599|NCT01474512|7428751|FG008|Induction Period|Lack of Efficacy|0
4584600|NCT01474512|7428752|FG009|Induction Period|Lack of Efficacy|0
4584601|NCT01474512|7428753|FG010|Induction Period|Lack of Efficacy|0
4584602|NCT01474512|7428754|FG011|Induction Period|Lack of Efficacy|0
4584603|NCT01474512|7428755|FG012|Induction Period|Lack of Efficacy|0
4584604|NCT01474512|7428756|FG013|Induction Period|Lack of Efficacy|0
4584605|NCT01474512|7428757|FG014|Induction Period|Lack of Efficacy|0
4584606|NCT01474512|7428758|FG015|Induction Period|Lack of Efficacy|0
4584607|NCT01474512|7428759|FG016|Induction Period|Lack of Efficacy|0
4584608|NCT01474512|7428760|FG017|Induction Period|Lack of Efficacy|0
4584609|NCT01474512|7428743|FG000|Induction Period|Withdrawal by Subject|6
4584610|NCT01474512|7428744|FG001|Induction Period|Withdrawal by Subject|6
4584611|NCT01474512|7428745|FG002|Induction Period|Withdrawal by Subject|5
4584612|NCT01474512|7428746|FG003|Induction Period|Withdrawal by Subject|0
4584613|NCT01474512|7428747|FG004|Induction Period|Withdrawal by Subject|0
4584614|NCT01474512|7428748|FG005|Induction Period|Withdrawal by Subject|0
4584615|NCT01474512|7428749|FG006|Induction Period|Withdrawal by Subject|0
4584616|NCT01474512|7428750|FG007|Induction Period|Withdrawal by Subject|0
4584617|NCT01474512|7428751|FG008|Induction Period|Withdrawal by Subject|0
4584618|NCT01474512|7428752|FG009|Induction Period|Withdrawal by Subject|0
4584619|NCT01474512|7428753|FG010|Induction Period|Withdrawal by Subject|0
4584620|NCT01474512|7428754|FG011|Induction Period|Withdrawal by Subject|0
4584621|NCT01474512|7428755|FG012|Induction Period|Withdrawal by Subject|0
4584622|NCT01474512|7428756|FG013|Induction Period|Withdrawal by Subject|0
4584623|NCT01474512|7428757|FG014|Induction Period|Withdrawal by Subject|0
4584624|NCT01474512|7428758|FG015|Induction Period|Withdrawal by Subject|0
4584625|NCT01474512|7428759|FG016|Induction Period|Withdrawal by Subject|0
4584626|NCT01474512|7428760|FG017|Induction Period|Withdrawal by Subject|0
4584627|NCT01474512|7428743|FG000|Induction Period|Protocol Violation|3
4584628|NCT01474512|7428744|FG001|Induction Period|Protocol Violation|6
4693243|NCT02589665|7603997|FG000|Induction Extension Period|Physician Decision|0
4693244|NCT02589665|7603998|FG001|Induction Extension Period|Physician Decision|0
4693245|NCT02589665|7603999|FG002|Induction Extension Period|Physician Decision|0
4693246|NCT02589665|7604000|FG003|Induction Extension Period|Physician Decision|0
4693247|NCT02589665|7604001|FG004|Induction Extension Period|Physician Decision|0
4693248|NCT02589665|7604002|FG005|Induction Extension Period|Physician Decision|0
4693249|NCT02589665|7604003|FG006|Induction Extension Period|Physician Decision|0
4693250|NCT02589665|7604004|FG007|Induction Extension Period|Physician Decision|0
4693251|NCT02589665|7604005|FG008|Induction Extension Period|Physician Decision|1
4693252|NCT02589665|7604006|FG009|Induction Extension Period|Physician Decision|0
4693253|NCT02589665|7603997|FG000|Induction Extension Period|Reason Not Collected|0
4693254|NCT02589665|7603998|FG001|Induction Extension Period|Reason Not Collected|0
4693255|NCT02589665|7603999|FG002|Induction Extension Period|Reason Not Collected|0
4693256|NCT02589665|7604000|FG003|Induction Extension Period|Reason Not Collected|0
4693257|NCT02589665|7604001|FG004|Induction Extension Period|Reason Not Collected|0
4693258|NCT02589665|7604002|FG005|Induction Extension Period|Reason Not Collected|0
4584629|NCT01474512|7428745|FG002|Induction Period|Protocol Violation|0
4584630|NCT01474512|7428746|FG003|Induction Period|Protocol Violation|0
4584631|NCT01474512|7428747|FG004|Induction Period|Protocol Violation|0
4584632|NCT01474512|7428748|FG005|Induction Period|Protocol Violation|0
4584633|NCT01474512|7428749|FG006|Induction Period|Protocol Violation|0
4584634|NCT01474512|7428750|FG007|Induction Period|Protocol Violation|0
4693259|NCT02589665|7604003|FG006|Induction Extension Period|Reason Not Collected|0
4584635|NCT01474512|7428751|FG008|Induction Period|Protocol Violation|0
4693260|NCT02589665|7604004|FG007|Induction Extension Period|Reason Not Collected|0
4693261|NCT02589665|7604005|FG008|Induction Extension Period|Reason Not Collected|1
4584636|NCT01474512|7428752|FG009|Induction Period|Protocol Violation|0
4584637|NCT01474512|7428753|FG010|Induction Period|Protocol Violation|0
4584638|NCT01474512|7428754|FG011|Induction Period|Protocol Violation|0
4584639|NCT01474512|7428755|FG012|Induction Period|Protocol Violation|0
4584640|NCT01474512|7428756|FG013|Induction Period|Protocol Violation|0
4584641|NCT01474512|7428757|FG014|Induction Period|Protocol Violation|0
4584642|NCT01474512|7428758|FG015|Induction Period|Protocol Violation|0
4584643|NCT01474512|7428759|FG016|Induction Period|Protocol Violation|0
4584644|NCT01474512|7428760|FG017|Induction Period|Protocol Violation|0
4584645|NCT01474512|7428743|FG000|Induction Period|Sponsor Decision|1
4584646|NCT01474512|7428744|FG001|Induction Period|Sponsor Decision|1
4584647|NCT01474512|7428745|FG002|Induction Period|Sponsor Decision|1
4584648|NCT01474512|7428746|FG003|Induction Period|Sponsor Decision|0
4584649|NCT01474512|7428747|FG004|Induction Period|Sponsor Decision|0
4584650|NCT01474512|7428748|FG005|Induction Period|Sponsor Decision|0
4584651|NCT01474512|7428749|FG006|Induction Period|Sponsor Decision|0
4584652|NCT01474512|7428750|FG007|Induction Period|Sponsor Decision|0
4584653|NCT01474512|7428751|FG008|Induction Period|Sponsor Decision|0
4584654|NCT01474512|7428752|FG009|Induction Period|Sponsor Decision|0
4584655|NCT01474512|7428753|FG010|Induction Period|Sponsor Decision|0
4584656|NCT01474512|7428754|FG011|Induction Period|Sponsor Decision|0
4584657|NCT01474512|7428755|FG012|Induction Period|Sponsor Decision|0
4584658|NCT01474512|7428756|FG013|Induction Period|Sponsor Decision|0
4584659|NCT01474512|7428757|FG014|Induction Period|Sponsor Decision|0
4584660|NCT01474512|7428758|FG015|Induction Period|Sponsor Decision|0
4584661|NCT01474512|7428759|FG016|Induction Period|Sponsor Decision|0
4584662|NCT01474512|7428760|FG017|Induction Period|Sponsor Decision|0
4584663|NCT01474512|7428743|FG000|Induction Period|Lost to Follow-up|1
4584664|NCT01474512|7428744|FG001|Induction Period|Lost to Follow-up|0
4584665|NCT01474512|7428745|FG002|Induction Period|Lost to Follow-up|2
4584666|NCT01474512|7428746|FG003|Induction Period|Lost to Follow-up|0
4584667|NCT01474512|7428747|FG004|Induction Period|Lost to Follow-up|0
4584668|NCT01474512|7428748|FG005|Induction Period|Lost to Follow-up|0
4584669|NCT01474512|7428749|FG006|Induction Period|Lost to Follow-up|0
4584670|NCT01474512|7428750|FG007|Induction Period|Lost to Follow-up|0
4584671|NCT01474512|7428751|FG008|Induction Period|Lost to Follow-up|0
4584672|NCT01474512|7428752|FG009|Induction Period|Lost to Follow-up|0
4584673|NCT01474512|7428753|FG010|Induction Period|Lost to Follow-up|0
4584674|NCT01474512|7428754|FG011|Induction Period|Lost to Follow-up|0
4584675|NCT01474512|7428755|FG012|Induction Period|Lost to Follow-up|0
4584676|NCT01474512|7428756|FG013|Induction Period|Lost to Follow-up|0
4584677|NCT01474512|7428757|FG014|Induction Period|Lost to Follow-up|0
4584678|NCT01474512|7428758|FG015|Induction Period|Lost to Follow-up|0
4584679|NCT01474512|7428759|FG016|Induction Period|Lost to Follow-up|0
4584680|NCT01474512|7428760|FG017|Induction Period|Lost to Follow-up|0
4584681|NCT01474512|7428743|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0
4584682|NCT01474512|7428744|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0
4584683|NCT01474512|7428745|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0
4584684|NCT01474512|7428746|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186
4584685|NCT01474512|7428747|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111
4584686|NCT01474512|7428748|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39
4584687|NCT01474512|7428749|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9
4584688|NCT01474512|7428750|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0
4584689|NCT01474512|7428751|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0
4584690|NCT01474512|7428752|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0
4584691|NCT01474512|7428753|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0
4584692|NCT01474512|7428754|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0
4584693|NCT01474512|7428755|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0
4584694|NCT01474512|7428756|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0
4584695|NCT01474512|7428757|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0
4584696|NCT01474512|7428758|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0
4584697|NCT01474512|7428759|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0
4584698|NCT01474512|7428760|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0
4584699|NCT01474512|7428743|FG000|Maintenance Period|Adverse Event|0
4584700|NCT01474512|7428744|FG001|Maintenance Period|Adverse Event|0
4584701|NCT01474512|7428745|FG002|Maintenance Period|Adverse Event|0
4584702|NCT01474512|7428746|FG003|Maintenance Period|Adverse Event|4
4584703|NCT01474512|7428747|FG004|Maintenance Period|Adverse Event|2
4584704|NCT01474512|7428748|FG005|Maintenance Period|Adverse Event|7
4584705|NCT01474512|7428749|FG006|Maintenance Period|Adverse Event|0
4584706|NCT01474512|7428750|FG007|Maintenance Period|Adverse Event|19
4584707|NCT01474512|7428751|FG008|Maintenance Period|Adverse Event|1
4584708|NCT01474512|7428752|FG009|Maintenance Period|Adverse Event|3
4584709|NCT01474512|7428753|FG010|Maintenance Period|Adverse Event|0
4584710|NCT01474512|7428754|FG011|Maintenance Period|Adverse Event|0
4584711|NCT01474512|7428755|FG012|Maintenance Period|Adverse Event|0
4584712|NCT01474512|7428756|FG013|Maintenance Period|Adverse Event|0
4584713|NCT01474512|7428757|FG014|Maintenance Period|Adverse Event|0
4584714|NCT01474512|7428758|FG015|Maintenance Period|Adverse Event|0
4584715|NCT01474512|7428759|FG016|Maintenance Period|Adverse Event|0
4584716|NCT01474512|7428760|FG017|Maintenance Period|Adverse Event|0
4584717|NCT01474512|7428743|FG000|Maintenance Period|Withdrawal by Subject|0
4584718|NCT01474512|7428744|FG001|Maintenance Period|Withdrawal by Subject|0
4584719|NCT01474512|7428745|FG002|Maintenance Period|Withdrawal by Subject|0
4584720|NCT01474512|7428746|FG003|Maintenance Period|Withdrawal by Subject|6
4584721|NCT01474512|7428747|FG004|Maintenance Period|Withdrawal by Subject|2
4584722|NCT01474512|7428748|FG005|Maintenance Period|Withdrawal by Subject|3
4584723|NCT01474512|7428749|FG006|Maintenance Period|Withdrawal by Subject|1
4584724|NCT01474512|7428750|FG007|Maintenance Period|Withdrawal by Subject|6
4584725|NCT01474512|7428751|FG008|Maintenance Period|Withdrawal by Subject|3
4584726|NCT01474512|7428752|FG009|Maintenance Period|Withdrawal by Subject|1
4584727|NCT01474512|7428753|FG010|Maintenance Period|Withdrawal by Subject|0
4584728|NCT01474512|7428754|FG011|Maintenance Period|Withdrawal by Subject|0
4584729|NCT01474512|7428755|FG012|Maintenance Period|Withdrawal by Subject|0
4584730|NCT01474512|7428756|FG013|Maintenance Period|Withdrawal by Subject|0
4584731|NCT01474512|7428757|FG014|Maintenance Period|Withdrawal by Subject|0
4584732|NCT01474512|7428758|FG015|Maintenance Period|Withdrawal by Subject|0
4584733|NCT01474512|7428759|FG016|Maintenance Period|Withdrawal by Subject|0
4584734|NCT01474512|7428760|FG017|Maintenance Period|Withdrawal by Subject|0
4584735|NCT01474512|7428743|FG000|Maintenance Period|Lost to Follow-up|0
4584736|NCT01474512|7428744|FG001|Maintenance Period|Lost to Follow-up|0
4584737|NCT01474512|7428745|FG002|Maintenance Period|Lost to Follow-up|0
4584738|NCT01474512|7428746|FG003|Maintenance Period|Lost to Follow-up|3
4584739|NCT01474512|7428747|FG004|Maintenance Period|Lost to Follow-up|3
4584740|NCT01474512|7428748|FG005|Maintenance Period|Lost to Follow-up|0
4584741|NCT01474512|7428749|FG006|Maintenance Period|Lost to Follow-up|0
4584742|NCT01474512|7428750|FG007|Maintenance Period|Lost to Follow-up|2
4584743|NCT01474512|7428751|FG008|Maintenance Period|Lost to Follow-up|1
4584744|NCT01474512|7428752|FG009|Maintenance Period|Lost to Follow-up|1
4584745|NCT01474512|7428753|FG010|Maintenance Period|Lost to Follow-up|0
4584746|NCT01474512|7428754|FG011|Maintenance Period|Lost to Follow-up|0
4584747|NCT01474512|7428755|FG012|Maintenance Period|Lost to Follow-up|0
4584748|NCT01474512|7428756|FG013|Maintenance Period|Lost to Follow-up|0
4584749|NCT01474512|7428757|FG014|Maintenance Period|Lost to Follow-up|0
4584750|NCT01474512|7428758|FG015|Maintenance Period|Lost to Follow-up|0
4584751|NCT01474512|7428759|FG016|Maintenance Period|Lost to Follow-up|0
4584752|NCT01474512|7428760|FG017|Maintenance Period|Lost to Follow-up|0
4584753|NCT01474512|7428743|FG000|Maintenance Period|Death|0
4584754|NCT01474512|7428744|FG001|Maintenance Period|Death|0
4584755|NCT01474512|7428745|FG002|Maintenance Period|Death|0
4584756|NCT01474512|7428746|FG003|Maintenance Period|Death|0
4584757|NCT01474512|7428747|FG004|Maintenance Period|Death|0
4584758|NCT01474512|7428748|FG005|Maintenance Period|Death|2
4584759|NCT01474512|7428749|FG006|Maintenance Period|Death|0
4584760|NCT01474512|7428750|FG007|Maintenance Period|Death|0
4584761|NCT01474512|7428751|FG008|Maintenance Period|Death|0
4584762|NCT01474512|7428752|FG009|Maintenance Period|Death|0
4584763|NCT01474512|7428753|FG010|Maintenance Period|Death|0
4584764|NCT01474512|7428754|FG011|Maintenance Period|Death|0
4584765|NCT01474512|7428755|FG012|Maintenance Period|Death|0
4584766|NCT01474512|7428756|FG013|Maintenance Period|Death|0
4584767|NCT01474512|7428757|FG014|Maintenance Period|Death|0
4584768|NCT01474512|7428758|FG015|Maintenance Period|Death|0
4584769|NCT01474512|7428759|FG016|Maintenance Period|Death|0
4584770|NCT01474512|7428760|FG017|Maintenance Period|Death|0
4584771|NCT01474512|7428743|FG000|Maintenance Period|Physician Decision|0
4584772|NCT01474512|7428744|FG001|Maintenance Period|Physician Decision|0
4584773|NCT01474512|7428745|FG002|Maintenance Period|Physician Decision|0
4584774|NCT01474512|7428746|FG003|Maintenance Period|Physician Decision|0
4584775|NCT01474512|7428747|FG004|Maintenance Period|Physician Decision|0
4584776|NCT01474512|7428748|FG005|Maintenance Period|Physician Decision|1
4584777|NCT01474512|7428749|FG006|Maintenance Period|Physician Decision|0
4584778|NCT01474512|7428750|FG007|Maintenance Period|Physician Decision|2
4584779|NCT01474512|7428751|FG008|Maintenance Period|Physician Decision|0
4584780|NCT01474512|7428752|FG009|Maintenance Period|Physician Decision|0
4584781|NCT01474512|7428753|FG010|Maintenance Period|Physician Decision|0
4584782|NCT01474512|7428754|FG011|Maintenance Period|Physician Decision|0
4584783|NCT01474512|7428755|FG012|Maintenance Period|Physician Decision|0
4584784|NCT01474512|7428756|FG013|Maintenance Period|Physician Decision|0
4584785|NCT01474512|7428757|FG014|Maintenance Period|Physician Decision|0
4584786|NCT01474512|7428758|FG015|Maintenance Period|Physician Decision|0
4584787|NCT01474512|7428759|FG016|Maintenance Period|Physician Decision|0
4584788|NCT01474512|7428760|FG017|Maintenance Period|Physician Decision|0
4584789|NCT01474512|7428743|FG000|Maintenance Period|Clinical Relapse|0
4584790|NCT01474512|7428744|FG001|Maintenance Period|Clinical Relapse|0
4584791|NCT01474512|7428745|FG002|Maintenance Period|Clinical Relapse|0
4584792|NCT01474512|7428746|FG003|Maintenance Period|Clinical Relapse|1
4584793|NCT01474512|7428747|FG004|Maintenance Period|Clinical Relapse|0
4584794|NCT01474512|7428748|FG005|Maintenance Period|Clinical Relapse|0
4584795|NCT01474512|7428749|FG006|Maintenance Period|Clinical Relapse|0
4584796|NCT01474512|7428750|FG007|Maintenance Period|Clinical Relapse|0
4584797|NCT01474512|7428751|FG008|Maintenance Period|Clinical Relapse|0
4584798|NCT01474512|7428752|FG009|Maintenance Period|Clinical Relapse|0
4584799|NCT01474512|7428753|FG010|Maintenance Period|Clinical Relapse|0
4584800|NCT01474512|7428754|FG011|Maintenance Period|Clinical Relapse|0
4584801|NCT01474512|7428755|FG012|Maintenance Period|Clinical Relapse|0
4584802|NCT01474512|7428756|FG013|Maintenance Period|Clinical Relapse|0
4584803|NCT01474512|7428757|FG014|Maintenance Period|Clinical Relapse|0
4584804|NCT01474512|7428758|FG015|Maintenance Period|Clinical Relapse|0
4584805|NCT01474512|7428759|FG016|Maintenance Period|Clinical Relapse|0
4584806|NCT01474512|7428760|FG017|Maintenance Period|Clinical Relapse|0
4584807|NCT01474512|7428743|FG000|Maintenance Period|Lack of Efficacy|0
4584808|NCT01474512|7428744|FG001|Maintenance Period|Lack of Efficacy|0
4584809|NCT01474512|7428745|FG002|Maintenance Period|Lack of Efficacy|0
4584810|NCT01474512|7428746|FG003|Maintenance Period|Lack of Efficacy|1
4584811|NCT01474512|7428747|FG004|Maintenance Period|Lack of Efficacy|0
4584812|NCT01474512|7428748|FG005|Maintenance Period|Lack of Efficacy|0
4584813|NCT01474512|7428749|FG006|Maintenance Period|Lack of Efficacy|0
4584814|NCT01474512|7428750|FG007|Maintenance Period|Lack of Efficacy|11
4584815|NCT01474512|7428751|FG008|Maintenance Period|Lack of Efficacy|11
4584816|NCT01474512|7428752|FG009|Maintenance Period|Lack of Efficacy|12
4584817|NCT01474512|7428753|FG010|Maintenance Period|Lack of Efficacy|0
4584818|NCT01474512|7428754|FG011|Maintenance Period|Lack of Efficacy|0
4584819|NCT01474512|7428755|FG012|Maintenance Period|Lack of Efficacy|0
4584820|NCT01474512|7428756|FG013|Maintenance Period|Lack of Efficacy|0
4584821|NCT01474512|7428757|FG014|Maintenance Period|Lack of Efficacy|0
4584822|NCT01474512|7428758|FG015|Maintenance Period|Lack of Efficacy|0
4584823|NCT01474512|7428759|FG016|Maintenance Period|Lack of Efficacy|0
4584824|NCT01474512|7428760|FG017|Maintenance Period|Lack of Efficacy|0
4584825|NCT01474512|7428743|FG000|Maintenance Period|Protocol Violation|0
4584826|NCT01474512|7428744|FG001|Maintenance Period|Protocol Violation|0
4584827|NCT01474512|7428745|FG002|Maintenance Period|Protocol Violation|0
4584828|NCT01474512|7428746|FG003|Maintenance Period|Protocol Violation|1
4584829|NCT01474512|7428747|FG004|Maintenance Period|Protocol Violation|0
4584830|NCT01474512|7428748|FG005|Maintenance Period|Protocol Violation|0
4584831|NCT01474512|7428749|FG006|Maintenance Period|Protocol Violation|0
4584832|NCT01474512|7428750|FG007|Maintenance Period|Protocol Violation|1
4584833|NCT01474512|7428751|FG008|Maintenance Period|Protocol Violation|0
4584834|NCT01474512|7428752|FG009|Maintenance Period|Protocol Violation|1
4584835|NCT01474512|7428753|FG010|Maintenance Period|Protocol Violation|0
4584836|NCT01474512|7428754|FG011|Maintenance Period|Protocol Violation|0
4584837|NCT01474512|7428755|FG012|Maintenance Period|Protocol Violation|0
4584838|NCT01474512|7428756|FG013|Maintenance Period|Protocol Violation|0
4584839|NCT01474512|7428757|FG014|Maintenance Period|Protocol Violation|0
4584840|NCT01474512|7428758|FG015|Maintenance Period|Protocol Violation|0
4584841|NCT01474512|7428759|FG016|Maintenance Period|Protocol Violation|0
4584842|NCT01474512|7428760|FG017|Maintenance Period|Protocol Violation|0
4584843|NCT01474512|7428743|FG000|Maintenance Period|Treated but Discontinued in Induction|0
4584844|NCT01474512|7428744|FG001|Maintenance Period|Treated but Discontinued in Induction|0
4584845|NCT01474512|7428745|FG002|Maintenance Period|Treated but Discontinued in Induction|0
4584846|NCT01474512|7428746|FG003|Maintenance Period|Treated but Discontinued in Induction|0
4584847|NCT01474512|7428747|FG004|Maintenance Period|Treated but Discontinued in Induction|1
4584848|NCT01474512|7428748|FG005|Maintenance Period|Treated but Discontinued in Induction|0
4584849|NCT01474512|7428749|FG006|Maintenance Period|Treated but Discontinued in Induction|0
4584850|NCT01474512|7428750|FG007|Maintenance Period|Treated but Discontinued in Induction|0
4584851|NCT01474512|7428751|FG008|Maintenance Period|Treated but Discontinued in Induction|0
4584852|NCT01474512|7428752|FG009|Maintenance Period|Treated but Discontinued in Induction|0
4584853|NCT01474512|7428753|FG010|Maintenance Period|Treated but Discontinued in Induction|0
4584854|NCT01474512|7428754|FG011|Maintenance Period|Treated but Discontinued in Induction|0
4584855|NCT01474512|7428755|FG012|Maintenance Period|Treated but Discontinued in Induction|0
4584856|NCT01474512|7428756|FG013|Maintenance Period|Treated but Discontinued in Induction|0
4584857|NCT01474512|7428757|FG014|Maintenance Period|Treated but Discontinued in Induction|0
4584858|NCT01474512|7428758|FG015|Maintenance Period|Treated but Discontinued in Induction|0
4584859|NCT01474512|7428759|FG016|Maintenance Period|Treated but Discontinued in Induction|0
4584860|NCT01474512|7428760|FG017|Maintenance Period|Treated but Discontinued in Induction|0
4584861|NCT01474512|7428743|FG000|Long-Term Extension Period|Withdrawal by Subject|0
4584862|NCT01474512|7428744|FG001|Long-Term Extension Period|Withdrawal by Subject|0
4584863|NCT01474512|7428745|FG002|Long-Term Extension Period|Withdrawal by Subject|0
4584864|NCT01474512|7428746|FG003|Long-Term Extension Period|Withdrawal by Subject|0
4584865|NCT01474512|7428747|FG004|Long-Term Extension Period|Withdrawal by Subject|0
4584866|NCT01474512|7428748|FG005|Long-Term Extension Period|Withdrawal by Subject|0
4584867|NCT01474512|7428749|FG006|Long-Term Extension Period|Withdrawal by Subject|0
4584868|NCT01474512|7428750|FG007|Long-Term Extension Period|Withdrawal by Subject|0
4584869|NCT01474512|7428751|FG008|Long-Term Extension Period|Withdrawal by Subject|0
4584870|NCT01474512|7428752|FG009|Long-Term Extension Period|Withdrawal by Subject|0
4584871|NCT01474512|7428753|FG010|Long-Term Extension Period|Withdrawal by Subject|0
4584872|NCT01474512|7428754|FG011|Long-Term Extension Period|Withdrawal by Subject|3
4584873|NCT01474512|7428755|FG012|Long-Term Extension Period|Withdrawal by Subject|61
4584874|NCT01474512|7428756|FG013|Long-Term Extension Period|Withdrawal by Subject|61
4584875|NCT01474512|7428757|FG014|Long-Term Extension Period|Withdrawal by Subject|0
4584876|NCT01474512|7428758|FG015|Long-Term Extension Period|Withdrawal by Subject|0
4584877|NCT01474512|7428759|FG016|Long-Term Extension Period|Withdrawal by Subject|0
4584878|NCT01474512|7428760|FG017|Long-Term Extension Period|Withdrawal by Subject|0
4584879|NCT01474512|7428743|FG000|Long-Term Extension Period|Adverse Event|0
4584880|NCT01474512|7428744|FG001|Long-Term Extension Period|Adverse Event|0
4584881|NCT01474512|7428745|FG002|Long-Term Extension Period|Adverse Event|0
4584882|NCT01474512|7428746|FG003|Long-Term Extension Period|Adverse Event|0
4584883|NCT01474512|7428747|FG004|Long-Term Extension Period|Adverse Event|0
4584884|NCT01474512|7428748|FG005|Long-Term Extension Period|Adverse Event|0
4584885|NCT01474512|7428749|FG006|Long-Term Extension Period|Adverse Event|0
4584886|NCT01474512|7428750|FG007|Long-Term Extension Period|Adverse Event|0
4584887|NCT01474512|7428751|FG008|Long-Term Extension Period|Adverse Event|0
4584888|NCT01474512|7428752|FG009|Long-Term Extension Period|Adverse Event|0
4584889|NCT01474512|7428753|FG010|Long-Term Extension Period|Adverse Event|0
4584890|NCT01474512|7428754|FG011|Long-Term Extension Period|Adverse Event|1
4584891|NCT01474512|7428755|FG012|Long-Term Extension Period|Adverse Event|57
4584892|NCT01474512|7428756|FG013|Long-Term Extension Period|Adverse Event|58
4584893|NCT01474512|7428757|FG014|Long-Term Extension Period|Adverse Event|0
4584894|NCT01474512|7428758|FG015|Long-Term Extension Period|Adverse Event|0
4584895|NCT01474512|7428759|FG016|Long-Term Extension Period|Adverse Event|0
4584896|NCT01474512|7428760|FG017|Long-Term Extension Period|Adverse Event|0
4584897|NCT01474512|7428743|FG000|Long-Term Extension Period|Lost to Follow-up|0
4584898|NCT01474512|7428744|FG001|Long-Term Extension Period|Lost to Follow-up|0
4584899|NCT01474512|7428745|FG002|Long-Term Extension Period|Lost to Follow-up|0
4584900|NCT01474512|7428746|FG003|Long-Term Extension Period|Lost to Follow-up|0
4584901|NCT01474512|7428747|FG004|Long-Term Extension Period|Lost to Follow-up|0
4584902|NCT01474512|7428748|FG005|Long-Term Extension Period|Lost to Follow-up|0
4584903|NCT01474512|7428749|FG006|Long-Term Extension Period|Lost to Follow-up|0
4584904|NCT01474512|7428750|FG007|Long-Term Extension Period|Lost to Follow-up|0
4584905|NCT01474512|7428751|FG008|Long-Term Extension Period|Lost to Follow-up|0
4584906|NCT01474512|7428752|FG009|Long-Term Extension Period|Lost to Follow-up|0
4584907|NCT01474512|7428753|FG010|Long-Term Extension Period|Lost to Follow-up|0
4584908|NCT01474512|7428754|FG011|Long-Term Extension Period|Lost to Follow-up|0
4584909|NCT01474512|7428755|FG012|Long-Term Extension Period|Lost to Follow-up|25
4584910|NCT01474512|7428756|FG013|Long-Term Extension Period|Lost to Follow-up|25
4584911|NCT01474512|7428757|FG014|Long-Term Extension Period|Lost to Follow-up|0
4584912|NCT01474512|7428758|FG015|Long-Term Extension Period|Lost to Follow-up|0
4584913|NCT01474512|7428759|FG016|Long-Term Extension Period|Lost to Follow-up|0
4584914|NCT01474512|7428760|FG017|Long-Term Extension Period|Lost to Follow-up|0
4584915|NCT01474512|7428743|FG000|Long-Term Extension Period|Lack of Efficacy|0
4584916|NCT01474512|7428744|FG001|Long-Term Extension Period|Lack of Efficacy|0
4584917|NCT01474512|7428745|FG002|Long-Term Extension Period|Lack of Efficacy|0
4584918|NCT01474512|7428746|FG003|Long-Term Extension Period|Lack of Efficacy|0
4693262|NCT02589665|7604006|FG009|Induction Extension Period|Reason Not Collected|0
4693263|NCT02589665|7603997|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
4693264|NCT02589665|7603998|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
4693265|NCT02589665|7603999|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
4693266|NCT02589665|7604000|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
4693267|NCT02589665|7604001|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
4693268|NCT02589665|7604002|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
4693269|NCT02589665|7604003|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
4693270|NCT02589665|7604004|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
4693271|NCT02589665|7604005|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
4693272|NCT02589665|7604006|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57
4693273|NCT02589665|7603997|FG000|Maintenance Extension Period|Withdrawal by Subject|0
4693274|NCT02589665|7603998|FG001|Maintenance Extension Period|Withdrawal by Subject|0
4693275|NCT02589665|7603999|FG002|Maintenance Extension Period|Withdrawal by Subject|0
4693276|NCT02589665|7604000|FG003|Maintenance Extension Period|Withdrawal by Subject|0
4693277|NCT02589665|7604001|FG004|Maintenance Extension Period|Withdrawal by Subject|0
4693278|NCT02589665|7604002|FG005|Maintenance Extension Period|Withdrawal by Subject|0
4693279|NCT02589665|7604003|FG006|Maintenance Extension Period|Withdrawal by Subject|0
4693280|NCT02589665|7604004|FG007|Maintenance Extension Period|Withdrawal by Subject|0
4693281|NCT02589665|7604005|FG008|Maintenance Extension Period|Withdrawal by Subject|0
4584919|NCT01474512|7428747|FG004|Long-Term Extension Period|Lack of Efficacy|0
4584920|NCT01474512|7428748|FG005|Long-Term Extension Period|Lack of Efficacy|0
4584921|NCT01474512|7428749|FG006|Long-Term Extension Period|Lack of Efficacy|0
4584922|NCT01474512|7428750|FG007|Long-Term Extension Period|Lack of Efficacy|0
4584923|NCT01474512|7428751|FG008|Long-Term Extension Period|Lack of Efficacy|0
4584924|NCT01474512|7428752|FG009|Long-Term Extension Period|Lack of Efficacy|0
4584925|NCT01474512|7428753|FG010|Long-Term Extension Period|Lack of Efficacy|0
4584926|NCT01474512|7428754|FG011|Long-Term Extension Period|Lack of Efficacy|1
4584927|NCT01474512|7428755|FG012|Long-Term Extension Period|Lack of Efficacy|24
4584928|NCT01474512|7428756|FG013|Long-Term Extension Period|Lack of Efficacy|25
4584929|NCT01474512|7428757|FG014|Long-Term Extension Period|Lack of Efficacy|0
4584930|NCT01474512|7428758|FG015|Long-Term Extension Period|Lack of Efficacy|0
4584931|NCT01474512|7428759|FG016|Long-Term Extension Period|Lack of Efficacy|0
4584932|NCT01474512|7428760|FG017|Long-Term Extension Period|Lack of Efficacy|0
4584933|NCT01474512|7428743|FG000|Long-Term Extension Period|Physician Decision|0
4584934|NCT01474512|7428744|FG001|Long-Term Extension Period|Physician Decision|0
4584935|NCT01474512|7428745|FG002|Long-Term Extension Period|Physician Decision|0
4584936|NCT01474512|7428746|FG003|Long-Term Extension Period|Physician Decision|0
4584937|NCT01474512|7428747|FG004|Long-Term Extension Period|Physician Decision|0
4584938|NCT01474512|7428748|FG005|Long-Term Extension Period|Physician Decision|0
4584939|NCT01474512|7428749|FG006|Long-Term Extension Period|Physician Decision|0
4584940|NCT01474512|7428750|FG007|Long-Term Extension Period|Physician Decision|0
4584941|NCT01474512|7428751|FG008|Long-Term Extension Period|Physician Decision|0
4584942|NCT01474512|7428752|FG009|Long-Term Extension Period|Physician Decision|0
4584943|NCT01474512|7428753|FG010|Long-Term Extension Period|Physician Decision|0
4584944|NCT01474512|7428754|FG011|Long-Term Extension Period|Physician Decision|0
4584945|NCT01474512|7428755|FG012|Long-Term Extension Period|Physician Decision|21
4584946|NCT01474512|7428756|FG013|Long-Term Extension Period|Physician Decision|21
4584947|NCT01474512|7428757|FG014|Long-Term Extension Period|Physician Decision|0
4584948|NCT01474512|7428758|FG015|Long-Term Extension Period|Physician Decision|0
4584949|NCT01474512|7428759|FG016|Long-Term Extension Period|Physician Decision|0
4584950|NCT01474512|7428760|FG017|Long-Term Extension Period|Physician Decision|0
4584951|NCT01474512|7428743|FG000|Long-Term Extension Period|Clinical Relapse|0
4584952|NCT01474512|7428744|FG001|Long-Term Extension Period|Clinical Relapse|0
4584953|NCT01474512|7428745|FG002|Long-Term Extension Period|Clinical Relapse|0
4584954|NCT01474512|7428746|FG003|Long-Term Extension Period|Clinical Relapse|0
4584955|NCT01474512|7428747|FG004|Long-Term Extension Period|Clinical Relapse|0
4584956|NCT01474512|7428748|FG005|Long-Term Extension Period|Clinical Relapse|0
4584957|NCT01474512|7428749|FG006|Long-Term Extension Period|Clinical Relapse|0
4584958|NCT01474512|7428750|FG007|Long-Term Extension Period|Clinical Relapse|0
4584959|NCT01474512|7428751|FG008|Long-Term Extension Period|Clinical Relapse|0
4584960|NCT01474512|7428752|FG009|Long-Term Extension Period|Clinical Relapse|0
4584961|NCT01474512|7428753|FG010|Long-Term Extension Period|Clinical Relapse|0
4584962|NCT01474512|7428754|FG011|Long-Term Extension Period|Clinical Relapse|0
4584963|NCT01474512|7428755|FG012|Long-Term Extension Period|Clinical Relapse|9
4584964|NCT01474512|7428756|FG013|Long-Term Extension Period|Clinical Relapse|9
4584965|NCT01474512|7428757|FG014|Long-Term Extension Period|Clinical Relapse|0
4584966|NCT01474512|7428758|FG015|Long-Term Extension Period|Clinical Relapse|0
4584967|NCT01474512|7428759|FG016|Long-Term Extension Period|Clinical Relapse|0
4584968|NCT01474512|7428760|FG017|Long-Term Extension Period|Clinical Relapse|0
4584969|NCT01474512|7428743|FG000|Long-Term Extension Period|Death|0
4584970|NCT01474512|7428744|FG001|Long-Term Extension Period|Death|0
4584971|NCT01474512|7428745|FG002|Long-Term Extension Period|Death|0
4584972|NCT01474512|7428746|FG003|Long-Term Extension Period|Death|0
4584973|NCT01474512|7428747|FG004|Long-Term Extension Period|Death|0
4584974|NCT01474512|7428748|FG005|Long-Term Extension Period|Death|0
4584975|NCT01474512|7428749|FG006|Long-Term Extension Period|Death|0
4584976|NCT01474512|7428750|FG007|Long-Term Extension Period|Death|0
4584977|NCT01474512|7428751|FG008|Long-Term Extension Period|Death|0
4584978|NCT01474512|7428752|FG009|Long-Term Extension Period|Death|0
4584979|NCT01474512|7428753|FG010|Long-Term Extension Period|Death|0
4584980|NCT01474512|7428754|FG011|Long-Term Extension Period|Death|0
4584981|NCT01474512|7428755|FG012|Long-Term Extension Period|Death|9
4584982|NCT01474512|7428756|FG013|Long-Term Extension Period|Death|9
4584983|NCT01474512|7428757|FG014|Long-Term Extension Period|Death|0
4584984|NCT01474512|7428758|FG015|Long-Term Extension Period|Death|0
4584985|NCT01474512|7428759|FG016|Long-Term Extension Period|Death|0
4584986|NCT01474512|7428760|FG017|Long-Term Extension Period|Death|0
4584987|NCT01474512|7428743|FG000|Long-Term Extension Period|Sponsor Decision|0
4584988|NCT01474512|7428744|FG001|Long-Term Extension Period|Sponsor Decision|0
4584989|NCT01474512|7428745|FG002|Long-Term Extension Period|Sponsor Decision|0
4584990|NCT01474512|7428746|FG003|Long-Term Extension Period|Sponsor Decision|0
4584991|NCT01474512|7428747|FG004|Long-Term Extension Period|Sponsor Decision|0
4584992|NCT01474512|7428748|FG005|Long-Term Extension Period|Sponsor Decision|0
4584993|NCT01474512|7428749|FG006|Long-Term Extension Period|Sponsor Decision|0
4584994|NCT01474512|7428750|FG007|Long-Term Extension Period|Sponsor Decision|0
4584995|NCT01474512|7428751|FG008|Long-Term Extension Period|Sponsor Decision|0
4584996|NCT01474512|7428752|FG009|Long-Term Extension Period|Sponsor Decision|0
4584997|NCT01474512|7428753|FG010|Long-Term Extension Period|Sponsor Decision|0
4584998|NCT01474512|7428754|FG011|Long-Term Extension Period|Sponsor Decision|0
4584999|NCT01474512|7428755|FG012|Long-Term Extension Period|Sponsor Decision|6
4585000|NCT01474512|7428756|FG013|Long-Term Extension Period|Sponsor Decision|6
4585001|NCT01474512|7428757|FG014|Long-Term Extension Period|Sponsor Decision|0
4585002|NCT01474512|7428758|FG015|Long-Term Extension Period|Sponsor Decision|0
4585003|NCT01474512|7428759|FG016|Long-Term Extension Period|Sponsor Decision|0
4585004|NCT01474512|7428760|FG017|Long-Term Extension Period|Sponsor Decision|0
4585005|NCT01474512|7428743|FG000|Long-Term Extension Period|Protocol Violation|0
4585006|NCT01474512|7428744|FG001|Long-Term Extension Period|Protocol Violation|0
4585007|NCT01474512|7428745|FG002|Long-Term Extension Period|Protocol Violation|0
4585008|NCT01474512|7428746|FG003|Long-Term Extension Period|Protocol Violation|0
4585009|NCT01474512|7428747|FG004|Long-Term Extension Period|Protocol Violation|0
4585010|NCT01474512|7428748|FG005|Long-Term Extension Period|Protocol Violation|0
4585011|NCT01474512|7428749|FG006|Long-Term Extension Period|Protocol Violation|0
4585012|NCT01474512|7428750|FG007|Long-Term Extension Period|Protocol Violation|0
4585013|NCT01474512|7428751|FG008|Long-Term Extension Period|Protocol Violation|0
4585014|NCT01474512|7428752|FG009|Long-Term Extension Period|Protocol Violation|0
4585015|NCT01474512|7428753|FG010|Long-Term Extension Period|Protocol Violation|0
4585016|NCT01474512|7428754|FG011|Long-Term Extension Period|Protocol Violation|0
4585017|NCT01474512|7428755|FG012|Long-Term Extension Period|Protocol Violation|5
4585018|NCT01474512|7428756|FG013|Long-Term Extension Period|Protocol Violation|5
4585019|NCT01474512|7428757|FG014|Long-Term Extension Period|Protocol Violation|0
4585020|NCT01474512|7428758|FG015|Long-Term Extension Period|Protocol Violation|0
4585021|NCT01474512|7428759|FG016|Long-Term Extension Period|Protocol Violation|0
4585022|NCT01474512|7428760|FG017|Long-Term Extension Period|Protocol Violation|0
4585023|NCT01474512|7428743|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0
4585024|NCT01474512|7428744|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0
4585025|NCT01474512|7428745|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0
4585026|NCT01474512|7428746|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0
4585027|NCT01474512|7428747|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0
4585028|NCT01474512|7428748|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0
4585029|NCT01474512|7428749|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0
4585030|NCT01474512|7428750|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0
4693282|NCT02589665|7604006|FG009|Maintenance Extension Period|Withdrawal by Subject|4
4693283|NCT02589665|7603997|FG000|Maintenance Extension Period|Lack of Efficacy|0
4693284|NCT02589665|7603998|FG001|Maintenance Extension Period|Lack of Efficacy|0
4693285|NCT02589665|7603999|FG002|Maintenance Extension Period|Lack of Efficacy|0
4693286|NCT02589665|7604000|FG003|Maintenance Extension Period|Lack of Efficacy|0
4693287|NCT02589665|7604001|FG004|Maintenance Extension Period|Lack of Efficacy|0
4693288|NCT02589665|7604002|FG005|Maintenance Extension Period|Lack of Efficacy|0
4693289|NCT02589665|7604003|FG006|Maintenance Extension Period|Lack of Efficacy|0
4693290|NCT02589665|7604004|FG007|Maintenance Extension Period|Lack of Efficacy|0
4693291|NCT02589665|7604005|FG008|Maintenance Extension Period|Lack of Efficacy|0
4693292|NCT02589665|7604006|FG009|Maintenance Extension Period|Lack of Efficacy|4
4693293|NCT02589665|7603997|FG000|Maintenance Extension Period|Adverse Event|0
4693294|NCT02589665|7603998|FG001|Maintenance Extension Period|Adverse Event|0
4693295|NCT02589665|7603999|FG002|Maintenance Extension Period|Adverse Event|0
4693296|NCT02589665|7604000|FG003|Maintenance Extension Period|Adverse Event|0
4693297|NCT02589665|7604001|FG004|Maintenance Extension Period|Adverse Event|0
4693298|NCT02589665|7604002|FG005|Maintenance Extension Period|Adverse Event|0
4693299|NCT02589665|7604003|FG006|Maintenance Extension Period|Adverse Event|0
4693300|NCT02589665|7604004|FG007|Maintenance Extension Period|Adverse Event|0
4693301|NCT02589665|7604005|FG008|Maintenance Extension Period|Adverse Event|0
4693302|NCT02589665|7604006|FG009|Maintenance Extension Period|Adverse Event|2
4693303|NCT02589665|7603997|FG000|Maintenance Extension Period|Non-responder|0
4693304|NCT02589665|7603998|FG001|Maintenance Extension Period|Non-responder|0
4693305|NCT02589665|7603999|FG002|Maintenance Extension Period|Non-responder|0
4693306|NCT02589665|7604000|FG003|Maintenance Extension Period|Non-responder|0
4693307|NCT02589665|7604001|FG004|Maintenance Extension Period|Non-responder|0
4693308|NCT02589665|7604002|FG005|Maintenance Extension Period|Non-responder|0
4693309|NCT02589665|7604003|FG006|Maintenance Extension Period|Non-responder|0
4693310|NCT02589665|7604004|FG007|Maintenance Extension Period|Non-responder|0
4693311|NCT02589665|7604005|FG008|Maintenance Extension Period|Non-responder|0
4693312|NCT02589665|7604006|FG009|Maintenance Extension Period|Non-responder|1
4693313|NCT02590003|7604059|FG000|Overall Study|Death|1
4693314|NCT02590003|7604060|FG001|Overall Study|Death|2
4693315|NCT02590354|7604066|FG000|Phase 1|Active hepatitis B or C infection|1
4693316|NCT02590354|7604066|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1
4693317|NCT02590354|7604066|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75
4693318|NCT02590354|7604066|FG000|Phase 1|Subject does not want to participate|20
4693319|NCT02590354|7604066|FG000|Phase 1|Lost to Follow-up|1
4693320|NCT02590354|7604066|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2
4693321|NCT02590406|7604073|FG000|Overall Study|Adverse Event|1
4693322|NCT02590406|7604074|FG001|Overall Study|Adverse Event|0
4693323|NCT02590406|7604073|FG000|Overall Study|Saturometer malfunction|0
4693324|NCT02590406|7604074|FG001|Overall Study|Saturometer malfunction|1
4693325|NCT02590432|7604082|FG000|Open-label Treatment Period|Adverse Event|97
4693326|NCT02590432|7604083|FG001|Open-label Treatment Period|Adverse Event|79
4693327|NCT02590432|7604084|FG002|Open-label Treatment Period|Adverse Event|0
4693328|NCT02590432|7604085|FG003|Open-label Treatment Period|Adverse Event|0
4693329|NCT02590432|7604086|FG004|Open-label Treatment Period|Adverse Event|0
4693330|NCT02590432|7604087|FG005|Open-label Treatment Period|Adverse Event|0
4693331|NCT02590432|7604088|FG006|Open-label Treatment Period|Adverse Event|0
4693332|NCT02590432|7604089|FG007|Open-label Treatment Period|Adverse Event|0
4693333|NCT02590432|7604090|FG008|Open-label Treatment Period|Adverse Event|0
4693334|NCT02590432|7604082|FG000|Open-label Treatment Period|Lack of Efficacy|14
4693335|NCT02590432|7604083|FG001|Open-label Treatment Period|Lack of Efficacy|5
4693336|NCT02590432|7604084|FG002|Open-label Treatment Period|Lack of Efficacy|0
4734978|NCT03515824|7682517|FG001|Overall Study|Study terminated by sponsor|1
4585031|NCT01474512|7428751|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0
4585032|NCT01474512|7428752|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0
4585033|NCT01474512|7428753|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0
4585034|NCT01474512|7428754|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0
4585035|NCT01474512|7428755|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1
4585036|NCT01474512|7428756|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1
4585037|NCT01474512|7428757|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0
4585038|NCT01474512|7428758|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0
4585039|NCT01474512|7428759|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0
4585040|NCT01474512|7428760|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0
4585041|NCT01474512|7428743|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0
4585042|NCT01474512|7428744|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0
4585043|NCT01474512|7428745|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0
4585044|NCT01474512|7428746|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0
4585045|NCT01474512|7428747|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0
4585046|NCT01474512|7428748|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0
4585047|NCT01474512|7428749|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0
4585048|NCT01474512|7428750|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0
4585049|NCT01474512|7428751|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0
4585050|NCT01474512|7428752|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0
4585051|NCT01474512|7428753|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0
4585052|NCT01474512|7428754|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21
4585053|NCT01474512|7428755|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0
4585054|NCT01474512|7428756|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0
4585055|NCT01474512|7428757|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0
4585056|NCT01474512|7428758|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0
4585057|NCT01474512|7428759|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0
4585058|NCT01474512|7428760|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0
4585059|NCT01474512|7428743|FG000|Post-Treatment Follow-Up|Adverse Event|0
4585060|NCT01474512|7428744|FG001|Post-Treatment Follow-Up|Adverse Event|0
4585061|NCT01474512|7428745|FG002|Post-Treatment Follow-Up|Adverse Event|0
4585062|NCT01474512|7428746|FG003|Post-Treatment Follow-Up|Adverse Event|0
4585063|NCT01474512|7428747|FG004|Post-Treatment Follow-Up|Adverse Event|0
4585064|NCT01474512|7428748|FG005|Post-Treatment Follow-Up|Adverse Event|0
4585065|NCT01474512|7428749|FG006|Post-Treatment Follow-Up|Adverse Event|0
4585066|NCT01474512|7428750|FG007|Post-Treatment Follow-Up|Adverse Event|0
4585067|NCT01474512|7428751|FG008|Post-Treatment Follow-Up|Adverse Event|0
4585068|NCT01474512|7428752|FG009|Post-Treatment Follow-Up|Adverse Event|0
4585069|NCT01474512|7428753|FG010|Post-Treatment Follow-Up|Adverse Event|0
4585070|NCT01474512|7428754|FG011|Post-Treatment Follow-Up|Adverse Event|0
4585071|NCT01474512|7428755|FG012|Post-Treatment Follow-Up|Adverse Event|0
4585072|NCT01474512|7428756|FG013|Post-Treatment Follow-Up|Adverse Event|0
4585073|NCT01474512|7428757|FG014|Post-Treatment Follow-Up|Adverse Event|8
4585074|NCT01474512|7428758|FG015|Post-Treatment Follow-Up|Adverse Event|2
4585075|NCT01474512|7428759|FG016|Post-Treatment Follow-Up|Adverse Event|58
4585076|NCT01474512|7428760|FG017|Post-Treatment Follow-Up|Adverse Event|11
4585077|NCT01474512|7428743|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0
4585078|NCT01474512|7428744|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0
4585079|NCT01474512|7428745|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0
4585080|NCT01474512|7428746|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0
4585081|NCT01474512|7428747|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0
4585082|NCT01474512|7428748|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0
4585083|NCT01474512|7428749|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0
4585084|NCT01474512|7428750|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0
4585085|NCT01474512|7428751|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0
4585086|NCT01474512|7428752|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0
4585087|NCT01474512|7428753|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0
4585088|NCT01474512|7428754|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0
4585089|NCT01474512|7428755|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0
4585090|NCT01474512|7428756|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0
4585091|NCT01474512|7428757|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3
4585092|NCT01474512|7428758|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2
4585093|NCT01474512|7428759|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36
4585094|NCT01474512|7428760|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17
4585095|NCT01474512|7428743|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0
4585096|NCT01474512|7428744|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0
4585097|NCT01474512|7428745|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0
4585098|NCT01474512|7428746|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0
4585099|NCT01474512|7428747|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0
4585100|NCT01474512|7428748|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0
4585101|NCT01474512|7428749|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0
4585102|NCT01474512|7428750|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0
4585103|NCT01474512|7428751|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0
4585104|NCT01474512|7428752|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0
4585105|NCT01474512|7428753|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0
4585106|NCT01474512|7428754|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0
4585107|NCT01474512|7428755|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0
4585108|NCT01474512|7428756|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0
4585109|NCT01474512|7428757|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3
4585110|NCT01474512|7428758|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2
4585111|NCT01474512|7428759|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31
4585112|NCT01474512|7428760|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3
4585113|NCT01474512|7428743|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0
4585114|NCT01474512|7428744|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0
4585115|NCT01474512|7428745|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0
4585116|NCT01474512|7428746|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0
4585117|NCT01474512|7428747|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0
4585118|NCT01474512|7428748|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0
4585119|NCT01474512|7428749|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0
4585120|NCT01474512|7428750|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0
4585121|NCT01474512|7428751|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0
4585122|NCT01474512|7428752|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0
4585123|NCT01474512|7428753|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0
4585124|NCT01474512|7428754|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0
4585125|NCT01474512|7428755|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0
4585126|NCT01474512|7428756|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0
4585127|NCT01474512|7428757|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0
4585128|NCT01474512|7428758|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0
4585129|NCT01474512|7428759|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12
4585130|NCT01474512|7428760|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7
4585131|NCT01474512|7428743|FG000|Post-Treatment Follow-Up|Physician Decision|0
4585132|NCT01474512|7428744|FG001|Post-Treatment Follow-Up|Physician Decision|0
4585133|NCT01474512|7428745|FG002|Post-Treatment Follow-Up|Physician Decision|0
4585134|NCT01474512|7428746|FG003|Post-Treatment Follow-Up|Physician Decision|0
4585135|NCT01474512|7428747|FG004|Post-Treatment Follow-Up|Physician Decision|0
4585136|NCT01474512|7428748|FG005|Post-Treatment Follow-Up|Physician Decision|0
4585137|NCT01474512|7428749|FG006|Post-Treatment Follow-Up|Physician Decision|0
4585138|NCT01474512|7428750|FG007|Post-Treatment Follow-Up|Physician Decision|0
4585139|NCT01474512|7428751|FG008|Post-Treatment Follow-Up|Physician Decision|0
4585140|NCT01474512|7428752|FG009|Post-Treatment Follow-Up|Physician Decision|0
4585141|NCT01474512|7428753|FG010|Post-Treatment Follow-Up|Physician Decision|0
4585142|NCT01474512|7428754|FG011|Post-Treatment Follow-Up|Physician Decision|0
4585143|NCT01474512|7428755|FG012|Post-Treatment Follow-Up|Physician Decision|0
4585144|NCT01474512|7428756|FG013|Post-Treatment Follow-Up|Physician Decision|0
4585145|NCT01474512|7428757|FG014|Post-Treatment Follow-Up|Physician Decision|0
4585146|NCT01474512|7428758|FG015|Post-Treatment Follow-Up|Physician Decision|0
4585147|NCT01474512|7428759|FG016|Post-Treatment Follow-Up|Physician Decision|4
4585148|NCT01474512|7428760|FG017|Post-Treatment Follow-Up|Physician Decision|5
4585149|NCT01474512|7428743|FG000|Post-Treatment Follow-Up|Clinical Relapse|0
4585150|NCT01474512|7428744|FG001|Post-Treatment Follow-Up|Clinical Relapse|0
4585151|NCT01474512|7428745|FG002|Post-Treatment Follow-Up|Clinical Relapse|0
4585152|NCT01474512|7428746|FG003|Post-Treatment Follow-Up|Clinical Relapse|0
4585153|NCT01474512|7428747|FG004|Post-Treatment Follow-Up|Clinical Relapse|0
4585154|NCT01474512|7428748|FG005|Post-Treatment Follow-Up|Clinical Relapse|0
4585155|NCT01474512|7428749|FG006|Post-Treatment Follow-Up|Clinical Relapse|0
4585156|NCT01474512|7428750|FG007|Post-Treatment Follow-Up|Clinical Relapse|0
4585157|NCT01474512|7428751|FG008|Post-Treatment Follow-Up|Clinical Relapse|0
4585158|NCT01474512|7428752|FG009|Post-Treatment Follow-Up|Clinical Relapse|0
4585159|NCT01474512|7428753|FG010|Post-Treatment Follow-Up|Clinical Relapse|0
4585160|NCT01474512|7428754|FG011|Post-Treatment Follow-Up|Clinical Relapse|0
4585161|NCT01474512|7428755|FG012|Post-Treatment Follow-Up|Clinical Relapse|0
4585162|NCT01474512|7428756|FG013|Post-Treatment Follow-Up|Clinical Relapse|0
4585163|NCT01474512|7428757|FG014|Post-Treatment Follow-Up|Clinical Relapse|0
4585164|NCT01474512|7428758|FG015|Post-Treatment Follow-Up|Clinical Relapse|0
4585165|NCT01474512|7428759|FG016|Post-Treatment Follow-Up|Clinical Relapse|6
4585166|NCT01474512|7428760|FG017|Post-Treatment Follow-Up|Clinical Relapse|2
4585167|NCT01474512|7428743|FG000|Post-Treatment Follow-Up|Protocol Violation|0
4585168|NCT01474512|7428744|FG001|Post-Treatment Follow-Up|Protocol Violation|0
4585169|NCT01474512|7428745|FG002|Post-Treatment Follow-Up|Protocol Violation|0
4585170|NCT01474512|7428746|FG003|Post-Treatment Follow-Up|Protocol Violation|0
4585171|NCT01474512|7428747|FG004|Post-Treatment Follow-Up|Protocol Violation|0
4585172|NCT01474512|7428748|FG005|Post-Treatment Follow-Up|Protocol Violation|0
4585173|NCT01474512|7428749|FG006|Post-Treatment Follow-Up|Protocol Violation|0
4585174|NCT01474512|7428750|FG007|Post-Treatment Follow-Up|Protocol Violation|0
4585175|NCT01474512|7428751|FG008|Post-Treatment Follow-Up|Protocol Violation|0
4585176|NCT01474512|7428752|FG009|Post-Treatment Follow-Up|Protocol Violation|0
4585177|NCT01474512|7428753|FG010|Post-Treatment Follow-Up|Protocol Violation|0
4585178|NCT01474512|7428754|FG011|Post-Treatment Follow-Up|Protocol Violation|0
4585179|NCT01474512|7428755|FG012|Post-Treatment Follow-Up|Protocol Violation|0
4585180|NCT01474512|7428756|FG013|Post-Treatment Follow-Up|Protocol Violation|0
4585181|NCT01474512|7428757|FG014|Post-Treatment Follow-Up|Protocol Violation|2
4585182|NCT01474512|7428758|FG015|Post-Treatment Follow-Up|Protocol Violation|2
4585183|NCT01474512|7428759|FG016|Post-Treatment Follow-Up|Protocol Violation|4
4585184|NCT01474512|7428760|FG017|Post-Treatment Follow-Up|Protocol Violation|0
4585185|NCT01474512|7428743|FG000|Post-Treatment Follow-Up|Sponsor Decision|0
4585186|NCT01474512|7428744|FG001|Post-Treatment Follow-Up|Sponsor Decision|0
4585187|NCT01474512|7428745|FG002|Post-Treatment Follow-Up|Sponsor Decision|0
4585188|NCT01474512|7428746|FG003|Post-Treatment Follow-Up|Sponsor Decision|0
4585189|NCT01474512|7428747|FG004|Post-Treatment Follow-Up|Sponsor Decision|0
4585190|NCT01474512|7428748|FG005|Post-Treatment Follow-Up|Sponsor Decision|0
4585191|NCT01474512|7428749|FG006|Post-Treatment Follow-Up|Sponsor Decision|0
4585192|NCT01474512|7428750|FG007|Post-Treatment Follow-Up|Sponsor Decision|0
4585193|NCT01474512|7428751|FG008|Post-Treatment Follow-Up|Sponsor Decision|0
4585194|NCT01474512|7428752|FG009|Post-Treatment Follow-Up|Sponsor Decision|0
4585195|NCT01474512|7428753|FG010|Post-Treatment Follow-Up|Sponsor Decision|0
4585196|NCT01474512|7428754|FG011|Post-Treatment Follow-Up|Sponsor Decision|0
4585197|NCT01474512|7428755|FG012|Post-Treatment Follow-Up|Sponsor Decision|0
4585198|NCT01474512|7428756|FG013|Post-Treatment Follow-Up|Sponsor Decision|0
4585199|NCT01474512|7428757|FG014|Post-Treatment Follow-Up|Sponsor Decision|1
4585200|NCT01474512|7428758|FG015|Post-Treatment Follow-Up|Sponsor Decision|0
4585201|NCT01474512|7428759|FG016|Post-Treatment Follow-Up|Sponsor Decision|4
4585202|NCT01474512|7428760|FG017|Post-Treatment Follow-Up|Sponsor Decision|0
4585203|NCT01474512|7428743|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
4585204|NCT01474512|7428744|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
4585205|NCT01474512|7428745|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
4585206|NCT01474512|7428746|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
4585207|NCT01474512|7428747|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
4585208|NCT01474512|7428748|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
4585209|NCT01474512|7428749|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
4585210|NCT01474512|7428750|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
4585211|NCT01474512|7428751|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
4585212|NCT01474512|7428752|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
4585213|NCT01474512|7428753|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
4585214|NCT01474512|7428754|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
4585215|NCT01474512|7428755|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
4585216|NCT01474512|7428756|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
4585217|NCT01474512|7428757|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1
4585218|NCT01474512|7428758|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
4585219|NCT01474512|7428759|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
4585220|NCT01474512|7428760|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1
4585221|NCT01474512|7428743|FG000|Post-Treatment Follow-Up|Death|0
4585222|NCT01474512|7428744|FG001|Post-Treatment Follow-Up|Death|0
4585223|NCT01474512|7428745|FG002|Post-Treatment Follow-Up|Death|0
4585224|NCT01474512|7428746|FG003|Post-Treatment Follow-Up|Death|0
4585225|NCT01474512|7428747|FG004|Post-Treatment Follow-Up|Death|0
4585226|NCT01474512|7428748|FG005|Post-Treatment Follow-Up|Death|0
4585227|NCT01474512|7428749|FG006|Post-Treatment Follow-Up|Death|0
4585228|NCT01474512|7428750|FG007|Post-Treatment Follow-Up|Death|0
4585229|NCT01474512|7428751|FG008|Post-Treatment Follow-Up|Death|0
4585230|NCT01474512|7428752|FG009|Post-Treatment Follow-Up|Death|0
4585231|NCT01474512|7428753|FG010|Post-Treatment Follow-Up|Death|0
4585232|NCT01474512|7428754|FG011|Post-Treatment Follow-Up|Death|0
4585233|NCT01474512|7428755|FG012|Post-Treatment Follow-Up|Death|0
4585234|NCT01474512|7428756|FG013|Post-Treatment Follow-Up|Death|0
4585235|NCT01474512|7428757|FG014|Post-Treatment Follow-Up|Death|0
4585236|NCT01474512|7428758|FG015|Post-Treatment Follow-Up|Death|0
4585237|NCT01474512|7428759|FG016|Post-Treatment Follow-Up|Death|1
4585238|NCT01474512|7428760|FG017|Post-Treatment Follow-Up|Death|0
4585239|NCT01474538|7428792|FG000|Treatment Period 1|Death|1
4585240|NCT01474538|7428793|FG001|Treatment Period 1|Death|0
4585241|NCT01474538|7428792|FG000|Treatment Period 1|Physician Decision|1
4585242|NCT01474538|7428793|FG001|Treatment Period 1|Physician Decision|0
4585243|NCT01474538|7428792|FG000|Treatment Period 1|Withdrawal by Subject|1
4585244|NCT01474538|7428793|FG001|Treatment Period 1|Withdrawal by Subject|3
4585245|NCT01474538|7428792|FG000|Treatment Period 1|Protocol Violation|0
4585246|NCT01474538|7428793|FG001|Treatment Period 1|Protocol Violation|1
4585247|NCT01474538|7428792|FG000|Treatment Period 2|Death|1
4585248|NCT01474538|7428793|FG001|Treatment Period 2|Death|0
4585249|NCT01474538|7428792|FG000|Treatment Period 2|Adverse Event|1
4585250|NCT01474538|7428793|FG001|Treatment Period 2|Adverse Event|1
4585251|NCT01474538|7428792|FG000|Treatment Period 2|Withdrawal by Subject|2
4585252|NCT01474538|7428793|FG001|Treatment Period 2|Withdrawal by Subject|0
4585253|NCT01474538|7428792|FG000|Treatment Period 2|Sponsor decision|1
4585254|NCT01474538|7428793|FG001|Treatment Period 2|Sponsor decision|0
4585255|NCT01474538|7428792|FG000|Treatment Period 2|Physician Decision|0
4585256|NCT01474538|7428793|FG001|Treatment Period 2|Physician Decision|1
4585257|NCT01474538|7428792|FG000|Treatment Period 2|Protocol Violation|1
4585258|NCT01474538|7428793|FG001|Treatment Period 2|Protocol Violation|0
4585259|NCT01474551|7428799|FG000|Overall Study|Death|1
4585260|NCT01474681|7428814|FG000|Overall Study|Death|0
4585261|NCT01474681|7428815|FG001|Overall Study|Death|3
4585262|NCT01474681|7428816|FG002|Overall Study|Death|2
4585263|NCT01474681|7428817|FG003|Overall Study|Death|6
4585264|NCT01474746|7428833|FG000|Overall Study|Lost to Follow-up|1
4585265|NCT01474746|7428834|FG001|Overall Study|Lost to Follow-up|1
4585266|NCT01474746|7428833|FG000|Overall Study|Withdrawal by Subject|2
4585267|NCT01474746|7428834|FG001|Overall Study|Withdrawal by Subject|1
4585268|NCT01474772|7428842|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6
4585269|NCT01474772|7428843|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1
4585270|NCT01474772|7428842|FG000|Period 1|AE not Related to Study Drug|1
4585271|NCT01474772|7428843|FG001|Period 1|AE not Related to Study Drug|0
4585272|NCT01474772|7428842|FG000|Period 1|Withdrawal by Subject|3
4585273|NCT01474772|7428843|FG001|Period 1|Withdrawal by Subject|1
4585274|NCT01474772|7428842|FG000|Period 1|Lost to Follow-up|1
4585275|NCT01474772|7428843|FG001|Period 1|Lost to Follow-up|0
4585276|NCT01474772|7428842|FG000|Period 1|Reason not Specified|1
4585277|NCT01474772|7428843|FG001|Period 1|Reason not Specified|1
4585278|NCT01474772|7428842|FG000|Washout|AE not Related to Study Drug|2
4585279|NCT01474772|7428843|FG001|Washout|AE not Related to Study Drug|0
4585280|NCT01474772|7428842|FG000|Washout|Withdrawal by Subject|1
4585281|NCT01474772|7428843|FG001|Washout|Withdrawal by Subject|0
4585282|NCT01474772|7428842|FG000|Washout|Lost to Follow-up|0
4585283|NCT01474772|7428843|FG001|Washout|Lost to Follow-up|1
4585284|NCT01474772|7428842|FG000|Washout|Reason not Specified|0
4585285|NCT01474772|7428843|FG001|Washout|Reason not Specified|1
4585286|NCT01474772|7428842|FG000|Period 2|Death|0
4585287|NCT01474772|7428843|FG001|Period 2|Death|1
4585288|NCT01474772|7428842|FG000|Period 2|AE Related to Study Drug|0
4585289|NCT01474772|7428843|FG001|Period 2|AE Related to Study Drug|1
4585290|NCT01474772|7428842|FG000|Period 2|AE not Related to Study Drug|4
4585291|NCT01474772|7428843|FG001|Period 2|AE not Related to Study Drug|1
4585292|NCT01474772|7428842|FG000|Period 2|Lack of Efficacy|1
4585293|NCT01474772|7428843|FG001|Period 2|Lack of Efficacy|0
4585294|NCT01474772|7428842|FG000|Period 2|Withdrawal by Subject|3
4585295|NCT01474772|7428843|FG001|Period 2|Withdrawal by Subject|4
4585296|NCT01474772|7428842|FG000|Period 2|Lost to Follow-up|1
4585297|NCT01474772|7428843|FG001|Period 2|Lost to Follow-up|1
4585298|NCT01474772|7428842|FG000|Period 2|Reason not Specified|0
4585299|NCT01474772|7428843|FG001|Period 2|Reason not Specified|2
4585300|NCT01474772|7428842|FG000|Follow-up|AE not Related to Study Drug|0
4585301|NCT01474772|7428843|FG001|Follow-up|AE not Related to Study Drug|1
4585302|NCT01474876|7428865|FG000|Overall Study|Adverse Event|11
4585303|NCT01474876|7428866|FG001|Overall Study|Adverse Event|5
4585304|NCT01474876|7428867|FG002|Overall Study|Adverse Event|0
4585305|NCT01474876|7428865|FG000|Overall Study|Serious Adverse Event|2
4585306|NCT01474876|7428866|FG001|Overall Study|Serious Adverse Event|3
4585307|NCT01474876|7428867|FG002|Overall Study|Serious Adverse Event|0
4585308|NCT01474876|7428865|FG000|Overall Study|Lost to Follow-up|5
4585309|NCT01474876|7428866|FG001|Overall Study|Lost to Follow-up|4
4585310|NCT01474876|7428867|FG002|Overall Study|Lost to Follow-up|0
4585311|NCT01474876|7428865|FG000|Overall Study|Investigator's decision|28
4585312|NCT01474876|7428866|FG001|Overall Study|Investigator's decision|6
4585313|NCT01474876|7428867|FG002|Overall Study|Investigator's decision|0
4585314|NCT01474876|7428865|FG000|Overall Study|Patient's request|19
4585315|NCT01474876|7428866|FG001|Overall Study|Patient's request|5
4585316|NCT01474876|7428867|FG002|Overall Study|Patient's request|0
4585317|NCT01474876|7428865|FG000|Overall Study|Investigator's decision and pt request|1
4585318|NCT01474876|7428866|FG001|Overall Study|Investigator's decision and pt request|0
4585319|NCT01474876|7428867|FG002|Overall Study|Investigator's decision and pt request|0
4585320|NCT01474993|7428885|FG000|Overall Study|Lost to Follow-up|1
4585321|NCT01474993|7428886|FG001|Overall Study|Lost to Follow-up|2
4585322|NCT01474993|7428885|FG000|Overall Study|Adverse Event|0
4585323|NCT01474993|7428886|FG001|Overall Study|Adverse Event|1
4585324|NCT01475071|7428894|FG000|Overall Study|Physician Decision|1
4585325|NCT01475071|7428894|FG000|Overall Study|Withdrawal by Subject|6
4585326|NCT01475071|7428894|FG000|Overall Study|Lost to Follow-up|1
4585327|NCT01475097|7428902|FG000|Overall Study|Protocol Violation|1
4585328|NCT01475097|7428903|FG001|Overall Study|Protocol Violation|1
4585329|NCT01475136|7428913|FG000|Overall Study|Sponsor Decision|0
4585330|NCT01475136|7428914|FG001|Overall Study|Sponsor Decision|1
4585331|NCT01475136|7428915|FG002|Overall Study|Sponsor Decision|0
4585332|NCT01475136|7428916|FG003|Overall Study|Sponsor Decision|0
4585333|NCT01475136|7428913|FG000|Overall Study|Entry Criteria Not Met|0
4585334|NCT01475136|7428914|FG001|Overall Study|Entry Criteria Not Met|2
4585335|NCT01475136|7428915|FG002|Overall Study|Entry Criteria Not Met|3
4585336|NCT01475136|7428916|FG003|Overall Study|Entry Criteria Not Met|1
4585337|NCT01475136|7428913|FG000|Overall Study|Withdrawal by Subject|0
4585338|NCT01475136|7428914|FG001|Overall Study|Withdrawal by Subject|0
4585339|NCT01475136|7428915|FG002|Overall Study|Withdrawal by Subject|0
4585340|NCT01475136|7428916|FG003|Overall Study|Withdrawal by Subject|2
4585341|NCT01475136|7428913|FG000|Overall Study|Adverse Event|1
4585342|NCT01475136|7428914|FG001|Overall Study|Adverse Event|0
4585343|NCT01475136|7428915|FG002|Overall Study|Adverse Event|0
4585344|NCT01475136|7428916|FG003|Overall Study|Adverse Event|1
4585345|NCT01475136|7428913|FG000|Overall Study|Death|0
4585346|NCT01475136|7428914|FG001|Overall Study|Death|0
4585347|NCT01475136|7428915|FG002|Overall Study|Death|0
4585348|NCT01475136|7428916|FG003|Overall Study|Death|1
4585349|NCT01475162|7428926|FG000|Overall Study|Physician Decision|1
4585350|NCT01475162|7428926|FG000|Overall Study|Death|10
4585351|NCT01475162|7428926|FG000|Overall Study|Study closed for safety|3
4585352|NCT01475214|7428938|FG000|Overall Study|Lost to Follow-up|1
4585353|NCT01475214|7428939|FG001|Overall Study|Lost to Follow-up|0
4585354|NCT01475214|7428940|FG002|Overall Study|Lost to Follow-up|1
4585355|NCT01475214|7428938|FG000|Overall Study|Physician Decision|2
4585356|NCT01475214|7428939|FG001|Overall Study|Physician Decision|0
4585357|NCT01475214|7428940|FG002|Overall Study|Physician Decision|0
4585358|NCT01475214|7428938|FG000|Overall Study|Withdrawal by Subject|2
4585359|NCT01475214|7428939|FG001|Overall Study|Withdrawal by Subject|4
4585360|NCT01475214|7428940|FG002|Overall Study|Withdrawal by Subject|1
4585361|NCT01475253|7428952|FG000|Randomized, Blinded Study|Withdrawal by Subject|1
4585362|NCT01475253|7428953|FG001|Randomized, Blinded Study|Withdrawal by Subject|1
4585363|NCT01475253|7428954|FG002|Randomized, Blinded Study|Withdrawal by Subject|0
4585364|NCT01475253|7428955|FG003|Randomized, Blinded Study|Withdrawal by Subject|0
4585365|NCT01475253|7428952|FG000|Randomized, Blinded Study|Lost to Follow-up|1
4585366|NCT01475253|7428953|FG001|Randomized, Blinded Study|Lost to Follow-up|0
4585367|NCT01475253|7428954|FG002|Randomized, Blinded Study|Lost to Follow-up|0
4585368|NCT01475253|7428955|FG003|Randomized, Blinded Study|Lost to Follow-up|0
4585369|NCT01475331|7428975|FG000|Overall Study|Osteophyte obstruction of the proximal|1
4585370|NCT01475331|7428976|FG001|Overall Study|Osteophyte obstruction of the proximal|0
4585371|NCT01475331|7428975|FG000|Overall Study|excessive main duct communication|1
4585372|NCT01475331|7428976|FG001|Overall Study|excessive main duct communication|1
4585373|NCT01475331|7428975|FG000|Overall Study|Loss of needle positioning due pt. cough|1
4585374|NCT01475331|7428976|FG001|Overall Study|Loss of needle positioning due pt. cough|0
4585375|NCT01475331|7428975|FG000|Overall Study|Sign of malignancy during the procedure|2
4585376|NCT01475331|7428976|FG001|Overall Study|Sign of malignancy during the procedure|0
4585377|NCT01475331|7428975|FG000|Overall Study|cyst found to be prohibitively small|0
4585378|NCT01475331|7428976|FG001|Overall Study|cyst found to be prohibitively small|1
4585379|NCT01475370|7428985|FG000|Overall Study|Exacerbation of primary disease|2
4585380|NCT01475370|7428986|FG001|Overall Study|Exacerbation of primary disease|2
4585381|NCT01475370|7428987|FG002|Overall Study|Exacerbation of primary disease|2
4693337|NCT02590432|7604085|FG003|Open-label Treatment Period|Lack of Efficacy|0
4693338|NCT02590432|7604086|FG004|Open-label Treatment Period|Lack of Efficacy|0
4693339|NCT02590432|7604087|FG005|Open-label Treatment Period|Lack of Efficacy|0
4693340|NCT02590432|7604088|FG006|Open-label Treatment Period|Lack of Efficacy|0
4693341|NCT02590432|7604089|FG007|Open-label Treatment Period|Lack of Efficacy|0
4693342|NCT02590432|7604090|FG008|Open-label Treatment Period|Lack of Efficacy|0
4693343|NCT02590432|7604082|FG000|Open-label Treatment Period|Withdrawal of Consent|43
4693344|NCT02590432|7604083|FG001|Open-label Treatment Period|Withdrawal of Consent|28
4693345|NCT02590432|7604084|FG002|Open-label Treatment Period|Withdrawal of Consent|0
4693346|NCT02590432|7604085|FG003|Open-label Treatment Period|Withdrawal of Consent|0
4693347|NCT02590432|7604086|FG004|Open-label Treatment Period|Withdrawal of Consent|0
4693348|NCT02590432|7604087|FG005|Open-label Treatment Period|Withdrawal of Consent|0
4693349|NCT02590432|7604088|FG006|Open-label Treatment Period|Withdrawal of Consent|0
4693350|NCT02590432|7604089|FG007|Open-label Treatment Period|Withdrawal of Consent|0
4693351|NCT02590432|7604090|FG008|Open-label Treatment Period|Withdrawal of Consent|0
4693352|NCT02590432|7604082|FG000|Open-label Treatment Period|Lost to Follow-up|51
4693353|NCT02590432|7604083|FG001|Open-label Treatment Period|Lost to Follow-up|29
4693354|NCT02590432|7604084|FG002|Open-label Treatment Period|Lost to Follow-up|0
4693355|NCT02590432|7604085|FG003|Open-label Treatment Period|Lost to Follow-up|0
4693356|NCT02590432|7604086|FG004|Open-label Treatment Period|Lost to Follow-up|0
4693357|NCT02590432|7604087|FG005|Open-label Treatment Period|Lost to Follow-up|0
4693358|NCT02590432|7604088|FG006|Open-label Treatment Period|Lost to Follow-up|0
4693359|NCT02590432|7604089|FG007|Open-label Treatment Period|Lost to Follow-up|0
4693360|NCT02590432|7604090|FG008|Open-label Treatment Period|Lost to Follow-up|0
4693361|NCT02590432|7604082|FG000|Open-label Treatment Period|Protocol Violation|10
4693362|NCT02590432|7604083|FG001|Open-label Treatment Period|Protocol Violation|4
4693363|NCT02590432|7604084|FG002|Open-label Treatment Period|Protocol Violation|0
4693364|NCT02590432|7604085|FG003|Open-label Treatment Period|Protocol Violation|0
4693365|NCT02590432|7604086|FG004|Open-label Treatment Period|Protocol Violation|0
4693366|NCT02590432|7604087|FG005|Open-label Treatment Period|Protocol Violation|0
4693367|NCT02590432|7604088|FG006|Open-label Treatment Period|Protocol Violation|0
4693368|NCT02590432|7604089|FG007|Open-label Treatment Period|Protocol Violation|0
4693369|NCT02590432|7604090|FG008|Open-label Treatment Period|Protocol Violation|0
4693370|NCT02590432|7604082|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7
4693371|NCT02590432|7604083|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1
4693372|NCT02590432|7604084|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0
4693373|NCT02590432|7604085|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0
4693374|NCT02590432|7604086|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0
4693375|NCT02590432|7604087|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0
4734979|NCT03515824|7682518|FG002|Overall Study|Study terminated by sponsor|6
4585382|NCT01475370|7428985|FG000|Overall Study|Study drug administration difficult|0
4585383|NCT01475370|7428986|FG001|Overall Study|Study drug administration difficult|1
4585384|NCT01475370|7428987|FG002|Overall Study|Study drug administration difficult|1
4585385|NCT01475370|7428985|FG000|Overall Study|Other than specified|1
4585386|NCT01475370|7428986|FG001|Overall Study|Other than specified|0
4585387|NCT01475370|7428987|FG002|Overall Study|Other than specified|0
4585388|NCT01475461|7429001|FG000|Run-in Period|Not meet eligibility criteria|16
4585389|NCT01475461|7429002|FG001|Run-in Period|Not meet eligibility criteria|0
4585390|NCT01475461|7429003|FG002|Run-in Period|Not meet eligibility criteria|0
4585391|NCT01475461|7429004|FG003|Run-in Period|Not meet eligibility criteria|0
4585392|NCT01475461|7429005|FG004|Run-in Period|Not meet eligibility criteria|0
4585393|NCT01475461|7429006|FG005|Run-in Period|Not meet eligibility criteria|0
4585394|NCT01475461|7429007|FG006|Run-in Period|Not meet eligibility criteria|0
4585395|NCT01475461|7429001|FG000|Run-in Period|Lost to Follow-up|7
4585396|NCT01475461|7429002|FG001|Run-in Period|Lost to Follow-up|0
4585397|NCT01475461|7429003|FG002|Run-in Period|Lost to Follow-up|0
4585398|NCT01475461|7429004|FG003|Run-in Period|Lost to Follow-up|0
4585399|NCT01475461|7429005|FG004|Run-in Period|Lost to Follow-up|0
4585400|NCT01475461|7429006|FG005|Run-in Period|Lost to Follow-up|0
4585401|NCT01475461|7429007|FG006|Run-in Period|Lost to Follow-up|0
4585402|NCT01475461|7429001|FG000|Run-in Period|Withdrawal by Subject|11
4585403|NCT01475461|7429002|FG001|Run-in Period|Withdrawal by Subject|0
4585404|NCT01475461|7429003|FG002|Run-in Period|Withdrawal by Subject|0
4585405|NCT01475461|7429004|FG003|Run-in Period|Withdrawal by Subject|0
4585406|NCT01475461|7429005|FG004|Run-in Period|Withdrawal by Subject|0
4585407|NCT01475461|7429006|FG005|Run-in Period|Withdrawal by Subject|0
4585408|NCT01475461|7429007|FG006|Run-in Period|Withdrawal by Subject|0
4585409|NCT01475461|7429001|FG000|Run-in Period|Other|3
4585410|NCT01475461|7429002|FG001|Run-in Period|Other|0
4585411|NCT01475461|7429003|FG002|Run-in Period|Other|0
4585412|NCT01475461|7429004|FG003|Run-in Period|Other|0
4585413|NCT01475461|7429005|FG004|Run-in Period|Other|0
4585414|NCT01475461|7429006|FG005|Run-in Period|Other|0
4585415|NCT01475461|7429007|FG006|Run-in Period|Other|0
4585416|NCT01475461|7429001|FG000|Run-in Period|Protocol Violation|4
4585417|NCT01475461|7429002|FG001|Run-in Period|Protocol Violation|0
4585418|NCT01475461|7429003|FG002|Run-in Period|Protocol Violation|0
4585419|NCT01475461|7429004|FG003|Run-in Period|Protocol Violation|0
4585420|NCT01475461|7429005|FG004|Run-in Period|Protocol Violation|0
4585421|NCT01475461|7429006|FG005|Run-in Period|Protocol Violation|0
4585422|NCT01475461|7429007|FG006|Run-in Period|Protocol Violation|0
4585423|NCT01475461|7429001|FG000|Treatment Period|Death|0
4585424|NCT01475461|7429002|FG001|Treatment Period|Death|0
4585425|NCT01475461|7429003|FG002|Treatment Period|Death|0
4585426|NCT01475461|7429004|FG003|Treatment Period|Death|1
4585427|NCT01475461|7429005|FG004|Treatment Period|Death|0
4585428|NCT01475461|7429006|FG005|Treatment Period|Death|0
4585429|NCT01475461|7429007|FG006|Treatment Period|Death|0
4585430|NCT01475461|7429001|FG000|Treatment Period|Lost to Follow-up|0
4585431|NCT01475461|7429002|FG001|Treatment Period|Lost to Follow-up|3
4585432|NCT01475461|7429003|FG002|Treatment Period|Lost to Follow-up|2
4585433|NCT01475461|7429004|FG003|Treatment Period|Lost to Follow-up|3
4585434|NCT01475461|7429005|FG004|Treatment Period|Lost to Follow-up|1
4585435|NCT01475461|7429006|FG005|Treatment Period|Lost to Follow-up|2
4585436|NCT01475461|7429007|FG006|Treatment Period|Lost to Follow-up|1
4585437|NCT01475461|7429001|FG000|Treatment Period|Withdrawal by Subject|0
4585438|NCT01475461|7429002|FG001|Treatment Period|Withdrawal by Subject|2
4585439|NCT01475461|7429003|FG002|Treatment Period|Withdrawal by Subject|2
4585440|NCT01475461|7429004|FG003|Treatment Period|Withdrawal by Subject|0
4585441|NCT01475461|7429005|FG004|Treatment Period|Withdrawal by Subject|2
4585442|NCT01475461|7429006|FG005|Treatment Period|Withdrawal by Subject|2
4585443|NCT01475461|7429007|FG006|Treatment Period|Withdrawal by Subject|0
4585444|NCT01475461|7429001|FG000|Treatment Period|Other|0
4585445|NCT01475461|7429002|FG001|Treatment Period|Other|1
4585446|NCT01475461|7429003|FG002|Treatment Period|Other|0
4585447|NCT01475461|7429004|FG003|Treatment Period|Other|0
4585448|NCT01475461|7429005|FG004|Treatment Period|Other|0
4585449|NCT01475461|7429006|FG005|Treatment Period|Other|0
4585450|NCT01475461|7429007|FG006|Treatment Period|Other|0
4585451|NCT01475461|7429001|FG000|Treatment Period|Protocol Violation|0
4585452|NCT01475461|7429002|FG001|Treatment Period|Protocol Violation|1
4585453|NCT01475461|7429003|FG002|Treatment Period|Protocol Violation|0
4585454|NCT01475461|7429004|FG003|Treatment Period|Protocol Violation|0
4585455|NCT01475461|7429005|FG004|Treatment Period|Protocol Violation|0
4585456|NCT01475461|7429006|FG005|Treatment Period|Protocol Violation|0
4585457|NCT01475461|7429007|FG006|Treatment Period|Protocol Violation|1
4585458|NCT01475461|7429001|FG000|Treatment Period|Lack of Efficacy|0
4585459|NCT01475461|7429002|FG001|Treatment Period|Lack of Efficacy|2
4585460|NCT01475461|7429003|FG002|Treatment Period|Lack of Efficacy|0
4585461|NCT01475461|7429004|FG003|Treatment Period|Lack of Efficacy|2
4585462|NCT01475461|7429005|FG004|Treatment Period|Lack of Efficacy|1
4585463|NCT01475461|7429006|FG005|Treatment Period|Lack of Efficacy|1
4585464|NCT01475461|7429007|FG006|Treatment Period|Lack of Efficacy|0
4585465|NCT01475461|7429001|FG000|Treatment Period|Medication Error|0
4585466|NCT01475461|7429002|FG001|Treatment Period|Medication Error|0
4585467|NCT01475461|7429003|FG002|Treatment Period|Medication Error|0
4585468|NCT01475461|7429004|FG003|Treatment Period|Medication Error|1
4585469|NCT01475461|7429005|FG004|Treatment Period|Medication Error|0
4585470|NCT01475461|7429006|FG005|Treatment Period|Medication Error|0
4585471|NCT01475461|7429007|FG006|Treatment Period|Medication Error|0
4585472|NCT01475461|7429001|FG000|Treatment Period|Adverse Event|0
4585473|NCT01475461|7429002|FG001|Treatment Period|Adverse Event|0
4585474|NCT01475461|7429003|FG002|Treatment Period|Adverse Event|0
4585475|NCT01475461|7429004|FG003|Treatment Period|Adverse Event|1
4585476|NCT01475461|7429005|FG004|Treatment Period|Adverse Event|0
4585477|NCT01475461|7429006|FG005|Treatment Period|Adverse Event|0
4585478|NCT01475461|7429007|FG006|Treatment Period|Adverse Event|0
4585479|NCT01475474|7429040|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4
4585480|NCT01475474|7429040|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2
4585481|NCT01475487|7429047|FG000|Overall Study|had to leave early for personal reasons|2
4585482|NCT01475487|7429048|FG001|Overall Study|had to leave early for personal reasons|1
4585483|NCT01475721|7429076|FG000|Overall Study|Death|3
4585484|NCT01475721|7429077|FG001|Overall Study|Death|6
4585485|NCT01475721|7429076|FG000|Overall Study|Withdrawal by Subject|8
4585486|NCT01475721|7429077|FG001|Overall Study|Withdrawal by Subject|8
4585487|NCT01475734|7429085|FG000|Overall Study|Withdrawal by Subject|1
4585488|NCT01475734|7429086|FG001|Overall Study|Withdrawal by Subject|0
4585489|NCT01475734|7429085|FG000|Overall Study|Protocol Violation|1
4585490|NCT01475734|7429086|FG001|Overall Study|Protocol Violation|0
4585491|NCT01475734|7429085|FG000|Overall Study|Physician Decision|0
4585492|NCT01475734|7429086|FG001|Overall Study|Physician Decision|1
4585493|NCT01475825|7429096|FG000|Overall Study|Adverse Event|41
4585494|NCT01475825|7429097|FG001|Overall Study|Adverse Event|15
4585495|NCT01475825|7429098|FG002|Overall Study|Adverse Event|27
4585496|NCT01475825|7429099|FG003|Overall Study|Adverse Event|11
4585497|NCT01475825|7429096|FG000|Overall Study|Death|1
4585498|NCT01475825|7429097|FG001|Overall Study|Death|0
4585499|NCT01475825|7429098|FG002|Overall Study|Death|1
4585500|NCT01475825|7429099|FG003|Overall Study|Death|0
4585501|NCT01475825|7429096|FG000|Overall Study|Lack of Efficacy|0
4585502|NCT01475825|7429097|FG001|Overall Study|Lack of Efficacy|0
4585503|NCT01475825|7429098|FG002|Overall Study|Lack of Efficacy|1
4585504|NCT01475825|7429099|FG003|Overall Study|Lack of Efficacy|0
4585505|NCT01475825|7429096|FG000|Overall Study|Lost to Follow-up|0
4585506|NCT01475825|7429097|FG001|Overall Study|Lost to Follow-up|0
4585507|NCT01475825|7429098|FG002|Overall Study|Lost to Follow-up|3
4585508|NCT01475825|7429099|FG003|Overall Study|Lost to Follow-up|1
4585509|NCT01475825|7429096|FG000|Overall Study|Non-compliance with Study Drug|1
4585510|NCT01475825|7429097|FG001|Overall Study|Non-compliance with Study Drug|2
4585511|NCT01475825|7429098|FG002|Overall Study|Non-compliance with Study Drug|4
4585512|NCT01475825|7429099|FG003|Overall Study|Non-compliance with Study Drug|0
4585513|NCT01475825|7429096|FG000|Overall Study|Other: Not available|0
4585514|NCT01475825|7429097|FG001|Overall Study|Other: Not available|0
4585515|NCT01475825|7429098|FG002|Overall Study|Other: Not available|2
4585516|NCT01475825|7429099|FG003|Overall Study|Other: Not available|0
4585517|NCT01475825|7429096|FG000|Overall Study|Protocol Violation|1
4585518|NCT01475825|7429097|FG001|Overall Study|Protocol Violation|0
4585519|NCT01475825|7429098|FG002|Overall Study|Protocol Violation|0
4585520|NCT01475825|7429099|FG003|Overall Study|Protocol Violation|0
4585521|NCT01475825|7429096|FG000|Overall Study|Physician Decision|0
4585522|NCT01475825|7429097|FG001|Overall Study|Physician Decision|1
4585523|NCT01475825|7429098|FG002|Overall Study|Physician Decision|0
4585524|NCT01475825|7429099|FG003|Overall Study|Physician Decision|0
4585525|NCT01475825|7429096|FG000|Overall Study|Withdrawal by Subject|8
4585526|NCT01475825|7429097|FG001|Overall Study|Withdrawal by Subject|3
4585527|NCT01475825|7429098|FG002|Overall Study|Withdrawal by Subject|11
4585528|NCT01475825|7429099|FG003|Overall Study|Withdrawal by Subject|7
4585529|NCT01475825|7429096|FG000|Overall Study|Did not enter OLC|15
4585530|NCT01475825|7429097|FG001|Overall Study|Did not enter OLC|11
4585531|NCT01475825|7429098|FG002|Overall Study|Did not enter OLC|15
4585532|NCT01475825|7429099|FG003|Overall Study|Did not enter OLC|11
4585533|NCT01475838|7429111|FG000|Randomized Phase|Randomized but Not Treated|0
4585534|NCT01475838|7429112|FG001|Randomized Phase|Randomized but Not Treated|5
4585535|NCT01475838|7429111|FG000|Randomized Phase|Adverse Event|6
4585536|NCT01475838|7429112|FG001|Randomized Phase|Adverse Event|1
4585537|NCT01475838|7429111|FG000|Randomized Phase|Pregnancy|0
4585538|NCT01475838|7429112|FG001|Randomized Phase|Pregnancy|1
4585539|NCT01475838|7429111|FG000|Randomized Phase|Investigators Discretion|1
4585540|NCT01475838|7429112|FG001|Randomized Phase|Investigators Discretion|2
4585541|NCT01475838|7429111|FG000|Randomized Phase|Withdrew Consent|10
4585542|NCT01475838|7429112|FG001|Randomized Phase|Withdrew Consent|14
4585543|NCT01475838|7429111|FG000|Randomized Phase|Lost to Follow-up|3
4585544|NCT01475838|7429112|FG001|Randomized Phase|Lost to Follow-up|4
4585545|NCT01475838|7429111|FG000|Randomized Phase|Participant Noncompliance|1
4585546|NCT01475838|7429112|FG001|Randomized Phase|Participant Noncompliance|5
4585547|NCT01475838|7429111|FG000|Randomized Phase|Protocol Violation|9
4585548|NCT01475838|7429112|FG001|Randomized Phase|Protocol Violation|4
4693376|NCT02590432|7604088|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0
4693377|NCT02590432|7604089|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0
4693378|NCT02590432|7604090|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0
4693379|NCT02590432|7604082|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10
4693380|NCT02590432|7604083|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6
4585549|NCT01475838|7429111|FG000|Extension Phase|Participant Noncompliance|1
4585550|NCT01475838|7429112|FG001|Extension Phase|Participant Noncompliance|0
4585551|NCT01475851|7429121|FG000|Overall Study|Protocol defined stopping criteria|1
4585552|NCT01475851|7429122|FG001|Overall Study|Protocol defined stopping criteria|0
4585553|NCT01476475|7429206|FG000|Overall Study|Adverse Event|6
4585554|NCT01476475|7429207|FG001|Overall Study|Adverse Event|0
4585555|NCT01476475|7429206|FG000|Overall Study|Poor compliance to protocol|1
4585556|NCT01476475|7429207|FG001|Overall Study|Poor compliance to protocol|1
4585557|NCT01476475|7429206|FG000|Overall Study|Other reasons|4
4585558|NCT01476475|7429207|FG001|Overall Study|Other reasons|2
4585559|NCT01476644|7429214|FG000|Overall Study|Death|5
4585560|NCT01476644|7429214|FG000|Overall Study|moved to another state|2
4585561|NCT01476644|7429214|FG000|Overall Study|Lost to Follow-up|19
4693381|NCT02590432|7604084|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0
4693382|NCT02590432|7604085|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0
4693383|NCT02590432|7604086|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0
4693384|NCT02590432|7604087|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0
4693385|NCT02590432|7604088|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0
4693386|NCT02590432|7604089|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0
4693387|NCT02590432|7604090|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0
4693388|NCT02590432|7604082|FG000|Double-blind Treatment Period|Adverse Event|0
4693389|NCT02590432|7604083|FG001|Double-blind Treatment Period|Adverse Event|0
4693390|NCT02590432|7604084|FG002|Double-blind Treatment Period|Adverse Event|14
4693391|NCT02590432|7604085|FG003|Double-blind Treatment Period|Adverse Event|12
4693392|NCT02590432|7604086|FG004|Double-blind Treatment Period|Adverse Event|6
4585562|NCT01476644|7429214|FG000|Overall Study|Withdrawal by Subject|13
4585563|NCT01476696|7429219|FG000|Overall Study|Sponsor decision|2
4585564|NCT01476696|7429220|FG001|Overall Study|Sponsor decision|1
4585565|NCT01476696|7429221|FG002|Overall Study|Sponsor decision|0
4585566|NCT01476696|7429219|FG000|Overall Study|Withdrawal by Subject|1
4585567|NCT01476696|7429220|FG001|Overall Study|Withdrawal by Subject|0
4693393|NCT02590432|7604087|FG005|Double-blind Treatment Period|Adverse Event|22
4693394|NCT02590432|7604088|FG006|Double-blind Treatment Period|Adverse Event|20
4693395|NCT02590432|7604089|FG007|Double-blind Treatment Period|Adverse Event|0
4693396|NCT02590432|7604090|FG008|Double-blind Treatment Period|Adverse Event|0
4693397|NCT02590432|7604082|FG000|Double-blind Treatment Period|Lack of Efficacy|0
4693398|NCT02590432|7604083|FG001|Double-blind Treatment Period|Lack of Efficacy|0
4693399|NCT02590432|7604084|FG002|Double-blind Treatment Period|Lack of Efficacy|1
4693400|NCT02590432|7604085|FG003|Double-blind Treatment Period|Lack of Efficacy|0
4693401|NCT02590432|7604086|FG004|Double-blind Treatment Period|Lack of Efficacy|0
4693402|NCT02590432|7604087|FG005|Double-blind Treatment Period|Lack of Efficacy|0
4693403|NCT02590432|7604088|FG006|Double-blind Treatment Period|Lack of Efficacy|0
4693404|NCT02590432|7604089|FG007|Double-blind Treatment Period|Lack of Efficacy|0
4693405|NCT02590432|7604090|FG008|Double-blind Treatment Period|Lack of Efficacy|0
4693406|NCT02590432|7604082|FG000|Double-blind Treatment Period|Withdrawal of Consent|0
4693407|NCT02590432|7604083|FG001|Double-blind Treatment Period|Withdrawal of Consent|0
4693408|NCT02590432|7604084|FG002|Double-blind Treatment Period|Withdrawal of Consent|1
4693409|NCT02590432|7604085|FG003|Double-blind Treatment Period|Withdrawal of Consent|3
4693410|NCT02590432|7604086|FG004|Double-blind Treatment Period|Withdrawal of Consent|3
4693411|NCT02590432|7604087|FG005|Double-blind Treatment Period|Withdrawal of Consent|1
4693412|NCT02590432|7604088|FG006|Double-blind Treatment Period|Withdrawal of Consent|1
4693413|NCT02590432|7604089|FG007|Double-blind Treatment Period|Withdrawal of Consent|0
4693414|NCT02590432|7604090|FG008|Double-blind Treatment Period|Withdrawal of Consent|0
4693415|NCT02590432|7604082|FG000|Double-blind Treatment Period|Lost to Follow-up|0
4693416|NCT02590432|7604083|FG001|Double-blind Treatment Period|Lost to Follow-up|0
4693417|NCT02590432|7604084|FG002|Double-blind Treatment Period|Lost to Follow-up|1
4693418|NCT02590432|7604085|FG003|Double-blind Treatment Period|Lost to Follow-up|0
4693419|NCT02590432|7604086|FG004|Double-blind Treatment Period|Lost to Follow-up|0
4693420|NCT02590432|7604087|FG005|Double-blind Treatment Period|Lost to Follow-up|2
4693421|NCT02590432|7604088|FG006|Double-blind Treatment Period|Lost to Follow-up|0
4693422|NCT02590432|7604089|FG007|Double-blind Treatment Period|Lost to Follow-up|0
4693423|NCT02590432|7604090|FG008|Double-blind Treatment Period|Lost to Follow-up|0
4693424|NCT02590432|7604082|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0
4693425|NCT02590432|7604083|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0
4693426|NCT02590432|7604084|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0
4585568|NCT01476696|7429221|FG002|Overall Study|Withdrawal by Subject|0
4585569|NCT01476722|7429234|FG000|Overall Study|Adverse Event|1
4585570|NCT01477333|7429260|FG000|Overall Study|Adverse Event|1
4585571|NCT01477333|7429260|FG000|Overall Study|Withdrawal by Subject|1
4693427|NCT02590432|7604085|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0
4585572|NCT01477333|7429260|FG000|Overall Study|Clinical Deterioration|1
4585573|NCT01477749|7429334|FG000|Overall Study|Physician Decision|4
4585574|NCT01477853|7429358|FG000|Phase A|Adverse Event|1
4585575|NCT01477853|7429359|FG001|Phase A|Adverse Event|2
4585576|NCT01477853|7429360|FG002|Phase A|Adverse Event|2
4585577|NCT01477853|7429358|FG000|Phase A|Lost to Follow-up|4
4585578|NCT01477853|7429359|FG001|Phase A|Lost to Follow-up|3
4585579|NCT01477853|7429360|FG002|Phase A|Lost to Follow-up|2
4585580|NCT01477853|7429358|FG000|Phase A|Physician Decision|1
4585581|NCT01477853|7429359|FG001|Phase A|Physician Decision|0
4585582|NCT01477853|7429360|FG002|Phase A|Physician Decision|1
4585583|NCT01477853|7429358|FG000|Phase A|Study terminated by sponsor|37
4585584|NCT01477853|7429359|FG001|Phase A|Study terminated by sponsor|40
4585585|NCT01477853|7429360|FG002|Phase A|Study terminated by sponsor|39
4585586|NCT01477853|7429358|FG000|Phase B|Lost to Follow-up|0
4585587|NCT01477853|7429359|FG001|Phase B|Lost to Follow-up|1
4585588|NCT01477853|7429360|FG002|Phase B|Lost to Follow-up|0
4585589|NCT01477853|7429358|FG000|Phase B|Study terminated by sponsor|12
4585590|NCT01477853|7429359|FG001|Phase B|Study terminated by sponsor|10
4585591|NCT01477853|7429360|FG002|Phase B|Study terminated by sponsor|11
4585592|NCT01477892|7429370|FG000|Overall Study|Withdrawal by Subject|0
4585593|NCT01477892|7429371|FG001|Overall Study|Withdrawal by Subject|2
4585594|NCT01478048|7429388|FG000|Overall Study|Disease Progression|52
4585595|NCT01478048|7429389|FG001|Overall Study|Disease Progression|35
4585596|NCT01478048|7429388|FG000|Overall Study|study drug toxicity|11
4585597|NCT01478048|7429389|FG001|Overall Study|study drug toxicity|14
4585598|NCT01478048|7429388|FG000|Overall Study|Adverse Event|2
4585599|NCT01478048|7429389|FG001|Overall Study|Adverse Event|11
4585600|NCT01478048|7429388|FG000|Overall Study|subject request to discontinue treatment|3
4585601|NCT01478048|7429389|FG001|Overall Study|subject request to discontinue treatment|5
4585602|NCT01478048|7429388|FG000|Overall Study|Withdrawal by Subject|2
4585603|NCT01478048|7429389|FG001|Overall Study|Withdrawal by Subject|5
4585604|NCT01478048|7429388|FG000|Overall Study|non-specified|6
4585605|NCT01478048|7429389|FG001|Overall Study|non-specified|4
4585606|NCT01478048|7429388|FG000|Overall Study|poor/non-compliance|0
4585607|NCT01478048|7429389|FG001|Overall Study|poor/non-compliance|1
4585608|NCT01478048|7429388|FG000|Overall Study|no longer meets study criteria|1
4585609|NCT01478048|7429389|FG001|Overall Study|no longer meets study criteria|0
4585610|NCT01478087|7429395|FG000|Overall Study|due to sponsor closing study|1
4585611|NCT01478321|7429410|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4
4585612|NCT01478321|7429410|FG000|Concurrent Therapy (5 Weeks)|Death|2
4585613|NCT01478321|7429410|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5
4585614|NCT01478321|7429410|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5
4585615|NCT01478321|7429410|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1
4585616|NCT01478321|7429410|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1
4585617|NCT01478321|7429410|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1
4585618|NCT01478321|7429410|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8
4585619|NCT01478347|7429414|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1
4585620|NCT01478347|7429414|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4
4585621|NCT01478347|7429414|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4
4585622|NCT01478360|7429420|FG000|Overall Study|Lost to Follow-up|1
4585623|NCT01478360|7429421|FG001|Overall Study|Lost to Follow-up|0
4585624|NCT01478360|7429420|FG000|Overall Study|Adverse Event|0
4585625|NCT01478360|7429421|FG001|Overall Study|Adverse Event|1
4585626|NCT01478360|7429420|FG000|Overall Study|Administrative problems|1
4585627|NCT01478360|7429421|FG001|Overall Study|Administrative problems|2
4585628|NCT01478373|7429427|FG000|Treatment Phase|Protocol Violation|1
4585629|NCT01478373|7429427|FG000|Survival Phase|Adverse Event|8
4585630|NCT01478373|7429427|FG000|Survival Phase|Protocol Violation|1
4585631|NCT01478373|7429427|FG000|Survival Phase|crossover to another study|2
4585632|NCT01478373|7429427|FG000|Survival Phase|Progressive Disease|27
4585633|NCT01478594|7429454|FG000|Overall Study|Randomized but Never Received Study Drug|0
4585634|NCT01478594|7429455|FG001|Overall Study|Randomized but Never Received Study Drug|1
4585635|NCT01478594|7429454|FG000|Overall Study|Death|45
4585636|NCT01478594|7429455|FG001|Overall Study|Death|18
4585637|NCT01478594|7429454|FG000|Overall Study|Lost to Follow-up|3
4585638|NCT01478594|7429455|FG001|Overall Study|Lost to Follow-up|1
4585639|NCT01478594|7429454|FG000|Overall Study|Withdrawal by Subject|9
4585640|NCT01478594|7429455|FG001|Overall Study|Withdrawal by Subject|3
4585641|NCT01478594|7429454|FG000|Overall Study|Study Closed by Sponsor|8
4585642|NCT01478594|7429455|FG001|Overall Study|Study Closed by Sponsor|5
4585643|NCT01478620|7429514|FG000|Overall Study|Lost to Follow-up|6
4585644|NCT01478828|7429518|FG000|Overall Study|Adverse Event|1
4585645|NCT01478958|7429530|FG000|Overall Study|Withdrawal by Subject|1
4585646|NCT01478958|7429531|FG001|Overall Study|Withdrawal by Subject|1
4585647|NCT01478958|7429532|FG002|Overall Study|Withdrawal by Subject|1
4585648|NCT01478958|7429530|FG000|Overall Study|Weight loss|1
4585649|NCT01478958|7429531|FG001|Overall Study|Weight loss|0
4585650|NCT01478958|7429532|FG002|Overall Study|Weight loss|0
4585651|NCT01478958|7429530|FG000|Overall Study|Re-located|0
4585652|NCT01478958|7429531|FG001|Overall Study|Re-located|1
4585653|NCT01478958|7429532|FG002|Overall Study|Re-located|0
4585654|NCT01478958|7429530|FG000|Overall Study|Unable to comply|0
4585655|NCT01478958|7429531|FG001|Overall Study|Unable to comply|0
4585656|NCT01478958|7429532|FG002|Overall Study|Unable to comply|2
4585657|NCT01478971|7429540|FG000|Standard of Care Period|Adverse Event|1
4585658|NCT01478971|7429540|FG000|Standard of Care Period|Withdrawal by Subject|3
4585659|NCT01478971|7429540|FG000|Standard of Care Period|Death|8
4585660|NCT01478971|7429540|FG000|Standard of Care Period|Lost to Follow-up|9
4585661|NCT01478971|7429540|FG000|Standard of Care Period|Other|4
4585662|NCT01478971|7429540|FG000|Peginesatide Treatment Period|Adverse Event|1
4585663|NCT01478971|7429540|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1
4585664|NCT01478971|7429540|FG000|Peginesatide Treatment Period|Death|4
4585665|NCT01478971|7429540|FG000|Peginesatide Treatment Period|Lost to Follow-up|4
4585666|NCT01478971|7429540|FG000|Peginesatide Treatment Period|Other|4
4585667|NCT01479374|7429576|FG000|Overall Study|Adverse Event|2
4585668|NCT01479374|7429577|FG001|Overall Study|Adverse Event|1
4585669|NCT01479374|7429578|FG002|Overall Study|Adverse Event|0
4585670|NCT01479374|7429576|FG000|Overall Study|Lost to Follow-up|1
4585671|NCT01479374|7429577|FG001|Overall Study|Lost to Follow-up|2
4585672|NCT01479374|7429578|FG002|Overall Study|Lost to Follow-up|0
4585673|NCT01479374|7429576|FG000|Overall Study|Decision Unrelated to Adverse Event|0
4585674|NCT01479374|7429577|FG001|Overall Study|Decision Unrelated to Adverse Event|1
4585675|NCT01479374|7429578|FG002|Overall Study|Decision Unrelated to Adverse Event|0
4585676|NCT01479374|7429576|FG000|Overall Study|Other|0
4585677|NCT01479374|7429577|FG001|Overall Study|Other|4
4585678|NCT01479374|7429578|FG002|Overall Study|Other|5
4585679|NCT01479439|7429598|FG000|Overall Study|Adverse Event|1
4585680|NCT01479439|7429599|FG001|Overall Study|Adverse Event|0
4585681|NCT01479439|7429600|FG002|Overall Study|Adverse Event|0
4585682|NCT01479439|7429598|FG000|Overall Study|Lost to Follow-up|0
4585683|NCT01479439|7429599|FG001|Overall Study|Lost to Follow-up|1
4585684|NCT01479439|7429600|FG002|Overall Study|Lost to Follow-up|0
4585685|NCT01479439|7429598|FG000|Overall Study|Protocol Violation|0
4585686|NCT01479439|7429599|FG001|Overall Study|Protocol Violation|0
4585687|NCT01479439|7429600|FG002|Overall Study|Protocol Violation|2
4585688|NCT01479465|7429615|FG000|Overall Study|Disease Progression|9
4585689|NCT01479465|7429616|FG001|Overall Study|Disease Progression|61
4585690|NCT01479465|7429617|FG002|Overall Study|Disease Progression|65
4585691|NCT01479465|7429618|FG003|Overall Study|Disease Progression|70
4585692|NCT01479465|7429615|FG000|Overall Study|Study Discontinued by Sponsor|0
4585693|NCT01479465|7429616|FG001|Overall Study|Study Discontinued by Sponsor|7
4585694|NCT01479465|7429617|FG002|Overall Study|Study Discontinued by Sponsor|5
4585695|NCT01479465|7429618|FG003|Overall Study|Study Discontinued by Sponsor|3
4585696|NCT01479465|7429615|FG000|Overall Study|Adverse Event|0
4585697|NCT01479465|7429616|FG001|Overall Study|Adverse Event|3
4585698|NCT01479465|7429617|FG002|Overall Study|Adverse Event|6
4585699|NCT01479465|7429618|FG003|Overall Study|Adverse Event|4
4585700|NCT01479465|7429615|FG000|Overall Study|Investigator Discretion|1
4693428|NCT02590432|7604086|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0
4693429|NCT02590432|7604087|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1
4693430|NCT02590432|7604088|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0
4693431|NCT02590432|7604089|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0
4693432|NCT02590432|7604090|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0
4693433|NCT02590432|7604082|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0
4693434|NCT02590432|7604083|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0
4693435|NCT02590432|7604084|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0
4693436|NCT02590432|7604085|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0
4693437|NCT02590432|7604086|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0
4693438|NCT02590432|7604087|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0
4693439|NCT02590432|7604088|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0
4693440|NCT02590432|7604089|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12
4693441|NCT02590432|7604090|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15
4693442|NCT02590432|7604082|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
4693443|NCT02590432|7604083|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
4693444|NCT02590432|7604084|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
4693445|NCT02590432|7604085|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
4693446|NCT02590432|7604086|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
4693447|NCT02590432|7604087|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
4693448|NCT02590432|7604088|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
4693449|NCT02590432|7604089|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1
4693450|NCT02590432|7604090|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
4693451|NCT02590432|7604082|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
4693452|NCT02590432|7604083|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
4585701|NCT01479465|7429616|FG001|Overall Study|Investigator Discretion|4
4585702|NCT01479465|7429617|FG002|Overall Study|Investigator Discretion|2
4585703|NCT01479465|7429618|FG003|Overall Study|Investigator Discretion|4
4585704|NCT01479465|7429615|FG000|Overall Study|Subject Request|1
4585705|NCT01479465|7429616|FG001|Overall Study|Subject Request|3
4585706|NCT01479465|7429617|FG002|Overall Study|Subject Request|4
4693453|NCT02590432|7604084|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
4693454|NCT02590432|7604085|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
4585707|NCT01479465|7429618|FG003|Overall Study|Subject Request|2
4585708|NCT01479465|7429615|FG000|Overall Study|Subject Withdrew Consent|0
4585709|NCT01479465|7429616|FG001|Overall Study|Subject Withdrew Consent|5
4585710|NCT01479465|7429617|FG002|Overall Study|Subject Withdrew Consent|2
4585711|NCT01479465|7429618|FG003|Overall Study|Subject Withdrew Consent|1
4585712|NCT01479465|7429615|FG000|Overall Study|Protocol Violation|0
4585713|NCT01479465|7429616|FG001|Overall Study|Protocol Violation|1
4585714|NCT01479465|7429617|FG002|Overall Study|Protocol Violation|1
4585715|NCT01479465|7429618|FG003|Overall Study|Protocol Violation|0
4585716|NCT01479465|7429615|FG000|Overall Study|Death|0
4585717|NCT01479465|7429616|FG001|Overall Study|Death|0
4585718|NCT01479465|7429617|FG002|Overall Study|Death|0
4585719|NCT01479465|7429618|FG003|Overall Study|Death|1
4585720|NCT01479465|7429615|FG000|Overall Study|Lost to Follow-up|0
4585721|NCT01479465|7429616|FG001|Overall Study|Lost to Follow-up|0
4585722|NCT01479465|7429617|FG002|Overall Study|Lost to Follow-up|1
4585723|NCT01479465|7429618|FG003|Overall Study|Lost to Follow-up|0
4585724|NCT01479530|7429652|FG000|Overall Study|Adverse Event|5
4585725|NCT01479530|7429653|FG001|Overall Study|Adverse Event|6
4585726|NCT01479530|7429652|FG000|Overall Study|Lack of Efficacy|0
4585727|NCT01479530|7429653|FG001|Overall Study|Lack of Efficacy|1
4585728|NCT01479530|7429652|FG000|Overall Study|Protocol Violation|2
4585729|NCT01479530|7429653|FG001|Overall Study|Protocol Violation|3
4585730|NCT01479530|7429652|FG000|Overall Study|Withdrawal of Consent|3
4585731|NCT01479530|7429653|FG001|Overall Study|Withdrawal of Consent|2
4585732|NCT01479595|7429682|FG000|Overall Study|Protocol deviation|0
4585733|NCT01479595|7429683|FG001|Overall Study|Protocol deviation|1
4585734|NCT01479595|7429682|FG000|Overall Study|Adverse Event|2
4585735|NCT01479595|7429683|FG001|Overall Study|Adverse Event|1
4585736|NCT01479621|7429695|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93
4585737|NCT01479621|7429696|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
4585738|NCT01479621|7429697|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
4585739|NCT01479621|7429698|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
4585740|NCT01479621|7429699|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
4585741|NCT01479621|7429700|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
4693455|NCT02590432|7604086|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
4693456|NCT02590432|7604087|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
4693457|NCT02590432|7604088|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
4693458|NCT02590432|7604089|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3
4693459|NCT02590432|7604090|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1
4693460|NCT02590432|7604082|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
4693461|NCT02590432|7604083|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
4693462|NCT02590432|7604084|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
4693463|NCT02590432|7604085|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
4693464|NCT02590432|7604086|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
4693465|NCT02590432|7604087|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
4693466|NCT02590432|7604088|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
4693467|NCT02590432|7604089|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
4693468|NCT02590432|7604090|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1
4693469|NCT02590432|7604082|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0
4693470|NCT02590432|7604083|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0
4693471|NCT02590432|7604084|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0
4693472|NCT02590432|7604085|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0
4693473|NCT02590432|7604086|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0
4693474|NCT02590432|7604087|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0
4693475|NCT02590432|7604088|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0
4693476|NCT02590432|7604089|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0
4693477|NCT02590432|7604090|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1
4693478|NCT02590432|7604082|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
4693479|NCT02590432|7604083|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
4693480|NCT02590432|7604084|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
4693481|NCT02590432|7604085|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
4693482|NCT02590432|7604086|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
4693483|NCT02590432|7604087|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
4693484|NCT02590432|7604088|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
4693485|NCT02590432|7604089|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1
4585742|NCT01479621|7429701|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
4585743|NCT01479621|7429695|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19
4585744|NCT01479621|7429696|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
4585745|NCT01479621|7429697|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
4585746|NCT01479621|7429698|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
4585747|NCT01479621|7429699|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
4585748|NCT01479621|7429700|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
4585749|NCT01479621|7429701|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
4585750|NCT01479621|7429695|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153
4585751|NCT01479621|7429696|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
4585752|NCT01479621|7429697|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
4585753|NCT01479621|7429698|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
4585754|NCT01479621|7429699|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
4585755|NCT01479621|7429700|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
4585756|NCT01479621|7429701|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
4585757|NCT01479621|7429695|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7
4585758|NCT01479621|7429696|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
4585759|NCT01479621|7429697|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
4585760|NCT01479621|7429698|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
4585761|NCT01479621|7429699|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
4585762|NCT01479621|7429700|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
4693486|NCT02590432|7604090|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
4693487|NCT02590432|7604082|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
4693488|NCT02590432|7604083|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
4693489|NCT02590432|7604084|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
4693490|NCT02590432|7604085|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
4693491|NCT02590432|7604086|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
4693492|NCT02590432|7604087|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
4693493|NCT02590432|7604088|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
4693494|NCT02590432|7604089|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1
4693495|NCT02590432|7604090|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
4693496|NCT02590562|7604102|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6
4693497|NCT02590588|7604112|FG000|Overall Study|Adverse Event|1
4693498|NCT02590939|7604118|FG000|Overall Study|Withdrawal by Subject|3
4693499|NCT02590939|7604119|FG001|Overall Study|Withdrawal by Subject|1
4693500|NCT02590939|7604118|FG000|Overall Study|Failed the nociceptive test|2
4693501|NCT02590939|7604119|FG001|Overall Study|Failed the nociceptive test|1
4693502|NCT02591238|7604133|FG000|Overall Study|Pregnancy|1
4693503|NCT02591238|7604134|FG001|Overall Study|Pregnancy|0
4693504|NCT02591238|7604135|FG002|Overall Study|Pregnancy|0
4693505|NCT02591238|7604136|FG003|Overall Study|Pregnancy|0
4693506|NCT02591238|7604133|FG000|Overall Study|Withdrawal by Subject|0
4693507|NCT02591238|7604134|FG001|Overall Study|Withdrawal by Subject|0
4693508|NCT02591238|7604135|FG002|Overall Study|Withdrawal by Subject|0
4693509|NCT02591238|7604136|FG003|Overall Study|Withdrawal by Subject|1
4693510|NCT02591238|7604133|FG000|Overall Study|influenza|0
4693511|NCT02591238|7604134|FG001|Overall Study|influenza|0
4693512|NCT02591238|7604135|FG002|Overall Study|influenza|0
4693513|NCT02591238|7604136|FG003|Overall Study|influenza|1
4693514|NCT02591238|7604133|FG000|Overall Study|personal circumstances|0
4693515|NCT02591238|7604134|FG001|Overall Study|personal circumstances|0
4693516|NCT02591238|7604135|FG002|Overall Study|personal circumstances|0
4693517|NCT02591238|7604136|FG003|Overall Study|personal circumstances|1
4693518|NCT02591238|7604133|FG000|Overall Study|personal circumstances|0
4693519|NCT02591238|7604134|FG001|Overall Study|personal circumstances|1
4693520|NCT02591238|7604135|FG002|Overall Study|personal circumstances|0
4693521|NCT02591238|7604136|FG003|Overall Study|personal circumstances|0
4693522|NCT02591290|7604146|FG000|Overall Study|Withdrawal by Subject|2
4693523|NCT02592018|7604169|FG000|Overall Study|Adverse Event|1
4693524|NCT02592018|7604169|FG000|Overall Study|Lost to Follow-up|1
4693525|NCT02592434|7604182|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12
4693526|NCT02592434|7604183|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0
4693527|NCT02592434|7604184|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0
4693528|NCT02592434|7604182|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21
4693529|NCT02592434|7604183|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0
4693530|NCT02592434|7604184|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0
4693531|NCT02592434|7604182|FG000|Open-Label Phase (18 Weeks)|Other|3
4693532|NCT02592434|7604183|FG001|Open-Label Phase (18 Weeks)|Other|0
4693533|NCT02592434|7604184|FG002|Open-Label Phase (18 Weeks)|Other|0
4693534|NCT02592434|7604182|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4
4693535|NCT02592434|7604183|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0
4693536|NCT02592434|7604184|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0
4693537|NCT02592434|7604182|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0
4693538|NCT02592434|7604183|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2
4693539|NCT02592434|7604184|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2
4693540|NCT02592434|7604182|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0
4693541|NCT02592434|7604183|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22
4693542|NCT02592434|7604184|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44
4585763|NCT01479621|7429701|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
4585764|NCT01479621|7429695|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15
4585765|NCT01479621|7429696|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0
4585766|NCT01479621|7429697|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0
4585767|NCT01479621|7429698|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0
4585768|NCT01479621|7429699|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0
4585769|NCT01479621|7429700|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0
4585770|NCT01479621|7429701|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0
4585771|NCT01479621|7429695|FG000|Treatment Period|Adverse Event|0
4585772|NCT01479621|7429696|FG001|Treatment Period|Adverse Event|0
4585773|NCT01479621|7429697|FG002|Treatment Period|Adverse Event|0
4585774|NCT01479621|7429698|FG003|Treatment Period|Adverse Event|0
4585775|NCT01479621|7429699|FG004|Treatment Period|Adverse Event|1
4585776|NCT01479621|7429700|FG005|Treatment Period|Adverse Event|2
4585777|NCT01479621|7429701|FG006|Treatment Period|Adverse Event|2
4585778|NCT01479621|7429695|FG000|Treatment Period|Withdrawal by Subject|0
4585779|NCT01479621|7429696|FG001|Treatment Period|Withdrawal by Subject|4
4585780|NCT01479621|7429697|FG002|Treatment Period|Withdrawal by Subject|2
4585781|NCT01479621|7429698|FG003|Treatment Period|Withdrawal by Subject|2
4585782|NCT01479621|7429699|FG004|Treatment Period|Withdrawal by Subject|5
4585783|NCT01479621|7429700|FG005|Treatment Period|Withdrawal by Subject|5
4585784|NCT01479621|7429701|FG006|Treatment Period|Withdrawal by Subject|1
4585785|NCT01479621|7429695|FG000|Treatment Period|Physician Decision|0
4585786|NCT01479621|7429696|FG001|Treatment Period|Physician Decision|0
4585787|NCT01479621|7429697|FG002|Treatment Period|Physician Decision|0
4585788|NCT01479621|7429698|FG003|Treatment Period|Physician Decision|0
4585789|NCT01479621|7429699|FG004|Treatment Period|Physician Decision|1
4585790|NCT01479621|7429700|FG005|Treatment Period|Physician Decision|1
4585791|NCT01479621|7429701|FG006|Treatment Period|Physician Decision|0
4585792|NCT01479621|7429695|FG000|Treatment Period|Non-compliance to study drug|0
4585793|NCT01479621|7429696|FG001|Treatment Period|Non-compliance to study drug|1
4585794|NCT01479621|7429697|FG002|Treatment Period|Non-compliance to study drug|0
4585795|NCT01479621|7429698|FG003|Treatment Period|Non-compliance to study drug|0
4585796|NCT01479621|7429699|FG004|Treatment Period|Non-compliance to study drug|0
4585797|NCT01479621|7429700|FG005|Treatment Period|Non-compliance to study drug|0
4585798|NCT01479621|7429701|FG006|Treatment Period|Non-compliance to study drug|1
4585799|NCT01479621|7429695|FG000|Treatment Period|Protocol Violation|0
4585800|NCT01479621|7429696|FG001|Treatment Period|Protocol Violation|9
4585801|NCT01479621|7429697|FG002|Treatment Period|Protocol Violation|6
4585802|NCT01479621|7429698|FG003|Treatment Period|Protocol Violation|5
4585803|NCT01479621|7429699|FG004|Treatment Period|Protocol Violation|2
4585804|NCT01479621|7429700|FG005|Treatment Period|Protocol Violation|10
4585805|NCT01479621|7429701|FG006|Treatment Period|Protocol Violation|6
4585806|NCT01479621|7429695|FG000|Treatment Period|Pregnancy|0
4585807|NCT01479621|7429696|FG001|Treatment Period|Pregnancy|0
4585808|NCT01479621|7429697|FG002|Treatment Period|Pregnancy|2
4585809|NCT01479621|7429698|FG003|Treatment Period|Pregnancy|0
4585810|NCT01479621|7429699|FG004|Treatment Period|Pregnancy|0
4585811|NCT01479621|7429700|FG005|Treatment Period|Pregnancy|0
4585812|NCT01479621|7429701|FG006|Treatment Period|Pregnancy|0
4585813|NCT01479621|7429695|FG000|Treatment Period|Sponsor request subject to be withdrawn|0
4585814|NCT01479621|7429696|FG001|Treatment Period|Sponsor request subject to be withdrawn|2
4585815|NCT01479621|7429697|FG002|Treatment Period|Sponsor request subject to be withdrawn|3
4585816|NCT01479621|7429698|FG003|Treatment Period|Sponsor request subject to be withdrawn|1
4585817|NCT01479621|7429699|FG004|Treatment Period|Sponsor request subject to be withdrawn|1
4585818|NCT01479621|7429700|FG005|Treatment Period|Sponsor request subject to be withdrawn|1
4585819|NCT01479621|7429701|FG006|Treatment Period|Sponsor request subject to be withdrawn|3
4585820|NCT01479621|7429695|FG000|Treatment Period|Lost to Follow-up|0
4585821|NCT01479621|7429696|FG001|Treatment Period|Lost to Follow-up|0
4585822|NCT01479621|7429697|FG002|Treatment Period|Lost to Follow-up|1
4585823|NCT01479621|7429698|FG003|Treatment Period|Lost to Follow-up|0
4585824|NCT01479621|7429699|FG004|Treatment Period|Lost to Follow-up|2
4585825|NCT01479621|7429700|FG005|Treatment Period|Lost to Follow-up|2
4585826|NCT01479621|7429701|FG006|Treatment Period|Lost to Follow-up|1
4585827|NCT01479621|7429695|FG000|Treatment Period|Met stopping criteria|0
4585828|NCT01479621|7429696|FG001|Treatment Period|Met stopping criteria|8
4585829|NCT01479621|7429697|FG002|Treatment Period|Met stopping criteria|7
4585830|NCT01479621|7429698|FG003|Treatment Period|Met stopping criteria|4
4585831|NCT01479621|7429699|FG004|Treatment Period|Met stopping criteria|9
4585832|NCT01479621|7429700|FG005|Treatment Period|Met stopping criteria|20
4585833|NCT01479621|7429701|FG006|Treatment Period|Met stopping criteria|6
4585834|NCT01479764|7429726|FG000|Randomized|Adverse Event|1
4585835|NCT01479764|7429727|FG001|Randomized|Adverse Event|1
4585836|NCT01479764|7429726|FG000|Randomized|Withdrawal by Subject|1
4585837|NCT01479764|7429727|FG001|Randomized|Withdrawal by Subject|0
4585838|NCT01479764|7429726|FG000|Treated|Lost to Follow-up|0
4585839|NCT01479764|7429727|FG001|Treated|Lost to Follow-up|2
4585840|NCT01479777|7429733|FG000|Overall Study|Physician Decision|2
4585841|NCT01479868|7429737|FG000|Overall Study|Adverse Event|1
4585842|NCT01479868|7429737|FG000|Overall Study|Lost to Follow-up|4
4585843|NCT01479868|7429737|FG000|Overall Study|Protocol Violation|1
4585844|NCT01479868|7429737|FG000|Overall Study|Withdrawal by Subject|1
4585845|NCT01479868|7429737|FG000|Overall Study|Sponsor's Decision|1
4585846|NCT01479868|7429737|FG000|Overall Study|Initiation of new HCV Therapy|1
4593508|NCT01552902|7441991|FG001|Overall Study|Other|4
4593509|NCT01552902|7441992|FG002|Overall Study|Other|3
4593510|NCT01552915|7442003|FG000|Overall Study|Adverse Event|3
4593511|NCT01552915|7442004|FG001|Overall Study|Adverse Event|14
4593512|NCT01552915|7442005|FG002|Overall Study|Adverse Event|3
4593513|NCT01552915|7442003|FG000|Overall Study|Lost to Follow-up|4
4593514|NCT01552915|7442004|FG001|Overall Study|Lost to Follow-up|6
4593515|NCT01552915|7442005|FG002|Overall Study|Lost to Follow-up|5
4593516|NCT01552915|7442003|FG000|Overall Study|Withdrawal by Subject|6
4593517|NCT01552915|7442004|FG001|Overall Study|Withdrawal by Subject|4
4593518|NCT01552915|7442005|FG002|Overall Study|Withdrawal by Subject|5
4593519|NCT01552915|7442003|FG000|Overall Study|Protocol Violation|0
4593520|NCT01552915|7442004|FG001|Overall Study|Protocol Violation|4
4593521|NCT01552915|7442005|FG002|Overall Study|Protocol Violation|4
4593522|NCT01552915|7442003|FG000|Overall Study|Lack of Efficacy|8
4593523|NCT01552915|7442004|FG001|Overall Study|Lack of Efficacy|1
4593524|NCT01552915|7442005|FG002|Overall Study|Lack of Efficacy|4
4593525|NCT01552915|7442003|FG000|Overall Study|Other|2
4593526|NCT01552915|7442004|FG001|Overall Study|Other|0
4593527|NCT01552915|7442005|FG002|Overall Study|Other|6
4593528|NCT01552928|7442017|FG000|Period 3|Adverse Event|0
4593529|NCT01552928|7442018|FG001|Period 3|Adverse Event|0
4593530|NCT01552928|7442019|FG002|Period 3|Adverse Event|1
4593531|NCT01552928|7442020|FG003|Period 3|Adverse Event|0
4593532|NCT01552954|7442039|FG000|Overall Study|Adverse Event|1
4593533|NCT01552954|7442040|FG001|Overall Study|Adverse Event|2
4593534|NCT01552954|7442039|FG000|Overall Study|Lost to Follow-up|1
4593535|NCT01552954|7442040|FG001|Overall Study|Lost to Follow-up|1
4593536|NCT01552954|7442039|FG000|Overall Study|Withdrawal by Subject|1
4593537|NCT01552954|7442040|FG001|Overall Study|Withdrawal by Subject|1
4593538|NCT01552954|7442039|FG000|Overall Study|Protocol Violation|1
4593539|NCT01552954|7442040|FG001|Overall Study|Protocol Violation|2
4593540|NCT01552954|7442039|FG000|Overall Study|diagnosed DM|1
4593541|NCT01552954|7442040|FG001|Overall Study|diagnosed DM|0
4693543|NCT02592434|7604182|FG000|Double Blind Phase (26 Weeks)|Other|0
4693544|NCT02592434|7604183|FG001|Double Blind Phase (26 Weeks)|Other|1
4693545|NCT02592434|7604184|FG002|Double Blind Phase (26 Weeks)|Other|0
4693546|NCT02592434|7604182|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0
4693547|NCT02592434|7604183|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0
4693548|NCT02592434|7604184|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1
4693549|NCT02592434|7604182|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0
4693550|NCT02592434|7604183|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1
4693551|NCT02592434|7604184|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0
4693552|NCT02592434|7604182|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0
4693553|NCT02592434|7604183|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1
4693554|NCT02592434|7604184|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0
4693555|NCT02592447|7604194|FG000|Overall Study|Lost to Follow-up|1
4693556|NCT02592447|7604195|FG001|Overall Study|Lost to Follow-up|0
4693557|NCT02592447|7604194|FG000|Overall Study|Ineligible after randomization|1
4693558|NCT02592447|7604195|FG001|Overall Study|Ineligible after randomization|0
4693559|NCT02592447|7604194|FG000|Overall Study|Withdrawal by Subject|0
4693560|NCT02592447|7604195|FG001|Overall Study|Withdrawal by Subject|1
4734980|NCT03515824|7682519|FG003|Overall Study|Study terminated by sponsor|0
4734981|NCT03515824|7682516|FG000|Overall Study|Status not recorded|0
4734982|NCT03515824|7682517|FG001|Overall Study|Status not recorded|0
4734983|NCT03515824|7682518|FG002|Overall Study|Status not recorded|2
4734984|NCT03515824|7682519|FG003|Overall Study|Status not recorded|0
4734985|NCT03515941|7682529|FG000|Overall Study|Adverse Event|1
4734986|NCT03515941|7682530|FG001|Overall Study|Adverse Event|0
4734987|NCT03517436|7682546|FG000|Overall Study|Death|3
4734988|NCT03517436|7682546|FG000|Overall Study|Withdrawal by Subject|4
4734989|NCT03517436|7682546|FG000|Overall Study|Did not receive study valve.|1
4734990|NCT03517566|7682555|FG000|Overall Study|Adverse Event|5
4734991|NCT03517566|7682556|FG001|Overall Study|Adverse Event|2
4734992|NCT03517566|7682557|FG002|Overall Study|Adverse Event|2
4734993|NCT03517566|7682558|FG003|Overall Study|Adverse Event|8
4734994|NCT03517566|7682559|FG004|Overall Study|Adverse Event|7
4734995|NCT03517566|7682555|FG000|Overall Study|Lack of Efficacy|3
4734996|NCT03517566|7682556|FG001|Overall Study|Lack of Efficacy|2
4734997|NCT03517566|7682557|FG002|Overall Study|Lack of Efficacy|1
4734998|NCT03517566|7682558|FG003|Overall Study|Lack of Efficacy|1
4734999|NCT03517566|7682559|FG004|Overall Study|Lack of Efficacy|4
4593542|NCT01553084|7442066|FG000|Overall Study|Withdrawal by Subject|15
4593543|NCT01553084|7442067|FG001|Overall Study|Withdrawal by Subject|13
4593544|NCT01553084|7442068|FG002|Overall Study|Withdrawal by Subject|35
4735000|NCT03517566|7682555|FG000|Overall Study|Lost to Follow-up|3
4593545|NCT01553136|7442080|FG000|Overall Study|Adverse Event|3
4593546|NCT01553136|7442081|FG001|Overall Study|Adverse Event|2
4593547|NCT01553136|7442080|FG000|Overall Study|Withdrawal by Subject|2
4585847|NCT01479985|7429743|FG000|Overall Study|Tablet malfunction, no data saved|1
4585848|NCT01479985|7429744|FG001|Overall Study|Tablet malfunction, no data saved|1
4585849|NCT01479985|7429743|FG000|Overall Study|No decisional conflict scale responses|0
4585850|NCT01479985|7429744|FG001|Overall Study|No decisional conflict scale responses|2
4585851|NCT01479985|7429743|FG000|Overall Study|No post-visit survey|5
4585852|NCT01479985|7429744|FG001|Overall Study|No post-visit survey|3
4585853|NCT01480076|7429752|FG000|Overall Study|Run-in Failure|52
4585854|NCT01480076|7429752|FG000|Overall Study|Adverse Event|39
4585855|NCT01480076|7429752|FG000|Overall Study|Death|2
4585856|NCT01480076|7429752|FG000|Overall Study|Disease Progression|5
4585857|NCT01480076|7429752|FG000|Overall Study|Non-compliance With Study Protocol|15
4585858|NCT01480076|7429752|FG000|Overall Study|Withdrawal by Subject|105
4585859|NCT01480076|7429752|FG000|Overall Study|Lost to Follow-up|7
4585860|NCT01480076|7429752|FG000|Overall Study|Investigator Decision|13
4585861|NCT01480076|7429752|FG000|Overall Study|Other|52
4585862|NCT01480258|7429805|FG000|Infant Series|Protocol Violation|2
4693561|NCT02592798|7604242|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1
4693562|NCT02592798|7604243|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0
4693563|NCT02592798|7604242|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0
4693564|NCT02592798|7604243|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1
4693565|NCT02592798|7604242|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1
4693566|NCT02592798|7604243|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3
4693567|NCT02592798|7604242|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1
4693568|NCT02592798|7604243|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2
4693569|NCT02592798|7604242|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3
4693570|NCT02592798|7604243|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2
4693571|NCT02592798|7604242|FG000|Double-Blind Period 2 (DB2)|Other reasons|1
4693572|NCT02592798|7604243|FG001|Double-Blind Period 2 (DB2)|Other reasons|0
4693573|NCT02592798|7604242|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1
4693574|NCT02592798|7604243|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0
4693575|NCT02592798|7604242|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1
4693576|NCT02592798|7604243|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0
4693577|NCT02592798|7604242|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1
4693578|NCT02592798|7604243|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2
4693579|NCT02592798|7604242|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1
4693580|NCT02592798|7604243|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0
4693581|NCT02592798|7604242|FG000|Transition From DB2 to OLE|Other reasons|1
4693582|NCT02592798|7604243|FG001|Transition From DB2 to OLE|Other reasons|0
4693583|NCT02592798|7604242|FG000|Open Label Period (OLE)|Other reasons|0
4693584|NCT02592798|7604243|FG001|Open Label Period (OLE)|Other reasons|2
4693585|NCT02592798|7604242|FG000|Open Label Period (OLE)|Participant request to discontinue|1
4693586|NCT02592798|7604243|FG001|Open Label Period (OLE)|Participant request to discontinue|0
4693587|NCT02592798|7604242|FG000|Open Label Period (OLE)|Lost to Follow-up|0
4693588|NCT02592798|7604243|FG001|Open Label Period (OLE)|Lost to Follow-up|1
4693589|NCT02592798|7604242|FG000|Open Label Period (OLE)|Lack of Efficacy|3
4693590|NCT02592798|7604243|FG001|Open Label Period (OLE)|Lack of Efficacy|5
4693591|NCT02592798|7604242|FG000|Open Label Period (OLE)|Adverse Event|0
4693592|NCT02592798|7604243|FG001|Open Label Period (OLE)|Adverse Event|1
4693593|NCT02592876|7604258|FG000|Overall Study|Withdrawal by Subject|3
4693594|NCT02592876|7604259|FG001|Overall Study|Withdrawal by Subject|3
4693595|NCT02592876|7604258|FG000|Overall Study|Study Termination by Sponsor|32
4693596|NCT02592876|7604259|FG001|Overall Study|Study Termination by Sponsor|27
4693597|NCT02592876|7604258|FG000|Overall Study|Lost to Follow-up|0
4693598|NCT02592876|7604259|FG001|Overall Study|Lost to Follow-up|1
4693599|NCT02592876|7604258|FG000|Overall Study|Death|6
4693600|NCT02592876|7604259|FG001|Overall Study|Death|9
4693601|NCT02593097|7604290|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1
4693602|NCT02593097|7604291|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2
4693603|NCT02593097|7604290|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1
4693604|NCT02593097|7604291|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2
4693605|NCT02593097|7604290|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1
4693606|NCT02593097|7604291|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1
4693607|NCT02593097|7604290|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1
4693608|NCT02593097|7604291|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0
4693609|NCT02593097|7604290|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1
4693610|NCT02593097|7604291|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0
4693611|NCT02593149|7604299|FG000|Run-In|Didn't use CVC for at least 21 days|36
4693612|NCT02593149|7604300|FG001|Run-In|Didn't use CVC for at least 21 days|38
4693613|NCT02593149|7604299|FG000|Intervention|Didn't use CVC for at least 21 day|116
4693614|NCT02593149|7604300|FG001|Intervention|Didn't use CVC for at least 21 day|115
4693615|NCT02593305|7604309|FG000|Post 1|Comparison only group. No intervention.|0
4693616|NCT02593305|7604310|FG001|Post 1|Comparison only group. No intervention.|0
4693617|NCT02593305|7604311|FG002|Post 1|Comparison only group. No intervention.|10
4693618|NCT02593318|7604322|FG000|Overall Study|Withdrawal by Subject|1
4585863|NCT01480258|7429806|FG001|Infant Series|Protocol Violation|0
4585864|NCT01480258|7429805|FG000|Infant Series|Physician Decision|0
4585865|NCT01480258|7429806|FG001|Infant Series|Physician Decision|1
4585866|NCT01480258|7429805|FG000|Infant Series|Not Vaccinated|3
4585867|NCT01480258|7429806|FG001|Infant Series|Not Vaccinated|0
4585868|NCT01480258|7429805|FG000|Infant Series|Adverse Event|1
4585869|NCT01480258|7429806|FG001|Infant Series|Adverse Event|1
4585870|NCT01480258|7429805|FG000|Infant Series|Withdrawal by Subject|1
4585871|NCT01480258|7429806|FG001|Infant Series|Withdrawal by Subject|6
4585872|NCT01480258|7429805|FG000|Interim Period|Lost to Follow-up|0
4585873|NCT01480258|7429806|FG001|Interim Period|Lost to Follow-up|2
4585874|NCT01480258|7429805|FG000|Interim Period|Physician Decision|1
4585875|NCT01480258|7429806|FG001|Interim Period|Physician Decision|0
4585876|NCT01480258|7429805|FG000|Interim Period|Protocol Violation|0
4585877|NCT01480258|7429806|FG001|Interim Period|Protocol Violation|1
4585878|NCT01480258|7429805|FG000|Interim Period|Withdrawal by Subject|9
4585879|NCT01480258|7429806|FG001|Interim Period|Withdrawal by Subject|6
4585880|NCT01480284|7429814|FG000|Overall Study|Withdrawal by Subject|2
4585881|NCT01480284|7429815|FG001|Overall Study|Withdrawal by Subject|0
4585882|NCT01480284|7429814|FG000|Overall Study|Adverse Event|1
4585883|NCT01480284|7429815|FG001|Overall Study|Adverse Event|0
4585884|NCT01480284|7429814|FG000|Overall Study|Study closed/terminated|3
4585885|NCT01480284|7429815|FG001|Overall Study|Study closed/terminated|0
4585886|NCT01480284|7429814|FG000|Overall Study|Lost to Follow-up|1
4585887|NCT01480284|7429815|FG001|Overall Study|Lost to Follow-up|0
4585888|NCT01480284|7429814|FG000|Overall Study|Physician Decision|1
4585889|NCT01480284|7429815|FG001|Overall Study|Physician Decision|0
4585890|NCT01480596|7429827|FG000|Overall Study|Adverse Event|3
4585891|NCT01480596|7429828|FG001|Overall Study|Adverse Event|0
4585892|NCT01480596|7429827|FG000|Overall Study|MG exacerbation or change in medication|2
4585893|NCT01480596|7429828|FG001|Overall Study|MG exacerbation or change in medication|2
4585894|NCT01480674|7429834|FG000|Overall Study|Death|23
4585895|NCT01480674|7429834|FG000|Overall Study|Lost to Follow-up|2
4585896|NCT01480674|7429834|FG000|Overall Study|visit not done|10
4585897|NCT01481116|7429845|FG000|Overall Study|Adverse Event|26
4585898|NCT01481116|7429846|FG001|Overall Study|Adverse Event|26
4585899|NCT01481116|7429847|FG002|Overall Study|Adverse Event|42
4585900|NCT01481116|7429845|FG000|Overall Study|Major Protocol Deviation|3
4585901|NCT01481116|7429846|FG001|Overall Study|Major Protocol Deviation|7
4585902|NCT01481116|7429847|FG002|Overall Study|Major Protocol Deviation|1
4585903|NCT01481116|7429845|FG000|Overall Study|Lost to Follow-up|8
4585904|NCT01481116|7429846|FG001|Overall Study|Lost to Follow-up|12
4585905|NCT01481116|7429847|FG002|Overall Study|Lost to Follow-up|11
4585906|NCT01481116|7429845|FG000|Overall Study|Withdrawal by Subject|37
4585907|NCT01481116|7429846|FG001|Overall Study|Withdrawal by Subject|33
4585908|NCT01481116|7429847|FG002|Overall Study|Withdrawal by Subject|37
4585909|NCT01481116|7429845|FG000|Overall Study|Study Termination|730
4585910|NCT01481116|7429846|FG001|Overall Study|Study Termination|729
4585911|NCT01481116|7429847|FG002|Overall Study|Study Termination|713
4585912|NCT01481116|7429845|FG000|Overall Study|Pregnancy|0
4585913|NCT01481116|7429846|FG001|Overall Study|Pregnancy|0
4585914|NCT01481116|7429847|FG002|Overall Study|Pregnancy|1
4585915|NCT01481116|7429845|FG000|Overall Study|Lack of Efficacy|3
4585916|NCT01481116|7429846|FG001|Overall Study|Lack of Efficacy|3
4585917|NCT01481116|7429847|FG002|Overall Study|Lack of Efficacy|1
4585918|NCT01481116|7429845|FG000|Overall Study|Contraindications|1
4585919|NCT01481116|7429846|FG001|Overall Study|Contraindications|1
4585920|NCT01481116|7429847|FG002|Overall Study|Contraindications|0
4585921|NCT01481116|7429845|FG000|Overall Study|Other|1
4585922|NCT01481116|7429846|FG001|Overall Study|Other|1
4585923|NCT01481116|7429847|FG002|Overall Study|Other|0
4585924|NCT01481116|7429845|FG000|Overall Study|Participant Started Taking Glipizide|1
4585925|NCT01481116|7429846|FG001|Overall Study|Participant Started Taking Glipizide|0
4585926|NCT01481116|7429847|FG002|Overall Study|Participant Started Taking Glipizide|0
4585927|NCT01481116|7429845|FG000|Overall Study|Participant Moved Out of Area|2
4585928|NCT01481116|7429846|FG001|Overall Study|Participant Moved Out of Area|0
4585929|NCT01481116|7429847|FG002|Overall Study|Participant Moved Out of Area|1
4585930|NCT01481116|7429845|FG000|Overall Study|Participant Moved Out of Country|1
4585931|NCT01481116|7429846|FG001|Overall Study|Participant Moved Out of Country|0
4585932|NCT01481116|7429847|FG002|Overall Study|Participant Moved Out of Country|1
4585933|NCT01481116|7429845|FG000|Overall Study|Investigator Decision|3
4585934|NCT01481116|7429846|FG001|Overall Study|Investigator Decision|2
4585935|NCT01481116|7429847|FG002|Overall Study|Investigator Decision|1
4585936|NCT01481116|7429845|FG000|Overall Study|Sponsor Decision|0
4585937|NCT01481116|7429846|FG001|Overall Study|Sponsor Decision|1
4585938|NCT01481116|7429847|FG002|Overall Study|Sponsor Decision|3
4585939|NCT01481116|7429845|FG000|Overall Study|Non-Compliant With Study Drug|0
4585940|NCT01481116|7429846|FG001|Overall Study|Non-Compliant With Study Drug|1
4585941|NCT01481116|7429847|FG002|Overall Study|Non-Compliant With Study Drug|1
4585942|NCT01481116|7429845|FG000|Overall Study|Investigator's Discretion|2
4585943|NCT01481116|7429846|FG001|Overall Study|Investigator's Discretion|0
4585944|NCT01481116|7429847|FG002|Overall Study|Investigator's Discretion|0
4585945|NCT01481116|7429845|FG000|Overall Study|Death|2
4585946|NCT01481116|7429846|FG001|Overall Study|Death|1
4585947|NCT01481116|7429847|FG002|Overall Study|Death|0
4585948|NCT01481116|7429845|FG000|Overall Study|Hypoglycemic Event|4
4585949|NCT01481116|7429846|FG001|Overall Study|Hypoglycemic Event|0
4585950|NCT01481116|7429847|FG002|Overall Study|Hypoglycemic Event|0
4585951|NCT01481324|7429862|FG000|Overall Study|Missing Data|0
4585952|NCT01481324|7429863|FG001|Overall Study|Missing Data|2
4693619|NCT02593318|7604323|FG001|Overall Study|Withdrawal by Subject|1
4693620|NCT02593539|7604344|FG000|Overall Study|Adverse Event|1
4693621|NCT02593773|7604356|FG000|Overall Study|Voluntary Withdrawal|3
4693622|NCT02593773|7604356|FG000|Overall Study|Study Terminated by Sponsor|31
4693623|NCT02593773|7604356|FG000|Overall Study|Death|1
4693624|NCT02593825|7604362|FG000|Intervention|Lost to Follow-up|10
4693625|NCT02593825|7604363|FG001|Intervention|Lost to Follow-up|12
4693626|NCT02593864|7604371|FG000|Overall Study|Withdrawal by Subject|3
4693627|NCT02593864|7604371|FG000|Overall Study|Lost to Follow-up|3
4693628|NCT02594098|7604386|FG000|Overall Study|Lack of Efficacy|17
4693629|NCT02594098|7604387|FG001|Overall Study|Lack of Efficacy|6
4693630|NCT02594098|7604386|FG000|Overall Study|Withdrawal by Subject|1
4693631|NCT02594098|7604387|FG001|Overall Study|Withdrawal by Subject|3
4693632|NCT02594098|7604386|FG000|Overall Study|Terminated participation|6
4693633|NCT02594098|7604387|FG001|Overall Study|Terminated participation|2
4693634|NCT02594098|7604386|FG000|Overall Study|Seek alternative treatment|2
4693635|NCT02594098|7604387|FG001|Overall Study|Seek alternative treatment|1
4693636|NCT02594098|7604386|FG000|Overall Study|Other|0
4693637|NCT02594098|7604387|FG001|Overall Study|Other|1
4693638|NCT02594163|7604406|FG000|Treatment Period|Progressive disease|2
4693639|NCT02594163|7604407|FG001|Treatment Period|Progressive disease|3
4693640|NCT02594163|7604406|FG000|Treatment Period|Adverse Event|1
4693641|NCT02594163|7604407|FG001|Treatment Period|Adverse Event|5
4693642|NCT02594163|7604406|FG000|Treatment Period|Physician Decision|1
4693643|NCT02594163|7604407|FG001|Treatment Period|Physician Decision|3
4693644|NCT02594163|7604406|FG000|Treatment Period|Study termination by sponsor|2
4693645|NCT02594163|7604407|FG001|Treatment Period|Study termination by sponsor|1
4693646|NCT02594163|7604406|FG000|Treatment Period|Other, Non-AE|1
4693647|NCT02594163|7604407|FG001|Treatment Period|Other, Non-AE|0
4585953|NCT01481324|7429864|FG002|Overall Study|Missing Data|2
4585954|NCT01481779|7429907|FG000|Overall Study|Adverse Event|23
4693648|NCT02594163|7604406|FG000|Follow-up Period|Withdrawal by Subject|0
4693649|NCT02594163|7604407|FG001|Follow-up Period|Withdrawal by Subject|1
4693650|NCT02594163|7604406|FG000|Follow-up Period|Study Termination by Sponsor|6
4693651|NCT02594163|7604407|FG001|Follow-up Period|Study Termination by Sponsor|4
4693652|NCT02594163|7604406|FG000|Follow-up Period|Lost to Follow-up|1
4693653|NCT02594163|7604407|FG001|Follow-up Period|Lost to Follow-up|0
4693654|NCT02594163|7604406|FG000|Follow-up Period|Death|2
4693655|NCT02594163|7604407|FG001|Follow-up Period|Death|5
4693656|NCT02594163|7604406|FG000|Follow-up Period|Adverse Event|0
4693657|NCT02594163|7604407|FG001|Follow-up Period|Adverse Event|1
4693658|NCT02594163|7604406|FG000|Follow-up Period|Progressive Disease|2
4693659|NCT02594163|7604407|FG001|Follow-up Period|Progressive Disease|0
4693660|NCT02594163|7604406|FG000|Follow-up Period|Physician Decision|0
4693661|NCT02594163|7604407|FG001|Follow-up Period|Physician Decision|1
4693662|NCT02595008|7604443|FG000|Overall Study|Enrolled In Error|1
4693663|NCT02595008|7604444|FG001|Overall Study|Enrolled In Error|0
4693664|NCT02595073|7604452|FG000|Overall Study|Progressive Disease|0
4693665|NCT02595073|7604453|FG001|Overall Study|Progressive Disease|1
4693666|NCT02595073|7604452|FG000|Overall Study|Protocol Violation|2
4693667|NCT02595073|7604453|FG001|Overall Study|Protocol Violation|0
4693668|NCT02595398|7604461|FG000|Overall Study|Non-compliance|1
4693669|NCT02595398|7604462|FG001|Overall Study|Non-compliance|0
4693670|NCT02595398|7604461|FG000|Overall Study|Withdrawal by Subject|2
4693671|NCT02595398|7604462|FG001|Overall Study|Withdrawal by Subject|1
4693672|NCT02595398|7604461|FG000|Overall Study|Lost to Follow-up|1
4693673|NCT02595398|7604462|FG001|Overall Study|Lost to Follow-up|0
4693674|NCT02595437|7604468|FG000|Triferic Via IV|Withdrawal by Subject|1
4693675|NCT02595450|7604480|FG000|Overall Study|Unspecified (only completed 1 cycle)|73
4693676|NCT02595450|7604480|FG000|Overall Study|Enrolled, but not treated|8
4693677|NCT02595502|7604484|FG000|Period 1|Adverse Event|0
4693678|NCT02595502|7604485|FG001|Period 1|Adverse Event|1
4693679|NCT02595502|7604484|FG000|Period 1|Withdrawal by Subject|1
4693680|NCT02595502|7604485|FG001|Period 1|Withdrawal by Subject|0
4693681|NCT02595502|7604484|FG000|Period 1|Lost to Follow-up|0
4693682|NCT02595502|7604485|FG001|Period 1|Lost to Follow-up|1
4693683|NCT02595502|7604484|FG000|Period 2|Adverse Event|1
4693684|NCT02595502|7604485|FG001|Period 2|Adverse Event|1
4693685|NCT02595502|7604484|FG000|Period 2|Received incorrect lens at Period 1|0
4693686|NCT02595502|7604485|FG001|Period 2|Received incorrect lens at Period 1|1
4693687|NCT02595502|7604484|FG000|Period 3|Protocol Violation|0
4693688|NCT02595502|7604485|FG001|Period 3|Protocol Violation|1
4693689|NCT02595502|7604484|FG000|Period 3|Lost to Follow-up|1
4693690|NCT02595502|7604485|FG001|Period 3|Lost to Follow-up|0
4693691|NCT02595502|7604484|FG000|Period 3|Received Incorrect Treatment at period 3|0
4693692|NCT02595502|7604485|FG001|Period 3|Received Incorrect Treatment at period 3|1
4693693|NCT02595528|7604495|FG000|Overall Study|Withdrawal by Subject|1
4693694|NCT02595528|7604496|FG001|Overall Study|Withdrawal by Subject|2
4693695|NCT02595528|7604497|FG002|Overall Study|Withdrawal by Subject|1
4693696|NCT02595528|7604498|FG003|Overall Study|Withdrawal by Subject|3
4693697|NCT02595528|7604495|FG000|Overall Study|Lost to Follow-up|1
4693698|NCT02595528|7604496|FG001|Overall Study|Lost to Follow-up|1
4693699|NCT02595528|7604497|FG002|Overall Study|Lost to Follow-up|0
4585955|NCT01481779|7429908|FG001|Overall Study|Adverse Event|5
4585956|NCT01481779|7429907|FG000|Overall Study|Lost to Follow-up|3
4585957|NCT01481779|7429908|FG001|Overall Study|Lost to Follow-up|2
4585958|NCT01481779|7429907|FG000|Overall Study|Protocol Violation|2
4585959|NCT01481779|7429908|FG001|Overall Study|Protocol Violation|3
4585960|NCT01481779|7429907|FG000|Overall Study|Withdrawal by Subject|26
4585961|NCT01481779|7429908|FG001|Overall Study|Withdrawal by Subject|13
4585962|NCT01481779|7429907|FG000|Overall Study|Physician Decision|13
4585963|NCT01481779|7429908|FG001|Overall Study|Physician Decision|4
4585964|NCT01481779|7429907|FG000|Overall Study|Sponsor Decision|3
4585965|NCT01481779|7429908|FG001|Overall Study|Sponsor Decision|1
4585966|NCT01481896|7429914|FG000|Overall Study|Lost to Follow-up|12
4585967|NCT01482065|7429930|FG000|Overall Study|Withdrawal by Subject|0
4585968|NCT01482065|7429931|FG001|Overall Study|Withdrawal by Subject|1
4585969|NCT01482169|7429946|FG000|Overall Study|Physician Decision|2
4585970|NCT01482221|7429956|FG000|Overall Study|Lack of Efficacy|1
4585971|NCT01482221|7429957|FG001|Overall Study|Lack of Efficacy|0
4585972|NCT01482221|7429958|FG002|Overall Study|Lack of Efficacy|1
4585973|NCT01482221|7429956|FG000|Overall Study|Lost to Follow-up|3
4585974|NCT01482221|7429957|FG001|Overall Study|Lost to Follow-up|2
4585975|NCT01482221|7429958|FG002|Overall Study|Lost to Follow-up|1
4585976|NCT01482221|7429956|FG000|Overall Study|Study-Specific Withdrawal Criteria|2
4585977|NCT01482221|7429957|FG001|Overall Study|Study-Specific Withdrawal Criteria|0
4585978|NCT01482221|7429958|FG002|Overall Study|Study-Specific Withdrawal Criteria|1
4585979|NCT01482221|7429956|FG000|Overall Study|Condition under Investigation Worsened|3
4585980|NCT01482221|7429957|FG001|Overall Study|Condition under Investigation Worsened|2
4585981|NCT01482221|7429958|FG002|Overall Study|Condition under Investigation Worsened|4
4585982|NCT01482221|7429956|FG000|Overall Study|Severe Non-Compliance to Protocol|1
4585983|NCT01482221|7429957|FG001|Overall Study|Severe Non-Compliance to Protocol|0
4585984|NCT01482221|7429958|FG002|Overall Study|Severe Non-Compliance to Protocol|1
4585985|NCT01482221|7429956|FG000|Overall Study|Adverse Event|1
4585986|NCT01482221|7429957|FG001|Overall Study|Adverse Event|7
4585987|NCT01482221|7429958|FG002|Overall Study|Adverse Event|3
4585988|NCT01482221|7429956|FG000|Overall Study|Withdrawal by Subject|10
4585989|NCT01482221|7429957|FG001|Overall Study|Withdrawal by Subject|7
4585990|NCT01482221|7429958|FG002|Overall Study|Withdrawal by Subject|12
4585991|NCT01482221|7429956|FG000|Overall Study|Incorrect randomization|0
4585992|NCT01482221|7429957|FG001|Overall Study|Incorrect randomization|1
4585993|NCT01482221|7429958|FG002|Overall Study|Incorrect randomization|0
4585994|NCT01482221|7429956|FG000|Overall Study|Physician Decision|0
4585995|NCT01482221|7429957|FG001|Overall Study|Physician Decision|1
4585996|NCT01482221|7429958|FG002|Overall Study|Physician Decision|0
4585997|NCT01482312|7429966|FG000|Period 1, 90 Minutes of Wear|Other|1
4585998|NCT01482312|7429967|FG001|Period 1, 90 Minutes of Wear|Other|0
4585999|NCT01482312|7429968|FG002|Period 1, 90 Minutes of Wear|Other|0
4586000|NCT01482312|7429966|FG000|Period 2, 90 Minutes of Wear|Other|1
4586001|NCT01482312|7429967|FG001|Period 2, 90 Minutes of Wear|Other|0
4586002|NCT01482312|7429968|FG002|Period 2, 90 Minutes of Wear|Other|0
4586003|NCT01482429|7429988|FG000|Care Usual|Protocol Violation|0
4586004|NCT01482429|7429989|FG001|Care Usual|Protocol Violation|172
4586005|NCT01482429|7429988|FG000|Care Usual|Lost to Follow-up|0
4586006|NCT01482429|7429989|FG001|Care Usual|Lost to Follow-up|1
4586007|NCT01482429|7429988|FG000|Protocol|Protocol Violation|275
4586008|NCT01482429|7429989|FG001|Protocol|Protocol Violation|0
4586009|NCT01482767|7430063|FG000|Overall Study|Death|1
4586010|NCT01482767|7430064|FG001|Overall Study|Death|1
4586011|NCT01482767|7430063|FG000|Overall Study|Withdrawal by Subject|7
4586012|NCT01482767|7430064|FG001|Overall Study|Withdrawal by Subject|5
4586013|NCT01482767|7430063|FG000|Overall Study|Lost to Follow-up|12
4586014|NCT01482767|7430064|FG001|Overall Study|Lost to Follow-up|6
4586015|NCT01482767|7430063|FG000|Overall Study|Adverse Event|0
4586016|NCT01482767|7430064|FG001|Overall Study|Adverse Event|3
4586017|NCT01482767|7430063|FG000|Overall Study|Site closure|22
4586018|NCT01482767|7430064|FG001|Overall Study|Site closure|14
4586019|NCT01482767|7430063|FG000|Overall Study|Non-adherence to study requirements|4
4586020|NCT01482767|7430064|FG001|Overall Study|Non-adherence to study requirements|7
4586021|NCT01482767|7430063|FG000|Overall Study|Alternate HCV treatment|7
4586022|NCT01482767|7430064|FG001|Overall Study|Alternate HCV treatment|8
4586023|NCT01482767|7430063|FG000|Overall Study|Ineligible|0
4586024|NCT01482767|7430064|FG001|Overall Study|Ineligible|5
4586025|NCT01482767|7430063|FG000|Overall Study|Nurse error|1
4586026|NCT01482767|7430064|FG001|Overall Study|Nurse error|0
4586027|NCT01482819|7430070|FG000|Overall Study|Lost to Follow-up|2
4586028|NCT01482884|7430080|FG000|Overall Study|Medical decision due to lack of efficacy|0
4586029|NCT01482884|7430081|FG001|Overall Study|Medical decision due to lack of efficacy|1
4586030|NCT01482884|7430080|FG000|Overall Study|Protocol Violation|1
4586031|NCT01482884|7430081|FG001|Overall Study|Protocol Violation|0
4586032|NCT01482884|7430080|FG000|Overall Study|Lost to Follow-up|2
4586033|NCT01482884|7430081|FG001|Overall Study|Lost to Follow-up|2
4586034|NCT01482884|7430080|FG000|Overall Study|Lack of Efficacy|0
4586035|NCT01482884|7430081|FG001|Overall Study|Lack of Efficacy|1
4586036|NCT01482884|7430080|FG000|Overall Study|Adverse Event|2
4586037|NCT01482884|7430081|FG001|Overall Study|Adverse Event|1
4586038|NCT01482884|7430080|FG000|Overall Study|Withdrawal by Subject|8
4586039|NCT01482884|7430081|FG001|Overall Study|Withdrawal by Subject|13
4586040|NCT01482910|7430089|FG000|Overall Study|Adverse Event|6
4693700|NCT02595528|7604498|FG003|Overall Study|Lost to Follow-up|1
4693701|NCT02595723|7604524|FG000|First Washout (21 Days)|Withdrawal by Subject|1
4693702|NCT02595723|7604525|FG001|First Washout (21 Days)|Withdrawal by Subject|0
4693703|NCT02595723|7604526|FG002|First Washout (21 Days)|Withdrawal by Subject|0
4693704|NCT02595723|7604524|FG000|First Washout (21 Days)|Lost to Follow-up|1
4693705|NCT02595723|7604525|FG001|First Washout (21 Days)|Lost to Follow-up|0
4693706|NCT02595723|7604526|FG002|First Washout (21 Days)|Lost to Follow-up|0
4693707|NCT02595749|7604536|FG000|Overall Study|Withdrawal by Subject|12
4693708|NCT02595749|7604537|FG001|Overall Study|Withdrawal by Subject|7
4693709|NCT02595970|7604543|FG000|Overall Study|Withdrawal by Subject|2
4693710|NCT02595970|7604543|FG000|Overall Study|Physician Decision|2
4693711|NCT02595970|7604543|FG000|Overall Study|Protocol Violation|4
4693712|NCT02595970|7604543|FG000|Overall Study|Adverse Event|5
4693713|NCT02595970|7604543|FG000|Overall Study|Lack of Efficacy|7
4693714|NCT02596009|7604552|FG000|Overall Study|Administrative problems|0
4693715|NCT02596009|7604553|FG001|Overall Study|Administrative problems|1
4693716|NCT02596009|7604554|FG002|Overall Study|Administrative problems|0
4693717|NCT02596009|7604555|FG003|Overall Study|Administrative problems|0
4693718|NCT02596009|7604556|FG004|Overall Study|Administrative problems|0
4693719|NCT02596009|7604557|FG005|Overall Study|Administrative problems|0
4693720|NCT02596035|7604575|FG000|Overall Study|Disease Progression|62
4693721|NCT02596035|7604576|FG001|Overall Study|Disease Progression|32
4693722|NCT02596035|7604577|FG002|Overall Study|Disease Progression|1
4693723|NCT02596035|7604575|FG000|Overall Study|Study Drug Toxicity|11
4693724|NCT02596035|7604576|FG001|Overall Study|Study Drug Toxicity|3
4693725|NCT02596035|7604577|FG002|Overall Study|Study Drug Toxicity|0
4693726|NCT02596035|7604575|FG000|Overall Study|Adverse Event|6
4693727|NCT02596035|7604576|FG001|Overall Study|Adverse Event|2
4693728|NCT02596035|7604577|FG002|Overall Study|Adverse Event|0
4693729|NCT02596035|7604575|FG000|Overall Study|Withdrawal by Subject|4
4693730|NCT02596035|7604576|FG001|Overall Study|Withdrawal by Subject|2
4693731|NCT02596035|7604577|FG002|Overall Study|Withdrawal by Subject|0
4693732|NCT02596035|7604575|FG000|Overall Study|Poor/Non-Compliance|0
4693733|NCT02596035|7604576|FG001|Overall Study|Poor/Non-Compliance|1
4693734|NCT02596035|7604577|FG002|Overall Study|Poor/Non-Compliance|0
4693735|NCT02596035|7604575|FG000|Overall Study|Other Reasons|3
4693736|NCT02596035|7604576|FG001|Overall Study|Other Reasons|4
4693737|NCT02596035|7604577|FG002|Overall Study|Other Reasons|0
4693738|NCT02596230|7604589|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714
4693739|NCT02596230|7604590|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228
4693740|NCT02596230|7604591|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0
4693741|NCT02596230|7604592|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846
4693742|NCT02596230|7604593|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0
4693743|NCT02596230|7604589|FG000|Objective 2, One Year|Lost to Follow-up|0
4693744|NCT02596230|7604590|FG001|Objective 2, One Year|Lost to Follow-up|41
4693745|NCT02596230|7604591|FG002|Objective 2, One Year|Lost to Follow-up|41
4693746|NCT02596230|7604592|FG003|Objective 2, One Year|Lost to Follow-up|32
4693747|NCT02596230|7604593|FG004|Objective 2, One Year|Lost to Follow-up|46
4693748|NCT02596230|7604589|FG000|Objective 2, One Year|Withdrawal by Subject|0
4693749|NCT02596230|7604590|FG001|Objective 2, One Year|Withdrawal by Subject|11
4693750|NCT02596230|7604591|FG002|Objective 2, One Year|Withdrawal by Subject|14
4693751|NCT02596230|7604592|FG003|Objective 2, One Year|Withdrawal by Subject|5
4693752|NCT02596230|7604593|FG004|Objective 2, One Year|Withdrawal by Subject|2
4693753|NCT02596230|7604589|FG000|Objective 2, One Year|Adverse drug reaction|0
4693754|NCT02596230|7604590|FG001|Objective 2, One Year|Adverse drug reaction|1
4693755|NCT02596230|7604591|FG002|Objective 2, One Year|Adverse drug reaction|0
4693756|NCT02596230|7604592|FG003|Objective 2, One Year|Adverse drug reaction|0
4693757|NCT02596230|7604593|FG004|Objective 2, One Year|Adverse drug reaction|0
4693758|NCT02596230|7604589|FG000|Objective 2, One Year|Death|0
4693759|NCT02596230|7604590|FG001|Objective 2, One Year|Death|12
4693760|NCT02596230|7604591|FG002|Objective 2, One Year|Death|41
4693761|NCT02596230|7604592|FG003|Objective 2, One Year|Death|21
4693762|NCT02596230|7604593|FG004|Objective 2, One Year|Death|30
4693763|NCT02596230|7604589|FG000|Objective 2, One Year|Other|0
4693764|NCT02596230|7604590|FG001|Objective 2, One Year|Other|3
4586041|NCT01482910|7430090|FG001|Overall Study|Adverse Event|5
4693765|NCT02596230|7604591|FG002|Objective 2, One Year|Other|2
4693766|NCT02596230|7604592|FG003|Objective 2, One Year|Other|0
4693767|NCT02596230|7604593|FG004|Objective 2, One Year|Other|0
4586042|NCT01482910|7430089|FG000|Overall Study|Lost to Follow-up|0
4586043|NCT01482910|7430090|FG001|Overall Study|Lost to Follow-up|1
4586044|NCT01482910|7430089|FG000|Overall Study|Protocol Violation|1
4586045|NCT01482910|7430090|FG001|Overall Study|Protocol Violation|1
4586046|NCT01482910|7430089|FG000|Overall Study|Withdrawal by Subject|7
4586047|NCT01482910|7430090|FG001|Overall Study|Withdrawal by Subject|2
4586048|NCT01482910|7430089|FG000|Overall Study|Death|1
4586049|NCT01482910|7430090|FG001|Overall Study|Death|0
4586050|NCT01482962|7430100|FG000|Overall Study|Progressive Disease|65
4586051|NCT01482962|7430101|FG001|Overall Study|Progressive Disease|53
4586052|NCT01482962|7430100|FG000|Overall Study|Unsatisfactory Therapeutic Response|37
4586053|NCT01482962|7430101|FG001|Overall Study|Unsatisfactory Therapeutic Response|23
4586054|NCT01482962|7430100|FG000|Overall Study|Adverse Event|18
4586055|NCT01482962|7430101|FG001|Overall Study|Adverse Event|22
4586056|NCT01482962|7430100|FG000|Overall Study|Withdrawal by Participant|8
4586057|NCT01482962|7430101|FG001|Overall Study|Withdrawal by Participant|13
4586058|NCT01482962|7430100|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3
4586059|NCT01482962|7430101|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9
4586060|NCT01482962|7430100|FG000|Overall Study|Other Reason|1
4586061|NCT01482962|7430101|FG001|Overall Study|Other Reason|5
4586062|NCT01482962|7430100|FG000|Overall Study|Study Terminated by Sponsor|5
4586063|NCT01482962|7430101|FG001|Overall Study|Study Terminated by Sponsor|2
4586064|NCT01482962|7430100|FG000|Overall Study|Did not Receive Study Drug|1
4586065|NCT01482962|7430101|FG001|Overall Study|Did not Receive Study Drug|6
4586066|NCT01483118|7430111|FG000|Overall Study|Lost to Follow-up|12
4586067|NCT01483118|7430112|FG001|Overall Study|Lost to Follow-up|16
4586068|NCT01483144|7430123|FG000|Overall Study|Adverse Event|9
4586069|NCT01483144|7430124|FG001|Overall Study|Adverse Event|4
4586070|NCT01483144|7430125|FG002|Overall Study|Adverse Event|6
4586071|NCT01483144|7430123|FG000|Overall Study|Withdrawal by Subject|0
4586072|NCT01483144|7430124|FG001|Overall Study|Withdrawal by Subject|2
4586073|NCT01483144|7430125|FG002|Overall Study|Withdrawal by Subject|5
4586074|NCT01483144|7430123|FG000|Overall Study|Physician Decision|1
4586075|NCT01483144|7430124|FG001|Overall Study|Physician Decision|0
4586076|NCT01483144|7430125|FG002|Overall Study|Physician Decision|0
4586077|NCT01483144|7430123|FG000|Overall Study|Lost to Follow-up|2
4586078|NCT01483144|7430124|FG001|Overall Study|Lost to Follow-up|4
4586079|NCT01483144|7430125|FG002|Overall Study|Lost to Follow-up|1
4586080|NCT01483144|7430123|FG000|Overall Study|Protocol Violation|3
4586081|NCT01483144|7430124|FG001|Overall Study|Protocol Violation|3
4586082|NCT01483144|7430125|FG002|Overall Study|Protocol Violation|3
4586083|NCT01483183|7430143|FG000|Overall Study|Physician Decision|0
4586084|NCT01483183|7430144|FG001|Overall Study|Physician Decision|0
4586085|NCT01483183|7430145|FG002|Overall Study|Physician Decision|0
4586086|NCT01483183|7430146|FG003|Overall Study|Physician Decision|0
4586087|NCT01483183|7430147|FG004|Overall Study|Physician Decision|0
4586088|NCT01483183|7430148|FG005|Overall Study|Physician Decision|0
4586089|NCT01483183|7430149|FG006|Overall Study|Physician Decision|2
4586090|NCT01483183|7430150|FG007|Overall Study|Physician Decision|0
4586091|NCT01483183|7430151|FG008|Overall Study|Physician Decision|0
4586092|NCT01483183|7430152|FG009|Overall Study|Physician Decision|0
4586093|NCT01483183|7430143|FG000|Overall Study|Withdrawal by Subject|0
4586094|NCT01483183|7430144|FG001|Overall Study|Withdrawal by Subject|0
4586095|NCT01483183|7430145|FG002|Overall Study|Withdrawal by Subject|0
4586096|NCT01483183|7430146|FG003|Overall Study|Withdrawal by Subject|0
4586097|NCT01483183|7430147|FG004|Overall Study|Withdrawal by Subject|0
4693768|NCT02596620|7604626|FG000|Overall Study|Lost to Follow-up|1
4693769|NCT02596620|7604627|FG001|Overall Study|Lost to Follow-up|1
4693770|NCT02596711|7604636|FG000|Overall Study|Lost to Follow-up|1
4693771|NCT02596711|7604637|FG001|Overall Study|Lost to Follow-up|2
4693772|NCT02596711|7604638|FG002|Overall Study|Lost to Follow-up|3
4693773|NCT02596854|7604656|FG000|Overall Study|Withdrawn|8
4693774|NCT02596893|7604669|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61
4693775|NCT02596893|7604670|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56
4693776|NCT02596893|7604671|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48
4693777|NCT02596893|7604672|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58
4693778|NCT02596893|7604669|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11
4693779|NCT02596893|7604670|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15
4693780|NCT02596893|7604671|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15
4693781|NCT02596893|7604672|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12
4693782|NCT02596893|7604669|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0
4693783|NCT02596893|7604670|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0
4693784|NCT02596893|7604671|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0
4586098|NCT01483183|7430148|FG005|Overall Study|Withdrawal by Subject|0
4586099|NCT01483183|7430149|FG006|Overall Study|Withdrawal by Subject|0
4586100|NCT01483183|7430150|FG007|Overall Study|Withdrawal by Subject|0
4586101|NCT01483183|7430151|FG008|Overall Study|Withdrawal by Subject|0
4586102|NCT01483183|7430152|FG009|Overall Study|Withdrawal by Subject|1
4586103|NCT01483599|7430207|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2
4586104|NCT01483599|7430208|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0
4586105|NCT01483599|7430209|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0
4586106|NCT01483599|7430210|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1
4586107|NCT01483599|7430211|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1
4586108|NCT01483599|7430212|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4
4586109|NCT01483599|7430213|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3
4586110|NCT01483599|7430214|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0
4586111|NCT01483599|7430215|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0
4586112|NCT01483599|7430216|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0
4586113|NCT01483599|7430217|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0
4586114|NCT01483599|7430218|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0
4586115|NCT01483599|7430219|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0
4586116|NCT01483599|7430220|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0
4586117|NCT01483599|7430207|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
4586118|NCT01483599|7430208|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
4586119|NCT01483599|7430209|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
4586120|NCT01483599|7430210|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
4586121|NCT01483599|7430211|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
4586122|NCT01483599|7430212|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
4586123|NCT01483599|7430213|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
4586124|NCT01483599|7430214|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
4586125|NCT01483599|7430215|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
4586126|NCT01483599|7430216|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
4586127|NCT01483599|7430217|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
4586128|NCT01483599|7430218|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
4586129|NCT01483599|7430219|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
4586130|NCT01483599|7430220|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
4586131|NCT01483599|7430207|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1
4586132|NCT01483599|7430208|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
4586133|NCT01483599|7430209|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
4586134|NCT01483599|7430210|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
4586135|NCT01483599|7430211|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
4586136|NCT01483599|7430212|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
4586137|NCT01483599|7430213|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
4586138|NCT01483599|7430214|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
4693785|NCT02596893|7604672|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1
4693786|NCT02596893|7604669|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15
4693787|NCT02596893|7604670|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14
4693788|NCT02596893|7604671|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14
4693789|NCT02596893|7604672|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13
4693790|NCT02596893|7604669|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10
4693791|NCT02596893|7604670|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4
4693792|NCT02596893|7604671|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13
4693793|NCT02596893|7604672|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5
4693794|NCT02596893|7604669|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1
4693795|NCT02596893|7604670|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2
4693796|NCT02596893|7604671|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0
4693797|NCT02596893|7604672|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2
4693798|NCT02596893|7604669|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0
4693799|NCT02596893|7604670|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1
4693800|NCT02596893|7604671|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1
4693801|NCT02596893|7604672|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1
4693802|NCT02596893|7604669|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0
4693803|NCT02596893|7604670|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0
4693804|NCT02596893|7604671|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1
4693805|NCT02596893|7604672|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2
4693806|NCT02596893|7604669|FG000|Overall Double-Blind Period Weeks 0-52|Death|0
4693807|NCT02596893|7604670|FG001|Overall Double-Blind Period Weeks 0-52|Death|0
4693808|NCT02596893|7604671|FG002|Overall Double-Blind Period Weeks 0-52|Death|1
4693809|NCT02596893|7604672|FG003|Overall Double-Blind Period Weeks 0-52|Death|0
4693810|NCT02596893|7604669|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0
4693811|NCT02596893|7604670|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0
4586139|NCT01483599|7430215|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
4586140|NCT01483599|7430216|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
4586141|NCT01483599|7430217|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
4586142|NCT01483599|7430218|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
4586143|NCT01483599|7430219|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
4586144|NCT01483599|7430220|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
4586145|NCT01483599|7430207|FG000|Controlled Period (CP) (up to Week 16)|Other|0
4693812|NCT02596893|7604671|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0
4693813|NCT02596893|7604672|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2
4586146|NCT01483599|7430208|FG001|Controlled Period (CP) (up to Week 16)|Other|2
4586147|NCT01483599|7430209|FG002|Controlled Period (CP) (up to Week 16)|Other|0
4586148|NCT01483599|7430210|FG003|Controlled Period (CP) (up to Week 16)|Other|1
4586149|NCT01483599|7430211|FG004|Controlled Period (CP) (up to Week 16)|Other|1
4586150|NCT01483599|7430212|FG005|Controlled Period (CP) (up to Week 16)|Other|0
4586151|NCT01483599|7430213|FG006|Controlled Period (CP) (up to Week 16)|Other|0
4586152|NCT01483599|7430214|FG007|Controlled Period (CP) (up to Week 16)|Other|0
4586153|NCT01483599|7430215|FG008|Controlled Period (CP) (up to Week 16)|Other|0
4586154|NCT01483599|7430216|FG009|Controlled Period (CP) (up to Week 16)|Other|0
4586155|NCT01483599|7430217|FG010|Controlled Period (CP) (up to Week 16)|Other|0
4586156|NCT01483599|7430218|FG011|Controlled Period (CP) (up to Week 16)|Other|0
4586157|NCT01483599|7430219|FG012|Controlled Period (CP) (up to Week 16)|Other|0
4586158|NCT01483599|7430220|FG013|Controlled Period (CP) (up to Week 16)|Other|0
4586159|NCT01483599|7430207|FG000|After Controlled Period(Week 16-Week 40)|Death|0
4586160|NCT01483599|7430208|FG001|After Controlled Period(Week 16-Week 40)|Death|0
4586161|NCT01483599|7430209|FG002|After Controlled Period(Week 16-Week 40)|Death|0
4586162|NCT01483599|7430210|FG003|After Controlled Period(Week 16-Week 40)|Death|0
4586163|NCT01483599|7430211|FG004|After Controlled Period(Week 16-Week 40)|Death|0
4586164|NCT01483599|7430212|FG005|After Controlled Period(Week 16-Week 40)|Death|0
4586165|NCT01483599|7430213|FG006|After Controlled Period(Week 16-Week 40)|Death|0
4586166|NCT01483599|7430214|FG007|After Controlled Period(Week 16-Week 40)|Death|0
4586167|NCT01483599|7430215|FG008|After Controlled Period(Week 16-Week 40)|Death|1
4586168|NCT01483599|7430216|FG009|After Controlled Period(Week 16-Week 40)|Death|0
4586169|NCT01483599|7430217|FG010|After Controlled Period(Week 16-Week 40)|Death|0
4586170|NCT01483599|7430218|FG011|After Controlled Period(Week 16-Week 40)|Death|0
4586171|NCT01483599|7430219|FG012|After Controlled Period(Week 16-Week 40)|Death|0
4586172|NCT01483599|7430220|FG013|After Controlled Period(Week 16-Week 40)|Death|0
4693814|NCT02596893|7604669|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66
4693815|NCT02596893|7604670|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76
4693816|NCT02596893|7604671|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69
4693817|NCT02596893|7604672|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70
4693818|NCT02596945|7604691|FG000|Overall Study|No documentation of study drug dosing|3
4693819|NCT02596945|7604691|FG000|Overall Study|Other|32
4693820|NCT02596945|7604691|FG000|Overall Study|Change to hemodialysis|15
4693821|NCT02596945|7604691|FG000|Overall Study|Other Erythropoietin stimulating agent|4
4693822|NCT02596945|7604691|FG000|Overall Study|Withdrawal by Subject|1
4693823|NCT02596945|7604691|FG000|Overall Study|Missing|1
4693824|NCT02596958|7604695|FG000|Overall Study|Serious Adverse Drug Reactions|44
4693825|NCT02596958|7604695|FG000|Overall Study|Cancer Progression|441
4693826|NCT02596958|7604695|FG000|Overall Study|Death From Cancer|112
4693827|NCT02596958|7604695|FG000|Overall Study|Death From Other Cause|33
4693828|NCT02596958|7604695|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61
4693829|NCT02596958|7604695|FG000|Overall Study|Administrative Reasons/Other|231
4693830|NCT02596958|7604695|FG000|Overall Study|Lost to Follow-up|33
4693831|NCT02596958|7604695|FG000|Overall Study|Missing|32
4693832|NCT02596958|7604695|FG000|Overall Study|Excluded Due to Second Line Treatment|9
4693833|NCT02596971|7604702|FG000|Overall Study|Death|5
4693834|NCT02596971|7604703|FG001|Overall Study|Death|1
4693835|NCT02596971|7604704|FG002|Overall Study|Death|5
4693836|NCT02596971|7604702|FG000|Overall Study|Withdrawal by Subject|5
4693837|NCT02596971|7604703|FG001|Overall Study|Withdrawal by Subject|1
4693838|NCT02596971|7604704|FG002|Overall Study|Withdrawal by Subject|4
4693839|NCT02597049|7604718|FG000|Overall Study|Lost to Follow-up|0
4693840|NCT02597049|7604719|FG001|Overall Study|Lost to Follow-up|3
4693841|NCT02597049|7604720|FG002|Overall Study|Lost to Follow-up|2
4693842|NCT02597049|7604718|FG000|Overall Study|Withdrawal by Subject|2
4693843|NCT02597049|7604719|FG001|Overall Study|Withdrawal by Subject|2
4693844|NCT02597049|7604720|FG002|Overall Study|Withdrawal by Subject|1
4693845|NCT02597049|7604718|FG000|Overall Study|Adverse Event|2
4693846|NCT02597049|7604719|FG001|Overall Study|Adverse Event|0
4693847|NCT02597049|7604720|FG002|Overall Study|Adverse Event|0
4693848|NCT02597049|7604718|FG000|Overall Study|Death|2
4693849|NCT02597049|7604719|FG001|Overall Study|Death|0
4693850|NCT02597049|7604720|FG002|Overall Study|Death|0
4693851|NCT02597049|7604718|FG000|Overall Study|Noncompliant with Study Visits|1
4693852|NCT02597049|7604719|FG001|Overall Study|Noncompliant with Study Visits|0
4693853|NCT02597049|7604720|FG002|Overall Study|Noncompliant with Study Visits|0
4693854|NCT02597452|7604791|FG000|Overall Study|testing incomplete|30
4693855|NCT02597478|7604797|FG000|Overall Study|Withdrawal by Subject|2
4693856|NCT02597478|7604798|FG001|Overall Study|Withdrawal by Subject|0
4693857|NCT02597478|7604797|FG000|Overall Study|Change of opioid dose|1
4693858|NCT02597478|7604798|FG001|Overall Study|Change of opioid dose|0
4693859|NCT02597478|7604797|FG000|Overall Study|Insufficient exertional dyspnea|0
4586173|NCT01483599|7430207|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0
4693860|NCT02597478|7604798|FG001|Overall Study|Insufficient exertional dyspnea|1
4693861|NCT02597712|7604844|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2
4693862|NCT02597712|7604845|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0
4693863|NCT02597712|7604844|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1
4586174|NCT01483599|7430208|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0
4586175|NCT01483599|7430209|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0
4586176|NCT01483599|7430210|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0
4586177|NCT01483599|7430211|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0
4586178|NCT01483599|7430212|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0
4586179|NCT01483599|7430213|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0
4586180|NCT01483599|7430214|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1
4586181|NCT01483599|7430215|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1
4586182|NCT01483599|7430216|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0
4586183|NCT01483599|7430217|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0
4586184|NCT01483599|7430218|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0
4586185|NCT01483599|7430219|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1
4586186|NCT01483599|7430220|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1
4586187|NCT01483599|7430207|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
4586188|NCT01483599|7430208|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
4586189|NCT01483599|7430209|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
4586190|NCT01483599|7430210|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
4586191|NCT01483599|7430211|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
4586192|NCT01483599|7430212|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
4586193|NCT01483599|7430213|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
4586194|NCT01483599|7430214|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
4586195|NCT01483599|7430215|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
4586196|NCT01483599|7430216|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
4586197|NCT01483599|7430217|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
4586198|NCT01483599|7430218|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
4586199|NCT01483599|7430219|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
4586200|NCT01483599|7430220|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
4586201|NCT01483599|7430207|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
4586202|NCT01483599|7430208|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
4586203|NCT01483599|7430209|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
4586204|NCT01483599|7430210|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
4586205|NCT01483599|7430211|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
4586206|NCT01483599|7430212|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
4586207|NCT01483599|7430213|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
4586208|NCT01483599|7430214|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
4586209|NCT01483599|7430215|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1
4586210|NCT01483599|7430216|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
4693864|NCT02597712|7604845|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0
4693865|NCT02597712|7604844|FG000|Overall Study|Recurrent metastatic prostate cancer|0
4693866|NCT02597712|7604845|FG001|Overall Study|Recurrent metastatic prostate cancer|1
4693867|NCT02597855|7604853|FG000|Overall Study|Lost to Follow-up|2
4693868|NCT02597855|7604854|FG001|Overall Study|Lost to Follow-up|1
4693869|NCT02597920|7604872|FG000|Overall Study|Worsening of other pre-existing disease|0
4693870|NCT02597920|7604873|FG001|Overall Study|Worsening of other pre-existing disease|1
4693871|NCT02597920|7604874|FG002|Overall Study|Worsening of other pre-existing disease|0
4693872|NCT02597920|7604872|FG000|Overall Study|Other adverse event|20
4693873|NCT02597920|7604873|FG001|Overall Study|Other adverse event|30
4693874|NCT02597920|7604874|FG002|Overall Study|Other adverse event|0
4693875|NCT02597920|7604872|FG000|Overall Study|Lost to Follow-up|7
4693876|NCT02597920|7604873|FG001|Overall Study|Lost to Follow-up|9
4693877|NCT02597920|7604874|FG002|Overall Study|Lost to Follow-up|0
4693878|NCT02597920|7604872|FG000|Overall Study|Refuse to continue in the study|3
4693879|NCT02597920|7604873|FG001|Overall Study|Refuse to continue in the study|13
4693880|NCT02597920|7604874|FG002|Overall Study|Refuse to continue in the study|1
4693881|NCT02597920|7604872|FG000|Overall Study|Other than specified|10
4693882|NCT02597920|7604873|FG001|Overall Study|Other than specified|31
4693883|NCT02597920|7604874|FG002|Overall Study|Other than specified|5
4693884|NCT02597920|7604872|FG000|Overall Study|Other|1
4693885|NCT02597920|7604873|FG001|Overall Study|Other|0
4693886|NCT02597920|7604874|FG002|Overall Study|Other|0
4693887|NCT02597933|7604886|FG000|Overall Study|Withdrawal by Subject|7
4693888|NCT02597933|7604887|FG001|Overall Study|Withdrawal by Subject|5
4693889|NCT02597933|7604886|FG000|Overall Study|Protocol Violation|2
4693890|NCT02597933|7604887|FG001|Overall Study|Protocol Violation|2
4693891|NCT02597933|7604886|FG000|Overall Study|Adverse Event|20
4693892|NCT02597933|7604887|FG001|Overall Study|Adverse Event|28
4693893|NCT02597933|7604886|FG000|Overall Study|Not treated|2
4693894|NCT02597933|7604887|FG001|Overall Study|Not treated|2
4693895|NCT02597933|7604886|FG000|Overall Study|Other than stated above|7
4693896|NCT02597933|7604887|FG001|Overall Study|Other than stated above|14
4693897|NCT02597946|7604893|FG000|Overall Study|Withdrawal by Subject|1
4693898|NCT02597946|7604893|FG000|Overall Study|Progressive disease|16
4693899|NCT02597946|7604893|FG000|Overall Study|Other than above|1
4586211|NCT01483599|7430217|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2
4586212|NCT01483599|7430218|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
4586213|NCT01483599|7430219|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
4586214|NCT01483599|7430220|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1
4586215|NCT01483599|7430207|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
4586216|NCT01483599|7430208|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
4586217|NCT01483599|7430209|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
4586218|NCT01483599|7430210|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
4586219|NCT01483599|7430211|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
4586220|NCT01483599|7430212|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
4693900|NCT02598076|7604899|FG000|Overall Study|Lost to Follow-up|2
4693901|NCT02598076|7604900|FG001|Overall Study|Lost to Follow-up|3
4693902|NCT02598128|7604922|FG000|Period A: Days -7 to -1|Adverse Event|1
4693903|NCT02598128|7604923|FG001|Period A: Days -7 to -1|Adverse Event|0
4693904|NCT02598128|7604924|FG002|Period A: Days -7 to -1|Adverse Event|0
4693905|NCT02598128|7604925|FG003|Period A: Days -7 to -1|Adverse Event|0
4693906|NCT02598193|7604937|FG000|Overall Study|Adverse Event|13
4693907|NCT02598193|7604937|FG000|Overall Study|Withdrawal by Subject|1
4693908|NCT02598193|7604937|FG000|Overall Study|Listed in active lung transplant list|1
4693909|NCT02598193|7604937|FG000|Overall Study|Does not want to take Nintedanib|1
4693910|NCT02598297|7604943|FG000|Overall Study|Study terminated by Sponsor|21
4693911|NCT02598297|7604944|FG001|Overall Study|Study terminated by Sponsor|23
4693912|NCT02598297|7604943|FG000|Overall Study|Adverse Event|1
4693913|NCT02598297|7604944|FG001|Overall Study|Adverse Event|1
4693914|NCT02598297|7604943|FG000|Overall Study|Physician Decision|1
4693915|NCT02598297|7604944|FG001|Overall Study|Physician Decision|0
4693916|NCT02598297|7604943|FG000|Overall Study|Subject/guardian decision|1
4693917|NCT02598297|7604944|FG001|Overall Study|Subject/guardian decision|0
4693918|NCT02598297|7604943|FG000|Overall Study|Followed for survival|1
4693919|NCT02598297|7604944|FG001|Overall Study|Followed for survival|0
4693920|NCT02598934|7604961|FG000|Overall Study|Adverse Event|11
4693921|NCT02598934|7604962|FG001|Overall Study|Adverse Event|13
4693922|NCT02598934|7604961|FG000|Overall Study|Failure to Return|3
4693923|NCT02598934|7604962|FG001|Overall Study|Failure to Return|3
4693924|NCT02598934|7604961|FG000|Overall Study|Withdrawal by Subject|2
4693925|NCT02598934|7604962|FG001|Overall Study|Withdrawal by Subject|3
4693926|NCT02598934|7604961|FG000|Overall Study|Administrative|2
4693927|NCT02598934|7604962|FG001|Overall Study|Administrative|1
4693928|NCT02598934|7604961|FG000|Overall Study|Protocol Violation|1
4693929|NCT02598934|7604962|FG001|Overall Study|Protocol Violation|2
4693930|NCT02599129|7604970|FG000|Overall Study|Lack of Efficacy|2
4693931|NCT02599129|7604971|FG001|Overall Study|Lack of Efficacy|2
4693932|NCT02599129|7604970|FG000|Overall Study|Lost to Follow-up|1
4693933|NCT02599129|7604971|FG001|Overall Study|Lost to Follow-up|0
4693934|NCT02599129|7604970|FG000|Overall Study|Withdrawal by Subject|2
4693935|NCT02599129|7604971|FG001|Overall Study|Withdrawal by Subject|1
4693936|NCT02599402|7604983|FG000|Overall Study|Disease progression|153
4693937|NCT02599402|7604983|FG000|Overall Study|Study drug toxicity|201
4693938|NCT02599402|7604983|FG000|Overall Study|Death|26
4693939|NCT02599402|7604983|FG000|Overall Study|Adverse Event unrelated to study drug|23
4693940|NCT02599402|7604983|FG000|Overall Study|Participant request to discontinue study treatment|13
4693941|NCT02599402|7604983|FG000|Overall Study|Participant withdrew consent|5
4693942|NCT02599402|7604983|FG000|Overall Study|Lost to Follow-up|1
4693943|NCT02599402|7604983|FG000|Overall Study|Maximum Clinical Benefit|7
4693944|NCT02599402|7604983|FG000|Overall Study|Poor/non-compliance|1
4693945|NCT02599402|7604983|FG000|Overall Study|Pregnancy|1
4693946|NCT02599402|7604983|FG000|Overall Study|Participant no longer met study criteria|7
4693947|NCT02599402|7604983|FG000|Overall Study|Other Reasons|95
4693948|NCT02599688|7605034|FG000|Overall Study|Lack of Efficacy|1
4586221|NCT01483599|7430213|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
4693949|NCT02599688|7605034|FG000|Overall Study|Withdrawal by Subject|1
4693950|NCT02599688|7605034|FG000|Overall Study|Termination by Sponsor|2
4693951|NCT02599961|7605046|FG000|Overall Study|Withdrawal by Subject|1
4693952|NCT02599961|7605046|FG000|Overall Study|Subject Non-Compliance|2
4693953|NCT02599961|7605046|FG000|Overall Study|Discontinuation of Study by Sponsor|9
4693954|NCT02599961|7605046|FG000|Overall Study|Other, Not Specified|3
4693955|NCT02600351|7605058|FG000|Overall Study|Lack of Efficacy|3
4586222|NCT01483599|7430214|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
4586223|NCT01483599|7430215|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5
4586224|NCT01483599|7430216|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
4586225|NCT01483599|7430217|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
4586226|NCT01483599|7430218|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
4586227|NCT01483599|7430219|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1
4586228|NCT01483599|7430220|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4
4586229|NCT01483599|7430207|FG000|After Controlled Period(Week 16-Week 40)|Other|0
4586230|NCT01483599|7430208|FG001|After Controlled Period(Week 16-Week 40)|Other|0
4586231|NCT01483599|7430209|FG002|After Controlled Period(Week 16-Week 40)|Other|0
4586232|NCT01483599|7430210|FG003|After Controlled Period(Week 16-Week 40)|Other|0
4586233|NCT01483599|7430211|FG004|After Controlled Period(Week 16-Week 40)|Other|0
4586234|NCT01483599|7430212|FG005|After Controlled Period(Week 16-Week 40)|Other|0
4586235|NCT01483599|7430213|FG006|After Controlled Period(Week 16-Week 40)|Other|0
4586236|NCT01483599|7430214|FG007|After Controlled Period(Week 16-Week 40)|Other|1
4586237|NCT01483599|7430215|FG008|After Controlled Period(Week 16-Week 40)|Other|0
4693956|NCT02600351|7605059|FG001|Overall Study|Lack of Efficacy|0
4693957|NCT02600351|7605060|FG002|Overall Study|Lack of Efficacy|5
4693958|NCT02600351|7605061|FG003|Overall Study|Lack of Efficacy|2
4693959|NCT02600351|7605058|FG000|Overall Study|Lost to Follow-up|1
4693960|NCT02600351|7605059|FG001|Overall Study|Lost to Follow-up|0
4693961|NCT02600351|7605060|FG002|Overall Study|Lost to Follow-up|0
4693962|NCT02600351|7605061|FG003|Overall Study|Lost to Follow-up|0
4693963|NCT02600351|7605058|FG000|Overall Study|Randomized but Not Treated|1
4693964|NCT02600351|7605059|FG001|Overall Study|Randomized but Not Treated|0
4693965|NCT02600351|7605060|FG002|Overall Study|Randomized but Not Treated|1
4693966|NCT02600351|7605061|FG003|Overall Study|Randomized but Not Treated|3
4693967|NCT02600559|7605089|FG000|Overall Study|Withdrawal by Subject|3
4693968|NCT02600559|7605089|FG000|Overall Study|Lost to Follow-up|20
4693969|NCT02600819|7605127|FG000|GEN Phase|Adverse Event|2
4693970|NCT02600819|7605128|FG001|GEN Phase|Adverse Event|0
4693971|NCT02600819|7605127|FG000|GEN Phase|Death|2
4693972|NCT02600819|7605128|FG001|GEN Phase|Death|0
4693973|NCT02600819|7605127|FG000|GEN Phase|Investigator's Discretion|4
4693974|NCT02600819|7605128|FG001|GEN Phase|Investigator's Discretion|0
4693975|NCT02600819|7605127|FG000|GEN Phase|Non-Compliance with Study Drug|1
4693976|NCT02600819|7605128|FG001|GEN Phase|Non-Compliance with Study Drug|0
4693977|NCT02600819|7605127|FG000|GEN Phase|Withdrew Consent|5
4693978|NCT02600819|7605128|FG001|GEN Phase|Withdrew Consent|0
4693979|NCT02600819|7605127|FG000|GEN Phase|Lost to Follow-up|2
4693980|NCT02600819|7605128|FG001|GEN Phase|Lost to Follow-up|0
4693981|NCT02600845|7605134|FG000|Overall Study|Reason Not Specified|3
4693982|NCT02600845|7605134|FG000|Overall Study|Non-compliance with Study Procedures|10
4693983|NCT02600845|7605134|FG000|Overall Study|Consent Withdrawal|5
4693984|NCT02600871|7605140|FG000|Overall Study|Lost to Follow-up|13
4693985|NCT02600871|7605141|FG001|Overall Study|Lost to Follow-up|10
4693986|NCT02601001|7605151|FG000|Dosing Period 2|Adverse Event|0
4693987|NCT02601001|7605152|FG001|Dosing Period 2|Adverse Event|0
4693988|NCT02601001|7605153|FG002|Dosing Period 2|Adverse Event|0
4693989|NCT02601001|7605154|FG003|Dosing Period 2|Adverse Event|0
4693990|NCT02601001|7605155|FG004|Dosing Period 2|Adverse Event|0
4693991|NCT02601001|7605156|FG005|Dosing Period 2|Adverse Event|0
4693992|NCT02601001|7605157|FG006|Dosing Period 2|Adverse Event|1
4693993|NCT02601027|7605180|FG000|Registration to Surgery|Withdrawal by Subject|20
4693994|NCT02601027|7605181|FG001|Registration to Surgery|Withdrawal by Subject|10
4693995|NCT02601300|7605202|FG000|Induction Phase|Lack of Efficacy|2
4693996|NCT02601300|7605202|FG000|Induction Phase|Protocol Violation|1
4693997|NCT02601300|7605202|FG000|Extension Phase|Withdrawal by Subject|3
4693998|NCT02601300|7605202|FG000|Extension Phase|Adverse Event|4
4693999|NCT02601300|7605202|FG000|Extension Phase|Lack of Efficacy|10
4694000|NCT02601313|7605211|FG000|Overall Study|Death|2
4694001|NCT02601313|7605212|FG001|Overall Study|Death|16
4694002|NCT02601313|7605213|FG002|Overall Study|Death|4
4694003|NCT02601313|7605211|FG000|Overall Study|Enrolled, did not initiate CTE/KTE-X19|0
4694004|NCT02601313|7605212|FG001|Overall Study|Enrolled, did not initiate CTE/KTE-X19|5
4694005|NCT02601313|7605213|FG002|Overall Study|Enrolled, did not initiate CTE/KTE-X19|2
4694006|NCT02601313|7605211|FG000|Overall Study|Enrolled, did not initiate KTE-X19|0
4694007|NCT02601313|7605212|FG001|Overall Study|Enrolled, did not initiate KTE-X19|1
4694008|NCT02601313|7605213|FG002|Overall Study|Enrolled, did not initiate KTE-X19|1
4694009|NCT02601313|7605211|FG000|Overall Study|Still on study|0
4694010|NCT02601313|7605212|FG001|Overall Study|Still on study|52
4694011|NCT02601313|7605213|FG002|Overall Study|Still on study|10
4694012|NCT02601313|7605211|FG000|Overall Study|Enrolled, did not initiate AC|4
4694013|NCT02601313|7605212|FG001|Overall Study|Enrolled, did not initiate AC|0
4694014|NCT02601313|7605213|FG002|Overall Study|Enrolled, did not initiate AC|0
4694015|NCT02601469|7605223|FG000|Overall Study|Enrolled in Error|1
4694016|NCT02601469|7605224|FG001|Overall Study|Enrolled in Error|0
4694017|NCT02601560|7605238|FG000|Overall Study|Other|0
4694018|NCT02601560|7605239|FG001|Overall Study|Other|0
4694019|NCT02601560|7605240|FG002|Overall Study|Other|0
4694020|NCT02601560|7605241|FG003|Overall Study|Other|0
4694021|NCT02601560|7605242|FG004|Overall Study|Other|0
4586238|NCT01483599|7430216|FG009|After Controlled Period(Week 16-Week 40)|Other|4
4694022|NCT02601560|7605243|FG005|Overall Study|Other|0
4694023|NCT02601560|7605244|FG006|Overall Study|Other|1
4694024|NCT02601560|7605245|FG007|Overall Study|Other|0
4694025|NCT02601573|7605275|FG000|Overall Study|Lost to Follow-up|0
4694026|NCT02601573|7605276|FG001|Overall Study|Lost to Follow-up|3
4694027|NCT02601573|7605277|FG002|Overall Study|Lost to Follow-up|1
4694028|NCT02601573|7605278|FG003|Overall Study|Lost to Follow-up|0
4694029|NCT02601573|7605279|FG004|Overall Study|Lost to Follow-up|2
4694030|NCT02601573|7605275|FG000|Overall Study|Withdrawal by Subject|0
4694031|NCT02601573|7605276|FG001|Overall Study|Withdrawal by Subject|1
4694032|NCT02601573|7605277|FG002|Overall Study|Withdrawal by Subject|0
4694033|NCT02601573|7605278|FG003|Overall Study|Withdrawal by Subject|1
4694034|NCT02601573|7605279|FG004|Overall Study|Withdrawal by Subject|0
4694035|NCT02601625|7605295|FG000|Overall Study|Lost to Follow-up|0
4694036|NCT02601625|7605296|FG001|Overall Study|Lost to Follow-up|0
4694037|NCT02601625|7605297|FG002|Overall Study|Lost to Follow-up|1
4694038|NCT02601625|7605298|FG003|Overall Study|Lost to Follow-up|1
4694039|NCT02601820|7605322|FG000|Early On-Treatment (T2)|Missing T2 Record|51
4694040|NCT02601820|7605322|FG000|Late On-Treatment (T3)|missing T3 Record|49
4694041|NCT02601820|7605322|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3
4694042|NCT02601820|7605322|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88
4735001|NCT03517566|7682556|FG001|Overall Study|Lost to Follow-up|1
4735002|NCT03517566|7682557|FG002|Overall Study|Lost to Follow-up|1
4735003|NCT03517566|7682558|FG003|Overall Study|Lost to Follow-up|1
4735004|NCT03517566|7682559|FG004|Overall Study|Lost to Follow-up|0
4735005|NCT03517566|7682555|FG000|Overall Study|Physician Decision|1
4735006|NCT03517566|7682556|FG001|Overall Study|Physician Decision|1
4735007|NCT03517566|7682557|FG002|Overall Study|Physician Decision|0
4735008|NCT03517566|7682558|FG003|Overall Study|Physician Decision|1
4735009|NCT03517566|7682559|FG004|Overall Study|Physician Decision|0
4735010|NCT03517566|7682555|FG000|Overall Study|Pregnancy|0
4735011|NCT03517566|7682556|FG001|Overall Study|Pregnancy|1
4735012|NCT03517566|7682557|FG002|Overall Study|Pregnancy|0
4735013|NCT03517566|7682558|FG003|Overall Study|Pregnancy|0
4735014|NCT03517566|7682559|FG004|Overall Study|Pregnancy|0
4735015|NCT03517566|7682555|FG000|Overall Study|Protocol Deviation|0
4735016|NCT03517566|7682556|FG001|Overall Study|Protocol Deviation|1
4735017|NCT03517566|7682557|FG002|Overall Study|Protocol Deviation|0
4735018|NCT03517566|7682558|FG003|Overall Study|Protocol Deviation|1
4735019|NCT03517566|7682559|FG004|Overall Study|Protocol Deviation|1
4735020|NCT03517566|7682555|FG000|Overall Study|Study terminated by Sponsor|11
4735021|NCT03517566|7682556|FG001|Overall Study|Study terminated by Sponsor|5
4735022|NCT03517566|7682557|FG002|Overall Study|Study terminated by Sponsor|6
4735023|NCT03517566|7682558|FG003|Overall Study|Study terminated by Sponsor|14
4735024|NCT03517566|7682559|FG004|Overall Study|Study terminated by Sponsor|12
4735025|NCT03517566|7682555|FG000|Overall Study|Subject Decision /Guardian Decision|9
4735026|NCT03517566|7682556|FG001|Overall Study|Subject Decision /Guardian Decision|8
4735027|NCT03517566|7682557|FG002|Overall Study|Subject Decision /Guardian Decision|5
4735028|NCT03517566|7682558|FG003|Overall Study|Subject Decision /Guardian Decision|8
4735029|NCT03517566|7682559|FG004|Overall Study|Subject Decision /Guardian Decision|8
4735030|NCT03518008|7682572|FG000|Period 2, Second Week of Wear|Family emergency|0
4735031|NCT03518008|7682573|FG001|Period 2, Second Week of Wear|Family emergency|1
4735032|NCT03518125|7682585|FG000|Overall Study|Lost to Follow-up|0
4735033|NCT03518125|7682586|FG001|Overall Study|Lost to Follow-up|2
4735034|NCT03518125|7682587|FG002|Overall Study|Lost to Follow-up|0
4735035|NCT03518125|7682588|FG003|Overall Study|Lost to Follow-up|0
4735036|NCT03518125|7682589|FG004|Overall Study|Lost to Follow-up|3
4735037|NCT03518125|7682590|FG005|Overall Study|Lost to Follow-up|5
4735038|NCT03518125|7682585|FG000|Overall Study|Physician Decision|0
4735039|NCT03518125|7682586|FG001|Overall Study|Physician Decision|1
4735040|NCT03518125|7682587|FG002|Overall Study|Physician Decision|0
4735041|NCT03518125|7682588|FG003|Overall Study|Physician Decision|0
4735042|NCT03518125|7682589|FG004|Overall Study|Physician Decision|0
4735043|NCT03518125|7682590|FG005|Overall Study|Physician Decision|0
4735044|NCT03518125|7682585|FG000|Overall Study|Withdrawal by Subject|1
4735045|NCT03518125|7682586|FG001|Overall Study|Withdrawal by Subject|1
4735046|NCT03518125|7682587|FG002|Overall Study|Withdrawal by Subject|0
4735047|NCT03518125|7682588|FG003|Overall Study|Withdrawal by Subject|1
4735048|NCT03518125|7682589|FG004|Overall Study|Withdrawal by Subject|1
4735049|NCT03518125|7682590|FG005|Overall Study|Withdrawal by Subject|3
4735050|NCT03518125|7682585|FG000|Overall Study|Missed Day 394 Visit|1
4735051|NCT03518125|7682586|FG001|Overall Study|Missed Day 394 Visit|0
4735052|NCT03518125|7682587|FG002|Overall Study|Missed Day 394 Visit|0
4735053|NCT03518125|7682588|FG003|Overall Study|Missed Day 394 Visit|0
4586239|NCT01483599|7430217|FG010|After Controlled Period(Week 16-Week 40)|Other|0
4586240|NCT01483599|7430218|FG011|After Controlled Period(Week 16-Week 40)|Other|0
4586241|NCT01483599|7430219|FG012|After Controlled Period(Week 16-Week 40)|Other|1
4586242|NCT01483599|7430220|FG013|After Controlled Period(Week 16-Week 40)|Other|0
4586243|NCT01483625|7430251|FG000|Overall Study|Adverse Event|1
4586244|NCT01483625|7430252|FG001|Overall Study|Adverse Event|1
4586245|NCT01483625|7430251|FG000|Overall Study|Refused to continue medication|2
4586246|NCT01483625|7430252|FG001|Overall Study|Refused to continue medication|1
4586247|NCT01483625|7430251|FG000|Overall Study|Due to other reason|1
4586248|NCT01483625|7430252|FG001|Overall Study|Due to other reason|0
4586249|NCT01483651|7430258|FG000|Overall Study|Withdrawal by Subject|0
4586250|NCT01483651|7430259|FG001|Overall Study|Withdrawal by Subject|1
4586251|NCT01483651|7430260|FG002|Overall Study|Withdrawal by Subject|1
4586252|NCT01483651|7430261|FG003|Overall Study|Withdrawal by Subject|0
4586253|NCT01483651|7430262|FG004|Overall Study|Withdrawal by Subject|0
4586254|NCT01483651|7430263|FG005|Overall Study|Withdrawal by Subject|1
4586255|NCT01483690|7430273|FG000|Overall Study|Adverse Event|1
4586256|NCT01483690|7430274|FG001|Overall Study|Adverse Event|2
4586257|NCT01483690|7430273|FG000|Overall Study|clinical deterioration|1
4586258|NCT01483690|7430274|FG001|Overall Study|clinical deterioration|0
4586259|NCT01483690|7430273|FG000|Overall Study|Physician Decision|0
4586260|NCT01483690|7430274|FG001|Overall Study|Physician Decision|2
4586261|NCT01483690|7430273|FG000|Overall Study|exclusionary procedure|0
4586262|NCT01483690|7430274|FG001|Overall Study|exclusionary procedure|1
4586263|NCT01483924|7430294|FG000|Overall Study|Withdrawal by Subject|2
4586264|NCT01483924|7430295|FG001|Overall Study|Withdrawal by Subject|0
4586265|NCT01483924|7430296|FG002|Overall Study|Withdrawal by Subject|0
4586266|NCT01483924|7430297|FG003|Overall Study|Withdrawal by Subject|1
4586267|NCT01483924|7430298|FG004|Overall Study|Withdrawal by Subject|1
4586268|NCT01483924|7430294|FG000|Overall Study|Adverse Event|0
4586269|NCT01483924|7430295|FG001|Overall Study|Adverse Event|0
4586270|NCT01483924|7430296|FG002|Overall Study|Adverse Event|1
4586271|NCT01483924|7430297|FG003|Overall Study|Adverse Event|1
4586272|NCT01483924|7430298|FG004|Overall Study|Adverse Event|0
4586273|NCT01483924|7430294|FG000|Overall Study|Non-compliance|0
4586274|NCT01483924|7430295|FG001|Overall Study|Non-compliance|0
4586275|NCT01483924|7430296|FG002|Overall Study|Non-compliance|0
4586276|NCT01483924|7430297|FG003|Overall Study|Non-compliance|1
4586277|NCT01483924|7430298|FG004|Overall Study|Non-compliance|1
4586278|NCT01483924|7430294|FG000|Overall Study|Sponsor concern over ECG result|0
4586279|NCT01483924|7430295|FG001|Overall Study|Sponsor concern over ECG result|0
4586280|NCT01483924|7430296|FG002|Overall Study|Sponsor concern over ECG result|0
4586281|NCT01483924|7430297|FG003|Overall Study|Sponsor concern over ECG result|1
4586282|NCT01483924|7430298|FG004|Overall Study|Sponsor concern over ECG result|0
4586283|NCT01483937|7430321|FG000|Overall Study|Withdrawal by Subject|4
4586284|NCT01483937|7430322|FG001|Overall Study|Withdrawal by Subject|3
4586285|NCT01484028|7430353|FG000|Period 1|Lost to Follow-up|0
4586286|NCT01484028|7430354|FG001|Period 1|Lost to Follow-up|1
4586287|NCT01484028|7430355|FG002|Period 1|Lost to Follow-up|0
4586288|NCT01484028|7430356|FG003|Period 1|Lost to Follow-up|0
4586289|NCT01484028|7430353|FG000|Period 1|Non-Compliance to Protocol|0
4586290|NCT01484028|7430354|FG001|Period 1|Non-Compliance to Protocol|1
4586291|NCT01484028|7430355|FG002|Period 1|Non-Compliance to Protocol|0
4586292|NCT01484028|7430356|FG003|Period 1|Non-Compliance to Protocol|1
4586293|NCT01484028|7430353|FG000|Period 1|Lens Discomfort|0
4586294|NCT01484028|7430354|FG001|Period 1|Lens Discomfort|1
4586295|NCT01484028|7430355|FG002|Period 1|Lens Discomfort|0
4586296|NCT01484028|7430356|FG003|Period 1|Lens Discomfort|0
4586297|NCT01484054|7430368|FG000|Period 1|Withdrawal by Subject|0
4586298|NCT01484054|7430369|FG001|Period 1|Withdrawal by Subject|1
4586299|NCT01484132|7430376|FG000|Overall Study|Lost to Follow-up|8
4586300|NCT01484132|7430376|FG000|Overall Study|Difficulty with time commitment|2
4586301|NCT01484132|7430376|FG000|Overall Study|Ineligible|1
4586302|NCT01484132|7430376|FG000|Overall Study|No pre-treatment urine sample collected|1
4586303|NCT01484132|7430376|FG000|Overall Study|No post-treatment urine sample collected|10
4586304|NCT01484197|7430380|FG000|Treatment Period 1|Adverse Event|1
4586305|NCT01484197|7430381|FG001|Treatment Period 1|Adverse Event|0
4586306|NCT01484197|7430382|FG002|Treatment Period 1|Adverse Event|0
4586307|NCT01484197|7430383|FG003|Treatment Period 1|Adverse Event|0
4586308|NCT01484197|7430380|FG000|Treatment Period 2|Subject withdrew consent|0
4586309|NCT01484197|7430381|FG001|Treatment Period 2|Subject withdrew consent|0
4586310|NCT01484197|7430382|FG002|Treatment Period 2|Subject withdrew consent|0
4586311|NCT01484197|7430383|FG003|Treatment Period 2|Subject withdrew consent|1
4586312|NCT01484275|7430395|FG000|Overall Study|Study terminated by sponsor|28
4586313|NCT01484275|7430396|FG001|Overall Study|Study terminated by sponsor|32
4586314|NCT01484275|7430395|FG000|Overall Study|Other|10
4586315|NCT01484275|7430396|FG001|Overall Study|Other|0
4586316|NCT01484275|7430395|FG000|Overall Study|Death|3
4586317|NCT01484275|7430396|FG001|Overall Study|Death|4
4586318|NCT01484275|7430395|FG000|Overall Study|Withdrawal by Subject|1
4586319|NCT01484275|7430396|FG001|Overall Study|Withdrawal by Subject|5
4586320|NCT01484275|7430395|FG000|Overall Study|Lost to Follow-up|1
4586321|NCT01484275|7430396|FG001|Overall Study|Lost to Follow-up|1
4586322|NCT01484431|7430418|FG000|Period 1: High Dose|Physician Decision|0
4586323|NCT01484431|7430419|FG001|Period 1: High Dose|Physician Decision|1
4586324|NCT01484431|7430420|FG002|Period 1: High Dose|Physician Decision|0
4586325|NCT01484431|7430418|FG000|Period 2|Death|0
4586326|NCT01484431|7430419|FG001|Period 2|Death|1
4586327|NCT01484431|7430420|FG002|Period 2|Death|1
4586328|NCT01484431|7430418|FG000|Period 2|Physician Decision|0
4586329|NCT01484431|7430419|FG001|Period 2|Physician Decision|0
4586330|NCT01484431|7430420|FG002|Period 2|Physician Decision|1
4586331|NCT01484431|7430418|FG000|Period 2|Non-Compliance with Study Drug|1
4586332|NCT01484431|7430419|FG001|Period 2|Non-Compliance with Study Drug|0
4586333|NCT01484431|7430420|FG002|Period 2|Non-Compliance with Study Drug|0
4586334|NCT01484496|7430435|FG000|Period 1|Protocol Violation|3
4586335|NCT01484496|7430436|FG001|Period 1|Protocol Violation|4
4586336|NCT01484496|7430437|FG002|Period 1|Protocol Violation|0
4586337|NCT01484496|7430438|FG003|Period 1|Protocol Violation|0
4586338|NCT01484496|7430435|FG000|Period 1|Physician Decision|5
4586339|NCT01484496|7430436|FG001|Period 1|Physician Decision|1
4586340|NCT01484496|7430437|FG002|Period 1|Physician Decision|0
4586341|NCT01484496|7430438|FG003|Period 1|Physician Decision|0
4586342|NCT01484496|7430435|FG000|Period 1|Lack of Efficacy|10
4586343|NCT01484496|7430436|FG001|Period 1|Lack of Efficacy|15
4586344|NCT01484496|7430437|FG002|Period 1|Lack of Efficacy|0
4586345|NCT01484496|7430438|FG003|Period 1|Lack of Efficacy|0
4586346|NCT01484496|7430435|FG000|Period 1|Adverse Event|25
4586347|NCT01484496|7430436|FG001|Period 1|Adverse Event|40
4586348|NCT01484496|7430437|FG002|Period 1|Adverse Event|0
4586349|NCT01484496|7430438|FG003|Period 1|Adverse Event|0
4586350|NCT01484496|7430435|FG000|Period 1|Withdrawal by Subject|15
4586351|NCT01484496|7430436|FG001|Period 1|Withdrawal by Subject|12
4586352|NCT01484496|7430437|FG002|Period 1|Withdrawal by Subject|0
4586353|NCT01484496|7430438|FG003|Period 1|Withdrawal by Subject|0
4586354|NCT01484496|7430435|FG000|Period 1|Lost to Follow-up|2
4586355|NCT01484496|7430436|FG001|Period 1|Lost to Follow-up|6
4586356|NCT01484496|7430437|FG002|Period 1|Lost to Follow-up|0
4586357|NCT01484496|7430438|FG003|Period 1|Lost to Follow-up|0
4586358|NCT01484496|7430435|FG000|Period 1|Positive Pregnancy|1
4586359|NCT01484496|7430436|FG001|Period 1|Positive Pregnancy|6
4586360|NCT01484496|7430437|FG002|Period 1|Positive Pregnancy|0
4586361|NCT01484496|7430438|FG003|Period 1|Positive Pregnancy|0
4586362|NCT01484496|7430435|FG000|Period 1|Treatment Failure|3
4586363|NCT01484496|7430436|FG001|Period 1|Treatment Failure|6
4586364|NCT01484496|7430437|FG002|Period 1|Treatment Failure|0
4586365|NCT01484496|7430438|FG003|Period 1|Treatment Failure|0
4586366|NCT01484496|7430435|FG000|Period 1|Lack of Compliance|2
4586367|NCT01484496|7430436|FG001|Period 1|Lack of Compliance|1
4586368|NCT01484496|7430437|FG002|Period 1|Lack of Compliance|0
4586369|NCT01484496|7430438|FG003|Period 1|Lack of Compliance|0
4586370|NCT01484496|7430435|FG000|Period 1|Unable to Visit Site|0
4586371|NCT01484496|7430436|FG001|Period 1|Unable to Visit Site|2
4586372|NCT01484496|7430437|FG002|Period 1|Unable to Visit Site|0
4586373|NCT01484496|7430438|FG003|Period 1|Unable to Visit Site|0
4586374|NCT01484496|7430435|FG000|Period 2|Lack of Efficacy|0
4586375|NCT01484496|7430436|FG001|Period 2|Lack of Efficacy|0
4586376|NCT01484496|7430437|FG002|Period 2|Lack of Efficacy|1
4586377|NCT01484496|7430438|FG003|Period 2|Lack of Efficacy|3
4586378|NCT01484496|7430435|FG000|Period 2|Adverse Event|0
4586379|NCT01484496|7430436|FG001|Period 2|Adverse Event|0
4586380|NCT01484496|7430437|FG002|Period 2|Adverse Event|5
4586381|NCT01484496|7430438|FG003|Period 2|Adverse Event|13
4586382|NCT01484496|7430435|FG000|Period 2|Other|0
4586383|NCT01484496|7430436|FG001|Period 2|Other|0
4586384|NCT01484496|7430437|FG002|Period 2|Other|9
4586385|NCT01484496|7430438|FG003|Period 2|Other|6
4586386|NCT01484561|7430448|FG000|Overall Study|Lack of Efficacy|3
4586387|NCT01484561|7430449|FG001|Overall Study|Lack of Efficacy|1
4586388|NCT01484561|7430448|FG000|Overall Study|Lost to Follow-up|1
4586389|NCT01484561|7430449|FG001|Overall Study|Lost to Follow-up|0
4586390|NCT01484561|7430448|FG000|Overall Study|Withdrawal by Subject|3
4586391|NCT01484561|7430449|FG001|Overall Study|Withdrawal by Subject|0
4586392|NCT01484561|7430448|FG000|Overall Study|Other|1
4586393|NCT01484561|7430449|FG001|Overall Study|Other|1
4586394|NCT01484561|7430448|FG000|Overall Study|Adverse Event|1
4586395|NCT01484561|7430449|FG001|Overall Study|Adverse Event|4
4586396|NCT01484834|7430472|FG000|Overall Study|Lost to Follow-up|5
4586397|NCT01484834|7430473|FG001|Overall Study|Lost to Follow-up|8
4586398|NCT01484834|7430474|FG002|Overall Study|Lost to Follow-up|1
4586399|NCT01484834|7430475|FG003|Overall Study|Lost to Follow-up|4
4586400|NCT01484873|7430485|FG000|Overall Study|Withdrawal by Subject|2
4586401|NCT01484912|7430492|FG000|Overall Study|Withdrawal by Subject|1
4586402|NCT01484912|7430493|FG001|Overall Study|Withdrawal by Subject|0
4586403|NCT01484912|7430492|FG000|Overall Study|Physician Decision|0
4586404|NCT01484912|7430493|FG001|Overall Study|Physician Decision|1
4586405|NCT01484938|7430499|FG000|Overall Study|Adverse Event|2
4586406|NCT01484938|7430499|FG000|Overall Study|Lost to Follow-up|1
4586407|NCT01484938|7430499|FG000|Overall Study|Noncompliance|1
4586408|NCT01484951|7430503|FG000|Overall Study|Adverse Event|3
4586409|NCT01484951|7430503|FG000|Overall Study|Personal Reasons|1
4586410|NCT01484951|7430503|FG000|Overall Study|Non-Compliance|1
4586411|NCT01484977|7430507|FG000|Overall Study|Adverse Event|8
4586412|NCT01484977|7430507|FG000|Overall Study|Lack of Efficacy|4
4586413|NCT01484977|7430507|FG000|Overall Study|Protocol Violation|6
4586414|NCT01484977|7430507|FG000|Overall Study|Lost to Follow-up|1
4586415|NCT01484977|7430507|FG000|Overall Study|Withdrawal by Subject|4
4586416|NCT01484977|7430507|FG000|Overall Study|Subject Protocol Non-compliant|1
4586417|NCT01484977|7430507|FG000|Overall Study|Moving Overseas|1
4586418|NCT01484977|7430507|FG000|Overall Study|Low White Blood Cell Count|1
4586419|NCT01484977|7430507|FG000|Overall Study|Lack of Compliance|1
4586420|NCT01485094|7430518|FG000|Overall Study|Adverse Event|1
4586421|NCT01485094|7430519|FG001|Overall Study|Adverse Event|1
4586422|NCT01485094|7430520|FG002|Overall Study|Adverse Event|1
4586423|NCT01485094|7430518|FG000|Overall Study|Lost to Follow-up|1
4586424|NCT01485094|7430519|FG001|Overall Study|Lost to Follow-up|0
4586425|NCT01485094|7430520|FG002|Overall Study|Lost to Follow-up|0
4586426|NCT01485094|7430518|FG000|Overall Study|Withdrawal by Subject|1
4586427|NCT01485094|7430519|FG001|Overall Study|Withdrawal by Subject|1
4586428|NCT01485094|7430520|FG002|Overall Study|Withdrawal by Subject|0
4586429|NCT01485120|7430528|FG000|Overall Study|Withdrawal by Subject|2
4586430|NCT01485172|7430539|FG000|Overall Study|Adverse Event|2
4586431|NCT01485172|7430540|FG001|Overall Study|Adverse Event|1
4586432|NCT01485172|7430541|FG002|Overall Study|Adverse Event|2
4586433|NCT01485172|7430542|FG003|Overall Study|Adverse Event|2
4586434|NCT01485172|7430543|FG004|Overall Study|Adverse Event|1
4694043|NCT02602080|7605358|FG000|Overall Study|Protocol Violation|6
4694044|NCT02602080|7605359|FG001|Overall Study|Protocol Violation|1
4694045|NCT02602080|7605360|FG002|Overall Study|Protocol Violation|3
4694046|NCT02603107|7605389|FG000|Randomized Phase|Withdrew consent|8
4694047|NCT02603107|7605390|FG001|Randomized Phase|Withdrew consent|15
4694048|NCT02603107|7605389|FG000|Randomized Phase|Lost to Follow-up|1
4694049|NCT02603107|7605390|FG001|Randomized Phase|Lost to Follow-up|3
4694050|NCT02603107|7605389|FG000|Randomized Phase|Adverse Event|2
4694051|NCT02603107|7605390|FG001|Randomized Phase|Adverse Event|0
4694052|NCT02603107|7605389|FG000|Randomized Phase|Death|1
4694053|NCT02603107|7605390|FG001|Randomized Phase|Death|1
4694054|NCT02603107|7605389|FG000|Randomized Phase|Non-compliance with study drug|1
4694055|NCT02603107|7605390|FG001|Randomized Phase|Non-compliance with study drug|1
4694056|NCT02603107|7605389|FG000|Randomized Phase|Investigator's discretion|0
4694057|NCT02603107|7605390|FG001|Randomized Phase|Investigator's discretion|1
4694058|NCT02603107|7605389|FG000|Randomized Phase|Lack of Efficacy|1
4694059|NCT02603107|7605390|FG001|Randomized Phase|Lack of Efficacy|0
4694060|NCT02603107|7605389|FG000|Randomized Phase|Protocol Violation|1
4694061|NCT02603107|7605390|FG001|Randomized Phase|Protocol Violation|0
4694062|NCT02603107|7605389|FG000|Optional Extension Phase|Lost to Follow-up|3
4694063|NCT02603107|7605390|FG001|Optional Extension Phase|Lost to Follow-up|3
4694064|NCT02603107|7605389|FG000|Optional Extension Phase|Withdrew consent|3
4694065|NCT02603107|7605390|FG001|Optional Extension Phase|Withdrew consent|2
4694066|NCT02603107|7605389|FG000|Optional Extension Phase|Investigator's discretion|2
4694067|NCT02603107|7605390|FG001|Optional Extension Phase|Investigator's discretion|2
4694068|NCT02603107|7605389|FG000|Optional Extension Phase|Pregnancy|0
4694069|NCT02603107|7605390|FG001|Optional Extension Phase|Pregnancy|3
4694070|NCT02603107|7605389|FG000|Optional Extension Phase|Adverse Event|0
4694071|NCT02603107|7605390|FG001|Optional Extension Phase|Adverse Event|2
4694072|NCT02603107|7605389|FG000|Optional Extension Phase|Not treated in extension phase|0
4694073|NCT02603107|7605390|FG001|Optional Extension Phase|Not treated in extension phase|1
4694074|NCT02603107|7605389|FG000|Optional Extension Phase|Protocol Violation|1
4694075|NCT02603107|7605390|FG001|Optional Extension Phase|Protocol Violation|0
4694076|NCT02603120|7605400|FG000|Double-Blind Treatment Phase|Withdrew consent|4
4694077|NCT02603120|7605401|FG001|Double-Blind Treatment Phase|Withdrew consent|8
4694078|NCT02603120|7605400|FG000|Double-Blind Treatment Phase|Adverse Event|3
4694079|NCT02603120|7605401|FG001|Double-Blind Treatment Phase|Adverse Event|3
4694080|NCT02603120|7605400|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4
4694081|NCT02603120|7605401|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2
4694082|NCT02603120|7605400|FG000|Double-Blind Treatment Phase|Death|2
4694083|NCT02603120|7605401|FG001|Double-Blind Treatment Phase|Death|0
4694084|NCT02603120|7605400|FG000|Double-Blind Treatment Phase|Investigator's discretion|2
4694085|NCT02603120|7605401|FG001|Double-Blind Treatment Phase|Investigator's discretion|0
4694086|NCT02603120|7605400|FG000|Double-Blind Treatment Phase|Pregnancy|1
4694087|NCT02603120|7605401|FG001|Double-Blind Treatment Phase|Pregnancy|1
4694088|NCT02603120|7605400|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1
4694089|NCT02603120|7605401|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0
4586435|NCT01485172|7430544|FG005|Overall Study|Adverse Event|2
4586436|NCT01485172|7430539|FG000|Overall Study|Lack of Efficacy|2
4586437|NCT01485172|7430540|FG001|Overall Study|Lack of Efficacy|0
4586438|NCT01485172|7430541|FG002|Overall Study|Lack of Efficacy|0
4586439|NCT01485172|7430542|FG003|Overall Study|Lack of Efficacy|0
4694090|NCT02603120|7605400|FG000|Double-Blind Treatment Phase|Did not receive study drug|2
4694091|NCT02603120|7605401|FG001|Double-Blind Treatment Phase|Did not receive study drug|2
4694092|NCT02603120|7605400|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3
4694093|NCT02603120|7605401|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4
4694094|NCT02603120|7605400|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1
4586440|NCT01485172|7430543|FG004|Overall Study|Lack of Efficacy|0
4586441|NCT01485172|7430544|FG005|Overall Study|Lack of Efficacy|0
4586442|NCT01485172|7430539|FG000|Overall Study|Protocol Violation|0
4586443|NCT01485172|7430540|FG001|Overall Study|Protocol Violation|0
4586444|NCT01485172|7430541|FG002|Overall Study|Protocol Violation|4
4586445|NCT01485172|7430542|FG003|Overall Study|Protocol Violation|5
4586446|NCT01485172|7430543|FG004|Overall Study|Protocol Violation|1
4586447|NCT01485172|7430544|FG005|Overall Study|Protocol Violation|0
4586448|NCT01485172|7430539|FG000|Overall Study|Protocol defined stopping criteria|1
4586449|NCT01485172|7430540|FG001|Overall Study|Protocol defined stopping criteria|0
4586450|NCT01485172|7430541|FG002|Overall Study|Protocol defined stopping criteria|0
4586451|NCT01485172|7430542|FG003|Overall Study|Protocol defined stopping criteria|0
4586452|NCT01485172|7430543|FG004|Overall Study|Protocol defined stopping criteria|1
4586453|NCT01485172|7430544|FG005|Overall Study|Protocol defined stopping criteria|0
4586454|NCT01485172|7430539|FG000|Overall Study|Lost to Follow-up|0
4586455|NCT01485172|7430540|FG001|Overall Study|Lost to Follow-up|0
4586456|NCT01485172|7430541|FG002|Overall Study|Lost to Follow-up|1
4586457|NCT01485172|7430542|FG003|Overall Study|Lost to Follow-up|0
4694095|NCT02603120|7605401|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2
4694096|NCT02603120|7605400|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1
4694097|NCT02603120|7605401|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2
4694098|NCT02603120|7605400|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0
4694099|NCT02603120|7605401|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1
4694100|NCT02603120|7605400|FG000|OL Extension B/F/TAF Treatment Phase|Death|0
4694101|NCT02603120|7605401|FG001|OL Extension B/F/TAF Treatment Phase|Death|1
4694102|NCT02603120|7605400|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0
4694103|NCT02603120|7605401|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1
4694104|NCT02603172|7605417|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0
4694105|NCT02603172|7605418|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0
4694106|NCT02603172|7605419|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1
4694107|NCT02603172|7605420|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0
4694108|NCT02603172|7605421|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0
4694109|NCT02603172|7605422|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0
4694110|NCT02603172|7605423|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0
4694111|NCT02603172|7605424|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0
4694112|NCT02603393|7605447|FG000|Overall Study|Patient/guardian decision|32
4694113|NCT02603393|7605448|FG001|Overall Study|Patient/guardian decision|18
4694114|NCT02603393|7605447|FG000|Overall Study|Adverse Event|17
4694115|NCT02603393|7605448|FG001|Overall Study|Adverse Event|15
4694116|NCT02603393|7605447|FG000|Overall Study|Technical problems|4
4694117|NCT02603393|7605448|FG001|Overall Study|Technical problems|7
4694118|NCT02603393|7605447|FG000|Overall Study|Lack of Efficacy|7
4694119|NCT02603393|7605448|FG001|Overall Study|Lack of Efficacy|2
4694120|NCT02603393|7605447|FG000|Overall Study|Death|3
4694121|NCT02603393|7605448|FG001|Overall Study|Death|4
4694122|NCT02603393|7605447|FG000|Overall Study|Physician Decision|3
4694123|NCT02603393|7605448|FG001|Overall Study|Physician Decision|3
4694124|NCT02603393|7605447|FG000|Overall Study|Protocol deviation|2
4694125|NCT02603393|7605448|FG001|Overall Study|Protocol deviation|3
4694126|NCT02603393|7605447|FG000|Overall Study|Lost to Follow-up|1
4694127|NCT02603393|7605448|FG001|Overall Study|Lost to Follow-up|2
4694128|NCT02603393|7605447|FG000|Overall Study|Non-compliance with study treatment|1
4694129|NCT02603393|7605448|FG001|Overall Study|Non-compliance with study treatment|0
4694130|NCT02603393|7605447|FG000|Overall Study|Sponsor decision|1
4694131|NCT02603393|7605448|FG001|Overall Study|Sponsor decision|0
4694132|NCT02603419|7605460|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
4694133|NCT02603419|7605461|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1
4694134|NCT02603419|7605462|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
4694135|NCT02603419|7605463|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
4694136|NCT02603419|7605464|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
4694137|NCT02603419|7605465|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
4694138|NCT02603419|7605460|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2
4694139|NCT02603419|7605461|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4
4694140|NCT02603419|7605462|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2
4694141|NCT02603419|7605463|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4
4694142|NCT02603419|7605464|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3
4694143|NCT02603419|7605465|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0
4694144|NCT02603419|7605460|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2
4586458|NCT01485172|7430543|FG004|Overall Study|Lost to Follow-up|0
4586459|NCT01485172|7430544|FG005|Overall Study|Lost to Follow-up|1
4586460|NCT01485172|7430539|FG000|Overall Study|Physician Decision|0
4586461|NCT01485172|7430540|FG001|Overall Study|Physician Decision|0
4694145|NCT02603419|7605461|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0
4694146|NCT02603419|7605462|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3
4694147|NCT02603419|7605463|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0
4694148|NCT02603419|7605464|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1
4694149|NCT02603419|7605465|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0
4735054|NCT03518125|7682589|FG004|Overall Study|Missed Day 394 Visit|0
4586462|NCT01485172|7430541|FG002|Overall Study|Physician Decision|0
4586463|NCT01485172|7430542|FG003|Overall Study|Physician Decision|0
4586464|NCT01485172|7430543|FG004|Overall Study|Physician Decision|1
4586465|NCT01485172|7430544|FG005|Overall Study|Physician Decision|0
4586466|NCT01485172|7430539|FG000|Overall Study|Withdrawal by Subject|2
4586467|NCT01485172|7430540|FG001|Overall Study|Withdrawal by Subject|0
4586468|NCT01485172|7430541|FG002|Overall Study|Withdrawal by Subject|0
4586469|NCT01485172|7430542|FG003|Overall Study|Withdrawal by Subject|1
4586470|NCT01485172|7430543|FG004|Overall Study|Withdrawal by Subject|1
4586471|NCT01485172|7430544|FG005|Overall Study|Withdrawal by Subject|1
4586472|NCT01485354|7430558|FG000|Overall Study|Withdrawal by Subject|5
4586473|NCT01485536|7430574|FG000|Overall Study|Withdrawal by Subject|3
4586474|NCT01485536|7430574|FG000|Overall Study|Adverse Event|1
4586475|NCT01485614|7430597|FG000|Randomization|Not Treated|1
4586476|NCT01485614|7430598|FG001|Randomization|Not Treated|0
4586477|NCT01485614|7430599|FG002|Randomization|Not Treated|0
4586478|NCT01485614|7430600|FG003|Randomization|Not Treated|0
4586479|NCT01485614|7430597|FG000|Weeks 0-20|Lost to Follow-up|2
4586480|NCT01485614|7430598|FG001|Weeks 0-20|Lost to Follow-up|0
4586481|NCT01485614|7430599|FG002|Weeks 0-20|Lost to Follow-up|0
4586482|NCT01485614|7430600|FG003|Weeks 0-20|Lost to Follow-up|0
4586483|NCT01485614|7430597|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5
4586484|NCT01485614|7430598|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2
4586485|NCT01485614|7430599|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0
4586486|NCT01485614|7430600|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0
4586487|NCT01485614|7430597|FG000|Weeks 0-20|Withdrawal by Subject|3
4586488|NCT01485614|7430598|FG001|Weeks 0-20|Withdrawal by Subject|2
4586489|NCT01485614|7430599|FG002|Weeks 0-20|Withdrawal by Subject|1
4586490|NCT01485614|7430600|FG003|Weeks 0-20|Withdrawal by Subject|0
4586491|NCT01485614|7430597|FG000|Weeks 20-54|Lost to Follow-up|4
4586492|NCT01485614|7430598|FG001|Weeks 20-54|Lost to Follow-up|3
4586493|NCT01485614|7430599|FG002|Weeks 20-54|Lost to Follow-up|1
4586494|NCT01485614|7430600|FG003|Weeks 20-54|Lost to Follow-up|0
4586495|NCT01485614|7430597|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2
4586496|NCT01485614|7430598|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2
4586497|NCT01485614|7430599|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1
4586498|NCT01485614|7430600|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0
4586499|NCT01485614|7430597|FG000|Weeks 20-54|Withdrawal by Subject|5
4586500|NCT01485614|7430598|FG001|Weeks 20-54|Withdrawal by Subject|3
4586501|NCT01485614|7430599|FG002|Weeks 20-54|Withdrawal by Subject|0
4586502|NCT01485614|7430600|FG003|Weeks 20-54|Withdrawal by Subject|0
4586503|NCT01485627|7430618|FG000|Overall Study|Patient withdrew|6
4586504|NCT01485627|7430619|FG001|Overall Study|Patient withdrew|5
4586505|NCT01485627|7430618|FG000|Overall Study|Patient died|3
4586506|NCT01485627|7430619|FG001|Overall Study|Patient died|1
4694150|NCT02603419|7605460|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
4694151|NCT02603419|7605461|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
4694152|NCT02603419|7605462|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
4694153|NCT02603419|7605463|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
4694154|NCT02603419|7605464|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1
4694155|NCT02603419|7605465|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
4694156|NCT02603419|7605460|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
4694157|NCT02603419|7605461|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1
4694158|NCT02603419|7605462|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
4694159|NCT02603419|7605463|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
4694160|NCT02603419|7605464|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
4694161|NCT02603419|7605465|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
4694162|NCT02603419|7605460|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2
4694163|NCT02603419|7605461|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1
4694164|NCT02603419|7605462|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1
4694165|NCT02603419|7605463|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0
4694166|NCT02603419|7605464|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1
4694167|NCT02603419|7605465|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0
4694168|NCT02603419|7605460|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
4694169|NCT02603419|7605461|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
4694170|NCT02603419|7605462|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
4694171|NCT02603419|7605463|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2
4694172|NCT02603419|7605464|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
4694173|NCT02603419|7605465|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
4694174|NCT02603419|7605460|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
4694175|NCT02603419|7605461|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
4694176|NCT02603419|7605462|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
4586507|NCT01485627|7430618|FG000|Overall Study|Patient lost to followup|0
4586508|NCT01485627|7430619|FG001|Overall Study|Patient lost to followup|1
4586509|NCT01485627|7430618|FG000|Overall Study|Caregiver withdrew|3
4586510|NCT01485627|7430619|FG001|Overall Study|Caregiver withdrew|3
4586511|NCT01485627|7430618|FG000|Overall Study|Caregiver lost to follow up|11
4586512|NCT01485627|7430619|FG001|Overall Study|Caregiver lost to follow up|12
4586513|NCT01485627|7430618|FG000|Overall Study|Caregiver died|1
4586514|NCT01485627|7430619|FG001|Overall Study|Caregiver died|0
4586515|NCT01485627|7430618|FG000|Overall Study|caregiver was not bereaved|42
4586516|NCT01485627|7430619|FG001|Overall Study|caregiver was not bereaved|35
4586517|NCT01485640|7430629|FG000|Overall Study|Adverse Event|10
4586518|NCT01485640|7430629|FG000|Overall Study|Lack of Efficacy|2
4586519|NCT01485640|7430629|FG000|Overall Study|Protocol Violation|1
4586520|NCT01485640|7430629|FG000|Overall Study|Withdrawal by Subject|14
4586521|NCT01485640|7430629|FG000|Overall Study|Terminated by Sponsor|95
4586522|NCT01485796|7430644|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1
4586523|NCT01485796|7430644|FG000|Period 2: Epoch 2|Withdrawal by Subject|6
4586524|NCT01485796|7430644|FG000|Period 2: Epoch 2|Adverse Event|3
4586525|NCT01485796|7430644|FG000|Period 2: Epoch 2|Switch to safety follow-up|26
4586526|NCT01485796|7430644|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1
4586527|NCT01485796|7430644|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6
4586528|NCT01485796|7430644|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3
4586529|NCT01485796|7430644|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2
4586530|NCT01485887|7430652|FG000|Overall Study|Withdrawal by Subject|2
4586531|NCT01485887|7430652|FG000|Overall Study|Adverse Event|8
4586532|NCT01485887|7430652|FG000|Overall Study|Deterioration of primary disease|1
4586533|NCT01485887|7430652|FG000|Overall Study|Primary disease markedly improved|1
4586534|NCT01485991|7430658|FG000|Overall Study|Adverse Event|0
4586535|NCT01485991|7430659|FG001|Overall Study|Adverse Event|4
4586536|NCT01485991|7430658|FG000|Overall Study|Lost to Follow-up|13
4586537|NCT01485991|7430659|FG001|Overall Study|Lost to Follow-up|10
4586538|NCT01485991|7430658|FG000|Overall Study|Withdrawal by Subject|13
4586539|NCT01485991|7430659|FG001|Overall Study|Withdrawal by Subject|20
4586540|NCT01485991|7430658|FG000|Overall Study|randomized but not treated|6
4586541|NCT01485991|7430659|FG001|Overall Study|randomized but not treated|2
4586542|NCT01486199|7430671|FG000|Two Year Period Between Study Days|Physician Decision|1
4586543|NCT01486199|7430672|FG001|Two Year Period Between Study Days|Physician Decision|0
4586544|NCT01486238|7430680|FG000|Overall Study|Death|0
4586545|NCT01486238|7430681|FG001|Overall Study|Death|2
4586546|NCT01486238|7430680|FG000|Overall Study|Withdrawal by Subject|2
4586547|NCT01486238|7430681|FG001|Overall Study|Withdrawal by Subject|1
4586548|NCT01486238|7430680|FG000|Overall Study|Lost to Follow-up|0
4586549|NCT01486238|7430681|FG001|Overall Study|Lost to Follow-up|3
4586550|NCT01486264|7430689|FG000|Overall Study|Death|1
4586551|NCT01486264|7430690|FG001|Overall Study|Death|1
4586552|NCT01486264|7430689|FG000|Overall Study|Adverse Event|3
4586553|NCT01486264|7430690|FG001|Overall Study|Adverse Event|3
4586554|NCT01486264|7430689|FG000|Overall Study|Lack of Efficacy|6
4586555|NCT01486264|7430690|FG001|Overall Study|Lack of Efficacy|10
4586556|NCT01486264|7430689|FG000|Overall Study|Withdrawal by Subject|7
4586557|NCT01486264|7430690|FG001|Overall Study|Withdrawal by Subject|18
4586558|NCT01486264|7430689|FG000|Overall Study|Physician Decision|1
4586559|NCT01486264|7430690|FG001|Overall Study|Physician Decision|1
4586560|NCT01486264|7430689|FG000|Overall Study|Protocol Violation|3
4586561|NCT01486264|7430690|FG001|Overall Study|Protocol Violation|0
4586562|NCT01486264|7430689|FG000|Overall Study|Lost to Follow-up|3
4586563|NCT01486264|7430690|FG001|Overall Study|Lost to Follow-up|2
4586564|NCT01486264|7430689|FG000|Overall Study|Other|5
4694177|NCT02603419|7605463|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
4694178|NCT02603419|7605464|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
4694179|NCT02603419|7605465|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1
4694180|NCT02603419|7605460|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0
4694181|NCT02603419|7605461|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0
4694182|NCT02603419|7605462|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0
4694183|NCT02603419|7605463|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0
4694184|NCT02603419|7605464|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0
4694185|NCT02603419|7605465|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1
4694186|NCT02603419|7605460|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
4694187|NCT02603419|7605461|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
4694188|NCT02603419|7605462|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
4694189|NCT02603419|7605463|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
4694190|NCT02603419|7605464|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
4694191|NCT02603419|7605465|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1
4694192|NCT02603809|7605490|FG000|Overall Study|Withdrawal by Subject|4
4586565|NCT01486264|7430690|FG001|Overall Study|Other|11
4586566|NCT01486264|7430689|FG000|Overall Study|Not treated|0
4586567|NCT01486264|7430690|FG001|Overall Study|Not treated|1
4586568|NCT01486316|7430699|FG000|Overall Study|Device explanted with/without re-implant|3
4586569|NCT01486316|7430700|FG001|Overall Study|Device explanted with/without re-implant|2
4586570|NCT01486316|7430701|FG002|Overall Study|Device explanted with/without re-implant|0
4586571|NCT01486316|7430702|FG003|Overall Study|Device explanted with/without re-implant|2
4586572|NCT01486316|7430699|FG000|Overall Study|Not meeting eligibility criteria|0
4586573|NCT01486316|7430700|FG001|Overall Study|Not meeting eligibility criteria|0
4586574|NCT01486316|7430701|FG002|Overall Study|Not meeting eligibility criteria|1
4586575|NCT01486316|7430702|FG003|Overall Study|Not meeting eligibility criteria|0
4694193|NCT02603809|7605491|FG001|Overall Study|Withdrawal by Subject|1
4694194|NCT02603809|7605492|FG002|Overall Study|Withdrawal by Subject|2
4694195|NCT02603809|7605493|FG003|Overall Study|Withdrawal by Subject|3
4694196|NCT02603809|7605494|FG004|Overall Study|Withdrawal by Subject|3
4694197|NCT02603809|7605495|FG005|Overall Study|Withdrawal by Subject|4
4694198|NCT02603809|7605490|FG000|Overall Study|Lost to Follow-up|2
4694199|NCT02603809|7605491|FG001|Overall Study|Lost to Follow-up|3
4694200|NCT02603809|7605492|FG002|Overall Study|Lost to Follow-up|1
4694201|NCT02603809|7605493|FG003|Overall Study|Lost to Follow-up|4
4694202|NCT02603809|7605494|FG004|Overall Study|Lost to Follow-up|2
4694203|NCT02603809|7605495|FG005|Overall Study|Lost to Follow-up|2
4694204|NCT02603809|7605490|FG000|Overall Study|Pre-specified discontinuation criteria|3
4694205|NCT02603809|7605491|FG001|Overall Study|Pre-specified discontinuation criteria|3
4694206|NCT02603809|7605492|FG002|Overall Study|Pre-specified discontinuation criteria|2
4694207|NCT02603809|7605493|FG003|Overall Study|Pre-specified discontinuation criteria|2
4694208|NCT02603809|7605494|FG004|Overall Study|Pre-specified discontinuation criteria|3
4694209|NCT02603809|7605495|FG005|Overall Study|Pre-specified discontinuation criteria|1
4694210|NCT02603809|7605490|FG000|Overall Study|Physician Decision|0
4694211|NCT02603809|7605491|FG001|Overall Study|Physician Decision|0
4694212|NCT02603809|7605492|FG002|Overall Study|Physician Decision|0
4694213|NCT02603809|7605493|FG003|Overall Study|Physician Decision|1
4694214|NCT02603809|7605494|FG004|Overall Study|Physician Decision|2
4694215|NCT02603809|7605495|FG005|Overall Study|Physician Decision|1
4694216|NCT02603809|7605490|FG000|Overall Study|Adverse Event|3
4694217|NCT02603809|7605491|FG001|Overall Study|Adverse Event|0
4694218|NCT02603809|7605492|FG002|Overall Study|Adverse Event|2
4694219|NCT02603809|7605493|FG003|Overall Study|Adverse Event|2
4694220|NCT02603809|7605494|FG004|Overall Study|Adverse Event|1
4694221|NCT02603809|7605495|FG005|Overall Study|Adverse Event|1
4694222|NCT02603809|7605490|FG000|Overall Study|Lack of Efficacy|0
4694223|NCT02603809|7605491|FG001|Overall Study|Lack of Efficacy|1
4694224|NCT02603809|7605492|FG002|Overall Study|Lack of Efficacy|0
4694225|NCT02603809|7605493|FG003|Overall Study|Lack of Efficacy|0
4694226|NCT02603809|7605494|FG004|Overall Study|Lack of Efficacy|0
4694227|NCT02603809|7605495|FG005|Overall Study|Lack of Efficacy|1
4694228|NCT02603952|7605520|FG000|Overall Study|Withdrawal by Subject|1
4694229|NCT02603952|7605521|FG001|Overall Study|Withdrawal by Subject|0
4694230|NCT02603952|7605522|FG002|Overall Study|Withdrawal by Subject|0
4694231|NCT02603952|7605523|FG003|Overall Study|Withdrawal by Subject|0
4694232|NCT02603952|7605520|FG000|Overall Study|Received oseltamivir by error|0
4694233|NCT02603952|7605521|FG001|Overall Study|Received oseltamivir by error|0
4694234|NCT02603952|7605522|FG002|Overall Study|Received oseltamivir by error|0
4694235|NCT02603952|7605523|FG003|Overall Study|Received oseltamivir by error|1
4694236|NCT02604017|7605538|FG000|Overall Study|Withdrew Consent|0
4694237|NCT02604017|7605539|FG001|Overall Study|Withdrew Consent|2
4694238|NCT02604017|7605538|FG000|Overall Study|Lost to Follow-up|5
4694239|NCT02604017|7605539|FG001|Overall Study|Lost to Follow-up|6
4694240|NCT02604017|7605538|FG000|Overall Study|Other|1
4694241|NCT02604017|7605539|FG001|Overall Study|Other|0
4694242|NCT02604160|7605547|FG000|Overall Study|Protocol Violation|0
4694243|NCT02604160|7605548|FG001|Overall Study|Protocol Violation|1
4694244|NCT02604160|7605547|FG000|Overall Study|Physician Decision|0
4694245|NCT02604160|7605548|FG001|Overall Study|Physician Decision|1
4694246|NCT02604199|7605573|FG000|Overall Study|Pregnancy|0
4694247|NCT02604199|7605574|FG001|Overall Study|Pregnancy|0
4694248|NCT02604199|7605575|FG002|Overall Study|Pregnancy|0
4694249|NCT02604199|7605576|FG003|Overall Study|Pregnancy|1
4694250|NCT02604199|7605573|FG000|Overall Study|Study terminated by sponsor|0
4694251|NCT02604199|7605574|FG001|Overall Study|Study terminated by sponsor|2
4694252|NCT02604199|7605575|FG002|Overall Study|Study terminated by sponsor|0
4694253|NCT02604199|7605576|FG003|Overall Study|Study terminated by sponsor|2
4694254|NCT02604199|7605573|FG000|Overall Study|Withdrawal by Subject|0
4694255|NCT02604199|7605574|FG001|Overall Study|Withdrawal by Subject|1
4694256|NCT02604199|7605575|FG002|Overall Study|Withdrawal by Subject|0
4694257|NCT02604199|7605576|FG003|Overall Study|Withdrawal by Subject|0
4694258|NCT02604212|7605593|FG000|Overall Study|Study Terminated by Sponsor|2
4694259|NCT02604212|7605594|FG001|Overall Study|Study Terminated by Sponsor|1
4694260|NCT02604212|7605595|FG002|Overall Study|Study Terminated by Sponsor|3
4694261|NCT02604212|7605596|FG003|Overall Study|Study Terminated by Sponsor|3
4694262|NCT02604212|7605593|FG000|Overall Study|Withdrawal by Subject|0
4694263|NCT02604212|7605594|FG001|Overall Study|Withdrawal by Subject|0
4694264|NCT02604212|7605595|FG002|Overall Study|Withdrawal by Subject|1
4694265|NCT02604212|7605596|FG003|Overall Study|Withdrawal by Subject|0
4694266|NCT02604264|7605613|FG000|Intervention|Didn't use CVC for at least 21 days|200
4694267|NCT02604264|7605614|FG001|Intervention|Didn't use CVC for at least 21 days|242
4694268|NCT02604342|7605622|FG000|Overall Study|Death|32
4694269|NCT02604342|7605623|FG001|Overall Study|Death|16
4694270|NCT02604342|7605622|FG000|Overall Study|Progression of disease|1
4694271|NCT02604342|7605623|FG001|Overall Study|Progression of disease|0
4694272|NCT02604342|7605622|FG000|Overall Study|Withdrawal by Subject|5
4694273|NCT02604342|7605623|FG001|Overall Study|Withdrawal by Subject|6
4586576|NCT01486316|7430699|FG000|Overall Study|Withdrawal by Subject|1
4586577|NCT01486316|7430700|FG001|Overall Study|Withdrawal by Subject|0
4586578|NCT01486316|7430701|FG002|Overall Study|Withdrawal by Subject|3
4586579|NCT01486316|7430702|FG003|Overall Study|Withdrawal by Subject|0
4586580|NCT01486316|7430699|FG000|Overall Study|Physician Decision|0
4586581|NCT01486316|7430700|FG001|Overall Study|Physician Decision|0
4586582|NCT01486316|7430701|FG002|Overall Study|Physician Decision|1
4586583|NCT01486316|7430702|FG003|Overall Study|Physician Decision|0
4586584|NCT01486316|7430699|FG000|Overall Study|Death|0
4586585|NCT01486316|7430700|FG001|Overall Study|Death|1
4586586|NCT01486316|7430701|FG002|Overall Study|Death|0
4586587|NCT01486316|7430702|FG003|Overall Study|Death|0
4586588|NCT01486446|7430713|FG000|Overall Study|Adverse Event|1
4586589|NCT01486446|7430714|FG001|Overall Study|Adverse Event|0
4586590|NCT01486758|7430739|FG000|Overall Study|Lost to Follow-up|0
4586591|NCT01486758|7430740|FG001|Overall Study|Lost to Follow-up|1
4586592|NCT01486784|7430753|FG000|Overall Study|Withdrawal by Subject|0
4586593|NCT01486784|7430754|FG001|Overall Study|Withdrawal by Subject|0
4586594|NCT01486784|7430755|FG002|Overall Study|Withdrawal by Subject|1
4586595|NCT01486784|7430756|FG003|Overall Study|Withdrawal by Subject|0
4586596|NCT01486784|7430757|FG004|Overall Study|Withdrawal by Subject|1
4586597|NCT01486784|7430758|FG005|Overall Study|Withdrawal by Subject|2
4586598|NCT01486784|7430753|FG000|Overall Study|Subject did not meet entry criteria|0
4586599|NCT01486784|7430754|FG001|Overall Study|Subject did not meet entry criteria|0
4586600|NCT01486784|7430755|FG002|Overall Study|Subject did not meet entry criteria|0
4586601|NCT01486784|7430756|FG003|Overall Study|Subject did not meet entry criteria|0
4586602|NCT01486784|7430757|FG004|Overall Study|Subject did not meet entry criteria|1
4586603|NCT01486784|7430758|FG005|Overall Study|Subject did not meet entry criteria|0
4586604|NCT01486784|7430753|FG000|Overall Study|Death|0
4586605|NCT01486784|7430754|FG001|Overall Study|Death|0
4586606|NCT01486784|7430755|FG002|Overall Study|Death|0
4586607|NCT01486784|7430756|FG003|Overall Study|Death|0
4586608|NCT01486784|7430757|FG004|Overall Study|Death|0
4586609|NCT01486784|7430758|FG005|Overall Study|Death|1
4586610|NCT01486927|7430776|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1
4586611|NCT01486927|7430776|FG000|Overall Study|Physician Decision|1
4586612|NCT01486927|7430776|FG000|Overall Study|50 Exposure days not reached|2
4586613|NCT01486927|7430776|FG000|Overall Study|Withdrawal by Subject|8
4586614|NCT01486927|7430776|FG000|Overall Study|Subject did not reach 6 mo of treatment|1
4586615|NCT01486966|7430789|FG000|Overall Study|Adverse Event|0
4586616|NCT01486966|7430790|FG001|Overall Study|Adverse Event|1
4586617|NCT01486966|7430789|FG000|Overall Study|Withdrawal by Subject|0
4586618|NCT01486966|7430790|FG001|Overall Study|Withdrawal by Subject|1
4586619|NCT01487161|7430800|FG000|Overall Study|Adverse Event|1
4586620|NCT01487161|7430801|FG001|Overall Study|Adverse Event|0
4586621|NCT01487161|7430802|FG002|Overall Study|Adverse Event|0
4586622|NCT01487161|7430803|FG003|Overall Study|Adverse Event|0
4586623|NCT01487161|7430800|FG000|Overall Study|Withdrawal by Subject|1
4586624|NCT01487161|7430801|FG001|Overall Study|Withdrawal by Subject|1
4586625|NCT01487161|7430802|FG002|Overall Study|Withdrawal by Subject|1
4586626|NCT01487161|7430803|FG003|Overall Study|Withdrawal by Subject|2
4586627|NCT01487161|7430800|FG000|Overall Study|missing data|0
4694274|NCT02604342|7605622|FG000|Overall Study|Other|1
4694275|NCT02604342|7605623|FG001|Overall Study|Other|0
4694276|NCT02604342|7605622|FG000|Overall Study|Study Termination by Sponsor|1
4586628|NCT01487161|7430801|FG001|Overall Study|missing data|1
4586629|NCT01487161|7430802|FG002|Overall Study|missing data|0
4586630|NCT01487161|7430803|FG003|Overall Study|missing data|0
4586631|NCT01487200|7430822|FG000|Overall Study|Withdrawal by Subject|0
4586632|NCT01487200|7430823|FG001|Overall Study|Withdrawal by Subject|1
4586633|NCT01487200|7430824|FG002|Overall Study|Withdrawal by Subject|0
4586634|NCT01487200|7430825|FG003|Overall Study|Withdrawal by Subject|0
4626334|NCT01839279|7491874|FG001|Overall Study|Classified as 'Other'|0
4735055|NCT03518125|7682590|FG005|Overall Study|Missed Day 394 Visit|0
4694277|NCT02604342|7605623|FG001|Overall Study|Study Termination by Sponsor|0
4694278|NCT02604342|7605622|FG000|Overall Study|Lost to Follow-up|1
4694279|NCT02604342|7605623|FG001|Overall Study|Lost to Follow-up|1
4694280|NCT02604342|7605622|FG000|Overall Study|Physician Decision|2
4694281|NCT02604342|7605623|FG001|Overall Study|Physician Decision|0
4694282|NCT02604407|7605632|FG000|Overall Study|Adverse Event|0
4694283|NCT02604407|7605633|FG001|Overall Study|Adverse Event|7
4694284|NCT02604407|7605634|FG002|Overall Study|Adverse Event|5
4694285|NCT02604407|7605632|FG000|Overall Study|Protocol Violation|2
4694286|NCT02604407|7605633|FG001|Overall Study|Protocol Violation|0
4694287|NCT02604407|7605634|FG002|Overall Study|Protocol Violation|0
4694288|NCT02604407|7605632|FG000|Overall Study|Withdrawal by Subject|3
4694289|NCT02604407|7605633|FG001|Overall Study|Withdrawal by Subject|3
4694290|NCT02604407|7605634|FG002|Overall Study|Withdrawal by Subject|5
4694291|NCT02604407|7605632|FG000|Overall Study|Lost to Follow-up|2
4694292|NCT02604407|7605633|FG001|Overall Study|Lost to Follow-up|1
4694293|NCT02604407|7605634|FG002|Overall Study|Lost to Follow-up|2
4694294|NCT02604407|7605632|FG000|Overall Study|Lack of Efficacy|1
4694295|NCT02604407|7605633|FG001|Overall Study|Lack of Efficacy|0
4694296|NCT02604407|7605634|FG002|Overall Study|Lack of Efficacy|0
4694297|NCT02604407|7605632|FG000|Overall Study|Other|3
4694298|NCT02604407|7605633|FG001|Overall Study|Other|1
4694299|NCT02604407|7605634|FG002|Overall Study|Other|4
4586635|NCT01487265|7430836|FG000|Overall Study|Adverse Event|8
4586636|NCT01487265|7430836|FG000|Overall Study|Withdrawal by Subject|5
4586637|NCT01487265|7430836|FG000|Overall Study|Disease Progression|21
4586638|NCT01487265|7430836|FG000|Overall Study|Death|2
4586639|NCT01487265|7430836|FG000|Overall Study|Still on Treatment|1
4586640|NCT01487525|7430842|FG000|Overall Study|Withdrawal by Subject|0
4586641|NCT01487525|7430843|FG001|Overall Study|Withdrawal by Subject|1
4586642|NCT01487577|7430849|FG000|Overall Study|Became ineligible after signing consent|1
4593548|NCT01553136|7442081|FG001|Overall Study|Withdrawal by Subject|3
4593549|NCT01553136|7442080|FG000|Overall Study|Lost to Follow-up|4
4593550|NCT01553136|7442081|FG001|Overall Study|Lost to Follow-up|10
4593551|NCT01553136|7442080|FG000|Overall Study|Physician Decision|2
4593552|NCT01553136|7442081|FG001|Overall Study|Physician Decision|3
4593553|NCT01553136|7442080|FG000|Overall Study|Scheduling Difficulties|5
4593554|NCT01553136|7442081|FG001|Overall Study|Scheduling Difficulties|4
4593555|NCT01553188|7442091|FG000|Overall Study|Patient choice|1
4593556|NCT01553188|7442092|FG001|Overall Study|Patient choice|0
4593557|NCT01553188|7442093|FG002|Overall Study|Patient choice|0
4593558|NCT01553188|7442094|FG003|Overall Study|Patient choice|0
4593559|NCT01553188|7442091|FG000|Overall Study|Intercurrent illness and adverse event|0
4593560|NCT01553188|7442092|FG001|Overall Study|Intercurrent illness and adverse event|1
4593561|NCT01553188|7442093|FG002|Overall Study|Intercurrent illness and adverse event|2
4593562|NCT01553188|7442094|FG003|Overall Study|Intercurrent illness and adverse event|0
4593563|NCT01553279|7442118|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1
4593564|NCT01553279|7442119|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0
4593565|NCT01553279|7442118|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1
4593566|NCT01553279|7442119|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1
4593567|NCT01553279|7442118|FG000|Interim Period|Withdrawal by Subject|2
4593568|NCT01553279|7442119|FG001|Interim Period|Withdrawal by Subject|2
4593569|NCT01553279|7442118|FG000|Interim Period|Lost to Follow-up|1
4593570|NCT01553279|7442119|FG001|Interim Period|Lost to Follow-up|0
4593571|NCT01553279|7442118|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0
4593572|NCT01553279|7442119|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5
4593573|NCT01553279|7442118|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3
4593574|NCT01553279|7442119|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2
4593575|NCT01553318|7442134|FG000|Overall Study|Protocol Violation|3
4593576|NCT01553318|7442135|FG001|Overall Study|Protocol Violation|2
4593577|NCT01553591|7442150|FG000|Overall Study|Voluntarily withdrew|94
4593578|NCT01553591|7442151|FG001|Overall Study|Voluntarily withdrew|79
4593579|NCT01553591|7442152|FG002|Overall Study|Voluntarily withdrew|96
4593580|NCT01553591|7442150|FG000|Overall Study|Adverse Event|36
4593581|NCT01553591|7442151|FG001|Overall Study|Adverse Event|45
4593582|NCT01553591|7442152|FG002|Overall Study|Adverse Event|16
4593583|NCT01553591|7442150|FG000|Overall Study|Lost to Follow-up|25
4593584|NCT01553591|7442151|FG001|Overall Study|Lost to Follow-up|23
4593585|NCT01553591|7442152|FG002|Overall Study|Lost to Follow-up|16
4593586|NCT01553591|7442150|FG000|Overall Study|Physician decision: other|11
4593587|NCT01553591|7442151|FG001|Overall Study|Physician decision: other|14
4593588|NCT01553591|7442152|FG002|Overall Study|Physician decision: other|16
4593589|NCT01553591|7442150|FG000|Overall Study|Physician decision: lack of efficacy|2
4593590|NCT01553591|7442151|FG001|Overall Study|Physician decision: lack of efficacy|3
4593591|NCT01553591|7442152|FG002|Overall Study|Physician decision: lack of efficacy|7
4694300|NCT02604550|7605644|FG000|Overall Study|Lost to Follow-up|7
4694301|NCT02604550|7605645|FG001|Overall Study|Lost to Follow-up|6
4694302|NCT02604550|7605644|FG000|Overall Study|Withdrawal by Subject|0
4694303|NCT02604550|7605645|FG001|Overall Study|Withdrawal by Subject|1
4586643|NCT01487863|7430866|FG000|Overall Study|Death|19
4586644|NCT01487863|7430867|FG001|Overall Study|Death|19
4586645|NCT01488071|7430895|FG000|Overall Study|Adverse Event|15
4586646|NCT01488071|7430896|FG001|Overall Study|Adverse Event|23
4586647|NCT01488071|7430895|FG000|Overall Study|Lack of Efficacy|11
4586648|NCT01488071|7430896|FG001|Overall Study|Lack of Efficacy|17
4586649|NCT01488071|7430895|FG000|Overall Study|Non-compliance with study drug|2
4586650|NCT01488071|7430896|FG001|Overall Study|Non-compliance with study drug|0
4586651|NCT01488071|7430895|FG000|Overall Study|Protocol Violation|5
4586652|NCT01488071|7430896|FG001|Overall Study|Protocol Violation|7
4586653|NCT01488071|7430895|FG000|Overall Study|Withdrawal of Consent|14
4586654|NCT01488071|7430896|FG001|Overall Study|Withdrawal of Consent|12
4586655|NCT01488071|7430895|FG000|Overall Study|Lost to Follow-up|1
4586656|NCT01488071|7430896|FG001|Overall Study|Lost to Follow-up|0
4586657|NCT01488071|7430895|FG000|Overall Study|Administrative or Other Reason(s)|5
4586658|NCT01488071|7430896|FG001|Overall Study|Administrative or Other Reason(s)|4
4586659|NCT01488097|7430902|FG000|Overall Study|Lost to Follow-up|1
4586660|NCT01488370|7430934|FG000|Overall Study|Protocol Violation|0
4586661|NCT01488370|7430935|FG001|Overall Study|Protocol Violation|1
4586662|NCT01488370|7430936|FG002|Overall Study|Protocol Violation|1
4586663|NCT01488448|7430955|FG000|Overall Study|Withdrawal by Subject|3
4586664|NCT01488448|7430956|FG001|Overall Study|Withdrawal by Subject|1
4586665|NCT01488448|7430955|FG000|Overall Study|Adverse Event|9
4586666|NCT01488448|7430956|FG001|Overall Study|Adverse Event|4
4586667|NCT01488448|7430955|FG000|Overall Study|Physician Decision|4
4586668|NCT01488448|7430956|FG001|Overall Study|Physician Decision|9
4586669|NCT01488448|7430955|FG000|Overall Study|Protocol Violation|4
4586670|NCT01488448|7430956|FG001|Overall Study|Protocol Violation|3
4586671|NCT01488487|7430964|FG000|Overall Study|Adverse Event|6
4586672|NCT01488487|7430964|FG000|Overall Study|Death|1
4586673|NCT01488487|7430964|FG000|Overall Study|Withdrawal by Subject|2
4586674|NCT01488578|7430968|FG000|Overall Study|Protocol Violation|1836
4586675|NCT01488994|7431020|FG000|Overall Study|Withdrawal by Subject|0
4586676|NCT01488994|7431021|FG001|Overall Study|Withdrawal by Subject|1
4586677|NCT01489020|7431038|FG000|Overall Study|Withdrawal by Subject|1
4586678|NCT01489020|7431039|FG001|Overall Study|Withdrawal by Subject|0
4586679|NCT01489020|7431040|FG002|Overall Study|Withdrawal by Subject|0
4586680|NCT01489020|7431041|FG003|Overall Study|Withdrawal by Subject|0
4586681|NCT01489020|7431042|FG004|Overall Study|Withdrawal by Subject|0
4586682|NCT01489020|7431043|FG005|Overall Study|Withdrawal by Subject|0
4586683|NCT01489020|7431038|FG000|Overall Study|Adverse Event|0
4586684|NCT01489020|7431039|FG001|Overall Study|Adverse Event|0
4586685|NCT01489020|7431040|FG002|Overall Study|Adverse Event|3
4586686|NCT01489020|7431041|FG003|Overall Study|Adverse Event|0
4586687|NCT01489020|7431042|FG004|Overall Study|Adverse Event|3
4586688|NCT01489020|7431043|FG005|Overall Study|Adverse Event|0
4464926|NCT00606684|7255972|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
4464927|NCT00606684|7255973|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
4464928|NCT00606684|7255974|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
4464929|NCT00606684|7255975|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
4464930|NCT00606684|7255969|FG000|2-week Single-Blind Run-in Period|Physician Decision|18
4464931|NCT00606684|7255970|FG001|2-week Single-Blind Run-in Period|Physician Decision|0
4464932|NCT00606684|7255971|FG002|2-week Single-Blind Run-in Period|Physician Decision|0
4464933|NCT00606684|7255972|FG003|2-week Single-Blind Run-in Period|Physician Decision|0
4464934|NCT00606684|7255973|FG004|2-week Single-Blind Run-in Period|Physician Decision|0
4464935|NCT00606684|7255974|FG005|2-week Single-Blind Run-in Period|Physician Decision|0
4464936|NCT00606684|7255975|FG006|2-week Single-Blind Run-in Period|Physician Decision|0
4464937|NCT00606684|7255969|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15
4464938|NCT00606684|7255970|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
4464939|NCT00606684|7255971|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
4464940|NCT00606684|7255972|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
4586689|NCT01489020|7431038|FG000|Overall Study|Concomitant disease|0
4586690|NCT01489020|7431039|FG001|Overall Study|Concomitant disease|0
4586691|NCT01489020|7431040|FG002|Overall Study|Concomitant disease|0
4586692|NCT01489020|7431041|FG003|Overall Study|Concomitant disease|0
4586693|NCT01489020|7431042|FG004|Overall Study|Concomitant disease|3
4586694|NCT01489020|7431043|FG005|Overall Study|Concomitant disease|0
4586695|NCT01489111|7431063|FG000|Overall Study|Withdrawal criterion|1
4586696|NCT01489189|7431069|FG000|Overall Study|Withdrawal by Subject|20
4586697|NCT01489189|7431070|FG001|Overall Study|Withdrawal by Subject|23
4586698|NCT01489189|7431069|FG000|Overall Study|Death|10
4586699|NCT01489189|7431070|FG001|Overall Study|Death|8
4586700|NCT01489189|7431069|FG000|Overall Study|Missed Visit|1
4586701|NCT01489189|7431070|FG001|Overall Study|Missed Visit|4
4586702|NCT01489254|7431080|FG000|Double-blind Part|Adverse Event|7
4586703|NCT01489254|7431081|FG001|Double-blind Part|Adverse Event|2
4586704|NCT01489254|7431082|FG002|Double-blind Part|Adverse Event|2
4586705|NCT01489254|7431083|FG003|Double-blind Part|Adverse Event|0
4586706|NCT01489254|7431080|FG000|Double-blind Part|Pregnancy|1
4586707|NCT01489254|7431081|FG001|Double-blind Part|Pregnancy|3
4586708|NCT01489254|7431082|FG002|Double-blind Part|Pregnancy|0
4586709|NCT01489254|7431083|FG003|Double-blind Part|Pregnancy|0
4586710|NCT01489254|7431080|FG000|Double-blind Part|Withdrawal by Subject|12
4586711|NCT01489254|7431081|FG001|Double-blind Part|Withdrawal by Subject|20
4586712|NCT01489254|7431082|FG002|Double-blind Part|Withdrawal by Subject|1
4586713|NCT01489254|7431083|FG003|Double-blind Part|Withdrawal by Subject|0
4586714|NCT01489254|7431080|FG000|Double-blind Part|Lost to Follow-up|1
4586715|NCT01489254|7431081|FG001|Double-blind Part|Lost to Follow-up|2
4586716|NCT01489254|7431082|FG002|Double-blind Part|Lost to Follow-up|0
4586717|NCT01489254|7431083|FG003|Double-blind Part|Lost to Follow-up|0
4586718|NCT01489254|7431080|FG000|Double-blind Part|Other reasons for not completing study|4
4586719|NCT01489254|7431081|FG001|Double-blind Part|Other reasons for not completing study|6
4586720|NCT01489254|7431082|FG002|Double-blind Part|Other reasons for not completing study|0
4586721|NCT01489254|7431083|FG003|Double-blind Part|Other reasons for not completing study|0
4586722|NCT01489254|7431080|FG000|Open-label Extension Part|Adverse Event|0
4586723|NCT01489254|7431081|FG001|Open-label Extension Part|Adverse Event|0
4586724|NCT01489254|7431082|FG002|Open-label Extension Part|Adverse Event|0
4586725|NCT01489254|7431083|FG003|Open-label Extension Part|Adverse Event|10
4586726|NCT01489254|7431080|FG000|Open-label Extension Part|Pregnancy|0
4586727|NCT01489254|7431081|FG001|Open-label Extension Part|Pregnancy|0
4586728|NCT01489254|7431082|FG002|Open-label Extension Part|Pregnancy|0
4586729|NCT01489254|7431083|FG003|Open-label Extension Part|Pregnancy|3
4586730|NCT01489254|7431080|FG000|Open-label Extension Part|Withdrawal by Subject|0
4586731|NCT01489254|7431081|FG001|Open-label Extension Part|Withdrawal by Subject|0
4586732|NCT01489254|7431082|FG002|Open-label Extension Part|Withdrawal by Subject|0
4586733|NCT01489254|7431083|FG003|Open-label Extension Part|Withdrawal by Subject|30
4586734|NCT01489254|7431080|FG000|Open-label Extension Part|Protocol Violation|0
4586735|NCT01489254|7431081|FG001|Open-label Extension Part|Protocol Violation|0
4586736|NCT01489254|7431082|FG002|Open-label Extension Part|Protocol Violation|0
4586737|NCT01489254|7431083|FG003|Open-label Extension Part|Protocol Violation|1
4586738|NCT01489254|7431080|FG000|Open-label Extension Part|Lost to Follow-up|0
4586739|NCT01489254|7431081|FG001|Open-label Extension Part|Lost to Follow-up|0
4586740|NCT01489254|7431082|FG002|Open-label Extension Part|Lost to Follow-up|0
4586741|NCT01489254|7431083|FG003|Open-label Extension Part|Lost to Follow-up|9
4586742|NCT01489254|7431080|FG000|Open-label Extension Part|Other reasons for not completing study|0
4586743|NCT01489254|7431081|FG001|Open-label Extension Part|Other reasons for not completing study|0
4586744|NCT01489254|7431082|FG002|Open-label Extension Part|Other reasons for not completing study|0
4586745|NCT01489254|7431083|FG003|Open-label Extension Part|Other reasons for not completing study|5
4586746|NCT01489358|7431095|FG000|Overall Study|Lost to Follow-up|0
4586747|NCT01489358|7431096|FG001|Overall Study|Lost to Follow-up|0
4586748|NCT01489358|7431097|FG002|Overall Study|Lost to Follow-up|2
4586749|NCT01489527|7431107|FG000|Overall Study|Pregnancy|9
4586750|NCT01489527|7431108|FG001|Overall Study|Pregnancy|14
4586751|NCT01489527|7431107|FG000|Overall Study|Participant moved|6
4586752|NCT01489527|7431108|FG001|Overall Study|Participant moved|7
4586753|NCT01489527|7431107|FG000|Overall Study|Withdrawal by Subject|0
4586754|NCT01489527|7431108|FG001|Overall Study|Withdrawal by Subject|4
4586755|NCT01489527|7431107|FG000|Overall Study|Lost to Follow-up|5
4586756|NCT01489527|7431108|FG001|Overall Study|Lost to Follow-up|1
4586757|NCT01489527|7431107|FG000|Overall Study|Procedures|1
4586758|NCT01489527|7431108|FG001|Overall Study|Procedures|0
4586759|NCT01489527|7431107|FG000|Overall Study|Not compliant|1
4586760|NCT01489527|7431108|FG001|Overall Study|Not compliant|0
4586761|NCT01489891|7431176|FG000|Overall Study|Endoscopy failure|1
4586762|NCT01489891|7431177|FG001|Overall Study|Endoscopy failure|0
4586763|NCT01489956|7431185|FG000|Overall Study|Lost to Follow-up|1
4586764|NCT01489956|7431186|FG001|Overall Study|Lost to Follow-up|0
4586765|NCT01489956|7431187|FG002|Overall Study|Lost to Follow-up|0
4586766|NCT01489956|7431185|FG000|Overall Study|Withdrawal by Subject|0
4586767|NCT01489956|7431186|FG001|Overall Study|Withdrawal by Subject|0
4586768|NCT01489956|7431187|FG002|Overall Study|Withdrawal by Subject|1
4586769|NCT01490060|7431210|FG000|Cycle 1|Change of Treatment|0
4586770|NCT01490060|7431211|FG001|Cycle 1|Change of Treatment|1
4586771|NCT01490060|7431212|FG002|Cycle 1|Change of Treatment|1
4586772|NCT01490060|7431213|FG003|Cycle 1|Change of Treatment|1
4586773|NCT01490060|7431210|FG000|Cycle 1|Insurance Denied|0
4586774|NCT01490060|7431211|FG001|Cycle 1|Insurance Denied|0
4586775|NCT01490060|7431212|FG002|Cycle 1|Insurance Denied|2
4586776|NCT01490060|7431213|FG003|Cycle 1|Insurance Denied|0
4586777|NCT01490060|7431210|FG000|Cycle 1|Withdrawal by Subject|0
4586778|NCT01490060|7431211|FG001|Cycle 1|Withdrawal by Subject|0
4586779|NCT01490060|7431212|FG002|Cycle 1|Withdrawal by Subject|0
4586780|NCT01490060|7431213|FG003|Cycle 1|Withdrawal by Subject|1
4586781|NCT01490060|7431210|FG000|Cycle 1|Treatment at Another Facility|0
4586782|NCT01490060|7431211|FG001|Cycle 1|Treatment at Another Facility|0
4586783|NCT01490060|7431212|FG002|Cycle 1|Treatment at Another Facility|0
4586784|NCT01490060|7431213|FG003|Cycle 1|Treatment at Another Facility|1
4586785|NCT01490060|7431210|FG000|Cycle 2|Change of Treatment|1
4586786|NCT01490060|7431211|FG001|Cycle 2|Change of Treatment|1
4586787|NCT01490060|7431212|FG002|Cycle 2|Change of Treatment|0
4586788|NCT01490060|7431213|FG003|Cycle 2|Change of Treatment|0
4586789|NCT01490060|7431210|FG000|Cycle 2|Non-Compliance|0
4586790|NCT01490060|7431211|FG001|Cycle 2|Non-Compliance|0
4586791|NCT01490060|7431212|FG002|Cycle 2|Non-Compliance|1
4586792|NCT01490060|7431213|FG003|Cycle 2|Non-Compliance|0
4586793|NCT01490060|7431210|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1
4586794|NCT01490060|7431211|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0
4586795|NCT01490060|7431212|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0
4586796|NCT01490060|7431213|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0
4586797|NCT01490086|7431235|FG000|Overall Study|Consent withdrawn|4
4586798|NCT01490086|7431236|FG001|Overall Study|Consent withdrawn|4
4586799|NCT01490086|7431237|FG002|Overall Study|Consent withdrawn|3
4586800|NCT01490086|7431238|FG003|Overall Study|Consent withdrawn|0
4586801|NCT01490086|7431239|FG004|Overall Study|Consent withdrawn|1
4586802|NCT01490086|7431235|FG000|Overall Study|Non-compliance|0
4586803|NCT01490086|7431236|FG001|Overall Study|Non-compliance|1
4586804|NCT01490086|7431237|FG002|Overall Study|Non-compliance|0
4586805|NCT01490086|7431238|FG003|Overall Study|Non-compliance|0
4586806|NCT01490086|7431239|FG004|Overall Study|Non-compliance|0
4586807|NCT01490086|7431235|FG000|Overall Study|Abnormal laboratory findings|1
4586808|NCT01490086|7431236|FG001|Overall Study|Abnormal laboratory findings|0
4586809|NCT01490086|7431237|FG002|Overall Study|Abnormal laboratory findings|0
4586810|NCT01490086|7431238|FG003|Overall Study|Abnormal laboratory findings|0
4586811|NCT01490086|7431239|FG004|Overall Study|Abnormal laboratory findings|0
4586812|NCT01490086|7431235|FG000|Overall Study|Lost to Follow-up|0
4586813|NCT01490086|7431236|FG001|Overall Study|Lost to Follow-up|0
4586814|NCT01490086|7431237|FG002|Overall Study|Lost to Follow-up|0
4586815|NCT01490086|7431238|FG003|Overall Study|Lost to Follow-up|0
4586816|NCT01490086|7431239|FG004|Overall Study|Lost to Follow-up|1
4586817|NCT01490086|7431235|FG000|Overall Study|Physician Decision|3
4447939|NCT00492856|7233154|FG002|Post-consolidation|Death|0
4447940|NCT00492856|7233155|FG003|Post-consolidation|Death|0
4447941|NCT00492856|7233152|FG000|Post-consolidation|Not protocol specified|0
4447942|NCT00492856|7233153|FG001|Post-consolidation|Not protocol specified|1
4447943|NCT00492856|7233154|FG002|Post-consolidation|Not protocol specified|0
4447944|NCT00492856|7233155|FG003|Post-consolidation|Not protocol specified|0
4447945|NCT00492856|7233152|FG000|Post-consolidation|Lost to Follow-up|0
4447946|NCT00492856|7233153|FG001|Post-consolidation|Lost to Follow-up|2
4447947|NCT00492856|7233154|FG002|Post-consolidation|Lost to Follow-up|0
4447948|NCT00492856|7233155|FG003|Post-consolidation|Lost to Follow-up|0
4447949|NCT00492856|7233152|FG000|Post-consolidation|Observation Arm|0
4447950|NCT00492856|7233153|FG001|Post-consolidation|Observation Arm|0
4447951|NCT00492856|7233154|FG002|Post-consolidation|Observation Arm|27
4447952|NCT00492856|7233155|FG003|Post-consolidation|Observation Arm|0
4447953|NCT00492921|7233167|FG000|Overall Study|Death|1
4447954|NCT00492921|7233168|FG001|Overall Study|Death|0
4447955|NCT00492921|7233169|FG002|Overall Study|Death|1
4447956|NCT00493012|7233188|FG000|Overall Study|Lost to Follow-up|18
4447957|NCT00493012|7233189|FG001|Overall Study|Lost to Follow-up|17
4586818|NCT01490086|7431236|FG001|Overall Study|Physician Decision|4
4586819|NCT01490086|7431237|FG002|Overall Study|Physician Decision|2
4586820|NCT01490086|7431238|FG003|Overall Study|Physician Decision|3
4586821|NCT01490086|7431239|FG004|Overall Study|Physician Decision|1
4586822|NCT01490086|7431235|FG000|Overall Study|Adverse Event|0
4586823|NCT01490086|7431236|FG001|Overall Study|Adverse Event|0
4586824|NCT01490086|7431237|FG002|Overall Study|Adverse Event|1
4586825|NCT01490086|7431238|FG003|Overall Study|Adverse Event|2
4586826|NCT01490086|7431239|FG004|Overall Study|Adverse Event|0
4586827|NCT01490086|7431235|FG000|Overall Study|Lack of Efficacy|0
4447958|NCT00493038|7233197|FG000|Treatment|Adverse Event|8
4447959|NCT00493038|7233198|FG001|Treatment|Adverse Event|4
4447960|NCT00493038|7233197|FG000|Treatment|Lost to Follow-up|5
4447961|NCT00493038|7233198|FG001|Treatment|Lost to Follow-up|3
4586828|NCT01490086|7431236|FG001|Overall Study|Lack of Efficacy|3
4586829|NCT01490086|7431237|FG002|Overall Study|Lack of Efficacy|1
4586830|NCT01490086|7431238|FG003|Overall Study|Lack of Efficacy|0
4586831|NCT01490086|7431239|FG004|Overall Study|Lack of Efficacy|8
4586832|NCT01490086|7431235|FG000|Overall Study|Worsening of symptoms|0
4586833|NCT01490086|7431236|FG001|Overall Study|Worsening of symptoms|1
4586834|NCT01490086|7431237|FG002|Overall Study|Worsening of symptoms|0
4586835|NCT01490086|7431238|FG003|Overall Study|Worsening of symptoms|1
4586836|NCT01490086|7431239|FG004|Overall Study|Worsening of symptoms|0
4586837|NCT01490086|7431235|FG000|Overall Study|Subject uncontrollable and abusive|0
4586838|NCT01490086|7431236|FG001|Overall Study|Subject uncontrollable and abusive|1
4586839|NCT01490086|7431237|FG002|Overall Study|Subject uncontrollable and abusive|0
4586840|NCT01490086|7431238|FG003|Overall Study|Subject uncontrollable and abusive|0
4586841|NCT01490086|7431239|FG004|Overall Study|Subject uncontrollable and abusive|0
4586842|NCT01490086|7431235|FG000|Overall Study|Subject left hospital|0
4586843|NCT01490086|7431236|FG001|Overall Study|Subject left hospital|1
4586844|NCT01490086|7431237|FG002|Overall Study|Subject left hospital|0
4586845|NCT01490086|7431238|FG003|Overall Study|Subject left hospital|1
4586846|NCT01490086|7431239|FG004|Overall Study|Subject left hospital|0
4586847|NCT01490125|7431251|FG000|Period I|Adverse Event|4
4586848|NCT01490125|7431252|FG001|Period I|Adverse Event|1
4586849|NCT01490125|7431253|FG002|Period I|Adverse Event|1
4586850|NCT01490125|7431254|FG003|Period I|Adverse Event|3
4586851|NCT01490125|7431255|FG004|Period I|Adverse Event|2
4586852|NCT01490125|7431256|FG005|Period I|Adverse Event|4
4586853|NCT01490125|7431251|FG000|Period I|Protocol Violation|1
4586854|NCT01490125|7431252|FG001|Period I|Protocol Violation|1
4371466|NCT04579393|7146062|FG000|Overall Study|Withdrawal by Subject|2
4586855|NCT01490125|7431253|FG002|Period I|Protocol Violation|1
4694304|NCT02604550|7605644|FG000|Overall Study|Incomplete data using paper journal|18
4586856|NCT01490125|7431254|FG003|Period I|Protocol Violation|1
4694305|NCT02604550|7605645|FG001|Overall Study|Incomplete data using paper journal|19
4694306|NCT02604589|7605654|FG000|Overall Study|catheter dislodgement|0
4694307|NCT02604589|7605655|FG001|Overall Study|catheter dislodgement|0
4694308|NCT02604589|7605656|FG002|Overall Study|catheter dislodgement|1
4694309|NCT02605122|7605672|FG000|Overall Study|Withdrawal by Subject|4
4694310|NCT02605122|7605673|FG001|Overall Study|Withdrawal by Subject|1
4694311|NCT02605122|7605672|FG000|Overall Study|Lost to Follow-up|1
4770453|NCT03614923|7746780|FG002|Overall Study|Lack of Efficacy|1
4586857|NCT01490125|7431255|FG004|Period I|Protocol Violation|0
4586858|NCT01490125|7431256|FG005|Period I|Protocol Violation|0
4586859|NCT01490125|7431251|FG000|Period I|Withdrawal by Subject|1
4586860|NCT01490125|7431252|FG001|Period I|Withdrawal by Subject|3
4586861|NCT01490125|7431253|FG002|Period I|Withdrawal by Subject|2
4586862|NCT01490125|7431254|FG003|Period I|Withdrawal by Subject|1
4586863|NCT01490125|7431255|FG004|Period I|Withdrawal by Subject|2
4586864|NCT01490125|7431256|FG005|Period I|Withdrawal by Subject|1
4586865|NCT01490125|7431251|FG000|Period II|Adverse Event|2
4586866|NCT01490125|7431252|FG001|Period II|Adverse Event|3
4586867|NCT01490125|7431253|FG002|Period II|Adverse Event|2
4586868|NCT01490125|7431254|FG003|Period II|Adverse Event|2
4586869|NCT01490125|7431255|FG004|Period II|Adverse Event|4
4586870|NCT01490125|7431256|FG005|Period II|Adverse Event|2
4586871|NCT01490125|7431251|FG000|Period II|Protocol Violation|0
4586872|NCT01490125|7431252|FG001|Period II|Protocol Violation|0
4586873|NCT01490125|7431253|FG002|Period II|Protocol Violation|1
4586874|NCT01490125|7431254|FG003|Period II|Protocol Violation|1
4586875|NCT01490125|7431255|FG004|Period II|Protocol Violation|0
4586876|NCT01490125|7431256|FG005|Period II|Protocol Violation|0
4586877|NCT01490125|7431251|FG000|Period II|Lost to Follow-up|0
4586878|NCT01490125|7431252|FG001|Period II|Lost to Follow-up|1
4371467|NCT04579393|7146063|FG001|Overall Study|Withdrawal by Subject|2
4586879|NCT01490125|7431253|FG002|Period II|Lost to Follow-up|0
4586880|NCT01490125|7431254|FG003|Period II|Lost to Follow-up|0
4586881|NCT01490125|7431255|FG004|Period II|Lost to Follow-up|0
4586882|NCT01490125|7431256|FG005|Period II|Lost to Follow-up|0
4586883|NCT01490125|7431251|FG000|Period II|Withdrawal by Subject|1
4586884|NCT01490125|7431252|FG001|Period II|Withdrawal by Subject|0
4586885|NCT01490125|7431253|FG002|Period II|Withdrawal by Subject|0
4586886|NCT01490125|7431254|FG003|Period II|Withdrawal by Subject|0
4586887|NCT01490125|7431255|FG004|Period II|Withdrawal by Subject|0
4586888|NCT01490125|7431256|FG005|Period II|Withdrawal by Subject|0
4586889|NCT01490125|7431251|FG000|Period III|Adverse Event|3
4586890|NCT01490125|7431252|FG001|Period III|Adverse Event|1
4694312|NCT02605122|7605673|FG001|Overall Study|Lost to Follow-up|1
4694313|NCT02605174|7605683|FG000|Overall Study|Adverse Event|0
4770454|NCT03614923|7746778|FG000|Overall Study|Non-compliance|0
4770455|NCT03614923|7746779|FG001|Overall Study|Non-compliance|1
4770456|NCT03614923|7746780|FG002|Overall Study|Non-compliance|0
4770457|NCT03614923|7746778|FG000|Overall Study|Other|0
4770458|NCT03614923|7746779|FG001|Overall Study|Other|1
4770459|NCT03614923|7746780|FG002|Overall Study|Other|1
4770460|NCT03502187|7746791|FG000|Overall Study|Withdrawal by Subject|4
4770461|NCT03502187|7746792|FG001|Overall Study|Withdrawal by Subject|3
4770462|NCT03502187|7746793|FG002|Overall Study|Withdrawal by Subject|3
4770463|NCT03502187|7746791|FG000|Overall Study|Lost to Follow-up|5
4770464|NCT03502187|7746792|FG001|Overall Study|Lost to Follow-up|4
4586891|NCT01490125|7431253|FG002|Period III|Adverse Event|0
4586892|NCT01490125|7431254|FG003|Period III|Adverse Event|1
4586893|NCT01490125|7431255|FG004|Period III|Adverse Event|0
4586894|NCT01490125|7431256|FG005|Period III|Adverse Event|0
4586895|NCT01490125|7431251|FG000|Period III|Death|0
4586896|NCT01490125|7431252|FG001|Period III|Death|0
4586897|NCT01490125|7431253|FG002|Period III|Death|0
4586898|NCT01490125|7431254|FG003|Period III|Death|1
4586899|NCT01490125|7431255|FG004|Period III|Death|0
4694314|NCT02605174|7605684|FG001|Overall Study|Adverse Event|0
4694315|NCT02605174|7605685|FG002|Overall Study|Adverse Event|1
4694316|NCT02605174|7605686|FG003|Overall Study|Adverse Event|0
4694317|NCT02605174|7605687|FG004|Overall Study|Adverse Event|4
4694318|NCT02605174|7605688|FG005|Overall Study|Adverse Event|0
4694319|NCT02605174|7605689|FG006|Overall Study|Adverse Event|0
4694320|NCT02605174|7605683|FG000|Overall Study|Lost to Follow-up|20
4694321|NCT02605174|7605684|FG001|Overall Study|Lost to Follow-up|7
4694322|NCT02605174|7605685|FG002|Overall Study|Lost to Follow-up|27
4586900|NCT01490125|7431256|FG005|Period III|Death|0
4586901|NCT01490125|7431251|FG000|Period III|Lack of Efficacy|0
4586902|NCT01490125|7431252|FG001|Period III|Lack of Efficacy|0
4586903|NCT01490125|7431253|FG002|Period III|Lack of Efficacy|0
4586904|NCT01490125|7431254|FG003|Period III|Lack of Efficacy|0
4586905|NCT01490125|7431255|FG004|Period III|Lack of Efficacy|1
4586906|NCT01490125|7431256|FG005|Period III|Lack of Efficacy|0
4586907|NCT01490294|7431274|FG000|Overall Study|Prematurely discontinuation|4
4586908|NCT01490294|7431275|FG001|Overall Study|Prematurely discontinuation|0
4586909|NCT01490294|7431276|FG002|Overall Study|Prematurely discontinuation|1
4586910|NCT01490294|7431277|FG003|Overall Study|Prematurely discontinuation|1
4586911|NCT01490294|7431274|FG000|Overall Study|Adverse Event|1
4586912|NCT01490294|7431275|FG001|Overall Study|Adverse Event|0
4586913|NCT01490294|7431276|FG002|Overall Study|Adverse Event|0
4586914|NCT01490294|7431277|FG003|Overall Study|Adverse Event|0
4586915|NCT01490450|7431301|FG000|Period 1|Lack of Efficacy|2
4586916|NCT01490450|7431302|FG001|Period 1|Lack of Efficacy|0
4586917|NCT01490450|7431303|FG002|Period 1|Lack of Efficacy|3
4586918|NCT01490450|7431304|FG003|Period 1|Lack of Efficacy|0
4586919|NCT01490450|7431301|FG000|Period 1|Adverse Event|0
4586920|NCT01490450|7431302|FG001|Period 1|Adverse Event|0
4586921|NCT01490450|7431303|FG002|Period 1|Adverse Event|0
4586922|NCT01490450|7431304|FG003|Period 1|Adverse Event|5
4586923|NCT01490450|7431301|FG000|Period 1|Request to discontinue treatment|1
4586924|NCT01490450|7431302|FG001|Period 1|Request to discontinue treatment|0
4586925|NCT01490450|7431303|FG002|Period 1|Request to discontinue treatment|0
4586926|NCT01490450|7431304|FG003|Period 1|Request to discontinue treatment|0
4586927|NCT01490450|7431301|FG000|Period 1|Withdrawal by Subject|0
4586928|NCT01490450|7431302|FG001|Period 1|Withdrawal by Subject|0
4586929|NCT01490450|7431303|FG002|Period 1|Withdrawal by Subject|0
4586930|NCT01490450|7431304|FG003|Period 1|Withdrawal by Subject|3
4586931|NCT01490450|7431301|FG000|Period 1|No longer met study criteria|0
4586932|NCT01490450|7431302|FG001|Period 1|No longer met study criteria|1
4586933|NCT01490450|7431303|FG002|Period 1|No longer met study criteria|1
4586934|NCT01490450|7431304|FG003|Period 1|No longer met study criteria|0
4586935|NCT01490450|7431301|FG000|Period 2|Lack of Efficacy|0
4586936|NCT01490450|7431302|FG001|Period 2|Lack of Efficacy|0
4586937|NCT01490450|7431303|FG002|Period 2|Lack of Efficacy|0
4586938|NCT01490450|7431304|FG003|Period 2|Lack of Efficacy|1
4586939|NCT01490450|7431301|FG000|Period 2|Adverse Event|1
4586940|NCT01490450|7431302|FG001|Period 2|Adverse Event|1
4586941|NCT01490450|7431303|FG002|Period 2|Adverse Event|0
4586942|NCT01490450|7431304|FG003|Period 2|Adverse Event|1
4586943|NCT01490450|7431301|FG000|Period 2|Withdrawal by Subject|1
4586944|NCT01490450|7431302|FG001|Period 2|Withdrawal by Subject|0
4586945|NCT01490450|7431303|FG002|Period 2|Withdrawal by Subject|0
4586946|NCT01490450|7431304|FG003|Period 2|Withdrawal by Subject|0
4586947|NCT01490450|7431301|FG000|Period 2|Lost to Follow-up|0
4586948|NCT01490450|7431302|FG001|Period 2|Lost to Follow-up|0
4586949|NCT01490450|7431303|FG002|Period 2|Lost to Follow-up|0
4586950|NCT01490450|7431304|FG003|Period 2|Lost to Follow-up|2
4586951|NCT01490580|7431319|FG000|Overall Study|Parents withdrew consent|0
4586952|NCT01490580|7431320|FG001|Overall Study|Parents withdrew consent|2
4586953|NCT01490632|7431335|FG000|Part A: Initial Treatment Period|Adverse Event|0
4586954|NCT01490632|7431336|FG001|Part A: Initial Treatment Period|Adverse Event|0
4586955|NCT01490632|7431337|FG002|Part A: Initial Treatment Period|Adverse Event|2
4586956|NCT01490632|7431338|FG003|Part A: Initial Treatment Period|Adverse Event|4
4586957|NCT01490632|7431339|FG004|Part A: Initial Treatment Period|Adverse Event|4
4586958|NCT01490632|7431340|FG005|Part A: Initial Treatment Period|Adverse Event|0
4586959|NCT01490632|7431341|FG006|Part A: Initial Treatment Period|Adverse Event|0
4586960|NCT01490632|7431342|FG007|Part A: Initial Treatment Period|Adverse Event|0
4586961|NCT01490632|7431343|FG008|Part A: Initial Treatment Period|Adverse Event|0
4586962|NCT01490632|7431344|FG009|Part A: Initial Treatment Period|Adverse Event|0
4586963|NCT01490632|7431345|FG010|Part A: Initial Treatment Period|Adverse Event|0
4586964|NCT01490632|7431346|FG011|Part A: Initial Treatment Period|Adverse Event|0
4694323|NCT02605174|7605686|FG003|Overall Study|Lost to Follow-up|10
4694324|NCT02605174|7605687|FG004|Overall Study|Lost to Follow-up|20
4694325|NCT02605174|7605688|FG005|Overall Study|Lost to Follow-up|10
4694326|NCT02605174|7605689|FG006|Overall Study|Lost to Follow-up|29
4694327|NCT02605174|7605683|FG000|Overall Study|Protocol Violation|10
4586965|NCT01490632|7431347|FG012|Part A: Initial Treatment Period|Adverse Event|0
4586966|NCT01490632|7431348|FG013|Part A: Initial Treatment Period|Adverse Event|0
4586967|NCT01490632|7431349|FG014|Part A: Initial Treatment Period|Adverse Event|0
4586968|NCT01490632|7431350|FG015|Part A: Initial Treatment Period|Adverse Event|0
4586969|NCT01490632|7431351|FG016|Part A: Initial Treatment Period|Adverse Event|0
4586970|NCT01490632|7431352|FG017|Part A: Initial Treatment Period|Adverse Event|0
4586971|NCT01490632|7431353|FG018|Part A: Initial Treatment Period|Adverse Event|0
4586972|NCT01490632|7431354|FG019|Part A: Initial Treatment Period|Adverse Event|0
4586973|NCT01490632|7431335|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3
4586974|NCT01490632|7431336|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1
4586975|NCT01490632|7431337|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2
4586976|NCT01490632|7431338|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2
4586977|NCT01490632|7431339|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0
4586978|NCT01490632|7431340|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0
4586979|NCT01490632|7431341|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0
4586980|NCT01490632|7431342|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0
4586981|NCT01490632|7431343|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0
4586982|NCT01490632|7431344|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0
4586983|NCT01490632|7431345|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0
4586984|NCT01490632|7431346|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0
4586985|NCT01490632|7431347|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0
4586986|NCT01490632|7431348|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0
4586987|NCT01490632|7431349|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0
4586988|NCT01490632|7431350|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0
4371468|NCT04579393|7146062|FG000|Overall Study|Death|1
4586989|NCT01490632|7431351|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0
4586990|NCT01490632|7431352|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0
4371469|NCT04579393|7146063|FG001|Overall Study|Death|3
4447962|NCT00493038|7233197|FG000|Treatment|Withdrawal by Subject|11
4447963|NCT00493038|7233198|FG001|Treatment|Withdrawal by Subject|12
4447964|NCT00493038|7233197|FG000|Treatment|Other|0
4447965|NCT00493038|7233198|FG001|Treatment|Other|1
4447966|NCT00493038|7233197|FG000|Follow-up|Lost to Follow-up|1
4447967|NCT00493038|7233198|FG001|Follow-up|Lost to Follow-up|0
4447968|NCT00493220|7233218|FG000|Third Intervention|Withdrawal by Subject|1
4447969|NCT00493220|7233219|FG001|Third Intervention|Withdrawal by Subject|0
4447970|NCT00493220|7233220|FG002|Third Intervention|Withdrawal by Subject|0
4447971|NCT00493220|7233221|FG003|Third Intervention|Withdrawal by Subject|0
4447972|NCT00493220|7233222|FG004|Third Intervention|Withdrawal by Subject|0
4447973|NCT00493220|7233223|FG005|Third Intervention|Withdrawal by Subject|0
4447974|NCT00493246|7233241|FG000|Overall Study|Withdrawal by Subject|0
4586991|NCT01490632|7431353|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0
4586992|NCT01490632|7431354|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0
4586993|NCT01490632|7431335|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0
4586994|NCT01490632|7431336|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0
4586995|NCT01490632|7431337|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1
4586996|NCT01490632|7431338|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1
4586997|NCT01490632|7431339|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2
4586998|NCT01490632|7431340|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0
4586999|NCT01490632|7431341|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0
4587000|NCT01490632|7431342|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0
4587001|NCT01490632|7431343|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0
4587002|NCT01490632|7431344|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0
4587003|NCT01490632|7431345|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0
4587004|NCT01490632|7431346|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0
4587005|NCT01490632|7431347|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0
4587006|NCT01490632|7431348|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0
4587007|NCT01490632|7431349|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0
4587008|NCT01490632|7431350|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0
4587009|NCT01490632|7431351|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0
4587010|NCT01490632|7431352|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0
4587011|NCT01490632|7431353|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0
4587012|NCT01490632|7431354|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0
4587013|NCT01490632|7431335|FG000|Part A: Initial Treatment Period|Physician Decision|0
4447975|NCT00493246|7233242|FG001|Overall Study|Withdrawal by Subject|0
4447976|NCT00493246|7233243|FG002|Overall Study|Withdrawal by Subject|0
4447977|NCT00493246|7233244|FG003|Overall Study|Withdrawal by Subject|0
4447978|NCT00493246|7233245|FG004|Overall Study|Withdrawal by Subject|1
4447979|NCT00493246|7233246|FG005|Overall Study|Withdrawal by Subject|0
4447980|NCT00493246|7233247|FG006|Overall Study|Withdrawal by Subject|0
4447981|NCT00493246|7233248|FG007|Overall Study|Withdrawal by Subject|0
4447982|NCT00493246|7233241|FG000|Overall Study|No access to draw blood|0
4447983|NCT00493246|7233242|FG001|Overall Study|No access to draw blood|0
4447984|NCT00493246|7233243|FG002|Overall Study|No access to draw blood|0
4447985|NCT00493246|7233244|FG003|Overall Study|No access to draw blood|0
4447986|NCT00493246|7233245|FG004|Overall Study|No access to draw blood|0
4587014|NCT01490632|7431336|FG001|Part A: Initial Treatment Period|Physician Decision|1
4587015|NCT01490632|7431337|FG002|Part A: Initial Treatment Period|Physician Decision|0
4587016|NCT01490632|7431338|FG003|Part A: Initial Treatment Period|Physician Decision|1
4587017|NCT01490632|7431339|FG004|Part A: Initial Treatment Period|Physician Decision|0
4587018|NCT01490632|7431340|FG005|Part A: Initial Treatment Period|Physician Decision|0
4587019|NCT01490632|7431341|FG006|Part A: Initial Treatment Period|Physician Decision|0
4587020|NCT01490632|7431342|FG007|Part A: Initial Treatment Period|Physician Decision|0
4587021|NCT01490632|7431343|FG008|Part A: Initial Treatment Period|Physician Decision|0
4587022|NCT01490632|7431344|FG009|Part A: Initial Treatment Period|Physician Decision|0
4587023|NCT01490632|7431345|FG010|Part A: Initial Treatment Period|Physician Decision|0
4587024|NCT01490632|7431346|FG011|Part A: Initial Treatment Period|Physician Decision|0
4587025|NCT01490632|7431347|FG012|Part A: Initial Treatment Period|Physician Decision|0
4587026|NCT01490632|7431348|FG013|Part A: Initial Treatment Period|Physician Decision|0
4587027|NCT01490632|7431349|FG014|Part A: Initial Treatment Period|Physician Decision|0
4587028|NCT01490632|7431350|FG015|Part A: Initial Treatment Period|Physician Decision|0
4587029|NCT01490632|7431351|FG016|Part A: Initial Treatment Period|Physician Decision|0
4587030|NCT01490632|7431352|FG017|Part A: Initial Treatment Period|Physician Decision|0
4371470|NCT04325906|7146081|FG000|Overall Study|Withdrawal by Subject|2
4371471|NCT04325906|7146082|FG001|Overall Study|Withdrawal by Subject|0
4371476|NCT03679884|7146106|FG000|Overall Study|Other|12
4371477|NCT03679884|7146107|FG001|Overall Study|Other|12
4371478|NCT03679884|7146108|FG002|Overall Study|Other|12
4371479|NCT03679884|7146109|FG003|Overall Study|Other|7
4371480|NCT03679884|7146110|FG004|Overall Study|Other|8
4371481|NCT03679884|7146106|FG000|Overall Study|Lack of Efficacy|15
4371482|NCT03679884|7146107|FG001|Overall Study|Lack of Efficacy|29
4371483|NCT03679884|7146108|FG002|Overall Study|Lack of Efficacy|13
4371484|NCT03679884|7146109|FG003|Overall Study|Lack of Efficacy|29
4371485|NCT03679884|7146110|FG004|Overall Study|Lack of Efficacy|10
4371486|NCT03679884|7146106|FG000|Overall Study|Death|1
4371487|NCT03679884|7146107|FG001|Overall Study|Death|0
4371488|NCT03679884|7146108|FG002|Overall Study|Death|0
4371489|NCT03679884|7146109|FG003|Overall Study|Death|0
4371490|NCT03679884|7146110|FG004|Overall Study|Death|0
4371491|NCT03679884|7146106|FG000|Overall Study|Adverse Event|2
4371492|NCT03679884|7146107|FG001|Overall Study|Adverse Event|10
4371493|NCT03679884|7146108|FG002|Overall Study|Adverse Event|9
4371494|NCT03679884|7146109|FG003|Overall Study|Adverse Event|6
4371495|NCT03679884|7146110|FG004|Overall Study|Adverse Event|6
4371496|NCT03679884|7146106|FG000|Overall Study|Withdrawal by Subject|12
4371497|NCT03679884|7146107|FG001|Overall Study|Withdrawal by Subject|23
4371498|NCT03679884|7146108|FG002|Overall Study|Withdrawal by Subject|8
4371499|NCT03679884|7146109|FG003|Overall Study|Withdrawal by Subject|8
4371500|NCT03679884|7146110|FG004|Overall Study|Withdrawal by Subject|9
4371501|NCT03679884|7146106|FG000|Overall Study|Lost to Follow-up|1
4371502|NCT03679884|7146107|FG001|Overall Study|Lost to Follow-up|4
4371503|NCT03679884|7146108|FG002|Overall Study|Lost to Follow-up|2
4371504|NCT03679884|7146109|FG003|Overall Study|Lost to Follow-up|0
4371505|NCT03679884|7146110|FG004|Overall Study|Lost to Follow-up|3
4371506|NCT03653026|7146124|FG000|Part 1: Placebo-controlled Period|Adverse Event|5
4371507|NCT03653026|7146125|FG001|Part 1: Placebo-controlled Period|Adverse Event|6
4371508|NCT03653026|7146126|FG002|Part 1: Placebo-controlled Period|Adverse Event|0
4371509|NCT03653026|7146127|FG003|Part 1: Placebo-controlled Period|Adverse Event|0
4371510|NCT03653026|7146124|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6
4371511|NCT03653026|7146125|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4
4371512|NCT03653026|7146126|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0
4371513|NCT03653026|7146127|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0
4371514|NCT03653026|7146124|FG000|Part 1: Placebo-controlled Period|Other|0
4371515|NCT03653026|7146125|FG001|Part 1: Placebo-controlled Period|Other|3
4371516|NCT03653026|7146126|FG002|Part 1: Placebo-controlled Period|Other|0
4371517|NCT03653026|7146127|FG003|Part 1: Placebo-controlled Period|Other|0
4371518|NCT03653026|7146124|FG000|Part 2: Open-label Extension|Adverse Event|0
4371519|NCT03653026|7146125|FG001|Part 2: Open-label Extension|Adverse Event|0
4371520|NCT03653026|7146126|FG002|Part 2: Open-label Extension|Adverse Event|1
4371521|NCT03653026|7146127|FG003|Part 2: Open-label Extension|Adverse Event|1
4371522|NCT03653026|7146124|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0
4371523|NCT03653026|7146125|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0
4371524|NCT03653026|7146126|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1
4371525|NCT03653026|7146127|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2
4371526|NCT03653026|7146124|FG000|Part 2: Open-label Extension|Other|0
4371527|NCT03653026|7146125|FG001|Part 2: Open-label Extension|Other|0
4371528|NCT03653026|7146126|FG002|Part 2: Open-label Extension|Other|1
4371529|NCT03653026|7146127|FG003|Part 2: Open-label Extension|Other|2
4371530|NCT03553498|7146141|FG000|Overall Study|Missing primary outcome|1
4371531|NCT03553498|7146142|FG001|Overall Study|Missing primary outcome|2
4371532|NCT03505749|7146150|FG000|Overall Study|Lost to Follow-up|7
4371533|NCT03505749|7146151|FG001|Overall Study|Lost to Follow-up|11
4371534|NCT03505749|7146150|FG000|Overall Study|Withdrawal by Subject|6
4464941|NCT00606684|7255973|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
4587031|NCT01490632|7431353|FG018|Part A: Initial Treatment Period|Physician Decision|0
4587032|NCT01490632|7431354|FG019|Part A: Initial Treatment Period|Physician Decision|0
4587033|NCT01490632|7431335|FG000|Part A: Initial Treatment Period|Sponsor Decision|2
4587034|NCT01490632|7431336|FG001|Part A: Initial Treatment Period|Sponsor Decision|0
4587035|NCT01490632|7431337|FG002|Part A: Initial Treatment Period|Sponsor Decision|0
4587036|NCT01490632|7431338|FG003|Part A: Initial Treatment Period|Sponsor Decision|0
4587037|NCT01490632|7431339|FG004|Part A: Initial Treatment Period|Sponsor Decision|0
4587038|NCT01490632|7431340|FG005|Part A: Initial Treatment Period|Sponsor Decision|0
4587039|NCT01490632|7431341|FG006|Part A: Initial Treatment Period|Sponsor Decision|0
4587040|NCT01490632|7431342|FG007|Part A: Initial Treatment Period|Sponsor Decision|0
4587041|NCT01490632|7431343|FG008|Part A: Initial Treatment Period|Sponsor Decision|0
4587042|NCT01490632|7431344|FG009|Part A: Initial Treatment Period|Sponsor Decision|0
4587043|NCT01490632|7431345|FG010|Part A: Initial Treatment Period|Sponsor Decision|0
4587044|NCT01490632|7431346|FG011|Part A: Initial Treatment Period|Sponsor Decision|0
4587045|NCT01490632|7431347|FG012|Part A: Initial Treatment Period|Sponsor Decision|0
4587046|NCT01490632|7431348|FG013|Part A: Initial Treatment Period|Sponsor Decision|0
4587047|NCT01490632|7431349|FG014|Part A: Initial Treatment Period|Sponsor Decision|0
4587048|NCT01490632|7431350|FG015|Part A: Initial Treatment Period|Sponsor Decision|0
4587049|NCT01490632|7431351|FG016|Part A: Initial Treatment Period|Sponsor Decision|0
4587050|NCT01490632|7431352|FG017|Part A: Initial Treatment Period|Sponsor Decision|0
4587051|NCT01490632|7431353|FG018|Part A: Initial Treatment Period|Sponsor Decision|0
4587052|NCT01490632|7431354|FG019|Part A: Initial Treatment Period|Sponsor Decision|0
4587053|NCT01490632|7431335|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2
4587054|NCT01490632|7431336|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2
4587055|NCT01490632|7431337|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0
4587056|NCT01490632|7431338|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1
4587057|NCT01490632|7431339|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2
4587058|NCT01490632|7431340|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0
4587059|NCT01490632|7431341|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0
4587060|NCT01490632|7431342|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0
4587061|NCT01490632|7431343|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0
4587062|NCT01490632|7431344|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0
4587063|NCT01490632|7431345|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0
4587064|NCT01490632|7431346|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0
4587065|NCT01490632|7431347|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0
4694328|NCT02605174|7605684|FG001|Overall Study|Protocol Violation|4
4694329|NCT02605174|7605685|FG002|Overall Study|Protocol Violation|14
4694330|NCT02605174|7605686|FG003|Overall Study|Protocol Violation|6
4694331|NCT02605174|7605687|FG004|Overall Study|Protocol Violation|7
4694332|NCT02605174|7605688|FG005|Overall Study|Protocol Violation|7
4694333|NCT02605174|7605689|FG006|Overall Study|Protocol Violation|12
4694334|NCT02605174|7605683|FG000|Overall Study|Pregnancy|1
4694335|NCT02605174|7605684|FG001|Overall Study|Pregnancy|0
4371472|NCT04203667|7146092|FG000|Overall Study|Withdrawal by Subject|1
4371473|NCT04203667|7146092|FG000|Overall Study|Lost to Follow-up|1
4371474|NCT04203667|7146092|FG000|Overall Study|Death|1
4371475|NCT04203667|7146092|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1
4371535|NCT03505749|7146151|FG001|Overall Study|Withdrawal by Subject|0
4371536|NCT03505749|7146150|FG000|Overall Study|Discharged from treatment|3
4371537|NCT03505749|7146151|FG001|Overall Study|Discharged from treatment|6
4371538|NCT03472885|7146160|FG000|Overall Study|Adverse Event|1
4447987|NCT00493246|7233246|FG005|Overall Study|No access to draw blood|1
4447988|NCT00493246|7233247|FG006|Overall Study|No access to draw blood|0
4447989|NCT00493246|7233248|FG007|Overall Study|No access to draw blood|0
4447990|NCT00493246|7233241|FG000|Overall Study|Lost to Follow-up|0
4447991|NCT00493246|7233242|FG001|Overall Study|Lost to Follow-up|0
4447992|NCT00493246|7233243|FG002|Overall Study|Lost to Follow-up|0
4447993|NCT00493246|7233244|FG003|Overall Study|Lost to Follow-up|0
4447994|NCT00493246|7233245|FG004|Overall Study|Lost to Follow-up|0
4447995|NCT00493246|7233246|FG005|Overall Study|Lost to Follow-up|0
4447996|NCT00493246|7233247|FG006|Overall Study|Lost to Follow-up|1
4447997|NCT00493246|7233248|FG007|Overall Study|Lost to Follow-up|0
4447998|NCT00493285|7233272|FG000|Overall Study|Lost to Follow-up|0
4447999|NCT00493285|7233273|FG001|Overall Study|Lost to Follow-up|0
4448000|NCT00493285|7233274|FG002|Overall Study|Lost to Follow-up|0
4448001|NCT00493285|7233275|FG003|Overall Study|Lost to Follow-up|0
4448002|NCT00493285|7233276|FG004|Overall Study|Lost to Follow-up|1
4448003|NCT00493285|7233277|FG005|Overall Study|Lost to Follow-up|0
4694336|NCT02605174|7605685|FG002|Overall Study|Pregnancy|0
4694337|NCT02605174|7605686|FG003|Overall Study|Pregnancy|2
4694338|NCT02605174|7605687|FG004|Overall Study|Pregnancy|0
4694339|NCT02605174|7605688|FG005|Overall Study|Pregnancy|0
4694340|NCT02605174|7605689|FG006|Overall Study|Pregnancy|0
4694341|NCT02605174|7605683|FG000|Overall Study|Withdrawal by Subject|9
4694342|NCT02605174|7605684|FG001|Overall Study|Withdrawal by Subject|6
4694343|NCT02605174|7605685|FG002|Overall Study|Withdrawal by Subject|14
4694344|NCT02605174|7605686|FG003|Overall Study|Withdrawal by Subject|11
4694345|NCT02605174|7605687|FG004|Overall Study|Withdrawal by Subject|6
4587066|NCT01490632|7431348|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0
4587067|NCT01490632|7431349|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0
4587068|NCT01490632|7431350|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0
4587069|NCT01490632|7431351|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0
4587070|NCT01490632|7431352|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0
4587071|NCT01490632|7431353|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0
4587072|NCT01490632|7431354|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0
4587073|NCT01490632|7431335|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
4587074|NCT01490632|7431336|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
4587075|NCT01490632|7431337|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
4587076|NCT01490632|7431338|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
4587077|NCT01490632|7431339|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9
4587078|NCT01490632|7431340|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
4587079|NCT01490632|7431341|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
4587080|NCT01490632|7431342|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
4587081|NCT01490632|7431343|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
4587082|NCT01490632|7431344|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
4587083|NCT01490632|7431345|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
4587084|NCT01490632|7431346|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
4587085|NCT01490632|7431347|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
4587086|NCT01490632|7431348|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
4587087|NCT01490632|7431349|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
4587088|NCT01490632|7431350|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
4587089|NCT01490632|7431351|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
4587090|NCT01490632|7431352|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
4587091|NCT01490632|7431353|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
4587092|NCT01490632|7431354|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
4587093|NCT01490632|7431335|FG000|Part B: Extension or Step-Up Period|Adverse Event|0
4587094|NCT01490632|7431336|FG001|Part B: Extension or Step-Up Period|Adverse Event|0
4587095|NCT01490632|7431337|FG002|Part B: Extension or Step-Up Period|Adverse Event|0
4587096|NCT01490632|7431338|FG003|Part B: Extension or Step-Up Period|Adverse Event|0
4587097|NCT01490632|7431339|FG004|Part B: Extension or Step-Up Period|Adverse Event|0
4587098|NCT01490632|7431340|FG005|Part B: Extension or Step-Up Period|Adverse Event|2
4587099|NCT01490632|7431341|FG006|Part B: Extension or Step-Up Period|Adverse Event|2
4587100|NCT01490632|7431342|FG007|Part B: Extension or Step-Up Period|Adverse Event|0
4587101|NCT01490632|7431343|FG008|Part B: Extension or Step-Up Period|Adverse Event|0
4587102|NCT01490632|7431344|FG009|Part B: Extension or Step-Up Period|Adverse Event|2
4587103|NCT01490632|7431345|FG010|Part B: Extension or Step-Up Period|Adverse Event|3
4587104|NCT01490632|7431346|FG011|Part B: Extension or Step-Up Period|Adverse Event|1
4587105|NCT01490632|7431347|FG012|Part B: Extension or Step-Up Period|Adverse Event|0
4587106|NCT01490632|7431348|FG013|Part B: Extension or Step-Up Period|Adverse Event|0
4587107|NCT01490632|7431349|FG014|Part B: Extension or Step-Up Period|Adverse Event|0
4587108|NCT01490632|7431350|FG015|Part B: Extension or Step-Up Period|Adverse Event|0
4587109|NCT01490632|7431351|FG016|Part B: Extension or Step-Up Period|Adverse Event|0
4587110|NCT01490632|7431352|FG017|Part B: Extension or Step-Up Period|Adverse Event|0
4587111|NCT01490632|7431353|FG018|Part B: Extension or Step-Up Period|Adverse Event|0
4587112|NCT01490632|7431354|FG019|Part B: Extension or Step-Up Period|Adverse Event|0
4587113|NCT01490632|7431335|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0
4587114|NCT01490632|7431336|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0
4587115|NCT01490632|7431337|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0
4587116|NCT01490632|7431338|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0
4587117|NCT01490632|7431339|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0
4587118|NCT01490632|7431340|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0
4587119|NCT01490632|7431341|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1
4587120|NCT01490632|7431342|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0
4371539|NCT03143153|7146176|FG000|Pre-Treatment|Participant request to discontinue study treatment|0
4371540|NCT03143153|7146177|FG001|Pre-Treatment|Participant request to discontinue study treatment|0
4371541|NCT03143153|7146178|FG002|Pre-Treatment|Participant request to discontinue study treatment|2
4371542|NCT03143153|7146176|FG000|Pre-Treatment|Participant withdrew consent|0
4371543|NCT03143153|7146177|FG001|Pre-Treatment|Participant withdrew consent|1
4371544|NCT03143153|7146178|FG002|Pre-Treatment|Participant withdrew consent|12
4371545|NCT03143153|7146176|FG000|Pre-Treatment|Participant no longer meets study criteria|0
4371546|NCT03143153|7146177|FG001|Pre-Treatment|Participant no longer meets study criteria|4
4371547|NCT03143153|7146178|FG002|Pre-Treatment|Participant no longer meets study criteria|2
4371548|NCT03143153|7146176|FG000|Pre-Treatment|Other Reasons|1
4371549|NCT03143153|7146177|FG001|Pre-Treatment|Other Reasons|2
4371550|NCT03143153|7146178|FG002|Pre-Treatment|Other Reasons|1
4371551|NCT03143153|7146176|FG000|Pre-Treatment|Disease Progression|1
4371552|NCT03143153|7146177|FG001|Pre-Treatment|Disease Progression|1
4587121|NCT01490632|7431343|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1
4587122|NCT01490632|7431344|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3
4587123|NCT01490632|7431345|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1
4587124|NCT01490632|7431346|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0
4587125|NCT01490632|7431347|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0
4587126|NCT01490632|7431348|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0
4587127|NCT01490632|7431349|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0
4587128|NCT01490632|7431350|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0
4587129|NCT01490632|7431351|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0
4587130|NCT01490632|7431352|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0
4587131|NCT01490632|7431353|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0
4587132|NCT01490632|7431354|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0
4587133|NCT01490632|7431335|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0
4587134|NCT01490632|7431336|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0
4587135|NCT01490632|7431337|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0
4587136|NCT01490632|7431338|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0
4587137|NCT01490632|7431339|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0
4587138|NCT01490632|7431340|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0
4587139|NCT01490632|7431341|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2
4587140|NCT01490632|7431342|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0
4587141|NCT01490632|7431343|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0
4587142|NCT01490632|7431344|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1
4587143|NCT01490632|7431345|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0
4587144|NCT01490632|7431346|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0
4587145|NCT01490632|7431347|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0
4587146|NCT01490632|7431348|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0
4587147|NCT01490632|7431349|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0
4587148|NCT01490632|7431350|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0
4587149|NCT01490632|7431351|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0
4587150|NCT01490632|7431352|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0
4587151|NCT01490632|7431353|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0
4587152|NCT01490632|7431354|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0
4587153|NCT01490632|7431335|FG000|Part B: Extension or Step-Up Period|Physician Decision|0
4587154|NCT01490632|7431336|FG001|Part B: Extension or Step-Up Period|Physician Decision|0
4587155|NCT01490632|7431337|FG002|Part B: Extension or Step-Up Period|Physician Decision|0
4587156|NCT01490632|7431338|FG003|Part B: Extension or Step-Up Period|Physician Decision|0
4587157|NCT01490632|7431339|FG004|Part B: Extension or Step-Up Period|Physician Decision|0
4587158|NCT01490632|7431340|FG005|Part B: Extension or Step-Up Period|Physician Decision|0
4587159|NCT01490632|7431341|FG006|Part B: Extension or Step-Up Period|Physician Decision|1
4587160|NCT01490632|7431342|FG007|Part B: Extension or Step-Up Period|Physician Decision|0
4587161|NCT01490632|7431343|FG008|Part B: Extension or Step-Up Period|Physician Decision|0
4587162|NCT01490632|7431344|FG009|Part B: Extension or Step-Up Period|Physician Decision|0
4587163|NCT01490632|7431345|FG010|Part B: Extension or Step-Up Period|Physician Decision|0
4587164|NCT01490632|7431346|FG011|Part B: Extension or Step-Up Period|Physician Decision|0
4587165|NCT01490632|7431347|FG012|Part B: Extension or Step-Up Period|Physician Decision|0
4587166|NCT01490632|7431348|FG013|Part B: Extension or Step-Up Period|Physician Decision|0
4587167|NCT01490632|7431349|FG014|Part B: Extension or Step-Up Period|Physician Decision|0
4587168|NCT01490632|7431350|FG015|Part B: Extension or Step-Up Period|Physician Decision|0
4587169|NCT01490632|7431351|FG016|Part B: Extension or Step-Up Period|Physician Decision|0
4587170|NCT01490632|7431352|FG017|Part B: Extension or Step-Up Period|Physician Decision|0
4587171|NCT01490632|7431353|FG018|Part B: Extension or Step-Up Period|Physician Decision|0
4587172|NCT01490632|7431354|FG019|Part B: Extension or Step-Up Period|Physician Decision|0
4587173|NCT01490632|7431335|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0
4587174|NCT01490632|7431336|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0
4587175|NCT01490632|7431337|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0
4587176|NCT01490632|7431338|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0
4587177|NCT01490632|7431339|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0
4587178|NCT01490632|7431340|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1
4587179|NCT01490632|7431341|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0
4587180|NCT01490632|7431342|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0
4587181|NCT01490632|7431343|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0
4587182|NCT01490632|7431344|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0
4587183|NCT01490632|7431345|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0
4587184|NCT01490632|7431346|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0
4587185|NCT01490632|7431347|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0
4587186|NCT01490632|7431348|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0
4587187|NCT01490632|7431349|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0
4587188|NCT01490632|7431350|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0
4587189|NCT01490632|7431351|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0
4587190|NCT01490632|7431352|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0
4587191|NCT01490632|7431353|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0
4587192|NCT01490632|7431354|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0
4587193|NCT01490632|7431335|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
4587194|NCT01490632|7431336|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
4587195|NCT01490632|7431337|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
4587196|NCT01490632|7431338|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
4587197|NCT01490632|7431339|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
4587198|NCT01490632|7431340|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
4587199|NCT01490632|7431341|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
4587200|NCT01490632|7431342|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
4587201|NCT01490632|7431343|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
4587202|NCT01490632|7431344|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
4587203|NCT01490632|7431345|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
4587204|NCT01490632|7431346|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2
4587205|NCT01490632|7431347|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
4587206|NCT01490632|7431348|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
4587207|NCT01490632|7431349|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
4587208|NCT01490632|7431350|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
4587209|NCT01490632|7431351|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
4587210|NCT01490632|7431352|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
4587211|NCT01490632|7431353|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
4587212|NCT01490632|7431354|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
4587213|NCT01490632|7431335|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
4587214|NCT01490632|7431336|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
4587215|NCT01490632|7431337|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
4587216|NCT01490632|7431338|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
4587217|NCT01490632|7431339|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
4587218|NCT01490632|7431340|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1
4587219|NCT01490632|7431341|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6
4587220|NCT01490632|7431342|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6
4587221|NCT01490632|7431343|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8
4371553|NCT03143153|7146178|FG002|Pre-Treatment|Disease Progression|2
4371554|NCT03143153|7146176|FG000|Pre-Treatment|Adverse event unrelated to study drug|1
4371555|NCT03143153|7146177|FG001|Pre-Treatment|Adverse event unrelated to study drug|3
4371556|NCT03143153|7146178|FG002|Pre-Treatment|Adverse event unrelated to study drug|1
4371557|NCT03143153|7146176|FG000|Treatment|Disease progression|174
4371558|NCT03143153|7146177|FG001|Treatment|Disease progression|184
4371559|NCT03143153|7146178|FG002|Treatment|Disease progression|193
4371560|NCT03143153|7146176|FG000|Treatment|Study drug toxicity|59
4371561|NCT03143153|7146177|FG001|Treatment|Study drug toxicity|33
4371562|NCT03143153|7146178|FG002|Treatment|Study drug toxicity|40
4371563|NCT03143153|7146176|FG000|Treatment|Death|5
4371564|NCT03143153|7146177|FG001|Treatment|Death|3
4371565|NCT03143153|7146178|FG002|Treatment|Death|4
4371566|NCT03143153|7146176|FG000|Treatment|Adverse event unrelated to study drug|19
4371567|NCT03143153|7146177|FG001|Treatment|Adverse event unrelated to study drug|28
4371568|NCT03143153|7146178|FG002|Treatment|Adverse event unrelated to study drug|12
4371569|NCT03143153|7146176|FG000|Treatment|Participant request to discontinue study treatment|13
4371570|NCT03143153|7146177|FG001|Treatment|Participant request to discontinue study treatment|15
4371571|NCT03143153|7146178|FG002|Treatment|Participant request to discontinue study treatment|20
4371572|NCT03143153|7146176|FG000|Treatment|Participant withdrew consent|3
4371573|NCT03143153|7146177|FG001|Treatment|Participant withdrew consent|4
4371574|NCT03143153|7146178|FG002|Treatment|Participant withdrew consent|12
4371575|NCT03143153|7146176|FG000|Treatment|Pregnancy|1
4371576|NCT03143153|7146177|FG001|Treatment|Pregnancy|0
4371577|NCT03143153|7146178|FG002|Treatment|Pregnancy|0
4371578|NCT03143153|7146176|FG000|Treatment|Maximum clinical benefit|1
4371579|NCT03143153|7146177|FG001|Treatment|Maximum clinical benefit|3
4371580|NCT03143153|7146178|FG002|Treatment|Maximum clinical benefit|4
4371581|NCT03143153|7146176|FG000|Treatment|Completed treatment as per Protocol|13
4371582|NCT03143153|7146177|FG001|Treatment|Completed treatment as per Protocol|8
4371583|NCT03143153|7146178|FG002|Treatment|Completed treatment as per Protocol|0
4371584|NCT03143153|7146176|FG000|Treatment|Other reasons|12
4371585|NCT03143153|7146177|FG001|Treatment|Other reasons|7
4371586|NCT03143153|7146178|FG002|Treatment|Other reasons|15
4371587|NCT03143153|7146176|FG000|Treatment|Not reported|1
4371588|NCT03143153|7146177|FG001|Treatment|Not reported|0
4371589|NCT03143153|7146178|FG002|Treatment|Not reported|0
4371590|NCT03118570|7146191|FG000|Overall Study|Adverse Event|2
4371591|NCT03118570|7146192|FG001|Overall Study|Adverse Event|0
4371592|NCT03118570|7146193|FG002|Overall Study|Adverse Event|0
4371593|NCT03118570|7146194|FG003|Overall Study|Adverse Event|0
4371594|NCT03118570|7146195|FG004|Overall Study|Adverse Event|3
4371595|NCT03118570|7146191|FG000|Overall Study|Withdrawal by Subject|0
4587222|NCT01490632|7431344|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19
4587223|NCT01490632|7431345|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16
4587224|NCT01490632|7431346|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5
4587225|NCT01490632|7431347|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
4587226|NCT01490632|7431348|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
4587227|NCT01490632|7431349|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
4587228|NCT01490632|7431350|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
4587229|NCT01490632|7431351|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
4694346|NCT02605174|7605688|FG005|Overall Study|Withdrawal by Subject|4
4694347|NCT02605174|7605689|FG006|Overall Study|Withdrawal by Subject|15
4694348|NCT02605174|7605683|FG000|Overall Study|Physician Decision|2
4371596|NCT03118570|7146192|FG001|Overall Study|Withdrawal by Subject|1
4371597|NCT03118570|7146193|FG002|Overall Study|Withdrawal by Subject|4
4371598|NCT03118570|7146194|FG003|Overall Study|Withdrawal by Subject|0
4371599|NCT03118570|7146195|FG004|Overall Study|Withdrawal by Subject|1
4371600|NCT03118570|7146191|FG000|Overall Study|Lost to Follow-up|2
4371601|NCT03118570|7146192|FG001|Overall Study|Lost to Follow-up|3
4371602|NCT03118570|7146193|FG002|Overall Study|Lost to Follow-up|1
4371603|NCT03118570|7146194|FG003|Overall Study|Lost to Follow-up|0
4371604|NCT03118570|7146195|FG004|Overall Study|Lost to Follow-up|1
4371605|NCT03118570|7146191|FG000|Overall Study|Other, Not Specified|1
4371606|NCT03118570|7146192|FG001|Overall Study|Other, Not Specified|3
4371607|NCT03118570|7146193|FG002|Overall Study|Other, Not Specified|0
4371608|NCT03118570|7146194|FG003|Overall Study|Other, Not Specified|0
4371609|NCT03118570|7146195|FG004|Overall Study|Other, Not Specified|0
4371610|NCT03094416|7146208|FG000|Run-in|Screening failure|8
4371611|NCT03094416|7146208|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8
4371612|NCT03094416|7146208|FG000|Run-in|Withdrawal by Subject|3
4371613|NCT03094416|7146208|FG000|Treatment Period|Withdrawal by Subject|2
4448004|NCT00493311|7233293|FG000|Overall Study|Need for rescue medication|2
4448005|NCT00493311|7233294|FG001|Overall Study|Need for rescue medication|2
4448006|NCT00493454|7233300|FG000|Overall Study|Withdrawal by Subject|1
4448007|NCT00493467|7233304|FG000|Overall Study|Death|1
4448008|NCT00493636|7233310|FG000|Overall Study|Withdrawal by Subject|1
4448009|NCT00493636|7233311|FG001|Overall Study|Withdrawal by Subject|0
4448010|NCT00493636|7233310|FG000|Overall Study|Disease progression/recurrence/relapse|0
4448011|NCT00493636|7233311|FG001|Overall Study|Disease progression/recurrence/relapse|1
4448012|NCT00493636|7233310|FG000|Overall Study|Mis-randomization|1
4448013|NCT00493636|7233311|FG001|Overall Study|Mis-randomization|1
4464942|NCT00606684|7255974|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
4464943|NCT00606684|7255975|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
4464944|NCT00606684|7255969|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5
4464945|NCT00606684|7255970|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0
4464946|NCT00606684|7255971|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0
4464947|NCT00606684|7255972|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0
4464948|NCT00606684|7255973|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0
4464949|NCT00606684|7255974|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0
4464950|NCT00606684|7255975|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0
4464951|NCT00606684|7255969|FG000|2-week Single-Blind Run-in Period|Adverse Event|2
4464952|NCT00606684|7255970|FG001|2-week Single-Blind Run-in Period|Adverse Event|0
4464953|NCT00606684|7255971|FG002|2-week Single-Blind Run-in Period|Adverse Event|0
4464954|NCT00606684|7255972|FG003|2-week Single-Blind Run-in Period|Adverse Event|0
4464955|NCT00606684|7255973|FG004|2-week Single-Blind Run-in Period|Adverse Event|0
4464956|NCT00606684|7255974|FG005|2-week Single-Blind Run-in Period|Adverse Event|0
4464957|NCT00606684|7255975|FG006|2-week Single-Blind Run-in Period|Adverse Event|0
4464958|NCT00606684|7255969|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1
4464959|NCT00606684|7255970|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
4464960|NCT00606684|7255971|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
4464961|NCT00606684|7255972|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
4464962|NCT00606684|7255973|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
4464963|NCT00606684|7255974|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
4464964|NCT00606684|7255975|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
4464965|NCT00606684|7255969|FG000|Double-Blind Treatment Period|Adverse Event|0
4464966|NCT00606684|7255970|FG001|Double-Blind Treatment Period|Adverse Event|3
4464967|NCT00606684|7255971|FG002|Double-Blind Treatment Period|Adverse Event|2
4464968|NCT00606684|7255972|FG003|Double-Blind Treatment Period|Adverse Event|4
4464969|NCT00606684|7255973|FG004|Double-Blind Treatment Period|Adverse Event|2
4464970|NCT00606684|7255974|FG005|Double-Blind Treatment Period|Adverse Event|0
4464971|NCT00606684|7255975|FG006|Double-Blind Treatment Period|Adverse Event|1
4464972|NCT00606684|7255969|FG000|Double-Blind Treatment Period|Lack of Efficacy|0
4464973|NCT00606684|7255970|FG001|Double-Blind Treatment Period|Lack of Efficacy|1
4464974|NCT00606684|7255971|FG002|Double-Blind Treatment Period|Lack of Efficacy|0
4587230|NCT01490632|7431352|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
4371614|NCT02811861|7146216|FG000|Overall Study|Radiological Disease Progression|123
4371615|NCT02811861|7146217|FG001|Overall Study|Radiological Disease Progression|97
4371616|NCT02811861|7146218|FG002|Overall Study|Radiological Disease Progression|174
4371617|NCT02811861|7146216|FG000|Overall Study|Clinical Disease Progression|20
4371618|NCT02811861|7146217|FG001|Overall Study|Clinical Disease Progression|19
4371619|NCT02811861|7146218|FG002|Overall Study|Clinical Disease Progression|22
4371620|NCT02811861|7146216|FG000|Overall Study|Adverse Event|63
4371621|NCT02811861|7146217|FG001|Overall Study|Adverse Event|60
4371622|NCT02811861|7146218|FG002|Overall Study|Adverse Event|41
4371623|NCT02811861|7146216|FG000|Overall Study|Lost to Follow-up|0
4371624|NCT02811861|7146217|FG001|Overall Study|Lost to Follow-up|0
4371625|NCT02811861|7146218|FG002|Overall Study|Lost to Follow-up|1
4371626|NCT02811861|7146216|FG000|Overall Study|Subject Choice|29
4371627|NCT02811861|7146217|FG001|Overall Study|Subject Choice|17
4371628|NCT02811861|7146218|FG002|Overall Study|Subject Choice|23
4371629|NCT02811861|7146216|FG000|Overall Study|Withdrawal by Subject|4
4371630|NCT02811861|7146217|FG001|Overall Study|Withdrawal by Subject|4
4371631|NCT02811861|7146218|FG002|Overall Study|Withdrawal by Subject|9
4371632|NCT02811861|7146216|FG000|Overall Study|Other|4
4371633|NCT02811861|7146217|FG001|Overall Study|Other|13
4371634|NCT02811861|7146218|FG002|Overall Study|Other|3
4371635|NCT02811861|7146216|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112
4371636|NCT02811861|7146217|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142
4371637|NCT02811861|7146218|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67
4371638|NCT02811861|7146216|FG000|Overall Study|Randomized but not treated|2
4371639|NCT02811861|7146217|FG001|Overall Study|Randomized but not treated|3
4371640|NCT02811861|7146218|FG002|Overall Study|Randomized but not treated|17
4371641|NCT02607930|7146246|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25
4371642|NCT02607930|7146247|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19
4371643|NCT02607930|7146248|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0
4371644|NCT02607930|7146249|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0
4371645|NCT02607930|7146246|FG000|Double-Blinded Treatment Phase|Withdrew consent|14
4371646|NCT02607930|7146247|FG001|Double-Blinded Treatment Phase|Withdrew consent|18
4371647|NCT02607930|7146248|FG002|Double-Blinded Treatment Phase|Withdrew consent|0
4371648|NCT02607930|7146249|FG003|Double-Blinded Treatment Phase|Withdrew consent|0
4371649|NCT02607930|7146246|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6
4371650|NCT02607930|7146247|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3
4371651|NCT02607930|7146248|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0
4371652|NCT02607930|7146249|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0
4371653|NCT02607930|7146246|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3
4371654|NCT02607930|7146247|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5
4371655|NCT02607930|7146248|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0
4371656|NCT02607930|7146249|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0
4371657|NCT02607930|7146246|FG000|Double-Blinded Treatment Phase|Protocol Violation|2
4371658|NCT02607930|7146247|FG001|Double-Blinded Treatment Phase|Protocol Violation|3
4371659|NCT02607930|7146248|FG002|Double-Blinded Treatment Phase|Protocol Violation|0
4371660|NCT02607930|7146249|FG003|Double-Blinded Treatment Phase|Protocol Violation|0
4371661|NCT02607930|7146246|FG000|Double-Blinded Treatment Phase|Adverse Event|0
4371662|NCT02607930|7146247|FG001|Double-Blinded Treatment Phase|Adverse Event|4
4371663|NCT02607930|7146248|FG002|Double-Blinded Treatment Phase|Adverse Event|0
4371664|NCT02607930|7146249|FG003|Double-Blinded Treatment Phase|Adverse Event|0
4371665|NCT02607930|7146246|FG000|Double-Blinded Treatment Phase|Death|2
4371666|NCT02607930|7146247|FG001|Double-Blinded Treatment Phase|Death|1
4371667|NCT02607930|7146248|FG002|Double-Blinded Treatment Phase|Death|0
4371668|NCT02607930|7146249|FG003|Double-Blinded Treatment Phase|Death|0
4371669|NCT02607930|7146246|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2
4371670|NCT02607930|7146247|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0
4371671|NCT02607930|7146248|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0
4371672|NCT02607930|7146249|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0
4371673|NCT02607930|7146246|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0
4371674|NCT02607930|7146247|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0
4371675|NCT02607930|7146248|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15
4371676|NCT02607930|7146249|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10
4371677|NCT02607930|7146246|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0
4371678|NCT02607930|7146247|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0
4371679|NCT02607930|7146248|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10
4371680|NCT02607930|7146249|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13
4371681|NCT02607930|7146246|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0
4371682|NCT02607930|7146247|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0
4371683|NCT02607930|7146248|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2
4448014|NCT00493649|7233317|FG000|Overall Study|Adverse Event|44
4587231|NCT01490632|7431353|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
4587232|NCT01490632|7431354|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
4587233|NCT01490632|7431335|FG000|Part C: Washout or Step-Down Period|Adverse Event|0
4587234|NCT01490632|7431336|FG001|Part C: Washout or Step-Down Period|Adverse Event|0
4587235|NCT01490632|7431337|FG002|Part C: Washout or Step-Down Period|Adverse Event|0
4587236|NCT01490632|7431338|FG003|Part C: Washout or Step-Down Period|Adverse Event|0
4587237|NCT01490632|7431339|FG004|Part C: Washout or Step-Down Period|Adverse Event|0
4587238|NCT01490632|7431340|FG005|Part C: Washout or Step-Down Period|Adverse Event|0
4587239|NCT01490632|7431341|FG006|Part C: Washout or Step-Down Period|Adverse Event|0
4587240|NCT01490632|7431342|FG007|Part C: Washout or Step-Down Period|Adverse Event|0
4587241|NCT01490632|7431343|FG008|Part C: Washout or Step-Down Period|Adverse Event|0
4587242|NCT01490632|7431344|FG009|Part C: Washout or Step-Down Period|Adverse Event|0
4587243|NCT01490632|7431345|FG010|Part C: Washout or Step-Down Period|Adverse Event|0
4587244|NCT01490632|7431346|FG011|Part C: Washout or Step-Down Period|Adverse Event|0
4587245|NCT01490632|7431347|FG012|Part C: Washout or Step-Down Period|Adverse Event|0
4587246|NCT01490632|7431348|FG013|Part C: Washout or Step-Down Period|Adverse Event|0
4587247|NCT01490632|7431349|FG014|Part C: Washout or Step-Down Period|Adverse Event|2
4587248|NCT01490632|7431350|FG015|Part C: Washout or Step-Down Period|Adverse Event|2
4587249|NCT01490632|7431351|FG016|Part C: Washout or Step-Down Period|Adverse Event|0
4587250|NCT01490632|7431352|FG017|Part C: Washout or Step-Down Period|Adverse Event|0
4587251|NCT01490632|7431353|FG018|Part C: Washout or Step-Down Period|Adverse Event|0
4587252|NCT01490632|7431354|FG019|Part C: Washout or Step-Down Period|Adverse Event|0
4587253|NCT01490632|7431335|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0
4587254|NCT01490632|7431336|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0
4587255|NCT01490632|7431337|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0
4587256|NCT01490632|7431338|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0
4587257|NCT01490632|7431339|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0
4587258|NCT01490632|7431340|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0
4587259|NCT01490632|7431341|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0
4587260|NCT01490632|7431342|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0
4587261|NCT01490632|7431343|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0
4587262|NCT01490632|7431344|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0
4587263|NCT01490632|7431345|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0
4587264|NCT01490632|7431346|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0
4593592|NCT01553591|7442150|FG000|Overall Study|Protocol Violation|3
4694349|NCT02605174|7605684|FG001|Overall Study|Physician Decision|0
4694350|NCT02605174|7605685|FG002|Overall Study|Physician Decision|0
4694351|NCT02605174|7605686|FG003|Overall Study|Physician Decision|0
4371684|NCT02607930|7146249|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5
4371685|NCT02607930|7146246|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0
4371686|NCT02607930|7146247|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0
4371687|NCT02607930|7146248|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4
4371688|NCT02607930|7146249|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2
4371689|NCT02607930|7146246|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0
4371690|NCT02607930|7146247|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0
4371691|NCT02607930|7146248|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1
4371692|NCT02607930|7146249|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1
4371693|NCT02607930|7146246|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0
4371694|NCT02607930|7146247|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0
4371695|NCT02607930|7146248|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1
4371696|NCT02607930|7146249|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1
4371697|NCT02607930|7146246|FG000|Open-Label B/F/TAF Extension Phase|Death|0
4694352|NCT02605174|7605687|FG004|Overall Study|Physician Decision|0
4694353|NCT02605174|7605688|FG005|Overall Study|Physician Decision|0
4694354|NCT02605174|7605689|FG006|Overall Study|Physician Decision|3
4694355|NCT02605174|7605683|FG000|Overall Study|Randomization Failure|22
4694356|NCT02605174|7605684|FG001|Overall Study|Randomization Failure|6
4694357|NCT02605174|7605685|FG002|Overall Study|Randomization Failure|20
4694358|NCT02605174|7605686|FG003|Overall Study|Randomization Failure|7
4694359|NCT02605174|7605687|FG004|Overall Study|Randomization Failure|16
4694360|NCT02605174|7605688|FG005|Overall Study|Randomization Failure|11
4694361|NCT02605174|7605689|FG006|Overall Study|Randomization Failure|30
4694362|NCT02605447|7605748|FG000|Overall Study|Death|66
4694363|NCT02605447|7605748|FG000|Overall Study|Physician Decision|1
4694364|NCT02605447|7605748|FG000|Overall Study|Lost to Follow-up|24
4694365|NCT02605447|7605748|FG000|Overall Study|Withdrawal by Subject|10
4694366|NCT02605447|7605748|FG000|Overall Study|Not disclosed|1
4694367|NCT02605642|7605755|FG000|Overall Study|Other|11
4694368|NCT02605642|7605756|FG001|Overall Study|Other|1
4694369|NCT02605642|7605755|FG000|Overall Study|Participant non-compliance|2
4694370|NCT02605642|7605756|FG001|Overall Study|Participant non-compliance|4
4694371|NCT02605642|7605755|FG000|Overall Study|Physician Decision|10
4371698|NCT02607930|7146247|FG001|Open-Label B/F/TAF Extension Phase|Death|0
4371699|NCT02607930|7146248|FG002|Open-Label B/F/TAF Extension Phase|Death|0
4371700|NCT02607930|7146249|FG003|Open-Label B/F/TAF Extension Phase|Death|1
4448015|NCT00493649|7233317|FG000|Overall Study|Patient Request|21
4587265|NCT01490632|7431347|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0
4587266|NCT01490632|7431348|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1
4587267|NCT01490632|7431349|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0
4587268|NCT01490632|7431350|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0
4587269|NCT01490632|7431351|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0
4587270|NCT01490632|7431352|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0
4587271|NCT01490632|7431353|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0
4587272|NCT01490632|7431354|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0
4587273|NCT01490632|7431335|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
4587274|NCT01490632|7431336|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
4587275|NCT01490632|7431337|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
4587276|NCT01490632|7431338|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
4371701|NCT02607930|7146246|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0
4371702|NCT02607930|7146247|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0
4371703|NCT02607930|7146248|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1
4371704|NCT02607930|7146249|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0
4371705|NCT02580058|7146262|FG000|Overall Study|Lost to Follow-up|4
4371706|NCT02580058|7146263|FG001|Overall Study|Lost to Follow-up|5
4371707|NCT02580058|7146264|FG002|Overall Study|Lost to Follow-up|4
4371708|NCT02580058|7146262|FG000|Overall Study|Ongoing|51
4371709|NCT02580058|7146263|FG001|Overall Study|Ongoing|55
4371710|NCT02580058|7146264|FG002|Overall Study|Ongoing|46
4371711|NCT02580058|7146262|FG000|Overall Study|Withdrawal by Subject|24
4371712|NCT02580058|7146263|FG001|Overall Study|Withdrawal by Subject|26
4371713|NCT02580058|7146264|FG002|Overall Study|Withdrawal by Subject|36
4371714|NCT02578680|7146274|FG000|Overall Study|Death|124
4371715|NCT02578680|7146275|FG001|Overall Study|Death|104
4371716|NCT02578680|7146274|FG000|Overall Study|Protocol Violation|1
4371717|NCT02578680|7146275|FG001|Overall Study|Protocol Violation|1
4371718|NCT02578680|7146274|FG000|Overall Study|Withdrawal by Parent/Guardian|1
4371719|NCT02578680|7146275|FG001|Overall Study|Withdrawal by Parent/Guardian|0
4371720|NCT02578680|7146274|FG000|Overall Study|Withdrawal by Subject|8
4371721|NCT02578680|7146275|FG001|Overall Study|Withdrawal by Subject|5
4371722|NCT02578680|7146274|FG000|Overall Study|Ongoing in Study|276
4371723|NCT02578680|7146275|FG001|Overall Study|Ongoing in Study|96
4448016|NCT00493649|7233317|FG000|Overall Study|Investigator Request|2
4448017|NCT00493649|7233317|FG000|Overall Study|Disease Progression|1
4448018|NCT00493649|7233317|FG000|Overall Study|Lost to Follow-up|1
4448019|NCT00493649|7233317|FG000|Overall Study|Other|13
4448020|NCT00493779|7233324|FG000|Overall Study|Logistical issue at site|1
4448021|NCT00493974|7233338|FG000|Overall Study|Death|1
4448022|NCT00493974|7233339|FG001|Overall Study|Death|2
4448023|NCT00493974|7233338|FG000|Overall Study|Withdrawal by Subject|8
4448024|NCT00493974|7233339|FG001|Overall Study|Withdrawal by Subject|6
4448025|NCT00493974|7233338|FG000|Overall Study|Lost to Follow-up|4
4448026|NCT00493974|7233339|FG001|Overall Study|Lost to Follow-up|6
4448027|NCT00494013|7233347|FG000|Overall Study|Adverse Event|0
4448028|NCT00494013|7233348|FG001|Overall Study|Adverse Event|1
4448029|NCT00494013|7233347|FG000|Overall Study|Entry Criteria Not Met|1
4448030|NCT00494013|7233348|FG001|Overall Study|Entry Criteria Not Met|4
4448031|NCT00494013|7233347|FG000|Overall Study|Lost to Follow-up|5
4448032|NCT00494013|7233348|FG001|Overall Study|Lost to Follow-up|6
4448033|NCT00494013|7233347|FG000|Overall Study|Physician Decision|3
4448034|NCT00494013|7233348|FG001|Overall Study|Physician Decision|5
4448035|NCT00494013|7233347|FG000|Overall Study|Protocol Violation|8
4448036|NCT00494013|7233348|FG001|Overall Study|Protocol Violation|5
4448037|NCT00494013|7233347|FG000|Overall Study|Withdrawal by Subject|13
4448038|NCT00494013|7233348|FG001|Overall Study|Withdrawal by Subject|14
4448039|NCT00494013|7233347|FG000|Overall Study|Sponsor Decision|0
4448040|NCT00494013|7233348|FG001|Overall Study|Sponsor Decision|1
4448041|NCT00494026|7233354|FG000|Overall Study|Sponsor Decision|4
4448042|NCT00494091|7233360|FG000|Overall Study|Death|5
4448043|NCT00494091|7233361|FG001|Overall Study|Death|54
4448044|NCT00494091|7233360|FG000|Overall Study|Lost to Follow-up|0
4448045|NCT00494091|7233361|FG001|Overall Study|Lost to Follow-up|4
4448046|NCT00494091|7233360|FG000|Overall Study|Other|1
4448047|NCT00494091|7233361|FG001|Overall Study|Other|11
4448048|NCT00494091|7233360|FG000|Overall Study|Withdrawal by Subject|0
4448049|NCT00494091|7233361|FG001|Overall Study|Withdrawal by Subject|7
4448050|NCT00494221|7233388|FG000|Overall Study|Death|15
4448051|NCT00494221|7233389|FG001|Overall Study|Death|9
4448052|NCT00494221|7233390|FG002|Overall Study|Death|14
4448053|NCT00494221|7233388|FG000|Overall Study|Withdrawal by Subject|1
4448054|NCT00494221|7233389|FG001|Overall Study|Withdrawal by Subject|2
4448055|NCT00494221|7233390|FG002|Overall Study|Withdrawal by Subject|0
4448056|NCT00494299|7233400|FG000|Overall Study|Adverse Event|93
4448057|NCT00494299|7233401|FG001|Overall Study|Adverse Event|13
4448058|NCT00494299|7233400|FG000|Overall Study|Lost to Follow-up|1
4448059|NCT00494299|7233401|FG001|Overall Study|Lost to Follow-up|0
4448060|NCT00494299|7233400|FG000|Overall Study|Physician Decision|0
4448061|NCT00494299|7233401|FG001|Overall Study|Physician Decision|2
4448062|NCT00494299|7233400|FG000|Overall Study|Protocol Violation|1
4448063|NCT00494299|7233401|FG001|Overall Study|Protocol Violation|2
4587277|NCT01490632|7431339|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
4587278|NCT01490632|7431340|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
4587279|NCT01490632|7431341|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
4587280|NCT01490632|7431342|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
4587281|NCT01490632|7431343|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
4587282|NCT01490632|7431344|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
4587283|NCT01490632|7431345|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
4587284|NCT01490632|7431346|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
4587285|NCT01490632|7431347|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
4371724|NCT02476201|7146285|FG000|Overall Study|Unable to program MPP|9
4371725|NCT02476201|7146285|FG000|Overall Study|Study echo not performed|5
4371726|NCT02476201|7146285|FG000|Overall Study|Adverse Event|4
4371727|NCT02476201|7146285|FG000|Overall Study|Death|2
4371728|NCT02476201|7146285|FG000|Overall Study|Lost to Follow-up|2
4371729|NCT02476201|7146285|FG000|Overall Study|MPP programmed to OFF|2
4371730|NCT02476201|7146285|FG000|Overall Study|Withdrawal by Subject|1
4371731|NCT02476201|7146285|FG000|Overall Study|Unsuccessful implant|1
4371732|NCT02454933|7146292|FG000|Overall Study|Progressive disease|7
4371733|NCT02454933|7146293|FG001|Overall Study|Progressive disease|5
4371734|NCT02454933|7146292|FG000|Overall Study|Adverse Event|1
4371735|NCT02454933|7146293|FG001|Overall Study|Adverse Event|1
4371736|NCT02454933|7146292|FG000|Overall Study|Withdrawal by Subject|0
4371737|NCT02454933|7146293|FG001|Overall Study|Withdrawal by Subject|2
4371738|NCT02337751|7146300|FG000|Overall Study|Pretreatment Event/Adverse Event|2
4371739|NCT02337751|7146301|FG001|Overall Study|Pretreatment Event/Adverse Event|3
4371740|NCT02337751|7146300|FG000|Overall Study|Voluntary Withdrawal|6
4371741|NCT02337751|7146301|FG001|Overall Study|Voluntary Withdrawal|8
4371742|NCT02337751|7146300|FG000|Overall Study|Lack of Efficacy|2
4371743|NCT02337751|7146301|FG001|Overall Study|Lack of Efficacy|5
4371744|NCT02337751|7146300|FG000|Overall Study|Investigator's Judgement|1
4371745|NCT02337751|7146301|FG001|Overall Study|Investigator's Judgement|0
4371746|NCT02337725|7146310|FG000|Overall Study|Pretreatment Event/AE before Treatment|0
4371747|NCT02337725|7146311|FG001|Overall Study|Pretreatment Event/AE before Treatment|1
4371748|NCT02337725|7146310|FG000|Overall Study|Pretreatment Event/AE in Treatment|8
4371749|NCT02337725|7146311|FG001|Overall Study|Pretreatment Event/AE in Treatment|3
4371750|NCT02337725|7146310|FG000|Overall Study|Major Protocol Deviation|0
4371751|NCT02337725|7146311|FG001|Overall Study|Major Protocol Deviation|1
4371752|NCT02337725|7146310|FG000|Overall Study|Voluntary Withdrawal|14
4371753|NCT02337725|7146311|FG001|Overall Study|Voluntary Withdrawal|3
4371754|NCT02337725|7146310|FG000|Overall Study|Lack of Efficacy|4
4371755|NCT02337725|7146311|FG001|Overall Study|Lack of Efficacy|0
4448064|NCT00494299|7233400|FG000|Overall Study|Withdrawal by Subject|8
4448065|NCT00494299|7233401|FG001|Overall Study|Withdrawal by Subject|3
4448066|NCT00494299|7233400|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109
4448067|NCT00494299|7233401|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185
4448068|NCT00494299|7233400|FG000|Overall Study|Participant Did Not Take Study Drug|0
4448069|NCT00494299|7233401|FG001|Overall Study|Participant Did Not Take Study Drug|2
4448070|NCT00494299|7233400|FG000|Overall Study|Site Closed by Sponsor|6
4448071|NCT00494299|7233401|FG001|Overall Study|Site Closed by Sponsor|0
4448072|NCT00494299|7233400|FG000|Overall Study|Protocol Driven Decision Point|11
4448073|NCT00494299|7233401|FG001|Overall Study|Protocol Driven Decision Point|22
4448074|NCT00494442|7233409|FG000|Overall Study|Death|1
4448075|NCT00494442|7233410|FG001|Overall Study|Death|1
4448076|NCT00494442|7233409|FG000|Overall Study|Lack of Efficacy|16
4448077|NCT00494442|7233410|FG001|Overall Study|Lack of Efficacy|10
4448078|NCT00494442|7233409|FG000|Overall Study|Adverse Event|0
4448079|NCT00494442|7233410|FG001|Overall Study|Adverse Event|2
4448080|NCT00494442|7233409|FG000|Overall Study|Physician Decision|0
4448081|NCT00494442|7233410|FG001|Overall Study|Physician Decision|1
4448082|NCT00494442|7233409|FG000|Overall Study|Non-compliance|0
4448083|NCT00494442|7233410|FG001|Overall Study|Non-compliance|1
4448084|NCT00494442|7233409|FG000|Overall Study|Intercurrent illness|0
4448085|NCT00494442|7233410|FG001|Overall Study|Intercurrent illness|1
4448086|NCT00494481|7233418|FG000|Overall Study|Condition under investigation worsened|11
4448087|NCT00494481|7233419|FG001|Overall Study|Condition under investigation worsened|13
4448088|NCT00494481|7233418|FG000|Overall Study|Adverse Event|15
4448089|NCT00494481|7233419|FG001|Overall Study|Adverse Event|11
4448090|NCT00494481|7233418|FG000|Overall Study|Other|1
4448091|NCT00494481|7233419|FG001|Overall Study|Other|0
4448092|NCT00494481|7233418|FG000|Overall Study|Never received IP|2
4448093|NCT00494481|7233419|FG001|Overall Study|Never received IP|0
4448094|NCT00494507|7233438|FG000|Double-Blind Phase|Adverse Event|2
4448095|NCT00494507|7233439|FG001|Double-Blind Phase|Adverse Event|0
4448096|NCT00494507|7233440|FG002|Double-Blind Phase|Adverse Event|1
4448097|NCT00494507|7233441|FG003|Double-Blind Phase|Adverse Event|0
4448098|NCT00494507|7233438|FG000|Double-Blind Phase|Withdrawal by Subject|1
4448099|NCT00494507|7233439|FG001|Double-Blind Phase|Withdrawal by Subject|0
4448100|NCT00494507|7233440|FG002|Double-Blind Phase|Withdrawal by Subject|0
4448101|NCT00494507|7233441|FG003|Double-Blind Phase|Withdrawal by Subject|0
4448102|NCT00494507|7233438|FG000|Double-Blind Phase|Subject Non-compliance|0
4448103|NCT00494507|7233439|FG001|Double-Blind Phase|Subject Non-compliance|0
4587286|NCT01490632|7431348|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
4587287|NCT01490632|7431349|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2
4587288|NCT01490632|7431350|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1
4371756|NCT02332655|7146317|FG000|Overall Study|Lack of Efficacy|1
4371757|NCT02184195|7146323|FG000|Overall Study|Patient decision|3
4371758|NCT02184195|7146324|FG001|Overall Study|Patient decision|1
4371759|NCT02184195|7146323|FG000|Overall Study|Eligibility criteria not fulfilled|0
4371760|NCT02184195|7146324|FG001|Overall Study|Eligibility criteria not fulfilled|1
4371761|NCT02184195|7146323|FG000|Overall Study|Death|40
4371762|NCT02184195|7146324|FG001|Overall Study|Death|29
4371763|NCT02184195|7146323|FG000|Overall Study|Lost to Follow-up|0
4371764|NCT02184195|7146324|FG001|Overall Study|Lost to Follow-up|2
4371765|NCT02184195|7146323|FG000|Overall Study|Other|0
4371766|NCT02184195|7146324|FG001|Overall Study|Other|2
4371767|NCT01994382|7146378|FG000|Overall Study|Informed consent withdrawn|0
4371768|NCT01994382|7146379|FG001|Overall Study|Informed consent withdrawn|0
4371769|NCT01994382|7146380|FG002|Overall Study|Informed consent withdrawn|0
4371770|NCT01994382|7146381|FG003|Overall Study|Informed consent withdrawn|0
4371771|NCT01994382|7146382|FG004|Overall Study|Informed consent withdrawn|0
4371772|NCT01994382|7146383|FG005|Overall Study|Informed consent withdrawn|0
4371773|NCT01994382|7146384|FG006|Overall Study|Informed consent withdrawn|1
4371774|NCT01994382|7146385|FG007|Overall Study|Informed consent withdrawn|0
4371775|NCT01994382|7146386|FG008|Overall Study|Informed consent withdrawn|0
4371776|NCT01994382|7146387|FG009|Overall Study|Informed consent withdrawn|0
4371777|NCT01994382|7146388|FG010|Overall Study|Informed consent withdrawn|0
4371778|NCT01994382|7146389|FG011|Overall Study|Informed consent withdrawn|0
4371779|NCT01994382|7146390|FG012|Overall Study|Informed consent withdrawn|0
4371780|NCT01994382|7146391|FG013|Overall Study|Informed consent withdrawn|0
4371781|NCT01994382|7146392|FG014|Overall Study|Informed consent withdrawn|0
4371782|NCT01994382|7146393|FG015|Overall Study|Informed consent withdrawn|0
4371783|NCT01994382|7146394|FG016|Overall Study|Informed consent withdrawn|0
4371784|NCT01994382|7146378|FG000|Overall Study|Progressive disease|3
4371785|NCT01994382|7146379|FG001|Overall Study|Progressive disease|4
4371786|NCT01994382|7146380|FG002|Overall Study|Progressive disease|4
4371787|NCT01994382|7146381|FG003|Overall Study|Progressive disease|3
4371788|NCT01994382|7146382|FG004|Overall Study|Progressive disease|2
4371789|NCT01994382|7146383|FG005|Overall Study|Progressive disease|3
4371790|NCT01994382|7146384|FG006|Overall Study|Progressive disease|3
4371791|NCT01994382|7146385|FG007|Overall Study|Progressive disease|6
4371792|NCT01994382|7146386|FG008|Overall Study|Progressive disease|2
4371793|NCT01994382|7146387|FG009|Overall Study|Progressive disease|2
4371794|NCT01994382|7146388|FG010|Overall Study|Progressive disease|13
4371795|NCT01994382|7146389|FG011|Overall Study|Progressive disease|8
4371796|NCT01994382|7146390|FG012|Overall Study|Progressive disease|7
4371797|NCT01994382|7146391|FG013|Overall Study|Progressive disease|3
4371798|NCT01994382|7146392|FG014|Overall Study|Progressive disease|6
4371799|NCT01994382|7146393|FG015|Overall Study|Progressive disease|44
4371800|NCT01994382|7146394|FG016|Overall Study|Progressive disease|28
4371801|NCT01994382|7146378|FG000|Overall Study|Physician Decision|0
4371802|NCT01994382|7146379|FG001|Overall Study|Physician Decision|1
4371803|NCT01994382|7146380|FG002|Overall Study|Physician Decision|0
4371804|NCT01994382|7146381|FG003|Overall Study|Physician Decision|0
4371805|NCT01994382|7146382|FG004|Overall Study|Physician Decision|0
4371806|NCT01994382|7146383|FG005|Overall Study|Physician Decision|0
4371807|NCT01994382|7146384|FG006|Overall Study|Physician Decision|0
4371808|NCT01994382|7146385|FG007|Overall Study|Physician Decision|0
4371809|NCT01994382|7146386|FG008|Overall Study|Physician Decision|0
4371810|NCT01994382|7146387|FG009|Overall Study|Physician Decision|0
4371811|NCT01994382|7146388|FG010|Overall Study|Physician Decision|3
4371812|NCT01994382|7146389|FG011|Overall Study|Physician Decision|1
4371813|NCT01994382|7146390|FG012|Overall Study|Physician Decision|1
4371814|NCT01994382|7146391|FG013|Overall Study|Physician Decision|0
4371815|NCT01994382|7146392|FG014|Overall Study|Physician Decision|1
4371816|NCT01994382|7146393|FG015|Overall Study|Physician Decision|4
4371817|NCT01994382|7146394|FG016|Overall Study|Physician Decision|2
4371818|NCT01994382|7146378|FG000|Overall Study|Death|0
4371819|NCT01994382|7146379|FG001|Overall Study|Death|0
4371820|NCT01994382|7146380|FG002|Overall Study|Death|0
4371821|NCT01994382|7146381|FG003|Overall Study|Death|0
4371822|NCT01994382|7146382|FG004|Overall Study|Death|1
4371823|NCT01994382|7146383|FG005|Overall Study|Death|0
4371824|NCT01994382|7146384|FG006|Overall Study|Death|0
4371825|NCT01994382|7146385|FG007|Overall Study|Death|0
4371826|NCT01994382|7146386|FG008|Overall Study|Death|1
4371827|NCT01994382|7146387|FG009|Overall Study|Death|1
4371828|NCT01994382|7146388|FG010|Overall Study|Death|0
4371829|NCT01994382|7146389|FG011|Overall Study|Death|0
4371830|NCT01994382|7146390|FG012|Overall Study|Death|0
4371831|NCT01994382|7146391|FG013|Overall Study|Death|0
4371832|NCT01994382|7146392|FG014|Overall Study|Death|0
4371833|NCT01994382|7146393|FG015|Overall Study|Death|1
4371834|NCT01994382|7146394|FG016|Overall Study|Death|0
4371835|NCT01994382|7146378|FG000|Overall Study|Adverse Event|0
4371836|NCT01994382|7146379|FG001|Overall Study|Adverse Event|1
4371837|NCT01994382|7146380|FG002|Overall Study|Adverse Event|2
4371838|NCT01994382|7146381|FG003|Overall Study|Adverse Event|0
4371839|NCT01994382|7146382|FG004|Overall Study|Adverse Event|0
4587289|NCT01490632|7431351|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
4587290|NCT01490632|7431352|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
4587291|NCT01490632|7431353|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
4587292|NCT01490632|7431354|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
4587293|NCT01490632|7431335|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
4587294|NCT01490632|7431336|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
4587295|NCT01490632|7431337|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
4587296|NCT01490632|7431338|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
4587297|NCT01490632|7431339|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
4371840|NCT01994382|7146383|FG005|Overall Study|Adverse Event|0
4371841|NCT01994382|7146384|FG006|Overall Study|Adverse Event|0
4371842|NCT01994382|7146385|FG007|Overall Study|Adverse Event|0
4371843|NCT01994382|7146386|FG008|Overall Study|Adverse Event|0
4371844|NCT01994382|7146387|FG009|Overall Study|Adverse Event|0
4371845|NCT01994382|7146388|FG010|Overall Study|Adverse Event|15
4371846|NCT01994382|7146389|FG011|Overall Study|Adverse Event|2
4371847|NCT01994382|7146390|FG012|Overall Study|Adverse Event|7
4371848|NCT01994382|7146391|FG013|Overall Study|Adverse Event|3
4371849|NCT01994382|7146392|FG014|Overall Study|Adverse Event|17
4371850|NCT01994382|7146393|FG015|Overall Study|Adverse Event|6
4371851|NCT01994382|7146394|FG016|Overall Study|Adverse Event|3
4371852|NCT01994382|7146378|FG000|Overall Study|Other than specified|0
4371853|NCT01994382|7146379|FG001|Overall Study|Other than specified|0
4371854|NCT01994382|7146380|FG002|Overall Study|Other than specified|0
4371855|NCT01994382|7146381|FG003|Overall Study|Other than specified|0
4371856|NCT01994382|7146382|FG004|Overall Study|Other than specified|0
4371857|NCT01994382|7146383|FG005|Overall Study|Other than specified|0
4371858|NCT01994382|7146384|FG006|Overall Study|Other than specified|0
4371859|NCT01994382|7146385|FG007|Overall Study|Other than specified|0
4371860|NCT01994382|7146386|FG008|Overall Study|Other than specified|0
4371861|NCT01994382|7146387|FG009|Overall Study|Other than specified|0
4371862|NCT01994382|7146388|FG010|Overall Study|Other than specified|2
4371863|NCT01994382|7146389|FG011|Overall Study|Other than specified|0
4371864|NCT01994382|7146390|FG012|Overall Study|Other than specified|2
4371865|NCT01994382|7146391|FG013|Overall Study|Other than specified|0
4371866|NCT01994382|7146392|FG014|Overall Study|Other than specified|0
4371867|NCT01994382|7146393|FG015|Overall Study|Other than specified|4
4371868|NCT01994382|7146394|FG016|Overall Study|Other than specified|4
4371869|NCT01994382|7146378|FG000|Overall Study|Withdrawal by Subject|0
4371870|NCT01994382|7146379|FG001|Overall Study|Withdrawal by Subject|0
4371871|NCT01994382|7146380|FG002|Overall Study|Withdrawal by Subject|0
4371872|NCT01994382|7146381|FG003|Overall Study|Withdrawal by Subject|0
4371873|NCT01994382|7146382|FG004|Overall Study|Withdrawal by Subject|0
4371874|NCT01994382|7146383|FG005|Overall Study|Withdrawal by Subject|0
4371875|NCT01994382|7146384|FG006|Overall Study|Withdrawal by Subject|0
4371876|NCT01994382|7146385|FG007|Overall Study|Withdrawal by Subject|0
4371877|NCT01994382|7146386|FG008|Overall Study|Withdrawal by Subject|0
4371878|NCT01994382|7146387|FG009|Overall Study|Withdrawal by Subject|0
4371879|NCT01994382|7146388|FG010|Overall Study|Withdrawal by Subject|6
4371880|NCT01994382|7146389|FG011|Overall Study|Withdrawal by Subject|0
4371881|NCT01994382|7146390|FG012|Overall Study|Withdrawal by Subject|2
4371882|NCT01994382|7146391|FG013|Overall Study|Withdrawal by Subject|0
4371883|NCT01994382|7146392|FG014|Overall Study|Withdrawal by Subject|4
4371884|NCT01994382|7146393|FG015|Overall Study|Withdrawal by Subject|3
4371885|NCT01994382|7146394|FG016|Overall Study|Withdrawal by Subject|0
4371886|NCT01994382|7146378|FG000|Overall Study|Lost to Follow-up|0
4371887|NCT01994382|7146379|FG001|Overall Study|Lost to Follow-up|0
4371888|NCT01994382|7146380|FG002|Overall Study|Lost to Follow-up|0
4371889|NCT01994382|7146381|FG003|Overall Study|Lost to Follow-up|0
4371890|NCT01994382|7146382|FG004|Overall Study|Lost to Follow-up|0
4371891|NCT01994382|7146383|FG005|Overall Study|Lost to Follow-up|0
4371892|NCT01994382|7146384|FG006|Overall Study|Lost to Follow-up|0
4371893|NCT01994382|7146385|FG007|Overall Study|Lost to Follow-up|0
4371894|NCT01994382|7146386|FG008|Overall Study|Lost to Follow-up|0
4371895|NCT01994382|7146387|FG009|Overall Study|Lost to Follow-up|0
4371896|NCT01994382|7146388|FG010|Overall Study|Lost to Follow-up|1
4371897|NCT01994382|7146389|FG011|Overall Study|Lost to Follow-up|0
4371898|NCT01994382|7146390|FG012|Overall Study|Lost to Follow-up|0
4371899|NCT01994382|7146391|FG013|Overall Study|Lost to Follow-up|0
4371900|NCT01994382|7146392|FG014|Overall Study|Lost to Follow-up|0
4371901|NCT01994382|7146393|FG015|Overall Study|Lost to Follow-up|0
4371902|NCT01994382|7146394|FG016|Overall Study|Lost to Follow-up|0
4371903|NCT01994382|7146378|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0
4371904|NCT01994382|7146379|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0
4371905|NCT01994382|7146380|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0
4371906|NCT01994382|7146381|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0
4371907|NCT01994382|7146382|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0
4371908|NCT01994382|7146383|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0
4587298|NCT01490632|7431340|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
4587299|NCT01490632|7431341|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
4694372|NCT02605642|7605756|FG001|Overall Study|Physician Decision|0
4371909|NCT01994382|7146384|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0
4371910|NCT01994382|7146385|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0
4371911|NCT01994382|7146386|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0
4371912|NCT01994382|7146387|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0
4371913|NCT01994382|7146388|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2
4371914|NCT01994382|7146389|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0
4371915|NCT01994382|7146390|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7
4371916|NCT01994382|7146391|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0
4371917|NCT01994382|7146392|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0
4371918|NCT01994382|7146393|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3
4694373|NCT02605642|7605755|FG000|Overall Study|Lost to Follow-up|12
4694374|NCT02605642|7605756|FG001|Overall Study|Lost to Follow-up|1
4694375|NCT02605642|7605755|FG000|Overall Study|Adverse Event|14
4694376|NCT02605642|7605756|FG001|Overall Study|Adverse Event|2
4694377|NCT02605642|7605755|FG000|Overall Study|Withdrawal by Subject|23
4694378|NCT02605642|7605756|FG001|Overall Study|Withdrawal by Subject|2
4694379|NCT02605642|7605755|FG000|Overall Study|Lack of response|24
4694380|NCT02605642|7605756|FG001|Overall Study|Lack of response|11
4694381|NCT02605837|7605764|FG000|Overall Study|Adverse Event|3
4694382|NCT02605837|7605765|FG001|Overall Study|Adverse Event|1
4694383|NCT02605837|7605764|FG000|Overall Study|Non-Compliance with Study Drug|0
4694384|NCT02605837|7605765|FG001|Overall Study|Non-Compliance with Study Drug|1
4694385|NCT02605837|7605764|FG000|Overall Study|Withdrawal by Subject|8
4694386|NCT02605837|7605765|FG001|Overall Study|Withdrawal by Subject|8
4694387|NCT02605837|7605764|FG000|Overall Study|Physician Decision|0
4694388|NCT02605837|7605765|FG001|Overall Study|Physician Decision|1
4694389|NCT02605928|7605794|FG000|Overall Study|Model tuning phase|28
4694390|NCT02605928|7605794|FG000|Overall Study|Lack of Efficacy|5
4694391|NCT02605954|7605800|FG000|Overall Study|Adverse Event|5
4694392|NCT02605954|7605801|FG001|Overall Study|Adverse Event|1
4694393|NCT02605954|7605800|FG000|Overall Study|Investigator's Discretion|1
4694394|NCT02605954|7605801|FG001|Overall Study|Investigator's Discretion|0
4694395|NCT02605954|7605800|FG000|Overall Study|Non-Compliance with Study Drug|1
4694396|NCT02605954|7605801|FG001|Overall Study|Non-Compliance with Study Drug|0
4694397|NCT02605954|7605800|FG000|Overall Study|Withdrew Consent|2
4694398|NCT02605954|7605801|FG001|Overall Study|Withdrew Consent|2
4694399|NCT02605954|7605800|FG000|Overall Study|Lost to Follow-up|3
4694400|NCT02605954|7605801|FG001|Overall Study|Lost to Follow-up|0
4694401|NCT02605954|7605800|FG000|Overall Study|Randomized but not treated|0
4694402|NCT02605954|7605801|FG001|Overall Study|Randomized but not treated|1
4694403|NCT02606253|7605813|FG000|Overall Study|Adverse Event|2
4694404|NCT02606253|7605814|FG001|Overall Study|Adverse Event|0
4694405|NCT02606253|7605815|FG002|Overall Study|Adverse Event|0
4694406|NCT02606253|7605813|FG000|Overall Study|Protocol Violation|2
4694407|NCT02606253|7605814|FG001|Overall Study|Protocol Violation|1
4371919|NCT01994382|7146394|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2
4371920|NCT01994382|7146378|FG000|Overall Study|Protocol violation/noncompliance|0
4371921|NCT01994382|7146379|FG001|Overall Study|Protocol violation/noncompliance|0
4371922|NCT01994382|7146380|FG002|Overall Study|Protocol violation/noncompliance|0
4371923|NCT01994382|7146381|FG003|Overall Study|Protocol violation/noncompliance|0
4371924|NCT01994382|7146382|FG004|Overall Study|Protocol violation/noncompliance|0
4371925|NCT01994382|7146383|FG005|Overall Study|Protocol violation/noncompliance|0
4371926|NCT01994382|7146384|FG006|Overall Study|Protocol violation/noncompliance|0
4371927|NCT01994382|7146385|FG007|Overall Study|Protocol violation/noncompliance|0
4371928|NCT01994382|7146386|FG008|Overall Study|Protocol violation/noncompliance|0
4371929|NCT01994382|7146387|FG009|Overall Study|Protocol violation/noncompliance|0
4371930|NCT01994382|7146388|FG010|Overall Study|Protocol violation/noncompliance|0
4371931|NCT01994382|7146389|FG011|Overall Study|Protocol violation/noncompliance|1
4371932|NCT01994382|7146390|FG012|Overall Study|Protocol violation/noncompliance|0
4371933|NCT01994382|7146391|FG013|Overall Study|Protocol violation/noncompliance|0
4371934|NCT01994382|7146392|FG014|Overall Study|Protocol violation/noncompliance|0
4694408|NCT02606253|7605815|FG002|Overall Study|Protocol Violation|0
4694409|NCT02606253|7605813|FG000|Overall Study|Physician Decision|1
4694410|NCT02606253|7605814|FG001|Overall Study|Physician Decision|1
4694411|NCT02606253|7605815|FG002|Overall Study|Physician Decision|0
4694412|NCT02606643|7605845|FG000|Overall Study|did not meet inclusion criteria|1
4694413|NCT02606643|7605846|FG001|Overall Study|did not meet inclusion criteria|3
4694414|NCT02606877|7605874|FG000|Overall Study|Adverse Event|3
4694415|NCT02606877|7605875|FG001|Overall Study|Adverse Event|0
4694416|NCT02606877|7605874|FG000|Overall Study|Non-compliance with protocol|0
4694417|NCT02606877|7605875|FG001|Overall Study|Non-compliance with protocol|1
4694418|NCT02606877|7605874|FG000|Overall Study|Other than listed above|1
4694419|NCT02606877|7605875|FG001|Overall Study|Other than listed above|0
4587300|NCT01490632|7431342|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
4587301|NCT01490632|7431343|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
4587302|NCT01490632|7431344|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
4587303|NCT01490632|7431345|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
4587304|NCT01490632|7431346|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
4587305|NCT01490632|7431347|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5
4587306|NCT01490632|7431348|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9
4587307|NCT01490632|7431349|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14
4587308|NCT01490632|7431350|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34
4587309|NCT01490632|7431351|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
4587310|NCT01490632|7431352|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
4587311|NCT01490632|7431353|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
4587312|NCT01490632|7431354|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
4587313|NCT01490632|7431335|FG000|Part D: Re-Treatment Period|Adverse Event|0
4587314|NCT01490632|7431336|FG001|Part D: Re-Treatment Period|Adverse Event|0
4587315|NCT01490632|7431337|FG002|Part D: Re-Treatment Period|Adverse Event|0
4587316|NCT01490632|7431338|FG003|Part D: Re-Treatment Period|Adverse Event|0
4587317|NCT01490632|7431339|FG004|Part D: Re-Treatment Period|Adverse Event|0
4587318|NCT01490632|7431340|FG005|Part D: Re-Treatment Period|Adverse Event|0
4587319|NCT01490632|7431341|FG006|Part D: Re-Treatment Period|Adverse Event|0
4587320|NCT01490632|7431342|FG007|Part D: Re-Treatment Period|Adverse Event|0
4587321|NCT01490632|7431343|FG008|Part D: Re-Treatment Period|Adverse Event|0
4587322|NCT01490632|7431344|FG009|Part D: Re-Treatment Period|Adverse Event|0
4587323|NCT01490632|7431345|FG010|Part D: Re-Treatment Period|Adverse Event|0
4694420|NCT02607228|7605904|FG000|Overall Study|Progressive Disease|4
4371935|NCT01994382|7146393|FG015|Overall Study|Protocol violation/noncompliance|0
4371936|NCT01994382|7146394|FG016|Overall Study|Protocol violation/noncompliance|2
4371937|NCT01994382|7146378|FG000|Overall Study|Rolled over to Phase 2a|0
4371938|NCT01994382|7146379|FG001|Overall Study|Rolled over to Phase 2a|0
4371939|NCT01994382|7146380|FG002|Overall Study|Rolled over to Phase 2a|1
4371940|NCT01994382|7146381|FG003|Overall Study|Rolled over to Phase 2a|0
4371941|NCT01994382|7146382|FG004|Overall Study|Rolled over to Phase 2a|0
4371942|NCT01994382|7146383|FG005|Overall Study|Rolled over to Phase 2a|0
4371943|NCT01994382|7146384|FG006|Overall Study|Rolled over to Phase 2a|0
4371944|NCT01994382|7146385|FG007|Overall Study|Rolled over to Phase 2a|0
4371945|NCT01994382|7146386|FG008|Overall Study|Rolled over to Phase 2a|0
4371946|NCT01994382|7146387|FG009|Overall Study|Rolled over to Phase 2a|2
4371947|NCT01994382|7146388|FG010|Overall Study|Rolled over to Phase 2a|0
4371948|NCT01994382|7146389|FG011|Overall Study|Rolled over to Phase 2a|0
4371949|NCT01994382|7146390|FG012|Overall Study|Rolled over to Phase 2a|0
4371950|NCT01994382|7146391|FG013|Overall Study|Rolled over to Phase 2a|0
4371951|NCT01994382|7146392|FG014|Overall Study|Rolled over to Phase 2a|0
4371952|NCT01994382|7146393|FG015|Overall Study|Rolled over to Phase 2a|0
4371953|NCT01994382|7146394|FG016|Overall Study|Rolled over to Phase 2a|0
4448104|NCT00494507|7233440|FG002|Double-Blind Phase|Subject Non-compliance|1
4448105|NCT00494507|7233441|FG003|Double-Blind Phase|Subject Non-compliance|0
4448106|NCT00494507|7233438|FG000|Double-Blind Phase|Negative DNA test|0
4448107|NCT00494507|7233439|FG001|Double-Blind Phase|Negative DNA test|0
4448108|NCT00494507|7233440|FG002|Double-Blind Phase|Negative DNA test|0
4448109|NCT00494507|7233441|FG003|Double-Blind Phase|Negative DNA test|1
4448110|NCT00494507|7233438|FG000|Open-Label Phase|Adverse Event|0
4448111|NCT00494507|7233439|FG001|Open-Label Phase|Adverse Event|1
4448112|NCT00494507|7233440|FG002|Open-Label Phase|Adverse Event|5
4448113|NCT00494507|7233441|FG003|Open-Label Phase|Adverse Event|3
4448114|NCT00494507|7233438|FG000|Open-Label Phase|Worsening Disease|0
4448115|NCT00494507|7233439|FG001|Open-Label Phase|Worsening Disease|0
4448116|NCT00494507|7233440|FG002|Open-Label Phase|Worsening Disease|0
4448117|NCT00494507|7233441|FG003|Open-Label Phase|Worsening Disease|2
4448118|NCT00494676|7233465|FG000|Allocation|Withdrawal by Subject|2
4448119|NCT00494676|7233466|FG001|Allocation|Withdrawal by Subject|4
4448120|NCT00494676|7233465|FG000|First Intervention|Withdrawal by Subject|1
4448121|NCT00494676|7233466|FG001|First Intervention|Withdrawal by Subject|3
4448122|NCT00494676|7233465|FG000|Second Intervention|Withdrawal by Subject|1
4448123|NCT00494676|7233466|FG001|Second Intervention|Withdrawal by Subject|1
4448124|NCT00494780|7233474|FG000|Overall Study|Adverse Event|1
4448125|NCT00494780|7233475|FG001|Overall Study|Adverse Event|0
4448126|NCT00494780|7233474|FG000|Overall Study|Withdrew before Dosed|0
4448127|NCT00494780|7233475|FG001|Overall Study|Withdrew before Dosed|1
4448128|NCT00494780|7233474|FG000|Overall Study|Progression of Study Disease|7
4448129|NCT00494780|7233475|FG001|Overall Study|Progression of Study Disease|8
4448130|NCT00494780|7233474|FG000|Overall Study|New Treatment|2
4448131|NCT00494780|7233475|FG001|Overall Study|New Treatment|2
4448132|NCT00494780|7233474|FG000|Overall Study|Non-compliance|1
4448133|NCT00494780|7233475|FG001|Overall Study|Non-compliance|0
4448134|NCT00494780|7233474|FG000|Overall Study|Residual Tumour Mass|0
4371954|NCT01896531|7146439|FG000|Overall Study|Death|57
4371955|NCT01896531|7146440|FG001|Overall Study|Death|59
4371956|NCT01896531|7146439|FG000|Overall Study|Lost to Follow-up|3
4371957|NCT01896531|7146440|FG001|Overall Study|Lost to Follow-up|0
4371958|NCT01896531|7146439|FG000|Overall Study|Non-compliance|0
4371959|NCT01896531|7146440|FG001|Overall Study|Non-compliance|1
4371960|NCT01896531|7146439|FG000|Overall Study|Study Ended by Sponsor|7
4371961|NCT01896531|7146440|FG001|Overall Study|Study Ended by Sponsor|20
4371962|NCT01896531|7146439|FG000|Overall Study|Withdrawal by Subject|3
4371963|NCT01896531|7146440|FG001|Overall Study|Withdrawal by Subject|2
4371964|NCT01896531|7146439|FG000|Overall Study|Death Prior to Treatment|1
4371965|NCT01896531|7146440|FG001|Overall Study|Death Prior to Treatment|0
4371966|NCT01864603|7146448|FG000|Stage 2|DSMB design modification|86056
4371967|NCT01864603|7146449|FG001|Stage 2|DSMB design modification|92558
4448135|NCT00494780|7233475|FG001|Overall Study|Residual Tumour Mass|1
4448136|NCT00494780|7233474|FG000|Overall Study|Insurance Issues|0
4448137|NCT00494780|7233475|FG001|Overall Study|Insurance Issues|1
4448138|NCT00494871|7233494|FG000|Double-blind (DB) Treatment Period|Adverse Event|73
4448139|NCT00494871|7233495|FG001|Double-blind (DB) Treatment Period|Adverse Event|70
4448140|NCT00494871|7233494|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26
4448141|NCT00494871|7233495|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35
4448142|NCT00494871|7233494|FG000|Double-blind (DB) Treatment Period|Death|8
4448143|NCT00494871|7233495|FG001|Double-blind (DB) Treatment Period|Death|3
4448144|NCT00494871|7233494|FG000|Double-blind (DB) Treatment Period|Physician Decision|4
4448145|NCT00494871|7233495|FG001|Double-blind (DB) Treatment Period|Physician Decision|13
4448146|NCT00494871|7233494|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4
4448147|NCT00494871|7233495|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1
4448148|NCT00494871|7233494|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9
4448149|NCT00494871|7233495|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9
4448150|NCT00494871|7233494|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18
4448151|NCT00494871|7233495|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28
4448152|NCT00494871|7233494|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3
4448153|NCT00494871|7233495|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1
4448154|NCT00494871|7233494|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12
4448155|NCT00494871|7233495|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8
4448156|NCT00494871|7233494|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1
4448157|NCT00494871|7233495|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2
4448158|NCT00494871|7233494|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1
4448159|NCT00494871|7233495|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1
4448160|NCT00494871|7233494|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1
4448161|NCT00494871|7233495|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1
4448162|NCT00494871|7233494|FG000|Follow-up (FU) Period|Adverse Event|1
4448163|NCT00494871|7233495|FG001|Follow-up (FU) Period|Adverse Event|1
4448164|NCT00494871|7233494|FG000|Follow-up (FU) Period|Death|13
4448165|NCT00494871|7233495|FG001|Follow-up (FU) Period|Death|12
4448166|NCT00494871|7233494|FG000|Follow-up (FU) Period|Lost to Follow-up|6
4448167|NCT00494871|7233495|FG001|Follow-up (FU) Period|Lost to Follow-up|2
4448168|NCT00494871|7233494|FG000|Follow-up (FU) Period|Physician Decision|0
4448169|NCT00494871|7233495|FG001|Follow-up (FU) Period|Physician Decision|1
4448170|NCT00494871|7233494|FG000|Follow-up (FU) Period|Protocol Violation|1
4448171|NCT00494871|7233495|FG001|Follow-up (FU) Period|Protocol Violation|0
4448172|NCT00494871|7233494|FG000|Follow-up (FU) Period|Withdrawal by Subject|5
4448173|NCT00494871|7233495|FG001|Follow-up (FU) Period|Withdrawal by Subject|5
4448174|NCT00494871|7233494|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3
4448175|NCT00494871|7233495|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2
4448176|NCT00495040|7233512|FG000|Overall Study|Withdrawal by Subject|3
4448177|NCT00495170|7233536|FG000|Overall Study|Lost to Follow-up|9
4448178|NCT00495170|7233536|FG000|Overall Study|Withdrawal by Subject|3
4448179|NCT00495170|7233536|FG000|Overall Study|Inappropriate staging|8
4448180|NCT00495391|7233542|FG000|Overall Study|Lack of Efficacy|34
4448181|NCT00495391|7233543|FG001|Overall Study|Lack of Efficacy|18
4448182|NCT00495391|7233542|FG000|Overall Study|Withdrawal by Subject|2
4448183|NCT00495391|7233543|FG001|Overall Study|Withdrawal by Subject|3
4448184|NCT00495469|7233556|FG000|Overall Study|Adverse Event|0
4448185|NCT00495469|7233557|FG001|Overall Study|Adverse Event|1
4448186|NCT00495469|7233558|FG002|Overall Study|Adverse Event|3
4448187|NCT00495469|7233559|FG003|Overall Study|Adverse Event|0
4448188|NCT00495469|7233560|FG004|Overall Study|Adverse Event|1
4448189|NCT00495469|7233561|FG005|Overall Study|Adverse Event|1
4448190|NCT00495469|7233562|FG006|Overall Study|Adverse Event|1
4448191|NCT00495469|7233556|FG000|Overall Study|Lost to Follow-up|1
4448192|NCT00495469|7233557|FG001|Overall Study|Lost to Follow-up|1
4448193|NCT00495469|7233558|FG002|Overall Study|Lost to Follow-up|3
4448194|NCT00495469|7233559|FG003|Overall Study|Lost to Follow-up|1
4448195|NCT00495469|7233560|FG004|Overall Study|Lost to Follow-up|0
4448196|NCT00495469|7233561|FG005|Overall Study|Lost to Follow-up|0
4448197|NCT00495469|7233562|FG006|Overall Study|Lost to Follow-up|0
4448198|NCT00495469|7233556|FG000|Overall Study|Protocol Violation|0
4448199|NCT00495469|7233557|FG001|Overall Study|Protocol Violation|0
4371968|NCT01399658|7146460|FG000|Overall Study|Ineligible|1
4371969|NCT01399658|7146460|FG000|Overall Study|Machine Technical Issue|3
4371970|NCT01399658|7146460|FG000|Overall Study|Standard of Care better than protocol therapy|1
4371971|NCT01399658|7146460|FG000|Overall Study|No reason given|1
4371972|NCT00919893|7146570|FG000|Overall Study|Protocol Violation|19
4371973|NCT00919893|7146571|FG001|Overall Study|Protocol Violation|9
4371974|NCT00909753|7146610|FG000|Period: Washout of 28 Days|Protocol Violation|2
4371975|NCT00909753|7146611|FG001|Period: Washout of 28 Days|Protocol Violation|3
4371976|NCT00909753|7146610|FG000|Period: Second Intervention|Protocol Violation|1
4371977|NCT00909753|7146611|FG001|Period: Second Intervention|Protocol Violation|0
4371978|NCT00909610|7146624|FG000|Period: First Intervention|Adverse Event|0
4371979|NCT00909610|7146625|FG001|Period: First Intervention|Adverse Event|1
4371980|NCT00909610|7146624|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3
4371981|NCT00909610|7146625|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6
4371982|NCT00909610|7146624|FG000|Period: Second Intervention|Adverse Event|1
4371983|NCT00909610|7146625|FG001|Period: Second Intervention|Adverse Event|0
4448200|NCT00495469|7233558|FG002|Overall Study|Protocol Violation|0
4448201|NCT00495469|7233559|FG003|Overall Study|Protocol Violation|0
4448202|NCT00495469|7233560|FG004|Overall Study|Protocol Violation|1
4448203|NCT00495469|7233561|FG005|Overall Study|Protocol Violation|2
4448204|NCT00495469|7233562|FG006|Overall Study|Protocol Violation|0
4448205|NCT00495469|7233556|FG000|Overall Study|Withdrawal by Subject|5
4448206|NCT00495469|7233557|FG001|Overall Study|Withdrawal by Subject|3
4448207|NCT00495469|7233558|FG002|Overall Study|Withdrawal by Subject|1
4448208|NCT00495469|7233559|FG003|Overall Study|Withdrawal by Subject|3
4448209|NCT00495469|7233560|FG004|Overall Study|Withdrawal by Subject|3
4448210|NCT00495469|7233561|FG005|Overall Study|Withdrawal by Subject|2
4448211|NCT00495469|7233562|FG006|Overall Study|Withdrawal by Subject|3
4448212|NCT00495469|7233556|FG000|Overall Study|Lack of Efficacy|0
4694421|NCT02607228|7605905|FG001|Overall Study|Progressive Disease|3
4694422|NCT02607228|7605906|FG002|Overall Study|Progressive Disease|1
4694423|NCT02607228|7605907|FG003|Overall Study|Progressive Disease|5
4694424|NCT02607228|7605908|FG004|Overall Study|Progressive Disease|4
4694425|NCT02607228|7605909|FG005|Overall Study|Progressive Disease|3
4694426|NCT02607228|7605910|FG006|Overall Study|Progressive Disease|1
4694427|NCT02607228|7605904|FG000|Overall Study|Adverse Event|1
4694428|NCT02607228|7605905|FG001|Overall Study|Adverse Event|0
4694429|NCT02607228|7605906|FG002|Overall Study|Adverse Event|1
4694430|NCT02607228|7605907|FG003|Overall Study|Adverse Event|0
4694431|NCT02607228|7605908|FG004|Overall Study|Adverse Event|1
4694432|NCT02607228|7605909|FG005|Overall Study|Adverse Event|1
4694433|NCT02607228|7605910|FG006|Overall Study|Adverse Event|1
4694434|NCT02607228|7605904|FG000|Overall Study|Investigator's Discretion|0
4694435|NCT02607228|7605905|FG001|Overall Study|Investigator's Discretion|0
4694436|NCT02607228|7605906|FG002|Overall Study|Investigator's Discretion|1
4694437|NCT02607228|7605907|FG003|Overall Study|Investigator's Discretion|0
4448213|NCT00495469|7233557|FG001|Overall Study|Lack of Efficacy|0
4448214|NCT00495469|7233558|FG002|Overall Study|Lack of Efficacy|0
4448215|NCT00495469|7233559|FG003|Overall Study|Lack of Efficacy|0
4448216|NCT00495469|7233560|FG004|Overall Study|Lack of Efficacy|0
4448217|NCT00495469|7233561|FG005|Overall Study|Lack of Efficacy|0
4448218|NCT00495469|7233562|FG006|Overall Study|Lack of Efficacy|1
4448219|NCT00495469|7233556|FG000|Overall Study|Liver function test abnormality|0
4448220|NCT00495469|7233557|FG001|Overall Study|Liver function test abnormality|1
4448221|NCT00495469|7233558|FG002|Overall Study|Liver function test abnormality|0
4448222|NCT00495469|7233559|FG003|Overall Study|Liver function test abnormality|0
4448223|NCT00495469|7233560|FG004|Overall Study|Liver function test abnormality|0
4448224|NCT00495469|7233561|FG005|Overall Study|Liver function test abnormality|0
4448225|NCT00495469|7233562|FG006|Overall Study|Liver function test abnormality|0
4448226|NCT00495469|7233556|FG000|Overall Study|ST depression at randomisation in ECG|0
4448227|NCT00495469|7233557|FG001|Overall Study|ST depression at randomisation in ECG|1
4448228|NCT00495469|7233558|FG002|Overall Study|ST depression at randomisation in ECG|0
4448229|NCT00495469|7233559|FG003|Overall Study|ST depression at randomisation in ECG|0
4448230|NCT00495469|7233560|FG004|Overall Study|ST depression at randomisation in ECG|0
4448231|NCT00495469|7233561|FG005|Overall Study|ST depression at randomisation in ECG|0
4448232|NCT00495469|7233562|FG006|Overall Study|ST depression at randomisation in ECG|0
4448233|NCT00495495|7233585|FG000|Overall Study|Protocol Violation|99
4448234|NCT00495521|7233592|FG000|Overall Study|Physician Decision|0
4448235|NCT00495521|7233593|FG001|Overall Study|Physician Decision|1
4448236|NCT00495586|7233601|FG000|Overall Study|Withdrawal by Subject|4
4448237|NCT00495586|7233602|FG001|Overall Study|Withdrawal by Subject|4
4448238|NCT00495612|7233612|FG000|Overall Study|Lost to Follow-up|1
4448239|NCT00495612|7233613|FG001|Overall Study|Lost to Follow-up|0
4694438|NCT02607228|7605908|FG004|Overall Study|Investigator's Discretion|0
4448240|NCT00495612|7233612|FG000|Overall Study|Subject's Decision to Withdraw|3
4448241|NCT00495612|7233613|FG001|Overall Study|Subject's Decision to Withdraw|0
4448242|NCT00495625|7233619|FG000|Overall Study|Did not complete at least 1 42 day cycle|10
4694439|NCT02607228|7605909|FG005|Overall Study|Investigator's Discretion|1
4694440|NCT02607228|7605910|FG006|Overall Study|Investigator's Discretion|0
4694441|NCT02607228|7605904|FG000|Overall Study|Withdrew Consent|0
4694442|NCT02607228|7605905|FG001|Overall Study|Withdrew Consent|1
4371984|NCT00905606|7146653|FG000|Period 1|Adverse Event|0
4371985|NCT00905606|7146654|FG001|Period 1|Adverse Event|1
4371986|NCT00905606|7146653|FG000|Washout|Withdrawal by Subject|1
4371987|NCT00905606|7146654|FG001|Washout|Withdrawal by Subject|0
4371988|NCT00905567|7146660|FG000|Washout|Withdrawal by Subject|0
4371989|NCT00905567|7146661|FG001|Washout|Withdrawal by Subject|1
4371990|NCT00905346|7146667|FG000|Period 1|Withdrawal by Subject|1
4371991|NCT00905346|7146668|FG001|Period 1|Withdrawal by Subject|0
4371992|NCT00905164|7146674|FG000|Period 1|Protocol Violation|0
4371993|NCT00905164|7146675|FG001|Period 1|Protocol Violation|1
4371994|NCT00890591|7146686|FG000|Overall Study|Lack of Efficacy|20
4371995|NCT00890409|7146694|FG000|Overall Study|Lost to Follow-up|20
4371996|NCT00890409|7146695|FG001|Overall Study|Lost to Follow-up|21
4371997|NCT00888355|7146703|FG000|Overall Study|Adverse Event|10
4371998|NCT00888355|7146704|FG001|Overall Study|Adverse Event|0
4371999|NCT00888355|7146705|FG002|Overall Study|Adverse Event|3
4372000|NCT00888355|7146706|FG003|Overall Study|Adverse Event|3
4372001|NCT00888355|7146703|FG000|Overall Study|Lack of Efficacy|9
4372002|NCT00888355|7146704|FG001|Overall Study|Lack of Efficacy|2
4372003|NCT00888355|7146705|FG002|Overall Study|Lack of Efficacy|5
4372004|NCT00888355|7146706|FG003|Overall Study|Lack of Efficacy|2
4372005|NCT00888355|7146703|FG000|Overall Study|Lost to Follow-up|0
4372006|NCT00888355|7146704|FG001|Overall Study|Lost to Follow-up|2
4372007|NCT00888355|7146705|FG002|Overall Study|Lost to Follow-up|2
4372008|NCT00888355|7146706|FG003|Overall Study|Lost to Follow-up|0
4372009|NCT00888355|7146703|FG000|Overall Study|Protocol Violation|3
4372010|NCT00888355|7146704|FG001|Overall Study|Protocol Violation|2
4372011|NCT00888355|7146705|FG002|Overall Study|Protocol Violation|1
4372012|NCT00888355|7146706|FG003|Overall Study|Protocol Violation|2
4372013|NCT00888355|7146703|FG000|Overall Study|Withdrawal by Subject|0
4372014|NCT00888355|7146704|FG001|Overall Study|Withdrawal by Subject|3
4372015|NCT00888355|7146705|FG002|Overall Study|Withdrawal by Subject|1
4372016|NCT00888355|7146706|FG003|Overall Study|Withdrawal by Subject|3
4372017|NCT00887250|7146715|FG000|Overall Study|Adverse Event|3
4372018|NCT00887250|7146716|FG001|Overall Study|Adverse Event|0
4372019|NCT00887250|7146717|FG002|Overall Study|Adverse Event|7
4372020|NCT00887250|7146715|FG000|Overall Study|Lack of Efficacy|9
4372021|NCT00887250|7146716|FG001|Overall Study|Lack of Efficacy|6
4372022|NCT00887250|7146717|FG002|Overall Study|Lack of Efficacy|1
4372023|NCT00887250|7146715|FG000|Overall Study|Lost to Follow-up|2
4372024|NCT00887250|7146716|FG001|Overall Study|Lost to Follow-up|3
4372025|NCT00887250|7146717|FG002|Overall Study|Lost to Follow-up|1
4372026|NCT00887250|7146715|FG000|Overall Study|Protocol Violation|2
4372027|NCT00887250|7146716|FG001|Overall Study|Protocol Violation|2
4372028|NCT00887250|7146717|FG002|Overall Study|Protocol Violation|1
4372029|NCT00887250|7146715|FG000|Overall Study|Withdrawal by Subject|2
4372030|NCT00887250|7146716|FG001|Overall Study|Withdrawal by Subject|1
4372031|NCT00887250|7146717|FG002|Overall Study|Withdrawal by Subject|2
4372032|NCT00887250|7146715|FG000|Overall Study|Patient uncooperative|0
4372033|NCT00887250|7146716|FG001|Overall Study|Patient uncooperative|0
4372034|NCT00887250|7146717|FG002|Overall Study|Patient uncooperative|1
4372035|NCT00886600|7146726|FG000|Double-blind Monotherapy|Adverse Event|1
4372036|NCT00886600|7146727|FG001|Double-blind Monotherapy|Adverse Event|1
4372037|NCT00886600|7146728|FG002|Double-blind Monotherapy|Adverse Event|1
4372038|NCT00886600|7146729|FG003|Double-blind Monotherapy|Adverse Event|1
4372039|NCT00886600|7146726|FG000|Double-blind Monotherapy|Protocol Violation|0
4372040|NCT00886600|7146727|FG001|Double-blind Monotherapy|Protocol Violation|0
4372041|NCT00886600|7146728|FG002|Double-blind Monotherapy|Protocol Violation|0
4372042|NCT00886600|7146729|FG003|Double-blind Monotherapy|Protocol Violation|1
4372043|NCT00886600|7146726|FG000|Double-blind Monotherapy|Withdrawal by Subject|1
4372044|NCT00886600|7146727|FG001|Double-blind Monotherapy|Withdrawal by Subject|0
4372045|NCT00886600|7146728|FG002|Double-blind Monotherapy|Withdrawal by Subject|0
4372046|NCT00886600|7146729|FG003|Double-blind Monotherapy|Withdrawal by Subject|0
4372047|NCT00886600|7146726|FG000|Combination Therapy Period|Adverse Event|0
4372048|NCT00886600|7146727|FG001|Combination Therapy Period|Adverse Event|0
4372049|NCT00886600|7146728|FG002|Combination Therapy Period|Adverse Event|1
4372050|NCT00886600|7146729|FG003|Combination Therapy Period|Adverse Event|0
4372051|NCT00886600|7146726|FG000|Combination Therapy Period|Protocol Violation|0
4372052|NCT00886600|7146727|FG001|Combination Therapy Period|Protocol Violation|0
4372053|NCT00886600|7146728|FG002|Combination Therapy Period|Protocol Violation|1
4372054|NCT00886600|7146729|FG003|Combination Therapy Period|Protocol Violation|0
4372055|NCT00882440|7146742|FG000|Overall Study|Adverse Event|2
4372056|NCT00882440|7146743|FG001|Overall Study|Adverse Event|2
4372057|NCT00882440|7146744|FG002|Overall Study|Adverse Event|2
4372058|NCT00882440|7146745|FG003|Overall Study|Adverse Event|1
4372059|NCT00882440|7146746|FG004|Overall Study|Adverse Event|1
4372060|NCT00882440|7146747|FG005|Overall Study|Adverse Event|4
4372061|NCT00882440|7146748|FG006|Overall Study|Adverse Event|2
4372062|NCT00882440|7146742|FG000|Overall Study|Lack of Efficacy|3
4372063|NCT00882440|7146743|FG001|Overall Study|Lack of Efficacy|5
4372064|NCT00882440|7146744|FG002|Overall Study|Lack of Efficacy|2
4372065|NCT00882440|7146745|FG003|Overall Study|Lack of Efficacy|0
4372066|NCT00882440|7146746|FG004|Overall Study|Lack of Efficacy|0
4372067|NCT00882440|7146747|FG005|Overall Study|Lack of Efficacy|3
4372068|NCT00882440|7146748|FG006|Overall Study|Lack of Efficacy|0
4372069|NCT00882440|7146742|FG000|Overall Study|Lost to Follow-up|2
4372070|NCT00882440|7146743|FG001|Overall Study|Lost to Follow-up|0
4372071|NCT00882440|7146744|FG002|Overall Study|Lost to Follow-up|1
4372072|NCT00882440|7146745|FG003|Overall Study|Lost to Follow-up|1
4372073|NCT00882440|7146746|FG004|Overall Study|Lost to Follow-up|1
4372074|NCT00882440|7146747|FG005|Overall Study|Lost to Follow-up|0
4372075|NCT00882440|7146748|FG006|Overall Study|Lost to Follow-up|1
4372076|NCT00882440|7146742|FG000|Overall Study|Protocol Violation|0
4372077|NCT00882440|7146743|FG001|Overall Study|Protocol Violation|0
4372078|NCT00882440|7146744|FG002|Overall Study|Protocol Violation|1
4372079|NCT00882440|7146745|FG003|Overall Study|Protocol Violation|1
4372080|NCT00882440|7146746|FG004|Overall Study|Protocol Violation|1
4372081|NCT00882440|7146747|FG005|Overall Study|Protocol Violation|0
4372082|NCT00882440|7146748|FG006|Overall Study|Protocol Violation|0
4372083|NCT00882440|7146742|FG000|Overall Study|Withdrawal by Subject|2
4372084|NCT00882440|7146743|FG001|Overall Study|Withdrawal by Subject|1
4372085|NCT00882440|7146744|FG002|Overall Study|Withdrawal by Subject|1
4372086|NCT00882440|7146745|FG003|Overall Study|Withdrawal by Subject|0
4372087|NCT00882440|7146746|FG004|Overall Study|Withdrawal by Subject|6
4372088|NCT00882440|7146747|FG005|Overall Study|Withdrawal by Subject|0
4372089|NCT00882440|7146748|FG006|Overall Study|Withdrawal by Subject|1
4372090|NCT00882440|7146742|FG000|Overall Study|Patient Uncooperative|2
4372091|NCT00882440|7146743|FG001|Overall Study|Patient Uncooperative|0
4372092|NCT00882440|7146744|FG002|Overall Study|Patient Uncooperative|0
4372093|NCT00882440|7146745|FG003|Overall Study|Patient Uncooperative|0
4372094|NCT00882440|7146746|FG004|Overall Study|Patient Uncooperative|1
4372095|NCT00882440|7146747|FG005|Overall Study|Patient Uncooperative|0
4372096|NCT00882440|7146748|FG006|Overall Study|Patient Uncooperative|0
4372097|NCT00870688|7146764|FG000|Overall Study|Lost to Follow-up|2
4372098|NCT00870688|7146764|FG000|Overall Study|Death, Unrelated|1
4372099|NCT00870688|7146764|FG000|Overall Study|Granules in the Stools|1
4372100|NCT00869128|7146767|FG000|Overall Study|lack of Compliance|6
4372101|NCT00869128|7146768|FG001|Overall Study|lack of Compliance|6
4372102|NCT00861705|7146776|FG000|Overall Study|Never Began Treatment|7
4372103|NCT00861705|7146777|FG001|Overall Study|Never Began Treatment|3
4372104|NCT00861705|7146778|FG002|Overall Study|Never Began Treatment|0
4372105|NCT00861705|7146779|FG003|Overall Study|Never Began Treatment|1
4372106|NCT00859521|7146799|FG000|Washout|Withdrawal by Subject|0
4372107|NCT00859521|7146800|FG001|Washout|Withdrawal by Subject|1
4372108|NCT00859430|7146806|FG000|First Intervention|Withdrawal by Subject|0
4372109|NCT00859430|7146807|FG001|First Intervention|Withdrawal by Subject|1
4448243|NCT00495677|7233630|FG000|Stage 1 (25 Days)|Adverse Event|0
4448244|NCT00495677|7233631|FG001|Stage 1 (25 Days)|Adverse Event|0
4448245|NCT00495677|7233632|FG002|Stage 1 (25 Days)|Adverse Event|1
4448246|NCT00495677|7233633|FG003|Stage 1 (25 Days)|Adverse Event|0
4448247|NCT00495677|7233634|FG004|Stage 1 (25 Days)|Adverse Event|0
4448248|NCT00495677|7233635|FG005|Stage 1 (25 Days)|Adverse Event|0
4448249|NCT00495677|7233636|FG006|Stage 1 (25 Days)|Adverse Event|0
4448250|NCT00495755|7233652|FG000|Overall Study|Adverse Event|3
4448251|NCT00495794|7233659|FG000|Overall Study|Pharmacist did not activate patient|522
4448252|NCT00495794|7233660|FG001|Overall Study|Pharmacist did not activate patient|0
4448253|NCT00495820|7233668|FG000|Overall Study|Adverse Event|1
4448254|NCT00495820|7233669|FG001|Overall Study|Adverse Event|1
4448255|NCT00496015|7233680|FG000|Overall Study|Other|1
4448256|NCT00496015|7233681|FG001|Overall Study|Other|0
4448257|NCT00496015|7233682|FG002|Overall Study|Other|0
4448258|NCT00496015|7233683|FG003|Overall Study|Other|1
4448259|NCT00496015|7233684|FG004|Overall Study|Other|0
4448260|NCT00496054|7233704|FG000|Overall Study|Adverse Event|1
4448261|NCT00496054|7233704|FG000|Overall Study|Lost to Follow-up|7
4448262|NCT00496080|7233708|FG000|Overall Study|Lost to Follow-up|9
4448263|NCT00496080|7233708|FG000|Overall Study|Surgical re-intervention|7
4448264|NCT00496080|7233708|FG000|Overall Study|Withdrawal by Subject|5
4448265|NCT00496080|7233708|FG000|Overall Study|Physician Decision|6
4448266|NCT00496197|7233713|FG000|Overall Study|Discontinued study due to death|43
4448267|NCT00496197|7233713|FG000|Overall Study|Adverse Event|13
4448268|NCT00496197|7233713|FG000|Overall Study|Does not meet entrance criteria|5
4448269|NCT00496197|7233713|FG000|Overall Study|Insufficient clinical response|3
4448270|NCT00496197|7233713|FG000|Overall Study|Insufficient bacteriological response|10
4448271|NCT00496197|7233713|FG000|Overall Study|Lost to Follow-up|11
4448272|NCT00496197|7233713|FG000|Overall Study|Withdrawal by Subject|11
4448273|NCT00496197|7233713|FG000|Overall Study|Pathogen not isolated baseline specimen|4
4448274|NCT00496197|7233713|FG000|Overall Study|Other|14
4448275|NCT00496197|7233713|FG000|Overall Study|Protocol Violation|8
4448276|NCT00496366|7233727|FG000|Overall Study|Death|1
4448277|NCT00496470|7233737|FG000|Overall Study|Adverse Event|8
4448278|NCT00496470|7233738|FG001|Overall Study|Adverse Event|10
4448279|NCT00496470|7233737|FG000|Overall Study|Withdrawal by Subject|5
4448280|NCT00496470|7233738|FG001|Overall Study|Withdrawal by Subject|12
4448281|NCT00496470|7233737|FG000|Overall Study|Incorrectly enrolled|13
4448282|NCT00496470|7233738|FG001|Overall Study|Incorrectly enrolled|5
4448283|NCT00496470|7233737|FG000|Overall Study|Other reason|0
4448284|NCT00496470|7233738|FG001|Overall Study|Other reason|2
4448285|NCT00496483|7233744|FG000|Overall Study|Not dosed|9
4448286|NCT00496483|7233744|FG000|Overall Study|Adverse Event|2
4372110|NCT00858702|7146813|FG000|Overall Study|Lack of Efficacy|1
4372111|NCT00858702|7146814|FG001|Overall Study|Lack of Efficacy|0
4372112|NCT00858702|7146813|FG000|Overall Study|Protocol Violation|1
4372113|NCT00858702|7146814|FG001|Overall Study|Protocol Violation|1
4372114|NCT00858702|7146813|FG000|Overall Study|Other|2
4372115|NCT00858702|7146814|FG001|Overall Study|Other|1
4372116|NCT00858702|7146813|FG000|Overall Study|Withdrawal by Subject|1
4372117|NCT00858702|7146814|FG001|Overall Study|Withdrawal by Subject|0
4372118|NCT00857285|7146822|FG000|Overall Study|Adverse Event|4
4372119|NCT00857285|7146823|FG001|Overall Study|Adverse Event|2
4372120|NCT00857285|7146822|FG000|Overall Study|Lack of Efficacy|0
4372121|NCT00857285|7146823|FG001|Overall Study|Lack of Efficacy|2
4372122|NCT00857285|7146822|FG000|Overall Study|Protocol Violation|3
4372123|NCT00857285|7146823|FG001|Overall Study|Protocol Violation|1
4372124|NCT00857285|7146822|FG000|Overall Study|Withdrawal by Subject|4
4372125|NCT00857285|7146823|FG001|Overall Study|Withdrawal by Subject|0
4372126|NCT00857285|7146822|FG000|Overall Study|Randomization criteria not met|1
4372127|NCT00857285|7146823|FG001|Overall Study|Randomization criteria not met|1
4372128|NCT00850174|7146839|FG000|Washout: One Week|Withdrawal by Subject|0
4372129|NCT00850174|7146840|FG001|Washout: One Week|Withdrawal by Subject|2
4372130|NCT00850174|7146839|FG000|Second Intervention|Withdrawal by Subject|1
4372131|NCT00850174|7146840|FG001|Second Intervention|Withdrawal by Subject|0
4372132|NCT00849797|7146853|FG000|First Intervention|bad veins|1
4372133|NCT00849797|7146854|FG001|First Intervention|bad veins|0
4372134|NCT00849797|7146853|FG000|First Intervention|Adverse Event|0
4372135|NCT00849797|7146854|FG001|First Intervention|Adverse Event|1
4372136|NCT00849797|7146853|FG000|Washout: One Week|Withdrawal by Subject|0
4372137|NCT00849797|7146854|FG001|Washout: One Week|Withdrawal by Subject|2
4372138|NCT00847405|7146868|FG000|First Intervention|Adverse Event|0
4372139|NCT00847405|7146869|FG001|First Intervention|Adverse Event|1
4372140|NCT00847405|7146868|FG000|Washout of 7 Days|Withdrawal by Subject|1
4372141|NCT00847405|7146869|FG001|Washout of 7 Days|Withdrawal by Subject|0
4770465|NCT03502187|7746793|FG002|Overall Study|Lost to Follow-up|5
4770466|NCT03447262|7746801|FG000|Overall Study|Adverse Event|7
4770467|NCT03447262|7746801|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2
4770468|NCT03447262|7746801|FG000|Overall Study|Commercial Drug is Available for Participant|9
4770469|NCT03447262|7746801|FG000|Overall Study|Death|2
4770470|NCT03447262|7746801|FG000|Overall Study|Study Termination by Sponsor|455
4770471|NCT03447262|7746801|FG000|Overall Study|Other|4
4770472|NCT03432819|7746810|FG000|Overall Study|Lost to Follow-up|2
4770473|NCT03432819|7746811|FG001|Overall Study|Lost to Follow-up|2
4770474|NCT03432819|7746810|FG000|Overall Study|Withdrawal by Subject|5
4770475|NCT03432819|7746811|FG001|Overall Study|Withdrawal by Subject|3
4770476|NCT03365791|7746817|FG000|Overall Study|Adverse Event|5
4770477|NCT03365791|7746817|FG000|Overall Study|Death|1
4770478|NCT03365791|7746817|FG000|Overall Study|Lost to Follow-up|1
4770479|NCT03365791|7746817|FG000|Overall Study|Physician Decision|9
4770480|NCT03365791|7746817|FG000|Overall Study|Progressive disease|51
4770481|NCT03365791|7746817|FG000|Overall Study|Subject/guardian decision|5
4770482|NCT03323749|7746824|FG000|Double-blind Period|Lost to Follow-up|4
4770483|NCT03323749|7746825|FG001|Double-blind Period|Lost to Follow-up|5
4770484|NCT03323749|7746824|FG000|Double-blind Period|Adverse Event|3
4770485|NCT03323749|7746825|FG001|Double-blind Period|Adverse Event|1
4770486|NCT03323749|7746824|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83
4770487|NCT03323749|7746825|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88
4770488|NCT03323749|7746824|FG000|Open-Label Period|Adverse Event|3
4770489|NCT03323749|7746825|FG001|Open-Label Period|Adverse Event|10
4770490|NCT03323749|7746824|FG000|Open-Label Period|Withdrawal by Subject|7
4770491|NCT03323749|7746825|FG001|Open-Label Period|Withdrawal by Subject|5
4770492|NCT03322566|7746838|FG000|Overall Study|Death|34
4770493|NCT03322566|7746839|FG001|Overall Study|Death|35
4770494|NCT03322566|7746840|FG002|Overall Study|Death|23
4770495|NCT03322566|7746838|FG000|Overall Study|Physician Decision|6
4770496|NCT03322566|7746839|FG001|Overall Study|Physician Decision|7
4770497|NCT03322566|7746840|FG002|Overall Study|Physician Decision|2
4770498|NCT03322566|7746838|FG000|Overall Study|Withdrawal by Subject|4
4770499|NCT03322566|7746839|FG001|Overall Study|Withdrawal by Subject|3
4694443|NCT02607228|7605906|FG002|Overall Study|Withdrew Consent|0
4694444|NCT02607228|7605907|FG003|Overall Study|Withdrew Consent|0
4694445|NCT02607228|7605908|FG004|Overall Study|Withdrew Consent|0
4770500|NCT03322566|7746840|FG002|Overall Study|Withdrawal by Subject|6
4770501|NCT03322566|7746838|FG000|Overall Study|Lost to Follow-up|0
4770502|NCT03322566|7746839|FG001|Overall Study|Lost to Follow-up|0
4770503|NCT03322566|7746840|FG002|Overall Study|Lost to Follow-up|1
4770504|NCT03322566|7746838|FG000|Overall Study|Study terminated by sponsor|1
4770505|NCT03322566|7746839|FG001|Overall Study|Study terminated by sponsor|0
4770506|NCT03322566|7746840|FG002|Overall Study|Study terminated by sponsor|1
4770507|NCT03322540|7746850|FG000|Overall Study|Death|21
4770508|NCT03322540|7746851|FG001|Overall Study|Death|28
4770509|NCT03322540|7746850|FG000|Overall Study|Lost to Follow-up|0
4770510|NCT03322540|7746851|FG001|Overall Study|Lost to Follow-up|1
4770511|NCT03322540|7746850|FG000|Overall Study|Physician Decision|7
4770512|NCT03322540|7746851|FG001|Overall Study|Physician Decision|6
4694446|NCT02607228|7605909|FG005|Overall Study|Withdrew Consent|1
4770513|NCT03322540|7746850|FG000|Overall Study|Withdrawal by Subject|3
4770514|NCT03322540|7746851|FG001|Overall Study|Withdrawal by Subject|1
4770515|NCT03322540|7746850|FG000|Overall Study|Study terminated by sponsor|0
4770516|NCT03322540|7746851|FG001|Overall Study|Study terminated by sponsor|1
4372196|NCT00841815|7146900|FG000|Washout|Withdrawal by Subject|0
4372197|NCT00841815|7146901|FG001|Washout|Withdrawal by Subject|1
4372198|NCT00841698|7146908|FG000|First Intervention|Withdrawal by Subject|1
4372199|NCT00841698|7146909|FG001|First Intervention|Withdrawal by Subject|0
4372200|NCT00841659|7146915|FG000|Washout: 2 Weeks|Protocol Violation|1
4372201|NCT00841659|7146916|FG001|Washout: 2 Weeks|Protocol Violation|0
4372202|NCT00841542|7146922|FG000|Period 1|Adverse Event|1
4372203|NCT00841542|7146923|FG001|Period 1|Adverse Event|0
4372204|NCT00840879|7146929|FG000|Second Intervention|Withdrawal by Subject|1
4372205|NCT00840879|7146930|FG001|Second Intervention|Withdrawal by Subject|0
4372206|NCT00840632|7146950|FG000|First Intervention|Withdrawal by Subject|0
4372207|NCT00840632|7146951|FG001|First Intervention|Withdrawal by Subject|1
4372208|NCT00840632|7146950|FG000|Washout|Withdrawal by Subject|1
4372209|NCT00840632|7146951|FG001|Washout|Withdrawal by Subject|1
4372210|NCT00840411|7146964|FG000|First Intervention|Adverse Event|1
4372211|NCT00840411|7146965|FG001|First Intervention|Adverse Event|0
4372212|NCT00840411|7146964|FG000|Washout|Withdrawal by Subject|1
4372213|NCT00840411|7146965|FG001|Washout|Withdrawal by Subject|0
4372214|NCT00840216|7146978|FG000|Washout: 7 Days|Withdrawal by Subject|1
4372215|NCT00840216|7146979|FG001|Washout: 7 Days|Withdrawal by Subject|0
4372216|NCT00840203|7146985|FG000|First Intervention|Protocol Violation|1
4372217|NCT00840203|7146986|FG001|First Intervention|Protocol Violation|1
4372218|NCT00840203|7146985|FG000|Washout|Protocol Violation|1
4372219|NCT00840203|7146986|FG001|Washout|Protocol Violation|0
4372220|NCT00840073|7146999|FG000|Second Intervention|Missed 72 hour blood draw|1
4372221|NCT00840073|7147000|FG001|Second Intervention|Missed 72 hour blood draw|1
4372222|NCT00838630|7147013|FG000|First Intervention|Adverse Event|1
4372223|NCT00838630|7147014|FG001|First Intervention|Adverse Event|0
4372224|NCT00838630|7147013|FG000|Washout: 7 Days|Protocol Violation|1
4372225|NCT00838630|7147014|FG001|Washout: 7 Days|Protocol Violation|0
4372226|NCT00838279|7147020|FG000|Washout|Protocol Violation|1
4372227|NCT00838279|7147021|FG001|Washout|Protocol Violation|0
4372228|NCT00838279|7147020|FG000|Washout|Withdrawal by Subject|0
4372229|NCT00838279|7147021|FG001|Washout|Withdrawal by Subject|1
4372230|NCT00836901|7147034|FG000|First Intervention|Withdrawal by Subject|1
4372231|NCT00836901|7147035|FG001|First Intervention|Withdrawal by Subject|0
4372232|NCT00836706|7147041|FG000|Washout: 7 Days|Withdrawal by Subject|0
4372233|NCT00836706|7147042|FG001|Washout: 7 Days|Withdrawal by Subject|1
4372234|NCT00836472|7147048|FG000|Washout|Adverse Event|1
4372235|NCT00836472|7147049|FG001|Washout|Adverse Event|2
4372236|NCT00836472|7147048|FG000|Washout|Withdrawal by Subject|1
4372237|NCT00836472|7147049|FG001|Washout|Withdrawal by Subject|1
4372238|NCT00836056|7147055|FG000|First Intervention|Adverse Event|1
4372239|NCT00836056|7147056|FG001|First Intervention|Adverse Event|0
4372240|NCT00835991|7147069|FG000|First Intervention|Adverse Event|0
4372241|NCT00835991|7147070|FG001|First Intervention|Adverse Event|1
4372242|NCT00835991|7147069|FG000|Washout|Protocol Violation|0
4372243|NCT00835991|7147070|FG001|Washout|Protocol Violation|2
4372244|NCT00835991|7147069|FG000|Washout|Withdrawal by Subject|3
4372245|NCT00835991|7147070|FG001|Washout|Withdrawal by Subject|1
4694447|NCT02607228|7605910|FG006|Overall Study|Withdrew Consent|0
4694448|NCT02607228|7605904|FG000|Overall Study|Study Terminated by Sponsor|0
4694449|NCT02607228|7605905|FG001|Overall Study|Study Terminated by Sponsor|0
4694450|NCT02607228|7605906|FG002|Overall Study|Study Terminated by Sponsor|0
4694451|NCT02607228|7605907|FG003|Overall Study|Study Terminated by Sponsor|1
4694452|NCT02607228|7605908|FG004|Overall Study|Study Terminated by Sponsor|0
4694453|NCT02607228|7605909|FG005|Overall Study|Study Terminated by Sponsor|0
4694454|NCT02607228|7605910|FG006|Overall Study|Study Terminated by Sponsor|0
4694455|NCT02607280|7605948|FG000|Overall Study|Adverse Event|4
4694456|NCT02607280|7605949|FG001|Overall Study|Adverse Event|0
4694457|NCT02607280|7605948|FG000|Overall Study|Decrease in CrCl <15|0
4694458|NCT02607280|7605949|FG001|Overall Study|Decrease in CrCl <15|1
4694459|NCT02607306|7605958|FG000|Overall Study|Adverse Event|8
4694460|NCT02607306|7605959|FG001|Overall Study|Adverse Event|6
4694461|NCT02607306|7605960|FG002|Overall Study|Adverse Event|6
4694462|NCT02607306|7605958|FG000|Overall Study|Unclassified|1
4694463|NCT02607306|7605959|FG001|Overall Study|Unclassified|4
4694464|NCT02607306|7605960|FG002|Overall Study|Unclassified|0
4372246|NCT00835796|7147076|FG000|First Intervention|Withdrawal by Subject|0
4372247|NCT00835796|7147077|FG001|First Intervention|Withdrawal by Subject|1
4372248|NCT00835705|7147083|FG000|First Intervention|Difficulty with vein|1
4372249|NCT00835705|7147084|FG001|First Intervention|Difficulty with vein|0
4372250|NCT00835705|7147083|FG000|Second Intervention|Difficulty with vein|1
4694465|NCT02607306|7605958|FG000|Overall Study|Withdrawal by Subject|8
4694466|NCT02607306|7605959|FG001|Overall Study|Withdrawal by Subject|10
4694467|NCT02607306|7605960|FG002|Overall Study|Withdrawal by Subject|2
4694468|NCT02607306|7605958|FG000|Overall Study|Lack of Efficacy|0
4372251|NCT00835705|7147084|FG001|Second Intervention|Difficulty with vein|0
4372252|NCT00835692|7147090|FG000|First Intervention|Withdrawal by Subject|1
4372253|NCT00835692|7147091|FG001|First Intervention|Withdrawal by Subject|0
4372254|NCT00835666|7147097|FG000|Washout|Protocol Violation|1
4372255|NCT00835666|7147098|FG001|Washout|Protocol Violation|0
4372256|NCT00835666|7147097|FG000|Washout|Withdrawal by Subject|1
4372257|NCT00835666|7147098|FG001|Washout|Withdrawal by Subject|0
4372258|NCT00835640|7147104|FG000|Second Intervention|Protocol Violation|1
4372259|NCT00835640|7147105|FG001|Second Intervention|Protocol Violation|0
4372260|NCT00835575|7147125|FG000|Washout of 14 Days|Withdrawal by Subject|1
4372261|NCT00835575|7147126|FG001|Washout of 14 Days|Withdrawal by Subject|0
4372262|NCT00835549|7147132|FG000|Washout of 7 Days|Withdrawal by Subject|2
4372263|NCT00835549|7147133|FG001|Washout of 7 Days|Withdrawal by Subject|0
4372264|NCT00835536|7147139|FG000|Washout of 5 Weeks|Withdrawal by Subject|1
4372265|NCT00835536|7147140|FG001|Washout of 5 Weeks|Withdrawal by Subject|0
4372266|NCT00835406|7147160|FG000|Period: First Intervention|Adverse Event|0
4372267|NCT00835406|7147161|FG001|Period: First Intervention|Adverse Event|1
4372268|NCT00835406|7147160|FG000|Period: First Intervention|Withdrawal by Subject|2
4372269|NCT00835406|7147161|FG001|Period: First Intervention|Withdrawal by Subject|0
4372270|NCT00835406|7147160|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0
4372271|NCT00835406|7147161|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2
4372272|NCT00835367|7147167|FG000|Washout|Adverse Event|2
4372273|NCT00835367|7147168|FG001|Washout|Adverse Event|0
4372274|NCT00835367|7147167|FG000|Washout|Withdrawal by Subject|1
4372275|NCT00835367|7147168|FG001|Washout|Withdrawal by Subject|0
4372276|NCT00835367|7147167|FG000|Second Intervention|Adverse Event|1
4372277|NCT00835367|7147168|FG001|Second Intervention|Adverse Event|1
4372278|NCT00835354|7147174|FG000|First Intervention|Adverse Event|0
4372279|NCT00835354|7147175|FG001|First Intervention|Adverse Event|1
4372280|NCT00835263|7147188|FG000|Second Intervention|Adverse Event|1
4372281|NCT00835263|7147189|FG001|Second Intervention|Adverse Event|0
4372282|NCT00835211|7147195|FG000|First Intervention|Withdrawal by Subject|0
4372283|NCT00835211|7147196|FG001|First Intervention|Withdrawal by Subject|1
4372284|NCT00835211|7147195|FG000|Washout: 7 Days|Adverse Event|2
4372285|NCT00835211|7147196|FG001|Washout: 7 Days|Adverse Event|1
4372286|NCT00835211|7147195|FG000|Washout: 7 Days|Withdrawal by Subject|1
4372287|NCT00835211|7147196|FG001|Washout: 7 Days|Withdrawal by Subject|0
4372288|NCT00835172|7147202|FG000|Washout|Protocol Violation|0
4372289|NCT00835172|7147203|FG001|Washout|Protocol Violation|1
4372290|NCT00835081|7147216|FG000|Washout of 7 Days|Withdrawal by Subject|1
4372291|NCT00835081|7147217|FG001|Washout of 7 Days|Withdrawal by Subject|0
4372292|NCT00835042|7147223|FG000|First Intervention|Withdrawal by Subject|3
4372293|NCT00835042|7147224|FG001|First Intervention|Withdrawal by Subject|0
4372294|NCT00835042|7147223|FG000|First Intervention|Adverse Event|1
4372295|NCT00835042|7147224|FG001|First Intervention|Adverse Event|2
4372296|NCT00835042|7147223|FG000|Washout of 21 Days|Withdrawal by Subject|0
4372297|NCT00835042|7147224|FG001|Washout of 21 Days|Withdrawal by Subject|2
4372298|NCT00834873|7147251|FG000|First Intervention|Adverse Event|0
4372299|NCT00834873|7147252|FG001|First Intervention|Adverse Event|1
4372300|NCT00834795|7147258|FG000|Washout: 7 Days|Withdrawal by Subject|0
4372301|NCT00834795|7147259|FG001|Washout: 7 Days|Withdrawal by Subject|1
4372302|NCT00834795|7147258|FG000|Second Intervention|Adverse Event|1
4372303|NCT00834795|7147259|FG001|Second Intervention|Adverse Event|0
4372304|NCT00834756|7147265|FG000|First Intervention|Adverse Event|1
4372305|NCT00834756|7147266|FG001|First Intervention|Adverse Event|0
4372306|NCT00834756|7147265|FG000|Washout: 21 Days|Withdrawal by Subject|1
4372307|NCT00834756|7147266|FG001|Washout: 21 Days|Withdrawal by Subject|0
4372308|NCT00834743|7147272|FG000|Second Intervention|Withdrawal by Subject|1
4372309|NCT00834743|7147273|FG001|Second Intervention|Withdrawal by Subject|0
4372310|NCT00834717|7147279|FG000|First Intervention|Adverse Event|1
4372311|NCT00834717|7147280|FG001|First Intervention|Adverse Event|0
4372312|NCT00834717|7147279|FG000|First Intervention|Withdrawal by Subject|0
4372313|NCT00834717|7147280|FG001|First Intervention|Withdrawal by Subject|1
4372314|NCT00834639|7147286|FG000|Second Intervention|Physician Decision|0
4372315|NCT00834639|7147287|FG001|Second Intervention|Physician Decision|2
4372316|NCT00834613|7147293|FG000|First Intervention|Protocol Violation|1
4372317|NCT00834613|7147294|FG001|First Intervention|Protocol Violation|0
4372318|NCT00834587|7147300|FG000|Washout: 7 Days|Withdrawal by Subject|1
4372319|NCT00834587|7147301|FG001|Washout: 7 Days|Withdrawal by Subject|0
4448287|NCT00496483|7233744|FG000|Overall Study|Lack of Efficacy|1
4448288|NCT00496587|7233751|FG000|Overall Study|Adverse Event|2
4448289|NCT00496587|7233751|FG000|Overall Study|Progressive Disease|24
4448290|NCT00496587|7233751|FG000|Overall Study|Withdrawal by Subject|2
4448291|NCT00496587|7233751|FG000|Overall Study|Death|1
4448292|NCT00496587|7233751|FG000|Overall Study|Complications unrelated|2
4464975|NCT00606684|7255972|FG003|Double-Blind Treatment Period|Lack of Efficacy|0
4464976|NCT00606684|7255973|FG004|Double-Blind Treatment Period|Lack of Efficacy|1
4464977|NCT00606684|7255974|FG005|Double-Blind Treatment Period|Lack of Efficacy|0
4464978|NCT00606684|7255975|FG006|Double-Blind Treatment Period|Lack of Efficacy|0
4448293|NCT00496626|7233757|FG000|Overall Study|Lost to Follow-up|0
4448294|NCT00496626|7233758|FG001|Overall Study|Lost to Follow-up|1
4448295|NCT00496626|7233757|FG000|Overall Study|Protocol Violation|1
4448296|NCT00496626|7233758|FG001|Overall Study|Protocol Violation|0
4372320|NCT00834522|7147328|FG000|Washout|Adverse Event|1
4372321|NCT00834522|7147329|FG001|Washout|Adverse Event|0
4372322|NCT00834522|7147328|FG000|Washout|Withdrawal by Subject|2
4372323|NCT00834522|7147329|FG001|Washout|Withdrawal by Subject|1
4372324|NCT00834444|7147335|FG000|First Intervention|Adverse Event|1
4372325|NCT00834444|7147336|FG001|First Intervention|Adverse Event|0
4372326|NCT00834444|7147335|FG000|First Intervention|Intolerance to Venopuncture|0
4372327|NCT00834444|7147336|FG001|First Intervention|Intolerance to Venopuncture|1
4372328|NCT00834444|7147335|FG000|Washout of 7 Days|Withdrawal by Subject|0
4372329|NCT00834444|7147336|FG001|Washout of 7 Days|Withdrawal by Subject|1
4372330|NCT00834444|7147335|FG000|Second Intervention|Adverse Event|1
4372331|NCT00834444|7147336|FG001|Second Intervention|Adverse Event|0
4372332|NCT00834431|7147342|FG000|First Intervention|Adverse Event|0
4372333|NCT00834431|7147343|FG001|First Intervention|Adverse Event|1
4372334|NCT00834431|7147342|FG000|Washout of 7 Days|Withdrawal by Subject|0
4372335|NCT00834431|7147343|FG001|Washout of 7 Days|Withdrawal by Subject|1
4372336|NCT00834418|7147349|FG000|Overall Study|Adverse Event|0
4372337|NCT00834418|7147350|FG001|Overall Study|Adverse Event|2
4372338|NCT00834340|7147363|FG000|Washout|Adverse Event|1
4372339|NCT00834340|7147364|FG001|Washout|Adverse Event|0
4372340|NCT00834340|7147363|FG000|Washout|Withdrawal by Subject|1
4372341|NCT00834340|7147364|FG001|Washout|Withdrawal by Subject|0
4372342|NCT00834249|7147377|FG000|Washout: 7 Days|Withdrawal by Subject|1
4372343|NCT00834249|7147378|FG001|Washout: 7 Days|Withdrawal by Subject|1
4372344|NCT00834249|7147377|FG000|Second Intervention|Adverse Event|1
4372345|NCT00834249|7147378|FG001|Second Intervention|Adverse Event|0
4372346|NCT00834067|7147398|FG000|Washout of 21 Days|Protocol Violation|0
4372347|NCT00834067|7147399|FG001|Washout of 21 Days|Protocol Violation|1
4372348|NCT00833937|7147405|FG000|Washout|Withdrawal by Subject|1
4372349|NCT00833937|7147406|FG001|Washout|Withdrawal by Subject|0
4372350|NCT00830336|7147433|FG000|Washout: 21 Days|Withdrawal by Subject|1
4372351|NCT00830336|7147434|FG001|Washout: 21 Days|Withdrawal by Subject|0
4372352|NCT00830258|7147440|FG000|First Intervention|Adverse Event|1
4372353|NCT00830258|7147441|FG001|First Intervention|Adverse Event|0
4372354|NCT00830258|7147440|FG000|Washout: 7 Days|Protocol Violation|1
4372355|NCT00830258|7147441|FG001|Washout: 7 Days|Protocol Violation|0
4372356|NCT00830219|7147447|FG000|Washout of 7 Days|Withdrawal by Subject|1
4372357|NCT00830219|7147448|FG001|Washout of 7 Days|Withdrawal by Subject|1
4372358|NCT00830206|7147454|FG000|Washout: 21 Days|Withdrawal by Subject|1
4372359|NCT00830206|7147455|FG001|Washout: 21 Days|Withdrawal by Subject|1
4372360|NCT00830024|7147461|FG000|Washout: 7 Days|Withdrawal by Subject|1
4372361|NCT00830024|7147462|FG001|Washout: 7 Days|Withdrawal by Subject|0
4372362|NCT00829998|7147468|FG000|Washout|Adverse Event|0
4372363|NCT00829998|7147469|FG001|Washout|Adverse Event|1
4372364|NCT00829868|7147475|FG000|Washout|Physician Decision|1
4372365|NCT00829868|7147476|FG001|Washout|Physician Decision|0
4372366|NCT00829790|7147482|FG000|Washout of 14 Days|Withdrawal by Subject|0
4372367|NCT00829790|7147483|FG001|Washout of 14 Days|Withdrawal by Subject|1
4372368|NCT00829764|7147489|FG000|First Intervention|Adverse Event|1
4372369|NCT00829764|7147490|FG001|First Intervention|Adverse Event|0
4372370|NCT00829764|7147489|FG000|First Intervention|Withdrawal by Subject|1
4372371|NCT00829764|7147490|FG001|First Intervention|Withdrawal by Subject|1
4372372|NCT00829712|7147496|FG000|Washout of 7 Days|Withdrawal by Subject|0
4372373|NCT00829712|7147497|FG001|Washout of 7 Days|Withdrawal by Subject|1
4372374|NCT00829673|7147510|FG000|Washout of 7 Days|Withdrawal by Subject|1
4372375|NCT00829673|7147511|FG001|Washout of 7 Days|Withdrawal by Subject|0
4372376|NCT00829530|7147517|FG000|First Intervention|Adverse Event|0
4372377|NCT00829530|7147518|FG001|First Intervention|Adverse Event|1
4372378|NCT00829530|7147517|FG000|First Intervention|Intolerance to Venopuncture|0
4372379|NCT00829530|7147518|FG001|First Intervention|Intolerance to Venopuncture|1
4372380|NCT00829530|7147517|FG000|Second Intervention|Intolerance to Venopuncture|1
4372381|NCT00829530|7147518|FG001|Second Intervention|Intolerance to Venopuncture|0
4372382|NCT00829504|7147524|FG000|First Intervention|Adverse Event|1
4372383|NCT00829504|7147525|FG001|First Intervention|Adverse Event|0
4372384|NCT00829504|7147524|FG000|Washout of 7 Days|Withdrawal by Subject|1
4372385|NCT00829504|7147525|FG001|Washout of 7 Days|Withdrawal by Subject|0
4372386|NCT00829504|7147524|FG000|Second Intervention|Physician Decision|1
4372387|NCT00829504|7147525|FG001|Second Intervention|Physician Decision|0
4372388|NCT00829452|7147531|FG000|First Intervention|Withdrawal by Subject|0
4372389|NCT00829452|7147532|FG001|First Intervention|Withdrawal by Subject|1
4372390|NCT00829452|7147531|FG000|Washout of 42 Days|Withdrawal by Subject|0
4372391|NCT00829452|7147532|FG001|Washout of 42 Days|Withdrawal by Subject|1
4372392|NCT00829452|7147531|FG000|Second Intervention|Physician Decision|0
4372393|NCT00829452|7147532|FG001|Second Intervention|Physician Decision|1
4372394|NCT00829426|7147538|FG000|Washout: 7 Days|Withdrawal by Subject|1
4372395|NCT00829426|7147539|FG001|Washout: 7 Days|Withdrawal by Subject|0
4372396|NCT00829309|7147545|FG000|Washout: 7 Days|Protocol Violation|1
4372397|NCT00829309|7147546|FG001|Washout: 7 Days|Protocol Violation|0
4372398|NCT00828321|7147552|FG000|Washout of 42 Days|Withdrawal by Subject|2
4372399|NCT00828321|7147553|FG001|Washout of 42 Days|Withdrawal by Subject|0
4372400|NCT00828321|7147552|FG000|Second Intervention|Protocol Violation|0
4372401|NCT00828321|7147553|FG001|Second Intervention|Protocol Violation|1
4372402|NCT00806403|7147559|FG000|Overall Study|Death|4
4372403|NCT00806403|7147560|FG001|Overall Study|Death|3
4372404|NCT00796523|7147600|FG000|Overall Study|Lost to Follow-up|9
4372405|NCT00796523|7147601|FG001|Overall Study|Lost to Follow-up|7
4372406|NCT00794924|7147607|FG000|Overall Study|Lost to Follow-up|6
4372407|NCT00794924|7147608|FG001|Overall Study|Lost to Follow-up|8
4372408|NCT00794924|7147607|FG000|Overall Study|Withdrawal by Subject|48
4372409|NCT00794924|7147608|FG001|Overall Study|Withdrawal by Subject|60
4372410|NCT00794924|7147607|FG000|Overall Study|Adverse Event|6
4372411|NCT00794924|7147608|FG001|Overall Study|Adverse Event|2
4372412|NCT00794677|7147614|FG000|First Intervention|Withdrawal by Subject|2
4372413|NCT00794677|7147615|FG001|First Intervention|Withdrawal by Subject|0
4448297|NCT00496626|7233757|FG000|Overall Study|Withdrawal by Subject|5
4448298|NCT00496626|7233758|FG001|Overall Study|Withdrawal by Subject|4
4448299|NCT00496626|7233757|FG000|Overall Study|Relocated|0
4448300|NCT00496626|7233758|FG001|Overall Study|Relocated|1
4448301|NCT00496769|7233770|FG000|Double Blind|>=1 reason assigned per patient|558
4448302|NCT00496769|7233771|FG001|Double Blind|>=1 reason assigned per patient|649
4448303|NCT00496769|7233772|FG002|Double Blind|>=1 reason assigned per patient|0
4448304|NCT00496769|7233770|FG000|Open Label|>=1 reason assigned per patient|0
4448305|NCT00496769|7233771|FG001|Open Label|>=1 reason assigned per patient|0
4448306|NCT00496769|7233772|FG002|Open Label|>=1 reason assigned per patient|1011
4448307|NCT00496873|7233798|FG000|Overall Study|Ineligible|2
4448308|NCT00496873|7233798|FG000|Overall Study|Death|2
4448309|NCT00496873|7233798|FG000|Overall Study|Withdrawal by Subject|3
4448310|NCT00496964|7233804|FG000|Overall Study|Withdrawal by Subject|0
4448311|NCT00496964|7233805|FG001|Overall Study|Withdrawal by Subject|1
4448312|NCT00497146|7233833|FG000|Treatment Period|Adverse Event|6
4448313|NCT00497146|7233834|FG001|Treatment Period|Adverse Event|2
4448314|NCT00497146|7233833|FG000|Treatment Period|Withdrawal by Subject|5
4448315|NCT00497146|7233834|FG001|Treatment Period|Withdrawal by Subject|9
4448316|NCT00497146|7233833|FG000|Treatment Period|Lost to Follow-up|1
4448317|NCT00497146|7233834|FG001|Treatment Period|Lost to Follow-up|3
4448318|NCT00497146|7233833|FG000|Treatment Period|Required dialysis|4
4448319|NCT00497146|7233834|FG001|Treatment Period|Required dialysis|1
4448320|NCT00497146|7233833|FG000|Treatment Period|Change in RAAS inhibitor therapy|5
4448321|NCT00497146|7233834|FG001|Treatment Period|Change in RAAS inhibitor therapy|2
4448322|NCT00497146|7233833|FG000|Treatment Period|Unable to dose reduce per protocol|4
4448323|NCT00497146|7233834|FG001|Treatment Period|Unable to dose reduce per protocol|1
4448324|NCT00497146|7233833|FG000|Treatment Period|Other Reason|2
4448325|NCT00497146|7233834|FG001|Treatment Period|Other Reason|3
4448326|NCT00497146|7233833|FG000|Long-term Follow-up Period|Adverse Event|2
4448327|NCT00497146|7233834|FG001|Long-term Follow-up Period|Adverse Event|2
4448328|NCT00497146|7233833|FG000|Long-term Follow-up Period|Withdrawal by Subject|8
4448329|NCT00497146|7233834|FG001|Long-term Follow-up Period|Withdrawal by Subject|2
4448330|NCT00497146|7233833|FG000|Long-term Follow-up Period|Lost to Follow-up|5
4448331|NCT00497146|7233834|FG001|Long-term Follow-up Period|Lost to Follow-up|1
4448332|NCT00497146|7233833|FG000|Long-term Follow-up Period|Other|0
4448333|NCT00497146|7233834|FG001|Long-term Follow-up Period|Other|1
4448334|NCT00497198|7233844|FG000|Overall Study|Adverse Event|4
4448335|NCT00497198|7233845|FG001|Overall Study|Adverse Event|2
4448336|NCT00497198|7233844|FG000|Overall Study|Physician Decision|1
4448337|NCT00497198|7233845|FG001|Overall Study|Physician Decision|2
4448338|NCT00497198|7233844|FG000|Overall Study|Withdrawal by Subject|0
4448339|NCT00497198|7233845|FG001|Overall Study|Withdrawal by Subject|1
4448340|NCT00497796|7233882|FG000|Overall Study|Adverse event (not related)|9
4448341|NCT00497796|7233883|FG001|Overall Study|Adverse event (not related)|9
4448342|NCT00497796|7233882|FG000|Overall Study|Adverse event (related)|5
4448343|NCT00497796|7233883|FG001|Overall Study|Adverse event (related)|4
4448344|NCT00497796|7233882|FG000|Overall Study|CMV infection or disease treatment|30
4448345|NCT00497796|7233883|FG001|Overall Study|CMV infection or disease treatment|4
4448346|NCT00497796|7233882|FG000|Overall Study|Consent withdrawn|10
4448347|NCT00497796|7233883|FG001|Overall Study|Consent withdrawn|3
4448348|NCT00497796|7233882|FG000|Overall Study|Investigator/sponsor discretion|31
4448349|NCT00497796|7233883|FG001|Overall Study|Investigator/sponsor discretion|34
4448350|NCT00497796|7233882|FG000|Overall Study|Lost to Follow-up|0
4448351|NCT00497796|7233883|FG001|Overall Study|Lost to Follow-up|1
4448352|NCT00497796|7233882|FG000|Overall Study|Not applicable (randomized not treated)|0
4448353|NCT00497796|7233883|FG001|Overall Study|Not applicable (randomized not treated)|4
4448354|NCT00497874|7233891|FG000|Overall Study|Withdrawal by Subject|48
4448355|NCT00497874|7233892|FG001|Overall Study|Withdrawal by Subject|17
4448356|NCT00497874|7233891|FG000|Overall Study|Illness|8
4448357|NCT00497874|7233892|FG001|Overall Study|Illness|4
4448358|NCT00497874|7233891|FG000|Overall Study|Death|2
4448359|NCT00497874|7233892|FG001|Overall Study|Death|4
4448360|NCT00497874|7233891|FG000|Overall Study|Unable to contact|52
4448361|NCT00497874|7233892|FG001|Overall Study|Unable to contact|67
4448362|NCT00497874|7233891|FG000|Overall Study|Unable to schedule|37
4448363|NCT00497874|7233892|FG001|Overall Study|Unable to schedule|24
4448364|NCT00498173|7233902|FG000|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|2
4448365|NCT00498173|7233903|FG001|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|1
4448366|NCT00498173|7233904|FG002|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|0
4448367|NCT00498186|7233912|FG000|Overall Study|Protocol Violation|10
4448368|NCT00498186|7233912|FG000|Overall Study|Lack of Efficacy|31
4372414|NCT00792116|7147621|FG000|Overall Study|Lost to Follow-up|0
4372415|NCT00792116|7147622|FG001|Overall Study|Lost to Follow-up|1
4372416|NCT00792116|7147621|FG000|Overall Study|Discontnued intervention|1
4372417|NCT00792116|7147622|FG001|Overall Study|Discontnued intervention|0
4372418|NCT00756574|7147642|FG000|Overall Study|Withdrawal by Subject|9
4372419|NCT00756574|7147643|FG001|Overall Study|Withdrawal by Subject|7
4372420|NCT00756574|7147642|FG000|Overall Study|Lost to Follow-up|4
4372421|NCT00756574|7147643|FG001|Overall Study|Lost to Follow-up|4
4448369|NCT00498186|7233912|FG000|Overall Study|Adverse Event|89
4448370|NCT00498186|7233912|FG000|Overall Study|Unsatisfactory compliance of subject|12
4448371|NCT00498186|7233912|FG000|Overall Study|Withdrawal by Subject|18
4448372|NCT00498186|7233912|FG000|Overall Study|Lost to Follow-up|3
4448373|NCT00498186|7233912|FG000|Overall Study|Other|10
4448374|NCT00498355|7233916|FG000|Overall Study|Lost to Follow-up|1
4448375|NCT00498368|7233923|FG000|Overall Study|Withdrawal by Subject|3
4448376|NCT00498368|7233924|FG001|Overall Study|Withdrawal by Subject|2
4448377|NCT00498433|7233933|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2
4448378|NCT00498433|7233934|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0
4448379|NCT00498433|7233935|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0
4448380|NCT00498433|7233933|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2
4448381|NCT00498433|7233934|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0
4448382|NCT00498433|7233935|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0
4448383|NCT00498433|7233933|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15
4448384|NCT00498433|7233934|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0
4448385|NCT00498433|7233935|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0
4448386|NCT00498433|7233933|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1
4448387|NCT00498433|7233934|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0
4448388|NCT00498433|7233935|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0
4448389|NCT00498485|7233954|FG000|Overall Study|Adverse Event|1
4448390|NCT00498485|7233955|FG001|Overall Study|Adverse Event|5
4448391|NCT00498602|7233979|FG000|Overall Study|Death|0
4448392|NCT00498602|7233980|FG001|Overall Study|Death|0
4448393|NCT00498602|7233981|FG002|Overall Study|Death|0
4448394|NCT00498602|7233982|FG003|Overall Study|Death|0
4448395|NCT00498602|7233983|FG004|Overall Study|Death|0
4448396|NCT00498602|7233984|FG005|Overall Study|Death|1
4448397|NCT00498602|7233985|FG006|Overall Study|Death|0
4448398|NCT00498602|7233979|FG000|Overall Study|Lack of Efficacy|1
4448399|NCT00498602|7233980|FG001|Overall Study|Lack of Efficacy|0
4448400|NCT00498602|7233981|FG002|Overall Study|Lack of Efficacy|0
4448401|NCT00498602|7233982|FG003|Overall Study|Lack of Efficacy|0
4448402|NCT00498602|7233983|FG004|Overall Study|Lack of Efficacy|0
4448403|NCT00498602|7233984|FG005|Overall Study|Lack of Efficacy|0
4448404|NCT00498602|7233985|FG006|Overall Study|Lack of Efficacy|0
4448405|NCT00498602|7233979|FG000|Overall Study|Lost to Follow-up|0
4448406|NCT00498602|7233980|FG001|Overall Study|Lost to Follow-up|2
4448407|NCT00498602|7233981|FG002|Overall Study|Lost to Follow-up|0
4448408|NCT00498602|7233982|FG003|Overall Study|Lost to Follow-up|2
4448409|NCT00498602|7233983|FG004|Overall Study|Lost to Follow-up|0
4448410|NCT00498602|7233984|FG005|Overall Study|Lost to Follow-up|0
4448411|NCT00498602|7233985|FG006|Overall Study|Lost to Follow-up|0
4448412|NCT00498602|7233979|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1
4448413|NCT00498602|7233980|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0
4448414|NCT00498602|7233981|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3
4448415|NCT00498602|7233982|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2
4448416|NCT00498602|7233983|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0
4448417|NCT00498602|7233984|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1
4448418|NCT00498602|7233985|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0
4448419|NCT00498602|7233979|FG000|Overall Study|AE not related to Study Drug|1
4448420|NCT00498602|7233980|FG001|Overall Study|AE not related to Study Drug|3
4448421|NCT00498602|7233981|FG002|Overall Study|AE not related to Study Drug|0
4448422|NCT00498602|7233982|FG003|Overall Study|AE not related to Study Drug|0
4448423|NCT00498602|7233983|FG004|Overall Study|AE not related to Study Drug|2
4448424|NCT00498602|7233984|FG005|Overall Study|AE not related to Study Drug|2
4448425|NCT00498602|7233985|FG006|Overall Study|AE not related to Study Drug|1
4448426|NCT00498602|7233979|FG000|Overall Study|Caregiver Request|2
4448427|NCT00498602|7233980|FG001|Overall Study|Caregiver Request|2
4448428|NCT00498602|7233981|FG002|Overall Study|Caregiver Request|2
4448429|NCT00498602|7233982|FG003|Overall Study|Caregiver Request|0
4448430|NCT00498602|7233983|FG004|Overall Study|Caregiver Request|1
4448431|NCT00498602|7233984|FG005|Overall Study|Caregiver Request|2
4448432|NCT00498602|7233985|FG006|Overall Study|Caregiver Request|0
4448433|NCT00498602|7233979|FG000|Overall Study|Investigator Request|0
4448434|NCT00498602|7233980|FG001|Overall Study|Investigator Request|0
4448435|NCT00498602|7233981|FG002|Overall Study|Investigator Request|1
4448436|NCT00498602|7233982|FG003|Overall Study|Investigator Request|0
4448437|NCT00498602|7233983|FG004|Overall Study|Investigator Request|0
4448438|NCT00498602|7233984|FG005|Overall Study|Investigator Request|0
4448439|NCT00498602|7233985|FG006|Overall Study|Investigator Request|0
4448440|NCT00498602|7233979|FG000|Overall Study|Subject Request|3
4372422|NCT00740480|7147650|FG000|Overall Study|Adverse Event|1
4372423|NCT00740480|7147650|FG000|Overall Study|Physician Decision|1
4372424|NCT00724698|7147653|FG000|Overall Study|Adverse Event|9
4372425|NCT00724698|7147653|FG000|Overall Study|Failure of Therapy|4
4372426|NCT00724698|7147653|FG000|Overall Study|Poor Compliance|16
4372427|NCT00724698|7147653|FG000|Overall Study|Lost to Follow-up|36
4372428|NCT00724698|7147653|FG000|Overall Study|No Info|25
4372429|NCT00711555|7147656|FG000|Overall Study|Adverse Event|3
4372430|NCT00676494|7147659|FG000|Overall Study|Missed Visit|8
4372431|NCT00676494|7147659|FG000|Overall Study|Withdrawal by Subject|6
4372432|NCT00659061|7147667|FG000|Overall Study|Migration due to political unrest|21
4372433|NCT00659061|7147668|FG001|Overall Study|Migration due to political unrest|15
4770517|NCT03189719|7746870|FG000|Overall Study|Death|260
4770518|NCT03189719|7746871|FG001|Overall Study|Death|308
4770519|NCT03189719|7746870|FG000|Overall Study|Withdrawal by Subject|5
4770520|NCT03189719|7746871|FG001|Overall Study|Withdrawal by Subject|3
4770521|NCT03189719|7746870|FG000|Overall Study|Ongoing in Study|108
4770522|NCT03189719|7746871|FG001|Overall Study|Ongoing in Study|65
4770523|NCT03155997|7746879|FG000|Overall Study|Withdrawal by Subject|119
4770524|NCT03155997|7746880|FG001|Overall Study|Withdrawal by Subject|134
4770525|NCT03155997|7746879|FG000|Overall Study|Lost to Follow-up|12
4770526|NCT03155997|7746880|FG001|Overall Study|Lost to Follow-up|13
4770527|NCT03155997|7746879|FG000|Overall Study|Missing disposition data|0
4770528|NCT03155997|7746880|FG001|Overall Study|Missing disposition data|1
4770529|NCT03155997|7746879|FG000|Overall Study|On study treatment|2027
4770530|NCT03155997|7746880|FG001|Overall Study|On study treatment|2074
4770531|NCT03104400|7746890|FG000|Overall Study|Adverse Event|5
4770532|NCT03104400|7746891|FG001|Overall Study|Adverse Event|7
4770533|NCT03104400|7746892|FG002|Overall Study|Adverse Event|11
4770534|NCT03104400|7746893|FG003|Overall Study|Adverse Event|9
4770535|NCT03104400|7746894|FG004|Overall Study|Adverse Event|21
4770536|NCT03104400|7746890|FG000|Overall Study|Withdrawal by Subject|17
4770537|NCT03104400|7746891|FG001|Overall Study|Withdrawal by Subject|19
4770538|NCT03104400|7746892|FG002|Overall Study|Withdrawal by Subject|29
4372458|NCT00529152|7147729|FG000|Overall Study|Adverse Event|2
4372459|NCT00529152|7147729|FG000|Overall Study|Withdrawal by Subject|2
4372460|NCT00529152|7147729|FG000|Overall Study|Lost to Follow-up|1
4372461|NCT00526227|7147732|FG000|Overall Study|Device not implanted|1
4372462|NCT00526227|7147732|FG000|Overall Study|Death|1
4372463|NCT00495131|7147752|FG000|Overall Study|Adverse Event|6
4372464|NCT00495131|7147753|FG001|Overall Study|Adverse Event|2
4372465|NCT00495131|7147752|FG000|Overall Study|Lack of Efficacy|0
4372466|NCT00495131|7147753|FG001|Overall Study|Lack of Efficacy|2
4372467|NCT00495131|7147752|FG000|Overall Study|Lost to Follow-up|0
4372468|NCT00495131|7147753|FG001|Overall Study|Lost to Follow-up|2
4372469|NCT00495131|7147752|FG000|Overall Study|Withdrawal by Subject|1
4372470|NCT00495131|7147753|FG001|Overall Study|Withdrawal by Subject|0
4372471|NCT00484419|7147767|FG000|Overall Study|Adverse Event|3
4372472|NCT00484419|7147768|FG001|Overall Study|Adverse Event|0
4372473|NCT00484419|7147769|FG002|Overall Study|Adverse Event|0
4372474|NCT00484419|7147767|FG000|Overall Study|Lost to Follow-up|1
4372475|NCT00484419|7147768|FG001|Overall Study|Lost to Follow-up|0
4372476|NCT00484419|7147769|FG002|Overall Study|Lost to Follow-up|2
4372477|NCT00484419|7147767|FG000|Overall Study|Withdrawal by Subject|3
4372478|NCT00484419|7147768|FG001|Overall Study|Withdrawal by Subject|1
4372479|NCT00484419|7147769|FG002|Overall Study|Withdrawal by Subject|1
4372480|NCT00484419|7147767|FG000|Overall Study|subject met discontinuation criteria|2
4372481|NCT00484419|7147768|FG001|Overall Study|subject met discontinuation criteria|2
4372482|NCT00484419|7147769|FG002|Overall Study|subject met discontinuation criteria|4
4372483|NCT00484419|7147767|FG000|Overall Study|required restricted medication|1
4372484|NCT00484419|7147768|FG001|Overall Study|required restricted medication|0
4372485|NCT00484419|7147769|FG002|Overall Study|required restricted medication|1
4372486|NCT00484419|7147767|FG000|Overall Study|Physician Decision|1
4372487|NCT00484419|7147768|FG001|Overall Study|Physician Decision|1
4372488|NCT00484419|7147769|FG002|Overall Study|Physician Decision|1
4372489|NCT00484419|7147767|FG000|Overall Study|subject unable to receive medication|1
4372490|NCT00484419|7147768|FG001|Overall Study|subject unable to receive medication|0
4372491|NCT00484419|7147769|FG002|Overall Study|subject unable to receive medication|0
4372492|NCT00484419|7147767|FG000|Overall Study|subject relocated|0
4372493|NCT00484419|7147768|FG001|Overall Study|subject relocated|1
4372494|NCT00484419|7147769|FG002|Overall Study|subject relocated|0
4372495|NCT00484419|7147767|FG000|Overall Study|sponsor decision, randomized in error|0
4372496|NCT00484419|7147768|FG001|Overall Study|sponsor decision, randomized in error|0
4372497|NCT00484419|7147769|FG002|Overall Study|sponsor decision, randomized in error|2
4372498|NCT00474188|7147781|FG000|Overall Study|Withdrawal by Subject|1
4372499|NCT00474188|7147781|FG000|Overall Study|Study discontinued by sponsor|5
4372500|NCT00440531|7147787|FG000|Overall Study|Adverse Event|1
4372501|NCT00440531|7147788|FG001|Overall Study|Adverse Event|0
4372502|NCT00440531|7147789|FG002|Overall Study|Adverse Event|2
4372503|NCT00440531|7147787|FG000|Overall Study|Withdrawal by Subject|2
4372504|NCT00440531|7147788|FG001|Overall Study|Withdrawal by Subject|0
4372505|NCT00440531|7147789|FG002|Overall Study|Withdrawal by Subject|0
4372506|NCT00440531|7147787|FG000|Overall Study|Protocol Violation|1
4372456|NCT00581477|7147688|FG000|Overall Study|Physician Decision|2
4372457|NCT00554190|7147709|FG000|Overall Study|Termination forms not completed|10
4372507|NCT00440531|7147788|FG001|Overall Study|Protocol Violation|2
4372508|NCT00440531|7147789|FG002|Overall Study|Protocol Violation|0
4372509|NCT00440531|7147787|FG000|Overall Study|Lost to Follow-up|4
4372510|NCT00440531|7147788|FG001|Overall Study|Lost to Follow-up|3
4372511|NCT00440531|7147789|FG002|Overall Study|Lost to Follow-up|5
4372512|NCT00440531|7147787|FG000|Overall Study|see pre-assignment details|2
4372513|NCT00440531|7147788|FG001|Overall Study|see pre-assignment details|0
4372514|NCT00440531|7147789|FG002|Overall Study|see pre-assignment details|0
4372515|NCT00439738|7147797|FG000|Overall Study|Withdrawal by Subject|16
4372516|NCT00439738|7147798|FG001|Overall Study|Withdrawal by Subject|13
4372517|NCT00439738|7147797|FG000|Overall Study|Adverse Event|6
4372518|NCT00439738|7147798|FG001|Overall Study|Adverse Event|4
4372519|NCT00439738|7147797|FG000|Overall Study|Lost to Follow-up|5
4372520|NCT00439738|7147798|FG001|Overall Study|Lost to Follow-up|6
4372521|NCT00439738|7147797|FG000|Overall Study|Protocol Violation|6
4372522|NCT00439738|7147798|FG001|Overall Study|Protocol Violation|3
4372523|NCT00439738|7147797|FG000|Overall Study|Lack of Efficacy|2
4372524|NCT00439738|7147798|FG001|Overall Study|Lack of Efficacy|2
4372525|NCT00439738|7147797|FG000|Overall Study|Abnormal Lab Values|1
4372526|NCT00439738|7147798|FG001|Overall Study|Abnormal Lab Values|0
4770539|NCT03104400|7746893|FG003|Overall Study|Withdrawal by Subject|25
4770540|NCT03104400|7746894|FG004|Overall Study|Withdrawal by Subject|24
4770541|NCT03104400|7746890|FG000|Overall Study|Lost to Follow-up|4
4770542|NCT03104400|7746891|FG001|Overall Study|Lost to Follow-up|1
4770543|NCT03104400|7746892|FG002|Overall Study|Lost to Follow-up|4
4770544|NCT03104400|7746893|FG003|Overall Study|Lost to Follow-up|8
4770545|NCT03104400|7746894|FG004|Overall Study|Lost to Follow-up|7
4770546|NCT03104400|7746890|FG000|Overall Study|Lack of Efficacy|6
4770547|NCT03104400|7746891|FG001|Overall Study|Lack of Efficacy|3
4770548|NCT03104400|7746892|FG002|Overall Study|Lack of Efficacy|8
4770549|NCT03104400|7746893|FG003|Overall Study|Lack of Efficacy|2
4770550|NCT03104400|7746894|FG004|Overall Study|Lack of Efficacy|1
4770551|NCT03104400|7746890|FG000|Overall Study|COVID Logistical Restrictions|0
4770552|NCT03104400|7746891|FG001|Overall Study|COVID Logistical Restrictions|0
4770553|NCT03104400|7746892|FG002|Overall Study|COVID Logistical Restrictions|0
4770554|NCT03104400|7746893|FG003|Overall Study|COVID Logistical Restrictions|1
4770555|NCT03104400|7746894|FG004|Overall Study|COVID Logistical Restrictions|0
4770556|NCT03104400|7746890|FG000|Overall Study|Other|2
4770557|NCT03104400|7746891|FG001|Overall Study|Other|3
4770558|NCT03104400|7746892|FG002|Overall Study|Other|7
4770559|NCT03104400|7746893|FG003|Overall Study|Other|6
4770560|NCT03104400|7746894|FG004|Overall Study|Other|4
4770561|NCT03104400|7746890|FG000|Overall Study|Other|0
4770562|NCT03104400|7746891|FG001|Overall Study|Other|1
4770563|NCT03104400|7746892|FG002|Overall Study|Other|0
4770564|NCT03104400|7746893|FG003|Overall Study|Other|0
4770565|NCT03104400|7746894|FG004|Overall Study|Other|0
4770566|NCT03104374|7746911|FG000|Overall Study|Adverse Event|7
4770567|NCT03104374|7746912|FG001|Overall Study|Adverse Event|6
4770568|NCT03104374|7746913|FG002|Overall Study|Adverse Event|12
4770569|NCT03104374|7746914|FG003|Overall Study|Adverse Event|15
4770570|NCT03104374|7746911|FG000|Overall Study|Withdrawal by Subject|18
4770571|NCT03104374|7746912|FG001|Overall Study|Withdrawal by Subject|10
4770572|NCT03104374|7746913|FG002|Overall Study|Withdrawal by Subject|10
4770573|NCT03104374|7746914|FG003|Overall Study|Withdrawal by Subject|17
4770574|NCT03104374|7746911|FG000|Overall Study|Lost to Follow-up|4
4770575|NCT03104374|7746912|FG001|Overall Study|Lost to Follow-up|4
4770576|NCT03104374|7746913|FG002|Overall Study|Lost to Follow-up|6
4770577|NCT03104374|7746914|FG003|Overall Study|Lost to Follow-up|8
4770578|NCT03104374|7746911|FG000|Overall Study|Lack of Efficacy|6
4770579|NCT03104374|7746912|FG001|Overall Study|Lack of Efficacy|7
4770580|NCT03104374|7746913|FG002|Overall Study|Lack of Efficacy|12
4770581|NCT03104374|7746914|FG003|Overall Study|Lack of Efficacy|6
4770582|NCT03104374|7746911|FG000|Overall Study|Other|2
4770583|NCT03104374|7746912|FG001|Overall Study|Other|2
4770584|NCT03104374|7746913|FG002|Overall Study|Other|4
4770585|NCT03104374|7746914|FG003|Overall Study|Other|7
4770586|NCT03072043|7746927|FG000|Overall Study|Death|0
4770587|NCT03072043|7746928|FG001|Overall Study|Death|0
4770588|NCT03072043|7746929|FG002|Overall Study|Death|3
4770589|NCT03072043|7746927|FG000|Overall Study|Adverse Event|0
4770590|NCT03072043|7746928|FG001|Overall Study|Adverse Event|0
4770591|NCT03072043|7746929|FG002|Overall Study|Adverse Event|2
4770592|NCT03072043|7746927|FG000|Overall Study|Withdrawal by Subject|0
4770593|NCT03072043|7746928|FG001|Overall Study|Withdrawal by Subject|0
4770594|NCT03072043|7746929|FG002|Overall Study|Withdrawal by Subject|4
4770595|NCT02905032|7746957|FG000|Overall Study|Withdrawal by Subject|2
4770596|NCT02905032|7746958|FG001|Overall Study|Withdrawal by Subject|0
4770597|NCT02905032|7746959|FG002|Overall Study|Withdrawal by Subject|0
4770598|NCT02905032|7746957|FG000|Overall Study|Protocol Violation|6
4770599|NCT02905032|7746958|FG001|Overall Study|Protocol Violation|12
4770600|NCT02905032|7746959|FG002|Overall Study|Protocol Violation|0
4448441|NCT00498602|7233980|FG001|Overall Study|Subject Request|0
4770601|NCT02837029|7746969|FG000|Screening|Failed to meet screening requirements.|7
4770602|NCT02837029|7746970|FG001|Screening|Failed to meet screening requirements.|3
4694469|NCT02607306|7605959|FG001|Overall Study|Lack of Efficacy|1
4770603|NCT02837029|7746971|FG002|Screening|Failed to meet screening requirements.|0
4770604|NCT02837029|7746969|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2
4770605|NCT02837029|7746970|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0
4770606|NCT02837029|7746971|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0
4448442|NCT00498602|7233981|FG002|Overall Study|Subject Request|1
4448443|NCT00498602|7233982|FG003|Overall Study|Subject Request|1
4448444|NCT00498602|7233983|FG004|Overall Study|Subject Request|1
4448445|NCT00498602|7233984|FG005|Overall Study|Subject Request|4
4448446|NCT00498602|7233985|FG006|Overall Study|Subject Request|1
4448447|NCT00498602|7233979|FG000|Overall Study|Other|2
4448448|NCT00498602|7233980|FG001|Overall Study|Other|3
4448449|NCT00498602|7233981|FG002|Overall Study|Other|1
4448450|NCT00498602|7233982|FG003|Overall Study|Other|0
4448451|NCT00498602|7233983|FG004|Overall Study|Other|0
4448452|NCT00498602|7233984|FG005|Overall Study|Other|3
4448453|NCT00498602|7233985|FG006|Overall Study|Other|0
4448454|NCT00498797|7234044|FG000|Overall Study|Withdrawal by Subject|4
4448455|NCT00498797|7234045|FG001|Overall Study|Withdrawal by Subject|2
4448456|NCT00498797|7234044|FG000|Overall Study|Adverse Event|12
4448457|NCT00498797|7234045|FG001|Overall Study|Adverse Event|5
4448458|NCT00498797|7234044|FG000|Overall Study|Condition under investigation worsened|19
4448459|NCT00498797|7234045|FG001|Overall Study|Condition under investigation worsened|21
4448460|NCT00498797|7234044|FG000|Overall Study|Other|3
4448461|NCT00498797|7234045|FG001|Overall Study|Other|1
4448462|NCT00499031|7234064|FG000|Overall Study|Improper pre-protocol treatment|1
4448463|NCT00499031|7234064|FG000|Overall Study|Required test not done|1
4448464|NCT00499031|7234064|FG000|Overall Study|Never treated|1
4448465|NCT00499083|7234068|FG000|Overall Study|Not evaluable|3
4448466|NCT00499122|7234095|FG000|Overall Study|Withdrawal by Subject|2
4448467|NCT00499174|7234102|FG000|Overall Study|Physician Decision|78
4448468|NCT00499174|7234103|FG001|Overall Study|Physician Decision|9
4448469|NCT00499252|7234111|FG000|Overall Study|Adverse Event|3
4448470|NCT00499252|7234111|FG000|Overall Study|Refused further treatment|2
4448471|NCT00499252|7234111|FG000|Overall Study|Ineligible|4
4448472|NCT00499252|7234111|FG000|Overall Study|<no further label>|3
4448473|NCT00499369|7234133|FG000|Overall Study|Adverse Event|2
4448474|NCT00499369|7234134|FG001|Overall Study|Adverse Event|2
4448475|NCT00499369|7234135|FG002|Overall Study|Adverse Event|3
4448476|NCT00499369|7234136|FG003|Overall Study|Adverse Event|1
4448477|NCT00499369|7234137|FG004|Overall Study|Adverse Event|2
4448478|NCT00499369|7234133|FG000|Overall Study|Withdrawal by Subject|0
4448479|NCT00499369|7234134|FG001|Overall Study|Withdrawal by Subject|1
4448480|NCT00499369|7234135|FG002|Overall Study|Withdrawal by Subject|1
4448481|NCT00499369|7234136|FG003|Overall Study|Withdrawal by Subject|0
4448482|NCT00499369|7234137|FG004|Overall Study|Withdrawal by Subject|0
4448483|NCT00499369|7234133|FG000|Overall Study|Progression|10
4448484|NCT00499369|7234134|FG001|Overall Study|Progression|12
4448485|NCT00499369|7234135|FG002|Overall Study|Progression|9
4448486|NCT00499369|7234136|FG003|Overall Study|Progression|6
4448487|NCT00499369|7234137|FG004|Overall Study|Progression|10
4448488|NCT00499369|7234133|FG000|Overall Study|Death|0
4448489|NCT00499369|7234134|FG001|Overall Study|Death|1
4448490|NCT00499369|7234135|FG002|Overall Study|Death|0
4448491|NCT00499369|7234136|FG003|Overall Study|Death|0
4448492|NCT00499369|7234137|FG004|Overall Study|Death|0
4448493|NCT00499369|7234133|FG000|Overall Study|Not protocol specified|2
4448494|NCT00499369|7234134|FG001|Overall Study|Not protocol specified|0
4448495|NCT00499369|7234135|FG002|Overall Study|Not protocol specified|3
4448496|NCT00499369|7234136|FG003|Overall Study|Not protocol specified|1
4448497|NCT00499369|7234137|FG004|Overall Study|Not protocol specified|0
4448498|NCT00499369|7234133|FG000|Overall Study|Ineligible|2
4448499|NCT00499369|7234134|FG001|Overall Study|Ineligible|2
4448500|NCT00499369|7234135|FG002|Overall Study|Ineligible|1
4448501|NCT00499369|7234136|FG003|Overall Study|Ineligible|1
4448502|NCT00499369|7234137|FG004|Overall Study|Ineligible|0
4448503|NCT00499460|7234159|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1
4448504|NCT00499460|7234160|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0
4448505|NCT00499460|7234159|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1
4448506|NCT00499460|7234160|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0
4448507|NCT00499460|7234159|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0
4448508|NCT00499460|7234160|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1
4448509|NCT00499486|7234185|FG000|Overall Study|Withdrawal by Subject|16
4448510|NCT00499603|7234191|FG000|Overall Study|Adverse Event|0
4448511|NCT00499603|7234192|FG001|Overall Study|Adverse Event|1
4448512|NCT00499616|7234204|FG000|Overall Study|Death|1
4694470|NCT02607306|7605960|FG002|Overall Study|Lack of Efficacy|1
4448513|NCT00499616|7234205|FG001|Overall Study|Death|5
4448514|NCT00499616|7234206|FG002|Overall Study|Death|3
4448515|NCT00499616|7234207|FG003|Overall Study|Death|1
4448516|NCT00499616|7234204|FG000|Overall Study|Lack of Efficacy|5
4448517|NCT00499616|7234205|FG001|Overall Study|Lack of Efficacy|0
4448518|NCT00499616|7234206|FG002|Overall Study|Lack of Efficacy|19
4694471|NCT02607306|7605958|FG000|Overall Study|Protocol Violation|4
4448519|NCT00499616|7234207|FG003|Overall Study|Lack of Efficacy|0
4448520|NCT00499616|7234204|FG000|Overall Study|Lost to Follow-up|0
4448521|NCT00499616|7234205|FG001|Overall Study|Lost to Follow-up|0
4372593|NCT00430950|7147827|FG000|Overall Study|Adverse Event|7
4372594|NCT00430950|7147828|FG001|Overall Study|Adverse Event|6
4372595|NCT00430950|7147827|FG000|Overall Study|Withdrawal by Subject|1
4372596|NCT00430950|7147828|FG001|Overall Study|Withdrawal by Subject|0
4372597|NCT00430950|7147827|FG000|Overall Study|concomitant medication,etc.|5
4372598|NCT00430950|7147828|FG001|Overall Study|concomitant medication,etc.|7
4372599|NCT00430508|7147836|FG000|Overall Study|Adverse Event|2
4372600|NCT00430508|7147837|FG001|Overall Study|Adverse Event|3
4372601|NCT00430508|7147838|FG002|Overall Study|Adverse Event|5
4372602|NCT00430508|7147839|FG003|Overall Study|Adverse Event|3
4372603|NCT00430508|7147836|FG000|Overall Study|Withdrawal by Subject|0
4372604|NCT00430508|7147837|FG001|Overall Study|Withdrawal by Subject|1
4372605|NCT00430508|7147838|FG002|Overall Study|Withdrawal by Subject|1
4372606|NCT00430508|7147839|FG003|Overall Study|Withdrawal by Subject|1
4372607|NCT00430508|7147836|FG000|Overall Study|responder at visit 4|0
4372608|NCT00430508|7147837|FG001|Overall Study|responder at visit 4|0
4372609|NCT00430508|7147838|FG002|Overall Study|responder at visit 4|2
4372610|NCT00430508|7147839|FG003|Overall Study|responder at visit 4|0
4372611|NCT00430508|7147836|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0
4372612|NCT00430508|7147837|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1
4372613|NCT00430508|7147838|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2
4372614|NCT00430508|7147839|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1
4372615|NCT00430508|7147836|FG000|Overall Study|Other|1
4372616|NCT00430508|7147837|FG001|Overall Study|Other|1
4372617|NCT00430508|7147838|FG002|Overall Study|Other|3
4372618|NCT00430508|7147839|FG003|Overall Study|Other|0
4372619|NCT00430092|7147848|FG000|Overall Study|Adverse Event|0
4372620|NCT00430092|7147849|FG001|Overall Study|Adverse Event|0
4372621|NCT00430092|7147850|FG002|Overall Study|Adverse Event|1
4372622|NCT00430092|7147848|FG000|Overall Study|Lack of Efficacy|5
4372623|NCT00430092|7147849|FG001|Overall Study|Lack of Efficacy|2
4372624|NCT00430092|7147850|FG002|Overall Study|Lack of Efficacy|54
4372625|NCT00430092|7147848|FG000|Overall Study|Lost to Follow-up|1
4372626|NCT00430092|7147849|FG001|Overall Study|Lost to Follow-up|0
4372627|NCT00430092|7147850|FG002|Overall Study|Lost to Follow-up|0
4372628|NCT00430092|7147848|FG000|Overall Study|Protocol Violation|0
4372629|NCT00430092|7147849|FG001|Overall Study|Protocol Violation|1
4372630|NCT00430092|7147850|FG002|Overall Study|Protocol Violation|1
4372631|NCT00430092|7147848|FG000|Overall Study|Withdrawal by Subject|0
4372632|NCT00430092|7147849|FG001|Overall Study|Withdrawal by Subject|1
4372633|NCT00430092|7147850|FG002|Overall Study|Withdrawal by Subject|1
4372634|NCT00429923|7147858|FG000|Overall Study|Adverse Event|0
4372635|NCT00429923|7147859|FG001|Overall Study|Adverse Event|2
4372636|NCT00429923|7147860|FG002|Overall Study|Adverse Event|3
4372637|NCT00429923|7147858|FG000|Overall Study|Lack of Efficacy|4
4372638|NCT00429923|7147859|FG001|Overall Study|Lack of Efficacy|1
4372639|NCT00429923|7147860|FG002|Overall Study|Lack of Efficacy|33
4372640|NCT00429923|7147858|FG000|Overall Study|Lost to Follow-up|0
4372641|NCT00429923|7147859|FG001|Overall Study|Lost to Follow-up|0
4372642|NCT00429923|7147860|FG002|Overall Study|Lost to Follow-up|2
4372643|NCT00429923|7147858|FG000|Overall Study|Withdrew Consent|1
4372644|NCT00429923|7147859|FG001|Overall Study|Withdrew Consent|0
4372645|NCT00429923|7147860|FG002|Overall Study|Withdrew Consent|1
4372646|NCT00429923|7147858|FG000|Overall Study|Early Termination|0
4372647|NCT00429923|7147859|FG001|Overall Study|Early Termination|1
4372648|NCT00429923|7147860|FG002|Overall Study|Early Termination|0
4372649|NCT00425100|7147865|FG000|Overall Study|Adverse Event|36
4372650|NCT00425100|7147865|FG000|Overall Study|Lack of Efficacy|4
4372651|NCT00425100|7147865|FG000|Overall Study|Lost to Follow-up|2
4372652|NCT00425100|7147865|FG000|Overall Study|Protocol Violation|4
4372653|NCT00425100|7147865|FG000|Overall Study|Withdrawal by Subject|7
4372654|NCT00415623|7147872|FG000|Overall Study|Adverse Event|3
4372655|NCT00415623|7147873|FG001|Overall Study|Adverse Event|4
4372656|NCT00415623|7147872|FG000|Overall Study|Death|1
4372657|NCT00415623|7147873|FG001|Overall Study|Death|0
4372658|NCT00415623|7147872|FG000|Overall Study|Withdrawal by Subject|1
4372659|NCT00415623|7147873|FG001|Overall Study|Withdrawal by Subject|1
4372660|NCT00412932|7147880|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1
4372661|NCT00412932|7147880|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2
4372662|NCT00412932|7147880|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1
4372663|NCT00412932|7147880|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2
4372664|NCT00412932|7147880|FG000|Olmesartan (Olm) 20 mg|Other|1
4372665|NCT00412932|7147880|FG000|Olmesartan 40 mg|Adverse Event|4
4372666|NCT00412932|7147880|FG000|Olmesartan 40 mg|Lack of Efficacy|3
4372667|NCT00412932|7147880|FG000|Olmesartan 40 mg|Withdrawal by Subject|1
4372668|NCT00412932|7147880|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3
4372669|NCT00412932|7147880|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3
4372670|NCT00412932|7147880|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1
4372671|NCT00412932|7147880|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1
4372672|NCT00397254|7147883|FG000|Overall Study|Lost to Follow-up|2
4372673|NCT00397254|7147884|FG001|Overall Study|Lost to Follow-up|2
4448522|NCT00499616|7234206|FG002|Overall Study|Lost to Follow-up|1
4448523|NCT00499616|7234207|FG003|Overall Study|Lost to Follow-up|0
4448524|NCT00499616|7234204|FG000|Overall Study|Physician Decision|6
4448525|NCT00499616|7234205|FG001|Overall Study|Physician Decision|16
4372674|NCT00338104|7147912|FG000|Overall Study|Protocol Violation|2
4372675|NCT00338104|7147913|FG001|Overall Study|Protocol Violation|1
4372676|NCT00338104|7147914|FG002|Overall Study|Protocol Violation|3
4372677|NCT00326183|7147924|FG000|Overall Study|Lost to Follow-up|104
4372678|NCT00326183|7147925|FG001|Overall Study|Lost to Follow-up|56
4372679|NCT00326183|7147924|FG000|Overall Study|Protocol Violation|6
4372680|NCT00326183|7147925|FG001|Overall Study|Protocol Violation|3
4372681|NCT00326183|7147924|FG000|Overall Study|Withdrawal by Subject|35
4372682|NCT00326183|7147925|FG001|Overall Study|Withdrawal by Subject|7
4372683|NCT00326183|7147924|FG000|Overall Study|Subject Moved|7
4372684|NCT00326183|7147925|FG001|Overall Study|Subject Moved|4
4372685|NCT00326183|7147924|FG000|Overall Study|Other|47
4372686|NCT00326183|7147925|FG001|Overall Study|Other|13
4372687|NCT00326183|7147924|FG000|Overall Study|Adverse Event|1
4372688|NCT00326183|7147925|FG001|Overall Study|Adverse Event|0
4372689|NCT00318656|7147938|FG000|Overall Study|Took Avandamet instead of Glim/Met|0
4372690|NCT00318656|7147939|FG001|Overall Study|Took Avandamet instead of Glim/Met|1
4372691|NCT00318656|7147938|FG000|Overall Study|Did not receive any treatment|0
4372692|NCT00318656|7147939|FG001|Overall Study|Did not receive any treatment|1
4372735|NCT00162942|7148056|FG000|Overall Study|Adverse Event|10
4372736|NCT00162942|7148057|FG001|Overall Study|Adverse Event|6
4372737|NCT00162942|7148056|FG000|Overall Study|Death|1
4372738|NCT00162942|7148057|FG001|Overall Study|Death|0
4372739|NCT00162942|7148056|FG000|Overall Study|Withdrawal by Subject|3
4372740|NCT00162942|7148057|FG001|Overall Study|Withdrawal by Subject|6
4372741|NCT00162942|7148056|FG000|Overall Study|Physician Decision|1
4372742|NCT00162942|7148057|FG001|Overall Study|Physician Decision|0
4372743|NCT00162942|7148056|FG000|Overall Study|Enter Open-Label Study|76
4372744|NCT00162942|7148057|FG001|Overall Study|Enter Open-Label Study|35
4372745|NCT00162942|7148056|FG000|Overall Study|Alternate Therapy|6
4372746|NCT00162942|7148057|FG001|Overall Study|Alternate Therapy|2
4372747|NCT00162942|7148056|FG000|Overall Study|Lack of Efficacy|1
4372748|NCT00162942|7148057|FG001|Overall Study|Lack of Efficacy|0
4372749|NCT00162942|7148056|FG000|Overall Study|Flare During Active Treatment|7
4372750|NCT00162942|7148057|FG001|Overall Study|Flare During Active Treatment|3
4372751|NCT00162942|7148056|FG000|Overall Study|2 or more consecutive treatments missed|1
4372752|NCT00162942|7148057|FG001|Overall Study|2 or more consecutive treatments missed|0
4372753|NCT00126776|7148077|FG000|Overall Study|follow up complete on all patients|0
4372754|NCT00126776|7148078|FG001|Overall Study|follow up complete on all patients|0
4372755|NCT00120042|7148085|FG000|Overall Study|all completed protocl|0
4372756|NCT00120042|7148086|FG001|Overall Study|all completed protocl|0
4372757|NCT00120042|7148087|FG002|Overall Study|all completed protocl|0
4372758|NCT00106626|7148096|FG000|Overall Study|Adverse Event|5
4372759|NCT00106626|7148097|FG001|Overall Study|Adverse Event|4
4372760|NCT00106626|7148098|FG002|Overall Study|Adverse Event|3
4372761|NCT00106626|7148099|FG003|Overall Study|Adverse Event|3
4372762|NCT00106626|7148096|FG000|Overall Study|Progressive Disease|4
4372763|NCT00106626|7148097|FG001|Overall Study|Progressive Disease|1
4372764|NCT00106626|7148098|FG002|Overall Study|Progressive Disease|9
4372765|NCT00106626|7148099|FG003|Overall Study|Progressive Disease|10
4372766|NCT00106626|7148096|FG000|Overall Study|Received radiation on new therapy|1
4372767|NCT00106626|7148097|FG001|Overall Study|Received radiation on new therapy|0
4372768|NCT00106626|7148098|FG002|Overall Study|Received radiation on new therapy|0
4372769|NCT00106626|7148099|FG003|Overall Study|Received radiation on new therapy|0
4372770|NCT00106626|7148096|FG000|Overall Study|> 14 day delay in therapy start|0
4372771|NCT00106626|7148097|FG001|Overall Study|> 14 day delay in therapy start|1
4372772|NCT00106626|7148098|FG002|Overall Study|> 14 day delay in therapy start|0
4372773|NCT00106626|7148099|FG003|Overall Study|> 14 day delay in therapy start|0
4372774|NCT00089141|7148116|FG000|Overall Study|Termination of trial|18
4372775|NCT00089141|7148117|FG001|Overall Study|Termination of trial|24
4372776|NCT00083759|7148123|FG000|Overall Study|Adverse Event|5
4372777|NCT00083759|7148124|FG001|Overall Study|Adverse Event|3
4372778|NCT00083759|7148123|FG000|Overall Study|Lost to Follow-up|1
4372779|NCT00083759|7148124|FG001|Overall Study|Lost to Follow-up|0
4372780|NCT00083759|7148123|FG000|Overall Study|Death|1
4372781|NCT00083759|7148124|FG001|Overall Study|Death|1
4372782|NCT00083759|7148123|FG000|Overall Study|Inadequate Therapeutic Response|32
4372783|NCT00083759|7148124|FG001|Overall Study|Inadequate Therapeutic Response|35
4372784|NCT00083759|7148123|FG000|Overall Study|Subject Withdrew Consent|2
4372785|NCT00083759|7148124|FG001|Overall Study|Subject Withdrew Consent|2
4372786|NCT00083759|7148123|FG000|Overall Study|Non-Compliance|1
4372787|NCT00083759|7148124|FG001|Overall Study|Non-Compliance|0
4372788|NCT00083759|7148123|FG000|Overall Study|Sponsor's Discretion|28
4372789|NCT00083759|7148124|FG001|Overall Study|Sponsor's Discretion|29
4372790|NCT00083759|7148123|FG000|Overall Study|Other|14
4372791|NCT00083759|7148124|FG001|Overall Study|Other|13
4372792|NCT03513068|7148130|FG000|Overall Study|Death|1
4372793|NCT03513068|7148131|FG001|Overall Study|Death|0
4372794|NCT03513068|7148130|FG000|Overall Study|Withdrawal by Subject|4
4372795|NCT03513068|7148131|FG001|Overall Study|Withdrawal by Subject|6
4372796|NCT03502811|7148137|FG000|Overall Study|Death|157
4372797|NCT03502811|7148137|FG000|Overall Study|Withdrawal by Subject|105
4372798|NCT03502811|7148137|FG000|Overall Study|Lost to Follow-up|26
4372799|NCT03502811|7148137|FG000|Overall Study|No Visits (Missed)|31
4372693|NCT00301262|7147945|FG000|Double Blind Phase (DB)|Adverse Event|1
4372694|NCT00301262|7147946|FG001|Double Blind Phase (DB)|Adverse Event|0
4372695|NCT00301262|7147945|FG000|Double Blind Phase (DB)|Lack of Efficacy|0
4372696|NCT00301262|7147946|FG001|Double Blind Phase (DB)|Lack of Efficacy|1
4372697|NCT00301262|7147945|FG000|Double Blind Phase (DB)|Lost to Follow-up|3
4372698|NCT00301262|7147946|FG001|Double Blind Phase (DB)|Lost to Follow-up|3
4372699|NCT00301262|7147945|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5
4372700|NCT00301262|7147946|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5
4372701|NCT00301262|7147945|FG000|Double Blind Phase (DB)|Other|1
4372702|NCT00301262|7147946|FG001|Double Blind Phase (DB)|Other|4
4372703|NCT00301262|7147945|FG000|Open Label Phase (OL)|Adverse Event|1
4372704|NCT00301262|7147946|FG001|Open Label Phase (OL)|Adverse Event|0
4372705|NCT00301262|7147945|FG000|Open Label Phase (OL)|Lost to Follow-up|1
4372706|NCT00301262|7147946|FG001|Open Label Phase (OL)|Lost to Follow-up|2
4372707|NCT00301262|7147945|FG000|Open Label Phase (OL)|Other|2
4372708|NCT00301262|7147946|FG001|Open Label Phase (OL)|Other|0
4372709|NCT00283868|7147973|FG000|Overall Study|Lost to Follow-up|7
4372710|NCT00283868|7147974|FG001|Overall Study|Lost to Follow-up|8
4372711|NCT00282867|7147981|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1
4372712|NCT00282867|7147982|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1
4372713|NCT00282867|7147983|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0
4372714|NCT00275340|7147990|FG000|Overall Study|Lost to Follow-up|2
4372715|NCT00275340|7147991|FG001|Overall Study|Lost to Follow-up|4
4372716|NCT00271544|7147995|FG000|Overall Study|Subjects did not receive a 4196 lead|7
4372717|NCT00271544|7147995|FG000|Overall Study|Model 4196 lead not attempted|9
4372718|NCT00271544|7147995|FG000|Overall Study|Implant not attempted|4
4372719|NCT00235326|7148032|FG000|Overall Study|Lost to Follow-up|746
4372720|NCT00235326|7148033|FG001|Overall Study|Lost to Follow-up|1400
4372721|NCT00232141|7148039|FG000|Overall Study|Adverse Event|9
4372722|NCT00232141|7148040|FG001|Overall Study|Adverse Event|4
4372723|NCT00232141|7148039|FG000|Overall Study|Lack of Efficacy|0
4372724|NCT00232141|7148040|FG001|Overall Study|Lack of Efficacy|3
4372725|NCT00232141|7148039|FG000|Overall Study|Lost to Follow-up|9
4372726|NCT00232141|7148040|FG001|Overall Study|Lost to Follow-up|6
4372727|NCT00232141|7148039|FG000|Overall Study|Other|8
4372728|NCT00232141|7148040|FG001|Overall Study|Other|10
4372729|NCT00232141|7148039|FG000|Overall Study|Withdrawal by Subject|5
4372730|NCT00232141|7148040|FG001|Overall Study|Withdrawal by Subject|3
4372731|NCT00224003|7148051|FG000|Overall Study|Adverse Event|1
4372732|NCT00224003|7148051|FG000|Overall Study|Protocol Violation|2
4372733|NCT00224003|7148051|FG000|Overall Study|Withdrawal by Subject|1
4372734|NCT00224003|7148051|FG000|Overall Study|unk|3
4372800|NCT04604184|7148143|FG000|Overall Study|Adverse Event|5
4372801|NCT04604184|7148144|FG001|Overall Study|Adverse Event|5
4372802|NCT04604184|7148143|FG000|Overall Study|Death|2
4372803|NCT04604184|7148144|FG001|Overall Study|Death|1
4372804|NCT04604184|7148143|FG000|Overall Study|Withdrawal by Subject|1
4372805|NCT04604184|7148144|FG001|Overall Study|Withdrawal by Subject|3
4372806|NCT04604184|7148143|FG000|Overall Study|Not treated|2
4372807|NCT04604184|7148144|FG001|Overall Study|Not treated|2
4372808|NCT04604184|7148143|FG000|Overall Study|Due to sponsor decision|9
4372809|NCT04604184|7148144|FG001|Overall Study|Due to sponsor decision|7
4372810|NCT04604184|7148143|FG000|Overall Study|Physician Decision|0
4372811|NCT04604184|7148144|FG001|Overall Study|Physician Decision|1
4372812|NCT04604184|7148143|FG000|Overall Study|Transfer to healthcare|1
4372813|NCT04604184|7148144|FG001|Overall Study|Transfer to healthcare|0
4448526|NCT00499616|7234206|FG002|Overall Study|Physician Decision|9
4448527|NCT00499616|7234207|FG003|Overall Study|Physician Decision|0
4448528|NCT00499616|7234204|FG000|Overall Study|Withdrawal by Subject|1
4448529|NCT00499616|7234205|FG001|Overall Study|Withdrawal by Subject|0
4448530|NCT00499616|7234206|FG002|Overall Study|Withdrawal by Subject|1
4448531|NCT00499616|7234207|FG003|Overall Study|Withdrawal by Subject|0
4448532|NCT00499616|7234204|FG000|Overall Study|Ineligible|1
4448533|NCT00499616|7234205|FG001|Overall Study|Ineligible|2
4448534|NCT00499616|7234206|FG002|Overall Study|Ineligible|0
4448535|NCT00499616|7234207|FG003|Overall Study|Ineligible|15
4448536|NCT00499616|7234204|FG000|Overall Study|Not evaluable|0
4448537|NCT00499616|7234205|FG001|Overall Study|Not evaluable|0
4448538|NCT00499616|7234206|FG002|Overall Study|Not evaluable|0
4448539|NCT00499616|7234207|FG003|Overall Study|Not evaluable|41
4448540|NCT00499616|7234204|FG000|Overall Study|Patient/Parent Refusal|1
4448541|NCT00499616|7234205|FG001|Overall Study|Patient/Parent Refusal|5
4448542|NCT00499616|7234206|FG002|Overall Study|Patient/Parent Refusal|3
4448543|NCT00499616|7234207|FG003|Overall Study|Patient/Parent Refusal|0
4448544|NCT00499681|7234232|FG000|Overall Study|toxicity|0
4448545|NCT00499681|7234233|FG001|Overall Study|toxicity|1
4448546|NCT00499681|7234232|FG000|Overall Study|disease progression|0
4448547|NCT00499681|7234233|FG001|Overall Study|disease progression|1
4448548|NCT00499694|7234239|FG000|Overall Study|Patient never received treatment.|1
4448549|NCT00499746|7234244|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7
4448550|NCT00499746|7234244|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3
4448551|NCT00499746|7234244|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1
4448552|NCT00499746|7234244|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1
4448553|NCT00499863|7234260|FG000|Overall Study|Lack of Efficacy|21
4372814|NCT04368429|7148152|FG000|Overall Study|Adverse Event|1
4372815|NCT04368429|7148153|FG001|Overall Study|Adverse Event|0
4372816|NCT03865316|7148171|FG000|Overall Study|Procedure Cancelled|4
4372817|NCT03865316|7148171|FG000|Overall Study|Equipment failure|4
4372818|NCT03688555|7148177|FG000|Treatment Period|Adverse Event|0
4372819|NCT03688555|7148178|FG001|Treatment Period|Adverse Event|0
4372820|NCT03688555|7148179|FG002|Treatment Period|Adverse Event|1
4372821|NCT03593213|7148189|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39
4372822|NCT03593213|7148190|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0
4372823|NCT03593213|7148191|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0
4372824|NCT03593213|7148192|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0
4372825|NCT03593213|7148189|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14
4372826|NCT03593213|7148190|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0
4372827|NCT03593213|7148191|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0
4372828|NCT03593213|7148192|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0
4372829|NCT03593213|7148189|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85
4372830|NCT03593213|7148190|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0
4372831|NCT03593213|7148191|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0
4372832|NCT03593213|7148192|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0
4372833|NCT03593213|7148189|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51
4372834|NCT03593213|7148190|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0
4372835|NCT03593213|7148191|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0
4372836|NCT03593213|7148192|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0
4372837|NCT03593213|7148189|FG000|Open-label Treatment Period (18 Weeks)|Death|1
4372838|NCT03593213|7148190|FG001|Open-label Treatment Period (18 Weeks)|Death|0
4372839|NCT03593213|7148191|FG002|Open-label Treatment Period (18 Weeks)|Death|0
4372840|NCT03593213|7148192|FG003|Open-label Treatment Period (18 Weeks)|Death|0
4372841|NCT03593213|7148189|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5
4372842|NCT03593213|7148190|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0
4372843|NCT03593213|7148191|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0
4372844|NCT03593213|7148192|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0
4372845|NCT03593213|7148189|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23
4372846|NCT03593213|7148190|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0
4372847|NCT03593213|7148191|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0
4372848|NCT03593213|7148192|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0
4372849|NCT03593213|7148189|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90
4372850|NCT03593213|7148190|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0
4372851|NCT03593213|7148191|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0
4372852|NCT03593213|7148192|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0
4372853|NCT03593213|7148189|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13
4372854|NCT03593213|7148190|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0
4372855|NCT03593213|7148191|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0
4372856|NCT03593213|7148192|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0
4372857|NCT03593213|7148189|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104
4372858|NCT03593213|7148190|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0
4372859|NCT03593213|7148191|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0
4372860|NCT03593213|7148192|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0
4372861|NCT03593213|7148189|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0
4372862|NCT03593213|7148190|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15
4372863|NCT03593213|7148191|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9
4372864|NCT03593213|7148192|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8
4372865|NCT03593213|7148189|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0
4372866|NCT03593213|7148190|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2
4372867|NCT03593213|7148191|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0
4372868|NCT03593213|7148192|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4
4372869|NCT03593213|7148189|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0
4372870|NCT03593213|7148190|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4
4372871|NCT03593213|7148191|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2
4372872|NCT03593213|7148192|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3
4372873|NCT03593213|7148189|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0
4372874|NCT03593213|7148190|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5
4372875|NCT03593213|7148191|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4
4372876|NCT03593213|7148192|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1
4372877|NCT03593213|7148189|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0
4372878|NCT03593213|7148190|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0
4372879|NCT03593213|7148191|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0
4372880|NCT03593213|7148192|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1
4372881|NCT03593213|7148189|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0
4372882|NCT03593213|7148190|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3
4372883|NCT03593213|7148191|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2
4372884|NCT03593213|7148192|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5
4372885|NCT03593213|7148189|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0
4372886|NCT03593213|7148190|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1
4372887|NCT03593213|7148191|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2
4372888|NCT03593213|7148192|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0
4372889|NCT03593213|7148189|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0
4372890|NCT03593213|7148190|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9
4372891|NCT03593213|7148191|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11
4372892|NCT03593213|7148192|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13
4372893|NCT03593213|7148189|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0
4372894|NCT03593213|7148190|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1
4372895|NCT03593213|7148191|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3
4372896|NCT03593213|7148192|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0
4448554|NCT00499863|7234261|FG001|Overall Study|Lack of Efficacy|27
4448555|NCT00499863|7234260|FG000|Overall Study|Protocol Violation|12
4448556|NCT00499863|7234261|FG001|Overall Study|Protocol Violation|7
4448557|NCT00499863|7234260|FG000|Overall Study|Withdrawal by Subject|6
4448558|NCT00499863|7234261|FG001|Overall Study|Withdrawal by Subject|4
4448559|NCT00499863|7234260|FG000|Overall Study|Adverse Event|8
4448560|NCT00499863|7234261|FG001|Overall Study|Adverse Event|2
4448561|NCT00499863|7234260|FG000|Overall Study|Sponsor decision|2
4448562|NCT00499863|7234261|FG001|Overall Study|Sponsor decision|2
4448563|NCT00499863|7234260|FG000|Overall Study|Lost to Follow-up|1
4448564|NCT00499863|7234261|FG001|Overall Study|Lost to Follow-up|1
4448565|NCT00499889|7234267|FG000|Overall Study|Infection prior to treatment|1
4448566|NCT00500110|7234280|FG000|Overall Study|Withdrawal by Subject|3
4448567|NCT00500149|7234284|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3
4448568|NCT00500149|7234285|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0
4448569|NCT00500149|7234284|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8
4448570|NCT00500149|7234285|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0
4448571|NCT00500149|7234284|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1
4448572|NCT00500149|7234285|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0
4448573|NCT00500149|7234284|FG000|First Intervention (Cross-over Phase)|Adverse Event|0
4448574|NCT00500149|7234285|FG001|First Intervention (Cross-over Phase)|Adverse Event|1
4448575|NCT00500149|7234284|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1
4448576|NCT00500149|7234285|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1
4448577|NCT00500149|7234284|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1
4448578|NCT00500149|7234285|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0
4448579|NCT00500149|7234284|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2
4448580|NCT00500149|7234285|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0
4464979|NCT00606684|7255969|FG000|Double-Blind Treatment Period|Protocol Violation|0
4464980|NCT00606684|7255970|FG001|Double-Blind Treatment Period|Protocol Violation|5
4464981|NCT00606684|7255971|FG002|Double-Blind Treatment Period|Protocol Violation|5
4464982|NCT00606684|7255972|FG003|Double-Blind Treatment Period|Protocol Violation|3
4464983|NCT00606684|7255973|FG004|Double-Blind Treatment Period|Protocol Violation|0
4464984|NCT00606684|7255974|FG005|Double-Blind Treatment Period|Protocol Violation|3
4464985|NCT00606684|7255975|FG006|Double-Blind Treatment Period|Protocol Violation|4
4464986|NCT00606684|7255969|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0
4464987|NCT00606684|7255970|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
4464988|NCT00606684|7255971|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2
4464989|NCT00606684|7255972|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
4464990|NCT00606684|7255973|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2
4464991|NCT00606684|7255974|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3
4464992|NCT00606684|7255975|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
4464993|NCT00606684|7255969|FG000|Double-Blind Treatment Period|Physician Decision|0
4464994|NCT00606684|7255970|FG001|Double-Blind Treatment Period|Physician Decision|5
4464995|NCT00606684|7255971|FG002|Double-Blind Treatment Period|Physician Decision|1
4464996|NCT00606684|7255972|FG003|Double-Blind Treatment Period|Physician Decision|0
4464997|NCT00606684|7255973|FG004|Double-Blind Treatment Period|Physician Decision|3
4464998|NCT00606684|7255974|FG005|Double-Blind Treatment Period|Physician Decision|1
4464999|NCT00606684|7255975|FG006|Double-Blind Treatment Period|Physician Decision|2
4465000|NCT00606684|7255969|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0
4465001|NCT00606684|7255970|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1
4465002|NCT00606684|7255971|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1
4465003|NCT00606684|7255972|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2
4465004|NCT00606684|7255973|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1
4465005|NCT00606684|7255974|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2
4372897|NCT03248531|7148241|FG000|Overall Study|Adverse Event|0
4372898|NCT03248531|7148242|FG001|Overall Study|Adverse Event|0
4372899|NCT03248531|7148243|FG002|Overall Study|Adverse Event|1
4372900|NCT03248531|7148241|FG000|Overall Study|Lost to Follow-up|1
4372901|NCT03248531|7148242|FG001|Overall Study|Lost to Follow-up|0
4372902|NCT03248531|7148243|FG002|Overall Study|Lost to Follow-up|5
4372903|NCT03248531|7148241|FG000|Overall Study|Withdrawal by Subject|3
4372904|NCT03248531|7148242|FG001|Overall Study|Withdrawal by Subject|3
4372905|NCT03248531|7148243|FG002|Overall Study|Withdrawal by Subject|2
4372906|NCT03248531|7148241|FG000|Overall Study|Sponsor Request|0
4372907|NCT03248531|7148242|FG001|Overall Study|Sponsor Request|2
4372908|NCT03248531|7148243|FG002|Overall Study|Sponsor Request|0
4372909|NCT03205605|7148258|FG000|Overall Study|Withdrawal by Subject|1
4372910|NCT02484456|7148274|FG000|Washout Period|Withdrawal by Subject|0
4372911|NCT02484456|7148275|FG001|Washout Period|Withdrawal by Subject|1
4372912|NCT02484456|7148274|FG000|Second Treatment Period: Week 1|Adverse Event|1
4372913|NCT02484456|7148275|FG001|Second Treatment Period: Week 1|Adverse Event|0
4372914|NCT02484456|7148274|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0
4372915|NCT02484456|7148275|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1
4372916|NCT02484456|7148274|FG000|Second Treatment Period: Week 2|Adverse Event|0
4372917|NCT02484456|7148275|FG001|Second Treatment Period: Week 2|Adverse Event|1
4372918|NCT02481830|7148284|FG000|Overall Study|No longer meets Study Criteria|1
4372919|NCT02481830|7148285|FG001|Overall Study|No longer meets Study Criteria|4
4372920|NCT02481830|7148284|FG000|Overall Study|Withdrawal by Subject|0
4372921|NCT02481830|7148285|FG001|Overall Study|Withdrawal by Subject|14
4372922|NCT02481830|7148284|FG000|Overall Study|Disease Progression|1
4372923|NCT02481830|7148285|FG001|Overall Study|Disease Progression|1
4372924|NCT02481830|7148284|FG000|Overall Study|Participant not eligible for trial|0
4372925|NCT02481830|7148285|FG001|Overall Study|Participant not eligible for trial|1
4372926|NCT02234323|7148291|FG000|All Enrolled|Not Treated: Completed study in database|2
4372927|NCT02234323|7148291|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2
4372928|NCT02234323|7148291|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1
4372929|NCT02234323|7148291|FG000|All Treated|Death|1
4372930|NCT02234323|7148291|FG000|All Treated|Physician Decision|5
4372931|NCT02234323|7148291|FG000|All Treated|Lack of Efficacy|3
4372932|NCT02234323|7148291|FG000|All Treated|Exceeded lab value limit|2
4372933|NCT02234323|7148291|FG000|All Treated|Other|7
4372934|NCT02220855|7148297|FG000|Overall Study|Adverse Event|8
4372935|NCT02220855|7148297|FG000|Overall Study|Disease Progression|5
4372936|NCT02220855|7148297|FG000|Overall Study|Withdrawal by Subject|1
4770607|NCT02837029|7746969|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0
4770608|NCT02837029|7746970|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2
4770609|NCT02837029|7746971|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0
4770610|NCT02837029|7746969|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0
4770611|NCT02837029|7746970|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1
4770612|NCT02837029|7746971|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0
4770613|NCT02837029|7746969|FG000|Cycle 2 and Beyond|Adverse Event|1
4770614|NCT02837029|7746970|FG001|Cycle 2 and Beyond|Adverse Event|0
4770615|NCT02837029|7746971|FG002|Cycle 2 and Beyond|Adverse Event|0
4770616|NCT02837029|7746969|FG000|2 Year Follow-up|Death|6
4770617|NCT02837029|7746970|FG001|2 Year Follow-up|Death|7
4770618|NCT02837029|7746971|FG002|2 Year Follow-up|Death|0
4770619|NCT02737475|7747026|FG000|Overall Study|Other reasons|0
4770620|NCT02737475|7747027|FG001|Overall Study|Other reasons|0
4770621|NCT02737475|7747028|FG002|Overall Study|Other reasons|0
4770622|NCT02737475|7747029|FG003|Overall Study|Other reasons|0
4770623|NCT02737475|7747030|FG004|Overall Study|Other reasons|1
4770624|NCT02737475|7747031|FG005|Overall Study|Other reasons|1
4770625|NCT02737475|7747032|FG006|Overall Study|Other reasons|0
4770626|NCT02737475|7747033|FG007|Overall Study|Other reasons|0
4770627|NCT02737475|7747034|FG008|Overall Study|Other reasons|1
4770628|NCT02737475|7747035|FG009|Overall Study|Other reasons|0
4770629|NCT02737475|7747036|FG010|Overall Study|Other reasons|1
4465006|NCT00606684|7255975|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0
4465007|NCT00606801|7255991|FG000|Intervention|Protocol Violation|3
4465008|NCT00606801|7255992|FG001|Intervention|Protocol Violation|3
4465009|NCT00606892|7256002|FG000|First Intervention|Protocol Violation|1
4465010|NCT00606892|7256003|FG001|First Intervention|Protocol Violation|4
4465011|NCT00606905|7256037|FG000|Overall Study|No Pregnancy|9
4465012|NCT00606905|7256038|FG001|Overall Study|No Pregnancy|6
4465013|NCT00606905|7256037|FG000|Overall Study|Non-Index Pregnancy|1
4770630|NCT02737475|7747037|FG011|Overall Study|Other reasons|0
4770631|NCT02737475|7747038|FG012|Overall Study|Other reasons|0
4770632|NCT02737475|7747039|FG013|Overall Study|Other reasons|0
4770633|NCT02737475|7747040|FG014|Overall Study|Other reasons|0
4770634|NCT02737475|7747041|FG015|Overall Study|Other reasons|0
4770635|NCT02737475|7747042|FG016|Overall Study|Other reasons|0
4770636|NCT02737475|7747043|FG017|Overall Study|Other reasons|0
4465014|NCT00606905|7256038|FG001|Overall Study|Non-Index Pregnancy|4
4465015|NCT00606905|7256037|FG000|Overall Study|Withdrew|5
4770637|NCT02737475|7747044|FG018|Overall Study|Other reasons|0
4770638|NCT02737475|7747045|FG019|Overall Study|Other reasons|0
4770639|NCT02737475|7747046|FG020|Overall Study|Other reasons|0
4770640|NCT02737475|7747047|FG021|Overall Study|Other reasons|1
4770641|NCT02737475|7747048|FG022|Overall Study|Other reasons|0
4770642|NCT02737475|7747049|FG023|Overall Study|Other reasons|1
4770643|NCT02737475|7747050|FG024|Overall Study|Other reasons|1
4770644|NCT02737475|7747051|FG025|Overall Study|Other reasons|1
4770645|NCT02737475|7747052|FG026|Overall Study|Other reasons|0
4770646|NCT02737475|7747026|FG000|Overall Study|Death|1
4770647|NCT02737475|7747027|FG001|Overall Study|Death|0
4770648|NCT02737475|7747028|FG002|Overall Study|Death|0
4770649|NCT02737475|7747029|FG003|Overall Study|Death|1
4770650|NCT02737475|7747030|FG004|Overall Study|Death|0
4770651|NCT02737475|7747031|FG005|Overall Study|Death|0
4770652|NCT02737475|7747032|FG006|Overall Study|Death|0
4770653|NCT02737475|7747033|FG007|Overall Study|Death|2
4770654|NCT02737475|7747034|FG008|Overall Study|Death|0
4770655|NCT02737475|7747035|FG009|Overall Study|Death|0
4770656|NCT02737475|7747036|FG010|Overall Study|Death|0
4770657|NCT02737475|7747037|FG011|Overall Study|Death|4
4770658|NCT02737475|7747038|FG012|Overall Study|Death|2
4770659|NCT02737475|7747039|FG013|Overall Study|Death|2
4770660|NCT02737475|7747040|FG014|Overall Study|Death|0
4448581|NCT00500266|7234302|FG000|Overall Study|Death|3
4448582|NCT00500266|7234302|FG000|Overall Study|Lost to Follow-up|3
4448583|NCT00500266|7234302|FG000|Overall Study|Withdrawal by Subject|3
4448584|NCT00500266|7234302|FG000|Overall Study|Assigned, not treated|4
4448585|NCT00500292|7234310|FG000|Overall Study|Adverse Event|3
4448586|NCT00500292|7234311|FG001|Overall Study|Adverse Event|6
4448587|NCT00500292|7234312|FG002|Overall Study|Adverse Event|4
4448588|NCT00500292|7234310|FG000|Overall Study|Condition under investigation worsened|21
4448589|NCT00500292|7234311|FG001|Overall Study|Condition under investigation worsened|23
4448590|NCT00500292|7234312|FG002|Overall Study|Condition under investigation worsened|19
4448591|NCT00500292|7234310|FG000|Overall Study|Withdrawal by Subject|0
4448592|NCT00500292|7234311|FG001|Overall Study|Withdrawal by Subject|1
4448593|NCT00500292|7234312|FG002|Overall Study|Withdrawal by Subject|0
4448594|NCT00500292|7234310|FG000|Overall Study|Other|1
4448595|NCT00500292|7234311|FG001|Overall Study|Other|1
4448596|NCT00500292|7234312|FG002|Overall Study|Other|4
4448597|NCT00500318|7234322|FG000|Overall Study|Adverse Event|3
4448598|NCT00500318|7234323|FG001|Overall Study|Adverse Event|8
4448599|NCT00500318|7234322|FG000|Overall Study|Protocol Violation|1
4448600|NCT00500318|7234323|FG001|Overall Study|Protocol Violation|3
4448601|NCT00500318|7234322|FG000|Overall Study|Withdrawal by Subject|1
4448602|NCT00500318|7234323|FG001|Overall Study|Withdrawal by Subject|2
4448603|NCT00500318|7234322|FG000|Overall Study|Lack of Efficacy|0
4448604|NCT00500318|7234323|FG001|Overall Study|Lack of Efficacy|3
4587324|NCT01490632|7431346|FG011|Part D: Re-Treatment Period|Adverse Event|0
4448605|NCT00500318|7234322|FG000|Overall Study|Other Reason|0
4448606|NCT00500318|7234323|FG001|Overall Study|Other Reason|1
4448607|NCT00500331|7234336|FG000|Overall Study|Adverse Event|0
4448608|NCT00500331|7234337|FG001|Overall Study|Adverse Event|2
4448609|NCT00500331|7234338|FG002|Overall Study|Adverse Event|0
4448610|NCT00500331|7234339|FG003|Overall Study|Adverse Event|1
4448611|NCT00500331|7234340|FG004|Overall Study|Adverse Event|2
4448612|NCT00500331|7234341|FG005|Overall Study|Adverse Event|2
4448613|NCT00500331|7234342|FG006|Overall Study|Adverse Event|0
4448614|NCT00500331|7234336|FG000|Overall Study|Lost to Follow-up|1
4448615|NCT00500331|7234337|FG001|Overall Study|Lost to Follow-up|1
4448616|NCT00500331|7234338|FG002|Overall Study|Lost to Follow-up|1
4448617|NCT00500331|7234339|FG003|Overall Study|Lost to Follow-up|2
4448618|NCT00500331|7234340|FG004|Overall Study|Lost to Follow-up|1
4448619|NCT00500331|7234341|FG005|Overall Study|Lost to Follow-up|0
4448620|NCT00500331|7234342|FG006|Overall Study|Lost to Follow-up|0
4448621|NCT00500331|7234336|FG000|Overall Study|Protocol Violation|3
4448622|NCT00500331|7234337|FG001|Overall Study|Protocol Violation|1
4448623|NCT00500331|7234338|FG002|Overall Study|Protocol Violation|1
4448624|NCT00500331|7234339|FG003|Overall Study|Protocol Violation|0
4448625|NCT00500331|7234340|FG004|Overall Study|Protocol Violation|1
4448626|NCT00500331|7234341|FG005|Overall Study|Protocol Violation|1
4448627|NCT00500331|7234342|FG006|Overall Study|Protocol Violation|1
4448628|NCT00500331|7234336|FG000|Overall Study|Withdrawal by Subject|4
4448629|NCT00500331|7234337|FG001|Overall Study|Withdrawal by Subject|0
4448630|NCT00500331|7234338|FG002|Overall Study|Withdrawal by Subject|1
4448631|NCT00500331|7234339|FG003|Overall Study|Withdrawal by Subject|5
4448632|NCT00500331|7234340|FG004|Overall Study|Withdrawal by Subject|0
4448633|NCT00500331|7234341|FG005|Overall Study|Withdrawal by Subject|1
4448634|NCT00500331|7234342|FG006|Overall Study|Withdrawal by Subject|1
4587325|NCT01490632|7431347|FG012|Part D: Re-Treatment Period|Adverse Event|0
4448635|NCT00500331|7234336|FG000|Overall Study|Lack of Efficacy|3
4448636|NCT00500331|7234337|FG001|Overall Study|Lack of Efficacy|1
4448637|NCT00500331|7234338|FG002|Overall Study|Lack of Efficacy|0
4448638|NCT00500331|7234339|FG003|Overall Study|Lack of Efficacy|0
4448639|NCT00500331|7234340|FG004|Overall Study|Lack of Efficacy|0
4448640|NCT00500331|7234341|FG005|Overall Study|Lack of Efficacy|0
4448641|NCT00500331|7234342|FG006|Overall Study|Lack of Efficacy|0
4448642|NCT00500331|7234336|FG000|Overall Study|Liver function test abnormality|0
4770661|NCT02737475|7747041|FG015|Overall Study|Death|2
4770662|NCT02737475|7747042|FG016|Overall Study|Death|2
4770663|NCT02737475|7747043|FG017|Overall Study|Death|2
4372993|NCT01791595|7148349|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1
4372994|NCT01791595|7148350|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0
4372995|NCT01791595|7148351|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0
4372996|NCT01791595|7148352|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0
4372997|NCT01791595|7148353|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0
4372998|NCT01791595|7148354|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0
4372999|NCT01791595|7148355|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0
4373000|NCT01791595|7148349|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2
4373001|NCT01791595|7148350|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0
4373002|NCT01791595|7148351|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0
4373003|NCT01791595|7148352|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0
4373004|NCT01791595|7148353|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0
4373005|NCT01791595|7148354|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0
4373006|NCT01791595|7148355|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0
4373007|NCT01791595|7148349|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0
4373008|NCT01791595|7148350|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5
4373009|NCT01791595|7148351|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0
4373010|NCT01791595|7148352|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0
4373011|NCT01791595|7148353|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0
4373012|NCT01791595|7148354|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0
4373013|NCT01791595|7148355|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0
4373014|NCT01791595|7148349|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0
4373015|NCT01791595|7148350|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0
4373016|NCT01791595|7148351|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1
4373017|NCT01791595|7148352|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0
4373018|NCT01791595|7148353|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0
4373019|NCT01791595|7148354|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0
4373020|NCT01791595|7148355|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0
4373021|NCT01791595|7148349|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0
4373022|NCT01791595|7148350|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0
4373023|NCT01791595|7148351|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6
4373024|NCT01791595|7148352|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0
4373025|NCT01791595|7148353|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0
4373026|NCT01791595|7148354|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0
4373027|NCT01791595|7148355|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0
4373028|NCT01791595|7148349|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0
4373029|NCT01791595|7148350|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0
4373030|NCT01791595|7148351|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1
4373031|NCT01791595|7148352|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0
4373032|NCT01791595|7148353|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0
4373033|NCT01791595|7148354|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0
4373034|NCT01791595|7148355|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0
4373035|NCT01791595|7148349|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0
4373036|NCT01791595|7148350|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0
4373037|NCT01791595|7148351|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0
4373038|NCT01791595|7148352|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2
4373039|NCT01791595|7148353|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0
4373040|NCT01791595|7148354|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0
4373041|NCT01791595|7148355|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0
4373042|NCT01791595|7148349|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0
4373043|NCT01791595|7148350|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0
4373044|NCT01791595|7148351|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0
4373045|NCT01791595|7148352|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2
4373046|NCT01791595|7148353|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0
4373047|NCT01791595|7148354|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0
4373048|NCT01791595|7148355|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0
4373049|NCT01791595|7148349|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0
4373050|NCT01791595|7148350|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0
4373051|NCT01791595|7148351|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0
4373052|NCT01791595|7148352|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0
4373053|NCT01791595|7148353|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4
4373054|NCT01791595|7148354|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0
4373055|NCT01791595|7148355|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0
4373056|NCT01791595|7148349|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0
4373057|NCT01791595|7148350|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0
4373058|NCT01791595|7148351|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0
4373059|NCT01791595|7148352|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0
4373060|NCT01791595|7148353|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5
4373061|NCT01791595|7148354|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0
4373062|NCT01791595|7148355|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0
4373063|NCT01791595|7148349|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0
4373064|NCT01791595|7148350|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0
4373065|NCT01791595|7148351|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0
4694472|NCT02607306|7605959|FG001|Overall Study|Protocol Violation|2
4694473|NCT02607306|7605960|FG002|Overall Study|Protocol Violation|1
4694474|NCT02607735|7605980|FG000|Primary Study|Randomized but Never Treated|1
4694475|NCT02607735|7605981|FG001|Primary Study|Randomized but Never Treated|0
4694476|NCT02607735|7605982|FG002|Primary Study|Randomized but Never Treated|0
4694477|NCT02607735|7605980|FG000|Primary Study|Lost to Follow-up|4
4694478|NCT02607735|7605981|FG001|Primary Study|Lost to Follow-up|0
4694479|NCT02607735|7605982|FG002|Primary Study|Lost to Follow-up|0
4694480|NCT02607735|7605980|FG000|Primary Study|Withdrew Consent|2
4694481|NCT02607735|7605981|FG001|Primary Study|Withdrew Consent|0
4694482|NCT02607735|7605982|FG002|Primary Study|Withdrew Consent|0
4694483|NCT02607735|7605980|FG000|Deferred Treatment Substudy|Lost to Follow-up|0
4694484|NCT02607735|7605981|FG001|Deferred Treatment Substudy|Lost to Follow-up|0
4694485|NCT02607735|7605982|FG002|Deferred Treatment Substudy|Lost to Follow-up|4
4694486|NCT02607735|7605980|FG000|Deferred Treatment Substudy|Withdrew Consent|0
4694487|NCT02607735|7605981|FG001|Deferred Treatment Substudy|Withdrew Consent|0
4694488|NCT02607735|7605982|FG002|Deferred Treatment Substudy|Withdrew Consent|1
4694489|NCT02607800|7605992|FG000|Overall Study|Lost to Follow-up|7
4694490|NCT02607800|7605993|FG001|Overall Study|Lost to Follow-up|10
4694491|NCT02607800|7605992|FG000|Overall Study|Withdrew Consent|2
4694492|NCT02607800|7605993|FG001|Overall Study|Withdrew Consent|0
4694493|NCT02607800|7605992|FG000|Overall Study|Randomized/Enrolled but Not Treated|1
4694494|NCT02607800|7605993|FG001|Overall Study|Randomized/Enrolled but Not Treated|1
4694495|NCT02607865|7606004|FG000|Overall Study|Lost to Follow-up|9
4694496|NCT02607865|7606005|FG001|Overall Study|Lost to Follow-up|7
4694497|NCT02607865|7606006|FG002|Overall Study|Lost to Follow-up|7
4694498|NCT02607865|7606007|FG003|Overall Study|Lost to Follow-up|5
4694499|NCT02607865|7606004|FG000|Overall Study|Withdrawal by Subject|18
4694500|NCT02607865|7606005|FG001|Overall Study|Withdrawal by Subject|18
4694501|NCT02607865|7606006|FG002|Overall Study|Withdrawal by Subject|17
4694502|NCT02607865|7606007|FG003|Overall Study|Withdrawal by Subject|8
4373066|NCT01791595|7148352|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0
4373067|NCT01791595|7148353|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1
4373068|NCT01791595|7148354|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0
4373069|NCT01791595|7148355|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0
4373070|NCT01791595|7148349|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0
4373071|NCT01791595|7148350|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0
4373072|NCT01791595|7148351|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0
4373073|NCT01791595|7148352|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0
4373074|NCT01791595|7148353|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1
4373075|NCT01791595|7148354|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0
4373076|NCT01791595|7148355|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0
4373077|NCT01791595|7148349|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0
4373078|NCT01791595|7148350|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0
4373079|NCT01791595|7148351|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0
4373080|NCT01791595|7148352|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0
4373081|NCT01791595|7148353|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0
4373082|NCT01791595|7148354|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5
4373083|NCT01791595|7148355|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0
4373084|NCT01791595|7148349|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0
4373085|NCT01791595|7148350|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0
4373086|NCT01791595|7148351|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0
4373087|NCT01791595|7148352|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0
4373088|NCT01791595|7148353|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0
4373089|NCT01791595|7148354|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3
4373090|NCT01791595|7148355|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0
4373091|NCT01791595|7148349|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0
4373092|NCT01791595|7148350|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0
4373093|NCT01791595|7148351|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0
4373094|NCT01791595|7148352|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0
4373095|NCT01791595|7148353|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0
4373096|NCT01791595|7148354|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0
4373097|NCT01791595|7148355|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1
4373098|NCT01791595|7148349|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0
4373099|NCT01791595|7148350|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0
4694503|NCT02607865|7606004|FG000|Overall Study|Death|5
4694504|NCT02607865|7606005|FG001|Overall Study|Death|4
4694505|NCT02607865|7606006|FG002|Overall Study|Death|1
4694506|NCT02607865|7606007|FG003|Overall Study|Death|3
4694507|NCT02607865|7606004|FG000|Overall Study|Unclassified|1
4373100|NCT01791595|7148351|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0
4373101|NCT01791595|7148352|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0
4694508|NCT02607865|7606005|FG001|Overall Study|Unclassified|1
4694509|NCT02607865|7606006|FG002|Overall Study|Unclassified|2
4694510|NCT02607865|7606007|FG003|Overall Study|Unclassified|0
4694511|NCT02608099|7606019|FG000|Overall Study|Ablation procedure not initiated|3
4373102|NCT01791595|7148353|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0
4373103|NCT01791595|7148354|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0
4373104|NCT01791595|7148355|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6
4373105|NCT01791595|7148349|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0
4373106|NCT01791595|7148350|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0
4373107|NCT01791595|7148351|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0
4373108|NCT01791595|7148352|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0
4373109|NCT01791595|7148353|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0
4373110|NCT01791595|7148354|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0
4373111|NCT01791595|7148355|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2
4373112|NCT01791595|7148349|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0
4373113|NCT01791595|7148350|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0
4373114|NCT01791595|7148351|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0
4373115|NCT01791595|7148352|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0
4373116|NCT01791595|7148353|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0
4373117|NCT01791595|7148354|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0
4373118|NCT01791595|7148355|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1
4373119|NCT01192776|7148379|FG000|Overall Study|Death|8
4373120|NCT01192776|7148380|FG001|Overall Study|Death|15
4373121|NCT01192776|7148381|FG002|Overall Study|Death|18
4373122|NCT01192776|7148382|FG003|Overall Study|Death|15
4373123|NCT01192776|7148379|FG000|Overall Study|Lost to Follow-up|3
4373124|NCT01192776|7148380|FG001|Overall Study|Lost to Follow-up|6
4373125|NCT01192776|7148381|FG002|Overall Study|Lost to Follow-up|3
4373126|NCT01192776|7148382|FG003|Overall Study|Lost to Follow-up|5
4373127|NCT00089791|7148414|FG000|Overall Study|Physician Decision|6
4373128|NCT00089791|7148415|FG001|Overall Study|Physician Decision|3
4373129|NCT00089791|7148414|FG000|Overall Study|Adverse Event|81
4373130|NCT00089791|7148415|FG001|Overall Study|Adverse Event|93
4373131|NCT00089791|7148414|FG000|Overall Study|Withdrawal by Subject|403
4373132|NCT00089791|7148415|FG001|Overall Study|Withdrawal by Subject|344
4373133|NCT00089791|7148414|FG000|Overall Study|Death|78
4373134|NCT00089791|7148415|FG001|Overall Study|Death|62
4373135|NCT00089791|7148414|FG000|Overall Study|Disease progression|7
4373136|NCT00089791|7148415|FG001|Overall Study|Disease progression|3
4373137|NCT00089791|7148414|FG000|Overall Study|Ineligibility determined|12
4373138|NCT00089791|7148415|FG001|Overall Study|Ineligibility determined|9
4373139|NCT00089791|7148414|FG000|Overall Study|Lost to Follow-up|57
4373140|NCT00089791|7148415|FG001|Overall Study|Lost to Follow-up|57
4373141|NCT00089791|7148414|FG000|Overall Study|Noncompliance|17
4373142|NCT00089791|7148415|FG001|Overall Study|Noncompliance|13
4373143|NCT00089791|7148414|FG000|Overall Study|Other|20
4373144|NCT00089791|7148415|FG001|Overall Study|Other|32
4373145|NCT00089791|7148414|FG000|Overall Study|Protocol deviation|12
4373146|NCT00089791|7148415|FG001|Overall Study|Protocol deviation|10
4373147|NCT00089791|7148414|FG000|Overall Study|Requirement for alternative therapy|7
4373148|NCT00089791|7148415|FG001|Overall Study|Requirement for alternative therapy|4
4448643|NCT00500331|7234337|FG001|Overall Study|Liver function test abnormality|0
4448644|NCT00500331|7234338|FG002|Overall Study|Liver function test abnormality|1
4448645|NCT00500331|7234339|FG003|Overall Study|Liver function test abnormality|0
4448646|NCT00500331|7234340|FG004|Overall Study|Liver function test abnormality|0
4448647|NCT00500331|7234341|FG005|Overall Study|Liver function test abnormality|0
4448648|NCT00500331|7234342|FG006|Overall Study|Liver function test abnormality|0
4448649|NCT00500331|7234336|FG000|Overall Study|Increased serum creatinine from Baseline|0
4448650|NCT00500331|7234337|FG001|Overall Study|Increased serum creatinine from Baseline|0
4448651|NCT00500331|7234338|FG002|Overall Study|Increased serum creatinine from Baseline|0
4448652|NCT00500331|7234339|FG003|Overall Study|Increased serum creatinine from Baseline|0
4448653|NCT00500331|7234340|FG004|Overall Study|Increased serum creatinine from Baseline|0
4448654|NCT00500331|7234341|FG005|Overall Study|Increased serum creatinine from Baseline|1
4448655|NCT00500331|7234342|FG006|Overall Study|Increased serum creatinine from Baseline|0
4694512|NCT02608099|7606020|FG001|Overall Study|Ablation procedure not initiated|2
4448656|NCT00500331|7234336|FG000|Overall Study|Didn't return for continuation of study|1
4448657|NCT00500331|7234337|FG001|Overall Study|Didn't return for continuation of study|0
4448658|NCT00500331|7234338|FG002|Overall Study|Didn't return for continuation of study|0
4448659|NCT00500331|7234339|FG003|Overall Study|Didn't return for continuation of study|0
4448660|NCT00500331|7234340|FG004|Overall Study|Didn't return for continuation of study|0
4448661|NCT00500331|7234341|FG005|Overall Study|Didn't return for continuation of study|0
4448662|NCT00500331|7234342|FG006|Overall Study|Didn't return for continuation of study|0
4448663|NCT00500331|7234336|FG000|Overall Study|Exclusion citeria not met on Visit 4|1
4448664|NCT00500331|7234337|FG001|Overall Study|Exclusion citeria not met on Visit 4|0
4373149|NCT03376789|7148423|FG000|Overall Study|Withdrawal by Subject|3
4373150|NCT03376789|7148424|FG001|Overall Study|Withdrawal by Subject|5
4373151|NCT03376789|7148423|FG000|Overall Study|Protocol Violation|0
4373152|NCT03376789|7148424|FG001|Overall Study|Protocol Violation|1
4373153|NCT03376789|7148423|FG000|Overall Study|Adverse Event|0
4373154|NCT03376789|7148424|FG001|Overall Study|Adverse Event|1
4373155|NCT03376789|7148423|FG000|Overall Study|Lost to Follow-up|1
4373156|NCT03376789|7148424|FG001|Overall Study|Lost to Follow-up|1
4373157|NCT03376789|7148423|FG000|Overall Study|Per sponsor due to noncompliance|1
4373158|NCT03376789|7148424|FG001|Overall Study|Per sponsor due to noncompliance|0
4373159|NCT03376789|7148423|FG000|Overall Study|Subject off study medication|0
4373160|NCT03376789|7148424|FG001|Overall Study|Subject off study medication|1
4373161|NCT03241225|7148478|FG000|Overall Study|Lost to Follow-up|2
4373162|NCT03241225|7148479|FG001|Overall Study|Lost to Follow-up|1
4373163|NCT03241225|7148478|FG000|Overall Study|Protocol Violation|4
4373164|NCT03241225|7148479|FG001|Overall Study|Protocol Violation|1
4373165|NCT03241225|7148478|FG000|Overall Study|Withdrawal by Subject|1
4373166|NCT03241225|7148479|FG001|Overall Study|Withdrawal by Subject|0
4373167|NCT03225846|7148492|FG000|Overall Study|Adverse Event|0
4373168|NCT03225846|7148493|FG001|Overall Study|Adverse Event|0
4373169|NCT03225846|7148494|FG002|Overall Study|Adverse Event|0
4373170|NCT03225846|7148495|FG003|Overall Study|Adverse Event|0
4373171|NCT03225846|7148496|FG004|Overall Study|Adverse Event|0
4373172|NCT03225846|7148497|FG005|Overall Study|Adverse Event|0
4373173|NCT03225846|7148498|FG006|Overall Study|Adverse Event|6
4373174|NCT03225846|7148492|FG000|Overall Study|Withdrawal by Subject|0
4373175|NCT03225846|7148493|FG001|Overall Study|Withdrawal by Subject|1
4373176|NCT03225846|7148494|FG002|Overall Study|Withdrawal by Subject|0
4373177|NCT03225846|7148495|FG003|Overall Study|Withdrawal by Subject|0
4373178|NCT03225846|7148496|FG004|Overall Study|Withdrawal by Subject|0
4373179|NCT03225846|7148497|FG005|Overall Study|Withdrawal by Subject|0
4373180|NCT03225846|7148498|FG006|Overall Study|Withdrawal by Subject|0
4373181|NCT03225846|7148492|FG000|Overall Study|Death|0
4373182|NCT03225846|7148493|FG001|Overall Study|Death|1
4373183|NCT03225846|7148494|FG002|Overall Study|Death|0
4373184|NCT03225846|7148495|FG003|Overall Study|Death|0
4373185|NCT03225846|7148496|FG004|Overall Study|Death|0
4373186|NCT03225846|7148497|FG005|Overall Study|Death|0
4373187|NCT03225846|7148498|FG006|Overall Study|Death|0
4373188|NCT03225846|7148492|FG000|Overall Study|Patient did not wish to comply with IC/EC|0
4373189|NCT03225846|7148493|FG001|Overall Study|Patient did not wish to comply with IC/EC|0
4373190|NCT03225846|7148494|FG002|Overall Study|Patient did not wish to comply with IC/EC|1
4373191|NCT03225846|7148495|FG003|Overall Study|Patient did not wish to comply with IC/EC|0
4373192|NCT03225846|7148496|FG004|Overall Study|Patient did not wish to comply with IC/EC|0
4373193|NCT03225846|7148497|FG005|Overall Study|Patient did not wish to comply with IC/EC|0
4373194|NCT03225846|7148498|FG006|Overall Study|Patient did not wish to comply with IC/EC|0
4373195|NCT03225846|7148492|FG000|Overall Study|Patient decision|0
4373196|NCT03225846|7148493|FG001|Overall Study|Patient decision|0
4373197|NCT03225846|7148494|FG002|Overall Study|Patient decision|0
4373198|NCT03225846|7148495|FG003|Overall Study|Patient decision|0
4373199|NCT03225846|7148496|FG004|Overall Study|Patient decision|0
4373200|NCT03225846|7148497|FG005|Overall Study|Patient decision|0
4373201|NCT03225846|7148498|FG006|Overall Study|Patient decision|1
4373202|NCT03203473|7148538|FG000|Induction Phase|Never started primary treatment|2
4373203|NCT03203473|7148539|FG001|Induction Phase|Never started primary treatment|0
4373204|NCT03203473|7148540|FG002|Induction Phase|Never started primary treatment|0
4373205|NCT03203473|7148538|FG000|Induction Phase|Withdrew from study due to progressive disease|7
4373206|NCT03203473|7148539|FG001|Induction Phase|Withdrew from study due to progressive disease|0
4373207|NCT03203473|7148540|FG002|Induction Phase|Withdrew from study due to progressive disease|0
4373208|NCT03203473|7148538|FG000|Induction Phase|Withdrew from study due to toxicity|7
4373209|NCT03203473|7148539|FG001|Induction Phase|Withdrew from study due to toxicity|0
4373210|NCT03203473|7148540|FG002|Induction Phase|Withdrew from study due to toxicity|0
4694513|NCT02608450|7606050|FG000|Overall Study|Lost to Follow-up|39
4694514|NCT02608450|7606051|FG001|Overall Study|Lost to Follow-up|32
4694515|NCT02608450|7606050|FG000|Overall Study|Withdrawal by Subject|21
4694516|NCT02608450|7606051|FG001|Overall Study|Withdrawal by Subject|15
4694517|NCT02608450|7606050|FG000|Overall Study|Adverse Event|3
4694518|NCT02608450|7606051|FG001|Overall Study|Adverse Event|6
4694519|NCT02608450|7606050|FG000|Overall Study|Withdrawal by parent|2
4694520|NCT02608450|7606051|FG001|Overall Study|Withdrawal by parent|3
4694521|NCT02608450|7606050|FG000|Overall Study|Lack of Efficacy|0
4694522|NCT02608450|7606051|FG001|Overall Study|Lack of Efficacy|3
4694523|NCT02608450|7606050|FG000|Overall Study|Noncompliance with study drug|0
4373211|NCT03203473|7148538|FG000|Arm Allocation Phase|Still on Arm A-observation|0
4373212|NCT03203473|7148539|FG001|Arm Allocation Phase|Still on Arm A-observation|7
4373213|NCT03203473|7148540|FG002|Arm Allocation Phase|Still on Arm A-observation|0
4373214|NCT03203473|7148538|FG000|Arm Allocation Phase|started salvage therapy|0
4373215|NCT03203473|7148539|FG001|Arm Allocation Phase|started salvage therapy|5
4373216|NCT03203473|7148540|FG002|Arm Allocation Phase|started salvage therapy|0
4694524|NCT02608450|7606051|FG001|Overall Study|Noncompliance with study drug|2
4694525|NCT02608450|7606050|FG000|Overall Study|Physician Decision|0
4373217|NCT03203473|7148538|FG000|Arm Allocation Phase|Disease progression|0
4373218|NCT03203473|7148539|FG001|Arm Allocation Phase|Disease progression|0
4373219|NCT03203473|7148540|FG002|Arm Allocation Phase|Disease progression|37
4373220|NCT03203473|7148538|FG000|Arm Allocation Phase|Adverse Event|0
4373221|NCT03203473|7148539|FG001|Arm Allocation Phase|Adverse Event|0
4373222|NCT03203473|7148540|FG002|Arm Allocation Phase|Adverse Event|11
4373223|NCT03203473|7148538|FG000|Arm Allocation Phase|Physician Decision|0
4373224|NCT03203473|7148539|FG001|Arm Allocation Phase|Physician Decision|0
4373225|NCT03203473|7148540|FG002|Arm Allocation Phase|Physician Decision|3
4373226|NCT03203473|7148538|FG000|Arm Allocation Phase|Death|0
4373227|NCT03203473|7148539|FG001|Arm Allocation Phase|Death|0
4373228|NCT03203473|7148540|FG002|Arm Allocation Phase|Death|1
4373229|NCT03203473|7148538|FG000|Arm Allocation Phase|Developed 2nd cancer|0
4373230|NCT03203473|7148539|FG001|Arm Allocation Phase|Developed 2nd cancer|0
4373231|NCT03203473|7148540|FG002|Arm Allocation Phase|Developed 2nd cancer|1
4373232|NCT03203473|7148538|FG000|Arm Allocation Phase|Intercurrent illness|0
4373233|NCT03203473|7148539|FG001|Arm Allocation Phase|Intercurrent illness|0
4373234|NCT03203473|7148540|FG002|Arm Allocation Phase|Intercurrent illness|1
4373235|NCT03203473|7148538|FG000|Arm Allocation Phase|Still on arm-B treatment|0
4373236|NCT03203473|7148539|FG001|Arm Allocation Phase|Still on arm-B treatment|0
4373237|NCT03203473|7148540|FG002|Arm Allocation Phase|Still on arm-B treatment|3
4448665|NCT00500331|7234338|FG002|Overall Study|Exclusion citeria not met on Visit 4|0
4448666|NCT00500331|7234339|FG003|Overall Study|Exclusion citeria not met on Visit 4|0
4448667|NCT00500331|7234340|FG004|Overall Study|Exclusion citeria not met on Visit 4|0
4448668|NCT00500331|7234341|FG005|Overall Study|Exclusion citeria not met on Visit 4|0
4448669|NCT00500331|7234342|FG006|Overall Study|Exclusion citeria not met on Visit 4|0
4448670|NCT00500331|7234336|FG000|Overall Study|Sponsor decided to withdraw participant|1
4587326|NCT01490632|7431348|FG013|Part D: Re-Treatment Period|Adverse Event|0
4587327|NCT01490632|7431349|FG014|Part D: Re-Treatment Period|Adverse Event|0
4587328|NCT01490632|7431350|FG015|Part D: Re-Treatment Period|Adverse Event|0
4587329|NCT01490632|7431351|FG016|Part D: Re-Treatment Period|Adverse Event|0
4587330|NCT01490632|7431352|FG017|Part D: Re-Treatment Period|Adverse Event|1
4587331|NCT01490632|7431353|FG018|Part D: Re-Treatment Period|Adverse Event|1
4587332|NCT01490632|7431354|FG019|Part D: Re-Treatment Period|Adverse Event|3
4587333|NCT01490632|7431335|FG000|Part D: Re-Treatment Period|Death|0
4587334|NCT01490632|7431336|FG001|Part D: Re-Treatment Period|Death|0
4587335|NCT01490632|7431337|FG002|Part D: Re-Treatment Period|Death|0
4587336|NCT01490632|7431338|FG003|Part D: Re-Treatment Period|Death|0
4587337|NCT01490632|7431339|FG004|Part D: Re-Treatment Period|Death|0
4587338|NCT01490632|7431340|FG005|Part D: Re-Treatment Period|Death|0
4587339|NCT01490632|7431341|FG006|Part D: Re-Treatment Period|Death|0
4587340|NCT01490632|7431342|FG007|Part D: Re-Treatment Period|Death|0
4448671|NCT00500331|7234337|FG001|Overall Study|Sponsor decided to withdraw participant|0
4448672|NCT00500331|7234338|FG002|Overall Study|Sponsor decided to withdraw participant|0
4448673|NCT00500331|7234339|FG003|Overall Study|Sponsor decided to withdraw participant|0
4448674|NCT00500331|7234340|FG004|Overall Study|Sponsor decided to withdraw participant|0
4448675|NCT00500331|7234341|FG005|Overall Study|Sponsor decided to withdraw participant|0
4448676|NCT00500331|7234342|FG006|Overall Study|Sponsor decided to withdraw participant|0
4448677|NCT00500331|7234336|FG000|Overall Study|Participant was randomized by mistake|1
4448678|NCT00500331|7234337|FG001|Overall Study|Participant was randomized by mistake|0
4448679|NCT00500331|7234338|FG002|Overall Study|Participant was randomized by mistake|0
4448680|NCT00500331|7234339|FG003|Overall Study|Participant was randomized by mistake|0
4448681|NCT00500331|7234340|FG004|Overall Study|Participant was randomized by mistake|0
4448682|NCT00500331|7234341|FG005|Overall Study|Participant was randomized by mistake|0
4448683|NCT00500331|7234342|FG006|Overall Study|Participant was randomized by mistake|0
4448684|NCT00500331|7234336|FG000|Overall Study|Diabetologist nurse in the study|0
4448685|NCT00500331|7234337|FG001|Overall Study|Diabetologist nurse in the study|0
4448686|NCT00500331|7234338|FG002|Overall Study|Diabetologist nurse in the study|1
4448687|NCT00500331|7234339|FG003|Overall Study|Diabetologist nurse in the study|0
4448688|NCT00500331|7234340|FG004|Overall Study|Diabetologist nurse in the study|0
4448689|NCT00500331|7234341|FG005|Overall Study|Diabetologist nurse in the study|0
4448690|NCT00500331|7234342|FG006|Overall Study|Diabetologist nurse in the study|0
4448691|NCT00500331|7234336|FG000|Overall Study|State ban of biological samples export|0
4448692|NCT00500331|7234337|FG001|Overall Study|State ban of biological samples export|0
4448693|NCT00500331|7234338|FG002|Overall Study|State ban of biological samples export|0
4448694|NCT00500331|7234339|FG003|Overall Study|State ban of biological samples export|1
4448695|NCT00500331|7234340|FG004|Overall Study|State ban of biological samples export|0
4448696|NCT00500331|7234341|FG005|Overall Study|State ban of biological samples export|0
4448697|NCT00500331|7234342|FG006|Overall Study|State ban of biological samples export|0
4448698|NCT00500331|7234336|FG000|Overall Study|Protocol violated|0
4448699|NCT00500331|7234337|FG001|Overall Study|Protocol violated|0
4448700|NCT00500331|7234338|FG002|Overall Study|Protocol violated|0
4448701|NCT00500331|7234339|FG003|Overall Study|Protocol violated|1
4448702|NCT00500331|7234340|FG004|Overall Study|Protocol violated|0
4587341|NCT01490632|7431343|FG008|Part D: Re-Treatment Period|Death|0
4587342|NCT01490632|7431344|FG009|Part D: Re-Treatment Period|Death|0
4587343|NCT01490632|7431345|FG010|Part D: Re-Treatment Period|Death|0
4373238|NCT03191903|7148554|FG000|Overall Study|Withdrawal by Subject|6
4373239|NCT03191903|7148555|FG001|Overall Study|Withdrawal by Subject|5
4373240|NCT03191903|7148556|FG002|Overall Study|Withdrawal by Subject|4
4373241|NCT03191903|7148554|FG000|Overall Study|Adverse Event|1
4373242|NCT03191903|7148555|FG001|Overall Study|Adverse Event|0
4373243|NCT03191903|7148556|FG002|Overall Study|Adverse Event|0
4373244|NCT04289051|7148569|FG000|Overall Study|Lost to Follow-up|0
4373245|NCT04289051|7148570|FG001|Overall Study|Lost to Follow-up|0
4373246|NCT04289051|7148571|FG002|Overall Study|Lost to Follow-up|2
4373247|NCT04210180|7148579|FG000|Overall Study|Withdrawal by Subject|2
4465016|NCT00606905|7256038|FG001|Overall Study|Withdrew|5
4465017|NCT00606931|7256044|FG000|Overall Study|Withdrawal by Subject|3
4465018|NCT00607022|7256060|FG000|Overall Study|Withdrawal by Subject|1
4465019|NCT00607022|7256061|FG001|Overall Study|Withdrawal by Subject|0
4465020|NCT00607022|7256062|FG002|Overall Study|Withdrawal by Subject|0
4465021|NCT00607048|7256072|FG000|Overall Study|Adverse Event|0
4465022|NCT00607048|7256073|FG001|Overall Study|Adverse Event|1
4465023|NCT00607048|7256074|FG002|Overall Study|Adverse Event|0
4465024|NCT00607048|7256075|FG003|Overall Study|Adverse Event|0
4465025|NCT00607048|7256076|FG004|Overall Study|Adverse Event|4
4465026|NCT00607048|7256077|FG005|Overall Study|Adverse Event|0
4465027|NCT00607048|7256072|FG000|Overall Study|Global deterioration of health|1
4465028|NCT00607048|7256073|FG001|Overall Study|Global deterioration of health|0
4465029|NCT00607048|7256074|FG002|Overall Study|Global deterioration of health|0
4465030|NCT00607048|7256075|FG003|Overall Study|Global deterioration of health|0
4465031|NCT00607048|7256076|FG004|Overall Study|Global deterioration of health|0
4465032|NCT00607048|7256077|FG005|Overall Study|Global deterioration of health|0
4465033|NCT00607048|7256072|FG000|Overall Study|Objective disease progression - relapse|1
4465034|NCT00607048|7256073|FG001|Overall Study|Objective disease progression - relapse|2
4465035|NCT00607048|7256074|FG002|Overall Study|Objective disease progression - relapse|4
4465036|NCT00607048|7256075|FG003|Overall Study|Objective disease progression - relapse|2
4465037|NCT00607048|7256076|FG004|Overall Study|Objective disease progression - relapse|2
4465038|NCT00607048|7256077|FG005|Overall Study|Objective disease progression - relapse|2
4465039|NCT00607048|7256072|FG000|Overall Study|Withdrawal by Subject|0
4465040|NCT00607048|7256073|FG001|Overall Study|Withdrawal by Subject|0
4465041|NCT00607048|7256074|FG002|Overall Study|Withdrawal by Subject|0
4465042|NCT00607048|7256075|FG003|Overall Study|Withdrawal by Subject|1
4465043|NCT00607048|7256076|FG004|Overall Study|Withdrawal by Subject|0
4465044|NCT00607048|7256077|FG005|Overall Study|Withdrawal by Subject|2
4465045|NCT00607048|7256072|FG000|Overall Study|Other|1
4465046|NCT00607048|7256073|FG001|Overall Study|Other|1
4465047|NCT00607048|7256074|FG002|Overall Study|Other|0
4465048|NCT00607048|7256075|FG003|Overall Study|Other|0
4465049|NCT00607048|7256076|FG004|Overall Study|Other|0
4465050|NCT00607048|7256077|FG005|Overall Study|Other|1
4465051|NCT00607087|7256096|FG000|Overall Study|Withdrawal by Subject|9
4465052|NCT00607087|7256097|FG001|Overall Study|Withdrawal by Subject|4
4465053|NCT00607087|7256098|FG002|Overall Study|Withdrawal by Subject|4
4465054|NCT00607087|7256096|FG000|Overall Study|Adverse Event|3
4465055|NCT00607087|7256097|FG001|Overall Study|Adverse Event|2
4465056|NCT00607087|7256098|FG002|Overall Study|Adverse Event|3
4465057|NCT00607087|7256096|FG000|Overall Study|Other reason|1
4465058|NCT00607087|7256097|FG001|Overall Study|Other reason|5
4465059|NCT00607087|7256098|FG002|Overall Study|Other reason|2
4587344|NCT01490632|7431346|FG011|Part D: Re-Treatment Period|Death|0
4587345|NCT01490632|7431347|FG012|Part D: Re-Treatment Period|Death|0
4587346|NCT01490632|7431348|FG013|Part D: Re-Treatment Period|Death|0
4587347|NCT01490632|7431349|FG014|Part D: Re-Treatment Period|Death|0
4587348|NCT01490632|7431350|FG015|Part D: Re-Treatment Period|Death|0
4587349|NCT01490632|7431351|FG016|Part D: Re-Treatment Period|Death|0
4587350|NCT01490632|7431352|FG017|Part D: Re-Treatment Period|Death|0
4587351|NCT01490632|7431353|FG018|Part D: Re-Treatment Period|Death|1
4587352|NCT01490632|7431354|FG019|Part D: Re-Treatment Period|Death|0
4587353|NCT01490632|7431335|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0
4587354|NCT01490632|7431336|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0
4587355|NCT01490632|7431337|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0
4587356|NCT01490632|7431338|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0
4373248|NCT03675308|7148622|FG000|Overall Study|Adverse Event|3
4373249|NCT03675308|7148623|FG001|Overall Study|Adverse Event|2
4373250|NCT03675308|7148622|FG000|Overall Study|Withdrawal by Subject|6
4373251|NCT03675308|7148623|FG001|Overall Study|Withdrawal by Subject|4
4373252|NCT03675308|7148622|FG000|Overall Study|Lost to Follow-up|3
4373253|NCT03675308|7148623|FG001|Overall Study|Lost to Follow-up|0
4373254|NCT03675308|7148622|FG000|Overall Study|Lack of Efficacy|1
4373255|NCT03675308|7148623|FG001|Overall Study|Lack of Efficacy|1
4373256|NCT03675308|7148622|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1
4373257|NCT03675308|7148623|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2
4373258|NCT03675308|7148622|FG000|Overall Study|Other|0
4373259|NCT03675308|7148623|FG001|Overall Study|Other|1
4373260|NCT03573817|7148631|FG000|Overall Study|Adverse Event|0
4373261|NCT03573817|7148632|FG001|Overall Study|Adverse Event|2
4373262|NCT03573817|7148631|FG000|Overall Study|Protocol Violation|0
4373263|NCT03573817|7148632|FG001|Overall Study|Protocol Violation|1
4373264|NCT03573817|7148631|FG000|Overall Study|Withdrawal by Subject|1
4373265|NCT03573817|7148632|FG001|Overall Study|Withdrawal by Subject|1
4373266|NCT03318861|7148648|FG000|Overall Study|Death|1
4373267|NCT03318861|7148649|FG001|Overall Study|Death|2
4373268|NCT03318861|7148650|FG002|Overall Study|Death|2
4373269|NCT03318861|7148651|FG003|Overall Study|Death|1
4373270|NCT03318861|7148652|FG004|Overall Study|Death|1
4373271|NCT03318861|7148648|FG000|Overall Study|Still on Study|2
4373272|NCT03318861|7148649|FG001|Overall Study|Still on Study|1
4373273|NCT03318861|7148650|FG002|Overall Study|Still on Study|1
4373274|NCT03318861|7148651|FG003|Overall Study|Still on Study|2
4373275|NCT03318861|7148652|FG004|Overall Study|Still on Study|1
4373276|NCT03318861|7148648|FG000|Overall Study|Enrolled But Did Not Initiate KITE-585|0
4373277|NCT03318861|7148649|FG001|Overall Study|Enrolled But Did Not Initiate KITE-585|1
4373278|NCT03318861|7148650|FG002|Overall Study|Enrolled But Did Not Initiate KITE-585|0
4373279|NCT03318861|7148651|FG003|Overall Study|Enrolled But Did Not Initiate KITE-585|1
4373280|NCT03318861|7148652|FG004|Overall Study|Enrolled But Did Not Initiate KITE-585|1
4373281|NCT03170349|7148664|FG000|At 30 Days Follow-up|Death|1
4373282|NCT03170349|7148664|FG000|At 6 Months Follow-up|Death|3
4373283|NCT03170349|7148664|FG000|At 6 Months Follow-up|Withdrawal by Subject|1
4373284|NCT03170349|7148664|FG000|At 6 Months Follow-up|Exited for Other Reasons|5
4373285|NCT03097328|7148679|FG000|Overall Study|Still on Therapy|2
4373286|NCT03097328|7148679|FG000|Overall Study|Progressive Disease|29
4373287|NCT03097328|7148679|FG000|Overall Study|Adverse Event|4
4373288|NCT03097328|7148679|FG000|Overall Study|Withdrawal by Subject|1
4373289|NCT03097328|7148679|FG000|Overall Study|Physician Decision|1
4373290|NCT03097328|7148679|FG000|Overall Study|Patient Decision|1
4373291|NCT03097328|7148679|FG000|Overall Study|Ineligible for Study Drug|1
4373292|NCT02919683|7148724|FG000|Post-Surgery Follow-Up|Death|2
4373293|NCT02919683|7148725|FG001|Post-Surgery Follow-Up|Death|2
4373294|NCT02919683|7148724|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1
4373295|NCT02919683|7148725|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0
4373296|NCT02901548|7148732|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4
4373297|NCT02790138|7148738|FG000|Overall Study|Adverse Event|5
4373298|NCT02790138|7148739|FG001|Overall Study|Adverse Event|2
4373299|NCT02790138|7148738|FG000|Overall Study|Significant Protocol Deviation|0
4373300|NCT02790138|7148739|FG001|Overall Study|Significant Protocol Deviation|1
4373301|NCT02790138|7148738|FG000|Overall Study|Lost to Follow-up|1
4373302|NCT02790138|7148739|FG001|Overall Study|Lost to Follow-up|0
4373303|NCT02790138|7148738|FG000|Overall Study|Voluntary Withdrawal|8
4373304|NCT02790138|7148739|FG001|Overall Study|Voluntary Withdrawal|9
4373305|NCT02790138|7148738|FG000|Overall Study|Lack of Efficacy|6
4373306|NCT02790138|7148739|FG001|Overall Study|Lack of Efficacy|7
4373307|NCT02790138|7148738|FG000|Overall Study|Reason not Specified|1
4373308|NCT02790138|7148739|FG001|Overall Study|Reason not Specified|0
4373309|NCT02514239|7148773|FG000|Overall Study|Refused to continue trial medication|0
4373310|NCT02514239|7148774|FG001|Overall Study|Refused to continue trial medication|0
4373311|NCT02514239|7148775|FG002|Overall Study|Refused to continue trial medication|0
4373312|NCT02514239|7148776|FG003|Overall Study|Refused to continue trial medication|0
4373313|NCT02514239|7148777|FG004|Overall Study|Refused to continue trial medication|0
4373314|NCT02514239|7148778|FG005|Overall Study|Refused to continue trial medication|0
4373315|NCT02514239|7148779|FG006|Overall Study|Refused to continue trial medication|0
4373316|NCT02514239|7148780|FG007|Overall Study|Refused to continue trial medication|0
4373317|NCT02514239|7148781|FG008|Overall Study|Refused to continue trial medication|0
4373318|NCT02514239|7148782|FG009|Overall Study|Refused to continue trial medication|1
4373319|NCT02514239|7148773|FG000|Overall Study|Dose-limiting toxicity (DLT)|0
4373320|NCT02514239|7148774|FG001|Overall Study|Dose-limiting toxicity (DLT)|0
4373321|NCT02514239|7148775|FG002|Overall Study|Dose-limiting toxicity (DLT)|0
4373322|NCT02514239|7148776|FG003|Overall Study|Dose-limiting toxicity (DLT)|0
4373323|NCT02514239|7148777|FG004|Overall Study|Dose-limiting toxicity (DLT)|0
4373324|NCT02514239|7148778|FG005|Overall Study|Dose-limiting toxicity (DLT)|0
4373325|NCT02514239|7148779|FG006|Overall Study|Dose-limiting toxicity (DLT)|0
4373326|NCT02514239|7148780|FG007|Overall Study|Dose-limiting toxicity (DLT)|0
4373327|NCT02514239|7148781|FG008|Overall Study|Dose-limiting toxicity (DLT)|1
4373328|NCT02514239|7148782|FG009|Overall Study|Dose-limiting toxicity (DLT)|2
4373329|NCT02514239|7148773|FG000|Overall Study|Not treated|0
4373330|NCT02514239|7148774|FG001|Overall Study|Not treated|1
4373331|NCT02514239|7148775|FG002|Overall Study|Not treated|0
4587357|NCT01490632|7431339|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0
4587358|NCT01490632|7431340|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0
4587359|NCT01490632|7431341|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0
4587360|NCT01490632|7431342|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0
4587361|NCT01490632|7431343|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0
4373332|NCT02514239|7148776|FG003|Overall Study|Not treated|0
4373333|NCT02514239|7148777|FG004|Overall Study|Not treated|0
4373334|NCT02514239|7148778|FG005|Overall Study|Not treated|0
4373335|NCT02514239|7148779|FG006|Overall Study|Not treated|0
4373336|NCT02514239|7148780|FG007|Overall Study|Not treated|0
4587362|NCT01490632|7431344|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0
4587363|NCT01490632|7431345|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0
4587364|NCT01490632|7431346|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0
4587365|NCT01490632|7431347|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0
4587366|NCT01490632|7431348|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0
4587367|NCT01490632|7431349|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0
4587368|NCT01490632|7431350|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0
4587369|NCT01490632|7431351|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0
4587370|NCT01490632|7431352|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3
4587371|NCT01490632|7431353|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1
4587372|NCT01490632|7431354|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2
4587373|NCT01490632|7431335|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0
4587374|NCT01490632|7431336|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0
4587375|NCT01490632|7431337|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0
4587376|NCT01490632|7431338|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0
4587377|NCT01490632|7431339|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0
4587378|NCT01490632|7431340|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0
4587379|NCT01490632|7431341|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0
4587380|NCT01490632|7431342|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0
4587381|NCT01490632|7431343|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0
4587382|NCT01490632|7431344|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0
4587383|NCT01490632|7431345|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0
4587384|NCT01490632|7431346|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0
4587385|NCT01490632|7431347|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0
4587386|NCT01490632|7431348|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0
4587387|NCT01490632|7431349|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0
4587388|NCT01490632|7431350|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0
4587389|NCT01490632|7431351|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0
4587390|NCT01490632|7431352|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0
4587391|NCT01490632|7431353|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1
4587392|NCT01490632|7431354|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0
4587393|NCT01490632|7431335|FG000|Part D: Re-Treatment Period|Physician Decision|0
4587394|NCT01490632|7431336|FG001|Part D: Re-Treatment Period|Physician Decision|0
4587395|NCT01490632|7431337|FG002|Part D: Re-Treatment Period|Physician Decision|0
4587396|NCT01490632|7431338|FG003|Part D: Re-Treatment Period|Physician Decision|0
4587397|NCT01490632|7431339|FG004|Part D: Re-Treatment Period|Physician Decision|0
4373337|NCT02514239|7148781|FG008|Overall Study|Not treated|0
4373338|NCT02514239|7148782|FG009|Overall Study|Not treated|0
4373339|NCT02514239|7148773|FG000|Overall Study|Other Adverse Events|2
4373340|NCT02514239|7148774|FG001|Overall Study|Other Adverse Events|0
4373341|NCT02514239|7148775|FG002|Overall Study|Other Adverse Events|0
4373342|NCT02514239|7148776|FG003|Overall Study|Other Adverse Events|1
4373343|NCT02514239|7148777|FG004|Overall Study|Other Adverse Events|0
4373344|NCT02514239|7148778|FG005|Overall Study|Other Adverse Events|1
4373345|NCT02514239|7148779|FG006|Overall Study|Other Adverse Events|0
4373346|NCT02514239|7148780|FG007|Overall Study|Other Adverse Events|1
4373347|NCT02514239|7148781|FG008|Overall Study|Other Adverse Events|2
4373348|NCT02514239|7148782|FG009|Overall Study|Other Adverse Events|0
4373349|NCT02514239|7148773|FG000|Overall Study|Progressive disease|3
4373350|NCT02514239|7148774|FG001|Overall Study|Progressive disease|3
4373351|NCT02514239|7148775|FG002|Overall Study|Progressive disease|2
4373352|NCT02514239|7148776|FG003|Overall Study|Progressive disease|2
4373353|NCT02514239|7148777|FG004|Overall Study|Progressive disease|3
4373354|NCT02514239|7148778|FG005|Overall Study|Progressive disease|3
4373355|NCT02514239|7148779|FG006|Overall Study|Progressive disease|4
4373356|NCT02514239|7148780|FG007|Overall Study|Progressive disease|2
4373357|NCT02514239|7148781|FG008|Overall Study|Progressive disease|5
4373358|NCT02514239|7148782|FG009|Overall Study|Progressive disease|0
4373359|NCT02245672|7148851|FG000|Overall Study|Adverse Event|4
4373360|NCT02245672|7148852|FG001|Overall Study|Adverse Event|4
4373361|NCT02245672|7148853|FG002|Overall Study|Adverse Event|4
4373362|NCT02245672|7148851|FG000|Overall Study|Lost to Follow-up|3
4373363|NCT02245672|7148852|FG001|Overall Study|Lost to Follow-up|5
4373364|NCT02245672|7148853|FG002|Overall Study|Lost to Follow-up|1
4373365|NCT02245672|7148851|FG000|Overall Study|Withdrawal by Subject|6
4373366|NCT02245672|7148852|FG001|Overall Study|Withdrawal by Subject|3
4373367|NCT02245672|7148853|FG002|Overall Study|Withdrawal by Subject|0
4373368|NCT02245672|7148851|FG000|Overall Study|Randomized in error (not treated)|0
4373369|NCT02245672|7148852|FG001|Overall Study|Randomized in error (not treated)|1
4373370|NCT02245672|7148853|FG002|Overall Study|Randomized in error (not treated)|0
4373371|NCT02109172|7148861|FG000|Overall Study|Withdrawal by Subject|1
4373372|NCT02109172|7148862|FG001|Overall Study|Withdrawal by Subject|0
4465060|NCT00607087|7256096|FG000|Overall Study|Poor compliance to protocol|1
4465061|NCT00607087|7256097|FG001|Overall Study|Poor compliance to protocol|0
4465062|NCT00607087|7256098|FG002|Overall Study|Poor compliance to protocol|1
4465063|NCT00607087|7256096|FG000|Overall Study|Lost to Follow-up|1
4465064|NCT00607087|7256097|FG001|Overall Study|Lost to Follow-up|0
4465065|NCT00607087|7256098|FG002|Overall Study|Lost to Follow-up|0
4465066|NCT00607087|7256096|FG000|Period 1|Withdrawal by Subject|7
4465067|NCT00607087|7256097|FG001|Period 1|Withdrawal by Subject|2
4373373|NCT02109172|7148863|FG002|Overall Study|Withdrawal by Subject|0
4373374|NCT02109172|7148864|FG003|Overall Study|Withdrawal by Subject|1
4373375|NCT02109172|7148865|FG004|Overall Study|Withdrawal by Subject|0
4373376|NCT02109172|7148866|FG005|Overall Study|Withdrawal by Subject|0
4373377|NCT02109172|7148861|FG000|Overall Study|Adverse Event|0
4373378|NCT02109172|7148862|FG001|Overall Study|Adverse Event|0
4373379|NCT02109172|7148863|FG002|Overall Study|Adverse Event|1
4373380|NCT02109172|7148864|FG003|Overall Study|Adverse Event|0
4373381|NCT02109172|7148865|FG004|Overall Study|Adverse Event|0
4373382|NCT02109172|7148866|FG005|Overall Study|Adverse Event|1
4373383|NCT02109172|7148861|FG000|Overall Study|Death|0
4373384|NCT02109172|7148862|FG001|Overall Study|Death|0
4373385|NCT02109172|7148863|FG002|Overall Study|Death|0
4373386|NCT02109172|7148864|FG003|Overall Study|Death|0
4373387|NCT02109172|7148865|FG004|Overall Study|Death|1
4373388|NCT02109172|7148866|FG005|Overall Study|Death|0
4448703|NCT00500331|7234341|FG005|Overall Study|Protocol violated|0
4448704|NCT00500331|7234342|FG006|Overall Study|Protocol violated|0
4448705|NCT00500357|7234359|FG000|Overall Study|Death|1
4448706|NCT00500370|7234376|FG000|Overall Study|Adverse Event|9
4448707|NCT00500370|7234377|FG001|Overall Study|Adverse Event|3
4448708|NCT00500370|7234376|FG000|Overall Study|Lost to Follow-up|10
4448709|NCT00500370|7234377|FG001|Overall Study|Lost to Follow-up|10
4448710|NCT00500370|7234376|FG000|Overall Study|Protocol Violation|2
4448711|NCT00500370|7234377|FG001|Overall Study|Protocol Violation|4
4448712|NCT00500370|7234376|FG000|Overall Study|Sponsor Decision|2
4448713|NCT00500370|7234377|FG001|Overall Study|Sponsor Decision|0
4448714|NCT00500370|7234376|FG000|Overall Study|Subject Decision|10
4448715|NCT00500370|7234377|FG001|Overall Study|Subject Decision|17
4448716|NCT00500539|7234392|FG000|Treatment Period (24 Weeks)|Adverse Event|4
4448717|NCT00500539|7234392|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1
4448718|NCT00500539|7234392|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1
4448719|NCT00500539|7234392|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2
4448720|NCT00500539|7234392|FG000|Treatment Period (24 Weeks)|Administrative problems|2
4448721|NCT00500539|7234392|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5
4448722|NCT00500539|7234392|FG000|Follow-up Period (16 Weeks)|Adverse Event|1
4448723|NCT00500539|7234392|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2
4448724|NCT00500539|7234392|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3
4448725|NCT00500539|7234392|FG000|Follow-up Period (16 Weeks)|Administrative problems|1
4448726|NCT00500539|7234392|FG000|Follow-up Period (16 Weeks)|Death|1
4448727|NCT00500539|7234392|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1
4448728|NCT00500539|7234392|FG000|Follow-up Period (16 Weeks)|Missing|3
4448729|NCT00500682|7234427|FG000|Overall Study|Adverse Event|37
4448730|NCT00500682|7234428|FG001|Overall Study|Adverse Event|29
4448731|NCT00500682|7234427|FG000|Overall Study|Death|25
4448732|NCT00500682|7234428|FG001|Overall Study|Death|16
4448733|NCT00500682|7234427|FG000|Overall Study|Lost to Follow-up|11
4448734|NCT00500682|7234428|FG001|Overall Study|Lost to Follow-up|11
4448735|NCT00500682|7234427|FG000|Overall Study|Physician Decision|6
4448736|NCT00500682|7234428|FG001|Overall Study|Physician Decision|10
4448737|NCT00500682|7234427|FG000|Overall Study|Pregnancy|2
4448738|NCT00500682|7234428|FG001|Overall Study|Pregnancy|0
4448739|NCT00500682|7234427|FG000|Overall Study|Protocol Violation|1
4694526|NCT02608450|7606051|FG001|Overall Study|Physician Decision|1
4694527|NCT02608450|7606050|FG000|Overall Study|Pregnancy|0
4694528|NCT02608450|7606051|FG001|Overall Study|Pregnancy|1
4694529|NCT02608450|7606050|FG000|Overall Study|Progressive disease|1
4694530|NCT02608450|7606051|FG001|Overall Study|Progressive disease|0
4694531|NCT02608450|7606050|FG000|Overall Study|Multiple reasons|0
4694532|NCT02608450|7606051|FG001|Overall Study|Multiple reasons|2
4694533|NCT02608476|7606073|FG000|Overall Study|Withdrawal by Subject|30
4694534|NCT02608476|7606074|FG001|Overall Study|Withdrawal by Subject|37
4694535|NCT02608476|7606073|FG000|Overall Study|Lost to Follow-up|24
4694536|NCT02608476|7606074|FG001|Overall Study|Lost to Follow-up|24
4694537|NCT02608476|7606073|FG000|Overall Study|Adverse Event|2
4694538|NCT02608476|7606074|FG001|Overall Study|Adverse Event|8
4694539|NCT02608476|7606073|FG000|Overall Study|Withdrawal by Parent/Guardian|5
4694540|NCT02608476|7606074|FG001|Overall Study|Withdrawal by Parent/Guardian|4
4694541|NCT02608476|7606073|FG000|Overall Study|Noncompliance with treatment|1
4694542|NCT02608476|7606074|FG001|Overall Study|Noncompliance with treatment|5
4694543|NCT02608476|7606073|FG000|Overall Study|Lack of Efficacy|3
4694544|NCT02608476|7606074|FG001|Overall Study|Lack of Efficacy|1
4694545|NCT02608476|7606073|FG000|Overall Study|Other|0
4694546|NCT02608476|7606074|FG001|Overall Study|Other|1
4448740|NCT00500682|7234428|FG001|Overall Study|Protocol Violation|3
4448741|NCT00500682|7234427|FG000|Overall Study|Withdrawal by Subject|80
4448742|NCT00500682|7234428|FG001|Overall Study|Withdrawal by Subject|74
4448743|NCT00500682|7234427|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144
4448744|NCT00500682|7234428|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144
4448745|NCT00500760|7234436|FG000|Overall Study|Death|32
4448746|NCT00500760|7234437|FG001|Overall Study|Death|15
4448747|NCT00500760|7234436|FG000|Overall Study|Withdrawal by Subject|5
4448748|NCT00500760|7234437|FG001|Overall Study|Withdrawal by Subject|7
4694547|NCT02608476|7606073|FG000|Overall Study|Physician Decision|1
4694548|NCT02608476|7606074|FG001|Overall Study|Physician Decision|0
4694549|NCT02608476|7606073|FG000|Overall Study|Pregnancy|0
4465068|NCT00607087|7256098|FG002|Period 1|Withdrawal by Subject|3
4465069|NCT00607087|7256096|FG000|Period 1|Adverse Event|3
4465070|NCT00607087|7256097|FG001|Period 1|Adverse Event|0
4465071|NCT00607087|7256098|FG002|Period 1|Adverse Event|0
4465072|NCT00607087|7256096|FG000|Period 1|Poor compliance to protocol|1
4465073|NCT00607087|7256097|FG001|Period 1|Poor compliance to protocol|0
4587398|NCT01490632|7431340|FG005|Part D: Re-Treatment Period|Physician Decision|0
4587399|NCT01490632|7431341|FG006|Part D: Re-Treatment Period|Physician Decision|0
4587400|NCT01490632|7431342|FG007|Part D: Re-Treatment Period|Physician Decision|0
4587401|NCT01490632|7431343|FG008|Part D: Re-Treatment Period|Physician Decision|0
4587402|NCT01490632|7431344|FG009|Part D: Re-Treatment Period|Physician Decision|0
4587403|NCT01490632|7431345|FG010|Part D: Re-Treatment Period|Physician Decision|0
4587404|NCT01490632|7431346|FG011|Part D: Re-Treatment Period|Physician Decision|0
4587405|NCT01490632|7431347|FG012|Part D: Re-Treatment Period|Physician Decision|0
4587406|NCT01490632|7431348|FG013|Part D: Re-Treatment Period|Physician Decision|0
4587407|NCT01490632|7431349|FG014|Part D: Re-Treatment Period|Physician Decision|0
4587408|NCT01490632|7431350|FG015|Part D: Re-Treatment Period|Physician Decision|0
4587409|NCT01490632|7431351|FG016|Part D: Re-Treatment Period|Physician Decision|0
4465074|NCT00607087|7256098|FG002|Period 1|Poor compliance to protocol|0
4465075|NCT00607087|7256096|FG000|Period 1|Lost to Follow-up|1
4465076|NCT00607087|7256097|FG001|Period 1|Lost to Follow-up|0
4465077|NCT00607087|7256098|FG002|Period 1|Lost to Follow-up|0
4465078|NCT00607087|7256096|FG000|Period 1|Other reason|0
4465079|NCT00607087|7256097|FG001|Period 1|Other reason|4
4465080|NCT00607087|7256098|FG002|Period 1|Other reason|2
4465081|NCT00607087|7256096|FG000|Period 2|Withdrawal by Subject|0
4373403|NCT00799396|7148933|FG000|Clopidogrel Treatment|Adverse Event|6
4373404|NCT00799396|7148933|FG000|Clopidogrel Treatment|Physician Decision|5
4373405|NCT00799396|7148933|FG000|Clopidogrel Treatment|Withdrawal by Subject|2
4373406|NCT00799396|7148933|FG000|Clopidogrel Plus Aspirin|Adverse Event|2
4373407|NCT00799396|7148933|FG000|Clopidogrel Plus Aspirin|Physician Decision|4
4373408|NCT00069238|7148937|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9
4587410|NCT01490632|7431352|FG017|Part D: Re-Treatment Period|Physician Decision|0
4587411|NCT01490632|7431353|FG018|Part D: Re-Treatment Period|Physician Decision|1
4587412|NCT01490632|7431354|FG019|Part D: Re-Treatment Period|Physician Decision|1
4587413|NCT01490632|7431335|FG000|Part D: Re-Treatment Period|Protocol Violation|0
4587414|NCT01490632|7431336|FG001|Part D: Re-Treatment Period|Protocol Violation|0
4587415|NCT01490632|7431337|FG002|Part D: Re-Treatment Period|Protocol Violation|0
4587416|NCT01490632|7431338|FG003|Part D: Re-Treatment Period|Protocol Violation|0
4587417|NCT01490632|7431339|FG004|Part D: Re-Treatment Period|Protocol Violation|0
4587418|NCT01490632|7431340|FG005|Part D: Re-Treatment Period|Protocol Violation|0
4587419|NCT01490632|7431341|FG006|Part D: Re-Treatment Period|Protocol Violation|0
4587420|NCT01490632|7431342|FG007|Part D: Re-Treatment Period|Protocol Violation|0
4587421|NCT01490632|7431343|FG008|Part D: Re-Treatment Period|Protocol Violation|0
4587422|NCT01490632|7431344|FG009|Part D: Re-Treatment Period|Protocol Violation|0
4587423|NCT01490632|7431345|FG010|Part D: Re-Treatment Period|Protocol Violation|0
4587424|NCT01490632|7431346|FG011|Part D: Re-Treatment Period|Protocol Violation|0
4587425|NCT01490632|7431347|FG012|Part D: Re-Treatment Period|Protocol Violation|0
4587426|NCT01490632|7431348|FG013|Part D: Re-Treatment Period|Protocol Violation|0
4587427|NCT01490632|7431349|FG014|Part D: Re-Treatment Period|Protocol Violation|0
4587428|NCT01490632|7431350|FG015|Part D: Re-Treatment Period|Protocol Violation|0
4587429|NCT01490632|7431351|FG016|Part D: Re-Treatment Period|Protocol Violation|0
4587430|NCT01490632|7431352|FG017|Part D: Re-Treatment Period|Protocol Violation|0
4587431|NCT01490632|7431353|FG018|Part D: Re-Treatment Period|Protocol Violation|1
4587432|NCT01490632|7431354|FG019|Part D: Re-Treatment Period|Protocol Violation|0
4587433|NCT01490632|7431335|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0
4587434|NCT01490632|7431336|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0
4587435|NCT01490632|7431337|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0
4587436|NCT01490632|7431338|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0
4587437|NCT01490632|7431339|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0
4587438|NCT01490632|7431340|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0
4587439|NCT01490632|7431341|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0
4587440|NCT01490632|7431342|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0
4587441|NCT01490632|7431343|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0
4626335|NCT01839279|7491875|FG002|Overall Study|Classified as 'Other'|0
4373409|NCT00069238|7148938|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0
4373410|NCT00069238|7148939|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0
4373411|NCT00069238|7148937|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0
4373412|NCT00069238|7148938|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2
4373413|NCT00069238|7148939|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0
4373414|NCT00069238|7148937|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0
4373415|NCT00069238|7148938|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0
4465082|NCT00607087|7256097|FG001|Period 2|Withdrawal by Subject|1
4465083|NCT00607087|7256098|FG002|Period 2|Withdrawal by Subject|1
4465084|NCT00607087|7256096|FG000|Period 2|Other reason|1
4465085|NCT00607087|7256097|FG001|Period 2|Other reason|1
4465086|NCT00607087|7256098|FG002|Period 2|Other reason|0
4465087|NCT00607087|7256096|FG000|Period 2|Adverse Event|0
4587442|NCT01490632|7431344|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0
4587443|NCT01490632|7431345|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0
4587444|NCT01490632|7431346|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0
4587445|NCT01490632|7431347|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0
4587446|NCT01490632|7431348|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0
4587447|NCT01490632|7431349|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0
4587448|NCT01490632|7431350|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0
4587449|NCT01490632|7431351|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0
4587450|NCT01490632|7431352|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1
4587451|NCT01490632|7431353|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1
4587452|NCT01490632|7431354|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1
4587453|NCT01490697|7431403|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1
4587454|NCT01490697|7431404|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2
4587455|NCT01490814|7431429|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3
4587456|NCT01490814|7431430|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3
4587457|NCT01490814|7431429|FG000|Overall Study|Physician Decision|1
4587458|NCT01490814|7431430|FG001|Overall Study|Physician Decision|0
4587459|NCT01490814|7431429|FG000|Overall Study|Withdrawal by Subject|0
4587460|NCT01490814|7431430|FG001|Overall Study|Withdrawal by Subject|5
4587461|NCT01490840|7431438|FG000|Phase 1|Lost to Follow-up|1
4587462|NCT01490840|7431439|FG001|Phase 1|Lost to Follow-up|0
4587463|NCT01490840|7431438|FG000|Phase 1|Adverse Event|2
4587464|NCT01490840|7431439|FG001|Phase 1|Adverse Event|1
4587465|NCT01490840|7431438|FG000|Phase 1|Withdrawal by Subject|6
4587466|NCT01490840|7431439|FG001|Phase 1|Withdrawal by Subject|5
4587467|NCT01490840|7431438|FG000|Phase 1|Visit 6a omitted|1
4587468|NCT01490840|7431439|FG001|Phase 1|Visit 6a omitted|0
4587469|NCT01490840|7431438|FG000|Phase 2|Withdrawal by Subject|4
4587470|NCT01490840|7431439|FG001|Phase 2|Withdrawal by Subject|3
4587471|NCT01490840|7431438|FG000|Phase 2|Permanent interruption of fingolimod|0
4587472|NCT01490840|7431439|FG001|Phase 2|Permanent interruption of fingolimod|1
4587473|NCT01490840|7431438|FG000|Phase 2|Lost to Follow-up|1
4587474|NCT01490840|7431439|FG001|Phase 2|Lost to Follow-up|1
4587475|NCT01490840|7431438|FG000|Phase 2|Adverse Event|1
4587476|NCT01490840|7431439|FG001|Phase 2|Adverse Event|1
4587477|NCT01490866|7431445|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6
4587478|NCT01490866|7431445|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6
4587479|NCT01490866|7431445|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5
4587480|NCT01490866|7431445|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1
4587481|NCT01490866|7431445|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1
4587482|NCT01490866|7431445|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2
4587483|NCT01490866|7431445|FG000|Axitinib Maintenance Therapy|Disease Progression|30
4587484|NCT01490866|7431445|FG000|Axitinib Maintenance Therapy|Adverse Event|12
4587485|NCT01490866|7431445|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3
4587486|NCT01490866|7431445|FG000|Axitinib Maintenance Therapy|Protocol Violation|2
4587487|NCT01490866|7431445|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2
4587488|NCT01490918|7431459|FG000|Overall Study|Lost to Follow-up|2
4587489|NCT01490918|7431460|FG001|Overall Study|Lost to Follow-up|1
4587490|NCT01490918|7431461|FG002|Overall Study|Lost to Follow-up|0
4373416|NCT00069238|7148939|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2
4448749|NCT00500760|7234436|FG000|Overall Study|Administrative decision|2
4448750|NCT00500760|7234437|FG001|Overall Study|Administrative decision|0
4448751|NCT00500760|7234436|FG000|Overall Study|Lost to Follow-up|3
4448752|NCT00500760|7234437|FG001|Overall Study|Lost to Follow-up|0
4448753|NCT00500760|7234436|FG000|Overall Study|Other|1
4448754|NCT00500760|7234437|FG001|Overall Study|Other|2
4448755|NCT00500903|7234446|FG000|Overall Study|Occurrence of Adverse Event(s)|10
4448756|NCT00500903|7234447|FG001|Overall Study|Occurrence of Adverse Event(s)|0
4448757|NCT00500903|7234448|FG002|Overall Study|Occurrence of Adverse Event(s)|0
4448758|NCT00500903|7234446|FG000|Overall Study|Unsatisfactory Therapeutic Response|2
4448759|NCT00500903|7234447|FG001|Overall Study|Unsatisfactory Therapeutic Response|0
4448760|NCT00500903|7234448|FG002|Overall Study|Unsatisfactory Therapeutic Response|0
4448761|NCT00500903|7234446|FG000|Overall Study|Progressive Disease|41
4448762|NCT00500903|7234447|FG001|Overall Study|Progressive Disease|2
4448763|NCT00500903|7234448|FG002|Overall Study|Progressive Disease|15
4448764|NCT00500903|7234446|FG000|Overall Study|Patient Declined Further Treatment|0
4448765|NCT00500903|7234447|FG001|Overall Study|Patient Declined Further Treatment|0
4448766|NCT00500903|7234448|FG002|Overall Study|Patient Declined Further Treatment|3
4448767|NCT00500903|7234446|FG000|Overall Study|Symptomatic Deterioration|2
4448768|NCT00500903|7234447|FG001|Overall Study|Symptomatic Deterioration|0
4448769|NCT00500903|7234448|FG002|Overall Study|Symptomatic Deterioration|0
4448770|NCT00500903|7234446|FG000|Overall Study|Reason Not Specified|10
4448771|NCT00500903|7234447|FG001|Overall Study|Reason Not Specified|0
4448772|NCT00500903|7234448|FG002|Overall Study|Reason Not Specified|2
4448773|NCT00501007|7234486|FG000|Overall Study|Inclusion criteria not met.|29
4587491|NCT01490918|7431459|FG000|Overall Study|Withdrawal by Subject|7
4587492|NCT01490918|7431460|FG001|Overall Study|Withdrawal by Subject|8
4448774|NCT00501007|7234487|FG001|Overall Study|Inclusion criteria not met.|25
4448775|NCT00501046|7234495|FG000|Overall Study|Adverse Event|21
4448776|NCT00501046|7234496|FG001|Overall Study|Adverse Event|25
4587493|NCT01490918|7431461|FG002|Overall Study|Withdrawal by Subject|3
4373417|NCT03138499|7148946|FG000|Overall Study|Lost to Follow-up|1
4373418|NCT03138499|7148947|FG001|Overall Study|Lost to Follow-up|0
4373419|NCT03138499|7148946|FG000|Overall Study|Participants withdrew consent|1
4373420|NCT03138499|7148947|FG001|Overall Study|Participants withdrew consent|0
4373421|NCT03138499|7148946|FG000|Overall Study|Participant discontinued study before treatment|0
4373422|NCT03138499|7148947|FG001|Overall Study|Participant discontinued study before treatment|1
4373423|NCT03138499|7148946|FG000|Overall Study|Disease Progression|2
4373424|NCT03138499|7148947|FG001|Overall Study|Disease Progression|6
4373425|NCT03138499|7148946|FG000|Overall Study|Study drug toxicity|2
4373426|NCT03138499|7148947|FG001|Overall Study|Study drug toxicity|2
4373427|NCT03138499|7148946|FG000|Overall Study|Participant request to discontinue study treatment|1
4373428|NCT03138499|7148947|FG001|Overall Study|Participant request to discontinue study treatment|1
4373429|NCT03138499|7148946|FG000|Overall Study|Other reasons|2
4373430|NCT03138499|7148947|FG001|Overall Study|Other reasons|0
4373431|NCT04980040|7149034|FG000|Overall Study|Violated the Inclusion Criteria|260
4373432|NCT04980040|7149034|FG000|Overall Study|Violated the Administration & Dosage|225
4373433|NCT04980040|7149034|FG000|Overall Study|Lost to Safety-Follow-up|4
4373434|NCT04980040|7149034|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3
4373435|NCT04167670|7149050|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1
4373436|NCT04167670|7149051|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7
4373437|NCT04167670|7149052|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4
4373438|NCT04167670|7149050|FG000|Overall Study|Significant protocol deviation|3
4373439|NCT04167670|7149051|FG001|Overall Study|Significant protocol deviation|1
4373440|NCT04167670|7149052|FG002|Overall Study|Significant protocol deviation|0
4373441|NCT04167670|7149050|FG000|Overall Study|Lost to Follow-up|0
4373442|NCT04167670|7149051|FG001|Overall Study|Lost to Follow-up|3
4373443|NCT04167670|7149052|FG002|Overall Study|Lost to Follow-up|3
4373444|NCT04167670|7149050|FG000|Overall Study|Voluntary Withdrawal|0
4373445|NCT04167670|7149051|FG001|Overall Study|Voluntary Withdrawal|1
4373446|NCT04167670|7149052|FG002|Overall Study|Voluntary Withdrawal|1
4373447|NCT04167670|7149050|FG000|Overall Study|Withdrawal of Consent|4
4373448|NCT04167670|7149051|FG001|Overall Study|Withdrawal of Consent|1
4373449|NCT04167670|7149052|FG002|Overall Study|Withdrawal of Consent|3
4373450|NCT04167670|7149050|FG000|Overall Study|Miscellaneous|7
4373451|NCT04167670|7149051|FG001|Overall Study|Miscellaneous|5
4373452|NCT04167670|7149052|FG002|Overall Study|Miscellaneous|3
4373453|NCT04076917|7149060|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49
4373454|NCT04076917|7149060|FG000|Overall Study|Study closure|13
4373455|NCT04076917|7149060|FG000|Overall Study|Physician Decision|3
4373456|NCT04076917|7149060|FG000|Overall Study|Death|1
4373457|NCT04076917|7149060|FG000|Overall Study|Lost to Follow-up|1
4373458|NCT04076917|7149060|FG000|Overall Study|Withdrawal by Subject|1
4373459|NCT04076917|7149060|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1
4373460|NCT04000009|7149064|FG000|Overall Study|Adverse Event|13
4373461|NCT04000009|7149064|FG000|Overall Study|Lack of Efficacy|7
4373462|NCT04000009|7149064|FG000|Overall Study|Lost to Follow-up|8
4373463|NCT04000009|7149064|FG000|Overall Study|Noncompliance with study drug|4
4373464|NCT04000009|7149064|FG000|Overall Study|Physician Decision|1
4373465|NCT04000009|7149064|FG000|Overall Study|Use of prohibited medication|3
4373466|NCT04000009|7149064|FG000|Overall Study|Pregnancy|1
4373467|NCT04000009|7149064|FG000|Overall Study|Withdrawal by Subject|22
4373468|NCT04000009|7149064|FG000|Overall Study|Study terminated by sponsor|98
4373469|NCT04000009|7149064|FG000|Overall Study|Not further specified|8
4373470|NCT03674112|7149092|FG000|Overall Study|Adverse Event|1
4373471|NCT03674112|7149093|FG001|Overall Study|Adverse Event|0
4373472|NCT03674112|7149092|FG000|Overall Study|Ongoing in the Study|79
4373473|NCT03674112|7149093|FG001|Overall Study|Ongoing in the Study|80
4373474|NCT03205371|7149145|FG000|Overall Study|Withdrawal by Subject|4
4373475|NCT03205371|7149146|FG001|Overall Study|Withdrawal by Subject|1
4373476|NCT03205371|7149147|FG002|Overall Study|Withdrawal by Subject|0
4373477|NCT03205371|7149148|FG003|Overall Study|Withdrawal by Subject|0
4465088|NCT00607087|7256097|FG001|Period 2|Adverse Event|1
4465089|NCT00607087|7256098|FG002|Period 2|Adverse Event|3
4465090|NCT00607087|7256096|FG000|Period 2|Poor compliance to protocol|0
4465091|NCT00607087|7256097|FG001|Period 2|Poor compliance to protocol|0
4465092|NCT00607087|7256098|FG002|Period 2|Poor compliance to protocol|1
4465093|NCT00607087|7256096|FG000|Period 3|Withdrawal by Subject|2
4465094|NCT00607087|7256097|FG001|Period 3|Withdrawal by Subject|1
4465095|NCT00607087|7256098|FG002|Period 3|Withdrawal by Subject|0
4465096|NCT00607087|7256096|FG000|Period 3|Adverse Event|0
4465097|NCT00607087|7256097|FG001|Period 3|Adverse Event|1
4465098|NCT00607087|7256098|FG002|Period 3|Adverse Event|0
4465099|NCT00607373|7256149|FG000|Treatment Period|Adverse Event|0
4465100|NCT00607373|7256150|FG001|Treatment Period|Adverse Event|4
4465101|NCT00607373|7256149|FG000|Treatment Period|Physician Decision|0
4465102|NCT00607373|7256150|FG001|Treatment Period|Physician Decision|1
4465103|NCT00607373|7256149|FG000|Treatment Period|Withdrawal by Subject|0
4465104|NCT00607373|7256150|FG001|Treatment Period|Withdrawal by Subject|1
4465105|NCT00607373|7256149|FG000|Follow-up Period|Other|0
4465106|NCT00607373|7256150|FG001|Follow-up Period|Other|1
4373478|NCT03205371|7149149|FG004|Overall Study|Withdrawal by Subject|0
4373479|NCT03205371|7149150|FG005|Overall Study|Withdrawal by Subject|0
4373480|NCT03205371|7149151|FG006|Overall Study|Withdrawal by Subject|4
4373481|NCT03205371|7149152|FG007|Overall Study|Withdrawal by Subject|0
4373482|NCT03205371|7149153|FG008|Overall Study|Withdrawal by Subject|2
4373483|NCT03205371|7149154|FG009|Overall Study|Withdrawal by Subject|0
4373484|NCT03205371|7149155|FG010|Overall Study|Withdrawal by Subject|0
4373485|NCT03205371|7149156|FG011|Overall Study|Withdrawal by Subject|1
4373486|NCT03205371|7149145|FG000|Overall Study|Lost to Follow-up|0
4373487|NCT03205371|7149146|FG001|Overall Study|Lost to Follow-up|0
4373488|NCT03205371|7149147|FG002|Overall Study|Lost to Follow-up|0
4373489|NCT03205371|7149148|FG003|Overall Study|Lost to Follow-up|0
4373490|NCT03205371|7149149|FG004|Overall Study|Lost to Follow-up|0
4373491|NCT03205371|7149150|FG005|Overall Study|Lost to Follow-up|0
4373492|NCT03205371|7149151|FG006|Overall Study|Lost to Follow-up|5
4373493|NCT03205371|7149152|FG007|Overall Study|Lost to Follow-up|2
4373494|NCT03205371|7149153|FG008|Overall Study|Lost to Follow-up|3
4373495|NCT03205371|7149154|FG009|Overall Study|Lost to Follow-up|0
4373496|NCT03205371|7149155|FG010|Overall Study|Lost to Follow-up|0
4373497|NCT03205371|7149156|FG011|Overall Study|Lost to Follow-up|0
4373498|NCT03205371|7149145|FG000|Overall Study|Protocol Violation|0
4373499|NCT03205371|7149146|FG001|Overall Study|Protocol Violation|0
4373500|NCT03205371|7149147|FG002|Overall Study|Protocol Violation|0
4373501|NCT03205371|7149148|FG003|Overall Study|Protocol Violation|0
4373502|NCT03205371|7149149|FG004|Overall Study|Protocol Violation|0
4373503|NCT03205371|7149150|FG005|Overall Study|Protocol Violation|0
4373504|NCT03205371|7149151|FG006|Overall Study|Protocol Violation|1
4373505|NCT03205371|7149152|FG007|Overall Study|Protocol Violation|0
4373506|NCT03205371|7149153|FG008|Overall Study|Protocol Violation|0
4373507|NCT03205371|7149154|FG009|Overall Study|Protocol Violation|0
4373508|NCT03205371|7149155|FG010|Overall Study|Protocol Violation|0
4373509|NCT03205371|7149156|FG011|Overall Study|Protocol Violation|0
4373510|NCT03205371|7149145|FG000|Overall Study|Adverse Event|0
4373511|NCT03205371|7149146|FG001|Overall Study|Adverse Event|0
4373512|NCT03205371|7149147|FG002|Overall Study|Adverse Event|0
4373513|NCT03205371|7149148|FG003|Overall Study|Adverse Event|0
4373514|NCT03205371|7149149|FG004|Overall Study|Adverse Event|0
4373515|NCT03205371|7149150|FG005|Overall Study|Adverse Event|0
4373516|NCT03205371|7149151|FG006|Overall Study|Adverse Event|0
4373517|NCT03205371|7149152|FG007|Overall Study|Adverse Event|1
4373518|NCT03205371|7149153|FG008|Overall Study|Adverse Event|0
4373519|NCT03205371|7149154|FG009|Overall Study|Adverse Event|0
4373520|NCT03205371|7149155|FG010|Overall Study|Adverse Event|0
4373521|NCT03205371|7149156|FG011|Overall Study|Adverse Event|0
4373522|NCT03165721|7149205|FG000|Overall Study|Refused further treatment|3
4373523|NCT03165721|7149206|FG001|Overall Study|Refused further treatment|0
4373524|NCT03165721|7149207|FG002|Overall Study|Refused further treatment|0
4373525|NCT03165721|7149205|FG000|Overall Study|Physician Decision|1
4373526|NCT03165721|7149206|FG001|Overall Study|Physician Decision|0
4373527|NCT03165721|7149207|FG002|Overall Study|Physician Decision|0
4373528|NCT03130959|7149227|FG000|Treatment Period|Disease progression|18
4373529|NCT03130959|7149228|FG001|Treatment Period|Disease progression|15
4373530|NCT03130959|7149229|FG002|Treatment Period|Disease progression|12
4373531|NCT03130959|7149230|FG003|Treatment Period|Disease progression|8
4373532|NCT03130959|7149231|FG004|Treatment Period|Disease progression|12
4373533|NCT03130959|7149232|FG005|Treatment Period|Disease progression|11
4373534|NCT03130959|7149233|FG006|Treatment Period|Disease progression|6
4373535|NCT03130959|7149234|FG007|Treatment Period|Disease progression|9
4373536|NCT03130959|7149235|FG008|Treatment Period|Disease progression|15
4373537|NCT03130959|7149236|FG009|Treatment Period|Disease progression|9
4373538|NCT03130959|7149227|FG000|Treatment Period|Study drug toxicity|2
4373539|NCT03130959|7149228|FG001|Treatment Period|Study drug toxicity|3
4373540|NCT03130959|7149229|FG002|Treatment Period|Study drug toxicity|1
4373541|NCT03130959|7149230|FG003|Treatment Period|Study drug toxicity|2
4373542|NCT03130959|7149231|FG004|Treatment Period|Study drug toxicity|1
4373543|NCT03130959|7149232|FG005|Treatment Period|Study drug toxicity|2
4373544|NCT03130959|7149233|FG006|Treatment Period|Study drug toxicity|3
4373545|NCT03130959|7149234|FG007|Treatment Period|Study drug toxicity|0
4373546|NCT03130959|7149235|FG008|Treatment Period|Study drug toxicity|3
4373547|NCT03130959|7149236|FG009|Treatment Period|Study drug toxicity|4
4373548|NCT03130959|7149227|FG000|Treatment Period|Other reasons|1
4373549|NCT03130959|7149228|FG001|Treatment Period|Other reasons|0
4373550|NCT03130959|7149229|FG002|Treatment Period|Other reasons|0
4373551|NCT03130959|7149230|FG003|Treatment Period|Other reasons|0
4373552|NCT03130959|7149231|FG004|Treatment Period|Other reasons|0
4373553|NCT03130959|7149232|FG005|Treatment Period|Other reasons|0
4373554|NCT03130959|7149233|FG006|Treatment Period|Other reasons|1
4373555|NCT03130959|7149234|FG007|Treatment Period|Other reasons|0
4373556|NCT03130959|7149235|FG008|Treatment Period|Other reasons|0
4373557|NCT03130959|7149236|FG009|Treatment Period|Other reasons|0
4373558|NCT03130959|7149227|FG000|Treatment Period|Participant request to stop therapy|0
4373559|NCT03130959|7149228|FG001|Treatment Period|Participant request to stop therapy|1
4373560|NCT03130959|7149229|FG002|Treatment Period|Participant request to stop therapy|1
4373561|NCT03130959|7149230|FG003|Treatment Period|Participant request to stop therapy|1
4373562|NCT03130959|7149231|FG004|Treatment Period|Participant request to stop therapy|0
4373563|NCT03130959|7149232|FG005|Treatment Period|Participant request to stop therapy|0
4373564|NCT03130959|7149233|FG006|Treatment Period|Participant request to stop therapy|1
4373565|NCT03130959|7149234|FG007|Treatment Period|Participant request to stop therapy|1
4373566|NCT03130959|7149235|FG008|Treatment Period|Participant request to stop therapy|0
4373567|NCT03130959|7149236|FG009|Treatment Period|Participant request to stop therapy|0
4373568|NCT03130959|7149227|FG000|Treatment Period|Not reported|0
4373569|NCT03130959|7149228|FG001|Treatment Period|Not reported|2
4373570|NCT03130959|7149229|FG002|Treatment Period|Not reported|0
4373571|NCT03130959|7149230|FG003|Treatment Period|Not reported|1
4373572|NCT03130959|7149231|FG004|Treatment Period|Not reported|0
4373573|NCT03130959|7149232|FG005|Treatment Period|Not reported|2
4373574|NCT03130959|7149233|FG006|Treatment Period|Not reported|0
4373575|NCT03130959|7149234|FG007|Treatment Period|Not reported|0
4373576|NCT03130959|7149235|FG008|Treatment Period|Not reported|0
4373577|NCT03130959|7149236|FG009|Treatment Period|Not reported|2
4373578|NCT03130959|7149227|FG000|Treatment Period|Adverse Event unrelated to drug|0
4373579|NCT03130959|7149228|FG001|Treatment Period|Adverse Event unrelated to drug|0
4373580|NCT03130959|7149229|FG002|Treatment Period|Adverse Event unrelated to drug|1
4373581|NCT03130959|7149230|FG003|Treatment Period|Adverse Event unrelated to drug|1
4373582|NCT03130959|7149231|FG004|Treatment Period|Adverse Event unrelated to drug|1
4373583|NCT03130959|7149232|FG005|Treatment Period|Adverse Event unrelated to drug|0
4373584|NCT03130959|7149233|FG006|Treatment Period|Adverse Event unrelated to drug|1
4373585|NCT03130959|7149234|FG007|Treatment Period|Adverse Event unrelated to drug|0
4373586|NCT03130959|7149235|FG008|Treatment Period|Adverse Event unrelated to drug|1
4373587|NCT03130959|7149236|FG009|Treatment Period|Adverse Event unrelated to drug|1
4373588|NCT03130959|7149227|FG000|Treatment Period|Participant withdrew consent|0
4373589|NCT03130959|7149228|FG001|Treatment Period|Participant withdrew consent|0
4373590|NCT03130959|7149229|FG002|Treatment Period|Participant withdrew consent|0
4373591|NCT03130959|7149230|FG003|Treatment Period|Participant withdrew consent|2
4465107|NCT00607373|7256149|FG000|Follow-up Period|Protocol Violation|0
4465108|NCT00607373|7256150|FG001|Follow-up Period|Protocol Violation|1
4465109|NCT00607373|7256149|FG000|Follow-up Period|Withdrawal by Subject|1
4465110|NCT00607373|7256150|FG001|Follow-up Period|Withdrawal by Subject|3
4465111|NCT00607386|7256156|FG000|Overall Study|Physician Decision|1
4465112|NCT00607724|7256198|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7
4465113|NCT00607724|7256199|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8
4465114|NCT00607724|7256200|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4
4465115|NCT00607724|7256201|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0
4465116|NCT00607724|7256202|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0
4465117|NCT00607724|7256203|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0
4465118|NCT00607724|7256204|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0
4465119|NCT00607724|7256198|FG000|Stage 2: Expanded Cohort|Adverse Event|0
4465120|NCT00607724|7256199|FG001|Stage 2: Expanded Cohort|Adverse Event|0
4465121|NCT00607724|7256200|FG002|Stage 2: Expanded Cohort|Adverse Event|0
4465122|NCT00607724|7256201|FG003|Stage 2: Expanded Cohort|Adverse Event|0
4465123|NCT00607724|7256202|FG004|Stage 2: Expanded Cohort|Adverse Event|0
4465124|NCT00607724|7256203|FG005|Stage 2: Expanded Cohort|Adverse Event|0
4465125|NCT00607724|7256204|FG006|Stage 2: Expanded Cohort|Adverse Event|1
4465126|NCT00607724|7256198|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0
4465127|NCT00607724|7256199|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0
4465128|NCT00607724|7256200|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0
4465129|NCT00607724|7256201|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4
4465130|NCT00607724|7256202|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8
4465131|NCT00607724|7256203|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11
4465132|NCT00607724|7256204|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10
4465133|NCT00607724|7256198|FG000|Stage 2: Expanded Cohort|Physician Decision|0
4465134|NCT00607724|7256199|FG001|Stage 2: Expanded Cohort|Physician Decision|0
4587494|NCT01490918|7431459|FG000|Overall Study|Adverse Event|0
4587495|NCT01490918|7431460|FG001|Overall Study|Adverse Event|0
4587496|NCT01490918|7431461|FG002|Overall Study|Adverse Event|1
4587497|NCT01490918|7431459|FG000|Overall Study|other cause|4
4587498|NCT01490918|7431460|FG001|Overall Study|other cause|5
4587499|NCT01490918|7431461|FG002|Overall Study|other cause|8
4587500|NCT01491035|7431498|FG000|Overall Study|Lost to Follow-up|0
4465135|NCT00607724|7256200|FG002|Stage 2: Expanded Cohort|Physician Decision|0
4465136|NCT00607724|7256201|FG003|Stage 2: Expanded Cohort|Physician Decision|0
4465137|NCT00607724|7256202|FG004|Stage 2: Expanded Cohort|Physician Decision|1
4465138|NCT00607724|7256203|FG005|Stage 2: Expanded Cohort|Physician Decision|1
4465139|NCT00607724|7256204|FG006|Stage 2: Expanded Cohort|Physician Decision|0
4465140|NCT00607724|7256198|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0
4465141|NCT00607724|7256199|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0
4465142|NCT00607724|7256200|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0
4465143|NCT00607724|7256201|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1
4465144|NCT00607724|7256202|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0
4587501|NCT01491035|7431499|FG001|Overall Study|Lost to Follow-up|0
4373592|NCT03130959|7149231|FG004|Treatment Period|Participant withdrew consent|1
4373593|NCT03130959|7149232|FG005|Treatment Period|Participant withdrew consent|0
4373594|NCT03130959|7149233|FG006|Treatment Period|Participant withdrew consent|0
4373595|NCT03130959|7149234|FG007|Treatment Period|Participant withdrew consent|0
4373596|NCT03130959|7149235|FG008|Treatment Period|Participant withdrew consent|0
4373597|NCT03130959|7149236|FG009|Treatment Period|Participant withdrew consent|2
4373598|NCT03130959|7149227|FG000|Follow-up Period|Death|16
4373599|NCT03130959|7149228|FG001|Follow-up Period|Death|17
4373600|NCT03130959|7149229|FG002|Follow-up Period|Death|12
4373601|NCT03130959|7149230|FG003|Follow-up Period|Death|10
4373602|NCT03130959|7149231|FG004|Follow-up Period|Death|11
4373603|NCT03130959|7149232|FG005|Follow-up Period|Death|8
4373604|NCT03130959|7149233|FG006|Follow-up Period|Death|9
4373605|NCT03130959|7149234|FG007|Follow-up Period|Death|7
4373606|NCT03130959|7149235|FG008|Follow-up Period|Death|17
4373607|NCT03130959|7149236|FG009|Follow-up Period|Death|10
4373608|NCT03130959|7149227|FG000|Follow-up Period|Participant withdrew consent|3
4373609|NCT03130959|7149228|FG001|Follow-up Period|Participant withdrew consent|1
4373610|NCT03130959|7149229|FG002|Follow-up Period|Participant withdrew consent|0
4373611|NCT03130959|7149230|FG003|Follow-up Period|Participant withdrew consent|3
4373612|NCT03130959|7149231|FG004|Follow-up Period|Participant withdrew consent|3
4373613|NCT03130959|7149232|FG005|Follow-up Period|Participant withdrew consent|0
4373614|NCT03130959|7149233|FG006|Follow-up Period|Participant withdrew consent|0
4373615|NCT03130959|7149234|FG007|Follow-up Period|Participant withdrew consent|1
4373616|NCT03130959|7149235|FG008|Follow-up Period|Participant withdrew consent|1
4373617|NCT03130959|7149236|FG009|Follow-up Period|Participant withdrew consent|3
4373618|NCT03130959|7149227|FG000|Follow-up Period|Lost to Follow-up|1
4587502|NCT01491035|7431500|FG002|Overall Study|Lost to Follow-up|0
4587503|NCT01491035|7431501|FG003|Overall Study|Lost to Follow-up|0
4694550|NCT02608476|7606074|FG001|Overall Study|Pregnancy|1
4373619|NCT03130959|7149228|FG001|Follow-up Period|Lost to Follow-up|1
4373620|NCT03130959|7149229|FG002|Follow-up Period|Lost to Follow-up|0
4373621|NCT03130959|7149230|FG003|Follow-up Period|Lost to Follow-up|0
4373622|NCT03130959|7149231|FG004|Follow-up Period|Lost to Follow-up|0
4373623|NCT03130959|7149232|FG005|Follow-up Period|Lost to Follow-up|2
4373624|NCT03130959|7149233|FG006|Follow-up Period|Lost to Follow-up|0
4373625|NCT03130959|7149234|FG007|Follow-up Period|Lost to Follow-up|0
4373626|NCT03130959|7149235|FG008|Follow-up Period|Lost to Follow-up|0
4373627|NCT03130959|7149236|FG009|Follow-up Period|Lost to Follow-up|1
4373628|NCT03130959|7149227|FG000|Follow-up Period|Other reasons|0
4587504|NCT01491035|7431502|FG004|Overall Study|Lost to Follow-up|1
4587505|NCT01491035|7431503|FG005|Overall Study|Lost to Follow-up|0
4694551|NCT02608476|7606073|FG000|Overall Study|Progressive disease|1
4694552|NCT02608476|7606074|FG001|Overall Study|Progressive disease|0
4694553|NCT02608879|7606092|FG000|Overall Study|Lost to Follow-up|1
4694554|NCT02608879|7606093|FG001|Overall Study|Lost to Follow-up|0
4694555|NCT02608879|7606094|FG002|Overall Study|Lost to Follow-up|0
4694556|NCT02608879|7606092|FG000|Overall Study|Did not meet continuation criteria|0
4694557|NCT02608879|7606093|FG001|Overall Study|Did not meet continuation criteria|0
4694558|NCT02608879|7606094|FG002|Overall Study|Did not meet continuation criteria|3
4694559|NCT02608892|7606104|FG000|Overall Study|Lost to Follow-up|1
4694560|NCT02608892|7606105|FG001|Overall Study|Lost to Follow-up|0
4694561|NCT02609178|7606132|FG000|First Crown|Withdrawal by Subject|0
4694562|NCT02609178|7606133|FG001|First Crown|Withdrawal by Subject|0
4694563|NCT02609178|7606134|FG002|First Crown|Withdrawal by Subject|1
4694564|NCT02609178|7606135|FG003|First Crown|Withdrawal by Subject|1
4694565|NCT02609178|7606136|FG004|First Crown|Withdrawal by Subject|0
4694566|NCT02609178|7606137|FG005|First Crown|Withdrawal by Subject|0
4694567|NCT02609399|7606159|FG000|Influenza Season 2015-2016|Lost to Follow-up|3
4373629|NCT03130959|7149228|FG001|Follow-up Period|Other reasons|1
4373630|NCT03130959|7149229|FG002|Follow-up Period|Other reasons|0
4373631|NCT03130959|7149230|FG003|Follow-up Period|Other reasons|1
4373632|NCT03130959|7149231|FG004|Follow-up Period|Other reasons|0
4373633|NCT03130959|7149232|FG005|Follow-up Period|Other reasons|0
4373634|NCT03130959|7149233|FG006|Follow-up Period|Other reasons|0
4373635|NCT03130959|7149234|FG007|Follow-up Period|Other reasons|0
4373636|NCT03130959|7149235|FG008|Follow-up Period|Other reasons|0
4373637|NCT03130959|7149236|FG009|Follow-up Period|Other reasons|2
4373638|NCT02955797|7149275|FG000|Overall Study|Protocol Violation|1
4373639|NCT02955797|7149276|FG001|Overall Study|Protocol Violation|0
4373640|NCT02955797|7149277|FG002|Overall Study|Protocol Violation|0
4373641|NCT02955797|7149278|FG003|Overall Study|Protocol Violation|1
4373642|NCT02955797|7149275|FG000|Overall Study|Withdrawal by Subject|2
4373643|NCT02955797|7149276|FG001|Overall Study|Withdrawal by Subject|2
4373644|NCT02955797|7149277|FG002|Overall Study|Withdrawal by Subject|0
4373645|NCT02955797|7149278|FG003|Overall Study|Withdrawal by Subject|1
4373646|NCT02955797|7149275|FG000|Overall Study|Lost to Follow-up|0
4373647|NCT02955797|7149276|FG001|Overall Study|Lost to Follow-up|1
4373648|NCT02955797|7149277|FG002|Overall Study|Lost to Follow-up|0
4373649|NCT02955797|7149278|FG003|Overall Study|Lost to Follow-up|0
4373650|NCT02893930|7149291|FG000|Overall Study|Adverse Event|3
4373651|NCT02893930|7149291|FG000|Overall Study|Death|1
4694568|NCT02609399|7606160|FG001|Influenza Season 2015-2016|Lost to Follow-up|2
4694569|NCT02609399|7606159|FG000|Influenza Season 2016-2017|Lost to Follow-up|8
4373652|NCT02893930|7149291|FG000|Overall Study|Disease progression|5
4373653|NCT02893930|7149291|FG000|Overall Study|Withdrawal by Subject|2
4373654|NCT02893930|7149291|FG000|Overall Study|Physician Decision|1
4373655|NCT02893930|7149291|FG000|Overall Study|Ineligible|1
4373656|NCT02859415|7149297|FG000|Overall Study|Physician Decision|1
4373657|NCT02859415|7149298|FG001|Overall Study|Physician Decision|0
4373658|NCT02859415|7149297|FG000|Overall Study|Off treatment due to cardiac event|0
4373659|NCT02859415|7149298|FG001|Overall Study|Off treatment due to cardiac event|1
4373660|NCT02842866|7149307|FG000|Overall Study|Serious Adverse Event|0
4373661|NCT02842866|7149308|FG001|Overall Study|Serious Adverse Event|1
4373662|NCT02842866|7149307|FG000|Overall Study|Protocol Violation|4
4373663|NCT02842866|7149308|FG001|Overall Study|Protocol Violation|2
4373664|NCT02842866|7149307|FG000|Overall Study|Lost to Follow-up|2
4373665|NCT02842866|7149308|FG001|Overall Study|Lost to Follow-up|0
4373666|NCT02842866|7149307|FG000|Overall Study|Withdrawal by Subject|1
4373667|NCT02842866|7149308|FG001|Overall Study|Withdrawal by Subject|0
4373668|NCT02842853|7149318|FG000|Overall Study|Non-compliance with the protocol|3
4373669|NCT02842853|7149319|FG001|Overall Study|Non-compliance with the protocol|7
4373670|NCT02842853|7149320|FG002|Overall Study|Non-compliance with the protocol|2
4373671|NCT02842853|7149321|FG003|Overall Study|Non-compliance with the protocol|5
4373672|NCT02842853|7149318|FG000|Overall Study|Subject met exclusion criteria|0
4373673|NCT02842853|7149319|FG001|Overall Study|Subject met exclusion criteria|1
4373674|NCT02842853|7149320|FG002|Overall Study|Subject met exclusion criteria|0
4373675|NCT02842853|7149321|FG003|Overall Study|Subject met exclusion criteria|0
4373676|NCT02842853|7149318|FG000|Overall Study|Withdrawal by Subject|11
4373677|NCT02842853|7149319|FG001|Overall Study|Withdrawal by Subject|13
4373678|NCT02842853|7149320|FG002|Overall Study|Withdrawal by Subject|9
4373679|NCT02842853|7149321|FG003|Overall Study|Withdrawal by Subject|8
4373680|NCT02842853|7149318|FG000|Overall Study|Lost to Follow-up|9
4373681|NCT02842853|7149319|FG001|Overall Study|Lost to Follow-up|13
4373682|NCT02842853|7149320|FG002|Overall Study|Lost to Follow-up|10
4373683|NCT02842853|7149321|FG003|Overall Study|Lost to Follow-up|11
4373684|NCT02759185|7149337|FG000|Stage 1|Adverse Event|0
4373685|NCT02759185|7149338|FG001|Stage 1|Adverse Event|1
4373686|NCT02759185|7149339|FG002|Stage 1|Adverse Event|3
4373687|NCT02759185|7149340|FG003|Stage 1|Adverse Event|0
4373688|NCT02759185|7149341|FG004|Stage 1|Adverse Event|0
4373689|NCT02759185|7149342|FG005|Stage 1|Adverse Event|0
4373690|NCT02759185|7149343|FG006|Stage 1|Adverse Event|0
4373691|NCT02759185|7149337|FG000|Stage 1|Withdrawal by Subject|1
4373692|NCT02759185|7149338|FG001|Stage 1|Withdrawal by Subject|0
4373693|NCT02759185|7149339|FG002|Stage 1|Withdrawal by Subject|0
4373694|NCT02759185|7149340|FG003|Stage 1|Withdrawal by Subject|0
4373695|NCT02759185|7149341|FG004|Stage 1|Withdrawal by Subject|0
4373696|NCT02759185|7149342|FG005|Stage 1|Withdrawal by Subject|0
4373697|NCT02759185|7149343|FG006|Stage 1|Withdrawal by Subject|0
4373698|NCT02759185|7149337|FG000|Stage 2|Adverse Event|0
4373699|NCT02759185|7149338|FG001|Stage 2|Adverse Event|0
4373700|NCT02759185|7149339|FG002|Stage 2|Adverse Event|0
4373701|NCT02759185|7149340|FG003|Stage 2|Adverse Event|0
4373702|NCT02759185|7149341|FG004|Stage 2|Adverse Event|1
4373703|NCT02759185|7149342|FG005|Stage 2|Adverse Event|2
4373704|NCT02759185|7149343|FG006|Stage 2|Adverse Event|0
4373705|NCT02759185|7149337|FG000|Stage 2|Withdrawal by Subject|0
4373706|NCT02759185|7149338|FG001|Stage 2|Withdrawal by Subject|0
4373707|NCT02759185|7149339|FG002|Stage 2|Withdrawal by Subject|0
4373708|NCT02759185|7149340|FG003|Stage 2|Withdrawal by Subject|0
4373709|NCT02759185|7149341|FG004|Stage 2|Withdrawal by Subject|1
4373710|NCT02759185|7149342|FG005|Stage 2|Withdrawal by Subject|1
4373711|NCT02759185|7149343|FG006|Stage 2|Withdrawal by Subject|1
4373712|NCT02752906|7149363|FG000|Overall Study|Protocol Violation|2
4373713|NCT02752906|7149364|FG001|Overall Study|Protocol Violation|1
4373714|NCT02752906|7149363|FG000|Overall Study|Withdrawal by Subject|2
4373715|NCT02752906|7149364|FG001|Overall Study|Withdrawal by Subject|2
4373716|NCT02752906|7149363|FG000|Overall Study|Lost to Follow-up|3
4373717|NCT02752906|7149364|FG001|Overall Study|Lost to Follow-up|2
4373718|NCT02693691|7149370|FG000|Primary Endpoint Analysis (First 12M)|Death|30
4373719|NCT02693691|7149370|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12
4373720|NCT02693691|7149370|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7
4373721|NCT02693691|7149370|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1
4373722|NCT02693691|7149370|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12
4373723|NCT02693691|7149370|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11
4373724|NCT02693691|7149370|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1
4448777|NCT00501046|7234495|FG000|Overall Study|Death|23
4448778|NCT00501046|7234496|FG001|Overall Study|Death|30
4448779|NCT00501046|7234495|FG000|Overall Study|Lost to Follow-up|14
4448780|NCT00501046|7234496|FG001|Overall Study|Lost to Follow-up|13
4448781|NCT00501046|7234495|FG000|Overall Study|Physician Decision|7
4448782|NCT00501046|7234496|FG001|Overall Study|Physician Decision|2
4448783|NCT00501046|7234495|FG000|Overall Study|Pregnancy|0
4448784|NCT00501046|7234496|FG001|Overall Study|Pregnancy|3
4448785|NCT00501046|7234495|FG000|Overall Study|Protocol Violation|2
4448786|NCT00501046|7234496|FG001|Overall Study|Protocol Violation|1
4448787|NCT00501046|7234495|FG000|Overall Study|Withdrawal by Subject|84
4448788|NCT00501046|7234496|FG001|Overall Study|Withdrawal by Subject|83
4373725|NCT02388906|7149392|FG000|Pre-Treatment Period|Participant withdrew consent|1
4373726|NCT02388906|7149393|FG001|Pre-Treatment Period|Participant withdrew consent|0
4373727|NCT02388906|7149392|FG000|Treatment Period|Disease progression|121
4373728|NCT02388906|7149393|FG001|Treatment Period|Disease progression|101
4373729|NCT02388906|7149392|FG000|Treatment Period|Study drug toxicity|41
4373730|NCT02388906|7149393|FG001|Treatment Period|Study drug toxicity|208
4373731|NCT02388906|7149392|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5
4373732|NCT02388906|7149393|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5
4373733|NCT02388906|7149392|FG000|Treatment Period|Participant request to stop treatment|5
4373734|NCT02388906|7149393|FG001|Treatment Period|Participant request to stop treatment|9
4373735|NCT02388906|7149392|FG000|Treatment Period|Participant withdrew consent|2
4373736|NCT02388906|7149393|FG001|Treatment Period|Participant withdrew consent|3
4373737|NCT02388906|7149392|FG000|Treatment Period|Poor/non-compliance|0
4373738|NCT02388906|7149393|FG001|Treatment Period|Poor/non-compliance|1
4373739|NCT02388906|7149392|FG000|Treatment Period|Participant no longer meets study criteria|0
4373740|NCT02388906|7149393|FG001|Treatment Period|Participant no longer meets study criteria|1
4373741|NCT02388906|7149392|FG000|Treatment Period|Other reasons|3
4373742|NCT02388906|7149393|FG001|Treatment Period|Other reasons|3
4373743|NCT02384993|7149401|FG000|Overall Study|Adverse Event|0
4373744|NCT02384993|7149402|FG001|Overall Study|Adverse Event|1
4373745|NCT02304302|7149411|FG000|Overall Study|Adverse Event|2
4373746|NCT02304302|7149412|FG001|Overall Study|Adverse Event|3
4373747|NCT02304302|7149411|FG000|Overall Study|Lost to Follow-up|1
4373748|NCT02304302|7149412|FG001|Overall Study|Lost to Follow-up|4
4373749|NCT02304302|7149411|FG000|Overall Study|Removed from analysis due to low medication compliance|0
4373750|NCT02304302|7149412|FG001|Overall Study|Removed from analysis due to low medication compliance|1
4373751|NCT02294461|7149424|FG000|Double-blind Period (up to 29.4 Months)|Death|6
4373752|NCT02294461|7149425|FG001|Double-blind Period (up to 29.4 Months)|Death|4
4373753|NCT02294461|7149424|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30
4373754|NCT02294461|7149425|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66
4373755|NCT02294461|7149424|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27
4373756|NCT02294461|7149425|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54
4373757|NCT02294461|7149424|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0
4373758|NCT02294461|7149425|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2
4373759|NCT02294461|7149424|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1
4373760|NCT02294461|7149425|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0
4373761|NCT02294461|7149424|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38
4373762|NCT02294461|7149425|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51
4373763|NCT02294461|7149424|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16
4373764|NCT02294461|7149425|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15
4373765|NCT02294461|7149424|FG000|Open-label Period (up to 54.3 Months)|Ongoing|19
4373766|NCT02294461|7149425|FG001|Open-label Period (up to 54.3 Months)|Ongoing|9
4373767|NCT02294461|7149424|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|16
4373768|NCT02294461|7149425|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|12
4373769|NCT02294461|7149424|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|18
4373770|NCT02294461|7149425|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|9
4373771|NCT02294461|7149424|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2
4373772|NCT02294461|7149425|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0
4373773|NCT02294461|7149424|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|3
4373774|NCT02294461|7149425|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|1
4373775|NCT02294461|7149424|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|15
4373776|NCT02294461|7149425|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|9
4373777|NCT02294461|7149424|FG000|Open-label Period (up to 54.3 Months)|Death|6
4373778|NCT02294461|7149425|FG001|Open-label Period (up to 54.3 Months)|Death|5
4373779|NCT02294461|7149424|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6
4373780|NCT02294461|7149425|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|6
4373781|NCT02269670|7149443|FG000|Overall Study|All subjects have not completed all research related interventions|3
4373782|NCT01860976|7149453|FG000|Blinded Treatment|Adverse Event|1
4373783|NCT01860976|7149454|FG001|Blinded Treatment|Adverse Event|3
4373784|NCT01860976|7149453|FG000|Blinded Treatment|Lack of Efficacy|5
4373785|NCT01860976|7149454|FG001|Blinded Treatment|Lack of Efficacy|12
4373786|NCT01860976|7149453|FG000|Blinded Treatment|Subject request to discontinue treatment|2
4373787|NCT01860976|7149454|FG001|Blinded Treatment|Subject request to discontinue treatment|3
4373788|NCT01860976|7149453|FG000|Blinded Treatment|Withdrawal by Subject|3
4373789|NCT01860976|7149454|FG001|Blinded Treatment|Withdrawal by Subject|5
4373790|NCT01860976|7149453|FG000|Blinded Treatment|Subject no longer met criteria|1
4373791|NCT01860976|7149454|FG001|Blinded Treatment|Subject no longer met criteria|0
4373792|NCT01860976|7149453|FG000|Blinded Treatment|Entered Open-Label in error|0
4373793|NCT01860976|7149454|FG001|Blinded Treatment|Entered Open-Label in error|1
4694570|NCT02609399|7606160|FG001|Influenza Season 2016-2017|Lost to Follow-up|5
4373794|NCT01860976|7149453|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76
4373795|NCT01860976|7149454|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89
4373796|NCT01860976|7149453|FG000|Open-Label|Adverse Event|2
4373797|NCT01860976|7149454|FG001|Open-Label|Adverse Event|4
4373798|NCT01860976|7149453|FG000|Open-Label|Lack of Efficacy|16
4373799|NCT01860976|7149454|FG001|Open-Label|Lack of Efficacy|8
4373800|NCT01860976|7149453|FG000|Open-Label|Lost to Follow-up|1
4373801|NCT01860976|7149454|FG001|Open-Label|Lost to Follow-up|2
4373802|NCT01860976|7149453|FG000|Open-Label|Subject request discontinue treatment|4
4373803|NCT01860976|7149454|FG001|Open-Label|Subject request discontinue treatment|3
4373804|NCT01860976|7149453|FG000|Open-Label|Withdrawal by Subject|4
4373805|NCT01860976|7149454|FG001|Open-Label|Withdrawal by Subject|1
4373806|NCT01860976|7149453|FG000|Open-Label|Other Reasons|1
4373807|NCT01860976|7149454|FG001|Open-Label|Other Reasons|1
4373808|NCT01860976|7149453|FG000|Long Term Extension|Adverse Event|4
4373809|NCT01860976|7149454|FG001|Long Term Extension|Adverse Event|0
4373810|NCT01860976|7149453|FG000|Long Term Extension|Lack of Efficacy|2
4373811|NCT01860976|7149454|FG001|Long Term Extension|Lack of Efficacy|0
4373812|NCT01860976|7149453|FG000|Long Term Extension|Subject request to discontinue treatment|10
4373813|NCT01860976|7149454|FG001|Long Term Extension|Subject request to discontinue treatment|0
4373814|NCT01860976|7149453|FG000|Long Term Extension|Lost to Follow-up|2
4373815|NCT01860976|7149454|FG001|Long Term Extension|Lost to Follow-up|0
4373816|NCT01860976|7149453|FG000|Long Term Extension|subject withdrew consent|7
4373817|NCT01860976|7149454|FG001|Long Term Extension|subject withdrew consent|0
4373818|NCT01761266|7149465|FG000|Overall Study|Death|415
4373819|NCT01761266|7149466|FG001|Overall Study|Death|402
4373820|NCT01761266|7149465|FG000|Overall Study|Lost to Follow-up|8
4373821|NCT01761266|7149466|FG001|Overall Study|Lost to Follow-up|12
4373822|NCT01761266|7149465|FG000|Overall Study|Withdrawal by Subject|14
4373823|NCT01761266|7149466|FG001|Overall Study|Withdrawal by Subject|10
4373824|NCT01761266|7149465|FG000|Overall Study|Sponsor Decision|41
4373825|NCT01761266|7149466|FG001|Overall Study|Sponsor Decision|52
4373826|NCT01550289|7149477|FG000|Overall Study|Protocol Violation|1
4373827|NCT01550289|7149478|FG001|Overall Study|Protocol Violation|0
4373828|NCT01550289|7149477|FG000|Overall Study|Lost to Follow-up|1
4373829|NCT01550289|7149478|FG001|Overall Study|Lost to Follow-up|1
4373830|NCT01550289|7149477|FG000|Overall Study|Withdrawal by Subject|11
4373831|NCT01550289|7149478|FG001|Overall Study|Withdrawal by Subject|3
4373832|NCT01346709|7149486|FG000|Overall Study|Protocol Violation|35
4373833|NCT01346709|7149486|FG000|Overall Study|Lost to Follow-up|31
4373834|NCT01346709|7149486|FG000|Overall Study|Missing data in candidate risk factor|285
4373835|NCT01081951|7149496|FG000|Overall Study|Death|54
4373836|NCT01081951|7149497|FG001|Overall Study|Death|47
4373837|NCT01081951|7149496|FG000|Overall Study|Withdrawal by Subject|2
4373838|NCT01081951|7149497|FG001|Overall Study|Withdrawal by Subject|6
4373839|NCT01081951|7149496|FG000|Overall Study|Allocated treatment but did not take it|0
4373840|NCT01081951|7149497|FG001|Overall Study|Allocated treatment but did not take it|1
4373841|NCT01081951|7149496|FG000|Overall Study|Lost to Follow-up|0
4373842|NCT01081951|7149497|FG001|Overall Study|Lost to Follow-up|1
4373843|NCT01074190|7149506|FG000|Overall Study|Emergency Cesarean Delivery|1
4373844|NCT01074190|7149507|FG001|Overall Study|Emergency Cesarean Delivery|2
4373845|NCT01074190|7149508|FG002|Overall Study|Emergency Cesarean Delivery|1
4373846|NCT01074190|7149506|FG000|Overall Study|Protocol Violation|2
4373847|NCT01074190|7149507|FG001|Overall Study|Protocol Violation|1
4373848|NCT01074190|7149508|FG002|Overall Study|Protocol Violation|0
4373849|NCT01074190|7149506|FG000|Overall Study|Delivered in under 90 minutes|0
4373850|NCT01074190|7149507|FG001|Overall Study|Delivered in under 90 minutes|2
4373851|NCT01074190|7149508|FG002|Overall Study|Delivered in under 90 minutes|1
4373852|NCT01074190|7149506|FG000|Overall Study|Subject withdrew consent|1
4373853|NCT01074190|7149507|FG001|Overall Study|Subject withdrew consent|1
4373854|NCT01074190|7149508|FG002|Overall Study|Subject withdrew consent|1
4373855|NCT00875524|7149528|FG000|Overall Study|Serious adverse event|0
4373856|NCT00875524|7149529|FG001|Overall Study|Serious adverse event|1
4373857|NCT00875524|7149528|FG000|Overall Study|Protocol Violation|4
4373858|NCT00875524|7149529|FG001|Overall Study|Protocol Violation|0
4373859|NCT00875524|7149528|FG000|Overall Study|Lost to Follow-up|1
4373860|NCT00875524|7149529|FG001|Overall Study|Lost to Follow-up|0
4373861|NCT00875524|7149528|FG000|Overall Study|Withdrawal by Subject|3
4373862|NCT00875524|7149529|FG001|Overall Study|Withdrawal by Subject|5
4373863|NCT00842530|7149537|FG000|Overall Study|Serious adverse event|0
4373864|NCT00842530|7149538|FG001|Overall Study|Serious adverse event|6
4373865|NCT00842530|7149537|FG000|Overall Study|Other adverse event|6
4373866|NCT00842530|7149538|FG001|Overall Study|Other adverse event|1
4373867|NCT00842530|7149537|FG000|Overall Study|Protocol Violation|32
4373868|NCT00842530|7149538|FG001|Overall Study|Protocol Violation|14
4373869|NCT00842530|7149537|FG000|Overall Study|Lost to Follow-up|6
4373870|NCT00842530|7149538|FG001|Overall Study|Lost to Follow-up|8
4373871|NCT00842530|7149537|FG000|Overall Study|Withdrawal by Subject|73
4373872|NCT00842530|7149538|FG001|Overall Study|Withdrawal by Subject|28
4373873|NCT00788151|7149547|FG000|Overall Study|Other adverse event|0
4373874|NCT00788151|7149548|FG001|Overall Study|Other adverse event|2
4373875|NCT00788151|7149547|FG000|Overall Study|Protocol Violation|0
4373876|NCT00788151|7149548|FG001|Overall Study|Protocol Violation|1
4373877|NCT00788151|7149547|FG000|Overall Study|Withdrawal by Subject|13
4373878|NCT00788151|7149548|FG001|Overall Study|Withdrawal by Subject|6
4373879|NCT00788151|7149547|FG000|Overall Study|Enrolled but not treated|1
4373880|NCT00788151|7149548|FG001|Overall Study|Enrolled but not treated|1
4373881|NCT00539591|7149557|FG000|Overall Study|Toxicity|3
4373882|NCT00539591|7149558|FG001|Overall Study|Toxicity|0
4373883|NCT00539591|7149559|FG002|Overall Study|Toxicity|0
4373884|NCT00539591|7149557|FG000|Overall Study|Disease progression|2
4373885|NCT00539591|7149558|FG001|Overall Study|Disease progression|2
4373886|NCT00539591|7149559|FG002|Overall Study|Disease progression|3
4448789|NCT00501046|7234495|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119
4448790|NCT00501046|7234496|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137
4448791|NCT00501059|7234504|FG000|Overall Study|Protocol Violation|80
4448792|NCT00501059|7234505|FG001|Overall Study|Protocol Violation|69
4448793|NCT00501059|7234504|FG000|Overall Study|Death|140
4448794|NCT00501059|7234505|FG001|Overall Study|Death|137
4448795|NCT00501059|7234504|FG000|Overall Study|Other|236
4448796|NCT00501059|7234505|FG001|Overall Study|Other|239
4448797|NCT00501059|7234504|FG000|Overall Study|Missing end-of-study page|91
4448798|NCT00501059|7234505|FG001|Overall Study|Missing end-of-study page|92
4448799|NCT00501059|7234504|FG000|Overall Study|Clinical endpoint reached|110
4448800|NCT00501059|7234505|FG001|Overall Study|Clinical endpoint reached|123
4448801|NCT00501059|7234504|FG000|Overall Study|Insufficient therapeutic effect|4
4448802|NCT00501059|7234505|FG001|Overall Study|Insufficient therapeutic effect|5
4448803|NCT00501059|7234504|FG000|Overall Study|Consent withdrawn by subject|817
4448804|NCT00501059|7234505|FG001|Overall Study|Consent withdrawn by subject|873
4448805|NCT00501059|7234504|FG000|Overall Study|Non-compliant with study treatment|23
4448806|NCT00501059|7234505|FG001|Overall Study|Non-compliant with study treatment|16
4448807|NCT00501059|7234504|FG000|Overall Study|Reason not given|3
4448808|NCT00501059|7234505|FG001|Overall Study|Reason not given|1
4448809|NCT00501059|7234504|FG000|Overall Study|Adverse Event|129
4448810|NCT00501059|7234505|FG001|Overall Study|Adverse Event|122
4448811|NCT00501059|7234504|FG000|Overall Study|Lost to Follow-up|210
4448812|NCT00501059|7234505|FG001|Overall Study|Lost to Follow-up|198
4448813|NCT00501059|7234504|FG000|Overall Study|Not treated|25
4448814|NCT00501059|7234505|FG001|Overall Study|Not treated|17
4465145|NCT00607724|7256203|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0
4465146|NCT00607724|7256204|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0
4465147|NCT00607789|7256230|FG000|Overall Study|Adverse Event|3
4465148|NCT00607789|7256231|FG001|Overall Study|Adverse Event|0
4465149|NCT00607789|7256230|FG000|Overall Study|Lack of Efficacy|0
4465150|NCT00607789|7256231|FG001|Overall Study|Lack of Efficacy|1
4465151|NCT00607789|7256230|FG000|Overall Study|Inadequate adherence|3
4465152|NCT00607789|7256231|FG001|Overall Study|Inadequate adherence|0
4465153|NCT00607789|7256230|FG000|Overall Study|Lost to Follow-up|0
4465154|NCT00607789|7256231|FG001|Overall Study|Lost to Follow-up|5
4465155|NCT00607789|7256230|FG000|Overall Study|Withdrawal by Subject|1
4465156|NCT00607789|7256231|FG001|Overall Study|Withdrawal by Subject|0
4465157|NCT00607880|7256259|FG000|Overall Study|Unable to place port due to occlusion|1
4465158|NCT00607880|7256260|FG001|Overall Study|Unable to place port due to occlusion|0
4465159|NCT00607893|7256268|FG000|Overall Study|Lost to Follow-up|4
4465160|NCT00607893|7256269|FG001|Overall Study|Lost to Follow-up|0
4465161|NCT00607893|7256268|FG000|Overall Study|withdrew due to loss of interest|0
4465162|NCT00607893|7256269|FG001|Overall Study|withdrew due to loss of interest|1
4465163|NCT00607893|7256268|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0
4465164|NCT00607893|7256269|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1
4465165|NCT00607893|7256268|FG000|Overall Study|withdrew could not tolerate CPAP|0
4465166|NCT00607893|7256269|FG001|Overall Study|withdrew could not tolerate CPAP|1
4465167|NCT00607893|7256268|FG000|Overall Study|Declined to be treated|1
4465168|NCT00607893|7256269|FG001|Overall Study|Declined to be treated|0
4465169|NCT00607893|7256268|FG000|Overall Study|Withdrew due to hypertensive urgency|1
4465170|NCT00607893|7256269|FG001|Overall Study|Withdrew due to hypertensive urgency|1
4465171|NCT00607919|7256279|FG000|Acute Phase|Adverse Event|9
4465172|NCT00607919|7256280|FG001|Acute Phase|Adverse Event|2
4465173|NCT00607919|7256279|FG000|Acute Phase|Entry Criteria Not Met|1
4465174|NCT00607919|7256280|FG001|Acute Phase|Entry Criteria Not Met|1
4465175|NCT00607919|7256279|FG000|Acute Phase|Lack of Efficacy|1
4465176|NCT00607919|7256280|FG001|Acute Phase|Lack of Efficacy|2
4465177|NCT00607919|7256279|FG000|Acute Phase|Lost to Follow-up|9
4465178|NCT00607919|7256280|FG001|Acute Phase|Lost to Follow-up|3
4465179|NCT00607919|7256279|FG000|Acute Phase|Parent/Caregiver Decision|6
4465180|NCT00607919|7256280|FG001|Acute Phase|Parent/Caregiver Decision|4
4465181|NCT00607919|7256279|FG000|Acute Phase|Protocol Violation|5
4465182|NCT00607919|7256280|FG001|Acute Phase|Protocol Violation|1
4465183|NCT00607919|7256279|FG000|Acute Phase|Withdrawal by Subject|3
4465184|NCT00607919|7256280|FG001|Acute Phase|Withdrawal by Subject|3
4465185|NCT00607919|7256279|FG000|Open-Label Phase|Adverse Event|1
4465186|NCT00607919|7256280|FG001|Open-Label Phase|Adverse Event|5
4465187|NCT00607919|7256279|FG000|Open-Label Phase|Lost to Follow-up|4
4465188|NCT00607919|7256280|FG001|Open-Label Phase|Lost to Follow-up|1
4465189|NCT00607919|7256279|FG000|Open-Label Phase|Protocol Violation|2
4465190|NCT00607919|7256280|FG001|Open-Label Phase|Protocol Violation|2
4465191|NCT00607919|7256279|FG000|Open-Label Phase|Withdrawal by Subject|2
4465192|NCT00607919|7256280|FG001|Open-Label Phase|Withdrawal by Subject|2
4465193|NCT00607919|7256279|FG000|Open-Label Phase|Parent/Caregiver Decision|1
4465194|NCT00607919|7256280|FG001|Open-Label Phase|Parent/Caregiver Decision|2
4373887|NCT04482647|7149626|FG000|Overall Study|Time constraints|2
4373888|NCT04482647|7149626|FG000|Overall Study|Health issues|1
4373889|NCT04482647|7149626|FG000|Overall Study|Death in the family|1
4373890|NCT04482647|7149626|FG000|Overall Study|Disliked the intervention|1
4373891|NCT04482647|7149626|FG000|Overall Study|No reasons specified|7
4373892|NCT04405570|7149634|FG000|Overall Study|Adverse Event|0
4373893|NCT04405570|7149635|FG001|Overall Study|Adverse Event|1
4373894|NCT04405570|7149636|FG002|Overall Study|Adverse Event|1
4373895|NCT04405570|7149637|FG003|Overall Study|Adverse Event|1
4373896|NCT04405570|7149634|FG000|Overall Study|Lost to Follow-up|0
4373897|NCT04405570|7149635|FG001|Overall Study|Lost to Follow-up|1
4373898|NCT04405570|7149636|FG002|Overall Study|Lost to Follow-up|0
4373899|NCT04405570|7149637|FG003|Overall Study|Lost to Follow-up|0
4373900|NCT04405570|7149634|FG000|Overall Study|Physician Decision|0
4373901|NCT04405570|7149635|FG001|Overall Study|Physician Decision|0
4373902|NCT04405570|7149636|FG002|Overall Study|Physician Decision|1
4373903|NCT04405570|7149637|FG003|Overall Study|Physician Decision|0
4373904|NCT04405570|7149634|FG000|Overall Study|Withdrawal by Subject|0
4373905|NCT04405570|7149635|FG001|Overall Study|Withdrawal by Subject|1
4373906|NCT04405570|7149636|FG002|Overall Study|Withdrawal by Subject|1
4373907|NCT04405570|7149637|FG003|Overall Study|Withdrawal by Subject|0
4373908|NCT04405570|7149634|FG000|Overall Study|Randomized not dosed|0
4373909|NCT04405570|7149635|FG001|Overall Study|Randomized not dosed|2
4373910|NCT04405570|7149636|FG002|Overall Study|Randomized not dosed|0
4373911|NCT04405570|7149637|FG003|Overall Study|Randomized not dosed|0
4373912|NCT04135937|7149650|FG000|Overall Study|Lost to Follow-up|2
4373913|NCT04135937|7149650|FG000|Overall Study|Withdrawal by Subject|1
4373914|NCT03989232|7149656|FG000|Overall Study|Lost to Follow-up|3
4373915|NCT03989232|7149657|FG001|Overall Study|Lost to Follow-up|10
4373916|NCT03989232|7149656|FG000|Overall Study|Withdrawal by Subject|6
4373917|NCT03989232|7149657|FG001|Overall Study|Withdrawal by Subject|6
4373918|NCT03989232|7149656|FG000|Overall Study|Death|1
4373919|NCT03989232|7149657|FG001|Overall Study|Death|2
4770664|NCT02737475|7747044|FG018|Overall Study|Death|1
4770665|NCT02737475|7747045|FG019|Overall Study|Death|0
4770666|NCT02737475|7747046|FG020|Overall Study|Death|0
4770667|NCT02737475|7747047|FG021|Overall Study|Death|0
4770668|NCT02737475|7747048|FG022|Overall Study|Death|0
4770669|NCT02737475|7747049|FG023|Overall Study|Death|0
4770670|NCT02737475|7747050|FG024|Overall Study|Death|0
4770671|NCT02737475|7747051|FG025|Overall Study|Death|0
4770672|NCT02737475|7747052|FG026|Overall Study|Death|0
4770673|NCT02737475|7747026|FG000|Overall Study|Participant withdrew consent|0
4770674|NCT02737475|7747027|FG001|Overall Study|Participant withdrew consent|0
4770675|NCT02737475|7747028|FG002|Overall Study|Participant withdrew consent|0
4465195|NCT00607997|7256292|FG000|Overall Study|Lack of Efficacy|6
4465196|NCT00607997|7256293|FG001|Overall Study|Lack of Efficacy|20
4465197|NCT00607997|7256294|FG002|Overall Study|Lack of Efficacy|14
4465198|NCT00607997|7256295|FG003|Overall Study|Lack of Efficacy|10
4465199|NCT00607997|7256292|FG000|Overall Study|Death|8
4465200|NCT00607997|7256293|FG001|Overall Study|Death|5
4465201|NCT00607997|7256294|FG002|Overall Study|Death|2
4465202|NCT00607997|7256295|FG003|Overall Study|Death|5
4465203|NCT00607997|7256292|FG000|Overall Study|Adverse Event|3
4465204|NCT00607997|7256293|FG001|Overall Study|Adverse Event|1
4465205|NCT00607997|7256294|FG002|Overall Study|Adverse Event|2
4465206|NCT00607997|7256295|FG003|Overall Study|Adverse Event|0
4465207|NCT00607997|7256292|FG000|Overall Study|Physician Decision|4
4694571|NCT02609399|7606159|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1
4694572|NCT02609399|7606160|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0
4694573|NCT02609607|7606170|FG000|Overall Study|Lost to Follow-up|0
4694574|NCT02609607|7606171|FG001|Overall Study|Lost to Follow-up|1
4694575|NCT02609633|7606179|FG000|Overall Study|Consent Withdrawn|0
4694576|NCT02609633|7606180|FG001|Overall Study|Consent Withdrawn|1
4694577|NCT02609633|7606179|FG000|Overall Study|Protocol Deviation|1
4694578|NCT02609633|7606180|FG001|Overall Study|Protocol Deviation|0
4770676|NCT02737475|7747029|FG003|Overall Study|Participant withdrew consent|0
4770677|NCT02737475|7747030|FG004|Overall Study|Participant withdrew consent|0
4770678|NCT02737475|7747031|FG005|Overall Study|Participant withdrew consent|2
4770679|NCT02737475|7747032|FG006|Overall Study|Participant withdrew consent|0
4770680|NCT02737475|7747033|FG007|Overall Study|Participant withdrew consent|0
4770681|NCT02737475|7747034|FG008|Overall Study|Participant withdrew consent|0
4770682|NCT02737475|7747035|FG009|Overall Study|Participant withdrew consent|0
4770683|NCT02737475|7747036|FG010|Overall Study|Participant withdrew consent|0
4770684|NCT02737475|7747037|FG011|Overall Study|Participant withdrew consent|0
4770685|NCT02737475|7747038|FG012|Overall Study|Participant withdrew consent|0
4770686|NCT02737475|7747039|FG013|Overall Study|Participant withdrew consent|0
4770687|NCT02737475|7747040|FG014|Overall Study|Participant withdrew consent|1
4770688|NCT02737475|7747041|FG015|Overall Study|Participant withdrew consent|0
4465208|NCT00607997|7256293|FG001|Overall Study|Physician Decision|1
4465209|NCT00607997|7256294|FG002|Overall Study|Physician Decision|0
4465210|NCT00607997|7256295|FG003|Overall Study|Physician Decision|0
4465211|NCT00607997|7256292|FG000|Overall Study|Relapse, recurrent illness|4
4465212|NCT00607997|7256293|FG001|Overall Study|Relapse, recurrent illness|0
4770689|NCT02737475|7747042|FG016|Overall Study|Participant withdrew consent|0
4770690|NCT02737475|7747043|FG017|Overall Study|Participant withdrew consent|2
4770691|NCT02737475|7747044|FG018|Overall Study|Participant withdrew consent|1
4770692|NCT02737475|7747045|FG019|Overall Study|Participant withdrew consent|0
4770693|NCT02737475|7747046|FG020|Overall Study|Participant withdrew consent|2
4770694|NCT02737475|7747047|FG021|Overall Study|Participant withdrew consent|0
4770695|NCT02737475|7747048|FG022|Overall Study|Participant withdrew consent|0
4770696|NCT02737475|7747049|FG023|Overall Study|Participant withdrew consent|0
4770697|NCT02737475|7747050|FG024|Overall Study|Participant withdrew consent|0
4770698|NCT02737475|7747051|FG025|Overall Study|Participant withdrew consent|0
4770699|NCT02737475|7747052|FG026|Overall Study|Participant withdrew consent|0
4465213|NCT00607997|7256294|FG002|Overall Study|Relapse, recurrent illness|2
4465214|NCT00607997|7256295|FG003|Overall Study|Relapse, recurrent illness|0
4465215|NCT00607997|7256292|FG000|Overall Study|Other without explanation|2
4465216|NCT00607997|7256293|FG001|Overall Study|Other without explanation|0
4465217|NCT00607997|7256294|FG002|Overall Study|Other without explanation|4
4465218|NCT00607997|7256295|FG003|Overall Study|Other without explanation|1
4465219|NCT00608205|7256357|FG000|Overall Study|Adverse Event|3
4465220|NCT00608205|7256358|FG001|Overall Study|Adverse Event|2
4465221|NCT00608205|7256357|FG000|Overall Study|Patient non-compliant|0
4465222|NCT00608205|7256358|FG001|Overall Study|Patient non-compliant|1
4465223|NCT00608244|7256366|FG000|Overall Study|Adverse Event|1
4465224|NCT00608244|7256366|FG000|Overall Study|Low trough levels|1
4465225|NCT00608322|7256374|FG000|Overall Study|Death|2
4465226|NCT00608322|7256375|FG001|Overall Study|Death|1
4465227|NCT00608426|7256383|FG000|Overall Study|Death|32
4465228|NCT00608426|7256384|FG001|Overall Study|Death|36
4465229|NCT00608426|7256383|FG000|Overall Study|Lost to Follow-up|485
4465230|NCT00608426|7256384|FG001|Overall Study|Lost to Follow-up|521
4465231|NCT00608426|7256383|FG000|Overall Study|refused, health issues, wrong address|319
4465232|NCT00608426|7256384|FG001|Overall Study|refused, health issues, wrong address|348
4465233|NCT00608517|7256402|FG000|Overall Study|Death|1
4465234|NCT00608517|7256403|FG001|Overall Study|Death|0
4465235|NCT00608517|7256404|FG002|Overall Study|Death|0
4465236|NCT00608530|7256417|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11
4465237|NCT00608530|7256418|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5
4465238|NCT00608530|7256419|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0
4465239|NCT00608530|7256420|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0
4465240|NCT00608530|7256417|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0
4465241|NCT00608530|7256418|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0
4465242|NCT00608530|7256419|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3
4465243|NCT00608530|7256420|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3
4465244|NCT00608530|7256417|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0
4465245|NCT00608530|7256418|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0
4465246|NCT00608530|7256419|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2
4465247|NCT00608530|7256420|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3
4465248|NCT00608530|7256417|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0
4465249|NCT00608530|7256418|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0
4465250|NCT00608530|7256419|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2
4465251|NCT00608530|7256420|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0
4465252|NCT00608530|7256417|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0
4465253|NCT00608530|7256418|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0
4465254|NCT00608530|7256419|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4
4465255|NCT00608530|7256420|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1
4465256|NCT00608530|7256417|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
4465257|NCT00608530|7256418|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
4465258|NCT00608530|7256419|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1
4465259|NCT00608530|7256420|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
4465260|NCT00608543|7256435|FG000|Overall Study|Adverse Event|4
4465261|NCT00608569|7256442|FG000|Overall Study|Death|4
4465262|NCT00608569|7256443|FG001|Overall Study|Death|3
4465263|NCT00608569|7256442|FG000|Overall Study|Lost to Follow-up|4
4465264|NCT00608569|7256443|FG001|Overall Study|Lost to Follow-up|5
4465265|NCT00608569|7256442|FG000|Overall Study|Withdrawal by Subject|1
4465266|NCT00608569|7256443|FG001|Overall Study|Withdrawal by Subject|0
4465267|NCT00608569|7256442|FG000|Overall Study|Adverse Event|1
4465268|NCT00608569|7256443|FG001|Overall Study|Adverse Event|0
4465269|NCT00608569|7256442|FG000|Overall Study|Unable to adhere with study requirements|0
4465270|NCT00608569|7256443|FG001|Overall Study|Unable to adhere with study requirements|1
4465271|NCT00608582|7256451|FG000|Overall Study|Lost to Follow-up|2
4465272|NCT00608582|7256452|FG001|Overall Study|Lost to Follow-up|0
4770700|NCT02737475|7747026|FG000|Overall Study|Lost to Follow-up|0
4770701|NCT02737475|7747027|FG001|Overall Study|Lost to Follow-up|0
4465273|NCT00608582|7256451|FG000|Overall Study|No Best Response in Phase 1 located|1
4465274|NCT00608582|7256452|FG001|Overall Study|No Best Response in Phase 1 located|1
4465275|NCT00608582|7256451|FG000|Overall Study|Illicit Drug Use|1
4465276|NCT00608582|7256452|FG001|Overall Study|Illicit Drug Use|0
4465277|NCT00608582|7256451|FG000|Overall Study|Early stage Design Change|0
4770702|NCT02737475|7747028|FG002|Overall Study|Lost to Follow-up|0
4770703|NCT02737475|7747029|FG003|Overall Study|Lost to Follow-up|0
4770704|NCT02737475|7747030|FG004|Overall Study|Lost to Follow-up|0
4770705|NCT02737475|7747031|FG005|Overall Study|Lost to Follow-up|0
4770706|NCT02737475|7747032|FG006|Overall Study|Lost to Follow-up|0
4770707|NCT02737475|7747033|FG007|Overall Study|Lost to Follow-up|0
4770708|NCT02737475|7747034|FG008|Overall Study|Lost to Follow-up|0
4373969|NCT03896295|7149698|FG000|Overall Study|Adverse Event|0
4373970|NCT03896295|7149699|FG001|Overall Study|Adverse Event|1
4373971|NCT03896295|7149698|FG000|Overall Study|COVID-19|7
4373972|NCT03896295|7149699|FG001|Overall Study|COVID-19|29
4373973|NCT03213457|7149713|FG000|Overall Study|Not Treated|1
4373974|NCT03213457|7149714|FG001|Overall Study|Not Treated|1
4373975|NCT03213457|7149715|FG002|Overall Study|Not Treated|0
4373976|NCT03213457|7149713|FG000|Overall Study|Adverse Event|16
4373977|NCT03213457|7149714|FG001|Overall Study|Adverse Event|9
4373978|NCT03213457|7149715|FG002|Overall Study|Adverse Event|41
4373979|NCT03213457|7149713|FG000|Overall Study|Non-Compliance With Study Drug|1
4373980|NCT03213457|7149714|FG001|Overall Study|Non-Compliance With Study Drug|2
4373981|NCT03213457|7149715|FG002|Overall Study|Non-Compliance With Study Drug|7
4373982|NCT03213457|7149713|FG000|Overall Study|Non-Compliance Other, Not Specified|0
4373983|NCT03213457|7149714|FG001|Overall Study|Non-Compliance Other, Not Specified|1
4373984|NCT03213457|7149715|FG002|Overall Study|Non-Compliance Other, Not Specified|5
4373985|NCT03213457|7149713|FG000|Overall Study|Withdrawal by Subject|18
4373986|NCT03213457|7149714|FG001|Overall Study|Withdrawal by Subject|7
4373987|NCT03213457|7149715|FG002|Overall Study|Withdrawal by Subject|35
4373988|NCT03213457|7149713|FG000|Overall Study|Lost to Follow-up|12
4373989|NCT03213457|7149714|FG001|Overall Study|Lost to Follow-up|12
4373990|NCT03213457|7149715|FG002|Overall Study|Lost to Follow-up|33
4373991|NCT03213457|7149713|FG000|Overall Study|Pregnancy|11
4373992|NCT03213457|7149714|FG001|Overall Study|Pregnancy|0
4373993|NCT03213457|7149715|FG002|Overall Study|Pregnancy|7
4373994|NCT03213457|7149713|FG000|Overall Study|Protocol Violation|1
4373995|NCT03213457|7149714|FG001|Overall Study|Protocol Violation|1
4373996|NCT03213457|7149715|FG002|Overall Study|Protocol Violation|6
4373997|NCT03213457|7149713|FG000|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|4
4373998|NCT03213457|7149714|FG001|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|0
4373999|NCT03213457|7149715|FG002|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|2
4374000|NCT03213457|7149713|FG000|Overall Study|Dual Energy X-Ray Absorptiometry Finding|1
4374001|NCT03213457|7149714|FG001|Overall Study|Dual Energy X-Ray Absorptiometry Finding|1
4374002|NCT03213457|7149715|FG002|Overall Study|Dual Energy X-Ray Absorptiometry Finding|3
4374003|NCT03213457|7149713|FG000|Overall Study|Lack of Efficacy|12
4374004|NCT03213457|7149714|FG001|Overall Study|Lack of Efficacy|2
4374005|NCT03213457|7149715|FG002|Overall Study|Lack of Efficacy|9
4374006|NCT03213457|7149713|FG000|Overall Study|Other, Not Specified|11
4374007|NCT03213457|7149714|FG001|Overall Study|Other, Not Specified|3
4374008|NCT03213457|7149715|FG002|Overall Study|Other, Not Specified|26
4374009|NCT02982720|7149723|FG000|Overall Study|Adverse Event|3
4374010|NCT02982720|7149723|FG000|Overall Study|Death|1
4374011|NCT02375672|7149736|FG000|Overall Study|remain on follow up|20
4374012|NCT02329327|7149742|FG000|Overall Study|Death|78
4374013|NCT02329327|7149743|FG001|Overall Study|Death|0
4374014|NCT02329327|7149742|FG000|Overall Study|Withdrawal by Subject|3
4374015|NCT02329327|7149743|FG001|Overall Study|Withdrawal by Subject|0
4374016|NCT02329327|7149742|FG000|Overall Study|Lost to Follow-up|4
4374017|NCT02329327|7149743|FG001|Overall Study|Lost to Follow-up|0
4374018|NCT02063724|7149788|FG000|Overall Study|Disease progression|1
4374019|NCT01942135|7149794|FG000|Overall Study|Adverse Event|9
4374020|NCT01942135|7149795|FG001|Overall Study|Adverse Event|3
4374021|NCT01942135|7149794|FG000|Overall Study|Global deterioration of health status|8
4374022|NCT01942135|7149795|FG001|Overall Study|Global deterioration of health status|3
4374023|NCT01942135|7149794|FG000|Overall Study|Randomized Not Treated|2
4374024|NCT01942135|7149795|FG001|Overall Study|Randomized Not Treated|2
4374025|NCT01942135|7149794|FG000|Overall Study|Death|0
4374026|NCT01942135|7149795|FG001|Overall Study|Death|1
4374027|NCT01942135|7149794|FG000|Overall Study|ObjectiveProgression+Progressive Disease|85
4374028|NCT01942135|7149795|FG001|Overall Study|ObjectiveProgression+Progressive Disease|87
4374029|NCT01942135|7149794|FG000|Overall Study|Participant Refused toContinue Treatment|1
4374030|NCT01942135|7149795|FG001|Overall Study|Participant Refused toContinue Treatment|1
4374031|NCT01942135|7149794|FG000|Overall Study|Withdrawal by Subject|4
4374032|NCT01942135|7149795|FG001|Overall Study|Withdrawal by Subject|2
4374033|NCT01942135|7149794|FG000|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|238
4374034|NCT01942135|7149795|FG001|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|75
4465278|NCT00608582|7256452|FG001|Overall Study|Early stage Design Change|3
4465279|NCT00608829|7256475|FG000|Overall Study|Death|6
4465280|NCT00608829|7256475|FG000|Overall Study|Withdrawal by Subject|4
4465281|NCT00608829|7256475|FG000|Overall Study|Subject refuses to follow up or return.|5
4465282|NCT00608842|7256483|FG000|Overall Study|Participant's Request|0
4465283|NCT00608842|7256484|FG001|Overall Study|Participant's Request|1
4465284|NCT00608842|7256485|FG002|Overall Study|Participant's Request|2
4465285|NCT00608842|7256486|FG003|Overall Study|Participant's Request|1
4465286|NCT00608842|7256483|FG000|Overall Study|Lost to Follow-up|1
4374035|NCT01566149|7149814|FG000|Overall Study|Adverse Event|0
4374036|NCT01566149|7149815|FG001|Overall Study|Adverse Event|1
4374037|NCT01566149|7149814|FG000|Overall Study|Non-compliance with study medication|2
4374038|NCT01566149|7149815|FG001|Overall Study|Non-compliance with study medication|0
4374039|NCT01566149|7149814|FG000|Overall Study|Protocol Violation|0
4374040|NCT01566149|7149815|FG001|Overall Study|Protocol Violation|1
4374041|NCT01566149|7149814|FG000|Overall Study|Withdrawal by Subject|1
4374042|NCT01566149|7149815|FG001|Overall Study|Withdrawal by Subject|0
4374043|NCT01386125|7149832|FG000|Overall Study|Lost to Follow-up|3
4374044|NCT01386125|7149833|FG001|Overall Study|Lost to Follow-up|9
4374045|NCT01386125|7149832|FG000|Overall Study|Physician Decision|0
4374046|NCT01386125|7149833|FG001|Overall Study|Physician Decision|1
4374047|NCT01386125|7149832|FG000|Overall Study|Protocol Violation|5
4374048|NCT01386125|7149833|FG001|Overall Study|Protocol Violation|7
4374049|NCT01386125|7149832|FG000|Overall Study|Disease Progress|1
4374050|NCT01386125|7149833|FG001|Overall Study|Disease Progress|2
4374051|NCT01386125|7149832|FG000|Overall Study|Withdrawal by Subject|13
4374052|NCT01386125|7149833|FG001|Overall Study|Withdrawal by Subject|12
4374053|NCT01386125|7149832|FG000|Overall Study|Adverse Event|2
4374054|NCT01386125|7149833|FG001|Overall Study|Adverse Event|5
4374055|NCT01386125|7149832|FG000|Overall Study|Lack of Efficacy|0
4374056|NCT01386125|7149833|FG001|Overall Study|Lack of Efficacy|1
4374057|NCT01386125|7149832|FG000|Overall Study|Participant Leaving Country|1
4374058|NCT01386125|7149833|FG001|Overall Study|Participant Leaving Country|0
4374059|NCT01257568|7149839|FG000|Overall Study|Lost to Follow-up|2
4374060|NCT01257568|7149839|FG000|Overall Study|Withdrawal by Subject|6
4374061|NCT01257568|7149839|FG000|Overall Study|Terminated|1
4374062|NCT01257568|7149839|FG000|Overall Study|Component Revision|24
4374063|NCT01165424|7149845|FG000|Overall Study|Clinical adverse experiences|1
4374064|NCT01165424|7149845|FG000|Overall Study|Laboratory adverse experiences|1
4374065|NCT01165424|7149845|FG000|Overall Study|Did not meet entry criteria|1
4374066|NCT01165424|7149845|FG000|Overall Study|Participant moved (relocated)|1
4374067|NCT01135134|7149851|FG000|Overall Study|Adverse Event|1
4374068|NCT01135134|7149852|FG001|Overall Study|Adverse Event|1
4374069|NCT01135134|7149851|FG000|Overall Study|Did not meet protocol eligibility|1
4374070|NCT01135134|7149852|FG001|Overall Study|Did not meet protocol eligibility|0
4374071|NCT00867165|7149860|FG000|Overall Study|Adverse Event|3
4374072|NCT00867165|7149861|FG001|Overall Study|Adverse Event|0
4374073|NCT00867165|7149860|FG000|Overall Study|Withdrawal by Subject|1
4374074|NCT00867165|7149861|FG001|Overall Study|Withdrawal by Subject|0
4374075|NCT00733005|7149869|FG000|Overall Study|Adverse Event|0
4374076|NCT00733005|7149870|FG001|Overall Study|Adverse Event|1
4374077|NCT00733005|7149869|FG000|Overall Study|Treatment Failure|0
4374078|NCT00733005|7149870|FG001|Overall Study|Treatment Failure|1
4465287|NCT00608842|7256484|FG001|Overall Study|Lost to Follow-up|0
4465288|NCT00608842|7256485|FG002|Overall Study|Lost to Follow-up|0
4465289|NCT00608842|7256486|FG003|Overall Study|Lost to Follow-up|0
4465290|NCT00608868|7256496|FG000|Overall Study|Withdrawal by Subject|7
4465291|NCT00608868|7256496|FG000|Overall Study|Protocol Violation|3
4465292|NCT00608868|7256496|FG000|Overall Study|Lost to Follow-up|2
4465293|NCT00608868|7256496|FG000|Overall Study|Adverse Event|1
4465294|NCT00608868|7256496|FG000|Overall Study|Physician Decision|2
4465295|NCT00608881|7256502|FG000|Overall Study|Death|22
4465296|NCT00608881|7256503|FG001|Overall Study|Death|13
4465297|NCT00608881|7256502|FG000|Overall Study|Adverse Event|5
4465298|NCT00608881|7256503|FG001|Overall Study|Adverse Event|3
4465299|NCT00608881|7256502|FG000|Overall Study|Lost to Follow-up|28
4465300|NCT00608881|7256503|FG001|Overall Study|Lost to Follow-up|14
4465301|NCT00608881|7256502|FG000|Overall Study|Withdrawal by Subject|18
4465302|NCT00608881|7256503|FG001|Overall Study|Withdrawal by Subject|29
4465303|NCT00608881|7256502|FG000|Overall Study|Physician Decision|5
4465304|NCT00608881|7256503|FG001|Overall Study|Physician Decision|5
4465305|NCT00608881|7256502|FG000|Overall Study|Institutionalized|1
4465306|NCT00608881|7256503|FG001|Overall Study|Institutionalized|2
4465307|NCT00608894|7256511|FG000|Overall Study|Withdrawal by Subject|0
4465308|NCT00608894|7256512|FG001|Overall Study|Withdrawal by Subject|2
4516277|NCT00958828|7327566|FG000|Period 1, 1 Week of Wear|Randomization break|0
4516278|NCT00958828|7327567|FG001|Period 1, 1 Week of Wear|Randomization break|1
4516279|NCT00958828|7327566|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0
4516280|NCT00958828|7327567|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1
4516281|NCT00958841|7327573|FG000|Overall Study|Abnormal laboratory value(s)|1
4516282|NCT00958841|7327573|FG000|Overall Study|Abnormal test procedure result(s)|3
4516283|NCT00958841|7327573|FG000|Overall Study|Administrative problems|1
4516284|NCT00958841|7327573|FG000|Overall Study|Adverse Event|8
4516285|NCT00958841|7327573|FG000|Overall Study|New cancer therapy|5
4374079|NCT00733005|7149869|FG000|Overall Study|Withdrawal by Subject|0
4374080|NCT00733005|7149870|FG001|Overall Study|Withdrawal by Subject|1
4374081|NCT00733005|7149869|FG000|Overall Study|Protocol Violation|2
4374082|NCT00733005|7149870|FG001|Overall Study|Protocol Violation|0
4374083|NCT00732381|7149878|FG000|Overall Study|Adverse Event|1
4374084|NCT00732381|7149879|FG001|Overall Study|Adverse Event|0
4516286|NCT00958841|7327573|FG000|Overall Study|Withdrawal by Subject|1
4516287|NCT00958841|7327573|FG000|Overall Study|Unsatisfactory therapeutic effect|22
4516288|NCT00958841|7327573|FG000|Overall Study|Completed M6/did not enter extension|27
4374085|NCT00732381|7149878|FG000|Overall Study|Treatment Failure|1
4374086|NCT00732381|7149879|FG001|Overall Study|Treatment Failure|1
4374087|NCT00654095|7149885|FG000|Overall Study|Drop in low density lipoprotein (1)|2
4374088|NCT00654095|7149885|FG000|Overall Study|Elevated triglyceride level (2)|1
4374089|NCT00654095|7149885|FG000|Overall Study|Elevated alanine aminotransferase (3)|1
4374090|NCT00654095|7149885|FG000|Overall Study|Adverse Event|11
4374091|NCT00654095|7149885|FG000|Overall Study|Withdrawal by Subject|5
4374092|NCT00654095|7149885|FG000|Overall Study|Elevated alanine aminotransferase (4)|7
4374093|NCT00654095|7149885|FG000|Overall Study|Adverse reaction did not improve (5)|4
4374094|NCT00654095|7149885|FG000|Overall Study|Did not meet inclusion criteria|1
4374095|NCT00653523|7149889|FG000|Overall Study|Drop in low density lipoprotein (1)|2
4374096|NCT00653523|7149889|FG000|Overall Study|Elevated creatine phosphokinase (2)|1
4374097|NCT00653523|7149889|FG000|Overall Study|Adverse Event|7
4374098|NCT00653523|7149889|FG000|Overall Study|Withdrawal by Subject|6
4374099|NCT00653523|7149889|FG000|Overall Study|Elevated alanine aminotransferase (3)|2
4374100|NCT00653523|7149889|FG000|Overall Study|Adverse reaction did not improve (4)|1
4374101|NCT00599027|7149895|FG000|Overall Study|Withdrawal by Subject|1
4374102|NCT00599027|7149896|FG001|Overall Study|Withdrawal by Subject|1
4374103|NCT00599027|7149895|FG000|Overall Study|Adverse Event|0
4374104|NCT00599027|7149896|FG001|Overall Study|Adverse Event|1
4374105|NCT00599027|7149895|FG000|Overall Study|Treatment Failure|0
4374106|NCT00599027|7149896|FG001|Overall Study|Treatment Failure|1
4374107|NCT00552032|7149904|FG000|Overall Study|Withdrawal by Subject|2
4374108|NCT00552032|7149905|FG001|Overall Study|Withdrawal by Subject|2
4374109|NCT00552032|7149904|FG000|Overall Study|Protocol Violation|7
4374110|NCT00552032|7149905|FG001|Overall Study|Protocol Violation|12
4374111|NCT00552032|7149904|FG000|Overall Study|Lost to Follow-up|8
4374112|NCT00552032|7149905|FG001|Overall Study|Lost to Follow-up|5
4374113|NCT00546052|7149911|FG000|Overall Study|Adverse Event|47
4374114|NCT00546052|7149911|FG000|Overall Study|Lost to Follow-up|144
4374115|NCT00546052|7149911|FG000|Overall Study|Protocol Violation|9
4374116|NCT00546052|7149911|FG000|Overall Study|Withdrawal by Subject|20
4374117|NCT00546052|7149911|FG000|Overall Study|Non Compliance|7
4374118|NCT00442117|7149920|FG000|Overall Study|Adverse Event|3
4374119|NCT00442117|7149921|FG001|Overall Study|Adverse Event|2
4374120|NCT00442117|7149920|FG000|Overall Study|Lack of Efficacy|2
4374121|NCT00442117|7149921|FG001|Overall Study|Lack of Efficacy|6
4374122|NCT00442117|7149920|FG000|Overall Study|Lost to Follow-up|1
4374123|NCT00442117|7149921|FG001|Overall Study|Lost to Follow-up|2
4374124|NCT00442117|7149920|FG000|Overall Study|Withdrawal by Subject|2
4374125|NCT00442117|7149921|FG001|Overall Study|Withdrawal by Subject|2
4374126|NCT00442117|7149920|FG000|Overall Study|Major Deviation|25
4374127|NCT00442117|7149921|FG001|Overall Study|Major Deviation|20
4374128|NCT00442117|7149920|FG000|Overall Study|Non compliance with protocol|3
4374129|NCT00442117|7149921|FG001|Overall Study|Non compliance with protocol|5
4374130|NCT00442117|7149920|FG000|Overall Study|Met Withdrawal Criteria|2
4374131|NCT00442117|7149921|FG001|Overall Study|Met Withdrawal Criteria|1
4374132|NCT00424008|7149929|FG000|Overall Study|Adverse Event|8
4374133|NCT00424008|7149930|FG001|Overall Study|Adverse Event|6
4374134|NCT00424008|7149929|FG000|Overall Study|Lack of Efficacy|40
4374135|NCT00424008|7149930|FG001|Overall Study|Lack of Efficacy|34
4374136|NCT00424008|7149929|FG000|Overall Study|Lost to Follow-up|1
4374137|NCT00424008|7149930|FG001|Overall Study|Lost to Follow-up|2
4374138|NCT00424008|7149929|FG000|Overall Study|Withdrawal by Subject|5
4374139|NCT00424008|7149930|FG001|Overall Study|Withdrawal by Subject|8
4374140|NCT00424008|7149929|FG000|Overall Study|Noncompliance with protocol|13
4374141|NCT00424008|7149930|FG001|Overall Study|Noncompliance with protocol|7
4374142|NCT00424008|7149929|FG000|Overall Study|Did not meet protocol eligibility|16
4374143|NCT00424008|7149930|FG001|Overall Study|Did not meet protocol eligibility|21
4374144|NCT00424008|7149929|FG000|Overall Study|Administrative|266
4374145|NCT00424008|7149930|FG001|Overall Study|Administrative|257
4374146|NCT00423176|7149939|FG000|Overall Study|Adverse Event|4
4374147|NCT00423176|7149940|FG001|Overall Study|Adverse Event|6
4374148|NCT00423176|7149939|FG000|Overall Study|Treatment Failure|1
4374149|NCT00423176|7149940|FG001|Overall Study|Treatment Failure|6
4374150|NCT00423176|7149939|FG000|Overall Study|Lost to Follow-up|4
4374151|NCT00423176|7149940|FG001|Overall Study|Lost to Follow-up|7
4374152|NCT00423176|7149939|FG000|Overall Study|Withdrawal by Subject|4
4374153|NCT00423176|7149940|FG001|Overall Study|Withdrawal by Subject|3
4374154|NCT00423176|7149939|FG000|Overall Study|Protocol Violation|1
4374155|NCT00423176|7149940|FG001|Overall Study|Protocol Violation|3
4374156|NCT00423176|7149939|FG000|Overall Study|Did not meet protocol eligibility|2
4374157|NCT00423176|7149940|FG001|Overall Study|Did not meet protocol eligibility|4
4374158|NCT00383240|7149950|FG000|Overall Study|Adverse Event|4
4374159|NCT00383240|7149951|FG001|Overall Study|Adverse Event|6
4374160|NCT00383240|7149952|FG002|Overall Study|Adverse Event|9
4374161|NCT00383240|7149953|FG003|Overall Study|Adverse Event|7
4374162|NCT00383240|7149950|FG000|Overall Study|Treatment Failure|8
4374163|NCT00383240|7149951|FG001|Overall Study|Treatment Failure|13
4374164|NCT00383240|7149952|FG002|Overall Study|Treatment Failure|47
4374165|NCT00383240|7149953|FG003|Overall Study|Treatment Failure|46
4374166|NCT00383240|7149950|FG000|Overall Study|Lost to Follow-up|3
4374167|NCT00383240|7149951|FG001|Overall Study|Lost to Follow-up|0
4374168|NCT00383240|7149952|FG002|Overall Study|Lost to Follow-up|0
4374169|NCT00383240|7149953|FG003|Overall Study|Lost to Follow-up|2
4374170|NCT00383240|7149950|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6
4374171|NCT00383240|7149951|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3
4374172|NCT00383240|7149952|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8
4374173|NCT00383240|7149953|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8
4374174|NCT00383240|7149950|FG000|Overall Study|Withdrawal by subjects, reasons related|0
4374175|NCT00383240|7149951|FG001|Overall Study|Withdrawal by subjects, reasons related|1
4374176|NCT00383240|7149952|FG002|Overall Study|Withdrawal by subjects, reasons related|3
4374177|NCT00383240|7149953|FG003|Overall Study|Withdrawal by subjects, reasons related|5
4374178|NCT00383240|7149950|FG000|Overall Study|Protocol Violation|4
4374179|NCT00383240|7149951|FG001|Overall Study|Protocol Violation|5
4374180|NCT00383240|7149952|FG002|Overall Study|Protocol Violation|9
4374181|NCT00383240|7149953|FG003|Overall Study|Protocol Violation|6
4374182|NCT00383240|7149950|FG000|Overall Study|Did not meet protocol eligibility|9
4374183|NCT00383240|7149951|FG001|Overall Study|Did not meet protocol eligibility|4
4374184|NCT00383240|7149952|FG002|Overall Study|Did not meet protocol eligibility|9
4374185|NCT00383240|7149953|FG003|Overall Study|Did not meet protocol eligibility|3
4374186|NCT00383240|7149950|FG000|Overall Study|Administrative|1
4374187|NCT00383240|7149951|FG001|Overall Study|Administrative|1
4374188|NCT00383240|7149952|FG002|Overall Study|Administrative|0
4374189|NCT00383240|7149953|FG003|Overall Study|Administrative|0
4465309|NCT00608907|7256523|FG000|Overall Study|Adverse Event|6
4465310|NCT00608907|7256524|FG001|Overall Study|Adverse Event|0
4465311|NCT00608907|7256525|FG002|Overall Study|Adverse Event|1
4465312|NCT00608907|7256523|FG000|Overall Study|Death|1
4465313|NCT00608907|7256524|FG001|Overall Study|Death|0
4465314|NCT00608907|7256525|FG002|Overall Study|Death|0
4465315|NCT00608907|7256523|FG000|Overall Study|Withdrawal by Subject|4
4465316|NCT00608907|7256524|FG001|Overall Study|Withdrawal by Subject|0
4465317|NCT00608907|7256525|FG002|Overall Study|Withdrawal by Subject|0
4465318|NCT00608907|7256523|FG000|Overall Study|Progressive Disease|1
4465319|NCT00608907|7256524|FG001|Overall Study|Progressive Disease|0
4465320|NCT00608907|7256525|FG002|Overall Study|Progressive Disease|0
4465321|NCT00608959|7256535|FG000|Part 1|Did not meet eligibility criteria|1
4465322|NCT00608985|7256549|FG000|Overall Study|Adverse Event|2
4465323|NCT00608985|7256550|FG001|Overall Study|Adverse Event|7
4465324|NCT00608985|7256551|FG002|Overall Study|Adverse Event|4
4465325|NCT00608985|7256552|FG003|Overall Study|Adverse Event|6
4465326|NCT00608985|7256549|FG000|Overall Study|Administrative/Other|7
4465327|NCT00608985|7256550|FG001|Overall Study|Administrative/Other|4
4465328|NCT00608985|7256551|FG002|Overall Study|Administrative/Other|1
4465329|NCT00608985|7256552|FG003|Overall Study|Administrative/Other|2
4465330|NCT00608985|7256549|FG000|Overall Study|Withdrawal of Consent|5
4465331|NCT00608985|7256550|FG001|Overall Study|Withdrawal of Consent|1
4465332|NCT00608985|7256551|FG002|Overall Study|Withdrawal of Consent|1
4465333|NCT00608985|7256552|FG003|Overall Study|Withdrawal of Consent|1
4465334|NCT00608985|7256549|FG000|Overall Study|Lost to Follow-up|2
4465335|NCT00608985|7256550|FG001|Overall Study|Lost to Follow-up|1
4465336|NCT00608985|7256551|FG002|Overall Study|Lost to Follow-up|0
4465337|NCT00608985|7256552|FG003|Overall Study|Lost to Follow-up|0
4465338|NCT00609167|7256569|FG000|Overall Study|Withdrawal by Subject|1
4465339|NCT00609167|7256570|FG001|Overall Study|Withdrawal by Subject|0
4465340|NCT00609167|7256569|FG000|Overall Study|Lack of Efficacy|1
4465341|NCT00609167|7256570|FG001|Overall Study|Lack of Efficacy|0
4465342|NCT00609167|7256569|FG000|Overall Study|Adverse Event|5
4465343|NCT00609167|7256570|FG001|Overall Study|Adverse Event|1
4465344|NCT00609167|7256569|FG000|Overall Study|Disease Progression|1
4465345|NCT00609167|7256570|FG001|Overall Study|Disease Progression|0
4465346|NCT00609167|7256569|FG000|Overall Study|Stem Cell Transplant|0
4465347|NCT00609167|7256570|FG001|Overall Study|Stem Cell Transplant|6
4465348|NCT00609245|7256576|FG000|Overall Study|Adverse Event|1
4465349|NCT00609336|7256591|FG000|Overall Study|Protocol Violation|3
4465350|NCT00609336|7256591|FG000|Overall Study|Death|1
4465351|NCT00609336|7256591|FG000|Overall Study|LA or Met at Surgery|9
4465352|NCT00609362|7256598|FG000|Overall Study|Withdrawal by Subject|2
4465353|NCT00609362|7256599|FG001|Overall Study|Withdrawal by Subject|1
4465354|NCT00609362|7256598|FG000|Overall Study|Adverse Event|1
4465355|NCT00609362|7256599|FG001|Overall Study|Adverse Event|0
4465356|NCT00609466|7256608|FG000|Overall Study|Withdrawal by Subject|0
4465357|NCT00609466|7256609|FG001|Overall Study|Withdrawal by Subject|1
4465358|NCT00609466|7256610|FG002|Overall Study|Withdrawal by Subject|1
4465359|NCT00609466|7256608|FG000|Overall Study|Adverse Event|2
4465360|NCT00609466|7256609|FG001|Overall Study|Adverse Event|3
4465361|NCT00609466|7256610|FG002|Overall Study|Adverse Event|1
4465362|NCT00609466|7256608|FG000|Overall Study|Lack of Efficacy|0
4465363|NCT00609466|7256609|FG001|Overall Study|Lack of Efficacy|2
4465364|NCT00609466|7256610|FG002|Overall Study|Lack of Efficacy|2
4465365|NCT00609492|7256621|FG000|Overall Study|Withdrawal by Subject|0
4465366|NCT00609492|7256622|FG001|Overall Study|Withdrawal by Subject|2
4465367|NCT00609492|7256623|FG002|Overall Study|Withdrawal by Subject|3
4465368|NCT00609492|7256621|FG000|Overall Study|Lost to Follow-up|1
4465369|NCT00609492|7256622|FG001|Overall Study|Lost to Follow-up|1
4465370|NCT00609492|7256623|FG002|Overall Study|Lost to Follow-up|4
4374190|NCT02765399|7149975|FG000|Overall Study|Nausea|1
4374191|NCT02765399|7149976|FG001|Overall Study|Nausea|0
4374192|NCT04539262|7149990|FG000|Overall Study|Adverse Event|0
4374193|NCT04539262|7149991|FG001|Overall Study|Adverse Event|0
4374194|NCT04539262|7149992|FG002|Overall Study|Adverse Event|1
4374195|NCT04539262|7149993|FG003|Overall Study|Adverse Event|0
4374196|NCT04539262|7149994|FG004|Overall Study|Adverse Event|0
4374197|NCT04539262|7149995|FG005|Overall Study|Adverse Event|0
4374198|NCT04539262|7149996|FG006|Overall Study|Adverse Event|0
4374199|NCT04539262|7149997|FG007|Overall Study|Adverse Event|0
4374200|NCT04539262|7149990|FG000|Overall Study|Withdrew Consent|0
4374201|NCT04539262|7149991|FG001|Overall Study|Withdrew Consent|0
4374202|NCT04539262|7149992|FG002|Overall Study|Withdrew Consent|0
4374203|NCT04539262|7149993|FG003|Overall Study|Withdrew Consent|1
4374204|NCT04539262|7149994|FG004|Overall Study|Withdrew Consent|0
4374205|NCT04539262|7149995|FG005|Overall Study|Withdrew Consent|0
4374206|NCT04539262|7149996|FG006|Overall Study|Withdrew Consent|0
4374207|NCT04539262|7149997|FG007|Overall Study|Withdrew Consent|0
4374208|NCT04539262|7149990|FG000|Overall Study|Randomized, Not treated|0
4374209|NCT04539262|7149991|FG001|Overall Study|Randomized, Not treated|1
4374210|NCT04539262|7149992|FG002|Overall Study|Randomized, Not treated|0
4374211|NCT04539262|7149993|FG003|Overall Study|Randomized, Not treated|0
4374212|NCT04539262|7149994|FG004|Overall Study|Randomized, Not treated|0
4374213|NCT04539262|7149995|FG005|Overall Study|Randomized, Not treated|0
4374214|NCT04539262|7149996|FG006|Overall Study|Randomized, Not treated|1
4374215|NCT04539262|7149997|FG007|Overall Study|Randomized, Not treated|0
4374216|NCT04482439|7150018|FG000|Overall Study|Lost to Follow-up|1
4374217|NCT04482439|7150018|FG000|Overall Study|Unrelated illness|1
4374236|NCT03950674|7150077|FG000|Overall Study|Death|3
4374237|NCT03950674|7150078|FG001|Overall Study|Death|7
4374238|NCT03950674|7150077|FG000|Overall Study|Ongoing in Study|22
4374239|NCT03950674|7150078|FG001|Overall Study|Ongoing in Study|8
4374240|NCT03847974|7150089|FG000|Overall Study|relocated out of region|3
4374241|NCT03847974|7150089|FG000|Overall Study|Withdrawal by Subject|2
4374242|NCT03847974|7150089|FG000|Overall Study|Adverse Event|1
4374243|NCT03846427|7150093|FG000|Overall Study|Death|7
4374244|NCT03846427|7150093|FG000|Overall Study|Withdrawal by Subject|2
4374245|NCT03846427|7150093|FG000|Overall Study|Remaining in study|59
4374246|NCT03671148|7150122|FG000|Overall Study|Adverse Event|3
4374247|NCT03671148|7150123|FG001|Overall Study|Adverse Event|2
4374248|NCT03671148|7150122|FG000|Overall Study|Withdrawal by Subject|8
4374249|NCT03671148|7150123|FG001|Overall Study|Withdrawal by Subject|2
4374250|NCT03671148|7150122|FG000|Overall Study|Lost to Follow-up|1
4374251|NCT03671148|7150123|FG001|Overall Study|Lost to Follow-up|2
4374252|NCT03671148|7150122|FG000|Overall Study|Lack of Efficacy|7
4374253|NCT03671148|7150123|FG001|Overall Study|Lack of Efficacy|2
4374254|NCT03671148|7150122|FG000|Overall Study|COVID-19 Logistical Restrictions|0
4374255|NCT03671148|7150123|FG001|Overall Study|COVID-19 Logistical Restrictions|1
4374256|NCT03671148|7150122|FG000|Overall Study|Other|1
4374257|NCT03671148|7150123|FG001|Overall Study|Other|0
4374258|NCT03671148|7150122|FG000|Overall Study|Incomplete Randomization Visit|1
4374259|NCT03671148|7150123|FG001|Overall Study|Incomplete Randomization Visit|0
4374260|NCT03612856|7150145|FG000|Pre-dose Period|Physician Decision|0
4374261|NCT03612856|7150146|FG001|Pre-dose Period|Physician Decision|1
4374262|NCT03612856|7150147|FG002|Pre-dose Period|Physician Decision|1
4374263|NCT03612856|7150145|FG000|Pre-dose Period|Withdrawal by Subject|0
4374264|NCT03612856|7150146|FG001|Pre-dose Period|Withdrawal by Subject|1
4374265|NCT03612856|7150147|FG002|Pre-dose Period|Withdrawal by Subject|0
4694579|NCT02609633|7606179|FG000|Overall Study|Non-Compliant with Study Procedures|2
4694580|NCT02609633|7606180|FG001|Overall Study|Non-Compliant with Study Procedures|0
4694581|NCT02609633|7606179|FG000|Overall Study|Reason not Specified|2
4694582|NCT02609633|7606180|FG001|Overall Study|Reason not Specified|1
4694583|NCT02609659|7606187|FG000|Overall Study|Adverse Event|1
4694584|NCT02609659|7606187|FG000|Overall Study|Lost to Follow-up|6
4694585|NCT02609659|7606187|FG000|Overall Study|Other|1
4694586|NCT02609672|7606193|FG000|Overall Study|Lost to Follow-up|3
4694587|NCT02609672|7606194|FG001|Overall Study|Lost to Follow-up|1
4374266|NCT03607487|7150159|FG000|Overall Study|Withdrawal by Subject|2
4374267|NCT03607487|7150160|FG001|Overall Study|Withdrawal by Subject|0
4374268|NCT03607487|7150161|FG002|Overall Study|Withdrawal by Subject|0
4374269|NCT03607487|7150162|FG003|Overall Study|Withdrawal by Subject|1
4374270|NCT03529773|7150227|FG000|Overall Study|Adverse Event|0
4374271|NCT03529773|7150228|FG001|Overall Study|Adverse Event|0
4374272|NCT03529773|7150229|FG002|Overall Study|Adverse Event|0
4374273|NCT03529773|7150230|FG003|Overall Study|Adverse Event|0
4374274|NCT03529773|7150231|FG004|Overall Study|Adverse Event|0
4374275|NCT03529773|7150232|FG005|Overall Study|Adverse Event|0
4374276|NCT03529773|7150233|FG006|Overall Study|Adverse Event|0
4374277|NCT03529773|7150234|FG007|Overall Study|Adverse Event|0
4694588|NCT02609984|7606210|FG000|Overall Study|Death|29
4374278|NCT03529773|7150235|FG008|Overall Study|Adverse Event|0
4374279|NCT03529773|7150236|FG009|Overall Study|Adverse Event|0
4374280|NCT03529773|7150237|FG010|Overall Study|Adverse Event|0
4374281|NCT03529773|7150238|FG011|Overall Study|Adverse Event|0
4374282|NCT03529773|7150239|FG012|Overall Study|Adverse Event|0
4374283|NCT03529773|7150240|FG013|Overall Study|Adverse Event|0
4374218|NCT04404725|7150027|FG000|First Intervention|Withdrawal by Subject|0
4374219|NCT04404725|7150028|FG001|First Intervention|Withdrawal by Subject|2
4374220|NCT04404725|7150027|FG000|Second Intervention|Adverse Event|1
4374221|NCT04404725|7150028|FG001|Second Intervention|Adverse Event|1
4374222|NCT04404725|7150027|FG000|Second Intervention|Withdrawal by Subject|0
4374223|NCT04404725|7150028|FG001|Second Intervention|Withdrawal by Subject|1
4374224|NCT04382586|7150036|FG000|Overall Study|Death|3
4374225|NCT04382586|7150037|FG001|Overall Study|Death|4
4374226|NCT04382586|7150036|FG000|Overall Study|Lost to Follow-up|11
4374227|NCT04382586|7150037|FG001|Overall Study|Lost to Follow-up|8
4374228|NCT04382586|7150036|FG000|Overall Study|Withdrawal by Subject|3
4374229|NCT04382586|7150037|FG001|Overall Study|Withdrawal by Subject|1
4374230|NCT04382586|7150036|FG000|Overall Study|Physician Decision|0
4374231|NCT04382586|7150037|FG001|Overall Study|Physician Decision|3
4374232|NCT04348656|7150045|FG000|Overall Study|Withdrawal by Subject|2
4374233|NCT04348656|7150046|FG001|Overall Study|Withdrawal by Subject|0
4374234|NCT04348656|7150045|FG000|Overall Study|Lost to Follow-up|11
4374235|NCT04348656|7150046|FG001|Overall Study|Lost to Follow-up|6
4374284|NCT03529773|7150241|FG014|Overall Study|Adverse Event|0
4374285|NCT03529773|7150242|FG015|Overall Study|Adverse Event|0
4374286|NCT03529773|7150243|FG016|Overall Study|Adverse Event|0
4374287|NCT03529773|7150244|FG017|Overall Study|Adverse Event|0
4374288|NCT03529773|7150245|FG018|Overall Study|Adverse Event|0
4374289|NCT03529773|7150246|FG019|Overall Study|Adverse Event|0
4374290|NCT03529773|7150247|FG020|Overall Study|Adverse Event|0
4374291|NCT03529773|7150248|FG021|Overall Study|Adverse Event|0
4374292|NCT03529773|7150249|FG022|Overall Study|Adverse Event|0
4374293|NCT03529773|7150250|FG023|Overall Study|Adverse Event|0
4374294|NCT03529773|7150251|FG024|Overall Study|Adverse Event|0
4374295|NCT03529773|7150252|FG025|Overall Study|Adverse Event|0
4374296|NCT03529773|7150253|FG026|Overall Study|Adverse Event|0
4374297|NCT03529773|7150254|FG027|Overall Study|Adverse Event|0
4374298|NCT03529773|7150255|FG028|Overall Study|Adverse Event|0
4374299|NCT03529773|7150256|FG029|Overall Study|Adverse Event|0
4374300|NCT03529773|7150257|FG030|Overall Study|Adverse Event|1
4374301|NCT03529773|7150258|FG031|Overall Study|Adverse Event|0
4374302|NCT03529773|7150259|FG032|Overall Study|Adverse Event|0
4374303|NCT03529773|7150260|FG033|Overall Study|Adverse Event|0
4374304|NCT03529773|7150261|FG034|Overall Study|Adverse Event|0
4374305|NCT03529773|7150262|FG035|Overall Study|Adverse Event|1
4374306|NCT03529773|7150263|FG036|Overall Study|Adverse Event|0
4374307|NCT03529773|7150264|FG037|Overall Study|Adverse Event|0
4374308|NCT03529773|7150265|FG038|Overall Study|Adverse Event|1
4694589|NCT02609984|7606211|FG001|Overall Study|Death|26
4694590|NCT02609984|7606210|FG000|Overall Study|Participation Discontinued by Sponsor|12
4694591|NCT02609984|7606211|FG001|Overall Study|Participation Discontinued by Sponsor|10
4694592|NCT02609984|7606210|FG000|Overall Study|Lost to Follow-up|1
4694593|NCT02609984|7606211|FG001|Overall Study|Lost to Follow-up|2
4694594|NCT02609984|7606210|FG000|Overall Study|Withdrawal by Subject|0
4694595|NCT02609984|7606211|FG001|Overall Study|Withdrawal by Subject|1
4694596|NCT02609984|7606210|FG000|Overall Study|Disease Progression|2
4694597|NCT02609984|7606211|FG001|Overall Study|Disease Progression|0
4694598|NCT02610140|7606219|FG000|Randomization and Treatment Period|Radiological progression|23
4694599|NCT02610140|7606220|FG001|Randomization and Treatment Period|Radiological progression|15
4694600|NCT02610140|7606219|FG000|Randomization and Treatment Period|Progressive disease - radiological|54
4694601|NCT02610140|7606220|FG001|Randomization and Treatment Period|Progressive disease - radiological|23
4694602|NCT02610140|7606219|FG000|Randomization and Treatment Period|Protocol Violation|1
4694603|NCT02610140|7606220|FG001|Randomization and Treatment Period|Protocol Violation|0
4694604|NCT02610140|7606219|FG000|Randomization and Treatment Period|Physician Decision|0
4694605|NCT02610140|7606220|FG001|Randomization and Treatment Period|Physician Decision|1
4694606|NCT02610140|7606219|FG000|Randomization and Treatment Period|Lack of Efficacy|1
4694607|NCT02610140|7606220|FG001|Randomization and Treatment Period|Lack of Efficacy|0
4694608|NCT02610140|7606219|FG000|Randomization and Treatment Period|Death|7
4694609|NCT02610140|7606220|FG001|Randomization and Treatment Period|Death|1
4694610|NCT02610140|7606219|FG000|Randomization and Treatment Period|Withdrawal by Subject|12
4694611|NCT02610140|7606220|FG001|Randomization and Treatment Period|Withdrawal by Subject|12
4694612|NCT02610140|7606219|FG000|Randomization and Treatment Period|Adverse Event|44
4694613|NCT02610140|7606220|FG001|Randomization and Treatment Period|Adverse Event|13
4694614|NCT02610140|7606219|FG000|Randomization and Treatment Period|Progressive disease - clinical|12
4374309|NCT03529773|7150266|FG039|Overall Study|Adverse Event|1
4374310|NCT03529773|7150227|FG000|Overall Study|Death|0
4374311|NCT03529773|7150228|FG001|Overall Study|Death|0
4374312|NCT03529773|7150229|FG002|Overall Study|Death|0
4374313|NCT03529773|7150230|FG003|Overall Study|Death|0
4374314|NCT03529773|7150231|FG004|Overall Study|Death|0
4374315|NCT03529773|7150232|FG005|Overall Study|Death|0
4374316|NCT03529773|7150233|FG006|Overall Study|Death|0
4374317|NCT03529773|7150234|FG007|Overall Study|Death|0
4374318|NCT03529773|7150235|FG008|Overall Study|Death|0
4374319|NCT03529773|7150236|FG009|Overall Study|Death|0
4374320|NCT03529773|7150237|FG010|Overall Study|Death|0
4374321|NCT03529773|7150238|FG011|Overall Study|Death|0
4374322|NCT03529773|7150239|FG012|Overall Study|Death|1
4374323|NCT03529773|7150240|FG013|Overall Study|Death|0
4374324|NCT03529773|7150241|FG014|Overall Study|Death|0
4374325|NCT03529773|7150242|FG015|Overall Study|Death|0
4374326|NCT03529773|7150243|FG016|Overall Study|Death|0
4374327|NCT03529773|7150244|FG017|Overall Study|Death|0
4374328|NCT03529773|7150245|FG018|Overall Study|Death|0
4374329|NCT03529773|7150246|FG019|Overall Study|Death|1
4374330|NCT03529773|7150247|FG020|Overall Study|Death|0
4374331|NCT03529773|7150248|FG021|Overall Study|Death|0
4374332|NCT03529773|7150249|FG022|Overall Study|Death|1
4374333|NCT03529773|7150250|FG023|Overall Study|Death|0
4374334|NCT03529773|7150251|FG024|Overall Study|Death|0
4374335|NCT03529773|7150252|FG025|Overall Study|Death|0
4374336|NCT03529773|7150253|FG026|Overall Study|Death|0
4374337|NCT03529773|7150254|FG027|Overall Study|Death|0
4374338|NCT03529773|7150255|FG028|Overall Study|Death|0
4374339|NCT03529773|7150256|FG029|Overall Study|Death|0
4374340|NCT03529773|7150257|FG030|Overall Study|Death|0
4374341|NCT03529773|7150258|FG031|Overall Study|Death|0
4374342|NCT03529773|7150259|FG032|Overall Study|Death|0
4374343|NCT03529773|7150260|FG033|Overall Study|Death|1
4374344|NCT03529773|7150261|FG034|Overall Study|Death|1
4374345|NCT03529773|7150262|FG035|Overall Study|Death|0
4465371|NCT00609518|7256635|FG000|Overall Study|Death from Study Disease|32
4465372|NCT00609518|7256636|FG001|Overall Study|Death from Study Disease|32
4465373|NCT00609518|7256635|FG000|Overall Study|Withdrawal by Subject|5
4465374|NCT00609518|7256636|FG001|Overall Study|Withdrawal by Subject|3
4465375|NCT00609518|7256635|FG000|Overall Study|Lost to Follow-up|3
4465376|NCT00609518|7256636|FG001|Overall Study|Lost to Follow-up|0
4465377|NCT00609518|7256635|FG000|Overall Study|Physician Decision|1
4465378|NCT00609518|7256636|FG001|Overall Study|Physician Decision|3
4465379|NCT00609518|7256635|FG000|Overall Study|Death from Adverse Event|2
4465380|NCT00609518|7256636|FG001|Overall Study|Death from Adverse Event|2
4465381|NCT00609609|7256644|FG000|Overall Study|Withdrawal by Subject|2
4465382|NCT00609609|7256645|FG001|Overall Study|Withdrawal by Subject|0
4465383|NCT00609609|7256644|FG000|Overall Study|Progression|4
4465384|NCT00609609|7256645|FG001|Overall Study|Progression|2
4465385|NCT00609622|7256653|FG000|Overall Study|Adverse Event|14
4465386|NCT00609622|7256654|FG001|Overall Study|Adverse Event|10
4465387|NCT00609622|7256653|FG000|Overall Study|Withdrawal by Subject|4
4465388|NCT00609622|7256654|FG001|Overall Study|Withdrawal by Subject|20
4465389|NCT00609622|7256653|FG000|Overall Study|Death|1
4465390|NCT00609622|7256654|FG001|Overall Study|Death|4
4465391|NCT00609622|7256653|FG000|Overall Study|Protocol Violation|1
4465392|NCT00609622|7256654|FG001|Overall Study|Protocol Violation|1
4465393|NCT00609622|7256653|FG000|Overall Study|Objective progression or relapse|47
4465394|NCT00609622|7256654|FG001|Overall Study|Objective progression or relapse|41
4465395|NCT00609622|7256653|FG000|Overall Study|Study terminated by sponsor|16
4465396|NCT00609622|7256654|FG001|Overall Study|Study terminated by sponsor|3
4465397|NCT00609622|7256653|FG000|Overall Study|Other|7
4465398|NCT00609622|7256654|FG001|Overall Study|Other|14
4465399|NCT00609622|7256653|FG000|Overall Study|Global deterioration of health status|6
4465400|NCT00609622|7256654|FG001|Overall Study|Global deterioration of health status|2
4465401|NCT00609674|7256662|FG000|Overall Study|Adverse Event|1
4465402|NCT00609674|7256663|FG001|Overall Study|Adverse Event|1
4465403|NCT00609674|7256662|FG000|Overall Study|Protocol Violation|3
4465404|NCT00609674|7256663|FG001|Overall Study|Protocol Violation|5
4465405|NCT00609674|7256662|FG000|Overall Study|Lost to Follow-up|1
4374346|NCT03529773|7150263|FG036|Overall Study|Death|1
4374347|NCT03529773|7150264|FG037|Overall Study|Death|0
4374348|NCT03529773|7150265|FG038|Overall Study|Death|0
4374349|NCT03529773|7150266|FG039|Overall Study|Death|0
4374350|NCT03529773|7150227|FG000|Overall Study|Lost to Follow-up|0
4374351|NCT03529773|7150228|FG001|Overall Study|Lost to Follow-up|0
4374352|NCT03529773|7150229|FG002|Overall Study|Lost to Follow-up|1
4374353|NCT03529773|7150230|FG003|Overall Study|Lost to Follow-up|0
4374354|NCT03529773|7150231|FG004|Overall Study|Lost to Follow-up|1
4374355|NCT03529773|7150232|FG005|Overall Study|Lost to Follow-up|1
4374356|NCT03529773|7150233|FG006|Overall Study|Lost to Follow-up|0
4374357|NCT03529773|7150234|FG007|Overall Study|Lost to Follow-up|0
4374358|NCT03529773|7150235|FG008|Overall Study|Lost to Follow-up|0
4374359|NCT03529773|7150236|FG009|Overall Study|Lost to Follow-up|0
4465406|NCT00609674|7256663|FG001|Overall Study|Lost to Follow-up|0
4465407|NCT00609674|7256662|FG000|Overall Study|Withdrew consent|2
4465408|NCT00609674|7256663|FG001|Overall Study|Withdrew consent|1
4465409|NCT00609869|7256685|FG000|Overall Study|Withdrawn, ischemic stroke|1
4465410|NCT00609869|7256685|FG000|Overall Study|Severe hematologic toxicity|1
4374360|NCT03529773|7150237|FG010|Overall Study|Lost to Follow-up|0
4374361|NCT03529773|7150238|FG011|Overall Study|Lost to Follow-up|0
4374362|NCT03529773|7150239|FG012|Overall Study|Lost to Follow-up|0
4374363|NCT03529773|7150240|FG013|Overall Study|Lost to Follow-up|1
4374364|NCT03529773|7150241|FG014|Overall Study|Lost to Follow-up|4
4374365|NCT03529773|7150242|FG015|Overall Study|Lost to Follow-up|1
4374366|NCT03529773|7150243|FG016|Overall Study|Lost to Follow-up|1
4374367|NCT03529773|7150244|FG017|Overall Study|Lost to Follow-up|0
4465411|NCT00609869|7256685|FG000|Overall Study|Withdrawal by Subject|1
4465412|NCT00609869|7256685|FG000|Overall Study|Seizures|1
4465413|NCT00609869|7256685|FG000|Overall Study|Severe tumor flare reaction|1
4465414|NCT00609869|7256685|FG000|Overall Study|Hepatitis B infection|1
4694615|NCT02610140|7606220|FG001|Randomization and Treatment Period|Progressive disease - clinical|5
4694616|NCT02610140|7606219|FG000|Randomization and Treatment Period|Ongoing but not completed|9
4694617|NCT02610140|7606220|FG001|Randomization and Treatment Period|Ongoing but not completed|2
4694618|NCT02610140|7606219|FG000|Randomization and Treatment Period|Not treated|3
4694619|NCT02610140|7606220|FG001|Randomization and Treatment Period|Not treated|10
4694620|NCT02610140|7606219|FG000|Safety Follow-up|Other|0
4694621|NCT02610140|7606220|FG001|Safety Follow-up|Other|2
4694622|NCT02610140|7606219|FG000|Safety Follow-up|Lost to Follow-up|1
4374368|NCT03529773|7150245|FG018|Overall Study|Lost to Follow-up|1
4374369|NCT03529773|7150246|FG019|Overall Study|Lost to Follow-up|1
4374370|NCT03529773|7150247|FG020|Overall Study|Lost to Follow-up|2
4374371|NCT03529773|7150248|FG021|Overall Study|Lost to Follow-up|4
4374372|NCT03529773|7150249|FG022|Overall Study|Lost to Follow-up|3
4374373|NCT03529773|7150250|FG023|Overall Study|Lost to Follow-up|4
4374374|NCT03529773|7150251|FG024|Overall Study|Lost to Follow-up|3
4374375|NCT03529773|7150252|FG025|Overall Study|Lost to Follow-up|5
4374376|NCT03529773|7150253|FG026|Overall Study|Lost to Follow-up|5
4374377|NCT03529773|7150254|FG027|Overall Study|Lost to Follow-up|0
4374378|NCT03529773|7150255|FG028|Overall Study|Lost to Follow-up|0
4374379|NCT03529773|7150256|FG029|Overall Study|Lost to Follow-up|0
4374380|NCT03529773|7150257|FG030|Overall Study|Lost to Follow-up|1
4374381|NCT03529773|7150258|FG031|Overall Study|Lost to Follow-up|0
4374382|NCT03529773|7150259|FG032|Overall Study|Lost to Follow-up|0
4374383|NCT03529773|7150260|FG033|Overall Study|Lost to Follow-up|1
4374384|NCT03529773|7150261|FG034|Overall Study|Lost to Follow-up|1
4374385|NCT03529773|7150262|FG035|Overall Study|Lost to Follow-up|0
4374386|NCT03529773|7150263|FG036|Overall Study|Lost to Follow-up|0
4374387|NCT03529773|7150264|FG037|Overall Study|Lost to Follow-up|3
4374388|NCT03529773|7150265|FG038|Overall Study|Lost to Follow-up|1
4374389|NCT03529773|7150266|FG039|Overall Study|Lost to Follow-up|1
4374390|NCT03529773|7150227|FG000|Overall Study|No longer meets eligibility criteria|0
4374391|NCT03529773|7150228|FG001|Overall Study|No longer meets eligibility criteria|0
4374392|NCT03529773|7150229|FG002|Overall Study|No longer meets eligibility criteria|0
4374393|NCT03529773|7150230|FG003|Overall Study|No longer meets eligibility criteria|0
4374394|NCT03529773|7150231|FG004|Overall Study|No longer meets eligibility criteria|0
4374395|NCT03529773|7150232|FG005|Overall Study|No longer meets eligibility criteria|0
4374396|NCT03529773|7150233|FG006|Overall Study|No longer meets eligibility criteria|0
4374397|NCT03529773|7150234|FG007|Overall Study|No longer meets eligibility criteria|0
4374398|NCT03529773|7150235|FG008|Overall Study|No longer meets eligibility criteria|0
4374399|NCT03529773|7150236|FG009|Overall Study|No longer meets eligibility criteria|0
4374400|NCT03529773|7150237|FG010|Overall Study|No longer meets eligibility criteria|0
4374401|NCT03529773|7150238|FG011|Overall Study|No longer meets eligibility criteria|0
4374402|NCT03529773|7150239|FG012|Overall Study|No longer meets eligibility criteria|0
4374403|NCT03529773|7150240|FG013|Overall Study|No longer meets eligibility criteria|0
4374404|NCT03529773|7150241|FG014|Overall Study|No longer meets eligibility criteria|0
4374405|NCT03529773|7150242|FG015|Overall Study|No longer meets eligibility criteria|0
4374406|NCT03529773|7150243|FG016|Overall Study|No longer meets eligibility criteria|0
4374407|NCT03529773|7150244|FG017|Overall Study|No longer meets eligibility criteria|0
4374408|NCT03529773|7150245|FG018|Overall Study|No longer meets eligibility criteria|0
4374409|NCT03529773|7150246|FG019|Overall Study|No longer meets eligibility criteria|0
4374410|NCT03529773|7150247|FG020|Overall Study|No longer meets eligibility criteria|0
4374411|NCT03529773|7150248|FG021|Overall Study|No longer meets eligibility criteria|0
4374412|NCT03529773|7150249|FG022|Overall Study|No longer meets eligibility criteria|1
4374413|NCT03529773|7150250|FG023|Overall Study|No longer meets eligibility criteria|0
4374414|NCT03529773|7150251|FG024|Overall Study|No longer meets eligibility criteria|0
4374415|NCT03529773|7150252|FG025|Overall Study|No longer meets eligibility criteria|0
4374416|NCT03529773|7150253|FG026|Overall Study|No longer meets eligibility criteria|0
4374417|NCT03529773|7150254|FG027|Overall Study|No longer meets eligibility criteria|0
4374418|NCT03529773|7150255|FG028|Overall Study|No longer meets eligibility criteria|0
4374419|NCT03529773|7150256|FG029|Overall Study|No longer meets eligibility criteria|0
4374420|NCT03529773|7150257|FG030|Overall Study|No longer meets eligibility criteria|0
4374421|NCT03529773|7150258|FG031|Overall Study|No longer meets eligibility criteria|0
4374422|NCT03529773|7150259|FG032|Overall Study|No longer meets eligibility criteria|0
4374423|NCT03529773|7150260|FG033|Overall Study|No longer meets eligibility criteria|0
4374424|NCT03529773|7150261|FG034|Overall Study|No longer meets eligibility criteria|0
4374425|NCT03529773|7150262|FG035|Overall Study|No longer meets eligibility criteria|0
4374426|NCT03529773|7150263|FG036|Overall Study|No longer meets eligibility criteria|0
4374427|NCT03529773|7150264|FG037|Overall Study|No longer meets eligibility criteria|0
4374428|NCT03529773|7150265|FG038|Overall Study|No longer meets eligibility criteria|1
4374429|NCT03529773|7150266|FG039|Overall Study|No longer meets eligibility criteria|0
4516289|NCT00958841|7327573|FG000|Overall Study|Discontinued prior to M*|28
4374430|NCT03529773|7150227|FG000|Overall Study|Other|0
4374431|NCT03529773|7150228|FG001|Overall Study|Other|0
4374432|NCT03529773|7150229|FG002|Overall Study|Other|0
4374433|NCT03529773|7150230|FG003|Overall Study|Other|0
4374434|NCT03529773|7150231|FG004|Overall Study|Other|0
4374435|NCT03529773|7150232|FG005|Overall Study|Other|0
4374436|NCT03529773|7150233|FG006|Overall Study|Other|0
4374437|NCT03529773|7150234|FG007|Overall Study|Other|0
4374438|NCT03529773|7150235|FG008|Overall Study|Other|0
4374439|NCT03529773|7150236|FG009|Overall Study|Other|0
4374440|NCT03529773|7150237|FG010|Overall Study|Other|0
4374441|NCT03529773|7150238|FG011|Overall Study|Other|0
4374442|NCT03529773|7150239|FG012|Overall Study|Other|1
4374443|NCT03529773|7150240|FG013|Overall Study|Other|0
4374444|NCT03529773|7150241|FG014|Overall Study|Other|2
4374445|NCT03529773|7150242|FG015|Overall Study|Other|0
4374446|NCT03529773|7150243|FG016|Overall Study|Other|0
4374447|NCT03529773|7150244|FG017|Overall Study|Other|3
4374448|NCT03529773|7150245|FG018|Overall Study|Other|0
4694623|NCT02610140|7606220|FG001|Safety Follow-up|Lost to Follow-up|0
4694624|NCT02610140|7606219|FG000|Safety Follow-up|No follow-up|5
4694625|NCT02610140|7606220|FG001|Safety Follow-up|No follow-up|3
4694626|NCT02610140|7606219|FG000|Safety Follow-up|Death|12
4694627|NCT02610140|7606220|FG001|Safety Follow-up|Death|2
4694628|NCT02610140|7606219|FG000|Safety Follow-up|Deterioration of general conditions|15
4694629|NCT02610140|7606220|FG001|Safety Follow-up|Deterioration of general conditions|5
4374449|NCT03529773|7150246|FG019|Overall Study|Other|0
4374450|NCT03529773|7150247|FG020|Overall Study|Other|1
4374451|NCT03529773|7150248|FG021|Overall Study|Other|0
4374452|NCT03529773|7150249|FG022|Overall Study|Other|1
4374453|NCT03529773|7150250|FG023|Overall Study|Other|0
4374454|NCT03529773|7150251|FG024|Overall Study|Other|3
4374455|NCT03529773|7150252|FG025|Overall Study|Other|2
4374456|NCT03529773|7150253|FG026|Overall Study|Other|2
4374457|NCT03529773|7150254|FG027|Overall Study|Other|0
4374458|NCT03529773|7150255|FG028|Overall Study|Other|0
4374459|NCT03529773|7150256|FG029|Overall Study|Other|0
4374460|NCT03529773|7150257|FG030|Overall Study|Other|0
4374461|NCT03529773|7150258|FG031|Overall Study|Other|0
4374462|NCT03529773|7150259|FG032|Overall Study|Other|0
4374463|NCT03529773|7150260|FG033|Overall Study|Other|0
4374464|NCT03529773|7150261|FG034|Overall Study|Other|1
4374465|NCT03529773|7150262|FG035|Overall Study|Other|1
4374466|NCT03529773|7150263|FG036|Overall Study|Other|0
4374467|NCT03529773|7150264|FG037|Overall Study|Other|0
4374468|NCT03529773|7150265|FG038|Overall Study|Other|0
4374469|NCT03529773|7150266|FG039|Overall Study|Other|0
4374470|NCT03529773|7150227|FG000|Overall Study|Physician Decision|0
4374471|NCT03529773|7150228|FG001|Overall Study|Physician Decision|0
4374472|NCT03529773|7150229|FG002|Overall Study|Physician Decision|0
4374473|NCT03529773|7150230|FG003|Overall Study|Physician Decision|0
4374474|NCT03529773|7150231|FG004|Overall Study|Physician Decision|0
4374475|NCT03529773|7150232|FG005|Overall Study|Physician Decision|0
4465415|NCT00609869|7256685|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1
4465416|NCT00609869|7256685|FG000|Overall Study|Mantle cell: not evaluable|4
4465417|NCT00609947|7256689|FG000|Overall Study|Death|1
4465418|NCT00609973|7256696|FG000|Overall Study|Adverse Event|2
4465419|NCT00609973|7256697|FG001|Overall Study|Adverse Event|1
4465420|NCT00609973|7256696|FG000|Overall Study|Protocol Violation|4
4465421|NCT00609973|7256697|FG001|Overall Study|Protocol Violation|3
4465422|NCT00609973|7256696|FG000|Overall Study|Lost to Follow-up|2
4465423|NCT00609973|7256697|FG001|Overall Study|Lost to Follow-up|1
4465424|NCT00609973|7256696|FG000|Overall Study|Withdrawal by Subject|0
4465425|NCT00609973|7256697|FG001|Overall Study|Withdrawal by Subject|1
4465426|NCT00609986|7256705|FG000|Overall Study|Did not receive transplant or treatment|8
4465427|NCT00609986|7256706|FG001|Overall Study|Did not receive transplant or treatment|3
4465428|NCT00610129|7256716|FG000|Overall Study|Not treated since patients ineligible|3
4465429|NCT00610155|7256720|FG000|Period 1|Withdrawal by Subject|0
4465430|NCT00610155|7256721|FG001|Period 1|Withdrawal by Subject|0
4465431|NCT00610155|7256722|FG002|Period 1|Withdrawal by Subject|1
4465432|NCT00610155|7256723|FG003|Period 1|Withdrawal by Subject|0
4465433|NCT00610155|7256724|FG004|Period 1|Withdrawal by Subject|0
4465434|NCT00610155|7256725|FG005|Period 1|Withdrawal by Subject|0
4465435|NCT00610155|7256720|FG000|Period 3|Adverse Event|1
4465436|NCT00610155|7256721|FG001|Period 3|Adverse Event|0
4465437|NCT00610155|7256722|FG002|Period 3|Adverse Event|0
4374476|NCT03529773|7150233|FG006|Overall Study|Physician Decision|0
4374477|NCT03529773|7150234|FG007|Overall Study|Physician Decision|0
4374478|NCT03529773|7150235|FG008|Overall Study|Physician Decision|0
4374479|NCT03529773|7150236|FG009|Overall Study|Physician Decision|0
4374480|NCT03529773|7150237|FG010|Overall Study|Physician Decision|0
4374481|NCT03529773|7150238|FG011|Overall Study|Physician Decision|0
4374482|NCT03529773|7150239|FG012|Overall Study|Physician Decision|0
4374483|NCT03529773|7150240|FG013|Overall Study|Physician Decision|0
4374484|NCT03529773|7150241|FG014|Overall Study|Physician Decision|0
4374485|NCT03529773|7150242|FG015|Overall Study|Physician Decision|0
4374486|NCT03529773|7150243|FG016|Overall Study|Physician Decision|0
4374487|NCT03529773|7150244|FG017|Overall Study|Physician Decision|0
4465438|NCT00610155|7256723|FG003|Period 3|Adverse Event|0
4465439|NCT00610155|7256724|FG004|Period 3|Adverse Event|0
4465440|NCT00610155|7256725|FG005|Period 3|Adverse Event|0
4465441|NCT00610168|7256735|FG000|Overall Study|Withdrawal by Subject|2
4465442|NCT00610168|7256736|FG001|Overall Study|Withdrawal by Subject|0
4465443|NCT00610207|7256742|FG000|Overall Study|Lost to Follow-up|3
4694630|NCT02610140|7606219|FG000|Safety Follow-up|Withdrawal by Subject|12
4374488|NCT03529773|7150245|FG018|Overall Study|Physician Decision|0
4374489|NCT03529773|7150246|FG019|Overall Study|Physician Decision|1
4374490|NCT03529773|7150247|FG020|Overall Study|Physician Decision|1
4374491|NCT03529773|7150248|FG021|Overall Study|Physician Decision|0
4374492|NCT03529773|7150249|FG022|Overall Study|Physician Decision|0
4374493|NCT03529773|7150250|FG023|Overall Study|Physician Decision|0
4374494|NCT03529773|7150251|FG024|Overall Study|Physician Decision|0
4374495|NCT03529773|7150252|FG025|Overall Study|Physician Decision|0
4374496|NCT03529773|7150253|FG026|Overall Study|Physician Decision|0
4374497|NCT03529773|7150254|FG027|Overall Study|Physician Decision|0
4374498|NCT03529773|7150255|FG028|Overall Study|Physician Decision|0
4374499|NCT03529773|7150256|FG029|Overall Study|Physician Decision|0
4374500|NCT03529773|7150257|FG030|Overall Study|Physician Decision|0
4374501|NCT03529773|7150258|FG031|Overall Study|Physician Decision|0
4374502|NCT03529773|7150259|FG032|Overall Study|Physician Decision|0
4374503|NCT03529773|7150260|FG033|Overall Study|Physician Decision|0
4374504|NCT03529773|7150261|FG034|Overall Study|Physician Decision|0
4374505|NCT03529773|7150262|FG035|Overall Study|Physician Decision|0
4374506|NCT03529773|7150263|FG036|Overall Study|Physician Decision|0
4374507|NCT03529773|7150264|FG037|Overall Study|Physician Decision|0
4374508|NCT03529773|7150265|FG038|Overall Study|Physician Decision|0
4374509|NCT03529773|7150266|FG039|Overall Study|Physician Decision|0
4374510|NCT03529773|7150227|FG000|Overall Study|Protocol Violation|0
4374511|NCT03529773|7150228|FG001|Overall Study|Protocol Violation|0
4374512|NCT03529773|7150229|FG002|Overall Study|Protocol Violation|0
4374513|NCT03529773|7150230|FG003|Overall Study|Protocol Violation|0
4374514|NCT03529773|7150231|FG004|Overall Study|Protocol Violation|0
4374515|NCT03529773|7150232|FG005|Overall Study|Protocol Violation|0
4374516|NCT03529773|7150233|FG006|Overall Study|Protocol Violation|0
4374517|NCT03529773|7150234|FG007|Overall Study|Protocol Violation|0
4374518|NCT03529773|7150235|FG008|Overall Study|Protocol Violation|0
4374519|NCT03529773|7150236|FG009|Overall Study|Protocol Violation|0
4374520|NCT03529773|7150237|FG010|Overall Study|Protocol Violation|0
4374521|NCT03529773|7150238|FG011|Overall Study|Protocol Violation|0
4374522|NCT03529773|7150239|FG012|Overall Study|Protocol Violation|0
4374523|NCT03529773|7150240|FG013|Overall Study|Protocol Violation|0
4374524|NCT03529773|7150241|FG014|Overall Study|Protocol Violation|0
4374525|NCT03529773|7150242|FG015|Overall Study|Protocol Violation|0
4374526|NCT03529773|7150243|FG016|Overall Study|Protocol Violation|0
4374527|NCT03529773|7150244|FG017|Overall Study|Protocol Violation|0
4374528|NCT03529773|7150245|FG018|Overall Study|Protocol Violation|0
4374529|NCT03529773|7150246|FG019|Overall Study|Protocol Violation|0
4374530|NCT03529773|7150247|FG020|Overall Study|Protocol Violation|0
4374531|NCT03529773|7150248|FG021|Overall Study|Protocol Violation|0
4374532|NCT03529773|7150249|FG022|Overall Study|Protocol Violation|0
4374533|NCT03529773|7150250|FG023|Overall Study|Protocol Violation|0
4374534|NCT03529773|7150251|FG024|Overall Study|Protocol Violation|0
4374535|NCT03529773|7150252|FG025|Overall Study|Protocol Violation|0
4374536|NCT03529773|7150253|FG026|Overall Study|Protocol Violation|0
4374537|NCT03529773|7150254|FG027|Overall Study|Protocol Violation|0
4374538|NCT03529773|7150255|FG028|Overall Study|Protocol Violation|0
4374539|NCT03529773|7150256|FG029|Overall Study|Protocol Violation|0
4374540|NCT03529773|7150257|FG030|Overall Study|Protocol Violation|1
4374541|NCT03529773|7150258|FG031|Overall Study|Protocol Violation|0
4374542|NCT03529773|7150259|FG032|Overall Study|Protocol Violation|0
4374543|NCT03529773|7150260|FG033|Overall Study|Protocol Violation|0
4374544|NCT03529773|7150261|FG034|Overall Study|Protocol Violation|0
4374545|NCT03529773|7150262|FG035|Overall Study|Protocol Violation|0
4374546|NCT03529773|7150263|FG036|Overall Study|Protocol Violation|0
4374547|NCT03529773|7150264|FG037|Overall Study|Protocol Violation|0
4374548|NCT03529773|7150265|FG038|Overall Study|Protocol Violation|0
4374549|NCT03529773|7150266|FG039|Overall Study|Protocol Violation|0
4374550|NCT03529773|7150227|FG000|Overall Study|Withdrawal by Subject|0
4374551|NCT03529773|7150228|FG001|Overall Study|Withdrawal by Subject|0
4374552|NCT03529773|7150229|FG002|Overall Study|Withdrawal by Subject|0
4374553|NCT03529773|7150230|FG003|Overall Study|Withdrawal by Subject|0
4374554|NCT03529773|7150231|FG004|Overall Study|Withdrawal by Subject|0
4374555|NCT03529773|7150232|FG005|Overall Study|Withdrawal by Subject|0
4374556|NCT03529773|7150233|FG006|Overall Study|Withdrawal by Subject|0
4374557|NCT03529773|7150234|FG007|Overall Study|Withdrawal by Subject|1
4374558|NCT03529773|7150235|FG008|Overall Study|Withdrawal by Subject|0
4374559|NCT03529773|7150236|FG009|Overall Study|Withdrawal by Subject|1
4374560|NCT03529773|7150237|FG010|Overall Study|Withdrawal by Subject|1
4374561|NCT03529773|7150238|FG011|Overall Study|Withdrawal by Subject|0
4374562|NCT03529773|7150239|FG012|Overall Study|Withdrawal by Subject|0
4374563|NCT03529773|7150240|FG013|Overall Study|Withdrawal by Subject|0
4374564|NCT03529773|7150241|FG014|Overall Study|Withdrawal by Subject|0
4374565|NCT03529773|7150242|FG015|Overall Study|Withdrawal by Subject|3
4374566|NCT03529773|7150243|FG016|Overall Study|Withdrawal by Subject|0
4374567|NCT03529773|7150244|FG017|Overall Study|Withdrawal by Subject|2
4374568|NCT03529773|7150245|FG018|Overall Study|Withdrawal by Subject|3
4374569|NCT03529773|7150246|FG019|Overall Study|Withdrawal by Subject|1
4374570|NCT03529773|7150247|FG020|Overall Study|Withdrawal by Subject|3
4374571|NCT03529773|7150248|FG021|Overall Study|Withdrawal by Subject|1
4374572|NCT03529773|7150249|FG022|Overall Study|Withdrawal by Subject|1
4374573|NCT03529773|7150250|FG023|Overall Study|Withdrawal by Subject|2
4374574|NCT03529773|7150251|FG024|Overall Study|Withdrawal by Subject|2
4374575|NCT03529773|7150252|FG025|Overall Study|Withdrawal by Subject|4
4374576|NCT03529773|7150253|FG026|Overall Study|Withdrawal by Subject|2
4374577|NCT03529773|7150254|FG027|Overall Study|Withdrawal by Subject|1
4374578|NCT03529773|7150255|FG028|Overall Study|Withdrawal by Subject|1
4374579|NCT03529773|7150256|FG029|Overall Study|Withdrawal by Subject|0
4374580|NCT03529773|7150257|FG030|Overall Study|Withdrawal by Subject|0
4374581|NCT03529773|7150258|FG031|Overall Study|Withdrawal by Subject|0
4374582|NCT03529773|7150259|FG032|Overall Study|Withdrawal by Subject|0
4374583|NCT03529773|7150260|FG033|Overall Study|Withdrawal by Subject|0
4374584|NCT03529773|7150261|FG034|Overall Study|Withdrawal by Subject|1
4374585|NCT03529773|7150262|FG035|Overall Study|Withdrawal by Subject|2
4374586|NCT03529773|7150263|FG036|Overall Study|Withdrawal by Subject|0
4374587|NCT03529773|7150264|FG037|Overall Study|Withdrawal by Subject|2
4374588|NCT03529773|7150265|FG038|Overall Study|Withdrawal by Subject|1
4374589|NCT03529773|7150266|FG039|Overall Study|Withdrawal by Subject|1
4374590|NCT03529773|7150227|FG000|Overall Study|Screen Failure|0
4374591|NCT03529773|7150228|FG001|Overall Study|Screen Failure|0
4374592|NCT03529773|7150229|FG002|Overall Study|Screen Failure|0
4374593|NCT03529773|7150230|FG003|Overall Study|Screen Failure|0
4374594|NCT03529773|7150231|FG004|Overall Study|Screen Failure|0
4374595|NCT03529773|7150232|FG005|Overall Study|Screen Failure|0
4374596|NCT03529773|7150233|FG006|Overall Study|Screen Failure|0
4374597|NCT03529773|7150234|FG007|Overall Study|Screen Failure|0
4374598|NCT03529773|7150235|FG008|Overall Study|Screen Failure|0
4374599|NCT03529773|7150236|FG009|Overall Study|Screen Failure|0
4374600|NCT03529773|7150237|FG010|Overall Study|Screen Failure|0
4374601|NCT03529773|7150238|FG011|Overall Study|Screen Failure|0
4374602|NCT03529773|7150239|FG012|Overall Study|Screen Failure|0
4374603|NCT03529773|7150240|FG013|Overall Study|Screen Failure|0
4374604|NCT03529773|7150241|FG014|Overall Study|Screen Failure|0
4374605|NCT03529773|7150242|FG015|Overall Study|Screen Failure|0
4374606|NCT03529773|7150243|FG016|Overall Study|Screen Failure|0
4374607|NCT03529773|7150244|FG017|Overall Study|Screen Failure|0
4374608|NCT03529773|7150245|FG018|Overall Study|Screen Failure|0
4374609|NCT03529773|7150246|FG019|Overall Study|Screen Failure|0
4374610|NCT03529773|7150247|FG020|Overall Study|Screen Failure|0
4374611|NCT03529773|7150248|FG021|Overall Study|Screen Failure|0
4374612|NCT03529773|7150249|FG022|Overall Study|Screen Failure|0
4374613|NCT03529773|7150250|FG023|Overall Study|Screen Failure|0
4374614|NCT03529773|7150251|FG024|Overall Study|Screen Failure|0
4374615|NCT03529773|7150252|FG025|Overall Study|Screen Failure|0
4374616|NCT03529773|7150253|FG026|Overall Study|Screen Failure|0
4374617|NCT03529773|7150254|FG027|Overall Study|Screen Failure|0
4374618|NCT03529773|7150255|FG028|Overall Study|Screen Failure|0
4694631|NCT02610140|7606220|FG001|Safety Follow-up|Withdrawal by Subject|12
4694632|NCT02610140|7606219|FG000|Active Follow-up|Progressive disease - radiological|30
4694633|NCT02610140|7606220|FG001|Active Follow-up|Progressive disease - radiological|22
4694634|NCT02610140|7606219|FG000|Active Follow-up|Death|8
4694635|NCT02610140|7606220|FG001|Active Follow-up|Death|1
4694636|NCT02610140|7606219|FG000|Active Follow-up|Withdrawal by Subject|4
4694637|NCT02610140|7606220|FG001|Active Follow-up|Withdrawal by Subject|0
4694638|NCT02610140|7606219|FG000|Active Follow-up|Progressive disease - clinical|1
4694639|NCT02610140|7606220|FG001|Active Follow-up|Progressive disease - clinical|2
4694640|NCT02610140|7606219|FG000|Active Follow-up|Deterioration of general conditions|1
4694641|NCT02610140|7606220|FG001|Active Follow-up|Deterioration of general conditions|0
4694642|NCT02610140|7606219|FG000|Active Follow-up|Ongoing but not completed|4
4694643|NCT02610140|7606220|FG001|Active Follow-up|Ongoing but not completed|1
4694644|NCT02610140|7606219|FG000|Long-term Follow-up|Death|86
4694645|NCT02610140|7606220|FG001|Long-term Follow-up|Death|44
4694646|NCT02610140|7606219|FG000|Long-term Follow-up|Withdrawal by Subject|6
4694647|NCT02610140|7606220|FG001|Long-term Follow-up|Withdrawal by Subject|3
4694648|NCT02610140|7606219|FG000|Long-term Follow-up|Lost to Follow-up|1
4694649|NCT02610140|7606220|FG001|Long-term Follow-up|Lost to Follow-up|2
4694650|NCT02610140|7606219|FG000|Long-term Follow-up|Ongoing but not completed|30
4374619|NCT03529773|7150256|FG029|Overall Study|Screen Failure|0
4374620|NCT03529773|7150257|FG030|Overall Study|Screen Failure|0
4374621|NCT03529773|7150258|FG031|Overall Study|Screen Failure|0
4587506|NCT01491035|7431504|FG006|Overall Study|Lost to Follow-up|0
4587507|NCT01491035|7431505|FG007|Overall Study|Lost to Follow-up|0
4587508|NCT01491178|7431546|FG000|Overall Study|Adverse Event|1016
4587509|NCT01491178|7431546|FG000|Overall Study|Improvement of NVAF|210
4587510|NCT01491178|7431546|FG000|Overall Study|To conduct invasive treatment|59
4587511|NCT01491178|7431546|FG000|Overall Study|Lost to follow-up (unknown reason)|287
4587512|NCT01491178|7431546|FG000|Overall Study|Lost to follow-up (changing hospital)|545
4587513|NCT01491178|7431546|FG000|Overall Study|To take a contraindication|20
4587514|NCT01491178|7431546|FG000|Overall Study|Other than specified above|657
4587515|NCT01491607|7431563|FG000|Overall Study|Lost to Follow-up|7
4694651|NCT02610140|7606220|FG001|Long-term Follow-up|Ongoing but not completed|17
4694652|NCT02610192|7606226|FG000|Overall Study|Received other treatment|8
4694653|NCT02610192|7606226|FG000|Overall Study|Physician Decision|1
4694654|NCT02610231|7606230|FG000|Overall Study|Withdrawal by Subject|27
4374622|NCT03529773|7150259|FG032|Overall Study|Screen Failure|0
4374623|NCT03529773|7150260|FG033|Overall Study|Screen Failure|0
4374624|NCT03529773|7150261|FG034|Overall Study|Screen Failure|0
4374625|NCT03529773|7150262|FG035|Overall Study|Screen Failure|0
4374626|NCT03529773|7150263|FG036|Overall Study|Screen Failure|1
4374627|NCT03529773|7150264|FG037|Overall Study|Screen Failure|1
4374628|NCT03529773|7150265|FG038|Overall Study|Screen Failure|0
4374629|NCT03529773|7150266|FG039|Overall Study|Screen Failure|1
4374630|NCT03529773|7150227|FG000|Overall Study|Randomized but not vaccinated|0
4374631|NCT03529773|7150228|FG001|Overall Study|Randomized but not vaccinated|0
4374632|NCT03529773|7150229|FG002|Overall Study|Randomized but not vaccinated|0
4374633|NCT03529773|7150230|FG003|Overall Study|Randomized but not vaccinated|0
4374634|NCT03529773|7150231|FG004|Overall Study|Randomized but not vaccinated|0
4374635|NCT03529773|7150232|FG005|Overall Study|Randomized but not vaccinated|0
4374636|NCT03529773|7150233|FG006|Overall Study|Randomized but not vaccinated|0
4374637|NCT03529773|7150234|FG007|Overall Study|Randomized but not vaccinated|0
4374638|NCT03529773|7150235|FG008|Overall Study|Randomized but not vaccinated|0
4374639|NCT03529773|7150236|FG009|Overall Study|Randomized but not vaccinated|0
4374640|NCT03529773|7150237|FG010|Overall Study|Randomized but not vaccinated|0
4374641|NCT03529773|7150238|FG011|Overall Study|Randomized but not vaccinated|0
4374642|NCT03529773|7150239|FG012|Overall Study|Randomized but not vaccinated|0
4374643|NCT03529773|7150240|FG013|Overall Study|Randomized but not vaccinated|0
4374644|NCT03529773|7150241|FG014|Overall Study|Randomized but not vaccinated|0
4374645|NCT03529773|7150242|FG015|Overall Study|Randomized but not vaccinated|0
4374646|NCT03529773|7150243|FG016|Overall Study|Randomized but not vaccinated|0
4374647|NCT03529773|7150244|FG017|Overall Study|Randomized but not vaccinated|1
4587516|NCT01491607|7431563|FG000|Overall Study|Withdrawal by Subject|3
4587517|NCT01491672|7431636|FG000|Overall Study|Lost to Follow-up|0
4587518|NCT01491672|7431637|FG001|Overall Study|Lost to Follow-up|4
4587519|NCT01491672|7431638|FG002|Overall Study|Lost to Follow-up|1
4587520|NCT01491672|7431636|FG000|Overall Study|Withdrawal by Subject|6
4587521|NCT01491672|7431637|FG001|Overall Study|Withdrawal by Subject|7
4587522|NCT01491672|7431638|FG002|Overall Study|Withdrawal by Subject|0
4587523|NCT01491672|7431636|FG000|Overall Study|Adverse Event|8
4694655|NCT02610231|7606230|FG000|Overall Study|Adverse Event|20
4374648|NCT03529773|7150245|FG018|Overall Study|Randomized but not vaccinated|0
4374649|NCT03529773|7150246|FG019|Overall Study|Randomized but not vaccinated|0
4374650|NCT03529773|7150247|FG020|Overall Study|Randomized but not vaccinated|0
4374651|NCT03529773|7150248|FG021|Overall Study|Randomized but not vaccinated|0
4374652|NCT03529773|7150249|FG022|Overall Study|Randomized but not vaccinated|0
4374653|NCT03529773|7150250|FG023|Overall Study|Randomized but not vaccinated|0
4374654|NCT03529773|7150251|FG024|Overall Study|Randomized but not vaccinated|0
4374655|NCT03529773|7150252|FG025|Overall Study|Randomized but not vaccinated|0
4374656|NCT03529773|7150253|FG026|Overall Study|Randomized but not vaccinated|0
4374657|NCT03529773|7150254|FG027|Overall Study|Randomized but not vaccinated|1
4694656|NCT02610231|7606230|FG000|Overall Study|Death|5
4694657|NCT02610231|7606230|FG000|Overall Study|Surgery|2
4694658|NCT02610231|7606230|FG000|Overall Study|Physician Decision|1
4694659|NCT02610231|7606230|FG000|Overall Study|Non Compliance|2
4694660|NCT02610231|7606230|FG000|Overall Study|Other|3
4694661|NCT02610725|7606246|FG000|Overall Study|Lost to Follow-up|197
4694662|NCT02610725|7606246|FG000|Overall Study|self-reported contraindication|9
4694663|NCT02610777|7606252|FG000|Overall Study|Ongoing in Follow-up|14
4694664|NCT02610777|7606253|FG001|Overall Study|Ongoing in Follow-up|12
4694665|NCT02610777|7606252|FG000|Overall Study|Withdrawal by Subject|1
4694666|NCT02610777|7606253|FG001|Overall Study|Withdrawal by Subject|2
4694667|NCT02610777|7606252|FG000|Overall Study|Other|0
4694668|NCT02610777|7606253|FG001|Overall Study|Other|1
4694669|NCT02610777|7606252|FG000|Overall Study|Ongoing on Treatment|6
4374658|NCT03529773|7150255|FG028|Overall Study|Randomized but not vaccinated|0
4374659|NCT03529773|7150256|FG029|Overall Study|Randomized but not vaccinated|0
4374660|NCT03529773|7150257|FG030|Overall Study|Randomized but not vaccinated|0
4374661|NCT03529773|7150258|FG031|Overall Study|Randomized but not vaccinated|0
4374662|NCT03529773|7150259|FG032|Overall Study|Randomized but not vaccinated|0
4374663|NCT03529773|7150260|FG033|Overall Study|Randomized but not vaccinated|0
4374664|NCT03529773|7150261|FG034|Overall Study|Randomized but not vaccinated|0
4374665|NCT03529773|7150262|FG035|Overall Study|Randomized but not vaccinated|0
4374666|NCT03529773|7150263|FG036|Overall Study|Randomized but not vaccinated|0
4374667|NCT03529773|7150264|FG037|Overall Study|Randomized but not vaccinated|0
4374668|NCT03529773|7150265|FG038|Overall Study|Randomized but not vaccinated|0
4374669|NCT03529773|7150266|FG039|Overall Study|Randomized but not vaccinated|0
4374670|NCT03502070|7150369|FG000|Overall Study|Withdrawal by Subject|1
4374671|NCT03502070|7150369|FG000|Overall Study|Screen Failure|1
4374672|NCT03485911|7150376|FG000|Overall Study|Withdrawal by Subject|0
4587524|NCT01491672|7431637|FG001|Overall Study|Adverse Event|10
4587525|NCT01491672|7431638|FG002|Overall Study|Adverse Event|4
4694670|NCT02610777|7606253|FG001|Overall Study|Ongoing on Treatment|7
4694671|NCT02610816|7606261|FG000|Phase 1|Withdrawal by Subject|2
4694672|NCT02610816|7606262|FG001|Phase 1|Withdrawal by Subject|6
4694673|NCT02610816|7606263|FG002|Phase 1|Withdrawal by Subject|0
4374673|NCT03485911|7150377|FG001|Overall Study|Withdrawal by Subject|2
4374674|NCT03485911|7150378|FG002|Overall Study|Withdrawal by Subject|2
4374675|NCT03485911|7150376|FG000|Overall Study|Adverse Event|1
4374676|NCT03485911|7150377|FG001|Overall Study|Adverse Event|0
4374677|NCT03485911|7150378|FG002|Overall Study|Adverse Event|1
4374678|NCT03485911|7150376|FG000|Overall Study|High frequency of HAE attacks|0
4374679|NCT03485911|7150377|FG001|Overall Study|High frequency of HAE attacks|0
4374680|NCT03485911|7150378|FG002|Overall Study|High frequency of HAE attacks|1
4374681|NCT03403634|7150386|FG000|Overall Study|Disease progression|3
4374682|NCT03403634|7150386|FG000|Overall Study|Did not meet eligibility criteria|4
4374683|NCT03382041|7150392|FG000|Overall Study|Consent Form Lost|2
4374684|NCT03382041|7150393|FG001|Overall Study|Consent Form Lost|1
4374685|NCT03382041|7150392|FG000|Overall Study|Withdrawal by Subject|1
4374686|NCT03382041|7150393|FG001|Overall Study|Withdrawal by Subject|4
4374687|NCT03382041|7150392|FG000|Overall Study|Lost to Follow-up|1
4374688|NCT03382041|7150393|FG001|Overall Study|Lost to Follow-up|4
4374689|NCT03332095|7150401|FG000|Overall Study|Lost to Follow-up|1
4374690|NCT03332095|7150402|FG001|Overall Study|Lost to Follow-up|0
4374691|NCT03332095|7150401|FG000|Overall Study|Pregnancy|0
4374692|NCT03332095|7150402|FG001|Overall Study|Pregnancy|1
4374693|NCT03201419|7150417|FG000|Overall Study|Adverse Event|3
4374694|NCT03201419|7150418|FG001|Overall Study|Adverse Event|1
4374695|NCT03201419|7150419|FG002|Overall Study|Adverse Event|0
4374696|NCT03201419|7150420|FG003|Overall Study|Adverse Event|0
4374697|NCT03201419|7150421|FG004|Overall Study|Adverse Event|1
4374698|NCT03201419|7150422|FG005|Overall Study|Adverse Event|1
4694674|NCT02610816|7606264|FG003|Phase 1|Withdrawal by Subject|0
4694675|NCT02610816|7606261|FG000|Phase 1|Lost to Follow-up|2
4694676|NCT02610816|7606262|FG001|Phase 1|Lost to Follow-up|1
4694677|NCT02610816|7606263|FG002|Phase 1|Lost to Follow-up|0
4694678|NCT02610816|7606264|FG003|Phase 1|Lost to Follow-up|0
4694679|NCT02610816|7606261|FG000|Phase 1|Physician Decision|0
4694680|NCT02610816|7606262|FG001|Phase 1|Physician Decision|1
4694681|NCT02610816|7606263|FG002|Phase 1|Physician Decision|0
4694682|NCT02610816|7606264|FG003|Phase 1|Physician Decision|0
4694683|NCT02610816|7606261|FG000|Phase 2|Withdrawal by Subject|0
4694684|NCT02610816|7606262|FG001|Phase 2|Withdrawal by Subject|0
4694685|NCT02610816|7606263|FG002|Phase 2|Withdrawal by Subject|9
4694686|NCT02610816|7606264|FG003|Phase 2|Withdrawal by Subject|3
4694687|NCT02610816|7606261|FG000|Phase 2|Lost to Follow-up|0
4694688|NCT02610816|7606262|FG001|Phase 2|Lost to Follow-up|0
4694689|NCT02610816|7606263|FG002|Phase 2|Lost to Follow-up|2
4694690|NCT02610816|7606264|FG003|Phase 2|Lost to Follow-up|0
4694691|NCT02610816|7606261|FG000|Phase 2|Physician Decision|0
4694692|NCT02610816|7606262|FG001|Phase 2|Physician Decision|0
4694693|NCT02610816|7606263|FG002|Phase 2|Physician Decision|0
4694694|NCT02610816|7606264|FG003|Phase 2|Physician Decision|2
4694695|NCT02610816|7606261|FG000|Phase 2|Pregnancy|0
4694696|NCT02610816|7606262|FG001|Phase 2|Pregnancy|0
4694697|NCT02610816|7606263|FG002|Phase 2|Pregnancy|0
4694698|NCT02610816|7606264|FG003|Phase 2|Pregnancy|1
4694699|NCT02610842|7606274|FG000|Overall Study|Lost to Follow-up|5
4694700|NCT02611362|7606330|FG000|Overall Study|Withdrawal by Subject|7
4694701|NCT02611362|7606331|FG001|Overall Study|Withdrawal by Subject|2
4694702|NCT02611362|7606330|FG000|Overall Study|Lost to Follow-up|2
4694703|NCT02611362|7606331|FG001|Overall Study|Lost to Follow-up|4
4694704|NCT02611479|7606338|FG000|Baseline Enrollment|Exited study|13
4694705|NCT02611479|7606338|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2
4694706|NCT02611479|7606338|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18
4694707|NCT02611479|7606338|FG000|Data Cleaning|No baseline function or pain metrics|2
4694708|NCT02611752|7606344|FG000|Overall Study|Adverse Event|0
4374699|NCT03201419|7150423|FG006|Overall Study|Adverse Event|5
4374700|NCT03201419|7150424|FG007|Overall Study|Adverse Event|0
4374701|NCT03201419|7150425|FG008|Overall Study|Adverse Event|0
4374702|NCT03201419|7150417|FG000|Overall Study|Lost to Follow-up|1
4374703|NCT03201419|7150418|FG001|Overall Study|Lost to Follow-up|0
4374704|NCT03201419|7150419|FG002|Overall Study|Lost to Follow-up|0
4374705|NCT03201419|7150420|FG003|Overall Study|Lost to Follow-up|0
4374706|NCT03201419|7150421|FG004|Overall Study|Lost to Follow-up|0
4374707|NCT03201419|7150422|FG005|Overall Study|Lost to Follow-up|0
4374708|NCT03201419|7150423|FG006|Overall Study|Lost to Follow-up|0
4374709|NCT03201419|7150424|FG007|Overall Study|Lost to Follow-up|0
4374710|NCT03201419|7150425|FG008|Overall Study|Lost to Follow-up|0
4374711|NCT03201419|7150417|FG000|Overall Study|Protocol Deviation|0
4374712|NCT03201419|7150418|FG001|Overall Study|Protocol Deviation|0
4374713|NCT03201419|7150419|FG002|Overall Study|Protocol Deviation|0
4374714|NCT03201419|7150420|FG003|Overall Study|Protocol Deviation|0
4374715|NCT03201419|7150421|FG004|Overall Study|Protocol Deviation|0
4694709|NCT02611752|7606345|FG001|Overall Study|Adverse Event|1
4694710|NCT02611778|7606375|FG000|Overall Study|Withdrawal by Subject|2
4694711|NCT02611778|7606376|FG001|Overall Study|Withdrawal by Subject|8
4374716|NCT03201419|7150422|FG005|Overall Study|Protocol Deviation|0
4374717|NCT03201419|7150423|FG006|Overall Study|Protocol Deviation|1
4374718|NCT03201419|7150424|FG007|Overall Study|Protocol Deviation|0
4694712|NCT02611778|7606375|FG000|Overall Study|Adverse Event|1
4694713|NCT02611778|7606376|FG001|Overall Study|Adverse Event|2
4694714|NCT02611778|7606375|FG000|Overall Study|Death|2
4694715|NCT02611778|7606376|FG001|Overall Study|Death|1
4374719|NCT03201419|7150425|FG008|Overall Study|Protocol Deviation|0
4374720|NCT03201419|7150417|FG000|Overall Study|Withdrawal by Subject|4
4374721|NCT03201419|7150418|FG001|Overall Study|Withdrawal by Subject|2
4374722|NCT03201419|7150419|FG002|Overall Study|Withdrawal by Subject|1
4374723|NCT03201419|7150420|FG003|Overall Study|Withdrawal by Subject|0
4374724|NCT03201419|7150421|FG004|Overall Study|Withdrawal by Subject|0
4374725|NCT03201419|7150422|FG005|Overall Study|Withdrawal by Subject|0
4374726|NCT03201419|7150423|FG006|Overall Study|Withdrawal by Subject|0
4374727|NCT03201419|7150424|FG007|Overall Study|Withdrawal by Subject|1
4374728|NCT03201419|7150425|FG008|Overall Study|Withdrawal by Subject|2
4374729|NCT03201419|7150417|FG000|Overall Study|Other|0
4374730|NCT03201419|7150418|FG001|Overall Study|Other|0
4374731|NCT03201419|7150419|FG002|Overall Study|Other|1
4374732|NCT03201419|7150420|FG003|Overall Study|Other|0
4374733|NCT03201419|7150421|FG004|Overall Study|Other|0
4374734|NCT03201419|7150422|FG005|Overall Study|Other|0
4374735|NCT03201419|7150423|FG006|Overall Study|Other|0
4374736|NCT03201419|7150424|FG007|Overall Study|Other|0
4374737|NCT03201419|7150425|FG008|Overall Study|Other|0
4374738|NCT03197766|7150461|FG000|Overall Study|Withdrawal by Subject|2
4374739|NCT03197766|7150462|FG001|Overall Study|Withdrawal by Subject|0
4465444|NCT00610363|7256752|FG000|Overall Study|Non-compliance with protocol|0
4465445|NCT00610363|7256753|FG001|Overall Study|Non-compliance with protocol|1
4465446|NCT00610363|7256752|FG000|Overall Study|Adverse Event|3
4465447|NCT00610363|7256753|FG001|Overall Study|Adverse Event|1
4465448|NCT00610363|7256752|FG000|Overall Study|Lack of Efficacy|2
4465449|NCT00610363|7256753|FG001|Overall Study|Lack of Efficacy|0
4465450|NCT00610363|7256752|FG000|Overall Study|Lost to Follow-up|4
4465451|NCT00610363|7256753|FG001|Overall Study|Lost to Follow-up|0
4465452|NCT00610363|7256752|FG000|Overall Study|Withdrawal by Subject|1
4465453|NCT00610363|7256753|FG001|Overall Study|Withdrawal by Subject|0
4465454|NCT00610363|7256752|FG000|Overall Study|Other than specified above|1
4465455|NCT00610363|7256753|FG001|Overall Study|Other than specified above|1
4465456|NCT00610441|7256777|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1
4465457|NCT00610441|7256778|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1
4465458|NCT00610441|7256779|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4
4465459|NCT00610441|7256780|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1
4465460|NCT00610441|7256777|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
4465461|NCT00610441|7256778|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
4465462|NCT00610441|7256779|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1
4465463|NCT00610441|7256780|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
4465464|NCT00610441|7256777|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
4465465|NCT00610441|7256778|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
4465466|NCT00610441|7256779|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
4465467|NCT00610441|7256780|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0
4465468|NCT00610441|7256777|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
4465469|NCT00610441|7256778|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0
4465470|NCT00610441|7256779|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
4465471|NCT00610441|7256780|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
4465472|NCT00610441|7256777|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0
4465473|NCT00610441|7256778|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0
4465474|NCT00610441|7256779|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2
4465475|NCT00610441|7256780|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0
4465476|NCT00610441|7256777|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
4465477|NCT00610441|7256778|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1
4465478|NCT00610441|7256779|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
4465479|NCT00610441|7256780|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
4465480|NCT00610441|7256777|FG000|Treatment Period 2 - 3 Weeks|Other|1
4465481|NCT00610441|7256778|FG001|Treatment Period 2 - 3 Weeks|Other|1
4465482|NCT00610441|7256779|FG002|Treatment Period 2 - 3 Weeks|Other|0
4465483|NCT00610441|7256780|FG003|Treatment Period 2 - 3 Weeks|Other|1
4465484|NCT00610441|7256777|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0
4465485|NCT00610441|7256778|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0
4465486|NCT00610441|7256779|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0
4465487|NCT00610441|7256780|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1
4465488|NCT00610441|7256777|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1
4465489|NCT00610441|7256778|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
4465490|NCT00610441|7256779|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
4465491|NCT00610441|7256780|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
4465492|NCT00610649|7256812|FG000|Overall Study|Adverse Event|1
4465493|NCT00610649|7256813|FG001|Overall Study|Adverse Event|0
4465494|NCT00610649|7256814|FG002|Overall Study|Adverse Event|0
4465495|NCT00610649|7256815|FG003|Overall Study|Adverse Event|0
4465496|NCT00610649|7256816|FG004|Overall Study|Adverse Event|0
4465497|NCT00610649|7256817|FG005|Overall Study|Adverse Event|0
4465498|NCT00610649|7256818|FG006|Overall Study|Adverse Event|0
4465499|NCT00610649|7256819|FG007|Overall Study|Adverse Event|0
4465500|NCT00610649|7256820|FG008|Overall Study|Adverse Event|0
4465501|NCT00610649|7256821|FG009|Overall Study|Adverse Event|0
4465502|NCT00610649|7256822|FG010|Overall Study|Adverse Event|1
4374740|NCT04516759|7150480|FG000|Overall Study|Withdrawal by Subject|1
4374741|NCT04516759|7150481|FG001|Overall Study|Withdrawal by Subject|1
4374742|NCT04516759|7150480|FG000|Overall Study|Other|0
4374743|NCT04516759|7150481|FG001|Overall Study|Other|1
4374744|NCT03409276|7150510|FG000|Overall Study|Withdrawal by Subject|0
4374745|NCT03409276|7150511|FG001|Overall Study|Withdrawal by Subject|0
4374746|NCT03409276|7150512|FG002|Overall Study|Withdrawal by Subject|0
4374747|NCT03409276|7150513|FG003|Overall Study|Withdrawal by Subject|0
4374748|NCT03409276|7150514|FG004|Overall Study|Withdrawal by Subject|1
4374749|NCT03409276|7150510|FG000|Overall Study|Lost to Follow-up|0
4374750|NCT03409276|7150511|FG001|Overall Study|Lost to Follow-up|0
4374751|NCT03409276|7150512|FG002|Overall Study|Lost to Follow-up|0
4374752|NCT03409276|7150513|FG003|Overall Study|Lost to Follow-up|2
4374753|NCT03409276|7150514|FG004|Overall Study|Lost to Follow-up|2
4374754|NCT03312907|7150542|FG000|Overall Study|Adverse Event|1
4374755|NCT03312907|7150543|FG001|Overall Study|Adverse Event|6
4374756|NCT03312907|7150544|FG002|Overall Study|Adverse Event|1
4374757|NCT03312907|7150542|FG000|Overall Study|Protocol Violation|2
4374758|NCT03312907|7150543|FG001|Overall Study|Protocol Violation|3
4374759|NCT03312907|7150544|FG002|Overall Study|Protocol Violation|4
4374760|NCT03312907|7150542|FG000|Overall Study|Lost to Follow-up|2
4374761|NCT03312907|7150543|FG001|Overall Study|Lost to Follow-up|3
4374762|NCT03312907|7150544|FG002|Overall Study|Lost to Follow-up|2
4374763|NCT03312907|7150542|FG000|Overall Study|Physician Decision|3
4374764|NCT03312907|7150543|FG001|Overall Study|Physician Decision|4
4374765|NCT03312907|7150544|FG002|Overall Study|Physician Decision|2
4374766|NCT03312907|7150542|FG000|Overall Study|Withdrawal by Subject|9
4374767|NCT03312907|7150543|FG001|Overall Study|Withdrawal by Subject|14
4374768|NCT03312907|7150544|FG002|Overall Study|Withdrawal by Subject|10
4374769|NCT03148756|7150554|FG000|Overall Study|Study Terminated|0
4374770|NCT03148756|7150555|FG001|Overall Study|Study Terminated|1
4374771|NCT03079102|7150563|FG000|Overall Study|Physician Decision|0
4374772|NCT03079102|7150564|FG001|Overall Study|Physician Decision|1
4374773|NCT03064126|7150574|FG000|Overall Study|Death|6
4374774|NCT03064126|7150575|FG001|Overall Study|Death|2
4374775|NCT03064126|7150576|FG002|Overall Study|Death|2
4374776|NCT03064126|7150577|FG003|Overall Study|Death|1
4374777|NCT03064126|7150574|FG000|Overall Study|Investigator Discretion|1
4374778|NCT03064126|7150575|FG001|Overall Study|Investigator Discretion|0
4374779|NCT03064126|7150576|FG002|Overall Study|Investigator Discretion|0
4374780|NCT03064126|7150577|FG003|Overall Study|Investigator Discretion|0
4374781|NCT03064126|7150574|FG000|Overall Study|Withdrawal by Subject|7
4374782|NCT03064126|7150575|FG001|Overall Study|Withdrawal by Subject|4
4374783|NCT03064126|7150576|FG002|Overall Study|Withdrawal by Subject|0
4374784|NCT03064126|7150577|FG003|Overall Study|Withdrawal by Subject|0
4374785|NCT03064126|7150574|FG000|Overall Study|Subject moved|1
4374786|NCT03064126|7150575|FG001|Overall Study|Subject moved|0
4374787|NCT03064126|7150576|FG002|Overall Study|Subject moved|0
4374788|NCT03064126|7150577|FG003|Overall Study|Subject moved|0
4374789|NCT03064126|7150574|FG000|Overall Study|Protocol Violation|11
4374790|NCT03064126|7150575|FG001|Overall Study|Protocol Violation|1
4374791|NCT03064126|7150576|FG002|Overall Study|Protocol Violation|1
4374792|NCT03064126|7150577|FG003|Overall Study|Protocol Violation|0
4374793|NCT02944513|7150590|FG000|Overall Study|Withdrawal by Subject|4
4374794|NCT02944513|7150591|FG001|Overall Study|Withdrawal by Subject|1
4374795|NCT02734433|7150608|FG000|Overall Study|Disease progression|1
4374796|NCT02734433|7150609|FG001|Overall Study|Disease progression|5
4374797|NCT02734433|7150608|FG000|Overall Study|Clinical progression|0
4374798|NCT02734433|7150609|FG001|Overall Study|Clinical progression|1
4374799|NCT02734433|7150608|FG000|Overall Study|Withdrawal by Subject|1
4374800|NCT02734433|7150609|FG001|Overall Study|Withdrawal by Subject|2
4374801|NCT02386839|7150621|FG000|Overall Study|Death|1
4374802|NCT02386839|7150622|FG001|Overall Study|Death|0
4374803|NCT02386839|7150621|FG000|Overall Study|Withdrawal by Subject|9
4374804|NCT02386839|7150622|FG001|Overall Study|Withdrawal by Subject|10
4374805|NCT02386839|7150621|FG000|Overall Study|Lost to Follow-up|4
4374806|NCT02386839|7150622|FG001|Overall Study|Lost to Follow-up|4
4374807|NCT02386839|7150621|FG000|Overall Study|Other (Site Terminated by Sponsor)|1
4374808|NCT02386839|7150622|FG001|Overall Study|Other (Site Terminated by Sponsor)|0
4374809|NCT02386839|7150621|FG000|Overall Study|Other (Covid 19 Pandemic)|0
4374810|NCT02386839|7150622|FG001|Overall Study|Other (Covid 19 Pandemic)|1
4374811|NCT02386839|7150621|FG000|Overall Study|Other (unspecified)|1
4374812|NCT02386839|7150622|FG001|Overall Study|Other (unspecified)|0
4374813|NCT02120469|7150649|FG000|Overall Study|HER-2/neu-amplified|1
4374814|NCT02120469|7150650|FG001|Overall Study|HER-2/neu-amplified|0
4374815|NCT02120469|7150651|FG002|Overall Study|HER-2/neu-amplified|1
4374816|NCT02091960|7150661|FG000|Overall Study|Death|7
4374817|NCT02091960|7150661|FG000|Overall Study|Withdrawal by Subject|1
4374818|NCT02091960|7150661|FG000|Overall Study|Miscellaneous Reasons|31
4374819|NCT02091960|7150661|FG000|Overall Study|On Study at Data Cut-off|12
4374820|NCT02048722|7150665|FG000|2 Cycles of Treatment|Adverse Event|2
4374821|NCT02048722|7150665|FG000|2 Cycles of Treatment|Withdrawal by Subject|4
4374822|NCT02048722|7150665|FG000|2 Cycles of Treatment|Progressive Disease|2
4374823|NCT02048722|7150665|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10
4374824|NCT02048722|7150665|FG000|Follow up 5 Years or Cut of Timepoint|Death|24
4374825|NCT02048722|7150665|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3
4587526|NCT01491672|7431636|FG000|Overall Study|Disease progression|42
4587527|NCT01491672|7431637|FG001|Overall Study|Disease progression|34
4587528|NCT01491672|7431638|FG002|Overall Study|Disease progression|6
4587529|NCT01491672|7431636|FG000|Overall Study|Protocol deviation|0
4587530|NCT01491672|7431637|FG001|Overall Study|Protocol deviation|1
4587531|NCT01491672|7431638|FG002|Overall Study|Protocol deviation|0
4587532|NCT01491672|7431636|FG000|Overall Study|Death|0
4587533|NCT01491672|7431637|FG001|Overall Study|Death|4
4587534|NCT01491672|7431638|FG002|Overall Study|Death|0
4587535|NCT01491737|7431650|FG000|Overall Study|Withdrawal by Subject|20
4587536|NCT01491737|7431651|FG001|Overall Study|Withdrawal by Subject|17
4587537|NCT01491737|7431650|FG000|Overall Study|Lost to Follow-up|2
4587538|NCT01491737|7431651|FG001|Overall Study|Lost to Follow-up|10
4587539|NCT01491737|7431650|FG000|Overall Study|Death|63
4587540|NCT01491737|7431651|FG001|Overall Study|Death|57
4587541|NCT01491737|7431650|FG000|Overall Study|Study Termination by Sponsor|36
4587542|NCT01491737|7431651|FG001|Overall Study|Study Termination by Sponsor|36
4587543|NCT01491737|7431650|FG000|Overall Study|Reason Not Specified|8
4587544|NCT01491737|7431651|FG001|Overall Study|Reason Not Specified|9
4587545|NCT01491802|7431657|FG000|Overall Study|Adverse Event|1
4587546|NCT01491802|7431658|FG001|Overall Study|Adverse Event|1
4587547|NCT01491802|7431657|FG000|Overall Study|Withdrawal by Subject|0
4587548|NCT01491802|7431658|FG001|Overall Study|Withdrawal by Subject|1
4587549|NCT01491841|7431665|FG000|Overall Study|Screen Failure|10
4374826|NCT01896102|7150669|FG000|Overall Study|Death|1
4374827|NCT01896102|7150669|FG000|Overall Study|Participant to receive allogenic transplant|2
4587550|NCT01491841|7431665|FG000|Overall Study|Withdrawal by Subject|1
4587551|NCT01491854|7431677|FG000|Overall Study|mainly due to premature termination|93
4587552|NCT01491854|7431677|FG000|Overall Study|Death|1
4587553|NCT01491854|7431677|FG000|Overall Study|Withdrawal by Subject|3
4587554|NCT01491854|7431677|FG000|Overall Study|Lost to Follow-up|33
4587555|NCT01491919|7431684|FG000|Overall Study|Insufficient PK sampling|1
4587556|NCT01491919|7431685|FG001|Overall Study|Insufficient PK sampling|2
4587557|NCT01491919|7431686|FG002|Overall Study|Insufficient PK sampling|1
4587558|NCT01491945|7431696|FG000|Overall Study|Death|30
4587559|NCT01491945|7431696|FG000|Overall Study|Withdrwan/LTF|16
4587560|NCT01491945|7431696|FG000|Overall Study|Conversion|4
4587561|NCT01491945|7431696|FG000|Overall Study|Missed Visit|1
4587562|NCT01492088|7431721|FG000|Overall Study|Withdrawal by Patient|0
4587563|NCT01492088|7431722|FG001|Overall Study|Withdrawal by Patient|2
4587564|NCT01492088|7431723|FG002|Overall Study|Withdrawal by Patient|0
4587565|NCT01492088|7431721|FG000|Overall Study|Death|1
4587566|NCT01492088|7431722|FG001|Overall Study|Death|6
4587567|NCT01492088|7431723|FG002|Overall Study|Death|2
4587568|NCT01492088|7431721|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2
4587569|NCT01492088|7431722|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0
4374828|NCT01885078|7150682|FG000|Treatment Period|Adverse Event|52
4374829|NCT01885078|7150683|FG001|Treatment Period|Adverse Event|136
4374830|NCT01885078|7150684|FG002|Treatment Period|Adverse Event|30
4374831|NCT01885078|7150685|FG003|Treatment Period|Adverse Event|73
4374832|NCT01885078|7150686|FG004|Treatment Period|Adverse Event|17
4374833|NCT01885078|7150687|FG005|Treatment Period|Adverse Event|72
4374834|NCT01885078|7150688|FG006|Treatment Period|Adverse Event|24
4374835|NCT01885078|7150689|FG007|Treatment Period|Adverse Event|5
4374836|NCT01885078|7150690|FG008|Treatment Period|Adverse Event|0
4374837|NCT01885078|7150691|FG009|Treatment Period|Adverse Event|0
4374838|NCT01885078|7150682|FG000|Treatment Period|Death|13
4374839|NCT01885078|7150683|FG001|Treatment Period|Death|33
4374840|NCT01885078|7150684|FG002|Treatment Period|Death|5
4374841|NCT01885078|7150685|FG003|Treatment Period|Death|9
4374842|NCT01885078|7150686|FG004|Treatment Period|Death|2
4374843|NCT01885078|7150687|FG005|Treatment Period|Death|10
4374844|NCT01885078|7150688|FG006|Treatment Period|Death|3
4374845|NCT01885078|7150689|FG007|Treatment Period|Death|2
4374846|NCT01885078|7150690|FG008|Treatment Period|Death|0
4374847|NCT01885078|7150691|FG009|Treatment Period|Death|0
4374848|NCT01885078|7150682|FG000|Treatment Period|Lack of Efficacy|12
4374849|NCT01885078|7150683|FG001|Treatment Period|Lack of Efficacy|33
4374850|NCT01885078|7150684|FG002|Treatment Period|Lack of Efficacy|10
4374851|NCT01885078|7150685|FG003|Treatment Period|Lack of Efficacy|23
4374852|NCT01885078|7150686|FG004|Treatment Period|Lack of Efficacy|24
4465503|NCT00610649|7256812|FG000|Overall Study|Family Emergency|0
4587570|NCT01492088|7431723|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1
4587571|NCT01492088|7431721|FG000|Overall Study|Alive at Last Follow-up|0
4587572|NCT01492088|7431722|FG001|Overall Study|Alive at Last Follow-up|6
4587573|NCT01492088|7431723|FG002|Overall Study|Alive at Last Follow-up|11
4374853|NCT01885078|7150687|FG005|Treatment Period|Lack of Efficacy|58
4374854|NCT01885078|7150688|FG006|Treatment Period|Lack of Efficacy|9
4374855|NCT01885078|7150689|FG007|Treatment Period|Lack of Efficacy|5
4374856|NCT01885078|7150690|FG008|Treatment Period|Lack of Efficacy|0
4374857|NCT01885078|7150691|FG009|Treatment Period|Lack of Efficacy|0
4374858|NCT01885078|7150682|FG000|Treatment Period|Lost to Follow-up|16
4374859|NCT01885078|7150683|FG001|Treatment Period|Lost to Follow-up|19
4374860|NCT01885078|7150684|FG002|Treatment Period|Lost to Follow-up|7
4587574|NCT01492101|7431736|FG000|Overall Study|Death|323
4587575|NCT01492101|7431737|FG001|Overall Study|Death|322
4374861|NCT01885078|7150685|FG003|Treatment Period|Lost to Follow-up|9
4374862|NCT01885078|7150686|FG004|Treatment Period|Lost to Follow-up|2
4374863|NCT01885078|7150687|FG005|Treatment Period|Lost to Follow-up|8
4374864|NCT01885078|7150688|FG006|Treatment Period|Lost to Follow-up|2
4374865|NCT01885078|7150689|FG007|Treatment Period|Lost to Follow-up|0
4374866|NCT01885078|7150690|FG008|Treatment Period|Lost to Follow-up|0
4374867|NCT01885078|7150691|FG009|Treatment Period|Lost to Follow-up|0
4374868|NCT01885078|7150682|FG000|Treatment Period|Physician Decision|19
4374869|NCT01885078|7150683|FG001|Treatment Period|Physician Decision|21
4374870|NCT01885078|7150684|FG002|Treatment Period|Physician Decision|5
4374871|NCT01885078|7150685|FG003|Treatment Period|Physician Decision|12
4374872|NCT01885078|7150686|FG004|Treatment Period|Physician Decision|9
4374873|NCT01885078|7150687|FG005|Treatment Period|Physician Decision|24
4374874|NCT01885078|7150688|FG006|Treatment Period|Physician Decision|4
4374875|NCT01885078|7150689|FG007|Treatment Period|Physician Decision|3
4374876|NCT01885078|7150690|FG008|Treatment Period|Physician Decision|0
4374877|NCT01885078|7150691|FG009|Treatment Period|Physician Decision|0
4374878|NCT01885078|7150682|FG000|Treatment Period|Protocol Violation|3
4374879|NCT01885078|7150683|FG001|Treatment Period|Protocol Violation|5
4374880|NCT01885078|7150684|FG002|Treatment Period|Protocol Violation|0
4374881|NCT01885078|7150685|FG003|Treatment Period|Protocol Violation|3
4374882|NCT01885078|7150686|FG004|Treatment Period|Protocol Violation|1
4374883|NCT01885078|7150687|FG005|Treatment Period|Protocol Violation|6
4374884|NCT01885078|7150688|FG006|Treatment Period|Protocol Violation|0
4374885|NCT01885078|7150689|FG007|Treatment Period|Protocol Violation|0
4374886|NCT01885078|7150690|FG008|Treatment Period|Protocol Violation|0
4374887|NCT01885078|7150691|FG009|Treatment Period|Protocol Violation|0
4374888|NCT01885078|7150682|FG000|Treatment Period|Sponsor Decision|245
4374889|NCT01885078|7150683|FG001|Treatment Period|Sponsor Decision|648
4374890|NCT01885078|7150684|FG002|Treatment Period|Sponsor Decision|49
4374891|NCT01885078|7150685|FG003|Treatment Period|Sponsor Decision|90
4374892|NCT01885078|7150686|FG004|Treatment Period|Sponsor Decision|20
4374893|NCT01885078|7150687|FG005|Treatment Period|Sponsor Decision|38
4374894|NCT01885078|7150688|FG006|Treatment Period|Sponsor Decision|162
4374895|NCT01885078|7150689|FG007|Treatment Period|Sponsor Decision|3
4374896|NCT01885078|7150690|FG008|Treatment Period|Sponsor Decision|0
4374897|NCT01885078|7150691|FG009|Treatment Period|Sponsor Decision|0
4374898|NCT01885078|7150682|FG000|Treatment Period|Withdrawal by Subject|72
4374899|NCT01885078|7150683|FG001|Treatment Period|Withdrawal by Subject|132
4374900|NCT01885078|7150684|FG002|Treatment Period|Withdrawal by Subject|25
4374901|NCT01885078|7150685|FG003|Treatment Period|Withdrawal by Subject|63
4374902|NCT01885078|7150686|FG004|Treatment Period|Withdrawal by Subject|15
4374903|NCT01885078|7150687|FG005|Treatment Period|Withdrawal by Subject|34
4374904|NCT01885078|7150688|FG006|Treatment Period|Withdrawal by Subject|17
4374905|NCT01885078|7150689|FG007|Treatment Period|Withdrawal by Subject|10
4374906|NCT01885078|7150690|FG008|Treatment Period|Withdrawal by Subject|0
4374907|NCT01885078|7150691|FG009|Treatment Period|Withdrawal by Subject|0
4374908|NCT01885078|7150682|FG000|Treatment Period|Other|0
4374909|NCT01885078|7150683|FG001|Treatment Period|Other|0
4374910|NCT01885078|7150684|FG002|Treatment Period|Other|0
4374911|NCT01885078|7150685|FG003|Treatment Period|Other|1
4374912|NCT01885078|7150686|FG004|Treatment Period|Other|0
4465504|NCT00610649|7256813|FG001|Overall Study|Family Emergency|1
4465505|NCT00610649|7256814|FG002|Overall Study|Family Emergency|0
4465506|NCT00610649|7256815|FG003|Overall Study|Family Emergency|0
4465507|NCT00610649|7256816|FG004|Overall Study|Family Emergency|0
4465508|NCT00610649|7256817|FG005|Overall Study|Family Emergency|0
4465509|NCT00610649|7256818|FG006|Overall Study|Family Emergency|0
4465510|NCT00610649|7256819|FG007|Overall Study|Family Emergency|0
4465511|NCT00610649|7256820|FG008|Overall Study|Family Emergency|0
4465512|NCT00610649|7256821|FG009|Overall Study|Family Emergency|0
4465513|NCT00610649|7256822|FG010|Overall Study|Family Emergency|0
4465514|NCT00610649|7256812|FG000|Overall Study|Withdrawal by Subject|0
4465515|NCT00610649|7256813|FG001|Overall Study|Withdrawal by Subject|0
4465516|NCT00610649|7256814|FG002|Overall Study|Withdrawal by Subject|0
4465517|NCT00610649|7256815|FG003|Overall Study|Withdrawal by Subject|0
4465518|NCT00610649|7256816|FG004|Overall Study|Withdrawal by Subject|0
4465519|NCT00610649|7256817|FG005|Overall Study|Withdrawal by Subject|0
4465520|NCT00610649|7256818|FG006|Overall Study|Withdrawal by Subject|0
4465521|NCT00610649|7256819|FG007|Overall Study|Withdrawal by Subject|0
4465522|NCT00610649|7256820|FG008|Overall Study|Withdrawal by Subject|0
4465523|NCT00610649|7256821|FG009|Overall Study|Withdrawal by Subject|1
4465524|NCT00610649|7256822|FG010|Overall Study|Withdrawal by Subject|0
4465525|NCT00610675|7256846|FG000|Overall Study|Untreated|4
4374913|NCT01885078|7150687|FG005|Treatment Period|Other|0
4374914|NCT01885078|7150688|FG006|Treatment Period|Other|0
4374915|NCT01885078|7150689|FG007|Treatment Period|Other|0
4374916|NCT01885078|7150690|FG008|Treatment Period|Other|0
4374917|NCT01885078|7150691|FG009|Treatment Period|Other|0
4374918|NCT01885078|7150682|FG000|Step-down Period|Sponsor Decision|0
4374919|NCT01885078|7150683|FG001|Step-down Period|Sponsor Decision|0
4374920|NCT01885078|7150684|FG002|Step-down Period|Sponsor Decision|0
4374921|NCT01885078|7150685|FG003|Step-down Period|Sponsor Decision|0
4374922|NCT01885078|7150686|FG004|Step-down Period|Sponsor Decision|0
4465526|NCT00610675|7256846|FG000|Overall Study|Adverse Event|67
4374923|NCT01885078|7150687|FG005|Step-down Period|Sponsor Decision|0
4374924|NCT01885078|7150688|FG006|Step-down Period|Sponsor Decision|0
4374925|NCT01885078|7150689|FG007|Step-down Period|Sponsor Decision|0
4374926|NCT01885078|7150690|FG008|Step-down Period|Sponsor Decision|1
4374927|NCT01885078|7150691|FG009|Step-down Period|Sponsor Decision|1
4374928|NCT01885078|7150682|FG000|Step-down Period|Adverse Event|0
4374929|NCT01885078|7150683|FG001|Step-down Period|Adverse Event|0
4374930|NCT01885078|7150684|FG002|Step-down Period|Adverse Event|0
4587576|NCT01492101|7431736|FG000|Overall Study|Withdrawal by Subject|14
4587577|NCT01492101|7431737|FG001|Overall Study|Withdrawal by Subject|18
4587578|NCT01492101|7431736|FG000|Overall Study|Lost to Follow-up|0
4587579|NCT01492101|7431737|FG001|Overall Study|Lost to Follow-up|2
4587580|NCT01492400|7431754|FG000|Overall Study|Miscellaneous Reasons|2
4587581|NCT01492400|7431755|FG001|Overall Study|Miscellaneous Reasons|3
4587582|NCT01492400|7431754|FG000|Overall Study|Personal Reasons|0
4374931|NCT01885078|7150685|FG003|Step-down Period|Adverse Event|0
4374932|NCT01885078|7150686|FG004|Step-down Period|Adverse Event|0
4374933|NCT01885078|7150687|FG005|Step-down Period|Adverse Event|0
4374934|NCT01885078|7150688|FG006|Step-down Period|Adverse Event|0
4374935|NCT01885078|7150689|FG007|Step-down Period|Adverse Event|0
4374936|NCT01885078|7150690|FG008|Step-down Period|Adverse Event|29
4374937|NCT01885078|7150691|FG009|Step-down Period|Adverse Event|38
4374938|NCT01885078|7150682|FG000|Step-down Period|Withdrawal by Subject|0
4374939|NCT01885078|7150683|FG001|Step-down Period|Withdrawal by Subject|0
4374940|NCT01885078|7150684|FG002|Step-down Period|Withdrawal by Subject|0
4374941|NCT01885078|7150685|FG003|Step-down Period|Withdrawal by Subject|0
4374942|NCT01885078|7150686|FG004|Step-down Period|Withdrawal by Subject|0
4374943|NCT01885078|7150687|FG005|Step-down Period|Withdrawal by Subject|0
4374944|NCT01885078|7150688|FG006|Step-down Period|Withdrawal by Subject|0
4374945|NCT01885078|7150689|FG007|Step-down Period|Withdrawal by Subject|0
4374946|NCT01885078|7150690|FG008|Step-down Period|Withdrawal by Subject|25
4374947|NCT01885078|7150691|FG009|Step-down Period|Withdrawal by Subject|15
4374948|NCT01885078|7150682|FG000|Step-down Period|Physician Decision|0
4374949|NCT01885078|7150683|FG001|Step-down Period|Physician Decision|0
4374950|NCT01885078|7150684|FG002|Step-down Period|Physician Decision|0
4374951|NCT01885078|7150685|FG003|Step-down Period|Physician Decision|0
4374952|NCT01885078|7150686|FG004|Step-down Period|Physician Decision|0
4374953|NCT01885078|7150687|FG005|Step-down Period|Physician Decision|0
4374954|NCT01885078|7150688|FG006|Step-down Period|Physician Decision|0
4374955|NCT01885078|7150689|FG007|Step-down Period|Physician Decision|0
4374956|NCT01885078|7150690|FG008|Step-down Period|Physician Decision|7
4374957|NCT01885078|7150691|FG009|Step-down Period|Physician Decision|2
4374958|NCT01885078|7150682|FG000|Step-down Period|Death|0
4374959|NCT01885078|7150683|FG001|Step-down Period|Death|0
4374960|NCT01885078|7150684|FG002|Step-down Period|Death|0
4374961|NCT01885078|7150685|FG003|Step-down Period|Death|0
4374962|NCT01885078|7150686|FG004|Step-down Period|Death|0
4374963|NCT01885078|7150687|FG005|Step-down Period|Death|0
4374964|NCT01885078|7150688|FG006|Step-down Period|Death|0
4374965|NCT01885078|7150689|FG007|Step-down Period|Death|0
4374966|NCT01885078|7150690|FG008|Step-down Period|Death|4
4374967|NCT01885078|7150691|FG009|Step-down Period|Death|3
4374968|NCT01885078|7150682|FG000|Step-down Period|Lost to Follow-up|0
4374969|NCT01885078|7150683|FG001|Step-down Period|Lost to Follow-up|0
4374970|NCT01885078|7150684|FG002|Step-down Period|Lost to Follow-up|0
4374971|NCT01885078|7150685|FG003|Step-down Period|Lost to Follow-up|0
4374972|NCT01885078|7150686|FG004|Step-down Period|Lost to Follow-up|0
4374973|NCT01885078|7150687|FG005|Step-down Period|Lost to Follow-up|0
4374974|NCT01885078|7150688|FG006|Step-down Period|Lost to Follow-up|0
4374975|NCT01885078|7150689|FG007|Step-down Period|Lost to Follow-up|0
4374976|NCT01885078|7150690|FG008|Step-down Period|Lost to Follow-up|1
4374977|NCT01885078|7150691|FG009|Step-down Period|Lost to Follow-up|1
4374978|NCT01885078|7150682|FG000|Step-down Period|Lack of Efficacy|0
4374979|NCT01885078|7150683|FG001|Step-down Period|Lack of Efficacy|0
4374980|NCT01885078|7150684|FG002|Step-down Period|Lack of Efficacy|0
4374981|NCT01885078|7150685|FG003|Step-down Period|Lack of Efficacy|0
4374982|NCT01885078|7150686|FG004|Step-down Period|Lack of Efficacy|0
4374983|NCT01885078|7150687|FG005|Step-down Period|Lack of Efficacy|0
4374984|NCT01885078|7150688|FG006|Step-down Period|Lack of Efficacy|0
4374985|NCT01885078|7150689|FG007|Step-down Period|Lack of Efficacy|0
4587583|NCT01492400|7431755|FG001|Overall Study|Personal Reasons|5
4587584|NCT01492400|7431754|FG000|Overall Study|Lost to Follow-up|3
4374986|NCT01885078|7150690|FG008|Step-down Period|Lack of Efficacy|1
4374987|NCT01885078|7150691|FG009|Step-down Period|Lack of Efficacy|0
4374988|NCT01885078|7150682|FG000|Step-down Period|Protocol Violation|0
4374989|NCT01885078|7150683|FG001|Step-down Period|Protocol Violation|0
4374990|NCT01885078|7150684|FG002|Step-down Period|Protocol Violation|0
4374991|NCT01885078|7150685|FG003|Step-down Period|Protocol Violation|0
4374992|NCT01885078|7150686|FG004|Step-down Period|Protocol Violation|0
4374993|NCT01885078|7150687|FG005|Step-down Period|Protocol Violation|0
4374994|NCT01885078|7150688|FG006|Step-down Period|Protocol Violation|0
4374995|NCT01885078|7150689|FG007|Step-down Period|Protocol Violation|0
4374996|NCT01885078|7150690|FG008|Step-down Period|Protocol Violation|1
4374997|NCT01885078|7150691|FG009|Step-down Period|Protocol Violation|1
4587585|NCT01492400|7431755|FG001|Overall Study|Lost to Follow-up|1
4374998|NCT01047683|7150715|FG000|Overall Study|Adverse Event|3
4374999|NCT01047683|7150716|FG001|Overall Study|Adverse Event|1
4375000|NCT01047683|7150717|FG002|Overall Study|Adverse Event|0
4375001|NCT01047683|7150715|FG000|Overall Study|Withdrew Consent|1
4375002|NCT01047683|7150716|FG001|Overall Study|Withdrew Consent|4
4375003|NCT01047683|7150717|FG002|Overall Study|Withdrew Consent|2
4375004|NCT01047683|7150715|FG000|Overall Study|Lost to Follow-up|0
4375005|NCT01047683|7150716|FG001|Overall Study|Lost to Follow-up|1
4375006|NCT01047683|7150717|FG002|Overall Study|Lost to Follow-up|0
4375007|NCT01047683|7150715|FG000|Overall Study|Triglycerides >2000 mg/dL|1
4375008|NCT01047683|7150716|FG001|Overall Study|Triglycerides >2000 mg/dL|0
4375009|NCT01047683|7150717|FG002|Overall Study|Triglycerides >2000 mg/dL|1
4375010|NCT01047501|7150728|FG000|Overall Study|Adverse Event|7
4375011|NCT01047501|7150729|FG001|Overall Study|Adverse Event|8
4375012|NCT01047501|7150730|FG002|Overall Study|Adverse Event|5
4375013|NCT01047501|7150728|FG000|Overall Study|Withdrew Consent|6
4375014|NCT01047501|7150729|FG001|Overall Study|Withdrew Consent|2
4375015|NCT01047501|7150730|FG002|Overall Study|Withdrew Consent|4
4375016|NCT01047501|7150728|FG000|Overall Study|Lost to Follow-up|0
4375017|NCT01047501|7150729|FG001|Overall Study|Lost to Follow-up|1
4375018|NCT01047501|7150730|FG002|Overall Study|Lost to Follow-up|1
4375019|NCT01047501|7150728|FG000|Overall Study|Triglycerides >800 mg/dL|1
4375020|NCT01047501|7150729|FG001|Overall Study|Triglycerides >800 mg/dL|0
4375021|NCT01047501|7150730|FG002|Overall Study|Triglycerides >800 mg/dL|0
4375022|NCT01047501|7150728|FG000|Overall Study|Death|1
4694716|NCT02611778|7606375|FG000|Overall Study|Protocol Violation|1
4694717|NCT02611778|7606376|FG001|Overall Study|Protocol Violation|0
4694718|NCT02611778|7606375|FG000|Overall Study|Lost to Follow-up|3
4694719|NCT02611778|7606376|FG001|Overall Study|Lost to Follow-up|1
4694720|NCT02611778|7606375|FG000|Overall Study|Need for alternative treatment|1
4694721|NCT02611778|7606376|FG001|Overall Study|Need for alternative treatment|0
4375023|NCT01047501|7150729|FG001|Overall Study|Death|0
4375024|NCT01047501|7150730|FG002|Overall Study|Death|0
4375025|NCT01047501|7150728|FG000|Overall Study|Other discontinuation|1
4375026|NCT01047501|7150729|FG001|Overall Study|Other discontinuation|0
4375027|NCT01047501|7150730|FG002|Overall Study|Other discontinuation|1
4375028|NCT01047501|7150728|FG000|Overall Study|Investigator judgement|0
4375029|NCT01047501|7150729|FG001|Overall Study|Investigator judgement|0
4375030|NCT01047501|7150730|FG002|Overall Study|Investigator judgement|1
4375031|NCT00981656|7150738|FG000|Overall Study|Protocol Violation|1
4375032|NCT00981656|7150738|FG000|Overall Study|Did not start protocol treatment|2
4375033|NCT00838526|7150744|FG000|Overall Study|Adverse Event|3
4375034|NCT00838526|7150745|FG001|Overall Study|Adverse Event|12
4375035|NCT00838526|7150744|FG000|Overall Study|Lost to Follow-up|4
4375036|NCT00838526|7150745|FG001|Overall Study|Lost to Follow-up|12
4375037|NCT00838526|7150744|FG000|Overall Study|Withdrawal by Subject|4
4375038|NCT00838526|7150745|FG001|Overall Study|Withdrawal by Subject|5
4375039|NCT00838526|7150744|FG000|Overall Study|Lack of Efficacy|2
4375040|NCT00838526|7150745|FG001|Overall Study|Lack of Efficacy|3
4375041|NCT00838526|7150744|FG000|Overall Study|Other|11
4375042|NCT00838526|7150745|FG001|Overall Study|Other|7
4375043|NCT00126672|7150751|FG000|Overall Study|Adverse Event|4
4375044|NCT00126672|7150751|FG000|Overall Study|Lost to Follow-up|4
4465527|NCT00610675|7256846|FG000|Overall Study|Insufficient Effect|31
4465528|NCT00610675|7256846|FG000|Overall Study|Withdrawal by Subject|28
4694722|NCT02611778|7606375|FG000|Overall Study|Other Reason|2
4694723|NCT02611778|7606376|FG001|Overall Study|Other Reason|1
4694724|NCT02611817|7606386|FG000|Open-label Induction Phase|Reason not Specified|9
4694725|NCT02611817|7606387|FG001|Open-label Induction Phase|Reason not Specified|0
4694726|NCT02611817|7606388|FG002|Open-label Induction Phase|Reason not Specified|0
4694727|NCT02611817|7606386|FG000|Open-label Induction Phase|Lack of Efficacy|8
4694728|NCT02611817|7606387|FG001|Open-label Induction Phase|Lack of Efficacy|0
4694729|NCT02611817|7606388|FG002|Open-label Induction Phase|Lack of Efficacy|0
4694730|NCT02611817|7606386|FG000|Open-label Induction Phase|Pregnancy|1
4694731|NCT02611817|7606387|FG001|Open-label Induction Phase|Pregnancy|0
4694732|NCT02611817|7606388|FG002|Open-label Induction Phase|Pregnancy|0
4694733|NCT02611817|7606386|FG000|Open-label Induction Phase|Withdrawal by Subject|9
4694734|NCT02611817|7606387|FG001|Open-label Induction Phase|Withdrawal by Subject|0
4694735|NCT02611817|7606388|FG002|Open-label Induction Phase|Withdrawal by Subject|0
4694736|NCT02611817|7606386|FG000|Open-label Induction Phase|Lost to Follow-up|2
4694737|NCT02611817|7606387|FG001|Open-label Induction Phase|Lost to Follow-up|0
4694738|NCT02611817|7606388|FG002|Open-label Induction Phase|Lost to Follow-up|0
4465529|NCT00610675|7256846|FG000|Overall Study|Reasons unrelated to trial|27
4465530|NCT00610675|7256846|FG000|Overall Study|Lack of Compliance|7
4465531|NCT00610675|7256846|FG000|Overall Study|Lost to Follow-up|31
4465532|NCT00610675|7256846|FG000|Overall Study|Other reason (not specified)|25
4465533|NCT00610714|7256874|FG000|Overall Study|Adverse Event|3
4465534|NCT00610714|7256875|FG001|Overall Study|Adverse Event|1
4465535|NCT00610714|7256874|FG000|Overall Study|Death|12
4465536|NCT00610714|7256875|FG001|Overall Study|Death|18
4465537|NCT00610714|7256874|FG000|Overall Study|Withdrawal by Subject|9
4465538|NCT00610714|7256875|FG001|Overall Study|Withdrawal by Subject|3
4465539|NCT00610714|7256874|FG000|Overall Study|Study completion at 120 PFS events|2
4465540|NCT00610714|7256875|FG001|Overall Study|Study completion at 120 PFS events|2
4375045|NCT03151304|7150768|FG000|Overall Study|Termination of study by Sponsor|23
4375046|NCT03151304|7150768|FG000|Overall Study|missing|3
4375047|NCT03151304|7150768|FG000|Overall Study|Withdrawal by Subject|8
4375048|NCT03151304|7150768|FG000|Overall Study|multiple reasons|30
4375049|NCT03113409|7150772|FG000|Overall Study|Withdrawal by Subject|5
4375050|NCT03113409|7150773|FG001|Overall Study|Withdrawal by Subject|0
4375051|NCT03113409|7150774|FG002|Overall Study|Withdrawal by Subject|0
4375052|NCT03084471|7150778|FG000|Overall Study|Development of study specific discontinuation criteria|2
4375053|NCT03084471|7150778|FG000|Overall Study|Condition under investigation worsened|84
4375054|NCT03084471|7150778|FG000|Overall Study|Lack of therapeutic response|2
4375055|NCT03084471|7150778|FG000|Overall Study|Protocol Violation|1
4375056|NCT03084471|7150778|FG000|Overall Study|Adverse Event|73
4375057|NCT03084471|7150778|FG000|Overall Study|Withdrawal by Subject|12
4375058|NCT03084471|7150778|FG000|Overall Study|Disease relapse|181
4375059|NCT03084471|7150778|FG000|Overall Study|Subjective disease progression|359
4375060|NCT03084471|7150778|FG000|Overall Study|Other (as recorded)|33
4375061|NCT03084471|7150778|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120
4375062|NCT03007979|7150785|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1
4375063|NCT02953340|7150791|FG000|Overall Study|Death|0
4375064|NCT02953340|7150792|FG001|Overall Study|Death|1
4375065|NCT02953340|7150791|FG000|Overall Study|Investigator Decision|3
4375066|NCT02953340|7150792|FG001|Overall Study|Investigator Decision|3
4375067|NCT02953340|7150791|FG000|Overall Study|Initiated Non-Protocol Therapy|5
4375068|NCT02953340|7150792|FG001|Overall Study|Initiated Non-Protocol Therapy|14
4375069|NCT02953340|7150791|FG000|Overall Study|Myeloid Growth Factors Treatment|0
4375070|NCT02953340|7150792|FG001|Overall Study|Myeloid Growth Factors Treatment|1
4375071|NCT02953340|7150791|FG000|Overall Study|Withdrawal by Subject|9
4375072|NCT02953340|7150792|FG001|Overall Study|Withdrawal by Subject|9
4375073|NCT02953340|7150791|FG000|Overall Study|Sponsor decision|0
4375074|NCT02953340|7150792|FG001|Overall Study|Sponsor decision|2
4375075|NCT02953340|7150791|FG000|Overall Study|Lost to Follow-up|3
4375076|NCT02953340|7150792|FG001|Overall Study|Lost to Follow-up|2
4375077|NCT02953340|7150791|FG000|Overall Study|Reason not specified|2
4375078|NCT02953340|7150792|FG001|Overall Study|Reason not specified|2
4375079|NCT02855944|7150815|FG000|Period 1: Treatment|Ongoing|44
4375080|NCT02855944|7150816|FG001|Period 1: Treatment|Ongoing|5
4375081|NCT02855944|7150815|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1
4375082|NCT02855944|7150816|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3
4375083|NCT02855944|7150815|FG000|Period 2: Crossover to Rucaparib|Ongoing|0
4375084|NCT02855944|7150816|FG001|Period 2: Crossover to Rucaparib|Ongoing|27
4375085|NCT02851407|7150825|FG000|Overall Study|Withdrawal by parent/guardian|2
4375086|NCT02851407|7150826|FG001|Overall Study|Withdrawal by parent/guardian|7
4375087|NCT02851407|7150825|FG000|Overall Study|Protocol deviation|0
4375088|NCT02851407|7150826|FG001|Overall Study|Protocol deviation|1
4375089|NCT02851407|7150825|FG000|Overall Study|Transferred to another hospital to continue|1
4375090|NCT02851407|7150826|FG001|Overall Study|Transferred to another hospital to continue|0
4375091|NCT02851407|7150825|FG000|Overall Study|Other Death|30
4375092|NCT02851407|7150826|FG001|Overall Study|Other Death|20
4375093|NCT02851407|7150825|FG000|Overall Study|Adverse event, serious fatal|6
4375094|NCT02851407|7150826|FG001|Overall Study|Adverse event, serious fatal|8
4375095|NCT02851407|7150825|FG000|Overall Study|Consent withdrawn by participant|5
4375096|NCT02851407|7150826|FG001|Overall Study|Consent withdrawn by participant|3
4375097|NCT02851407|7150825|FG000|Overall Study|Screen failure|2
4375098|NCT02851407|7150826|FG001|Overall Study|Screen failure|1
4465541|NCT00610857|7256914|FG000|Overall Study|Not evaluable for response|2
4465542|NCT00610935|7256924|FG000|Overall Study|Lost to Follow-up|0
4465543|NCT00610935|7256925|FG001|Overall Study|Lost to Follow-up|1
4465544|NCT00610935|7256924|FG000|Overall Study|Withdrawal by Subject|0
4465545|NCT00610935|7256925|FG001|Overall Study|Withdrawal by Subject|2
4465546|NCT00610935|7256924|FG000|Overall Study|Sponsor Discontinuation|1
4465547|NCT00610935|7256925|FG001|Overall Study|Sponsor Discontinuation|0
4465548|NCT00611026|7256943|FG000|Randomized to Double-blind Treatment|Not treated|2
4465549|NCT00611026|7256944|FG001|Randomized to Double-blind Treatment|Not treated|1
4465550|NCT00611026|7256945|FG002|Randomized to Double-blind Treatment|Not treated|3
4465551|NCT00611026|7256943|FG000|Double-blind Treatment Period|Death|1
4465552|NCT00611026|7256944|FG001|Double-blind Treatment Period|Death|0
4465553|NCT00611026|7256945|FG002|Double-blind Treatment Period|Death|0
4465554|NCT00611026|7256943|FG000|Double-blind Treatment Period|Adverse Event|9
4465555|NCT00611026|7256944|FG001|Double-blind Treatment Period|Adverse Event|28
4465556|NCT00611026|7256945|FG002|Double-blind Treatment Period|Adverse Event|46
4465557|NCT00611026|7256943|FG000|Double-blind Treatment Period|Lack of Efficacy|11
4465558|NCT00611026|7256944|FG001|Double-blind Treatment Period|Lack of Efficacy|10
4465559|NCT00611026|7256945|FG002|Double-blind Treatment Period|Lack of Efficacy|4
4465560|NCT00611026|7256943|FG000|Double-blind Treatment Period|Lost to Follow-up|6
4465561|NCT00611026|7256944|FG001|Double-blind Treatment Period|Lost to Follow-up|11
4375099|NCT02851407|7150825|FG000|Overall Study|Disease relapse|9
4465562|NCT00611026|7256945|FG002|Double-blind Treatment Period|Lost to Follow-up|14
4465563|NCT00611026|7256943|FG000|Double-blind Treatment Period|Withdrawal by Subject|7
4465564|NCT00611026|7256944|FG001|Double-blind Treatment Period|Withdrawal by Subject|19
4375100|NCT02851407|7150826|FG001|Overall Study|Disease relapse|6
4375101|NCT02851407|7150825|FG000|Overall Study|Physician Decision|7
4375102|NCT02851407|7150826|FG001|Overall Study|Physician Decision|6
4375103|NCT02851407|7150825|FG000|Overall Study|Transferred to hospital closer to home|0
4375104|NCT02851407|7150826|FG001|Overall Study|Transferred to hospital closer to home|1
4375105|NCT02851407|7150825|FG000|Overall Study|Enrolled in an investigational study|0
4375106|NCT02851407|7150826|FG001|Overall Study|Enrolled in an investigational study|1
4375107|NCT02851407|7150825|FG000|Overall Study|Early recovery|1
4375108|NCT02851407|7150826|FG001|Overall Study|Early recovery|0
4375109|NCT02851407|7150825|FG000|Overall Study|Adverse event, non-fatal|7
4375110|NCT02851407|7150826|FG001|Overall Study|Adverse event, non-fatal|5
4375111|NCT02851407|7150825|FG000|Overall Study|Lost to Follow-up|0
4375112|NCT02851407|7150826|FG001|Overall Study|Lost to Follow-up|2
4375113|NCT02717611|7150832|FG000|Overall Study|Death|13
4375114|NCT02717611|7150832|FG000|Overall Study|Withdrawal by Subject|6
4375115|NCT02717611|7150832|FG000|Overall Study|Active, not recruiting|40
4375116|NCT02717611|7150832|FG000|Overall Study|Complicating disease|1
4375117|NCT02666430|7150855|FG000|Period 1|Lost to Follow-up|1
4375118|NCT02666430|7150856|FG001|Period 1|Lost to Follow-up|0
4375119|NCT02666430|7150855|FG000|Period 1|Adverse Event|0
4375120|NCT02666430|7150856|FG001|Period 1|Adverse Event|1
4375121|NCT02666430|7150855|FG000|Period 2|Withdrawal by Subject|1
4375122|NCT02666430|7150856|FG001|Period 2|Withdrawal by Subject|4
4375123|NCT02666430|7150855|FG000|Period 3|Lost to Follow-up|1
4375124|NCT02666430|7150856|FG001|Period 3|Lost to Follow-up|0
4375125|NCT02643420|7150864|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6
4375126|NCT02643420|7150865|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12
4375127|NCT02643420|7150864|FG000|Overall Study|Withdrawal by Subject|25
4375128|NCT02643420|7150865|FG001|Overall Study|Withdrawal by Subject|19
4375129|NCT02643420|7150864|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6
4375130|NCT02643420|7150865|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10
4375131|NCT02643420|7150864|FG000|Overall Study|Lost to Follow-up|6
4375132|NCT02643420|7150865|FG001|Overall Study|Lost to Follow-up|10
4375133|NCT02643420|7150864|FG000|Overall Study|Investigator Decision|2
4375134|NCT02643420|7150865|FG001|Overall Study|Investigator Decision|4
4375135|NCT02643420|7150864|FG000|Overall Study|Sponsor decision|1
4375136|NCT02643420|7150865|FG001|Overall Study|Sponsor decision|1
4375137|NCT02643420|7150864|FG000|Overall Study|Death|0
4375138|NCT02643420|7150865|FG001|Overall Study|Death|2
4375139|NCT02643420|7150864|FG000|Overall Study|Reason not Specified|8
4375140|NCT02643420|7150865|FG001|Overall Study|Reason not Specified|7
4375141|NCT02639559|7150879|FG000|Overall Study|Mobilization failure|0
4375142|NCT02639559|7150880|FG001|Overall Study|Mobilization failure|3
4375143|NCT02639559|7150879|FG000|Overall Study|Issues with vascular acess|1
4375144|NCT02639559|7150880|FG001|Overall Study|Issues with vascular acess|0
4375145|NCT02569476|7150886|FG000|Overall Study|Roll over to Long-Term Extension Study|73
4375146|NCT02569476|7150886|FG000|Overall Study|Death|33
4375147|NCT02569476|7150886|FG000|Overall Study|Withdrawal by Subject|9
4375148|NCT02569476|7150886|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1
4375149|NCT02569476|7150886|FG000|Overall Study|Palliative care|1
4375150|NCT02569476|7150886|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1
4375151|NCT02569476|7150886|FG000|Overall Study|Transitioned to Long Term Extension Study|1
4375152|NCT02496676|7150902|FG000|Phase 1 - Period 1|Adverse Event|0
4375153|NCT02496676|7150903|FG001|Phase 1 - Period 1|Adverse Event|1
4375154|NCT02496676|7150902|FG000|Phase 2 - IV MgSO4|Adverse Event|0
4375155|NCT02496676|7150903|FG001|Phase 2 - IV MgSO4|Adverse Event|1
4375156|NCT02412618|7150928|FG000|Overall Study|Withdrawal by Subject|1
4375157|NCT02412618|7150929|FG001|Overall Study|Withdrawal by Subject|1
4375158|NCT02412618|7150928|FG000|Overall Study|Expulsion|1
4375159|NCT02412618|7150929|FG001|Overall Study|Expulsion|1
4375160|NCT02351180|7150946|FG000|Overall Study|Withdrawal by Subject|1
4375161|NCT02351180|7150947|FG001|Overall Study|Withdrawal by Subject|0
4375162|NCT02337764|7150953|FG000|Overall Study|Pretreatment Event/Adverse Event|46
4375163|NCT02337764|7150953|FG000|Overall Study|Voluntary Withdrawal|12
4587586|NCT01492400|7431754|FG000|Overall Study|Pregnancy|0
4587587|NCT01492400|7431755|FG001|Overall Study|Pregnancy|1
4587588|NCT01492400|7431754|FG000|Overall Study|Lack of Efficacy|1
4587589|NCT01492400|7431755|FG001|Overall Study|Lack of Efficacy|1
4587590|NCT01492400|7431754|FG000|Overall Study|Adverse Event|10
4375164|NCT02337764|7150953|FG000|Overall Study|Lack of Efficacy|2
4375165|NCT02337738|7150960|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0
4375166|NCT02337738|7150961|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1
4465565|NCT00611026|7256945|FG002|Double-blind Treatment Period|Withdrawal by Subject|16
4587591|NCT01492400|7431755|FG001|Overall Study|Adverse Event|5
4587592|NCT01492426|7431763|FG000|Treatment|Death|0
4375167|NCT02337738|7150962|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0
4375168|NCT02337738|7150960|FG000|Overall Study|Pretreatment Event/Adverse Event|9
4375169|NCT02337738|7150961|FG001|Overall Study|Pretreatment Event/Adverse Event|18
4375170|NCT02337738|7150962|FG002|Overall Study|Pretreatment Event/Adverse Event|21
4375171|NCT02337738|7150960|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0
4587593|NCT01492426|7431764|FG001|Treatment|Death|1
4375172|NCT02337738|7150961|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1
4375173|NCT02337738|7150962|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0
4375174|NCT02337738|7150960|FG000|Overall Study|Voluntary Withdrawal|10
4375175|NCT02337738|7150961|FG001|Overall Study|Voluntary Withdrawal|5
4375176|NCT02337738|7150962|FG002|Overall Study|Voluntary Withdrawal|2
4375177|NCT02337738|7150960|FG000|Overall Study|Lack of Efficacy|2
4375178|NCT02337738|7150961|FG001|Overall Study|Lack of Efficacy|4
4375179|NCT02337738|7150962|FG002|Overall Study|Lack of Efficacy|0
4375180|NCT02337738|7150960|FG000|Overall Study|Investigator's Judgment|1
4375181|NCT02337738|7150961|FG001|Overall Study|Investigator's Judgment|1
4375182|NCT02337738|7150962|FG002|Overall Study|Investigator's Judgment|3
4375183|NCT02332187|7150972|FG000|Overall Study|Withdrawal by Subject|2
4375184|NCT02332187|7150973|FG001|Overall Study|Withdrawal by Subject|2
4375185|NCT02332187|7150972|FG000|Overall Study|Adverse Event|0
4375186|NCT02332187|7150973|FG001|Overall Study|Adverse Event|1
4465566|NCT00611026|7256943|FG000|Double-blind Treatment Period|Other|13
4465567|NCT00611026|7256944|FG001|Double-blind Treatment Period|Other|20
4465568|NCT00611026|7256945|FG002|Double-blind Treatment Period|Other|18
4465569|NCT00611130|7256957|FG000|Overall Study|Lost to Follow-up|25
4465570|NCT00611130|7256958|FG001|Overall Study|Lost to Follow-up|29
4465571|NCT00611130|7256957|FG000|Overall Study|Protocol noncompliance|7
4465572|NCT00611130|7256958|FG001|Overall Study|Protocol noncompliance|6
4465573|NCT00611130|7256957|FG000|Overall Study|Withdrawal by Subject|6
4465574|NCT00611130|7256958|FG001|Overall Study|Withdrawal by Subject|5
4465575|NCT00611130|7256957|FG000|Overall Study|Other|5
4465576|NCT00611130|7256958|FG001|Overall Study|Other|4
4465577|NCT00611130|7256957|FG000|Overall Study|Incarceration|3
4465578|NCT00611130|7256958|FG001|Overall Study|Incarceration|2
4465579|NCT00611130|7256957|FG000|Overall Study|Administrative|1
4465580|NCT00611130|7256958|FG001|Overall Study|Administrative|1
4465581|NCT00611130|7256957|FG000|Overall Study|Adverse Event|1
4465582|NCT00611130|7256958|FG001|Overall Study|Adverse Event|0
4465583|NCT00611130|7256957|FG000|Overall Study|Death|1
4465584|NCT00611130|7256958|FG001|Overall Study|Death|0
4465585|NCT00611247|7256967|FG000|Overall Study|Death|1
4465586|NCT00611247|7256968|FG001|Overall Study|Death|5
4465587|NCT00611247|7256967|FG000|Overall Study|Lack of Efficacy|1
4465588|NCT00611247|7256968|FG001|Overall Study|Lack of Efficacy|16
4465589|NCT00611455|7257008|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2
4465590|NCT00611455|7257009|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8
4465591|NCT00611455|7257010|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0
4465592|NCT00611455|7257008|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2
4694739|NCT02611817|7606386|FG000|Open-label Induction Phase|Protocol Violation|5
4694740|NCT02611817|7606387|FG001|Open-label Induction Phase|Protocol Violation|0
4694741|NCT02611817|7606388|FG002|Open-label Induction Phase|Protocol Violation|0
4694742|NCT02611817|7606386|FG000|Open-label Induction Phase|Adverse Event|16
4694743|NCT02611817|7606387|FG001|Open-label Induction Phase|Adverse Event|0
4694744|NCT02611817|7606388|FG002|Open-label Induction Phase|Adverse Event|0
4694745|NCT02611817|7606386|FG000|Double-blind Maintenance Phase|Adverse Event|0
4694746|NCT02611817|7606387|FG001|Double-blind Maintenance Phase|Adverse Event|12
4694747|NCT02611817|7606388|FG002|Double-blind Maintenance Phase|Adverse Event|11
4694748|NCT02611817|7606386|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0
4694749|NCT02611817|7606387|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1
4694750|NCT02611817|7606388|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0
4694751|NCT02611817|7606386|FG000|Double-blind Maintenance Phase|Reason not Specified|0
4694752|NCT02611817|7606387|FG001|Double-blind Maintenance Phase|Reason not Specified|1
4694753|NCT02611817|7606388|FG002|Double-blind Maintenance Phase|Reason not Specified|2
4694754|NCT02611817|7606386|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0
4694755|NCT02611817|7606387|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43
4694756|NCT02611817|7606388|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78
4694757|NCT02611817|7606386|FG000|Double-blind Maintenance Phase|Pregnancy|0
4694758|NCT02611817|7606387|FG001|Double-blind Maintenance Phase|Pregnancy|0
4694759|NCT02611817|7606388|FG002|Double-blind Maintenance Phase|Pregnancy|1
4694760|NCT02611817|7606386|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0
4694761|NCT02611817|7606387|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5
4694762|NCT02611817|7606388|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14
4694763|NCT02611817|7606386|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0
4694764|NCT02611817|7606387|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0
4694765|NCT02611817|7606388|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1
4694766|NCT02611830|7606399|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9
4694767|NCT02611830|7606400|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0
4465593|NCT00611455|7257009|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
4465594|NCT00611455|7257010|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
4465595|NCT00611455|7257008|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4
4465596|NCT00611455|7257009|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1
4465597|NCT00611455|7257010|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0
4465598|NCT00611455|7257008|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2
4465599|NCT00611455|7257009|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3
4516290|NCT00958880|7327589|FG000|Overall Study|Lost to Follow-up|2
4375187|NCT02296125|7150981|FG000|Overall Study|Withdrawal by Subject|18
4375188|NCT02296125|7150982|FG001|Overall Study|Withdrawal by Subject|8
4375189|NCT02296125|7150983|FG002|Overall Study|Withdrawal by Subject|6
4375190|NCT02296125|7150984|FG003|Overall Study|Withdrawal by Subject|2
4375191|NCT02296125|7150981|FG000|Overall Study|Adverse Event|41
4375192|NCT02296125|7150982|FG001|Overall Study|Adverse Event|52
4375193|NCT02296125|7150983|FG002|Overall Study|Adverse Event|9
4375194|NCT02296125|7150984|FG003|Overall Study|Adverse Event|4
4375195|NCT02296125|7150981|FG000|Overall Study|Severe non-compliance to protocol|0
4375196|NCT02296125|7150982|FG001|Overall Study|Severe non-compliance to protocol|1
4375197|NCT02296125|7150983|FG002|Overall Study|Severe non-compliance to protocol|0
4375198|NCT02296125|7150984|FG003|Overall Study|Severe non-compliance to protocol|0
4375199|NCT02296125|7150981|FG000|Overall Study|Condition under investigation worsened|153
4375200|NCT02296125|7150982|FG001|Overall Study|Condition under investigation worsened|199
4375201|NCT02296125|7150983|FG002|Overall Study|Condition under investigation worsened|39
4375202|NCT02296125|7150984|FG003|Overall Study|Condition under investigation worsened|56
4375203|NCT02296125|7150981|FG000|Overall Study|Any reason not specifically recorded|6
4375204|NCT02296125|7150982|FG001|Overall Study|Any reason not specifically recorded|4
4375205|NCT02296125|7150983|FG002|Overall Study|Any reason not specifically recorded|2
4375206|NCT02296125|7150984|FG003|Overall Study|Any reason not specifically recorded|0
4375207|NCT02227875|7150997|FG000|Overall Study|Protocol Violation|10
4375208|NCT02227875|7150998|FG001|Overall Study|Protocol Violation|7
4375209|NCT02227875|7150997|FG000|Overall Study|Other|1
4375210|NCT02227875|7150998|FG001|Overall Study|Other|3
4375211|NCT02227875|7150997|FG000|Overall Study|Physician Decision|1
4375212|NCT02227875|7150998|FG001|Overall Study|Physician Decision|0
4375213|NCT02227875|7150997|FG000|Overall Study|Adverse Event|3
4375214|NCT02227875|7150998|FG001|Overall Study|Adverse Event|0
4375215|NCT02227875|7150997|FG000|Overall Study|Withdrawal by Subject|12
4375216|NCT02227875|7150998|FG001|Overall Study|Withdrawal by Subject|13
4375217|NCT02227875|7150997|FG000|Overall Study|Lost to Follow-up|10
4375218|NCT02227875|7150998|FG001|Overall Study|Lost to Follow-up|10
4375219|NCT02227862|7151006|FG000|Overall Study|Protocol Violation|7
4375220|NCT02227862|7151007|FG001|Overall Study|Protocol Violation|9
4375221|NCT02227862|7151006|FG000|Overall Study|Other|0
4375222|NCT02227862|7151007|FG001|Overall Study|Other|2
4375223|NCT02227862|7151006|FG000|Overall Study|Adverse Event|4
4375224|NCT02227862|7151007|FG001|Overall Study|Adverse Event|3
4375225|NCT02227862|7151006|FG000|Overall Study|Withdrawal by Subject|7
4694768|NCT02611830|7606401|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0
4694769|NCT02611830|7606402|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0
4694770|NCT02611830|7606399|FG000|OL Induction Phase|Significant Protocol Deviation|4
4694771|NCT02611830|7606400|FG001|OL Induction Phase|Significant Protocol Deviation|0
4694772|NCT02611830|7606401|FG002|OL Induction Phase|Significant Protocol Deviation|0
4694773|NCT02611830|7606402|FG003|OL Induction Phase|Significant Protocol Deviation|0
4694774|NCT02611830|7606399|FG000|OL Induction Phase|Voluntary Withdrawal|5
4694775|NCT02611830|7606400|FG001|OL Induction Phase|Voluntary Withdrawal|0
4694776|NCT02611830|7606401|FG002|OL Induction Phase|Voluntary Withdrawal|0
4694777|NCT02611830|7606402|FG003|OL Induction Phase|Voluntary Withdrawal|0
4694778|NCT02611830|7606399|FG000|OL Induction Phase|Lack of Efficacy|9
4694779|NCT02611830|7606400|FG001|OL Induction Phase|Lack of Efficacy|0
4694780|NCT02611830|7606401|FG002|OL Induction Phase|Lack of Efficacy|0
4694781|NCT02611830|7606402|FG003|OL Induction Phase|Lack of Efficacy|0
4694782|NCT02611830|7606399|FG000|OL Induction Phase|Reason not specified|3
4694783|NCT02611830|7606400|FG001|OL Induction Phase|Reason not specified|0
4694784|NCT02611830|7606401|FG002|OL Induction Phase|Reason not specified|0
4694785|NCT02611830|7606402|FG003|OL Induction Phase|Reason not specified|0
4694786|NCT02611830|7606399|FG000|Maintenance Phase|Lack of Efficacy|0
4694787|NCT02611830|7606400|FG001|Maintenance Phase|Lack of Efficacy|29
4694788|NCT02611830|7606401|FG002|Maintenance Phase|Lack of Efficacy|18
4694789|NCT02611830|7606402|FG003|Maintenance Phase|Lack of Efficacy|6
4694790|NCT02611830|7606399|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0
4694791|NCT02611830|7606400|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5
4694792|NCT02611830|7606401|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5
4694793|NCT02611830|7606402|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2
4694794|NCT02611830|7606399|FG000|Maintenance Phase|Significant Protocol Deviation|0
4694795|NCT02611830|7606400|FG001|Maintenance Phase|Significant Protocol Deviation|0
4694796|NCT02611830|7606401|FG002|Maintenance Phase|Significant Protocol Deviation|1
4694797|NCT02611830|7606402|FG003|Maintenance Phase|Significant Protocol Deviation|1
4694798|NCT02611830|7606399|FG000|Maintenance Phase|Lost to Follow-up|0
4694799|NCT02611830|7606400|FG001|Maintenance Phase|Lost to Follow-up|0
4694800|NCT02611830|7606401|FG002|Maintenance Phase|Lost to Follow-up|0
4694801|NCT02611830|7606402|FG003|Maintenance Phase|Lost to Follow-up|1
4694802|NCT02611830|7606399|FG000|Maintenance Phase|Voluntary Withdrawal|0
4694803|NCT02611830|7606400|FG001|Maintenance Phase|Voluntary Withdrawal|1
4375226|NCT02227862|7151007|FG001|Overall Study|Withdrawal by Subject|6
4375227|NCT02227862|7151006|FG000|Overall Study|Lost to Follow-up|1
4375228|NCT02227862|7151007|FG001|Overall Study|Lost to Follow-up|2
4375229|NCT02200939|7151015|FG000|Overall Study|Participant withdrew consent|0
4375230|NCT02200939|7151016|FG001|Overall Study|Participant withdrew consent|1
4375231|NCT02200939|7151015|FG000|Overall Study|Lost to Follow-up|2
4375232|NCT02200939|7151016|FG001|Overall Study|Lost to Follow-up|9
4375233|NCT02200939|7151015|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0
4375234|NCT02200939|7151016|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1
4375235|NCT02108964|7151034|FG000|Overall Study|Progressive disease|12
4375236|NCT02108964|7151035|FG001|Overall Study|Progressive disease|25
4375237|NCT02108964|7151036|FG002|Overall Study|Progressive disease|50
4375238|NCT02108964|7151037|FG003|Overall Study|Progressive disease|6
4375239|NCT02108964|7151038|FG004|Overall Study|Progressive disease|18
4375240|NCT02108964|7151039|FG005|Overall Study|Progressive disease|5
4375241|NCT02108964|7151040|FG006|Overall Study|Progressive disease|7
4375242|NCT02108964|7151041|FG007|Overall Study|Progressive disease|9
4375243|NCT02108964|7151034|FG000|Overall Study|Physician Decision|1
4375244|NCT02108964|7151035|FG001|Overall Study|Physician Decision|5
4375245|NCT02108964|7151036|FG002|Overall Study|Physician Decision|6
4465600|NCT00611455|7257010|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0
4465601|NCT00611455|7257008|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2
4465602|NCT00611455|7257009|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2
4465603|NCT00611455|7257010|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0
4465604|NCT00611455|7257008|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1
4465605|NCT00611455|7257009|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0
4465606|NCT00611455|7257010|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0
4465607|NCT00611455|7257008|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0
4465608|NCT00611455|7257009|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17
4465609|NCT00611455|7257010|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0
4465610|NCT00611455|7257008|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
4465611|NCT00611455|7257009|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9
4465612|NCT00611455|7257010|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
4465613|NCT00611455|7257008|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0
4465614|NCT00611455|7257009|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3
4465615|NCT00611455|7257010|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0
4375246|NCT02108964|7151037|FG003|Overall Study|Physician Decision|0
4375247|NCT02108964|7151038|FG004|Overall Study|Physician Decision|1
4375248|NCT02108964|7151039|FG005|Overall Study|Physician Decision|0
4375249|NCT02108964|7151040|FG006|Overall Study|Physician Decision|0
4375250|NCT02108964|7151041|FG007|Overall Study|Physician Decision|0
4375251|NCT02108964|7151034|FG000|Overall Study|Adverse Event|0
4375252|NCT02108964|7151035|FG001|Overall Study|Adverse Event|0
4375253|NCT02108964|7151036|FG002|Overall Study|Adverse Event|4
4375254|NCT02108964|7151037|FG003|Overall Study|Adverse Event|0
4375255|NCT02108964|7151038|FG004|Overall Study|Adverse Event|1
4375256|NCT02108964|7151039|FG005|Overall Study|Adverse Event|0
4375257|NCT02108964|7151040|FG006|Overall Study|Adverse Event|3
4375258|NCT02108964|7151041|FG007|Overall Study|Adverse Event|1
4375259|NCT02108964|7151034|FG000|Overall Study|Death|1
4375260|NCT02108964|7151035|FG001|Overall Study|Death|1
4375261|NCT02108964|7151036|FG002|Overall Study|Death|2
4375262|NCT02108964|7151037|FG003|Overall Study|Death|0
4375263|NCT02108964|7151038|FG004|Overall Study|Death|3
4375264|NCT02108964|7151039|FG005|Overall Study|Death|0
4375265|NCT02108964|7151040|FG006|Overall Study|Death|0
4375266|NCT02108964|7151041|FG007|Overall Study|Death|1
4375267|NCT02108964|7151034|FG000|Overall Study|Subject/Guardian decision|0
4375268|NCT02108964|7151035|FG001|Overall Study|Subject/Guardian decision|1
4375269|NCT02108964|7151036|FG002|Overall Study|Subject/Guardian decision|3
4375270|NCT02108964|7151037|FG003|Overall Study|Subject/Guardian decision|0
4375271|NCT02108964|7151038|FG004|Overall Study|Subject/Guardian decision|2
4375272|NCT02108964|7151039|FG005|Overall Study|Subject/Guardian decision|0
4375273|NCT02108964|7151040|FG006|Overall Study|Subject/Guardian decision|1
4375274|NCT02108964|7151041|FG007|Overall Study|Subject/Guardian decision|1
4375275|NCT01922895|7151084|FG000|Overall Study|Death|0
4375276|NCT01922895|7151085|FG001|Overall Study|Death|1
4375277|NCT01922895|7151084|FG000|Overall Study|Withdrawal by Subject|1
4375278|NCT01922895|7151085|FG001|Overall Study|Withdrawal by Subject|2
4375279|NCT01922895|7151084|FG000|Overall Study|Lost to Follow-up|5
4375280|NCT01922895|7151085|FG001|Overall Study|Lost to Follow-up|11
4375281|NCT01901289|7151091|FG000|Overall Study|Death|32
4375282|NCT01901289|7151091|FG000|Overall Study|Lost to Follow-up|16
4375283|NCT01901289|7151091|FG000|Overall Study|Withdrawal by Subject|35
4375284|NCT01901289|7151091|FG000|Overall Study|Other type of endpoint met|2
4375285|NCT01595581|7151110|FG000|Overall Study|Withdrawal by Subject|1
4375286|NCT01595581|7151111|FG001|Overall Study|Withdrawal by Subject|0
4375287|NCT01514682|7151121|FG000|Overall Study|Withdrawal by Subject|2
4375288|NCT01514682|7151122|FG001|Overall Study|Withdrawal by Subject|3
4375289|NCT01514682|7151121|FG000|Overall Study|Physician Decision|4
4375290|NCT01514682|7151122|FG001|Overall Study|Physician Decision|3
4375291|NCT01453140|7151128|FG000|Overall Study|Adverse Event|3
4375292|NCT01408641|7151138|FG000|Overall Study|Physician Decision|1
4375293|NCT01408641|7151139|FG001|Overall Study|Physician Decision|0
4375294|NCT00679783|7151161|FG000|Overall Study|Adverse Event|0
4375295|NCT00679783|7151162|FG001|Overall Study|Adverse Event|0
4375296|NCT00679783|7151163|FG002|Overall Study|Adverse Event|0
4375297|NCT00679783|7151164|FG003|Overall Study|Adverse Event|3
4375298|NCT00679783|7151165|FG004|Overall Study|Adverse Event|0
4375299|NCT00679783|7151166|FG005|Overall Study|Adverse Event|0
4375300|NCT00679783|7151167|FG006|Overall Study|Adverse Event|1
4375301|NCT00679783|7151161|FG000|Overall Study|Lack of Efficacy|0
4375302|NCT00679783|7151162|FG001|Overall Study|Lack of Efficacy|1
4375303|NCT00679783|7151163|FG002|Overall Study|Lack of Efficacy|0
4375304|NCT00679783|7151164|FG003|Overall Study|Lack of Efficacy|2
4375305|NCT00679783|7151165|FG004|Overall Study|Lack of Efficacy|0
4375306|NCT00679783|7151166|FG005|Overall Study|Lack of Efficacy|0
4375307|NCT00679783|7151167|FG006|Overall Study|Lack of Efficacy|0
4375308|NCT00679783|7151161|FG000|Overall Study|Withdrawal by Subject|0
4375309|NCT00679783|7151162|FG001|Overall Study|Withdrawal by Subject|0
4375310|NCT00679783|7151163|FG002|Overall Study|Withdrawal by Subject|1
4375311|NCT00679783|7151164|FG003|Overall Study|Withdrawal by Subject|1
4375312|NCT00679783|7151165|FG004|Overall Study|Withdrawal by Subject|0
4375313|NCT00679783|7151166|FG005|Overall Study|Withdrawal by Subject|0
4375314|NCT00679783|7151167|FG006|Overall Study|Withdrawal by Subject|0
4375315|NCT00679783|7151161|FG000|Overall Study|Not Captured|0
4375316|NCT00679783|7151162|FG001|Overall Study|Not Captured|0
4587594|NCT01492426|7431763|FG000|Treatment|Other|1
4587595|NCT01492426|7431764|FG001|Treatment|Other|0
4587596|NCT01492426|7431763|FG000|Treatment|Adverse Event|25
4587597|NCT01492426|7431764|FG001|Treatment|Adverse Event|25
4587598|NCT01492426|7431763|FG000|Treatment|Lack of Efficacy|38
4587599|NCT01492426|7431764|FG001|Treatment|Lack of Efficacy|5
4587600|NCT01492426|7431763|FG000|Treatment|Participant withdrew consent|1
4587601|NCT01492426|7431764|FG001|Treatment|Participant withdrew consent|2
4587602|NCT01492426|7431763|FG000|Treatment|Poor compliance/noncompliance|1
4587603|NCT01492426|7431764|FG001|Treatment|Poor compliance/noncompliance|0
4375317|NCT00679783|7151163|FG002|Overall Study|Not Captured|0
4375318|NCT00679783|7151164|FG003|Overall Study|Not Captured|5
4375319|NCT00679783|7151165|FG004|Overall Study|Not Captured|0
4375320|NCT00679783|7151166|FG005|Overall Study|Not Captured|0
4375321|NCT00679783|7151167|FG006|Overall Study|Not Captured|0
4375322|NCT00679783|7151161|FG000|Overall Study|Ongoing at data cut-off|2
4375323|NCT00679783|7151162|FG001|Overall Study|Ongoing at data cut-off|2
4375324|NCT00679783|7151163|FG002|Overall Study|Ongoing at data cut-off|0
4375325|NCT00679783|7151164|FG003|Overall Study|Ongoing at data cut-off|9
4375326|NCT00679783|7151165|FG004|Overall Study|Ongoing at data cut-off|1
4375327|NCT00679783|7151166|FG005|Overall Study|Ongoing at data cut-off|0
4375328|NCT00679783|7151167|FG006|Overall Study|Ongoing at data cut-off|0
4375329|NCT00653068|7151187|FG000|Overall Study|Death|9
4375330|NCT00653068|7151187|FG000|Overall Study|Lack of Efficacy|34
4375331|NCT00653068|7151187|FG000|Overall Study|Physician Decision|4
4375332|NCT00653068|7151187|FG000|Overall Study|Withdrawal by Subject|1
4375333|NCT00653068|7151187|FG000|Overall Study|Ineligible|2
4375334|NCT00601900|7151196|FG000|Overall Study|Withdrawal by Subject|0
4375335|NCT00601900|7151197|FG001|Overall Study|Withdrawal by Subject|3
4375336|NCT00193479|7151203|FG000|Induction Chemotherapy|Adverse Event|2
4375337|NCT00193479|7151203|FG000|Induction Chemotherapy|Disease Progression|1
4375338|NCT00193479|7151203|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2
4375339|NCT00193479|7151203|FG000|Maintenance Rituximab|Withdrawal by Subject|2
4375340|NCT00085735|7151222|FG000|Overall Study|Adverse Event|1
4375341|NCT00085735|7151223|FG001|Overall Study|Adverse Event|0
4375342|NCT00085735|7151224|FG002|Overall Study|Adverse Event|0
4375343|NCT00085735|7151225|FG003|Overall Study|Adverse Event|0
4375344|NCT00085735|7151226|FG004|Overall Study|Adverse Event|0
4375345|NCT00085735|7151227|FG005|Overall Study|Adverse Event|0
4375346|NCT00085735|7151222|FG000|Overall Study|Lack of Efficacy|2
4375347|NCT00085735|7151223|FG001|Overall Study|Lack of Efficacy|4
4375348|NCT00085735|7151224|FG002|Overall Study|Lack of Efficacy|6
4375349|NCT00085735|7151225|FG003|Overall Study|Lack of Efficacy|3
4375350|NCT00085735|7151226|FG004|Overall Study|Lack of Efficacy|4
4375351|NCT00085735|7151227|FG005|Overall Study|Lack of Efficacy|3
4375352|NCT00085735|7151222|FG000|Overall Study|Lost to Follow-up|0
4375353|NCT00085735|7151223|FG001|Overall Study|Lost to Follow-up|1
4375354|NCT00085735|7151224|FG002|Overall Study|Lost to Follow-up|0
4375355|NCT00085735|7151225|FG003|Overall Study|Lost to Follow-up|0
4587604|NCT01492426|7431763|FG000|Treatment|Subject requested discontinue study drug|7
4587605|NCT01492426|7431764|FG001|Treatment|Subject requested discontinue study drug|3
4375356|NCT00085735|7151226|FG004|Overall Study|Lost to Follow-up|1
4375357|NCT00085735|7151227|FG005|Overall Study|Lost to Follow-up|0
4375358|NCT00085735|7151222|FG000|Overall Study|Physician Decision|2
4375359|NCT00085735|7151223|FG001|Overall Study|Physician Decision|3
4375360|NCT00085735|7151224|FG002|Overall Study|Physician Decision|2
4375361|NCT00085735|7151225|FG003|Overall Study|Physician Decision|3
4375362|NCT00085735|7151226|FG004|Overall Study|Physician Decision|11
4375363|NCT00085735|7151227|FG005|Overall Study|Physician Decision|8
4375364|NCT00085735|7151222|FG000|Overall Study|Protocol Violation|1
4375365|NCT00085735|7151223|FG001|Overall Study|Protocol Violation|0
4375366|NCT00085735|7151224|FG002|Overall Study|Protocol Violation|0
4375367|NCT00085735|7151225|FG003|Overall Study|Protocol Violation|0
4587606|NCT01492426|7431763|FG000|Treatment|Lost to Follow-up|9
4375368|NCT00085735|7151226|FG004|Overall Study|Protocol Violation|0
4375369|NCT00085735|7151227|FG005|Overall Study|Protocol Violation|0
4375370|NCT00085735|7151222|FG000|Overall Study|Withdrawal by Subject|1
4375371|NCT00085735|7151223|FG001|Overall Study|Withdrawal by Subject|0
4375372|NCT00085735|7151224|FG002|Overall Study|Withdrawal by Subject|4
4375373|NCT00085735|7151225|FG003|Overall Study|Withdrawal by Subject|5
4375374|NCT00085735|7151226|FG004|Overall Study|Withdrawal by Subject|7
4375375|NCT00085735|7151227|FG005|Overall Study|Withdrawal by Subject|8
4375376|NCT00085735|7151222|FG000|Overall Study|Patient ineligible|1
4375377|NCT00085735|7151223|FG001|Overall Study|Patient ineligible|0
4375378|NCT00085735|7151224|FG002|Overall Study|Patient ineligible|3
4375379|NCT00085735|7151225|FG003|Overall Study|Patient ineligible|7
4375380|NCT00085735|7151226|FG004|Overall Study|Patient ineligible|17
4375381|NCT00085735|7151227|FG005|Overall Study|Patient ineligible|8
4375382|NCT00085735|7151222|FG000|Overall Study|Excess residual disease|2
4375383|NCT00085735|7151223|FG001|Overall Study|Excess residual disease|2
4375384|NCT00085735|7151224|FG002|Overall Study|Excess residual disease|1
4375385|NCT00085735|7151225|FG003|Overall Study|Excess residual disease|1
4375386|NCT00085735|7151226|FG004|Overall Study|Excess residual disease|1
4587607|NCT01492426|7431764|FG001|Treatment|Lost to Follow-up|4
4375387|NCT00085735|7151227|FG005|Overall Study|Excess residual disease|4
4375388|NCT00085735|7151222|FG000|Overall Study|Reason not documented|1
4375389|NCT00085735|7151223|FG001|Overall Study|Reason not documented|0
4375390|NCT00085735|7151224|FG002|Overall Study|Reason not documented|1
4375391|NCT00085735|7151225|FG003|Overall Study|Reason not documented|0
4375392|NCT00085735|7151226|FG004|Overall Study|Reason not documented|1
4375393|NCT00085735|7151227|FG005|Overall Study|Reason not documented|0
4375394|NCT00085735|7151222|FG000|Overall Study|Pt transferred to inst w/out study open|1
4375395|NCT00085735|7151223|FG001|Overall Study|Pt transferred to inst w/out study open|0
4375396|NCT00085735|7151224|FG002|Overall Study|Pt transferred to inst w/out study open|0
4375397|NCT00085735|7151225|FG003|Overall Study|Pt transferred to inst w/out study open|0
4375398|NCT00085735|7151226|FG004|Overall Study|Pt transferred to inst w/out study open|0
4375399|NCT00085735|7151227|FG005|Overall Study|Pt transferred to inst w/out study open|0
4375400|NCT00002874|7151265|FG000|Overall Study|Withdrawal by Subject|1
4375401|NCT00002874|7151266|FG001|Overall Study|Withdrawal by Subject|1
4375402|NCT00002874|7151265|FG000|Overall Study|Protocol Violation|44
4375403|NCT00002874|7151266|FG001|Overall Study|Protocol Violation|34
4465616|NCT00611455|7257008|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
4465617|NCT00611455|7257009|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12
4465618|NCT00611455|7257010|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
4465619|NCT00611455|7257008|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
4465620|NCT00611455|7257009|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110
4465621|NCT00611455|7257010|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
4465622|NCT00611455|7257008|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0
4465623|NCT00611455|7257009|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5
4465624|NCT00611455|7257010|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0
4465625|NCT00611455|7257008|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0
4465626|NCT00611455|7257009|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5
4465627|NCT00611455|7257010|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0
4465628|NCT00611455|7257008|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
4465629|NCT00611455|7257009|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18
4465630|NCT00611455|7257010|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
4465631|NCT00611455|7257008|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0
4465632|NCT00611455|7257009|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0
4465633|NCT00611455|7257010|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30
4465634|NCT00611455|7257008|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0
4465635|NCT00611455|7257009|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0
4465636|NCT00611455|7257010|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12
4465637|NCT00611455|7257008|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0
4465638|NCT00611455|7257009|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0
4465639|NCT00611455|7257010|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4
4465640|NCT00611455|7257008|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0
4465641|NCT00611455|7257009|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0
4465642|NCT00611455|7257010|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23
4465643|NCT00611455|7257008|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0
4465644|NCT00611455|7257009|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0
4465645|NCT00611455|7257010|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80
4465646|NCT00611455|7257008|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0
4465647|NCT00611455|7257009|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0
4465648|NCT00611455|7257010|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13
4465649|NCT00611455|7257008|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0
4465650|NCT00611455|7257009|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0
4465651|NCT00611455|7257010|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49
4375404|NCT04399356|7151274|FG000|Overall Study|Lost to Follow-up|1
4375405|NCT04399356|7151275|FG001|Overall Study|Lost to Follow-up|1
4375406|NCT04399356|7151274|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1
4375407|NCT04399356|7151275|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2
4375408|NCT04399356|7151274|FG000|Overall Study|Withdrawal by Subject|1
4375409|NCT04399356|7151275|FG001|Overall Study|Withdrawal by Subject|0
4375410|NCT04156399|7151305|FG000|Overall Study|hospitalization unrelated to acupuncture|1
4375411|NCT04156399|7151305|FG000|Overall Study|study suspension due to COVID pandemic|3
4375412|NCT04052620|7151324|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1
4375413|NCT04052620|7151325|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0
4375414|NCT04052620|7151324|FG000|Overall Study|Withdrawal by Subject|1
4375415|NCT04052620|7151325|FG001|Overall Study|Withdrawal by Subject|0
4375416|NCT04052620|7151324|FG000|Overall Study|Lost to Follow-up|1
4375417|NCT04052620|7151325|FG001|Overall Study|Lost to Follow-up|1
4375418|NCT04052620|7151324|FG000|Overall Study|Adverse Event|1
4375419|NCT04052620|7151325|FG001|Overall Study|Adverse Event|0
4375420|NCT04052620|7151324|FG000|Overall Study|Subject did not meet study Criteria|0
4375421|NCT04052620|7151325|FG001|Overall Study|Subject did not meet study Criteria|1
4375422|NCT04052620|7151324|FG000|Overall Study|Screened failure, randomized by mistake|0
4375423|NCT04052620|7151325|FG001|Overall Study|Screened failure, randomized by mistake|1
4375424|NCT04052620|7151324|FG000|Overall Study|Personal reasons|2
4375425|NCT04052620|7151325|FG001|Overall Study|Personal reasons|4
4375426|NCT04052620|7151324|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1
4375427|NCT04052620|7151325|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0
4375428|NCT03933449|7151333|FG000|Overall Study|Adverse Event|6
4375429|NCT03933449|7151334|FG001|Overall Study|Adverse Event|4
4375430|NCT03933449|7151333|FG000|Overall Study|Death|36
4375431|NCT03933449|7151334|FG001|Overall Study|Death|51
4375432|NCT03933449|7151333|FG000|Overall Study|Ongoing in Study|20
4375433|NCT03933449|7151334|FG001|Overall Study|Ongoing in Study|6
4375434|NCT03826667|7151340|FG000|Overall Study|Protocol deviation|21
4375435|NCT03600909|7151353|FG000|Overall Study|Not treated|0
4375436|NCT03600909|7151354|FG001|Overall Study|Not treated|3
4375437|NCT03600909|7151355|FG002|Overall Study|Not treated|0
4375438|NCT03366428|7151371|FG000|Overall Study|Progressive disease per RECIST v1.1|33
4375439|NCT03366428|7151371|FG000|Overall Study|Adverse Event|12
4375440|NCT03366428|7151371|FG000|Overall Study|Clinical progression|2
4587608|NCT01492426|7431763|FG000|Treatment|Participant does not meet study criteria|1
4587609|NCT01492426|7431764|FG001|Treatment|Participant does not meet study criteria|0
4587610|NCT01492426|7431763|FG000|Follow-Up|Protocol Requires no Follow-Up|2
4587611|NCT01492426|7431764|FG001|Follow-Up|Protocol Requires no Follow-Up|1
4587612|NCT01492426|7431763|FG000|Follow-Up|Death|1
4587613|NCT01492426|7431764|FG001|Follow-Up|Death|0
4587614|NCT01492426|7431763|FG000|Follow-Up|Other|4
4587615|NCT01492426|7431764|FG001|Follow-Up|Other|2
4375441|NCT03366428|7151371|FG000|Overall Study|Withdrawal by Subject|4
4375442|NCT03131219|7151383|FG000|Initial Evaluation Period|Adverse Event|1
4375443|NCT03131219|7151384|FG001|Initial Evaluation Period|Adverse Event|0
4375444|NCT03131219|7151383|FG000|Initial Evaluation Period|Protocol Violation|1
4375445|NCT03131219|7151384|FG001|Initial Evaluation Period|Protocol Violation|0
4375446|NCT03131219|7151383|FG000|Initial Evaluation Period|Deemed ineligible post treatment|2
4375447|NCT03131219|7151384|FG001|Initial Evaluation Period|Deemed ineligible post treatment|0
4375448|NCT03075527|7151390|FG000|Overall Study|Ongoing treatment|2
4375449|NCT02756611|7151394|FG000|Overall Study|Death|39
4375450|NCT02756611|7151394|FG000|Overall Study|Withdrawal by Subject|1
4375451|NCT02756611|7151394|FG000|Overall Study|Lost to Follow-up|2
4375452|NCT02756611|7151394|FG000|Overall Study|Other|7
4375453|NCT02756611|7151394|FG000|Overall Study|Missing|2
4375454|NCT02756611|7151394|FG000|Overall Study|Active on Study|205
4375455|NCT02724878|7151398|FG000|Overall Study|Still on Active Therapy|15
4375456|NCT02724878|7151398|FG000|Overall Study|Disease Progression|31
4375457|NCT02724878|7151398|FG000|Overall Study|Toxicity|5
4375458|NCT02724878|7151398|FG000|Overall Study|Death|1
4375459|NCT02724878|7151398|FG000|Overall Study|Withdrawal by Subject|4
4375460|NCT02724878|7151398|FG000|Overall Study|Lost to Follow-up|2
4375461|NCT02724878|7151398|FG000|Overall Study|Protocol Violation|1
4375462|NCT02724878|7151398|FG000|Overall Study|Ineligible for Study Drug|5
4375463|NCT02724878|7151398|FG000|Overall Study|not started|1
4375464|NCT02562235|7151419|FG000|Overall Study|Adverse Event|3
4375465|NCT02487095|7151442|FG000|Dose Expansion|Unable to scan/restage participant|0
4375466|NCT02487095|7151443|FG001|Dose Expansion|Unable to scan/restage participant|0
4375467|NCT02487095|7151444|FG002|Dose Expansion|Unable to scan/restage participant|0
4375468|NCT02487095|7151445|FG003|Dose Expansion|Unable to scan/restage participant|0
4375469|NCT02487095|7151446|FG004|Dose Expansion|Unable to scan/restage participant|1
4587616|NCT01492426|7431763|FG000|Follow-Up|Participant Withdrew Consent|6
4465652|NCT00611533|7257027|FG000|First Intervention (6 Weeks)|Never started study|0
4465653|NCT00611533|7257028|FG001|First Intervention (6 Weeks)|Never started study|1
4465654|NCT00611533|7257027|FG000|First Intervention (6 Weeks)|Adverse Event|0
4465655|NCT00611533|7257028|FG001|First Intervention (6 Weeks)|Adverse Event|1
4465656|NCT00611533|7257027|FG000|Second Intervention (6 Weeks)|Adverse Event|0
4587617|NCT01492426|7431764|FG001|Follow-Up|Participant Withdrew Consent|1
4465657|NCT00611533|7257028|FG001|Second Intervention (6 Weeks)|Adverse Event|2
4465658|NCT00611559|7257038|FG000|Overall Study|Lost to Follow-up|0
4465659|NCT00611559|7257039|FG001|Overall Study|Lost to Follow-up|1
4465660|NCT00611559|7257040|FG002|Overall Study|Lost to Follow-up|0
4465661|NCT00611559|7257038|FG000|Overall Study|Protocol Violation|1
4465662|NCT00611559|7257039|FG001|Overall Study|Protocol Violation|0
4465663|NCT00611559|7257040|FG002|Overall Study|Protocol Violation|1
4465664|NCT00611715|7257055|FG000|Overall Study|Disease Progression|24
4465665|NCT00611715|7257056|FG001|Overall Study|Disease Progression|4
4465666|NCT00611715|7257055|FG000|Overall Study|Withdrawal by Subject|5
4465667|NCT00611715|7257056|FG001|Overall Study|Withdrawal by Subject|1
4465668|NCT00611715|7257055|FG000|Overall Study|Adverse Event|9
4587618|NCT01492426|7431763|FG000|Follow-Up|Lost to Follow-up|12
4587619|NCT01492426|7431764|FG001|Follow-Up|Lost to Follow-up|6
4587620|NCT01492439|7431776|FG000|Overall Study|Withdrew from RTE|4
4587621|NCT01492439|7431777|FG001|Overall Study|Withdrew from RTE|9
4587622|NCT01492686|7431815|FG000|Double-blind Phase|Adverse Event|0
4694804|NCT02611830|7606401|FG002|Maintenance Phase|Voluntary Withdrawal|2
4694805|NCT02611830|7606402|FG003|Maintenance Phase|Voluntary Withdrawal|5
4694806|NCT02611830|7606399|FG000|Maintenance Phase|Pregnancy|0
4694807|NCT02611830|7606400|FG001|Maintenance Phase|Pregnancy|0
4694808|NCT02611830|7606401|FG002|Maintenance Phase|Pregnancy|1
4694809|NCT02611830|7606402|FG003|Maintenance Phase|Pregnancy|0
4694810|NCT02611830|7606399|FG000|Maintenance Phase|Reason not specified|0
4694811|NCT02611830|7606400|FG001|Maintenance Phase|Reason not specified|1
4694812|NCT02611830|7606401|FG002|Maintenance Phase|Reason not specified|4
4694813|NCT02611830|7606402|FG003|Maintenance Phase|Reason not specified|0
4694814|NCT02611882|7606414|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33
4694815|NCT02611882|7606415|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0
4694816|NCT02611882|7606416|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0
4694817|NCT02612064|7606425|FG000|Overall Study|Withdrawal by Subject|1
4694818|NCT02612064|7606426|FG001|Overall Study|Withdrawal by Subject|1
4694819|NCT02612064|7606425|FG000|Overall Study|Other|0
4694820|NCT02612064|7606426|FG001|Overall Study|Other|2
4694821|NCT02612077|7606432|FG000|Overall Study|Adverse Event|3
4694822|NCT02612077|7606432|FG000|Overall Study|Withdrawal by Subject|9
4694823|NCT02612077|7606432|FG000|Overall Study|Protocol Violation|28
4694824|NCT02612077|7606432|FG000|Overall Study|Lost to Follow-up|20
4694825|NCT02612077|7606432|FG000|Overall Study|Death|377
4694826|NCT02612077|7606432|FG000|Overall Study|Moved or Changed Medical Team|23
4694827|NCT02612077|7606432|FG000|Overall Study|Enrollment in a Clinical Trial|1
4694828|NCT02612077|7606432|FG000|Overall Study|Disease Progression|3
4694829|NCT02612077|7606432|FG000|Overall Study|Unknown reason|2
4694830|NCT02612155|7606441|FG000|Overall Study|Death|1
4694831|NCT02612155|7606442|FG001|Overall Study|Death|1
4694832|NCT02612155|7606441|FG000|Overall Study|Lost to Follow-up|2
4694833|NCT02612155|7606442|FG001|Overall Study|Lost to Follow-up|2
4694834|NCT02612428|7606450|FG000|VTL-308|Death|14
4694835|NCT02612428|7606451|FG001|VTL-308|Death|16
4694836|NCT02612428|7606450|FG000|VTL-308|Withdrawal by Subject|0
4694837|NCT02612428|7606451|FG001|VTL-308|Withdrawal by Subject|1
4694838|NCT02612428|7606450|FG000|VTL-308E|Death|9
4694839|NCT02612428|7606451|FG001|VTL-308E|Death|7
4694840|NCT02612428|7606450|FG000|VTL-308E|Lost to Follow-up|2
4694841|NCT02612428|7606451|FG001|VTL-308E|Lost to Follow-up|0
4735056|NCT03518658|7682607|FG000|Overall Study|Other|51
4735057|NCT03518658|7682608|FG001|Overall Study|Other|0
4735058|NCT03518840|7682616|FG000|Overall Study|Lost to Follow-up|6
4735059|NCT03519087|7682625|FG000|Clinic Evaluation|Physician Decision|15
4735060|NCT03519087|7682626|FG001|Clinic Evaluation|Physician Decision|18
4735061|NCT03519087|7682627|FG002|Clinic Evaluation|Physician Decision|0
4735062|NCT03519087|7682628|FG003|Clinic Evaluation|Physician Decision|0
4735063|NCT03519087|7682629|FG004|Clinic Evaluation|Physician Decision|0
4735064|NCT03519087|7682625|FG000|Clinic Evaluation|Protocol Violation|1
4587623|NCT01492686|7431816|FG001|Double-blind Phase|Adverse Event|2
4587624|NCT01492686|7431815|FG000|Double-blind Phase|Physician Decision|0
4587625|NCT01492686|7431816|FG001|Double-blind Phase|Physician Decision|1
4587626|NCT01492686|7431815|FG000|Double-blind Phase|Withdrawal by Subject|0
4587627|NCT01492686|7431816|FG001|Double-blind Phase|Withdrawal by Subject|2
4735065|NCT03519087|7682626|FG001|Clinic Evaluation|Protocol Violation|0
4735066|NCT03519087|7682627|FG002|Clinic Evaluation|Protocol Violation|0
4735067|NCT03519087|7682628|FG003|Clinic Evaluation|Protocol Violation|0
4735068|NCT03519087|7682629|FG004|Clinic Evaluation|Protocol Violation|0
4735069|NCT03519087|7682625|FG000|Re-randomization for Treatment|Withdrawal by Subject|25
4735070|NCT03519087|7682626|FG001|Re-randomization for Treatment|Withdrawal by Subject|29
4735071|NCT03519087|7682627|FG002|Re-randomization for Treatment|Withdrawal by Subject|0
4735072|NCT03519087|7682628|FG003|Re-randomization for Treatment|Withdrawal by Subject|0
4735073|NCT03519087|7682629|FG004|Re-randomization for Treatment|Withdrawal by Subject|0
4465669|NCT00611715|7257056|FG001|Overall Study|Adverse Event|1
4375490|NCT02335658|7151502|FG000|Overall Study|Adverse Event|18
4587628|NCT01492686|7431815|FG000|Double-blind Phase|Due to a discontinuation criterion|2
4735074|NCT03519087|7682625|FG000|Re-randomization for Treatment|Not appropriate|2
4735075|NCT03519087|7682626|FG001|Re-randomization for Treatment|Not appropriate|3
4375491|NCT02335658|7151503|FG001|Overall Study|Adverse Event|12
4375492|NCT02335658|7151502|FG000|Overall Study|Lack of Efficacy|4
4375493|NCT02335658|7151503|FG001|Overall Study|Lack of Efficacy|5
4375494|NCT02335658|7151502|FG000|Overall Study|Pregnancy|1
4375495|NCT02335658|7151503|FG001|Overall Study|Pregnancy|0
4375496|NCT02335658|7151502|FG000|Overall Study|Withdrawal by Subject|13
4375497|NCT02335658|7151503|FG001|Overall Study|Withdrawal by Subject|21
4375498|NCT02335658|7151502|FG000|Overall Study|non-compliance|2
4375499|NCT02335658|7151503|FG001|Overall Study|non-compliance|3
4375500|NCT02335658|7151502|FG000|Overall Study|other reason|2
4375501|NCT02335658|7151503|FG001|Overall Study|other reason|3
4375502|NCT02287584|7151514|FG000|the Double-blind Phase|Adverse Event|17
4375503|NCT02287584|7151515|FG001|the Double-blind Phase|Adverse Event|17
4375504|NCT02287584|7151516|FG002|the Double-blind Phase|Adverse Event|12
4375505|NCT02287584|7151517|FG003|the Double-blind Phase|Adverse Event|0
4465670|NCT00611715|7257055|FG000|Overall Study|Death|1
4465671|NCT00611715|7257056|FG001|Overall Study|Death|0
4694842|NCT02612610|7606461|FG000|Overall Study|Withdrawal by Subject|1
4694843|NCT02612610|7606462|FG001|Overall Study|Withdrawal by Subject|1
4694844|NCT02612610|7606463|FG002|Overall Study|Withdrawal by Subject|0
4694845|NCT02612610|7606464|FG003|Overall Study|Withdrawal by Subject|2
4694846|NCT02612610|7606461|FG000|Overall Study|Adverse Event|2
4694847|NCT02612610|7606462|FG001|Overall Study|Adverse Event|2
4694848|NCT02612610|7606463|FG002|Overall Study|Adverse Event|3
4694849|NCT02612610|7606464|FG003|Overall Study|Adverse Event|10
4694850|NCT02612610|7606461|FG000|Overall Study|Lost to Follow-up|0
4694851|NCT02612610|7606462|FG001|Overall Study|Lost to Follow-up|1
4694852|NCT02612610|7606463|FG002|Overall Study|Lost to Follow-up|0
4694853|NCT02612610|7606464|FG003|Overall Study|Lost to Follow-up|0
4694854|NCT02612610|7606461|FG000|Overall Study|Protocol Violation|0
4694855|NCT02612610|7606462|FG001|Overall Study|Protocol Violation|1
4694856|NCT02612610|7606463|FG002|Overall Study|Protocol Violation|1
4694857|NCT02612610|7606464|FG003|Overall Study|Protocol Violation|0
4694858|NCT02612610|7606461|FG000|Overall Study|Lack of Efficacy|1
4694859|NCT02612610|7606462|FG001|Overall Study|Lack of Efficacy|2
4694860|NCT02612610|7606463|FG002|Overall Study|Lack of Efficacy|0
4694861|NCT02612610|7606464|FG003|Overall Study|Lack of Efficacy|1
4694862|NCT02612610|7606461|FG000|Overall Study|Physician Decision|0
4694863|NCT02612610|7606462|FG001|Overall Study|Physician Decision|1
4694864|NCT02612610|7606463|FG002|Overall Study|Physician Decision|0
4694865|NCT02612610|7606464|FG003|Overall Study|Physician Decision|0
4694866|NCT02612610|7606461|FG000|Overall Study|Noncompliance|1
4694867|NCT02612610|7606462|FG001|Overall Study|Noncompliance|0
4694868|NCT02612610|7606463|FG002|Overall Study|Noncompliance|0
4694869|NCT02612610|7606464|FG003|Overall Study|Noncompliance|0
4694870|NCT02612610|7606461|FG000|Overall Study|Cough Improvement|0
4694871|NCT02612610|7606462|FG001|Overall Study|Cough Improvement|0
4694872|NCT02612610|7606463|FG002|Overall Study|Cough Improvement|1
4694873|NCT02612610|7606464|FG003|Overall Study|Cough Improvement|0
4694874|NCT02612623|7606478|FG000|Overall Study|Withdrawal by Subject|0
4694875|NCT02612623|7606479|FG001|Overall Study|Withdrawal by Subject|1
4694876|NCT02612623|7606480|FG002|Overall Study|Withdrawal by Subject|0
4694877|NCT02612623|7606481|FG003|Overall Study|Withdrawal by Subject|0
4694878|NCT02612623|7606478|FG000|Overall Study|Adverse Event|1
4694879|NCT02612623|7606479|FG001|Overall Study|Adverse Event|0
4694880|NCT02612623|7606480|FG002|Overall Study|Adverse Event|1
4694881|NCT02612623|7606481|FG003|Overall Study|Adverse Event|0
4694882|NCT02612727|7606504|FG000|Overall Study|Parent request|4
4694883|NCT02612727|7606505|FG001|Overall Study|Parent request|1
4694884|NCT02612727|7606504|FG000|Overall Study|Needed treatment incompatible with PT|1
4694885|NCT02612727|7606505|FG001|Overall Study|Needed treatment incompatible with PT|1
4694886|NCT02612727|7606504|FG000|Overall Study|Direct hyperbilirubinemia|0
4694887|NCT02612727|7606505|FG001|Overall Study|Direct hyperbilirubinemia|2
4694888|NCT02612779|7606513|FG000|Overall Study|Administrative reason by sponsor|4
4694889|NCT02612779|7606514|FG001|Overall Study|Administrative reason by sponsor|1
4694890|NCT02612779|7606513|FG000|Overall Study|No longer meet study criteria|0
4694891|NCT02612779|7606514|FG001|Overall Study|No longer meet study criteria|1
4694892|NCT02612779|7606513|FG000|Overall Study|Disease progression|29
4375506|NCT02287584|7151518|FG004|the Double-blind Phase|Adverse Event|0
4375507|NCT02287584|7151519|FG005|the Double-blind Phase|Adverse Event|0
4375508|NCT02287584|7151514|FG000|the Double-blind Phase|Lack of Efficacy|18
4375509|NCT02287584|7151515|FG001|the Double-blind Phase|Lack of Efficacy|8
4375510|NCT02287584|7151516|FG002|the Double-blind Phase|Lack of Efficacy|8
4375511|NCT02287584|7151517|FG003|the Double-blind Phase|Lack of Efficacy|0
4375512|NCT02287584|7151518|FG004|the Double-blind Phase|Lack of Efficacy|0
4375513|NCT02287584|7151519|FG005|the Double-blind Phase|Lack of Efficacy|0
4375514|NCT02287584|7151514|FG000|the Double-blind Phase|Lost to Follow-up|0
4375515|NCT02287584|7151515|FG001|the Double-blind Phase|Lost to Follow-up|1
4694893|NCT02612779|7606514|FG001|Overall Study|Disease progression|2
4694894|NCT02612779|7606513|FG000|Overall Study|Study drug toxicity|10
4694895|NCT02612779|7606514|FG001|Overall Study|Study drug toxicity|1
4694896|NCT02612779|7606513|FG000|Overall Study|Death|1
4694897|NCT02612779|7606514|FG001|Overall Study|Death|0
4375516|NCT02287584|7151516|FG002|the Double-blind Phase|Lost to Follow-up|1
4375517|NCT02287584|7151517|FG003|the Double-blind Phase|Lost to Follow-up|0
4375518|NCT02287584|7151518|FG004|the Double-blind Phase|Lost to Follow-up|0
4375519|NCT02287584|7151519|FG005|the Double-blind Phase|Lost to Follow-up|0
4465672|NCT00611715|7257055|FG000|Overall Study|two patients are still on treatment|2
4465673|NCT00611715|7257056|FG001|Overall Study|two patients are still on treatment|0
4465674|NCT00611767|7257070|FG000|Overall Study|Withdrawal by Subject|4
4465675|NCT00611767|7257071|FG001|Overall Study|Withdrawal by Subject|1
4465676|NCT00611767|7257070|FG000|Overall Study|Thiopental not available|3
4465677|NCT00611767|7257071|FG001|Overall Study|Thiopental not available|0
4694898|NCT02612779|7606513|FG000|Overall Study|Adverse event unrelated to study drug|5
4694899|NCT02612779|7606514|FG001|Overall Study|Adverse event unrelated to study drug|0
4694900|NCT02612779|7606513|FG000|Overall Study|Participant withdrew consent|4
4694901|NCT02612779|7606514|FG001|Overall Study|Participant withdrew consent|0
4694902|NCT02612779|7606513|FG000|Overall Study|Lost to Follow-up|1
4694903|NCT02612779|7606514|FG001|Overall Study|Lost to Follow-up|0
4694904|NCT02612779|7606513|FG000|Overall Study|Maximum clinical benefit|10
4694905|NCT02612779|7606514|FG001|Overall Study|Maximum clinical benefit|1
4694906|NCT02612779|7606513|FG000|Overall Study|Other reasons|4
4694907|NCT02612779|7606514|FG001|Overall Study|Other reasons|0
4694908|NCT02612909|7606539|FG000|Phase 2|Withdrawal by Subject|2
4694909|NCT02612909|7606540|FG001|Phase 2|Withdrawal by Subject|5
4694910|NCT02612909|7606541|FG002|Phase 2|Withdrawal by Subject|0
4694911|NCT02612909|7606542|FG003|Phase 2|Withdrawal by Subject|0
4694912|NCT02612909|7606543|FG004|Phase 2|Withdrawal by Subject|0
4694913|NCT02612909|7606539|FG000|Phase 2|Pregnancy|0
4694914|NCT02612909|7606540|FG001|Phase 2|Pregnancy|0
4694915|NCT02612909|7606541|FG002|Phase 2|Pregnancy|1
4694916|NCT02612909|7606542|FG003|Phase 2|Pregnancy|0
4694917|NCT02612909|7606543|FG004|Phase 2|Pregnancy|0
4694918|NCT02612909|7606539|FG000|Phase 3|Withdrawal by Subject|0
4694919|NCT02612909|7606540|FG001|Phase 3|Withdrawal by Subject|0
4694920|NCT02612909|7606541|FG002|Phase 3|Withdrawal by Subject|0
4694921|NCT02612909|7606542|FG003|Phase 3|Withdrawal by Subject|1
4694922|NCT02612909|7606543|FG004|Phase 3|Withdrawal by Subject|0
4694923|NCT02613169|7606568|FG000|Overall Study|Withdrawal by Subject|4
4694924|NCT02613169|7606569|FG001|Overall Study|Withdrawal by Subject|1
4694925|NCT02613169|7606568|FG000|Overall Study|Lost to Follow-up|0
4694926|NCT02613169|7606569|FG001|Overall Study|Lost to Follow-up|5
4694927|NCT02613169|7606568|FG000|Overall Study|HIV|0
4694928|NCT02613169|7606569|FG001|Overall Study|HIV|2
4694929|NCT02613169|7606568|FG000|Overall Study|No TB infection endpoint|14
4694930|NCT02613169|7606569|FG001|Overall Study|No TB infection endpoint|9
4694931|NCT02613182|7606575|FG000|Overall Study|Death|6
4694932|NCT02613182|7606575|FG000|Overall Study|Physician Decision|1
4694933|NCT02613182|7606575|FG000|Overall Study|Study Terminated by Sponsor|21
4694934|NCT02613182|7606575|FG000|Overall Study|Withdrawal by Subject|6
4694935|NCT02613208|7606579|FG000|Overall Study|Withdrawal by Subject|1
4694936|NCT02613208|7606579|FG000|Overall Study|Change of address|2
4694937|NCT02613208|7606579|FG000|Overall Study|Physician Decision|2
4694938|NCT02613208|7606579|FG000|Overall Study|Lost to Follow-up|5
4694939|NCT02613208|7606579|FG000|Overall Study|Death|37
4694940|NCT02613221|7606583|FG000|Overall Study|Lack of efficacy (exacerbation)|50
4694941|NCT02613221|7606583|FG000|Overall Study|Adverse Event|2
4694942|NCT02613221|7606583|FG000|Overall Study|Voluntary Discontinuation|1
4694943|NCT02613221|7606583|FG000|Overall Study|Delayed Treatment|1
4694944|NCT02613221|7606583|FG000|Overall Study|Enrolled but Not Treated|1
4694945|NCT02613364|7606594|FG000|Overall Study|Other|19
4694946|NCT02613364|7606595|FG001|Overall Study|Other|29
4694947|NCT02613364|7606596|FG002|Overall Study|Other|17
4694948|NCT02613364|7606594|FG000|Overall Study|Too time consuming|21
4694949|NCT02613364|7606595|FG001|Overall Study|Too time consuming|26
4694950|NCT02613364|7606596|FG002|Overall Study|Too time consuming|26
4694951|NCT02613364|7606594|FG000|Overall Study|Withdrawal by Subject|13
4694952|NCT02613364|7606595|FG001|Overall Study|Withdrawal by Subject|18
4694953|NCT02613364|7606596|FG002|Overall Study|Withdrawal by Subject|17
4694954|NCT02613364|7606594|FG000|Overall Study|Medical|12
4694955|NCT02613364|7606595|FG001|Overall Study|Medical|13
4694956|NCT02613364|7606596|FG002|Overall Study|Medical|9
4694957|NCT02613364|7606594|FG000|Overall Study|Disliked Study Procedure|1
4694958|NCT02613364|7606595|FG001|Overall Study|Disliked Study Procedure|1
4694959|NCT02613364|7606596|FG002|Overall Study|Disliked Study Procedure|4
4694960|NCT02613364|7606594|FG000|Overall Study|Disliked Intervention|0
4694961|NCT02613364|7606595|FG001|Overall Study|Disliked Intervention|3
4694962|NCT02613364|7606596|FG002|Overall Study|Disliked Intervention|3
4694963|NCT02613403|7606608|FG000|Overall Study|Lost to Follow-up|0
4694964|NCT02613403|7606609|FG001|Overall Study|Lost to Follow-up|1
4694965|NCT02613403|7606610|FG002|Overall Study|Lost to Follow-up|0
4694966|NCT02613403|7606611|FG003|Overall Study|Lost to Follow-up|0
4694967|NCT02613403|7606612|FG004|Overall Study|Lost to Follow-up|0
4694968|NCT02613403|7606608|FG000|Overall Study|Withdrawal by Subject|2
4694969|NCT02613403|7606609|FG001|Overall Study|Withdrawal by Subject|0
4694970|NCT02613403|7606610|FG002|Overall Study|Withdrawal by Subject|0
4694971|NCT02613403|7606611|FG003|Overall Study|Withdrawal by Subject|0
4465678|NCT00611767|7257070|FG000|Overall Study|didn't like the medication|1
4465679|NCT00611767|7257071|FG001|Overall Study|didn't like the medication|1
4694972|NCT02613403|7606612|FG004|Overall Study|Withdrawal by Subject|0
4694973|NCT02613481|7606622|FG000|Overall Study|Lost to Follow-up|7
4375520|NCT02287584|7151514|FG000|the Double-blind Phase|Withdrawal by Subject|17
4375521|NCT02287584|7151515|FG001|the Double-blind Phase|Withdrawal by Subject|17
4375522|NCT02287584|7151516|FG002|the Double-blind Phase|Withdrawal by Subject|11
4375523|NCT02287584|7151517|FG003|the Double-blind Phase|Withdrawal by Subject|0
4375524|NCT02287584|7151518|FG004|the Double-blind Phase|Withdrawal by Subject|0
4375525|NCT02287584|7151519|FG005|the Double-blind Phase|Withdrawal by Subject|0
4375526|NCT02287584|7151514|FG000|the Double-blind Phase|Pregnancy|0
4375527|NCT02287584|7151515|FG001|the Double-blind Phase|Pregnancy|1
4375528|NCT02287584|7151516|FG002|the Double-blind Phase|Pregnancy|0
4375529|NCT02287584|7151517|FG003|the Double-blind Phase|Pregnancy|0
4375530|NCT02287584|7151518|FG004|the Double-blind Phase|Pregnancy|0
4375531|NCT02287584|7151519|FG005|the Double-blind Phase|Pregnancy|0
4375532|NCT02287584|7151514|FG000|the Double-blind Phase|Protocol Violation|0
4375533|NCT02287584|7151515|FG001|the Double-blind Phase|Protocol Violation|3
4375534|NCT02287584|7151516|FG002|the Double-blind Phase|Protocol Violation|0
4375535|NCT02287584|7151517|FG003|the Double-blind Phase|Protocol Violation|0
4375536|NCT02287584|7151518|FG004|the Double-blind Phase|Protocol Violation|0
4375537|NCT02287584|7151519|FG005|the Double-blind Phase|Protocol Violation|0
4375538|NCT02287584|7151514|FG000|the Double-blind Phase|other reasons|0
4375539|NCT02287584|7151515|FG001|the Double-blind Phase|other reasons|0
4375540|NCT02287584|7151516|FG002|the Double-blind Phase|other reasons|1
4375541|NCT02287584|7151517|FG003|the Double-blind Phase|other reasons|0
4375542|NCT02287584|7151518|FG004|the Double-blind Phase|other reasons|0
4375543|NCT02287584|7151519|FG005|the Double-blind Phase|other reasons|0
4375544|NCT02287584|7151514|FG000|the Open-label Phase|Did not receive drug|0
4375545|NCT02287584|7151515|FG001|the Open-label Phase|Did not receive drug|0
4375546|NCT02287584|7151516|FG002|the Open-label Phase|Did not receive drug|0
4375547|NCT02287584|7151517|FG003|the Open-label Phase|Did not receive drug|7
4375548|NCT02287584|7151518|FG004|the Open-label Phase|Did not receive drug|6
4375549|NCT02287584|7151519|FG005|the Open-label Phase|Did not receive drug|4
4375550|NCT02287584|7151514|FG000|the Open-label Phase|Adverse Event|0
4375551|NCT02287584|7151515|FG001|the Open-label Phase|Adverse Event|0
4375552|NCT02287584|7151516|FG002|the Open-label Phase|Adverse Event|0
4375553|NCT02287584|7151517|FG003|the Open-label Phase|Adverse Event|15
4375554|NCT02287584|7151518|FG004|the Open-label Phase|Adverse Event|12
4375555|NCT02287584|7151519|FG005|the Open-label Phase|Adverse Event|16
4375556|NCT02287584|7151514|FG000|the Open-label Phase|Lack of Efficacy|0
4375557|NCT02287584|7151515|FG001|the Open-label Phase|Lack of Efficacy|0
4375558|NCT02287584|7151516|FG002|the Open-label Phase|Lack of Efficacy|0
4375559|NCT02287584|7151517|FG003|the Open-label Phase|Lack of Efficacy|8
4375560|NCT02287584|7151518|FG004|the Open-label Phase|Lack of Efficacy|3
4375561|NCT02287584|7151519|FG005|the Open-label Phase|Lack of Efficacy|7
4375562|NCT02287584|7151514|FG000|the Open-label Phase|Lost to Follow-up|0
4375563|NCT02287584|7151515|FG001|the Open-label Phase|Lost to Follow-up|0
4375564|NCT02287584|7151516|FG002|the Open-label Phase|Lost to Follow-up|0
4375565|NCT02287584|7151517|FG003|the Open-label Phase|Lost to Follow-up|4
4375566|NCT02287584|7151518|FG004|the Open-label Phase|Lost to Follow-up|1
4375567|NCT02287584|7151519|FG005|the Open-label Phase|Lost to Follow-up|2
4375568|NCT02287584|7151514|FG000|the Open-label Phase|Withdrawal by Subject|0
4375569|NCT02287584|7151515|FG001|the Open-label Phase|Withdrawal by Subject|0
4375570|NCT02287584|7151516|FG002|the Open-label Phase|Withdrawal by Subject|0
4375571|NCT02287584|7151517|FG003|the Open-label Phase|Withdrawal by Subject|18
4375572|NCT02287584|7151518|FG004|the Open-label Phase|Withdrawal by Subject|29
4375573|NCT02287584|7151519|FG005|the Open-label Phase|Withdrawal by Subject|21
4375574|NCT02287584|7151514|FG000|the Open-label Phase|non-compliance|0
4375575|NCT02287584|7151515|FG001|the Open-label Phase|non-compliance|0
4375576|NCT02287584|7151516|FG002|the Open-label Phase|non-compliance|0
4375577|NCT02287584|7151517|FG003|the Open-label Phase|non-compliance|2
4375578|NCT02287584|7151518|FG004|the Open-label Phase|non-compliance|5
4375579|NCT02287584|7151519|FG005|the Open-label Phase|non-compliance|1
4375580|NCT02287584|7151514|FG000|the Open-label Phase|other reasons|0
4375581|NCT02287584|7151515|FG001|the Open-label Phase|other reasons|0
4375582|NCT02287584|7151516|FG002|the Open-label Phase|other reasons|0
4375583|NCT02287584|7151517|FG003|the Open-label Phase|other reasons|3
4375584|NCT02287584|7151518|FG004|the Open-label Phase|other reasons|6
4375585|NCT02287584|7151519|FG005|the Open-label Phase|other reasons|6
4375586|NCT02178566|7151535|FG000|Overall Study|patient did not complete due to noncompliance|0
4375587|NCT02178566|7151536|FG001|Overall Study|patient did not complete due to noncompliance|1
4375588|NCT02173301|7151546|FG000|Overall Study|Adverse Event|7
4375589|NCT02173301|7151547|FG001|Overall Study|Adverse Event|8
4375590|NCT02173301|7151548|FG002|Overall Study|Adverse Event|13
4375591|NCT02173301|7151549|FG003|Overall Study|Adverse Event|5
4375592|NCT02173301|7151546|FG000|Overall Study|Withdrawal by Subject|8
4694974|NCT02613481|7606622|FG000|Overall Study|Withdrawal by Subject|2
4694975|NCT02613507|7606628|FG000|Overall Study|Disease Progression|237
4694976|NCT02613507|7606629|FG001|Overall Study|Disease Progression|109
4694977|NCT02613507|7606628|FG000|Overall Study|Study Drug Toxicity|15
4694978|NCT02613507|7606629|FG001|Overall Study|Study Drug Toxicity|14
4694979|NCT02613507|7606628|FG000|Overall Study|Death|3
4375593|NCT02173301|7151547|FG001|Overall Study|Withdrawal by Subject|10
4694980|NCT02613507|7606629|FG001|Overall Study|Death|0
4375594|NCT02173301|7151548|FG002|Overall Study|Withdrawal by Subject|4
4375595|NCT02173301|7151549|FG003|Overall Study|Withdrawal by Subject|8
4375596|NCT02173301|7151546|FG000|Overall Study|Lost to Follow-up|4
4375597|NCT02173301|7151547|FG001|Overall Study|Lost to Follow-up|4
4375598|NCT02173301|7151548|FG002|Overall Study|Lost to Follow-up|2
4375599|NCT02173301|7151549|FG003|Overall Study|Lost to Follow-up|2
4375600|NCT02173301|7151546|FG000|Overall Study|Protocol Violation|0
4375601|NCT02173301|7151547|FG001|Overall Study|Protocol Violation|1
4375602|NCT02173301|7151548|FG002|Overall Study|Protocol Violation|0
4375603|NCT02173301|7151549|FG003|Overall Study|Protocol Violation|0
4375604|NCT02173301|7151546|FG000|Overall Study|Physician Decision|0
4375605|NCT02173301|7151547|FG001|Overall Study|Physician Decision|0
4375606|NCT02173301|7151548|FG002|Overall Study|Physician Decision|1
4375607|NCT02173301|7151549|FG003|Overall Study|Physician Decision|0
4375608|NCT02173301|7151546|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1
4465680|NCT00611767|7257070|FG000|Overall Study|Physician Decision|1
4587629|NCT01492686|7431816|FG001|Double-blind Phase|Due to a discontinuation criterion|3
4587630|NCT01492686|7431815|FG000|Open-label Phase|Adverse Event|1
4587631|NCT01492686|7431816|FG001|Open-label Phase|Adverse Event|2
4587632|NCT01492686|7431815|FG000|Open-label Phase|Physician Decision|1
4587633|NCT01492686|7431816|FG001|Open-label Phase|Physician Decision|0
4587634|NCT01492686|7431815|FG000|Open-label Phase|Withdrawal by Subject|6
4587635|NCT01492686|7431816|FG001|Open-label Phase|Withdrawal by Subject|7
4694981|NCT02613507|7606628|FG000|Overall Study|Adverse Event Unrelated to Study Drug|17
4694982|NCT02613507|7606629|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2
4694983|NCT02613507|7606628|FG000|Overall Study|Request to Discontinue Study Treatment|8
4694984|NCT02613507|7606629|FG001|Overall Study|Request to Discontinue Study Treatment|17
4694985|NCT02613507|7606628|FG000|Overall Study|Participant Withdrew Consent|0
4694986|NCT02613507|7606629|FG001|Overall Study|Participant Withdrew Consent|2
4694987|NCT02613507|7606628|FG000|Overall Study|Lost to Follow-up|1
4694988|NCT02613507|7606629|FG001|Overall Study|Lost to Follow-up|0
4694989|NCT02613507|7606628|FG000|Overall Study|Maximum Clinical Benefit|4
4694990|NCT02613507|7606629|FG001|Overall Study|Maximum Clinical Benefit|10
4694991|NCT02613507|7606628|FG000|Overall Study|Brain Radiotherapy Activity Limited|1
4694992|NCT02613507|7606629|FG001|Overall Study|Brain Radiotherapy Activity Limited|0
4694993|NCT02613507|7606628|FG000|Overall Study|Subject no Longer Meets Study Criteria|1
4694994|NCT02613507|7606629|FG001|Overall Study|Subject no Longer Meets Study Criteria|0
4694995|NCT02613507|7606628|FG000|Overall Study|Randomized but not Treated|1
4694996|NCT02613507|7606629|FG001|Overall Study|Randomized but not Treated|10
4694997|NCT02613572|7606638|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1
4694998|NCT02613572|7606639|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0
4694999|NCT02613572|7606640|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0
4695000|NCT02613572|7606638|FG000|Phase II: Double-Blind Rand Plac Control|Death|0
4695001|NCT02613572|7606639|FG001|Phase II: Double-Blind Rand Plac Control|Death|1
4695002|NCT02613572|7606640|FG002|Phase II: Double-Blind Rand Plac Control|Death|0
4695003|NCT02613871|7606652|FG000|Overall Study|Death|2
4695004|NCT02613871|7606652|FG000|Overall Study|Withdrew Consent|1
4375609|NCT02173301|7151547|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0
4375610|NCT02173301|7151548|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0
4375611|NCT02173301|7151549|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0
4375612|NCT02043678|7151561|FG000|Overall Study|Never treated|11
4375613|NCT02043678|7151562|FG001|Overall Study|Never treated|9
4375614|NCT02043678|7151561|FG000|Overall Study|AE with clinical progressive disease(PD)|18
4375615|NCT02043678|7151562|FG001|Overall Study|AE with clinical progressive disease(PD)|18
4375616|NCT02043678|7151561|FG000|Overall Study|AE without clinical PD|51
4375617|NCT02043678|7151562|FG001|Overall Study|AE without clinical PD|34
4375618|NCT02043678|7151561|FG000|Overall Study|Lost to Follow-up|1
4375619|NCT02043678|7151562|FG001|Overall Study|Lost to Follow-up|1
4375620|NCT02043678|7151561|FG000|Overall Study|Other|19
4375621|NCT02043678|7151562|FG001|Overall Study|Other|16
4375622|NCT02043678|7151561|FG000|Overall Study|Clinical PD|108
4375623|NCT02043678|7151562|FG001|Overall Study|Clinical PD|138
4375624|NCT02043678|7151561|FG000|Overall Study|Radiological PD|91
4375625|NCT02043678|7151562|FG001|Overall Study|Radiological PD|80
4375626|NCT02043678|7151561|FG000|Overall Study|Protocol-driven decision point|56
4375627|NCT02043678|7151562|FG001|Overall Study|Protocol-driven decision point|56
4375628|NCT02043678|7151561|FG000|Overall Study|Withdrawal by Subject|12
4375629|NCT02043678|7151562|FG001|Overall Study|Withdrawal by Subject|15
4375630|NCT02043678|7151561|FG000|Overall Study|Ongoing with treatment|34
4375631|NCT02043678|7151562|FG001|Overall Study|Ongoing with treatment|38
4375632|NCT01986114|7151568|FG000|Overall Study|Adverse Event|59
4375633|NCT01986114|7151568|FG000|Overall Study|Lack of Efficacy|23
4375634|NCT01986114|7151568|FG000|Overall Study|Withdrawal by Subject|58
4375635|NCT01986114|7151568|FG000|Overall Study|Noncompliance|3
4375636|NCT01986114|7151568|FG000|Overall Study|Protocol Violation|1
4375637|NCT01986114|7151568|FG000|Overall Study|Lost to Follow-up|5
4375638|NCT01986114|7151568|FG000|Overall Study|Other reason|7
4375639|NCT01813305|7151633|FG000|Overall Study|Withdrawal by Subject|12
4375640|NCT01813305|7151634|FG001|Overall Study|Withdrawal by Subject|5
4375641|NCT01813305|7151633|FG000|Overall Study|Safety Concern|4
4375642|NCT01813305|7151634|FG001|Overall Study|Safety Concern|0
4375643|NCT01813305|7151633|FG000|Overall Study|Ulcer became worse|4
4375644|NCT01813305|7151634|FG001|Overall Study|Ulcer became worse|0
4465681|NCT00611767|7257071|FG001|Overall Study|Physician Decision|0
4465682|NCT00611806|7257079|FG000|Overall Study|Withdrawal by Subject|8
4465683|NCT00611806|7257080|FG001|Overall Study|Withdrawal by Subject|2
4465684|NCT00611806|7257079|FG000|Overall Study|Adverse Event|2
4465685|NCT00611806|7257080|FG001|Overall Study|Adverse Event|1
4465686|NCT00611806|7257079|FG000|Overall Study|Lost to Follow-up|6
4465687|NCT00611806|7257080|FG001|Overall Study|Lost to Follow-up|0
4465688|NCT00611858|7257086|FG000|Overall Study|Adverse Event|2
4465689|NCT00611858|7257086|FG000|Overall Study|Withdrawal by Subject|2
4465690|NCT00611884|7257096|FG000|Overall Study|Adverse Event|1
4465691|NCT00611884|7257097|FG001|Overall Study|Adverse Event|0
4465692|NCT00611884|7257098|FG002|Overall Study|Adverse Event|0
4465693|NCT00611884|7257099|FG003|Overall Study|Adverse Event|1
4465694|NCT00611884|7257096|FG000|Overall Study|Non-Compliance|1
4465695|NCT00611884|7257097|FG001|Overall Study|Non-Compliance|4
4465696|NCT00611884|7257098|FG002|Overall Study|Non-Compliance|2
4465697|NCT00611884|7257099|FG003|Overall Study|Non-Compliance|2
4465698|NCT00611884|7257096|FG000|Overall Study|Lack of Efficacy|0
4465699|NCT00611884|7257097|FG001|Overall Study|Lack of Efficacy|1
4465700|NCT00611884|7257098|FG002|Overall Study|Lack of Efficacy|0
4465701|NCT00611884|7257099|FG003|Overall Study|Lack of Efficacy|0
4465702|NCT00611884|7257096|FG000|Overall Study|Unclassified|7
4465703|NCT00611884|7257097|FG001|Overall Study|Unclassified|4
4465704|NCT00611884|7257098|FG002|Overall Study|Unclassified|2
4465705|NCT00611884|7257099|FG003|Overall Study|Unclassified|3
4465706|NCT00611923|7257120|FG000|Overall Study|Withdrawal by Subject|2
4465707|NCT00611923|7257121|FG001|Overall Study|Withdrawal by Subject|2
4465708|NCT00611975|7257131|FG000|Overall Study|Withdrawal by Subject|3
4465709|NCT00611975|7257132|FG001|Overall Study|Withdrawal by Subject|7
4465710|NCT00611975|7257131|FG000|Overall Study|Pregnancy|2
4465711|NCT00611975|7257132|FG001|Overall Study|Pregnancy|1
4465712|NCT00612040|7257141|FG000|Overall Study|Adverse Event|0
4465713|NCT00612040|7257142|FG001|Overall Study|Adverse Event|2
4465714|NCT00612040|7257143|FG002|Overall Study|Adverse Event|1
4465715|NCT00612040|7257141|FG000|Overall Study|Protocol Violation|1
4465716|NCT00612040|7257142|FG001|Overall Study|Protocol Violation|2
4465717|NCT00612040|7257143|FG002|Overall Study|Protocol Violation|1
4465718|NCT00612040|7257141|FG000|Overall Study|Lack of Efficacy|2
4465719|NCT00612040|7257142|FG001|Overall Study|Lack of Efficacy|1
4465720|NCT00612040|7257143|FG002|Overall Study|Lack of Efficacy|0
4465721|NCT00612040|7257141|FG000|Overall Study|Unclassified|2
4465722|NCT00612040|7257142|FG001|Overall Study|Unclassified|2
4465723|NCT00612040|7257143|FG002|Overall Study|Unclassified|5
4465724|NCT00612066|7257151|FG000|Overall Study|Adverse Event|1
4465725|NCT00612105|7257157|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18
4465726|NCT00612105|7257158|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1
4465727|NCT00612105|7257157|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6
4465728|NCT00612105|7257158|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1
4465729|NCT00612105|7257157|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2
4465730|NCT00612105|7257158|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0
4465731|NCT00612105|7257157|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1
4465732|NCT00612105|7257158|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1
4465733|NCT00612105|7257157|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1
4695005|NCT02613884|7606656|FG000|Overall Study|Death|1
4695006|NCT02613884|7606656|FG000|Overall Study|Lost to Follow-up|1
4695007|NCT02613910|7606675|FG000|Overall Study|Termination of study|1
4695008|NCT02614079|7606679|FG000|Overall Study|Withdrawal by Subject|1
4695009|NCT02614131|7606690|FG000|Overall Study|Withdrawal by Subject|1
4695010|NCT02614131|7606691|FG001|Overall Study|Withdrawal by Subject|0
4695011|NCT02614131|7606692|FG002|Overall Study|Withdrawal by Subject|0
4695012|NCT02614131|7606693|FG003|Overall Study|Withdrawal by Subject|0
4695013|NCT02614131|7606694|FG004|Overall Study|Withdrawal by Subject|0
4695014|NCT02614131|7606695|FG005|Overall Study|Withdrawal by Subject|0
4695015|NCT02614131|7606696|FG006|Overall Study|Withdrawal by Subject|0
4695016|NCT02614131|7606690|FG000|Overall Study|Adverse Event|0
4695017|NCT02614131|7606691|FG001|Overall Study|Adverse Event|0
4695018|NCT02614131|7606692|FG002|Overall Study|Adverse Event|0
4695019|NCT02614131|7606693|FG003|Overall Study|Adverse Event|0
4695020|NCT02614131|7606694|FG004|Overall Study|Adverse Event|0
4695021|NCT02614131|7606695|FG005|Overall Study|Adverse Event|0
4465734|NCT00612105|7257158|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0
4465735|NCT00612105|7257157|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3
4465736|NCT00612105|7257158|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1
4465737|NCT00612105|7257157|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5
4465738|NCT00612105|7257158|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0
4375645|NCT01813305|7151633|FG000|Overall Study|Physician Decision|4
4375646|NCT01813305|7151634|FG001|Overall Study|Physician Decision|0
4375647|NCT01813305|7151633|FG000|Overall Study|Lost to Follow-up|3
4375648|NCT01813305|7151634|FG001|Overall Study|Lost to Follow-up|1
4375649|NCT01813305|7151633|FG000|Overall Study|Protocol Violation|1
4375650|NCT01813305|7151634|FG001|Overall Study|Protocol Violation|0
4375651|NCT01813305|7151633|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7
4375652|NCT01813305|7151634|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2
4375653|NCT01740427|7151644|FG000|Overall Study|Ongoing at date of cutoff (26 Feb 2016)|205
4375654|NCT01740427|7151645|FG001|Overall Study|Ongoing at date of cutoff (26 Feb 2016)|61
4375655|NCT01740427|7151644|FG000|Overall Study|Objective progression or relapse|172
4375656|NCT01740427|7151645|FG001|Overall Study|Objective progression or relapse|125
4375657|NCT01740427|7151644|FG000|Overall Study|Adverse Event|20
4375658|NCT01740427|7151645|FG001|Overall Study|Adverse Event|9
4375659|NCT01740427|7151644|FG000|Overall Study|Global deterioration of health status|16
4375660|NCT01740427|7151645|FG001|Overall Study|Global deterioration of health status|9
4375661|NCT01740427|7151644|FG000|Overall Study|Subject refused continued treatment|12
4375662|NCT01740427|7151645|FG001|Overall Study|Subject refused continued treatment|9
4375663|NCT01740427|7151644|FG000|Overall Study|Unspecified reasons|6
4375664|NCT01740427|7151645|FG001|Overall Study|Unspecified reasons|4
4375665|NCT01740427|7151644|FG000|Overall Study|Death|6
4375666|NCT01740427|7151645|FG001|Overall Study|Death|2
4695022|NCT02614131|7606696|FG006|Overall Study|Adverse Event|1
4695023|NCT02614183|7606721|FG000|Double Blind Treatment Phase|Adverse Event|10
4695024|NCT02614183|7606722|FG001|Double Blind Treatment Phase|Adverse Event|9
4695025|NCT02614183|7606723|FG002|Double Blind Treatment Phase|Adverse Event|7
4695026|NCT02614183|7606721|FG000|Double Blind Treatment Phase|Lack of Efficacy|10
4695027|NCT02614183|7606722|FG001|Double Blind Treatment Phase|Lack of Efficacy|1
4695028|NCT02614183|7606723|FG002|Double Blind Treatment Phase|Lack of Efficacy|2
4695029|NCT02614183|7606721|FG000|Double Blind Treatment Phase|Lost to Follow-up|18
4695030|NCT02614183|7606722|FG001|Double Blind Treatment Phase|Lost to Follow-up|9
4695031|NCT02614183|7606723|FG002|Double Blind Treatment Phase|Lost to Follow-up|5
4695032|NCT02614183|7606721|FG000|Double Blind Treatment Phase|Physician Decision|7
4695033|NCT02614183|7606722|FG001|Double Blind Treatment Phase|Physician Decision|3
4695034|NCT02614183|7606723|FG002|Double Blind Treatment Phase|Physician Decision|2
4695035|NCT02614183|7606721|FG000|Double Blind Treatment Phase|Pregnancy|2
4695036|NCT02614183|7606722|FG001|Double Blind Treatment Phase|Pregnancy|1
4695037|NCT02614183|7606723|FG002|Double Blind Treatment Phase|Pregnancy|3
4695038|NCT02614183|7606721|FG000|Double Blind Treatment Phase|Protocol Violation|2
4695039|NCT02614183|7606722|FG001|Double Blind Treatment Phase|Protocol Violation|2
4695040|NCT02614183|7606723|FG002|Double Blind Treatment Phase|Protocol Violation|2
4695041|NCT02614183|7606721|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33
4695042|NCT02614183|7606722|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11
4695043|NCT02614183|7606723|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16
4695044|NCT02614183|7606721|FG000|Double Blind Treatment Phase|Did not receive study drug|1
4695045|NCT02614183|7606722|FG001|Double Blind Treatment Phase|Did not receive study drug|1
4695046|NCT02614183|7606723|FG002|Double Blind Treatment Phase|Did not receive study drug|2
4695047|NCT02614183|7606721|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5
4695048|NCT02614183|7606722|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3
4695049|NCT02614183|7606723|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5
4695050|NCT02614183|7606721|FG000|Post Treatment Follow-up Phase|Physician Decision|5
4695051|NCT02614183|7606722|FG001|Post Treatment Follow-up Phase|Physician Decision|1
4695052|NCT02614183|7606723|FG002|Post Treatment Follow-up Phase|Physician Decision|2
4695053|NCT02614183|7606721|FG000|Post Treatment Follow-up Phase|Protocol Violation|1
4695054|NCT02614183|7606722|FG001|Post Treatment Follow-up Phase|Protocol Violation|0
4695055|NCT02614183|7606723|FG002|Post Treatment Follow-up Phase|Protocol Violation|0
4695056|NCT02614183|7606721|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7
4695057|NCT02614183|7606722|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2
4695058|NCT02614183|7606723|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5
4695059|NCT02614196|7606743|FG000|Double Blind Treatment Phase|Adverse Event|8
4695060|NCT02614196|7606744|FG001|Double Blind Treatment Phase|Adverse Event|5
4695061|NCT02614196|7606745|FG002|Double Blind Treatment Phase|Adverse Event|9
4695062|NCT02614196|7606746|FG003|Double Blind Treatment Phase|Adverse Event|0
4695063|NCT02614196|7606747|FG004|Double Blind Treatment Phase|Adverse Event|0
4695064|NCT02614196|7606748|FG005|Double Blind Treatment Phase|Adverse Event|0
4695065|NCT02614196|7606743|FG000|Double Blind Treatment Phase|Lack of Efficacy|6
4695066|NCT02614196|7606744|FG001|Double Blind Treatment Phase|Lack of Efficacy|1
4695067|NCT02614196|7606745|FG002|Double Blind Treatment Phase|Lack of Efficacy|1
4695068|NCT02614196|7606746|FG003|Double Blind Treatment Phase|Lack of Efficacy|0
4695069|NCT02614196|7606747|FG004|Double Blind Treatment Phase|Lack of Efficacy|0
4695070|NCT02614196|7606748|FG005|Double Blind Treatment Phase|Lack of Efficacy|0
4695071|NCT02614196|7606743|FG000|Double Blind Treatment Phase|Lost to Follow-up|10
4695072|NCT02614196|7606744|FG001|Double Blind Treatment Phase|Lost to Follow-up|7
4695073|NCT02614196|7606745|FG002|Double Blind Treatment Phase|Lost to Follow-up|1
4695074|NCT02614196|7606746|FG003|Double Blind Treatment Phase|Lost to Follow-up|0
4695075|NCT02614196|7606747|FG004|Double Blind Treatment Phase|Lost to Follow-up|0
4695076|NCT02614196|7606748|FG005|Double Blind Treatment Phase|Lost to Follow-up|0
4375667|NCT01740427|7151644|FG000|Overall Study|Protocol Violation|5
4375668|NCT01740427|7151645|FG001|Overall Study|Protocol Violation|3
4375669|NCT01740427|7151644|FG000|Overall Study|Lost to Follow-up|1
4375670|NCT01740427|7151645|FG001|Overall Study|Lost to Follow-up|0
4375671|NCT01740427|7151644|FG000|Overall Study|Study terminated by Sponsor|1
4375672|NCT01740427|7151645|FG001|Overall Study|Study terminated by Sponsor|0
4375673|NCT01680965|7151655|FG000|Overall Study|Death|0
4375674|NCT01680965|7151656|FG001|Overall Study|Death|0
4375675|NCT01680965|7151657|FG002|Overall Study|Death|0
4375676|NCT01680965|7151658|FG003|Overall Study|Death|6
4375677|NCT01592370|7151690|FG000|Overall Study|Disease Progression|62
4375678|NCT01592370|7151691|FG001|Overall Study|Disease Progression|16
4375679|NCT01592370|7151692|FG002|Overall Study|Disease Progression|52
4375680|NCT01592370|7151693|FG003|Overall Study|Disease Progression|3
4375681|NCT01592370|7151694|FG004|Overall Study|Disease Progression|3
4375682|NCT01592370|7151695|FG005|Overall Study|Disease Progression|31
4375683|NCT01592370|7151696|FG006|Overall Study|Disease Progression|14
4375684|NCT01592370|7151690|FG000|Overall Study|Study Drug Toxicity|14
4375685|NCT01592370|7151691|FG001|Overall Study|Study Drug Toxicity|3
4375686|NCT01592370|7151692|FG002|Overall Study|Study Drug Toxicity|0
4375687|NCT01592370|7151693|FG003|Overall Study|Study Drug Toxicity|0
4375688|NCT01592370|7151694|FG004|Overall Study|Study Drug Toxicity|0
4375689|NCT01592370|7151695|FG005|Overall Study|Study Drug Toxicity|0
4375690|NCT01592370|7151696|FG006|Overall Study|Study Drug Toxicity|1
4465739|NCT00612105|7257157|FG000|Period Title 1: 6-Week Titration Phase|Other|0
4465740|NCT00612105|7257158|FG001|Period Title 1: 6-Week Titration Phase|Other|1
4465741|NCT00612105|7257157|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9
4465742|NCT00612105|7257158|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1
4465743|NCT00612105|7257157|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1
4465744|NCT00612105|7257158|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1
4465745|NCT00612105|7257157|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1
4465746|NCT00612105|7257158|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0
4465747|NCT00612105|7257157|FG000|Period Title 3: 3-Week Taper Phase|Other|1
4465748|NCT00612105|7257158|FG001|Period Title 3: 3-Week Taper Phase|Other|0
4465749|NCT00612313|7257188|FG000|Overall Study|Withdrawal by Subject|6
4465750|NCT00612313|7257189|FG001|Overall Study|Withdrawal by Subject|9
4465751|NCT00612313|7257188|FG000|Overall Study|Lost to Follow-up|11
4465752|NCT00612313|7257189|FG001|Overall Study|Lost to Follow-up|4
4465753|NCT00612352|7257207|FG000|Overall Study|Adverse Event|1
4465754|NCT00612352|7257208|FG001|Overall Study|Adverse Event|0
4465755|NCT00612352|7257207|FG000|Overall Study|Withdrawal by Subject|3
4465756|NCT00612352|7257208|FG001|Overall Study|Withdrawal by Subject|5
4465757|NCT00612352|7257207|FG000|Overall Study|moved out of state|1
4465758|NCT00612352|7257208|FG001|Overall Study|moved out of state|0
4465759|NCT00612352|7257207|FG000|Overall Study|didn't return calls/show up on test date|4
4465760|NCT00612352|7257208|FG001|Overall Study|didn't return calls/show up on test date|1
4465761|NCT00612456|7257228|FG000|Overall Study|Adverse Event|1
4465762|NCT00612456|7257229|FG001|Overall Study|Adverse Event|0
4465763|NCT00612456|7257230|FG002|Overall Study|Adverse Event|0
4695077|NCT02614196|7606743|FG000|Double Blind Treatment Phase|Physician Decision|4
4695078|NCT02614196|7606744|FG001|Double Blind Treatment Phase|Physician Decision|0
4695079|NCT02614196|7606745|FG002|Double Blind Treatment Phase|Physician Decision|2
4695080|NCT02614196|7606746|FG003|Double Blind Treatment Phase|Physician Decision|0
4695081|NCT02614196|7606747|FG004|Double Blind Treatment Phase|Physician Decision|0
4695082|NCT02614196|7606748|FG005|Double Blind Treatment Phase|Physician Decision|0
4695083|NCT02614196|7606743|FG000|Double Blind Treatment Phase|Pregnancy|1
4695084|NCT02614196|7606744|FG001|Double Blind Treatment Phase|Pregnancy|2
4695085|NCT02614196|7606745|FG002|Double Blind Treatment Phase|Pregnancy|0
4695086|NCT02614196|7606746|FG003|Double Blind Treatment Phase|Pregnancy|0
4695087|NCT02614196|7606747|FG004|Double Blind Treatment Phase|Pregnancy|0
4695088|NCT02614196|7606748|FG005|Double Blind Treatment Phase|Pregnancy|0
4695089|NCT02614196|7606743|FG000|Double Blind Treatment Phase|Protocol Violation|5
4695090|NCT02614196|7606744|FG001|Double Blind Treatment Phase|Protocol Violation|2
4695091|NCT02614196|7606745|FG002|Double Blind Treatment Phase|Protocol Violation|1
4695092|NCT02614196|7606746|FG003|Double Blind Treatment Phase|Protocol Violation|0
4695093|NCT02614196|7606747|FG004|Double Blind Treatment Phase|Protocol Violation|1
4695094|NCT02614196|7606748|FG005|Double Blind Treatment Phase|Protocol Violation|0
4695095|NCT02614196|7606743|FG000|Double Blind Treatment Phase|Terminated by sponsor|1
4695096|NCT02614196|7606744|FG001|Double Blind Treatment Phase|Terminated by sponsor|0
4375691|NCT01592370|7151690|FG000|Overall Study|AE unrelated to study drug|4
4465764|NCT00612456|7257228|FG000|Overall Study|Lack of Efficacy|1
4465765|NCT00612456|7257229|FG001|Overall Study|Lack of Efficacy|1
4465766|NCT00612456|7257230|FG002|Overall Study|Lack of Efficacy|0
4465767|NCT00612456|7257228|FG000|Overall Study|Withdrawal by Subject|0
4465768|NCT00612456|7257229|FG001|Overall Study|Withdrawal by Subject|1
4695097|NCT02614196|7606745|FG002|Double Blind Treatment Phase|Terminated by sponsor|0
4375692|NCT01592370|7151691|FG001|Overall Study|AE unrelated to study drug|3
4375693|NCT01592370|7151692|FG002|Overall Study|AE unrelated to study drug|0
4695098|NCT02614196|7606746|FG003|Double Blind Treatment Phase|Terminated by sponsor|0
4695099|NCT02614196|7606747|FG004|Double Blind Treatment Phase|Terminated by sponsor|0
4375694|NCT01592370|7151693|FG003|Overall Study|AE unrelated to study drug|0
4375695|NCT01592370|7151694|FG004|Overall Study|AE unrelated to study drug|0
4375696|NCT01592370|7151695|FG005|Overall Study|AE unrelated to study drug|0
4375697|NCT01592370|7151696|FG006|Overall Study|AE unrelated to study drug|1
4375698|NCT01592370|7151690|FG000|Overall Study|Request to discontinue study treatment|5
4375699|NCT01592370|7151691|FG001|Overall Study|Request to discontinue study treatment|0
4375700|NCT01592370|7151692|FG002|Overall Study|Request to discontinue study treatment|2
4375701|NCT01592370|7151693|FG003|Overall Study|Request to discontinue study treatment|0
4375702|NCT01592370|7151694|FG004|Overall Study|Request to discontinue study treatment|1
4375703|NCT01592370|7151695|FG005|Overall Study|Request to discontinue study treatment|2
4375704|NCT01592370|7151696|FG006|Overall Study|Request to discontinue study treatment|0
4375705|NCT01592370|7151690|FG000|Overall Study|Withdrew consent|1
4375706|NCT01592370|7151691|FG001|Overall Study|Withdrew consent|2
4375707|NCT01592370|7151692|FG002|Overall Study|Withdrew consent|1
4375708|NCT01592370|7151693|FG003|Overall Study|Withdrew consent|1
4375709|NCT01592370|7151694|FG004|Overall Study|Withdrew consent|0
4375710|NCT01592370|7151695|FG005|Overall Study|Withdrew consent|0
4375711|NCT01592370|7151696|FG006|Overall Study|Withdrew consent|0
4375712|NCT01592370|7151690|FG000|Overall Study|Maximum clinical benefit|11
4375713|NCT01592370|7151691|FG001|Overall Study|Maximum clinical benefit|1
4375714|NCT01592370|7151692|FG002|Overall Study|Maximum clinical benefit|7
4375715|NCT01592370|7151693|FG003|Overall Study|Maximum clinical benefit|1
4375716|NCT01592370|7151694|FG004|Overall Study|Maximum clinical benefit|0
4375717|NCT01592370|7151695|FG005|Overall Study|Maximum clinical benefit|0
4375718|NCT01592370|7151696|FG006|Overall Study|Maximum clinical benefit|0
4375719|NCT01592370|7151690|FG000|Overall Study|No longer meets study criteria|1
4375720|NCT01592370|7151691|FG001|Overall Study|No longer meets study criteria|0
4375721|NCT01592370|7151692|FG002|Overall Study|No longer meets study criteria|0
4375722|NCT01592370|7151693|FG003|Overall Study|No longer meets study criteria|0
4587636|NCT01492686|7431815|FG000|Open-label Phase|Due to a discontinuation criterion|4
4695100|NCT02614196|7606748|FG005|Double Blind Treatment Phase|Terminated by sponsor|0
4695101|NCT02614196|7606743|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39
4695102|NCT02614196|7606744|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11
4695103|NCT02614196|7606745|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14
4695104|NCT02614196|7606746|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4
4695105|NCT02614196|7606747|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0
4695106|NCT02614196|7606748|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0
4695107|NCT02614196|7606743|FG000|Double Blind Treatment Phase|Did not receive study drug|2
4695108|NCT02614196|7606744|FG001|Double Blind Treatment Phase|Did not receive study drug|2
4695109|NCT02614196|7606745|FG002|Double Blind Treatment Phase|Did not receive study drug|3
4695110|NCT02614196|7606746|FG003|Double Blind Treatment Phase|Did not receive study drug|0
4695111|NCT02614196|7606747|FG004|Double Blind Treatment Phase|Did not receive study drug|0
4695112|NCT02614196|7606748|FG005|Double Blind Treatment Phase|Did not receive study drug|0
4695113|NCT02614196|7606743|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8
4375723|NCT01592370|7151694|FG004|Overall Study|No longer meets study criteria|0
4375724|NCT01592370|7151695|FG005|Overall Study|No longer meets study criteria|0
4375725|NCT01592370|7151696|FG006|Overall Study|No longer meets study criteria|0
4375726|NCT01592370|7151690|FG000|Overall Study|Other Reasons|6
4375727|NCT01592370|7151691|FG001|Overall Study|Other Reasons|0
4375728|NCT01592370|7151692|FG002|Overall Study|Other Reasons|10
4587637|NCT01492686|7431816|FG001|Open-label Phase|Due to a discontinuation criterion|9
4587638|NCT01493089|7431844|FG000|Overall Study|Protocol Violation|2
4695114|NCT02614196|7606744|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3
4587639|NCT01493089|7431845|FG001|Overall Study|Protocol Violation|2
4587640|NCT01493089|7431844|FG000|Overall Study|Withdrawal by Subject|1
4587641|NCT01493089|7431845|FG001|Overall Study|Withdrawal by Subject|0
4587642|NCT01493089|7431844|FG000|Overall Study|Physician Decision|0
4587643|NCT01493089|7431845|FG001|Overall Study|Physician Decision|1
4587644|NCT01493284|7431866|FG000|Overall Study|Death|29
4695115|NCT02614196|7606745|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3
4695116|NCT02614196|7606746|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0
4695117|NCT02614196|7606747|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1
4695118|NCT02614196|7606748|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0
4695119|NCT02614196|7606743|FG000|Post Treatment Follow-up Phase|Pregnancy|2
4587645|NCT01493284|7431866|FG000|Overall Study|Withdrawal by Subject|32
4587646|NCT01493414|7431870|FG000|Overall Study|Adverse Event|405
4587647|NCT01493414|7431870|FG000|Overall Study|Disease progression|204
4587648|NCT01493414|7431870|FG000|Overall Study|Death|101
4587649|NCT01493414|7431870|FG000|Overall Study|Physician Decision|93
4587650|NCT01493414|7431870|FG000|Overall Study|Withdrawal by Subject|79
4695120|NCT02614196|7606744|FG001|Post Treatment Follow-up Phase|Pregnancy|0
4695121|NCT02614196|7606745|FG002|Post Treatment Follow-up Phase|Pregnancy|0
4695122|NCT02614196|7606746|FG003|Post Treatment Follow-up Phase|Pregnancy|0
4375729|NCT01592370|7151693|FG003|Overall Study|Other Reasons|0
4375730|NCT01592370|7151694|FG004|Overall Study|Other Reasons|0
4375731|NCT01592370|7151695|FG005|Overall Study|Other Reasons|1
4375732|NCT01592370|7151696|FG006|Overall Study|Other Reasons|0
4465769|NCT00612456|7257230|FG002|Overall Study|Withdrawal by Subject|0
4375733|NCT00152477|7151737|FG000|Chemotherapy Period|Adverse Event|9
4375734|NCT00152477|7151738|FG001|Chemotherapy Period|Adverse Event|4
4375735|NCT00152477|7151739|FG002|Chemotherapy Period|Adverse Event|5
4375736|NCT00152477|7151737|FG000|Chemotherapy Period|Death|1
4375737|NCT00152477|7151738|FG001|Chemotherapy Period|Death|3
4375738|NCT00152477|7151739|FG002|Chemotherapy Period|Death|3
4375739|NCT00152477|7151737|FG000|Chemotherapy Period|Lack of Efficacy|4
4375740|NCT00152477|7151738|FG001|Chemotherapy Period|Lack of Efficacy|5
4375741|NCT00152477|7151739|FG002|Chemotherapy Period|Lack of Efficacy|6
4375742|NCT00152477|7151737|FG000|Chemotherapy Period|Lost to Follow-up|1
4375743|NCT00152477|7151738|FG001|Chemotherapy Period|Lost to Follow-up|0
4375744|NCT00152477|7151739|FG002|Chemotherapy Period|Lost to Follow-up|1
4375745|NCT00152477|7151737|FG000|Chemotherapy Period|Protocol Violation|1
4375746|NCT00152477|7151738|FG001|Chemotherapy Period|Protocol Violation|1
4375747|NCT00152477|7151739|FG002|Chemotherapy Period|Protocol Violation|0
4375748|NCT00152477|7151737|FG000|Chemotherapy Period|Withdrawal by Subject|5
4375749|NCT00152477|7151738|FG001|Chemotherapy Period|Withdrawal by Subject|1
4375750|NCT00152477|7151739|FG002|Chemotherapy Period|Withdrawal by Subject|0
4375751|NCT00152477|7151737|FG000|Chemotherapy Period|Progression of Disease|6
4375752|NCT00152477|7151738|FG001|Chemotherapy Period|Progression of Disease|8
4375753|NCT00152477|7151739|FG002|Chemotherapy Period|Progression of Disease|4
4375754|NCT00152477|7151737|FG000|Chemotherapy Period|Investigator decision|0
4375755|NCT00152477|7151738|FG001|Chemotherapy Period|Investigator decision|0
4375756|NCT00152477|7151739|FG002|Chemotherapy Period|Investigator decision|1
4375757|NCT00152477|7151737|FG000|Chemotherapy Period|Patient condition worsened|1
4375758|NCT00152477|7151738|FG001|Chemotherapy Period|Patient condition worsened|0
4375759|NCT00152477|7151739|FG002|Chemotherapy Period|Patient condition worsened|0
4375760|NCT00152477|7151737|FG000|Monotherapy Period|Adverse Event|1
4375761|NCT00152477|7151738|FG001|Monotherapy Period|Adverse Event|0
4375762|NCT00152477|7151739|FG002|Monotherapy Period|Adverse Event|5
4375763|NCT00152477|7151737|FG000|Monotherapy Period|Death|2
4375764|NCT00152477|7151738|FG001|Monotherapy Period|Death|0
4375765|NCT00152477|7151739|FG002|Monotherapy Period|Death|1
4375766|NCT00152477|7151737|FG000|Monotherapy Period|Lack of Efficacy|7
4375767|NCT00152477|7151738|FG001|Monotherapy Period|Lack of Efficacy|16
4375768|NCT00152477|7151739|FG002|Monotherapy Period|Lack of Efficacy|10
4375769|NCT00152477|7151737|FG000|Monotherapy Period|Protocol Violation|0
4375770|NCT00152477|7151738|FG001|Monotherapy Period|Protocol Violation|1
4375771|NCT00152477|7151739|FG002|Monotherapy Period|Protocol Violation|0
4375772|NCT00152477|7151737|FG000|Monotherapy Period|Withdrawal by Subject|0
4375773|NCT00152477|7151738|FG001|Monotherapy Period|Withdrawal by Subject|0
4375774|NCT00152477|7151739|FG002|Monotherapy Period|Withdrawal by Subject|4
4587651|NCT01493414|7431870|FG000|Overall Study|Protocol deviation|27
4587652|NCT01493414|7431870|FG000|Overall Study|Administrative problems|25
4587653|NCT01493414|7431870|FG000|Overall Study|Lost to Follow-up|16
4587654|NCT01493427|7431878|FG000|Overall Study|Adverse Event|10
4587655|NCT01493427|7431878|FG000|Overall Study|Personal Reasons|4
4695123|NCT02614196|7606747|FG004|Post Treatment Follow-up Phase|Pregnancy|0
4587656|NCT01493427|7431878|FG000|Overall Study|Lost to Follow-up|2
4587657|NCT01493427|7431878|FG000|Overall Study|Inability to Follow Instructions|2
4587658|NCT01493427|7431878|FG000|Overall Study|Other|2
4587659|NCT01493531|7431885|FG000|Overall Study|Adverse Event|4
4587660|NCT01493531|7431886|FG001|Overall Study|Adverse Event|12
4587661|NCT01493531|7431887|FG002|Overall Study|Adverse Event|9
4587662|NCT01493531|7431885|FG000|Overall Study|Gout flare|3
4587663|NCT01493531|7431886|FG001|Overall Study|Gout flare|0
4587664|NCT01493531|7431887|FG002|Overall Study|Gout flare|2
4587665|NCT01493531|7431885|FG000|Overall Study|Protocol Violation|8
4587666|NCT01493531|7431886|FG001|Overall Study|Protocol Violation|15
4587667|NCT01493531|7431887|FG002|Overall Study|Protocol Violation|12
4587668|NCT01493531|7431885|FG000|Overall Study|Sponsor terminated study|5
4587669|NCT01493531|7431886|FG001|Overall Study|Sponsor terminated study|2
4587670|NCT01493531|7431887|FG002|Overall Study|Sponsor terminated study|3
4587671|NCT01493531|7431885|FG000|Overall Study|Lost to Follow-up|5
4587672|NCT01493531|7431886|FG001|Overall Study|Lost to Follow-up|7
4587673|NCT01493531|7431887|FG002|Overall Study|Lost to Follow-up|11
4587674|NCT01493531|7431885|FG000|Overall Study|Withdrawal by Subject|16
4587675|NCT01493531|7431886|FG001|Overall Study|Withdrawal by Subject|13
4587676|NCT01493531|7431887|FG002|Overall Study|Withdrawal by Subject|11
4587677|NCT01493531|7431885|FG000|Overall Study|Death|0
4587678|NCT01493531|7431886|FG001|Overall Study|Death|1
4587679|NCT01493531|7431887|FG002|Overall Study|Death|0
4587680|NCT01493557|7431898|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0
4587681|NCT01493557|7431899|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0
4587682|NCT01493557|7431900|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1
4587683|NCT01493557|7431898|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0
4587684|NCT01493557|7431899|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0
4587685|NCT01493557|7431900|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9
4587686|NCT01493557|7431898|FG000|Not Randomized to Management Strategies|Other adverse event|0
4587687|NCT01493557|7431899|FG001|Not Randomized to Management Strategies|Other adverse event|0
4695124|NCT02614196|7606748|FG005|Post Treatment Follow-up Phase|Pregnancy|0
4375775|NCT00152477|7151737|FG000|Monotherapy Period|Progression of Disease|5
4375776|NCT00152477|7151738|FG001|Monotherapy Period|Progression of Disease|11
4375777|NCT00152477|7151739|FG002|Monotherapy Period|Progression of Disease|12
4375778|NCT00152477|7151737|FG000|Monotherapy Period|Patient decision|0
4375779|NCT00152477|7151738|FG001|Monotherapy Period|Patient decision|1
4375780|NCT00152477|7151739|FG002|Monotherapy Period|Patient decision|1
4375781|NCT00152477|7151737|FG000|Monotherapy Period|Study personel decision|0
4375782|NCT00152477|7151738|FG001|Monotherapy Period|Study personel decision|0
4375783|NCT00152477|7151739|FG002|Monotherapy Period|Study personel decision|1
4465770|NCT00612508|7257242|FG000|Overall Study|Withdrawal by Subject|3
4465771|NCT00612508|7257243|FG001|Overall Study|Withdrawal by Subject|4
4465772|NCT00612534|7257255|FG000|Overall Study|Adverse Event|0
4465773|NCT00612534|7257256|FG001|Overall Study|Adverse Event|4
4465774|NCT00612534|7257257|FG002|Overall Study|Adverse Event|2
4465775|NCT00612534|7257258|FG003|Overall Study|Adverse Event|1
4465776|NCT00612534|7257255|FG000|Overall Study|Lack of Efficacy|13
4465777|NCT00612534|7257256|FG001|Overall Study|Lack of Efficacy|12
4465778|NCT00612534|7257257|FG002|Overall Study|Lack of Efficacy|5
4465779|NCT00612534|7257258|FG003|Overall Study|Lack of Efficacy|16
4465780|NCT00612534|7257255|FG000|Overall Study|Other Reason|0
4695125|NCT02614196|7606743|FG000|Post Treatment Follow-up Phase|Protocol Violation|0
4695126|NCT02614196|7606744|FG001|Post Treatment Follow-up Phase|Protocol Violation|1
4695127|NCT02614196|7606745|FG002|Post Treatment Follow-up Phase|Protocol Violation|0
4695128|NCT02614196|7606746|FG003|Post Treatment Follow-up Phase|Protocol Violation|0
4695129|NCT02614196|7606747|FG004|Post Treatment Follow-up Phase|Protocol Violation|1
4695130|NCT02614196|7606748|FG005|Post Treatment Follow-up Phase|Protocol Violation|0
4695131|NCT02614196|7606743|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10
4695132|NCT02614196|7606744|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1
4695133|NCT02614196|7606745|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5
4695134|NCT02614196|7606746|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1
4465781|NCT00612534|7257256|FG001|Overall Study|Other Reason|1
4465782|NCT00612534|7257257|FG002|Overall Study|Other Reason|0
4465783|NCT00612534|7257258|FG003|Overall Study|Other Reason|0
4695135|NCT02614196|7606747|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0
4695136|NCT02614196|7606748|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0
4695137|NCT02614261|7606788|FG000|Overall Study|Adverse Event|6
4695138|NCT02614261|7606789|FG001|Overall Study|Adverse Event|3
4695139|NCT02614261|7606790|FG002|Overall Study|Adverse Event|2
4695140|NCT02614261|7606788|FG000|Overall Study|Lack of Efficacy|4
4695141|NCT02614261|7606789|FG001|Overall Study|Lack of Efficacy|0
4695142|NCT02614261|7606790|FG002|Overall Study|Lack of Efficacy|0
4695143|NCT02614261|7606788|FG000|Overall Study|Lost to Follow-up|10
4695144|NCT02614261|7606789|FG001|Overall Study|Lost to Follow-up|4
4695145|NCT02614261|7606790|FG002|Overall Study|Lost to Follow-up|1
4695146|NCT02614261|7606788|FG000|Overall Study|Physician Decision|2
4695147|NCT02614261|7606789|FG001|Overall Study|Physician Decision|1
4695148|NCT02614261|7606790|FG002|Overall Study|Physician Decision|1
4695149|NCT02614261|7606788|FG000|Overall Study|Pregnancy|2
4695150|NCT02614261|7606789|FG001|Overall Study|Pregnancy|2
4695151|NCT02614261|7606790|FG002|Overall Study|Pregnancy|0
4695152|NCT02614261|7606788|FG000|Overall Study|Protocol Violation|6
4695153|NCT02614261|7606789|FG001|Overall Study|Protocol Violation|1
4695154|NCT02614261|7606790|FG002|Overall Study|Protocol Violation|0
4695155|NCT02614261|7606788|FG000|Overall Study|Withdrawal by Subject|19
4695156|NCT02614261|7606789|FG001|Overall Study|Withdrawal by Subject|4
4695157|NCT02614261|7606790|FG002|Overall Study|Withdrawal by Subject|7
4695158|NCT02614287|7606812|FG000|Open Label (OL) Treatment Phase|Adverse Event|7
4695159|NCT02614287|7606813|FG001|Open Label (OL) Treatment Phase|Adverse Event|6
4695160|NCT02614287|7606812|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13
4695161|NCT02614287|7606813|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5
4695162|NCT02614287|7606812|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7
4695163|NCT02614287|7606813|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4
4695164|NCT02614287|7606812|FG000|Open Label (OL) Treatment Phase|Physician Decision|1
4695165|NCT02614287|7606813|FG001|Open Label (OL) Treatment Phase|Physician Decision|0
4695166|NCT02614287|7606812|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10
4695167|NCT02614287|7606813|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7
4695168|NCT02614287|7606812|FG000|Post Treatment Follow-up Phase|Adverse Event|1
4695169|NCT02614287|7606813|FG001|Post Treatment Follow-up Phase|Adverse Event|0
4695170|NCT02614287|7606812|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2
4695171|NCT02614287|7606813|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2
4695172|NCT02614287|7606812|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6
4695173|NCT02614287|7606813|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3
4695174|NCT02614560|7606835|FG000|Overall Study|Death|6
4695175|NCT02614560|7606836|FG001|Overall Study|Death|2
4695176|NCT02614703|7606844|FG000|Overall Study|Withdrawal by Subject|7
4465784|NCT00612586|7257304|FG000|Overall Study|Adverse Event|6
4465785|NCT00612586|7257305|FG001|Overall Study|Adverse Event|2
4695177|NCT02614703|7606845|FG001|Overall Study|Withdrawal by Subject|1
4695178|NCT02614729|7606853|FG000|Overall Study|Withdrawal by Subject|1
4695179|NCT02614729|7606854|FG001|Overall Study|Withdrawal by Subject|0
4695180|NCT02614794|7606864|FG000|Overall Study|On treatment|118
4375784|NCT04471935|7151750|FG000|Overall Study|Withdrawal by Subject|1
4375785|NCT04471935|7151750|FG000|Overall Study|Deemed ineligible to participate|1
4375786|NCT04439344|7151754|FG000|Overall Study|Never started threapy|3
4375787|NCT04439344|7151754|FG000|Overall Study|Ineligible|3
4375788|NCT04439344|7151754|FG000|Overall Study|Adverse Event|13
4375789|NCT04439344|7151754|FG000|Overall Study|Death|2
4375790|NCT04439344|7151754|FG000|Overall Study|Disease progression|29
4375791|NCT04439344|7151754|FG000|Overall Study|Withdrawal by Subject|2
4375792|NCT04439344|7151754|FG000|Overall Study|Alternative therapy|1
4465786|NCT00612586|7257304|FG000|Overall Study|Death|1
4465787|NCT00612586|7257305|FG001|Overall Study|Death|0
4465788|NCT00612586|7257304|FG000|Overall Study|Entry Criteria Not Met|0
4465789|NCT00612586|7257305|FG001|Overall Study|Entry Criteria Not Met|2
4465790|NCT00612586|7257304|FG000|Overall Study|Withdrawal by Subject|7
4465791|NCT00612586|7257305|FG001|Overall Study|Withdrawal by Subject|9
4465792|NCT00612586|7257304|FG000|Overall Study|Physician Decision|1
4465793|NCT00612586|7257305|FG001|Overall Study|Physician Decision|2
4465794|NCT00612586|7257304|FG000|Overall Study|Sponsor Decision|1
4465795|NCT00612586|7257305|FG001|Overall Study|Sponsor Decision|1
4465796|NCT00612586|7257304|FG000|Overall Study|Progressive Disease|26
4465797|NCT00612586|7257305|FG001|Overall Study|Progressive Disease|24
4465798|NCT00612586|7257304|FG000|Overall Study|Randomized and Not Treated|1
4465799|NCT00612586|7257305|FG001|Overall Study|Randomized and Not Treated|1
4465800|NCT00612690|7257314|FG000|Overall Study|Lost to Follow-up|72
4465801|NCT00612690|7257315|FG001|Overall Study|Lost to Follow-up|98
4465802|NCT00612690|7257314|FG000|Overall Study|Withdrawal by Subject|32
4465803|NCT00612690|7257315|FG001|Overall Study|Withdrawal by Subject|20
4465804|NCT00612690|7257314|FG000|Overall Study|Withdrawal by Site|11
4465805|NCT00612690|7257315|FG001|Overall Study|Withdrawal by Site|0
4465806|NCT00612807|7257354|FG000|Overall Study|Withdrawal by Subject|2
4465807|NCT00612807|7257355|FG001|Overall Study|Withdrawal by Subject|0
4465808|NCT00613015|7257377|FG000|Overall Study|Lost to Follow-up|0
4695181|NCT02614794|7606865|FG001|Overall Study|On treatment|27
4695182|NCT02614794|7606864|FG000|Overall Study|In long term follow up|148
4695183|NCT02614794|7606865|FG001|Overall Study|In long term follow up|85
4695184|NCT02614794|7606864|FG000|Overall Study|Death|126
4695185|NCT02614794|7606865|FG001|Overall Study|Death|84
4695186|NCT02614794|7606864|FG000|Overall Study|Withdrawal by Subject|16
4695187|NCT02614794|7606865|FG001|Overall Study|Withdrawal by Subject|5
4695188|NCT02614794|7606864|FG000|Overall Study|Lost to Follow-up|2
4695189|NCT02614794|7606865|FG001|Overall Study|Lost to Follow-up|0
4695190|NCT02614794|7606864|FG000|Overall Study|Physician Decision|0
4695191|NCT02614794|7606865|FG001|Overall Study|Physician Decision|1
4695192|NCT02615145|7606884|FG000|Overall Study|Did Not Start Treatment|0
4695193|NCT02615145|7606885|FG001|Overall Study|Did Not Start Treatment|0
4695194|NCT02615145|7606886|FG002|Overall Study|Did Not Start Treatment|1
4695195|NCT02615145|7606887|FG003|Overall Study|Did Not Start Treatment|1
4695196|NCT02615145|7606884|FG000|Overall Study|Failure to Return|20
4695197|NCT02615145|7606885|FG001|Overall Study|Failure to Return|10
4695198|NCT02615145|7606886|FG002|Overall Study|Failure to Return|7
4695199|NCT02615145|7606887|FG003|Overall Study|Failure to Return|0
4695200|NCT02615145|7606884|FG000|Overall Study|Death|2
4695201|NCT02615145|7606885|FG001|Overall Study|Death|3
4695202|NCT02615145|7606886|FG002|Overall Study|Death|0
4695203|NCT02615145|7606887|FG003|Overall Study|Death|0
4695204|NCT02615145|7606884|FG000|Overall Study|Other, Not Specified|5
4695205|NCT02615145|7606885|FG001|Overall Study|Other, Not Specified|2
4695206|NCT02615145|7606886|FG002|Overall Study|Other, Not Specified|0
4695207|NCT02615145|7606887|FG003|Overall Study|Other, Not Specified|0
4695208|NCT02615171|7606928|FG000|Overall Study|Lost to Follow-up|2
4695209|NCT02615171|7606929|FG001|Overall Study|Lost to Follow-up|1
4695210|NCT02615249|7606935|FG000|Overall Study|Withdrawal by Subject|1
4695211|NCT02615470|7606942|FG000|Overall Study|Lost to Follow-up|21
4695212|NCT02615470|7606943|FG001|Overall Study|Lost to Follow-up|32
4695213|NCT02615509|7606949|FG000|Overall Study|Lost to Follow-up|134
4695214|NCT02615509|7606949|FG000|Overall Study|Death|4
4695215|NCT02615509|7606949|FG000|Overall Study|Withdrawal by Subject|8
4695216|NCT02616029|7606982|FG000|Overall Study|Adverse Event|1
4695217|NCT02616029|7606983|FG001|Overall Study|Adverse Event|0
4695218|NCT02616029|7606982|FG000|Overall Study|Death|0
4695219|NCT02616029|7606983|FG001|Overall Study|Death|1
4695220|NCT02616029|7606982|FG000|Overall Study|Protocol Violation|1
4695221|NCT02616029|7606983|FG001|Overall Study|Protocol Violation|0
4465809|NCT00613015|7257378|FG001|Overall Study|Lost to Follow-up|1
4465810|NCT00613015|7257379|FG002|Overall Study|Lost to Follow-up|3
4695222|NCT02616029|7606982|FG000|Overall Study|Withdrew Consent|1
4695223|NCT02616029|7606983|FG001|Overall Study|Withdrew Consent|0
4695224|NCT02616029|7606982|FG000|Overall Study|Enrolled and Never Treated|1
4695225|NCT02616029|7606983|FG001|Overall Study|Enrolled and Never Treated|1
4695226|NCT02616380|7606998|FG000|Overall Study|Lost to Follow-up|1
4695227|NCT02616380|7606998|FG000|Overall Study|Other|2
4695228|NCT02616601|7607021|FG000|Overall Study|Withdrawal by Subject|4
4465811|NCT00613015|7257380|FG003|Overall Study|Lost to Follow-up|3
4695229|NCT02616601|7607022|FG001|Overall Study|Withdrawal by Subject|4
4695230|NCT02616601|7607023|FG002|Overall Study|Withdrawal by Subject|3
4695231|NCT02616601|7607021|FG000|Overall Study|Adverse Event|2
4695232|NCT02616601|7607022|FG001|Overall Study|Adverse Event|0
4375793|NCT04439279|7151758|FG000|Overall Study|Adverse Event|7
4375794|NCT04439279|7151758|FG000|Overall Study|Death|4
4375795|NCT04439279|7151758|FG000|Overall Study|Disease progression|17
4375796|NCT04439279|7151758|FG000|Overall Study|Complicating disease|3
4375797|NCT04439279|7151758|FG000|Overall Study|Withdrawal by Subject|2
4375798|NCT04439279|7151758|FG000|Overall Study|Ineligible|1
4375799|NCT04439279|7151758|FG000|Overall Study|Treatment still ongoing|1
4375800|NCT04439123|7151762|FG000|Overall Study|Adverse Event|11
4375801|NCT04439123|7151762|FG000|Overall Study|Death|1
4375802|NCT04439123|7151762|FG000|Overall Study|Disease progression|19
4375803|NCT04439123|7151762|FG000|Overall Study|Withdrawal by Subject|2
4375804|NCT04439123|7151762|FG000|Overall Study|Still on treatment|2
4375805|NCT04439110|7151766|FG000|Overall Study|Ineligible|2
4375806|NCT04439110|7151766|FG000|Overall Study|Adverse Event|4
4375807|NCT04439110|7151766|FG000|Overall Study|Death|2
4375808|NCT04439110|7151766|FG000|Overall Study|Disease proression|25
4375809|NCT04439110|7151766|FG000|Overall Study|Withdrawal by Subject|1
4375810|NCT04439110|7151766|FG000|Overall Study|Alternative therapy|1
4375811|NCT04439110|7151766|FG000|Overall Study|Other complicating disease|1
4375812|NCT04439110|7151766|FG000|Overall Study|Personal reasons|1
4375813|NCT04439110|7151766|FG000|Overall Study|Still on treatment|1
4465812|NCT00613015|7257381|FG004|Overall Study|Lost to Follow-up|2
4465813|NCT00613015|7257382|FG005|Overall Study|Lost to Follow-up|3
4465814|NCT00613080|7257405|FG000|Overall Study|Ineligible / no protocol treatment|11
4465815|NCT00613106|7257411|FG000|Overall Study|Adverse Event|3
4695233|NCT02616601|7607023|FG002|Overall Study|Adverse Event|2
4695234|NCT02616601|7607021|FG000|Overall Study|Death|1
4695235|NCT02616601|7607022|FG001|Overall Study|Death|0
4695236|NCT02616601|7607023|FG002|Overall Study|Death|0
4695237|NCT02616601|7607021|FG000|Overall Study|Lost to Follow-up|1
4695238|NCT02616601|7607022|FG001|Overall Study|Lost to Follow-up|0
4695239|NCT02616601|7607023|FG002|Overall Study|Lost to Follow-up|1
4695240|NCT02616601|7607021|FG000|Overall Study|Non-Compliance with Test Article|1
4465816|NCT00613106|7257412|FG001|Overall Study|Adverse Event|1
4465817|NCT00613106|7257411|FG000|Overall Study|Withdrawal by Subject|6
4465818|NCT00613106|7257412|FG001|Overall Study|Withdrawal by Subject|3
4465819|NCT00613106|7257411|FG000|Overall Study|Lost to Follow-up|7
4465820|NCT00613106|7257412|FG001|Overall Study|Lost to Follow-up|2
4465821|NCT00613106|7257411|FG000|Overall Study|misc|4
4465822|NCT00613106|7257412|FG001|Overall Study|misc|3
4465823|NCT00613171|7257418|FG000|Overall Study|Adverse Event|7
4465824|NCT00613171|7257418|FG000|Overall Study|Withdrawal by Subject|3
4465825|NCT00613171|7257418|FG000|Overall Study|Reason not Specified|4
4465826|NCT00613301|7257423|FG000|Overall Study|Adverse Event|49
4465827|NCT00613301|7257423|FG000|Overall Study|Lost to Follow-up|88
4465828|NCT00613301|7257423|FG000|Overall Study|Withdrawal by Subject|5
4465829|NCT00613301|7257423|FG000|Overall Study|Death|6
4465830|NCT00613301|7257423|FG000|Overall Study|Lack of Efficacy|13
4465831|NCT00613301|7257423|FG000|Overall Study|Physician Decision|2
4465832|NCT00613301|7257423|FG000|Overall Study|No data was collected|53
4465833|NCT00613301|7257423|FG000|Overall Study|Irregularly enrolled patients|12
4465834|NCT00613314|7257428|FG000|Overall Study|Adverse Event|5
4465835|NCT00613314|7257428|FG000|Overall Study|Protocol Violation|14
4465836|NCT00613314|7257428|FG000|Overall Study|Lost to Follow-up|46
4465837|NCT00613314|7257428|FG000|Overall Study|Other reason not defined above|90
4465838|NCT00613327|7257432|FG000|Overall Study|Adverse Event|38
4695241|NCT02616601|7607022|FG001|Overall Study|Non-Compliance with Test Article|0
4695242|NCT02616601|7607023|FG002|Overall Study|Non-Compliance with Test Article|1
4695243|NCT02616614|7607034|FG000|Overall Study|Withdrawal by Subject|10
4695244|NCT02616614|7607035|FG001|Overall Study|Withdrawal by Subject|5
4695245|NCT02616614|7607036|FG002|Overall Study|Withdrawal by Subject|6
4695246|NCT02616614|7607034|FG000|Overall Study|Physician Decision|2
4695247|NCT02616614|7607035|FG001|Overall Study|Physician Decision|1
4695248|NCT02616614|7607036|FG002|Overall Study|Physician Decision|0
4695249|NCT02616614|7607034|FG000|Overall Study|Adverse Event|1
4695250|NCT02616614|7607035|FG001|Overall Study|Adverse Event|4
4695251|NCT02616614|7607036|FG002|Overall Study|Adverse Event|1
4695252|NCT02616614|7607034|FG000|Overall Study|Protocol Violation|0
4695253|NCT02616614|7607035|FG001|Overall Study|Protocol Violation|3
4465839|NCT00613327|7257432|FG000|Overall Study|Lost to Follow-up|8
4465840|NCT00613327|7257432|FG000|Overall Study|Withdrawal by Subject|6
4465841|NCT00613327|7257432|FG000|Overall Study|Protocol Violation|2
4465842|NCT00613327|7257432|FG000|Overall Study|Other|47
4465843|NCT00613366|7257438|FG000|Overall Study|Withdrawal by Subject|3
4465844|NCT00613366|7257439|FG001|Overall Study|Withdrawal by Subject|2
4465845|NCT00613509|7257469|FG000|Cycle 1|Adverse Event|2
4465846|NCT00613509|7257470|FG001|Cycle 1|Adverse Event|1
4465847|NCT00613509|7257469|FG000|Cycle 1|Disease Progression|2
4465848|NCT00613509|7257470|FG001|Cycle 1|Disease Progression|6
4465849|NCT00613509|7257469|FG000|Cycle 1|Unacceptable Toxicity|1
4465850|NCT00613509|7257470|FG001|Cycle 1|Unacceptable Toxicity|0
4465851|NCT00613509|7257469|FG000|Cycle 1|Other administrative reason|0
4465852|NCT00613509|7257470|FG001|Cycle 1|Other administrative reason|1
4695254|NCT02616614|7607036|FG002|Overall Study|Protocol Violation|1
4695255|NCT02616614|7607034|FG000|Overall Study|Prohibited Medication|12
4695256|NCT02616614|7607035|FG001|Overall Study|Prohibited Medication|9
4695257|NCT02616614|7607036|FG002|Overall Study|Prohibited Medication|5
4695258|NCT02616614|7607034|FG000|Overall Study|More than 3 applications missed|6
4695259|NCT02616614|7607035|FG001|Overall Study|More than 3 applications missed|8
4695260|NCT02616614|7607036|FG002|Overall Study|More than 3 applications missed|1
4695261|NCT02616614|7607034|FG000|Overall Study|Lost to Follow-up|31
4375814|NCT04498832|7151802|FG000|Overall Study|Adverse Event|1
4375815|NCT04498832|7151803|FG001|Overall Study|Adverse Event|3
4375816|NCT04498832|7151802|FG000|Overall Study|Withdrawal by Subject|0
4375817|NCT04498832|7151803|FG001|Overall Study|Withdrawal by Subject|1
4375818|NCT04109222|7151812|FG000|Overall Study|Adverse Event|1
4695262|NCT02616614|7607035|FG001|Overall Study|Lost to Follow-up|28
4695263|NCT02616614|7607036|FG002|Overall Study|Lost to Follow-up|13
4695264|NCT02616614|7607034|FG000|Overall Study|Pregnancy|2
4695265|NCT02616614|7607035|FG001|Overall Study|Pregnancy|0
4695266|NCT02616614|7607036|FG002|Overall Study|Pregnancy|1
4695267|NCT02616614|7607034|FG000|Overall Study|Other|1
4695268|NCT02616614|7607035|FG001|Overall Study|Other|2
4695269|NCT02616614|7607036|FG002|Overall Study|Other|1
4695270|NCT02616783|7607047|FG000|Overall Study|Randomized but Not Treated|1
4695271|NCT02616783|7607048|FG001|Overall Study|Randomized but Not Treated|0
4695272|NCT02616783|7607047|FG000|Overall Study|Adverse Event|1
4695273|NCT02616783|7607048|FG001|Overall Study|Adverse Event|0
4695274|NCT02616783|7607047|FG000|Overall Study|Death|1
4695275|NCT02616783|7607048|FG001|Overall Study|Death|0
4695276|NCT02616783|7607047|FG000|Overall Study|Non-Compliance with Study Drug|1
4695277|NCT02616783|7607048|FG001|Overall Study|Non-Compliance with Study Drug|0
4695278|NCT02616783|7607047|FG000|Overall Study|Protocol Violation|1
4695279|NCT02616783|7607048|FG001|Overall Study|Protocol Violation|1
4695280|NCT02616783|7607047|FG000|Overall Study|Withdrew Consent|1
4695281|NCT02616783|7607048|FG001|Overall Study|Withdrew Consent|1
4695282|NCT02616900|7607054|FG000|Overall Study|Lack of Efficacy|7
4695283|NCT02616900|7607054|FG000|Overall Study|Lost to Follow-up|2
4695284|NCT02616900|7607054|FG000|Overall Study|Protocol Violation|5
4695285|NCT02616900|7607054|FG000|Overall Study|Withdrawal by Subject|3
4695286|NCT02616900|7607054|FG000|Overall Study|Incomplete data|6
4695287|NCT02617628|7607060|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62
4695288|NCT02617628|7607061|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61
4695289|NCT02618382|7607149|FG000|Overall Study|Physician Decision|1
4695290|NCT02618382|7607149|FG000|Overall Study|Withdrawal by Subject|1
4695291|NCT02618382|7607149|FG000|Overall Study|Protocol Violation|1
4695292|NCT02618616|7607159|FG000|Overall Study|Lack of Efficacy|4
4695293|NCT02618616|7607160|FG001|Overall Study|Lack of Efficacy|0
4695294|NCT02618616|7607159|FG000|Overall Study|Pregnancy|0
4695295|NCT02618616|7607160|FG001|Overall Study|Pregnancy|1
4695296|NCT02618616|7607159|FG000|Overall Study|Adverse Event|8
4695297|NCT02618616|7607160|FG001|Overall Study|Adverse Event|0
4695298|NCT02618616|7607159|FG000|Overall Study|Failure to comply with dosing/evaluation|1
4695299|NCT02618616|7607160|FG001|Overall Study|Failure to comply with dosing/evaluation|0
4695300|NCT02618616|7607159|FG000|Overall Study|Consent withdrawn by subject|8
4695301|NCT02618616|7607160|FG001|Overall Study|Consent withdrawn by subject|5
4695302|NCT02618616|7607159|FG000|Overall Study|Lost to Follow-up|0
4695303|NCT02618616|7607160|FG001|Overall Study|Lost to Follow-up|1
4695304|NCT02618759|7607193|FG000|Overall Study|Lost to Follow-up|0
4695305|NCT02618759|7607194|FG001|Overall Study|Lost to Follow-up|1
4695306|NCT02618759|7607193|FG000|Overall Study|Withdrawal by Subject|1
4695307|NCT02618759|7607194|FG001|Overall Study|Withdrawal by Subject|0
4695308|NCT02618759|7607193|FG000|Overall Study|Other Reasons|1
4695309|NCT02618759|7607194|FG001|Overall Study|Other Reasons|4
4695310|NCT02618928|7607220|FG000|Overall Study|Failure to Return|28
4695311|NCT02618928|7607220|FG000|Overall Study|Insufficient Virological Response|1
4695312|NCT02618928|7607220|FG000|Overall Study|Withdrawal by Subject|2
4695313|NCT02618928|7607220|FG000|Overall Study|Death|3
4695314|NCT02618928|7607220|FG000|Overall Study|Other|11
4695315|NCT02618928|7607220|FG000|Overall Study|Missing|6
4695316|NCT02618928|7607220|FG000|Overall Study|Treatment Never Started|7
4695317|NCT02618967|7607235|FG000|Overall Study|Lost to Follow-up|0
4695318|NCT02618967|7607236|FG001|Overall Study|Lost to Follow-up|0
4695319|NCT02618967|7607237|FG002|Overall Study|Lost to Follow-up|1
4695320|NCT02618967|7607238|FG003|Overall Study|Lost to Follow-up|0
4695321|NCT02618967|7607239|FG004|Overall Study|Lost to Follow-up|2
4695322|NCT02618967|7607240|FG005|Overall Study|Lost to Follow-up|0
4695323|NCT02618967|7607241|FG006|Overall Study|Lost to Follow-up|0
4375819|NCT04109222|7151813|FG001|Overall Study|Adverse Event|0
4695324|NCT02618967|7607242|FG007|Overall Study|Lost to Follow-up|0
4695325|NCT02618967|7607235|FG000|Overall Study|Withdrawal by Subject|1
4695326|NCT02618967|7607236|FG001|Overall Study|Withdrawal by Subject|0
4695327|NCT02618967|7607237|FG002|Overall Study|Withdrawal by Subject|0
4695328|NCT02618967|7607238|FG003|Overall Study|Withdrawal by Subject|0
4695329|NCT02618967|7607239|FG004|Overall Study|Withdrawal by Subject|0
4695330|NCT02618967|7607240|FG005|Overall Study|Withdrawal by Subject|0
4695331|NCT02618967|7607241|FG006|Overall Study|Withdrawal by Subject|0
4695332|NCT02618967|7607242|FG007|Overall Study|Withdrawal by Subject|0
4695333|NCT02619175|7607262|FG000|Overall Study|Withdrawal by Subject|1
4695334|NCT02619175|7607263|FG001|Overall Study|Withdrawal by Subject|0
4695335|NCT02619175|7607262|FG000|Overall Study|foot pain|1
4375820|NCT04109222|7151814|FG002|Overall Study|Adverse Event|0
4375821|NCT04046939|7151826|FG000|Primary Assessment Period|Adverse Event|1
4375822|NCT04046939|7151827|FG001|Primary Assessment Period|Adverse Event|0
4375823|NCT04046939|7151828|FG002|Primary Assessment Period|Adverse Event|0
4375824|NCT04046939|7151829|FG003|Primary Assessment Period|Adverse Event|0
4375825|NCT04046939|7151826|FG000|Primary Assessment Period|Withdrawal by Subject|1
4375826|NCT04046939|7151827|FG001|Primary Assessment Period|Withdrawal by Subject|0
4375827|NCT04046939|7151828|FG002|Primary Assessment Period|Withdrawal by Subject|1
4375828|NCT04046939|7151829|FG003|Primary Assessment Period|Withdrawal by Subject|0
4375829|NCT04046939|7151826|FG000|Primary Assessment Period|Physician Decision|0
4375830|NCT04046939|7151827|FG001|Primary Assessment Period|Physician Decision|0
4375831|NCT04046939|7151828|FG002|Primary Assessment Period|Physician Decision|1
4375832|NCT04046939|7151829|FG003|Primary Assessment Period|Physician Decision|0
4375833|NCT04046939|7151826|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1
4375834|NCT04046939|7151827|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0
4375835|NCT04046939|7151828|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0
4375836|NCT04046939|7151829|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1
4375837|NCT03912259|7151847|FG000|Overall Study|Adverse Event (AE)|2
4375838|NCT03912259|7151848|FG001|Overall Study|Adverse Event (AE)|4
4375839|NCT03912259|7151847|FG000|Overall Study|Lack of Efficacy|4
4375840|NCT03912259|7151848|FG001|Overall Study|Lack of Efficacy|1
4375841|NCT03912259|7151847|FG000|Overall Study|Withdrawal by Subject|11
4375842|NCT03912259|7151848|FG001|Overall Study|Withdrawal by Subject|1
4375843|NCT03890367|7151858|FG000|Overall Study|Withdrawal by parent/guardian|1
4375844|NCT03890367|7151859|FG001|Overall Study|Withdrawal by parent/guardian|3
4375845|NCT03890367|7151860|FG002|Overall Study|Withdrawal by parent/guardian|0
4375846|NCT03890367|7151858|FG000|Overall Study|Protocol deviation|2
4375847|NCT03890367|7151859|FG001|Overall Study|Protocol deviation|2
4375848|NCT03890367|7151860|FG002|Overall Study|Protocol deviation|1
4375849|NCT03890367|7151858|FG000|Overall Study|Lost to Follow-up|1
4375850|NCT03890367|7151859|FG001|Overall Study|Lost to Follow-up|1
4375851|NCT03890367|7151860|FG002|Overall Study|Lost to Follow-up|0
4695336|NCT02619175|7607263|FG001|Overall Study|foot pain|0
4695337|NCT02619617|7607321|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0
4695338|NCT02619617|7607322|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1
4695339|NCT02619617|7607321|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0
4695340|NCT02619617|7607322|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3
4695341|NCT02620020|7607343|FG000|Overall Study|Adverse Event|8
4695342|NCT02620020|7607344|FG001|Overall Study|Adverse Event|4
4695343|NCT02620020|7607345|FG002|Overall Study|Adverse Event|3
4695344|NCT02620020|7607346|FG003|Overall Study|Adverse Event|5
4695345|NCT02620020|7607343|FG000|Overall Study|Lost to Follow-up|4
4695346|NCT02620020|7607344|FG001|Overall Study|Lost to Follow-up|8
4695347|NCT02620020|7607345|FG002|Overall Study|Lost to Follow-up|1
4695348|NCT02620020|7607346|FG003|Overall Study|Lost to Follow-up|4
4695349|NCT02620020|7607343|FG000|Overall Study|Physician Decision|7
4695350|NCT02620020|7607344|FG001|Overall Study|Physician Decision|4
4695351|NCT02620020|7607345|FG002|Overall Study|Physician Decision|3
4695352|NCT02620020|7607346|FG003|Overall Study|Physician Decision|4
4695353|NCT02620020|7607343|FG000|Overall Study|Protocol Violation|5
4695354|NCT02620020|7607344|FG001|Overall Study|Protocol Violation|2
4695355|NCT02620020|7607345|FG002|Overall Study|Protocol Violation|1
4695356|NCT02620020|7607346|FG003|Overall Study|Protocol Violation|1
4695357|NCT02620020|7607343|FG000|Overall Study|Withdrawal by Subject|20
4695358|NCT02620020|7607344|FG001|Overall Study|Withdrawal by Subject|16
4695359|NCT02620020|7607345|FG002|Overall Study|Withdrawal by Subject|17
4695360|NCT02620020|7607346|FG003|Overall Study|Withdrawal by Subject|12
4695361|NCT02620020|7607343|FG000|Overall Study|Death|0
4695362|NCT02620020|7607344|FG001|Overall Study|Death|1
4695363|NCT02620020|7607345|FG002|Overall Study|Death|0
4695364|NCT02620020|7607346|FG003|Overall Study|Death|0
4695365|NCT02620384|7607358|FG000|Overall Study|Adverse Event|2
4695366|NCT02620384|7607359|FG001|Overall Study|Adverse Event|1
4695367|NCT02620384|7607358|FG000|Overall Study|Discharged prior to 2nd dose|2
4695368|NCT02620384|7607359|FG001|Overall Study|Discharged prior to 2nd dose|5
4695369|NCT02620384|7607358|FG000|Overall Study|Drug shortage prevented 2nd dose|0
4695370|NCT02620384|7607359|FG001|Overall Study|Drug shortage prevented 2nd dose|1
4695371|NCT02620787|7607382|FG000|Overall Study|Adverse Event|1
4695372|NCT02620787|7607383|FG001|Overall Study|Adverse Event|0
4695373|NCT02620787|7607382|FG000|Overall Study|Eligibility Criteria Not Met|1
4695374|NCT02620787|7607383|FG001|Overall Study|Eligibility Criteria Not Met|0
4695375|NCT02621034|7607414|FG000|Overall Study|Lost to Follow-up|3
4695376|NCT02621034|7607415|FG001|Overall Study|Lost to Follow-up|2
4695377|NCT02621034|7607416|FG002|Overall Study|Lost to Follow-up|5
4695378|NCT02621047|7607429|FG000|Overall Study|Adverse Event|0
4465853|NCT00613574|7257476|FG000|Overall Study|Adverse Event|3
4465854|NCT00613574|7257476|FG000|Overall Study|Lost to Follow-up|2
4465855|NCT00613574|7257476|FG000|Overall Study|Other|1
4695379|NCT02621047|7607430|FG001|Overall Study|Adverse Event|0
4695380|NCT02621047|7607431|FG002|Overall Study|Adverse Event|1
4695381|NCT02621073|7607451|FG000|Overall Study|Lost to Follow-up|0
4695382|NCT02621073|7607452|FG001|Overall Study|Lost to Follow-up|1
4695383|NCT02621073|7607451|FG000|Overall Study|Physician Decision|3
4695384|NCT02621073|7607452|FG001|Overall Study|Physician Decision|2
4695385|NCT02621606|7607465|FG000|Overall Study|Withdrawal by Subject|0
4695386|NCT02621606|7607466|FG001|Overall Study|Withdrawal by Subject|1
4695387|NCT02621606|7607467|FG002|Overall Study|Withdrawal by Subject|0
4695388|NCT02621931|7607496|FG000|Overall Study|Death|0
4695389|NCT02621931|7607497|FG001|Overall Study|Death|1
4695390|NCT02621931|7607498|FG002|Overall Study|Death|0
4695391|NCT02621931|7607496|FG000|Overall Study|Adverse Event|8
4695392|NCT02621931|7607497|FG001|Overall Study|Adverse Event|5
4695393|NCT02621931|7607498|FG002|Overall Study|Adverse Event|7
4375852|NCT03607422|7151878|FG000|Overall Study|Adverse Event|7
4375853|NCT03607422|7151879|FG001|Overall Study|Adverse Event|3
4375854|NCT03607422|7151880|FG002|Overall Study|Adverse Event|2
4375855|NCT03607422|7151881|FG003|Overall Study|Adverse Event|0
4375856|NCT03607422|7151882|FG004|Overall Study|Adverse Event|2
4375857|NCT03607422|7151883|FG005|Overall Study|Adverse Event|0
4375858|NCT03607422|7151878|FG000|Overall Study|Withdrawal by Subject|11
4375859|NCT03607422|7151879|FG001|Overall Study|Withdrawal by Subject|3
4375860|NCT03607422|7151880|FG002|Overall Study|Withdrawal by Subject|6
4375861|NCT03607422|7151881|FG003|Overall Study|Withdrawal by Subject|2
4375862|NCT03607422|7151882|FG004|Overall Study|Withdrawal by Subject|0
4375863|NCT03607422|7151883|FG005|Overall Study|Withdrawal by Subject|0
4375864|NCT03607422|7151878|FG000|Overall Study|Lost to Follow-up|0
4375865|NCT03607422|7151879|FG001|Overall Study|Lost to Follow-up|0
4375866|NCT03607422|7151880|FG002|Overall Study|Lost to Follow-up|1
4375867|NCT03607422|7151881|FG003|Overall Study|Lost to Follow-up|0
4375868|NCT03607422|7151882|FG004|Overall Study|Lost to Follow-up|0
4375869|NCT03607422|7151883|FG005|Overall Study|Lost to Follow-up|0
4695394|NCT02621931|7607496|FG000|Overall Study|Withdrawal by Subject|12
4695395|NCT02621931|7607497|FG001|Overall Study|Withdrawal by Subject|10
4695396|NCT02621931|7607498|FG002|Overall Study|Withdrawal by Subject|11
4695397|NCT02621931|7607496|FG000|Overall Study|Protocol Violation|2
4695398|NCT02621931|7607497|FG001|Overall Study|Protocol Violation|2
4695399|NCT02621931|7607498|FG002|Overall Study|Protocol Violation|2
4695400|NCT02621931|7607496|FG000|Overall Study|Pregnancy|2
4695401|NCT02621931|7607497|FG001|Overall Study|Pregnancy|0
4695402|NCT02621931|7607498|FG002|Overall Study|Pregnancy|0
4695403|NCT02621931|7607496|FG000|Overall Study|Noncompliance to study procedures|0
4695404|NCT02621931|7607497|FG001|Overall Study|Noncompliance to study procedures|1
4695405|NCT02621931|7607498|FG002|Overall Study|Noncompliance to study procedures|2
4695406|NCT02621931|7607496|FG000|Overall Study|Lost to Follow-up|8
4695407|NCT02621931|7607497|FG001|Overall Study|Lost to Follow-up|7
4695408|NCT02621931|7607498|FG002|Overall Study|Lost to Follow-up|10
4695409|NCT02621931|7607496|FG000|Overall Study|Lack of Efficacy|0
4695410|NCT02621931|7607497|FG001|Overall Study|Lack of Efficacy|0
4695411|NCT02621931|7607498|FG002|Overall Study|Lack of Efficacy|1
4695412|NCT02621931|7607496|FG000|Overall Study|Other|1
4695413|NCT02621931|7607497|FG001|Overall Study|Other|1
4695414|NCT02621931|7607498|FG002|Overall Study|Other|3
4695415|NCT02622074|7607523|FG000|Overall Study|Death|4
4695416|NCT02622074|7607524|FG001|Overall Study|Death|0
4695417|NCT02622074|7607525|FG002|Overall Study|Death|0
4695418|NCT02622074|7607526|FG003|Overall Study|Death|1
4695419|NCT02622074|7607527|FG004|Overall Study|Death|1
4695420|NCT02622074|7607528|FG005|Overall Study|Death|0
4695421|NCT02622074|7607523|FG000|Overall Study|Withdrawal by Subject|0
4695422|NCT02622074|7607524|FG001|Overall Study|Withdrawal by Subject|1
4695423|NCT02622074|7607525|FG002|Overall Study|Withdrawal by Subject|0
4695424|NCT02622074|7607526|FG003|Overall Study|Withdrawal by Subject|0
4695425|NCT02622074|7607527|FG004|Overall Study|Withdrawal by Subject|0
4695426|NCT02622074|7607528|FG005|Overall Study|Withdrawal by Subject|0
4695427|NCT02622113|7607544|FG000|Overall Study|Adverse Event|4
4695428|NCT02622113|7607545|FG001|Overall Study|Adverse Event|4
4695429|NCT02622113|7607544|FG000|Overall Study|Physician Decision|0
4695430|NCT02622113|7607545|FG001|Overall Study|Physician Decision|1
4695431|NCT02622113|7607544|FG000|Overall Study|Withdrawal by Subject|0
4695432|NCT02622113|7607545|FG001|Overall Study|Withdrawal by Subject|2
4695433|NCT02622113|7607544|FG000|Overall Study|Stopping Criteria|1
4695434|NCT02622113|7607545|FG001|Overall Study|Stopping Criteria|3
4695435|NCT02622321|7607579|FG000|Overall Study|Withdrawal by Subject|2
4375870|NCT03607422|7151878|FG000|Overall Study|Other|12
4375871|NCT03607422|7151879|FG001|Overall Study|Other|4
4375872|NCT03607422|7151880|FG002|Overall Study|Other|1
4375873|NCT03607422|7151881|FG003|Overall Study|Other|2
4375874|NCT03607422|7151882|FG004|Overall Study|Other|0
4375875|NCT03607422|7151883|FG005|Overall Study|Other|2
4695436|NCT02622321|7607580|FG001|Overall Study|Withdrawal by Subject|0
4695437|NCT02622321|7607581|FG002|Overall Study|Withdrawal by Subject|0
4695438|NCT02622321|7607582|FG003|Overall Study|Withdrawal by Subject|0
4695439|NCT02622321|7607579|FG000|Overall Study|Death|0
4695440|NCT02622321|7607580|FG001|Overall Study|Death|0
4695441|NCT02622321|7607581|FG002|Overall Study|Death|1
4695442|NCT02622321|7607582|FG003|Overall Study|Death|0
4695443|NCT02622321|7607579|FG000|Overall Study|Physician Decision|1
4695444|NCT02622321|7607580|FG001|Overall Study|Physician Decision|0
4695445|NCT02622321|7607581|FG002|Overall Study|Physician Decision|0
4695446|NCT02622321|7607582|FG003|Overall Study|Physician Decision|0
4695447|NCT02622568|7607608|FG000|Overall Study|Lost to Follow-up|5
4375876|NCT03607422|7151878|FG000|Overall Study|Ongoing at Time of Analysis|8
4375877|NCT03607422|7151879|FG001|Overall Study|Ongoing at Time of Analysis|0
4375878|NCT03607422|7151880|FG002|Overall Study|Ongoing at Time of Analysis|2
4375879|NCT03607422|7151881|FG003|Overall Study|Ongoing at Time of Analysis|1
4375880|NCT03607422|7151882|FG004|Overall Study|Ongoing at Time of Analysis|1
4375881|NCT03607422|7151883|FG005|Overall Study|Ongoing at Time of Analysis|1
4375882|NCT03600805|7151901|FG000|Overall Study|Adverse Event|2
4375883|NCT03600805|7151902|FG001|Overall Study|Adverse Event|1
4375884|NCT03600805|7151903|FG002|Overall Study|Adverse Event|1
4375885|NCT03600805|7151904|FG003|Overall Study|Adverse Event|7
4375886|NCT03600805|7151901|FG000|Overall Study|Lack of Efficacy|2
4375887|NCT03600805|7151902|FG001|Overall Study|Lack of Efficacy|1
4375888|NCT03600805|7151903|FG002|Overall Study|Lack of Efficacy|0
4375889|NCT03600805|7151904|FG003|Overall Study|Lack of Efficacy|0
4375890|NCT03600805|7151901|FG000|Overall Study|Withdrawal by Subject|1
4375891|NCT03600805|7151902|FG001|Overall Study|Withdrawal by Subject|0
4375892|NCT03600805|7151903|FG002|Overall Study|Withdrawal by Subject|0
4695448|NCT02622568|7607609|FG001|Overall Study|Lost to Follow-up|5
4735076|NCT03519087|7682627|FG002|Re-randomization for Treatment|Not appropriate|0
4735077|NCT03519087|7682628|FG003|Re-randomization for Treatment|Not appropriate|0
4735078|NCT03519087|7682629|FG004|Re-randomization for Treatment|Not appropriate|0
4735079|NCT03519087|7682625|FG000|Laboratory Testing|Lost to Follow-up|0
4735080|NCT03519087|7682626|FG001|Laboratory Testing|Lost to Follow-up|0
4735081|NCT03519087|7682627|FG002|Laboratory Testing|Lost to Follow-up|2
4735082|NCT03519087|7682628|FG003|Laboratory Testing|Lost to Follow-up|3
4735083|NCT03519087|7682629|FG004|Laboratory Testing|Lost to Follow-up|6
4735084|NCT03519087|7682625|FG000|Laboratory Testing|Protocol Violation|0
4735085|NCT03519087|7682626|FG001|Laboratory Testing|Protocol Violation|0
4735086|NCT03519087|7682627|FG002|Laboratory Testing|Protocol Violation|0
4735087|NCT03519087|7682628|FG003|Laboratory Testing|Protocol Violation|1
4735088|NCT03519087|7682629|FG004|Laboratory Testing|Protocol Violation|0
4735089|NCT03519204|7682647|FG000|Overall Study|Lost to Follow-up|3
4735090|NCT03519204|7682648|FG001|Overall Study|Lost to Follow-up|8
4735091|NCT03519204|7682647|FG000|Overall Study|Withdrawal by Subject|9
4735092|NCT03519204|7682648|FG001|Overall Study|Withdrawal by Subject|7
4735093|NCT03519204|7682647|FG000|Overall Study|Other Miscellaneous Reasons|1
4735094|NCT03519204|7682648|FG001|Overall Study|Other Miscellaneous Reasons|0
4735095|NCT03519516|7682681|FG000|Overall Study|Adverse Event|0
4735096|NCT03519516|7682682|FG001|Overall Study|Adverse Event|1
4735097|NCT03519854|7682706|FG000|Overall Study|Technical Error|0
4735098|NCT03519854|7682707|FG001|Overall Study|Technical Error|0
4735099|NCT03519854|7682708|FG002|Overall Study|Technical Error|1
4735100|NCT03519854|7682709|FG003|Overall Study|Technical Error|0
4735101|NCT03519854|7682710|FG004|Overall Study|Technical Error|0
4735102|NCT03519854|7682711|FG005|Overall Study|Technical Error|0
4735103|NCT03519854|7682712|FG006|Overall Study|Technical Error|0
4735104|NCT03519854|7682713|FG007|Overall Study|Technical Error|0
4735105|NCT03519854|7682714|FG008|Overall Study|Technical Error|0
4735106|NCT03519854|7682715|FG009|Overall Study|Technical Error|0
4735107|NCT03519854|7682716|FG010|Overall Study|Technical Error|0
4735108|NCT03519854|7682717|FG011|Overall Study|Technical Error|0
4735109|NCT03519854|7682718|FG012|Overall Study|Technical Error|0
4735110|NCT03519854|7682719|FG013|Overall Study|Technical Error|0
4735111|NCT03519854|7682720|FG014|Overall Study|Technical Error|0
4735112|NCT03519854|7682721|FG015|Overall Study|Technical Error|0
4735113|NCT03519854|7682722|FG016|Overall Study|Technical Error|0
4735114|NCT03519854|7682723|FG017|Overall Study|Technical Error|0
4735115|NCT03519867|7682771|FG000|Overall Study|Adverse Event|1
4735116|NCT03519867|7682772|FG001|Overall Study|Adverse Event|1
4735117|NCT03519867|7682773|FG002|Overall Study|Adverse Event|0
4735118|NCT03519867|7682774|FG003|Overall Study|Adverse Event|0
4735119|NCT03519867|7682775|FG004|Overall Study|Adverse Event|0
4735120|NCT03519867|7682776|FG005|Overall Study|Adverse Event|0
4735121|NCT03519867|7682777|FG006|Overall Study|Adverse Event|0
4735122|NCT03519867|7682778|FG007|Overall Study|Adverse Event|0
4735123|NCT03519867|7682779|FG008|Overall Study|Adverse Event|0
4735124|NCT03519867|7682780|FG009|Overall Study|Adverse Event|0
4375893|NCT03600805|7151904|FG003|Overall Study|Withdrawal by Subject|1
4375894|NCT03600805|7151901|FG000|Overall Study|Other unspecified|14
4735125|NCT03519867|7682771|FG000|Overall Study|Protocol Violation|0
4735126|NCT03519867|7682772|FG001|Overall Study|Protocol Violation|0
4735127|NCT03519867|7682773|FG002|Overall Study|Protocol Violation|0
4735128|NCT03519867|7682774|FG003|Overall Study|Protocol Violation|0
4735129|NCT03519867|7682775|FG004|Overall Study|Protocol Violation|0
4735130|NCT03519867|7682776|FG005|Overall Study|Protocol Violation|1
4375895|NCT03600805|7151902|FG001|Overall Study|Other unspecified|6
4375896|NCT03600805|7151903|FG002|Overall Study|Other unspecified|7
4375897|NCT03600805|7151904|FG003|Overall Study|Other unspecified|11
4375898|NCT03434119|7151927|FG000|Overall Study|Randomized but not treated|1
4735131|NCT03519867|7682777|FG006|Overall Study|Protocol Violation|0
4735132|NCT03519867|7682778|FG007|Overall Study|Protocol Violation|0
4735133|NCT03519867|7682779|FG008|Overall Study|Protocol Violation|0
4735134|NCT03519867|7682780|FG009|Overall Study|Protocol Violation|0
4735135|NCT03519867|7682771|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0
4735136|NCT03519867|7682772|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0
4375899|NCT03434119|7151928|FG001|Overall Study|Randomized but not treated|0
4375900|NCT03434119|7151927|FG000|Overall Study|Adverse Event|1
4375901|NCT03434119|7151928|FG001|Overall Study|Adverse Event|0
4375902|NCT03434119|7151927|FG000|Overall Study|Poor Compliance to Protocol|0
4375903|NCT03434119|7151928|FG001|Overall Study|Poor Compliance to Protocol|1
4375904|NCT03434119|7151927|FG000|Overall Study|Study Terminated by Sponsor|91
4375905|NCT03434119|7151928|FG001|Overall Study|Study Terminated by Sponsor|102
4375906|NCT03434119|7151927|FG000|Overall Study|Withdrawal by Subject|7
4375907|NCT03434119|7151928|FG001|Overall Study|Withdrawal by Subject|5
4375908|NCT03434119|7151927|FG000|Overall Study|Other than specified|7
4375909|NCT03434119|7151928|FG001|Overall Study|Other than specified|5
4375910|NCT03417245|7151936|FG000|Overall Study|Adverse Event|1
4375911|NCT03417245|7151937|FG001|Overall Study|Adverse Event|0
4375912|NCT03417245|7151936|FG000|Overall Study|Protocol Violation|1
4375913|NCT03417245|7151937|FG001|Overall Study|Protocol Violation|0
4375914|NCT03417245|7151936|FG000|Overall Study|Withdrawal by Subject|1
4375915|NCT03417245|7151937|FG001|Overall Study|Withdrawal by Subject|1
4375916|NCT03417102|7151945|FG000|Overall Study|Adverse Event|0
4375917|NCT03417102|7151946|FG001|Overall Study|Adverse Event|1
4375918|NCT03417102|7151945|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0
4695449|NCT02622724|7607617|FG000|Overall Study|Death|51
4695450|NCT02622724|7607618|FG001|Overall Study|Death|53
4695451|NCT02622724|7607617|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4
4695452|NCT02622724|7607618|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7
4695453|NCT02622724|7607617|FG000|Overall Study|Early termination of study|38
4695454|NCT02622724|7607618|FG001|Overall Study|Early termination of study|43
4695455|NCT02623218|7607635|FG000|Overall Study|Lost to Follow-up|0
4695456|NCT02623218|7607636|FG001|Overall Study|Lost to Follow-up|1
4695457|NCT02623218|7607637|FG002|Overall Study|Lost to Follow-up|0
4695458|NCT02623218|7607638|FG003|Overall Study|Lost to Follow-up|0
4695459|NCT02623218|7607639|FG004|Overall Study|Lost to Follow-up|0
4695460|NCT02623322|7607654|FG000|Overall Study|Lost to Follow-up|2
4695461|NCT02623322|7607655|FG001|Overall Study|Lost to Follow-up|1
4695462|NCT02623322|7607656|FG002|Overall Study|Lost to Follow-up|0
4695463|NCT02623335|7607668|FG000|Overall Study|Death|8
4695464|NCT02623335|7607669|FG001|Overall Study|Death|7
4695465|NCT02623335|7607668|FG000|Overall Study|Lost to Follow-up|15
4695466|NCT02623335|7607669|FG001|Overall Study|Lost to Follow-up|23
4695467|NCT02623335|7607668|FG000|Overall Study|Withdrawal by Subject|2
4695468|NCT02623335|7607669|FG001|Overall Study|Withdrawal by Subject|5
4695469|NCT02623335|7607668|FG000|Overall Study|Protocol Violation|2
4695470|NCT02623335|7607669|FG001|Overall Study|Protocol Violation|1
4695471|NCT02623361|7607686|FG000|Overall Study|Protocol Violation|0
4695472|NCT02623361|7607687|FG001|Overall Study|Protocol Violation|1
4695473|NCT02623361|7607686|FG000|Overall Study|Withdrawal by Subject|0
4695474|NCT02623361|7607687|FG001|Overall Study|Withdrawal by Subject|1
4695475|NCT02623829|7607704|FG000|Overall Study|Lost to Follow-up|1
4695476|NCT02623829|7607705|FG001|Overall Study|Lost to Follow-up|1
4695477|NCT02624050|7607722|FG000|Overall Study|Physician Decision|4
4695478|NCT02624050|7607723|FG001|Overall Study|Physician Decision|0
4695479|NCT02624050|7607722|FG000|Overall Study|Protocol Violation|2
4695480|NCT02624050|7607723|FG001|Overall Study|Protocol Violation|0
4695481|NCT02624284|7607741|FG000|Overall Study|Withdrawal by Subject|3
4695482|NCT02624284|7607742|FG001|Overall Study|Withdrawal by Subject|6
4695483|NCT02624284|7607743|FG002|Overall Study|Withdrawal by Subject|3
4695484|NCT02624284|7607741|FG000|Overall Study|Protocol Violation|9
4695485|NCT02624284|7607742|FG001|Overall Study|Protocol Violation|10
4695486|NCT02624284|7607743|FG002|Overall Study|Protocol Violation|7
4695487|NCT02624284|7607741|FG000|Overall Study|Revealed exclusionary condition|2
4695488|NCT02624284|7607742|FG001|Overall Study|Revealed exclusionary condition|2
4695489|NCT02624284|7607743|FG002|Overall Study|Revealed exclusionary condition|0
4695490|NCT02624284|7607741|FG000|Overall Study|Adverse Event|0
4695491|NCT02624284|7607742|FG001|Overall Study|Adverse Event|0
4695492|NCT02624284|7607743|FG002|Overall Study|Adverse Event|1
4695493|NCT02624492|7607758|FG000|Overall Study|Adverse Event|2
4695494|NCT02624492|7607759|FG001|Overall Study|Adverse Event|2
4695495|NCT02624492|7607760|FG002|Overall Study|Adverse Event|2
4695496|NCT02624492|7607758|FG000|Overall Study|Progressive disease|0
4695497|NCT02624492|7607759|FG001|Overall Study|Progressive disease|2
4695498|NCT02624492|7607760|FG002|Overall Study|Progressive disease|3
4695499|NCT02624687|7607770|FG000|Overall Study|Withdrawal by Subject|1
4695500|NCT02624687|7607771|FG001|Overall Study|Withdrawal by Subject|1
4695501|NCT02624687|7607770|FG000|Overall Study|medical leave from work|0
4695502|NCT02624687|7607771|FG001|Overall Study|medical leave from work|1
4695503|NCT02624713|7607790|FG000|Overall Study|Lost to Follow-up|14
4695504|NCT02624713|7607791|FG001|Overall Study|Lost to Follow-up|0
4375919|NCT03417102|7151946|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3
4375920|NCT03417102|7151945|FG000|Overall Study|Other|0
4375921|NCT03417102|7151946|FG001|Overall Study|Other|1
4695505|NCT02624791|7607798|FG000|Overall Study|Withdrawal by Subject|2
4695506|NCT02624791|7607799|FG001|Overall Study|Withdrawal by Subject|0
4375922|NCT03278626|7151958|FG000|Overall Study|Death|2
4375923|NCT03278626|7151958|FG000|Overall Study|Toxicity|1
4375924|NCT03278626|7151958|FG000|Overall Study|Disease Progression|2
4695507|NCT02624791|7607800|FG002|Overall Study|Withdrawal by Subject|0
4375925|NCT03211858|7151964|FG000|Overall Study|Adverse Event|8
4375926|NCT03211858|7151965|FG001|Overall Study|Adverse Event|6
4375927|NCT03211858|7151964|FG000|Overall Study|Lack of Efficacy|0
4375928|NCT03211858|7151965|FG001|Overall Study|Lack of Efficacy|4
4375929|NCT03211858|7151964|FG000|Overall Study|Poor compliance to protocol|6
4375930|NCT03211858|7151965|FG001|Overall Study|Poor compliance to protocol|2
4375931|NCT03211858|7151964|FG000|Overall Study|Non-serious Hypoglycemia|1
4375932|NCT03211858|7151965|FG001|Overall Study|Non-serious Hypoglycemia|0
4375933|NCT03211858|7151964|FG000|Overall Study|Other than specified above|22
4375934|NCT03211858|7151965|FG001|Overall Study|Other than specified above|21
4375935|NCT03077438|7151981|FG000|Overall Study|Protocol Violation|3
4375936|NCT03077438|7151982|FG001|Overall Study|Protocol Violation|5
4375937|NCT03077438|7151981|FG000|Overall Study|Withdrawal by Subject|3
4375938|NCT03077438|7151982|FG001|Overall Study|Withdrawal by Subject|6
4375939|NCT03077438|7151981|FG000|Overall Study|Lost to Follow-up|6
4375940|NCT03077438|7151982|FG001|Overall Study|Lost to Follow-up|3
4375941|NCT02948959|7151998|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0
4375942|NCT02948959|7151999|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2
4375943|NCT02948959|7151998|FG000|52 Weeks Treatment Period|Adverse Event|2
4375944|NCT02948959|7151999|FG001|52 Weeks Treatment Period|Adverse Event|5
4695508|NCT02624791|7607801|FG003|Overall Study|Withdrawal by Subject|0
4695509|NCT02624791|7607802|FG004|Overall Study|Withdrawal by Subject|0
4695510|NCT02624791|7607803|FG005|Overall Study|Withdrawal by Subject|0
4695511|NCT02624986|7607828|FG000|Overall Study|Death|0
4695512|NCT02624986|7607829|FG001|Overall Study|Death|1
4695513|NCT02624986|7607830|FG002|Overall Study|Death|2
4695514|NCT02624986|7607831|FG003|Overall Study|Death|2
4695515|NCT02624986|7607832|FG004|Overall Study|Death|2
4695516|NCT02624986|7607833|FG005|Overall Study|Death|0
4695517|NCT02624986|7607834|FG006|Overall Study|Death|0
4695518|NCT02624986|7607835|FG007|Overall Study|Death|1
4695519|NCT02624986|7607828|FG000|Overall Study|Study Terminated by Sponsor|1
4695520|NCT02624986|7607829|FG001|Overall Study|Study Terminated by Sponsor|1
4695521|NCT02624986|7607830|FG002|Overall Study|Study Terminated by Sponsor|0
4695522|NCT02624986|7607831|FG003|Overall Study|Study Terminated by Sponsor|1
4695523|NCT02624986|7607832|FG004|Overall Study|Study Terminated by Sponsor|2
4695524|NCT02624986|7607833|FG005|Overall Study|Study Terminated by Sponsor|2
4695525|NCT02624986|7607834|FG006|Overall Study|Study Terminated by Sponsor|4
4695526|NCT02624986|7607835|FG007|Overall Study|Study Terminated by Sponsor|3
4695527|NCT02624986|7607828|FG000|Overall Study|Progressive Disease|0
4695528|NCT02624986|7607829|FG001|Overall Study|Progressive Disease|1
4695529|NCT02624986|7607830|FG002|Overall Study|Progressive Disease|0
4695530|NCT02624986|7607831|FG003|Overall Study|Progressive Disease|0
4695531|NCT02624986|7607832|FG004|Overall Study|Progressive Disease|0
4695532|NCT02624986|7607833|FG005|Overall Study|Progressive Disease|0
4695533|NCT02624986|7607834|FG006|Overall Study|Progressive Disease|0
4695534|NCT02624986|7607835|FG007|Overall Study|Progressive Disease|0
4695535|NCT02624986|7607828|FG000|Overall Study|Protocol Violation|1
4695536|NCT02624986|7607829|FG001|Overall Study|Protocol Violation|0
4695537|NCT02624986|7607830|FG002|Overall Study|Protocol Violation|0
4695538|NCT02624986|7607831|FG003|Overall Study|Protocol Violation|0
4695539|NCT02624986|7607832|FG004|Overall Study|Protocol Violation|0
4695540|NCT02624986|7607833|FG005|Overall Study|Protocol Violation|0
4695541|NCT02624986|7607834|FG006|Overall Study|Protocol Violation|0
4695542|NCT02624986|7607835|FG007|Overall Study|Protocol Violation|0
4695543|NCT02624986|7607828|FG000|Overall Study|Withdrawal by Subject|0
4695544|NCT02624986|7607829|FG001|Overall Study|Withdrawal by Subject|0
4695545|NCT02624986|7607830|FG002|Overall Study|Withdrawal by Subject|0
4695546|NCT02624986|7607831|FG003|Overall Study|Withdrawal by Subject|0
4695547|NCT02624986|7607832|FG004|Overall Study|Withdrawal by Subject|0
4695548|NCT02624986|7607833|FG005|Overall Study|Withdrawal by Subject|0
4695549|NCT02624986|7607834|FG006|Overall Study|Withdrawal by Subject|0
4695550|NCT02624986|7607835|FG007|Overall Study|Withdrawal by Subject|1
4695551|NCT02625220|7607891|FG000|Overall Study|Adverse Event|2
4695552|NCT02625220|7607891|FG000|Overall Study|Lost to Follow-up|2
4695553|NCT02625220|7607891|FG000|Overall Study|Protocol Violation|1
4695554|NCT02625220|7607891|FG000|Overall Study|Study discontinued at site|2
4695555|NCT02625233|7607897|FG000|Overall Study|Adverse Event|2
4695556|NCT02625233|7607898|FG001|Overall Study|Adverse Event|0
4695557|NCT02625259|7607909|FG000|First Intervention (Day 1)|Other|0
4695558|NCT02625259|7607910|FG001|First Intervention (Day 1)|Other|0
4695559|NCT02625259|7607911|FG002|First Intervention (Day 1)|Other|1
4695560|NCT02625259|7607912|FG003|First Intervention (Day 1)|Other|0
4465856|NCT00613626|7257483|FG000|Overall Study|Ineligible|0
4465857|NCT00613626|7257484|FG001|Overall Study|Ineligible|1
4465858|NCT00613626|7257485|FG002|Overall Study|Ineligible|0
4465859|NCT00613821|7257494|FG000|Overall Study|Withdrawal by Subject|1
4465860|NCT00613821|7257495|FG001|Overall Study|Withdrawal by Subject|0
4465861|NCT00613821|7257494|FG000|Overall Study|Physician Decision|1
4695561|NCT02625259|7607913|FG004|First Intervention (Day 1)|Other|0
4695562|NCT02625259|7607909|FG000|First Intervention (Day 1)|Adverse Event|2
4695563|NCT02625259|7607910|FG001|First Intervention (Day 1)|Adverse Event|1
4695564|NCT02625259|7607911|FG002|First Intervention (Day 1)|Adverse Event|0
4695565|NCT02625259|7607912|FG003|First Intervention (Day 1)|Adverse Event|0
4695566|NCT02625259|7607913|FG004|First Intervention (Day 1)|Adverse Event|0
4375945|NCT02948959|7151998|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2
4587688|NCT01493557|7431900|FG002|Not Randomized to Management Strategies|Other adverse event|54
4587689|NCT01493557|7431898|FG000|Not Randomized to Management Strategies|Protocol Violation|0
4587690|NCT01493557|7431899|FG001|Not Randomized to Management Strategies|Protocol Violation|0
4587691|NCT01493557|7431900|FG002|Not Randomized to Management Strategies|Protocol Violation|1
4587692|NCT01493557|7431898|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0
4587693|NCT01493557|7431899|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0
4587694|NCT01493557|7431900|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4
4587695|NCT01493557|7431898|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0
4587696|NCT01493557|7431899|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0
4587697|NCT01493557|7431900|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10
4587698|NCT01493557|7431898|FG000|Not Randomized to Management Strategies|Early termination|0
4587699|NCT01493557|7431899|FG001|Not Randomized to Management Strategies|Early termination|0
4587700|NCT01493557|7431900|FG002|Not Randomized to Management Strategies|Early termination|34
4587701|NCT01493557|7431898|FG000|Not Randomized to Management Strategies|Other than stated above|0
4587702|NCT01493557|7431899|FG001|Not Randomized to Management Strategies|Other than stated above|0
4587703|NCT01493557|7431900|FG002|Not Randomized to Management Strategies|Other than stated above|21
4587704|NCT01493557|7431898|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3
4587705|NCT01493557|7431899|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2
4587706|NCT01493557|7431900|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0
4587707|NCT01493557|7431898|FG000|Randomized to Management Strategies|Other adverse event|8
4587708|NCT01493557|7431899|FG001|Randomized to Management Strategies|Other adverse event|5
4587709|NCT01493557|7431900|FG002|Randomized to Management Strategies|Other adverse event|0
4587710|NCT01493557|7431898|FG000|Randomized to Management Strategies|Protocol Violation|3
4587711|NCT01493557|7431899|FG001|Randomized to Management Strategies|Protocol Violation|0
4587712|NCT01493557|7431900|FG002|Randomized to Management Strategies|Protocol Violation|0
4587713|NCT01493557|7431898|FG000|Randomized to Management Strategies|Withdrawal by Subject|0
4695567|NCT02625259|7607909|FG000|First Intervention (Day 1)|Withdrawal by Subject|0
4695568|NCT02625259|7607910|FG001|First Intervention (Day 1)|Withdrawal by Subject|0
4695569|NCT02625259|7607911|FG002|First Intervention (Day 1)|Withdrawal by Subject|0
4695570|NCT02625259|7607912|FG003|First Intervention (Day 1)|Withdrawal by Subject|1
4695571|NCT02625259|7607913|FG004|First Intervention (Day 1)|Withdrawal by Subject|0
4695572|NCT02625324|7607939|FG000|30-Day Follow-up for Primary Endpoint|Death|1
4375946|NCT02948959|7151999|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2
4375947|NCT02948959|7151998|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1
4375948|NCT02948959|7151999|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6
4375949|NCT02948959|7151998|FG000|52 Weeks Treatment Period|Randomized by error|0
4375950|NCT02948959|7151999|FG001|52 Weeks Treatment Period|Randomized by error|5
4375951|NCT02948959|7151998|FG000|52 Weeks Treatment Period|Randomized and not treated|0
4375952|NCT02948959|7151999|FG001|52 Weeks Treatment Period|Randomized and not treated|3
4375953|NCT02948959|7151998|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0
4375954|NCT02948959|7151999|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1
4375955|NCT02948959|7151998|FG000|52 Weeks Treatment Period|Change of residence location|0
4375956|NCT02948959|7151999|FG001|52 Weeks Treatment Period|Change of residence location|1
4375957|NCT02948959|7151998|FG000|12 Weeks Follow-up Period|Adverse Event|0
4375958|NCT02948959|7151999|FG001|12 Weeks Follow-up Period|Adverse Event|2
4375959|NCT02948959|7151998|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1
4695573|NCT02625324|7607939|FG000|30-Day Follow-up for Secondary Endpoint|Death|1
4695574|NCT02625324|7607939|FG000|6-Month Follow-up Subject Accountability|Death|5
4695575|NCT02625324|7607939|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2
4695576|NCT02625324|7607939|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1
4695577|NCT02625324|7607939|FG000|12-Month Follow-up Secondary Endpoint|Death|4
4695578|NCT02625324|7607939|FG000|24-Month Follow-up Secondary Endpoint|Death|2
4695579|NCT02625324|7607939|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3
4695580|NCT02625324|7607939|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2
4695581|NCT02625324|7607939|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28
4695582|NCT02625610|7607977|FG000|Overall Study|Ongoing|34
4695583|NCT02625610|7607978|FG001|Overall Study|Ongoing|54
4695584|NCT02625623|7607986|FG000|Overall Study|Participants randomized but not treated|9
4695585|NCT02625623|7607987|FG001|Overall Study|Participants randomized but not treated|1
4695586|NCT02625909|7608001|FG000|Overall Study|Death|2
4695587|NCT02625909|7608002|FG001|Overall Study|Death|0
4695588|NCT02625909|7608001|FG000|Overall Study|Lost to Follow-up|3
4375960|NCT02948959|7151999|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2
4375961|NCT02948959|7151998|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3
4375962|NCT02948959|7151999|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3
4375963|NCT02948959|7151998|FG000|12 Weeks Follow-up Period|Randomized by error|0
4375964|NCT02948959|7151999|FG001|12 Weeks Follow-up Period|Randomized by error|3
4375965|NCT02948959|7151998|FG000|12 Weeks Follow-up Period|Change of residence location|0
4465862|NCT00613821|7257495|FG001|Overall Study|Physician Decision|1
4375966|NCT02948959|7151999|FG001|12 Weeks Follow-up Period|Change of residence location|2
4375967|NCT02948959|7151998|FG000|12 Weeks Follow-up Period|Study site closure|1
4375968|NCT02948959|7151999|FG001|12 Weeks Follow-up Period|Study site closure|0
4695589|NCT02625909|7608002|FG001|Overall Study|Lost to Follow-up|5
4695590|NCT02625909|7608001|FG000|Overall Study|Lack of Efficacy|9
4695591|NCT02625909|7608002|FG001|Overall Study|Lack of Efficacy|2
4695592|NCT02625909|7608001|FG000|Overall Study|Reinfection|3
4695593|NCT02625909|7608002|FG001|Overall Study|Reinfection|2
4695594|NCT02625922|7608010|FG000|Overall Study|Non-availability of IMP|1
4695595|NCT02625922|7608011|FG001|Overall Study|Non-availability of IMP|1
4695596|NCT02625922|7608010|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1
4695597|NCT02625922|7608011|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1
4695598|NCT02625974|7608022|FG000|Overall Study|Adverse Event|12
4695599|NCT02625974|7608023|FG001|Overall Study|Adverse Event|2
4695600|NCT02625974|7608022|FG000|Overall Study|Withdrawal by Subject|3
4695601|NCT02625974|7608023|FG001|Overall Study|Withdrawal by Subject|1
4695602|NCT02625974|7608022|FG000|Overall Study|positive parasitemia|1
4695603|NCT02625974|7608023|FG001|Overall Study|positive parasitemia|0
4695604|NCT02625974|7608022|FG000|Overall Study|non-compliance with study drug|0
4695605|NCT02625974|7608023|FG001|Overall Study|non-compliance with study drug|2
4695606|NCT02625974|7608022|FG000|Overall Study|Protocol Violation|0
4695607|NCT02625974|7608023|FG001|Overall Study|Protocol Violation|1
4695608|NCT02626000|7608065|FG000|Overall Study|Decision by Sponsor|1
4695609|NCT02626000|7608065|FG000|Overall Study|Death|29
4695610|NCT02626026|7608076|FG000|Overall Study|Randomized but Never Treated|0
4695611|NCT02626026|7608077|FG001|Overall Study|Randomized but Never Treated|0
4695612|NCT02626026|7608078|FG002|Overall Study|Randomized but Never Treated|0
4695613|NCT02626026|7608079|FG003|Overall Study|Randomized but Never Treated|0
4695614|NCT02626026|7608080|FG004|Overall Study|Randomized but Never Treated|1
4695615|NCT02626026|7608081|FG005|Overall Study|Randomized but Never Treated|0
4695616|NCT02626182|7608122|FG000|Overall Study|Adverse Event|2
4695617|NCT02626182|7608123|FG001|Overall Study|Adverse Event|0
4695618|NCT02626780|7608149|FG000|Overall Study|Withdrawal by Subject|3
4695619|NCT02626819|7608155|FG000|Overall Study|Lost to Follow-up|3
4695620|NCT02626819|7608156|FG001|Overall Study|Lost to Follow-up|2
4695621|NCT02626819|7608155|FG000|Overall Study|Withdrawal by Subject|1
4695622|NCT02626819|7608156|FG001|Overall Study|Withdrawal by Subject|0
4695623|NCT02626819|7608155|FG000|Overall Study|Diagnosed w/ catastrophic illness|0
4695624|NCT02626819|7608156|FG001|Overall Study|Diagnosed w/ catastrophic illness|1
4695625|NCT02627144|7608193|FG000|Overall Study|Serious adverse event|32
4695626|NCT02627144|7608193|FG000|Overall Study|Cancer progression|171
4695627|NCT02627144|7608193|FG000|Overall Study|Death from cancer|20
4695628|NCT02627144|7608193|FG000|Overall Study|Death from other cause|8
4695629|NCT02627144|7608193|FG000|Overall Study|Refusal of treatment / poor cooperation|38
4695630|NCT02627144|7608193|FG000|Overall Study|Administrative reasons|65
4695631|NCT02627144|7608193|FG000|Overall Study|Lost to Follow-up|8
4695632|NCT02627144|7608193|FG000|Overall Study|Enrolled, not treated|6
4695633|NCT02627144|7608193|FG000|Overall Study|Other|17
4695634|NCT02627495|7608197|FG000|Overall Study|Withdrawal by Subject|4
4695635|NCT02627677|7608204|FG000|Overall Study|Adverse event (not progressive disease)|1
4695636|NCT02627677|7608205|FG001|Overall Study|Adverse event (not progressive disease)|4
4695637|NCT02627677|7608206|FG002|Overall Study|Adverse event (not progressive disease)|1
4695638|NCT02627677|7608204|FG000|Overall Study|Progressive disease|1
4695639|NCT02627677|7608205|FG001|Overall Study|Progressive disease|3
4695640|NCT02627677|7608206|FG002|Overall Study|Progressive disease|0
4695641|NCT02627677|7608204|FG000|Overall Study|Lack of Efficacy|1
4695642|NCT02627677|7608205|FG001|Overall Study|Lack of Efficacy|2
4695643|NCT02627677|7608206|FG002|Overall Study|Lack of Efficacy|0
4695644|NCT02627677|7608204|FG000|Overall Study|Lost to Follow-up|0
4695645|NCT02627677|7608205|FG001|Overall Study|Lost to Follow-up|0
4695646|NCT02627677|7608206|FG002|Overall Study|Lost to Follow-up|1
4695647|NCT02627677|7608204|FG000|Overall Study|Pregnancy|0
4695648|NCT02627677|7608205|FG001|Overall Study|Pregnancy|1
4695649|NCT02627677|7608206|FG002|Overall Study|Pregnancy|0
4695650|NCT02627677|7608204|FG000|Overall Study|Study Terminated by Sponsor|5
4695651|NCT02627677|7608205|FG001|Overall Study|Study Terminated by Sponsor|10
4695652|NCT02627677|7608206|FG002|Overall Study|Study Terminated by Sponsor|6
4695653|NCT02627677|7608204|FG000|Overall Study|Physician Decision|0
4695654|NCT02627677|7608205|FG001|Overall Study|Physician Decision|0
4695655|NCT02627677|7608206|FG002|Overall Study|Physician Decision|2
4695656|NCT02627677|7608204|FG000|Overall Study|Withdrawal by Subject|2
4695657|NCT02627677|7608205|FG001|Overall Study|Withdrawal by Subject|1
4695658|NCT02627677|7608206|FG002|Overall Study|Withdrawal by Subject|1
4695659|NCT02627677|7608204|FG000|Overall Study|Reason not Specified|0
4695660|NCT02627677|7608205|FG001|Overall Study|Reason not Specified|0
4695661|NCT02627677|7608206|FG002|Overall Study|Reason not Specified|1
4695662|NCT02627677|7608204|FG000|Overall Study|Randomized but not Treated|1
4695663|NCT02627677|7608205|FG001|Overall Study|Randomized but not Treated|0
4695664|NCT02627677|7608206|FG002|Overall Study|Randomized but not Treated|0
4695665|NCT02628028|7608237|FG000|Dosing Period|Withdrawal by Subject|0
4695666|NCT02628028|7608238|FG001|Dosing Period|Withdrawal by Subject|0
4375969|NCT02878603|7152015|FG000|Overall Study|Lost to Follow-up|4
4375970|NCT02878603|7152016|FG001|Overall Study|Lost to Follow-up|1
4375971|NCT02878603|7152015|FG000|Overall Study|Withdrawal by Subject|1
4375972|NCT02878603|7152016|FG001|Overall Study|Withdrawal by Subject|1
4375973|NCT02878603|7152015|FG000|Overall Study|Death|1
4375974|NCT02878603|7152016|FG001|Overall Study|Death|0
4375975|NCT02878603|7152015|FG000|Overall Study|Physician Decision|0
4375976|NCT02878603|7152016|FG001|Overall Study|Physician Decision|3
4375977|NCT02864407|7152022|FG000|Overall Study|Protocol Violation|3
4375978|NCT02864407|7152022|FG000|Overall Study|Lost to Follow-up|115
4375979|NCT02864407|7152022|FG000|Overall Study|Not treated with Vahelva® Respimat®|1
4375980|NCT02864407|7152022|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3
4375981|NCT02864407|7152022|FG000|Overall Study|Consent prior to the contract date|1
4375982|NCT02846532|7152029|FG000|Overall Study|Lost to Follow-up|0
4375983|NCT02846532|7152030|FG001|Overall Study|Lost to Follow-up|1
4375984|NCT02846532|7152031|FG002|Overall Study|Lost to Follow-up|1
4375985|NCT02846532|7152029|FG000|Overall Study|Withdrawal by Subject|1
4375986|NCT02846532|7152030|FG001|Overall Study|Withdrawal by Subject|2
4375987|NCT02846532|7152031|FG002|Overall Study|Withdrawal by Subject|0
4375988|NCT02688933|7152041|FG000|Overall Study|Adverse Event|3
4375989|NCT02688933|7152042|FG001|Overall Study|Adverse Event|1
4375990|NCT02688933|7152041|FG000|Overall Study|Lack of Efficacy|2
4375991|NCT02688933|7152042|FG001|Overall Study|Lack of Efficacy|2
4375992|NCT02688933|7152041|FG000|Overall Study|Poor compliance to protocol|7
4375993|NCT02688933|7152042|FG001|Overall Study|Poor compliance to protocol|4
4375994|NCT02688933|7152041|FG000|Overall Study|Hypoglycemia|2
4587714|NCT01493557|7431899|FG001|Randomized to Management Strategies|Withdrawal by Subject|1
4587715|NCT01493557|7431900|FG002|Randomized to Management Strategies|Withdrawal by Subject|0
4587716|NCT01493557|7431898|FG000|Randomized to Management Strategies|Other than stated above|1
4587717|NCT01493557|7431899|FG001|Randomized to Management Strategies|Other than stated above|3
4695667|NCT02628028|7608239|FG002|Dosing Period|Withdrawal by Subject|1
4695668|NCT02628028|7608240|FG003|Dosing Period|Withdrawal by Subject|0
4695669|NCT02628028|7608241|FG004|Dosing Period|Withdrawal by Subject|2
4695670|NCT02628028|7608242|FG005|Dosing Period|Withdrawal by Subject|4
4695671|NCT02628028|7608243|FG006|Dosing Period|Withdrawal by Subject|1
4695672|NCT02628028|7608244|FG007|Dosing Period|Withdrawal by Subject|1
4695673|NCT02628028|7608237|FG000|Dosing Period|Adverse Event|0
4695674|NCT02628028|7608238|FG001|Dosing Period|Adverse Event|0
4695675|NCT02628028|7608239|FG002|Dosing Period|Adverse Event|0
4695676|NCT02628028|7608240|FG003|Dosing Period|Adverse Event|0
4695677|NCT02628028|7608241|FG004|Dosing Period|Adverse Event|2
4695678|NCT02628028|7608242|FG005|Dosing Period|Adverse Event|1
4587718|NCT01493557|7431900|FG002|Randomized to Management Strategies|Other than stated above|0
4587719|NCT01493557|7431898|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1
4587720|NCT01493557|7431899|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1
4626336|NCT01839487|7491905|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1
4695679|NCT02628028|7608243|FG006|Dosing Period|Adverse Event|3
4695680|NCT02628028|7608244|FG007|Dosing Period|Adverse Event|2
4695681|NCT02628028|7608237|FG000|Dosing Period|Death|0
4695682|NCT02628028|7608238|FG001|Dosing Period|Death|0
4695683|NCT02628028|7608239|FG002|Dosing Period|Death|0
4695684|NCT02628028|7608240|FG003|Dosing Period|Death|0
4695685|NCT02628028|7608241|FG004|Dosing Period|Death|0
4695686|NCT02628028|7608242|FG005|Dosing Period|Death|0
4695687|NCT02628028|7608243|FG006|Dosing Period|Death|0
4695688|NCT02628028|7608244|FG007|Dosing Period|Death|1
4695689|NCT02628028|7608237|FG000|Dosing Period|Lack of Efficacy|0
4695690|NCT02628028|7608238|FG001|Dosing Period|Lack of Efficacy|0
4695691|NCT02628028|7608239|FG002|Dosing Period|Lack of Efficacy|0
4695692|NCT02628028|7608240|FG003|Dosing Period|Lack of Efficacy|0
4695693|NCT02628028|7608241|FG004|Dosing Period|Lack of Efficacy|3
4695694|NCT02628028|7608242|FG005|Dosing Period|Lack of Efficacy|0
4695695|NCT02628028|7608243|FG006|Dosing Period|Lack of Efficacy|1
4695696|NCT02628028|7608244|FG007|Dosing Period|Lack of Efficacy|0
4695697|NCT02628028|7608237|FG000|Dosing Period|Study Terminated by Sponsor|0
4695698|NCT02628028|7608238|FG001|Dosing Period|Study Terminated by Sponsor|0
4695699|NCT02628028|7608239|FG002|Dosing Period|Study Terminated by Sponsor|0
4695700|NCT02628028|7608240|FG003|Dosing Period|Study Terminated by Sponsor|0
4695701|NCT02628028|7608241|FG004|Dosing Period|Study Terminated by Sponsor|7
4695702|NCT02628028|7608242|FG005|Dosing Period|Study Terminated by Sponsor|6
4375995|NCT02688933|7152042|FG001|Overall Study|Hypoglycemia|0
4695703|NCT02628028|7608243|FG006|Dosing Period|Study Terminated by Sponsor|7
4375996|NCT02688933|7152041|FG000|Overall Study|Other than Specified|14
4375997|NCT02688933|7152042|FG001|Overall Study|Other than Specified|25
4375998|NCT02688933|7152041|FG000|Overall Study|Lost to Follow-up|1
4375999|NCT02688933|7152042|FG001|Overall Study|Lost to Follow-up|5
4465863|NCT00613834|7257503|FG000|Overall Study|Withdrawal by Subject|0
4695704|NCT02628028|7608244|FG007|Dosing Period|Study Terminated by Sponsor|7
4695705|NCT02628028|7608237|FG000|Dosing Period|Physician Decision|0
4695706|NCT02628028|7608238|FG001|Dosing Period|Physician Decision|0
4695707|NCT02628028|7608239|FG002|Dosing Period|Physician Decision|0
4695708|NCT02628028|7608240|FG003|Dosing Period|Physician Decision|0
4695709|NCT02628028|7608241|FG004|Dosing Period|Physician Decision|0
4695710|NCT02628028|7608242|FG005|Dosing Period|Physician Decision|1
4376000|NCT02492165|7152061|FG000|Overall Study|Withdrawal by Subject|0
4376001|NCT02492165|7152062|FG001|Overall Study|Withdrawal by Subject|1
4376002|NCT02492165|7152063|FG002|Overall Study|Withdrawal by Subject|0
4376003|NCT02492165|7152064|FG003|Overall Study|Withdrawal by Subject|0
4376004|NCT02476006|7152074|FG000|Overall Study|Death|4
4376005|NCT02476006|7152074|FG000|Overall Study|Lack of treatment efficacy|2
4376006|NCT02476006|7152074|FG000|Overall Study|Pregnancy|1
4376007|NCT02476006|7152074|FG000|Overall Study|Participant did not wish to continue|39
4587721|NCT01493557|7431900|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0
4587722|NCT01493557|7431898|FG000|Adding the Second Strategy|Other adverse event|1
4587723|NCT01493557|7431899|FG001|Adding the Second Strategy|Other adverse event|2
4695711|NCT02628028|7608243|FG006|Dosing Period|Physician Decision|0
4695712|NCT02628028|7608244|FG007|Dosing Period|Physician Decision|0
4695713|NCT02628028|7608237|FG000|Dosing Period|Site Terminated by Sponsor|0
4695714|NCT02628028|7608238|FG001|Dosing Period|Site Terminated by Sponsor|0
4695715|NCT02628028|7608239|FG002|Dosing Period|Site Terminated by Sponsor|0
4695716|NCT02628028|7608240|FG003|Dosing Period|Site Terminated by Sponsor|0
4695717|NCT02628028|7608241|FG004|Dosing Period|Site Terminated by Sponsor|0
4695718|NCT02628028|7608242|FG005|Dosing Period|Site Terminated by Sponsor|1
4695719|NCT02628028|7608243|FG006|Dosing Period|Site Terminated by Sponsor|1
4695720|NCT02628028|7608244|FG007|Dosing Period|Site Terminated by Sponsor|0
4695721|NCT02628028|7608237|FG000|Dosing Period|Lost to Follow-up|0
4695722|NCT02628028|7608238|FG001|Dosing Period|Lost to Follow-up|0
4695723|NCT02628028|7608239|FG002|Dosing Period|Lost to Follow-up|0
4695724|NCT02628028|7608240|FG003|Dosing Period|Lost to Follow-up|0
4695725|NCT02628028|7608241|FG004|Dosing Period|Lost to Follow-up|0
4695726|NCT02628028|7608242|FG005|Dosing Period|Lost to Follow-up|0
4695727|NCT02628028|7608243|FG006|Dosing Period|Lost to Follow-up|1
4695728|NCT02628028|7608244|FG007|Dosing Period|Lost to Follow-up|0
4695729|NCT02628028|7608237|FG000|Dosing Period|Other|0
4695730|NCT02628028|7608238|FG001|Dosing Period|Other|0
4695731|NCT02628028|7608239|FG002|Dosing Period|Other|0
4695732|NCT02628028|7608240|FG003|Dosing Period|Other|0
4695733|NCT02628028|7608241|FG004|Dosing Period|Other|2
4695734|NCT02628028|7608242|FG005|Dosing Period|Other|1
4695735|NCT02628028|7608243|FG006|Dosing Period|Other|2
4695736|NCT02628028|7608244|FG007|Dosing Period|Other|4
4695737|NCT02628028|7608237|FG000|Long-term Extension (LTE) Period|Adverse Event|0
4695738|NCT02628028|7608238|FG001|Long-term Extension (LTE) Period|Adverse Event|0
4695739|NCT02628028|7608239|FG002|Long-term Extension (LTE) Period|Adverse Event|0
4695740|NCT02628028|7608240|FG003|Long-term Extension (LTE) Period|Adverse Event|0
4695741|NCT02628028|7608241|FG004|Long-term Extension (LTE) Period|Adverse Event|0
4695742|NCT02628028|7608242|FG005|Long-term Extension (LTE) Period|Adverse Event|1
4695743|NCT02628028|7608243|FG006|Long-term Extension (LTE) Period|Adverse Event|0
4695744|NCT02628028|7608244|FG007|Long-term Extension (LTE) Period|Adverse Event|3
4695745|NCT02628028|7608237|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0
4695746|NCT02628028|7608238|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0
4695747|NCT02628028|7608239|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0
4695748|NCT02628028|7608240|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0
4695749|NCT02628028|7608241|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0
4695750|NCT02628028|7608242|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2
4695751|NCT02628028|7608243|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0
4695752|NCT02628028|7608244|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1
4695753|NCT02628028|7608237|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
4587724|NCT01493557|7431900|FG002|Adding the Second Strategy|Other adverse event|0
4587725|NCT01493557|7431898|FG000|Adding the Second Strategy|Withdrawal by Subject|0
4587726|NCT01493557|7431899|FG001|Adding the Second Strategy|Withdrawal by Subject|1
4587727|NCT01493557|7431900|FG002|Adding the Second Strategy|Withdrawal by Subject|0
4587728|NCT01493687|7431936|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2
4587729|NCT01493687|7431937|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0
4587730|NCT01493687|7431936|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0
4587731|NCT01493687|7431937|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1
4587732|NCT01493687|7431936|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7
4587733|NCT01493687|7431937|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4
4587734|NCT01493687|7431936|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18
4587735|NCT01493687|7431937|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7
4587736|NCT01493687|7431936|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2
4587737|NCT01493687|7431937|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1
4587738|NCT01493687|7431936|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7
4587739|NCT01493687|7431937|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
4587740|NCT01493687|7431936|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1
4587741|NCT01493687|7431937|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1
4695754|NCT02628028|7608238|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
4376008|NCT02476006|7152074|FG000|Overall Study|Adverse Event|41
4376009|NCT02476006|7152074|FG000|Overall Study|Poor compliance to study protocol|3
4376010|NCT02476006|7152074|FG000|Overall Study|Sponsor decision|6
4695755|NCT02628028|7608239|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
4695756|NCT02628028|7608240|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
4376011|NCT02476006|7152074|FG000|Overall Study|Lost to Follow-up|5
4376012|NCT02476006|7152074|FG000|Overall Study|Physician Decision|5
4376013|NCT02476006|7152074|FG000|Overall Study|Study ended treatment not available|4
4376014|NCT02476006|7152074|FG000|Overall Study|Switched to commercial drug|4
4376015|NCT02476006|7152074|FG000|Overall Study|Excluded from study|1
4376016|NCT02476006|7152074|FG000|Overall Study|Protocol Violation|1
4376017|NCT02476006|7152074|FG000|Overall Study|Enrolled but not treated|4
4376018|NCT02468414|7152080|FG000|Overall Study|Early Study Termination by Sponsor|1
4376019|NCT02468414|7152081|FG001|Overall Study|Early Study Termination by Sponsor|0
4376020|NCT02468414|7152080|FG000|Overall Study|Poor in-vitro secreting TARGTs|1
4376021|NCT02468414|7152081|FG001|Overall Study|Poor in-vitro secreting TARGTs|0
4376022|NCT02468414|7152080|FG000|Overall Study|Screen Failure|1
4376023|NCT02468414|7152081|FG001|Overall Study|Screen Failure|0
4376024|NCT02462876|7152087|FG000|Overall Study|Death|3
4376025|NCT02462876|7152087|FG000|Overall Study|Lost to Follow-up|7
4376026|NCT02462876|7152087|FG000|Overall Study|Surgical Bypass|9
4376027|NCT02462876|7152087|FG000|Overall Study|Amputation Above the Metatarsals|1
4376028|NCT02462876|7152087|FG000|Overall Study|36 months follow-up visit missed|1
4376029|NCT02462876|7152087|FG000|Overall Study|Patient did not come back since 4 months follow-up|1
4376030|NCT02462876|7152087|FG000|Overall Study|Patient did not come back to the vascular department|1
4376031|NCT02462876|7152087|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1
4376032|NCT02462876|7152087|FG000|Overall Study|Patient refused to come back|1
4376033|NCT02462876|7152087|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1
4376034|NCT02462876|7152087|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1
4376035|NCT02332590|7152093|FG000|DB Period (up to 24 Weeks)|Adverse Event|15
4376036|NCT02332590|7152094|FG001|DB Period (up to 24 Weeks)|Adverse Event|11
4376037|NCT02332590|7152093|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4
4376038|NCT02332590|7152094|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2
4376039|NCT02332590|7152093|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3
4376040|NCT02332590|7152094|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1
4376041|NCT02332590|7152093|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1
4376042|NCT02332590|7152094|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0
4376043|NCT02332590|7152093|FG000|DB Period (up to 24 Weeks)|Other than specified above|6
4376044|NCT02332590|7152094|FG001|DB Period (up to 24 Weeks)|Other than specified above|5
4376045|NCT02332590|7152093|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20
4376046|NCT02332590|7152094|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23
4376047|NCT02332590|7152093|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2
4376048|NCT02332590|7152094|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6
4376049|NCT02332590|7152093|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5
4376050|NCT02332590|7152094|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1
4376051|NCT02332590|7152093|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20
4376052|NCT02332590|7152094|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15
4376053|NCT02255656|7152102|FG000|Overall Study|Adverse Event|11
4376054|NCT02255656|7152102|FG000|Overall Study|Poor compliance to protocol|3
4376055|NCT02255656|7152102|FG000|Overall Study|Lost to Follow-up|30
4376056|NCT02255656|7152102|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300
4376057|NCT02255656|7152102|FG000|Overall Study|Other|126
4376058|NCT02134028|7152121|FG000|Overall Study|Lack of Efficacy|1
4376059|NCT02134028|7152122|FG001|Overall Study|Lack of Efficacy|0
4376060|NCT02134028|7152123|FG002|Overall Study|Lack of Efficacy|3
4376061|NCT02134028|7152124|FG003|Overall Study|Lack of Efficacy|2
4376062|NCT02134028|7152125|FG004|Overall Study|Lack of Efficacy|1
4376063|NCT02134028|7152126|FG005|Overall Study|Lack of Efficacy|2
4695757|NCT02628028|7608241|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
4695758|NCT02628028|7608242|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52
4695759|NCT02628028|7608243|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51
4695760|NCT02628028|7608244|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51
4695761|NCT02628028|7608237|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0
4695762|NCT02628028|7608238|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0
4695763|NCT02628028|7608239|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0
4695764|NCT02628028|7608240|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0
4695765|NCT02628028|7608241|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0
4695766|NCT02628028|7608242|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2
4695767|NCT02628028|7608243|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3
4695768|NCT02628028|7608244|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3
4376064|NCT02134028|7152127|FG006|Overall Study|Lack of Efficacy|1
4376065|NCT02134028|7152128|FG007|Overall Study|Lack of Efficacy|0
4376066|NCT02134028|7152121|FG000|Overall Study|Poor compliance to protocol|1
4376067|NCT02134028|7152122|FG001|Overall Study|Poor compliance to protocol|1
4376068|NCT02134028|7152123|FG002|Overall Study|Poor compliance to protocol|3
4376069|NCT02134028|7152124|FG003|Overall Study|Poor compliance to protocol|7
4376070|NCT02134028|7152125|FG004|Overall Study|Poor compliance to protocol|1
4376071|NCT02134028|7152126|FG005|Overall Study|Poor compliance to protocol|1
4376072|NCT02134028|7152127|FG006|Overall Study|Poor compliance to protocol|0
4376073|NCT02134028|7152128|FG007|Overall Study|Poor compliance to protocol|0
4376074|NCT02134028|7152121|FG000|Overall Study|Other unspecified|4
4376075|NCT02134028|7152122|FG001|Overall Study|Other unspecified|22
4376076|NCT02134028|7152123|FG002|Overall Study|Other unspecified|33
4376077|NCT02134028|7152124|FG003|Overall Study|Other unspecified|64
4376078|NCT02134028|7152125|FG004|Overall Study|Other unspecified|8
4376079|NCT02134028|7152126|FG005|Overall Study|Other unspecified|6
4376080|NCT02134028|7152127|FG006|Overall Study|Other unspecified|2
4376081|NCT02134028|7152128|FG007|Overall Study|Other unspecified|1
4376082|NCT02134028|7152121|FG000|Overall Study|Adverse Event|3
4376083|NCT02134028|7152122|FG001|Overall Study|Adverse Event|19
4376084|NCT02134028|7152123|FG002|Overall Study|Adverse Event|13
4376085|NCT02134028|7152124|FG003|Overall Study|Adverse Event|32
4376086|NCT02134028|7152125|FG004|Overall Study|Adverse Event|4
4376087|NCT02134028|7152126|FG005|Overall Study|Adverse Event|5
4376088|NCT02134028|7152127|FG006|Overall Study|Adverse Event|1
4376089|NCT02134028|7152128|FG007|Overall Study|Adverse Event|2
4376090|NCT01902173|7152158|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1
4376091|NCT01902173|7152159|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0
4376092|NCT01902173|7152160|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0
4376093|NCT01902173|7152161|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0
4376094|NCT01902173|7152162|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0
4376095|NCT01902173|7152163|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0
4376096|NCT01902173|7152158|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2
4376097|NCT01902173|7152159|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0
4376098|NCT01902173|7152160|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0
4376099|NCT01902173|7152161|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0
4376100|NCT01902173|7152162|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0
4376101|NCT01902173|7152163|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0
4376102|NCT01902173|7152158|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0
4376103|NCT01902173|7152159|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5
4376104|NCT01902173|7152160|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0
4376105|NCT01902173|7152161|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0
4376106|NCT01902173|7152162|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0
4376107|NCT01902173|7152163|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0
4376108|NCT01902173|7152158|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0
4376109|NCT01902173|7152159|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1
4376110|NCT01902173|7152160|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0
4376111|NCT01902173|7152161|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0
4376112|NCT01902173|7152162|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0
4376113|NCT01902173|7152163|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0
4376114|NCT01902173|7152158|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0
4376115|NCT01902173|7152159|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3
4376116|NCT01902173|7152160|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0
4376117|NCT01902173|7152161|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0
4376118|NCT01902173|7152162|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0
4376119|NCT01902173|7152163|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0
4376120|NCT01902173|7152158|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0
4376121|NCT01902173|7152159|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0
4376122|NCT01902173|7152160|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3
4376123|NCT01902173|7152161|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0
4376124|NCT01902173|7152162|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0
4376125|NCT01902173|7152163|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0
4376126|NCT01902173|7152158|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0
4376127|NCT01902173|7152159|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0
4376128|NCT01902173|7152160|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1
4376129|NCT01902173|7152161|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0
4376130|NCT01902173|7152162|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0
4376131|NCT01902173|7152163|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0
4695769|NCT02628028|7608237|FG000|Long-term Extension (LTE) Period|Other|0
4376132|NCT01902173|7152158|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0
4376133|NCT01902173|7152159|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0
4376134|NCT01902173|7152160|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0
4376135|NCT01902173|7152161|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1
4376136|NCT01902173|7152162|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0
4376137|NCT01902173|7152163|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0
4376138|NCT01902173|7152158|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0
4376139|NCT01902173|7152159|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0
4376140|NCT01902173|7152160|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0
4376141|NCT01902173|7152161|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2
4376142|NCT01902173|7152162|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0
4376143|NCT01902173|7152163|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0
4376144|NCT01902173|7152158|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0
4376145|NCT01902173|7152159|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0
4376146|NCT01902173|7152160|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0
4376147|NCT01902173|7152161|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0
4376148|NCT01902173|7152162|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1
4376149|NCT01902173|7152163|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0
4376150|NCT01902173|7152158|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0
4376151|NCT01902173|7152159|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0
4376152|NCT01902173|7152160|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0
4376153|NCT01902173|7152161|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0
4376154|NCT01902173|7152162|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2
4376155|NCT01902173|7152163|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0
4376156|NCT01902173|7152158|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0
4376157|NCT01902173|7152159|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0
4376158|NCT01902173|7152160|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0
4376159|NCT01902173|7152161|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0
4465864|NCT00613834|7257504|FG001|Overall Study|Withdrawal by Subject|3
4465865|NCT00613925|7257514|FG000|Overall Study|1 did not tolerate outpatient biopsy|0
4465866|NCT00613925|7257515|FG001|Overall Study|1 did not tolerate outpatient biopsy|1
4465867|NCT00613938|7257525|FG000|Overall Study|Withdrawal by Subject|2
4465868|NCT00613938|7257526|FG001|Overall Study|Withdrawal by Subject|4
4465869|NCT00613938|7257527|FG002|Overall Study|Withdrawal by Subject|9
4465870|NCT00613938|7257528|FG003|Overall Study|Withdrawal by Subject|9
4465871|NCT00613938|7257525|FG000|Overall Study|Adverse Event|1
4465872|NCT00613938|7257526|FG001|Overall Study|Adverse Event|4
4465873|NCT00613938|7257527|FG002|Overall Study|Adverse Event|8
4465874|NCT00613938|7257528|FG003|Overall Study|Adverse Event|5
4465875|NCT00613938|7257525|FG000|Overall Study|Lack of Efficacy|16
4465876|NCT00613938|7257526|FG001|Overall Study|Lack of Efficacy|18
4465877|NCT00613938|7257527|FG002|Overall Study|Lack of Efficacy|5
4465878|NCT00613938|7257528|FG003|Overall Study|Lack of Efficacy|9
4465879|NCT00613938|7257525|FG000|Overall Study|Other|1
4465880|NCT00613938|7257526|FG001|Overall Study|Other|2
4465881|NCT00613938|7257527|FG002|Overall Study|Other|1
4465882|NCT00613938|7257528|FG003|Overall Study|Other|3
4516291|NCT00958880|7327590|FG001|Overall Study|Lost to Follow-up|2
4516292|NCT00959049|7327616|FG000|Overall Study|Adverse Event|1
4516293|NCT00959049|7327617|FG001|Overall Study|Adverse Event|0
4516294|NCT00959049|7327618|FG002|Overall Study|Adverse Event|0
4516295|NCT00959049|7327619|FG003|Overall Study|Adverse Event|0
4516296|NCT00959049|7327620|FG004|Overall Study|Adverse Event|0
4516297|NCT00959049|7327621|FG005|Overall Study|Adverse Event|0
4516298|NCT00959049|7327616|FG000|Overall Study|Lost to Follow-up|17
4516299|NCT00959049|7327617|FG001|Overall Study|Lost to Follow-up|5
4516300|NCT00959049|7327618|FG002|Overall Study|Lost to Follow-up|1
4516301|NCT00959049|7327619|FG003|Overall Study|Lost to Follow-up|10
4516302|NCT00959049|7327620|FG004|Overall Study|Lost to Follow-up|9
4516303|NCT00959049|7327621|FG005|Overall Study|Lost to Follow-up|1
4516304|NCT00959049|7327616|FG000|Overall Study|Contraindicated medication|0
4516305|NCT00959049|7327617|FG001|Overall Study|Contraindicated medication|0
4516306|NCT00959049|7327618|FG002|Overall Study|Contraindicated medication|0
4516307|NCT00959049|7327619|FG003|Overall Study|Contraindicated medication|1
4516308|NCT00959049|7327620|FG004|Overall Study|Contraindicated medication|0
4516309|NCT00959049|7327621|FG005|Overall Study|Contraindicated medication|0
4516310|NCT00959049|7327616|FG000|Overall Study|Withdrawal by Subject|0
4516311|NCT00959049|7327617|FG001|Overall Study|Withdrawal by Subject|2
4516312|NCT00959049|7327618|FG002|Overall Study|Withdrawal by Subject|0
4516313|NCT00959049|7327619|FG003|Overall Study|Withdrawal by Subject|0
4516314|NCT00959049|7327620|FG004|Overall Study|Withdrawal by Subject|0
4516315|NCT00959049|7327621|FG005|Overall Study|Withdrawal by Subject|0
4516316|NCT00959192|7327659|FG000|Overall Study|Adverse Event|1
4516317|NCT00959192|7327660|FG001|Overall Study|Adverse Event|1
4516318|NCT00959192|7327661|FG002|Overall Study|Adverse Event|1
4516319|NCT00959192|7327662|FG003|Overall Study|Adverse Event|0
4516320|NCT00959192|7327659|FG000|Overall Study|Investigator Request|1
4516321|NCT00959192|7327660|FG001|Overall Study|Investigator Request|0
4516322|NCT00959192|7327661|FG002|Overall Study|Investigator Request|0
4516323|NCT00959192|7327662|FG003|Overall Study|Investigator Request|0
4516324|NCT00959192|7327659|FG000|Overall Study|Caregiver Request|0
4516325|NCT00959192|7327660|FG001|Overall Study|Caregiver Request|0
4516326|NCT00959192|7327661|FG002|Overall Study|Caregiver Request|2
4516327|NCT00959192|7327662|FG003|Overall Study|Caregiver Request|1
4516328|NCT00959374|7327673|FG000|Overall Study|Withdrawal by Subject|2
4516329|NCT00959374|7327673|FG000|Overall Study|Lost to Follow-up|14
4516330|NCT00959374|7327673|FG000|Overall Study|Death|1
4516331|NCT00959374|7327673|FG000|Overall Study|Protocol Violation|1
4516332|NCT00959374|7327673|FG000|Overall Study|Implant Removed/Not Replaced|4
4516333|NCT00959374|7327673|FG000|Overall Study|Physician Decision|1
4516334|NCT00959647|7327681|FG000|Overall Study|Adverse Event|2
4516335|NCT00959647|7327681|FG000|Overall Study|Progressive disease|6
4516336|NCT00959647|7327681|FG000|Overall Study|Study terminated by sponsor|4
4516337|NCT00959647|7327681|FG000|Overall Study|Withdrawal by Subject|7
4516338|NCT00959699|7327704|FG000|Treatment Period|Adverse Event|3
4516339|NCT00959699|7327705|FG001|Treatment Period|Adverse Event|13
4516340|NCT00959699|7327704|FG000|Treatment Period|Lack of Efficacy|15
4516341|NCT00959699|7327705|FG001|Treatment Period|Lack of Efficacy|6
4516342|NCT00959699|7327704|FG000|Treatment Period|Lost to Follow-up|0
4376160|NCT01902173|7152162|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0
4376161|NCT01902173|7152163|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1
4376162|NCT01902173|7152158|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0
4376163|NCT01902173|7152159|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0
4376164|NCT01902173|7152160|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0
4376165|NCT01902173|7152161|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0
4376166|NCT01902173|7152162|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0
4376167|NCT01902173|7152163|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3
4376168|NCT01902173|7152158|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0
4376169|NCT01902173|7152159|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0
4376170|NCT01902173|7152160|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0
4376171|NCT01902173|7152161|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0
4376172|NCT01902173|7152162|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0
4376173|NCT01902173|7152163|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1
4376174|NCT01900444|7152180|FG000|Overall Study|Protocol Violation|2
4376175|NCT01900444|7152180|FG000|Overall Study|Lost to Follow-up|1
4376176|NCT01887912|7152186|FG000|Overall Study|Serious adverse event|400
4376177|NCT01887912|7152187|FG001|Overall Study|Serious adverse event|198
4376178|NCT01887912|7152186|FG000|Overall Study|Other Adverse Event|34
4376179|NCT01887912|7152187|FG001|Overall Study|Other Adverse Event|15
4376180|NCT01887912|7152186|FG000|Overall Study|Protocol Violation|67
4376181|NCT01887912|7152187|FG001|Overall Study|Protocol Violation|37
4376182|NCT01887912|7152186|FG000|Overall Study|Lost to Follow-up|163
4376183|NCT01887912|7152187|FG001|Overall Study|Lost to Follow-up|74
4376184|NCT01887912|7152186|FG000|Overall Study|Withdrawal by Subject|606
4376185|NCT01887912|7152187|FG001|Overall Study|Withdrawal by Subject|349
4376186|NCT01887912|7152186|FG000|Overall Study|Other|122
4376187|NCT01887912|7152187|FG001|Overall Study|Other|58
4376188|NCT01886872|7152196|FG000|Overall Study|Ineligible|7
4376189|NCT01886872|7152197|FG001|Overall Study|Ineligible|4
4376190|NCT01886872|7152198|FG002|Overall Study|Ineligible|12
4376191|NCT01835145|7152209|FG000|Overall Study|Ineligible prior to treatment|1
4376192|NCT01835145|7152210|FG001|Overall Study|Ineligible prior to treatment|0
4376193|NCT01437423|7152255|FG000|Overall Study|Lost to Follow-up|12
4376194|NCT01437423|7152255|FG000|Overall Study|Off label usage|3
4376195|NCT01410890|7152261|FG000|Overall Study|Withdrawal by Subject|0
4376196|NCT01410890|7152262|FG001|Overall Study|Withdrawal by Subject|1
4376197|NCT01251861|7152272|FG000|Overall Study|Disease progression|6
4465883|NCT00613951|7257541|FG000|Overall Study|Adverse Event|1
4465884|NCT00613951|7257542|FG001|Overall Study|Adverse Event|0
4465885|NCT00613951|7257543|FG002|Overall Study|Adverse Event|1
4465886|NCT00613951|7257541|FG000|Overall Study|Lack of Efficacy|0
4465887|NCT00613951|7257542|FG001|Overall Study|Lack of Efficacy|1
4465888|NCT00613951|7257543|FG002|Overall Study|Lack of Efficacy|1
4465889|NCT00613951|7257541|FG000|Overall Study|Protocol Violation|1
4465890|NCT00613951|7257542|FG001|Overall Study|Protocol Violation|1
4465891|NCT00613951|7257543|FG002|Overall Study|Protocol Violation|1
4465892|NCT00613951|7257541|FG000|Overall Study|Unclassified|5
4465893|NCT00613951|7257542|FG001|Overall Study|Unclassified|3
4465894|NCT00613951|7257543|FG002|Overall Study|Unclassified|2
4465895|NCT00614055|7257557|FG000|Overall Study|Adverse Event|1
4465896|NCT00614055|7257558|FG001|Overall Study|Adverse Event|0
4465897|NCT00614055|7257559|FG002|Overall Study|Adverse Event|0
4465898|NCT00614055|7257557|FG000|Overall Study|Protocol Violation|2
4465899|NCT00614055|7257558|FG001|Overall Study|Protocol Violation|2
4465900|NCT00614055|7257559|FG002|Overall Study|Protocol Violation|1
4465901|NCT00614055|7257557|FG000|Overall Study|Lack of Efficacy|0
4465902|NCT00614055|7257558|FG001|Overall Study|Lack of Efficacy|0
4465903|NCT00614055|7257559|FG002|Overall Study|Lack of Efficacy|2
4465904|NCT00614055|7257557|FG000|Overall Study|Unclassified|1
4465905|NCT00614055|7257558|FG001|Overall Study|Unclassified|4
4465906|NCT00614055|7257559|FG002|Overall Study|Unclassified|2
4465907|NCT00614120|7257574|FG000|Overall Study|Adverse Event|9
4465908|NCT00614120|7257575|FG001|Overall Study|Adverse Event|22
4465909|NCT00614120|7257576|FG002|Overall Study|Adverse Event|30
4465910|NCT00614120|7257577|FG003|Overall Study|Adverse Event|3
4465911|NCT00614120|7257574|FG000|Overall Study|Lack of Efficacy|3
4465912|NCT00614120|7257575|FG001|Overall Study|Lack of Efficacy|3
4465913|NCT00614120|7257576|FG002|Overall Study|Lack of Efficacy|2
4465914|NCT00614120|7257577|FG003|Overall Study|Lack of Efficacy|2
4465915|NCT00614120|7257574|FG000|Overall Study|Protocol Violation|2
4465916|NCT00614120|7257575|FG001|Overall Study|Protocol Violation|5
4465917|NCT00614120|7257576|FG002|Overall Study|Protocol Violation|3
4465918|NCT00614120|7257577|FG003|Overall Study|Protocol Violation|1
4465919|NCT00614120|7257574|FG000|Overall Study|Withdrawal criteria|1
4465920|NCT00614120|7257575|FG001|Overall Study|Withdrawal criteria|0
4465921|NCT00614120|7257576|FG002|Overall Study|Withdrawal criteria|0
4465922|NCT00614120|7257577|FG003|Overall Study|Withdrawal criteria|0
4465923|NCT00614120|7257574|FG000|Overall Study|Withdrawal by Subject|9
4465924|NCT00614120|7257575|FG001|Overall Study|Withdrawal by Subject|10
4465925|NCT00614120|7257576|FG002|Overall Study|Withdrawal by Subject|16
4465926|NCT00614120|7257577|FG003|Overall Study|Withdrawal by Subject|3
4465927|NCT00614120|7257574|FG000|Overall Study|Did not meet trial criteria|0
4465928|NCT00614120|7257575|FG001|Overall Study|Did not meet trial criteria|1
4376198|NCT01251861|7152273|FG001|Overall Study|Disease progression|6
4376199|NCT01251861|7152272|FG000|Overall Study|Adverse Event|2
4376200|NCT01251861|7152273|FG001|Overall Study|Adverse Event|17
4376201|NCT01251861|7152272|FG000|Overall Study|Withdrawal by Subject|2
4376202|NCT01251861|7152273|FG001|Overall Study|Withdrawal by Subject|2
4376203|NCT01251861|7152272|FG000|Overall Study|Alternative therapy|1
4376204|NCT01251861|7152273|FG001|Overall Study|Alternative therapy|0
4376205|NCT01251861|7152272|FG000|Overall Study|Other complicating disease|0
4376206|NCT01251861|7152273|FG001|Overall Study|Other complicating disease|1
4376207|NCT01251861|7152272|FG000|Overall Study|Physician Decision|1
4376208|NCT01251861|7152273|FG001|Overall Study|Physician Decision|0
4376209|NCT01251861|7152272|FG000|Overall Study|Continued treatment beyond 18 cycles|1
4376210|NCT01251861|7152273|FG001|Overall Study|Continued treatment beyond 18 cycles|0
4376211|NCT01251861|7152272|FG000|Overall Study|Other|1
4376212|NCT01251861|7152273|FG001|Overall Study|Other|0
4376213|NCT01251861|7152272|FG000|Overall Study|Never started therapy|4
4376214|NCT01251861|7152273|FG001|Overall Study|Never started therapy|1
4376215|NCT01251861|7152272|FG000|Overall Study|Potential interaction of drugs|0
4376216|NCT01251861|7152273|FG001|Overall Study|Potential interaction of drugs|1
4695770|NCT02628028|7608238|FG001|Long-term Extension (LTE) Period|Other|0
4695771|NCT02628028|7608239|FG002|Long-term Extension (LTE) Period|Other|0
4695772|NCT02628028|7608240|FG003|Long-term Extension (LTE) Period|Other|0
4695773|NCT02628028|7608241|FG004|Long-term Extension (LTE) Period|Other|0
4695774|NCT02628028|7608242|FG005|Long-term Extension (LTE) Period|Other|3
4695775|NCT02628028|7608243|FG006|Long-term Extension (LTE) Period|Other|4
4695776|NCT02628028|7608244|FG007|Long-term Extension (LTE) Period|Other|3
4695777|NCT02628418|7608294|FG000|Overall Study|Lost to Follow-up|1
4695778|NCT02628418|7608295|FG001|Overall Study|Lost to Follow-up|2
4695779|NCT02628600|7608309|FG000|Overall Study|Death|2
4695780|NCT02628600|7608310|FG001|Overall Study|Death|1
4695781|NCT02628600|7608309|FG000|Overall Study|Adverse Event|3
4695782|NCT02628600|7608310|FG001|Overall Study|Adverse Event|20
4695783|NCT02628600|7608309|FG000|Overall Study|Protocol Violation|0
4695784|NCT02628600|7608310|FG001|Overall Study|Protocol Violation|1
4695785|NCT02628600|7608309|FG000|Overall Study|Lack of Efficacy|2
4695786|NCT02628600|7608310|FG001|Overall Study|Lack of Efficacy|0
4695787|NCT02628600|7608309|FG000|Overall Study|Withdrawal by Subject|13
4695788|NCT02628600|7608310|FG001|Overall Study|Withdrawal by Subject|8
4695789|NCT02628600|7608309|FG000|Overall Study|Lost to Follow-up|1
4695790|NCT02628600|7608310|FG001|Overall Study|Lost to Follow-up|0
4695791|NCT02628600|7608309|FG000|Overall Study|Physician Decision|2
4695792|NCT02628600|7608310|FG001|Overall Study|Physician Decision|2
4695793|NCT02628600|7608309|FG000|Overall Study|Other not specified|1
4695794|NCT02628600|7608310|FG001|Overall Study|Other not specified|0
4695795|NCT02628743|7608316|FG000|Overall Study|Other|3
4695796|NCT02628743|7608316|FG000|Overall Study|Withdrawal by Subject|50
4695797|NCT02628743|7608316|FG000|Overall Study|Study Terminated by Sponsor|76
4695798|NCT02628743|7608316|FG000|Overall Study|Physician Decision|2
4695799|NCT02628769|7608320|FG000|First Intervention|Adverse Event|1
4695800|NCT02628769|7608321|FG001|First Intervention|Adverse Event|0
4695801|NCT02628769|7608320|FG000|First Intervention|Withdrawal by Subject|0
4695802|NCT02628769|7608321|FG001|First Intervention|Withdrawal by Subject|1
4695803|NCT02628769|7608320|FG000|Second Intervention|Adverse Event|2
4695804|NCT02628769|7608321|FG001|Second Intervention|Adverse Event|0
4695805|NCT02628769|7608320|FG000|Second Intervention|Physician Decision|0
4695806|NCT02628769|7608321|FG001|Second Intervention|Physician Decision|1
4695807|NCT02628873|7608329|FG000|Break (1 Hour)|Withdrawal by Subject|0
4695808|NCT02628873|7608330|FG001|Break (1 Hour)|Withdrawal by Subject|1
4695809|NCT02628873|7608329|FG000|Second Test (1 Hour)|Physician Decision|1
4695810|NCT02628873|7608330|FG001|Second Test (1 Hour)|Physician Decision|0
4695811|NCT02628938|7608339|FG000|Overall Study|Did not attend the follow up recall|2
4695812|NCT02628938|7608340|FG001|Overall Study|Did not attend the follow up recall|2
4695813|NCT02628938|7608341|FG002|Overall Study|Did not attend the follow up recall|1
4695814|NCT02628938|7608339|FG000|Overall Study|Failure to comply with the instructions|3
4695815|NCT02628938|7608340|FG001|Overall Study|Failure to comply with the instructions|0
4695816|NCT02628938|7608341|FG002|Overall Study|Failure to comply with the instructions|3
4695817|NCT02629133|7608364|FG000|Overall Study|Lost to Follow-up|3
4695818|NCT02629133|7608365|FG001|Overall Study|Lost to Follow-up|1
4770709|NCT02737475|7747035|FG009|Overall Study|Lost to Follow-up|0
4770710|NCT02737475|7747036|FG010|Overall Study|Lost to Follow-up|0
4770711|NCT02737475|7747037|FG011|Overall Study|Lost to Follow-up|0
4770712|NCT02737475|7747038|FG012|Overall Study|Lost to Follow-up|0
4695819|NCT02629133|7608364|FG000|Overall Study|Withdrawal by Subject|1
4695820|NCT02629133|7608365|FG001|Overall Study|Withdrawal by Subject|1
4695821|NCT02629822|7608380|FG000|Base Study|Lost to Follow-up|2
4695822|NCT02629822|7608380|FG000|Base Study|Non-Compliance With Study Drug|1
4695823|NCT02629822|7608380|FG000|Extension Study|Adverse Event|1
4695824|NCT02629822|7608380|FG000|Extension Study|Lost to Follow-up|1
4695825|NCT02629861|7608388|FG000|Overall Study|Adverse Event|7
4695826|NCT02629861|7608389|FG001|Overall Study|Adverse Event|5
4695827|NCT02629861|7608390|FG002|Overall Study|Adverse Event|4
4695828|NCT02629861|7608388|FG000|Overall Study|Withdrawal by Subject|5
4695829|NCT02629861|7608389|FG001|Overall Study|Withdrawal by Subject|8
4695830|NCT02629861|7608390|FG002|Overall Study|Withdrawal by Subject|13
4770713|NCT02737475|7747039|FG013|Overall Study|Lost to Follow-up|0
4770714|NCT02737475|7747040|FG014|Overall Study|Lost to Follow-up|0
4770715|NCT02737475|7747041|FG015|Overall Study|Lost to Follow-up|1
4770716|NCT02737475|7747042|FG016|Overall Study|Lost to Follow-up|0
4770717|NCT02737475|7747043|FG017|Overall Study|Lost to Follow-up|0
4770718|NCT02737475|7747044|FG018|Overall Study|Lost to Follow-up|0
4770719|NCT02737475|7747045|FG019|Overall Study|Lost to Follow-up|0
4770720|NCT02737475|7747046|FG020|Overall Study|Lost to Follow-up|0
4770721|NCT02737475|7747047|FG021|Overall Study|Lost to Follow-up|0
4770722|NCT02737475|7747048|FG022|Overall Study|Lost to Follow-up|0
4770723|NCT02737475|7747049|FG023|Overall Study|Lost to Follow-up|0
4770724|NCT02737475|7747050|FG024|Overall Study|Lost to Follow-up|0
4770725|NCT02737475|7747051|FG025|Overall Study|Lost to Follow-up|0
4770726|NCT02737475|7747052|FG026|Overall Study|Lost to Follow-up|0
4770727|NCT02737475|7747026|FG000|Overall Study|Disease Progression|0
4770728|NCT02737475|7747027|FG001|Overall Study|Disease Progression|0
4770729|NCT02737475|7747028|FG002|Overall Study|Disease Progression|0
4770730|NCT02737475|7747029|FG003|Overall Study|Disease Progression|0
4770731|NCT02737475|7747030|FG004|Overall Study|Disease Progression|0
4770732|NCT02737475|7747031|FG005|Overall Study|Disease Progression|0
4770733|NCT02737475|7747032|FG006|Overall Study|Disease Progression|0
4770734|NCT02737475|7747033|FG007|Overall Study|Disease Progression|0
4770735|NCT02737475|7747034|FG008|Overall Study|Disease Progression|0
4770736|NCT02737475|7747035|FG009|Overall Study|Disease Progression|0
4770737|NCT02737475|7747036|FG010|Overall Study|Disease Progression|0
4770738|NCT02737475|7747037|FG011|Overall Study|Disease Progression|0
4770739|NCT02737475|7747038|FG012|Overall Study|Disease Progression|0
4770740|NCT02737475|7747039|FG013|Overall Study|Disease Progression|0
4770741|NCT02737475|7747040|FG014|Overall Study|Disease Progression|0
4770742|NCT02737475|7747041|FG015|Overall Study|Disease Progression|0
4770743|NCT02737475|7747042|FG016|Overall Study|Disease Progression|0
4770744|NCT02737475|7747043|FG017|Overall Study|Disease Progression|0
4376253|NCT01190228|7152303|FG000|Overall Study|Protocol Violation|4
4376254|NCT01190228|7152304|FG001|Overall Study|Protocol Violation|0
4376255|NCT01190228|7152305|FG002|Overall Study|Protocol Violation|0
4376256|NCT01190228|7152303|FG000|Overall Study|Withdrawal by Subject|1
4376257|NCT01190228|7152304|FG001|Overall Study|Withdrawal by Subject|0
4376258|NCT01190228|7152305|FG002|Overall Study|Withdrawal by Subject|0
4376259|NCT01146652|7152317|FG000|Overall Study|Adverse Event|506
4376260|NCT01146652|7152318|FG001|Overall Study|Adverse Event|15
4376261|NCT01146652|7152317|FG000|Overall Study|Lack of Efficacy|91
4376262|NCT01146652|7152318|FG001|Overall Study|Lack of Efficacy|7
4376263|NCT01146652|7152317|FG000|Overall Study|Poor compliance to protocol|38
4376264|NCT01146652|7152318|FG001|Overall Study|Poor compliance to protocol|1
4376265|NCT01146652|7152317|FG000|Overall Study|Other unspecified reasons|314
4376266|NCT01146652|7152318|FG001|Overall Study|Other unspecified reasons|22
4376267|NCT01146652|7152317|FG000|Overall Study|Enrolled but not treated|2
4376268|NCT01146652|7152318|FG001|Overall Study|Enrolled but not treated|0
4376269|NCT01049035|7152338|FG000|Overall Study|Serious adverse event|0
4376270|NCT01049035|7152339|FG001|Overall Study|Serious adverse event|1
4376271|NCT01049035|7152340|FG002|Overall Study|Serious adverse event|1
4376272|NCT01049035|7152341|FG003|Overall Study|Serious adverse event|2
4376273|NCT01049035|7152342|FG004|Overall Study|Serious adverse event|0
4376274|NCT01049035|7152343|FG005|Overall Study|Serious adverse event|0
4376275|NCT01049035|7152344|FG006|Overall Study|Serious adverse event|0
4376276|NCT01049035|7152338|FG000|Overall Study|Other adverse event (AE)|0
4376277|NCT01049035|7152339|FG001|Overall Study|Other adverse event (AE)|0
4376278|NCT01049035|7152340|FG002|Overall Study|Other adverse event (AE)|0
4376279|NCT01049035|7152341|FG003|Overall Study|Other adverse event (AE)|1
4376280|NCT01049035|7152342|FG004|Overall Study|Other adverse event (AE)|0
4376281|NCT01049035|7152343|FG005|Overall Study|Other adverse event (AE)|0
4376282|NCT01049035|7152344|FG006|Overall Study|Other adverse event (AE)|0
4376283|NCT01049035|7152338|FG000|Overall Study|Non-compliance with the protocol|12
4376284|NCT01049035|7152339|FG001|Overall Study|Non-compliance with the protocol|6
4376285|NCT01049035|7152340|FG002|Overall Study|Non-compliance with the protocol|14
4376286|NCT01049035|7152341|FG003|Overall Study|Non-compliance with the protocol|5
4376287|NCT01049035|7152342|FG004|Overall Study|Non-compliance with the protocol|3
4376288|NCT01049035|7152343|FG005|Overall Study|Non-compliance with the protocol|4
4376289|NCT01049035|7152344|FG006|Overall Study|Non-compliance with the protocol|10
4376290|NCT01049035|7152338|FG000|Overall Study|Lost to Follow-up|5
4376291|NCT01049035|7152339|FG001|Overall Study|Lost to Follow-up|4
4376292|NCT01049035|7152340|FG002|Overall Study|Lost to Follow-up|4
4376293|NCT01049035|7152341|FG003|Overall Study|Lost to Follow-up|1
4376294|NCT01049035|7152342|FG004|Overall Study|Lost to Follow-up|0
4376295|NCT01049035|7152343|FG005|Overall Study|Lost to Follow-up|3
4376296|NCT01049035|7152344|FG006|Overall Study|Lost to Follow-up|3
4376297|NCT01049035|7152338|FG000|Overall Study|Voluntary withdrawal not due to an AE|16
4376298|NCT01049035|7152339|FG001|Overall Study|Voluntary withdrawal not due to an AE|10
4376299|NCT01049035|7152340|FG002|Overall Study|Voluntary withdrawal not due to an AE|8
4376300|NCT01049035|7152341|FG003|Overall Study|Voluntary withdrawal not due to an AE|2
4376301|NCT01049035|7152342|FG004|Overall Study|Voluntary withdrawal not due to an AE|1
4376302|NCT01049035|7152343|FG005|Overall Study|Voluntary withdrawal not due to an AE|5
4376303|NCT01049035|7152344|FG006|Overall Study|Voluntary withdrawal not due to an AE|2
4376304|NCT00728884|7152370|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13
4376305|NCT00728884|7152370|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4
4376306|NCT00726063|7152387|FG000|Overall Study|Adverse Event|9
4376307|NCT00726063|7152388|FG001|Overall Study|Adverse Event|7
4376308|NCT00713206|7152405|FG000|Overall Study|Lost to Follow-up|4
4376309|NCT00713206|7152406|FG001|Overall Study|Lost to Follow-up|4
4376310|NCT00713206|7152405|FG000|Overall Study|Death|1
4376311|NCT00713206|7152406|FG001|Overall Study|Death|0
4376312|NCT00658814|7152414|FG000|Remission Induction Chemotherapy|Adverse Event|1
4376313|NCT00658814|7152415|FG001|Remission Induction Chemotherapy|Adverse Event|3
4376314|NCT00658814|7152414|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3
4376315|NCT00658814|7152415|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4
4376316|NCT00658814|7152414|FG000|Remission Induction Chemotherapy|Progression/Relapse|0
4376317|NCT00658814|7152415|FG001|Remission Induction Chemotherapy|Progression/Relapse|1
4376318|NCT00658814|7152414|FG000|Remission Induction Chemotherapy|Death|1
4376319|NCT00658814|7152415|FG001|Remission Induction Chemotherapy|Death|4
4376320|NCT00658814|7152414|FG000|Remission Induction Chemotherapy|Not protocol specified|2
4376321|NCT00658814|7152415|FG001|Remission Induction Chemotherapy|Not protocol specified|4
4376322|NCT00658814|7152414|FG000|Remission Induction Chemotherapy|Not eligible|1
4376323|NCT00658814|7152415|FG001|Remission Induction Chemotherapy|Not eligible|2
4376324|NCT00658814|7152414|FG000|Consolidation Therapy|Not protocol specified|0
4376325|NCT00658814|7152415|FG001|Consolidation Therapy|Not protocol specified|1
4376326|NCT00658814|7152414|FG000|Consolidation Therapy|Not eligible|2
4376327|NCT00658814|7152415|FG001|Consolidation Therapy|Not eligible|2
4376328|NCT00658814|7152414|FG000|Maintenance Therapy|Adverse Event|1
4376329|NCT00658814|7152415|FG001|Maintenance Therapy|Adverse Event|1
4376330|NCT00658814|7152414|FG000|Maintenance Therapy|Not protocol specified|1
4376331|NCT00658814|7152415|FG001|Maintenance Therapy|Not protocol specified|0
4376332|NCT00658814|7152414|FG000|Maintenance Therapy|Not eligible|1
4376333|NCT00658814|7152415|FG001|Maintenance Therapy|Not eligible|0
4770745|NCT02737475|7747044|FG018|Overall Study|Disease Progression|0
4770746|NCT02737475|7747045|FG019|Overall Study|Disease Progression|0
4770747|NCT02737475|7747046|FG020|Overall Study|Disease Progression|0
4770748|NCT02737475|7747047|FG021|Overall Study|Disease Progression|0
4770749|NCT02737475|7747048|FG022|Overall Study|Disease Progression|0
4770750|NCT02737475|7747049|FG023|Overall Study|Disease Progression|0
4770751|NCT02737475|7747050|FG024|Overall Study|Disease Progression|0
4770752|NCT02737475|7747051|FG025|Overall Study|Disease Progression|0
4770753|NCT02737475|7747052|FG026|Overall Study|Disease Progression|1
4770754|NCT02642965|7747144|FG000|Overall Study|Lack of Efficacy|4
4770755|NCT02642965|7747144|FG000|Overall Study|Physician Decision|9
4770756|NCT02629159|7747151|FG000|Overall Study|Adverse Event|17
4770757|NCT02629159|7747152|FG001|Overall Study|Adverse Event|20
4770758|NCT02629159|7747153|FG002|Overall Study|Adverse Event|22
4770759|NCT02629159|7747151|FG000|Overall Study|Withdrawal by Subject|22
4770760|NCT02629159|7747152|FG001|Overall Study|Withdrawal by Subject|11
4770761|NCT02629159|7747153|FG002|Overall Study|Withdrawal by Subject|15
4770762|NCT02629159|7747151|FG000|Overall Study|Lost to Follow-up|7
4770763|NCT02629159|7747152|FG001|Overall Study|Lost to Follow-up|4
4770764|NCT02629159|7747153|FG002|Overall Study|Lost to Follow-up|5
4770765|NCT02629159|7747151|FG000|Overall Study|Lack of Efficacy|4
4770766|NCT02629159|7747152|FG001|Overall Study|Lack of Efficacy|0
4770767|NCT02629159|7747153|FG002|Overall Study|Lack of Efficacy|1
4770768|NCT02629159|7747151|FG000|Overall Study|Other|6
4770769|NCT02629159|7747152|FG001|Overall Study|Other|4
4770770|NCT02629159|7747153|FG002|Overall Study|Other|8
4770771|NCT02604433|7747166|FG000|Overall Study|Withdrawal by Subject|37
4770772|NCT02604433|7747167|FG001|Overall Study|Withdrawal by Subject|16
4376362|NCT00569127|7152436|FG000|Overall Study|Adverse Event|57
4376363|NCT00569127|7152437|FG001|Overall Study|Adverse Event|47
4376364|NCT00569127|7152436|FG000|Overall Study|Withdrawal by Subject|13
4376365|NCT00569127|7152437|FG001|Overall Study|Withdrawal by Subject|27
4587742|NCT01493687|7431936|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5
4587743|NCT01493687|7431937|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1
4587744|NCT01493687|7431936|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2
4376366|NCT00569127|7152436|FG000|Overall Study|Progression|99
4376367|NCT00569127|7152437|FG001|Overall Study|Progression|100
4376368|NCT00569127|7152436|FG000|Overall Study|Death|4
4376369|NCT00569127|7152437|FG001|Overall Study|Death|3
4376370|NCT00569127|7152436|FG000|Overall Study|Other|20
4376371|NCT00569127|7152437|FG001|Overall Study|Other|19
4376372|NCT00569127|7152436|FG000|Overall Study|Lost to Follow-up|0
4376373|NCT00569127|7152437|FG001|Overall Study|Lost to Follow-up|3
4376374|NCT00569127|7152436|FG000|Overall Study|Not Eligible|14
4376375|NCT00569127|7152437|FG001|Overall Study|Not Eligible|11
4376376|NCT00569127|7152436|FG000|Overall Study|Still on Treatment|7
4376377|NCT00569127|7152437|FG001|Overall Study|Still on Treatment|3
4770773|NCT02604433|7747166|FG000|Overall Study|Adverse Event|4
4770774|NCT02604433|7747167|FG001|Overall Study|Adverse Event|0
4770775|NCT02604433|7747166|FG000|Overall Study|Other reasons|3
4770776|NCT02604433|7747167|FG001|Overall Study|Other reasons|5
4770777|NCT02604433|7747166|FG000|Overall Study|Death|4
4770778|NCT02604433|7747167|FG001|Overall Study|Death|1
4770779|NCT02604433|7747166|FG000|Overall Study|Transition to Rollover Protocol|169
4770780|NCT02604433|7747167|FG001|Overall Study|Transition to Rollover Protocol|82
4770781|NCT02604433|7747166|FG000|Overall Study|Physician Decision|1
4770782|NCT02604433|7747167|FG001|Overall Study|Physician Decision|1
4770783|NCT02604433|7747166|FG000|Overall Study|Lack of Efficacy|0
4770784|NCT02604433|7747167|FG001|Overall Study|Lack of Efficacy|1
4465929|NCT00614120|7257576|FG002|Overall Study|Did not meet trial criteria|1
4465930|NCT00614120|7257577|FG003|Overall Study|Did not meet trial criteria|1
4465931|NCT00614120|7257574|FG000|Overall Study|hCG positive (not pregnant)|0
4465932|NCT00614120|7257575|FG001|Overall Study|hCG positive (not pregnant)|0
4465933|NCT00614120|7257576|FG002|Overall Study|hCG positive (not pregnant)|1
4465934|NCT00614120|7257577|FG003|Overall Study|hCG positive (not pregnant)|0
4465935|NCT00614120|7257574|FG000|Overall Study|Hypoglycaemia|0
4465936|NCT00614120|7257575|FG001|Overall Study|Hypoglycaemia|0
4465937|NCT00614120|7257576|FG002|Overall Study|Hypoglycaemia|0
4465938|NCT00614120|7257577|FG003|Overall Study|Hypoglycaemia|1
4465939|NCT00614120|7257574|FG000|Overall Study|Lack of trial product|3
4465940|NCT00614120|7257575|FG001|Overall Study|Lack of trial product|3
4465941|NCT00614120|7257576|FG002|Overall Study|Lack of trial product|2
4465942|NCT00614120|7257577|FG003|Overall Study|Lack of trial product|0
4465943|NCT00614120|7257574|FG000|Overall Study|Late syphilis, latent|1
4465944|NCT00614120|7257575|FG001|Overall Study|Late syphilis, latent|0
4465945|NCT00614120|7257576|FG002|Overall Study|Late syphilis, latent|0
4465946|NCT00614120|7257577|FG003|Overall Study|Late syphilis, latent|0
4465947|NCT00614120|7257574|FG000|Overall Study|Taken inhibition medication eg Prandin|0
4465948|NCT00614120|7257575|FG001|Overall Study|Taken inhibition medication eg Prandin|0
4465949|NCT00614120|7257576|FG002|Overall Study|Taken inhibition medication eg Prandin|1
4465950|NCT00614120|7257577|FG003|Overall Study|Taken inhibition medication eg Prandin|1
4465951|NCT00614120|7257574|FG000|Overall Study|Lost to Follow-up|1
4465952|NCT00614120|7257575|FG001|Overall Study|Lost to Follow-up|2
4465953|NCT00614120|7257576|FG002|Overall Study|Lost to Follow-up|3
4465954|NCT00614120|7257577|FG003|Overall Study|Lost to Follow-up|4
4465955|NCT00614380|7257604|FG000|Overall Study|Adverse Event|14
4465956|NCT00614380|7257605|FG001|Overall Study|Adverse Event|4
4465957|NCT00614380|7257606|FG002|Overall Study|Adverse Event|0
4465958|NCT00614380|7257607|FG003|Overall Study|Adverse Event|0
4465959|NCT00614380|7257604|FG000|Overall Study|Lost to Follow-up|6
4465960|NCT00614380|7257605|FG001|Overall Study|Lost to Follow-up|1
4465961|NCT00614380|7257606|FG002|Overall Study|Lost to Follow-up|0
4465962|NCT00614380|7257607|FG003|Overall Study|Lost to Follow-up|0
4465963|NCT00614380|7257604|FG000|Overall Study|Non compliant with the protocol|12
4465964|NCT00614380|7257605|FG001|Overall Study|Non compliant with the protocol|2
4465965|NCT00614380|7257606|FG002|Overall Study|Non compliant with the protocol|1
4465966|NCT00614380|7257607|FG003|Overall Study|Non compliant with the protocol|2
4465967|NCT00614380|7257604|FG000|Overall Study|Consent withdrawn|3
4465968|NCT00614380|7257605|FG001|Overall Study|Consent withdrawn|1
4465969|NCT00614380|7257606|FG002|Overall Study|Consent withdrawn|0
4465970|NCT00614380|7257607|FG003|Overall Study|Consent withdrawn|0
4465971|NCT00614393|7257627|FG000|Overall Study|Adverse Event|20
4465972|NCT00614393|7257628|FG001|Overall Study|Adverse Event|2
4465973|NCT00614393|7257629|FG002|Overall Study|Adverse Event|3
4465974|NCT00614393|7257630|FG003|Overall Study|Adverse Event|13
4465975|NCT00614393|7257631|FG004|Overall Study|Adverse Event|21
4465976|NCT00614393|7257627|FG000|Overall Study|Lost to Follow-up|0
4465977|NCT00614393|7257628|FG001|Overall Study|Lost to Follow-up|0
4465978|NCT00614393|7257629|FG002|Overall Study|Lost to Follow-up|0
4465979|NCT00614393|7257630|FG003|Overall Study|Lost to Follow-up|1
4465980|NCT00614393|7257631|FG004|Overall Study|Lost to Follow-up|2
4465981|NCT00614393|7257627|FG000|Overall Study|Physician Decision|17
4465982|NCT00614393|7257628|FG001|Overall Study|Physician Decision|0
4465983|NCT00614393|7257629|FG002|Overall Study|Physician Decision|1
4465984|NCT00614393|7257630|FG003|Overall Study|Physician Decision|8
4465985|NCT00614393|7257631|FG004|Overall Study|Physician Decision|9
4465986|NCT00614393|7257627|FG000|Overall Study|Progressive Disease|118
4465987|NCT00614393|7257628|FG001|Overall Study|Progressive Disease|5
4465988|NCT00614393|7257629|FG002|Overall Study|Progressive Disease|5
4465989|NCT00614393|7257630|FG003|Overall Study|Progressive Disease|138
4465990|NCT00614393|7257631|FG004|Overall Study|Progressive Disease|130
4465991|NCT00614393|7257627|FG000|Overall Study|Protocol Violation|1
4465992|NCT00614393|7257628|FG001|Overall Study|Protocol Violation|0
4465993|NCT00614393|7257629|FG002|Overall Study|Protocol Violation|0
4465994|NCT00614393|7257630|FG003|Overall Study|Protocol Violation|0
4465995|NCT00614393|7257631|FG004|Overall Study|Protocol Violation|0
4465996|NCT00614393|7257627|FG000|Overall Study|Terminated by Sponsor|0
4465997|NCT00614393|7257628|FG001|Overall Study|Terminated by Sponsor|0
4465998|NCT00614393|7257629|FG002|Overall Study|Terminated by Sponsor|0
4587745|NCT01493687|7431937|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3
4695831|NCT02629861|7608388|FG000|Overall Study|Protocol Violation|2
4376398|NCT04422990|7152463|FG000|Overall Study|Withdrawal by Subject|0
4376399|NCT04422990|7152464|FG001|Overall Study|Withdrawal by Subject|1
4376400|NCT04422990|7152463|FG000|Overall Study|Travel|3
4376401|NCT04422990|7152464|FG001|Overall Study|Travel|0
4376402|NCT04358549|7152479|FG000|Overall Study|Adverse Event|0
4376403|NCT04358549|7152480|FG001|Overall Study|Adverse Event|1
4376404|NCT04358549|7152479|FG000|Overall Study|Death|1
4376405|NCT04358549|7152480|FG001|Overall Study|Death|0
4376406|NCT04358549|7152479|FG000|Overall Study|Lost to Follow-up|2
4376407|NCT04358549|7152480|FG001|Overall Study|Lost to Follow-up|1
4376408|NCT04358549|7152479|FG000|Overall Study|Withdrawal by Subject|6
4376409|NCT04358549|7152480|FG001|Overall Study|Withdrawal by Subject|6
4376410|NCT04358549|7152479|FG000|Overall Study|Start remdesivir|1
4376411|NCT04358549|7152480|FG001|Overall Study|Start remdesivir|0
4376412|NCT04018612|7152509|FG000|Overall Study|Withdrawal by Subject|1
4376413|NCT04018612|7152510|FG001|Overall Study|Withdrawal by Subject|0
4376414|NCT04018612|7152511|FG002|Overall Study|Withdrawal by Subject|1
4376415|NCT03976648|7152521|FG000|Overall Study|Adverse Event|0
4376416|NCT03976648|7152522|FG001|Overall Study|Adverse Event|2
4376417|NCT03976648|7152521|FG000|Overall Study|Study terminated by sponsor|21
4376418|NCT03976648|7152522|FG001|Overall Study|Study terminated by sponsor|8
4376430|NCT03470922|7152586|FG000|Overall Study|Death|107
4376431|NCT03470922|7152587|FG001|Overall Study|Death|118
4376432|NCT03470922|7152586|FG000|Overall Study|Lost to Follow-up|5
4376433|NCT03470922|7152587|FG001|Overall Study|Lost to Follow-up|5
4376434|NCT03470922|7152586|FG000|Overall Study|Participant Withdrew Consent|4
4376435|NCT03470922|7152587|FG001|Overall Study|Participant Withdrew Consent|9
4376436|NCT03470922|7152586|FG000|Overall Study|Other reasons|1
4376437|NCT03470922|7152587|FG001|Overall Study|Other reasons|0
4376438|NCT03470922|7152586|FG000|Overall Study|Not reported|1
4376439|NCT03470922|7152587|FG001|Overall Study|Not reported|0
4376440|NCT03387852|7152597|FG000|Overall Study|Adverse event (AE)|3
4376441|NCT03387852|7152598|FG001|Overall Study|Adverse event (AE)|0
4376442|NCT03387852|7152599|FG002|Overall Study|Adverse event (AE)|2
4376443|NCT03387852|7152600|FG003|Overall Study|Adverse event (AE)|0
4376444|NCT03387852|7152597|FG000|Overall Study|Loss of asthma control (LOAC)|28
4376445|NCT03387852|7152598|FG001|Overall Study|Loss of asthma control (LOAC)|16
4376446|NCT03387852|7152599|FG002|Overall Study|Loss of asthma control (LOAC)|20
4376447|NCT03387852|7152600|FG003|Overall Study|Loss of asthma control (LOAC)|14
4376448|NCT03387852|7152597|FG000|Overall Study|Withdrawal by participant|1
4376449|NCT03387852|7152598|FG001|Overall Study|Withdrawal by participant|1
4376450|NCT03387852|7152599|FG002|Overall Study|Withdrawal by participant|3
4376451|NCT03387852|7152600|FG003|Overall Study|Withdrawal by participant|2
4376452|NCT03387852|7152597|FG000|Overall Study|Other- Unspecified|1
4376453|NCT03387852|7152598|FG001|Overall Study|Other- Unspecified|1
4376454|NCT03387852|7152599|FG002|Overall Study|Other- Unspecified|2
4376455|NCT03387852|7152600|FG003|Overall Study|Other- Unspecified|1
4376456|NCT03387852|7152597|FG000|Overall Study|Poor compliance to protocol|0
4376457|NCT03387852|7152598|FG001|Overall Study|Poor compliance to protocol|0
4376458|NCT03387852|7152599|FG002|Overall Study|Poor compliance to protocol|0
4376459|NCT03387852|7152600|FG003|Overall Study|Poor compliance to protocol|1
4376460|NCT03387852|7152597|FG000|Overall Study|Randomized and not treated|0
4376461|NCT03387852|7152598|FG001|Overall Study|Randomized and not treated|0
4376462|NCT03387852|7152599|FG002|Overall Study|Randomized and not treated|0
4695832|NCT02629861|7608389|FG001|Overall Study|Protocol Violation|3
4695833|NCT02629861|7608390|FG002|Overall Study|Protocol Violation|7
4695834|NCT02629861|7608388|FG000|Overall Study|Lost to Follow-up|12
4695835|NCT02629861|7608389|FG001|Overall Study|Lost to Follow-up|9
4695836|NCT02629861|7608390|FG002|Overall Study|Lost to Follow-up|4
4695837|NCT02629861|7608388|FG000|Overall Study|Other|1
4695838|NCT02629861|7608389|FG001|Overall Study|Other|1
4695839|NCT02629861|7608390|FG002|Overall Study|Other|0
4695840|NCT02629861|7608388|FG000|Overall Study|Pregnancy|2
4695841|NCT02629861|7608389|FG001|Overall Study|Pregnancy|1
4695842|NCT02629861|7608390|FG002|Overall Study|Pregnancy|0
4695843|NCT02629965|7608398|FG000|Period 1|Adverse Event|1
4376463|NCT03387852|7152600|FG003|Overall Study|Randomized and not treated|1
4376464|NCT03308825|7152615|FG000|Overall Study|Lost to Follow-up|2
4376465|NCT03308825|7152616|FG001|Overall Study|Lost to Follow-up|2
4376466|NCT03308825|7152617|FG002|Overall Study|Lost to Follow-up|1
4376467|NCT03308825|7152618|FG003|Overall Study|Lost to Follow-up|0
4376468|NCT03308825|7152615|FG000|Overall Study|Protocol Violation|0
4376469|NCT03308825|7152616|FG001|Overall Study|Protocol Violation|2
4376470|NCT03308825|7152617|FG002|Overall Study|Protocol Violation|0
4376471|NCT03308825|7152618|FG003|Overall Study|Protocol Violation|0
4376472|NCT02915302|7152634|FG000|Overall Study|Adverse Event|3
4376473|NCT02915302|7152635|FG001|Overall Study|Adverse Event|0
4376474|NCT02915302|7152634|FG000|Overall Study|Protocol Violation|20
4376475|NCT02915302|7152635|FG001|Overall Study|Protocol Violation|27
4376476|NCT02915302|7152634|FG000|Overall Study|Lost to Follow-up|19
4695844|NCT02629965|7608399|FG001|Period 1|Adverse Event|0
4695845|NCT02629965|7608398|FG000|Period 1|Unexpected worsening of disease|2
4695846|NCT02629965|7608399|FG001|Period 1|Unexpected worsening of disease|0
4695847|NCT02629965|7608398|FG000|Period 1|Other than listed above|1
4376419|NCT03895840|7152532|FG000|Overall Study|Withdrawal by Subject|21
4376420|NCT03619902|7152536|FG000|Overall Study|Termination of Study by Investigator|1
4376421|NCT03619902|7152536|FG000|Overall Study|Use of Excluded/Prohibited Medication|1
4376422|NCT03517449|7152577|FG000|Overall Study|Death|184
4376423|NCT03517449|7152578|FG001|Overall Study|Death|236
4376424|NCT03517449|7152577|FG000|Overall Study|Lost to Follow-up|0
4376425|NCT03517449|7152578|FG001|Overall Study|Lost to Follow-up|2
4376426|NCT03517449|7152577|FG000|Overall Study|Withdrawal by Subject|7
4376427|NCT03517449|7152578|FG001|Overall Study|Withdrawal by Subject|26
4376428|NCT03517449|7152577|FG000|Overall Study|Participants Ongoing|220
4376429|NCT03517449|7152578|FG001|Overall Study|Participants Ongoing|152
4376477|NCT02915302|7152635|FG001|Overall Study|Lost to Follow-up|22
4376478|NCT02915302|7152634|FG000|Overall Study|Withdrawal by Subject|22
4376479|NCT02915302|7152635|FG001|Overall Study|Withdrawal by Subject|29
4376480|NCT02915302|7152634|FG000|Overall Study|Other|1
4376481|NCT02915302|7152635|FG001|Overall Study|Other|0
4376482|NCT02744040|7152658|FG000|Overall Study|Withdrawal by Subject|3
4376483|NCT02744040|7152659|FG001|Overall Study|Withdrawal by Subject|2
4376484|NCT02744040|7152660|FG002|Overall Study|Withdrawal by Subject|2
4376485|NCT02744040|7152658|FG000|Overall Study|Physician Decision|0
4376486|NCT02744040|7152659|FG001|Overall Study|Physician Decision|8
4376487|NCT02744040|7152660|FG002|Overall Study|Physician Decision|13
4376488|NCT02744040|7152658|FG000|Overall Study|Lost to Follow-up|3
4376489|NCT02744040|7152659|FG001|Overall Study|Lost to Follow-up|1
4376490|NCT02744040|7152660|FG002|Overall Study|Lost to Follow-up|7
4376491|NCT02698826|7152668|FG000|Overall Study|Death|13
4376492|NCT02698826|7152668|FG000|Overall Study|Adverse Event|1
4376493|NCT02617589|7152676|FG000|All Randomized|Request to discontinue study treatment|1
4376494|NCT02617589|7152677|FG001|All Randomized|Request to discontinue study treatment|3
4376495|NCT02617589|7152676|FG000|All Randomized|Participant Withdrew Consent|1
4376496|NCT02617589|7152677|FG001|All Randomized|Participant Withdrew Consent|2
4376497|NCT02617589|7152676|FG000|Treatment Period|Other Reasons|2
4376498|NCT02617589|7152677|FG001|Treatment Period|Other Reasons|2
4376499|NCT02617589|7152676|FG000|Treatment Period|Not reported|1
4376500|NCT02617589|7152677|FG001|Treatment Period|Not reported|0
4376501|NCT02617589|7152676|FG000|Treatment Period|Poor/Non compliance|1
4376502|NCT02617589|7152677|FG001|Treatment Period|Poor/Non compliance|1
4376503|NCT02617589|7152676|FG000|Treatment Period|Maximum Clinical Benefit|0
4376504|NCT02617589|7152677|FG001|Treatment Period|Maximum Clinical Benefit|2
4376505|NCT02617589|7152676|FG000|Treatment Period|Participant Withdrew Consent|2
4376506|NCT02617589|7152677|FG001|Treatment Period|Participant Withdrew Consent|6
4376507|NCT02617589|7152676|FG000|Treatment Period|Participant Request to discontinue|12
4376508|NCT02617589|7152677|FG001|Treatment Period|Participant Request to discontinue|20
4376509|NCT02617589|7152676|FG000|Treatment Period|Adverse event unrelated to study drug|15
4376510|NCT02617589|7152677|FG001|Treatment Period|Adverse event unrelated to study drug|9
4376511|NCT02617589|7152676|FG000|Treatment Period|Death|1
4376512|NCT02617589|7152677|FG001|Treatment Period|Death|1
4376513|NCT02617589|7152676|FG000|Treatment Period|Study Drug Toxicity|26
4376514|NCT02617589|7152677|FG001|Treatment Period|Study Drug Toxicity|20
4376515|NCT02617589|7152676|FG000|Treatment Period|Disease Progression|214
4376516|NCT02617589|7152677|FG001|Treatment Period|Disease Progression|137
4376517|NCT02617589|7152676|FG000|Treatment Period|Completed Treatment|0
4376518|NCT02617589|7152677|FG001|Treatment Period|Completed Treatment|76
4376519|NCT02614859|7152685|FG000|Overall Study|Physician Decision|0
4376520|NCT02614859|7152686|FG001|Overall Study|Physician Decision|1
4465999|NCT00614393|7257630|FG003|Overall Study|Terminated by Sponsor|0
4466000|NCT00614393|7257631|FG004|Overall Study|Terminated by Sponsor|1
4466001|NCT00614393|7257627|FG000|Overall Study|Withdrawal by Subject|20
4466002|NCT00614393|7257628|FG001|Overall Study|Withdrawal by Subject|1
4466003|NCT00614393|7257629|FG002|Overall Study|Withdrawal by Subject|1
4466004|NCT00614393|7257630|FG003|Overall Study|Withdrawal by Subject|16
4466005|NCT00614393|7257631|FG004|Overall Study|Withdrawal by Subject|13
4466006|NCT00614393|7257627|FG000|Overall Study|Other|4
4466007|NCT00614393|7257628|FG001|Overall Study|Other|0
4466008|NCT00614393|7257629|FG002|Overall Study|Other|0
4466009|NCT00614393|7257630|FG003|Overall Study|Other|4
4466010|NCT00614393|7257631|FG004|Overall Study|Other|2
4466011|NCT00614393|7257627|FG000|Overall Study|Not Treated|0
4466012|NCT00614393|7257628|FG001|Overall Study|Not Treated|0
4466013|NCT00614393|7257629|FG002|Overall Study|Not Treated|0
4466014|NCT00614393|7257630|FG003|Overall Study|Not Treated|0
4466015|NCT00614393|7257631|FG004|Overall Study|Not Treated|2
4466016|NCT00614523|7257681|FG000|Overall Study|Adverse Event|4
4466017|NCT00614523|7257682|FG001|Overall Study|Adverse Event|20
4466018|NCT00614523|7257681|FG000|Overall Study|Death|5
4466019|NCT00614523|7257682|FG001|Overall Study|Death|8
4466020|NCT00614523|7257681|FG000|Overall Study|Lack of Efficacy|9
4466021|NCT00614523|7257682|FG001|Overall Study|Lack of Efficacy|11
4466022|NCT00614523|7257681|FG000|Overall Study|Lost to Follow-up|0
4466023|NCT00614523|7257682|FG001|Overall Study|Lost to Follow-up|1
4466024|NCT00614523|7257681|FG000|Overall Study|Protocol Violation|3
4466025|NCT00614523|7257682|FG001|Overall Study|Protocol Violation|2
4466026|NCT00614523|7257681|FG000|Overall Study|Withdrawal by Subject|12
4466027|NCT00614523|7257682|FG001|Overall Study|Withdrawal by Subject|22
4466028|NCT00614523|7257681|FG000|Overall Study|Other|6
4376521|NCT02614066|7152698|FG000|Overall Study|Initiated KTE-X19 and Died|5
4376522|NCT02614066|7152699|FG001|Overall Study|Initiated KTE-X19 and Died|12
4376523|NCT02614066|7152700|FG002|Overall Study|Initiated KTE-X19 and Died|11
4376524|NCT02614066|7152701|FG003|Overall Study|Initiated KTE-X19 and Died|20
4376525|NCT02614066|7152698|FG000|Overall Study|Full Consent Withdrawn|0
4376526|NCT02614066|7152699|FG001|Overall Study|Full Consent Withdrawn|1
4376527|NCT02614066|7152700|FG002|Overall Study|Full Consent Withdrawn|0
4376528|NCT02614066|7152701|FG003|Overall Study|Full Consent Withdrawn|3
4376529|NCT02614066|7152698|FG000|Overall Study|Lost to Follow-up|0
4376530|NCT02614066|7152699|FG001|Overall Study|Lost to Follow-up|1
4376531|NCT02614066|7152700|FG002|Overall Study|Lost to Follow-up|0
4376532|NCT02614066|7152701|FG003|Overall Study|Lost to Follow-up|0
4376533|NCT02614066|7152698|FG000|Overall Study|Still on-study|1
4376534|NCT02614066|7152699|FG001|Overall Study|Still on-study|9
4376535|NCT02614066|7152700|FG002|Overall Study|Still on-study|5
4376536|NCT02614066|7152701|FG003|Overall Study|Still on-study|32
4376537|NCT02614066|7152698|FG000|Overall Study|Enrolled But Did Not Initiate KTE-X19|0
4376538|NCT02614066|7152699|FG001|Overall Study|Enrolled But Did Not Initiate KTE-X19|5
4376539|NCT02614066|7152700|FG002|Overall Study|Enrolled But Did Not Initiate KTE-X19|4
4376540|NCT02614066|7152701|FG003|Overall Study|Enrolled But Did Not Initiate KTE-X19|16
4376541|NCT02519348|7152729|FG000|Overall Study|Death|31
4376542|NCT02519348|7152730|FG001|Overall Study|Death|74
4376543|NCT02519348|7152731|FG002|Overall Study|Death|47
4376544|NCT02519348|7152732|FG003|Overall Study|Death|54
4376545|NCT02519348|7152733|FG004|Overall Study|Death|63
4376546|NCT02519348|7152734|FG005|Overall Study|Death|18
4376547|NCT02519348|7152735|FG006|Overall Study|Death|2
4376548|NCT02519348|7152736|FG007|Overall Study|Death|5
4376549|NCT02519348|7152737|FG008|Overall Study|Death|5
4376550|NCT02519348|7152729|FG000|Overall Study|Withdrawal by Subject|4
4376551|NCT02519348|7152730|FG001|Overall Study|Withdrawal by Subject|7
4376552|NCT02519348|7152731|FG002|Overall Study|Withdrawal by Subject|4
4695848|NCT02629965|7608399|FG001|Period 1|Other than listed above|2
4695849|NCT02629965|7608398|FG000|Period 2|Adverse Event|1
4695850|NCT02629965|7608399|FG001|Period 2|Adverse Event|0
4695851|NCT02630186|7608436|FG000|Overall Study|Withdrawal by Subject|1
4695852|NCT02630251|7608444|FG000|Overall Study|Physician Decision|0
4695853|NCT02630251|7608445|FG001|Overall Study|Physician Decision|0
4695854|NCT02630251|7608446|FG002|Overall Study|Physician Decision|1
4695855|NCT02630251|7608447|FG003|Overall Study|Physician Decision|0
4770785|NCT02550652|7747175|FG000|Overall Study|Death|1
4770786|NCT02550652|7747176|FG001|Overall Study|Death|4
4770787|NCT02550652|7747175|FG000|Overall Study|Lack of Efficacy|1
4770788|NCT02550652|7747176|FG001|Overall Study|Lack of Efficacy|0
4770789|NCT02550652|7747175|FG000|Overall Study|Withdrawal by Subject|3
4770790|NCT02550652|7747176|FG001|Overall Study|Withdrawal by Subject|7
4770791|NCT02550652|7747175|FG000|Overall Study|Post Trial Access|1
4770792|NCT02550652|7747176|FG001|Overall Study|Post Trial Access|0
4770793|NCT02550652|7747175|FG000|Overall Study|Lost to Follow-up|1
4770794|NCT02550652|7747176|FG001|Overall Study|Lost to Follow-up|3
4770795|NCT02550652|7747175|FG000|Overall Study|Physician Decision|0
4770796|NCT02550652|7747176|FG001|Overall Study|Physician Decision|2
4770797|NCT02550652|7747175|FG000|Overall Study|Ongoing in safety/B-cell follow-up period|14
4770798|NCT02550652|7747176|FG001|Overall Study|Ongoing in safety/B-cell follow-up period|5
4770799|NCT02420821|7747201|FG000|Overall Study|Lost to Follow-up|2
4770800|NCT02420821|7747202|FG001|Overall Study|Lost to Follow-up|0
4770801|NCT02420821|7747201|FG000|Overall Study|Non-compliance|1
4770802|NCT02420821|7747202|FG001|Overall Study|Non-compliance|2
4770803|NCT02420821|7747201|FG000|Overall Study|Physician Decision|5
4770804|NCT02420821|7747202|FG001|Overall Study|Physician Decision|2
4770805|NCT02420821|7747201|FG000|Overall Study|Withdrawal by Subject|31
4770806|NCT02420821|7747202|FG001|Overall Study|Withdrawal by Subject|17
4770807|NCT02420821|7747201|FG000|Overall Study|Death|129
4770808|NCT02420821|7747202|FG001|Overall Study|Death|116
4770809|NCT02412670|7747211|FG000|Overall Study|Adverse Event|4
4770810|NCT02412670|7747212|FG001|Overall Study|Adverse Event|1
4770811|NCT02412670|7747211|FG000|Overall Study|Physician Decision|1
4770812|NCT02412670|7747212|FG001|Overall Study|Physician Decision|0
4770813|NCT02412670|7747211|FG000|Overall Study|Withdrawal by Subject|1
4770814|NCT02412670|7747212|FG001|Overall Study|Withdrawal by Subject|0
4770815|NCT02412670|7747211|FG000|Overall Study|Ineligible|1
4770816|NCT02412670|7747212|FG001|Overall Study|Ineligible|0
4376553|NCT02519348|7152732|FG003|Overall Study|Withdrawal by Subject|3
4376554|NCT02519348|7152733|FG004|Overall Study|Withdrawal by Subject|3
4376555|NCT02519348|7152734|FG005|Overall Study|Withdrawal by Subject|2
4376556|NCT02519348|7152735|FG006|Overall Study|Withdrawal by Subject|0
4376557|NCT02519348|7152736|FG007|Overall Study|Withdrawal by Subject|0
4376558|NCT02519348|7152737|FG008|Overall Study|Withdrawal by Subject|1
4376559|NCT02519348|7152729|FG000|Overall Study|Lost to Follow-up|0
4376560|NCT02519348|7152730|FG001|Overall Study|Lost to Follow-up|0
4376561|NCT02519348|7152731|FG002|Overall Study|Lost to Follow-up|1
4376562|NCT02519348|7152732|FG003|Overall Study|Lost to Follow-up|0
4376563|NCT02519348|7152733|FG004|Overall Study|Lost to Follow-up|2
4770817|NCT02410343|7747220|FG000|Core Period (24 Weeks)|Adverse Event|1
4770818|NCT02410343|7747221|FG001|Core Period (24 Weeks)|Adverse Event|0
4376564|NCT02519348|7152734|FG005|Overall Study|Lost to Follow-up|1
4376565|NCT02519348|7152735|FG006|Overall Study|Lost to Follow-up|1
4376566|NCT02519348|7152736|FG007|Overall Study|Lost to Follow-up|0
4376567|NCT02519348|7152737|FG008|Overall Study|Lost to Follow-up|0
4376568|NCT02519348|7152729|FG000|Overall Study|Other|0
4376569|NCT02519348|7152730|FG001|Overall Study|Other|3
4376570|NCT02519348|7152731|FG002|Overall Study|Other|0
4376571|NCT02519348|7152732|FG003|Overall Study|Other|0
4376572|NCT02519348|7152733|FG004|Overall Study|Other|1
4376573|NCT02519348|7152734|FG005|Overall Study|Other|0
4376574|NCT02519348|7152735|FG006|Overall Study|Other|0
4376575|NCT02519348|7152736|FG007|Overall Study|Other|0
4466029|NCT00614523|7257682|FG001|Overall Study|Other|11
4466030|NCT00614523|7257681|FG000|Overall Study|Ineligibility Determined|1
4466031|NCT00614523|7257682|FG001|Overall Study|Ineligibility Determined|2
4466032|NCT00614523|7257681|FG000|Overall Study|Disease Progression|0
4466033|NCT00614523|7257682|FG001|Overall Study|Disease Progression|8
4466034|NCT00614523|7257681|FG000|Overall Study|Administrative Decision|23
4466035|NCT00614523|7257682|FG001|Overall Study|Administrative Decision|46
4466036|NCT00614575|7257688|FG000|Overall Study|Adverse Event|106
4466037|NCT00614575|7257688|FG000|Overall Study|Lost to Follow-up|55
4466038|NCT00614575|7257688|FG000|Overall Study|Lack of Efficacy|14
4466039|NCT00614575|7257688|FG000|Overall Study|Withdrawal by Subject|6
4466040|NCT00614575|7257688|FG000|Overall Study|Death|3
4466041|NCT00614575|7257688|FG000|Overall Study|Physician Decision|2
4466042|NCT00614575|7257688|FG000|Overall Study|No data were collected.|18
4466043|NCT00614575|7257688|FG000|Overall Study|Irregularly enrolled patients|23
4466044|NCT00614575|7257688|FG000|Overall Study|No treatment|1
4466045|NCT00614614|7257694|FG000|Primary Vaccination Phase|Adverse Event|6
4466046|NCT00614614|7257695|FG001|Primary Vaccination Phase|Adverse Event|0
4466047|NCT00614614|7257696|FG002|Primary Vaccination Phase|Adverse Event|0
4466048|NCT00614614|7257697|FG003|Primary Vaccination Phase|Adverse Event|0
4466049|NCT00614614|7257698|FG004|Primary Vaccination Phase|Adverse Event|0
4466050|NCT00614614|7257694|FG000|Primary Vaccination Phase|Withdrawal by Subject|45
4466051|NCT00614614|7257695|FG001|Primary Vaccination Phase|Withdrawal by Subject|6
4466052|NCT00614614|7257696|FG002|Primary Vaccination Phase|Withdrawal by Subject|0
4466053|NCT00614614|7257697|FG003|Primary Vaccination Phase|Withdrawal by Subject|0
4466054|NCT00614614|7257698|FG004|Primary Vaccination Phase|Withdrawal by Subject|0
4466055|NCT00614614|7257694|FG000|Primary Vaccination Phase|Lost to Follow-up|26
4466056|NCT00614614|7257695|FG001|Primary Vaccination Phase|Lost to Follow-up|8
4466057|NCT00614614|7257696|FG002|Primary Vaccination Phase|Lost to Follow-up|0
4466058|NCT00614614|7257697|FG003|Primary Vaccination Phase|Lost to Follow-up|0
4466059|NCT00614614|7257698|FG004|Primary Vaccination Phase|Lost to Follow-up|0
4466060|NCT00614614|7257694|FG000|Primary Vaccination Phase|Protocol Violation|9
4466061|NCT00614614|7257695|FG001|Primary Vaccination Phase|Protocol Violation|3
4466062|NCT00614614|7257696|FG002|Primary Vaccination Phase|Protocol Violation|0
4466063|NCT00614614|7257697|FG003|Primary Vaccination Phase|Protocol Violation|0
4466064|NCT00614614|7257698|FG004|Primary Vaccination Phase|Protocol Violation|0
4466065|NCT00614614|7257694|FG000|Primary Vaccination Phase|Other|4
4466066|NCT00614614|7257695|FG001|Primary Vaccination Phase|Other|0
4466067|NCT00614614|7257696|FG002|Primary Vaccination Phase|Other|0
4466068|NCT00614614|7257697|FG003|Primary Vaccination Phase|Other|0
4466069|NCT00614614|7257698|FG004|Primary Vaccination Phase|Other|0
4466070|NCT00614614|7257694|FG000|Booster Vaccination Phase|Adverse Event|0
4466071|NCT00614614|7257695|FG001|Booster Vaccination Phase|Adverse Event|0
4466072|NCT00614614|7257696|FG002|Booster Vaccination Phase|Adverse Event|1
4466073|NCT00614614|7257697|FG003|Booster Vaccination Phase|Adverse Event|1
4466074|NCT00614614|7257698|FG004|Booster Vaccination Phase|Adverse Event|0
4466075|NCT00614614|7257694|FG000|Booster Vaccination Phase|Withdrawal by Subject|0
4466076|NCT00614614|7257695|FG001|Booster Vaccination Phase|Withdrawal by Subject|0
4770819|NCT02410343|7747220|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4
4770820|NCT02410343|7747221|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7
4770821|NCT02410343|7747220|FG000|Extension Period (12 Months)|Adverse Event|1
4770822|NCT02410343|7747221|FG001|Extension Period (12 Months)|Adverse Event|0
4770823|NCT02410343|7747220|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0
4770824|NCT02410343|7747221|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1
4466077|NCT00614614|7257696|FG002|Booster Vaccination Phase|Withdrawal by Subject|4
4466078|NCT00614614|7257697|FG003|Booster Vaccination Phase|Withdrawal by Subject|3
4466079|NCT00614614|7257698|FG004|Booster Vaccination Phase|Withdrawal by Subject|4
4466080|NCT00614614|7257694|FG000|Booster Vaccination Phase|Lost to Follow-up|0
4466081|NCT00614614|7257695|FG001|Booster Vaccination Phase|Lost to Follow-up|5
4466082|NCT00614614|7257696|FG002|Booster Vaccination Phase|Lost to Follow-up|17
4466083|NCT00614614|7257697|FG003|Booster Vaccination Phase|Lost to Follow-up|10
4466084|NCT00614614|7257698|FG004|Booster Vaccination Phase|Lost to Follow-up|8
4466085|NCT00614614|7257694|FG000|Booster Vaccination Phase|Protocol Violation|0
4466086|NCT00614614|7257695|FG001|Booster Vaccination Phase|Protocol Violation|0
4466087|NCT00614614|7257696|FG002|Booster Vaccination Phase|Protocol Violation|2
4466088|NCT00614614|7257697|FG003|Booster Vaccination Phase|Protocol Violation|3
4376576|NCT02519348|7152737|FG008|Overall Study|Other|0
4376577|NCT02519348|7152729|FG000|Overall Study|Ongoing at the time of data cut-off date|5
4376578|NCT02519348|7152730|FG001|Overall Study|Ongoing at the time of data cut-off date|20
4376579|NCT02519348|7152731|FG002|Overall Study|Ongoing at the time of data cut-off date|23
4376580|NCT02519348|7152732|FG003|Overall Study|Ongoing at the time of data cut-off date|12
4376581|NCT02519348|7152733|FG004|Overall Study|Ongoing at the time of data cut-off date|15
4376582|NCT02519348|7152734|FG005|Overall Study|Ongoing at the time of data cut-off date|26
4376583|NCT02519348|7152735|FG006|Overall Study|Ongoing at the time of data cut-off date|0
4376584|NCT02519348|7152736|FG007|Overall Study|Ongoing at the time of data cut-off date|0
4376585|NCT02519348|7152737|FG008|Overall Study|Ongoing at the time of data cut-off date|0
4376586|NCT02429414|7152760|FG000|Overall Study|Physician Decision|0
4376587|NCT02429414|7152761|FG001|Overall Study|Physician Decision|1
4770825|NCT02339740|7747234|FG000|Overall Study|Death|1
4770826|NCT02339740|7747235|FG001|Overall Study|Death|0
4770827|NCT02339740|7747234|FG000|Overall Study|Physician Decision|0
4466089|NCT00614614|7257698|FG004|Booster Vaccination Phase|Protocol Violation|0
4466090|NCT00614614|7257694|FG000|Booster Vaccination Phase|Other|0
4466091|NCT00614614|7257695|FG001|Booster Vaccination Phase|Other|1
4466092|NCT00614614|7257696|FG002|Booster Vaccination Phase|Other|3
4587746|NCT01493687|7431936|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5
4587747|NCT01493687|7431937|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4
4587748|NCT01493687|7431936|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27
4587749|NCT01493687|7431937|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16
4587750|NCT01493687|7431936|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1
4587751|NCT01493687|7431937|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0
4587752|NCT01493687|7431936|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16
4587753|NCT01493687|7431937|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10
4587754|NCT01493687|7431936|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5
4587755|NCT01493687|7431937|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1
4587756|NCT01493687|7431936|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0
4587757|NCT01493687|7431937|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1
4587758|NCT01493778|7431949|FG000|Overall Study|Withdrawal by Subject|8
4587759|NCT01493960|7431976|FG000|Overall Study|Adverse Event|0
4587760|NCT01493960|7431977|FG001|Overall Study|Adverse Event|1
4466093|NCT00614614|7257697|FG003|Booster Vaccination Phase|Other|2
4466094|NCT00614614|7257698|FG004|Booster Vaccination Phase|Other|1
4466095|NCT00614744|7257715|FG000|Overall Study|Lost to Follow-up|5
4466096|NCT00614744|7257716|FG001|Overall Study|Lost to Follow-up|4
4466097|NCT00614744|7257715|FG000|Overall Study|Incomplete for Behavior Issues|0
4466098|NCT00614744|7257716|FG001|Overall Study|Incomplete for Behavior Issues|2
4466099|NCT00614822|7257722|FG000|Overall Study|Adverse Event|3
4466100|NCT00614874|7257727|FG000|Overall Study|Protocol Violation|1
4466101|NCT00614874|7257727|FG000|Overall Study|Withdrawal by Subject|1
4466102|NCT00614926|7257737|FG000|Overall Study|Burden of travel|1
4466103|NCT00614926|7257738|FG001|Overall Study|Burden of travel|0
4466104|NCT00614926|7257737|FG000|Overall Study|Adverse Event|3
4466105|NCT00614926|7257738|FG001|Overall Study|Adverse Event|0
4466106|NCT00614939|7257746|FG000|Overall Study|Withdrawal by Subject|10
4466107|NCT00614939|7257747|FG001|Overall Study|Withdrawal by Subject|17
4466108|NCT00614939|7257746|FG000|Overall Study|Study specific discontinuation criteris|13
4466109|NCT00614939|7257747|FG001|Overall Study|Study specific discontinuation criteris|16
4466110|NCT00614939|7257746|FG000|Overall Study|Adverse Event|2
4466111|NCT00614939|7257747|FG001|Overall Study|Adverse Event|5
4466112|NCT00614939|7257746|FG000|Overall Study|Incorrect enrollment|1
4466113|NCT00614939|7257747|FG001|Overall Study|Incorrect enrollment|2
4466114|NCT00614939|7257746|FG000|Overall Study|Death|4
4466115|NCT00614939|7257747|FG001|Overall Study|Death|3
4466116|NCT00614939|7257746|FG000|Overall Study|Poor/non-compliance|4
4466117|NCT00614939|7257747|FG001|Overall Study|Poor/non-compliance|0
4466118|NCT00614939|7257746|FG000|Overall Study|Hospitalized due to kidney transplant|1
4466119|NCT00614939|7257747|FG001|Overall Study|Hospitalized due to kidney transplant|0
4466120|NCT00614991|7257759|FG000|Overall Study|Adverse Event|3
4466121|NCT00614991|7257760|FG001|Overall Study|Adverse Event|3
4466122|NCT00614991|7257761|FG002|Overall Study|Adverse Event|0
4466123|NCT00614991|7257762|FG003|Overall Study|Adverse Event|0
4466124|NCT00614991|7257763|FG004|Overall Study|Adverse Event|1
4466125|NCT00614991|7257764|FG005|Overall Study|Adverse Event|0
4466126|NCT00615017|7257789|FG000|Overall Study|Adverse Event|0
4466127|NCT00615017|7257790|FG001|Overall Study|Adverse Event|1
4466128|NCT00615017|7257791|FG002|Overall Study|Adverse Event|2
4466129|NCT00615017|7257792|FG003|Overall Study|Adverse Event|0
4466130|NCT00615017|7257793|FG004|Overall Study|Adverse Event|0
4466131|NCT00615017|7257794|FG005|Overall Study|Adverse Event|1
4466132|NCT00615017|7257789|FG000|Overall Study|Death|0
4466133|NCT00615017|7257790|FG001|Overall Study|Death|0
4587761|NCT01493960|7431976|FG000|Overall Study|Lack of Efficacy|15
4587762|NCT01493960|7431977|FG001|Overall Study|Lack of Efficacy|9
4587763|NCT01493960|7431976|FG000|Overall Study|Protocol Violation|3
4587764|NCT01493960|7431977|FG001|Overall Study|Protocol Violation|0
4587765|NCT01493960|7431976|FG000|Overall Study|Withdrawal by Subject|10
4587766|NCT01493960|7431977|FG001|Overall Study|Withdrawal by Subject|4
4587767|NCT01493960|7431976|FG000|Overall Study|Non-specified|4
4770828|NCT02339740|7747235|FG001|Overall Study|Physician Decision|2
4770829|NCT02339740|7747234|FG000|Overall Study|Withdrawal by Subject|5
4770830|NCT02339740|7747235|FG001|Overall Study|Withdrawal by Subject|1
4770831|NCT02339740|7747234|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3
4770832|NCT02339740|7747235|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1
4770833|NCT02045303|7747258|FG000|Overall Study|Protocol Violation|2
4770834|NCT02045303|7747259|FG001|Overall Study|Protocol Violation|1
4770835|NCT02045303|7747260|FG002|Overall Study|Protocol Violation|0
4770836|NCT02045303|7747258|FG000|Overall Study|Withdrawal by Subject|0
4770837|NCT02045303|7747259|FG001|Overall Study|Withdrawal by Subject|2
4770838|NCT02045303|7747260|FG002|Overall Study|Withdrawal by Subject|0
4770839|NCT02025556|7747272|FG000|Overall Study|Adverse Event|0
4770840|NCT02025556|7747273|FG001|Overall Study|Adverse Event|4
4770841|NCT02025556|7747274|FG002|Overall Study|Adverse Event|2
4770842|NCT02025556|7747272|FG000|Overall Study|Lack of Efficacy|2
4770843|NCT02025556|7747273|FG001|Overall Study|Lack of Efficacy|1
4770844|NCT02025556|7747274|FG002|Overall Study|Lack of Efficacy|0
4770845|NCT02025556|7747272|FG000|Overall Study|Protocol Violation|2
4770846|NCT02025556|7747273|FG001|Overall Study|Protocol Violation|1
4770847|NCT02025556|7747274|FG002|Overall Study|Protocol Violation|0
4770848|NCT02025556|7747272|FG000|Overall Study|Withdrawal by Subject|0
4770849|NCT02025556|7747273|FG001|Overall Study|Withdrawal by Subject|3
4770850|NCT02025556|7747274|FG002|Overall Study|Withdrawal by Subject|6
4770851|NCT02025556|7747272|FG000|Overall Study|Lost to Follow-up|2
4770852|NCT02025556|7747273|FG001|Overall Study|Lost to Follow-up|4
4770853|NCT02025556|7747274|FG002|Overall Study|Lost to Follow-up|0
4770854|NCT02025556|7747272|FG000|Overall Study|Reason not reported|0
4770855|NCT02025556|7747273|FG001|Overall Study|Reason not reported|0
4770856|NCT02025556|7747274|FG002|Overall Study|Reason not reported|1
4770857|NCT01986933|7747287|FG000|Placebo-controlled (Part A)|Adverse Event|1
4770858|NCT01986933|7747288|FG001|Placebo-controlled (Part A)|Adverse Event|5
4770859|NCT01986933|7747289|FG002|Placebo-controlled (Part A)|Adverse Event|2
4770860|NCT01986933|7747290|FG003|Placebo-controlled (Part A)|Adverse Event|2
4376624|NCT02258659|7152780|FG000|Overall Study|Withdrawal by Subject|1
4376625|NCT02111850|7152795|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0
4376626|NCT02111850|7152796|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0
4376627|NCT02111850|7152797|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0
4376628|NCT02111850|7152798|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0
4376629|NCT02111850|7152799|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1
4376630|NCT02111850|7152800|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0
4376631|NCT02111850|7152801|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0
4376632|NCT02111850|7152802|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0
4376633|NCT02111850|7152803|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0
4376634|NCT02111850|7152804|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0
4376635|NCT02111850|7152805|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0
4376636|NCT01483027|7152858|FG000|Overall Study|Administrative Reasons|2
4376637|NCT01483027|7152859|FG001|Overall Study|Administrative Reasons|1
4376638|NCT01483027|7152858|FG000|Overall Study|Withdrawal by Subject|21
4376639|NCT01483027|7152859|FG001|Overall Study|Withdrawal by Subject|32
4376640|NCT01483027|7152858|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22
4376641|NCT01483027|7152859|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24
4376642|NCT01483027|7152858|FG000|Overall Study|Lost to Follow-up|1
4376643|NCT01483027|7152859|FG001|Overall Study|Lost to Follow-up|1
4376644|NCT01483027|7152858|FG000|Overall Study|Adverse Event|0
4376645|NCT01483027|7152859|FG001|Overall Study|Adverse Event|1
4376646|NCT01483027|7152858|FG000|Overall Study|Withdrawal by Subject|0
4376647|NCT01483027|7152859|FG001|Overall Study|Withdrawal by Subject|1
4376648|NCT01379781|7152871|FG000|Overall Study|Lost to Follow-up|11
4376649|NCT01379781|7152872|FG001|Overall Study|Lost to Follow-up|8
4376650|NCT01065454|7152882|FG000|Treatment|Adverse Event|7
4376651|NCT01065454|7152883|FG001|Treatment|Adverse Event|4
4376652|NCT01065454|7152884|FG002|Treatment|Adverse Event|3
4376653|NCT01065454|7152885|FG003|Treatment|Adverse Event|6
4376654|NCT01065454|7152882|FG000|Treatment|Death|1
4376655|NCT01065454|7152883|FG001|Treatment|Death|0
4376656|NCT01065454|7152884|FG002|Treatment|Death|0
4376657|NCT01065454|7152885|FG003|Treatment|Death|0
4376658|NCT01065454|7152882|FG000|Treatment|Non-compliance|1
4376659|NCT01065454|7152883|FG001|Treatment|Non-compliance|0
4376660|NCT01065454|7152884|FG002|Treatment|Non-compliance|0
4376661|NCT01065454|7152885|FG003|Treatment|Non-compliance|1
4376662|NCT01065454|7152882|FG000|Treatment|Protocol Decision|0
4376663|NCT01065454|7152883|FG001|Treatment|Protocol Decision|0
4376664|NCT01065454|7152884|FG002|Treatment|Protocol Decision|3
4376665|NCT01065454|7152885|FG003|Treatment|Protocol Decision|2
4376666|NCT01065454|7152882|FG000|Treatment|Protocol Violation|1
4770861|NCT01986933|7747291|FG004|Placebo-controlled (Part A)|Adverse Event|4
4770862|NCT01986933|7747287|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3
4770863|NCT01986933|7747288|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1
4770864|NCT01986933|7747289|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1
4376667|NCT01065454|7152883|FG001|Treatment|Protocol Violation|0
4376668|NCT01065454|7152884|FG002|Treatment|Protocol Violation|1
4376669|NCT01065454|7152885|FG003|Treatment|Protocol Violation|0
4376670|NCT01065454|7152882|FG000|Treatment|Withdrawal by Subject|3
4376671|NCT01065454|7152883|FG001|Treatment|Withdrawal by Subject|1
4376672|NCT01065454|7152884|FG002|Treatment|Withdrawal by Subject|2
4376673|NCT01065454|7152885|FG003|Treatment|Withdrawal by Subject|3
4376674|NCT01065454|7152882|FG000|Follow up|Adverse Event|1
4376675|NCT01065454|7152883|FG001|Follow up|Adverse Event|0
4376676|NCT01065454|7152884|FG002|Follow up|Adverse Event|0
4376677|NCT01065454|7152885|FG003|Follow up|Adverse Event|1
4376678|NCT01065454|7152882|FG000|Follow up|Death|0
4376679|NCT01065454|7152883|FG001|Follow up|Death|1
4376680|NCT01065454|7152884|FG002|Follow up|Death|1
4376681|NCT01065454|7152885|FG003|Follow up|Death|0
4376682|NCT01065454|7152882|FG000|Follow up|Lost to Follow-up|0
4376683|NCT01065454|7152883|FG001|Follow up|Lost to Follow-up|0
4376684|NCT01065454|7152884|FG002|Follow up|Lost to Follow-up|0
4376685|NCT01065454|7152885|FG003|Follow up|Lost to Follow-up|1
4376686|NCT01065454|7152882|FG000|Follow up|Progressive disease|0
4376687|NCT01065454|7152883|FG001|Follow up|Progressive disease|0
4376688|NCT01065454|7152884|FG002|Follow up|Progressive disease|0
4376689|NCT01065454|7152885|FG003|Follow up|Progressive disease|1
4376690|NCT01065454|7152882|FG000|Follow up|Withdrawal by Subject|1
4376691|NCT01065454|7152883|FG001|Follow up|Withdrawal by Subject|1
4376692|NCT01065454|7152884|FG002|Follow up|Withdrawal by Subject|1
4376693|NCT01065454|7152885|FG003|Follow up|Withdrawal by Subject|0
4376694|NCT01065454|7152882|FG000|Follow up|study ongoing|37
4376695|NCT01065454|7152883|FG001|Follow up|study ongoing|22
4376696|NCT01065454|7152884|FG002|Follow up|study ongoing|15
4376697|NCT01065454|7152885|FG003|Follow up|study ongoing|41
4376698|NCT00180414|7152897|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4
4376699|NCT00180414|7152898|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4
4466134|NCT00615017|7257791|FG002|Overall Study|Death|2
4466135|NCT00615017|7257792|FG003|Overall Study|Death|0
4466136|NCT00615017|7257793|FG004|Overall Study|Death|1
4466137|NCT00615017|7257794|FG005|Overall Study|Death|1
4466138|NCT00615017|7257789|FG000|Overall Study|Sepsis resolved|0
4466139|NCT00615017|7257790|FG001|Overall Study|Sepsis resolved|0
4466140|NCT00615017|7257791|FG002|Overall Study|Sepsis resolved|1
4466141|NCT00615017|7257792|FG003|Overall Study|Sepsis resolved|0
4466142|NCT00615017|7257793|FG004|Overall Study|Sepsis resolved|0
4466143|NCT00615017|7257794|FG005|Overall Study|Sepsis resolved|0
4466144|NCT00615017|7257789|FG000|Overall Study|Transferred out of Intensive Care Unit|0
4466145|NCT00615017|7257790|FG001|Overall Study|Transferred out of Intensive Care Unit|0
4466146|NCT00615017|7257791|FG002|Overall Study|Transferred out of Intensive Care Unit|0
4466147|NCT00615017|7257792|FG003|Overall Study|Transferred out of Intensive Care Unit|1
4466148|NCT00615017|7257793|FG004|Overall Study|Transferred out of Intensive Care Unit|0
4466149|NCT00615017|7257794|FG005|Overall Study|Transferred out of Intensive Care Unit|0
4466150|NCT00615017|7257789|FG000|Overall Study|Physician discontinued drug|0
4466151|NCT00615017|7257790|FG001|Overall Study|Physician discontinued drug|0
4466152|NCT00615017|7257791|FG002|Overall Study|Physician discontinued drug|0
4466153|NCT00615017|7257792|FG003|Overall Study|Physician discontinued drug|0
4466154|NCT00615017|7257793|FG004|Overall Study|Physician discontinued drug|0
4466155|NCT00615017|7257794|FG005|Overall Study|Physician discontinued drug|1
4466156|NCT00615030|7257808|FG000|Period I|Administrative problem|0
4466157|NCT00615030|7257809|FG001|Period I|Administrative problem|0
4466158|NCT00615030|7257810|FG002|Period I|Administrative problem|0
4466159|NCT00615030|7257811|FG003|Period I|Administrative problem|0
4466160|NCT00615030|7257812|FG004|Period I|Administrative problem|1
4466161|NCT00615030|7257813|FG005|Period I|Administrative problem|0
4466162|NCT00615030|7257814|FG006|Period I|Administrative problem|0
4466163|NCT00615030|7257815|FG007|Period I|Administrative problem|0
4466164|NCT00615030|7257816|FG008|Period I|Administrative problem|0
4466165|NCT00615030|7257817|FG009|Period I|Administrative problem|0
4466166|NCT00615030|7257818|FG010|Period I|Administrative problem|0
4466167|NCT00615030|7257819|FG011|Period I|Administrative problem|0
4466168|NCT00615030|7257808|FG000|Period I|Protocol deviation|1
4466169|NCT00615030|7257809|FG001|Period I|Protocol deviation|0
4466170|NCT00615030|7257810|FG002|Period I|Protocol deviation|0
4466171|NCT00615030|7257811|FG003|Period I|Protocol deviation|0
4466172|NCT00615030|7257812|FG004|Period I|Protocol deviation|0
4466173|NCT00615030|7257813|FG005|Period I|Protocol deviation|0
4466174|NCT00615030|7257814|FG006|Period I|Protocol deviation|0
4466175|NCT00615030|7257815|FG007|Period I|Protocol deviation|0
4466176|NCT00615030|7257816|FG008|Period I|Protocol deviation|0
4466177|NCT00615030|7257817|FG009|Period I|Protocol deviation|0
4466178|NCT00615030|7257818|FG010|Period I|Protocol deviation|0
4466179|NCT00615030|7257819|FG011|Period I|Protocol deviation|0
4466180|NCT00615030|7257808|FG000|Period I|Subject withdrew consent|0
4466181|NCT00615030|7257809|FG001|Period I|Subject withdrew consent|0
4466182|NCT00615030|7257810|FG002|Period I|Subject withdrew consent|0
4466183|NCT00615030|7257811|FG003|Period I|Subject withdrew consent|0
4466184|NCT00615030|7257812|FG004|Period I|Subject withdrew consent|0
4466185|NCT00615030|7257813|FG005|Period I|Subject withdrew consent|0
4466186|NCT00615030|7257814|FG006|Period I|Subject withdrew consent|0
4466187|NCT00615030|7257815|FG007|Period I|Subject withdrew consent|0
4376700|NCT02513394|7152910|FG000|Overall Study|Withdrawal by Subject|11
4376701|NCT02513394|7152911|FG001|Overall Study|Withdrawal by Subject|23
4376702|NCT02513394|7152910|FG000|Overall Study|Ineligible|1
4376703|NCT02513394|7152911|FG001|Overall Study|Ineligible|0
4376704|NCT03298867|7152959|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1
4376705|NCT03298867|7152960|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1
4376706|NCT03298867|7152959|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1
4376707|NCT03298867|7152960|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1
4376708|NCT03298867|7152959|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1
4376709|NCT03298867|7152960|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9
4376710|NCT03298867|7152959|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0
4376711|NCT03298867|7152960|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1
4376712|NCT03298867|7152959|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0
4376713|NCT03298867|7152960|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1
4376714|NCT03298867|7152959|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0
4376715|NCT03298867|7152960|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2
4376716|NCT03298867|7152959|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0
4376717|NCT03298867|7152960|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1
4376718|NCT03298867|7152959|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0
4376719|NCT03298867|7152960|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2
4376720|NCT03298867|7152959|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0
4376721|NCT03298867|7152960|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1
4376722|NCT03227224|7152970|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1
4376723|NCT03227224|7152971|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0
4376724|NCT03227224|7152972|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2
4376725|NCT03227224|7152973|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0
4376726|NCT03227224|7152970|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2
4376727|NCT03227224|7152971|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2
4376728|NCT03227224|7152972|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0
4376729|NCT03227224|7152973|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0
4376730|NCT03227224|7152970|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3
4376731|NCT03227224|7152971|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2
4376732|NCT03227224|7152972|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3
4376733|NCT03227224|7152973|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2
4376734|NCT03227224|7152970|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1
4376735|NCT03227224|7152971|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0
4376736|NCT03227224|7152972|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0
4376737|NCT03227224|7152973|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0
4376738|NCT03227224|7152970|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0
4376739|NCT03227224|7152971|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0
4376740|NCT03227224|7152972|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1
4376741|NCT03227224|7152973|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0
4376742|NCT03227224|7152970|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2
4376743|NCT03227224|7152971|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1
4376744|NCT03227224|7152972|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1
4376745|NCT03227224|7152973|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4
4376746|NCT03227224|7152970|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2
4376747|NCT03227224|7152971|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1
4376748|NCT03227224|7152972|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0
4376749|NCT03227224|7152973|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1
4376750|NCT03227224|7152970|FG000|Double-blind Treatment Period (6 Weeks)|Other|4
4376751|NCT03227224|7152971|FG001|Double-blind Treatment Period (6 Weeks)|Other|0
4376752|NCT03227224|7152972|FG002|Double-blind Treatment Period (6 Weeks)|Other|1
4376753|NCT03227224|7152973|FG003|Double-blind Treatment Period (6 Weeks)|Other|0
4376754|NCT03227224|7152970|FG000|Follow-up Phase (2 Weeks)|Other|4
4376755|NCT03227224|7152971|FG001|Follow-up Phase (2 Weeks)|Other|4
4376756|NCT03227224|7152972|FG002|Follow-up Phase (2 Weeks)|Other|6
4376757|NCT03227224|7152973|FG003|Follow-up Phase (2 Weeks)|Other|3
4376758|NCT03220581|7152992|FG000|Overall Study|Withdrawal by Subject|0
4376759|NCT03220581|7152993|FG001|Overall Study|Withdrawal by Subject|1
4376760|NCT03220581|7152992|FG000|Overall Study|Lost to Follow-up|3
4376761|NCT03220581|7152993|FG001|Overall Study|Lost to Follow-up|6
4376762|NCT02991482|7153007|FG000|Overall Study|Disease progression|56
4376763|NCT02991482|7153008|FG001|Overall Study|Disease progression|47
4376764|NCT02991482|7153007|FG000|Overall Study|Death|4
4376765|NCT02991482|7153008|FG001|Overall Study|Death|4
4376766|NCT02991482|7153007|FG000|Overall Study|Adverse Event|1
4587768|NCT01493960|7431977|FG001|Overall Study|Non-specified|4
4376767|NCT02991482|7153008|FG001|Overall Study|Adverse Event|6
4376768|NCT02991482|7153007|FG000|Overall Study|Patient decision|1
4376769|NCT02991482|7153008|FG001|Overall Study|Patient decision|1
4376770|NCT02991482|7153007|FG000|Overall Study|Physician Decision|0
4376771|NCT02991482|7153008|FG001|Overall Study|Physician Decision|6
4376772|NCT02991482|7153007|FG000|Overall Study|Clinical deterioration|1
4376773|NCT02991482|7153008|FG001|Overall Study|Clinical deterioration|0
4376774|NCT02991482|7153007|FG000|Overall Study|Patient feeling too unwell|1
4376775|NCT02991482|7153008|FG001|Overall Study|Patient feeling too unwell|0
4376776|NCT02991482|7153007|FG000|Overall Study|Worsening of performance status|0
4376777|NCT02991482|7153008|FG001|Overall Study|Worsening of performance status|1
4376778|NCT02991482|7153007|FG000|Overall Study|Death prior to study drug initiation|1
4376779|NCT02991482|7153008|FG001|Overall Study|Death prior to study drug initiation|0
4376780|NCT02991482|7153007|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0
4376781|NCT02991482|7153008|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1
4376782|NCT02768870|7153014|FG000|Overall Study|Not Implanted with Device|2
4376783|NCT02768870|7153014|FG000|Overall Study|Death|1
4376784|NCT02768870|7153014|FG000|Overall Study|Reoperation|4
4376785|NCT02768870|7153014|FG000|Overall Study|On Study|19
4376786|NCT02648698|7153020|FG000|Overall Study|Protocol Violation|1
4376787|NCT02648698|7153021|FG001|Overall Study|Protocol Violation|5
4376788|NCT02432196|7153027|FG000|Overall Study|Not Implanted with Device|1
4376789|NCT02432196|7153027|FG000|Overall Study|Death|2
4376790|NCT02432196|7153027|FG000|Overall Study|Reoperation|3
4376791|NCT02432196|7153027|FG000|Overall Study|On Study|20
4376792|NCT02000882|7153035|FG000|Overall Study|Adverse Event|3
4376793|NCT02000882|7153035|FG000|Overall Study|Physician Decision|2
4376794|NCT02000882|7153035|FG000|Overall Study|Withdrawal by Subject|1
4376795|NCT01642004|7153054|FG000|Randomization|Adverse Event unrelated to study drug|1
4376796|NCT01642004|7153055|FG001|Randomization|Adverse Event unrelated to study drug|0
4376797|NCT01642004|7153054|FG000|Randomization|Withdrawal by Subject|1
4376798|NCT01642004|7153055|FG001|Randomization|Withdrawal by Subject|6
4376799|NCT01642004|7153054|FG000|Randomization|No longer meets study criteria|2
4376800|NCT01642004|7153055|FG001|Randomization|No longer meets study criteria|2
4376801|NCT01642004|7153054|FG000|Treatment|Disease progression|88
4376802|NCT01642004|7153055|FG001|Treatment|Disease progression|80
4376803|NCT01642004|7153054|FG000|Treatment|Study drug toxicity|5
4376804|NCT01642004|7153055|FG001|Treatment|Study drug toxicity|13
4376805|NCT01642004|7153054|FG000|Treatment|Death|1
4376806|NCT01642004|7153055|FG001|Treatment|Death|0
4376807|NCT01642004|7153054|FG000|Treatment|Adverse event unrelated to study drug|6
4376808|NCT01642004|7153055|FG001|Treatment|Adverse event unrelated to study drug|13
4376809|NCT01642004|7153054|FG000|Treatment|Withdrawal by Subject|5
4376810|NCT01642004|7153055|FG001|Treatment|Withdrawal by Subject|9
4376811|NCT01642004|7153054|FG000|Treatment|Maximum clinical benefit|2
4376812|NCT01642004|7153055|FG001|Treatment|Maximum clinical benefit|7
4376813|NCT01642004|7153054|FG000|Treatment|Poor/non-compliance|1
4376814|NCT01642004|7153055|FG001|Treatment|Poor/non-compliance|0
4376815|NCT01642004|7153054|FG000|Treatment|No longer meets study criteria|1
4466188|NCT00615030|7257816|FG008|Period I|Subject withdrew consent|1
4466189|NCT00615030|7257817|FG009|Period I|Subject withdrew consent|0
4466190|NCT00615030|7257818|FG010|Period I|Subject withdrew consent|1
4466191|NCT00615030|7257819|FG011|Period I|Subject withdrew consent|1
4466192|NCT00615030|7257808|FG000|Period I|Abnormal laboratory value(s)|0
4466193|NCT00615030|7257809|FG001|Period I|Abnormal laboratory value(s)|0
4466194|NCT00615030|7257810|FG002|Period I|Abnormal laboratory value(s)|0
4466195|NCT00615030|7257811|FG003|Period I|Abnormal laboratory value(s)|0
4466196|NCT00615030|7257812|FG004|Period I|Abnormal laboratory value(s)|0
4466197|NCT00615030|7257813|FG005|Period I|Abnormal laboratory value(s)|1
4466198|NCT00615030|7257814|FG006|Period I|Abnormal laboratory value(s)|0
4466199|NCT00615030|7257815|FG007|Period I|Abnormal laboratory value(s)|0
4466200|NCT00615030|7257816|FG008|Period I|Abnormal laboratory value(s)|0
4466201|NCT00615030|7257817|FG009|Period I|Abnormal laboratory value(s)|0
4466202|NCT00615030|7257818|FG010|Period I|Abnormal laboratory value(s)|0
4466203|NCT00615030|7257819|FG011|Period I|Abnormal laboratory value(s)|0
4466204|NCT00615030|7257808|FG000|Period II|Adverse Event|0
4466205|NCT00615030|7257809|FG001|Period II|Adverse Event|0
4466206|NCT00615030|7257810|FG002|Period II|Adverse Event|1
4466207|NCT00615030|7257811|FG003|Period II|Adverse Event|0
4466208|NCT00615030|7257812|FG004|Period II|Adverse Event|0
4466209|NCT00615030|7257813|FG005|Period II|Adverse Event|0
4466210|NCT00615030|7257814|FG006|Period II|Adverse Event|0
4466211|NCT00615030|7257815|FG007|Period II|Adverse Event|0
4466212|NCT00615030|7257816|FG008|Period II|Adverse Event|1
4466213|NCT00615030|7257817|FG009|Period II|Adverse Event|0
4466214|NCT00615030|7257818|FG010|Period II|Adverse Event|0
4466215|NCT00615030|7257819|FG011|Period II|Adverse Event|0
4466216|NCT00615030|7257808|FG000|Period II|Subject withdrew consent|0
4466217|NCT00615030|7257809|FG001|Period II|Subject withdrew consent|0
4466218|NCT00615030|7257810|FG002|Period II|Subject withdrew consent|0
4466219|NCT00615030|7257811|FG003|Period II|Subject withdrew consent|1
4466220|NCT00615030|7257812|FG004|Period II|Subject withdrew consent|0
4466221|NCT00615030|7257813|FG005|Period II|Subject withdrew consent|0
4466222|NCT00615030|7257814|FG006|Period II|Subject withdrew consent|1
4466223|NCT00615030|7257815|FG007|Period II|Subject withdrew consent|0
4466224|NCT00615030|7257816|FG008|Period II|Subject withdrew consent|0
4376816|NCT01642004|7153055|FG001|Treatment|No longer meets study criteria|2
4376817|NCT01642004|7153054|FG000|Treatment|Other|1
4376818|NCT01642004|7153055|FG001|Treatment|Other|2
4376819|NCT01642004|7153054|FG000|Treatment|Missing from data|0
4376820|NCT01642004|7153055|FG001|Treatment|Missing from data|1
4376821|NCT01366092|7153061|FG000|Overall Study|Progressive cGVHD|2
4376822|NCT01366092|7153061|FG000|Overall Study|Physician Decision|1
4376823|NCT01366092|7153061|FG000|Overall Study|Withdrawal by Subject|1
4376824|NCT01326104|7153067|FG000|Overall Study|progressed prior to vaccine|0
4376825|NCT01326104|7153068|FG001|Overall Study|progressed prior to vaccine|2
4376826|NCT01326104|7153067|FG000|Overall Study|unable to make vaccine|0
4376827|NCT01326104|7153068|FG001|Overall Study|unable to make vaccine|2
4376828|NCT01244815|7153078|FG000|Overall Study|Not Treated|0
4376829|NCT01244815|7153079|FG001|Overall Study|Not Treated|1
4376830|NCT01244815|7153080|FG002|Overall Study|Not Treated|0
4376831|NCT01244815|7153081|FG003|Overall Study|Not Treated|0
4376832|NCT01244815|7153078|FG000|Overall Study|Adverse Event|4
4376833|NCT01244815|7153079|FG001|Overall Study|Adverse Event|7
4376834|NCT01244815|7153080|FG002|Overall Study|Adverse Event|5
4376835|NCT01244815|7153081|FG003|Overall Study|Adverse Event|5
4376836|NCT01244815|7153078|FG000|Overall Study|Treatment Failure|0
4376837|NCT01244815|7153079|FG001|Overall Study|Treatment Failure|0
4376838|NCT01244815|7153080|FG002|Overall Study|Treatment Failure|0
4376839|NCT01244815|7153081|FG003|Overall Study|Treatment Failure|1
4376840|NCT01244815|7153078|FG000|Overall Study|Lost to Follow-up|3
4376841|NCT01244815|7153079|FG001|Overall Study|Lost to Follow-up|2
4376842|NCT01244815|7153080|FG002|Overall Study|Lost to Follow-up|3
4376843|NCT01244815|7153081|FG003|Overall Study|Lost to Follow-up|2
4376844|NCT01244815|7153078|FG000|Overall Study|Withdrawal by Subject|0
4376845|NCT01244815|7153079|FG001|Overall Study|Withdrawal by Subject|2
4376846|NCT01244815|7153080|FG002|Overall Study|Withdrawal by Subject|0
4376847|NCT01244815|7153081|FG003|Overall Study|Withdrawal by Subject|3
4376848|NCT01244815|7153078|FG000|Overall Study|Protocol Violation|7
4376849|NCT01244815|7153079|FG001|Overall Study|Protocol Violation|4
4376850|NCT01244815|7153080|FG002|Overall Study|Protocol Violation|3
4376851|NCT01244815|7153081|FG003|Overall Study|Protocol Violation|1
4376852|NCT01244815|7153078|FG000|Overall Study|Did Not Meet Protocol Eligibility|0
4376853|NCT01244815|7153079|FG001|Overall Study|Did Not Meet Protocol Eligibility|1
4376854|NCT01244815|7153080|FG002|Overall Study|Did Not Meet Protocol Eligibility|0
4376855|NCT01244815|7153081|FG003|Overall Study|Did Not Meet Protocol Eligibility|0
4376856|NCT01142596|7153093|FG000|Overall Study|Withdrawal by Subject|9
4376857|NCT01142596|7153094|FG001|Overall Study|Withdrawal by Subject|35
4376858|NCT01142596|7153093|FG000|Overall Study|Adverse Event|8
4376859|NCT01142596|7153094|FG001|Overall Study|Adverse Event|35
4376860|NCT01142596|7153093|FG000|Overall Study|Lack of Efficacy|5
4376861|NCT01142596|7153094|FG001|Overall Study|Lack of Efficacy|9
4376862|NCT01142596|7153093|FG000|Overall Study|Lost to Follow-up|2
4376863|NCT01142596|7153094|FG001|Overall Study|Lost to Follow-up|3
4376864|NCT01142596|7153093|FG000|Overall Study|Other reason (not specified)|5
4376865|NCT01142596|7153094|FG001|Overall Study|Other reason (not specified)|4
4376866|NCT01098110|7153103|FG000|Overall Study|Withdrawal by Subject|14
4376867|NCT01098110|7153104|FG001|Overall Study|Withdrawal by Subject|24
4376868|NCT01098110|7153105|FG002|Overall Study|Withdrawal by Subject|19
4376869|NCT01098110|7153103|FG000|Overall Study|Adverse Event|30
4376870|NCT01098110|7153104|FG001|Overall Study|Adverse Event|32
4376871|NCT01098110|7153105|FG002|Overall Study|Adverse Event|43
4376872|NCT01098110|7153103|FG000|Overall Study|Lack of Efficacy|13
4376873|NCT01098110|7153104|FG001|Overall Study|Lack of Efficacy|9
4376874|NCT01098110|7153105|FG002|Overall Study|Lack of Efficacy|27
4376875|NCT01098110|7153103|FG000|Overall Study|Other|4
4376876|NCT01098110|7153104|FG001|Overall Study|Other|7
4376877|NCT01098110|7153105|FG002|Overall Study|Other|5
4376878|NCT01098110|7153103|FG000|Overall Study|Untreated|1
4376879|NCT01098110|7153104|FG001|Overall Study|Untreated|1
4376880|NCT01098110|7153105|FG002|Overall Study|Untreated|0
4376881|NCT01006265|7153117|FG000|Overall Study|Lost to Follow-up|1
4376882|NCT01006265|7153118|FG001|Overall Study|Lost to Follow-up|0
4376883|NCT01006265|7153119|FG002|Overall Study|Lost to Follow-up|1
4376884|NCT01006265|7153120|FG003|Overall Study|Lost to Follow-up|0
4376885|NCT01006265|7153117|FG000|Overall Study|Withdrawal by Subject|4
4376886|NCT01006265|7153118|FG001|Overall Study|Withdrawal by Subject|7
4376887|NCT01006265|7153119|FG002|Overall Study|Withdrawal by Subject|5
4376888|NCT01006265|7153120|FG003|Overall Study|Withdrawal by Subject|5
4376889|NCT01006265|7153117|FG000|Overall Study|Administrative reason|1
4376890|NCT01006265|7153118|FG001|Overall Study|Administrative reason|2
4376891|NCT01006265|7153119|FG002|Overall Study|Administrative reason|3
4376892|NCT01006265|7153120|FG003|Overall Study|Administrative reason|0
4466225|NCT00615030|7257817|FG009|Period II|Subject withdrew consent|0
4466226|NCT00615030|7257818|FG010|Period II|Subject withdrew consent|0
4466227|NCT00615030|7257819|FG011|Period II|Subject withdrew consent|0
4466228|NCT00615030|7257808|FG000|Period III|Administrative problems|1
4466229|NCT00615030|7257809|FG001|Period III|Administrative problems|0
4466230|NCT00615030|7257810|FG002|Period III|Administrative problems|0
4466231|NCT00615030|7257811|FG003|Period III|Administrative problems|1
4466232|NCT00615030|7257812|FG004|Period III|Administrative problems|0
4770865|NCT01986933|7747290|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2
4770866|NCT01986933|7747291|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1
4770867|NCT01986933|7747287|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5
4770868|NCT01986933|7747288|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2
4770869|NCT01986933|7747289|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6
4770870|NCT01986933|7747290|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2
4770871|NCT01986933|7747291|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7
4770872|NCT01986933|7747287|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0
4770873|NCT01986933|7747288|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1
4770874|NCT01986933|7747289|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0
4770875|NCT01986933|7747290|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1
4770876|NCT01986933|7747291|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0
4770877|NCT01986933|7747287|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0
4770878|NCT01986933|7747288|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0
4770879|NCT01986933|7747289|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0
4770880|NCT01986933|7747290|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0
4770881|NCT01986933|7747291|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2
4770882|NCT01986933|7747287|FG000|Active-to-active (Part B)|Adverse Event|0
4770883|NCT01986933|7747288|FG001|Active-to-active (Part B)|Adverse Event|2
4770884|NCT01986933|7747289|FG002|Active-to-active (Part B)|Adverse Event|0
4770885|NCT01986933|7747290|FG003|Active-to-active (Part B)|Adverse Event|1
4770886|NCT01986933|7747291|FG004|Active-to-active (Part B)|Adverse Event|3
4770887|NCT01986933|7747287|FG000|Active-to-active (Part B)|Lack of Efficacy|0
4770888|NCT01986933|7747288|FG001|Active-to-active (Part B)|Lack of Efficacy|3
4695912|NCT02630563|7608502|FG000|Overall Study|Administrative|1
4695913|NCT02630693|7608509|FG000|Overall Study|No receive treatment|0
4695914|NCT02630693|7608510|FG001|Overall Study|No receive treatment|1
4695915|NCT02630706|7608519|FG000|Overall Study|Adverse Event|2
4695916|NCT02630706|7608520|FG001|Overall Study|Adverse Event|1
4695917|NCT02630706|7608521|FG002|Overall Study|Adverse Event|1
4695918|NCT02630706|7608519|FG000|Overall Study|Lost to Follow-up|0
4695919|NCT02630706|7608520|FG001|Overall Study|Lost to Follow-up|1
4695920|NCT02630706|7608521|FG002|Overall Study|Lost to Follow-up|2
4695921|NCT02630706|7608519|FG000|Overall Study|Physician Decision|1
4695922|NCT02630706|7608520|FG001|Overall Study|Physician Decision|1
4695923|NCT02630706|7608521|FG002|Overall Study|Physician Decision|0
4695924|NCT02630706|7608519|FG000|Overall Study|Pregnancy|0
4695925|NCT02630706|7608520|FG001|Overall Study|Pregnancy|1
4695926|NCT02630706|7608521|FG002|Overall Study|Pregnancy|0
4695927|NCT02630706|7608519|FG000|Overall Study|Withdrawal by Subject|4
4695928|NCT02630706|7608520|FG001|Overall Study|Withdrawal by Subject|5
4695929|NCT02630706|7608521|FG002|Overall Study|Withdrawal by Subject|7
4695930|NCT02630966|7608549|FG000|Overall Study|Adverse Event|1
4695931|NCT02630966|7608550|FG001|Overall Study|Adverse Event|3
4695932|NCT02630966|7608549|FG000|Overall Study|Significant Protocol Deviation|0
4695933|NCT02630966|7608550|FG001|Overall Study|Significant Protocol Deviation|2
4695934|NCT02630966|7608549|FG000|Overall Study|Voluntary Withdrawal|1
4695935|NCT02630966|7608550|FG001|Overall Study|Voluntary Withdrawal|1
4695936|NCT02630966|7608549|FG000|Overall Study|Lack of Efficacy|0
4695937|NCT02630966|7608550|FG001|Overall Study|Lack of Efficacy|2
4695938|NCT02631538|7608582|FG000|Treatment Period (Up to Week 52)|Adverse Event|1
4695939|NCT02631538|7608583|FG001|Treatment Period (Up to Week 52)|Adverse Event|5
4695940|NCT02631538|7608584|FG002|Treatment Period (Up to Week 52)|Adverse Event|2
4695941|NCT02631538|7608585|FG003|Treatment Period (Up to Week 52)|Adverse Event|2
4695942|NCT02631538|7608582|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1
4695943|NCT02631538|7608583|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1
4695944|NCT02631538|7608584|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2
4376893|NCT00534976|7153142|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0
4376894|NCT00534976|7153143|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1
4466233|NCT00615030|7257813|FG005|Period III|Administrative problems|0
4587769|NCT01494038|7431985|FG000|Overall Study|Protocol Violation|1
4587770|NCT01494038|7431986|FG001|Overall Study|Protocol Violation|1
4587771|NCT01494038|7431985|FG000|Overall Study|Lost to Follow-up|18
4587772|NCT01494038|7431986|FG001|Overall Study|Lost to Follow-up|20
4587773|NCT01494038|7431985|FG000|Overall Study|Withdrawal by Subject|44
4587774|NCT01494038|7431986|FG001|Overall Study|Withdrawal by Subject|34
4587775|NCT01494038|7431985|FG000|Overall Study|Not able to get to clinic|21
4587776|NCT01494038|7431986|FG001|Overall Study|Not able to get to clinic|15
4587777|NCT01494038|7431985|FG000|Overall Study|Not willing to adhere to reqs|2
4587778|NCT01494038|7431986|FG001|Overall Study|Not willing to adhere to reqs|9
4695945|NCT02631538|7608585|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5
4695946|NCT02631538|7608582|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1
4695947|NCT02631538|7608583|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1
4695948|NCT02631538|7608584|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0
4695949|NCT02631538|7608585|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0
4695950|NCT02631538|7608582|FG000|Treatment Period (Up to Week 52)|Physician Decision|1
4770889|NCT01986933|7747289|FG002|Active-to-active (Part B)|Lack of Efficacy|2
4770890|NCT01986933|7747290|FG003|Active-to-active (Part B)|Lack of Efficacy|0
4587779|NCT01494038|7431985|FG000|Overall Study|Death|2
4587780|NCT01494038|7431986|FG001|Overall Study|Death|4
4587781|NCT01494298|7432018|FG000|Overall Study|Protocol Violation|2
4587782|NCT01494298|7432019|FG001|Overall Study|Protocol Violation|8
4587783|NCT01494350|7432027|FG000|Overall Study|Worsening of lesion|1
4587784|NCT01494467|7432033|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1
4587785|NCT01494467|7432034|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0
4587786|NCT01494467|7432033|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6
4587787|NCT01494467|7432034|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4
4587788|NCT01494467|7432033|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9
4587789|NCT01494467|7432034|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8
4587790|NCT01494467|7432033|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4
4587791|NCT01494467|7432034|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0
4587792|NCT01494467|7432033|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
4587793|NCT01494467|7432034|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
4587794|NCT01494467|7432033|FG000|Part A Vehicle Control (12 Weeks)|Other|1
4587795|NCT01494467|7432034|FG001|Part A Vehicle Control (12 Weeks)|Other|1
4587796|NCT01494467|7432033|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1
4587797|NCT01494467|7432034|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0
4587798|NCT01494467|7432033|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2
4587799|NCT01494467|7432034|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0
4587800|NCT01494467|7432033|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1
4587801|NCT01494467|7432034|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3
4587802|NCT01494467|7432033|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3
4376895|NCT00534976|7153142|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1
4376896|NCT00534976|7153143|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0
4376897|NCT00534976|7153142|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1
4376898|NCT00534976|7153143|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0
4376899|NCT00337675|7153152|FG000|Overall Study|Adverse Event|10
4376900|NCT00337675|7153153|FG001|Overall Study|Adverse Event|9
4376901|NCT00337675|7153154|FG002|Overall Study|Adverse Event|19
4376902|NCT00337675|7153152|FG000|Overall Study|Lack of Efficacy|10
4376903|NCT00337675|7153153|FG001|Overall Study|Lack of Efficacy|7
4376904|NCT00337675|7153154|FG002|Overall Study|Lack of Efficacy|9
4376905|NCT00337675|7153152|FG000|Overall Study|Lost to Follow-up|22
4376906|NCT00337675|7153153|FG001|Overall Study|Lost to Follow-up|19
4376907|NCT00337675|7153154|FG002|Overall Study|Lost to Follow-up|17
4376908|NCT00337675|7153152|FG000|Overall Study|Physician Decision|9
4376909|NCT00337675|7153153|FG001|Overall Study|Physician Decision|17
4376910|NCT00337675|7153154|FG002|Overall Study|Physician Decision|14
4376911|NCT00337675|7153152|FG000|Overall Study|Protocol Violation|21
4376912|NCT00337675|7153153|FG001|Overall Study|Protocol Violation|24
4376913|NCT00337675|7153154|FG002|Overall Study|Protocol Violation|19
4376914|NCT00337675|7153152|FG000|Overall Study|Withdrawal by Subject|25
4376915|NCT00337675|7153153|FG001|Overall Study|Withdrawal by Subject|25
4376916|NCT00337675|7153154|FG002|Overall Study|Withdrawal by Subject|19
4376917|NCT00337675|7153152|FG000|Overall Study|Progressive Disease|0
4376918|NCT00337675|7153153|FG001|Overall Study|Progressive Disease|2
4376919|NCT00337675|7153154|FG002|Overall Study|Progressive Disease|0
4376920|NCT00337675|7153152|FG000|Overall Study|Trial Terminated|0
4376921|NCT00337675|7153153|FG001|Overall Study|Trial Terminated|0
4376922|NCT00337675|7153154|FG002|Overall Study|Trial Terminated|2
4376923|NCT00317772|7153166|FG000|Overall Study|Adverse Event|0
4376924|NCT00317772|7153167|FG001|Overall Study|Adverse Event|0
4376925|NCT00317772|7153168|FG002|Overall Study|Adverse Event|0
4376926|NCT00317772|7153169|FG003|Overall Study|Adverse Event|2
4376927|NCT00317772|7153166|FG000|Overall Study|Disease Progression|2
4376928|NCT00317772|7153167|FG001|Overall Study|Disease Progression|2
4376929|NCT00317772|7153168|FG002|Overall Study|Disease Progression|1
4376930|NCT00317772|7153169|FG003|Overall Study|Disease Progression|7
4376931|NCT00291486|7153185|FG000|Overall Study|Adverse Event|0
4376932|NCT00291486|7153186|FG001|Overall Study|Adverse Event|3
4376933|NCT00291486|7153187|FG002|Overall Study|Adverse Event|0
4376934|NCT00291486|7153188|FG003|Overall Study|Adverse Event|1
4376935|NCT00291486|7153189|FG004|Overall Study|Adverse Event|0
4376936|NCT00291486|7153185|FG000|Overall Study|Withdrawal by Subject|0
4376937|NCT00291486|7153186|FG001|Overall Study|Withdrawal by Subject|0
4376938|NCT00291486|7153187|FG002|Overall Study|Withdrawal by Subject|0
4376939|NCT00291486|7153188|FG003|Overall Study|Withdrawal by Subject|0
4376940|NCT00291486|7153189|FG004|Overall Study|Withdrawal by Subject|1
4376941|NCT00291486|7153185|FG000|Overall Study|Disease progression|1
4376942|NCT00291486|7153186|FG001|Overall Study|Disease progression|0
4376943|NCT00291486|7153187|FG002|Overall Study|Disease progression|1
4376944|NCT00291486|7153188|FG003|Overall Study|Disease progression|0
4376945|NCT00291486|7153189|FG004|Overall Study|Disease progression|0
4376946|NCT00284856|7153213|FG000|Overall Study|Adverse Event|3
4376947|NCT00284856|7153214|FG001|Overall Study|Adverse Event|3
4587803|NCT01494467|7432034|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5
4587804|NCT01494467|7432033|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32
4587805|NCT01494467|7432034|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24
4376948|NCT00284856|7153215|FG002|Overall Study|Adverse Event|3
4376949|NCT00284856|7153213|FG000|Overall Study|Lack of Efficacy|2
4376950|NCT00284856|7153214|FG001|Overall Study|Lack of Efficacy|1
4376951|NCT00284856|7153215|FG002|Overall Study|Lack of Efficacy|8
4376952|NCT00284856|7153213|FG000|Overall Study|Lost to Follow-up|25
4376953|NCT00284856|7153214|FG001|Overall Study|Lost to Follow-up|21
4376954|NCT00284856|7153215|FG002|Overall Study|Lost to Follow-up|22
4376955|NCT00284856|7153213|FG000|Overall Study|Protocol Violation|5
4376956|NCT00284856|7153214|FG001|Overall Study|Protocol Violation|4
4376957|NCT00284856|7153215|FG002|Overall Study|Protocol Violation|5
4376958|NCT00284856|7153213|FG000|Overall Study|Withdrawal by Subject|12
4376959|NCT00284856|7153214|FG001|Overall Study|Withdrawal by Subject|16
4376960|NCT00284856|7153215|FG002|Overall Study|Withdrawal by Subject|18
4376961|NCT00284856|7153213|FG000|Overall Study|Other|4
4376962|NCT00284856|7153214|FG001|Overall Study|Other|5
4376963|NCT00284856|7153215|FG002|Overall Study|Other|4
4376964|NCT00070707|7153225|FG000|Overall Study|Adverse Event|1
4376965|NCT00070707|7153226|FG001|Overall Study|Adverse Event|2
4376966|NCT00070707|7153225|FG000|Overall Study|Lack of Efficacy|4
4376967|NCT00070707|7153226|FG001|Overall Study|Lack of Efficacy|1
4376968|NCT00070707|7153225|FG000|Overall Study|Protocol Violation|8
4376969|NCT00070707|7153226|FG001|Overall Study|Protocol Violation|4
4376970|NCT00070707|7153225|FG000|Overall Study|Unrelated to Study Medication|1
4376971|NCT00070707|7153226|FG001|Overall Study|Unrelated to Study Medication|0
4466234|NCT00615030|7257814|FG006|Period III|Administrative problems|0
4466235|NCT00615030|7257815|FG007|Period III|Administrative problems|0
4466236|NCT00615030|7257816|FG008|Period III|Administrative problems|0
4466237|NCT00615030|7257817|FG009|Period III|Administrative problems|0
4466238|NCT00615030|7257818|FG010|Period III|Administrative problems|0
4466239|NCT00615030|7257819|FG011|Period III|Administrative problems|0
4466240|NCT00615056|7257837|FG000|Overall Study|Death|31
4466241|NCT00615056|7257838|FG001|Overall Study|Death|31
4466242|NCT00615056|7257839|FG002|Overall Study|Death|21
4466243|NCT00615056|7257840|FG003|Overall Study|Death|23
4466244|NCT00615056|7257837|FG000|Overall Study|Lost to Follow-up|1
4466245|NCT00615056|7257838|FG001|Overall Study|Lost to Follow-up|2
4466246|NCT00615056|7257839|FG002|Overall Study|Lost to Follow-up|4
4466247|NCT00615056|7257840|FG003|Overall Study|Lost to Follow-up|5
4466248|NCT00615056|7257837|FG000|Overall Study|Other|13
4466249|NCT00615056|7257838|FG001|Overall Study|Other|15
4466250|NCT00615056|7257839|FG002|Overall Study|Other|10
4466251|NCT00615056|7257840|FG003|Overall Study|Other|7
4466252|NCT00615056|7257837|FG000|Overall Study|Objective progression or relapse|0
4466253|NCT00615056|7257838|FG001|Overall Study|Objective progression or relapse|2
4466254|NCT00615056|7257839|FG002|Overall Study|Objective progression or relapse|0
4466255|NCT00615056|7257840|FG003|Overall Study|Objective progression or relapse|0
4466256|NCT00615056|7257837|FG000|Overall Study|Withdrawal by Subject|0
4466257|NCT00615056|7257838|FG001|Overall Study|Withdrawal by Subject|1
4466258|NCT00615056|7257839|FG002|Overall Study|Withdrawal by Subject|1
4466259|NCT00615056|7257840|FG003|Overall Study|Withdrawal by Subject|0
4466260|NCT00615056|7257837|FG000|Overall Study|Discontinued by Sponsor|1
4466261|NCT00615056|7257838|FG001|Overall Study|Discontinued by Sponsor|0
4466262|NCT00615056|7257839|FG002|Overall Study|Discontinued by Sponsor|0
4466263|NCT00615056|7257840|FG003|Overall Study|Discontinued by Sponsor|0
4466264|NCT00615056|7257837|FG000|Overall Study|Randomized but not treated|3
4466265|NCT00615056|7257838|FG001|Overall Study|Randomized but not treated|0
4466266|NCT00615056|7257839|FG002|Overall Study|Randomized but not treated|0
4466267|NCT00615056|7257840|FG003|Overall Study|Randomized but not treated|0
4466268|NCT00615069|7257850|FG000|Overall Study|Death|10
4466269|NCT00615069|7257850|FG000|Overall Study|Physician Decision|2
4466270|NCT00615069|7257850|FG000|Overall Study|Withdrawal by Subject|4
4466271|NCT00615108|7257854|FG000|Overall Study|Adverse Event|122
4466272|NCT00615108|7257854|FG000|Overall Study|Other|370
4466273|NCT00615108|7257854|FG000|Overall Study|Lost to Follow-up|15
4466274|NCT00615199|7257864|FG000|Overall Study|Adverse Event|3
4466275|NCT00615199|7257865|FG001|Overall Study|Adverse Event|1
4466276|NCT00615199|7257866|FG002|Overall Study|Adverse Event|1
4466277|NCT00615199|7257867|FG003|Overall Study|Adverse Event|0
4466278|NCT00615199|7257864|FG000|Overall Study|Lack of Efficacy|2
4466279|NCT00615199|7257865|FG001|Overall Study|Lack of Efficacy|0
4466280|NCT00615199|7257866|FG002|Overall Study|Lack of Efficacy|0
4466281|NCT00615199|7257867|FG003|Overall Study|Lack of Efficacy|1
4466282|NCT00615199|7257864|FG000|Overall Study|Lost to Follow-up|1
4466283|NCT00615199|7257865|FG001|Overall Study|Lost to Follow-up|0
4466284|NCT00615199|7257866|FG002|Overall Study|Lost to Follow-up|0
4466285|NCT00615199|7257867|FG003|Overall Study|Lost to Follow-up|0
4466286|NCT00615199|7257864|FG000|Overall Study|Other|0
4466287|NCT00615199|7257865|FG001|Overall Study|Other|0
4466288|NCT00615199|7257866|FG002|Overall Study|Other|0
4466289|NCT00615199|7257867|FG003|Overall Study|Other|1
4466290|NCT00615199|7257864|FG000|Overall Study|Withdrawal by Subject|2
4466291|NCT00615199|7257865|FG001|Overall Study|Withdrawal by Subject|1
4466292|NCT00615199|7257866|FG002|Overall Study|Withdrawal by Subject|0
4466293|NCT00615199|7257867|FG003|Overall Study|Withdrawal by Subject|0
4466294|NCT00615264|7257879|FG000|Overall Study|Withdrawal by Subject|17
4466295|NCT00615264|7257880|FG001|Overall Study|Withdrawal by Subject|19
4466296|NCT00615264|7257879|FG000|Overall Study|Lost to Follow-up|6
4376972|NCT05096312|7153254|FG000|Overall Study|Lost to Follow-up|2
4376973|NCT05096312|7153255|FG001|Overall Study|Lost to Follow-up|4
4376974|NCT05096312|7153254|FG000|Overall Study|Adverse Event|1
4376975|NCT05096312|7153255|FG001|Overall Study|Adverse Event|0
4376976|NCT03560258|7153264|FG000|Overall Study|Lost to Follow-up|3
4376977|NCT03560258|7153265|FG001|Overall Study|Lost to Follow-up|0
4376978|NCT03560258|7153266|FG002|Overall Study|Lost to Follow-up|0
4376979|NCT03560258|7153264|FG000|Overall Study|Protocol Violation|0
4376980|NCT03560258|7153265|FG001|Overall Study|Protocol Violation|1
4376981|NCT03560258|7153266|FG002|Overall Study|Protocol Violation|0
4376982|NCT03560258|7153264|FG000|Overall Study|Withdrawal by Subject|0
4376983|NCT03560258|7153265|FG001|Overall Study|Withdrawal by Subject|0
4376984|NCT03560258|7153266|FG002|Overall Study|Withdrawal by Subject|1
4376985|NCT04528641|7153289|FG000|Overall Study|Withdrawal by Subject|0
4376986|NCT04528641|7153290|FG001|Overall Study|Withdrawal by Subject|0
4376987|NCT04528641|7153291|FG002|Overall Study|Withdrawal by Subject|0
4376988|NCT04528641|7153292|FG003|Overall Study|Withdrawal by Subject|1
4587806|NCT01494467|7432033|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3
4587807|NCT01494467|7432034|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5
4587808|NCT01494467|7432033|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26
4376989|NCT04528641|7153293|FG004|Overall Study|Withdrawal by Subject|0
4376990|NCT04528641|7153294|FG005|Overall Study|Withdrawal by Subject|1
4376991|NCT04034238|7153330|FG000|Dose Escalation Phase|Withdrawal by Subject|1
4376992|NCT04034238|7153331|FG001|Dose Escalation Phase|Withdrawal by Subject|0
4376993|NCT04034238|7153332|FG002|Dose Escalation Phase|Withdrawal by Subject|0
4376994|NCT04034238|7153333|FG003|Dose Escalation Phase|Withdrawal by Subject|0
4376995|NCT04034238|7153330|FG000|Dose Escalation Phase|Screen failures|0
4376996|NCT04034238|7153331|FG001|Dose Escalation Phase|Screen failures|0
4376997|NCT04034238|7153332|FG002|Dose Escalation Phase|Screen failures|0
4376998|NCT04034238|7153333|FG003|Dose Escalation Phase|Screen failures|2
4376999|NCT04034238|7153330|FG000|Dose Expansion Phase|Not treated due to study hold.|0
4377000|NCT04034238|7153331|FG001|Dose Expansion Phase|Not treated due to study hold.|0
4377001|NCT04034238|7153332|FG002|Dose Expansion Phase|Not treated due to study hold.|0
4377002|NCT04034238|7153333|FG003|Dose Expansion Phase|Not treated due to study hold.|1
4377003|NCT04034238|7153330|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0
4377004|NCT04034238|7153331|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0
4377005|NCT04034238|7153332|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1
4377006|NCT04034238|7153333|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0
4377007|NCT03984305|7153346|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19
4377008|NCT03984305|7153347|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15
4377009|NCT03984305|7153346|FG000|Overall Study|Withdrawal by Subject|3
4377010|NCT03984305|7153347|FG001|Overall Study|Withdrawal by Subject|3
4377011|NCT03984305|7153346|FG000|Overall Study|Lost to Follow-up|1
4377012|NCT03984305|7153347|FG001|Overall Study|Lost to Follow-up|0
4377013|NCT03982368|7153356|FG000|Overall Study|Adverse Event|6
4377014|NCT03982368|7153357|FG001|Overall Study|Adverse Event|4
4377015|NCT03982368|7153358|FG002|Overall Study|Adverse Event|3
4377016|NCT03982368|7153356|FG000|Overall Study|Lost to Follow-up|2
4377017|NCT03982368|7153357|FG001|Overall Study|Lost to Follow-up|1
4377018|NCT03982368|7153358|FG002|Overall Study|Lost to Follow-up|0
4377019|NCT03982368|7153356|FG000|Overall Study|Withdrawal by Subject|1
4377020|NCT03982368|7153357|FG001|Overall Study|Withdrawal by Subject|2
4377021|NCT03982368|7153358|FG002|Overall Study|Withdrawal by Subject|0
4377022|NCT03982368|7153356|FG000|Overall Study|unknow|4
4377023|NCT03982368|7153357|FG001|Overall Study|unknow|0
4377024|NCT03982368|7153358|FG002|Overall Study|unknow|2
4377025|NCT03952143|7153371|FG000|Lead-In Period|Adverse Event|2
4377026|NCT03952143|7153372|FG001|Lead-In Period|Adverse Event|0
4377027|NCT03952143|7153373|FG002|Lead-In Period|Adverse Event|0
4377028|NCT03952143|7153371|FG000|Lead-In Period|Lack of Efficacy|2
4377029|NCT03952143|7153372|FG001|Lead-In Period|Lack of Efficacy|0
4377030|NCT03952143|7153373|FG002|Lead-In Period|Lack of Efficacy|0
4377031|NCT03952143|7153371|FG000|Lead-In Period|Physician Decision|5
4377032|NCT03952143|7153372|FG001|Lead-In Period|Physician Decision|0
4377033|NCT03952143|7153373|FG002|Lead-In Period|Physician Decision|0
4377034|NCT03952143|7153371|FG000|Lead-In Period|Protocol Violation|5
4377035|NCT03952143|7153372|FG001|Lead-In Period|Protocol Violation|0
4377036|NCT03952143|7153373|FG002|Lead-In Period|Protocol Violation|0
4377037|NCT03952143|7153371|FG000|Lead-In Period|Withdrawal by Subject|19
4377038|NCT03952143|7153372|FG001|Lead-In Period|Withdrawal by Subject|0
4377039|NCT03952143|7153373|FG002|Lead-In Period|Withdrawal by Subject|0
4377040|NCT03952143|7153371|FG000|Treatment Period|Adverse Event|0
4587809|NCT01494467|7432034|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10
4593593|NCT01553591|7442151|FG001|Overall Study|Protocol Violation|4
4377041|NCT03952143|7153372|FG001|Treatment Period|Adverse Event|0
4377042|NCT03952143|7153373|FG002|Treatment Period|Adverse Event|1
4377043|NCT03952143|7153371|FG000|Treatment Period|Lost to Follow-up|0
4377044|NCT03952143|7153372|FG001|Treatment Period|Lost to Follow-up|2
4377045|NCT03952143|7153373|FG002|Treatment Period|Lost to Follow-up|0
4377046|NCT03952143|7153371|FG000|Treatment Period|Physician Decision|0
4377047|NCT03952143|7153372|FG001|Treatment Period|Physician Decision|0
4377048|NCT03952143|7153373|FG002|Treatment Period|Physician Decision|2
4377049|NCT03952143|7153371|FG000|Treatment Period|Protocol Violation|0
4377050|NCT03952143|7153372|FG001|Treatment Period|Protocol Violation|0
4377051|NCT03952143|7153373|FG002|Treatment Period|Protocol Violation|1
4377052|NCT03952143|7153371|FG000|Treatment Period|Withdrawal by Subject|0
4377053|NCT03952143|7153372|FG001|Treatment Period|Withdrawal by Subject|5
4377054|NCT03952143|7153373|FG002|Treatment Period|Withdrawal by Subject|26
4377055|NCT03952143|7153371|FG000|Treatment Period|Due to COVID 19 restrictions|0
4377056|NCT03952143|7153372|FG001|Treatment Period|Due to COVID 19 restrictions|2
4377057|NCT03952143|7153373|FG002|Treatment Period|Due to COVID 19 restrictions|5
4377058|NCT03952143|7153371|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0
4377059|NCT03952143|7153372|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0
4377060|NCT03952143|7153373|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1
4466297|NCT00615264|7257880|FG001|Overall Study|Lost to Follow-up|13
4466298|NCT00615264|7257879|FG000|Overall Study|Adverse Event|8
4466299|NCT00615264|7257880|FG001|Overall Study|Adverse Event|5
4466300|NCT00615264|7257879|FG000|Overall Study|Death|1
4466301|NCT00615264|7257880|FG001|Overall Study|Death|1
4466302|NCT00615264|7257879|FG000|Overall Study|Protocol Violation|11
4466303|NCT00615264|7257880|FG001|Overall Study|Protocol Violation|7
4466304|NCT00615264|7257879|FG000|Overall Study|Not defined|7
4466305|NCT00615264|7257880|FG001|Overall Study|Not defined|4
4466306|NCT00615264|7257879|FG000|Overall Study|Dermal Hypersensitivity|0
4466307|NCT00615264|7257880|FG001|Overall Study|Dermal Hypersensitivity|3
4466308|NCT00615290|7257886|FG000|Overall Study|Adverse Event|2
4466309|NCT00615290|7257886|FG000|Overall Study|Lost to Follow-up|3
4466310|NCT00615290|7257886|FG000|Overall Study|Withdrawal by Subject|1
4466311|NCT00615290|7257886|FG000|Overall Study|Other|2
4466312|NCT00615459|7257917|FG000|Period I|Adverse Event|2
4466313|NCT00615459|7257918|FG001|Period I|Adverse Event|0
4466314|NCT00615459|7257919|FG002|Period I|Adverse Event|1
4466315|NCT00615459|7257920|FG003|Period I|Adverse Event|0
4466316|NCT00615459|7257917|FG000|Period I|Subject withdrew consent|1
4466317|NCT00615459|7257918|FG001|Period I|Subject withdrew consent|0
4466318|NCT00615459|7257919|FG002|Period I|Subject withdrew consent|0
4466319|NCT00615459|7257920|FG003|Period I|Subject withdrew consent|1
4466320|NCT00615459|7257917|FG000|Period I|Abnormal test procedure results|1
4466321|NCT00615459|7257918|FG001|Period I|Abnormal test procedure results|1
4466322|NCT00615459|7257919|FG002|Period I|Abnormal test procedure results|1
4466323|NCT00615459|7257920|FG003|Period I|Abnormal test procedure results|0
4466324|NCT00615459|7257917|FG000|Period II|Adverse Event|1
4466325|NCT00615459|7257918|FG001|Period II|Adverse Event|0
4466326|NCT00615459|7257919|FG002|Period II|Adverse Event|0
4466327|NCT00615459|7257920|FG003|Period II|Adverse Event|0
4466328|NCT00615459|7257917|FG000|Period II|Lost to Follow-up|0
4466329|NCT00615459|7257918|FG001|Period II|Lost to Follow-up|0
4466330|NCT00615459|7257919|FG002|Period II|Lost to Follow-up|0
4466331|NCT00615459|7257920|FG003|Period II|Lost to Follow-up|1
4466332|NCT00615459|7257917|FG000|Period III|Adverse Event|0
4466333|NCT00615459|7257918|FG001|Period III|Adverse Event|1
4466334|NCT00615459|7257919|FG002|Period III|Adverse Event|0
4466335|NCT00615459|7257920|FG003|Period III|Adverse Event|0
4466336|NCT00615459|7257917|FG000|Period III|Administrative problems|0
4466337|NCT00615459|7257918|FG001|Period III|Administrative problems|1
4466338|NCT00615459|7257919|FG002|Period III|Administrative problems|1
4466339|NCT00615459|7257920|FG003|Period III|Administrative problems|0
4466340|NCT00615459|7257917|FG000|Period III|Unsatisfactory therapeutic effect|0
4466341|NCT00615459|7257918|FG001|Period III|Unsatisfactory therapeutic effect|1
4466342|NCT00615459|7257919|FG002|Period III|Unsatisfactory therapeutic effect|0
4466343|NCT00615459|7257920|FG003|Period III|Unsatisfactory therapeutic effect|0
4466344|NCT00615550|7257941|FG000|Overall Study|Lost to Follow-up|6
4466345|NCT00615550|7257942|FG001|Overall Study|Lost to Follow-up|1
4466346|NCT00615719|7257953|FG000|Overall Study|Physician Decision|5
4466347|NCT00615836|7257965|FG000|Extension Study (FE992026 CS31)|Adverse Event|7
4466348|NCT00615836|7257966|FG001|Extension Study (FE992026 CS31)|Adverse Event|12
4466349|NCT00615836|7257967|FG002|Extension Study (FE992026 CS31)|Adverse Event|15
4466350|NCT00615836|7257968|FG003|Extension Study (FE992026 CS31)|Adverse Event|13
4466351|NCT00615836|7257969|FG004|Extension Study (FE992026 CS31)|Adverse Event|0
4466352|NCT00615836|7257965|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1
4466353|NCT00615836|7257966|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0
4466354|NCT00615836|7257967|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3
4466355|NCT00615836|7257968|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3
4466356|NCT00615836|7257969|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0
4466357|NCT00615836|7257965|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1
4466358|NCT00615836|7257966|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2
4466359|NCT00615836|7257967|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1
4466360|NCT00615836|7257968|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0
4466361|NCT00615836|7257969|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0
4466362|NCT00615836|7257965|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4
4516343|NCT00959699|7327705|FG001|Treatment Period|Lost to Follow-up|1
4377061|NCT03691428|7153390|FG000|Overall Study|Withdrawal by Subject|6
4377062|NCT03691428|7153391|FG001|Overall Study|Withdrawal by Subject|8
4377063|NCT03685708|7153400|FG000|Overall Study|Withdrawal by Subject|0
4377064|NCT03685708|7153401|FG001|Overall Study|Withdrawal by Subject|0
4377065|NCT03685708|7153402|FG002|Overall Study|Withdrawal by Subject|1
4377066|NCT03685708|7153400|FG000|Overall Study|Screen Fail|0
4377067|NCT03685708|7153401|FG001|Overall Study|Screen Fail|1
4377068|NCT03685708|7153402|FG002|Overall Study|Screen Fail|1
4377069|NCT03685708|7153400|FG000|Overall Study|COVID 19 Pandemic|1
4377070|NCT03685708|7153401|FG001|Overall Study|COVID 19 Pandemic|1
4377071|NCT03685708|7153402|FG002|Overall Study|COVID 19 Pandemic|6
4377072|NCT03685708|7153400|FG000|Overall Study|Disease Progression|0
4466363|NCT00615836|7257966|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5
4466364|NCT00615836|7257967|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2
4466365|NCT00615836|7257968|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3
4466366|NCT00615836|7257969|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0
4466367|NCT00615836|7257965|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37
4466368|NCT00615836|7257966|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42
4466369|NCT00615836|7257967|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38
4466370|NCT00615836|7257968|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43
4466371|NCT00615836|7257969|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0
4466372|NCT00615836|7257965|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10
4466373|NCT00615836|7257966|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14
4466374|NCT00615836|7257967|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5
4466375|NCT00615836|7257968|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10
4466376|NCT00615836|7257969|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0
4466377|NCT00615836|7257965|FG000|Extension Study (FE992026 CS31)|Other|10
4466378|NCT00615836|7257966|FG001|Extension Study (FE992026 CS31)|Other|7
4466379|NCT00615836|7257967|FG002|Extension Study (FE992026 CS31)|Other|8
4466380|NCT00615836|7257968|FG003|Extension Study (FE992026 CS31)|Other|8
4466381|NCT00615836|7257969|FG004|Extension Study (FE992026 CS31)|Other|0
4466382|NCT00615836|7257965|FG000|Extension Study (FE992026 CS31)|Not reported|6
4466383|NCT00615836|7257966|FG001|Extension Study (FE992026 CS31)|Not reported|4
4466384|NCT00615836|7257967|FG002|Extension Study (FE992026 CS31)|Not reported|1
4466385|NCT00615836|7257968|FG003|Extension Study (FE992026 CS31)|Not reported|4
4466386|NCT00615836|7257969|FG004|Extension Study (FE992026 CS31)|Not reported|0
4466387|NCT00615836|7257965|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65
4466388|NCT00615836|7257966|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
4466389|NCT00615836|7257967|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
4466390|NCT00615836|7257968|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
4466391|NCT00615836|7257969|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
4466392|NCT00615901|7257985|FG000|Overall Study|Withdrawal by Subject|2
4466393|NCT00615901|7257985|FG000|Overall Study|Adverse Event|7
4466394|NCT00615914|7257989|FG000|Overall Study|Adverse Event|274
4466395|NCT00615914|7257989|FG000|Overall Study|Death|20
4466396|NCT00615914|7257989|FG000|Overall Study|Lack of Efficacy|59
4466397|NCT00615914|7257989|FG000|Overall Study|Lost to Follow-up|187
4466398|NCT00615914|7257989|FG000|Overall Study|Withdrawal by Subject|16
4466399|NCT00615914|7257989|FG000|Overall Study|Physician Decision|4
4466400|NCT00615914|7257989|FG000|Overall Study|No data was collected.|65
4466401|NCT00615914|7257989|FG000|Overall Study|No treatment|2
4466402|NCT00615914|7257989|FG000|Overall Study|Irregularly enrolled patients|10
4466403|NCT00615992|7258003|FG000|Overall Study|Protocol Violation|67
4466404|NCT00616018|7258007|FG000|Overall Study|Protocol Violation|3
4466405|NCT00616239|7258031|FG000|Overall Study|Withdrawal by Subject|2
4466406|NCT00616421|7258038|FG000|Overall Study|Withdrawal by Subject|9
4466407|NCT00616421|7258039|FG001|Overall Study|Withdrawal by Subject|11
4466408|NCT00616421|7258040|FG002|Overall Study|Withdrawal by Subject|8
4466409|NCT00616421|7258038|FG000|Overall Study|Lost to Follow-up|12
4466410|NCT00616421|7258039|FG001|Overall Study|Lost to Follow-up|26
4466411|NCT00616421|7258040|FG002|Overall Study|Lost to Follow-up|30
4466412|NCT00616421|7258038|FG000|Overall Study|Inappropriate enrollment|3
4466413|NCT00616421|7258039|FG001|Overall Study|Inappropriate enrollment|0
4466414|NCT00616421|7258040|FG002|Overall Study|Inappropriate enrollment|1
4466415|NCT00616421|7258038|FG000|Overall Study|Administrative reason|1
4466416|NCT00616421|7258039|FG001|Overall Study|Administrative reason|0
4466417|NCT00616421|7258040|FG002|Overall Study|Administrative reason|0
4466418|NCT00616421|7258038|FG000|Overall Study|Protocol Violation|0
4466419|NCT00616421|7258039|FG001|Overall Study|Protocol Violation|1
4466420|NCT00616421|7258040|FG002|Overall Study|Protocol Violation|2
4466421|NCT00616421|7258038|FG000|Overall Study|Unable to classify|1
4466422|NCT00616421|7258039|FG001|Overall Study|Unable to classify|0
4466423|NCT00616421|7258040|FG002|Overall Study|Unable to classify|0
4466424|NCT00616434|7258064|FG000|Overall Study|Adverse Event|5
4466425|NCT00616434|7258065|FG001|Overall Study|Adverse Event|2
4466426|NCT00616434|7258064|FG000|Overall Study|Physician Decision|0
4466427|NCT00616434|7258065|FG001|Overall Study|Physician Decision|4
4466428|NCT00616434|7258064|FG000|Overall Study|Withdrawal by Subject|1
4377073|NCT03685708|7153401|FG001|Overall Study|Disease Progression|0
4377074|NCT03685708|7153402|FG002|Overall Study|Disease Progression|1
4377075|NCT03669588|7153412|FG000|Overall Study|Adverse Event|1
4377076|NCT03669588|7153413|FG001|Overall Study|Adverse Event|0
4377077|NCT03669588|7153412|FG000|Overall Study|Physician Decision|0
4377078|NCT03669588|7153413|FG001|Overall Study|Physician Decision|1
4377079|NCT03669588|7153412|FG000|Overall Study|Protocol Violation|1
4377080|NCT03669588|7153413|FG001|Overall Study|Protocol Violation|0
4377081|NCT03669588|7153412|FG000|Overall Study|Sponsor Decision|1
4377082|NCT03669588|7153413|FG001|Overall Study|Sponsor Decision|1
4377083|NCT03669588|7153412|FG000|Overall Study|Withdrawal by Subject|1
4377084|NCT03669588|7153413|FG001|Overall Study|Withdrawal by Subject|4
4377085|NCT03669588|7153412|FG000|Overall Study|Rescue Therapy Needed|0
4377086|NCT03669588|7153413|FG001|Overall Study|Rescue Therapy Needed|1
4377087|NCT03531632|7153422|FG000|Overall Study|Adverse Event|0
4377088|NCT03531632|7153423|FG001|Overall Study|Adverse Event|0
4377089|NCT03531632|7153424|FG002|Overall Study|Adverse Event|1
4377090|NCT03531632|7153422|FG000|Overall Study|Death|4
4377091|NCT03531632|7153423|FG001|Overall Study|Death|0
4377092|NCT03531632|7153424|FG002|Overall Study|Death|14
4377093|NCT03531632|7153422|FG000|Overall Study|Study Terminated|1
4377094|NCT03531632|7153423|FG001|Overall Study|Study Terminated|3
4377095|NCT03531632|7153424|FG002|Overall Study|Study Terminated|11
4377096|NCT03412604|7153447|FG000|Overall Study|Withdrawal by Subject|1
4377097|NCT03206073|7153455|FG000|Overall Study|Participant Noncompliance|0
4377098|NCT03206073|7153456|FG001|Overall Study|Participant Noncompliance|1
4377099|NCT03206073|7153457|FG002|Overall Study|Participant Noncompliance|0
4377100|NCT03206073|7153458|FG003|Overall Study|Participant Noncompliance|0
4377101|NCT03206073|7153455|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1
4377102|NCT03206073|7153456|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0
4377103|NCT03206073|7153457|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0
4377104|NCT03206073|7153458|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0
4377105|NCT03206073|7153455|FG000|Overall Study|Death|0
4377106|NCT03206073|7153456|FG001|Overall Study|Death|0
4377107|NCT03206073|7153457|FG002|Overall Study|Death|1
4377108|NCT03206073|7153458|FG003|Overall Study|Death|0
4377109|NCT03206073|7153455|FG000|Overall Study|Taken off active treatment|0
4377110|NCT03206073|7153456|FG001|Overall Study|Taken off active treatment|0
4377111|NCT03206073|7153457|FG002|Overall Study|Taken off active treatment|3
4377112|NCT03206073|7153458|FG003|Overall Study|Taken off active treatment|0
4377113|NCT03102034|7153483|FG000|Overall Study|Withdrawal by Subject|1
4377114|NCT03102034|7153484|FG001|Overall Study|Withdrawal by Subject|0
4466429|NCT00616434|7258065|FG001|Overall Study|Withdrawal by Subject|1
4466430|NCT00616434|7258064|FG000|Overall Study|Protocol deviation|0
4466431|NCT00616434|7258065|FG001|Overall Study|Protocol deviation|1
4466432|NCT00616629|7258076|FG000|Overall Study|Protocol Violation|1
4466433|NCT00616629|7258077|FG001|Overall Study|Protocol Violation|2
4466434|NCT00616629|7258078|FG002|Overall Study|Protocol Violation|1
4466435|NCT00616629|7258079|FG003|Overall Study|Protocol Violation|0
4466436|NCT00616629|7258080|FG004|Overall Study|Protocol Violation|0
4466437|NCT00616629|7258076|FG000|Overall Study|AV-block|1
4466438|NCT00616629|7258077|FG001|Overall Study|AV-block|0
4466439|NCT00616629|7258078|FG002|Overall Study|AV-block|0
4466440|NCT00616629|7258079|FG003|Overall Study|AV-block|0
4466441|NCT00616629|7258080|FG004|Overall Study|AV-block|0
4466442|NCT00616655|7258095|FG000|Overall Study|Adverse Event|10
4466443|NCT00616655|7258096|FG001|Overall Study|Adverse Event|7
4466444|NCT00616655|7258097|FG002|Overall Study|Adverse Event|12
4466445|NCT00616655|7258095|FG000|Overall Study|Lack of Efficacy|5
4466446|NCT00616655|7258096|FG001|Overall Study|Lack of Efficacy|5
4466447|NCT00616655|7258097|FG002|Overall Study|Lack of Efficacy|5
4466448|NCT00616655|7258095|FG000|Overall Study|Lost to Follow-up|3
4466449|NCT00616655|7258096|FG001|Overall Study|Lost to Follow-up|12
4466450|NCT00616655|7258097|FG002|Overall Study|Lost to Follow-up|10
4466451|NCT00616655|7258095|FG000|Overall Study|Protocol Violation|2
4466452|NCT00616655|7258096|FG001|Overall Study|Protocol Violation|4
4466453|NCT00616655|7258097|FG002|Overall Study|Protocol Violation|3
4466454|NCT00616655|7258095|FG000|Overall Study|Withdrawal by Subject|9
4466455|NCT00616655|7258096|FG001|Overall Study|Withdrawal by Subject|7
4466456|NCT00616655|7258097|FG002|Overall Study|Withdrawal by Subject|11
4466457|NCT00616655|7258095|FG000|Overall Study|Does not meet in/ex criteria|0
4466458|NCT00616655|7258096|FG001|Overall Study|Does not meet in/ex criteria|0
4466459|NCT00616655|7258097|FG002|Overall Study|Does not meet in/ex criteria|2
4466460|NCT00616655|7258095|FG000|Overall Study|Other|6
4466461|NCT00616655|7258096|FG001|Overall Study|Other|6
4466462|NCT00616655|7258097|FG002|Overall Study|Other|5
4466463|NCT00616902|7258116|FG000|Overall Study|Termination of study|6
4466464|NCT00616902|7258117|FG001|Overall Study|Termination of study|6
4466465|NCT00616928|7258127|FG000|Overall Study|Adverse Event|6
4466466|NCT00616928|7258128|FG001|Overall Study|Adverse Event|3
4466467|NCT00616928|7258129|FG002|Overall Study|Adverse Event|2
4466468|NCT00616928|7258130|FG003|Overall Study|Adverse Event|2
4466469|NCT00616928|7258127|FG000|Overall Study|Other|51
4466470|NCT00616928|7258128|FG001|Overall Study|Other|8
4466471|NCT00616928|7258129|FG002|Overall Study|Other|15
4466472|NCT00616928|7258130|FG003|Overall Study|Other|5
4466473|NCT00616928|7258127|FG000|Overall Study|Lost to Follow-up|5
4466474|NCT00616928|7258128|FG001|Overall Study|Lost to Follow-up|7
4377115|NCT02723864|7153501|FG000|Overall Study|Refused further treatment|1
4377116|NCT02723864|7153502|FG001|Overall Study|Refused further treatment|0
4377117|NCT02723864|7153503|FG002|Overall Study|Refused further treatment|0
4377118|NCT02723864|7153504|FG003|Overall Study|Refused further treatment|0
4377119|NCT02723864|7153505|FG004|Overall Study|Refused further treatment|1
4377120|NCT02723864|7153506|FG005|Overall Study|Refused further treatment|2
4377121|NCT02723864|7153507|FG006|Overall Study|Refused further treatment|0
4377122|NCT02723864|7153501|FG000|Overall Study|Exceed treatment hold time|0
4377123|NCT02723864|7153502|FG001|Overall Study|Exceed treatment hold time|1
4377124|NCT02723864|7153503|FG002|Overall Study|Exceed treatment hold time|0
4377125|NCT02723864|7153504|FG003|Overall Study|Exceed treatment hold time|0
4377126|NCT02723864|7153505|FG004|Overall Study|Exceed treatment hold time|0
4377127|NCT02723864|7153506|FG005|Overall Study|Exceed treatment hold time|0
4377128|NCT02723864|7153507|FG006|Overall Study|Exceed treatment hold time|0
4377129|NCT02723864|7153501|FG000|Overall Study|Clinical progression|0
4377130|NCT02723864|7153502|FG001|Overall Study|Clinical progression|0
4377131|NCT02723864|7153503|FG002|Overall Study|Clinical progression|1
4377132|NCT02723864|7153504|FG003|Overall Study|Clinical progression|0
4377133|NCT02723864|7153505|FG004|Overall Study|Clinical progression|0
4377134|NCT02723864|7153506|FG005|Overall Study|Clinical progression|3
4377135|NCT02723864|7153507|FG006|Overall Study|Clinical progression|1
4377136|NCT02723864|7153501|FG000|Overall Study|Physician Decision|0
4377137|NCT02723864|7153502|FG001|Overall Study|Physician Decision|0
4377138|NCT02723864|7153503|FG002|Overall Study|Physician Decision|0
4377139|NCT02723864|7153504|FG003|Overall Study|Physician Decision|0
4377140|NCT02723864|7153505|FG004|Overall Study|Physician Decision|0
4377141|NCT02723864|7153506|FG005|Overall Study|Physician Decision|0
4377142|NCT02723864|7153507|FG006|Overall Study|Physician Decision|1
4377143|NCT02723864|7153501|FG000|Overall Study|Changes in patient condition|0
4377144|NCT02723864|7153502|FG001|Overall Study|Changes in patient condition|0
4377145|NCT02723864|7153503|FG002|Overall Study|Changes in patient condition|0
4377146|NCT02723864|7153504|FG003|Overall Study|Changes in patient condition|0
4377147|NCT02723864|7153505|FG004|Overall Study|Changes in patient condition|0
4377148|NCT02723864|7153506|FG005|Overall Study|Changes in patient condition|1
4377149|NCT02723864|7153507|FG006|Overall Study|Changes in patient condition|0
4377150|NCT02723864|7153501|FG000|Overall Study|Patient choice|0
4377151|NCT02723864|7153502|FG001|Overall Study|Patient choice|0
4377152|NCT02723864|7153503|FG002|Overall Study|Patient choice|0
4377153|NCT02723864|7153504|FG003|Overall Study|Patient choice|0
4377154|NCT02723864|7153505|FG004|Overall Study|Patient choice|0
4377155|NCT02723864|7153506|FG005|Overall Study|Patient choice|1
4377156|NCT02723864|7153507|FG006|Overall Study|Patient choice|0
4377157|NCT02723864|7153501|FG000|Overall Study|Adverse Event|0
4377158|NCT02723864|7153502|FG001|Overall Study|Adverse Event|0
4377159|NCT02723864|7153503|FG002|Overall Study|Adverse Event|0
4377160|NCT02723864|7153504|FG003|Overall Study|Adverse Event|0
4377161|NCT02723864|7153505|FG004|Overall Study|Adverse Event|0
4377162|NCT02723864|7153506|FG005|Overall Study|Adverse Event|1
4377163|NCT02723864|7153507|FG006|Overall Study|Adverse Event|0
4377164|NCT02723864|7153501|FG000|Overall Study|Started new treatment|0
4377165|NCT02723864|7153502|FG001|Overall Study|Started new treatment|0
4377166|NCT02723864|7153503|FG002|Overall Study|Started new treatment|0
4377167|NCT02723864|7153504|FG003|Overall Study|Started new treatment|0
4377168|NCT02723864|7153505|FG004|Overall Study|Started new treatment|0
4377169|NCT02723864|7153506|FG005|Overall Study|Started new treatment|1
4377170|NCT02723864|7153507|FG006|Overall Study|Started new treatment|0
4377171|NCT02723864|7153501|FG000|Overall Study|Switched to alternative treatment|0
4377172|NCT02723864|7153502|FG001|Overall Study|Switched to alternative treatment|0
4377173|NCT02723864|7153503|FG002|Overall Study|Switched to alternative treatment|0
4377174|NCT02723864|7153504|FG003|Overall Study|Switched to alternative treatment|0
4377175|NCT02723864|7153505|FG004|Overall Study|Switched to alternative treatment|0
4377176|NCT02723864|7153506|FG005|Overall Study|Switched to alternative treatment|1
4377177|NCT02723864|7153507|FG006|Overall Study|Switched to alternative treatment|0
4377178|NCT02723864|7153501|FG000|Overall Study|Late determination of ineligibility|0
4377179|NCT02723864|7153502|FG001|Overall Study|Late determination of ineligibility|0
4377180|NCT02723864|7153503|FG002|Overall Study|Late determination of ineligibility|0
4377181|NCT02723864|7153504|FG003|Overall Study|Late determination of ineligibility|0
4377182|NCT02723864|7153505|FG004|Overall Study|Late determination of ineligibility|0
4377183|NCT02723864|7153506|FG005|Overall Study|Late determination of ineligibility|1
4377184|NCT02723864|7153507|FG006|Overall Study|Late determination of ineligibility|0
4377185|NCT02691013|7153555|FG000|Overall Study|Withdrawal by Subject|3
4377186|NCT02691013|7153556|FG001|Overall Study|Withdrawal by Subject|0
4377187|NCT02597062|7153564|FG000|Overall Study|Ineligible|1
4377188|NCT02130882|7153570|FG000|Overall Study|Withdrawal by Subject|0
4377189|NCT02130882|7153571|FG001|Overall Study|Withdrawal by Subject|1
4377190|NCT01920932|7153577|FG000|Overall Study|Death|1
4377191|NCT01920932|7153577|FG000|Overall Study|Withdrawal of consent|1
4377192|NCT01850563|7153600|FG000|Overall Study|Not eligible|3
4377193|NCT01850563|7153601|FG001|Overall Study|Not eligible|0
4377194|NCT01827111|7153608|FG000|Overall Study|Disease Progression|1
4770891|NCT01986933|7747291|FG004|Active-to-active (Part B)|Lack of Efficacy|4
4770892|NCT01986933|7747287|FG000|Active-to-active (Part B)|Pregnancy|0
4770893|NCT01986933|7747288|FG001|Active-to-active (Part B)|Pregnancy|0
4770894|NCT01986933|7747289|FG002|Active-to-active (Part B)|Pregnancy|0
4770895|NCT01986933|7747290|FG003|Active-to-active (Part B)|Pregnancy|0
4377201|NCT01437111|7153621|FG000|Overall Study|Adverse Event|2
4377202|NCT01437111|7153621|FG000|Overall Study|Withdrawal by Subject|4
4377203|NCT01437111|7153621|FG000|Overall Study|Not reported|5
4377204|NCT01437111|7153621|FG000|Overall Study|Physician Decision|1
4377205|NCT01437111|7153621|FG000|Overall Study|Lost to Follow-up|5
4377206|NCT01437111|7153621|FG000|Overall Study|Protocol Violation|1
4377207|NCT01004263|7153658|FG000|Overall Study|Adverse Event|15
4377208|NCT01004263|7153658|FG000|Overall Study|Withdrawal by Subject|58
4377209|NCT01004263|7153658|FG000|Overall Study|Protocol Violation|10
4377210|NCT01004263|7153658|FG000|Overall Study|Lost to Follow-up|64
4377211|NCT01004263|7153658|FG000|Overall Study|Lack of Efficacy|13
4377212|NCT01004263|7153658|FG000|Overall Study|Pregnancy|2
4377213|NCT01004263|7153658|FG000|Overall Study|Physician Decision|15
4377214|NCT01004263|7153658|FG000|Overall Study|Lack of Qualifying Event|2
4377215|NCT01001234|7153667|FG000|Overall Study|Withdrawal by Subject|2
4377216|NCT01001234|7153668|FG001|Overall Study|Withdrawal by Subject|0
4377217|NCT01001234|7153669|FG002|Overall Study|Withdrawal by Subject|3
4377218|NCT01001234|7153670|FG003|Overall Study|Withdrawal by Subject|0
4377219|NCT01001234|7153671|FG004|Overall Study|Withdrawal by Subject|0
4377220|NCT01001234|7153667|FG000|Overall Study|Protocol Violation|34
4377221|NCT01001234|7153668|FG001|Overall Study|Protocol Violation|3
4377222|NCT01001234|7153669|FG002|Overall Study|Protocol Violation|19
4377223|NCT01001234|7153670|FG003|Overall Study|Protocol Violation|18
4377224|NCT01001234|7153671|FG004|Overall Study|Protocol Violation|0
4377225|NCT01001234|7153667|FG000|Overall Study|Lost to Follow-up|0
4377226|NCT01001234|7153668|FG001|Overall Study|Lost to Follow-up|0
4377227|NCT01001234|7153669|FG002|Overall Study|Lost to Follow-up|1
4377228|NCT01001234|7153670|FG003|Overall Study|Lost to Follow-up|2
4377229|NCT01001234|7153671|FG004|Overall Study|Lost to Follow-up|0
4377230|NCT01001234|7153667|FG000|Overall Study|Physician Decision|1
4377231|NCT01001234|7153668|FG001|Overall Study|Physician Decision|0
4377232|NCT01001234|7153669|FG002|Overall Study|Physician Decision|0
4377233|NCT01001234|7153670|FG003|Overall Study|Physician Decision|0
4377234|NCT01001234|7153671|FG004|Overall Study|Physician Decision|0
4377235|NCT01001234|7153667|FG000|Overall Study|Not Treated: Adverse Event|1
4377236|NCT01001234|7153668|FG001|Overall Study|Not Treated: Adverse Event|0
4377237|NCT01001234|7153669|FG002|Overall Study|Not Treated: Adverse Event|0
4377238|NCT01001234|7153670|FG003|Overall Study|Not Treated: Adverse Event|0
4377239|NCT01001234|7153671|FG004|Overall Study|Not Treated: Adverse Event|0
4377240|NCT01001234|7153667|FG000|Overall Study|Not Treated: Withdrawal by Subject|23
4377241|NCT01001234|7153668|FG001|Overall Study|Not Treated: Withdrawal by Subject|2
4377242|NCT01001234|7153669|FG002|Overall Study|Not Treated: Withdrawal by Subject|2
4377243|NCT01001234|7153670|FG003|Overall Study|Not Treated: Withdrawal by Subject|0
4377244|NCT01001234|7153671|FG004|Overall Study|Not Treated: Withdrawal by Subject|0
4377245|NCT01001234|7153667|FG000|Overall Study|Not Treated: Protocol Violation|3
4466475|NCT00616928|7258129|FG002|Overall Study|Lost to Follow-up|0
4466476|NCT00616928|7258130|FG003|Overall Study|Lost to Follow-up|0
4466477|NCT00616941|7258155|FG000|Overall Study|Progressive Disease|1
4466478|NCT00616941|7258156|FG001|Overall Study|Progressive Disease|2
4466479|NCT00616941|7258157|FG002|Overall Study|Progressive Disease|1
4466480|NCT00616941|7258155|FG000|Overall Study|Adverse Event|0
4466481|NCT00616941|7258156|FG001|Overall Study|Adverse Event|1
4466482|NCT00616941|7258157|FG002|Overall Study|Adverse Event|1
4466483|NCT00616941|7258155|FG000|Overall Study|Subject Non-compliance|0
4466484|NCT00616941|7258156|FG001|Overall Study|Subject Non-compliance|0
4466485|NCT00616941|7258157|FG002|Overall Study|Subject Non-compliance|1
4466486|NCT00616941|7258155|FG000|Overall Study|Unrelated Medical Illness/Complication|0
4466487|NCT00616941|7258156|FG001|Overall Study|Unrelated Medical Illness/Complication|2
4466488|NCT00616941|7258157|FG002|Overall Study|Unrelated Medical Illness/Complication|0
4466489|NCT00616941|7258155|FG000|Overall Study|Vaccination Suspended|0
4466490|NCT00616941|7258156|FG001|Overall Study|Vaccination Suspended|0
4466491|NCT00616941|7258157|FG002|Overall Study|Vaccination Suspended|3
4466492|NCT00617084|7258180|FG000|Overall Study|Withdrawal by Subject|5
4466493|NCT00617084|7258181|FG001|Overall Study|Withdrawal by Subject|7
4466494|NCT00617084|7258180|FG000|Overall Study|Missed 12 Months visit|16
4466495|NCT00617084|7258181|FG001|Overall Study|Missed 12 Months visit|19
4466496|NCT00617123|7258200|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36
4466497|NCT00617123|7258201|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24
4695951|NCT02631538|7608583|FG001|Treatment Period (Up to Week 52)|Physician Decision|0
4466498|NCT00617123|7258200|FG000|Referral Screening Period|Did Not Wish To Continue|3
4466499|NCT00617123|7258201|FG001|Referral Screening Period|Did Not Wish To Continue|1
4466500|NCT00617123|7258200|FG000|Referral Screening Period|Adverse Event|0
4466501|NCT00617123|7258201|FG001|Referral Screening Period|Adverse Event|1
4466502|NCT00617123|7258200|FG000|Study Treatment Period|Withdrawal by Subject|8
4466503|NCT00617123|7258201|FG001|Study Treatment Period|Withdrawal by Subject|12
4466504|NCT00617123|7258200|FG000|Study Treatment Period|Adverse Event|7
4466505|NCT00617123|7258201|FG001|Study Treatment Period|Adverse Event|3
4466506|NCT00617123|7258200|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2
4377246|NCT01001234|7153668|FG001|Overall Study|Not Treated: Protocol Violation|0
4377247|NCT01001234|7153669|FG002|Overall Study|Not Treated: Protocol Violation|0
4587810|NCT01494467|7432033|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8
4377248|NCT01001234|7153670|FG003|Overall Study|Not Treated: Protocol Violation|0
4377249|NCT01001234|7153671|FG004|Overall Study|Not Treated: Protocol Violation|0
4377250|NCT01001234|7153667|FG000|Overall Study|Not Treated: Lost to Follow-up|53
4377251|NCT01001234|7153668|FG001|Overall Study|Not Treated: Lost to Follow-up|4
4377252|NCT01001234|7153669|FG002|Overall Study|Not Treated: Lost to Follow-up|7
4377253|NCT01001234|7153670|FG003|Overall Study|Not Treated: Lost to Follow-up|5
4377254|NCT01001234|7153671|FG004|Overall Study|Not Treated: Lost to Follow-up|0
4377255|NCT01001234|7153667|FG000|Overall Study|Not Treated: Pregnancy|3
4377256|NCT01001234|7153668|FG001|Overall Study|Not Treated: Pregnancy|0
4377257|NCT01001234|7153669|FG002|Overall Study|Not Treated: Pregnancy|0
4377258|NCT01001234|7153670|FG003|Overall Study|Not Treated: Pregnancy|0
4377259|NCT01001234|7153671|FG004|Overall Study|Not Treated: Pregnancy|0
4377260|NCT01001234|7153667|FG000|Overall Study|Not Treated: Physician Decision|37
4377261|NCT01001234|7153668|FG001|Overall Study|Not Treated: Physician Decision|4
4377262|NCT01001234|7153669|FG002|Overall Study|Not Treated: Physician Decision|0
4377263|NCT01001234|7153670|FG003|Overall Study|Not Treated: Physician Decision|0
4377264|NCT01001234|7153671|FG004|Overall Study|Not Treated: Physician Decision|0
4377265|NCT01001234|7153667|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248
4377266|NCT01001234|7153668|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13
4377267|NCT01001234|7153669|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0
4377268|NCT01001234|7153670|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0
4377269|NCT01001234|7153671|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0
4377270|NCT00924170|7153679|FG000|Overall Study|Refused further treatment|0
4377271|NCT00924170|7153680|FG001|Overall Study|Refused further treatment|1
4377272|NCT00924170|7153679|FG000|Overall Study|Physician Decision|0
4377273|NCT00924170|7153680|FG001|Overall Study|Physician Decision|1
4377274|NCT00924170|7153679|FG000|Overall Study|Progressive disease|3
4377275|NCT00924170|7153680|FG001|Overall Study|Progressive disease|6
4377276|NCT00924170|7153679|FG000|Overall Study|Stopped due to neutralizing antibodies|3
4377277|NCT00924170|7153680|FG001|Overall Study|Stopped due to neutralizing antibodies|0
4377278|NCT00924170|7153679|FG000|Overall Study|Death|1
4377279|NCT00924170|7153680|FG001|Overall Study|Death|0
4377280|NCT00894556|7153695|FG000|Baseline Phase|Did not meet Randomization Criteria|0
4377281|NCT00894556|7153696|FG001|Baseline Phase|Did not meet Randomization Criteria|0
4377282|NCT00894556|7153697|FG002|Baseline Phase|Did not meet Randomization Criteria|0
4377283|NCT00894556|7153698|FG003|Baseline Phase|Did not meet Randomization Criteria|85
4377284|NCT00894556|7153695|FG000|Treatment Phase|Lost to Follow-up|2
4377285|NCT00894556|7153696|FG001|Treatment Phase|Lost to Follow-up|3
4377286|NCT00894556|7153697|FG002|Treatment Phase|Lost to Follow-up|1
4377287|NCT00894556|7153698|FG003|Treatment Phase|Lost to Follow-up|0
4377288|NCT00894556|7153695|FG000|Treatment Phase|Lack of Qualifying Event|2
4377289|NCT00894556|7153696|FG001|Treatment Phase|Lack of Qualifying Event|1
4377290|NCT00894556|7153697|FG002|Treatment Phase|Lack of Qualifying Event|0
4377291|NCT00894556|7153698|FG003|Treatment Phase|Lack of Qualifying Event|0
4377292|NCT00840177|7153708|FG000|Overall Study|Adverse Event|5
4377293|NCT00840177|7153709|FG001|Overall Study|Adverse Event|1
4377294|NCT00840177|7153710|FG002|Overall Study|Adverse Event|1
4377295|NCT00840177|7153708|FG000|Overall Study|Refusal unrelated to adverse events|1
4377296|NCT00840177|7153709|FG001|Overall Study|Refusal unrelated to adverse events|0
4377297|NCT00840177|7153710|FG002|Overall Study|Refusal unrelated to adverse events|1
4377298|NCT00840177|7153708|FG000|Overall Study|Progression/relapse|2
4377299|NCT00840177|7153709|FG001|Overall Study|Progression/relapse|0
4377300|NCT00840177|7153710|FG002|Overall Study|Progression/relapse|0
4377301|NCT00840177|7153708|FG000|Overall Study|Death|4
4377302|NCT00840177|7153709|FG001|Overall Study|Death|5
4377303|NCT00840177|7153710|FG002|Overall Study|Death|5
4377304|NCT00840177|7153708|FG000|Overall Study|not protocol specified|6
4377305|NCT00840177|7153709|FG001|Overall Study|not protocol specified|3
4377306|NCT00840177|7153710|FG002|Overall Study|not protocol specified|0
4377307|NCT00840177|7153708|FG000|Overall Study|Ineligible|0
4377308|NCT00840177|7153709|FG001|Overall Study|Ineligible|0
4377309|NCT00840177|7153710|FG002|Overall Study|Ineligible|3
4377310|NCT00840177|7153708|FG000|Overall Study|Did not start treatment|0
4377311|NCT00840177|7153709|FG001|Overall Study|Did not start treatment|0
4377312|NCT00840177|7153710|FG002|Overall Study|Did not start treatment|1
4377313|NCT00820950|7153723|FG000|Overall Study|Scheduling Conflict|0
4377314|NCT00820950|7153724|FG001|Overall Study|Scheduling Conflict|0
4377315|NCT00820950|7153725|FG002|Overall Study|Scheduling Conflict|0
4587811|NCT01494467|7432034|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2
4377316|NCT00820950|7153726|FG003|Overall Study|Scheduling Conflict|0
4377317|NCT00820950|7153727|FG004|Overall Study|Scheduling Conflict|0
4377318|NCT00820950|7153728|FG005|Overall Study|Scheduling Conflict|0
4377319|NCT00820950|7153729|FG006|Overall Study|Scheduling Conflict|1
4377320|NCT00820950|7153730|FG007|Overall Study|Scheduling Conflict|1
4377321|NCT00820950|7153731|FG008|Overall Study|Scheduling Conflict|0
4377322|NCT00820950|7153732|FG009|Overall Study|Scheduling Conflict|0
4377323|NCT00820950|7153723|FG000|Overall Study|Protocol Violation|1
4377324|NCT00820950|7153724|FG001|Overall Study|Protocol Violation|1
4587812|NCT01494506|7432049|FG000|Overall Study|Lack of Efficacy|77
4587813|NCT01494506|7432050|FG001|Overall Study|Lack of Efficacy|83
4377325|NCT00820950|7153725|FG002|Overall Study|Protocol Violation|0
4377326|NCT00820950|7153726|FG003|Overall Study|Protocol Violation|0
4377327|NCT00820950|7153727|FG004|Overall Study|Protocol Violation|0
4377328|NCT00820950|7153728|FG005|Overall Study|Protocol Violation|0
4377329|NCT00820950|7153729|FG006|Overall Study|Protocol Violation|0
4377330|NCT00820950|7153730|FG007|Overall Study|Protocol Violation|0
4377331|NCT00820950|7153731|FG008|Overall Study|Protocol Violation|0
4377332|NCT00820950|7153732|FG009|Overall Study|Protocol Violation|0
4377333|NCT00806416|7153774|FG000|Period 1 - Part I|Adverse Event|0
4377334|NCT00806416|7153775|FG001|Period 1 - Part I|Adverse Event|1
4377335|NCT00806416|7153776|FG002|Period 1 - Part I|Adverse Event|0
4377336|NCT00806416|7153777|FG003|Period 1 - Part I|Adverse Event|0
4377337|NCT00806416|7153774|FG000|Period 1 - Part I|Lost to Follow-up|0
4377338|NCT00806416|7153775|FG001|Period 1 - Part I|Lost to Follow-up|2
4377339|NCT00806416|7153776|FG002|Period 1 - Part I|Lost to Follow-up|0
4377340|NCT00806416|7153777|FG003|Period 1 - Part I|Lost to Follow-up|0
4377341|NCT00806416|7153774|FG000|Period 1 - Part I|Withdrawal by Subject|3
4377342|NCT00806416|7153775|FG001|Period 1 - Part I|Withdrawal by Subject|1
4377343|NCT00806416|7153776|FG002|Period 1 - Part I|Withdrawal by Subject|0
4377344|NCT00806416|7153777|FG003|Period 1 - Part I|Withdrawal by Subject|0
4377345|NCT00806416|7153774|FG000|Period 1 - Part II|Withdrawal by Subject|0
4377346|NCT00806416|7153775|FG001|Period 1 - Part II|Withdrawal by Subject|0
4377347|NCT00806416|7153776|FG002|Period 1 - Part II|Withdrawal by Subject|0
4377348|NCT00806416|7153777|FG003|Period 1 - Part II|Withdrawal by Subject|2
4377349|NCT00729651|7153787|FG000|Overall Study|Withdrawal by Subject|5
4377350|NCT00729651|7153788|FG001|Overall Study|Withdrawal by Subject|6
4377351|NCT00729651|7153787|FG000|Overall Study|Lost to Follow-up|5
4377352|NCT00729651|7153788|FG001|Overall Study|Lost to Follow-up|4
4377353|NCT00729651|7153787|FG000|Overall Study|Protocol Violation|0
4377354|NCT00729651|7153788|FG001|Overall Study|Protocol Violation|1
4377355|NCT00729651|7153787|FG000|Overall Study|Adverse Event|7
4377356|NCT00729651|7153788|FG001|Overall Study|Adverse Event|3
4377357|NCT00729651|7153787|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0
4377358|NCT00729651|7153788|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4
4377359|NCT00729651|7153787|FG000|Overall Study|Subject's private reason|2
4377360|NCT00729651|7153788|FG001|Overall Study|Subject's private reason|0
4377361|NCT00698815|7153797|FG000|Overall Study|Death|1
4377362|NCT00698815|7153798|FG001|Overall Study|Death|2
4377363|NCT00698815|7153799|FG002|Overall Study|Death|4
4377364|NCT00698815|7153797|FG000|Overall Study|Withdrawal by Subject|6
4377365|NCT00698815|7153798|FG001|Overall Study|Withdrawal by Subject|3
4377366|NCT00698815|7153799|FG002|Overall Study|Withdrawal by Subject|2
4377367|NCT00698815|7153797|FG000|Overall Study|MD discretion|2
4377368|NCT00698815|7153798|FG001|Overall Study|MD discretion|7
4377369|NCT00698815|7153799|FG002|Overall Study|MD discretion|2
4377370|NCT00698815|7153797|FG000|Overall Study|Did not receive protocol treatment|1
4377371|NCT00698815|7153798|FG001|Overall Study|Did not receive protocol treatment|2
4377372|NCT00698815|7153799|FG002|Overall Study|Did not receive protocol treatment|2
4377373|NCT00692913|7153822|FG000|Overall Study|Adverse Event|8
4377374|NCT00692913|7153823|FG001|Overall Study|Adverse Event|4
4377375|NCT00692913|7153822|FG000|Overall Study|Lost to Follow-up|3
4377376|NCT00692913|7153823|FG001|Overall Study|Lost to Follow-up|5
4377377|NCT00692913|7153822|FG000|Overall Study|Physician Decision|2
4377378|NCT00692913|7153823|FG001|Overall Study|Physician Decision|0
4377379|NCT00692913|7153822|FG000|Overall Study|Protocol Violation|1
4377380|NCT00692913|7153823|FG001|Overall Study|Protocol Violation|1
4377381|NCT00692913|7153822|FG000|Overall Study|Withdrawal by Subject|15
4377382|NCT00692913|7153823|FG001|Overall Study|Withdrawal by Subject|20
4377383|NCT00617708|7153869|FG000|Overall Study|Adverse Event|0
4377384|NCT00617708|7153870|FG001|Overall Study|Adverse Event|6
4377385|NCT00617708|7153871|FG002|Overall Study|Adverse Event|9
4377386|NCT00617708|7153869|FG000|Overall Study|Withdrawal by Subject|1
4377387|NCT00617708|7153870|FG001|Overall Study|Withdrawal by Subject|1
4377388|NCT00617708|7153871|FG002|Overall Study|Withdrawal by Subject|7
4377389|NCT00617708|7153869|FG000|Overall Study|Death|0
4377390|NCT00617708|7153870|FG001|Overall Study|Death|6
4377391|NCT00617708|7153871|FG002|Overall Study|Death|5
4377392|NCT00617708|7153869|FG000|Overall Study|Progression/Relapse|7
4377393|NCT00617708|7153870|FG001|Overall Study|Progression/Relapse|40
4377394|NCT00617708|7153871|FG002|Overall Study|Progression/Relapse|36
4377395|NCT00617708|7153869|FG000|Overall Study|Not protocol specified|1
4377396|NCT00617708|7153870|FG001|Overall Study|Not protocol specified|4
4377397|NCT00617708|7153871|FG002|Overall Study|Not protocol specified|2
4377398|NCT00617708|7153869|FG000|Overall Study|Not eligible|1
4377399|NCT00617708|7153870|FG001|Overall Study|Not eligible|3
4377400|NCT00617708|7153871|FG002|Overall Study|Not eligible|5
4377401|NCT00516737|7153883|FG000|Overall Study|Lost to Follow-up|2
4377402|NCT00516737|7153884|FG001|Overall Study|Lost to Follow-up|0
4377403|NCT00516737|7153883|FG000|Overall Study|Physician Decision|0
4377404|NCT00516737|7153884|FG001|Overall Study|Physician Decision|1
4377405|NCT00516737|7153883|FG000|Overall Study|Withdrawal by Subject|0
4377406|NCT00516737|7153884|FG001|Overall Study|Withdrawal by Subject|1
4377407|NCT00516737|7153883|FG000|Overall Study|Lack of Qualifying Event|9
4377408|NCT00516737|7153884|FG001|Overall Study|Lack of Qualifying Event|6
4377409|NCT00358527|7153892|FG000|Overall Study|Adverse Event|4
4377410|NCT00358527|7153893|FG001|Overall Study|Adverse Event|0
4377411|NCT00358527|7153892|FG000|Overall Study|Withdrawal by Subject|1
4377412|NCT00358527|7153893|FG001|Overall Study|Withdrawal by Subject|1
4377413|NCT00358527|7153892|FG000|Overall Study|Non-compliance with protocol|6
4377414|NCT00358527|7153893|FG001|Overall Study|Non-compliance with protocol|1
4695952|NCT02631538|7608584|FG002|Treatment Period (Up to Week 52)|Physician Decision|0
4695953|NCT02631538|7608585|FG003|Treatment Period (Up to Week 52)|Physician Decision|1
4695954|NCT02631538|7608582|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0
4695955|NCT02631538|7608583|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0
4695956|NCT02631538|7608584|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1
4377415|NCT00358527|7153892|FG000|Overall Study|Administrative|2
4377416|NCT00358527|7153893|FG001|Overall Study|Administrative|1
4377417|NCT00326898|7153902|FG000|Overall Study|Disease progression|52
4377418|NCT00326898|7153903|FG001|Overall Study|Disease progression|54
4377419|NCT00326898|7153904|FG002|Overall Study|Disease progression|102
4377420|NCT00326898|7153902|FG000|Overall Study|Adverse Event|124
4377421|NCT00326898|7153903|FG001|Overall Study|Adverse Event|128
4377422|NCT00326898|7153904|FG002|Overall Study|Adverse Event|33
4377423|NCT00326898|7153902|FG000|Overall Study|Death|2
4377424|NCT00326898|7153903|FG001|Overall Study|Death|0
4377425|NCT00326898|7153904|FG002|Overall Study|Death|0
4377426|NCT00326898|7153902|FG000|Overall Study|Withdrawal by Subject|134
4377427|NCT00326898|7153903|FG001|Overall Study|Withdrawal by Subject|128
4377428|NCT00326898|7153904|FG002|Overall Study|Withdrawal by Subject|32
4377429|NCT00326898|7153902|FG000|Overall Study|Alternative therapy|1
4377430|NCT00326898|7153903|FG001|Overall Study|Alternative therapy|0
4377431|NCT00326898|7153904|FG002|Overall Study|Alternative therapy|0
4377432|NCT00326898|7153902|FG000|Overall Study|Other complicating disease|5
4377433|NCT00326898|7153903|FG001|Overall Study|Other complicating disease|5
4377434|NCT00326898|7153904|FG002|Overall Study|Other complicating disease|4
4377435|NCT00326898|7153902|FG000|Overall Study|Other/Missing/Unknown|33
4587814|NCT01494506|7432051|FG002|Overall Study|Lack of Efficacy|57
4587815|NCT01494506|7432049|FG000|Overall Study|Adverse Event|17
4377436|NCT00326898|7153903|FG001|Overall Study|Other/Missing/Unknown|28
4377437|NCT00326898|7153904|FG002|Overall Study|Other/Missing/Unknown|32
4377438|NCT00156065|7153915|FG000|Overall Study|Enrolled But Never Received Treatment|1
4377439|NCT00156065|7153916|FG001|Overall Study|Enrolled But Never Received Treatment|1
4377440|NCT00156065|7153917|FG002|Overall Study|Enrolled But Never Received Treatment|0
4377441|NCT00156065|7153915|FG000|Overall Study|Adverse Event|8
4377442|NCT00156065|7153916|FG001|Overall Study|Adverse Event|11
4377443|NCT00156065|7153917|FG002|Overall Study|Adverse Event|4
4377444|NCT00156065|7153915|FG000|Overall Study|Lack of Efficacy|2
4377445|NCT00156065|7153916|FG001|Overall Study|Lack of Efficacy|9
4377446|NCT00156065|7153917|FG002|Overall Study|Lack of Efficacy|3
4377447|NCT00156065|7153915|FG000|Overall Study|Withdrawal by Subject|13
4377448|NCT00156065|7153916|FG001|Overall Study|Withdrawal by Subject|26
4377449|NCT00156065|7153917|FG002|Overall Study|Withdrawal by Subject|16
4377450|NCT00156065|7153915|FG000|Overall Study|Lost to Follow-up|5
4377451|NCT00156065|7153916|FG001|Overall Study|Lost to Follow-up|7
4377452|NCT00156065|7153917|FG002|Overall Study|Lost to Follow-up|1
4377453|NCT00156065|7153915|FG000|Overall Study|Other|2
4377454|NCT00156065|7153916|FG001|Overall Study|Other|9
4377455|NCT00156065|7153917|FG002|Overall Study|Other|3
4377456|NCT00150176|7153927|FG000|Overall Study|Adverse Event|16
4377457|NCT00150176|7153928|FG001|Overall Study|Adverse Event|53
4377458|NCT00150176|7153927|FG000|Overall Study|Relapse/Impending relapse, non-AE|10
4377459|NCT00150176|7153928|FG001|Overall Study|Relapse/Impending relapse, non-AE|39
4377460|NCT00150176|7153927|FG000|Overall Study|Withdrawal by Subject|19
4377461|NCT00150176|7153928|FG001|Overall Study|Withdrawal by Subject|12
4377462|NCT00150176|7153927|FG000|Overall Study|Lost to Follow-up|3
4377463|NCT00150176|7153928|FG001|Overall Study|Lost to Follow-up|3
4377464|NCT00150176|7153927|FG000|Overall Study|OTHER|11
4377465|NCT00150176|7153928|FG001|Overall Study|OTHER|13
4377466|NCT00145509|7153937|FG000|Overall Study|Adverse Event|10
4377467|NCT00145509|7153938|FG001|Overall Study|Adverse Event|3
4377468|NCT00145509|7153937|FG000|Overall Study|Lack of Efficacy|3
4377469|NCT00145509|7153938|FG001|Overall Study|Lack of Efficacy|1
4377470|NCT00145509|7153937|FG000|Overall Study|Lost to Follow-up|5
4377471|NCT00145509|7153938|FG001|Overall Study|Lost to Follow-up|9
4377472|NCT00145509|7153937|FG000|Overall Study|Withdrew Consent|2
4377473|NCT00145509|7153938|FG001|Overall Study|Withdrew Consent|7
4587816|NCT01494506|7432050|FG001|Overall Study|Adverse Event|10
4587817|NCT01494506|7432051|FG002|Overall Study|Adverse Event|11
4587818|NCT01494506|7432049|FG000|Overall Study|Death|9
4587819|NCT01494506|7432050|FG001|Overall Study|Death|5
4587820|NCT01494506|7432051|FG002|Overall Study|Death|2
4377474|NCT00145509|7153937|FG000|Overall Study|Reason not provided|2
4377475|NCT00145509|7153938|FG001|Overall Study|Reason not provided|1
4377476|NCT00145496|7153946|FG000|Overall Study|Adverse Event|42
4377477|NCT00145496|7153947|FG001|Overall Study|Adverse Event|30
4377478|NCT00145496|7153946|FG000|Overall Study|Lack of Efficacy|12
4377479|NCT00145496|7153947|FG001|Overall Study|Lack of Efficacy|7
4377480|NCT00145496|7153946|FG000|Overall Study|Withdrawal by Subject|32
4377481|NCT00145496|7153947|FG001|Overall Study|Withdrawal by Subject|26
4377482|NCT00145496|7153946|FG000|Overall Study|Lost to Follow-up|12
4377483|NCT00145496|7153947|FG001|Overall Study|Lost to Follow-up|5
4377484|NCT00145496|7153946|FG000|Overall Study|Other|25
4377485|NCT00145496|7153947|FG001|Overall Study|Other|13
4377486|NCT00145470|7153955|FG000|Overall Study|Adverse Event|19
4377487|NCT00145470|7153956|FG001|Overall Study|Adverse Event|25
4377488|NCT00145470|7153955|FG000|Overall Study|Lack of Efficacy|27
4377489|NCT00145470|7153956|FG001|Overall Study|Lack of Efficacy|13
4377490|NCT00145470|7153955|FG000|Overall Study|Withdrawal by Subject|36
4377491|NCT00145470|7153956|FG001|Overall Study|Withdrawal by Subject|34
4377492|NCT00145470|7153955|FG000|Overall Study|Lost to Follow-up|21
4377493|NCT00145470|7153956|FG001|Overall Study|Lost to Follow-up|17
4377494|NCT00145470|7153955|FG000|Overall Study|Reason Not Reported|9
4377495|NCT00145470|7153956|FG001|Overall Study|Reason Not Reported|9
4587821|NCT01494506|7432049|FG000|Overall Study|Physician Decision|7
4587822|NCT01494506|7432050|FG001|Overall Study|Physician Decision|5
4587823|NCT01494506|7432051|FG002|Overall Study|Physician Decision|4
4587824|NCT01494506|7432049|FG000|Overall Study|Withdrawal by Subject|17
4587825|NCT01494506|7432050|FG001|Overall Study|Withdrawal by Subject|20
4587826|NCT01494506|7432051|FG002|Overall Study|Withdrawal by Subject|14
4587827|NCT01494506|7432049|FG000|Overall Study|Clinical Deterioration|21
4587828|NCT01494506|7432050|FG001|Overall Study|Clinical Deterioration|17
4587829|NCT01494506|7432051|FG002|Overall Study|Clinical Deterioration|13
4695957|NCT02631538|7608585|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0
4377496|NCT00129402|7153964|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
4377497|NCT00129402|7153965|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
4377498|NCT00129402|7153966|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
4377499|NCT00129402|7153967|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
4377500|NCT00129402|7153968|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
4377501|NCT00129402|7153969|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
4377502|NCT00129402|7153970|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
4377503|NCT00129402|7153964|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
4377504|NCT00129402|7153965|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
4377505|NCT00129402|7153966|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
4377506|NCT00129402|7153967|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
4377507|NCT00129402|7153968|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
4377508|NCT00129402|7153969|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1
4377509|NCT00129402|7153970|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
4377510|NCT00129402|7153964|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
4377511|NCT00129402|7153965|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
4377512|NCT00129402|7153966|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
4377513|NCT00129402|7153967|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1
4377514|NCT00129402|7153968|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
4377515|NCT00129402|7153969|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
4377516|NCT00129402|7153970|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
4377517|NCT00129402|7153964|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
4377518|NCT00129402|7153965|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
4377519|NCT00129402|7153966|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1
4377520|NCT00129402|7153967|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
4377521|NCT00129402|7153968|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1
4377522|NCT00129402|7153969|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
4377523|NCT00129402|7153970|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
4377524|NCT00129402|7153964|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
4377525|NCT00129402|7153965|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
4377526|NCT00129402|7153966|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2
4377527|NCT00129402|7153967|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
4377528|NCT00129402|7153968|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
4377529|NCT00129402|7153969|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
4377530|NCT00129402|7153970|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
4377531|NCT00129402|7153964|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
4377532|NCT00129402|7153965|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
4377533|NCT00129402|7153966|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3
4377534|NCT00129402|7153967|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
4377535|NCT00129402|7153968|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
4377536|NCT00129402|7153969|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1
4377537|NCT00129402|7153970|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
4377538|NCT00129402|7153964|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
4377539|NCT00129402|7153965|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
4377540|NCT00129402|7153966|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1
4587830|NCT01494506|7432049|FG000|Overall Study|Sponsor Decision|0
4695958|NCT02631538|7608582|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1
4377541|NCT00129402|7153967|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
4377542|NCT00129402|7153968|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
4377543|NCT00129402|7153969|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
4377544|NCT00129402|7153970|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
4377545|NCT00129402|7153964|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
4377546|NCT00129402|7153965|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
4377547|NCT00129402|7153966|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1
4377548|NCT00129402|7153967|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
4377549|NCT00129402|7153968|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
4377550|NCT00129402|7153969|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3
4377551|NCT00129402|7153970|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
4377552|NCT00129402|7153964|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
4377553|NCT00129402|7153965|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
4377554|NCT00129402|7153966|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1
4377555|NCT00129402|7153967|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
4377556|NCT00129402|7153968|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
4377557|NCT00129402|7153969|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1
4377558|NCT00129402|7153970|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
4377559|NCT00129402|7153964|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
4377560|NCT00129402|7153965|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
4377561|NCT00129402|7153966|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
4377562|NCT00129402|7153967|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
4377563|NCT00129402|7153968|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
4377564|NCT00129402|7153969|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
4377565|NCT00129402|7153970|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1
4377566|NCT00129402|7153964|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
4377567|NCT00129402|7153965|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
4377568|NCT00129402|7153966|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
4377569|NCT00129402|7153967|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
4377570|NCT00129402|7153968|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
4377571|NCT00129402|7153969|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
4377572|NCT00129402|7153970|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3
4377573|NCT00129402|7153964|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0
4377574|NCT00129402|7153965|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0
4377575|NCT00129402|7153966|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0
4377576|NCT00129402|7153967|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0
4377577|NCT00129402|7153968|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0
4377578|NCT00129402|7153969|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0
4377579|NCT00129402|7153970|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1
4377580|NCT00129402|7153964|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
4377581|NCT00129402|7153965|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
4377582|NCT00129402|7153966|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
4377583|NCT00129402|7153967|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
4377584|NCT00129402|7153968|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
4587831|NCT01494506|7432050|FG001|Overall Study|Sponsor Decision|0
4587832|NCT01494506|7432051|FG002|Overall Study|Sponsor Decision|1
4587833|NCT01494506|7432049|FG000|Overall Study|Other|0
4587834|NCT01494506|7432050|FG001|Overall Study|Other|3
4587835|NCT01494506|7432051|FG002|Overall Study|Other|1
4587836|NCT01494532|7432067|FG000|Overall Study|Adverse Event|4
4377585|NCT00129402|7153969|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
4377586|NCT00129402|7153970|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1
4377587|NCT00101439|7153980|FG000|Period 2|Withdrawal by Subject|0
4377588|NCT00101439|7153981|FG001|Period 2|Withdrawal by Subject|2
4377589|NCT00096200|7153990|FG000|Overall Study|Adverse Event|0
4377590|NCT00096200|7153991|FG001|Overall Study|Adverse Event|4
4377591|NCT00096200|7153992|FG002|Overall Study|Adverse Event|0
4377592|NCT00096200|7153990|FG000|Overall Study|Withdrawal by Subject|1
4377593|NCT00096200|7153991|FG001|Overall Study|Withdrawal by Subject|2
4377594|NCT00096200|7153992|FG002|Overall Study|Withdrawal by Subject|0
4377595|NCT00096200|7153990|FG000|Overall Study|Ineligible pathology|0
4377596|NCT00096200|7153991|FG001|Overall Study|Ineligible pathology|1
4377597|NCT00096200|7153992|FG002|Overall Study|Ineligible pathology|0
4466507|NCT00617123|7258201|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0
4466508|NCT00617123|7258200|FG000|Study Treatment Period|Noncompliance with Protocol|0
4466509|NCT00617123|7258201|FG001|Study Treatment Period|Noncompliance with Protocol|1
4466510|NCT00617201|7258222|FG000|Overall Study|Lost to Follow-up|9
4466511|NCT00617201|7258223|FG001|Overall Study|Lost to Follow-up|13
4466512|NCT00617240|7258233|FG000|Overall Study|Lack of Efficacy|1
4466513|NCT00617240|7258234|FG001|Overall Study|Lack of Efficacy|0
4587837|NCT01494532|7432068|FG001|Overall Study|Adverse Event|1
4377598|NCT03257267|7154002|FG000|Overall Study|Adverse Event|9
4377599|NCT03257267|7154003|FG001|Overall Study|Adverse Event|7
4377600|NCT03257267|7154002|FG000|Overall Study|Death|92
4377601|NCT03257267|7154003|FG001|Overall Study|Death|95
4377602|NCT03257267|7154002|FG000|Overall Study|Lost to Follow-up|2
4377603|NCT03257267|7154003|FG001|Overall Study|Lost to Follow-up|2
4377604|NCT03257267|7154002|FG000|Overall Study|Non-compliance with Study Drug|0
4377605|NCT03257267|7154003|FG001|Overall Study|Non-compliance with Study Drug|1
4377606|NCT03257267|7154002|FG000|Overall Study|Participant Decision|34
4377607|NCT03257267|7154003|FG001|Overall Study|Participant Decision|42
4377608|NCT03257267|7154002|FG000|Overall Study|Physician Decision|1
4377609|NCT03257267|7154003|FG001|Overall Study|Physician Decision|3
4377610|NCT03257267|7154002|FG000|Overall Study|Disease Progression|98
4377611|NCT03257267|7154003|FG001|Overall Study|Disease Progression|117
4377612|NCT03257267|7154002|FG000|Overall Study|Withdrawal of Consent|8
4377613|NCT03257267|7154003|FG001|Overall Study|Withdrawal of Consent|26
4377614|NCT03257267|7154002|FG000|Overall Study|Study Ongoing|53
4377615|NCT03257267|7154003|FG001|Overall Study|Study Ongoing|11
4377616|NCT04223830|7154031|FG000|Overall Study|Lost to Follow-up|9
4377617|NCT04223830|7154031|FG000|Overall Study|Adverse Event|1
4377630|NCT03886220|7154125|FG000|Treatment Period|Discontinued study drug during the treatment period|5
4377631|NCT03886220|7154126|FG001|Treatment Period|Discontinued study drug during the treatment period|12
4377632|NCT03886220|7154125|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1
4377633|NCT03886220|7154126|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
4377634|NCT03886220|7154125|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1
4377635|NCT03886220|7154126|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2
4377636|NCT03627091|7154148|FG000|Overall Study|Adverse Event|0
4377637|NCT03627091|7154149|FG001|Overall Study|Adverse Event|0
4377638|NCT03627091|7154150|FG002|Overall Study|Adverse Event|2
4377639|NCT03627091|7154148|FG000|Overall Study|Withdrawal by Subject|2
4377640|NCT03627091|7154149|FG001|Overall Study|Withdrawal by Subject|0
4377641|NCT03627091|7154150|FG002|Overall Study|Withdrawal by Subject|2
4377642|NCT03627091|7154148|FG000|Overall Study|Physician Decision|2
4377643|NCT03627091|7154149|FG001|Overall Study|Physician Decision|0
4377644|NCT03627091|7154150|FG002|Overall Study|Physician Decision|0
4377645|NCT03627091|7154148|FG000|Overall Study|Site terminated by sponsor|0
4377646|NCT03627091|7154149|FG001|Overall Study|Site terminated by sponsor|1
4377647|NCT03627091|7154150|FG002|Overall Study|Site terminated by sponsor|0
4377648|NCT03627091|7154148|FG000|Overall Study|Disease relapse|7
4377649|NCT03627091|7154149|FG001|Overall Study|Disease relapse|5
4377650|NCT03627091|7154150|FG002|Overall Study|Disease relapse|1
4377651|NCT03627091|7154148|FG000|Overall Study|Other|1
4377652|NCT03627091|7154149|FG001|Overall Study|Other|0
4377653|NCT03627091|7154150|FG002|Overall Study|Other|0
4377717|NCT03434379|7154239|FG001|Global Period|Death|179
4377718|NCT03434379|7154240|FG002|Global Period|Death|0
4377719|NCT03434379|7154241|FG003|Global Period|Death|0
4377720|NCT03434379|7154238|FG000|Global Period|Withdrawal by Subject|20
4377721|NCT03434379|7154239|FG001|Global Period|Withdrawal by Subject|20
4377722|NCT03434379|7154240|FG002|Global Period|Withdrawal by Subject|0
4377723|NCT03434379|7154241|FG003|Global Period|Withdrawal by Subject|0
4377724|NCT03434379|7154238|FG000|Global Period|On Study|43
4377725|NCT03434379|7154239|FG001|Global Period|On Study|136
4377726|NCT03434379|7154240|FG002|Global Period|On Study|0
4377727|NCT03434379|7154241|FG003|Global Period|On Study|0
4377728|NCT03434379|7154238|FG000|China Extension Period|Lost to Follow-up|0
4377729|NCT03434379|7154239|FG001|China Extension Period|Lost to Follow-up|0
4377730|NCT03434379|7154240|FG002|China Extension Period|Lost to Follow-up|1
4377731|NCT03434379|7154241|FG003|China Extension Period|Lost to Follow-up|0
4377732|NCT03434379|7154238|FG000|China Extension Period|Death|0
4377733|NCT03434379|7154239|FG001|China Extension Period|Death|0
4377734|NCT03434379|7154240|FG002|China Extension Period|Death|38
4377735|NCT03434379|7154241|FG003|China Extension Period|Death|61
4377736|NCT03434379|7154238|FG000|China Extension Period|Withdrawal by Subject|0
4377737|NCT03434379|7154239|FG001|China Extension Period|Withdrawal by Subject|0
4377738|NCT03434379|7154240|FG002|China Extension Period|Withdrawal by Subject|7
4377739|NCT03434379|7154241|FG003|China Extension Period|Withdrawal by Subject|6
4377740|NCT03434379|7154238|FG000|China Extension Period|On Study|0
4377741|NCT03434379|7154239|FG001|China Extension Period|On Study|0
4377742|NCT03434379|7154240|FG002|China Extension Period|On Study|15
4377743|NCT03434379|7154241|FG003|China Extension Period|On Study|66
4377744|NCT03368170|7154255|FG000|Overall Study|Adverse Event|2
4377745|NCT03368170|7154256|FG001|Overall Study|Adverse Event|1
4377746|NCT03336528|7154264|FG000|Overall Study|Protocol Violation|1
4377747|NCT03336528|7154265|FG001|Overall Study|Protocol Violation|1
4377748|NCT03336528|7154264|FG000|Overall Study|Discharged within 48 hours of study medication|8
4377749|NCT03336528|7154265|FG001|Overall Study|Discharged within 48 hours of study medication|6
4377750|NCT03336528|7154264|FG000|Overall Study|Did not receive study medication|1
4377751|NCT03336528|7154265|FG001|Overall Study|Did not receive study medication|2
4377752|NCT03334409|7154275|FG000|Overall Study|Did not meet inclusion criteria|1
4377753|NCT03334409|7154276|FG001|Overall Study|Did not meet inclusion criteria|0
4377754|NCT03332498|7154285|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0
4377755|NCT03332498|7154286|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0
4377618|NCT04153188|7154047|FG000|Overall Study|Lost to Follow-up|1
4377619|NCT04153188|7154048|FG001|Overall Study|Lost to Follow-up|1
4377620|NCT04153188|7154047|FG000|Overall Study|Withdrawal by Subject|2
4377621|NCT04153188|7154048|FG001|Overall Study|Withdrawal by Subject|0
4377622|NCT04153188|7154047|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0
4377623|NCT04153188|7154048|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1
4377624|NCT04110314|7154071|FG000|Overall Study|Did not meet inclusion criteria|35255
4377625|NCT04110314|7154072|FG001|Overall Study|Did not meet inclusion criteria|35104
4377626|NCT04110314|7154073|FG002|Overall Study|Did not meet inclusion criteria|35636
4377627|NCT04110314|7154074|FG003|Overall Study|Did not meet inclusion criteria|35135
4377628|NCT04110314|7154075|FG004|Overall Study|Did not meet inclusion criteria|35247
4377629|NCT04110314|7154076|FG005|Overall Study|Did not meet inclusion criteria|35727
4377654|NCT03568318|7154186|FG000|Overall Study|Adverse Event|3
4377655|NCT03568318|7154187|FG001|Overall Study|Adverse Event|1
4377656|NCT03568318|7154188|FG002|Overall Study|Adverse Event|1
4377657|NCT03568318|7154189|FG003|Overall Study|Adverse Event|0
4377658|NCT03568318|7154190|FG004|Overall Study|Adverse Event|1
4377659|NCT03568318|7154191|FG005|Overall Study|Adverse Event|0
4377660|NCT03568318|7154186|FG000|Overall Study|Withdrawal by Subject|6
4377661|NCT03568318|7154187|FG001|Overall Study|Withdrawal by Subject|5
4377662|NCT03568318|7154188|FG002|Overall Study|Withdrawal by Subject|2
4377663|NCT03568318|7154189|FG003|Overall Study|Withdrawal by Subject|1
4377664|NCT03568318|7154190|FG004|Overall Study|Withdrawal by Subject|0
4377665|NCT03568318|7154191|FG005|Overall Study|Withdrawal by Subject|0
4377666|NCT03568318|7154186|FG000|Overall Study|Lost to Follow-up|3
4377667|NCT03568318|7154187|FG001|Overall Study|Lost to Follow-up|2
4377668|NCT03568318|7154188|FG002|Overall Study|Lost to Follow-up|2
4377669|NCT03568318|7154189|FG003|Overall Study|Lost to Follow-up|2
4377670|NCT03568318|7154190|FG004|Overall Study|Lost to Follow-up|1
4377671|NCT03568318|7154191|FG005|Overall Study|Lost to Follow-up|0
4377672|NCT03568318|7154186|FG000|Overall Study|Other|3
4377673|NCT03568318|7154187|FG001|Overall Study|Other|1
4377674|NCT03568318|7154188|FG002|Overall Study|Other|3
4377675|NCT03568318|7154189|FG003|Overall Study|Other|0
4377676|NCT03568318|7154190|FG004|Overall Study|Other|0
4377677|NCT03568318|7154191|FG005|Overall Study|Other|0
4377678|NCT03568318|7154186|FG000|Overall Study|Ongoing at Time of Analysis|5
4377679|NCT03568318|7154187|FG001|Overall Study|Ongoing at Time of Analysis|3
4377680|NCT03568318|7154188|FG002|Overall Study|Ongoing at Time of Analysis|2
4377681|NCT03568318|7154189|FG003|Overall Study|Ongoing at Time of Analysis|1
4377682|NCT03568318|7154190|FG004|Overall Study|Ongoing at Time of Analysis|0
4377683|NCT03568318|7154191|FG005|Overall Study|Ongoing at Time of Analysis|0
4377684|NCT03525678|7154208|FG000|Overall Study|Ongoing at the time of interim analysis|60
4377685|NCT03525678|7154209|FG001|Overall Study|Ongoing at the time of interim analysis|65
4377686|NCT03525678|7154210|FG002|Overall Study|Ongoing at the time of interim analysis|21
4377687|NCT03525678|7154208|FG000|Overall Study|Withdrawal by Subject|3
4377688|NCT03525678|7154209|FG001|Overall Study|Withdrawal by Subject|1
4377689|NCT03525678|7154210|FG002|Overall Study|Withdrawal by Subject|0
4377690|NCT03525678|7154208|FG000|Overall Study|Physician Decision|1
4377691|NCT03525678|7154209|FG001|Overall Study|Physician Decision|2
4377692|NCT03525678|7154210|FG002|Overall Study|Physician Decision|0
4377693|NCT03525678|7154208|FG000|Overall Study|Lost to Follow-up|1
4377694|NCT03525678|7154209|FG001|Overall Study|Lost to Follow-up|0
4377695|NCT03525678|7154210|FG002|Overall Study|Lost to Follow-up|0
4377696|NCT03525678|7154208|FG000|Overall Study|Death|32
4377697|NCT03525678|7154209|FG001|Overall Study|Death|31
4377698|NCT03525678|7154210|FG002|Overall Study|Death|4
4377699|NCT03498560|7154218|FG000|Overall Study|Found Ineligible|2
4587838|NCT01494532|7432069|FG002|Overall Study|Adverse Event|8
4587839|NCT01494532|7432070|FG003|Overall Study|Adverse Event|6
4587840|NCT01494532|7432071|FG004|Overall Study|Adverse Event|5
4587841|NCT01494532|7432072|FG005|Overall Study|Adverse Event|0
4587842|NCT01494532|7432067|FG000|Overall Study|Lack of Efficacy|0
4587843|NCT01494532|7432068|FG001|Overall Study|Lack of Efficacy|0
4587844|NCT01494532|7432069|FG002|Overall Study|Lack of Efficacy|0
4377700|NCT03498560|7154218|FG000|Overall Study|Withdrawal by Subject|14
4377701|NCT03498560|7154218|FG000|Overall Study|Lost to Follow-up|4
4377702|NCT03498560|7154218|FG000|Overall Study|Death|1
4377703|NCT03441360|7154226|FG000|Overall Study|Radiological disease progression|5
4377704|NCT03441360|7154227|FG001|Overall Study|Radiological disease progression|6
4377705|NCT03441360|7154228|FG002|Overall Study|Radiological disease progression|4
4377706|NCT03441360|7154226|FG000|Overall Study|Clinical disease progression|2
4377707|NCT03441360|7154227|FG001|Overall Study|Clinical disease progression|2
4377708|NCT03441360|7154228|FG002|Overall Study|Clinical disease progression|0
4587845|NCT01494532|7432070|FG003|Overall Study|Lack of Efficacy|0
4377709|NCT03441360|7154226|FG000|Overall Study|Adverse Event|1
4377710|NCT03441360|7154227|FG001|Overall Study|Adverse Event|0
4377711|NCT03441360|7154228|FG002|Overall Study|Adverse Event|1
4377712|NCT03434379|7154238|FG000|Global Period|Lost to Follow-up|3
4377713|NCT03434379|7154239|FG001|Global Period|Lost to Follow-up|1
4377714|NCT03434379|7154240|FG002|Global Period|Lost to Follow-up|0
4377715|NCT03434379|7154241|FG003|Global Period|Lost to Follow-up|0
4377716|NCT03434379|7154238|FG000|Global Period|Death|99
4587846|NCT01494532|7432071|FG004|Overall Study|Lack of Efficacy|2
4377756|NCT03332498|7154287|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2
4466514|NCT00617279|7258242|FG000|Overall Study|Study terminated by Sponsor|10
4466515|NCT00617279|7258243|FG001|Overall Study|Study terminated by Sponsor|15
4466516|NCT00617279|7258242|FG000|Overall Study|Graft abandonment|2
4466517|NCT00617279|7258243|FG001|Overall Study|Graft abandonment|0
4466518|NCT00617279|7258242|FG000|Overall Study|Lost to Follow-up|1
4466519|NCT00617279|7258243|FG001|Overall Study|Lost to Follow-up|0
4466520|NCT00617279|7258242|FG000|Overall Study|Death|1
4466521|NCT00617279|7258243|FG001|Overall Study|Death|2
4466522|NCT00617305|7258252|FG000|Overall Study|Adverse Event|4
4466523|NCT00617305|7258253|FG001|Overall Study|Adverse Event|0
4466524|NCT00617305|7258254|FG002|Overall Study|Adverse Event|0
4466525|NCT00617305|7258252|FG000|Overall Study|Death|1
4466526|NCT00617305|7258253|FG001|Overall Study|Death|0
4466527|NCT00617305|7258254|FG002|Overall Study|Death|0
4466528|NCT00617305|7258252|FG000|Overall Study|Physician Decision|1
4466529|NCT00617305|7258253|FG001|Overall Study|Physician Decision|0
4466530|NCT00617305|7258254|FG002|Overall Study|Physician Decision|0
4466531|NCT00617305|7258252|FG000|Overall Study|Protocol Violation|1
4466532|NCT00617305|7258253|FG001|Overall Study|Protocol Violation|0
4466533|NCT00617305|7258254|FG002|Overall Study|Protocol Violation|1
4466534|NCT00617305|7258252|FG000|Overall Study|Withdrawal by Subject|1
4466535|NCT00617305|7258253|FG001|Overall Study|Withdrawal by Subject|0
4466536|NCT00617305|7258254|FG002|Overall Study|Withdrawal by Subject|0
4466537|NCT00617344|7258268|FG000|Overall Study|Serious adverse event|1
4466538|NCT00617344|7258269|FG001|Overall Study|Serious adverse event|0
4466539|NCT00617344|7258270|FG002|Overall Study|Serious adverse event|0
4466540|NCT00617344|7258268|FG000|Overall Study|Other Adverse Event|1
4466541|NCT00617344|7258269|FG001|Overall Study|Other Adverse Event|1
4466542|NCT00617344|7258270|FG002|Overall Study|Other Adverse Event|0
4466543|NCT00617344|7258268|FG000|Overall Study|Protocol Violation|10
4466544|NCT00617344|7258269|FG001|Overall Study|Protocol Violation|8
4466545|NCT00617344|7258270|FG002|Overall Study|Protocol Violation|5
4466546|NCT00617344|7258268|FG000|Overall Study|Lost to Follow-up|5
4466547|NCT00617344|7258269|FG001|Overall Study|Lost to Follow-up|4
4466548|NCT00617344|7258270|FG002|Overall Study|Lost to Follow-up|1
4466549|NCT00617344|7258268|FG000|Overall Study|Withdrawal by Subject|8
4466550|NCT00617344|7258269|FG001|Overall Study|Withdrawal by Subject|9
4466551|NCT00617344|7258270|FG002|Overall Study|Withdrawal by Subject|2
4466552|NCT00617357|7258278|FG000|Overall Study|Lost to Follow-up|7
4466553|NCT00617357|7258278|FG000|Overall Study|Death|5
4466554|NCT00617357|7258278|FG000|Overall Study|insurance concerns|2
4466555|NCT00617357|7258278|FG000|Overall Study|Withdrawal by Subject|1
4466556|NCT00617357|7258278|FG000|Overall Study|Physician Decision|1
4466557|NCT00617409|7258290|FG000|Overall Study|Withdrawal by Subject|4
4466558|NCT00617409|7258291|FG001|Overall Study|Withdrawal by Subject|1
4466559|NCT00617409|7258292|FG002|Overall Study|Withdrawal by Subject|2
4466560|NCT00617409|7258290|FG000|Overall Study|Adverse Event|0
4466561|NCT00617409|7258291|FG001|Overall Study|Adverse Event|2
4466562|NCT00617409|7258292|FG002|Overall Study|Adverse Event|3
4466563|NCT00617409|7258290|FG000|Overall Study|Disease Progression|8
4466564|NCT00617409|7258291|FG001|Overall Study|Disease Progression|8
4466565|NCT00617409|7258292|FG002|Overall Study|Disease Progression|18
4466566|NCT00617409|7258290|FG000|Overall Study|Death|3
4466567|NCT00617409|7258291|FG001|Overall Study|Death|5
4466568|NCT00617409|7258292|FG002|Overall Study|Death|4
4466569|NCT00617409|7258290|FG000|Overall Study|Alternative Therapy|1
4466570|NCT00617409|7258291|FG001|Overall Study|Alternative Therapy|2
4466571|NCT00617409|7258292|FG002|Overall Study|Alternative Therapy|0
4466572|NCT00617461|7258301|FG000|First Treatment Intervention Period|Adverse Event|2
4466573|NCT00617461|7258302|FG001|First Treatment Intervention Period|Adverse Event|0
4466574|NCT00617461|7258301|FG000|First Treatment Intervention Period|Lack of Efficacy|1
4466575|NCT00617461|7258302|FG001|First Treatment Intervention Period|Lack of Efficacy|0
4466576|NCT00617461|7258301|FG000|First Treatment Intervention Period|Protocol Violation|2
4466577|NCT00617461|7258302|FG001|First Treatment Intervention Period|Protocol Violation|1
4466578|NCT00617461|7258301|FG000|First Treatment Intervention Period|Lost to Follow-up|0
4466579|NCT00617461|7258302|FG001|First Treatment Intervention Period|Lost to Follow-up|1
4466580|NCT00617461|7258301|FG000|First Treatment Intervention Period|Investigator Discretion|1
4466581|NCT00617461|7258302|FG001|First Treatment Intervention Period|Investigator Discretion|1
4466582|NCT00617461|7258301|FG000|First Treatment Intervention Period|Withdrawal by Subject|4
4466583|NCT00617461|7258302|FG001|First Treatment Intervention Period|Withdrawal by Subject|0
4466584|NCT00617461|7258301|FG000|4-Day Crossover Period|Withdrawal by Subject|1
4466585|NCT00617461|7258302|FG001|4-Day Crossover Period|Withdrawal by Subject|0
4466586|NCT00617461|7258301|FG000|Second Treatment Intervention Period|Adverse Event|0
4466587|NCT00617461|7258302|FG001|Second Treatment Intervention Period|Adverse Event|1
4466588|NCT00617461|7258301|FG000|Second Treatment Intervention Period|Lack of Efficacy|0
4466589|NCT00617461|7258302|FG001|Second Treatment Intervention Period|Lack of Efficacy|3
4466590|NCT00617461|7258301|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1
4466591|NCT00617461|7258302|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0
4466592|NCT00617461|7258301|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1
4466593|NCT00617461|7258302|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2
4516344|NCT00959699|7327704|FG000|Treatment Period|Withdrawal by Subject|1
4377757|NCT03230292|7154303|FG000|Overall Study|Adverse Event|1
4377758|NCT03230292|7154303|FG000|Overall Study|Protocol Violation|1
4377759|NCT03230292|7154303|FG000|Overall Study|Lost to Follow-up|1
4377760|NCT03230292|7154303|FG000|Overall Study|Withdrawal by Subject|3
4377761|NCT03131960|7154324|FG000|Overall Study|Adverse Event|0
4377762|NCT03131960|7154325|FG001|Overall Study|Adverse Event|1
4377763|NCT03084536|7154334|FG000|Overall Study|Determined to be ineligible|0
4377764|NCT03084536|7154335|FG001|Overall Study|Determined to be ineligible|0
4377765|NCT03084536|7154336|FG002|Overall Study|Determined to be ineligible|16
4377766|NCT03084536|7154334|FG000|Overall Study|Withdrawal by Subject|0
4377767|NCT03084536|7154335|FG001|Overall Study|Withdrawal by Subject|0
4377768|NCT03084536|7154336|FG002|Overall Study|Withdrawal by Subject|4
4377769|NCT03084536|7154334|FG000|Overall Study|Physician Decision|0
4377770|NCT03084536|7154335|FG001|Overall Study|Physician Decision|0
4377771|NCT03084536|7154336|FG002|Overall Study|Physician Decision|3
4377772|NCT03084536|7154334|FG000|Overall Study|Death|0
4377773|NCT03084536|7154335|FG001|Overall Study|Death|0
4377774|NCT03084536|7154336|FG002|Overall Study|Death|1
4377775|NCT03084536|7154334|FG000|Overall Study|Lost to Follow-up|0
4377776|NCT03084536|7154335|FG001|Overall Study|Lost to Follow-up|0
4377777|NCT03084536|7154336|FG002|Overall Study|Lost to Follow-up|1
4377778|NCT03084536|7154334|FG000|Overall Study|Protocol Violation|0
4377779|NCT03084536|7154335|FG001|Overall Study|Protocol Violation|0
4377780|NCT03084536|7154336|FG002|Overall Study|Protocol Violation|1
4377781|NCT03084536|7154334|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0
4377782|NCT03084536|7154335|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0
4377783|NCT03084536|7154336|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1
4377784|NCT02988661|7154388|FG000|Overall Study|Death|2
4377785|NCT02988661|7154389|FG001|Overall Study|Death|18
4377786|NCT02988661|7154388|FG000|Overall Study|Lost to Follow-up|0
4377787|NCT02988661|7154389|FG001|Overall Study|Lost to Follow-up|33
4377788|NCT02988661|7154388|FG000|Overall Study|Withdrawal by Subject|0
4377789|NCT02988661|7154389|FG001|Overall Study|Withdrawal by Subject|6
4377790|NCT02988661|7154388|FG000|Overall Study|Unable to complete the 18-month survey|1
4377791|NCT02988661|7154389|FG001|Overall Study|Unable to complete the 18-month survey|27
4377792|NCT02951767|7154395|FG000|Overall Study|Ongoing at data cutoff 04 July 2016|54
4377793|NCT02951767|7154395|FG000|Overall Study|Withdrawal by Subject|5
4377794|NCT02951767|7154395|FG000|Overall Study|Death|59
4377795|NCT02951767|7154395|FG000|Overall Study|Lost to Follow-up|1
4377796|NCT02951052|7154401|FG000|Overall Study|Adverse Event|13
4377797|NCT02951052|7154402|FG001|Overall Study|Adverse Event|5
4377798|NCT02951052|7154401|FG000|Overall Study|Withdrawal by Subject|1
4377799|NCT02951052|7154402|FG001|Overall Study|Withdrawal by Subject|5
4377800|NCT02951052|7154401|FG000|Overall Study|Physician Decision|2
4377801|NCT02951052|7154402|FG001|Overall Study|Physician Decision|0
4377802|NCT02951052|7154401|FG000|Overall Study|Lost to Follow-up|1
4377803|NCT02951052|7154402|FG001|Overall Study|Lost to Follow-up|1
4377804|NCT02951052|7154401|FG000|Overall Study|Protocol-specified withdrawal criterion|1
4377805|NCT02951052|7154402|FG001|Overall Study|Protocol-specified withdrawal criterion|0
4377806|NCT02951052|7154401|FG000|Overall Study|Protocol Violation|5
4377807|NCT02951052|7154402|FG001|Overall Study|Protocol Violation|3
4377808|NCT02951052|7154401|FG000|Overall Study|Lack of Efficacy|3
4377809|NCT02951052|7154402|FG001|Overall Study|Lack of Efficacy|4
4377810|NCT02951052|7154401|FG000|Overall Study|Ongoing|1
4377811|NCT02951052|7154402|FG001|Overall Study|Ongoing|0
4377812|NCT02921776|7154418|FG000|Overall Study|patient deterioration, fatigue|2
4377813|NCT02921776|7154419|FG001|Overall Study|patient deterioration, fatigue|6
4377814|NCT02921776|7154420|FG002|Overall Study|patient deterioration, fatigue|0
4377815|NCT02921776|7154421|FG003|Overall Study|patient deterioration, fatigue|0
4377816|NCT02921776|7154422|FG004|Overall Study|patient deterioration, fatigue|0
4377817|NCT02921776|7154423|FG005|Overall Study|patient deterioration, fatigue|0
4377818|NCT02921776|7154424|FG006|Overall Study|patient deterioration, fatigue|0
4377819|NCT02921776|7154425|FG007|Overall Study|patient deterioration, fatigue|0
4377820|NCT02921776|7154418|FG000|Overall Study|Withdrawal by Subject|0
4377821|NCT02921776|7154419|FG001|Overall Study|Withdrawal by Subject|2
4377822|NCT02921776|7154420|FG002|Overall Study|Withdrawal by Subject|0
4377823|NCT02921776|7154421|FG003|Overall Study|Withdrawal by Subject|1
4377824|NCT02921776|7154422|FG004|Overall Study|Withdrawal by Subject|1
4377825|NCT02921776|7154423|FG005|Overall Study|Withdrawal by Subject|0
4377826|NCT02921776|7154424|FG006|Overall Study|Withdrawal by Subject|8
4377827|NCT02921776|7154425|FG007|Overall Study|Withdrawal by Subject|1
4377828|NCT02921776|7154418|FG000|Overall Study|Death|0
4377829|NCT02921776|7154419|FG001|Overall Study|Death|0
4377830|NCT02921776|7154420|FG002|Overall Study|Death|0
4377831|NCT02921776|7154421|FG003|Overall Study|Death|2
4377832|NCT02921776|7154422|FG004|Overall Study|Death|0
4377833|NCT02921776|7154423|FG005|Overall Study|Death|0
4377834|NCT02921776|7154424|FG006|Overall Study|Death|0
4377835|NCT02921776|7154425|FG007|Overall Study|Death|0
4377836|NCT02921776|7154418|FG000|Overall Study|extubation or early discharge|0
4377837|NCT02921776|7154419|FG001|Overall Study|extubation or early discharge|0
4377838|NCT02921776|7154420|FG002|Overall Study|extubation or early discharge|0
4377839|NCT02921776|7154421|FG003|Overall Study|extubation or early discharge|5
4377840|NCT02921776|7154422|FG004|Overall Study|extubation or early discharge|5
4377841|NCT02921776|7154423|FG005|Overall Study|extubation or early discharge|0
4377842|NCT02921776|7154424|FG006|Overall Study|extubation or early discharge|0
4377843|NCT02921776|7154425|FG007|Overall Study|extubation or early discharge|0
4377844|NCT02921776|7154418|FG000|Overall Study|Lost to Follow-up|0
4377845|NCT02921776|7154419|FG001|Overall Study|Lost to Follow-up|0
4377846|NCT02921776|7154420|FG002|Overall Study|Lost to Follow-up|0
4377847|NCT02921776|7154421|FG003|Overall Study|Lost to Follow-up|0
4377848|NCT02921776|7154422|FG004|Overall Study|Lost to Follow-up|0
4377849|NCT02921776|7154423|FG005|Overall Study|Lost to Follow-up|2
4377850|NCT02921776|7154424|FG006|Overall Study|Lost to Follow-up|3
4377851|NCT02921776|7154425|FG007|Overall Study|Lost to Follow-up|6
4377852|NCT02898259|7154454|FG000|Overall Study|Adverse Event|0
4377853|NCT02898259|7154455|FG001|Overall Study|Adverse Event|0
4377854|NCT02898259|7154456|FG002|Overall Study|Adverse Event|1
4377855|NCT02898259|7154457|FG003|Overall Study|Adverse Event|0
4377856|NCT02898259|7154458|FG004|Overall Study|Adverse Event|0
4377857|NCT02898259|7154454|FG000|Overall Study|Lack of Efficacy|1
4377858|NCT02898259|7154455|FG001|Overall Study|Lack of Efficacy|1
4377859|NCT02898259|7154456|FG002|Overall Study|Lack of Efficacy|3
4377860|NCT02898259|7154457|FG003|Overall Study|Lack of Efficacy|0
4377861|NCT02898259|7154458|FG004|Overall Study|Lack of Efficacy|0
4377862|NCT02898259|7154454|FG000|Overall Study|Lost to Follow-up|0
4377863|NCT02898259|7154455|FG001|Overall Study|Lost to Follow-up|0
4377864|NCT02898259|7154456|FG002|Overall Study|Lost to Follow-up|1
4377865|NCT02898259|7154457|FG003|Overall Study|Lost to Follow-up|0
4377866|NCT02898259|7154458|FG004|Overall Study|Lost to Follow-up|0
4377867|NCT02898259|7154454|FG000|Overall Study|Transformation before study began|0
4377868|NCT02898259|7154455|FG001|Overall Study|Transformation before study began|0
4377869|NCT02898259|7154456|FG002|Overall Study|Transformation before study began|0
4377870|NCT02898259|7154457|FG003|Overall Study|Transformation before study began|1
4377871|NCT02898259|7154458|FG004|Overall Study|Transformation before study began|0
4466594|NCT00617591|7258329|FG000|Overall Study|Withdrew consent during Induction|4
4466595|NCT00617591|7258329|FG000|Overall Study|Withdrew consent during Maintenance|6
4466596|NCT00617604|7258336|FG000|Overall Study|Death|2
4466597|NCT00617604|7258337|FG001|Overall Study|Death|1
4466598|NCT00617604|7258336|FG000|Overall Study|Lost to Follow-up|1
4466599|NCT00617604|7258337|FG001|Overall Study|Lost to Follow-up|0
4466600|NCT00617604|7258336|FG000|Overall Study|Miscellaneous Reasons|8
4466601|NCT00617604|7258337|FG001|Overall Study|Miscellaneous Reasons|10
4466602|NCT00617604|7258336|FG000|Overall Study|Withdrawal by Subject|4
4466603|NCT00617604|7258337|FG001|Overall Study|Withdrawal by Subject|6
4466604|NCT00617604|7258336|FG000|Overall Study|Randomized but Never Received Study Drug|3
4466605|NCT00617604|7258337|FG001|Overall Study|Randomized but Never Received Study Drug|3
4466606|NCT00617669|7258345|FG000|Overall Study|Withdrawal by Subject|71
4466607|NCT00617669|7258346|FG001|Overall Study|Withdrawal by Subject|77
4466608|NCT00617669|7258345|FG000|Overall Study|Lost to Follow-up|3
4466609|NCT00617669|7258346|FG001|Overall Study|Lost to Follow-up|2
4466610|NCT00617669|7258345|FG000|Overall Study|Adverse Event|87
4466611|NCT00617669|7258346|FG001|Overall Study|Adverse Event|76
4466612|NCT00617669|7258345|FG000|Overall Study|Protocol Violation|2
4466613|NCT00617669|7258346|FG001|Overall Study|Protocol Violation|3
4466614|NCT00617669|7258345|FG000|Overall Study|Reason not otherwise captured, eg; death|265
4466615|NCT00617669|7258346|FG001|Overall Study|Reason not otherwise captured, eg; death|290
4466616|NCT00617669|7258345|FG000|Overall Study|Patients randomized but not treated|2
4466617|NCT00617669|7258346|FG001|Overall Study|Patients randomized but not treated|3
4466618|NCT00617734|7258354|FG000|Overall Study|Withdrew Consent|2
4466619|NCT00617734|7258355|FG001|Overall Study|Withdrew Consent|0
4466620|NCT00617734|7258354|FG000|Overall Study|Adverse Event|4
4466621|NCT00617734|7258355|FG001|Overall Study|Adverse Event|1
4466622|NCT00617734|7258354|FG000|Overall Study|Protocol Violation|1
4466623|NCT00617734|7258355|FG001|Overall Study|Protocol Violation|0
4466624|NCT00617734|7258354|FG000|Overall Study|Found Ineligible After Randomization|1
4466625|NCT00617734|7258355|FG001|Overall Study|Found Ineligible After Randomization|4
4466626|NCT00617734|7258354|FG000|Overall Study|Lost to Follow-up|0
4466627|NCT00617734|7258355|FG001|Overall Study|Lost to Follow-up|1
4466628|NCT00617773|7258361|FG000|Overall Study|Physician Decision|1
4466629|NCT00617773|7258361|FG000|Overall Study|Lack of compliance with the protocol|1
4466630|NCT00617773|7258361|FG000|Overall Study|Withdrawal by Subject|1
4466631|NCT00617773|7258361|FG000|Overall Study|Death|1
4466632|NCT00617773|7258361|FG000|Overall Study|Progressive disease|19
4466633|NCT00617773|7258361|FG000|Overall Study|Protocol Violation|1
4466634|NCT00617851|7258369|FG000|Overall Study|Death|0
4466635|NCT00617851|7258370|FG001|Overall Study|Death|0
4466636|NCT00617851|7258371|FG002|Overall Study|Death|0
4466637|NCT00617851|7258372|FG003|Overall Study|Death|1
4466638|NCT00617851|7258369|FG000|Overall Study|Withdrawal by Subject|14
4466639|NCT00617851|7258370|FG001|Overall Study|Withdrawal by Subject|7
4466640|NCT00617851|7258371|FG002|Overall Study|Withdrawal by Subject|12
4466641|NCT00617851|7258372|FG003|Overall Study|Withdrawal by Subject|4
4466642|NCT00617851|7258369|FG000|Overall Study|Lost to Follow-up|27
4466643|NCT00617851|7258370|FG001|Overall Study|Lost to Follow-up|29
4466644|NCT00617851|7258371|FG002|Overall Study|Lost to Follow-up|31
4466645|NCT00617851|7258372|FG003|Overall Study|Lost to Follow-up|19
4377872|NCT02870348|7154471|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4
4377873|NCT02841280|7154477|FG000|Overall Study|Adverse Event|2
4377874|NCT02841280|7154478|FG001|Overall Study|Adverse Event|1
4377875|NCT02841280|7154477|FG000|Overall Study|Death|1
4377876|NCT02841280|7154478|FG001|Overall Study|Death|0
4377877|NCT02841280|7154477|FG000|Overall Study|Lost to Follow-up|2
4377878|NCT02841280|7154478|FG001|Overall Study|Lost to Follow-up|2
4377879|NCT02841280|7154477|FG000|Overall Study|Withdrawal by Subject|7
4377880|NCT02841280|7154478|FG001|Overall Study|Withdrawal by Subject|3
4377881|NCT02841280|7154477|FG000|Overall Study|Stop Point: BP above threshold|2
4377882|NCT02841280|7154478|FG001|Overall Study|Stop Point: BP above threshold|0
4377883|NCT02771275|7154501|FG000|Overall Study|Reoperation|2
4377884|NCT02771275|7154501|FG000|Overall Study|On Study|11
4377885|NCT02675426|7154508|FG000|Overall Study|Adverse Event|6
4377886|NCT02675426|7154509|FG001|Overall Study|Adverse Event|2
4377887|NCT02675426|7154510|FG002|Overall Study|Adverse Event|9
4377888|NCT02675426|7154508|FG000|Overall Study|Withdrawal by Subject|3
4377889|NCT02675426|7154509|FG001|Overall Study|Withdrawal by Subject|5
4377890|NCT02675426|7154510|FG002|Overall Study|Withdrawal by Subject|5
4377891|NCT02675426|7154508|FG000|Overall Study|Lost to Follow-up|1
4377892|NCT02675426|7154509|FG001|Overall Study|Lost to Follow-up|0
4377893|NCT02675426|7154510|FG002|Overall Study|Lost to Follow-up|2
4377894|NCT02675426|7154508|FG000|Overall Study|Other|3
4377895|NCT02675426|7154509|FG001|Overall Study|Other|1
4377896|NCT02675426|7154510|FG002|Overall Study|Other|2
4377897|NCT02639546|7154526|FG000|Overall Study|Death|2
4377898|NCT02639546|7154527|FG001|Overall Study|Death|2
4377899|NCT02639546|7154528|FG002|Overall Study|Death|1
4377900|NCT02639546|7154529|FG003|Overall Study|Death|2
4377901|NCT02639546|7154530|FG004|Overall Study|Death|2
4377902|NCT02639546|7154531|FG005|Overall Study|Death|2
4377903|NCT02639546|7154532|FG006|Overall Study|Death|0
4377904|NCT02639546|7154533|FG007|Overall Study|Death|0
4377905|NCT02639546|7154526|FG000|Overall Study|Lost to Follow-up|0
4377906|NCT02639546|7154527|FG001|Overall Study|Lost to Follow-up|0
4377907|NCT02639546|7154528|FG002|Overall Study|Lost to Follow-up|1
4377908|NCT02639546|7154529|FG003|Overall Study|Lost to Follow-up|0
4377909|NCT02639546|7154530|FG004|Overall Study|Lost to Follow-up|1
4377910|NCT02639546|7154531|FG005|Overall Study|Lost to Follow-up|1
4377911|NCT02639546|7154532|FG006|Overall Study|Lost to Follow-up|0
4377912|NCT02639546|7154533|FG007|Overall Study|Lost to Follow-up|1
4377913|NCT02639546|7154526|FG000|Overall Study|PI, physician decision; no response to trt.|2
4377914|NCT02639546|7154527|FG001|Overall Study|PI, physician decision; no response to trt.|0
4377915|NCT02639546|7154528|FG002|Overall Study|PI, physician decision; no response to trt.|0
4377916|NCT02639546|7154529|FG003|Overall Study|PI, physician decision; no response to trt.|0
4377917|NCT02639546|7154530|FG004|Overall Study|PI, physician decision; no response to trt.|0
4377918|NCT02639546|7154531|FG005|Overall Study|PI, physician decision; no response to trt.|1
4377919|NCT02639546|7154532|FG006|Overall Study|PI, physician decision; no response to trt.|0
4377920|NCT02639546|7154533|FG007|Overall Study|PI, physician decision; no response to trt.|1
4377921|NCT02639546|7154526|FG000|Overall Study|Study Terminated By Sponsor|0
4377922|NCT02639546|7154527|FG001|Overall Study|Study Terminated By Sponsor|2
4377923|NCT02639546|7154528|FG002|Overall Study|Study Terminated By Sponsor|3
4377924|NCT02639546|7154529|FG003|Overall Study|Study Terminated By Sponsor|4
4377925|NCT02639546|7154530|FG004|Overall Study|Study Terminated By Sponsor|4
4377926|NCT02639546|7154531|FG005|Overall Study|Study Terminated By Sponsor|3
4377927|NCT02639546|7154532|FG006|Overall Study|Study Terminated By Sponsor|3
4377928|NCT02639546|7154533|FG007|Overall Study|Study Terminated By Sponsor|9
4377929|NCT02639546|7154526|FG000|Overall Study|Withdrawal by Subject|2
4377930|NCT02639546|7154527|FG001|Overall Study|Withdrawal by Subject|2
4377931|NCT02639546|7154528|FG002|Overall Study|Withdrawal by Subject|1
4377932|NCT02639546|7154529|FG003|Overall Study|Withdrawal by Subject|0
4466646|NCT00617851|7258369|FG000|Overall Study|Inappropriate Enrollment|5
4466647|NCT00617851|7258370|FG001|Overall Study|Inappropriate Enrollment|4
4466648|NCT00617851|7258371|FG002|Overall Study|Inappropriate Enrollment|1
4466649|NCT00617851|7258372|FG003|Overall Study|Inappropriate Enrollment|1
4466650|NCT00617851|7258369|FG000|Overall Study|Unable to classify|1
4466651|NCT00617851|7258370|FG001|Overall Study|Unable to classify|0
4377933|NCT02639546|7154530|FG004|Overall Study|Withdrawal by Subject|0
4377934|NCT02639546|7154531|FG005|Overall Study|Withdrawal by Subject|1
4377935|NCT02639546|7154532|FG006|Overall Study|Withdrawal by Subject|2
4377936|NCT02639546|7154533|FG007|Overall Study|Withdrawal by Subject|1
4377937|NCT02575339|7154568|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1
4377938|NCT02575339|7154569|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0
4377939|NCT02575339|7154570|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0
4377940|NCT02575339|7154568|FG000|Study Treatment|Disease Progression|5
4377941|NCT02575339|7154569|FG001|Study Treatment|Disease Progression|2
4377942|NCT02575339|7154570|FG002|Study Treatment|Disease Progression|0
4377943|NCT02575339|7154568|FG000|Study Treatment|Adverse Event|1
4377944|NCT02575339|7154569|FG001|Study Treatment|Adverse Event|2
4377945|NCT02575339|7154570|FG002|Study Treatment|Adverse Event|0
4377946|NCT02575339|7154568|FG000|Follow up|Death|6
4377947|NCT02575339|7154569|FG001|Follow up|Death|2
4377948|NCT02575339|7154570|FG002|Follow up|Death|0
4377949|NCT02575339|7154568|FG000|Follow up|Study Terminated|0
4377950|NCT02575339|7154569|FG001|Follow up|Study Terminated|2
4377951|NCT02575339|7154570|FG002|Follow up|Study Terminated|0
4377952|NCT02575339|7154568|FG000|Follow up|Death due to progressive disease after coming off treatment early|1
4377953|NCT02575339|7154569|FG001|Follow up|Death due to progressive disease after coming off treatment early|0
4377954|NCT02575339|7154570|FG002|Follow up|Death due to progressive disease after coming off treatment early|0
4377955|NCT02542267|7154580|FG000|Overall Study|Withdrawal by Subject|10
4377956|NCT02542267|7154580|FG000|Overall Study|Physician Decision|6
4377957|NCT02542267|7154580|FG000|Overall Study|Lost to Follow-up|4
4377958|NCT02542267|7154580|FG000|Overall Study|Death|13
4377959|NCT02542267|7154580|FG000|Overall Study|Surgical Bypass of All Study Devices|13
4377960|NCT02542267|7154580|FG000|Overall Study|Other|9
4377961|NCT02498444|7154586|FG000|Overall Study|Withdrawal by Subject|3
4377962|NCT02498444|7154587|FG001|Overall Study|Withdrawal by Subject|0
4377963|NCT02498444|7154586|FG000|Overall Study|Physician Decision|1
4377964|NCT02498444|7154587|FG001|Overall Study|Physician Decision|0
4377965|NCT02487108|7154597|FG000|Overall Study|Adverse Event|1
4377966|NCT02487108|7154598|FG001|Overall Study|Adverse Event|6
4377967|NCT02487108|7154599|FG002|Overall Study|Adverse Event|12
4377968|NCT02487108|7154600|FG003|Overall Study|Adverse Event|6
4377969|NCT02487108|7154597|FG000|Overall Study|Withdrawal by Subject|8
4377970|NCT02487108|7154598|FG001|Overall Study|Withdrawal by Subject|5
4377971|NCT02487108|7154599|FG002|Overall Study|Withdrawal by Subject|5
4377972|NCT02487108|7154600|FG003|Overall Study|Withdrawal by Subject|0
4377973|NCT02487108|7154597|FG000|Overall Study|Non-compliance to study medication|3
4377974|NCT02487108|7154598|FG001|Overall Study|Non-compliance to study medication|2
4377975|NCT02487108|7154599|FG002|Overall Study|Non-compliance to study medication|5
4377976|NCT02487108|7154600|FG003|Overall Study|Non-compliance to study medication|4
4377977|NCT02487108|7154597|FG000|Overall Study|Protocol Violation|1
4377978|NCT02487108|7154598|FG001|Overall Study|Protocol Violation|1
4377979|NCT02487108|7154599|FG002|Overall Study|Protocol Violation|2
4377980|NCT02487108|7154600|FG003|Overall Study|Protocol Violation|0
4377981|NCT02487108|7154597|FG000|Overall Study|Non-compliance to study procedures|0
4377982|NCT02487108|7154598|FG001|Overall Study|Non-compliance to study procedures|0
4377983|NCT02487108|7154599|FG002|Overall Study|Non-compliance to study procedures|0
4377984|NCT02487108|7154600|FG003|Overall Study|Non-compliance to study procedures|1
4377985|NCT02487108|7154597|FG000|Overall Study|Other than specified|3
4377986|NCT02487108|7154598|FG001|Overall Study|Other than specified|2
4377987|NCT02487108|7154599|FG002|Overall Study|Other than specified|2
4377988|NCT02487108|7154600|FG003|Overall Study|Other than specified|0
4377989|NCT02455557|7154610|FG000|Overall Study|Withdrawal by Subject|2
4377990|NCT02435849|7154614|FG000|Overall Study|Enrolled but not infused|18
4377991|NCT02435849|7154614|FG000|Overall Study|Death|16
4377992|NCT02435849|7154614|FG000|Overall Study|Lack of Efficacy|9
4377993|NCT02435849|7154614|FG000|Overall Study|New therapy for study indication|7
4377994|NCT02435849|7154614|FG000|Overall Study|Subject/guardian decision|2
4377995|NCT02435849|7154614|FG000|Overall Study|Study follow-up ongoing|45
4377996|NCT02387996|7154627|FG000|Overall Study|Disease Progression|144
4377997|NCT02387996|7154627|FG000|Overall Study|Study Drug Toxicity|14
4377998|NCT02387996|7154627|FG000|Overall Study|Adverse Event Unrelated to Study Drug|34
4377999|NCT02387996|7154627|FG000|Overall Study|Subject Request to Discontinue Treatment|9
4378000|NCT02387996|7154627|FG000|Overall Study|Subject Withdrew Consent|1
4378001|NCT02387996|7154627|FG000|Overall Study|Lost to Follow-up|1
4378002|NCT02387996|7154627|FG000|Overall Study|Poor/Non-Compliance|1
4378003|NCT02351856|7154644|FG000|Overall Study|Adverse Event|2
4378004|NCT02351856|7154644|FG000|Overall Study|Physician Decision|5
4378005|NCT02351856|7154644|FG000|Overall Study|Study terminated by sponsor|1
4378006|NCT02349386|7154652|FG000|24-Week Double-Blind Main Study|Adverse Event|0
4378007|NCT02349386|7154653|FG001|24-Week Double-Blind Main Study|Adverse Event|0
4378008|NCT02349386|7154654|FG002|24-Week Double-Blind Main Study|Adverse Event|1
4378009|NCT02349386|7154655|FG003|24-Week Double-Blind Main Study|Adverse Event|1
4378010|NCT02349386|7154652|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6
4378011|NCT02349386|7154653|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6
4378012|NCT02349386|7154654|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2
4378013|NCT02349386|7154655|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7
4378014|NCT02349386|7154652|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0
4378015|NCT02349386|7154653|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0
4378016|NCT02349386|7154654|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1
4378017|NCT02349386|7154655|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0
4378018|NCT02349386|7154652|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0
4378019|NCT02349386|7154653|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0
4378020|NCT02349386|7154654|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1
4378021|NCT02349386|7154655|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0
4378022|NCT02349386|7154652|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2
4378023|NCT02349386|7154653|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0
4378024|NCT02349386|7154654|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2
4378025|NCT02349386|7154655|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0
4378026|NCT02349386|7154652|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0
4378027|NCT02349386|7154653|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0
4378028|NCT02349386|7154654|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1
4378029|NCT02349386|7154655|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0
4466652|NCT00617851|7258371|FG002|Overall Study|Unable to classify|1
4466653|NCT00617851|7258372|FG003|Overall Study|Unable to classify|0
4466654|NCT00617890|7258396|FG000|Overall Study|Treatment ongoing at data cut-off|0
4466655|NCT00617890|7258397|FG001|Overall Study|Treatment ongoing at data cut-off|0
4587847|NCT01494532|7432072|FG005|Overall Study|Lack of Efficacy|0
4466656|NCT00617890|7258398|FG002|Overall Study|Treatment ongoing at data cut-off|0
4466657|NCT00617890|7258399|FG003|Overall Study|Treatment ongoing at data cut-off|5
4466658|NCT00617890|7258396|FG000|Overall Study|Lack of Efficacy|23
4466659|NCT00617890|7258397|FG001|Overall Study|Lack of Efficacy|26
4466660|NCT00617890|7258398|FG002|Overall Study|Lack of Efficacy|30
4466661|NCT00617890|7258399|FG003|Overall Study|Lack of Efficacy|97
4466662|NCT00617890|7258396|FG000|Overall Study|Lost to Follow-up|0
4466663|NCT00617890|7258397|FG001|Overall Study|Lost to Follow-up|0
4466664|NCT00617890|7258398|FG002|Overall Study|Lost to Follow-up|1
4466665|NCT00617890|7258399|FG003|Overall Study|Lost to Follow-up|2
4466666|NCT00617890|7258396|FG000|Overall Study|Withdrawal by Subject|4
4466667|NCT00617890|7258397|FG001|Overall Study|Withdrawal by Subject|1
4466668|NCT00617890|7258398|FG002|Overall Study|Withdrawal by Subject|0
4466669|NCT00617890|7258399|FG003|Overall Study|Withdrawal by Subject|2
4466670|NCT00617890|7258396|FG000|Overall Study|Protocol Violation|2
4466671|NCT00617890|7258397|FG001|Overall Study|Protocol Violation|1
4466672|NCT00617890|7258398|FG002|Overall Study|Protocol Violation|0
4466673|NCT00617890|7258399|FG003|Overall Study|Protocol Violation|0
4466674|NCT00617890|7258396|FG000|Overall Study|Adverse Event|1
4466675|NCT00617890|7258397|FG001|Overall Study|Adverse Event|0
4466676|NCT00617890|7258398|FG002|Overall Study|Adverse Event|3
4466677|NCT00617890|7258399|FG003|Overall Study|Adverse Event|8
4466678|NCT00617890|7258396|FG000|Overall Study|Not treated|1
4466679|NCT00617890|7258397|FG001|Overall Study|Not treated|0
4466680|NCT00617890|7258398|FG002|Overall Study|Not treated|1
4466681|NCT00617890|7258399|FG003|Overall Study|Not treated|1
4466682|NCT00617903|7258414|FG000|Overall Study|Withdrawal by Subject|2
4466683|NCT00617903|7258415|FG001|Overall Study|Withdrawal by Subject|3
4466684|NCT00617903|7258414|FG000|Overall Study|Lost to Follow-up|1
4466685|NCT00617903|7258415|FG001|Overall Study|Lost to Follow-up|1
4466686|NCT00617903|7258414|FG000|Overall Study|Lack of Efficacy|0
4466687|NCT00617903|7258415|FG001|Overall Study|Lack of Efficacy|1
4466688|NCT00617903|7258414|FG000|Overall Study|Adverse Event|0
4466689|NCT00617903|7258415|FG001|Overall Study|Adverse Event|1
4466690|NCT00617903|7258414|FG000|Overall Study|noncompliance|0
4466691|NCT00617903|7258415|FG001|Overall Study|noncompliance|1
4466692|NCT00617929|7258421|FG000|Overall Study|Physician Decision|1
4466693|NCT00618072|7258452|FG000|Overall Study|Lost to Follow-up|2
4466694|NCT00618072|7258453|FG001|Overall Study|Lost to Follow-up|0
4466695|NCT00618072|7258454|FG002|Overall Study|Lost to Follow-up|3
4466696|NCT00618072|7258452|FG000|Overall Study|Physician Decision|0
4466697|NCT00618072|7258453|FG001|Overall Study|Physician Decision|1
4466698|NCT00618072|7258454|FG002|Overall Study|Physician Decision|1
4466699|NCT00618371|7258471|FG000|Overall Study|Withdrawal by Subject|2
4466700|NCT00618410|7258476|FG000|Washout Period (2 Weeks)|Physician Decision|0
4466701|NCT00618410|7258477|FG001|Washout Period (2 Weeks)|Physician Decision|1
4466702|NCT00618449|7258494|FG000|Overall Study|Lost to Follow-up|98
4466703|NCT00618449|7258495|FG001|Overall Study|Lost to Follow-up|110
4466704|NCT00618514|7258503|FG000|Overall Study|Lost to Follow-up|11
4466705|NCT00618514|7258504|FG001|Overall Study|Lost to Follow-up|12
4466706|NCT00618514|7258505|FG002|Overall Study|Lost to Follow-up|4
4466707|NCT00618618|7258520|FG000|Overall Study|Patient Request|0
4466708|NCT00618618|7258521|FG001|Overall Study|Patient Request|0
4466709|NCT00618618|7258522|FG002|Overall Study|Patient Request|2
4466710|NCT00618618|7258523|FG003|Overall Study|Patient Request|0
4466711|NCT00618618|7258520|FG000|Overall Study|Inability to Complete Study Procedures|0
4466712|NCT00618618|7258521|FG001|Overall Study|Inability to Complete Study Procedures|1
4466713|NCT00618618|7258522|FG002|Overall Study|Inability to Complete Study Procedures|0
4466714|NCT00618618|7258523|FG003|Overall Study|Inability to Complete Study Procedures|0
4466715|NCT00618618|7258520|FG000|Overall Study|Lost to Follow-up|3
4466716|NCT00618618|7258521|FG001|Overall Study|Lost to Follow-up|0
4466717|NCT00618618|7258522|FG002|Overall Study|Lost to Follow-up|0
4466718|NCT00618618|7258523|FG003|Overall Study|Lost to Follow-up|1
4466719|NCT00618618|7258520|FG000|Overall Study|Non-compliance|1
4466720|NCT00618618|7258521|FG001|Overall Study|Non-compliance|1
4466721|NCT00618618|7258522|FG002|Overall Study|Non-compliance|0
4466722|NCT00618618|7258523|FG003|Overall Study|Non-compliance|0
4466723|NCT00618618|7258520|FG000|Overall Study|Did Not Meet Entry Criteria|0
4466724|NCT00618618|7258521|FG001|Overall Study|Did Not Meet Entry Criteria|0
4466725|NCT00618618|7258522|FG002|Overall Study|Did Not Meet Entry Criteria|1
4466726|NCT00618618|7258523|FG003|Overall Study|Did Not Meet Entry Criteria|0
4466727|NCT00618618|7258520|FG000|Overall Study|Death|0
4466728|NCT00618618|7258521|FG001|Overall Study|Death|1
4466729|NCT00618618|7258522|FG002|Overall Study|Death|0
4378030|NCT02328014|7154669|FG000|Overall Study|Adverse Event|1
4378031|NCT02328014|7154670|FG001|Overall Study|Adverse Event|0
4378032|NCT02328014|7154671|FG002|Overall Study|Adverse Event|0
4587848|NCT01494532|7432067|FG000|Overall Study|Protocol deviation|2
4378033|NCT02328014|7154672|FG003|Overall Study|Adverse Event|1
4378034|NCT02328014|7154669|FG000|Overall Study|Death|0
4378035|NCT02328014|7154670|FG001|Overall Study|Death|0
4378036|NCT02328014|7154671|FG002|Overall Study|Death|0
4378037|NCT02328014|7154672|FG003|Overall Study|Death|4
4378038|NCT02328014|7154669|FG000|Overall Study|Physician Decision|0
4378039|NCT02328014|7154670|FG001|Overall Study|Physician Decision|0
4378040|NCT02328014|7154671|FG002|Overall Study|Physician Decision|0
4378041|NCT02328014|7154672|FG003|Overall Study|Physician Decision|1
4378042|NCT02328014|7154669|FG000|Overall Study|Disease Progression|1
4378043|NCT02328014|7154670|FG001|Overall Study|Disease Progression|0
4378044|NCT02328014|7154671|FG002|Overall Study|Disease Progression|1
4378045|NCT02328014|7154672|FG003|Overall Study|Disease Progression|3
4378046|NCT02328014|7154669|FG000|Overall Study|Study Terminated by Sponsor|4
4378047|NCT02328014|7154670|FG001|Overall Study|Study Terminated by Sponsor|1
4378048|NCT02328014|7154671|FG002|Overall Study|Study Terminated by Sponsor|1
4378049|NCT02328014|7154672|FG003|Overall Study|Study Terminated by Sponsor|0
4378050|NCT02328014|7154669|FG000|Overall Study|Subject Started Another Cancer Therapy|0
4378051|NCT02328014|7154670|FG001|Overall Study|Subject Started Another Cancer Therapy|5
4378052|NCT02328014|7154671|FG002|Overall Study|Subject Started Another Cancer Therapy|4
4378053|NCT02328014|7154672|FG003|Overall Study|Subject Started Another Cancer Therapy|12
4378054|NCT02328014|7154669|FG000|Overall Study|Withdrawal by Subject|0
4378055|NCT02328014|7154670|FG001|Overall Study|Withdrawal by Subject|0
4378056|NCT02328014|7154671|FG002|Overall Study|Withdrawal by Subject|0
4378057|NCT02328014|7154672|FG003|Overall Study|Withdrawal by Subject|1
4378058|NCT02108652|7154695|FG000|Overall Study|Death|226
4378059|NCT02108652|7154695|FG000|Overall Study|Lost to Follow-up|2
4378060|NCT02108652|7154695|FG000|Overall Study|Withdrawal by Subject|8
4378061|NCT02108652|7154695|FG000|Overall Study|Ongoing at data cutoff 04 July 2016|74
4378062|NCT01904032|7154710|FG000|Overall Study|Adverse Event|3
4378063|NCT01904032|7154711|FG001|Overall Study|Adverse Event|1
4378064|NCT01904032|7154710|FG000|Overall Study|Lost to Follow-up|4
4378065|NCT01904032|7154711|FG001|Overall Study|Lost to Follow-up|2
4378066|NCT01772472|7154728|FG000|Overall Study|Death|56
4378067|NCT01772472|7154729|FG001|Overall Study|Death|42
4378068|NCT01772472|7154728|FG000|Overall Study|Physician Decision|1
4378069|NCT01772472|7154729|FG001|Overall Study|Physician Decision|3
4378070|NCT01772472|7154728|FG000|Overall Study|Other|5
4378071|NCT01772472|7154729|FG001|Overall Study|Other|5
4378072|NCT01772472|7154728|FG000|Overall Study|Lost to Follow-up|12
4378073|NCT01772472|7154729|FG001|Overall Study|Lost to Follow-up|8
4378074|NCT01772472|7154728|FG000|Overall Study|Withdrawal by Subject|72
4378075|NCT01772472|7154729|FG001|Overall Study|Withdrawal by Subject|50
4378076|NCT01772472|7154728|FG000|Overall Study|Ongoing|597
4378077|NCT01772472|7154729|FG001|Overall Study|Ongoing|635
4378078|NCT01632878|7154746|FG000|Screening|Physician Decision|268
4378079|NCT01632878|7154746|FG000|Treatment|Lost to Follow-up|41
4378080|NCT01632878|7154746|FG000|Treatment|Withdrawal by Subject|36
4378081|NCT01632878|7154746|FG000|Treatment|Physician Decision|34
4378082|NCT01632878|7154746|FG000|Treatment|missing information|4
4378083|NCT01632878|7154746|FG000|Treatment|no information on study completion|43
4378084|NCT01097005|7154754|FG000|Overall Study|Case Report Form not collected|18
4378085|NCT01097005|7154754|FG000|Overall Study|Subjects cannot visit the hospital|1
4378086|NCT01097005|7154754|FG000|Overall Study|Poor medication compliance|1
4378087|NCT01097005|7154754|FG000|Overall Study|No examination data available|244
4378088|NCT01097005|7154754|FG000|Overall Study|Deviation from exclusion criteria|37
4378089|NCT01097005|7154754|FG000|Overall Study|Adverse Event|14
4378090|NCT01097005|7154754|FG000|Overall Study|Discontinuance by complication|50
4378091|NCT00931255|7154766|FG000|Overall Study|Follow up biopsy not done|2
4378092|NCT00931255|7154767|FG001|Overall Study|Follow up biopsy not done|3
4378093|NCT00669669|7154773|FG000|Overall Study|To late to start treatment|1
4378094|NCT00608023|7154780|FG000|Overall Study|Withdrawal by Subject|8
4378095|NCT00608023|7154781|FG001|Overall Study|Withdrawal by Subject|10
4378096|NCT00608023|7154782|FG002|Overall Study|Withdrawal by Subject|7
4378097|NCT00608023|7154780|FG000|Overall Study|Adverse Event|1
4378098|NCT00608023|7154781|FG001|Overall Study|Adverse Event|4
4378099|NCT00608023|7154782|FG002|Overall Study|Adverse Event|5
4378100|NCT00608023|7154780|FG000|Overall Study|Lost to Follow-up|2
4378101|NCT00608023|7154781|FG001|Overall Study|Lost to Follow-up|2
4378102|NCT00608023|7154782|FG002|Overall Study|Lost to Follow-up|1
4378103|NCT00608023|7154780|FG000|Overall Study|Protocol Violation|1
4378104|NCT00608023|7154781|FG001|Overall Study|Protocol Violation|3
4378105|NCT00608023|7154782|FG002|Overall Study|Protocol Violation|1
4378106|NCT00608023|7154780|FG000|Overall Study|Unknown reason|0
4378107|NCT00608023|7154781|FG001|Overall Study|Unknown reason|3
4378108|NCT00608023|7154782|FG002|Overall Study|Unknown reason|0
4770896|NCT01986933|7747291|FG004|Active-to-active (Part B)|Pregnancy|1
4770897|NCT01986933|7747287|FG000|Active-to-active (Part B)|Physician Decision|0
4770898|NCT01986933|7747288|FG001|Active-to-active (Part B)|Physician Decision|0
4770899|NCT01986933|7747289|FG002|Active-to-active (Part B)|Physician Decision|1
4770900|NCT01986933|7747290|FG003|Active-to-active (Part B)|Physician Decision|1
4770901|NCT01986933|7747291|FG004|Active-to-active (Part B)|Physician Decision|0
4770902|NCT01986933|7747287|FG000|Active-to-active (Part B)|Withdrawal by Subject|0
4770903|NCT01986933|7747288|FG001|Active-to-active (Part B)|Withdrawal by Subject|4
4770904|NCT01986933|7747289|FG002|Active-to-active (Part B)|Withdrawal by Subject|7
4770905|NCT01986933|7747290|FG003|Active-to-active (Part B)|Withdrawal by Subject|6
4770906|NCT01986933|7747291|FG004|Active-to-active (Part B)|Withdrawal by Subject|6
4770907|NCT01986933|7747287|FG000|Active-to-active (Part B)|Lost to Follow-up|0
4770908|NCT01986933|7747288|FG001|Active-to-active (Part B)|Lost to Follow-up|0
4770909|NCT01986933|7747289|FG002|Active-to-active (Part B)|Lost to Follow-up|0
4770910|NCT01986933|7747290|FG003|Active-to-active (Part B)|Lost to Follow-up|0
4770911|NCT01986933|7747291|FG004|Active-to-active (Part B)|Lost to Follow-up|1
4770912|NCT01986933|7747287|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0
4770913|NCT01986933|7747288|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1
4770914|NCT01986933|7747289|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0
4770915|NCT01986933|7747290|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1
4770916|NCT01986933|7747291|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1
4770917|NCT01986933|7747287|FG000|Placebo-to-active (Part B)|Adverse Event|0
4770918|NCT01986933|7747288|FG001|Placebo-to-active (Part B)|Adverse Event|1
4770919|NCT01986933|7747289|FG002|Placebo-to-active (Part B)|Adverse Event|0
4770920|NCT01986933|7747290|FG003|Placebo-to-active (Part B)|Adverse Event|1
4770921|NCT01986933|7747291|FG004|Placebo-to-active (Part B)|Adverse Event|0
4770922|NCT01986933|7747287|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0
4770923|NCT01986933|7747288|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0
4770924|NCT01986933|7747289|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0
4770925|NCT01986933|7747290|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1
4770926|NCT01986933|7747291|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0
4466730|NCT00618618|7258523|FG003|Overall Study|Death|0
4466731|NCT00618722|7258538|FG000|Overall Study|Refusal of Treatment|0
4466732|NCT00618722|7258539|FG001|Overall Study|Refusal of Treatment|0
4466733|NCT00618722|7258540|FG002|Overall Study|Refusal of Treatment|1
4466734|NCT00618722|7258541|FG003|Overall Study|Refusal of Treatment|0
4466735|NCT00618722|7258538|FG000|Overall Study|Patient Request|1
4466736|NCT00618722|7258539|FG001|Overall Study|Patient Request|1
4466737|NCT00618722|7258540|FG002|Overall Study|Patient Request|1
4466738|NCT00618722|7258541|FG003|Overall Study|Patient Request|1
4466739|NCT00618722|7258538|FG000|Overall Study|Inability to Complete Study Procedure|0
4466740|NCT00618722|7258539|FG001|Overall Study|Inability to Complete Study Procedure|1
4466741|NCT00618722|7258540|FG002|Overall Study|Inability to Complete Study Procedure|0
4466742|NCT00618722|7258541|FG003|Overall Study|Inability to Complete Study Procedure|0
4466743|NCT00618722|7258538|FG000|Overall Study|Lost to Follow-up|2
4466744|NCT00618722|7258539|FG001|Overall Study|Lost to Follow-up|0
4466745|NCT00618722|7258540|FG002|Overall Study|Lost to Follow-up|0
4466746|NCT00618722|7258541|FG003|Overall Study|Lost to Follow-up|2
4466747|NCT00618722|7258538|FG000|Overall Study|Miscellaneous Reasons|0
4466748|NCT00618722|7258539|FG001|Overall Study|Miscellaneous Reasons|0
4466749|NCT00618722|7258540|FG002|Overall Study|Miscellaneous Reasons|1
4466750|NCT00618722|7258541|FG003|Overall Study|Miscellaneous Reasons|1
4466751|NCT00618748|7258554|FG000|Overall Study|Adverse Event|4
4466752|NCT00618748|7258555|FG001|Overall Study|Adverse Event|3
4466753|NCT00618748|7258556|FG002|Overall Study|Adverse Event|8
4466754|NCT00618748|7258554|FG000|Overall Study|Physician Decision|3
4466755|NCT00618748|7258555|FG001|Overall Study|Physician Decision|1
4466756|NCT00618748|7258556|FG002|Overall Study|Physician Decision|1
4466757|NCT00618748|7258554|FG000|Overall Study|Withdrawal by Subject|4
4466758|NCT00618748|7258555|FG001|Overall Study|Withdrawal by Subject|1
4466759|NCT00618748|7258556|FG002|Overall Study|Withdrawal by Subject|5
4466760|NCT00618774|7258566|FG000|Overall Study|Adverse Event|5
4466761|NCT00618774|7258567|FG001|Overall Study|Adverse Event|3
4466762|NCT00618774|7258566|FG000|Overall Study|Withdrawal by Subject|1
4466763|NCT00618774|7258567|FG001|Overall Study|Withdrawal by Subject|0
4466764|NCT00618787|7258575|FG000|Overall Study|Adverse Event|0
4466765|NCT00618787|7258576|FG001|Overall Study|Adverse Event|1
4466766|NCT00618787|7258575|FG000|Overall Study|Withdrawal by Subject|2
4466767|NCT00618787|7258576|FG001|Overall Study|Withdrawal by Subject|1
4466768|NCT00618787|7258575|FG000|Overall Study|Lost to Follow-up|1
4466769|NCT00618787|7258576|FG001|Overall Study|Lost to Follow-up|0
4466770|NCT00618813|7258582|FG000|Overall Study|Lack of Efficacy|1
4466771|NCT00618813|7258582|FG000|Overall Study|Physician Decision|2
4466772|NCT00618813|7258582|FG000|Overall Study|Withdrawal by Subject|1
4466773|NCT00618826|7258586|FG000|Overall Study|Adverse Event|1
4516345|NCT00959699|7327705|FG001|Treatment Period|Withdrawal by Subject|3
4516346|NCT00959699|7327704|FG000|Treatment Period|Non-Compliance with Protocol|0
4516347|NCT00959699|7327705|FG001|Treatment Period|Non-Compliance with Protocol|1
4516348|NCT00959699|7327704|FG000|Treatment Period|Did not receive treatment|0
4516349|NCT00959699|7327705|FG001|Treatment Period|Did not receive treatment|1
4516350|NCT00959699|7327704|FG000|Treatment Period|Futility/crossover to boceprevir|4
4516351|NCT00959699|7327705|FG001|Treatment Period|Futility/crossover to boceprevir|0
4516352|NCT00959699|7327704|FG000|Follow-up Period|Lost to Follow-up|3
4770927|NCT01986933|7747287|FG000|Placebo-to-active (Part B)|Protocol Violation|0
4466774|NCT00618956|7258613|FG000|Overall Study|Adverse Event|10
4466775|NCT00618956|7258614|FG001|Overall Study|Adverse Event|34
4466776|NCT00618956|7258613|FG000|Overall Study|Lack of Efficacy|2
4466777|NCT00618956|7258614|FG001|Overall Study|Lack of Efficacy|1
4466778|NCT00618956|7258613|FG000|Overall Study|Withdrawal by Subject|5
4466779|NCT00618956|7258614|FG001|Overall Study|Withdrawal by Subject|7
4466780|NCT00618956|7258613|FG000|Overall Study|Lost to Follow-up|4
4466781|NCT00618956|7258614|FG001|Overall Study|Lost to Follow-up|5
4466782|NCT00618956|7258613|FG000|Overall Study|Protocol Violation|2
4466783|NCT00618956|7258614|FG001|Overall Study|Protocol Violation|2
4466784|NCT00618956|7258613|FG000|Overall Study|did not meet criteria, non-compliance|2
4466785|NCT00618956|7258614|FG001|Overall Study|did not meet criteria, non-compliance|1
4466786|NCT00618982|7258626|FG000|Overall Study|Adverse Event|23
4466787|NCT00618982|7258626|FG000|Overall Study|Withdrawal by Subject|1
4466788|NCT00618982|7258626|FG000|Overall Study|Protocol Violation|1
4466789|NCT00618982|7258626|FG000|Overall Study|ongoing, still treated with study med.|25
4466790|NCT00618995|7258633|FG000|Period 1|Adverse Event|0
4466791|NCT00618995|7258634|FG001|Period 1|Adverse Event|0
4466792|NCT00618995|7258635|FG002|Period 1|Adverse Event|1
4466793|NCT00618995|7258636|FG003|Period 1|Adverse Event|0
4466794|NCT00618995|7258633|FG000|Period 1|Protocol Violation|0
4466795|NCT00618995|7258634|FG001|Period 1|Protocol Violation|1
4466796|NCT00618995|7258635|FG002|Period 1|Protocol Violation|1
4466797|NCT00618995|7258636|FG003|Period 1|Protocol Violation|0
4466798|NCT00618995|7258633|FG000|Period 2|Protocol Violation|0
4466799|NCT00618995|7258634|FG001|Period 2|Protocol Violation|0
4466800|NCT00618995|7258635|FG002|Period 2|Protocol Violation|1
4466801|NCT00618995|7258636|FG003|Period 2|Protocol Violation|0
4466802|NCT00618995|7258633|FG000|Period 4|Adverse Event|1
4466803|NCT00618995|7258634|FG001|Period 4|Adverse Event|0
4466804|NCT00618995|7258635|FG002|Period 4|Adverse Event|0
4466805|NCT00618995|7258636|FG003|Period 4|Adverse Event|0
4466806|NCT00619099|7258664|FG000|Overall Study|Progressive Disease|7
4466807|NCT00619099|7258665|FG001|Overall Study|Progressive Disease|5
4466808|NCT00619099|7258664|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2
4466809|NCT00619099|7258665|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1
4466810|NCT00619099|7258664|FG000|Overall Study|Adverse Event|4
4466811|NCT00619099|7258665|FG001|Overall Study|Adverse Event|3
4466812|NCT00619099|7258664|FG000|Overall Study|Emergence of Clinically Significant Lab|1
4466813|NCT00619099|7258665|FG001|Overall Study|Emergence of Clinically Significant Lab|2
4466814|NCT00619099|7258664|FG000|Overall Study|Withdrawal by Subject|10
4466815|NCT00619099|7258665|FG001|Overall Study|Withdrawal by Subject|2
4466816|NCT00619099|7258664|FG000|Overall Study|Physician Decision|9
4466817|NCT00619099|7258665|FG001|Overall Study|Physician Decision|6
4466818|NCT00619112|7258673|FG000|Overall Study|Adverse Event|1
4466819|NCT00619112|7258674|FG001|Overall Study|Adverse Event|2
4466820|NCT00619177|7258683|FG000|Overall Study|Adverse Event|18
4466821|NCT00619177|7258683|FG000|Overall Study|Lost to Follow-up|2
4466822|NCT00619177|7258683|FG000|Overall Study|Lack of Efficacy|1
4466823|NCT00619177|7258683|FG000|Overall Study|Missing termination information|481
4466824|NCT00619177|7258683|FG000|Overall Study|Not specified reasons|6
4466825|NCT00619229|7258698|FG000|Overall Study|Withdrawal by Subject|1
4466826|NCT00619229|7258699|FG001|Overall Study|Withdrawal by Subject|1
4466827|NCT00619229|7258698|FG000|Overall Study|Lost to Follow-up|1
4466828|NCT00619229|7258699|FG001|Overall Study|Lost to Follow-up|0
4466829|NCT00619229|7258698|FG000|Overall Study|Termination of the Study by the Sponsor|1
4466830|NCT00619229|7258699|FG001|Overall Study|Termination of the Study by the Sponsor|1
4466831|NCT00619229|7258698|FG000|Overall Study|Investigator planned Cataract Operation|1
4466832|NCT00619229|7258699|FG001|Overall Study|Investigator planned Cataract Operation|0
4466833|NCT00619307|7258716|FG000|Overall Study|Adverse Event|0
4466834|NCT00619307|7258717|FG001|Overall Study|Adverse Event|1
4466835|NCT00619307|7258716|FG000|Overall Study|Lost to Follow-up|0
4466836|NCT00619307|7258717|FG001|Overall Study|Lost to Follow-up|1
4466837|NCT00619307|7258716|FG000|Overall Study|Protocol Violation|3
4466838|NCT00619307|7258717|FG001|Overall Study|Protocol Violation|0
4466839|NCT00619307|7258716|FG000|Overall Study|Withdrew consent|1
4466840|NCT00619307|7258717|FG001|Overall Study|Withdrew consent|0
4466841|NCT00619307|7258716|FG000|Overall Study|Severe migraine|0
4466842|NCT00619307|7258717|FG001|Overall Study|Severe migraine|1
4466843|NCT00619307|7258716|FG000|Overall Study|MS attack plus steroids|0
4466844|NCT00619307|7258717|FG001|Overall Study|MS attack plus steroids|1
4466845|NCT00619359|7258725|FG000|Overall Study|Adverse Event|32
4466846|NCT00619359|7258726|FG001|Overall Study|Adverse Event|36
4466847|NCT00619359|7258725|FG000|Overall Study|Lost to Follow-up|12
4466848|NCT00619359|7258726|FG001|Overall Study|Lost to Follow-up|16
4466849|NCT00619359|7258725|FG000|Overall Study|Physician Decision|0
4466850|NCT00619359|7258726|FG001|Overall Study|Physician Decision|7
4466851|NCT00619359|7258725|FG000|Overall Study|Protocol Violation|1
4466852|NCT00619359|7258726|FG001|Overall Study|Protocol Violation|1
4466853|NCT00619359|7258725|FG000|Overall Study|Withdrawal by Subject|19
4466854|NCT00619359|7258726|FG001|Overall Study|Withdrawal by Subject|20
4466855|NCT00619359|7258725|FG000|Overall Study|Progressive Disease|3
4466856|NCT00619359|7258726|FG001|Overall Study|Progressive Disease|1
4770928|NCT01986933|7747288|FG001|Placebo-to-active (Part B)|Protocol Violation|0
4770929|NCT01986933|7747289|FG002|Placebo-to-active (Part B)|Protocol Violation|1
4770930|NCT01986933|7747290|FG003|Placebo-to-active (Part B)|Protocol Violation|0
4770931|NCT01986933|7747291|FG004|Placebo-to-active (Part B)|Protocol Violation|0
4770932|NCT01986933|7747287|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0
4770933|NCT01986933|7747288|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3
4770934|NCT01986933|7747289|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4
4770935|NCT01986933|7747290|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3
4770936|NCT01986933|7747291|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0
4770937|NCT01986933|7747287|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0
4770938|NCT01986933|7747288|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1
4770939|NCT01986933|7747289|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0
4770940|NCT01986933|7747290|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0
4770941|NCT01986933|7747291|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0
4770942|NCT01701674|7747333|FG000|Overall Study|Unable to safely complete treatment|1
4770943|NCT01563107|7747395|FG000|Overall Study|Physician Decision|0
4770944|NCT01563107|7747396|FG001|Overall Study|Physician Decision|1
4770945|NCT01563107|7747397|FG002|Overall Study|Physician Decision|1
4770946|NCT01563107|7747398|FG003|Overall Study|Physician Decision|3
4770947|NCT01563107|7747395|FG000|Overall Study|Withdrawal by Subject|1
4770948|NCT01563107|7747396|FG001|Overall Study|Withdrawal by Subject|2
4770949|NCT01563107|7747397|FG002|Overall Study|Withdrawal by Subject|1
4770950|NCT01563107|7747398|FG003|Overall Study|Withdrawal by Subject|2
4770951|NCT01116648|7747483|FG000|Phase 1 Dose Level 3|Adverse Event|0
4770952|NCT01116648|7747484|FG001|Phase 1 Dose Level 3|Adverse Event|0
4770953|NCT01116648|7747485|FG002|Phase 1 Dose Level 3|Adverse Event|0
4770954|NCT01116648|7747486|FG003|Phase 1 Dose Level 3|Adverse Event|2
4770955|NCT01116648|7747487|FG004|Phase 1 Dose Level 3|Adverse Event|0
4770956|NCT01116648|7747488|FG005|Phase 1 Dose Level 3|Adverse Event|0
4770957|NCT01116648|7747489|FG006|Phase 1 Dose Level 3|Adverse Event|0
4770958|NCT01116648|7747490|FG007|Phase 1 Dose Level 3|Adverse Event|0
4770959|NCT01116648|7747491|FG008|Phase 1 Dose Level 3|Adverse Event|0
4770960|NCT01116648|7747492|FG009|Phase 1 Dose Level 3|Adverse Event|0
4770961|NCT01116648|7747493|FG010|Phase 1 Dose Level 3|Adverse Event|0
4770962|NCT01116648|7747494|FG011|Phase 1 Dose Level 3|Adverse Event|0
4770963|NCT01116648|7747495|FG012|Phase 1 Dose Level 3|Adverse Event|0
4770964|NCT01116648|7747496|FG013|Phase 1 Dose Level 3|Adverse Event|0
4770965|NCT01116648|7747497|FG014|Phase 1 Dose Level 3|Adverse Event|0
4770966|NCT01064479|7747524|FG000|Overall Study|Death|10
4770967|NCT01064479|7747525|FG001|Overall Study|Death|11
4770968|NCT01064479|7747524|FG000|Overall Study|Withdrawal by Subject|2
4770969|NCT01064479|7747525|FG001|Overall Study|Withdrawal by Subject|2
4770970|NCT01064479|7747524|FG000|Overall Study|Disease progression|1
4770971|NCT01064479|7747525|FG001|Overall Study|Disease progression|1
4770972|NCT01064479|7747524|FG000|Overall Study|Toxicity|1
4587849|NCT01494532|7432068|FG001|Overall Study|Protocol deviation|1
4587850|NCT01494532|7432069|FG002|Overall Study|Protocol deviation|3
4770973|NCT01064479|7747525|FG001|Overall Study|Toxicity|1
4770974|NCT01064479|7747524|FG000|Overall Study|Other|1
4770975|NCT01064479|7747525|FG001|Overall Study|Other|2
4770976|NCT01042522|7747533|FG000|Overall Study|Adverse Event|1
4770977|NCT01042522|7747534|FG001|Overall Study|Adverse Event|2
4770978|NCT01042522|7747533|FG000|Overall Study|Disease Progression|5
4770979|NCT01042522|7747534|FG001|Overall Study|Disease Progression|0
4770980|NCT01042522|7747533|FG000|Overall Study|Death|1
4770981|NCT01042522|7747534|FG001|Overall Study|Death|0
4770982|NCT01042522|7747533|FG000|Overall Study|Patient Refused|0
4770983|NCT01042522|7747534|FG001|Overall Study|Patient Refused|3
4770984|NCT01042522|7747533|FG000|Overall Study|Withdrawal by Subject|1
4770985|NCT01042522|7747534|FG001|Overall Study|Withdrawal by Subject|1
4770986|NCT00710970|7747573|FG000|Overall Study|Never took drug|3
4770987|NCT00685919|7747581|FG000|Overall Study|Withdrawal by Subject|0
4770988|NCT00685919|7747582|FG001|Overall Study|Withdrawal by Subject|0
4770989|NCT00685919|7747583|FG002|Overall Study|Withdrawal by Subject|1
4770990|NCT00685919|7747584|FG003|Overall Study|Withdrawal by Subject|0
4770991|NCT00685919|7747581|FG000|Overall Study|Physician Decision|1
4770992|NCT00685919|7747582|FG001|Overall Study|Physician Decision|0
4770993|NCT00685919|7747583|FG002|Overall Study|Physician Decision|0
4770994|NCT00685919|7747584|FG003|Overall Study|Physician Decision|0
4770995|NCT00344487|7747594|FG000|Overall Study|immunologic failure|1
4770996|NCT00281658|7747602|FG000|Double-blind, Randomized Phase|Death|120
4770997|NCT00281658|7747603|FG001|Double-blind, Randomized Phase|Death|46
4770998|NCT00281658|7747604|FG002|Double-blind, Randomized Phase|Death|0
4770999|NCT00281658|7747602|FG000|Double-blind, Randomized Phase|Lost to Follow-up|12
4771000|NCT00281658|7747603|FG001|Double-blind, Randomized Phase|Lost to Follow-up|5
4771001|NCT00281658|7747604|FG002|Double-blind, Randomized Phase|Lost to Follow-up|0
4771002|NCT00281658|7747602|FG000|Double-blind, Randomized Phase|Withdrawal by Subject|4
4771003|NCT00281658|7747603|FG001|Double-blind, Randomized Phase|Withdrawal by Subject|1
4587851|NCT01494532|7432070|FG003|Overall Study|Protocol deviation|2
4771004|NCT00281658|7747604|FG002|Double-blind, Randomized Phase|Withdrawal by Subject|0
4771005|NCT00281658|7747602|FG000|Double-blind, Randomized Phase|Participant Entered New Protocol|1
4771006|NCT00281658|7747603|FG001|Double-blind, Randomized Phase|Participant Entered New Protocol|1
4771007|NCT00281658|7747604|FG002|Double-blind, Randomized Phase|Participant Entered New Protocol|0
4771008|NCT00281658|7747602|FG000|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|0
4771009|NCT00281658|7747603|FG001|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|1
4466857|NCT00619385|7258735|FG000|Overall Study|Adverse Event|0
4466858|NCT00619385|7258736|FG001|Overall Study|Adverse Event|0
4466859|NCT00619385|7258737|FG002|Overall Study|Adverse Event|3
4587852|NCT01494532|7432071|FG004|Overall Study|Protocol deviation|3
4587853|NCT01494532|7432072|FG005|Overall Study|Protocol deviation|0
4466860|NCT00619385|7258735|FG000|Overall Study|Other|1
4466861|NCT00619385|7258736|FG001|Overall Study|Other|2
4466862|NCT00619385|7258737|FG002|Overall Study|Other|1
4466863|NCT00619476|7258752|FG000|Overall Study|Adverse Event|12
4466864|NCT00619476|7258753|FG001|Overall Study|Adverse Event|6
4466865|NCT00619476|7258754|FG002|Overall Study|Adverse Event|12
4466866|NCT00619476|7258755|FG003|Overall Study|Adverse Event|16
4466867|NCT00619476|7258752|FG000|Overall Study|Lack of Efficacy|6
4466868|NCT00619476|7258753|FG001|Overall Study|Lack of Efficacy|1
4466869|NCT00619476|7258754|FG002|Overall Study|Lack of Efficacy|1
4466870|NCT00619476|7258755|FG003|Overall Study|Lack of Efficacy|4
4466871|NCT00619476|7258752|FG000|Overall Study|Protocol Violation|5
4466872|NCT00619476|7258753|FG001|Overall Study|Protocol Violation|4
4466873|NCT00619476|7258754|FG002|Overall Study|Protocol Violation|4
4466874|NCT00619476|7258755|FG003|Overall Study|Protocol Violation|9
4466875|NCT00619476|7258752|FG000|Overall Study|Lost to Follow-up|1
4466876|NCT00619476|7258753|FG001|Overall Study|Lost to Follow-up|2
4466877|NCT00619476|7258754|FG002|Overall Study|Lost to Follow-up|0
4466878|NCT00619476|7258755|FG003|Overall Study|Lost to Follow-up|1
4466879|NCT00619476|7258752|FG000|Overall Study|Investigator Discretion|2
4466880|NCT00619476|7258753|FG001|Overall Study|Investigator Discretion|2
4466881|NCT00619476|7258754|FG002|Overall Study|Investigator Discretion|2
4466882|NCT00619476|7258755|FG003|Overall Study|Investigator Discretion|0
4466883|NCT00619476|7258752|FG000|Overall Study|Withdrawal by Subject|5
4466884|NCT00619476|7258753|FG001|Overall Study|Withdrawal by Subject|7
4466885|NCT00619476|7258754|FG002|Overall Study|Withdrawal by Subject|5
4466886|NCT00619476|7258755|FG003|Overall Study|Withdrawal by Subject|4
4466887|NCT00619489|7258767|FG000|Overall Study|Adverse Event|0
4466888|NCT00619489|7258768|FG001|Overall Study|Adverse Event|7
4466889|NCT00619489|7258767|FG000|Overall Study|Withdrawal by Subject|1
4466890|NCT00619489|7258768|FG001|Overall Study|Withdrawal by Subject|1
4466891|NCT00619489|7258767|FG000|Overall Study|Lack of Efficacy|0
4466892|NCT00619489|7258768|FG001|Overall Study|Lack of Efficacy|11
4466893|NCT00619489|7258767|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22
4466894|NCT00619489|7258768|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15
4466895|NCT00619502|7258776|FG000|Overall Study|Lost to Follow-up|8
4466896|NCT00619502|7258777|FG001|Overall Study|Lost to Follow-up|10
4466897|NCT00619619|7258793|FG000|Overall Study|Physician Decision|0
4466898|NCT00619619|7258794|FG001|Overall Study|Physician Decision|0
4466899|NCT00619619|7258795|FG002|Overall Study|Physician Decision|1
4466900|NCT00619619|7258796|FG003|Overall Study|Physician Decision|0
4466901|NCT00619619|7258797|FG004|Overall Study|Physician Decision|0
4466902|NCT00619619|7258798|FG005|Overall Study|Physician Decision|0
4466903|NCT00619619|7258799|FG006|Overall Study|Physician Decision|0
4466904|NCT00619619|7258800|FG007|Overall Study|Physician Decision|0
4466905|NCT00619619|7258793|FG000|Overall Study|Protocol Violation|0
4466906|NCT00619619|7258794|FG001|Overall Study|Protocol Violation|0
4466907|NCT00619619|7258795|FG002|Overall Study|Protocol Violation|0
4466908|NCT00619619|7258796|FG003|Overall Study|Protocol Violation|1
4466909|NCT00619619|7258797|FG004|Overall Study|Protocol Violation|0
4466910|NCT00619619|7258798|FG005|Overall Study|Protocol Violation|0
4466911|NCT00619619|7258799|FG006|Overall Study|Protocol Violation|1
4466912|NCT00619619|7258800|FG007|Overall Study|Protocol Violation|1
4466913|NCT00619619|7258793|FG000|Overall Study|Adverse Event|0
4466914|NCT00619619|7258794|FG001|Overall Study|Adverse Event|0
4466915|NCT00619619|7258795|FG002|Overall Study|Adverse Event|0
4466916|NCT00619619|7258796|FG003|Overall Study|Adverse Event|0
4466917|NCT00619619|7258797|FG004|Overall Study|Adverse Event|2
4466918|NCT00619619|7258798|FG005|Overall Study|Adverse Event|0
4466919|NCT00619619|7258799|FG006|Overall Study|Adverse Event|0
4466920|NCT00619619|7258800|FG007|Overall Study|Adverse Event|2
4466921|NCT00619645|7258821|FG000|Overall Study|Adverse Event|1
4466922|NCT00619801|7258845|FG000|Overall Study|Lack of Efficacy|0
4466923|NCT00619801|7258846|FG001|Overall Study|Lack of Efficacy|1
4466924|NCT00619801|7258845|FG000|Overall Study|Withdrawal by Subject|1
4466925|NCT00619801|7258846|FG001|Overall Study|Withdrawal by Subject|1
4466926|NCT00619801|7258845|FG000|Overall Study|Loss of efficacy|0
4466927|NCT00619801|7258846|FG001|Overall Study|Loss of efficacy|1
4466928|NCT00619827|7258854|FG000|Overall Study|Adverse Event|1
4466929|NCT00619827|7258855|FG001|Overall Study|Adverse Event|2
4466930|NCT00619827|7258854|FG000|Overall Study|Withdrawal by Subject|2
4466931|NCT00619827|7258855|FG001|Overall Study|Withdrawal by Subject|2
4466932|NCT00619866|7258864|FG000|Weeks 1 - 12|Adverse Event|0
4466933|NCT00619866|7258865|FG001|Weeks 1 - 12|Adverse Event|1
4466934|NCT00619866|7258866|FG002|Weeks 1 - 12|Adverse Event|2
4466935|NCT00619866|7258867|FG003|Weeks 1 - 12|Adverse Event|0
4466936|NCT00619866|7258868|FG004|Weeks 1 - 12|Adverse Event|0
4466937|NCT00619866|7258864|FG000|Weeks 1 - 12|Non-compliance|0
4771010|NCT00281658|7747604|FG002|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|0
4771011|NCT00281658|7747602|FG000|Open-label Monotherapy Extension Phase|Death|0
4771012|NCT00281658|7747603|FG001|Open-label Monotherapy Extension Phase|Death|0
4771013|NCT00281658|7747604|FG002|Open-label Monotherapy Extension Phase|Death|97
4771014|NCT00281658|7747602|FG000|Open-label Monotherapy Extension Phase|Lost to Follow-up|0
4771015|NCT00281658|7747603|FG001|Open-label Monotherapy Extension Phase|Lost to Follow-up|0
4771016|NCT00281658|7747604|FG002|Open-label Monotherapy Extension Phase|Lost to Follow-up|3
4771017|NCT00281658|7747602|FG000|Open-label Monotherapy Extension Phase|Withdrawal by Subject|0
4771018|NCT00281658|7747603|FG001|Open-label Monotherapy Extension Phase|Withdrawal by Subject|0
4771019|NCT00281658|7747604|FG002|Open-label Monotherapy Extension Phase|Withdrawal by Subject|1
4695959|NCT02631538|7608583|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0
4695960|NCT02631538|7608584|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0
4695961|NCT02631538|7608585|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1
4695962|NCT02631551|7608599|FG000|Overall Study|Adverse Event|1
4695963|NCT02631551|7608600|FG001|Overall Study|Adverse Event|2
4695964|NCT02631551|7608601|FG002|Overall Study|Adverse Event|4
4695965|NCT02631551|7608602|FG003|Overall Study|Adverse Event|0
4695966|NCT02631551|7608599|FG000|Overall Study|Lack of Efficacy|0
4695967|NCT02631551|7608600|FG001|Overall Study|Lack of Efficacy|0
4695968|NCT02631551|7608601|FG002|Overall Study|Lack of Efficacy|1
4695969|NCT02631551|7608602|FG003|Overall Study|Lack of Efficacy|0
4695970|NCT02631551|7608599|FG000|Overall Study|Lost to Follow-up|1
4695971|NCT02631551|7608600|FG001|Overall Study|Lost to Follow-up|2
4695972|NCT02631551|7608601|FG002|Overall Study|Lost to Follow-up|0
4695973|NCT02631551|7608602|FG003|Overall Study|Lost to Follow-up|3
4695974|NCT02631551|7608599|FG000|Overall Study|Withdrawal by Subject|2
4695975|NCT02631551|7608600|FG001|Overall Study|Withdrawal by Subject|2
4695976|NCT02631551|7608601|FG002|Overall Study|Withdrawal by Subject|0
4695977|NCT02631551|7608602|FG003|Overall Study|Withdrawal by Subject|5
4695978|NCT02631551|7608599|FG000|Overall Study|Protocol deviation|3
4695979|NCT02631551|7608600|FG001|Overall Study|Protocol deviation|6
4695980|NCT02631551|7608601|FG002|Overall Study|Protocol deviation|3
4695981|NCT02631551|7608602|FG003|Overall Study|Protocol deviation|0
4695982|NCT02631551|7608599|FG000|Overall Study|Non-compliance with study procedures|0
4695983|NCT02631551|7608600|FG001|Overall Study|Non-compliance with study procedures|0
4695984|NCT02631551|7608601|FG002|Overall Study|Non-compliance with study procedures|1
4695985|NCT02631551|7608602|FG003|Overall Study|Non-compliance with study procedures|1
4695986|NCT02631551|7608599|FG000|Overall Study|Non-compliance with study drug|1
4695987|NCT02631551|7608600|FG001|Overall Study|Non-compliance with study drug|0
4695988|NCT02631551|7608601|FG002|Overall Study|Non-compliance with study drug|0
4695989|NCT02631551|7608602|FG003|Overall Study|Non-compliance with study drug|0
4695990|NCT02631551|7608599|FG000|Overall Study|Other, specific reasons not collected|5
4695991|NCT02631551|7608600|FG001|Overall Study|Other, specific reasons not collected|7
4695992|NCT02631551|7608601|FG002|Overall Study|Other, specific reasons not collected|2
4695993|NCT02631551|7608602|FG003|Overall Study|Other, specific reasons not collected|2
4695994|NCT02631746|7608616|FG000|Overall Study|Lack of Efficacy|3
4695995|NCT02631850|7608633|FG000|Treatment Period|Lost to Follow-up|0
4695996|NCT02631850|7608634|FG001|Treatment Period|Lost to Follow-up|1
4695997|NCT02631850|7608635|FG002|Treatment Period|Lost to Follow-up|0
4695998|NCT02631850|7608636|FG003|Treatment Period|Lost to Follow-up|0
4695999|NCT02631850|7608633|FG000|Treatment Period|Protocol Violation|1
4696000|NCT02631850|7608634|FG001|Treatment Period|Protocol Violation|0
4696001|NCT02631850|7608635|FG002|Treatment Period|Protocol Violation|0
4696002|NCT02631850|7608636|FG003|Treatment Period|Protocol Violation|0
4696003|NCT02631850|7608633|FG000|Treatment Period|Withdrawal by Subject|0
4696004|NCT02631850|7608634|FG001|Treatment Period|Withdrawal by Subject|5
4696005|NCT02631850|7608635|FG002|Treatment Period|Withdrawal by Subject|2
4696006|NCT02631850|7608636|FG003|Treatment Period|Withdrawal by Subject|2
4696007|NCT02631850|7608633|FG000|Treatment Period|Adverse Event|1
4696008|NCT02631850|7608634|FG001|Treatment Period|Adverse Event|0
4696009|NCT02631850|7608635|FG002|Treatment Period|Adverse Event|2
4696010|NCT02631850|7608636|FG003|Treatment Period|Adverse Event|3
4696011|NCT02631850|7608633|FG000|Treatment Period|Family medical issue|1
4696012|NCT02631850|7608634|FG001|Treatment Period|Family medical issue|0
4771020|NCT04034355|7747635|FG000|Overall Study|Study terminated by Sponsor|10
4771021|NCT04034355|7747636|FG001|Overall Study|Study terminated by Sponsor|17
4771022|NCT04034355|7747635|FG000|Overall Study|Withdrawal by Subject|12
4771023|NCT04034355|7747636|FG001|Overall Study|Withdrawal by Subject|11
4771024|NCT04034355|7747635|FG000|Overall Study|Site terminated by Sponsor|4
4771025|NCT04034355|7747636|FG001|Overall Study|Site terminated by Sponsor|5
4771026|NCT04034355|7747635|FG000|Overall Study|Adverse Event|2
4771027|NCT04034355|7747636|FG001|Overall Study|Adverse Event|0
4771028|NCT04034355|7747635|FG000|Overall Study|Death|1
4771029|NCT04034355|7747636|FG001|Overall Study|Death|1
4771030|NCT04034355|7747635|FG000|Overall Study|Not reported|2
4771031|NCT04034355|7747636|FG001|Overall Study|Not reported|0
4771032|NCT04034355|7747635|FG000|Overall Study|Lost to Follow-up|1
4771033|NCT04034355|7747636|FG001|Overall Study|Lost to Follow-up|0
4771034|NCT04034355|7747635|FG000|Overall Study|Physician Decision|1
4771035|NCT04034355|7747636|FG001|Overall Study|Physician Decision|0
4771036|NCT04034355|7747635|FG000|Overall Study|Protocol Violation|0
4771037|NCT04034355|7747636|FG001|Overall Study|Protocol Violation|1
4771038|NCT04034355|7747635|FG000|Overall Study|Progressive disease|1
4771039|NCT04034355|7747636|FG001|Overall Study|Progressive disease|0
4771040|NCT03721276|7747648|FG000|Overall Study|Lost to Follow-up|5
4771041|NCT03721276|7747649|FG001|Overall Study|Lost to Follow-up|3
4771042|NCT03721276|7747648|FG000|Overall Study|Adverse Event|0
4771043|NCT03721276|7747649|FG001|Overall Study|Adverse Event|1
4771044|NCT03637491|7747672|FG000|Overall Study|Death|9
4771045|NCT03637491|7747673|FG001|Overall Study|Death|9
4771046|NCT03637491|7747674|FG002|Overall Study|Death|5
4771047|NCT03637491|7747675|FG003|Overall Study|Death|3
4771048|NCT03637491|7747672|FG000|Overall Study|Lost to Follow-up|0
4771049|NCT03637491|7747673|FG001|Overall Study|Lost to Follow-up|1
4771050|NCT03637491|7747674|FG002|Overall Study|Lost to Follow-up|0
4771051|NCT03637491|7747675|FG003|Overall Study|Lost to Follow-up|1
4771052|NCT03637491|7747672|FG000|Overall Study|Study Terminated By Sponsor|0
4771053|NCT03637491|7747673|FG001|Overall Study|Study Terminated By Sponsor|2
4771054|NCT03637491|7747674|FG002|Overall Study|Study Terminated By Sponsor|1
4771055|NCT03637491|7747675|FG003|Overall Study|Study Terminated By Sponsor|0
4771056|NCT03637491|7747672|FG000|Overall Study|Withdrawal by Subject|1
4771057|NCT03637491|7747673|FG001|Overall Study|Withdrawal by Subject|0
4771058|NCT03637491|7747674|FG002|Overall Study|Withdrawal by Subject|1
4771059|NCT03637491|7747675|FG003|Overall Study|Withdrawal by Subject|2
4771060|NCT03334539|7747766|FG000|Overall Study|Adverse Event|3
4771061|NCT03334539|7747767|FG001|Overall Study|Adverse Event|5
4466938|NCT00619866|7258865|FG001|Weeks 1 - 12|Non-compliance|0
4466939|NCT00619866|7258866|FG002|Weeks 1 - 12|Non-compliance|1
4466940|NCT00619866|7258867|FG003|Weeks 1 - 12|Non-compliance|0
4466941|NCT00619866|7258868|FG004|Weeks 1 - 12|Non-compliance|0
4466942|NCT00619866|7258864|FG000|Weeks 1 - 12|Withdrawal by Subject|7
4466943|NCT00619866|7258865|FG001|Weeks 1 - 12|Withdrawal by Subject|2
4466944|NCT00619866|7258866|FG002|Weeks 1 - 12|Withdrawal by Subject|4
4466945|NCT00619866|7258867|FG003|Weeks 1 - 12|Withdrawal by Subject|0
4466946|NCT00619866|7258868|FG004|Weeks 1 - 12|Withdrawal by Subject|0
4466947|NCT00619866|7258864|FG000|Weeks 1 - 12|Lack of Efficacy|3
4466948|NCT00619866|7258865|FG001|Weeks 1 - 12|Lack of Efficacy|2
4466949|NCT00619866|7258866|FG002|Weeks 1 - 12|Lack of Efficacy|1
4466950|NCT00619866|7258867|FG003|Weeks 1 - 12|Lack of Efficacy|0
4466951|NCT00619866|7258868|FG004|Weeks 1 - 12|Lack of Efficacy|0
4466952|NCT00619866|7258864|FG000|Weeks 1 - 12|Lost to Follow-up|4
4466953|NCT00619866|7258865|FG001|Weeks 1 - 12|Lost to Follow-up|0
4466954|NCT00619866|7258866|FG002|Weeks 1 - 12|Lost to Follow-up|2
4466955|NCT00619866|7258867|FG003|Weeks 1 - 12|Lost to Follow-up|0
4466956|NCT00619866|7258868|FG004|Weeks 1 - 12|Lost to Follow-up|0
4466957|NCT00619866|7258864|FG000|Weeks 1 - 12|Sponsor Decision|0
4466958|NCT00619866|7258865|FG001|Weeks 1 - 12|Sponsor Decision|1
4466959|NCT00619866|7258866|FG002|Weeks 1 - 12|Sponsor Decision|0
4466960|NCT00619866|7258867|FG003|Weeks 1 - 12|Sponsor Decision|0
4466961|NCT00619866|7258868|FG004|Weeks 1 - 12|Sponsor Decision|0
4466962|NCT00619866|7258864|FG000|Weeks 13 - 24|Adverse Event|0
4466963|NCT00619866|7258865|FG001|Weeks 13 - 24|Adverse Event|0
4771062|NCT03334539|7747768|FG002|Overall Study|Adverse Event|0
4771063|NCT03334539|7747766|FG000|Overall Study|Withdrawal by Subject|0
4771064|NCT03334539|7747767|FG001|Overall Study|Withdrawal by Subject|1
4771065|NCT03334539|7747768|FG002|Overall Study|Withdrawal by Subject|1
4771066|NCT03334539|7747766|FG000|Overall Study|Administrative Reasons|1
4771067|NCT03334539|7747767|FG001|Overall Study|Administrative Reasons|0
4771068|NCT03334539|7747768|FG002|Overall Study|Administrative Reasons|0
4771069|NCT03334539|7747766|FG000|Overall Study|Hypertension Not Controlled|0
4771070|NCT03334539|7747767|FG001|Overall Study|Hypertension Not Controlled|1
4771071|NCT03334539|7747768|FG002|Overall Study|Hypertension Not Controlled|0
4771072|NCT03269344|7747790|FG000|Overall Study|Protocol Violation|4
4771073|NCT03269344|7747791|FG001|Overall Study|Protocol Violation|3
4771074|NCT03076775|7747805|FG000|Overall Study|Lost to Follow-up|1
4771075|NCT03076775|7747806|FG001|Overall Study|Lost to Follow-up|0
4771076|NCT02660827|7747846|FG000|From Study to End of Continued Access|Withdrawal by Subject|21
4771077|NCT02660827|7747846|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2
4771078|NCT02660827|7747846|FG000|From Study to End of Continued Access|Adverse Event|3
4771079|NCT02660827|7747846|FG000|From Study to End of Continued Access|didn't participate continued access period|5
4771080|NCT02660827|7747846|FG000|Period 1: Study Period|Withdrawal by Subject|1
4771081|NCT02660827|7747846|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20
4771082|NCT02660827|7747846|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2
4771083|NCT02660827|7747846|FG000|Period 2: Continued Access Period|Adverse Event|3
4771084|NCT02581930|7747862|FG000|Overall Study|Withdrawal by Subject|1
4771085|NCT02581930|7747862|FG000|Overall Study|patient declined further treatment|1
4771086|NCT02425644|7747868|FG000|Overall Study|Lost to Follow-up|2
4771087|NCT02425644|7747869|FG001|Overall Study|Lost to Follow-up|3
4771088|NCT02425644|7747868|FG000|Overall Study|Withdrawal by Subject|41
4771089|NCT02425644|7747869|FG001|Overall Study|Withdrawal by Subject|36
4771090|NCT02425644|7747868|FG000|Overall Study|Lack of Efficacy|3
4771091|NCT02425644|7747869|FG001|Overall Study|Lack of Efficacy|10
4771092|NCT02425644|7747868|FG000|Overall Study|Adverse Event|13
4771093|NCT02425644|7747869|FG001|Overall Study|Adverse Event|3
4771094|NCT02425644|7747868|FG000|Overall Study|Death|0
4771095|NCT02425644|7747869|FG001|Overall Study|Death|2
4771096|NCT02425644|7747868|FG000|Overall Study|Other|18
4771097|NCT02425644|7747869|FG001|Overall Study|Other|17
4771098|NCT02340221|7747882|FG000|Overall Study|Death|58
4771099|NCT02340221|7747883|FG001|Overall Study|Death|101
4771100|NCT02340221|7747882|FG000|Overall Study|Withdrawal by Participant|14
4771101|NCT02340221|7747883|FG001|Overall Study|Withdrawal by Participant|22
4771102|NCT02340221|7747882|FG000|Overall Study|Lost to Follow-up|2
4771103|NCT02340221|7747883|FG001|Overall Study|Lost to Follow-up|3
4771104|NCT02340221|7747882|FG000|Overall Study|Reason Not Specified|0
4771105|NCT02340221|7747883|FG001|Overall Study|Reason Not Specified|1
4771106|NCT02340221|7747882|FG000|Overall Study|Continued on study|140
4771107|NCT02340221|7747883|FG001|Overall Study|Continued on study|290
4771108|NCT02270957|7747892|FG000|Overall Study|Lack of Efficacy|2
4771109|NCT02270957|7747893|FG001|Overall Study|Lack of Efficacy|4
4771110|NCT02270957|7747892|FG000|Overall Study|Adverse Event|2
4771111|NCT02270957|7747893|FG001|Overall Study|Adverse Event|0
4771112|NCT02134925|7747902|FG000|Overall Study|Withdrawal by Subject|1
4771113|NCT02134925|7747903|FG001|Overall Study|Withdrawal by Subject|0
4771114|NCT02134925|7747902|FG000|Overall Study|Cancel|1
4771115|NCT02134925|7747903|FG001|Overall Study|Cancel|6
4771116|NCT02054104|7747911|FG000|Overall Study|Did not want to continue due to college classes|1
4771117|NCT02054104|7747912|FG001|Overall Study|Did not want to continue due to college classes|0
4771118|NCT02054104|7747911|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1
4771119|NCT02054104|7747912|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0
4771120|NCT02054104|7747911|FG000|Overall Study|No evidence of immunologic response|2
4771121|NCT02054104|7747912|FG001|Overall Study|No evidence of immunologic response|2
4771122|NCT02054104|7747911|FG000|Overall Study|Disease Progression On Study|4
4771123|NCT02054104|7747912|FG001|Overall Study|Disease Progression On Study|5
4771124|NCT02054104|7747911|FG000|Overall Study|Diagnosis of lymphoma|0
4466964|NCT00619866|7258866|FG002|Weeks 13 - 24|Adverse Event|2
4466965|NCT00619866|7258867|FG003|Weeks 13 - 24|Adverse Event|1
4466966|NCT00619866|7258868|FG004|Weeks 13 - 24|Adverse Event|0
4466967|NCT00619866|7258864|FG000|Weeks 13 - 24|Protocol Deviation|0
4466968|NCT00619866|7258865|FG001|Weeks 13 - 24|Protocol Deviation|0
4466969|NCT00619866|7258866|FG002|Weeks 13 - 24|Protocol Deviation|0
4466970|NCT00619866|7258867|FG003|Weeks 13 - 24|Protocol Deviation|1
4466971|NCT00619866|7258868|FG004|Weeks 13 - 24|Protocol Deviation|0
4466972|NCT00619866|7258864|FG000|Weeks 13 - 24|Withdrawal by Subject|0
4466973|NCT00619866|7258865|FG001|Weeks 13 - 24|Withdrawal by Subject|3
4466974|NCT00619866|7258866|FG002|Weeks 13 - 24|Withdrawal by Subject|2
4466975|NCT00619866|7258867|FG003|Weeks 13 - 24|Withdrawal by Subject|2
4466976|NCT00619866|7258868|FG004|Weeks 13 - 24|Withdrawal by Subject|2
4466977|NCT00619866|7258864|FG000|Weeks 13 - 24|Non-compliance|0
4466978|NCT00619866|7258865|FG001|Weeks 13 - 24|Non-compliance|1
4466979|NCT00619866|7258866|FG002|Weeks 13 - 24|Non-compliance|1
4466980|NCT00619866|7258867|FG003|Weeks 13 - 24|Non-compliance|0
4466981|NCT00619866|7258868|FG004|Weeks 13 - 24|Non-compliance|0
4466982|NCT00619866|7258864|FG000|Weeks 13 - 24|Lost to Follow-up|0
4466983|NCT00619866|7258865|FG001|Weeks 13 - 24|Lost to Follow-up|3
4466984|NCT00619866|7258866|FG002|Weeks 13 - 24|Lost to Follow-up|0
4466985|NCT00619866|7258867|FG003|Weeks 13 - 24|Lost to Follow-up|0
4466986|NCT00619866|7258868|FG004|Weeks 13 - 24|Lost to Follow-up|0
4771125|NCT02054104|7747912|FG001|Overall Study|Diagnosis of lymphoma|1
4771126|NCT02054104|7747911|FG000|Overall Study|Inconclusive response|0
4771127|NCT02054104|7747912|FG001|Overall Study|Inconclusive response|1
4771128|NCT01899144|7747918|FG000|Treatment Period 2|Other|1
4771129|NCT01899144|7747918|FG000|Treatment Period 3|Other|2
4771130|NCT01899144|7747918|FG000|Treatment Period 5|Other|1
4771131|NCT01793610|7747933|FG000|Overall Study|Withdrawal by Subject|1
4771132|NCT01793610|7747934|FG001|Overall Study|Withdrawal by Subject|0
4771133|NCT01793610|7747935|FG002|Overall Study|Withdrawal by Subject|1
4771134|NCT01757665|7747949|FG000|Overall Study|Still on Study - Visit Completed|240
4771135|NCT01757665|7747950|FG001|Overall Study|Still on Study - Visit Completed|30
4771136|NCT01757665|7747949|FG000|Overall Study|Still on Study - Visit Pending|398
4771137|NCT01757665|7747950|FG001|Overall Study|Still on Study - Visit Pending|40
4378341|NCT04537078|7154862|FG000|Overall Study|Protocol Violation|3
4378342|NCT04537078|7154863|FG001|Overall Study|Protocol Violation|2
4378343|NCT04537078|7154862|FG000|Overall Study|Lost to Follow-up|1
4378344|NCT04537078|7154863|FG001|Overall Study|Lost to Follow-up|0
4378345|NCT04537078|7154862|FG000|Overall Study|Withdrawal by Subject|0
4378346|NCT04537078|7154863|FG001|Overall Study|Withdrawal by Subject|1
4378383|NCT03694353|7154924|FG000|Overall Study|Withdrawal by Subject|1
4378384|NCT03694353|7154924|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1
4378385|NCT03583554|7154928|FG000|Period 2|Did not receive treatment due to loss of contact|1
4378386|NCT03583554|7154929|FG001|Period 2|Did not receive treatment due to loss of contact|0
4378387|NCT03583554|7154930|FG002|Period 2|Did not receive treatment due to loss of contact|1
4378388|NCT03408873|7154947|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3
4378389|NCT03408873|7154947|FG000|Visit 2 Assessment|Lost to Follow-up|1
4378390|NCT03408873|7154947|FG000|Visit 3 Assessment|Withdrawal by Subject|1
4378391|NCT03408873|7154947|FG000|Visit 4 Assessment|Lost to Follow-up|2
4378392|NCT03408873|7154947|FG000|Visit 5 Assessment|Lost to Follow-up|1
4378393|NCT03408873|7154947|FG000|Visit 6 Assessment|Withdrawal by Subject|1
4378394|NCT03132467|7154951|FG000|Overall Study|Adverse Event|2
4378395|NCT03132467|7154951|FG000|Overall Study|Withdrawal by Subject|2
4378396|NCT03096288|7154960|FG000|Overall Study|Withdrawal by Subject|0
4378397|NCT03096288|7154961|FG001|Overall Study|Withdrawal by Subject|1
4378398|NCT03096288|7154962|FG002|Overall Study|Withdrawal by Subject|0
4378399|NCT03096288|7154963|FG003|Overall Study|Withdrawal by Subject|1
4378400|NCT02919436|7154975|FG000|Overall Study|Did not undergo surgery|16
4378401|NCT02919436|7154976|FG001|Overall Study|Did not undergo surgery|20
4378402|NCT02919436|7154975|FG000|Overall Study|Enrolled before trial registration|44
4378403|NCT02919436|7154976|FG001|Overall Study|Enrolled before trial registration|33
4378404|NCT02877134|7154991|FG000|Overall Study|Death|0
4378405|NCT02877134|7154992|FG001|Overall Study|Death|1
4378406|NCT02877134|7154993|FG002|Overall Study|Death|0
4378407|NCT02877134|7154994|FG003|Overall Study|Death|0
4378408|NCT02877134|7154995|FG004|Overall Study|Death|0
4378409|NCT02877134|7154996|FG005|Overall Study|Death|1
4378410|NCT02877134|7154997|FG006|Overall Study|Death|0
4378411|NCT02877134|7154991|FG000|Overall Study|Lost to Follow-up|0
4378412|NCT02877134|7154992|FG001|Overall Study|Lost to Follow-up|4
4378413|NCT02877134|7154993|FG002|Overall Study|Lost to Follow-up|0
4378414|NCT02877134|7154994|FG003|Overall Study|Lost to Follow-up|1
4378415|NCT02877134|7154995|FG004|Overall Study|Lost to Follow-up|0
4378416|NCT02877134|7154996|FG005|Overall Study|Lost to Follow-up|0
4378417|NCT02877134|7154997|FG006|Overall Study|Lost to Follow-up|0
4378418|NCT02877134|7154991|FG000|Overall Study|Withdrawal by Subject|13
4378419|NCT02877134|7154992|FG001|Overall Study|Withdrawal by Subject|19
4378420|NCT02877134|7154993|FG002|Overall Study|Withdrawal by Subject|4
4378421|NCT02877134|7154994|FG003|Overall Study|Withdrawal by Subject|6
4378422|NCT02877134|7154995|FG004|Overall Study|Withdrawal by Subject|3
4378423|NCT02877134|7154996|FG005|Overall Study|Withdrawal by Subject|5
4378424|NCT02877134|7154997|FG006|Overall Study|Withdrawal by Subject|0
4378425|NCT02877134|7154991|FG000|Overall Study|Other|1
4378426|NCT02877134|7154992|FG001|Overall Study|Other|1
4378427|NCT02877134|7154993|FG002|Overall Study|Other|2
4378428|NCT02877134|7154994|FG003|Overall Study|Other|6
4378429|NCT02877134|7154995|FG004|Overall Study|Other|3
4378430|NCT02877134|7154996|FG005|Overall Study|Other|1
4378431|NCT02877134|7154997|FG006|Overall Study|Other|1
4771138|NCT01757665|7747949|FG000|Overall Study|Still on Study - Missed Visit|14
4771139|NCT01757665|7747950|FG001|Overall Study|Still on Study - Missed Visit|1
4771140|NCT01757665|7747949|FG000|Overall Study|Death|25
4771141|NCT01757665|7747950|FG001|Overall Study|Death|8
4771142|NCT01757665|7747949|FG000|Overall Study|Explant|1
4771143|NCT01757665|7747950|FG001|Overall Study|Explant|2
4771144|NCT01757665|7747949|FG000|Overall Study|Withdrawal by Subject|10
4771145|NCT01757665|7747950|FG001|Overall Study|Withdrawal by Subject|0
4771146|NCT01757665|7747949|FG000|Overall Study|Lost to Follow-up|1
4771147|NCT01757665|7747950|FG001|Overall Study|Lost to Follow-up|1
4771148|NCT01757665|7747949|FG000|Overall Study|Not Implanted with Device|5
4771149|NCT01757665|7747950|FG001|Overall Study|Not Implanted with Device|1
4771150|NCT00822120|7747991|FG000|Initial Registration|Adverse Event|1
4771151|NCT00822120|7747992|FG001|Initial Registration|Adverse Event|0
4771152|NCT00822120|7747993|FG002|Initial Registration|Adverse Event|0
4771153|NCT00822120|7747994|FG003|Initial Registration|Adverse Event|0
4378448|NCT02028884|7155038|FG000|Double-blind Period|Adverse Event|5
4378449|NCT02028884|7155039|FG001|Double-blind Period|Adverse Event|3
4378450|NCT02028884|7155038|FG000|Double-blind Period|Eligibility Violation|1
4378451|NCT02028884|7155039|FG001|Double-blind Period|Eligibility Violation|0
4378452|NCT02028884|7155038|FG000|Double-blind Period|Non-Compliance With Study Drug|2
4378453|NCT02028884|7155039|FG001|Double-blind Period|Non-Compliance With Study Drug|0
4378454|NCT02028884|7155038|FG000|Double-blind Period|Withdrawal by Subject|2
4378455|NCT02028884|7155039|FG001|Double-blind Period|Withdrawal by Subject|0
4378456|NCT02028884|7155038|FG000|Double-blind Period|On-going in Study|8
4378457|NCT02028884|7155039|FG001|Double-blind Period|On-going in Study|20
4378458|NCT02028884|7155038|FG000|Open-label Extension Period|Adverse Event|2
4378459|NCT02028884|7155039|FG001|Open-label Extension Period|Adverse Event|1
4378460|NCT02028884|7155038|FG000|Open-label Extension Period|Lack of Efficacy|3
4378347|NCT04425252|7154878|FG000|Overall Study|Withdrawal by Subject|2
4378348|NCT04425252|7154879|FG001|Overall Study|Withdrawal by Subject|1
4378349|NCT04425252|7154878|FG000|Overall Study|Lost to Follow-up|1
4378350|NCT04425252|7154879|FG001|Overall Study|Lost to Follow-up|0
4378351|NCT04425252|7154878|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1
4378352|NCT04425252|7154879|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1
4378353|NCT03875313|7154908|FG000|Overall Study|Withdrawal by Subject|1
4378354|NCT03875313|7154909|FG001|Overall Study|Withdrawal by Subject|3
4378355|NCT03875313|7154910|FG002|Overall Study|Withdrawal by Subject|0
4378356|NCT03875313|7154911|FG003|Overall Study|Withdrawal by Subject|0
4378357|NCT03875313|7154912|FG004|Overall Study|Withdrawal by Subject|0
4378358|NCT03875313|7154908|FG000|Overall Study|Death|0
4378359|NCT03875313|7154909|FG001|Overall Study|Death|0
4587854|NCT01494532|7432067|FG000|Overall Study|Protocol-defined stopping criteria|0
4378360|NCT03875313|7154910|FG002|Overall Study|Death|0
4378361|NCT03875313|7154911|FG003|Overall Study|Death|0
4378362|NCT03875313|7154912|FG004|Overall Study|Death|1
4378363|NCT03875313|7154908|FG000|Overall Study|Lost to Follow-up|0
4378364|NCT03875313|7154909|FG001|Overall Study|Lost to Follow-up|0
4378365|NCT03875313|7154910|FG002|Overall Study|Lost to Follow-up|0
4378366|NCT03875313|7154911|FG003|Overall Study|Lost to Follow-up|0
4378367|NCT03875313|7154912|FG004|Overall Study|Lost to Follow-up|1
4378368|NCT03875313|7154908|FG000|Overall Study|Study Termination by Sponsor|0
4378369|NCT03875313|7154909|FG001|Overall Study|Study Termination by Sponsor|1
4378370|NCT03875313|7154910|FG002|Overall Study|Study Termination by Sponsor|1
4378371|NCT03875313|7154911|FG003|Overall Study|Study Termination by Sponsor|0
4378372|NCT03875313|7154912|FG004|Overall Study|Study Termination by Sponsor|1
4378373|NCT03875313|7154908|FG000|Overall Study|New Anticancer Treatment|0
4378374|NCT03875313|7154909|FG001|Overall Study|New Anticancer Treatment|1
4378375|NCT03875313|7154910|FG002|Overall Study|New Anticancer Treatment|2
4378376|NCT03875313|7154911|FG003|Overall Study|New Anticancer Treatment|1
4378377|NCT03875313|7154912|FG004|Overall Study|New Anticancer Treatment|0
4378378|NCT03875313|7154908|FG000|Overall Study|Other, Not Specified|2
4378379|NCT03875313|7154909|FG001|Overall Study|Other, Not Specified|11
4378380|NCT03875313|7154910|FG002|Overall Study|Other, Not Specified|3
4378381|NCT03875313|7154911|FG003|Overall Study|Other, Not Specified|3
4378382|NCT03875313|7154912|FG004|Overall Study|Other, Not Specified|1
4378461|NCT02028884|7155039|FG001|Open-label Extension Period|Lack of Efficacy|0
4378462|NCT02028884|7155038|FG000|Open-label Extension Period|Non-Compliance With Study Drug|0
4378463|NCT02028884|7155039|FG001|Open-label Extension Period|Non-Compliance With Study Drug|1
4378464|NCT02028884|7155038|FG000|Open-label Extension Period|Withdrawal by Subject|0
4378465|NCT02028884|7155039|FG001|Open-label Extension Period|Withdrawal by Subject|2
4378466|NCT02028884|7155038|FG000|Open-label Extension Period|On-going in Study|19
4378467|NCT02028884|7155039|FG001|Open-label Extension Period|On-going in Study|14
4378468|NCT01983774|7155050|FG000|Overall Study|Lung Transplant|0
4378469|NCT01983774|7155051|FG001|Overall Study|Lung Transplant|1
4378470|NCT01983774|7155050|FG000|Overall Study|Lost to Follow-up|1
4378471|NCT01983774|7155051|FG001|Overall Study|Lost to Follow-up|0
4378472|NCT01974206|7155061|FG000|Overall Study|Did Not Take Study Drug|0
4378473|NCT01974206|7155062|FG001|Overall Study|Did Not Take Study Drug|1
4378474|NCT01974206|7155061|FG000|Overall Study|Physician Decision|1
4378475|NCT01974206|7155062|FG001|Overall Study|Physician Decision|0
4378476|NCT01974206|7155061|FG000|Overall Study|Withdrawal by Subject|3
4378477|NCT01974206|7155062|FG001|Overall Study|Withdrawal by Subject|0
4378478|NCT01974206|7155061|FG000|Overall Study|Lost to Follow-up|1
4378479|NCT01974206|7155062|FG001|Overall Study|Lost to Follow-up|0
4378480|NCT01974206|7155061|FG000|Overall Study|Death|1
4378481|NCT01974206|7155062|FG001|Overall Study|Death|0
4378482|NCT01970865|7155085|FG000|Overall Study|Death|3
4378483|NCT01970865|7155086|FG001|Overall Study|Death|1
4378484|NCT01970865|7155087|FG002|Overall Study|Death|3
4378485|NCT01970865|7155088|FG003|Overall Study|Death|4
4378486|NCT01970865|7155089|FG004|Overall Study|Death|6
4378487|NCT01970865|7155090|FG005|Overall Study|Death|3
4378488|NCT01970865|7155091|FG006|Overall Study|Death|1
4378489|NCT01970865|7155092|FG007|Overall Study|Death|3
4378490|NCT01970865|7155093|FG008|Overall Study|Death|2
4378491|NCT01970865|7155094|FG009|Overall Study|Death|1
4378492|NCT01970865|7155095|FG010|Overall Study|Death|1
4378493|NCT01970865|7155096|FG011|Overall Study|Death|4
4378494|NCT01970865|7155097|FG012|Overall Study|Death|14
4466987|NCT00619892|7258882|FG000|Overall Study|Adverse Event|3
4466988|NCT00619892|7258883|FG001|Overall Study|Adverse Event|0
4466989|NCT00619892|7258882|FG000|Overall Study|Lost to Follow-up|0
4466990|NCT00619892|7258883|FG001|Overall Study|Lost to Follow-up|1
4466991|NCT00619892|7258882|FG000|Overall Study|Intercurrent illness|0
4466992|NCT00619892|7258883|FG001|Overall Study|Intercurrent illness|1
4466993|NCT00619918|7258893|FG000|Overall Study|Withdrawal by Subject|4
4466994|NCT00619918|7258894|FG001|Overall Study|Withdrawal by Subject|3
4466995|NCT00619918|7258893|FG000|Overall Study|Physician Decision|8
4378495|NCT01970865|7155098|FG013|Overall Study|Death|19
4378496|NCT01970865|7155099|FG014|Overall Study|Death|15
4378497|NCT01970865|7155100|FG015|Overall Study|Death|10
4378498|NCT01970865|7155101|FG016|Overall Study|Death|1
4378499|NCT01970865|7155085|FG000|Overall Study|Lost to Follow-up|0
4378500|NCT01970865|7155086|FG001|Overall Study|Lost to Follow-up|0
4378501|NCT01970865|7155087|FG002|Overall Study|Lost to Follow-up|0
4378502|NCT01970865|7155088|FG003|Overall Study|Lost to Follow-up|1
4378503|NCT01970865|7155089|FG004|Overall Study|Lost to Follow-up|1
4378504|NCT01970865|7155090|FG005|Overall Study|Lost to Follow-up|0
4378505|NCT01970865|7155091|FG006|Overall Study|Lost to Follow-up|0
4378506|NCT01970865|7155092|FG007|Overall Study|Lost to Follow-up|0
4378507|NCT01970865|7155093|FG008|Overall Study|Lost to Follow-up|0
4378508|NCT01970865|7155094|FG009|Overall Study|Lost to Follow-up|0
4378509|NCT01970865|7155095|FG010|Overall Study|Lost to Follow-up|0
4378510|NCT01970865|7155096|FG011|Overall Study|Lost to Follow-up|0
4378511|NCT01970865|7155097|FG012|Overall Study|Lost to Follow-up|1
4378512|NCT01970865|7155098|FG013|Overall Study|Lost to Follow-up|0
4378513|NCT01970865|7155099|FG014|Overall Study|Lost to Follow-up|0
4378514|NCT01970865|7155100|FG015|Overall Study|Lost to Follow-up|0
4378515|NCT01970865|7155101|FG016|Overall Study|Lost to Follow-up|0
4378516|NCT01970865|7155085|FG000|Overall Study|Withdrawal by Subject|0
4378517|NCT01970865|7155086|FG001|Overall Study|Withdrawal by Subject|0
4378518|NCT01970865|7155087|FG002|Overall Study|Withdrawal by Subject|0
4378519|NCT01970865|7155088|FG003|Overall Study|Withdrawal by Subject|1
4378520|NCT01970865|7155089|FG004|Overall Study|Withdrawal by Subject|2
4378521|NCT01970865|7155090|FG005|Overall Study|Withdrawal by Subject|0
4378522|NCT01970865|7155091|FG006|Overall Study|Withdrawal by Subject|0
4378523|NCT01970865|7155092|FG007|Overall Study|Withdrawal by Subject|0
4378524|NCT01970865|7155093|FG008|Overall Study|Withdrawal by Subject|0
4378525|NCT01970865|7155094|FG009|Overall Study|Withdrawal by Subject|0
4378526|NCT01970865|7155095|FG010|Overall Study|Withdrawal by Subject|0
4378527|NCT01970865|7155096|FG011|Overall Study|Withdrawal by Subject|1
4378528|NCT01970865|7155097|FG012|Overall Study|Withdrawal by Subject|2
4378529|NCT01970865|7155098|FG013|Overall Study|Withdrawal by Subject|5
4378530|NCT01970865|7155099|FG014|Overall Study|Withdrawal by Subject|2
4378531|NCT01970865|7155100|FG015|Overall Study|Withdrawal by Subject|7
4378532|NCT01970865|7155101|FG016|Overall Study|Withdrawal by Subject|0
4378533|NCT01970865|7155085|FG000|Overall Study|Other|0
4378534|NCT01970865|7155086|FG001|Overall Study|Other|0
4378535|NCT01970865|7155087|FG002|Overall Study|Other|0
4378536|NCT01970865|7155088|FG003|Overall Study|Other|1
4378537|NCT01970865|7155089|FG004|Overall Study|Other|0
4378538|NCT01970865|7155090|FG005|Overall Study|Other|0
4378539|NCT01970865|7155091|FG006|Overall Study|Other|0
4378540|NCT01970865|7155092|FG007|Overall Study|Other|0
4378541|NCT01970865|7155093|FG008|Overall Study|Other|0
4378542|NCT01970865|7155094|FG009|Overall Study|Other|0
4378543|NCT01970865|7155095|FG010|Overall Study|Other|0
4378544|NCT01970865|7155096|FG011|Overall Study|Other|0
4378545|NCT01970865|7155097|FG012|Overall Study|Other|0
4378546|NCT01970865|7155098|FG013|Overall Study|Other|1
4378547|NCT01970865|7155099|FG014|Overall Study|Other|0
4378548|NCT01970865|7155100|FG015|Overall Study|Other|1
4378549|NCT01970865|7155101|FG016|Overall Study|Other|0
4378550|NCT01970865|7155085|FG000|Overall Study|Study ongoing|0
4378551|NCT01970865|7155086|FG001|Overall Study|Study ongoing|2
4378552|NCT01970865|7155087|FG002|Overall Study|Study ongoing|0
4378553|NCT01970865|7155088|FG003|Overall Study|Study ongoing|6
4378554|NCT01970865|7155089|FG004|Overall Study|Study ongoing|8
4378555|NCT01970865|7155090|FG005|Overall Study|Study ongoing|0
4378556|NCT01970865|7155091|FG006|Overall Study|Study ongoing|2
4378557|NCT01970865|7155092|FG007|Overall Study|Study ongoing|0
4378558|NCT01970865|7155093|FG008|Overall Study|Study ongoing|1
4378559|NCT01970865|7155094|FG009|Overall Study|Study ongoing|3
4378560|NCT01970865|7155095|FG010|Overall Study|Study ongoing|29
4378561|NCT01970865|7155096|FG011|Overall Study|Study ongoing|22
4378562|NCT01970865|7155097|FG012|Overall Study|Study ongoing|43
4378563|NCT01970865|7155098|FG013|Overall Study|Study ongoing|41
4378564|NCT01970865|7155099|FG014|Overall Study|Study ongoing|29
4378565|NCT01970865|7155100|FG015|Overall Study|Study ongoing|29
4378566|NCT01970865|7155101|FG016|Overall Study|Study ongoing|2
4771154|NCT00822120|7747995|FG004|Initial Registration|Adverse Event|0
4771155|NCT00822120|7747996|FG005|Initial Registration|Adverse Event|0
4378569|NCT00589420|7155171|FG000|Overall Study|screen failure|1
4466996|NCT00619918|7258894|FG001|Overall Study|Physician Decision|8
4466997|NCT00619918|7258893|FG000|Overall Study|Transfer to outside facility|3
4466998|NCT00619918|7258894|FG001|Overall Study|Transfer to outside facility|3
4466999|NCT00619918|7258893|FG000|Overall Study|Left before receiving first dose|5
4467000|NCT00619918|7258894|FG001|Overall Study|Left before receiving first dose|8
4467001|NCT00619957|7258902|FG000|Month 24 Double-Blind|Adverse Event|9
4467002|NCT00619957|7258903|FG001|Month 24 Double-Blind|Adverse Event|7
4467003|NCT00619957|7258902|FG000|Month 24 Double-Blind|Protocol Violation|1
4467004|NCT00619957|7258903|FG001|Month 24 Double-Blind|Protocol Violation|0
4467005|NCT00619957|7258902|FG000|Month 24 Double-Blind|Withdrawal by Subject|7
4467006|NCT00619957|7258903|FG001|Month 24 Double-Blind|Withdrawal by Subject|9
4467007|NCT00619957|7258902|FG000|Month 24 Double-Blind|Lost to Follow-up|1
4467008|NCT00619957|7258903|FG001|Month 24 Double-Blind|Lost to Follow-up|0
4467009|NCT00619957|7258902|FG000|Month 24 Double-Blind|Did not take any study medication|0
4467010|NCT00619957|7258903|FG001|Month 24 Double-Blind|Did not take any study medication|1
4378570|NCT04993339|7155181|FG000|Overall Study|Lost to Follow-up|0
4378571|NCT04993339|7155182|FG001|Overall Study|Lost to Follow-up|1
4378572|NCT04993339|7155181|FG000|Overall Study|no MRI scan|3
4378573|NCT04993339|7155182|FG001|Overall Study|no MRI scan|1
4378574|NCT04919161|7155224|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1
4378575|NCT04919161|7155225|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0
4378576|NCT04919161|7155224|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0
4378577|NCT04919161|7155225|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1
4378578|NCT04919161|7155224|FG000|Overall Study|Acute ankle sprain after session 1|0
4378579|NCT04919161|7155225|FG001|Overall Study|Acute ankle sprain after session 1|1
4378580|NCT04883541|7155307|FG000|Overall Study|Not attending regular yoga class|16
4378581|NCT04883541|7155308|FG001|Overall Study|Not attending regular yoga class|0
4378582|NCT04883541|7155307|FG000|Overall Study|Not attending the pregnancy school|0
4378583|NCT04883541|7155308|FG001|Overall Study|Not attending the pregnancy school|9
4378584|NCT04357782|7155324|FG000|Overall Study|Discharged from hospital|1
4378585|NCT04357782|7155325|FG001|Overall Study|Discharged from hospital|0
4378586|NCT04357782|7155324|FG000|Overall Study|Death|0
4378587|NCT04357782|7155325|FG001|Overall Study|Death|2
4378588|NCT03760068|7155352|FG000|Overall Study|Withdrawal by Subject|7
4378589|NCT03760068|7155353|FG001|Overall Study|Withdrawal by Subject|8
4378590|NCT03760068|7155352|FG000|Overall Study|Adverse Event|1
4378591|NCT03760068|7155353|FG001|Overall Study|Adverse Event|2
4378592|NCT03760068|7155352|FG000|Overall Study|Administrative Decision by Sponsor|0
4378593|NCT03760068|7155353|FG001|Overall Study|Administrative Decision by Sponsor|2
4378594|NCT03760068|7155352|FG000|Overall Study|Physician Decision|1
4378595|NCT03760068|7155353|FG001|Overall Study|Physician Decision|2
4378596|NCT03760068|7155352|FG000|Overall Study|Lost to Follow-up|4
4378597|NCT03760068|7155353|FG001|Overall Study|Lost to Follow-up|9
4378598|NCT03760068|7155352|FG000|Overall Study|Subject Moved Out of State|1
4378599|NCT03760068|7155353|FG001|Overall Study|Subject Moved Out of State|0
4378600|NCT03628781|7155371|FG000|Overall Study|Lost to Follow-up|16
4378601|NCT03628781|7155372|FG001|Overall Study|Lost to Follow-up|8
4378602|NCT03628781|7155371|FG000|Overall Study|Withdrawal by Subject|16
4378603|NCT03628781|7155372|FG001|Overall Study|Withdrawal by Subject|1
4378604|NCT03560206|7155380|FG000|Overall Study|Lost to Follow-up|19
4378605|NCT03560206|7155381|FG001|Overall Study|Lost to Follow-up|11
4378606|NCT03560206|7155380|FG000|Overall Study|Withdrawal by Subject|2
4378607|NCT03560206|7155381|FG001|Overall Study|Withdrawal by Subject|4
4378608|NCT03560206|7155380|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5
4378609|NCT03560206|7155381|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0
4378610|NCT03560206|7155380|FG000|Overall Study|Busy schedule|14
4378611|NCT03560206|7155381|FG001|Overall Study|Busy schedule|2
4378612|NCT03560206|7155380|FG000|Overall Study|patients' new health condition such as cancer|10
4378613|NCT03560206|7155381|FG001|Overall Study|patients' new health condition such as cancer|1
4378614|NCT03340766|7155399|FG000|Overall Study|Death|6
4378615|NCT03340766|7155400|FG001|Overall Study|Death|6
4378616|NCT03340766|7155401|FG002|Overall Study|Death|2
4378617|NCT03340766|7155399|FG000|Overall Study|Withdrawal by Subject|2
4378618|NCT03340766|7155400|FG001|Overall Study|Withdrawal by Subject|1
4378619|NCT03340766|7155401|FG002|Overall Study|Withdrawal by Subject|2
4378620|NCT03340766|7155399|FG000|Overall Study|Continuing Study|3
4378621|NCT03340766|7155400|FG001|Overall Study|Continuing Study|3
4378622|NCT03340766|7155401|FG002|Overall Study|Continuing Study|5
4378623|NCT02706847|7155435|FG000|Day 1 to Week 12|Adverse Event|2
4378624|NCT02706847|7155436|FG001|Day 1 to Week 12|Adverse Event|2
4378625|NCT02706847|7155437|FG002|Day 1 to Week 12|Adverse Event|1
4378626|NCT02706847|7155438|FG003|Day 1 to Week 12|Adverse Event|12
4378627|NCT02706847|7155435|FG000|Day 1 to Week 12|Withdrawal by Subject|2
4378628|NCT02706847|7155436|FG001|Day 1 to Week 12|Withdrawal by Subject|1
4378629|NCT02706847|7155437|FG002|Day 1 to Week 12|Withdrawal by Subject|4
4378630|NCT02706847|7155438|FG003|Day 1 to Week 12|Withdrawal by Subject|2
4378631|NCT02706847|7155435|FG000|Day 1 to Week 12|Lost to Follow-up|2
4378632|NCT02706847|7155436|FG001|Day 1 to Week 12|Lost to Follow-up|1
4378633|NCT02706847|7155437|FG002|Day 1 to Week 12|Lost to Follow-up|0
4378634|NCT02706847|7155438|FG003|Day 1 to Week 12|Lost to Follow-up|0
4378635|NCT02706847|7155435|FG000|Day 1 to Week 12|Other|4
4378636|NCT02706847|7155436|FG001|Day 1 to Week 12|Other|4
4378637|NCT02706847|7155437|FG002|Day 1 to Week 12|Other|2
4378638|NCT02706847|7155438|FG003|Day 1 to Week 12|Other|2
4378639|NCT02706847|7155435|FG000|Day 1 to Week 12|Randomized in Error|0
4378640|NCT02706847|7155436|FG001|Day 1 to Week 12|Randomized in Error|0
4378641|NCT02706847|7155437|FG002|Day 1 to Week 12|Randomized in Error|1
4378642|NCT02706847|7155438|FG003|Day 1 to Week 12|Randomized in Error|0
4378643|NCT02706847|7155435|FG000|Week 12 to Week 24|Adverse Event|1
4378644|NCT02706847|7155436|FG001|Week 12 to Week 24|Adverse Event|2
4378645|NCT02706847|7155437|FG002|Week 12 to Week 24|Adverse Event|2
4378646|NCT02706847|7155438|FG003|Week 12 to Week 24|Adverse Event|5
4378647|NCT02706847|7155435|FG000|Week 12 to Week 24|Withdrawal by Subject|1
4378648|NCT02706847|7155436|FG001|Week 12 to Week 24|Withdrawal by Subject|0
4378649|NCT02706847|7155437|FG002|Week 12 to Week 24|Withdrawal by Subject|1
4378650|NCT02706847|7155438|FG003|Week 12 to Week 24|Withdrawal by Subject|4
4378651|NCT02706847|7155435|FG000|Week 12 to Week 24|Lost to Follow-up|0
4378652|NCT02706847|7155436|FG001|Week 12 to Week 24|Lost to Follow-up|0
4378653|NCT02706847|7155437|FG002|Week 12 to Week 24|Lost to Follow-up|0
4378654|NCT02706847|7155438|FG003|Week 12 to Week 24|Lost to Follow-up|1
4378655|NCT02706847|7155435|FG000|Week 12 to Week 24|Other|1
4378656|NCT02706847|7155436|FG001|Week 12 to Week 24|Other|0
4378657|NCT02706847|7155437|FG002|Week 12 to Week 24|Other|1
4378658|NCT02706847|7155438|FG003|Week 12 to Week 24|Other|4
4378659|NCT02701777|7155452|FG000|Overall Study|Some subjects did not like the stimulation.|4
4378660|NCT02701777|7155453|FG001|Overall Study|Some subjects did not like the stimulation.|0
4378661|NCT02701777|7155454|FG002|Overall Study|Some subjects did not like the stimulation.|0
4378662|NCT02701777|7155455|FG003|Overall Study|Some subjects did not like the stimulation.|2
4378663|NCT02701777|7155452|FG000|Overall Study|Some subjects were unable to commit to the training study.|0
4378664|NCT02701777|7155453|FG001|Overall Study|Some subjects were unable to commit to the training study.|3
4378665|NCT02701777|7155454|FG002|Overall Study|Some subjects were unable to commit to the training study.|4
4378666|NCT02701777|7155455|FG003|Overall Study|Some subjects were unable to commit to the training study.|0
4378667|NCT02677896|7155471|FG000|Overall Study|Adverse Event|28
4378668|NCT02677896|7155472|FG001|Overall Study|Adverse Event|21
4378669|NCT02677896|7155471|FG000|Overall Study|Death|9
4378670|NCT02677896|7155472|FG001|Overall Study|Death|7
4696013|NCT02631850|7608635|FG002|Treatment Period|Family medical issue|0
4696014|NCT02631850|7608636|FG003|Treatment Period|Family medical issue|0
4696015|NCT02631850|7608633|FG000|6 Month Follow up|Lost to Follow-up|5
4378671|NCT02677896|7155471|FG000|Overall Study|Lost to Follow-up|0
4378672|NCT02677896|7155472|FG001|Overall Study|Lost to Follow-up|1
4378673|NCT02677896|7155471|FG000|Overall Study|Progressive disease:|65
4378674|NCT02677896|7155472|FG001|Overall Study|Progressive disease:|171
4378675|NCT02677896|7155471|FG000|Overall Study|Protocol deviation|2
4378676|NCT02677896|7155472|FG001|Overall Study|Protocol deviation|1
4378677|NCT02677896|7155471|FG000|Overall Study|Withdrawal by patient:|25
4378678|NCT02677896|7155472|FG001|Overall Study|Withdrawal by patient:|30
4378679|NCT02677896|7155471|FG000|Overall Study|Miscellaneous|6
4378680|NCT02677896|7155472|FG001|Overall Study|Miscellaneous|11
4378681|NCT02677896|7155471|FG000|Overall Study|Did not receive study drug|2
4378682|NCT02677896|7155472|FG001|Overall Study|Did not receive study drug|2
4378683|NCT02657434|7155480|FG000|Overall Study|On-Going in Study|77
4378684|NCT02657434|7155481|FG001|Overall Study|On-Going in Study|91
4378685|NCT02657434|7155480|FG000|Overall Study|Death|177
4378686|NCT02657434|7155481|FG001|Overall Study|Death|183
4378687|NCT02657434|7155480|FG000|Overall Study|Lost to Follow-up|2
4378688|NCT02657434|7155481|FG001|Overall Study|Lost to Follow-up|2
4378689|NCT02657434|7155480|FG000|Overall Study|Randomization by Error|2
4378690|NCT02657434|7155481|FG001|Overall Study|Randomization by Error|0
4378691|NCT02657434|7155480|FG000|Overall Study|Withdrawal by Subject|27
4378692|NCT02657434|7155481|FG001|Overall Study|Withdrawal by Subject|16
4378693|NCT02657434|7155480|FG000|Overall Study|Protocol Violation|1
4378694|NCT02657434|7155481|FG001|Overall Study|Protocol Violation|0
4378695|NCT02564900|7155503|FG000|Dose Escalation|Progressive disease per RECIST|2
4378696|NCT02564900|7155504|FG001|Dose Escalation|Progressive disease per RECIST|3
4378697|NCT02564900|7155505|FG002|Dose Escalation|Progressive disease per RECIST|3
4378698|NCT02564900|7155506|FG003|Dose Escalation|Progressive disease per RECIST|3
4378699|NCT02564900|7155507|FG004|Dose Escalation|Progressive disease per RECIST|3
4378700|NCT02564900|7155508|FG005|Dose Escalation|Progressive disease per RECIST|1
4378701|NCT02564900|7155509|FG006|Dose Escalation|Progressive disease per RECIST|0
4378702|NCT02564900|7155510|FG007|Dose Escalation|Progressive disease per RECIST|0
4378703|NCT02564900|7155511|FG008|Dose Escalation|Progressive disease per RECIST|0
4378704|NCT02564900|7155512|FG009|Dose Escalation|Progressive disease per RECIST|0
4378705|NCT02564900|7155513|FG010|Dose Escalation|Progressive disease per RECIST|0
4467011|NCT00619957|7258902|FG000|Month 48 Open-Label|Adverse Event|4
4467012|NCT00619957|7258903|FG001|Month 48 Open-Label|Adverse Event|4
4467013|NCT00619957|7258902|FG000|Month 48 Open-Label|Lost to Follow-up|2
4467014|NCT00619957|7258903|FG001|Month 48 Open-Label|Lost to Follow-up|4
4467015|NCT00619957|7258902|FG000|Month 48 Open-Label|Withdrawal by Subject|6
4467016|NCT00619957|7258903|FG001|Month 48 Open-Label|Withdrawal by Subject|9
4587855|NCT01494532|7432068|FG001|Overall Study|Protocol-defined stopping criteria|0
4587856|NCT01494532|7432069|FG002|Overall Study|Protocol-defined stopping criteria|1
4587857|NCT01494532|7432070|FG003|Overall Study|Protocol-defined stopping criteria|0
4587858|NCT01494532|7432071|FG004|Overall Study|Protocol-defined stopping criteria|0
4696016|NCT02631850|7608634|FG001|6 Month Follow up|Lost to Follow-up|8
4467017|NCT00619983|7258930|FG000|Test Drug Alone|Withdrawal by Subject|1
4467018|NCT00619983|7258931|FG001|Test Drug Alone|Withdrawal by Subject|0
4467019|NCT00619983|7258932|FG002|Test Drug Alone|Withdrawal by Subject|0
4467020|NCT00619983|7258933|FG003|Test Drug Alone|Withdrawal by Subject|1
4467021|NCT00619983|7258930|FG000|Test Drug Alone|Failure of daily diary device|1
4467022|NCT00619983|7258931|FG001|Test Drug Alone|Failure of daily diary device|1
4467023|NCT00619983|7258932|FG002|Test Drug Alone|Failure of daily diary device|2
4467024|NCT00619983|7258933|FG003|Test Drug Alone|Failure of daily diary device|2
4378706|NCT02564900|7155514|FG011|Dose Escalation|Progressive disease per RECIST|0
4378707|NCT02564900|7155515|FG012|Dose Escalation|Progressive disease per RECIST|0
4378708|NCT02564900|7155516|FG013|Dose Escalation|Progressive disease per RECIST|0
4378709|NCT02564900|7155517|FG014|Dose Escalation|Progressive disease per RECIST|0
4378710|NCT02564900|7155503|FG000|Dose Escalation|Ongoing|1
4378711|NCT02564900|7155504|FG001|Dose Escalation|Ongoing|0
4378712|NCT02564900|7155505|FG002|Dose Escalation|Ongoing|0
4378713|NCT02564900|7155506|FG003|Dose Escalation|Ongoing|2
4378714|NCT02564900|7155507|FG004|Dose Escalation|Ongoing|2
4378715|NCT02564900|7155508|FG005|Dose Escalation|Ongoing|2
4378716|NCT02564900|7155509|FG006|Dose Escalation|Ongoing|0
4378717|NCT02564900|7155510|FG007|Dose Escalation|Ongoing|0
4378718|NCT02564900|7155511|FG008|Dose Escalation|Ongoing|0
4378719|NCT02564900|7155512|FG009|Dose Escalation|Ongoing|0
4378720|NCT02564900|7155513|FG010|Dose Escalation|Ongoing|0
4378721|NCT02564900|7155514|FG011|Dose Escalation|Ongoing|0
4378722|NCT02564900|7155515|FG012|Dose Escalation|Ongoing|0
4378723|NCT02564900|7155516|FG013|Dose Escalation|Ongoing|0
4378724|NCT02564900|7155517|FG014|Dose Escalation|Ongoing|0
4378725|NCT02564900|7155503|FG000|Dose Escalation|Adverse Event|0
4378726|NCT02564900|7155504|FG001|Dose Escalation|Adverse Event|0
4378727|NCT02564900|7155505|FG002|Dose Escalation|Adverse Event|0
4378728|NCT02564900|7155506|FG003|Dose Escalation|Adverse Event|1
4378729|NCT02564900|7155507|FG004|Dose Escalation|Adverse Event|1
4378730|NCT02564900|7155508|FG005|Dose Escalation|Adverse Event|3
4378731|NCT02564900|7155509|FG006|Dose Escalation|Adverse Event|0
4378732|NCT02564900|7155510|FG007|Dose Escalation|Adverse Event|0
4378733|NCT02564900|7155511|FG008|Dose Escalation|Adverse Event|0
4378734|NCT02564900|7155512|FG009|Dose Escalation|Adverse Event|0
4378735|NCT02564900|7155513|FG010|Dose Escalation|Adverse Event|0
4378736|NCT02564900|7155514|FG011|Dose Escalation|Adverse Event|0
4378737|NCT02564900|7155515|FG012|Dose Escalation|Adverse Event|0
4378738|NCT02564900|7155516|FG013|Dose Escalation|Adverse Event|0
4378739|NCT02564900|7155517|FG014|Dose Escalation|Adverse Event|0
4378740|NCT02564900|7155503|FG000|Dose Expansion|Progressive disease per RECIST|0
4378741|NCT02564900|7155504|FG001|Dose Expansion|Progressive disease per RECIST|0
4378742|NCT02564900|7155505|FG002|Dose Expansion|Progressive disease per RECIST|0
4378743|NCT02564900|7155506|FG003|Dose Expansion|Progressive disease per RECIST|0
4378744|NCT02564900|7155507|FG004|Dose Expansion|Progressive disease per RECIST|0
4378745|NCT02564900|7155508|FG005|Dose Expansion|Progressive disease per RECIST|0
4378746|NCT02564900|7155509|FG006|Dose Expansion|Progressive disease per RECIST|19
4378747|NCT02564900|7155510|FG007|Dose Expansion|Progressive disease per RECIST|17
4378748|NCT02564900|7155511|FG008|Dose Expansion|Progressive disease per RECIST|8
4378749|NCT02564900|7155512|FG009|Dose Expansion|Progressive disease per RECIST|16
4378750|NCT02564900|7155513|FG010|Dose Expansion|Progressive disease per RECIST|13
4378751|NCT02564900|7155514|FG011|Dose Expansion|Progressive disease per RECIST|19
4378752|NCT02564900|7155515|FG012|Dose Expansion|Progressive disease per RECIST|10
4378753|NCT02564900|7155516|FG013|Dose Expansion|Progressive disease per RECIST|13
4378754|NCT02564900|7155517|FG014|Dose Expansion|Progressive disease per RECIST|11
4378755|NCT02564900|7155503|FG000|Dose Expansion|Clinical progression|0
4378756|NCT02564900|7155504|FG001|Dose Expansion|Clinical progression|0
4378757|NCT02564900|7155505|FG002|Dose Expansion|Clinical progression|0
4378758|NCT02564900|7155506|FG003|Dose Expansion|Clinical progression|0
4378759|NCT02564900|7155507|FG004|Dose Expansion|Clinical progression|0
4378760|NCT02564900|7155508|FG005|Dose Expansion|Clinical progression|0
4378761|NCT02564900|7155509|FG006|Dose Expansion|Clinical progression|5
4378762|NCT02564900|7155510|FG007|Dose Expansion|Clinical progression|12
4378763|NCT02564900|7155511|FG008|Dose Expansion|Clinical progression|0
4378764|NCT02564900|7155512|FG009|Dose Expansion|Clinical progression|3
4378765|NCT02564900|7155513|FG010|Dose Expansion|Clinical progression|2
4378766|NCT02564900|7155514|FG011|Dose Expansion|Clinical progression|0
4378767|NCT02564900|7155515|FG012|Dose Expansion|Clinical progression|1
4378768|NCT02564900|7155516|FG013|Dose Expansion|Clinical progression|3
4378769|NCT02564900|7155517|FG014|Dose Expansion|Clinical progression|1
4378770|NCT02564900|7155503|FG000|Dose Expansion|Adverse Event|0
4378771|NCT02564900|7155504|FG001|Dose Expansion|Adverse Event|0
4378772|NCT02564900|7155505|FG002|Dose Expansion|Adverse Event|0
4378773|NCT02564900|7155506|FG003|Dose Expansion|Adverse Event|0
4378774|NCT02564900|7155507|FG004|Dose Expansion|Adverse Event|0
4378775|NCT02564900|7155508|FG005|Dose Expansion|Adverse Event|0
4378776|NCT02564900|7155509|FG006|Dose Expansion|Adverse Event|9
4378777|NCT02564900|7155510|FG007|Dose Expansion|Adverse Event|22
4378778|NCT02564900|7155511|FG008|Dose Expansion|Adverse Event|0
4378779|NCT02564900|7155512|FG009|Dose Expansion|Adverse Event|11
4378780|NCT02564900|7155513|FG010|Dose Expansion|Adverse Event|0
4378781|NCT02564900|7155514|FG011|Dose Expansion|Adverse Event|5
4378782|NCT02564900|7155515|FG012|Dose Expansion|Adverse Event|2
4378783|NCT02564900|7155516|FG013|Dose Expansion|Adverse Event|2
4378784|NCT02564900|7155517|FG014|Dose Expansion|Adverse Event|1
4378785|NCT02564900|7155503|FG000|Dose Expansion|Ongoing|0
4378786|NCT02564900|7155504|FG001|Dose Expansion|Ongoing|0
4378787|NCT02564900|7155505|FG002|Dose Expansion|Ongoing|0
4378788|NCT02564900|7155506|FG003|Dose Expansion|Ongoing|0
4378789|NCT02564900|7155507|FG004|Dose Expansion|Ongoing|0
4378790|NCT02564900|7155508|FG005|Dose Expansion|Ongoing|0
4378791|NCT02564900|7155509|FG006|Dose Expansion|Ongoing|9
4378792|NCT02564900|7155510|FG007|Dose Expansion|Ongoing|10
4378793|NCT02564900|7155511|FG008|Dose Expansion|Ongoing|11
4378794|NCT02564900|7155512|FG009|Dose Expansion|Ongoing|3
4378795|NCT02564900|7155513|FG010|Dose Expansion|Ongoing|0
4378796|NCT02564900|7155514|FG011|Dose Expansion|Ongoing|0
4378797|NCT02564900|7155515|FG012|Dose Expansion|Ongoing|4
4378798|NCT02564900|7155516|FG013|Dose Expansion|Ongoing|0
4378799|NCT02564900|7155517|FG014|Dose Expansion|Ongoing|6
4378800|NCT02564900|7155503|FG000|Dose Expansion|Death|0
4378801|NCT02564900|7155504|FG001|Dose Expansion|Death|0
4378802|NCT02564900|7155505|FG002|Dose Expansion|Death|0
4378803|NCT02564900|7155506|FG003|Dose Expansion|Death|0
4378804|NCT02564900|7155507|FG004|Dose Expansion|Death|0
4378805|NCT02564900|7155508|FG005|Dose Expansion|Death|0
4378806|NCT02564900|7155509|FG006|Dose Expansion|Death|1
4378807|NCT02564900|7155510|FG007|Dose Expansion|Death|0
4378808|NCT02564900|7155511|FG008|Dose Expansion|Death|0
4378809|NCT02564900|7155512|FG009|Dose Expansion|Death|0
4378810|NCT02564900|7155513|FG010|Dose Expansion|Death|1
4378811|NCT02564900|7155514|FG011|Dose Expansion|Death|0
4378812|NCT02564900|7155515|FG012|Dose Expansion|Death|1
4378813|NCT02564900|7155516|FG013|Dose Expansion|Death|1
4378814|NCT02564900|7155517|FG014|Dose Expansion|Death|0
4378815|NCT02564900|7155503|FG000|Dose Expansion|Withdrawal by Subject|0
4378816|NCT02564900|7155504|FG001|Dose Expansion|Withdrawal by Subject|0
4467025|NCT00620022|7258943|FG000|Treatment Period 1|Adverse Event|4
4467026|NCT00620022|7258944|FG001|Treatment Period 1|Adverse Event|6
4467027|NCT00620022|7258943|FG000|Treatment Period 1|Subject withdrew consent|1
4467028|NCT00620022|7258944|FG001|Treatment Period 1|Subject withdrew consent|0
4467029|NCT00620022|7258943|FG000|Treatment Period 2|Adverse Event|2
4467030|NCT00620022|7258944|FG001|Treatment Period 2|Adverse Event|2
4467031|NCT00620074|7258955|FG000|Overall Study|Adverse Event|1
4467032|NCT00620113|7258963|FG000|Overall Study|Adverse Event|3
4467033|NCT00620113|7258964|FG001|Overall Study|Adverse Event|2
4467034|NCT00620113|7258965|FG002|Overall Study|Adverse Event|2
4467035|NCT00620113|7258966|FG003|Overall Study|Adverse Event|1
4467036|NCT00620113|7258963|FG000|Overall Study|Lack of Efficacy|2
4467037|NCT00620113|7258964|FG001|Overall Study|Lack of Efficacy|3
4467038|NCT00620113|7258965|FG002|Overall Study|Lack of Efficacy|0
4467039|NCT00620113|7258966|FG003|Overall Study|Lack of Efficacy|2
4467040|NCT00620113|7258963|FG000|Overall Study|Physician Decision|1
4467041|NCT00620113|7258964|FG001|Overall Study|Physician Decision|0
4467042|NCT00620113|7258965|FG002|Overall Study|Physician Decision|0
4467043|NCT00620113|7258966|FG003|Overall Study|Physician Decision|2
4467044|NCT00620113|7258963|FG000|Overall Study|Protocol Violation|2
4467045|NCT00620113|7258964|FG001|Overall Study|Protocol Violation|1
4467046|NCT00620113|7258965|FG002|Overall Study|Protocol Violation|0
4467047|NCT00620113|7258966|FG003|Overall Study|Protocol Violation|0
4467048|NCT00620113|7258963|FG000|Overall Study|Withdrawal by Subject|5
4467049|NCT00620113|7258964|FG001|Overall Study|Withdrawal by Subject|1
4467050|NCT00620113|7258965|FG002|Overall Study|Withdrawal by Subject|3
4467051|NCT00620113|7258966|FG003|Overall Study|Withdrawal by Subject|5
4467052|NCT00620282|7259002|FG000|Overall Study|Adverse Event|0
4467053|NCT00620282|7259003|FG001|Overall Study|Adverse Event|1
4467054|NCT00620282|7259004|FG002|Overall Study|Adverse Event|0
4467055|NCT00620282|7259002|FG000|Overall Study|Arterial line unable to be placed|0
4467056|NCT00620282|7259003|FG001|Overall Study|Arterial line unable to be placed|0
4467057|NCT00620282|7259004|FG002|Overall Study|Arterial line unable to be placed|1
4467058|NCT00620282|7259002|FG000|Overall Study|Withdrawal by Subject|0
4467059|NCT00620282|7259003|FG001|Overall Study|Withdrawal by Subject|1
4467060|NCT00620282|7259004|FG002|Overall Study|Withdrawal by Subject|0
4467061|NCT00620321|7259014|FG000|Overall Study|Adverse Event|1
4467062|NCT00620321|7259015|FG001|Overall Study|Adverse Event|1
4467063|NCT00620321|7259014|FG000|Overall Study|Death|1
4467064|NCT00620321|7259015|FG001|Overall Study|Death|1
4467065|NCT00620321|7259014|FG000|Overall Study|Physician Decision|0
4467066|NCT00620321|7259015|FG001|Overall Study|Physician Decision|7
4467067|NCT00620321|7259014|FG000|Overall Study|Progressive Disease|5
4467068|NCT00620321|7259015|FG001|Overall Study|Progressive Disease|5
4467069|NCT00620321|7259014|FG000|Overall Study|Sponsor Decision|0
4467070|NCT00620321|7259015|FG001|Overall Study|Sponsor Decision|1
4467071|NCT00620321|7259014|FG000|Overall Study|Withdrawal by Subject|1
4467072|NCT00620321|7259015|FG001|Overall Study|Withdrawal by Subject|1
4467073|NCT00620373|7259021|FG000|Overall Study|Unverified cancer status|33
4467074|NCT00620542|7259054|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12
4467075|NCT00620542|7259055|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15
4467076|NCT00620542|7259056|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0
4467077|NCT00620542|7259057|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0
4467078|NCT00620542|7259054|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406
4467079|NCT00620542|7259055|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409
4467080|NCT00620542|7259056|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0
4467081|NCT00620542|7259057|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0
4378817|NCT02564900|7155505|FG002|Dose Expansion|Withdrawal by Subject|0
4378818|NCT02564900|7155506|FG003|Dose Expansion|Withdrawal by Subject|0
4467082|NCT00620542|7259054|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43
4467083|NCT00620542|7259055|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40
4467084|NCT00620542|7259056|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0
4467085|NCT00620542|7259057|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0
4467086|NCT00620542|7259054|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7
4378819|NCT02564900|7155507|FG004|Dose Expansion|Withdrawal by Subject|0
4378820|NCT02564900|7155508|FG005|Dose Expansion|Withdrawal by Subject|0
4378821|NCT02564900|7155509|FG006|Dose Expansion|Withdrawal by Subject|4
4378822|NCT02564900|7155510|FG007|Dose Expansion|Withdrawal by Subject|0
4378823|NCT02564900|7155511|FG008|Dose Expansion|Withdrawal by Subject|0
4378824|NCT02564900|7155512|FG009|Dose Expansion|Withdrawal by Subject|0
4378825|NCT02564900|7155513|FG010|Dose Expansion|Withdrawal by Subject|1
4378826|NCT02564900|7155514|FG011|Dose Expansion|Withdrawal by Subject|0
4378827|NCT02564900|7155515|FG012|Dose Expansion|Withdrawal by Subject|0
4378828|NCT02564900|7155516|FG013|Dose Expansion|Withdrawal by Subject|1
4378829|NCT02564900|7155517|FG014|Dose Expansion|Withdrawal by Subject|1
4378830|NCT02564900|7155503|FG000|Dose Expansion|Other|0
4378831|NCT02564900|7155504|FG001|Dose Expansion|Other|0
4378832|NCT02564900|7155505|FG002|Dose Expansion|Other|0
4378833|NCT02564900|7155506|FG003|Dose Expansion|Other|0
4378834|NCT02564900|7155507|FG004|Dose Expansion|Other|0
4378835|NCT02564900|7155508|FG005|Dose Expansion|Other|0
4378836|NCT02564900|7155509|FG006|Dose Expansion|Other|1
4378837|NCT02564900|7155510|FG007|Dose Expansion|Other|0
4378838|NCT02564900|7155511|FG008|Dose Expansion|Other|1
4378839|NCT02564900|7155512|FG009|Dose Expansion|Other|0
4378840|NCT02564900|7155513|FG010|Dose Expansion|Other|0
4378841|NCT02564900|7155514|FG011|Dose Expansion|Other|0
4378842|NCT02564900|7155515|FG012|Dose Expansion|Other|0
4378843|NCT02564900|7155516|FG013|Dose Expansion|Other|0
4378844|NCT02564900|7155517|FG014|Dose Expansion|Other|1
4378845|NCT02564900|7155503|FG000|Dose Expansion|Did not receive treatment|0
4378846|NCT02564900|7155504|FG001|Dose Expansion|Did not receive treatment|0
4378847|NCT02564900|7155505|FG002|Dose Expansion|Did not receive treatment|0
4378848|NCT02564900|7155506|FG003|Dose Expansion|Did not receive treatment|0
4378849|NCT02564900|7155507|FG004|Dose Expansion|Did not receive treatment|0
4378850|NCT02564900|7155508|FG005|Dose Expansion|Did not receive treatment|0
4378851|NCT02564900|7155509|FG006|Dose Expansion|Did not receive treatment|1
4378852|NCT02564900|7155510|FG007|Dose Expansion|Did not receive treatment|1
4378853|NCT02564900|7155511|FG008|Dose Expansion|Did not receive treatment|0
4378854|NCT02564900|7155512|FG009|Dose Expansion|Did not receive treatment|0
4378855|NCT02564900|7155513|FG010|Dose Expansion|Did not receive treatment|0
4378856|NCT02564900|7155514|FG011|Dose Expansion|Did not receive treatment|0
4378857|NCT02564900|7155515|FG012|Dose Expansion|Did not receive treatment|0
4378858|NCT02564900|7155516|FG013|Dose Expansion|Did not receive treatment|0
4378859|NCT02564900|7155517|FG014|Dose Expansion|Did not receive treatment|1
4378860|NCT02561299|7155560|FG000|Overall Study|Death|2
4378861|NCT02561299|7155561|FG001|Overall Study|Death|4
4378862|NCT02561299|7155560|FG000|Overall Study|Lost to Follow-up|1
4378863|NCT02561299|7155561|FG001|Overall Study|Lost to Follow-up|0
4378864|NCT02561299|7155560|FG000|Overall Study|Withdrawal by Subject|2
4378865|NCT02561299|7155561|FG001|Overall Study|Withdrawal by Subject|2
4378866|NCT02548143|7155569|FG000|Overall Study|Adverse Event|1
4378867|NCT02548143|7155570|FG001|Overall Study|Adverse Event|0
4378868|NCT02548143|7155569|FG000|Overall Study|Withdrawal by Subject|0
4378869|NCT02548143|7155570|FG001|Overall Study|Withdrawal by Subject|1
4378870|NCT02448680|7155578|FG000|Overall Study|Physician Decision|1
4378871|NCT02448680|7155579|FG001|Overall Study|Physician Decision|1
4378872|NCT02448680|7155578|FG000|Overall Study|Withdrawal by Subject|0
4378873|NCT02448680|7155579|FG001|Overall Study|Withdrawal by Subject|2
4378874|NCT02393859|7155589|FG000|Overall Study|Decision by Sponsor|1
4378875|NCT02393859|7155590|FG001|Overall Study|Decision by Sponsor|1
4378876|NCT02393859|7155589|FG000|Overall Study|Withdrawal by Subject|5
4378877|NCT02393859|7155590|FG001|Overall Study|Withdrawal by Subject|2
4378878|NCT02393859|7155589|FG000|Overall Study|Death|16
4378879|NCT02393859|7155590|FG001|Overall Study|Death|8
4378880|NCT02393859|7155589|FG000|Overall Study|Continuing Study|32
4378881|NCT02393859|7155590|FG001|Overall Study|Continuing Study|43
4378882|NCT02178358|7155622|FG000|Overall Study|Withdrawal by Subject|0
4378883|NCT02178358|7155623|FG001|Overall Study|Withdrawal by Subject|2
4378884|NCT02178358|7155624|FG002|Overall Study|Withdrawal by Subject|2
4378885|NCT02178358|7155622|FG000|Overall Study|Lost to Follow-up|1
4378886|NCT02178358|7155623|FG001|Overall Study|Lost to Follow-up|0
4378887|NCT02178358|7155624|FG002|Overall Study|Lost to Follow-up|0
4378888|NCT02073279|7155635|FG000|Double-blind Period|Adverse Event|1
4378889|NCT02073279|7155636|FG001|Double-blind Period|Adverse Event|1
4378890|NCT02073279|7155635|FG000|Double-blind Period|Protocol Deviation|0
4378891|NCT02073279|7155636|FG001|Double-blind Period|Protocol Deviation|1
4378892|NCT02073279|7155635|FG000|Double-blind Period|Withdrawal by Subject|2
4378893|NCT02073279|7155636|FG001|Double-blind Period|Withdrawal by Subject|2
4378894|NCT02073279|7155635|FG000|Double-blind Period|Reason Not Specified|1
4378895|NCT02073279|7155636|FG001|Double-blind Period|Reason Not Specified|2
4378896|NCT02073279|7155635|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0
4378897|NCT02073279|7155636|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1
4378898|NCT02073279|7155635|FG000|Double-blind Period|On-going in Study|11
4378899|NCT02073279|7155636|FG001|Double-blind Period|On-going in Study|40
4378900|NCT02073279|7155635|FG000|Open-label Extension Period|Lack of Efficacy|1
4378901|NCT02073279|7155636|FG001|Open-label Extension Period|Lack of Efficacy|0
4378902|NCT02073279|7155635|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0
4378903|NCT02073279|7155636|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1
4378904|NCT02073279|7155635|FG000|Open-label Extension Period|Withdrawal by Subject|1
4378905|NCT02073279|7155636|FG001|Open-label Extension Period|Withdrawal by Subject|1
4378906|NCT02073279|7155635|FG000|Open-label Extension Period|Reason Not Specified|1
4378907|NCT02073279|7155636|FG001|Open-label Extension Period|Reason Not Specified|1
4378908|NCT02073279|7155635|FG000|Open-label Extension Period|On-going in Study|14
4378909|NCT02073279|7155636|FG001|Open-label Extension Period|On-going in Study|13
4378910|NCT01544127|7155648|FG000|Overall Study|Lost to Follow-up|4
4378911|NCT01544127|7155649|FG001|Overall Study|Lost to Follow-up|2
4378912|NCT01544127|7155650|FG002|Overall Study|Lost to Follow-up|9
4696017|NCT02631850|7608635|FG002|6 Month Follow up|Lost to Follow-up|3
4696018|NCT02631850|7608636|FG003|6 Month Follow up|Lost to Follow-up|5
4696019|NCT02631850|7608633|FG000|6 Month Follow up|Withdrawal by Subject|1
4696020|NCT02631850|7608634|FG001|6 Month Follow up|Withdrawal by Subject|0
4696021|NCT02631850|7608635|FG002|6 Month Follow up|Withdrawal by Subject|0
4696022|NCT02631850|7608636|FG003|6 Month Follow up|Withdrawal by Subject|2
4378913|NCT01544127|7155648|FG000|Overall Study|Withdrawal by Subject|2
4378914|NCT01544127|7155649|FG001|Overall Study|Withdrawal by Subject|2
4378915|NCT01544127|7155650|FG002|Overall Study|Withdrawal by Subject|1
4378916|NCT01544127|7155648|FG000|Overall Study|Discharged out of catchment area|1
4378917|NCT01544127|7155649|FG001|Overall Study|Discharged out of catchment area|1
4378918|NCT01544127|7155650|FG002|Overall Study|Discharged out of catchment area|1
4378919|NCT01544127|7155648|FG000|Overall Study|Death|1
4378920|NCT01544127|7155649|FG001|Overall Study|Death|0
4378921|NCT01544127|7155650|FG002|Overall Study|Death|0
4378922|NCT01544127|7155648|FG000|Overall Study|Jail or Prison|1
4378923|NCT01544127|7155649|FG001|Overall Study|Jail or Prison|1
4378924|NCT01544127|7155650|FG002|Overall Study|Jail or Prison|2
4378925|NCT01544127|7155648|FG000|Overall Study|Became Psychotic|1
4378926|NCT01544127|7155649|FG001|Overall Study|Became Psychotic|0
4378927|NCT01544127|7155650|FG002|Overall Study|Became Psychotic|0
4467087|NCT00620542|7259055|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6
4467088|NCT00620542|7259056|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0
4467089|NCT00620542|7259057|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0
4467090|NCT00620542|7259054|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0
4467091|NCT00620542|7259055|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1
4467092|NCT00620542|7259056|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0
4467093|NCT00620542|7259057|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0
4467094|NCT00620542|7259054|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0
4467095|NCT00620542|7259055|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1
4467096|NCT00620542|7259056|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0
4467097|NCT00620542|7259057|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0
4467098|NCT00620542|7259054|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4
4467099|NCT00620542|7259055|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4
4467100|NCT00620542|7259056|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0
4467101|NCT00620542|7259057|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0
4467102|NCT00620542|7259054|FG000|Part B (2 Year Core Study)|Adverse Event|0
4467103|NCT00620542|7259055|FG001|Part B (2 Year Core Study)|Adverse Event|0
4467104|NCT00620542|7259056|FG002|Part B (2 Year Core Study)|Adverse Event|46
4467105|NCT00620542|7259057|FG003|Part B (2 Year Core Study)|Adverse Event|49
4467106|NCT00620542|7259054|FG000|Part B (2 Year Core Study)|Protocol Violation|0
4467107|NCT00620542|7259055|FG001|Part B (2 Year Core Study)|Protocol Violation|0
4467108|NCT00620542|7259056|FG002|Part B (2 Year Core Study)|Protocol Violation|3
4467109|NCT00620542|7259057|FG003|Part B (2 Year Core Study)|Protocol Violation|5
4467110|NCT00620542|7259054|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0
4467111|NCT00620542|7259055|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0
4467112|NCT00620542|7259056|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55
4467113|NCT00620542|7259057|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54
4467114|NCT00620542|7259054|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0
4467115|NCT00620542|7259055|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0
4467116|NCT00620542|7259056|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20
4467117|NCT00620542|7259057|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9
4467118|NCT00620542|7259054|FG000|Part B (2 Year Core Study)|Protocol Violation|0
4467119|NCT00620542|7259055|FG001|Part B (2 Year Core Study)|Protocol Violation|0
4467120|NCT00620542|7259056|FG002|Part B (2 Year Core Study)|Protocol Violation|13
4467121|NCT00620542|7259057|FG003|Part B (2 Year Core Study)|Protocol Violation|16
4467122|NCT00620542|7259054|FG000|Part B (2 Year Core Study)|Safety reasons|0
4467123|NCT00620542|7259055|FG001|Part B (2 Year Core Study)|Safety reasons|0
4467124|NCT00620542|7259056|FG002|Part B (2 Year Core Study)|Safety reasons|2
4467125|NCT00620542|7259057|FG003|Part B (2 Year Core Study)|Safety reasons|3
4467126|NCT00620542|7259054|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0
4467127|NCT00620542|7259055|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0
4467128|NCT00620542|7259056|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6
4467129|NCT00620542|7259057|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6
4467130|NCT00620542|7259054|FG000|Part B (2 Year Core Study)|IVUS not available|0
4467131|NCT00620542|7259055|FG001|Part B (2 Year Core Study)|IVUS not available|0
4696023|NCT02631850|7608633|FG000|6 Month Follow up|Adverse Event|1
4696024|NCT02631850|7608634|FG001|6 Month Follow up|Adverse Event|4
4378928|NCT01544127|7155648|FG000|Overall Study|Researcher withdrew|1
4378929|NCT01544127|7155649|FG001|Overall Study|Researcher withdrew|0
4378930|NCT01544127|7155650|FG002|Overall Study|Researcher withdrew|0
4378931|NCT01544127|7155648|FG000|Overall Study|Went active duty|0
4378932|NCT01544127|7155649|FG001|Overall Study|Went active duty|0
4378933|NCT01544127|7155650|FG002|Overall Study|Went active duty|1
4378934|NCT00442559|7155677|FG000|Overall Study|Lost to Follow-up|32
4378935|NCT00442559|7155678|FG001|Overall Study|Lost to Follow-up|34
4378936|NCT00442559|7155677|FG000|Overall Study|Protocol Violation|1
4378937|NCT00442559|7155678|FG001|Overall Study|Protocol Violation|1
4378938|NCT00442559|7155677|FG000|Overall Study|Withdrawal by Subject|1
4378939|NCT00442559|7155678|FG001|Overall Study|Withdrawal by Subject|0
4378940|NCT00117338|7155692|FG000|Overall Study|Adverse Event|0
4378941|NCT00117338|7155693|FG001|Overall Study|Adverse Event|1
4378942|NCT00117338|7155692|FG000|Overall Study|Protocol Violation|3
4378943|NCT00117338|7155693|FG001|Overall Study|Protocol Violation|2
4378944|NCT00117338|7155692|FG000|Overall Study|Withdrawal by Subject|1
4378945|NCT00117338|7155693|FG001|Overall Study|Withdrawal by Subject|0
4378946|NCT00117338|7155692|FG000|Overall Study|Did not meet Inclusion Criteria|1
4378947|NCT00117338|7155693|FG001|Overall Study|Did not meet Inclusion Criteria|0
4378948|NCT00117338|7155692|FG000|Overall Study|Lack of Efficacy|0
4378949|NCT00117338|7155693|FG001|Overall Study|Lack of Efficacy|1
4467132|NCT00620542|7259056|FG002|Part B (2 Year Core Study)|IVUS not available|3
4467133|NCT00620542|7259057|FG003|Part B (2 Year Core Study)|IVUS not available|2
4467134|NCT00620555|7259065|FG000|Overall Study|Adverse Event|4
4467135|NCT00620555|7259065|FG000|Overall Study|Protocol Violation|2
4467136|NCT00620555|7259065|FG000|Overall Study|Lack of Efficacy|12
4467137|NCT00620555|7259065|FG000|Overall Study|Withdrawal by Subject|1
4467138|NCT00620555|7259065|FG000|Overall Study|Choice of other treatment|1
4467139|NCT00620555|7259065|FG000|Overall Study|Visit failure against planned|1
4467140|NCT00620659|7259069|FG000|Treatment Period 1|Adverse Event|1
4467141|NCT00620659|7259070|FG001|Treatment Period 1|Adverse Event|0
4467142|NCT00620659|7259071|FG002|Treatment Period 1|Adverse Event|0
4467143|NCT00620659|7259072|FG003|Treatment Period 1|Adverse Event|3
4467144|NCT00620659|7259073|FG004|Treatment Period 1|Adverse Event|0
4467145|NCT00620659|7259074|FG005|Treatment Period 1|Adverse Event|0
4467146|NCT00620659|7259069|FG000|Treatment Period 1|Protocol Violation|1
4467147|NCT00620659|7259070|FG001|Treatment Period 1|Protocol Violation|0
4467148|NCT00620659|7259071|FG002|Treatment Period 1|Protocol Violation|0
4467149|NCT00620659|7259072|FG003|Treatment Period 1|Protocol Violation|0
4467150|NCT00620659|7259073|FG004|Treatment Period 1|Protocol Violation|0
4467151|NCT00620659|7259074|FG005|Treatment Period 1|Protocol Violation|0
4467152|NCT00620659|7259069|FG000|Treatment Period 1|Withdrawal by Subject|1
4467153|NCT00620659|7259070|FG001|Treatment Period 1|Withdrawal by Subject|0
4467154|NCT00620659|7259071|FG002|Treatment Period 1|Withdrawal by Subject|1
4467155|NCT00620659|7259072|FG003|Treatment Period 1|Withdrawal by Subject|0
4467156|NCT00620659|7259073|FG004|Treatment Period 1|Withdrawal by Subject|1
4467157|NCT00620659|7259074|FG005|Treatment Period 1|Withdrawal by Subject|0
4467158|NCT00620659|7259069|FG000|Placebo Washout Period 1|Withdrawal by Subject|0
4467159|NCT00620659|7259070|FG001|Placebo Washout Period 1|Withdrawal by Subject|0
4467160|NCT00620659|7259071|FG002|Placebo Washout Period 1|Withdrawal by Subject|0
4467161|NCT00620659|7259072|FG003|Placebo Washout Period 1|Withdrawal by Subject|1
4467162|NCT00620659|7259073|FG004|Placebo Washout Period 1|Withdrawal by Subject|0
4467163|NCT00620659|7259074|FG005|Placebo Washout Period 1|Withdrawal by Subject|0
4467164|NCT00620659|7259069|FG000|Treatment Period 2|Adverse Event|0
4467165|NCT00620659|7259070|FG001|Treatment Period 2|Adverse Event|3
4467166|NCT00620659|7259071|FG002|Treatment Period 2|Adverse Event|0
4467167|NCT00620659|7259072|FG003|Treatment Period 2|Adverse Event|0
4467168|NCT00620659|7259073|FG004|Treatment Period 2|Adverse Event|2
4467169|NCT00620659|7259074|FG005|Treatment Period 2|Adverse Event|0
4467170|NCT00620659|7259069|FG000|Treatment Period 2|Withdrawal by Subject|0
4467171|NCT00620659|7259070|FG001|Treatment Period 2|Withdrawal by Subject|0
4467172|NCT00620659|7259071|FG002|Treatment Period 2|Withdrawal by Subject|1
4467173|NCT00620659|7259072|FG003|Treatment Period 2|Withdrawal by Subject|0
4467174|NCT00620659|7259073|FG004|Treatment Period 2|Withdrawal by Subject|3
4467175|NCT00620659|7259074|FG005|Treatment Period 2|Withdrawal by Subject|0
4467176|NCT00620659|7259069|FG000|Placebo Washout Period 2|Adverse Event|2
4467177|NCT00620659|7259070|FG001|Placebo Washout Period 2|Adverse Event|0
4467178|NCT00620659|7259071|FG002|Placebo Washout Period 2|Adverse Event|0
4467179|NCT00620659|7259072|FG003|Placebo Washout Period 2|Adverse Event|0
4467180|NCT00620659|7259073|FG004|Placebo Washout Period 2|Adverse Event|0
4467181|NCT00620659|7259074|FG005|Placebo Washout Period 2|Adverse Event|0
4467182|NCT00620659|7259069|FG000|Treatment Period 3|Adverse Event|0
4467183|NCT00620659|7259070|FG001|Treatment Period 3|Adverse Event|2
4467184|NCT00620659|7259071|FG002|Treatment Period 3|Adverse Event|0
4467185|NCT00620659|7259072|FG003|Treatment Period 3|Adverse Event|0
4467186|NCT00620659|7259073|FG004|Treatment Period 3|Adverse Event|0
4467187|NCT00620659|7259074|FG005|Treatment Period 3|Adverse Event|0
4467188|NCT00620659|7259069|FG000|Treatment Period 3|Withdrawal by Subject|0
4467189|NCT00620659|7259070|FG001|Treatment Period 3|Withdrawal by Subject|0
4467190|NCT00620659|7259071|FG002|Treatment Period 3|Withdrawal by Subject|0
4467191|NCT00620659|7259072|FG003|Treatment Period 3|Withdrawal by Subject|1
4467192|NCT00620659|7259073|FG004|Treatment Period 3|Withdrawal by Subject|0
4378950|NCT04851314|7155701|FG000|Overall Study|Unable to complete research set-up procedures|0
4378951|NCT04851314|7155702|FG001|Overall Study|Unable to complete research set-up procedures|2
4378952|NCT04851314|7155701|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3
4378953|NCT04851314|7155702|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2
4378954|NCT04821245|7155727|FG000|Overall Study|Withdrawal by Subject|3
4378955|NCT04821245|7155727|FG000|Overall Study|Physician Decision|1
4378956|NCT04821245|7155727|FG000|Overall Study|Protocol Violation|5
4378957|NCT04799782|7155742|FG000|Washout|Physician Decision|2
4378958|NCT04799782|7155743|FG001|Washout|Physician Decision|0
4378959|NCT04799782|7155742|FG000|Washout|Withdrawal by Subject|0
4378960|NCT04799782|7155743|FG001|Washout|Withdrawal by Subject|2
4378961|NCT04799782|7155742|FG000|Washout|Lost to Follow-up|0
4378962|NCT04799782|7155743|FG001|Washout|Lost to Follow-up|1
4378963|NCT04755595|7155778|FG000|Overall Study|Lost to Follow-up|1
4378964|NCT04749745|7155783|FG000|Overall Study|Withdrawal by Subject|1
4378965|NCT04749745|7155784|FG001|Overall Study|Withdrawal by Subject|0
4378968|NCT04737278|7155801|FG000|Overall Study|Lost to Follow-up|1
4378969|NCT04737278|7155802|FG001|Overall Study|Lost to Follow-up|1
4378970|NCT04737278|7155801|FG000|Overall Study|Withdrawal by Subject|1
4378971|NCT04737278|7155802|FG001|Overall Study|Withdrawal by Subject|0
4378972|NCT04737278|7155801|FG000|Overall Study|Protocol Violation|1
4378973|NCT04737278|7155802|FG001|Overall Study|Protocol Violation|1
4378974|NCT04737278|7155801|FG000|Overall Study|failure to complete questionnaire|1
4378975|NCT04737278|7155802|FG001|Overall Study|failure to complete questionnaire|1
4378976|NCT04524598|7155836|FG000|Phase I - Feasibility|Lost to Follow-up|2
4378977|NCT04524598|7155837|FG001|Phase I - Feasibility|Lost to Follow-up|4
4378978|NCT04524598|7155838|FG002|Phase I - Feasibility|Lost to Follow-up|0
4378979|NCT04524598|7155839|FG003|Phase I - Feasibility|Lost to Follow-up|0
4378980|NCT04524598|7155840|FG004|Phase I - Feasibility|Lost to Follow-up|0
4378981|NCT04524598|7155836|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2
4378982|NCT04524598|7155837|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1
4378983|NCT04524598|7155838|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0
4378984|NCT04524598|7155839|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0
4378985|NCT04524598|7155840|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0
4378986|NCT04524598|7155836|FG000|Phase II - Outcomes|Lost to Follow-up|0
4378987|NCT04524598|7155837|FG001|Phase II - Outcomes|Lost to Follow-up|0
4378988|NCT04524598|7155838|FG002|Phase II - Outcomes|Lost to Follow-up|16
4378989|NCT04524598|7155839|FG003|Phase II - Outcomes|Lost to Follow-up|8
4378990|NCT04524598|7155840|FG004|Phase II - Outcomes|Lost to Follow-up|0
4378991|NCT04524598|7155836|FG000|Phase II - Outcomes|Withdrawal by Subject|0
4378992|NCT04524598|7155837|FG001|Phase II - Outcomes|Withdrawal by Subject|0
4378993|NCT04524598|7155838|FG002|Phase II - Outcomes|Withdrawal by Subject|2
4378994|NCT04524598|7155839|FG003|Phase II - Outcomes|Withdrawal by Subject|0
4378995|NCT04524598|7155840|FG004|Phase II - Outcomes|Withdrawal by Subject|0
4378996|NCT04524598|7155836|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0
4378997|NCT04524598|7155837|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0
4378998|NCT04524598|7155838|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8
4378999|NCT04524598|7155839|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5
4379000|NCT04524598|7155840|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0
4379001|NCT04524598|7155836|FG000|Phase II - Control Extension|Lost to Follow-up|0
4379002|NCT04524598|7155837|FG001|Phase II - Control Extension|Lost to Follow-up|0
4379003|NCT04524598|7155838|FG002|Phase II - Control Extension|Lost to Follow-up|0
4379004|NCT04524598|7155839|FG003|Phase II - Control Extension|Lost to Follow-up|0
4379005|NCT04524598|7155840|FG004|Phase II - Control Extension|Lost to Follow-up|6
4379006|NCT04524598|7155836|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0
4379007|NCT04524598|7155837|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0
4379008|NCT04524598|7155838|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0
4379009|NCT04524598|7155839|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0
4379010|NCT04524598|7155840|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6
4379011|NCT04334460|7155856|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4
4379012|NCT04334460|7155857|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1
4379013|NCT04334460|7155856|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4
4379014|NCT04334460|7155857|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1
4379015|NCT04247828|7155864|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9
4379016|NCT04084769|7155872|FG000|Overall Study|Protocol Violation|1
4379017|NCT04084769|7155873|FG001|Overall Study|Protocol Violation|3
4379018|NCT04084769|7155874|FG002|Overall Study|Protocol Violation|0
4379019|NCT04084769|7155875|FG003|Overall Study|Protocol Violation|1
4379020|NCT04084769|7155872|FG000|Overall Study|Withdrawal by Subject|0
4379021|NCT04084769|7155873|FG001|Overall Study|Withdrawal by Subject|1
4378966|NCT04748341|7155792|FG000|Overall Study|Lost to Follow-up|1
4378967|NCT04748341|7155793|FG001|Overall Study|Lost to Follow-up|1
4379022|NCT04084769|7155874|FG002|Overall Study|Withdrawal by Subject|0
4379023|NCT04084769|7155875|FG003|Overall Study|Withdrawal by Subject|0
4379024|NCT04084769|7155872|FG000|Overall Study|Withdrawal by parent/guardian|1
4379025|NCT04084769|7155873|FG001|Overall Study|Withdrawal by parent/guardian|0
4379026|NCT04084769|7155874|FG002|Overall Study|Withdrawal by parent/guardian|0
4379027|NCT04084769|7155875|FG003|Overall Study|Withdrawal by parent/guardian|1
4379028|NCT04084769|7155872|FG000|Overall Study|Lost to Follow-up|2
4379029|NCT04084769|7155873|FG001|Overall Study|Lost to Follow-up|0
4379030|NCT04084769|7155874|FG002|Overall Study|Lost to Follow-up|0
4379031|NCT04084769|7155875|FG003|Overall Study|Lost to Follow-up|0
4379032|NCT04024228|7155892|FG000|Overall Study|Adverse Event|1
4379033|NCT04024228|7155893|FG001|Overall Study|Adverse Event|0
4379034|NCT04024228|7155892|FG000|Overall Study|Protocol Deviation|0
4379035|NCT04024228|7155893|FG001|Overall Study|Protocol Deviation|2
4379036|NCT04024228|7155892|FG000|Overall Study|Withdrawal by Subject|3
4379037|NCT04024228|7155893|FG001|Overall Study|Withdrawal by Subject|4
4379038|NCT03980938|7155916|FG000|Treatment Period 1|Study Terminated|1
4379039|NCT03980938|7155917|FG001|Treatment Period 1|Study Terminated|1
4379040|NCT03980938|7155916|FG000|Treatment Period 2|Study Terminated|2
4379041|NCT03980938|7155917|FG001|Treatment Period 2|Study Terminated|2
4379042|NCT03863353|7155925|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24
4379043|NCT03863353|7155926|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20
4467193|NCT00620659|7259074|FG005|Treatment Period 3|Withdrawal by Subject|0
4467194|NCT00620750|7259095|FG000|Overall Study|Lost to Follow-up|25
4467195|NCT00620763|7259099|FG000|Period: First Intervention|Withdrawal by Subject|0
4467196|NCT00620763|7259100|FG001|Period: First Intervention|Withdrawal by Subject|2
4467197|NCT00620763|7259099|FG000|Period: First Intervention|Protocol Violation|0
4467198|NCT00620763|7259100|FG001|Period: First Intervention|Protocol Violation|3
4467199|NCT00620763|7259099|FG000|Period: Second Intervention|Withdrawal by Subject|1
4467200|NCT00620763|7259100|FG001|Period: Second Intervention|Withdrawal by Subject|0
4467201|NCT00620776|7259108|FG000|Overall Study|Did not receive treatment|3
4467202|NCT00620776|7259109|FG001|Overall Study|Did not receive treatment|5
4467203|NCT00620776|7259108|FG000|Overall Study|Adverse Event|2
4467204|NCT00620776|7259109|FG001|Overall Study|Adverse Event|3
4467205|NCT00620776|7259108|FG000|Overall Study|Lack of Efficacy|2
4467206|NCT00620776|7259109|FG001|Overall Study|Lack of Efficacy|1
4467207|NCT00620776|7259108|FG000|Overall Study|Lost to Follow-up|2
4467208|NCT00620776|7259109|FG001|Overall Study|Lost to Follow-up|5
4467209|NCT00620776|7259108|FG000|Overall Study|Withdrawal by Subject|3
4467210|NCT00620776|7259109|FG001|Overall Study|Withdrawal by Subject|2
4467211|NCT00620815|7259118|FG000|Overall Study|Adverse Event|1
4467212|NCT00620815|7259119|FG001|Overall Study|Adverse Event|1
4467213|NCT00620815|7259120|FG002|Overall Study|Adverse Event|2
4467214|NCT00620815|7259118|FG000|Overall Study|Withdrawal by Subject|1
4467215|NCT00620815|7259119|FG001|Overall Study|Withdrawal by Subject|2
4467216|NCT00620815|7259120|FG002|Overall Study|Withdrawal by Subject|0
4467217|NCT00620815|7259118|FG000|Overall Study|Lost to Follow-up|1
4467218|NCT00620815|7259119|FG001|Overall Study|Lost to Follow-up|6
4467219|NCT00620815|7259120|FG002|Overall Study|Lost to Follow-up|3
4467220|NCT00620815|7259118|FG000|Overall Study|Inappropriate enrolment|0
4467221|NCT00620815|7259119|FG001|Overall Study|Inappropriate enrolment|0
4467222|NCT00620815|7259120|FG002|Overall Study|Inappropriate enrolment|1
4467223|NCT00620815|7259118|FG000|Overall Study|Protocol Violation|1
4467224|NCT00620815|7259119|FG001|Overall Study|Protocol Violation|2
4467225|NCT00620815|7259120|FG002|Overall Study|Protocol Violation|1
4467226|NCT00620854|7259159|FG000|Washout 1|Withdrawal by Subject|0
4467227|NCT00620854|7259160|FG001|Washout 1|Withdrawal by Subject|0
4467228|NCT00620854|7259161|FG002|Washout 1|Withdrawal by Subject|1
4467229|NCT00620854|7259162|FG003|Washout 1|Withdrawal by Subject|1
4467230|NCT00620854|7259163|FG004|Washout 1|Withdrawal by Subject|0
4467231|NCT00620854|7259164|FG005|Washout 1|Withdrawal by Subject|0
4696025|NCT02631850|7608635|FG002|6 Month Follow up|Adverse Event|1
4696026|NCT02631850|7608636|FG003|6 Month Follow up|Adverse Event|3
4696027|NCT02631850|7608633|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0
4696028|NCT02631850|7608634|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1
4735137|NCT03519867|7682773|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0
4467232|NCT00621023|7259179|FG000|Overall Study|Death|5
4467233|NCT00621023|7259179|FG000|Overall Study|Follow up discontinued|1
4467234|NCT00621140|7259194|FG000|Overall Study|Adverse Event|4
4467235|NCT00621140|7259195|FG001|Overall Study|Adverse Event|5
4467236|NCT00621140|7259194|FG000|Overall Study|Lost to Follow-up|1
4467237|NCT00621140|7259195|FG001|Overall Study|Lost to Follow-up|2
4467238|NCT00621140|7259194|FG000|Overall Study|Withdrawal by Subject|4
4467239|NCT00621140|7259195|FG001|Overall Study|Withdrawal by Subject|6
4467240|NCT00621140|7259194|FG000|Overall Study|Other incl. lack of efficacy|6
4467241|NCT00621140|7259195|FG001|Overall Study|Other incl. lack of efficacy|5
4467242|NCT00621153|7259203|FG000|Overall Study|Safety Reason|8
4467243|NCT00621153|7259204|FG001|Overall Study|Safety Reason|7
4467244|NCT00621153|7259203|FG000|Overall Study|Adverse Event|3
4467245|NCT00621153|7259204|FG001|Overall Study|Adverse Event|2
4696029|NCT02631850|7608635|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2
4696030|NCT02631850|7608636|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1
4696031|NCT02631876|7608649|FG000|Overall Study|Death|96
4696032|NCT02631876|7608650|FG001|Overall Study|Death|50
4696033|NCT02631876|7608649|FG000|Overall Study|Investigator's discretion|1
4696034|NCT02631876|7608650|FG001|Overall Study|Investigator's discretion|0
4696035|NCT02631876|7608649|FG000|Overall Study|Lost to Follow-up|2
4696036|NCT02631876|7608650|FG001|Overall Study|Lost to Follow-up|0
4696037|NCT02631876|7608649|FG000|Overall Study|Withdrawal by Subject|16
4696038|NCT02631876|7608650|FG001|Overall Study|Withdrawal by Subject|9
4696039|NCT02631876|7608649|FG000|Overall Study|Other than specified|4
4696040|NCT02631876|7608650|FG001|Overall Study|Other than specified|4
4696041|NCT02632110|7608671|FG000|Overall Study|Withdrawal by Subject|1
4696042|NCT02632110|7608672|FG001|Overall Study|Withdrawal by Subject|1
4696043|NCT02632110|7608673|FG002|Overall Study|Withdrawal by Subject|0
4696044|NCT02632110|7608674|FG003|Overall Study|Withdrawal by Subject|0
4696045|NCT02632110|7608675|FG004|Overall Study|Withdrawal by Subject|1
4696046|NCT02632110|7608676|FG005|Overall Study|Withdrawal by Subject|1
4696047|NCT02632110|7608677|FG006|Overall Study|Withdrawal by Subject|3
4696048|NCT02632110|7608678|FG007|Overall Study|Withdrawal by Subject|3
4696049|NCT02632110|7608679|FG008|Overall Study|Withdrawal by Subject|1
4696050|NCT02632110|7608680|FG009|Overall Study|Withdrawal by Subject|1
4696051|NCT02632552|7608755|FG000|Overall Study|Lost to Follow-up|14
4696052|NCT02632552|7608756|FG001|Overall Study|Lost to Follow-up|8
4696053|NCT02632552|7608755|FG000|Overall Study|Withdrawal by Subject|2
4696054|NCT02632552|7608756|FG001|Overall Study|Withdrawal by Subject|0
4696055|NCT02632552|7608755|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7
4696056|NCT02632552|7608756|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2
4696057|NCT02632747|7608765|FG000|Wash-out Period|Adverse Event|1
4696058|NCT02632747|7608766|FG001|Wash-out Period|Adverse Event|0
4696059|NCT02632786|7608774|FG000|Overall Study|Adverse Event|2
4696060|NCT02632786|7608775|FG001|Overall Study|Adverse Event|1
4696061|NCT02632786|7608774|FG000|Overall Study|Death|3
4696062|NCT02632786|7608775|FG001|Overall Study|Death|2
4379044|NCT03622593|7155935|FG000|Overall Study|Withdrawal by Subject|5
4379045|NCT03622593|7155936|FG001|Overall Study|Withdrawal by Subject|4
4379046|NCT03622593|7155937|FG002|Overall Study|Withdrawal by Subject|3
4379047|NCT03622593|7155935|FG000|Overall Study|Death|5
4379048|NCT03622593|7155936|FG001|Overall Study|Death|0
4379049|NCT03622593|7155937|FG002|Overall Study|Death|5
4379050|NCT03622593|7155935|FG000|Overall Study|Lost to Follow-up|5
4379051|NCT03622593|7155936|FG001|Overall Study|Lost to Follow-up|2
4379052|NCT03622593|7155937|FG002|Overall Study|Lost to Follow-up|3
4379053|NCT03622593|7155935|FG000|Overall Study|Adverse Event|2
4379054|NCT03622593|7155936|FG001|Overall Study|Adverse Event|1
4379055|NCT03622593|7155937|FG002|Overall Study|Adverse Event|3
4379056|NCT03622593|7155935|FG000|Overall Study|Physician Decision|1
4379057|NCT03622593|7155936|FG001|Overall Study|Physician Decision|0
4379058|NCT03622593|7155937|FG002|Overall Study|Physician Decision|1
4379059|NCT03622593|7155935|FG000|Overall Study|Other|1
4379060|NCT03622593|7155936|FG001|Overall Study|Other|0
4379061|NCT03622593|7155937|FG002|Overall Study|Other|1
4379062|NCT03622593|7155935|FG000|Overall Study|Completed up to Week 56 (study was still ongoing)|298
4379063|NCT03622593|7155936|FG001|Overall Study|Completed up to Week 56 (study was still ongoing)|312
4379064|NCT03622593|7155937|FG002|Overall Study|Completed up to Week 56 (study was still ongoing)|299
4379065|NCT03622580|7155949|FG000|Overall Study|Death|7
4379066|NCT03622580|7155950|FG001|Overall Study|Death|9
4379067|NCT03622580|7155951|FG002|Overall Study|Death|4
4379068|NCT03622580|7155949|FG000|Overall Study|Adverse Event|5
4379069|NCT03622580|7155950|FG001|Overall Study|Adverse Event|6
4379070|NCT03622580|7155951|FG002|Overall Study|Adverse Event|2
4379071|NCT03622580|7155949|FG000|Overall Study|Withdrawal by Subject|5
4379072|NCT03622580|7155950|FG001|Overall Study|Withdrawal by Subject|3
4379073|NCT03622580|7155951|FG002|Overall Study|Withdrawal by Subject|9
4379074|NCT03622580|7155949|FG000|Overall Study|Lost to Follow-up|5
4379075|NCT03622580|7155950|FG001|Overall Study|Lost to Follow-up|6
4379076|NCT03622580|7155951|FG002|Overall Study|Lost to Follow-up|2
4379077|NCT03622580|7155949|FG000|Overall Study|Protocol Violation|1
4379078|NCT03622580|7155950|FG001|Overall Study|Protocol Violation|0
4379079|NCT03622580|7155951|FG002|Overall Study|Protocol Violation|1
4379080|NCT03622580|7155949|FG000|Overall Study|Lack of Efficacy|0
4379081|NCT03622580|7155950|FG001|Overall Study|Lack of Efficacy|0
4696063|NCT02632786|7608774|FG000|Overall Study|Physician Decision|5
4696064|NCT02632786|7608775|FG001|Overall Study|Physician Decision|4
4696065|NCT02632786|7608774|FG000|Overall Study|Withdrawal by Subject|1
4696066|NCT02632786|7608775|FG001|Overall Study|Withdrawal by Subject|0
4735138|NCT03519867|7682774|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0
4379082|NCT03622580|7155951|FG002|Overall Study|Lack of Efficacy|1
4379083|NCT03622580|7155949|FG000|Overall Study|Physician Decision|1
4379084|NCT03622580|7155950|FG001|Overall Study|Physician Decision|0
4735139|NCT03519867|7682775|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0
4735140|NCT03519867|7682776|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0
4379085|NCT03622580|7155951|FG002|Overall Study|Physician Decision|1
4379086|NCT03622580|7155949|FG000|Overall Study|Completed up to Week 56 (study was still ongoing)|291
4379087|NCT03622580|7155950|FG001|Overall Study|Completed up to Week 56 (study was still ongoing)|289
4379088|NCT03622580|7155951|FG002|Overall Study|Completed up to Week 56 (study was still ongoing)|292
4379089|NCT03333928|7155991|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0
4379090|NCT03333928|7155992|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0
4379091|NCT03333928|7155993|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1
4379092|NCT03333928|7155991|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0
4379093|NCT03333928|7155992|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1
4379094|NCT03333928|7155993|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1
4379095|NCT03333928|7155991|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1
4379096|NCT03333928|7155992|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0
4379097|NCT03333928|7155993|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1
4379098|NCT03333928|7155991|FG000|Initial Dosing Period (Period 1)|Adverse Event|0
4379099|NCT03333928|7155992|FG001|Initial Dosing Period (Period 1)|Adverse Event|3
4379100|NCT03333928|7155993|FG002|Initial Dosing Period (Period 1)|Adverse Event|1
4379101|NCT03333928|7155991|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2
4379102|NCT03333928|7155992|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1
4379103|NCT03333928|7155993|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0
4379104|NCT03333928|7155991|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1
4379105|NCT03333928|7155992|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0
4379106|NCT03333928|7155993|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0
4379107|NCT03333928|7155991|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1
4379108|NCT03333928|7155992|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0
4379109|NCT03333928|7155993|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0
4379110|NCT03333928|7155991|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1
4379111|NCT03333928|7155992|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0
4379112|NCT03333928|7155993|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1
4467246|NCT00621153|7259203|FG000|Overall Study|Lost to Follow-up|5
4467247|NCT00621153|7259204|FG001|Overall Study|Lost to Follow-up|1
4467248|NCT00621153|7259203|FG000|Overall Study|Withdrawal by Subject|4
4467249|NCT00621153|7259204|FG001|Overall Study|Withdrawal by Subject|5
4467250|NCT00621192|7259231|FG000|Overall Study|Withdrawal by Subject|0
4467251|NCT00621192|7259232|FG001|Overall Study|Withdrawal by Subject|0
4467252|NCT00621192|7259233|FG002|Overall Study|Withdrawal by Subject|2
4467253|NCT00621192|7259234|FG003|Overall Study|Withdrawal by Subject|0
4467254|NCT00621192|7259231|FG000|Overall Study|Physician Decision|1
4467255|NCT00621192|7259232|FG001|Overall Study|Physician Decision|3
4467256|NCT00621192|7259233|FG002|Overall Study|Physician Decision|0
4467257|NCT00621192|7259234|FG003|Overall Study|Physician Decision|0
4467258|NCT00621192|7259231|FG000|Overall Study|Protocol Violation|1
4467259|NCT00621192|7259232|FG001|Overall Study|Protocol Violation|0
4467260|NCT00621192|7259233|FG002|Overall Study|Protocol Violation|0
4467261|NCT00621192|7259234|FG003|Overall Study|Protocol Violation|1
4467262|NCT00621192|7259231|FG000|Overall Study|Adverse Event|0
4467263|NCT00621192|7259232|FG001|Overall Study|Adverse Event|1
4467264|NCT00621192|7259233|FG002|Overall Study|Adverse Event|0
4467265|NCT00621192|7259234|FG003|Overall Study|Adverse Event|1
4467266|NCT00621192|7259231|FG000|Overall Study|Death|2
4467267|NCT00621192|7259232|FG001|Overall Study|Death|5
4467268|NCT00621192|7259233|FG002|Overall Study|Death|0
4467269|NCT00621192|7259234|FG003|Overall Study|Death|0
4467270|NCT00621192|7259231|FG000|Overall Study|Final Assessments not Completed|0
4467271|NCT00621192|7259232|FG001|Overall Study|Final Assessments not Completed|0
4467272|NCT00621192|7259233|FG002|Overall Study|Final Assessments not Completed|3
4467273|NCT00621192|7259234|FG003|Overall Study|Final Assessments not Completed|1
4467274|NCT00621244|7259248|FG000|Overall Study|Withdrawal by Subject|7
4467275|NCT00621244|7259249|FG001|Overall Study|Withdrawal by Subject|3
4467276|NCT00621244|7259250|FG002|Overall Study|Withdrawal by Subject|3
4467277|NCT00621244|7259251|FG003|Overall Study|Withdrawal by Subject|3
4467278|NCT00621244|7259248|FG000|Overall Study|Disease progression|44
4467279|NCT00621244|7259249|FG001|Overall Study|Disease progression|20
4467280|NCT00621244|7259250|FG002|Overall Study|Disease progression|20
4467281|NCT00621244|7259251|FG003|Overall Study|Disease progression|15
4467282|NCT00621244|7259248|FG000|Overall Study|Death|3
4467283|NCT00621244|7259249|FG001|Overall Study|Death|3
4467284|NCT00621244|7259250|FG002|Overall Study|Death|1
4467285|NCT00621244|7259251|FG003|Overall Study|Death|1
4467286|NCT00621244|7259248|FG000|Overall Study|Adverse Event|27
4467287|NCT00621244|7259249|FG001|Overall Study|Adverse Event|7
4467288|NCT00621244|7259250|FG002|Overall Study|Adverse Event|9
4467289|NCT00621244|7259251|FG003|Overall Study|Adverse Event|2
4467290|NCT00621244|7259248|FG000|Overall Study|Administrative problems|5
4467291|NCT00621244|7259249|FG001|Overall Study|Administrative problems|1
4467292|NCT00621244|7259250|FG002|Overall Study|Administrative problems|0
4467293|NCT00621244|7259251|FG003|Overall Study|Administrative problems|2
4467294|NCT00621257|7259330|FG000|Overall Study|Lost to Follow-up|4
4467295|NCT00621257|7259331|FG001|Overall Study|Lost to Follow-up|0
4467296|NCT00621257|7259332|FG002|Overall Study|Lost to Follow-up|2
4379113|NCT03298984|7156013|FG000|Overall Study|Physician Decision|1
4379114|NCT03298984|7156014|FG001|Overall Study|Physician Decision|0
4379115|NCT03298984|7156015|FG002|Overall Study|Physician Decision|0
4379116|NCT03298984|7156016|FG003|Overall Study|Physician Decision|6
4379117|NCT03298984|7156013|FG000|Overall Study|Lack of Efficacy|0
4379118|NCT03298984|7156014|FG001|Overall Study|Lack of Efficacy|1
4379119|NCT03298984|7156015|FG002|Overall Study|Lack of Efficacy|1
4379120|NCT03298984|7156016|FG003|Overall Study|Lack of Efficacy|4
4379121|NCT03298984|7156013|FG000|Overall Study|Relapsed disease (following remission)|0
4379122|NCT03298984|7156014|FG001|Overall Study|Relapsed disease (following remission)|0
4379123|NCT03298984|7156015|FG002|Overall Study|Relapsed disease (following remission)|1
4379124|NCT03298984|7156016|FG003|Overall Study|Relapsed disease (following remission)|1
4379125|NCT03298984|7156013|FG000|Overall Study|Adverse Event|0
4379126|NCT03298984|7156014|FG001|Overall Study|Adverse Event|0
4379127|NCT03298984|7156015|FG002|Overall Study|Adverse Event|0
4379128|NCT03298984|7156016|FG003|Overall Study|Adverse Event|1
4379129|NCT03298984|7156013|FG000|Overall Study|Death|0
4379130|NCT03298984|7156014|FG001|Overall Study|Death|0
4379131|NCT03298984|7156015|FG002|Overall Study|Death|0
4379132|NCT03298984|7156016|FG003|Overall Study|Death|2
4379133|NCT03298984|7156013|FG000|Overall Study|Insurance Company Decision|0
4379134|NCT03298984|7156014|FG001|Overall Study|Insurance Company Decision|0
4379135|NCT03298984|7156015|FG002|Overall Study|Insurance Company Decision|0
4379136|NCT03298984|7156016|FG003|Overall Study|Insurance Company Decision|1
4379137|NCT03175198|7156027|FG000|Overall Study|Adverse Event|480
4379138|NCT03175198|7156027|FG000|Overall Study|No actual visit|120
4379139|NCT03175198|7156027|FG000|Overall Study|Registration rule not followed|4
4379140|NCT03175198|7156027|FG000|Overall Study|Patients received Prazaxa treatment before|5
4379141|NCT03175198|7156027|FG000|Overall Study|Other personal reason|509
4467297|NCT00621257|7259333|FG003|Overall Study|Lost to Follow-up|4
4467298|NCT00621257|7259334|FG004|Overall Study|Lost to Follow-up|7
4467299|NCT00621257|7259330|FG000|Overall Study|Adverse Event|0
4467300|NCT00621257|7259331|FG001|Overall Study|Adverse Event|1
4467301|NCT00621257|7259332|FG002|Overall Study|Adverse Event|1
4467302|NCT00621257|7259333|FG003|Overall Study|Adverse Event|0
4467303|NCT00621257|7259334|FG004|Overall Study|Adverse Event|0
4467304|NCT00621257|7259330|FG000|Overall Study|Physician Decision|0
4467305|NCT00621257|7259331|FG001|Overall Study|Physician Decision|2
4467306|NCT00621257|7259332|FG002|Overall Study|Physician Decision|0
4467307|NCT00621257|7259333|FG003|Overall Study|Physician Decision|1
4467308|NCT00621257|7259334|FG004|Overall Study|Physician Decision|1
4467309|NCT00621257|7259330|FG000|Overall Study|Withdrawal by Subject|0
4467310|NCT00621257|7259331|FG001|Overall Study|Withdrawal by Subject|0
4467311|NCT00621257|7259332|FG002|Overall Study|Withdrawal by Subject|0
4467312|NCT00621257|7259333|FG003|Overall Study|Withdrawal by Subject|1
4467313|NCT00621257|7259334|FG004|Overall Study|Withdrawal by Subject|1
4467314|NCT00621296|7259346|FG000|Overall Study|Adverse Event|2
4467315|NCT00621296|7259346|FG000|Overall Study|Lack of Efficacy|1
4467316|NCT00621296|7259346|FG000|Overall Study|Physician Decision|7
4467317|NCT00621296|7259346|FG000|Overall Study|Unmatch Criteria|1
4467318|NCT00621296|7259346|FG000|Overall Study|Stopping Criteria|3
4467319|NCT00621309|7259350|FG000|Overall Study|Withdrawal by Subject|2
4467320|NCT00621309|7259351|FG001|Overall Study|Withdrawal by Subject|0
4467321|NCT00621309|7259352|FG002|Overall Study|Withdrawal by Subject|1
4467322|NCT00621309|7259353|FG003|Overall Study|Withdrawal by Subject|1
4467323|NCT00621309|7259354|FG004|Overall Study|Withdrawal by Subject|1
4467324|NCT00621309|7259355|FG005|Overall Study|Withdrawal by Subject|1
4467325|NCT00621322|7259367|FG000|Overall Study|Lost to Follow-up|0
4467326|NCT00621322|7259368|FG001|Overall Study|Lost to Follow-up|0
4467327|NCT00621322|7259369|FG002|Overall Study|Lost to Follow-up|0
4467328|NCT00621322|7259370|FG003|Overall Study|Lost to Follow-up|0
4467329|NCT00621322|7259371|FG004|Overall Study|Lost to Follow-up|1
4467330|NCT00621322|7259372|FG005|Overall Study|Lost to Follow-up|0
4467331|NCT00621322|7259367|FG000|Overall Study|Physician Decision|0
4467332|NCT00621322|7259368|FG001|Overall Study|Physician Decision|0
4467333|NCT00621322|7259369|FG002|Overall Study|Physician Decision|1
4467334|NCT00621322|7259370|FG003|Overall Study|Physician Decision|1
4467335|NCT00621322|7259371|FG004|Overall Study|Physician Decision|0
4467336|NCT00621322|7259372|FG005|Overall Study|Physician Decision|0
4467337|NCT00621322|7259367|FG000|Overall Study|Withdrawal by Subject|0
4467338|NCT00621322|7259368|FG001|Overall Study|Withdrawal by Subject|0
4467339|NCT00621322|7259369|FG002|Overall Study|Withdrawal by Subject|0
4467340|NCT00621322|7259370|FG003|Overall Study|Withdrawal by Subject|1
4467341|NCT00621322|7259371|FG004|Overall Study|Withdrawal by Subject|0
4467342|NCT00621322|7259372|FG005|Overall Study|Withdrawal by Subject|2
4467343|NCT00621322|7259367|FG000|Overall Study|Migrated/moved from study area|1
4467344|NCT00621322|7259368|FG001|Overall Study|Migrated/moved from study area|0
4467345|NCT00621322|7259369|FG002|Overall Study|Migrated/moved from study area|1
4467346|NCT00621322|7259370|FG003|Overall Study|Migrated/moved from study area|1
4467347|NCT00621322|7259371|FG004|Overall Study|Migrated/moved from study area|0
4467348|NCT00621322|7259372|FG005|Overall Study|Migrated/moved from study area|2
4467349|NCT00621504|7259401|FG000|Overall Study|Adverse Event|1
4467350|NCT00621504|7259402|FG001|Overall Study|Adverse Event|3
4467351|NCT00621504|7259401|FG000|Overall Study|At the request of sponsor/investigator|1
4696067|NCT02632838|7608793|FG000|Overall Study|Withdrawal by Subject|3
4696068|NCT02632838|7608794|FG001|Overall Study|Withdrawal by Subject|0
4696069|NCT02632838|7608793|FG000|Overall Study|Lost to Follow-up|0
4696070|NCT02632838|7608794|FG001|Overall Study|Lost to Follow-up|2
4696071|NCT02633020|7608806|FG000|Overall Study|Adverse Event|1
4696072|NCT02633020|7608807|FG001|Overall Study|Adverse Event|0
4696073|NCT02633046|7608813|FG000|Overall Study|Adverse Event|8
4696074|NCT02633046|7608813|FG000|Overall Study|Physician Decision|7
4696075|NCT02633046|7608813|FG000|Overall Study|Withdrawal by Subject|8
4696076|NCT02633046|7608813|FG000|Overall Study|Increased proteinuria|2
4696077|NCT02633046|7608813|FG000|Overall Study|Participant decided not to continue with open label extension|1
4696078|NCT02633046|7608813|FG000|Overall Study|Mutual decision patient and physician|1
4696079|NCT02633215|7608819|FG000|Overall Study|Lost to Follow-up|2
4696080|NCT02633215|7608820|FG001|Overall Study|Lost to Follow-up|3
4696081|NCT02633306|7608826|FG000|Overall Study|Withdrawal by Subject|3
4696082|NCT02633501|7608860|FG000|Overall Study|Adverse Event|0
4696083|NCT02633501|7608861|FG001|Overall Study|Adverse Event|0
4696084|NCT02633501|7608862|FG002|Overall Study|Adverse Event|1
4696085|NCT02633501|7608863|FG003|Overall Study|Adverse Event|0
4696086|NCT02633501|7608864|FG004|Overall Study|Adverse Event|1
4696087|NCT02633501|7608865|FG005|Overall Study|Adverse Event|1
4696088|NCT02633501|7608860|FG000|Overall Study|Withdrawal by Subject|2
4696089|NCT02633501|7608861|FG001|Overall Study|Withdrawal by Subject|1
4696090|NCT02633501|7608862|FG002|Overall Study|Withdrawal by Subject|2
4696091|NCT02633501|7608863|FG003|Overall Study|Withdrawal by Subject|2
4696092|NCT02633501|7608864|FG004|Overall Study|Withdrawal by Subject|1
4696093|NCT02633501|7608865|FG005|Overall Study|Withdrawal by Subject|3
4696094|NCT02633501|7608860|FG000|Overall Study|Various other reasons|0
4696095|NCT02633501|7608861|FG001|Overall Study|Various other reasons|2
4696096|NCT02633501|7608862|FG002|Overall Study|Various other reasons|4
4696097|NCT02633501|7608863|FG003|Overall Study|Various other reasons|1
4696098|NCT02633501|7608864|FG004|Overall Study|Various other reasons|7
4696099|NCT02633501|7608865|FG005|Overall Study|Various other reasons|11
4696100|NCT02633501|7608860|FG000|Overall Study|Lost to Follow-up|0
4696101|NCT02633501|7608861|FG001|Overall Study|Lost to Follow-up|0
4696102|NCT02633501|7608862|FG002|Overall Study|Lost to Follow-up|0
4696103|NCT02633501|7608863|FG003|Overall Study|Lost to Follow-up|1
4696104|NCT02633501|7608864|FG004|Overall Study|Lost to Follow-up|2
4696105|NCT02633501|7608865|FG005|Overall Study|Lost to Follow-up|0
4696106|NCT02633527|7608889|FG000|Overall Study|Failed to meet eligibility|0
4696107|NCT02633527|7608890|FG001|Overall Study|Failed to meet eligibility|1
4696108|NCT02633527|7608891|FG002|Overall Study|Failed to meet eligibility|1
4696109|NCT02633527|7608892|FG003|Overall Study|Failed to meet eligibility|0
4696110|NCT02633527|7608893|FG004|Overall Study|Failed to meet eligibility|1
4696111|NCT02633527|7608889|FG000|Overall Study|Adverse Event|0
4696112|NCT02633527|7608890|FG001|Overall Study|Adverse Event|4
4696113|NCT02633527|7608891|FG002|Overall Study|Adverse Event|3
4696114|NCT02633527|7608892|FG003|Overall Study|Adverse Event|1
4696115|NCT02633527|7608893|FG004|Overall Study|Adverse Event|5
4696116|NCT02633527|7608889|FG000|Overall Study|Lost to Follow-up|1
4696117|NCT02633527|7608890|FG001|Overall Study|Lost to Follow-up|2
4696118|NCT02633527|7608891|FG002|Overall Study|Lost to Follow-up|5
4379142|NCT03175198|7156027|FG000|Overall Study|To take a contraindication/careful administration drug|8
4379143|NCT03175198|7156027|FG000|Overall Study|Lost to follow-up (changing hospital)|373
4379144|NCT03175198|7156027|FG000|Overall Study|Lost to follow-up (unknown reason)|146
4379145|NCT03175198|7156027|FG000|Overall Study|To conduct invasive treatment of operation|53
4587859|NCT01494532|7432072|FG005|Overall Study|Protocol-defined stopping criteria|0
4587860|NCT01494532|7432067|FG000|Overall Study|Lost to Follow-up|1
4587861|NCT01494532|7432068|FG001|Overall Study|Lost to Follow-up|0
4587862|NCT01494532|7432069|FG002|Overall Study|Lost to Follow-up|0
4587863|NCT01494532|7432070|FG003|Overall Study|Lost to Follow-up|2
4587864|NCT01494532|7432071|FG004|Overall Study|Lost to Follow-up|0
4587865|NCT01494532|7432072|FG005|Overall Study|Lost to Follow-up|0
4587866|NCT01494532|7432067|FG000|Overall Study|Physician Decision|0
4587867|NCT01494532|7432068|FG001|Overall Study|Physician Decision|1
4587868|NCT01494532|7432069|FG002|Overall Study|Physician Decision|1
4379146|NCT03175198|7156027|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629
4379147|NCT03158727|7156033|FG000|Overall Study|Withdrawal by Subject|2
4379148|NCT03158727|7156034|FG001|Overall Study|Withdrawal by Subject|6
4379149|NCT03158727|7156033|FG000|Overall Study|Death|11
4379150|NCT03158727|7156034|FG001|Overall Study|Death|12
4379151|NCT03158727|7156033|FG000|Overall Study|Lost to Follow-up|1
4379152|NCT03158727|7156034|FG001|Overall Study|Lost to Follow-up|0
4379153|NCT03158727|7156033|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2
4587869|NCT01494532|7432070|FG003|Overall Study|Physician Decision|2
4587870|NCT01494532|7432071|FG004|Overall Study|Physician Decision|0
4587871|NCT01494532|7432072|FG005|Overall Study|Physician Decision|0
4587872|NCT01494532|7432067|FG000|Overall Study|Withdrawal by Subject|3
4696119|NCT02633527|7608892|FG003|Overall Study|Lost to Follow-up|5
4696120|NCT02633527|7608893|FG004|Overall Study|Lost to Follow-up|4
4587873|NCT01494532|7432068|FG001|Overall Study|Withdrawal by Subject|1
4587874|NCT01494532|7432069|FG002|Overall Study|Withdrawal by Subject|4
4696121|NCT02633527|7608889|FG000|Overall Study|Withdrawal by Subject|0
4587875|NCT01494532|7432070|FG003|Overall Study|Withdrawal by Subject|3
4587876|NCT01494532|7432071|FG004|Overall Study|Withdrawal by Subject|2
4587877|NCT01494532|7432072|FG005|Overall Study|Withdrawal by Subject|0
4587878|NCT01494584|7432094|FG000|Overall Study|Study Closed/Terminated|1
4587879|NCT01494610|7432117|FG000|Period 1|Withdrawal by Subject|1
4587880|NCT01494610|7432118|FG001|Period 1|Withdrawal by Subject|1
4587881|NCT01494610|7432117|FG000|Period 3|Adverse Event|1
4587882|NCT01494610|7432118|FG001|Period 3|Adverse Event|0
4587883|NCT01494610|7432117|FG000|Period 3|Withdrawal by Subject|1
4587884|NCT01494610|7432118|FG001|Period 3|Withdrawal by Subject|0
4587885|NCT01494610|7432117|FG000|Period 4|Protocol Violation|1
4587886|NCT01494610|7432118|FG001|Period 4|Protocol Violation|0
4587887|NCT01494649|7432132|FG000|Overall Study|Lost to Follow-up|0
4587888|NCT01494649|7432133|FG001|Overall Study|Lost to Follow-up|1
4587889|NCT01494818|7432152|FG000|Overall Study|Relocation|1
4587890|NCT01494818|7432153|FG001|Overall Study|Relocation|2
4587891|NCT01494818|7432152|FG000|Overall Study|Lost to Follow-up|1
4587892|NCT01494818|7432153|FG001|Overall Study|Lost to Follow-up|0
4593594|NCT01553591|7442152|FG002|Overall Study|Protocol Violation|4
4593595|NCT01553591|7442150|FG000|Overall Study|Sponsor decision|1
4593596|NCT01553591|7442151|FG001|Overall Study|Sponsor decision|0
4593597|NCT01553591|7442152|FG002|Overall Study|Sponsor decision|3
4593598|NCT01553591|7442150|FG000|Overall Study|Randomized and never dispensed drug|0
4593599|NCT01553591|7442151|FG001|Overall Study|Randomized and never dispensed drug|1
4626337|NCT01839487|7491906|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0
4626338|NCT01839487|7491907|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0
4626339|NCT01839487|7491908|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0
4626340|NCT01839487|7491909|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0
4626341|NCT01839487|7491910|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0
4626342|NCT01839487|7491905|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14
4626343|NCT01839487|7491906|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6
4626344|NCT01839487|7491907|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0
4626345|NCT01839487|7491908|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0
4626346|NCT01839487|7491909|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0
4626347|NCT01839487|7491910|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0
4626348|NCT01839487|7491905|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0
4626349|NCT01839487|7491906|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1
4626350|NCT01839487|7491907|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0
4626351|NCT01839487|7491908|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0
4626352|NCT01839487|7491909|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0
4626353|NCT01839487|7491910|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0
4626354|NCT01839487|7491905|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1
4626355|NCT01839487|7491906|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0
4626356|NCT01839487|7491907|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0
4626357|NCT01839487|7491908|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0
4626358|NCT01839487|7491909|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0
4626359|NCT01839487|7491910|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0
4626360|NCT01839487|7491905|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0
4626361|NCT01839487|7491906|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0
4626362|NCT01839487|7491907|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12
4626363|NCT01839487|7491908|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9
4626364|NCT01839487|7491909|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4
4626365|NCT01839487|7491910|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8
4626366|NCT01839487|7491905|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0
4626367|NCT01839487|7491906|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0
4626368|NCT01839487|7491907|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46
4626369|NCT01839487|7491908|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49
4626370|NCT01839487|7491909|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71
4626371|NCT01839487|7491910|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32
4626372|NCT01839487|7491905|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0
4626373|NCT01839487|7491906|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0
4626374|NCT01839487|7491907|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2
4626375|NCT01839487|7491908|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0
4626376|NCT01839487|7491909|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1
4626377|NCT01839487|7491910|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0
4626378|NCT01839487|7491905|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0
4626379|NCT01839487|7491906|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0
4626380|NCT01839487|7491907|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0
4696122|NCT02633527|7608890|FG001|Overall Study|Withdrawal by Subject|3
4696123|NCT02633527|7608891|FG002|Overall Study|Withdrawal by Subject|5
4696124|NCT02633527|7608892|FG003|Overall Study|Withdrawal by Subject|4
4696125|NCT02633527|7608893|FG004|Overall Study|Withdrawal by Subject|4
4696126|NCT02633527|7608889|FG000|Overall Study|Protocol Violation|0
4696127|NCT02633527|7608890|FG001|Overall Study|Protocol Violation|1
4593600|NCT01553591|7442152|FG002|Overall Study|Randomized and never dispensed drug|0
4587893|NCT01494922|7432159|FG000|Overall Study|Adverse Event|1
4587894|NCT01494987|7432165|FG000|Overall Study|Adverse Event|6
4587895|NCT01494987|7432166|FG001|Overall Study|Adverse Event|5
4587896|NCT01494987|7432165|FG000|Overall Study|Hyperglycemia|6
4587897|NCT01494987|7432166|FG001|Overall Study|Hyperglycemia|4
4587898|NCT01494987|7432165|FG000|Overall Study|Investigator's Discretion|1
4587899|NCT01494987|7432166|FG001|Overall Study|Investigator's Discretion|2
4587900|NCT01494987|7432165|FG000|Overall Study|Lost to Follow-up|1
4587901|NCT01494987|7432166|FG001|Overall Study|Lost to Follow-up|1
4379154|NCT03158727|7156034|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0
4379155|NCT03158727|7156033|FG000|Overall Study|Visit 11 not done by mistake|0
4379156|NCT03158727|7156034|FG001|Overall Study|Visit 11 not done by mistake|1
4379157|NCT03158727|7156033|FG000|Overall Study|Enrolled, not treated|1
4379158|NCT03158727|7156034|FG001|Overall Study|Enrolled, not treated|0
4467352|NCT00621504|7259402|FG001|Overall Study|At the request of sponsor/investigator|0
4467353|NCT00621504|7259401|FG000|Overall Study|Withdrew consent|9
4467354|NCT00621504|7259402|FG001|Overall Study|Withdrew consent|6
4467355|NCT00621504|7259401|FG000|Overall Study|Lost to Follow-up|8
4467356|NCT00621504|7259402|FG001|Overall Study|Lost to Follow-up|10
4467357|NCT00621504|7259401|FG000|Overall Study|Other|1
4467358|NCT00621504|7259402|FG001|Overall Study|Other|0
4467359|NCT00621504|7259401|FG000|Overall Study|Death|6
4467360|NCT00621504|7259402|FG001|Overall Study|Death|6
4467361|NCT00621517|7259410|FG000|Overall Study|Lost to Follow-up|3
4467362|NCT00621517|7259411|FG001|Overall Study|Lost to Follow-up|3
4467363|NCT00621517|7259410|FG000|Overall Study|Withdrawal by Subject|3
4467364|NCT00621517|7259411|FG001|Overall Study|Withdrawal by Subject|4
4467365|NCT00621517|7259410|FG000|Overall Study|Adverse Event|1
4467366|NCT00621517|7259411|FG001|Overall Study|Adverse Event|0
4467367|NCT00621543|7259429|FG000|Overall Study|Lost to Follow-up|23
4467368|NCT00621582|7259433|FG000|Overall Study|Adverse Event|7
4467369|NCT00621582|7259433|FG000|Overall Study|Protocol Violation|57
4467370|NCT00621582|7259433|FG000|Overall Study|Lost to Follow-up|24
4467371|NCT00621582|7259433|FG000|Overall Study|issues not identified by investigators|18
4467372|NCT00621621|7259440|FG000|Overall Study|Subjects were exited at EP study|30
4467373|NCT00621621|7259441|FG001|Overall Study|Subjects were exited at EP study|0
4467374|NCT00621764|7259463|FG000|Overall Study|Protocol Violation|0
4467375|NCT00621764|7259464|FG001|Overall Study|Protocol Violation|0
4467376|NCT00621764|7259465|FG002|Overall Study|Protocol Violation|0
4467377|NCT00621764|7259466|FG003|Overall Study|Protocol Violation|1
4467378|NCT00621777|7259479|FG000|Open Phase|Adverse Event|20
4467379|NCT00621777|7259480|FG001|Open Phase|Adverse Event|0
4467380|NCT00621777|7259479|FG000|Open Phase|Did not abstain during open phase|56
4467381|NCT00621777|7259480|FG001|Open Phase|Did not abstain during open phase|0
4467382|NCT00621777|7259479|FG000|Open Phase|Withdrawal by Subject|17
4467383|NCT00621777|7259480|FG001|Open Phase|Withdrawal by Subject|0
4467384|NCT00621777|7259479|FG000|Open Phase|administrative|13
4467385|NCT00621777|7259480|FG001|Open Phase|administrative|0
4467386|NCT00621777|7259479|FG000|Open Phase|Lost to Follow-up|10
4587902|NCT01494987|7432165|FG000|Overall Study|Protocol Violation|3
4587903|NCT01494987|7432166|FG001|Overall Study|Protocol Violation|3
4587904|NCT01494987|7432165|FG000|Overall Study|Subject Non-Compliance|9
4587905|NCT01494987|7432166|FG001|Overall Study|Subject Non-Compliance|10
4696128|NCT02633527|7608891|FG002|Overall Study|Protocol Violation|1
4696129|NCT02633527|7608892|FG003|Overall Study|Protocol Violation|1
4696130|NCT02633527|7608893|FG004|Overall Study|Protocol Violation|1
4696131|NCT02633527|7608889|FG000|Overall Study|Physician Decision|0
4696132|NCT02633527|7608890|FG001|Overall Study|Physician Decision|0
4379159|NCT03075826|7156040|FG000|Overall Study|Withdrawal by Subject|1
4379160|NCT03075826|7156040|FG000|Overall Study|Received less than 3 cycles of study drug|5
4379161|NCT02993731|7156046|FG000|Overall Study|Study Termination|101
4379162|NCT02993731|7156047|FG001|Overall Study|Study Termination|105
4379163|NCT02831764|7156065|FG000|Overall Study|Protocol specific withdrawal criteria|0
4379164|NCT02831764|7156066|FG001|Overall Study|Protocol specific withdrawal criteria|2
4379165|NCT02831764|7156065|FG000|Overall Study|Withdrawal by Subject|7
4379166|NCT02831764|7156066|FG001|Overall Study|Withdrawal by Subject|6
4379167|NCT02831764|7156065|FG000|Overall Study|Physician Decision|2
4587906|NCT01494987|7432165|FG000|Overall Study|Subject Withdrew Consent|2
4587907|NCT01494987|7432166|FG001|Overall Study|Subject Withdrew Consent|3
4587908|NCT01495000|7432174|FG000|Overall Study|Lost to Follow-up|2
4587909|NCT01495000|7432175|FG001|Overall Study|Lost to Follow-up|2
4587910|NCT01495000|7432174|FG000|Overall Study|Protocol Violation|1
4587911|NCT01495000|7432175|FG001|Overall Study|Protocol Violation|0
4587912|NCT01495000|7432174|FG000|Overall Study|Withdrawal by Subject|10
4379168|NCT02831764|7156066|FG001|Overall Study|Physician Decision|2
4379169|NCT02831764|7156065|FG000|Overall Study|Lost to Follow-up|6
4467387|NCT00621777|7259480|FG001|Open Phase|Lost to Follow-up|0
4467388|NCT00621777|7259479|FG000|Randomized Phase|Adverse Event|3
4587913|NCT01495000|7432175|FG001|Overall Study|Withdrawal by Subject|10
4587914|NCT01495702|7432231|FG000|Randomized Phase|Randomized But Not Treated|1
4587915|NCT01495702|7432232|FG001|Randomized Phase|Randomized But Not Treated|4
4467389|NCT00621777|7259480|FG001|Randomized Phase|Adverse Event|3
4467390|NCT00621777|7259479|FG000|Randomized Phase|Lost to Follow-up|3
4587916|NCT01495702|7432231|FG000|Randomized Phase|Adverse Event|2
4379170|NCT02831764|7156066|FG001|Overall Study|Lost to Follow-up|5
4379171|NCT02831764|7156065|FG000|Overall Study|Adverse Event|8
4379172|NCT02831764|7156066|FG001|Overall Study|Adverse Event|5
4379173|NCT02831764|7156065|FG000|Overall Study|Lack of Efficacy|2
4379174|NCT02831764|7156066|FG001|Overall Study|Lack of Efficacy|2
4379175|NCT02831764|7156065|FG000|Overall Study|Protocol Violation|5
4379176|NCT02831764|7156066|FG001|Overall Study|Protocol Violation|2
4379177|NCT02831764|7156065|FG000|Overall Study|Ongoing at the time of the analysis|330
4379178|NCT02831764|7156066|FG001|Overall Study|Ongoing at the time of the analysis|335
4379179|NCT02586025|7156082|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1
4379180|NCT02586025|7156083|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0
4379181|NCT02586025|7156082|FG000|Neoadjuvant Treatment|Death|1
4379182|NCT02586025|7156083|FG001|Neoadjuvant Treatment|Death|0
4379183|NCT02586025|7156082|FG000|Neoadjuvant Treatment|Adverse Event|1
4379184|NCT02586025|7156083|FG001|Neoadjuvant Treatment|Adverse Event|0
4379185|NCT02586025|7156082|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4
4379186|NCT02586025|7156083|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3
4379187|NCT02586025|7156082|FG000|Neoadjuvant Treatment|Physician Decision|2
4379188|NCT02586025|7156083|FG001|Neoadjuvant Treatment|Physician Decision|1
4379189|NCT02586025|7156082|FG000|Neoadjuvant Treatment|Progressive Disease|2
4379190|NCT02586025|7156083|FG001|Neoadjuvant Treatment|Progressive Disease|3
4379191|NCT02586025|7156082|FG000|Adjuvant Treatment|Remain in Adjuvant Treatment|133
4379192|NCT02586025|7156083|FG001|Adjuvant Treatment|Remain in Adjuvant Treatment|61
4379193|NCT02586025|7156082|FG000|Adjuvant Treatment|Withdrawal by Subject|5
4379194|NCT02586025|7156083|FG001|Adjuvant Treatment|Withdrawal by Subject|3
4379195|NCT02586025|7156082|FG000|Adjuvant Treatment|Physician Decision|0
4379196|NCT02586025|7156083|FG001|Adjuvant Treatment|Physician Decision|1
4379197|NCT02586025|7156082|FG000|Adjuvant Treatment|Recurrent Disease|1
4379198|NCT02586025|7156083|FG001|Adjuvant Treatment|Recurrent Disease|4
4379199|NCT02586025|7156082|FG000|Treatment-Free Follow-Up|Remain in Treatment-Free Follow-Up|56
4379200|NCT02586025|7156083|FG001|Treatment-Free Follow-Up|Remain in Treatment-Free Follow-Up|35
4379201|NCT02520011|7156092|FG000|Overall Study|Adverse Event|0
4379202|NCT02520011|7156093|FG001|Overall Study|Adverse Event|1
4379203|NCT02520011|7156094|FG002|Overall Study|Adverse Event|2
4379204|NCT02520011|7156092|FG000|Overall Study|Death|0
4379205|NCT02520011|7156093|FG001|Overall Study|Death|8
4379206|NCT02520011|7156094|FG002|Overall Study|Death|1
4379207|NCT02520011|7156092|FG000|Overall Study|Lack of Efficacy|4
4379208|NCT02520011|7156093|FG001|Overall Study|Lack of Efficacy|26
4379209|NCT02520011|7156094|FG002|Overall Study|Lack of Efficacy|4
4379210|NCT02520011|7156092|FG000|Overall Study|Physician Decision|0
4379211|NCT02520011|7156093|FG001|Overall Study|Physician Decision|2
4379212|NCT02520011|7156094|FG002|Overall Study|Physician Decision|0
4379213|NCT02520011|7156092|FG000|Overall Study|Withdrawal by Subject|1
4379214|NCT02520011|7156093|FG001|Overall Study|Withdrawal by Subject|3
4379215|NCT02520011|7156094|FG002|Overall Study|Withdrawal by Subject|0
4379216|NCT02520011|7156092|FG000|Overall Study|Protocol Deviation|0
4379217|NCT02520011|7156093|FG001|Overall Study|Protocol Deviation|1
4379218|NCT02520011|7156094|FG002|Overall Study|Protocol Deviation|0
4379219|NCT02520011|7156092|FG000|Overall Study|Patient went to hospice|0
4379220|NCT02520011|7156093|FG001|Overall Study|Patient went to hospice|1
4379221|NCT02520011|7156094|FG002|Overall Study|Patient went to hospice|0
4379222|NCT02520011|7156092|FG000|Overall Study|Progressive disease following response|0
4379223|NCT02520011|7156093|FG001|Overall Study|Progressive disease following response|4
4379224|NCT02520011|7156094|FG002|Overall Study|Progressive disease following response|2
4467391|NCT00621777|7259480|FG001|Randomized Phase|Lost to Follow-up|3
4467392|NCT00621777|7259479|FG000|Randomized Phase|Withdrawal by Subject|1
4467393|NCT00621777|7259480|FG001|Randomized Phase|Withdrawal by Subject|9
4467394|NCT00621777|7259479|FG000|Randomized Phase|administrative|0
4467395|NCT00621777|7259480|FG001|Randomized Phase|administrative|3
4467396|NCT00621777|7259479|FG000|Randomized Phase|Death|0
4467397|NCT00621777|7259480|FG001|Randomized Phase|Death|1
4467398|NCT00621842|7259488|FG000|Overall Study|Adverse Event|6
4467399|NCT00621842|7259488|FG000|Overall Study|Withdrawal by Subject|7
4467400|NCT00621842|7259488|FG000|Overall Study|Protocol Violation|4
4467401|NCT00621842|7259488|FG000|Overall Study|Lack of Efficacy|2
4467402|NCT00621855|7259497|FG000|Overall Study|Adverse Event|32
4467403|NCT00621855|7259498|FG001|Overall Study|Adverse Event|31
4467404|NCT00621855|7259499|FG002|Overall Study|Adverse Event|48
4467405|NCT00621855|7259500|FG003|Overall Study|Adverse Event|34
4467406|NCT00621855|7259501|FG004|Overall Study|Adverse Event|31
4467407|NCT00621855|7259497|FG000|Overall Study|Lost to Follow-up|0
4467408|NCT00621855|7259498|FG001|Overall Study|Lost to Follow-up|1
4467409|NCT00621855|7259499|FG002|Overall Study|Lost to Follow-up|3
4467410|NCT00621855|7259500|FG003|Overall Study|Lost to Follow-up|4
4467411|NCT00621855|7259501|FG004|Overall Study|Lost to Follow-up|1
4467412|NCT00621855|7259497|FG000|Overall Study|Protocol Violation|16
4467413|NCT00621855|7259498|FG001|Overall Study|Protocol Violation|8
4467414|NCT00621855|7259499|FG002|Overall Study|Protocol Violation|6
4467415|NCT00621855|7259500|FG003|Overall Study|Protocol Violation|7
4467416|NCT00621855|7259501|FG004|Overall Study|Protocol Violation|8
4467417|NCT00621855|7259497|FG000|Overall Study|Withdrawal by Subject|16
4467418|NCT00621855|7259498|FG001|Overall Study|Withdrawal by Subject|11
4379225|NCT02279719|7156131|FG000|Overall Study|Patients randomized but never treated|0
4379226|NCT02279719|7156132|FG001|Overall Study|Patients randomized but never treated|0
4379227|NCT02279719|7156133|FG002|Overall Study|Patients randomized but never treated|0
4379228|NCT02279719|7156134|FG003|Overall Study|Patients randomized but never treated|0
4379229|NCT02279719|7156135|FG004|Overall Study|Patients randomized but never treated|3
4379230|NCT02279719|7156136|FG005|Overall Study|Patients randomized but never treated|0
4379231|NCT02279719|7156137|FG006|Overall Study|Patients randomized but never treated|3
4379232|NCT02178956|7156172|FG000|Overall Study|Lost to Follow-up|4
4379233|NCT02178956|7156173|FG001|Overall Study|Lost to Follow-up|4
4379234|NCT02178956|7156172|FG000|Overall Study|Sponsor terminated study|49
4379235|NCT02178956|7156173|FG001|Overall Study|Sponsor terminated study|58
4379236|NCT02178956|7156172|FG000|Overall Study|Withdrawal by Subject|15
4379237|NCT02178956|7156173|FG001|Overall Study|Withdrawal by Subject|11
4379238|NCT02178956|7156172|FG000|Overall Study|Various Reasons|3
4379239|NCT02178956|7156173|FG001|Overall Study|Various Reasons|5
4379240|NCT02167945|7156183|FG000|Overall Study|Adverse Event|16
4379241|NCT02167945|7156183|FG000|Overall Study|Withdrew Consent|42
4379242|NCT02167945|7156183|FG000|Overall Study|Lost to Follow-up|122
4379243|NCT02167945|7156183|FG000|Overall Study|COVID-19 logistical restrictions|6
4379244|NCT02167945|7156183|FG000|Overall Study|Other, not specified|63
4379245|NCT02097420|7156195|FG000|Overall Study|Death|4
4379246|NCT02097420|7156195|FG000|Overall Study|Device explanted|3
4379247|NCT02097420|7156195|FG000|Overall Study|Not reached 12-month visit|7
4379248|NCT01925131|7156252|FG000|Overall Study|Death|0
4379249|NCT01925131|7156253|FG001|Overall Study|Death|0
4379250|NCT01925131|7156254|FG002|Overall Study|Death|1
4379251|NCT01925131|7156255|FG003|Overall Study|Death|0
4379252|NCT01925131|7156256|FG004|Overall Study|Death|0
4379253|NCT01925131|7156257|FG005|Overall Study|Death|0
4379254|NCT01925131|7156252|FG000|Overall Study|Progression/Relapse|1
4379255|NCT01925131|7156253|FG001|Overall Study|Progression/Relapse|1
4379256|NCT01925131|7156254|FG002|Overall Study|Progression/Relapse|4
4587917|NCT01495702|7432232|FG001|Randomized Phase|Adverse Event|2
4587918|NCT01495702|7432231|FG000|Randomized Phase|Death|1
4587919|NCT01495702|7432232|FG001|Randomized Phase|Death|0
4587920|NCT01495702|7432231|FG000|Randomized Phase|Lack of Efficacy|2
4587921|NCT01495702|7432232|FG001|Randomized Phase|Lack of Efficacy|0
4587922|NCT01495702|7432231|FG000|Randomized Phase|Investigators Discretion|2
4587923|NCT01495702|7432232|FG001|Randomized Phase|Investigators Discretion|0
4587924|NCT01495702|7432231|FG000|Randomized Phase|Withdrew Consent|10
4587925|NCT01495702|7432232|FG001|Randomized Phase|Withdrew Consent|18
4587926|NCT01495702|7432231|FG000|Randomized Phase|Lost to Follow-up|4
4587927|NCT01495702|7432232|FG001|Randomized Phase|Lost to Follow-up|3
4587928|NCT01495702|7432231|FG000|Randomized Phase|Participant Noncompliance|1
4587929|NCT01495702|7432232|FG001|Randomized Phase|Participant Noncompliance|0
4587930|NCT01495702|7432231|FG000|Randomized Phase|Protocol Violation|3
4587931|NCT01495702|7432232|FG001|Randomized Phase|Protocol Violation|1
4587932|NCT01495793|7432239|FG000|Overall Study|Lost to Follow-up|1
4587933|NCT01495793|7432239|FG000|Overall Study|Violation of inclusion criteria|1
4587934|NCT01495975|7432278|FG000|Overall Study|Lost to Follow-up|1
4587935|NCT01495975|7432279|FG001|Overall Study|Lost to Follow-up|0
4587936|NCT01496066|7432287|FG000|Overall Study|Lost to Follow-up|8
4587937|NCT01496066|7432288|FG001|Overall Study|Lost to Follow-up|5
4587938|NCT01496066|7432287|FG000|Overall Study|Explant|3
4587939|NCT01496066|7432288|FG001|Overall Study|Explant|0
4587940|NCT01496066|7432287|FG000|Overall Study|Death|1
4587941|NCT01496066|7432288|FG001|Overall Study|Death|4
4587942|NCT01496183|7432316|FG000|Overall Study|Physician Decision|3
4587943|NCT01496183|7432317|FG001|Overall Study|Physician Decision|1
4587944|NCT01496183|7432316|FG000|Overall Study|Withdrawal by Subject|0
4587945|NCT01496183|7432317|FG001|Overall Study|Withdrawal by Subject|1
4587946|NCT01496274|7432330|FG000|Overall Study|Protocol Violation|0
4587947|NCT01496274|7432331|FG001|Overall Study|Protocol Violation|1
4587948|NCT01496274|7432330|FG000|Overall Study|Adverse Event|1
4587949|NCT01496274|7432331|FG001|Overall Study|Adverse Event|1
4587950|NCT01496274|7432330|FG000|Overall Study|Withdrawal by Subject|2
4587951|NCT01496274|7432331|FG001|Overall Study|Withdrawal by Subject|0
4587952|NCT01496274|7432330|FG000|Overall Study|Lost to Follow-up|0
4587953|NCT01496274|7432331|FG001|Overall Study|Lost to Follow-up|3
4587954|NCT01496287|7432352|FG000|Overall Study|Lost to Follow-up|1
4587955|NCT01496287|7432352|FG000|Overall Study|Incomplete anesthesia|5
4587956|NCT01496365|7432391|FG000|Overall Study|Adverse Event|2
4587957|NCT01496365|7432392|FG001|Overall Study|Adverse Event|3
4587958|NCT01496365|7432393|FG002|Overall Study|Adverse Event|3
4587959|NCT01496365|7432394|FG003|Overall Study|Adverse Event|2
4587960|NCT01496365|7432395|FG004|Overall Study|Adverse Event|5
4379257|NCT01925131|7156255|FG003|Overall Study|Progression/Relapse|0
4379258|NCT01925131|7156256|FG004|Overall Study|Progression/Relapse|0
4379259|NCT01925131|7156257|FG005|Overall Study|Progression/Relapse|1
4379260|NCT01925131|7156252|FG000|Overall Study|Patient Refusal|1
4379261|NCT01925131|7156253|FG001|Overall Study|Patient Refusal|0
4379262|NCT01925131|7156254|FG002|Overall Study|Patient Refusal|0
4379263|NCT01925131|7156255|FG003|Overall Study|Patient Refusal|0
4379264|NCT01925131|7156256|FG004|Overall Study|Patient Refusal|0
4587961|NCT01496365|7432396|FG005|Overall Study|Adverse Event|6
4379265|NCT01925131|7156257|FG005|Overall Study|Patient Refusal|0
4379266|NCT01925131|7156252|FG000|Overall Study|Adverse Event|0
4379267|NCT01925131|7156253|FG001|Overall Study|Adverse Event|0
4379268|NCT01925131|7156254|FG002|Overall Study|Adverse Event|2
4379269|NCT01925131|7156255|FG003|Overall Study|Adverse Event|0
4379270|NCT01925131|7156256|FG004|Overall Study|Adverse Event|1
4379271|NCT01925131|7156257|FG005|Overall Study|Adverse Event|3
4379272|NCT01925131|7156252|FG000|Overall Study|Other - Not Protocol Specified|3
4379273|NCT01925131|7156253|FG001|Overall Study|Other - Not Protocol Specified|1
4379274|NCT01925131|7156254|FG002|Overall Study|Other - Not Protocol Specified|2
4379275|NCT01925131|7156255|FG003|Overall Study|Other - Not Protocol Specified|5
4379276|NCT01925131|7156256|FG004|Overall Study|Other - Not Protocol Specified|10
4379277|NCT01925131|7156257|FG005|Overall Study|Other - Not Protocol Specified|6
4379278|NCT01776307|7156276|FG000|Overall Study|Not dosed|0
4379279|NCT01776307|7156277|FG001|Overall Study|Not dosed|0
4379280|NCT01776307|7156278|FG002|Overall Study|Not dosed|1
4379281|NCT01535274|7156322|FG000|Overall Study|Determined to be ineligible|0
4379282|NCT01535274|7156323|FG001|Overall Study|Determined to be ineligible|1
4379283|NCT01535274|7156322|FG000|Overall Study|Misallocated to propofol intervention|0
4379284|NCT01535274|7156323|FG001|Overall Study|Misallocated to propofol intervention|1
4379285|NCT00539981|7156337|FG000|Overall Study|Adverse events (AE)|3
4379286|NCT00539981|7156338|FG001|Overall Study|Adverse events (AE)|3
4379287|NCT00539981|7156337|FG000|Overall Study|Lost to Follow-up|260
4379288|NCT00539981|7156338|FG001|Overall Study|Lost to Follow-up|251
4379289|NCT00539981|7156337|FG000|Overall Study|Withdrew consent|22
4379290|NCT00539981|7156338|FG001|Overall Study|Withdrew consent|14
4379291|NCT00539981|7156337|FG000|Overall Study|Death|1
4379292|NCT00539981|7156338|FG001|Overall Study|Death|1
4379293|NCT00539981|7156337|FG000|Overall Study|Other reason-unspecified|9
4379294|NCT00539981|7156338|FG001|Overall Study|Other reason-unspecified|13
4467419|NCT00621855|7259499|FG002|Overall Study|Withdrawal by Subject|13
4467420|NCT00621855|7259500|FG003|Overall Study|Withdrawal by Subject|13
4467421|NCT00621855|7259501|FG004|Overall Study|Withdrawal by Subject|9
4467422|NCT00621855|7259497|FG000|Overall Study|Other|9
4467423|NCT00621855|7259498|FG001|Overall Study|Other|7
4467424|NCT00621855|7259499|FG002|Overall Study|Other|6
4467425|NCT00621855|7259500|FG003|Overall Study|Other|5
4467426|NCT00621855|7259501|FG004|Overall Study|Other|4
4467427|NCT00621855|7259497|FG000|Overall Study|Patients did not receive study drug|3
4467428|NCT00621855|7259498|FG001|Overall Study|Patients did not receive study drug|3
4467429|NCT00621855|7259499|FG002|Overall Study|Patients did not receive study drug|5
4467430|NCT00621855|7259500|FG003|Overall Study|Patients did not receive study drug|4
4467431|NCT00621855|7259501|FG004|Overall Study|Patients did not receive study drug|2
4467432|NCT00621959|7259529|FG000|Overall Study|Adverse Event|4
4467433|NCT00621959|7259530|FG001|Overall Study|Adverse Event|2
4467434|NCT00621959|7259529|FG000|Overall Study|Lack of Efficacy|1
4467435|NCT00621959|7259530|FG001|Overall Study|Lack of Efficacy|1
4467436|NCT00621959|7259529|FG000|Overall Study|Lost to Follow-up|0
4467437|NCT00621959|7259530|FG001|Overall Study|Lost to Follow-up|2
4467438|NCT00621959|7259529|FG000|Overall Study|Withdrawal by Subject|1
4467439|NCT00621959|7259530|FG001|Overall Study|Withdrawal by Subject|1
4467440|NCT00621959|7259529|FG000|Overall Study|Other|1
4467441|NCT00621959|7259530|FG001|Overall Study|Other|3
4467442|NCT00621985|7259536|FG000|Dexamethasone Admission|Adverse Event|1
4467443|NCT00622180|7259542|FG000|Overall Study|Lost to Follow-up|1
4467444|NCT00622180|7259543|FG001|Overall Study|Lost to Follow-up|2
4467445|NCT00622284|7259551|FG000|Overall Study|Lack of Efficacy|45
4467446|NCT00622284|7259552|FG001|Overall Study|Lack of Efficacy|15
4467447|NCT00622284|7259551|FG000|Overall Study|Adverse Event|61
4467448|NCT00622284|7259552|FG001|Overall Study|Adverse Event|90
4467449|NCT00622284|7259551|FG000|Overall Study|Protocol Violation|12
4467450|NCT00622284|7259552|FG001|Overall Study|Protocol Violation|5
4467451|NCT00622284|7259551|FG000|Overall Study|Lost to Follow-up|11
4467452|NCT00622284|7259552|FG001|Overall Study|Lost to Follow-up|13
4467453|NCT00622284|7259551|FG000|Overall Study|Withdrawal by Subject|27
4467454|NCT00622284|7259552|FG001|Overall Study|Withdrawal by Subject|24
4467455|NCT00622284|7259551|FG000|Overall Study|Other reason (not specified)|33
4467456|NCT00622284|7259552|FG001|Overall Study|Other reason (not specified)|24
4467457|NCT00622336|7259558|FG000|Treatment Phase|Progression of Disease|181
4467458|NCT00622336|7259558|FG000|Treatment Phase|Adverse Event|46
4467459|NCT00622336|7259558|FG000|Treatment Phase|Other|40
4467460|NCT00622336|7259558|FG000|Treatment Phase|Death|14
4467461|NCT00622336|7259558|FG000|Treatment Phase|Lack of therapeutic effect|13
4467462|NCT00622336|7259558|FG000|Treatment Phase|Withdrawal by Subject|13
4467463|NCT00622336|7259558|FG000|Treatment Phase|Lost to Follow-up|2
4467464|NCT00622336|7259558|FG000|Extension Phase|Adverse Event|2
4467465|NCT00622336|7259558|FG000|Extension Phase|Progressive Disease|6
4467466|NCT00622336|7259558|FG000|Extension Phase|Lack of therapeutic effect|2
4467467|NCT00622336|7259558|FG000|Extension Phase|Withdrawal by Subject|1
4467468|NCT00622336|7259558|FG000|Extension Phase|Lost to Follow-up|1
4467469|NCT00622336|7259558|FG000|Extension Phase|Other|9
4467470|NCT00622388|7259564|FG000|Overall Study|Disease Progression|47
4467471|NCT00622388|7259564|FG000|Overall Study|Adverse Event|6
4467472|NCT00622388|7259564|FG000|Overall Study|Protocol Violation|3
4467473|NCT00622388|7259564|FG000|Overall Study|Participant Refusal|1
4379295|NCT04732338|7156358|FG000|Overall Study|Lost to Follow-up|3
4379296|NCT04732338|7156359|FG001|Overall Study|Lost to Follow-up|3
4379312|NCT04716426|7156404|FG000|Overall Study|Vaccination|1
4379313|NCT04716426|7156405|FG001|Overall Study|Vaccination|1
4379314|NCT04716426|7156404|FG000|Overall Study|Contamination|1
4379315|NCT04716426|7156405|FG001|Overall Study|Contamination|0
4379316|NCT04698993|7156437|FG000|Overall Study|PCR results not accessible|2
4379317|NCT04698993|7156438|FG001|Overall Study|PCR results not accessible|7
4379318|NCT04698993|7156437|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1
4379319|NCT04698993|7156438|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0
4379320|NCT04674644|7156465|FG000|Overall Study|with missing data|37
4379321|NCT04668989|7156483|FG000|First Intervention|Covid-19 related self-isolation|0
4379322|NCT04668989|7156484|FG001|First Intervention|Covid-19 related self-isolation|1
4379323|NCT04668989|7156483|FG000|Second Intervention|Adverse Event|0
4379324|NCT04668989|7156484|FG001|Second Intervention|Adverse Event|1
4379325|NCT04646109|7156550|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0
4379326|NCT04646109|7156551|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6
4379327|NCT04633642|7156586|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1
4379328|NCT04633642|7156587|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2
4379329|NCT04615507|7156642|FG000|Period 1|Covid-19 exposure|2
4379330|NCT04615507|7156643|FG001|Period 1|Covid-19 exposure|1
4379331|NCT04615507|7156642|FG000|Period 2|Covid-19 exposure|0
4379332|NCT04615507|7156643|FG001|Period 2|Covid-19 exposure|1
4379333|NCT04615507|7156642|FG000|Period 2|Protocol Violation|1
4379334|NCT04615507|7156643|FG001|Period 2|Protocol Violation|0
4379335|NCT04615507|7156642|FG000|Period 2|Withdrawal by Subject|1
4379336|NCT04615507|7156643|FG001|Period 2|Withdrawal by Subject|0
4379337|NCT04615507|7156642|FG000|Period 2|Adverse Event|0
4379338|NCT04615507|7156643|FG001|Period 2|Adverse Event|1
4379339|NCT04615507|7156642|FG000|Period 3|Covid-19 exposure|0
4379340|NCT04615507|7156643|FG001|Period 3|Covid-19 exposure|1
4379341|NCT04608500|7156656|FG000|Overall Study|Adverse Event|2
4379342|NCT04608500|7156657|FG001|Overall Study|Adverse Event|0
4379343|NCT04608500|7156656|FG000|Overall Study|Lost to Follow-up|15
4379344|NCT04608500|7156657|FG001|Overall Study|Lost to Follow-up|9
4379345|NCT04608500|7156656|FG000|Overall Study|Participant request|11
4379346|NCT04608500|7156657|FG001|Overall Study|Participant request|7
4379347|NCT04608500|7156656|FG000|Overall Study|Protocol Violation|1
4379348|NCT04608500|7156657|FG001|Overall Study|Protocol Violation|0
4379349|NCT04608500|7156656|FG000|Overall Study|Other|6
4379350|NCT04608500|7156657|FG001|Overall Study|Other|2
4379351|NCT04590027|7156686|FG000|Overall Study|Lost to Follow-up|17
4379352|NCT04590027|7156687|FG001|Overall Study|Lost to Follow-up|14
4379353|NCT04590027|7156686|FG000|Overall Study|Protocol Violation|0
4379354|NCT04590027|7156687|FG001|Overall Study|Protocol Violation|3
4379355|NCT04578457|7156697|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2
4379356|NCT04578457|7156697|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2
4379357|NCT04578457|7156697|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2
4379358|NCT04578457|7156697|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2
4379377|NCT04542694|7156801|FG000|Overall Study|The need for prohibited therapy|2
4587962|NCT01496365|7432397|FG006|Overall Study|Adverse Event|4
4587963|NCT01496365|7432391|FG000|Overall Study|Withdrawal by Subject|6
4587964|NCT01496365|7432392|FG001|Overall Study|Withdrawal by Subject|6
4587965|NCT01496365|7432393|FG002|Overall Study|Withdrawal by Subject|0
4587966|NCT01496365|7432394|FG003|Overall Study|Withdrawal by Subject|1
4587967|NCT01496365|7432395|FG004|Overall Study|Withdrawal by Subject|3
4587968|NCT01496365|7432396|FG005|Overall Study|Withdrawal by Subject|2
4587969|NCT01496365|7432397|FG006|Overall Study|Withdrawal by Subject|1
4379378|NCT04542694|7156802|FG001|Overall Study|The need for prohibited therapy|0
4379379|NCT04542694|7156801|FG000|Overall Study|Adverse Event|1
4379380|NCT04542694|7156802|FG001|Overall Study|Adverse Event|0
4379381|NCT04542694|7156801|FG000|Overall Study|Protocol Violation|1
4379382|NCT04542694|7156802|FG001|Overall Study|Protocol Violation|0
4379383|NCT04534491|7156844|FG000|Overall Study|Not completed end-of-study interview|24
4379384|NCT04534491|7156844|FG000|Overall Study|Non-users|70
4379385|NCT04534491|7156844|FG000|Overall Study|Non-verifiable users|58
4379400|NCT04093258|7156898|FG000|Period 2|Subject no longer meets the eligibility criteria|1
4379401|NCT04093258|7156899|FG001|Period 2|Subject no longer meets the eligibility criteria|0
4379402|NCT03993379|7156913|FG000|Overall Study|The study was terminated early due to business decision.|0
4379403|NCT03993379|7156914|FG001|Overall Study|The study was terminated early due to business decision.|2
4587970|NCT01496365|7432391|FG000|Overall Study|Protocol Violation|2
4696133|NCT02633527|7608891|FG002|Overall Study|Physician Decision|0
4696134|NCT02633527|7608892|FG003|Overall Study|Physician Decision|0
4696135|NCT02633527|7608893|FG004|Overall Study|Physician Decision|1
4379404|NCT03993379|7156915|FG002|Overall Study|The study was terminated early due to business decision.|0
4379405|NCT03993379|7156916|FG003|Overall Study|The study was terminated early due to business decision.|0
4379406|NCT03993379|7156913|FG000|Overall Study|Withdrawal by Subject|0
4379407|NCT03993379|7156914|FG001|Overall Study|Withdrawal by Subject|1
4379408|NCT03993379|7156915|FG002|Overall Study|Withdrawal by Subject|0
4587971|NCT01496365|7432392|FG001|Overall Study|Protocol Violation|1
4379297|NCT04728802|7156367|FG000|Overall Study|Withdrawal by Subject|4
4379298|NCT04728802|7156368|FG001|Overall Study|Withdrawal by Subject|20
4379299|NCT04728802|7156367|FG000|Overall Study|Physician Decision|7
4379300|NCT04728802|7156368|FG001|Overall Study|Physician Decision|7
4379301|NCT04728802|7156367|FG000|Overall Study|Protocol Violation|10
4379302|NCT04728802|7156368|FG001|Overall Study|Protocol Violation|4
4379303|NCT04728802|7156367|FG000|Overall Study|Transfer|1
4379304|NCT04728802|7156368|FG001|Overall Study|Transfer|0
4379305|NCT04728802|7156367|FG000|Overall Study|Death|4
4379306|NCT04728802|7156368|FG001|Overall Study|Death|5
4379307|NCT04728802|7156367|FG000|Overall Study|Other|3
4379308|NCT04728802|7156368|FG001|Overall Study|Other|0
4379359|NCT04577183|7156709|FG000|Overall Study|Death|1
4379360|NCT04577183|7156709|FG000|Overall Study|Withdrawal by Subject|3
4379361|NCT04577183|7156709|FG000|Overall Study|Early termination|2
4379386|NCT04533204|7156866|FG000|Overall Study|Unable to understand training instructions|1
4379387|NCT04533204|7156867|FG001|Overall Study|Unable to understand training instructions|1
4379409|NCT03993379|7156916|FG003|Overall Study|Withdrawal by Subject|0
4379410|NCT03956615|7156926|FG000|Overall Study|No multiple myeloma confirmed|2
4379411|NCT03956615|7156926|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1
4379412|NCT03956615|7156926|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2
4379413|NCT03956615|7156926|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2
4379414|NCT03803059|7156930|FG000|Overall Study|Protocol Violation|2
4379415|NCT03803059|7156930|FG000|Overall Study|Lost to Follow-up|1
4379416|NCT03723590|7156935|FG000|Overall Study|Withdrawal by Subject|3
4379417|NCT03430895|7156958|FG000|Overall Study|Not Treated|2
4379418|NCT03230838|7156981|FG000|Overall Study|Withdrawal by Subject|3
4379419|NCT03230838|7156982|FG001|Overall Study|Withdrawal by Subject|0
4379420|NCT03230838|7156981|FG000|Overall Study|Temperature excursion|1
4379421|NCT03230838|7156982|FG001|Overall Study|Temperature excursion|0
4379422|NCT03183778|7156988|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1
4379423|NCT03029234|7156996|FG000|Overall Study|Sponsor Decision|1
4379424|NCT03029234|7156996|FG000|Overall Study|Withdrawal by Subject|5
4379425|NCT03029234|7156996|FG000|Overall Study|Death|61
4379426|NCT02926833|7157020|FG000|Overall Study|Full Consent Withdrawal|0
4379427|NCT02926833|7157021|FG001|Overall Study|Full Consent Withdrawal|0
4379428|NCT02926833|7157022|FG002|Overall Study|Full Consent Withdrawal|0
4379429|NCT02926833|7157023|FG003|Overall Study|Full Consent Withdrawal|2
4379430|NCT02926833|7157020|FG000|Overall Study|Death|1
4379431|NCT02926833|7157021|FG001|Overall Study|Death|1
4379432|NCT02926833|7157022|FG002|Overall Study|Death|1
4379433|NCT02926833|7157023|FG003|Overall Study|Death|7
4379434|NCT02926833|7157020|FG000|Overall Study|Still on study|2
4379435|NCT02926833|7157021|FG001|Overall Study|Still on study|3
4379436|NCT02926833|7157022|FG002|Overall Study|Still on study|5
4379437|NCT02926833|7157023|FG003|Overall Study|Still on study|14
4379438|NCT02926833|7157020|FG000|Overall Study|Adverse Event|0
4379439|NCT02926833|7157021|FG001|Overall Study|Adverse Event|0
4379440|NCT02926833|7157022|FG002|Overall Study|Adverse Event|1
4379441|NCT02926833|7157023|FG003|Overall Study|Adverse Event|0
4379442|NCT02700698|7157036|FG000|Overall Study|Withdrawal by Subject|1
4379443|NCT02700698|7157037|FG001|Overall Study|Withdrawal by Subject|0
4467474|NCT00622388|7259564|FG000|Overall Study|Death|3
4467475|NCT00622388|7259564|FG000|Overall Study|Received Alternate Anticancer Therapy|8
4467476|NCT00622388|7259564|FG000|Overall Study|Took Prohibited Medication|2
4467477|NCT00622388|7259564|FG000|Overall Study|Withdrew Consent|1
4467478|NCT00622388|7259564|FG000|Overall Study|Insurance Expired|1
4467479|NCT00622401|7259572|FG000|Overall Study|Disease progression prior to treatment|3
4467480|NCT00622401|7259573|FG001|Overall Study|Disease progression prior to treatment|2
4467481|NCT00622401|7259574|FG002|Overall Study|Disease progression prior to treatment|0
4467482|NCT00622440|7259594|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4
4467483|NCT00622440|7259595|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1
4467484|NCT00622440|7259594|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3
4467485|NCT00622440|7259595|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5
4467486|NCT00622440|7259594|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0
4467487|NCT00622440|7259595|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1
4467488|NCT00622440|7259594|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0
4467489|NCT00622440|7259595|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1
4467490|NCT00622466|7259601|FG000|Overall Study|Death|1
4467491|NCT00622466|7259601|FG000|Overall Study|Adverse Event|1
4467492|NCT00622466|7259601|FG000|Overall Study|Withdrawal by Subject|2
4467493|NCT00622505|7259607|FG000|Overall Study|Adverse Event|9
4467494|NCT00622505|7259608|FG001|Overall Study|Adverse Event|7
4467495|NCT00622505|7259607|FG000|Overall Study|Abnormal Laboratory Value(s)|3
4467496|NCT00622505|7259608|FG001|Overall Study|Abnormal Laboratory Value(s)|5
4467497|NCT00622505|7259607|FG000|Overall Study|Abnormal Test Procedure Result(s)|1
4467498|NCT00622505|7259608|FG001|Overall Study|Abnormal Test Procedure Result(s)|0
4467499|NCT00622505|7259607|FG000|Overall Study|Withdrawal by Subject|12
4467500|NCT00622505|7259608|FG001|Overall Study|Withdrawal by Subject|5
4467501|NCT00622505|7259607|FG000|Overall Study|Administrative Problems|2
4379309|NCT04725500|7156389|FG000|Screening|Screen Failure|26
4379310|NCT04725500|7156389|FG000|Screening|Withdrawal by Subject|1
4379311|NCT04725500|7156389|FG000|2 Week Take Home|Screen Fail|5
4379362|NCT04574999|7156715|FG000|Overall Study|Adverse Event|1
4379363|NCT04574999|7156716|FG001|Overall Study|Adverse Event|0
4379364|NCT04574999|7156715|FG000|Overall Study|Lack of Efficacy|2
4379365|NCT04574999|7156716|FG001|Overall Study|Lack of Efficacy|3
4379366|NCT04574999|7156715|FG000|Overall Study|Protocol Violation|1
4379367|NCT04574999|7156716|FG001|Overall Study|Protocol Violation|0
4379368|NCT04574999|7156715|FG000|Overall Study|Withdrawal by Subject|2
4379369|NCT04574999|7156716|FG001|Overall Study|Withdrawal by Subject|2
4379370|NCT04574999|7156715|FG000|Overall Study|Lost to Follow-up|1
4379371|NCT04574999|7156716|FG001|Overall Study|Lost to Follow-up|0
4379372|NCT04574999|7156715|FG000|Overall Study|Personal problems|1
4379373|NCT04574999|7156716|FG001|Overall Study|Personal problems|0
4379374|NCT04574999|7156715|FG000|Overall Study|Previous planned surgery|1
4379375|NCT04574999|7156716|FG001|Overall Study|Previous planned surgery|0
4379388|NCT04532164|7156873|FG000|Overall Study|Adverse Event|1
4379389|NCT04532164|7156873|FG000|Overall Study|Protocol Violation|5
4379390|NCT04532164|7156873|FG000|Overall Study|Lost to Follow-up|1
4379391|NCT04532164|7156873|FG000|Overall Study|Found to be Ineligible|3
4379392|NCT04532164|7156873|FG000|Overall Study|Withdrawal by Subject|14
4379393|NCT04531813|7156878|FG000|Overall Study|Protocol Violation|1
4379394|NCT04531813|7156878|FG000|Overall Study|Withdrawal by Subject|1
4379395|NCT04531527|7156882|FG000|Overall Study|Found to be Ineligible|3
4379396|NCT04531540|7156886|FG000|Overall Study|Adverse Event|1
4379397|NCT04531540|7156886|FG000|Overall Study|Protocol Violation|3
4379398|NCT04531540|7156886|FG000|Overall Study|Withdrawal by Subject|4
4379399|NCT04531540|7156886|FG000|Overall Study|Found to be Ineligible|1
4379444|NCT02698865|7157054|FG000|Overall Study|Other|11
4379445|NCT02698865|7157055|FG001|Overall Study|Other|11
4379446|NCT02698865|7157054|FG000|Overall Study|Withdrawal by Subject|20
4379447|NCT02698865|7157055|FG001|Overall Study|Withdrawal by Subject|16
4379448|NCT02698865|7157054|FG000|Overall Study|Physician Decision|0
4379449|NCT02698865|7157055|FG001|Overall Study|Physician Decision|4
4379450|NCT02698865|7157054|FG000|Overall Study|Lost to Follow-up|4
4379451|NCT02698865|7157055|FG001|Overall Study|Lost to Follow-up|2
4379452|NCT02660086|7157063|FG000|Overall Study- 12-month|Withdrawal by Subject|5
4379453|NCT02660086|7157064|FG001|Overall Study- 12-month|Withdrawal by Subject|5
4379454|NCT02660086|7157063|FG000|Overall Study- 12-month|Left full-time employment|12
4379455|NCT02660086|7157064|FG001|Overall Study- 12-month|Left full-time employment|20
4379456|NCT02660086|7157063|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8
4379457|NCT02660086|7157064|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4
4379458|NCT02660086|7157063|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1
4379459|NCT02660086|7157064|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0
4379460|NCT02660086|7157063|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17
4379461|NCT02660086|7157064|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8
4379462|NCT02660086|7157063|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9
4379463|NCT02660086|7157064|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16
4379464|NCT02129647|7157074|FG000|Overall Study|Adverse Event|2
4379465|NCT02129647|7157074|FG000|Overall Study|surgical intervention for clinically progressive disease|1
4379466|NCT01959139|7157086|FG000|Phase II|Disease progression|0
4379467|NCT01959139|7157087|FG001|Phase II|Disease progression|0
4379468|NCT01959139|7157088|FG002|Phase II|Disease progression|26
4379469|NCT01959139|7157089|FG003|Phase II|Disease progression|34
4379470|NCT01959139|7157086|FG000|Phase II|Adverse Event|0
4379471|NCT01959139|7157087|FG001|Phase II|Adverse Event|0
4379472|NCT01959139|7157088|FG002|Phase II|Adverse Event|10
4379473|NCT01959139|7157089|FG003|Phase II|Adverse Event|11
4379474|NCT01959139|7157086|FG000|Phase II|Patient Refusal|0
4379475|NCT01959139|7157087|FG001|Phase II|Patient Refusal|0
4379476|NCT01959139|7157088|FG002|Phase II|Patient Refusal|5
4379477|NCT01959139|7157089|FG003|Phase II|Patient Refusal|4
4379478|NCT01959139|7157086|FG000|Phase II|Death|0
4379479|NCT01959139|7157087|FG001|Phase II|Death|0
4379480|NCT01959139|7157088|FG002|Phase II|Death|3
4379481|NCT01959139|7157089|FG003|Phase II|Death|1
4379482|NCT01959139|7157086|FG000|Phase II|Other/Unknown|0
4379483|NCT01959139|7157087|FG001|Phase II|Other/Unknown|0
4379484|NCT01959139|7157088|FG002|Phase II|Other/Unknown|8
4379485|NCT01959139|7157089|FG003|Phase II|Other/Unknown|5
4379486|NCT01959139|7157086|FG000|Phase II|On treatment|0
4379487|NCT01959139|7157087|FG001|Phase II|On treatment|0
4379488|NCT01959139|7157088|FG002|Phase II|On treatment|4
4379489|NCT01959139|7157089|FG003|Phase II|On treatment|0
4379490|NCT01597778|7157106|FG000|Overall Study|Death|7
4379491|NCT01597778|7157107|FG001|Overall Study|Death|10
4379492|NCT01597778|7157106|FG000|Overall Study|Withdrawal by Subject|3
4379493|NCT01597778|7157107|FG001|Overall Study|Withdrawal by Subject|4
4379494|NCT01597778|7157106|FG000|Overall Study|Adverse Event|1
4379495|NCT01597778|7157107|FG001|Overall Study|Adverse Event|1
4379496|NCT01597778|7157106|FG000|Overall Study|Protocol Violation|1
4379497|NCT01597778|7157107|FG001|Overall Study|Protocol Violation|11
4379498|NCT01597778|7157106|FG000|Overall Study|Transplanted off protocol|2
4379499|NCT01597778|7157107|FG001|Overall Study|Transplanted off protocol|3
4379376|NCT04572997|7156722|FG000|Overall Study|Adverse Event|1
4587972|NCT01496365|7432393|FG002|Overall Study|Protocol Violation|1
4587973|NCT01496365|7432394|FG003|Overall Study|Protocol Violation|0
4587974|NCT01496365|7432395|FG004|Overall Study|Protocol Violation|0
4587975|NCT01496365|7432396|FG005|Overall Study|Protocol Violation|1
4587976|NCT01496365|7432397|FG006|Overall Study|Protocol Violation|0
4587977|NCT01496365|7432391|FG000|Overall Study|Lack of Efficacy|1
4379500|NCT01522976|7157116|FG000|Overall Study|Ineligible|4
4379501|NCT01522976|7157117|FG001|Overall Study|Ineligible|0
4379502|NCT01522976|7157118|FG002|Overall Study|Ineligible|1
4379503|NCT01522976|7157116|FG000|Overall Study|Death|7
4379504|NCT01522976|7157117|FG001|Overall Study|Death|6
4379505|NCT01522976|7157118|FG002|Overall Study|Death|2
4379506|NCT01522976|7157116|FG000|Overall Study|Still on treatment|9
4379507|NCT01522976|7157117|FG001|Overall Study|Still on treatment|9
4379508|NCT01522976|7157118|FG002|Overall Study|Still on treatment|6
4379509|NCT01522976|7157116|FG000|Overall Study|Disease progression|28
4379510|NCT01522976|7157117|FG001|Overall Study|Disease progression|30
4379511|NCT01522976|7157118|FG002|Overall Study|Disease progression|25
4379512|NCT01522976|7157116|FG000|Overall Study|Adverse Event|17
4379513|NCT01522976|7157117|FG001|Overall Study|Adverse Event|7
4379514|NCT01522976|7157118|FG002|Overall Study|Adverse Event|18
4379515|NCT01522976|7157116|FG000|Overall Study|Refusal unrelated to adverse event|10
4379516|NCT01522976|7157117|FG001|Overall Study|Refusal unrelated to adverse event|13
4379517|NCT01522976|7157118|FG002|Overall Study|Refusal unrelated to adverse event|14
4379518|NCT01522976|7157116|FG000|Overall Study|Not protocol specified|22
4379519|NCT01522976|7157117|FG001|Overall Study|Not protocol specified|27
4379520|NCT01522976|7157118|FG002|Overall Study|Not protocol specified|27
4379521|NCT01286272|7157131|FG000|Overall Study|Ineligible after beginning treatment|1
4379522|NCT01286272|7157132|FG001|Overall Study|Ineligible after beginning treatment|3
4379523|NCT01145495|7157138|FG000|Overall Study|Adverse Event|6
4379524|NCT01145495|7157138|FG000|Overall Study|Withdrawal by Subject|5
4379525|NCT01145495|7157138|FG000|Overall Study|Disease progression after respone|1
4379526|NCT00879086|7157153|FG000|Overall Study|Adverse Event|3
4379527|NCT00879086|7157154|FG001|Overall Study|Adverse Event|15
4379528|NCT00879086|7157153|FG000|Overall Study|Participant choice|2
4379529|NCT00879086|7157154|FG001|Overall Study|Participant choice|2
4467502|NCT00622505|7259608|FG001|Overall Study|Administrative Problems|4
4467503|NCT00622505|7259607|FG000|Overall Study|Death|2
4467504|NCT00622505|7259608|FG001|Overall Study|Death|2
4467505|NCT00622635|7259627|FG000|Treatment Period 1|Adverse Event|0
4467506|NCT00622635|7259628|FG001|Treatment Period 1|Adverse Event|0
4467507|NCT00622635|7259629|FG002|Treatment Period 1|Adverse Event|1
4467508|NCT00622635|7259630|FG003|Treatment Period 1|Adverse Event|0
4467509|NCT00622635|7259631|FG004|Treatment Period 1|Adverse Event|0
4467510|NCT00622635|7259632|FG005|Treatment Period 1|Adverse Event|0
4467511|NCT00622635|7259627|FG000|Treatment Period 1|Withdrawal by Subject|0
4467512|NCT00622635|7259628|FG001|Treatment Period 1|Withdrawal by Subject|1
4467513|NCT00622635|7259629|FG002|Treatment Period 1|Withdrawal by Subject|0
4467514|NCT00622635|7259630|FG003|Treatment Period 1|Withdrawal by Subject|0
4467515|NCT00622635|7259631|FG004|Treatment Period 1|Withdrawal by Subject|0
4467516|NCT00622635|7259632|FG005|Treatment Period 1|Withdrawal by Subject|0
4467517|NCT00622635|7259627|FG000|Treatment Period 1|Abnormal test procedure result(s)|0
4467518|NCT00622635|7259628|FG001|Treatment Period 1|Abnormal test procedure result(s)|0
4467519|NCT00622635|7259629|FG002|Treatment Period 1|Abnormal test procedure result(s)|0
4467520|NCT00622635|7259630|FG003|Treatment Period 1|Abnormal test procedure result(s)|0
4467521|NCT00622635|7259631|FG004|Treatment Period 1|Abnormal test procedure result(s)|1
4467522|NCT00622635|7259632|FG005|Treatment Period 1|Abnormal test procedure result(s)|0
4467523|NCT00622635|7259627|FG000|Treatment Period 2|Adverse Event|1
4467524|NCT00622635|7259628|FG001|Treatment Period 2|Adverse Event|0
4467525|NCT00622635|7259629|FG002|Treatment Period 2|Adverse Event|0
4467526|NCT00622635|7259630|FG003|Treatment Period 2|Adverse Event|0
4467527|NCT00622635|7259631|FG004|Treatment Period 2|Adverse Event|0
4467528|NCT00622635|7259632|FG005|Treatment Period 2|Adverse Event|0
4467529|NCT00622635|7259627|FG000|Treatment Period 3|Adverse Event|0
4467530|NCT00622635|7259628|FG001|Treatment Period 3|Adverse Event|0
4467531|NCT00622635|7259629|FG002|Treatment Period 3|Adverse Event|0
4467532|NCT00622635|7259630|FG003|Treatment Period 3|Adverse Event|2
4467533|NCT00622635|7259631|FG004|Treatment Period 3|Adverse Event|0
4467534|NCT00622635|7259632|FG005|Treatment Period 3|Adverse Event|0
4467535|NCT00622635|7259627|FG000|Treatment Period 3|Withdrawal by Subject|0
4467536|NCT00622635|7259628|FG001|Treatment Period 3|Withdrawal by Subject|0
4467537|NCT00622635|7259629|FG002|Treatment Period 3|Withdrawal by Subject|0
4467538|NCT00622635|7259630|FG003|Treatment Period 3|Withdrawal by Subject|1
4467539|NCT00622635|7259631|FG004|Treatment Period 3|Withdrawal by Subject|0
4467540|NCT00622635|7259632|FG005|Treatment Period 3|Withdrawal by Subject|0
4467541|NCT00622700|7259643|FG000|Core Treatment Period|Randomized but Not Treated|0
4467542|NCT00622700|7259644|FG001|Core Treatment Period|Randomized but Not Treated|2
4467543|NCT00622700|7259645|FG002|Core Treatment Period|Randomized but Not Treated|2
4467544|NCT00622700|7259646|FG003|Core Treatment Period|Randomized but Not Treated|0
4379530|NCT00879086|7157153|FG000|Overall Study|Progression of disease|40
4379531|NCT00879086|7157154|FG001|Overall Study|Progression of disease|26
4467545|NCT00622700|7259647|FG004|Core Treatment Period|Randomized but Not Treated|0
4587978|NCT01496365|7432392|FG001|Overall Study|Lack of Efficacy|0
4587979|NCT01496365|7432393|FG002|Overall Study|Lack of Efficacy|0
4587980|NCT01496365|7432394|FG003|Overall Study|Lack of Efficacy|0
4587981|NCT01496365|7432395|FG004|Overall Study|Lack of Efficacy|0
4587982|NCT01496365|7432396|FG005|Overall Study|Lack of Efficacy|1
4379532|NCT00879086|7157153|FG000|Overall Study|Withdrawal of consent|2
4379533|NCT00879086|7157154|FG001|Overall Study|Withdrawal of consent|1
4379534|NCT00879086|7157153|FG000|Overall Study|Other|4
4379535|NCT00879086|7157154|FG001|Overall Study|Other|6
4379536|NCT00879086|7157153|FG000|Overall Study|Death|1
4379537|NCT00879086|7157154|FG001|Overall Study|Death|2
4379538|NCT00864227|7157160|FG000|Overall Study|Withdrawal by Subject|1
4379539|NCT00864227|7157160|FG000|Overall Study|Disease Relapse/Progression|3
4379540|NCT00731731|7157167|FG000|Overall Study|Protocol Violation|0
4379541|NCT00731731|7157168|FG001|Overall Study|Protocol Violation|0
4379542|NCT00731731|7157169|FG002|Overall Study|Protocol Violation|1
4379543|NCT00731731|7157167|FG000|Overall Study|Cancel prior to treatment|0
4379544|NCT00731731|7157168|FG001|Overall Study|Cancel prior to treatment|0
4379545|NCT00731731|7157169|FG002|Overall Study|Cancel prior to treatment|2
4379546|NCT00685360|7157185|FG000|Overall Study|Lost to Follow-up|0
4379547|NCT00685360|7157186|FG001|Overall Study|Lost to Follow-up|1
4379548|NCT00685360|7157187|FG002|Overall Study|Lost to Follow-up|2
4379549|NCT00685360|7157185|FG000|Overall Study|Adverse Event|4
4379550|NCT00685360|7157186|FG001|Overall Study|Adverse Event|6
4379551|NCT00685360|7157187|FG002|Overall Study|Adverse Event|4
4379552|NCT00685360|7157185|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1
4379553|NCT00685360|7157186|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0
4379554|NCT00685360|7157187|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2
4379555|NCT00685360|7157185|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0
4379556|NCT00685360|7157186|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4
4379557|NCT00685360|7157187|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1
4379558|NCT00685360|7157185|FG000|Overall Study|Subject Withdrew Consent to Participate|13
4379559|NCT00685360|7157186|FG001|Overall Study|Subject Withdrew Consent to Participate|2
4379560|NCT00685360|7157187|FG002|Overall Study|Subject Withdrew Consent to Participate|5
4379561|NCT00685360|7157185|FG000|Overall Study|Protocol Deviation|0
4379562|NCT00685360|7157186|FG001|Overall Study|Protocol Deviation|1
4379563|NCT00685360|7157187|FG002|Overall Study|Protocol Deviation|1
4379564|NCT00299728|7157197|FG000|Overall Study|Lost to Follow-up|0
4379565|NCT00299728|7157198|FG001|Overall Study|Lost to Follow-up|1
4379566|NCT00299728|7157197|FG000|Overall Study|Withdrawal by Subject|0
4379567|NCT00299728|7157198|FG001|Overall Study|Withdrawal by Subject|1
4379568|NCT00299728|7157197|FG000|Overall Study|Progressive disease|0
4379569|NCT00299728|7157198|FG001|Overall Study|Progressive disease|1
4379570|NCT00070499|7157213|FG000|Overall Study|Adverse Event|6
4379571|NCT00070499|7157214|FG001|Overall Study|Adverse Event|6
4379572|NCT00070499|7157215|FG002|Overall Study|Adverse Event|19
4379573|NCT00070499|7157216|FG003|Overall Study|Adverse Event|15
4379574|NCT00070499|7157213|FG000|Overall Study|Refusal unrelated to adverse effects|7
4379575|NCT00070499|7157214|FG001|Overall Study|Refusal unrelated to adverse effects|5
4379576|NCT00070499|7157215|FG002|Overall Study|Refusal unrelated to adverse effects|5
4379577|NCT00070499|7157216|FG003|Overall Study|Refusal unrelated to adverse effects|8
4379578|NCT00070499|7157213|FG000|Overall Study|Progression/relapse|4
4379579|NCT00070499|7157214|FG001|Overall Study|Progression/relapse|2
4379580|NCT00070499|7157215|FG002|Overall Study|Progression/relapse|1
4379581|NCT00070499|7157216|FG003|Overall Study|Progression/relapse|4
4379582|NCT00070499|7157213|FG000|Overall Study|Death|1
4379583|NCT00070499|7157214|FG001|Overall Study|Death|1
4379584|NCT00070499|7157215|FG002|Overall Study|Death|1
4379585|NCT00070499|7157216|FG003|Overall Study|Death|2
4379586|NCT00070499|7157213|FG000|Overall Study|Other - not protocol specified|7
4379587|NCT00070499|7157214|FG001|Overall Study|Other - not protocol specified|3
4379588|NCT00070499|7157215|FG002|Overall Study|Other - not protocol specified|12
4379589|NCT00070499|7157216|FG003|Overall Study|Other - not protocol specified|20
4379590|NCT00070499|7157213|FG000|Overall Study|Still on protocol treatment|10
4379591|NCT00070499|7157214|FG001|Overall Study|Still on protocol treatment|4
4379592|NCT00070499|7157215|FG002|Overall Study|Still on protocol treatment|79
4379593|NCT00070499|7157216|FG003|Overall Study|Still on protocol treatment|57
4379594|NCT00070499|7157213|FG000|Overall Study|Did not start treatment|1
4379595|NCT00070499|7157214|FG001|Overall Study|Did not start treatment|0
4379596|NCT00070499|7157215|FG002|Overall Study|Did not start treatment|0
4379597|NCT00070499|7157216|FG003|Overall Study|Did not start treatment|2
4379598|NCT00070499|7157213|FG000|Overall Study|Not eligible|2
4379599|NCT00070499|7157214|FG001|Overall Study|Not eligible|5
4379600|NCT00070499|7157215|FG002|Overall Study|Not eligible|3
4379601|NCT00070499|7157216|FG003|Overall Study|Not eligible|2
4467546|NCT00622700|7259648|FG005|Core Treatment Period|Randomized but Not Treated|0
4467547|NCT00622700|7259649|FG006|Core Treatment Period|Randomized but Not Treated|0
4467548|NCT00622700|7259643|FG000|Core Treatment Period|Adverse Event|18
4467549|NCT00622700|7259644|FG001|Core Treatment Period|Adverse Event|25
4467550|NCT00622700|7259645|FG002|Core Treatment Period|Adverse Event|18
4467551|NCT00622700|7259646|FG003|Core Treatment Period|Adverse Event|0
4379602|NCT04330157|7157251|FG000|Overall Study|Protocol Violation|4
4379603|NCT04330157|7157251|FG000|Overall Study|Not extubated within 24 h postoperatively|3
4379604|NCT04160988|7157272|FG000|Overall Study|poor image quality|28
4379605|NCT04079114|7157281|FG000|Overall Study|Study prematuely terminated.|166
4379606|NCT04461795|7157406|FG000|Overall Study|Lost to Follow-up|2
4379607|NCT04461795|7157406|FG000|Overall Study|Withdrawal by Subject|2
4379608|NCT04461795|7157406|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1
4379609|NCT04035473|7157427|FG000|Screening/Baseline|Death|0
4379610|NCT04035473|7157428|FG001|Screening/Baseline|Death|1
4379611|NCT04035473|7157427|FG000|Screening/Baseline|Adverse Event|0
4379612|NCT04035473|7157428|FG001|Screening/Baseline|Adverse Event|1
4379613|NCT04035473|7157427|FG000|Follow-up Period|Adverse Event|2
4379614|NCT04035473|7157428|FG001|Follow-up Period|Adverse Event|0
4379615|NCT03905694|7157434|FG000|Long-term Extension Period|Remained in this Period at Time of Data Cut|18
4379616|NCT03891264|7157438|FG000|Overall Study|Adverse Event|1
4379617|NCT03891264|7157438|FG000|Overall Study|Withdrawal by Subject|2
4379618|NCT03891264|7157438|FG000|Overall Study|Physician Decision|2
4379619|NCT03796676|7157445|FG000|Overall Study|Adverse Event|2
4379620|NCT03796676|7157446|FG001|Overall Study|Adverse Event|1
4379621|NCT03796676|7157447|FG002|Overall Study|Adverse Event|2
4379622|NCT03796676|7157445|FG000|Overall Study|Lost to Follow-up|2
4379623|NCT03796676|7157446|FG001|Overall Study|Lost to Follow-up|1
4379624|NCT03796676|7157447|FG002|Overall Study|Lost to Follow-up|0
4379625|NCT03796676|7157445|FG000|Overall Study|Protocol Violation|0
4379626|NCT03796676|7157446|FG001|Overall Study|Protocol Violation|0
4379627|NCT03796676|7157447|FG002|Overall Study|Protocol Violation|1
4379628|NCT03796676|7157445|FG000|Overall Study|Withdrawal by Subject|1
4379629|NCT03796676|7157446|FG001|Overall Study|Withdrawal by Subject|1
4379630|NCT03796676|7157447|FG002|Overall Study|Withdrawal by Subject|0
4379631|NCT03796676|7157445|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1
4379632|NCT03796676|7157446|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0
4587983|NCT01496365|7432397|FG006|Overall Study|Lack of Efficacy|0
4587984|NCT01496365|7432391|FG000|Overall Study|Lost to Follow-up|0
4587985|NCT01496365|7432392|FG001|Overall Study|Lost to Follow-up|1
4587986|NCT01496365|7432393|FG002|Overall Study|Lost to Follow-up|0
4379633|NCT03796676|7157447|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0
4379634|NCT03681184|7157460|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0
4379635|NCT03681184|7157461|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1
4379636|NCT03681184|7157460|FG000|3-Month Blinded Extension Period|Remained in this Period at Time of Data Cut|12
4379637|NCT03681184|7157461|FG001|3-Month Blinded Extension Period|Remained in this Period at Time of Data Cut|23
4379638|NCT03681184|7157460|FG000|Open-Label Extension Period|Remained in this Period at Time of Data Cut|1
4379639|NCT03681184|7157461|FG001|Open-Label Extension Period|Remained in this Period at Time of Data Cut|1
4379640|NCT03215810|7157476|FG000|Overall Study|Still responding to nivolumab|1
4379641|NCT03215810|7157476|FG000|Overall Study|Insufficient TIL growth|1
4379642|NCT03215810|7157476|FG000|Overall Study|Decline in performance status|1
4379643|NCT03215810|7157476|FG000|Overall Study|Withdrawal by Subject|1
4379644|NCT02989857|7157482|FG000|Randomization Phase|Adverse Event|8
4379645|NCT02989857|7157483|FG001|Randomization Phase|Adverse Event|4
4379646|NCT02989857|7157484|FG002|Randomization Phase|Adverse Event|0
4379647|NCT02989857|7157482|FG000|Randomization Phase|Death|6
4379648|NCT02989857|7157483|FG001|Randomization Phase|Death|0
4379649|NCT02989857|7157484|FG002|Randomization Phase|Death|0
4379650|NCT02989857|7157482|FG000|Randomization Phase|Progressive Disease|98
4379651|NCT02989857|7157483|FG001|Randomization Phase|Progressive Disease|51
4379652|NCT02989857|7157484|FG002|Randomization Phase|Progressive Disease|0
4379653|NCT02989857|7157482|FG000|Randomization Phase|Withdrawal by Subject|6
4379654|NCT02989857|7157483|FG001|Randomization Phase|Withdrawal by Subject|2
4467552|NCT00622700|7259647|FG004|Core Treatment Period|Adverse Event|0
4467553|NCT00622700|7259648|FG005|Core Treatment Period|Adverse Event|0
4467554|NCT00622700|7259649|FG006|Core Treatment Period|Adverse Event|0
4467555|NCT00622700|7259643|FG000|Core Treatment Period|Lack of Efficacy|19
4467556|NCT00622700|7259644|FG001|Core Treatment Period|Lack of Efficacy|6
4467557|NCT00622700|7259645|FG002|Core Treatment Period|Lack of Efficacy|12
4467558|NCT00622700|7259646|FG003|Core Treatment Period|Lack of Efficacy|0
4467559|NCT00622700|7259647|FG004|Core Treatment Period|Lack of Efficacy|0
4467560|NCT00622700|7259648|FG005|Core Treatment Period|Lack of Efficacy|0
4467561|NCT00622700|7259649|FG006|Core Treatment Period|Lack of Efficacy|0
4467562|NCT00622700|7259643|FG000|Core Treatment Period|Lost to Follow-up|1
4467563|NCT00622700|7259644|FG001|Core Treatment Period|Lost to Follow-up|1
4467564|NCT00622700|7259645|FG002|Core Treatment Period|Lost to Follow-up|1
4467565|NCT00622700|7259646|FG003|Core Treatment Period|Lost to Follow-up|0
4467566|NCT00622700|7259647|FG004|Core Treatment Period|Lost to Follow-up|0
4467567|NCT00622700|7259648|FG005|Core Treatment Period|Lost to Follow-up|0
4467568|NCT00622700|7259649|FG006|Core Treatment Period|Lost to Follow-up|0
4467569|NCT00622700|7259643|FG000|Core Treatment Period|Death|1
4467570|NCT00622700|7259644|FG001|Core Treatment Period|Death|0
4467571|NCT00622700|7259645|FG002|Core Treatment Period|Death|0
4467572|NCT00622700|7259646|FG003|Core Treatment Period|Death|0
4467573|NCT00622700|7259647|FG004|Core Treatment Period|Death|0
4467574|NCT00622700|7259648|FG005|Core Treatment Period|Death|0
4587987|NCT01496365|7432394|FG003|Overall Study|Lost to Follow-up|0
4379655|NCT02989857|7157484|FG002|Randomization Phase|Withdrawal by Subject|0
4379656|NCT02989857|7157482|FG000|Randomization Phase|Withdrawal of Consent|2
4379657|NCT02989857|7157483|FG001|Randomization Phase|Withdrawal of Consent|1
4379658|NCT02989857|7157484|FG002|Randomization Phase|Withdrawal of Consent|0
4379659|NCT02989857|7157482|FG000|Randomization Phase|Reason not specified|3
4379660|NCT02989857|7157483|FG001|Randomization Phase|Reason not specified|1
4379661|NCT02989857|7157484|FG002|Randomization Phase|Reason not specified|0
4379662|NCT02989857|7157482|FG000|Randomization Phase|Not Treated|3
4379663|NCT02989857|7157483|FG001|Randomization Phase|Not Treated|2
4379664|NCT02989857|7157484|FG002|Randomization Phase|Not Treated|0
4379665|NCT02989857|7157482|FG000|Cross Over Phase|Adverse Event|0
4379666|NCT02989857|7157483|FG001|Cross Over Phase|Adverse Event|0
4379667|NCT02989857|7157484|FG002|Cross Over Phase|Adverse Event|2
4379668|NCT02989857|7157482|FG000|Cross Over Phase|Physician Decision|0
4379669|NCT02989857|7157483|FG001|Cross Over Phase|Physician Decision|0
4379670|NCT02989857|7157484|FG002|Cross Over Phase|Physician Decision|2
4379671|NCT02989857|7157482|FG000|Cross Over Phase|Progressive Disease|0
4379672|NCT02989857|7157483|FG001|Cross Over Phase|Progressive Disease|0
4379673|NCT02989857|7157484|FG002|Cross Over Phase|Progressive Disease|36
4379674|NCT02989857|7157482|FG000|Cross Over Phase|Withdrawal by Consent|0
4379675|NCT02989857|7157483|FG001|Cross Over Phase|Withdrawal by Consent|0
4379676|NCT02989857|7157484|FG002|Cross Over Phase|Withdrawal by Consent|3
4379677|NCT02983799|7157496|FG000|Overall Study|Withdrawn from study before data cut-off|28
4379678|NCT02983799|7157497|FG001|Overall Study|Withdrawn from study before data cut-off|12
4379679|NCT02983799|7157498|FG002|Overall Study|Withdrawn from study before data cut-off|23
4379680|NCT02983799|7157499|FG003|Overall Study|Withdrawn from study before data cut-off|25
4379681|NCT02983799|7157500|FG004|Overall Study|Withdrawn from study before data cut-off|1
4379682|NCT02983799|7157496|FG000|Overall Study|Death|20
4379683|NCT02983799|7157497|FG001|Overall Study|Death|5
4379684|NCT02983799|7157498|FG002|Overall Study|Death|23
4379685|NCT02983799|7157499|FG003|Overall Study|Death|47
4379686|NCT02983799|7157500|FG004|Overall Study|Death|7
4379687|NCT02983799|7157496|FG000|Overall Study|Withdrawal by Subject|1
4379688|NCT02983799|7157497|FG001|Overall Study|Withdrawal by Subject|0
4379689|NCT02983799|7157498|FG002|Overall Study|Withdrawal by Subject|3
4379690|NCT02983799|7157499|FG003|Overall Study|Withdrawal by Subject|4
4379691|NCT02983799|7157500|FG004|Overall Study|Withdrawal by Subject|1
4379692|NCT02983799|7157496|FG000|Overall Study|Protocol Violation|0
4379693|NCT02983799|7157497|FG001|Overall Study|Protocol Violation|1
4379694|NCT02983799|7157498|FG002|Overall Study|Protocol Violation|0
4379695|NCT02983799|7157499|FG003|Overall Study|Protocol Violation|0
4379696|NCT02983799|7157500|FG004|Overall Study|Protocol Violation|1
4379697|NCT02983799|7157496|FG000|Overall Study|Lost to Follow-up|1
4379698|NCT02983799|7157497|FG001|Overall Study|Lost to Follow-up|0
4379699|NCT02983799|7157498|FG002|Overall Study|Lost to Follow-up|1
4379700|NCT02983799|7157499|FG003|Overall Study|Lost to Follow-up|0
4379701|NCT02983799|7157500|FG004|Overall Study|Lost to Follow-up|0
4379702|NCT02971683|7157518|FG000|Overall Study|Other reasons|0
4379703|NCT02971683|7157519|FG001|Overall Study|Other reasons|1
4379704|NCT02971683|7157518|FG000|Overall Study|Poor/Non-Compliance|0
4379705|NCT02971683|7157519|FG001|Overall Study|Poor/Non-Compliance|1
4379706|NCT02971683|7157518|FG000|Overall Study|Lost to Follow-up|1
4379707|NCT02971683|7157519|FG001|Overall Study|Lost to Follow-up|0
4379708|NCT02971683|7157518|FG000|Overall Study|Participant withdrew consent|1
4379709|NCT02971683|7157519|FG001|Overall Study|Participant withdrew consent|1
4379710|NCT02971683|7157518|FG000|Overall Study|Participant request to discontinue study treatment|1
4379711|NCT02971683|7157519|FG001|Overall Study|Participant request to discontinue study treatment|1
4379712|NCT02971683|7157518|FG000|Overall Study|Adverse Event|1
4379713|NCT02971683|7157519|FG001|Overall Study|Adverse Event|2
4379714|NCT02971683|7157518|FG000|Overall Study|Lack of Efficacy|2
4379715|NCT02971683|7157519|FG001|Overall Study|Lack of Efficacy|2
4379716|NCT02631577|7157531|FG000|Overall Study|Death|1
4379717|NCT02631577|7157532|FG001|Overall Study|Death|7
4379718|NCT02631577|7157531|FG000|Overall Study|Withdrawal by Subject|0
4379719|NCT02631577|7157532|FG001|Overall Study|Withdrawal by Subject|3
4467575|NCT00622700|7259649|FG006|Core Treatment Period|Death|0
4467576|NCT00622700|7259643|FG000|Core Treatment Period|Progressive Disease|3
4467577|NCT00622700|7259644|FG001|Core Treatment Period|Progressive Disease|1
4467578|NCT00622700|7259645|FG002|Core Treatment Period|Progressive Disease|0
4467579|NCT00622700|7259646|FG003|Core Treatment Period|Progressive Disease|0
4467580|NCT00622700|7259647|FG004|Core Treatment Period|Progressive Disease|0
4467581|NCT00622700|7259648|FG005|Core Treatment Period|Progressive Disease|0
4467582|NCT00622700|7259649|FG006|Core Treatment Period|Progressive Disease|0
4467583|NCT00622700|7259643|FG000|Core Treatment Period|Withdrawal by Subject|12
4467584|NCT00622700|7259644|FG001|Core Treatment Period|Withdrawal by Subject|18
4467585|NCT00622700|7259645|FG002|Core Treatment Period|Withdrawal by Subject|15
4467586|NCT00622700|7259646|FG003|Core Treatment Period|Withdrawal by Subject|0
4467587|NCT00622700|7259647|FG004|Core Treatment Period|Withdrawal by Subject|0
4467588|NCT00622700|7259648|FG005|Core Treatment Period|Withdrawal by Subject|0
4467589|NCT00622700|7259649|FG006|Core Treatment Period|Withdrawal by Subject|0
4467590|NCT00622700|7259643|FG000|Core Treatment Period|Other than specified above|2
4467591|NCT00622700|7259644|FG001|Core Treatment Period|Other than specified above|2
4587988|NCT01496365|7432395|FG004|Overall Study|Lost to Follow-up|2
4587989|NCT01496365|7432396|FG005|Overall Study|Lost to Follow-up|0
4587990|NCT01496365|7432397|FG006|Overall Study|Lost to Follow-up|0
4587991|NCT01496365|7432391|FG000|Overall Study|Other|4
4587992|NCT01496365|7432392|FG001|Overall Study|Other|4
4379720|NCT02300233|7157559|FG000|Overall Study|Adverse Event or Serious Adverse Event|3
4379721|NCT02300233|7157560|FG001|Overall Study|Adverse Event or Serious Adverse Event|1
4379722|NCT02300233|7157561|FG002|Overall Study|Adverse Event or Serious Adverse Event|14
4379723|NCT02300233|7157559|FG000|Overall Study|Withdrawal by Subject|1
4379724|NCT02300233|7157560|FG001|Overall Study|Withdrawal by Subject|0
4379725|NCT02300233|7157561|FG002|Overall Study|Withdrawal by Subject|3
4379726|NCT02300233|7157559|FG000|Overall Study|Investigator Judgement|0
4379727|NCT02300233|7157560|FG001|Overall Study|Investigator Judgement|0
4379728|NCT02300233|7157561|FG002|Overall Study|Investigator Judgement|1
4379729|NCT02300233|7157559|FG000|Overall Study|Reason Not Specified|0
4379730|NCT02300233|7157560|FG001|Overall Study|Reason Not Specified|0
4379731|NCT02300233|7157561|FG002|Overall Study|Reason Not Specified|5
4379732|NCT02211209|7157572|FG000|Overall Study|Investigator judgment|0
4379733|NCT02211209|7157573|FG001|Overall Study|Investigator judgment|1
4379734|NCT02211209|7157572|FG000|Overall Study|Voluntary withdrawal|1
4379735|NCT02211209|7157573|FG001|Overall Study|Voluntary withdrawal|4
4379736|NCT02211209|7157572|FG000|Overall Study|Adverse Event or Serious Adverse Event|0
4379737|NCT02211209|7157573|FG001|Overall Study|Adverse Event or Serious Adverse Event|9
4379738|NCT02211209|7157572|FG000|Overall Study|Reason Not Specified|1
4379739|NCT02211209|7157573|FG001|Overall Study|Reason Not Specified|0
4379740|NCT02125461|7157581|FG000|Overall Study|Withdrawal by Subject|30
4379741|NCT02125461|7157582|FG001|Overall Study|Withdrawal by Subject|16
4379742|NCT02125461|7157581|FG000|Overall Study|Lost to Follow-up|8
4379743|NCT02125461|7157582|FG001|Overall Study|Lost to Follow-up|3
4379744|NCT02125461|7157581|FG000|Overall Study|Death|260
4379745|NCT02125461|7157582|FG001|Overall Study|Death|149
4379746|NCT02125461|7157581|FG000|Overall Study|Missing Termination Reason|0
4379747|NCT02125461|7157582|FG001|Overall Study|Missing Termination Reason|1
4379748|NCT02000115|7157591|FG000|Overall Study|Death|56
4379749|NCT02000115|7157592|FG001|Overall Study|Death|45
4379750|NCT02000115|7157593|FG002|Overall Study|Death|0
4379751|NCT02000115|7157594|FG003|Overall Study|Death|0
4379752|NCT02000115|7157591|FG000|Overall Study|Missed Visit|6
4379753|NCT02000115|7157592|FG001|Overall Study|Missed Visit|8
4379754|NCT02000115|7157593|FG002|Overall Study|Missed Visit|1
4379755|NCT02000115|7157594|FG003|Overall Study|Missed Visit|0
4379756|NCT02000115|7157591|FG000|Overall Study|Protocol Violation|2
4379757|NCT02000115|7157592|FG001|Overall Study|Protocol Violation|1
4379758|NCT02000115|7157593|FG002|Overall Study|Protocol Violation|0
4379759|NCT02000115|7157594|FG003|Overall Study|Protocol Violation|0
4379760|NCT02000115|7157591|FG000|Overall Study|Physician Decision|2
4379761|NCT02000115|7157592|FG001|Overall Study|Physician Decision|0
4379762|NCT02000115|7157593|FG002|Overall Study|Physician Decision|0
4379763|NCT02000115|7157594|FG003|Overall Study|Physician Decision|0
4379764|NCT02000115|7157591|FG000|Overall Study|Withdrawal by Subject|11
4379765|NCT02000115|7157592|FG001|Overall Study|Withdrawal by Subject|11
4379766|NCT02000115|7157593|FG002|Overall Study|Withdrawal by Subject|0
4379767|NCT02000115|7157594|FG003|Overall Study|Withdrawal by Subject|0
4379768|NCT02000115|7157591|FG000|Overall Study|Lost to Follow-up|0
4379769|NCT02000115|7157592|FG001|Overall Study|Lost to Follow-up|1
4379770|NCT02000115|7157593|FG002|Overall Study|Lost to Follow-up|0
4379771|NCT02000115|7157594|FG003|Overall Study|Lost to Follow-up|0
4379772|NCT02000115|7157591|FG000|Overall Study|Non-compliance|2
4379773|NCT02000115|7157592|FG001|Overall Study|Non-compliance|1
4379774|NCT02000115|7157593|FG002|Overall Study|Non-compliance|0
4379775|NCT02000115|7157594|FG003|Overall Study|Non-compliance|0
4379776|NCT02000115|7157591|FG000|Overall Study|Withdrawn on day of randomization|0
4379777|NCT02000115|7157592|FG001|Overall Study|Withdrawn on day of randomization|1
4379778|NCT02000115|7157593|FG002|Overall Study|Withdrawn on day of randomization|0
4379779|NCT02000115|7157594|FG003|Overall Study|Withdrawn on day of randomization|0
4379780|NCT02000115|7157591|FG000|Overall Study|Still on Study|0
4379781|NCT02000115|7157592|FG001|Overall Study|Still on Study|0
4379782|NCT02000115|7157593|FG002|Overall Study|Still on Study|0
4379783|NCT02000115|7157594|FG003|Overall Study|Still on Study|53
4379784|NCT01695317|7157618|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2
4379785|NCT01695317|7157619|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1
4379786|NCT01695317|7157618|FG000|Cross-over to Period 2|Withdrawal by Subject|4
4379787|NCT01695317|7157619|FG001|Cross-over to Period 2|Withdrawal by Subject|34
4379788|NCT01515748|7157641|FG000|Overall Study|Withdrawal by Subject|32
4379789|NCT01515748|7157642|FG001|Overall Study|Withdrawal by Subject|41
4379790|NCT01515748|7157641|FG000|Overall Study|Lost to Follow-up|2
4379791|NCT01515748|7157642|FG001|Overall Study|Lost to Follow-up|4
4379792|NCT01515748|7157641|FG000|Overall Study|Ongoing|86
4379793|NCT01515748|7157642|FG001|Overall Study|Ongoing|90
4379794|NCT01127451|7157660|FG000|Overall Study|Other|2
4379795|NCT01127451|7157661|FG001|Overall Study|Other|1
4379796|NCT01127451|7157660|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14
4379797|NCT01127451|7157661|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12
4379798|NCT01127451|7157660|FG000|Overall Study|Death|22
4379799|NCT01127451|7157661|FG001|Overall Study|Death|17
4379800|NCT01127451|7157660|FG000|Overall Study|Lost to Follow-up|3
4379801|NCT01127451|7157661|FG001|Overall Study|Lost to Follow-up|0
4379802|NCT01127451|7157660|FG000|Overall Study|Administrative Reason by Sponsor|2
4379803|NCT01127451|7157661|FG001|Overall Study|Administrative Reason by Sponsor|2
4467592|NCT00622700|7259645|FG002|Core Treatment Period|Other than specified above|5
4467593|NCT00622700|7259646|FG003|Core Treatment Period|Other than specified above|0
4467594|NCT00622700|7259647|FG004|Core Treatment Period|Other than specified above|0
4467595|NCT00622700|7259648|FG005|Core Treatment Period|Other than specified above|0
4467596|NCT00622700|7259649|FG006|Core Treatment Period|Other than specified above|0
4467597|NCT00622700|7259643|FG000|Extension Treatment Period|Adverse Event|0
4467598|NCT00622700|7259644|FG001|Extension Treatment Period|Adverse Event|0
4467599|NCT00622700|7259645|FG002|Extension Treatment Period|Adverse Event|0
4467600|NCT00622700|7259646|FG003|Extension Treatment Period|Adverse Event|5
4467601|NCT00622700|7259647|FG004|Extension Treatment Period|Adverse Event|9
4467602|NCT00622700|7259648|FG005|Extension Treatment Period|Adverse Event|6
4467603|NCT00622700|7259649|FG006|Extension Treatment Period|Adverse Event|8
4467604|NCT00622700|7259643|FG000|Extension Treatment Period|Lack of Efficacy|0
4467605|NCT00622700|7259644|FG001|Extension Treatment Period|Lack of Efficacy|0
4467606|NCT00622700|7259645|FG002|Extension Treatment Period|Lack of Efficacy|0
4467607|NCT00622700|7259646|FG003|Extension Treatment Period|Lack of Efficacy|2
4467608|NCT00622700|7259647|FG004|Extension Treatment Period|Lack of Efficacy|8
4467609|NCT00622700|7259648|FG005|Extension Treatment Period|Lack of Efficacy|1
4467610|NCT00622700|7259649|FG006|Extension Treatment Period|Lack of Efficacy|9
4467611|NCT00622700|7259643|FG000|Extension Treatment Period|Protocol Violation|0
4467612|NCT00622700|7259644|FG001|Extension Treatment Period|Protocol Violation|0
4467613|NCT00622700|7259645|FG002|Extension Treatment Period|Protocol Violation|0
4467614|NCT00622700|7259646|FG003|Extension Treatment Period|Protocol Violation|0
4467615|NCT00622700|7259647|FG004|Extension Treatment Period|Protocol Violation|0
4467616|NCT00622700|7259648|FG005|Extension Treatment Period|Protocol Violation|2
4467617|NCT00622700|7259649|FG006|Extension Treatment Period|Protocol Violation|0
4467618|NCT00622700|7259643|FG000|Extension Treatment Period|Lost to Follow-up|0
4467619|NCT00622700|7259644|FG001|Extension Treatment Period|Lost to Follow-up|0
4467620|NCT00622700|7259645|FG002|Extension Treatment Period|Lost to Follow-up|0
4467621|NCT00622700|7259646|FG003|Extension Treatment Period|Lost to Follow-up|0
4467622|NCT00622700|7259647|FG004|Extension Treatment Period|Lost to Follow-up|1
4467623|NCT00622700|7259648|FG005|Extension Treatment Period|Lost to Follow-up|0
4467624|NCT00622700|7259649|FG006|Extension Treatment Period|Lost to Follow-up|0
4467625|NCT00622700|7259643|FG000|Extension Treatment Period|Progressive Disease|0
4467626|NCT00622700|7259644|FG001|Extension Treatment Period|Progressive Disease|0
4467627|NCT00622700|7259645|FG002|Extension Treatment Period|Progressive Disease|0
4467628|NCT00622700|7259646|FG003|Extension Treatment Period|Progressive Disease|1
4467629|NCT00622700|7259647|FG004|Extension Treatment Period|Progressive Disease|2
4467630|NCT00622700|7259648|FG005|Extension Treatment Period|Progressive Disease|0
4467631|NCT00622700|7259649|FG006|Extension Treatment Period|Progressive Disease|2
4467632|NCT00622700|7259643|FG000|Extension Treatment Period|Withdrawal by Subject|0
4467633|NCT00622700|7259644|FG001|Extension Treatment Period|Withdrawal by Subject|0
4467634|NCT00622700|7259645|FG002|Extension Treatment Period|Withdrawal by Subject|0
4467635|NCT00622700|7259646|FG003|Extension Treatment Period|Withdrawal by Subject|11
4467636|NCT00622700|7259647|FG004|Extension Treatment Period|Withdrawal by Subject|16
4467637|NCT00622700|7259648|FG005|Extension Treatment Period|Withdrawal by Subject|6
4467638|NCT00622700|7259649|FG006|Extension Treatment Period|Withdrawal by Subject|10
4467639|NCT00622700|7259643|FG000|Extension Treatment Period|Missing|0
4467640|NCT00622700|7259644|FG001|Extension Treatment Period|Missing|0
4467641|NCT00622700|7259645|FG002|Extension Treatment Period|Missing|0
4467642|NCT00622700|7259646|FG003|Extension Treatment Period|Missing|2
4467643|NCT00622700|7259647|FG004|Extension Treatment Period|Missing|3
4467644|NCT00622700|7259648|FG005|Extension Treatment Period|Missing|1
4467645|NCT00622700|7259649|FG006|Extension Treatment Period|Missing|0
4467646|NCT00622700|7259643|FG000|Extension Treatment Period|Other than specified above|0
4467647|NCT00622700|7259644|FG001|Extension Treatment Period|Other than specified above|0
4467648|NCT00622700|7259645|FG002|Extension Treatment Period|Other than specified above|0
4467649|NCT00622700|7259646|FG003|Extension Treatment Period|Other than specified above|0
4467650|NCT00622700|7259647|FG004|Extension Treatment Period|Other than specified above|0
4467651|NCT00622700|7259648|FG005|Extension Treatment Period|Other than specified above|1
4467652|NCT00622700|7259649|FG006|Extension Treatment Period|Other than specified above|1
4467653|NCT00622713|7259666|FG000|Overall Study|Adverse Event|35
4467654|NCT00622713|7259666|FG000|Overall Study|Administrative problems|4
4467655|NCT00622713|7259666|FG000|Overall Study|Withdrawal by Subject|11
4467656|NCT00622713|7259666|FG000|Overall Study|Lost to Follow-up|5
4467657|NCT00622713|7259666|FG000|Overall Study|Death|2
4467658|NCT00622713|7259666|FG000|Overall Study|Subject no longer required study drug|1
4467659|NCT00622713|7259666|FG000|Overall Study|Did not meet eligibility criteria|1
4467660|NCT00622726|7259672|FG000|March, 2008 to August, 2010|Death|5
4467661|NCT00622726|7259673|FG001|March, 2008 to August, 2010|Death|2
4467662|NCT00622726|7259672|FG000|August, 2010 to April, 2013|Death|1
4379804|NCT04559698|7157693|FG000|Overall Study|Lost to Follow-up|14
4379805|NCT04559698|7157694|FG001|Overall Study|Lost to Follow-up|15
4379806|NCT04559698|7157693|FG000|Overall Study|Withdrawal by Subject|0
4379807|NCT04559698|7157694|FG001|Overall Study|Withdrawal by Subject|1
4379859|NCT03713281|7157756|FG000|Overall Study|Lens handling difficuluties|2
4379860|NCT03713281|7157756|FG000|Overall Study|Subject was not dispensed enough lenses|1
4379861|NCT03608254|7157760|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2
4379862|NCT03608254|7157760|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1
4379863|NCT03512275|7157766|FG000|Overall Study|Withdrawal by Subject|1
4379864|NCT03512275|7157767|FG001|Overall Study|Withdrawal by Subject|3
4379865|NCT03512275|7157766|FG000|Overall Study|Physician Decision|0
4379866|NCT03512275|7157767|FG001|Overall Study|Physician Decision|1
4379867|NCT03512275|7157766|FG000|Overall Study|Lost to Follow-up|0
4379868|NCT03512275|7157767|FG001|Overall Study|Lost to Follow-up|3
4379869|NCT03512275|7157766|FG000|Overall Study|Other|1
4379870|NCT03512275|7157767|FG001|Overall Study|Other|0
4379871|NCT03414983|7157775|FG000|Pre-Treatment|Other reasons|1
4379872|NCT03414983|7157776|FG001|Pre-Treatment|Other reasons|0
4379873|NCT03414983|7157775|FG000|Pre-Treatment|Participant no longer meets study criteria|2
4379874|NCT03414983|7157776|FG001|Pre-Treatment|Participant no longer meets study criteria|3
4379875|NCT03414983|7157775|FG000|Pre-Treatment|Participant withdrew consent|1
4379876|NCT03414983|7157776|FG001|Pre-Treatment|Participant withdrew consent|3
4379877|NCT03414983|7157775|FG000|Treatment|Participant withdrew consent|4
4379878|NCT03414983|7157776|FG001|Treatment|Participant withdrew consent|3
4379879|NCT03414983|7157775|FG000|Treatment|Participant request to discontinue study treatment|8
4379880|NCT03414983|7157776|FG001|Treatment|Participant request to discontinue study treatment|10
4379881|NCT03414983|7157775|FG000|Treatment|Adverse Event Unrelated to Study Drug|5
4379882|NCT03414983|7157776|FG001|Treatment|Adverse Event Unrelated to Study Drug|2
4379883|NCT03414983|7157775|FG000|Treatment|Death|0
4379884|NCT03414983|7157776|FG001|Treatment|Death|2
4379885|NCT03414983|7157775|FG000|Treatment|Study Drug Toxicity|11
4379886|NCT03414983|7157776|FG001|Treatment|Study Drug Toxicity|4
4379887|NCT03414983|7157775|FG000|Treatment|Disease Progression|72
4379888|NCT03414983|7157776|FG001|Treatment|Disease Progression|27
4379889|NCT03414983|7157775|FG000|Treatment|Not reported|1
4379890|NCT03414983|7157776|FG001|Treatment|Not reported|0
4379891|NCT03414983|7157775|FG000|Treatment|Other reasons|3
4379892|NCT03414983|7157776|FG001|Treatment|Other reasons|2
4379893|NCT03414983|7157775|FG000|Treatment|Completed treatment as per protocol|8
4379894|NCT03414983|7157776|FG001|Treatment|Completed treatment as per protocol|0
4379895|NCT03414983|7157775|FG000|Treatment|Poor/non-compliance|2
4379896|NCT03414983|7157776|FG001|Treatment|Poor/non-compliance|0
4379897|NCT03414983|7157775|FG000|Treatment|Maximum clinical benefit|5
4379898|NCT03414983|7157776|FG001|Treatment|Maximum clinical benefit|9
4379899|NCT03414983|7157775|FG000|Treatment|Lost to Follow-up|0
4379900|NCT03414983|7157776|FG001|Treatment|Lost to Follow-up|1
4379901|NCT03383692|7157784|FG000|Overall Study|Progressive disease as per RECIST|3
4379902|NCT03383692|7157785|FG001|Overall Study|Progressive disease as per RECIST|3
4379903|NCT03383692|7157784|FG000|Overall Study|Clinical progression|0
4379904|NCT03383692|7157785|FG001|Overall Study|Clinical progression|1
4379905|NCT03383692|7157784|FG000|Overall Study|Adverse Event|3
4379906|NCT03383692|7157785|FG001|Overall Study|Adverse Event|0
4379907|NCT03371251|7157799|FG000|Overall Study|Withdrawal by Subject|1
4379908|NCT03371251|7157800|FG001|Overall Study|Withdrawal by Subject|0
4379909|NCT03371251|7157801|FG002|Overall Study|Withdrawal by Subject|1
4379910|NCT03371251|7157802|FG003|Overall Study|Withdrawal by Subject|0
4379911|NCT03371251|7157803|FG004|Overall Study|Withdrawal by Subject|2
4379912|NCT03371251|7157804|FG005|Overall Study|Withdrawal by Subject|2
4379913|NCT03371251|7157799|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1
4379914|NCT03371251|7157800|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0
4467663|NCT00622726|7259673|FG001|August, 2010 to April, 2013|Death|5
4467664|NCT00622739|7259685|FG000|Overall Study|Physician Decision|1
4467665|NCT00622739|7259686|FG001|Overall Study|Physician Decision|0
4467666|NCT00622739|7259685|FG000|Overall Study|Adverse Event|1
4467667|NCT00622739|7259686|FG001|Overall Study|Adverse Event|2
4467668|NCT00622739|7259685|FG000|Overall Study|Lack of Efficacy|0
4467669|NCT00622739|7259686|FG001|Overall Study|Lack of Efficacy|2
4467670|NCT00622739|7259685|FG000|Overall Study|Withdrawal by Subject|0
4467671|NCT00622739|7259686|FG001|Overall Study|Withdrawal by Subject|1
4467672|NCT00622739|7259685|FG000|Overall Study|Lost to Follow-up|0
4467673|NCT00622739|7259686|FG001|Overall Study|Lost to Follow-up|1
4467674|NCT00622869|7259697|FG000|Overall Study|Subject Withdrew Consent|13
4467675|NCT00622869|7259698|FG001|Overall Study|Subject Withdrew Consent|17
4467676|NCT00622869|7259699|FG002|Overall Study|Subject Withdrew Consent|11
4467677|NCT00622869|7259697|FG000|Overall Study|Administrative Problems|11
4467678|NCT00622869|7259698|FG001|Overall Study|Administrative Problems|17
4467679|NCT00622869|7259699|FG002|Overall Study|Administrative Problems|13
4467680|NCT00622869|7259697|FG000|Overall Study|Death|12
4467681|NCT00622869|7259698|FG001|Overall Study|Death|15
4467682|NCT00622869|7259699|FG002|Overall Study|Death|10
4467683|NCT00622869|7259697|FG000|Overall Study|Lost to Follow-up|2
4467684|NCT00622869|7259698|FG001|Overall Study|Lost to Follow-up|4
4379808|NCT04492475|7157702|FG000|Overall Study|Enrolled but not treated|8
4379809|NCT04492475|7157703|FG001|Overall Study|Enrolled but not treated|8
4379810|NCT04492475|7157702|FG000|Overall Study|Withdrawal by Subject|4
4379811|NCT04492475|7157703|FG001|Overall Study|Withdrawal by Subject|0
4379812|NCT04492475|7157702|FG000|Overall Study|Became ineligible after enrollment|2
4379813|NCT04492475|7157703|FG001|Overall Study|Became ineligible after enrollment|0
4379814|NCT04401579|7157718|FG000|Overall Study|Death|23
4379815|NCT04401579|7157719|FG001|Overall Study|Death|36
4379816|NCT04401579|7157718|FG000|Overall Study|Lost to Follow-up|40
4379817|NCT04401579|7157719|FG001|Overall Study|Lost to Follow-up|41
4379818|NCT04401579|7157718|FG000|Overall Study|Withdrawal by Subject|8
4379819|NCT04401579|7157719|FG001|Overall Study|Withdrawal by Subject|16
4379820|NCT04401579|7157718|FG000|Overall Study|Physician Decision|1
4379821|NCT04401579|7157719|FG001|Overall Study|Physician Decision|2
4379822|NCT04401579|7157718|FG000|Overall Study|Became ineligible after enrollment|1
4379823|NCT04401579|7157719|FG001|Overall Study|Became ineligible after enrollment|1
4379824|NCT04401579|7157718|FG000|Overall Study|Enrolled but treatment not administered|7
4379825|NCT04401579|7157719|FG001|Overall Study|Enrolled but treatment not administered|9
4379826|NCT04401579|7157718|FG000|Overall Study|Adverse Event|2
4379827|NCT04401579|7157719|FG001|Overall Study|Adverse Event|1
4379828|NCT04401579|7157718|FG000|Overall Study|Scheduling error|1
4379829|NCT04401579|7157719|FG001|Overall Study|Scheduling error|2
4379830|NCT04401579|7157718|FG000|Overall Study|Transferred to another hospital|1
4379831|NCT04401579|7157719|FG001|Overall Study|Transferred to another hospital|2
4379832|NCT04321460|7157727|FG000|Overall Study|Participants who had no defecation or no data about it|1
4379833|NCT04321460|7157728|FG001|Overall Study|Participants who had no defecation or no data about it|1
4379834|NCT04280705|7157736|FG000|Overall Study|Enrolled but not treated|4
4379835|NCT04280705|7157737|FG001|Overall Study|Enrolled but not treated|10
4379836|NCT04280705|7157736|FG000|Overall Study|Physician Decision|1
4379837|NCT04280705|7157737|FG001|Overall Study|Physician Decision|0
4379838|NCT04280705|7157736|FG000|Overall Study|Withdrawal by Subject|7
4379839|NCT04280705|7157737|FG001|Overall Study|Withdrawal by Subject|9
4379840|NCT04280705|7157736|FG000|Overall Study|Adverse Event|0
4379841|NCT04280705|7157737|FG001|Overall Study|Adverse Event|4
4379842|NCT04280705|7157736|FG000|Overall Study|Transferred to another hospital|1
4379843|NCT04280705|7157737|FG001|Overall Study|Transferred to another hospital|1
4379844|NCT04208750|7157745|FG000|Overall Study|Lost to Follow-up|16
4379845|NCT04208750|7157746|FG001|Overall Study|Lost to Follow-up|15
4379846|NCT04126733|7157752|FG000|Treatment Period|Other Reason|1
4379847|NCT04126733|7157752|FG000|Treatment Period|Death|1
4379848|NCT04126733|7157752|FG000|Treatment Period|Physician Decision|3
4379849|NCT04126733|7157752|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7
4379850|NCT04126733|7157752|FG000|Treatment Period|Adverse Event|7
4379851|NCT04126733|7157752|FG000|Treatment Period|Progressive Disease - Radiological Progression|44
4379852|NCT04126733|7157752|FG000|Treatment Period|Ongoing with Study Treatment|7
4379853|NCT04126733|7157752|FG000|Active Follow-up Period|Death|13
4379854|NCT04126733|7157752|FG000|Active Follow-up Period|Other Reason|1
4379855|NCT04126733|7157752|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4
4379856|NCT04126733|7157752|FG000|Active Follow-up Period|Withdrawal by Subject|2
4379857|NCT04126733|7157752|FG000|Long-term Follow-up Period|Withdrawal by Subject|1
4379858|NCT04126733|7157752|FG000|Long-term Follow-up Period|Death|5
4379915|NCT03371251|7157801|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0
4379916|NCT03371251|7157802|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0
4379917|NCT03371251|7157803|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2
4379918|NCT03371251|7157804|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3
4379919|NCT03371251|7157799|FG000|Overall Study|Adverse Event|0
4379920|NCT03371251|7157800|FG001|Overall Study|Adverse Event|0
4379921|NCT03371251|7157801|FG002|Overall Study|Adverse Event|0
4379922|NCT03371251|7157802|FG003|Overall Study|Adverse Event|0
4379923|NCT03371251|7157803|FG004|Overall Study|Adverse Event|1
4379924|NCT03371251|7157804|FG005|Overall Study|Adverse Event|0
4379925|NCT03371251|7157799|FG000|Overall Study|Decision by Sponsor|0
4379926|NCT03371251|7157800|FG001|Overall Study|Decision by Sponsor|0
4379927|NCT03371251|7157801|FG002|Overall Study|Decision by Sponsor|0
4379928|NCT03371251|7157802|FG003|Overall Study|Decision by Sponsor|0
4379929|NCT03371251|7157803|FG004|Overall Study|Decision by Sponsor|2
4379930|NCT03371251|7157804|FG005|Overall Study|Decision by Sponsor|0
4379931|NCT03307785|7157844|FG000|Part A: Up to 28.5 Months|Disease progression|2
4379932|NCT03307785|7157845|FG001|Part A: Up to 28.5 Months|Disease progression|0
4379933|NCT03307785|7157846|FG002|Part A: Up to 28.5 Months|Disease progression|0
4379934|NCT03307785|7157847|FG003|Part A: Up to 28.5 Months|Disease progression|0
4379935|NCT03307785|7157848|FG004|Part A: Up to 28.5 Months|Disease progression|0
4379936|NCT03307785|7157849|FG005|Part A: Up to 28.5 Months|Disease progression|0
4379937|NCT03307785|7157850|FG006|Part A: Up to 28.5 Months|Disease progression|0
4379938|NCT03307785|7157851|FG007|Part A: Up to 28.5 Months|Disease progression|0
4379939|NCT03307785|7157852|FG008|Part A: Up to 28.5 Months|Disease progression|0
4379940|NCT03307785|7157853|FG009|Part A: Up to 28.5 Months|Disease progression|0
4379941|NCT03307785|7157854|FG010|Part A: Up to 28.5 Months|Disease progression|0
4379942|NCT03307785|7157844|FG000|Part A: Up to 28.5 Months|Withdrawal by Subject|7
4379943|NCT03307785|7157845|FG001|Part A: Up to 28.5 Months|Withdrawal by Subject|1
4379944|NCT03307785|7157846|FG002|Part A: Up to 28.5 Months|Withdrawal by Subject|0
4379945|NCT03307785|7157847|FG003|Part A: Up to 28.5 Months|Withdrawal by Subject|0
4379946|NCT03307785|7157848|FG004|Part A: Up to 28.5 Months|Withdrawal by Subject|0
4379947|NCT03307785|7157849|FG005|Part A: Up to 28.5 Months|Withdrawal by Subject|0
4379948|NCT03307785|7157850|FG006|Part A: Up to 28.5 Months|Withdrawal by Subject|0
4379949|NCT03307785|7157851|FG007|Part A: Up to 28.5 Months|Withdrawal by Subject|0
4379950|NCT03307785|7157852|FG008|Part A: Up to 28.5 Months|Withdrawal by Subject|0
4379951|NCT03307785|7157853|FG009|Part A: Up to 28.5 Months|Withdrawal by Subject|0
4379952|NCT03307785|7157854|FG010|Part A: Up to 28.5 Months|Withdrawal by Subject|0
4379953|NCT03307785|7157844|FG000|Part A: Up to 28.5 Months|Death|4
4379954|NCT03307785|7157845|FG001|Part A: Up to 28.5 Months|Death|4
4379955|NCT03307785|7157846|FG002|Part A: Up to 28.5 Months|Death|0
4379956|NCT03307785|7157847|FG003|Part A: Up to 28.5 Months|Death|0
4379957|NCT03307785|7157848|FG004|Part A: Up to 28.5 Months|Death|0
4379958|NCT03307785|7157849|FG005|Part A: Up to 28.5 Months|Death|0
4379959|NCT03307785|7157850|FG006|Part A: Up to 28.5 Months|Death|0
4379960|NCT03307785|7157851|FG007|Part A: Up to 28.5 Months|Death|0
4379961|NCT03307785|7157852|FG008|Part A: Up to 28.5 Months|Death|0
4379962|NCT03307785|7157853|FG009|Part A: Up to 28.5 Months|Death|0
4379963|NCT03307785|7157854|FG010|Part A: Up to 28.5 Months|Death|0
4379964|NCT03307785|7157844|FG000|Part A: Up to 28.5 Months|Physician Decision|3
4379965|NCT03307785|7157845|FG001|Part A: Up to 28.5 Months|Physician Decision|1
4379966|NCT03307785|7157846|FG002|Part A: Up to 28.5 Months|Physician Decision|0
4379967|NCT03307785|7157847|FG003|Part A: Up to 28.5 Months|Physician Decision|0
4379968|NCT03307785|7157848|FG004|Part A: Up to 28.5 Months|Physician Decision|0
4379969|NCT03307785|7157849|FG005|Part A: Up to 28.5 Months|Physician Decision|0
4379970|NCT03307785|7157850|FG006|Part A: Up to 28.5 Months|Physician Decision|0
4379971|NCT03307785|7157851|FG007|Part A: Up to 28.5 Months|Physician Decision|0
4379972|NCT03307785|7157852|FG008|Part A: Up to 28.5 Months|Physician Decision|0
4379973|NCT03307785|7157853|FG009|Part A: Up to 28.5 Months|Physician Decision|0
4379974|NCT03307785|7157854|FG010|Part A: Up to 28.5 Months|Physician Decision|0
4379975|NCT03307785|7157844|FG000|Part B: Up to 28.5 Months|Disease progression|0
4379976|NCT03307785|7157845|FG001|Part B: Up to 28.5 Months|Disease progression|0
4379977|NCT03307785|7157846|FG002|Part B: Up to 28.5 Months|Disease progression|1
4379978|NCT03307785|7157847|FG003|Part B: Up to 28.5 Months|Disease progression|0
4379979|NCT03307785|7157848|FG004|Part B: Up to 28.5 Months|Disease progression|0
4379980|NCT03307785|7157849|FG005|Part B: Up to 28.5 Months|Disease progression|0
4379981|NCT03307785|7157850|FG006|Part B: Up to 28.5 Months|Disease progression|0
4379982|NCT03307785|7157851|FG007|Part B: Up to 28.5 Months|Disease progression|0
4379983|NCT03307785|7157852|FG008|Part B: Up to 28.5 Months|Disease progression|0
4379984|NCT03307785|7157853|FG009|Part B: Up to 28.5 Months|Disease progression|0
4379985|NCT03307785|7157854|FG010|Part B: Up to 28.5 Months|Disease progression|0
4379986|NCT03307785|7157844|FG000|Part B: Up to 28.5 Months|Physician Decision|0
4379987|NCT03307785|7157845|FG001|Part B: Up to 28.5 Months|Physician Decision|0
4379988|NCT03307785|7157846|FG002|Part B: Up to 28.5 Months|Physician Decision|1
4379989|NCT03307785|7157847|FG003|Part B: Up to 28.5 Months|Physician Decision|0
4379990|NCT03307785|7157848|FG004|Part B: Up to 28.5 Months|Physician Decision|0
4379991|NCT03307785|7157849|FG005|Part B: Up to 28.5 Months|Physician Decision|0
4379992|NCT03307785|7157850|FG006|Part B: Up to 28.5 Months|Physician Decision|0
4379993|NCT03307785|7157851|FG007|Part B: Up to 28.5 Months|Physician Decision|0
4379994|NCT03307785|7157852|FG008|Part B: Up to 28.5 Months|Physician Decision|0
4379995|NCT03307785|7157853|FG009|Part B: Up to 28.5 Months|Physician Decision|0
4379996|NCT03307785|7157854|FG010|Part B: Up to 28.5 Months|Physician Decision|0
4379997|NCT03307785|7157844|FG000|Part B: Up to 28.5 Months|Death|0
4379998|NCT03307785|7157845|FG001|Part B: Up to 28.5 Months|Death|0
4379999|NCT03307785|7157846|FG002|Part B: Up to 28.5 Months|Death|7
4380000|NCT03307785|7157847|FG003|Part B: Up to 28.5 Months|Death|0
4380001|NCT03307785|7157848|FG004|Part B: Up to 28.5 Months|Death|0
4380002|NCT03307785|7157849|FG005|Part B: Up to 28.5 Months|Death|0
4380003|NCT03307785|7157850|FG006|Part B: Up to 28.5 Months|Death|0
4380004|NCT03307785|7157851|FG007|Part B: Up to 28.5 Months|Death|0
4380005|NCT03307785|7157852|FG008|Part B: Up to 28.5 Months|Death|0
4380006|NCT03307785|7157853|FG009|Part B: Up to 28.5 Months|Death|0
4380007|NCT03307785|7157854|FG010|Part B: Up to 28.5 Months|Death|0
4380008|NCT03307785|7157844|FG000|Part B: Up to 28.5 Months|Withdrawal by Subject|0
4380009|NCT03307785|7157845|FG001|Part B: Up to 28.5 Months|Withdrawal by Subject|0
4380010|NCT03307785|7157846|FG002|Part B: Up to 28.5 Months|Withdrawal by Subject|1
4380011|NCT03307785|7157847|FG003|Part B: Up to 28.5 Months|Withdrawal by Subject|0
4380012|NCT03307785|7157848|FG004|Part B: Up to 28.5 Months|Withdrawal by Subject|0
4380013|NCT03307785|7157849|FG005|Part B: Up to 28.5 Months|Withdrawal by Subject|0
4380014|NCT03307785|7157850|FG006|Part B: Up to 28.5 Months|Withdrawal by Subject|0
4380015|NCT03307785|7157851|FG007|Part B: Up to 28.5 Months|Withdrawal by Subject|0
4380016|NCT03307785|7157852|FG008|Part B: Up to 28.5 Months|Withdrawal by Subject|0
4380017|NCT03307785|7157853|FG009|Part B: Up to 28.5 Months|Withdrawal by Subject|0
4380018|NCT03307785|7157854|FG010|Part B: Up to 28.5 Months|Withdrawal by Subject|0
4380019|NCT03307785|7157844|FG000|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
4380020|NCT03307785|7157845|FG001|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
4380021|NCT03307785|7157846|FG002|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|4
4380022|NCT03307785|7157847|FG003|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
4380023|NCT03307785|7157848|FG004|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
4380024|NCT03307785|7157849|FG005|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
4380025|NCT03307785|7157850|FG006|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
4380026|NCT03307785|7157851|FG007|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
4380027|NCT03307785|7157852|FG008|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
4380028|NCT03307785|7157853|FG009|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
4380029|NCT03307785|7157854|FG010|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0
4380030|NCT03307785|7157844|FG000|Part C: Up to 22.5 Months|Disease progression|0
4380031|NCT03307785|7157845|FG001|Part C: Up to 22.5 Months|Disease progression|0
4380032|NCT03307785|7157846|FG002|Part C: Up to 22.5 Months|Disease progression|0
4380033|NCT03307785|7157847|FG003|Part C: Up to 22.5 Months|Disease progression|0
4380034|NCT03307785|7157848|FG004|Part C: Up to 22.5 Months|Disease progression|1
4380035|NCT03307785|7157849|FG005|Part C: Up to 22.5 Months|Disease progression|0
4380036|NCT03307785|7157850|FG006|Part C: Up to 22.5 Months|Disease progression|0
4380037|NCT03307785|7157851|FG007|Part C: Up to 22.5 Months|Disease progression|0
4380038|NCT03307785|7157852|FG008|Part C: Up to 22.5 Months|Disease progression|0
4380039|NCT03307785|7157853|FG009|Part C: Up to 22.5 Months|Disease progression|0
4380040|NCT03307785|7157854|FG010|Part C: Up to 22.5 Months|Disease progression|0
4380041|NCT03307785|7157844|FG000|Part C: Up to 22.5 Months|Physician Decision|0
4380042|NCT03307785|7157845|FG001|Part C: Up to 22.5 Months|Physician Decision|0
4380043|NCT03307785|7157846|FG002|Part C: Up to 22.5 Months|Physician Decision|0
4380044|NCT03307785|7157847|FG003|Part C: Up to 22.5 Months|Physician Decision|3
4380045|NCT03307785|7157848|FG004|Part C: Up to 22.5 Months|Physician Decision|1
4380046|NCT03307785|7157849|FG005|Part C: Up to 22.5 Months|Physician Decision|0
4380047|NCT03307785|7157850|FG006|Part C: Up to 22.5 Months|Physician Decision|0
4380048|NCT03307785|7157851|FG007|Part C: Up to 22.5 Months|Physician Decision|0
4380049|NCT03307785|7157852|FG008|Part C: Up to 22.5 Months|Physician Decision|0
4380050|NCT03307785|7157853|FG009|Part C: Up to 22.5 Months|Physician Decision|0
4380051|NCT03307785|7157854|FG010|Part C: Up to 22.5 Months|Physician Decision|0
4380052|NCT03307785|7157844|FG000|Part C: Up to 22.5 Months|Death|0
4380053|NCT03307785|7157845|FG001|Part C: Up to 22.5 Months|Death|0
4380054|NCT03307785|7157846|FG002|Part C: Up to 22.5 Months|Death|0
4380055|NCT03307785|7157847|FG003|Part C: Up to 22.5 Months|Death|1
4380056|NCT03307785|7157848|FG004|Part C: Up to 22.5 Months|Death|4
4380057|NCT03307785|7157849|FG005|Part C: Up to 22.5 Months|Death|0
4380058|NCT03307785|7157850|FG006|Part C: Up to 22.5 Months|Death|0
4380059|NCT03307785|7157851|FG007|Part C: Up to 22.5 Months|Death|0
4380060|NCT03307785|7157852|FG008|Part C: Up to 22.5 Months|Death|0
4380061|NCT03307785|7157853|FG009|Part C: Up to 22.5 Months|Death|0
4380062|NCT03307785|7157854|FG010|Part C: Up to 22.5 Months|Death|0
4380063|NCT03307785|7157844|FG000|Part C: Up to 22.5 Months|Withdrawal by Subject|0
4380064|NCT03307785|7157845|FG001|Part C: Up to 22.5 Months|Withdrawal by Subject|0
4380065|NCT03307785|7157846|FG002|Part C: Up to 22.5 Months|Withdrawal by Subject|0
4587993|NCT01496365|7432393|FG002|Overall Study|Other|2
4587994|NCT01496365|7432394|FG003|Overall Study|Other|1
4587995|NCT01496365|7432395|FG004|Overall Study|Other|3
4587996|NCT01496365|7432396|FG005|Overall Study|Other|0
4587997|NCT01496365|7432397|FG006|Overall Study|Other|1
4587998|NCT01496430|7432416|FG000|Overall Study|Adverse Event|0
4587999|NCT01496430|7432417|FG001|Overall Study|Adverse Event|0
4588000|NCT01496430|7432418|FG002|Overall Study|Adverse Event|1
4588001|NCT01496430|7432416|FG000|Overall Study|Major Protocol Deviation|0
4380066|NCT03307785|7157847|FG003|Part C: Up to 22.5 Months|Withdrawal by Subject|1
4380067|NCT03307785|7157848|FG004|Part C: Up to 22.5 Months|Withdrawal by Subject|0
4380068|NCT03307785|7157849|FG005|Part C: Up to 22.5 Months|Withdrawal by Subject|0
4380069|NCT03307785|7157850|FG006|Part C: Up to 22.5 Months|Withdrawal by Subject|0
4380070|NCT03307785|7157851|FG007|Part C: Up to 22.5 Months|Withdrawal by Subject|0
4380071|NCT03307785|7157852|FG008|Part C: Up to 22.5 Months|Withdrawal by Subject|0
4380072|NCT03307785|7157853|FG009|Part C: Up to 22.5 Months|Withdrawal by Subject|0
4380073|NCT03307785|7157854|FG010|Part C: Up to 22.5 Months|Withdrawal by Subject|0
4380074|NCT03307785|7157844|FG000|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0
4380075|NCT03307785|7157845|FG001|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0
4380076|NCT03307785|7157846|FG002|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0
4380077|NCT03307785|7157847|FG003|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|1
4380078|NCT03307785|7157848|FG004|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|1
4380079|NCT03307785|7157849|FG005|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0
4380080|NCT03307785|7157850|FG006|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0
4467685|NCT00622869|7259699|FG002|Overall Study|Lost to Follow-up|2
4467686|NCT00622869|7259697|FG000|Overall Study|Graft Loss|5
4467687|NCT00622869|7259698|FG001|Overall Study|Graft Loss|3
4467688|NCT00622869|7259699|FG002|Overall Study|Graft Loss|2
4467689|NCT00622869|7259697|FG000|Overall Study|Missing|0
4588002|NCT01496430|7432417|FG001|Overall Study|Major Protocol Deviation|0
4588003|NCT01496430|7432418|FG002|Overall Study|Major Protocol Deviation|1
4380081|NCT03307785|7157851|FG007|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0
4380082|NCT03307785|7157852|FG008|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0
4380083|NCT03307785|7157853|FG009|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0
4380084|NCT03307785|7157854|FG010|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0
4380085|NCT03307785|7157844|FG000|Part D: Up to 9.5 Months|Physician Decision|0
4380086|NCT03307785|7157845|FG001|Part D: Up to 9.5 Months|Physician Decision|0
4380087|NCT03307785|7157846|FG002|Part D: Up to 9.5 Months|Physician Decision|0
4380088|NCT03307785|7157847|FG003|Part D: Up to 9.5 Months|Physician Decision|0
4380089|NCT03307785|7157848|FG004|Part D: Up to 9.5 Months|Physician Decision|0
4380090|NCT03307785|7157849|FG005|Part D: Up to 9.5 Months|Physician Decision|1
4380091|NCT03307785|7157850|FG006|Part D: Up to 9.5 Months|Physician Decision|0
4380092|NCT03307785|7157851|FG007|Part D: Up to 9.5 Months|Physician Decision|0
4380093|NCT03307785|7157852|FG008|Part D: Up to 9.5 Months|Physician Decision|0
4380094|NCT03307785|7157853|FG009|Part D: Up to 9.5 Months|Physician Decision|0
4380095|NCT03307785|7157854|FG010|Part D: Up to 9.5 Months|Physician Decision|0
4380096|NCT03307785|7157844|FG000|Part D: Up to 9.5 Months|Death|0
4380097|NCT03307785|7157845|FG001|Part D: Up to 9.5 Months|Death|0
4380098|NCT03307785|7157846|FG002|Part D: Up to 9.5 Months|Death|0
4380099|NCT03307785|7157847|FG003|Part D: Up to 9.5 Months|Death|0
4380100|NCT03307785|7157848|FG004|Part D: Up to 9.5 Months|Death|0
4380101|NCT03307785|7157849|FG005|Part D: Up to 9.5 Months|Death|1
4380102|NCT03307785|7157850|FG006|Part D: Up to 9.5 Months|Death|0
4380103|NCT03307785|7157851|FG007|Part D: Up to 9.5 Months|Death|0
4380104|NCT03307785|7157852|FG008|Part D: Up to 9.5 Months|Death|0
4380105|NCT03307785|7157853|FG009|Part D: Up to 9.5 Months|Death|0
4380106|NCT03307785|7157854|FG010|Part D: Up to 9.5 Months|Death|0
4380107|NCT03307785|7157844|FG000|Part D: Up to 9.5 Months|Withdrawal by Subject|0
4380108|NCT03307785|7157845|FG001|Part D: Up to 9.5 Months|Withdrawal by Subject|0
4380109|NCT03307785|7157846|FG002|Part D: Up to 9.5 Months|Withdrawal by Subject|0
4380110|NCT03307785|7157847|FG003|Part D: Up to 9.5 Months|Withdrawal by Subject|0
4380111|NCT03307785|7157848|FG004|Part D: Up to 9.5 Months|Withdrawal by Subject|0
4380112|NCT03307785|7157849|FG005|Part D: Up to 9.5 Months|Withdrawal by Subject|1
4380113|NCT03307785|7157850|FG006|Part D: Up to 9.5 Months|Withdrawal by Subject|0
4380114|NCT03307785|7157851|FG007|Part D: Up to 9.5 Months|Withdrawal by Subject|0
4380115|NCT03307785|7157852|FG008|Part D: Up to 9.5 Months|Withdrawal by Subject|0
4380116|NCT03307785|7157853|FG009|Part D: Up to 9.5 Months|Withdrawal by Subject|0
4380117|NCT03307785|7157854|FG010|Part D: Up to 9.5 Months|Withdrawal by Subject|0
4380118|NCT03307785|7157844|FG000|Part E: Up to 4.4 Months|Death|0
4380119|NCT03307785|7157845|FG001|Part E: Up to 4.4 Months|Death|0
4380120|NCT03307785|7157846|FG002|Part E: Up to 4.4 Months|Death|0
4380121|NCT03307785|7157847|FG003|Part E: Up to 4.4 Months|Death|0
4380122|NCT03307785|7157848|FG004|Part E: Up to 4.4 Months|Death|0
4380123|NCT03307785|7157849|FG005|Part E: Up to 4.4 Months|Death|0
4380124|NCT03307785|7157850|FG006|Part E: Up to 4.4 Months|Death|1
4380125|NCT03307785|7157851|FG007|Part E: Up to 4.4 Months|Death|0
4380126|NCT03307785|7157852|FG008|Part E: Up to 4.4 Months|Death|0
4380127|NCT03307785|7157853|FG009|Part E: Up to 4.4 Months|Death|0
4380128|NCT03307785|7157854|FG010|Part E: Up to 4.4 Months|Death|0
4380129|NCT03307785|7157844|FG000|Part E: Up to 4.4 Months|Physician Decision|0
4380130|NCT03307785|7157845|FG001|Part E: Up to 4.4 Months|Physician Decision|0
4380131|NCT03307785|7157846|FG002|Part E: Up to 4.4 Months|Physician Decision|0
4380132|NCT03307785|7157847|FG003|Part E: Up to 4.4 Months|Physician Decision|0
4380133|NCT03307785|7157848|FG004|Part E: Up to 4.4 Months|Physician Decision|0
4380134|NCT03307785|7157849|FG005|Part E: Up to 4.4 Months|Physician Decision|0
4380135|NCT03307785|7157850|FG006|Part E: Up to 4.4 Months|Physician Decision|1
4380136|NCT03307785|7157851|FG007|Part E: Up to 4.4 Months|Physician Decision|0
4380137|NCT03307785|7157852|FG008|Part E: Up to 4.4 Months|Physician Decision|0
4380138|NCT03307785|7157853|FG009|Part E: Up to 4.4 Months|Physician Decision|0
4380139|NCT03307785|7157854|FG010|Part E: Up to 4.4 Months|Physician Decision|0
4380140|NCT03307785|7157844|FG000|Part F: Up to 3.5 Months|Physician Decision|0
4380141|NCT03307785|7157845|FG001|Part F: Up to 3.5 Months|Physician Decision|0
4588004|NCT01496430|7432416|FG000|Overall Study|Lost to Follow-up|2
4588005|NCT01496430|7432417|FG001|Overall Study|Lost to Follow-up|3
4588006|NCT01496430|7432418|FG002|Overall Study|Lost to Follow-up|1
4588007|NCT01496430|7432416|FG000|Overall Study|Voluntary Withdrawal|2
4588008|NCT01496430|7432417|FG001|Overall Study|Voluntary Withdrawal|1
4588009|NCT01496430|7432418|FG002|Overall Study|Voluntary Withdrawal|6
4588010|NCT01496430|7432416|FG000|Overall Study|Principal Investigator Discretion|0
4588011|NCT01496430|7432417|FG001|Overall Study|Principal Investigator Discretion|1
4588012|NCT01496430|7432418|FG002|Overall Study|Principal Investigator Discretion|1
4588013|NCT01496430|7432416|FG000|Overall Study|Other|2
4588014|NCT01496430|7432417|FG001|Overall Study|Other|0
4588015|NCT01496430|7432418|FG002|Overall Study|Other|0
4588016|NCT01496456|7432426|FG000|Overall Study|Protocol Violation|1
4588017|NCT01496456|7432426|FG000|Overall Study|Lost to Follow-up|7
4380142|NCT03307785|7157846|FG002|Part F: Up to 3.5 Months|Physician Decision|0
4588018|NCT01496469|7432435|FG000|Overall Study|Adverse Event|1
4588019|NCT01496469|7432436|FG001|Overall Study|Adverse Event|0
4588020|NCT01496469|7432435|FG000|Overall Study|Protocol Violation|2
4588021|NCT01496469|7432436|FG001|Overall Study|Protocol Violation|0
4588022|NCT01496469|7432435|FG000|Overall Study|Lost to Follow-up|1
4588023|NCT01496469|7432436|FG001|Overall Study|Lost to Follow-up|1
4588024|NCT01496469|7432435|FG000|Overall Study|Withdrawal by Subject|4
4588025|NCT01496469|7432436|FG001|Overall Study|Withdrawal by Subject|4
4380143|NCT03307785|7157847|FG003|Part F: Up to 3.5 Months|Physician Decision|0
4380144|NCT03307785|7157848|FG004|Part F: Up to 3.5 Months|Physician Decision|0
4380145|NCT03307785|7157849|FG005|Part F: Up to 3.5 Months|Physician Decision|0
4380146|NCT03307785|7157850|FG006|Part F: Up to 3.5 Months|Physician Decision|0
4380147|NCT03307785|7157851|FG007|Part F: Up to 3.5 Months|Physician Decision|1
4380148|NCT03307785|7157852|FG008|Part F: Up to 3.5 Months|Physician Decision|0
4380149|NCT03307785|7157853|FG009|Part F: Up to 3.5 Months|Physician Decision|0
4380150|NCT03307785|7157854|FG010|Part F: Up to 3.5 Months|Physician Decision|0
4467690|NCT00622869|7259698|FG001|Overall Study|Missing|1
4467691|NCT00622869|7259699|FG002|Overall Study|Missing|1
4467692|NCT00622908|7259716|FG000|Overall Study|Protocol Violation|1
4467693|NCT00622908|7259717|FG001|Overall Study|Protocol Violation|0
4467694|NCT00622908|7259716|FG000|Overall Study|Adverse Event|0
4467695|NCT00622908|7259717|FG001|Overall Study|Adverse Event|1
4467696|NCT00622908|7259716|FG000|Overall Study|Lack of Efficacy|1
4467697|NCT00622908|7259717|FG001|Overall Study|Lack of Efficacy|7
4467698|NCT00622908|7259716|FG000|Overall Study|Lost to Follow-up|1
4467699|NCT00622908|7259717|FG001|Overall Study|Lost to Follow-up|0
4467700|NCT00622908|7259716|FG000|Overall Study|Refusal|0
4467701|NCT00622908|7259717|FG001|Overall Study|Refusal|1
4467702|NCT00622908|7259716|FG000|Overall Study|Termination by study sponser|0
4467703|NCT00622908|7259717|FG001|Overall Study|Termination by study sponser|1
4516353|NCT00959699|7327705|FG001|Follow-up Period|Lost to Follow-up|2
4516354|NCT00959699|7327704|FG000|Follow-up Period|Withdrawal by Subject|3
4516355|NCT00959699|7327705|FG001|Follow-up Period|Withdrawal by Subject|4
4516356|NCT00959751|7327714|FG000|Overall Study|Lost to Follow-up|2
4516357|NCT00959751|7327715|FG001|Overall Study|Lost to Follow-up|3
4516358|NCT00959751|7327714|FG000|Overall Study|Consent Withdrawn|0
4588026|NCT01496469|7432435|FG000|Overall Study|BP exceeds protocol limits|1
4588027|NCT01496469|7432436|FG001|Overall Study|BP exceeds protocol limits|2
4588028|NCT01496469|7432435|FG000|Overall Study|Other|1
4588029|NCT01496469|7432436|FG001|Overall Study|Other|1
4588030|NCT01496612|7432442|FG000|1st Intervention|Adverse Event|1
4588031|NCT01496612|7432443|FG001|1st Intervention|Adverse Event|0
4588032|NCT01496612|7432442|FG000|1st Intervention|Withdrawal by Subject|1
4588033|NCT01496612|7432443|FG001|1st Intervention|Withdrawal by Subject|0
4588034|NCT01496807|7432451|FG000|Overall Study|Progressive Disease|21
4588035|NCT01496807|7432451|FG000|Overall Study|Participant preference/toxicity|8
4588036|NCT01496807|7432451|FG000|Overall Study|Change in diagnosis|1
4588037|NCT01496846|7432461|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1
4588038|NCT01496846|7432462|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1
4588039|NCT01496846|7432463|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
4588040|NCT01496846|7432464|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
4588041|NCT01496846|7432465|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
4588042|NCT01496846|7432466|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
4588043|NCT01496885|7432477|FG000|Overall Study|Lost to Follow-up|13
4588044|NCT01496885|7432477|FG000|Overall Study|Withdrawal by Subject|7
4588045|NCT01496885|7432477|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2
4588046|NCT01496885|7432477|FG000|Overall Study|Death|1
4516359|NCT00959751|7327715|FG001|Overall Study|Consent Withdrawn|1
4516360|NCT00959751|7327714|FG000|Overall Study|Non-compliance to Study Procedures|0
4516361|NCT00959751|7327715|FG001|Overall Study|Non-compliance to Study Procedures|1
4516362|NCT00959751|7327714|FG000|Overall Study|No migraine headache without aura|7
4516363|NCT00959751|7327715|FG001|Overall Study|No migraine headache without aura|7
4516364|NCT00959894|7327741|FG000|Overall Study|Lost to Follow-up|10
4516365|NCT00959894|7327741|FG000|Overall Study|Adverse Event|3
4516366|NCT00959894|7327741|FG000|Overall Study|Withdrawal by Subject|1
4516367|NCT00959894|7327741|FG000|Overall Study|Need for contraindicated medication|1
4516368|NCT00959894|7327741|FG000|Overall Study|Subject moved out of town|1
4696136|NCT02633527|7608889|FG000|Overall Study|Administrative reason|1
4696137|NCT02633527|7608890|FG001|Overall Study|Administrative reason|0
4696138|NCT02633527|7608891|FG002|Overall Study|Administrative reason|0
4696139|NCT02633527|7608892|FG003|Overall Study|Administrative reason|1
4696140|NCT02633527|7608893|FG004|Overall Study|Administrative reason|0
4696141|NCT02633527|7608889|FG000|Overall Study|Multiple reasons|1
4696142|NCT02633527|7608890|FG001|Overall Study|Multiple reasons|0
4696143|NCT02633527|7608891|FG002|Overall Study|Multiple reasons|2
4696144|NCT02633527|7608892|FG003|Overall Study|Multiple reasons|2
4696145|NCT02633527|7608893|FG004|Overall Study|Multiple reasons|1
4696146|NCT02633787|7608914|FG000|Overall Study|Withdrawal by Subject|1
4588047|NCT01497067|7432481|FG000|Overall Study|Lost to Follow-up|56
4588048|NCT01497067|7432481|FG000|Overall Study|Adverse Event|3
4588049|NCT01497067|7432481|FG000|Overall Study|Patient decision unrel to Adverse Event|10
4588050|NCT01497067|7432481|FG000|Overall Study|Other|13
4696147|NCT02633800|7608920|FG000|Overall Study|Death|3
4516369|NCT00959907|7327748|FG000|Overall Study|Protocol Violation|0
4516370|NCT00959907|7327749|FG001|Overall Study|Protocol Violation|1
4588051|NCT01497197|7432488|FG000|Overall Study|Lost to Follow-up|1
4588052|NCT01497197|7432489|FG001|Overall Study|Lost to Follow-up|0
4588053|NCT01497197|7432488|FG000|Overall Study|Protocol Violation|0
4588054|NCT01497197|7432489|FG001|Overall Study|Protocol Violation|2
4588055|NCT01497197|7432488|FG000|Overall Study|Withdrawal by Subject|2
4588056|NCT01497197|7432489|FG001|Overall Study|Withdrawal by Subject|1
4588057|NCT01497197|7432488|FG000|Overall Study|Excessive/lack of response to treatment|1
4588058|NCT01497197|7432489|FG001|Overall Study|Excessive/lack of response to treatment|0
4588059|NCT01497197|7432488|FG000|Overall Study|Risk of OHSS|1
4588060|NCT01497197|7432489|FG001|Overall Study|Risk of OHSS|0
4588061|NCT01497197|7432488|FG000|Overall Study|No oocytes retrieved|3
4588062|NCT01497197|7432489|FG001|Overall Study|No oocytes retrieved|2
4588063|NCT01497197|7432488|FG000|Overall Study|No fertilisation|6
4588064|NCT01497197|7432489|FG001|Overall Study|No fertilisation|5
4588065|NCT01497197|7432488|FG000|Overall Study|Intention to freeze all embryos|0
4588066|NCT01497197|7432489|FG001|Overall Study|Intention to freeze all embryos|1
4588067|NCT01497197|7432488|FG000|Overall Study|All embryos discarded|0
4588068|NCT01497197|7432489|FG001|Overall Study|All embryos discarded|3
4588069|NCT01497197|7432488|FG000|Overall Study|Other|3
4588070|NCT01497197|7432489|FG001|Overall Study|Other|1
4588071|NCT01497262|7432495|FG000|Overall Study|Abnormal Lab Values|4
4588072|NCT01497262|7432495|FG000|Overall Study|Abnormal Test Procedure Result|1
4588073|NCT01497262|7432495|FG000|Overall Study|Physician Decision|1
4588074|NCT01497262|7432495|FG000|Overall Study|Withdrawal by Subject|2
4588075|NCT01497262|7432495|FG000|Overall Study|Adverse Event|2
4588076|NCT01497262|7432495|FG000|Overall Study|Protocol Violation|1
4588077|NCT01497275|7432499|FG000|Overall Study|Death|1
4588078|NCT01497275|7432499|FG000|Overall Study|Adverse Event|1
4588079|NCT01497366|7432505|FG000|Overall Study|Virologic failure|2
4588080|NCT01497366|7432506|FG001|Overall Study|Virologic failure|50
4588081|NCT01497366|7432505|FG000|Overall Study|Lost to Follow-up|11
4588082|NCT01497366|7432506|FG001|Overall Study|Lost to Follow-up|10
4588083|NCT01497366|7432505|FG000|Overall Study|Withdrawal by Subject|6
4588084|NCT01497366|7432506|FG001|Overall Study|Withdrawal by Subject|6
4380151|NCT03090737|7157875|FG000|Overall Study|Participant withdrew consent|4
4380152|NCT03090737|7157875|FG000|Overall Study|Death|27
4380153|NCT03043872|7157891|FG000|Overall Study|Withdrawal by Subject|6
4380154|NCT03043872|7157892|FG001|Overall Study|Withdrawal by Subject|6
4380155|NCT03043872|7157893|FG002|Overall Study|Withdrawal by Subject|15
4380156|NCT03043872|7157891|FG000|Overall Study|Lost to Follow-up|2
4380157|NCT03043872|7157892|FG001|Overall Study|Lost to Follow-up|1
4380158|NCT03043872|7157893|FG002|Overall Study|Lost to Follow-up|1
4380159|NCT03043872|7157891|FG000|Overall Study|Death|270
4380160|NCT03043872|7157892|FG001|Overall Study|Death|269
4380161|NCT03043872|7157893|FG002|Overall Study|Death|296
4380162|NCT01984346|7157930|FG000|Overall Study|Physician Decision|4
4380163|NCT01984346|7157931|FG001|Overall Study|Physician Decision|2
4380164|NCT01984346|7157930|FG000|Overall Study|Withdrawal by Subject|2
4380165|NCT01984346|7157931|FG001|Overall Study|Withdrawal by Subject|2
4380166|NCT01984346|7157930|FG000|Overall Study|Enrollment Closed|8
4380167|NCT01984346|7157931|FG001|Overall Study|Enrollment Closed|1
4380168|NCT01984346|7157930|FG000|Overall Study|Insurance Coverage|1
4380169|NCT01984346|7157931|FG001|Overall Study|Insurance Coverage|0
4380170|NCT01984346|7157930|FG000|Overall Study|Intra-operative Exclusion|2
4380171|NCT01984346|7157931|FG001|Overall Study|Intra-operative Exclusion|0
4380172|NCT01828112|7157939|FG000|Overall Study|Adverse Event|6
4380173|NCT01828112|7157940|FG001|Overall Study|Adverse Event|8
4380174|NCT01828112|7157939|FG000|Overall Study|Death|9
4380175|NCT01828112|7157940|FG001|Overall Study|Death|5
4380176|NCT01828112|7157939|FG000|Overall Study|Physician Decision|5
4380177|NCT01828112|7157940|FG001|Overall Study|Physician Decision|5
4380178|NCT01828112|7157939|FG000|Overall Study|Progressive disease|56
4380179|NCT01828112|7157940|FG001|Overall Study|Progressive disease|82
4380180|NCT01828112|7157939|FG000|Overall Study|Subject/guardian decision|6
4380181|NCT01828112|7157940|FG001|Overall Study|Subject/guardian decision|8
4380182|NCT01750281|7157949|FG000|Overall Study|Discontinued Selumetinib/Placebo|37
4380183|NCT01750281|7157950|FG001|Overall Study|Discontinued Selumetinib/Placebo|77
4467704|NCT00623103|7259729|FG000|Overall Study|Adverse Event|70
4588085|NCT01497366|7432505|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7
4588086|NCT01497366|7432506|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0
4588087|NCT01497366|7432505|FG000|Overall Study|Other|5
4588088|NCT01497366|7432506|FG001|Overall Study|Other|0
4588089|NCT01497366|7432505|FG000|Overall Study|Death|1
4588090|NCT01497366|7432506|FG001|Overall Study|Death|1
4588091|NCT01497366|7432505|FG000|Overall Study|Randomized but not treated|7
4380184|NCT01750281|7157951|FG002|Overall Study|Discontinued Selumetinib/Placebo|75
4380185|NCT01750281|7157949|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6
4380186|NCT01750281|7157950|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7
4380187|NCT01750281|7157951|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9
4380188|NCT01750281|7157949|FG000|Overall Study|Did not receive treatment|0
4380189|NCT01750281|7157950|FG001|Overall Study|Did not receive treatment|1
4380190|NCT01750281|7157951|FG002|Overall Study|Did not receive treatment|0
4380191|NCT01252953|7157970|FG000|Overall Study|Withdrawal by Subject|16
4380192|NCT01252953|7157971|FG001|Overall Study|Withdrawal by Subject|17
4380193|NCT01252953|7157970|FG000|Overall Study|Lost to Follow-up|22
4380194|NCT01252953|7157971|FG001|Overall Study|Lost to Follow-up|21
4380195|NCT01012609|7157980|FG000|Overall Study|Withdrawal by Subject|1
4380196|NCT01012609|7157981|FG001|Overall Study|Withdrawal by Subject|1
4380197|NCT00920387|7157990|FG000|Stage 1|Adverse Event|1
4380198|NCT00920387|7157991|FG001|Stage 1|Adverse Event|0
4380199|NCT00920387|7157992|FG002|Stage 1|Adverse Event|0
4380200|NCT00494234|7158001|FG000|Overall Study|Lack of Efficacy|12
4380201|NCT00494234|7158002|FG001|Overall Study|Lack of Efficacy|9
4380202|NCT00494234|7158001|FG000|Overall Study|Withdrawal by Subject|1
4380203|NCT00494234|7158002|FG001|Overall Study|Withdrawal by Subject|0
4380204|NCT00494234|7158001|FG000|Overall Study|Death|2
4380205|NCT00494234|7158002|FG001|Overall Study|Death|1
4380206|NCT00403559|7158033|FG000|Overall Study|Adverse Event|0
4380207|NCT00403559|7158034|FG001|Overall Study|Adverse Event|1
4380208|NCT00403559|7158033|FG000|Overall Study|Lost to Follow-up|3
4380209|NCT00403559|7158034|FG001|Overall Study|Lost to Follow-up|3
4380210|NCT00403559|7158033|FG000|Overall Study|Withdrawal by Subject|1
4380211|NCT00403559|7158034|FG001|Overall Study|Withdrawal by Subject|0
4467705|NCT00623103|7259730|FG001|Overall Study|Adverse Event|60
4467706|NCT00623103|7259729|FG000|Overall Study|Unsatisfactory therapeutic effect|4
4467707|NCT00623103|7259730|FG001|Overall Study|Unsatisfactory therapeutic effect|12
4467708|NCT00623103|7259729|FG000|Overall Study|Withdrawal by Subject|18
4467709|NCT00623103|7259730|FG001|Overall Study|Withdrawal by Subject|24
4467710|NCT00623103|7259729|FG000|Overall Study|Lost to Follow-up|4
4467711|NCT00623103|7259730|FG001|Overall Study|Lost to Follow-up|1
4467712|NCT00623103|7259729|FG000|Overall Study|Administrative problems|2
4467713|NCT00623103|7259730|FG001|Overall Study|Administrative problems|4
4467714|NCT00623103|7259729|FG000|Overall Study|Death|11
4467715|NCT00623103|7259730|FG001|Overall Study|Death|11
4467716|NCT00623103|7259729|FG000|Overall Study|Protocol deviation|2
4467717|NCT00623103|7259730|FG001|Overall Study|Protocol deviation|1
4467718|NCT00623194|7259749|FG000|Overall Study|Lack of Efficacy|1
4467719|NCT00623194|7259749|FG000|Overall Study|Protocol Violation|3
4467720|NCT00623194|7259749|FG000|Overall Study|Unclassified|1
4467721|NCT00623233|7259753|FG000|Overall Study|Adverse Event|10
4467722|NCT00623233|7259753|FG000|Overall Study|Physician Decision|10
4467723|NCT00623233|7259753|FG000|Overall Study|Lost to Follow-up|1
4467724|NCT00623233|7259753|FG000|Overall Study|Withdrawal by Subject|3
4467725|NCT00623363|7259759|FG000|Overall Study|Adverse Event|2
4467726|NCT00623363|7259760|FG001|Overall Study|Adverse Event|2
4467727|NCT00623428|7259769|FG000|Treatment Period|Adverse event/intercurrent illness|0
4467728|NCT00623428|7259770|FG001|Treatment Period|Adverse event/intercurrent illness|9
4588092|NCT01497366|7432506|FG001|Overall Study|Randomized but not treated|21
4588093|NCT01497899|7432559|FG000|Double-Blind Phase|Randomized but not Treated|1
4696148|NCT02633800|7608921|FG001|Overall Study|Death|3
4696149|NCT02633800|7608920|FG000|Overall Study|Reason not provided|1
4696150|NCT02633800|7608921|FG001|Overall Study|Reason not provided|0
4696151|NCT02633800|7608920|FG000|Overall Study|Radiologic(al) progression|23
4696152|NCT02633800|7608921|FG001|Overall Study|Radiologic(al) progression|23
4696153|NCT02633800|7608920|FG000|Overall Study|Clinical progression|3
4696154|NCT02633800|7608921|FG001|Overall Study|Clinical progression|6
4696155|NCT02633800|7608920|FG000|Overall Study|Study terminated by sponsor|6
4696156|NCT02633800|7608921|FG001|Overall Study|Study terminated by sponsor|5
4696157|NCT02633800|7608920|FG000|Overall Study|Adverse event, non-fatal|7
4696158|NCT02633800|7608921|FG001|Overall Study|Adverse event, non-fatal|2
4696159|NCT02633800|7608920|FG000|Overall Study|Withdrawal by Subject|0
4696160|NCT02633800|7608921|FG001|Overall Study|Withdrawal by Subject|3
4696161|NCT02633800|7608920|FG000|Overall Study|Patient Request|1
4696162|NCT02633800|7608921|FG001|Overall Study|Patient Request|1
4696163|NCT02634151|7608963|FG000|Overall Study|Withdrawal by Subject|1
4696164|NCT02634151|7608964|FG001|Overall Study|Withdrawal by Subject|0
4696165|NCT02634151|7608963|FG000|Overall Study|Non-Compliance|0
4696166|NCT02634151|7608964|FG001|Overall Study|Non-Compliance|1
4696167|NCT02634151|7608963|FG000|Overall Study|Other|0
4696168|NCT02634151|7608964|FG001|Overall Study|Other|1
4696169|NCT02634320|7608979|FG000|Overall Study|Adverse Event|2
4696170|NCT02634320|7608979|FG000|Overall Study|Lost to Follow-up|3
4696171|NCT02634320|7608979|FG000|Overall Study|Moved out of area|2
4696172|NCT02634320|7608979|FG000|Overall Study|Out of window for study visits|1
4696173|NCT02634320|7608979|FG000|Overall Study|Protocol Violation|1
4696174|NCT02634320|7608979|FG000|Overall Study|Withdrawal by Subject|5
4696175|NCT02634320|7608979|FG000|Overall Study|Lack of Efficacy|2
4696176|NCT02634333|7608985|FG000|Overall Study|Completed out of Window|3
4696177|NCT02634333|7608986|FG001|Overall Study|Completed out of Window|2
4696178|NCT02634333|7608985|FG000|Overall Study|Missed Visit|5
4696179|NCT02634333|7608986|FG001|Overall Study|Missed Visit|2
4696180|NCT02634333|7608985|FG000|Overall Study|Lost to Follow-up|12
4696181|NCT02634333|7608986|FG001|Overall Study|Lost to Follow-up|7
4467729|NCT00623428|7259769|FG000|Treatment Period|Death|0
4467730|NCT00623428|7259770|FG001|Treatment Period|Death|1
4467731|NCT00623428|7259769|FG000|Treatment Period|Did not cooperate / refused treatment|0
4467732|NCT00623428|7259770|FG001|Treatment Period|Did not cooperate / refused treatment|13
4467733|NCT00623428|7259769|FG000|Treatment Period|Insufficient therapeutic response|0
4516371|NCT00959907|7327748|FG000|Overall Study|Adverse Event|1
4588094|NCT01497899|7432560|FG001|Double-Blind Phase|Randomized but not Treated|0
4588095|NCT01497899|7432561|FG002|Double-Blind Phase|Randomized but not Treated|0
4588096|NCT01497899|7432562|FG003|Double-Blind Phase|Randomized but not Treated|0
4588097|NCT01497899|7432559|FG000|Double-Blind Phase|Adverse Event|1
4588098|NCT01497899|7432560|FG001|Double-Blind Phase|Adverse Event|0
4588099|NCT01497899|7432561|FG002|Double-Blind Phase|Adverse Event|0
4588100|NCT01497899|7432562|FG003|Double-Blind Phase|Adverse Event|0
4588101|NCT01497899|7432559|FG000|Double-Blind Phase|Lack of Efficacy|0
4588102|NCT01497899|7432560|FG001|Double-Blind Phase|Lack of Efficacy|1
4380212|NCT04702984|7158075|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1
4380213|NCT04633564|7158083|FG000|Period 1|Adverse Event|28
4380214|NCT04633564|7158084|FG001|Period 1|Adverse Event|19
4380215|NCT04633564|7158083|FG000|Period 1|Death|8
4380216|NCT04633564|7158084|FG001|Period 1|Death|7
4380217|NCT04633564|7158083|FG000|Period 1|Lost to Follow-up|3
4380218|NCT04633564|7158084|FG001|Period 1|Lost to Follow-up|5
4380219|NCT04633564|7158083|FG000|Period 1|Physician Decision|4
4380220|NCT04633564|7158084|FG001|Period 1|Physician Decision|12
4380221|NCT04633564|7158083|FG000|Period 1|Protocol Violation|0
4380222|NCT04633564|7158084|FG001|Period 1|Protocol Violation|1
4380223|NCT04633564|7158083|FG000|Period 1|Withdrawal by Subject|10
4380224|NCT04633564|7158084|FG001|Period 1|Withdrawal by Subject|8
4380225|NCT04633564|7158083|FG000|Period 1|Progressive disease|47
4380226|NCT04633564|7158084|FG001|Period 1|Progressive disease|51
4380227|NCT04633564|7158083|FG000|Period 1|Terminated by Sponsor|8
4380228|NCT04633564|7158084|FG001|Period 1|Terminated by Sponsor|6
4380229|NCT04633564|7158083|FG000|Period 2|Adverse Event|3
4380230|NCT04633564|7158084|FG001|Period 2|Adverse Event|4
4380231|NCT04633564|7158083|FG000|Period 2|Death|0
4380232|NCT04633564|7158084|FG001|Period 2|Death|2
4380233|NCT04633564|7158083|FG000|Period 2|Lost to Follow-up|0
4380234|NCT04633564|7158084|FG001|Period 2|Lost to Follow-up|1
4380235|NCT04633564|7158083|FG000|Period 2|Physician Decision|2
4380236|NCT04633564|7158084|FG001|Period 2|Physician Decision|4
4380237|NCT04633564|7158083|FG000|Period 2|Withdrawal by Subject|5
4380238|NCT04633564|7158084|FG001|Period 2|Withdrawal by Subject|1
4380239|NCT04633564|7158083|FG000|Period 2|Progressive Disease|74
4380240|NCT04633564|7158084|FG001|Period 2|Progressive Disease|82
4380241|NCT04633564|7158083|FG000|Period 2|Terminated by Sponsor|9
4380242|NCT04633564|7158084|FG001|Period 2|Terminated by Sponsor|3
4380243|NCT04191148|7158105|FG000|Overall Study|Withdrawal by Subject|1
4380244|NCT04191148|7158106|FG001|Overall Study|Withdrawal by Subject|0
4380245|NCT04191148|7158105|FG000|Overall Study|Adverse Event|1
4380246|NCT04191148|7158106|FG001|Overall Study|Adverse Event|0
4380247|NCT04022733|7158147|FG000|Overall Study|conversion to open surgery|3
4380248|NCT04022733|7158148|FG001|Overall Study|conversion to open surgery|2
4380249|NCT04022733|7158147|FG000|Overall Study|bradycardia|0
4380250|NCT04022733|7158148|FG001|Overall Study|bradycardia|1
4380251|NCT04021524|7158156|FG000|Overall Study|Change in surgical intervention|0
4380252|NCT04021524|7158157|FG001|Overall Study|Change in surgical intervention|1
4380253|NCT03605680|7158194|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6
4380254|NCT03605680|7158195|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0
4380255|NCT03605680|7158196|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0
4380256|NCT03605680|7158197|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0
4380257|NCT03605680|7158194|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1
4380258|NCT03605680|7158195|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0
4380259|NCT03605680|7158196|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0
4380260|NCT03605680|7158197|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0
4380261|NCT03605680|7158194|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9
4380262|NCT03605680|7158195|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0
4380263|NCT03605680|7158196|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0
4380264|NCT03605680|7158197|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0
4380265|NCT03605680|7158194|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3
4380266|NCT03605680|7158195|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0
4588103|NCT01497899|7432561|FG002|Double-Blind Phase|Lack of Efficacy|0
4588104|NCT01497899|7432562|FG003|Double-Blind Phase|Lack of Efficacy|0
4588105|NCT01497899|7432559|FG000|Double-Blind Phase|Investigator's Discretion|1
4588106|NCT01497899|7432560|FG001|Double-Blind Phase|Investigator's Discretion|0
4588107|NCT01497899|7432561|FG002|Double-Blind Phase|Investigator's Discretion|0
4588108|NCT01497899|7432562|FG003|Double-Blind Phase|Investigator's Discretion|0
4588109|NCT01497899|7432559|FG000|Double-Blind Phase|Withdrew Consent|0
4588110|NCT01497899|7432560|FG001|Double-Blind Phase|Withdrew Consent|1
4588111|NCT01497899|7432561|FG002|Double-Blind Phase|Withdrew Consent|0
4588112|NCT01497899|7432562|FG003|Double-Blind Phase|Withdrew Consent|0
4588113|NCT01497899|7432559|FG000|Double-Blind Phase|Lost to Follow-up|3
4588114|NCT01497899|7432560|FG001|Double-Blind Phase|Lost to Follow-up|2
4588115|NCT01497899|7432561|FG002|Double-Blind Phase|Lost to Follow-up|0
4588116|NCT01497899|7432562|FG003|Double-Blind Phase|Lost to Follow-up|0
4588117|NCT01497899|7432559|FG000|Double-Blind Phase|Subject Non-Compliance|0
4588118|NCT01497899|7432560|FG001|Double-Blind Phase|Subject Non-Compliance|1
4380267|NCT03605680|7158196|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0
4380268|NCT03605680|7158197|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0
4380269|NCT03605680|7158194|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13
4380270|NCT03605680|7158195|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0
4380271|NCT03605680|7158196|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0
4380272|NCT03605680|7158197|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0
4380273|NCT03605680|7158194|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12
4380274|NCT03605680|7158195|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0
4588119|NCT01497899|7432561|FG002|Double-Blind Phase|Subject Non-Compliance|0
4588120|NCT01497899|7432562|FG003|Double-Blind Phase|Subject Non-Compliance|0
4588121|NCT01497899|7432559|FG000|Open-Label Extension Phase|Adverse Event|1
4588122|NCT01497899|7432560|FG001|Open-Label Extension Phase|Adverse Event|0
4588123|NCT01497899|7432561|FG002|Open-Label Extension Phase|Adverse Event|0
4380275|NCT03605680|7158196|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0
4380276|NCT03605680|7158197|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0
4380277|NCT03605680|7158194|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1
4380278|NCT03605680|7158195|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0
4380279|NCT03605680|7158196|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0
4380280|NCT03605680|7158197|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0
4380281|NCT03605680|7158194|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6
4380282|NCT03605680|7158195|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0
4380283|NCT03605680|7158196|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0
4380284|NCT03605680|7158197|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0
4380285|NCT03605680|7158194|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87
4380286|NCT03605680|7158195|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0
4380287|NCT03605680|7158196|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0
4380288|NCT03605680|7158197|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0
4380289|NCT03605680|7158194|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0
4380290|NCT03605680|7158195|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5
4380291|NCT03605680|7158196|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7
4380292|NCT03605680|7158197|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8
4380293|NCT03605680|7158194|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0
4380294|NCT03605680|7158195|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8
4380295|NCT03605680|7158196|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8
4380296|NCT03605680|7158197|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3
4380297|NCT03605680|7158194|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0
4380298|NCT03605680|7158195|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0
4380299|NCT03605680|7158196|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0
4380300|NCT03605680|7158197|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1
4380301|NCT03605680|7158194|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0
4380302|NCT03605680|7158195|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3
4380303|NCT03605680|7158196|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4
4380304|NCT03605680|7158197|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3
4380305|NCT03605680|7158194|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0
4380306|NCT03605680|7158195|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3
4380307|NCT03605680|7158196|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1
4380308|NCT03605680|7158197|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2
4380309|NCT03605680|7158194|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0
4380310|NCT03605680|7158195|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14
4380311|NCT03605680|7158196|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7
4380312|NCT03605680|7158197|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5
4380313|NCT03605680|7158194|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0
4380314|NCT03605680|7158195|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4
4380315|NCT03605680|7158196|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4
4380316|NCT03605680|7158197|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7
4380317|NCT03605680|7158194|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0
4380318|NCT03605680|7158195|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1
4380319|NCT03605680|7158196|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2
4380320|NCT03605680|7158197|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0
4380321|NCT03605680|7158194|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0
4380322|NCT03605680|7158195|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5
4380323|NCT03605680|7158196|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4
4380324|NCT03605680|7158197|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3
4380325|NCT03605680|7158194|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0
4380326|NCT03605680|7158195|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1
4380327|NCT03605680|7158196|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2
4516372|NCT00959907|7327749|FG001|Overall Study|Adverse Event|0
4380328|NCT03605680|7158197|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3
4380329|NCT03485950|7158208|FG000|Overall Study|Adverse Event|1
4380330|NCT03485950|7158209|FG001|Overall Study|Adverse Event|0
4380331|NCT03485950|7158208|FG000|Overall Study|Death|3
4380332|NCT03485950|7158209|FG001|Overall Study|Death|2
4380333|NCT03485950|7158208|FG000|Overall Study|Withdrawal by Subject|3
4380334|NCT03485950|7158209|FG001|Overall Study|Withdrawal by Subject|0
4467734|NCT00623428|7259770|FG001|Treatment Period|Insufficient therapeutic response|2
4467735|NCT00623428|7259769|FG000|Treatment Period|Other|0
4467736|NCT00623428|7259770|FG001|Treatment Period|Other|1
4467737|NCT00623428|7259769|FG000|Treatment Period|Withdrawal by Subject|0
4467738|NCT00623428|7259770|FG001|Treatment Period|Withdrawal by Subject|1
4467739|NCT00623428|7259769|FG000|Follow-up Period|Relapse post-treatment|11
4467740|NCT00623428|7259770|FG001|Follow-up Period|Relapse post-treatment|3
4467741|NCT00623428|7259769|FG000|Follow-up Period|Failure to return|10
4467742|NCT00623428|7259770|FG001|Follow-up Period|Failure to return|2
4467743|NCT00623428|7259769|FG000|Follow-up Period|Patient withdrew consent|5
4467744|NCT00623428|7259770|FG001|Follow-up Period|Patient withdrew consent|4
4467745|NCT00623428|7259769|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2
4467746|NCT00623428|7259770|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1
4467747|NCT00623428|7259769|FG000|Follow-up Period|Did not cooperate|0
4467748|NCT00623428|7259770|FG001|Follow-up Period|Did not cooperate|3
4467749|NCT00623428|7259769|FG000|Follow-up Period|Reason not specified|1
4467750|NCT00623428|7259770|FG001|Follow-up Period|Reason not specified|1
4467751|NCT00623428|7259769|FG000|Follow-up Period|Death|0
4467752|NCT00623428|7259770|FG001|Follow-up Period|Death|1
4467753|NCT00623467|7259780|FG000|Overall Study|Lost to Follow-up|1
4467754|NCT00623467|7259780|FG000|Overall Study|Protocol Violation|4
4467755|NCT00623467|7259780|FG000|Overall Study|Withdrawal by Subject|2
4467756|NCT00623480|7259788|FG000|Overall Study|Lost to Follow-up|0
4467757|NCT00623480|7259789|FG001|Overall Study|Lost to Follow-up|1
4467758|NCT00623480|7259788|FG000|Overall Study|Withdrawal by Subject|2
4467759|NCT00623480|7259789|FG001|Overall Study|Withdrawal by Subject|4
4467760|NCT00623480|7259788|FG000|Overall Study|Lack of Efficacy|1
4467761|NCT00623480|7259789|FG001|Overall Study|Lack of Efficacy|0
4467762|NCT00623480|7259788|FG000|Overall Study|Non-compliant with study medication|4
4467763|NCT00623480|7259789|FG001|Overall Study|Non-compliant with study medication|0
4467764|NCT00623480|7259788|FG000|Overall Study|Protocol Violation|0
4467765|NCT00623480|7259789|FG001|Overall Study|Protocol Violation|1
4467766|NCT00623480|7259788|FG000|Overall Study|Site closed by sponsor|0
4467767|NCT00623480|7259789|FG001|Overall Study|Site closed by sponsor|1
4467768|NCT00623545|7259804|FG000|Overall Study|Adverse Event|6
4467769|NCT00623545|7259804|FG000|Overall Study|Withdrawal by Subject|4
4467770|NCT00623597|7259811|FG000|Overall Study|Failed to return|1
4467771|NCT00623597|7259812|FG001|Overall Study|Failed to return|0
4467772|NCT00623623|7259822|FG000|Overall Study|Previous enrolment into this study|1
4588124|NCT01497899|7432562|FG003|Open-Label Extension Phase|Adverse Event|0
4588125|NCT01497899|7432559|FG000|Open-Label Extension Phase|Death|1
4588126|NCT01497899|7432560|FG001|Open-Label Extension Phase|Death|0
4588127|NCT01497899|7432561|FG002|Open-Label Extension Phase|Death|0
4588128|NCT01497899|7432562|FG003|Open-Label Extension Phase|Death|0
4588129|NCT01497899|7432559|FG000|Open-Label Extension Phase|Withdrew Consent|8
4588130|NCT01497899|7432560|FG001|Open-Label Extension Phase|Withdrew Consent|3
4588131|NCT01497899|7432561|FG002|Open-Label Extension Phase|Withdrew Consent|2
4588132|NCT01497899|7432562|FG003|Open-Label Extension Phase|Withdrew Consent|0
4588133|NCT01497899|7432559|FG000|Open-Label Extension Phase|Pregnancy|0
4588134|NCT01497899|7432560|FG001|Open-Label Extension Phase|Pregnancy|1
4588135|NCT01497899|7432561|FG002|Open-Label Extension Phase|Pregnancy|1
4588136|NCT01497899|7432562|FG003|Open-Label Extension Phase|Pregnancy|0
4588137|NCT01497899|7432559|FG000|Open-Label Extension Phase|Protocol Violation|0
4467773|NCT00623623|7259823|FG001|Overall Study|Previous enrolment into this study|1
4467774|NCT00623727|7259848|FG000|Double Blind (DB)|Adverse Event|1
4467775|NCT00623727|7259849|FG001|Double Blind (DB)|Adverse Event|3
4588138|NCT01497899|7432560|FG001|Open-Label Extension Phase|Protocol Violation|0
4588139|NCT01497899|7432561|FG002|Open-Label Extension Phase|Protocol Violation|1
4588140|NCT01497899|7432562|FG003|Open-Label Extension Phase|Protocol Violation|0
4588141|NCT01497899|7432559|FG000|Open-Label Extension Phase|Lost to Follow-up|9
4588142|NCT01497899|7432560|FG001|Open-Label Extension Phase|Lost to Follow-up|3
4588143|NCT01497899|7432561|FG002|Open-Label Extension Phase|Lost to Follow-up|5
4588144|NCT01497899|7432562|FG003|Open-Label Extension Phase|Lost to Follow-up|5
4588145|NCT01497938|7432571|FG000|Overall Study|Adverse Event|0
4696182|NCT02634333|7608985|FG000|Overall Study|Withdrawal by Subject|9
4696183|NCT02634333|7608986|FG001|Overall Study|Withdrawal by Subject|13
4696184|NCT02634333|7608985|FG000|Overall Study|Death|11
4696185|NCT02634333|7608986|FG001|Overall Study|Death|8
4696186|NCT02634346|7608996|FG000|Overall Study|Withdrawal by Subject|8
4696187|NCT02634346|7608997|FG001|Overall Study|Withdrawal by Subject|9
4467776|NCT00623727|7259848|FG000|Double Blind (DB)|Physician Decision|0
4467777|NCT00623727|7259849|FG001|Double Blind (DB)|Physician Decision|1
4467778|NCT00623727|7259848|FG000|Double Blind (DB)|Withdrawal by Subject|8
4467779|NCT00623727|7259849|FG001|Double Blind (DB)|Withdrawal by Subject|2
4696188|NCT02634346|7608998|FG002|Overall Study|Withdrawal by Subject|8
4380335|NCT03404518|7158217|FG000|Overall Study|Lost to Follow-up|28
4380336|NCT03404518|7158218|FG001|Overall Study|Lost to Follow-up|30
4380337|NCT03404518|7158217|FG000|Overall Study|Protocol Violation|13
4380338|NCT03404518|7158218|FG001|Overall Study|Protocol Violation|6
4380339|NCT03402841|7158224|FG000|Overall Study|Withdrawal by Subject|4
4380340|NCT03402841|7158224|FG000|Overall Study|Lost to Follow-up|3
4380341|NCT03402841|7158224|FG000|Overall Study|Death|85
4380342|NCT03289143|7158252|FG000|Overall Study|Caregiver Unavailability|1
4380343|NCT03289143|7158253|FG001|Overall Study|Caregiver Unavailability|1
4380344|NCT03289143|7158254|FG002|Overall Study|Caregiver Unavailability|0
4380345|NCT03289143|7158255|FG003|Overall Study|Caregiver Unavailability|0
4380346|NCT03289143|7158252|FG000|Overall Study|Research Department Closure|0
4380347|NCT03289143|7158253|FG001|Overall Study|Research Department Closure|0
4380348|NCT03289143|7158254|FG002|Overall Study|Research Department Closure|1
4380349|NCT03289143|7158255|FG003|Overall Study|Research Department Closure|0
4380350|NCT03289143|7158252|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0
4380351|NCT03289143|7158253|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0
4380352|NCT03289143|7158254|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1
4380353|NCT03289143|7158255|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0
4380354|NCT03289143|7158252|FG000|Overall Study|Medical Monitor Decision|1
4380355|NCT03289143|7158253|FG001|Overall Study|Medical Monitor Decision|0
4380356|NCT03289143|7158254|FG002|Overall Study|Medical Monitor Decision|0
4380357|NCT03289143|7158255|FG003|Overall Study|Medical Monitor Decision|0
4380358|NCT03289143|7158252|FG000|Overall Study|Participant Non-Compliance|0
4380359|NCT03289143|7158253|FG001|Overall Study|Participant Non-Compliance|0
4380360|NCT03289143|7158254|FG002|Overall Study|Participant Non-Compliance|1
4380361|NCT03289143|7158255|FG003|Overall Study|Participant Non-Compliance|0
4380362|NCT03289143|7158252|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0
4380363|NCT03289143|7158253|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0
4380364|NCT03289143|7158254|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1
4380365|NCT03289143|7158255|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0
4380366|NCT03289143|7158252|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0
4380367|NCT03289143|7158253|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0
4467780|NCT00623727|7259848|FG000|Double Blind (DB)|Lack of Efficacy|2
4467781|NCT00623727|7259849|FG001|Double Blind (DB)|Lack of Efficacy|2
4588146|NCT01497938|7432572|FG001|Overall Study|Adverse Event|1
4588147|NCT01497938|7432571|FG000|Overall Study|Physician Decision|0
4588148|NCT01497938|7432572|FG001|Overall Study|Physician Decision|1
4588149|NCT01497938|7432571|FG000|Overall Study|Withdrawal by Subject|4
4588150|NCT01497938|7432572|FG001|Overall Study|Withdrawal by Subject|0
4588151|NCT01497938|7432571|FG000|Overall Study|Device Violation|1
4588152|NCT01497938|7432572|FG001|Overall Study|Device Violation|0
4588153|NCT01498068|7432580|FG000|Overall Study|Withdrawal by Subject|1
4588154|NCT01498068|7432581|FG001|Overall Study|Withdrawal by Subject|1
4588155|NCT01498120|7432587|FG000|Overall Study|Lost to Follow-up|1
4588156|NCT01498120|7432587|FG000|Overall Study|Withdrawal by Subject|5
4588157|NCT01498120|7432587|FG000|Overall Study|AE, non-serious non-fatal|3
4467782|NCT00623727|7259848|FG000|Double Blind (DB)|Termination of the double-blind period|22
4467783|NCT00623727|7259849|FG001|Double Blind (DB)|Termination of the double-blind period|21
4467784|NCT00623727|7259848|FG000|Double Blind (DB)|Lost to Follow-up|1
4467785|NCT00623727|7259849|FG001|Double Blind (DB)|Lost to Follow-up|1
4467786|NCT00623727|7259848|FG000|Double Blind (DB)|Protocol Violation|2
4467787|NCT00623727|7259849|FG001|Double Blind (DB)|Protocol Violation|2
4467788|NCT00623727|7259848|FG000|Open Label Follow-up|Withdrawal by Subject|0
4467789|NCT00623727|7259849|FG001|Open Label Follow-up|Withdrawal by Subject|1
4467790|NCT00623727|7259848|FG000|Open Label Follow-up|Study termination|0
4467791|NCT00623727|7259849|FG001|Open Label Follow-up|Study termination|6
4467792|NCT00623727|7259848|FG000|Open Label Follow-up|Participant convenience|0
4467793|NCT00623727|7259849|FG001|Open Label Follow-up|Participant convenience|1
4467794|NCT00623766|7259859|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36
4467795|NCT00623766|7259860|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16
4467796|NCT00623766|7259859|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4
4467797|NCT00623766|7259860|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0
4467798|NCT00623766|7259859|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4
4467799|NCT00623766|7259860|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0
4467800|NCT00623766|7259859|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1
4467801|NCT00623766|7259860|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2
4467802|NCT00623766|7259859|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1
4467803|NCT00623766|7259860|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0
4467804|NCT00623779|7259873|FG000|Overall Study|Adverse Event|1
4467805|NCT00623779|7259874|FG001|Overall Study|Adverse Event|3
4467806|NCT00623779|7259875|FG002|Overall Study|Adverse Event|0
4467807|NCT00623779|7259873|FG000|Overall Study|Criteria from CSR|2
4467808|NCT00623779|7259874|FG001|Overall Study|Criteria from CSR|0
4467809|NCT00623779|7259875|FG002|Overall Study|Criteria from CSR|1
4588158|NCT01498120|7432587|FG000|Overall Study|Other|4
4588159|NCT01498185|7432596|FG000|Overall Study|Adverse Event|0
4588160|NCT01498185|7432597|FG001|Overall Study|Adverse Event|0
4380368|NCT03289143|7158254|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1
4380369|NCT03289143|7158255|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0
4380370|NCT03289143|7158252|FG000|Overall Study|Caregiver Passed Away|1
4380371|NCT03289143|7158253|FG001|Overall Study|Caregiver Passed Away|0
4380372|NCT03289143|7158254|FG002|Overall Study|Caregiver Passed Away|0
4380373|NCT03289143|7158255|FG003|Overall Study|Caregiver Passed Away|0
4380374|NCT03289143|7158252|FG000|Overall Study|Physician Decision|0
4380375|NCT03289143|7158253|FG001|Overall Study|Physician Decision|2
4380376|NCT03289143|7158254|FG002|Overall Study|Physician Decision|2
4380377|NCT03289143|7158255|FG003|Overall Study|Physician Decision|2
4380378|NCT03289143|7158252|FG000|Overall Study|Protocol Deviation|2
4380379|NCT03289143|7158253|FG001|Overall Study|Protocol Deviation|1
4380380|NCT03289143|7158254|FG002|Overall Study|Protocol Deviation|3
4380381|NCT03289143|7158255|FG003|Overall Study|Protocol Deviation|1
4380382|NCT03289143|7158252|FG000|Overall Study|Study Terminated By Sponsor|101
4380383|NCT03289143|7158253|FG001|Overall Study|Study Terminated By Sponsor|75
4380384|NCT03289143|7158254|FG002|Overall Study|Study Terminated By Sponsor|100
4380385|NCT03289143|7158255|FG003|Overall Study|Study Terminated By Sponsor|69
4380386|NCT03289143|7158252|FG000|Overall Study|Withdrawal by Subject|14
4380387|NCT03289143|7158253|FG001|Overall Study|Withdrawal by Subject|6
4380388|NCT03289143|7158254|FG002|Overall Study|Withdrawal by Subject|14
4380389|NCT03289143|7158255|FG003|Overall Study|Withdrawal by Subject|12
4380390|NCT03289143|7158252|FG000|Overall Study|Adverse Event|10
4380391|NCT03289143|7158253|FG001|Overall Study|Adverse Event|7
4380392|NCT03289143|7158254|FG002|Overall Study|Adverse Event|6
4380393|NCT03289143|7158255|FG003|Overall Study|Adverse Event|5
4380394|NCT03289143|7158252|FG000|Overall Study|Death|2
4380395|NCT03289143|7158253|FG001|Overall Study|Death|0
4380396|NCT03289143|7158254|FG002|Overall Study|Death|2
4380397|NCT03289143|7158255|FG003|Overall Study|Death|1
4380398|NCT03289143|7158252|FG000|Overall Study|Lost to Follow-up|2
4380399|NCT03289143|7158253|FG001|Overall Study|Lost to Follow-up|1
4380400|NCT03289143|7158254|FG002|Overall Study|Lost to Follow-up|1
4380401|NCT03289143|7158255|FG003|Overall Study|Lost to Follow-up|0
4380402|NCT03289143|7158252|FG000|Overall Study|Participant No Longer Has Study Partner|0
4380403|NCT03289143|7158253|FG001|Overall Study|Participant No Longer Has Study Partner|0
4380404|NCT03289143|7158254|FG002|Overall Study|Participant No Longer Has Study Partner|0
4380405|NCT03289143|7158255|FG003|Overall Study|Participant No Longer Has Study Partner|1
4380406|NCT03289143|7158252|FG000|Overall Study|Withdrawal by Caregiver|0
4380407|NCT03289143|7158253|FG001|Overall Study|Withdrawal by Caregiver|1
4380408|NCT03289143|7158254|FG002|Overall Study|Withdrawal by Caregiver|0
4380409|NCT03289143|7158255|FG003|Overall Study|Withdrawal by Caregiver|0
4380410|NCT03289143|7158252|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0
4380411|NCT03289143|7158253|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0
4380412|NCT03289143|7158254|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1
4380413|NCT03289143|7158255|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0
4380414|NCT03289143|7158252|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0
4380415|NCT03289143|7158253|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0
4380416|NCT03289143|7158254|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0
4380417|NCT03289143|7158255|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1
4380418|NCT03156504|7158270|FG000|Overall Study|Withdrawal by Subject|1
4771156|NCT00822120|7747991|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1
4771157|NCT00822120|7747992|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0
4771158|NCT00822120|7747993|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0
4771159|NCT00822120|7747994|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0
4771160|NCT00822120|7747995|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0
4771161|NCT00822120|7747996|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0
4771162|NCT00822120|7747991|FG000|Initial Registration|Reasons not Protocol Specified|2
4771163|NCT00822120|7747992|FG001|Initial Registration|Reasons not Protocol Specified|0
4771164|NCT00822120|7747993|FG002|Initial Registration|Reasons not Protocol Specified|0
4771165|NCT00822120|7747994|FG003|Initial Registration|Reasons not Protocol Specified|0
4771166|NCT00822120|7747995|FG004|Initial Registration|Reasons not Protocol Specified|0
4380433|NCT03006926|7158285|FG000|Overall Study|Death|0
4380434|NCT03006926|7158286|FG001|Overall Study|Death|33
4380435|NCT03006926|7158285|FG000|Overall Study|Ongoing Survival Follow-up|0
4380436|NCT03006926|7158286|FG001|Overall Study|Ongoing Survival Follow-up|26
4380437|NCT03006926|7158285|FG000|Overall Study|Ongoing-on Treatment|0
4380438|NCT03006926|7158286|FG001|Overall Study|Ongoing-on Treatment|36
4467810|NCT00623805|7259885|FG000|Overall Study|Adverse Event|9
4467811|NCT00623805|7259886|FG001|Overall Study|Adverse Event|6
4380439|NCT03006926|7158285|FG000|Overall Study|Lost to Follow-up|0
4380440|NCT03006926|7158286|FG001|Overall Study|Lost to Follow-up|1
4380441|NCT03006926|7158285|FG000|Overall Study|Withdrawal by Subject|0
4380442|NCT03006926|7158286|FG001|Overall Study|Withdrawal by Subject|2
4380443|NCT02993926|7158294|FG000|Enantone Treatment Phase|Adverse Event|1
4380444|NCT02993926|7158295|FG001|Enantone Treatment Phase|Adverse Event|0
4380445|NCT02993926|7158296|FG002|Enantone Treatment Phase|Adverse Event|0
4380446|NCT02993926|7158294|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26
4380447|NCT02993926|7158295|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0
4588161|NCT01498185|7432598|FG002|Overall Study|Adverse Event|0
4588162|NCT01498185|7432599|FG003|Overall Study|Adverse Event|1
4588163|NCT01498185|7432600|FG004|Overall Study|Adverse Event|0
4588164|NCT01498185|7432596|FG000|Overall Study|Withdrawal by Subject|1
4588165|NCT01498185|7432597|FG001|Overall Study|Withdrawal by Subject|1
4588166|NCT01498185|7432598|FG002|Overall Study|Withdrawal by Subject|0
4588167|NCT01498185|7432599|FG003|Overall Study|Withdrawal by Subject|2
4588168|NCT01498185|7432600|FG004|Overall Study|Withdrawal by Subject|1
4588169|NCT01498185|7432596|FG000|Overall Study|No longer met criteria, etc|0
4588170|NCT01498185|7432597|FG001|Overall Study|No longer met criteria, etc|0
4588171|NCT01498185|7432598|FG002|Overall Study|No longer met criteria, etc|0
4588172|NCT01498185|7432599|FG003|Overall Study|No longer met criteria, etc|0
4588173|NCT01498185|7432600|FG004|Overall Study|No longer met criteria, etc|2
4588174|NCT01498289|7432618|FG000|Overall Study|Adverse Event|16
4588175|NCT01498289|7432619|FG001|Overall Study|Adverse Event|18
4588176|NCT01498289|7432618|FG000|Overall Study|Death|6
4588177|NCT01498289|7432619|FG001|Overall Study|Death|8
4588178|NCT01498289|7432618|FG000|Overall Study|Withdrawal unrelated to AE|16
4588179|NCT01498289|7432619|FG001|Overall Study|Withdrawal unrelated to AE|16
4588180|NCT01498289|7432618|FG000|Overall Study|Progression/relapse|53
4588181|NCT01498289|7432619|FG001|Overall Study|Progression/relapse|59
4588182|NCT01498289|7432618|FG000|Overall Study|Not protocol specified|7
4588183|NCT01498289|7432619|FG001|Overall Study|Not protocol specified|2
4588184|NCT01498289|7432618|FG000|Overall Study|Reason under review|0
4588185|NCT01498289|7432619|FG001|Overall Study|Reason under review|1
4588186|NCT01498445|7432652|FG000|Overall Study|Lack of Efficacy|0
4588187|NCT01498445|7432653|FG001|Overall Study|Lack of Efficacy|0
4588188|NCT01498445|7432654|FG002|Overall Study|Lack of Efficacy|1
4588189|NCT01498445|7432655|FG003|Overall Study|Lack of Efficacy|2
4588190|NCT01498445|7432656|FG004|Overall Study|Lack of Efficacy|0
4588191|NCT01498445|7432657|FG005|Overall Study|Lack of Efficacy|0
4588192|NCT01498445|7432652|FG000|Overall Study|Screen Failure|0
4588193|NCT01498445|7432653|FG001|Overall Study|Screen Failure|0
4588194|NCT01498445|7432654|FG002|Overall Study|Screen Failure|0
4588195|NCT01498445|7432655|FG003|Overall Study|Screen Failure|0
4588196|NCT01498445|7432656|FG004|Overall Study|Screen Failure|1
4588197|NCT01498445|7432657|FG005|Overall Study|Screen Failure|1
4588198|NCT01498458|7432671|FG000|Overall Study|Adverse Event|4
4588199|NCT01498458|7432671|FG000|Overall Study|Physician Decision|3
4588200|NCT01498575|7432691|FG000|Overall Sample|Withdrawal by Subject|60
4588201|NCT01498575|7432692|FG001|Overall Sample|Withdrawal by Subject|14
4588202|NCT01498575|7432691|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19
4588203|NCT01498575|7432692|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6
4588204|NCT01498575|7432691|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23
4588205|NCT01498575|7432692|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18
4588206|NCT01498640|7432711|FG000|Overall Study|Lost to Follow-up|1
4588207|NCT01498640|7432711|FG000|Overall Study|Death|1
4588208|NCT01498640|7432711|FG000|Overall Study|Other|3
4588209|NCT01498653|7432721|FG000|Overall Study|Adverse Event|2
4588210|NCT01498653|7432722|FG001|Overall Study|Adverse Event|2
4588211|NCT01498653|7432721|FG000|Overall Study|Lack of Efficacy|12
4588212|NCT01498653|7432722|FG001|Overall Study|Lack of Efficacy|26
4588213|NCT01498653|7432721|FG000|Overall Study|Protocol Violation|0
4588214|NCT01498653|7432722|FG001|Overall Study|Protocol Violation|4
4588215|NCT01498653|7432721|FG000|Overall Study|Lost to Follow-up|1
4588216|NCT01498653|7432722|FG001|Overall Study|Lost to Follow-up|0
4588217|NCT01498653|7432721|FG000|Overall Study|Physician Decision|2
4588218|NCT01498653|7432722|FG001|Overall Study|Physician Decision|0
4588219|NCT01498653|7432721|FG000|Overall Study|Withdrawal by Subject|2
4588220|NCT01498653|7432722|FG001|Overall Study|Withdrawal by Subject|3
4588221|NCT01498679|7432730|FG000|Overall Study|Adverse Event|1
4588222|NCT01498679|7432731|FG001|Overall Study|Adverse Event|4
4588223|NCT01498679|7432730|FG000|Overall Study|Lack of Efficacy|72
4588224|NCT01498679|7432731|FG001|Overall Study|Lack of Efficacy|12
4588225|NCT01498679|7432730|FG000|Overall Study|Protocol Violation|4
4696189|NCT02634346|7608996|FG000|Overall Study|Adverse Event|2
4696190|NCT02634346|7608997|FG001|Overall Study|Adverse Event|2
4696191|NCT02634346|7608998|FG002|Overall Study|Adverse Event|7
4696192|NCT02634346|7608996|FG000|Overall Study|Lack of Efficacy|1
4696193|NCT02634346|7608997|FG001|Overall Study|Lack of Efficacy|2
4696194|NCT02634346|7608998|FG002|Overall Study|Lack of Efficacy|8
4696195|NCT02634346|7608996|FG000|Overall Study|Lost to Follow-up|1
4696196|NCT02634346|7608997|FG001|Overall Study|Lost to Follow-up|0
4696197|NCT02634346|7608998|FG002|Overall Study|Lost to Follow-up|0
4696198|NCT02634346|7608996|FG000|Overall Study|Protocol Violation|0
4588226|NCT01498679|7432731|FG001|Overall Study|Protocol Violation|0
4588227|NCT01498679|7432730|FG000|Overall Study|Physician Decision|0
4588228|NCT01498679|7432731|FG001|Overall Study|Physician Decision|2
4588229|NCT01498679|7432730|FG000|Overall Study|Withdrawal by Subject|12
4588230|NCT01498679|7432731|FG001|Overall Study|Withdrawal by Subject|4
4588231|NCT01498692|7432737|FG000|Overall Study|Death|4
4696199|NCT02634346|7608997|FG001|Overall Study|Protocol Violation|1
4696200|NCT02634346|7608998|FG002|Overall Study|Protocol Violation|0
4696201|NCT02634580|7609010|FG000|Double-blind Treatment Period|Subject Request|1
4588232|NCT01498692|7432737|FG000|Overall Study|Withdrawal by Subject|1
4588233|NCT01498692|7432737|FG000|Overall Study|Missed 12-month visit|3
4588234|NCT01498822|7432752|FG000|Overall Study|Protocol Violation|8
4588235|NCT01498822|7432753|FG001|Overall Study|Protocol Violation|4
4588236|NCT01498822|7432752|FG000|Overall Study|Other Reason|5
4588237|NCT01498822|7432753|FG001|Overall Study|Other Reason|2
4588238|NCT01498822|7432752|FG000|Overall Study|Lack of Efficacy|7
4588239|NCT01498822|7432753|FG001|Overall Study|Lack of Efficacy|2
4588240|NCT01498822|7432752|FG000|Overall Study|AE, non-serious non-fatal|8
4588241|NCT01498822|7432753|FG001|Overall Study|AE, non-serious non-fatal|17
4588242|NCT01498822|7432752|FG000|Overall Study|SAE, non-fatal|2
4588243|NCT01498822|7432753|FG001|Overall Study|SAE, non-fatal|2
4588244|NCT01498822|7432752|FG000|Overall Study|Adverse Event, serious fatal|1
4588245|NCT01498822|7432753|FG001|Overall Study|Adverse Event, serious fatal|1
4588246|NCT01498822|7432752|FG000|Overall Study|Withdrawal by Subject|15
4588247|NCT01498822|7432753|FG001|Overall Study|Withdrawal by Subject|25
4588248|NCT01498822|7432752|FG000|Overall Study|Lost to Follow-up|8
4588249|NCT01498822|7432753|FG001|Overall Study|Lost to Follow-up|3
4588250|NCT01498887|7432763|FG000|Overall Study|Administrative problems|1
4588251|NCT01498887|7432764|FG001|Overall Study|Administrative problems|0
4588252|NCT01498887|7432763|FG000|Overall Study|Lost to Follow-up|1
4588253|NCT01498887|7432764|FG001|Overall Study|Lost to Follow-up|1
4588254|NCT01498887|7432763|FG000|Overall Study|Withdrawal by Subject|1
4588255|NCT01498887|7432764|FG001|Overall Study|Withdrawal by Subject|0
4588256|NCT01498887|7432763|FG000|Overall Study|Protocol Violation|1
4588257|NCT01498887|7432764|FG001|Overall Study|Protocol Violation|3
4588258|NCT01498887|7432763|FG000|Overall Study|Lack of Efficacy|5
4588259|NCT01498887|7432764|FG001|Overall Study|Lack of Efficacy|3
4588260|NCT01498887|7432763|FG000|Overall Study|Abnormal result from test procedure|1
4588261|NCT01498887|7432764|FG001|Overall Study|Abnormal result from test procedure|1
4588262|NCT01498887|7432763|FG000|Overall Study|Abnormal laboratory value|2
4588263|NCT01498887|7432764|FG001|Overall Study|Abnormal laboratory value|2
4588264|NCT01498887|7432763|FG000|Overall Study|Adverse Event|4
4588265|NCT01498887|7432764|FG001|Overall Study|Adverse Event|1
4588266|NCT01498952|7432773|FG000|Overall Study|Death|2
4588267|NCT01498952|7432774|FG001|Overall Study|Death|2
4588268|NCT01498952|7432775|FG002|Overall Study|Death|0
4588269|NCT01498952|7432776|FG003|Overall Study|Death|0
4588270|NCT01498952|7432777|FG004|Overall Study|Death|0
4588271|NCT01499043|7432796|FG000|Overall Study|Progressive disease (radiographic)|2
4588272|NCT01499043|7432796|FG000|Overall Study|Progressive disease (clinical)|1
4588273|NCT01499043|7432796|FG000|Overall Study|Withdrawal by Subject|2
4588274|NCT01499043|7432796|FG000|Overall Study|Adverse Event|1
4588275|NCT01499134|7432807|FG000|Overall Study|Withdrawal by Subject|0
4588276|NCT01499134|7432808|FG001|Overall Study|Withdrawal by Subject|1
4588277|NCT01499199|7432832|FG000|Overall Study|Adverse Event|1
4588278|NCT01499199|7432832|FG000|Overall Study|Lack of Efficacy|1
4380448|NCT02993926|7158296|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0
4380449|NCT02993926|7158294|FG000|Enantone Treatment Phase|Investigator Judgment|1
4380450|NCT02993926|7158295|FG001|Enantone Treatment Phase|Investigator Judgment|0
4380451|NCT02993926|7158296|FG002|Enantone Treatment Phase|Investigator Judgment|0
4380452|NCT02993926|7158294|FG000|Enantone Treatment Phase|Reason Not Specified|4
4380453|NCT02993926|7158295|FG001|Enantone Treatment Phase|Reason Not Specified|0
4380454|NCT02993926|7158296|FG002|Enantone Treatment Phase|Reason Not Specified|0
4380455|NCT02932579|7158308|FG000|Overall Study|Withdrawal by Subject|4
4380456|NCT02932579|7158309|FG001|Overall Study|Withdrawal by Subject|1
4380457|NCT02928224|7158319|FG000|Overall Study|Randomized, Not Treated|0
4380458|NCT02928224|7158320|FG001|Overall Study|Randomized, Not Treated|2
4380459|NCT02928224|7158321|FG002|Overall Study|Randomized, Not Treated|4
4380460|NCT02928224|7158322|FG003|Overall Study|Randomized, Not Treated|28
4380461|NCT02928224|7158319|FG000|Overall Study|Treatment Ongoing|6
4380462|NCT02928224|7158320|FG001|Overall Study|Treatment Ongoing|78
4380463|NCT02928224|7158321|FG002|Overall Study|Treatment Ongoing|78
4380464|NCT02928224|7158322|FG003|Overall Study|Treatment Ongoing|37
4380465|NCT02928224|7158319|FG000|Overall Study|Progressive Disease|23
4380466|NCT02928224|7158320|FG001|Overall Study|Progressive Disease|104
4380467|NCT02928224|7158321|FG002|Overall Study|Progressive Disease|101
4380468|NCT02928224|7158322|FG003|Overall Study|Progressive Disease|103
4588279|NCT01499277|7432838|FG000|Overall Study|Adverse Event|3
4588280|NCT01499277|7432839|FG001|Overall Study|Adverse Event|6
4588281|NCT01499277|7432838|FG000|Overall Study|Death|3
4588282|NCT01499277|7432839|FG001|Overall Study|Death|2
4588283|NCT01499277|7432838|FG000|Overall Study|Lost to Follow-up|15
4380469|NCT02928224|7158319|FG000|Overall Study|Adverse Event|2
4380470|NCT02928224|7158320|FG001|Overall Study|Adverse Event|11
4380471|NCT02928224|7158321|FG002|Overall Study|Adverse Event|11
4380472|NCT02928224|7158322|FG003|Overall Study|Adverse Event|10
4588284|NCT01499277|7432839|FG001|Overall Study|Lost to Follow-up|8
4588285|NCT01499277|7432838|FG000|Overall Study|Protocol Violation|2
4588286|NCT01499277|7432839|FG001|Overall Study|Protocol Violation|3
4588287|NCT01499277|7432838|FG000|Overall Study|Withdrawal by Subject|16
4588288|NCT01499277|7432839|FG001|Overall Study|Withdrawal by Subject|6
4588289|NCT01499277|7432838|FG000|Overall Study|Lack of therapeutic response and other|8
4588290|NCT01499277|7432839|FG001|Overall Study|Lack of therapeutic response and other|7
4380473|NCT02928224|7158319|FG000|Overall Study|Changes in Patient's Condition|3
4380474|NCT02928224|7158320|FG001|Overall Study|Changes in Patient's Condition|9
4380475|NCT02928224|7158321|FG002|Overall Study|Changes in Patient's Condition|9
4380476|NCT02928224|7158322|FG003|Overall Study|Changes in Patient's Condition|13
4380477|NCT02928224|7158319|FG000|Overall Study|Death|1
4380478|NCT02928224|7158320|FG001|Overall Study|Death|7
4380479|NCT02928224|7158321|FG002|Overall Study|Death|5
4380480|NCT02928224|7158322|FG003|Overall Study|Death|11
4380481|NCT02928224|7158319|FG000|Overall Study|Withdrawal by Subject|1
4380482|NCT02928224|7158320|FG001|Overall Study|Withdrawal by Subject|4
4380483|NCT02928224|7158321|FG002|Overall Study|Withdrawal by Subject|3
4380484|NCT02928224|7158322|FG003|Overall Study|Withdrawal by Subject|9
4380485|NCT02928224|7158319|FG000|Overall Study|Dose Interruptions>28|1
4380486|NCT02928224|7158320|FG001|Overall Study|Dose Interruptions>28|2
4380487|NCT02928224|7158321|FG002|Overall Study|Dose Interruptions>28|2
4380488|NCT02928224|7158322|FG003|Overall Study|Dose Interruptions>28|4
4380489|NCT02928224|7158319|FG000|Overall Study|Patient Decision to Discontinue Drug|0
4380490|NCT02928224|7158320|FG001|Overall Study|Patient Decision to Discontinue Drug|2
4380491|NCT02928224|7158321|FG002|Overall Study|Patient Decision to Discontinue Drug|2
4380492|NCT02928224|7158322|FG003|Overall Study|Patient Decision to Discontinue Drug|4
4380493|NCT02928224|7158319|FG000|Overall Study|Physician Decision|0
4380494|NCT02928224|7158320|FG001|Overall Study|Physician Decision|2
4380495|NCT02928224|7158321|FG002|Overall Study|Physician Decision|4
4380496|NCT02928224|7158322|FG003|Overall Study|Physician Decision|2
4380497|NCT02928224|7158319|FG000|Overall Study|not listed|0
4467812|NCT00623805|7259885|FG000|Overall Study|Death|2
4467813|NCT00623805|7259886|FG001|Overall Study|Death|0
4467814|NCT00623805|7259885|FG000|Overall Study|Lack of Efficacy|3
4467815|NCT00623805|7259886|FG001|Overall Study|Lack of Efficacy|7
4467816|NCT00623805|7259885|FG000|Overall Study|Lost to Follow-up|2
4467817|NCT00623805|7259886|FG001|Overall Study|Lost to Follow-up|2
4467818|NCT00623805|7259885|FG000|Overall Study|Protocol Violation|1
4467819|NCT00623805|7259886|FG001|Overall Study|Protocol Violation|1
4588291|NCT01499290|7432847|FG000|Overall Study|Withdrawal by Subject|22
4588292|NCT01499290|7432848|FG001|Overall Study|Withdrawal by Subject|15
4588293|NCT01499290|7432847|FG000|Overall Study|Not specified in study report|11
4696202|NCT02634580|7609011|FG001|Double-blind Treatment Period|Subject Request|0
4467820|NCT00623805|7259885|FG000|Overall Study|Reason not Specified|3
4467821|NCT00623805|7259886|FG001|Overall Study|Reason not Specified|6
4467822|NCT00623831|7259894|FG000|Overall Study|Withdrawal by Subject|1
4467823|NCT00623831|7259895|FG001|Overall Study|Withdrawal by Subject|0
4467824|NCT00623831|7259894|FG000|Overall Study|Progressive Disease|0
4467825|NCT00623831|7259895|FG001|Overall Study|Progressive Disease|1
4467826|NCT00623935|7259904|FG000|Overall Study|Death|1
4467827|NCT00623935|7259904|FG000|Overall Study|Patient Declined Transplant|1
4467828|NCT00624052|7259923|FG000|Overall Study|Adverse Event|7
4467829|NCT00624052|7259924|FG001|Overall Study|Adverse Event|6
4467830|NCT00624052|7259925|FG002|Overall Study|Adverse Event|0
4467831|NCT00624052|7259926|FG003|Overall Study|Adverse Event|3
4467832|NCT00624052|7259923|FG000|Overall Study|Lack of Efficacy|1
4467833|NCT00624052|7259924|FG001|Overall Study|Lack of Efficacy|1
4467834|NCT00624052|7259925|FG002|Overall Study|Lack of Efficacy|0
4467835|NCT00624052|7259926|FG003|Overall Study|Lack of Efficacy|0
4467836|NCT00624052|7259923|FG000|Overall Study|Lost to Follow-up|2
4467837|NCT00624052|7259924|FG001|Overall Study|Lost to Follow-up|3
4467838|NCT00624052|7259925|FG002|Overall Study|Lost to Follow-up|1
4467839|NCT00624052|7259926|FG003|Overall Study|Lost to Follow-up|0
4467840|NCT00624052|7259923|FG000|Overall Study|Non compliant with the protocol|2
4696203|NCT02634580|7609012|FG002|Double-blind Treatment Period|Subject Request|1
4696204|NCT02634580|7609013|FG003|Double-blind Treatment Period|Subject Request|1
4696205|NCT02634580|7609010|FG000|Open-label Extension Period|Withdrawal by Subject|0
4696206|NCT02634580|7609011|FG001|Open-label Extension Period|Withdrawal by Subject|1
4696207|NCT02634580|7609012|FG002|Open-label Extension Period|Withdrawal by Subject|0
4696208|NCT02634580|7609013|FG003|Open-label Extension Period|Withdrawal by Subject|1
4696209|NCT02634788|7609043|FG000|Overall Study|Adverse Event|0
4696210|NCT02634788|7609044|FG001|Overall Study|Adverse Event|8
4696211|NCT02634788|7609045|FG002|Overall Study|Adverse Event|3
4696212|NCT02634788|7609046|FG003|Overall Study|Adverse Event|1
4696213|NCT02634788|7609043|FG000|Overall Study|Lack of Efficacy|4
4696214|NCT02634788|7609044|FG001|Overall Study|Lack of Efficacy|0
4467841|NCT00624052|7259924|FG001|Overall Study|Non compliant with the protocol|1
4467842|NCT00624052|7259925|FG002|Overall Study|Non compliant with the protocol|1
4467843|NCT00624052|7259926|FG003|Overall Study|Non compliant with the protocol|1
4467844|NCT00624052|7259923|FG000|Overall Study|Consent withdrawn|3
4467845|NCT00624052|7259924|FG001|Overall Study|Consent withdrawn|1
4467846|NCT00624052|7259925|FG002|Overall Study|Consent withdrawn|1
4467847|NCT00624052|7259926|FG003|Overall Study|Consent withdrawn|0
4467848|NCT00624052|7259923|FG000|Overall Study|Changed job/ran out if meds|0
4588294|NCT01499290|7432848|FG001|Overall Study|Not specified in study report|5
4696215|NCT02634788|7609045|FG002|Overall Study|Lack of Efficacy|1
4696216|NCT02634788|7609046|FG003|Overall Study|Lack of Efficacy|4
4467849|NCT00624052|7259924|FG001|Overall Study|Changed job/ran out if meds|2
4467850|NCT00624052|7259925|FG002|Overall Study|Changed job/ran out if meds|0
4380498|NCT02928224|7158320|FG001|Overall Study|not listed|3
4380499|NCT02928224|7158321|FG002|Overall Study|not listed|1
4380500|NCT02928224|7158322|FG003|Overall Study|not listed|0
4467851|NCT00624052|7259926|FG003|Overall Study|Changed job/ran out if meds|0
4467852|NCT00624065|7259942|FG000|Overall Study|Adverse Event|5
4467853|NCT00624065|7259943|FG001|Overall Study|Adverse Event|6
4467854|NCT00624065|7259942|FG000|Overall Study|Lost to Follow-up|4
4467855|NCT00624065|7259943|FG001|Overall Study|Lost to Follow-up|1
4467856|NCT00624065|7259942|FG000|Overall Study|Consent withdrawn|6
4467857|NCT00624065|7259943|FG001|Overall Study|Consent withdrawn|5
4467858|NCT00624065|7259942|FG000|Overall Study|Lack of Efficacy|0
4467859|NCT00624065|7259943|FG001|Overall Study|Lack of Efficacy|3
4467860|NCT00624065|7259942|FG000|Overall Study|Met protocol-defined stopping criteria|4
4467861|NCT00624065|7259943|FG001|Overall Study|Met protocol-defined stopping criteria|9
4467862|NCT00624286|7259994|FG000|Overall Study|Protocol Deviation|7
4467863|NCT00624286|7259995|FG001|Overall Study|Protocol Deviation|9
4467864|NCT00624286|7259994|FG000|Overall Study|Adverse Event|6
4467865|NCT00624286|7259995|FG001|Overall Study|Adverse Event|3
4467866|NCT00624286|7259994|FG000|Overall Study|Withdrawal by Subject|5
4467867|NCT00624286|7259995|FG001|Overall Study|Withdrawal by Subject|4
4467868|NCT00624286|7259994|FG000|Overall Study|Lost to Follow-up|3
4467869|NCT00624286|7259995|FG001|Overall Study|Lost to Follow-up|2
4467870|NCT00624286|7259994|FG000|Overall Study|Administrative problems|3
4467871|NCT00624286|7259995|FG001|Overall Study|Administrative problems|0
4467872|NCT00624286|7259994|FG000|Overall Study|Lack of Efficacy|1
4467873|NCT00624286|7259995|FG001|Overall Study|Lack of Efficacy|6
4467874|NCT00624286|7259994|FG000|Overall Study|Not stated|0
4467875|NCT00624286|7259995|FG001|Overall Study|Not stated|1
4467876|NCT00624286|7259994|FG000|Overall Study|Abnormal test procedure result(s)|0
4467877|NCT00624286|7259995|FG001|Overall Study|Abnormal test procedure result(s)|1
4467878|NCT00624286|7259994|FG000|Overall Study|Death|0
4467879|NCT00624286|7259995|FG001|Overall Study|Death|1
4467880|NCT00624338|7260004|FG000|Overall Study|Adverse Event|14
4467881|NCT00624338|7260005|FG001|Overall Study|Adverse Event|14
4467882|NCT00624338|7260006|FG002|Overall Study|Adverse Event|18
4467883|NCT00624338|7260004|FG000|Overall Study|Lost to Follow-up|1
4467884|NCT00624338|7260005|FG001|Overall Study|Lost to Follow-up|0
4467885|NCT00624338|7260006|FG002|Overall Study|Lost to Follow-up|0
4467886|NCT00624338|7260004|FG000|Overall Study|Lack of Efficacy|11
4467887|NCT00624338|7260005|FG001|Overall Study|Lack of Efficacy|3
4467888|NCT00624338|7260006|FG002|Overall Study|Lack of Efficacy|14
4467889|NCT00624338|7260004|FG000|Overall Study|Protocol Violation|3
4467890|NCT00624338|7260005|FG001|Overall Study|Protocol Violation|3
4467891|NCT00624338|7260006|FG002|Overall Study|Protocol Violation|2
4467892|NCT00624338|7260004|FG000|Overall Study|Death|0
4467893|NCT00624338|7260005|FG001|Overall Study|Death|2
4467894|NCT00624338|7260006|FG002|Overall Study|Death|0
4467895|NCT00624338|7260004|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1
4467896|NCT00624338|7260005|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0
4467897|NCT00624338|7260006|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0
4467898|NCT00624338|7260004|FG000|Overall Study|Termination of 150 mg group by Sponsor|0
4467899|NCT00624338|7260005|FG001|Overall Study|Termination of 150 mg group by Sponsor|55
4467900|NCT00624338|7260006|FG002|Overall Study|Termination of 150 mg group by Sponsor|0
4467901|NCT00624338|7260004|FG000|Overall Study|Other|15
4467902|NCT00624338|7260005|FG001|Overall Study|Other|5
4467903|NCT00624338|7260006|FG002|Overall Study|Other|9
4467904|NCT00624338|7260004|FG000|Overall Study|Randomized but not treated|2
4467905|NCT00624338|7260005|FG001|Overall Study|Randomized but not treated|1
4467906|NCT00624338|7260006|FG002|Overall Study|Randomized but not treated|3
4467907|NCT00624377|7260014|FG000|Overall Study|Lost to Follow-up|355
4467908|NCT00624377|7260014|FG000|Overall Study|Withdrawal by Subject|100
4467909|NCT00624377|7260014|FG000|Overall Study|Adverse Event|14
4467910|NCT00624377|7260014|FG000|Overall Study|Other|91
4467911|NCT00624377|7260014|FG000|Overall Study|Non-evaluable population|84
4467912|NCT00624468|7260066|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13
4467913|NCT00624468|7260067|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12
4467914|NCT00624468|7260068|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0
4467915|NCT00624468|7260069|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0
4467916|NCT00624468|7260066|FG000|Double-blind Period|Withdrew Prematurely|1
4467917|NCT00624468|7260067|FG001|Double-blind Period|Withdrew Prematurely|1
4467918|NCT00624468|7260068|FG002|Double-blind Period|Withdrew Prematurely|0
4467919|NCT00624468|7260069|FG003|Double-blind Period|Withdrew Prematurely|0
4467920|NCT00624468|7260066|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0
4467921|NCT00624468|7260067|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0
4696217|NCT02634788|7609043|FG000|Overall Study|Lost to Follow-up|0
4696218|NCT02634788|7609044|FG001|Overall Study|Lost to Follow-up|1
4467922|NCT00624468|7260068|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1
4467923|NCT00624468|7260069|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2
4467924|NCT00624468|7260066|FG000|Safety Follow-up (SFU) Period|Other|0
4696219|NCT02634788|7609045|FG002|Overall Study|Lost to Follow-up|0
4467925|NCT00624468|7260067|FG001|Safety Follow-up (SFU) Period|Other|0
4467926|NCT00624468|7260068|FG002|Safety Follow-up (SFU) Period|Other|1
4467927|NCT00624468|7260069|FG003|Safety Follow-up (SFU) Period|Other|1
4380501|NCT02852967|7158347|FG000|Overall Study|Adverse Event|3
4380502|NCT02852967|7158348|FG001|Overall Study|Adverse Event|1
4380503|NCT02852967|7158349|FG002|Overall Study|Adverse Event|0
4588295|NCT01499290|7432847|FG000|Overall Study|Condition improved/subject recovered|1
4588296|NCT01499290|7432848|FG001|Overall Study|Condition improved/subject recovered|0
4380504|NCT02852967|7158350|FG003|Overall Study|Adverse Event|1
4380505|NCT02852967|7158351|FG004|Overall Study|Adverse Event|0
4380506|NCT02852967|7158347|FG000|Overall Study|Death|1
4380507|NCT02852967|7158348|FG001|Overall Study|Death|0
4380508|NCT02852967|7158349|FG002|Overall Study|Death|0
4380509|NCT02852967|7158350|FG003|Overall Study|Death|0
4380510|NCT02852967|7158351|FG004|Overall Study|Death|0
4380511|NCT02852967|7158347|FG000|Overall Study|Lost to Follow-up|1
4380512|NCT02852967|7158348|FG001|Overall Study|Lost to Follow-up|2
4380513|NCT02852967|7158349|FG002|Overall Study|Lost to Follow-up|3
4380514|NCT02852967|7158350|FG003|Overall Study|Lost to Follow-up|4
4588297|NCT01499290|7432847|FG000|Overall Study|Lack of Efficacy|7
4380515|NCT02852967|7158351|FG004|Overall Study|Lost to Follow-up|4
4380516|NCT02852967|7158347|FG000|Overall Study|Withdrawal by Subject|6
4380517|NCT02852967|7158348|FG001|Overall Study|Withdrawal by Subject|12
4380518|NCT02852967|7158349|FG002|Overall Study|Withdrawal by Subject|7
4380519|NCT02852967|7158350|FG003|Overall Study|Withdrawal by Subject|10
4380520|NCT02852967|7158351|FG004|Overall Study|Withdrawal by Subject|10
4380521|NCT02852967|7158347|FG000|Overall Study|SAE|0
4380522|NCT02852967|7158348|FG001|Overall Study|SAE|0
4380523|NCT02852967|7158349|FG002|Overall Study|SAE|0
4380524|NCT02852967|7158350|FG003|Overall Study|SAE|3
4380525|NCT02852967|7158351|FG004|Overall Study|SAE|0
4380526|NCT02852967|7158347|FG000|Overall Study|Elevated Liver Enzymes|2
4380527|NCT02852967|7158348|FG001|Overall Study|Elevated Liver Enzymes|0
4380528|NCT02852967|7158349|FG002|Overall Study|Elevated Liver Enzymes|0
4380529|NCT02852967|7158350|FG003|Overall Study|Elevated Liver Enzymes|2
4380530|NCT02852967|7158351|FG004|Overall Study|Elevated Liver Enzymes|2
4380531|NCT02852967|7158347|FG000|Overall Study|Physician Decision|0
4380532|NCT02852967|7158348|FG001|Overall Study|Physician Decision|0
4380533|NCT02852967|7158349|FG002|Overall Study|Physician Decision|0
4380534|NCT02852967|7158350|FG003|Overall Study|Physician Decision|1
4380535|NCT02852967|7158351|FG004|Overall Study|Physician Decision|0
4380536|NCT02852967|7158347|FG000|Overall Study|Lack of Efficacy|0
4380537|NCT02852967|7158348|FG001|Overall Study|Lack of Efficacy|1
4380538|NCT02852967|7158349|FG002|Overall Study|Lack of Efficacy|0
4380539|NCT02852967|7158350|FG003|Overall Study|Lack of Efficacy|0
4380540|NCT02852967|7158351|FG004|Overall Study|Lack of Efficacy|0
4380541|NCT02852967|7158347|FG000|Overall Study|Non-compliance|0
4380542|NCT02852967|7158348|FG001|Overall Study|Non-compliance|0
4380543|NCT02852967|7158349|FG002|Overall Study|Non-compliance|1
4380544|NCT02852967|7158350|FG003|Overall Study|Non-compliance|1
4380545|NCT02852967|7158351|FG004|Overall Study|Non-compliance|0
4380546|NCT02852967|7158347|FG000|Overall Study|Dispensing Drug Violation|0
4380547|NCT02852967|7158348|FG001|Overall Study|Dispensing Drug Violation|0
4380548|NCT02852967|7158349|FG002|Overall Study|Dispensing Drug Violation|1
4380549|NCT02852967|7158350|FG003|Overall Study|Dispensing Drug Violation|0
4588298|NCT01499290|7432848|FG001|Overall Study|Lack of Efficacy|8
4588299|NCT01499290|7432847|FG000|Overall Study|Adverse Event|14
4588300|NCT01499290|7432848|FG001|Overall Study|Adverse Event|7
4588301|NCT01499303|7432875|FG000|Overall Study|Ongoing|2
4588302|NCT01499303|7432876|FG001|Overall Study|Ongoing|1
4588303|NCT01499303|7432875|FG000|Overall Study|Withdrawal by Subject|0
4588304|NCT01499303|7432876|FG001|Overall Study|Withdrawal by Subject|1
4588305|NCT01499303|7432875|FG000|Overall Study|Adverse Event|1
4696220|NCT02634788|7609046|FG003|Overall Study|Lost to Follow-up|0
4696221|NCT02634788|7609043|FG000|Overall Study|Withdrawal by Subject|0
4696222|NCT02634788|7609044|FG001|Overall Study|Withdrawal by Subject|1
4696223|NCT02634788|7609045|FG002|Overall Study|Withdrawal by Subject|1
4696224|NCT02634788|7609046|FG003|Overall Study|Withdrawal by Subject|0
4696225|NCT02634801|7609059|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2
4696226|NCT02634801|7609060|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20
4696227|NCT02634801|7609061|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0
4696228|NCT02634801|7609059|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0
4696229|NCT02634801|7609060|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2
4696230|NCT02634801|7609061|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0
4696231|NCT02634801|7609059|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2
4696232|NCT02634801|7609060|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1
4588306|NCT01499303|7432876|FG001|Overall Study|Adverse Event|4
4588307|NCT01499303|7432875|FG000|Overall Study|Other|0
4696233|NCT02634801|7609061|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1
4380550|NCT02852967|7158351|FG004|Overall Study|Dispensing Drug Violation|0
4380551|NCT02852967|7158347|FG000|Overall Study|Inclusion/Exclusion Violation|1
4588308|NCT01499303|7432876|FG001|Overall Study|Other|1
4588309|NCT01499355|7432882|FG000|Run-In Period|Study Termination|15
4380552|NCT02852967|7158348|FG001|Overall Study|Inclusion/Exclusion Violation|0
4380553|NCT02852967|7158349|FG002|Overall Study|Inclusion/Exclusion Violation|0
4380554|NCT02852967|7158350|FG003|Overall Study|Inclusion/Exclusion Violation|0
4380555|NCT02852967|7158351|FG004|Overall Study|Inclusion/Exclusion Violation|0
4380556|NCT02810418|7158378|FG000|Arm A Dose Escalation|Adverse Event|2
4380557|NCT02810418|7158379|FG001|Arm A Dose Escalation|Adverse Event|1
4380558|NCT02810418|7158380|FG002|Arm A Dose Escalation|Adverse Event|0
4380559|NCT02810418|7158381|FG003|Arm A Dose Escalation|Adverse Event|0
4380560|NCT02810418|7158382|FG004|Arm A Dose Escalation|Adverse Event|0
4380561|NCT02810418|7158383|FG005|Arm A Dose Escalation|Adverse Event|0
4380562|NCT02810418|7158384|FG006|Arm A Dose Escalation|Adverse Event|0
4380563|NCT02810418|7158378|FG000|Dose Expansion|Adverse Event|0
4380564|NCT02810418|7158379|FG001|Dose Expansion|Adverse Event|1
4380565|NCT02810418|7158380|FG002|Dose Expansion|Adverse Event|1
4380566|NCT02810418|7158381|FG003|Dose Expansion|Adverse Event|0
4380567|NCT02810418|7158382|FG004|Dose Expansion|Adverse Event|0
4380568|NCT02810418|7158383|FG005|Dose Expansion|Adverse Event|0
4380569|NCT02810418|7158384|FG006|Dose Expansion|Adverse Event|0
4588310|NCT01499355|7432883|FG001|Run-In Period|Study Termination|0
4588311|NCT01499355|7432884|FG002|Run-In Period|Study Termination|0
4588312|NCT01499355|7432885|FG003|Run-In Period|Study Termination|0
4588313|NCT01499355|7432882|FG000|Run-In Period|Other|3
4588314|NCT01499355|7432883|FG001|Run-In Period|Other|0
4588315|NCT01499355|7432884|FG002|Run-In Period|Other|0
4588316|NCT01499355|7432885|FG003|Run-In Period|Other|0
4588317|NCT01499355|7432882|FG000|Run-In Period|Death|2
4588318|NCT01499355|7432883|FG001|Run-In Period|Death|0
4588319|NCT01499355|7432884|FG002|Run-In Period|Death|0
4588320|NCT01499355|7432885|FG003|Run-In Period|Death|0
4588321|NCT01499355|7432882|FG000|Run-In Period|Investigator Decision|2
4588322|NCT01499355|7432883|FG001|Run-In Period|Investigator Decision|0
4696234|NCT02634801|7609059|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0
4696235|NCT02634801|7609060|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0
4380570|NCT02810418|7158378|FG000|Dose Expansion|Physician Decision|0
4380571|NCT02810418|7158379|FG001|Dose Expansion|Physician Decision|0
4380572|NCT02810418|7158380|FG002|Dose Expansion|Physician Decision|2
4380573|NCT02810418|7158381|FG003|Dose Expansion|Physician Decision|0
4380574|NCT02810418|7158382|FG004|Dose Expansion|Physician Decision|0
4380575|NCT02810418|7158383|FG005|Dose Expansion|Physician Decision|0
4588323|NCT01499355|7432884|FG002|Run-In Period|Investigator Decision|0
4696236|NCT02634801|7609061|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1
4696237|NCT02634801|7609059|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0
4696238|NCT02634801|7609060|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8
4696239|NCT02634801|7609061|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3
4696240|NCT02634801|7609059|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0
4696241|NCT02634801|7609060|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0
4696242|NCT02634801|7609061|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1
4696243|NCT02634801|7609059|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1
4696244|NCT02634801|7609060|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0
4696245|NCT02634801|7609061|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0
4696246|NCT02634801|7609059|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1
4696247|NCT02634801|7609060|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1
4696248|NCT02634801|7609061|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1
4696249|NCT02634801|7609059|FG000|Extension Period (Weeks 24 to 36)|Missing|1
4696250|NCT02634801|7609060|FG001|Extension Period (Weeks 24 to 36)|Missing|0
4696251|NCT02634801|7609061|FG002|Extension Period (Weeks 24 to 36)|Missing|0
4696252|NCT02634801|7609059|FG000|Follow-up Period|Lost to Follow-up|3
4696253|NCT02634801|7609060|FG001|Follow-up Period|Lost to Follow-up|1
4696254|NCT02634801|7609061|FG002|Follow-up Period|Lost to Follow-up|2
4696255|NCT02634801|7609059|FG000|Follow-up Period|Physician Decision|0
4696256|NCT02634801|7609060|FG001|Follow-up Period|Physician Decision|0
4696257|NCT02634801|7609061|FG002|Follow-up Period|Physician Decision|1
4696258|NCT02634801|7609059|FG000|Follow-up Period|Withdrawal by Subject|1
4696259|NCT02634801|7609060|FG001|Follow-up Period|Withdrawal by Subject|2
4696260|NCT02634801|7609061|FG002|Follow-up Period|Withdrawal by Subject|5
4696261|NCT02634801|7609059|FG000|Follow-up Period|Adverse Event|1
4696262|NCT02634801|7609060|FG001|Follow-up Period|Adverse Event|5
4696263|NCT02634801|7609061|FG002|Follow-up Period|Adverse Event|0
4696264|NCT02634983|7609086|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2
4696265|NCT02634983|7609087|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0
4696266|NCT02635204|7609104|FG000|Overall Study|Adverse Event|1
4696267|NCT02635204|7609105|FG001|Overall Study|Adverse Event|0
4696268|NCT02635204|7609104|FG000|Overall Study|Lost to Follow-up|1
4696269|NCT02635204|7609105|FG001|Overall Study|Lost to Follow-up|1
4696270|NCT02635347|7609113|FG000|Overall Study|Failed screening|20
4696271|NCT02635347|7609114|FG001|Overall Study|Failed screening|7
4696272|NCT02635386|7609126|FG000|Overall Study|Pregnancy|2
4696273|NCT02635386|7609127|FG001|Overall Study|Pregnancy|0
4696274|NCT02635386|7609128|FG002|Overall Study|Pregnancy|0
4696275|NCT02635386|7609129|FG003|Overall Study|Pregnancy|0
4696276|NCT02635386|7609130|FG004|Overall Study|Pregnancy|2
4696277|NCT02635386|7609126|FG000|Overall Study|Withdrawal by Subject|1
4696278|NCT02635386|7609127|FG001|Overall Study|Withdrawal by Subject|1
4696279|NCT02635386|7609128|FG002|Overall Study|Withdrawal by Subject|0
4380576|NCT02810418|7158384|FG006|Dose Expansion|Physician Decision|0
4588324|NCT01499355|7432885|FG003|Run-In Period|Investigator Decision|0
4588325|NCT01499355|7432882|FG000|Run-In Period|Consent Withdrawn|1
4588326|NCT01499355|7432883|FG001|Run-In Period|Consent Withdrawn|0
4380577|NCT02810418|7158378|FG000|Arm B Dose Escalation|Adverse Event|0
4380578|NCT02810418|7158379|FG001|Arm B Dose Escalation|Adverse Event|0
4380579|NCT02810418|7158380|FG002|Arm B Dose Escalation|Adverse Event|0
4380580|NCT02810418|7158381|FG003|Arm B Dose Escalation|Adverse Event|0
4380581|NCT02810418|7158382|FG004|Arm B Dose Escalation|Adverse Event|1
4380582|NCT02810418|7158383|FG005|Arm B Dose Escalation|Adverse Event|2
4380583|NCT02810418|7158384|FG006|Arm B Dose Escalation|Adverse Event|0
4380584|NCT02781584|7158465|FG000|Pre-treatment Phase|Investigator's Discretion|0
4380585|NCT02781584|7158466|FG001|Pre-treatment Phase|Investigator's Discretion|0
4380586|NCT02781584|7158467|FG002|Pre-treatment Phase|Investigator's Discretion|0
4380587|NCT02781584|7158468|FG003|Pre-treatment Phase|Investigator's Discretion|0
4380588|NCT02781584|7158469|FG004|Pre-treatment Phase|Investigator's Discretion|0
4380589|NCT02781584|7158470|FG005|Pre-treatment Phase|Investigator's Discretion|0
4380590|NCT02781584|7158471|FG006|Pre-treatment Phase|Investigator's Discretion|0
4380591|NCT02781584|7158472|FG007|Pre-treatment Phase|Investigator's Discretion|0
4380592|NCT02781584|7158473|FG008|Pre-treatment Phase|Investigator's Discretion|0
4380593|NCT02781584|7158474|FG009|Pre-treatment Phase|Investigator's Discretion|0
4380594|NCT02781584|7158475|FG010|Pre-treatment Phase|Investigator's Discretion|0
4380595|NCT02781584|7158476|FG011|Pre-treatment Phase|Investigator's Discretion|2
4380596|NCT02781584|7158477|FG012|Pre-treatment Phase|Investigator's Discretion|1
4467928|NCT00624520|7260079|FG000|Overall Study|Withdrawal by Subject|12
4467929|NCT00624520|7260080|FG001|Overall Study|Withdrawal by Subject|7
4467930|NCT00624520|7260079|FG000|Overall Study|Death|0
4467931|NCT00624520|7260080|FG001|Overall Study|Death|1
4467932|NCT00624585|7260103|FG000|Overall Study|Death|3
4467933|NCT00624585|7260103|FG000|Overall Study|Disease Progression|6
4467934|NCT00624585|7260103|FG000|Overall Study|Adverse Event|3
4467935|NCT00624780|7260113|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7
4467936|NCT00624780|7260114|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5
4467937|NCT00624780|7260115|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15
4467938|NCT00624780|7260116|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3
4467939|NCT00624780|7260117|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9
4467940|NCT00624780|7260118|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5
4467941|NCT00624780|7260113|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5
4467942|NCT00624780|7260114|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2
4467943|NCT00624780|7260115|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10
4467944|NCT00624780|7260116|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5
4467945|NCT00624780|7260117|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9
4467946|NCT00624780|7260118|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1
4467947|NCT00624780|7260113|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1
4467948|NCT00624780|7260114|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0
4467949|NCT00624780|7260115|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2
4467950|NCT00624780|7260116|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0
4467951|NCT00624780|7260117|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2
4467952|NCT00624780|7260118|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1
4467953|NCT00624780|7260113|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10
4467954|NCT00624780|7260114|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2
4467955|NCT00624780|7260115|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7
4467956|NCT00624780|7260116|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4
4467957|NCT00624780|7260117|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10
4467958|NCT00624780|7260118|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4
4467959|NCT00624780|7260113|FG000|Treatment Optimization (Up to Week 12)|Other|10
4467960|NCT00624780|7260114|FG001|Treatment Optimization (Up to Week 12)|Other|4
4467961|NCT00624780|7260115|FG002|Treatment Optimization (Up to Week 12)|Other|8
4467962|NCT00624780|7260116|FG003|Treatment Optimization (Up to Week 12)|Other|2
4467963|NCT00624780|7260117|FG004|Treatment Optimization (Up to Week 12)|Other|9
4467964|NCT00624780|7260118|FG005|Treatment Optimization (Up to Week 12)|Other|0
4467965|NCT00624780|7260113|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5
4467966|NCT00624780|7260114|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4
4467967|NCT00624780|7260115|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5
4467968|NCT00624780|7260116|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2
4467969|NCT00624780|7260117|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3
4467970|NCT00624780|7260118|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1
4467971|NCT00624780|7260113|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
4467972|NCT00624780|7260114|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1
4467973|NCT00624780|7260115|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
4467974|NCT00624780|7260116|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5
4467975|NCT00624780|7260117|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5
4467976|NCT00624780|7260118|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
4467977|NCT00624780|7260113|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
4467978|NCT00624780|7260114|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0
4467979|NCT00624780|7260115|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
4467980|NCT00624780|7260116|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0
4380597|NCT02781584|7158465|FG000|Pre-treatment Phase|Adverse Event|0
4380598|NCT02781584|7158466|FG001|Pre-treatment Phase|Adverse Event|0
4380599|NCT02781584|7158467|FG002|Pre-treatment Phase|Adverse Event|0
4380600|NCT02781584|7158468|FG003|Pre-treatment Phase|Adverse Event|0
4380601|NCT02781584|7158469|FG004|Pre-treatment Phase|Adverse Event|0
4380602|NCT02781584|7158470|FG005|Pre-treatment Phase|Adverse Event|0
4380603|NCT02781584|7158471|FG006|Pre-treatment Phase|Adverse Event|0
4380604|NCT02781584|7158472|FG007|Pre-treatment Phase|Adverse Event|0
4380605|NCT02781584|7158473|FG008|Pre-treatment Phase|Adverse Event|0
4380606|NCT02781584|7158474|FG009|Pre-treatment Phase|Adverse Event|0
4380607|NCT02781584|7158475|FG010|Pre-treatment Phase|Adverse Event|0
4380608|NCT02781584|7158476|FG011|Pre-treatment Phase|Adverse Event|1
4380609|NCT02781584|7158477|FG012|Pre-treatment Phase|Adverse Event|0
4380610|NCT02781584|7158465|FG000|Treatment Phase|Withdrew Consent|0
4380611|NCT02781584|7158466|FG001|Treatment Phase|Withdrew Consent|0
4380612|NCT02781584|7158467|FG002|Treatment Phase|Withdrew Consent|0
4380613|NCT02781584|7158468|FG003|Treatment Phase|Withdrew Consent|0
4380614|NCT02781584|7158469|FG004|Treatment Phase|Withdrew Consent|0
4380615|NCT02781584|7158470|FG005|Treatment Phase|Withdrew Consent|1
4380616|NCT02781584|7158471|FG006|Treatment Phase|Withdrew Consent|0
4380617|NCT02781584|7158472|FG007|Treatment Phase|Withdrew Consent|0
4380618|NCT02781584|7158473|FG008|Treatment Phase|Withdrew Consent|0
4380619|NCT02781584|7158474|FG009|Treatment Phase|Withdrew Consent|0
4380620|NCT02781584|7158475|FG010|Treatment Phase|Withdrew Consent|1
4380621|NCT02781584|7158476|FG011|Treatment Phase|Withdrew Consent|2
4380622|NCT02781584|7158477|FG012|Treatment Phase|Withdrew Consent|0
4380623|NCT02781584|7158465|FG000|Treatment Phase|Adverse Event|0
4380624|NCT02781584|7158466|FG001|Treatment Phase|Adverse Event|0
4380625|NCT02781584|7158467|FG002|Treatment Phase|Adverse Event|0
4380626|NCT02781584|7158468|FG003|Treatment Phase|Adverse Event|0
4380627|NCT02781584|7158469|FG004|Treatment Phase|Adverse Event|0
4380628|NCT02781584|7158470|FG005|Treatment Phase|Adverse Event|0
4380629|NCT02781584|7158471|FG006|Treatment Phase|Adverse Event|0
4380630|NCT02781584|7158472|FG007|Treatment Phase|Adverse Event|1
4380631|NCT02781584|7158473|FG008|Treatment Phase|Adverse Event|0
4380632|NCT02781584|7158474|FG009|Treatment Phase|Adverse Event|0
4380633|NCT02781584|7158475|FG010|Treatment Phase|Adverse Event|0
4380634|NCT02781584|7158476|FG011|Treatment Phase|Adverse Event|0
4380635|NCT02781584|7158477|FG012|Treatment Phase|Adverse Event|0
4696280|NCT02635386|7609129|FG003|Overall Study|Withdrawal by Subject|1
4696281|NCT02635386|7609130|FG004|Overall Study|Withdrawal by Subject|0
4696282|NCT02635386|7609126|FG000|Overall Study|Physician Decision|0
4696283|NCT02635386|7609127|FG001|Overall Study|Physician Decision|1
4696284|NCT02635386|7609128|FG002|Overall Study|Physician Decision|0
4696285|NCT02635386|7609129|FG003|Overall Study|Physician Decision|0
4696286|NCT02635386|7609130|FG004|Overall Study|Physician Decision|0
4696287|NCT02635386|7609126|FG000|Overall Study|Moved Out of State|0
4696288|NCT02635386|7609127|FG001|Overall Study|Moved Out of State|1
4696289|NCT02635386|7609128|FG002|Overall Study|Moved Out of State|0
4696290|NCT02635386|7609129|FG003|Overall Study|Moved Out of State|0
4696291|NCT02635386|7609130|FG004|Overall Study|Moved Out of State|0
4696292|NCT02635386|7609126|FG000|Overall Study|Noncompliant|0
4696293|NCT02635386|7609127|FG001|Overall Study|Noncompliant|2
4696294|NCT02635386|7609128|FG002|Overall Study|Noncompliant|1
4696295|NCT02635386|7609129|FG003|Overall Study|Noncompliant|1
4696296|NCT02635386|7609130|FG004|Overall Study|Noncompliant|1
4696297|NCT02635386|7609126|FG000|Overall Study|side effects|0
4696298|NCT02635386|7609127|FG001|Overall Study|side effects|0
4696299|NCT02635386|7609128|FG002|Overall Study|side effects|1
4696300|NCT02635386|7609129|FG003|Overall Study|side effects|4
4696301|NCT02635386|7609130|FG004|Overall Study|side effects|6
4696302|NCT02635386|7609126|FG000|Overall Study|needed other major surgery|0
4696303|NCT02635386|7609127|FG001|Overall Study|needed other major surgery|1
4696304|NCT02635386|7609128|FG002|Overall Study|needed other major surgery|0
4696305|NCT02635386|7609129|FG003|Overall Study|needed other major surgery|0
4696306|NCT02635386|7609130|FG004|Overall Study|needed other major surgery|0
4696307|NCT02635386|7609126|FG000|Overall Study|Other medical problems not drug related|0
4696308|NCT02635386|7609127|FG001|Overall Study|Other medical problems not drug related|0
4696309|NCT02635386|7609128|FG002|Overall Study|Other medical problems not drug related|0
4696310|NCT02635386|7609129|FG003|Overall Study|Other medical problems not drug related|1
4696311|NCT02635386|7609130|FG004|Overall Study|Other medical problems not drug related|0
4696312|NCT02635646|7609167|FG000|Overall Study|Lost to Follow-up|24
4696313|NCT02635646|7609168|FG001|Overall Study|Lost to Follow-up|25
4696314|NCT02635646|7609167|FG000|Overall Study|Pregnancy|1
4696315|NCT02635646|7609168|FG001|Overall Study|Pregnancy|1
4380636|NCT02714062|7158512|FG000|Overall Study|Adverse Event|0
4380637|NCT02714062|7158513|FG001|Overall Study|Adverse Event|0
4380638|NCT02714062|7158514|FG002|Overall Study|Adverse Event|2
4380639|NCT02714062|7158512|FG000|Overall Study|Withdrawal by Subject|1
4380640|NCT02714062|7158513|FG001|Overall Study|Withdrawal by Subject|0
4696316|NCT02635724|7609183|FG000|Overall Study|Withdrawal by Subject|0
4696317|NCT02635724|7609184|FG001|Overall Study|Withdrawal by Subject|1
4696318|NCT02635724|7609185|FG002|Overall Study|Withdrawal by Subject|0
4380641|NCT02714062|7158514|FG002|Overall Study|Withdrawal by Subject|1
4380642|NCT02714062|7158512|FG000|Overall Study|Protocol Violation|0
4696319|NCT02635737|7609193|FG000|Overall Study|Protocol Violation|1
4380643|NCT02714062|7158513|FG001|Overall Study|Protocol Violation|1
4380644|NCT02714062|7158514|FG002|Overall Study|Protocol Violation|0
4380645|NCT02707055|7158526|FG000|Phase 1|Withdrawal by Subject|1
4380646|NCT02707055|7158527|FG001|Phase 1|Withdrawal by Subject|2
4380647|NCT02707055|7158526|FG000|Phase 1|Physician Decision|0
4467981|NCT00624780|7260117|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
4467982|NCT00624780|7260118|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
4467983|NCT00624780|7260113|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2
4467984|NCT00624780|7260114|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3
4467985|NCT00624780|7260115|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6
4467986|NCT00624780|7260116|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3
4467987|NCT00624780|7260117|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6
4467988|NCT00624780|7260118|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2
4467989|NCT00624780|7260113|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5
4467990|NCT00624780|7260114|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3
4467991|NCT00624780|7260115|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4
4467992|NCT00624780|7260116|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1
4467993|NCT00624780|7260117|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4
4467994|NCT00624780|7260118|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3
4467995|NCT00624780|7260113|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1
4467996|NCT00624780|7260114|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0
4467997|NCT00624780|7260115|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2
4467998|NCT00624780|7260116|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1
4467999|NCT00624780|7260117|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0
4468000|NCT00624780|7260118|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1
4468001|NCT00624780|7260113|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1
4468002|NCT00624780|7260114|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
4468003|NCT00624780|7260115|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
4468004|NCT00624780|7260116|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
4468005|NCT00624780|7260117|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
4468006|NCT00624780|7260118|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
4468007|NCT00624780|7260113|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
4468008|NCT00624780|7260114|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
4468009|NCT00624780|7260115|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1
4468010|NCT00624780|7260116|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
4468011|NCT00624780|7260117|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
4468012|NCT00624780|7260118|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
4468013|NCT00624780|7260113|FG000|Follow-up (Week 26)|Death|0
4468014|NCT00624780|7260114|FG001|Follow-up (Week 26)|Death|0
4468015|NCT00624780|7260115|FG002|Follow-up (Week 26)|Death|1
4468016|NCT00624780|7260116|FG003|Follow-up (Week 26)|Death|0
4468017|NCT00624780|7260117|FG004|Follow-up (Week 26)|Death|0
4468018|NCT00624780|7260118|FG005|Follow-up (Week 26)|Death|0
4468019|NCT00624780|7260113|FG000|Follow-up (Week 26)|Adverse Event|0
4468020|NCT00624780|7260114|FG001|Follow-up (Week 26)|Adverse Event|0
4468021|NCT00624780|7260115|FG002|Follow-up (Week 26)|Adverse Event|0
4468022|NCT00624780|7260116|FG003|Follow-up (Week 26)|Adverse Event|0
4468023|NCT00624780|7260117|FG004|Follow-up (Week 26)|Adverse Event|1
4468024|NCT00624780|7260118|FG005|Follow-up (Week 26)|Adverse Event|0
4468025|NCT00624780|7260113|FG000|Follow-up (Week 26)|Lost to Follow-up|0
4468026|NCT00624780|7260114|FG001|Follow-up (Week 26)|Lost to Follow-up|0
4468027|NCT00624780|7260115|FG002|Follow-up (Week 26)|Lost to Follow-up|1
4468028|NCT00624780|7260116|FG003|Follow-up (Week 26)|Lost to Follow-up|0
4468029|NCT00624780|7260117|FG004|Follow-up (Week 26)|Lost to Follow-up|1
4468030|NCT00624780|7260118|FG005|Follow-up (Week 26)|Lost to Follow-up|0
4468031|NCT00624780|7260113|FG000|Follow-up (Week 26)|Withdrawal by Subject|1
4468032|NCT00624780|7260114|FG001|Follow-up (Week 26)|Withdrawal by Subject|0
4468033|NCT00624780|7260115|FG002|Follow-up (Week 26)|Withdrawal by Subject|0
4468034|NCT00624780|7260116|FG003|Follow-up (Week 26)|Withdrawal by Subject|0
4468035|NCT00624780|7260117|FG004|Follow-up (Week 26)|Withdrawal by Subject|0
4468036|NCT00624780|7260118|FG005|Follow-up (Week 26)|Withdrawal by Subject|0
4468037|NCT00624780|7260113|FG000|Follow-up (Week 26)|Other|1
4468038|NCT00624780|7260114|FG001|Follow-up (Week 26)|Other|1
4468039|NCT00624780|7260115|FG002|Follow-up (Week 26)|Other|0
4468040|NCT00624780|7260116|FG003|Follow-up (Week 26)|Other|0
4468041|NCT00624780|7260117|FG004|Follow-up (Week 26)|Other|0
4468042|NCT00624780|7260118|FG005|Follow-up (Week 26)|Other|0
4468043|NCT00624819|7260148|FG000|Follow-up Period: Year 4|Parents decision|0
4468044|NCT00624819|7260149|FG001|Follow-up Period: Year 4|Parents decision|0
4468045|NCT00624819|7260150|FG002|Follow-up Period: Year 4|Parents decision|1
4468046|NCT00624819|7260151|FG003|Follow-up Period: Year 4|Parents decision|0
4468047|NCT00624819|7260148|FG000|Follow-up Period: Year 4|Lost to Follow-up|1
4468048|NCT00624819|7260149|FG001|Follow-up Period: Year 4|Lost to Follow-up|1
4468049|NCT00624819|7260150|FG002|Follow-up Period: Year 4|Lost to Follow-up|0
4468050|NCT00624819|7260151|FG003|Follow-up Period: Year 4|Lost to Follow-up|0
4468051|NCT00624832|7260165|FG000|Overall Study|Adverse Event|0
4468052|NCT00624832|7260166|FG001|Overall Study|Adverse Event|1
4468053|NCT00624832|7260167|FG002|Overall Study|Adverse Event|0
4468054|NCT00624832|7260168|FG003|Overall Study|Adverse Event|1
4468055|NCT00624832|7260165|FG000|Overall Study|Abnormal Laboratory Value|2
4380648|NCT02707055|7158527|FG001|Phase 1|Physician Decision|1
4380649|NCT02707055|7158526|FG000|Phase 2|Adverse Event|1
4380650|NCT02707055|7158527|FG001|Phase 2|Adverse Event|2
4380651|NCT02656290|7158541|FG000|Overall Study|Subjects Remain On Study|26
4380652|NCT02652130|7158545|FG000|Overall Study|Death|1
4380653|NCT02616393|7158552|FG000|Overall Study|Death|5
4380654|NCT02616393|7158553|FG001|Overall Study|Death|12
4380655|NCT02616393|7158554|FG002|Overall Study|Death|1
4380656|NCT02616393|7158552|FG000|Overall Study|Termination by Sponsor|4
4380657|NCT02616393|7158553|FG001|Overall Study|Termination by Sponsor|5
4380658|NCT02616393|7158554|FG002|Overall Study|Termination by Sponsor|2
4380659|NCT02616393|7158552|FG000|Overall Study|Other|3
4380660|NCT02616393|7158553|FG001|Overall Study|Other|0
4380661|NCT02616393|7158554|FG002|Overall Study|Other|0
4380662|NCT02616393|7158552|FG000|Overall Study|Withdrawal by Subject|1
4380663|NCT02616393|7158553|FG001|Overall Study|Withdrawal by Subject|1
4380664|NCT02616393|7158554|FG002|Overall Study|Withdrawal by Subject|0
4380665|NCT02616393|7158552|FG000|Overall Study|Lost to Follow-up|0
4380666|NCT02616393|7158553|FG001|Overall Study|Lost to Follow-up|2
4380667|NCT02616393|7158554|FG002|Overall Study|Lost to Follow-up|0
4380668|NCT02602288|7158580|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14
4380669|NCT02602288|7158581|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10
4380670|NCT02602288|7158580|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2
4588327|NCT01499355|7432884|FG002|Run-In Period|Consent Withdrawn|0
4588328|NCT01499355|7432885|FG003|Run-In Period|Consent Withdrawn|0
4588329|NCT01499355|7432882|FG000|Run-In Period|Adverse Event|8
4588330|NCT01499355|7432883|FG001|Run-In Period|Adverse Event|0
4588331|NCT01499355|7432884|FG002|Run-In Period|Adverse Event|0
4588332|NCT01499355|7432885|FG003|Run-In Period|Adverse Event|0
4588333|NCT01499355|7432882|FG000|Double-Blind Period|Adverse Event|0
4588334|NCT01499355|7432883|FG001|Double-Blind Period|Adverse Event|2
4588335|NCT01499355|7432884|FG002|Double-Blind Period|Adverse Event|3
4588336|NCT01499355|7432885|FG003|Double-Blind Period|Adverse Event|2
4588337|NCT01499355|7432882|FG000|Double-Blind Period|Study Termination|0
4588338|NCT01499355|7432883|FG001|Double-Blind Period|Study Termination|18
4588339|NCT01499355|7432884|FG002|Double-Blind Period|Study Termination|16
4696320|NCT02635984|7609207|FG000|Overall Study|Lost to Follow-up|2
4696321|NCT02635984|7609208|FG001|Overall Study|Lost to Follow-up|4
4696322|NCT02635984|7609207|FG000|Overall Study|Study Arm Closed|1
4696323|NCT02635984|7609208|FG001|Overall Study|Study Arm Closed|0
4696324|NCT02636361|7609220|FG000|Period 4|Physician Decision|0
4696325|NCT02636361|7609221|FG001|Period 4|Physician Decision|0
4696326|NCT02636361|7609222|FG002|Period 4|Physician Decision|0
4696327|NCT02636361|7609223|FG003|Period 4|Physician Decision|1
4696328|NCT02636361|7609224|FG004|Period 4|Physician Decision|0
4696329|NCT02636595|7609238|FG000|Overall Study|Lost to Follow-up|1
4696330|NCT02636595|7609238|FG000|Overall Study|Other|1
4696331|NCT02636608|7609242|FG000|Overall Study|Failure to Return|4
4696332|NCT02636608|7609242|FG000|Overall Study|Insufficient Virological Response|1
4696333|NCT02636608|7609242|FG000|Overall Study|Death|3
4696334|NCT02636608|7609242|FG000|Overall Study|Other|2
4696335|NCT02636608|7609242|FG000|Overall Study|Did Not Receive Treatment|1
4696336|NCT02636699|7609251|FG000|Overall Study|Adverse Event|4
4696337|NCT02636699|7609252|FG001|Overall Study|Adverse Event|0
4696338|NCT02636699|7609251|FG000|Overall Study|Lost to Follow-up|3
4696339|NCT02636699|7609252|FG001|Overall Study|Lost to Follow-up|3
4696340|NCT02636699|7609251|FG000|Overall Study|Non-compliance with the investigational product (IP)|2
4696341|NCT02636699|7609252|FG001|Overall Study|Non-compliance with the investigational product (IP)|0
4696342|NCT02636699|7609251|FG000|Overall Study|Physician Decision|0
4696343|NCT02636699|7609252|FG001|Overall Study|Physician Decision|1
4696344|NCT02636699|7609251|FG000|Overall Study|Withdrawal by Subject|13
4696345|NCT02636699|7609252|FG001|Overall Study|Withdrawal by Subject|6
4696346|NCT02636699|7609251|FG000|Overall Study|Other|3
4696347|NCT02636699|7609252|FG001|Overall Study|Other|1
4696348|NCT02636725|7609263|FG000|Baseline|Adverse Event|1
4696349|NCT02636725|7609263|FG000|Baseline|Lack of Efficacy|2
4696350|NCT02636868|7609270|FG000|Overall Study|Death|0
4696351|NCT02636868|7609271|FG001|Overall Study|Death|1
4696352|NCT02636868|7609272|FG002|Overall Study|Death|2
4696353|NCT02636907|7609280|FG000|Autoinjector Assessment Period|Adverse Event|2
4696354|NCT02636907|7609280|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2
4696355|NCT02636907|7609280|FG000|Extension Phase|Adverse Event|2
4696356|NCT02636907|7609280|FG000|Extension Phase|Withdrawal by Subject|4
4696357|NCT02636907|7609280|FG000|Extension Phase|Physician Decision|1
4696358|NCT02636907|7609280|FG000|Extension Phase|Lost to Follow-up|2
4696359|NCT02636907|7609280|FG000|Extension Phase|Lack of Efficacy|1
4696360|NCT02637037|7609286|FG000|Overall Study|Positive drug screen at admission|1
4696361|NCT02637037|7609287|FG001|Overall Study|Positive drug screen at admission|0
4696362|NCT02637037|7609286|FG000|Overall Study|Withdrawal by Subject|2
4696363|NCT02637037|7609287|FG001|Overall Study|Withdrawal by Subject|1
4696364|NCT02637037|7609286|FG000|Overall Study|Adverse Event|1
4696365|NCT02637037|7609287|FG001|Overall Study|Adverse Event|0
4380671|NCT02602288|7158581|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2
4696366|NCT02637063|7609308|FG000|Overall Study|Lost to Follow-up|3
4696367|NCT02637063|7609309|FG001|Overall Study|Lost to Follow-up|2
4696368|NCT02637063|7609310|FG002|Overall Study|Lost to Follow-up|3
4380672|NCT02602288|7158580|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9
4380673|NCT02602288|7158581|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6
4380674|NCT02602288|7158580|FG000|12 Month Follow-up|Lost to Follow-up|0
4380675|NCT02602288|7158581|FG001|12 Month Follow-up|Lost to Follow-up|4
4380676|NCT02602288|7158580|FG000|12 Month Follow-up|Withdrawal by Subject|2
4380677|NCT02602288|7158581|FG001|12 Month Follow-up|Withdrawal by Subject|0
4380678|NCT02577523|7158589|FG000|Overall Study|Adverse Event|1
4380679|NCT02577523|7158590|FG001|Overall Study|Adverse Event|1
4380680|NCT02577523|7158589|FG000|Overall Study|Lack of Efficacy|1
4380681|NCT02577523|7158590|FG001|Overall Study|Lack of Efficacy|1
4380682|NCT02577523|7158589|FG000|Overall Study|Withdrawal by Subject|1
4380683|NCT02577523|7158590|FG001|Overall Study|Withdrawal by Subject|0
4380684|NCT02563002|7158598|FG000|Overall Study|Death|62
4380685|NCT02563002|7158599|FG001|Overall Study|Death|75
4380686|NCT02563002|7158598|FG000|Overall Study|Lost to Follow-up|1
4380687|NCT02563002|7158599|FG001|Overall Study|Lost to Follow-up|0
4380688|NCT02563002|7158598|FG000|Overall Study|Withdrawal by Subject|0
4380689|NCT02563002|7158599|FG001|Overall Study|Withdrawal by Subject|9
4380690|NCT02563002|7158598|FG000|Overall Study|Ongoing|90
4380691|NCT02563002|7158599|FG001|Overall Study|Ongoing|70
4380692|NCT02427958|7158617|FG000|Overall Study|Pretreatment Event (PTE) or AE|3
4380693|NCT02427958|7158617|FG000|Overall Study|Lost to Follow-up|6
4380694|NCT02427958|7158617|FG000|Overall Study|Withdrawal by Subject|14
4380695|NCT02427958|7158617|FG000|Overall Study|Lack of Efficacy|1
4380696|NCT02425826|7158623|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5
4380697|NCT02425826|7158624|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2
4380698|NCT02425826|7158625|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0
4380699|NCT02425826|7158623|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0
4380700|NCT02425826|7158624|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1
4380701|NCT02425826|7158625|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0
4588340|NCT01499355|7432885|FG003|Double-Blind Period|Study Termination|14
4588341|NCT01499355|7432882|FG000|Double-Blind Period|Other|0
4588342|NCT01499355|7432883|FG001|Double-Blind Period|Other|1
4588343|NCT01499355|7432884|FG002|Double-Blind Period|Other|2
4588344|NCT01499355|7432885|FG003|Double-Blind Period|Other|2
4588345|NCT01499355|7432882|FG000|Double-Blind Period|Death|0
4588346|NCT01499355|7432883|FG001|Double-Blind Period|Death|1
4588347|NCT01499355|7432884|FG002|Double-Blind Period|Death|0
4588348|NCT01499355|7432885|FG003|Double-Blind Period|Death|0
4588349|NCT01499355|7432882|FG000|Double-Blind Period|Investigator Decision|0
4588350|NCT01499355|7432883|FG001|Double-Blind Period|Investigator Decision|0
4588351|NCT01499355|7432884|FG002|Double-Blind Period|Investigator Decision|3
4588352|NCT01499355|7432885|FG003|Double-Blind Period|Investigator Decision|3
4588353|NCT01499355|7432882|FG000|Double-Blind Period|Consent Withdrawn|0
4588354|NCT01499355|7432883|FG001|Double-Blind Period|Consent Withdrawn|0
4588355|NCT01499355|7432884|FG002|Double-Blind Period|Consent Withdrawn|1
4588356|NCT01499355|7432885|FG003|Double-Blind Period|Consent Withdrawn|2
4588357|NCT01499355|7432882|FG000|Double-Blind Period|Lost to Follow-up|0
4588358|NCT01499355|7432883|FG001|Double-Blind Period|Lost to Follow-up|1
4588359|NCT01499355|7432884|FG002|Double-Blind Period|Lost to Follow-up|0
4588360|NCT01499355|7432885|FG003|Double-Blind Period|Lost to Follow-up|0
4588361|NCT01499368|7432898|FG000|Overall Study|Did not meet I/E criteria|8
4588362|NCT01499368|7432899|FG001|Overall Study|Did not meet I/E criteria|4
4588363|NCT01499368|7432900|FG002|Overall Study|Did not meet I/E criteria|4
4588364|NCT01499368|7432898|FG000|Overall Study|Prohibited Concomitant medication|1
4588365|NCT01499368|7432899|FG001|Overall Study|Prohibited Concomitant medication|1
4588366|NCT01499368|7432900|FG002|Overall Study|Prohibited Concomitant medication|0
4588367|NCT01499368|7432898|FG000|Overall Study|Withdrawal by Subject|11
4588368|NCT01499368|7432899|FG001|Overall Study|Withdrawal by Subject|10
4588369|NCT01499368|7432900|FG002|Overall Study|Withdrawal by Subject|8
4588370|NCT01499368|7432898|FG000|Overall Study|Lost to Follow-up|3
4588371|NCT01499368|7432899|FG001|Overall Study|Lost to Follow-up|2
4588372|NCT01499368|7432900|FG002|Overall Study|Lost to Follow-up|5
4588373|NCT01499368|7432898|FG000|Overall Study|Adverse Event|4
4588374|NCT01499368|7432899|FG001|Overall Study|Adverse Event|0
4588375|NCT01499368|7432900|FG002|Overall Study|Adverse Event|2
4588376|NCT01499368|7432898|FG000|Overall Study|Physician Decision|0
4588377|NCT01499368|7432899|FG001|Overall Study|Physician Decision|1
4588378|NCT01499368|7432900|FG002|Overall Study|Physician Decision|0
4588379|NCT01499368|7432898|FG000|Overall Study|Deviation from visit window|0
4588380|NCT01499368|7432899|FG001|Overall Study|Deviation from visit window|0
4588381|NCT01499368|7432900|FG002|Overall Study|Deviation from visit window|1
4588382|NCT01499368|7432898|FG000|Overall Study|Error of Prescriptions|0
4588383|NCT01499368|7432899|FG001|Overall Study|Error of Prescriptions|0
4588384|NCT01499368|7432900|FG002|Overall Study|Error of Prescriptions|1
4588385|NCT01499511|7432917|FG000|Overall Study|Death|1
4588386|NCT01499511|7432918|FG001|Overall Study|Death|0
4588387|NCT01499576|7432925|FG000|Overall Study|Physician Decision|12
4588388|NCT01499576|7432925|FG000|Overall Study|Withdrawal by Subject|9
4588389|NCT01499667|7432943|FG000|Overall Study|administrative problems|4
4588390|NCT01499667|7432944|FG001|Overall Study|administrative problems|5
4380702|NCT02425826|7158623|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9
4380703|NCT02425826|7158624|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1
4380704|NCT02425826|7158625|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0
4380705|NCT02425826|7158623|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10
4380706|NCT02425826|7158624|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4
4380707|NCT02425826|7158625|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0
4380708|NCT02425826|7158623|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3
4380709|NCT02425826|7158624|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1
4380710|NCT02425826|7158625|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0
4380711|NCT02425826|7158623|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7
4380712|NCT02425826|7158624|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0
4380713|NCT02425826|7158625|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2
4380714|NCT02425826|7158623|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8
4380715|NCT02425826|7158624|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0
4380716|NCT02425826|7158625|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6
4380717|NCT02425826|7158623|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12
4468056|NCT00624832|7260166|FG001|Overall Study|Abnormal Laboratory Value|0
4468057|NCT00624832|7260167|FG002|Overall Study|Abnormal Laboratory Value|0
4468058|NCT00624832|7260168|FG003|Overall Study|Abnormal Laboratory Value|0
4468059|NCT00625131|7260203|FG000|Overall Study|Lost to Follow-up|3
4468060|NCT00625131|7260204|FG001|Overall Study|Lost to Follow-up|2
4468061|NCT00625131|7260205|FG002|Overall Study|Lost to Follow-up|0
4468062|NCT00625131|7260203|FG000|Overall Study|Withdrawal by Subject|1
4468063|NCT00625131|7260204|FG001|Overall Study|Withdrawal by Subject|0
4468064|NCT00625131|7260205|FG002|Overall Study|Withdrawal by Subject|5
4468065|NCT00625183|7260211|FG000|Overall Study|Disease Progression|1
4468066|NCT00625365|7260217|FG000|Overall Study|Withdrawal by Subject|1
4468067|NCT00625365|7260217|FG000|Overall Study|No IV access|5
4468068|NCT00625365|7260217|FG000|Overall Study|VSD|1
4468069|NCT00625443|7260254|FG000|Overall Study|Adverse Event|1
4468070|NCT00625443|7260255|FG001|Overall Study|Adverse Event|4
4468071|NCT00625443|7260256|FG002|Overall Study|Adverse Event|0
4468072|NCT00625443|7260254|FG000|Overall Study|Non-compliance with protocol|0
4468073|NCT00625443|7260255|FG001|Overall Study|Non-compliance with protocol|1
4468074|NCT00625443|7260256|FG002|Overall Study|Non-compliance with protocol|0
4468075|NCT00625443|7260254|FG000|Overall Study|Platelet count increase >=500,000/mm3|1
4468076|NCT00625443|7260255|FG001|Overall Study|Platelet count increase >=500,000/mm3|0
4468077|NCT00625443|7260256|FG002|Overall Study|Platelet count increase >=500,000/mm3|0
4468078|NCT00625443|7260254|FG000|Overall Study|Withdrawal by Subject|0
4696369|NCT02637063|7609308|FG000|Overall Study|Withdrawal by Subject|2
4696370|NCT02637063|7609309|FG001|Overall Study|Withdrawal by Subject|2
4696371|NCT02637063|7609310|FG002|Overall Study|Withdrawal by Subject|3
4696372|NCT02637076|7609320|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1
4696373|NCT02637076|7609321|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1
4696374|NCT02637076|7609320|FG000|Overall Study|Withdrawal by Subject|0
4696375|NCT02637076|7609321|FG001|Overall Study|Withdrawal by Subject|4
4696376|NCT02637141|7609330|FG000|Overall Study|Adverse Event|1
4696377|NCT02637141|7609331|FG001|Overall Study|Adverse Event|1
4696378|NCT02637141|7609332|FG002|Overall Study|Adverse Event|0
4696379|NCT02637141|7609330|FG000|Overall Study|Withdrawal by Subject|1
4696380|NCT02637141|7609331|FG001|Overall Study|Withdrawal by Subject|1
4696381|NCT02637141|7609332|FG002|Overall Study|Withdrawal by Subject|1
4696382|NCT02637232|7609340|FG000|Overall Study|Lost to Follow-up|42
4696383|NCT02637232|7609340|FG000|Overall Study|Adverse Event|11
4696384|NCT02637232|7609340|FG000|Overall Study|patient 's decision|2
4696385|NCT02637323|7609346|FG000|Overall Study|Lost to Follow-up|2
4696386|NCT02637323|7609347|FG001|Overall Study|Lost to Follow-up|0
4696387|NCT02637323|7609346|FG000|Overall Study|Protocol Violation|0
4696388|NCT02637323|7609347|FG001|Overall Study|Protocol Violation|1
4696389|NCT02637557|7609367|FG000|Overall Study|Adverse Event|3
4696390|NCT02637557|7609368|FG001|Overall Study|Adverse Event|1
4696391|NCT02637557|7609369|FG002|Overall Study|Adverse Event|3
4696392|NCT02637557|7609370|FG003|Overall Study|Adverse Event|3
4696393|NCT02637557|7609367|FG000|Overall Study|Lost to Follow-up|1
4696394|NCT02637557|7609368|FG001|Overall Study|Lost to Follow-up|1
4696395|NCT02637557|7609369|FG002|Overall Study|Lost to Follow-up|0
4696396|NCT02637557|7609370|FG003|Overall Study|Lost to Follow-up|1
4696397|NCT02637557|7609367|FG000|Overall Study|Physician Decision|1
4696398|NCT02637557|7609368|FG001|Overall Study|Physician Decision|0
4696399|NCT02637557|7609369|FG002|Overall Study|Physician Decision|0
4696400|NCT02637557|7609370|FG003|Overall Study|Physician Decision|0
4696401|NCT02637557|7609367|FG000|Overall Study|Protocol Violation|2
4696402|NCT02637557|7609368|FG001|Overall Study|Protocol Violation|0
4696403|NCT02637557|7609369|FG002|Overall Study|Protocol Violation|2
4696404|NCT02637557|7609370|FG003|Overall Study|Protocol Violation|1
4696405|NCT02637557|7609367|FG000|Overall Study|Withdrawal by Subject|1
4696406|NCT02637557|7609368|FG001|Overall Study|Withdrawal by Subject|3
4696407|NCT02637557|7609369|FG002|Overall Study|Withdrawal by Subject|4
4696408|NCT02637557|7609370|FG003|Overall Study|Withdrawal by Subject|2
4380718|NCT02425826|7158624|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0
4380719|NCT02425826|7158625|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4
4380720|NCT02425826|7158623|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8
4380721|NCT02425826|7158624|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0
4380722|NCT02425826|7158625|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1
4380723|NCT02425826|7158623|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0
4380724|NCT02425826|7158624|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0
4380725|NCT02425826|7158625|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1
4380726|NCT02315703|7158691|FG000|Overall Study|Adverse Event|0
4380727|NCT02315703|7158692|FG001|Overall Study|Adverse Event|0
4380728|NCT02315703|7158693|FG002|Overall Study|Adverse Event|0
4380729|NCT02315703|7158694|FG003|Overall Study|Adverse Event|1
4380730|NCT02315703|7158695|FG004|Overall Study|Adverse Event|1
4380731|NCT02315703|7158696|FG005|Overall Study|Adverse Event|0
4380732|NCT02315703|7158697|FG006|Overall Study|Adverse Event|1
4380733|NCT02315703|7158698|FG007|Overall Study|Adverse Event|0
4380734|NCT02315703|7158691|FG000|Overall Study|Lost to Follow-up|1
4380735|NCT02315703|7158692|FG001|Overall Study|Lost to Follow-up|5
4380736|NCT02315703|7158693|FG002|Overall Study|Lost to Follow-up|3
4380737|NCT02315703|7158694|FG003|Overall Study|Lost to Follow-up|3
4380738|NCT02315703|7158695|FG004|Overall Study|Lost to Follow-up|2
4380739|NCT02315703|7158696|FG005|Overall Study|Lost to Follow-up|1
4380740|NCT02315703|7158697|FG006|Overall Study|Lost to Follow-up|2
4696409|NCT02637856|7609402|FG000|Main Study (Baseline to Week 100)|Adverse Event|9
4696410|NCT02637856|7609403|FG001|Main Study (Baseline to Week 100)|Adverse Event|0
4696411|NCT02637856|7609402|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5
4696412|NCT02637856|7609403|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0
4696413|NCT02637856|7609402|FG000|Main Study (Baseline to Week 100)|Physician Decision|2
4696414|NCT02637856|7609403|FG001|Main Study (Baseline to Week 100)|Physician Decision|0
4696415|NCT02637856|7609402|FG000|Main Study (Baseline to Week 100)|Pregnancy|7
4696416|NCT02637856|7609403|FG001|Main Study (Baseline to Week 100)|Pregnancy|0
4696417|NCT02637856|7609402|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20
4696418|NCT02637856|7609403|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0
4696419|NCT02637856|7609402|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2
4696420|NCT02637856|7609403|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0
4696421|NCT02637856|7609402|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164
4696422|NCT02637856|7609403|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0
4696423|NCT02637856|7609402|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1
4696424|NCT02637856|7609403|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0
4696425|NCT02637856|7609402|FG000|Main Study (Baseline to Week 100)|Incarceration|1
4696426|NCT02637856|7609403|FG001|Main Study (Baseline to Week 100)|Incarceration|0
4696427|NCT02637856|7609402|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2
4696428|NCT02637856|7609403|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0
4696429|NCT02637856|7609402|FG000|Main Study (Baseline to Week 100)|Site Closing|6
4696430|NCT02637856|7609403|FG001|Main Study (Baseline to Week 100)|Site Closing|0
4696431|NCT02637856|7609402|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0
4696432|NCT02637856|7609403|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1
4696433|NCT02637856|7609402|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0
4696434|NCT02637856|7609403|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3
4696435|NCT02637895|7609411|FG000|Overall Study|Lost to Follow-up|4
4696436|NCT02637895|7609412|FG001|Overall Study|Lost to Follow-up|0
4696437|NCT02637895|7609411|FG000|Overall Study|Protocol Violation|0
4696438|NCT02637895|7609412|FG001|Overall Study|Protocol Violation|1
4696439|NCT02637895|7609411|FG000|Overall Study|Lack of Efficacy|1
4696440|NCT02637895|7609412|FG001|Overall Study|Lack of Efficacy|0
4696441|NCT02637895|7609411|FG000|Overall Study|Withdrawal by Subject|1
4696442|NCT02637895|7609412|FG001|Overall Study|Withdrawal by Subject|1
4696443|NCT02637895|7609411|FG000|Overall Study|Abnormal baseline lab|0
4696444|NCT02637895|7609412|FG001|Overall Study|Abnormal baseline lab|1
4696445|NCT02638012|7609432|FG000|Overall Study|Lost to Follow-up|1
4696446|NCT02638103|7609449|FG000|Overall Study|Adverse Event|13
4696447|NCT02638103|7609450|FG001|Overall Study|Adverse Event|12
4696448|NCT02638103|7609451|FG002|Overall Study|Adverse Event|19
4696449|NCT02638103|7609452|FG003|Overall Study|Adverse Event|12
4696450|NCT02638103|7609449|FG000|Overall Study|Withdrawal by Subject|43
4696451|NCT02638103|7609450|FG001|Overall Study|Withdrawal by Subject|53
4696452|NCT02638103|7609451|FG002|Overall Study|Withdrawal by Subject|30
4696453|NCT02638103|7609452|FG003|Overall Study|Withdrawal by Subject|61
4696454|NCT02638103|7609449|FG000|Overall Study|Protocol Violation|1
4696455|NCT02638103|7609450|FG001|Overall Study|Protocol Violation|2
4696456|NCT02638103|7609451|FG002|Overall Study|Protocol Violation|1
4696457|NCT02638103|7609452|FG003|Overall Study|Protocol Violation|4
4696458|NCT02638103|7609449|FG000|Overall Study|Pregnancy|2
4696459|NCT02638103|7609450|FG001|Overall Study|Pregnancy|3
4380741|NCT02315703|7158698|FG007|Overall Study|Lost to Follow-up|2
4380742|NCT02315703|7158691|FG000|Overall Study|Pregnancy|0
4380743|NCT02315703|7158692|FG001|Overall Study|Pregnancy|0
4380744|NCT02315703|7158693|FG002|Overall Study|Pregnancy|0
4380745|NCT02315703|7158694|FG003|Overall Study|Pregnancy|0
4380746|NCT02315703|7158695|FG004|Overall Study|Pregnancy|0
4380747|NCT02315703|7158696|FG005|Overall Study|Pregnancy|0
4380748|NCT02315703|7158697|FG006|Overall Study|Pregnancy|0
4380749|NCT02315703|7158698|FG007|Overall Study|Pregnancy|1
4380750|NCT02315703|7158691|FG000|Overall Study|Withdrawal by Subject|1
4380751|NCT02315703|7158692|FG001|Overall Study|Withdrawal by Subject|3
4380752|NCT02315703|7158693|FG002|Overall Study|Withdrawal by Subject|0
4380753|NCT02315703|7158694|FG003|Overall Study|Withdrawal by Subject|3
4380754|NCT02315703|7158695|FG004|Overall Study|Withdrawal by Subject|4
4380755|NCT02315703|7158696|FG005|Overall Study|Withdrawal by Subject|1
4380756|NCT02315703|7158697|FG006|Overall Study|Withdrawal by Subject|1
4380757|NCT02315703|7158698|FG007|Overall Study|Withdrawal by Subject|2
4380758|NCT02315703|7158691|FG000|Overall Study|Physician Decision|0
4380759|NCT02315703|7158692|FG001|Overall Study|Physician Decision|0
4380760|NCT02315703|7158693|FG002|Overall Study|Physician Decision|0
4380761|NCT02315703|7158694|FG003|Overall Study|Physician Decision|0
4380762|NCT02315703|7158695|FG004|Overall Study|Physician Decision|0
4380763|NCT02315703|7158696|FG005|Overall Study|Physician Decision|2
4380764|NCT02315703|7158697|FG006|Overall Study|Physician Decision|1
4380765|NCT02315703|7158698|FG007|Overall Study|Physician Decision|0
4380766|NCT02315703|7158691|FG000|Overall Study|Other|4
4380767|NCT02315703|7158692|FG001|Overall Study|Other|2
4380768|NCT02315703|7158693|FG002|Overall Study|Other|2
4380769|NCT02315703|7158694|FG003|Overall Study|Other|2
4380770|NCT02315703|7158695|FG004|Overall Study|Other|1
4380771|NCT02315703|7158696|FG005|Overall Study|Other|2
4380772|NCT02315703|7158697|FG006|Overall Study|Other|8
4380773|NCT02315703|7158698|FG007|Overall Study|Other|2
4468079|NCT00625443|7260255|FG001|Overall Study|Withdrawal by Subject|1
4468080|NCT00625443|7260256|FG002|Overall Study|Withdrawal by Subject|2
4468081|NCT00625443|7260254|FG000|Overall Study|Physician Decision|0
4468082|NCT00625443|7260255|FG001|Overall Study|Physician Decision|4
4468083|NCT00625443|7260256|FG002|Overall Study|Physician Decision|2
4468084|NCT00625443|7260254|FG000|Overall Study|Other|0
4468085|NCT00625443|7260255|FG001|Overall Study|Other|1
4468086|NCT00625443|7260256|FG002|Overall Study|Other|1
4468087|NCT00625807|7260274|FG000|Overall Study|schedule conflict|2
4468088|NCT00625807|7260275|FG001|Overall Study|schedule conflict|8
4468089|NCT00625820|7260283|FG000|Overall Study|Withdrawal by Subject|1
4468090|NCT00625846|7260292|FG000|Overall Study|Withdrawal by Subject|2
4468091|NCT00625846|7260293|FG001|Overall Study|Withdrawal by Subject|0
4696460|NCT02638103|7609451|FG002|Overall Study|Pregnancy|0
4696461|NCT02638103|7609452|FG003|Overall Study|Pregnancy|1
4696462|NCT02638103|7609449|FG000|Overall Study|Non-compliance to Study Procedures|2
4696463|NCT02638103|7609450|FG001|Overall Study|Non-compliance to Study Procedures|1
4696464|NCT02638103|7609451|FG002|Overall Study|Non-compliance to Study Procedures|1
4696465|NCT02638103|7609452|FG003|Overall Study|Non-compliance to Study Procedures|1
4696466|NCT02638103|7609449|FG000|Overall Study|Lost to Follow-up|26
4696467|NCT02638103|7609450|FG001|Overall Study|Lost to Follow-up|33
4696468|NCT02638103|7609451|FG002|Overall Study|Lost to Follow-up|20
4696469|NCT02638103|7609452|FG003|Overall Study|Lost to Follow-up|37
4696470|NCT02638103|7609449|FG000|Overall Study|Lack of Efficacy|14
4696471|NCT02638103|7609450|FG001|Overall Study|Lack of Efficacy|10
4696472|NCT02638103|7609451|FG002|Overall Study|Lack of Efficacy|12
4696473|NCT02638103|7609452|FG003|Overall Study|Lack of Efficacy|22
4696474|NCT02638103|7609449|FG000|Overall Study|Other than specified|5
4696475|NCT02638103|7609450|FG001|Overall Study|Other than specified|4
4696476|NCT02638103|7609451|FG002|Overall Study|Other than specified|2
4696477|NCT02638103|7609452|FG003|Overall Study|Other than specified|4
4696478|NCT02638259|7609492|FG000|Treatment Period 1|Adverse Event|1
4696479|NCT02638259|7609493|FG001|Treatment Period 1|Adverse Event|5
4696480|NCT02638259|7609492|FG000|Treatment Period 1|Death|0
4696481|NCT02638259|7609493|FG001|Treatment Period 1|Death|1
4696482|NCT02638259|7609492|FG000|Treatment Period 1|Lack of Efficacy|0
4696483|NCT02638259|7609493|FG001|Treatment Period 1|Lack of Efficacy|1
4696484|NCT02638259|7609492|FG000|Treatment Period 1|Protocol Violation|0
4696485|NCT02638259|7609493|FG001|Treatment Period 1|Protocol Violation|3
4696486|NCT02638259|7609492|FG000|Treatment Period 1|Withdrawal by Subject|4
4696487|NCT02638259|7609493|FG001|Treatment Period 1|Withdrawal by Subject|6
4696488|NCT02638259|7609492|FG000|Treatment Period 1|Withdrawn per sponsor decision|0
4696489|NCT02638259|7609493|FG001|Treatment Period 1|Withdrawn per sponsor decision|2
4696490|NCT02638259|7609492|FG000|Treatment Period 2|Adverse Event|5
4696491|NCT02638259|7609493|FG001|Treatment Period 2|Adverse Event|4
4696492|NCT02638259|7609492|FG000|Treatment Period 2|Withdrawal by Subject|1
4696493|NCT02638259|7609493|FG001|Treatment Period 2|Withdrawal by Subject|7
4696494|NCT02638337|7609505|FG000|Overall Study|Adverse Event|6
4468092|NCT00625846|7260294|FG002|Overall Study|Withdrawal by Subject|1
4696495|NCT02638337|7609506|FG001|Overall Study|Adverse Event|10
4696496|NCT02638337|7609505|FG000|Overall Study|Protocol Violation|3
4468093|NCT00625846|7260295|FG003|Overall Study|Withdrawal by Subject|2
4468094|NCT00625872|7260311|FG000|Overall Study|Withdrawal by Subject|1
4468095|NCT00625872|7260312|FG001|Overall Study|Withdrawal by Subject|0
4468096|NCT00625872|7260311|FG000|Overall Study|Does not meet inclusion criteria|1
4468097|NCT00625872|7260312|FG001|Overall Study|Does not meet inclusion criteria|0
4696497|NCT02638337|7609506|FG001|Overall Study|Protocol Violation|0
4696498|NCT02638337|7609505|FG000|Overall Study|Withdrawal by Subject|13
4588391|NCT01499667|7432945|FG002|Overall Study|administrative problems|5
4696499|NCT02638337|7609506|FG001|Overall Study|Withdrawal by Subject|16
4380774|NCT02000622|7158728|FG000|Overall Study|Withdrawal by Subject|5
4380775|NCT02000622|7158729|FG001|Overall Study|Withdrawal by Subject|7
4380776|NCT02000622|7158728|FG000|Overall Study|Lost to Follow-up|4
4380777|NCT02000622|7158729|FG001|Overall Study|Lost to Follow-up|0
4380778|NCT02000622|7158728|FG000|Overall Study|Death|159
4380779|NCT02000622|7158729|FG001|Overall Study|Death|73
4380780|NCT02000622|7158728|FG000|Overall Study|Withdrawn due to site closure|1
4380781|NCT02000622|7158729|FG001|Overall Study|Withdrawn due to site closure|0
4380782|NCT01933932|7158737|FG000|Overall Study|Death|173
4380783|NCT01933932|7158738|FG001|Overall Study|Death|163
4380784|NCT01933932|7158737|FG000|Overall Study|Withdrawal by Subject|11
4380785|NCT01933932|7158738|FG001|Overall Study|Withdrawal by Subject|14
4380786|NCT01933932|7158737|FG000|Overall Study|Eligibility criteria not fulfilled|0
4380787|NCT01933932|7158738|FG001|Overall Study|Eligibility criteria not fulfilled|1
4380788|NCT01927068|7158746|FG000|Overall Study|Death|37
4380789|NCT01927068|7158747|FG001|Overall Study|Death|3
4380790|NCT01927068|7158746|FG000|Overall Study|Withdrawal by Subject|50
4380791|NCT01927068|7158747|FG001|Overall Study|Withdrawal by Subject|3
4380792|NCT01927068|7158746|FG000|Overall Study|Lost to Follow-up|10
4380793|NCT01927068|7158747|FG001|Overall Study|Lost to Follow-up|2
4380794|NCT01927068|7158746|FG000|Overall Study|Physician Decision|9
4380795|NCT01927068|7158747|FG001|Overall Study|Physician Decision|0
4380796|NCT01927068|7158746|FG000|Overall Study|Missed last follow-up visit|2
4380797|NCT01927068|7158747|FG001|Overall Study|Missed last follow-up visit|0
4380798|NCT01813435|7158765|FG000|Overall Study|did not finish experimental regimen|1902
4380799|NCT01813435|7158766|FG001|Overall Study|did not finish experimental regimen|770
4380800|NCT01813435|7158765|FG000|Overall Study|Lost to Follow-up|268
4380801|NCT01813435|7158766|FG001|Overall Study|Lost to Follow-up|237
4771167|NCT00822120|7747996|FG005|Initial Registration|Reasons not Protocol Specified|0
4771168|NCT00822120|7747991|FG000|Initial Registration|Ineligible|22
4771169|NCT00822120|7747992|FG001|Initial Registration|Ineligible|1
4771170|NCT00822120|7747993|FG002|Initial Registration|Ineligible|0
4771171|NCT00822120|7747994|FG003|Initial Registration|Ineligible|0
4771172|NCT00822120|7747995|FG004|Initial Registration|Ineligible|0
4771173|NCT00822120|7747996|FG005|Initial Registration|Ineligible|0
4771174|NCT00822120|7747991|FG000|PET-directed Therapy|Adverse Event|0
4771175|NCT00822120|7747992|FG001|PET-directed Therapy|Adverse Event|0
4771176|NCT00822120|7747993|FG002|PET-directed Therapy|Adverse Event|0
4771177|NCT00822120|7747994|FG003|PET-directed Therapy|Adverse Event|1
4771178|NCT00822120|7747995|FG004|PET-directed Therapy|Adverse Event|0
4771179|NCT00822120|7747996|FG005|PET-directed Therapy|Adverse Event|0
4771180|NCT00822120|7747991|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
4771181|NCT00822120|7747992|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
4771182|NCT00822120|7747993|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
4771183|NCT00822120|7747994|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1
4771184|NCT00822120|7747995|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
4771185|NCT00822120|7747996|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
4771186|NCT00822120|7747991|FG000|PET-directed Therapy|Death|0
4771187|NCT00822120|7747992|FG001|PET-directed Therapy|Death|0
4771188|NCT00822120|7747993|FG002|PET-directed Therapy|Death|0
4771189|NCT00822120|7747994|FG003|PET-directed Therapy|Death|2
4771190|NCT00822120|7747995|FG004|PET-directed Therapy|Death|0
4771191|NCT00822120|7747996|FG005|PET-directed Therapy|Death|0
4771192|NCT00822120|7747991|FG000|PET-directed Therapy|Protocol Violation|0
4771193|NCT00822120|7747992|FG001|PET-directed Therapy|Protocol Violation|0
4771194|NCT00822120|7747993|FG002|PET-directed Therapy|Protocol Violation|0
4771195|NCT00822120|7747994|FG003|PET-directed Therapy|Protocol Violation|6
4771196|NCT00822120|7747995|FG004|PET-directed Therapy|Protocol Violation|0
4771197|NCT00822120|7747996|FG005|PET-directed Therapy|Protocol Violation|0
4771198|NCT00603954|7748019|FG000|Overall Study|Protocol Violation|1
4771199|NCT00603954|7748020|FG001|Overall Study|Protocol Violation|2
4380850|NCT01690299|7158807|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2
4380851|NCT01690299|7158808|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2
4380852|NCT01690299|7158809|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1
4380853|NCT01690299|7158810|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
4380854|NCT01690299|7158811|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
4380855|NCT01690299|7158812|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
4380856|NCT01690299|7158807|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4
4380857|NCT01690299|7158808|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
4380858|NCT01690299|7158809|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
4380859|NCT01690299|7158810|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
4380860|NCT01690299|7158811|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
4380861|NCT01690299|7158812|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
4380862|NCT01690299|7158807|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1
4380863|NCT01690299|7158808|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3
4380864|NCT01690299|7158809|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
4380865|NCT01690299|7158810|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
4380866|NCT01690299|7158811|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
4380867|NCT01690299|7158812|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
4380868|NCT01690299|7158807|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2
4380869|NCT01690299|7158808|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1
4380870|NCT01690299|7158809|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1
4380871|NCT01690299|7158810|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0
4380872|NCT01690299|7158811|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0
4380873|NCT01690299|7158812|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0
4380874|NCT01690299|7158807|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
4380875|NCT01690299|7158808|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
4380876|NCT01690299|7158809|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
4380877|NCT01690299|7158810|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3
4380878|NCT01690299|7158811|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4
4380879|NCT01690299|7158812|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3
4380880|NCT01690299|7158807|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
4380881|NCT01690299|7158808|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
4380882|NCT01690299|7158809|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
4380883|NCT01690299|7158810|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9
4380884|NCT01690299|7158811|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10
4380885|NCT01690299|7158812|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8
4380886|NCT01690299|7158807|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
4380887|NCT01690299|7158808|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
4380888|NCT01690299|7158809|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
4380889|NCT01690299|7158810|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
4380890|NCT01690299|7158811|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1
4380891|NCT01690299|7158812|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1
4380892|NCT01690299|7158807|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
4380893|NCT01690299|7158808|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
4380894|NCT01690299|7158809|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
4380895|NCT01690299|7158810|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8
4380896|NCT01690299|7158811|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5
4380897|NCT01690299|7158812|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11
4380898|NCT01690299|7158807|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
4380899|NCT01690299|7158808|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
4380900|NCT01690299|7158809|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
4380901|NCT01690299|7158810|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6
4380902|NCT01690299|7158811|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13
4380903|NCT01690299|7158812|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6
4380904|NCT01690299|7158807|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
4380905|NCT01690299|7158808|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
4380906|NCT01690299|7158809|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
4380907|NCT01690299|7158810|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
4380908|NCT01690299|7158811|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
4380909|NCT01690299|7158812|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1
4380910|NCT01452152|7158866|FG000|Overall Study|Study termination by sponsor|5
4380911|NCT01452152|7158867|FG001|Overall Study|Study termination by sponsor|0
4380912|NCT01452152|7158868|FG002|Overall Study|Study termination by sponsor|4
4380913|NCT01420926|7158878|FG000|Overall Study|Adverse Event|6
4380914|NCT01420926|7158879|FG001|Overall Study|Adverse Event|4
4380915|NCT01420926|7158878|FG000|Overall Study|Death|18
4380916|NCT01420926|7158879|FG001|Overall Study|Death|17
4380917|NCT01420926|7158878|FG000|Overall Study|Withdrawal by Subject|11
4380918|NCT01420926|7158879|FG001|Overall Study|Withdrawal by Subject|16
4380919|NCT01420926|7158878|FG000|Overall Study|Non-protocol treatment|17
4380920|NCT01420926|7158879|FG001|Overall Study|Non-protocol treatment|20
4380921|NCT01420926|7158878|FG000|Overall Study|Physician Decision|7
4380922|NCT01420926|7158879|FG001|Overall Study|Physician Decision|5
4380923|NCT01420926|7158878|FG000|Overall Study|Continues on active treatment|1
4380924|NCT01420926|7158879|FG001|Overall Study|Continues on active treatment|3
4380925|NCT01386385|7158890|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1
4380926|NCT01386385|7158891|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0
4380927|NCT01386385|7158892|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0
4380928|NCT01386385|7158893|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0
4380929|NCT01386385|7158894|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0
4380930|NCT01386385|7158895|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0
4380931|NCT01386385|7158896|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0
4380932|NCT01386385|7158897|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0
4380933|NCT01386385|7158890|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1
4380934|NCT01386385|7158891|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0
4380935|NCT01386385|7158892|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0
4380936|NCT01386385|7158893|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0
4380937|NCT01386385|7158894|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0
4380938|NCT01386385|7158895|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0
4380939|NCT01386385|7158896|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0
4468098|NCT00625872|7260311|FG000|Overall Study|Terminated by sponsor|2
4468099|NCT00625872|7260312|FG001|Overall Study|Terminated by sponsor|5
4696500|NCT02638337|7609505|FG000|Overall Study|Lost to Follow-up|7
4696501|NCT02638337|7609506|FG001|Overall Study|Lost to Follow-up|7
4696502|NCT02638337|7609505|FG000|Overall Study|Other - Miscellaneous|4
4696503|NCT02638337|7609506|FG001|Overall Study|Other - Miscellaneous|3
4696504|NCT02638493|7609515|FG000|Overall Study|Inability to provide semen samples|2
4696505|NCT02638493|7609516|FG001|Overall Study|Inability to provide semen samples|0
4696506|NCT02638493|7609517|FG002|Overall Study|Inability to provide semen samples|0
4696507|NCT02638623|7609538|FG000|Overall Study|Surgery timing|5
4696508|NCT02638623|7609539|FG001|Overall Study|Surgery timing|6
4696509|NCT02638623|7609538|FG000|Overall Study|Not given intervention|2
4696510|NCT02638623|7609539|FG001|Overall Study|Not given intervention|0
4696511|NCT02638948|7609549|FG000|Overall Study|Withdrawal by Subject|4
4696512|NCT02638948|7609550|FG001|Overall Study|Withdrawal by Subject|5
4696513|NCT02638948|7609551|FG002|Overall Study|Withdrawal by Subject|3
4696514|NCT02638948|7609552|FG003|Overall Study|Withdrawal by Subject|1
4696515|NCT02638948|7609549|FG000|Overall Study|Administrative Reason by Sponsor|0
4696516|NCT02638948|7609550|FG001|Overall Study|Administrative Reason by Sponsor|1
4696517|NCT02638948|7609551|FG002|Overall Study|Administrative Reason by Sponsor|0
4696518|NCT02638948|7609552|FG003|Overall Study|Administrative Reason by Sponsor|4
4696519|NCT02638948|7609549|FG000|Overall Study|Adverse Event|0
4696520|NCT02638948|7609550|FG001|Overall Study|Adverse Event|0
4696521|NCT02638948|7609551|FG002|Overall Study|Adverse Event|1
4696522|NCT02638948|7609552|FG003|Overall Study|Adverse Event|1
4696523|NCT02638948|7609549|FG000|Overall Study|Lack of Efficacy|1
4696524|NCT02638948|7609550|FG001|Overall Study|Lack of Efficacy|1
4696525|NCT02638948|7609551|FG002|Overall Study|Lack of Efficacy|0
4696526|NCT02638948|7609552|FG003|Overall Study|Lack of Efficacy|0
4696527|NCT02638948|7609549|FG000|Overall Study|Lost to Follow-up|0
4696528|NCT02638948|7609550|FG001|Overall Study|Lost to Follow-up|0
4696529|NCT02638948|7609551|FG002|Overall Study|Lost to Follow-up|1
4696530|NCT02638948|7609552|FG003|Overall Study|Lost to Follow-up|1
4696531|NCT02638948|7609549|FG000|Overall Study|Poor/Non-Compliance|0
4696532|NCT02638948|7609550|FG001|Overall Study|Poor/Non-Compliance|2
4696533|NCT02638948|7609551|FG002|Overall Study|Poor/Non-Compliance|1
4696534|NCT02638948|7609552|FG003|Overall Study|Poor/Non-Compliance|0
4696535|NCT02638948|7609549|FG000|Overall Study|Participant no longer met study criteria|0
4696536|NCT02638948|7609550|FG001|Overall Study|Participant no longer met study criteria|1
4696537|NCT02638948|7609551|FG002|Overall Study|Participant no longer met study criteria|0
4696538|NCT02638948|7609552|FG003|Overall Study|Participant no longer met study criteria|0
4696539|NCT02638948|7609549|FG000|Overall Study|Other than specified above|4
4696540|NCT02638948|7609550|FG001|Overall Study|Other than specified above|1
4696541|NCT02638948|7609551|FG002|Overall Study|Other than specified above|1
4696542|NCT02638948|7609552|FG003|Overall Study|Other than specified above|1
4696543|NCT02639052|7609574|FG000|Overall Study|Lost to Follow-up|1
4696544|NCT02639182|7609582|FG000|Overall Study|Disease Progression|50
4696545|NCT02639182|7609583|FG001|Overall Study|Disease Progression|49
4696546|NCT02639182|7609582|FG000|Overall Study|Adverse Event|7
4696547|NCT02639182|7609583|FG001|Overall Study|Adverse Event|5
4696548|NCT02639182|7609582|FG000|Overall Study|Physician Decision|3
4696549|NCT02639182|7609583|FG001|Overall Study|Physician Decision|3
4696550|NCT02639182|7609582|FG000|Overall Study|Withdrew Consent|5
4696551|NCT02639182|7609583|FG001|Overall Study|Withdrew Consent|4
4696552|NCT02639182|7609582|FG000|Overall Study|Lost to Follow-up|0
4696553|NCT02639182|7609583|FG001|Overall Study|Lost to Follow-up|1
4696554|NCT02639182|7609582|FG000|Overall Study|Study Closure|1
4696555|NCT02639182|7609583|FG001|Overall Study|Study Closure|2
4696556|NCT02639182|7609582|FG000|Overall Study|Sponsor Ended Study|0
4696557|NCT02639182|7609583|FG001|Overall Study|Sponsor Ended Study|1
4696558|NCT02639182|7609582|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1
4696559|NCT02639182|7609583|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1
4696560|NCT02639247|7609591|FG000|Overall Study|Lost to Follow-up|2
4696561|NCT02639247|7609592|FG001|Overall Study|Lost to Follow-up|1
4696562|NCT02639247|7609591|FG000|Overall Study|Death|2
4696563|NCT02639247|7609592|FG001|Overall Study|Death|0
4696564|NCT02639247|7609591|FG000|Overall Study|Withdrew Consent|0
4380940|NCT01386385|7158897|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0
4380941|NCT01386385|7158890|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0
4380942|NCT01386385|7158891|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0
4380943|NCT01386385|7158892|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2
4380944|NCT01386385|7158893|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0
4380945|NCT01386385|7158894|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0
4380946|NCT01386385|7158895|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0
4380947|NCT01386385|7158896|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0
4380948|NCT01386385|7158897|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0
4380949|NCT01386385|7158890|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0
4380950|NCT01386385|7158891|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0
4380951|NCT01386385|7158892|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0
4380952|NCT01386385|7158893|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0
4380953|NCT01386385|7158894|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1
4380954|NCT01386385|7158895|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0
4588392|NCT01499667|7432943|FG000|Overall Study|Protocol Violation|1
4588393|NCT01499667|7432944|FG001|Overall Study|Protocol Violation|3
4588394|NCT01499667|7432945|FG002|Overall Study|Protocol Violation|2
4588395|NCT01499667|7432943|FG000|Overall Study|Adverse Event|0
4588396|NCT01499667|7432944|FG001|Overall Study|Adverse Event|2
4588397|NCT01499667|7432945|FG002|Overall Study|Adverse Event|2
4588398|NCT01499667|7432943|FG000|Overall Study|Withdrawal by Subject|2
4588399|NCT01499667|7432944|FG001|Overall Study|Withdrawal by Subject|1
4588400|NCT01499667|7432945|FG002|Overall Study|Withdrawal by Subject|1
4588401|NCT01499667|7432943|FG000|Overall Study|Lack of Efficacy|2
4588402|NCT01499667|7432944|FG001|Overall Study|Lack of Efficacy|0
4588403|NCT01499667|7432945|FG002|Overall Study|Lack of Efficacy|0
4380955|NCT01386385|7158896|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0
4380956|NCT01386385|7158897|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0
4380957|NCT01386385|7158890|FG000|Phase II Concurrent CRT|Adverse Event|0
4380958|NCT01386385|7158891|FG001|Phase II Concurrent CRT|Adverse Event|0
4380959|NCT01386385|7158892|FG002|Phase II Concurrent CRT|Adverse Event|0
4380960|NCT01386385|7158893|FG003|Phase II Concurrent CRT|Adverse Event|0
4380961|NCT01386385|7158894|FG004|Phase II Concurrent CRT|Adverse Event|0
4380962|NCT01386385|7158895|FG005|Phase II Concurrent CRT|Adverse Event|0
4380963|NCT01386385|7158896|FG006|Phase II Concurrent CRT|Adverse Event|3
4380964|NCT01386385|7158897|FG007|Phase II Concurrent CRT|Adverse Event|3
4380965|NCT01386385|7158890|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0
4380966|NCT01386385|7158891|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0
4380967|NCT01386385|7158892|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0
4380968|NCT01386385|7158893|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0
4380969|NCT01386385|7158894|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0
4380970|NCT01386385|7158895|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0
4696565|NCT02639247|7609592|FG001|Overall Study|Withdrew Consent|1
4696566|NCT02639247|7609591|FG000|Overall Study|Protocol Violation|1
4696567|NCT02639247|7609592|FG001|Overall Study|Protocol Violation|0
4696568|NCT02639338|7609609|FG000|Overall Study|Lost to Follow-up|2
4696569|NCT02639338|7609610|FG001|Overall Study|Lost to Follow-up|2
4696570|NCT02639338|7609609|FG000|Overall Study|Withdrew Consent|1
4696571|NCT02639338|7609610|FG001|Overall Study|Withdrew Consent|2
4696572|NCT02639338|7609609|FG000|Overall Study|Death|1
4696573|NCT02639338|7609610|FG001|Overall Study|Death|0
4696574|NCT02639338|7609609|FG000|Overall Study|Randomized but Not Treated|0
4696575|NCT02639338|7609610|FG001|Overall Study|Randomized but Not Treated|1
4696576|NCT02640053|7609681|FG000|Overall Study|Withdrawal by Subject|2
4696577|NCT02640053|7609682|FG001|Overall Study|Withdrawal by Subject|1
4696578|NCT02640053|7609681|FG000|Overall Study|Adverse Event|1
4696579|NCT02640053|7609682|FG001|Overall Study|Adverse Event|1
4696580|NCT02640053|7609681|FG000|Overall Study|Alternative Therapy|1
4696581|NCT02640053|7609682|FG001|Overall Study|Alternative Therapy|1
4696582|NCT02640053|7609681|FG000|Overall Study|Chemo regimen changed after 1st Rx|0
4696583|NCT02640053|7609682|FG001|Overall Study|Chemo regimen changed after 1st Rx|1
4696584|NCT02640157|7609691|FG000|Overall Study|Adverse Event|2
4696585|NCT02640157|7609692|FG001|Overall Study|Adverse Event|2
4696586|NCT02640157|7609693|FG002|Overall Study|Adverse Event|1
4696587|NCT02640157|7609691|FG000|Overall Study|Withdrew consent|2
4696588|NCT02640157|7609692|FG001|Overall Study|Withdrew consent|0
4696589|NCT02640157|7609693|FG002|Overall Study|Withdrew consent|2
4696590|NCT02640157|7609691|FG000|Overall Study|Lost to Follow-up|9
4696591|NCT02640157|7609692|FG001|Overall Study|Lost to Follow-up|2
4696592|NCT02640157|7609693|FG002|Overall Study|Lost to Follow-up|7
4380971|NCT01386385|7158896|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3
4380972|NCT01386385|7158897|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0
4380973|NCT01386385|7158890|FG000|Phase II: Consolidation Therapy|Adverse Event|0
4380974|NCT01386385|7158891|FG001|Phase II: Consolidation Therapy|Adverse Event|0
4380975|NCT01386385|7158892|FG002|Phase II: Consolidation Therapy|Adverse Event|0
4380976|NCT01386385|7158893|FG003|Phase II: Consolidation Therapy|Adverse Event|0
4696593|NCT02640157|7609691|FG000|Overall Study|Randomized in error; did not receive Tx|0
4380977|NCT01386385|7158894|FG004|Phase II: Consolidation Therapy|Adverse Event|0
4380978|NCT01386385|7158895|FG005|Phase II: Consolidation Therapy|Adverse Event|0
4380979|NCT01386385|7158896|FG006|Phase II: Consolidation Therapy|Adverse Event|2
4380980|NCT01386385|7158897|FG007|Phase II: Consolidation Therapy|Adverse Event|1
4380981|NCT01386385|7158890|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0
4380982|NCT01386385|7158891|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0
4380983|NCT01386385|7158892|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0
4380984|NCT01386385|7158893|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0
4380985|NCT01386385|7158894|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0
4380986|NCT01386385|7158895|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0
4380987|NCT01386385|7158896|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2
4380988|NCT01386385|7158897|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0
4380989|NCT01386385|7158890|FG000|Phase II: Consolidation Therapy|Progression/relapse|0
4380990|NCT01386385|7158891|FG001|Phase II: Consolidation Therapy|Progression/relapse|0
4380991|NCT01386385|7158892|FG002|Phase II: Consolidation Therapy|Progression/relapse|0
4380992|NCT01386385|7158893|FG003|Phase II: Consolidation Therapy|Progression/relapse|0
4696594|NCT02640157|7609692|FG001|Overall Study|Randomized in error; did not receive Tx|1
4696595|NCT02640157|7609693|FG002|Overall Study|Randomized in error; did not receive Tx|0
4696596|NCT02640235|7609704|FG000|Overall Study|Withdrawal by Subject|7
4696597|NCT02640235|7609705|FG001|Overall Study|Withdrawal by Subject|6
4696598|NCT02640235|7609704|FG000|Overall Study|Lost to Follow-up|4
4696599|NCT02640235|7609705|FG001|Overall Study|Lost to Follow-up|3
4696600|NCT02640235|7609704|FG000|Overall Study|Death|2
4696601|NCT02640235|7609705|FG001|Overall Study|Death|3
4696602|NCT02640235|7609704|FG000|Overall Study|Other|1
4696603|NCT02640235|7609705|FG001|Overall Study|Other|2
4696604|NCT02640404|7609713|FG000|Overall Study|Protocol Violation|1
4696605|NCT02640404|7609714|FG001|Overall Study|Protocol Violation|0
4696606|NCT02640404|7609713|FG000|Overall Study|Withdrawal by Subject|1
4696607|NCT02640404|7609714|FG001|Overall Study|Withdrawal by Subject|0
4696608|NCT02640482|7609722|FG000|Overall Study|Lost to Follow-up|3
4696609|NCT02640482|7609723|FG001|Overall Study|Lost to Follow-up|0
4696610|NCT02640547|7609729|FG000|Overall Study|Failure to Return|1
4696611|NCT02640547|7609729|FG000|Overall Study|Withdrawal by Subject|1
4696612|NCT02640547|7609729|FG000|Overall Study|Death|6
4696613|NCT02640547|7609729|FG000|Overall Study|Miscellaneous|3
4696614|NCT02640612|7609744|FG000|Overall Study|Adverse Event|6
4696615|NCT02640612|7609745|FG001|Overall Study|Adverse Event|7
4696616|NCT02640612|7609746|FG002|Overall Study|Adverse Event|2
4696617|NCT02640612|7609744|FG000|Overall Study|Death|1
4696618|NCT02640612|7609745|FG001|Overall Study|Death|0
4696619|NCT02640612|7609746|FG002|Overall Study|Death|0
4696620|NCT02640612|7609744|FG000|Overall Study|Withdrawal by Subject|10
4696621|NCT02640612|7609745|FG001|Overall Study|Withdrawal by Subject|3
4696622|NCT02640612|7609746|FG002|Overall Study|Withdrawal by Subject|3
4696623|NCT02640612|7609744|FG000|Overall Study|Lost to Follow-up|4
4696624|NCT02640612|7609745|FG001|Overall Study|Lost to Follow-up|1
4696625|NCT02640612|7609746|FG002|Overall Study|Lost to Follow-up|1
4696626|NCT02640612|7609744|FG000|Overall Study|Protocol Violation|0
4696627|NCT02640612|7609745|FG001|Overall Study|Protocol Violation|2
4696628|NCT02640612|7609746|FG002|Overall Study|Protocol Violation|0
4696629|NCT02640612|7609744|FG000|Overall Study|Lack of Efficacy|1
4696630|NCT02640612|7609745|FG001|Overall Study|Lack of Efficacy|1
4696631|NCT02640612|7609746|FG002|Overall Study|Lack of Efficacy|0
4696632|NCT02640755|7609765|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0
4696633|NCT02640755|7609766|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1
4696634|NCT02640755|7609765|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1
4696635|NCT02640755|7609766|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0
4696636|NCT02640755|7609765|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1
4696637|NCT02640755|7609766|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0
4696638|NCT02641080|7609797|FG000|Overall Study|Physician Decision|2
4696639|NCT02641080|7609798|FG001|Overall Study|Physician Decision|0
4696640|NCT02641080|7609797|FG000|Overall Study|Withdrawal by Subject|0
4696641|NCT02641080|7609798|FG001|Overall Study|Withdrawal by Subject|1
4696642|NCT02641080|7609797|FG000|Overall Study|Rehab Center denied use of pumps|0
4696643|NCT02641080|7609798|FG001|Overall Study|Rehab Center denied use of pumps|3
4696644|NCT02641080|7609797|FG000|Overall Study|Lost to Follow-up|0
4696645|NCT02641080|7609798|FG001|Overall Study|Lost to Follow-up|3
4696646|NCT02641379|7609836|FG000|Overall Study|Exclusion criterion during screening|1
4696647|NCT02641379|7609837|FG001|Overall Study|Exclusion criterion during screening|0
4696648|NCT02641379|7609838|FG002|Overall Study|Exclusion criterion during screening|0
4696649|NCT02641379|7609839|FG003|Overall Study|Exclusion criterion during screening|1
4696650|NCT02641379|7609840|FG004|Overall Study|Exclusion criterion during screening|2
4696651|NCT02641379|7609841|FG005|Overall Study|Exclusion criterion during screening|0
4696652|NCT02641379|7609842|FG006|Overall Study|Exclusion criterion during screening|0
4696653|NCT02641379|7609843|FG007|Overall Study|Exclusion criterion during screening|0
4696654|NCT02641379|7609844|FG008|Overall Study|Exclusion criterion during screening|0
4696655|NCT02641379|7609845|FG009|Overall Study|Exclusion criterion during screening|0
4696656|NCT02641379|7609846|FG010|Overall Study|Exclusion criterion during screening|0
4696657|NCT02641379|7609836|FG000|Overall Study|Withdrawal of informed consent|0
4380993|NCT01386385|7158894|FG004|Phase II: Consolidation Therapy|Progression/relapse|0
4380994|NCT01386385|7158895|FG005|Phase II: Consolidation Therapy|Progression/relapse|0
4380995|NCT01386385|7158896|FG006|Phase II: Consolidation Therapy|Progression/relapse|1
4380996|NCT01386385|7158897|FG007|Phase II: Consolidation Therapy|Progression/relapse|1
4380997|NCT01358877|7158920|FG000|Overall Study|Death|80
4380998|NCT01358877|7158921|FG001|Overall Study|Death|89
4380999|NCT01358877|7158920|FG000|Overall Study|Ongoing follow-up for post-recurrence|87
4381000|NCT01358877|7158921|FG001|Overall Study|Ongoing follow-up for post-recurrence|108
4381001|NCT01358877|7158920|FG000|Overall Study|Ongoing follow-up for IDFS event|2084
4381002|NCT01358877|7158921|FG001|Overall Study|Ongoing follow-up for IDFS event|2073
4381003|NCT01358877|7158920|FG000|Overall Study|Ongoing follow-up for overall survival|7
4381004|NCT01358877|7158921|FG001|Overall Study|Ongoing follow-up for overall survival|5
4381005|NCT01358877|7158920|FG000|Overall Study|Other|142
4381006|NCT01358877|7158921|FG001|Overall Study|Other|129
4381007|NCT01267955|7158932|FG000|Stage 1 (6 Months)|Death|3
4381008|NCT01267955|7158932|FG000|Stage 2 (6 Months)|Death|5
4381009|NCT01267955|7158932|FG000|Stage 2 (6 Months)|Protocol Violation|1
4381010|NCT01256398|7158936|FG000|Overall Study|Withdrawal by Subject|1
4381011|NCT01232283|7158947|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12
4381012|NCT01232283|7158948|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8
4381013|NCT01232283|7158949|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
4381014|NCT01232283|7158950|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
4381015|NCT01232283|7158951|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
4381016|NCT01232283|7158952|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
4381017|NCT01232283|7158953|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
4381018|NCT01232283|7158954|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
4381019|NCT01232283|7158955|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
4381020|NCT01232283|7158956|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
4381021|NCT01232283|7158947|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3
4381022|NCT01232283|7158948|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2
4381023|NCT01232283|7158949|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
4381024|NCT01232283|7158950|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
4468100|NCT00625872|7260311|FG000|Overall Study|Randomized but not treated|0
4468101|NCT00625872|7260312|FG001|Overall Study|Randomized but not treated|1
4468102|NCT00626028|7260326|FG000|Overall Study|Adverse Event|1
4468103|NCT00626028|7260327|FG001|Overall Study|Adverse Event|1
4468104|NCT00626028|7260326|FG000|Overall Study|Device Failure|0
4468105|NCT00626028|7260327|FG001|Overall Study|Device Failure|1
4468106|NCT00626028|7260326|FG000|Overall Study|Physician Decision|2
4468107|NCT00626028|7260327|FG001|Overall Study|Physician Decision|1
4468108|NCT00626028|7260326|FG000|Overall Study|Inclusion/Exclusion Criteria|3
4468109|NCT00626028|7260327|FG001|Overall Study|Inclusion/Exclusion Criteria|6
4696658|NCT02641379|7609837|FG001|Overall Study|Withdrawal of informed consent|1
4696659|NCT02641379|7609838|FG002|Overall Study|Withdrawal of informed consent|0
4696660|NCT02641379|7609839|FG003|Overall Study|Withdrawal of informed consent|0
4696661|NCT02641379|7609840|FG004|Overall Study|Withdrawal of informed consent|0
4696662|NCT02641379|7609841|FG005|Overall Study|Withdrawal of informed consent|0
4696663|NCT02641379|7609842|FG006|Overall Study|Withdrawal of informed consent|0
4696664|NCT02641379|7609843|FG007|Overall Study|Withdrawal of informed consent|1
4696665|NCT02641379|7609844|FG008|Overall Study|Withdrawal of informed consent|0
4696666|NCT02641379|7609845|FG009|Overall Study|Withdrawal of informed consent|0
4696667|NCT02641379|7609846|FG010|Overall Study|Withdrawal of informed consent|0
4696668|NCT02641379|7609836|FG000|Overall Study|Adverse Event|7
4696669|NCT02641379|7609837|FG001|Overall Study|Adverse Event|8
4696670|NCT02641379|7609838|FG002|Overall Study|Adverse Event|2
4696671|NCT02641379|7609839|FG003|Overall Study|Adverse Event|2
4696672|NCT02641379|7609840|FG004|Overall Study|Adverse Event|5
4696673|NCT02641379|7609841|FG005|Overall Study|Adverse Event|1
4696674|NCT02641379|7609842|FG006|Overall Study|Adverse Event|5
4696675|NCT02641379|7609843|FG007|Overall Study|Adverse Event|0
4696676|NCT02641379|7609844|FG008|Overall Study|Adverse Event|1
4696677|NCT02641379|7609845|FG009|Overall Study|Adverse Event|1
4696678|NCT02641379|7609846|FG010|Overall Study|Adverse Event|5
4696679|NCT02641379|7609836|FG000|Overall Study|Lack of Efficacy|0
4696680|NCT02641379|7609837|FG001|Overall Study|Lack of Efficacy|0
4696681|NCT02641379|7609838|FG002|Overall Study|Lack of Efficacy|2
4696682|NCT02641379|7609839|FG003|Overall Study|Lack of Efficacy|0
4696683|NCT02641379|7609840|FG004|Overall Study|Lack of Efficacy|0
4696684|NCT02641379|7609841|FG005|Overall Study|Lack of Efficacy|2
4696685|NCT02641379|7609842|FG006|Overall Study|Lack of Efficacy|0
4696686|NCT02641379|7609843|FG007|Overall Study|Lack of Efficacy|5
4696687|NCT02641379|7609844|FG008|Overall Study|Lack of Efficacy|0
4696688|NCT02641379|7609845|FG009|Overall Study|Lack of Efficacy|0
4468110|NCT00626093|7260333|FG000|Overall Study|Lost to Follow-up|5
4468111|NCT00626093|7260333|FG000|Overall Study|Death|1
4468112|NCT00626093|7260333|FG000|Overall Study|Physician Decision|4
4468113|NCT00626093|7260333|FG000|Overall Study|Withdrawal by Subject|6
4468114|NCT00626093|7260333|FG000|Overall Study|Protocol Violation|1
4696689|NCT02641379|7609846|FG010|Overall Study|Lack of Efficacy|0
4696690|NCT02641379|7609836|FG000|Overall Study|Participant unable to attend study visit|4
4381025|NCT01232283|7158951|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
4381026|NCT01232283|7158952|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
4381027|NCT01232283|7158953|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
4381028|NCT01232283|7158954|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
4381029|NCT01232283|7158955|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
4381030|NCT01232283|7158956|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
4381031|NCT01232283|7158947|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1
4381032|NCT01232283|7158948|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
4381033|NCT01232283|7158949|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
4381034|NCT01232283|7158950|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
4381035|NCT01232283|7158951|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
4381036|NCT01232283|7158952|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
4381037|NCT01232283|7158953|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
4381038|NCT01232283|7158954|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
4381039|NCT01232283|7158955|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
4381040|NCT01232283|7158956|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
4381041|NCT01232283|7158947|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9
4381042|NCT01232283|7158948|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7
4381043|NCT01232283|7158949|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
4381044|NCT01232283|7158950|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
4381045|NCT01232283|7158951|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
4381046|NCT01232283|7158952|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
4381047|NCT01232283|7158953|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
4381048|NCT01232283|7158954|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
4381049|NCT01232283|7158955|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
4381050|NCT01232283|7158956|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
4381051|NCT01232283|7158947|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6
4381052|NCT01232283|7158948|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6
4381053|NCT01232283|7158949|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
4381054|NCT01232283|7158950|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
4381055|NCT01232283|7158951|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
4381056|NCT01232283|7158952|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
4381057|NCT01232283|7158953|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
4381058|NCT01232283|7158954|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
4381059|NCT01232283|7158955|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
4381060|NCT01232283|7158956|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
4381061|NCT01232283|7158947|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3
4381062|NCT01232283|7158948|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2
4381063|NCT01232283|7158949|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
4381064|NCT01232283|7158950|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
4381065|NCT01232283|7158951|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
4381066|NCT01232283|7158952|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
4381067|NCT01232283|7158953|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
4381068|NCT01232283|7158954|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
4381069|NCT01232283|7158955|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
4381070|NCT01232283|7158956|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
4381071|NCT01232283|7158947|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2
4381072|NCT01232283|7158948|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1
4381073|NCT01232283|7158949|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0
4381074|NCT01232283|7158950|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0
4381075|NCT01232283|7158951|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0
4381076|NCT01232283|7158952|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0
4381077|NCT01232283|7158953|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0
4381078|NCT01232283|7158954|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0
4381079|NCT01232283|7158955|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0
4381080|NCT01232283|7158956|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0
4381081|NCT01232283|7158947|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0
4381082|NCT01232283|7158948|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0
4381083|NCT01232283|7158949|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8
4381084|NCT01232283|7158950|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2
4381085|NCT01232283|7158951|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0
4381086|NCT01232283|7158952|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0
4381087|NCT01232283|7158953|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0
4381088|NCT01232283|7158954|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0
4381089|NCT01232283|7158955|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0
4381090|NCT01232283|7158956|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0
4381091|NCT01232283|7158947|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
4381092|NCT01232283|7158948|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
4381093|NCT01232283|7158949|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19
4381094|NCT01232283|7158950|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3
4381095|NCT01232283|7158951|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
4381096|NCT01232283|7158952|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
4381097|NCT01232283|7158953|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
4381098|NCT01232283|7158954|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
4381099|NCT01232283|7158955|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
4381100|NCT01232283|7158956|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
4381101|NCT01232283|7158947|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
4381102|NCT01232283|7158948|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
4381103|NCT01232283|7158949|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1
4381104|NCT01232283|7158950|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
4381105|NCT01232283|7158951|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
4381106|NCT01232283|7158952|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
4381107|NCT01232283|7158953|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
4381108|NCT01232283|7158954|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
4381109|NCT01232283|7158955|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
4381110|NCT01232283|7158956|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
4381111|NCT01232283|7158947|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
4381112|NCT01232283|7158948|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
4381113|NCT01232283|7158949|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7
4381114|NCT01232283|7158950|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1
4381115|NCT01232283|7158951|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
4381116|NCT01232283|7158952|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
4381117|NCT01232283|7158953|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
4381118|NCT01232283|7158954|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
4381119|NCT01232283|7158955|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
4381120|NCT01232283|7158956|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
4381121|NCT01232283|7158947|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
4381122|NCT01232283|7158948|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
4381123|NCT01232283|7158949|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3
4381124|NCT01232283|7158950|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2
4381125|NCT01232283|7158951|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
4381126|NCT01232283|7158952|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
4381127|NCT01232283|7158953|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
4381128|NCT01232283|7158954|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
4381129|NCT01232283|7158955|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
4381130|NCT01232283|7158956|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
4381131|NCT01232283|7158947|FG000|Maintenance Phase (Weeks16-32)|Other|0
4381132|NCT01232283|7158948|FG001|Maintenance Phase (Weeks16-32)|Other|0
4381133|NCT01232283|7158949|FG002|Maintenance Phase (Weeks16-32)|Other|2
4381134|NCT01232283|7158950|FG003|Maintenance Phase (Weeks16-32)|Other|0
4381135|NCT01232283|7158951|FG004|Maintenance Phase (Weeks16-32)|Other|0
4381136|NCT01232283|7158952|FG005|Maintenance Phase (Weeks16-32)|Other|0
4381137|NCT01232283|7158953|FG006|Maintenance Phase (Weeks16-32)|Other|0
4381138|NCT01232283|7158954|FG007|Maintenance Phase (Weeks16-32)|Other|0
4381139|NCT01232283|7158955|FG008|Maintenance Phase (Weeks16-32)|Other|0
4381140|NCT01232283|7158956|FG009|Maintenance Phase (Weeks16-32)|Other|0
4381141|NCT01232283|7158947|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
4381142|NCT01232283|7158948|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
4381143|NCT01232283|7158949|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
4381144|NCT01232283|7158950|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
4696691|NCT02641379|7609837|FG001|Overall Study|Participant unable to attend study visit|10
4696692|NCT02641379|7609838|FG002|Overall Study|Participant unable to attend study visit|1
4696693|NCT02641379|7609839|FG003|Overall Study|Participant unable to attend study visit|2
4696694|NCT02641379|7609840|FG004|Overall Study|Participant unable to attend study visit|5
4696695|NCT02641379|7609841|FG005|Overall Study|Participant unable to attend study visit|1
4696696|NCT02641379|7609842|FG006|Overall Study|Participant unable to attend study visit|1
4696697|NCT02641379|7609843|FG007|Overall Study|Participant unable to attend study visit|1
4696698|NCT02641379|7609844|FG008|Overall Study|Participant unable to attend study visit|0
4696699|NCT02641379|7609845|FG009|Overall Study|Participant unable to attend study visit|2
4696700|NCT02641379|7609846|FG010|Overall Study|Participant unable to attend study visit|0
4696701|NCT02641379|7609836|FG000|Overall Study|Participant's compliance|0
4696702|NCT02641379|7609837|FG001|Overall Study|Participant's compliance|1
4696703|NCT02641379|7609838|FG002|Overall Study|Participant's compliance|0
4696704|NCT02641379|7609839|FG003|Overall Study|Participant's compliance|1
4696705|NCT02641379|7609840|FG004|Overall Study|Participant's compliance|0
4696706|NCT02641379|7609841|FG005|Overall Study|Participant's compliance|2
4696707|NCT02641379|7609842|FG006|Overall Study|Participant's compliance|0
4696708|NCT02641379|7609843|FG007|Overall Study|Participant's compliance|0
4381145|NCT01232283|7158951|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2
4381146|NCT01232283|7158952|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1
4381147|NCT01232283|7158953|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
4381148|NCT01232283|7158954|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1
4381149|NCT01232283|7158955|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
4381150|NCT01232283|7158956|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
4696709|NCT02641379|7609844|FG008|Overall Study|Participant's compliance|1
4696710|NCT02641379|7609845|FG009|Overall Study|Participant's compliance|1
4696711|NCT02641379|7609846|FG010|Overall Study|Participant's compliance|1
4696712|NCT02641379|7609836|FG000|Overall Study|Participant cannot be reached|4
4696713|NCT02641379|7609837|FG001|Overall Study|Participant cannot be reached|4
4696714|NCT02641379|7609838|FG002|Overall Study|Participant cannot be reached|0
4696715|NCT02641379|7609839|FG003|Overall Study|Participant cannot be reached|8
4696716|NCT02641379|7609840|FG004|Overall Study|Participant cannot be reached|2
4696717|NCT02641379|7609841|FG005|Overall Study|Participant cannot be reached|1
4696718|NCT02641379|7609842|FG006|Overall Study|Participant cannot be reached|0
4696719|NCT02641379|7609843|FG007|Overall Study|Participant cannot be reached|1
4696720|NCT02641379|7609844|FG008|Overall Study|Participant cannot be reached|0
4696721|NCT02641379|7609845|FG009|Overall Study|Participant cannot be reached|2
4696722|NCT02641379|7609846|FG010|Overall Study|Participant cannot be reached|1
4696723|NCT02641379|7609836|FG000|Overall Study|PCR positive at Week 24|15
4696724|NCT02641379|7609837|FG001|Overall Study|PCR positive at Week 24|21
4696725|NCT02641379|7609838|FG002|Overall Study|PCR positive at Week 24|62
4696726|NCT02641379|7609839|FG003|Overall Study|PCR positive at Week 24|0
4696727|NCT02641379|7609840|FG004|Overall Study|PCR positive at Week 24|0
4696728|NCT02641379|7609841|FG005|Overall Study|PCR positive at Week 24|6
4696729|NCT02641379|7609842|FG006|Overall Study|PCR positive at Week 24|3
4696730|NCT02641379|7609843|FG007|Overall Study|PCR positive at Week 24|8
4696731|NCT02641379|7609844|FG008|Overall Study|PCR positive at Week 24|0
4696732|NCT02641379|7609845|FG009|Overall Study|PCR positive at Week 24|1
4696733|NCT02641379|7609846|FG010|Overall Study|PCR positive at Week 24|0
4696734|NCT02641379|7609836|FG000|Overall Study|PCR positive at follow up 2|1
4696735|NCT02641379|7609837|FG001|Overall Study|PCR positive at follow up 2|0
4696736|NCT02641379|7609838|FG002|Overall Study|PCR positive at follow up 2|0
4696737|NCT02641379|7609839|FG003|Overall Study|PCR positive at follow up 2|0
4696738|NCT02641379|7609840|FG004|Overall Study|PCR positive at follow up 2|0
4696739|NCT02641379|7609841|FG005|Overall Study|PCR positive at follow up 2|0
4696740|NCT02641379|7609842|FG006|Overall Study|PCR positive at follow up 2|0
4696741|NCT02641379|7609843|FG007|Overall Study|PCR positive at follow up 2|0
4696742|NCT02641379|7609844|FG008|Overall Study|PCR positive at follow up 2|0
4696743|NCT02641379|7609845|FG009|Overall Study|PCR positive at follow up 2|0
4696744|NCT02641379|7609846|FG010|Overall Study|PCR positive at follow up 2|0
4696745|NCT02641379|7609836|FG000|Overall Study|Participant showed relapse|1
4696746|NCT02641379|7609837|FG001|Overall Study|Participant showed relapse|0
4696747|NCT02641379|7609838|FG002|Overall Study|Participant showed relapse|0
4696748|NCT02641379|7609839|FG003|Overall Study|Participant showed relapse|0
4696749|NCT02641379|7609840|FG004|Overall Study|Participant showed relapse|0
4696750|NCT02641379|7609841|FG005|Overall Study|Participant showed relapse|0
4696751|NCT02641379|7609842|FG006|Overall Study|Participant showed relapse|1
4696752|NCT02641379|7609843|FG007|Overall Study|Participant showed relapse|0
4696753|NCT02641379|7609844|FG008|Overall Study|Participant showed relapse|0
4696754|NCT02641379|7609845|FG009|Overall Study|Participant showed relapse|0
4696755|NCT02641379|7609846|FG010|Overall Study|Participant showed relapse|0
4696756|NCT02641379|7609836|FG000|Overall Study|Participant stopped study/treatment|1
4696757|NCT02641379|7609837|FG001|Overall Study|Participant stopped study/treatment|3
4696758|NCT02641379|7609838|FG002|Overall Study|Participant stopped study/treatment|1
4696759|NCT02641379|7609839|FG003|Overall Study|Participant stopped study/treatment|0
4696760|NCT02641379|7609840|FG004|Overall Study|Participant stopped study/treatment|0
4696761|NCT02641379|7609841|FG005|Overall Study|Participant stopped study/treatment|1
4696762|NCT02641379|7609842|FG006|Overall Study|Participant stopped study/treatment|2
4696763|NCT02641379|7609843|FG007|Overall Study|Participant stopped study/treatment|0
4696764|NCT02641379|7609844|FG008|Overall Study|Participant stopped study/treatment|1
4696765|NCT02641379|7609845|FG009|Overall Study|Participant stopped study/treatment|0
4696766|NCT02641379|7609846|FG010|Overall Study|Participant stopped study/treatment|0
4696767|NCT02641379|7609836|FG000|Overall Study|Therapy stopped due to misunderstanding|1
4696768|NCT02641379|7609837|FG001|Overall Study|Therapy stopped due to misunderstanding|0
4696769|NCT02641379|7609838|FG002|Overall Study|Therapy stopped due to misunderstanding|0
4696770|NCT02641379|7609839|FG003|Overall Study|Therapy stopped due to misunderstanding|0
4696771|NCT02641379|7609840|FG004|Overall Study|Therapy stopped due to misunderstanding|0
4696772|NCT02641379|7609841|FG005|Overall Study|Therapy stopped due to misunderstanding|0
4696773|NCT02641379|7609842|FG006|Overall Study|Therapy stopped due to misunderstanding|0
4696774|NCT02641379|7609843|FG007|Overall Study|Therapy stopped due to misunderstanding|0
4696775|NCT02641379|7609844|FG008|Overall Study|Therapy stopped due to misunderstanding|0
4696776|NCT02641379|7609845|FG009|Overall Study|Therapy stopped due to misunderstanding|0
4696777|NCT02641379|7609846|FG010|Overall Study|Therapy stopped due to misunderstanding|0
4381151|NCT01232283|7158947|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
4516373|NCT00959907|7327748|FG000|Overall Study|Withdrawal by Subject|2
4696778|NCT02641379|7609836|FG000|Overall Study|Financial problems|0
4696779|NCT02641379|7609837|FG001|Overall Study|Financial problems|1
4696780|NCT02641379|7609838|FG002|Overall Study|Financial problems|0
4381152|NCT01232283|7158948|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
4381153|NCT01232283|7158949|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
4381154|NCT01232283|7158950|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
4381155|NCT01232283|7158951|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4
4381156|NCT01232283|7158952|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
4381157|NCT01232283|7158953|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13
4381158|NCT01232283|7158954|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5
4381159|NCT01232283|7158955|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
4381160|NCT01232283|7158956|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
4381161|NCT01232283|7158947|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
4381162|NCT01232283|7158948|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
4381163|NCT01232283|7158949|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
4381164|NCT01232283|7158950|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
4381165|NCT01232283|7158951|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
4381166|NCT01232283|7158952|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
4381167|NCT01232283|7158953|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
4381168|NCT01232283|7158954|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4
4381169|NCT01232283|7158955|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
4381170|NCT01232283|7158956|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
4381171|NCT01232283|7158947|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
4381172|NCT01232283|7158948|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
4381173|NCT01232283|7158949|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
4696781|NCT02641379|7609839|FG003|Overall Study|Financial problems|0
4696782|NCT02641379|7609840|FG004|Overall Study|Financial problems|0
4696783|NCT02641379|7609841|FG005|Overall Study|Financial problems|0
4696784|NCT02641379|7609842|FG006|Overall Study|Financial problems|0
4696785|NCT02641379|7609843|FG007|Overall Study|Financial problems|0
4696786|NCT02641379|7609844|FG008|Overall Study|Financial problems|0
4696787|NCT02641379|7609845|FG009|Overall Study|Financial problems|0
4696788|NCT02641379|7609846|FG010|Overall Study|Financial problems|0
4696789|NCT02641379|7609836|FG000|Overall Study|PCR positive at Week 68|0
4696790|NCT02641379|7609837|FG001|Overall Study|PCR positive at Week 68|1
4696791|NCT02641379|7609838|FG002|Overall Study|PCR positive at Week 68|0
4696792|NCT02641379|7609839|FG003|Overall Study|PCR positive at Week 68|0
4696793|NCT02641379|7609840|FG004|Overall Study|PCR positive at Week 68|0
4696794|NCT02641379|7609841|FG005|Overall Study|PCR positive at Week 68|0
4696795|NCT02641379|7609842|FG006|Overall Study|PCR positive at Week 68|0
4696796|NCT02641379|7609843|FG007|Overall Study|PCR positive at Week 68|0
4696797|NCT02641379|7609844|FG008|Overall Study|PCR positive at Week 68|0
4696798|NCT02641379|7609845|FG009|Overall Study|PCR positive at Week 68|0
4696799|NCT02641379|7609846|FG010|Overall Study|PCR positive at Week 68|0
4696800|NCT02641379|7609836|FG000|Overall Study|PCR positive at Week 48|0
4696801|NCT02641379|7609837|FG001|Overall Study|PCR positive at Week 48|1
4696802|NCT02641379|7609838|FG002|Overall Study|PCR positive at Week 48|0
4696803|NCT02641379|7609839|FG003|Overall Study|PCR positive at Week 48|0
4696804|NCT02641379|7609840|FG004|Overall Study|PCR positive at Week 48|0
4696805|NCT02641379|7609841|FG005|Overall Study|PCR positive at Week 48|0
4696806|NCT02641379|7609842|FG006|Overall Study|PCR positive at Week 48|0
4696807|NCT02641379|7609843|FG007|Overall Study|PCR positive at Week 48|0
4696808|NCT02641379|7609844|FG008|Overall Study|PCR positive at Week 48|0
4696809|NCT02641379|7609845|FG009|Overall Study|PCR positive at Week 48|0
4696810|NCT02641379|7609846|FG010|Overall Study|PCR positive at Week 48|0
4696811|NCT02641379|7609836|FG000|Overall Study|PCR not performed at Week 12|0
4696812|NCT02641379|7609837|FG001|Overall Study|PCR not performed at Week 12|0
4696813|NCT02641379|7609838|FG002|Overall Study|PCR not performed at Week 12|1
4696814|NCT02641379|7609839|FG003|Overall Study|PCR not performed at Week 12|0
4696815|NCT02641379|7609840|FG004|Overall Study|PCR not performed at Week 12|0
4696816|NCT02641379|7609841|FG005|Overall Study|PCR not performed at Week 12|0
4696817|NCT02641379|7609842|FG006|Overall Study|PCR not performed at Week 12|0
4696818|NCT02641379|7609843|FG007|Overall Study|PCR not performed at Week 12|0
4696819|NCT02641379|7609844|FG008|Overall Study|PCR not performed at Week 12|0
4696820|NCT02641379|7609845|FG009|Overall Study|PCR not performed at Week 12|0
4696821|NCT02641379|7609846|FG010|Overall Study|PCR not performed at Week 12|0
4696822|NCT02641379|7609836|FG000|Overall Study|No PCR at baseline|0
4696823|NCT02641379|7609837|FG001|Overall Study|No PCR at baseline|0
4696824|NCT02641379|7609838|FG002|Overall Study|No PCR at baseline|1
4696825|NCT02641379|7609839|FG003|Overall Study|No PCR at baseline|0
4696826|NCT02641379|7609840|FG004|Overall Study|No PCR at baseline|0
4696827|NCT02641379|7609841|FG005|Overall Study|No PCR at baseline|0
4696828|NCT02641379|7609842|FG006|Overall Study|No PCR at baseline|0
4696829|NCT02641379|7609843|FG007|Overall Study|No PCR at baseline|0
4696830|NCT02641379|7609844|FG008|Overall Study|No PCR at baseline|0
4696831|NCT02641379|7609845|FG009|Overall Study|No PCR at baseline|0
4696832|NCT02641379|7609846|FG010|Overall Study|No PCR at baseline|0
4696833|NCT02641379|7609836|FG000|Overall Study|PCR positive at Week 28|0
4696834|NCT02641379|7609837|FG001|Overall Study|PCR positive at Week 28|0
4696835|NCT02641379|7609838|FG002|Overall Study|PCR positive at Week 28|1
4381174|NCT01232283|7158950|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
4381175|NCT01232283|7158951|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1
4381176|NCT01232283|7158952|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
4381177|NCT01232283|7158953|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
4381178|NCT01232283|7158954|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
4381179|NCT01232283|7158955|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
4381180|NCT01232283|7158956|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
4381181|NCT01232283|7158947|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
4381182|NCT01232283|7158948|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
4381183|NCT01232283|7158949|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
4381184|NCT01232283|7158950|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
4381185|NCT01232283|7158951|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2
4381186|NCT01232283|7158952|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
4381187|NCT01232283|7158953|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1
4381188|NCT01232283|7158954|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1
4381189|NCT01232283|7158955|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
4381190|NCT01232283|7158956|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
4381191|NCT01232283|7158947|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
4381192|NCT01232283|7158948|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
4381193|NCT01232283|7158949|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
4381194|NCT01232283|7158950|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
4381195|NCT01232283|7158951|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
4381196|NCT01232283|7158952|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
4381197|NCT01232283|7158953|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
4468115|NCT00626093|7260333|FG000|Overall Study|One of the required devices not implante|6
4468116|NCT00626197|7260340|FG000|Overall Study|Did not cooperate|2
4468117|NCT00626197|7260341|FG001|Overall Study|Did not cooperate|6
4468118|NCT00626197|7260342|FG002|Overall Study|Did not cooperate|1
4468119|NCT00626197|7260340|FG000|Overall Study|Failure to return|6
4468120|NCT00626197|7260341|FG001|Overall Study|Failure to return|5
4468121|NCT00626197|7260342|FG002|Overall Study|Failure to return|6
4468122|NCT00626197|7260340|FG000|Overall Study|Adverse event, serious fatal|3
4468123|NCT00626197|7260341|FG001|Overall Study|Adverse event, serious fatal|6
4468124|NCT00626197|7260342|FG002|Overall Study|Adverse event, serious fatal|6
4468125|NCT00626197|7260340|FG000|Overall Study|Adverse Event|1
4468126|NCT00626197|7260341|FG001|Overall Study|Adverse Event|1
4468127|NCT00626197|7260342|FG002|Overall Study|Adverse Event|2
4468128|NCT00626197|7260340|FG000|Overall Study|Withdrawal by Subject|17
4468129|NCT00626197|7260341|FG001|Overall Study|Withdrawal by Subject|17
4468130|NCT00626197|7260342|FG002|Overall Study|Withdrawal by Subject|7
4468131|NCT00626197|7260340|FG000|Overall Study|Administrative reasons|15
4468132|NCT00626197|7260341|FG001|Overall Study|Administrative reasons|19
4468133|NCT00626197|7260342|FG002|Overall Study|Administrative reasons|55
4468134|NCT00626275|7260360|FG000|Part A - Treatment Period 1|Adverse Event|1
4468135|NCT00626275|7260361|FG001|Part A - Treatment Period 1|Adverse Event|0
4468136|NCT00626275|7260362|FG002|Part A - Treatment Period 1|Adverse Event|0
4468137|NCT00626275|7260363|FG003|Part A - Treatment Period 1|Adverse Event|0
4468138|NCT00626275|7260364|FG004|Part A - Treatment Period 1|Adverse Event|0
4468139|NCT00626275|7260365|FG005|Part A - Treatment Period 1|Adverse Event|0
4468140|NCT00626275|7260366|FG006|Part A - Treatment Period 1|Adverse Event|0
4468141|NCT00626275|7260367|FG007|Part A - Treatment Period 1|Adverse Event|0
4468142|NCT00626275|7260360|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0
4468143|NCT00626275|7260361|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0
4468144|NCT00626275|7260362|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1
4468145|NCT00626275|7260363|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0
4468146|NCT00626275|7260364|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0
4468147|NCT00626275|7260365|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0
4468148|NCT00626275|7260366|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0
4468149|NCT00626275|7260367|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0
4696836|NCT02641379|7609839|FG003|Overall Study|PCR positive at Week 28|0
4696837|NCT02641379|7609840|FG004|Overall Study|PCR positive at Week 28|0
4696838|NCT02641379|7609841|FG005|Overall Study|PCR positive at Week 28|0
4696839|NCT02641379|7609842|FG006|Overall Study|PCR positive at Week 28|0
4696840|NCT02641379|7609843|FG007|Overall Study|PCR positive at Week 28|0
4696841|NCT02641379|7609844|FG008|Overall Study|PCR positive at Week 28|0
4696842|NCT02641379|7609845|FG009|Overall Study|PCR positive at Week 28|0
4696843|NCT02641379|7609846|FG010|Overall Study|PCR positive at Week 28|0
4696844|NCT02641379|7609836|FG000|Overall Study|PCR sample for Week 4 not drawn|0
4696845|NCT02641379|7609837|FG001|Overall Study|PCR sample for Week 4 not drawn|0
4696846|NCT02641379|7609838|FG002|Overall Study|PCR sample for Week 4 not drawn|0
4696847|NCT02641379|7609839|FG003|Overall Study|PCR sample for Week 4 not drawn|1
4696848|NCT02641379|7609840|FG004|Overall Study|PCR sample for Week 4 not drawn|0
4468150|NCT00626275|7260360|FG000|Part B|Lost to Follow-up|0
4468151|NCT00626275|7260361|FG001|Part B|Lost to Follow-up|0
4468152|NCT00626275|7260362|FG002|Part B|Lost to Follow-up|0
4696849|NCT02641379|7609841|FG005|Overall Study|PCR sample for Week 4 not drawn|0
4381198|NCT01232283|7158954|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1
4381199|NCT01232283|7158955|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
4468153|NCT00626275|7260363|FG003|Part B|Lost to Follow-up|0
4468154|NCT00626275|7260364|FG004|Part B|Lost to Follow-up|0
4468155|NCT00626275|7260365|FG005|Part B|Lost to Follow-up|0
4468156|NCT00626275|7260366|FG006|Part B|Lost to Follow-up|1
4468157|NCT00626275|7260367|FG007|Part B|Lost to Follow-up|0
4696850|NCT02641379|7609842|FG006|Overall Study|PCR sample for Week 4 not drawn|0
4696851|NCT02641379|7609843|FG007|Overall Study|PCR sample for Week 4 not drawn|0
4696852|NCT02641379|7609844|FG008|Overall Study|PCR sample for Week 4 not drawn|0
4696853|NCT02641379|7609845|FG009|Overall Study|PCR sample for Week 4 not drawn|0
4696854|NCT02641379|7609846|FG010|Overall Study|PCR sample for Week 4 not drawn|0
4696855|NCT02641379|7609836|FG000|Overall Study|Inclusion criteria not fulfilled|0
4696856|NCT02641379|7609837|FG001|Overall Study|Inclusion criteria not fulfilled|0
4696857|NCT02641379|7609838|FG002|Overall Study|Inclusion criteria not fulfilled|0
4696858|NCT02641379|7609839|FG003|Overall Study|Inclusion criteria not fulfilled|1
4696859|NCT02641379|7609840|FG004|Overall Study|Inclusion criteria not fulfilled|0
4696860|NCT02641379|7609841|FG005|Overall Study|Inclusion criteria not fulfilled|0
4696861|NCT02641379|7609842|FG006|Overall Study|Inclusion criteria not fulfilled|0
4696862|NCT02641379|7609843|FG007|Overall Study|Inclusion criteria not fulfilled|0
4696863|NCT02641379|7609844|FG008|Overall Study|Inclusion criteria not fulfilled|0
4696864|NCT02641379|7609845|FG009|Overall Study|Inclusion criteria not fulfilled|0
4696865|NCT02641379|7609846|FG010|Overall Study|Inclusion criteria not fulfilled|0
4696866|NCT02641379|7609836|FG000|Overall Study|Baseline viral load unavailable|0
4696867|NCT02641379|7609837|FG001|Overall Study|Baseline viral load unavailable|0
4696868|NCT02641379|7609838|FG002|Overall Study|Baseline viral load unavailable|0
4696869|NCT02641379|7609839|FG003|Overall Study|Baseline viral load unavailable|1
4696870|NCT02641379|7609840|FG004|Overall Study|Baseline viral load unavailable|0
4696871|NCT02641379|7609841|FG005|Overall Study|Baseline viral load unavailable|0
4696872|NCT02641379|7609842|FG006|Overall Study|Baseline viral load unavailable|0
4696873|NCT02641379|7609843|FG007|Overall Study|Baseline viral load unavailable|0
4696874|NCT02641379|7609844|FG008|Overall Study|Baseline viral load unavailable|0
4696875|NCT02641379|7609845|FG009|Overall Study|Baseline viral load unavailable|0
4696876|NCT02641379|7609846|FG010|Overall Study|Baseline viral load unavailable|0
4696877|NCT02641379|7609836|FG000|Overall Study|Blood could not be drawn|0
4696878|NCT02641379|7609837|FG001|Overall Study|Blood could not be drawn|0
4696879|NCT02641379|7609838|FG002|Overall Study|Blood could not be drawn|0
4696880|NCT02641379|7609839|FG003|Overall Study|Blood could not be drawn|0
4696881|NCT02641379|7609840|FG004|Overall Study|Blood could not be drawn|1
4696882|NCT02641379|7609841|FG005|Overall Study|Blood could not be drawn|0
4696883|NCT02641379|7609842|FG006|Overall Study|Blood could not be drawn|0
4696884|NCT02641379|7609843|FG007|Overall Study|Blood could not be drawn|0
4696885|NCT02641379|7609844|FG008|Overall Study|Blood could not be drawn|0
4696886|NCT02641379|7609845|FG009|Overall Study|Blood could not be drawn|0
4696887|NCT02641379|7609846|FG010|Overall Study|Blood could not be drawn|0
4696888|NCT02641379|7609836|FG000|Overall Study|Protocol Violation|0
4696889|NCT02641379|7609837|FG001|Overall Study|Protocol Violation|0
4696890|NCT02641379|7609838|FG002|Overall Study|Protocol Violation|0
4696891|NCT02641379|7609839|FG003|Overall Study|Protocol Violation|0
4696892|NCT02641379|7609840|FG004|Overall Study|Protocol Violation|2
4696893|NCT02641379|7609841|FG005|Overall Study|Protocol Violation|0
4696894|NCT02641379|7609842|FG006|Overall Study|Protocol Violation|0
4696895|NCT02641379|7609843|FG007|Overall Study|Protocol Violation|0
4696896|NCT02641379|7609844|FG008|Overall Study|Protocol Violation|1
4696897|NCT02641379|7609845|FG009|Overall Study|Protocol Violation|0
4696898|NCT02641379|7609846|FG010|Overall Study|Protocol Violation|0
4696899|NCT02641379|7609836|FG000|Overall Study|Participation in sili rescue study|0
4696900|NCT02641379|7609837|FG001|Overall Study|Participation in sili rescue study|0
4696901|NCT02641379|7609838|FG002|Overall Study|Participation in sili rescue study|0
4696902|NCT02641379|7609839|FG003|Overall Study|Participation in sili rescue study|0
4696903|NCT02641379|7609840|FG004|Overall Study|Participation in sili rescue study|0
4696904|NCT02641379|7609841|FG005|Overall Study|Participation in sili rescue study|1
4696905|NCT02641379|7609842|FG006|Overall Study|Participation in sili rescue study|0
4696906|NCT02641379|7609843|FG007|Overall Study|Participation in sili rescue study|0
4696907|NCT02641379|7609844|FG008|Overall Study|Participation in sili rescue study|0
4696908|NCT02641379|7609845|FG009|Overall Study|Participation in sili rescue study|0
4696909|NCT02641379|7609846|FG010|Overall Study|Participation in sili rescue study|0
4696910|NCT02641379|7609836|FG000|Overall Study|Lost to Follow-up|0
4696911|NCT02641379|7609837|FG001|Overall Study|Lost to Follow-up|0
4696912|NCT02641379|7609838|FG002|Overall Study|Lost to Follow-up|0
4696913|NCT02641379|7609839|FG003|Overall Study|Lost to Follow-up|0
4696914|NCT02641379|7609840|FG004|Overall Study|Lost to Follow-up|0
4468158|NCT00626275|7260360|FG000|Part B|Withdrawal by Subject|0
4696915|NCT02641379|7609841|FG005|Overall Study|Lost to Follow-up|0
4696916|NCT02641379|7609842|FG006|Overall Study|Lost to Follow-up|0
4696917|NCT02641379|7609843|FG007|Overall Study|Lost to Follow-up|0
4696918|NCT02641379|7609844|FG008|Overall Study|Lost to Follow-up|1
4696919|NCT02641379|7609845|FG009|Overall Study|Lost to Follow-up|0
4696920|NCT02641379|7609846|FG010|Overall Study|Lost to Follow-up|0
4381200|NCT01232283|7158956|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
4381201|NCT01232283|7158947|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
4381202|NCT01232283|7158948|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
4381203|NCT01232283|7158949|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
4381204|NCT01232283|7158950|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
4696921|NCT02641379|7609836|FG000|Overall Study|Source data not found|0
4696922|NCT02641379|7609837|FG001|Overall Study|Source data not found|0
4696923|NCT02641379|7609838|FG002|Overall Study|Source data not found|0
4696924|NCT02641379|7609839|FG003|Overall Study|Source data not found|0
4696925|NCT02641379|7609840|FG004|Overall Study|Source data not found|0
4696926|NCT02641379|7609841|FG005|Overall Study|Source data not found|1
4696927|NCT02641379|7609842|FG006|Overall Study|Source data not found|0
4696928|NCT02641379|7609843|FG007|Overall Study|Source data not found|0
4696929|NCT02641379|7609844|FG008|Overall Study|Source data not found|0
4696930|NCT02641379|7609845|FG009|Overall Study|Source data not found|0
4696931|NCT02641379|7609846|FG010|Overall Study|Source data not found|0
4696932|NCT02641379|7609836|FG000|Overall Study|Participant showed weight reduction|0
4696933|NCT02641379|7609837|FG001|Overall Study|Participant showed weight reduction|0
4696934|NCT02641379|7609838|FG002|Overall Study|Participant showed weight reduction|0
4696935|NCT02641379|7609839|FG003|Overall Study|Participant showed weight reduction|0
4696936|NCT02641379|7609840|FG004|Overall Study|Participant showed weight reduction|0
4696937|NCT02641379|7609841|FG005|Overall Study|Participant showed weight reduction|0
4696938|NCT02641379|7609842|FG006|Overall Study|Participant showed weight reduction|0
4696939|NCT02641379|7609843|FG007|Overall Study|Participant showed weight reduction|1
4696940|NCT02641379|7609844|FG008|Overall Study|Participant showed weight reduction|0
4696941|NCT02641379|7609845|FG009|Overall Study|Participant showed weight reduction|0
4696942|NCT02641379|7609846|FG010|Overall Study|Participant showed weight reduction|0
4696943|NCT02641379|7609836|FG000|Overall Study|Non-response Week 12|0
4696944|NCT02641379|7609837|FG001|Overall Study|Non-response Week 12|0
4696945|NCT02641379|7609838|FG002|Overall Study|Non-response Week 12|0
4696946|NCT02641379|7609839|FG003|Overall Study|Non-response Week 12|0
4696947|NCT02641379|7609840|FG004|Overall Study|Non-response Week 12|0
4696948|NCT02641379|7609841|FG005|Overall Study|Non-response Week 12|0
4696949|NCT02641379|7609842|FG006|Overall Study|Non-response Week 12|0
4696950|NCT02641379|7609843|FG007|Overall Study|Non-response Week 12|1
4696951|NCT02641379|7609844|FG008|Overall Study|Non-response Week 12|0
4696952|NCT02641379|7609845|FG009|Overall Study|Non-response Week 12|0
4696953|NCT02641379|7609846|FG010|Overall Study|Non-response Week 12|0
4696954|NCT02641379|7609836|FG000|Overall Study|No 2 Log drop at Week 12|0
4696955|NCT02641379|7609837|FG001|Overall Study|No 2 Log drop at Week 12|0
4696956|NCT02641379|7609838|FG002|Overall Study|No 2 Log drop at Week 12|0
4696957|NCT02641379|7609839|FG003|Overall Study|No 2 Log drop at Week 12|0
4696958|NCT02641379|7609840|FG004|Overall Study|No 2 Log drop at Week 12|0
4696959|NCT02641379|7609841|FG005|Overall Study|No 2 Log drop at Week 12|0
4696960|NCT02641379|7609842|FG006|Overall Study|No 2 Log drop at Week 12|0
4696961|NCT02641379|7609843|FG007|Overall Study|No 2 Log drop at Week 12|0
4696962|NCT02641379|7609844|FG008|Overall Study|No 2 Log drop at Week 12|0
4696963|NCT02641379|7609845|FG009|Overall Study|No 2 Log drop at Week 12|0
4696964|NCT02641379|7609846|FG010|Overall Study|No 2 Log drop at Week 12|1
4696965|NCT02641379|7609836|FG000|Overall Study|Negative PCR result|0
4696966|NCT02641379|7609837|FG001|Overall Study|Negative PCR result|0
4696967|NCT02641379|7609838|FG002|Overall Study|Negative PCR result|0
4696968|NCT02641379|7609839|FG003|Overall Study|Negative PCR result|0
4696969|NCT02641379|7609840|FG004|Overall Study|Negative PCR result|0
4696970|NCT02641379|7609841|FG005|Overall Study|Negative PCR result|0
4696971|NCT02641379|7609842|FG006|Overall Study|Negative PCR result|0
4696972|NCT02641379|7609843|FG007|Overall Study|Negative PCR result|0
4696973|NCT02641379|7609844|FG008|Overall Study|Negative PCR result|0
4696974|NCT02641379|7609845|FG009|Overall Study|Negative PCR result|1
4696975|NCT02641379|7609846|FG010|Overall Study|Negative PCR result|0
4696976|NCT02641379|7609836|FG000|Overall Study|Participant's PCR high|0
4696977|NCT02641379|7609837|FG001|Overall Study|Participant's PCR high|0
4696978|NCT02641379|7609838|FG002|Overall Study|Participant's PCR high|0
4696979|NCT02641379|7609839|FG003|Overall Study|Participant's PCR high|0
4696980|NCT02641379|7609840|FG004|Overall Study|Participant's PCR high|0
4696981|NCT02641379|7609841|FG005|Overall Study|Participant's PCR high|0
4696982|NCT02641379|7609842|FG006|Overall Study|Participant's PCR high|0
4696983|NCT02641379|7609843|FG007|Overall Study|Participant's PCR high|1
4696984|NCT02641379|7609844|FG008|Overall Study|Participant's PCR high|0
4696985|NCT02641379|7609845|FG009|Overall Study|Participant's PCR high|0
4696986|NCT02641379|7609846|FG010|Overall Study|Participant's PCR high|0
4696987|NCT02641379|7609836|FG000|Overall Study|Participant treated after Week 24|0
4696988|NCT02641379|7609837|FG001|Overall Study|Participant treated after Week 24|0
4696989|NCT02641379|7609838|FG002|Overall Study|Participant treated after Week 24|0
4696990|NCT02641379|7609839|FG003|Overall Study|Participant treated after Week 24|0
4696991|NCT02641379|7609840|FG004|Overall Study|Participant treated after Week 24|0
4696992|NCT02641379|7609841|FG005|Overall Study|Participant treated after Week 24|0
4696993|NCT02641379|7609842|FG006|Overall Study|Participant treated after Week 24|0
4696994|NCT02641379|7609843|FG007|Overall Study|Participant treated after Week 24|0
4696995|NCT02641379|7609844|FG008|Overall Study|Participant treated after Week 24|1
4696996|NCT02641379|7609845|FG009|Overall Study|Participant treated after Week 24|0
4381205|NCT01232283|7158951|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
4381206|NCT01232283|7158952|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1
4381207|NCT01232283|7158953|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
4381208|NCT01232283|7158954|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
4381209|NCT01232283|7158955|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
4588404|NCT01499810|7432953|FG000|Overall Study|Lost to Follow-up|10
4588405|NCT01499810|7432953|FG000|Overall Study|Protocol Violation|1
4696997|NCT02641379|7609846|FG010|Overall Study|Participant treated after Week 24|0
4696998|NCT02641379|7609836|FG000|Overall Study|Missing PCR result at Week 8|0
4696999|NCT02641379|7609837|FG001|Overall Study|Missing PCR result at Week 8|0
4697000|NCT02641379|7609838|FG002|Overall Study|Missing PCR result at Week 8|0
4697001|NCT02641379|7609839|FG003|Overall Study|Missing PCR result at Week 8|0
4697002|NCT02641379|7609840|FG004|Overall Study|Missing PCR result at Week 8|0
4697003|NCT02641379|7609841|FG005|Overall Study|Missing PCR result at Week 8|0
4697004|NCT02641379|7609842|FG006|Overall Study|Missing PCR result at Week 8|0
4697005|NCT02641379|7609843|FG007|Overall Study|Missing PCR result at Week 8|0
4697006|NCT02641379|7609844|FG008|Overall Study|Missing PCR result at Week 8|0
4697007|NCT02641379|7609845|FG009|Overall Study|Missing PCR result at Week 8|1
4697008|NCT02641379|7609846|FG010|Overall Study|Missing PCR result at Week 8|0
4697009|NCT02641379|7609836|FG000|Overall Study|PCR positive|0
4697010|NCT02641379|7609837|FG001|Overall Study|PCR positive|0
4697011|NCT02641379|7609838|FG002|Overall Study|PCR positive|0
4697012|NCT02641379|7609839|FG003|Overall Study|PCR positive|0
4697013|NCT02641379|7609840|FG004|Overall Study|PCR positive|0
4697014|NCT02641379|7609841|FG005|Overall Study|PCR positive|0
4697015|NCT02641379|7609842|FG006|Overall Study|PCR positive|1
4697016|NCT02641379|7609843|FG007|Overall Study|PCR positive|0
4697017|NCT02641379|7609844|FG008|Overall Study|PCR positive|0
4697018|NCT02641379|7609845|FG009|Overall Study|PCR positive|0
4697019|NCT02641379|7609846|FG010|Overall Study|PCR positive|0
4697020|NCT02641392|7609878|FG000|Overall Study|Lost to Follow-up|0
4697021|NCT02641392|7609879|FG001|Overall Study|Lost to Follow-up|0
4697022|NCT02641392|7609880|FG002|Overall Study|Lost to Follow-up|2
4697023|NCT02641392|7609878|FG000|Overall Study|Withdrawal by Subject|0
4697024|NCT02641392|7609879|FG001|Overall Study|Withdrawal by Subject|0
4588406|NCT01499810|7432953|FG000|Overall Study|Withdrawal by Subject|1
4588407|NCT01499849|7432960|FG000|Overall Study|Adverse Event|28
4588408|NCT01499849|7432961|FG001|Overall Study|Adverse Event|32
4588409|NCT01499849|7432960|FG000|Overall Study|Chemo completed or Change in Therapy|70
4588410|NCT01499849|7432961|FG001|Overall Study|Chemo completed or Change in Therapy|67
4588411|NCT01499849|7432960|FG000|Overall Study|Withdrawal by Subject|43
4588412|NCT01499849|7432961|FG001|Overall Study|Withdrawal by Subject|43
4588413|NCT01499849|7432960|FG000|Overall Study|Death|5
4588414|NCT01499849|7432961|FG001|Overall Study|Death|7
4588415|NCT01499849|7432960|FG000|Overall Study|Disease Progression|11
4588416|NCT01499849|7432961|FG001|Overall Study|Disease Progression|10
4588417|NCT01499849|7432960|FG000|Overall Study|Protocol Violation|11
4697025|NCT02641392|7609880|FG002|Overall Study|Withdrawal by Subject|17
4697026|NCT02641392|7609878|FG000|Overall Study|Adverse Event|0
4697027|NCT02641392|7609879|FG001|Overall Study|Adverse Event|1
4697028|NCT02641392|7609880|FG002|Overall Study|Adverse Event|25
4697029|NCT02641392|7609878|FG000|Overall Study|Study Terminated by Sponsor|4
4697030|NCT02641392|7609879|FG001|Overall Study|Study Terminated by Sponsor|12
4697031|NCT02641392|7609880|FG002|Overall Study|Study Terminated by Sponsor|144
4697032|NCT02641392|7609878|FG000|Overall Study|Lack of Efficacy|0
4697033|NCT02641392|7609879|FG001|Overall Study|Lack of Efficacy|0
4697034|NCT02641392|7609880|FG002|Overall Study|Lack of Efficacy|101
4697035|NCT02641392|7609878|FG000|Overall Study|Miscellaneous|0
4588418|NCT01499849|7432961|FG001|Overall Study|Protocol Violation|11
4588419|NCT01499849|7432960|FG000|Overall Study|Physician Decision|20
4588420|NCT01499849|7432961|FG001|Overall Study|Physician Decision|19
4588421|NCT01499849|7432960|FG000|Overall Study|Lack of Efficacy|3
4588422|NCT01499849|7432961|FG001|Overall Study|Lack of Efficacy|4
4588423|NCT01499849|7432960|FG000|Overall Study|Lost to Follow-up|6
4588424|NCT01499849|7432961|FG001|Overall Study|Lost to Follow-up|3
4588425|NCT01499849|7432960|FG000|Overall Study|Other Reasons|27
4588426|NCT01499849|7432961|FG001|Overall Study|Other Reasons|30
4588427|NCT01499940|7432985|FG000|Overall Study|Study was withdrawn before completion.|9
4588428|NCT01500031|7432989|FG000|Overall Study|Death|1
4588429|NCT01500031|7432989|FG000|Overall Study|Withdrawal by Subject|4
4588430|NCT01500057|7432995|FG000|Overall Study|Lost to Follow-up|6
4588431|NCT01500057|7432996|FG001|Overall Study|Lost to Follow-up|4
4588432|NCT01500083|7433004|FG000|Overall Study|Adverse Event|4
4588433|NCT01500083|7433005|FG001|Overall Study|Adverse Event|17
4697036|NCT02641392|7609879|FG001|Overall Study|Miscellaneous|0
4697037|NCT02641392|7609880|FG002|Overall Study|Miscellaneous|3
4588434|NCT01500083|7433004|FG000|Overall Study|Death|0
4588435|NCT01500083|7433005|FG001|Overall Study|Death|2
4697038|NCT02641392|7609878|FG000|Overall Study|Death|0
4697039|NCT02641392|7609879|FG001|Overall Study|Death|0
4697040|NCT02641392|7609880|FG002|Overall Study|Death|1
4697041|NCT02641587|7609912|FG000|Confinement Period|Adverse Event|1
4588436|NCT01500083|7433004|FG000|Overall Study|Lost to Follow-up|1
4588437|NCT01500083|7433005|FG001|Overall Study|Lost to Follow-up|0
4381210|NCT01232283|7158956|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
4381211|NCT01232283|7158947|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
4381212|NCT01232283|7158948|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
4381213|NCT01232283|7158949|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
4381214|NCT01232283|7158950|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
4381215|NCT01232283|7158951|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
4381216|NCT01232283|7158952|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
4381217|NCT01232283|7158953|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
4381218|NCT01232283|7158954|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
4381219|NCT01232283|7158955|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11
4468159|NCT00626275|7260361|FG001|Part B|Withdrawal by Subject|0
4588438|NCT01500083|7433004|FG000|Overall Study|Withdrawal of Consent|0
4588439|NCT01500083|7433005|FG001|Overall Study|Withdrawal of Consent|1
4588440|NCT01500083|7433004|FG000|Overall Study|Disease Progression|2
4588441|NCT01500083|7433005|FG001|Overall Study|Disease Progression|10
4697042|NCT02641587|7609913|FG001|Confinement Period|Adverse Event|0
4697043|NCT02641587|7609912|FG000|Confinement Period|Withdrawal by Subject|2
4697044|NCT02641587|7609913|FG001|Confinement Period|Withdrawal by Subject|1
4697045|NCT02641587|7609912|FG000|Ambulatory Period|Withdrawal by Subject|1
4697046|NCT02641587|7609913|FG001|Ambulatory Period|Withdrawal by Subject|0
4735141|NCT03519867|7682777|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1
4735142|NCT03519867|7682778|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0
4735143|NCT03519867|7682779|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0
4735144|NCT03519867|7682780|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0
4735145|NCT03519867|7682771|FG000|Overall Study|Admin. of other reversal agent|1
4588442|NCT01500083|7433004|FG000|Overall Study|Investigator Discretion|3
4588443|NCT01500083|7433005|FG001|Overall Study|Investigator Discretion|8
4588444|NCT01500083|7433004|FG000|Overall Study|Other Reasons|2
4735146|NCT03519867|7682772|FG001|Overall Study|Admin. of other reversal agent|1
4735147|NCT03519867|7682773|FG002|Overall Study|Admin. of other reversal agent|0
4735148|NCT03519867|7682774|FG003|Overall Study|Admin. of other reversal agent|0
4735149|NCT03519867|7682775|FG004|Overall Study|Admin. of other reversal agent|0
4735150|NCT03519867|7682776|FG005|Overall Study|Admin. of other reversal agent|1
4735151|NCT03519867|7682777|FG006|Overall Study|Admin. of other reversal agent|0
4735152|NCT03519867|7682778|FG007|Overall Study|Admin. of other reversal agent|0
4735153|NCT03519867|7682779|FG008|Overall Study|Admin. of other reversal agent|0
4735154|NCT03519867|7682780|FG009|Overall Study|Admin. of other reversal agent|0
4735155|NCT03519867|7682771|FG000|Overall Study|Reason not provided|1
4735156|NCT03519867|7682772|FG001|Overall Study|Reason not provided|1
4735157|NCT03519867|7682773|FG002|Overall Study|Reason not provided|1
4735158|NCT03519867|7682774|FG003|Overall Study|Reason not provided|1
4735159|NCT03519867|7682775|FG004|Overall Study|Reason not provided|0
4735160|NCT03519867|7682776|FG005|Overall Study|Reason not provided|1
4735161|NCT03519867|7682777|FG006|Overall Study|Reason not provided|0
4735162|NCT03519867|7682778|FG007|Overall Study|Reason not provided|1
4735163|NCT03519867|7682779|FG008|Overall Study|Reason not provided|1
4735164|NCT03519867|7682780|FG009|Overall Study|Reason not provided|0
4735165|NCT03519919|7682802|FG000|Overall Study|Withdrawal by Subject|1
4735166|NCT03519919|7682802|FG000|Overall Study|Lack of Efficacy|1
4735167|NCT03519919|7682802|FG000|Overall Study|Screen Failure|1
4735168|NCT03519932|7682832|FG000|First Intervention|Adverse Event|1
4735169|NCT03519932|7682833|FG001|First Intervention|Adverse Event|3
4735170|NCT03520387|7682876|FG000|Pre-Randomization|Withdrawal by Subject|1
4735171|NCT03520387|7682877|FG001|Pre-Randomization|Withdrawal by Subject|0
4735172|NCT03520387|7682878|FG002|Pre-Randomization|Withdrawal by Subject|0
4735173|NCT03520387|7682879|FG003|Pre-Randomization|Withdrawal by Subject|0
4735174|NCT03520387|7682880|FG004|Pre-Randomization|Withdrawal by Subject|0
4735175|NCT03520387|7682876|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2
4735176|NCT03520387|7682877|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0
4735177|NCT03520387|7682878|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0
4735178|NCT03520387|7682879|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0
4735179|NCT03520387|7682880|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0
4735180|NCT03520400|7682893|FG000|Overall Study|Physician Decision|15
4735181|NCT03520400|7682894|FG001|Overall Study|Physician Decision|7
4735182|NCT03520920|7682903|FG000|Overall Study|Death|13
4735183|NCT03520920|7682904|FG001|Overall Study|Death|1
4735184|NCT03520920|7682905|FG002|Overall Study|Death|0
4735185|NCT03520920|7682903|FG000|Overall Study|Withdrawal by Subject|2
4735186|NCT03520920|7682904|FG001|Overall Study|Withdrawal by Subject|1
4735187|NCT03520920|7682905|FG002|Overall Study|Withdrawal by Subject|0
4735188|NCT03520920|7682903|FG000|Overall Study|Study Terminated by the Sponsor|5
4735189|NCT03520920|7682904|FG001|Overall Study|Study Terminated by the Sponsor|14
4735190|NCT03520920|7682905|FG002|Overall Study|Study Terminated by the Sponsor|5
4735191|NCT03520959|7682921|FG000|Overall Study|Study terminated by Sponsor|0
4735192|NCT03520959|7682922|FG001|Overall Study|Study terminated by Sponsor|1
4737565|NCT03614078|7687790|FG000|Overall Study|Participant Did Not Return for Visit|0
4737566|NCT03614078|7687791|FG001|Overall Study|Participant Did Not Return for Visit|1
4468160|NCT00626275|7260362|FG002|Part B|Withdrawal by Subject|0
4381220|NCT01232283|7158956|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6
4381221|NCT01232283|7158947|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
4381222|NCT01232283|7158948|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
4381223|NCT01232283|7158949|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
4381224|NCT01232283|7158950|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
4468161|NCT00626275|7260363|FG003|Part B|Withdrawal by Subject|0
4468162|NCT00626275|7260364|FG004|Part B|Withdrawal by Subject|0
4468163|NCT00626275|7260365|FG005|Part B|Withdrawal by Subject|0
4468164|NCT00626275|7260366|FG006|Part B|Withdrawal by Subject|0
4468165|NCT00626275|7260367|FG007|Part B|Withdrawal by Subject|1
4468166|NCT00626327|7260384|FG000|Overall Study|Withdrawal by Subject|21
4468167|NCT00626327|7260385|FG001|Overall Study|Withdrawal by Subject|29
4468168|NCT00626327|7260386|FG002|Overall Study|Withdrawal by Subject|30
4468169|NCT00626327|7260384|FG000|Overall Study|Adverse Event|1
4468170|NCT00626327|7260385|FG001|Overall Study|Adverse Event|0
4468171|NCT00626327|7260386|FG002|Overall Study|Adverse Event|0
4468172|NCT00626327|7260384|FG000|Overall Study|Lost to Follow-up|24
4468173|NCT00626327|7260385|FG001|Overall Study|Lost to Follow-up|21
4468174|NCT00626327|7260386|FG002|Overall Study|Lost to Follow-up|23
4468175|NCT00626327|7260384|FG000|Overall Study|Inappropriate enrollment|4
4468176|NCT00626327|7260385|FG001|Overall Study|Inappropriate enrollment|5
4468177|NCT00626327|7260386|FG002|Overall Study|Inappropriate enrollment|3
4468178|NCT00626327|7260384|FG000|Overall Study|Administrative Reason|2
4468179|NCT00626327|7260385|FG001|Overall Study|Administrative Reason|0
4468180|NCT00626327|7260386|FG002|Overall Study|Administrative Reason|6
4468181|NCT00626327|7260384|FG000|Overall Study|Protocol Violation|26
4468182|NCT00626327|7260385|FG001|Overall Study|Protocol Violation|4
4468183|NCT00626327|7260386|FG002|Overall Study|Protocol Violation|26
4468184|NCT00626392|7260421|FG000|Run-in Period|Adverse Event|0
4468185|NCT00626392|7260422|FG001|Run-in Period|Adverse Event|0
4468186|NCT00626392|7260423|FG002|Run-in Period|Adverse Event|1
4468187|NCT00626392|7260424|FG003|Run-in Period|Adverse Event|0
4468188|NCT00626392|7260425|FG004|Run-in Period|Adverse Event|1
4468189|NCT00626392|7260426|FG005|Run-in Period|Adverse Event|0
4697047|NCT02641730|7609939|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2
4697048|NCT02641730|7609940|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
4697049|NCT02641730|7609941|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
4697050|NCT02641730|7609942|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1
4697051|NCT02641730|7609943|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2
4697052|NCT02641730|7609939|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0
4697053|NCT02641730|7609940|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1
4697054|NCT02641730|7609941|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1
4697055|NCT02641730|7609942|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5
4697056|NCT02641730|7609943|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4
4697057|NCT02641730|7609939|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0
4697058|NCT02641730|7609940|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2
4697059|NCT02641730|7609941|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0
4697060|NCT02641730|7609942|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2
4697061|NCT02641730|7609943|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0
4697062|NCT02641730|7609939|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0
4697063|NCT02641730|7609940|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0
4697064|NCT02641730|7609941|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0
4697065|NCT02641730|7609942|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1
4697066|NCT02641730|7609943|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1
4697067|NCT02641730|7609939|FG000|After Controlled Period (Week 16 - 52)|Other|0
4697068|NCT02641730|7609940|FG001|After Controlled Period (Week 16 - 52)|Other|1
4697069|NCT02641730|7609941|FG002|After Controlled Period (Week 16 - 52)|Other|1
4697070|NCT02641730|7609942|FG003|After Controlled Period (Week 16 - 52)|Other|0
4697071|NCT02641730|7609943|FG004|After Controlled Period (Week 16 - 52)|Other|1
4697072|NCT02641730|7609939|FG000|Observational Period (Week 60 - Week 84)|Other|0
4697073|NCT02641730|7609940|FG001|Observational Period (Week 60 - Week 84)|Other|0
4697074|NCT02641730|7609941|FG002|Observational Period (Week 60 - Week 84)|Other|0
4697075|NCT02641730|7609942|FG003|Observational Period (Week 60 - Week 84)|Other|0
4697076|NCT02641730|7609943|FG004|Observational Period (Week 60 - Week 84)|Other|1
4697077|NCT02642159|7609982|FG000|Overall Study|Randomized but not treated|1
4697078|NCT02642159|7609983|FG001|Overall Study|Randomized but not treated|0
4697079|NCT02642159|7609982|FG000|Overall Study|Adverse Event|10
4697080|NCT02642159|7609983|FG001|Overall Study|Adverse Event|4
4697081|NCT02642159|7609982|FG000|Overall Study|Withdrawal by Subject|9
4697082|NCT02642159|7609983|FG001|Overall Study|Withdrawal by Subject|1
4697083|NCT02642159|7609982|FG000|Overall Study|Poor compliance to study protocol|1
4468190|NCT00626392|7260421|FG000|Run-in Period|Withdrawal by Subject|0
4697084|NCT02642159|7609983|FG001|Overall Study|Poor compliance to study protocol|0
4697085|NCT02642159|7609982|FG000|Overall Study|Other than specified above|10
4697086|NCT02642159|7609983|FG001|Overall Study|Other than specified above|3
4697087|NCT02642432|7610008|FG000|Overall Study|Adverse Event|2
4468191|NCT00626392|7260422|FG001|Run-in Period|Withdrawal by Subject|1
4468192|NCT00626392|7260423|FG002|Run-in Period|Withdrawal by Subject|1
4381225|NCT01232283|7158951|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
4697088|NCT02642432|7610008|FG000|Overall Study|Withdrew Consent|1
4697089|NCT02642432|7610008|FG000|Overall Study|Lost to Follow-up|2
4697090|NCT02642432|7610008|FG000|Overall Study|Other|3
4697091|NCT02642614|7610029|FG000|Overall Study|Adverse Event|1
4697092|NCT02642614|7610030|FG001|Overall Study|Adverse Event|1
4697093|NCT02642614|7610031|FG002|Overall Study|Adverse Event|2
4697094|NCT02642614|7610032|FG003|Overall Study|Adverse Event|2
4697095|NCT02642614|7610029|FG000|Overall Study|Lost to Follow-up|1
4697096|NCT02642614|7610030|FG001|Overall Study|Lost to Follow-up|0
4697097|NCT02642614|7610031|FG002|Overall Study|Lost to Follow-up|0
4697098|NCT02642614|7610032|FG003|Overall Study|Lost to Follow-up|0
4697099|NCT02642614|7610029|FG000|Overall Study|Withdrawal by Subject|1
4697100|NCT02642614|7610030|FG001|Overall Study|Withdrawal by Subject|1
4697101|NCT02642614|7610031|FG002|Overall Study|Withdrawal by Subject|0
4697102|NCT02642614|7610032|FG003|Overall Study|Withdrawal by Subject|0
4697103|NCT02642653|7610052|FG000|Overall Study|Adverse Event|2
4697104|NCT02642653|7610053|FG001|Overall Study|Adverse Event|0
4697105|NCT02642679|7610059|FG000|Overall Study|Withdrawal by Subject|1
4697106|NCT02642679|7610059|FG000|Overall Study|Physician Decision|1
4697107|NCT02642679|7610059|FG000|Overall Study|Physician Decision|1
4697108|NCT02643082|7610093|FG000|Period 1|Adverse Event|1
4697109|NCT02643082|7610094|FG001|Period 1|Adverse Event|0
4697110|NCT02643251|7610121|FG000|Overall Study|Adverse Event|3
4697111|NCT02643251|7610122|FG001|Overall Study|Adverse Event|1
4697112|NCT02643251|7610121|FG000|Overall Study|Withdrawal by Subject|2
4697113|NCT02643251|7610122|FG001|Overall Study|Withdrawal by Subject|0
4697114|NCT02643251|7610121|FG000|Overall Study|Lost to Follow-up|4
4697115|NCT02643251|7610122|FG001|Overall Study|Lost to Follow-up|1
4697116|NCT02643251|7610121|FG000|Overall Study|Protocol Violation|1
4697117|NCT02643251|7610122|FG001|Overall Study|Protocol Violation|0
4697118|NCT02643251|7610121|FG000|Overall Study|PI Decision to terminate patient|1
4697119|NCT02643251|7610122|FG001|Overall Study|PI Decision to terminate patient|0
4697120|NCT02643355|7610130|FG000|Overall Study|Withdrawal by Subject|1
4697121|NCT02643355|7610131|FG001|Overall Study|Withdrawal by Subject|3
4697122|NCT02643355|7610130|FG000|Overall Study|Protocol Violation|0
4697123|NCT02643355|7610131|FG001|Overall Study|Protocol Violation|2
4697124|NCT02643394|7610139|FG000|Overall Study|Protocol Violation|4
4697125|NCT02643394|7610140|FG001|Overall Study|Protocol Violation|5
4697126|NCT02643472|7610158|FG000|Overall Study|Death|2
4697127|NCT02643472|7610159|FG001|Overall Study|Death|5
4697128|NCT02643472|7610158|FG000|Overall Study|Withdrawal by Subject|3
4697129|NCT02643472|7610159|FG001|Overall Study|Withdrawal by Subject|2
4697130|NCT02643472|7610158|FG000|Overall Study|Protocol Violation|0
4697131|NCT02643472|7610159|FG001|Overall Study|Protocol Violation|1
4697132|NCT02643472|7610158|FG000|Overall Study|Lost to Follow-up|22
4697133|NCT02643472|7610159|FG001|Overall Study|Lost to Follow-up|26
4697134|NCT02643628|7610179|FG000|Overall Study|Lost to Follow-up|1
4697135|NCT02643628|7610180|FG001|Overall Study|Lost to Follow-up|4
4588445|NCT01500083|7433005|FG001|Overall Study|Other Reasons|5
4588446|NCT01500096|7433015|FG000|Overall Study|Lost to Follow-up|1
4697136|NCT02643628|7610179|FG000|Overall Study|Withdrawal by Subject|0
4697137|NCT02643628|7610180|FG001|Overall Study|Withdrawal by Subject|1
4588447|NCT01500096|7433016|FG001|Overall Study|Lost to Follow-up|0
4588448|NCT01500096|7433017|FG002|Overall Study|Lost to Follow-up|0
4588449|NCT01500096|7433018|FG003|Overall Study|Lost to Follow-up|2
4588450|NCT01500135|7433030|FG000|Overall Study|Withdrawal of Consent|4
4588451|NCT01500135|7433031|FG001|Overall Study|Withdrawal of Consent|0
4588452|NCT01500135|7433030|FG000|Overall Study|Lost to Follow-up|6
4588453|NCT01500135|7433031|FG001|Overall Study|Lost to Follow-up|4
4588454|NCT01500135|7433030|FG000|Overall Study|Fatal Adverse Event (AE)|5
4588455|NCT01500135|7433031|FG001|Overall Study|Fatal Adverse Event (AE)|5
4588456|NCT01500135|7433030|FG000|Overall Study|Principal Investigator (PI) Discretion|1
4588457|NCT01500135|7433031|FG001|Overall Study|Principal Investigator (PI) Discretion|0
4588458|NCT01500135|7433030|FG000|Overall Study|Patient Missed Scheduled Appointments|0
4588459|NCT01500135|7433031|FG001|Overall Study|Patient Missed Scheduled Appointments|1
4588460|NCT01500135|7433030|FG000|Overall Study|Participant was a Safety Concern|1
4588461|NCT01500135|7433031|FG001|Overall Study|Participant was a Safety Concern|0
4588462|NCT01500135|7433030|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0
4588463|NCT01500135|7433031|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1
4697138|NCT02643628|7610179|FG000|Overall Study|Relocated out of state|0
4697139|NCT02643628|7610180|FG001|Overall Study|Relocated out of state|1
4697140|NCT02643693|7610188|FG000|Overall Study|Physician Decision|0
4697141|NCT02643693|7610189|FG001|Overall Study|Physician Decision|1
4468193|NCT00626392|7260424|FG003|Run-in Period|Withdrawal by Subject|1
4468194|NCT00626392|7260425|FG004|Run-in Period|Withdrawal by Subject|3
4588464|NCT01500187|7433039|FG000|Overall Study|Lost to Follow-up|6
4697142|NCT02643693|7610190|FG002|Overall Study|Physician Decision|0
4697143|NCT02643693|7610191|FG003|Overall Study|Physician Decision|0
4697144|NCT02643693|7610192|FG004|Overall Study|Physician Decision|0
4697145|NCT02643693|7610193|FG005|Overall Study|Physician Decision|0
4697146|NCT02643693|7610188|FG000|Overall Study|Withdrawal by Subject|0
4697147|NCT02643693|7610189|FG001|Overall Study|Withdrawal by Subject|1
4697148|NCT02643693|7610190|FG002|Overall Study|Withdrawal by Subject|0
4381226|NCT01232283|7158952|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
4381227|NCT01232283|7158953|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
4381228|NCT01232283|7158954|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
4381229|NCT01232283|7158955|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46
4381230|NCT01232283|7158956|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30
4381231|NCT01232283|7158947|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
4381232|NCT01232283|7158948|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
4381233|NCT01232283|7158949|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
4468195|NCT00626392|7260426|FG005|Run-in Period|Withdrawal by Subject|1
4468196|NCT00626392|7260421|FG000|Run-in Period|Noncompliance|1
4468197|NCT00626392|7260422|FG001|Run-in Period|Noncompliance|0
4468198|NCT00626392|7260423|FG002|Run-in Period|Noncompliance|1
4468199|NCT00626392|7260424|FG003|Run-in Period|Noncompliance|0
4468200|NCT00626392|7260425|FG004|Run-in Period|Noncompliance|0
4468201|NCT00626392|7260426|FG005|Run-in Period|Noncompliance|0
4468202|NCT00626392|7260421|FG000|Coadministration Period|Adverse Event|3
4468203|NCT00626392|7260422|FG001|Coadministration Period|Adverse Event|1
4468204|NCT00626392|7260423|FG002|Coadministration Period|Adverse Event|7
4468205|NCT00626392|7260424|FG003|Coadministration Period|Adverse Event|4
4468206|NCT00626392|7260425|FG004|Coadministration Period|Adverse Event|3
4468207|NCT00626392|7260426|FG005|Coadministration Period|Adverse Event|4
4468208|NCT00626392|7260421|FG000|Coadministration Period|Withdrawal by Subject|1
4468209|NCT00626392|7260422|FG001|Coadministration Period|Withdrawal by Subject|1
4468210|NCT00626392|7260423|FG002|Coadministration Period|Withdrawal by Subject|0
4468211|NCT00626392|7260424|FG003|Coadministration Period|Withdrawal by Subject|1
4468212|NCT00626392|7260425|FG004|Coadministration Period|Withdrawal by Subject|0
4468213|NCT00626392|7260426|FG005|Coadministration Period|Withdrawal by Subject|1
4468214|NCT00626392|7260421|FG000|Coadministration Period|Protocol Violation|0
4468215|NCT00626392|7260422|FG001|Coadministration Period|Protocol Violation|1
4468216|NCT00626392|7260423|FG002|Coadministration Period|Protocol Violation|0
4468217|NCT00626392|7260424|FG003|Coadministration Period|Protocol Violation|1
4468218|NCT00626392|7260425|FG004|Coadministration Period|Protocol Violation|1
4468219|NCT00626392|7260426|FG005|Coadministration Period|Protocol Violation|0
4468220|NCT00626392|7260421|FG000|Coadministration Period|Other|0
4468221|NCT00626392|7260422|FG001|Coadministration Period|Other|2
4468222|NCT00626392|7260423|FG002|Coadministration Period|Other|3
4468223|NCT00626392|7260424|FG003|Coadministration Period|Other|1
4468224|NCT00626392|7260425|FG004|Coadministration Period|Other|1
4468225|NCT00626392|7260426|FG005|Coadministration Period|Other|1
4468226|NCT00626405|7260434|FG000|Overall Study|Deemed Ineligible|1
4468227|NCT00626405|7260435|FG001|Overall Study|Deemed Ineligible|0
4468228|NCT00626405|7260434|FG000|Overall Study|Withdrawal by Subject|0
4468229|NCT00626405|7260435|FG001|Overall Study|Withdrawal by Subject|1
4468230|NCT00626522|7260456|FG000|Overall Study|Protocol Violation|0
4468231|NCT00626522|7260457|FG001|Overall Study|Protocol Violation|0
4468232|NCT00626522|7260458|FG002|Overall Study|Protocol Violation|0
4468233|NCT00626522|7260459|FG003|Overall Study|Protocol Violation|0
4468234|NCT00626522|7260460|FG004|Overall Study|Protocol Violation|1
4468235|NCT00626522|7260461|FG005|Overall Study|Protocol Violation|0
4468236|NCT00626522|7260456|FG000|Overall Study|Adverse Event|2
4468237|NCT00626522|7260457|FG001|Overall Study|Adverse Event|1
4468238|NCT00626522|7260458|FG002|Overall Study|Adverse Event|2
4468239|NCT00626522|7260459|FG003|Overall Study|Adverse Event|0
4468240|NCT00626522|7260460|FG004|Overall Study|Adverse Event|1
4468241|NCT00626522|7260461|FG005|Overall Study|Adverse Event|1
4468242|NCT00626522|7260456|FG000|Overall Study|Withdrawal by Subject|2
4468243|NCT00626522|7260457|FG001|Overall Study|Withdrawal by Subject|5
4468244|NCT00626522|7260458|FG002|Overall Study|Withdrawal by Subject|5
4468245|NCT00626522|7260459|FG003|Overall Study|Withdrawal by Subject|0
4468246|NCT00626522|7260460|FG004|Overall Study|Withdrawal by Subject|4
4468247|NCT00626522|7260461|FG005|Overall Study|Withdrawal by Subject|1
4468248|NCT00626522|7260456|FG000|Overall Study|COPD exacerbation|0
4468249|NCT00626522|7260457|FG001|Overall Study|COPD exacerbation|0
4697149|NCT02643693|7610191|FG003|Overall Study|Withdrawal by Subject|0
4697150|NCT02643693|7610192|FG004|Overall Study|Withdrawal by Subject|0
4697151|NCT02643693|7610193|FG005|Overall Study|Withdrawal by Subject|0
4697152|NCT02643693|7610188|FG000|Overall Study|Protocol Adherence Issues|2
4697153|NCT02643693|7610189|FG001|Overall Study|Protocol Adherence Issues|0
4697154|NCT02643693|7610190|FG002|Overall Study|Protocol Adherence Issues|1
4697155|NCT02643693|7610191|FG003|Overall Study|Protocol Adherence Issues|0
4697156|NCT02643693|7610192|FG004|Overall Study|Protocol Adherence Issues|0
4697157|NCT02643693|7610193|FG005|Overall Study|Protocol Adherence Issues|1
4697158|NCT02644096|7610230|FG000|Overall Study|Withdrawal by Subject|28
4468250|NCT00626522|7260458|FG002|Overall Study|COPD exacerbation|0
4697159|NCT02644096|7610231|FG001|Overall Study|Withdrawal by Subject|25
4697160|NCT02644109|7610239|FG000|Overall Study|Adverse Event|0
4468251|NCT00626522|7260459|FG003|Overall Study|COPD exacerbation|1
4468252|NCT00626522|7260460|FG004|Overall Study|COPD exacerbation|1
4468253|NCT00626522|7260461|FG005|Overall Study|COPD exacerbation|0
4468254|NCT00626522|7260456|FG000|Overall Study|Lost to Follow-up|0
4468255|NCT00626522|7260457|FG001|Overall Study|Lost to Follow-up|1
4381234|NCT01232283|7158950|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
4381235|NCT01232283|7158951|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
4381236|NCT01232283|7158952|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
4381237|NCT01232283|7158953|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
4381238|NCT01232283|7158954|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
4381239|NCT01232283|7158955|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3
4381240|NCT01232283|7158956|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2
4381241|NCT01232283|7158947|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
4381242|NCT01232283|7158948|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
4381243|NCT01232283|7158949|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
4381244|NCT01232283|7158950|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
4381245|NCT01232283|7158951|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
4381246|NCT01232283|7158952|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
4381247|NCT01232283|7158953|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
4381248|NCT01232283|7158954|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
4381249|NCT01232283|7158955|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30
4381250|NCT01232283|7158956|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14
4381251|NCT01232283|7158947|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
4381252|NCT01232283|7158948|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
4381253|NCT01232283|7158949|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
4381254|NCT01232283|7158950|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
4381255|NCT01232283|7158951|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
4381256|NCT01232283|7158952|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
4381257|NCT01232283|7158953|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
4381258|NCT01232283|7158954|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
4381259|NCT01232283|7158955|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9
4381260|NCT01232283|7158956|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6
4381261|NCT01232283|7158947|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0
4588465|NCT01500187|7433040|FG001|Overall Study|Lost to Follow-up|0
4588466|NCT01500200|7433049|FG000|Stage 1|Adverse Event|1
4588467|NCT01500200|7433050|FG001|Stage 1|Adverse Event|4
4588468|NCT01500200|7433051|FG002|Stage 1|Adverse Event|5
4588469|NCT01500200|7433052|FG003|Stage 1|Adverse Event|0
4588470|NCT01500200|7433053|FG004|Stage 1|Adverse Event|0
4588471|NCT01500200|7433054|FG005|Stage 1|Adverse Event|0
4588472|NCT01500200|7433049|FG000|Stage 1|Lost to Follow-up|2
4588473|NCT01500200|7433050|FG001|Stage 1|Lost to Follow-up|2
4697161|NCT02644109|7610240|FG001|Overall Study|Adverse Event|4
4381262|NCT01232283|7158948|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0
4381263|NCT01232283|7158949|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0
4381264|NCT01232283|7158950|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0
4381265|NCT01232283|7158951|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0
4381266|NCT01232283|7158952|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0
4381267|NCT01232283|7158953|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0
4381268|NCT01232283|7158954|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0
4697162|NCT02644122|7610246|FG000|Overall Study|Withdrawal by Subject|1
4697163|NCT02644343|7610268|FG000|Overall Study|Withdrawal by Subject|1
4697164|NCT02644356|7610272|FG000|Overall Study|Withdrawal by Subject|2
4697165|NCT02644668|7610279|FG000|Overall Study|Adverse Event|2
4697166|NCT02644668|7610280|FG001|Overall Study|Adverse Event|0
4697167|NCT02644668|7610281|FG002|Overall Study|Adverse Event|1
4381269|NCT01232283|7158955|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1
4381270|NCT01232283|7158956|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0
4381271|NCT01232283|7158947|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
4381272|NCT01232283|7158948|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
4381273|NCT01232283|7158949|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
4381274|NCT01232283|7158950|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
4381275|NCT01232283|7158951|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
4381276|NCT01232283|7158952|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
4381277|NCT01232283|7158953|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
4381278|NCT01232283|7158954|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
4381279|NCT01232283|7158955|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1
4381280|NCT01232283|7158956|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
4381281|NCT01232283|7158947|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
4381282|NCT01232283|7158948|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
4381283|NCT01232283|7158949|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
4381284|NCT01232283|7158950|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
4588474|NCT01500200|7433051|FG002|Stage 1|Lost to Follow-up|1
4588475|NCT01500200|7433052|FG003|Stage 1|Lost to Follow-up|0
4588476|NCT01500200|7433053|FG004|Stage 1|Lost to Follow-up|0
4588477|NCT01500200|7433054|FG005|Stage 1|Lost to Follow-up|0
4697168|NCT02644668|7610279|FG000|Overall Study|Protocol Violation|0
4697169|NCT02644668|7610280|FG001|Overall Study|Protocol Violation|0
4381285|NCT01232283|7158951|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
4381286|NCT01232283|7158952|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
4381287|NCT01232283|7158953|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
4381288|NCT01232283|7158954|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
4381289|NCT01232283|7158955|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7
4381290|NCT01232283|7158956|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3
4381291|NCT01231516|7158980|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4
4381292|NCT01231516|7158981|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11
4381293|NCT01231516|7158980|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20
4381294|NCT01231516|7158981|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42
4381295|NCT01231516|7158980|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9
4381296|NCT01231516|7158981|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6
4381297|NCT01231516|7158980|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5
4381298|NCT01231516|7158981|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3
4381299|NCT01231516|7158980|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5
4381300|NCT01231516|7158981|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10
4381301|NCT01231516|7158980|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1
4381302|NCT01231516|7158981|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1
4381303|NCT01231516|7158980|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11
4381304|NCT01231516|7158981|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5
4381305|NCT01231516|7158980|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3
4381306|NCT01231516|7158981|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1
4381307|NCT01231516|7158980|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3
4381308|NCT01231516|7158981|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2
4381309|NCT01231516|7158980|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5
4381310|NCT01231516|7158981|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0
4381311|NCT01231516|7158980|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27
4381312|NCT01231516|7158981|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11
4381313|NCT01231516|7158980|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10
4381314|NCT01231516|7158981|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0
4381315|NCT01231516|7158980|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6
4381316|NCT01231516|7158981|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3
4381317|NCT01231516|7158980|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2
4381318|NCT01231516|7158981|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0
4381319|NCT01231516|7158980|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6
4381320|NCT01231516|7158981|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1
4381321|NCT01231516|7158980|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12
4381322|NCT01231516|7158981|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2
4381323|NCT01194219|7159000|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23
4381324|NCT01194219|7159001|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5
4381325|NCT01194219|7159002|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
4381326|NCT01194219|7159003|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
4381327|NCT01194219|7159004|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
4381328|NCT01194219|7159005|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
4381329|NCT01194219|7159006|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
4381330|NCT01194219|7159007|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
4381331|NCT01194219|7159008|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
4381332|NCT01194219|7159009|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
4381333|NCT01194219|7159000|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2
4381334|NCT01194219|7159001|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7
4381335|NCT01194219|7159002|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
4381336|NCT01194219|7159003|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
4381337|NCT01194219|7159004|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
4381338|NCT01194219|7159005|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
4381339|NCT01194219|7159006|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
4381340|NCT01194219|7159007|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
4381341|NCT01194219|7159008|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
4381342|NCT01194219|7159009|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
4381343|NCT01194219|7159000|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7
4381344|NCT01194219|7159001|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
4381345|NCT01194219|7159002|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
4381346|NCT01194219|7159003|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
4381347|NCT01194219|7159004|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
4381348|NCT01194219|7159005|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
4381349|NCT01194219|7159006|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
4381350|NCT01194219|7159007|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
4381351|NCT01194219|7159008|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
4381352|NCT01194219|7159009|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
4381353|NCT01194219|7159000|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12
4381354|NCT01194219|7159001|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9
4381355|NCT01194219|7159002|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
4381356|NCT01194219|7159003|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
4381357|NCT01194219|7159004|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
4381358|NCT01194219|7159005|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
4381359|NCT01194219|7159006|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
4381360|NCT01194219|7159007|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
4468256|NCT00626522|7260458|FG002|Overall Study|Lost to Follow-up|0
4468257|NCT00626522|7260459|FG003|Overall Study|Lost to Follow-up|0
4468258|NCT00626522|7260460|FG004|Overall Study|Lost to Follow-up|0
4468259|NCT00626522|7260461|FG005|Overall Study|Lost to Follow-up|0
4468260|NCT00626522|7260456|FG000|Overall Study|Inconsistent reason reported|1
4468261|NCT00626522|7260457|FG001|Overall Study|Inconsistent reason reported|0
4468262|NCT00626522|7260458|FG002|Overall Study|Inconsistent reason reported|0
4468263|NCT00626522|7260459|FG003|Overall Study|Inconsistent reason reported|0
4468264|NCT00626522|7260460|FG004|Overall Study|Inconsistent reason reported|0
4468265|NCT00626522|7260461|FG005|Overall Study|Inconsistent reason reported|0
4468266|NCT00626522|7260456|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1
4468267|NCT00626522|7260457|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0
4468268|NCT00626522|7260458|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1
4468269|NCT00626522|7260459|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1
4468270|NCT00626522|7260460|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0
4468271|NCT00626522|7260461|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0
4468272|NCT00626548|7260477|FG000|Overall Study|Adverse Event|164
4468273|NCT00626548|7260478|FG001|Overall Study|Adverse Event|44
4468274|NCT00626548|7260477|FG000|Overall Study|Withdrawal by Subject|42
4468275|NCT00626548|7260478|FG001|Overall Study|Withdrawal by Subject|46
4468276|NCT00626548|7260477|FG000|Overall Study|Protocol Violation|4
4468277|NCT00626548|7260478|FG001|Overall Study|Protocol Violation|11
4468278|NCT00626548|7260477|FG000|Overall Study|Lost to Follow-up|2
4468279|NCT00626548|7260478|FG001|Overall Study|Lost to Follow-up|2
4468280|NCT00626548|7260477|FG000|Overall Study|Other termination reason|493
4468281|NCT00626548|7260478|FG001|Overall Study|Other termination reason|613
4468282|NCT00626639|7260507|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2
4468283|NCT00626639|7260508|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2
4468284|NCT00626795|7260539|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0
4468285|NCT00626795|7260540|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1
4468286|NCT00626795|7260541|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0
4468287|NCT00626795|7260539|FG000|Blinded Treatment|Lack of Efficacy|2
4468288|NCT00626795|7260540|FG001|Blinded Treatment|Lack of Efficacy|0
4468289|NCT00626795|7260541|FG002|Blinded Treatment|Lack of Efficacy|0
4468290|NCT00626795|7260539|FG000|Blinded Treatment|Unacceptable adverse event|0
4468291|NCT00626795|7260540|FG001|Blinded Treatment|Unacceptable adverse event|0
4468292|NCT00626795|7260541|FG002|Blinded Treatment|Unacceptable adverse event|1
4468293|NCT00626795|7260539|FG000|Blinded Treatment|Protocol Violation|0
4468294|NCT00626795|7260540|FG001|Blinded Treatment|Protocol Violation|1
4468295|NCT00626795|7260541|FG002|Blinded Treatment|Protocol Violation|1
4468296|NCT00626795|7260539|FG000|Blinded Treatment|Withdrawal by Subject|1
4468297|NCT00626795|7260540|FG001|Blinded Treatment|Withdrawal by Subject|1
4468298|NCT00626795|7260541|FG002|Blinded Treatment|Withdrawal by Subject|0
4468299|NCT00626795|7260539|FG000|Blinded Treatment|Other reasons|2
4468300|NCT00626795|7260540|FG001|Blinded Treatment|Other reasons|0
4468301|NCT00626795|7260541|FG002|Blinded Treatment|Other reasons|2
4468302|NCT00626795|7260539|FG000|Blinded Treatment|Missing reason for withdrawal|5
4468303|NCT00626795|7260540|FG001|Blinded Treatment|Missing reason for withdrawal|3
4468304|NCT00626795|7260541|FG002|Blinded Treatment|Missing reason for withdrawal|5
4468305|NCT00626821|7260570|FG000|Overall Study|Adverse Event|44
4468306|NCT00626821|7260570|FG000|Overall Study|Protocol Violation|33
4468307|NCT00626821|7260570|FG000|Overall Study|Withdrawal by Subject|10
4468308|NCT00626821|7260570|FG000|Overall Study|Physician Decision|9
4468309|NCT00626821|7260570|FG000|Overall Study|Product dysfunction|21
4468310|NCT00626821|7260570|FG000|Overall Study|other/unknown reason|104
4468311|NCT00626925|7260594|FG000|Overall Study|Lost to Follow-up|1
4468312|NCT00626925|7260595|FG001|Overall Study|Lost to Follow-up|2
4468313|NCT00626925|7260594|FG000|Overall Study|relapse|1
4468314|NCT00626925|7260595|FG001|Overall Study|relapse|0
4468315|NCT00626925|7260594|FG000|Overall Study|Adverse effect|6
4468316|NCT00626925|7260595|FG001|Overall Study|Adverse effect|2
4468317|NCT00626925|7260594|FG000|Overall Study|Lack of Efficacy|1
4468318|NCT00626925|7260595|FG001|Overall Study|Lack of Efficacy|4
4468319|NCT00626925|7260594|FG000|Overall Study|Time constraints|3
4468320|NCT00626925|7260595|FG001|Overall Study|Time constraints|1
4468321|NCT00627016|7260617|FG000|Overall Study|Adverse Event|1
4468322|NCT00627016|7260618|FG001|Overall Study|Adverse Event|1
4468323|NCT00627016|7260617|FG000|Overall Study|Protocol Violation|0
4468324|NCT00627016|7260618|FG001|Overall Study|Protocol Violation|2
4468325|NCT00627016|7260617|FG000|Overall Study|Lost to Follow-up|0
4381361|NCT01194219|7159008|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
4381362|NCT01194219|7159009|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
4381363|NCT01194219|7159000|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0
4381364|NCT01194219|7159001|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1
4381365|NCT01194219|7159002|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0
4468326|NCT00627016|7260618|FG001|Overall Study|Lost to Follow-up|1
4468327|NCT00627016|7260617|FG000|Overall Study|Withdrawal by Subject|2
4468328|NCT00627016|7260618|FG001|Overall Study|Withdrawal by Subject|1
4468329|NCT00627016|7260617|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0
4468330|NCT00627016|7260618|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1
4468331|NCT00627016|7260617|FG000|Overall Study|Lack of Efficacy|1
4468332|NCT00627016|7260618|FG001|Overall Study|Lack of Efficacy|0
4468333|NCT00627016|7260617|FG000|Overall Study|Placed on Excluded Drugs|1
4468334|NCT00627016|7260618|FG001|Overall Study|Placed on Excluded Drugs|0
4468335|NCT00627016|7260617|FG000|Overall Study|Pregnancy|1
4468336|NCT00627016|7260618|FG001|Overall Study|Pregnancy|0
4468337|NCT00627042|7260624|FG000|Overall Study|Withdrawal by Subject|2
4468338|NCT00627094|7260630|FG000|Overall Study|Adverse Event|8
4468339|NCT00627094|7260631|FG001|Overall Study|Adverse Event|7
4468340|NCT00627094|7260630|FG000|Overall Study|Lost to Follow-up|1
4468341|NCT00627094|7260631|FG001|Overall Study|Lost to Follow-up|0
4468342|NCT00627094|7260630|FG000|Overall Study|Withdrawal by Subject|1
4468343|NCT00627094|7260631|FG001|Overall Study|Withdrawal by Subject|1
4468344|NCT00627094|7260630|FG000|Overall Study|ulcer healed|1
4468345|NCT00627094|7260631|FG001|Overall Study|ulcer healed|7
4468346|NCT00627094|7260630|FG000|Overall Study|Other reason|1
4468347|NCT00627094|7260631|FG001|Overall Study|Other reason|0
4468348|NCT00627393|7260651|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5
4468349|NCT00627393|7260652|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3
4468350|NCT00627393|7260651|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4
4468351|NCT00627393|7260652|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5
4468352|NCT00627393|7260651|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6
4468353|NCT00627393|7260652|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3
4468354|NCT00627393|7260651|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4
4468355|NCT00627393|7260652|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10
4468356|NCT00627445|7260679|FG000|Overall Study|Adverse Event|3
4468357|NCT00627445|7260680|FG001|Overall Study|Adverse Event|3
4468358|NCT00627445|7260679|FG000|Overall Study|Lack of Efficacy|0
4468359|NCT00627445|7260680|FG001|Overall Study|Lack of Efficacy|1
4468360|NCT00627445|7260679|FG000|Overall Study|Other|6
4468361|NCT00627445|7260680|FG001|Overall Study|Other|8
4468362|NCT00627458|7260691|FG000|Overall Study|Migrated from study area|1
4468363|NCT00627458|7260692|FG001|Overall Study|Migrated from study area|0
4468364|NCT00627458|7260693|FG002|Overall Study|Migrated from study area|1
4468365|NCT00627458|7260691|FG000|Overall Study|Withdrawal by Subject|2
4468366|NCT00627458|7260692|FG001|Overall Study|Withdrawal by Subject|6
4468367|NCT00627458|7260693|FG002|Overall Study|Withdrawal by Subject|5
4468368|NCT00627458|7260691|FG000|Overall Study|Lost to Follow-up|1
4468369|NCT00627458|7260692|FG001|Overall Study|Lost to Follow-up|1
4468370|NCT00627458|7260693|FG002|Overall Study|Lost to Follow-up|0
4468371|NCT00627497|7260706|FG000|Overall Study|Lost to Follow-up|1
4468372|NCT00627497|7260707|FG001|Overall Study|Lost to Follow-up|1
4468373|NCT00627497|7260708|FG002|Overall Study|Lost to Follow-up|0
4468374|NCT00627497|7260709|FG003|Overall Study|Lost to Follow-up|0
4468375|NCT00627523|7260721|FG000|Overall Study|Lack of Efficacy|1
4468376|NCT00627523|7260722|FG001|Overall Study|Lack of Efficacy|0
4468377|NCT00627523|7260721|FG000|Overall Study|Withdrawal by Subject|0
4468378|NCT00627523|7260722|FG001|Overall Study|Withdrawal by Subject|2
4468379|NCT00627523|7260721|FG000|Overall Study|Other|1
4468380|NCT00627523|7260722|FG001|Overall Study|Other|0
4468381|NCT00627705|7260743|FG000|Overall Study|Unwilling to take the compound (taste)|1
4468382|NCT00627705|7260744|FG001|Overall Study|Unwilling to take the compound (taste)|3
4588478|NCT01500200|7433049|FG000|Stage 1|Withdrawal by Subject|3
4588479|NCT01500200|7433050|FG001|Stage 1|Withdrawal by Subject|0
4588480|NCT01500200|7433051|FG002|Stage 1|Withdrawal by Subject|0
4588481|NCT01500200|7433052|FG003|Stage 1|Withdrawal by Subject|0
4588482|NCT01500200|7433053|FG004|Stage 1|Withdrawal by Subject|0
4588483|NCT01500200|7433054|FG005|Stage 1|Withdrawal by Subject|0
4588484|NCT01500200|7433049|FG000|Stage 1|Noncompliance with Study Drug|1
4588485|NCT01500200|7433050|FG001|Stage 1|Noncompliance with Study Drug|0
4588486|NCT01500200|7433051|FG002|Stage 1|Noncompliance with Study Drug|0
4588487|NCT01500200|7433052|FG003|Stage 1|Noncompliance with Study Drug|0
4588488|NCT01500200|7433053|FG004|Stage 1|Noncompliance with Study Drug|0
4588489|NCT01500200|7433054|FG005|Stage 1|Noncompliance with Study Drug|0
4588490|NCT01500200|7433049|FG000|Stage 1|Physician Decision|1
4468383|NCT00627705|7260743|FG000|Overall Study|Adverse Event|1
4468384|NCT00627705|7260744|FG001|Overall Study|Adverse Event|0
4468385|NCT00627705|7260743|FG000|Overall Study|Withdrawal by Subject|0
4468386|NCT00627705|7260744|FG001|Overall Study|Withdrawal by Subject|2
4468387|NCT00627705|7260743|FG000|Overall Study|Lost to Follow-up|0
4468388|NCT00627705|7260744|FG001|Overall Study|Lost to Follow-up|1
4468389|NCT00627926|7260759|FG000|Overall Study|Adverse Event|26
4588491|NCT01500200|7433050|FG001|Stage 1|Physician Decision|0
4588492|NCT01500200|7433051|FG002|Stage 1|Physician Decision|0
4588493|NCT01500200|7433052|FG003|Stage 1|Physician Decision|0
4588494|NCT01500200|7433053|FG004|Stage 1|Physician Decision|0
4588495|NCT01500200|7433054|FG005|Stage 1|Physician Decision|0
4588496|NCT01500200|7433049|FG000|Stage 2|Adverse Event|0
4588497|NCT01500200|7433050|FG001|Stage 2|Adverse Event|0
4588498|NCT01500200|7433051|FG002|Stage 2|Adverse Event|0
4588499|NCT01500200|7433052|FG003|Stage 2|Adverse Event|0
4588500|NCT01500200|7433053|FG004|Stage 2|Adverse Event|5
4588501|NCT01500200|7433054|FG005|Stage 2|Adverse Event|4
4588502|NCT01500213|7433070|FG000|Overall Study|Adverse Event|35
4588503|NCT01500213|7433071|FG001|Overall Study|Adverse Event|35
4588504|NCT01500213|7433070|FG000|Overall Study|Chemo Completed or Change in Therapy|84
4588505|NCT01500213|7433071|FG001|Overall Study|Chemo Completed or Change in Therapy|81
4588506|NCT01500213|7433070|FG000|Overall Study|Withdrawal by Subject|28
4588507|NCT01500213|7433071|FG001|Overall Study|Withdrawal by Subject|37
4697170|NCT02644668|7610281|FG002|Overall Study|Protocol Violation|1
4697171|NCT02644668|7610279|FG000|Overall Study|Withdrawal by Subject|0
4697172|NCT02644668|7610280|FG001|Overall Study|Withdrawal by Subject|0
4697173|NCT02644668|7610281|FG002|Overall Study|Withdrawal by Subject|1
4381366|NCT01194219|7159003|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0
4381367|NCT01194219|7159004|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0
4381368|NCT01194219|7159005|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0
4381369|NCT01194219|7159006|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0
4381370|NCT01194219|7159007|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0
4381371|NCT01194219|7159008|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0
4381372|NCT01194219|7159009|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0
4381373|NCT01194219|7159000|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7
4381374|NCT01194219|7159001|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9
4381375|NCT01194219|7159002|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
4381376|NCT01194219|7159003|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
4381377|NCT01194219|7159004|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
4381378|NCT01194219|7159005|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
4381379|NCT01194219|7159006|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
4381380|NCT01194219|7159007|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
4381381|NCT01194219|7159008|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
4381382|NCT01194219|7159009|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
4381383|NCT01194219|7159000|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7
4381384|NCT01194219|7159001|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1
4381385|NCT01194219|7159002|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
4381386|NCT01194219|7159003|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
4381387|NCT01194219|7159004|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
4381388|NCT01194219|7159005|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
4381389|NCT01194219|7159006|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
4381390|NCT01194219|7159007|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
4381391|NCT01194219|7159008|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
4381392|NCT01194219|7159009|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
4381393|NCT01194219|7159000|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1
4381394|NCT01194219|7159001|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1
4381395|NCT01194219|7159002|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
4381396|NCT01194219|7159003|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
4381397|NCT01194219|7159004|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
4381398|NCT01194219|7159005|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
4381399|NCT01194219|7159006|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
4381400|NCT01194219|7159007|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
4381401|NCT01194219|7159008|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
4381402|NCT01194219|7159009|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
4697174|NCT02645409|7610349|FG000|Overall Study|Withdrawal by Subject|3
4697175|NCT02645409|7610350|FG001|Overall Study|Withdrawal by Subject|0
4697176|NCT02645409|7610349|FG000|Overall Study|Physician Decision|1
4381403|NCT01194219|7159000|FG000|Maintenance Phase Weeks16-32|Adverse Event|0
4381404|NCT01194219|7159001|FG001|Maintenance Phase Weeks16-32|Adverse Event|0
4381405|NCT01194219|7159002|FG002|Maintenance Phase Weeks16-32|Adverse Event|8
4381406|NCT01194219|7159003|FG003|Maintenance Phase Weeks16-32|Adverse Event|9
4381407|NCT01194219|7159004|FG004|Maintenance Phase Weeks16-32|Adverse Event|0
4381408|NCT01194219|7159005|FG005|Maintenance Phase Weeks16-32|Adverse Event|0
4381409|NCT01194219|7159006|FG006|Maintenance Phase Weeks16-32|Adverse Event|0
4381410|NCT01194219|7159007|FG007|Maintenance Phase Weeks16-32|Adverse Event|0
4381411|NCT01194219|7159008|FG008|Maintenance Phase Weeks16-32|Adverse Event|0
4381412|NCT01194219|7159009|FG009|Maintenance Phase Weeks16-32|Adverse Event|0
4588508|NCT01500213|7433070|FG000|Overall Study|Death|7
4588509|NCT01500213|7433071|FG001|Overall Study|Death|3
4588510|NCT01500213|7433070|FG000|Overall Study|Disease Progression|13
4588511|NCT01500213|7433071|FG001|Overall Study|Disease Progression|21
4697177|NCT02645409|7610350|FG001|Overall Study|Physician Decision|0
4697178|NCT02646124|7610371|FG000|Overall Study|Lost to Follow-up|0
4697179|NCT02646124|7610372|FG001|Overall Study|Lost to Follow-up|2
4381413|NCT01194219|7159000|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0
4381414|NCT01194219|7159001|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0
4381415|NCT01194219|7159002|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37
4381416|NCT01194219|7159003|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15
4381417|NCT01194219|7159004|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0
4381418|NCT01194219|7159005|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0
4381419|NCT01194219|7159006|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0
4381420|NCT01194219|7159007|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0
4381421|NCT01194219|7159008|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0
4381422|NCT01194219|7159009|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0
4381423|NCT01194219|7159000|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
4381424|NCT01194219|7159001|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
4381425|NCT01194219|7159002|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2
4381426|NCT01194219|7159003|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1
4381427|NCT01194219|7159004|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
4381428|NCT01194219|7159005|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
4381429|NCT01194219|7159006|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
4381430|NCT01194219|7159007|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
4381431|NCT01194219|7159008|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
4381432|NCT01194219|7159009|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
4381433|NCT01194219|7159000|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
4381434|NCT01194219|7159001|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
4381435|NCT01194219|7159002|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12
4381436|NCT01194219|7159003|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3
4381437|NCT01194219|7159004|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
4381438|NCT01194219|7159005|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
4381439|NCT01194219|7159006|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
4381440|NCT01194219|7159007|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
4381441|NCT01194219|7159008|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
4381442|NCT01194219|7159009|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
4381443|NCT01194219|7159000|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0
4381444|NCT01194219|7159001|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0
4381445|NCT01194219|7159002|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9
4381446|NCT01194219|7159003|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0
4381447|NCT01194219|7159004|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0
4381448|NCT01194219|7159005|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0
4381449|NCT01194219|7159006|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0
4381450|NCT01194219|7159007|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0
4381451|NCT01194219|7159008|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0
4381452|NCT01194219|7159009|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0
4381453|NCT01194219|7159000|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0
4381454|NCT01194219|7159001|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0
4381455|NCT01194219|7159002|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0
4381456|NCT01194219|7159003|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1
4381457|NCT01194219|7159004|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0
4381458|NCT01194219|7159005|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0
4381459|NCT01194219|7159006|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0
4381460|NCT01194219|7159007|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0
4381461|NCT01194219|7159008|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0
4381462|NCT01194219|7159009|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0
4381463|NCT01194219|7159000|FG000|Maintenance Phase Weeks16-32|Other|0
4381464|NCT01194219|7159001|FG001|Maintenance Phase Weeks16-32|Other|0
4381465|NCT01194219|7159002|FG002|Maintenance Phase Weeks16-32|Other|2
4381466|NCT01194219|7159003|FG003|Maintenance Phase Weeks16-32|Other|1
4381467|NCT01194219|7159004|FG004|Maintenance Phase Weeks16-32|Other|0
4381468|NCT01194219|7159005|FG005|Maintenance Phase Weeks16-32|Other|0
4381469|NCT01194219|7159006|FG006|Maintenance Phase Weeks16-32|Other|0
4381470|NCT01194219|7159007|FG007|Maintenance Phase Weeks16-32|Other|0
4381471|NCT01194219|7159008|FG008|Maintenance Phase Weeks16-32|Other|0
4381472|NCT01194219|7159009|FG009|Maintenance Phase Weeks16-32|Other|0
4381473|NCT01194219|7159000|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
4381474|NCT01194219|7159001|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
4381475|NCT01194219|7159002|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
4381476|NCT01194219|7159003|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
4381477|NCT01194219|7159004|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
4381478|NCT01194219|7159005|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1
4381479|NCT01194219|7159006|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6
4381480|NCT01194219|7159007|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5
4381481|NCT01194219|7159008|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
4381482|NCT01194219|7159009|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
4381483|NCT01194219|7159000|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
4381484|NCT01194219|7159001|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
4381485|NCT01194219|7159002|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
4381486|NCT01194219|7159003|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
4381487|NCT01194219|7159004|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1
4381488|NCT01194219|7159005|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1
4381489|NCT01194219|7159006|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35
4381490|NCT01194219|7159007|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33
4381491|NCT01194219|7159008|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
4381492|NCT01194219|7159009|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
4381493|NCT01194219|7159000|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
4381494|NCT01194219|7159001|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
4381495|NCT01194219|7159002|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
4381496|NCT01194219|7159003|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
4381497|NCT01194219|7159004|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1
4381498|NCT01194219|7159005|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
4381499|NCT01194219|7159006|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2
4381500|NCT01194219|7159007|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
4381501|NCT01194219|7159008|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
4381502|NCT01194219|7159009|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
4381503|NCT01194219|7159000|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
4381504|NCT01194219|7159001|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
4381505|NCT01194219|7159002|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
4381506|NCT01194219|7159003|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
4381507|NCT01194219|7159004|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1
4381508|NCT01194219|7159005|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
4468390|NCT00627926|7260760|FG001|Overall Study|Adverse Event|37
4468391|NCT00627926|7260761|FG002|Overall Study|Adverse Event|36
4468392|NCT00627926|7260759|FG000|Overall Study|Death|1
4468393|NCT00627926|7260760|FG001|Overall Study|Death|0
4468394|NCT00627926|7260761|FG002|Overall Study|Death|0
4468395|NCT00627926|7260759|FG000|Overall Study|Lost to Follow-up|4
4468396|NCT00627926|7260760|FG001|Overall Study|Lost to Follow-up|3
4468397|NCT00627926|7260761|FG002|Overall Study|Lost to Follow-up|4
4468398|NCT00627926|7260759|FG000|Overall Study|Withdrawal by Subject|2
4468399|NCT00627926|7260760|FG001|Overall Study|Withdrawal by Subject|1
4468400|NCT00627926|7260761|FG002|Overall Study|Withdrawal by Subject|0
4468401|NCT00627926|7260759|FG000|Overall Study|Lack of Efficacy|118
4468402|NCT00627926|7260760|FG001|Overall Study|Lack of Efficacy|40
4468403|NCT00627926|7260761|FG002|Overall Study|Lack of Efficacy|38
4468404|NCT00627926|7260759|FG000|Overall Study|Noncompliance/unspecified|8
4468405|NCT00627926|7260760|FG001|Overall Study|Noncompliance/unspecified|23
4468406|NCT00627926|7260761|FG002|Overall Study|Noncompliance/unspecified|17
4468407|NCT00628030|7260780|FG000|Baseline to Post-Assessment|Lost to Follow-up|28
4468408|NCT00628030|7260781|FG001|Baseline to Post-Assessment|Lost to Follow-up|29
4468409|NCT00628030|7260780|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5
4468410|NCT00628030|7260781|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0
4468411|NCT00628030|7260780|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32
4468412|NCT00628030|7260781|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30
4468413|NCT00628108|7260789|FG000|Overall Study|Adverse Event|0
4468414|NCT00628108|7260790|FG001|Overall Study|Adverse Event|3
4468415|NCT00628108|7260789|FG000|Overall Study|Withdrawal by Subject|1
4468416|NCT00628108|7260790|FG001|Overall Study|Withdrawal by Subject|0
4468417|NCT00628212|7260816|FG000|Overall Study|Adverse Event|2
4468418|NCT00628212|7260817|FG001|Overall Study|Adverse Event|0
4468419|NCT00628212|7260818|FG002|Overall Study|Adverse Event|1
4468420|NCT00628212|7260819|FG003|Overall Study|Adverse Event|2
4468421|NCT00628212|7260816|FG000|Overall Study|Physician Decision|1
4468422|NCT00628212|7260817|FG001|Overall Study|Physician Decision|1
4468423|NCT00628212|7260818|FG002|Overall Study|Physician Decision|2
4468424|NCT00628212|7260819|FG003|Overall Study|Physician Decision|3
4468425|NCT00628251|7260832|FG000|Randomised Part|Withdrawal by Subject|0
4468426|NCT00628251|7260833|FG001|Randomised Part|Withdrawal by Subject|0
4468427|NCT00628251|7260834|FG002|Randomised Part|Withdrawal by Subject|1
4468428|NCT00628251|7260832|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1
4468429|NCT00628251|7260833|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2
4468430|NCT00628251|7260834|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3
4468431|NCT00628251|7260832|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19
4468432|NCT00628251|7260833|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15
4468433|NCT00628251|7260834|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13
4468434|NCT00628251|7260832|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1
4468435|NCT00628251|7260833|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2
4468436|NCT00628251|7260834|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1
4468437|NCT00628251|7260832|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0
4468438|NCT00628251|7260833|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1
4381509|NCT01194219|7159006|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12
4381510|NCT01194219|7159007|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6
4381511|NCT01194219|7159008|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
4381512|NCT01194219|7159009|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
4381513|NCT01194219|7159000|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
4381514|NCT01194219|7159001|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
4381515|NCT01194219|7159002|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
4381516|NCT01194219|7159003|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
4381517|NCT01194219|7159004|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1
4381518|NCT01194219|7159005|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2
4381519|NCT01194219|7159006|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5
4381520|NCT01194219|7159007|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
4381521|NCT01194219|7159008|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
4381522|NCT01194219|7159009|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
4381523|NCT01194219|7159000|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
4381524|NCT01194219|7159001|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
4381525|NCT01194219|7159002|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
4381526|NCT01194219|7159003|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
4381527|NCT01194219|7159004|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
4381528|NCT01194219|7159005|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
4381529|NCT01194219|7159006|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
4381530|NCT01194219|7159007|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1
4381531|NCT01194219|7159008|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
4381532|NCT01194219|7159009|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
4381533|NCT01194219|7159000|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0
4381534|NCT01194219|7159001|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0
4381535|NCT01194219|7159002|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0
4381536|NCT01194219|7159003|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0
4381537|NCT01194219|7159004|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0
4381538|NCT01194219|7159005|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0
4381539|NCT01194219|7159006|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1
4381540|NCT01194219|7159007|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0
4381541|NCT01194219|7159008|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0
4381542|NCT01194219|7159009|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0
4381543|NCT01194219|7159000|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0
4381544|NCT01194219|7159001|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0
4381545|NCT01194219|7159002|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0
4381546|NCT01194219|7159003|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0
4381547|NCT01194219|7159004|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0
4381548|NCT01194219|7159005|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0
4381549|NCT01194219|7159006|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0
4381550|NCT01194219|7159007|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0
4381551|NCT01194219|7159008|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25
4381552|NCT01194219|7159009|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14
4381553|NCT01194219|7159000|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
4381554|NCT01194219|7159001|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
4381555|NCT01194219|7159002|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
4381556|NCT01194219|7159003|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
4381557|NCT01194219|7159004|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
4381558|NCT01194219|7159005|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
4381559|NCT01194219|7159006|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
4381560|NCT01194219|7159007|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
4381561|NCT01194219|7159008|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81
4381562|NCT01194219|7159009|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49
4381563|NCT01194219|7159000|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
4381564|NCT01194219|7159001|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
4381565|NCT01194219|7159002|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
4381566|NCT01194219|7159003|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
4381567|NCT01194219|7159004|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
4381568|NCT01194219|7159005|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
4381569|NCT01194219|7159006|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
4381570|NCT01194219|7159007|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
4381571|NCT01194219|7159008|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9
4381572|NCT01194219|7159009|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4
4381573|NCT01194219|7159000|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
4381574|NCT01194219|7159001|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
4381575|NCT01194219|7159002|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
4381576|NCT01194219|7159003|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
4381577|NCT01194219|7159004|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
4381578|NCT01194219|7159005|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
4381579|NCT01194219|7159006|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
4381580|NCT01194219|7159007|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
4381581|NCT01194219|7159008|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66
4381582|NCT01194219|7159009|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32
4381583|NCT01194219|7159000|FG000|Long-Term Extension Weeks 52 to 260|Death|0
4381584|NCT01194219|7159001|FG001|Long-Term Extension Weeks 52 to 260|Death|0
4381585|NCT01194219|7159002|FG002|Long-Term Extension Weeks 52 to 260|Death|0
4381586|NCT01194219|7159003|FG003|Long-Term Extension Weeks 52 to 260|Death|0
4381587|NCT01194219|7159004|FG004|Long-Term Extension Weeks 52 to 260|Death|0
4381588|NCT01194219|7159005|FG005|Long-Term Extension Weeks 52 to 260|Death|0
4381589|NCT01194219|7159006|FG006|Long-Term Extension Weeks 52 to 260|Death|0
4381590|NCT01194219|7159007|FG007|Long-Term Extension Weeks 52 to 260|Death|0
4381591|NCT01194219|7159008|FG008|Long-Term Extension Weeks 52 to 260|Death|1
4381592|NCT01194219|7159009|FG009|Long-Term Extension Weeks 52 to 260|Death|1
4381593|NCT01194219|7159000|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
4381594|NCT01194219|7159001|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
4381595|NCT01194219|7159002|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
4381596|NCT01194219|7159003|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
4381597|NCT01194219|7159004|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
4381598|NCT01194219|7159005|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
4381599|NCT01194219|7159006|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
4381600|NCT01194219|7159007|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
4381601|NCT01194219|7159008|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24
4381602|NCT01194219|7159009|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10
4381603|NCT01194219|7159000|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
4381604|NCT01194219|7159001|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
4381605|NCT01194219|7159002|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
4381606|NCT01194219|7159003|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
4381607|NCT01194219|7159004|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
4381608|NCT01194219|7159005|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
4697180|NCT02646332|7610380|FG000|Overall Study|Lost to Follow-up|0
4697181|NCT02646332|7610381|FG001|Overall Study|Lost to Follow-up|3
4697182|NCT02646423|7610398|FG000|Overall Study|Adverse Event|5
4697183|NCT02646423|7610399|FG001|Overall Study|Adverse Event|7
4697184|NCT02646423|7610398|FG000|Overall Study|Ineligible|2
4697185|NCT02646423|7610399|FG001|Overall Study|Ineligible|1
4697186|NCT02646566|7610417|FG000|Overall Study|Lost to Follow-up|5
4697187|NCT02646566|7610418|FG001|Overall Study|Lost to Follow-up|4
4697188|NCT02646566|7610419|FG002|Overall Study|Lost to Follow-up|5
4697189|NCT02646566|7610417|FG000|Overall Study|Treatment failure|1
4697190|NCT02646566|7610418|FG001|Overall Study|Treatment failure|0
4381609|NCT01194219|7159006|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
4381610|NCT01194219|7159007|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
4381611|NCT01194219|7159008|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3
4381612|NCT01194219|7159009|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
4381613|NCT01194219|7159000|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
4381614|NCT01194219|7159001|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
4381615|NCT01194219|7159002|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
4381616|NCT01194219|7159003|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
4381617|NCT01194219|7159004|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
4381618|NCT01194219|7159005|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
4381619|NCT01194219|7159006|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
4381620|NCT01194219|7159007|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
4381621|NCT01194219|7159008|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11
4381622|NCT01194219|7159009|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2
4381623|NCT01193842|7159037|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
4381624|NCT01193842|7159038|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1
4381625|NCT01193842|7159039|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
4381626|NCT01193842|7159040|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
4381627|NCT01193842|7159041|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
4381628|NCT01193842|7159037|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1
4381629|NCT01193842|7159038|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
4381630|NCT01193842|7159039|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
4381631|NCT01193842|7159040|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
4381632|NCT01193842|7159041|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
4381633|NCT01193842|7159037|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
4381634|NCT01193842|7159038|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
4381635|NCT01193842|7159039|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1
4381636|NCT01193842|7159040|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
4381637|NCT01193842|7159041|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
4381638|NCT01193842|7159037|FG000|Phase II: Randomized Groups|Death|0
4381639|NCT01193842|7159038|FG001|Phase II: Randomized Groups|Death|0
4381640|NCT01193842|7159039|FG002|Phase II: Randomized Groups|Death|0
4381641|NCT01193842|7159040|FG003|Phase II: Randomized Groups|Death|1
4697191|NCT02646566|7610419|FG002|Overall Study|Treatment failure|0
4697192|NCT02646618|7610429|FG000|Overall Study|Lost to Follow-up|10
4381642|NCT01193842|7159041|FG004|Phase II: Randomized Groups|Death|1
4381643|NCT01193842|7159037|FG000|Phase II: Randomized Groups|Adverse Event|0
4381644|NCT01193842|7159038|FG001|Phase II: Randomized Groups|Adverse Event|0
4468439|NCT00628251|7260834|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6
4468440|NCT00628251|7260832|FG000|Ongoing Initial Study Treatment at DCO|Other|1
4468441|NCT00628251|7260833|FG001|Ongoing Initial Study Treatment at DCO|Other|0
4468442|NCT00628251|7260834|FG002|Ongoing Initial Study Treatment at DCO|Other|2
4468443|NCT00628355|7260846|FG000|Overall Study|Withdrawal by Subject|1
4468444|NCT00628355|7260847|FG001|Overall Study|Withdrawal by Subject|1
4516374|NCT00959907|7327749|FG001|Overall Study|Withdrawal by Subject|0
4516375|NCT00959946|7327774|FG000|Overall Study|Adverse Event|0
4516376|NCT00959946|7327775|FG001|Overall Study|Adverse Event|0
4516377|NCT00959946|7327776|FG002|Overall Study|Adverse Event|2
4516378|NCT00959946|7327777|FG003|Overall Study|Adverse Event|1
4516379|NCT00959946|7327778|FG004|Overall Study|Adverse Event|0
4516380|NCT00959946|7327779|FG005|Overall Study|Adverse Event|1
4516381|NCT00959946|7327780|FG006|Overall Study|Adverse Event|0
4516382|NCT00959946|7327781|FG007|Overall Study|Adverse Event|0
4516383|NCT00959946|7327774|FG000|Overall Study|Death|0
4516384|NCT00959946|7327775|FG001|Overall Study|Death|0
4516385|NCT00959946|7327776|FG002|Overall Study|Death|0
4516386|NCT00959946|7327777|FG003|Overall Study|Death|0
4516387|NCT00959946|7327778|FG004|Overall Study|Death|0
4516388|NCT00959946|7327779|FG005|Overall Study|Death|1
4516389|NCT00959946|7327780|FG006|Overall Study|Death|0
4516390|NCT00959946|7327781|FG007|Overall Study|Death|0
4516391|NCT00959946|7327774|FG000|Overall Study|Disease Progression|2
4516392|NCT00959946|7327775|FG001|Overall Study|Disease Progression|4
4516393|NCT00959946|7327776|FG002|Overall Study|Disease Progression|2
4516394|NCT00959946|7327777|FG003|Overall Study|Disease Progression|4
4516395|NCT00959946|7327778|FG004|Overall Study|Disease Progression|4
4516396|NCT00959946|7327779|FG005|Overall Study|Disease Progression|6
4516397|NCT00959946|7327780|FG006|Overall Study|Disease Progression|2
4516398|NCT00959946|7327781|FG007|Overall Study|Disease Progression|2
4516399|NCT00959946|7327774|FG000|Overall Study|Withdrawal by Subject|0
4516400|NCT00959946|7327775|FG001|Overall Study|Withdrawal by Subject|0
4516401|NCT00959946|7327776|FG002|Overall Study|Withdrawal by Subject|0
4516402|NCT00959946|7327777|FG003|Overall Study|Withdrawal by Subject|0
4516403|NCT00959946|7327778|FG004|Overall Study|Withdrawal by Subject|0
4516404|NCT00959946|7327779|FG005|Overall Study|Withdrawal by Subject|1
4516405|NCT00959946|7327780|FG006|Overall Study|Withdrawal by Subject|0
4516406|NCT00959946|7327781|FG007|Overall Study|Withdrawal by Subject|0
4516407|NCT00960011|7327823|FG000|Overall Study|Death|5
4516408|NCT00960011|7327824|FG001|Overall Study|Death|0
4516409|NCT00960011|7327823|FG000|Overall Study|Lost to Follow-up|6
4516410|NCT00960011|7327824|FG001|Overall Study|Lost to Follow-up|2
4516411|NCT00960063|7327867|FG000|Overall Study|Adverse Event|1
4516412|NCT00960063|7327868|FG001|Overall Study|Adverse Event|0
4516413|NCT00960063|7327869|FG002|Overall Study|Adverse Event|0
4516414|NCT00960063|7327867|FG000|Overall Study|Progression of Disease|0
4516415|NCT00960063|7327868|FG001|Overall Study|Progression of Disease|0
4516416|NCT00960063|7327869|FG002|Overall Study|Progression of Disease|3
4516417|NCT00960076|7327879|FG000|Overall Study|Adverse Event|1
4516418|NCT00960076|7327880|FG001|Overall Study|Adverse Event|7
4516419|NCT00960076|7327879|FG000|Overall Study|No longer met study criteria|1
4516420|NCT00960076|7327880|FG001|Overall Study|No longer met study criteria|5
4516421|NCT00960076|7327879|FG000|Overall Study|Withdrawal by Subject|1
4516422|NCT00960076|7327880|FG001|Overall Study|Withdrawal by Subject|2
4516423|NCT00960076|7327879|FG000|Overall Study|Lost to Follow-up|3
4516424|NCT00960076|7327880|FG001|Overall Study|Lost to Follow-up|3
4516425|NCT00960076|7327879|FG000|Overall Study|Severe non-compliance to protocol|1
4516426|NCT00960076|7327880|FG001|Overall Study|Severe non-compliance to protocol|2
4516427|NCT00960076|7327879|FG000|Overall Study|Hyperglycemia|1
4516428|NCT00960076|7327880|FG001|Overall Study|Hyperglycemia|5
4516429|NCT00960076|7327879|FG000|Overall Study|Did not attend the termination visit|0
4516430|NCT00960076|7327880|FG001|Overall Study|Did not attend the termination visit|1
4516431|NCT00960115|7327888|FG000|Overall Study|Ongoing treatment at data cut-off date|19
4516432|NCT00960115|7327889|FG001|Overall Study|Ongoing treatment at data cut-off date|15
4516433|NCT00960193|7327895|FG000|14 Day Washout Period|Withdrawal by Subject|1
4516434|NCT00960206|7327905|FG000|Overall Study|Death|7
4516435|NCT00960206|7327906|FG001|Overall Study|Death|4
4516436|NCT00960206|7327907|FG002|Overall Study|Death|1
4516437|NCT00960206|7327905|FG000|Overall Study|Unwilling/Unable to return|1
4516438|NCT00960206|7327906|FG001|Overall Study|Unwilling/Unable to return|2
4516439|NCT00960206|7327907|FG002|Overall Study|Unwilling/Unable to return|0
4516440|NCT00960206|7327905|FG000|Overall Study|Lost to Follow-up|8
4516441|NCT00960206|7327906|FG001|Overall Study|Lost to Follow-up|14
4516442|NCT00960206|7327907|FG002|Overall Study|Lost to Follow-up|8
4516443|NCT00960206|7327905|FG000|Overall Study|Withdrawal by Subject|2
4516444|NCT00960206|7327906|FG001|Overall Study|Withdrawal by Subject|4
4516445|NCT00960206|7327907|FG002|Overall Study|Withdrawal by Subject|0
4516446|NCT00960206|7327905|FG000|Overall Study|Revision of study component|2
4516447|NCT00960206|7327906|FG001|Overall Study|Revision of study component|2
4516448|NCT00960206|7327907|FG002|Overall Study|Revision of study component|2
4381645|NCT01193842|7159039|FG002|Phase II: Randomized Groups|Adverse Event|0
4381646|NCT01193842|7159040|FG003|Phase II: Randomized Groups|Adverse Event|5
4381647|NCT01193842|7159041|FG004|Phase II: Randomized Groups|Adverse Event|3
4381648|NCT01193842|7159037|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0
4381649|NCT01193842|7159038|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0
4381650|NCT01193842|7159039|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0
4381651|NCT01193842|7159040|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1
4381652|NCT01193842|7159041|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2
4381653|NCT01193842|7159037|FG000|Phase II: Randomized Groups|Ineligible|0
4381654|NCT01193842|7159038|FG001|Phase II: Randomized Groups|Ineligible|0
4381655|NCT01193842|7159039|FG002|Phase II: Randomized Groups|Ineligible|0
4381656|NCT01193842|7159040|FG003|Phase II: Randomized Groups|Ineligible|0
4381657|NCT01193842|7159041|FG004|Phase II: Randomized Groups|Ineligible|1
4381658|NCT01193842|7159037|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0
4381659|NCT01193842|7159038|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0
4381660|NCT01193842|7159039|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0
4381661|NCT01193842|7159040|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5
4381662|NCT01193842|7159041|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3
4381663|NCT01064648|7159061|FG000|Phase I Cohort1: Dose Level 1|Progression|5
4381664|NCT01064648|7159062|FG001|Phase I Cohort1: Dose Level 1|Progression|0
4381665|NCT01064648|7159063|FG002|Phase I Cohort1: Dose Level 1|Progression|0
4381666|NCT01064648|7159064|FG003|Phase I Cohort1: Dose Level 1|Progression|0
4381667|NCT01064648|7159061|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2
4381668|NCT01064648|7159062|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0
4381669|NCT01064648|7159063|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0
4381670|NCT01064648|7159064|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0
4381671|NCT01064648|7159061|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0
4381672|NCT01064648|7159062|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3
4381673|NCT01064648|7159063|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0
4381674|NCT01064648|7159064|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0
4381675|NCT01064648|7159061|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0
4381676|NCT01064648|7159062|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1
4381677|NCT01064648|7159063|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0
4381678|NCT01064648|7159064|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0
4381679|NCT01064648|7159061|FG000|Phase I Cohort 2: Dose Level 2|Progression|0
4381680|NCT01064648|7159062|FG001|Phase I Cohort 2: Dose Level 2|Progression|5
4381681|NCT01064648|7159063|FG002|Phase I Cohort 2: Dose Level 2|Progression|0
4381682|NCT01064648|7159064|FG003|Phase I Cohort 2: Dose Level 2|Progression|0
4381683|NCT01064648|7159061|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0
4381684|NCT01064648|7159062|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4
4381685|NCT01064648|7159063|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0
4381686|NCT01064648|7159064|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0
4381687|NCT01064648|7159061|FG000|Phase II|Adverse Event|0
4381688|NCT01064648|7159062|FG001|Phase II|Adverse Event|0
4381689|NCT01064648|7159063|FG002|Phase II|Adverse Event|15
4381690|NCT01064648|7159064|FG003|Phase II|Adverse Event|8
4381691|NCT01064648|7159061|FG000|Phase II|Death|0
4381692|NCT01064648|7159062|FG001|Phase II|Death|0
4381693|NCT01064648|7159063|FG002|Phase II|Death|4
4381694|NCT01064648|7159064|FG003|Phase II|Death|5
4381695|NCT01064648|7159061|FG000|Phase II|Withdrawal by Subject|0
4381696|NCT01064648|7159062|FG001|Phase II|Withdrawal by Subject|0
4381697|NCT01064648|7159063|FG002|Phase II|Withdrawal by Subject|2
4381698|NCT01064648|7159064|FG003|Phase II|Withdrawal by Subject|5
4381699|NCT01064648|7159061|FG000|Phase II|Progression|0
4381700|NCT01064648|7159062|FG001|Phase II|Progression|0
4381701|NCT01064648|7159063|FG002|Phase II|Progression|21
4381702|NCT01064648|7159064|FG003|Phase II|Progression|27
4381703|NCT01064648|7159061|FG000|Phase II|Non-protocol specified|0
4381704|NCT01064648|7159062|FG001|Phase II|Non-protocol specified|0
4381705|NCT01064648|7159063|FG002|Phase II|Non-protocol specified|5
4381706|NCT01064648|7159064|FG003|Phase II|Non-protocol specified|3
4381707|NCT01064648|7159061|FG000|Phase II|Under Review|0
4381708|NCT01064648|7159062|FG001|Phase II|Under Review|0
4381709|NCT01064648|7159063|FG002|Phase II|Under Review|2
4381710|NCT01064648|7159064|FG003|Phase II|Under Review|0
4381711|NCT00980538|7159077|FG000|Overall Study|Lost to Follow-up|20
4381712|NCT00980538|7159077|FG000|Overall Study|Sponsor's Decision|4
4381713|NCT00980538|7159077|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34
4381714|NCT00980538|7159077|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12
4381715|NCT00980538|7159077|FG000|Overall Study|Switch to Commercially Available Medication|25
4381716|NCT00980538|7159077|FG000|Overall Study|Participant Non-Compliant|9
4381717|NCT00980538|7159077|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9
4381718|NCT00980538|7159077|FG000|Overall Study|Participant Ineligible to Continue the Trial|6
4381719|NCT00980538|7159077|FG000|Overall Study|Other|60
4381720|NCT00980538|7159077|FG000|Overall Study|Other|1
4381721|NCT00855803|7159081|FG000|Overall Study|Death|2
4381722|NCT00855803|7159081|FG000|Overall Study|Lost to Follow-up|2
4381723|NCT00855803|7159081|FG000|Overall Study|Technical inability to undergo procedure|2
4381724|NCT00855803|7159081|FG000|Overall Study|Not evaluable at 3 month timepoint|2
4381725|NCT00855803|7159081|FG000|Overall Study|Withdrawal by Subject|3
4381726|NCT00855803|7159081|FG000|Overall Study|Physician Decision|3
4381727|NCT00792948|7159085|FG000|Overall Study|Adverse Event|6
4381728|NCT00792948|7159085|FG000|Overall Study|Death|4
4381729|NCT00792948|7159085|FG000|Overall Study|Withdrawal by Subject|3
4381730|NCT00792948|7159085|FG000|Overall Study|Ineligible|2
4381731|NCT00792948|7159085|FG000|Overall Study|Insurance denial - not treated|1
4381732|NCT00792948|7159085|FG000|Overall Study|Physician Decision|11
4381733|NCT00792948|7159085|FG000|Overall Study|Protocol Violation|1
4381734|NCT00740116|7159098|FG000|Overall Study|Withdrawal by Subject|1
4381735|NCT00740116|7159099|FG001|Overall Study|Withdrawal by Subject|1
4381736|NCT00740116|7159098|FG000|Overall Study|Protocol Violation|1
4381737|NCT00740116|7159099|FG001|Overall Study|Protocol Violation|4
4381738|NCT00565617|7159107|FG000|Overall Study|Withdrawal by Subject|1
4381739|NCT00551616|7159113|FG000|Overall Study|Lost to Follow-up|48
4381740|NCT00551616|7159114|FG001|Overall Study|Lost to Follow-up|40
4468445|NCT00628758|7260903|FG000|Overall Study|Adverse Event|2
4468446|NCT00628758|7260904|FG001|Overall Study|Adverse Event|3
4468447|NCT00628758|7260903|FG000|Overall Study|Withdrawal by Subject|6
4468448|NCT00628758|7260904|FG001|Overall Study|Withdrawal by Subject|3
4468449|NCT00628758|7260903|FG000|Overall Study|Death|1
4468450|NCT00628758|7260904|FG001|Overall Study|Death|0
4468451|NCT00628758|7260903|FG000|Overall Study|Protocol Violation|5
4468452|NCT00628758|7260904|FG001|Overall Study|Protocol Violation|1
4468453|NCT00628758|7260903|FG000|Overall Study|Lost to Follow-up|25
4468454|NCT00628758|7260904|FG001|Overall Study|Lost to Follow-up|31
4468455|NCT00628758|7260903|FG000|Overall Study|Pregnancy|2
4468456|NCT00628758|7260904|FG001|Overall Study|Pregnancy|2
4468457|NCT00628758|7260903|FG000|Overall Study|Investigator Moved|3
4468458|NCT00628758|7260904|FG001|Overall Study|Investigator Moved|0
4588512|NCT01500213|7433070|FG000|Overall Study|Protocol Violation|19
4588513|NCT01500213|7433071|FG001|Overall Study|Protocol Violation|19
4588514|NCT01500213|7433070|FG000|Overall Study|Physician Decision|12
4588515|NCT01500213|7433071|FG001|Overall Study|Physician Decision|10
4588516|NCT01500213|7433070|FG000|Overall Study|Lack of Efficacy|9
4588517|NCT01500213|7433071|FG001|Overall Study|Lack of Efficacy|7
4588518|NCT01500213|7433070|FG000|Overall Study|Lost to Follow-up|3
4588519|NCT01500213|7433071|FG001|Overall Study|Lost to Follow-up|6
4588520|NCT01500213|7433070|FG000|Overall Study|Other Reasons|7
4588521|NCT01500213|7433071|FG001|Overall Study|Other Reasons|5
4588522|NCT01500226|7433079|FG000|Overall Study|Adverse Event|31
4588523|NCT01500226|7433080|FG001|Overall Study|Adverse Event|38
4588524|NCT01500226|7433079|FG000|Overall Study|Chemo Completed or Change in Therapy|235
4588525|NCT01500226|7433080|FG001|Overall Study|Chemo Completed or Change in Therapy|237
4588526|NCT01500226|7433079|FG000|Overall Study|Withdrawal by Subject|93
4588527|NCT01500226|7433080|FG001|Overall Study|Withdrawal by Subject|96
4588528|NCT01500226|7433079|FG000|Overall Study|Death|12
4588529|NCT01500226|7433080|FG001|Overall Study|Death|4
4588530|NCT01500226|7433079|FG000|Overall Study|Disease Progression|16
4588531|NCT01500226|7433080|FG001|Overall Study|Disease Progression|14
4588532|NCT01500226|7433079|FG000|Overall Study|Protocol Violation|53
4588533|NCT01500226|7433080|FG001|Overall Study|Protocol Violation|39
4588534|NCT01500226|7433079|FG000|Overall Study|Physician Decision|17
4588535|NCT01500226|7433080|FG001|Overall Study|Physician Decision|15
4468459|NCT00628758|7260903|FG000|Overall Study|Treatment Failure|0
4468460|NCT00628758|7260904|FG001|Overall Study|Treatment Failure|2
4468461|NCT00628862|7260915|FG000|Overall Study|Adverse Event|6
4468462|NCT00628862|7260916|FG001|Overall Study|Adverse Event|8
4468463|NCT00628862|7260917|FG002|Overall Study|Adverse Event|10
4468464|NCT00628862|7260915|FG000|Overall Study|Withdrawal by Subject|4
4468465|NCT00628862|7260916|FG001|Overall Study|Withdrawal by Subject|6
4468466|NCT00628862|7260917|FG002|Overall Study|Withdrawal by Subject|11
4468467|NCT00628862|7260915|FG000|Overall Study|Lost to Follow-up|0
4468468|NCT00628862|7260916|FG001|Overall Study|Lost to Follow-up|2
4468469|NCT00628862|7260917|FG002|Overall Study|Lost to Follow-up|1
4468470|NCT00628862|7260915|FG000|Overall Study|Protocol Violation|1
4468471|NCT00628862|7260916|FG001|Overall Study|Protocol Violation|0
4468472|NCT00628862|7260917|FG002|Overall Study|Protocol Violation|0
4468473|NCT00628862|7260915|FG000|Overall Study|COPD Exacerbation|0
4468474|NCT00628862|7260916|FG001|Overall Study|COPD Exacerbation|1
4468475|NCT00628862|7260917|FG002|Overall Study|COPD Exacerbation|0
4468476|NCT00628927|7260936|FG000|Overall Study|Problems performing blood draw|6
4588536|NCT01500226|7433079|FG000|Overall Study|Lack of Efficacy|14
4588537|NCT01500226|7433080|FG001|Overall Study|Lack of Efficacy|30
4468477|NCT00628927|7260937|FG001|Overall Study|Problems performing blood draw|0
4468478|NCT00628927|7260936|FG000|Overall Study|Lost to Follow-up|1
4468479|NCT00628927|7260937|FG001|Overall Study|Lost to Follow-up|0
4468480|NCT00628927|7260936|FG000|Overall Study|Equipment failure|1
4468481|NCT00628927|7260937|FG001|Overall Study|Equipment failure|0
4468482|NCT00629083|7260959|FG000|Overall Study|Adverse Event|0
4468483|NCT00629083|7260960|FG001|Overall Study|Adverse Event|2
4588538|NCT01500226|7433079|FG000|Overall Study|Lost to Follow-up|9
4588539|NCT01500226|7433080|FG001|Overall Study|Lost to Follow-up|5
4381741|NCT00470704|7159122|FG000|Overall Study|Withdrawal by Subject|4
4381742|NCT00470704|7159123|FG001|Overall Study|Withdrawal by Subject|3
4381743|NCT00470704|7159122|FG000|Overall Study|Relapse/Progression|37
4381744|NCT00470704|7159123|FG001|Overall Study|Relapse/Progression|42
4381745|NCT00470704|7159122|FG000|Overall Study|toxicity|0
4381746|NCT00470704|7159123|FG001|Overall Study|toxicity|1
4381747|NCT00142584|7159151|FG000|Overall Study|Sponsor Termination of Study, etc.|72
4381748|NCT00142584|7159152|FG001|Overall Study|Sponsor Termination of Study, etc.|16
4381749|NCT00142584|7159151|FG000|Overall Study|Withdrawal by Subject|30
4381750|NCT00142584|7159152|FG001|Overall Study|Withdrawal by Subject|16
4381751|NCT00142584|7159151|FG000|Overall Study|Lost to Follow-up|22
4381752|NCT00142584|7159152|FG001|Overall Study|Lost to Follow-up|12
4381753|NCT00142584|7159151|FG000|Overall Study|Adverse Event|14
4381754|NCT00142584|7159152|FG001|Overall Study|Adverse Event|5
4381755|NCT00142584|7159151|FG000|Overall Study|Protocol Violation|4
4381756|NCT00142584|7159152|FG001|Overall Study|Protocol Violation|7
4381757|NCT00142584|7159151|FG000|Overall Study|Treatment Failure|2
4381758|NCT00142584|7159152|FG001|Overall Study|Treatment Failure|0
4468484|NCT00629083|7260959|FG000|Overall Study|Lack of Efficacy|3
4468485|NCT00629083|7260960|FG001|Overall Study|Lack of Efficacy|1
4468486|NCT00629083|7260959|FG000|Overall Study|Withdrawal by Subject|10
4468487|NCT00629083|7260960|FG001|Overall Study|Withdrawal by Subject|2
4468488|NCT00629083|7260959|FG000|Overall Study|Lost to Follow-up|12
4468489|NCT00629083|7260960|FG001|Overall Study|Lost to Follow-up|8
4468490|NCT00629083|7260959|FG000|Overall Study|Moved out of country/state|2
4468491|NCT00629083|7260960|FG001|Overall Study|Moved out of country/state|1
4468492|NCT00629083|7260959|FG000|Overall Study|Refused to return for 12 month visit|1
4468493|NCT00629083|7260960|FG001|Overall Study|Refused to return for 12 month visit|0
4468494|NCT00629239|7260979|FG000|Overall Study|Adverse Event|7
4468495|NCT00629239|7260980|FG001|Overall Study|Adverse Event|4
4468496|NCT00629239|7260979|FG000|Overall Study|Physician Decision|1
4468497|NCT00629239|7260980|FG001|Overall Study|Physician Decision|0
4468498|NCT00629265|7260988|FG000|Overall Study|Lost to Follow-up|4
4468499|NCT00629265|7260989|FG001|Overall Study|Lost to Follow-up|5
4468500|NCT00629265|7260988|FG000|Overall Study|Withdrawal by Subject|11
4468501|NCT00629265|7260989|FG001|Overall Study|Withdrawal by Subject|8
4468502|NCT00629265|7260988|FG000|Overall Study|Death|1
4468503|NCT00629265|7260989|FG001|Overall Study|Death|0
4468504|NCT00629265|7260988|FG000|Overall Study|Adverse Event|2
4468505|NCT00629265|7260989|FG001|Overall Study|Adverse Event|0
4468506|NCT00629265|7260988|FG000|Overall Study|HNC Recurrence|4
4468507|NCT00629265|7260989|FG001|Overall Study|HNC Recurrence|0
4468508|NCT00629265|7260988|FG000|Overall Study|Other CA Requiring Treatment|1
4468509|NCT00629265|7260989|FG001|Overall Study|Other CA Requiring Treatment|3
4468510|NCT00629265|7260988|FG000|Overall Study|Needed Esophageal Dilation|4
4468511|NCT00629265|7260989|FG001|Overall Study|Needed Esophageal Dilation|1
4468512|NCT00629265|7260988|FG000|Overall Study|Unrelated Medical Complications|3
4468513|NCT00629265|7260989|FG001|Overall Study|Unrelated Medical Complications|1
4468514|NCT00629265|7260988|FG000|Overall Study|Unknown Reason|2
4468515|NCT00629265|7260989|FG001|Overall Study|Unknown Reason|2
4468516|NCT00629707|7261005|FG000|Overall Study|Withdrawal by Subject|0
4468517|NCT00629707|7261006|FG001|Overall Study|Withdrawal by Subject|1
4468518|NCT00629707|7261005|FG000|Overall Study|Physician Decision|0
4468519|NCT00629707|7261006|FG001|Overall Study|Physician Decision|1
4468520|NCT00629772|7261014|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1
4468521|NCT00629772|7261015|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1
4468522|NCT00629772|7261014|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0
4468523|NCT00629772|7261015|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1
4468524|NCT00630032|7261024|FG000|Overall Study|Death|55
4468525|NCT00630032|7261025|FG001|Overall Study|Death|49
4468526|NCT00630032|7261024|FG000|Overall Study|Withdrawal by Subject|3
4468527|NCT00630032|7261025|FG001|Overall Study|Withdrawal by Subject|2
4468528|NCT00630032|7261024|FG000|Overall Study|Lost to Follow-up|18
4468529|NCT00630032|7261025|FG001|Overall Study|Lost to Follow-up|31
4468530|NCT00630032|7261024|FG000|Overall Study|Protocol Violation|1
4468531|NCT00630032|7261025|FG001|Overall Study|Protocol Violation|0
4468532|NCT00630032|7261024|FG000|Overall Study|Patient has moved|1
4468533|NCT00630032|7261025|FG001|Overall Study|Patient has moved|1
4468534|NCT00630032|7261024|FG000|Overall Study|Disease progression|1
4468535|NCT00630032|7261025|FG001|Overall Study|Disease progression|1
4468536|NCT00630032|7261024|FG000|Overall Study|End of monitoring in US centers|11
4468537|NCT00630032|7261025|FG001|Overall Study|End of monitoring in US centers|11
4468538|NCT00630058|7261033|FG000|Overall Study|Adverse Event|1
4468539|NCT00630058|7261034|FG001|Overall Study|Adverse Event|1
4468540|NCT00630058|7261033|FG000|Overall Study|Withdrawal by Subject|0
4468541|NCT00630058|7261034|FG001|Overall Study|Withdrawal by Subject|1
4468542|NCT00630058|7261033|FG000|Overall Study|stopping criteria|3
4468543|NCT00630058|7261034|FG001|Overall Study|stopping criteria|2
4468544|NCT00630305|7261053|FG000|Overall Study|Withdrawal by Subject|1
4468545|NCT00630305|7261053|FG000|Overall Study|Inability to insert contact lens|1
4468546|NCT00630331|7261069|FG000|Overall Study|Death|2
4468547|NCT00630331|7261070|FG001|Overall Study|Death|1
4468548|NCT00630331|7261071|FG002|Overall Study|Death|1
4468549|NCT00630331|7261069|FG000|Overall Study|Adverse Event|1
4468550|NCT00630331|7261070|FG001|Overall Study|Adverse Event|0
4468551|NCT00630331|7261071|FG002|Overall Study|Adverse Event|0
4381759|NCT04794803|7159162|FG000|Overall Study|Death|1
4381760|NCT04794803|7159163|FG001|Overall Study|Death|3
4381761|NCT04794803|7159162|FG000|Overall Study|Lost to Follow-up|2
4381762|NCT04794803|7159163|FG001|Overall Study|Lost to Follow-up|2
4381763|NCT04794803|7159162|FG000|Overall Study|Withdrawal by Subject|1
4381764|NCT04794803|7159163|FG001|Overall Study|Withdrawal by Subject|0
4381765|NCT04794803|7159162|FG000|Overall Study|Physician Decision|1
4381766|NCT04794803|7159163|FG001|Overall Study|Physician Decision|1
4381767|NCT04794803|7159162|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4
4381768|NCT04794803|7159163|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1
4381769|NCT04794803|7159162|FG000|Overall Study|Refused to continue the treatment|1
4381770|NCT04794803|7159163|FG001|Overall Study|Refused to continue the treatment|0
4381771|NCT04794803|7159162|FG000|Overall Study|Patient admitted to ICU|0
4381772|NCT04794803|7159163|FG001|Overall Study|Patient admitted to ICU|1
4381773|NCT04551898|7159191|FG000|Overall Study|Participant randomized but did not receive study drug|0
4381774|NCT04551898|7159192|FG001|Overall Study|Participant randomized but did not receive study drug|1
4381775|NCT04551898|7159193|FG002|Overall Study|Participant randomized but did not receive study drug|3
4381776|NCT04551898|7159194|FG003|Overall Study|Participant randomized but did not receive study drug|1
4381777|NCT04551898|7159191|FG000|Overall Study|Withdrawal by Subject|5
4381778|NCT04551898|7159192|FG001|Overall Study|Withdrawal by Subject|1
4381779|NCT04551898|7159193|FG002|Overall Study|Withdrawal by Subject|2
4381780|NCT04551898|7159194|FG003|Overall Study|Withdrawal by Subject|2
4381781|NCT04551898|7159191|FG000|Overall Study|Lost to Follow-up|2
4381782|NCT04551898|7159192|FG001|Overall Study|Lost to Follow-up|1
4588540|NCT01500226|7433079|FG000|Overall Study|Other Reasons|19
4588541|NCT01500226|7433080|FG001|Overall Study|Other Reasons|16
4381783|NCT04551898|7159193|FG002|Overall Study|Lost to Follow-up|2
4381784|NCT04551898|7159194|FG003|Overall Study|Lost to Follow-up|2
4381785|NCT04551898|7159191|FG000|Overall Study|Death|1
4381786|NCT04551898|7159192|FG001|Overall Study|Death|0
4381787|NCT04551898|7159193|FG002|Overall Study|Death|0
4381788|NCT04551898|7159194|FG003|Overall Study|Death|0
4381789|NCT04551898|7159191|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0
4381790|NCT04551898|7159192|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0
4381791|NCT04551898|7159193|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1
4381792|NCT04551898|7159194|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0
4381793|NCT04402866|7159216|FG000|Overall Study|Discontinued Prior to Treatment|0
4381794|NCT04402866|7159217|FG001|Overall Study|Discontinued Prior to Treatment|0
4381795|NCT04402866|7159218|FG002|Overall Study|Discontinued Prior to Treatment|0
4381796|NCT04402866|7159219|FG003|Overall Study|Discontinued Prior to Treatment|0
4381797|NCT04402866|7159220|FG004|Overall Study|Discontinued Prior to Treatment|2
4381798|NCT04402866|7159221|FG005|Overall Study|Discontinued Prior to Treatment|3
4381799|NCT04402866|7159216|FG000|Overall Study|Adverse Event|2
4381800|NCT04402866|7159217|FG001|Overall Study|Adverse Event|1
4381801|NCT04402866|7159218|FG002|Overall Study|Adverse Event|0
4381802|NCT04402866|7159219|FG003|Overall Study|Adverse Event|0
4381803|NCT04402866|7159220|FG004|Overall Study|Adverse Event|13
4381804|NCT04402866|7159221|FG005|Overall Study|Adverse Event|8
4381805|NCT04402866|7159216|FG000|Overall Study|Miscellaneous|0
4381806|NCT04402866|7159217|FG001|Overall Study|Miscellaneous|0
4381807|NCT04402866|7159218|FG002|Overall Study|Miscellaneous|1
4381808|NCT04402866|7159219|FG003|Overall Study|Miscellaneous|0
4381809|NCT04402866|7159220|FG004|Overall Study|Miscellaneous|0
4381810|NCT04402866|7159221|FG005|Overall Study|Miscellaneous|0
4381811|NCT04402866|7159216|FG000|Overall Study|Lost to Follow-up|0
4381812|NCT04402866|7159217|FG001|Overall Study|Lost to Follow-up|0
4381813|NCT04402866|7159218|FG002|Overall Study|Lost to Follow-up|0
4381814|NCT04402866|7159219|FG003|Overall Study|Lost to Follow-up|0
4381815|NCT04402866|7159220|FG004|Overall Study|Lost to Follow-up|0
4381816|NCT04402866|7159221|FG005|Overall Study|Lost to Follow-up|1
4381817|NCT04402866|7159216|FG000|Overall Study|Withdrawal by Subject|0
4381818|NCT04402866|7159217|FG001|Overall Study|Withdrawal by Subject|0
4381819|NCT04402866|7159218|FG002|Overall Study|Withdrawal by Subject|0
4381820|NCT04402866|7159219|FG003|Overall Study|Withdrawal by Subject|0
4381821|NCT04402866|7159220|FG004|Overall Study|Withdrawal by Subject|0
4381822|NCT04402866|7159221|FG005|Overall Study|Withdrawal by Subject|2
4381823|NCT04327388|7159234|FG000|Overall Study|Adverse Event|17
4381824|NCT04327388|7159235|FG001|Overall Study|Adverse Event|18
4381825|NCT04327388|7159236|FG002|Overall Study|Adverse Event|9
4381826|NCT04327388|7159234|FG000|Overall Study|Other|1
4381827|NCT04327388|7159235|FG001|Overall Study|Other|2
4381828|NCT04327388|7159236|FG002|Overall Study|Other|0
4381829|NCT04327388|7159234|FG000|Overall Study|Randomized and not treated|2
4381830|NCT04327388|7159235|FG001|Overall Study|Randomized and not treated|0
4381831|NCT04327388|7159236|FG002|Overall Study|Randomized and not treated|2
4381832|NCT03860259|7159256|FG000|Overall Study|Lost to Follow-up|5
4381833|NCT03860259|7159257|FG001|Overall Study|Lost to Follow-up|5
4381834|NCT03860259|7159256|FG000|Overall Study|Protocol Violation|1
4381835|NCT03860259|7159257|FG001|Overall Study|Protocol Violation|0
4381836|NCT03446573|7159279|FG000|Overall Study|Withdrawal by Subject|7
4588542|NCT01500252|7433088|FG000|Overall Study|Death|4
4588543|NCT01500252|7433089|FG001|Overall Study|Death|2
4588544|NCT01500252|7433088|FG000|Overall Study|Lost to Follow-up|5
4588545|NCT01500252|7433089|FG001|Overall Study|Lost to Follow-up|4
4588546|NCT01500278|7433098|FG000|Week 0 - Week 12|Lack of Efficacy|0
4381837|NCT03446573|7159280|FG001|Overall Study|Withdrawal by Subject|16
4381838|NCT03446573|7159279|FG000|Overall Study|Physician Decision|1
4468552|NCT00630331|7261069|FG000|Overall Study|Withdrawal by Subject|12
4468553|NCT00630331|7261070|FG001|Overall Study|Withdrawal by Subject|7
4468554|NCT00630331|7261071|FG002|Overall Study|Withdrawal by Subject|5
4468555|NCT00630331|7261069|FG000|Overall Study|Lost to Follow-up|175
4468556|NCT00630331|7261070|FG001|Overall Study|Lost to Follow-up|143
4468557|NCT00630331|7261071|FG002|Overall Study|Lost to Follow-up|170
4468558|NCT00630331|7261069|FG000|Overall Study|Inappropriate enrollment|3
4468559|NCT00630331|7261070|FG001|Overall Study|Inappropriate enrollment|6
4468560|NCT00630331|7261071|FG002|Overall Study|Inappropriate enrollment|3
4468561|NCT00630331|7261069|FG000|Overall Study|Unable to classify|9
4468562|NCT00630331|7261070|FG001|Overall Study|Unable to classify|4
4468563|NCT00630331|7261071|FG002|Overall Study|Unable to classify|3
4468564|NCT00630331|7261069|FG000|Overall Study|Protocol Violation|4
4468565|NCT00630331|7261070|FG001|Overall Study|Protocol Violation|5
4468566|NCT00630331|7261071|FG002|Overall Study|Protocol Violation|6
4468567|NCT00630344|7261079|FG000|Overall Study|Adverse Event|5
4468568|NCT00630344|7261079|FG000|Overall Study|Progressive Disease|19
4468569|NCT00630344|7261079|FG000|Overall Study|Physician Decision|9
4468570|NCT00630344|7261079|FG000|Overall Study|Withdrawal by Subject|1
4468571|NCT00630344|7261079|FG000|Overall Study|Intercurrent Illness|1
4468572|NCT00630344|7261079|FG000|Overall Study|Other|1
4468573|NCT00630396|7261084|FG000|Overall Study|Death|4
4468574|NCT00630396|7261084|FG000|Overall Study|Lost to Follow-up|3
4468575|NCT00630539|7261097|FG000|Overall Study|Adverse Event|1
4468576|NCT00630539|7261098|FG001|Overall Study|Adverse Event|3
4468577|NCT00630539|7261099|FG002|Overall Study|Adverse Event|1
4468578|NCT00630539|7261100|FG003|Overall Study|Adverse Event|2
4468579|NCT00630539|7261097|FG000|Overall Study|Withdrawal by Subject|0
4468580|NCT00630539|7261098|FG001|Overall Study|Withdrawal by Subject|1
4468581|NCT00630539|7261099|FG002|Overall Study|Withdrawal by Subject|0
4468582|NCT00630539|7261100|FG003|Overall Study|Withdrawal by Subject|1
4468583|NCT00630747|7261132|FG000|Overall Study|Death|1
4468584|NCT00630747|7261132|FG000|Overall Study|Transferred to Study TKT031NPU|7
4468585|NCT00630747|7261132|FG000|Overall Study|Returned to country of origin|1
4468586|NCT00630786|7261139|FG000|Overall Study|Physician Decision|0
4468587|NCT00630786|7261140|FG001|Overall Study|Physician Decision|0
4468588|NCT00630786|7261141|FG002|Overall Study|Physician Decision|1
4468589|NCT00630786|7261139|FG000|Overall Study|Withdrawal by Subject|0
4468590|NCT00630786|7261140|FG001|Overall Study|Withdrawal by Subject|1
4468591|NCT00630786|7261141|FG002|Overall Study|Withdrawal by Subject|1
4468592|NCT00630786|7261139|FG000|Overall Study|Lost to Follow-up|0
4468593|NCT00630786|7261140|FG001|Overall Study|Lost to Follow-up|1
4468594|NCT00630786|7261141|FG002|Overall Study|Lost to Follow-up|0
4468595|NCT00630786|7261139|FG000|Overall Study|Other|1
4468596|NCT00630786|7261140|FG001|Overall Study|Other|0
4468597|NCT00630786|7261141|FG002|Overall Study|Other|0
4468598|NCT00630812|7261149|FG000|Randomisation to First Dose|Adverse Event|1
4468599|NCT00630812|7261150|FG001|Randomisation to First Dose|Adverse Event|1
4468600|NCT00630812|7261149|FG000|Randomisation to First Dose|Withdrawal by Subject|2
4468601|NCT00630812|7261150|FG001|Randomisation to First Dose|Withdrawal by Subject|3
4468602|NCT00630812|7261149|FG000|Randomisation to First Dose|Lost to Follow-up|1
4468603|NCT00630812|7261150|FG001|Randomisation to First Dose|Lost to Follow-up|0
4468604|NCT00630812|7261149|FG000|Randomisation to First Dose|Protocol Violation|4
4468605|NCT00630812|7261150|FG001|Randomisation to First Dose|Protocol Violation|1
4468606|NCT00630812|7261149|FG000|Double Blind Treatment Period|Adverse Event|13
4468607|NCT00630812|7261150|FG001|Double Blind Treatment Period|Adverse Event|5
4468608|NCT00630812|7261149|FG000|Double Blind Treatment Period|Lost to Follow-up|1
4468609|NCT00630812|7261150|FG001|Double Blind Treatment Period|Lost to Follow-up|0
4468610|NCT00630812|7261149|FG000|Double Blind Treatment Period|Physician Decision|2
4468611|NCT00630812|7261150|FG001|Double Blind Treatment Period|Physician Decision|1
4468612|NCT00630812|7261149|FG000|Double Blind Treatment Period|Protocol Violation|1
4468613|NCT00630812|7261150|FG001|Double Blind Treatment Period|Protocol Violation|0
4468614|NCT00630812|7261149|FG000|Double Blind Treatment Period|Withdrawal by Subject|13
4468615|NCT00630812|7261150|FG001|Double Blind Treatment Period|Withdrawal by Subject|7
4468616|NCT00630812|7261149|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1
4468617|NCT00630812|7261150|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0
4468618|NCT00630812|7261149|FG000|Double Blind Treatment Period|Non-compliance|0
4468619|NCT00630812|7261150|FG001|Double Blind Treatment Period|Non-compliance|1
4468620|NCT00630825|7261160|FG000|Overall Study|Adverse Event|4
4468621|NCT00630825|7261161|FG001|Overall Study|Adverse Event|4
4468622|NCT00630825|7261162|FG002|Overall Study|Adverse Event|3
4468623|NCT00630825|7261163|FG003|Overall Study|Adverse Event|1
4468624|NCT00630825|7261160|FG000|Overall Study|Entry Criteria Not Met|1
4468625|NCT00630825|7261161|FG001|Overall Study|Entry Criteria Not Met|0
4468626|NCT00630825|7261162|FG002|Overall Study|Entry Criteria Not Met|2
4468627|NCT00630825|7261163|FG003|Overall Study|Entry Criteria Not Met|1
4381839|NCT03446573|7159280|FG001|Overall Study|Physician Decision|1
4381840|NCT03446573|7159279|FG000|Overall Study|Lost to Follow-up|3
4381841|NCT03446573|7159280|FG001|Overall Study|Lost to Follow-up|5
4381842|NCT03446573|7159279|FG000|Overall Study|Protocol Violation|3
4381843|NCT03446573|7159280|FG001|Overall Study|Protocol Violation|2
4381844|NCT03446573|7159279|FG000|Overall Study|Lack of Efficacy|0
4381845|NCT03446573|7159280|FG001|Overall Study|Lack of Efficacy|3
4381846|NCT03446573|7159279|FG000|Overall Study|Adverse Event|13
4381847|NCT03446573|7159280|FG001|Overall Study|Adverse Event|2
4381848|NCT03446573|7159279|FG000|Overall Study|Ongoing at the time of interim analysis|342
4381849|NCT03446573|7159280|FG001|Overall Study|Ongoing at the time of interim analysis|343
4381850|NCT03388138|7159291|FG000|Overall Study|Protocol Violation|1
4381851|NCT03388138|7159292|FG001|Overall Study|Protocol Violation|0
4468628|NCT00630825|7261160|FG000|Overall Study|Lost to Follow-up|1
4468629|NCT00630825|7261161|FG001|Overall Study|Lost to Follow-up|1
4468630|NCT00630825|7261162|FG002|Overall Study|Lost to Follow-up|1
4468631|NCT00630825|7261163|FG003|Overall Study|Lost to Follow-up|1
4468632|NCT00630825|7261160|FG000|Overall Study|Physician Decision|1
4468633|NCT00630825|7261161|FG001|Overall Study|Physician Decision|0
4468634|NCT00630825|7261162|FG002|Overall Study|Physician Decision|0
4468635|NCT00630825|7261163|FG003|Overall Study|Physician Decision|0
4468636|NCT00630825|7261160|FG000|Overall Study|Withdrawal by Subject|2
4468637|NCT00630825|7261161|FG001|Overall Study|Withdrawal by Subject|2
4468638|NCT00630825|7261162|FG002|Overall Study|Withdrawal by Subject|2
4468639|NCT00630825|7261163|FG003|Overall Study|Withdrawal by Subject|3
4468640|NCT00630838|7261175|FG000|Overall Study|Death|0
4468641|NCT00630838|7261176|FG001|Overall Study|Death|1
4468642|NCT00630838|7261175|FG000|Overall Study|Lost to Follow-up|0
4468643|NCT00630838|7261176|FG001|Overall Study|Lost to Follow-up|1
4468644|NCT00630864|7261184|FG000|Part 1 (up to Week 6)|Adverse Event|1
4468645|NCT00630864|7261184|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2
4468646|NCT00630877|7261191|FG000|Overall Study|Adverse Event|11
4468647|NCT00630877|7261192|FG001|Overall Study|Adverse Event|8
4468648|NCT00630877|7261193|FG002|Overall Study|Adverse Event|7
4468649|NCT00630877|7261191|FG000|Overall Study|Withdrawal by Subject|3
4468650|NCT00630877|7261192|FG001|Overall Study|Withdrawal by Subject|4
4468651|NCT00630877|7261193|FG002|Overall Study|Withdrawal by Subject|0
4468652|NCT00630877|7261191|FG000|Overall Study|Lost to Follow-up|2
4468653|NCT00630877|7261192|FG001|Overall Study|Lost to Follow-up|0
4468654|NCT00630877|7261193|FG002|Overall Study|Lost to Follow-up|0
4468655|NCT00630877|7261191|FG000|Overall Study|Noncompliance|2
4468656|NCT00630877|7261192|FG001|Overall Study|Noncompliance|3
4468657|NCT00630877|7261193|FG002|Overall Study|Noncompliance|1
4468658|NCT00630877|7261191|FG000|Overall Study|Protocol violation|1
4468659|NCT00630877|7261192|FG001|Overall Study|Protocol violation|0
4468660|NCT00630877|7261193|FG002|Overall Study|Protocol violation|1
4468661|NCT00630877|7261191|FG000|Overall Study|Personal reasons|0
4468662|NCT00630877|7261192|FG001|Overall Study|Personal reasons|0
4468663|NCT00630877|7261193|FG002|Overall Study|Personal reasons|1
4468664|NCT00630916|7261205|FG000|Overall Study|Death|110
4468665|NCT00630916|7261205|FG000|Overall Study|Explant|8
4468666|NCT00630916|7261205|FG000|Overall Study|Lost to Follow-up|5
4468667|NCT00630916|7261205|FG000|Overall Study|Withdrawal by Subject|30
4468668|NCT00630916|7261205|FG000|Overall Study|Protocol Violation|7
4468669|NCT00630916|7261205|FG000|Overall Study|Physician Decision|47
4468670|NCT00630916|7261205|FG000|Overall Study|Lack of Efficacy|3
4468671|NCT00630994|7261222|FG000|Overall Study|Adverse Event|1
4468672|NCT00630994|7261222|FG000|Overall Study|Disease Progression|1
4468673|NCT00630994|7261222|FG000|Overall Study|Lack of Efficacy|1
4468674|NCT00630994|7261222|FG000|Overall Study|Other|1
4468675|NCT00631007|7261232|FG000|Overall Study|Adverse Event|0
4468676|NCT00631007|7261233|FG001|Overall Study|Adverse Event|2
4468677|NCT00631007|7261234|FG002|Overall Study|Adverse Event|0
4468678|NCT00631007|7261235|FG003|Overall Study|Adverse Event|2
4468679|NCT00631007|7261236|FG004|Overall Study|Adverse Event|3
4468680|NCT00631007|7261237|FG005|Overall Study|Adverse Event|2
4468681|NCT00631007|7261232|FG000|Overall Study|Lost to Follow-up|2
4468682|NCT00631007|7261233|FG001|Overall Study|Lost to Follow-up|1
4468683|NCT00631007|7261234|FG002|Overall Study|Lost to Follow-up|2
4468684|NCT00631007|7261235|FG003|Overall Study|Lost to Follow-up|4
4468685|NCT00631007|7261236|FG004|Overall Study|Lost to Follow-up|5
4468686|NCT00631007|7261237|FG005|Overall Study|Lost to Follow-up|3
4468687|NCT00631007|7261232|FG000|Overall Study|Physician Decision|1
4468688|NCT00631007|7261233|FG001|Overall Study|Physician Decision|0
4468689|NCT00631007|7261234|FG002|Overall Study|Physician Decision|1
4468690|NCT00631007|7261235|FG003|Overall Study|Physician Decision|0
4468691|NCT00631007|7261236|FG004|Overall Study|Physician Decision|0
4468692|NCT00631007|7261237|FG005|Overall Study|Physician Decision|2
4468693|NCT00631007|7261232|FG000|Overall Study|Persistent Hyperglycemia|2
4468694|NCT00631007|7261233|FG001|Overall Study|Persistent Hyperglycemia|2
4468695|NCT00631007|7261234|FG002|Overall Study|Persistent Hyperglycemia|5
4468696|NCT00631007|7261235|FG003|Overall Study|Persistent Hyperglycemia|1
4468697|NCT00631007|7261236|FG004|Overall Study|Persistent Hyperglycemia|2
4468698|NCT00631007|7261237|FG005|Overall Study|Persistent Hyperglycemia|5
4468699|NCT00631007|7261232|FG000|Overall Study|Withdrawal by Subject|4
4468700|NCT00631007|7261233|FG001|Overall Study|Withdrawal by Subject|5
4381852|NCT02981082|7159358|FG000|Overall Study|Withdrawal by Subject|2
4381853|NCT02981082|7159359|FG001|Overall Study|Withdrawal by Subject|0
4381854|NCT02981082|7159358|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1
4381855|NCT02981082|7159359|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0
4381856|NCT02981082|7159358|FG000|Overall Study|Adverse Event|0
4381857|NCT02981082|7159359|FG001|Overall Study|Adverse Event|1
4381858|NCT02924129|7159367|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2
4381859|NCT02924129|7159368|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1
4381860|NCT02924129|7159367|FG000|Overall Study|Withdrawal by Subject|2
4381861|NCT02924129|7159368|FG001|Overall Study|Withdrawal by Subject|2
4381862|NCT02924129|7159367|FG000|Overall Study|Physician Decision|1
4381863|NCT02924129|7159368|FG001|Overall Study|Physician Decision|0
4381864|NCT02924129|7159367|FG000|Overall Study|Missed Visit|0
4381865|NCT02924129|7159368|FG001|Overall Study|Missed Visit|1
4381866|NCT02831673|7159376|FG000|Overall Study|Adverse Event|6
4381867|NCT02831673|7159377|FG001|Overall Study|Adverse Event|4
4381868|NCT02831673|7159376|FG000|Overall Study|Lack of Efficacy|3
4381869|NCT02831673|7159377|FG001|Overall Study|Lack of Efficacy|1
4381870|NCT02831673|7159376|FG000|Overall Study|Protocol Violation|5
4381871|NCT02831673|7159377|FG001|Overall Study|Protocol Violation|4
4381872|NCT02831673|7159376|FG000|Overall Study|Protocol Withdrawal Criterion Met|1
4381873|NCT02831673|7159377|FG001|Overall Study|Protocol Withdrawal Criterion Met|6
4381874|NCT02831673|7159376|FG000|Overall Study|Lost to Follow-up|9
4381875|NCT02831673|7159377|FG001|Overall Study|Lost to Follow-up|6
4381876|NCT02831673|7159376|FG000|Overall Study|Physician Decision|6
4381877|NCT02831673|7159377|FG001|Overall Study|Physician Decision|3
4381878|NCT02831673|7159376|FG000|Overall Study|Withdrawal by Subject|6
4381879|NCT02831673|7159377|FG001|Overall Study|Withdrawal by Subject|4
4381880|NCT02831673|7159376|FG000|Overall Study|Ongoing at Week 48 primary analysis.|320
4381881|NCT02831673|7159377|FG001|Overall Study|Ongoing at Week 48 primary analysis.|330
4381882|NCT02741700|7159385|FG000|Overall Study|Lost to Follow-up|17
4381883|NCT02741700|7159386|FG001|Overall Study|Lost to Follow-up|8
4381884|NCT02741700|7159385|FG000|Overall Study|Withdrawal by Subject|2
4381885|NCT02741700|7159386|FG001|Overall Study|Withdrawal by Subject|5
4381886|NCT02741700|7159385|FG000|Overall Study|Physician Decision|3
4381887|NCT02741700|7159386|FG001|Overall Study|Physician Decision|0
4381888|NCT02741700|7159385|FG000|Overall Study|Moved out of State|0
4381889|NCT02741700|7159386|FG001|Overall Study|Moved out of State|1
4381890|NCT02741700|7159385|FG000|Overall Study|Death|4
4381891|NCT02741700|7159386|FG001|Overall Study|Death|5
4381892|NCT02635776|7159394|FG000|Overall Study|Physician Decision|1
4381893|NCT02635776|7159395|FG001|Overall Study|Physician Decision|0
4381894|NCT02635776|7159394|FG000|Overall Study|Adverse Event|51
4381895|NCT02635776|7159395|FG001|Overall Study|Adverse Event|3
4381896|NCT02635776|7159394|FG000|Overall Study|Withdrawal by Subject|41
4381897|NCT02635776|7159395|FG001|Overall Study|Withdrawal by Subject|7
4381898|NCT02635776|7159394|FG000|Overall Study|Lost to Follow-up|4
4381899|NCT02635776|7159395|FG001|Overall Study|Lost to Follow-up|0
4381900|NCT02635776|7159394|FG000|Overall Study|Other reasons|5
4381901|NCT02635776|7159395|FG001|Overall Study|Other reasons|1
4381902|NCT02609724|7159406|FG000|Overall Study|Death|2
4381903|NCT02609724|7159407|FG001|Overall Study|Death|0
4381904|NCT02609724|7159408|FG002|Overall Study|Death|1
4381905|NCT02609724|7159406|FG000|Overall Study|Withdrawal by Subject|1
4381906|NCT02609724|7159407|FG001|Overall Study|Withdrawal by Subject|2
4381907|NCT02609724|7159408|FG002|Overall Study|Withdrawal by Subject|3
4381908|NCT02609724|7159406|FG000|Overall Study|Illness|2
4381909|NCT02609724|7159407|FG001|Overall Study|Illness|1
4381910|NCT02609724|7159408|FG002|Overall Study|Illness|0
4381911|NCT02359994|7159418|FG000|Overall Population Study|Adverse Event|1
4381912|NCT02359994|7159419|FG001|Overall Population Study|Adverse Event|1
4381913|NCT02359994|7159418|FG000|Overall Population Study|Death|1
4381914|NCT02359994|7159419|FG001|Overall Population Study|Death|5
4381915|NCT02359994|7159418|FG000|Overall Population Study|Lost to Follow-up|1
4381916|NCT02359994|7159419|FG001|Overall Population Study|Lost to Follow-up|1
4381917|NCT02359994|7159418|FG000|Overall Population Study|Withdrawal by Subject|1
4381918|NCT02359994|7159419|FG001|Overall Population Study|Withdrawal by Subject|0
4381919|NCT02359994|7159418|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1
4381920|NCT02359994|7159419|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0
4381921|NCT02359994|7159418|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0
4381922|NCT02359994|7159419|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1
4381923|NCT02359994|7159418|FG000|Extended Oncology 24-Month Survival|Death|19
4381924|NCT02359994|7159419|FG001|Extended Oncology 24-Month Survival|Death|21
4381925|NCT02359994|7159418|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1
4381926|NCT02359994|7159419|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0
4381927|NCT02336230|7159425|FG000|Overall Study|Adverse Event|1
4381928|NCT02336230|7159425|FG000|Overall Study|Withdrawal of consent|1
4381929|NCT02336230|7159425|FG000|Overall Study|Death|9
4381930|NCT02336230|7159425|FG000|Overall Study|Dose not received due to shipping delay|1
4381931|NCT02336230|7159425|FG000|Overall Study|Discontinuation of MSC infusion|1
4381932|NCT02041533|7159431|FG000|Overall Study|Disease Progression|168
4381933|NCT02041533|7159432|FG001|Overall Study|Disease Progression|142
4381934|NCT02041533|7159431|FG000|Overall Study|Study drug toxicity|27
4381935|NCT02041533|7159432|FG001|Overall Study|Study drug toxicity|30
4381936|NCT02041533|7159431|FG000|Overall Study|Death|1
4381937|NCT02041533|7159432|FG001|Overall Study|Death|0
4381938|NCT02041533|7159431|FG000|Overall Study|Adverse Event unrelated to study drug|20
4381939|NCT02041533|7159432|FG001|Overall Study|Adverse Event unrelated to study drug|21
4381940|NCT02041533|7159431|FG000|Overall Study|Subject request to discontinue treatment|5
4381941|NCT02041533|7159432|FG001|Overall Study|Subject request to discontinue treatment|9
4381942|NCT02041533|7159431|FG000|Overall Study|Withdrawal by Subject|2
4381943|NCT02041533|7159432|FG001|Overall Study|Withdrawal by Subject|1
4381944|NCT02041533|7159431|FG000|Overall Study|Maximum clinical benefit|0
4381945|NCT02041533|7159432|FG001|Overall Study|Maximum clinical benefit|18
4381946|NCT02041533|7159431|FG000|Overall Study|Poor/non-compliance|1
4381947|NCT02041533|7159432|FG001|Overall Study|Poor/non-compliance|0
4381948|NCT02041533|7159431|FG000|Overall Study|Other reasons|0
4381949|NCT02041533|7159432|FG001|Overall Study|Other reasons|1
4381950|NCT02041533|7159431|FG000|Overall Study|Completed max number of chemo cycles|0
4381951|NCT02041533|7159432|FG001|Overall Study|Completed max number of chemo cycles|29
4381952|NCT02041533|7159431|FG000|Overall Study|Randomized, not treated|4
4381953|NCT02041533|7159432|FG001|Overall Study|Randomized, not treated|7
4381954|NCT02032823|7159440|FG000|Overall Study|Death|59
4381955|NCT02032823|7159441|FG001|Overall Study|Death|86
4381956|NCT02032823|7159440|FG000|Overall Study|Lost to Follow-up|12
4381957|NCT02032823|7159441|FG001|Overall Study|Lost to Follow-up|15
4381958|NCT02032823|7159440|FG000|Overall Study|Withdrawal by Subject|65
4381959|NCT02032823|7159441|FG001|Overall Study|Withdrawal by Subject|49
4381960|NCT02032823|7159440|FG000|Overall Study|Ongoing study at data cut-off|782
4381961|NCT02032823|7159441|FG001|Overall Study|Ongoing study at data cut-off|760
4381962|NCT02032823|7159440|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3
4381963|NCT02032823|7159441|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5
4381964|NCT01557751|7159447|FG000|Overall Study|Physician Decision|3
4381965|NCT00378482|7159473|FG000|Overall Study|Lost to Follow-up|1
4381966|NCT00378482|7159473|FG000|Overall Study|Lack of Efficacy|8
4381967|NCT00378482|7159473|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9
4381968|NCT00378482|7159473|FG000|Overall Study|Withdrawal by Subject|4
4381969|NCT00378482|7159473|FG000|Overall Study|Adverse Event|9
4468701|NCT00631007|7261234|FG002|Overall Study|Withdrawal by Subject|2
4468702|NCT00631007|7261235|FG003|Overall Study|Withdrawal by Subject|2
4468703|NCT00631007|7261236|FG004|Overall Study|Withdrawal by Subject|1
4468704|NCT00631007|7261237|FG005|Overall Study|Withdrawal by Subject|3
4468705|NCT00631007|7261232|FG000|Overall Study|Other|2
4468706|NCT00631007|7261233|FG001|Overall Study|Other|1
4468707|NCT00631007|7261234|FG002|Overall Study|Other|0
4468708|NCT00631007|7261235|FG003|Overall Study|Other|0
4468709|NCT00631007|7261236|FG004|Overall Study|Other|1
4468710|NCT00631007|7261237|FG005|Overall Study|Other|0
4468711|NCT00631020|7261251|FG000|Overall Study|Lost to Follow-up|7
4468712|NCT00631020|7261251|FG000|Overall Study|Incarcerated|1
4468713|NCT00631163|7261255|FG000|Number of Participants in Year 1|Adverse Event|12
4468714|NCT00631163|7261255|FG000|Number of Participants in Year 1|Withdrawal by Subject|8
4468715|NCT00631163|7261255|FG000|Number of Participants in Year 1|Death|6
4468716|NCT00631163|7261255|FG000|Number of Participants in Year 1|Lost to Follow-up|1
4468717|NCT00631163|7261255|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1
4468718|NCT00631163|7261255|FG000|Number of Participants in Year 1|Administrative problems|6
4468719|NCT00631163|7261255|FG000|Number of Participants in Year 2|Withdrawal by Subject|2
4468720|NCT00631163|7261255|FG000|Number of Participants in Year 2|Adverse Event|1
4468721|NCT00631163|7261255|FG000|Number of Participants in Year 2|Protocol Violation|1
4468722|NCT00631163|7261255|FG000|Number of Participants in Year 2|Abnormal laboratory value|1
4468723|NCT00631189|7261270|FG000|Initial Phase|Protocol Violation|347
4468724|NCT00631189|7261271|FG001|Initial Phase|Protocol Violation|0
4468725|NCT00631189|7261272|FG002|Initial Phase|Protocol Violation|0
4468726|NCT00631189|7261273|FG003|Initial Phase|Protocol Violation|0
4468727|NCT00631189|7261270|FG000|Initial Phase|Withdrawal by Subject|4
4468728|NCT00631189|7261271|FG001|Initial Phase|Withdrawal by Subject|0
4468729|NCT00631189|7261272|FG002|Initial Phase|Withdrawal by Subject|0
4468730|NCT00631189|7261273|FG003|Initial Phase|Withdrawal by Subject|0
4468731|NCT00631189|7261270|FG000|Treatment Phase|Withdrawal by Subject|0
4468732|NCT00631189|7261271|FG001|Treatment Phase|Withdrawal by Subject|2
4468733|NCT00631189|7261272|FG002|Treatment Phase|Withdrawal by Subject|1
4468734|NCT00631189|7261273|FG003|Treatment Phase|Withdrawal by Subject|1
4468735|NCT00631189|7261270|FG000|Treatment Phase|Protocol Violation|0
4468736|NCT00631189|7261271|FG001|Treatment Phase|Protocol Violation|1
4468737|NCT00631189|7261272|FG002|Treatment Phase|Protocol Violation|6
4468738|NCT00631189|7261273|FG003|Treatment Phase|Protocol Violation|2
4468739|NCT00631189|7261270|FG000|Treatment Phase|Adverse Event|0
4468740|NCT00631189|7261271|FG001|Treatment Phase|Adverse Event|3
4468741|NCT00631189|7261272|FG002|Treatment Phase|Adverse Event|2
4468742|NCT00631189|7261273|FG003|Treatment Phase|Adverse Event|4
4381970|NCT03790917|7159499|FG000|Overall Study|Death|1
4381971|NCT05017493|7159515|FG000|Overall Study|Withdrawal by Subject|26
4381972|NCT05017493|7159516|FG001|Overall Study|Withdrawal by Subject|0
4381973|NCT05017493|7159515|FG000|Overall Study|Physician Decision|15
4381974|NCT05017493|7159516|FG001|Overall Study|Physician Decision|0
4381975|NCT05017493|7159515|FG000|Overall Study|Protocol Violation|81
4381976|NCT05017493|7159516|FG001|Overall Study|Protocol Violation|0
4381977|NCT04348500|7159549|FG000|Overall Study|Death|2
4381978|NCT04348500|7159550|FG001|Overall Study|Death|2
4381979|NCT04348500|7159549|FG000|Overall Study|Withdrawn by subject due to dementia|0
4381980|NCT04348500|7159550|FG001|Overall Study|Withdrawn by subject due to dementia|1
4381981|NCT03799198|7159593|FG000|Overall Study|Lost to Follow-up|4
4381982|NCT03799198|7159594|FG001|Overall Study|Lost to Follow-up|8
4381983|NCT03799198|7159593|FG000|Overall Study|Death|0
4381984|NCT03799198|7159594|FG001|Overall Study|Death|1
4381985|NCT03770728|7159604|FG000|Overall Study|Adverse Event|1
4381986|NCT03770728|7159605|FG001|Overall Study|Adverse Event|0
4381987|NCT03770728|7159606|FG002|Overall Study|Adverse Event|1
4381988|NCT03770728|7159607|FG003|Overall Study|Adverse Event|0
4381989|NCT03770728|7159604|FG000|Overall Study|Poor compliance to protocol|0
4381990|NCT03770728|7159605|FG001|Overall Study|Poor compliance to protocol|0
4381991|NCT03770728|7159606|FG002|Overall Study|Poor compliance to protocol|1
4381992|NCT03770728|7159607|FG003|Overall Study|Poor compliance to protocol|0
4381993|NCT03770728|7159604|FG000|Overall Study|Withdrawal by Subject|13
4381994|NCT03770728|7159605|FG001|Overall Study|Withdrawal by Subject|8
4381995|NCT03770728|7159606|FG002|Overall Study|Withdrawal by Subject|9
4381996|NCT03770728|7159607|FG003|Overall Study|Withdrawal by Subject|13
4381997|NCT03770728|7159604|FG000|Overall Study|Other than specified|24
4381998|NCT03770728|7159605|FG001|Overall Study|Other than specified|23
4381999|NCT03770728|7159606|FG002|Overall Study|Other than specified|21
4382000|NCT03770728|7159607|FG003|Overall Study|Other than specified|22
4382001|NCT03760146|7159625|FG000|Overall Study|Adverse Event|11
4382002|NCT03760146|7159626|FG001|Overall Study|Adverse Event|8
4382003|NCT03760146|7159627|FG002|Overall Study|Adverse Event|0
4588547|NCT01500278|7433099|FG001|Week 0 - Week 12|Lack of Efficacy|1
4588548|NCT01500278|7433098|FG000|Week 0 - Week 12|Protocol Violation|10
4588549|NCT01500278|7433099|FG001|Week 0 - Week 12|Protocol Violation|16
4588550|NCT01500278|7433098|FG000|Week 0 - Week 12|Lost to Follow-up|1
4588551|NCT01500278|7433099|FG001|Week 0 - Week 12|Lost to Follow-up|1
4588552|NCT01500278|7433098|FG000|Week 0 - Week 12|Withdrawal by Subject|7
4588553|NCT01500278|7433099|FG001|Week 0 - Week 12|Withdrawal by Subject|2
4588554|NCT01500278|7433098|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1
4588555|NCT01500278|7433099|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0
4588556|NCT01500278|7433098|FG000|Week 0 - Week 12|Patient decision|1
4588557|NCT01500278|7433099|FG001|Week 0 - Week 12|Patient decision|0
4588558|NCT01500278|7433098|FG000|Week 0 - Week 12|Exclusion criteria not met|1
4588559|NCT01500278|7433099|FG001|Week 0 - Week 12|Exclusion criteria not met|0
4588560|NCT01500278|7433098|FG000|Week 0 - Week 12|Investigator decision|1
4588561|NCT01500278|7433099|FG001|Week 0 - Week 12|Investigator decision|0
4588562|NCT01500278|7433098|FG000|Week 0 - Week 12|Prior history of serious disease|1
4588563|NCT01500278|7433099|FG001|Week 0 - Week 12|Prior history of serious disease|0
4588564|NCT01500278|7433098|FG000|Week 0 - Week 12|Sponsor decision|1
4588565|NCT01500278|7433099|FG001|Week 0 - Week 12|Sponsor decision|0
4588566|NCT01500278|7433098|FG000|Week 0 - Week 12|Personal reason|0
4588567|NCT01500278|7433099|FG001|Week 0 - Week 12|Personal reason|1
4588568|NCT01500278|7433098|FG000|Week 0 - Week 12|Other serious disease|0
4588569|NCT01500278|7433099|FG001|Week 0 - Week 12|Other serious disease|1
4588570|NCT01500278|7433098|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7
4588571|NCT01500278|7433099|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8
4588572|NCT01500278|7433098|FG000|Week 13 - Week 104|Lack of Efficacy|11
4588573|NCT01500278|7433099|FG001|Week 13 - Week 104|Lack of Efficacy|12
4588574|NCT01500278|7433098|FG000|Week 13 - Week 104|Protocol Violation|6
4588575|NCT01500278|7433099|FG001|Week 13 - Week 104|Protocol Violation|6
4588576|NCT01500278|7433098|FG000|Week 13 - Week 104|Lost to Follow-up|6
4626381|NCT01839487|7491908|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1
4626382|NCT01839487|7491909|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10
4382004|NCT03760146|7159628|FG003|Overall Study|Adverse Event|0
4382005|NCT03760146|7159629|FG004|Overall Study|Adverse Event|0
4382006|NCT03760146|7159630|FG005|Overall Study|Adverse Event|0
4382007|NCT03760146|7159625|FG000|Overall Study|Death|1
4382008|NCT03760146|7159626|FG001|Overall Study|Death|0
4382009|NCT03760146|7159627|FG002|Overall Study|Death|0
4382010|NCT03760146|7159628|FG003|Overall Study|Death|0
4382011|NCT03760146|7159629|FG004|Overall Study|Death|0
4382012|NCT03760146|7159630|FG005|Overall Study|Death|0
4382013|NCT03760146|7159625|FG000|Overall Study|Lost to Follow-up|41
4382014|NCT03760146|7159626|FG001|Overall Study|Lost to Follow-up|28
4382015|NCT03760146|7159627|FG002|Overall Study|Lost to Follow-up|9
4382016|NCT03760146|7159628|FG003|Overall Study|Lost to Follow-up|2
4382017|NCT03760146|7159629|FG004|Overall Study|Lost to Follow-up|14
4382018|NCT03760146|7159630|FG005|Overall Study|Lost to Follow-up|8
4382019|NCT03760146|7159625|FG000|Overall Study|No longer met eligibility criteria|3
4382020|NCT03760146|7159626|FG001|Overall Study|No longer met eligibility criteria|9
4382021|NCT03760146|7159627|FG002|Overall Study|No longer met eligibility criteria|0
4382022|NCT03760146|7159628|FG003|Overall Study|No longer met eligibility criteria|0
4382023|NCT03760146|7159629|FG004|Overall Study|No longer met eligibility criteria|1
4382024|NCT03760146|7159630|FG005|Overall Study|No longer met eligibility criteria|0
4382025|NCT03760146|7159625|FG000|Overall Study|Protocol Violation|21
4382026|NCT03760146|7159626|FG001|Overall Study|Protocol Violation|13
4382027|NCT03760146|7159627|FG002|Overall Study|Protocol Violation|1
4382028|NCT03760146|7159628|FG003|Overall Study|Protocol Violation|0
4382029|NCT03760146|7159629|FG004|Overall Study|Protocol Violation|1
4382030|NCT03760146|7159630|FG005|Overall Study|Protocol Violation|0
4382031|NCT03760146|7159625|FG000|Overall Study|Withdrawal by Subject|19
4382032|NCT03760146|7159626|FG001|Overall Study|Withdrawal by Subject|20
4382033|NCT03760146|7159627|FG002|Overall Study|Withdrawal by Subject|1
4382034|NCT03760146|7159628|FG003|Overall Study|Withdrawal by Subject|0
4382035|NCT03760146|7159629|FG004|Overall Study|Withdrawal by Subject|1
4382036|NCT03760146|7159630|FG005|Overall Study|Withdrawal by Subject|0
4382037|NCT03760081|7159650|FG000|Overall Study|Miscellaneous|0
4382038|NCT03760081|7159651|FG001|Overall Study|Miscellaneous|1
4382039|NCT03760081|7159650|FG000|Overall Study|Progressive Disease|5
4382040|NCT03760081|7159651|FG001|Overall Study|Progressive Disease|10
4382041|NCT03760081|7159650|FG000|Overall Study|Death|1
4382042|NCT03760081|7159651|FG001|Overall Study|Death|1
4382043|NCT03737110|7159661|FG000|Run-in (RI) Period|Lack of Efficacy|3
4382044|NCT03737110|7159662|FG001|Run-in (RI) Period|Lack of Efficacy|0
4382045|NCT03737110|7159663|FG002|Run-in (RI) Period|Lack of Efficacy|0
4382046|NCT03737110|7159661|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3
4382047|NCT03737110|7159662|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0
4382048|NCT03737110|7159663|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0
4382049|NCT03737110|7159661|FG000|Run-in (RI) Period|Adverse Event|4
4382050|NCT03737110|7159662|FG001|Run-in (RI) Period|Adverse Event|0
4382051|NCT03737110|7159663|FG002|Run-in (RI) Period|Adverse Event|0
4382052|NCT03737110|7159661|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0
4382053|NCT03737110|7159662|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1
4382054|NCT03737110|7159663|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0
4382055|NCT03737110|7159661|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0
4382056|NCT03737110|7159662|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0
4382057|NCT03737110|7159663|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1
4382058|NCT03713684|7159685|FG000|Overall Study|Adverse Event|1
4382059|NCT03713684|7159686|FG001|Overall Study|Adverse Event|3
4382060|NCT03713684|7159687|FG002|Overall Study|Adverse Event|1
4382061|NCT03713684|7159688|FG003|Overall Study|Adverse Event|0
4382062|NCT03713684|7159685|FG000|Overall Study|Poor compliance to protocol|2
4382063|NCT03713684|7159686|FG001|Overall Study|Poor compliance to protocol|1
4382064|NCT03713684|7159687|FG002|Overall Study|Poor compliance to protocol|0
4382065|NCT03713684|7159688|FG003|Overall Study|Poor compliance to protocol|1
4382066|NCT03713684|7159685|FG000|Overall Study|Withdrawal by Subject|14
4382067|NCT03713684|7159686|FG001|Overall Study|Withdrawal by Subject|6
4382068|NCT03713684|7159687|FG002|Overall Study|Withdrawal by Subject|14
4382069|NCT03713684|7159688|FG003|Overall Study|Withdrawal by Subject|16
4382070|NCT03713684|7159685|FG000|Overall Study|Other than specified|69
4382071|NCT03713684|7159686|FG001|Overall Study|Other than specified|77
4382072|NCT03713684|7159687|FG002|Overall Study|Other than specified|73
4382073|NCT03713684|7159688|FG003|Overall Study|Other than specified|70
4382074|NCT03644550|7159698|FG000|Overall Study|Withdrawal by Subject|3
4382075|NCT03644550|7159698|FG000|Overall Study|Progressive disease|15
4382076|NCT03557970|7159705|FG000|Overall Study|Study closure|1
4382077|NCT03557970|7159706|FG001|Overall Study|Study closure|0
4382078|NCT03557970|7159705|FG000|Overall Study|Physician Decision|0
4382079|NCT03557970|7159706|FG001|Overall Study|Physician Decision|1
4382080|NCT03557970|7159705|FG000|Overall Study|Death|0
4382081|NCT03557970|7159706|FG001|Overall Study|Death|1
4468743|NCT00631189|7261270|FG000|Treatment Phase|Lost to Follow-up|0
4588577|NCT01500278|7433099|FG001|Week 13 - Week 104|Lost to Follow-up|5
4468744|NCT00631189|7261271|FG001|Treatment Phase|Lost to Follow-up|1
4468745|NCT00631189|7261272|FG002|Treatment Phase|Lost to Follow-up|0
4468746|NCT00631189|7261273|FG003|Treatment Phase|Lost to Follow-up|0
4468747|NCT00631189|7261270|FG000|Treatment Phase|Pregnancy|0
4468748|NCT00631189|7261271|FG001|Treatment Phase|Pregnancy|0
4468749|NCT00631189|7261272|FG002|Treatment Phase|Pregnancy|1
4468750|NCT00631189|7261273|FG003|Treatment Phase|Pregnancy|0
4468751|NCT00631189|7261270|FG000|Treatment Phase|patient did not take pravastatin|0
4468752|NCT00631189|7261271|FG001|Treatment Phase|patient did not take pravastatin|0
4468753|NCT00631189|7261272|FG002|Treatment Phase|patient did not take pravastatin|1
4468754|NCT00631189|7261273|FG003|Treatment Phase|patient did not take pravastatin|0
4468755|NCT00631371|7261304|FG000|Overall Study|Lost to Follow-up|24
4468756|NCT00631371|7261305|FG001|Overall Study|Lost to Follow-up|19
4468757|NCT00631371|7261304|FG000|Overall Study|Other reason|5
4468758|NCT00631371|7261305|FG001|Overall Study|Other reason|12
4468759|NCT00631371|7261304|FG000|Overall Study|subject request|38
4468760|NCT00631371|7261305|FG001|Overall Study|subject request|45
4468761|NCT00631371|7261304|FG000|Overall Study|Discontinuation of study by Sponsor|70
4468762|NCT00631371|7261305|FG001|Overall Study|Discontinuation of study by Sponsor|76
4697193|NCT02646618|7610430|FG001|Overall Study|Lost to Follow-up|14
4697194|NCT02646891|7610474|FG000|Overall Study|Adverse Event|0
4697195|NCT02646891|7610475|FG001|Overall Study|Adverse Event|1
4697196|NCT02646891|7610476|FG002|Overall Study|Adverse Event|0
4697197|NCT02646891|7610477|FG003|Overall Study|Adverse Event|0
4697198|NCT02646891|7610478|FG004|Overall Study|Adverse Event|0
4697199|NCT02646891|7610479|FG005|Overall Study|Adverse Event|0
4697200|NCT02646891|7610480|FG006|Overall Study|Adverse Event|0
4697201|NCT02646891|7610481|FG007|Overall Study|Adverse Event|0
4697202|NCT02646891|7610482|FG008|Overall Study|Adverse Event|0
4697203|NCT02646891|7610483|FG009|Overall Study|Adverse Event|0
4697204|NCT02646891|7610474|FG000|Overall Study|Lost to Follow-up|0
4697205|NCT02646891|7610475|FG001|Overall Study|Lost to Follow-up|0
4697206|NCT02646891|7610476|FG002|Overall Study|Lost to Follow-up|0
4697207|NCT02646891|7610477|FG003|Overall Study|Lost to Follow-up|0
4697208|NCT02646891|7610478|FG004|Overall Study|Lost to Follow-up|0
4697209|NCT02646891|7610479|FG005|Overall Study|Lost to Follow-up|0
4697210|NCT02646891|7610480|FG006|Overall Study|Lost to Follow-up|2
4697211|NCT02646891|7610481|FG007|Overall Study|Lost to Follow-up|2
4697212|NCT02646891|7610482|FG008|Overall Study|Lost to Follow-up|2
4697213|NCT02646891|7610483|FG009|Overall Study|Lost to Follow-up|2
4697214|NCT02646891|7610474|FG000|Overall Study|Protocol Violation|0
4382082|NCT03022461|7159725|FG000|Overall Study|Death|3
4382083|NCT02964039|7159741|FG000|Overall Study|Medical reason unrelated to study participation|1
4382084|NCT02964039|7159742|FG001|Overall Study|Medical reason unrelated to study participation|0
4382085|NCT02964039|7159743|FG002|Overall Study|Medical reason unrelated to study participation|3
4382086|NCT02964039|7159741|FG000|Overall Study|Research shutdown due to pandemic|2
4382087|NCT02964039|7159742|FG001|Overall Study|Research shutdown due to pandemic|0
4382088|NCT02964039|7159743|FG002|Overall Study|Research shutdown due to pandemic|1
4382089|NCT02964039|7159741|FG000|Overall Study|Withdrawal by Subject|0
4382090|NCT02964039|7159742|FG001|Overall Study|Withdrawal by Subject|1
4382091|NCT02964039|7159743|FG002|Overall Study|Withdrawal by Subject|0
4382092|NCT02964039|7159741|FG000|Overall Study|Lost to Follow-up|1
4382093|NCT02964039|7159742|FG001|Overall Study|Lost to Follow-up|0
4382094|NCT02964039|7159743|FG002|Overall Study|Lost to Follow-up|1
4382095|NCT02930889|7159751|FG000|Overall Study|Lost to Follow-up|2
4382096|NCT02930889|7159751|FG000|Overall Study|Withdrawal by Subject|6
4382097|NCT02930889|7159751|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8
4382098|NCT02919618|7159755|FG000|Overall Study|Death|1
4382099|NCT02844946|7159772|FG000|Overall Study|Lost to Follow-up|7
4382100|NCT02844946|7159773|FG001|Overall Study|Lost to Follow-up|0
4382101|NCT02564796|7159790|FG000|Overall Study|Physician Decision|2
4382102|NCT02564796|7159791|FG001|Overall Study|Physician Decision|2
4382103|NCT02562716|7159799|FG000|Overall Study|Adverse Event|7
4382104|NCT02562716|7159800|FG001|Overall Study|Adverse Event|14
4382105|NCT02562716|7159799|FG000|Overall Study|Withdrawal unrelated to AE|7
4382106|NCT02562716|7159800|FG001|Overall Study|Withdrawal unrelated to AE|1
4382107|NCT02562716|7159799|FG000|Overall Study|Progression|8
4382108|NCT02562716|7159800|FG001|Overall Study|Progression|10
4382109|NCT02562716|7159799|FG000|Overall Study|Death|2
4382110|NCT02562716|7159800|FG001|Overall Study|Death|1
4382111|NCT02562716|7159799|FG000|Overall Study|Not protocol specified|4
4382112|NCT02562716|7159800|FG001|Overall Study|Not protocol specified|2
4382113|NCT02211131|7159810|FG000|Overall Study|Death|20
4382114|NCT02211131|7159811|FG001|Overall Study|Death|11
4382115|NCT02211131|7159810|FG000|Overall Study|Lost to Follow-up|1
4382116|NCT02211131|7159811|FG001|Overall Study|Lost to Follow-up|0
4382117|NCT02211131|7159810|FG000|Overall Study|Decision by Sponsor|1
4382118|NCT02211131|7159811|FG001|Overall Study|Decision by Sponsor|1
4382119|NCT02211131|7159810|FG000|Overall Study|Withdrawal by Subject|3
4382120|NCT02211131|7159811|FG001|Overall Study|Withdrawal by Subject|4
4382121|NCT02211131|7159810|FG000|Overall Study|Continuing on Study|49
4382122|NCT02211131|7159811|FG001|Overall Study|Continuing on Study|60
4382123|NCT01472081|7159835|FG000|Overall Study|Continuing treatment at time of analysis|1
4382124|NCT01472081|7159836|FG001|Overall Study|Continuing treatment at time of analysis|4
4382125|NCT01472081|7159837|FG002|Overall Study|Continuing treatment at time of analysis|1
4382126|NCT01472081|7159838|FG003|Overall Study|Continuing treatment at time of analysis|8
4382127|NCT01472081|7159839|FG004|Overall Study|Continuing treatment at time of analysis|9
4382128|NCT01472081|7159840|FG005|Overall Study|Continuing treatment at time of analysis|0
4382129|NCT01472081|7159835|FG000|Overall Study|Disease Progression|4
4382130|NCT01472081|7159836|FG001|Overall Study|Disease Progression|10
4382131|NCT01472081|7159837|FG002|Overall Study|Disease Progression|12
4382132|NCT01472081|7159838|FG003|Overall Study|Disease Progression|31
4382133|NCT01472081|7159839|FG004|Overall Study|Disease Progression|22
4382134|NCT01472081|7159840|FG005|Overall Study|Disease Progression|3
4382135|NCT01472081|7159835|FG000|Overall Study|Study drug toxicity|2
4382136|NCT01472081|7159836|FG001|Overall Study|Study drug toxicity|9
4382137|NCT01472081|7159837|FG002|Overall Study|Study drug toxicity|4
4697215|NCT02646891|7610475|FG001|Overall Study|Protocol Violation|0
4697216|NCT02646891|7610476|FG002|Overall Study|Protocol Violation|0
4697217|NCT02646891|7610477|FG003|Overall Study|Protocol Violation|0
4697218|NCT02646891|7610478|FG004|Overall Study|Protocol Violation|0
4697219|NCT02646891|7610479|FG005|Overall Study|Protocol Violation|0
4697220|NCT02646891|7610480|FG006|Overall Study|Protocol Violation|1
4697221|NCT02646891|7610481|FG007|Overall Study|Protocol Violation|1
4382138|NCT01472081|7159838|FG003|Overall Study|Study drug toxicity|6
4382139|NCT01472081|7159839|FG004|Overall Study|Study drug toxicity|13
4382140|NCT01472081|7159840|FG005|Overall Study|Study drug toxicity|2
4382141|NCT01472081|7159835|FG000|Overall Study|Death|0
4382142|NCT01472081|7159836|FG001|Overall Study|Death|0
4382143|NCT01472081|7159837|FG002|Overall Study|Death|0
4382144|NCT01472081|7159838|FG003|Overall Study|Death|0
4382145|NCT01472081|7159839|FG004|Overall Study|Death|1
4382146|NCT01472081|7159840|FG005|Overall Study|Death|0
4382147|NCT01472081|7159835|FG000|Overall Study|Adverse Event unrelated to study drug|0
4382148|NCT01472081|7159836|FG001|Overall Study|Adverse Event unrelated to study drug|0
4382149|NCT01472081|7159837|FG002|Overall Study|Adverse Event unrelated to study drug|0
4382150|NCT01472081|7159838|FG003|Overall Study|Adverse Event unrelated to study drug|0
4382151|NCT01472081|7159839|FG004|Overall Study|Adverse Event unrelated to study drug|1
4382152|NCT01472081|7159840|FG005|Overall Study|Adverse Event unrelated to study drug|0
4382153|NCT01472081|7159835|FG000|Overall Study|Withdrawal by Subject|0
4382154|NCT01472081|7159836|FG001|Overall Study|Withdrawal by Subject|0
4382155|NCT01472081|7159837|FG002|Overall Study|Withdrawal by Subject|0
4382156|NCT01472081|7159838|FG003|Overall Study|Withdrawal by Subject|0
4382157|NCT01472081|7159839|FG004|Overall Study|Withdrawal by Subject|0
4382158|NCT01472081|7159840|FG005|Overall Study|Withdrawal by Subject|1
4382159|NCT01472081|7159835|FG000|Overall Study|Poor/non-compliance|0
4382160|NCT01472081|7159836|FG001|Overall Study|Poor/non-compliance|0
4382161|NCT01472081|7159837|FG002|Overall Study|Poor/non-compliance|1
4382162|NCT01472081|7159838|FG003|Overall Study|Poor/non-compliance|0
4382163|NCT01472081|7159839|FG004|Overall Study|Poor/non-compliance|1
4382164|NCT01472081|7159840|FG005|Overall Study|Poor/non-compliance|0
4382165|NCT01472081|7159835|FG000|Overall Study|No longer meets study criteria|0
4382166|NCT01472081|7159836|FG001|Overall Study|No longer meets study criteria|0
4382167|NCT01472081|7159837|FG002|Overall Study|No longer meets study criteria|1
4382168|NCT01472081|7159838|FG003|Overall Study|No longer meets study criteria|0
4382169|NCT01472081|7159839|FG004|Overall Study|No longer meets study criteria|0
4382170|NCT01472081|7159840|FG005|Overall Study|No longer meets study criteria|0
4382171|NCT01472081|7159835|FG000|Overall Study|Subject request to discontinue treatment|0
4382172|NCT01472081|7159836|FG001|Overall Study|Subject request to discontinue treatment|3
4382173|NCT01472081|7159837|FG002|Overall Study|Subject request to discontinue treatment|1
4382174|NCT01472081|7159838|FG003|Overall Study|Subject request to discontinue treatment|1
4382175|NCT01472081|7159839|FG004|Overall Study|Subject request to discontinue treatment|0
4382176|NCT01472081|7159840|FG005|Overall Study|Subject request to discontinue treatment|0
4588578|NCT01500278|7433098|FG000|Week 13 - Week 104|Withdrawal by Subject|22
4588579|NCT01500278|7433099|FG001|Week 13 - Week 104|Withdrawal by Subject|13
4588580|NCT01500278|7433098|FG000|Week 13 - Week 104|Week 24 Non-Responder|20
4588581|NCT01500278|7433099|FG001|Week 13 - Week 104|Week 24 Non-Responder|16
4588582|NCT01500278|7433098|FG000|Week 13 - Week 104|Non/bad compliance|7
4588583|NCT01500278|7433099|FG001|Week 13 - Week 104|Non/bad compliance|5
4588584|NCT01500278|7433098|FG000|Week 13 - Week 104|Recurrent infections|1
4588585|NCT01500278|7433099|FG001|Week 13 - Week 104|Recurrent infections|0
4588586|NCT01500278|7433098|FG000|Week 13 - Week 104|False positive test|1
4588587|NCT01500278|7433099|FG001|Week 13 - Week 104|False positive test|2
4588588|NCT01500278|7433098|FG000|Week 13 - Week 104|Sponsor request|4
4588589|NCT01500278|7433099|FG001|Week 13 - Week 104|Sponsor request|0
4588590|NCT01500278|7433098|FG000|Week 13 - Week 104|Withdrawn in error|1
4588591|NCT01500278|7433099|FG001|Week 13 - Week 104|Withdrawn in error|0
4588592|NCT01500278|7433098|FG000|Week 13 - Week 104|Exclusion criteria not met|1
4588593|NCT01500278|7433099|FG001|Week 13 - Week 104|Exclusion criteria not met|0
4588594|NCT01500278|7433098|FG000|Week 13 - Week 104|Protocol deviation|1
4588595|NCT01500278|7433099|FG001|Week 13 - Week 104|Protocol deviation|0
4588596|NCT01500278|7433098|FG000|Week 13 - Week 104|Principal investigator retiring|1
4588597|NCT01500278|7433099|FG001|Week 13 - Week 104|Principal investigator retiring|0
4588598|NCT01500278|7433098|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1
4588599|NCT01500278|7433099|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0
4588600|NCT01500278|7433098|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0
4588601|NCT01500278|7433099|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2
4588602|NCT01500278|7433098|FG000|Week 13 - Week 104|Relocation|0
4588603|NCT01500278|7433099|FG001|Week 13 - Week 104|Relocation|1
4588604|NCT01500278|7433098|FG000|Week 13 - Week 104|Sponsor decision|0
4588605|NCT01500278|7433099|FG001|Week 13 - Week 104|Sponsor decision|2
4588606|NCT01500278|7433098|FG000|Week 13 - Week 104|Medical monitor decision|0
4588607|NCT01500278|7433099|FG001|Week 13 - Week 104|Medical monitor decision|2
4588608|NCT01500278|7433098|FG000|Week 13 - Week 104|Personal reason|0
4588609|NCT01500278|7433099|FG001|Week 13 - Week 104|Personal reason|1
4588610|NCT01500278|7433098|FG000|Week 13 - Week 104|Not completed|0
4588611|NCT01500278|7433099|FG001|Week 13 - Week 104|Not completed|1
4588612|NCT01500278|7433098|FG000|Week 13 - Week 104|Death|2
4588613|NCT01500278|7433099|FG001|Week 13 - Week 104|Death|4
4588614|NCT01500278|7433098|FG000|Week 13 - Week 104|Adverse Event|54
4588615|NCT01500278|7433099|FG001|Week 13 - Week 104|Adverse Event|54
4382177|NCT01309672|7159853|FG000|Overall Study|Lack of Efficacy|20
4382178|NCT01309672|7159853|FG000|Overall Study|Other|9
4382179|NCT01309672|7159853|FG000|Overall Study|Adverse Event|5
4588616|NCT01500317|7433110|FG000|Overall Study|Withdrawal by Subject|3
4588617|NCT01500317|7433111|FG001|Overall Study|Withdrawal by Subject|2
4588618|NCT01500317|7433112|FG002|Overall Study|Withdrawal by Subject|0
4588619|NCT01500382|7433124|FG000|Washout Period|Study site went out of business|0
4588620|NCT01500382|7433125|FG001|Washout Period|Study site went out of business|0
4588621|NCT01500382|7433126|FG002|Washout Period|Study site went out of business|1
4588622|NCT01500382|7433127|FG003|Washout Period|Study site went out of business|0
4588623|NCT01500434|7433137|FG000|Overall Study|Death|1
4588624|NCT01500434|7433137|FG000|Overall Study|Withdrawal by Subject|1
4588625|NCT01500434|7433137|FG000|Overall Study|Missed 12-month follow-up|5
4588626|NCT01500629|7433152|FG000|Washout Period of 14 to 30 Days|Pregnancy|1
4588627|NCT01500629|7433153|FG001|Washout Period of 14 to 30 Days|Pregnancy|0
4593601|NCT01553747|7442172|FG000|Overall Study|Protocol Violation|0
4593602|NCT01553747|7442173|FG001|Overall Study|Protocol Violation|2
4593603|NCT01553747|7442174|FG002|Overall Study|Protocol Violation|0
4593604|NCT01553747|7442172|FG000|Overall Study|Voluntarily withdrew|70
4593605|NCT01553747|7442173|FG001|Overall Study|Voluntarily withdrew|66
4593606|NCT01553747|7442174|FG002|Overall Study|Voluntarily withdrew|74
4593607|NCT01553747|7442172|FG000|Overall Study|Adverse event or SAE|32
4593608|NCT01553747|7442173|FG001|Overall Study|Adverse event or SAE|28
4593609|NCT01553747|7442174|FG002|Overall Study|Adverse event or SAE|19
4593610|NCT01553747|7442172|FG000|Overall Study|Physician decision: other|10
4593611|NCT01553747|7442173|FG001|Overall Study|Physician decision: other|8
4593612|NCT01553747|7442174|FG002|Overall Study|Physician decision: other|7
4593613|NCT01553747|7442172|FG000|Overall Study|Lost to Follow-up|11
4593614|NCT01553747|7442173|FG001|Overall Study|Lost to Follow-up|5
4593615|NCT01553747|7442174|FG002|Overall Study|Lost to Follow-up|6
4593616|NCT01553747|7442172|FG000|Overall Study|Sponsor decision, specify|7
4593617|NCT01553747|7442173|FG001|Overall Study|Sponsor decision, specify|5
4593618|NCT01553747|7442174|FG002|Overall Study|Sponsor decision, specify|0
4593619|NCT01553747|7442172|FG000|Overall Study|Physician decision: lack of efficacy|1
4593620|NCT01553747|7442173|FG001|Overall Study|Physician decision: lack of efficacy|5
4593621|NCT01553747|7442174|FG002|Overall Study|Physician decision: lack of efficacy|3
4593622|NCT01553851|7442185|FG000|Overall Study|Adverse Event|2
4593623|NCT01553851|7442185|FG000|Overall Study|constipation|1
4593624|NCT01553916|7442189|FG000|Overall Study|Withdrawal by Subject|2
4593625|NCT01553916|7442189|FG000|Overall Study|Pre-treatment MRI metastatic disease|1
4593626|NCT01554176|7442195|FG000|Treatment Phase|Protocol Violation|1
4593627|NCT01554176|7442196|FG001|Treatment Phase|Protocol Violation|2
4593628|NCT01554176|7442197|FG002|Treatment Phase|Protocol Violation|0
4593629|NCT01554176|7442198|FG003|Treatment Phase|Protocol Violation|0
4593630|NCT01554176|7442199|FG004|Treatment Phase|Protocol Violation|0
4593631|NCT01554176|7442195|FG000|Treatment Phase|Physician Decision|1
4593632|NCT01554176|7442196|FG001|Treatment Phase|Physician Decision|1
4593633|NCT01554176|7442197|FG002|Treatment Phase|Physician Decision|0
4593634|NCT01554176|7442198|FG003|Treatment Phase|Physician Decision|0
4593635|NCT01554176|7442199|FG004|Treatment Phase|Physician Decision|0
4593636|NCT01554176|7442195|FG000|Treatment Phase|Lack of Efficacy|0
4593637|NCT01554176|7442196|FG001|Treatment Phase|Lack of Efficacy|1
4593638|NCT01554176|7442197|FG002|Treatment Phase|Lack of Efficacy|0
4593639|NCT01554176|7442198|FG003|Treatment Phase|Lack of Efficacy|0
4593640|NCT01554176|7442199|FG004|Treatment Phase|Lack of Efficacy|0
4593641|NCT01554176|7442195|FG000|Treatment Phase|Adverse event, non-fatal|1
4593642|NCT01554176|7442196|FG001|Treatment Phase|Adverse event, non-fatal|1
4593643|NCT01554176|7442197|FG002|Treatment Phase|Adverse event, non-fatal|0
4593644|NCT01554176|7442198|FG003|Treatment Phase|Adverse event, non-fatal|0
4593645|NCT01554176|7442199|FG004|Treatment Phase|Adverse event, non-fatal|0
4593646|NCT01554176|7442195|FG000|Treatment Phase|Non-compliance with study drug|1
4593647|NCT01554176|7442196|FG001|Treatment Phase|Non-compliance with study drug|0
4593648|NCT01554176|7442197|FG002|Treatment Phase|Non-compliance with study drug|0
4593649|NCT01554176|7442198|FG003|Treatment Phase|Non-compliance with study drug|0
4593650|NCT01554176|7442199|FG004|Treatment Phase|Non-compliance with study drug|0
4593651|NCT01554176|7442195|FG000|Treatment Phase|Withdrawal by Subject|1
4593652|NCT01554176|7442196|FG001|Treatment Phase|Withdrawal by Subject|0
4593653|NCT01554176|7442197|FG002|Treatment Phase|Withdrawal by Subject|0
4593654|NCT01554176|7442198|FG003|Treatment Phase|Withdrawal by Subject|0
4593655|NCT01554176|7442199|FG004|Treatment Phase|Withdrawal by Subject|0
4593656|NCT01554176|7442195|FG000|Treatment Phase|Lost to Follow-up|3
4593657|NCT01554176|7442196|FG001|Treatment Phase|Lost to Follow-up|0
4593658|NCT01554176|7442197|FG002|Treatment Phase|Lost to Follow-up|0
4593659|NCT01554176|7442198|FG003|Treatment Phase|Lost to Follow-up|0
4593660|NCT01554176|7442199|FG004|Treatment Phase|Lost to Follow-up|0
4593661|NCT01554176|7442195|FG000|Run-out Phase|Protocol Violation|0
4593662|NCT01554176|7442196|FG001|Run-out Phase|Protocol Violation|0
4593663|NCT01554176|7442197|FG002|Run-out Phase|Protocol Violation|0
4593664|NCT01554176|7442198|FG003|Run-out Phase|Protocol Violation|1
4593665|NCT01554176|7442199|FG004|Run-out Phase|Protocol Violation|0
4593666|NCT01554241|7442215|FG000|Overall Study|Death|3
4593667|NCT01554241|7442216|FG001|Overall Study|Death|1
4593668|NCT01554241|7442217|FG002|Overall Study|Death|1
4593669|NCT01554241|7442218|FG003|Overall Study|Death|0
4593670|NCT01554241|7442215|FG000|Overall Study|protocol specified renal stone|0
4588628|NCT01500694|7433168|FG000|Overall Study|Adverse Event|4
4588629|NCT01500694|7433169|FG001|Overall Study|Adverse Event|3
4588630|NCT01500694|7433168|FG000|Overall Study|Protocol Violation|0
4588631|NCT01500694|7433169|FG001|Overall Study|Protocol Violation|1
4588632|NCT01500694|7433168|FG000|Overall Study|Withdrawal by Subject|23
4588633|NCT01500694|7433169|FG001|Overall Study|Withdrawal by Subject|14
4588634|NCT01500694|7433168|FG000|Overall Study|Lost to Follow-up|2
4588635|NCT01500694|7433169|FG001|Overall Study|Lost to Follow-up|3
4588636|NCT01500694|7433168|FG000|Overall Study|Lack of Efficacy|14
4588637|NCT01500694|7433169|FG001|Overall Study|Lack of Efficacy|5
4588638|NCT01500694|7433168|FG000|Overall Study|Other|9
4588639|NCT01500694|7433169|FG001|Overall Study|Other|3
4588640|NCT01500720|7433177|FG000|Overall Study|Randomized But Not Treated|1
4588641|NCT01500720|7433178|FG001|Overall Study|Randomized But Not Treated|1
4588642|NCT01500720|7433177|FG000|Overall Study|Other|4
4382180|NCT01309672|7159853|FG000|Overall Study|Withdrawal by Subject|3
4382181|NCT00774345|7159870|FG000|Pre-treatment|Other reasons|2
4382182|NCT00774345|7159871|FG001|Pre-treatment|Other reasons|0
4382183|NCT00774345|7159870|FG000|Treatment|Adverse Event|61
4382184|NCT00774345|7159871|FG001|Treatment|Adverse Event|15
4382185|NCT00774345|7159870|FG000|Treatment|Progressive Disease without histologic transformation|51
4382186|NCT00774345|7159871|FG001|Treatment|Progressive Disease without histologic transformation|111
4382187|NCT00774345|7159870|FG000|Treatment|Progressive Disease with histologic transformation|4
4382188|NCT00774345|7159871|FG001|Treatment|Progressive Disease with histologic transformation|2
4382189|NCT00774345|7159870|FG000|Treatment|Withdrawal by Subject|5
4382190|NCT00774345|7159871|FG001|Treatment|Withdrawal by Subject|2
4382191|NCT00774345|7159870|FG000|Treatment|Lost to Follow-up|1
4382192|NCT00774345|7159871|FG001|Treatment|Lost to Follow-up|1
4382193|NCT00774345|7159870|FG000|Treatment|Death|4
4382194|NCT00774345|7159871|FG001|Treatment|Death|0
4382195|NCT00774345|7159870|FG000|Treatment|Other Reasons|32
4382196|NCT00774345|7159871|FG001|Treatment|Other Reasons|26
4468763|NCT00631371|7261304|FG000|Overall Study|Death|263
4468764|NCT00631371|7261305|FG001|Overall Study|Death|239
4468765|NCT00631410|7261313|FG000|Overall Study|Adverse Event|1
4468766|NCT00631410|7261314|FG001|Overall Study|Adverse Event|3
4468767|NCT00631410|7261313|FG000|Overall Study|Objective Progression or Relapse|4
4468768|NCT00631410|7261314|FG001|Overall Study|Objective Progression or Relapse|3
4468769|NCT00631410|7261313|FG000|Overall Study|Surgery|1
4468770|NCT00631410|7261314|FG001|Overall Study|Surgery|0
4468771|NCT00631475|7261334|FG000|Overall Study|Death|18
4468772|NCT00631475|7261334|FG000|Overall Study|Adverse Event|14
4468773|NCT00631475|7261334|FG000|Overall Study|Withdrew consent|5
4468774|NCT00631475|7261334|FG000|Overall Study|Preparation for lung transplant|8
4468775|NCT00631488|7261341|FG000|Overall Study|Adverse Event|1
4468776|NCT00631488|7261342|FG001|Overall Study|Adverse Event|0
4468777|NCT00631488|7261343|FG002|Overall Study|Adverse Event|0
4468778|NCT00631488|7261341|FG000|Overall Study|Lost to Follow-up|2
4468779|NCT00631488|7261342|FG001|Overall Study|Lost to Follow-up|2
4468780|NCT00631488|7261343|FG002|Overall Study|Lost to Follow-up|0
4468781|NCT00631488|7261341|FG000|Overall Study|Physician Decision|1
4468782|NCT00631488|7261342|FG001|Overall Study|Physician Decision|0
4468783|NCT00631488|7261343|FG002|Overall Study|Physician Decision|1
4468784|NCT00631488|7261341|FG000|Overall Study|Protocol Violation|0
4468785|NCT00631488|7261342|FG001|Overall Study|Protocol Violation|0
4468786|NCT00631488|7261343|FG002|Overall Study|Protocol Violation|1
4468787|NCT00631540|7261351|FG000|Overall Study|Withdrawal by Subject|5
4468788|NCT00631540|7261351|FG000|Overall Study|Death|4
4468789|NCT00631540|7261351|FG000|Overall Study|Lost to Follow-up|2
4468790|NCT00631540|7261351|FG000|Overall Study|Core Lab Data Unavailable|3
4468791|NCT00631657|7261370|FG000|6-Month Treatment Period|Adverse Event|47
4468792|NCT00631657|7261371|FG001|6-Month Treatment Period|Adverse Event|0
4468793|NCT00631657|7261372|FG002|6-Month Treatment Period|Adverse Event|7
4468794|NCT00631657|7261370|FG000|6-Month Treatment Period|Withdrawal by Subject|14
4468795|NCT00631657|7261371|FG001|6-Month Treatment Period|Withdrawal by Subject|0
4468796|NCT00631657|7261372|FG002|6-Month Treatment Period|Withdrawal by Subject|5
4468797|NCT00631657|7261370|FG000|6-Month Treatment Period|Lack of Efficacy|34
4468798|NCT00631657|7261371|FG001|6-Month Treatment Period|Lack of Efficacy|0
4468799|NCT00631657|7261372|FG002|6-Month Treatment Period|Lack of Efficacy|25
4468800|NCT00631657|7261370|FG000|6-Month Treatment Period|Lost to Follow-up|7
4468801|NCT00631657|7261371|FG001|6-Month Treatment Period|Lost to Follow-up|0
4468802|NCT00631657|7261372|FG002|6-Month Treatment Period|Lost to Follow-up|2
4468803|NCT00631657|7261370|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21
4468804|NCT00631657|7261371|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0
4468805|NCT00631657|7261372|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6
4468806|NCT00631657|7261370|FG000|6-Month Treatment Period|Other|16
4468807|NCT00631657|7261371|FG001|6-Month Treatment Period|Other|0
4468808|NCT00631657|7261372|FG002|6-Month Treatment Period|Other|4
4468809|NCT00631657|7261370|FG000|6-Month Treatment Period|Not Treated|2
4588643|NCT01500720|7433178|FG001|Overall Study|Other|8
4588644|NCT01501110|7433213|FG000|Overall Study|Death|0
4588645|NCT01501110|7433214|FG001|Overall Study|Death|1
4588646|NCT01502033|7433236|FG000|Overall Study|1 participant had scalp discomfort|1
4588647|NCT01502033|7433236|FG000|Overall Study|1 participant had worsening depression|1
4382197|NCT00000135|7159955|FG000|Overall Study|Death|27
4382198|NCT00000135|7159956|FG001|Overall Study|Death|14
4382199|NCT00000378|7160004|FG000|Overall Study|Lack of Efficacy|16
4382200|NCT00000378|7160005|FG001|Overall Study|Lack of Efficacy|14
4382201|NCT00000620|7160052|FG000|Overall Study|Death|86
4382202|NCT00000620|7160053|FG001|Overall Study|Death|67
4382203|NCT00000620|7160054|FG002|Overall Study|Death|112
4382204|NCT00000620|7160055|FG003|Overall Study|Death|126
4382205|NCT00000620|7160056|FG004|Overall Study|Death|64
4382206|NCT00000620|7160057|FG005|Overall Study|Death|77
4382207|NCT00000620|7160058|FG006|Overall Study|Death|91
4382208|NCT00000620|7160059|FG007|Overall Study|Death|95
4382209|NCT00000620|7160052|FG000|Overall Study|Lost to Follow-up|14
4382210|NCT00000620|7160053|FG001|Overall Study|Lost to Follow-up|14
4382211|NCT00000620|7160054|FG002|Overall Study|Lost to Follow-up|14
4382212|NCT00000620|7160055|FG003|Overall Study|Lost to Follow-up|14
4382213|NCT00000620|7160056|FG004|Overall Study|Lost to Follow-up|15
4382214|NCT00000620|7160057|FG005|Overall Study|Lost to Follow-up|15
4382215|NCT00000620|7160058|FG006|Overall Study|Lost to Follow-up|13
4382216|NCT00000620|7160059|FG007|Overall Study|Lost to Follow-up|14
4382217|NCT00000620|7160052|FG000|Overall Study|Withdrawal by Subject|40
4382218|NCT00000620|7160053|FG001|Overall Study|Withdrawal by Subject|27
4382219|NCT00000620|7160054|FG002|Overall Study|Withdrawal by Subject|28
4382220|NCT00000620|7160055|FG003|Overall Study|Withdrawal by Subject|27
4382221|NCT00000620|7160056|FG004|Overall Study|Withdrawal by Subject|30
4382222|NCT00000620|7160057|FG005|Overall Study|Withdrawal by Subject|32
4382223|NCT00000620|7160058|FG006|Overall Study|Withdrawal by Subject|32
4382224|NCT00000620|7160059|FG007|Overall Study|Withdrawal by Subject|21
4382225|NCT00000620|7160052|FG000|Overall Study|missed closeout visit|22
4382226|NCT00000620|7160053|FG001|Overall Study|missed closeout visit|28
4588648|NCT01502033|7433236|FG000|Overall Study|1 participant went back to school|1
4588649|NCT01502072|7433245|FG000|Overall Study|Withdrawal by Subject|1
4588650|NCT01502072|7433246|FG001|Overall Study|Withdrawal by Subject|0
4588651|NCT01502072|7433247|FG002|Overall Study|Withdrawal by Subject|0
4588652|NCT01502072|7433245|FG000|Overall Study|Death|0
4588653|NCT01502072|7433246|FG001|Overall Study|Death|1
4382227|NCT00000620|7160054|FG002|Overall Study|missed closeout visit|16
4382228|NCT00000620|7160055|FG003|Overall Study|missed closeout visit|11
4382229|NCT00000620|7160056|FG004|Overall Study|missed closeout visit|26
4382230|NCT00000620|7160057|FG005|Overall Study|missed closeout visit|28
4382231|NCT00000620|7160058|FG006|Overall Study|missed closeout visit|13
4382232|NCT00000620|7160059|FG007|Overall Study|missed closeout visit|16
4382233|NCT00001213|7160075|FG000|Overall Study|Death|18
4382234|NCT00001262|7160082|FG000|Overall Study|Death|10
4382235|NCT00001262|7160083|FG001|Overall Study|Death|11
4382236|NCT00001262|7160084|FG002|Overall Study|Death|0
4382237|NCT00001262|7160082|FG000|Overall Study|Withdrawal by Subject|0
4382238|NCT00001262|7160083|FG001|Overall Study|Withdrawal by Subject|3
4382239|NCT00001262|7160084|FG002|Overall Study|Withdrawal by Subject|0
4382240|NCT00001566|7160105|FG000|Overall Study|patients' choice to discontinue protocol|3
4382241|NCT00001566|7160105|FG000|Overall Study|stopped after C3 due to symptomatic PD|1
4382242|NCT00001566|7160105|FG000|Overall Study|Death|13
4382243|NCT00001566|7160105|FG000|Overall Study|Lost to Follow-up|1
4382244|NCT00001566|7160105|FG000|Overall Study|unable to complete initial apheresis|1
4382245|NCT00001575|7160109|FG000|Overall Study|Screening failures-Ph I portion|22
4382246|NCT00001575|7160109|FG000|Overall Study|Withdrawn/deaths|23
4382247|NCT00001596|7160124|FG000|Overall Study|Death|1
4382248|NCT00001596|7160125|FG001|Overall Study|Death|0
4382249|NCT00001596|7160124|FG000|Overall Study|Withdrawal by Subject|3
4382250|NCT00001596|7160125|FG001|Overall Study|Withdrawal by Subject|1
4382251|NCT00001596|7160124|FG000|Overall Study|Study Termination|12
4382252|NCT00001596|7160125|FG001|Overall Study|Study Termination|9
4382253|NCT00001596|7160124|FG000|Overall Study|Adverse Event|1
4382254|NCT00001596|7160125|FG001|Overall Study|Adverse Event|0
4382255|NCT00001703|7160140|FG000|Overall Study|progressed disease|2
4382256|NCT00001703|7160140|FG000|Overall Study|No evidence of disease|1
4382257|NCT00001703|7160140|FG000|Overall Study|recurrent disease|2
4382258|NCT00001723|7160146|FG000|Overall Study|Lack of Efficacy|6
4382259|NCT00001723|7160147|FG001|Overall Study|Lack of Efficacy|7
4382260|NCT00001723|7160146|FG000|Overall Study|Lack of family interest|4
4382261|NCT00001723|7160147|FG001|Overall Study|Lack of family interest|5
4382262|NCT00001723|7160146|FG000|Overall Study|Lost to Follow-up|2
4382263|NCT00001723|7160147|FG001|Overall Study|Lost to Follow-up|2
4382264|NCT00001723|7160146|FG000|Overall Study|medication intolerance|1
4382265|NCT00001723|7160147|FG001|Overall Study|medication intolerance|2
4382266|NCT00001832|7160171|FG000|Apheresis Period|not able to manufacture treatment cells|60
4382267|NCT00001832|7160172|FG001|Apheresis Period|not able to manufacture treatment cells|0
4382268|NCT00001832|7160173|FG002|Apheresis Period|not able to manufacture treatment cells|0
4382269|NCT00001832|7160174|FG003|Apheresis Period|not able to manufacture treatment cells|0
4382270|NCT00001832|7160175|FG004|Apheresis Period|not able to manufacture treatment cells|0
4382271|NCT00001832|7160176|FG005|Apheresis Period|not able to manufacture treatment cells|0
4382272|NCT00001832|7160177|FG006|Apheresis Period|not able to manufacture treatment cells|0
4382273|NCT00001832|7160178|FG007|Apheresis Period|not able to manufacture treatment cells|0
4382274|NCT00001832|7160179|FG008|Apheresis Period|not able to manufacture treatment cells|0
4382275|NCT00001832|7160180|FG009|Apheresis Period|not able to manufacture treatment cells|0
4382276|NCT00001832|7160181|FG010|Apheresis Period|not able to manufacture treatment cells|0
4382277|NCT00001832|7160182|FG011|Apheresis Period|not able to manufacture treatment cells|0
4382278|NCT00001832|7160183|FG012|Apheresis Period|not able to manufacture treatment cells|0
4382279|NCT00001832|7160184|FG013|Apheresis Period|not able to manufacture treatment cells|0
4382280|NCT00001832|7160185|FG014|Apheresis Period|not able to manufacture treatment cells|0
4382281|NCT00001832|7160171|FG000|Treatment Period|Death during treatment|0
4382282|NCT00001832|7160172|FG001|Treatment Period|Death during treatment|0
4382283|NCT00001832|7160173|FG002|Treatment Period|Death during treatment|0
4382284|NCT00001832|7160174|FG003|Treatment Period|Death during treatment|0
4382285|NCT00001832|7160175|FG004|Treatment Period|Death during treatment|0
4382286|NCT00001832|7160176|FG005|Treatment Period|Death during treatment|1
4382287|NCT00001832|7160177|FG006|Treatment Period|Death during treatment|0
4382288|NCT00001832|7160178|FG007|Treatment Period|Death during treatment|0
4382289|NCT00001832|7160179|FG008|Treatment Period|Death during treatment|0
4382290|NCT00001832|7160180|FG009|Treatment Period|Death during treatment|0
4382291|NCT00001832|7160181|FG010|Treatment Period|Death during treatment|0
4468810|NCT00631657|7261371|FG001|6-Month Treatment Period|Not Treated|0
4468811|NCT00631657|7261372|FG002|6-Month Treatment Period|Not Treated|1
4468812|NCT00631657|7261370|FG000|7-Day Discontinuation Period|Not Treated|1
4468813|NCT00631657|7261371|FG001|7-Day Discontinuation Period|Not Treated|1
4468814|NCT00631657|7261372|FG002|7-Day Discontinuation Period|Not Treated|1
4468815|NCT00631657|7261370|FG000|7-Day Discontinuation Period|Other|1
4468816|NCT00631657|7261371|FG001|7-Day Discontinuation Period|Other|0
4468817|NCT00631657|7261372|FG002|7-Day Discontinuation Period|Other|0
4468818|NCT00631696|7261398|FG000|Overall Study|Entered, not randomized to treatment|1
4468819|NCT00631696|7261399|FG001|Overall Study|Entered, not randomized to treatment|1
4468820|NCT00631696|7261398|FG000|Overall Study|Discontinued after database release date|1
4468821|NCT00631696|7261399|FG001|Overall Study|Discontinued after database release date|0
4468822|NCT00631696|7261398|FG000|Overall Study|Follow up after database release date|1
4468823|NCT00631696|7261399|FG001|Overall Study|Follow up after database release date|0
4468824|NCT00631696|7261398|FG000|Overall Study|Lost to Follow-up|7
4468825|NCT00631696|7261399|FG001|Overall Study|Lost to Follow-up|10
4468826|NCT00631696|7261398|FG000|Overall Study|Withdrawal by Subject|2
4468827|NCT00631696|7261399|FG001|Overall Study|Withdrawal by Subject|9
4468828|NCT00631696|7261398|FG000|Overall Study|Other|8
4468829|NCT00631696|7261399|FG001|Overall Study|Other|8
4468830|NCT00631696|7261398|FG000|Overall Study|Protocol Violation|9
4468831|NCT00631696|7261399|FG001|Overall Study|Protocol Violation|9
4468832|NCT00631696|7261398|FG000|Overall Study|Study terminated by sponsor|3
4468833|NCT00631696|7261399|FG001|Overall Study|Study terminated by sponsor|3
4468834|NCT00631696|7261398|FG000|Overall Study|Adverse Event|5
4468835|NCT00631696|7261399|FG001|Overall Study|Adverse Event|0
4468836|NCT00631917|7261421|FG000|Overall Study|Adverse Event|34
4468837|NCT00631917|7261422|FG001|Overall Study|Adverse Event|45
4468838|NCT00631917|7261421|FG000|Overall Study|Abnormal laboratory value(s)|2
4468839|NCT00631917|7261422|FG001|Overall Study|Abnormal laboratory value(s)|1
4468840|NCT00631917|7261421|FG000|Overall Study|Abnormal test procedure result(s)|3
4468841|NCT00631917|7261422|FG001|Overall Study|Abnormal test procedure result(s)|2
4468842|NCT00631917|7261421|FG000|Overall Study|Unsatisfactory therapeutic effect|8
4468843|NCT00631917|7261422|FG001|Overall Study|Unsatisfactory therapeutic effect|14
4468844|NCT00631917|7261421|FG000|Overall Study|No longer required study drug|0
4468845|NCT00631917|7261422|FG001|Overall Study|No longer required study drug|1
4468846|NCT00631917|7261421|FG000|Overall Study|Protocol deviation|6
4468847|NCT00631917|7261422|FG001|Overall Study|Protocol deviation|5
4588654|NCT01502072|7433247|FG002|Overall Study|Death|0
4588655|NCT01502228|7433255|FG000|Overall Study|Death|1
4588656|NCT01502293|7433262|FG000|Overall Study|Progressive Disease|20
4588657|NCT01502293|7433263|FG001|Overall Study|Progressive Disease|12
4588658|NCT01502293|7433264|FG002|Overall Study|Progressive Disease|2
4588659|NCT01502293|7433262|FG000|Overall Study|Withdrawal by Subject|3
4588660|NCT01502293|7433263|FG001|Overall Study|Withdrawal by Subject|3
4588661|NCT01502293|7433264|FG002|Overall Study|Withdrawal by Subject|1
4588662|NCT01502293|7433262|FG000|Overall Study|Adverse Event|0
4588663|NCT01502293|7433263|FG001|Overall Study|Adverse Event|2
4588664|NCT01502293|7433264|FG002|Overall Study|Adverse Event|0
4588665|NCT01502293|7433262|FG000|Overall Study|Reason Not Specified|2
4588666|NCT01502293|7433263|FG001|Overall Study|Reason Not Specified|0
4588667|NCT01502293|7433264|FG002|Overall Study|Reason Not Specified|0
4588668|NCT01502293|7433262|FG000|Overall Study|Physician Decision|0
4588669|NCT01502293|7433263|FG001|Overall Study|Physician Decision|0
4588670|NCT01502293|7433264|FG002|Overall Study|Physician Decision|1
4588671|NCT01502410|7433301|FG000|Overall Study|Adverse Event|1
4588672|NCT01502410|7433302|FG001|Overall Study|Adverse Event|2
4588673|NCT01502410|7433303|FG002|Overall Study|Adverse Event|0
4588674|NCT01502410|7433304|FG003|Overall Study|Adverse Event|0
4588675|NCT01502410|7433301|FG000|Overall Study|Lack of Efficacy|7
4588676|NCT01502410|7433302|FG001|Overall Study|Lack of Efficacy|7
4588677|NCT01502410|7433303|FG002|Overall Study|Lack of Efficacy|0
4588678|NCT01502410|7433304|FG003|Overall Study|Lack of Efficacy|0
4588679|NCT01502410|7433301|FG000|Overall Study|Physician Decision|0
4382292|NCT00001832|7160182|FG011|Treatment Period|Death during treatment|0
4382293|NCT00001832|7160183|FG012|Treatment Period|Death during treatment|0
4382294|NCT00001832|7160184|FG013|Treatment Period|Death during treatment|0
4382295|NCT00001832|7160185|FG014|Treatment Period|Death during treatment|0
4382296|NCT00001832|7160171|FG000|Treatment Period|Not treated|0
4382297|NCT00001832|7160172|FG001|Treatment Period|Not treated|0
4382298|NCT00001832|7160173|FG002|Treatment Period|Not treated|0
4382299|NCT00001832|7160174|FG003|Treatment Period|Not treated|0
4382300|NCT00001832|7160175|FG004|Treatment Period|Not treated|0
4382301|NCT00001832|7160176|FG005|Treatment Period|Not treated|0
4382302|NCT00001832|7160177|FG006|Treatment Period|Not treated|0
4382303|NCT00001832|7160178|FG007|Treatment Period|Not treated|1
4382304|NCT00001832|7160179|FG008|Treatment Period|Not treated|0
4382305|NCT00001832|7160180|FG009|Treatment Period|Not treated|0
4382306|NCT00001832|7160181|FG010|Treatment Period|Not treated|0
4382307|NCT00001832|7160182|FG011|Treatment Period|Not treated|0
4382308|NCT00001832|7160183|FG012|Treatment Period|Not treated|0
4382309|NCT00001832|7160184|FG013|Treatment Period|Not treated|0
4382310|NCT00001832|7160185|FG014|Treatment Period|Not treated|0
4382311|NCT00001849|7160215|FG000|Overall Study|Death|4
4382312|NCT00001849|7160215|FG000|Overall Study|Lost to Follow-up|2
4382313|NCT00001849|7160215|FG000|Overall Study|Withdrawal by Subject|2
4382314|NCT00001849|7160215|FG000|Overall Study|tumor remained occult|6
4382315|NCT00001880|7160228|FG000|Overall Study|Death|14
4382316|NCT00001941|7160232|FG000|Overall Study|not treated- rapidly progressing disease|0
4382317|NCT00001941|7160233|FG001|Overall Study|not treated- rapidly progressing disease|0
4382318|NCT00001941|7160234|FG002|Overall Study|not treated- rapidly progressing disease|0
4382319|NCT00001941|7160235|FG003|Overall Study|not treated- rapidly progressing disease|0
4382320|NCT00001941|7160236|FG004|Overall Study|not treated- rapidly progressing disease|1
4382321|NCT00001959|7160241|FG000|Overall Study|newly diagnosed colon cancer|1
4382322|NCT00001959|7160241|FG000|Overall Study|disabling sedation|1
4382323|NCT00001959|7160241|FG000|Overall Study|non-compliance|1
4382324|NCT00001962|7160245|FG000|Overall Study|Lack of Efficacy|18
4382325|NCT00001962|7160245|FG000|Overall Study|Lack of Accrual|6
4382326|NCT00001962|7160245|FG000|Overall Study|Death|1
4382327|NCT00001962|7160245|FG000|Overall Study|Lost to Follow-up|2
4382328|NCT00001962|7160245|FG000|Overall Study|Adverse Event|1
4382329|NCT00002525|7160255|FG000|Overall Study|Adverse Event|36
4382330|NCT00002525|7160256|FG001|Overall Study|Adverse Event|0
4382331|NCT00002525|7160255|FG000|Overall Study|Death|5
4382332|NCT00002525|7160256|FG001|Overall Study|Death|0
4382333|NCT00002525|7160255|FG000|Overall Study|Withdrawal by Subject|11
4382334|NCT00002525|7160256|FG001|Overall Study|Withdrawal by Subject|0
4382335|NCT00002525|7160255|FG000|Overall Study|Start non-protocol therapy|1
4382336|NCT00002525|7160256|FG001|Overall Study|Start non-protocol therapy|0
4382337|NCT00002525|7160255|FG000|Overall Study|Other complicating disease|1
4382338|NCT00002525|7160256|FG001|Overall Study|Other complicating disease|0
4382339|NCT00002525|7160255|FG000|Overall Study|Duke's A, B1, D disease|92
4382340|NCT00002525|7160256|FG001|Overall Study|Duke's A, B1, D disease|0
4382341|NCT00002525|7160255|FG000|Overall Study|Error|6
4382342|NCT00002525|7160256|FG001|Overall Study|Error|0
4382343|NCT00002525|7160255|FG000|Overall Study|Other|26
4382344|NCT00002525|7160256|FG001|Overall Study|Other|0
4382345|NCT00002525|7160255|FG000|Overall Study|Never start protocol therapy|8
4382346|NCT00002525|7160256|FG001|Overall Study|Never start protocol therapy|0
4382347|NCT00002540|7160266|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0
4382348|NCT00002540|7160267|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25
4382349|NCT00002540|7160266|FG000|Overall Study|Died Before Randomization|2
4382350|NCT00002540|7160267|FG001|Overall Study|Died Before Randomization|6
4382351|NCT00002540|7160266|FG000|Overall Study|Died Before ASU (Control)|202
4382352|NCT00002540|7160267|FG001|Overall Study|Died Before ASU (Control)|0
4382353|NCT00002540|7160266|FG000|Overall Study|Refused ASU (Control)|597
4382354|NCT00002540|7160267|FG001|Overall Study|Refused ASU (Control)|0
4382355|NCT00002540|7160266|FG000|Overall Study|Refused Screen (Prostate Screening)|0
4382356|NCT00002540|7160267|FG001|Overall Study|Refused Screen (Prostate Screening)|2433
4382357|NCT00002558|7160275|FG000|Overall Study|Withdrawal by Subject|0
4382358|NCT00002558|7160276|FG001|Overall Study|Withdrawal by Subject|1
4382359|NCT00002597|7160284|FG000|Overall Study|Protocol Violation|19
4382360|NCT00002597|7160285|FG001|Overall Study|Protocol Violation|17
4382361|NCT00002597|7160284|FG000|Overall Study|Withdrawal by Subject|7
4382362|NCT00002597|7160285|FG001|Overall Study|Withdrawal by Subject|6
4382363|NCT00002651|7160299|FG000|Induction|Adverse Event|44
4382364|NCT00002651|7160300|FG001|Induction|Adverse Event|0
4382365|NCT00002651|7160301|FG002|Induction|Adverse Event|0
4382366|NCT00002651|7160299|FG000|Induction|Refusal unrelated to adverse event|50
4382367|NCT00002651|7160300|FG001|Induction|Refusal unrelated to adverse event|0
4382368|NCT00002651|7160301|FG002|Induction|Refusal unrelated to adverse event|0
4382369|NCT00002651|7160299|FG000|Induction|Progression/relapse|274
4382370|NCT00002651|7160300|FG001|Induction|Progression/relapse|0
4382371|NCT00002651|7160301|FG002|Induction|Progression/relapse|0
4382372|NCT00002651|7160299|FG000|Induction|Death|62
4382373|NCT00002651|7160300|FG001|Induction|Death|0
4382374|NCT00002651|7160301|FG002|Induction|Death|0
4382375|NCT00002651|7160299|FG000|Induction|Other|823
4382376|NCT00002651|7160300|FG001|Induction|Other|0
4382377|NCT00002651|7160301|FG002|Induction|Other|0
4382378|NCT00002651|7160299|FG000|Induction|not eligible|90
4382379|NCT00002651|7160300|FG001|Induction|not eligible|0
4382380|NCT00002651|7160301|FG002|Induction|not eligible|0
4382381|NCT00002651|7160299|FG000|Consolidation and Randomization|Adverse Event|0
4382382|NCT00002651|7160300|FG001|Consolidation and Randomization|Adverse Event|36
4382383|NCT00002651|7160301|FG002|Consolidation and Randomization|Adverse Event|14
4382384|NCT00002651|7160299|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0
4382385|NCT00002651|7160300|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53
4382386|NCT00002651|7160301|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75
4382387|NCT00002651|7160299|FG000|Consolidation and Randomization|Progression/relapse|0
4382388|NCT00002651|7160300|FG001|Consolidation and Randomization|Progression/relapse|295
4382389|NCT00002651|7160301|FG002|Consolidation and Randomization|Progression/relapse|298
4382390|NCT00002651|7160299|FG000|Consolidation and Randomization|Death|0
4382391|NCT00002651|7160300|FG001|Consolidation and Randomization|Death|38
4382392|NCT00002651|7160301|FG002|Consolidation and Randomization|Death|48
4382393|NCT00002651|7160299|FG000|Consolidation and Randomization|Other|0
4382394|NCT00002651|7160300|FG001|Consolidation and Randomization|Other|314
4382395|NCT00002651|7160301|FG002|Consolidation and Randomization|Other|313
4382396|NCT00002651|7160299|FG000|Consolidation and Randomization|not eligible|0
4382397|NCT00002651|7160300|FG001|Consolidation and Randomization|not eligible|102
4382398|NCT00002651|7160301|FG002|Consolidation and Randomization|not eligible|112
4382399|NCT00002766|7160311|FG000|Overall Study|Withdrawal by Subject|0
4382400|NCT00002766|7160312|FG001|Overall Study|Withdrawal by Subject|1
4382401|NCT00002766|7160311|FG000|Overall Study|Patient Not Treated|1
4382402|NCT00002766|7160312|FG001|Overall Study|Patient Not Treated|2
4382403|NCT00002766|7160311|FG000|Overall Study|Adverse Event|1
4382404|NCT00002766|7160312|FG001|Overall Study|Adverse Event|1
4382405|NCT00002766|7160311|FG000|Overall Study|Protocol Violation|1
4382406|NCT00002766|7160312|FG001|Overall Study|Protocol Violation|0
4382407|NCT00002842|7160318|FG000|Overall Study|ineligible for surgical resection|27
4382408|NCT00002850|7160325|FG000|Overall Study|Death|4
4382409|NCT00002850|7160326|FG001|Overall Study|Death|1
4382410|NCT00002850|7160327|FG002|Overall Study|Death|3
4382411|NCT00002850|7160325|FG000|Overall Study|Protocol Violation|1
4382412|NCT00002850|7160326|FG001|Overall Study|Protocol Violation|0
4382413|NCT00002850|7160327|FG002|Overall Study|Protocol Violation|1
4382414|NCT00002850|7160325|FG000|Overall Study|Withdrawal by Subject|0
4382415|NCT00002850|7160326|FG001|Overall Study|Withdrawal by Subject|1
4382416|NCT00002850|7160327|FG002|Overall Study|Withdrawal by Subject|0
4382417|NCT00002931|7160335|FG000|Overall Study|rapidly progressing disease during|2
4382418|NCT00003138|7160341|FG000|Step 1|Reasons off treatment not documented|60
4382419|NCT00003138|7160342|FG001|Step 1|Reasons off treatment not documented|57
4382420|NCT00003138|7160341|FG000|Step 1|Never started treatment|1
4382421|NCT00003138|7160342|FG001|Step 1|Never started treatment|0
4382422|NCT00003138|7160341|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26
4382423|NCT00003138|7160342|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0
4382424|NCT00003138|7160341|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12
4382425|NCT00003138|7160342|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19
4382426|NCT00003138|7160341|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0
4382427|NCT00003138|7160342|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1
4382428|NCT00003138|7160341|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6
4382429|NCT00003138|7160342|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7
4382430|NCT00003199|7160351|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5
4382431|NCT00003199|7160351|FG000|Overall Study|Lack of insurance clearance|2
4588680|NCT01502410|7433302|FG001|Overall Study|Physician Decision|1
4588681|NCT01502410|7433303|FG002|Overall Study|Physician Decision|0
4588682|NCT01502410|7433304|FG003|Overall Study|Physician Decision|0
4588683|NCT01502410|7433301|FG000|Overall Study|Withdrawal by Subject|2
4588684|NCT01502410|7433302|FG001|Overall Study|Withdrawal by Subject|0
4588685|NCT01502410|7433303|FG002|Overall Study|Withdrawal by Subject|0
4588686|NCT01502410|7433304|FG003|Overall Study|Withdrawal by Subject|0
4588687|NCT01502423|7433315|FG000|Overall Study|Withdrawal by Subject|0
4588688|NCT01502423|7433316|FG001|Overall Study|Withdrawal by Subject|1
4588689|NCT01502631|7433324|FG000|Overall Study|Adverse Event|5
4588690|NCT01502631|7433325|FG001|Overall Study|Adverse Event|8
4588691|NCT01502631|7433324|FG000|Overall Study|Lost to Follow-up|2
4588692|NCT01502631|7433325|FG001|Overall Study|Lost to Follow-up|2
4382432|NCT00003199|7160351|FG000|Overall Study|Screen fail|15
4382433|NCT00003222|7160357|FG000|Overall Study|Physician Decision|0
4382434|NCT00003222|7160358|FG001|Overall Study|Physician Decision|1
4468848|NCT00631917|7261421|FG000|Overall Study|Subject withdrew consent|25
4468849|NCT00631917|7261422|FG001|Overall Study|Subject withdrew consent|33
4468850|NCT00631917|7261421|FG000|Overall Study|Lost to Follow-up|7
4468851|NCT00631917|7261422|FG001|Overall Study|Lost to Follow-up|7
4468852|NCT00631917|7261421|FG000|Overall Study|Administrative problems|2
4588693|NCT01502631|7433324|FG000|Overall Study|Participant withdrew consent|2
4588694|NCT01502631|7433325|FG001|Overall Study|Participant withdrew consent|4
4468853|NCT00631917|7261422|FG001|Overall Study|Administrative problems|0
4468854|NCT00631917|7261421|FG000|Overall Study|Death|1
4382435|NCT04617860|7160394|FG000|Overall Study|Adverse Event|0
4382436|NCT04617860|7160395|FG001|Overall Study|Adverse Event|2
4382437|NCT04617860|7160396|FG002|Overall Study|Adverse Event|2
4382438|NCT04617860|7160394|FG000|Overall Study|Withdrawal by Subject|0
4382439|NCT04617860|7160395|FG001|Overall Study|Withdrawal by Subject|0
4382440|NCT04617860|7160396|FG002|Overall Study|Withdrawal by Subject|2
4382441|NCT04617860|7160394|FG000|Overall Study|Physician Decision|0
4382442|NCT04617860|7160395|FG001|Overall Study|Physician Decision|1
4382443|NCT04617860|7160396|FG002|Overall Study|Physician Decision|0
4382444|NCT04617860|7160394|FG000|Overall Study|Sponsor Decision|0
4382445|NCT04617860|7160395|FG001|Overall Study|Sponsor Decision|3
4382446|NCT04617860|7160396|FG002|Overall Study|Sponsor Decision|1
4382447|NCT04617860|7160394|FG000|Overall Study|Termination of Study by Sponsor|8
4382448|NCT04617860|7160395|FG001|Overall Study|Termination of Study by Sponsor|4
4382449|NCT04617860|7160396|FG002|Overall Study|Termination of Study by Sponsor|13
4382450|NCT04617847|7160408|FG000|Overall Study|Withdrawal by Subject|1
4382451|NCT04617847|7160409|FG001|Overall Study|Withdrawal by Subject|0
4382452|NCT04617847|7160408|FG000|Overall Study|Adverse Event|0
4382453|NCT04617847|7160409|FG001|Overall Study|Adverse Event|2
4382454|NCT04617847|7160408|FG000|Overall Study|Death|0
4382455|NCT04617847|7160409|FG001|Overall Study|Death|1
4382456|NCT04617847|7160408|FG000|Overall Study|Termination of Study by Sponsor|2
4382457|NCT04617847|7160409|FG001|Overall Study|Termination of Study by Sponsor|21
4382458|NCT04426318|7160419|FG000|Overall Study|failed attention checks and had their data removed from analyses|2
4382459|NCT04426318|7160420|FG001|Overall Study|failed attention checks and had their data removed from analyses|2
4382460|NCT04063657|7160432|FG000|Overall Study|Lost to Follow-up|1
4382461|NCT04063657|7160433|FG001|Overall Study|Lost to Follow-up|0
4382462|NCT03882047|7160446|FG000|Overall Study|Adverse Event|0
4382463|NCT03882047|7160447|FG001|Overall Study|Adverse Event|2
4382464|NCT03882047|7160448|FG002|Overall Study|Adverse Event|2
4382465|NCT03882047|7160446|FG000|Overall Study|Treatment Failure|3
4382466|NCT03882047|7160447|FG001|Overall Study|Treatment Failure|3
4382467|NCT03882047|7160448|FG002|Overall Study|Treatment Failure|12
4382468|NCT03882047|7160446|FG000|Overall Study|Lost to Follow-up|0
4382469|NCT03882047|7160447|FG001|Overall Study|Lost to Follow-up|1
4382470|NCT03882047|7160448|FG002|Overall Study|Lost to Follow-up|0
4382471|NCT03882047|7160446|FG000|Overall Study|Did Not Wish to Continue|1
4382472|NCT03882047|7160447|FG001|Overall Study|Did Not Wish to Continue|4
4382473|NCT03882047|7160448|FG002|Overall Study|Did Not Wish to Continue|1
4382474|NCT03882047|7160446|FG000|Overall Study|Noncompliance With Protocol|2
4382475|NCT03882047|7160447|FG001|Overall Study|Noncompliance With Protocol|0
4382476|NCT03882047|7160448|FG002|Overall Study|Noncompliance With Protocol|0
4382477|NCT03882047|7160446|FG000|Overall Study|Did Not Meet Eligibility|0
4382478|NCT03882047|7160447|FG001|Overall Study|Did Not Meet Eligibility|0
4382479|NCT03882047|7160448|FG002|Overall Study|Did Not Meet Eligibility|1
4382480|NCT03879772|7160461|FG000|Overall Study|Adverse Event|2
4382481|NCT03879772|7160462|FG001|Overall Study|Adverse Event|2
4382482|NCT03879772|7160463|FG002|Overall Study|Adverse Event|3
4382483|NCT03879772|7160464|FG003|Overall Study|Adverse Event|4
4382484|NCT03879772|7160465|FG004|Overall Study|Adverse Event|3
4382485|NCT03879772|7160461|FG000|Overall Study|Treatment Failure|1
4382486|NCT03879772|7160462|FG001|Overall Study|Treatment Failure|0
4382487|NCT03879772|7160463|FG002|Overall Study|Treatment Failure|0
4382488|NCT03879772|7160464|FG003|Overall Study|Treatment Failure|2
4382489|NCT03879772|7160465|FG004|Overall Study|Treatment Failure|1
4382490|NCT03879772|7160461|FG000|Overall Study|Lost to Follow-up|0
4382491|NCT03879772|7160462|FG001|Overall Study|Lost to Follow-up|0
4382492|NCT03879772|7160463|FG002|Overall Study|Lost to Follow-up|0
4382493|NCT03879772|7160464|FG003|Overall Study|Lost to Follow-up|0
4382494|NCT03879772|7160465|FG004|Overall Study|Lost to Follow-up|1
4382495|NCT03879772|7160461|FG000|Overall Study|Withdrawal by Subject|0
4382496|NCT03879772|7160462|FG001|Overall Study|Withdrawal by Subject|1
4382497|NCT03879772|7160463|FG002|Overall Study|Withdrawal by Subject|3
4382498|NCT03879772|7160464|FG003|Overall Study|Withdrawal by Subject|1
4382499|NCT03879772|7160465|FG004|Overall Study|Withdrawal by Subject|1
4382500|NCT03879772|7160461|FG000|Overall Study|Protocol Violation|0
4382501|NCT03879772|7160462|FG001|Overall Study|Protocol Violation|0
4382502|NCT03879772|7160463|FG002|Overall Study|Protocol Violation|3
4382503|NCT03879772|7160464|FG003|Overall Study|Protocol Violation|1
4382504|NCT03879772|7160465|FG004|Overall Study|Protocol Violation|2
4382505|NCT03879772|7160461|FG000|Overall Study|Did Not Meet Entry Requirements|1
4382506|NCT03879772|7160462|FG001|Overall Study|Did Not Meet Entry Requirements|0
4382507|NCT03879772|7160463|FG002|Overall Study|Did Not Meet Entry Requirements|1
4382508|NCT03879772|7160464|FG003|Overall Study|Did Not Meet Entry Requirements|0
4382509|NCT03879772|7160465|FG004|Overall Study|Did Not Meet Entry Requirements|0
4588695|NCT01502631|7433324|FG000|Overall Study|Participant non-compliant|1
4588696|NCT01502631|7433325|FG001|Overall Study|Participant non-compliant|0
4588697|NCT01502631|7433324|FG000|Overall Study|Investigator's decision|0
4468855|NCT00631917|7261422|FG001|Overall Study|Death|0
4382510|NCT03861559|7160479|FG000|Overall Study|Adverse Event|0
4382511|NCT03861559|7160480|FG001|Overall Study|Adverse Event|2
4382512|NCT03861559|7160479|FG000|Overall Study|Treatment failure|0
4382513|NCT03861559|7160480|FG001|Overall Study|Treatment failure|2
4382514|NCT03861559|7160479|FG000|Overall Study|Noncompliance|1
4382515|NCT03861559|7160480|FG001|Overall Study|Noncompliance|1
4382516|NCT03861559|7160479|FG000|Overall Study|Did not meet eligibility requirements|1
4382517|NCT03861559|7160480|FG001|Overall Study|Did not meet eligibility requirements|0
4382518|NCT03855228|7160490|FG000|Overall Study|Adverse Event|2
4382519|NCT03855228|7160491|FG001|Overall Study|Adverse Event|4
4382520|NCT03855228|7160492|FG002|Overall Study|Adverse Event|4
4382521|NCT03855228|7160493|FG003|Overall Study|Adverse Event|8
4382522|NCT03855228|7160490|FG000|Overall Study|Treatment Failure|1
4382523|NCT03855228|7160491|FG001|Overall Study|Treatment Failure|2
4382524|NCT03855228|7160492|FG002|Overall Study|Treatment Failure|1
4382525|NCT03855228|7160493|FG003|Overall Study|Treatment Failure|8
4382526|NCT03855228|7160490|FG000|Overall Study|Lost to Follow-up|0
4382527|NCT03855228|7160491|FG001|Overall Study|Lost to Follow-up|0
4382528|NCT03855228|7160492|FG002|Overall Study|Lost to Follow-up|0
4382529|NCT03855228|7160493|FG003|Overall Study|Lost to Follow-up|1
4382530|NCT03855228|7160490|FG000|Overall Study|Protocol Violation|0
4382531|NCT03855228|7160491|FG001|Overall Study|Protocol Violation|1
4382532|NCT03855228|7160492|FG002|Overall Study|Protocol Violation|2
4382533|NCT03855228|7160493|FG003|Overall Study|Protocol Violation|1
4382534|NCT03855228|7160490|FG000|Overall Study|Did Not Meet Entry Requirements|0
4382535|NCT03855228|7160491|FG001|Overall Study|Did Not Meet Entry Requirements|2
4382536|NCT03855228|7160492|FG002|Overall Study|Did Not Meet Entry Requirements|1
4382537|NCT03855228|7160493|FG003|Overall Study|Did Not Meet Entry Requirements|1
4382538|NCT03855189|7160506|FG000|Overall Study|Adverse Event|5
4382539|NCT03855189|7160507|FG001|Overall Study|Adverse Event|2
4382540|NCT03855189|7160508|FG002|Overall Study|Adverse Event|4
4382541|NCT03855189|7160506|FG000|Overall Study|Treatment Failure|1
4382542|NCT03855189|7160507|FG001|Overall Study|Treatment Failure|1
4382543|NCT03855189|7160508|FG002|Overall Study|Treatment Failure|2
4382544|NCT03855189|7160506|FG000|Overall Study|Noncompliance with Protocol|0
4382545|NCT03855189|7160507|FG001|Overall Study|Noncompliance with Protocol|1
4382546|NCT03855189|7160508|FG002|Overall Study|Noncompliance with Protocol|0
4382547|NCT03855189|7160506|FG000|Overall Study|Did Not Return|4
4382548|NCT03855189|7160507|FG001|Overall Study|Did Not Return|3
4382549|NCT03855189|7160508|FG002|Overall Study|Did Not Return|0
4468856|NCT00631969|7261430|FG000|Overall Study|Adverse Event|3
4468857|NCT00631969|7261431|FG001|Overall Study|Adverse Event|1
4468858|NCT00631969|7261430|FG000|Overall Study|Lack of Efficacy|2
4468859|NCT00631969|7261431|FG001|Overall Study|Lack of Efficacy|8
4468860|NCT00631969|7261430|FG000|Overall Study|Lost to Follow-up|2
4468861|NCT00631969|7261431|FG001|Overall Study|Lost to Follow-up|1
4468862|NCT00631969|7261430|FG000|Overall Study|Protocol Violation|1
4468863|NCT00631969|7261431|FG001|Overall Study|Protocol Violation|1
4468864|NCT00631969|7261430|FG000|Overall Study|Consent Withdrawn|5
4468865|NCT00631969|7261431|FG001|Overall Study|Consent Withdrawn|7
4468866|NCT00631969|7261430|FG000|Overall Study|Noncompliant With Study Medication|0
4468867|NCT00631969|7261431|FG001|Overall Study|Noncompliant With Study Medication|1
4468868|NCT00631969|7261430|FG000|Overall Study|No Drug Exposure|2
4468869|NCT00631969|7261431|FG001|Overall Study|No Drug Exposure|2
4468870|NCT00632021|7261441|FG000|Overall Study|Withdrawal/death|4
4468871|NCT00632021|7261442|FG001|Overall Study|Withdrawal/death|7
4468872|NCT00632099|7261451|FG000|Overall Study|Lost to Follow-up|3
4468873|NCT00632099|7261452|FG001|Overall Study|Lost to Follow-up|3
4468874|NCT00632125|7261458|FG000|Overall Study|Death|82
4468875|NCT00632125|7261458|FG000|Overall Study|Withdrawal by Subject|44
4468876|NCT00632125|7261458|FG000|Overall Study|Adverse Event|36
4468877|NCT00632125|7261458|FG000|Overall Study|Renal transplantation|17
4468878|NCT00632125|7261458|FG000|Overall Study|Need for systemic immunosuppressive medi|8
4468879|NCT00632125|7261458|FG000|Overall Study|Non-compliance|8
4468880|NCT00632125|7261458|FG000|Overall Study|Development of uncontrolled hypertension|5
4468881|NCT00632125|7261458|FG000|Overall Study|Moved to other dialysis unit, etc.|102
4468882|NCT00632203|7261464|FG000|Overall Study|Did not start study treatment|1
4468883|NCT00632203|7261465|FG001|Overall Study|Did not start study treatment|0
4468884|NCT00632229|7261473|FG000|Overall Study|Adverse Event|6
4468885|NCT00632229|7261474|FG001|Overall Study|Adverse Event|0
4468886|NCT00632229|7261473|FG000|Overall Study|Lost to Follow-up|0
4468887|NCT00632229|7261474|FG001|Overall Study|Lost to Follow-up|3
4468888|NCT00632229|7261473|FG000|Overall Study|Lack of Efficacy|0
4588698|NCT01502631|7433325|FG001|Overall Study|Investigator's decision|1
4588699|NCT01502631|7433324|FG000|Overall Study|Other|10
4588700|NCT01502631|7433325|FG001|Overall Study|Other|5
4588701|NCT01502644|7433334|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1
4588702|NCT01502644|7433335|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
4588703|NCT01502644|7433336|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
4588704|NCT01502644|7433337|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
4593792|NCT01555125|7442335|FG004|Extension|Subject/guardian decision|0
4468889|NCT00632229|7261474|FG001|Overall Study|Lack of Efficacy|2
4468890|NCT00632229|7261473|FG000|Overall Study|Undisclosed reasons within the first wee|0
4468891|NCT00632229|7261474|FG001|Overall Study|Undisclosed reasons within the first wee|1
4468892|NCT00632359|7261484|FG000|Overall Study|Withdrawal by Subject|2
4468893|NCT00632424|7261501|FG000|Overall Study|Disease Progression|17
4468894|NCT00632424|7261501|FG000|Overall Study|Study Drug Toxicity|1
4468895|NCT00632463|7261518|FG000|Overall Study|Adverse Event|0
4697222|NCT02646891|7610482|FG008|Overall Study|Protocol Violation|0
4697223|NCT02646891|7610483|FG009|Overall Study|Protocol Violation|0
4697224|NCT02646891|7610474|FG000|Overall Study|Withdrawal by Subject|2
4697225|NCT02646891|7610475|FG001|Overall Study|Withdrawal by Subject|0
4697226|NCT02646891|7610476|FG002|Overall Study|Withdrawal by Subject|1
4697227|NCT02646891|7610477|FG003|Overall Study|Withdrawal by Subject|0
4697228|NCT02646891|7610478|FG004|Overall Study|Withdrawal by Subject|0
4697229|NCT02646891|7610479|FG005|Overall Study|Withdrawal by Subject|0
4697230|NCT02646891|7610480|FG006|Overall Study|Withdrawal by Subject|5
4697231|NCT02646891|7610481|FG007|Overall Study|Withdrawal by Subject|9
4697232|NCT02646891|7610482|FG008|Overall Study|Withdrawal by Subject|7
4697233|NCT02646891|7610483|FG009|Overall Study|Withdrawal by Subject|3
4382550|NCT03764631|7160518|FG000|Overall Study|Personal Reasons|3
4382551|NCT03764631|7160519|FG001|Overall Study|Personal Reasons|2
4382552|NCT03764631|7160518|FG000|Overall Study|Switching Therapy|3
4382553|NCT03764631|7160519|FG001|Overall Study|Switching Therapy|3
4382554|NCT03764631|7160518|FG000|Overall Study|Adverse Event|0
4382555|NCT03764631|7160519|FG001|Overall Study|Adverse Event|1
4382556|NCT03764631|7160518|FG000|Overall Study|Lost to Follow-up|33
4382557|NCT03764631|7160519|FG001|Overall Study|Lost to Follow-up|41
4468896|NCT00632463|7261519|FG001|Overall Study|Adverse Event|1
4468897|NCT00632463|7261520|FG002|Overall Study|Adverse Event|0
4468898|NCT00632502|7261543|FG000|Overall Study|Adverse Event|0
4468899|NCT00632502|7261544|FG001|Overall Study|Adverse Event|1
4468900|NCT00632502|7261543|FG000|Overall Study|Randomized not treated|3
4468901|NCT00632502|7261544|FG001|Overall Study|Randomized not treated|0
4468902|NCT00632541|7261551|FG000|Overall Study|Adverse Event|7
4468903|NCT00632736|7261573|FG000|Overall Study|Adverse Event|104
4468904|NCT00632736|7261573|FG000|Overall Study|Lost to Follow-up|15
4468905|NCT00632736|7261573|FG000|Overall Study|Protocol Violation|14
4468906|NCT00632736|7261573|FG000|Overall Study|Withdrawal by Subject|99
4468907|NCT00632736|7261573|FG000|Overall Study|Lack of Efficacy|5
4468908|NCT00632736|7261573|FG000|Overall Study|Sponsor terminated study|5
4468909|NCT00632736|7261573|FG000|Overall Study|Non-compliance|10
4468910|NCT00632736|7261573|FG000|Overall Study|Other|16
4468911|NCT00632749|7261591|FG000|Overall Study|Progressive disease|3
4468912|NCT00632749|7261592|FG001|Overall Study|Progressive disease|2
4468913|NCT00632749|7261593|FG002|Overall Study|Progressive disease|2
4468914|NCT00632749|7261594|FG003|Overall Study|Progressive disease|2
4468915|NCT00632749|7261595|FG004|Overall Study|Progressive disease|4
4468916|NCT00632749|7261596|FG005|Overall Study|Progressive disease|4
4468917|NCT00632749|7261597|FG006|Overall Study|Progressive disease|3
4468918|NCT00632749|7261598|FG007|Overall Study|Progressive disease|2
4468919|NCT00632749|7261599|FG008|Overall Study|Progressive disease|3
4468920|NCT00632749|7261600|FG009|Overall Study|Progressive disease|2
4468921|NCT00632749|7261601|FG010|Overall Study|Progressive disease|4
4468922|NCT00632749|7261602|FG011|Overall Study|Progressive disease|3
4468923|NCT00632749|7261603|FG012|Overall Study|Progressive disease|2
4468924|NCT00632749|7261604|FG013|Overall Study|Progressive disease|4
4468925|NCT00632749|7261591|FG000|Overall Study|Other Adverse event|1
4468926|NCT00632749|7261592|FG001|Overall Study|Other Adverse event|1
4468927|NCT00632749|7261593|FG002|Overall Study|Other Adverse event|1
4468928|NCT00632749|7261594|FG003|Overall Study|Other Adverse event|1
4468929|NCT00632749|7261595|FG004|Overall Study|Other Adverse event|2
4468930|NCT00632749|7261596|FG005|Overall Study|Other Adverse event|4
4468931|NCT00632749|7261597|FG006|Overall Study|Other Adverse event|1
4468932|NCT00632749|7261598|FG007|Overall Study|Other Adverse event|2
4468933|NCT00632749|7261599|FG008|Overall Study|Other Adverse event|2
4468934|NCT00632749|7261600|FG009|Overall Study|Other Adverse event|0
4468935|NCT00632749|7261601|FG010|Overall Study|Other Adverse event|1
4468936|NCT00632749|7261602|FG011|Overall Study|Other Adverse event|0
4468937|NCT00632749|7261603|FG012|Overall Study|Other Adverse event|1
4468938|NCT00632749|7261604|FG013|Overall Study|Other Adverse event|0
4468939|NCT00632749|7261591|FG000|Overall Study|Refuse to continue medication|0
4468940|NCT00632749|7261592|FG001|Overall Study|Refuse to continue medication|0
4468941|NCT00632749|7261593|FG002|Overall Study|Refuse to continue medication|0
4468942|NCT00632749|7261594|FG003|Overall Study|Refuse to continue medication|1
4468943|NCT00632749|7261595|FG004|Overall Study|Refuse to continue medication|0
4468944|NCT00632749|7261596|FG005|Overall Study|Refuse to continue medication|0
4468945|NCT00632749|7261597|FG006|Overall Study|Refuse to continue medication|0
4468946|NCT00632749|7261598|FG007|Overall Study|Refuse to continue medication|0
4468947|NCT00632749|7261599|FG008|Overall Study|Refuse to continue medication|0
4468948|NCT00632749|7261600|FG009|Overall Study|Refuse to continue medication|1
4468949|NCT00632749|7261601|FG010|Overall Study|Refuse to continue medication|0
4468950|NCT00632749|7261602|FG011|Overall Study|Refuse to continue medication|0
4468951|NCT00632749|7261603|FG012|Overall Study|Refuse to continue medication|0
4697234|NCT02646891|7610474|FG000|Overall Study|Death|0
4697235|NCT02646891|7610475|FG001|Overall Study|Death|0
4697236|NCT02646891|7610476|FG002|Overall Study|Death|0
4468952|NCT00632749|7261604|FG013|Overall Study|Refuse to continue medication|0
4468953|NCT00632749|7261591|FG000|Overall Study|Reason other than those specified above|0
4468954|NCT00632749|7261592|FG001|Overall Study|Reason other than those specified above|2
4468955|NCT00632749|7261593|FG002|Overall Study|Reason other than those specified above|0
4697237|NCT02646891|7610477|FG003|Overall Study|Death|0
4382558|NCT03764631|7160518|FG000|Overall Study|No data as study site was closed|2
4382559|NCT03764631|7160519|FG001|Overall Study|No data as study site was closed|6
4382560|NCT03764072|7160531|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0
4382561|NCT03764072|7160532|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0
4382562|NCT03764072|7160533|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1
4382563|NCT03764072|7160534|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0
4382564|NCT03764072|7160535|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0
4382565|NCT03764072|7160536|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0
4382566|NCT03764072|7160531|FG000|Overall Study|Withdrawal of consent (for other reason)|0
4382567|NCT03764072|7160532|FG001|Overall Study|Withdrawal of consent (for other reason)|0
4382568|NCT03764072|7160533|FG002|Overall Study|Withdrawal of consent (for other reason)|0
4588705|NCT01502644|7433334|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2
4382569|NCT03764072|7160534|FG003|Overall Study|Withdrawal of consent (for other reason)|0
4382570|NCT03764072|7160535|FG004|Overall Study|Withdrawal of consent (for other reason)|0
4382571|NCT03764072|7160536|FG005|Overall Study|Withdrawal of consent (for other reason)|1
4382572|NCT03764072|7160531|FG000|Overall Study|Lost to Follow-up|0
4382573|NCT03764072|7160532|FG001|Overall Study|Lost to Follow-up|0
4382574|NCT03764072|7160533|FG002|Overall Study|Lost to Follow-up|0
4382575|NCT03764072|7160534|FG003|Overall Study|Lost to Follow-up|0
4382576|NCT03764072|7160535|FG004|Overall Study|Lost to Follow-up|1
4382577|NCT03764072|7160536|FG005|Overall Study|Lost to Follow-up|0
4382578|NCT03578809|7160568|FG000|Overall Study|Death|0
4382579|NCT03578809|7160569|FG001|Overall Study|Death|2
4382580|NCT03578809|7160570|FG002|Overall Study|Death|0
4382581|NCT03578809|7160571|FG003|Overall Study|Death|1
4382582|NCT03578809|7160568|FG000|Overall Study|Lost to Follow-up|0
4382583|NCT03578809|7160569|FG001|Overall Study|Lost to Follow-up|1
4382584|NCT03578809|7160570|FG002|Overall Study|Lost to Follow-up|0
4382585|NCT03578809|7160571|FG003|Overall Study|Lost to Follow-up|0
4382586|NCT03578809|7160568|FG000|Overall Study|Withdrawal by Subject|3
4382587|NCT03578809|7160569|FG001|Overall Study|Withdrawal by Subject|5
4382588|NCT03578809|7160570|FG002|Overall Study|Withdrawal by Subject|2
4382589|NCT03578809|7160571|FG003|Overall Study|Withdrawal by Subject|0
4382590|NCT03578809|7160568|FG000|Overall Study|Other|3
4382591|NCT03578809|7160569|FG001|Overall Study|Other|6
4382592|NCT03578809|7160570|FG002|Overall Study|Other|2
4382593|NCT03578809|7160571|FG003|Overall Study|Other|8
4382594|NCT03571204|7160587|FG000|Overall Study|Stopped due to COVID-19 pandemic|1
4382595|NCT03571204|7160588|FG001|Overall Study|Stopped due to COVID-19 pandemic|1
4382596|NCT03571204|7160589|FG002|Overall Study|Stopped due to COVID-19 pandemic|0
4382597|NCT03571204|7160587|FG000|Overall Study|Physician Decision|0
4382598|NCT03571204|7160588|FG001|Overall Study|Physician Decision|1
4382599|NCT03571204|7160589|FG002|Overall Study|Physician Decision|0
4382600|NCT03523091|7160600|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1
4382601|NCT03523091|7160601|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0
4382602|NCT03523091|7160600|FG000|Overall Study|Withdrawal by Subject|0
4382603|NCT03523091|7160601|FG001|Overall Study|Withdrawal by Subject|3
4382604|NCT03523091|7160600|FG000|Overall Study|Increase Botox dose|0
4382605|NCT03523091|7160601|FG001|Overall Study|Increase Botox dose|1
4382606|NCT03391960|7160629|FG000|Overall Study|Protocol Violation|0
4382607|NCT03391960|7160630|FG001|Overall Study|Protocol Violation|
4382608|NCT03362190|7160649|FG000|Overall Study|Adverse Event|0
4382609|NCT03362190|7160650|FG001|Overall Study|Adverse Event|0
4382610|NCT03362190|7160651|FG002|Overall Study|Adverse Event|0
4382611|NCT03362190|7160652|FG003|Overall Study|Adverse Event|1
4382612|NCT03362190|7160649|FG000|Overall Study|Withdrawal by Subject|0
4382613|NCT03362190|7160650|FG001|Overall Study|Withdrawal by Subject|0
4382614|NCT03362190|7160651|FG002|Overall Study|Withdrawal by Subject|0
4382615|NCT03362190|7160652|FG003|Overall Study|Withdrawal by Subject|1
4382616|NCT03338790|7160669|FG000|Overall Study|Disease Progression|65
4382617|NCT03338790|7160670|FG001|Overall Study|Disease Progression|43
4382618|NCT03338790|7160671|FG002|Overall Study|Disease Progression|50
4382619|NCT03338790|7160672|FG003|Overall Study|Disease Progression|37
4382620|NCT03338790|7160669|FG000|Overall Study|Study Drug Toxicity|9
4382621|NCT03338790|7160670|FG001|Overall Study|Study Drug Toxicity|8
4382622|NCT03338790|7160671|FG002|Overall Study|Study Drug Toxicity|15
4382623|NCT03338790|7160672|FG003|Overall Study|Study Drug Toxicity|0
4382624|NCT03338790|7160669|FG000|Overall Study|Death|1
4382625|NCT03338790|7160670|FG001|Overall Study|Death|1
4382626|NCT03338790|7160671|FG002|Overall Study|Death|1
4382627|NCT03338790|7160672|FG003|Overall Study|Death|0
4382628|NCT03338790|7160669|FG000|Overall Study|Adverse Event unrelated to Study Drug|4
4382629|NCT03338790|7160670|FG001|Overall Study|Adverse Event unrelated to Study Drug|4
4382630|NCT03338790|7160671|FG002|Overall Study|Adverse Event unrelated to Study Drug|6
4382631|NCT03338790|7160672|FG003|Overall Study|Adverse Event unrelated to Study Drug|4
4382632|NCT03338790|7160669|FG000|Overall Study|Participant request to discontinue study treatment|3
4382633|NCT03338790|7160670|FG001|Overall Study|Participant request to discontinue study treatment|3
4382634|NCT03338790|7160671|FG002|Overall Study|Participant request to discontinue study treatment|2
4382635|NCT03338790|7160672|FG003|Overall Study|Participant request to discontinue study treatment|1
4382636|NCT03338790|7160669|FG000|Overall Study|Poor/non-compliance|0
4382637|NCT03338790|7160670|FG001|Overall Study|Poor/non-compliance|1
4382638|NCT03338790|7160671|FG002|Overall Study|Poor/non-compliance|0
4382639|NCT03338790|7160672|FG003|Overall Study|Poor/non-compliance|0
4382640|NCT03338790|7160669|FG000|Overall Study|Participant withdrew consent|1
4382641|NCT03338790|7160670|FG001|Overall Study|Participant withdrew consent|0
4382642|NCT03338790|7160671|FG002|Overall Study|Participant withdrew consent|1
4382643|NCT03338790|7160672|FG003|Overall Study|Participant withdrew consent|1
4382644|NCT03338790|7160669|FG000|Overall Study|Other reasons|0
4382645|NCT03338790|7160670|FG001|Overall Study|Other reasons|5
4382646|NCT03338790|7160671|FG002|Overall Study|Other reasons|0
4382647|NCT03338790|7160672|FG003|Overall Study|Other reasons|2
4382648|NCT03338790|7160669|FG000|Overall Study|Not reported|0
4382649|NCT03338790|7160670|FG001|Overall Study|Not reported|0
4382650|NCT03338790|7160671|FG002|Overall Study|Not reported|1
4382651|NCT03338790|7160672|FG003|Overall Study|Not reported|0
4382652|NCT03338790|7160669|FG000|Overall Study|Completed treatment period|1
4382653|NCT03338790|7160670|FG001|Overall Study|Completed treatment period|2
4382654|NCT03338790|7160671|FG002|Overall Study|Completed treatment period|0
4382655|NCT03338790|7160672|FG003|Overall Study|Completed treatment period|0
4468956|NCT00632749|7261594|FG003|Overall Study|Reason other than those specified above|0
4468957|NCT00632749|7261595|FG004|Overall Study|Reason other than those specified above|1
4468958|NCT00632749|7261596|FG005|Overall Study|Reason other than those specified above|0
4468959|NCT00632749|7261597|FG006|Overall Study|Reason other than those specified above|1
4468960|NCT00632749|7261598|FG007|Overall Study|Reason other than those specified above|0
4468961|NCT00632749|7261599|FG008|Overall Study|Reason other than those specified above|0
4468962|NCT00632749|7261600|FG009|Overall Study|Reason other than those specified above|0
4468963|NCT00632749|7261601|FG010|Overall Study|Reason other than those specified above|2
4468964|NCT00632749|7261602|FG011|Overall Study|Reason other than those specified above|1
4468965|NCT00632749|7261603|FG012|Overall Study|Reason other than those specified above|0
4468966|NCT00632749|7261604|FG013|Overall Study|Reason other than those specified above|2
4468967|NCT00632827|7261653|FG000|Overall Study|Excluded after GVD (Not evaluable)|2
4468968|NCT00632827|7261653|FG000|Overall Study|Death|2
4468969|NCT00632827|7261653|FG000|Overall Study|Adverse Event|5
4468970|NCT00632827|7261653|FG000|Overall Study|Lost to Follow-up|1
4468971|NCT00632931|7261658|FG000|Part 1, Period 1|Protocol Violation|1
4468972|NCT00632931|7261659|FG001|Part 1, Period 1|Protocol Violation|0
4468973|NCT00632931|7261660|FG002|Part 1, Period 1|Protocol Violation|0
4468974|NCT00632931|7261658|FG000|Part 1, Period 1|Withdrawal by Subject|1
4468975|NCT00632931|7261659|FG001|Part 1, Period 1|Withdrawal by Subject|0
4468976|NCT00632931|7261660|FG002|Part 1, Period 1|Withdrawal by Subject|0
4468977|NCT00632931|7261658|FG000|Part 2|Adverse Event|0
4468978|NCT00632931|7261659|FG001|Part 2|Adverse Event|0
4468979|NCT00632931|7261660|FG002|Part 2|Adverse Event|3
4468980|NCT00632931|7261658|FG000|Part 2|Death|0
4468981|NCT00632931|7261659|FG001|Part 2|Death|0
4468982|NCT00632931|7261660|FG002|Part 2|Death|1
4468983|NCT00632931|7261658|FG000|Part 2|Lack of Efficacy|0
4468984|NCT00632931|7261659|FG001|Part 2|Lack of Efficacy|0
4468985|NCT00632931|7261660|FG002|Part 2|Lack of Efficacy|17
4468986|NCT00632931|7261658|FG000|Part 2|Withdrawal by Subject|0
4468987|NCT00632931|7261659|FG001|Part 2|Withdrawal by Subject|0
4468988|NCT00632931|7261660|FG002|Part 2|Withdrawal by Subject|3
4468989|NCT00633022|7261693|FG000|Overall Study|Adverse Event|1
4468990|NCT00633022|7261694|FG001|Overall Study|Adverse Event|0
4468991|NCT00633022|7261695|FG002|Overall Study|Adverse Event|5
4468992|NCT00633022|7261693|FG000|Overall Study|Physician Decision|0
4468993|NCT00633022|7261694|FG001|Overall Study|Physician Decision|1
4468994|NCT00633022|7261695|FG002|Overall Study|Physician Decision|0
4468995|NCT00633074|7261705|FG000|Overall Study|Adverse Event|1
4468996|NCT00633074|7261706|FG001|Overall Study|Adverse Event|0
4468997|NCT00633126|7261712|FG000|Overall Study|Did not receive full dose|1
4468998|NCT00633139|7261719|FG000|Overall Study|Non compliance|0
4468999|NCT00633139|7261720|FG001|Overall Study|Non compliance|0
4469000|NCT00633139|7261721|FG002|Overall Study|Non compliance|1
4469001|NCT00633139|7261719|FG000|Overall Study|Withdrawal by Subject|0
4469002|NCT00633139|7261720|FG001|Overall Study|Withdrawal by Subject|1
4469003|NCT00633139|7261721|FG002|Overall Study|Withdrawal by Subject|0
4469004|NCT00633152|7261731|FG000|Overall Study|Adverse Event|1
4469005|NCT00633152|7261732|FG001|Overall Study|Adverse Event|0
4469006|NCT00633152|7261731|FG000|Overall Study|Randomized, did not receive study drug|5
4469007|NCT00633152|7261732|FG001|Overall Study|Randomized, did not receive study drug|2
4469008|NCT00633152|7261731|FG000|Overall Study|Withdrawal by Subject|1
4469009|NCT00633152|7261732|FG001|Overall Study|Withdrawal by Subject|1
4469010|NCT00633152|7261731|FG000|Overall Study|Lost to Follow-up|4
4469011|NCT00633152|7261732|FG001|Overall Study|Lost to Follow-up|1
4469012|NCT00633152|7261731|FG000|Overall Study|Miscellaneous Other|3
4469013|NCT00633152|7261732|FG001|Overall Study|Miscellaneous Other|2
4469014|NCT00633217|7261742|FG000|Overall Study|Adverse Event|5
4469015|NCT00633217|7261743|FG001|Overall Study|Adverse Event|9
4469016|NCT00633217|7261742|FG000|Overall Study|Lack of Efficacy|0
4469017|NCT00633217|7261743|FG001|Overall Study|Lack of Efficacy|2
4469018|NCT00633217|7261742|FG000|Overall Study|Protocol Violation|3
4469019|NCT00633217|7261743|FG001|Overall Study|Protocol Violation|7
4382656|NCT03252522|7160684|FG000|Overall Study|Adverse Event|3
4382657|NCT03252522|7160685|FG001|Overall Study|Adverse Event|1
4382658|NCT03252522|7160686|FG002|Overall Study|Adverse Event|0
4382659|NCT03252522|7160684|FG000|Overall Study|Unable to swallow pills|4
4382660|NCT03252522|7160685|FG001|Overall Study|Unable to swallow pills|1
4382661|NCT03252522|7160686|FG002|Overall Study|Unable to swallow pills|0
4382662|NCT03252522|7160684|FG000|Overall Study|Commenced stimulant medication|1
4382663|NCT03252522|7160685|FG001|Overall Study|Commenced stimulant medication|1
4382664|NCT03252522|7160686|FG002|Overall Study|Commenced stimulant medication|0
4382665|NCT03252522|7160684|FG000|Overall Study|Protocol Violation|1
4382666|NCT03252522|7160685|FG001|Overall Study|Protocol Violation|0
4382667|NCT03252522|7160686|FG002|Overall Study|Protocol Violation|0
4382668|NCT03235544|7160701|FG000|Overall Study|Participants Still Ongoing in the Study|1
4382669|NCT03235544|7160702|FG001|Overall Study|Participants Still Ongoing in the Study|13
4382670|NCT03235544|7160703|FG002|Overall Study|Participants Still Ongoing in the Study|19
4382671|NCT03235544|7160704|FG003|Overall Study|Participants Still Ongoing in the Study|55
4382672|NCT03235544|7160701|FG000|Overall Study|Death|11
4382673|NCT03235544|7160702|FG001|Overall Study|Death|23
4382674|NCT03235544|7160703|FG002|Overall Study|Death|11
4382675|NCT03235544|7160704|FG003|Overall Study|Death|20
4382676|NCT03235544|7160701|FG000|Overall Study|Lost to Follow-up|0
4382677|NCT03235544|7160702|FG001|Overall Study|Lost to Follow-up|1
4382678|NCT03235544|7160703|FG002|Overall Study|Lost to Follow-up|0
4382679|NCT03235544|7160704|FG003|Overall Study|Lost to Follow-up|1
4382680|NCT03235544|7160701|FG000|Overall Study|Withdrawal by Participant|0
4382681|NCT03235544|7160702|FG001|Overall Study|Withdrawal by Participant|0
4382682|NCT03235544|7160703|FG002|Overall Study|Withdrawal by Participant|1
4382683|NCT03235544|7160704|FG003|Overall Study|Withdrawal by Participant|0
4382684|NCT03235544|7160701|FG000|Overall Study|Reason not Specified|0
4382685|NCT03235544|7160702|FG001|Overall Study|Reason not Specified|4
4382686|NCT03235544|7160703|FG002|Overall Study|Reason not Specified|0
4382687|NCT03235544|7160704|FG003|Overall Study|Reason not Specified|1
4382688|NCT03225833|7160721|FG000|Overall Study|Adverse Event|0
4382689|NCT03225833|7160722|FG001|Overall Study|Adverse Event|1
4382690|NCT03225833|7160723|FG002|Overall Study|Adverse Event|2
4382691|NCT03225833|7160724|FG003|Overall Study|Adverse Event|0
4382692|NCT03225833|7160725|FG004|Overall Study|Adverse Event|0
4382693|NCT03225833|7160726|FG005|Overall Study|Adverse Event|2
4382694|NCT03225833|7160721|FG000|Overall Study|Withdrawal by Subject|1
4382695|NCT03225833|7160722|FG001|Overall Study|Withdrawal by Subject|0
4382696|NCT03225833|7160723|FG002|Overall Study|Withdrawal by Subject|0
4382697|NCT03225833|7160724|FG003|Overall Study|Withdrawal by Subject|0
4382698|NCT03225833|7160725|FG004|Overall Study|Withdrawal by Subject|1
4382699|NCT03225833|7160726|FG005|Overall Study|Withdrawal by Subject|0
4382700|NCT03225833|7160721|FG000|Overall Study|Termination of Study by Sponsor|4
4382701|NCT03225833|7160722|FG001|Overall Study|Termination of Study by Sponsor|0
4382702|NCT03225833|7160723|FG002|Overall Study|Termination of Study by Sponsor|0
4382703|NCT03225833|7160724|FG003|Overall Study|Termination of Study by Sponsor|0
4382704|NCT03225833|7160725|FG004|Overall Study|Termination of Study by Sponsor|0
4382705|NCT03225833|7160726|FG005|Overall Study|Termination of Study by Sponsor|7
4382706|NCT03225833|7160721|FG000|Overall Study|Sponsor Decision|0
4469020|NCT00633217|7261742|FG000|Overall Study|Lost to Follow-up|2
4469021|NCT00633217|7261743|FG001|Overall Study|Lost to Follow-up|2
4469022|NCT00633217|7261742|FG000|Overall Study|Investigator Discretion|2
4469023|NCT00633217|7261743|FG001|Overall Study|Investigator Discretion|0
4469024|NCT00633217|7261742|FG000|Overall Study|Withdrew Consent|3
4469025|NCT00633217|7261743|FG001|Overall Study|Withdrew Consent|3
4469026|NCT00633243|7261751|FG000|Overall Study|Withdrawal by Subject|0
4469027|NCT00633243|7261752|FG001|Overall Study|Withdrawal by Subject|1
4469028|NCT00633243|7261751|FG000|Overall Study|incarceration|0
4469029|NCT00633243|7261752|FG001|Overall Study|incarceration|2
4469030|NCT00633243|7261751|FG000|Overall Study|Homeless--no refrigeration for meds|0
4469031|NCT00633243|7261752|FG001|Overall Study|Homeless--no refrigeration for meds|1
4469032|NCT00633243|7261751|FG000|Overall Study|Not comfortable with self-injecting|0
4593793|NCT01555125|7442331|FG000|Extension|Technical Problems|1
4469033|NCT00633243|7261752|FG001|Overall Study|Not comfortable with self-injecting|1
4469034|NCT00633243|7261751|FG000|Overall Study|Mental Health--Depression|0
4469035|NCT00633243|7261752|FG001|Overall Study|Mental Health--Depression|1
4469036|NCT00633243|7261751|FG000|Overall Study|Couldn't tolerate side-effects|1
4469037|NCT00633243|7261752|FG001|Overall Study|Couldn't tolerate side-effects|1
4469038|NCT00633360|7261769|FG000|Overall Study|Lost to Follow-up|1
4469039|NCT00633360|7261770|FG001|Overall Study|Lost to Follow-up|1
4469040|NCT00633360|7261769|FG000|Overall Study|Adverse Event|3
4469041|NCT00633360|7261770|FG001|Overall Study|Adverse Event|1
4469042|NCT00633360|7261769|FG000|Overall Study|Protocol Violation|0
4469043|NCT00633360|7261770|FG001|Overall Study|Protocol Violation|1
4469044|NCT00633464|7261789|FG000|Overall Study|Never Treated (Not met study criteria)|0
4469045|NCT00633464|7261790|FG001|Overall Study|Never Treated (Not met study criteria)|1
4469046|NCT00633464|7261789|FG000|Overall Study|Never Treated (Randomized in error)|0
4469047|NCT00633464|7261790|FG001|Overall Study|Never Treated (Randomized in error)|1
4469048|NCT00633477|7261798|FG000|Overall Study|Death|1
4382707|NCT03225833|7160722|FG001|Overall Study|Sponsor Decision|0
4382708|NCT03225833|7160723|FG002|Overall Study|Sponsor Decision|0
4382709|NCT03225833|7160724|FG003|Overall Study|Sponsor Decision|0
4382710|NCT03225833|7160725|FG004|Overall Study|Sponsor Decision|0
4382711|NCT03225833|7160726|FG005|Overall Study|Sponsor Decision|1
4382712|NCT03167242|7160757|FG000|Overall Study|Patient/Guardian Decision|0
4382713|NCT03167242|7160758|FG001|Overall Study|Patient/Guardian Decision|1
4382714|NCT03167242|7160759|FG002|Overall Study|Patient/Guardian Decision|2
4382715|NCT03167242|7160760|FG003|Overall Study|Patient/Guardian Decision|1
4382716|NCT03167242|7160761|FG004|Overall Study|Patient/Guardian Decision|1
4382717|NCT03167242|7160762|FG005|Overall Study|Patient/Guardian Decision|1
4382718|NCT03167242|7160763|FG006|Overall Study|Patient/Guardian Decision|0
4382719|NCT03167242|7160764|FG007|Overall Study|Patient/Guardian Decision|0
4382720|NCT03167242|7160765|FG008|Overall Study|Patient/Guardian Decision|0
4382721|NCT03167242|7160766|FG009|Overall Study|Patient/Guardian Decision|0
4382722|NCT03167242|7160767|FG010|Overall Study|Patient/Guardian Decision|1
4382723|NCT03167242|7160768|FG011|Overall Study|Patient/Guardian Decision|0
4382724|NCT03167242|7160757|FG000|Overall Study|Lost to Follow-up|0
4382725|NCT03167242|7160758|FG001|Overall Study|Lost to Follow-up|0
4382726|NCT03167242|7160759|FG002|Overall Study|Lost to Follow-up|1
4382727|NCT03167242|7160760|FG003|Overall Study|Lost to Follow-up|0
4382728|NCT03167242|7160761|FG004|Overall Study|Lost to Follow-up|0
4382729|NCT03167242|7160762|FG005|Overall Study|Lost to Follow-up|1
4382730|NCT03167242|7160763|FG006|Overall Study|Lost to Follow-up|2
4382731|NCT03167242|7160764|FG007|Overall Study|Lost to Follow-up|1
4382732|NCT03167242|7160765|FG008|Overall Study|Lost to Follow-up|0
4382733|NCT03167242|7160766|FG009|Overall Study|Lost to Follow-up|0
4382734|NCT03167242|7160767|FG010|Overall Study|Lost to Follow-up|1
4382735|NCT03167242|7160768|FG011|Overall Study|Lost to Follow-up|1
4382736|NCT03167242|7160757|FG000|Overall Study|Reason not provided|0
4382737|NCT03167242|7160758|FG001|Overall Study|Reason not provided|0
4382738|NCT03167242|7160759|FG002|Overall Study|Reason not provided|0
4382739|NCT03167242|7160760|FG003|Overall Study|Reason not provided|0
4382740|NCT03167242|7160761|FG004|Overall Study|Reason not provided|0
4382741|NCT03167242|7160762|FG005|Overall Study|Reason not provided|0
4382742|NCT03167242|7160763|FG006|Overall Study|Reason not provided|0
4382743|NCT03167242|7160764|FG007|Overall Study|Reason not provided|0
4382744|NCT03167242|7160765|FG008|Overall Study|Reason not provided|1
4382745|NCT03167242|7160766|FG009|Overall Study|Reason not provided|0
4382746|NCT03167242|7160767|FG010|Overall Study|Reason not provided|0
4382747|NCT03167242|7160768|FG011|Overall Study|Reason not provided|0
4382748|NCT03144674|7160808|FG000|Overall Study|Participants Still Ongoing in the Study|1
4382749|NCT03144674|7160809|FG001|Overall Study|Participants Still Ongoing in the Study|4
4382750|NCT03144674|7160810|FG002|Overall Study|Participants Still Ongoing in the Study|24
4382751|NCT03144674|7160811|FG003|Overall Study|Participants Still Ongoing in the Study|54
4382752|NCT03144674|7160808|FG000|Overall Study|Death|3
4382753|NCT03144674|7160809|FG001|Overall Study|Death|1
4382754|NCT03144674|7160810|FG002|Overall Study|Death|1
4382755|NCT03144674|7160811|FG003|Overall Study|Death|10
4382756|NCT03144674|7160808|FG000|Overall Study|Lost to Follow-up|0
4382757|NCT03144674|7160809|FG001|Overall Study|Lost to Follow-up|1
4382758|NCT03144674|7160810|FG002|Overall Study|Lost to Follow-up|1
4382759|NCT03144674|7160811|FG003|Overall Study|Lost to Follow-up|1
4382760|NCT03144674|7160808|FG000|Overall Study|Withdrawal by Participant|0
4382761|NCT03144674|7160809|FG001|Overall Study|Withdrawal by Participant|0
4382762|NCT03144674|7160810|FG002|Overall Study|Withdrawal by Participant|0
4382763|NCT03144674|7160811|FG003|Overall Study|Withdrawal by Participant|3
4382764|NCT03144674|7160808|FG000|Overall Study|Reason not Specified|0
4382765|NCT03144674|7160809|FG001|Overall Study|Reason not Specified|0
4382766|NCT03144674|7160810|FG002|Overall Study|Reason not Specified|2
4382767|NCT03144674|7160811|FG003|Overall Study|Reason not Specified|4
4382768|NCT03137537|7160828|FG000|Overall Study|Adverse Event|0
4382769|NCT03137537|7160829|FG001|Overall Study|Adverse Event|1
4382770|NCT03126019|7160837|FG000|Overall Study|Participants Still Ongoing in the Study|17
4382771|NCT03126019|7160838|FG001|Overall Study|Participants Still Ongoing in the Study|87
4382772|NCT03126019|7160837|FG000|Overall Study|Death|2
4382773|NCT03126019|7160838|FG001|Overall Study|Death|7
4382774|NCT03126019|7160837|FG000|Overall Study|Lost to Follow-up|2
4382775|NCT03126019|7160838|FG001|Overall Study|Lost to Follow-up|3
4382776|NCT03126019|7160837|FG000|Overall Study|Withdrawal by Participant|1
4382777|NCT03126019|7160838|FG001|Overall Study|Withdrawal by Participant|3
4382778|NCT03126019|7160837|FG000|Overall Study|Reason not Specified|1
4382779|NCT03126019|7160838|FG001|Overall Study|Reason not Specified|3
4382780|NCT03113383|7160845|FG000|Overall Study|Death|4
4382781|NCT03113383|7160846|FG001|Overall Study|Death|0
4382782|NCT02978326|7160877|FG000|Part B (Up to 45 Days)|Adverse Event|0
4382783|NCT02978326|7160878|FG001|Part B (Up to 45 Days)|Adverse Event|0
4382784|NCT02978326|7160879|FG002|Part B (Up to 45 Days)|Adverse Event|1
4382785|NCT02978326|7160877|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0
4382786|NCT02978326|7160878|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3
4382787|NCT02978326|7160879|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0
4382788|NCT02978326|7160877|FG000|Part B (Up to 45 Days)|Non-compliance|0
4382789|NCT02978326|7160878|FG001|Part B (Up to 45 Days)|Non-compliance|2
4382790|NCT02978326|7160879|FG002|Part B (Up to 45 Days)|Non-compliance|0
4382791|NCT02978326|7160877|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0
4382792|NCT02978326|7160878|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2
4382793|NCT02978326|7160879|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3
4382794|NCT02970929|7160889|FG000|Overall Study|Adverse Event|18
4382795|NCT02970929|7160889|FG000|Overall Study|Lack of Efficacy|8
4382796|NCT02970929|7160889|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1
4382797|NCT02970929|7160889|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1
4382798|NCT02970929|7160889|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1
4382799|NCT02970929|7160889|FG000|Overall Study|LOST TO FOLLOWUP|6
4382800|NCT02970929|7160889|FG000|Overall Study|MOVED OUT OF STATE|1
4382801|NCT02970929|7160889|FG000|Overall Study|Withdrawal by Subject|16
4382802|NCT02797951|7160923|FG000|Overall Study|Adverse Event|4
4382803|NCT02797951|7160923|FG000|Overall Study|Death|1
4382804|NCT02797951|7160923|FG000|Overall Study|Lack of Efficacy|19
4697238|NCT02646891|7610478|FG004|Overall Study|Death|0
4382805|NCT02797951|7160923|FG000|Overall Study|Lost to Follow-up|4
4382806|NCT02797951|7160923|FG000|Overall Study|Physician Decision|6
4382807|NCT02797951|7160923|FG000|Overall Study|Withdrawal by Subject|15
4382808|NCT02748057|7160938|FG000|Overall Study|Adverse Event|1
4382809|NCT02748057|7160939|FG001|Overall Study|Adverse Event|0
4382810|NCT02748057|7160938|FG000|Overall Study|Physician Decision|0
4382811|NCT02748057|7160939|FG001|Overall Study|Physician Decision|1
4382812|NCT02748057|7160938|FG000|Overall Study|Protocol Violation|2
4382813|NCT02748057|7160939|FG001|Overall Study|Protocol Violation|1
4382814|NCT02748057|7160938|FG000|Overall Study|Participant Moved|1
4382815|NCT02748057|7160939|FG001|Overall Study|Participant Moved|0
4382816|NCT02748057|7160938|FG000|Overall Study|Withdrawal by Subject|1
4382817|NCT02748057|7160939|FG001|Overall Study|Withdrawal by Subject|0
4382818|NCT02741271|7160947|FG000|Overall Study|Lost to Follow-up|2
4382819|NCT02741271|7160948|FG001|Overall Study|Lost to Follow-up|0
4382820|NCT02741271|7160947|FG000|Overall Study|Withdrawal by Parent/Guardian|0
4382821|NCT02741271|7160948|FG001|Overall Study|Withdrawal by Parent/Guardian|2
4382822|NCT02741245|7160961|FG000|Overall Study|Adverse Event|0
4382823|NCT02741245|7160962|FG001|Overall Study|Adverse Event|0
4382824|NCT02741245|7160963|FG002|Overall Study|Adverse Event|0
4382825|NCT02741245|7160964|FG003|Overall Study|Adverse Event|2
4382826|NCT02741245|7160965|FG004|Overall Study|Adverse Event|2
4382827|NCT02741245|7160961|FG000|Overall Study|Protocol Violation|0
4382828|NCT02741245|7160962|FG001|Overall Study|Protocol Violation|1
4382829|NCT02741245|7160963|FG002|Overall Study|Protocol Violation|0
4382830|NCT02741245|7160964|FG003|Overall Study|Protocol Violation|1
4382831|NCT02741245|7160965|FG004|Overall Study|Protocol Violation|0
4382832|NCT02741245|7160961|FG000|Overall Study|Withdrawal by Subject|0
4382833|NCT02741245|7160962|FG001|Overall Study|Withdrawal by Subject|0
4382834|NCT02741245|7160963|FG002|Overall Study|Withdrawal by Subject|0
4382835|NCT02741245|7160964|FG003|Overall Study|Withdrawal by Subject|1
4382836|NCT02741245|7160965|FG004|Overall Study|Withdrawal by Subject|0
4469049|NCT00633477|7261799|FG001|Overall Study|Death|0
4469050|NCT00633477|7261798|FG000|Overall Study|Randomized but not treated|1
4469051|NCT00633477|7261799|FG001|Overall Study|Randomized but not treated|0
4469052|NCT00633594|7261808|FG000|Overall Study|Adverse Event|0
4469053|NCT00633594|7261809|FG001|Overall Study|Adverse Event|4
4469054|NCT00633594|7261810|FG002|Overall Study|Adverse Event|7
4469055|NCT00633594|7261808|FG000|Overall Study|Death|0
4469056|NCT00633594|7261809|FG001|Overall Study|Death|1
4469057|NCT00633594|7261810|FG002|Overall Study|Death|2
4469058|NCT00633594|7261808|FG000|Overall Study|Disease Progression|0
4469059|NCT00633594|7261809|FG001|Overall Study|Disease Progression|0
4469060|NCT00633594|7261810|FG002|Overall Study|Disease Progression|1
4469061|NCT00633750|7261821|FG000|Overall Study|Adverse Event|2
4469062|NCT00633750|7261821|FG000|Overall Study|Withdrawal by Subject|3
4469063|NCT00633880|7261839|FG000|Open Label Titration|Lack of Efficacy|1
4469064|NCT00633880|7261840|FG001|Open Label Titration|Lack of Efficacy|0
4469065|NCT00633880|7261841|FG002|Open Label Titration|Lack of Efficacy|0
4469066|NCT00633880|7261839|FG000|Open Label Titration|Adverse Event|13
4469067|NCT00633880|7261840|FG001|Open Label Titration|Adverse Event|0
4469068|NCT00633880|7261841|FG002|Open Label Titration|Adverse Event|0
4469069|NCT00633880|7261839|FG000|Open Label Titration|Treatment Failure|55
4469070|NCT00633880|7261840|FG001|Open Label Titration|Treatment Failure|0
4469071|NCT00633880|7261841|FG002|Open Label Titration|Treatment Failure|0
4469072|NCT00633880|7261839|FG000|Open Label Titration|Protocol Violation|6
4469073|NCT00633880|7261840|FG001|Open Label Titration|Protocol Violation|0
4469074|NCT00633880|7261841|FG002|Open Label Titration|Protocol Violation|0
4469075|NCT00633880|7261839|FG000|Open Label Titration|Physician Decision|1
4469076|NCT00633880|7261840|FG001|Open Label Titration|Physician Decision|0
4469077|NCT00633880|7261841|FG002|Open Label Titration|Physician Decision|0
4469078|NCT00633880|7261839|FG000|Open Label Titration|Withdrawal by Subject|4
4469079|NCT00633880|7261840|FG001|Open Label Titration|Withdrawal by Subject|0
4469080|NCT00633880|7261841|FG002|Open Label Titration|Withdrawal by Subject|0
4469081|NCT00633893|7261851|FG000|Overall Study|Death|1
4469082|NCT00633893|7261852|FG001|Overall Study|Death|3
4469083|NCT00633893|7261853|FG002|Overall Study|Death|9
4469084|NCT00633893|7261851|FG000|Overall Study|Adverse Event|65
4697239|NCT02646891|7610479|FG005|Overall Study|Death|0
4697240|NCT02646891|7610480|FG006|Overall Study|Death|1
4382837|NCT02688608|7160977|FG000|Overall Study|Lost to Follow-up|1
4382838|NCT02675231|7160984|FG000|Overall Study|Withdrawal by Subject|1
4382839|NCT02675231|7160985|FG001|Overall Study|Withdrawal by Subject|3
4382840|NCT02675231|7160986|FG002|Overall Study|Withdrawal by Subject|1
4382841|NCT02675231|7160984|FG000|Overall Study|Lost to Follow-up|2
4382842|NCT02675231|7160985|FG001|Overall Study|Lost to Follow-up|2
4382843|NCT02675231|7160986|FG002|Overall Study|Lost to Follow-up|2
4382844|NCT02675231|7160984|FG000|Overall Study|On study treatment/follow up|23
4382845|NCT02675231|7160985|FG001|Overall Study|On study treatment/follow up|31
4382846|NCT02675231|7160986|FG002|Overall Study|On study treatment/follow up|23
4382847|NCT02605967|7161006|FG000|Overall Study|subject / guardian decision|1
4382848|NCT02605967|7161007|FG001|Overall Study|subject / guardian decision|2
4382849|NCT02605967|7161006|FG000|Overall Study|Physician Decision|10
4382850|NCT02605967|7161007|FG001|Overall Study|Physician Decision|1
4382851|NCT02605967|7161006|FG000|Overall Study|Death|4
4382852|NCT02605967|7161007|FG001|Overall Study|Death|2
4382853|NCT02605967|7161006|FG000|Overall Study|Adverse Event|1
4382854|NCT02605967|7161007|FG001|Overall Study|Adverse Event|0
4382855|NCT02605967|7161006|FG000|Overall Study|progressive disease|66
4382856|NCT02605967|7161007|FG001|Overall Study|progressive disease|35
4382857|NCT02584634|7161019|FG000|Overall Study|Adverse Event|3
4382858|NCT02584634|7161020|FG001|Overall Study|Adverse Event|3
4382859|NCT02584634|7161019|FG000|Overall Study|Death|0
4382860|NCT02584634|7161020|FG001|Overall Study|Death|1
4382861|NCT02584634|7161019|FG000|Overall Study|Lost to Follow-up|0
4382862|NCT02584634|7161020|FG001|Overall Study|Lost to Follow-up|1
4382863|NCT02584634|7161019|FG000|Overall Study|Physician Decision|1
4382864|NCT02584634|7161020|FG001|Overall Study|Physician Decision|1
4382865|NCT02584634|7161019|FG000|Overall Study|Progressive disease|7
4382866|NCT02584634|7161020|FG001|Overall Study|Progressive disease|14
4382867|NCT02584634|7161019|FG000|Overall Study|Withdrawal by Subject|1
4382868|NCT02584634|7161020|FG001|Overall Study|Withdrawal by Subject|1
4382869|NCT02584634|7161019|FG000|Overall Study|Other|0
4382870|NCT02584634|7161020|FG001|Overall Study|Other|2
4382871|NCT02584634|7161019|FG000|Overall Study|Ongoing|0
4382872|NCT02584634|7161020|FG001|Overall Study|Ongoing|8
4382873|NCT02553265|7161042|FG000|Enrollment|Death|0
4382874|NCT02553265|7161043|FG001|Enrollment|Death|0
4382875|NCT02553265|7161044|FG002|Enrollment|Death|1
4382876|NCT02553265|7161042|FG000|First Intervention (28 Days)|Adverse Event|1
4382877|NCT02553265|7161043|FG001|First Intervention (28 Days)|Adverse Event|0
4382878|NCT02553265|7161044|FG002|First Intervention (28 Days)|Adverse Event|0
4382879|NCT02553265|7161042|FG000|First Intervention (28 Days)|Withdrawal by Subject|0
4382880|NCT02553265|7161043|FG001|First Intervention (28 Days)|Withdrawal by Subject|0
4382881|NCT02553265|7161044|FG002|First Intervention (28 Days)|Withdrawal by Subject|1
4382882|NCT02553265|7161042|FG000|Second Intervention (28 Days)|Adverse Event|1
4382883|NCT02553265|7161043|FG001|Second Intervention (28 Days)|Adverse Event|0
4382884|NCT02553265|7161044|FG002|Second Intervention (28 Days)|Adverse Event|0
4382885|NCT02553265|7161042|FG000|Third Intervention (28 Days)|Adverse Event|1
4382886|NCT02553265|7161043|FG001|Third Intervention (28 Days)|Adverse Event|0
4382887|NCT02553265|7161044|FG002|Third Intervention (28 Days)|Adverse Event|0
4382888|NCT02553265|7161042|FG000|Third Intervention (28 Days)|Lost to Follow-up|0
4382889|NCT02553265|7161043|FG001|Third Intervention (28 Days)|Lost to Follow-up|0
4382890|NCT02553265|7161044|FG002|Third Intervention (28 Days)|Lost to Follow-up|1
4382891|NCT02550288|7161060|FG000|Overall Study|Adverse Event|0
4382892|NCT02550288|7161061|FG001|Overall Study|Adverse Event|1
4382893|NCT02550288|7161062|FG002|Overall Study|Adverse Event|0
4382894|NCT02550288|7161063|FG003|Overall Study|Adverse Event|0
4382895|NCT02550288|7161064|FG004|Overall Study|Adverse Event|0
4382896|NCT02550288|7161060|FG000|Overall Study|Physician Decision|0
4382897|NCT02550288|7161061|FG001|Overall Study|Physician Decision|0
4382898|NCT02550288|7161062|FG002|Overall Study|Physician Decision|0
4382899|NCT02550288|7161063|FG003|Overall Study|Physician Decision|1
4382900|NCT02550288|7161064|FG004|Overall Study|Physician Decision|0
4382901|NCT02550288|7161060|FG000|Overall Study|Protocol Violation|2
4382902|NCT02550288|7161061|FG001|Overall Study|Protocol Violation|2
4382903|NCT02550288|7161062|FG002|Overall Study|Protocol Violation|1
4382904|NCT02550288|7161063|FG003|Overall Study|Protocol Violation|0
4382905|NCT02550288|7161064|FG004|Overall Study|Protocol Violation|3
4382906|NCT02550288|7161060|FG000|Overall Study|Participant moved|0
4382907|NCT02550288|7161061|FG001|Overall Study|Participant moved|0
4382908|NCT02550288|7161062|FG002|Overall Study|Participant moved|0
4382909|NCT02550288|7161063|FG003|Overall Study|Participant moved|1
4382910|NCT02550288|7161064|FG004|Overall Study|Participant moved|0
4382911|NCT02550288|7161060|FG000|Overall Study|Withdrawal by Subject|0
4382912|NCT02550288|7161061|FG001|Overall Study|Withdrawal by Subject|0
4382913|NCT02550288|7161062|FG002|Overall Study|Withdrawal by Subject|0
4382914|NCT02550288|7161063|FG003|Overall Study|Withdrawal by Subject|1
4382915|NCT02550288|7161064|FG004|Overall Study|Withdrawal by Subject|0
4382916|NCT02510040|7161079|FG000|Overall Study|Deemed no longer eligible|18
4382917|NCT02510040|7161080|FG001|Overall Study|Deemed no longer eligible|3
4382918|NCT02510040|7161081|FG002|Overall Study|Deemed no longer eligible|1
4382919|NCT02499328|7161109|FG000|Overall Study|Withdrawal by Subject|1
4382920|NCT02499328|7161110|FG001|Overall Study|Withdrawal by Subject|1
4382921|NCT02499328|7161111|FG002|Overall Study|Withdrawal by Subject|5
4382922|NCT02499328|7161112|FG003|Overall Study|Withdrawal by Subject|3
4382923|NCT02499328|7161113|FG004|Overall Study|Withdrawal by Subject|5
4382924|NCT02499328|7161114|FG005|Overall Study|Withdrawal by Subject|0
4382925|NCT02499328|7161115|FG006|Overall Study|Withdrawal by Subject|0
4382926|NCT02499328|7161116|FG007|Overall Study|Withdrawal by Subject|0
4382927|NCT02499328|7161117|FG008|Overall Study|Withdrawal by Subject|2
4382928|NCT02499328|7161118|FG009|Overall Study|Withdrawal by Subject|2
4382929|NCT02499328|7161119|FG010|Overall Study|Withdrawal by Subject|0
4382930|NCT02499328|7161120|FG011|Overall Study|Withdrawal by Subject|3
4382931|NCT02499328|7161121|FG012|Overall Study|Withdrawal by Subject|7
4382932|NCT02499328|7161122|FG013|Overall Study|Withdrawal by Subject|3
4382933|NCT02499328|7161123|FG014|Overall Study|Withdrawal by Subject|1
4382934|NCT02499328|7161124|FG015|Overall Study|Withdrawal by Subject|0
4382935|NCT02499328|7161125|FG016|Overall Study|Withdrawal by Subject|0
4382936|NCT02499328|7161126|FG017|Overall Study|Withdrawal by Subject|3
4382937|NCT02499328|7161127|FG018|Overall Study|Withdrawal by Subject|0
4382938|NCT02499328|7161109|FG000|Overall Study|Lost to Follow-up|0
4382939|NCT02499328|7161110|FG001|Overall Study|Lost to Follow-up|1
4382940|NCT02499328|7161111|FG002|Overall Study|Lost to Follow-up|1
4382941|NCT02499328|7161112|FG003|Overall Study|Lost to Follow-up|2
4382942|NCT02499328|7161113|FG004|Overall Study|Lost to Follow-up|0
4382943|NCT02499328|7161114|FG005|Overall Study|Lost to Follow-up|0
4382944|NCT02499328|7161115|FG006|Overall Study|Lost to Follow-up|0
4382945|NCT02499328|7161116|FG007|Overall Study|Lost to Follow-up|2
4382946|NCT02499328|7161117|FG008|Overall Study|Lost to Follow-up|3
4382947|NCT02499328|7161118|FG009|Overall Study|Lost to Follow-up|0
4382948|NCT02499328|7161119|FG010|Overall Study|Lost to Follow-up|0
4382949|NCT02499328|7161120|FG011|Overall Study|Lost to Follow-up|0
4382950|NCT02499328|7161121|FG012|Overall Study|Lost to Follow-up|0
4382951|NCT02499328|7161122|FG013|Overall Study|Lost to Follow-up|0
4382952|NCT02499328|7161123|FG014|Overall Study|Lost to Follow-up|0
4382953|NCT02499328|7161124|FG015|Overall Study|Lost to Follow-up|0
4382954|NCT02499328|7161125|FG016|Overall Study|Lost to Follow-up|0
4382955|NCT02499328|7161126|FG017|Overall Study|Lost to Follow-up|0
4382956|NCT02499328|7161127|FG018|Overall Study|Lost to Follow-up|1
4382957|NCT02499328|7161109|FG000|Overall Study|Death|0
4382958|NCT02499328|7161110|FG001|Overall Study|Death|3
4382959|NCT02499328|7161111|FG002|Overall Study|Death|3
4382960|NCT02499328|7161112|FG003|Overall Study|Death|2
4382961|NCT02499328|7161113|FG004|Overall Study|Death|4
4382962|NCT02499328|7161114|FG005|Overall Study|Death|7
4382963|NCT02499328|7161115|FG006|Overall Study|Death|3
4382964|NCT02499328|7161116|FG007|Overall Study|Death|0
4382965|NCT02499328|7161117|FG008|Overall Study|Death|2
4382966|NCT02499328|7161118|FG009|Overall Study|Death|6
4382967|NCT02499328|7161119|FG010|Overall Study|Death|6
4593671|NCT01554241|7442216|FG001|Overall Study|protocol specified renal stone|0
4382968|NCT02499328|7161120|FG011|Overall Study|Death|20
4382969|NCT02499328|7161121|FG012|Overall Study|Death|9
4382970|NCT02499328|7161122|FG013|Overall Study|Death|7
4382971|NCT02499328|7161123|FG014|Overall Study|Death|3
4382972|NCT02499328|7161124|FG015|Overall Study|Death|1
4382973|NCT02499328|7161125|FG016|Overall Study|Death|1
4382974|NCT02499328|7161126|FG017|Overall Study|Death|16
4382975|NCT02499328|7161127|FG018|Overall Study|Death|5
4382976|NCT02499328|7161109|FG000|Overall Study|"Other"|2
4382977|NCT02499328|7161110|FG001|Overall Study|"Other"|2
4382978|NCT02499328|7161111|FG002|Overall Study|"Other"|1
4382979|NCT02499328|7161112|FG003|Overall Study|"Other"|3
4382980|NCT02499328|7161113|FG004|Overall Study|"Other"|6
4382981|NCT02499328|7161114|FG005|Overall Study|"Other"|2
4382982|NCT02499328|7161115|FG006|Overall Study|"Other"|3
4382983|NCT02499328|7161116|FG007|Overall Study|"Other"|4
4382984|NCT02499328|7161117|FG008|Overall Study|"Other"|6
4382985|NCT02499328|7161118|FG009|Overall Study|"Other"|16
4382986|NCT02499328|7161119|FG010|Overall Study|"Other"|13
4382987|NCT02499328|7161120|FG011|Overall Study|"Other"|31
4382988|NCT02499328|7161121|FG012|Overall Study|"Other"|8
4382989|NCT02499328|7161122|FG013|Overall Study|"Other"|7
4382990|NCT02499328|7161123|FG014|Overall Study|"Other"|6
4469085|NCT00633893|7261852|FG001|Overall Study|Adverse Event|58
4382991|NCT02499328|7161124|FG015|Overall Study|"Other"|0
4382992|NCT02499328|7161125|FG016|Overall Study|"Other"|0
4382993|NCT02499328|7161126|FG017|Overall Study|"Other"|34
4382994|NCT02499328|7161127|FG018|Overall Study|"Other"|43
4382995|NCT02499328|7161109|FG000|Overall Study|Disease Progression|0
4382996|NCT02499328|7161110|FG001|Overall Study|Disease Progression|0
4382997|NCT02499328|7161111|FG002|Overall Study|Disease Progression|0
4382998|NCT02499328|7161112|FG003|Overall Study|Disease Progression|0
4382999|NCT02499328|7161113|FG004|Overall Study|Disease Progression|0
4383000|NCT02499328|7161114|FG005|Overall Study|Disease Progression|0
4383001|NCT02499328|7161115|FG006|Overall Study|Disease Progression|1
4383002|NCT02499328|7161116|FG007|Overall Study|Disease Progression|0
4383003|NCT02499328|7161117|FG008|Overall Study|Disease Progression|1
4383004|NCT02499328|7161118|FG009|Overall Study|Disease Progression|0
4383005|NCT02499328|7161119|FG010|Overall Study|Disease Progression|1
4383006|NCT02499328|7161120|FG011|Overall Study|Disease Progression|0
4383007|NCT02499328|7161121|FG012|Overall Study|Disease Progression|0
4383008|NCT02499328|7161122|FG013|Overall Study|Disease Progression|0
4383009|NCT02499328|7161123|FG014|Overall Study|Disease Progression|0
4383010|NCT02499328|7161124|FG015|Overall Study|Disease Progression|0
4383011|NCT02499328|7161125|FG016|Overall Study|Disease Progression|0
4383012|NCT02499328|7161126|FG017|Overall Study|Disease Progression|2
4383013|NCT02499328|7161127|FG018|Overall Study|Disease Progression|0
4383014|NCT02499328|7161109|FG000|Overall Study|Adverse Event|1
4383015|NCT02499328|7161110|FG001|Overall Study|Adverse Event|0
4383016|NCT02499328|7161111|FG002|Overall Study|Adverse Event|0
4383017|NCT02499328|7161112|FG003|Overall Study|Adverse Event|1
4383018|NCT02499328|7161113|FG004|Overall Study|Adverse Event|0
4383019|NCT02499328|7161114|FG005|Overall Study|Adverse Event|0
4383020|NCT02499328|7161115|FG006|Overall Study|Adverse Event|0
4383021|NCT02499328|7161116|FG007|Overall Study|Adverse Event|0
4383022|NCT02499328|7161117|FG008|Overall Study|Adverse Event|0
4383023|NCT02499328|7161118|FG009|Overall Study|Adverse Event|0
4383024|NCT02499328|7161119|FG010|Overall Study|Adverse Event|0
4383025|NCT02499328|7161120|FG011|Overall Study|Adverse Event|0
4383026|NCT02499328|7161121|FG012|Overall Study|Adverse Event|1
4383027|NCT02499328|7161122|FG013|Overall Study|Adverse Event|0
4383028|NCT02499328|7161123|FG014|Overall Study|Adverse Event|0
4383029|NCT02499328|7161124|FG015|Overall Study|Adverse Event|0
4383030|NCT02499328|7161125|FG016|Overall Study|Adverse Event|0
4383031|NCT02499328|7161126|FG017|Overall Study|Adverse Event|0
4383032|NCT02499328|7161127|FG018|Overall Study|Adverse Event|0
4383033|NCT02460224|7161248|FG000|Overall Study|Adverse Event|0
4383034|NCT02460224|7161249|FG001|Overall Study|Adverse Event|0
4383035|NCT02460224|7161250|FG002|Overall Study|Adverse Event|0
4383036|NCT02460224|7161251|FG003|Overall Study|Adverse Event|0
4383037|NCT02460224|7161252|FG004|Overall Study|Adverse Event|0
4383038|NCT02460224|7161253|FG005|Overall Study|Adverse Event|0
4383039|NCT02460224|7161254|FG006|Overall Study|Adverse Event|1
4383040|NCT02460224|7161255|FG007|Overall Study|Adverse Event|0
4383041|NCT02460224|7161256|FG008|Overall Study|Adverse Event|0
4383042|NCT02460224|7161257|FG009|Overall Study|Adverse Event|0
4383043|NCT02460224|7161258|FG010|Overall Study|Adverse Event|0
4383044|NCT02460224|7161259|FG011|Overall Study|Adverse Event|0
4383045|NCT02460224|7161260|FG012|Overall Study|Adverse Event|1
4383046|NCT02460224|7161261|FG013|Overall Study|Adverse Event|0
4383047|NCT02460224|7161262|FG014|Overall Study|Adverse Event|0
4383048|NCT02460224|7161263|FG015|Overall Study|Adverse Event|0
4383049|NCT02460224|7161264|FG016|Overall Study|Adverse Event|1
4383050|NCT02460224|7161265|FG017|Overall Study|Adverse Event|0
4383051|NCT02460224|7161266|FG018|Overall Study|Adverse Event|1
4383052|NCT02460224|7161267|FG019|Overall Study|Adverse Event|0
4383053|NCT02460224|7161268|FG020|Overall Study|Adverse Event|1
4383054|NCT02460224|7161269|FG021|Overall Study|Adverse Event|1
4383055|NCT02460224|7161270|FG022|Overall Study|Adverse Event|1
4383056|NCT02460224|7161271|FG023|Overall Study|Adverse Event|0
4383057|NCT02460224|7161272|FG024|Overall Study|Adverse Event|0
4383058|NCT02460224|7161273|FG025|Overall Study|Adverse Event|0
4383059|NCT02460224|7161274|FG026|Overall Study|Adverse Event|11
4383060|NCT02460224|7161275|FG027|Overall Study|Adverse Event|1
4383061|NCT02460224|7161276|FG028|Overall Study|Adverse Event|6
4383062|NCT02460224|7161248|FG000|Overall Study|Death|0
4383063|NCT02460224|7161249|FG001|Overall Study|Death|0
4383064|NCT02460224|7161250|FG002|Overall Study|Death|0
4383065|NCT02460224|7161251|FG003|Overall Study|Death|0
4383066|NCT02460224|7161252|FG004|Overall Study|Death|0
4383067|NCT02460224|7161253|FG005|Overall Study|Death|2
4383068|NCT02460224|7161254|FG006|Overall Study|Death|1
4383069|NCT02460224|7161255|FG007|Overall Study|Death|0
4383070|NCT02460224|7161256|FG008|Overall Study|Death|0
4383071|NCT02460224|7161257|FG009|Overall Study|Death|1
4383072|NCT02460224|7161258|FG010|Overall Study|Death|0
4383073|NCT02460224|7161259|FG011|Overall Study|Death|0
4383074|NCT02460224|7161260|FG012|Overall Study|Death|0
4383075|NCT02460224|7161261|FG013|Overall Study|Death|1
4383076|NCT02460224|7161262|FG014|Overall Study|Death|0
4383077|NCT02460224|7161263|FG015|Overall Study|Death|0
4383078|NCT02460224|7161264|FG016|Overall Study|Death|2
4383079|NCT02460224|7161265|FG017|Overall Study|Death|1
4383080|NCT02460224|7161266|FG018|Overall Study|Death|0
4383081|NCT02460224|7161267|FG019|Overall Study|Death|2
4383082|NCT02460224|7161268|FG020|Overall Study|Death|0
4383083|NCT02460224|7161269|FG021|Overall Study|Death|0
4383084|NCT02460224|7161270|FG022|Overall Study|Death|0
4383085|NCT02460224|7161271|FG023|Overall Study|Death|0
4383086|NCT02460224|7161272|FG024|Overall Study|Death|1
4383087|NCT02460224|7161273|FG025|Overall Study|Death|1
4383088|NCT02460224|7161274|FG026|Overall Study|Death|5
4383089|NCT02460224|7161275|FG027|Overall Study|Death|0
4383090|NCT02460224|7161276|FG028|Overall Study|Death|1
4383091|NCT02460224|7161248|FG000|Overall Study|Lost to Follow-up|0
4383092|NCT02460224|7161249|FG001|Overall Study|Lost to Follow-up|0
4383093|NCT02460224|7161250|FG002|Overall Study|Lost to Follow-up|0
4383094|NCT02460224|7161251|FG003|Overall Study|Lost to Follow-up|0
4383095|NCT02460224|7161252|FG004|Overall Study|Lost to Follow-up|0
4383096|NCT02460224|7161253|FG005|Overall Study|Lost to Follow-up|0
4383097|NCT02460224|7161254|FG006|Overall Study|Lost to Follow-up|0
4383098|NCT02460224|7161255|FG007|Overall Study|Lost to Follow-up|0
4383099|NCT02460224|7161256|FG008|Overall Study|Lost to Follow-up|0
4383100|NCT02460224|7161257|FG009|Overall Study|Lost to Follow-up|0
4383101|NCT02460224|7161258|FG010|Overall Study|Lost to Follow-up|0
4383102|NCT02460224|7161259|FG011|Overall Study|Lost to Follow-up|0
4588706|NCT01502644|7433335|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
4383103|NCT02460224|7161260|FG012|Overall Study|Lost to Follow-up|0
4383104|NCT02460224|7161261|FG013|Overall Study|Lost to Follow-up|0
4383105|NCT02460224|7161262|FG014|Overall Study|Lost to Follow-up|0
4383106|NCT02460224|7161263|FG015|Overall Study|Lost to Follow-up|0
4383107|NCT02460224|7161264|FG016|Overall Study|Lost to Follow-up|0
4383108|NCT02460224|7161265|FG017|Overall Study|Lost to Follow-up|0
4383109|NCT02460224|7161266|FG018|Overall Study|Lost to Follow-up|0
4383110|NCT02460224|7161267|FG019|Overall Study|Lost to Follow-up|0
4383111|NCT02460224|7161268|FG020|Overall Study|Lost to Follow-up|0
4383112|NCT02460224|7161269|FG021|Overall Study|Lost to Follow-up|0
4383113|NCT02460224|7161270|FG022|Overall Study|Lost to Follow-up|1
4383114|NCT02460224|7161271|FG023|Overall Study|Lost to Follow-up|0
4383115|NCT02460224|7161272|FG024|Overall Study|Lost to Follow-up|0
4383116|NCT02460224|7161273|FG025|Overall Study|Lost to Follow-up|0
4383117|NCT02460224|7161274|FG026|Overall Study|Lost to Follow-up|0
4383118|NCT02460224|7161275|FG027|Overall Study|Lost to Follow-up|0
4383119|NCT02460224|7161276|FG028|Overall Study|Lost to Follow-up|0
4383120|NCT02460224|7161248|FG000|Overall Study|Physician Decision|0
4383121|NCT02460224|7161249|FG001|Overall Study|Physician Decision|1
4383122|NCT02460224|7161250|FG002|Overall Study|Physician Decision|0
4383123|NCT02460224|7161251|FG003|Overall Study|Physician Decision|0
4383124|NCT02460224|7161252|FG004|Overall Study|Physician Decision|1
4383125|NCT02460224|7161253|FG005|Overall Study|Physician Decision|0
4383126|NCT02460224|7161254|FG006|Overall Study|Physician Decision|0
4383127|NCT02460224|7161255|FG007|Overall Study|Physician Decision|1
4383128|NCT02460224|7161256|FG008|Overall Study|Physician Decision|0
4383129|NCT02460224|7161257|FG009|Overall Study|Physician Decision|0
4383130|NCT02460224|7161258|FG010|Overall Study|Physician Decision|0
4383131|NCT02460224|7161259|FG011|Overall Study|Physician Decision|1
4383132|NCT02460224|7161260|FG012|Overall Study|Physician Decision|0
4383133|NCT02460224|7161261|FG013|Overall Study|Physician Decision|1
4383134|NCT02460224|7161262|FG014|Overall Study|Physician Decision|0
4383135|NCT02460224|7161263|FG015|Overall Study|Physician Decision|0
4383136|NCT02460224|7161264|FG016|Overall Study|Physician Decision|2
4383137|NCT02460224|7161265|FG017|Overall Study|Physician Decision|1
4383138|NCT02460224|7161266|FG018|Overall Study|Physician Decision|1
4383139|NCT02460224|7161267|FG019|Overall Study|Physician Decision|2
4383140|NCT02460224|7161268|FG020|Overall Study|Physician Decision|1
4383141|NCT02460224|7161269|FG021|Overall Study|Physician Decision|1
4383142|NCT02460224|7161270|FG022|Overall Study|Physician Decision|0
4383143|NCT02460224|7161271|FG023|Overall Study|Physician Decision|0
4383144|NCT02460224|7161272|FG024|Overall Study|Physician Decision|1
4383145|NCT02460224|7161273|FG025|Overall Study|Physician Decision|0
4383146|NCT02460224|7161274|FG026|Overall Study|Physician Decision|14
4383147|NCT02460224|7161275|FG027|Overall Study|Physician Decision|1
4383148|NCT02460224|7161276|FG028|Overall Study|Physician Decision|6
4383149|NCT02460224|7161248|FG000|Overall Study|Progressive disease|15
4383150|NCT02460224|7161249|FG001|Overall Study|Progressive disease|11
4383151|NCT02460224|7161250|FG002|Overall Study|Progressive disease|5
4383152|NCT02460224|7161251|FG003|Overall Study|Progressive disease|6
4383153|NCT02460224|7161252|FG004|Overall Study|Progressive disease|3
4383154|NCT02460224|7161253|FG005|Overall Study|Progressive disease|26
4383155|NCT02460224|7161254|FG006|Overall Study|Progressive disease|28
4383156|NCT02460224|7161255|FG007|Overall Study|Progressive disease|4
4383157|NCT02460224|7161256|FG008|Overall Study|Progressive disease|5
4383158|NCT02460224|7161257|FG009|Overall Study|Progressive disease|9
4383159|NCT02460224|7161258|FG010|Overall Study|Progressive disease|5
4383160|NCT02460224|7161259|FG011|Overall Study|Progressive disease|4
4383161|NCT02460224|7161260|FG012|Overall Study|Progressive disease|5
4383162|NCT02460224|7161261|FG013|Overall Study|Progressive disease|4
4383163|NCT02460224|7161262|FG014|Overall Study|Progressive disease|5
4383164|NCT02460224|7161263|FG015|Overall Study|Progressive disease|5
4383165|NCT02460224|7161264|FG016|Overall Study|Progressive disease|15
4588707|NCT01502644|7433336|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
4383166|NCT02460224|7161265|FG017|Overall Study|Progressive disease|3
4383167|NCT02460224|7161266|FG018|Overall Study|Progressive disease|8
4383168|NCT02460224|7161267|FG019|Overall Study|Progressive disease|3
4383169|NCT02460224|7161268|FG020|Overall Study|Progressive disease|4
4383170|NCT02460224|7161269|FG021|Overall Study|Progressive disease|9
4383171|NCT02460224|7161270|FG022|Overall Study|Progressive disease|4
4383172|NCT02460224|7161271|FG023|Overall Study|Progressive disease|11
4383173|NCT02460224|7161272|FG024|Overall Study|Progressive disease|4
4383174|NCT02460224|7161273|FG025|Overall Study|Progressive disease|5
4383175|NCT02460224|7161274|FG026|Overall Study|Progressive disease|85
4383176|NCT02460224|7161275|FG027|Overall Study|Progressive disease|17
4383177|NCT02460224|7161276|FG028|Overall Study|Progressive disease|77
4383178|NCT02460224|7161248|FG000|Overall Study|Subject/guardian decision|2
4383179|NCT02460224|7161249|FG001|Overall Study|Subject/guardian decision|0
4383180|NCT02460224|7161250|FG002|Overall Study|Subject/guardian decision|1
4383181|NCT02460224|7161251|FG003|Overall Study|Subject/guardian decision|0
4383182|NCT02460224|7161252|FG004|Overall Study|Subject/guardian decision|2
4383183|NCT02460224|7161253|FG005|Overall Study|Subject/guardian decision|2
4383184|NCT02460224|7161254|FG006|Overall Study|Subject/guardian decision|0
4383185|NCT02460224|7161255|FG007|Overall Study|Subject/guardian decision|0
4383186|NCT02460224|7161256|FG008|Overall Study|Subject/guardian decision|1
4383187|NCT02460224|7161257|FG009|Overall Study|Subject/guardian decision|1
4383188|NCT02460224|7161258|FG010|Overall Study|Subject/guardian decision|0
4383189|NCT02460224|7161259|FG011|Overall Study|Subject/guardian decision|1
4383190|NCT02460224|7161260|FG012|Overall Study|Subject/guardian decision|0
4383191|NCT02460224|7161261|FG013|Overall Study|Subject/guardian decision|0
4383192|NCT02460224|7161262|FG014|Overall Study|Subject/guardian decision|0
4383193|NCT02460224|7161263|FG015|Overall Study|Subject/guardian decision|1
4383194|NCT02460224|7161264|FG016|Overall Study|Subject/guardian decision|0
4383195|NCT02460224|7161265|FG017|Overall Study|Subject/guardian decision|1
4383196|NCT02460224|7161266|FG018|Overall Study|Subject/guardian decision|2
4383197|NCT02460224|7161267|FG019|Overall Study|Subject/guardian decision|0
4383198|NCT02460224|7161268|FG020|Overall Study|Subject/guardian decision|0
4383199|NCT02460224|7161269|FG021|Overall Study|Subject/guardian decision|1
4383200|NCT02460224|7161270|FG022|Overall Study|Subject/guardian decision|0
4383201|NCT02460224|7161271|FG023|Overall Study|Subject/guardian decision|0
4383202|NCT02460224|7161272|FG024|Overall Study|Subject/guardian decision|0
4383203|NCT02460224|7161273|FG025|Overall Study|Subject/guardian decision|0
4383204|NCT02460224|7161274|FG026|Overall Study|Subject/guardian decision|6
4383205|NCT02460224|7161275|FG027|Overall Study|Subject/guardian decision|2
4383206|NCT02460224|7161276|FG028|Overall Study|Subject/guardian decision|3
4383207|NCT02460159|7161350|FG000|Overall Study|Adverse Event|4
4383208|NCT02460159|7161351|FG001|Overall Study|Adverse Event|1
4383209|NCT02460159|7161350|FG000|Overall Study|Withdrawal by Subject|2
4383210|NCT02460159|7161351|FG001|Overall Study|Withdrawal by Subject|0
4383211|NCT02457910|7161363|FG000|Overall Study|Withdrawal by Subject|0
4383212|NCT02457910|7161364|FG001|Overall Study|Withdrawal by Subject|0
4383213|NCT02457910|7161365|FG002|Overall Study|Withdrawal by Subject|0
4383214|NCT02457910|7161366|FG003|Overall Study|Withdrawal by Subject|0
4383215|NCT02457910|7161367|FG004|Overall Study|Withdrawal by Subject|0
4383216|NCT02457910|7161368|FG005|Overall Study|Withdrawal by Subject|1
4383217|NCT02457910|7161363|FG000|Overall Study|Adverse Event|0
4383218|NCT02457910|7161364|FG001|Overall Study|Adverse Event|2
4383219|NCT02457910|7161365|FG002|Overall Study|Adverse Event|1
4383220|NCT02457910|7161366|FG003|Overall Study|Adverse Event|1
4383221|NCT02457910|7161367|FG004|Overall Study|Adverse Event|1
4383222|NCT02457910|7161368|FG005|Overall Study|Adverse Event|3
4383223|NCT02457910|7161363|FG000|Overall Study|Disease progression|3
4469086|NCT00633893|7261853|FG002|Overall Study|Adverse Event|126
4469087|NCT00633893|7261851|FG000|Overall Study|Withdrawal by Subject|7
4469088|NCT00633893|7261852|FG001|Overall Study|Withdrawal by Subject|12
4469089|NCT00633893|7261853|FG002|Overall Study|Withdrawal by Subject|6
4469090|NCT00633893|7261851|FG000|Overall Study|Lost to Follow-up|2
4469091|NCT00633893|7261852|FG001|Overall Study|Lost to Follow-up|4
4469092|NCT00633893|7261853|FG002|Overall Study|Lost to Follow-up|8
4469093|NCT00633893|7261851|FG000|Overall Study|Poor/non-compliance|5
4469094|NCT00633893|7261852|FG001|Overall Study|Poor/non-compliance|12
4469095|NCT00633893|7261853|FG002|Overall Study|Poor/non-compliance|3
4469096|NCT00633893|7261851|FG000|Overall Study|Pregnancy|2
4469097|NCT00633893|7261852|FG001|Overall Study|Pregnancy|1
4469098|NCT00633893|7261853|FG002|Overall Study|Pregnancy|1
4469099|NCT00633893|7261851|FG000|Overall Study|Not meet/no longer meets criteria|4
4469100|NCT00633893|7261852|FG001|Overall Study|Not meet/no longer meets criteria|6
4469101|NCT00633893|7261853|FG002|Overall Study|Not meet/no longer meets criteria|4
4469102|NCT00633893|7261851|FG000|Overall Study|Other|28
4469103|NCT00633893|7261852|FG001|Overall Study|Other|33
4469104|NCT00633893|7261853|FG002|Overall Study|Other|31
4469105|NCT00633932|7261873|FG000|Overall Study|Adverse Event|1
4469106|NCT00633932|7261874|FG001|Overall Study|Adverse Event|3
4469107|NCT00633932|7261875|FG002|Overall Study|Adverse Event|4
4469108|NCT00633932|7261873|FG000|Overall Study|Withdrawal by Subject|3
4469109|NCT00633932|7261874|FG001|Overall Study|Withdrawal by Subject|9
4469110|NCT00633932|7261875|FG002|Overall Study|Withdrawal by Subject|1
4469111|NCT00633932|7261873|FG000|Overall Study|Lost to Follow-up|1
4469112|NCT00633932|7261874|FG001|Overall Study|Lost to Follow-up|0
4469113|NCT00633932|7261875|FG002|Overall Study|Lost to Follow-up|2
4469114|NCT00633932|7261873|FG000|Overall Study|Protocol Violation|5
4469115|NCT00633932|7261874|FG001|Overall Study|Protocol Violation|2
4469116|NCT00633932|7261875|FG002|Overall Study|Protocol Violation|3
4469117|NCT00633932|7261873|FG000|Overall Study|Physician Decision|0
4469118|NCT00633932|7261874|FG001|Overall Study|Physician Decision|0
4469119|NCT00633932|7261875|FG002|Overall Study|Physician Decision|1
4469120|NCT00633932|7261873|FG000|Overall Study|Doctor's judgement|1
4469121|NCT00633932|7261874|FG001|Overall Study|Doctor's judgement|0
4469122|NCT00633932|7261875|FG002|Overall Study|Doctor's judgement|0
4469123|NCT00633932|7261873|FG000|Overall Study|Moved Away|1
4469124|NCT00633932|7261874|FG001|Overall Study|Moved Away|0
4469125|NCT00633932|7261875|FG002|Overall Study|Moved Away|0
4469126|NCT00633945|7261883|FG000|Overall Study|Physician Decision|2
4516449|NCT00960206|7327905|FG000|Overall Study|Missing 10 year data|20
4516450|NCT00960206|7327906|FG001|Overall Study|Missing 10 year data|1
4516451|NCT00960206|7327907|FG002|Overall Study|Missing 10 year data|1
4516452|NCT00960323|7327916|FG000|Atorvastatin Alone|Withdrawal by Subject|1
4516453|NCT00960375|7327926|FG000|Overall Study|Lost to Follow-up|20
4383224|NCT02457910|7161364|FG001|Overall Study|Disease progression|3
4383225|NCT02457910|7161365|FG002|Overall Study|Disease progression|1
4383226|NCT02457910|7161366|FG003|Overall Study|Disease progression|1
4588708|NCT01502644|7433337|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
4593794|NCT01555125|7442332|FG001|Extension|Technical Problems|0
4383227|NCT02457910|7161367|FG004|Overall Study|Disease progression|4
4383228|NCT02457910|7161368|FG005|Overall Study|Disease progression|6
4383229|NCT02457910|7161363|FG000|Overall Study|Other complicating illness|0
4383230|NCT02457910|7161364|FG001|Overall Study|Other complicating illness|0
4383231|NCT02457910|7161365|FG002|Overall Study|Other complicating illness|0
4383232|NCT02457910|7161366|FG003|Overall Study|Other complicating illness|0
4383233|NCT02457910|7161367|FG004|Overall Study|Other complicating illness|0
4383234|NCT02457910|7161368|FG005|Overall Study|Other complicating illness|1
4383235|NCT02457910|7161363|FG000|Overall Study|Death|0
4383236|NCT02457910|7161364|FG001|Overall Study|Death|0
4383237|NCT02457910|7161365|FG002|Overall Study|Death|1
4383238|NCT02457910|7161366|FG003|Overall Study|Death|0
4383239|NCT02457910|7161367|FG004|Overall Study|Death|0
4383240|NCT02457910|7161368|FG005|Overall Study|Death|0
4383241|NCT02407236|7161393|FG000|Induction Study (8 Weeks)|Adverse Event|3
4383242|NCT02407236|7161394|FG001|Induction Study (8 Weeks)|Adverse Event|0
4383243|NCT02407236|7161395|FG002|Induction Study (8 Weeks)|Adverse Event|1
4383244|NCT02407236|7161396|FG003|Induction Study (8 Weeks)|Adverse Event|0
4383245|NCT02407236|7161397|FG004|Induction Study (8 Weeks)|Adverse Event|0
4383246|NCT02407236|7161398|FG005|Induction Study (8 Weeks)|Adverse Event|0
4383247|NCT02407236|7161399|FG006|Induction Study (8 Weeks)|Adverse Event|0
4383248|NCT02407236|7161400|FG007|Induction Study (8 Weeks)|Adverse Event|0
4383249|NCT02407236|7161393|FG000|Induction Study (8 Weeks)|Death|0
4383250|NCT02407236|7161394|FG001|Induction Study (8 Weeks)|Death|0
4383251|NCT02407236|7161395|FG002|Induction Study (8 Weeks)|Death|1
4383252|NCT02407236|7161396|FG003|Induction Study (8 Weeks)|Death|0
4383253|NCT02407236|7161397|FG004|Induction Study (8 Weeks)|Death|0
4383254|NCT02407236|7161398|FG005|Induction Study (8 Weeks)|Death|0
4383255|NCT02407236|7161399|FG006|Induction Study (8 Weeks)|Death|0
4383256|NCT02407236|7161400|FG007|Induction Study (8 Weeks)|Death|0
4383257|NCT02407236|7161393|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17
4383258|NCT02407236|7161394|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9
4383259|NCT02407236|7161395|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7
4383260|NCT02407236|7161396|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0
4383261|NCT02407236|7161397|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0
4383262|NCT02407236|7161398|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0
4383263|NCT02407236|7161399|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0
4383264|NCT02407236|7161400|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0
4383265|NCT02407236|7161393|FG000|Induction Study (8 Weeks)|Lost to Follow-up|0
4383266|NCT02407236|7161394|FG001|Induction Study (8 Weeks)|Lost to Follow-up|0
4383267|NCT02407236|7161395|FG002|Induction Study (8 Weeks)|Lost to Follow-up|1
4383268|NCT02407236|7161396|FG003|Induction Study (8 Weeks)|Lost to Follow-up|0
4383269|NCT02407236|7161397|FG004|Induction Study (8 Weeks)|Lost to Follow-up|0
4383270|NCT02407236|7161398|FG005|Induction Study (8 Weeks)|Lost to Follow-up|0
4383271|NCT02407236|7161399|FG006|Induction Study (8 Weeks)|Lost to Follow-up|0
4383272|NCT02407236|7161400|FG007|Induction Study (8 Weeks)|Lost to Follow-up|0
4383273|NCT02407236|7161393|FG000|Induction Study (8 Weeks)|Physician Decision|1
4383274|NCT02407236|7161394|FG001|Induction Study (8 Weeks)|Physician Decision|1
4383275|NCT02407236|7161395|FG002|Induction Study (8 Weeks)|Physician Decision|0
4383276|NCT02407236|7161396|FG003|Induction Study (8 Weeks)|Physician Decision|0
4383277|NCT02407236|7161397|FG004|Induction Study (8 Weeks)|Physician Decision|0
4383278|NCT02407236|7161398|FG005|Induction Study (8 Weeks)|Physician Decision|0
4383279|NCT02407236|7161399|FG006|Induction Study (8 Weeks)|Physician Decision|0
4383280|NCT02407236|7161400|FG007|Induction Study (8 Weeks)|Physician Decision|0
4383281|NCT02407236|7161393|FG000|Induction Study (8 Weeks)|Other|2
4383282|NCT02407236|7161394|FG001|Induction Study (8 Weeks)|Other|1
4383283|NCT02407236|7161395|FG002|Induction Study (8 Weeks)|Other|5
4383284|NCT02407236|7161396|FG003|Induction Study (8 Weeks)|Other|0
4383285|NCT02407236|7161397|FG004|Induction Study (8 Weeks)|Other|0
4383286|NCT02407236|7161398|FG005|Induction Study (8 Weeks)|Other|0
4383287|NCT02407236|7161399|FG006|Induction Study (8 Weeks)|Other|0
4383288|NCT02407236|7161400|FG007|Induction Study (8 Weeks)|Other|0
4383289|NCT02407236|7161393|FG000|Maintenance Study (44 Weeks)|Lost to Follow-up|0
4383290|NCT02407236|7161394|FG001|Maintenance Study (44 Weeks)|Lost to Follow-up|0
4383291|NCT02407236|7161395|FG002|Maintenance Study (44 Weeks)|Lost to Follow-up|0
4383292|NCT02407236|7161396|FG003|Maintenance Study (44 Weeks)|Lost to Follow-up|1
4383293|NCT02407236|7161397|FG004|Maintenance Study (44 Weeks)|Lost to Follow-up|0
4383294|NCT02407236|7161398|FG005|Maintenance Study (44 Weeks)|Lost to Follow-up|1
4383295|NCT02407236|7161399|FG006|Maintenance Study (44 Weeks)|Lost to Follow-up|0
4383296|NCT02407236|7161400|FG007|Maintenance Study (44 Weeks)|Lost to Follow-up|1
4383297|NCT02407236|7161393|FG000|Maintenance Study (44 Weeks)|Death|0
4383298|NCT02407236|7161394|FG001|Maintenance Study (44 Weeks)|Death|0
4383299|NCT02407236|7161395|FG002|Maintenance Study (44 Weeks)|Death|0
4383300|NCT02407236|7161396|FG003|Maintenance Study (44 Weeks)|Death|0
4383301|NCT02407236|7161397|FG004|Maintenance Study (44 Weeks)|Death|0
4469127|NCT00633984|7261891|FG000|Overall Study|Lost to Follow-up|0
4383302|NCT02407236|7161398|FG005|Maintenance Study (44 Weeks)|Death|0
4383303|NCT02407236|7161399|FG006|Maintenance Study (44 Weeks)|Death|0
4383304|NCT02407236|7161400|FG007|Maintenance Study (44 Weeks)|Death|1
4383305|NCT02407236|7161393|FG000|Maintenance Study (44 Weeks)|Withdraw of consent|0
4383306|NCT02407236|7161394|FG001|Maintenance Study (44 Weeks)|Withdraw of consent|0
4383307|NCT02407236|7161395|FG002|Maintenance Study (44 Weeks)|Withdraw of consent|0
4383308|NCT02407236|7161396|FG003|Maintenance Study (44 Weeks)|Withdraw of consent|8
4383309|NCT02407236|7161397|FG004|Maintenance Study (44 Weeks)|Withdraw of consent|10
4383310|NCT02407236|7161398|FG005|Maintenance Study (44 Weeks)|Withdraw of consent|5
4383311|NCT02407236|7161399|FG006|Maintenance Study (44 Weeks)|Withdraw of consent|7
4383312|NCT02407236|7161400|FG007|Maintenance Study (44 Weeks)|Withdraw of consent|5
4383313|NCT02407236|7161393|FG000|Maintenance Study (44 Weeks)|Sponsor decision|0
4383314|NCT02407236|7161394|FG001|Maintenance Study (44 Weeks)|Sponsor decision|0
4383315|NCT02407236|7161395|FG002|Maintenance Study (44 Weeks)|Sponsor decision|0
4383316|NCT02407236|7161396|FG003|Maintenance Study (44 Weeks)|Sponsor decision|1
4383317|NCT02407236|7161397|FG004|Maintenance Study (44 Weeks)|Sponsor decision|0
4383318|NCT02407236|7161398|FG005|Maintenance Study (44 Weeks)|Sponsor decision|1
4383319|NCT02407236|7161399|FG006|Maintenance Study (44 Weeks)|Sponsor decision|0
4383320|NCT02407236|7161400|FG007|Maintenance Study (44 Weeks)|Sponsor decision|0
4383321|NCT02407236|7161393|FG000|Maintenance Study (44 Weeks)|Other|0
4383322|NCT02407236|7161394|FG001|Maintenance Study (44 Weeks)|Other|0
4383323|NCT02407236|7161395|FG002|Maintenance Study (44 Weeks)|Other|0
4383324|NCT02407236|7161396|FG003|Maintenance Study (44 Weeks)|Other|0
4383325|NCT02407236|7161397|FG004|Maintenance Study (44 Weeks)|Other|1
4383326|NCT02407236|7161398|FG005|Maintenance Study (44 Weeks)|Other|1
4383327|NCT02407236|7161399|FG006|Maintenance Study (44 Weeks)|Other|2
4383328|NCT02407236|7161400|FG007|Maintenance Study (44 Weeks)|Other|1
4383329|NCT02320396|7161420|FG000|Overall Study|Adverse Event|2
4383330|NCT02320396|7161421|FG001|Overall Study|Adverse Event|2
4383331|NCT02320396|7161420|FG000|Overall Study|Pregnancy|0
4383332|NCT02320396|7161421|FG001|Overall Study|Pregnancy|1
4383333|NCT02320396|7161420|FG000|Overall Study|Protocol Violation|0
4383334|NCT02320396|7161421|FG001|Overall Study|Protocol Violation|1
4383335|NCT02320396|7161420|FG000|Overall Study|Withdrawal by Subject|2
4383336|NCT02320396|7161421|FG001|Overall Study|Withdrawal by Subject|0
4383337|NCT02282345|7161429|FG000|Overall Study|Progression|0
4383338|NCT02282345|7161430|FG001|Overall Study|Progression|1
4383339|NCT02230410|7161439|FG000|Overall Study|Screen Failure|3
4383340|NCT02053246|7161443|FG000|Overall Study|Withdrawal by Subject|3
4383341|NCT02053246|7161443|FG000|Overall Study|Physician Decision|1
4383342|NCT02005471|7161449|FG000|Overall Study|Ongoing in Study|144
4383343|NCT02005471|7161450|FG001|Overall Study|Ongoing in Study|171
4383344|NCT02005471|7161449|FG000|Overall Study|Adverse Event|1
4383345|NCT02005471|7161450|FG001|Overall Study|Adverse Event|0
4383346|NCT02005471|7161449|FG000|Overall Study|Death|26
4383347|NCT02005471|7161450|FG001|Overall Study|Death|15
4383348|NCT02005471|7161449|FG000|Overall Study|Lost to Follow-up|1
4383349|NCT02005471|7161450|FG001|Overall Study|Lost to Follow-up|0
4383350|NCT02005471|7161449|FG000|Overall Study|Physician Decision|2
4383351|NCT02005471|7161450|FG001|Overall Study|Physician Decision|1
4383352|NCT02005471|7161449|FG000|Overall Study|Progressive Disease|3
4383353|NCT02005471|7161450|FG001|Overall Study|Progressive Disease|0
4383354|NCT02005471|7161449|FG000|Overall Study|Withdrawal by Subject|18
4383355|NCT02005471|7161450|FG001|Overall Study|Withdrawal by Subject|7
4383356|NCT01980940|7161467|FG000|Overall Study|Protocol Violation|0
4383357|NCT01980940|7161468|FG001|Overall Study|Protocol Violation|0
4383358|NCT01980940|7161469|FG002|Overall Study|Protocol Violation|0
4383359|NCT01980940|7161470|FG003|Overall Study|Protocol Violation|0
4383360|NCT01980940|7161471|FG004|Overall Study|Protocol Violation|0
4383361|NCT01980940|7161472|FG005|Overall Study|Protocol Violation|2
4383362|NCT01980940|7161473|FG006|Overall Study|Protocol Violation|0
4383363|NCT01980940|7161474|FG007|Overall Study|Protocol Violation|0
4383364|NCT01918033|7161505|FG000|Overall Study|Adverse Event|1
4383365|NCT01918033|7161506|FG001|Overall Study|Adverse Event|0
4383366|NCT01918033|7161507|FG002|Overall Study|Adverse Event|2
4383367|NCT01918033|7161505|FG000|Overall Study|Lost to Follow-up|0
4383368|NCT01918033|7161506|FG001|Overall Study|Lost to Follow-up|1
4383369|NCT01918033|7161507|FG002|Overall Study|Lost to Follow-up|0
4383370|NCT01918033|7161505|FG000|Overall Study|Protocol Violation|2
4383371|NCT01918033|7161506|FG001|Overall Study|Protocol Violation|0
4383372|NCT01918033|7161507|FG002|Overall Study|Protocol Violation|1
4383373|NCT01918033|7161505|FG000|Overall Study|Withdrawal by Subject|2
4383374|NCT01918033|7161506|FG001|Overall Study|Withdrawal by Subject|1
4383375|NCT01918033|7161507|FG002|Overall Study|Withdrawal by Subject|0
4383376|NCT01916980|7161517|FG000|Overall Study|Adverse Event|4
4383377|NCT01916980|7161518|FG001|Overall Study|Adverse Event|2
4383378|NCT01916980|7161517|FG000|Overall Study|Lack of Efficacy|2
4383379|NCT01916980|7161518|FG001|Overall Study|Lack of Efficacy|2
4383380|NCT01916980|7161517|FG000|Overall Study|Withdrawal by Subject|1
4383381|NCT01916980|7161518|FG001|Overall Study|Withdrawal by Subject|0
4383382|NCT01916967|7161527|FG000|Overall Study|Adverse Event|0
4383383|NCT01916967|7161528|FG001|Overall Study|Adverse Event|0
4383384|NCT01916967|7161529|FG002|Overall Study|Adverse Event|2
4383385|NCT01916967|7161527|FG000|Overall Study|Lack of Efficacy|0
4383386|NCT01916967|7161528|FG001|Overall Study|Lack of Efficacy|0
4383387|NCT01916967|7161529|FG002|Overall Study|Lack of Efficacy|6
4383388|NCT01916967|7161527|FG000|Overall Study|Physician Decision|0
4383389|NCT01916967|7161528|FG001|Overall Study|Physician Decision|0
4383390|NCT01916967|7161529|FG002|Overall Study|Physician Decision|1
4383391|NCT01916967|7161527|FG000|Overall Study|Protocol Violation|0
4383392|NCT01916967|7161528|FG001|Overall Study|Protocol Violation|1
4383393|NCT01916967|7161529|FG002|Overall Study|Protocol Violation|0
4383394|NCT01910402|7161541|FG000|Randomized Phase|Adverse Event|10
4383395|NCT01910402|7161542|FG001|Randomized Phase|Adverse Event|18
4383396|NCT01910402|7161541|FG000|Randomized Phase|Physician Decision|1
4383397|NCT01910402|7161542|FG001|Randomized Phase|Physician Decision|0
4383398|NCT01910402|7161541|FG000|Randomized Phase|Lack of Efficacy|5
4383399|NCT01910402|7161542|FG001|Randomized Phase|Lack of Efficacy|4
4383400|NCT01910402|7161541|FG000|Randomized Phase|Lost to Follow-up|11
4383401|NCT01910402|7161542|FG001|Randomized Phase|Lost to Follow-up|13
4383402|NCT01910402|7161541|FG000|Randomized Phase|Protocol Violation|10
4383403|NCT01910402|7161542|FG001|Randomized Phase|Protocol Violation|13
4383404|NCT01910402|7161541|FG000|Randomized Phase|Withdrawal by Subject|5
4383405|NCT01910402|7161542|FG001|Randomized Phase|Withdrawal by Subject|7
4383406|NCT01910402|7161541|FG000|Continuation Phase|Ongoing|84
4383407|NCT01910402|7161542|FG001|Continuation Phase|Ongoing|0
4383408|NCT01910402|7161541|FG000|Continuation Phase|Adverse Event|1
4383409|NCT01910402|7161542|FG001|Continuation Phase|Adverse Event|0
4383410|NCT01910402|7161541|FG000|Continuation Phase|Protocol Violation|3
4383411|NCT01910402|7161542|FG001|Continuation Phase|Protocol Violation|0
4383412|NCT01910402|7161541|FG000|Continuation Phase|Withdrawal by Subject|2
4383413|NCT01910402|7161542|FG001|Continuation Phase|Withdrawal by Subject|0
4383414|NCT01870401|7161561|FG000|Overall Study|Death|48
4383415|NCT01870401|7161562|FG001|Overall Study|Death|24
4383416|NCT01870401|7161561|FG000|Overall Study|Withdrawal by Subject|39
4383417|NCT01870401|7161562|FG001|Overall Study|Withdrawal by Subject|26
4383418|NCT01870401|7161561|FG000|Overall Study|Lost to Follow-up|19
4383419|NCT01870401|7161562|FG001|Overall Study|Lost to Follow-up|14
4383420|NCT01870401|7161561|FG000|Overall Study|Other|9
4383421|NCT01870401|7161562|FG001|Overall Study|Other|7
4383422|NCT01870401|7161561|FG000|Overall Study|On-going in the Study|35
4383423|NCT01870401|7161562|FG001|Overall Study|On-going in the Study|25
4383424|NCT01867606|7161572|FG000|Overall Study|Withdrawal by Subject|10
4383425|NCT01867606|7161573|FG001|Overall Study|Withdrawal by Subject|14
4383426|NCT01867606|7161572|FG000|Overall Study|Protocol Violation|0
4383427|NCT01867606|7161573|FG001|Overall Study|Protocol Violation|1
4383428|NCT01857063|7161587|FG000|Period 1 (7 Days)|Adverse Event|0
4383429|NCT01857063|7161588|FG001|Period 1 (7 Days)|Adverse Event|1
4383430|NCT01857063|7161587|FG000|Period 1 (7 Days)|Physician Decision|1
4383431|NCT01857063|7161588|FG001|Period 1 (7 Days)|Physician Decision|0
4383432|NCT01857063|7161587|FG000|Period 1 (7 Days)|Withdrawal by Subject|1
4383433|NCT01857063|7161588|FG001|Period 1 (7 Days)|Withdrawal by Subject|3
4383434|NCT01857063|7161587|FG000|Period 2 (7 Days)|Adverse Event|2
4383435|NCT01857063|7161588|FG001|Period 2 (7 Days)|Adverse Event|1
4383436|NCT01857063|7161587|FG000|Period 2 (7 Days)|Physician Decision|1
4383437|NCT01857063|7161588|FG001|Period 2 (7 Days)|Physician Decision|1
4383438|NCT01857063|7161587|FG000|Period 2 (7 Days)|Withdrawal by Subject|1
4383439|NCT01857063|7161588|FG001|Period 2 (7 Days)|Withdrawal by Subject|0
4383440|NCT01852812|7161601|FG000|Overall Study|Adverse Event|0
4383441|NCT01852812|7161602|FG001|Overall Study|Adverse Event|0
4383442|NCT01852812|7161603|FG002|Overall Study|Adverse Event|1
4383443|NCT01852812|7161601|FG000|Overall Study|Non-compliance With Study Drug|0
4383444|NCT01852812|7161602|FG001|Overall Study|Non-compliance With Study Drug|1
4383445|NCT01852812|7161603|FG002|Overall Study|Non-compliance With Study Drug|0
4383446|NCT01844986|7161613|FG000|Overall Study|Severe non-compliance to protocol|1
4383447|NCT01844986|7161614|FG001|Overall Study|Severe non-compliance to protocol|0
4383448|NCT01844986|7161613|FG000|Overall Study|Withdrawal by Subject|21
4383449|NCT01844986|7161614|FG001|Overall Study|Withdrawal by Subject|14
4383450|NCT01844986|7161613|FG000|Overall Study|Death|55
4383451|NCT01844986|7161614|FG001|Overall Study|Death|26
4383452|NCT01828021|7161620|FG000|Overall Study|Adverse Event|5
4383453|NCT01828021|7161620|FG000|Overall Study|Lack of Efficacy|17
4383454|NCT01828021|7161620|FG000|Overall Study|Withdrawal by Subject|2
4383455|NCT01828021|7161620|FG000|Overall Study|Ileal obstruction, unrelated|1
4383456|NCT01709318|7161631|FG000|Overall Study|Adverse Event|3
4383457|NCT01709318|7161632|FG001|Overall Study|Adverse Event|4
4383458|NCT01709318|7161633|FG002|Overall Study|Adverse Event|2
4383459|NCT01709318|7161634|FG003|Overall Study|Adverse Event|2
4383460|NCT01709318|7161635|FG004|Overall Study|Adverse Event|0
4383461|NCT01709318|7161636|FG005|Overall Study|Adverse Event|1
4383462|NCT01709318|7161637|FG006|Overall Study|Adverse Event|2
4383463|NCT01709318|7161631|FG000|Overall Study|Lost to Follow-up|2
4383464|NCT01709318|7161632|FG001|Overall Study|Lost to Follow-up|0
4383465|NCT01709318|7161633|FG002|Overall Study|Lost to Follow-up|0
4383466|NCT01709318|7161634|FG003|Overall Study|Lost to Follow-up|0
4383467|NCT01709318|7161635|FG004|Overall Study|Lost to Follow-up|1
4383468|NCT01709318|7161636|FG005|Overall Study|Lost to Follow-up|1
4383469|NCT01709318|7161637|FG006|Overall Study|Lost to Follow-up|1
4383470|NCT01709318|7161631|FG000|Overall Study|Non-compliance with Study Drug|0
4383471|NCT01709318|7161632|FG001|Overall Study|Non-compliance with Study Drug|2
4383472|NCT01709318|7161633|FG002|Overall Study|Non-compliance with Study Drug|1
4383473|NCT01709318|7161634|FG003|Overall Study|Non-compliance with Study Drug|1
4383474|NCT01709318|7161635|FG004|Overall Study|Non-compliance with Study Drug|0
4383475|NCT01709318|7161636|FG005|Overall Study|Non-compliance with Study Drug|0
4383476|NCT01709318|7161637|FG006|Overall Study|Non-compliance with Study Drug|2
4383477|NCT01709318|7161631|FG000|Overall Study|Physician Decision|0
4383478|NCT01709318|7161632|FG001|Overall Study|Physician Decision|0
4383479|NCT01709318|7161633|FG002|Overall Study|Physician Decision|0
4383480|NCT01709318|7161634|FG003|Overall Study|Physician Decision|0
4383481|NCT01709318|7161635|FG004|Overall Study|Physician Decision|0
4383482|NCT01709318|7161636|FG005|Overall Study|Physician Decision|0
4383483|NCT01709318|7161637|FG006|Overall Study|Physician Decision|1
4383484|NCT01709318|7161631|FG000|Overall Study|Pregnancy|0
4383485|NCT01709318|7161632|FG001|Overall Study|Pregnancy|0
4383486|NCT01709318|7161633|FG002|Overall Study|Pregnancy|0
4383487|NCT01709318|7161634|FG003|Overall Study|Pregnancy|0
4383488|NCT01709318|7161635|FG004|Overall Study|Pregnancy|1
4383489|NCT01709318|7161636|FG005|Overall Study|Pregnancy|0
4383490|NCT01709318|7161637|FG006|Overall Study|Pregnancy|0
4383491|NCT01709318|7161631|FG000|Overall Study|Protocol Violation|0
4383492|NCT01709318|7161632|FG001|Overall Study|Protocol Violation|0
4383493|NCT01709318|7161633|FG002|Overall Study|Protocol Violation|0
4383494|NCT01709318|7161634|FG003|Overall Study|Protocol Violation|0
4383495|NCT01709318|7161635|FG004|Overall Study|Protocol Violation|2
4383496|NCT01709318|7161636|FG005|Overall Study|Protocol Violation|0
4383497|NCT01709318|7161637|FG006|Overall Study|Protocol Violation|1
4383498|NCT01709318|7161631|FG000|Overall Study|Technical Problems|1
4383499|NCT01709318|7161632|FG001|Overall Study|Technical Problems|0
4383500|NCT01709318|7161633|FG002|Overall Study|Technical Problems|0
4383501|NCT01709318|7161634|FG003|Overall Study|Technical Problems|0
4383502|NCT01709318|7161635|FG004|Overall Study|Technical Problems|0
4383503|NCT01709318|7161636|FG005|Overall Study|Technical Problems|0
4383504|NCT01709318|7161637|FG006|Overall Study|Technical Problems|0
4383505|NCT01709318|7161631|FG000|Overall Study|Withdrawal by Subject|3
4383506|NCT01709318|7161632|FG001|Overall Study|Withdrawal by Subject|0
4383507|NCT01709318|7161633|FG002|Overall Study|Withdrawal by Subject|3
4383508|NCT01709318|7161634|FG003|Overall Study|Withdrawal by Subject|3
4383509|NCT01709318|7161635|FG004|Overall Study|Withdrawal by Subject|0
4383510|NCT01709318|7161636|FG005|Overall Study|Withdrawal by Subject|2
4469128|NCT00633984|7261892|FG001|Overall Study|Lost to Follow-up|6
4469129|NCT00633984|7261891|FG000|Overall Study|Withdrawal by Subject|8
4469130|NCT00633984|7261892|FG001|Overall Study|Withdrawal by Subject|7
4469131|NCT00633984|7261891|FG000|Overall Study|Hospitalized|1
4588709|NCT01502644|7433334|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6
4469132|NCT00633984|7261892|FG001|Overall Study|Hospitalized|0
4469133|NCT00634036|7261900|FG000|Overall Study|Lost to Follow-up|1
4469134|NCT00634036|7261901|FG001|Overall Study|Lost to Follow-up|1
4469135|NCT00634036|7261900|FG000|Overall Study|Withdrawal by Subject|1
4469136|NCT00634036|7261901|FG001|Overall Study|Withdrawal by Subject|1
4469137|NCT00634049|7261907|FG000|Overall Study|Never received study drug|1
4469138|NCT00634049|7261907|FG000|Overall Study|Died prior to receiving study drug|1
4469139|NCT00634049|7261907|FG000|Overall Study|Screening failure|1
4469140|NCT00634088|7261944|FG000|Time Period 1: Dose Level 1|Disease progression|2
4469141|NCT00634088|7261945|FG001|Time Period 1: Dose Level 1|Disease progression|0
4469142|NCT00634088|7261946|FG002|Time Period 1: Dose Level 1|Disease progression|0
4469143|NCT00634088|7261947|FG003|Time Period 1: Dose Level 1|Disease progression|0
4469144|NCT00634088|7261944|FG000|Time Period 1: Dose Level 1|Physician Decision|1
4469145|NCT00634088|7261945|FG001|Time Period 1: Dose Level 1|Physician Decision|0
4469146|NCT00634088|7261946|FG002|Time Period 1: Dose Level 1|Physician Decision|0
4469147|NCT00634088|7261947|FG003|Time Period 1: Dose Level 1|Physician Decision|0
4469148|NCT00634088|7261944|FG000|Time Period 1: Dose Level 1|Adverse Event|3
4469149|NCT00634088|7261945|FG001|Time Period 1: Dose Level 1|Adverse Event|0
4469150|NCT00634088|7261946|FG002|Time Period 1: Dose Level 1|Adverse Event|0
4469151|NCT00634088|7261947|FG003|Time Period 1: Dose Level 1|Adverse Event|0
4469152|NCT00634088|7261944|FG000|Time Period 2: Dose Level 2|Adverse Event|0
4469153|NCT00634088|7261945|FG001|Time Period 2: Dose Level 2|Adverse Event|2
4469154|NCT00634088|7261946|FG002|Time Period 2: Dose Level 2|Adverse Event|0
4469155|NCT00634088|7261947|FG003|Time Period 2: Dose Level 2|Adverse Event|0
4469156|NCT00634088|7261944|FG000|Time Period 2: Dose Level 2|Progressive disease|0
4469157|NCT00634088|7261945|FG001|Time Period 2: Dose Level 2|Progressive disease|1
4469158|NCT00634088|7261946|FG002|Time Period 2: Dose Level 2|Progressive disease|0
4469159|NCT00634088|7261947|FG003|Time Period 2: Dose Level 2|Progressive disease|0
4469160|NCT00634088|7261944|FG000|Time Period 3: Dose Level 3|Progressive disease|0
4469161|NCT00634088|7261945|FG001|Time Period 3: Dose Level 3|Progressive disease|0
4588710|NCT01502644|7433335|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
4469162|NCT00634088|7261946|FG002|Time Period 3: Dose Level 3|Progressive disease|1
4469163|NCT00634088|7261947|FG003|Time Period 3: Dose Level 3|Progressive disease|0
4469164|NCT00634101|7261959|FG000|Overall Study|Study Terminated|3
4469165|NCT00634101|7261960|FG001|Overall Study|Study Terminated|3
4469166|NCT00634101|7261959|FG000|Overall Study|Lost to Follow-up|2
4469167|NCT00634101|7261960|FG001|Overall Study|Lost to Follow-up|0
4383511|NCT01709318|7161637|FG006|Overall Study|Withdrawal by Subject|4
4383512|NCT01709318|7161631|FG000|Overall Study|Other Protocol Specified Criteria|0
4383513|NCT01709318|7161632|FG001|Overall Study|Other Protocol Specified Criteria|1
4383514|NCT01709318|7161633|FG002|Overall Study|Other Protocol Specified Criteria|0
4383515|NCT01709318|7161634|FG003|Overall Study|Other Protocol Specified Criteria|0
4383516|NCT01709318|7161635|FG004|Overall Study|Other Protocol Specified Criteria|0
4383517|NCT01709318|7161636|FG005|Overall Study|Other Protocol Specified Criteria|0
4383518|NCT01709318|7161637|FG006|Overall Study|Other Protocol Specified Criteria|0
4383519|NCT01698918|7161653|FG000|First Line Treatment (Core+Extension)|Adverse Event|33
4383520|NCT01698918|7161653|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11
4383521|NCT01698918|7161653|FG000|First Line Treatment (Core+Extension)|Death|2
4383522|NCT01698918|7161653|FG000|First Line Treatment (Core+Extension)|Disease progression|120
4383523|NCT01698918|7161653|FG000|First Line Treatment (Core+Extension)|Physician Decision|7
4383524|NCT01698918|7161653|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3
4383525|NCT01698918|7161653|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1
4383526|NCT01698918|7161653|FG000|Second Line Treatment (Core+Extension)|Death|1
4383527|NCT01698918|7161653|FG000|Second Line Treatment (Core+Extension)|Disease progression|38
4383528|NCT01698918|7161653|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3
4383529|NCT01673620|7161667|FG000|Overall Study|Adverse Event|1
4383530|NCT01673620|7161668|FG001|Overall Study|Adverse Event|0
4383531|NCT01660243|7161678|FG000|Overall Study|Adverse Event|1
4383532|NCT01660243|7161679|FG001|Overall Study|Adverse Event|0
4383533|NCT01660243|7161680|FG002|Overall Study|Adverse Event|1
4383534|NCT01660243|7161681|FG003|Overall Study|Adverse Event|0
4383535|NCT01660243|7161678|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1
4383536|NCT01660243|7161679|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0
4383537|NCT01660243|7161680|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0
4383538|NCT01660243|7161681|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0
4383539|NCT01660243|7161678|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0
4383540|NCT01660243|7161679|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0
4383541|NCT01660243|7161680|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1
4383542|NCT01660243|7161681|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0
4383543|NCT01660243|7161678|FG000|Overall Study|Randomization error|0
4383544|NCT01660243|7161679|FG001|Overall Study|Randomization error|0
4383545|NCT01660243|7161680|FG002|Overall Study|Randomization error|0
4383546|NCT01660243|7161681|FG003|Overall Study|Randomization error|1
4383547|NCT01617187|7161695|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
4383548|NCT01617187|7161696|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
4383549|NCT01617187|7161697|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
4383550|NCT01617187|7161698|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1
4383551|NCT01617187|7161695|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0
4383552|NCT01617187|7161696|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0
4383553|NCT01617187|7161697|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0
4383554|NCT01617187|7161698|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1
4383555|NCT01617187|7161695|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1
4383556|NCT01617187|7161696|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0
4383557|NCT01617187|7161697|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0
4383558|NCT01617187|7161698|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0
4383559|NCT01617187|7161695|FG000|Treatment Through Study Completion|Adverse Event|1
4383560|NCT01617187|7161696|FG001|Treatment Through Study Completion|Adverse Event|1
4383561|NCT01617187|7161697|FG002|Treatment Through Study Completion|Adverse Event|0
4383562|NCT01617187|7161698|FG003|Treatment Through Study Completion|Adverse Event|1
4383563|NCT01617187|7161695|FG000|Treatment Through Study Completion|Lost to Follow-up|4
4383564|NCT01617187|7161696|FG001|Treatment Through Study Completion|Lost to Follow-up|2
4383565|NCT01617187|7161697|FG002|Treatment Through Study Completion|Lost to Follow-up|2
4383566|NCT01617187|7161698|FG003|Treatment Through Study Completion|Lost to Follow-up|2
4383567|NCT01617187|7161695|FG000|Treatment Through Study Completion|Withdrawal by Subject|5
4383568|NCT01617187|7161696|FG001|Treatment Through Study Completion|Withdrawal by Subject|8
4383569|NCT01617187|7161697|FG002|Treatment Through Study Completion|Withdrawal by Subject|3
4383570|NCT01617187|7161698|FG003|Treatment Through Study Completion|Withdrawal by Subject|6
4383571|NCT01617187|7161695|FG000|Treatment Through Study Completion|Protocol Violation|1
4383572|NCT01617187|7161696|FG001|Treatment Through Study Completion|Protocol Violation|0
4383573|NCT01617187|7161697|FG002|Treatment Through Study Completion|Protocol Violation|0
4383574|NCT01617187|7161698|FG003|Treatment Through Study Completion|Protocol Violation|1
4383575|NCT01611883|7161710|FG000|Overall Study|Adverse Event|1
4383576|NCT01611883|7161711|FG001|Overall Study|Adverse Event|1
4383577|NCT01572675|7161719|FG000|Overall Study|End of prescribed treatment|140
4383578|NCT01572675|7161720|FG001|Overall Study|End of prescribed treatment|118
4383579|NCT01572675|7161719|FG000|Overall Study|Recovery|16
4383580|NCT01572675|7161720|FG001|Overall Study|Recovery|23
4383581|NCT01572675|7161719|FG000|Overall Study|Lack of Efficacy|31
4383582|NCT01572675|7161720|FG001|Overall Study|Lack of Efficacy|31
4383583|NCT01572675|7161719|FG000|Overall Study|Intolerance|6
4383584|NCT01572675|7161720|FG001|Overall Study|Intolerance|5
4383585|NCT01572675|7161719|FG000|Overall Study|Improved symptoms|8
4383586|NCT01572675|7161720|FG001|Overall Study|Improved symptoms|2
4383587|NCT01572675|7161719|FG000|Overall Study|Surgical intervention|3
4383588|NCT01572675|7161720|FG001|Overall Study|Surgical intervention|6
4383589|NCT01572675|7161719|FG000|Overall Study|Withdrawal by Subject|5
4383590|NCT01572675|7161720|FG001|Overall Study|Withdrawal by Subject|1
4383591|NCT01572675|7161719|FG000|Overall Study|Physician Decision|2
4383592|NCT01572675|7161720|FG001|Overall Study|Physician Decision|2
4383593|NCT01572675|7161719|FG000|Overall Study|Death unrelated to coxibs|1
4383594|NCT01572675|7161720|FG001|Overall Study|Death unrelated to coxibs|1
4383595|NCT01572675|7161719|FG000|Overall Study|Other disease detected|1
4383596|NCT01572675|7161720|FG001|Overall Study|Other disease detected|1
4383597|NCT01572675|7161719|FG000|Overall Study|Unknown reason|1
4383598|NCT01572675|7161720|FG001|Overall Study|Unknown reason|1
4383599|NCT01572675|7161719|FG000|Overall Study|Rheumatologist new evaluation|0
4383600|NCT01572675|7161720|FG001|Overall Study|Rheumatologist new evaluation|1
4383601|NCT01572675|7161719|FG000|Overall Study|Missing data|1
4383602|NCT01572675|7161720|FG001|Overall Study|Missing data|4
4383603|NCT01572675|7161719|FG000|Overall Study|Lost to Follow-up|22
4383604|NCT01572675|7161720|FG001|Overall Study|Lost to Follow-up|27
4383605|NCT01554163|7161741|FG000|Overall Study|Adverse Event|3
4383606|NCT01554163|7161742|FG001|Overall Study|Adverse Event|0
4383607|NCT01554163|7161741|FG000|Overall Study|Lack of Efficacy|1
4383608|NCT01554163|7161742|FG001|Overall Study|Lack of Efficacy|0
4383609|NCT01554163|7161741|FG000|Overall Study|Lost to Follow-up|1
4383610|NCT01554163|7161742|FG001|Overall Study|Lost to Follow-up|0
4383611|NCT01554163|7161741|FG000|Overall Study|Non-Compliance With Study Drug|1
4383612|NCT01554163|7161742|FG001|Overall Study|Non-Compliance With Study Drug|1
4383613|NCT01554163|7161741|FG000|Overall Study|Protocol Violation|0
4383614|NCT01554163|7161742|FG001|Overall Study|Protocol Violation|4
4383615|NCT01554163|7161741|FG000|Overall Study|Withdrawal by Subject|1
4383616|NCT01554163|7161742|FG001|Overall Study|Withdrawal by Subject|5
4383617|NCT01554163|7161741|FG000|Overall Study|Not Treated|1
4383618|NCT01554163|7161742|FG001|Overall Study|Not Treated|0
4383619|NCT01502371|7161753|FG000|Overall Study|Withdrawal by Subject|1
4383620|NCT01502371|7161754|FG001|Overall Study|Withdrawal by Subject|2
4383621|NCT01502371|7161755|FG002|Overall Study|Withdrawal by Subject|1
4383622|NCT01502371|7161756|FG003|Overall Study|Withdrawal by Subject|1
4383623|NCT01502371|7161757|FG004|Overall Study|Withdrawal by Subject|1
4383624|NCT01502371|7161753|FG000|Overall Study|Adverse Event|2
4383625|NCT01502371|7161754|FG001|Overall Study|Adverse Event|1
4383626|NCT01502371|7161755|FG002|Overall Study|Adverse Event|0
4383627|NCT01502371|7161756|FG003|Overall Study|Adverse Event|4
4383628|NCT01502371|7161757|FG004|Overall Study|Adverse Event|3
4383629|NCT01502371|7161753|FG000|Overall Study|Treatment Failure|22
4383630|NCT01502371|7161754|FG001|Overall Study|Treatment Failure|20
4383631|NCT01502371|7161755|FG002|Overall Study|Treatment Failure|12
4383632|NCT01502371|7161756|FG003|Overall Study|Treatment Failure|19
4383633|NCT01502371|7161757|FG004|Overall Study|Treatment Failure|30
4383634|NCT01502371|7161753|FG000|Overall Study|Lack of Efficacy|3
4383635|NCT01502371|7161754|FG001|Overall Study|Lack of Efficacy|3
4383636|NCT01502371|7161755|FG002|Overall Study|Lack of Efficacy|2
4383637|NCT01502371|7161756|FG003|Overall Study|Lack of Efficacy|2
4383638|NCT01502371|7161757|FG004|Overall Study|Lack of Efficacy|4
4469168|NCT00634114|7261969|FG000|Overall Study|Adverse Event|6
4469169|NCT00634114|7261970|FG001|Overall Study|Adverse Event|8
4469170|NCT00634114|7261971|FG002|Overall Study|Adverse Event|3
4469171|NCT00634114|7261969|FG000|Overall Study|Withdrawal by Subject|9
4469172|NCT00634114|7261970|FG001|Overall Study|Withdrawal by Subject|6
4469173|NCT00634114|7261971|FG002|Overall Study|Withdrawal by Subject|11
4469174|NCT00634114|7261969|FG000|Overall Study|Lost to Follow-up|0
4469175|NCT00634114|7261970|FG001|Overall Study|Lost to Follow-up|0
4469176|NCT00634114|7261971|FG002|Overall Study|Lost to Follow-up|1
4469177|NCT00634114|7261969|FG000|Overall Study|Protocol Violation|3
4469178|NCT00634114|7261970|FG001|Overall Study|Protocol Violation|3
4469179|NCT00634114|7261971|FG002|Overall Study|Protocol Violation|1
4469180|NCT00634114|7261969|FG000|Overall Study|Pregnancy|1
4469181|NCT00634114|7261970|FG001|Overall Study|Pregnancy|0
4469182|NCT00634114|7261971|FG002|Overall Study|Pregnancy|0
4469183|NCT00634114|7261969|FG000|Overall Study|Incorrect enrolment|0
4469184|NCT00634114|7261970|FG001|Overall Study|Incorrect enrolment|1
4469185|NCT00634114|7261971|FG002|Overall Study|Incorrect enrolment|0
4469186|NCT00634114|7261969|FG000|Overall Study|Recurrence of reflux esophagitis|5
4469187|NCT00634114|7261970|FG001|Overall Study|Recurrence of reflux esophagitis|15
4469188|NCT00634114|7261971|FG002|Overall Study|Recurrence of reflux esophagitis|21
4469189|NCT00634114|7261969|FG000|Overall Study|Difficult to continue|3
4469190|NCT00634114|7261970|FG001|Overall Study|Difficult to continue|1
4383639|NCT01502371|7161753|FG000|Overall Study|Physician Decision|3
4383640|NCT01502371|7161754|FG001|Overall Study|Physician Decision|0
4383641|NCT01502371|7161755|FG002|Overall Study|Physician Decision|0
4383642|NCT01502371|7161756|FG003|Overall Study|Physician Decision|0
4383643|NCT01502371|7161757|FG004|Overall Study|Physician Decision|1
4383644|NCT01502371|7161753|FG000|Overall Study|Noncompliance with Study Drug|0
4383645|NCT01502371|7161754|FG001|Overall Study|Noncompliance with Study Drug|0
4383646|NCT01502371|7161755|FG002|Overall Study|Noncompliance with Study Drug|1
4383647|NCT01502371|7161756|FG003|Overall Study|Noncompliance with Study Drug|2
4383648|NCT01502371|7161757|FG004|Overall Study|Noncompliance with Study Drug|1
4383649|NCT01502371|7161753|FG000|Overall Study|Technical Problems|1
4383650|NCT01502371|7161754|FG001|Overall Study|Technical Problems|0
4383651|NCT01502371|7161755|FG002|Overall Study|Technical Problems|2
4383652|NCT01502371|7161756|FG003|Overall Study|Technical Problems|4
4383653|NCT01502371|7161757|FG004|Overall Study|Technical Problems|1
4383654|NCT01502371|7161753|FG000|Overall Study|Protocol Violation|9
4383655|NCT01502371|7161754|FG001|Overall Study|Protocol Violation|5
4383656|NCT01502371|7161755|FG002|Overall Study|Protocol Violation|6
4383657|NCT01502371|7161756|FG003|Overall Study|Protocol Violation|5
4383658|NCT01502371|7161757|FG004|Overall Study|Protocol Violation|10
4383659|NCT01502371|7161753|FG000|Overall Study|Excluded Medication|0
4383660|NCT01502371|7161754|FG001|Overall Study|Excluded Medication|1
4383661|NCT01502371|7161755|FG002|Overall Study|Excluded Medication|1
4383662|NCT01502371|7161756|FG003|Overall Study|Excluded Medication|0
4383663|NCT01502371|7161757|FG004|Overall Study|Excluded Medication|1
4383664|NCT01490190|7161770|FG000|Overall Study|Withdrawal by Subject|9
4383665|NCT01490190|7161770|FG000|Overall Study|Adverse Event|17
4383666|NCT01490190|7161770|FG000|Overall Study|Protocol Violation|5
4383667|NCT01490190|7161770|FG000|Overall Study|Lost to Follow-up|13
4383668|NCT01490190|7161770|FG000|Overall Study|Relocation|1
4383669|NCT01490190|7161770|FG000|Overall Study|Inconvenience|1
4383670|NCT01490190|7161770|FG000|Overall Study|Ring expulsion|2
4469191|NCT00634114|7261971|FG002|Overall Study|Difficult to continue|1
4469192|NCT00634114|7261969|FG000|Overall Study|Other reason|1
4469193|NCT00634114|7261970|FG001|Overall Study|Other reason|1
4469194|NCT00634114|7261971|FG002|Overall Study|Other reason|1
4469195|NCT00634179|7261988|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1
4469196|NCT00634244|7261998|FG000|Overall Study|Never started treatment|0
4469197|NCT00634244|7261999|FG001|Overall Study|Never started treatment|1
4469198|NCT00634244|7262000|FG002|Overall Study|Never started treatment|0
4469199|NCT00634244|7261998|FG000|Overall Study|Death|1
4469200|NCT00634244|7261999|FG001|Overall Study|Death|6
4469201|NCT00634244|7262000|FG002|Overall Study|Death|0
4469202|NCT00634244|7261998|FG000|Overall Study|Adverse Event|0
4469203|NCT00634244|7261999|FG001|Overall Study|Adverse Event|2
4469204|NCT00634244|7262000|FG002|Overall Study|Adverse Event|0
4469205|NCT00634244|7261998|FG000|Overall Study|Withdrawal by Subject|0
4469206|NCT00634244|7261999|FG001|Overall Study|Withdrawal by Subject|1
4469207|NCT00634244|7262000|FG002|Overall Study|Withdrawal by Subject|0
4469208|NCT00634244|7261998|FG000|Overall Study|Physician Decision|0
4469209|NCT00634244|7261999|FG001|Overall Study|Physician Decision|1
4469210|NCT00634244|7262000|FG002|Overall Study|Physician Decision|0
4469211|NCT00634244|7261998|FG000|Overall Study|Disease progression/relapse|0
4469212|NCT00634244|7261999|FG001|Overall Study|Disease progression/relapse|1
4469213|NCT00634244|7262000|FG002|Overall Study|Disease progression/relapse|0
4469214|NCT00634244|7261998|FG000|Overall Study|Other complicating disease|0
4469215|NCT00634244|7261999|FG001|Overall Study|Other complicating disease|1
4469216|NCT00634244|7262000|FG002|Overall Study|Other complicating disease|0
4469217|NCT00634504|7262031|FG000|Overall Study|Protocol Violation|1
4469218|NCT00634504|7262032|FG001|Overall Study|Protocol Violation|0
4469219|NCT00634543|7262040|FG000|Overall Study|Other|1
4469220|NCT00634543|7262041|FG001|Overall Study|Other|2
4469221|NCT00634543|7262040|FG000|Overall Study|Protocol Violation|3
4469222|NCT00634543|7262041|FG001|Overall Study|Protocol Violation|3
4469223|NCT00634543|7262040|FG000|Overall Study|Adverse Event|11
4469224|NCT00634543|7262041|FG001|Overall Study|Adverse Event|11
4469225|NCT00634543|7262040|FG000|Overall Study|Withdrawal by Subject|4
4469226|NCT00634543|7262041|FG001|Overall Study|Withdrawal by Subject|4
4469227|NCT00634543|7262040|FG000|Overall Study|Lost to Follow-up|0
4469228|NCT00634543|7262041|FG001|Overall Study|Lost to Follow-up|1
4469229|NCT00634569|7262049|FG000|Overall Study|Withdrawal by Subject|0
4469230|NCT00634569|7262050|FG001|Overall Study|Withdrawal by Subject|4
4469231|NCT00634569|7262049|FG000|Overall Study|Physician Decision|0
4469232|NCT00634569|7262050|FG001|Overall Study|Physician Decision|1
4469233|NCT00634647|7262064|FG000|Overall Study|death on study|3
4469234|NCT00634647|7262064|FG000|Overall Study|refused further treatment|3
4469235|NCT00634647|7262064|FG000|Overall Study|declined to participate before treatment|1
4469236|NCT00634751|7262072|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1
4469237|NCT00634751|7262073|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0
4469238|NCT00634751|7262074|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0
4469239|NCT00634751|7262075|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0
4469240|NCT00634751|7262072|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0
4469241|NCT00634751|7262073|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1
4469242|NCT00634751|7262074|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0
4469243|NCT00634751|7262075|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0
4469244|NCT00634751|7262072|FG000|Pancreatic and Bilial Tract Cancer|Death|0
4469245|NCT00634751|7262073|FG001|Pancreatic and Bilial Tract Cancer|Death|0
4383671|NCT01471340|7161776|FG000|Overall Study|Death|5
4383672|NCT01471340|7161777|FG001|Overall Study|Death|4
4383673|NCT01471340|7161776|FG000|Overall Study|Lost to Follow-up|0
4383674|NCT01471340|7161777|FG001|Overall Study|Lost to Follow-up|1
4383675|NCT01471340|7161776|FG000|Overall Study|Investigational site closure|0
4383676|NCT01471340|7161777|FG001|Overall Study|Investigational site closure|1
4383677|NCT01471340|7161776|FG000|Overall Study|Invalid informed consent|1
4383678|NCT01471340|7161777|FG001|Overall Study|Invalid informed consent|0
4383679|NCT01462370|7161783|FG000|Overall Study|Lack of Qualifying Event|1
4383680|NCT01462370|7161784|FG001|Overall Study|Lack of Qualifying Event|1
4383681|NCT01462370|7161783|FG000|Overall Study|Physician Decision|0
4383682|NCT01462370|7161784|FG001|Overall Study|Physician Decision|1
4383683|NCT01462370|7161783|FG000|Overall Study|Withdrawal by Subject|0
4383684|NCT01462370|7161784|FG001|Overall Study|Withdrawal by Subject|3
4383685|NCT01436253|7161790|FG000|Overall Study|Lost to Follow-up|182
4383686|NCT01436253|7161790|FG000|Overall Study|Not meeting all eligibility criteria|117
4383687|NCT01381679|7161824|FG000|Overall Study|Adverse Event|3
4383688|NCT01381679|7161824|FG000|Overall Study|Lost to Follow-up|885
4383689|NCT01370603|7161830|FG000|Period 1|Adverse Event|5
4383690|NCT01370603|7161831|FG001|Period 1|Adverse Event|3
4383691|NCT01370603|7161830|FG000|Period 1|Lost to Follow-up|2
4383692|NCT01370603|7161831|FG001|Period 1|Lost to Follow-up|0
4383693|NCT01370603|7161830|FG000|Period 1|Protocol Violation|2
4383694|NCT01370603|7161831|FG001|Period 1|Protocol Violation|2
4383695|NCT01370603|7161830|FG000|Period 1|Withdrawal by Subject|5
4383696|NCT01370603|7161831|FG001|Period 1|Withdrawal by Subject|5
4383697|NCT01370603|7161830|FG000|Crossover Washout|Adverse Event|2
4469246|NCT00634751|7262074|FG002|Pancreatic and Bilial Tract Cancer|Death|1
4469247|NCT00634751|7262075|FG003|Pancreatic and Bilial Tract Cancer|Death|1
4469248|NCT00634803|7262088|FG000|Overall Study|Lost to Follow-up|6
4469249|NCT00634803|7262089|FG001|Overall Study|Lost to Follow-up|7
4469250|NCT00634803|7262090|FG002|Overall Study|Lost to Follow-up|7
4469251|NCT00634842|7262100|FG000|Overall Study|Adverse Event|2
4469252|NCT00634842|7262101|FG001|Overall Study|Adverse Event|3
4469253|NCT00634842|7262100|FG000|Overall Study|Protocol Violation|8
4469254|NCT00634842|7262101|FG001|Overall Study|Protocol Violation|4
4469255|NCT00634842|7262100|FG000|Overall Study|Move to another state|1
4469256|NCT00634842|7262101|FG001|Overall Study|Move to another state|0
4469257|NCT00634842|7262100|FG000|Overall Study|Inclusion criteria were not met|1
4469258|NCT00634842|7262101|FG001|Overall Study|Inclusion criteria were not met|0
4469259|NCT00634842|7262100|FG000|Overall Study|Lost to Follow-up|1
4469260|NCT00634842|7262101|FG001|Overall Study|Lost to Follow-up|2
4469261|NCT00634842|7262100|FG000|Overall Study|Physician Decision|1
4469262|NCT00634842|7262101|FG001|Overall Study|Physician Decision|0
4469263|NCT00634842|7262100|FG000|Overall Study|Withdrawal by Subject|1
4469264|NCT00634842|7262101|FG001|Overall Study|Withdrawal by Subject|3
4469265|NCT00634842|7262100|FG000|Overall Study|Lack of time and intolerance to drug|0
4469266|NCT00634842|7262101|FG001|Overall Study|Lack of time and intolerance to drug|1
4469267|NCT00634842|7262100|FG000|Overall Study|Discontinued due to injection|0
4469268|NCT00634842|7262101|FG001|Overall Study|Discontinued due to injection|2
4469269|NCT00634842|7262100|FG000|Overall Study|No need of study drug to treat diabetes|0
4469270|NCT00634842|7262101|FG001|Overall Study|No need of study drug to treat diabetes|1
4469271|NCT00634842|7262100|FG000|Overall Study|No wish to keep taking Avandia|0
4469272|NCT00634842|7262101|FG001|Overall Study|No wish to keep taking Avandia|1
4469273|NCT00634842|7262100|FG000|Overall Study|Subject off study drug for too long|0
4469274|NCT00634842|7262101|FG001|Overall Study|Subject off study drug for too long|1
4469275|NCT00634907|7262109|FG000|Overall Study|Withdrawal by Subject|3
4469276|NCT00634907|7262110|FG001|Overall Study|Withdrawal by Subject|0
4469277|NCT00634907|7262109|FG000|Overall Study|Physician Decision|3
4469278|NCT00634907|7262110|FG001|Overall Study|Physician Decision|9
4469279|NCT00634907|7262109|FG000|Overall Study|Withdrawal by Subject|11
4469280|NCT00634907|7262110|FG001|Overall Study|Withdrawal by Subject|8
4469281|NCT00634920|7262119|FG000|Period 1 - Pre-Randomization|Adverse Event|0
4469282|NCT00634920|7262120|FG001|Period 1 - Pre-Randomization|Adverse Event|0
4469283|NCT00634920|7262121|FG002|Period 1 - Pre-Randomization|Adverse Event|36
4469284|NCT00634920|7262119|FG000|Period 1 - Pre-Randomization|Wound healing problems|0
4469285|NCT00634920|7262120|FG001|Period 1 - Pre-Randomization|Wound healing problems|0
4469286|NCT00634920|7262121|FG002|Period 1 - Pre-Randomization|Wound healing problems|16
4469287|NCT00634920|7262119|FG000|Period 1 - Pre-Randomization|Rejections|0
4469288|NCT00634920|7262120|FG001|Period 1 - Pre-Randomization|Rejections|0
4469289|NCT00634920|7262121|FG002|Period 1 - Pre-Randomization|Rejections|55
4469290|NCT00634920|7262119|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0
4469291|NCT00634920|7262120|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0
4469292|NCT00634920|7262121|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21
4469293|NCT00634920|7262119|FG000|Period 1 - Pre-Randomization|Non-Compliance|0
4469294|NCT00634920|7262120|FG001|Period 1 - Pre-Randomization|Non-Compliance|0
4469295|NCT00634920|7262121|FG002|Period 1 - Pre-Randomization|Non-Compliance|3
4469296|NCT00634920|7262119|FG000|Period 1 - Pre-Randomization|Other issues|0
4469297|NCT00634920|7262120|FG001|Period 1 - Pre-Randomization|Other issues|0
4383698|NCT01370603|7161831|FG001|Crossover Washout|Adverse Event|1
4383699|NCT01370603|7161830|FG000|Crossover Washout|Lost to Follow-up|2
4383700|NCT01370603|7161831|FG001|Crossover Washout|Lost to Follow-up|0
4383701|NCT01370603|7161830|FG000|Crossover Washout|Protocol Violation|1
4383702|NCT01370603|7161831|FG001|Crossover Washout|Protocol Violation|0
4383703|NCT01370603|7161830|FG000|Crossover Washout|Withdrawal by Subject|4
4383704|NCT01370603|7161831|FG001|Crossover Washout|Withdrawal by Subject|1
4383705|NCT01370603|7161830|FG000|Crossover Washout|Non-compliance with Study Drug|0
4383706|NCT01370603|7161831|FG001|Crossover Washout|Non-compliance with Study Drug|2
4383707|NCT01370603|7161830|FG000|Period 2|Adverse Event|1
4697241|NCT02646891|7610481|FG007|Overall Study|Death|1
4383708|NCT01370603|7161831|FG001|Period 2|Adverse Event|4
4383709|NCT01370603|7161830|FG000|Period 2|Lost to Follow-up|1
4383710|NCT01370603|7161831|FG001|Period 2|Lost to Follow-up|0
4383711|NCT01370603|7161830|FG000|Period 2|Withdrawal by Subject|1
4383712|NCT01370603|7161831|FG001|Period 2|Withdrawal by Subject|0
4383713|NCT01370590|7161839|FG000|Period 1|Adverse Event|8
4383714|NCT01370590|7161840|FG001|Period 1|Adverse Event|4
4383715|NCT01370590|7161839|FG000|Period 1|Lost to Follow-up|2
4383716|NCT01370590|7161840|FG001|Period 1|Lost to Follow-up|2
4383717|NCT01370590|7161839|FG000|Period 1|Protocol Violation|2
4383718|NCT01370590|7161840|FG001|Period 1|Protocol Violation|2
4383719|NCT01370590|7161839|FG000|Period 1|Withdrawal by Subject|4
4383720|NCT01370590|7161840|FG001|Period 1|Withdrawal by Subject|2
4383721|NCT01370590|7161839|FG000|Period 1|Could not access randomization system|0
4383722|NCT01370590|7161840|FG001|Period 1|Could not access randomization system|1
4383723|NCT01370590|7161839|FG000|Crossover Washout Period|Adverse Event|1
4383724|NCT01370590|7161840|FG001|Crossover Washout Period|Adverse Event|4
4383725|NCT01370590|7161839|FG000|Crossover Washout Period|Lost to Follow-up|2
4383726|NCT01370590|7161840|FG001|Crossover Washout Period|Lost to Follow-up|0
4383727|NCT01370590|7161839|FG000|Crossover Washout Period|Non-compliance with Study Drug|1
4383728|NCT01370590|7161840|FG001|Crossover Washout Period|Non-compliance with Study Drug|0
4383729|NCT01370590|7161839|FG000|Crossover Washout Period|Withdrawal by Subject|2
4383730|NCT01370590|7161840|FG001|Crossover Washout Period|Withdrawal by Subject|2
4383731|NCT01370590|7161839|FG000|Period 2|Adverse Event|0
4383732|NCT01370590|7161840|FG001|Period 2|Adverse Event|1
4383733|NCT01370590|7161839|FG000|Period 2|Withdrawal by Subject|1
4383734|NCT01370590|7161840|FG001|Period 2|Withdrawal by Subject|1
4383735|NCT01349907|7161852|FG000|Overall Study|Adverse Event|37
4383736|NCT01349907|7161853|FG001|Overall Study|Adverse Event|11
4383737|NCT01349907|7161852|FG000|Overall Study|Treatment failure|13
4383738|NCT01349907|7161853|FG001|Overall Study|Treatment failure|4
4383739|NCT01349907|7161852|FG000|Overall Study|Lost to Follow-up|25
4383740|NCT01349907|7161853|FG001|Overall Study|Lost to Follow-up|6
4383741|NCT01349907|7161852|FG000|Overall Study|Withdrawal by Subject|30
4383742|NCT01349907|7161853|FG001|Overall Study|Withdrawal by Subject|8
4383743|NCT01349907|7161852|FG000|Overall Study|Protocol Violation|33
4383744|NCT01349907|7161853|FG001|Overall Study|Protocol Violation|13
4383745|NCT01349907|7161852|FG000|Overall Study|Administrative|1
4383746|NCT01349907|7161853|FG001|Overall Study|Administrative|1
4383747|NCT01345786|7161863|FG000|Overall Study|Adverse Event|0
4383748|NCT01345786|7161864|FG001|Overall Study|Adverse Event|1
4383749|NCT01345786|7161865|FG002|Overall Study|Adverse Event|3
4383750|NCT01345786|7161866|FG003|Overall Study|Adverse Event|1
4383751|NCT01345786|7161863|FG000|Overall Study|Subject withdrew consent|2
4383752|NCT01345786|7161864|FG001|Overall Study|Subject withdrew consent|2
4383753|NCT01345786|7161865|FG002|Overall Study|Subject withdrew consent|1
4383754|NCT01345786|7161866|FG003|Overall Study|Subject withdrew consent|0
4383755|NCT01345786|7161863|FG000|Overall Study|Noncompliance with protocol|1
4383756|NCT01345786|7161864|FG001|Overall Study|Noncompliance with protocol|0
4383757|NCT01345786|7161865|FG002|Overall Study|Noncompliance with protocol|1
4383758|NCT01345786|7161866|FG003|Overall Study|Noncompliance with protocol|0
4383759|NCT01345786|7161863|FG000|Overall Study|Administrative|3
4383760|NCT01345786|7161864|FG001|Overall Study|Administrative|5
4383761|NCT01345786|7161865|FG002|Overall Study|Administrative|0
4383762|NCT01345786|7161866|FG003|Overall Study|Administrative|0
4383763|NCT01345786|7161863|FG000|Overall Study|Lost to Follow-up|0
4383764|NCT01345786|7161864|FG001|Overall Study|Lost to Follow-up|0
4383765|NCT01345786|7161865|FG002|Overall Study|Lost to Follow-up|0
4383766|NCT01345786|7161866|FG003|Overall Study|Lost to Follow-up|2
4383767|NCT01306929|7161876|FG000|Overall Study|Withdrawal by Subject|23
4383768|NCT01306929|7161876|FG000|Overall Study|Adverse Event|21
4383769|NCT01306929|7161876|FG000|Overall Study|Physician Decision|13
4383770|NCT01306929|7161876|FG000|Overall Study|Death|8
4383771|NCT01306929|7161876|FG000|Overall Study|Withdrawal by parent/guardian|5
4383772|NCT01306929|7161876|FG000|Overall Study|Protocol Violation|3
4383773|NCT01306929|7161876|FG000|Overall Study|Non-compliance with study drug|2
4383774|NCT01306929|7161876|FG000|Overall Study|Lost to Follow-up|2
4383775|NCT01306929|7161876|FG000|Overall Study|Various|17
4383776|NCT01294696|7161882|FG000|Overall Study|Screening failures|7
4383777|NCT01294696|7161882|FG000|Overall Study|Protocol Violation|8
4383778|NCT01294696|7161882|FG000|Overall Study|Missing BPI Response|7
4383779|NCT01294696|7161882|FG000|Overall Study|Site closure|52
4383780|NCT01277822|7161889|FG000|Overall Study|Adverse Event|2
4383781|NCT01277822|7161890|FG001|Overall Study|Adverse Event|1
4383782|NCT01277822|7161889|FG000|Overall Study|Withdrawal by Subject|6
4383783|NCT01277822|7161890|FG001|Overall Study|Withdrawal by Subject|7
4383784|NCT01277822|7161889|FG000|Overall Study|Physician Decision|1
4383785|NCT01277822|7161890|FG001|Overall Study|Physician Decision|1
4383786|NCT01277822|7161889|FG000|Overall Study|Protocol Violation|1
4383787|NCT01277822|7161890|FG001|Overall Study|Protocol Violation|0
4383788|NCT01277822|7161889|FG000|Overall Study|Lost to Follow-up|2
4383789|NCT01277822|7161890|FG001|Overall Study|Lost to Follow-up|1
4383790|NCT01277822|7161889|FG000|Overall Study|Contraindicated medication used|2
4383791|NCT01277822|7161890|FG001|Overall Study|Contraindicated medication used|1
4383792|NCT01277822|7161889|FG000|Overall Study|Participant moved|1
4383793|NCT01277822|7161890|FG001|Overall Study|Participant moved|0
4383794|NCT01261247|7161896|FG000|Overall Study|Ineligible|2
4383795|NCT01244763|7161906|FG000|Overall Study|Adverse Event|1
4383796|NCT01244763|7161907|FG001|Overall Study|Adverse Event|0
4383797|NCT01244763|7161908|FG002|Overall Study|Adverse Event|0
4383798|NCT01244763|7161909|FG003|Overall Study|Adverse Event|0
4383799|NCT01244763|7161910|FG004|Overall Study|Adverse Event|0
4383800|NCT01244763|7161911|FG005|Overall Study|Adverse Event|1
4383801|NCT01244763|7161906|FG000|Overall Study|Death|1
4383802|NCT01244763|7161907|FG001|Overall Study|Death|0
4383803|NCT01244763|7161908|FG002|Overall Study|Death|1
4383804|NCT01244763|7161909|FG003|Overall Study|Death|0
4383805|NCT01244763|7161910|FG004|Overall Study|Death|2
4383806|NCT01244763|7161911|FG005|Overall Study|Death|0
4383807|NCT01244763|7161906|FG000|Overall Study|Physician Decision|0
4383808|NCT01244763|7161907|FG001|Overall Study|Physician Decision|0
4383809|NCT01244763|7161908|FG002|Overall Study|Physician Decision|1
4383810|NCT01244763|7161909|FG003|Overall Study|Physician Decision|0
4383811|NCT01244763|7161910|FG004|Overall Study|Physician Decision|0
4383812|NCT01244763|7161911|FG005|Overall Study|Physician Decision|0
4383813|NCT01244763|7161906|FG000|Overall Study|Withdrawal by Subject|1
4383814|NCT01244763|7161907|FG001|Overall Study|Withdrawal by Subject|2
4383815|NCT01244763|7161908|FG002|Overall Study|Withdrawal by Subject|0
4383816|NCT01244763|7161909|FG003|Overall Study|Withdrawal by Subject|1
4383817|NCT01244763|7161910|FG004|Overall Study|Withdrawal by Subject|1
4383818|NCT01244763|7161911|FG005|Overall Study|Withdrawal by Subject|2
4383819|NCT01244763|7161906|FG000|Overall Study|Lost to Follow-up|0
4383820|NCT01244763|7161907|FG001|Overall Study|Lost to Follow-up|1
4383821|NCT01244763|7161908|FG002|Overall Study|Lost to Follow-up|0
4383822|NCT01244763|7161909|FG003|Overall Study|Lost to Follow-up|0
4383823|NCT01244763|7161910|FG004|Overall Study|Lost to Follow-up|0
4383824|NCT01244763|7161911|FG005|Overall Study|Lost to Follow-up|0
4383825|NCT01244763|7161906|FG000|Overall Study|Enrolled into the Extension Study|0
4383826|NCT01244763|7161907|FG001|Overall Study|Enrolled into the Extension Study|0
4383827|NCT01244763|7161908|FG002|Overall Study|Enrolled into the Extension Study|0
4383828|NCT01244763|7161909|FG003|Overall Study|Enrolled into the Extension Study|0
4383829|NCT01244763|7161910|FG004|Overall Study|Enrolled into the Extension Study|0
4383830|NCT01244763|7161911|FG005|Overall Study|Enrolled into the Extension Study|1
4383831|NCT01208207|7161928|FG000|Part I|Adverse Event|19
4383832|NCT01208207|7161929|FG001|Part I|Adverse Event|2
4383833|NCT01208207|7161930|FG002|Part I|Adverse Event|6
4383834|NCT01208207|7161931|FG003|Part I|Adverse Event|0
4383835|NCT01208207|7161932|FG004|Part I|Adverse Event|0
4383836|NCT01208207|7161933|FG005|Part I|Adverse Event|0
4383837|NCT01208207|7161934|FG006|Part I|Adverse Event|0
4383838|NCT01208207|7161928|FG000|Part I|Lack of Efficacy|21
4383839|NCT01208207|7161929|FG001|Part I|Lack of Efficacy|3
4383840|NCT01208207|7161930|FG002|Part I|Lack of Efficacy|2
4383841|NCT01208207|7161931|FG003|Part I|Lack of Efficacy|0
4383842|NCT01208207|7161932|FG004|Part I|Lack of Efficacy|0
4383843|NCT01208207|7161933|FG005|Part I|Lack of Efficacy|0
4383844|NCT01208207|7161934|FG006|Part I|Lack of Efficacy|0
4383845|NCT01208207|7161928|FG000|Part I|Lost to Follow-up|6
4383846|NCT01208207|7161929|FG001|Part I|Lost to Follow-up|1
4383847|NCT01208207|7161930|FG002|Part I|Lost to Follow-up|0
4383848|NCT01208207|7161931|FG003|Part I|Lost to Follow-up|0
4383849|NCT01208207|7161932|FG004|Part I|Lost to Follow-up|0
4383850|NCT01208207|7161933|FG005|Part I|Lost to Follow-up|0
4383851|NCT01208207|7161934|FG006|Part I|Lost to Follow-up|0
4383852|NCT01208207|7161928|FG000|Part I|Non-Compliance With Study Drug|1
4383853|NCT01208207|7161929|FG001|Part I|Non-Compliance With Study Drug|0
4383854|NCT01208207|7161930|FG002|Part I|Non-Compliance With Study Drug|1
4383855|NCT01208207|7161931|FG003|Part I|Non-Compliance With Study Drug|0
4383856|NCT01208207|7161932|FG004|Part I|Non-Compliance With Study Drug|0
4383857|NCT01208207|7161933|FG005|Part I|Non-Compliance With Study Drug|0
4383858|NCT01208207|7161934|FG006|Part I|Non-Compliance With Study Drug|0
4383859|NCT01208207|7161928|FG000|Part I|Physician Decision|0
4383860|NCT01208207|7161929|FG001|Part I|Physician Decision|1
4383861|NCT01208207|7161930|FG002|Part I|Physician Decision|0
4383862|NCT01208207|7161931|FG003|Part I|Physician Decision|0
4383863|NCT01208207|7161932|FG004|Part I|Physician Decision|0
4383864|NCT01208207|7161933|FG005|Part I|Physician Decision|0
4383865|NCT01208207|7161934|FG006|Part I|Physician Decision|0
4383866|NCT01208207|7161928|FG000|Part I|Progressive Disease|1
4383867|NCT01208207|7161929|FG001|Part I|Progressive Disease|0
4383868|NCT01208207|7161930|FG002|Part I|Progressive Disease|0
4383869|NCT01208207|7161931|FG003|Part I|Progressive Disease|0
4383870|NCT01208207|7161932|FG004|Part I|Progressive Disease|0
4383871|NCT01208207|7161933|FG005|Part I|Progressive Disease|0
4383872|NCT01208207|7161934|FG006|Part I|Progressive Disease|0
4383873|NCT01208207|7161928|FG000|Part I|Protocol Violation|8
4383874|NCT01208207|7161929|FG001|Part I|Protocol Violation|0
4383875|NCT01208207|7161930|FG002|Part I|Protocol Violation|2
4383876|NCT01208207|7161931|FG003|Part I|Protocol Violation|0
4383877|NCT01208207|7161932|FG004|Part I|Protocol Violation|0
4383878|NCT01208207|7161933|FG005|Part I|Protocol Violation|0
4383879|NCT01208207|7161934|FG006|Part I|Protocol Violation|0
4383880|NCT01208207|7161928|FG000|Part I|Withdrawal by Subject|14
4383881|NCT01208207|7161929|FG001|Part I|Withdrawal by Subject|4
4383882|NCT01208207|7161930|FG002|Part I|Withdrawal by Subject|4
4383883|NCT01208207|7161931|FG003|Part I|Withdrawal by Subject|0
4588711|NCT01502644|7433336|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
4588712|NCT01502644|7433337|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
4383884|NCT01208207|7161932|FG004|Part I|Withdrawal by Subject|0
4383885|NCT01208207|7161933|FG005|Part I|Withdrawal by Subject|0
4383886|NCT01208207|7161934|FG006|Part I|Withdrawal by Subject|0
4383887|NCT01208207|7161928|FG000|Part II|Withdrawal by Subject|0
4383888|NCT01208207|7161929|FG001|Part II|Withdrawal by Subject|0
4383889|NCT01208207|7161930|FG002|Part II|Withdrawal by Subject|0
4383890|NCT01208207|7161931|FG003|Part II|Withdrawal by Subject|10
4383891|NCT01208207|7161932|FG004|Part II|Withdrawal by Subject|9
4383892|NCT01208207|7161933|FG005|Part II|Withdrawal by Subject|3
4383893|NCT01208207|7161934|FG006|Part II|Withdrawal by Subject|5
4383894|NCT01208207|7161928|FG000|Part II|Adverse Event|0
4383895|NCT01208207|7161929|FG001|Part II|Adverse Event|0
4383896|NCT01208207|7161930|FG002|Part II|Adverse Event|0
4383897|NCT01208207|7161931|FG003|Part II|Adverse Event|5
4383898|NCT01208207|7161932|FG004|Part II|Adverse Event|9
4383899|NCT01208207|7161933|FG005|Part II|Adverse Event|4
4383900|NCT01208207|7161934|FG006|Part II|Adverse Event|2
4383901|NCT01208207|7161928|FG000|Part II|Lack of Efficacy|0
4383902|NCT01208207|7161929|FG001|Part II|Lack of Efficacy|0
4383903|NCT01208207|7161930|FG002|Part II|Lack of Efficacy|0
4383904|NCT01208207|7161931|FG003|Part II|Lack of Efficacy|6
4383905|NCT01208207|7161932|FG004|Part II|Lack of Efficacy|4
4383906|NCT01208207|7161933|FG005|Part II|Lack of Efficacy|3
4383907|NCT01208207|7161934|FG006|Part II|Lack of Efficacy|3
4383908|NCT01208207|7161928|FG000|Part II|Lost to Follow-up|0
4383909|NCT01208207|7161929|FG001|Part II|Lost to Follow-up|0
4383910|NCT01208207|7161930|FG002|Part II|Lost to Follow-up|0
4383911|NCT01208207|7161931|FG003|Part II|Lost to Follow-up|4
4383912|NCT01208207|7161932|FG004|Part II|Lost to Follow-up|0
4383913|NCT01208207|7161933|FG005|Part II|Lost to Follow-up|2
4383914|NCT01208207|7161934|FG006|Part II|Lost to Follow-up|1
4383915|NCT01208207|7161928|FG000|Part II|Non-Compliance With Study Drug|0
4383916|NCT01208207|7161929|FG001|Part II|Non-Compliance With Study Drug|0
4383917|NCT01208207|7161930|FG002|Part II|Non-Compliance With Study Drug|0
4383918|NCT01208207|7161931|FG003|Part II|Non-Compliance With Study Drug|4
4383919|NCT01208207|7161932|FG004|Part II|Non-Compliance With Study Drug|1
4383920|NCT01208207|7161933|FG005|Part II|Non-Compliance With Study Drug|1
4383921|NCT01208207|7161934|FG006|Part II|Non-Compliance With Study Drug|0
4383922|NCT01208207|7161928|FG000|Part II|Physician Decision|0
4383923|NCT01208207|7161929|FG001|Part II|Physician Decision|0
4383924|NCT01208207|7161930|FG002|Part II|Physician Decision|0
4383925|NCT01208207|7161931|FG003|Part II|Physician Decision|1
4383926|NCT01208207|7161932|FG004|Part II|Physician Decision|0
4383927|NCT01208207|7161933|FG005|Part II|Physician Decision|2
4383928|NCT01208207|7161934|FG006|Part II|Physician Decision|0
4383929|NCT01208207|7161928|FG000|Part II|Protocol Violation|0
4383930|NCT01208207|7161929|FG001|Part II|Protocol Violation|0
4383931|NCT01208207|7161930|FG002|Part II|Protocol Violation|0
4383932|NCT01208207|7161931|FG003|Part II|Protocol Violation|1
4383933|NCT01208207|7161932|FG004|Part II|Protocol Violation|0
4383934|NCT01208207|7161933|FG005|Part II|Protocol Violation|0
4383935|NCT01208207|7161934|FG006|Part II|Protocol Violation|0
4383936|NCT01208207|7161928|FG000|Part II|Technical Problems|0
4383937|NCT01208207|7161929|FG001|Part II|Technical Problems|0
4383938|NCT01208207|7161930|FG002|Part II|Technical Problems|0
4383939|NCT01208207|7161931|FG003|Part II|Technical Problems|1
4383940|NCT01208207|7161932|FG004|Part II|Technical Problems|0
4383941|NCT01208207|7161933|FG005|Part II|Technical Problems|1
4383942|NCT01208207|7161934|FG006|Part II|Technical Problems|0
4383943|NCT01208181|7161959|FG000|Part 1|Withdrawal by Subject|11
4383944|NCT01208181|7161960|FG001|Part 1|Withdrawal by Subject|10
4383945|NCT01208181|7161961|FG002|Part 1|Withdrawal by Subject|0
4383946|NCT01208181|7161962|FG003|Part 1|Withdrawal by Subject|0
4383947|NCT01208181|7161963|FG004|Part 1|Withdrawal by Subject|0
4383948|NCT01208181|7161959|FG000|Part 1|Technical problem|5
4383949|NCT01208181|7161960|FG001|Part 1|Technical problem|0
4383950|NCT01208181|7161961|FG002|Part 1|Technical problem|0
4383951|NCT01208181|7161962|FG003|Part 1|Technical problem|0
4383952|NCT01208181|7161963|FG004|Part 1|Technical problem|0
4383953|NCT01208181|7161959|FG000|Part 1|Protocol Violation|10
4383954|NCT01208181|7161960|FG001|Part 1|Protocol Violation|5
4383955|NCT01208181|7161961|FG002|Part 1|Protocol Violation|0
4383956|NCT01208181|7161962|FG003|Part 1|Protocol Violation|0
4383957|NCT01208181|7161963|FG004|Part 1|Protocol Violation|0
4383958|NCT01208181|7161959|FG000|Part 1|Physician Decision|4
4383959|NCT01208181|7161960|FG001|Part 1|Physician Decision|0
4383960|NCT01208181|7161961|FG002|Part 1|Physician Decision|0
4383961|NCT01208181|7161962|FG003|Part 1|Physician Decision|0
4383962|NCT01208181|7161963|FG004|Part 1|Physician Decision|0
4383963|NCT01208181|7161959|FG000|Part 1|Non-compliance with study drug|1
4383964|NCT01208181|7161960|FG001|Part 1|Non-compliance with study drug|1
4383965|NCT01208181|7161961|FG002|Part 1|Non-compliance with study drug|0
4383966|NCT01208181|7161962|FG003|Part 1|Non-compliance with study drug|0
4383967|NCT01208181|7161963|FG004|Part 1|Non-compliance with study drug|0
4383968|NCT01208181|7161959|FG000|Part 1|Lost to Follow-up|5
4383969|NCT01208181|7161960|FG001|Part 1|Lost to Follow-up|3
4383970|NCT01208181|7161961|FG002|Part 1|Lost to Follow-up|0
4383971|NCT01208181|7161962|FG003|Part 1|Lost to Follow-up|0
4469298|NCT00634920|7262121|FG002|Period 1 - Pre-Randomization|Other issues|6
4588713|NCT01502644|7433334|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0
4588714|NCT01502644|7433335|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6
4588715|NCT01502644|7433336|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2
4588716|NCT01502644|7433337|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7
4588717|NCT01502644|7433334|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0
4588718|NCT01502644|7433335|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0
4588719|NCT01502644|7433336|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1
4588720|NCT01502644|7433337|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1
4588721|NCT01502709|7433347|FG000|Overall Study|Lost to Follow-up|4
4588722|NCT01502709|7433348|FG001|Overall Study|Lost to Follow-up|0
4588723|NCT01502956|7433389|FG000|Overall Study|Death|0
4588724|NCT01502956|7433390|FG001|Overall Study|Death|2
4588725|NCT01502956|7433389|FG000|Overall Study|Lost to Follow-up|14
4588726|NCT01502956|7433390|FG001|Overall Study|Lost to Follow-up|11
4588727|NCT01502956|7433389|FG000|Overall Study|Physician Decision|2
4588728|NCT01502956|7433390|FG001|Overall Study|Physician Decision|3
4588729|NCT01502956|7433389|FG000|Overall Study|Withdrawal by Subject|8
4588730|NCT01502956|7433390|FG001|Overall Study|Withdrawal by Subject|10
4588731|NCT01503021|7433398|FG000|Overall Study|Adverse Event|7
4588732|NCT01503021|7433399|FG001|Overall Study|Adverse Event|6
4588733|NCT01503021|7433398|FG000|Overall Study|Death|0
4588734|NCT01503021|7433399|FG001|Overall Study|Death|2
4588735|NCT01503021|7433398|FG000|Overall Study|Lost to Follow-up|2
4588736|NCT01503021|7433399|FG001|Overall Study|Lost to Follow-up|0
4697242|NCT02646891|7610482|FG008|Overall Study|Death|1
4697243|NCT02646891|7610483|FG009|Overall Study|Death|0
4697244|NCT02647281|7610549|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
4697245|NCT02647281|7610550|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
4697246|NCT02647281|7610551|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
4697247|NCT02647281|7610552|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
4697248|NCT02647281|7610553|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
4697249|NCT02647281|7610554|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
4697250|NCT02647281|7610555|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
4697251|NCT02647281|7610556|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
4697252|NCT02647281|7610557|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1
4697253|NCT02647320|7610591|FG000|Overall Study|Adverse Event|0
4697254|NCT02647320|7610592|FG001|Overall Study|Adverse Event|1
4697255|NCT02647320|7610593|FG002|Overall Study|Adverse Event|3
4697256|NCT02647320|7610594|FG003|Overall Study|Adverse Event|2
4588737|NCT01503021|7433398|FG000|Overall Study|Physician Decision|3
4588738|NCT01503021|7433399|FG001|Overall Study|Physician Decision|0
4588739|NCT01503021|7433398|FG000|Overall Study|Protocol Violation|1
4588740|NCT01503021|7433399|FG001|Overall Study|Protocol Violation|3
4588741|NCT01503021|7433398|FG000|Overall Study|Withdrawal by Subject|9
4588742|NCT01503021|7433399|FG001|Overall Study|Withdrawal by Subject|8
4588743|NCT01503021|7433398|FG000|Overall Study|Moved, received transplant, etc.|5
4588744|NCT01503021|7433399|FG001|Overall Study|Moved, received transplant, etc.|7
4588745|NCT01503164|7433412|FG000|Overall Study|Withdrawal by Subject|2
4588746|NCT01503164|7433413|FG001|Overall Study|Withdrawal by Subject|1
4588747|NCT01503229|7433419|FG000|Overall Study|Withdrew consent|1
4588748|NCT01504204|7433455|FG000|Overall Study|Lost to Follow-up|1
4588749|NCT01504204|7433456|FG001|Overall Study|Lost to Follow-up|1
4588750|NCT01504412|7433467|FG000|Overall Study|Adverse Event|1
4588751|NCT01504412|7433468|FG001|Overall Study|Adverse Event|8
4588752|NCT01504412|7433469|FG002|Overall Study|Adverse Event|1
4588753|NCT01504412|7433470|FG003|Overall Study|Adverse Event|7
4588754|NCT01504412|7433471|FG004|Overall Study|Adverse Event|10
4588755|NCT01504412|7433467|FG000|Overall Study|Withdrawal by Subject|2
4588756|NCT01504412|7433468|FG001|Overall Study|Withdrawal by Subject|1
4588757|NCT01504412|7433469|FG002|Overall Study|Withdrawal by Subject|1
4588758|NCT01504412|7433470|FG003|Overall Study|Withdrawal by Subject|5
4588759|NCT01504412|7433471|FG004|Overall Study|Withdrawal by Subject|1
4588760|NCT01504412|7433467|FG000|Overall Study|Other|2
4697257|NCT02647320|7610595|FG004|Overall Study|Adverse Event|1
4383972|NCT01208181|7161963|FG004|Part 1|Lost to Follow-up|1
4383973|NCT01208181|7161959|FG000|Part 1|Lack of Efficacy|37
4383974|NCT01208181|7161960|FG001|Part 1|Lack of Efficacy|12
4383975|NCT01208181|7161961|FG002|Part 1|Lack of Efficacy|0
4588761|NCT01504412|7433468|FG001|Overall Study|Other|1
4588762|NCT01504412|7433469|FG002|Overall Study|Other|1
4588763|NCT01504412|7433470|FG003|Overall Study|Other|6
4588764|NCT01504412|7433471|FG004|Overall Study|Other|1
4588765|NCT01504412|7433467|FG000|Overall Study|Lost to Follow-up|0
4588766|NCT01504412|7433468|FG001|Overall Study|Lost to Follow-up|2
4588767|NCT01504412|7433469|FG002|Overall Study|Lost to Follow-up|0
4588768|NCT01504412|7433470|FG003|Overall Study|Lost to Follow-up|0
4588769|NCT01504412|7433471|FG004|Overall Study|Lost to Follow-up|0
4588770|NCT01504412|7433467|FG000|Overall Study|Lack of Efficacy|0
4588771|NCT01504412|7433468|FG001|Overall Study|Lack of Efficacy|0
4588772|NCT01504412|7433469|FG002|Overall Study|Lack of Efficacy|1
4588773|NCT01504412|7433470|FG003|Overall Study|Lack of Efficacy|0
4588774|NCT01504412|7433471|FG004|Overall Study|Lack of Efficacy|1
4588775|NCT01504412|7433467|FG000|Overall Study|Death|0
4588776|NCT01504412|7433468|FG001|Overall Study|Death|0
4588777|NCT01504412|7433469|FG002|Overall Study|Death|0
4588778|NCT01504412|7433470|FG003|Overall Study|Death|1
4588779|NCT01504412|7433471|FG004|Overall Study|Death|0
4588780|NCT01504841|7433505|FG000|Overall Study|Withdrawal by Subject|1
4588781|NCT01504841|7433506|FG001|Overall Study|Withdrawal by Subject|1
4588782|NCT01504841|7433507|FG002|Overall Study|Withdrawal by Subject|0
4588783|NCT01504867|7433525|FG000|Overall Study|Inclusion criteria not met|2
4588784|NCT01504867|7433526|FG001|Overall Study|Inclusion criteria not met|2
4588785|NCT01504867|7433525|FG000|Overall Study|Consent revoked|5
4588786|NCT01504867|7433526|FG001|Overall Study|Consent revoked|1
4588787|NCT01504971|7433545|FG000|Overall Study|Physician Decision|13
4588788|NCT01505010|7433559|FG000|Overall Study|Protocol Violation|0
4588789|NCT01505010|7433560|FG001|Overall Study|Protocol Violation|1
4588790|NCT01505010|7433559|FG000|Overall Study|Lost to Follow-up|0
4588791|NCT01505010|7433560|FG001|Overall Study|Lost to Follow-up|1
4588792|NCT01505114|7433583|FG000|Overall Study|Withdrawal by Subject|5
4588793|NCT01505114|7433584|FG001|Overall Study|Withdrawal by Subject|4
4697258|NCT02647320|7610591|FG000|Overall Study|Protocol Violation|0
4697259|NCT02647320|7610592|FG001|Overall Study|Protocol Violation|0
4697260|NCT02647320|7610593|FG002|Overall Study|Protocol Violation|3
4697261|NCT02647320|7610594|FG003|Overall Study|Protocol Violation|0
4697262|NCT02647320|7610595|FG004|Overall Study|Protocol Violation|0
4697263|NCT02647320|7610591|FG000|Overall Study|Withdrawal by Subject|7
4697264|NCT02647320|7610592|FG001|Overall Study|Withdrawal by Subject|4
4697265|NCT02647320|7610593|FG002|Overall Study|Withdrawal by Subject|2
4697266|NCT02647320|7610594|FG003|Overall Study|Withdrawal by Subject|2
4697267|NCT02647320|7610595|FG004|Overall Study|Withdrawal by Subject|7
4697268|NCT02647320|7610591|FG000|Overall Study|Persistent hyperglycemia|0
4697269|NCT02647320|7610592|FG001|Overall Study|Persistent hyperglycemia|1
4697270|NCT02647320|7610593|FG002|Overall Study|Persistent hyperglycemia|1
4697271|NCT02647320|7610594|FG003|Overall Study|Persistent hyperglycemia|1
4697272|NCT02647320|7610595|FG004|Overall Study|Persistent hyperglycemia|1
4697273|NCT02647320|7610591|FG000|Overall Study|Study terminated by sponsor|1
4697274|NCT02647320|7610592|FG001|Overall Study|Study terminated by sponsor|1
4697275|NCT02647320|7610593|FG002|Overall Study|Study terminated by sponsor|1
4697276|NCT02647320|7610594|FG003|Overall Study|Study terminated by sponsor|1
4697277|NCT02647320|7610595|FG004|Overall Study|Study terminated by sponsor|2
4588794|NCT01505114|7433585|FG002|Overall Study|Withdrawal by Subject|4
4588795|NCT01505114|7433586|FG003|Overall Study|Withdrawal by Subject|7
4588796|NCT01505114|7433583|FG000|Overall Study|Death|1
4588797|NCT01505114|7433584|FG001|Overall Study|Death|0
4588798|NCT01505114|7433585|FG002|Overall Study|Death|0
4588799|NCT01505114|7433586|FG003|Overall Study|Death|1
4588800|NCT01505114|7433583|FG000|Overall Study|unable to adhere to visit schedule|3
4588801|NCT01505114|7433584|FG001|Overall Study|unable to adhere to visit schedule|2
4588802|NCT01505114|7433585|FG002|Overall Study|unable to adhere to visit schedule|3
4383976|NCT01208181|7161962|FG003|Part 1|Lack of Efficacy|0
4383977|NCT01208181|7161963|FG004|Part 1|Lack of Efficacy|17
4383978|NCT01208181|7161959|FG000|Part 1|Adverse Event|26
4588803|NCT01505114|7433586|FG003|Overall Study|unable to adhere to visit schedule|3
4588804|NCT01505114|7433583|FG000|Overall Study|Lost to Follow-up|11
4588805|NCT01505114|7433584|FG001|Overall Study|Lost to Follow-up|5
4588806|NCT01505114|7433585|FG002|Overall Study|Lost to Follow-up|8
4588807|NCT01505114|7433586|FG003|Overall Study|Lost to Follow-up|7
4588808|NCT01505114|7433583|FG000|Overall Study|relocated|4
4588809|NCT01505114|7433584|FG001|Overall Study|relocated|2
4697278|NCT02647320|7610591|FG000|Overall Study|Reason not provided|0
4697279|NCT02647320|7610592|FG001|Overall Study|Reason not provided|0
4697280|NCT02647320|7610593|FG002|Overall Study|Reason not provided|1
4697281|NCT02647320|7610594|FG003|Overall Study|Reason not provided|0
4697282|NCT02647320|7610595|FG004|Overall Study|Reason not provided|2
4383979|NCT01208181|7161960|FG001|Part 1|Adverse Event|24
4588810|NCT01505114|7433585|FG002|Overall Study|relocated|2
4588811|NCT01505114|7433586|FG003|Overall Study|relocated|3
4588812|NCT01505114|7433583|FG000|Overall Study|inadvertent enrollment due to peanut all|0
4588813|NCT01505114|7433584|FG001|Overall Study|inadvertent enrollment due to peanut all|0
4588814|NCT01505114|7433585|FG002|Overall Study|inadvertent enrollment due to peanut all|0
4588815|NCT01505114|7433586|FG003|Overall Study|inadvertent enrollment due to peanut all|1
4588816|NCT01505114|7433583|FG000|Overall Study|staff safety concerns|0
4588817|NCT01505114|7433584|FG001|Overall Study|staff safety concerns|0
4588818|NCT01505114|7433585|FG002|Overall Study|staff safety concerns|0
4697283|NCT02647320|7610591|FG000|Overall Study|Lost to Follow-up|1
4383980|NCT01208181|7161961|FG002|Part 1|Adverse Event|0
4383981|NCT01208181|7161962|FG003|Part 1|Adverse Event|0
4383982|NCT01208181|7161963|FG004|Part 1|Adverse Event|4
4383983|NCT01208181|7161959|FG000|Part 2|Adverse Event|0
4383984|NCT01208181|7161960|FG001|Part 2|Adverse Event|0
4383985|NCT01208181|7161961|FG002|Part 2|Adverse Event|6
4383986|NCT01208181|7161962|FG003|Part 2|Adverse Event|7
4383987|NCT01208181|7161963|FG004|Part 2|Adverse Event|0
4383988|NCT01208181|7161959|FG000|Part 2|Withdrawal by Subject|0
4383989|NCT01208181|7161960|FG001|Part 2|Withdrawal by Subject|0
4383990|NCT01208181|7161961|FG002|Part 2|Withdrawal by Subject|1
4383991|NCT01208181|7161962|FG003|Part 2|Withdrawal by Subject|1
4383992|NCT01208181|7161963|FG004|Part 2|Withdrawal by Subject|0
4383993|NCT01208181|7161959|FG000|Part 2|Protocol Violation|0
4383994|NCT01208181|7161960|FG001|Part 2|Protocol Violation|0
4383995|NCT01208181|7161961|FG002|Part 2|Protocol Violation|1
4383996|NCT01208181|7161962|FG003|Part 2|Protocol Violation|0
4383997|NCT01208181|7161963|FG004|Part 2|Protocol Violation|0
4383998|NCT01208181|7161959|FG000|Part 2|Physician Decision|0
4383999|NCT01208181|7161960|FG001|Part 2|Physician Decision|0
4384000|NCT01208181|7161961|FG002|Part 2|Physician Decision|1
4384001|NCT01208181|7161962|FG003|Part 2|Physician Decision|2
4384002|NCT01208181|7161963|FG004|Part 2|Physician Decision|0
4384003|NCT01208181|7161959|FG000|Part 2|Non-compliance with study drug|0
4384004|NCT01208181|7161960|FG001|Part 2|Non-compliance with study drug|0
4384005|NCT01208181|7161961|FG002|Part 2|Non-compliance with study drug|1
4384006|NCT01208181|7161962|FG003|Part 2|Non-compliance with study drug|1
4384007|NCT01208181|7161963|FG004|Part 2|Non-compliance with study drug|0
4384008|NCT01208181|7161959|FG000|Part 2|Lost to Follow-up|0
4384009|NCT01208181|7161960|FG001|Part 2|Lost to Follow-up|0
4384010|NCT01208181|7161961|FG002|Part 2|Lost to Follow-up|1
4384011|NCT01208181|7161962|FG003|Part 2|Lost to Follow-up|2
4384012|NCT01208181|7161963|FG004|Part 2|Lost to Follow-up|0
4384013|NCT01208181|7161959|FG000|Part 2|Lack of Efficacy|0
4384014|NCT01208181|7161960|FG001|Part 2|Lack of Efficacy|0
4384015|NCT01208181|7161961|FG002|Part 2|Lack of Efficacy|5
4384016|NCT01208181|7161962|FG003|Part 2|Lack of Efficacy|7
4384017|NCT01208181|7161963|FG004|Part 2|Lack of Efficacy|0
4384018|NCT01206517|7161986|FG000|Overall Study|Withdrawal by Subject|0
4384019|NCT01206517|7161987|FG001|Overall Study|Withdrawal by Subject|0
4384020|NCT01206517|7161988|FG002|Overall Study|Withdrawal by Subject|2
4588819|NCT01505114|7433586|FG003|Overall Study|staff safety concerns|1
4588820|NCT01505114|7433583|FG000|Overall Study|investigator decision|1
4588821|NCT01505114|7433584|FG001|Overall Study|investigator decision|0
4588822|NCT01505114|7433585|FG002|Overall Study|investigator decision|1
4588823|NCT01505114|7433586|FG003|Overall Study|investigator decision|0
4588824|NCT01505374|7433620|FG000|Overall Study|Lost to Follow-up|1
4588825|NCT01505374|7433621|FG001|Overall Study|Lost to Follow-up|0
4588826|NCT01505387|7433630|FG000|Overall Study|Protocol Violation|1
4588827|NCT01505387|7433631|FG001|Overall Study|Protocol Violation|0
4588828|NCT01505387|7433630|FG000|Overall Study|Withdrawal by Subject|1
4588829|NCT01505387|7433631|FG001|Overall Study|Withdrawal by Subject|1
4588830|NCT01505491|7433649|FG000|Overall Study|Other reason not listed|1
4588831|NCT01505491|7433650|FG001|Overall Study|Other reason not listed|0
4588832|NCT01505491|7433651|FG002|Overall Study|Other reason not listed|0
4588833|NCT01505491|7433649|FG000|Overall Study|Withdrawal by Subject|1
4588834|NCT01505491|7433650|FG001|Overall Study|Withdrawal by Subject|1
4588835|NCT01505491|7433651|FG002|Overall Study|Withdrawal by Subject|4
4588836|NCT01505491|7433649|FG000|Overall Study|Lost to Follow-up|0
4588837|NCT01505491|7433650|FG001|Overall Study|Lost to Follow-up|0
4588838|NCT01505491|7433651|FG002|Overall Study|Lost to Follow-up|1
4588839|NCT01505530|7433662|FG000|Overall Study|Progressive Disease|19
4588840|NCT01505530|7433663|FG001|Overall Study|Progressive Disease|17
4588841|NCT01505530|7433664|FG002|Overall Study|Progressive Disease|18
4588842|NCT01505530|7433662|FG000|Overall Study|Adverse Event|1
4588843|NCT01505530|7433663|FG001|Overall Study|Adverse Event|1
4588844|NCT01505530|7433664|FG002|Overall Study|Adverse Event|0
4588845|NCT01505530|7433662|FG000|Overall Study|Withdrawal by Subject|7
4588846|NCT01505530|7433663|FG001|Overall Study|Withdrawal by Subject|8
4588847|NCT01505530|7433664|FG002|Overall Study|Withdrawal by Subject|6
4588848|NCT01505530|7433662|FG000|Overall Study|Physician Decision|6
4697284|NCT02647320|7610592|FG001|Overall Study|Lost to Follow-up|1
4588849|NCT01505530|7433663|FG001|Overall Study|Physician Decision|2
4588850|NCT01505530|7433664|FG002|Overall Study|Physician Decision|5
4384021|NCT01206517|7161989|FG003|Overall Study|Withdrawal by Subject|0
4384022|NCT01206517|7161990|FG004|Overall Study|Withdrawal by Subject|1
4384023|NCT01206517|7161991|FG005|Overall Study|Withdrawal by Subject|0
4384024|NCT01190267|7162004|FG000|Overall Study|Adverse Event|10
4384025|NCT01190267|7162005|FG001|Overall Study|Adverse Event|0
4384026|NCT01190267|7162004|FG000|Overall Study|Treatment Failure|8
4384027|NCT01190267|7162005|FG001|Overall Study|Treatment Failure|2
4384028|NCT01190267|7162004|FG000|Overall Study|Lost to Follow-up|2
4384029|NCT01190267|7162005|FG001|Overall Study|Lost to Follow-up|0
4384030|NCT01190267|7162004|FG000|Overall Study|Withdrawal by Subject|13
4384031|NCT01190267|7162005|FG001|Overall Study|Withdrawal by Subject|1
4384032|NCT01190267|7162004|FG000|Overall Study|Protocol Violation|8
4588851|NCT01505530|7433662|FG000|Overall Study|Sponsor Decision|1
4588852|NCT01505530|7433663|FG001|Overall Study|Sponsor Decision|8
4588853|NCT01505530|7433664|FG002|Overall Study|Sponsor Decision|7
4588854|NCT01505530|7433662|FG000|Overall Study|Death|7
4588855|NCT01505530|7433663|FG001|Overall Study|Death|6
4588856|NCT01505530|7433664|FG002|Overall Study|Death|5
4588857|NCT01505530|7433662|FG000|Overall Study|entry criteria not met|0
4588858|NCT01505530|7433663|FG001|Overall Study|entry criteria not met|1
4588859|NCT01505530|7433664|FG002|Overall Study|entry criteria not met|0
4384033|NCT01190267|7162005|FG001|Overall Study|Protocol Violation|1
4384034|NCT01190254|7162014|FG000|Overall Study|Adverse Event|3
4384035|NCT01190254|7162015|FG001|Overall Study|Adverse Event|6
4384036|NCT01190254|7162016|FG002|Overall Study|Adverse Event|8
4384037|NCT01190254|7162014|FG000|Overall Study|Lack of Efficacy|7
4384038|NCT01190254|7162015|FG001|Overall Study|Lack of Efficacy|4
4384039|NCT01190254|7162016|FG002|Overall Study|Lack of Efficacy|5
4384040|NCT01190254|7162014|FG000|Overall Study|Lost to Follow-up|4
4384041|NCT01190254|7162015|FG001|Overall Study|Lost to Follow-up|2
4384042|NCT01190254|7162016|FG002|Overall Study|Lost to Follow-up|0
4384043|NCT01190254|7162014|FG000|Overall Study|Withdrawal by Subject|4
4384044|NCT01190254|7162015|FG001|Overall Study|Withdrawal by Subject|5
4384045|NCT01190254|7162016|FG002|Overall Study|Withdrawal by Subject|7
4384046|NCT01190254|7162014|FG000|Overall Study|Protocol Violation|2
4384047|NCT01190254|7162015|FG001|Overall Study|Protocol Violation|0
4384048|NCT01190254|7162016|FG002|Overall Study|Protocol Violation|2
4384049|NCT01190254|7162014|FG000|Overall Study|Did not meet protocol eligibility|1
4384050|NCT01190254|7162015|FG001|Overall Study|Did not meet protocol eligibility|0
4384051|NCT01190254|7162016|FG002|Overall Study|Did not meet protocol eligibility|0
4384052|NCT01154036|7162027|FG000|Phase I|Physician Decision|0
4384053|NCT01154036|7162028|FG001|Phase I|Physician Decision|1
4384054|NCT01154036|7162029|FG002|Phase I|Physician Decision|0
4384055|NCT01154036|7162030|FG003|Phase I|Physician Decision|0
4384056|NCT01154036|7162031|FG004|Phase I|Physician Decision|0
4384057|NCT01154036|7162032|FG005|Phase I|Physician Decision|0
4384058|NCT01154036|7162033|FG006|Phase I|Physician Decision|0
4384059|NCT01154036|7162034|FG007|Phase I|Physician Decision|0
4384060|NCT01154036|7162027|FG000|Phase I|Lost to Follow-up|0
4384061|NCT01154036|7162028|FG001|Phase I|Lost to Follow-up|3
4384062|NCT01154036|7162029|FG002|Phase I|Lost to Follow-up|6
4384063|NCT01154036|7162030|FG003|Phase I|Lost to Follow-up|0
4384064|NCT01154036|7162031|FG004|Phase I|Lost to Follow-up|0
4384065|NCT01154036|7162032|FG005|Phase I|Lost to Follow-up|0
4384066|NCT01154036|7162033|FG006|Phase I|Lost to Follow-up|0
4384067|NCT01154036|7162034|FG007|Phase I|Lost to Follow-up|0
4384068|NCT01154036|7162027|FG000|Phase I|Protocol Violation|0
4384069|NCT01154036|7162028|FG001|Phase I|Protocol Violation|3
4384070|NCT01154036|7162029|FG002|Phase I|Protocol Violation|9
4384071|NCT01154036|7162030|FG003|Phase I|Protocol Violation|0
4384072|NCT01154036|7162031|FG004|Phase I|Protocol Violation|0
4384073|NCT01154036|7162032|FG005|Phase I|Protocol Violation|0
4384074|NCT01154036|7162033|FG006|Phase I|Protocol Violation|0
4384075|NCT01154036|7162034|FG007|Phase I|Protocol Violation|0
4384076|NCT01154036|7162027|FG000|Phase I|Withdrawal by Subject|2
4384077|NCT01154036|7162028|FG001|Phase I|Withdrawal by Subject|10
4384078|NCT01154036|7162029|FG002|Phase I|Withdrawal by Subject|29
4384079|NCT01154036|7162030|FG003|Phase I|Withdrawal by Subject|0
4384080|NCT01154036|7162031|FG004|Phase I|Withdrawal by Subject|0
4384081|NCT01154036|7162032|FG005|Phase I|Withdrawal by Subject|0
4384082|NCT01154036|7162033|FG006|Phase I|Withdrawal by Subject|0
4384083|NCT01154036|7162034|FG007|Phase I|Withdrawal by Subject|0
4384084|NCT01154036|7162027|FG000|Phase I|Adverse Event|1
4384085|NCT01154036|7162028|FG001|Phase I|Adverse Event|11
4384086|NCT01154036|7162029|FG002|Phase I|Adverse Event|12
4384087|NCT01154036|7162030|FG003|Phase I|Adverse Event|0
4384088|NCT01154036|7162031|FG004|Phase I|Adverse Event|0
4384089|NCT01154036|7162032|FG005|Phase I|Adverse Event|0
4384090|NCT01154036|7162033|FG006|Phase I|Adverse Event|0
4588860|NCT01505634|7433675|FG000|Overall Study|Withdrawal by Subject|2
4588861|NCT01505634|7433676|FG001|Overall Study|Withdrawal by Subject|5
4588862|NCT01505634|7433677|FG002|Overall Study|Withdrawal by Subject|1
4588863|NCT01505634|7433675|FG000|Overall Study|Physician Decision|1
4588864|NCT01505634|7433676|FG001|Overall Study|Physician Decision|1
4588865|NCT01505634|7433677|FG002|Overall Study|Physician Decision|0
4588866|NCT01505634|7433675|FG000|Overall Study|Adverse Event|1
4384091|NCT01154036|7162034|FG007|Phase I|Adverse Event|0
4384092|NCT01154036|7162027|FG000|Phase II|Adverse Event|0
4384093|NCT01154036|7162028|FG001|Phase II|Adverse Event|0
4384094|NCT01154036|7162029|FG002|Phase II|Adverse Event|0
4384095|NCT01154036|7162030|FG003|Phase II|Adverse Event|0
4384096|NCT01154036|7162031|FG004|Phase II|Adverse Event|1
4384097|NCT01154036|7162032|FG005|Phase II|Adverse Event|1
4384098|NCT01154036|7162033|FG006|Phase II|Adverse Event|1
4384099|NCT01154036|7162034|FG007|Phase II|Adverse Event|1
4384100|NCT01154036|7162027|FG000|Phase II|Physician Decision|0
4384101|NCT01154036|7162028|FG001|Phase II|Physician Decision|0
4384102|NCT01154036|7162029|FG002|Phase II|Physician Decision|0
4384103|NCT01154036|7162030|FG003|Phase II|Physician Decision|0
4384104|NCT01154036|7162031|FG004|Phase II|Physician Decision|0
4384105|NCT01154036|7162032|FG005|Phase II|Physician Decision|0
4384106|NCT01154036|7162033|FG006|Phase II|Physician Decision|1
4384107|NCT01154036|7162034|FG007|Phase II|Physician Decision|0
4384108|NCT01154036|7162027|FG000|Phase II|Lost to Follow-up|0
4384109|NCT01154036|7162028|FG001|Phase II|Lost to Follow-up|0
4384110|NCT01154036|7162029|FG002|Phase II|Lost to Follow-up|0
4384111|NCT01154036|7162030|FG003|Phase II|Lost to Follow-up|1
4384112|NCT01154036|7162031|FG004|Phase II|Lost to Follow-up|2
4384113|NCT01154036|7162032|FG005|Phase II|Lost to Follow-up|0
4384114|NCT01154036|7162033|FG006|Phase II|Lost to Follow-up|2
4384115|NCT01154036|7162034|FG007|Phase II|Lost to Follow-up|1
4384116|NCT01154036|7162027|FG000|Phase II|Protocol Violation|0
4384117|NCT01154036|7162028|FG001|Phase II|Protocol Violation|0
4588867|NCT01505634|7433676|FG001|Overall Study|Adverse Event|0
4588868|NCT01505634|7433677|FG002|Overall Study|Adverse Event|0
4588869|NCT01505634|7433675|FG000|Overall Study|Insufficient supply of drug at site|1
4588870|NCT01505634|7433676|FG001|Overall Study|Insufficient supply of drug at site|0
4588871|NCT01505634|7433677|FG002|Overall Study|Insufficient supply of drug at site|0
4588872|NCT01505634|7433675|FG000|Overall Study|Protocol Violation|2
4588873|NCT01505634|7433676|FG001|Overall Study|Protocol Violation|0
4588874|NCT01505634|7433677|FG002|Overall Study|Protocol Violation|0
4588875|NCT01505634|7433675|FG000|Overall Study|Lost to Follow-up|1
4588876|NCT01505634|7433676|FG001|Overall Study|Lost to Follow-up|4
4588877|NCT01505634|7433677|FG002|Overall Study|Lost to Follow-up|4
4588878|NCT01505634|7433675|FG000|Overall Study|Death|1
4697285|NCT02647320|7610593|FG002|Overall Study|Lost to Follow-up|0
4697286|NCT02647320|7610594|FG003|Overall Study|Lost to Follow-up|0
4697287|NCT02647320|7610595|FG004|Overall Study|Lost to Follow-up|0
4697288|NCT02647320|7610591|FG000|Overall Study|Develop anemia|1
4697289|NCT02647320|7610592|FG001|Overall Study|Develop anemia|0
4697290|NCT02647320|7610593|FG002|Overall Study|Develop anemia|0
4697291|NCT02647320|7610594|FG003|Overall Study|Develop anemia|0
4697292|NCT02647320|7610595|FG004|Overall Study|Develop anemia|0
4697293|NCT02647320|7610591|FG000|Overall Study|Lack of Efficacy|0
4697294|NCT02647320|7610592|FG001|Overall Study|Lack of Efficacy|0
4697295|NCT02647320|7610593|FG002|Overall Study|Lack of Efficacy|0
4697296|NCT02647320|7610594|FG003|Overall Study|Lack of Efficacy|1
4697297|NCT02647320|7610595|FG004|Overall Study|Lack of Efficacy|0
4697298|NCT02647320|7610591|FG000|Overall Study|Disposition Missing Due to Fire at Site|2
4697299|NCT02647320|7610592|FG001|Overall Study|Disposition Missing Due to Fire at Site|3
4697300|NCT02647320|7610593|FG002|Overall Study|Disposition Missing Due to Fire at Site|4
4697301|NCT02647320|7610594|FG003|Overall Study|Disposition Missing Due to Fire at Site|3
4697302|NCT02647320|7610595|FG004|Overall Study|Disposition Missing Due to Fire at Site|4
4697303|NCT02647645|7610615|FG000|Overall Study|Lost to Follow-up|2
4697304|NCT02647645|7610616|FG001|Overall Study|Lost to Follow-up|1
4697305|NCT02647658|7610624|FG000|Overall Study|Consent refusal|15
4697306|NCT02647658|7610625|FG001|Overall Study|Consent refusal|24
4697307|NCT02647788|7610633|FG000|Overall Study|Lost to Follow-up|13
4697308|NCT02647788|7610634|FG001|Overall Study|Lost to Follow-up|11
4697309|NCT02647788|7610633|FG000|Overall Study|Did not want opiate|0
4697310|NCT02647788|7610634|FG001|Overall Study|Did not want opiate|1
4384118|NCT01154036|7162029|FG002|Phase II|Protocol Violation|0
4384119|NCT01154036|7162030|FG003|Phase II|Protocol Violation|0
4384120|NCT01154036|7162031|FG004|Phase II|Protocol Violation|1
4384121|NCT01154036|7162032|FG005|Phase II|Protocol Violation|2
4384122|NCT01154036|7162033|FG006|Phase II|Protocol Violation|0
4588879|NCT01505634|7433676|FG001|Overall Study|Death|0
4588880|NCT01505634|7433677|FG002|Overall Study|Death|0
4384123|NCT01154036|7162034|FG007|Phase II|Protocol Violation|0
4384124|NCT01154036|7162027|FG000|Phase II|Withdrawal by Subject|0
4384125|NCT01154036|7162028|FG001|Phase II|Withdrawal by Subject|0
4384126|NCT01154036|7162029|FG002|Phase II|Withdrawal by Subject|0
4384127|NCT01154036|7162030|FG003|Phase II|Withdrawal by Subject|0
4384128|NCT01154036|7162031|FG004|Phase II|Withdrawal by Subject|4
4384129|NCT01154036|7162032|FG005|Phase II|Withdrawal by Subject|2
4384130|NCT01154036|7162033|FG006|Phase II|Withdrawal by Subject|5
4384131|NCT01154036|7162034|FG007|Phase II|Withdrawal by Subject|4
4384132|NCT01098071|7162065|FG000|Overall Study|Surgery (adenoidectomy)|2
4384133|NCT01098071|7162065|FG000|Overall Study|Lost to Follow-up|13
4384134|NCT01070966|7162078|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59
4384135|NCT01070966|7162078|FG000|Participants for Safety Evaluation|Off-label use|9
4384136|NCT01070966|7162078|FG000|Participants for Safety Evaluation|Duplicate Participants|4
4384137|NCT01070966|7162078|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3
4384138|NCT01070966|7162078|FG000|Participants for Safety Evaluation|TMT given before date of contract|3
4588881|NCT01505634|7433675|FG000|Overall Study|In a conflict zone|0
4588882|NCT01505634|7433676|FG001|Overall Study|In a conflict zone|0
4588883|NCT01505634|7433677|FG002|Overall Study|In a conflict zone|1
4384139|NCT01070966|7162078|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61
4384140|NCT01070966|7162078|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19
4384141|NCT01070966|7162078|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2
4588884|NCT01505647|7433687|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1
4593795|NCT01555125|7442333|FG002|Extension|Technical Problems|0
4697311|NCT02647788|7610633|FG000|Overall Study|Withdrawal by Subject|1
4697312|NCT02647788|7610634|FG001|Overall Study|Withdrawal by Subject|0
4697313|NCT02647788|7610633|FG000|Overall Study|Felt itchy with assigned medication|1
4697314|NCT02647788|7610634|FG001|Overall Study|Felt itchy with assigned medication|0
4384142|NCT01070953|7162089|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612
4384143|NCT01070953|7162089|FG000|Participants for Safety Evaluation|Off-label use|283
4384144|NCT01070953|7162089|FG000|Participants for Safety Evaluation|Duplicated participants|22
4384145|NCT01070953|7162089|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8
4384146|NCT01070953|7162089|FG000|Participants for Safety Evaluation|Uncontracted participants|4
4384147|NCT01070953|7162089|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1
4384148|NCT01070953|7162089|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1
4384149|NCT01070953|7162089|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119
4384150|NCT01070953|7162089|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106
4384151|NCT01070953|7162089|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2
4384152|NCT01030341|7162099|FG000|Overall Study|Withdrawal by Subject|1
4384153|NCT01030341|7162099|FG000|Overall Study|Lost to Follow-up|2
4384154|NCT00979901|7162107|FG000|Overall Study|Adverse Event|1
4384155|NCT00979901|7162108|FG001|Overall Study|Adverse Event|3
4384156|NCT00979901|7162109|FG002|Overall Study|Adverse Event|9
4384157|NCT00979901|7162110|FG003|Overall Study|Adverse Event|2
4384158|NCT00979901|7162107|FG000|Overall Study|Lack of Efficacy|8
4384159|NCT00979901|7162108|FG001|Overall Study|Lack of Efficacy|4
4384160|NCT00979901|7162109|FG002|Overall Study|Lack of Efficacy|9
4384161|NCT00979901|7162110|FG003|Overall Study|Lack of Efficacy|0
4384162|NCT00979901|7162107|FG000|Overall Study|Lost to Follow-up|1
4384163|NCT00979901|7162108|FG001|Overall Study|Lost to Follow-up|1
4384164|NCT00979901|7162109|FG002|Overall Study|Lost to Follow-up|2
4384165|NCT00979901|7162110|FG003|Overall Study|Lost to Follow-up|0
4384166|NCT00979901|7162107|FG000|Overall Study|Protocol Violation|2
4384167|NCT00979901|7162108|FG001|Overall Study|Protocol Violation|2
4384168|NCT00979901|7162109|FG002|Overall Study|Protocol Violation|7
4384169|NCT00979901|7162110|FG003|Overall Study|Protocol Violation|1
4384170|NCT00979901|7162107|FG000|Overall Study|Withdrawal by Subject|2
4384171|NCT00979901|7162108|FG001|Overall Study|Withdrawal by Subject|1
4384172|NCT00979901|7162109|FG002|Overall Study|Withdrawal by Subject|1
4469299|NCT00634920|7262119|FG000|Period 2 - Post-Randomization|Adverse Event|37
4469300|NCT00634920|7262120|FG001|Period 2 - Post-Randomization|Adverse Event|9
4469301|NCT00634920|7262121|FG002|Period 2 - Post-Randomization|Adverse Event|0
4469302|NCT00634920|7262119|FG000|Period 2 - Post-Randomization|Rejection|11
4469303|NCT00634920|7262120|FG001|Period 2 - Post-Randomization|Rejection|5
4469304|NCT00634920|7262121|FG002|Period 2 - Post-Randomization|Rejection|0
4469305|NCT00634920|7262119|FG000|Period 2 - Post-Randomization|Death|2
4469306|NCT00634920|7262120|FG001|Period 2 - Post-Randomization|Death|5
4469307|NCT00634920|7262121|FG002|Period 2 - Post-Randomization|Death|0
4469308|NCT00634920|7262119|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9
4469309|NCT00634920|7262120|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13
4469310|NCT00634920|7262121|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0
4469311|NCT00634920|7262119|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2
4469312|NCT00634920|7262120|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0
4469313|NCT00634920|7262121|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0
4469314|NCT00634933|7262130|FG000|Part A: Baseline to Week 24|Adverse Event|4
4469315|NCT00634933|7262131|FG001|Part A: Baseline to Week 24|Adverse Event|4
4469316|NCT00634933|7262132|FG002|Part A: Baseline to Week 24|Adverse Event|8
4469317|NCT00634933|7262133|FG003|Part A: Baseline to Week 24|Adverse Event|0
4469318|NCT00634933|7262134|FG004|Part A: Baseline to Week 24|Adverse Event|0
4469319|NCT00634933|7262130|FG000|Part A: Baseline to Week 24|Death|1
4469320|NCT00634933|7262131|FG001|Part A: Baseline to Week 24|Death|0
4469321|NCT00634933|7262132|FG002|Part A: Baseline to Week 24|Death|0
4469322|NCT00634933|7262133|FG003|Part A: Baseline to Week 24|Death|0
4469323|NCT00634933|7262134|FG004|Part A: Baseline to Week 24|Death|0
4469324|NCT00634933|7262130|FG000|Part A: Baseline to Week 24|Failed to Return|1
4469325|NCT00634933|7262131|FG001|Part A: Baseline to Week 24|Failed to Return|0
4469326|NCT00634933|7262132|FG002|Part A: Baseline to Week 24|Failed to Return|0
4469327|NCT00634933|7262133|FG003|Part A: Baseline to Week 24|Failed to Return|0
4469328|NCT00634933|7262134|FG004|Part A: Baseline to Week 24|Failed to Return|0
4469329|NCT00634933|7262130|FG000|Part A: Baseline to Week 24|Investigator Request|1
4469330|NCT00634933|7262131|FG001|Part A: Baseline to Week 24|Investigator Request|1
4469331|NCT00634933|7262132|FG002|Part A: Baseline to Week 24|Investigator Request|1
4469332|NCT00634933|7262133|FG003|Part A: Baseline to Week 24|Investigator Request|0
4469333|NCT00634933|7262134|FG004|Part A: Baseline to Week 24|Investigator Request|0
4469334|NCT00634933|7262130|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0
4469335|NCT00634933|7262131|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1
4469336|NCT00634933|7262132|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1
4469337|NCT00634933|7262133|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0
4469338|NCT00634933|7262134|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0
4469339|NCT00634933|7262130|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0
4469340|NCT00634933|7262131|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3
4469341|NCT00634933|7262132|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3
4469342|NCT00634933|7262133|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0
4469343|NCT00634933|7262134|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0
4384173|NCT00979901|7162110|FG003|Overall Study|Withdrawal by Subject|1
4384174|NCT00979901|7162107|FG000|Overall Study|Noncompliance|1
4384175|NCT00979901|7162108|FG001|Overall Study|Noncompliance|0
4384176|NCT00979901|7162109|FG002|Overall Study|Noncompliance|0
4384177|NCT00979901|7162110|FG003|Overall Study|Noncompliance|0
4384178|NCT00979901|7162107|FG000|Overall Study|out-of-state|1
4384179|NCT00979901|7162108|FG001|Overall Study|out-of-state|0
4384180|NCT00979901|7162109|FG002|Overall Study|out-of-state|0
4384181|NCT00979901|7162110|FG003|Overall Study|out-of-state|0
4384182|NCT00979901|7162107|FG000|Overall Study|vacation|1
4384183|NCT00979901|7162108|FG001|Overall Study|vacation|0
4384184|NCT00979901|7162109|FG002|Overall Study|vacation|0
4384185|NCT00979901|7162110|FG003|Overall Study|vacation|0
4384186|NCT00979901|7162107|FG000|Overall Study|elevated lab values pre-randomization|1
4384187|NCT00979901|7162108|FG001|Overall Study|elevated lab values pre-randomization|0
4384188|NCT00979901|7162109|FG002|Overall Study|elevated lab values pre-randomization|0
4384189|NCT00979901|7162110|FG003|Overall Study|elevated lab values pre-randomization|0
4384190|NCT00979901|7162107|FG000|Overall Study|Discontinued in Error|0
4384191|NCT00979901|7162108|FG001|Overall Study|Discontinued in Error|1
4384192|NCT00979901|7162109|FG002|Overall Study|Discontinued in Error|0
4384193|NCT00979901|7162110|FG003|Overall Study|Discontinued in Error|0
4384194|NCT00979901|7162107|FG000|Overall Study|Left Country|0
4384195|NCT00979901|7162108|FG001|Overall Study|Left Country|0
4384196|NCT00979901|7162109|FG002|Overall Study|Left Country|1
4384197|NCT00979901|7162110|FG003|Overall Study|Left Country|0
4384198|NCT00979901|7162107|FG000|Overall Study|Treatment Group Terminated by Sponsor|0
4384199|NCT00979901|7162108|FG001|Overall Study|Treatment Group Terminated by Sponsor|0
4384200|NCT00979901|7162109|FG002|Overall Study|Treatment Group Terminated by Sponsor|0
4384201|NCT00979901|7162110|FG003|Overall Study|Treatment Group Terminated by Sponsor|112
4771200|NCT04532294|7748034|FG000|Overall Study|Withdrawal by Subject|0
4771201|NCT04532294|7748035|FG001|Overall Study|Withdrawal by Subject|0
4771202|NCT04532294|7748036|FG002|Overall Study|Withdrawal by Subject|1
4384205|NCT00963599|7162136|FG000|Overall Study|Adverse Event|2
4384206|NCT00963599|7162137|FG001|Overall Study|Adverse Event|0
4384207|NCT00963599|7162138|FG002|Overall Study|Adverse Event|1
4384208|NCT00963599|7162139|FG003|Overall Study|Adverse Event|2
4384209|NCT00963599|7162136|FG000|Overall Study|Lack of Efficacy|0
4384210|NCT00963599|7162137|FG001|Overall Study|Lack of Efficacy|2
4384211|NCT00963599|7162138|FG002|Overall Study|Lack of Efficacy|1
4384212|NCT00963599|7162139|FG003|Overall Study|Lack of Efficacy|4
4384213|NCT00963599|7162136|FG000|Overall Study|Lost to Follow-up|0
4384214|NCT00963599|7162137|FG001|Overall Study|Lost to Follow-up|1
4384215|NCT00963599|7162138|FG002|Overall Study|Lost to Follow-up|1
4384216|NCT00963599|7162139|FG003|Overall Study|Lost to Follow-up|1
4384217|NCT00963599|7162136|FG000|Overall Study|Protocol Violation|2
4384218|NCT00963599|7162137|FG001|Overall Study|Protocol Violation|2
4384219|NCT00963599|7162138|FG002|Overall Study|Protocol Violation|3
4384220|NCT00963599|7162139|FG003|Overall Study|Protocol Violation|4
4384221|NCT00963599|7162136|FG000|Overall Study|Withdrawal by Subject|2
4384222|NCT00963599|7162137|FG001|Overall Study|Withdrawal by Subject|1
4384223|NCT00963599|7162138|FG002|Overall Study|Withdrawal by Subject|3
4384224|NCT00963599|7162139|FG003|Overall Study|Withdrawal by Subject|3
4384225|NCT00953680|7162154|FG000|Period 1|Withdrawal by Subject|0
4384226|NCT00953680|7162155|FG001|Period 1|Withdrawal by Subject|1
4384227|NCT00943852|7162168|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
4384228|NCT00943852|7162169|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
4384229|NCT00943852|7162170|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
4384230|NCT00943852|7162171|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1
4384231|NCT00943852|7162172|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
4384232|NCT00943852|7162173|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
4384233|NCT00943852|7162174|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
4384234|NCT00943852|7162175|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
4384235|NCT00943852|7162176|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
4384236|NCT00943852|7162177|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
4384237|NCT00943852|7162168|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0
4384238|NCT00943852|7162169|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0
4384239|NCT00943852|7162170|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0
4384240|NCT00943852|7162171|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0
4384241|NCT00943852|7162172|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0
4384242|NCT00943852|7162173|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1
4384243|NCT00943852|7162174|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0
4384244|NCT00943852|7162175|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0
4384245|NCT00943852|7162176|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0
4384246|NCT00943852|7162177|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0
4384247|NCT00943852|7162168|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
4469344|NCT00634933|7262130|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3
4384248|NCT00943852|7162169|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
4384249|NCT00943852|7162170|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
4384250|NCT00943852|7162171|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
4588885|NCT01505647|7433688|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0
4588886|NCT01505647|7433687|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1
4384251|NCT00943852|7162172|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
4384252|NCT00943852|7162173|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
4384253|NCT00943852|7162174|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1
4384254|NCT00943852|7162175|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
4384255|NCT00943852|7162176|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
4384256|NCT00943852|7162177|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
4384257|NCT00943852|7162168|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
4384258|NCT00943852|7162169|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
4384259|NCT00943852|7162170|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
4384260|NCT00943852|7162171|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
4384261|NCT00943852|7162172|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
4384262|NCT00943852|7162173|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
4384263|NCT00943852|7162174|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
4384264|NCT00943852|7162175|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1
4384265|NCT00943852|7162176|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
4384266|NCT00943852|7162177|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
4384267|NCT00943852|7162168|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1
4384268|NCT00943852|7162169|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0
4384269|NCT00943852|7162170|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1
4384270|NCT00943852|7162171|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1
4384271|NCT00943852|7162172|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0
4384272|NCT00943852|7162173|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0
4384273|NCT00943852|7162174|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1
4469345|NCT00634933|7262131|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1
4469346|NCT00634933|7262132|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0
4469347|NCT00634933|7262133|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0
4469348|NCT00634933|7262134|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0
4469349|NCT00634933|7262130|FG000|Part A: Baseline to Week 24|Other|1
4469350|NCT00634933|7262131|FG001|Part A: Baseline to Week 24|Other|8
4469351|NCT00634933|7262132|FG002|Part A: Baseline to Week 24|Other|5
4469352|NCT00634933|7262133|FG003|Part A: Baseline to Week 24|Other|0
4469353|NCT00634933|7262134|FG004|Part A: Baseline to Week 24|Other|0
4469354|NCT00634933|7262130|FG000|Between Part A and Part B|Physician Decision|0
4469355|NCT00634933|7262131|FG001|Between Part A and Part B|Physician Decision|1
4469356|NCT00634933|7262132|FG002|Between Part A and Part B|Physician Decision|0
4469357|NCT00634933|7262133|FG003|Between Part A and Part B|Physician Decision|0
4469358|NCT00634933|7262134|FG004|Between Part A and Part B|Physician Decision|0
4469359|NCT00634933|7262130|FG000|Part B: Week 24 to Week 52|Adverse Event|0
4469360|NCT00634933|7262131|FG001|Part B: Week 24 to Week 52|Adverse Event|1
4469361|NCT00634933|7262132|FG002|Part B: Week 24 to Week 52|Adverse Event|1
4469362|NCT00634933|7262133|FG003|Part B: Week 24 to Week 52|Adverse Event|1
4588887|NCT01505647|7433688|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0
4469363|NCT00634933|7262134|FG004|Part B: Week 24 to Week 52|Adverse Event|0
4469364|NCT00634933|7262130|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0
4469365|NCT00634933|7262131|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11
4469366|NCT00634933|7262132|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14
4469367|NCT00634933|7262133|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3
4469368|NCT00634933|7262134|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7
4469369|NCT00634933|7262130|FG000|Part B: Week 24 to Week 52|Physician Decision|0
4469370|NCT00634933|7262131|FG001|Part B: Week 24 to Week 52|Physician Decision|1
4469371|NCT00634933|7262132|FG002|Part B: Week 24 to Week 52|Physician Decision|1
4469372|NCT00634933|7262133|FG003|Part B: Week 24 to Week 52|Physician Decision|0
4469373|NCT00634933|7262134|FG004|Part B: Week 24 to Week 52|Physician Decision|0
4469374|NCT00634933|7262130|FG000|Part B: Week 24 to Week 52|Protocol Violation|0
4469375|NCT00634933|7262131|FG001|Part B: Week 24 to Week 52|Protocol Violation|0
4469376|NCT00634933|7262132|FG002|Part B: Week 24 to Week 52|Protocol Violation|0
4469377|NCT00634933|7262133|FG003|Part B: Week 24 to Week 52|Protocol Violation|0
4469378|NCT00634933|7262134|FG004|Part B: Week 24 to Week 52|Protocol Violation|1
4469379|NCT00634933|7262130|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0
4469380|NCT00634933|7262131|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0
4469381|NCT00634933|7262132|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0
4469382|NCT00634933|7262133|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2
4469383|NCT00634933|7262134|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1
4384274|NCT00943852|7162175|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0
4384275|NCT00943852|7162176|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0
4384276|NCT00943852|7162177|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0
4384277|NCT00927953|7162189|FG000|Overall Study|Death|2
4384278|NCT00927953|7162190|FG001|Overall Study|Death|1
4384279|NCT00909389|7162197|FG000|Overall Study|Adverse Event|6
4384280|NCT00909389|7162197|FG000|Overall Study|Death|4
4384281|NCT00909389|7162197|FG000|Overall Study|Poor Compliance|16
4384282|NCT00909389|7162197|FG000|Overall Study|Lost to Follow-up|4
4384283|NCT00909389|7162197|FG000|Overall Study|No Information|103
4384284|NCT00820027|7162205|FG000|Overall Study|Adverse Event|15
4384285|NCT00820027|7162206|FG001|Overall Study|Adverse Event|8
4384286|NCT00820027|7162207|FG002|Overall Study|Adverse Event|10
4384287|NCT00820027|7162208|FG003|Overall Study|Adverse Event|5
4384288|NCT00820027|7162205|FG000|Overall Study|Lack of Efficacy|2
4384289|NCT00820027|7162206|FG001|Overall Study|Lack of Efficacy|1
4384290|NCT00820027|7162207|FG002|Overall Study|Lack of Efficacy|2
4384291|NCT00820027|7162208|FG003|Overall Study|Lack of Efficacy|2
4384292|NCT00820027|7162205|FG000|Overall Study|Physician Decision|0
4384293|NCT00820027|7162206|FG001|Overall Study|Physician Decision|1
4384294|NCT00820027|7162207|FG002|Overall Study|Physician Decision|1
4384295|NCT00820027|7162208|FG003|Overall Study|Physician Decision|0
4384296|NCT00820027|7162205|FG000|Overall Study|Protocol Violation|3
4384297|NCT00820027|7162206|FG001|Overall Study|Protocol Violation|0
4384298|NCT00820027|7162207|FG002|Overall Study|Protocol Violation|4
4384299|NCT00820027|7162208|FG003|Overall Study|Protocol Violation|0
4384300|NCT00820027|7162205|FG000|Overall Study|Withdrawal by Subject|6
4384301|NCT00820027|7162206|FG001|Overall Study|Withdrawal by Subject|4
4384302|NCT00820027|7162207|FG002|Overall Study|Withdrawal by Subject|4
4384303|NCT00820027|7162208|FG003|Overall Study|Withdrawal by Subject|6
4384304|NCT00788710|7162222|FG000|Overall Study|Adverse Event|1
4384305|NCT00788710|7162223|FG001|Overall Study|Adverse Event|3
4384306|NCT00788710|7162224|FG002|Overall Study|Adverse Event|4
4384307|NCT00788710|7162222|FG000|Overall Study|Lack of Efficacy|0
4384308|NCT00788710|7162223|FG001|Overall Study|Lack of Efficacy|0
4384309|NCT00788710|7162224|FG002|Overall Study|Lack of Efficacy|1
4384310|NCT00788710|7162222|FG000|Overall Study|Lost to Follow-up|0
4384311|NCT00788710|7162223|FG001|Overall Study|Lost to Follow-up|1
4384312|NCT00788710|7162224|FG002|Overall Study|Lost to Follow-up|0
4384313|NCT00788710|7162222|FG000|Overall Study|Physician Decision|2
4384314|NCT00788710|7162223|FG001|Overall Study|Physician Decision|1
4384315|NCT00788710|7162224|FG002|Overall Study|Physician Decision|0
4384316|NCT00788710|7162222|FG000|Overall Study|Protocol Violation|0
4384317|NCT00788710|7162223|FG001|Overall Study|Protocol Violation|1
4384318|NCT00788710|7162224|FG002|Overall Study|Protocol Violation|1
4697315|NCT02647788|7610633|FG000|Overall Study|Felt nauseous with assigned medication|1
4697316|NCT02647788|7610634|FG001|Overall Study|Felt nauseous with assigned medication|1
4697317|NCT02647866|7610645|FG000|Overall Study|Adverse Event|0
4697318|NCT02647866|7610646|FG001|Overall Study|Adverse Event|0
4697319|NCT02647866|7610647|FG002|Overall Study|Adverse Event|2
4697320|NCT02647866|7610648|FG003|Overall Study|Adverse Event|2
4697321|NCT02647866|7610649|FG004|Overall Study|Adverse Event|1
4697322|NCT02647866|7610645|FG000|Overall Study|Disease Worsening|3
4697323|NCT02647866|7610646|FG001|Overall Study|Disease Worsening|1
4697324|NCT02647866|7610647|FG002|Overall Study|Disease Worsening|0
4697325|NCT02647866|7610648|FG003|Overall Study|Disease Worsening|0
4697326|NCT02647866|7610649|FG004|Overall Study|Disease Worsening|1
4697327|NCT02647866|7610645|FG000|Overall Study|Withdrawal by Subject|1
4697328|NCT02647866|7610646|FG001|Overall Study|Withdrawal by Subject|1
4697329|NCT02647866|7610647|FG002|Overall Study|Withdrawal by Subject|2
4697330|NCT02647866|7610648|FG003|Overall Study|Withdrawal by Subject|4
4697331|NCT02647866|7610649|FG004|Overall Study|Withdrawal by Subject|4
4697332|NCT02647866|7610645|FG000|Overall Study|Physician Decision|0
4697333|NCT02647866|7610646|FG001|Overall Study|Physician Decision|1
4697334|NCT02647866|7610647|FG002|Overall Study|Physician Decision|1
4697335|NCT02647866|7610648|FG003|Overall Study|Physician Decision|0
4697336|NCT02647866|7610649|FG004|Overall Study|Physician Decision|2
4697337|NCT02647866|7610645|FG000|Overall Study|Death|0
4697338|NCT02647866|7610646|FG001|Overall Study|Death|1
4697339|NCT02647866|7610647|FG002|Overall Study|Death|0
4697340|NCT02647866|7610648|FG003|Overall Study|Death|0
4697341|NCT02647866|7610649|FG004|Overall Study|Death|0
4697342|NCT02647866|7610645|FG000|Overall Study|Subject moved to different country|1
4697343|NCT02647866|7610646|FG001|Overall Study|Subject moved to different country|0
4697344|NCT02647866|7610647|FG002|Overall Study|Subject moved to different country|0
4697345|NCT02647866|7610648|FG003|Overall Study|Subject moved to different country|0
4697346|NCT02647866|7610649|FG004|Overall Study|Subject moved to different country|0
4697347|NCT02647905|7610669|FG000|Overall Study|Lost to Follow-up|1
4697348|NCT02647905|7610669|FG000|Overall Study|Withdrawal by Subject|2
4697349|NCT02647944|7610675|FG000|Overall Study|Withdrawal by Subject|0
4697350|NCT02647944|7610676|FG001|Overall Study|Withdrawal by Subject|3
4697351|NCT02647944|7610675|FG000|Overall Study|Adverse Event|2
4384319|NCT00788710|7162222|FG000|Overall Study|Withdrawal by Subject|2
4384320|NCT00788710|7162223|FG001|Overall Study|Withdrawal by Subject|2
4384321|NCT00788710|7162224|FG002|Overall Study|Withdrawal by Subject|0
4384322|NCT00783224|7162236|FG000|Overall Study|Adverse Event|0
4384323|NCT00783224|7162237|FG001|Overall Study|Adverse Event|0
4384324|NCT00783224|7162238|FG002|Overall Study|Adverse Event|1
4384325|NCT00783224|7162239|FG003|Overall Study|Adverse Event|0
4384326|NCT00783224|7162236|FG000|Overall Study|Discarded the Investigational Drug Used|0
4384327|NCT00783224|7162237|FG001|Overall Study|Discarded the Investigational Drug Used|0
4384328|NCT00783224|7162238|FG002|Overall Study|Discarded the Investigational Drug Used|0
4384329|NCT00783224|7162239|FG003|Overall Study|Discarded the Investigational Drug Used|1
4384330|NCT00783224|7162236|FG000|Overall Study|Inappropriate as a study subject|0
4384331|NCT00783224|7162237|FG001|Overall Study|Inappropriate as a study subject|0
4384332|NCT00783224|7162238|FG002|Overall Study|Inappropriate as a study subject|0
4384333|NCT00783224|7162239|FG003|Overall Study|Inappropriate as a study subject|1
4384334|NCT00778700|7162268|FG000|Overall Study|Adverse Event|6
4384335|NCT00778700|7162269|FG001|Overall Study|Adverse Event|1
4384336|NCT00778700|7162270|FG002|Overall Study|Adverse Event|3
4384337|NCT00778700|7162271|FG003|Overall Study|Adverse Event|5
4384338|NCT00778700|7162268|FG000|Overall Study|Protocol Violation|1
4384339|NCT00778700|7162269|FG001|Overall Study|Protocol Violation|1
4384340|NCT00778700|7162270|FG002|Overall Study|Protocol Violation|0
4384341|NCT00778700|7162271|FG003|Overall Study|Protocol Violation|0
4384342|NCT00778700|7162268|FG000|Overall Study|Subject Withdrew Consent|6
4384343|NCT00778700|7162269|FG001|Overall Study|Subject Withdrew Consent|4
4384344|NCT00778700|7162270|FG002|Overall Study|Subject Withdrew Consent|1
4384345|NCT00778700|7162271|FG003|Overall Study|Subject Withdrew Consent|4
4384346|NCT00778700|7162268|FG000|Overall Study|Lost to Follow-up|3
4384347|NCT00778700|7162269|FG001|Overall Study|Lost to Follow-up|1
4384348|NCT00778700|7162270|FG002|Overall Study|Lost to Follow-up|0
4384349|NCT00778700|7162271|FG003|Overall Study|Lost to Follow-up|1
4384350|NCT00778700|7162268|FG000|Overall Study|Reason not Specified|2
4384351|NCT00778700|7162269|FG001|Overall Study|Reason not Specified|0
4384352|NCT00778700|7162270|FG002|Overall Study|Reason not Specified|1
4384353|NCT00778700|7162271|FG003|Overall Study|Reason not Specified|3
4384354|NCT00778700|7162268|FG000|Overall Study|Other|0
4384355|NCT00778700|7162269|FG001|Overall Study|Other|0
4384356|NCT00778700|7162270|FG002|Overall Study|Other|1
4384357|NCT00778700|7162271|FG003|Overall Study|Other|0
4384358|NCT00764478|7162288|FG000|Overall Study|Adverse Event|1
4384359|NCT00764478|7162289|FG001|Overall Study|Adverse Event|1
4384360|NCT00764478|7162290|FG002|Overall Study|Adverse Event|1
4384361|NCT00764478|7162288|FG000|Overall Study|Withdrawal by Subject|7
4384362|NCT00764478|7162289|FG001|Overall Study|Withdrawal by Subject|12
4384363|NCT00764478|7162290|FG002|Overall Study|Withdrawal by Subject|1
4384364|NCT00764478|7162288|FG000|Overall Study|Lost to Follow-up|7
4384365|NCT00764478|7162289|FG001|Overall Study|Lost to Follow-up|8
4384366|NCT00764478|7162290|FG002|Overall Study|Lost to Follow-up|5
4384367|NCT00764478|7162288|FG000|Overall Study|Protocol Violation|0
4384368|NCT00764478|7162289|FG001|Overall Study|Protocol Violation|1
4384369|NCT00764478|7162290|FG002|Overall Study|Protocol Violation|1
4384370|NCT00761527|7162298|FG000|Overall Study|Adverse Event|3
4384371|NCT00761527|7162298|FG000|Overall Study|Poor Compliance|8
4384372|NCT00761527|7162298|FG000|Overall Study|Lost to Follow-up|9
4384373|NCT00761527|7162298|FG000|Overall Study|Unknown reason|2
4384374|NCT00757627|7162302|FG000|Overall Study|Adverse Event|15
4384375|NCT00757627|7162302|FG000|Overall Study|Lack of Efficacy|10
4384376|NCT00757627|7162302|FG000|Overall Study|Lost to Follow-up|28
4384377|NCT00757627|7162302|FG000|Overall Study|Withdrawal by Subject|27
4384378|NCT00757627|7162302|FG000|Overall Study|Other|1
4384379|NCT00756938|7162314|FG000|12-week Base Study|Protocol-specific Criteria Met|1
4384380|NCT00756938|7162315|FG001|12-week Base Study|Protocol-specific Criteria Met|0
4384381|NCT00756938|7162316|FG002|12-week Base Study|Protocol-specific Criteria Met|1
4384382|NCT00756938|7162317|FG003|12-week Base Study|Protocol-specific Criteria Met|0
4588888|NCT01505647|7433687|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1
4384383|NCT00756938|7162314|FG000|12-week Base Study|Protocol Violation|0
4384384|NCT00756938|7162315|FG001|12-week Base Study|Protocol Violation|0
4384385|NCT00756938|7162316|FG002|12-week Base Study|Protocol Violation|1
4384386|NCT00756938|7162317|FG003|12-week Base Study|Protocol Violation|0
4384387|NCT00756938|7162314|FG000|12-week Base Study|Lost to Follow-up|1
4384388|NCT00756938|7162315|FG001|12-week Base Study|Lost to Follow-up|0
4384389|NCT00756938|7162316|FG002|12-week Base Study|Lost to Follow-up|0
4384390|NCT00756938|7162317|FG003|12-week Base Study|Lost to Follow-up|0
4384391|NCT00756938|7162314|FG000|Optional Extension|Lack of Efficacy|0
4384392|NCT00756938|7162315|FG001|Optional Extension|Lack of Efficacy|0
4384393|NCT00756938|7162316|FG002|Optional Extension|Lack of Efficacy|0
4384394|NCT00756938|7162317|FG003|Optional Extension|Lack of Efficacy|1
4384395|NCT00756938|7162314|FG000|Optional Extension|End of Study|0
4384396|NCT00756938|7162315|FG001|Optional Extension|End of Study|0
4384397|NCT00756938|7162316|FG002|Optional Extension|End of Study|0
4384398|NCT00756938|7162317|FG003|Optional Extension|End of Study|11
4384399|NCT00756938|7162314|FG000|Optional Extension|Protocol-specific criteria met|0
4384400|NCT00756938|7162315|FG001|Optional Extension|Protocol-specific criteria met|0
4384401|NCT00756938|7162316|FG002|Optional Extension|Protocol-specific criteria met|0
4384402|NCT00756938|7162317|FG003|Optional Extension|Protocol-specific criteria met|9
4384403|NCT00756938|7162314|FG000|Optional Extension|Physician Decision|0
4384404|NCT00756938|7162315|FG001|Optional Extension|Physician Decision|0
4384405|NCT00756938|7162316|FG002|Optional Extension|Physician Decision|0
4384406|NCT00756938|7162317|FG003|Optional Extension|Physician Decision|3
4384407|NCT00756938|7162314|FG000|Optional Extension|Lost to Follow-up|0
4384408|NCT00756938|7162315|FG001|Optional Extension|Lost to Follow-up|0
4384409|NCT00756938|7162316|FG002|Optional Extension|Lost to Follow-up|0
4384410|NCT00756938|7162317|FG003|Optional Extension|Lost to Follow-up|1
4384411|NCT00756938|7162314|FG000|Optional Extension|Protocol Violation|0
4384412|NCT00756938|7162315|FG001|Optional Extension|Protocol Violation|0
4384413|NCT00756938|7162316|FG002|Optional Extension|Protocol Violation|0
4384414|NCT00756938|7162317|FG003|Optional Extension|Protocol Violation|1
4384415|NCT00756938|7162314|FG000|Optional Extension|Withdrawal by Subject|0
4384416|NCT00756938|7162315|FG001|Optional Extension|Withdrawal by Subject|0
4384417|NCT00756938|7162316|FG002|Optional Extension|Withdrawal by Subject|0
4384418|NCT00756938|7162317|FG003|Optional Extension|Withdrawal by Subject|10
4384419|NCT00756938|7162314|FG000|Optional Extension|Adverse Event|0
4384420|NCT00756938|7162315|FG001|Optional Extension|Adverse Event|0
4384421|NCT00756938|7162316|FG002|Optional Extension|Adverse Event|0
4384422|NCT00756938|7162317|FG003|Optional Extension|Adverse Event|1
4384423|NCT00746590|7162335|FG000|Overall Study|Death|1
4384424|NCT00730132|7162339|FG000|Overall Study|Protocol Violation|154
4384425|NCT00730132|7162339|FG000|Overall Study|Death|1
4384426|NCT00728416|7162348|FG000|Overall Study|Adverse Event|1
4384427|NCT00728416|7162349|FG001|Overall Study|Adverse Event|1
4384428|NCT00728416|7162348|FG000|Overall Study|Treatment Failure|0
4384429|NCT00728416|7162349|FG001|Overall Study|Treatment Failure|1
4384430|NCT00728416|7162348|FG000|Overall Study|Withdrawal by Subject|1
4384431|NCT00728416|7162349|FG001|Overall Study|Withdrawal by Subject|0
4384432|NCT00704535|7162376|FG000|Overall Study|Adverse Event|2
4384433|NCT00704535|7162376|FG000|Overall Study|Death|2
4384434|NCT00704535|7162376|FG000|Overall Study|Lost to Follow-up|8
4384435|NCT00704535|7162376|FG000|Overall Study|Protocol Violation|10
4384436|NCT00704535|7162376|FG000|Overall Study|Completed status not on Case Report Form|124
4384437|NCT00694369|7162385|FG000|Overall Study|Adverse Event|0
4384438|NCT00694369|7162386|FG001|Overall Study|Adverse Event|1
4384439|NCT00694369|7162387|FG002|Overall Study|Adverse Event|0
4384440|NCT00694369|7162388|FG003|Overall Study|Adverse Event|1
4384441|NCT00694369|7162389|FG004|Overall Study|Adverse Event|3
4384442|NCT00694369|7162385|FG000|Overall Study|Lost to Follow-up|0
4384443|NCT00694369|7162386|FG001|Overall Study|Lost to Follow-up|0
4384444|NCT00694369|7162387|FG002|Overall Study|Lost to Follow-up|1
4384445|NCT00694369|7162388|FG003|Overall Study|Lost to Follow-up|1
4384446|NCT00694369|7162389|FG004|Overall Study|Lost to Follow-up|0
4384447|NCT00694369|7162385|FG000|Overall Study|Physician Decision|0
4384448|NCT00694369|7162386|FG001|Overall Study|Physician Decision|0
4384449|NCT00694369|7162387|FG002|Overall Study|Physician Decision|0
4384450|NCT00694369|7162388|FG003|Overall Study|Physician Decision|0
4384451|NCT00694369|7162389|FG004|Overall Study|Physician Decision|1
4384452|NCT00694369|7162385|FG000|Overall Study|Protocol Violation|0
4588889|NCT01505647|7433688|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0
4588890|NCT01505647|7433687|FG000|Day 43 Through Day 182 Follow-up|Death|0
4588891|NCT01505647|7433688|FG001|Day 43 Through Day 182 Follow-up|Death|1
4588892|NCT01505647|7433687|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1
4588893|NCT01505647|7433688|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2
4588894|NCT01505868|7433718|FG000|Overall Study|Withdrawal by Subject|1
4588895|NCT01505868|7433719|FG001|Overall Study|Withdrawal by Subject|0
4588896|NCT01505868|7433720|FG002|Overall Study|Withdrawal by Subject|0
4588897|NCT01505868|7433721|FG003|Overall Study|Withdrawal by Subject|0
4588898|NCT01505868|7433722|FG004|Overall Study|Withdrawal by Subject|0
4384453|NCT00694369|7162386|FG001|Overall Study|Protocol Violation|1
4384454|NCT00694369|7162387|FG002|Overall Study|Protocol Violation|0
4384455|NCT00694369|7162388|FG003|Overall Study|Protocol Violation|0
4384456|NCT00694369|7162389|FG004|Overall Study|Protocol Violation|0
4384457|NCT00694369|7162385|FG000|Overall Study|Withdrawal by Subject|1
4384458|NCT00694369|7162386|FG001|Overall Study|Withdrawal by Subject|1
4384459|NCT00694369|7162387|FG002|Overall Study|Withdrawal by Subject|1
4384460|NCT00694369|7162388|FG003|Overall Study|Withdrawal by Subject|1
4384461|NCT00694369|7162389|FG004|Overall Study|Withdrawal by Subject|2
4384462|NCT00667823|7162414|FG000|Overall Study|Lost to Follow-up|5
4384463|NCT00667823|7162414|FG000|Overall Study|Adverse Event|7
4384464|NCT00667823|7162414|FG000|Overall Study|Death|182
4384465|NCT00667823|7162414|FG000|Overall Study|Withdrawal by Subject|12
4384466|NCT00667823|7162414|FG000|Overall Study|Other|8
4384467|NCT00667823|7162414|FG000|Overall Study|Missing (completion page missing)|2
4588899|NCT01505881|7433736|FG000|Overall Study|Adverse Event|0
4384468|NCT00652327|7162420|FG000|Overall Study|Adverse Event|0
4384469|NCT00652327|7162421|FG001|Overall Study|Adverse Event|2
4384470|NCT00652327|7162420|FG000|Overall Study|Lost to Follow-up|0
4588900|NCT01505881|7433737|FG001|Overall Study|Adverse Event|1
4384471|NCT00652327|7162421|FG001|Overall Study|Lost to Follow-up|3
4384472|NCT00604500|7162427|FG000|Overall Study|Adverse Event|2
4384473|NCT00604500|7162427|FG000|Overall Study|Protocol Violation|2
4384474|NCT00604500|7162427|FG000|Overall Study|Treatment Failure|1
4384475|NCT00604500|7162427|FG000|Overall Study|Withdrawal by Subject|4
4384476|NCT00604500|7162427|FG000|Overall Study|Administrative|1
4384477|NCT00604500|7162427|FG000|Overall Study|Did not meet protocol eligibility|1
4384478|NCT00568178|7162433|FG000|Double Blind Base Study|Adverse Event|0
4384479|NCT00568178|7162434|FG001|Double Blind Base Study|Adverse Event|2
4384480|NCT00568178|7162435|FG002|Double Blind Base Study|Adverse Event|1
4384481|NCT00568178|7162436|FG003|Double Blind Base Study|Adverse Event|2
4384482|NCT00568178|7162437|FG004|Double Blind Base Study|Adverse Event|0
4384483|NCT00568178|7162438|FG005|Double Blind Base Study|Adverse Event|0
4384484|NCT00568178|7162433|FG000|Double Blind Base Study|Lost to Follow-up|1
4384485|NCT00568178|7162434|FG001|Double Blind Base Study|Lost to Follow-up|0
4384486|NCT00568178|7162435|FG002|Double Blind Base Study|Lost to Follow-up|0
4384487|NCT00568178|7162436|FG003|Double Blind Base Study|Lost to Follow-up|1
4384488|NCT00568178|7162437|FG004|Double Blind Base Study|Lost to Follow-up|0
4384489|NCT00568178|7162438|FG005|Double Blind Base Study|Lost to Follow-up|0
4384490|NCT00568178|7162433|FG000|Double Blind Base Study|Physician Decision|1
4384491|NCT00568178|7162434|FG001|Double Blind Base Study|Physician Decision|1
4384492|NCT00568178|7162435|FG002|Double Blind Base Study|Physician Decision|0
4384493|NCT00568178|7162436|FG003|Double Blind Base Study|Physician Decision|1
4384494|NCT00568178|7162437|FG004|Double Blind Base Study|Physician Decision|0
4384495|NCT00568178|7162438|FG005|Double Blind Base Study|Physician Decision|0
4384496|NCT00568178|7162433|FG000|Double Blind Base Study|Protocol Violation|3
4384497|NCT00568178|7162434|FG001|Double Blind Base Study|Protocol Violation|2
4384498|NCT00568178|7162435|FG002|Double Blind Base Study|Protocol Violation|0
4384499|NCT00568178|7162436|FG003|Double Blind Base Study|Protocol Violation|0
4384500|NCT00568178|7162437|FG004|Double Blind Base Study|Protocol Violation|0
4384501|NCT00568178|7162438|FG005|Double Blind Base Study|Protocol Violation|0
4384502|NCT00568178|7162433|FG000|Double Blind Base Study|Withdrawal by Subject|1
4384503|NCT00568178|7162434|FG001|Double Blind Base Study|Withdrawal by Subject|1
4384504|NCT00568178|7162435|FG002|Double Blind Base Study|Withdrawal by Subject|0
4384505|NCT00568178|7162436|FG003|Double Blind Base Study|Withdrawal by Subject|0
4384506|NCT00568178|7162437|FG004|Double Blind Base Study|Withdrawal by Subject|0
4384507|NCT00568178|7162438|FG005|Double Blind Base Study|Withdrawal by Subject|0
4384508|NCT00568178|7162433|FG000|Double Blind Base Study|Progressive Disease|0
4384509|NCT00568178|7162434|FG001|Double Blind Base Study|Progressive Disease|0
4384510|NCT00568178|7162435|FG002|Double Blind Base Study|Progressive Disease|0
4384511|NCT00568178|7162436|FG003|Double Blind Base Study|Progressive Disease|1
4384512|NCT00568178|7162437|FG004|Double Blind Base Study|Progressive Disease|0
4384513|NCT00568178|7162438|FG005|Double Blind Base Study|Progressive Disease|0
4384514|NCT00568178|7162433|FG000|Open Label Extension|Adverse Event|0
4384515|NCT00568178|7162434|FG001|Open Label Extension|Adverse Event|0
4384516|NCT00568178|7162435|FG002|Open Label Extension|Adverse Event|0
4384517|NCT00568178|7162436|FG003|Open Label Extension|Adverse Event|0
4384518|NCT00568178|7162437|FG004|Open Label Extension|Adverse Event|11
4384519|NCT00568178|7162438|FG005|Open Label Extension|Adverse Event|8
4384520|NCT00568178|7162433|FG000|Open Label Extension|Protocol Violation|0
4384521|NCT00568178|7162434|FG001|Open Label Extension|Protocol Violation|0
4384522|NCT00568178|7162435|FG002|Open Label Extension|Protocol Violation|0
4384523|NCT00568178|7162436|FG003|Open Label Extension|Protocol Violation|0
4384524|NCT00568178|7162437|FG004|Open Label Extension|Protocol Violation|1
4384525|NCT00568178|7162438|FG005|Open Label Extension|Protocol Violation|0
4384526|NCT00568178|7162433|FG000|Open Label Extension|Lost to Follow-up|0
4384527|NCT00568178|7162434|FG001|Open Label Extension|Lost to Follow-up|0
4384528|NCT00568178|7162435|FG002|Open Label Extension|Lost to Follow-up|0
4384529|NCT00568178|7162436|FG003|Open Label Extension|Lost to Follow-up|0
4384530|NCT00568178|7162437|FG004|Open Label Extension|Lost to Follow-up|6
4384531|NCT00568178|7162438|FG005|Open Label Extension|Lost to Follow-up|11
4384532|NCT00568178|7162433|FG000|Open Label Extension|Physician Decision|0
4384533|NCT00568178|7162434|FG001|Open Label Extension|Physician Decision|0
4384534|NCT00568178|7162435|FG002|Open Label Extension|Physician Decision|0
4384535|NCT00568178|7162436|FG003|Open Label Extension|Physician Decision|0
4384536|NCT00568178|7162437|FG004|Open Label Extension|Physician Decision|9
4384537|NCT00568178|7162438|FG005|Open Label Extension|Physician Decision|8
4384538|NCT00568178|7162433|FG000|Open Label Extension|Pregnancy|0
4384539|NCT00568178|7162434|FG001|Open Label Extension|Pregnancy|0
4384540|NCT00568178|7162435|FG002|Open Label Extension|Pregnancy|0
4384541|NCT00568178|7162436|FG003|Open Label Extension|Pregnancy|0
4384542|NCT00568178|7162437|FG004|Open Label Extension|Pregnancy|0
4384543|NCT00568178|7162438|FG005|Open Label Extension|Pregnancy|1
4384544|NCT00568178|7162433|FG000|Open Label Extension|Progressive Disease|0
4384545|NCT00568178|7162434|FG001|Open Label Extension|Progressive Disease|0
4384546|NCT00568178|7162435|FG002|Open Label Extension|Progressive Disease|0
4384547|NCT00568178|7162436|FG003|Open Label Extension|Progressive Disease|0
4384548|NCT00568178|7162437|FG004|Open Label Extension|Progressive Disease|3
4384549|NCT00568178|7162438|FG005|Open Label Extension|Progressive Disease|1
4384550|NCT00568178|7162433|FG000|Open Label Extension|Termination of Trial|0
4384551|NCT00568178|7162434|FG001|Open Label Extension|Termination of Trial|0
4384552|NCT00568178|7162435|FG002|Open Label Extension|Termination of Trial|0
4384553|NCT00568178|7162436|FG003|Open Label Extension|Termination of Trial|0
4469384|NCT00634933|7262130|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0
4384554|NCT00568178|7162437|FG004|Open Label Extension|Termination of Trial|45
4384555|NCT00568178|7162438|FG005|Open Label Extension|Termination of Trial|47
4384556|NCT00568178|7162433|FG000|Open Label Extension|Withdrawal by Subject|0
4384557|NCT00568178|7162434|FG001|Open Label Extension|Withdrawal by Subject|0
4384558|NCT00568178|7162435|FG002|Open Label Extension|Withdrawal by Subject|0
4384559|NCT00568178|7162436|FG003|Open Label Extension|Withdrawal by Subject|0
4384560|NCT00568178|7162437|FG004|Open Label Extension|Withdrawal by Subject|4
4384561|NCT00568178|7162438|FG005|Open Label Extension|Withdrawal by Subject|4
4384562|NCT00549848|7162455|FG000|Overall Study|Death|1
4384563|NCT00549848|7162456|FG001|Overall Study|Death|4
4384564|NCT00549848|7162457|FG002|Overall Study|Death|13
4384565|NCT00549848|7162455|FG000|Overall Study|Physician Decision|0
4384566|NCT00549848|7162456|FG001|Overall Study|Physician Decision|0
4384567|NCT00549848|7162457|FG002|Overall Study|Physician Decision|4
4384568|NCT00549848|7162455|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3
4384569|NCT00549848|7162456|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4
4384570|NCT00549848|7162457|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4
4384571|NCT00549848|7162455|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1
4384572|NCT00549848|7162456|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0
4384573|NCT00549848|7162457|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1
4384574|NCT00549848|7162455|FG000|Overall Study|Participant/Family Withdraw|2
4384575|NCT00549848|7162456|FG001|Overall Study|Participant/Family Withdraw|3
4384576|NCT00549848|7162457|FG002|Overall Study|Participant/Family Withdraw|5
4469385|NCT00634933|7262131|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1
4469386|NCT00634933|7262132|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1
4469387|NCT00634933|7262133|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0
4469388|NCT00634933|7262134|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0
4469389|NCT00634933|7262130|FG000|Part B: Week 24 to Week 52|Other|0
4469390|NCT00634933|7262131|FG001|Part B: Week 24 to Week 52|Other|0
4469391|NCT00634933|7262132|FG002|Part B: Week 24 to Week 52|Other|5
4469392|NCT00634933|7262133|FG003|Part B: Week 24 to Week 52|Other|0
4469393|NCT00634933|7262134|FG004|Part B: Week 24 to Week 52|Other|1
4469394|NCT00635024|7262146|FG000|Overall Study|Adverse Event|1
4469395|NCT00635050|7262150|FG000|Overall Study|Withdrawal by Subject|1
4469396|NCT00635089|7262157|FG000|Overall Study|Adverse Event|7
4469397|NCT00635089|7262157|FG000|Overall Study|Lack of Efficacy|28
4469398|NCT00635089|7262157|FG000|Overall Study|Protocol Deviation|4
4469399|NCT00635089|7262157|FG000|Overall Study|Lost to Follow-up|8
4469400|NCT00635089|7262157|FG000|Overall Study|Other|31
4469401|NCT00635102|7262176|FG000|Overall Study|Withdrawal by Subject|7
4469402|NCT00635102|7262177|FG001|Overall Study|Withdrawal by Subject|8
4469403|NCT00635154|7262194|FG000|Overall Study|Alternative Treatment|8
4469404|NCT00635154|7262194|FG000|Overall Study|Other|4
4469405|NCT00635154|7262194|FG000|Overall Study|Still on treatment|21
4469406|NCT00635219|7262205|FG000|Overall Study|Adverse Event|12
4469407|NCT00635219|7262206|FG001|Overall Study|Adverse Event|10
4469408|NCT00635219|7262207|FG002|Overall Study|Adverse Event|18
4469409|NCT00635219|7262208|FG003|Overall Study|Adverse Event|15
4469410|NCT00635219|7262209|FG004|Overall Study|Adverse Event|19
4469411|NCT00635219|7262205|FG000|Overall Study|Lack of Efficacy|5
4469412|NCT00635219|7262206|FG001|Overall Study|Lack of Efficacy|6
4469413|NCT00635219|7262207|FG002|Overall Study|Lack of Efficacy|3
4469414|NCT00635219|7262208|FG003|Overall Study|Lack of Efficacy|4
4469415|NCT00635219|7262209|FG004|Overall Study|Lack of Efficacy|6
4469416|NCT00635219|7262205|FG000|Overall Study|Non-compliance With Study Product|0
4469417|NCT00635219|7262206|FG001|Overall Study|Non-compliance With Study Product|0
4469418|NCT00635219|7262207|FG002|Overall Study|Non-compliance With Study Product|0
4469419|NCT00635219|7262208|FG003|Overall Study|Non-compliance With Study Product|2
4469420|NCT00635219|7262209|FG004|Overall Study|Non-compliance With Study Product|1
4469421|NCT00635219|7262205|FG000|Overall Study|Protocol Violation|0
4469422|NCT00635219|7262206|FG001|Overall Study|Protocol Violation|2
4469423|NCT00635219|7262207|FG002|Overall Study|Protocol Violation|3
4469424|NCT00635219|7262208|FG003|Overall Study|Protocol Violation|2
4469425|NCT00635219|7262209|FG004|Overall Study|Protocol Violation|4
4469426|NCT00635219|7262205|FG000|Overall Study|Withdrawal of Consent|8
4469427|NCT00635219|7262206|FG001|Overall Study|Withdrawal of Consent|6
4469428|NCT00635219|7262207|FG002|Overall Study|Withdrawal of Consent|8
4469429|NCT00635219|7262208|FG003|Overall Study|Withdrawal of Consent|11
4469430|NCT00635219|7262209|FG004|Overall Study|Withdrawal of Consent|8
4469431|NCT00635219|7262205|FG000|Overall Study|Lost to Follow-up|0
4469432|NCT00635219|7262206|FG001|Overall Study|Lost to Follow-up|0
4469433|NCT00635219|7262207|FG002|Overall Study|Lost to Follow-up|2
4469434|NCT00635219|7262208|FG003|Overall Study|Lost to Follow-up|0
4469435|NCT00635219|7262209|FG004|Overall Study|Lost to Follow-up|3
4469436|NCT00635219|7262205|FG000|Overall Study|Administrative or Other Reasons|0
4469437|NCT00635219|7262206|FG001|Overall Study|Administrative or Other Reasons|1
4469438|NCT00635219|7262207|FG002|Overall Study|Administrative or Other Reasons|1
4469439|NCT00635219|7262208|FG003|Overall Study|Administrative or Other Reasons|0
4469440|NCT00635219|7262209|FG004|Overall Study|Administrative or Other Reasons|1
4469441|NCT00635349|7262244|FG000|Overall Study|Other|8
4469442|NCT00635349|7262245|FG001|Overall Study|Other|6
4469443|NCT00635349|7262244|FG000|Overall Study|Protocol Violation|18
4469444|NCT00635349|7262245|FG001|Overall Study|Protocol Violation|22
4384577|NCT00549848|7162455|FG000|Overall Study|Second Malignancy|1
4384578|NCT00549848|7162456|FG001|Overall Study|Second Malignancy|0
4384579|NCT00549848|7162457|FG002|Overall Study|Second Malignancy|0
4384580|NCT00549848|7162455|FG000|Overall Study|Transplant|3
4384581|NCT00549848|7162456|FG001|Overall Study|Transplant|3
4384582|NCT00549848|7162457|FG002|Overall Study|Transplant|18
4384583|NCT00549848|7162455|FG000|Overall Study|Unacceptable Toxicity|1
4384584|NCT00549848|7162456|FG001|Overall Study|Unacceptable Toxicity|6
4384585|NCT00549848|7162457|FG002|Overall Study|Unacceptable Toxicity|6
4384586|NCT00545844|7162473|FG000|Overall Study|Lost to Follow-up|9
4384587|NCT00545844|7162473|FG000|Overall Study|Protocol Violation|1
4384588|NCT00545844|7162473|FG000|Overall Study|Withdrawal by Subject|2
4384589|NCT00511433|7162481|FG000|Overall Study|Adverse Event|5
4384590|NCT00511433|7162482|FG001|Overall Study|Adverse Event|0
4384591|NCT00511433|7162481|FG000|Overall Study|Other Reason|1
4384592|NCT00511433|7162482|FG001|Overall Study|Other Reason|1
4384593|NCT00511355|7162492|FG000|Overall Study|Adverse Event|4
4384594|NCT00511355|7162493|FG001|Overall Study|Adverse Event|4
4384595|NCT00511355|7162492|FG000|Overall Study|Pregnancy Wish|1
4384596|NCT00511355|7162493|FG001|Overall Study|Pregnancy Wish|0
4384597|NCT00511355|7162492|FG000|Overall Study|Lost to Follow-up|2
4384598|NCT00511355|7162493|FG001|Overall Study|Lost to Follow-up|1
4384599|NCT00511355|7162492|FG000|Overall Study|Other Reason|0
4384600|NCT00511355|7162493|FG001|Overall Study|Other Reason|1
4384601|NCT00511355|7162492|FG000|Overall Study|Pre-treatment (serious) adverse event|0
4384602|NCT00511355|7162493|FG001|Overall Study|Pre-treatment (serious) adverse event|1
4384603|NCT00511355|7162492|FG000|Overall Study|Withdrawal of informed consent|0
4384604|NCT00511355|7162493|FG001|Overall Study|Withdrawal of informed consent|1
4384605|NCT00511355|7162492|FG000|Overall Study|Other reason pre-treatment|0
4384606|NCT00511355|7162493|FG001|Overall Study|Other reason pre-treatment|1
4384607|NCT00511342|7162503|FG000|Overall Study|Unacceptable vaginal bleeding|2
4384608|NCT00511342|7162504|FG001|Overall Study|Unacceptable vaginal bleeding|1
4384609|NCT00511342|7162503|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8
4384610|NCT00511342|7162504|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12
4384611|NCT00511342|7162503|FG000|Overall Study|Pregnancy|0
4384612|NCT00511342|7162504|FG001|Overall Study|Pregnancy|1
4384613|NCT00511342|7162503|FG000|Overall Study|Pregnancy wish|0
4384614|NCT00511342|7162504|FG001|Overall Study|Pregnancy wish|1
4384615|NCT00511342|7162503|FG000|Overall Study|Lost to Follow-up|1
4384616|NCT00511342|7162504|FG001|Overall Study|Lost to Follow-up|5
4384617|NCT00511342|7162503|FG000|Overall Study|Other Reason|2
4384618|NCT00511342|7162504|FG001|Overall Study|Other Reason|2
4384619|NCT00511199|7162512|FG000|Overall Study|Unacceptable Vaginal Bleeding|63
4384620|NCT00511199|7162513|FG001|Overall Study|Unacceptable Vaginal Bleeding|4
4384621|NCT00511199|7162512|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227
4384622|NCT00511199|7162513|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52
4384623|NCT00511199|7162512|FG000|Overall Study|Withdrawal of Informed Consent|19
4384624|NCT00511199|7162513|FG001|Overall Study|Withdrawal of Informed Consent|4
4384625|NCT00511199|7162512|FG000|Overall Study|Pregnancy|6
4384626|NCT00511199|7162513|FG001|Overall Study|Pregnancy|3
4384627|NCT00511199|7162512|FG000|Overall Study|Pregnancy Wish|16
4384628|NCT00511199|7162513|FG001|Overall Study|Pregnancy Wish|8
4384629|NCT00511199|7162512|FG000|Overall Study|Lost to Follow-up|40
4384630|NCT00511199|7162513|FG001|Overall Study|Lost to Follow-up|17
4384631|NCT00511199|7162512|FG000|Overall Study|Other Reason|78
4384632|NCT00511199|7162513|FG001|Overall Study|Other Reason|37
4384633|NCT00491504|7162525|FG000|Overall Study|Adverse Event|0
4384634|NCT00491504|7162526|FG001|Overall Study|Adverse Event|1
4384635|NCT00491504|7162527|FG002|Overall Study|Adverse Event|0
4384636|NCT00491504|7162528|FG003|Overall Study|Adverse Event|0
4384637|NCT00491504|7162525|FG000|Overall Study|Withdrawal by Subject|0
4384638|NCT00491504|7162526|FG001|Overall Study|Withdrawal by Subject|0
4384639|NCT00491504|7162527|FG002|Overall Study|Withdrawal by Subject|1
4384640|NCT00491504|7162528|FG003|Overall Study|Withdrawal by Subject|2
4384641|NCT00491504|7162525|FG000|Overall Study|Protocol Violation|0
4384642|NCT00491504|7162526|FG001|Overall Study|Protocol Violation|0
4384643|NCT00491504|7162527|FG002|Overall Study|Protocol Violation|3
4384644|NCT00491504|7162528|FG003|Overall Study|Protocol Violation|2
4384645|NCT00468312|7162538|FG000|Overall Study|Adverse Event|2
4384646|NCT00468312|7162539|FG001|Overall Study|Adverse Event|1
4384647|NCT00468312|7162538|FG000|Overall Study|Lack of Efficacy|0
4384648|NCT00468312|7162539|FG001|Overall Study|Lack of Efficacy|1
4384649|NCT00468312|7162538|FG000|Overall Study|Withdrawal by Subject|0
4384650|NCT00468312|7162539|FG001|Overall Study|Withdrawal by Subject|1
4384651|NCT00468312|7162538|FG000|Overall Study|Protocol Violation|2
4384652|NCT00468312|7162539|FG001|Overall Study|Protocol Violation|1
4384653|NCT00468312|7162538|FG000|Overall Study|Did not meet protocol eligibility|0
4384654|NCT00468312|7162539|FG001|Overall Study|Did not meet protocol eligibility|1
4384655|NCT00453063|7162547|FG000|Overall Study|Adverse Event|1
4384656|NCT00453063|7162548|FG001|Overall Study|Adverse Event|2
4384657|NCT00453063|7162547|FG000|Overall Study|Withdrawal by Subject|1
4384658|NCT00453063|7162548|FG001|Overall Study|Withdrawal by Subject|1
4384659|NCT00453063|7162547|FG000|Overall Study|Protocol Violation|1
4384660|NCT00453063|7162548|FG001|Overall Study|Protocol Violation|0
4384661|NCT00447603|7162554|FG000|Screening|Withdrawal by Subject|1
4384662|NCT00447603|7162555|FG001|Screening|Withdrawal by Subject|0
4384663|NCT00447603|7162556|FG002|Screening|Withdrawal by Subject|0
4384664|NCT00447603|7162554|FG000|Screening|Protocol Violation|1
4384665|NCT00447603|7162555|FG001|Screening|Protocol Violation|0
4384666|NCT00447603|7162556|FG002|Screening|Protocol Violation|0
4384667|NCT00447603|7162554|FG000|Screening|Screen Failure|4
4384668|NCT00447603|7162555|FG001|Screening|Screen Failure|0
4384669|NCT00447603|7162556|FG002|Screening|Screen Failure|0
4384670|NCT00447603|7162554|FG000|Screening|Study Terminated by Sponsor|15
4384671|NCT00447603|7162555|FG001|Screening|Study Terminated by Sponsor|0
4384672|NCT00447603|7162556|FG002|Screening|Study Terminated by Sponsor|0
4384673|NCT00447603|7162554|FG000|Filter Period|Adverse Event|0
4384674|NCT00447603|7162555|FG001|Filter Period|Adverse Event|0
4384675|NCT00447603|7162556|FG002|Filter Period|Adverse Event|1
4384676|NCT00447603|7162554|FG000|Filter Period|Screen Failure|0
4384677|NCT00447603|7162555|FG001|Filter Period|Screen Failure|3
4384678|NCT00447603|7162556|FG002|Filter Period|Screen Failure|4
4384679|NCT00447603|7162554|FG000|Filter Period|Study terminated by Sponsor|0
4384680|NCT00447603|7162555|FG001|Filter Period|Study terminated by Sponsor|1
4384681|NCT00447603|7162556|FG002|Filter Period|Study terminated by Sponsor|10
4384682|NCT00442351|7162566|FG000|Overall Study|Administrative|6
4384683|NCT00442351|7162567|FG001|Overall Study|Administrative|5
4384684|NCT00442351|7162566|FG000|Overall Study|Did not meet protocol eligibility|1
4384685|NCT00442351|7162567|FG001|Overall Study|Did not meet protocol eligibility|0
4384686|NCT00442351|7162566|FG000|Overall Study|Other|0
4384687|NCT00442351|7162567|FG001|Overall Study|Other|1
4384688|NCT00423488|7162575|FG000|Overall Study|No evidence of study drug intake|2
4384689|NCT00423488|7162576|FG001|Overall Study|No evidence of study drug intake|1
4384690|NCT00423488|7162575|FG000|Overall Study|No post baseline data|3
4384691|NCT00423488|7162576|FG001|Overall Study|No post baseline data|0
4384692|NCT00413972|7162586|FG000|Overall Study|Adverse Event|2
4384693|NCT00413972|7162587|FG001|Overall Study|Adverse Event|1
4384694|NCT00413972|7162588|FG002|Overall Study|Adverse Event|0
4384695|NCT00413972|7162589|FG003|Overall Study|Adverse Event|0
4384696|NCT00413972|7162586|FG000|Overall Study|Lost to Follow-up|1
4384697|NCT00413972|7162587|FG001|Overall Study|Lost to Follow-up|2
4384698|NCT00413972|7162588|FG002|Overall Study|Lost to Follow-up|1
4384699|NCT00413972|7162589|FG003|Overall Study|Lost to Follow-up|0
4384700|NCT00413972|7162586|FG000|Overall Study|Withdrawal by Subject|4
4384701|NCT00413972|7162587|FG001|Overall Study|Withdrawal by Subject|5
4384702|NCT00413972|7162588|FG002|Overall Study|Withdrawal by Subject|7
4384703|NCT00413972|7162589|FG003|Overall Study|Withdrawal by Subject|2
4384704|NCT00413972|7162586|FG000|Overall Study|Protocol Violation|0
4384705|NCT00413972|7162587|FG001|Overall Study|Protocol Violation|0
4384706|NCT00413972|7162588|FG002|Overall Study|Protocol Violation|2
4384707|NCT00413972|7162589|FG003|Overall Study|Protocol Violation|0
4384708|NCT00413972|7162586|FG000|Overall Study|Other|0
4384709|NCT00413972|7162587|FG001|Overall Study|Other|0
4384710|NCT00413972|7162588|FG002|Overall Study|Other|0
4384711|NCT00413972|7162589|FG003|Overall Study|Other|1
4384712|NCT00413062|7162601|FG000|Overall Study|Adverse event/serious adverse event|289
4384713|NCT00413062|7162602|FG001|Overall Study|Adverse event/serious adverse event|56
4384714|NCT00413062|7162601|FG000|Overall Study|Pre-treatment (serious) adverse event|1
4384715|NCT00413062|7162602|FG001|Overall Study|Pre-treatment (serious) adverse event|0
4384716|NCT00413062|7162601|FG000|Overall Study|Withdrawal of informed consent|111
4384717|NCT00413062|7162602|FG001|Overall Study|Withdrawal of informed consent|36
4384718|NCT00413062|7162601|FG000|Overall Study|Pregnancy|15
4384719|NCT00413062|7162602|FG001|Overall Study|Pregnancy|5
4384720|NCT00413062|7162601|FG000|Overall Study|Pregnancy wish|17
4384721|NCT00413062|7162602|FG001|Overall Study|Pregnancy wish|6
4384722|NCT00413062|7162601|FG000|Overall Study|Lost to Follow-up|175
4384723|NCT00413062|7162602|FG001|Overall Study|Lost to Follow-up|73
4384724|NCT00413062|7162601|FG000|Overall Study|Other reason|70
4384725|NCT00413062|7162602|FG001|Overall Study|Other reason|34
4384726|NCT00391170|7162612|FG000|Overall Study|Withdrawal by Subject|1
4384727|NCT00391170|7162613|FG001|Overall Study|Withdrawal by Subject|0
4384728|NCT00391170|7162612|FG000|Overall Study|Adverse Event|3
4384729|NCT00391170|7162613|FG001|Overall Study|Adverse Event|2
4384730|NCT00391170|7162612|FG000|Overall Study|Physician Decision|2
4384731|NCT00391170|7162613|FG001|Overall Study|Physician Decision|2
4384732|NCT00319449|7162647|FG000|Overall Study|Subject did not wish to continue|1
4384733|NCT00319449|7162648|FG001|Overall Study|Subject did not wish to continue|0
4384734|NCT00319449|7162647|FG000|Overall Study|Noncompliance with the protocol|1
4384735|NCT00319449|7162648|FG001|Overall Study|Noncompliance with the protocol|0
4384736|NCT00289887|7162660|FG000|Overall Study|Adverse Event|3
4384737|NCT00289887|7162661|FG001|Overall Study|Adverse Event|3
4469445|NCT00635349|7262244|FG000|Overall Study|Withdrawal by Subject|3
4469446|NCT00635349|7262245|FG001|Overall Study|Withdrawal by Subject|8
4469447|NCT00635349|7262244|FG000|Overall Study|Lost to Follow-up|4
4469448|NCT00635349|7262245|FG001|Overall Study|Lost to Follow-up|3
4469449|NCT00635349|7262244|FG000|Overall Study|Adverse Event|11
4469450|NCT00635349|7262245|FG001|Overall Study|Adverse Event|9
4469451|NCT00635427|7262265|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0
4516454|NCT00960375|7327927|FG001|Overall Study|Lost to Follow-up|22
4384738|NCT00289887|7162660|FG000|Overall Study|Lack of Efficacy|3
4384739|NCT00289887|7162661|FG001|Overall Study|Lack of Efficacy|11
4384740|NCT00289887|7162660|FG000|Overall Study|Lost to Follow-up|3
4384741|NCT00289887|7162661|FG001|Overall Study|Lost to Follow-up|3
4384742|NCT00289887|7162660|FG000|Overall Study|Protocol Violation|3
4384743|NCT00289887|7162661|FG001|Overall Study|Protocol Violation|1
4384744|NCT00289887|7162660|FG000|Overall Study|Withdrawal by Subject|3
4384745|NCT00289887|7162661|FG001|Overall Study|Withdrawal by Subject|8
4384746|NCT00289887|7162660|FG000|Overall Study|Other|7
4384747|NCT00289887|7162661|FG001|Overall Study|Other|3
4384748|NCT00281320|7162669|FG000|Overall Study|Adverse Event|12
4384749|NCT00281320|7162670|FG001|Overall Study|Adverse Event|9
4384750|NCT00281320|7162669|FG000|Overall Study|Lack of Efficacy|4
4384751|NCT00281320|7162670|FG001|Overall Study|Lack of Efficacy|3
4384752|NCT00281320|7162669|FG000|Overall Study|Withdrawal by Subject|5
4384753|NCT00281320|7162670|FG001|Overall Study|Withdrawal by Subject|6
4384754|NCT00281320|7162669|FG000|Overall Study|Lost to Follow-up|1
4384755|NCT00281320|7162670|FG001|Overall Study|Lost to Follow-up|2
4384756|NCT00281320|7162669|FG000|Overall Study|Other|3
4384757|NCT00281320|7162670|FG001|Overall Study|Other|1
4384758|NCT00276016|7162688|FG000|Intervention 1|Withdrawal by Subject|0
4384759|NCT00276016|7162689|FG001|Intervention 1|Withdrawal by Subject|1
4384760|NCT00276016|7162690|FG002|Intervention 1|Withdrawal by Subject|0
4384761|NCT00276016|7162691|FG003|Intervention 1|Withdrawal by Subject|0
4384762|NCT00276016|7162692|FG004|Intervention 1|Withdrawal by Subject|0
4384763|NCT00276016|7162693|FG005|Intervention 1|Withdrawal by Subject|0
4469452|NCT00635427|7262266|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0
4469453|NCT00635427|7262267|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1
4469454|NCT00635427|7262268|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0
4469455|NCT00635427|7262269|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0
4469456|NCT00635427|7262265|FG000|Overall Study|Death|0
4469457|NCT00635427|7262266|FG001|Overall Study|Death|0
4469458|NCT00635427|7262267|FG002|Overall Study|Death|0
4469459|NCT00635427|7262268|FG003|Overall Study|Death|1
4469460|NCT00635427|7262269|FG004|Overall Study|Death|0
4469461|NCT00635427|7262265|FG000|Overall Study|Termination Of Study By Sponsor|12
4469462|NCT00635427|7262266|FG001|Overall Study|Termination Of Study By Sponsor|6
4469463|NCT00635427|7262267|FG002|Overall Study|Termination Of Study By Sponsor|10
4469464|NCT00635427|7262268|FG003|Overall Study|Termination Of Study By Sponsor|6
4469465|NCT00635427|7262269|FG004|Overall Study|Termination Of Study By Sponsor|6
4469466|NCT00635427|7262265|FG000|Overall Study|Withdrawal Of Consent|0
4469467|NCT00635427|7262266|FG001|Overall Study|Withdrawal Of Consent|0
4469468|NCT00635427|7262267|FG002|Overall Study|Withdrawal Of Consent|0
4469469|NCT00635427|7262268|FG003|Overall Study|Withdrawal Of Consent|2
4469470|NCT00635427|7262269|FG004|Overall Study|Withdrawal Of Consent|2
4469471|NCT00635492|7262299|FG000|Overall Study|Death|12
4469472|NCT00635492|7262300|FG001|Overall Study|Death|40
4469473|NCT00635492|7262299|FG000|Overall Study|Lost to Follow-up|151
4469474|NCT00635492|7262300|FG001|Overall Study|Lost to Follow-up|172
4469475|NCT00635492|7262299|FG000|Overall Study|Physician Decision|32
4469476|NCT00635492|7262300|FG001|Overall Study|Physician Decision|22
4469477|NCT00635492|7262299|FG000|Overall Study|Sponsor decision|2
4469478|NCT00635492|7262300|FG001|Overall Study|Sponsor decision|3
4469479|NCT00635492|7262299|FG000|Overall Study|Withdrawal by Subject|82
4469480|NCT00635492|7262300|FG001|Overall Study|Withdrawal by Subject|45
4469481|NCT00635570|7262312|FG000|Overall Study|Lost to Follow-up|8
4469482|NCT00635570|7262313|FG001|Overall Study|Lost to Follow-up|8
4469483|NCT00635570|7262312|FG000|Overall Study|Withdrawal by Subject|1
4469484|NCT00635570|7262313|FG001|Overall Study|Withdrawal by Subject|1
4469485|NCT00635570|7262312|FG000|Overall Study|Adverse Event|2
4469486|NCT00635570|7262313|FG001|Overall Study|Adverse Event|0
4469487|NCT00635570|7262312|FG000|Overall Study|Physician Decision|1
4469488|NCT00635570|7262313|FG001|Overall Study|Physician Decision|0
4469489|NCT00635570|7262312|FG000|Overall Study|Did not complete survey|2
4469490|NCT00635570|7262313|FG001|Overall Study|Did not complete survey|1
4469491|NCT00635570|7262312|FG000|Overall Study|Early termination(No sexual activity)|1
4469492|NCT00635570|7262313|FG001|Overall Study|Early termination(No sexual activity)|1
4469493|NCT00635648|7262328|FG000|Overall Study|Adverse Event|12
4469494|NCT00635648|7262328|FG000|Overall Study|Withdrawal by Subject|9
4469495|NCT00635648|7262328|FG000|Overall Study|Physician Decision|4
4469496|NCT00635648|7262328|FG000|Overall Study|Rapid progression of baseline disease|4
4469497|NCT00635648|7262328|FG000|Overall Study|Use of other antifungal agent needed|1
4469498|NCT00635648|7262328|FG000|Overall Study|No improvement after 7-10 days treatment|4
4469499|NCT00635648|7262328|FG000|Overall Study|Noncompliance with protocol|1
4469500|NCT00635648|7262328|FG000|Overall Study|Other reason|2
4469501|NCT00635661|7262332|FG000|Overall Study|Withdrawal by Subject|4
4469502|NCT00635778|7262361|FG000|Overall Study|Adverse Event|1
4469503|NCT00635778|7262362|FG001|Overall Study|Adverse Event|0
4469504|NCT00635778|7262363|FG002|Overall Study|Adverse Event|0
4469505|NCT00635778|7262364|FG003|Overall Study|Adverse Event|3
4469506|NCT00635778|7262365|FG004|Overall Study|Adverse Event|3
4469507|NCT00635778|7262366|FG005|Overall Study|Adverse Event|6
4469508|NCT00635778|7262367|FG006|Overall Study|Adverse Event|1
4469509|NCT00635778|7262361|FG000|Overall Study|Withdrawal by Subject|0
4384764|NCT00265343|7162704|FG000|Overall Study|Adverse Event|10
4384765|NCT00265343|7162705|FG001|Overall Study|Adverse Event|7
4384766|NCT00265343|7162704|FG000|Overall Study|Withdrawal by Subject|3
4384767|NCT00265343|7162705|FG001|Overall Study|Withdrawal by Subject|9
4384768|NCT00265343|7162704|FG000|Overall Study|Other|8
4384769|NCT00265343|7162705|FG001|Overall Study|Other|3
4384770|NCT00264147|7162716|FG000|Treatment I Period|Adverse Event|3
4384771|NCT00264147|7162717|FG001|Treatment I Period|Adverse Event|6
4384772|NCT00264147|7162718|FG002|Treatment I Period|Adverse Event|3
4384773|NCT00264147|7162719|FG003|Treatment I Period|Adverse Event|5
4384774|NCT00264147|7162720|FG004|Treatment I Period|Adverse Event|7
4384775|NCT00264147|7162721|FG005|Treatment I Period|Adverse Event|0
4384776|NCT00264147|7162716|FG000|Treatment I Period|Laboratory Adverse Event|0
4384777|NCT00264147|7162717|FG001|Treatment I Period|Laboratory Adverse Event|0
4469510|NCT00635778|7262362|FG001|Overall Study|Withdrawal by Subject|0
4469511|NCT00635778|7262363|FG002|Overall Study|Withdrawal by Subject|0
4469512|NCT00635778|7262364|FG003|Overall Study|Withdrawal by Subject|1
4469513|NCT00635778|7262365|FG004|Overall Study|Withdrawal by Subject|0
4469514|NCT00635778|7262366|FG005|Overall Study|Withdrawal by Subject|1
4469515|NCT00635778|7262367|FG006|Overall Study|Withdrawal by Subject|1
4469516|NCT00635778|7262361|FG000|Overall Study|Progressive disease|0
4469517|NCT00635778|7262362|FG001|Overall Study|Progressive disease|3
4469518|NCT00635778|7262363|FG002|Overall Study|Progressive disease|3
4469519|NCT00635778|7262364|FG003|Overall Study|Progressive disease|4
4469520|NCT00635778|7262365|FG004|Overall Study|Progressive disease|5
4469521|NCT00635778|7262366|FG005|Overall Study|Progressive disease|14
4469522|NCT00635778|7262367|FG006|Overall Study|Progressive disease|4
4469523|NCT00635804|7262392|FG000|Overall Study|Adverse Event|0
4469524|NCT00635804|7262393|FG001|Overall Study|Adverse Event|0
4469525|NCT00635804|7262394|FG002|Overall Study|Adverse Event|0
4469526|NCT00635804|7262395|FG003|Overall Study|Adverse Event|0
4469527|NCT00635804|7262396|FG004|Overall Study|Adverse Event|0
4469528|NCT00635804|7262397|FG005|Overall Study|Adverse Event|1
4469529|NCT00635804|7262398|FG006|Overall Study|Adverse Event|0
4469530|NCT00635804|7262399|FG007|Overall Study|Adverse Event|0
4469531|NCT00635804|7262392|FG000|Overall Study|Withdrawal by Subject|1
4469532|NCT00635804|7262393|FG001|Overall Study|Withdrawal by Subject|0
4469533|NCT00635804|7262394|FG002|Overall Study|Withdrawal by Subject|0
4469534|NCT00635804|7262395|FG003|Overall Study|Withdrawal by Subject|0
4469535|NCT00635804|7262396|FG004|Overall Study|Withdrawal by Subject|0
4469536|NCT00635804|7262397|FG005|Overall Study|Withdrawal by Subject|0
4469537|NCT00635804|7262398|FG006|Overall Study|Withdrawal by Subject|0
4469538|NCT00635804|7262399|FG007|Overall Study|Withdrawal by Subject|0
4469539|NCT00635999|7262451|FG000|Overall Study|Withdrawal by Subject|4
4469540|NCT00635999|7262452|FG001|Overall Study|Withdrawal by Subject|2
4469541|NCT00635999|7262453|FG002|Overall Study|Withdrawal by Subject|1
4469542|NCT00636155|7262474|FG000|Overall Study|Adverse Event|8
4469543|NCT00636155|7262474|FG000|Overall Study|Lack of Efficacy|1
4469544|NCT00636155|7262474|FG000|Overall Study|Withdrawal by Subject|3
4469545|NCT00636155|7262474|FG000|Overall Study|Stem cell transplant|1
4469546|NCT00636155|7262474|FG000|Overall Study|Physician Decision|5
4469547|NCT00636168|7262480|FG000|Randomized to Study Drug|Withdrawal by Subject|2
4469548|NCT00636168|7262481|FG001|Randomized to Study Drug|Withdrawal by Subject|2
4469549|NCT00636168|7262480|FG000|Randomized to Study Drug|Adverse Event|1
4469550|NCT00636168|7262481|FG001|Randomized to Study Drug|Adverse Event|0
4469551|NCT00636168|7262480|FG000|Randomized to Study Drug|No longer meets study criteria|1
4469552|NCT00636168|7262481|FG001|Randomized to Study Drug|No longer meets study criteria|0
4469553|NCT00636168|7262480|FG000|Treated With Study Drug|Recurrence of disease|135
4469554|NCT00636168|7262481|FG001|Treated With Study Drug|Recurrence of disease|282
4469555|NCT00636168|7262480|FG000|Treated With Study Drug|Adverse Event|250
4469556|NCT00636168|7262481|FG001|Treated With Study Drug|Adverse Event|22
4469557|NCT00636168|7262480|FG000|Treated With Study Drug|Participant withdrew consent|16
4469558|NCT00636168|7262481|FG001|Treated With Study Drug|Participant withdrew consent|21
4469559|NCT00636168|7262480|FG000|Treated With Study Drug|Poor/non-compliance|1
4469560|NCT00636168|7262481|FG001|Treated With Study Drug|Poor/non-compliance|3
4469561|NCT00636168|7262480|FG000|Treated With Study Drug|Death|3
4469562|NCT00636168|7262481|FG001|Treated With Study Drug|Death|0
4469563|NCT00636168|7262480|FG000|Treated With Study Drug|Pregnancy|1
4469564|NCT00636168|7262481|FG001|Treated With Study Drug|Pregnancy|0
4469565|NCT00636168|7262480|FG000|Treated With Study Drug|No longer meets study criteria|1
4469566|NCT00636168|7262481|FG001|Treated With Study Drug|No longer meets study criteria|0
4469567|NCT00636168|7262480|FG000|Treated With Study Drug|Other reason|1
4469568|NCT00636168|7262481|FG001|Treated With Study Drug|Other reason|3
4469569|NCT00636168|7262480|FG000|Long Term Follow-Up|Lost to Follow-up|3
4469570|NCT00636168|7262481|FG001|Long Term Follow-Up|Lost to Follow-up|3
4469571|NCT00636168|7262480|FG000|Long Term Follow-Up|Participant withdrew consent|0
4469572|NCT00636168|7262481|FG001|Long Term Follow-Up|Participant withdrew consent|2
4469573|NCT00636168|7262480|FG000|Long Term Follow-Up|Death|8
4469574|NCT00636168|7262481|FG001|Long Term Follow-Up|Death|9
4469575|NCT00636181|7262490|FG000|Overall Study|Withdrawal by Subject|8
4469576|NCT00636181|7262491|FG001|Overall Study|Withdrawal by Subject|6
4469577|NCT00636181|7262492|FG002|Overall Study|Withdrawal by Subject|10
4697352|NCT02647944|7610676|FG001|Overall Study|Adverse Event|0
4697353|NCT02648204|7610699|FG000|Overall Study|Withdrawal by Subject|12
4697354|NCT02648204|7610700|FG001|Overall Study|Withdrawal by Subject|8
4697355|NCT02648204|7610701|FG002|Overall Study|Withdrawal by Subject|2
4697356|NCT02648204|7610702|FG003|Overall Study|Withdrawal by Subject|6
4697357|NCT02648204|7610699|FG000|Overall Study|Lost to Follow-up|5
4697358|NCT02648204|7610700|FG001|Overall Study|Lost to Follow-up|8
4697359|NCT02648204|7610701|FG002|Overall Study|Lost to Follow-up|4
4697360|NCT02648204|7610702|FG003|Overall Study|Lost to Follow-up|6
4697361|NCT02648204|7610699|FG000|Overall Study|Missing follow-up information|4
4697362|NCT02648204|7610700|FG001|Overall Study|Missing follow-up information|4
4697363|NCT02648204|7610701|FG002|Overall Study|Missing follow-up information|4
4697364|NCT02648204|7610702|FG003|Overall Study|Missing follow-up information|2
4697365|NCT02648204|7610699|FG000|Overall Study|Death|1
4697366|NCT02648204|7610700|FG001|Overall Study|Death|1
4697367|NCT02648204|7610701|FG002|Overall Study|Death|2
4697368|NCT02648204|7610702|FG003|Overall Study|Death|2
4697369|NCT02648204|7610699|FG000|Overall Study|Adverse Event|0
4697370|NCT02648204|7610700|FG001|Overall Study|Adverse Event|0
4697371|NCT02648204|7610701|FG002|Overall Study|Adverse Event|1
4697372|NCT02648204|7610702|FG003|Overall Study|Adverse Event|0
4697373|NCT02648217|7610714|FG000|Overall Study|Adverse Event|0
4697374|NCT02648217|7610715|FG001|Overall Study|Adverse Event|1
4697375|NCT02648217|7610714|FG000|Overall Study|Lost to Follow-up|1
4697376|NCT02648217|7610715|FG001|Overall Study|Lost to Follow-up|1
4697377|NCT02648217|7610714|FG000|Overall Study|Withdrawal by Subject|4
4697378|NCT02648217|7610715|FG001|Overall Study|Withdrawal by Subject|3
4697379|NCT02648217|7610714|FG000|Overall Study|Unclassified|5
4697380|NCT02648217|7610715|FG001|Overall Study|Unclassified|0
4697381|NCT02648438|7610728|FG000|Overall Study|Eligibility criteria not fulfilled|0
4697382|NCT02648438|7610729|FG001|Overall Study|Eligibility criteria not fulfilled|2
4697383|NCT02648438|7610730|FG002|Overall Study|Eligibility criteria not fulfilled|0
4697384|NCT02648438|7610728|FG000|Overall Study|Protocol Violation|2
4697385|NCT02648438|7610729|FG001|Overall Study|Protocol Violation|0
4697386|NCT02648438|7610730|FG002|Overall Study|Protocol Violation|0
4697387|NCT02648438|7610728|FG000|Overall Study|Withdrawal by Subject|1
4697388|NCT02648438|7610729|FG001|Overall Study|Withdrawal by Subject|1
4697389|NCT02648438|7610730|FG002|Overall Study|Withdrawal by Subject|0
4697390|NCT02648932|7610761|FG000|Overall Study|No transplant|3
4697391|NCT02648932|7610762|FG001|Overall Study|No transplant|1
4697392|NCT02649218|7610815|FG000|Overall Study|Adverse Event|8
4697393|NCT02649218|7610815|FG000|Overall Study|Lack of Efficacy|8
4697394|NCT02649218|7610815|FG000|Overall Study|Pregnancy|3
4697395|NCT02649218|7610815|FG000|Overall Study|Protocol Violation|3
4697396|NCT02649218|7610815|FG000|Overall Study|Physician Decision|1
4697397|NCT02649218|7610815|FG000|Overall Study|Withdrawal by Subject|2
4697398|NCT02649231|7610824|FG000|Overall Study|Adverse Event|0
4697399|NCT02649231|7610825|FG001|Overall Study|Adverse Event|0
4697400|NCT02649231|7610826|FG002|Overall Study|Adverse Event|0
4697401|NCT02649231|7610827|FG003|Overall Study|Adverse Event|1
4697402|NCT02649231|7610824|FG000|Overall Study|Lost to Follow-up|2
4697403|NCT02649231|7610825|FG001|Overall Study|Lost to Follow-up|1
4697404|NCT02649231|7610826|FG002|Overall Study|Lost to Follow-up|1
4697405|NCT02649231|7610827|FG003|Overall Study|Lost to Follow-up|0
4697406|NCT02649231|7610824|FG000|Overall Study|Withdrawal by Subject|0
4697407|NCT02649231|7610825|FG001|Overall Study|Withdrawal by Subject|1
4697408|NCT02649231|7610826|FG002|Overall Study|Withdrawal by Subject|0
4384778|NCT00264147|7162718|FG002|Treatment I Period|Laboratory Adverse Event|0
4384779|NCT00264147|7162719|FG003|Treatment I Period|Laboratory Adverse Event|1
4384780|NCT00264147|7162720|FG004|Treatment I Period|Laboratory Adverse Event|0
4384781|NCT00264147|7162721|FG005|Treatment I Period|Laboratory Adverse Event|0
4384782|NCT00264147|7162716|FG000|Treatment I Period|Lack of Efficacy|6
4384783|NCT00264147|7162717|FG001|Treatment I Period|Lack of Efficacy|2
4384784|NCT00264147|7162718|FG002|Treatment I Period|Lack of Efficacy|8
4384785|NCT00264147|7162719|FG003|Treatment I Period|Lack of Efficacy|0
4384786|NCT00264147|7162720|FG004|Treatment I Period|Lack of Efficacy|1
4384787|NCT00264147|7162721|FG005|Treatment I Period|Lack of Efficacy|0
4384788|NCT00264147|7162716|FG000|Treatment I Period|Lost to Follow-up|1
4384789|NCT00264147|7162717|FG001|Treatment I Period|Lost to Follow-up|0
4384790|NCT00264147|7162718|FG002|Treatment I Period|Lost to Follow-up|0
4384791|NCT00264147|7162719|FG003|Treatment I Period|Lost to Follow-up|1
4384792|NCT00264147|7162720|FG004|Treatment I Period|Lost to Follow-up|1
4384793|NCT00264147|7162721|FG005|Treatment I Period|Lost to Follow-up|0
4384794|NCT00264147|7162716|FG000|Treatment I Period|Protocol Violation|2
4384795|NCT00264147|7162717|FG001|Treatment I Period|Protocol Violation|2
4384796|NCT00264147|7162718|FG002|Treatment I Period|Protocol Violation|0
4384797|NCT00264147|7162719|FG003|Treatment I Period|Protocol Violation|0
4384798|NCT00264147|7162720|FG004|Treatment I Period|Protocol Violation|0
4384799|NCT00264147|7162721|FG005|Treatment I Period|Protocol Violation|0
4384800|NCT00264147|7162716|FG000|Treatment I Period|Withdrawal by Subject|2
4697409|NCT02649231|7610827|FG003|Overall Study|Withdrawal by Subject|1
4697410|NCT02649231|7610824|FG000|Overall Study|Protocol Violation|2
4697411|NCT02649231|7610825|FG001|Overall Study|Protocol Violation|1
4697412|NCT02649231|7610826|FG002|Overall Study|Protocol Violation|1
4384801|NCT00264147|7162717|FG001|Treatment I Period|Withdrawal by Subject|0
4384802|NCT00264147|7162718|FG002|Treatment I Period|Withdrawal by Subject|0
4588901|NCT01505881|7433736|FG000|Overall Study|Lost to Follow-up|2
4588902|NCT01505881|7433737|FG001|Overall Study|Lost to Follow-up|0
4588903|NCT01505881|7433736|FG000|Overall Study|Withdrawal by Subject|2
4384803|NCT00264147|7162719|FG003|Treatment I Period|Withdrawal by Subject|2
4384804|NCT00264147|7162720|FG004|Treatment I Period|Withdrawal by Subject|2
4384805|NCT00264147|7162721|FG005|Treatment I Period|Withdrawal by Subject|0
4384806|NCT00264147|7162716|FG000|Treatment I Period|Patient out of town for an extended time|0
4384807|NCT00264147|7162717|FG001|Treatment I Period|Patient out of town for an extended time|1
4384808|NCT00264147|7162718|FG002|Treatment I Period|Patient out of town for an extended time|0
4384809|NCT00264147|7162719|FG003|Treatment I Period|Patient out of town for an extended time|0
4384810|NCT00264147|7162720|FG004|Treatment I Period|Patient out of town for an extended time|0
4384811|NCT00264147|7162721|FG005|Treatment I Period|Patient out of town for an extended time|0
4384812|NCT00264147|7162716|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0
4384813|NCT00264147|7162717|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0
4384814|NCT00264147|7162718|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1
4384815|NCT00264147|7162719|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0
4384816|NCT00264147|7162720|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0
4384817|NCT00264147|7162721|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0
4384818|NCT00264147|7162716|FG000|Treatment I Period|Reassigned to Treatment II Period|84
4384819|NCT00264147|7162717|FG001|Treatment I Period|Reassigned to Treatment II Period|72
4384820|NCT00264147|7162718|FG002|Treatment I Period|Reassigned to Treatment II Period|65
4384821|NCT00264147|7162719|FG003|Treatment I Period|Reassigned to Treatment II Period|63
4384822|NCT00264147|7162720|FG004|Treatment I Period|Reassigned to Treatment II Period|45
4384823|NCT00264147|7162721|FG005|Treatment I Period|Reassigned to Treatment II Period|0
4384824|NCT00264147|7162716|FG000|Treatment II Period|Adverse Event|0
4384825|NCT00264147|7162717|FG001|Treatment II Period|Adverse Event|0
4384826|NCT00264147|7162718|FG002|Treatment II Period|Adverse Event|0
4384827|NCT00264147|7162719|FG003|Treatment II Period|Adverse Event|0
4384828|NCT00264147|7162720|FG004|Treatment II Period|Adverse Event|9
4384829|NCT00264147|7162721|FG005|Treatment II Period|Adverse Event|9
4384830|NCT00264147|7162716|FG000|Treatment II Period|Laboratory Adverse Event|0
4384831|NCT00264147|7162717|FG001|Treatment II Period|Laboratory Adverse Event|0
4384832|NCT00264147|7162718|FG002|Treatment II Period|Laboratory Adverse Event|0
4384833|NCT00264147|7162719|FG003|Treatment II Period|Laboratory Adverse Event|0
4469578|NCT00636194|7262502|FG000|Overall Study|Study related symptoms and complaints|1
4469579|NCT00636194|7262503|FG001|Overall Study|Study related symptoms and complaints|0
4469580|NCT00636194|7262502|FG000|Overall Study|Protocol Violation|2
4469581|NCT00636194|7262503|FG001|Overall Study|Protocol Violation|0
4469582|NCT00636207|7262512|FG000|Overall Study|Adverse Event|1
4469583|NCT00636207|7262513|FG001|Overall Study|Adverse Event|0
4469584|NCT00636207|7262514|FG002|Overall Study|Adverse Event|0
4469585|NCT00636207|7262515|FG003|Overall Study|Adverse Event|0
4469586|NCT00636207|7262516|FG004|Overall Study|Adverse Event|0
4469587|NCT00636207|7262517|FG005|Overall Study|Adverse Event|0
4588904|NCT01505881|7433737|FG001|Overall Study|Withdrawal by Subject|0
4588905|NCT01506193|7433756|FG000|Overall Study|Protocol Violation|1
4588906|NCT01506193|7433757|FG001|Overall Study|Protocol Violation|0
4588907|NCT01506193|7433758|FG002|Overall Study|Protocol Violation|1
4588908|NCT01506193|7433756|FG000|Overall Study|Migrated/moved from study area|0
4588909|NCT01506193|7433757|FG001|Overall Study|Migrated/moved from study area|0
4588910|NCT01506193|7433758|FG002|Overall Study|Migrated/moved from study area|1
4588911|NCT01506193|7433756|FG000|Overall Study|Adverse event, non-fatal|0
4469588|NCT00636207|7262518|FG006|Overall Study|Adverse Event|0
4469589|NCT00636207|7262512|FG000|Overall Study|Withdrawal by Subject|0
4469590|NCT00636207|7262513|FG001|Overall Study|Withdrawal by Subject|1
4469591|NCT00636207|7262514|FG002|Overall Study|Withdrawal by Subject|0
4469592|NCT00636207|7262515|FG003|Overall Study|Withdrawal by Subject|0
4469593|NCT00636207|7262516|FG004|Overall Study|Withdrawal by Subject|1
4469594|NCT00636207|7262517|FG005|Overall Study|Withdrawal by Subject|0
4469595|NCT00636207|7262518|FG006|Overall Study|Withdrawal by Subject|0
4469596|NCT00636363|7262546|FG000|Overall Study|Conjunctivitis|0
4469597|NCT00636363|7262547|FG001|Overall Study|Conjunctivitis|0
4469598|NCT00636363|7262548|FG002|Overall Study|Conjunctivitis|1
4469599|NCT00636363|7262546|FG000|Overall Study|Adverse Event|0
4469600|NCT00636363|7262547|FG001|Overall Study|Adverse Event|0
4469601|NCT00636363|7262548|FG002|Overall Study|Adverse Event|1
4469602|NCT00636363|7262546|FG000|Overall Study|Positive slit lamp finding|0
4469603|NCT00636363|7262547|FG001|Overall Study|Positive slit lamp finding|2
4469604|NCT00636363|7262548|FG002|Overall Study|Positive slit lamp finding|1
4469605|NCT00636363|7262546|FG000|Overall Study|Study related symptoms/complaints|8
4469606|NCT00636363|7262547|FG001|Overall Study|Study related symptoms/complaints|7
4469607|NCT00636363|7262548|FG002|Overall Study|Study related symptoms/complaints|4
4469608|NCT00636363|7262546|FG000|Overall Study|Met ineligibility criteria|0
4469609|NCT00636363|7262547|FG001|Overall Study|Met ineligibility criteria|0
4469610|NCT00636363|7262548|FG002|Overall Study|Met ineligibility criteria|3
4588912|NCT01506193|7433757|FG001|Overall Study|Adverse event, non-fatal|0
4384834|NCT00264147|7162720|FG004|Treatment II Period|Laboratory Adverse Event|0
4384835|NCT00264147|7162721|FG005|Treatment II Period|Laboratory Adverse Event|1
4384836|NCT00264147|7162716|FG000|Treatment II Period|Lack of Efficacy|0
4384837|NCT00264147|7162717|FG001|Treatment II Period|Lack of Efficacy|0
4384838|NCT00264147|7162718|FG002|Treatment II Period|Lack of Efficacy|0
4384839|NCT00264147|7162719|FG003|Treatment II Period|Lack of Efficacy|0
4384840|NCT00264147|7162720|FG004|Treatment II Period|Lack of Efficacy|20
4384841|NCT00264147|7162721|FG005|Treatment II Period|Lack of Efficacy|19
4384842|NCT00264147|7162716|FG000|Treatment II Period|Lost to Follow-up|0
4384843|NCT00264147|7162717|FG001|Treatment II Period|Lost to Follow-up|0
4384844|NCT00264147|7162718|FG002|Treatment II Period|Lost to Follow-up|0
4384845|NCT00264147|7162719|FG003|Treatment II Period|Lost to Follow-up|0
4384846|NCT00264147|7162720|FG004|Treatment II Period|Lost to Follow-up|1
4384847|NCT00264147|7162721|FG005|Treatment II Period|Lost to Follow-up|1
4384848|NCT00264147|7162716|FG000|Treatment II Period|Withdrawal by Subject|0
4384849|NCT00264147|7162717|FG001|Treatment II Period|Withdrawal by Subject|0
4588913|NCT01506193|7433758|FG002|Overall Study|Adverse event, non-fatal|1
4588914|NCT01506193|7433756|FG000|Overall Study|Withdrawal by Subject|5
4384850|NCT00264147|7162718|FG002|Treatment II Period|Withdrawal by Subject|0
4384851|NCT00264147|7162719|FG003|Treatment II Period|Withdrawal by Subject|0
4384852|NCT00264147|7162720|FG004|Treatment II Period|Withdrawal by Subject|3
4384853|NCT00264147|7162721|FG005|Treatment II Period|Withdrawal by Subject|2
4384854|NCT00264147|7162716|FG000|Treatment II Period|Pre-scheduled total hip replacement|0
4384855|NCT00264147|7162717|FG001|Treatment II Period|Pre-scheduled total hip replacement|0
4384856|NCT00264147|7162718|FG002|Treatment II Period|Pre-scheduled total hip replacement|0
4384857|NCT00264147|7162719|FG003|Treatment II Period|Pre-scheduled total hip replacement|0
4384858|NCT00264147|7162720|FG004|Treatment II Period|Pre-scheduled total hip replacement|0
4384859|NCT00264147|7162721|FG005|Treatment II Period|Pre-scheduled total hip replacement|1
4588915|NCT01506193|7433757|FG001|Overall Study|Withdrawal by Subject|1
4588916|NCT01506193|7433758|FG002|Overall Study|Withdrawal by Subject|8
4588917|NCT01506193|7433756|FG000|Overall Study|Lost to Follow-up|8
4588918|NCT01506193|7433757|FG001|Overall Study|Lost to Follow-up|3
4588919|NCT01506193|7433758|FG002|Overall Study|Lost to Follow-up|3
4588920|NCT01506271|7433770|FG000|Overall Study|Progressive disease|0
4588921|NCT01506271|7433771|FG001|Overall Study|Progressive disease|1
4588922|NCT01506271|7433772|FG002|Overall Study|Progressive disease|0
4384860|NCT00202878|7162737|FG000|Overall Study|Death|964
4384861|NCT00202878|7162738|FG001|Overall Study|Death|968
4384862|NCT00202878|7162737|FG000|Overall Study|Only Vital Status Known|357
4384863|NCT00202878|7162738|FG001|Overall Study|Only Vital Status Known|356
4384864|NCT00202878|7162737|FG000|Overall Study|Lost to Follow-up|44
4384865|NCT00202878|7162738|FG001|Overall Study|Lost to Follow-up|49
4384866|NCT00202878|7162737|FG000|Overall Study|Site Closure|39
4384867|NCT00202878|7162738|FG001|Overall Study|Site Closure|36
4384868|NCT00202878|7162737|FG000|Overall Study|Withdrawal by Subject|795
4384869|NCT00202878|7162738|FG001|Overall Study|Withdrawal by Subject|808
4384870|NCT00174265|7162746|FG000|Overall Study|Adverse Event|7
4384871|NCT00174265|7162747|FG001|Overall Study|Adverse Event|4
4384872|NCT00174265|7162746|FG000|Overall Study|Lack of Efficacy|2
4384873|NCT00174265|7162747|FG001|Overall Study|Lack of Efficacy|2
4384874|NCT00174265|7162746|FG000|Overall Study|Withdrawal by Subject|3
4384875|NCT00174265|7162747|FG001|Overall Study|Withdrawal by Subject|5
4384876|NCT00174265|7162746|FG000|Overall Study|Lost to Follow-up|1
4384877|NCT00174265|7162747|FG001|Overall Study|Lost to Follow-up|0
4384878|NCT00174265|7162746|FG000|Overall Study|Other (Not specified)|16
4384879|NCT00174265|7162747|FG001|Overall Study|Other (Not specified)|10
4384880|NCT00159783|7162756|FG000|Overall Study|Adverse Event|5
4384881|NCT00159783|7162757|FG001|Overall Study|Adverse Event|7
4384882|NCT00159783|7162758|FG002|Overall Study|Adverse Event|9
4384883|NCT00159783|7162756|FG000|Overall Study|Lack of Efficacy|1
4384884|NCT00159783|7162757|FG001|Overall Study|Lack of Efficacy|2
4384885|NCT00159783|7162758|FG002|Overall Study|Lack of Efficacy|3
4384886|NCT00159783|7162756|FG000|Overall Study|Withdrawal by Subject|7
4384887|NCT00159783|7162757|FG001|Overall Study|Withdrawal by Subject|11
4384888|NCT00159783|7162758|FG002|Overall Study|Withdrawal by Subject|12
4384889|NCT00159783|7162756|FG000|Overall Study|Lost to Follow-up|6
4384890|NCT00159783|7162757|FG001|Overall Study|Lost to Follow-up|5
4384891|NCT00159783|7162758|FG002|Overall Study|Lost to Follow-up|11
4384892|NCT00159783|7162756|FG000|Overall Study|Other|0
4384893|NCT00159783|7162757|FG001|Overall Study|Other|2
4384894|NCT00159783|7162758|FG002|Overall Study|Other|4
4384895|NCT00092677|7162780|FG000|Overall Study|Lost to Follow-up|0
4384896|NCT00092677|7162781|FG001|Overall Study|Lost to Follow-up|2
4384897|NCT00092677|7162780|FG000|Overall Study|Adminstrative|5
4384898|NCT00092677|7162781|FG001|Overall Study|Adminstrative|9
4384899|NCT00090259|7162789|FG000|Overall Study|Lost to Follow-up|30
4384900|NCT00090259|7162790|FG001|Overall Study|Lost to Follow-up|26
4588923|NCT01506271|7433770|FG000|Overall Study|Protocol Violation|3
4384901|NCT00090259|7162789|FG000|Overall Study|Withdrawal by Subject|21
4384902|NCT00090259|7162790|FG001|Overall Study|Withdrawal by Subject|15
4384903|NCT00090259|7162789|FG000|Overall Study|Investigator site closed|11
4384904|NCT00090259|7162790|FG001|Overall Study|Investigator site closed|7
4384905|NCT00003298|7162796|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1
4384906|NCT00003298|7162796|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3
4384907|NCT00003298|7162796|FG000|Surgery|Unresectable at surgery|3
4384908|NCT00003298|7162796|FG000|Surgery|Progression before surgery|2
4384909|NCT00003298|7162796|FG000|Surgery|Unevaluable and off study|2
4384910|NCT00003298|7162796|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7
4384911|NCT00003298|7162796|FG000|Re-register to Step 2 After Surgery|Positive margins|5
4384912|NCT00003298|7162796|FG000|Re-register to Step 2 After Surgery|Other complications|2
4384913|NCT00003298|7162796|FG000|Re-register to Step 2 After Surgery|Reason unknown|1
4384914|NCT00003298|7162796|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3
4384915|NCT00003298|7162796|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1
4384916|NCT00003298|7162796|FG000|Step 2 (Adjuvant Therapy)|Death|1
4384917|NCT00003298|7162796|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1
4384918|NCT00003298|7162796|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1
4384919|NCT00003298|7162796|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2
4384920|NCT00003377|7162806|FG000|Period I|Dose Limiting Toxicity(DLT)|0
4384921|NCT00003377|7162807|FG001|Period I|Dose Limiting Toxicity(DLT)|0
4384922|NCT00003377|7162808|FG002|Period I|Dose Limiting Toxicity(DLT)|1
4384923|NCT00003377|7162809|FG003|Period I|Dose Limiting Toxicity(DLT)|1
4384924|NCT00003377|7162810|FG004|Period I|Dose Limiting Toxicity(DLT)|0
4384925|NCT00003377|7162806|FG000|Period II|Ureteral stent complications|0
4384926|NCT00003377|7162807|FG001|Period II|Ureteral stent complications|0
4384927|NCT00003377|7162808|FG002|Period II|Ureteral stent complications|0
4384928|NCT00003377|7162809|FG003|Period II|Ureteral stent complications|0
4384929|NCT00003377|7162810|FG004|Period II|Ureteral stent complications|1
4384930|NCT00003389|7162825|FG000|Overall Study|Disease progression|6
4384931|NCT00003389|7162826|FG001|Overall Study|Disease progression|1
4384932|NCT00003389|7162825|FG000|Overall Study|Adverse Event|13
4384933|NCT00003389|7162826|FG001|Overall Study|Adverse Event|2
4384934|NCT00003389|7162825|FG000|Overall Study|Death|0
4384935|NCT00003389|7162826|FG001|Overall Study|Death|3
4384936|NCT00003389|7162825|FG000|Overall Study|Withdrawal by Subject|12
4384937|NCT00003389|7162826|FG001|Overall Study|Withdrawal by Subject|5
4384938|NCT00003389|7162825|FG000|Overall Study|Alternative therapy|2
4384939|NCT00003389|7162826|FG001|Overall Study|Alternative therapy|1
4384940|NCT00003389|7162825|FG000|Overall Study|Complicating disease|1
4384941|NCT00003389|7162826|FG001|Overall Study|Complicating disease|0
4384942|NCT00003389|7162825|FG000|Overall Study|Off-treatment reason missing|31
4384943|NCT00003389|7162826|FG001|Overall Study|Off-treatment reason missing|21
4384944|NCT00003389|7162825|FG000|Overall Study|Ineligible|33
4384945|NCT00003389|7162826|FG001|Overall Study|Ineligible|27
4384946|NCT00003456|7162841|FG000|Overall Study|Not evaluable|8
4384947|NCT00003457|7162845|FG000|Overall Study|Not evaluable|9
4384948|NCT00003470|7162865|FG000|Overall Study|Not evaluable|6
4384949|NCT00003471|7162869|FG000|Overall Study|Not evaluable|4
4384950|NCT00003472|7162873|FG000|Overall Study|Not evaluable|3
4384951|NCT00003473|7162877|FG000|Overall Study|Three patients were not evaluable.|3
4384952|NCT00003474|7162881|FG000|Overall Study|Not Evaluable|14
4384953|NCT00003475|7162885|FG000|Overall Study|Not evaluable|13
4384954|NCT00003476|7162890|FG000|Overall Study|Not evaluable|1
4384955|NCT00003477|7162894|FG000|Overall Study|Not evalauable|4
4384956|NCT00003483|7162898|FG000|Overall Study|Not evaluable|1
4384957|NCT00003487|7162902|FG000|Overall Study|Not evaluable|2
4384958|NCT00003492|7162906|FG000|Overall Study|Not evaluable|6
4384959|NCT00003498|7162910|FG000|Overall Study|Not evaluable.|4
4384960|NCT00003499|7162914|FG000|Overall Study|Not evaluable|8
4384961|NCT00003508|7162918|FG000|Overall Study|Not evaluable|5
4384962|NCT00003509|7162922|FG000|Overall Study|Not evaluable|5
4384963|NCT00003511|7162926|FG000|Overall Study|Not evaluable|4
4384964|NCT00003526|7162930|FG000|Overall Study|Not evaluable|6
4384965|NCT00003531|7162934|FG000|Overall Study|Not evaluable|10
4384966|NCT00003535|7162938|FG000|Overall Study|Not evaluable|5
4384967|NCT00003537|7162942|FG000|Overall Study|Not evalauable|1
4384968|NCT00003590|7162946|FG000|Overall Study|Ineligible Patient|1
4384969|NCT00003590|7162946|FG000|Overall Study|Adverse Event|7
4384970|NCT00003590|7162946|FG000|Overall Study|Withdrawal by Subject|1
4384971|NCT00003590|7162946|FG000|Overall Study|Lack of Efficacy|11
4384972|NCT00003590|7162946|FG000|Overall Study|Death|1
4384973|NCT00003590|7162946|FG000|Overall Study|Physician Decision|1
4384974|NCT00003631|7162953|FG000|Overall Study|Patient not treated|1
4384975|NCT00003631|7162954|FG001|Overall Study|Patient not treated|0
4384976|NCT00003631|7162955|FG002|Overall Study|Patient not treated|1
4384977|NCT00003631|7162953|FG000|Overall Study|Protocol Violation|1
4384978|NCT00003631|7162954|FG001|Overall Study|Protocol Violation|0
4384979|NCT00003631|7162955|FG002|Overall Study|Protocol Violation|0
4384980|NCT00003631|7162953|FG000|Overall Study|Adverse Event|1
4384981|NCT00003631|7162954|FG001|Overall Study|Adverse Event|1
4384982|NCT00003631|7162955|FG002|Overall Study|Adverse Event|5
4384983|NCT00003631|7162953|FG000|Overall Study|Death|0
4384984|NCT00003631|7162954|FG001|Overall Study|Death|0
4384985|NCT00003631|7162955|FG002|Overall Study|Death|1
4384986|NCT00003631|7162953|FG000|Overall Study|Evaluable for toxicity only|0
4384987|NCT00003631|7162954|FG001|Overall Study|Evaluable for toxicity only|0
4384988|NCT00003631|7162955|FG002|Overall Study|Evaluable for toxicity only|2
4384989|NCT00003641|7162965|FG000|Overall Study|Withdrawal by Subject|0
4384990|NCT00003641|7162966|FG001|Overall Study|Withdrawal by Subject|100
4384991|NCT00003641|7162965|FG000|Overall Study|Adverse Event|0
4384992|NCT00003641|7162966|FG001|Overall Study|Adverse Event|38
4384993|NCT00003641|7162965|FG000|Overall Study|Disease progression|0
4384994|NCT00003641|7162966|FG001|Overall Study|Disease progression|2
4384995|NCT00003641|7162965|FG000|Overall Study|Unknown/missing|0
4384996|NCT00003641|7162966|FG001|Overall Study|Unknown/missing|22
4384997|NCT00003641|7162965|FG000|Overall Study|Should not receive interferon therapy|2
4384998|NCT00003641|7162966|FG001|Overall Study|Should not receive interferon therapy|0
4384999|NCT00003641|7162965|FG000|Overall Study|Never started interferon|567
4385000|NCT00003641|7162966|FG001|Overall Study|Never started interferon|12
4385001|NCT00003645|7162985|FG000|Overall Study|Death|4
4385002|NCT00003645|7162986|FG001|Overall Study|Death|1
4385003|NCT00003645|7162985|FG000|Overall Study|Lost to Follow-up|7
4385004|NCT00003645|7162986|FG001|Overall Study|Lost to Follow-up|8
4385005|NCT00003645|7162985|FG000|Overall Study|Withdrawal by Subject|1
4385006|NCT00003645|7162986|FG001|Overall Study|Withdrawal by Subject|3
4385007|NCT00003659|7162994|FG000|Overall Study|Withdrawal by Subject|3
4385008|NCT00003702|7163000|FG000|Overall Study|Ineligible cell types|2
4385009|NCT00003702|7163001|FG001|Overall Study|Ineligible cell types|2
4385010|NCT00003702|7163000|FG000|Overall Study|Did not meet criteria for persistence|8
4385011|NCT00003702|7163001|FG001|Overall Study|Did not meet criteria for persistence|5
4385012|NCT00003702|7163000|FG000|Overall Study|WHO score > 6|2
4385013|NCT00003702|7163001|FG001|Overall Study|WHO score > 6|1
4385014|NCT00003702|7163000|FG000|Overall Study|Inadequate documentation of disease|1
4385015|NCT00003702|7163001|FG001|Overall Study|Inadequate documentation of disease|3
4385016|NCT00003782|7163011|FG000|Overall Study|No follow up data|30
4385017|NCT00003782|7163012|FG001|Overall Study|No follow up data|31
4385018|NCT00003782|7163013|FG002|Overall Study|No follow up data|26
4385019|NCT00003830|7163051|FG000|Overall Study|No follow up data|3
4385020|NCT00003830|7163052|FG001|Overall Study|No follow up data|0
4385021|NCT00003830|7163051|FG000|Overall Study|Sentinel node positive patients|829
4385022|NCT00003830|7163052|FG001|Overall Study|Sentinel node positive patients|793
4385023|NCT00003869|7163062|FG000|Overall Study|Adverse Event|14
4385024|NCT00003869|7163063|FG001|Overall Study|Adverse Event|3
4385025|NCT00003869|7163062|FG000|Overall Study|Withdrawal by Subject|21
4385026|NCT00003869|7163063|FG001|Overall Study|Withdrawal by Subject|3
4385027|NCT00003869|7163062|FG000|Overall Study|Death|1
4385028|NCT00003869|7163063|FG001|Overall Study|Death|2
4385029|NCT00003869|7163062|FG000|Overall Study|Alternative treatmnt, medical problems|5
4385030|NCT00003869|7163063|FG001|Overall Study|Alternative treatmnt, medical problems|4
4385031|NCT00003875|7163069|FG000|Overall Study|Screen Failed|1
4385032|NCT00003895|7163075|FG000|Overall Study|Adverse Event|4
4385033|NCT00003895|7163076|FG001|Overall Study|Adverse Event|0
4385034|NCT00003895|7163075|FG000|Overall Study|Lack of Efficacy|1
4385035|NCT00003895|7163076|FG001|Overall Study|Lack of Efficacy|1
4385036|NCT00003895|7163075|FG000|Overall Study|Patient Vacation|2
4385037|NCT00003895|7163076|FG001|Overall Study|Patient Vacation|0
4385038|NCT00003895|7163075|FG000|Overall Study|Withdrawal by Subject|0
4385039|NCT00003895|7163076|FG001|Overall Study|Withdrawal by Subject|3
4385040|NCT00003896|7163082|FG000|Overall Study|Adverse Event|16
4385041|NCT00003896|7163082|FG000|Overall Study|Withdrawal by Subject|1
4385042|NCT00003896|7163082|FG000|Overall Study|Lack of Efficacy|1
4385043|NCT00003896|7163082|FG000|Overall Study|Death|3
4385044|NCT00003896|7163082|FG000|Overall Study|not protocol specified|3
4385045|NCT00003896|7163082|FG000|Overall Study|ineligible|5
4385046|NCT00003901|7163087|FG000|Overall Study|Adverse Event|1
4385047|NCT00003901|7163087|FG000|Overall Study|Withdrawal by Subject|1
4385048|NCT00003901|7163087|FG000|Overall Study|Ineligible|6
4385049|NCT00003901|7163087|FG000|Overall Study|CT Scan not within protocol requirement|2
4385050|NCT00003901|7163087|FG000|Overall Study|Chest X-Ray not done prior registration|1
4385051|NCT00003901|7163087|FG000|Overall Study|Medical problems|6
4385052|NCT00003907|7163096|FG000|Overall Study|Adverse Event|2
4385053|NCT00003907|7163097|FG001|Overall Study|Adverse Event|11
4385054|NCT00003907|7163096|FG000|Overall Study|Death|2
4385055|NCT00003907|7163097|FG001|Overall Study|Death|0
4385056|NCT00003907|7163096|FG000|Overall Study|Withdrawal by Subject|1
4385057|NCT00003907|7163097|FG001|Overall Study|Withdrawal by Subject|3
4385058|NCT00003907|7163096|FG000|Overall Study|Progressive disease|4
4385059|NCT00003907|7163097|FG001|Overall Study|Progressive disease|4
4385060|NCT00003907|7163096|FG000|Overall Study|Complicating disease|1
4385061|NCT00003907|7163097|FG001|Overall Study|Complicating disease|0
4385062|NCT00003907|7163096|FG000|Overall Study|Other|1
4385063|NCT00003907|7163097|FG001|Overall Study|Other|3
4385064|NCT00003907|7163096|FG000|Overall Study|ineligible or not treated|2
4385065|NCT00003907|7163097|FG001|Overall Study|ineligible or not treated|2
4385066|NCT00004031|7163112|FG000|Overall Study|Adverse Event|5
4385067|NCT00004031|7163113|FG001|Overall Study|Adverse Event|0
4385068|NCT00004031|7163112|FG000|Overall Study|Refusal unrelated to adverse events|2
4385069|NCT00004031|7163113|FG001|Overall Study|Refusal unrelated to adverse events|11
4385070|NCT00004031|7163112|FG000|Overall Study|Progression/relapse|9
4385071|NCT00004031|7163113|FG001|Overall Study|Progression/relapse|4
4385072|NCT00004031|7163112|FG000|Overall Study|Death|3
4385073|NCT00004031|7163113|FG001|Overall Study|Death|1
4385074|NCT00004031|7163112|FG000|Overall Study|Other- not protocol specified|3
4385075|NCT00004031|7163113|FG001|Overall Study|Other- not protocol specified|3
4385076|NCT00004031|7163112|FG000|Overall Study|Reason under review|3
4385077|NCT00004031|7163113|FG001|Overall Study|Reason under review|2
4385078|NCT00004088|7163130|FG000|Overall Study|No C2 given due to study on hold by IRB|4
4385079|NCT00004088|7163130|FG000|Overall Study|Withdrawal by Subject|1
4385080|NCT00004088|7163130|FG000|Overall Study|Protocol Violation|3
4385081|NCT00004088|7163130|FG000|Overall Study|Physician Decision|1
4385082|NCT00004124|7163145|FG000|Overall Study|Received no protocol therapy|12
4385083|NCT00004124|7163146|FG001|Overall Study|Received no protocol therapy|20
4385084|NCT00004228|7163169|FG000|Overall Study|Adverse Event|0
4385085|NCT00004228|7163170|FG001|Overall Study|Adverse Event|1
4385086|NCT00004228|7163171|FG002|Overall Study|Adverse Event|0
4385087|NCT00004228|7163172|FG003|Overall Study|Adverse Event|0
4385088|NCT00004228|7163173|FG004|Overall Study|Adverse Event|1
4385089|NCT00004228|7163174|FG005|Overall Study|Adverse Event|0
4385090|NCT00004228|7163175|FG006|Overall Study|Adverse Event|0
4385091|NCT00004228|7163169|FG000|Overall Study|Death|0
4385092|NCT00004228|7163170|FG001|Overall Study|Death|1
4385093|NCT00004228|7163171|FG002|Overall Study|Death|2
4385094|NCT00004228|7163172|FG003|Overall Study|Death|0
4385095|NCT00004228|7163173|FG004|Overall Study|Death|1
4385096|NCT00004228|7163174|FG005|Overall Study|Death|0
4385097|NCT00004228|7163175|FG006|Overall Study|Death|0
4385098|NCT00004228|7163169|FG000|Overall Study|Lack of Efficacy|1
4385099|NCT00004228|7163170|FG001|Overall Study|Lack of Efficacy|6
4385100|NCT00004228|7163171|FG002|Overall Study|Lack of Efficacy|5
4385101|NCT00004228|7163172|FG003|Overall Study|Lack of Efficacy|3
4385102|NCT00004228|7163173|FG004|Overall Study|Lack of Efficacy|9
4385103|NCT00004228|7163174|FG005|Overall Study|Lack of Efficacy|8
4385104|NCT00004228|7163175|FG006|Overall Study|Lack of Efficacy|4
4385105|NCT00004228|7163169|FG000|Overall Study|Lost to Follow-up|0
4385106|NCT00004228|7163170|FG001|Overall Study|Lost to Follow-up|0
4385107|NCT00004228|7163171|FG002|Overall Study|Lost to Follow-up|1
4385108|NCT00004228|7163172|FG003|Overall Study|Lost to Follow-up|0
4385109|NCT00004228|7163173|FG004|Overall Study|Lost to Follow-up|0
4385110|NCT00004228|7163174|FG005|Overall Study|Lost to Follow-up|0
4385111|NCT00004228|7163175|FG006|Overall Study|Lost to Follow-up|0
4588924|NCT01506271|7433771|FG001|Overall Study|Protocol Violation|1
4385112|NCT00004228|7163169|FG000|Overall Study|Physician Decision|1
4385113|NCT00004228|7163170|FG001|Overall Study|Physician Decision|0
4385114|NCT00004228|7163171|FG002|Overall Study|Physician Decision|3
4385115|NCT00004228|7163172|FG003|Overall Study|Physician Decision|2
4385116|NCT00004228|7163173|FG004|Overall Study|Physician Decision|1
4385117|NCT00004228|7163174|FG005|Overall Study|Physician Decision|1
4385118|NCT00004228|7163175|FG006|Overall Study|Physician Decision|1
4385119|NCT00004228|7163169|FG000|Overall Study|Protocol Violation|0
4385120|NCT00004228|7163170|FG001|Overall Study|Protocol Violation|5
4385121|NCT00004228|7163171|FG002|Overall Study|Protocol Violation|2
4385122|NCT00004228|7163172|FG003|Overall Study|Protocol Violation|1
4385123|NCT00004228|7163173|FG004|Overall Study|Protocol Violation|1
4385124|NCT00004228|7163174|FG005|Overall Study|Protocol Violation|2
4385125|NCT00004228|7163175|FG006|Overall Study|Protocol Violation|0
4385126|NCT00004228|7163169|FG000|Overall Study|Withdrawal by Subject|3
4385127|NCT00004228|7163170|FG001|Overall Study|Withdrawal by Subject|0
4385128|NCT00004228|7163171|FG002|Overall Study|Withdrawal by Subject|1
4385129|NCT00004228|7163172|FG003|Overall Study|Withdrawal by Subject|0
4385130|NCT00004228|7163173|FG004|Overall Study|Withdrawal by Subject|2
4385131|NCT00004228|7163174|FG005|Overall Study|Withdrawal by Subject|1
4385132|NCT00004228|7163175|FG006|Overall Study|Withdrawal by Subject|2
4385133|NCT00004228|7163169|FG000|Overall Study|Other|0
4385134|NCT00004228|7163170|FG001|Overall Study|Other|0
4385135|NCT00004228|7163171|FG002|Overall Study|Other|1
4385136|NCT00004228|7163172|FG003|Overall Study|Other|0
4385137|NCT00004228|7163173|FG004|Overall Study|Other|0
4385138|NCT00004228|7163174|FG005|Overall Study|Other|0
4385139|NCT00004228|7163175|FG006|Overall Study|Other|0
4385140|NCT00004228|7163169|FG000|Overall Study|ineligible|4
4385141|NCT00004228|7163170|FG001|Overall Study|ineligible|2
4385142|NCT00004228|7163171|FG002|Overall Study|ineligible|4
4385143|NCT00004228|7163172|FG003|Overall Study|ineligible|1
4385144|NCT00004228|7163173|FG004|Overall Study|ineligible|1
4385145|NCT00004228|7163174|FG005|Overall Study|ineligible|2
4385146|NCT00004228|7163175|FG006|Overall Study|ineligible|5
4385147|NCT00004259|7163196|FG000|Overall Study|Protocol Violation|1
4385148|NCT00004259|7163197|FG001|Overall Study|Protocol Violation|2
4385149|NCT00004259|7163198|FG002|Overall Study|Protocol Violation|0
4385150|NCT00004259|7163199|FG003|Overall Study|Protocol Violation|0
4385151|NCT00004259|7163196|FG000|Overall Study|Withdrawal by Subject|0
4385152|NCT00004259|7163197|FG001|Overall Study|Withdrawal by Subject|2
4385153|NCT00004259|7163198|FG002|Overall Study|Withdrawal by Subject|0
4385154|NCT00004259|7163199|FG003|Overall Study|Withdrawal by Subject|0
4385155|NCT00004412|7163215|FG000|Randomized Period|Moved to Crossover Period|3
4385156|NCT00004412|7163216|FG001|Randomized Period|Moved to Crossover Period|0
4385157|NCT00004412|7163217|FG002|Randomized Period|Moved to Crossover Period|0
4385158|NCT00004445|7163227|FG000|Overall Study|Physician Decision|2
4385159|NCT00004445|7163227|FG000|Overall Study|Withdrawal by Subject|1
4385160|NCT00004562|7163256|FG000|Overall Study|Lost to Follow-up|102
4385161|NCT00004562|7163257|FG001|Overall Study|Lost to Follow-up|91
4385162|NCT00004563|7163265|FG000|Overall Study|Withdrawal by Subject|20
4385163|NCT00004563|7163266|FG001|Overall Study|Withdrawal by Subject|16
4385164|NCT00004563|7163265|FG000|Overall Study|Lack of Efficacy|3
4385165|NCT00004563|7163266|FG001|Overall Study|Lack of Efficacy|5
4385166|NCT00004563|7163265|FG000|Overall Study|Death|2
4385167|NCT00004563|7163266|FG001|Overall Study|Death|3
4385168|NCT00004635|7163274|FG000|Period One|refused|2
4385169|NCT00004635|7163275|FG001|Period One|refused|1
4385170|NCT00004635|7163274|FG000|Period One|Withdrawal by Subject|1
4385171|NCT00004635|7163275|FG001|Period One|Withdrawal by Subject|1
4385172|NCT00004635|7163274|FG000|Period One|Protocol Violation|1
4385173|NCT00004635|7163275|FG001|Period One|Protocol Violation|0
4385174|NCT00004635|7163274|FG000|Period One|PSA did not go <5 ng/mL|1
4385175|NCT00004635|7163275|FG001|Period One|PSA did not go <5 ng/mL|0
4385176|NCT00004635|7163274|FG000|Period One|second malignancy|1
4385177|NCT00004635|7163275|FG001|Period One|second malignancy|0
4385178|NCT00004635|7163274|FG000|Period One|progressed|0
4385179|NCT00004635|7163275|FG001|Period One|progressed|2
4385180|NCT00004635|7163274|FG000|Period One|health problem|0
4385181|NCT00004635|7163275|FG001|Period One|health problem|1
4385182|NCT00004635|7163274|FG000|Period One|discrepancy in data entry|0
4385183|NCT00004635|7163275|FG001|Period One|discrepancy in data entry|1
4385184|NCT00004635|7163274|FG000|Period Two|progression|2
4385185|NCT00004635|7163275|FG001|Period Two|progression|3
4385186|NCT00004635|7163274|FG000|Period Two|Adverse Event|1
4385187|NCT00004635|7163275|FG001|Period Two|Adverse Event|0
4385188|NCT00004635|7163274|FG000|Period Two|refused|0
4385189|NCT00004635|7163275|FG001|Period Two|refused|2
4385190|NCT00004635|7163274|FG000|Period Two|health problem|1
4385191|NCT00004635|7163275|FG001|Period Two|health problem|1
4385192|NCT00004635|7163274|FG000|Period Two|travel issues|0
4385193|NCT00004635|7163275|FG001|Period Two|travel issues|1
4385194|NCT00004635|7163274|FG000|Period Two|secondary malignancy|1
4385195|NCT00004635|7163275|FG001|Period Two|secondary malignancy|1
4385196|NCT00004635|7163274|FG000|Period Two|Lost to Follow-up|1
4385197|NCT00004635|7163275|FG001|Period Two|Lost to Follow-up|0
4385198|NCT00004635|7163274|FG000|Period Two|discrepancy in data entry|0
4385199|NCT00004635|7163275|FG001|Period Two|discrepancy in data entry|1
4385200|NCT00004732|7163286|FG000|Overall Study|Withdrawal by Subject|36
4385201|NCT00004732|7163287|FG001|Overall Study|Withdrawal by Subject|64
4385202|NCT00004732|7163286|FG000|Overall Study|Lost to Follow-up|33
4385203|NCT00004732|7163287|FG001|Overall Study|Lost to Follow-up|47
4385204|NCT00004859|7163297|FG000|Overall Study|Lack of Efficacy|43
4385205|NCT00004859|7163298|FG001|Overall Study|Lack of Efficacy|113
4385206|NCT00004859|7163297|FG000|Overall Study|Adverse Event|31
4385207|NCT00004859|7163298|FG001|Overall Study|Adverse Event|93
4385208|NCT00004859|7163297|FG000|Overall Study|Death|5
4385209|NCT00004859|7163298|FG001|Overall Study|Death|5
4385210|NCT00004859|7163297|FG000|Overall Study|Withdrawal by Subject|7
4385211|NCT00004859|7163298|FG001|Overall Study|Withdrawal by Subject|33
4385212|NCT00004859|7163297|FG000|Overall Study|Protocol Violation|2
4385213|NCT00004859|7163298|FG001|Overall Study|Protocol Violation|2
4385214|NCT00004859|7163297|FG000|Overall Study|other disease|0
4385215|NCT00004859|7163298|FG001|Overall Study|other disease|3
4385216|NCT00004859|7163297|FG000|Overall Study|error|3
4385217|NCT00004859|7163298|FG001|Overall Study|error|1
4385218|NCT00004859|7163297|FG000|Overall Study|missing data|14
4385219|NCT00004859|7163298|FG001|Overall Study|missing data|11
4385220|NCT00004859|7163297|FG000|Overall Study|Other|13
4385221|NCT00004859|7163298|FG001|Overall Study|Other|21
4385222|NCT00004888|7163308|FG000|Overall Study|Adverse Event|5
4385223|NCT00004888|7163309|FG001|Overall Study|Adverse Event|10
4385224|NCT00004888|7163308|FG000|Overall Study|Withdrawal by Subject|0
4385225|NCT00004888|7163309|FG001|Overall Study|Withdrawal by Subject|3
4385226|NCT00004888|7163308|FG000|Overall Study|Physician Decision|1
4385227|NCT00004888|7163309|FG001|Overall Study|Physician Decision|1
4385228|NCT00004888|7163308|FG000|Overall Study|Progressive Disease|4
4385229|NCT00004888|7163309|FG001|Overall Study|Progressive Disease|9
4385230|NCT00004888|7163308|FG000|Overall Study|Death without progressive disease|0
4385231|NCT00004888|7163309|FG001|Overall Study|Death without progressive disease|1
4385232|NCT00004888|7163308|FG000|Overall Study|Toxic death|1
4385233|NCT00004888|7163309|FG001|Overall Study|Toxic death|0
4385234|NCT00004978|7163317|FG000|Overall Study|Death|107
4469611|NCT00636363|7262546|FG000|Overall Study|Missed > 1 visit|0
4469612|NCT00636363|7262547|FG001|Overall Study|Missed > 1 visit|1
4469613|NCT00636363|7262548|FG002|Overall Study|Missed > 1 visit|3
4469614|NCT00636363|7262546|FG000|Overall Study|Lack of motivation|1
4469615|NCT00636363|7262547|FG001|Overall Study|Lack of motivation|0
4469616|NCT00636363|7262548|FG002|Overall Study|Lack of motivation|1
4469617|NCT00636363|7262546|FG000|Overall Study|Protocol Violation|0
4385235|NCT00004978|7163318|FG001|Overall Study|Death|116
4385236|NCT00004978|7163317|FG000|Overall Study|Lost to Follow-up|101
4385237|NCT00004978|7163318|FG001|Overall Study|Lost to Follow-up|108
4385238|NCT00004978|7163317|FG000|Overall Study|Withdrawal by Subject|17
4385239|NCT00004978|7163318|FG001|Overall Study|Withdrawal by Subject|26
4385240|NCT00004978|7163317|FG000|Overall Study|site closure - not in analysis cohort|19
4469618|NCT00636363|7262547|FG001|Overall Study|Protocol Violation|3
4385241|NCT00004978|7163318|FG001|Overall Study|site closure - not in analysis cohort|20
4385242|NCT00004980|7163326|FG000|Overall Study|Withdrawal by Subject|1
4385243|NCT00004980|7163327|FG001|Overall Study|Withdrawal by Subject|0
4385244|NCT00004980|7163326|FG000|Overall Study|memory difficulties|1
4385245|NCT00004980|7163327|FG001|Overall Study|memory difficulties|1
4385246|NCT00004980|7163326|FG000|Overall Study|Physician Decision|0
4385247|NCT00004980|7163327|FG001|Overall Study|Physician Decision|1
4385248|NCT00005044|7163335|FG000|Overall Study|Protocol Violation|37
4385249|NCT00005044|7163336|FG001|Overall Study|Protocol Violation|46
4385250|NCT00005044|7163335|FG000|Overall Study|Withdrawal by Subject|1
4385251|NCT00005044|7163336|FG001|Overall Study|Withdrawal by Subject|5
4385252|NCT00005044|7163335|FG000|Overall Study|No protocol treatment|0
4385253|NCT00005044|7163336|FG001|Overall Study|No protocol treatment|1
4385254|NCT00005047|7163346|FG000|Overall Study|Withdrawal by Subject|12
4385255|NCT00005047|7163347|FG001|Overall Study|Withdrawal by Subject|0
4385256|NCT00005047|7163348|FG002|Overall Study|Withdrawal by Subject|0
4385257|NCT00005047|7163349|FG003|Overall Study|Withdrawal by Subject|0
4385258|NCT00005047|7163346|FG000|Overall Study|Adverse Event|5
4385259|NCT00005047|7163347|FG001|Overall Study|Adverse Event|0
4385260|NCT00005047|7163348|FG002|Overall Study|Adverse Event|0
4385261|NCT00005047|7163349|FG003|Overall Study|Adverse Event|0
4385262|NCT00005047|7163346|FG000|Overall Study|Lost to Follow-up|1
4385263|NCT00005047|7163347|FG001|Overall Study|Lost to Follow-up|0
4385264|NCT00005047|7163348|FG002|Overall Study|Lost to Follow-up|0
4385265|NCT00005047|7163349|FG003|Overall Study|Lost to Follow-up|0
4385266|NCT00005047|7163346|FG000|Overall Study|Lack of Efficacy|1
4385267|NCT00005047|7163347|FG001|Overall Study|Lack of Efficacy|0
4385268|NCT00005047|7163348|FG002|Overall Study|Lack of Efficacy|0
4385269|NCT00005047|7163349|FG003|Overall Study|Lack of Efficacy|0
4385270|NCT00005879|7163377|FG000|Overall Study|Withdrawal by Subject|8
4385271|NCT00005879|7163378|FG001|Overall Study|Withdrawal by Subject|10
4385272|NCT00005906|7163393|FG000|Overall Study|Lack of Efficacy|3
4385273|NCT00005908|7163397|FG000|Overall Study|Withdrawal by Subject|1
4385274|NCT00005908|7163398|FG001|Overall Study|Withdrawal by Subject|0
4385275|NCT00005937|7163407|FG000|Overall Study|Lack of Efficacy|5
4385276|NCT00005947|7163413|FG000|Overall Study|Death|54
4385277|NCT00005947|7163414|FG001|Overall Study|Death|40
4385278|NCT00005947|7163413|FG000|Overall Study|Patient Refused to Continue|2
4385279|NCT00005947|7163414|FG001|Overall Study|Patient Refused to Continue|1
4385280|NCT00005947|7163413|FG000|Overall Study|Site Closure|1
4385281|NCT00005947|7163414|FG001|Overall Study|Site Closure|0
4385282|NCT00005957|7163424|FG000|Overall Study|No treated|3
4385283|NCT00005957|7163425|FG001|Overall Study|No treated|9
4385284|NCT00005957|7163424|FG000|Overall Study|Crossover to the other arm|5
4385285|NCT00005957|7163425|FG001|Overall Study|Crossover to the other arm|19
4385286|NCT00006011|7163434|FG000|Overall Study|Disease progression|13
4385287|NCT00006011|7163435|FG001|Overall Study|Disease progression|6
4385288|NCT00006011|7163436|FG002|Overall Study|Disease progression|26
4385289|NCT00006011|7163434|FG000|Overall Study|Refused further treatment|15
4385290|NCT00006011|7163435|FG001|Overall Study|Refused further treatment|13
4385291|NCT00006011|7163436|FG002|Overall Study|Refused further treatment|26
4385292|NCT00006011|7163434|FG000|Overall Study|Adverse Event|15
4385293|NCT00006011|7163435|FG001|Overall Study|Adverse Event|39
4385294|NCT00006011|7163436|FG002|Overall Study|Adverse Event|5
4385295|NCT00006011|7163434|FG000|Overall Study|Death|0
4385296|NCT00006011|7163435|FG001|Overall Study|Death|1
4385297|NCT00006011|7163436|FG002|Overall Study|Death|2
4385298|NCT00006011|7163434|FG000|Overall Study|Other|4
4385299|NCT00006011|7163435|FG001|Overall Study|Other|2
4385300|NCT00006011|7163436|FG002|Overall Study|Other|5
4385301|NCT00006011|7163434|FG000|Overall Study|Ineligible|18
4385302|NCT00006011|7163435|FG001|Overall Study|Ineligible|16
4385303|NCT00006011|7163436|FG002|Overall Study|Ineligible|9
4385304|NCT00006046|7163447|FG000|Overall Study|Adverse Event|3
4385305|NCT00006046|7163448|FG001|Overall Study|Adverse Event|0
4385306|NCT00006046|7163449|FG002|Overall Study|Adverse Event|0
4385307|NCT00006046|7163450|FG003|Overall Study|Adverse Event|0
4385308|NCT00006046|7163451|FG004|Overall Study|Adverse Event|0
4385309|NCT00006046|7163447|FG000|Overall Study|Disease Progression|2
4588925|NCT01506271|7433772|FG002|Overall Study|Protocol Violation|0
4385310|NCT00006046|7163448|FG001|Overall Study|Disease Progression|0
4385311|NCT00006046|7163449|FG002|Overall Study|Disease Progression|0
4385312|NCT00006046|7163450|FG003|Overall Study|Disease Progression|0
4385313|NCT00006046|7163451|FG004|Overall Study|Disease Progression|0
4385314|NCT00006164|7163515|FG000|Overall Study|Withdrew or lost to follow-up|70
4385315|NCT00006164|7163516|FG001|Overall Study|Withdrew or lost to follow-up|81
4469619|NCT00636363|7262548|FG002|Overall Study|Protocol Violation|0
4469620|NCT00636363|7262546|FG000|Overall Study|Lost to Follow-up|3
4469621|NCT00636363|7262547|FG001|Overall Study|Lost to Follow-up|4
4469622|NCT00636363|7262548|FG002|Overall Study|Lost to Follow-up|2
4469623|NCT00636363|7262546|FG000|Overall Study|Withdrawal by Subject|1
4469624|NCT00636363|7262547|FG001|Overall Study|Withdrawal by Subject|3
4469625|NCT00636363|7262548|FG002|Overall Study|Withdrawal by Subject|2
4469626|NCT00636441|7262570|FG000|Overall Study|Adverse Event|0
4588926|NCT01506271|7433770|FG000|Overall Study|Death|0
4469627|NCT00636441|7262571|FG001|Overall Study|Adverse Event|1
4469628|NCT00636441|7262572|FG002|Overall Study|Adverse Event|1
4588927|NCT01506271|7433771|FG001|Overall Study|Death|1
4588928|NCT01506271|7433772|FG002|Overall Study|Death|0
4588929|NCT01506271|7433770|FG000|Overall Study|Adverse Event|0
4588930|NCT01506271|7433771|FG001|Overall Study|Adverse Event|2
4588931|NCT01506271|7433772|FG002|Overall Study|Adverse Event|0
4588932|NCT01506271|7433770|FG000|Overall Study|Insufficient supply of study drug|1
4588933|NCT01506271|7433771|FG001|Overall Study|Insufficient supply of study drug|0
4588934|NCT01506271|7433772|FG002|Overall Study|Insufficient supply of study drug|0
4588935|NCT01506271|7433770|FG000|Overall Study|Withdrawal by Subject|0
4771203|NCT04532294|7748034|FG000|Overall Study|Participants Not Dosed|0
4771204|NCT04532294|7748035|FG001|Overall Study|Participants Not Dosed|0
4385318|NCT04323800|7163547|FG000|Overall Study|Withdrawal by Subject|4
4385319|NCT04323800|7163548|FG001|Overall Study|Withdrawal by Subject|4
4385320|NCT04323800|7163547|FG000|Overall Study|Incomplete transfusion|1
4385321|NCT04323800|7163548|FG001|Overall Study|Incomplete transfusion|0
4385322|NCT04323800|7163547|FG000|Overall Study|Other|0
4385323|NCT04323800|7163548|FG001|Overall Study|Other|1
4385324|NCT04323800|7163547|FG000|Overall Study|Positive RT-PCR at transfusion|1
4385325|NCT04323800|7163548|FG001|Overall Study|Positive RT-PCR at transfusion|1
4385326|NCT04110145|7163568|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0
4385327|NCT04110145|7163569|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0
4385328|NCT04110145|7163570|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0
4385329|NCT04110145|7163571|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1
4385330|NCT04110145|7163572|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0
4385331|NCT03986866|7163586|FG000|Overall Study|Withdrawal by Subject|0
4385332|NCT03986866|7163587|FG001|Overall Study|Withdrawal by Subject|3
4385333|NCT03986866|7163586|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2
4385334|NCT03986866|7163587|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2
4385335|NCT03636269|7163595|FG000|Period 1: Double-blind Phase|Adverse Event|13
4385336|NCT03636269|7163596|FG001|Period 1: Double-blind Phase|Adverse Event|7
4385337|NCT03636269|7163597|FG002|Period 1: Double-blind Phase|Adverse Event|0
4385338|NCT03636269|7163595|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1
4385339|NCT03636269|7163596|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0
4385340|NCT03636269|7163597|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0
4385341|NCT03636269|7163595|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2
4385342|NCT03636269|7163596|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0
4385343|NCT03636269|7163597|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0
4385344|NCT03636269|7163595|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5
4385345|NCT03636269|7163596|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1
4385346|NCT03636269|7163597|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0
4385347|NCT03636269|7163595|FG000|Period 1: Double-blind Phase|Other|6
4385348|NCT03636269|7163596|FG001|Period 1: Double-blind Phase|Other|3
4385349|NCT03636269|7163597|FG002|Period 1: Double-blind Phase|Other|0
4385350|NCT03636269|7163595|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1
4385351|NCT03636269|7163596|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0
4385352|NCT03636269|7163597|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0
4385353|NCT03636269|7163595|FG000|Period 1: Double-blind Phase|Subject non-compliance|1
4385354|NCT03636269|7163596|FG001|Period 1: Double-blind Phase|Subject non-compliance|2
4385355|NCT03636269|7163597|FG002|Period 1: Double-blind Phase|Subject non-compliance|0
4385356|NCT03636269|7163595|FG000|Period 2: Open-label Phase|Adverse Event|0
4385357|NCT03636269|7163596|FG001|Period 2: Open-label Phase|Adverse Event|0
4385358|NCT03636269|7163597|FG002|Period 2: Open-label Phase|Adverse Event|21
4385359|NCT03636269|7163595|FG000|Period 2: Open-label Phase|Lack of Efficacy|0
4385360|NCT03636269|7163596|FG001|Period 2: Open-label Phase|Lack of Efficacy|0
4385361|NCT03636269|7163597|FG002|Period 2: Open-label Phase|Lack of Efficacy|2
4385362|NCT03636269|7163595|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0
4385363|NCT03636269|7163596|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0
4385364|NCT03636269|7163597|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2
4385365|NCT03636269|7163595|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0
4385366|NCT03636269|7163596|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0
4385367|NCT03636269|7163597|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11
4385368|NCT03636269|7163595|FG000|Period 2: Open-label Phase|Administrative|0
4588936|NCT01506271|7433771|FG001|Overall Study|Withdrawal by Subject|1
4385369|NCT03636269|7163596|FG001|Period 2: Open-label Phase|Administrative|0
4385370|NCT03636269|7163597|FG002|Period 2: Open-label Phase|Administrative|36
4385371|NCT03636269|7163595|FG000|Period 2: Open-label Phase|Other|0
4385372|NCT03636269|7163596|FG001|Period 2: Open-label Phase|Other|0
4385373|NCT03636269|7163597|FG002|Period 2: Open-label Phase|Other|9
4385374|NCT03636269|7163595|FG000|Period 2: Open-label Phase|Sponsor stopping study|0
4385375|NCT03636269|7163596|FG001|Period 2: Open-label Phase|Sponsor stopping study|0
4385376|NCT03636269|7163597|FG002|Period 2: Open-label Phase|Sponsor stopping study|313
4385377|NCT03447314|7163637|FG000|Part 1 (Up to 27 Months)|Death|6
4385378|NCT03447314|7163638|FG001|Part 1 (Up to 27 Months)|Death|5
4385379|NCT03447314|7163639|FG002|Part 1 (Up to 27 Months)|Death|3
4588937|NCT01506271|7433772|FG002|Overall Study|Withdrawal by Subject|1
4385380|NCT03447314|7163640|FG003|Part 1 (Up to 27 Months)|Death|3
4385381|NCT03447314|7163641|FG004|Part 1 (Up to 27 Months)|Death|0
4385382|NCT03447314|7163642|FG005|Part 1 (Up to 27 Months)|Death|4
4385383|NCT03447314|7163643|FG006|Part 1 (Up to 27 Months)|Death|3
4385384|NCT03447314|7163644|FG007|Part 1 (Up to 27 Months)|Death|0
4385385|NCT03447314|7163645|FG008|Part 1 (Up to 27 Months)|Death|0
4385386|NCT03447314|7163646|FG009|Part 1 (Up to 27 Months)|Death|0
4385387|NCT03447314|7163647|FG010|Part 1 (Up to 27 Months)|Death|4
4385388|NCT03447314|7163648|FG011|Part 1 (Up to 27 Months)|Death|2
4385389|NCT03447314|7163649|FG012|Part 1 (Up to 27 Months)|Death|0
4385390|NCT03447314|7163650|FG013|Part 1 (Up to 27 Months)|Death|0
4385391|NCT03447314|7163651|FG014|Part 1 (Up to 27 Months)|Death|0
4385392|NCT03447314|7163652|FG015|Part 1 (Up to 27 Months)|Death|0
4385393|NCT03447314|7163653|FG016|Part 1 (Up to 27 Months)|Death|0
4385394|NCT03447314|7163654|FG017|Part 1 (Up to 27 Months)|Death|0
4385395|NCT03447314|7163637|FG000|Part 1 (Up to 27 Months)|Ongoing in the study|2
4385396|NCT03447314|7163638|FG001|Part 1 (Up to 27 Months)|Ongoing in the study|1
4385397|NCT03447314|7163639|FG002|Part 1 (Up to 27 Months)|Ongoing in the study|3
4385398|NCT03447314|7163640|FG003|Part 1 (Up to 27 Months)|Ongoing in the study|1
4385399|NCT03447314|7163641|FG004|Part 1 (Up to 27 Months)|Ongoing in the study|2
4385400|NCT03447314|7163642|FG005|Part 1 (Up to 27 Months)|Ongoing in the study|1
4385401|NCT03447314|7163643|FG006|Part 1 (Up to 27 Months)|Ongoing in the study|2
4385402|NCT03447314|7163644|FG007|Part 1 (Up to 27 Months)|Ongoing in the study|0
4385403|NCT03447314|7163645|FG008|Part 1 (Up to 27 Months)|Ongoing in the study|0
4469629|NCT00636441|7262573|FG003|Overall Study|Adverse Event|0
4469630|NCT00636441|7262574|FG004|Overall Study|Adverse Event|0
4469631|NCT00636441|7262575|FG005|Overall Study|Adverse Event|1
4469632|NCT00636441|7262576|FG006|Overall Study|Adverse Event|0
4469633|NCT00636441|7262570|FG000|Overall Study|Late, ineligible|0
4469634|NCT00636441|7262571|FG001|Overall Study|Late, ineligible|0
4469635|NCT00636441|7262572|FG002|Overall Study|Late, ineligible|0
4469636|NCT00636441|7262573|FG003|Overall Study|Late, ineligible|0
4469637|NCT00636441|7262574|FG004|Overall Study|Late, ineligible|0
4469638|NCT00636441|7262575|FG005|Overall Study|Late, ineligible|0
4469639|NCT00636441|7262576|FG006|Overall Study|Late, ineligible|1
4469640|NCT00636441|7262570|FG000|Overall Study|Screen Failure|0
4469641|NCT00636441|7262571|FG001|Overall Study|Screen Failure|0
4469642|NCT00636441|7262572|FG002|Overall Study|Screen Failure|0
4469643|NCT00636441|7262573|FG003|Overall Study|Screen Failure|0
4469644|NCT00636441|7262574|FG004|Overall Study|Screen Failure|0
4469645|NCT00636441|7262575|FG005|Overall Study|Screen Failure|0
4469646|NCT00636441|7262576|FG006|Overall Study|Screen Failure|17
4469647|NCT00636506|7262587|FG000|Overall Study|Lost to Follow-up|8
4469648|NCT00636506|7262587|FG000|Overall Study|Explanted|1
4469649|NCT00636506|7262587|FG000|Overall Study|Withdrawal by Subject|6
4469650|NCT00636506|7262587|FG000|Overall Study|Procedure aborted|1
4469651|NCT00636610|7262611|FG000|Overall Study|Adverse Event|4
4469652|NCT00636610|7262612|FG001|Overall Study|Adverse Event|4
4469653|NCT00636610|7262611|FG000|Overall Study|Death|6
4469654|NCT00636610|7262612|FG001|Overall Study|Death|3
4469655|NCT00636610|7262611|FG000|Overall Study|Physician decision to withdraw patient|15
4469656|NCT00636610|7262612|FG001|Overall Study|Physician decision to withdraw patient|9
4469657|NCT00636610|7262611|FG000|Overall Study|Subject decision to withdraw|15
4469658|NCT00636610|7262612|FG001|Overall Study|Subject decision to withdraw|11
4469659|NCT00636610|7262611|FG000|Overall Study|Disease progression - radiographic|41
4469660|NCT00636610|7262612|FG001|Overall Study|Disease progression - radiographic|51
4469661|NCT00636610|7262611|FG000|Overall Study|Disease progression - clinical|8
4469662|NCT00636610|7262612|FG001|Overall Study|Disease progression - clinical|3
4469663|NCT00636610|7262611|FG000|Overall Study|Reason for discontinuation not available|3
4469664|NCT00636610|7262612|FG001|Overall Study|Reason for discontinuation not available|2
4469665|NCT00636636|7262622|FG000|Overall Study|Other reason|4
4469666|NCT00636636|7262623|FG001|Overall Study|Other reason|6
4469667|NCT00636636|7262622|FG000|Overall Study|Adverse Event|19
4469668|NCT00636636|7262623|FG001|Overall Study|Adverse Event|8
4469669|NCT00636636|7262622|FG000|Overall Study|Lack of Efficacy|7
4469670|NCT00636636|7262623|FG001|Overall Study|Lack of Efficacy|12
4469671|NCT00636636|7262622|FG000|Overall Study|Protocol Violation|2
4469672|NCT00636636|7262623|FG001|Overall Study|Protocol Violation|2
4469673|NCT00636636|7262622|FG000|Overall Study|Lost to Follow-up|0
4469674|NCT00636636|7262623|FG001|Overall Study|Lost to Follow-up|1
4469675|NCT00636636|7262622|FG000|Overall Study|Death|0
4469676|NCT00636636|7262623|FG001|Overall Study|Death|1
4469677|NCT00636636|7262622|FG000|Overall Study|Withdrawal by Subject|4
4469678|NCT00636636|7262623|FG001|Overall Study|Withdrawal by Subject|9
4469679|NCT00636675|7262644|FG000|Overall Study|Lost to Follow-up|121
4469680|NCT00636675|7262645|FG001|Overall Study|Lost to Follow-up|31
4469681|NCT00636675|7262644|FG000|Overall Study|Withdrawal by Subject|19
4469682|NCT00636675|7262645|FG001|Overall Study|Withdrawal by Subject|10
4469683|NCT00636792|7262660|FG000|Overall Study|Adverse Event|16
4469684|NCT00636792|7262660|FG000|Overall Study|Physician Decision|7
4469685|NCT00636792|7262660|FG000|Overall Study|Progressive Disease|4
4469686|NCT00636792|7262660|FG000|Overall Study|Withdrawal by Subject|3
4469687|NCT00636792|7262660|FG000|Overall Study|Other|3
4469688|NCT00636818|7262668|FG000|Overall Study|Adverse Event|1
4469689|NCT00636818|7262668|FG000|Overall Study|Lost to Follow-up|2
4385404|NCT03447314|7163646|FG009|Part 1 (Up to 27 Months)|Ongoing in the study|0
4385405|NCT03447314|7163647|FG010|Part 1 (Up to 27 Months)|Ongoing in the study|3
4385406|NCT03447314|7163648|FG011|Part 1 (Up to 27 Months)|Ongoing in the study|4
4385407|NCT03447314|7163649|FG012|Part 1 (Up to 27 Months)|Ongoing in the study|0
4385408|NCT03447314|7163650|FG013|Part 1 (Up to 27 Months)|Ongoing in the study|0
4385409|NCT03447314|7163651|FG014|Part 1 (Up to 27 Months)|Ongoing in the study|0
4385410|NCT03447314|7163652|FG015|Part 1 (Up to 27 Months)|Ongoing in the study|0
4588938|NCT01506271|7433770|FG000|Overall Study|Lost to Follow-up|0
4697413|NCT02649231|7610827|FG003|Overall Study|Protocol Violation|0
4385411|NCT03447314|7163653|FG016|Part 1 (Up to 27 Months)|Ongoing in the study|0
4385412|NCT03447314|7163654|FG017|Part 1 (Up to 27 Months)|Ongoing in the study|0
4385413|NCT03447314|7163637|FG000|Part 1 (Up to 27 Months)|Withdrawal by Subject|1
4385414|NCT03447314|7163638|FG001|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
4385415|NCT03447314|7163639|FG002|Part 1 (Up to 27 Months)|Withdrawal by Subject|1
4385416|NCT03447314|7163640|FG003|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
4385417|NCT03447314|7163641|FG004|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
4385418|NCT03447314|7163642|FG005|Part 1 (Up to 27 Months)|Withdrawal by Subject|1
4385419|NCT03447314|7163643|FG006|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
4697414|NCT02649439|7610848|FG000|Overall Study|Switched to alternative treatment|6
4697415|NCT02649439|7610849|FG001|Overall Study|Switched to alternative treatment|4
4697416|NCT02649439|7610848|FG000|Overall Study|Patient decision|1
4697417|NCT02649439|7610849|FG001|Overall Study|Patient decision|0
4697418|NCT02649439|7610848|FG000|Overall Study|Patient going out of country|1
4697419|NCT02649439|7610849|FG001|Overall Study|Patient going out of country|0
4697420|NCT02649439|7610848|FG000|Overall Study|To start finasteride|1
4697421|NCT02649439|7610849|FG001|Overall Study|To start finasteride|0
4697422|NCT02649439|7610848|FG000|Overall Study|Physician Decision|1
4697423|NCT02649439|7610849|FG001|Overall Study|Physician Decision|0
4697424|NCT02649439|7610848|FG000|Overall Study|Disease progression on study|12
4697425|NCT02649439|7610849|FG001|Overall Study|Disease progression on study|13
4697426|NCT02649439|7610848|FG000|Overall Study|Refused further treatment|1
4697427|NCT02649439|7610849|FG001|Overall Study|Refused further treatment|0
4697428|NCT02649439|7610848|FG000|Overall Study|Refused further follow up|2
4697429|NCT02649439|7610849|FG001|Overall Study|Refused further follow up|7
4697430|NCT02649439|7610848|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1
4697431|NCT02649439|7610849|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0
4697432|NCT02649439|7610848|FG000|Overall Study|No treatment, per protocol|1
4697433|NCT02649439|7610849|FG001|Overall Study|No treatment, per protocol|0
4697434|NCT02649439|7610848|FG000|Overall Study|PSA DT makes ineligible|0
4697435|NCT02649439|7610849|FG001|Overall Study|PSA DT makes ineligible|1
4697436|NCT02649439|7610848|FG000|Overall Study|Rising PSA No Mets|0
4697437|NCT02649439|7610849|FG001|Overall Study|Rising PSA No Mets|1
4697438|NCT02649439|7610848|FG000|Overall Study|Rising PSA|0
4697439|NCT02649439|7610849|FG001|Overall Study|Rising PSA|1
4697440|NCT02649439|7610848|FG000|Overall Study|Signed follow up protocol|0
4697441|NCT02649439|7610849|FG001|Overall Study|Signed follow up protocol|1
4697442|NCT02649634|7610916|FG000|Overall Study|Withdrawal by Subject|3
4697443|NCT02649634|7610917|FG001|Overall Study|Withdrawal by Subject|5
4697444|NCT02649634|7610916|FG000|Overall Study|Lost to Follow-up|0
4697445|NCT02649634|7610917|FG001|Overall Study|Lost to Follow-up|1
4697446|NCT02649894|7610931|FG000|Overall Study|Adverse Event|1
4697447|NCT02649894|7610932|FG001|Overall Study|Adverse Event|0
4697448|NCT02649894|7610931|FG000|Overall Study|Physician Decision|0
4697449|NCT02649894|7610932|FG001|Overall Study|Physician Decision|1
4697450|NCT02649894|7610931|FG000|Overall Study|Withdrawal by Subject|5
4697451|NCT02649894|7610932|FG001|Overall Study|Withdrawal by Subject|2
4697452|NCT02649894|7610931|FG000|Overall Study|Lost to Follow-up|2
4697453|NCT02649894|7610932|FG001|Overall Study|Lost to Follow-up|1
4697454|NCT02649894|7610931|FG000|Overall Study|Death|30
4697455|NCT02649894|7610932|FG001|Overall Study|Death|7
4697456|NCT02649894|7610931|FG000|Overall Study|Other, not specified|6
4697457|NCT02649894|7610932|FG001|Overall Study|Other, not specified|0
4697458|NCT02650128|7610938|FG000|Overall Study|Death|2
4697459|NCT02650284|7610968|FG000|Overall Study|Lost to Follow-up|3
4697460|NCT02650284|7610969|FG001|Overall Study|Lost to Follow-up|3
4697461|NCT02650284|7610968|FG000|Overall Study|Consent incorrectly taken|0
4697462|NCT02650284|7610969|FG001|Overall Study|Consent incorrectly taken|1
4697463|NCT02650466|7610984|FG000|Overall Study|Physician Decision|1
4697464|NCT02650466|7610984|FG000|Overall Study|Withdrawal by Subject|5
4697465|NCT02650466|7610984|FG000|Overall Study|Lost to Follow-up|1
4697466|NCT02650895|7611005|FG000|Overall Study|Withdrawal by Subject|0
4697467|NCT02650895|7611006|FG001|Overall Study|Withdrawal by Subject|1
4697468|NCT02650895|7611007|FG002|Overall Study|Withdrawal by Subject|0
4697469|NCT02650895|7611008|FG003|Overall Study|Withdrawal by Subject|0
4697470|NCT02650895|7611009|FG004|Overall Study|Withdrawal by Subject|0
4697471|NCT02650895|7611010|FG005|Overall Study|Withdrawal by Subject|0
4697472|NCT02650921|7611029|FG000|Overall Study|Withdrawal by Subject|4
4697473|NCT02650921|7611029|FG000|Overall Study|Lost to Follow-up|2
4385420|NCT03447314|7163644|FG007|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
4697474|NCT02650921|7611029|FG000|Overall Study|Adverse Event|1
4385421|NCT03447314|7163645|FG008|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
4385422|NCT03447314|7163646|FG009|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
4385423|NCT03447314|7163647|FG010|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
4385424|NCT03447314|7163648|FG011|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
4385425|NCT03447314|7163649|FG012|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
4385426|NCT03447314|7163650|FG013|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
4469690|NCT00636818|7262668|FG000|Overall Study|Entry Criteria Exclusion|3
4469691|NCT00636818|7262668|FG000|Overall Study|Protocol Violation|1
4469692|NCT00636818|7262668|FG000|Overall Study|Withdrawal by Subject|4
4469693|NCT00636961|7262674|FG000|Period 1|Administrative problems|1
4469694|NCT00636961|7262675|FG001|Period 1|Administrative problems|1
4469695|NCT00636961|7262674|FG000|Period 2|Adverse Event|1
4469696|NCT00636961|7262675|FG001|Period 2|Adverse Event|0
4469697|NCT00636987|7262681|FG000|Overall Study|Death|44
4469698|NCT00636987|7262681|FG000|Overall Study|Explanted|13
4469699|NCT00636987|7262681|FG000|Overall Study|Lost to Follow-up|63
4469700|NCT00636987|7262681|FG000|Overall Study|5 year visit window not complete|69
4469701|NCT00637000|7262691|FG000|Overall Study|Withdrawal by Subject|4
4469702|NCT00637000|7262692|FG001|Overall Study|Withdrawal by Subject|3
4469703|NCT00637156|7262700|FG000|Overall Study|Withdrawal by Subject|0
4469704|NCT00637156|7262701|FG001|Overall Study|Withdrawal by Subject|7
4469705|NCT00637156|7262700|FG000|Overall Study|Death|0
4469706|NCT00637156|7262701|FG001|Overall Study|Death|1
4469707|NCT00637156|7262700|FG000|Overall Study|Lost to Follow-up|10
4469708|NCT00637156|7262701|FG001|Overall Study|Lost to Follow-up|16
4469709|NCT00637195|7262709|FG000|Overall Study|Lost to Follow-up|1
4469710|NCT00637195|7262710|FG001|Overall Study|Lost to Follow-up|0
4469711|NCT00637195|7262709|FG000|Overall Study|Other|2
4469712|NCT00637195|7262710|FG001|Overall Study|Other|0
4469713|NCT00637195|7262709|FG000|Overall Study|Withdrawal by Subject|0
4469714|NCT00637195|7262710|FG001|Overall Study|Withdrawal by Subject|1
4469715|NCT00637273|7262730|FG000|Overall Study|Adverse Event|11
4469716|NCT00637273|7262731|FG001|Overall Study|Adverse Event|5
4469717|NCT00637273|7262732|FG002|Overall Study|Adverse Event|7
4469718|NCT00637273|7262730|FG000|Overall Study|Lost to Follow-up|8
4469719|NCT00637273|7262731|FG001|Overall Study|Lost to Follow-up|9
4469720|NCT00637273|7262732|FG002|Overall Study|Lost to Follow-up|13
4469721|NCT00637273|7262730|FG000|Overall Study|Protocol Violation|2
4469722|NCT00637273|7262731|FG001|Overall Study|Protocol Violation|4
4469723|NCT00637273|7262732|FG002|Overall Study|Protocol Violation|1
4469724|NCT00637273|7262730|FG000|Overall Study|Withdrawal of Consent|18
4469725|NCT00637273|7262731|FG001|Overall Study|Withdrawal of Consent|6
4469726|NCT00637273|7262732|FG002|Overall Study|Withdrawal of Consent|18
4469727|NCT00637273|7262730|FG000|Overall Study|Investigator Decision|1
4469728|NCT00637273|7262731|FG001|Overall Study|Investigator Decision|3
4469729|NCT00637273|7262732|FG002|Overall Study|Investigator Decision|1
4469730|NCT00637273|7262730|FG000|Overall Study|Administrative|2
4469731|NCT00637273|7262731|FG001|Overall Study|Administrative|0
4469732|NCT00637273|7262732|FG002|Overall Study|Administrative|0
4469733|NCT00637273|7262730|FG000|Overall Study|Loss of Glucose Control|1
4469734|NCT00637273|7262731|FG001|Overall Study|Loss of Glucose Control|1
4469735|NCT00637273|7262732|FG002|Overall Study|Loss of Glucose Control|1
4516455|NCT00960440|7327937|FG000|Overall Study|Death|0
4516456|NCT00960440|7327938|FG001|Overall Study|Death|0
4516457|NCT00960440|7327939|FG002|Overall Study|Death|0
4516458|NCT00960440|7327940|FG003|Overall Study|Death|1
4516459|NCT00960440|7327937|FG000|Overall Study|Adverse Event|12
4516460|NCT00960440|7327938|FG001|Overall Study|Adverse Event|12
4516461|NCT00960440|7327939|FG002|Overall Study|Adverse Event|4
4516462|NCT00960440|7327940|FG003|Overall Study|Adverse Event|4
4516463|NCT00960440|7327937|FG000|Overall Study|Lack of Efficacy|2
4516464|NCT00960440|7327938|FG001|Overall Study|Lack of Efficacy|5
4516465|NCT00960440|7327939|FG002|Overall Study|Lack of Efficacy|3
4516466|NCT00960440|7327940|FG003|Overall Study|Lack of Efficacy|8
4516467|NCT00960440|7327937|FG000|Overall Study|Protocol Violation|2
4516468|NCT00960440|7327938|FG001|Overall Study|Protocol Violation|8
4516469|NCT00960440|7327939|FG002|Overall Study|Protocol Violation|3
4516470|NCT00960440|7327940|FG003|Overall Study|Protocol Violation|4
4588939|NCT01506271|7433771|FG001|Overall Study|Lost to Follow-up|1
4588940|NCT01506271|7433772|FG002|Overall Study|Lost to Follow-up|2
4516471|NCT00960440|7327937|FG000|Overall Study|Withdrawal by Subject|9
4516472|NCT00960440|7327938|FG001|Overall Study|Withdrawal by Subject|5
4516473|NCT00960440|7327939|FG002|Overall Study|Withdrawal by Subject|2
4516474|NCT00960440|7327940|FG003|Overall Study|Withdrawal by Subject|1
4516475|NCT00960440|7327937|FG000|Overall Study|Other|1
4516476|NCT00960440|7327938|FG001|Overall Study|Other|1
4516477|NCT00960440|7327939|FG002|Overall Study|Other|1
4516478|NCT00960440|7327940|FG003|Overall Study|Other|0
4516479|NCT00960531|7327975|FG000|Overall Study|Lack of Efficacy|1
4516480|NCT00960531|7327976|FG001|Overall Study|Lack of Efficacy|0
4516481|NCT00960531|7327977|FG002|Overall Study|Lack of Efficacy|0
4516482|NCT00960531|7327978|FG003|Overall Study|Lack of Efficacy|0
4516483|NCT00960531|7327979|FG004|Overall Study|Lack of Efficacy|0
4516484|NCT00960531|7327980|FG005|Overall Study|Lack of Efficacy|0
4516485|NCT00960531|7327981|FG006|Overall Study|Lack of Efficacy|0
4516486|NCT00960531|7327982|FG007|Overall Study|Lack of Efficacy|0
4516487|NCT00960531|7327983|FG008|Overall Study|Lack of Efficacy|0
4516488|NCT00960531|7327984|FG009|Overall Study|Lack of Efficacy|0
4697475|NCT02650921|7611029|FG000|Overall Study|Due to Medical Condition|1
4735193|NCT03521115|7682948|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56
4735194|NCT03521115|7682949|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40
4735195|NCT03521115|7682948|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3
4735196|NCT03521115|7682949|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1
4735197|NCT03521141|7682964|FG000|Overall Study|Death|1
4735198|NCT03521141|7682965|FG001|Overall Study|Death|0
4735199|NCT03521141|7682966|FG002|Overall Study|Death|1
4735200|NCT03521193|7682976|FG000|Overall Study|Withdrawal by Subject|8
4735201|NCT03521193|7682977|FG001|Overall Study|Withdrawal by Subject|0
4735202|NCT03521193|7682976|FG000|Overall Study|non compliant to ASA treatment|8
4735203|NCT03521193|7682977|FG001|Overall Study|non compliant to ASA treatment|0
4735204|NCT03521635|7683012|FG000|Overall Study|Adverse Event|1
4735205|NCT03521635|7683013|FG001|Overall Study|Adverse Event|1
4735206|NCT03521635|7683012|FG000|Overall Study|Refused to complete study visit|1
4735207|NCT03521635|7683013|FG001|Overall Study|Refused to complete study visit|0
4735208|NCT03521635|7683012|FG000|Overall Study|Refused to continue trial medication|2
4735209|NCT03521635|7683013|FG001|Overall Study|Refused to continue trial medication|2
4735210|NCT03521635|7683012|FG000|Overall Study|Lost to Follow-up|0
4735211|NCT03521635|7683013|FG001|Overall Study|Lost to Follow-up|1
4735212|NCT03521635|7683012|FG000|Overall Study|Meet exclusion criteria|0
4735213|NCT03521635|7683013|FG001|Overall Study|Meet exclusion criteria|1
4735214|NCT03521635|7683012|FG000|Overall Study|Patient not taken study medicine|0
4735215|NCT03521635|7683013|FG001|Overall Study|Patient not taken study medicine|1
4735216|NCT03521791|7683021|FG000|Overall Study|Protocol Violation|7
4735217|NCT03521791|7683022|FG001|Overall Study|Protocol Violation|17
4735218|NCT03521817|7683030|FG000|Overall Study|Protocol Violation|0
4735219|NCT03521817|7683031|FG001|Overall Study|Protocol Violation|1
4735220|NCT03522506|7683060|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0
4735221|NCT03522506|7683061|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0
4735222|NCT03522506|7683062|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0
4735223|NCT03522506|7683063|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1
4385427|NCT03447314|7163651|FG014|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
4385428|NCT03447314|7163652|FG015|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
4385429|NCT03447314|7163653|FG016|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
4385430|NCT03447314|7163654|FG017|Part 1 (Up to 27 Months)|Withdrawal by Subject|0
4385431|NCT03447314|7163637|FG000|Part 1 (Up to 27 Months)|Disease progression|0
4385432|NCT03447314|7163638|FG001|Part 1 (Up to 27 Months)|Disease progression|0
4385433|NCT03447314|7163639|FG002|Part 1 (Up to 27 Months)|Disease progression|1
4385434|NCT03447314|7163640|FG003|Part 1 (Up to 27 Months)|Disease progression|0
4385435|NCT03447314|7163641|FG004|Part 1 (Up to 27 Months)|Disease progression|0
4385436|NCT03447314|7163642|FG005|Part 1 (Up to 27 Months)|Disease progression|0
4385437|NCT03447314|7163643|FG006|Part 1 (Up to 27 Months)|Disease progression|0
4385438|NCT03447314|7163644|FG007|Part 1 (Up to 27 Months)|Disease progression|0
4385439|NCT03447314|7163645|FG008|Part 1 (Up to 27 Months)|Disease progression|0
4385440|NCT03447314|7163646|FG009|Part 1 (Up to 27 Months)|Disease progression|0
4385441|NCT03447314|7163647|FG010|Part 1 (Up to 27 Months)|Disease progression|0
4385442|NCT03447314|7163648|FG011|Part 1 (Up to 27 Months)|Disease progression|0
4385443|NCT03447314|7163649|FG012|Part 1 (Up to 27 Months)|Disease progression|0
4385444|NCT03447314|7163650|FG013|Part 1 (Up to 27 Months)|Disease progression|0
4385445|NCT03447314|7163651|FG014|Part 1 (Up to 27 Months)|Disease progression|0
4385446|NCT03447314|7163652|FG015|Part 1 (Up to 27 Months)|Disease progression|0
4385447|NCT03447314|7163653|FG016|Part 1 (Up to 27 Months)|Disease progression|0
4385448|NCT03447314|7163654|FG017|Part 1 (Up to 27 Months)|Disease progression|0
4385449|NCT03447314|7163637|FG000|Part 1 (Up to 27 Months)|Lost to Follow-up|0
4385450|NCT03447314|7163638|FG001|Part 1 (Up to 27 Months)|Lost to Follow-up|0
4385451|NCT03447314|7163639|FG002|Part 1 (Up to 27 Months)|Lost to Follow-up|1
4385452|NCT03447314|7163640|FG003|Part 1 (Up to 27 Months)|Lost to Follow-up|0
4385453|NCT03447314|7163641|FG004|Part 1 (Up to 27 Months)|Lost to Follow-up|0
4385454|NCT03447314|7163642|FG005|Part 1 (Up to 27 Months)|Lost to Follow-up|0
4385455|NCT03447314|7163643|FG006|Part 1 (Up to 27 Months)|Lost to Follow-up|0
4385456|NCT03447314|7163644|FG007|Part 1 (Up to 27 Months)|Lost to Follow-up|0
4385457|NCT03447314|7163645|FG008|Part 1 (Up to 27 Months)|Lost to Follow-up|0
4385458|NCT03447314|7163646|FG009|Part 1 (Up to 27 Months)|Lost to Follow-up|0
4385459|NCT03447314|7163647|FG010|Part 1 (Up to 27 Months)|Lost to Follow-up|0
4385460|NCT03447314|7163648|FG011|Part 1 (Up to 27 Months)|Lost to Follow-up|0
4385461|NCT03447314|7163649|FG012|Part 1 (Up to 27 Months)|Lost to Follow-up|0
4385462|NCT03447314|7163650|FG013|Part 1 (Up to 27 Months)|Lost to Follow-up|0
4385463|NCT03447314|7163651|FG014|Part 1 (Up to 27 Months)|Lost to Follow-up|0
4385464|NCT03447314|7163652|FG015|Part 1 (Up to 27 Months)|Lost to Follow-up|0
4385465|NCT03447314|7163653|FG016|Part 1 (Up to 27 Months)|Lost to Follow-up|0
4385466|NCT03447314|7163654|FG017|Part 1 (Up to 27 Months)|Lost to Follow-up|0
4385467|NCT03320330|7163711|FG000|Overall Study|Lack of Efficacy|5
4385468|NCT03320330|7163712|FG001|Overall Study|Lack of Efficacy|5
4385469|NCT03320330|7163713|FG002|Overall Study|Lack of Efficacy|14
4385470|NCT03320330|7163711|FG000|Overall Study|Physician Decision|1
4735224|NCT03522506|7683060|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0
4385471|NCT03320330|7163712|FG001|Overall Study|Physician Decision|0
4385472|NCT03320330|7163713|FG002|Overall Study|Physician Decision|0
4385473|NCT03271151|7163724|FG000|Overall Study|Lost to Follow-up|1
4385474|NCT03271151|7163725|FG001|Overall Study|Lost to Follow-up|3
4385475|NCT03271151|7163724|FG000|Overall Study|Withdrawal by Subject|1
4385476|NCT03271151|7163725|FG001|Overall Study|Withdrawal by Subject|0
4385477|NCT03141177|7163734|FG000|Overall Study|Death|62
4385478|NCT03141177|7163735|FG001|Overall Study|Death|13
4385479|NCT03141177|7163736|FG002|Overall Study|Death|84
4385480|NCT03141177|7163734|FG000|Overall Study|Participant withdrew consent|9
4385481|NCT03141177|7163735|FG001|Overall Study|Participant withdrew consent|2
4385482|NCT03141177|7163736|FG002|Overall Study|Participant withdrew consent|13
4385483|NCT03141177|7163734|FG000|Overall Study|Not reported|1
4385484|NCT03141177|7163735|FG001|Overall Study|Not reported|0
4385485|NCT03141177|7163736|FG002|Overall Study|Not reported|1
4385486|NCT03141177|7163734|FG000|Overall Study|Lost to Follow-up|2
4385487|NCT03141177|7163735|FG001|Overall Study|Lost to Follow-up|1
4385488|NCT03141177|7163736|FG002|Overall Study|Lost to Follow-up|1
4385489|NCT03141177|7163734|FG000|Overall Study|Other reasons|4
4385490|NCT03141177|7163735|FG001|Overall Study|Other reasons|0
4385491|NCT03141177|7163736|FG002|Overall Study|Other reasons|11
4385492|NCT03141177|7163734|FG000|Overall Study|Participants did not start treatment period|3
4385493|NCT03141177|7163735|FG001|Overall Study|Participants did not start treatment period|0
4385494|NCT03141177|7163736|FG002|Overall Study|Participants did not start treatment period|8
4385495|NCT03117049|7163747|FG000|Overall Study|Continued the follow-up period|109
4385496|NCT03117049|7163748|FG001|Overall Study|Continued the follow-up period|129
4385497|NCT03117049|7163747|FG000|Overall Study|Died|82
4385498|NCT03117049|7163748|FG001|Overall Study|Died|93
4385499|NCT03117049|7163747|FG000|Overall Study|Consent withdrawal|7
4385500|NCT03117049|7163748|FG001|Overall Study|Consent withdrawal|6
4385501|NCT03117049|7163747|FG000|Overall Study|Missing contact|3
4385502|NCT03117049|7163748|FG001|Overall Study|Missing contact|3
4385503|NCT03023813|7163757|FG000|Overall Study|Lost to Follow-up|1
4385504|NCT03023813|7163758|FG001|Overall Study|Lost to Follow-up|2
4385505|NCT03023813|7163759|FG002|Overall Study|Lost to Follow-up|0
4385506|NCT02993822|7163772|FG000|Overall Study|Lack of Efficacy|1
4385507|NCT02993822|7163773|FG001|Overall Study|Lack of Efficacy|1
4385508|NCT02993822|7163774|FG002|Overall Study|Lack of Efficacy|0
4385509|NCT02993822|7163775|FG003|Overall Study|Lack of Efficacy|0
4385510|NCT02993822|7163772|FG000|Overall Study|Protocol Violation|1
4385511|NCT02993822|7163773|FG001|Overall Study|Protocol Violation|0
4385512|NCT02993822|7163774|FG002|Overall Study|Protocol Violation|0
4385513|NCT02993822|7163775|FG003|Overall Study|Protocol Violation|0
4385514|NCT02993822|7163772|FG000|Overall Study|Unable to attend follow-up due to illness|0
4385515|NCT02993822|7163773|FG001|Overall Study|Unable to attend follow-up due to illness|0
4385516|NCT02993822|7163774|FG002|Overall Study|Unable to attend follow-up due to illness|0
4385517|NCT02993822|7163775|FG003|Overall Study|Unable to attend follow-up due to illness|1
4385518|NCT02993822|7163772|FG000|Overall Study|Adverse Event|3
4385519|NCT02993822|7163773|FG001|Overall Study|Adverse Event|1
4385520|NCT02993822|7163774|FG002|Overall Study|Adverse Event|7
4385521|NCT02993822|7163775|FG003|Overall Study|Adverse Event|0
4385522|NCT02993822|7163772|FG000|Overall Study|Withdrawal by Subject|4
4385523|NCT02993822|7163773|FG001|Overall Study|Withdrawal by Subject|2
4385524|NCT02993822|7163774|FG002|Overall Study|Withdrawal by Subject|2
4385525|NCT02993822|7163775|FG003|Overall Study|Withdrawal by Subject|3
4385526|NCT02993822|7163772|FG000|Overall Study|Lost to Follow-up|1
4385527|NCT02993822|7163773|FG001|Overall Study|Lost to Follow-up|0
4385528|NCT02993822|7163774|FG002|Overall Study|Lost to Follow-up|1
4385529|NCT02993822|7163775|FG003|Overall Study|Lost to Follow-up|0
4385530|NCT02753127|7163800|FG000|Overall Study|Lost to Follow-up|13
4385531|NCT02753127|7163801|FG001|Overall Study|Lost to Follow-up|11
4385532|NCT02753127|7163800|FG000|Overall Study|Withdrawal by Subject|37
4385533|NCT02753127|7163801|FG001|Overall Study|Withdrawal by Subject|47
4385534|NCT02753127|7163800|FG000|Overall Study|Other|3
4385535|NCT02753127|7163801|FG001|Overall Study|Other|8
4385536|NCT02753127|7163800|FG000|Overall Study|Hospice|0
4385537|NCT02753127|7163801|FG001|Overall Study|Hospice|2
4385538|NCT02460198|7163826|FG000|Overall Study|Adverse Event|1
4385539|NCT02460198|7163827|FG001|Overall Study|Adverse Event|3
4385540|NCT02460198|7163826|FG000|Overall Study|Death|36
4385541|NCT02460198|7163827|FG001|Overall Study|Death|28
4385542|NCT02460198|7163826|FG000|Overall Study|Lost to Follow-up|1
4385543|NCT02460198|7163827|FG001|Overall Study|Lost to Follow-up|1
4385544|NCT02460198|7163826|FG000|Overall Study|Transferred to Extension Study|15
4385545|NCT02460198|7163827|FG001|Overall Study|Transferred to Extension Study|15
4385546|NCT02460198|7163826|FG000|Overall Study|Withdrawal by Subject|2
4385547|NCT02460198|7163827|FG001|Overall Study|Withdrawal by Subject|4
4385548|NCT02460198|7163826|FG000|Overall Study|Site Terminated By Sponsor|0
4385549|NCT02460198|7163827|FG001|Overall Study|Site Terminated By Sponsor|1
4385550|NCT02460198|7163826|FG000|Overall Study|Did Not Continue on Extension Study|6
4385551|NCT02460198|7163827|FG001|Overall Study|Did Not Continue on Extension Study|11
4385552|NCT02421939|7163837|FG000|Overall Study|Progressive disease|70
4385553|NCT02421939|7163838|FG001|Overall Study|Progressive disease|16
4385554|NCT02421939|7163837|FG000|Overall Study|Lack of Efficacy|21
4385555|NCT02421939|7163838|FG001|Overall Study|Lack of Efficacy|31
4385556|NCT02421939|7163837|FG000|Overall Study|Death|36
4385557|NCT02421939|7163838|FG001|Overall Study|Death|10
4385558|NCT02421939|7163837|FG000|Overall Study|Disease relapse|33
4385559|NCT02421939|7163838|FG001|Overall Study|Disease relapse|2
4385560|NCT02421939|7163837|FG000|Overall Study|Adverse Event|28
4385561|NCT02421939|7163838|FG001|Overall Study|Adverse Event|5
4385562|NCT02421939|7163837|FG000|Overall Study|Withdrawal by Subject|5
4385563|NCT02421939|7163838|FG001|Overall Study|Withdrawal by Subject|24
4385564|NCT02421939|7163837|FG000|Overall Study|Physician Decision|11
4385565|NCT02421939|7163838|FG001|Overall Study|Physician Decision|11
4385566|NCT02421939|7163837|FG000|Overall Study|Completed 1 or 2 chemo cycles with CRs|0
4385567|NCT02421939|7163838|FG001|Overall Study|Completed 1 or 2 chemo cycles with CRs|19
4385568|NCT02421939|7163837|FG000|Overall Study|Miscellaneous|4
4385569|NCT02421939|7163838|FG001|Overall Study|Miscellaneous|5
4385570|NCT02421939|7163837|FG000|Overall Study|Protocol deviation|1
4385571|NCT02421939|7163838|FG001|Overall Study|Protocol deviation|1
4385572|NCT01892722|7163900|FG000|Overall Study|Protocol deviation|0
4385573|NCT01892722|7163901|FG001|Overall Study|Protocol deviation|1
4385574|NCT01892722|7163900|FG000|Overall Study|Administrative problems|0
4385575|NCT01892722|7163901|FG001|Overall Study|Administrative problems|1
4385576|NCT01892722|7163900|FG000|Overall Study|Patient/guardian decision|0
4385577|NCT01892722|7163901|FG001|Overall Study|Patient/guardian decision|2
4385578|NCT01892722|7163900|FG000|Overall Study|Physician Decision|1
4385579|NCT01892722|7163901|FG001|Overall Study|Physician Decision|2
4385580|NCT01892722|7163900|FG000|Overall Study|Adverse Event|3
4385581|NCT01892722|7163901|FG001|Overall Study|Adverse Event|2
4385582|NCT01892722|7163900|FG000|Overall Study|Lack of Efficacy|0
4385583|NCT01892722|7163901|FG001|Overall Study|Lack of Efficacy|7
4385584|NCT01892722|7163900|FG000|Overall Study|Withdrawal by Subject|3
4385585|NCT01892722|7163901|FG001|Overall Study|Withdrawal by Subject|5
4385586|NCT01516216|7163909|FG000|Overall Study|Adverse Event|2
4385587|NCT01516216|7163910|FG001|Overall Study|Adverse Event|4
4385588|NCT01516216|7163909|FG000|Overall Study|Disease Progression|38
4385589|NCT01516216|7163910|FG001|Overall Study|Disease Progression|34
4385590|NCT01516216|7163909|FG000|Overall Study|Withdrawal by Subject|9
4385591|NCT01516216|7163910|FG001|Overall Study|Withdrawal by Subject|11
4385592|NCT01516216|7163909|FG000|Overall Study|Potentially Curative Resection|6
4385593|NCT01516216|7163910|FG001|Overall Study|Potentially Curative Resection|12
4385594|NCT01516216|7163909|FG000|Overall Study|Nonadherence|2
4385595|NCT01516216|7163910|FG001|Overall Study|Nonadherence|3
4385596|NCT01516216|7163909|FG000|Overall Study|Physician Decision|6
4588941|NCT01506323|7433782|FG000|Overall Study|Lost to Follow-up|5
4697476|NCT02651116|7611045|FG000|Overall Study|Adverse Event|0
4385597|NCT01516216|7163910|FG001|Overall Study|Physician Decision|3
4385598|NCT01516216|7163909|FG000|Overall Study|Prolonged Treatment Delay|5
4385599|NCT01516216|7163910|FG001|Overall Study|Prolonged Treatment Delay|1
4385600|NCT01516216|7163909|FG000|Overall Study|Intercurrent Illness|1
4385601|NCT01516216|7163910|FG001|Overall Study|Intercurrent Illness|0
4385602|NCT01516216|7163909|FG000|Overall Study|Death|1
4385603|NCT01516216|7163910|FG001|Overall Study|Death|1
4385604|NCT00381641|7163926|FG000|Overall Study|Withdrawal by Subject|0
4385605|NCT00381641|7163927|FG001|Overall Study|Withdrawal by Subject|2
4469736|NCT00637377|7262753|FG000|Overall Study|Adverse Event|2
4469737|NCT00637377|7262754|FG001|Overall Study|Adverse Event|6
4469738|NCT00637377|7262755|FG002|Overall Study|Adverse Event|8
4469739|NCT00637377|7262756|FG003|Overall Study|Adverse Event|9
4469740|NCT00637377|7262753|FG000|Overall Study|Death|1
4469741|NCT00637377|7262754|FG001|Overall Study|Death|3
4469742|NCT00637377|7262755|FG002|Overall Study|Death|2
4469743|NCT00637377|7262756|FG003|Overall Study|Death|1
4469744|NCT00637377|7262753|FG000|Overall Study|Lack of Efficacy|0
4469745|NCT00637377|7262754|FG001|Overall Study|Lack of Efficacy|0
4469746|NCT00637377|7262755|FG002|Overall Study|Lack of Efficacy|1
4469747|NCT00637377|7262756|FG003|Overall Study|Lack of Efficacy|1
4469748|NCT00637377|7262753|FG000|Overall Study|Lost to Follow-up|4
4469749|NCT00637377|7262754|FG001|Overall Study|Lost to Follow-up|1
4469750|NCT00637377|7262755|FG002|Overall Study|Lost to Follow-up|2
4469751|NCT00637377|7262756|FG003|Overall Study|Lost to Follow-up|2
4469752|NCT00637377|7262753|FG000|Overall Study|Protocol Violation|2
4469753|NCT00637377|7262754|FG001|Overall Study|Protocol Violation|1
4469754|NCT00637377|7262755|FG002|Overall Study|Protocol Violation|1
4469755|NCT00637377|7262756|FG003|Overall Study|Protocol Violation|0
4697477|NCT02651116|7611046|FG001|Overall Study|Adverse Event|1
4469756|NCT00637377|7262753|FG000|Overall Study|Withdrawal by Subject|11
4469757|NCT00637377|7262754|FG001|Overall Study|Withdrawal by Subject|15
4469758|NCT00637377|7262755|FG002|Overall Study|Withdrawal by Subject|13
4469759|NCT00637377|7262756|FG003|Overall Study|Withdrawal by Subject|11
4469760|NCT00637377|7262753|FG000|Overall Study|Other (no further information available)|7
4469761|NCT00637377|7262754|FG001|Overall Study|Other (no further information available)|6
4469762|NCT00637377|7262755|FG002|Overall Study|Other (no further information available)|10
4469763|NCT00637377|7262756|FG003|Overall Study|Other (no further information available)|5
4469764|NCT00637572|7262777|FG000|Overall Study|Adverse Event|1
4469765|NCT00637572|7262778|FG001|Overall Study|Adverse Event|2
4469766|NCT00637572|7262777|FG000|Overall Study|Death|0
4469767|NCT00637572|7262778|FG001|Overall Study|Death|1
4385606|NCT00006184|7163939|FG000|Overall Study|Death|1
4385607|NCT00006184|7163940|FG001|Overall Study|Death|0
4385608|NCT00006237|7163952|FG000|Overall Study|Adverse Event|39
4385609|NCT00006237|7163953|FG001|Overall Study|Adverse Event|29
4385610|NCT00006237|7163952|FG000|Overall Study|Death|1
4385611|NCT00006237|7163953|FG001|Overall Study|Death|0
4385612|NCT00006237|7163952|FG000|Overall Study|Refusal unrelated to adverse effects|8
4385613|NCT00006237|7163953|FG001|Overall Study|Refusal unrelated to adverse effects|4
4385614|NCT00006237|7163952|FG000|Overall Study|Progression/relapse|54
4385615|NCT00006237|7163953|FG001|Overall Study|Progression/relapse|2
4385616|NCT00006237|7163952|FG000|Overall Study|Not eligible|9
4385617|NCT00006237|7163953|FG001|Overall Study|Not eligible|20
4385618|NCT00006237|7163952|FG000|Overall Study|Withdrawal by Subject|0
4385619|NCT00006237|7163953|FG001|Overall Study|Withdrawal by Subject|1
4385620|NCT00006237|7163952|FG000|Overall Study|Not protocol specified|14
4385621|NCT00006237|7163953|FG001|Overall Study|Not protocol specified|5
4385622|NCT00006289|7163968|FG000|First Intervention (5 Weeks)|Adverse Event|1
4385623|NCT00006289|7163969|FG001|First Intervention (5 Weeks)|Adverse Event|0
4385624|NCT00006289|7163968|FG000|Second Intervention (5 Weeks)|Protocol Violation|1
4385625|NCT00006289|7163969|FG001|Second Intervention (5 Weeks)|Protocol Violation|1
4385626|NCT00006305|7163989|FG000|Overall Study|Withdrawal by Subject|17
4385627|NCT00006305|7163990|FG001|Overall Study|Withdrawal by Subject|10
4385628|NCT00006305|7163991|FG002|Overall Study|Withdrawal by Subject|15
4385629|NCT00006305|7163992|FG003|Overall Study|Withdrawal by Subject|14
4385630|NCT00006389|7164002|FG000|Overall Study|Adverse Event|1
4385631|NCT00006392|7164011|FG000|Overall Study|Ineligible|11
4385632|NCT00006392|7164012|FG001|Overall Study|Ineligible|3
4385633|NCT00006392|7164013|FG002|Overall Study|Ineligible|5
4385634|NCT00006392|7164014|FG003|Overall Study|Ineligible|5
4385635|NCT00006392|7164011|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156
4385636|NCT00006392|7164012|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155
4385637|NCT00006392|7164013|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155
4385638|NCT00006392|7164014|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155
4385639|NCT00006409|7164039|FG000|Baseline|Protocol Violation|48
4385640|NCT00006409|7164040|FG001|Baseline|Protocol Violation|70
4385641|NCT00006409|7164041|FG002|Baseline|Protocol Violation|0
4385642|NCT00006409|7164042|FG003|Baseline|Protocol Violation|0
4385643|NCT00006409|7164043|FG004|Baseline|Protocol Violation|0
4385644|NCT00006409|7164044|FG005|Baseline|Protocol Violation|0
4385645|NCT00006409|7164039|FG000|Post-2 Year Intervention|Protocol Violation|0
4385646|NCT00006409|7164040|FG001|Post-2 Year Intervention|Protocol Violation|0
4385647|NCT00006409|7164041|FG002|Post-2 Year Intervention|Protocol Violation|251
4385648|NCT00006409|7164042|FG003|Post-2 Year Intervention|Protocol Violation|168
4385649|NCT00006409|7164043|FG004|Post-2 Year Intervention|Protocol Violation|0
4385650|NCT00006409|7164044|FG005|Post-2 Year Intervention|Protocol Violation|0
4385651|NCT00006409|7164039|FG000|Post-3 Year Intervention|Protocol Violation|0
4385652|NCT00006409|7164040|FG001|Post-3 Year Intervention|Protocol Violation|0
4385653|NCT00006409|7164041|FG002|Post-3 Year Intervention|Protocol Violation|0
4385654|NCT00006409|7164042|FG003|Post-3 Year Intervention|Protocol Violation|0
4385655|NCT00006409|7164043|FG004|Post-3 Year Intervention|Protocol Violation|62
4385656|NCT00006409|7164044|FG005|Post-3 Year Intervention|Protocol Violation|62
4385657|NCT00006489|7164071|FG000|Overall Study|Adverse Event|3
4385658|NCT00006489|7164072|FG001|Overall Study|Adverse Event|2
4385659|NCT00006489|7164073|FG002|Overall Study|Adverse Event|4
4385660|NCT00006489|7164074|FG003|Overall Study|Adverse Event|3
4385661|NCT00006489|7164071|FG000|Overall Study|Withdrawal by Subject|10
4385662|NCT00006489|7164072|FG001|Overall Study|Withdrawal by Subject|9
4385663|NCT00006489|7164073|FG002|Overall Study|Withdrawal by Subject|9
4385664|NCT00006489|7164074|FG003|Overall Study|Withdrawal by Subject|6
4385665|NCT00006489|7164071|FG000|Overall Study|Scheduling Conflict|0
4385666|NCT00006489|7164072|FG001|Overall Study|Scheduling Conflict|3
4385667|NCT00006489|7164073|FG002|Overall Study|Scheduling Conflict|2
4385668|NCT00006489|7164074|FG003|Overall Study|Scheduling Conflict|1
4385669|NCT00006489|7164071|FG000|Overall Study|Death|0
4385670|NCT00006489|7164072|FG001|Overall Study|Death|0
4385671|NCT00006489|7164073|FG002|Overall Study|Death|0
4385672|NCT00006489|7164074|FG003|Overall Study|Death|1
4385673|NCT00006604|7164091|FG000|Overall Study|Met study objective - no further FU|1
4385674|NCT00006604|7164092|FG001|Overall Study|Met study objective - no further FU|0
4385675|NCT00006604|7164093|FG002|Overall Study|Met study objective - no further FU|0
4385676|NCT00006604|7164094|FG003|Overall Study|Met study objective - no further FU|0
4385677|NCT00006604|7164095|FG004|Overall Study|Met study objective - no further FU|0
4385678|NCT00006604|7164096|FG005|Overall Study|Met study objective - no further FU|0
4385679|NCT00006604|7164097|FG006|Overall Study|Met study objective - no further FU|0
4385680|NCT00006604|7164098|FG007|Overall Study|Met study objective - no further FU|0
4385681|NCT00006604|7164099|FG008|Overall Study|Met study objective - no further FU|0
4385682|NCT00006604|7164100|FG009|Overall Study|Met study objective - no further FU|0
4385683|NCT00006604|7164101|FG010|Overall Study|Met study objective - no further FU|0
4385684|NCT00006604|7164102|FG011|Overall Study|Met study objective - no further FU|0
4385685|NCT00006604|7164103|FG012|Overall Study|Met study objective - no further FU|0
4385686|NCT00006604|7164104|FG013|Overall Study|Met study objective - no further FU|0
4385687|NCT00006604|7164105|FG014|Overall Study|Met study objective - no further FU|1
4385688|NCT00006604|7164106|FG015|Overall Study|Met study objective - no further FU|1
4385689|NCT00006604|7164107|FG016|Overall Study|Met study objective - no further FU|0
4385690|NCT00006604|7164091|FG000|Overall Study|Randomization entry error-no RX, no FU|0
4385691|NCT00006604|7164092|FG001|Overall Study|Randomization entry error-no RX, no FU|0
4385692|NCT00006604|7164093|FG002|Overall Study|Randomization entry error-no RX, no FU|0
4385693|NCT00006604|7164094|FG003|Overall Study|Randomization entry error-no RX, no FU|0
4385694|NCT00006604|7164095|FG004|Overall Study|Randomization entry error-no RX, no FU|0
4385695|NCT00006604|7164096|FG005|Overall Study|Randomization entry error-no RX, no FU|0
4385696|NCT00006604|7164097|FG006|Overall Study|Randomization entry error-no RX, no FU|0
4385697|NCT00006604|7164098|FG007|Overall Study|Randomization entry error-no RX, no FU|0
4385698|NCT00006604|7164099|FG008|Overall Study|Randomization entry error-no RX, no FU|0
4385699|NCT00006604|7164100|FG009|Overall Study|Randomization entry error-no RX, no FU|0
4385700|NCT00006604|7164101|FG010|Overall Study|Randomization entry error-no RX, no FU|0
4385701|NCT00006604|7164102|FG011|Overall Study|Randomization entry error-no RX, no FU|1
4697478|NCT02651116|7611045|FG000|Overall Study|No Longer Willing To Participate In Study|1
4697479|NCT02651116|7611046|FG001|Overall Study|No Longer Willing To Participate In Study|0
4697480|NCT02651155|7611054|FG000|Overall Study|Pretreatment Event/Adverse Event|1
4697481|NCT02651155|7611055|FG001|Overall Study|Pretreatment Event/Adverse Event|2
4697482|NCT02651155|7611054|FG000|Overall Study|Voluntary Withdrawal|5
4697483|NCT02651155|7611055|FG001|Overall Study|Voluntary Withdrawal|0
4697484|NCT02651194|7611061|FG000|Overall Study|Lost to Follow-up|3
4697485|NCT02651194|7611061|FG000|Overall Study|Other|2
4697486|NCT02651220|7611068|FG000|Overall Study|Adverse Event|1
4697487|NCT02651220|7611069|FG001|Overall Study|Adverse Event|5
4385702|NCT00006604|7164103|FG012|Overall Study|Randomization entry error-no RX, no FU|0
4385703|NCT00006604|7164104|FG013|Overall Study|Randomization entry error-no RX, no FU|0
4385704|NCT00006604|7164105|FG014|Overall Study|Randomization entry error-no RX, no FU|0
4385705|NCT00006604|7164106|FG015|Overall Study|Randomization entry error-no RX, no FU|0
4385706|NCT00006604|7164107|FG016|Overall Study|Randomization entry error-no RX, no FU|0
4385707|NCT00006604|7164091|FG000|Overall Study|Death|0
4469768|NCT00637572|7262777|FG000|Overall Study|Lost to Follow-up|0
4469769|NCT00637572|7262778|FG001|Overall Study|Lost to Follow-up|1
4469770|NCT00637572|7262777|FG000|Overall Study|Physician Decision|1
4469771|NCT00637572|7262778|FG001|Overall Study|Physician Decision|1
4469772|NCT00637572|7262777|FG000|Overall Study|Withdrawal by Subject|0
4469773|NCT00637572|7262778|FG001|Overall Study|Withdrawal by Subject|2
4469774|NCT00637572|7262777|FG000|Overall Study|Illicit Drug Use|1
4469775|NCT00637572|7262778|FG001|Overall Study|Illicit Drug Use|0
4469776|NCT00638027|7262808|FG000|Overall Study|Adverse Event|0
4469777|NCT00638027|7262809|FG001|Overall Study|Adverse Event|2
4469778|NCT00638157|7262817|FG000|Overall Study|Adverse Event|0
4469779|NCT00638157|7262818|FG001|Overall Study|Adverse Event|1
4469780|NCT00638157|7262817|FG000|Overall Study|Clinical (symptomatic) failure|1
4469781|NCT00638157|7262818|FG001|Overall Study|Clinical (symptomatic) failure|1
4469782|NCT00638157|7262817|FG000|Overall Study|Microbiological failure|1
4469783|NCT00638157|7262818|FG001|Overall Study|Microbiological failure|0
4469784|NCT00638157|7262817|FG000|Overall Study|Lost to Follow-up|1
4469785|NCT00638157|7262818|FG001|Overall Study|Lost to Follow-up|0
4469786|NCT00638157|7262817|FG000|Overall Study|Physician Decision|1
4469787|NCT00638157|7262818|FG001|Overall Study|Physician Decision|0
4469788|NCT00638157|7262817|FG000|Overall Study|Other|1
4469789|NCT00638157|7262818|FG001|Overall Study|Other|2
4469790|NCT00638157|7262817|FG000|Overall Study|Randomized, not treated|2
4469791|NCT00638157|7262818|FG001|Overall Study|Randomized, not treated|0
4469792|NCT00638183|7262825|FG000|Overall Study|Adverse Event|23
4469793|NCT00638183|7262825|FG000|Overall Study|Lack of Efficacy|14
4469794|NCT00638183|7262825|FG000|Overall Study|Physician Decision|9
4469795|NCT00638183|7262825|FG000|Overall Study|Lost to Follow-up|46
4469796|NCT00638183|7262825|FG000|Overall Study|Other reason not defined above|27
4469797|NCT00638235|7262838|FG000|Overall Study|Lost to Follow-up|31
4469798|NCT00638235|7262839|FG001|Overall Study|Lost to Follow-up|3
4469799|NCT00638235|7262840|FG002|Overall Study|Lost to Follow-up|18
4469800|NCT00638235|7262841|FG003|Overall Study|Lost to Follow-up|10
4469801|NCT00638235|7262842|FG004|Overall Study|Lost to Follow-up|13
4469802|NCT00638235|7262843|FG005|Overall Study|Lost to Follow-up|26
4469803|NCT00638235|7262844|FG006|Overall Study|Lost to Follow-up|0
4469804|NCT00638235|7262845|FG007|Overall Study|Lost to Follow-up|1
4469805|NCT00638235|7262846|FG008|Overall Study|Lost to Follow-up|18
4469806|NCT00638378|7262895|FG000|Overall Study|Death|2
4469807|NCT00638378|7262895|FG000|Overall Study|Adverse Event|1
4469808|NCT00638378|7262895|FG000|Overall Study|Disease progression|15
4469809|NCT00638378|7262895|FG000|Overall Study|Physician Decision|4
4469810|NCT00638404|7262901|FG000|Overall Study|Physician Decision|8
4469811|NCT00638404|7262902|FG001|Overall Study|Physician Decision|0
4469812|NCT00638443|7262912|FG000|First Intervention|Adverse Event|2
4469813|NCT00638443|7262913|FG001|First Intervention|Adverse Event|1
4697488|NCT02651220|7611070|FG002|Overall Study|Adverse Event|1
4697489|NCT02651220|7611068|FG000|Overall Study|Lost to Follow-up|8
4697490|NCT02651220|7611069|FG001|Overall Study|Lost to Follow-up|14
4469814|NCT00638456|7262923|FG000|Overall Study|Withdrawal by Subject|6
4385708|NCT00006604|7164092|FG001|Overall Study|Death|0
4385709|NCT00006604|7164093|FG002|Overall Study|Death|0
4385710|NCT00006604|7164094|FG003|Overall Study|Death|0
4385711|NCT00006604|7164095|FG004|Overall Study|Death|0
4385712|NCT00006604|7164096|FG005|Overall Study|Death|0
4385713|NCT00006604|7164097|FG006|Overall Study|Death|0
4385714|NCT00006604|7164098|FG007|Overall Study|Death|0
4385715|NCT00006604|7164099|FG008|Overall Study|Death|0
4385716|NCT00006604|7164100|FG009|Overall Study|Death|1
4385717|NCT00006604|7164101|FG010|Overall Study|Death|1
4385718|NCT00006604|7164102|FG011|Overall Study|Death|1
4385719|NCT00006604|7164103|FG012|Overall Study|Death|0
4385720|NCT00006604|7164104|FG013|Overall Study|Death|0
4385721|NCT00006604|7164105|FG014|Overall Study|Death|0
4385722|NCT00006604|7164106|FG015|Overall Study|Death|0
4385723|NCT00006604|7164107|FG016|Overall Study|Death|0
4385724|NCT00006604|7164091|FG000|Overall Study|Severe debilitation, unable to continue|0
4385725|NCT00006604|7164092|FG001|Overall Study|Severe debilitation, unable to continue|0
4385726|NCT00006604|7164093|FG002|Overall Study|Severe debilitation, unable to continue|0
4385727|NCT00006604|7164094|FG003|Overall Study|Severe debilitation, unable to continue|0
4385728|NCT00006604|7164095|FG004|Overall Study|Severe debilitation, unable to continue|0
4385729|NCT00006604|7164096|FG005|Overall Study|Severe debilitation, unable to continue|0
4385730|NCT00006604|7164097|FG006|Overall Study|Severe debilitation, unable to continue|3
4385731|NCT00006604|7164098|FG007|Overall Study|Severe debilitation, unable to continue|0
4697491|NCT02651220|7611070|FG002|Overall Study|Lost to Follow-up|14
4697492|NCT02651220|7611068|FG000|Overall Study|Non-Compliance with Study Drug|4
4697493|NCT02651220|7611069|FG001|Overall Study|Non-Compliance with Study Drug|0
4697494|NCT02651220|7611070|FG002|Overall Study|Non-Compliance with Study Drug|1
4697495|NCT02651220|7611068|FG000|Overall Study|Pregnancy|1
4697496|NCT02651220|7611069|FG001|Overall Study|Pregnancy|0
4697497|NCT02651220|7611070|FG002|Overall Study|Pregnancy|1
4697498|NCT02651220|7611068|FG000|Overall Study|Protocol Violation|0
4697499|NCT02651220|7611069|FG001|Overall Study|Protocol Violation|0
4697500|NCT02651220|7611070|FG002|Overall Study|Protocol Violation|1
4697501|NCT02651220|7611068|FG000|Overall Study|Withdrawal by Subject|5
4697502|NCT02651220|7611069|FG001|Overall Study|Withdrawal by Subject|6
4697503|NCT02651220|7611070|FG002|Overall Study|Withdrawal by Subject|8
4697504|NCT02651220|7611068|FG000|Overall Study|Miscellaneous|4
4697505|NCT02651220|7611069|FG001|Overall Study|Miscellaneous|1
4697506|NCT02651220|7611070|FG002|Overall Study|Miscellaneous|2
4697507|NCT02651220|7611068|FG000|Overall Study|Withdrawal by Parent/Guardian|0
4697508|NCT02651220|7611069|FG001|Overall Study|Withdrawal by Parent/Guardian|1
4697509|NCT02651220|7611070|FG002|Overall Study|Withdrawal by Parent/Guardian|1
4697510|NCT02651467|7611119|FG000|Overall Study|Withdrawal by Subject|0
4697511|NCT02651467|7611120|FG001|Overall Study|Withdrawal by Subject|0
4697512|NCT02651467|7611121|FG002|Overall Study|Withdrawal by Subject|2
4697513|NCT02651467|7611119|FG000|Overall Study|Other (Not specified)|1
4697514|NCT02651467|7611120|FG001|Overall Study|Other (Not specified)|0
4697515|NCT02651467|7611121|FG002|Overall Study|Other (Not specified)|2
4697516|NCT02651688|7611154|FG000|Overall Study|Non-compliance|0
4697517|NCT02651688|7611155|FG001|Overall Study|Non-compliance|0
4697518|NCT02651688|7611156|FG002|Overall Study|Non-compliance|1
4697519|NCT02651688|7611154|FG000|Overall Study|Principal Investigator (PI) decision|0
4697520|NCT02651688|7611155|FG001|Overall Study|Principal Investigator (PI) decision|2
4697521|NCT02651688|7611156|FG002|Overall Study|Principal Investigator (PI) decision|0
4697522|NCT02651688|7611154|FG000|Overall Study|Lost to Follow-up|1
4697523|NCT02651688|7611155|FG001|Overall Study|Lost to Follow-up|3
4697524|NCT02651688|7611156|FG002|Overall Study|Lost to Follow-up|0
4697525|NCT02651688|7611154|FG000|Overall Study|Withdrawal by Subject|1
4697526|NCT02651688|7611155|FG001|Overall Study|Withdrawal by Subject|0
4697527|NCT02651688|7611156|FG002|Overall Study|Withdrawal by Subject|2
4697528|NCT02651922|7611164|FG000|Overall Study|due to exclusion criteria|2
4697529|NCT02651987|7611170|FG000|Overall Study|Adverse Event|2
4697530|NCT02651987|7611171|FG001|Overall Study|Adverse Event|2
4697531|NCT02651987|7611170|FG000|Overall Study|Consent Withdrawn|2
4385732|NCT00006604|7164099|FG008|Overall Study|Severe debilitation, unable to continue|0
4385733|NCT00006604|7164100|FG009|Overall Study|Severe debilitation, unable to continue|5
4385734|NCT00006604|7164101|FG010|Overall Study|Severe debilitation, unable to continue|0
4385735|NCT00006604|7164102|FG011|Overall Study|Severe debilitation, unable to continue|2
4385736|NCT00006604|7164103|FG012|Overall Study|Severe debilitation, unable to continue|1
4385737|NCT00006604|7164104|FG013|Overall Study|Severe debilitation, unable to continue|0
4385738|NCT00006604|7164105|FG014|Overall Study|Severe debilitation, unable to continue|2
4385739|NCT00006604|7164106|FG015|Overall Study|Severe debilitation, unable to continue|0
4697532|NCT02651987|7611171|FG001|Overall Study|Consent Withdrawn|0
4697533|NCT02651987|7611170|FG000|Overall Study|Local PD|0
4697534|NCT02651987|7611171|FG001|Overall Study|Local PD|2
4385740|NCT00006604|7164107|FG016|Overall Study|Severe debilitation, unable to continue|0
4385741|NCT00006604|7164091|FG000|Overall Study|Subj/Parent not able to get to clinic|0
4697535|NCT02651987|7611170|FG000|Overall Study|Investigator Decision|1
4697536|NCT02651987|7611171|FG001|Overall Study|Investigator Decision|1
4697537|NCT02652156|7611183|FG000|Overall Study|Physician Decision|1
4697538|NCT02652156|7611184|FG001|Overall Study|Physician Decision|0
4385742|NCT00006604|7164092|FG001|Overall Study|Subj/Parent not able to get to clinic|0
4385743|NCT00006604|7164093|FG002|Overall Study|Subj/Parent not able to get to clinic|0
4385744|NCT00006604|7164094|FG003|Overall Study|Subj/Parent not able to get to clinic|1
4385745|NCT00006604|7164095|FG004|Overall Study|Subj/Parent not able to get to clinic|1
4385746|NCT00006604|7164096|FG005|Overall Study|Subj/Parent not able to get to clinic|0
4385747|NCT00006604|7164097|FG006|Overall Study|Subj/Parent not able to get to clinic|1
4385748|NCT00006604|7164098|FG007|Overall Study|Subj/Parent not able to get to clinic|0
4385749|NCT00006604|7164099|FG008|Overall Study|Subj/Parent not able to get to clinic|0
4385750|NCT00006604|7164100|FG009|Overall Study|Subj/Parent not able to get to clinic|1
4385751|NCT00006604|7164101|FG010|Overall Study|Subj/Parent not able to get to clinic|2
4385752|NCT00006604|7164102|FG011|Overall Study|Subj/Parent not able to get to clinic|1
4385753|NCT00006604|7164103|FG012|Overall Study|Subj/Parent not able to get to clinic|1
4385754|NCT00006604|7164104|FG013|Overall Study|Subj/Parent not able to get to clinic|1
4385755|NCT00006604|7164105|FG014|Overall Study|Subj/Parent not able to get to clinic|3
4385756|NCT00006604|7164106|FG015|Overall Study|Subj/Parent not able to get to clinic|0
4385757|NCT00006604|7164107|FG016|Overall Study|Subj/Parent not able to get to clinic|0
4385758|NCT00006604|7164091|FG000|Overall Study|Site closing|0
4385759|NCT00006604|7164092|FG001|Overall Study|Site closing|0
4385760|NCT00006604|7164093|FG002|Overall Study|Site closing|1
4385761|NCT00006604|7164094|FG003|Overall Study|Site closing|1
4385762|NCT00006604|7164095|FG004|Overall Study|Site closing|0
4385763|NCT00006604|7164096|FG005|Overall Study|Site closing|0
4385764|NCT00006604|7164097|FG006|Overall Study|Site closing|0
4385765|NCT00006604|7164098|FG007|Overall Study|Site closing|1
4385766|NCT00006604|7164099|FG008|Overall Study|Site closing|0
4385767|NCT00006604|7164100|FG009|Overall Study|Site closing|0
4385768|NCT00006604|7164101|FG010|Overall Study|Site closing|0
4385769|NCT00006604|7164102|FG011|Overall Study|Site closing|1
4385770|NCT00006604|7164103|FG012|Overall Study|Site closing|1
4385771|NCT00006604|7164104|FG013|Overall Study|Site closing|1
4385772|NCT00006604|7164105|FG014|Overall Study|Site closing|0
4385773|NCT00006604|7164106|FG015|Overall Study|Site closing|0
4385774|NCT00006604|7164107|FG016|Overall Study|Site closing|1
4385775|NCT00006604|7164091|FG000|Overall Study|Withdrawal by Subject|1
4385776|NCT00006604|7164092|FG001|Overall Study|Withdrawal by Subject|0
4385777|NCT00006604|7164093|FG002|Overall Study|Withdrawal by Subject|2
4385778|NCT00006604|7164094|FG003|Overall Study|Withdrawal by Subject|0
4385779|NCT00006604|7164095|FG004|Overall Study|Withdrawal by Subject|1
4385780|NCT00006604|7164096|FG005|Overall Study|Withdrawal by Subject|2
4385781|NCT00006604|7164097|FG006|Overall Study|Withdrawal by Subject|2
4385782|NCT00006604|7164098|FG007|Overall Study|Withdrawal by Subject|0
4385783|NCT00006604|7164099|FG008|Overall Study|Withdrawal by Subject|1
4385784|NCT00006604|7164100|FG009|Overall Study|Withdrawal by Subject|3
4385785|NCT00006604|7164101|FG010|Overall Study|Withdrawal by Subject|2
4385786|NCT00006604|7164102|FG011|Overall Study|Withdrawal by Subject|0
4385787|NCT00006604|7164103|FG012|Overall Study|Withdrawal by Subject|1
4385788|NCT00006604|7164104|FG013|Overall Study|Withdrawal by Subject|2
4385789|NCT00006604|7164105|FG014|Overall Study|Withdrawal by Subject|1
4385790|NCT00006604|7164106|FG015|Overall Study|Withdrawal by Subject|0
4385791|NCT00006604|7164107|FG016|Overall Study|Withdrawal by Subject|1
4385792|NCT00006604|7164091|FG000|Overall Study|Subj/parent not willing to adhere to req|0
4385793|NCT00006604|7164092|FG001|Overall Study|Subj/parent not willing to adhere to req|0
4469815|NCT00638456|7262924|FG001|Overall Study|Withdrawal by Subject|2
4469816|NCT00638508|7262932|FG000|Overall Study|Physician Decision|5
4469817|NCT00638508|7262933|FG001|Overall Study|Physician Decision|2
4469818|NCT00638690|7262950|FG000|Overall Study|Death|655
4469819|NCT00638690|7262951|FG001|Overall Study|Death|335
4469820|NCT00638690|7262950|FG000|Overall Study|Withdrawal by Subject|22
4469821|NCT00638690|7262951|FG001|Overall Study|Withdrawal by Subject|5
4469822|NCT00638690|7262950|FG000|Overall Study|Lost to Follow-up|4
4469823|NCT00638690|7262951|FG001|Overall Study|Lost to Follow-up|2
4469824|NCT00638846|7262977|FG000|Overall Study|Adverse Event|0
4469825|NCT00638846|7262978|FG001|Overall Study|Adverse Event|1
4469826|NCT00638846|7262977|FG000|Overall Study|Lost to Follow-up|3
4469827|NCT00638846|7262978|FG001|Overall Study|Lost to Follow-up|2
4588942|NCT01506323|7433783|FG001|Overall Study|Lost to Follow-up|4
4697539|NCT02652156|7611185|FG002|Overall Study|Physician Decision|0
4697540|NCT02652260|7611209|FG000|Overall Study|Pregnancy|0
4469828|NCT00638846|7262977|FG000|Overall Study|lens issue|1
4469829|NCT00638846|7262978|FG001|Overall Study|lens issue|3
4469830|NCT00638963|7263000|FG000|Overall Study|Withdrawal by Subject|1
4469831|NCT00638963|7263001|FG001|Overall Study|Withdrawal by Subject|0
4516489|NCT00960531|7327975|FG000|Overall Study|Withdrawal by Subject|1
4516490|NCT00960531|7327976|FG001|Overall Study|Withdrawal by Subject|0
4516491|NCT00960531|7327977|FG002|Overall Study|Withdrawal by Subject|5
4516492|NCT00960531|7327978|FG003|Overall Study|Withdrawal by Subject|2
4516493|NCT00960531|7327979|FG004|Overall Study|Withdrawal by Subject|0
4516494|NCT00960531|7327980|FG005|Overall Study|Withdrawal by Subject|0
4516495|NCT00960531|7327981|FG006|Overall Study|Withdrawal by Subject|2
4516496|NCT00960531|7327982|FG007|Overall Study|Withdrawal by Subject|0
4516497|NCT00960531|7327983|FG008|Overall Study|Withdrawal by Subject|1
4385794|NCT00006604|7164093|FG002|Overall Study|Subj/parent not willing to adhere to req|1
4385795|NCT00006604|7164094|FG003|Overall Study|Subj/parent not willing to adhere to req|3
4385796|NCT00006604|7164095|FG004|Overall Study|Subj/parent not willing to adhere to req|0
4385797|NCT00006604|7164096|FG005|Overall Study|Subj/parent not willing to adhere to req|0
4385798|NCT00006604|7164097|FG006|Overall Study|Subj/parent not willing to adhere to req|3
4385799|NCT00006604|7164098|FG007|Overall Study|Subj/parent not willing to adhere to req|1
4385800|NCT00006604|7164099|FG008|Overall Study|Subj/parent not willing to adhere to req|0
4385801|NCT00006604|7164100|FG009|Overall Study|Subj/parent not willing to adhere to req|6
4385802|NCT00006604|7164101|FG010|Overall Study|Subj/parent not willing to adhere to req|3
4385803|NCT00006604|7164102|FG011|Overall Study|Subj/parent not willing to adhere to req|0
4385804|NCT00006604|7164103|FG012|Overall Study|Subj/parent not willing to adhere to req|0
4385805|NCT00006604|7164104|FG013|Overall Study|Subj/parent not willing to adhere to req|2
4385806|NCT00006604|7164105|FG014|Overall Study|Subj/parent not willing to adhere to req|3
4385807|NCT00006604|7164106|FG015|Overall Study|Subj/parent not willing to adhere to req|3
4385808|NCT00006604|7164107|FG016|Overall Study|Subj/parent not willing to adhere to req|4
4385809|NCT00006604|7164091|FG000|Overall Study|Lost to Follow-up|0
4385810|NCT00006604|7164092|FG001|Overall Study|Lost to Follow-up|0
4385811|NCT00006604|7164093|FG002|Overall Study|Lost to Follow-up|0
4385812|NCT00006604|7164094|FG003|Overall Study|Lost to Follow-up|0
4385813|NCT00006604|7164095|FG004|Overall Study|Lost to Follow-up|0
4385814|NCT00006604|7164096|FG005|Overall Study|Lost to Follow-up|0
4385815|NCT00006604|7164097|FG006|Overall Study|Lost to Follow-up|0
4385816|NCT00006604|7164098|FG007|Overall Study|Lost to Follow-up|1
4385817|NCT00006604|7164099|FG008|Overall Study|Lost to Follow-up|0
4385818|NCT00006604|7164100|FG009|Overall Study|Lost to Follow-up|2
4385819|NCT00006604|7164101|FG010|Overall Study|Lost to Follow-up|0
4385820|NCT00006604|7164102|FG011|Overall Study|Lost to Follow-up|0
4385821|NCT00006604|7164103|FG012|Overall Study|Lost to Follow-up|0
4385822|NCT00006604|7164104|FG013|Overall Study|Lost to Follow-up|0
4385823|NCT00006604|7164105|FG014|Overall Study|Lost to Follow-up|0
4385824|NCT00006604|7164106|FG015|Overall Study|Lost to Follow-up|1
4385825|NCT00006604|7164107|FG016|Overall Study|Lost to Follow-up|3
4385826|NCT00006604|7164091|FG000|Overall Study|Other Reason|0
4385827|NCT00006604|7164092|FG001|Overall Study|Other Reason|0
4385828|NCT00006604|7164093|FG002|Overall Study|Other Reason|0
4385829|NCT00006604|7164094|FG003|Overall Study|Other Reason|0
4385830|NCT00006604|7164095|FG004|Overall Study|Other Reason|0
4385831|NCT00006604|7164096|FG005|Overall Study|Other Reason|1
4385832|NCT00006604|7164097|FG006|Overall Study|Other Reason|0
4385833|NCT00006604|7164098|FG007|Overall Study|Other Reason|0
4385834|NCT00006604|7164099|FG008|Overall Study|Other Reason|0
4385835|NCT00006604|7164100|FG009|Overall Study|Other Reason|1
4385836|NCT00006604|7164101|FG010|Overall Study|Other Reason|0
4385837|NCT00006604|7164102|FG011|Overall Study|Other Reason|0
4385838|NCT00006604|7164103|FG012|Overall Study|Other Reason|0
4385839|NCT00006604|7164104|FG013|Overall Study|Other Reason|0
4385840|NCT00006604|7164105|FG014|Overall Study|Other Reason|0
4385841|NCT00006604|7164106|FG015|Overall Study|Other Reason|0
4385842|NCT00006604|7164107|FG016|Overall Study|Other Reason|0
4385843|NCT00006721|7164133|FG000|Overall Study|Adverse Event|0
4385844|NCT00006721|7164134|FG001|Overall Study|Adverse Event|4
4385845|NCT00006721|7164135|FG002|Overall Study|Adverse Event|4
4385846|NCT00006721|7164133|FG000|Overall Study|Refusal Unrelated to Adverse Event|1
4385847|NCT00006721|7164134|FG001|Overall Study|Refusal Unrelated to Adverse Event|0
4385848|NCT00006721|7164135|FG002|Overall Study|Refusal Unrelated to Adverse Event|8
4385849|NCT00006721|7164133|FG000|Overall Study|Progression/Relapse|0
4385850|NCT00006721|7164134|FG001|Overall Study|Progression/Relapse|1
4385851|NCT00006721|7164135|FG002|Overall Study|Progression/Relapse|2
4385852|NCT00006721|7164133|FG000|Overall Study|Death|0
4385853|NCT00006721|7164134|FG001|Overall Study|Death|1
4385854|NCT00006721|7164135|FG002|Overall Study|Death|2
4385855|NCT00006721|7164133|FG000|Overall Study|Other - Not Protocol Specified|0
4385856|NCT00006721|7164134|FG001|Overall Study|Other - Not Protocol Specified|7
4385857|NCT00006721|7164135|FG002|Overall Study|Other - Not Protocol Specified|7
4385858|NCT00006721|7164133|FG000|Overall Study|Ineligible|2
4385859|NCT00006721|7164134|FG001|Overall Study|Ineligible|12
4385860|NCT00006721|7164135|FG002|Overall Study|Ineligible|10
4385861|NCT00006721|7164133|FG000|Overall Study|Eligible but no Treatment Received|1
4385862|NCT00006721|7164134|FG001|Overall Study|Eligible but no Treatment Received|0
4385863|NCT00006721|7164135|FG002|Overall Study|Eligible but no Treatment Received|0
4385864|NCT00006903|7164147|FG000|Overall Study|Still receiving treatment|0
4385865|NCT00006903|7164148|FG001|Overall Study|Still receiving treatment|0
4385866|NCT00006903|7164149|FG002|Overall Study|Still receiving treatment|1
4385867|NCT00006903|7164147|FG000|Overall Study|Refused further treatment|0
4385868|NCT00006903|7164148|FG001|Overall Study|Refused further treatment|2
4385869|NCT00006903|7164149|FG002|Overall Study|Refused further treatment|1
4385870|NCT00006903|7164147|FG000|Overall Study|Adverse Event|0
4385871|NCT00006903|7164148|FG001|Overall Study|Adverse Event|0
4385872|NCT00006903|7164149|FG002|Overall Study|Adverse Event|1
4385873|NCT00006903|7164147|FG000|Overall Study|Death|0
4385874|NCT00006903|7164148|FG001|Overall Study|Death|1
4385875|NCT00006903|7164149|FG002|Overall Study|Death|0
4385876|NCT00006903|7164147|FG000|Overall Study|Patient never treated|0
4385877|NCT00006903|7164148|FG001|Overall Study|Patient never treated|0
4385878|NCT00006903|7164149|FG002|Overall Study|Patient never treated|1
4385879|NCT00006903|7164147|FG000|Overall Study|Ineligible|10
4385880|NCT00006903|7164148|FG001|Overall Study|Ineligible|1
4385881|NCT00006903|7164149|FG002|Overall Study|Ineligible|2
4385882|NCT00007020|7164157|FG000|Overall Study|Death|16
4385883|NCT00007020|7164157|FG000|Overall Study|Lost to Follow-up|13
4385884|NCT00007020|7164157|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1
4385885|NCT00007020|7164157|FG000|Overall Study|Pt withdrawn (liver transplant)|4
4385886|NCT00007020|7164157|FG000|Overall Study|Pt cared for by outside physician|4
4385887|NCT00007020|7164157|FG000|Overall Study|No evidence of treatment|6
4385888|NCT00007345|7164165|FG000|Overall Study|Refused further treatment|0
4385889|NCT00007345|7164166|FG001|Overall Study|Refused further treatment|7
4385890|NCT00007345|7164165|FG000|Overall Study|Switched to alternative treatment|0
4385891|NCT00007345|7164166|FG001|Overall Study|Switched to alternative treatment|3
4385892|NCT00007345|7164165|FG000|Overall Study|Intercurrent illness|1
4385893|NCT00007345|7164166|FG001|Overall Study|Intercurrent illness|0
4385894|NCT00007345|7164165|FG000|Overall Study|Death on study|1
4385895|NCT00007345|7164166|FG001|Overall Study|Death on study|1
4385896|NCT00007475|7164175|FG000|Overall Study|Withdrawal by Subject|1
4385897|NCT00007475|7164176|FG001|Overall Study|Withdrawal by Subject|0
4385898|NCT00007475|7164177|FG002|Overall Study|Withdrawal by Subject|0
4385899|NCT00007475|7164178|FG003|Overall Study|Withdrawal by Subject|0
4385900|NCT00007475|7164175|FG000|Overall Study|Adverse Event|3
4385901|NCT00007475|7164176|FG001|Overall Study|Adverse Event|0
4385902|NCT00007475|7164177|FG002|Overall Study|Adverse Event|0
4385903|NCT00007475|7164178|FG003|Overall Study|Adverse Event|0
4385904|NCT00008138|7164197|FG000|Neoadjuvant Chemotherapy|Adverse Event|3
4385905|NCT00008138|7164197|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3
4385906|NCT00008138|7164197|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6
4385907|NCT00008138|7164197|FG000|Neoadjuvant Chemotherapy|not protocol specified|8
4385908|NCT00008138|7164197|FG000|Interval Debulking|Withdrawal by Subject|2
4385909|NCT00008138|7164197|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6
4385910|NCT00008138|7164197|FG000|Post-Cytoreduction Chemotherapy|Progression|1
4385911|NCT00008138|7164197|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1
4385912|NCT00008385|7164204|FG000|Overall Study|Off treatment reasons not reported|79
4385913|NCT00008385|7164205|FG001|Overall Study|Off treatment reasons not reported|70
4469832|NCT00638989|7263010|FG000|Overall Study|Lost to Follow-up|0
4469833|NCT00638989|7263011|FG001|Overall Study|Lost to Follow-up|0
4469834|NCT00638989|7263012|FG002|Overall Study|Lost to Follow-up|1
4469835|NCT00639002|7263022|FG000|Overall Study|Death|1
4469836|NCT00639002|7263022|FG000|Overall Study|Adverse Event|1
4469837|NCT00639002|7263022|FG000|Overall Study|Protocol Violation|1
4469838|NCT00639002|7263022|FG000|Overall Study|Disease progression|3
4697541|NCT02652260|7611210|FG001|Overall Study|Pregnancy|1
4697542|NCT02652260|7611209|FG000|Overall Study|Withdrawal by Subject|0
4697543|NCT02652260|7611210|FG001|Overall Study|Withdrawal by Subject|1
4469839|NCT00639002|7263022|FG000|Overall Study|Physician Decision|6
4469840|NCT00639002|7263022|FG000|Overall Study|Lack of Efficacy|1
4469841|NCT00639223|7263047|FG000|Overall Study|Lost to Follow-up|0
4469842|NCT00639223|7263048|FG001|Overall Study|Lost to Follow-up|2
4469843|NCT00639379|7263054|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2
4469844|NCT00639379|7263055|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0
4469845|NCT00639379|7263054|FG000|Period 1 - 2 Weeks|lens issue|3
4469846|NCT00639379|7263055|FG001|Period 1 - 2 Weeks|lens issue|0
4469847|NCT00639457|7263084|FG000|Overall Study|Withdrawal by Subject|2
4469848|NCT00639457|7263085|FG001|Overall Study|Withdrawal by Subject|3
4469849|NCT00639509|7263091|FG000|Overall Study|Death|1
4469850|NCT00639678|7263099|FG000|Overall Study|Withdrawal by Subject|3
4469851|NCT00639678|7263100|FG001|Overall Study|Withdrawal by Subject|0
4469852|NCT00639678|7263101|FG002|Overall Study|Withdrawal by Subject|4
4469853|NCT00639678|7263102|FG003|Overall Study|Withdrawal by Subject|0
4469854|NCT00639678|7263099|FG000|Overall Study|Lost to Follow-up|1
4469855|NCT00639678|7263100|FG001|Overall Study|Lost to Follow-up|0
4469856|NCT00639678|7263101|FG002|Overall Study|Lost to Follow-up|6
4469857|NCT00639678|7263102|FG003|Overall Study|Lost to Follow-up|0
4469858|NCT00639678|7263099|FG000|Overall Study|Adverse Event|0
4469859|NCT00639678|7263100|FG001|Overall Study|Adverse Event|1
4469860|NCT00639678|7263101|FG002|Overall Study|Adverse Event|0
4469861|NCT00639678|7263102|FG003|Overall Study|Adverse Event|0
4469862|NCT00639678|7263099|FG000|Overall Study|Lack of Compliance|0
4469863|NCT00639678|7263100|FG001|Overall Study|Lack of Compliance|0
4469864|NCT00639678|7263101|FG002|Overall Study|Lack of Compliance|1
4469865|NCT00639678|7263102|FG003|Overall Study|Lack of Compliance|0
4469866|NCT00639769|7263118|FG000|Overall Study|Death|2
4469867|NCT00639769|7263118|FG000|Overall Study|Adverse Event|7
4697544|NCT02652442|7611255|FG000|Centrifugation - Distance|Lost to Follow-up|1
4469868|NCT00639769|7263118|FG000|Overall Study|Lack of Efficacy|1
4469869|NCT00639769|7263118|FG000|Overall Study|Disease progression|26
4469870|NCT00639769|7263118|FG000|Overall Study|Withdrawal by Subject|4
4469871|NCT00640016|7263130|FG000|Overall Study|Withdrawal by Subject|0
4469872|NCT00640016|7263131|FG001|Overall Study|Withdrawal by Subject|1
4469873|NCT00640016|7263132|FG002|Overall Study|Withdrawal by Subject|0
4697545|NCT02652624|7611273|FG000|Randomized Phase|Pregnancy|3
4385914|NCT00008385|7164204|FG000|Overall Study|Progressive disease|52
4385915|NCT00008385|7164205|FG001|Overall Study|Progressive disease|117
4385916|NCT00008385|7164204|FG000|Overall Study|Adverse Event|8
4385917|NCT00008385|7164205|FG001|Overall Study|Adverse Event|20
4385918|NCT00008385|7164204|FG000|Overall Study|Death|12
4385919|NCT00008385|7164205|FG001|Overall Study|Death|18
4385920|NCT00008385|7164204|FG000|Overall Study|Withdrawal by Subject|67
4385921|NCT00008385|7164205|FG001|Overall Study|Withdrawal by Subject|157
4385922|NCT00008385|7164204|FG000|Overall Study|Start non-protocol therapy|3
4385923|NCT00008385|7164205|FG001|Overall Study|Start non-protocol therapy|1
4385924|NCT00008385|7164204|FG000|Overall Study|Other complicating disease|17
4385925|NCT00008385|7164205|FG001|Overall Study|Other complicating disease|30
4385926|NCT00008385|7164204|FG000|Overall Study|Maximum dose reached|0
4385927|NCT00008385|7164205|FG001|Overall Study|Maximum dose reached|2
4385928|NCT00008385|7164204|FG000|Overall Study|Other|105
4385929|NCT00008385|7164205|FG001|Overall Study|Other|212
4385930|NCT00008385|7164204|FG000|Overall Study|Not start protocol therapy|44
4385931|NCT00008385|7164205|FG001|Overall Study|Not start protocol therapy|175
4385932|NCT00009737|7164213|FG000|Overall Study|Adverse Event|112
4385933|NCT00009737|7164214|FG001|Overall Study|Adverse Event|75
4385934|NCT00009737|7164213|FG000|Overall Study|Death|4
4385935|NCT00009737|7164214|FG001|Overall Study|Death|6
4385936|NCT00009737|7164213|FG000|Overall Study|Lack of Efficacy|17
4385937|NCT00009737|7164214|FG001|Overall Study|Lack of Efficacy|15
4385938|NCT00009737|7164213|FG000|Overall Study|Violation of Selection Criteria at Entry|13
4385939|NCT00009737|7164214|FG001|Overall Study|Violation of Selection Criteria at Entry|9
4385940|NCT00009737|7164213|FG000|Overall Study|Other Protocol Violation|1
4385941|NCT00009737|7164214|FG001|Overall Study|Other Protocol Violation|0
4385942|NCT00009737|7164213|FG000|Overall Study|Refused Treatment|15
4385943|NCT00009737|7164214|FG001|Overall Study|Refused Treatment|16
4385944|NCT00009737|7164213|FG000|Overall Study|Lost to Follow-up|1
4385945|NCT00009737|7164214|FG001|Overall Study|Lost to Follow-up|1
4385946|NCT00009737|7164213|FG000|Overall Study|Administrative/Other Reasons|7
4385947|NCT00009737|7164214|FG001|Overall Study|Administrative/Other Reasons|1
4385948|NCT00009945|7164222|FG000|Overall Study|no follow up data|7
4385949|NCT00009945|7164223|FG001|Overall Study|no follow up data|5
4385950|NCT00010257|7164231|FG000|Overall Study|Withdrawal by Subject|1
4385951|NCT00010257|7164232|FG001|Overall Study|Withdrawal by Subject|0
4385952|NCT00010374|7164238|FG000|Overall Study|False positive phrenic nerve test|1
4385953|NCT00010803|7164249|FG000|Overall Study|Withdrawal by Subject|97
4385954|NCT00010803|7164250|FG001|Overall Study|Withdrawal by Subject|98
4385955|NCT00012012|7164284|FG000|Overall Study|Protocol Violation|1
4469874|NCT00640016|7263133|FG003|Overall Study|Withdrawal by Subject|0
4469875|NCT00640016|7263130|FG000|Overall Study|Study termination|2
4469876|NCT00640016|7263131|FG001|Overall Study|Study termination|1
4469877|NCT00640016|7263132|FG002|Overall Study|Study termination|3
4469878|NCT00640016|7263133|FG003|Overall Study|Study termination|2
4469879|NCT00640016|7263130|FG000|Overall Study|Adverse Event|0
4469880|NCT00640016|7263131|FG001|Overall Study|Adverse Event|0
4469881|NCT00640016|7263132|FG002|Overall Study|Adverse Event|0
4469882|NCT00640016|7263133|FG003|Overall Study|Adverse Event|1
4469883|NCT00640042|7263150|FG000|Enrollment|Did not receive study drug|83
4469884|NCT00640133|7263156|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1
4469885|NCT00640133|7263157|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0
4469886|NCT00640133|7263156|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1
4469887|NCT00640133|7263157|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0
4469888|NCT00640133|7263156|FG000|Open Label Phase (Month 4-12)|Adverse Event|1
4469889|NCT00640133|7263157|FG001|Open Label Phase (Month 4-12)|Adverse Event|0
4469890|NCT00640146|7263167|FG000|Overall Study|Adverse Event|2
4469891|NCT00640146|7263168|FG001|Overall Study|Adverse Event|0
4469892|NCT00640146|7263167|FG000|Overall Study|Lost to Follow-up|0
4469893|NCT00640146|7263168|FG001|Overall Study|Lost to Follow-up|1
4469894|NCT00640146|7263167|FG000|Overall Study|Lack of Efficacy|0
4469895|NCT00640146|7263168|FG001|Overall Study|Lack of Efficacy|1
4469896|NCT00640146|7263167|FG000|Overall Study|Withdrawal by Subject|1
4469897|NCT00640146|7263168|FG001|Overall Study|Withdrawal by Subject|1
4469898|NCT00640146|7263167|FG000|Overall Study|Randomized but not treated|1
4469899|NCT00640146|7263168|FG001|Overall Study|Randomized but not treated|3
4469900|NCT00640224|7263178|FG000|Overall Study|Lost to Follow-up|5
4469901|NCT00640224|7263179|FG001|Overall Study|Lost to Follow-up|2
4469902|NCT00640224|7263180|FG002|Overall Study|Lost to Follow-up|0
4469903|NCT00640224|7263181|FG003|Overall Study|Lost to Follow-up|0
4469904|NCT00640224|7263178|FG000|Overall Study|Withdrawal by Subject|1
4469905|NCT00640224|7263179|FG001|Overall Study|Withdrawal by Subject|0
4469906|NCT00640224|7263180|FG002|Overall Study|Withdrawal by Subject|0
4469907|NCT00640224|7263181|FG003|Overall Study|Withdrawal by Subject|0
4469908|NCT00640224|7263178|FG000|Overall Study|Headaches|0
4469909|NCT00640224|7263179|FG001|Overall Study|Headaches|1
4469910|NCT00640224|7263180|FG002|Overall Study|Headaches|0
4469911|NCT00640224|7263181|FG003|Overall Study|Headaches|0
4469912|NCT00640289|7263294|FG000|Overall Study|Death|3
4469913|NCT00640289|7263294|FG000|Overall Study|Withdrawal by Subject|1
4469914|NCT00640289|7263294|FG000|Overall Study|Lost to Follow-up|1
4469915|NCT00640289|7263294|FG000|Overall Study|Data collected under different amendment|2
4697546|NCT02652624|7611274|FG001|Randomized Phase|Pregnancy|1
4697547|NCT02652624|7611273|FG000|Randomized Phase|Investigator's Discretion|0
4697548|NCT02652624|7611274|FG001|Randomized Phase|Investigator's Discretion|2
4697549|NCT02652624|7611273|FG000|Randomized Phase|Death|0
4697550|NCT02652624|7611274|FG001|Randomized Phase|Death|1
4697551|NCT02652624|7611273|FG000|Randomized Phase|Lost to Follow-up|0
4385956|NCT00012012|7164285|FG001|Overall Study|Protocol Violation|1
4385957|NCT00012012|7164284|FG000|Overall Study|Withdrawal by Subject|0
4385958|NCT00012012|7164285|FG001|Overall Study|Withdrawal by Subject|2
4385959|NCT00013611|7164324|FG000|Overall Study|Lost to Follow-up|91
4385960|NCT00013611|7164325|FG001|Overall Study|Lost to Follow-up|100
4385961|NCT00014495|7164348|FG000|Overall Study|Death|0
4385962|NCT00014495|7164349|FG001|Overall Study|Death|0
4385963|NCT00014495|7164350|FG002|Overall Study|Death|1
4385964|NCT00014495|7164351|FG003|Overall Study|Death|0
4385965|NCT00014495|7164348|FG000|Overall Study|Clinical deterioration|0
4385966|NCT00014495|7164349|FG001|Overall Study|Clinical deterioration|0
4385967|NCT00014495|7164350|FG002|Overall Study|Clinical deterioration|0
4385968|NCT00014495|7164351|FG003|Overall Study|Clinical deterioration|1
4385969|NCT00014911|7164358|FG000|Overall Study|Adverse Event|1
4385970|NCT00014911|7164358|FG000|Overall Study|Lost to Follow-up|1
4385971|NCT00014911|7164358|FG000|Overall Study|Withdrawal by Subject|6
4385972|NCT00014911|7164358|FG000|Overall Study|Unknown Reasons|2
4385973|NCT00014911|7164358|FG000|Overall Study|Immunosuppression-related Side Effects|1
4385974|NCT00015457|7164362|FG000|First Intervention|Adverse Event|0
4385975|NCT00015457|7164363|FG001|First Intervention|Adverse Event|2
4385976|NCT00015457|7164362|FG000|First Intervention|Lack of Efficacy|0
4385977|NCT00015457|7164363|FG001|First Intervention|Lack of Efficacy|1
4385978|NCT00015457|7164362|FG000|Second Intervention|Withdrawal by Subject|1
4385979|NCT00015457|7164363|FG001|Second Intervention|Withdrawal by Subject|0
4385980|NCT00016354|7164373|FG000|Overall Study|Lack of Efficacy|0
4385981|NCT00016354|7164374|FG001|Overall Study|Lack of Efficacy|0
4385982|NCT00016354|7164375|FG002|Overall Study|Lack of Efficacy|0
4385983|NCT00016354|7164376|FG003|Overall Study|Lack of Efficacy|0
4385984|NCT00016354|7164377|FG004|Overall Study|Lack of Efficacy|0
4385985|NCT00016354|7164378|FG005|Overall Study|Lack of Efficacy|0
4385986|NCT00016354|7164379|FG006|Overall Study|Lack of Efficacy|0
4385987|NCT00016354|7164380|FG007|Overall Study|Lack of Efficacy|1
4385988|NCT00019604|7164409|FG000|Overall Study|Death|1
4385989|NCT00019604|7164409|FG000|Overall Study|Progressive disease|23
4385990|NCT00019604|7164409|FG000|Overall Study|Refused treatment|1
4385991|NCT00019604|7164409|FG000|Overall Study|Carcinoid tumor, not treatable|1
4385992|NCT00019604|7164409|FG000|Overall Study|Going to have liver transplant|1
4385993|NCT00019604|7164409|FG000|Overall Study|Move to a different study|1
4385994|NCT00019604|7164409|FG000|Overall Study|Non compliant on systemic CH|1
4385995|NCT00019604|7164409|FG000|Overall Study|Non compliant|1
4385996|NCT00019604|7164409|FG000|Overall Study|Resectable disease|1
4385997|NCT00019604|7164409|FG000|Overall Study|Started new chemo regimen|1
4385998|NCT00019604|7164409|FG000|Overall Study|Pt going to immunotherapy study|1
4385999|NCT00019604|7164409|FG000|Overall Study|Too much disease|1
4386000|NCT00019604|7164409|FG000|Overall Study|Unable to evaluate|1
4386001|NCT00019604|7164409|FG000|Overall Study|Details for other not available|4
4386002|NCT00021229|7164425|FG000|Overall Study|Adverse Event|10
4386003|NCT00021229|7164426|FG001|Overall Study|Adverse Event|5
4386004|NCT00021229|7164427|FG002|Overall Study|Adverse Event|2
4386005|NCT00021229|7164425|FG000|Overall Study|Death|0
4697552|NCT02652624|7611274|FG001|Randomized Phase|Lost to Follow-up|1
4697553|NCT02652624|7611273|FG000|Extension Phase|Lost to Follow-up|3
4697554|NCT02652624|7611274|FG001|Extension Phase|Lost to Follow-up|1
4697555|NCT02652624|7611273|FG000|Extension Phase|Pregnancy|1
4697556|NCT02652624|7611274|FG001|Extension Phase|Pregnancy|1
4386006|NCT00021229|7164426|FG001|Overall Study|Death|1
4386007|NCT00021229|7164427|FG002|Overall Study|Death|0
4386008|NCT00021229|7164425|FG000|Overall Study|Withdrawal by Subject|7
4386009|NCT00021229|7164426|FG001|Overall Study|Withdrawal by Subject|7
4386010|NCT00021229|7164427|FG002|Overall Study|Withdrawal by Subject|1
4386011|NCT00021229|7164425|FG000|Overall Study|Progressive Disease|15
4386012|NCT00021229|7164426|FG001|Overall Study|Progressive Disease|19
4386013|NCT00021229|7164427|FG002|Overall Study|Progressive Disease|12
4386014|NCT00021229|7164425|FG000|Overall Study|Protocol Violation|1
4386015|NCT00021229|7164426|FG001|Overall Study|Protocol Violation|1
4386016|NCT00021229|7164427|FG002|Overall Study|Protocol Violation|0
4386017|NCT00021229|7164425|FG000|Overall Study|Physician Decision|0
4386018|NCT00021229|7164426|FG001|Overall Study|Physician Decision|0
4386019|NCT00021229|7164427|FG002|Overall Study|Physician Decision|1
4386020|NCT00021229|7164425|FG000|Overall Study|Punctate hemmorrhage post RT|2
4386021|NCT00021229|7164426|FG001|Overall Study|Punctate hemmorrhage post RT|0
4386022|NCT00021229|7164427|FG002|Overall Study|Punctate hemmorrhage post RT|0
4386023|NCT00021255|7164440|FG000|Overall Study|Death|1
4386024|NCT00021255|7164441|FG001|Overall Study|Death|0
4386025|NCT00021255|7164442|FG002|Overall Study|Death|2
4386026|NCT00021255|7164440|FG000|Overall Study|Breast cancer relapse|5
4386027|NCT00021255|7164441|FG001|Overall Study|Breast cancer relapse|18
4386028|NCT00021255|7164442|FG002|Overall Study|Breast cancer relapse|11
4386029|NCT00021255|7164440|FG000|Overall Study|Second primary malignancy|0
4697557|NCT02652624|7611273|FG000|Extension Phase|Adverse Event|0
4697558|NCT02652624|7611274|FG001|Extension Phase|Adverse Event|1
4697559|NCT02652624|7611273|FG000|Extension Phase|Withdrew Consent|0
4697560|NCT02652624|7611274|FG001|Extension Phase|Withdrew Consent|1
4386030|NCT00021255|7164441|FG001|Overall Study|Second primary malignancy|4
4386031|NCT00021255|7164442|FG002|Overall Study|Second primary malignancy|1
4386032|NCT00021255|7164440|FG000|Overall Study|Withdrawal by Subject|41
4386033|NCT00021255|7164441|FG001|Overall Study|Withdrawal by Subject|64
4386034|NCT00021255|7164442|FG002|Overall Study|Withdrawal by Subject|26
4386035|NCT00021255|7164440|FG000|Overall Study|Lost to Follow-up|0
4386036|NCT00021255|7164441|FG001|Overall Study|Lost to Follow-up|2
4386037|NCT00021255|7164442|FG002|Overall Study|Lost to Follow-up|3
4386038|NCT00021255|7164440|FG000|Overall Study|Cardiac toxicity|0
4386039|NCT00021255|7164441|FG001|Overall Study|Cardiac toxicity|61
4386040|NCT00021255|7164442|FG002|Overall Study|Cardiac toxicity|32
4386041|NCT00021255|7164440|FG000|Overall Study|Herceptin toxicity|0
4386042|NCT00021255|7164441|FG001|Overall Study|Herceptin toxicity|22
4386043|NCT00021255|7164442|FG002|Overall Study|Herceptin toxicity|6
4386044|NCT00021255|7164440|FG000|Overall Study|Adverse Event|46
4386045|NCT00021255|7164441|FG001|Overall Study|Adverse Event|30
4386046|NCT00021255|7164442|FG002|Overall Study|Adverse Event|18
4386047|NCT00021255|7164440|FG000|Overall Study|Protocol Violation|0
4386048|NCT00021255|7164441|FG001|Overall Study|Protocol Violation|2
4386049|NCT00021255|7164442|FG002|Overall Study|Protocol Violation|0
4386050|NCT00021255|7164440|FG000|Overall Study|Other than specified above|0
4386051|NCT00021255|7164441|FG001|Overall Study|Other than specified above|38
4386052|NCT00021255|7164442|FG002|Overall Study|Other than specified above|19
4386053|NCT00021255|7164440|FG000|Overall Study|Missing|0
4386054|NCT00021255|7164441|FG001|Overall Study|Missing|27
4386055|NCT00021255|7164442|FG002|Overall Study|Missing|13
4386056|NCT00021255|7164440|FG000|Overall Study|Randomized but not treated|28
4386057|NCT00021255|7164441|FG001|Overall Study|Randomized but not treated|2
4386058|NCT00021255|7164442|FG002|Overall Study|Randomized but not treated|18
4386059|NCT00021541|7164452|FG000|Period 1-First Treatment|Withdrawal by Subject|3
4386060|NCT00021541|7164453|FG001|Period 1-First Treatment|Withdrawal by Subject|3
4386061|NCT00021541|7164452|FG000|Period 1-First Treatment|Adverse Event|2
4386062|NCT00021541|7164453|FG001|Period 1-First Treatment|Adverse Event|1
4386063|NCT00021541|7164452|FG000|Period 1-First Treatment|non-adherence|3
4386064|NCT00021541|7164453|FG001|Period 1-First Treatment|non-adherence|0
4386065|NCT00021541|7164452|FG000|Period 1-First Treatment|Death|1
4386066|NCT00021541|7164453|FG001|Period 1-First Treatment|Death|0
4386067|NCT00021541|7164452|FG000|Period 1-First Treatment|Pts that did not progress|2
4386068|NCT00021541|7164453|FG001|Period 1-First Treatment|Pts that did not progress|2
4386069|NCT00021541|7164452|FG000|Period 1-First Treatment|Ineligible|0
4386070|NCT00021541|7164453|FG001|Period 1-First Treatment|Ineligible|2
4697561|NCT02652767|7611282|FG000|Overall Study|Death|2
4697562|NCT02652767|7611282|FG000|Overall Study|Lost to Follow-up|1
4697563|NCT02652767|7611282|FG000|Overall Study|Withdrawal by Subject|1
4697564|NCT02653170|7611311|FG000|Overall Study|Withdrawal by Subject|3
4697565|NCT02653170|7611312|FG001|Overall Study|Withdrawal by Subject|8
4588943|NCT01506323|7433782|FG000|Overall Study|Withdrawal by Subject|4
4588944|NCT01506323|7433783|FG001|Overall Study|Withdrawal by Subject|4
4588945|NCT01506323|7433782|FG000|Overall Study|Lack of Efficacy|1
4588946|NCT01506323|7433783|FG001|Overall Study|Lack of Efficacy|3
4697566|NCT02653170|7611313|FG002|Overall Study|Withdrawal by Subject|3
4386071|NCT00021541|7164452|FG000|Period 2-crossover|refused phase B|2
4386072|NCT00021541|7164453|FG001|Period 2-crossover|refused phase B|2
4386073|NCT00021541|7164452|FG000|Period 2-crossover|Withdrawal by Subject|3
4386074|NCT00021541|7164453|FG001|Period 2-crossover|Withdrawal by Subject|4
4386075|NCT00021541|7164452|FG000|Period 2-crossover|Adverse Event|2
4386076|NCT00021541|7164453|FG001|Period 2-crossover|Adverse Event|2
4386077|NCT00021541|7164452|FG000|Period 2-crossover|non-adherence|1
4386078|NCT00021541|7164453|FG001|Period 2-crossover|non-adherence|0
4386079|NCT00021541|7164452|FG000|Period 2-crossover|Pts that did not progress|2
4386080|NCT00021541|7164453|FG001|Period 2-crossover|Pts that did not progress|3
4386081|NCT00022516|7164467|FG000|Overall Study|Adverse Event|0
4386082|NCT00022516|7164468|FG001|Overall Study|Adverse Event|59
4386083|NCT00022516|7164467|FG000|Overall Study|Lack of Efficacy|0
4386084|NCT00022516|7164468|FG001|Overall Study|Lack of Efficacy|27
4386085|NCT00022516|7164467|FG000|Overall Study|Physician Decision|0
4386086|NCT00022516|7164468|FG001|Overall Study|Physician Decision|1
4386087|NCT00022516|7164467|FG000|Overall Study|Protocol Violation|1
4386088|NCT00022516|7164468|FG001|Overall Study|Protocol Violation|3
4386089|NCT00022516|7164467|FG000|Overall Study|Withdrawal by Subject|2
4386090|NCT00022516|7164468|FG001|Overall Study|Withdrawal by Subject|113
4386091|NCT00022516|7164467|FG000|Overall Study|Incomplete documentation|0
4386092|NCT00022516|7164468|FG001|Overall Study|Incomplete documentation|27
4386093|NCT00022633|7164476|FG000|Overall Study|Adverse Event|11
4386094|NCT00022633|7164477|FG001|Overall Study|Adverse Event|1
4469916|NCT00640289|7263294|FG000|Overall Study|Transferred to another center|1
4469917|NCT00640289|7263294|FG000|Overall Study|Missing status|5
4469918|NCT00640315|7263300|FG000|Overall Study|Withdrawal by Subject|0
4697567|NCT02653170|7611311|FG000|Overall Study|withdrawn by study team|2
4697568|NCT02653170|7611312|FG001|Overall Study|withdrawn by study team|4
4386095|NCT00022633|7164476|FG000|Overall Study|Refusal unrelated to adverse event|1
4386096|NCT00022633|7164477|FG001|Overall Study|Refusal unrelated to adverse event|0
4386097|NCT00022633|7164476|FG000|Overall Study|Progression/relapse|9
4386098|NCT00022633|7164477|FG001|Overall Study|Progression/relapse|2
4386099|NCT00022633|7164476|FG000|Overall Study|Death|4
4386100|NCT00022633|7164477|FG001|Overall Study|Death|0
4386101|NCT00022633|7164476|FG000|Overall Study|Other - not protocol specified|3
4386102|NCT00022633|7164477|FG001|Overall Study|Other - not protocol specified|2
4386103|NCT00022633|7164476|FG000|Overall Study|Ineligible|4
4386104|NCT00022633|7164477|FG001|Overall Study|Ineligible|0
4386105|NCT00022659|7164482|FG000|Overall Study|Ineligible: wrong primary|1
4386106|NCT00022659|7164482|FG000|Overall Study|Never treated|1
4386107|NCT00022672|7164492|FG000|Main Phase: 24 Months|Adverse Event|6
4386108|NCT00022672|7164493|FG001|Main Phase: 24 Months|Adverse Event|0
4386109|NCT00022672|7164492|FG000|Main Phase: 24 Months|Death|0
4386110|NCT00022672|7164493|FG001|Main Phase: 24 Months|Death|3
4386111|NCT00022672|7164492|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75
4386112|NCT00022672|7164493|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91
4386113|NCT00022672|7164492|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0
4386114|NCT00022672|7164493|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1
4386115|NCT00022672|7164492|FG000|Main Phase: 24 Months|Other Protocol Violation|1
4386116|NCT00022672|7164493|FG001|Main Phase: 24 Months|Other Protocol Violation|0
4386117|NCT00022672|7164492|FG000|Main Phase: 24 Months|Refused Treatment|3
4386118|NCT00022672|7164493|FG001|Main Phase: 24 Months|Refused Treatment|4
4386119|NCT00022672|7164492|FG000|Main Phase: 24 Months|Failure to Return|1
4386120|NCT00022672|7164493|FG001|Main Phase: 24 Months|Failure to Return|1
4386121|NCT00022672|7164492|FG000|Main Phase: 24 Months|Other|1
4386122|NCT00022672|7164493|FG001|Main Phase: 24 Months|Other|0
4386123|NCT00022672|7164492|FG000|Extension Phase|Adverse Event|1
4386124|NCT00022672|7164493|FG001|Extension Phase|Adverse Event|3
4386125|NCT00022672|7164492|FG000|Extension Phase|Death|0
4386126|NCT00022672|7164493|FG001|Extension Phase|Death|1
4386127|NCT00022672|7164492|FG000|Extension Phase|Insufficient Therapeutic Response|1
4386128|NCT00022672|7164493|FG001|Extension Phase|Insufficient Therapeutic Response|44
4386129|NCT00022672|7164492|FG000|Extension Phase|Refused Treatment|0
4386130|NCT00022672|7164493|FG001|Extension Phase|Refused Treatment|2
4386131|NCT00022672|7164492|FG000|Extension Phase|Other|1
4386132|NCT00022672|7164493|FG001|Extension Phase|Other|1
4386133|NCT00022698|7164502|FG000|Overall Study|Adverse Event|5
4386134|NCT00022698|7164503|FG001|Overall Study|Adverse Event|9
4386135|NCT00022698|7164502|FG000|Overall Study|Death|0
4386136|NCT00022698|7164503|FG001|Overall Study|Death|2
4386137|NCT00022698|7164502|FG000|Overall Study|Failure to return|0
4386138|NCT00022698|7164503|FG001|Overall Study|Failure to return|1
4386139|NCT00022698|7164502|FG000|Overall Study|Refused treatment|0
4386140|NCT00022698|7164503|FG001|Overall Study|Refused treatment|2
4386141|NCT00022698|7164502|FG000|Overall Study|Insufficient therapeutic response|2
4386142|NCT00022698|7164503|FG001|Overall Study|Insufficient therapeutic response|14
4386143|NCT00022698|7164502|FG000|Overall Study|Administrative /other|1
4386144|NCT00022698|7164503|FG001|Overall Study|Administrative /other|7
4386145|NCT00022763|7164513|FG000|Overall Study|Adverse Event|1
4386146|NCT00022763|7164514|FG001|Overall Study|Adverse Event|2
4386147|NCT00022763|7164513|FG000|Overall Study|Injection Site Reactions|0
4386148|NCT00022763|7164514|FG001|Overall Study|Injection Site Reactions|2
4386149|NCT00022763|7164513|FG000|Overall Study|Death|0
4386150|NCT00022763|7164514|FG001|Overall Study|Death|1
4386151|NCT00022763|7164513|FG000|Overall Study|Lost to Follow-up|0
4386152|NCT00022763|7164514|FG001|Overall Study|Lost to Follow-up|3
4386153|NCT00022763|7164513|FG000|Overall Study|Withdrawal by Subject|4
4386154|NCT00022763|7164514|FG001|Overall Study|Withdrawal by Subject|7
4386155|NCT00022763|7164513|FG000|Overall Study|Insufficient Therapy|1
4386156|NCT00022763|7164514|FG001|Overall Study|Insufficient Therapy|0
4386157|NCT00022763|7164513|FG000|Overall Study|Admin|3
4386158|NCT00022763|7164514|FG001|Overall Study|Admin|2
4386159|NCT00023322|7164528|FG000|Overall Study|Lost to Follow-up|1
4386160|NCT00023452|7164534|FG000|Overall Study|Ineligible for Study|163
4386161|NCT00023452|7164535|FG001|Overall Study|Ineligible for Study|159
4386162|NCT00023452|7164534|FG000|Overall Study|Out of Window|129
4386163|NCT00023452|7164535|FG001|Overall Study|Out of Window|69
4386164|NCT00023452|7164534|FG000|Overall Study|Death|2
4386165|NCT00023452|7164535|FG001|Overall Study|Death|0
4386166|NCT00023452|7164534|FG000|Overall Study|Withdrawal by Subject|66
4386167|NCT00023452|7164535|FG001|Overall Study|Withdrawal by Subject|54
4386168|NCT00023452|7164534|FG000|Overall Study|Adverse Event|139
4386169|NCT00023452|7164535|FG001|Overall Study|Adverse Event|196
4588947|NCT01506323|7433782|FG000|Overall Study|Moved out of area|5
4386170|NCT00023452|7164534|FG000|Overall Study|Lost to Follow-up|293
4386171|NCT00023452|7164535|FG001|Overall Study|Lost to Follow-up|60
4386172|NCT00023452|7164534|FG000|Overall Study|Physician Decision|49
4386173|NCT00023452|7164535|FG001|Overall Study|Physician Decision|21
4386174|NCT00023452|7164534|FG000|Overall Study|Refused Treatment (continued follow-up)|225
4386175|NCT00023452|7164535|FG001|Overall Study|Refused Treatment (continued follow-up)|224
4386176|NCT00023452|7164534|FG000|Overall Study|Pregnant|53
4386177|NCT00023452|7164535|FG001|Overall Study|Pregnant|20
4386178|NCT00023452|7164534|FG000|Overall Study|Other|204
4386179|NCT00023452|7164535|FG001|Overall Study|Other|69
4386180|NCT00023595|7164550|FG000|5 Year Follow up|Lost to Follow-up|2
4386181|NCT00023595|7164551|FG001|5 Year Follow up|Lost to Follow-up|2
4386182|NCT00023595|7164552|FG002|5 Year Follow up|Lost to Follow-up|1
4386183|NCT00023595|7164553|FG003|5 Year Follow up|Lost to Follow-up|7
4386184|NCT00023595|7164554|FG004|5 Year Follow up|Lost to Follow-up|3
4386185|NCT00023595|7164550|FG000|10 Year Follow up|Lost to Follow-up|12
4386186|NCT00023595|7164551|FG001|10 Year Follow up|Lost to Follow-up|10
4386187|NCT00023595|7164552|FG002|10 Year Follow up|Lost to Follow-up|3
4386188|NCT00023595|7164553|FG003|10 Year Follow up|Lost to Follow-up|0
4386189|NCT00023595|7164554|FG004|10 Year Follow up|Lost to Follow-up|0
4386190|NCT00023673|7164580|FG000|Overall Study|Ineligible / no protocol treatment|0
4386191|NCT00023673|7164581|FG001|Overall Study|Ineligible / no protocol treatment|0
4386192|NCT00023673|7164582|FG002|Overall Study|Ineligible / no protocol treatment|0
4386193|NCT00023673|7164583|FG003|Overall Study|Ineligible / no protocol treatment|1
4386194|NCT00023673|7164580|FG000|Overall Study|Patient withdrew consent|0
4386195|NCT00023673|7164581|FG001|Overall Study|Patient withdrew consent|0
4386196|NCT00023673|7164582|FG002|Overall Study|Patient withdrew consent|0
4386197|NCT00023673|7164583|FG003|Overall Study|Patient withdrew consent|1
4386198|NCT00023712|7164595|FG000|Overall Study|Not platinum sensitive|1
4386199|NCT00023712|7164596|FG001|Overall Study|Not platinum sensitive|0
4386200|NCT00023712|7164595|FG000|Overall Study|Never treated|1
4386201|NCT00023712|7164596|FG001|Overall Study|Never treated|1
4386202|NCT00023764|7164612|FG000|Overall Study|Other|1
4386203|NCT00023764|7164612|FG000|Overall Study|Adverse Event|4
4386204|NCT00023764|7164612|FG000|Overall Study|Withdrawal by Subject|1
4386205|NCT00023764|7164612|FG000|Overall Study|Progression of disease|6
4386206|NCT00023764|7164612|FG000|Overall Study|patient received other treatment|1
4386207|NCT00023764|7164612|FG000|Overall Study|delay in obtaining staging images|1
4386208|NCT00024167|7164633|FG000|Overall Study|Death|53
4386209|NCT00024167|7164634|FG001|Overall Study|Death|47
4386210|NCT00024258|7164641|FG000|Overall Study|Withdrawal by Subject|1
4386211|NCT00024258|7164641|FG000|Overall Study|Disease Progression|8
4386212|NCT00025155|7164645|FG000|Overall Study|Ineligible: Wrong primary cancer site|1
4386213|NCT00025155|7164645|FG000|Overall Study|Ineligible: Second primary cancer site|1
4386214|NCT00025233|7164654|FG000|Overall Study|Ineligible: wrong cell type|1
4386215|NCT00025233|7164654|FG000|Overall Study|Ineligible: wrong primary|1
4386216|NCT00025233|7164654|FG000|Overall Study|Ineligible: improper prior treatment|1
4386217|NCT00025233|7164654|FG000|Overall Study|Never treated|1
4386218|NCT00025259|7164671|FG000|Overall Study|Death|1
4386219|NCT00025259|7164672|FG001|Overall Study|Death|3
4386220|NCT00025259|7164673|FG002|Overall Study|Death|0
4386221|NCT00025259|7164674|FG003|Overall Study|Death|3
4386222|NCT00025259|7164675|FG004|Overall Study|Death|0
4386223|NCT00025259|7164676|FG005|Overall Study|Death|1
4386224|NCT00025259|7164677|FG006|Overall Study|Death|2
4386225|NCT00025259|7164671|FG000|Overall Study|Lack of Efficacy|2
4386226|NCT00025259|7164672|FG001|Overall Study|Lack of Efficacy|46
4386227|NCT00025259|7164673|FG002|Overall Study|Lack of Efficacy|60
4386228|NCT00025259|7164674|FG003|Overall Study|Lack of Efficacy|78
4386229|NCT00025259|7164675|FG004|Overall Study|Lack of Efficacy|11
4386230|NCT00025259|7164676|FG005|Overall Study|Lack of Efficacy|30
4386231|NCT00025259|7164677|FG006|Overall Study|Lack of Efficacy|38
4386232|NCT00025259|7164671|FG000|Overall Study|Lost to Follow-up|2
4386233|NCT00025259|7164672|FG001|Overall Study|Lost to Follow-up|9
4386234|NCT00025259|7164673|FG002|Overall Study|Lost to Follow-up|13
4386235|NCT00025259|7164674|FG003|Overall Study|Lost to Follow-up|13
4386236|NCT00025259|7164675|FG004|Overall Study|Lost to Follow-up|1
4386237|NCT00025259|7164676|FG005|Overall Study|Lost to Follow-up|3
4386238|NCT00025259|7164677|FG006|Overall Study|Lost to Follow-up|1
4386239|NCT00025259|7164671|FG000|Overall Study|Physician Decision|12
4386240|NCT00025259|7164672|FG001|Overall Study|Physician Decision|1
4386241|NCT00025259|7164673|FG002|Overall Study|Physician Decision|0
4386242|NCT00025259|7164674|FG003|Overall Study|Physician Decision|5
4386243|NCT00025259|7164675|FG004|Overall Study|Physician Decision|4
4386244|NCT00025259|7164676|FG005|Overall Study|Physician Decision|2
4386245|NCT00025259|7164677|FG006|Overall Study|Physician Decision|1
4386246|NCT00025259|7164671|FG000|Overall Study|Protocol Violation|3
4386247|NCT00025259|7164672|FG001|Overall Study|Protocol Violation|2
4386248|NCT00025259|7164673|FG002|Overall Study|Protocol Violation|2
4386249|NCT00025259|7164674|FG003|Overall Study|Protocol Violation|1
4469919|NCT00640315|7263301|FG001|Overall Study|Withdrawal by Subject|1
4469920|NCT00640328|7263313|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0
4469921|NCT00640328|7263314|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1
4469922|NCT00640328|7263315|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0
4469923|NCT00640328|7263316|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0
4469924|NCT00640328|7263317|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0
4469925|NCT00640328|7263318|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0
4469926|NCT00640328|7263313|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0
4469927|NCT00640328|7263314|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0
4469928|NCT00640328|7263315|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0
4469929|NCT00640328|7263316|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0
4469930|NCT00640328|7263317|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1
4469931|NCT00640328|7263318|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0
4469932|NCT00640328|7263313|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
4469933|NCT00640328|7263314|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
4469934|NCT00640328|7263315|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1
4469935|NCT00640328|7263316|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
4469936|NCT00640328|7263317|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
4469937|NCT00640328|7263318|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
4469938|NCT00640328|7263313|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
4469939|NCT00640328|7263314|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1
4469940|NCT00640328|7263315|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
4469941|NCT00640328|7263316|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1
4469942|NCT00640328|7263317|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
4469943|NCT00640328|7263318|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
4469944|NCT00640341|7263342|FG000|Overall Study|Adverse Event|0
4469945|NCT00640341|7263343|FG001|Overall Study|Adverse Event|0
4469946|NCT00640341|7263344|FG002|Overall Study|Adverse Event|1
4469947|NCT00640341|7263342|FG000|Overall Study|Positive Slit Lamp Findings|0
4469948|NCT00640341|7263343|FG001|Overall Study|Positive Slit Lamp Findings|0
4469949|NCT00640341|7263344|FG002|Overall Study|Positive Slit Lamp Findings|1
4469950|NCT00640341|7263342|FG000|Overall Study|Study Related Symptoms/Complaints|2
4469951|NCT00640341|7263343|FG001|Overall Study|Study Related Symptoms/Complaints|1
4469952|NCT00640341|7263344|FG002|Overall Study|Study Related Symptoms/Complaints|2
4469953|NCT00640341|7263342|FG000|Overall Study|Inability to Maintain Wearing Schedule|1
4469954|NCT00640341|7263343|FG001|Overall Study|Inability to Maintain Wearing Schedule|1
4469955|NCT00640341|7263344|FG002|Overall Study|Inability to Maintain Wearing Schedule|0
4469956|NCT00640341|7263342|FG000|Overall Study|Failure to Follow Subject Instructions|1
4469957|NCT00640341|7263343|FG001|Overall Study|Failure to Follow Subject Instructions|0
4469958|NCT00640341|7263344|FG002|Overall Study|Failure to Follow Subject Instructions|0
4469959|NCT00640341|7263342|FG000|Overall Study|Lost to Follow-up|2
4469960|NCT00640341|7263343|FG001|Overall Study|Lost to Follow-up|0
4469961|NCT00640341|7263344|FG002|Overall Study|Lost to Follow-up|0
4469962|NCT00640341|7263342|FG000|Overall Study|Withdrawal by Subject|4
4469963|NCT00640341|7263343|FG001|Overall Study|Withdrawal by Subject|0
4469964|NCT00640341|7263344|FG002|Overall Study|Withdrawal by Subject|1
4469965|NCT00640341|7263342|FG000|Overall Study|Unacceptable Lens Movement|1
4469966|NCT00640341|7263343|FG001|Overall Study|Unacceptable Lens Movement|0
4469967|NCT00640341|7263344|FG002|Overall Study|Unacceptable Lens Movement|0
4469968|NCT00640341|7263342|FG000|Overall Study|Poor fit/Uncomfortable|4
4469969|NCT00640341|7263343|FG001|Overall Study|Poor fit/Uncomfortable|0
4469970|NCT00640341|7263344|FG002|Overall Study|Poor fit/Uncomfortable|0
4469971|NCT00640341|7263342|FG000|Overall Study|Ineligable at Baseline|5
4469972|NCT00640341|7263343|FG001|Overall Study|Ineligable at Baseline|3
4469973|NCT00640341|7263344|FG002|Overall Study|Ineligable at Baseline|2
4469974|NCT00640341|7263342|FG000|Overall Study|Adverse event and positive slit lamp|1
4469975|NCT00640341|7263343|FG001|Overall Study|Adverse event and positive slit lamp|0
4469976|NCT00640341|7263344|FG002|Overall Study|Adverse event and positive slit lamp|0
4469977|NCT00640393|7263352|FG000|Part 1|Lost to Follow-up|2
4469978|NCT00640393|7263353|FG001|Part 1|Lost to Follow-up|0
4469979|NCT00640393|7263354|FG002|Part 1|Lost to Follow-up|0
4469980|NCT00640393|7263352|FG000|Part 1|Withdrawal by Subject|3
4469981|NCT00640393|7263353|FG001|Part 1|Withdrawal by Subject|0
4469982|NCT00640393|7263354|FG002|Part 1|Withdrawal by Subject|0
4469983|NCT00640393|7263352|FG000|Randomization|Withdrawn per protocol|17
4469984|NCT00640393|7263353|FG001|Randomization|Withdrawn per protocol|0
4469985|NCT00640393|7263354|FG002|Randomization|Withdrawn per protocol|0
4469986|NCT00640393|7263352|FG000|Randomization|Never randomized by site|2
4469987|NCT00640393|7263353|FG001|Randomization|Never randomized by site|0
4469988|NCT00640393|7263354|FG002|Randomization|Never randomized by site|0
4469989|NCT00640393|7263352|FG000|Part 2|Lost to Follow-up|0
4469990|NCT00640393|7263353|FG001|Part 2|Lost to Follow-up|2
4469991|NCT00640393|7263354|FG002|Part 2|Lost to Follow-up|2
4469992|NCT00640393|7263352|FG000|Part 2|Withdrawal by Subject|0
4469993|NCT00640393|7263353|FG001|Part 2|Withdrawal by Subject|6
4469994|NCT00640393|7263354|FG002|Part 2|Withdrawal by Subject|1
4469995|NCT00640393|7263352|FG000|Part 2|Non-adherence|0
4469996|NCT00640393|7263353|FG001|Part 2|Non-adherence|1
4469997|NCT00640393|7263354|FG002|Part 2|Non-adherence|0
4469998|NCT00640393|7263352|FG000|Part 2|Adverse Event|0
4469999|NCT00640393|7263353|FG001|Part 2|Adverse Event|1
4470000|NCT00640393|7263354|FG002|Part 2|Adverse Event|0
4470001|NCT00640510|7263364|FG000|Overall Study|Lack of Efficacy|0
4470002|NCT00640510|7263365|FG001|Overall Study|Lack of Efficacy|1
4470003|NCT00640510|7263364|FG000|Overall Study|Protocol Violation|1
4470004|NCT00640510|7263365|FG001|Overall Study|Protocol Violation|0
4470005|NCT00640510|7263364|FG000|Overall Study|Physician Decision|0
4470006|NCT00640510|7263365|FG001|Overall Study|Physician Decision|1
4470007|NCT00640562|7263373|FG000|Overall Study|Adverse Event|8
4470008|NCT00640562|7263374|FG001|Overall Study|Adverse Event|5
4470009|NCT00640562|7263373|FG000|Overall Study|Lack of Efficacy|1
4470010|NCT00640562|7263374|FG001|Overall Study|Lack of Efficacy|4
4386250|NCT00025259|7164675|FG004|Overall Study|Protocol Violation|2
4386251|NCT00025259|7164676|FG005|Overall Study|Protocol Violation|1
4386252|NCT00025259|7164677|FG006|Overall Study|Protocol Violation|3
4386253|NCT00025259|7164671|FG000|Overall Study|Withdrawal by Subject|9
4386254|NCT00025259|7164672|FG001|Overall Study|Withdrawal by Subject|27
4386255|NCT00025259|7164673|FG002|Overall Study|Withdrawal by Subject|6
4386256|NCT00025259|7164674|FG003|Overall Study|Withdrawal by Subject|14
4386257|NCT00025259|7164675|FG004|Overall Study|Withdrawal by Subject|11
4386258|NCT00025259|7164676|FG005|Overall Study|Withdrawal by Subject|8
4386259|NCT00025259|7164677|FG006|Overall Study|Withdrawal by Subject|3
4386260|NCT00025259|7164671|FG000|Overall Study|Ineligible|14
4386261|NCT00025259|7164672|FG001|Overall Study|Ineligible|1
4386262|NCT00025259|7164673|FG002|Overall Study|Ineligible|0
4386263|NCT00025259|7164674|FG003|Overall Study|Ineligible|0
4386264|NCT00025259|7164675|FG004|Overall Study|Ineligible|6
4386265|NCT00025259|7164676|FG005|Overall Study|Ineligible|0
4386266|NCT00025259|7164677|FG006|Overall Study|Ineligible|1
4386267|NCT00025259|7164671|FG000|Overall Study|Randomization error|1
4386268|NCT00025259|7164672|FG001|Overall Study|Randomization error|0
4386269|NCT00025259|7164673|FG002|Overall Study|Randomization error|0
4386270|NCT00025259|7164674|FG003|Overall Study|Randomization error|0
4386271|NCT00025259|7164675|FG004|Overall Study|Randomization error|1
4386272|NCT00025259|7164676|FG005|Overall Study|Randomization error|7
4386273|NCT00025259|7164677|FG006|Overall Study|Randomization error|2
4386274|NCT00025259|7164671|FG000|Overall Study|Adverse Event|1
4386275|NCT00025259|7164672|FG001|Overall Study|Adverse Event|0
4386276|NCT00025259|7164673|FG002|Overall Study|Adverse Event|0
4386277|NCT00025259|7164674|FG003|Overall Study|Adverse Event|0
4386278|NCT00025259|7164675|FG004|Overall Study|Adverse Event|0
4386279|NCT00025259|7164676|FG005|Overall Study|Adverse Event|0
4386280|NCT00025259|7164677|FG006|Overall Study|Adverse Event|0
4386281|NCT00025506|7164696|FG000|Overall Study|Ineligible: clerical error|1
4386282|NCT00025506|7164696|FG000|Overall Study|Ineligible: wrong cell type|5
4386283|NCT00025506|7164696|FG000|Overall Study|Ineligible: inadequate pathology|2
4386284|NCT00025506|7164696|FG000|Overall Study|Never Treated|2
4386285|NCT00025662|7164705|FG000|Overall Study|Withdrawal by Subject|2
4386286|NCT00025662|7164705|FG000|Overall Study|Technical failure of manipulation|1
4386287|NCT00025883|7164711|FG000|Overall Study|had atypical progeriod lipodystrophy|4
4386288|NCT00025883|7164711|FG000|Overall Study|no baseline data|1
4386289|NCT00025883|7164711|FG000|Overall Study|Death|1
4386290|NCT00025883|7164711|FG000|Overall Study|Adverse Event|1
4386291|NCT00025883|7164711|FG000|Overall Study|didn't reach 6 months of Metreleptin|10
4386292|NCT00026208|7164718|FG000|Overall Study|Complications of auto accident|1
4386293|NCT00026208|7164719|FG001|Overall Study|Complications of auto accident|0
4386294|NCT00026494|7164742|FG000|Overall Study|Withdrawal by Subject|1
4386295|NCT00026494|7164743|FG001|Overall Study|Withdrawal by Subject|0
4386296|NCT00026494|7164744|FG002|Overall Study|Withdrawal by Subject|1
4386297|NCT00026494|7164745|FG003|Overall Study|Withdrawal by Subject|0
4386298|NCT00026494|7164742|FG000|Overall Study|Patient non-compliance|1
4386299|NCT00026494|7164743|FG001|Overall Study|Patient non-compliance|0
4386300|NCT00026494|7164744|FG002|Overall Study|Patient non-compliance|0
4386301|NCT00026494|7164745|FG003|Overall Study|Patient non-compliance|0
4386302|NCT00026494|7164742|FG000|Overall Study|Patient not treated|0
4386303|NCT00026494|7164743|FG001|Overall Study|Patient not treated|0
4386304|NCT00026494|7164744|FG002|Overall Study|Patient not treated|2
4386305|NCT00026494|7164745|FG003|Overall Study|Patient not treated|0
4386306|NCT00026494|7164742|FG000|Overall Study|Clinical progression|0
4386307|NCT00026494|7164743|FG001|Overall Study|Clinical progression|0
4386308|NCT00026494|7164744|FG002|Overall Study|Clinical progression|3
4386309|NCT00026494|7164745|FG003|Overall Study|Clinical progression|0
4386310|NCT00026793|7164755|FG000|Overall Study|Death on study due to underlying disease|4
4386311|NCT00026793|7164755|FG000|Overall Study|Physician Decision|2
4386312|NCT00026793|7164755|FG000|Overall Study|Off study|2
4386313|NCT00027027|7164764|FG000|Overall Study|Adverse Event|0
4386314|NCT00027027|7164765|FG001|Overall Study|Adverse Event|0
4386315|NCT00027027|7164766|FG002|Overall Study|Adverse Event|1
4386316|NCT00027027|7164767|FG003|Overall Study|Adverse Event|0
4386317|NCT00027027|7164768|FG004|Overall Study|Adverse Event|1
4386318|NCT00027027|7164764|FG000|Overall Study|Admitted for Signs of PD|0
4386319|NCT00027027|7164765|FG001|Overall Study|Admitted for Signs of PD|0
4386320|NCT00027027|7164766|FG002|Overall Study|Admitted for Signs of PD|0
4386321|NCT00027027|7164767|FG003|Overall Study|Admitted for Signs of PD|0
4386322|NCT00027027|7164768|FG004|Overall Study|Admitted for Signs of PD|1
4386323|NCT00027027|7164764|FG000|Overall Study|Clinical Symptoms Progression not PD|1
4386324|NCT00027027|7164765|FG001|Overall Study|Clinical Symptoms Progression not PD|0
4386325|NCT00027027|7164766|FG002|Overall Study|Clinical Symptoms Progression not PD|0
4386326|NCT00027027|7164767|FG003|Overall Study|Clinical Symptoms Progression not PD|0
4386327|NCT00027027|7164768|FG004|Overall Study|Clinical Symptoms Progression not PD|0
4386328|NCT00027027|7164764|FG000|Overall Study|PD Requiring Surgery|0
4386329|NCT00027027|7164765|FG001|Overall Study|PD Requiring Surgery|0
4470011|NCT00640562|7263373|FG000|Overall Study|Protocol Violation|2
4470012|NCT00640562|7263374|FG001|Overall Study|Protocol Violation|4
4470013|NCT00640562|7263373|FG000|Overall Study|Withdrawal by Subject|6
4470014|NCT00640562|7263374|FG001|Overall Study|Withdrawal by Subject|10
4470015|NCT00640562|7263373|FG000|Overall Study|Known risperidone intolerance|0
4470016|NCT00640562|7263374|FG001|Overall Study|Known risperidone intolerance|1
4470017|NCT00640562|7263373|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0
4470018|NCT00640562|7263374|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1
4470019|NCT00640562|7263373|FG000|Overall Study|Low study drug dose|0
4470020|NCT00640562|7263374|FG001|Overall Study|Low study drug dose|1
4470021|NCT00640562|7263373|FG000|Overall Study|Glycosylated Hemoglobin >8|1
4470022|NCT00640562|7263374|FG001|Overall Study|Glycosylated Hemoglobin >8|0
4470023|NCT00640601|7263380|FG000|Overall Study|Adverse Event|43
4470024|NCT00640601|7263380|FG000|Overall Study|Withdrawal by Subject|20
4470025|NCT00640601|7263380|FG000|Overall Study|Protocol Violation|6
4470026|NCT00640601|7263380|FG000|Overall Study|Lack of Efficacy|16
4470027|NCT00640601|7263380|FG000|Overall Study|Lost to Follow-up|9
4470028|NCT00640601|7263380|FG000|Overall Study|Physician Decision|8
4470029|NCT00640601|7263380|FG000|Overall Study|treatment naive, combination therapy|10
4470030|NCT00640614|7263386|FG000|Overall Study|Lost to Follow-up|1
4470031|NCT00640614|7263387|FG001|Overall Study|Lost to Follow-up|0
4470032|NCT00640835|7263452|FG000|Overall Study|Adverse Event|5
4470033|NCT00640835|7263453|FG001|Overall Study|Adverse Event|3
4470034|NCT00640835|7263452|FG000|Overall Study|Withdrawal by Subject|12
4470035|NCT00640835|7263453|FG001|Overall Study|Withdrawal by Subject|14
4470036|NCT00640835|7263452|FG000|Overall Study|Physician Decision|10
4470037|NCT00640835|7263453|FG001|Overall Study|Physician Decision|14
4470038|NCT00640835|7263452|FG000|Overall Study|Sponsor's Decision|11
4470039|NCT00640835|7263453|FG001|Overall Study|Sponsor's Decision|7
4470040|NCT00640835|7263452|FG000|Overall Study|Protocol Violation|2
4470041|NCT00640835|7263453|FG001|Overall Study|Protocol Violation|2
4470042|NCT00640835|7263452|FG000|Overall Study|Lost to Follow-up|17
4470043|NCT00640835|7263453|FG001|Overall Study|Lost to Follow-up|13
4470044|NCT00640835|7263452|FG000|Overall Study|Other Reason|19
4470045|NCT00640835|7263453|FG001|Overall Study|Other Reason|4
4470046|NCT00640926|7263462|FG000|Overall Study|Adverse Event|2
4470047|NCT00640926|7263463|FG001|Overall Study|Adverse Event|3
4470048|NCT00640926|7263464|FG002|Overall Study|Adverse Event|2
4470049|NCT00640926|7263462|FG000|Overall Study|Lack of Efficacy|0
4470050|NCT00640926|7263463|FG001|Overall Study|Lack of Efficacy|2
4470051|NCT00640926|7263464|FG002|Overall Study|Lack of Efficacy|1
4470052|NCT00640926|7263462|FG000|Overall Study|Protocol Violation|2
4470053|NCT00640926|7263463|FG001|Overall Study|Protocol Violation|0
4470054|NCT00640926|7263464|FG002|Overall Study|Protocol Violation|2
4588948|NCT01506323|7433783|FG001|Overall Study|Moved out of area|2
4588949|NCT01506323|7433782|FG000|Overall Study|Schedule or Transportation conflict|8
4588950|NCT01506323|7433783|FG001|Overall Study|Schedule or Transportation conflict|0
4588951|NCT01506323|7433782|FG000|Overall Study|Started another treatment|1
4588952|NCT01506323|7433783|FG001|Overall Study|Started another treatment|0
4588953|NCT01506453|7433800|FG000|Overall Study|Withdrawal prior to treatment|0
4588954|NCT01506453|7433801|FG001|Overall Study|Withdrawal prior to treatment|2
4588955|NCT01506479|7433810|FG000|Overall Study|Lost to Follow-up|1
4470055|NCT00640926|7263462|FG000|Overall Study|Lost to Follow-up|3
4470056|NCT00640926|7263463|FG001|Overall Study|Lost to Follow-up|1
4470057|NCT00640926|7263464|FG002|Overall Study|Lost to Follow-up|2
4470058|NCT00640926|7263462|FG000|Overall Study|Withdrawal by Subject|1
4470059|NCT00640926|7263463|FG001|Overall Study|Withdrawal by Subject|0
4470060|NCT00640926|7263464|FG002|Overall Study|Withdrawal by Subject|1
4470061|NCT00641043|7263478|FG000|Overall Study|Adverse Event|6
4470062|NCT00641043|7263479|FG001|Overall Study|Adverse Event|4
4470063|NCT00641043|7263478|FG000|Overall Study|Protocol Violation|2
4470064|NCT00641043|7263479|FG001|Overall Study|Protocol Violation|3
4470065|NCT00641043|7263478|FG000|Overall Study|Lost to Follow-up|3
4470066|NCT00641043|7263479|FG001|Overall Study|Lost to Follow-up|2
4470067|NCT00641043|7263478|FG000|Overall Study|Withdrawal by Subject|4
4470068|NCT00641043|7263479|FG001|Overall Study|Withdrawal by Subject|4
4470069|NCT00641043|7263478|FG000|Overall Study|Other incl. lack of efficacy|4
4470070|NCT00641043|7263479|FG001|Overall Study|Other incl. lack of efficacy|2
4470071|NCT00641056|7263487|FG000|Overall Study|Adverse Event|12
4470072|NCT00641056|7263488|FG001|Overall Study|Adverse Event|2
4470073|NCT00641056|7263487|FG000|Overall Study|Lost to Follow-up|2
4470074|NCT00641056|7263488|FG001|Overall Study|Lost to Follow-up|1
4470075|NCT00641056|7263487|FG000|Overall Study|Physician Decision|3
4470076|NCT00641056|7263488|FG001|Overall Study|Physician Decision|1
4470077|NCT00641056|7263487|FG000|Overall Study|Protocol Violation|2
4470078|NCT00641056|7263488|FG001|Overall Study|Protocol Violation|0
4470079|NCT00641056|7263487|FG000|Overall Study|Entry Criteria Not Met|3
4470080|NCT00641056|7263488|FG001|Overall Study|Entry Criteria Not Met|0
4470081|NCT00641056|7263487|FG000|Overall Study|Subject Decision|6
4470082|NCT00641056|7263488|FG001|Overall Study|Subject Decision|19
4470083|NCT00641056|7263487|FG000|Overall Study|Sponsor Decision|1
4470084|NCT00641056|7263488|FG001|Overall Study|Sponsor Decision|2
4470085|NCT00641147|7263500|FG000|Completed 4 Months.|Physician Decision|1
4470086|NCT00641147|7263501|FG001|Completed 4 Months.|Physician Decision|0
4470087|NCT00641147|7263500|FG000|Completed 4 Months.|Adverse Event|1
4470088|NCT00641147|7263501|FG001|Completed 4 Months.|Adverse Event|0
4470089|NCT00641147|7263500|FG000|Completed 8 Months.|Physician Decision|2
4470090|NCT00641147|7263501|FG001|Completed 8 Months.|Physician Decision|1
4470091|NCT00641147|7263500|FG000|Completed 8 Months.|non compliance|1
4470092|NCT00641147|7263501|FG001|Completed 8 Months.|non compliance|0
4470093|NCT00641147|7263500|FG000|Completed 8 Months.|Withdrawal by Subject|0
4470094|NCT00641147|7263501|FG001|Completed 8 Months.|Withdrawal by Subject|1
4470095|NCT00641147|7263500|FG000|Completed 12 Months.|Physician Decision|1
4470096|NCT00641147|7263501|FG001|Completed 12 Months.|Physician Decision|1
4470097|NCT00641147|7263500|FG000|Completed 12 Months.|Withdrawal by Subject|0
4470098|NCT00641147|7263501|FG001|Completed 12 Months.|Withdrawal by Subject|1
4470099|NCT00641147|7263500|FG000|Completed 16 Months.|Physician Decision|1
4470100|NCT00641147|7263501|FG001|Completed 16 Months.|Physician Decision|0
4470101|NCT00641147|7263500|FG000|Completed 16 Months.|Lost to Follow-up|1
4470102|NCT00641147|7263501|FG001|Completed 16 Months.|Lost to Follow-up|0
4470103|NCT00641667|7263522|FG000|Overall Study|Withdrawal by Subject|1
4470104|NCT00641667|7263522|FG000|Overall Study|Adverse Event|1
4470105|NCT00641667|7263522|FG000|Overall Study|Physician Decision|1
4470106|NCT00641667|7263522|FG000|Overall Study|Worsening of underlying disease|3
4470107|NCT00641706|7263528|FG000|Overall Study|Adverse Event|2
4470108|NCT00641706|7263529|FG001|Overall Study|Adverse Event|1
4470109|NCT00641706|7263528|FG000|Overall Study|Withdrawal by Subject|6
4470110|NCT00641706|7263529|FG001|Overall Study|Withdrawal by Subject|1
4470111|NCT00641706|7263528|FG000|Overall Study|Clinical Decline|1
4470112|NCT00641706|7263529|FG001|Overall Study|Clinical Decline|0
4470113|NCT00641706|7263528|FG000|Overall Study|Lead Investigator Decision|0
4470114|NCT00641706|7263529|FG001|Overall Study|Lead Investigator Decision|1
4470115|NCT00641719|7263537|FG000|Overall Study|Lack of Efficacy|1
4470116|NCT00641719|7263538|FG001|Overall Study|Lack of Efficacy|2
4470117|NCT00641719|7263537|FG000|Overall Study|Adverse Event|24
4470118|NCT00641719|7263538|FG001|Overall Study|Adverse Event|29
4470119|NCT00641719|7263537|FG000|Overall Study|Withdrawal by Subject|4
4470120|NCT00641719|7263538|FG001|Overall Study|Withdrawal by Subject|4
4470121|NCT00641719|7263537|FG000|Overall Study|Reason Not Specified|1
4470122|NCT00641719|7263538|FG001|Overall Study|Reason Not Specified|2
4470123|NCT00642018|7263573|FG000|Overall Study|Adverse Event|11
4470124|NCT00642018|7263574|FG001|Overall Study|Adverse Event|36
4470125|NCT00642018|7263573|FG000|Overall Study|Withdrawal by Subject|4
4470126|NCT00642018|7263574|FG001|Overall Study|Withdrawal by Subject|10
4470127|NCT00642018|7263573|FG000|Overall Study|Progressive Disease|13
4470128|NCT00642018|7263574|FG001|Overall Study|Progressive Disease|18
4470129|NCT00642018|7263573|FG000|Overall Study|Physician Decision|0
4470130|NCT00642018|7263574|FG001|Overall Study|Physician Decision|10
4470131|NCT00642018|7263573|FG000|Overall Study|Protocol Violation|0
4470132|NCT00642018|7263574|FG001|Overall Study|Protocol Violation|1
4470133|NCT00642018|7263573|FG000|Overall Study|Death|0
4470134|NCT00642018|7263574|FG001|Overall Study|Death|3
4470135|NCT00642018|7263573|FG000|Overall Study|Entry Criteria Not Met|0
4470136|NCT00642018|7263574|FG001|Overall Study|Entry Criteria Not Met|1
4470137|NCT00642174|7263583|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0
4470138|NCT00642174|7263584|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1
4470139|NCT00642278|7263597|FG000|Overall Study|Adverse Event|2
4470140|NCT00642278|7263598|FG001|Overall Study|Adverse Event|1
4470141|NCT00642278|7263599|FG002|Overall Study|Adverse Event|3
4470142|NCT00642278|7263600|FG003|Overall Study|Adverse Event|1
4470143|NCT00642278|7263601|FG004|Overall Study|Adverse Event|2
4470144|NCT00642278|7263602|FG005|Overall Study|Adverse Event|2
4470145|NCT00642278|7263603|FG006|Overall Study|Adverse Event|0
4470146|NCT00642278|7263597|FG000|Overall Study|Lack of Efficacy|0
4470147|NCT00642278|7263598|FG001|Overall Study|Lack of Efficacy|1
4470148|NCT00642278|7263599|FG002|Overall Study|Lack of Efficacy|0
4470149|NCT00642278|7263600|FG003|Overall Study|Lack of Efficacy|0
4470150|NCT00642278|7263601|FG004|Overall Study|Lack of Efficacy|0
4470151|NCT00642278|7263602|FG005|Overall Study|Lack of Efficacy|0
4470152|NCT00642278|7263603|FG006|Overall Study|Lack of Efficacy|0
4470153|NCT00642278|7263597|FG000|Overall Study|Lost to Follow-up|5
4470154|NCT00642278|7263598|FG001|Overall Study|Lost to Follow-up|1
4470155|NCT00642278|7263599|FG002|Overall Study|Lost to Follow-up|0
4470156|NCT00642278|7263600|FG003|Overall Study|Lost to Follow-up|1
4470157|NCT00642278|7263601|FG004|Overall Study|Lost to Follow-up|0
4470158|NCT00642278|7263602|FG005|Overall Study|Lost to Follow-up|1
4470159|NCT00642278|7263603|FG006|Overall Study|Lost to Follow-up|1
4470160|NCT00642278|7263597|FG000|Overall Study|Physician Decision|0
4470161|NCT00642278|7263598|FG001|Overall Study|Physician Decision|0
4470162|NCT00642278|7263599|FG002|Overall Study|Physician Decision|0
4470163|NCT00642278|7263600|FG003|Overall Study|Physician Decision|1
4470164|NCT00642278|7263601|FG004|Overall Study|Physician Decision|0
4470165|NCT00642278|7263602|FG005|Overall Study|Physician Decision|0
4470166|NCT00642278|7263603|FG006|Overall Study|Physician Decision|0
4470167|NCT00642278|7263597|FG000|Overall Study|Protocol Violation|0
4470168|NCT00642278|7263598|FG001|Overall Study|Protocol Violation|0
4470169|NCT00642278|7263599|FG002|Overall Study|Protocol Violation|1
4470170|NCT00642278|7263600|FG003|Overall Study|Protocol Violation|1
4470171|NCT00642278|7263601|FG004|Overall Study|Protocol Violation|0
4470172|NCT00642278|7263602|FG005|Overall Study|Protocol Violation|1
4470173|NCT00642278|7263603|FG006|Overall Study|Protocol Violation|2
4470174|NCT00642278|7263597|FG000|Overall Study|Withdrawal by Subject|1
4697569|NCT02653170|7611313|FG002|Overall Study|withdrawn by study team|5
4697570|NCT02653170|7611311|FG000|Overall Study|Lost to Follow-up|12
4697571|NCT02653170|7611312|FG001|Overall Study|Lost to Follow-up|4
4697572|NCT02653170|7611313|FG002|Overall Study|Lost to Follow-up|10
4697573|NCT02653300|7611330|FG000|Overall Study|Withdrawal by Subject|2
4697574|NCT02653326|7611336|FG000|Overall Study|Lost to Follow-up|10
4697575|NCT02653326|7611337|FG001|Overall Study|Lost to Follow-up|7
4697576|NCT02653625|7611431|FG000|Overall Study|Adverse Event|1
4697577|NCT02653625|7611431|FG000|Overall Study|Non-compliance with Study Drug|1
4697578|NCT02653625|7611431|FG000|Overall Study|Protocol Violation|1
4697579|NCT02653625|7611431|FG000|Overall Study|Suspected Drug Induced Liver Injury|1
4697580|NCT02653664|7611438|FG000|Post-Treatment|Withdrawal by Subject|6
4697581|NCT02653664|7611439|FG001|Post-Treatment|Withdrawal by Subject|5
4697582|NCT02653664|7611440|FG002|Post-Treatment|Withdrawal by Subject|7
4470175|NCT00642278|7263598|FG001|Overall Study|Withdrawal by Subject|1
4470176|NCT00642278|7263599|FG002|Overall Study|Withdrawal by Subject|1
4697583|NCT02653664|7611438|FG000|Post-Treatment|Lost to Follow-up|8
4697584|NCT02653664|7611439|FG001|Post-Treatment|Lost to Follow-up|1
4697585|NCT02653664|7611440|FG002|Post-Treatment|Lost to Follow-up|7
4697586|NCT02653664|7611438|FG000|3 Month Follow-Up|Withdrawal by Subject|9
4470177|NCT00642278|7263600|FG003|Overall Study|Withdrawal by Subject|3
4470178|NCT00642278|7263601|FG004|Overall Study|Withdrawal by Subject|6
4470179|NCT00642278|7263602|FG005|Overall Study|Withdrawal by Subject|2
4470180|NCT00642278|7263603|FG006|Overall Study|Withdrawal by Subject|2
4470181|NCT00642278|7263597|FG000|Overall Study|Noncompliance with study drug regimen|0
4470182|NCT00642278|7263598|FG001|Overall Study|Noncompliance with study drug regimen|0
4470183|NCT00642278|7263599|FG002|Overall Study|Noncompliance with study drug regimen|0
4470184|NCT00642278|7263600|FG003|Overall Study|Noncompliance with study drug regimen|1
4470185|NCT00642278|7263601|FG004|Overall Study|Noncompliance with study drug regimen|0
4470186|NCT00642278|7263602|FG005|Overall Study|Noncompliance with study drug regimen|0
4470187|NCT00642278|7263603|FG006|Overall Study|Noncompliance with study drug regimen|0
4470188|NCT00642278|7263597|FG000|Overall Study|Other|2
4470189|NCT00642278|7263598|FG001|Overall Study|Other|1
4470190|NCT00642278|7263599|FG002|Overall Study|Other|0
4470191|NCT00642278|7263600|FG003|Overall Study|Other|1
4470192|NCT00642278|7263601|FG004|Overall Study|Other|0
4470193|NCT00642278|7263602|FG005|Overall Study|Other|1
4470194|NCT00642278|7263603|FG006|Overall Study|Other|0
4470195|NCT00642304|7263619|FG000|Overall Study|Adverse Event|1
4470196|NCT00642304|7263619|FG000|Overall Study|Death|1
4470197|NCT00642304|7263619|FG000|Overall Study|Blood transfusion|2
4470198|NCT00642304|7263619|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1
4470199|NCT00642304|7263619|FG000|Overall Study|Transplantation|1
4470200|NCT00642356|7263625|FG000|Overall Study|Adverse Event|1
4470201|NCT00642356|7263626|FG001|Overall Study|Adverse Event|0
4470202|NCT00642356|7263625|FG000|Overall Study|Protocol Violation|0
4470203|NCT00642356|7263626|FG001|Overall Study|Protocol Violation|3
4470204|NCT00642356|7263625|FG000|Overall Study|Lack of Efficacy|1
4470205|NCT00642356|7263626|FG001|Overall Study|Lack of Efficacy|0
4470206|NCT00642369|7263634|FG000|Overall Study|Adverse Event|2
4470207|NCT00642369|7263635|FG001|Overall Study|Adverse Event|3
4470208|NCT00642369|7263634|FG000|Overall Study|Withdrawal by Subject|1
4470209|NCT00642369|7263635|FG001|Overall Study|Withdrawal by Subject|0
4470210|NCT00642369|7263634|FG000|Overall Study|misdiagnosis|0
4470211|NCT00642369|7263635|FG001|Overall Study|misdiagnosis|1
4470212|NCT00642369|7263634|FG000|Overall Study|Lack of Efficacy|2
4470213|NCT00642369|7263635|FG001|Overall Study|Lack of Efficacy|2
4470214|NCT00642460|7263645|FG000|Part I: 12 Week Double-Blind|Adverse Event|0
4470215|NCT00642460|7263646|FG001|Part I: 12 Week Double-Blind|Adverse Event|1
4470216|NCT00642460|7263647|FG002|Part I: 12 Week Double-Blind|Adverse Event|1
4470217|NCT00642460|7263648|FG003|Part I: 12 Week Double-Blind|Adverse Event|0
4470218|NCT00642460|7263649|FG004|Part I: 12 Week Double-Blind|Adverse Event|0
4470219|NCT00642460|7263650|FG005|Part I: 12 Week Double-Blind|Adverse Event|0
4470220|NCT00642460|7263645|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1
4470221|NCT00642460|7263646|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0
4697587|NCT02653664|7611439|FG001|3 Month Follow-Up|Withdrawal by Subject|5
4697588|NCT02653664|7611440|FG002|3 Month Follow-Up|Withdrawal by Subject|9
4470222|NCT00642460|7263647|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0
4470223|NCT00642460|7263648|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0
4470224|NCT00642460|7263649|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0
4470225|NCT00642460|7263650|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0
4470226|NCT00642460|7263645|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4
4470227|NCT00642460|7263646|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2
4470228|NCT00642460|7263647|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0
4470229|NCT00642460|7263648|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0
4470230|NCT00642460|7263649|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0
4697589|NCT02653664|7611438|FG000|3 Month Follow-Up|Lost to Follow-up|9
4697590|NCT02653664|7611439|FG001|3 Month Follow-Up|Lost to Follow-up|8
4470231|NCT00642460|7263650|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0
4470232|NCT00642460|7263645|FG000|Part II: Open-Label Up to Week 92|Death|0
4470233|NCT00642460|7263646|FG001|Part II: Open-Label Up to Week 92|Death|1
4470234|NCT00642460|7263647|FG002|Part II: Open-Label Up to Week 92|Death|0
4470235|NCT00642460|7263648|FG003|Part II: Open-Label Up to Week 92|Death|2
4470236|NCT00642460|7263649|FG004|Part II: Open-Label Up to Week 92|Death|0
4470237|NCT00642460|7263650|FG005|Part II: Open-Label Up to Week 92|Death|0
4470238|NCT00642460|7263645|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2
4470239|NCT00642460|7263646|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3
4470240|NCT00642460|7263647|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
4470241|NCT00642460|7263648|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
4470242|NCT00642460|7263649|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
4470243|NCT00642460|7263650|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
4470244|NCT00642460|7263645|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3
4470245|NCT00642460|7263646|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1
4470246|NCT00642460|7263647|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0
4470247|NCT00642460|7263648|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0
4470248|NCT00642460|7263649|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0
4470249|NCT00642460|7263650|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0
4470250|NCT00642460|7263645|FG000|Part II: Open-Label Up to Week 92|Failure to return|0
4470251|NCT00642460|7263646|FG001|Part II: Open-Label Up to Week 92|Failure to return|1
4470252|NCT00642460|7263647|FG002|Part II: Open-Label Up to Week 92|Failure to return|0
4470253|NCT00642460|7263648|FG003|Part II: Open-Label Up to Week 92|Failure to return|0
4470254|NCT00642460|7263649|FG004|Part II: Open-Label Up to Week 92|Failure to return|0
4470255|NCT00642460|7263650|FG005|Part II: Open-Label Up to Week 92|Failure to return|0
4470256|NCT00642460|7263645|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0
4470257|NCT00642460|7263646|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0
4470258|NCT00642460|7263647|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0
4470259|NCT00642460|7263648|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1
4470260|NCT00642460|7263649|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0
4470261|NCT00642460|7263650|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0
4470262|NCT00642460|7263645|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0
4470263|NCT00642460|7263646|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0
4470264|NCT00642460|7263647|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0
4470265|NCT00642460|7263648|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0
4470266|NCT00642460|7263649|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7
4470267|NCT00642460|7263650|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6
4470268|NCT00642460|7263645|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
4470269|NCT00642460|7263646|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
4470270|NCT00642460|7263647|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
4470271|NCT00642460|7263648|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
4470272|NCT00642460|7263649|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3
4470273|NCT00642460|7263650|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4
4470274|NCT00642460|7263645|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
4470275|NCT00642460|7263646|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
4470276|NCT00642460|7263647|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
4470277|NCT00642460|7263648|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
4470278|NCT00642460|7263649|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4
4470279|NCT00642460|7263650|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1
4470280|NCT00642460|7263645|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
4470281|NCT00642460|7263646|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
4470282|NCT00642460|7263647|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
4470283|NCT00642460|7263648|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
4470284|NCT00642460|7263649|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1
4470285|NCT00642460|7263650|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1
4470286|NCT00642460|7263645|FG000|Part III: Open-Label Up to Week 260|Other|0
4470287|NCT00642460|7263646|FG001|Part III: Open-Label Up to Week 260|Other|0
4470288|NCT00642460|7263647|FG002|Part III: Open-Label Up to Week 260|Other|0
4470289|NCT00642460|7263648|FG003|Part III: Open-Label Up to Week 260|Other|0
4470290|NCT00642460|7263649|FG004|Part III: Open-Label Up to Week 260|Other|2
4470291|NCT00642460|7263650|FG005|Part III: Open-Label Up to Week 260|Other|2
4470292|NCT00642460|7263645|FG000|Part III: Open-Label Up to Week 260|Death|0
4470293|NCT00642460|7263646|FG001|Part III: Open-Label Up to Week 260|Death|0
4470294|NCT00642460|7263647|FG002|Part III: Open-Label Up to Week 260|Death|0
4470295|NCT00642460|7263648|FG003|Part III: Open-Label Up to Week 260|Death|0
4470296|NCT00642460|7263649|FG004|Part III: Open-Label Up to Week 260|Death|0
4470297|NCT00642460|7263650|FG005|Part III: Open-Label Up to Week 260|Death|3
4470298|NCT00642460|7263645|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0
4470299|NCT00642460|7263646|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0
4470300|NCT00642460|7263647|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0
4470301|NCT00642460|7263648|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0
4470302|NCT00642460|7263649|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0
4470303|NCT00642460|7263650|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1
4470304|NCT00642460|7263645|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0
4470305|NCT00642460|7263646|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0
4470306|NCT00642460|7263647|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0
4470307|NCT00642460|7263648|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0
4470308|NCT00642460|7263649|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8
4470309|NCT00642460|7263650|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3
4470310|NCT00642473|7263662|FG000|Overall Study|Withdrawal by Subject|0
4470311|NCT00642473|7263663|FG001|Overall Study|Withdrawal by Subject|5
4470312|NCT00642473|7263662|FG000|Overall Study|Progression or death|2
4470313|NCT00642473|7263663|FG001|Overall Study|Progression or death|4
4470314|NCT00642473|7263662|FG000|Overall Study|Other|2
4470315|NCT00642473|7263663|FG001|Overall Study|Other|2
4470316|NCT00642616|7263676|FG000|Overall Study|Adverse Event|2
4470317|NCT00642616|7263677|FG001|Overall Study|Adverse Event|0
4470318|NCT00642616|7263678|FG002|Overall Study|Adverse Event|1
4470319|NCT00642616|7263679|FG003|Overall Study|Adverse Event|0
4470320|NCT00642616|7263676|FG000|Overall Study|Study Terminated by Sponsor|7
4470321|NCT00642616|7263677|FG001|Overall Study|Study Terminated by Sponsor|6
4470322|NCT00642616|7263678|FG002|Overall Study|Study Terminated by Sponsor|4
4470323|NCT00642616|7263679|FG003|Overall Study|Study Terminated by Sponsor|5
4470324|NCT00642616|7263676|FG000|Overall Study|Withdrawal by Subject|0
4470325|NCT00642616|7263677|FG001|Overall Study|Withdrawal by Subject|1
4470326|NCT00642616|7263678|FG002|Overall Study|Withdrawal by Subject|1
4588956|NCT01506479|7433811|FG001|Overall Study|Lost to Follow-up|2
4588957|NCT01506479|7433812|FG002|Overall Study|Lost to Follow-up|2
4588958|NCT01506479|7433810|FG000|Overall Study|Withdrawal by Subject|1
4470327|NCT00642616|7263679|FG003|Overall Study|Withdrawal by Subject|1
4470328|NCT00642616|7263676|FG000|Overall Study|Protocol Violation|0
4470329|NCT00642616|7263677|FG001|Overall Study|Protocol Violation|0
4470330|NCT00642616|7263678|FG002|Overall Study|Protocol Violation|2
4470331|NCT00642616|7263679|FG003|Overall Study|Protocol Violation|0
4470332|NCT00642616|7263676|FG000|Overall Study|Physician Decision|0
4470333|NCT00642616|7263677|FG001|Overall Study|Physician Decision|0
4470334|NCT00642616|7263678|FG002|Overall Study|Physician Decision|1
4470335|NCT00642616|7263679|FG003|Overall Study|Physician Decision|1
4470336|NCT00642642|7263691|FG000|Treatment & Follow Up|Adverse Event|2
4470337|NCT00642642|7263691|FG000|Treatment & Follow Up|Withdrawal by Subject|5
4470338|NCT00642642|7263691|FG000|Treatment & Follow Up|Lost to Follow-up|10
4470339|NCT00642668|7263701|FG000|Overall Study|Lost to Follow-up|1
4470340|NCT00642668|7263701|FG000|Overall Study|Adverse Event|2
4470341|NCT00642668|7263701|FG000|Overall Study|Death|2
4470342|NCT00642668|7263701|FG000|Overall Study|Insufficient Therapeutic Response|1
4470343|NCT00642668|7263701|FG000|Overall Study|Failure to Return|1
4470344|NCT00642668|7263701|FG000|Overall Study|Dialysis Initiation|5
4470345|NCT00642668|7263701|FG000|Overall Study|Blood Transfusion|2
4470346|NCT00642707|7263718|FG000|Overall Study|Adverse Event|0
4470347|NCT00642707|7263719|FG001|Overall Study|Adverse Event|0
4470348|NCT00642707|7263720|FG002|Overall Study|Adverse Event|0
4470349|NCT00642707|7263721|FG003|Overall Study|Adverse Event|2
4470350|NCT00642707|7263718|FG000|Overall Study|Withdrawal by Subject|1
4470351|NCT00642707|7263719|FG001|Overall Study|Withdrawal by Subject|0
4470352|NCT00642707|7263720|FG002|Overall Study|Withdrawal by Subject|0
4470353|NCT00642707|7263721|FG003|Overall Study|Withdrawal by Subject|0
4470354|NCT00642746|7263733|FG000|Overall Study|Patient unevaluable|1
4470355|NCT00642746|7263734|FG001|Overall Study|Patient unevaluable|0
4470356|NCT00642759|7263740|FG000|Overall Study|Protocol Violation|1
4470357|NCT00642772|7263745|FG000|Overall Study|Lost to Follow-up|3
4470358|NCT00642772|7263745|FG000|Overall Study|Withdrawal by Subject|7
4470359|NCT00642811|7263755|FG000|Overall Study|Adverse Event|2
4470360|NCT00642811|7263756|FG001|Overall Study|Adverse Event|3
4470361|NCT00642811|7263757|FG002|Overall Study|Adverse Event|0
4470362|NCT00642811|7263758|FG003|Overall Study|Adverse Event|0
4470363|NCT00642811|7263759|FG004|Overall Study|Adverse Event|0
4470364|NCT00642811|7263760|FG005|Overall Study|Adverse Event|1
4470365|NCT00642811|7263755|FG000|Overall Study|Developement of discontinuation criteria|0
4470366|NCT00642811|7263756|FG001|Overall Study|Developement of discontinuation criteria|0
4470367|NCT00642811|7263757|FG002|Overall Study|Developement of discontinuation criteria|0
4470368|NCT00642811|7263758|FG003|Overall Study|Developement of discontinuation criteria|0
4470369|NCT00642811|7263759|FG004|Overall Study|Developement of discontinuation criteria|1
4470370|NCT00642811|7263760|FG005|Overall Study|Developement of discontinuation criteria|0
4470371|NCT00642811|7263755|FG000|Overall Study|Severe Non-compliance to protocol|1
4470372|NCT00642811|7263756|FG001|Overall Study|Severe Non-compliance to protocol|0
4470373|NCT00642811|7263757|FG002|Overall Study|Severe Non-compliance to protocol|0
4470374|NCT00642811|7263758|FG003|Overall Study|Severe Non-compliance to protocol|0
4470375|NCT00642811|7263759|FG004|Overall Study|Severe Non-compliance to protocol|0
4470376|NCT00642811|7263760|FG005|Overall Study|Severe Non-compliance to protocol|0
4470377|NCT00642811|7263755|FG000|Overall Study|Other|0
4470378|NCT00642811|7263756|FG001|Overall Study|Other|1
4470379|NCT00642811|7263757|FG002|Overall Study|Other|0
4470380|NCT00642811|7263758|FG003|Overall Study|Other|1
4470381|NCT00642811|7263759|FG004|Overall Study|Other|0
4470382|NCT00642811|7263760|FG005|Overall Study|Other|0
4470383|NCT00642850|7263774|FG000|Overall Study|Death|7
4470384|NCT00642850|7263774|FG000|Overall Study|Adverse Event|2
4470385|NCT00642850|7263774|FG000|Overall Study|Lack of Efficacy|1
4470386|NCT00642850|7263774|FG000|Overall Study|Protocol Violation|2
4470387|NCT00642850|7263774|FG000|Overall Study|Kidney transplantation|8
4470388|NCT00642850|7263774|FG000|Overall Study|Blood transfusion|6
4470389|NCT00642850|7263774|FG000|Overall Study|Other reasons|7
4470390|NCT00642902|7263782|FG000|Overall Study|Adverse Event|0
4470391|NCT00642902|7263783|FG001|Overall Study|Adverse Event|1
4470392|NCT00642902|7263784|FG002|Overall Study|Adverse Event|3
4470393|NCT00642902|7263785|FG003|Overall Study|Adverse Event|1
4470394|NCT00642902|7263782|FG000|Overall Study|Lost to Follow-up|1
4470395|NCT00642902|7263783|FG001|Overall Study|Lost to Follow-up|1
4470396|NCT00642902|7263784|FG002|Overall Study|Lost to Follow-up|0
4470397|NCT00642902|7263785|FG003|Overall Study|Lost to Follow-up|0
4470398|NCT00642902|7263782|FG000|Overall Study|Lack of Efficacy|0
4470399|NCT00642902|7263783|FG001|Overall Study|Lack of Efficacy|3
4470400|NCT00642902|7263784|FG002|Overall Study|Lack of Efficacy|3
4470401|NCT00642902|7263785|FG003|Overall Study|Lack of Efficacy|0
4470402|NCT00642902|7263782|FG000|Overall Study|Death|1
4470403|NCT00642902|7263783|FG001|Overall Study|Death|0
4470404|NCT00642902|7263784|FG002|Overall Study|Death|0
4470405|NCT00642902|7263785|FG003|Overall Study|Death|0
4470406|NCT00642902|7263782|FG000|Overall Study|Premature termination of clinical trial|37
4470407|NCT00642902|7263783|FG001|Overall Study|Premature termination of clinical trial|32
4470408|NCT00642902|7263784|FG002|Overall Study|Premature termination of clinical trial|35
4470409|NCT00642902|7263785|FG003|Overall Study|Premature termination of clinical trial|35
4470410|NCT00642902|7263782|FG000|Overall Study|Randomized, but not treated|0
4470411|NCT00642902|7263783|FG001|Overall Study|Randomized, but not treated|0
4470412|NCT00642902|7263784|FG002|Overall Study|Randomized, but not treated|1
4470413|NCT00642902|7263785|FG003|Overall Study|Randomized, but not treated|0
4470414|NCT00642902|7263782|FG000|Overall Study|Other|1
4470415|NCT00642902|7263783|FG001|Overall Study|Other|5
4470416|NCT00642902|7263784|FG002|Overall Study|Other|1
4470417|NCT00642902|7263785|FG003|Overall Study|Other|4
4470418|NCT00642941|7263807|FG000|Overall Study|Physician Decision|3
4470419|NCT00642941|7263808|FG001|Overall Study|Physician Decision|1
4470420|NCT00642941|7263809|FG002|Overall Study|Physician Decision|0
4470421|NCT00642941|7263810|FG003|Overall Study|Physician Decision|0
4470422|NCT00642941|7263811|FG004|Overall Study|Physician Decision|0
4470423|NCT00642941|7263812|FG005|Overall Study|Physician Decision|0
4470424|NCT00642941|7263813|FG006|Overall Study|Physician Decision|1
4470425|NCT00642941|7263814|FG007|Overall Study|Physician Decision|0
4470426|NCT00642941|7263815|FG008|Overall Study|Physician Decision|0
4470427|NCT00642941|7263816|FG009|Overall Study|Physician Decision|1
4470428|NCT00642941|7263817|FG010|Overall Study|Physician Decision|0
4470429|NCT00642941|7263818|FG011|Overall Study|Physician Decision|1
4470430|NCT00642941|7263807|FG000|Overall Study|Death|4
4470431|NCT00642941|7263808|FG001|Overall Study|Death|0
4470432|NCT00642941|7263809|FG002|Overall Study|Death|1
4470433|NCT00642941|7263810|FG003|Overall Study|Death|1
4470434|NCT00642941|7263811|FG004|Overall Study|Death|2
4470435|NCT00642941|7263812|FG005|Overall Study|Death|1
4470436|NCT00642941|7263813|FG006|Overall Study|Death|0
4470437|NCT00642941|7263814|FG007|Overall Study|Death|0
4470438|NCT00642941|7263815|FG008|Overall Study|Death|0
4470439|NCT00642941|7263816|FG009|Overall Study|Death|0
4470440|NCT00642941|7263817|FG010|Overall Study|Death|0
4470441|NCT00642941|7263818|FG011|Overall Study|Death|1
4470442|NCT00642941|7263807|FG000|Overall Study|Study closed by Sponsor|0
4470443|NCT00642941|7263808|FG001|Overall Study|Study closed by Sponsor|1
4470444|NCT00642941|7263809|FG002|Overall Study|Study closed by Sponsor|0
4470445|NCT00642941|7263810|FG003|Overall Study|Study closed by Sponsor|0
4470446|NCT00642941|7263811|FG004|Overall Study|Study closed by Sponsor|0
4470447|NCT00642941|7263812|FG005|Overall Study|Study closed by Sponsor|0
4470448|NCT00642941|7263813|FG006|Overall Study|Study closed by Sponsor|0
4470449|NCT00642941|7263814|FG007|Overall Study|Study closed by Sponsor|0
4470450|NCT00642941|7263815|FG008|Overall Study|Study closed by Sponsor|0
4470451|NCT00642941|7263816|FG009|Overall Study|Study closed by Sponsor|0
4470452|NCT00642941|7263817|FG010|Overall Study|Study closed by Sponsor|0
4470453|NCT00642941|7263818|FG011|Overall Study|Study closed by Sponsor|0
4470454|NCT00642941|7263807|FG000|Overall Study|Withdrawal by Subject|1
4470455|NCT00642941|7263808|FG001|Overall Study|Withdrawal by Subject|0
4470456|NCT00642941|7263809|FG002|Overall Study|Withdrawal by Subject|0
4697591|NCT02653664|7611440|FG002|3 Month Follow-Up|Lost to Follow-up|16
4697592|NCT02653664|7611438|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0
4697593|NCT02653664|7611439|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2
4470457|NCT00642941|7263810|FG003|Overall Study|Withdrawal by Subject|2
4470458|NCT00642941|7263811|FG004|Overall Study|Withdrawal by Subject|0
4470459|NCT00642941|7263812|FG005|Overall Study|Withdrawal by Subject|0
4470460|NCT00642941|7263813|FG006|Overall Study|Withdrawal by Subject|2
4470461|NCT00642941|7263814|FG007|Overall Study|Withdrawal by Subject|0
4470462|NCT00642941|7263815|FG008|Overall Study|Withdrawal by Subject|1
4470463|NCT00642941|7263816|FG009|Overall Study|Withdrawal by Subject|0
4470464|NCT00642941|7263817|FG010|Overall Study|Withdrawal by Subject|0
4470465|NCT00642941|7263818|FG011|Overall Study|Withdrawal by Subject|1
4470466|NCT00642941|7263807|FG000|Overall Study|Protocol Violation|0
4470467|NCT00642941|7263808|FG001|Overall Study|Protocol Violation|0
4470468|NCT00642941|7263809|FG002|Overall Study|Protocol Violation|0
4470469|NCT00642941|7263810|FG003|Overall Study|Protocol Violation|0
4470470|NCT00642941|7263811|FG004|Overall Study|Protocol Violation|0
4470471|NCT00642941|7263812|FG005|Overall Study|Protocol Violation|0
4470472|NCT00642941|7263813|FG006|Overall Study|Protocol Violation|1
4470473|NCT00642941|7263814|FG007|Overall Study|Protocol Violation|0
4470474|NCT00642941|7263815|FG008|Overall Study|Protocol Violation|0
4470475|NCT00642941|7263816|FG009|Overall Study|Protocol Violation|0
4470476|NCT00642941|7263817|FG010|Overall Study|Protocol Violation|0
4470477|NCT00642941|7263818|FG011|Overall Study|Protocol Violation|0
4470478|NCT00642941|7263807|FG000|Overall Study|Adverse Event|1
4470479|NCT00642941|7263808|FG001|Overall Study|Adverse Event|1
4470480|NCT00642941|7263809|FG002|Overall Study|Adverse Event|0
4470481|NCT00642941|7263810|FG003|Overall Study|Adverse Event|0
4470482|NCT00642941|7263811|FG004|Overall Study|Adverse Event|0
4470483|NCT00642941|7263812|FG005|Overall Study|Adverse Event|0
4470484|NCT00642941|7263813|FG006|Overall Study|Adverse Event|1
4470485|NCT00642941|7263814|FG007|Overall Study|Adverse Event|1
4470486|NCT00642941|7263815|FG008|Overall Study|Adverse Event|0
4470487|NCT00642941|7263816|FG009|Overall Study|Adverse Event|1
4470488|NCT00642941|7263817|FG010|Overall Study|Adverse Event|0
4470489|NCT00642941|7263818|FG011|Overall Study|Adverse Event|0
4470490|NCT00642941|7263807|FG000|Overall Study|Other|1
4470491|NCT00642941|7263808|FG001|Overall Study|Other|1
4470492|NCT00642941|7263809|FG002|Overall Study|Other|1
4470493|NCT00642941|7263810|FG003|Overall Study|Other|1
4470494|NCT00642941|7263811|FG004|Overall Study|Other|0
4470495|NCT00642941|7263812|FG005|Overall Study|Other|1
4470496|NCT00642941|7263813|FG006|Overall Study|Other|0
4470497|NCT00642941|7263814|FG007|Overall Study|Other|1
4470498|NCT00642941|7263815|FG008|Overall Study|Other|0
4470499|NCT00642941|7263816|FG009|Overall Study|Other|0
4470500|NCT00642941|7263817|FG010|Overall Study|Other|0
4470501|NCT00642941|7263818|FG011|Overall Study|Other|1
4470502|NCT00642941|7263807|FG000|Overall Study|Disease progression|60
4470503|NCT00642941|7263808|FG001|Overall Study|Disease progression|50
4470504|NCT00642941|7263809|FG002|Overall Study|Disease progression|5
4470505|NCT00642941|7263810|FG003|Overall Study|Disease progression|36
4470506|NCT00642941|7263811|FG004|Overall Study|Disease progression|23
4470507|NCT00642941|7263812|FG005|Overall Study|Disease progression|39
4470508|NCT00642941|7263813|FG006|Overall Study|Disease progression|18
4470509|NCT00642941|7263814|FG007|Overall Study|Disease progression|12
4470510|NCT00642941|7263815|FG008|Overall Study|Disease progression|10
4470511|NCT00642941|7263816|FG009|Overall Study|Disease progression|7
4470512|NCT00642941|7263817|FG010|Overall Study|Disease progression|12
4470513|NCT00642941|7263818|FG011|Overall Study|Disease progression|7
4470514|NCT00642954|7263870|FG000|Overall Study|Progressive Disease|3
4470515|NCT00642954|7263871|FG001|Overall Study|Progressive Disease|3
4470516|NCT00642954|7263872|FG002|Overall Study|Progressive Disease|3
4470517|NCT00642954|7263873|FG003|Overall Study|Progressive Disease|3
4470518|NCT00642954|7263874|FG004|Overall Study|Progressive Disease|9
4470519|NCT00642954|7263870|FG000|Overall Study|Withdrawal by Subject|0
4470520|NCT00642954|7263871|FG001|Overall Study|Withdrawal by Subject|0
4470521|NCT00642954|7263872|FG002|Overall Study|Withdrawal by Subject|0
4470522|NCT00642954|7263873|FG003|Overall Study|Withdrawal by Subject|0
4470523|NCT00642954|7263874|FG004|Overall Study|Withdrawal by Subject|1
4470524|NCT00642954|7263870|FG000|Overall Study|Adverse Event|1
4588959|NCT01506479|7433811|FG001|Overall Study|Withdrawal by Subject|2
4588960|NCT01506479|7433812|FG002|Overall Study|Withdrawal by Subject|1
4588961|NCT01506479|7433810|FG000|Overall Study|Missing assessment|1
4588962|NCT01506479|7433811|FG001|Overall Study|Missing assessment|0
4588963|NCT01506479|7433812|FG002|Overall Study|Missing assessment|0
4588964|NCT01506479|7433810|FG000|Overall Study|Adverse Event|0
4588965|NCT01506479|7433811|FG001|Overall Study|Adverse Event|1
4588966|NCT01506479|7433812|FG002|Overall Study|Adverse Event|0
4588967|NCT01506596|7433822|FG000|Overall Study|ineligible pathology|1
4588968|NCT01506609|7433832|FG000|Overall Study|Adverse Event Related to Progression|0
4470525|NCT00642954|7263871|FG001|Overall Study|Adverse Event|1
4470526|NCT00642954|7263872|FG002|Overall Study|Adverse Event|0
4470527|NCT00642954|7263873|FG003|Overall Study|Adverse Event|0
4470528|NCT00642954|7263874|FG004|Overall Study|Adverse Event|6
4470529|NCT00642993|7263888|FG000|Overall Study|Adverse Event|85
4470530|NCT00642993|7263889|FG001|Overall Study|Adverse Event|4
4470531|NCT00642993|7263888|FG000|Overall Study|Lost to Follow-up|8
4470532|NCT00642993|7263889|FG001|Overall Study|Lost to Follow-up|4
4470533|NCT00642993|7263888|FG000|Overall Study|Withdrew - reason unrelated to treatment|11
4470534|NCT00642993|7263889|FG001|Overall Study|Withdrew - reason unrelated to treatment|3
4470535|NCT00642993|7263888|FG000|Overall Study|Protocol Violation|1
4470536|NCT00642993|7263889|FG001|Overall Study|Protocol Violation|4
4470537|NCT00642993|7263888|FG000|Overall Study|Did not meet protocol eligibility|0
4470538|NCT00642993|7263889|FG001|Overall Study|Did not meet protocol eligibility|1
4470539|NCT00642993|7263888|FG000|Overall Study|Administrative|1
4470540|NCT00642993|7263889|FG001|Overall Study|Administrative|0
4470541|NCT00643006|7263897|FG000|Overall Study|Lost to Follow-up|5
4470542|NCT00643006|7263898|FG001|Overall Study|Lost to Follow-up|4
4470543|NCT00643123|7263921|FG000|Overall Study|Lost to Follow-up|4
4470544|NCT00643123|7263922|FG001|Overall Study|Lost to Follow-up|0
4470545|NCT00643123|7263921|FG000|Overall Study|Withdrawal by Subject|1
4470546|NCT00643123|7263922|FG001|Overall Study|Withdrawal by Subject|1
4470547|NCT00643162|7263930|FG000|Overall Study|Withdrawal by Subject|1
4470548|NCT00643162|7263931|FG001|Overall Study|Withdrawal by Subject|1
4470549|NCT00643201|7263939|FG000|Randomized, Completed 6 Months of Study|Death|20
4470550|NCT00643201|7263940|FG001|Randomized, Completed 6 Months of Study|Death|26
4470551|NCT00643201|7263939|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150
4470552|NCT00643201|7263940|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182
4470553|NCT00643201|7263939|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49
4470554|NCT00643201|7263940|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49
4470555|NCT00643201|7263939|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14
4470556|NCT00643201|7263940|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14
4470557|NCT00643201|7263939|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20
4470558|NCT00643201|7263940|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23
4470559|NCT00643201|7263939|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3
4470560|NCT00643201|7263940|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2
4470561|NCT00643201|7263939|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13
4470562|NCT00643201|7263940|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9
4470563|NCT00643201|7263939|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1
4470564|NCT00643201|7263940|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1
4470565|NCT00643201|7263939|FG000|Randomized, Completed 6 Months of Study|Other|107
4470566|NCT00643201|7263940|FG001|Randomized, Completed 6 Months of Study|Other|107
4470567|NCT00643201|7263939|FG000|Completed Study Follow Up|Death|28
4470568|NCT00643201|7263940|FG001|Completed Study Follow Up|Death|34
4470569|NCT00643201|7263939|FG000|Completed Study Follow Up|Withdrawal by Subject|23
4470570|NCT00643201|7263940|FG001|Completed Study Follow Up|Withdrawal by Subject|29
4470571|NCT00643201|7263939|FG000|Completed Study Follow Up|Lost to Follow-up|18
4470572|NCT00643201|7263940|FG001|Completed Study Follow Up|Lost to Follow-up|16
4470573|NCT00643201|7263939|FG000|Completed Study Follow Up|non-specified|1
4470574|NCT00643201|7263940|FG001|Completed Study Follow Up|non-specified|0
4470575|NCT00643279|7263950|FG000|Overall Study|Death|13
4470576|NCT00643279|7263951|FG001|Overall Study|Death|11
4470577|NCT00643279|7263950|FG000|Overall Study|Withdrawal by Subject|3
4470578|NCT00643279|7263951|FG001|Overall Study|Withdrawal by Subject|0
4470579|NCT00643279|7263950|FG000|Overall Study|Lost to Follow-up|0
4470580|NCT00643279|7263951|FG001|Overall Study|Lost to Follow-up|1
4470581|NCT00643279|7263950|FG000|Overall Study|Physician Decision|0
4470582|NCT00643279|7263951|FG001|Overall Study|Physician Decision|1
4470583|NCT00643448|7263962|FG000|Overall Study|Lack of Efficacy|2
4470584|NCT00643448|7263963|FG001|Overall Study|Lack of Efficacy|0
4470585|NCT00643448|7263964|FG002|Overall Study|Lack of Efficacy|4
4470586|NCT00643448|7263962|FG000|Overall Study|Adverse Event|2
4470587|NCT00643448|7263963|FG001|Overall Study|Adverse Event|2
4470588|NCT00643448|7263964|FG002|Overall Study|Adverse Event|2
4470589|NCT00643448|7263962|FG000|Overall Study|QTcF>550 ms|0
4470590|NCT00643448|7263963|FG001|Overall Study|QTcF>550 ms|3
4470591|NCT00643448|7263964|FG002|Overall Study|QTcF>550 ms|0
4470592|NCT00643487|7263974|FG000|Overall Study|Technical difficulty|3
4470593|NCT00643565|7263980|FG000|Overall Study|Death|12
4470594|NCT00643565|7263981|FG001|Overall Study|Death|11
4470595|NCT00643565|7263980|FG000|Overall Study|Withdrawal by Subject|4
4470596|NCT00643565|7263981|FG001|Overall Study|Withdrawal by Subject|1
4470597|NCT00643565|7263980|FG000|Overall Study|Lost to Follow-up|0
4470598|NCT00643565|7263981|FG001|Overall Study|Lost to Follow-up|6
4470599|NCT00643565|7263980|FG000|Overall Study|Other|7
4470600|NCT00643565|7263981|FG001|Overall Study|Other|8
4470601|NCT00643565|7263980|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0
4470602|NCT00643565|7263981|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1
4470603|NCT00643565|7263980|FG000|Overall Study|Recurrence of Disease|2
4470604|NCT00643565|7263981|FG001|Overall Study|Recurrence of Disease|1
4470605|NCT00643565|7263980|FG000|Overall Study|Progression of Disease|18
4470606|NCT00643565|7263981|FG001|Overall Study|Progression of Disease|14
4470607|NCT00643565|7263980|FG000|Overall Study|Protocol Violation|3
4470608|NCT00643565|7263981|FG001|Overall Study|Protocol Violation|0
4470609|NCT00643565|7263980|FG000|Overall Study|Did Not Cooperate|0
4470610|NCT00643565|7263981|FG001|Overall Study|Did Not Cooperate|1
4697594|NCT02653664|7611440|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0
4771205|NCT04532294|7748036|FG002|Overall Study|Participants Not Dosed|2
4470611|NCT00643565|7263980|FG000|Overall Study|Administrative|22
4470612|NCT00643565|7263981|FG001|Overall Study|Administrative|16
4470613|NCT00643565|7263980|FG000|Overall Study|Adverse Event|5
4470614|NCT00643565|7263981|FG001|Overall Study|Adverse Event|8
4470615|NCT00643604|7263997|FG000|Overall Study|Death|1
4470616|NCT00643682|7264003|FG000|Overall Study|did not keep appointment|522
4470617|NCT00643682|7264004|FG001|Overall Study|did not keep appointment|509
4470618|NCT00643760|7264015|FG000|Overall Study|Adverse Event|11
4470619|NCT00643760|7264016|FG001|Overall Study|Adverse Event|5
4470620|NCT00643760|7264017|FG002|Overall Study|Adverse Event|12
4470621|NCT00643760|7264018|FG003|Overall Study|Adverse Event|21
4470622|NCT00643760|7264019|FG004|Overall Study|Adverse Event|6
4470623|NCT00643760|7264015|FG000|Overall Study|Lack of Efficacy|3
4470624|NCT00643760|7264016|FG001|Overall Study|Lack of Efficacy|1
4470625|NCT00643760|7264017|FG002|Overall Study|Lack of Efficacy|0
4470626|NCT00643760|7264018|FG003|Overall Study|Lack of Efficacy|4
4470627|NCT00643760|7264019|FG004|Overall Study|Lack of Efficacy|3
4470628|NCT00643760|7264015|FG000|Overall Study|Protocol Violation|7
4470629|NCT00643760|7264016|FG001|Overall Study|Protocol Violation|6
4470630|NCT00643760|7264017|FG002|Overall Study|Protocol Violation|4
4470631|NCT00643760|7264018|FG003|Overall Study|Protocol Violation|4
4470632|NCT00643760|7264019|FG004|Overall Study|Protocol Violation|6
4470633|NCT00643760|7264015|FG000|Overall Study|Lost to Follow-up|6
4470634|NCT00643760|7264016|FG001|Overall Study|Lost to Follow-up|2
4470635|NCT00643760|7264017|FG002|Overall Study|Lost to Follow-up|1
4470636|NCT00643760|7264018|FG003|Overall Study|Lost to Follow-up|3
4470637|NCT00643760|7264019|FG004|Overall Study|Lost to Follow-up|3
4470638|NCT00643760|7264015|FG000|Overall Study|Investigator Discretion|0
4470639|NCT00643760|7264016|FG001|Overall Study|Investigator Discretion|0
4470640|NCT00643760|7264017|FG002|Overall Study|Investigator Discretion|0
4470641|NCT00643760|7264018|FG003|Overall Study|Investigator Discretion|2
4470642|NCT00643760|7264019|FG004|Overall Study|Investigator Discretion|0
4470643|NCT00643760|7264015|FG000|Overall Study|Withdrawal by Subject|3
4470644|NCT00643760|7264016|FG001|Overall Study|Withdrawal by Subject|1
4470645|NCT00643760|7264017|FG002|Overall Study|Withdrawal by Subject|2
4470646|NCT00643760|7264018|FG003|Overall Study|Withdrawal by Subject|4
4470647|NCT00643760|7264019|FG004|Overall Study|Withdrawal by Subject|1
4470648|NCT00643851|7264034|FG000|Overall Study|Death|0
4470649|NCT00643851|7264035|FG001|Overall Study|Death|1
4470650|NCT00643851|7264036|FG002|Overall Study|Death|0
4470651|NCT00643851|7264034|FG000|Overall Study|Lack of Efficacy|0
4470652|NCT00643851|7264035|FG001|Overall Study|Lack of Efficacy|1
4470653|NCT00643851|7264036|FG002|Overall Study|Lack of Efficacy|0
4470654|NCT00643851|7264034|FG000|Overall Study|Adverse Event|2
4470655|NCT00643851|7264035|FG001|Overall Study|Adverse Event|6
4470656|NCT00643851|7264036|FG002|Overall Study|Adverse Event|6
4470657|NCT00643851|7264034|FG000|Overall Study|Lost to Follow-up|4
4470658|NCT00643851|7264035|FG001|Overall Study|Lost to Follow-up|6
4470659|NCT00643851|7264036|FG002|Overall Study|Lost to Follow-up|9
4470660|NCT00643851|7264034|FG000|Overall Study|Withdrawal by Subject|8
4470661|NCT00643851|7264035|FG001|Overall Study|Withdrawal by Subject|15
4470662|NCT00643851|7264036|FG002|Overall Study|Withdrawal by Subject|9
4470663|NCT00643851|7264034|FG000|Overall Study|Non-compl., not met criteria, etc.|3
4470664|NCT00643851|7264035|FG001|Overall Study|Non-compl., not met criteria, etc.|4
4470665|NCT00643851|7264036|FG002|Overall Study|Non-compl., not met criteria, etc.|6
4470666|NCT00643916|7264050|FG000|Overall Study|Protocol Violation|0
4470667|NCT00643916|7264051|FG001|Overall Study|Protocol Violation|1
4470668|NCT00643916|7264052|FG002|Overall Study|Protocol Violation|1
4470669|NCT00643916|7264053|FG003|Overall Study|Protocol Violation|1
4470670|NCT00643916|7264054|FG004|Overall Study|Protocol Violation|0
4470671|NCT00643916|7264055|FG005|Overall Study|Protocol Violation|0
4470672|NCT00643916|7264050|FG000|Overall Study|Lost to Follow-up|0
4470673|NCT00643916|7264051|FG001|Overall Study|Lost to Follow-up|1
4470674|NCT00643916|7264052|FG002|Overall Study|Lost to Follow-up|0
4470675|NCT00643916|7264053|FG003|Overall Study|Lost to Follow-up|0
4470676|NCT00643916|7264054|FG004|Overall Study|Lost to Follow-up|0
4470677|NCT00643916|7264055|FG005|Overall Study|Lost to Follow-up|0
4470678|NCT00643916|7264050|FG000|Overall Study|Withdrawal by Subject|2
4470679|NCT00643916|7264051|FG001|Overall Study|Withdrawal by Subject|2
4470680|NCT00643916|7264052|FG002|Overall Study|Withdrawal by Subject|2
4470681|NCT00643916|7264053|FG003|Overall Study|Withdrawal by Subject|1
4470682|NCT00643916|7264054|FG004|Overall Study|Withdrawal by Subject|0
4470683|NCT00643916|7264055|FG005|Overall Study|Withdrawal by Subject|1
4470684|NCT00643916|7264050|FG000|Overall Study|Not Vaccinated|2
4470685|NCT00643916|7264051|FG001|Overall Study|Not Vaccinated|2
4470686|NCT00643916|7264052|FG002|Overall Study|Not Vaccinated|3
4470687|NCT00643916|7264053|FG003|Overall Study|Not Vaccinated|0
4470688|NCT00643916|7264054|FG004|Overall Study|Not Vaccinated|2
4470689|NCT00643916|7264055|FG005|Overall Study|Not Vaccinated|0
4470690|NCT00644059|7264072|FG000|Overall Study|Lost to Follow-up|37
4470691|NCT00644059|7264073|FG001|Overall Study|Lost to Follow-up|34
4470692|NCT00644059|7264074|FG002|Overall Study|Lost to Follow-up|16
4470693|NCT00644059|7264072|FG000|Overall Study|Withdrawal by Subject|52
4470694|NCT00644059|7264073|FG001|Overall Study|Withdrawal by Subject|60
4470695|NCT00644059|7264074|FG002|Overall Study|Withdrawal by Subject|30
4470696|NCT00644059|7264072|FG000|Overall Study|Adverse Event|8
4470697|NCT00644059|7264073|FG001|Overall Study|Adverse Event|5
4470698|NCT00644059|7264074|FG002|Overall Study|Adverse Event|1
4470699|NCT00644059|7264072|FG000|Overall Study|Inappropriate Enrollment|1
4470700|NCT00644059|7264073|FG001|Overall Study|Inappropriate Enrollment|3
4470701|NCT00644059|7264074|FG002|Overall Study|Inappropriate Enrollment|0
4470702|NCT00644059|7264072|FG000|Overall Study|Protocol Deviation/violation|20
4470703|NCT00644059|7264073|FG001|Overall Study|Protocol Deviation/violation|19
4470704|NCT00644059|7264074|FG002|Overall Study|Protocol Deviation/violation|15
4470705|NCT00644059|7264072|FG000|Overall Study|Unable to classify|6
4470706|NCT00644059|7264073|FG001|Overall Study|Unable to classify|2
4470707|NCT00644059|7264074|FG002|Overall Study|Unable to classify|3
4470708|NCT00644332|7264141|FG000|Overall Study|Adverse Event|11
4470709|NCT00644332|7264141|FG000|Overall Study|Withdrawal by Subject|6
4470710|NCT00644332|7264141|FG000|Overall Study|Completion Status Unknown|2
4470711|NCT00644332|7264141|FG000|Overall Study|Did Not Meet Eligibility Requirements|1
4470712|NCT00644332|7264141|FG000|Overall Study|Could Not Attend Scheduled Visits|1
4470713|NCT00644358|7264145|FG000|Overall Study|Adverse Event|124
4470714|NCT00644358|7264145|FG000|Overall Study|Lost to Follow-up|105
4470715|NCT00644358|7264145|FG000|Overall Study|Consent Withdrawal|64
4470716|NCT00644358|7264145|FG000|Overall Study|Lack of Effectiveness|39
4470717|NCT00644358|7264145|FG000|Overall Study|Protocol Violation|5
4470718|NCT00644358|7264145|FG000|Overall Study|Noncompliance|14
4470719|NCT00644358|7264145|FG000|Overall Study|Other Unspecified|11
4697595|NCT02653664|7611438|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3
4697596|NCT02653664|7611439|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0
4697597|NCT02653664|7611440|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0
4697598|NCT02653664|7611438|FG000|6 Month Follow-Up|Withdrawal by Subject|13
4697599|NCT02653664|7611439|FG001|6 Month Follow-Up|Withdrawal by Subject|7
4697600|NCT02653664|7611440|FG002|6 Month Follow-Up|Withdrawal by Subject|14
4697601|NCT02653664|7611438|FG000|6 Month Follow-Up|Lost to Follow-up|10
4697602|NCT02653664|7611439|FG001|6 Month Follow-Up|Lost to Follow-up|11
4697603|NCT02653664|7611440|FG002|6 Month Follow-Up|Lost to Follow-up|9
4697604|NCT02653664|7611438|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0
4697605|NCT02653664|7611439|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2
4697606|NCT02653664|7611440|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0
4697607|NCT02653664|7611438|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0
4697608|NCT02653664|7611439|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1
4697609|NCT02653664|7611440|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0
4697610|NCT02654002|7611483|FG000|Overall Study|Adverse Event|0
4697611|NCT02654002|7611484|FG001|Overall Study|Adverse Event|0
4697612|NCT02654002|7611485|FG002|Overall Study|Adverse Event|0
4697613|NCT02654002|7611486|FG003|Overall Study|Adverse Event|0
4697614|NCT02654002|7611487|FG004|Overall Study|Adverse Event|0
4697615|NCT02654002|7611488|FG005|Overall Study|Adverse Event|0
4697616|NCT02654002|7611489|FG006|Overall Study|Adverse Event|1
4697617|NCT02654002|7611490|FG007|Overall Study|Adverse Event|0
4697618|NCT02654002|7611491|FG008|Overall Study|Adverse Event|0
4697619|NCT02654002|7611483|FG000|Overall Study|Withdrew Consent|0
4697620|NCT02654002|7611484|FG001|Overall Study|Withdrew Consent|0
4697621|NCT02654002|7611485|FG002|Overall Study|Withdrew Consent|0
4697622|NCT02654002|7611486|FG003|Overall Study|Withdrew Consent|0
4697623|NCT02654002|7611487|FG004|Overall Study|Withdrew Consent|0
4697624|NCT02654002|7611488|FG005|Overall Study|Withdrew Consent|1
4697625|NCT02654002|7611489|FG006|Overall Study|Withdrew Consent|0
4697626|NCT02654002|7611490|FG007|Overall Study|Withdrew Consent|1
4697627|NCT02654002|7611491|FG008|Overall Study|Withdrew Consent|0
4697628|NCT02654054|7611529|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2
4697629|NCT02654054|7611530|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6
4697630|NCT02654054|7611531|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7
4697631|NCT02654054|7611529|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3
4697632|NCT02654054|7611530|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0
4697633|NCT02654054|7611531|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13
4697634|NCT02654054|7611529|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2
4697635|NCT02654054|7611530|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2
4697636|NCT02654054|7611531|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2
4697637|NCT02654054|7611529|FG000|Post-Treatment Follow-Up Period|Other|1
4697638|NCT02654054|7611530|FG001|Post-Treatment Follow-Up Period|Other|0
4697639|NCT02654054|7611531|FG002|Post-Treatment Follow-Up Period|Other|4
4697640|NCT02654054|7611529|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0
4697641|NCT02654054|7611530|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0
4697642|NCT02654054|7611531|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4
4697643|NCT02654145|7611540|FG000|Overall Study|Lack of Efficacy|1
4697644|NCT02654145|7611540|FG000|Overall Study|Protocol Violation|1
4697645|NCT02654145|7611540|FG000|Overall Study|Withdrawal by Subject|5
4697646|NCT02654717|7611574|FG000|Overall Study|Adverse Event|2
4697647|NCT02654717|7611575|FG001|Overall Study|Adverse Event|2
4697648|NCT02654717|7611574|FG000|Overall Study|Protocol Violation|1
4697649|NCT02654717|7611575|FG001|Overall Study|Protocol Violation|2
4697650|NCT02654717|7611574|FG000|Overall Study|Withdrawal by Subject|0
4697651|NCT02654717|7611575|FG001|Overall Study|Withdrawal by Subject|1
4697652|NCT02654717|7611574|FG000|Overall Study|Non-permitted medication|3
4697653|NCT02654717|7611575|FG001|Overall Study|Non-permitted medication|0
4697654|NCT02654977|7611632|FG000|Overall Study|Death|1
4697655|NCT02654977|7611632|FG000|Overall Study|Lost to Follow-up|1
4697656|NCT02654977|7611632|FG000|Overall Study|Adverse Event|1
4697657|NCT02654977|7611632|FG000|Overall Study|Withdrawal by Subject|1
4697658|NCT02654977|7611632|FG000|Overall Study|Lack of Efficacy|3
4697659|NCT02655224|7611638|FG000|Overall Study|Adverse Event|1
4697660|NCT02655224|7611639|FG001|Overall Study|Adverse Event|1
4697661|NCT02655237|7611647|FG000|Overall Study|Adverse Event|10
4697662|NCT02655237|7611648|FG001|Overall Study|Adverse Event|7
4697663|NCT02655237|7611647|FG000|Overall Study|Protocol Deviation|2
4697664|NCT02655237|7611648|FG001|Overall Study|Protocol Deviation|0
4697665|NCT02655237|7611647|FG000|Overall Study|Withdrawal by Participant|1
4470720|NCT00644423|7264151|FG000|Overall Study|Lost to Follow-up|1
4470721|NCT00644423|7264152|FG001|Overall Study|Lost to Follow-up|1
4470722|NCT00644787|7264171|FG000|Period 1: Titration Phase|Adverse Event|11
4470723|NCT00644787|7264172|FG001|Period 1: Titration Phase|Adverse Event|0
4470724|NCT00644787|7264173|FG002|Period 1: Titration Phase|Adverse Event|0
4470725|NCT00644787|7264171|FG000|Period 1: Titration Phase|Withdrawal by Subject|2
4470726|NCT00644787|7264172|FG001|Period 1: Titration Phase|Withdrawal by Subject|0
4470727|NCT00644787|7264173|FG002|Period 1: Titration Phase|Withdrawal by Subject|0
4470728|NCT00644787|7264171|FG000|Period 1: Titration Phase|Physician Decision|1
4470729|NCT00644787|7264172|FG001|Period 1: Titration Phase|Physician Decision|0
4470730|NCT00644787|7264173|FG002|Period 1: Titration Phase|Physician Decision|0
4470731|NCT00644787|7264171|FG000|Period 1: Titration Phase|Worsening of underlying disease|5
4470732|NCT00644787|7264172|FG001|Period 1: Titration Phase|Worsening of underlying disease|0
4470733|NCT00644787|7264173|FG002|Period 1: Titration Phase|Worsening of underlying disease|0
4470734|NCT00644787|7264171|FG000|Period 1: Titration Phase|Worsening of complications|1
4470735|NCT00644787|7264172|FG001|Period 1: Titration Phase|Worsening of complications|0
4470736|NCT00644787|7264173|FG002|Period 1: Titration Phase|Worsening of complications|0
4470737|NCT00644787|7264171|FG000|Period 1: Titration Phase|Worsening of symptoms|1
4470738|NCT00644787|7264172|FG001|Period 1: Titration Phase|Worsening of symptoms|0
4470739|NCT00644787|7264173|FG002|Period 1: Titration Phase|Worsening of symptoms|0
4470740|NCT00644787|7264171|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3
4470741|NCT00644787|7264172|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0
4470742|NCT00644787|7264173|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0
4470743|NCT00644787|7264171|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3
4470744|NCT00644787|7264172|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0
4470745|NCT00644787|7264173|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0
4470746|NCT00644787|7264171|FG000|Period 2: Double Blind Phase|Adverse Event|0
4470747|NCT00644787|7264172|FG001|Period 2: Double Blind Phase|Adverse Event|2
4470748|NCT00644787|7264173|FG002|Period 2: Double Blind Phase|Adverse Event|4
4470749|NCT00644787|7264171|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0
4470750|NCT00644787|7264172|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1
4470751|NCT00644787|7264173|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0
4470752|NCT00644787|7264171|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0
4470753|NCT00644787|7264172|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6
4470754|NCT00644787|7264173|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2
4470755|NCT00644787|7264171|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0
4470756|NCT00644787|7264172|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0
4470757|NCT00644787|7264173|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1
4697666|NCT02655237|7611648|FG001|Overall Study|Withdrawal by Participant|2
4697667|NCT02655237|7611647|FG000|Overall Study|Lack of Efficacy|0
4697668|NCT02655237|7611648|FG001|Overall Study|Lack of Efficacy|1
4697669|NCT02655237|7611647|FG000|Overall Study|Recovery Leading to Surgery|2
4697670|NCT02655237|7611648|FG001|Overall Study|Recovery Leading to Surgery|1
4697671|NCT02655237|7611647|FG000|Overall Study|Reduction of Hemoglobin Concentration|1
4697672|NCT02655237|7611648|FG001|Overall Study|Reduction of Hemoglobin Concentration|0
4697673|NCT02655237|7611647|FG000|Overall Study|Randomized but Not Treated|1
4697674|NCT02655237|7611648|FG001|Overall Study|Randomized but Not Treated|0
4697675|NCT02655419|7611665|FG000|Overall Study|Enrolled but not treated|1
4697676|NCT02655419|7611666|FG001|Overall Study|Enrolled but not treated|5
4697677|NCT02655419|7611665|FG000|Overall Study|Withdrawal by Subject|4
4697678|NCT02655419|7611666|FG001|Overall Study|Withdrawal by Subject|1
4697679|NCT02655419|7611665|FG000|Overall Study|Other|0
4697680|NCT02655419|7611666|FG001|Overall Study|Other|1
4697681|NCT02655666|7611704|FG000|Overall Study|Sponsor stopped this clinical research.|12
4697682|NCT02655679|7611713|FG000|Overall Study|Adverse Event|0
4697683|NCT02655679|7611714|FG001|Overall Study|Adverse Event|1
4697684|NCT02655679|7611715|FG002|Overall Study|Adverse Event|0
4697685|NCT02655679|7611716|FG003|Overall Study|Adverse Event|0
4697686|NCT02655679|7611717|FG004|Overall Study|Adverse Event|0
4697687|NCT02655679|7611713|FG000|Overall Study|Withdrawal by Subject|1
4697688|NCT02655679|7611714|FG001|Overall Study|Withdrawal by Subject|1
4697689|NCT02655679|7611715|FG002|Overall Study|Withdrawal by Subject|0
4697690|NCT02655679|7611716|FG003|Overall Study|Withdrawal by Subject|3
4697691|NCT02655679|7611717|FG004|Overall Study|Withdrawal by Subject|1
4697692|NCT02655679|7611713|FG000|Overall Study|Inability to Comply with the Protocol|1
4697693|NCT02655679|7611714|FG001|Overall Study|Inability to Comply with the Protocol|0
4697694|NCT02655679|7611715|FG002|Overall Study|Inability to Comply with the Protocol|0
4470758|NCT00644878|7264181|FG000|Overall Study|Adverse Event|2
4470759|NCT00644878|7264181|FG000|Overall Study|Abnormal laboratory value|3
4470760|NCT00644878|7264181|FG000|Overall Study|Protocol deviation|2
4470761|NCT00644878|7264181|FG000|Overall Study|Treatment duration completed as per protocol|11
4470762|NCT00644917|7264185|FG000|Overall Study|Withdrawal by Subject|2
4470763|NCT00644969|7264195|FG000|Treatment Phase|Randomized, not treated|1
4470764|NCT00644969|7264196|FG001|Treatment Phase|Randomized, not treated|0
4470765|NCT00644969|7264195|FG000|Treatment Phase|Adverse Event|3
4470766|NCT00644969|7264196|FG001|Treatment Phase|Adverse Event|0
4470767|NCT00644969|7264195|FG000|Treatment Phase|Withdrawal by Subject|4
4470768|NCT00644969|7264196|FG001|Treatment Phase|Withdrawal by Subject|0
4470769|NCT00644969|7264195|FG000|Treatment Phase|Lost to Follow-up|2
4470770|NCT00644969|7264196|FG001|Treatment Phase|Lost to Follow-up|2
4470771|NCT00644969|7264195|FG000|Treatment Phase|Other|4
4470772|NCT00644969|7264196|FG001|Treatment Phase|Other|1
4470773|NCT00644969|7264195|FG000|Post Treatment Phase|Death|1
4470774|NCT00644969|7264196|FG001|Post Treatment Phase|Death|0
4470775|NCT00644969|7264195|FG000|Post Treatment Phase|Withdrawal by Subject|4
4470776|NCT00644969|7264196|FG001|Post Treatment Phase|Withdrawal by Subject|2
4470777|NCT00644969|7264195|FG000|Post Treatment Phase|Lost to Follow-up|4
4470778|NCT00644969|7264196|FG001|Post Treatment Phase|Lost to Follow-up|1
4470779|NCT00644969|7264195|FG000|Post Treatment Phase|Other|1
4470780|NCT00644969|7264196|FG001|Post Treatment Phase|Other|0
4470781|NCT00644995|7264204|FG000|Overall Study|Lost to Follow-up|1
4470782|NCT00644995|7264205|FG001|Overall Study|Lost to Follow-up|4
4470783|NCT00644995|7264204|FG000|Overall Study|Refused|1
4470784|NCT00644995|7264205|FG001|Overall Study|Refused|0
4470785|NCT00645099|7264224|FG000|Overall Study|Lack of Efficacy|15
4470786|NCT00645099|7264225|FG001|Overall Study|Lack of Efficacy|6
4470787|NCT00645099|7264224|FG000|Overall Study|Withdrawal by Subject|30
4470788|NCT00645099|7264225|FG001|Overall Study|Withdrawal by Subject|22
4470789|NCT00645099|7264224|FG000|Overall Study|Lost to Follow-up|6
4470790|NCT00645099|7264225|FG001|Overall Study|Lost to Follow-up|4
4470791|NCT00645099|7264224|FG000|Overall Study|Adverse Event|11
4470792|NCT00645099|7264225|FG001|Overall Study|Adverse Event|5
4470793|NCT00645099|7264224|FG000|Overall Study|Other|9
4470794|NCT00645099|7264225|FG001|Overall Study|Other|5
4470795|NCT00645164|7264231|FG000|Overall Study|Lost to Follow-up|2
4470796|NCT00645164|7264231|FG000|Overall Study|Withdrawal by Subject|4
4470797|NCT00645164|7264231|FG000|Overall Study|Protocol Violation|1
4470798|NCT00645411|7264243|FG000|Overall Study|Adverse Event|0
4470799|NCT00645411|7264244|FG001|Overall Study|Adverse Event|0
4470800|NCT00645411|7264245|FG002|Overall Study|Adverse Event|0
4470801|NCT00645411|7264246|FG003|Overall Study|Adverse Event|2
4470802|NCT00645411|7264243|FG000|Overall Study|Withdrawal by Subject|2
4470803|NCT00645411|7264244|FG001|Overall Study|Withdrawal by Subject|1
4470804|NCT00645411|7264245|FG002|Overall Study|Withdrawal by Subject|19
4470805|NCT00645411|7264246|FG003|Overall Study|Withdrawal by Subject|21
4470806|NCT00645411|7264243|FG000|Overall Study|Lost to Follow-up|10
4470807|NCT00645411|7264244|FG001|Overall Study|Lost to Follow-up|5
4470808|NCT00645411|7264245|FG002|Overall Study|Lost to Follow-up|124
4470809|NCT00645411|7264246|FG003|Overall Study|Lost to Follow-up|75
4470810|NCT00645411|7264243|FG000|Overall Study|Protocol Violation|1
4470811|NCT00645411|7264244|FG001|Overall Study|Protocol Violation|0
4470812|NCT00645411|7264245|FG002|Overall Study|Protocol Violation|1
4470813|NCT00645411|7264246|FG003|Overall Study|Protocol Violation|0
4470814|NCT00645411|7264243|FG000|Overall Study|Inappropriate enrollment|0
4470815|NCT00645411|7264244|FG001|Overall Study|Inappropriate enrollment|0
4470816|NCT00645411|7264245|FG002|Overall Study|Inappropriate enrollment|4
4470817|NCT00645411|7264246|FG003|Overall Study|Inappropriate enrollment|1
4470818|NCT00645411|7264243|FG000|Overall Study|Unable to classify|0
4470819|NCT00645411|7264244|FG001|Overall Study|Unable to classify|0
4470820|NCT00645411|7264245|FG002|Overall Study|Unable to classify|3
4470821|NCT00645411|7264246|FG003|Overall Study|Unable to classify|4
4516498|NCT00960531|7327984|FG009|Overall Study|Withdrawal by Subject|0
4516499|NCT00960531|7327975|FG000|Overall Study|Caregiver Request|2
4516500|NCT00960531|7327976|FG001|Overall Study|Caregiver Request|0
4516501|NCT00960531|7327977|FG002|Overall Study|Caregiver Request|6
4516502|NCT00960531|7327978|FG003|Overall Study|Caregiver Request|5
4516503|NCT00960531|7327979|FG004|Overall Study|Caregiver Request|0
4516504|NCT00960531|7327980|FG005|Overall Study|Caregiver Request|2
4516505|NCT00960531|7327981|FG006|Overall Study|Caregiver Request|3
4516506|NCT00960531|7327982|FG007|Overall Study|Caregiver Request|1
4516507|NCT00960531|7327983|FG008|Overall Study|Caregiver Request|3
4516508|NCT00960531|7327984|FG009|Overall Study|Caregiver Request|0
4516509|NCT00960531|7327975|FG000|Overall Study|Investigator Request|0
4516510|NCT00960531|7327976|FG001|Overall Study|Investigator Request|0
4516511|NCT00960531|7327977|FG002|Overall Study|Investigator Request|1
4516512|NCT00960531|7327978|FG003|Overall Study|Investigator Request|0
4516513|NCT00960531|7327979|FG004|Overall Study|Investigator Request|0
4516514|NCT00960531|7327980|FG005|Overall Study|Investigator Request|0
4516515|NCT00960531|7327981|FG006|Overall Study|Investigator Request|0
4516516|NCT00960531|7327982|FG007|Overall Study|Investigator Request|0
4516517|NCT00960531|7327983|FG008|Overall Study|Investigator Request|0
4516518|NCT00960531|7327984|FG009|Overall Study|Investigator Request|0
4516519|NCT00960531|7327975|FG000|Overall Study|Discontinuation of Study by Sponsor|0
4516520|NCT00960531|7327976|FG001|Overall Study|Discontinuation of Study by Sponsor|0
4516521|NCT00960531|7327977|FG002|Overall Study|Discontinuation of Study by Sponsor|0
4470822|NCT00645528|7264272|FG000|Overall Study|Did not show up for Visit 2|7
4470823|NCT00645593|7264278|FG000|Overall Study|Later found to be ineligible|1
4470824|NCT00645593|7264279|FG001|Overall Study|Later found to be ineligible|0
4470825|NCT00645671|7264287|FG000|Overall Study|Protocol Violation|1
4470826|NCT00645671|7264288|FG001|Overall Study|Protocol Violation|0
4470827|NCT00645671|7264287|FG000|Overall Study|Withdrawal by Subject|0
4470828|NCT00645671|7264288|FG001|Overall Study|Withdrawal by Subject|4
4470829|NCT00645671|7264287|FG000|Overall Study|Adverse Event|0
4470830|NCT00645671|7264288|FG001|Overall Study|Adverse Event|1
4470831|NCT00645671|7264287|FG000|Overall Study|Physician Decision|0
4470832|NCT00645671|7264288|FG001|Overall Study|Physician Decision|1
4470833|NCT00645788|7264318|FG000|Overall Study|Did not receive study drug|1
4470834|NCT00645788|7264319|FG001|Overall Study|Did not receive study drug|1
4470835|NCT00645788|7264320|FG002|Overall Study|Did not receive study drug|0
4470836|NCT00645788|7264321|FG003|Overall Study|Did not receive study drug|0
4470837|NCT00645788|7264318|FG000|Overall Study|Adverse Event|4
4470838|NCT00645788|7264319|FG001|Overall Study|Adverse Event|9
4470839|NCT00645788|7264320|FG002|Overall Study|Adverse Event|5
4470840|NCT00645788|7264321|FG003|Overall Study|Adverse Event|3
4470841|NCT00645788|7264318|FG000|Overall Study|Lost to Follow-up|1
4470842|NCT00645788|7264319|FG001|Overall Study|Lost to Follow-up|0
4470843|NCT00645788|7264320|FG002|Overall Study|Lost to Follow-up|0
4470844|NCT00645788|7264321|FG003|Overall Study|Lost to Follow-up|0
4470845|NCT00645788|7264318|FG000|Overall Study|Protocol Violation|1
4470846|NCT00645788|7264319|FG001|Overall Study|Protocol Violation|0
4470847|NCT00645788|7264320|FG002|Overall Study|Protocol Violation|2
4470848|NCT00645788|7264321|FG003|Overall Study|Protocol Violation|0
4470849|NCT00645788|7264318|FG000|Overall Study|Withdrawal by Subject|0
4470850|NCT00645788|7264319|FG001|Overall Study|Withdrawal by Subject|1
4470851|NCT00645788|7264320|FG002|Overall Study|Withdrawal by Subject|0
4470852|NCT00645788|7264321|FG003|Overall Study|Withdrawal by Subject|2
4470853|NCT00645788|7264318|FG000|Overall Study|Pulmonary exacerbation|13
4470854|NCT00645788|7264319|FG001|Overall Study|Pulmonary exacerbation|16
4470855|NCT00645788|7264320|FG002|Overall Study|Pulmonary exacerbation|11
4470856|NCT00645788|7264321|FG003|Overall Study|Pulmonary exacerbation|9
4470857|NCT00645840|7264340|FG000|Overall Study|Protocol Violation|3
4470858|NCT00645853|7264346|FG000|Overall Study|Adverse Event|18
4470859|NCT00645853|7264347|FG001|Overall Study|Adverse Event|7
4470860|NCT00645853|7264346|FG000|Overall Study|AZ study closure in Hungary|60
4470861|NCT00645853|7264347|FG001|Overall Study|AZ study closure in Hungary|40
4470862|NCT00645853|7264346|FG000|Overall Study|Withdrawal by Subject|5
4470863|NCT00645853|7264347|FG001|Overall Study|Withdrawal by Subject|2
4470864|NCT00645853|7264346|FG000|Overall Study|Protocol Violation|0
4470865|NCT00645853|7264347|FG001|Overall Study|Protocol Violation|2
4470866|NCT00645853|7264346|FG000|Overall Study|Discontinuation criteria|2
4470867|NCT00645853|7264347|FG001|Overall Study|Discontinuation criteria|2
4470868|NCT00645853|7264346|FG000|Overall Study|recall of ICF, planned operation, death|7
4470869|NCT00645853|7264347|FG001|Overall Study|recall of ICF, planned operation, death|4
4470870|NCT00645944|7264355|FG000|Randomized|Withdrawal by Subject|1
4470871|NCT00645944|7264356|FG001|Randomized|Withdrawal by Subject|2
4470872|NCT00645944|7264355|FG000|Received Medication|Adverse Event|2
4470873|NCT00645944|7264356|FG001|Received Medication|Adverse Event|1
4470874|NCT00645944|7264355|FG000|Received Medication|Withdrawal by Subject|1
4470875|NCT00645944|7264356|FG001|Received Medication|Withdrawal by Subject|1
4470876|NCT00645944|7264355|FG000|Received Medication|Lost to Follow-up|1
4470877|NCT00645944|7264356|FG001|Received Medication|Lost to Follow-up|0
4470878|NCT00645944|7264355|FG000|Received Medication|Protocol Violation|2
4470879|NCT00645944|7264356|FG001|Received Medication|Protocol Violation|1
4470880|NCT00646113|7264375|FG000|Overall Study|Lost to Follow-up|5
4470881|NCT00646113|7264375|FG000|Overall Study|Adverse Event|3
4470882|NCT00646399|7264381|FG000|Overall Study|Death|63
4470883|NCT00646399|7264382|FG001|Overall Study|Death|53
4470884|NCT00646399|7264381|FG000|Overall Study|Withdrawal by Subject|9
4470885|NCT00646399|7264382|FG001|Overall Study|Withdrawal by Subject|10
4470886|NCT00646399|7264381|FG000|Overall Study|Other Reason|11
4470887|NCT00646399|7264382|FG001|Overall Study|Other Reason|11
4470888|NCT00646451|7264388|FG000|Overall Study|Adverse Event|3
4470889|NCT00646451|7264389|FG001|Overall Study|Adverse Event|0
4470890|NCT00646451|7264388|FG000|Overall Study|Exacerbation of pre-existing condition|1
4470891|NCT00646451|7264389|FG001|Overall Study|Exacerbation of pre-existing condition|0
4470892|NCT00646776|7264434|FG000|Overall Study|Adverse Event|1
4470893|NCT00646776|7264435|FG001|Overall Study|Adverse Event|9
4470894|NCT00646776|7264434|FG000|Overall Study|Investigator discretion|0
4470895|NCT00646776|7264435|FG001|Overall Study|Investigator discretion|4
4470896|NCT00646906|7264448|FG000|Crossover Period 1|Withdrawal by Subject|1
4470897|NCT00646906|7264449|FG001|Crossover Period 1|Withdrawal by Subject|0
4470898|NCT00646906|7264450|FG002|Crossover Period 1|Withdrawal by Subject|0
4470899|NCT00646906|7264451|FG003|Crossover Period 1|Withdrawal by Subject|0
4470900|NCT00646906|7264452|FG004|Crossover Period 1|Withdrawal by Subject|0
4470901|NCT00646906|7264453|FG005|Crossover Period 1|Withdrawal by Subject|1
4470902|NCT00646906|7264454|FG006|Crossover Period 1|Withdrawal by Subject|0
4470903|NCT00646906|7264448|FG000|Crossover Period 2|Withdrawal by Subject|0
4470904|NCT00646906|7264449|FG001|Crossover Period 2|Withdrawal by Subject|1
4470905|NCT00646906|7264450|FG002|Crossover Period 2|Withdrawal by Subject|2
4470906|NCT00646906|7264451|FG003|Crossover Period 2|Withdrawal by Subject|1
4470907|NCT00646906|7264452|FG004|Crossover Period 2|Withdrawal by Subject|0
4470908|NCT00646906|7264453|FG005|Crossover Period 2|Withdrawal by Subject|0
4470909|NCT00646906|7264454|FG006|Crossover Period 2|Withdrawal by Subject|0
4470910|NCT00646906|7264448|FG000|Crossover Period 2|Physician Decision|0
4470911|NCT00646906|7264449|FG001|Crossover Period 2|Physician Decision|0
4470912|NCT00646906|7264450|FG002|Crossover Period 2|Physician Decision|0
4470913|NCT00646906|7264451|FG003|Crossover Period 2|Physician Decision|0
4470914|NCT00646906|7264452|FG004|Crossover Period 2|Physician Decision|0
4470915|NCT00646906|7264453|FG005|Crossover Period 2|Physician Decision|0
4470916|NCT00646906|7264454|FG006|Crossover Period 2|Physician Decision|1
4470917|NCT00646958|7264470|FG000|Overall Study|Lack of Efficacy|1
4470918|NCT00646958|7264471|FG001|Overall Study|Lack of Efficacy|0
4470919|NCT00646958|7264472|FG002|Overall Study|Lack of Efficacy|0
4470920|NCT00646958|7264470|FG000|Overall Study|Adverse Event|4
4470921|NCT00646958|7264471|FG001|Overall Study|Adverse Event|0
4470922|NCT00646958|7264472|FG002|Overall Study|Adverse Event|0
4470923|NCT00646958|7264470|FG000|Overall Study|Lost to Follow-up|1
4470924|NCT00646958|7264471|FG001|Overall Study|Lost to Follow-up|5
4470925|NCT00646958|7264472|FG002|Overall Study|Lost to Follow-up|7
4470926|NCT00646958|7264470|FG000|Overall Study|Protocol Violation|1
4470927|NCT00646958|7264471|FG001|Overall Study|Protocol Violation|1
4470928|NCT00646958|7264472|FG002|Overall Study|Protocol Violation|0
4470929|NCT00646958|7264470|FG000|Overall Study|Abnormal screening lab tests|1
4470930|NCT00646958|7264471|FG001|Overall Study|Abnormal screening lab tests|1
4470931|NCT00646958|7264472|FG002|Overall Study|Abnormal screening lab tests|0
4470932|NCT00646958|7264470|FG000|Overall Study|Withdrawal by Subject|1
4470933|NCT00646958|7264471|FG001|Overall Study|Withdrawal by Subject|2
4697695|NCT02655679|7611716|FG003|Overall Study|Inability to Comply with the Protocol|0
4697696|NCT02655679|7611717|FG004|Overall Study|Inability to Comply with the Protocol|0
4697697|NCT02655679|7611713|FG000|Overall Study|Lost to Follow-up|0
4697698|NCT02655679|7611714|FG001|Overall Study|Lost to Follow-up|1
4697699|NCT02655679|7611715|FG002|Overall Study|Lost to Follow-up|1
4697700|NCT02655679|7611716|FG003|Overall Study|Lost to Follow-up|1
4697701|NCT02655679|7611717|FG004|Overall Study|Lost to Follow-up|0
4697702|NCT02655679|7611713|FG000|Overall Study|Other Miscellaneous Reasons|1
4697703|NCT02655679|7611714|FG001|Overall Study|Other Miscellaneous Reasons|0
4697704|NCT02655679|7611715|FG002|Overall Study|Other Miscellaneous Reasons|0
4697705|NCT02655679|7611716|FG003|Overall Study|Other Miscellaneous Reasons|0
4697706|NCT02655679|7611717|FG004|Overall Study|Other Miscellaneous Reasons|0
4697707|NCT02655887|7611730|FG000|Overall Study|Lost to Follow-up|3
4697708|NCT02655887|7611730|FG000|Overall Study|Death|4
4697709|NCT02655887|7611730|FG000|Overall Study|Withdrawal by Subject|3
4697710|NCT02655887|7611730|FG000|Overall Study|Missed 12-month follow-up visit|4
4697711|NCT02656173|7611752|FG000|Overall Study|Deviation from the Eligible Criteria|3
4697712|NCT02656173|7611753|FG001|Overall Study|Deviation from the Eligible Criteria|2
4697713|NCT02656173|7611752|FG000|Overall Study|Adverse Event|7
4697714|NCT02656173|7611753|FG001|Overall Study|Adverse Event|5
4697715|NCT02656173|7611752|FG000|Overall Study|Withdrawal by Subject|1
4697716|NCT02656173|7611753|FG001|Overall Study|Withdrawal by Subject|3
4697717|NCT02656173|7611752|FG000|Overall Study|Protocol Violation|0
4697718|NCT02656173|7611753|FG001|Overall Study|Protocol Violation|1
4697719|NCT02656173|7611752|FG000|Overall Study|Miscellaneous|2
4697720|NCT02656173|7611753|FG001|Overall Study|Miscellaneous|0
4697721|NCT02656329|7611763|FG000|Overall Study|Lost to Follow-up|2
4697722|NCT02656329|7611764|FG001|Overall Study|Lost to Follow-up|3
4697723|NCT02656329|7611763|FG000|Overall Study|Withdrawal by Subject|7
4697724|NCT02656329|7611764|FG001|Overall Study|Withdrawal by Subject|6
4697725|NCT02656329|7611763|FG000|Overall Study|Study termination by Sponsor|150
4697726|NCT02656329|7611764|FG001|Overall Study|Study termination by Sponsor|142
4697727|NCT02656329|7611763|FG000|Overall Study|Other than specified above|5
4697728|NCT02656329|7611764|FG001|Overall Study|Other than specified above|6
4697729|NCT02656680|7611811|FG000|Overall Study|Lost to Follow-up|0
4697730|NCT02656680|7611812|FG001|Overall Study|Lost to Follow-up|1
4697731|NCT02656693|7611823|FG000|Overall Study|Pregnancy|1
4697732|NCT02656693|7611824|FG001|Overall Study|Pregnancy|1
4697733|NCT02656693|7611825|FG002|Overall Study|Pregnancy|1
4697734|NCT02656693|7611823|FG000|Overall Study|Bariatric surgery|0
4697735|NCT02656693|7611824|FG001|Overall Study|Bariatric surgery|1
4697736|NCT02656693|7611825|FG002|Overall Study|Bariatric surgery|2
4697737|NCT02657031|7611850|FG000|Overall Study|Adverse Event|1
4697738|NCT02657031|7611851|FG001|Overall Study|Adverse Event|2
4697739|NCT02657369|7611873|FG000|Overall Study|Death|27
4697740|NCT02657369|7611873|FG000|Overall Study|Study terminated by sponsor|7
4697741|NCT02657408|7611879|FG000|Overall Study|Adverse Event|3
4697742|NCT02657408|7611880|FG001|Overall Study|Adverse Event|7
4697743|NCT02657889|7611911|FG000|Overall Study|Death|5
4470934|NCT00646958|7264472|FG002|Overall Study|Withdrawal by Subject|0
4470935|NCT00646958|7264470|FG000|Overall Study|Did not receive study drug|2
4470936|NCT00646958|7264471|FG001|Overall Study|Did not receive study drug|0
4470937|NCT00646958|7264472|FG002|Overall Study|Did not receive study drug|2
4470938|NCT00647270|7264483|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2
4518749|NCT00976209|7331019|FG000|Wash-out Period|Adverse Event|1
4470939|NCT00647270|7264484|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7
4470940|NCT00647270|7264485|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7
4470941|NCT00647270|7264483|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0
4470942|NCT00647270|7264484|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1
4470943|NCT00647270|7264485|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1
4470944|NCT00647270|7264483|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2
4470945|NCT00647270|7264484|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1
4470946|NCT00647270|7264485|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7
4470947|NCT00647270|7264483|FG000|Period 1, Placebo-control (12 Weeks)|Other|4
4470948|NCT00647270|7264484|FG001|Period 1, Placebo-control (12 Weeks)|Other|4
4470949|NCT00647270|7264485|FG002|Period 1, Placebo-control (12 Weeks)|Other|8
4470950|NCT00647270|7264483|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1
4470951|NCT00647270|7264484|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3
4470952|NCT00647270|7264485|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3
4470953|NCT00647270|7264483|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0
4470954|NCT00647270|7264484|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0
4470955|NCT00647270|7264485|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4
4470956|NCT00647270|7264483|FG000|Period 2, Placebo Switched to Adalimumab|Other|2
4470957|NCT00647270|7264484|FG001|Period 2, Placebo Switched to Adalimumab|Other|6
4470958|NCT00647270|7264485|FG002|Period 2, Placebo Switched to Adalimumab|Other|0
4470959|NCT00647296|7264500|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0
4470960|NCT00647296|7264501|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0
4470961|NCT00647296|7264502|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0
4470962|NCT00647296|7264503|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1
4470963|NCT00647296|7264500|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1
4470964|NCT00647296|7264501|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0
4470965|NCT00647296|7264502|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0
4470966|NCT00647296|7264503|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1
4470967|NCT00647296|7264500|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0
4470968|NCT00647296|7264501|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1
4470969|NCT00647296|7264502|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0
4470970|NCT00647296|7264503|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0
4470971|NCT00647296|7264500|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1
4470972|NCT00647296|7264501|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0
4470973|NCT00647296|7264502|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0
4470974|NCT00647296|7264503|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0
4470975|NCT00647296|7264500|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1
4470976|NCT00647296|7264501|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0
4470977|NCT00647296|7264502|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0
4470978|NCT00647296|7264503|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0
4470979|NCT00647296|7264500|FG000|Part 2: 4-week Placebo Washout|Death|3
4470980|NCT00647296|7264501|FG001|Part 2: 4-week Placebo Washout|Death|0
4470981|NCT00647296|7264502|FG002|Part 2: 4-week Placebo Washout|Death|0
4470982|NCT00647296|7264503|FG003|Part 2: 4-week Placebo Washout|Death|0
4470983|NCT00647296|7264500|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0
4470984|NCT00647296|7264501|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5
4470985|NCT00647296|7264502|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0
4470986|NCT00647296|7264503|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4
4470987|NCT00647296|7264500|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0
4470988|NCT00647296|7264501|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1
4470989|NCT00647296|7264502|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0
4470990|NCT00647296|7264503|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4
4470991|NCT00647296|7264500|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0
4470992|NCT00647296|7264501|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1
4470993|NCT00647296|7264502|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0
4470994|NCT00647296|7264503|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0
4470995|NCT00647296|7264500|FG000|Part 2: 76-week Double-Blind Treatment|Death|0
4470996|NCT00647296|7264501|FG001|Part 2: 76-week Double-Blind Treatment|Death|7
4470997|NCT00647296|7264502|FG002|Part 2: 76-week Double-Blind Treatment|Death|0
4470998|NCT00647296|7264503|FG003|Part 2: 76-week Double-Blind Treatment|Death|5
4470999|NCT00647296|7264500|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0
4471000|NCT00647296|7264501|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1
4471001|NCT00647296|7264502|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0
4471002|NCT00647296|7264503|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1
4471003|NCT00647348|7264527|FG000|Overall Study|Lost to Follow-up|3
4471004|NCT00647348|7264528|FG001|Overall Study|Lost to Follow-up|6
4471005|NCT00647556|7264545|FG000|Overall Study|Adverse Event|0
4471006|NCT00647556|7264546|FG001|Overall Study|Adverse Event|1
4471007|NCT00647556|7264545|FG000|Overall Study|Lost to Follow-up|1
4471008|NCT00647556|7264546|FG001|Overall Study|Lost to Follow-up|0
4471009|NCT00647556|7264545|FG000|Overall Study|Protocol Violation|0
4471010|NCT00647556|7264546|FG001|Overall Study|Protocol Violation|1
4471011|NCT00647556|7264545|FG000|Overall Study|Withdrawal by Subject|1
4471012|NCT00647556|7264546|FG001|Overall Study|Withdrawal by Subject|0
4471013|NCT00647556|7264545|FG000|Overall Study|Surgery for pre-existing neck pain|1
4471014|NCT00647556|7264546|FG001|Overall Study|Surgery for pre-existing neck pain|0
4588969|NCT01506609|7433833|FG001|Overall Study|Adverse Event Related to Progression|0
4588970|NCT01506609|7433834|FG002|Overall Study|Adverse Event Related to Progression|0
4588971|NCT01506609|7433835|FG003|Overall Study|Adverse Event Related to Progression|3
4588972|NCT01506609|7433836|FG004|Overall Study|Adverse Event Related to Progression|7
4588973|NCT01506609|7433837|FG005|Overall Study|Adverse Event Related to Progression|3
4588974|NCT01506609|7433832|FG000|Overall Study|Adverse Event Not Related to Progression|0
4588975|NCT01506609|7433833|FG001|Overall Study|Adverse Event Not Related to Progression|1
4588976|NCT01506609|7433834|FG002|Overall Study|Adverse Event Not Related to Progression|0
4588977|NCT01506609|7433835|FG003|Overall Study|Adverse Event Not Related to Progression|6
4697744|NCT02657889|7611912|FG001|Overall Study|Death|2
4471015|NCT00647699|7264554|FG000|Overall Study|Lost to Follow-up|5
4471016|NCT00647699|7264555|FG001|Overall Study|Lost to Follow-up|4
4471017|NCT00647699|7264554|FG000|Overall Study|Withdrawal by Subject|3
4471018|NCT00647699|7264555|FG001|Overall Study|Withdrawal by Subject|8
4471019|NCT00648037|7264572|FG000|Overall Study|Not Treated|1
4471020|NCT00648037|7264572|FG000|Overall Study|Withdrawal by Subject|1
4471021|NCT00648037|7264572|FG000|Overall Study|Adverse Event|11
4471022|NCT00648037|7264572|FG000|Overall Study|Relapse|2
4471023|NCT00648037|7264572|FG000|Overall Study|Other|1
4471024|NCT00648167|7264589|FG000|Overall Study|Adverse Event|6
4471025|NCT00648167|7264589|FG000|Overall Study|unable to swallow tablets|1
4471026|NCT00648739|7264715|FG000|Overall Study|Adverse Event|1
4471027|NCT00648739|7264716|FG001|Overall Study|Adverse Event|0
4471028|NCT00648739|7264717|FG002|Overall Study|Adverse Event|1
4471029|NCT00648739|7264718|FG003|Overall Study|Adverse Event|2
4471030|NCT00648739|7264719|FG004|Overall Study|Adverse Event|1
4471031|NCT00648739|7264720|FG005|Overall Study|Adverse Event|0
4471032|NCT00648739|7264721|FG006|Overall Study|Adverse Event|0
4471033|NCT00648739|7264715|FG000|Overall Study|Withdrawal by Subject|1
4471034|NCT00648739|7264716|FG001|Overall Study|Withdrawal by Subject|0
4471035|NCT00648739|7264717|FG002|Overall Study|Withdrawal by Subject|1
4697745|NCT02657889|7611913|FG002|Overall Study|Death|20
4697746|NCT02657889|7611914|FG003|Overall Study|Death|34
4697747|NCT02657889|7611911|FG000|Overall Study|Lost to Follow-up|2
4471036|NCT00648739|7264718|FG003|Overall Study|Withdrawal by Subject|0
4471037|NCT00648739|7264719|FG004|Overall Study|Withdrawal by Subject|0
4471038|NCT00648739|7264720|FG005|Overall Study|Withdrawal by Subject|2
4697748|NCT02657889|7611912|FG001|Overall Study|Lost to Follow-up|0
4697749|NCT02657889|7611913|FG002|Overall Study|Lost to Follow-up|1
4697750|NCT02657889|7611914|FG003|Overall Study|Lost to Follow-up|2
4697751|NCT02657889|7611911|FG000|Overall Study|Withdrawal by Subject|0
4697752|NCT02657889|7611912|FG001|Overall Study|Withdrawal by Subject|0
4697753|NCT02657889|7611913|FG002|Overall Study|Withdrawal by Subject|8
4697754|NCT02657889|7611914|FG003|Overall Study|Withdrawal by Subject|0
4697755|NCT02657889|7611911|FG000|Overall Study|Ongoing in Study|0
4697756|NCT02657889|7611912|FG001|Overall Study|Ongoing in Study|5
4697757|NCT02657889|7611913|FG002|Overall Study|Ongoing in Study|24
4697758|NCT02657889|7611914|FG003|Overall Study|Ongoing in Study|19
4697759|NCT02658019|7611945|FG000|Overall Study|Adverse Event|1
4697760|NCT02658084|7611951|FG000|Overall Study|Withdrawal by Subject|1
4697761|NCT02658084|7611952|FG001|Overall Study|Withdrawal by Subject|0
4697762|NCT02658084|7611951|FG000|Overall Study|Study Termination|1
4697763|NCT02658084|7611952|FG001|Overall Study|Study Termination|0
4697764|NCT02658149|7611959|FG000|Overall Study|Physician Decision|1
4697765|NCT02658149|7611960|FG001|Overall Study|Physician Decision|0
4697766|NCT02658175|7611969|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1
4697767|NCT02658175|7611970|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0
4697768|NCT02658175|7611971|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0
4697769|NCT02658175|7611969|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6
4697770|NCT02658175|7611970|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2
4697771|NCT02658175|7611971|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0
4697772|NCT02658175|7611969|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8
4697773|NCT02658175|7611970|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5
4697774|NCT02658175|7611971|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0
4697775|NCT02658175|7611969|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1
4471039|NCT00648739|7264721|FG006|Overall Study|Withdrawal by Subject|0
4471040|NCT00648739|7264715|FG000|Overall Study|Lack of Efficacy|0
4697776|NCT02658175|7611970|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0
4471041|NCT00648739|7264716|FG001|Overall Study|Lack of Efficacy|0
4471042|NCT00648739|7264717|FG002|Overall Study|Lack of Efficacy|0
4471043|NCT00648739|7264718|FG003|Overall Study|Lack of Efficacy|0
4471044|NCT00648739|7264719|FG004|Overall Study|Lack of Efficacy|1
4471045|NCT00648739|7264720|FG005|Overall Study|Lack of Efficacy|2
4471046|NCT00648739|7264721|FG006|Overall Study|Lack of Efficacy|0
4518750|NCT00976209|7331020|FG001|Wash-out Period|Adverse Event|2
4471047|NCT00648739|7264715|FG000|Overall Study|Investigator Considered it Advisable|0
4471048|NCT00648739|7264716|FG001|Overall Study|Investigator Considered it Advisable|0
4471049|NCT00648739|7264717|FG002|Overall Study|Investigator Considered it Advisable|0
4471050|NCT00648739|7264718|FG003|Overall Study|Investigator Considered it Advisable|0
4471051|NCT00648739|7264719|FG004|Overall Study|Investigator Considered it Advisable|0
4471052|NCT00648739|7264720|FG005|Overall Study|Investigator Considered it Advisable|1
4471053|NCT00648739|7264721|FG006|Overall Study|Investigator Considered it Advisable|1
4471054|NCT00648739|7264715|FG000|Overall Study|Death|0
4471055|NCT00648739|7264716|FG001|Overall Study|Death|1
4471056|NCT00648739|7264717|FG002|Overall Study|Death|0
4471057|NCT00648739|7264718|FG003|Overall Study|Death|0
4471058|NCT00648739|7264719|FG004|Overall Study|Death|0
4471059|NCT00648739|7264720|FG005|Overall Study|Death|0
4471060|NCT00648739|7264721|FG006|Overall Study|Death|0
4471061|NCT00648739|7264715|FG000|Overall Study|Positive Human Anti-human Antibody|0
4471062|NCT00648739|7264716|FG001|Overall Study|Positive Human Anti-human Antibody|0
4471063|NCT00648739|7264717|FG002|Overall Study|Positive Human Anti-human Antibody|1
4471064|NCT00648739|7264718|FG003|Overall Study|Positive Human Anti-human Antibody|0
4471065|NCT00648739|7264719|FG004|Overall Study|Positive Human Anti-human Antibody|0
4471066|NCT00648739|7264720|FG005|Overall Study|Positive Human Anti-human Antibody|0
4471067|NCT00648739|7264721|FG006|Overall Study|Positive Human Anti-human Antibody|0
4471068|NCT00648739|7264715|FG000|Overall Study|Follow-up Visits Not Completed|0
4471069|NCT00648739|7264716|FG001|Overall Study|Follow-up Visits Not Completed|1
4471070|NCT00648739|7264717|FG002|Overall Study|Follow-up Visits Not Completed|0
4471071|NCT00648739|7264718|FG003|Overall Study|Follow-up Visits Not Completed|0
4471072|NCT00648739|7264719|FG004|Overall Study|Follow-up Visits Not Completed|0
4471073|NCT00648739|7264720|FG005|Overall Study|Follow-up Visits Not Completed|0
4471074|NCT00648739|7264721|FG006|Overall Study|Follow-up Visits Not Completed|0
4471075|NCT00649220|7264747|FG000|Overall Study|Adverse Event|2
4471076|NCT00649220|7264747|FG000|Overall Study|Withdrawal by Subject|1
4471077|NCT00649389|7264755|FG000|Overall Study|Adverse Event|22
4471078|NCT00649389|7264756|FG001|Overall Study|Adverse Event|46
4471079|NCT00649389|7264757|FG002|Overall Study|Adverse Event|38
4471080|NCT00649389|7264758|FG003|Overall Study|Adverse Event|48
4471081|NCT00649389|7264755|FG000|Overall Study|Lost to Follow-up|15
4588978|NCT01506609|7433836|FG004|Overall Study|Adverse Event Not Related to Progression|10
4697777|NCT02658175|7611971|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0
4697778|NCT02658175|7611969|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4
4697779|NCT02658175|7611970|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0
4697780|NCT02658175|7611971|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1
4697781|NCT02658175|7611969|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7
4697782|NCT02658175|7611970|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0
4697783|NCT02658175|7611971|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0
4697784|NCT02658175|7611969|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1
4697785|NCT02658175|7611970|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0
4697786|NCT02658175|7611971|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1
4697787|NCT02658175|7611969|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8
4697788|NCT02658175|7611970|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2
4697789|NCT02658175|7611971|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0
4697790|NCT02658175|7611969|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0
4697791|NCT02658175|7611970|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0
4697792|NCT02658175|7611971|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1
4697793|NCT02658175|7611969|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1
4697794|NCT02658175|7611970|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0
4697795|NCT02658175|7611971|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0
4697796|NCT02658448|7611988|FG000|Overall Study|Lost to Follow-up|1
4697797|NCT02658487|7612007|FG000|Overall Study|Death|2
4697798|NCT02658487|7612007|FG000|Overall Study|Disease progression|10
4697799|NCT02658487|7612007|FG000|Overall Study|Alternative therapy|1
4697800|NCT02658487|7612007|FG000|Overall Study|Adverse Event|1
4697801|NCT02658487|7612007|FG000|Overall Study|Treatment Failure, circulating blasts|1
4697802|NCT02658487|7612007|FG000|Overall Study|Refractory AML|1
4697803|NCT02658630|7612012|FG000|Overall Study|Withdrawal by Subject|4
4697804|NCT02658734|7612016|FG000|Overall Study|Adverse Event|2
4697805|NCT02658734|7612016|FG000|Overall Study|Death|4
4697806|NCT02658734|7612016|FG000|Overall Study|Lost to Follow-up|7
4697807|NCT02658734|7612016|FG000|Overall Study|Withdrawal of Consent|16
4697808|NCT02658734|7612016|FG000|Overall Study|Disease Progression|28
4697809|NCT02659020|7612045|FG000|Overall Study|Adverse Event|1
4697810|NCT02659020|7612046|FG001|Overall Study|Adverse Event|0
4697811|NCT02659020|7612047|FG002|Overall Study|Adverse Event|0
4697812|NCT02659020|7612048|FG003|Overall Study|Adverse Event|6
4697813|NCT02659020|7612049|FG004|Overall Study|Adverse Event|3
4697814|NCT02659020|7612050|FG005|Overall Study|Adverse Event|4
4697815|NCT02659020|7612051|FG006|Overall Study|Adverse Event|4
4471082|NCT00649389|7264756|FG001|Overall Study|Lost to Follow-up|17
4471083|NCT00649389|7264757|FG002|Overall Study|Lost to Follow-up|21
4471084|NCT00649389|7264758|FG003|Overall Study|Lost to Follow-up|26
4471085|NCT00649389|7264755|FG000|Overall Study|Protocol Violation|11
4471086|NCT00649389|7264756|FG001|Overall Study|Protocol Violation|13
4471087|NCT00649389|7264757|FG002|Overall Study|Protocol Violation|9
4471088|NCT00649389|7264758|FG003|Overall Study|Protocol Violation|8
4471089|NCT00649389|7264755|FG000|Overall Study|Withdrawal by Subject|20
4471090|NCT00649389|7264756|FG001|Overall Study|Withdrawal by Subject|21
4471091|NCT00649389|7264757|FG002|Overall Study|Withdrawal by Subject|19
4471092|NCT00649389|7264758|FG003|Overall Study|Withdrawal by Subject|23
4471093|NCT00649389|7264755|FG000|Overall Study|Other|3
4471094|NCT00649389|7264756|FG001|Overall Study|Other|9
4471095|NCT00649389|7264757|FG002|Overall Study|Other|1
4471096|NCT00649389|7264758|FG003|Overall Study|Other|6
4471097|NCT00649428|7264770|FG000|Overall Study|Adverse Event|2
4471098|NCT00649428|7264771|FG001|Overall Study|Adverse Event|2
4471099|NCT00649428|7264770|FG000|Overall Study|Withdrawal by Subject|6
4471100|NCT00649428|7264771|FG001|Overall Study|Withdrawal by Subject|6
4471101|NCT00649428|7264770|FG000|Overall Study|Lost to Follow-up|1
4471102|NCT00649428|7264771|FG001|Overall Study|Lost to Follow-up|3
4471103|NCT00649428|7264770|FG000|Overall Study|Insufficient manufacturing yield|5
4471104|NCT00649428|7264771|FG001|Overall Study|Insufficient manufacturing yield|1
4471105|NCT00649428|7264770|FG000|Overall Study|Protocol Violation|6
4471106|NCT00649428|7264771|FG001|Overall Study|Protocol Violation|2
4471107|NCT00649428|7264770|FG000|Overall Study|Physician Decision|0
4471108|NCT00649428|7264771|FG001|Overall Study|Physician Decision|1
4471109|NCT00650091|7264797|FG000|Amended Study Design|Withdrawal by Subject|12
4471110|NCT00650091|7264798|FG001|Amended Study Design|Withdrawal by Subject|11
4471111|NCT00650091|7264799|FG002|Amended Study Design|Withdrawal by Subject|0
4471112|NCT00650091|7264797|FG000|Amended Study Design|Physician Decision|5
4588979|NCT01506609|7433837|FG005|Overall Study|Adverse Event Not Related to Progression|5
4588980|NCT01506609|7433832|FG000|Overall Study|Withdrawal by Subject|0
4588981|NCT01506609|7433833|FG001|Overall Study|Withdrawal by Subject|0
4588982|NCT01506609|7433834|FG002|Overall Study|Withdrawal by Subject|0
4588983|NCT01506609|7433835|FG003|Overall Study|Withdrawal by Subject|9
4588984|NCT01506609|7433836|FG004|Overall Study|Withdrawal by Subject|7
4588985|NCT01506609|7433837|FG005|Overall Study|Withdrawal by Subject|7
4588986|NCT01506609|7433832|FG000|Overall Study|Lost to Follow-up|0
4588987|NCT01506609|7433833|FG001|Overall Study|Lost to Follow-up|0
4588988|NCT01506609|7433834|FG002|Overall Study|Lost to Follow-up|0
4588989|NCT01506609|7433835|FG003|Overall Study|Lost to Follow-up|1
4588990|NCT01506609|7433836|FG004|Overall Study|Lost to Follow-up|2
4588991|NCT01506609|7433837|FG005|Overall Study|Lost to Follow-up|0
4588992|NCT01506609|7433832|FG000|Overall Study|Sponsor Discontinued Study|0
4588993|NCT01506609|7433833|FG001|Overall Study|Sponsor Discontinued Study|0
4588994|NCT01506609|7433834|FG002|Overall Study|Sponsor Discontinued Study|0
4588995|NCT01506609|7433835|FG003|Overall Study|Sponsor Discontinued Study|2
4588996|NCT01506609|7433836|FG004|Overall Study|Sponsor Discontinued Study|2
4588997|NCT01506609|7433837|FG005|Overall Study|Sponsor Discontinued Study|0
4588998|NCT01506609|7433832|FG000|Overall Study|Progressive Disease per Protocol|1
4588999|NCT01506609|7433833|FG001|Overall Study|Progressive Disease per Protocol|0
4589000|NCT01506609|7433834|FG002|Overall Study|Progressive Disease per Protocol|0
4589001|NCT01506609|7433835|FG003|Overall Study|Progressive Disease per Protocol|64
4697816|NCT02659020|7612045|FG000|Overall Study|Lost to Follow-up|1
4697817|NCT02659020|7612046|FG001|Overall Study|Lost to Follow-up|2
4697818|NCT02659020|7612047|FG002|Overall Study|Lost to Follow-up|1
4697819|NCT02659020|7612048|FG003|Overall Study|Lost to Follow-up|4
4697820|NCT02659020|7612049|FG004|Overall Study|Lost to Follow-up|1
4471113|NCT00650091|7264798|FG001|Amended Study Design|Physician Decision|0
4697821|NCT02659020|7612050|FG005|Overall Study|Lost to Follow-up|5
4697822|NCT02659020|7612051|FG006|Overall Study|Lost to Follow-up|0
4697823|NCT02659020|7612045|FG000|Overall Study|Physician Decision|0
4697824|NCT02659020|7612046|FG001|Overall Study|Physician Decision|0
4697825|NCT02659020|7612047|FG002|Overall Study|Physician Decision|1
4697826|NCT02659020|7612048|FG003|Overall Study|Physician Decision|1
4697827|NCT02659020|7612049|FG004|Overall Study|Physician Decision|6
4697828|NCT02659020|7612050|FG005|Overall Study|Physician Decision|3
4697829|NCT02659020|7612051|FG006|Overall Study|Physician Decision|1
4697830|NCT02659020|7612045|FG000|Overall Study|Withdrawal by Subject|2
4697831|NCT02659020|7612046|FG001|Overall Study|Withdrawal by Subject|3
4697832|NCT02659020|7612047|FG002|Overall Study|Withdrawal by Subject|1
4697833|NCT02659020|7612048|FG003|Overall Study|Withdrawal by Subject|4
4697834|NCT02659020|7612049|FG004|Overall Study|Withdrawal by Subject|4
4471114|NCT00650091|7264799|FG002|Amended Study Design|Physician Decision|0
4589002|NCT01506609|7433836|FG004|Overall Study|Progressive Disease per Protocol|57
4589003|NCT01506609|7433837|FG005|Overall Study|Progressive Disease per Protocol|74
4471115|NCT00650091|7264797|FG000|Amended Study Design|Adverse Event|1
4471116|NCT00650091|7264798|FG001|Amended Study Design|Adverse Event|4
4589004|NCT01506609|7433832|FG000|Overall Study|Other, Not Specified|0
4589005|NCT01506609|7433833|FG001|Overall Study|Other, Not Specified|0
4589006|NCT01506609|7433834|FG002|Overall Study|Other, Not Specified|0
4589007|NCT01506609|7433835|FG003|Overall Study|Other, Not Specified|10
4697835|NCT02659020|7612050|FG005|Overall Study|Withdrawal by Subject|9
4697836|NCT02659020|7612051|FG006|Overall Study|Withdrawal by Subject|3
4471117|NCT00650091|7264799|FG002|Amended Study Design|Adverse Event|0
4471118|NCT00650091|7264797|FG000|Amended Study Design|Lung transplantation|4
4471119|NCT00650091|7264798|FG001|Amended Study Design|Lung transplantation|2
4471120|NCT00650091|7264799|FG002|Amended Study Design|Lung transplantation|0
4697837|NCT02659020|7612045|FG000|Overall Study|Progressive Disease|2
4471121|NCT00650091|7264797|FG000|Amended Study Design|Other|1
4471122|NCT00650091|7264798|FG001|Amended Study Design|Other|3
4471123|NCT00650091|7264799|FG002|Amended Study Design|Other|0
4471124|NCT00650104|7264807|FG000|Overall Study|Adverse Event|17
4471125|NCT00650104|7264807|FG000|Overall Study|Death|2
4471126|NCT00650104|7264807|FG000|Overall Study|Withdrawal by Subject|11
4471127|NCT00650104|7264807|FG000|Overall Study|Physician Decision|7
4471128|NCT00650104|7264807|FG000|Overall Study|Lost to Follow-up|1
4471129|NCT00650104|7264807|FG000|Overall Study|Non-compliance|2
4471130|NCT00650104|7264807|FG000|Overall Study|Sponsor Terminated Dosing|1
4471131|NCT00650585|7264827|FG000|Overall Study|Lost to Follow-up|505
4471132|NCT00650585|7264828|FG001|Overall Study|Lost to Follow-up|482
4471133|NCT00650585|7264827|FG000|Overall Study|No parental consent|935
4471134|NCT00650585|7264828|FG001|Overall Study|No parental consent|866
4471135|NCT00650585|7264827|FG000|Overall Study|Excluded/ruled ineligible|357
4471136|NCT00650585|7264828|FG001|Overall Study|Excluded/ruled ineligible|129
4471137|NCT00650767|7264838|FG000|Overall Study|Adverse Event|0
4471138|NCT00650767|7264839|FG001|Overall Study|Adverse Event|3
4471139|NCT00650767|7264840|FG002|Overall Study|Adverse Event|10
4471140|NCT00650767|7264841|FG003|Overall Study|Adverse Event|8
4471141|NCT00650767|7264838|FG000|Overall Study|Death|1
4471142|NCT00650767|7264839|FG001|Overall Study|Death|0
4471143|NCT00650767|7264840|FG002|Overall Study|Death|0
4471144|NCT00650767|7264841|FG003|Overall Study|Death|0
4471145|NCT00650767|7264838|FG000|Overall Study|Withdrawal by Subject|2
4471146|NCT00650767|7264839|FG001|Overall Study|Withdrawal by Subject|4
4471147|NCT00650767|7264840|FG002|Overall Study|Withdrawal by Subject|3
4471148|NCT00650767|7264841|FG003|Overall Study|Withdrawal by Subject|3
4471149|NCT00650767|7264838|FG000|Overall Study|Lost to Follow-up|1
4471150|NCT00650767|7264839|FG001|Overall Study|Lost to Follow-up|1
4471151|NCT00650767|7264840|FG002|Overall Study|Lost to Follow-up|1
4471152|NCT00650767|7264841|FG003|Overall Study|Lost to Follow-up|0
4471153|NCT00650767|7264838|FG000|Overall Study|Other|1
4471154|NCT00650767|7264839|FG001|Overall Study|Other|1
4471155|NCT00650767|7264840|FG002|Overall Study|Other|0
4471156|NCT00650767|7264841|FG003|Overall Study|Other|0
4471157|NCT00650806|7264855|FG000|Overall Study|Adverse Event|0
4471158|NCT00650806|7264856|FG001|Overall Study|Adverse Event|5
4471159|NCT00650806|7264857|FG002|Overall Study|Adverse Event|3
4471160|NCT00650806|7264858|FG003|Overall Study|Adverse Event|4
4471161|NCT00650806|7264855|FG000|Overall Study|Lost to Follow-up|7
4471162|NCT00650806|7264856|FG001|Overall Study|Lost to Follow-up|6
4471163|NCT00650806|7264857|FG002|Overall Study|Lost to Follow-up|11
4471164|NCT00650806|7264858|FG003|Overall Study|Lost to Follow-up|10
4471165|NCT00650806|7264855|FG000|Overall Study|Protocol Violation|0
4471166|NCT00650806|7264856|FG001|Overall Study|Protocol Violation|0
4471167|NCT00650806|7264857|FG002|Overall Study|Protocol Violation|0
4471168|NCT00650806|7264858|FG003|Overall Study|Protocol Violation|1
4471169|NCT00650806|7264855|FG000|Overall Study|Pregnancy|0
4471170|NCT00650806|7264856|FG001|Overall Study|Pregnancy|0
4471171|NCT00650806|7264857|FG002|Overall Study|Pregnancy|0
4471172|NCT00650806|7264858|FG003|Overall Study|Pregnancy|1
4471173|NCT00650806|7264855|FG000|Overall Study|Withdrawal by Subject|7
4471174|NCT00650806|7264856|FG001|Overall Study|Withdrawal by Subject|5
4471175|NCT00650806|7264857|FG002|Overall Study|Withdrawal by Subject|8
4471176|NCT00650806|7264858|FG003|Overall Study|Withdrawal by Subject|6
4471177|NCT00650806|7264855|FG000|Overall Study|Noncompliance with study drug regimen|1
4471178|NCT00650806|7264856|FG001|Overall Study|Noncompliance with study drug regimen|1
4471179|NCT00650806|7264857|FG002|Overall Study|Noncompliance with study drug regimen|0
4471180|NCT00650806|7264858|FG003|Overall Study|Noncompliance with study drug regimen|0
4471181|NCT00650806|7264855|FG000|Overall Study|Study terminated by sponsor|2
4471182|NCT00650806|7264856|FG001|Overall Study|Study terminated by sponsor|3
4471183|NCT00650806|7264857|FG002|Overall Study|Study terminated by sponsor|5
4471184|NCT00650806|7264858|FG003|Overall Study|Study terminated by sponsor|4
4471185|NCT00650806|7264855|FG000|Overall Study|Other|1
4471186|NCT00650806|7264856|FG001|Overall Study|Other|1
4471187|NCT00650806|7264857|FG002|Overall Study|Other|2
4471188|NCT00650806|7264858|FG003|Overall Study|Other|0
4471189|NCT00650845|7264872|FG000|Overall Study|Withdrawal by Subject|5
4471190|NCT00650845|7264873|FG001|Overall Study|Withdrawal by Subject|0
4471191|NCT00650845|7264872|FG000|Overall Study|Protocol Violation|0
4471192|NCT00650845|7264873|FG001|Overall Study|Protocol Violation|13
4471193|NCT00651118|7264910|FG000|Overall Study|Adverse Event|4
4471194|NCT00651118|7264911|FG001|Overall Study|Adverse Event|0
4471195|NCT00651118|7264912|FG002|Overall Study|Adverse Event|1
4471196|NCT00651118|7264913|FG003|Overall Study|Adverse Event|1
4471197|NCT00651118|7264910|FG000|Overall Study|Protocol Violation|2
4471198|NCT00651118|7264911|FG001|Overall Study|Protocol Violation|2
4471199|NCT00651118|7264912|FG002|Overall Study|Protocol Violation|6
4471200|NCT00651118|7264913|FG003|Overall Study|Protocol Violation|2
4471201|NCT00651118|7264910|FG000|Overall Study|Lost to Follow-up|2
4471202|NCT00651118|7264911|FG001|Overall Study|Lost to Follow-up|0
4471203|NCT00651118|7264912|FG002|Overall Study|Lost to Follow-up|1
4471204|NCT00651118|7264913|FG003|Overall Study|Lost to Follow-up|2
4471205|NCT00651118|7264910|FG000|Overall Study|administrative|1
4471206|NCT00651118|7264911|FG001|Overall Study|administrative|4
4471207|NCT00651118|7264912|FG002|Overall Study|administrative|2
4471208|NCT00651118|7264913|FG003|Overall Study|administrative|1
4471209|NCT00651118|7264910|FG000|Overall Study|Withdrawal by Subject|0
4471210|NCT00651118|7264911|FG001|Overall Study|Withdrawal by Subject|1
4471211|NCT00651118|7264912|FG002|Overall Study|Withdrawal by Subject|1
4471212|NCT00651118|7264913|FG003|Overall Study|Withdrawal by Subject|1
4471213|NCT00651157|7264926|FG000|Overall Study|Death|1
4471214|NCT00651157|7264926|FG000|Overall Study|Protocol Violation|1
4471215|NCT00651183|7264932|FG000|Overall Study|Lack of Efficacy|1
4471216|NCT00651183|7264933|FG001|Overall Study|Lack of Efficacy|0
4471217|NCT00651183|7264932|FG000|Overall Study|Efficacy insufficient + patients wish|0
4471218|NCT00651183|7264933|FG001|Overall Study|Efficacy insufficient + patients wish|1
4471219|NCT00651183|7264932|FG000|Overall Study|Tolerability insufficient|5
4697838|NCT02659020|7612046|FG001|Overall Study|Progressive Disease|2
4697839|NCT02659020|7612047|FG002|Overall Study|Progressive Disease|2
4697840|NCT02659020|7612048|FG003|Overall Study|Progressive Disease|15
4697841|NCT02659020|7612049|FG004|Overall Study|Progressive Disease|6
4697842|NCT02659020|7612050|FG005|Overall Study|Progressive Disease|7
4697843|NCT02659020|7612051|FG006|Overall Study|Progressive Disease|6
4697844|NCT02659020|7612045|FG000|Overall Study|On Treatment|0
4697845|NCT02659020|7612046|FG001|Overall Study|On Treatment|0
4697846|NCT02659020|7612047|FG002|Overall Study|On Treatment|0
4697847|NCT02659020|7612048|FG003|Overall Study|On Treatment|0
4697848|NCT02659020|7612049|FG004|Overall Study|On Treatment|0
4697849|NCT02659020|7612050|FG005|Overall Study|On Treatment|0
4697850|NCT02659020|7612051|FG006|Overall Study|On Treatment|1
4697851|NCT02659098|7612074|FG000|Overall Study|Withdrawal by Subject|7
4697852|NCT02659150|7612078|FG000|Subject Enrollment|Physician Decision|3
4697853|NCT02659150|7612078|FG000|Subject Enrollment|Withdrawal by Subject|2
4697854|NCT02659150|7612078|FG000|Baseline Imaging|Withdrawal by Subject|1
4697855|NCT02659150|7612078|FG000|Baseline Imaging|Physician Decision|1
4697856|NCT02659150|7612078|FG000|Study Drug Dosing|Adverse Event|1
4697857|NCT02659540|7612094|FG000|Overall Study|Adverse Event|3
4697858|NCT02659540|7612095|FG001|Overall Study|Adverse Event|2
4697859|NCT02659540|7612094|FG000|Overall Study|Death|1
4697860|NCT02659540|7612095|FG001|Overall Study|Death|0
4697861|NCT02659540|7612094|FG000|Overall Study|Progressive disease|2
4697862|NCT02659540|7612095|FG001|Overall Study|Progressive disease|6
4697863|NCT02659631|7612111|FG000|Overall Study|Lost to Follow-up|0
4697864|NCT02659631|7612112|FG001|Overall Study|Lost to Follow-up|0
4697865|NCT02659631|7612113|FG002|Overall Study|Lost to Follow-up|2
4697866|NCT02659631|7612114|FG003|Overall Study|Lost to Follow-up|0
4697867|NCT02659631|7612115|FG004|Overall Study|Lost to Follow-up|0
4697868|NCT02659631|7612116|FG005|Overall Study|Lost to Follow-up|1
4697869|NCT02659631|7612117|FG006|Overall Study|Lost to Follow-up|0
4697870|NCT02659631|7612118|FG007|Overall Study|Lost to Follow-up|0
4697871|NCT02659631|7612119|FG008|Overall Study|Lost to Follow-up|0
4697872|NCT02659631|7612120|FG009|Overall Study|Lost to Follow-up|0
4697873|NCT02659631|7612111|FG000|Overall Study|Withdrawal prior to treatment|0
4697874|NCT02659631|7612112|FG001|Overall Study|Withdrawal prior to treatment|0
4697875|NCT02659631|7612113|FG002|Overall Study|Withdrawal prior to treatment|0
4697876|NCT02659631|7612114|FG003|Overall Study|Withdrawal prior to treatment|0
4697877|NCT02659631|7612115|FG004|Overall Study|Withdrawal prior to treatment|1
4697878|NCT02659631|7612116|FG005|Overall Study|Withdrawal prior to treatment|0
4697879|NCT02659631|7612117|FG006|Overall Study|Withdrawal prior to treatment|0
4697880|NCT02659631|7612118|FG007|Overall Study|Withdrawal prior to treatment|0
4697881|NCT02659631|7612119|FG008|Overall Study|Withdrawal prior to treatment|0
4697882|NCT02659631|7612120|FG009|Overall Study|Withdrawal prior to treatment|0
4697883|NCT02659631|7612111|FG000|Overall Study|Participant refused further follow-up|0
4697884|NCT02659631|7612112|FG001|Overall Study|Participant refused further follow-up|0
4697885|NCT02659631|7612113|FG002|Overall Study|Participant refused further follow-up|0
4697886|NCT02659631|7612114|FG003|Overall Study|Participant refused further follow-up|1
4697887|NCT02659631|7612115|FG004|Overall Study|Participant refused further follow-up|0
4697888|NCT02659631|7612116|FG005|Overall Study|Participant refused further follow-up|0
4697889|NCT02659631|7612117|FG006|Overall Study|Participant refused further follow-up|0
4697890|NCT02659631|7612118|FG007|Overall Study|Participant refused further follow-up|0
4697891|NCT02659631|7612119|FG008|Overall Study|Participant refused further follow-up|1
4697892|NCT02659631|7612120|FG009|Overall Study|Participant refused further follow-up|0
4697893|NCT02659631|7612111|FG000|Overall Study|Death (follow-up phase)|1
4697894|NCT02659631|7612112|FG001|Overall Study|Death (follow-up phase)|2
4697895|NCT02659631|7612113|FG002|Overall Study|Death (follow-up phase)|1
4697896|NCT02659631|7612114|FG003|Overall Study|Death (follow-up phase)|1
4697897|NCT02659631|7612115|FG004|Overall Study|Death (follow-up phase)|3
4471220|NCT00651183|7264933|FG001|Overall Study|Tolerability insufficient|2
4471221|NCT00651183|7264932|FG000|Overall Study|Tolerability insufficient +Patients wish|0
4518751|NCT00976209|7331019|FG000|Wash-out Period|Lost to Follow-up|1
4697898|NCT02659631|7612116|FG005|Overall Study|Death (follow-up phase)|2
4697899|NCT02659631|7612117|FG006|Overall Study|Death (follow-up phase)|0
4589008|NCT01506609|7433836|FG004|Overall Study|Other, Not Specified|7
4589009|NCT01506609|7433837|FG005|Overall Study|Other, Not Specified|3
4471222|NCT00651183|7264933|FG001|Overall Study|Tolerability insufficient +Patients wish|1
4471223|NCT00651183|7264932|FG000|Overall Study|Withdrawal by Subject|6
4471224|NCT00651183|7264933|FG001|Overall Study|Withdrawal by Subject|3
4471225|NCT00651183|7264932|FG000|Overall Study|Lost to Follow-up|3
4471226|NCT00651183|7264933|FG001|Overall Study|Lost to Follow-up|1
4471227|NCT00651183|7264932|FG000|Overall Study|Other reasons|4
4471228|NCT00651183|7264933|FG001|Overall Study|Other reasons|2
4471229|NCT00651183|7264932|FG000|Overall Study|missing|1
4471230|NCT00651183|7264933|FG001|Overall Study|missing|0
4471231|NCT00651261|7264941|FG000|Overall Study|Adverse Event|32
4471232|NCT00651261|7264942|FG001|Overall Study|Adverse Event|22
4471233|NCT00651261|7264941|FG000|Overall Study|Death|18
4471234|NCT00651261|7264942|FG001|Overall Study|Death|18
4471235|NCT00651261|7264941|FG000|Overall Study|Withdrawal by Subject|22
4471236|NCT00651261|7264942|FG001|Overall Study|Withdrawal by Subject|40
4471237|NCT00651261|7264941|FG000|Overall Study|Induction failure|24
4471238|NCT00651261|7264942|FG001|Overall Study|Induction failure|35
4471239|NCT00651261|7264941|FG000|Overall Study|Disease progression|58
4471240|NCT00651261|7264942|FG001|Overall Study|Disease progression|58
4471241|NCT00651261|7264941|FG000|Overall Study|Alternative therapy|109
4697900|NCT02659631|7612118|FG007|Overall Study|Death (follow-up phase)|3
4697901|NCT02659631|7612119|FG008|Overall Study|Death (follow-up phase)|1
4697902|NCT02659631|7612120|FG009|Overall Study|Death (follow-up phase)|0
4697903|NCT02659631|7612111|FG000|Overall Study|Death (treatment phase)|0
4697904|NCT02659631|7612112|FG001|Overall Study|Death (treatment phase)|0
4697905|NCT02659631|7612113|FG002|Overall Study|Death (treatment phase)|0
4697906|NCT02659631|7612114|FG003|Overall Study|Death (treatment phase)|0
4697907|NCT02659631|7612115|FG004|Overall Study|Death (treatment phase)|1
4697908|NCT02659631|7612116|FG005|Overall Study|Death (treatment phase)|0
4697909|NCT02659631|7612117|FG006|Overall Study|Death (treatment phase)|1
4697910|NCT02659631|7612118|FG007|Overall Study|Death (treatment phase)|0
4697911|NCT02659631|7612119|FG008|Overall Study|Death (treatment phase)|0
4697912|NCT02659631|7612120|FG009|Overall Study|Death (treatment phase)|0
4735225|NCT03522506|7683061|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0
4735226|NCT03522506|7683062|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0
4735227|NCT03522506|7683063|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1
4735228|NCT03522675|7683077|FG000|Overall Study|Screen fail|1
4735229|NCT03522675|7683077|FG000|Overall Study|Non-reactive to histamine|1
4735230|NCT03522948|7683085|FG000|Overall Study|Lost to Follow-up|1
4735231|NCT03523715|7683091|FG000|Overall Study|Lost to Follow-up|11
4735232|NCT03523715|7683092|FG001|Overall Study|Lost to Follow-up|14
4735233|NCT03523715|7683091|FG000|Overall Study|Did not meet inclusion criteria|1
4735234|NCT03523715|7683092|FG001|Overall Study|Did not meet inclusion criteria|0
4735235|NCT03523715|7683091|FG000|Overall Study|Internally inconsistent reporting|0
4735236|NCT03523715|7683092|FG001|Overall Study|Internally inconsistent reporting|2
4735237|NCT03523871|7683098|FG000|Overall Study|Death|1
4735238|NCT03524157|7683118|FG000|Overall Study|cytology not readable|0
4735239|NCT03524157|7683119|FG001|Overall Study|cytology not readable|0
4735240|NCT03524157|7683120|FG002|Overall Study|cytology not readable|1
4735241|NCT03525119|7683140|FG000|Overall Study|Adverse Event|0
4735242|NCT03525119|7683141|FG001|Overall Study|Adverse Event|1
4735243|NCT03525119|7683142|FG002|Overall Study|Adverse Event|0
4735244|NCT03525119|7683140|FG000|Overall Study|Lost to Follow-up|32
4735245|NCT03525119|7683141|FG001|Overall Study|Lost to Follow-up|33
4735246|NCT03525119|7683142|FG002|Overall Study|Lost to Follow-up|37
4735247|NCT03525119|7683140|FG000|Overall Study|Withdrawal by Subject|5
4735248|NCT03525119|7683141|FG001|Overall Study|Withdrawal by Subject|4
4735249|NCT03525119|7683142|FG002|Overall Study|Withdrawal by Subject|2
4735250|NCT03525119|7683140|FG000|Overall Study|Reason not Specified|2
4735251|NCT03525119|7683141|FG001|Overall Study|Reason not Specified|1
4735252|NCT03525119|7683142|FG002|Overall Study|Reason not Specified|2
4735253|NCT03525119|7683140|FG000|Overall Study|Randomized but not Vaccinated|1
4735254|NCT03525119|7683141|FG001|Overall Study|Randomized but not Vaccinated|0
4735255|NCT03525119|7683142|FG002|Overall Study|Randomized but not Vaccinated|2
4735256|NCT03525444|7683163|FG000|Overall Study|Adverse Event|0
4735257|NCT03525444|7683164|FG001|Overall Study|Adverse Event|1
4735258|NCT03525444|7683163|FG000|Overall Study|Withdrawal of consent (not due to AE)|0
4735259|NCT03525444|7683164|FG001|Overall Study|Withdrawal of consent (not due to AE)|1
4471242|NCT00651261|7264942|FG001|Overall Study|Alternative therapy|107
4471243|NCT00651261|7264941|FG000|Overall Study|Other disease or participant decisions|23
4589010|NCT01506609|7433832|FG000|Overall Study|Missing / Unknown Reason|1
4589011|NCT01506609|7433833|FG001|Overall Study|Missing / Unknown Reason|0
4735260|NCT03525444|7683163|FG000|Overall Study|Other|0
4735261|NCT03525444|7683164|FG001|Overall Study|Other|1
4735262|NCT03525834|7683180|FG000|Overall Study|Progressive disease|1
4735263|NCT03526458|7683194|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2
4735264|NCT03526458|7683195|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2
4735265|NCT03526458|7683194|FG000|Overall Study|Stone passed, surgery cancelled|2
4471244|NCT00651261|7264942|FG001|Overall Study|Other disease or participant decisions|23
4471245|NCT00651261|7264941|FG000|Overall Study|Never treated|5
4471246|NCT00651261|7264942|FG001|Overall Study|Never treated|3
4471247|NCT00651313|7264950|FG000|Overall Study|Adverse Event|0
4471248|NCT00651313|7264951|FG001|Overall Study|Adverse Event|1
4471249|NCT00651313|7264950|FG000|Overall Study|Withdrawal by Subject|3
4471250|NCT00651313|7264951|FG001|Overall Study|Withdrawal by Subject|1
4471251|NCT00651313|7264950|FG000|Overall Study|Lost to Follow-up|1
4471252|NCT00651313|7264951|FG001|Overall Study|Lost to Follow-up|1
4471253|NCT00651313|7264950|FG000|Overall Study|Adminstrative Discontinuation|2
4471254|NCT00651313|7264951|FG001|Overall Study|Adminstrative Discontinuation|3
4471255|NCT00651664|7264990|FG000|Overall Study|Occurrence of Adverse Event(s)|0
4471256|NCT00651664|7264991|FG001|Overall Study|Occurrence of Adverse Event(s)|0
4471257|NCT00651664|7264992|FG002|Overall Study|Occurrence of Adverse Event(s)|0
4471258|NCT00651664|7264993|FG003|Overall Study|Occurrence of Adverse Event(s)|0
4471259|NCT00651664|7264994|FG004|Overall Study|Occurrence of Adverse Event(s)|0
4471260|NCT00651664|7264995|FG005|Overall Study|Occurrence of Adverse Event(s)|0
4471261|NCT00651664|7264996|FG006|Overall Study|Occurrence of Adverse Event(s)|1
4471262|NCT00651664|7264997|FG007|Overall Study|Occurrence of Adverse Event(s)|0
4471263|NCT00651664|7264998|FG008|Overall Study|Occurrence of Adverse Event(s)|1
4471264|NCT00651664|7264999|FG009|Overall Study|Occurrence of Adverse Event(s)|0
4471265|NCT00651664|7264990|FG000|Overall Study|Unsatisfactory Therapeutic Response|0
4471266|NCT00651664|7264991|FG001|Overall Study|Unsatisfactory Therapeutic Response|0
4471267|NCT00651664|7264992|FG002|Overall Study|Unsatisfactory Therapeutic Response|0
4471268|NCT00651664|7264993|FG003|Overall Study|Unsatisfactory Therapeutic Response|0
4471269|NCT00651664|7264994|FG004|Overall Study|Unsatisfactory Therapeutic Response|1
4471270|NCT00651664|7264995|FG005|Overall Study|Unsatisfactory Therapeutic Response|1
4471271|NCT00651664|7264996|FG006|Overall Study|Unsatisfactory Therapeutic Response|0
4471272|NCT00651664|7264997|FG007|Overall Study|Unsatisfactory Therapeutic Response|1
4471273|NCT00651664|7264998|FG008|Overall Study|Unsatisfactory Therapeutic Response|0
4471274|NCT00651664|7264999|FG009|Overall Study|Unsatisfactory Therapeutic Response|1
4471275|NCT00651664|7264990|FG000|Overall Study|Progressive Disease|3
4471276|NCT00651664|7264991|FG001|Overall Study|Progressive Disease|3
4471277|NCT00651664|7264992|FG002|Overall Study|Progressive Disease|3
4471278|NCT00651664|7264993|FG003|Overall Study|Progressive Disease|12
4471279|NCT00651664|7264994|FG004|Overall Study|Progressive Disease|4
4471280|NCT00651664|7264995|FG005|Overall Study|Progressive Disease|1
4471281|NCT00651664|7264996|FG006|Overall Study|Progressive Disease|3
4471282|NCT00651664|7264997|FG007|Overall Study|Progressive Disease|6
4471283|NCT00651664|7264998|FG008|Overall Study|Progressive Disease|5
4471284|NCT00651664|7264999|FG009|Overall Study|Progressive Disease|5
4471285|NCT00651664|7264990|FG000|Overall Study|Patient Declined Further Treatment|0
4471286|NCT00651664|7264991|FG001|Overall Study|Patient Declined Further Treatment|0
4471287|NCT00651664|7264992|FG002|Overall Study|Patient Declined Further Treatment|0
4471288|NCT00651664|7264993|FG003|Overall Study|Patient Declined Further Treatment|1
4471289|NCT00651664|7264994|FG004|Overall Study|Patient Declined Further Treatment|1
4471290|NCT00651664|7264995|FG005|Overall Study|Patient Declined Further Treatment|1
4471291|NCT00651664|7264996|FG006|Overall Study|Patient Declined Further Treatment|0
4471292|NCT00651664|7264997|FG007|Overall Study|Patient Declined Further Treatment|0
4471293|NCT00651664|7264998|FG008|Overall Study|Patient Declined Further Treatment|0
4471294|NCT00651664|7264999|FG009|Overall Study|Patient Declined Further Treatment|1
4471295|NCT00651664|7264990|FG000|Overall Study|Symptomatic Deterioration|0
4471296|NCT00651664|7264991|FG001|Overall Study|Symptomatic Deterioration|0
4471297|NCT00651664|7264992|FG002|Overall Study|Symptomatic Deterioration|0
4471298|NCT00651664|7264993|FG003|Overall Study|Symptomatic Deterioration|1
4471299|NCT00651664|7264994|FG004|Overall Study|Symptomatic Deterioration|0
4471300|NCT00651664|7264995|FG005|Overall Study|Symptomatic Deterioration|0
4471301|NCT00651664|7264996|FG006|Overall Study|Symptomatic Deterioration|1
4471302|NCT00651664|7264997|FG007|Overall Study|Symptomatic Deterioration|0
4471303|NCT00651664|7264998|FG008|Overall Study|Symptomatic Deterioration|1
4471304|NCT00651664|7264999|FG009|Overall Study|Symptomatic Deterioration|0
4471305|NCT00651664|7264990|FG000|Overall Study|Reason not Specified|0
4471306|NCT00651664|7264991|FG001|Overall Study|Reason not Specified|0
4471307|NCT00651664|7264992|FG002|Overall Study|Reason not Specified|0
4471308|NCT00651664|7264993|FG003|Overall Study|Reason not Specified|0
4471309|NCT00651664|7264994|FG004|Overall Study|Reason not Specified|0
4471310|NCT00651664|7264995|FG005|Overall Study|Reason not Specified|0
4471311|NCT00651664|7264996|FG006|Overall Study|Reason not Specified|1
4471312|NCT00651664|7264997|FG007|Overall Study|Reason not Specified|0
4471313|NCT00651664|7264998|FG008|Overall Study|Reason not Specified|0
4471314|NCT00651664|7264999|FG009|Overall Study|Reason not Specified|0
4471315|NCT00651755|7265025|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1
4471316|NCT00651755|7265026|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0
4471317|NCT00651755|7265025|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0
4589012|NCT01506609|7433834|FG002|Overall Study|Missing / Unknown Reason|1
4589013|NCT01506609|7433835|FG003|Overall Study|Missing / Unknown Reason|4
4589014|NCT01506609|7433836|FG004|Overall Study|Missing / Unknown Reason|4
4589015|NCT01506609|7433837|FG005|Overall Study|Missing / Unknown Reason|2
4589016|NCT01506726|7433850|FG000|Overall Study|Adverse Event|1
4589017|NCT01506726|7433851|FG001|Overall Study|Adverse Event|2
4589018|NCT01506882|7433859|FG000|Overall Study|Lack of Efficacy|4
4589019|NCT01506882|7433860|FG001|Overall Study|Lack of Efficacy|3
4589020|NCT01506882|7433859|FG000|Overall Study|Lost to Follow-up|1
4589021|NCT01506882|7433860|FG001|Overall Study|Lost to Follow-up|0
4471318|NCT00651755|7265026|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1
4471319|NCT00651820|7265046|FG000|Overall Study|Lost to Follow-up|2
4471320|NCT00651924|7265054|FG000|Overall Study|Withdrawal by PI|0
4471321|NCT00651924|7265055|FG001|Overall Study|Withdrawal by PI|2
4471322|NCT00651924|7265054|FG000|Overall Study|Withdrawal by Subject|0
4471323|NCT00651924|7265055|FG001|Overall Study|Withdrawal by Subject|5
4471324|NCT00651937|7265063|FG000|Overall Study|Withdrawal by Subject|4
4471325|NCT00651937|7265064|FG001|Overall Study|Withdrawal by Subject|1
4471326|NCT00652028|7265074|FG000|Overall Study|Adverse Event|1
4471327|NCT00652028|7265075|FG001|Overall Study|Adverse Event|0
4471328|NCT00652028|7265076|FG002|Overall Study|Adverse Event|0
4471329|NCT00652028|7265077|FG003|Overall Study|Adverse Event|0
4471330|NCT00652028|7265074|FG000|Overall Study|No Longer Meets Entry Criteria|0
4471331|NCT00652028|7265075|FG001|Overall Study|No Longer Meets Entry Criteria|1
4471332|NCT00652028|7265076|FG002|Overall Study|No Longer Meets Entry Criteria|0
4471333|NCT00652028|7265077|FG003|Overall Study|No Longer Meets Entry Criteria|0
4471334|NCT00652028|7265074|FG000|Overall Study|Physician Decision|0
4471335|NCT00652028|7265075|FG001|Overall Study|Physician Decision|0
4471336|NCT00652028|7265076|FG002|Overall Study|Physician Decision|1
4471337|NCT00652028|7265077|FG003|Overall Study|Physician Decision|0
4471338|NCT00652093|7265099|FG000|Overall Study|Withdrawal by Subject|0
4471339|NCT00652093|7265100|FG001|Overall Study|Withdrawal by Subject|0
4471340|NCT00652093|7265101|FG002|Overall Study|Withdrawal by Subject|1
4471341|NCT00652093|7265102|FG003|Overall Study|Withdrawal by Subject|0
4471342|NCT00652093|7265103|FG004|Overall Study|Withdrawal by Subject|1
4471343|NCT00652093|7265104|FG005|Overall Study|Withdrawal by Subject|0
4471344|NCT00652093|7265099|FG000|Overall Study|Physician Decision|0
4471345|NCT00652093|7265100|FG001|Overall Study|Physician Decision|0
4471346|NCT00652093|7265101|FG002|Overall Study|Physician Decision|0
4471347|NCT00652093|7265102|FG003|Overall Study|Physician Decision|0
4471348|NCT00652093|7265103|FG004|Overall Study|Physician Decision|1
4471349|NCT00652093|7265104|FG005|Overall Study|Physician Decision|0
4471350|NCT00652340|7265140|FG000|Overall Study|Had not progressed.|4
4471351|NCT00652340|7265141|FG001|Overall Study|Had not progressed.|3
4471352|NCT00652366|7265152|FG000|Overall Study|Adverse Event|8
4471353|NCT00652366|7265153|FG001|Overall Study|Adverse Event|4
4471354|NCT00652366|7265154|FG002|Overall Study|Adverse Event|7
4471355|NCT00652366|7265155|FG003|Overall Study|Adverse Event|17
4471356|NCT00652366|7265156|FG004|Overall Study|Adverse Event|13
4471357|NCT00652366|7265152|FG000|Overall Study|Death|5
4471358|NCT00652366|7265153|FG001|Overall Study|Death|4
4471359|NCT00652366|7265154|FG002|Overall Study|Death|1
4471360|NCT00652366|7265155|FG003|Overall Study|Death|8
4471361|NCT00652366|7265156|FG004|Overall Study|Death|5
4471362|NCT00652366|7265152|FG000|Overall Study|Lack of Efficacy|84
4471363|NCT00652366|7265153|FG001|Overall Study|Lack of Efficacy|58
4471364|NCT00652366|7265154|FG002|Overall Study|Lack of Efficacy|53
4471365|NCT00652366|7265155|FG003|Overall Study|Lack of Efficacy|133
4589022|NCT01506882|7433859|FG000|Overall Study|Withdrawal by Subject|9
4589023|NCT01506882|7433860|FG001|Overall Study|Withdrawal by Subject|3
4589024|NCT01506882|7433859|FG000|Overall Study|SAE, non-fatal|2
4589025|NCT01506882|7433860|FG001|Overall Study|SAE, non-fatal|0
4589026|NCT01506882|7433859|FG000|Overall Study|AE, non-serious non-fatal|3
4589027|NCT01506882|7433860|FG001|Overall Study|AE, non-serious non-fatal|1
4589028|NCT01506882|7433859|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
4589029|NCT01506882|7433860|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
4589030|NCT01506882|7433859|FG000|Overall Study|Other Reason|2
4589031|NCT01506882|7433860|FG001|Overall Study|Other Reason|0
4589032|NCT01506908|7433870|FG000|Overall Study|Adverse Event|1
4589033|NCT01506908|7433871|FG001|Overall Study|Adverse Event|0
4589034|NCT01506947|7433879|FG000|Overall Study|Lost to Follow-up|7
4589035|NCT01506947|7433879|FG000|Overall Study|Adverse Event|5
4589036|NCT01506947|7433879|FG000|Overall Study|Death|1
4589037|NCT01506947|7433879|FG000|Overall Study|Did Not Meet Eligibility Criteria|3
4589038|NCT01506960|7433885|FG000|Overall Study|Did not meet angiographic criteria|47
4589039|NCT01507051|7433895|FG000|Overall Study|Withdrawal by Subject|1
4589040|NCT01507051|7433896|FG001|Overall Study|Withdrawal by Subject|3
4589041|NCT01507051|7433897|FG002|Overall Study|Withdrawal by Subject|1
4471366|NCT00652366|7265156|FG004|Overall Study|Lack of Efficacy|13
4471367|NCT00652366|7265152|FG000|Overall Study|Violation of Selection Criteria|0
4471368|NCT00652366|7265153|FG001|Overall Study|Violation of Selection Criteria|0
4471369|NCT00652366|7265154|FG002|Overall Study|Violation of Selection Criteria|1
4471370|NCT00652366|7265155|FG003|Overall Study|Violation of Selection Criteria|0
4471371|NCT00652366|7265156|FG004|Overall Study|Violation of Selection Criteria|0
4471372|NCT00652366|7265152|FG000|Overall Study|Protocol Violation|1
4471373|NCT00652366|7265153|FG001|Overall Study|Protocol Violation|0
4471374|NCT00652366|7265154|FG002|Overall Study|Protocol Violation|0
4589042|NCT01507051|7433898|FG003|Overall Study|Withdrawal by Subject|6
4589043|NCT01507051|7433895|FG000|Overall Study|Physician Decision|0
4589044|NCT01507051|7433896|FG001|Overall Study|Physician Decision|0
4589045|NCT01507051|7433897|FG002|Overall Study|Physician Decision|0
4589046|NCT01507051|7433898|FG003|Overall Study|Physician Decision|1
4589047|NCT01507051|7433895|FG000|Overall Study|Adverse Event|1
4589048|NCT01507051|7433896|FG001|Overall Study|Adverse Event|0
4589049|NCT01507051|7433897|FG002|Overall Study|Adverse Event|0
4589050|NCT01507051|7433898|FG003|Overall Study|Adverse Event|0
4589051|NCT01507090|7433908|FG000|Overall Study|incomplete dataset|18
4589052|NCT01507246|7433956|FG000|Overall Study|Required different surgical procedures|2
4589053|NCT01507246|7433957|FG001|Overall Study|Required different surgical procedures|1
4589054|NCT01507298|7433968|FG000|Overall Study|Protocol Violation|0
4589055|NCT01507298|7433969|FG001|Overall Study|Protocol Violation|6
4589056|NCT01507662|7433991|FG000|Overall Study|Death|26
4471375|NCT00652366|7265155|FG003|Overall Study|Protocol Violation|0
4471376|NCT00652366|7265156|FG004|Overall Study|Protocol Violation|0
4471377|NCT00652366|7265152|FG000|Overall Study|Refused treatment|3
4471378|NCT00652366|7265153|FG001|Overall Study|Refused treatment|7
4471379|NCT00652366|7265154|FG002|Overall Study|Refused treatment|6
4471380|NCT00652366|7265155|FG003|Overall Study|Refused treatment|17
4471381|NCT00652366|7265156|FG004|Overall Study|Refused treatment|5
4471382|NCT00652366|7265152|FG000|Overall Study|Other|5
4471383|NCT00652366|7265153|FG001|Overall Study|Other|2
4471384|NCT00652366|7265154|FG002|Overall Study|Other|3
4471385|NCT00652366|7265155|FG003|Overall Study|Other|4
4471386|NCT00652366|7265156|FG004|Overall Study|Other|0
4471387|NCT00652626|7265177|FG000|Initial Treatment Phase|Adverse Event|0
4471388|NCT00652626|7265178|FG001|Initial Treatment Phase|Adverse Event|0
4471389|NCT00652626|7265179|FG002|Initial Treatment Phase|Adverse Event|0
4471390|NCT00652626|7265180|FG003|Initial Treatment Phase|Adverse Event|0
4471391|NCT00652626|7265181|FG004|Initial Treatment Phase|Adverse Event|1
4471392|NCT00652626|7265182|FG005|Initial Treatment Phase|Adverse Event|0
4471393|NCT00652626|7265183|FG006|Initial Treatment Phase|Adverse Event|0
4471394|NCT00652626|7265177|FG000|Initial Treatment Phase|Protocol Violation|0
4471395|NCT00652626|7265178|FG001|Initial Treatment Phase|Protocol Violation|0
4471396|NCT00652626|7265179|FG002|Initial Treatment Phase|Protocol Violation|0
4471397|NCT00652626|7265180|FG003|Initial Treatment Phase|Protocol Violation|1
4471398|NCT00652626|7265181|FG004|Initial Treatment Phase|Protocol Violation|0
4471399|NCT00652626|7265182|FG005|Initial Treatment Phase|Protocol Violation|0
4471400|NCT00652626|7265183|FG006|Initial Treatment Phase|Protocol Violation|0
4471401|NCT00652626|7265177|FG000|Initial Treatment Phase|Physician Decision|0
4471402|NCT00652626|7265178|FG001|Initial Treatment Phase|Physician Decision|0
4471403|NCT00652626|7265179|FG002|Initial Treatment Phase|Physician Decision|0
4471404|NCT00652626|7265180|FG003|Initial Treatment Phase|Physician Decision|0
4471405|NCT00652626|7265181|FG004|Initial Treatment Phase|Physician Decision|1
4471406|NCT00652626|7265182|FG005|Initial Treatment Phase|Physician Decision|0
4471407|NCT00652626|7265183|FG006|Initial Treatment Phase|Physician Decision|0
4471408|NCT00652626|7265177|FG000|Initial Treatment Phase|Sponsor Request|0
4471409|NCT00652626|7265178|FG001|Initial Treatment Phase|Sponsor Request|0
4471410|NCT00652626|7265179|FG002|Initial Treatment Phase|Sponsor Request|1
4471411|NCT00652626|7265180|FG003|Initial Treatment Phase|Sponsor Request|0
4471412|NCT00652626|7265181|FG004|Initial Treatment Phase|Sponsor Request|0
4471413|NCT00652626|7265182|FG005|Initial Treatment Phase|Sponsor Request|0
4471414|NCT00652626|7265183|FG006|Initial Treatment Phase|Sponsor Request|0
4471415|NCT00652626|7265177|FG000|Initial Treatment Phase|Lost to Follow-up|0
4471416|NCT00652626|7265178|FG001|Initial Treatment Phase|Lost to Follow-up|0
4471417|NCT00652626|7265179|FG002|Initial Treatment Phase|Lost to Follow-up|0
4471418|NCT00652626|7265180|FG003|Initial Treatment Phase|Lost to Follow-up|0
4471419|NCT00652626|7265181|FG004|Initial Treatment Phase|Lost to Follow-up|1
4471420|NCT00652626|7265182|FG005|Initial Treatment Phase|Lost to Follow-up|0
4471421|NCT00652626|7265183|FG006|Initial Treatment Phase|Lost to Follow-up|0
4471422|NCT00652626|7265177|FG000|Extension Phase|Withdrawal by Subject|0
4471423|NCT00652626|7265178|FG001|Extension Phase|Withdrawal by Subject|0
4471424|NCT00652626|7265179|FG002|Extension Phase|Withdrawal by Subject|0
4471425|NCT00652626|7265180|FG003|Extension Phase|Withdrawal by Subject|0
4471426|NCT00652626|7265181|FG004|Extension Phase|Withdrawal by Subject|0
4471427|NCT00652626|7265182|FG005|Extension Phase|Withdrawal by Subject|2
4471428|NCT00652626|7265183|FG006|Extension Phase|Withdrawal by Subject|0
4471429|NCT00652626|7265177|FG000|Extension Phase|Adverse Event|0
4471430|NCT00652626|7265178|FG001|Extension Phase|Adverse Event|0
4471431|NCT00652626|7265179|FG002|Extension Phase|Adverse Event|0
4471432|NCT00652626|7265180|FG003|Extension Phase|Adverse Event|0
4471433|NCT00652626|7265181|FG004|Extension Phase|Adverse Event|0
4471434|NCT00652626|7265182|FG005|Extension Phase|Adverse Event|2
4471435|NCT00652626|7265183|FG006|Extension Phase|Adverse Event|1
4471436|NCT00652626|7265177|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0
4471437|NCT00652626|7265178|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0
4471438|NCT00652626|7265179|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0
4471439|NCT00652626|7265180|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0
4471440|NCT00652626|7265181|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0
4471441|NCT00652626|7265182|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6
4471442|NCT00652626|7265183|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0
4471443|NCT00652626|7265177|FG000|Extension Phase|Physician Decision|0
4471444|NCT00652626|7265178|FG001|Extension Phase|Physician Decision|0
4589057|NCT01507662|7433992|FG001|Overall Study|Death|18
4471445|NCT00652626|7265179|FG002|Extension Phase|Physician Decision|0
4471446|NCT00652626|7265180|FG003|Extension Phase|Physician Decision|0
4471447|NCT00652626|7265181|FG004|Extension Phase|Physician Decision|0
4471448|NCT00652626|7265182|FG005|Extension Phase|Physician Decision|1
4471449|NCT00652626|7265183|FG006|Extension Phase|Physician Decision|1
4471450|NCT00652626|7265177|FG000|Extension Phase|Death|0
4471451|NCT00652626|7265178|FG001|Extension Phase|Death|0
4471452|NCT00652626|7265179|FG002|Extension Phase|Death|0
4471453|NCT00652626|7265180|FG003|Extension Phase|Death|0
4471454|NCT00652626|7265181|FG004|Extension Phase|Death|0
4471455|NCT00652626|7265182|FG005|Extension Phase|Death|1
4471456|NCT00652626|7265183|FG006|Extension Phase|Death|1
4471457|NCT00652743|7265204|FG000|Months 12-18|Lost to Follow-up|1
4471458|NCT00652743|7265205|FG001|Months 12-18|Lost to Follow-up|2
4471459|NCT00652743|7265206|FG002|Months 12-18|Lost to Follow-up|7
4471460|NCT00652743|7265204|FG000|Months 24-30|Other|5
4471461|NCT00652743|7265205|FG001|Months 24-30|Other|1
4471462|NCT00652743|7265206|FG002|Months 24-30|Other|11
4471463|NCT00652743|7265204|FG000|Months 36-42|Serious Adverse Events|0
4471464|NCT00652743|7265205|FG001|Months 36-42|Serious Adverse Events|1
4471465|NCT00652743|7265206|FG002|Months 36-42|Serious Adverse Events|1
4471466|NCT00652743|7265204|FG000|Months 36-42|Withdrawal by Subject|1
4471467|NCT00652743|7265205|FG001|Months 36-42|Withdrawal by Subject|1
4471468|NCT00652743|7265206|FG002|Months 36-42|Withdrawal by Subject|0
4471469|NCT00652743|7265204|FG000|Months 36-42|Lost to Follow-up|0
4471470|NCT00652743|7265205|FG001|Months 36-42|Lost to Follow-up|1
4471471|NCT00652743|7265206|FG002|Months 36-42|Lost to Follow-up|0
4471472|NCT00652743|7265204|FG000|Months 36-42|Migrated/moved from study area|1
4471473|NCT00652743|7265205|FG001|Months 36-42|Migrated/moved from study area|0
4697913|NCT02659943|7612162|FG000|Overall Study|Switched to alternative treatment|1
4697914|NCT02659943|7612163|FG001|Overall Study|Switched to alternative treatment|1
4697915|NCT02659943|7612164|FG002|Overall Study|Switched to alternative treatment|0
4697916|NCT02659943|7612165|FG003|Overall Study|Switched to alternative treatment|2
4697917|NCT02659943|7612166|FG004|Overall Study|Switched to alternative treatment|1
4697918|NCT02659943|7612167|FG005|Overall Study|Switched to alternative treatment|0
4697919|NCT02659943|7612168|FG006|Overall Study|Switched to alternative treatment|1
4697920|NCT02659943|7612162|FG000|Overall Study|Disease progression on study|0
4697921|NCT02659943|7612163|FG001|Overall Study|Disease progression on study|1
4697922|NCT02659943|7612164|FG002|Overall Study|Disease progression on study|1
4697923|NCT02659943|7612165|FG003|Overall Study|Disease progression on study|1
4697924|NCT02659943|7612166|FG004|Overall Study|Disease progression on study|1
4697925|NCT02659943|7612167|FG005|Overall Study|Disease progression on study|4
4697926|NCT02659943|7612168|FG006|Overall Study|Disease progression on study|0
4697927|NCT02659943|7612162|FG000|Overall Study|Patient's condition per principal investigator|0
4697928|NCT02659943|7612163|FG001|Overall Study|Patient's condition per principal investigator|0
4697929|NCT02659943|7612164|FG002|Overall Study|Patient's condition per principal investigator|0
4697930|NCT02659943|7612165|FG003|Overall Study|Patient's condition per principal investigator|0
4697931|NCT02659943|7612166|FG004|Overall Study|Patient's condition per principal investigator|0
4697932|NCT02659943|7612167|FG005|Overall Study|Patient's condition per principal investigator|1
4697933|NCT02659943|7612168|FG006|Overall Study|Patient's condition per principal investigator|0
4697934|NCT02659943|7612162|FG000|Overall Study|Ineligible|0
4697935|NCT02659943|7612163|FG001|Overall Study|Ineligible|0
4697936|NCT02659943|7612164|FG002|Overall Study|Ineligible|0
4697937|NCT02659943|7612165|FG003|Overall Study|Ineligible|0
4697938|NCT02659943|7612166|FG004|Overall Study|Ineligible|0
4697939|NCT02659943|7612167|FG005|Overall Study|Ineligible|0
4697940|NCT02659943|7612168|FG006|Overall Study|Ineligible|1
4697941|NCT02659943|7612162|FG000|Overall Study|No longer meets eligibility|0
4697942|NCT02659943|7612163|FG001|Overall Study|No longer meets eligibility|0
4697943|NCT02659943|7612164|FG002|Overall Study|No longer meets eligibility|0
4697944|NCT02659943|7612165|FG003|Overall Study|No longer meets eligibility|0
4697945|NCT02659943|7612166|FG004|Overall Study|No longer meets eligibility|0
4697946|NCT02659943|7612167|FG005|Overall Study|No longer meets eligibility|0
4697947|NCT02659943|7612168|FG006|Overall Study|No longer meets eligibility|1
4697948|NCT02659943|7612162|FG000|Overall Study|No treatment, per protocol|0
4697949|NCT02659943|7612163|FG001|Overall Study|No treatment, per protocol|0
4697950|NCT02659943|7612164|FG002|Overall Study|No treatment, per protocol|0
4697951|NCT02659943|7612165|FG003|Overall Study|No treatment, per protocol|0
4697952|NCT02659943|7612166|FG004|Overall Study|No treatment, per protocol|0
4697953|NCT02659943|7612167|FG005|Overall Study|No treatment, per protocol|0
4471474|NCT00652743|7265206|FG002|Months 36-42|Migrated/moved from study area|0
4471475|NCT00652743|7265204|FG000|Months 36-42|Other|4
4471476|NCT00652743|7265205|FG001|Months 36-42|Other|2
4471477|NCT00652743|7265206|FG002|Months 36-42|Other|8
4697954|NCT02659943|7612168|FG006|Overall Study|No treatment, per protocol|3
4697955|NCT02660138|7612196|FG000|Overall Study|Adverse Event|0
4697956|NCT02660138|7612197|FG001|Overall Study|Adverse Event|3
4697957|NCT02660138|7612198|FG002|Overall Study|Adverse Event|2
4697958|NCT02660138|7612196|FG000|Overall Study|Lack of Efficacy|1
4697959|NCT02660138|7612197|FG001|Overall Study|Lack of Efficacy|2
4471478|NCT00652834|7265217|FG000|Overall Study|Withdrawal by Subject|3
4471479|NCT00652834|7265217|FG000|Overall Study|Lost to Follow-up|2
4471480|NCT00652899|7265221|FG000|Overall Study|Death|1
4471481|NCT00652899|7265221|FG000|Overall Study|Treating physician decision|1
4471482|NCT00652938|7265232|FG000|Overall Study|Adverse Event|1
4471483|NCT00652938|7265233|FG001|Overall Study|Adverse Event|0
4471484|NCT00652938|7265234|FG002|Overall Study|Adverse Event|2
4471485|NCT00652938|7265232|FG000|Overall Study|Withdrawal by Subject|0
4471486|NCT00652938|7265233|FG001|Overall Study|Withdrawal by Subject|6
4471487|NCT00652938|7265234|FG002|Overall Study|Withdrawal by Subject|1
4471488|NCT00652938|7265232|FG000|Overall Study|Lost to Follow-up|0
4471489|NCT00652938|7265233|FG001|Overall Study|Lost to Follow-up|0
4471490|NCT00652938|7265234|FG002|Overall Study|Lost to Follow-up|2
4471491|NCT00652938|7265232|FG000|Overall Study|fear of blood sampling|0
4471492|NCT00652938|7265233|FG001|Overall Study|fear of blood sampling|1
4471493|NCT00652938|7265234|FG002|Overall Study|fear of blood sampling|0
4471494|NCT00652951|7265245|FG000|Booster Phase|Adverse event, non-fatal|0
4471495|NCT00652951|7265246|FG001|Booster Phase|Adverse event, non-fatal|1
4471496|NCT00652951|7265247|FG002|Booster Phase|Adverse event, non-fatal|0
4471497|NCT00652951|7265245|FG000|Booster Phase|Other|1
4471498|NCT00652951|7265246|FG001|Booster Phase|Other|0
4471499|NCT00652951|7265247|FG002|Booster Phase|Other|0
4697960|NCT02660138|7612198|FG002|Overall Study|Lack of Efficacy|1
4697961|NCT02660138|7612196|FG000|Overall Study|Withdrawal by Subject|7
4697962|NCT02660138|7612197|FG001|Overall Study|Withdrawal by Subject|6
4697963|NCT02660138|7612198|FG002|Overall Study|Withdrawal by Subject|6
4697964|NCT02660138|7612196|FG000|Overall Study|Lost to Follow-up|4
4697965|NCT02660138|7612197|FG001|Overall Study|Lost to Follow-up|4
4697966|NCT02660138|7612198|FG002|Overall Study|Lost to Follow-up|1
4697967|NCT02660138|7612196|FG000|Overall Study|Sponsor Decision to Terminate Study|57
4697968|NCT02660138|7612197|FG001|Overall Study|Sponsor Decision to Terminate Study|57
4697969|NCT02660138|7612198|FG002|Overall Study|Sponsor Decision to Terminate Study|62
4697970|NCT02660138|7612196|FG000|Overall Study|Other|1
4697971|NCT02660138|7612197|FG001|Overall Study|Other|1
4697972|NCT02660138|7612198|FG002|Overall Study|Other|0
4697973|NCT02660138|7612196|FG000|Overall Study|Not treated|0
4697974|NCT02660138|7612197|FG001|Overall Study|Not treated|1
4697975|NCT02660138|7612198|FG002|Overall Study|Not treated|0
4697976|NCT02660229|7612211|FG000|Overall Study|Adverse Event|2
4697977|NCT02660229|7612212|FG001|Overall Study|Adverse Event|0
4697978|NCT02660229|7612211|FG000|Overall Study|Withdrawal by Subject|0
4697979|NCT02660229|7612212|FG001|Overall Study|Withdrawal by Subject|1
4697980|NCT02660242|7612218|FG000|Glucose Tabs|Lost to Follow-up|1
4697981|NCT02660242|7612218|FG000|Glucagon Injection|Lost to Follow-up|1
4697982|NCT02660359|7612234|FG000|Overall Study|Protocol Deviation|0
4697983|NCT02660359|7612235|FG001|Overall Study|Protocol Deviation|0
4697984|NCT02660359|7612236|FG002|Overall Study|Protocol Deviation|1
4697985|NCT02660359|7612234|FG000|Overall Study|Sponsor Decision to Terminate Study|73
4697986|NCT02660359|7612235|FG001|Overall Study|Sponsor Decision to Terminate Study|75
4697987|NCT02660359|7612236|FG002|Overall Study|Sponsor Decision to Terminate Study|71
4697988|NCT02660359|7612234|FG000|Overall Study|Lack of Efficacy|1
4697989|NCT02660359|7612235|FG001|Overall Study|Lack of Efficacy|1
4697990|NCT02660359|7612236|FG002|Overall Study|Lack of Efficacy|1
4697991|NCT02660359|7612234|FG000|Overall Study|Adverse Event|0
4697992|NCT02660359|7612235|FG001|Overall Study|Adverse Event|1
4697993|NCT02660359|7612236|FG002|Overall Study|Adverse Event|0
4697994|NCT02660359|7612234|FG000|Overall Study|Other|2
4697995|NCT02660359|7612235|FG001|Overall Study|Other|1
4697996|NCT02660359|7612236|FG002|Overall Study|Other|3
4697997|NCT02660359|7612234|FG000|Overall Study|Withdrawal by Subject|7
4697998|NCT02660359|7612235|FG001|Overall Study|Withdrawal by Subject|5
4697999|NCT02660359|7612236|FG002|Overall Study|Withdrawal by Subject|8
4698000|NCT02660359|7612234|FG000|Overall Study|Lost to Follow-up|3
4698001|NCT02660359|7612235|FG001|Overall Study|Lost to Follow-up|3
4698002|NCT02660359|7612236|FG002|Overall Study|Lost to Follow-up|0
4698003|NCT02660489|7612246|FG000|Overall Study|Lost to Follow-up|1
4698004|NCT02660489|7612247|FG001|Overall Study|Lost to Follow-up|1
4698005|NCT02660489|7612246|FG000|Overall Study|Adverse Event|1
4698006|NCT02660489|7612247|FG001|Overall Study|Adverse Event|3
4471500|NCT00653159|7265266|FG000|Overall Study|Adverse Event|4
4471501|NCT00653159|7265267|FG001|Overall Study|Adverse Event|1
4471502|NCT00653159|7265266|FG000|Overall Study|Lost to Follow-up|1
4471503|NCT00653159|7265267|FG001|Overall Study|Lost to Follow-up|2
4471504|NCT00653224|7265275|FG000|Overall Study|Adverse Event|2
4698007|NCT02660489|7612246|FG000|Overall Study|no rhinovirus infection|4
4698008|NCT02660489|7612247|FG001|Overall Study|no rhinovirus infection|4
4698009|NCT02660580|7612255|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1
4698010|NCT02660580|7612256|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1
4698011|NCT02660580|7612257|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0
4698012|NCT02660580|7612258|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0
4698013|NCT02660580|7612259|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0
4698014|NCT02660580|7612255|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3
4698015|NCT02660580|7612256|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1
4698016|NCT02660580|7612257|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0
4698017|NCT02660580|7612258|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0
4771206|NCT04250077|7748049|FG000|Overall Study|Withdrawal by Subject|0
4471505|NCT00653224|7265276|FG001|Overall Study|Adverse Event|1
4471506|NCT00653224|7265275|FG000|Overall Study|Lack of Efficacy|1
4471507|NCT00653224|7265276|FG001|Overall Study|Lack of Efficacy|2
4471508|NCT00653224|7265275|FG000|Overall Study|Loss of efficacy|1
4698018|NCT02660580|7612259|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0
4698019|NCT02660580|7612255|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1
4698020|NCT02660580|7612256|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0
4698021|NCT02660580|7612257|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0
4698022|NCT02660580|7612258|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0
4698023|NCT02660580|7612259|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0
4698024|NCT02660580|7612255|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
4698025|NCT02660580|7612256|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2
4698026|NCT02660580|7612257|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
4698027|NCT02660580|7612258|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
4698028|NCT02660580|7612259|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
4698029|NCT02660580|7612255|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2
4698030|NCT02660580|7612256|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9
4698031|NCT02660580|7612257|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0
4698032|NCT02660580|7612258|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0
4698033|NCT02660580|7612259|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0
4698034|NCT02660580|7612255|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1
4698035|NCT02660580|7612256|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4
4698036|NCT02660580|7612257|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0
4698037|NCT02660580|7612258|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0
4698038|NCT02660580|7612259|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0
4698039|NCT02660580|7612255|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1
4698040|NCT02660580|7612256|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2
4698041|NCT02660580|7612257|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0
4698042|NCT02660580|7612258|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0
4698043|NCT02660580|7612259|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0
4698044|NCT02660580|7612255|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0
4698045|NCT02660580|7612256|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0
4698046|NCT02660580|7612257|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2
4698047|NCT02660580|7612258|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0
4698048|NCT02660580|7612259|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1
4698049|NCT02660580|7612255|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0
4698050|NCT02660580|7612256|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0
4698051|NCT02660580|7612257|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1
4698052|NCT02660580|7612258|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0
4698053|NCT02660580|7612259|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1
4698054|NCT02660580|7612255|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0
4698055|NCT02660580|7612256|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0
4698056|NCT02660580|7612257|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4
4698057|NCT02660580|7612258|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2
4698058|NCT02660580|7612259|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2
4698059|NCT02660580|7612255|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0
4698060|NCT02660580|7612256|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0
4698061|NCT02660580|7612257|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8
4698062|NCT02660580|7612258|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6
4698063|NCT02660580|7612259|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4
4698064|NCT02660580|7612255|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0
4698065|NCT02660580|7612256|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0
4698066|NCT02660580|7612257|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3
4698067|NCT02660580|7612258|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2
4698068|NCT02660580|7612259|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2
4698069|NCT02660580|7612255|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0
4698070|NCT02660580|7612256|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0
4698071|NCT02660580|7612257|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0
4698072|NCT02660580|7612258|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1
4698073|NCT02660580|7612259|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1
4698074|NCT02660944|7612310|FG000|Overall Study|Adverse Event|3
4698075|NCT02660944|7612311|FG001|Overall Study|Adverse Event|4
4698076|NCT02660944|7612310|FG000|Overall Study|Physician Decision|3
4698077|NCT02660944|7612311|FG001|Overall Study|Physician Decision|1
4698078|NCT02660944|7612310|FG000|Overall Study|Withdrawal by Subject|5
4698079|NCT02660944|7612311|FG001|Overall Study|Withdrawal by Subject|3
4698080|NCT02660944|7612310|FG000|Overall Study|Lost to Follow-up|4
4698081|NCT02660944|7612311|FG001|Overall Study|Lost to Follow-up|1
4698082|NCT02660944|7612310|FG000|Overall Study|Subject schedule|0
4471509|NCT00653224|7265276|FG001|Overall Study|Loss of efficacy|0
4471510|NCT00653224|7265275|FG000|Overall Study|Lost to Follow-up|1
4471511|NCT00653224|7265276|FG001|Overall Study|Lost to Follow-up|0
4471512|NCT00653224|7265275|FG000|Overall Study|Other|2
4471513|NCT00653224|7265276|FG001|Overall Study|Other|4
4471514|NCT00653263|7265282|FG000|Overall Study|Withdrawal by Subject|1
4471515|NCT00653263|7265282|FG000|Overall Study|Physician Decision|1
4698083|NCT02660944|7612311|FG001|Overall Study|Subject schedule|1
4698084|NCT02660944|7612310|FG000|Overall Study|Exclusion criteria met|2
4698085|NCT02660944|7612311|FG001|Overall Study|Exclusion criteria met|0
4698086|NCT02660983|7612319|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1
4698087|NCT02660983|7612320|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5
4698088|NCT02660983|7612319|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15
4698089|NCT02660983|7612320|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12
4698090|NCT02660983|7612319|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8
4698091|NCT02660983|7612320|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9
4698092|NCT02660983|7612319|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1
4698093|NCT02660983|7612320|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1
4698094|NCT02660983|7612319|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1
4698095|NCT02660983|7612320|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4
4698096|NCT02660983|7612319|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1
4698097|NCT02660983|7612320|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3
4698098|NCT02660983|7612319|FG000|Open Label Extension Phase (24 Weeks)|Other|0
4698099|NCT02660983|7612320|FG001|Open Label Extension Phase (24 Weeks)|Other|1
4698100|NCT02661061|7612329|FG000|Overall Study|Lack of Efficacy|1
4698101|NCT02661061|7612330|FG001|Overall Study|Lack of Efficacy|1
4698102|NCT02661061|7612329|FG000|Overall Study|Withdrawal by Subject|1
4698103|NCT02661061|7612330|FG001|Overall Study|Withdrawal by Subject|1
4698104|NCT02661178|7612360|FG000|Part 1|Protocol Violation|1
4698105|NCT02661178|7612361|FG001|Part 1|Protocol Violation|0
4698106|NCT02661178|7612362|FG002|Part 1|Protocol Violation|0
4698107|NCT02661178|7612363|FG003|Part 1|Protocol Violation|0
4698108|NCT02661178|7612364|FG004|Part 1|Protocol Violation|0
4698109|NCT02661178|7612365|FG005|Part 1|Protocol Violation|0
4698110|NCT02661178|7612366|FG006|Part 1|Protocol Violation|0
4698111|NCT02661178|7612367|FG007|Part 1|Protocol Violation|0
4698112|NCT02661178|7612368|FG008|Part 1|Protocol Violation|0
4698113|NCT02661178|7612369|FG009|Part 1|Protocol Violation|0
4698114|NCT02661178|7612370|FG010|Part 1|Protocol Violation|0
4698115|NCT02661178|7612371|FG011|Part 1|Protocol Violation|0
4698116|NCT02661178|7612372|FG012|Part 1|Protocol Violation|0
4698117|NCT02661178|7612373|FG013|Part 1|Protocol Violation|0
4698118|NCT02661178|7612374|FG014|Part 1|Protocol Violation|0
4698119|NCT02661217|7612426|FG000|Overall Study|Physician Decision|12
4698120|NCT02661217|7612427|FG001|Overall Study|Physician Decision|15
4698121|NCT02661217|7612426|FG000|Overall Study|Lost to Follow-up|1
4698122|NCT02661217|7612427|FG001|Overall Study|Lost to Follow-up|4
4698123|NCT02661217|7612426|FG000|Overall Study|Protocol Deviation|0
4698124|NCT02661217|7612427|FG001|Overall Study|Protocol Deviation|4
4698125|NCT02661217|7612426|FG000|Overall Study|Non-compliance with study treatment|5
4698126|NCT02661217|7612427|FG001|Overall Study|Non-compliance with study treatment|5
4698127|NCT02661217|7612426|FG000|Overall Study|Death|21
4698128|NCT02661217|7612427|FG001|Overall Study|Death|15
4698129|NCT02661217|7612426|FG000|Overall Study|Adverse Event|10
4698130|NCT02661217|7612427|FG001|Overall Study|Adverse Event|8
4698131|NCT02661217|7612426|FG000|Overall Study|Withdrawal by Subject|15
4698132|NCT02661217|7612427|FG001|Overall Study|Withdrawal by Subject|19
4698133|NCT02661217|7612426|FG000|Overall Study|Did not enter follow-up epoch|7
4698134|NCT02661217|7612427|FG001|Overall Study|Did not enter follow-up epoch|10
4698135|NCT02661217|7612426|FG000|Overall Study|Death - no study drug received|1
4698136|NCT02661217|7612427|FG001|Overall Study|Death - no study drug received|2
4698137|NCT02661217|7612426|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3
4698138|NCT02661217|7612427|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1
4698139|NCT02661490|7612445|FG000|Overall Study|Lost to Follow-up|0
4698140|NCT02661490|7612446|FG001|Overall Study|Lost to Follow-up|1
4698141|NCT02661490|7612447|FG002|Overall Study|Lost to Follow-up|0
4698142|NCT02661490|7612448|FG003|Overall Study|Lost to Follow-up|0
4698143|NCT02661490|7612449|FG004|Overall Study|Lost to Follow-up|2
4698144|NCT02661490|7612445|FG000|Overall Study|Withdrawal by Subject|2
4698145|NCT02661490|7612446|FG001|Overall Study|Withdrawal by Subject|0
4698146|NCT02661490|7612447|FG002|Overall Study|Withdrawal by Subject|2
4698147|NCT02661490|7612448|FG003|Overall Study|Withdrawal by Subject|0
4698148|NCT02661490|7612449|FG004|Overall Study|Withdrawal by Subject|0
4698149|NCT02661490|7612445|FG000|Overall Study|Death|1
4698150|NCT02661490|7612446|FG001|Overall Study|Death|1
4698151|NCT02661490|7612447|FG002|Overall Study|Death|0
4698152|NCT02661490|7612448|FG003|Overall Study|Death|1
4698153|NCT02661490|7612449|FG004|Overall Study|Death|0
4698154|NCT02661490|7612445|FG000|Overall Study|Reason not Specified|0
4698155|NCT02661490|7612446|FG001|Overall Study|Reason not Specified|0
4698156|NCT02661490|7612447|FG002|Overall Study|Reason not Specified|0
4698157|NCT02661490|7612448|FG003|Overall Study|Reason not Specified|0
4698158|NCT02661490|7612449|FG004|Overall Study|Reason not Specified|1
4698159|NCT02661594|7612465|FG000|Overall Study|Protocol Violation|1
4471516|NCT00653328|7265286|FG000|Overall Study|Withdrawal by Subject|1
4698160|NCT02661594|7612466|FG001|Overall Study|Protocol Violation|0
4471517|NCT00653328|7265286|FG000|Overall Study|Adverse Event|2
4471518|NCT00653328|7265286|FG000|Overall Study|Disease progression|10
4471519|NCT00653328|7265286|FG000|Overall Study|Drug manufacturer no longing making drug|2
4471520|NCT00653432|7265292|FG000|Overall Study|Adverse Event|4
4471521|NCT00653432|7265293|FG001|Overall Study|Adverse Event|1
4471522|NCT00653432|7265292|FG000|Overall Study|Withdrawal by Subject|4
4471523|NCT00653432|7265293|FG001|Overall Study|Withdrawal by Subject|5
4471524|NCT00653432|7265292|FG000|Overall Study|Lost to Follow-up|7
4471525|NCT00653432|7265293|FG001|Overall Study|Lost to Follow-up|6
4471526|NCT00653432|7265292|FG000|Overall Study|Use/Need of Con Therapy|2
4471527|NCT00653432|7265293|FG001|Overall Study|Use/Need of Con Therapy|1
4471528|NCT00653432|7265292|FG000|Overall Study|Other - Reason Not Provided|5
4471529|NCT00653432|7265293|FG001|Overall Study|Other - Reason Not Provided|3
4698161|NCT02661594|7612467|FG002|Overall Study|Protocol Violation|1
4698162|NCT02661594|7612468|FG003|Overall Study|Protocol Violation|0
4698163|NCT02661815|7612486|FG000|Overall Study|Withdrawal by Subject|1
4698164|NCT02661815|7612487|FG001|Overall Study|Withdrawal by Subject|0
4698165|NCT02661815|7612488|FG002|Overall Study|Withdrawal by Subject|0
4698166|NCT02661815|7612489|FG003|Overall Study|Withdrawal by Subject|0
4698167|NCT02662556|7612546|FG000|Overall Study|Adverse Event|4
4698168|NCT02662556|7612546|FG000|Overall Study|Lack of Efficacy|4
4698169|NCT02662569|7612555|FG000|Overall Study|Withdrawal by Subject|6
4698170|NCT02662569|7612556|FG001|Overall Study|Withdrawal by Subject|1
4698171|NCT02662569|7612557|FG002|Overall Study|Withdrawal by Subject|6
4698172|NCT02662569|7612558|FG003|Overall Study|Withdrawal by Subject|4
4698173|NCT02662569|7612555|FG000|Overall Study|Lost to Follow-up|1
4698174|NCT02662569|7612556|FG001|Overall Study|Lost to Follow-up|0
4698175|NCT02662569|7612557|FG002|Overall Study|Lost to Follow-up|0
4698176|NCT02662569|7612558|FG003|Overall Study|Lost to Follow-up|0
4698177|NCT02662582|7612570|FG000|Treatment Period 1 (14 Days)|Adverse Event|3
4698178|NCT02662582|7612571|FG001|Treatment Period 1 (14 Days)|Adverse Event|2
4698179|NCT02662582|7612570|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0
4698180|NCT02662582|7612571|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1
4698181|NCT02662582|7612570|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1
4698182|NCT02662582|7612571|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0
4698183|NCT02662582|7612570|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
4698184|NCT02662582|7612571|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
4698185|NCT02662764|7612582|FG000|Overall Study|Adverse Event|6
4698186|NCT02662764|7612582|FG000|Overall Study|Lack of Efficacy|8
4698187|NCT02662764|7612582|FG000|Overall Study|Protocol Violation|1
4698188|NCT02662764|7612582|FG000|Overall Study|Withdrawal by Subject|5
4698189|NCT02662764|7612582|FG000|Overall Study|Device failure|4
4698190|NCT02662764|7612582|FG000|Overall Study|Patient changed treatment|1
4698191|NCT02662764|7612582|FG000|Overall Study|Patient discharged prior to 24 hrs|5
4698192|NCT02663128|7612593|FG000|Period 2|Physician Decision|0
4698193|NCT02663128|7612594|FG001|Period 2|Physician Decision|0
4698194|NCT02663128|7612595|FG002|Period 2|Physician Decision|0
4698195|NCT02663128|7612596|FG003|Period 2|Physician Decision|0
4698196|NCT02663128|7612597|FG004|Period 2|Physician Decision|1
4698197|NCT02663128|7612598|FG005|Period 2|Physician Decision|0
4698198|NCT02663453|7612613|FG000|Overall Study|Death|4
4698199|NCT02663453|7612614|FG001|Overall Study|Death|4
4698200|NCT02663453|7612613|FG000|Overall Study|Withdrawal by Subject|1
4698201|NCT02663453|7612614|FG001|Overall Study|Withdrawal by Subject|0
4698202|NCT02663674|7612622|FG000|Overall Study|Lost to Follow-up|5
4698203|NCT02663674|7612623|FG001|Overall Study|Lost to Follow-up|4
4698204|NCT02663674|7612622|FG000|Overall Study|Withdrawal by Subject|1
4698205|NCT02663674|7612623|FG001|Overall Study|Withdrawal by Subject|4
4698206|NCT02663674|7612622|FG000|Overall Study|Physician Decision|1
4698207|NCT02663674|7612623|FG001|Overall Study|Physician Decision|1
4698208|NCT02663674|7612622|FG000|Overall Study|Other Event (Health Related)|0
4698209|NCT02663674|7612623|FG001|Overall Study|Other Event (Health Related)|1
4698210|NCT02663687|7612634|FG000|Overall Study|Adverse Event|1
4698211|NCT02663687|7612635|FG001|Overall Study|Adverse Event|0
4698212|NCT02663687|7612636|FG002|Overall Study|Adverse Event|0
4698213|NCT02663687|7612637|FG003|Overall Study|Adverse Event|0
4698214|NCT02663687|7612638|FG004|Overall Study|Adverse Event|0
4698215|NCT02663687|7612634|FG000|Overall Study|Other|1
4698216|NCT02663687|7612635|FG001|Overall Study|Other|0
4698217|NCT02663687|7612636|FG002|Overall Study|Other|1
4698218|NCT02663687|7612637|FG003|Overall Study|Other|0
4698219|NCT02663687|7612638|FG004|Overall Study|Other|0
4698220|NCT02663817|7612663|FG000|Overall Study|Screen failure|2
4471530|NCT00653939|7265310|FG000|Overall Study|Adverse Event|1
4471531|NCT00653939|7265311|FG001|Overall Study|Adverse Event|3
4471532|NCT00653939|7265310|FG000|Overall Study|Withdrawal by Subject|3
4698221|NCT02663882|7612671|FG000|Overall Study|Lost to Follow-up|4
4698222|NCT02663882|7612672|FG001|Overall Study|Lost to Follow-up|2
4698223|NCT02663895|7612678|FG000|Overall Study|Adverse Event|3
4698224|NCT02663895|7612678|FG000|Overall Study|Physician Decision|2
4698225|NCT02663895|7612678|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1
4698226|NCT02663895|7612678|FG000|Overall Study|Withdrawal by Subject|1
4698227|NCT02664272|7612692|FG000|Overall Study|Fluoroscopic images not made available|2
4698228|NCT02664415|7612711|FG000|Overall Study|Adverse Event|1
4471533|NCT00653939|7265311|FG001|Overall Study|Withdrawal by Subject|3
4471534|NCT00653939|7265310|FG000|Overall Study|Physician Decision|4
4471535|NCT00653939|7265311|FG001|Overall Study|Physician Decision|0
4471536|NCT00653939|7265310|FG000|Overall Study|Disease Progression|2
4471537|NCT00653939|7265311|FG001|Overall Study|Disease Progression|3
4471538|NCT00653939|7265310|FG000|Overall Study|Other|2
4471539|NCT00653939|7265311|FG001|Overall Study|Other|6
4471540|NCT00653991|7265321|FG000|3 Month Follow-up|Participant would not respond|150
4471541|NCT00653991|7265322|FG001|3 Month Follow-up|Participant would not respond|157
4471542|NCT00653991|7265321|FG000|6 Month Follow-up|Participant would not respond|133
4471543|NCT00653991|7265322|FG001|6 Month Follow-up|Participant would not respond|141
4471544|NCT00654004|7265332|FG000|Overall Study|Lost to Follow-up|1
4471545|NCT00654004|7265333|FG001|Overall Study|Lost to Follow-up|0
4471546|NCT00654186|7265365|FG000|Overall Study|Withdrawal by Subject|5
4471547|NCT00654238|7265369|FG000|Overall Study|Screen Failures|4
4471548|NCT00654355|7265393|FG000|Overall Study|Lost to Follow-up|2
4471549|NCT00654355|7265394|FG001|Overall Study|Lost to Follow-up|2
4471550|NCT00654368|7265403|FG000|Overall Study|Ineligibility determined|6
4471551|NCT00654368|7265404|FG001|Overall Study|Ineligibility determined|0
4471552|NCT00654368|7265405|FG002|Overall Study|Ineligibility determined|0
4471553|NCT00654368|7265403|FG000|Overall Study|Protocol deviation|3
4471554|NCT00654368|7265404|FG001|Overall Study|Protocol deviation|2
4471555|NCT00654368|7265405|FG002|Overall Study|Protocol deviation|1
4471556|NCT00654368|7265403|FG000|Overall Study|Non-compliance|2
4471557|NCT00654368|7265404|FG001|Overall Study|Non-compliance|1
4471558|NCT00654368|7265405|FG002|Overall Study|Non-compliance|2
4471559|NCT00654368|7265403|FG000|Overall Study|Withdrawal by Subject|5
4471560|NCT00654368|7265404|FG001|Overall Study|Withdrawal by Subject|2
4471561|NCT00654368|7265405|FG002|Overall Study|Withdrawal by Subject|2
4471562|NCT00654368|7265403|FG000|Overall Study|Disease progression|21
4471563|NCT00654368|7265404|FG001|Overall Study|Disease progression|31
4471564|NCT00654368|7265405|FG002|Overall Study|Disease progression|13
4471565|NCT00654368|7265403|FG000|Overall Study|Requirement for alternative therapy|1
4471566|NCT00654368|7265404|FG001|Overall Study|Requirement for alternative therapy|1
4471567|NCT00654368|7265405|FG002|Overall Study|Requirement for alternative therapy|1
4471568|NCT00654368|7265403|FG000|Overall Study|Physician Decision|0
4471569|NCT00654368|7265404|FG001|Overall Study|Physician Decision|0
4471570|NCT00654368|7265405|FG002|Overall Study|Physician Decision|2
4471571|NCT00654368|7265403|FG000|Overall Study|Death|1
4471572|NCT00654368|7265404|FG001|Overall Study|Death|0
4471573|NCT00654368|7265405|FG002|Overall Study|Death|0
4471574|NCT00654368|7265403|FG000|Overall Study|Pregnancy|0
4471575|NCT00654368|7265404|FG001|Overall Study|Pregnancy|0
4471576|NCT00654368|7265405|FG002|Overall Study|Pregnancy|2
4471577|NCT00654368|7265403|FG000|Overall Study|Other|0
4471578|NCT00654368|7265404|FG001|Overall Study|Other|2
4471579|NCT00654368|7265405|FG002|Overall Study|Other|3
4471580|NCT00654368|7265403|FG000|Overall Study|Adverse Event|14
4471581|NCT00654368|7265404|FG001|Overall Study|Adverse Event|9
4471582|NCT00654368|7265405|FG002|Overall Study|Adverse Event|6
4698229|NCT02664415|7612712|FG001|Overall Study|Adverse Event|0
4698230|NCT02665052|7612774|FG000|Overall Study|Lost to Follow-up|1
4698231|NCT02665052|7612775|FG001|Overall Study|Lost to Follow-up|0
4698232|NCT02665052|7612776|FG002|Overall Study|Lost to Follow-up|0
4698233|NCT02665052|7612777|FG003|Overall Study|Lost to Follow-up|0
4698234|NCT02665052|7612774|FG000|Overall Study|Withdrawal by Subject|1
4698235|NCT02665052|7612775|FG001|Overall Study|Withdrawal by Subject|1
4698236|NCT02665052|7612776|FG002|Overall Study|Withdrawal by Subject|0
4698237|NCT02665052|7612777|FG003|Overall Study|Withdrawal by Subject|5
4698238|NCT02665052|7612774|FG000|Overall Study|Adverse Event|1
4698239|NCT02665052|7612775|FG001|Overall Study|Adverse Event|1
4698240|NCT02665052|7612776|FG002|Overall Study|Adverse Event|0
4698241|NCT02665052|7612777|FG003|Overall Study|Adverse Event|0
4698242|NCT02665286|7612821|FG000|Overall Study|Lost to Follow-up|3
4698243|NCT02665286|7612822|FG001|Overall Study|Lost to Follow-up|2
4698244|NCT02665286|7612823|FG002|Overall Study|Lost to Follow-up|1
4698245|NCT02665455|7612840|FG000|Overall Study|Withdrawal by Subject|6
4698246|NCT02665455|7612840|FG000|Overall Study|Lost to Follow-up|1
4698247|NCT02665455|7612840|FG000|Overall Study|Adverse Event|1
4698248|NCT02665455|7612840|FG000|Overall Study|Protocol Violation|1
4698249|NCT02665689|7612855|FG000|Overall Study|Adverse Event|1
4471583|NCT00654381|7265416|FG000|1st Stage|Adverse Event|3
4471584|NCT00654381|7265417|FG001|1st Stage|Adverse Event|3
4471585|NCT00654381|7265418|FG002|1st Stage|Adverse Event|3
4471586|NCT00654381|7265419|FG003|1st Stage|Adverse Event|3
4471587|NCT00654381|7265420|FG004|1st Stage|Adverse Event|2
4471588|NCT00654381|7265421|FG005|1st Stage|Adverse Event|1
4471589|NCT00654381|7265416|FG000|1st Stage|Withdrawal by Subject|0
4471590|NCT00654381|7265417|FG001|1st Stage|Withdrawal by Subject|0
4471591|NCT00654381|7265418|FG002|1st Stage|Withdrawal by Subject|0
4471592|NCT00654381|7265419|FG003|1st Stage|Withdrawal by Subject|1
4471593|NCT00654381|7265420|FG004|1st Stage|Withdrawal by Subject|0
4471594|NCT00654381|7265421|FG005|1st Stage|Withdrawal by Subject|1
4471595|NCT00654381|7265416|FG000|1st Stage|Investigator's decision|0
4471596|NCT00654381|7265417|FG001|1st Stage|Investigator's decision|0
4471597|NCT00654381|7265418|FG002|1st Stage|Investigator's decision|0
4698250|NCT02665689|7612856|FG001|Overall Study|Adverse Event|0
4698251|NCT02665689|7612855|FG000|Overall Study|Trial termination|1
4698252|NCT02665689|7612856|FG001|Overall Study|Trial termination|1
4698253|NCT02665689|7612855|FG000|Overall Study|Lost to Follow-up|0
4698254|NCT02665689|7612856|FG001|Overall Study|Lost to Follow-up|1
4698255|NCT02666222|7612888|FG000|Overall Study|Death|2
4698256|NCT02666664|7612928|FG000|Overall Study|Physician Decision|0
4698257|NCT02666664|7612929|FG001|Overall Study|Physician Decision|1
4471598|NCT00654381|7265419|FG003|1st Stage|Investigator's decision|1
4471599|NCT00654381|7265420|FG004|1st Stage|Investigator's decision|0
4471600|NCT00654381|7265421|FG005|1st Stage|Investigator's decision|0
4698258|NCT02666664|7612928|FG000|Overall Study|Protocol Violation|0
4698259|NCT02666664|7612929|FG001|Overall Study|Protocol Violation|2
4698260|NCT02666664|7612928|FG000|Overall Study|Other|0
4698261|NCT02666664|7612929|FG001|Overall Study|Other|1
4698262|NCT02666664|7612928|FG000|Overall Study|Adverse Event|12
4698263|NCT02666664|7612929|FG001|Overall Study|Adverse Event|37
4698264|NCT02666664|7612928|FG000|Overall Study|Withdrawal by participant|23
4698265|NCT02666664|7612929|FG001|Overall Study|Withdrawal by participant|40
4698266|NCT02666664|7612928|FG000|Overall Study|Sponsor decision|0
4698267|NCT02666664|7612929|FG001|Overall Study|Sponsor decision|1
4698268|NCT02666664|7612928|FG000|Overall Study|Lost to Follow-up|1
4698269|NCT02666664|7612929|FG001|Overall Study|Lost to Follow-up|2
4698270|NCT02667236|7612987|FG000|Overall Study|Adverse Event|1
4698271|NCT02667236|7612988|FG001|Overall Study|Adverse Event|1
4698272|NCT02667236|7612987|FG000|Overall Study|Withdrawal by Subject|2
4698273|NCT02667236|7612988|FG001|Overall Study|Withdrawal by Subject|0
4698274|NCT02667275|7612996|FG000|Overall Study|Protocol Violation|11
4698275|NCT02667275|7612997|FG001|Overall Study|Protocol Violation|7
4698276|NCT02667275|7612996|FG000|Overall Study|Lost to Follow-up|0
4698277|NCT02667275|7612997|FG001|Overall Study|Lost to Follow-up|2
4698278|NCT02667275|7612996|FG000|Overall Study|Withdrawal by Subject|0
4698279|NCT02667275|7612997|FG001|Overall Study|Withdrawal by Subject|5
4698280|NCT02667275|7612996|FG000|Overall Study|Discontinued early without completing|0
4698281|NCT02667275|7612997|FG001|Overall Study|Discontinued early without completing|1
4698282|NCT02667288|7613003|FG000|Overall Study|Protocol Violation|5
4698283|NCT02667288|7613003|FG000|Overall Study|Lost to Follow-up|3
4698284|NCT02667288|7613003|FG000|Overall Study|Withdrawal by Subject|5
4698285|NCT02667301|7613007|FG000|Overall Study|Adverse Event|1
4698286|NCT02667301|7613007|FG000|Overall Study|Lack of Efficacy|1
4698287|NCT02667457|7613019|FG000|Overall Study|Withdrawal by Subject|1
4698288|NCT02667457|7613020|FG001|Overall Study|Withdrawal by Subject|0
4698289|NCT02667457|7613019|FG000|Overall Study|Other Reason|0
4698290|NCT02667457|7613020|FG001|Overall Study|Other Reason|2
4698291|NCT02667626|7613029|FG000|Overall Study|Withdrawal by Subject|0
4698292|NCT02667626|7613030|FG001|Overall Study|Withdrawal by Subject|1
4698293|NCT02667912|7613053|FG000|Overall Study|Death|3
4698294|NCT02667912|7613054|FG001|Overall Study|Death|1
4698295|NCT02667912|7613053|FG000|Overall Study|Withdrawal by Subject|1
4698296|NCT02667912|7613054|FG001|Overall Study|Withdrawal by Subject|2
4698297|NCT02667912|7613053|FG000|Overall Study|Withdrawal by Subject|1
4698298|NCT02667912|7613054|FG001|Overall Study|Withdrawal by Subject|0
4698299|NCT02668185|7613078|FG000|First Intervention (4 Weeks)|Physician Decision|2
4698300|NCT02668185|7613079|FG001|First Intervention (4 Weeks)|Physician Decision|0
4698301|NCT02668185|7613078|FG000|Washout Period (2 Weeks)|Adverse Event|1
4698302|NCT02668185|7613079|FG001|Washout Period (2 Weeks)|Adverse Event|0
4698303|NCT02668185|7613078|FG000|Washout Period (2 Weeks)|Physician Decision|0
4698304|NCT02668185|7613079|FG001|Washout Period (2 Weeks)|Physician Decision|2
4698305|NCT02668185|7613078|FG000|Second Intervention (4 Weeks)|Physician Decision|1
4698306|NCT02668185|7613079|FG001|Second Intervention (4 Weeks)|Physician Decision|3
4698307|NCT02668302|7613092|FG000|Overall Study|Withdrawal by Subject|1
4698308|NCT02668302|7613093|FG001|Overall Study|Withdrawal by Subject|0
4698309|NCT02668393|7613101|FG000|Overall Study|Progressive disease|6
4698310|NCT02668393|7613102|FG001|Overall Study|Progressive disease|3
4698311|NCT02668393|7613101|FG000|Overall Study|Adverse Event|0
4698312|NCT02668393|7613102|FG001|Overall Study|Adverse Event|2
4698313|NCT02668393|7613101|FG000|Overall Study|Withdrawal from the trial|0
4698314|NCT02668393|7613102|FG001|Overall Study|Withdrawal from the trial|1
4698315|NCT02668393|7613101|FG000|Overall Study|Lack of benefit and side effects|1
4698316|NCT02668393|7613102|FG001|Overall Study|Lack of benefit and side effects|0
4698317|NCT02668640|7613118|FG000|Overall Study|Lost to Follow-up|13
4471601|NCT00654381|7265416|FG000|2nd Stage|Adverse Event|2
4698318|NCT02668640|7613118|FG000|Overall Study|Other, not specified|1
4471602|NCT00654381|7265417|FG001|2nd Stage|Adverse Event|0
4698319|NCT02668692|7613124|FG000|Overall Study|Adverse Event|1
4698320|NCT02668692|7613125|FG001|Overall Study|Adverse Event|0
4698321|NCT02669017|7613149|FG000|Overall Study|Death|1
4698322|NCT02669017|7613150|FG001|Overall Study|Death|2
4698323|NCT02669017|7613151|FG002|Overall Study|Death|2
4698324|NCT02669017|7613152|FG003|Overall Study|Death|3
4698325|NCT02669017|7613153|FG004|Overall Study|Death|8
4698326|NCT02669017|7613154|FG005|Overall Study|Death|18
4698327|NCT02669017|7613155|FG006|Overall Study|Death|10
4698328|NCT02669017|7613156|FG007|Overall Study|Death|47
4471603|NCT00654381|7265418|FG002|2nd Stage|Adverse Event|2
4698329|NCT02669017|7613157|FG008|Overall Study|Death|20
4698330|NCT02669017|7613149|FG000|Overall Study|Withdrawal by Subject|0
4471604|NCT00654381|7265419|FG003|2nd Stage|Adverse Event|3
4471605|NCT00654381|7265420|FG004|2nd Stage|Adverse Event|7
4471606|NCT00654381|7265421|FG005|2nd Stage|Adverse Event|2
4471607|NCT00654381|7265416|FG000|2nd Stage|Withdrawal by Subject|0
4471608|NCT00654381|7265417|FG001|2nd Stage|Withdrawal by Subject|0
4471609|NCT00654381|7265418|FG002|2nd Stage|Withdrawal by Subject|0
4471610|NCT00654381|7265419|FG003|2nd Stage|Withdrawal by Subject|0
4471611|NCT00654381|7265420|FG004|2nd Stage|Withdrawal by Subject|1
4471612|NCT00654381|7265421|FG005|2nd Stage|Withdrawal by Subject|1
4471613|NCT00654381|7265416|FG000|2nd Stage|Investigator's decision|0
4471614|NCT00654381|7265417|FG001|2nd Stage|Investigator's decision|0
4471615|NCT00654381|7265418|FG002|2nd Stage|Investigator's decision|1
4471616|NCT00654381|7265419|FG003|2nd Stage|Investigator's decision|1
4471617|NCT00654381|7265420|FG004|2nd Stage|Investigator's decision|0
4471618|NCT00654381|7265421|FG005|2nd Stage|Investigator's decision|0
4471619|NCT00654381|7265416|FG000|Extension Stage|Adverse Event|1
4471620|NCT00654381|7265417|FG001|Extension Stage|Adverse Event|2
4471621|NCT00654381|7265418|FG002|Extension Stage|Adverse Event|9
4471622|NCT00654381|7265419|FG003|Extension Stage|Adverse Event|7
4471623|NCT00654381|7265420|FG004|Extension Stage|Adverse Event|1
4589058|NCT01507662|7433991|FG000|Overall Study|Withdrawal by Subject|290
4589059|NCT01507662|7433992|FG001|Overall Study|Withdrawal by Subject|287
4698331|NCT02669017|7613150|FG001|Overall Study|Withdrawal by Subject|0
4698332|NCT02669017|7613151|FG002|Overall Study|Withdrawal by Subject|0
4698333|NCT02669017|7613152|FG003|Overall Study|Withdrawal by Subject|1
4698334|NCT02669017|7613153|FG004|Overall Study|Withdrawal by Subject|2
4698335|NCT02669017|7613154|FG005|Overall Study|Withdrawal by Subject|0
4698336|NCT02669017|7613155|FG006|Overall Study|Withdrawal by Subject|0
4698337|NCT02669017|7613156|FG007|Overall Study|Withdrawal by Subject|2
4698338|NCT02669017|7613157|FG008|Overall Study|Withdrawal by Subject|2
4698339|NCT02669017|7613149|FG000|Overall Study|Lost to Follow-up|0
4698340|NCT02669017|7613150|FG001|Overall Study|Lost to Follow-up|0
4698341|NCT02669017|7613151|FG002|Overall Study|Lost to Follow-up|0
4698342|NCT02669017|7613152|FG003|Overall Study|Lost to Follow-up|0
4698343|NCT02669017|7613153|FG004|Overall Study|Lost to Follow-up|0
4698344|NCT02669017|7613154|FG005|Overall Study|Lost to Follow-up|0
4698345|NCT02669017|7613155|FG006|Overall Study|Lost to Follow-up|0
4698346|NCT02669017|7613156|FG007|Overall Study|Lost to Follow-up|0
4698347|NCT02669017|7613157|FG008|Overall Study|Lost to Follow-up|1
4698348|NCT02669017|7613149|FG000|Overall Study|Miscellaneous|0
4698349|NCT02669017|7613150|FG001|Overall Study|Miscellaneous|0
4698350|NCT02669017|7613151|FG002|Overall Study|Miscellaneous|0
4698351|NCT02669017|7613152|FG003|Overall Study|Miscellaneous|0
4698352|NCT02669017|7613153|FG004|Overall Study|Miscellaneous|2
4698353|NCT02669017|7613154|FG005|Overall Study|Miscellaneous|1
4698354|NCT02669017|7613155|FG006|Overall Study|Miscellaneous|1
4698355|NCT02669017|7613156|FG007|Overall Study|Miscellaneous|13
4698356|NCT02669017|7613157|FG008|Overall Study|Miscellaneous|2
4698357|NCT02669043|7613185|FG000|Overall Study|Didn't meet I/E criteria|4
4698358|NCT02669082|7613189|FG000|Overall Study|Adverse Event|1
4698359|NCT02669095|7613195|FG000|Overall Study|Adverse Event|1
4698360|NCT02669095|7613196|FG001|Overall Study|Adverse Event|0
4698361|NCT02669095|7613195|FG000|Overall Study|Unsatisfactory Lens Fitting|0
4698362|NCT02669095|7613196|FG001|Overall Study|Unsatisfactory Lens Fitting|1
4698363|NCT02669095|7613195|FG000|Overall Study|Torn Lens|0
4698364|NCT02669095|7613196|FG001|Overall Study|Torn Lens|1
4698365|NCT02669095|7613195|FG000|Overall Study|Visit 5 assessments not completed|0
4698366|NCT02669095|7613196|FG001|Overall Study|Visit 5 assessments not completed|1
4698367|NCT02669121|7613204|FG000|Overall Study|Adverse Event|4
4698368|NCT02669121|7613205|FG001|Overall Study|Adverse Event|5
4698369|NCT02669121|7613204|FG000|Overall Study|Lost to Follow-up|15
4698370|NCT02669121|7613205|FG001|Overall Study|Lost to Follow-up|27
4698371|NCT02669121|7613204|FG000|Overall Study|Withdrawal by Subject|132
4698372|NCT02669121|7613205|FG001|Overall Study|Withdrawal by Subject|140
4698373|NCT02669121|7613204|FG000|Overall Study|Pregnancy|0
4698374|NCT02669121|7613205|FG001|Overall Study|Pregnancy|1
4698375|NCT02669121|7613204|FG000|Overall Study|Discharged from US Military Active Service|117
4698376|NCT02669121|7613205|FG001|Overall Study|Discharged from US Military Active Service|91
4698377|NCT02669121|7613204|FG000|Overall Study|Reason not Specified|22
4698378|NCT02669121|7613205|FG001|Overall Study|Reason not Specified|18
4698379|NCT02669264|7613218|FG000|Overall Study|Death|5
4698380|NCT02669264|7613219|FG001|Overall Study|Death|5
4471624|NCT00654381|7265421|FG005|Extension Stage|Adverse Event|1
4471625|NCT00654381|7265416|FG000|Extension Stage|Protocol Violation|0
4698381|NCT02669264|7613220|FG002|Overall Study|Death|3
4698382|NCT02669264|7613221|FG003|Overall Study|Death|3
4698383|NCT02669264|7613222|FG004|Overall Study|Death|3
4698384|NCT02669264|7613223|FG005|Overall Study|Death|6
4698385|NCT02669264|7613224|FG006|Overall Study|Death|3
4698386|NCT02669264|7613218|FG000|Overall Study|Withdrawal by Subject|0
4698387|NCT02669264|7613219|FG001|Overall Study|Withdrawal by Subject|1
4698388|NCT02669264|7613220|FG002|Overall Study|Withdrawal by Subject|0
4471626|NCT00654381|7265417|FG001|Extension Stage|Protocol Violation|0
4471627|NCT00654381|7265418|FG002|Extension Stage|Protocol Violation|0
4471628|NCT00654381|7265419|FG003|Extension Stage|Protocol Violation|1
4698389|NCT02669264|7613221|FG003|Overall Study|Withdrawal by Subject|0
4471629|NCT00654381|7265420|FG004|Extension Stage|Protocol Violation|0
4471630|NCT00654381|7265421|FG005|Extension Stage|Protocol Violation|0
4471631|NCT00654381|7265416|FG000|Extension Stage|Lack of Efficacy|0
4589060|NCT01507662|7433991|FG000|Overall Study|Lost to Follow-up|498
4589061|NCT01507662|7433992|FG001|Overall Study|Lost to Follow-up|523
4589062|NCT01507662|7433991|FG000|Overall Study|Proxy interview done|2
4698390|NCT02669264|7613222|FG004|Overall Study|Withdrawal by Subject|1
4698391|NCT02669264|7613223|FG005|Overall Study|Withdrawal by Subject|0
4698392|NCT02669264|7613224|FG006|Overall Study|Withdrawal by Subject|0
4698393|NCT02669264|7613218|FG000|Overall Study|Lost to Follow-up|0
4698394|NCT02669264|7613219|FG001|Overall Study|Lost to Follow-up|0
4698395|NCT02669264|7613220|FG002|Overall Study|Lost to Follow-up|0
4698396|NCT02669264|7613221|FG003|Overall Study|Lost to Follow-up|0
4698397|NCT02669264|7613222|FG004|Overall Study|Lost to Follow-up|1
4698398|NCT02669264|7613223|FG005|Overall Study|Lost to Follow-up|0
4698399|NCT02669264|7613224|FG006|Overall Study|Lost to Follow-up|0
4698400|NCT02669264|7613218|FG000|Overall Study|Miscellaneous|0
4698401|NCT02669264|7613219|FG001|Overall Study|Miscellaneous|0
4698402|NCT02669264|7613220|FG002|Overall Study|Miscellaneous|0
4698403|NCT02669264|7613221|FG003|Overall Study|Miscellaneous|0
4698404|NCT02669264|7613222|FG004|Overall Study|Miscellaneous|0
4698405|NCT02669264|7613223|FG005|Overall Study|Miscellaneous|0
4698406|NCT02669264|7613224|FG006|Overall Study|Miscellaneous|2
4698407|NCT02669407|7613246|FG000|Overall Study|Physician Decision|3
4735266|NCT03526458|7683195|FG001|Overall Study|Stone passed, surgery cancelled|1
4735267|NCT03526458|7683194|FG000|Overall Study|Withdrawal by Subject|1
4735268|NCT03526458|7683195|FG001|Overall Study|Withdrawal by Subject|0
4735269|NCT03526458|7683194|FG000|Overall Study|Physician Decision|2
4735270|NCT03526458|7683195|FG001|Overall Study|Physician Decision|1
4735271|NCT03526458|7683194|FG000|Overall Study|Lack of equipment|1
4735272|NCT03526458|7683195|FG001|Overall Study|Lack of equipment|1
4735273|NCT03526861|7683204|FG000|Initial Treatment Period|Not dosed|1
4735274|NCT03526861|7683205|FG001|Initial Treatment Period|Not dosed|1
4735275|NCT03526861|7683206|FG002|Initial Treatment Period|Not dosed|1
4735276|NCT03526861|7683207|FG003|Initial Treatment Period|Not dosed|0
4735277|NCT03526861|7683208|FG004|Initial Treatment Period|Not dosed|0
4735278|NCT03526861|7683209|FG005|Initial Treatment Period|Not dosed|0
4735279|NCT03526861|7683210|FG006|Initial Treatment Period|Not dosed|0
4735280|NCT03526861|7683211|FG007|Initial Treatment Period|Not dosed|0
4735281|NCT03526861|7683212|FG008|Initial Treatment Period|Not dosed|0
4735282|NCT03526861|7683204|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3
4735283|NCT03526861|7683205|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1
4735284|NCT03526861|7683206|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5
4735285|NCT03526861|7683207|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
4735286|NCT03526861|7683208|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
4735287|NCT03526861|7683209|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
4735288|NCT03526861|7683210|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
4735289|NCT03526861|7683211|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
4735290|NCT03526861|7683212|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
4735291|NCT03526861|7683204|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3
4735292|NCT03526861|7683205|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5
4735293|NCT03526861|7683206|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8
4735294|NCT03526861|7683207|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0
4735295|NCT03526861|7683208|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0
4735296|NCT03526861|7683209|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0
4735297|NCT03526861|7683210|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0
4735298|NCT03526861|7683211|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0
4735299|NCT03526861|7683212|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0
4735300|NCT03526861|7683204|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
4735301|NCT03526861|7683205|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
4735302|NCT03526861|7683206|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
4735303|NCT03526861|7683207|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1
4735304|NCT03526861|7683208|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1
4735305|NCT03526861|7683209|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
4735306|NCT03526861|7683210|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1
4735307|NCT03526861|7683211|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
4735308|NCT03526861|7683212|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
4735309|NCT03526861|7683204|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0
4735310|NCT03526861|7683205|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0
4471632|NCT00654381|7265417|FG001|Extension Stage|Lack of Efficacy|0
4471633|NCT00654381|7265418|FG002|Extension Stage|Lack of Efficacy|1
4471634|NCT00654381|7265419|FG003|Extension Stage|Lack of Efficacy|0
4471635|NCT00654381|7265420|FG004|Extension Stage|Lack of Efficacy|0
4698408|NCT02669433|7613253|FG000|Overall Study|Protocol Violation|0
4698409|NCT02669433|7613254|FG001|Overall Study|Protocol Violation|4
4698410|NCT02669433|7613255|FG002|Overall Study|Protocol Violation|1
4698411|NCT02669433|7613253|FG000|Overall Study|Disease Progression|1
4698412|NCT02669433|7613254|FG001|Overall Study|Disease Progression|0
4698413|NCT02669433|7613255|FG002|Overall Study|Disease Progression|0
4698414|NCT02669433|7613253|FG000|Overall Study|Physician Decision|1
4698415|NCT02669433|7613254|FG001|Overall Study|Physician Decision|1
4698416|NCT02669433|7613255|FG002|Overall Study|Physician Decision|0
4698417|NCT02669433|7613253|FG000|Overall Study|Adverse Event|6
4698418|NCT02669433|7613254|FG001|Overall Study|Adverse Event|7
4698419|NCT02669433|7613255|FG002|Overall Study|Adverse Event|10
4698420|NCT02669433|7613253|FG000|Overall Study|Sponsor Termination|1
4698421|NCT02669433|7613254|FG001|Overall Study|Sponsor Termination|0
4698422|NCT02669433|7613255|FG002|Overall Study|Sponsor Termination|1
4698423|NCT02669433|7613253|FG000|Overall Study|Withdrawal by Subject|5
4698424|NCT02669433|7613254|FG001|Overall Study|Withdrawal by Subject|1
4698425|NCT02669433|7613255|FG002|Overall Study|Withdrawal by Subject|0
4698426|NCT02669433|7613253|FG000|Overall Study|Withdrawal by Caregiver|1
4698427|NCT02669433|7613254|FG001|Overall Study|Withdrawal by Caregiver|0
4698428|NCT02669433|7613255|FG002|Overall Study|Withdrawal by Caregiver|2
4698429|NCT02669433|7613253|FG000|Overall Study|Death|0
4698430|NCT02669433|7613254|FG001|Overall Study|Death|1
4698431|NCT02669433|7613255|FG002|Overall Study|Death|1
4698432|NCT02669667|7613274|FG000|Overall Study|Lost to Follow-up|0
4698433|NCT02669667|7613275|FG001|Overall Study|Lost to Follow-up|0
4698434|NCT02669667|7613276|FG002|Overall Study|Lost to Follow-up|0
4698435|NCT02669667|7613277|FG003|Overall Study|Lost to Follow-up|0
4698436|NCT02669667|7613278|FG004|Overall Study|Lost to Follow-up|0
4698437|NCT02669667|7613279|FG005|Overall Study|Lost to Follow-up|1
4698438|NCT02669667|7613280|FG006|Overall Study|Lost to Follow-up|0
4698439|NCT02669758|7613302|FG000|Overall Study|Withdrawal by Subject|43
4698440|NCT02669758|7613302|FG000|Overall Study|Lost to Follow-up|19
4698441|NCT02669758|7613302|FG000|Overall Study|Adverse Event|16
4698442|NCT02669758|7613302|FG000|Overall Study|Non-Compliance with Study Drug|8
4698443|NCT02669758|7613302|FG000|Overall Study|Lack of Efficacy|5
4698444|NCT02669758|7613302|FG000|Overall Study|Pregnancy|1
4698445|NCT02669758|7613302|FG000|Overall Study|Study noncompliance|1
4698446|NCT02669758|7613302|FG000|Overall Study|Protocol Violation|1
4698447|NCT02669849|7613318|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0
4698448|NCT02669849|7613319|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0
4698449|NCT02669849|7613320|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3
4698450|NCT02669849|7613318|FG000|Overall Study|Lost to Follow-up|1
4698451|NCT02669849|7613319|FG001|Overall Study|Lost to Follow-up|0
4698452|NCT02669849|7613320|FG002|Overall Study|Lost to Follow-up|3
4698453|NCT02669849|7613318|FG000|Overall Study|Death|1
4698454|NCT02669849|7613319|FG001|Overall Study|Death|1
4698455|NCT02669849|7613320|FG002|Overall Study|Death|2
4698456|NCT02669849|7613318|FG000|Overall Study|Study terminated by sponsor|16
4698457|NCT02669849|7613319|FG001|Overall Study|Study terminated by sponsor|1
4698458|NCT02669849|7613320|FG002|Overall Study|Study terminated by sponsor|14
4698459|NCT02669849|7613318|FG000|Overall Study|Other|0
4698460|NCT02669849|7613319|FG001|Overall Study|Other|0
4698461|NCT02669849|7613320|FG002|Overall Study|Other|2
4698462|NCT02669862|7613331|FG000|Overall Study|Lost to Follow-up|0
4698463|NCT02669862|7613332|FG001|Overall Study|Lost to Follow-up|2
4698464|NCT02669862|7613333|FG002|Overall Study|Lost to Follow-up|1
4698465|NCT02669862|7613331|FG000|Overall Study|Withdrawal by Subject|2
4698466|NCT02669862|7613332|FG001|Overall Study|Withdrawal by Subject|2
4698467|NCT02669862|7613333|FG002|Overall Study|Withdrawal by Subject|3
4698468|NCT02669862|7613331|FG000|Overall Study|moved|0
4698469|NCT02669862|7613332|FG001|Overall Study|moved|1
4698470|NCT02669862|7613333|FG002|Overall Study|moved|0
4698471|NCT02669862|7613331|FG000|Overall Study|Protocol Violation|0
4698472|NCT02669862|7613332|FG001|Overall Study|Protocol Violation|0
4698473|NCT02669862|7613333|FG002|Overall Study|Protocol Violation|1
4698474|NCT02669940|7613359|FG000|Overall Study|Failure to return|0
4698475|NCT02669940|7613360|FG001|Overall Study|Failure to return|3
4698476|NCT02669940|7613359|FG000|Overall Study|Insufficient follow-up data|1
4698477|NCT02669940|7613360|FG001|Overall Study|Insufficient follow-up data|0
4698478|NCT02670083|7613375|FG000|Overall Study|Adverse Event|16
4698479|NCT02670083|7613376|FG001|Overall Study|Adverse Event|13
4698480|NCT02670083|7613375|FG000|Overall Study|Death|4
4698481|NCT02670083|7613376|FG001|Overall Study|Death|6
4698482|NCT02670083|7613375|FG000|Overall Study|Lost to Follow-up|2
4698483|NCT02670083|7613376|FG001|Overall Study|Lost to Follow-up|2
4698484|NCT02670083|7613375|FG000|Overall Study|Multiple Reasons|9
4698485|NCT02670083|7613376|FG001|Overall Study|Multiple Reasons|9
4698486|NCT02670083|7613375|FG000|Overall Study|Physician Decision|0
4471636|NCT00654381|7265421|FG005|Extension Stage|Lack of Efficacy|0
4698487|NCT02670083|7613376|FG001|Overall Study|Physician Decision|2
4698488|NCT02670083|7613375|FG000|Overall Study|Study Terminated By Sponsor|257
4698489|NCT02670083|7613376|FG001|Overall Study|Study Terminated By Sponsor|254
4471637|NCT00654381|7265416|FG000|Extension Stage|Withdrawal by Subject|0
4471638|NCT00654381|7265417|FG001|Extension Stage|Withdrawal by Subject|0
4471639|NCT00654381|7265418|FG002|Extension Stage|Withdrawal by Subject|1
4471640|NCT00654381|7265419|FG003|Extension Stage|Withdrawal by Subject|1
4471641|NCT00654381|7265420|FG004|Extension Stage|Withdrawal by Subject|1
4471642|NCT00654381|7265421|FG005|Extension Stage|Withdrawal by Subject|1
4471643|NCT00654381|7265416|FG000|Extension Stage|Closure of the trial site|0
4471644|NCT00654381|7265417|FG001|Extension Stage|Closure of the trial site|0
4471645|NCT00654381|7265418|FG002|Extension Stage|Closure of the trial site|0
4471646|NCT00654381|7265419|FG003|Extension Stage|Closure of the trial site|0
4471647|NCT00654381|7265420|FG004|Extension Stage|Closure of the trial site|1
4471648|NCT00654381|7265421|FG005|Extension Stage|Closure of the trial site|1
4471649|NCT00654420|7265442|FG000|Phase I (Dose Escalation)|Adverse Event|0
4471650|NCT00654420|7265443|FG001|Phase I (Dose Escalation)|Adverse Event|1
4471651|NCT00654420|7265444|FG002|Phase I (Dose Escalation)|Adverse Event|0
4471652|NCT00654420|7265445|FG003|Phase I (Dose Escalation)|Adverse Event|0
4471653|NCT00654420|7265442|FG000|Phase I (Dose Escalation)|Progressive Disease|4
4471654|NCT00654420|7265443|FG001|Phase I (Dose Escalation)|Progressive Disease|15
4471655|NCT00654420|7265444|FG002|Phase I (Dose Escalation)|Progressive Disease|0
4471656|NCT00654420|7265445|FG003|Phase I (Dose Escalation)|Progressive Disease|0
4471657|NCT00654420|7265442|FG000|Phase II|Adverse Event|0
4471658|NCT00654420|7265443|FG001|Phase II|Adverse Event|0
4471659|NCT00654420|7265444|FG002|Phase II|Adverse Event|3
4471660|NCT00654420|7265445|FG003|Phase II|Adverse Event|3
4471661|NCT00654420|7265442|FG000|Phase II|Lost to Follow-up|0
4471662|NCT00654420|7265443|FG001|Phase II|Lost to Follow-up|0
4471663|NCT00654420|7265444|FG002|Phase II|Lost to Follow-up|0
4471664|NCT00654420|7265445|FG003|Phase II|Lost to Follow-up|1
4471665|NCT00654420|7265442|FG000|Phase II|Physician Decision|0
4471666|NCT00654420|7265443|FG001|Phase II|Physician Decision|0
4471667|NCT00654420|7265444|FG002|Phase II|Physician Decision|0
4471668|NCT00654420|7265445|FG003|Phase II|Physician Decision|4
4471669|NCT00654420|7265442|FG000|Phase II|Progressive Disease|0
4471670|NCT00654420|7265443|FG001|Phase II|Progressive Disease|0
4471671|NCT00654420|7265444|FG002|Phase II|Progressive Disease|29
4471672|NCT00654420|7265445|FG003|Phase II|Progressive Disease|29
4471673|NCT00654420|7265442|FG000|Phase II|Withdrawal by Subject|0
4471674|NCT00654420|7265443|FG001|Phase II|Withdrawal by Subject|0
4471675|NCT00654420|7265444|FG002|Phase II|Withdrawal by Subject|4
4471676|NCT00654420|7265445|FG003|Phase II|Withdrawal by Subject|1
4471677|NCT00654420|7265442|FG000|Phase II|Missing Disposition Record|0
4471678|NCT00654420|7265443|FG001|Phase II|Missing Disposition Record|0
4471679|NCT00654420|7265444|FG002|Phase II|Missing Disposition Record|1
4471680|NCT00654420|7265445|FG003|Phase II|Missing Disposition Record|0
4471681|NCT00654498|7265457|FG000|Overall Study|Not Treated|1
4471682|NCT00654498|7265458|FG001|Overall Study|Not Treated|0
4471683|NCT00654498|7265457|FG000|Overall Study|Adverse Event|6
4471684|NCT00654498|7265458|FG001|Overall Study|Adverse Event|1
4471685|NCT00654498|7265457|FG000|Overall Study|Protocol Violation|1
4471686|NCT00654498|7265458|FG001|Overall Study|Protocol Violation|1
4471687|NCT00654498|7265457|FG000|Overall Study|Lost to Follow-up|1
4471688|NCT00654498|7265458|FG001|Overall Study|Lost to Follow-up|5
4471689|NCT00654498|7265457|FG000|Overall Study|Withdrawal by Subject|1
4471690|NCT00654498|7265458|FG001|Overall Study|Withdrawal by Subject|0
4471691|NCT00654498|7265457|FG000|Overall Study|Other reason not defined above|4
4471692|NCT00654498|7265458|FG001|Overall Study|Other reason not defined above|5
4516522|NCT00960531|7327978|FG003|Overall Study|Discontinuation of Study by Sponsor|0
4516523|NCT00960531|7327979|FG004|Overall Study|Discontinuation of Study by Sponsor|0
4516524|NCT00960531|7327980|FG005|Overall Study|Discontinuation of Study by Sponsor|0
4516525|NCT00960531|7327981|FG006|Overall Study|Discontinuation of Study by Sponsor|0
4516526|NCT00960531|7327982|FG007|Overall Study|Discontinuation of Study by Sponsor|1
4516527|NCT00960531|7327983|FG008|Overall Study|Discontinuation of Study by Sponsor|0
4516528|NCT00960531|7327984|FG009|Overall Study|Discontinuation of Study by Sponsor|0
4516529|NCT00960531|7327975|FG000|Overall Study|Lost to Follow-up|0
4516530|NCT00960531|7327976|FG001|Overall Study|Lost to Follow-up|0
4698490|NCT02670083|7613375|FG000|Overall Study|Symptomatic Deterioration|0
4698491|NCT02670083|7613376|FG001|Overall Study|Symptomatic Deterioration|2
4698492|NCT02670083|7613375|FG000|Overall Study|Withdrawal by Subject|32
4698493|NCT02670083|7613376|FG001|Overall Study|Withdrawal by Subject|31
4698494|NCT02670083|7613375|FG000|Overall Study|Non-Compliance With Study Drug|1
4516531|NCT00960531|7327977|FG002|Overall Study|Lost to Follow-up|1
4516532|NCT00960531|7327978|FG003|Overall Study|Lost to Follow-up|0
4516533|NCT00960531|7327979|FG004|Overall Study|Lost to Follow-up|0
4516534|NCT00960531|7327980|FG005|Overall Study|Lost to Follow-up|0
4516535|NCT00960531|7327981|FG006|Overall Study|Lost to Follow-up|1
4516536|NCT00960531|7327982|FG007|Overall Study|Lost to Follow-up|0
4516537|NCT00960531|7327983|FG008|Overall Study|Lost to Follow-up|0
4516538|NCT00960531|7327984|FG009|Overall Study|Lost to Follow-up|0
4516539|NCT00960531|7327975|FG000|Overall Study|Failed to Return|2
4516540|NCT00960531|7327976|FG001|Overall Study|Failed to Return|0
4516541|NCT00960531|7327977|FG002|Overall Study|Failed to Return|0
4516542|NCT00960531|7327978|FG003|Overall Study|Failed to Return|0
4516543|NCT00960531|7327979|FG004|Overall Study|Failed to Return|0
4516544|NCT00960531|7327980|FG005|Overall Study|Failed to Return|0
4471693|NCT00654641|7265496|FG000|Overall Study|Lost to Follow-up|2
4471694|NCT00654641|7265497|FG001|Overall Study|Lost to Follow-up|3
4471695|NCT00654732|7265509|FG000|Overall Study|Adverse Event|4
4471696|NCT00654732|7265510|FG001|Overall Study|Adverse Event|6
4471697|NCT00654745|7265516|FG000|Overall Study|Adverse Event|12
4471698|NCT00654745|7265516|FG000|Overall Study|Lost to Follow-up|7
4471699|NCT00654745|7265516|FG000|Overall Study|Protocol Violation|11
4698495|NCT02670083|7613376|FG001|Overall Study|Non-Compliance With Study Drug|0
4698496|NCT02670122|7613383|FG000|Overall Study|Lost to Follow-up|4
4698497|NCT02670330|7613396|FG000|Overall Study|Protocol Deviation|1
4698498|NCT02670330|7613397|FG001|Overall Study|Protocol Deviation|0
4698499|NCT02670330|7613396|FG000|Overall Study|Study Terminated By Sponsor|36
4698500|NCT02670330|7613397|FG001|Overall Study|Study Terminated By Sponsor|43
4698501|NCT02670330|7613396|FG000|Overall Study|Adverse Event|1
4698502|NCT02670330|7613397|FG001|Overall Study|Adverse Event|3
4698503|NCT02670330|7613396|FG000|Overall Study|Withdrawal by Subject|34
4698504|NCT02670330|7613397|FG001|Overall Study|Withdrawal by Subject|29
4698505|NCT02670330|7613396|FG000|Overall Study|Lost to Follow-up|3
4698506|NCT02670330|7613397|FG001|Overall Study|Lost to Follow-up|2
4698507|NCT02670382|7613407|FG000|Placebo lead-in Phase|Withdrawal by Subject|2
4698508|NCT02670382|7613408|FG001|Placebo lead-in Phase|Withdrawal by Subject|1
4698509|NCT02670473|7613416|FG000|Overall Study|Withdrawal by Subject|1
4698510|NCT02670538|7613432|FG000|Overall Study|Withdrawal of Consent|8
4698511|NCT02670538|7613433|FG001|Overall Study|Withdrawal of Consent|6
4698512|NCT02670538|7613434|FG002|Overall Study|Withdrawal of Consent|5
4698513|NCT02670538|7613432|FG000|Overall Study|Lost to Follow-up|8
4698514|NCT02670538|7613433|FG001|Overall Study|Lost to Follow-up|12
4698515|NCT02670538|7613434|FG002|Overall Study|Lost to Follow-up|7
4698516|NCT02670538|7613432|FG000|Overall Study|Adverse Event|5
4698517|NCT02670538|7613433|FG001|Overall Study|Adverse Event|5
4698518|NCT02670538|7613434|FG002|Overall Study|Adverse Event|11
4698519|NCT02670538|7613432|FG000|Overall Study|Lack of Efficacy|7
4698520|NCT02670538|7613433|FG001|Overall Study|Lack of Efficacy|1
4698521|NCT02670538|7613434|FG002|Overall Study|Lack of Efficacy|2
4698522|NCT02670538|7613432|FG000|Overall Study|Protocol Violation|3
4698523|NCT02670538|7613433|FG001|Overall Study|Protocol Violation|4
4698524|NCT02670538|7613434|FG002|Overall Study|Protocol Violation|1
4698525|NCT02670538|7613432|FG000|Overall Study|Noncompliance with Study Drug|1
4698526|NCT02670538|7613433|FG001|Overall Study|Noncompliance with Study Drug|3
4698527|NCT02670538|7613434|FG002|Overall Study|Noncompliance with Study Drug|2
4698528|NCT02670538|7613432|FG000|Overall Study|Other Miscellaneous Reasons|0
4698529|NCT02670538|7613433|FG001|Overall Study|Other Miscellaneous Reasons|1
4698530|NCT02670538|7613434|FG002|Overall Study|Other Miscellaneous Reasons|2
4698531|NCT02670551|7613445|FG000|Overall Study|Adverse Event|4
4698532|NCT02670551|7613446|FG001|Overall Study|Adverse Event|7
4698533|NCT02670551|7613447|FG002|Overall Study|Adverse Event|9
4698534|NCT02670551|7613445|FG000|Overall Study|Lack of Efficacy|2
4698535|NCT02670551|7613446|FG001|Overall Study|Lack of Efficacy|0
4698536|NCT02670551|7613447|FG002|Overall Study|Lack of Efficacy|3
4698537|NCT02670551|7613445|FG000|Overall Study|Withdrawal of Consent|6
4698538|NCT02670551|7613446|FG001|Overall Study|Withdrawal of Consent|3
4698539|NCT02670551|7613447|FG002|Overall Study|Withdrawal of Consent|8
4698540|NCT02670551|7613445|FG000|Overall Study|Lost to Follow-up|5
4698541|NCT02670551|7613446|FG001|Overall Study|Lost to Follow-up|7
4698542|NCT02670551|7613447|FG002|Overall Study|Lost to Follow-up|6
4698543|NCT02670551|7613445|FG000|Overall Study|Protocol Violation|1
4698544|NCT02670551|7613446|FG001|Overall Study|Protocol Violation|0
4698545|NCT02670551|7613447|FG002|Overall Study|Protocol Violation|0
4698546|NCT02670551|7613445|FG000|Overall Study|Noncompliance with study drug|3
4698547|NCT02670551|7613446|FG001|Overall Study|Noncompliance with study drug|3
4698548|NCT02670551|7613447|FG002|Overall Study|Noncompliance with study drug|2
4698549|NCT02670551|7613445|FG000|Overall Study|Other Miscellaneous Reasons|2
4698550|NCT02670551|7613446|FG001|Overall Study|Other Miscellaneous Reasons|3
4698551|NCT02670551|7613447|FG002|Overall Study|Other Miscellaneous Reasons|3
4698552|NCT02670551|7613445|FG000|Overall Study|Did Not Receive Treatment|5
4698553|NCT02670551|7613446|FG001|Overall Study|Did Not Receive Treatment|3
4698554|NCT02670551|7613447|FG002|Overall Study|Did Not Receive Treatment|0
4698555|NCT02670915|7613476|FG000|Overall Study|Withdrawal by Subject|0
4698556|NCT02670915|7613477|FG001|Overall Study|Withdrawal by Subject|1
4698557|NCT02670915|7613478|FG002|Overall Study|Withdrawal by Subject|4
4698558|NCT02670915|7613476|FG000|Overall Study|Withdrawal by parent/guardian|4
4698559|NCT02670915|7613477|FG001|Overall Study|Withdrawal by parent/guardian|4
4698560|NCT02670915|7613478|FG002|Overall Study|Withdrawal by parent/guardian|1
4698561|NCT02670915|7613476|FG000|Overall Study|Unclassified|0
4698562|NCT02670915|7613477|FG001|Overall Study|Unclassified|3
4698563|NCT02670915|7613478|FG002|Overall Study|Unclassified|0
4698564|NCT02670928|7613488|FG000|Overall Study|Adverse Event|3
4698565|NCT02670928|7613489|FG001|Overall Study|Adverse Event|1
4698566|NCT02670928|7613488|FG000|Overall Study|Withdrawal by Subject|4
4698567|NCT02670928|7613489|FG001|Overall Study|Withdrawal by Subject|0
4471700|NCT00654745|7265516|FG000|Overall Study|Withdrawal by Subject|10
4516545|NCT00960531|7327981|FG006|Overall Study|Failed to Return|0
4698568|NCT02670928|7613488|FG000|Overall Study|Lost to Follow-up|1
4698569|NCT02670928|7613489|FG001|Overall Study|Lost to Follow-up|0
4471701|NCT00654745|7265516|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3
4471702|NCT00654875|7265541|FG000|Overall Study|Adverse Event|5
4471703|NCT00654875|7265542|FG001|Overall Study|Adverse Event|5
4471704|NCT00654875|7265541|FG000|Overall Study|Withdrawal by Subject|4
4471705|NCT00654875|7265542|FG001|Overall Study|Withdrawal by Subject|4
4471706|NCT00654875|7265541|FG000|Overall Study|Protocol Violation|3
4471707|NCT00654875|7265542|FG001|Overall Study|Protocol Violation|3
4471708|NCT00654875|7265541|FG000|Overall Study|Lack of Efficacy|2
4471709|NCT00654875|7265542|FG001|Overall Study|Lack of Efficacy|2
4471710|NCT00654875|7265541|FG000|Overall Study|Lost to Follow-up|1
4471711|NCT00654875|7265542|FG001|Overall Study|Lost to Follow-up|3
4471712|NCT00654875|7265541|FG000|Overall Study|Abnormal Test Procedure Result(s)|1
4471713|NCT00654875|7265542|FG001|Overall Study|Abnormal Test Procedure Result(s)|0
4698570|NCT02670928|7613488|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2
4698571|NCT02670928|7613489|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0
4698572|NCT02671266|7613501|FG000|Overall Study|Withdrawal by Subject|1
4698573|NCT02671266|7613502|FG001|Overall Study|Withdrawal by Subject|1
4471714|NCT00654875|7265541|FG000|Overall Study|Administrative Problems|1
4471715|NCT00654875|7265542|FG001|Overall Study|Administrative Problems|0
4471716|NCT00654901|7265552|FG000|Overall Study|Lost to Follow-up|1
4471717|NCT00654901|7265553|FG001|Overall Study|Lost to Follow-up|0
4471718|NCT00654901|7265554|FG002|Overall Study|Lost to Follow-up|1
4471719|NCT00654901|7265555|FG003|Overall Study|Lost to Follow-up|0
4471720|NCT00654901|7265552|FG000|Overall Study|Withdrawal by Subject|3
4471721|NCT00654901|7265553|FG001|Overall Study|Withdrawal by Subject|0
4471722|NCT00654901|7265554|FG002|Overall Study|Withdrawal by Subject|1
4471723|NCT00654901|7265555|FG003|Overall Study|Withdrawal by Subject|0
4698574|NCT02671422|7613508|FG000|Overall Study|Lost to Follow-up|1
4698575|NCT02671422|7613508|FG000|Overall Study|Adverse Event|68
4698576|NCT02671422|7613508|FG000|Overall Study|Lack of Efficacy|1
4698577|NCT02671422|7613508|FG000|Overall Study|Lost to Follow-up|4
4698578|NCT02671422|7613508|FG000|Overall Study|Withdrawal by Subject|7
4698579|NCT02671422|7613508|FG000|Overall Study|Progressive Disease|156
4698580|NCT02671422|7613508|FG000|Overall Study|Worsening of Disease|4
4698581|NCT02671422|7613508|FG000|Overall Study|Sponsor decision|5
4698582|NCT02671422|7613508|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8
4698583|NCT02671422|7613508|FG000|Overall Study|Not treated with Vargatef®|3
4698584|NCT02671422|7613508|FG000|Overall Study|Other not defined above|3
4698585|NCT02671500|7613512|FG000|Overall Study|Lack of Efficacy|12
4698586|NCT02671500|7613512|FG000|Overall Study|Lost to Follow-up|2
4698587|NCT02671760|7613520|FG000|Overall Study|Lost to Follow-up|0
4698588|NCT02671760|7613521|FG001|Overall Study|Lost to Follow-up|1
4698589|NCT02671760|7613522|FG002|Overall Study|Lost to Follow-up|0
4698590|NCT02672423|7613555|FG000|Period 1|Adverse Event|0
4698591|NCT02672423|7613556|FG001|Period 1|Adverse Event|0
4698592|NCT02672423|7613557|FG002|Period 1|Adverse Event|0
4698593|NCT02672423|7613558|FG003|Period 1|Adverse Event|0
4698594|NCT02672423|7613559|FG004|Period 1|Adverse Event|1
4698595|NCT02672423|7613560|FG005|Period 1|Adverse Event|0
4698596|NCT02672423|7613561|FG006|Period 1|Adverse Event|0
4698597|NCT02672423|7613562|FG007|Period 1|Adverse Event|0
4698598|NCT02672423|7613563|FG008|Period 1|Adverse Event|0
4698599|NCT02672423|7613564|FG009|Period 1|Adverse Event|0
4698600|NCT02672423|7613555|FG000|Period 2|Withdrawal by Subject|0
4698601|NCT02672423|7613556|FG001|Period 2|Withdrawal by Subject|0
4698602|NCT02672423|7613557|FG002|Period 2|Withdrawal by Subject|1
4698603|NCT02672423|7613558|FG003|Period 2|Withdrawal by Subject|0
4698604|NCT02672423|7613559|FG004|Period 2|Withdrawal by Subject|0
4698605|NCT02672423|7613560|FG005|Period 2|Withdrawal by Subject|0
4698606|NCT02672423|7613561|FG006|Period 2|Withdrawal by Subject|0
4698607|NCT02672423|7613562|FG007|Period 2|Withdrawal by Subject|0
4698608|NCT02672423|7613563|FG008|Period 2|Withdrawal by Subject|0
4698609|NCT02672423|7613564|FG009|Period 2|Withdrawal by Subject|0
4698610|NCT02672423|7613555|FG000|Period 3|Withdrawal by Subject|0
4698611|NCT02672423|7613556|FG001|Period 3|Withdrawal by Subject|0
4698612|NCT02672423|7613557|FG002|Period 3|Withdrawal by Subject|0
4698613|NCT02672423|7613558|FG003|Period 3|Withdrawal by Subject|0
4698614|NCT02672423|7613559|FG004|Period 3|Withdrawal by Subject|0
4698615|NCT02672423|7613560|FG005|Period 3|Withdrawal by Subject|0
4698616|NCT02672423|7613561|FG006|Period 3|Withdrawal by Subject|0
4698617|NCT02672423|7613562|FG007|Period 3|Withdrawal by Subject|1
4471724|NCT00654940|7265571|FG000|Period 1|Adverse Event|0
4698618|NCT02672423|7613563|FG008|Period 3|Withdrawal by Subject|0
4698619|NCT02672423|7613564|FG009|Period 3|Withdrawal by Subject|0
4698620|NCT02672423|7613555|FG000|Period 3|Physician Decision|0
4698621|NCT02672423|7613556|FG001|Period 3|Physician Decision|0
4698622|NCT02672423|7613557|FG002|Period 3|Physician Decision|0
4698623|NCT02672423|7613558|FG003|Period 3|Physician Decision|0
4698624|NCT02672423|7613559|FG004|Period 3|Physician Decision|0
4698625|NCT02672423|7613560|FG005|Period 3|Physician Decision|1
4471725|NCT00654940|7265572|FG001|Period 1|Adverse Event|1
4471726|NCT00654940|7265571|FG000|Period 1|Intolerable Pain Level|1
4471727|NCT00654940|7265572|FG001|Period 1|Intolerable Pain Level|0
4471728|NCT00655356|7265608|FG000|Overall Study|Withdrawal by Subject|3
4698626|NCT02672423|7613561|FG006|Period 3|Physician Decision|0
4698627|NCT02672423|7613562|FG007|Period 3|Physician Decision|0
4698628|NCT02672423|7613563|FG008|Period 3|Physician Decision|0
4471729|NCT00655356|7265609|FG001|Overall Study|Withdrawal by Subject|4
4471730|NCT00655356|7265608|FG000|Overall Study|Sponsor Request|10
4471731|NCT00655356|7265609|FG001|Overall Study|Sponsor Request|4
4471732|NCT00655356|7265608|FG000|Overall Study|Adverse Event|1
4471733|NCT00655356|7265609|FG001|Overall Study|Adverse Event|1
4471734|NCT00655356|7265608|FG000|Overall Study|Protocol Violation|2
4471735|NCT00655356|7265609|FG001|Overall Study|Protocol Violation|1
4471736|NCT00655356|7265608|FG000|Overall Study|Other Reason|1
4471737|NCT00655356|7265609|FG001|Overall Study|Other Reason|0
4471738|NCT00655486|7265624|FG000|Overall Study|Adverse Event|10
4471739|NCT00655486|7265624|FG000|Overall Study|Lack of Efficacy|8
4471740|NCT00655486|7265624|FG000|Overall Study|Withdrawal by Subject|4
4471741|NCT00655486|7265624|FG000|Overall Study|Protocol Violation|1
4471742|NCT00655486|7265624|FG000|Overall Study|Unsatisfactory compliance|2
4471743|NCT00655486|7265624|FG000|Overall Study|Other: Pregnancy|1
4471744|NCT00655486|7265624|FG000|Overall Study|Other: Could not tolerate BID dosing|1
4471745|NCT00655486|7265624|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1
4471746|NCT00655499|7265628|FG000|Overall Study|not eligible|4
4471747|NCT00655551|7265645|FG000|All Periods Combined|Adverse Event|0
4589063|NCT01507662|7433992|FG001|Overall Study|Proxy interview done|3
4698629|NCT02672423|7613564|FG009|Period 3|Physician Decision|0
4698630|NCT02672553|7613596|FG000|Overall Study|Death|3
4698631|NCT02672553|7613597|FG001|Overall Study|Death|5
4698632|NCT02672553|7613596|FG000|Overall Study|Valve Explant|1
4698633|NCT02672553|7613597|FG001|Overall Study|Valve Explant|0
4698634|NCT02672553|7613596|FG000|Overall Study|Conversion to Commercial Valve|3
4698635|NCT02672553|7613597|FG001|Overall Study|Conversion to Commercial Valve|0
4698636|NCT02672553|7613596|FG000|Overall Study|Withdrawal by Subject|3
4698637|NCT02672553|7613597|FG001|Overall Study|Withdrawal by Subject|3
4698638|NCT02672553|7613596|FG000|Overall Study|Intraoperative screen failure|2
4698639|NCT02672553|7613597|FG001|Overall Study|Intraoperative screen failure|0
4698640|NCT02672852|7613606|FG000|Part A1|Disease Worsening|1
4698641|NCT02672852|7613607|FG001|Part A1|Disease Worsening|0
4698642|NCT02672852|7613608|FG002|Part A1|Disease Worsening|0
4698643|NCT02672852|7613609|FG003|Part A1|Disease Worsening|0
4698644|NCT02672852|7613610|FG004|Part A1|Disease Worsening|0
4698645|NCT02672852|7613611|FG005|Part A1|Disease Worsening|0
4698646|NCT02672852|7613612|FG006|Part A1|Disease Worsening|0
4698647|NCT02672852|7613606|FG000|Part A1|Adverse Event|0
4698648|NCT02672852|7613607|FG001|Part A1|Adverse Event|1
4698649|NCT02672852|7613608|FG002|Part A1|Adverse Event|0
4698650|NCT02672852|7613609|FG003|Part A1|Adverse Event|0
4698651|NCT02672852|7613610|FG004|Part A1|Adverse Event|0
4698652|NCT02672852|7613611|FG005|Part A1|Adverse Event|0
4698653|NCT02672852|7613612|FG006|Part A1|Adverse Event|0
4698654|NCT02672852|7613606|FG000|Part A1|Lost to Follow-up|1
4698655|NCT02672852|7613607|FG001|Part A1|Lost to Follow-up|2
4698656|NCT02672852|7613608|FG002|Part A1|Lost to Follow-up|0
4698657|NCT02672852|7613609|FG003|Part A1|Lost to Follow-up|0
4698658|NCT02672852|7613610|FG004|Part A1|Lost to Follow-up|0
4698659|NCT02672852|7613611|FG005|Part A1|Lost to Follow-up|0
4698660|NCT02672852|7613612|FG006|Part A1|Lost to Follow-up|0
4698661|NCT02672852|7613606|FG000|Part A1|Withdrawal by Subject|1
4698662|NCT02672852|7613607|FG001|Part A1|Withdrawal by Subject|1
4698663|NCT02672852|7613608|FG002|Part A1|Withdrawal by Subject|0
4698664|NCT02672852|7613609|FG003|Part A1|Withdrawal by Subject|0
4698665|NCT02672852|7613610|FG004|Part A1|Withdrawal by Subject|0
4698666|NCT02672852|7613611|FG005|Part A1|Withdrawal by Subject|0
4698667|NCT02672852|7613612|FG006|Part A1|Withdrawal by Subject|0
4698668|NCT02672852|7613606|FG000|Part A2|Disease worsening|0
4698669|NCT02672852|7613607|FG001|Part A2|Disease worsening|0
4698670|NCT02672852|7613608|FG002|Part A2|Disease worsening|1
4698671|NCT02672852|7613609|FG003|Part A2|Disease worsening|0
4698672|NCT02672852|7613610|FG004|Part A2|Disease worsening|0
4698673|NCT02672852|7613611|FG005|Part A2|Disease worsening|0
4698674|NCT02672852|7613612|FG006|Part A2|Disease worsening|0
4698675|NCT02672852|7613606|FG000|Part A2|Adverse Event|0
4698676|NCT02672852|7613607|FG001|Part A2|Adverse Event|0
4698677|NCT02672852|7613608|FG002|Part A2|Adverse Event|3
4698678|NCT02672852|7613609|FG003|Part A2|Adverse Event|0
4698679|NCT02672852|7613610|FG004|Part A2|Adverse Event|0
4698680|NCT02672852|7613611|FG005|Part A2|Adverse Event|0
4698681|NCT02672852|7613612|FG006|Part A2|Adverse Event|0
4698682|NCT02672852|7613606|FG000|Part A2|Lost to Follow-up|0
4698683|NCT02672852|7613607|FG001|Part A2|Lost to Follow-up|0
4471748|NCT00655551|7265646|FG001|All Periods Combined|Adverse Event|3
4471749|NCT00655551|7265647|FG002|All Periods Combined|Adverse Event|4
4471750|NCT00655551|7265645|FG000|Period 2 (up to 7 Days)|Adverse Event|0
4589064|NCT01507831|7434020|FG000|Overall Study|Randomized but not treated|0
4698684|NCT02672852|7613608|FG002|Part A2|Lost to Follow-up|2
4698685|NCT02672852|7613609|FG003|Part A2|Lost to Follow-up|0
4698686|NCT02672852|7613610|FG004|Part A2|Lost to Follow-up|0
4698687|NCT02672852|7613611|FG005|Part A2|Lost to Follow-up|0
4698688|NCT02672852|7613612|FG006|Part A2|Lost to Follow-up|0
4698689|NCT02672852|7613606|FG000|Part A2|Withdrawal by Subject|0
4698690|NCT02672852|7613607|FG001|Part A2|Withdrawal by Subject|0
4698691|NCT02672852|7613608|FG002|Part A2|Withdrawal by Subject|1
4698692|NCT02672852|7613609|FG003|Part A2|Withdrawal by Subject|0
4698693|NCT02672852|7613610|FG004|Part A2|Withdrawal by Subject|0
4698694|NCT02672852|7613611|FG005|Part A2|Withdrawal by Subject|0
4471751|NCT00655551|7265646|FG001|Period 2 (up to 7 Days)|Adverse Event|1
4471752|NCT00655551|7265647|FG002|Period 2 (up to 7 Days)|Adverse Event|0
4471753|NCT00655551|7265645|FG000|Period 3 (up to 7 Days)|Adverse Event|0
4471754|NCT00655551|7265646|FG001|Period 3 (up to 7 Days)|Adverse Event|0
4471755|NCT00655551|7265647|FG002|Period 3 (up to 7 Days)|Adverse Event|4
4471756|NCT00655551|7265645|FG000|Period 4 (up to 7 Days)|Adverse Event|0
4471757|NCT00655551|7265646|FG001|Period 4 (up to 7 Days)|Adverse Event|2
4471758|NCT00655551|7265647|FG002|Period 4 (up to 7 Days)|Adverse Event|0
4471759|NCT00655564|7265655|FG000|Overall Study|Adverse Event|1
4471760|NCT00655564|7265655|FG000|Overall Study|Lost to Follow-up|1
4471761|NCT00655564|7265655|FG000|Overall Study|Desired Alternate Therapy|1
4698695|NCT02672852|7613612|FG006|Part A2|Withdrawal by Subject|0
4698696|NCT02672852|7613606|FG000|Part A2|Other|0
4698697|NCT02672852|7613607|FG001|Part A2|Other|0
4698698|NCT02672852|7613608|FG002|Part A2|Other|3
4698699|NCT02672852|7613609|FG003|Part A2|Other|0
4698700|NCT02672852|7613610|FG004|Part A2|Other|0
4698701|NCT02672852|7613611|FG005|Part A2|Other|0
4698702|NCT02672852|7613612|FG006|Part A2|Other|0
4698703|NCT02672852|7613606|FG000|Part A2|Not entered in Part B|0
4698704|NCT02672852|7613607|FG001|Part A2|Not entered in Part B|0
4698705|NCT02672852|7613608|FG002|Part A2|Not entered in Part B|0
4698706|NCT02672852|7613609|FG003|Part A2|Not entered in Part B|4
4698707|NCT02672852|7613610|FG004|Part A2|Not entered in Part B|0
4698708|NCT02672852|7613611|FG005|Part A2|Not entered in Part B|0
4698709|NCT02672852|7613612|FG006|Part A2|Not entered in Part B|0
4698710|NCT02672852|7613606|FG000|Part B|Disease worsening|0
4698711|NCT02672852|7613607|FG001|Part B|Disease worsening|0
4698712|NCT02672852|7613608|FG002|Part B|Disease worsening|0
4698713|NCT02672852|7613609|FG003|Part B|Disease worsening|0
4698714|NCT02672852|7613610|FG004|Part B|Disease worsening|1
4698715|NCT02672852|7613611|FG005|Part B|Disease worsening|0
4698716|NCT02672852|7613612|FG006|Part B|Disease worsening|1
4698717|NCT02672852|7613606|FG000|Part B|Worsening pre-existing condition|0
4698718|NCT02672852|7613607|FG001|Part B|Worsening pre-existing condition|0
4698719|NCT02672852|7613608|FG002|Part B|Worsening pre-existing condition|0
4698720|NCT02672852|7613609|FG003|Part B|Worsening pre-existing condition|0
4698721|NCT02672852|7613610|FG004|Part B|Worsening pre-existing condition|0
4698722|NCT02672852|7613611|FG005|Part B|Worsening pre-existing condition|1
4698723|NCT02672852|7613612|FG006|Part B|Worsening pre-existing condition|0
4698724|NCT02672852|7613606|FG000|Part B|Other adverse event|0
4698725|NCT02672852|7613607|FG001|Part B|Other adverse event|0
4698726|NCT02672852|7613608|FG002|Part B|Other adverse event|0
4698727|NCT02672852|7613609|FG003|Part B|Other adverse event|0
4698728|NCT02672852|7613610|FG004|Part B|Other adverse event|3
4698729|NCT02672852|7613611|FG005|Part B|Other adverse event|5
4698730|NCT02672852|7613612|FG006|Part B|Other adverse event|1
4698731|NCT02672852|7613606|FG000|Part B|Lost to Follow-up|0
4698732|NCT02672852|7613607|FG001|Part B|Lost to Follow-up|0
4698733|NCT02672852|7613608|FG002|Part B|Lost to Follow-up|0
4698734|NCT02672852|7613609|FG003|Part B|Lost to Follow-up|0
4698735|NCT02672852|7613610|FG004|Part B|Lost to Follow-up|3
4698736|NCT02672852|7613611|FG005|Part B|Lost to Follow-up|4
4698737|NCT02672852|7613612|FG006|Part B|Lost to Follow-up|1
4698738|NCT02672852|7613606|FG000|Part B|Withdrawal by Subject|0
4698739|NCT02672852|7613607|FG001|Part B|Withdrawal by Subject|0
4698740|NCT02672852|7613608|FG002|Part B|Withdrawal by Subject|0
4698741|NCT02672852|7613609|FG003|Part B|Withdrawal by Subject|0
4698742|NCT02672852|7613610|FG004|Part B|Withdrawal by Subject|5
4698743|NCT02672852|7613611|FG005|Part B|Withdrawal by Subject|0
4698744|NCT02672852|7613612|FG006|Part B|Withdrawal by Subject|7
4698745|NCT02672852|7613606|FG000|Part B|Other|0
4698746|NCT02672852|7613607|FG001|Part B|Other|0
4698747|NCT02672852|7613608|FG002|Part B|Other|0
4698748|NCT02672852|7613609|FG003|Part B|Other|0
4698749|NCT02672852|7613610|FG004|Part B|Other|4
4698750|NCT02672852|7613611|FG005|Part B|Other|1
4698751|NCT02672852|7613612|FG006|Part B|Other|2
4698752|NCT02673489|7613649|FG000|Treatment Period|Lost to Follow-up|3
4698753|NCT02673489|7613650|FG001|Treatment Period|Lost to Follow-up|0
4698754|NCT02673489|7613649|FG000|Treatment Period|Participant request to discontinue|1
4698755|NCT02673489|7613650|FG001|Treatment Period|Participant request to discontinue|1
4698756|NCT02673489|7613649|FG000|Treatment Period|Participant moved to another province|1
4698757|NCT02673489|7613650|FG001|Treatment Period|Participant moved to another province|0
4698758|NCT02673489|7613649|FG000|Treatment Period|Participant was incarcerated|0
4698759|NCT02673489|7613650|FG001|Treatment Period|Participant was incarcerated|1
4698760|NCT02673489|7613649|FG000|Treatment Period|Adverse Event|0
4698761|NCT02673489|7613650|FG001|Treatment Period|Adverse Event|1
4698762|NCT02673489|7613649|FG000|Follow Up Period|Unable to return for week 24 follow-up|0
4471762|NCT00655629|7265662|FG000|Overall Study|Adverse Event|4
4471763|NCT00655629|7265663|FG001|Overall Study|Adverse Event|1
4471764|NCT00655629|7265662|FG000|Overall Study|Lack of Efficacy|2
4698763|NCT02673489|7613650|FG001|Follow Up Period|Unable to return for week 24 follow-up|1
4698764|NCT02673489|7613649|FG000|Follow Up Period|Unable to return for follow-up|0
4698765|NCT02673489|7613650|FG001|Follow Up Period|Unable to return for follow-up|1
4698766|NCT02673515|7613659|FG000|Overall Study|Lack of motivation|2
4698767|NCT02673515|7613660|FG001|Overall Study|Lack of motivation|1
4698768|NCT02673619|7613679|FG000|Overall Study|Lost to Follow-up|1
4471765|NCT00655629|7265663|FG001|Overall Study|Lack of Efficacy|12
4471766|NCT00655629|7265662|FG000|Overall Study|Lost to Follow-up|4
4471767|NCT00655629|7265663|FG001|Overall Study|Lost to Follow-up|3
4471768|NCT00655629|7265662|FG000|Overall Study|Protocol Violation|5
4471769|NCT00655629|7265663|FG001|Overall Study|Protocol Violation|3
4471770|NCT00655629|7265662|FG000|Overall Study|consent withdrawn|6
4471771|NCT00655629|7265663|FG001|Overall Study|consent withdrawn|4
4698769|NCT02673619|7613680|FG001|Overall Study|Lost to Follow-up|0
4698770|NCT02673619|7613681|FG002|Overall Study|Lost to Follow-up|0
4698771|NCT02673619|7613682|FG003|Overall Study|Lost to Follow-up|0
4698772|NCT02673619|7613679|FG000|Overall Study|Withdrawal by Subject|1
4698773|NCT02673619|7613680|FG001|Overall Study|Withdrawal by Subject|1
4698774|NCT02673619|7613681|FG002|Overall Study|Withdrawal by Subject|1
4698775|NCT02673619|7613682|FG003|Overall Study|Withdrawal by Subject|0
4698776|NCT02673619|7613679|FG000|Overall Study|Adverse Event|0
4698777|NCT02673619|7613680|FG001|Overall Study|Adverse Event|0
4698778|NCT02673619|7613681|FG002|Overall Study|Adverse Event|1
4698779|NCT02673619|7613682|FG003|Overall Study|Adverse Event|0
4698780|NCT02673619|7613679|FG000|Overall Study|Lack of Efficacy|0
4698781|NCT02673619|7613680|FG001|Overall Study|Lack of Efficacy|0
4698782|NCT02673619|7613681|FG002|Overall Study|Lack of Efficacy|1
4698783|NCT02673619|7613682|FG003|Overall Study|Lack of Efficacy|0
4698784|NCT02674334|7613711|FG000|Overall Study|Lost to Follow-up|5
4698785|NCT02674334|7613712|FG001|Overall Study|Lost to Follow-up|3
4698786|NCT02674334|7613711|FG000|Overall Study|participant difficulty breathing|1
4698787|NCT02674334|7613712|FG001|Overall Study|participant difficulty breathing|0
4698788|NCT02674334|7613711|FG000|Overall Study|NIRS not recording|1
4698789|NCT02674334|7613712|FG001|Overall Study|NIRS not recording|0
4698790|NCT02674386|7613721|FG000|Overall Study|Lost to Follow-up|0
4698791|NCT02674386|7613722|FG001|Overall Study|Lost to Follow-up|1
4698792|NCT02674386|7613723|FG002|Overall Study|Lost to Follow-up|1
4698793|NCT02674386|7613721|FG000|Overall Study|Withdrawal by Subject|0
4698794|NCT02674386|7613722|FG001|Overall Study|Withdrawal by Subject|4
4698795|NCT02674386|7613723|FG002|Overall Study|Withdrawal by Subject|0
4698796|NCT02674386|7613721|FG000|Overall Study|Other|0
4698797|NCT02674386|7613722|FG001|Overall Study|Other|1
4698798|NCT02674386|7613723|FG002|Overall Study|Other|0
4698799|NCT02674386|7613721|FG000|Overall Study|Enrolled but not evaluated|0
4698800|NCT02674386|7613722|FG001|Overall Study|Enrolled but not evaluated|4
4698801|NCT02674386|7613723|FG002|Overall Study|Enrolled but not evaluated|0
4698802|NCT02674399|7613738|FG000|Overall Study|Lost to Follow-up|2
4698803|NCT02674399|7613739|FG001|Overall Study|Lost to Follow-up|0
4698804|NCT02674477|7613755|FG000|Overall Study|Protocol Violation|8
4698805|NCT02674477|7613756|FG001|Overall Study|Protocol Violation|2
4698806|NCT02674568|7613762|FG000|Overall Study|Withdrawal by Subject|5
4698807|NCT02674568|7613762|FG000|Overall Study|Death|303
4698808|NCT02674568|7613762|FG000|Overall Study|Physician Decision|2
4698809|NCT02674568|7613762|FG000|Overall Study|Lost to Follow-up|9
4698810|NCT02674568|7613762|FG000|Overall Study|Other, Not Specified|20
4698811|NCT02674633|7613773|FG000|Overall Study|Lost to Follow-up|3
4698812|NCT02674633|7613774|FG001|Overall Study|Lost to Follow-up|2
4698813|NCT02674633|7613773|FG000|Overall Study|Physician Decision|1
4698814|NCT02674633|7613774|FG001|Overall Study|Physician Decision|0
4698815|NCT02674633|7613773|FG000|Overall Study|Withdrawal by Parent/Guardian|1
4698816|NCT02674633|7613774|FG001|Overall Study|Withdrawal by Parent/Guardian|2
4698817|NCT02674685|7613789|FG000|Overall Study|Protocol Violation|4
4698818|NCT02674854|7613796|FG000|Overall Study|Adverse Event|17
4698819|NCT02674854|7613797|FG001|Overall Study|Adverse Event|15
4698820|NCT02674854|7613798|FG002|Overall Study|Adverse Event|5
4698821|NCT02674854|7613796|FG000|Overall Study|Withdrawal by Subject|1
4698822|NCT02674854|7613797|FG001|Overall Study|Withdrawal by Subject|5
4698823|NCT02674854|7613798|FG002|Overall Study|Withdrawal by Subject|4
4698824|NCT02674854|7613796|FG000|Overall Study|No-compliant subject|1
4698825|NCT02674854|7613797|FG001|Overall Study|No-compliant subject|0
4698826|NCT02674854|7613798|FG002|Overall Study|No-compliant subject|1
4698827|NCT02674854|7613796|FG000|Overall Study|Lost to Follow-up|1
4698828|NCT02674854|7613797|FG001|Overall Study|Lost to Follow-up|0
4698829|NCT02674854|7613798|FG002|Overall Study|Lost to Follow-up|2
4698830|NCT02674854|7613796|FG000|Overall Study|Lack of Efficacy|0
4698831|NCT02674854|7613797|FG001|Overall Study|Lack of Efficacy|3
4471772|NCT00655668|7265686|FG000|Overall Study|Adverse Event|6
4698832|NCT02674854|7613798|FG002|Overall Study|Lack of Efficacy|0
4698833|NCT02674854|7613796|FG000|Overall Study|Disallowed Concurrent Medication|2
4698834|NCT02674854|7613797|FG001|Overall Study|Disallowed Concurrent Medication|2
4698835|NCT02674854|7613798|FG002|Overall Study|Disallowed Concurrent Medication|0
4698836|NCT02674854|7613796|FG000|Overall Study|Protocol Violation|1
4698837|NCT02674854|7613797|FG001|Overall Study|Protocol Violation|1
4698838|NCT02674854|7613798|FG002|Overall Study|Protocol Violation|2
4698839|NCT02674854|7613796|FG000|Overall Study|Death|0
4698840|NCT02674854|7613797|FG001|Overall Study|Death|1
4698841|NCT02674854|7613798|FG002|Overall Study|Death|0
4698842|NCT02674854|7613796|FG000|Overall Study|Subject missed V6.2|1
4698843|NCT02674854|7613797|FG001|Overall Study|Subject missed V6.2|0
4698844|NCT02674854|7613798|FG002|Overall Study|Subject missed V6.2|0
4698845|NCT02675075|7613808|FG000|Overall Study|Lost to Follow-up|3
4698846|NCT02675075|7613809|FG001|Overall Study|Lost to Follow-up|0
4471773|NCT00655668|7265686|FG000|Overall Study|Death|5
4471774|NCT00655668|7265686|FG000|Overall Study|Disease Progression|27
4471775|NCT00655668|7265686|FG000|Overall Study|Study Terminated|9
4471776|NCT00655668|7265686|FG000|Overall Study|Other|1
4471777|NCT00655668|7265686|FG000|Overall Study|New Lymphoma Treatment Started|4
4471778|NCT00655668|7265686|FG000|Overall Study|Withdrawal by Subject|2
4471779|NCT00655733|7265697|FG000|Overall Study|Lost to Follow-up|2
4471780|NCT00655733|7265698|FG001|Overall Study|Lost to Follow-up|2
4471781|NCT00655733|7265697|FG000|Overall Study|Adverse Event|2
4471782|NCT00655733|7265698|FG001|Overall Study|Adverse Event|2
4471783|NCT00655733|7265697|FG000|Overall Study|Withdrawal by Subject|3
4471784|NCT00655733|7265698|FG001|Overall Study|Withdrawal by Subject|3
4471785|NCT00655733|7265697|FG000|Overall Study|Physician Decision|0
4471786|NCT00655733|7265698|FG001|Overall Study|Physician Decision|1
4471787|NCT00655746|7265706|FG000|Overall Study|Withdrawal by Subject|1
4471788|NCT00655850|7265724|FG000|Overall Study|Death|2
4471789|NCT00655850|7265724|FG000|Overall Study|Withdrawal by Subject|1
4471790|NCT00655863|7265733|FG000|Overall Study|Lost to Follow-up|0
4471791|NCT00655863|7265734|FG001|Overall Study|Lost to Follow-up|0
4471792|NCT00655863|7265735|FG002|Overall Study|Lost to Follow-up|1
4471793|NCT00655876|7265745|FG000|Overall Study|Protocol Violation|9
4471794|NCT00655876|7265746|FG001|Overall Study|Protocol Violation|7
4471795|NCT00655889|7265752|FG000|Overall Study|Inadequate cell growth|1
4471796|NCT00655889|7265752|FG000|Overall Study|Protocol Violation|1
4471797|NCT00655928|7265758|FG000|Overall Study|Withdrawal by Subject|2
4471798|NCT00655928|7265759|FG001|Overall Study|Withdrawal by Subject|1
4471799|NCT00655928|7265758|FG000|Overall Study|Physician Decision|1
4471800|NCT00655928|7265759|FG001|Overall Study|Physician Decision|1
4471801|NCT00655980|7265768|FG000|Overall Study|surgery canceled; or subject or anesthes|26
4471802|NCT00655980|7265769|FG001|Overall Study|surgery canceled; or subject or anesthes|31
4471803|NCT00655980|7265770|FG002|Overall Study|surgery canceled; or subject or anesthes|5
4471804|NCT00656019|7265785|FG000|Overall Study|Not Eligible|10
4471805|NCT00656019|7265786|FG001|Overall Study|Not Eligible|0
4471806|NCT00656019|7265787|FG002|Overall Study|Not Eligible|0
4471807|NCT00656019|7265788|FG003|Overall Study|Not Eligible|0
4471808|NCT00656019|7265785|FG000|Overall Study|Withdrawal by Subject|2
4471809|NCT00656019|7265786|FG001|Overall Study|Withdrawal by Subject|0
4471810|NCT00656019|7265787|FG002|Overall Study|Withdrawal by Subject|0
4471811|NCT00656019|7265788|FG003|Overall Study|Withdrawal by Subject|0
4471812|NCT00656019|7265785|FG000|Overall Study|Lost to Follow-up|2
4471813|NCT00656019|7265786|FG001|Overall Study|Lost to Follow-up|1
4471814|NCT00656019|7265787|FG002|Overall Study|Lost to Follow-up|0
4471815|NCT00656019|7265788|FG003|Overall Study|Lost to Follow-up|0
4471816|NCT00656058|7265798|FG000|Overall Study|Withdrawal by Subject|2
4471817|NCT00656058|7265798|FG000|Overall Study|Withdrawal by Subject|4
4471818|NCT00656084|7265802|FG000|Overall Study|Adverse Event|4
4471819|NCT00656084|7265802|FG000|Overall Study|Withdrawal by Subject|1
4471820|NCT00656084|7265802|FG000|Overall Study|Patient Request|1
4471821|NCT00656084|7265802|FG000|Overall Study|Investigator Request|1
4471822|NCT00656136|7265808|FG000|Overall Study|Progressive disease|177
4471823|NCT00656136|7265809|FG001|Overall Study|Progressive disease|322
4471824|NCT00656136|7265808|FG000|Overall Study|Other Adverse Event|5
4471825|NCT00656136|7265809|FG001|Overall Study|Other Adverse Event|51
4471826|NCT00656136|7265808|FG000|Overall Study|Protocol Violation|2
4471827|NCT00656136|7265809|FG001|Overall Study|Protocol Violation|3
4471828|NCT00656136|7265808|FG000|Overall Study|Patient refused to take study medication|7
4471829|NCT00656136|7265809|FG001|Overall Study|Patient refused to take study medication|10
4471830|NCT00656136|7265808|FG000|Overall Study|Unknown and others|4
4471831|NCT00656136|7265809|FG001|Overall Study|Unknown and others|4
4471832|NCT00656175|7265817|FG000|Overall Study|Adverse Event|1
4471833|NCT00656175|7265818|FG001|Overall Study|Adverse Event|0
4471834|NCT00656175|7265817|FG000|Overall Study|Transportation issues|0
4471835|NCT00656175|7265818|FG001|Overall Study|Transportation issues|1
4471836|NCT00656292|7265835|FG000|Overall Study|Withdrawal by Subject|2
4471837|NCT00656292|7265836|FG001|Overall Study|Withdrawal by Subject|3
4471838|NCT00656292|7265835|FG000|Overall Study|Screen failure|1
4471839|NCT00656292|7265836|FG001|Overall Study|Screen failure|2
4471840|NCT00656370|7265851|FG000|Overall Study|Screen Failures|7
4471841|NCT00656370|7265851|FG000|Overall Study|Alternates|3
4471842|NCT00656474|7265867|FG000|Overall Study|Other Reason|1
4471843|NCT00656513|7265888|FG000|Overall Study|Protocol Violation|1
4471844|NCT00656513|7265889|FG001|Overall Study|Protocol Violation|0
4471845|NCT00656513|7265890|FG002|Overall Study|Protocol Violation|2
4471846|NCT00656513|7265888|FG000|Overall Study|Withdrawal by Subject|0
4471847|NCT00656513|7265889|FG001|Overall Study|Withdrawal by Subject|11
4471848|NCT00656513|7265890|FG002|Overall Study|Withdrawal by Subject|4
4471849|NCT00656513|7265888|FG000|Overall Study|Death|0
4471850|NCT00656513|7265889|FG001|Overall Study|Death|0
4471851|NCT00656513|7265890|FG002|Overall Study|Death|1
4471852|NCT00656513|7265888|FG000|Overall Study|Missing data|0
4471853|NCT00656513|7265889|FG001|Overall Study|Missing data|11
4471854|NCT00656513|7265890|FG002|Overall Study|Missing data|9
4471855|NCT00656513|7265888|FG000|Overall Study|Incomplete treatment|3
4471856|NCT00656513|7265889|FG001|Overall Study|Incomplete treatment|0
4471857|NCT00656513|7265890|FG002|Overall Study|Incomplete treatment|0
4471858|NCT00656513|7265888|FG000|Overall Study|Treatment completed outside of timeframe|0
4471859|NCT00656513|7265889|FG001|Overall Study|Treatment completed outside of timeframe|3
4471860|NCT00656513|7265890|FG002|Overall Study|Treatment completed outside of timeframe|1
4471861|NCT00656513|7265888|FG000|Overall Study|Missing baseline form|0
4471862|NCT00656513|7265889|FG001|Overall Study|Missing baseline form|5
4471863|NCT00656513|7265890|FG002|Overall Study|Missing baseline form|5
4471864|NCT00656617|7265898|FG000|Overall Study|Adverse Event|1
4698847|NCT02675517|7613817|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8
4698848|NCT02675517|7613817|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151
4698849|NCT02675634|7613830|FG000|Test Period 1|Adverse Event|0
4471865|NCT00656617|7265898|FG000|Overall Study|Death|2
4471866|NCT00656617|7265898|FG000|Overall Study|Insurance Issues|2
4471867|NCT00656617|7265898|FG000|Overall Study|Move to different clinical trial|2
4471868|NCT00656669|7265920|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4
4471869|NCT00656669|7265920|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2
4471870|NCT00656669|7265920|FG000|AC (Cycles 6-9)|Adverse Event|1
4471871|NCT00656669|7265920|FG000|AC (Cycles 6-9)|Did not start segment 3|1
4471872|NCT00656799|7265929|FG000|Overall Study|Death|2
4471873|NCT00656851|7265935|FG000|Overall Study|Withdrawal by Subject|0
4471874|NCT00656851|7265936|FG001|Overall Study|Withdrawal by Subject|4
4589065|NCT01507831|7434021|FG001|Overall Study|Randomized but not treated|3
4471875|NCT00657020|7265951|FG000|PERIOD 1|Adverse Event|0
4471876|NCT00657020|7265952|FG001|PERIOD 1|Adverse Event|1
4471877|NCT00657046|7265967|FG000|Overall Study|Adverse Event|1
4471878|NCT00657046|7265968|FG001|Overall Study|Adverse Event|1
4471879|NCT00657046|7265969|FG002|Overall Study|Adverse Event|0
4471880|NCT00657046|7265967|FG000|Overall Study|Protocol Violation|2
4471881|NCT00657046|7265968|FG001|Overall Study|Protocol Violation|2
4471882|NCT00657046|7265969|FG002|Overall Study|Protocol Violation|0
4471883|NCT00657046|7265967|FG000|Overall Study|Withdrawal by Subject|1
4471884|NCT00657046|7265968|FG001|Overall Study|Withdrawal by Subject|0
4471885|NCT00657046|7265969|FG002|Overall Study|Withdrawal by Subject|0
4471886|NCT00657046|7265967|FG000|Overall Study|Death|0
4471887|NCT00657046|7265968|FG001|Overall Study|Death|0
4471888|NCT00657046|7265969|FG002|Overall Study|Death|1
4471889|NCT00657046|7265967|FG000|Overall Study|Surgery|0
4471890|NCT00657046|7265968|FG001|Overall Study|Surgery|0
4471891|NCT00657046|7265969|FG002|Overall Study|Surgery|1
4471892|NCT00657150|7265979|FG000|Overall Study|Adverse Event|19
4471893|NCT00657150|7265980|FG001|Overall Study|Adverse Event|10
4471894|NCT00657150|7265979|FG000|Overall Study|Non-compliant with protocol|5
4471895|NCT00657150|7265980|FG001|Overall Study|Non-compliant with protocol|9
4471896|NCT00657150|7265979|FG000|Overall Study|Lost to Follow-up|2
4471897|NCT00657150|7265980|FG001|Overall Study|Lost to Follow-up|0
4471898|NCT00657150|7265979|FG000|Overall Study|Withdrawal by Subject|51
4471899|NCT00657150|7265980|FG001|Overall Study|Withdrawal by Subject|36
4471900|NCT00657150|7265979|FG000|Overall Study|Other|38
4471901|NCT00657150|7265980|FG001|Overall Study|Other|38
4471902|NCT00657150|7265979|FG000|Treatment|Adverse Event|60
4471903|NCT00657150|7265980|FG001|Treatment|Adverse Event|53
4471904|NCT00657150|7265979|FG000|Treatment|Non-compliant with protocol|10
4471905|NCT00657150|7265980|FG001|Treatment|Non-compliant with protocol|9
4471906|NCT00657150|7265979|FG000|Treatment|Lost to Follow-up|1
4471907|NCT00657150|7265980|FG001|Treatment|Lost to Follow-up|0
4471908|NCT00657150|7265979|FG000|Treatment|Withdrawal by Subject|23
4471909|NCT00657150|7265980|FG001|Treatment|Withdrawal by Subject|20
4471910|NCT00657150|7265979|FG000|Treatment|Other|13
4471911|NCT00657150|7265980|FG001|Treatment|Other|15
4471912|NCT00657267|7265986|FG000|Overall Study|Progressive disease|45
4471913|NCT00657267|7265986|FG000|Overall Study|Adverse Event|9
4471914|NCT00657358|7265996|FG000|Overall Study|Lack of Efficacy|6
4471915|NCT00657371|7266001|FG000|Overall Study|Poor bowel preparation|15
4471916|NCT00657371|7266001|FG000|Overall Study|Unable to intubate the cecum|5
4471917|NCT00657371|7266001|FG000|Overall Study|Protocol Violation|2
4471918|NCT00657371|7266001|FG000|Overall Study|Device- related reasons|13
4471919|NCT00657371|7266001|FG000|Overall Study|Pre-existing medical condition|4
4471920|NCT00657540|7266007|FG000|Overall Study|Lost to Follow-up|1
4471921|NCT00657540|7266008|FG001|Overall Study|Lost to Follow-up|4
4471922|NCT00657618|7266018|FG000|Overall Study|Adverse Event|32
4471923|NCT00657618|7266018|FG000|Overall Study|Withdrawal by Subject|8
4471924|NCT00657618|7266018|FG000|Overall Study|negative for leishmaniasis|2
4471925|NCT00657618|7266018|FG000|Overall Study|didn't start due to schedule conflicts|1
4471926|NCT00657709|7266031|FG000|Overall Study|AE or Death|7
4471927|NCT00657709|7266032|FG001|Overall Study|AE or Death|7
4471928|NCT00657709|7266033|FG002|Overall Study|AE or Death|6
4589066|NCT01507831|7434020|FG000|Overall Study|Adverse Event|48
4698850|NCT02675634|7613831|FG001|Test Period 1|Adverse Event|1
4471929|NCT00657709|7266034|FG003|Overall Study|AE or Death|7
4471930|NCT00657709|7266035|FG004|Overall Study|AE or Death|1
4471931|NCT00657709|7266031|FG000|Overall Study|Withdrawal by Subject|7
4471932|NCT00657709|7266032|FG001|Overall Study|Withdrawal by Subject|15
4471933|NCT00657709|7266033|FG002|Overall Study|Withdrawal by Subject|15
4471934|NCT00657709|7266034|FG003|Overall Study|Withdrawal by Subject|5
4471935|NCT00657709|7266035|FG004|Overall Study|Withdrawal by Subject|9
4471936|NCT00657709|7266031|FG000|Overall Study|Lost to Follow-up|9
4698851|NCT02675634|7613832|FG002|Test Period 1|Adverse Event|0
4471937|NCT00657709|7266032|FG001|Overall Study|Lost to Follow-up|9
4471938|NCT00657709|7266033|FG002|Overall Study|Lost to Follow-up|7
4471939|NCT00657709|7266034|FG003|Overall Study|Lost to Follow-up|1
4471940|NCT00657709|7266035|FG004|Overall Study|Lost to Follow-up|21
4471941|NCT00657709|7266031|FG000|Overall Study|Protocol Violation|0
4471942|NCT00657709|7266032|FG001|Overall Study|Protocol Violation|2
4471943|NCT00657709|7266033|FG002|Overall Study|Protocol Violation|0
4471944|NCT00657709|7266034|FG003|Overall Study|Protocol Violation|1
4471945|NCT00657709|7266035|FG004|Overall Study|Protocol Violation|2
4471946|NCT00658021|7266064|FG000|28-Week Treatment Period|Adverse Event|3
4471947|NCT00658021|7266065|FG001|28-Week Treatment Period|Adverse Event|1
4471948|NCT00658021|7266066|FG002|28-Week Treatment Period|Adverse Event|0
4471949|NCT00658021|7266064|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0
4471950|NCT00658021|7266065|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2
4471951|NCT00658021|7266066|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0
4471952|NCT00658021|7266064|FG000|28-Week Treatment Period|Protocol Violation|0
4471953|NCT00658021|7266065|FG001|28-Week Treatment Period|Protocol Violation|2
4471954|NCT00658021|7266066|FG002|28-Week Treatment Period|Protocol Violation|1
4471955|NCT00658021|7266064|FG000|28-Week Treatment Period|Withdrawal by Subject|1
4471956|NCT00658021|7266065|FG001|28-Week Treatment Period|Withdrawal by Subject|1
4471957|NCT00658021|7266066|FG002|28-Week Treatment Period|Withdrawal by Subject|3
4471958|NCT00658021|7266064|FG000|28-Week Treatment Period|Physician Decision|1
4471959|NCT00658021|7266065|FG001|28-Week Treatment Period|Physician Decision|2
4471960|NCT00658021|7266066|FG002|28-Week Treatment Period|Physician Decision|1
4471961|NCT00658021|7266064|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1
4471962|NCT00658021|7266065|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1
4471963|NCT00658021|7266066|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1
4471964|NCT00658021|7266064|FG000|28-Week Treatment Period|Loss of glucose control|1
4471965|NCT00658021|7266065|FG001|28-Week Treatment Period|Loss of glucose control|1
4471966|NCT00658021|7266066|FG002|28-Week Treatment Period|Loss of glucose control|10
4471967|NCT00658021|7266064|FG000|28-Week Treatment Period|Other|2
4471968|NCT00658021|7266065|FG001|28-Week Treatment Period|Other|3
4471969|NCT00658021|7266066|FG002|28-Week Treatment Period|Other|1
4471970|NCT00658021|7266064|FG000|28-Week Treatment Period|Did not receive treatment|2
4471971|NCT00658021|7266065|FG001|28-Week Treatment Period|Did not receive treatment|0
4471972|NCT00658021|7266066|FG002|28-Week Treatment Period|Did not receive treatment|0
4471973|NCT00658021|7266064|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0
4471974|NCT00658021|7266065|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1
4471975|NCT00658021|7266066|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0
4471976|NCT00658021|7266064|FG000|Long-term Safety Follow-up Period|Physician Decision|0
4471977|NCT00658021|7266065|FG001|Long-term Safety Follow-up Period|Physician Decision|2
4471978|NCT00658021|7266066|FG002|Long-term Safety Follow-up Period|Physician Decision|0
4471979|NCT00658320|7266087|FG000|Core Study: 12 Months|Subject withdrew consent|5
4471980|NCT00658320|7266088|FG001|Core Study: 12 Months|Subject withdrew consent|3
4471981|NCT00658320|7266087|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3
4471982|NCT00658320|7266088|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0
4471983|NCT00658320|7266087|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3
4471984|NCT00658320|7266088|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7
4471985|NCT00658320|7266087|FG000|Extension Study: After Month 24|Subject withdrew consent|2
4471986|NCT00658320|7266088|FG001|Extension Study: After Month 24|Subject withdrew consent|0
4471987|NCT00658333|7266098|FG000|Overall Study|Adverse Event|2
4471988|NCT00658333|7266099|FG001|Overall Study|Adverse Event|1
4471989|NCT00658359|7266108|FG000|Overall Study|Death|3
4471990|NCT00658359|7266109|FG001|Overall Study|Death|1
4471991|NCT00658359|7266110|FG002|Overall Study|Death|2
4471992|NCT00658359|7266108|FG000|Overall Study|Adverse Event|13
4471993|NCT00658359|7266109|FG001|Overall Study|Adverse Event|6
4471994|NCT00658359|7266110|FG002|Overall Study|Adverse Event|9
4471995|NCT00658359|7266108|FG000|Overall Study|Protocol Violation|1
4471996|NCT00658359|7266109|FG001|Overall Study|Protocol Violation|0
4471997|NCT00658359|7266110|FG002|Overall Study|Protocol Violation|0
4471998|NCT00658359|7266108|FG000|Overall Study|Includes protocol Amendments 3 and 4|2
4471999|NCT00658359|7266109|FG001|Overall Study|Includes protocol Amendments 3 and 4|31
4472000|NCT00658359|7266110|FG002|Overall Study|Includes protocol Amendments 3 and 4|29
4472001|NCT00658359|7266108|FG000|Overall Study|Withdrawal by Subject|7
4472002|NCT00658359|7266109|FG001|Overall Study|Withdrawal by Subject|4
4472003|NCT00658359|7266110|FG002|Overall Study|Withdrawal by Subject|2
4472004|NCT00658359|7266108|FG000|Overall Study|Lost to Follow-up|2
4472005|NCT00658359|7266109|FG001|Overall Study|Lost to Follow-up|2
4472006|NCT00658359|7266110|FG002|Overall Study|Lost to Follow-up|4
4472007|NCT00658359|7266108|FG000|Overall Study|Lack of Efficacy|0
4472008|NCT00658359|7266109|FG001|Overall Study|Lack of Efficacy|1
4472009|NCT00658359|7266110|FG002|Overall Study|Lack of Efficacy|0
4472010|NCT00658528|7266143|FG000|Overall Study|Adverse Event|5
4472011|NCT00658528|7266144|FG001|Overall Study|Adverse Event|7
4472012|NCT00658528|7266143|FG000|Overall Study|Lost to Follow-up|14
4472013|NCT00658528|7266144|FG001|Overall Study|Lost to Follow-up|22
4472014|NCT00658528|7266143|FG000|Overall Study|Withdrawal by Subject|8
4472015|NCT00658528|7266144|FG001|Overall Study|Withdrawal by Subject|6
4472016|NCT00658528|7266143|FG000|Overall Study|Withdrawal of consent|5
4472017|NCT00658528|7266144|FG001|Overall Study|Withdrawal of consent|6
4472018|NCT00658528|7266143|FG000|Overall Study|Other|8
4472019|NCT00658528|7266144|FG001|Overall Study|Other|4
4472020|NCT00658541|7266150|FG000|Washout Period of 7 Days|Withdrawal by Subject|1
4472021|NCT00658541|7266151|FG001|Washout Period of 7 Days|Withdrawal by Subject|1
4472022|NCT00658541|7266150|FG000|Washout Period of 7 Days|Withdrawal by Subject|0
4472023|NCT00658541|7266151|FG001|Washout Period of 7 Days|Withdrawal by Subject|1
4472024|NCT00658567|7266160|FG000|Overall Study|Adverse Event|5
4472025|NCT00658567|7266161|FG001|Overall Study|Adverse Event|2
4472026|NCT00658567|7266162|FG002|Overall Study|Adverse Event|3
4472027|NCT00658567|7266160|FG000|Overall Study|Voluntary Withdrawal of Consent|2
4472028|NCT00658567|7266161|FG001|Overall Study|Voluntary Withdrawal of Consent|0
4472029|NCT00658567|7266162|FG002|Overall Study|Voluntary Withdrawal of Consent|2
4472030|NCT00658567|7266160|FG000|Overall Study|Physician Decision|0
4472031|NCT00658567|7266161|FG001|Overall Study|Physician Decision|1
4472032|NCT00658567|7266162|FG002|Overall Study|Physician Decision|0
4472033|NCT00658567|7266160|FG000|Overall Study|At Discretion of Sponsor|1
4472034|NCT00658567|7266161|FG001|Overall Study|At Discretion of Sponsor|1
4472035|NCT00658567|7266162|FG002|Overall Study|At Discretion of Sponsor|1
4472036|NCT00658606|7266172|FG000|Overall Study|Adverse Event|2
4472037|NCT00658606|7266173|FG001|Overall Study|Adverse Event|1
4472038|NCT00658606|7266172|FG000|Overall Study|Lack of Efficacy|6
4472039|NCT00658606|7266173|FG001|Overall Study|Lack of Efficacy|3
4472040|NCT00658606|7266172|FG000|Overall Study|Lost to Follow-up|1
4472041|NCT00658606|7266173|FG001|Overall Study|Lost to Follow-up|0
4472042|NCT00658606|7266172|FG000|Overall Study|Withdrawal by Subject|7
4472043|NCT00658606|7266173|FG001|Overall Study|Withdrawal by Subject|16
4472044|NCT00658606|7266172|FG000|Overall Study|Lack of Compliance|0
4472045|NCT00658606|7266173|FG001|Overall Study|Lack of Compliance|3
4472046|NCT00658632|7266199|FG000|Overall Study|Adverse Event|13
4472047|NCT00658632|7266200|FG001|Overall Study|Adverse Event|11
4472048|NCT00658632|7266199|FG000|Overall Study|Lost to Follow-up|25
4472049|NCT00658632|7266200|FG001|Overall Study|Lost to Follow-up|23
4472050|NCT00658632|7266199|FG000|Overall Study|Withdrawal by Subject|10
4472051|NCT00658632|7266200|FG001|Overall Study|Withdrawal by Subject|7
4472052|NCT00658632|7266199|FG000|Overall Study|Lack of Efficacy|0
4472053|NCT00658632|7266200|FG001|Overall Study|Lack of Efficacy|1
4472054|NCT00658632|7266199|FG000|Overall Study|Withdrawal of consent|8
4472055|NCT00658632|7266200|FG001|Overall Study|Withdrawal of consent|14
4472056|NCT00658632|7266199|FG000|Overall Study|Pregnancy|1
4472057|NCT00658632|7266200|FG001|Overall Study|Pregnancy|1
4472058|NCT00658632|7266199|FG000|Overall Study|Other|7
4589067|NCT01507831|7434021|FG001|Overall Study|Adverse Event|113
4589068|NCT01507831|7434020|FG000|Overall Study|Death|6
4589069|NCT01507831|7434021|FG001|Overall Study|Death|2
4589070|NCT01507831|7434020|FG000|Overall Study|Poor compliance to protocol|38
4589071|NCT01507831|7434021|FG001|Overall Study|Poor compliance to protocol|60
4472059|NCT00658632|7266200|FG001|Overall Study|Other|8
4472060|NCT00658658|7266211|FG000|Overall Study|Withdrawal by Subject|0
4472061|NCT00658658|7266212|FG001|Overall Study|Withdrawal by Subject|1
4472062|NCT00658658|7266213|FG002|Overall Study|Withdrawal by Subject|0
4472063|NCT00658658|7266214|FG003|Overall Study|Withdrawal by Subject|0
4472064|NCT00658658|7266215|FG004|Overall Study|Withdrawal by Subject|0
4472065|NCT00658658|7266211|FG000|Overall Study|Death|4
4472066|NCT00658658|7266212|FG001|Overall Study|Death|0
4472067|NCT00658658|7266213|FG002|Overall Study|Death|0
4472068|NCT00658658|7266214|FG003|Overall Study|Death|1
4472069|NCT00658658|7266215|FG004|Overall Study|Death|1
4472070|NCT00658658|7266211|FG000|Overall Study|Disease Progression|0
4472071|NCT00658658|7266212|FG001|Overall Study|Disease Progression|1
4472072|NCT00658658|7266213|FG002|Overall Study|Disease Progression|0
4472073|NCT00658658|7266214|FG003|Overall Study|Disease Progression|1
4472074|NCT00658658|7266215|FG004|Overall Study|Disease Progression|3
4472075|NCT00658658|7266211|FG000|Overall Study|Protocol-specified Criteria|1
4472076|NCT00658658|7266212|FG001|Overall Study|Protocol-specified Criteria|0
4472077|NCT00658658|7266213|FG002|Overall Study|Protocol-specified Criteria|0
4472078|NCT00658658|7266214|FG003|Overall Study|Protocol-specified Criteria|0
4472079|NCT00658658|7266215|FG004|Overall Study|Protocol-specified Criteria|0
4472080|NCT00658658|7266211|FG000|Overall Study|Other|0
4472081|NCT00658658|7266212|FG001|Overall Study|Other|0
4472082|NCT00658658|7266213|FG002|Overall Study|Other|0
4472083|NCT00658658|7266214|FG003|Overall Study|Other|0
4472084|NCT00658658|7266215|FG004|Overall Study|Other|1
4472085|NCT00658684|7266230|FG000|Overall Study|Adverse Event|10
4472086|NCT00658684|7266231|FG001|Overall Study|Adverse Event|8
4472087|NCT00658684|7266232|FG002|Overall Study|Adverse Event|2
4472088|NCT00658684|7266233|FG003|Overall Study|Adverse Event|0
4472089|NCT00658684|7266230|FG000|Overall Study|Withdrawal by Subject|6
4472090|NCT00658684|7266231|FG001|Overall Study|Withdrawal by Subject|4
4472091|NCT00658684|7266232|FG002|Overall Study|Withdrawal by Subject|1
4472092|NCT00658684|7266233|FG003|Overall Study|Withdrawal by Subject|1
4472093|NCT00658684|7266230|FG000|Overall Study|Lack of Efficacy|1
4472094|NCT00658684|7266231|FG001|Overall Study|Lack of Efficacy|1
4472095|NCT00658684|7266232|FG002|Overall Study|Lack of Efficacy|0
4472096|NCT00658684|7266233|FG003|Overall Study|Lack of Efficacy|0
4472097|NCT00658684|7266230|FG000|Overall Study|Protocol Violation|1
4472098|NCT00658684|7266231|FG001|Overall Study|Protocol Violation|1
4472099|NCT00658684|7266232|FG002|Overall Study|Protocol Violation|0
4472100|NCT00658684|7266233|FG003|Overall Study|Protocol Violation|0
4472101|NCT00658684|7266230|FG000|Overall Study|Pregnancy|1
4472102|NCT00658684|7266231|FG001|Overall Study|Pregnancy|1
4472103|NCT00658684|7266232|FG002|Overall Study|Pregnancy|0
4472104|NCT00658684|7266233|FG003|Overall Study|Pregnancy|0
4472105|NCT00658723|7266251|FG000|Overall Study|Lost to Follow-up|0
4472106|NCT00658723|7266252|FG001|Overall Study|Lost to Follow-up|2
4472107|NCT00658723|7266253|FG002|Overall Study|Lost to Follow-up|2
4472108|NCT00658723|7266251|FG000|Overall Study|Death|2
4472109|NCT00658723|7266252|FG001|Overall Study|Death|1
4472110|NCT00658723|7266253|FG002|Overall Study|Death|4
4472111|NCT00658723|7266251|FG000|Overall Study|Scheduling Issue|1
4472112|NCT00658723|7266252|FG001|Overall Study|Scheduling Issue|1
4472113|NCT00658723|7266253|FG002|Overall Study|Scheduling Issue|0
4472114|NCT00658723|7266251|FG000|Overall Study|Withdrawal by Subject|1
4472115|NCT00658723|7266252|FG001|Overall Study|Withdrawal by Subject|0
4472116|NCT00658723|7266253|FG002|Overall Study|Withdrawal by Subject|1
4472117|NCT00658775|7266275|FG000|Overall Study|Adverse Event|4
4472118|NCT00658775|7266276|FG001|Overall Study|Adverse Event|6
4472119|NCT00658775|7266275|FG000|Overall Study|Lost to Follow-up|17
4472120|NCT00658775|7266276|FG001|Overall Study|Lost to Follow-up|18
4472121|NCT00658775|7266275|FG000|Overall Study|Withdrawal by Subject|6
4472122|NCT00658775|7266276|FG001|Overall Study|Withdrawal by Subject|4
4472123|NCT00658775|7266275|FG000|Overall Study|Withdrawal of consent|8
4472124|NCT00658775|7266276|FG001|Overall Study|Withdrawal of consent|7
4472125|NCT00658775|7266275|FG000|Overall Study|Other|7
4472126|NCT00658775|7266276|FG001|Overall Study|Other|8
4472127|NCT00658788|7266282|FG000|Overall Study|Adverse Event|11
4472128|NCT00658788|7266282|FG000|Overall Study|Withdrawal by Subject|13
4472129|NCT00658788|7266282|FG000|Overall Study|Lost to Follow-up|18
4472130|NCT00658788|7266282|FG000|Overall Study|Treatment Discontinuation|32
4472131|NCT00658879|7266295|FG000|Overall Study|Protocol Violation|1
4472132|NCT00658996|7266299|FG000|First Intervention|Positive slit lamp finding|1
4472133|NCT00658996|7266300|FG001|First Intervention|Positive slit lamp finding|0
4472134|NCT00658996|7266299|FG000|First Intervention|Lack of lenses|0
4472135|NCT00658996|7266300|FG001|First Intervention|Lack of lenses|1
4472136|NCT00658996|7266299|FG000|Crossover Period|Physician Decision|1
4472137|NCT00658996|7266300|FG001|Crossover Period|Physician Decision|0
4472138|NCT00658996|7266299|FG000|Crossover Period|Ineligible|1
4472139|NCT00658996|7266300|FG001|Crossover Period|Ineligible|1
4472140|NCT00658996|7266299|FG000|Second Intervention|Developed a stye on upper lid|1
4472141|NCT00658996|7266300|FG001|Second Intervention|Developed a stye on upper lid|0
4472142|NCT00658996|7266299|FG000|Second Intervention|Positive slit lamp finding|0
4472143|NCT00658996|7266300|FG001|Second Intervention|Positive slit lamp finding|1
4472144|NCT00659230|7266317|FG000|Overall Study|Lost to Follow-up|2
4472145|NCT00659230|7266318|FG001|Overall Study|Lost to Follow-up|5
4472146|NCT00659230|7266317|FG000|Overall Study|Lost source documentation|5
4472147|NCT00659230|7266318|FG001|Overall Study|Lost source documentation|4
4472148|NCT00659230|7266317|FG000|Overall Study|Did not return post-randomization|2
4472149|NCT00659230|7266318|FG001|Overall Study|Did not return post-randomization|3
4472150|NCT00659269|7266326|FG000|Overall Study|Physician Decision|1
4472151|NCT00659269|7266327|FG001|Overall Study|Physician Decision|1
4472152|NCT00659334|7266358|FG000|Overall Study|Screen Failure|8
4472153|NCT00659334|7266359|FG001|Overall Study|Screen Failure|5
4472154|NCT00659334|7266360|FG002|Overall Study|Screen Failure|0
4472155|NCT00659334|7266361|FG003|Overall Study|Screen Failure|0
4472156|NCT00659334|7266362|FG004|Overall Study|Screen Failure|0
4472157|NCT00659334|7266363|FG005|Overall Study|Screen Failure|0
4472158|NCT00659334|7266364|FG006|Overall Study|Screen Failure|1
4472159|NCT00659373|7266388|FG000|Overall Study|Withdrawal by Subject|3
4472160|NCT00659373|7266389|FG001|Overall Study|Withdrawal by Subject|5
4472161|NCT00659373|7266388|FG000|Overall Study|Assessment Missed|2
4472162|NCT00659373|7266389|FG001|Overall Study|Assessment Missed|2
4472163|NCT00659425|7266405|FG000|Overall Study|Disease progression|1
4472164|NCT00659425|7266406|FG001|Overall Study|Disease progression|0
4472165|NCT00659425|7266407|FG002|Overall Study|Disease progression|0
4472166|NCT00659425|7266408|FG003|Overall Study|Disease progression|1
4472167|NCT00659425|7266409|FG004|Overall Study|Disease progression|0
4472168|NCT00659425|7266410|FG005|Overall Study|Disease progression|2
4472169|NCT00659425|7266411|FG006|Overall Study|Disease progression|4
4472170|NCT00659425|7266412|FG007|Overall Study|Disease progression|3
4472171|NCT00659425|7266413|FG008|Overall Study|Disease progression|5
4472172|NCT00659425|7266414|FG009|Overall Study|Disease progression|3
4472173|NCT00659425|7266405|FG000|Overall Study|Death|0
4472174|NCT00659425|7266406|FG001|Overall Study|Death|0
4472175|NCT00659425|7266407|FG002|Overall Study|Death|0
4472176|NCT00659425|7266408|FG003|Overall Study|Death|1
4472177|NCT00659425|7266409|FG004|Overall Study|Death|0
4472178|NCT00659425|7266410|FG005|Overall Study|Death|0
4472179|NCT00659425|7266411|FG006|Overall Study|Death|1
4472180|NCT00659425|7266412|FG007|Overall Study|Death|0
4472181|NCT00659425|7266413|FG008|Overall Study|Death|0
4472182|NCT00659425|7266414|FG009|Overall Study|Death|0
4472183|NCT00659425|7266405|FG000|Overall Study|Adverse Event|0
4472184|NCT00659425|7266406|FG001|Overall Study|Adverse Event|0
4472185|NCT00659425|7266407|FG002|Overall Study|Adverse Event|0
4472186|NCT00659425|7266408|FG003|Overall Study|Adverse Event|0
4472187|NCT00659425|7266409|FG004|Overall Study|Adverse Event|0
4472188|NCT00659425|7266410|FG005|Overall Study|Adverse Event|1
4472189|NCT00659425|7266411|FG006|Overall Study|Adverse Event|0
4472190|NCT00659425|7266412|FG007|Overall Study|Adverse Event|3
4472191|NCT00659425|7266413|FG008|Overall Study|Adverse Event|1
4472192|NCT00659425|7266414|FG009|Overall Study|Adverse Event|4
4472193|NCT00659425|7266405|FG000|Overall Study|Investigator Discretion|0
4472194|NCT00659425|7266406|FG001|Overall Study|Investigator Discretion|0
4472195|NCT00659425|7266407|FG002|Overall Study|Investigator Discretion|0
4472196|NCT00659425|7266408|FG003|Overall Study|Investigator Discretion|0
4472197|NCT00659425|7266409|FG004|Overall Study|Investigator Discretion|0
4472198|NCT00659425|7266410|FG005|Overall Study|Investigator Discretion|1
4472199|NCT00659425|7266411|FG006|Overall Study|Investigator Discretion|0
4472200|NCT00659425|7266412|FG007|Overall Study|Investigator Discretion|3
4472201|NCT00659425|7266413|FG008|Overall Study|Investigator Discretion|0
4472202|NCT00659425|7266414|FG009|Overall Study|Investigator Discretion|0
4472203|NCT00659425|7266405|FG000|Overall Study|Other|0
4472204|NCT00659425|7266406|FG001|Overall Study|Other|1
4472205|NCT00659425|7266407|FG002|Overall Study|Other|1
4472206|NCT00659425|7266408|FG003|Overall Study|Other|2
4472207|NCT00659425|7266409|FG004|Overall Study|Other|4
4472208|NCT00659425|7266410|FG005|Overall Study|Other|0
4472209|NCT00659425|7266411|FG006|Overall Study|Other|3
4472210|NCT00659425|7266412|FG007|Overall Study|Other|2
4472211|NCT00659425|7266413|FG008|Overall Study|Other|0
4472212|NCT00659425|7266414|FG009|Overall Study|Other|6
4472213|NCT00659438|7266451|FG000|Overall Study|Withdrawal by Subject|2
4472214|NCT00659438|7266452|FG001|Overall Study|Withdrawal by Subject|2
4472215|NCT00659438|7266451|FG000|Overall Study|Death|11
4472216|NCT00659438|7266452|FG001|Overall Study|Death|6
4472217|NCT00659438|7266451|FG000|Overall Study|Lost to Follow-up|1
4472218|NCT00659438|7266452|FG001|Overall Study|Lost to Follow-up|0
4516546|NCT00960531|7327982|FG007|Overall Study|Failed to Return|2
4516547|NCT00960531|7327983|FG008|Overall Study|Failed to Return|0
4516548|NCT00960531|7327984|FG009|Overall Study|Failed to Return|0
4516549|NCT00960531|7327975|FG000|Overall Study|Adverse Event (AE)|2
4516550|NCT00960531|7327976|FG001|Overall Study|Adverse Event (AE)|0
4516551|NCT00960531|7327977|FG002|Overall Study|Adverse Event (AE)|0
4516552|NCT00960531|7327978|FG003|Overall Study|Adverse Event (AE)|0
4516553|NCT00960531|7327979|FG004|Overall Study|Adverse Event (AE)|0
4516554|NCT00960531|7327980|FG005|Overall Study|Adverse Event (AE)|1
4589072|NCT01507831|7434020|FG000|Overall Study|Physician Decision|0
4589073|NCT01507831|7434021|FG001|Overall Study|Physician Decision|4
4589074|NCT01507831|7434020|FG000|Overall Study|Participant moved|5
4589075|NCT01507831|7434021|FG001|Overall Study|Participant moved|19
4589076|NCT01507831|7434020|FG000|Overall Study|Consent withdrawn by participant|34
4589077|NCT01507831|7434021|FG001|Overall Study|Consent withdrawn by participant|72
4589078|NCT01507831|7434020|FG000|Overall Study|Related to study drug administration|5
4589079|NCT01507831|7434021|FG001|Overall Study|Related to study drug administration|14
4516555|NCT00960531|7327981|FG006|Overall Study|Adverse Event (AE)|2
4516556|NCT00960531|7327982|FG007|Overall Study|Adverse Event (AE)|0
4516557|NCT00960531|7327983|FG008|Overall Study|Adverse Event (AE)|2
4516558|NCT00960531|7327984|FG009|Overall Study|Adverse Event (AE)|0
4516559|NCT00960531|7327975|FG000|Overall Study|Reason not Specified|2
4516560|NCT00960531|7327976|FG001|Overall Study|Reason not Specified|1
4516561|NCT00960531|7327977|FG002|Overall Study|Reason not Specified|13
4516562|NCT00960531|7327978|FG003|Overall Study|Reason not Specified|1
4516563|NCT00960531|7327979|FG004|Overall Study|Reason not Specified|2
4516564|NCT00960531|7327980|FG005|Overall Study|Reason not Specified|0
4516565|NCT00960531|7327981|FG006|Overall Study|Reason not Specified|16
4516566|NCT00960531|7327982|FG007|Overall Study|Reason not Specified|0
4516567|NCT00960531|7327983|FG008|Overall Study|Reason not Specified|8
4516568|NCT00960531|7327984|FG009|Overall Study|Reason not Specified|1
4516569|NCT00960570|7328010|FG000|21 Day Washout Period|Adverse Event|1
4516570|NCT00960570|7328010|FG000|21 Day Washout Period|Withdrawal by Subject|1
4516571|NCT00960570|7328010|FG000|1 Day Period Between Dosing|Adverse Event|2
4516572|NCT00960570|7328010|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1
4516573|NCT00960661|7328028|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6
4516574|NCT00960661|7328029|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0
4516575|NCT00960661|7328030|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0
4516576|NCT00960661|7328028|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4
4516577|NCT00960661|7328029|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0
4516578|NCT00960661|7328030|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0
4516579|NCT00960661|7328028|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331
4516580|NCT00960661|7328029|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0
4516581|NCT00960661|7328030|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0
4516582|NCT00960661|7328028|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47
4516583|NCT00960661|7328029|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0
4472219|NCT00659490|7266461|FG000|Overall Study|Lost to Follow-up|2
4472220|NCT00659490|7266462|FG001|Overall Study|Lost to Follow-up|0
4472221|NCT00659490|7266463|FG002|Overall Study|Lost to Follow-up|1
4472222|NCT00659529|7266471|FG000|Overall Study|Withdrawal by Subject|4
4472223|NCT00659529|7266471|FG000|Overall Study|Protocol Violation|3
4472224|NCT00659529|7266471|FG000|Overall Study|Screen failure|9
4472225|NCT00659581|7266475|FG000|Overall Study|Adverse Event|1006
4472226|NCT00659581|7266475|FG000|Overall Study|Lack of Efficacy|1183
4472227|NCT00659581|7266475|FG000|Overall Study|Other|6393
4472228|NCT00659607|7266479|FG000|Overall Study|No blood pressure recorded|147
4472229|NCT00659607|7266479|FG000|Overall Study|Unknown measuring date of blood pressure|85
4472230|NCT00659607|7266479|FG000|Overall Study|'Unable to evaluate' for the final asses|67
4472231|NCT00659607|7266479|FG000|Overall Study|No recorded efficacy data|15
4472232|NCT00659607|7266479|FG000|Overall Study|Inconsistent BP measuring date|2
4472233|NCT00659815|7266528|FG000|Overall Study|Study related symptoms and complaints|2
4472234|NCT00659815|7266529|FG001|Overall Study|Study related symptoms and complaints|1
4472235|NCT00659815|7266528|FG000|Overall Study|Inability to maintain wearing schedule|1
4472236|NCT00659815|7266529|FG001|Overall Study|Inability to maintain wearing schedule|2
4472237|NCT00659815|7266528|FG000|Overall Study|Withdrawal by Subject|1
4472238|NCT00659815|7266529|FG001|Overall Study|Withdrawal by Subject|1
4472239|NCT00659880|7266539|FG000|Overall Study|Lost to Follow-up|5
4472240|NCT00659984|7266553|FG000|Overall Study|Adverse Event|1
4472241|NCT00660010|7266563|FG000|Overall Study|Withdrawal by Subject|2
4472242|NCT00660010|7266563|FG000|Overall Study|Lost to Follow-up|3
4472243|NCT00660010|7266563|FG000|Overall Study|Adverse Event|1
4472244|NCT00660010|7266563|FG000|Overall Study|Noncompliance with visit schedule|3
4472245|NCT00660023|7266567|FG000|Overall Study|Adverse Event|2
4472246|NCT00660023|7266567|FG000|Overall Study|Death|8
4472247|NCT00660023|7266567|FG000|Overall Study|Blood Transfusion|5
4472248|NCT00660023|7266567|FG000|Overall Study|Renal Transplantation|3
4472249|NCT00660023|7266567|FG000|Overall Study|Withdrawal by Subject|1
4472250|NCT00660023|7266567|FG000|Overall Study|Missed Pregnancy Test|1
4472251|NCT00660023|7266567|FG000|Overall Study|Other Screening Failure|9
4472252|NCT00660179|7266587|FG000|Overall Study|Death|44
4472253|NCT00660179|7266588|FG001|Overall Study|Death|47
4472254|NCT00660179|7266589|FG002|Overall Study|Death|34
4472255|NCT00660179|7266587|FG000|Overall Study|Withdrawal of consent|4
4472256|NCT00660179|7266588|FG001|Overall Study|Withdrawal of consent|6
4472257|NCT00660179|7266589|FG002|Overall Study|Withdrawal of consent|4
4472258|NCT00660179|7266587|FG000|Overall Study|Lost to Follow-up|7
4472259|NCT00660179|7266588|FG001|Overall Study|Lost to Follow-up|5
4472260|NCT00660179|7266589|FG002|Overall Study|Lost to Follow-up|2
4472261|NCT00660179|7266587|FG000|Overall Study|Administrative reason|0
4472262|NCT00660179|7266588|FG001|Overall Study|Administrative reason|0
4472263|NCT00660179|7266589|FG002|Overall Study|Administrative reason|1
4472264|NCT00660179|7266587|FG000|Overall Study|Incorrect randomization|1
4472265|NCT00660179|7266588|FG001|Overall Study|Incorrect randomization|0
4472266|NCT00660179|7266589|FG002|Overall Study|Incorrect randomization|0
4472267|NCT00660192|7266599|FG000|Overall Study|Lost to Follow-up|2
4472268|NCT00660192|7266600|FG001|Overall Study|Lost to Follow-up|3
4472269|NCT00660309|7266608|FG000|Overall Study|Adverse Event|2
4472270|NCT00660309|7266609|FG001|Overall Study|Adverse Event|0
4472271|NCT00660309|7266608|FG000|Overall Study|Withdrawal by Subject|0
4472272|NCT00660309|7266609|FG001|Overall Study|Withdrawal by Subject|3
4472273|NCT00660387|7266618|FG000|Overall Study|Adverse Event|1
4472274|NCT00660387|7266619|FG001|Overall Study|Adverse Event|2
4472275|NCT00660387|7266618|FG000|Overall Study|Lack of Efficacy|0
4472276|NCT00660387|7266619|FG001|Overall Study|Lack of Efficacy|1
4472277|NCT00660387|7266618|FG000|Overall Study|Protocol Violation|1
4472278|NCT00660387|7266619|FG001|Overall Study|Protocol Violation|0
4472279|NCT00660400|7266625|FG000|Overall Study|Lack of insurance approval|1
4472280|NCT00660400|7266625|FG000|Overall Study|Suboptimal organ function|1
4472281|NCT00660400|7266625|FG000|Overall Study|Intracranial hemorrhage|1
4472282|NCT00660400|7266625|FG000|Overall Study|Withdrawal by Subject|1
4472283|NCT00660660|7266673|FG000|Overall Study|Adverse Event|1
4472284|NCT00660660|7266674|FG001|Overall Study|Adverse Event|0
4472285|NCT00660660|7266673|FG000|Overall Study|Lost to Follow-up|0
4472286|NCT00660660|7266674|FG001|Overall Study|Lost to Follow-up|6
4472287|NCT00660660|7266673|FG000|Overall Study|Lack of Efficacy|0
4589080|NCT01507831|7434020|FG000|Overall Study|Last visit outside protocol visit window|51
4472288|NCT00660660|7266674|FG001|Overall Study|Lack of Efficacy|2
4472289|NCT00660660|7266673|FG000|Overall Study|Withdrawal by Subject|3
4472290|NCT00660660|7266674|FG001|Overall Study|Withdrawal by Subject|0
4472291|NCT00660660|7266673|FG000|Overall Study|Incorrect enrollment and other|0
4472292|NCT00660660|7266674|FG001|Overall Study|Incorrect enrollment and other|1
4472293|NCT00660660|7266673|FG000|Overall Study|New medication after randomization|1
4472294|NCT00660660|7266674|FG001|Overall Study|New medication after randomization|0
4472295|NCT00660699|7266680|FG000|Overall Study|Withdrawal by Subject|2
4472296|NCT00660790|7266684|FG000|Baseline to 3 Months|Death|1
4472297|NCT00660790|7266684|FG000|Baseline to 3 Months|Withdrawal by Subject|2
4472298|NCT00660790|7266684|FG000|3 Months to 2 Years|Withdrawal by Subject|17
4472299|NCT00660816|7266690|FG000|Overall Study|Adverse Event|1
4472300|NCT00660816|7266691|FG001|Overall Study|Adverse Event|2
4589081|NCT01507831|7434021|FG001|Overall Study|Last visit outside protocol visit window|143
4589082|NCT01507831|7434020|FG000|Overall Study|Selection criteria finally not met|0
4589083|NCT01507831|7434021|FG001|Overall Study|Selection criteria finally not met|1
4589084|NCT01507831|7434020|FG000|Overall Study|Site closure|0
4472301|NCT00660816|7266690|FG000|Overall Study|Withdrawal by Subject|1
4472302|NCT00660816|7266691|FG001|Overall Study|Withdrawal by Subject|0
4472303|NCT00660816|7266690|FG000|Overall Study|Death|0
4472304|NCT00660816|7266691|FG001|Overall Study|Death|2
4472305|NCT00660816|7266690|FG000|Overall Study|Lack of Efficacy|1
4472306|NCT00660816|7266691|FG001|Overall Study|Lack of Efficacy|0
4472307|NCT00660816|7266690|FG000|Overall Study|Physician Decision|0
4472308|NCT00660816|7266691|FG001|Overall Study|Physician Decision|2
4472309|NCT00660816|7266690|FG000|Overall Study|Protocol Violation|1
4472310|NCT00660816|7266691|FG001|Overall Study|Protocol Violation|0
4472311|NCT00660816|7266690|FG000|Overall Study|Disease Progression|16
4472312|NCT00660816|7266691|FG001|Overall Study|Disease Progression|12
4472313|NCT00660816|7266690|FG000|Overall Study|Complicating Disease|0
4472314|NCT00660816|7266691|FG001|Overall Study|Complicating Disease|1
4472315|NCT00660829|7266699|FG000|Overall Study|Adverse Event|3
4472316|NCT00660829|7266700|FG001|Overall Study|Adverse Event|4
4472317|NCT00660829|7266699|FG000|Overall Study|Lack of Efficacy|2
4472318|NCT00660829|7266700|FG001|Overall Study|Lack of Efficacy|3
4472319|NCT00660829|7266699|FG000|Overall Study|Non-Compliance|0
4472320|NCT00660829|7266700|FG001|Overall Study|Non-Compliance|4
4472321|NCT00660829|7266699|FG000|Overall Study|Withdrawal by Subject|1
4472322|NCT00660829|7266700|FG001|Overall Study|Withdrawal by Subject|2
4472323|NCT00660829|7266699|FG000|Overall Study|Lost to Follow-up|3
4472324|NCT00660829|7266700|FG001|Overall Study|Lost to Follow-up|2
4472325|NCT00660829|7266699|FG000|Overall Study|Other|9
4472326|NCT00660829|7266700|FG001|Overall Study|Other|4
4472327|NCT00660907|7266708|FG000|Overall Study|Incorrect Enrollment|1
4472328|NCT00660907|7266709|FG001|Overall Study|Incorrect Enrollment|1
4472329|NCT00660907|7266708|FG000|Overall Study|Adverse Event|33
4472330|NCT00660907|7266709|FG001|Overall Study|Adverse Event|19
4472331|NCT00660907|7266708|FG000|Overall Study|Subject No Longer Meets Study Criteria|6
4472332|NCT00660907|7266709|FG001|Overall Study|Subject No Longer Meets Study Criteria|27
4472333|NCT00660907|7266708|FG000|Overall Study|Withdrawal by Subject|23
4472334|NCT00660907|7266709|FG001|Overall Study|Withdrawal by Subject|32
4472335|NCT00660907|7266708|FG000|Overall Study|Lost to Follow-up|3
4472336|NCT00660907|7266709|FG001|Overall Study|Lost to Follow-up|3
4472337|NCT00660907|7266708|FG000|Overall Study|Poor/Non-Compliance|5
4472338|NCT00660907|7266709|FG001|Overall Study|Poor/Non-Compliance|1
4472339|NCT00660907|7266708|FG000|Overall Study|Safety|1
4472340|NCT00660907|7266709|FG001|Overall Study|Safety|0
4472341|NCT00660907|7266708|FG000|Overall Study|Death|1
4472342|NCT00660907|7266709|FG001|Overall Study|Death|3
4472343|NCT00660907|7266708|FG000|Overall Study|Various|11
4472344|NCT00660907|7266709|FG001|Overall Study|Various|8
4472345|NCT00661089|7266737|FG000|Overall Study|1 subject withdrawal|0
4472346|NCT00661089|7266738|FG001|Overall Study|1 subject withdrawal|1
4472347|NCT00661089|7266737|FG000|Overall Study|death at 8 weeks due to new stroke|0
4472348|NCT00661089|7266738|FG001|Overall Study|death at 8 weeks due to new stroke|1
4472349|NCT00661193|7266774|FG000|Overall Study|Adverse Event|2
4472350|NCT00661193|7266775|FG001|Overall Study|Adverse Event|1
4472351|NCT00661193|7266774|FG000|Overall Study|Withdrawal by Subject|3
4472352|NCT00661193|7266775|FG001|Overall Study|Withdrawal by Subject|1
4472353|NCT00661193|7266774|FG000|Overall Study|Progression|27
4472354|NCT00661193|7266775|FG001|Overall Study|Progression|24
4472355|NCT00661193|7266774|FG000|Overall Study|Not protocol specified|1
4472356|NCT00661193|7266775|FG001|Overall Study|Not protocol specified|0
4472357|NCT00661258|7266783|FG000|Overall Study|Death|1
4472358|NCT00661258|7266784|FG001|Overall Study|Death|0
4472359|NCT00661258|7266783|FG000|Overall Study|caught by police and in detox center|2
4472360|NCT00661258|7266784|FG001|Overall Study|caught by police and in detox center|1
4472361|NCT00661271|7266792|FG000|Overall Study|Lost to Follow-up|28
4472362|NCT00661271|7266793|FG001|Overall Study|Lost to Follow-up|25
4472363|NCT00661362|7266801|FG000|Overall Study|Adverse Event|5
4472364|NCT00661362|7266802|FG001|Overall Study|Adverse Event|4
4472365|NCT00661362|7266801|FG000|Overall Study|Incorrect enrollment|2
4472366|NCT00661362|7266802|FG001|Overall Study|Incorrect enrollment|0
4472367|NCT00661362|7266801|FG000|Overall Study|Study specific discontinuation criteria|4
4472368|NCT00661362|7266802|FG001|Overall Study|Study specific discontinuation criteria|11
4472369|NCT00661362|7266801|FG000|Overall Study|Withdrawal by Subject|13
4472370|NCT00661362|7266802|FG001|Overall Study|Withdrawal by Subject|23
4472371|NCT00661362|7266801|FG000|Overall Study|Lost to Follow-up|3
4472372|NCT00661362|7266802|FG001|Overall Study|Lost to Follow-up|1
4472373|NCT00661362|7266801|FG000|Overall Study|Severe non-compliance to protocol|0
4472374|NCT00661362|7266802|FG001|Overall Study|Severe non-compliance to protocol|1
4472375|NCT00661362|7266801|FG000|Overall Study|Safety reasons|1
4472376|NCT00661362|7266802|FG001|Overall Study|Safety reasons|0
4472377|NCT00661362|7266801|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1
4472378|NCT00661362|7266802|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0
4472379|NCT00661388|7266808|FG000|Overall Study|Adverse Event|14
4472380|NCT00661388|7266808|FG000|Overall Study|Protocol Violation|7
4472381|NCT00661388|7266808|FG000|Overall Study|Renal transplantation|1
4472382|NCT00661388|7266808|FG000|Overall Study|Dialysis initiation|1
4472383|NCT00661388|7266808|FG000|Overall Study|Administrative reasons|1
4472384|NCT00661427|7266814|FG000|Overall Study|Adverse Event|5
4472385|NCT00661427|7266815|FG001|Overall Study|Adverse Event|5
4472386|NCT00661427|7266814|FG000|Overall Study|Patient not treated|0
4472387|NCT00661427|7266815|FG001|Overall Study|Patient not treated|2
4472388|NCT00661492|7266843|FG000|Overall Study|Adverse Event|16
4472389|NCT00661492|7266844|FG001|Overall Study|Adverse Event|13
4472390|NCT00661492|7266843|FG000|Overall Study|Disease Progression|44
4472391|NCT00661492|7266844|FG001|Overall Study|Disease Progression|14
4472392|NCT00661492|7266843|FG000|Overall Study|Patient Request|6
4472393|NCT00661492|7266844|FG001|Overall Study|Patient Request|1
4472394|NCT00661492|7266843|FG000|Overall Study|Investigator Request|1
4472395|NCT00661492|7266844|FG001|Overall Study|Investigator Request|0
4472396|NCT00661492|7266843|FG000|Overall Study|Lost to Follow-up|0
4472397|NCT00661492|7266844|FG001|Overall Study|Lost to Follow-up|1
4472398|NCT00661492|7266843|FG000|Overall Study|Other|1
4472399|NCT00661492|7266844|FG001|Overall Study|Other|0
4472400|NCT00661505|7266850|FG000|Overall Study|Adverse Event|3
4472401|NCT00661505|7266850|FG000|Overall Study|Protocol Violation|14
4472402|NCT00661505|7266850|FG000|Overall Study|Withdrawal by Subject|8
4472403|NCT00661505|7266850|FG000|Overall Study|Lost to Follow-up|3
4472404|NCT00661505|7266850|FG000|Overall Study|Other|2
4472405|NCT00661531|7266855|FG000|Overall Study|Withdrawal by Subject|3
4472406|NCT00661609|7266889|FG000|Overall Study|Adverse Event|4
4472407|NCT00661609|7266889|FG000|Overall Study|Death|20
4472408|NCT00661609|7266889|FG000|Overall Study|Withdrawal by Subject|2
4472409|NCT00661609|7266889|FG000|Overall Study|PI Decision|1
4472410|NCT00661609|7266889|FG000|Overall Study|Survival follow up stage discontinued|11
4472411|NCT00661609|7266889|FG000|Overall Study|Disease progression|3
4472412|NCT00661622|7266895|FG000|Overall Study|Protocol Violation|1
4472413|NCT00661622|7266896|FG001|Overall Study|Protocol Violation|0
4472414|NCT00661661|7266905|FG000|Overall Study|Adverse Event|99
4472415|NCT00661661|7266906|FG001|Overall Study|Adverse Event|24
4472416|NCT00661661|7266905|FG000|Overall Study|Lack of Efficacy|3
4472417|NCT00661661|7266906|FG001|Overall Study|Lack of Efficacy|2
4472418|NCT00661661|7266905|FG000|Overall Study|Lost to Follow-up|0
4472419|NCT00661661|7266906|FG001|Overall Study|Lost to Follow-up|1
4472420|NCT00661661|7266905|FG000|Overall Study|Withdrawal by Subject|15
4472421|NCT00661661|7266906|FG001|Overall Study|Withdrawal by Subject|5
4472422|NCT00661661|7266905|FG000|Overall Study|Other|22
4472423|NCT00661661|7266906|FG001|Overall Study|Other|7
4472424|NCT00661661|7266905|FG000|Overall Study|Not assigned treatment|1
4472425|NCT00661661|7266906|FG001|Overall Study|Not assigned treatment|0
4472426|NCT00661687|7266927|FG000|Overall Study|Study related symptoms and complaints|5
4472427|NCT00661687|7266927|FG000|Overall Study|Positive slit lamp findings|4
4472428|NCT00661687|7266927|FG000|Overall Study|Inability to maintain wearing schedule|3
4472429|NCT00661687|7266927|FG000|Overall Study|Physician Decision|1
4472430|NCT00661687|7266927|FG000|Overall Study|Adverse Event|2
4472431|NCT00661713|7266941|FG000|Overall Study|Death|1
4472432|NCT00661713|7266942|FG001|Overall Study|Death|0
4472433|NCT00661713|7266943|FG002|Overall Study|Death|0
4472434|NCT00661713|7266944|FG003|Overall Study|Death|0
4472435|NCT00661713|7266945|FG004|Overall Study|Death|1
4472436|NCT00661713|7266946|FG005|Overall Study|Death|0
4472437|NCT00661713|7266947|FG006|Overall Study|Death|0
4472438|NCT00661713|7266948|FG007|Overall Study|Death|0
4472439|NCT00661713|7266941|FG000|Overall Study|Unable to Classify|1
4472440|NCT00661713|7266942|FG001|Overall Study|Unable to Classify|0
4472441|NCT00661713|7266943|FG002|Overall Study|Unable to Classify|0
4472442|NCT00661713|7266944|FG003|Overall Study|Unable to Classify|0
4472443|NCT00661713|7266945|FG004|Overall Study|Unable to Classify|0
4472444|NCT00661713|7266946|FG005|Overall Study|Unable to Classify|0
4472445|NCT00661713|7266947|FG006|Overall Study|Unable to Classify|0
4472446|NCT00661713|7266948|FG007|Overall Study|Unable to Classify|0
4472447|NCT00661713|7266941|FG000|Overall Study|Protocol Violation|1
4472448|NCT00661713|7266942|FG001|Overall Study|Protocol Violation|6
4472449|NCT00661713|7266943|FG002|Overall Study|Protocol Violation|3
4472450|NCT00661713|7266944|FG003|Overall Study|Protocol Violation|3
4472451|NCT00661713|7266945|FG004|Overall Study|Protocol Violation|0
4472452|NCT00661713|7266946|FG005|Overall Study|Protocol Violation|2
4472453|NCT00661713|7266947|FG006|Overall Study|Protocol Violation|2
4472454|NCT00661713|7266948|FG007|Overall Study|Protocol Violation|1
4472455|NCT00661713|7266941|FG000|Overall Study|Withdrawal by Subject|11
4472456|NCT00661713|7266942|FG001|Overall Study|Withdrawal by Subject|25
4472457|NCT00661713|7266943|FG002|Overall Study|Withdrawal by Subject|12
4472458|NCT00661713|7266944|FG003|Overall Study|Withdrawal by Subject|21
4472459|NCT00661713|7266945|FG004|Overall Study|Withdrawal by Subject|12
4472460|NCT00661713|7266946|FG005|Overall Study|Withdrawal by Subject|26
4472461|NCT00661713|7266947|FG006|Overall Study|Withdrawal by Subject|45
4472462|NCT00661713|7266948|FG007|Overall Study|Withdrawal by Subject|9
4472463|NCT00661713|7266941|FG000|Overall Study|Lost to Follow-up|2
4472464|NCT00661713|7266942|FG001|Overall Study|Lost to Follow-up|7
4472465|NCT00661713|7266943|FG002|Overall Study|Lost to Follow-up|2
4472466|NCT00661713|7266944|FG003|Overall Study|Lost to Follow-up|2
4472467|NCT00661713|7266945|FG004|Overall Study|Lost to Follow-up|5
4472468|NCT00661713|7266946|FG005|Overall Study|Lost to Follow-up|7
4472469|NCT00661713|7266947|FG006|Overall Study|Lost to Follow-up|14
4472470|NCT00661713|7266948|FG007|Overall Study|Lost to Follow-up|1
4472471|NCT00661713|7266941|FG000|Overall Study|Administrative Reason|0
4472472|NCT00661713|7266942|FG001|Overall Study|Administrative Reason|1
4472473|NCT00661713|7266943|FG002|Overall Study|Administrative Reason|0
4472474|NCT00661713|7266944|FG003|Overall Study|Administrative Reason|2
4472475|NCT00661713|7266945|FG004|Overall Study|Administrative Reason|2
4472476|NCT00661713|7266946|FG005|Overall Study|Administrative Reason|2
4472477|NCT00661713|7266947|FG006|Overall Study|Administrative Reason|1
4472478|NCT00661713|7266948|FG007|Overall Study|Administrative Reason|0
4472479|NCT00661713|7266941|FG000|Overall Study|Adverse Event|0
4472480|NCT00661713|7266942|FG001|Overall Study|Adverse Event|0
4472481|NCT00661713|7266943|FG002|Overall Study|Adverse Event|0
4472482|NCT00661713|7266944|FG003|Overall Study|Adverse Event|0
4472483|NCT00661713|7266945|FG004|Overall Study|Adverse Event|0
4472484|NCT00661713|7266946|FG005|Overall Study|Adverse Event|0
4472485|NCT00661713|7266947|FG006|Overall Study|Adverse Event|1
4472486|NCT00661713|7266948|FG007|Overall Study|Adverse Event|0
4472487|NCT00661713|7266941|FG000|Overall Study|Inappropriate Enrollment|0
4472488|NCT00661713|7266942|FG001|Overall Study|Inappropriate Enrollment|0
4472489|NCT00661713|7266943|FG002|Overall Study|Inappropriate Enrollment|0
4472490|NCT00661713|7266944|FG003|Overall Study|Inappropriate Enrollment|0
4472491|NCT00661713|7266945|FG004|Overall Study|Inappropriate Enrollment|0
4472492|NCT00661713|7266946|FG005|Overall Study|Inappropriate Enrollment|0
4472493|NCT00661713|7266947|FG006|Overall Study|Inappropriate Enrollment|1
4472494|NCT00661713|7266948|FG007|Overall Study|Inappropriate Enrollment|0
4472495|NCT00661726|7266968|FG000|Overall Study|Adverse Event|1
4472496|NCT00661778|7266972|FG000|Overall Study|Disease Progression|23
4472497|NCT00661778|7266972|FG000|Overall Study|Adverse Event|18
4472498|NCT00661778|7266972|FG000|Overall Study|Reason not Specified|6
4472499|NCT00661778|7266972|FG000|Overall Study|Protocol Violation|2
4472500|NCT00661778|7266972|FG000|Overall Study|Withdrawal of Consent|1
4472501|NCT00661830|7266978|FG000|Overall Study|Death|37
4472502|NCT00661830|7266979|FG001|Overall Study|Death|33
4472503|NCT00661830|7266978|FG000|Overall Study|Lost to Follow-up|1
4472504|NCT00661830|7266979|FG001|Overall Study|Lost to Follow-up|3
4472505|NCT00661830|7266978|FG000|Overall Study|Withdrawal by Subject|1
4472506|NCT00661830|7266979|FG001|Overall Study|Withdrawal by Subject|1
4472507|NCT00661830|7266978|FG000|Overall Study|Other reason|1
4472508|NCT00661830|7266979|FG001|Overall Study|Other reason|5
4472509|NCT00661999|7267010|FG000|Overall Study|Adverse Event|11
4472510|NCT00661999|7267011|FG001|Overall Study|Adverse Event|5
4472511|NCT00661999|7267012|FG002|Overall Study|Adverse Event|8
4472512|NCT00661999|7267010|FG000|Overall Study|Death|8
4472513|NCT00661999|7267011|FG001|Overall Study|Death|6
4472514|NCT00661999|7267012|FG002|Overall Study|Death|3
4472515|NCT00661999|7267010|FG000|Overall Study|Other Reasons|5
4472516|NCT00661999|7267011|FG001|Overall Study|Other Reasons|12
4472517|NCT00661999|7267012|FG002|Overall Study|Other Reasons|23
4472518|NCT00661999|7267010|FG000|Overall Study|Withdrawal by Subject|30
4472519|NCT00661999|7267011|FG001|Overall Study|Withdrawal by Subject|23
4472520|NCT00661999|7267012|FG002|Overall Study|Withdrawal by Subject|14
4472521|NCT00661999|7267010|FG000|Overall Study|Alternative Treatment|1
4472522|NCT00661999|7267011|FG001|Overall Study|Alternative Treatment|0
4472523|NCT00661999|7267012|FG002|Overall Study|Alternative Treatment|0
4472524|NCT00661999|7267010|FG000|Overall Study|Other Medical Problems|4
4472525|NCT00661999|7267011|FG001|Overall Study|Other Medical Problems|4
4472526|NCT00661999|7267012|FG002|Overall Study|Other Medical Problems|9
4472527|NCT00662012|7267020|FG000|Overall Study|Lost to Follow-up|85
4472528|NCT00662012|7267020|FG000|Overall Study|Death|1
4472529|NCT00662012|7267020|FG000|Overall Study|Withdrawal by Subject|1
4472530|NCT00662025|7267024|FG000|Overall Study|Objective progression or relapse|51
4472531|NCT00662025|7267024|FG000|Overall Study|Adverse Event|7
4472532|NCT00662025|7267024|FG000|Overall Study|Withdrawal by Subject|1
4472533|NCT00662025|7267024|FG000|Overall Study|Results of other clinical study|2
4472534|NCT00662025|7267024|FG000|Overall Study|Target lesion cannot be evaluated|1
4472535|NCT00662025|7267024|FG000|Overall Study|Domestic circumstances|1
4472536|NCT00662038|7267028|FG000|Overall Study|Reason not specified|3
4472537|NCT00662038|7267028|FG000|Overall Study|Withdrawn consent|22
4472538|NCT00662038|7267028|FG000|Overall Study|Withdrawal by Subject|83
4472539|NCT00662038|7267028|FG000|Overall Study|Sponsor decision|1
4472540|NCT00662038|7267028|FG000|Overall Study|Physician Decision|19
4472541|NCT00662038|7267028|FG000|Overall Study|Lung transplantation|44
4472542|NCT00662038|7267028|FG000|Overall Study|Lost to Follow-up|1
4472543|NCT00662038|7267028|FG000|Overall Study|Death|95
4472544|NCT00662038|7267028|FG000|Overall Study|Adverse Event|358
4472545|NCT00662038|7267028|FG000|Overall Study|Continued treatment|5
4472546|NCT00662129|7267032|FG000|Overall Study|Protocol Violation|1
4472547|NCT00662129|7267032|FG000|Overall Study|Cancel prior to beginning treatment|1
4472548|NCT00662129|7267032|FG000|Overall Study|Ineligible|1
4472549|NCT00662259|7267059|FG000|Overall Study|Adverse Event|2
4472550|NCT00662259|7267060|FG001|Overall Study|Adverse Event|0
4472551|NCT00662311|7267073|FG000|Overall Study|Respiratory Infection|1
4472552|NCT00662311|7267074|FG001|Overall Study|Respiratory Infection|0
4472553|NCT00662311|7267075|FG002|Overall Study|Respiratory Infection|0
4472554|NCT00662363|7267085|FG000|Overall Study|Withdrawal by Subject|6
4472555|NCT00662363|7267086|FG001|Overall Study|Withdrawal by Subject|5
4472556|NCT00662363|7267085|FG000|Overall Study|Adverse Event|0
4472557|NCT00662363|7267086|FG001|Overall Study|Adverse Event|3
4472558|NCT00662363|7267085|FG000|Overall Study|Discharged early from rehab|4
4472559|NCT00662363|7267086|FG001|Overall Study|Discharged early from rehab|1
4472560|NCT00662363|7267085|FG000|Overall Study|Protocol Violation|1
4472561|NCT00662363|7267086|FG001|Overall Study|Protocol Violation|1
4472562|NCT00662532|7267096|FG000|Overall Study|Adverse Event|0
4472563|NCT00662532|7267097|FG001|Overall Study|Adverse Event|1
4472564|NCT00662532|7267096|FG000|Overall Study|Lost to Follow-up|0
4472565|NCT00662532|7267097|FG001|Overall Study|Lost to Follow-up|1
4472566|NCT00662558|7267114|FG000|Overall Study|Adverse Event|21
4472567|NCT00662558|7267115|FG001|Overall Study|Adverse Event|59
4472568|NCT00662558|7267114|FG000|Overall Study|Lack of Efficacy|4
4472569|NCT00662558|7267115|FG001|Overall Study|Lack of Efficacy|7
4472570|NCT00662558|7267114|FG000|Overall Study|Lost to Follow-up|13
4472571|NCT00662558|7267115|FG001|Overall Study|Lost to Follow-up|10
4472572|NCT00662558|7267114|FG000|Overall Study|Other|9
4472573|NCT00662558|7267115|FG001|Overall Study|Other|14
4472574|NCT00662558|7267114|FG000|Overall Study|Withdrawal by Subject|7
4472575|NCT00662558|7267115|FG001|Overall Study|Withdrawal by Subject|12
4472576|NCT00662558|7267114|FG000|Overall Study|Randomized But Did Not Receive Treatment|2
4472577|NCT00662558|7267115|FG001|Overall Study|Randomized But Did Not Receive Treatment|8
4472578|NCT00662649|7267125|FG000|Core Study (24 Months)|Withdrawal by Subject|31
4472579|NCT00662649|7267126|FG001|Core Study (24 Months)|Withdrawal by Subject|17
4472580|NCT00662649|7267127|FG002|Core Study (24 Months)|Withdrawal by Subject|28
4472581|NCT00662649|7267128|FG003|Core Study (24 Months)|Withdrawal by Subject|0
4472582|NCT00662649|7267129|FG004|Core Study (24 Months)|Withdrawal by Subject|0
4472583|NCT00662649|7267125|FG000|Core Study (24 Months)|Adverse Event|22
4472584|NCT00662649|7267126|FG001|Core Study (24 Months)|Adverse Event|13
4472585|NCT00662649|7267127|FG002|Core Study (24 Months)|Adverse Event|18
4472586|NCT00662649|7267128|FG003|Core Study (24 Months)|Adverse Event|0
4472587|NCT00662649|7267129|FG004|Core Study (24 Months)|Adverse Event|0
4472588|NCT00662649|7267125|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13
4472589|NCT00662649|7267126|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6
4472590|NCT00662649|7267127|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25
4472591|NCT00662649|7267128|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0
4472592|NCT00662649|7267129|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0
4472593|NCT00662649|7267125|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20
4472594|NCT00662649|7267126|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9
4472595|NCT00662649|7267127|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1
4472596|NCT00662649|7267128|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0
4472597|NCT00662649|7267129|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0
4472598|NCT00662649|7267125|FG000|Core Study (24 Months)|Lost to Follow-up|3
4472599|NCT00662649|7267126|FG001|Core Study (24 Months)|Lost to Follow-up|5
4472600|NCT00662649|7267127|FG002|Core Study (24 Months)|Lost to Follow-up|7
4472601|NCT00662649|7267128|FG003|Core Study (24 Months)|Lost to Follow-up|0
4472602|NCT00662649|7267129|FG004|Core Study (24 Months)|Lost to Follow-up|0
4472603|NCT00662649|7267125|FG000|Core Study (24 Months)|Protocol Violation|5
4472604|NCT00662649|7267126|FG001|Core Study (24 Months)|Protocol Violation|5
4472605|NCT00662649|7267127|FG002|Core Study (24 Months)|Protocol Violation|4
4472606|NCT00662649|7267128|FG003|Core Study (24 Months)|Protocol Violation|0
4472607|NCT00662649|7267129|FG004|Core Study (24 Months)|Protocol Violation|0
4472608|NCT00662649|7267125|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2
4472609|NCT00662649|7267126|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1
4472610|NCT00662649|7267127|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1
4472611|NCT00662649|7267128|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0
4472612|NCT00662649|7267129|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0
4472613|NCT00662649|7267125|FG000|Core Study (24 Months)|Death|1
4472614|NCT00662649|7267126|FG001|Core Study (24 Months)|Death|0
4472615|NCT00662649|7267127|FG002|Core Study (24 Months)|Death|2
4472616|NCT00662649|7267128|FG003|Core Study (24 Months)|Death|0
4472617|NCT00662649|7267129|FG004|Core Study (24 Months)|Death|0
4472618|NCT00662649|7267125|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10
4472619|NCT00662649|7267126|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5
4472620|NCT00662649|7267127|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0
4472621|NCT00662649|7267128|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8
4472622|NCT00662649|7267129|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3
4472623|NCT00662649|7267125|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3
4472624|NCT00662649|7267126|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1
4472625|NCT00662649|7267127|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0
4472626|NCT00662649|7267128|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1
4472627|NCT00662649|7267129|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3
4472628|NCT00662649|7267125|FG000|Extension Study (Month 24 to 60)|Administrative problems|0
4518752|NCT00976209|7331020|FG001|Wash-out Period|Lost to Follow-up|0
4472629|NCT00662649|7267126|FG001|Extension Study (Month 24 to 60)|Administrative problems|0
4472630|NCT00662649|7267127|FG002|Extension Study (Month 24 to 60)|Administrative problems|0
4472631|NCT00662649|7267128|FG003|Extension Study (Month 24 to 60)|Administrative problems|1
4472632|NCT00662649|7267129|FG004|Extension Study (Month 24 to 60)|Administrative problems|0
4472633|NCT00662649|7267125|FG000|Extension Study (Month 24 to 60)|Adverse Event|6
4472634|NCT00662649|7267126|FG001|Extension Study (Month 24 to 60)|Adverse Event|9
4472635|NCT00662649|7267127|FG002|Extension Study (Month 24 to 60)|Adverse Event|0
4698852|NCT02675634|7613833|FG003|Test Period 1|Adverse Event|1
4698853|NCT02675634|7613834|FG004|Test Period 1|Adverse Event|0
4698854|NCT02675634|7613835|FG005|Test Period 1|Adverse Event|0
4698855|NCT02675634|7613830|FG000|Test Period 1|Device deficiency that did not lead to A|0
4698856|NCT02675634|7613831|FG001|Test Period 1|Device deficiency that did not lead to A|0
4698857|NCT02675634|7613832|FG002|Test Period 1|Device deficiency that did not lead to A|1
4698858|NCT02675634|7613833|FG003|Test Period 1|Device deficiency that did not lead to A|0
4698859|NCT02675634|7613834|FG004|Test Period 1|Device deficiency that did not lead to A|0
4698860|NCT02675634|7613835|FG005|Test Period 1|Device deficiency that did not lead to A|0
4698861|NCT02675634|7613830|FG000|Test Period 2|Lack of Efficacy|1
4698862|NCT02675634|7613831|FG001|Test Period 2|Lack of Efficacy|0
4698863|NCT02675634|7613832|FG002|Test Period 2|Lack of Efficacy|0
4698864|NCT02675634|7613833|FG003|Test Period 2|Lack of Efficacy|0
4698865|NCT02675634|7613834|FG004|Test Period 2|Lack of Efficacy|0
4698866|NCT02675634|7613835|FG005|Test Period 2|Lack of Efficacy|0
4698867|NCT02675634|7613830|FG000|Test Period 2|Adverse Event|0
4698868|NCT02675634|7613831|FG001|Test Period 2|Adverse Event|0
4698869|NCT02675634|7613832|FG002|Test Period 2|Adverse Event|0
4698870|NCT02675634|7613833|FG003|Test Period 2|Adverse Event|0
4698871|NCT02675634|7613834|FG004|Test Period 2|Adverse Event|0
4698872|NCT02675634|7613835|FG005|Test Period 2|Adverse Event|1
4698873|NCT02675907|7613854|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4
4698874|NCT02675907|7613855|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4
4698875|NCT02675907|7613854|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1
4698876|NCT02675907|7613855|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1
4698877|NCT02675907|7613854|FG000|Study Overall|Lack of Efficacy|1
4698878|NCT02675907|7613855|FG001|Study Overall|Lack of Efficacy|0
4698879|NCT02675907|7613854|FG000|Study Overall|Withdrawal by Subject|2
4698880|NCT02675907|7613855|FG001|Study Overall|Withdrawal by Subject|2
4698881|NCT02675907|7613854|FG000|Study Overall|Lost to Follow-up|0
4698882|NCT02675907|7613855|FG001|Study Overall|Lost to Follow-up|2
4698883|NCT02675998|7613865|FG000|8-Week Treatment Period|Adverse Event|6
4698884|NCT02675998|7613866|FG001|8-Week Treatment Period|Adverse Event|5
4698885|NCT02675998|7613867|FG002|8-Week Treatment Period|Adverse Event|6
4698886|NCT02675998|7613868|FG003|8-Week Treatment Period|Adverse Event|0
4698887|NCT02675998|7613865|FG000|8-Week Treatment Period|Withdrawal by Subject|3
4698888|NCT02675998|7613866|FG001|8-Week Treatment Period|Withdrawal by Subject|3
4698889|NCT02675998|7613867|FG002|8-Week Treatment Period|Withdrawal by Subject|3
4698890|NCT02675998|7613868|FG003|8-Week Treatment Period|Withdrawal by Subject|0
4698891|NCT02675998|7613865|FG000|8-Week Treatment Period|Lack of Efficacy|2
4698892|NCT02675998|7613866|FG001|8-Week Treatment Period|Lack of Efficacy|5
4698893|NCT02675998|7613867|FG002|8-Week Treatment Period|Lack of Efficacy|3
4698894|NCT02675998|7613868|FG003|8-Week Treatment Period|Lack of Efficacy|0
4698895|NCT02675998|7613865|FG000|8-Week Treatment Period|Physician Decision|1
4698896|NCT02675998|7613866|FG001|8-Week Treatment Period|Physician Decision|0
4698897|NCT02675998|7613867|FG002|8-Week Treatment Period|Physician Decision|2
4698898|NCT02675998|7613868|FG003|8-Week Treatment Period|Physician Decision|0
4698899|NCT02675998|7613865|FG000|8-Week Treatment Period|GI side Effects|1
4698900|NCT02675998|7613866|FG001|8-Week Treatment Period|GI side Effects|4
4698901|NCT02675998|7613867|FG002|8-Week Treatment Period|GI side Effects|2
4698902|NCT02675998|7613868|FG003|8-Week Treatment Period|GI side Effects|0
4698903|NCT02675998|7613865|FG000|8-Week Treatment Period|Protocol Violation|1
4698904|NCT02675998|7613866|FG001|8-Week Treatment Period|Protocol Violation|1
4698905|NCT02675998|7613867|FG002|8-Week Treatment Period|Protocol Violation|1
4698906|NCT02675998|7613868|FG003|8-Week Treatment Period|Protocol Violation|0
4698907|NCT02675998|7613865|FG000|8-Week Treatment Period|Other|3
4698908|NCT02675998|7613866|FG001|8-Week Treatment Period|Other|1
4698909|NCT02675998|7613867|FG002|8-Week Treatment Period|Other|2
4698910|NCT02675998|7613868|FG003|8-Week Treatment Period|Other|0
4698911|NCT02675998|7613865|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0
4698912|NCT02675998|7613866|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1
4698913|NCT02675998|7613867|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1
4698914|NCT02675998|7613868|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3
4698915|NCT02675998|7613865|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0
4698916|NCT02675998|7613866|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0
4698917|NCT02675998|7613867|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1
4698918|NCT02675998|7613868|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3
4698919|NCT02675998|7613865|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0
4698920|NCT02675998|7613866|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0
4698921|NCT02675998|7613867|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0
4698922|NCT02675998|7613868|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1
4698923|NCT02675998|7613865|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1
4698924|NCT02675998|7613866|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0
4698925|NCT02675998|7613867|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0
4698926|NCT02675998|7613868|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0
4698927|NCT02675998|7613865|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0
4698928|NCT02675998|7613866|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0
4698929|NCT02675998|7613867|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0
4698930|NCT02675998|7613868|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1
4698931|NCT02676466|7613899|FG000|Overall Study|Death|0
4698932|NCT02676466|7613900|FG001|Overall Study|Death|2
4698933|NCT02676466|7613901|FG002|Overall Study|Death|1
4698934|NCT02676466|7613902|FG003|Overall Study|Death|0
4698935|NCT02676466|7613903|FG004|Overall Study|Death|0
4698936|NCT02676466|7613904|FG005|Overall Study|Death|0
4698937|NCT02676466|7613905|FG006|Overall Study|Death|0
4698938|NCT02676466|7613906|FG007|Overall Study|Death|0
4698939|NCT02676466|7613899|FG000|Overall Study|Withdrawal by Subject|4
4698940|NCT02676466|7613900|FG001|Overall Study|Withdrawal by Subject|3
4698941|NCT02676466|7613901|FG002|Overall Study|Withdrawal by Subject|1
4698942|NCT02676466|7613902|FG003|Overall Study|Withdrawal by Subject|0
4698943|NCT02676466|7613903|FG004|Overall Study|Withdrawal by Subject|3
4698944|NCT02676466|7613904|FG005|Overall Study|Withdrawal by Subject|1
4698945|NCT02676466|7613905|FG006|Overall Study|Withdrawal by Subject|1
4698946|NCT02676466|7613906|FG007|Overall Study|Withdrawal by Subject|1
4698947|NCT02676778|7613931|FG000|Overall Study|Disease Progression|7
4698948|NCT02676778|7613932|FG001|Overall Study|Disease Progression|3
4698949|NCT02676778|7613933|FG002|Overall Study|Disease Progression|1
4698950|NCT02676778|7613931|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1
4698951|NCT02676778|7613932|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1
4698952|NCT02676778|7613933|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0
4698953|NCT02676778|7613931|FG000|Overall Study|Withdrawal by Subject|3
4698954|NCT02676778|7613932|FG001|Overall Study|Withdrawal by Subject|2
4698955|NCT02676778|7613933|FG002|Overall Study|Withdrawal by Subject|0
4698956|NCT02676778|7613931|FG000|Overall Study|Other|4
4698957|NCT02676778|7613932|FG001|Overall Study|Other|3
4698958|NCT02676778|7613933|FG002|Overall Study|Other|0
4698959|NCT02676778|7613931|FG000|Overall Study|Adverse Event|2
4698960|NCT02676778|7613932|FG001|Overall Study|Adverse Event|3
4698961|NCT02676778|7613933|FG002|Overall Study|Adverse Event|0
4698962|NCT02676882|7613949|FG000|Overall Study|Adverse Event|1
4698963|NCT02676882|7613950|FG001|Overall Study|Adverse Event|0
4698964|NCT02676882|7613949|FG000|Overall Study|Lost to Follow-up|1
4698965|NCT02676882|7613950|FG001|Overall Study|Lost to Follow-up|0
4698966|NCT02676882|7613949|FG000|Overall Study|Withdrawal by Subject|1
4698967|NCT02676882|7613950|FG001|Overall Study|Withdrawal by Subject|2
4698968|NCT02676895|7613959|FG000|Overall Study|Administrative reason|1
4698969|NCT02676895|7613960|FG001|Overall Study|Administrative reason|0
4698970|NCT02676895|7613961|FG002|Overall Study|Administrative reason|0
4698971|NCT02676895|7613959|FG000|Overall Study|Protocol Violation|1
4698972|NCT02676895|7613960|FG001|Overall Study|Protocol Violation|0
4698973|NCT02676895|7613961|FG002|Overall Study|Protocol Violation|0
4698974|NCT02676895|7613959|FG000|Overall Study|Adverse Event|0
4698975|NCT02676895|7613960|FG001|Overall Study|Adverse Event|3
4698976|NCT02676895|7613961|FG002|Overall Study|Adverse Event|1
4698977|NCT02676895|7613959|FG000|Overall Study|Lost to Follow-up|0
4698978|NCT02676895|7613960|FG001|Overall Study|Lost to Follow-up|0
4698979|NCT02676895|7613961|FG002|Overall Study|Lost to Follow-up|1
4698980|NCT02676895|7613959|FG000|Overall Study|Withdrawal by Subject|0
4698981|NCT02676895|7613960|FG001|Overall Study|Withdrawal by Subject|0
4698982|NCT02676895|7613961|FG002|Overall Study|Withdrawal by Subject|1
4698983|NCT02677116|7613979|FG000|Overall Study|Adverse Event|0
4698984|NCT02677116|7613980|FG001|Overall Study|Adverse Event|1
4698985|NCT02677116|7613981|FG002|Overall Study|Adverse Event|0
4698986|NCT02677116|7613982|FG003|Overall Study|Adverse Event|0
4698987|NCT02677116|7613983|FG004|Overall Study|Adverse Event|0
4698988|NCT02677116|7613984|FG005|Overall Study|Adverse Event|1
4698989|NCT02677116|7613985|FG006|Overall Study|Adverse Event|1
4698990|NCT02677116|7613986|FG007|Overall Study|Adverse Event|0
4698991|NCT02677116|7613987|FG008|Overall Study|Adverse Event|0
4698992|NCT02677116|7613979|FG000|Overall Study|Physician Decision|0
4698993|NCT02677116|7613980|FG001|Overall Study|Physician Decision|2
4698994|NCT02677116|7613981|FG002|Overall Study|Physician Decision|3
4698995|NCT02677116|7613982|FG003|Overall Study|Physician Decision|2
4698996|NCT02677116|7613983|FG004|Overall Study|Physician Decision|1
4698997|NCT02677116|7613984|FG005|Overall Study|Physician Decision|3
4698998|NCT02677116|7613985|FG006|Overall Study|Physician Decision|1
4698999|NCT02677116|7613986|FG007|Overall Study|Physician Decision|1
4699000|NCT02677116|7613987|FG008|Overall Study|Physician Decision|2
4699001|NCT02677116|7613979|FG000|Overall Study|Withdrawal by parent or guardian|2
4699002|NCT02677116|7613980|FG001|Overall Study|Withdrawal by parent or guardian|1
4699003|NCT02677116|7613981|FG002|Overall Study|Withdrawal by parent or guardian|0
4699004|NCT02677116|7613982|FG003|Overall Study|Withdrawal by parent or guardian|1
4589085|NCT01507831|7434021|FG001|Overall Study|Site closure|3
4589086|NCT01507831|7434020|FG000|Overall Study|Potential lost to follow-up|3
4589087|NCT01507831|7434021|FG001|Overall Study|Potential lost to follow-up|0
4589088|NCT01507831|7434020|FG000|Overall Study|Other|3
4589089|NCT01507831|7434021|FG001|Overall Study|Other|6
4589090|NCT01507896|7434027|FG000|Overall Study|Withdrawal by Subject|1
4589091|NCT01507896|7434027|FG000|Overall Study|The surgery was denied by the sponsor.|1
4589092|NCT01508130|7434094|FG000|Overall Study|Adverse Event|81
4589093|NCT01508130|7434095|FG001|Overall Study|Adverse Event|28
4699005|NCT02677116|7613983|FG004|Overall Study|Withdrawal by parent or guardian|0
4699006|NCT02677116|7613984|FG005|Overall Study|Withdrawal by parent or guardian|0
4699007|NCT02677116|7613985|FG006|Overall Study|Withdrawal by parent or guardian|2
4699008|NCT02677116|7613986|FG007|Overall Study|Withdrawal by parent or guardian|1
4699009|NCT02677116|7613987|FG008|Overall Study|Withdrawal by parent or guardian|0
4699010|NCT02677116|7613979|FG000|Overall Study|Withdrawal by Subject|1
4699011|NCT02677116|7613980|FG001|Overall Study|Withdrawal by Subject|0
4699012|NCT02677116|7613981|FG002|Overall Study|Withdrawal by Subject|0
4699013|NCT02677116|7613982|FG003|Overall Study|Withdrawal by Subject|0
4472636|NCT00662649|7267128|FG003|Extension Study (Month 24 to 60)|Adverse Event|6
4472637|NCT00662649|7267129|FG004|Extension Study (Month 24 to 60)|Adverse Event|10
4589094|NCT01508130|7434094|FG000|Overall Study|Death|3
4589095|NCT01508130|7434095|FG001|Overall Study|Death|1
4589096|NCT01508130|7434094|FG000|Overall Study|Protocol Violation|2
4589097|NCT01508130|7434095|FG001|Overall Study|Protocol Violation|0
4589098|NCT01508130|7434094|FG000|Overall Study|Lost to Follow-up|25
4589099|NCT01508130|7434095|FG001|Overall Study|Lost to Follow-up|2
4589100|NCT01508130|7434094|FG000|Overall Study|Withdrawal by Subject|3
4589101|NCT01508130|7434095|FG001|Overall Study|Withdrawal by Subject|3
4589102|NCT01508130|7434094|FG000|Overall Study|Subject's substantial non-compliance|25
4589103|NCT01508130|7434095|FG001|Overall Study|Subject's substantial non-compliance|9
4589104|NCT01508130|7434094|FG000|Overall Study|Insufficient therapeutic response|74
4589105|NCT01508130|7434095|FG001|Overall Study|Insufficient therapeutic response|23
4589106|NCT01508130|7434094|FG000|Overall Study|Administrative|14
4589107|NCT01508130|7434095|FG001|Overall Study|Administrative|3
4589108|NCT01508169|7434105|FG000|Overall Study|Adverse Event|1
4589109|NCT01508169|7434106|FG001|Overall Study|Adverse Event|0
4589110|NCT01508169|7434105|FG000|Overall Study|Withdrawal by Subject|1
4589111|NCT01508169|7434106|FG001|Overall Study|Withdrawal by Subject|0
4589112|NCT01508169|7434105|FG000|Overall Study|Lost to Follow-up|1
4589113|NCT01508169|7434106|FG001|Overall Study|Lost to Follow-up|2
4589114|NCT01508325|7434120|FG000|Overall Study|Withdrawal by Subject|8
4589115|NCT01508325|7434121|FG001|Overall Study|Withdrawal by Subject|9
4589116|NCT01508325|7434120|FG000|Overall Study|Protocol Violation|0
4589117|NCT01508325|7434121|FG001|Overall Study|Protocol Violation|3
4589118|NCT01508325|7434120|FG000|Overall Study|Physician Decision|2
4589119|NCT01508325|7434121|FG001|Overall Study|Physician Decision|1
4589120|NCT01508325|7434120|FG000|Overall Study|Adverse Event|1
4589121|NCT01508325|7434121|FG001|Overall Study|Adverse Event|0
4589122|NCT01508325|7434120|FG000|Overall Study|Lost to Follow-up|5
4589123|NCT01508325|7434121|FG001|Overall Study|Lost to Follow-up|6
4589124|NCT01508325|7434120|FG000|Overall Study|Other|2
4472638|NCT00662649|7267125|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2
4472639|NCT00662649|7267126|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0
4472640|NCT00662649|7267127|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0
4472641|NCT00662649|7267128|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1
4472642|NCT00662649|7267129|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1
4472643|NCT00662649|7267125|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1
4472644|NCT00662649|7267126|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1
4472645|NCT00662649|7267127|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0
4472646|NCT00662649|7267128|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0
4472647|NCT00662649|7267129|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0
4472648|NCT00662649|7267125|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19
4472649|NCT00662649|7267126|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23
4472650|NCT00662649|7267127|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0
4472651|NCT00662649|7267128|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15
4472652|NCT00662649|7267129|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9
4472653|NCT00662649|7267125|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
4472654|NCT00662649|7267126|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1
4472655|NCT00662649|7267127|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
4472656|NCT00662649|7267128|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
4472657|NCT00662649|7267129|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
4518753|NCT00976209|7331019|FG000|Wash-out Period|Protocol Violation|1
4589125|NCT01508325|7434121|FG001|Overall Study|Other|2
4589126|NCT01508650|7434133|FG000|Overall Study|Lost to Follow-up|0
4589127|NCT01508650|7434134|FG001|Overall Study|Lost to Follow-up|3
4589128|NCT01508676|7434142|FG000|Phase I (2 Weeks)|Medication Exclusion|1
4589129|NCT01508676|7434143|FG001|Phase I (2 Weeks)|Medication Exclusion|1
4589130|NCT01508676|7434142|FG000|Phase I (2 Weeks)|Wrong Pain Type|1
4472658|NCT00662649|7267125|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3
4472659|NCT00662649|7267126|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1
4472660|NCT00662649|7267127|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0
4472661|NCT00662649|7267128|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1
4472662|NCT00662649|7267129|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3
4472663|NCT00662831|7267165|FG000|Overall Study|Death|4
4472664|NCT00662831|7267166|FG001|Overall Study|Death|1
4472665|NCT00662831|7267165|FG000|Overall Study|Lack of Efficacy|6
4472666|NCT00662831|7267166|FG001|Overall Study|Lack of Efficacy|6
4472667|NCT00662831|7267165|FG000|Overall Study|Lost to Follow-up|1
4472668|NCT00662831|7267166|FG001|Overall Study|Lost to Follow-up|0
4472669|NCT00662831|7267165|FG000|Overall Study|Withdrawal by Subject|2
4472670|NCT00662831|7267166|FG001|Overall Study|Withdrawal by Subject|1
4472671|NCT00662831|7267165|FG000|Overall Study|Other|62
4472672|NCT00662831|7267166|FG001|Overall Study|Other|31
4472673|NCT00662831|7267165|FG000|Overall Study|Protocol Violation|8
4472674|NCT00662831|7267166|FG001|Overall Study|Protocol Violation|4
4472675|NCT00662831|7267165|FG000|Overall Study|Adverse Event|23
4472676|NCT00662831|7267166|FG001|Overall Study|Adverse Event|16
4472677|NCT00662857|7267172|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0
4472678|NCT00662857|7267173|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1
4472679|NCT00662857|7267172|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0
4472680|NCT00662857|7267173|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1
4472681|NCT00662857|7267172|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1
4472682|NCT00662857|7267173|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0
4472683|NCT00662909|7267185|FG000|Overall Study|Adverse Event|17
4472684|NCT00662909|7267186|FG001|Overall Study|Adverse Event|18
4472685|NCT00662909|7267187|FG002|Overall Study|Adverse Event|19
4472686|NCT00662909|7267185|FG000|Overall Study|Lack of Efficacy|9
4472687|NCT00662909|7267186|FG001|Overall Study|Lack of Efficacy|1
4472688|NCT00662909|7267187|FG002|Overall Study|Lack of Efficacy|5
4472689|NCT00662909|7267185|FG000|Overall Study|Withdrawal by Subject|29
4472690|NCT00662909|7267186|FG001|Overall Study|Withdrawal by Subject|22
4472691|NCT00662909|7267187|FG002|Overall Study|Withdrawal by Subject|16
4472692|NCT00662909|7267185|FG000|Overall Study|Lost to Follow-up|2
4472693|NCT00662909|7267186|FG001|Overall Study|Lost to Follow-up|9
4472694|NCT00662909|7267187|FG002|Overall Study|Lost to Follow-up|3
4472695|NCT00662909|7267185|FG000|Overall Study|Protocol Violation|7
4472696|NCT00662909|7267186|FG001|Overall Study|Protocol Violation|4
4472697|NCT00662909|7267187|FG002|Overall Study|Protocol Violation|5
4472698|NCT00662909|7267185|FG000|Overall Study|Randomized- never received study drug|1
4472699|NCT00662909|7267186|FG001|Overall Study|Randomized- never received study drug|0
4472700|NCT00662909|7267187|FG002|Overall Study|Randomized- never received study drug|0
4472701|NCT00662909|7267185|FG000|Overall Study|Non-compliance with study procedures|3
4472702|NCT00662909|7267186|FG001|Overall Study|Non-compliance with study procedures|3
4472703|NCT00662909|7267187|FG002|Overall Study|Non-compliance with study procedures|2
4472704|NCT00662909|7267185|FG000|Overall Study|Physician Decision|1
4472705|NCT00662909|7267186|FG001|Overall Study|Physician Decision|1
4472706|NCT00662909|7267187|FG002|Overall Study|Physician Decision|2
4472707|NCT00662909|7267185|FG000|Overall Study|Eligibility criterion not met|0
4472708|NCT00662909|7267186|FG001|Overall Study|Eligibility criterion not met|1
4472709|NCT00662909|7267187|FG002|Overall Study|Eligibility criterion not met|1
4472710|NCT00663026|7267198|FG000|Overall Study|Lost to Follow-up|1
4472711|NCT00663026|7267199|FG001|Overall Study|Lost to Follow-up|0
4472712|NCT00663026|7267200|FG002|Overall Study|Lost to Follow-up|0
4472713|NCT00663026|7267198|FG000|Overall Study|Other|1
4472714|NCT00663026|7267199|FG001|Overall Study|Other|2
4472715|NCT00663026|7267200|FG002|Overall Study|Other|0
4472716|NCT00663026|7267198|FG000|Overall Study|Adverse Event|0
4472717|NCT00663026|7267199|FG001|Overall Study|Adverse Event|2
4472718|NCT00663026|7267200|FG002|Overall Study|Adverse Event|3
4472719|NCT00663026|7267198|FG000|Overall Study|Caregiver Request|0
4472720|NCT00663026|7267199|FG001|Overall Study|Caregiver Request|2
4472721|NCT00663026|7267200|FG002|Overall Study|Caregiver Request|0
4472722|NCT00663026|7267198|FG000|Overall Study|Withdrawal by Subject|0
4472723|NCT00663026|7267199|FG001|Overall Study|Withdrawal by Subject|0
4472724|NCT00663026|7267200|FG002|Overall Study|Withdrawal by Subject|1
4472725|NCT00663117|7267219|FG000|Overall Study|Lack of Efficacy|1
4472726|NCT00663117|7267220|FG001|Overall Study|Lack of Efficacy|0
4472727|NCT00663208|7267248|FG000|Treatment Period|Lost to Follow-up|0
4472728|NCT00663208|7267249|FG001|Treatment Period|Lost to Follow-up|1
4472729|NCT00663208|7267250|FG002|Treatment Period|Lost to Follow-up|0
4472730|NCT00663208|7267251|FG003|Treatment Period|Lost to Follow-up|0
4472731|NCT00663208|7267252|FG004|Treatment Period|Lost to Follow-up|0
4472732|NCT00663208|7267253|FG005|Treatment Period|Lost to Follow-up|0
4472733|NCT00663208|7267254|FG006|Treatment Period|Lost to Follow-up|0
4472734|NCT00663208|7267248|FG000|Follow-up Period|Lost to Follow-up|2
4472735|NCT00663208|7267249|FG001|Follow-up Period|Lost to Follow-up|0
4472736|NCT00663208|7267250|FG002|Follow-up Period|Lost to Follow-up|3
4472737|NCT00663208|7267251|FG003|Follow-up Period|Lost to Follow-up|2
4472738|NCT00663208|7267252|FG004|Follow-up Period|Lost to Follow-up|0
4472739|NCT00663208|7267253|FG005|Follow-up Period|Lost to Follow-up|0
4472740|NCT00663208|7267254|FG006|Follow-up Period|Lost to Follow-up|0
4472741|NCT00663208|7267248|FG000|Follow-up Period|Other reason|1
4472742|NCT00663208|7267249|FG001|Follow-up Period|Other reason|0
4472743|NCT00663208|7267250|FG002|Follow-up Period|Other reason|0
4472744|NCT00663208|7267251|FG003|Follow-up Period|Other reason|0
4472745|NCT00663208|7267252|FG004|Follow-up Period|Other reason|0
4472746|NCT00663208|7267253|FG005|Follow-up Period|Other reason|0
4472747|NCT00663208|7267254|FG006|Follow-up Period|Other reason|1
4472748|NCT00663234|7267272|FG000|Overall Study|Not willing to adhere to requirements|1
4472749|NCT00663260|7267283|FG000|Overall Study|Lack of Efficacy|2
4472750|NCT00663260|7267284|FG001|Overall Study|Lack of Efficacy|0
4472751|NCT00663260|7267285|FG002|Overall Study|Lack of Efficacy|0
4472752|NCT00663260|7267283|FG000|Overall Study|Adverse Event|12
4472753|NCT00663260|7267284|FG001|Overall Study|Adverse Event|7
4472754|NCT00663260|7267285|FG002|Overall Study|Adverse Event|6
4472755|NCT00663260|7267283|FG000|Overall Study|Withdrawal by Subject|3
4472756|NCT00663260|7267284|FG001|Overall Study|Withdrawal by Subject|1
4472757|NCT00663260|7267285|FG002|Overall Study|Withdrawal by Subject|6
4472758|NCT00663260|7267283|FG000|Overall Study|Death|1
4472759|NCT00663260|7267284|FG001|Overall Study|Death|0
4472760|NCT00663260|7267285|FG002|Overall Study|Death|1
4472761|NCT00663260|7267283|FG000|Overall Study|Lost to Follow-up|0
4472762|NCT00663260|7267284|FG001|Overall Study|Lost to Follow-up|1
4472763|NCT00663260|7267285|FG002|Overall Study|Lost to Follow-up|0
4472764|NCT00663260|7267283|FG000|Overall Study|non-compliance, not met criteria, etc.|3
4472765|NCT00663260|7267284|FG001|Overall Study|non-compliance, not met criteria, etc.|2
4472766|NCT00663260|7267285|FG002|Overall Study|non-compliance, not met criteria, etc.|3
4472767|NCT00663702|7267299|FG000|Overall Study|Adverse Event|8
4472768|NCT00663702|7267300|FG001|Overall Study|Adverse Event|4
4472769|NCT00663702|7267299|FG000|Overall Study|Withdrawal by Subject|3
4472770|NCT00663702|7267300|FG001|Overall Study|Withdrawal by Subject|1
4472771|NCT00663702|7267299|FG000|Overall Study|Pregnancy|0
4472772|NCT00663702|7267300|FG001|Overall Study|Pregnancy|1
4472773|NCT00663702|7267299|FG000|Overall Study|Lost to Follow-up|3
4472774|NCT00663702|7267300|FG001|Overall Study|Lost to Follow-up|0
4472775|NCT00663702|7267299|FG000|Overall Study|Death|1
4472776|NCT00663702|7267300|FG001|Overall Study|Death|1
4472777|NCT00663702|7267299|FG000|Overall Study|Lack of Efficacy|3
4472778|NCT00663702|7267300|FG001|Overall Study|Lack of Efficacy|3
4472779|NCT00663858|7267329|FG000|Overall Study|Adverse Event|9
4472780|NCT00663858|7267330|FG001|Overall Study|Adverse Event|1
4472781|NCT00663858|7267331|FG002|Overall Study|Adverse Event|6
4472782|NCT00663858|7267329|FG000|Overall Study|Lack of Efficacy|5
4472783|NCT00663858|7267330|FG001|Overall Study|Lack of Efficacy|1
4472784|NCT00663858|7267331|FG002|Overall Study|Lack of Efficacy|3
4472785|NCT00663858|7267329|FG000|Overall Study|Withdrawal by Subject|7
4472786|NCT00663858|7267330|FG001|Overall Study|Withdrawal by Subject|3
4472787|NCT00663858|7267331|FG002|Overall Study|Withdrawal by Subject|3
4472788|NCT00663858|7267329|FG000|Overall Study|Protocol Violation|5
4472789|NCT00663858|7267330|FG001|Overall Study|Protocol Violation|3
4472790|NCT00663858|7267331|FG002|Overall Study|Protocol Violation|4
4472791|NCT00663858|7267329|FG000|Overall Study|Other|8
4472792|NCT00663858|7267330|FG001|Overall Study|Other|2
4472793|NCT00663858|7267331|FG002|Overall Study|Other|4
4472794|NCT00663871|7267341|FG000|Overall Study|Lost to Follow-up|5
4472795|NCT00663871|7267342|FG001|Overall Study|Lost to Follow-up|5
4472796|NCT00663871|7267341|FG000|Overall Study|Withdrawal by Subject|5
4472797|NCT00663871|7267342|FG001|Overall Study|Withdrawal by Subject|2
4472798|NCT00663923|7267350|FG000|Overall Study|Lost to Follow-up|2
4472799|NCT00663962|7267358|FG000|Overall Study|somnolence|1
4472800|NCT00663962|7267359|FG001|Overall Study|somnolence|0
4472801|NCT00664105|7267365|FG000|Overall Study|Death|3
4472802|NCT00664105|7267365|FG000|Overall Study|Withdrawal by Subject|5
4472803|NCT00664105|7267365|FG000|Overall Study|Adverse Event|9
4472804|NCT00664105|7267365|FG000|Overall Study|Disease progression|7
4472805|NCT00664209|7267370|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7
4472806|NCT00664209|7267370|FG000|Study Treatment Period|Physician Decision|4
4472807|NCT00664209|7267370|FG000|Study Treatment Period|Withdrawal by Subject|2
4516584|NCT00960661|7328030|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0
4516585|NCT00960661|7328028|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8
4516586|NCT00960661|7328029|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0
4516587|NCT00960661|7328030|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0
4516588|NCT00960661|7328028|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3
4516589|NCT00960661|7328029|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0
4516590|NCT00960661|7328030|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0
4516591|NCT00960661|7328028|FG000|Interventional Phase|Adverse Event|0
4516592|NCT00960661|7328029|FG001|Interventional Phase|Adverse Event|17
4516593|NCT00960661|7328030|FG002|Interventional Phase|Adverse Event|8
4516594|NCT00960661|7328028|FG000|Interventional Phase|Death|0
4516595|NCT00960661|7328029|FG001|Interventional Phase|Death|1
4516596|NCT00960661|7328030|FG002|Interventional Phase|Death|0
4516597|NCT00960661|7328028|FG000|Interventional Phase|Lost to Follow-up|0
4516598|NCT00960661|7328029|FG001|Interventional Phase|Lost to Follow-up|0
4516599|NCT00960661|7328030|FG002|Interventional Phase|Lost to Follow-up|2
4472808|NCT00664326|7267375|FG000|Overall Study|Adverse Event|14
4472809|NCT00664326|7267375|FG000|Overall Study|Noncompliance with study medication|3
4472810|NCT00664326|7267375|FG000|Overall Study|Withdrawal by Subject|1
4472811|NCT00664326|7267375|FG000|Overall Study|Physician Decision|1
4472812|NCT00664326|7267375|FG000|Overall Study|Other Reasons|3
4472813|NCT00664326|7267375|FG000|Overall Study|Death|2
4472814|NCT00664326|7267375|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24
4472815|NCT00664521|7267385|FG000|Overall Study|Adverse Event|4
4472816|NCT00664521|7267386|FG001|Overall Study|Adverse Event|1
4472817|NCT00664521|7267385|FG000|Overall Study|Lost to Follow-up|1
4472818|NCT00664521|7267386|FG001|Overall Study|Lost to Follow-up|0
4472819|NCT00664521|7267385|FG000|Overall Study|Other|1
4472820|NCT00664521|7267386|FG001|Overall Study|Other|0
4472821|NCT00664534|7267394|FG000|Overall Study|Adverse Event|2
4472822|NCT00664534|7267395|FG001|Overall Study|Adverse Event|3
4472823|NCT00664534|7267394|FG000|Overall Study|Lost to Follow-up|6
4472824|NCT00664534|7267395|FG001|Overall Study|Lost to Follow-up|10
4472825|NCT00664534|7267394|FG000|Overall Study|Protocol Violation|10
4472826|NCT00664534|7267395|FG001|Overall Study|Protocol Violation|8
4472827|NCT00664534|7267394|FG000|Overall Study|Withdrawal by Subject|7
4472828|NCT00664534|7267395|FG001|Overall Study|Withdrawal by Subject|6
4472829|NCT00664534|7267394|FG000|Overall Study|Physician Decision|8
4472830|NCT00664534|7267395|FG001|Overall Study|Physician Decision|0
4472831|NCT00664534|7267394|FG000|Overall Study|Sponsor decision|8
4472832|NCT00664534|7267395|FG001|Overall Study|Sponsor decision|6
4472833|NCT00664560|7267404|FG000|Overall Study|Adverse Event|19
4472834|NCT00664560|7267405|FG001|Overall Study|Adverse Event|16
4472835|NCT00664560|7267406|FG002|Overall Study|Adverse Event|7
4472836|NCT00664560|7267404|FG000|Overall Study|Withdrawal by Subject|9
4472837|NCT00664560|7267405|FG001|Overall Study|Withdrawal by Subject|13
4472838|NCT00664560|7267406|FG002|Overall Study|Withdrawal by Subject|7
4472839|NCT00664560|7267404|FG000|Overall Study|Lost to Follow-up|0
4472840|NCT00664560|7267405|FG001|Overall Study|Lost to Follow-up|2
4472841|NCT00664560|7267406|FG002|Overall Study|Lost to Follow-up|0
4472842|NCT00664560|7267404|FG000|Overall Study|Other|11
4472843|NCT00664560|7267405|FG001|Overall Study|Other|4
4472844|NCT00664560|7267406|FG002|Overall Study|Other|5
4472845|NCT00664742|7267414|FG000|Overall Study|Withdrawn due to adverse events|3
4472846|NCT00664742|7267414|FG000|Overall Study|Withdrawal by Subject|31
4472847|NCT00664742|7267414|FG000|Overall Study|Lost to Follow-up|92
4472848|NCT00664859|7267430|FG000|Overall Study|Adverse Event|2
4472849|NCT00664859|7267431|FG001|Overall Study|Adverse Event|1
4472850|NCT00664859|7267432|FG002|Overall Study|Adverse Event|3
4472851|NCT00664859|7267430|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6
4589131|NCT01508676|7434143|FG001|Phase I (2 Weeks)|Wrong Pain Type|0
4589132|NCT01508676|7434142|FG000|Phase I (2 Weeks)|Positive Drug Screen|0
4589133|NCT01508676|7434143|FG001|Phase I (2 Weeks)|Positive Drug Screen|2
4589134|NCT01508676|7434142|FG000|Phase II (2 Weeks)|Skin Sensitivity|0
4589135|NCT01508676|7434143|FG001|Phase II (2 Weeks)|Skin Sensitivity|1
4589136|NCT01508676|7434142|FG000|Phase II (2 Weeks)|Medication Exclusion|1
4472852|NCT00664859|7267431|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4
4472853|NCT00664859|7267432|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4
4472854|NCT00664859|7267430|FG000|Overall Study|Noncompliance with protocol|1
4472855|NCT00664859|7267431|FG001|Overall Study|Noncompliance with protocol|0
4472856|NCT00664859|7267432|FG002|Overall Study|Noncompliance with protocol|4
4472857|NCT00664859|7267430|FG000|Overall Study|Laboratory abnormality|2
4472858|NCT00664859|7267431|FG001|Overall Study|Laboratory abnormality|1
4472859|NCT00664859|7267432|FG002|Overall Study|Laboratory abnormality|4
4472860|NCT00664859|7267430|FG000|Overall Study|Withdrawal by Subject|4
4472861|NCT00664859|7267431|FG001|Overall Study|Withdrawal by Subject|1
4472862|NCT00664859|7267432|FG002|Overall Study|Withdrawal by Subject|3
4472863|NCT00664859|7267430|FG000|Overall Study|Lost to Follow-up|2
4472864|NCT00664859|7267431|FG001|Overall Study|Lost to Follow-up|2
4472865|NCT00664859|7267432|FG002|Overall Study|Lost to Follow-up|1
4472866|NCT00664859|7267430|FG000|Overall Study|Other|0
4472867|NCT00664859|7267431|FG001|Overall Study|Other|1
4472868|NCT00664859|7267432|FG002|Overall Study|Other|2
4472869|NCT00665002|7267440|FG000|Overall Study|Progression/relapse during treatment|11
4472870|NCT00665002|7267440|FG000|Overall Study|Cytogenetic resistance|1
4472871|NCT00665353|7267448|FG000|Study Step 1|Adverse Event|1
4472872|NCT00665353|7267448|FG000|Study Step 1|Withdrawal by Subject|2
4472873|NCT00665353|7267448|FG000|Study Step 2|Lost to Follow-up|2
4472874|NCT00665353|7267448|FG000|Study Step 2|Lack of Efficacy|12
4472875|NCT00665366|7267454|FG000|Overall Study|Lack of Efficacy|11
4472876|NCT00665366|7267455|FG001|Overall Study|Lack of Efficacy|10
4472877|NCT00665366|7267454|FG000|Overall Study|Adverse Event|25
4472878|NCT00665366|7267455|FG001|Overall Study|Adverse Event|23
4472879|NCT00665366|7267454|FG000|Overall Study|Withdrawal by Subject|11
4472880|NCT00665366|7267455|FG001|Overall Study|Withdrawal by Subject|14
4472881|NCT00665366|7267454|FG000|Overall Study|Lost to Follow-up|3
4472882|NCT00665366|7267455|FG001|Overall Study|Lost to Follow-up|5
4472883|NCT00665366|7267454|FG000|Overall Study|Poor compliance/noncompliance|3
4472884|NCT00665366|7267455|FG001|Overall Study|Poor compliance/noncompliance|5
4472885|NCT00665366|7267454|FG000|Overall Study|Pregnancy|1
4589137|NCT01508676|7434143|FG001|Phase II (2 Weeks)|Medication Exclusion|0
4472886|NCT00665366|7267455|FG001|Overall Study|Pregnancy|0
4472887|NCT00665366|7267454|FG000|Overall Study|No longer meets study criteria|0
4472888|NCT00665366|7267455|FG001|Overall Study|No longer meets study criteria|1
4472889|NCT00665366|7267454|FG000|Overall Study|Other reasons|4
4472890|NCT00665366|7267455|FG001|Overall Study|Other reasons|1
4472891|NCT00665392|7267461|FG000|Overall Study|not treated|1
4472892|NCT00665431|7267469|FG000|Overall Study|Adverse Event|16
4472893|NCT00665431|7267470|FG001|Overall Study|Adverse Event|22
4472894|NCT00665431|7267471|FG002|Overall Study|Adverse Event|6
4472895|NCT00665431|7267469|FG000|Overall Study|Withdrawal by Subject|17
4472896|NCT00665431|7267470|FG001|Overall Study|Withdrawal by Subject|25
4472897|NCT00665431|7267471|FG002|Overall Study|Withdrawal by Subject|15
4472898|NCT00665431|7267469|FG000|Overall Study|Lost to Follow-up|3
4699014|NCT02677116|7613983|FG004|Overall Study|Withdrawal by Subject|0
4699015|NCT02677116|7613984|FG005|Overall Study|Withdrawal by Subject|0
4699016|NCT02677116|7613985|FG006|Overall Study|Withdrawal by Subject|0
4699017|NCT02677116|7613986|FG007|Overall Study|Withdrawal by Subject|0
4472899|NCT00665431|7267470|FG001|Overall Study|Lost to Follow-up|3
4472900|NCT00665431|7267471|FG002|Overall Study|Lost to Follow-up|1
4472901|NCT00665431|7267469|FG000|Overall Study|Other|4
4472902|NCT00665431|7267470|FG001|Overall Study|Other|7
4472903|NCT00665431|7267471|FG002|Overall Study|Other|2
4472904|NCT00665561|7267494|FG000|Overall Study|Death recorded on subject summary pages|75
4472905|NCT00665561|7267495|FG001|Overall Study|Death recorded on subject summary pages|75
4472906|NCT00665561|7267494|FG000|Overall Study|Does not meet entrance criteria|19
4472907|NCT00665561|7267495|FG001|Overall Study|Does not meet entrance criteria|21
4472908|NCT00665561|7267494|FG000|Overall Study|Lost to Follow-up|203
4472909|NCT00665561|7267495|FG001|Overall Study|Lost to Follow-up|264
4472910|NCT00665561|7267494|FG000|Overall Study|Withdrawal by Subject|74
4472911|NCT00665561|7267495|FG001|Overall Study|Withdrawal by Subject|65
4472912|NCT00665561|7267494|FG000|Overall Study|Other|123
4472913|NCT00665561|7267495|FG001|Overall Study|Other|108
4472914|NCT00665561|7267494|FG000|Overall Study|Site closed|8
4472915|NCT00665561|7267495|FG001|Overall Study|Site closed|0
4472916|NCT00665561|7267494|FG000|Overall Study|Withdrawn due to pregnancy|0
4472917|NCT00665561|7267495|FG001|Overall Study|Withdrawn due to pregnancy|1
4472918|NCT00665626|7267503|FG000|Overall Study|Lack of Efficacy|8
4472919|NCT00665626|7267504|FG001|Overall Study|Lack of Efficacy|5
4472920|NCT00665626|7267503|FG000|Overall Study|Lost to Follow-up|0
4472921|NCT00665626|7267504|FG001|Overall Study|Lost to Follow-up|2
4472922|NCT00665626|7267503|FG000|Overall Study|Withdrawal by Subject|0
4472923|NCT00665626|7267504|FG001|Overall Study|Withdrawal by Subject|1
4472924|NCT00665626|7267503|FG000|Overall Study|Protocol Violation|0
4472925|NCT00665626|7267504|FG001|Overall Study|Protocol Violation|2
4472926|NCT00665626|7267503|FG000|Overall Study|Adverse Event|1
4472927|NCT00665626|7267504|FG001|Overall Study|Adverse Event|9
4472928|NCT00665626|7267503|FG000|Overall Study|Due to exclusion criteria|0
4472929|NCT00665626|7267504|FG001|Overall Study|Due to exclusion criteria|1
4472930|NCT00665626|7267503|FG000|Overall Study|Did not fulfil inclusion criteria|0
4472931|NCT00665626|7267504|FG001|Overall Study|Did not fulfil inclusion criteria|1
4472932|NCT00665626|7267503|FG000|Overall Study|Unably to comply with dosing regimen|0
4472933|NCT00665626|7267504|FG001|Overall Study|Unably to comply with dosing regimen|1
4472934|NCT00665626|7267503|FG000|Overall Study|Death|1
4472935|NCT00665626|7267504|FG001|Overall Study|Death|0
4472936|NCT00665652|7267510|FG000|Overall Study|Adverse Event|4
4472937|NCT00665652|7267510|FG000|Overall Study|Death|1
4472938|NCT00665652|7267510|FG000|Overall Study|No longer met inclusion criteria.|1
4472939|NCT00665847|7267518|FG000|Overall Study|Adverse Event|8
4472940|NCT00665847|7267518|FG000|Overall Study|Withdrawal by Subject|2
4472941|NCT00665847|7267518|FG000|Overall Study|Subject non-compliant|8
4472942|NCT00665847|7267518|FG000|Overall Study|Subject reached a virologic endpoint|4
4472943|NCT00665847|7267518|FG000|Overall Study|Resistance to TMC125|1
4472944|NCT00665847|7267518|FG000|Overall Study|Subject ineligible to continue the trial|1
4472945|NCT00665847|7267518|FG000|Overall Study|Switch to Commercial Medication|1
4472946|NCT00665925|7267526|FG000|Overall Study|Lack of Efficacy|10
4472947|NCT00665925|7267527|FG001|Overall Study|Lack of Efficacy|8
4472948|NCT00665925|7267528|FG002|Overall Study|Lack of Efficacy|9
4472949|NCT00665925|7267529|FG003|Overall Study|Lack of Efficacy|8
4472950|NCT00665925|7267526|FG000|Overall Study|Lost to Follow-up|1
4472951|NCT00665925|7267527|FG001|Overall Study|Lost to Follow-up|2
4472952|NCT00665925|7267528|FG002|Overall Study|Lost to Follow-up|2
4699018|NCT02677116|7613987|FG008|Overall Study|Withdrawal by Subject|0
4699019|NCT02677220|7614030|FG000|Overall Study|Adverse Event|1
4699020|NCT02677324|7614035|FG000|Overall Study|Disease Progression|6
4472953|NCT00665925|7267529|FG003|Overall Study|Lost to Follow-up|2
4472954|NCT00665925|7267526|FG000|Overall Study|Withdrawal by Subject|2
4472955|NCT00665925|7267527|FG001|Overall Study|Withdrawal by Subject|2
4472956|NCT00665925|7267528|FG002|Overall Study|Withdrawal by Subject|3
4472957|NCT00665925|7267529|FG003|Overall Study|Withdrawal by Subject|2
4472958|NCT00665925|7267526|FG000|Overall Study|Physician Decision|0
4472959|NCT00665925|7267527|FG001|Overall Study|Physician Decision|0
4472960|NCT00665925|7267528|FG002|Overall Study|Physician Decision|1
4472961|NCT00665925|7267529|FG003|Overall Study|Physician Decision|2
4472962|NCT00665925|7267526|FG000|Overall Study|Severe Non-Compliance to Protocol|0
4472963|NCT00665925|7267527|FG001|Overall Study|Severe Non-Compliance to Protocol|0
4472964|NCT00665925|7267528|FG002|Overall Study|Severe Non-Compliance to Protocol|1
4472965|NCT00665925|7267529|FG003|Overall Study|Severe Non-Compliance to Protocol|1
4472966|NCT00665925|7267526|FG000|Overall Study|Adverse Event|1
4472967|NCT00665925|7267527|FG001|Overall Study|Adverse Event|5
4472968|NCT00665925|7267528|FG002|Overall Study|Adverse Event|10
4472969|NCT00665925|7267529|FG003|Overall Study|Adverse Event|5
4472970|NCT00665925|7267526|FG000|Overall Study|Enrolled by mistake|0
4472971|NCT00665925|7267527|FG001|Overall Study|Enrolled by mistake|0
4472972|NCT00665925|7267528|FG002|Overall Study|Enrolled by mistake|0
4472973|NCT00665925|7267529|FG003|Overall Study|Enrolled by mistake|1
4472974|NCT00665925|7267526|FG000|Overall Study|Due to exclusion criteria|1
4472975|NCT00665925|7267527|FG001|Overall Study|Due to exclusion criteria|0
4472976|NCT00665925|7267528|FG002|Overall Study|Due to exclusion criteria|0
4472977|NCT00665925|7267529|FG003|Overall Study|Due to exclusion criteria|0
4472978|NCT00666198|7267550|FG000|Overall Study|Protocol Violation|10
4472979|NCT00666198|7267550|FG000|Overall Study|No Visit After First Day of Treatment|13
4472980|NCT00666198|7267550|FG000|Overall Study|Safety Not Assessable|6
4472981|NCT00666198|7267550|FG000|Overall Study|No Drug Administration|4
4472982|NCT00666211|7267556|FG000|Overall Study|Withdrawal by Subject|10
4472983|NCT00666211|7267557|FG001|Overall Study|Withdrawal by Subject|13
4472984|NCT00666211|7267556|FG000|Overall Study|went off medication, no more pain|1
4472985|NCT00666211|7267557|FG001|Overall Study|went off medication, no more pain|0
4472986|NCT00666211|7267556|FG000|Overall Study|patient non-compliant|6
4472987|NCT00666211|7267557|FG001|Overall Study|patient non-compliant|6
4472988|NCT00666211|7267556|FG000|Overall Study|disease progression|1
4699021|NCT02677324|7614035|FG000|Overall Study|Inability to Swallow pills|1
4699022|NCT02677324|7614035|FG000|Overall Study|Non-compliance|1
4699023|NCT02677324|7614035|FG000|Overall Study|Lack of Efficacy|1
4699024|NCT02677324|7614035|FG000|Overall Study|Medical insurance coverage|1
4699025|NCT02677324|7614035|FG000|Overall Study|Adverse Event|1
4699026|NCT02677324|7614035|FG000|Overall Study|IgM Myeloma diagnosis|1
4699027|NCT02677714|7614094|FG000|Overall Study|Withdrawal by Subject|2
4699028|NCT02677714|7614095|FG001|Overall Study|Withdrawal by Subject|0
4699029|NCT02677844|7614139|FG000|Period 3|Withdrawal by Subject|0
4699030|NCT02677844|7614140|FG001|Period 3|Withdrawal by Subject|0
4699031|NCT02677844|7614141|FG002|Period 3|Withdrawal by Subject|0
4699032|NCT02677844|7614142|FG003|Period 3|Withdrawal by Subject|1
4699033|NCT02677844|7614143|FG004|Period 3|Withdrawal by Subject|0
4699034|NCT02677844|7614144|FG005|Period 3|Withdrawal by Subject|0
4699035|NCT02677844|7614145|FG006|Period 3|Withdrawal by Subject|0
4699036|NCT02678000|7614169|FG000|PART 2|Adverse Event|0
4699037|NCT02678000|7614170|FG001|PART 2|Adverse Event|0
4699038|NCT02678000|7614171|FG002|PART 2|Adverse Event|2
4699039|NCT02678000|7614172|FG003|PART 2|Adverse Event|1
4699040|NCT02678000|7614173|FG004|PART 2|Adverse Event|0
4699041|NCT02678000|7614169|FG000|PART 2|Withdrawal by Subject|0
4699042|NCT02678000|7614170|FG001|PART 2|Withdrawal by Subject|0
4699043|NCT02678000|7614171|FG002|PART 2|Withdrawal by Subject|1
4699044|NCT02678000|7614172|FG003|PART 2|Withdrawal by Subject|0
4699045|NCT02678000|7614173|FG004|PART 2|Withdrawal by Subject|0
4699046|NCT02678247|7614209|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0
4699047|NCT02678247|7614210|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2
4699048|NCT02678247|7614209|FG000|First Intervention (7 Weeks)|Adverse Event|1
4699049|NCT02678247|7614210|FG001|First Intervention (7 Weeks)|Adverse Event|2
4699050|NCT02678247|7614209|FG000|First Intervention (7 Weeks)|Physician Decision|1
4472989|NCT00666211|7267557|FG001|Overall Study|disease progression|8
4472990|NCT00666211|7267556|FG000|Overall Study|Lost to Follow-up|2
4472991|NCT00666211|7267557|FG001|Overall Study|Lost to Follow-up|0
4472992|NCT00666211|7267556|FG000|Overall Study|toxicity|0
4472993|NCT00666211|7267557|FG001|Overall Study|toxicity|2
4472994|NCT00666211|7267556|FG000|Overall Study|hospital admission|0
4472995|NCT00666211|7267557|FG001|Overall Study|hospital admission|5
4472996|NCT00666211|7267556|FG000|Overall Study|Death|0
4472997|NCT00666211|7267557|FG001|Overall Study|Death|2
4472998|NCT00666211|7267556|FG000|Overall Study|off tx for other complicating disease|0
4699051|NCT02678247|7614210|FG001|First Intervention (7 Weeks)|Physician Decision|0
4699052|NCT02678247|7614209|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1
4699053|NCT02678247|7614210|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1
4699054|NCT02678247|7614209|FG000|Second Intervention (7 Weeks)|Adverse Event|2
4699055|NCT02678247|7614210|FG001|Second Intervention (7 Weeks)|Adverse Event|1
4699056|NCT02678247|7614209|FG000|Second Intervention (7 Weeks)|Physician Decision|1
4699057|NCT02678247|7614210|FG001|Second Intervention (7 Weeks)|Physician Decision|0
4699058|NCT02678286|7614223|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2
4699059|NCT02678286|7614224|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1
4472999|NCT00666211|7267557|FG001|Overall Study|off tx for other complicating disease|1
4473000|NCT00666211|7267556|FG000|Overall Study|Physician Decision|0
4473001|NCT00666211|7267557|FG001|Overall Study|Physician Decision|1
4473002|NCT00666224|7267565|FG000|Double-Blind|Adverse Event|15
4473003|NCT00666224|7267566|FG001|Double-Blind|Adverse Event|5
4473004|NCT00666224|7267565|FG000|Double-Blind|Lost to Follow-up|2
4473005|NCT00666224|7267566|FG001|Double-Blind|Lost to Follow-up|2
4473006|NCT00666224|7267565|FG000|Double-Blind|Withdrawal by Subject|18
4626383|NCT01839487|7491910|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3
4473007|NCT00666224|7267566|FG001|Double-Blind|Withdrawal by Subject|14
4473008|NCT00666224|7267565|FG000|Double-Blind|Physician Decision|0
4473009|NCT00666224|7267566|FG001|Double-Blind|Physician Decision|3
4473010|NCT00666224|7267565|FG000|Double-Blind|Sponsor decision|1
4473011|NCT00666224|7267566|FG001|Double-Blind|Sponsor decision|0
4473012|NCT00666224|7267565|FG000|Double-Blind|Pregnancy|3
4473013|NCT00666224|7267566|FG001|Double-Blind|Pregnancy|2
4473014|NCT00666224|7267565|FG000|Double-Blind|Noncompliance|1
4473015|NCT00666224|7267566|FG001|Double-Blind|Noncompliance|0
4473016|NCT00666224|7267565|FG000|Double-Blind|Death|1
4473017|NCT00666224|7267566|FG001|Double-Blind|Death|0
4473018|NCT00666224|7267565|FG000|Double-Blind|Undefined/Unknown|4
4473019|NCT00666224|7267566|FG001|Double-Blind|Undefined/Unknown|1
4473020|NCT00666224|7267565|FG000|Open-Label|Adverse Event|8
4473021|NCT00666224|7267566|FG001|Open-Label|Adverse Event|43
4473022|NCT00666224|7267565|FG000|Open-Label|Lost to Follow-up|4
4473023|NCT00666224|7267566|FG001|Open-Label|Lost to Follow-up|5
4473024|NCT00666224|7267565|FG000|Open-Label|Withdrawal by Subject|12
4473025|NCT00666224|7267566|FG001|Open-Label|Withdrawal by Subject|25
4473026|NCT00666224|7267565|FG000|Open-Label|Physician Decision|7
4473027|NCT00666224|7267566|FG001|Open-Label|Physician Decision|5
4473028|NCT00666224|7267565|FG000|Open-Label|Pregnancy|1
4473029|NCT00666224|7267566|FG001|Open-Label|Pregnancy|5
4473030|NCT00666224|7267565|FG000|Open-Label|Noncompliance|2
4473031|NCT00666224|7267566|FG001|Open-Label|Noncompliance|1
4473032|NCT00666224|7267565|FG000|Open-Label|Undefined/Unknown|1
4473033|NCT00666224|7267566|FG001|Open-Label|Undefined/Unknown|1
4473034|NCT00666263|7267573|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0
4473035|NCT00666263|7267574|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1
4473036|NCT00666263|7267573|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1
4473037|NCT00666263|7267574|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0
4473038|NCT00666263|7267573|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0
4473039|NCT00666263|7267574|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1
4473040|NCT00666276|7267619|FG000|Overall Study|Protocol Violation|34
4473041|NCT00666328|7267642|FG000|Overall Study|Death|2
4473042|NCT00666328|7267642|FG000|Overall Study|Lost to Follow-up|2
4473043|NCT00666328|7267642|FG000|Overall Study|No longer met eligibility criteria|1
4473044|NCT00666458|7267656|FG000|Overall Study|Adverse Event|8
4473045|NCT00666458|7267657|FG001|Overall Study|Adverse Event|7
4473046|NCT00666458|7267656|FG000|Overall Study|Withdrawal by Subject|5
4473047|NCT00666458|7267657|FG001|Overall Study|Withdrawal by Subject|4
4473048|NCT00666458|7267656|FG000|Overall Study|Lost to Follow-up|0
4473049|NCT00666458|7267657|FG001|Overall Study|Lost to Follow-up|3
4473050|NCT00666458|7267656|FG000|Overall Study|Administrative reason by sponsor|1
4473051|NCT00666458|7267657|FG001|Overall Study|Administrative reason by sponsor|1
4473052|NCT00666458|7267656|FG000|Overall Study|Incorrect enrollment|7
4473053|NCT00666458|7267657|FG001|Overall Study|Incorrect enrollment|1
4473054|NCT00666458|7267656|FG000|Overall Study|Study specific discontinuation criteria|14
4473055|NCT00666458|7267657|FG001|Overall Study|Study specific discontinuation criteria|7
4473056|NCT00666458|7267656|FG000|Overall Study|Severe non-compliance to the protocol|1
4473057|NCT00666458|7267657|FG001|Overall Study|Severe non-compliance to the protocol|1
4473058|NCT00666458|7267656|FG000|Overall Study|Safety reasons|1
4473059|NCT00666458|7267657|FG001|Overall Study|Safety reasons|0
4473060|NCT00666458|7267656|FG000|Overall Study|Medical history of anemia|1
4473061|NCT00666458|7267657|FG001|Overall Study|Medical history of anemia|0
4473062|NCT00666536|7267665|FG000|Overall Study|Adverse Event|9
4473063|NCT00666536|7267666|FG001|Overall Study|Adverse Event|19
4473064|NCT00666536|7267665|FG000|Overall Study|Unsatisfactory therapeutic effect|2
4473065|NCT00666536|7267666|FG001|Overall Study|Unsatisfactory therapeutic effect|0
4473066|NCT00666536|7267665|FG000|Overall Study|Protocol deviation(s)|8
4473067|NCT00666536|7267666|FG001|Overall Study|Protocol deviation(s)|6
4473068|NCT00666536|7267665|FG000|Overall Study|Withdrawal by Subject|10
4473069|NCT00666536|7267666|FG001|Overall Study|Withdrawal by Subject|9
4473070|NCT00666536|7267665|FG000|Overall Study|Lost to Follow-up|4
4473071|NCT00666536|7267666|FG001|Overall Study|Lost to Follow-up|3
4473072|NCT00666562|7267675|FG000|Overall Study|Withdrawal by Subject|0
4473073|NCT00666562|7267676|FG001|Overall Study|Withdrawal by Subject|1
4473074|NCT00666562|7267677|FG002|Overall Study|Withdrawal by Subject|0
4473075|NCT00666562|7267675|FG000|Overall Study|Concomitant Medication|0
4473076|NCT00666562|7267676|FG001|Overall Study|Concomitant Medication|1
4473077|NCT00666562|7267677|FG002|Overall Study|Concomitant Medication|0
4473078|NCT00666588|7267696|FG000|Overall Study|ineligible|2
4473079|NCT00666588|7267697|FG001|Overall Study|ineligible|0
4473080|NCT00666588|7267698|FG002|Overall Study|ineligible|0
4473081|NCT00666588|7267699|FG003|Overall Study|ineligible|2
4473082|NCT00666588|7267696|FG000|Overall Study|inevaluable|2
4473083|NCT00666588|7267697|FG001|Overall Study|inevaluable|0
4473084|NCT00666588|7267698|FG002|Overall Study|inevaluable|0
4473085|NCT00666588|7267699|FG003|Overall Study|inevaluable|0
4473086|NCT00666679|7267715|FG000|First Intervention|Lost to Follow-up|1
4473087|NCT00666679|7267716|FG001|First Intervention|Lost to Follow-up|0
4473088|NCT00666679|7267715|FG000|First Intervention|Protocol Violation|1
4473089|NCT00666679|7267716|FG001|First Intervention|Protocol Violation|0
4473090|NCT00666679|7267715|FG000|First Intervention|Withdrawal by Subject|1
4473091|NCT00666679|7267716|FG001|First Intervention|Withdrawal by Subject|0
4473092|NCT00666679|7267715|FG000|First Intervention|Randomized did not start treatment|1
4473093|NCT00666679|7267716|FG001|First Intervention|Randomized did not start treatment|1
4473094|NCT00666679|7267715|FG000|Washout Period of 1 Week|Lost to Follow-up|0
4473095|NCT00666679|7267716|FG001|Washout Period of 1 Week|Lost to Follow-up|1
4473096|NCT00666679|7267715|FG000|Washout Period of 1 Week|Protocol Violation|0
4473097|NCT00666679|7267716|FG001|Washout Period of 1 Week|Protocol Violation|1
4473098|NCT00666679|7267715|FG000|Second Intervention|Adverse Event|1
4473099|NCT00666679|7267716|FG001|Second Intervention|Adverse Event|0
4473100|NCT00666679|7267715|FG000|Second Intervention|Death|0
4473101|NCT00666679|7267716|FG001|Second Intervention|Death|1
4473102|NCT00666705|7267722|FG000|Overall Study|Withdrawal by Subject|1
4473103|NCT00666718|7267733|FG000|Overall Study|Adverse Event|0
4473104|NCT00666718|7267734|FG001|Overall Study|Adverse Event|1
4473105|NCT00666718|7267733|FG000|Overall Study|Death|1
4473106|NCT00666718|7267734|FG001|Overall Study|Death|0
4473107|NCT00666718|7267733|FG000|Overall Study|Lost to Follow-up|1
4473108|NCT00666718|7267734|FG001|Overall Study|Lost to Follow-up|0
4473109|NCT00666718|7267733|FG000|Overall Study|Entry Criteria Not Met|2
4473110|NCT00666718|7267734|FG001|Overall Study|Entry Criteria Not Met|0
4473111|NCT00666718|7267733|FG000|Overall Study|Protocol Violation|1
4473112|NCT00666718|7267734|FG001|Overall Study|Protocol Violation|3
4473113|NCT00666718|7267733|FG000|Overall Study|Withdrawal by Subject|7
4473114|NCT00666718|7267734|FG001|Overall Study|Withdrawal by Subject|12
4473115|NCT00666718|7267733|FG000|Overall Study|Physician Decision|0
4473116|NCT00666718|7267734|FG001|Overall Study|Physician Decision|2
4473117|NCT00666757|7267742|FG000|Overall Study|Lost to Follow-up|39
4473118|NCT00666757|7267743|FG001|Overall Study|Lost to Follow-up|35
4473119|NCT00666757|7267742|FG000|Overall Study|Protocol Violation|23
4473120|NCT00666757|7267743|FG001|Overall Study|Protocol Violation|24
4473121|NCT00666757|7267742|FG000|Overall Study|Adverse Event|22
4473122|NCT00666757|7267743|FG001|Overall Study|Adverse Event|12
4473123|NCT00666757|7267742|FG000|Overall Study|Withdrawal by Subject|13
4473124|NCT00666757|7267743|FG001|Overall Study|Withdrawal by Subject|17
4473125|NCT00666757|7267742|FG000|Overall Study|Lack of Efficacy|3
4473126|NCT00666757|7267743|FG001|Overall Study|Lack of Efficacy|6
4473127|NCT00666757|7267742|FG000|Overall Study|Physician Decision|0
4473128|NCT00666757|7267743|FG001|Overall Study|Physician Decision|2
4473129|NCT00666757|7267742|FG000|Overall Study|Sponsor decision|0
4473130|NCT00666757|7267743|FG001|Overall Study|Sponsor decision|1
4473131|NCT00666835|7267754|FG000|Overall Study|Withdrawal by Subject|5
4473132|NCT00666835|7267755|FG001|Overall Study|Withdrawal by Subject|2
4473133|NCT00666835|7267754|FG000|Overall Study|Lack of Efficacy|0
4473134|NCT00666835|7267755|FG001|Overall Study|Lack of Efficacy|1
4473135|NCT00666835|7267754|FG000|Overall Study|Incl./excl. not fulfilled|7
4473136|NCT00666835|7267755|FG001|Overall Study|Incl./excl. not fulfilled|2
4473137|NCT00666835|7267754|FG000|Overall Study|Adverse Event|7
4473138|NCT00666835|7267755|FG001|Overall Study|Adverse Event|6
4473139|NCT00666835|7267754|FG000|Overall Study|Protocol Violation|2
4473140|NCT00666835|7267755|FG001|Overall Study|Protocol Violation|0
4473141|NCT00666835|7267754|FG000|Overall Study|Death|15
4473142|NCT00666835|7267755|FG001|Overall Study|Death|4
4473143|NCT00666835|7267754|FG000|Overall Study|Kidney Transplantation (NTX)|10
4473144|NCT00666835|7267755|FG001|Overall Study|Kidney Transplantation (NTX)|2
4473145|NCT00666835|7267754|FG000|Overall Study|Hemoglobulin concentration|4
4473146|NCT00666835|7267755|FG001|Overall Study|Hemoglobulin concentration|3
4473147|NCT00666835|7267754|FG000|Overall Study|Planned operation|2
4473148|NCT00666835|7267755|FG001|Overall Study|Planned operation|0
4473149|NCT00666835|7267754|FG000|Overall Study|Physician Decision|1
4473150|NCT00666835|7267755|FG001|Overall Study|Physician Decision|2
4473151|NCT00666926|7267775|FG000|Overall Study|Adverse Event|0
4473152|NCT00666926|7267776|FG001|Overall Study|Adverse Event|0
4473153|NCT00666926|7267777|FG002|Overall Study|Adverse Event|0
4473154|NCT00666926|7267778|FG003|Overall Study|Adverse Event|0
4473155|NCT00666926|7267779|FG004|Overall Study|Adverse Event|0
4473156|NCT00666926|7267780|FG005|Overall Study|Adverse Event|0
4473157|NCT00666926|7267781|FG006|Overall Study|Adverse Event|0
4473158|NCT00666926|7267782|FG007|Overall Study|Adverse Event|0
4473159|NCT00666926|7267783|FG008|Overall Study|Adverse Event|0
4473160|NCT00666926|7267784|FG009|Overall Study|Adverse Event|2
4473161|NCT00666926|7267785|FG010|Overall Study|Adverse Event|2
4473162|NCT00666926|7267786|FG011|Overall Study|Adverse Event|2
4473163|NCT00666926|7267787|FG012|Overall Study|Adverse Event|0
4473164|NCT00666926|7267788|FG013|Overall Study|Adverse Event|1
4473165|NCT00666926|7267789|FG014|Overall Study|Adverse Event|0
4473166|NCT00666926|7267790|FG015|Overall Study|Adverse Event|0
4473167|NCT00666926|7267775|FG000|Overall Study|Laboratory abnormality|0
4473168|NCT00666926|7267776|FG001|Overall Study|Laboratory abnormality|0
4473169|NCT00666926|7267777|FG002|Overall Study|Laboratory abnormality|0
4473170|NCT00666926|7267778|FG003|Overall Study|Laboratory abnormality|0
4473171|NCT00666926|7267779|FG004|Overall Study|Laboratory abnormality|0
4473172|NCT00666926|7267780|FG005|Overall Study|Laboratory abnormality|0
4473173|NCT00666926|7267781|FG006|Overall Study|Laboratory abnormality|0
4473174|NCT00666926|7267782|FG007|Overall Study|Laboratory abnormality|0
4473175|NCT00666926|7267783|FG008|Overall Study|Laboratory abnormality|0
4473176|NCT00666926|7267784|FG009|Overall Study|Laboratory abnormality|0
4473177|NCT00666926|7267785|FG010|Overall Study|Laboratory abnormality|1
4473178|NCT00666926|7267786|FG011|Overall Study|Laboratory abnormality|0
4473179|NCT00666926|7267787|FG012|Overall Study|Laboratory abnormality|0
4473180|NCT00666926|7267788|FG013|Overall Study|Laboratory abnormality|0
4473181|NCT00666926|7267789|FG014|Overall Study|Laboratory abnormality|0
4473182|NCT00666926|7267790|FG015|Overall Study|Laboratory abnormality|1
4473183|NCT00666926|7267775|FG000|Overall Study|Lack of Efficacy|0
4473184|NCT00666926|7267776|FG001|Overall Study|Lack of Efficacy|0
4473185|NCT00666926|7267777|FG002|Overall Study|Lack of Efficacy|0
4473186|NCT00666926|7267778|FG003|Overall Study|Lack of Efficacy|0
4473187|NCT00666926|7267779|FG004|Overall Study|Lack of Efficacy|0
4473188|NCT00666926|7267780|FG005|Overall Study|Lack of Efficacy|1
4473189|NCT00666926|7267781|FG006|Overall Study|Lack of Efficacy|0
4473190|NCT00666926|7267782|FG007|Overall Study|Lack of Efficacy|0
4473191|NCT00666926|7267783|FG008|Overall Study|Lack of Efficacy|0
4473192|NCT00666926|7267784|FG009|Overall Study|Lack of Efficacy|0
4473193|NCT00666926|7267785|FG010|Overall Study|Lack of Efficacy|0
4473194|NCT00666926|7267786|FG011|Overall Study|Lack of Efficacy|1
4473195|NCT00666926|7267787|FG012|Overall Study|Lack of Efficacy|0
4473196|NCT00666926|7267788|FG013|Overall Study|Lack of Efficacy|0
4473197|NCT00666926|7267789|FG014|Overall Study|Lack of Efficacy|0
4473198|NCT00666926|7267790|FG015|Overall Study|Lack of Efficacy|0
4473199|NCT00666926|7267775|FG000|Overall Study|Lost to Follow-up|0
4473200|NCT00666926|7267776|FG001|Overall Study|Lost to Follow-up|0
4473201|NCT00666926|7267777|FG002|Overall Study|Lost to Follow-up|0
4473202|NCT00666926|7267778|FG003|Overall Study|Lost to Follow-up|1
4473203|NCT00666926|7267779|FG004|Overall Study|Lost to Follow-up|0
4473204|NCT00666926|7267780|FG005|Overall Study|Lost to Follow-up|0
4473205|NCT00666926|7267781|FG006|Overall Study|Lost to Follow-up|0
4473206|NCT00666926|7267782|FG007|Overall Study|Lost to Follow-up|0
4473207|NCT00666926|7267783|FG008|Overall Study|Lost to Follow-up|0
4473208|NCT00666926|7267784|FG009|Overall Study|Lost to Follow-up|0
4473209|NCT00666926|7267785|FG010|Overall Study|Lost to Follow-up|0
4473210|NCT00666926|7267786|FG011|Overall Study|Lost to Follow-up|0
4473211|NCT00666926|7267787|FG012|Overall Study|Lost to Follow-up|0
4473212|NCT00666926|7267788|FG013|Overall Study|Lost to Follow-up|0
4473213|NCT00666926|7267789|FG014|Overall Study|Lost to Follow-up|0
4473214|NCT00666926|7267790|FG015|Overall Study|Lost to Follow-up|0
4473215|NCT00666926|7267775|FG000|Overall Study|Other|2
4473216|NCT00666926|7267776|FG001|Overall Study|Other|4
4473217|NCT00666926|7267777|FG002|Overall Study|Other|3
4473218|NCT00666926|7267778|FG003|Overall Study|Other|3
4473219|NCT00666926|7267779|FG004|Overall Study|Other|3
4473220|NCT00666926|7267780|FG005|Overall Study|Other|3
4473221|NCT00666926|7267781|FG006|Overall Study|Other|4
4473222|NCT00666926|7267782|FG007|Overall Study|Other|0
4473223|NCT00666926|7267783|FG008|Overall Study|Other|3
4473224|NCT00666926|7267784|FG009|Overall Study|Other|5
4473225|NCT00666926|7267785|FG010|Overall Study|Other|3
4473226|NCT00666926|7267786|FG011|Overall Study|Other|26
4473227|NCT00666926|7267787|FG012|Overall Study|Other|3
4473228|NCT00666926|7267788|FG013|Overall Study|Other|2
4473229|NCT00666926|7267789|FG014|Overall Study|Other|4
4473230|NCT00666926|7267790|FG015|Overall Study|Other|4
4473231|NCT00666926|7267775|FG000|Overall Study|Withdrawal by Subject|0
4473232|NCT00666926|7267776|FG001|Overall Study|Withdrawal by Subject|0
4473233|NCT00666926|7267777|FG002|Overall Study|Withdrawal by Subject|0
4473234|NCT00666926|7267778|FG003|Overall Study|Withdrawal by Subject|0
4473235|NCT00666926|7267779|FG004|Overall Study|Withdrawal by Subject|0
4473236|NCT00666926|7267780|FG005|Overall Study|Withdrawal by Subject|0
4473237|NCT00666926|7267781|FG006|Overall Study|Withdrawal by Subject|0
4473238|NCT00666926|7267782|FG007|Overall Study|Withdrawal by Subject|1
4473239|NCT00666926|7267783|FG008|Overall Study|Withdrawal by Subject|0
4473240|NCT00666926|7267784|FG009|Overall Study|Withdrawal by Subject|3
4473241|NCT00666926|7267785|FG010|Overall Study|Withdrawal by Subject|0
4473242|NCT00666926|7267786|FG011|Overall Study|Withdrawal by Subject|3
4473243|NCT00666926|7267787|FG012|Overall Study|Withdrawal by Subject|0
4473244|NCT00666926|7267788|FG013|Overall Study|Withdrawal by Subject|1
4473245|NCT00666926|7267789|FG014|Overall Study|Withdrawal by Subject|3
4473246|NCT00666926|7267790|FG015|Overall Study|Withdrawal by Subject|3
4473247|NCT00666926|7267775|FG000|Overall Study|Death|0
4473248|NCT00666926|7267776|FG001|Overall Study|Death|0
4473249|NCT00666926|7267777|FG002|Overall Study|Death|0
4473250|NCT00666926|7267778|FG003|Overall Study|Death|0
4473251|NCT00666926|7267779|FG004|Overall Study|Death|0
4473252|NCT00666926|7267780|FG005|Overall Study|Death|0
4473253|NCT00666926|7267781|FG006|Overall Study|Death|0
4473254|NCT00666926|7267782|FG007|Overall Study|Death|0
4473255|NCT00666926|7267783|FG008|Overall Study|Death|0
4473256|NCT00666926|7267784|FG009|Overall Study|Death|0
4473257|NCT00666926|7267785|FG010|Overall Study|Death|0
4473258|NCT00666926|7267786|FG011|Overall Study|Death|1
4473259|NCT00666926|7267787|FG012|Overall Study|Death|0
4473260|NCT00666926|7267788|FG013|Overall Study|Death|0
4473261|NCT00666926|7267789|FG014|Overall Study|Death|0
4473262|NCT00666926|7267790|FG015|Overall Study|Death|0
4473263|NCT00666965|7267845|FG000|Overall Study|Adverse Event|0
4473264|NCT00666965|7267846|FG001|Overall Study|Adverse Event|2
4473265|NCT00666965|7267847|FG002|Overall Study|Adverse Event|1
4473266|NCT00666965|7267848|FG003|Overall Study|Adverse Event|9
4473267|NCT00666965|7267845|FG000|Overall Study|Lack of Efficacy|1
4473268|NCT00666965|7267846|FG001|Overall Study|Lack of Efficacy|1
4473269|NCT00666965|7267847|FG002|Overall Study|Lack of Efficacy|0
4473270|NCT00666965|7267848|FG003|Overall Study|Lack of Efficacy|0
4473271|NCT00666965|7267845|FG000|Overall Study|Protocol Violation|0
4473272|NCT00666965|7267846|FG001|Overall Study|Protocol Violation|0
4473273|NCT00666965|7267847|FG002|Overall Study|Protocol Violation|0
4473274|NCT00666965|7267848|FG003|Overall Study|Protocol Violation|2
4473275|NCT00666965|7267845|FG000|Overall Study|Discontinuation criteria|2
4473276|NCT00666965|7267846|FG001|Overall Study|Discontinuation criteria|1
4473277|NCT00666965|7267847|FG002|Overall Study|Discontinuation criteria|1
4473278|NCT00666965|7267848|FG003|Overall Study|Discontinuation criteria|2
4473279|NCT00666965|7267845|FG000|Overall Study|Withdrawal by Subject|0
4473280|NCT00666965|7267846|FG001|Overall Study|Withdrawal by Subject|0
4473281|NCT00666965|7267847|FG002|Overall Study|Withdrawal by Subject|0
4473282|NCT00666965|7267848|FG003|Overall Study|Withdrawal by Subject|2
4473283|NCT00667095|7267880|FG000|Overall Study|Withdrawal by Subject|0
4473284|NCT00667095|7267881|FG001|Overall Study|Withdrawal by Subject|1
4473285|NCT00667225|7267898|FG000|Overall Study|Subject had no more lesions to treat.|1
4473286|NCT00667225|7267899|FG001|Overall Study|Subject had no more lesions to treat.|0
4473287|NCT00667225|7267898|FG000|Overall Study|Lost to Follow-up|0
4473288|NCT00667225|7267899|FG001|Overall Study|Lost to Follow-up|1
4473289|NCT00667277|7267905|FG000|Overall Study|Withdrawal by Subject|2
4473290|NCT00667342|7267912|FG000|Overall Study|Protocol Violation|1
4473291|NCT00667342|7267913|FG001|Overall Study|Protocol Violation|0
4473292|NCT00667342|7267914|FG002|Overall Study|Protocol Violation|0
4473293|NCT00667342|7267912|FG000|Overall Study|Withdrawal by Subject|1
4473294|NCT00667342|7267913|FG001|Overall Study|Withdrawal by Subject|0
4473295|NCT00667342|7267914|FG002|Overall Study|Withdrawal by Subject|0
4473296|NCT00667342|7267912|FG000|Overall Study|Physician Decision|3
4473297|NCT00667342|7267913|FG001|Overall Study|Physician Decision|0
4473298|NCT00667342|7267914|FG002|Overall Study|Physician Decision|0
4473299|NCT00667342|7267912|FG000|Overall Study|Relapse or tumor progression|9
4473300|NCT00667342|7267913|FG001|Overall Study|Relapse or tumor progression|0
4473301|NCT00667342|7267914|FG002|Overall Study|Relapse or tumor progression|7
4473302|NCT00667342|7267912|FG000|Overall Study|Adverse Event|0
4473303|NCT00667342|7267913|FG001|Overall Study|Adverse Event|0
4473304|NCT00667342|7267914|FG002|Overall Study|Adverse Event|1
4473305|NCT00667342|7267912|FG000|Overall Study|Ineligible|0
4473306|NCT00667342|7267913|FG001|Overall Study|Ineligible|0
4473307|NCT00667342|7267914|FG002|Overall Study|Ineligible|1
4473308|NCT00667355|7267928|FG000|Overall Study|Adverse Event|5
4473309|NCT00667355|7267928|FG000|Overall Study|Lost to Follow-up|1
4473310|NCT00667355|7267928|FG000|Overall Study|Other reason was not specified|5
4473311|NCT00667368|7267934|FG000|Overall Study|Lost to Follow-up|176
4473312|NCT00667368|7267935|FG001|Overall Study|Lost to Follow-up|155
4473313|NCT00667368|7267934|FG000|Overall Study|Discontinued early|24
4473314|NCT00667368|7267935|FG001|Overall Study|Discontinued early|17
4473315|NCT00667394|7267952|FG000|Overall Study|Adverse Event|3
4473316|NCT00667394|7267953|FG001|Overall Study|Adverse Event|0
4473317|NCT00667394|7267952|FG000|Overall Study|Progressive disease|1
4473318|NCT00667394|7267953|FG001|Overall Study|Progressive disease|0
4699060|NCT02678286|7614223|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0
4699061|NCT02678286|7614224|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1
4699062|NCT02678286|7614223|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1
4699063|NCT02678286|7614224|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0
4699064|NCT02678286|7614223|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3
4699065|NCT02678286|7614224|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2
4699066|NCT02678286|7614223|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2
4699067|NCT02678286|7614224|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2
4699068|NCT02678390|7614232|FG000|AE (1 Day)|Withdrawal by Subject|0
4699069|NCT02678390|7614233|FG001|AE (1 Day)|Withdrawal by Subject|1
4699070|NCT02678416|7614241|FG000|Part 1|Withdrawal by Subject|1
4699071|NCT02678416|7614241|FG000|Part 2|Adverse Event|2
4699072|NCT02678416|7614241|FG000|Part 2|Withdrawal by Subject|1
4699073|NCT02678676|7614270|FG000|Overall Study|Death|619
4473319|NCT00667420|7267959|FG000|Overall Study|Adverse Event|2
4473320|NCT00667420|7267959|FG000|Overall Study|Lack of Efficacy|5
4473321|NCT00667420|7267959|FG000|Overall Study|Physician Decision|1
4473322|NCT00667420|7267959|FG000|Overall Study|Withdrawal by Subject|2
4473323|NCT00667446|7267966|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13
4473324|NCT00667446|7267967|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15
4473325|NCT00667446|7267966|FG000|Treatment Period (36 Months)|Other|2
4473326|NCT00667446|7267967|FG001|Treatment Period (36 Months)|Other|2
4473327|NCT00667446|7267966|FG000|Treatment Period (36 Months)|Personal reasons|2
4473328|NCT00667446|7267967|FG001|Treatment Period (36 Months)|Personal reasons|2
4699074|NCT02678676|7614271|FG001|Overall Study|Death|649
4518754|NCT00976209|7331020|FG001|Wash-out Period|Protocol Violation|0
4699075|NCT02678676|7614270|FG000|Overall Study|Withdrawal by Subject|13
4699076|NCT02678676|7614271|FG001|Overall Study|Withdrawal by Subject|5
4473329|NCT00667446|7267966|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0
4473330|NCT00667446|7267967|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4
4473331|NCT00667446|7267966|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3
4473332|NCT00667446|7267967|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0
4473333|NCT00667446|7267966|FG000|Treatment Period (36 Months)|Lost to Follow-up|1
4473334|NCT00667446|7267967|FG001|Treatment Period (36 Months)|Lost to Follow-up|0
4473335|NCT00667446|7267966|FG000|Treatment Period (36 Months)|Protocol Violation|1
4473336|NCT00667446|7267967|FG001|Treatment Period (36 Months)|Protocol Violation|1
4473337|NCT00667446|7267966|FG000|Treatment Period (36 Months)|Therapeutic Failure|1
4473338|NCT00667446|7267967|FG001|Treatment Period (36 Months)|Therapeutic Failure|1
4473339|NCT00667446|7267966|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0
4473340|NCT00667446|7267967|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1
4473341|NCT00667459|7267975|FG000|Overall Study|Death|0
4473342|NCT00667459|7267976|FG001|Overall Study|Death|2
4473343|NCT00667459|7267975|FG000|Overall Study|Lost to Follow-up|8
4473344|NCT00667459|7267976|FG001|Overall Study|Lost to Follow-up|43
4473345|NCT00667563|7267988|FG000|Overall Study|Protocol Violation|24
4473346|NCT00667576|7267997|FG000|Overall Study|Withdrawal by Subject|1
4473347|NCT00667576|7267998|FG001|Overall Study|Withdrawal by Subject|0
4473348|NCT00667576|7267999|FG002|Overall Study|Withdrawal by Subject|1
4473349|NCT00667576|7268000|FG003|Overall Study|Withdrawal by Subject|1
4473350|NCT00667576|7268001|FG004|Overall Study|Withdrawal by Subject|1
4473351|NCT00667576|7267997|FG000|Overall Study|Adverse Event|1
4473352|NCT00667576|7267998|FG001|Overall Study|Adverse Event|1
4473353|NCT00667576|7267999|FG002|Overall Study|Adverse Event|0
4473354|NCT00667576|7268000|FG003|Overall Study|Adverse Event|0
4473355|NCT00667576|7268001|FG004|Overall Study|Adverse Event|0
4473356|NCT00667576|7267997|FG000|Overall Study|Lost to Follow-up|0
4473357|NCT00667576|7267998|FG001|Overall Study|Lost to Follow-up|0
4473358|NCT00667576|7267999|FG002|Overall Study|Lost to Follow-up|1
4473359|NCT00667576|7268000|FG003|Overall Study|Lost to Follow-up|0
4473360|NCT00667576|7268001|FG004|Overall Study|Lost to Follow-up|0
4473361|NCT00667576|7267997|FG000|Overall Study|Protocol Violation|0
4473362|NCT00667576|7267998|FG001|Overall Study|Protocol Violation|0
4473363|NCT00667576|7267999|FG002|Overall Study|Protocol Violation|0
4473364|NCT00667576|7268000|FG003|Overall Study|Protocol Violation|1
4473365|NCT00667576|7268001|FG004|Overall Study|Protocol Violation|0
4473366|NCT00667576|7267997|FG000|Overall Study|Physician Decision|0
4473367|NCT00667576|7267998|FG001|Overall Study|Physician Decision|0
4473368|NCT00667576|7267999|FG002|Overall Study|Physician Decision|0
4473369|NCT00667576|7268000|FG003|Overall Study|Physician Decision|1
4473370|NCT00667576|7268001|FG004|Overall Study|Physician Decision|0
4473371|NCT00667576|7267997|FG000|Overall Study|Missed Visit|0
4473372|NCT00667576|7267998|FG001|Overall Study|Missed Visit|0
4473373|NCT00667576|7267999|FG002|Overall Study|Missed Visit|0
4473374|NCT00667576|7268000|FG003|Overall Study|Missed Visit|1
4473375|NCT00667576|7268001|FG004|Overall Study|Missed Visit|0
4473376|NCT00667602|7268033|FG000|Overall Study|Withdrawal by Subject|4
4473377|NCT00667602|7268034|FG001|Overall Study|Withdrawal by Subject|9
4473378|NCT00667602|7268035|FG002|Overall Study|Withdrawal by Subject|10
4473379|NCT00667602|7268033|FG000|Overall Study|Lost to Follow-up|4
4473380|NCT00667602|7268034|FG001|Overall Study|Lost to Follow-up|5
4473381|NCT00667602|7268035|FG002|Overall Study|Lost to Follow-up|6
4473382|NCT00667602|7268033|FG000|Overall Study|Administrative reason|0
4473383|NCT00667602|7268034|FG001|Overall Study|Administrative reason|0
4473384|NCT00667602|7268035|FG002|Overall Study|Administrative reason|2
4473385|NCT00667602|7268033|FG000|Overall Study|Protocol Violation|0
4473386|NCT00667602|7268034|FG001|Overall Study|Protocol Violation|1
4473387|NCT00667602|7268035|FG002|Overall Study|Protocol Violation|0
4473388|NCT00667719|7268061|FG000|Overall Study|Adverse Event|39
4473389|NCT00667719|7268061|FG000|Overall Study|Abnormal Test Procedure|1
4473390|NCT00667719|7268061|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3
4473391|NCT00667719|7268061|FG000|Overall Study|Protocol Violation|3
4473392|NCT00667719|7268061|FG000|Overall Study|Withdrawal by Subject|17
4473393|NCT00667719|7268061|FG000|Overall Study|Lost to Follow-up|8
4473394|NCT00667732|7268072|FG000|Run -In (8 Weeks)|Adverse Event|4
4473395|NCT00667732|7268073|FG001|Run -In (8 Weeks)|Adverse Event|0
4473396|NCT00667732|7268074|FG002|Run -In (8 Weeks)|Adverse Event|0
4473397|NCT00667732|7268072|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3
4473398|NCT00667732|7268073|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0
4473399|NCT00667732|7268074|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0
4473400|NCT00667732|7268072|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0
4473401|NCT00667732|7268073|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1
4473402|NCT00667732|7268074|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0
4473403|NCT00667810|7268098|FG000|Overall Study|Adverse Event|13
4473404|NCT00667810|7268099|FG001|Overall Study|Adverse Event|14
4473405|NCT00667810|7268100|FG002|Overall Study|Adverse Event|19
4473406|NCT00667810|7268101|FG003|Overall Study|Adverse Event|1
4473407|NCT00667810|7268098|FG000|Overall Study|Death|1
4473408|NCT00667810|7268099|FG001|Overall Study|Death|1
4473409|NCT00667810|7268100|FG002|Overall Study|Death|3
4473410|NCT00667810|7268101|FG003|Overall Study|Death|0
4473411|NCT00667810|7268098|FG000|Overall Study|Lack of Efficacy|1
4473412|NCT00667810|7268099|FG001|Overall Study|Lack of Efficacy|0
4473413|NCT00667810|7268100|FG002|Overall Study|Lack of Efficacy|2
4473414|NCT00667810|7268101|FG003|Overall Study|Lack of Efficacy|0
4473415|NCT00667810|7268098|FG000|Overall Study|Lost to Follow-up|1
4473416|NCT00667810|7268099|FG001|Overall Study|Lost to Follow-up|4
4473417|NCT00667810|7268100|FG002|Overall Study|Lost to Follow-up|2
4473418|NCT00667810|7268101|FG003|Overall Study|Lost to Follow-up|0
4473419|NCT00667810|7268098|FG000|Overall Study|Physician Decision|1
4473420|NCT00667810|7268099|FG001|Overall Study|Physician Decision|1
4473421|NCT00667810|7268100|FG002|Overall Study|Physician Decision|2
4473422|NCT00667810|7268101|FG003|Overall Study|Physician Decision|0
4473423|NCT00667810|7268098|FG000|Overall Study|Protocol Violation|0
4473424|NCT00667810|7268099|FG001|Overall Study|Protocol Violation|2
4473425|NCT00667810|7268100|FG002|Overall Study|Protocol Violation|0
4473426|NCT00667810|7268101|FG003|Overall Study|Protocol Violation|0
4473427|NCT00667810|7268098|FG000|Overall Study|Withdrawal by Subject|14
4473428|NCT00667810|7268099|FG001|Overall Study|Withdrawal by Subject|20
4473429|NCT00667810|7268100|FG002|Overall Study|Withdrawal by Subject|29
4473430|NCT00667810|7268101|FG003|Overall Study|Withdrawal by Subject|1
4473431|NCT00667810|7268098|FG000|Overall Study|Discontinuation of Study by Sponsor|130
4473432|NCT00667810|7268099|FG001|Overall Study|Discontinuation of Study by Sponsor|118
4473433|NCT00667810|7268100|FG002|Overall Study|Discontinuation of Study by Sponsor|155
4473434|NCT00667810|7268101|FG003|Overall Study|Discontinuation of Study by Sponsor|0
4473435|NCT00667810|7268098|FG000|Overall Study|Failed to Return|0
4473436|NCT00667810|7268099|FG001|Overall Study|Failed to Return|0
4473437|NCT00667810|7268100|FG002|Overall Study|Failed to Return|2
4473438|NCT00667810|7268101|FG003|Overall Study|Failed to Return|0
4473439|NCT00667810|7268098|FG000|Overall Study|Loss of Caregiver|0
4473440|NCT00667810|7268099|FG001|Overall Study|Loss of Caregiver|1
4473441|NCT00667810|7268100|FG002|Overall Study|Loss of Caregiver|3
4473442|NCT00667810|7268101|FG003|Overall Study|Loss of Caregiver|0
4473443|NCT00667810|7268098|FG000|Overall Study|Vasogenic Edema Recurrence|0
4473444|NCT00667810|7268099|FG001|Overall Study|Vasogenic Edema Recurrence|3
4473445|NCT00667810|7268100|FG002|Overall Study|Vasogenic Edema Recurrence|0
4473446|NCT00667810|7268101|FG003|Overall Study|Vasogenic Edema Recurrence|0
4473447|NCT00667810|7268098|FG000|Overall Study|Other|6
4473448|NCT00667810|7268099|FG001|Overall Study|Other|6
4473449|NCT00667810|7268100|FG002|Overall Study|Other|5
4473450|NCT00667810|7268101|FG003|Overall Study|Other|0
4473451|NCT00667862|7268128|FG000|Overall Study|Adverse Event|9
4473452|NCT00667862|7268128|FG000|Overall Study|Death|1
4473453|NCT00667862|7268128|FG000|Overall Study|Disease Progression|22
4473454|NCT00667862|7268128|FG000|Overall Study|Withdrawal by Subject|3
4473455|NCT00667875|7268135|FG000|Overall Study|Adverse Event|0
4473456|NCT00667875|7268136|FG001|Overall Study|Adverse Event|2
4473457|NCT00667875|7268137|FG002|Overall Study|Adverse Event|6
4473458|NCT00667875|7268135|FG000|Overall Study|Withdrawal by Subject|10
4473459|NCT00667875|7268136|FG001|Overall Study|Withdrawal by Subject|9
4473460|NCT00667875|7268137|FG002|Overall Study|Withdrawal by Subject|7
4473461|NCT00667888|7268153|FG000|Overall Study|Death|1
4473462|NCT00667888|7268154|FG001|Overall Study|Death|1
4473463|NCT00667888|7268153|FG000|Overall Study|Withdrawal by Subject|6
4473464|NCT00667888|7268154|FG001|Overall Study|Withdrawal by Subject|3
4473465|NCT00667888|7268153|FG000|Overall Study|Proceed with other treatment|3
4473466|NCT00667888|7268154|FG001|Overall Study|Proceed with other treatment|3
4473467|NCT00667888|7268153|FG000|Overall Study|Ineligible after SIM|0
4473468|NCT00667888|7268154|FG001|Overall Study|Ineligible after SIM|2
4473469|NCT00667992|7268162|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2
4473470|NCT00667992|7268163|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3
4473471|NCT00667992|7268162|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2
4473472|NCT00667992|7268163|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0
4473473|NCT00667992|7268162|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0
4473474|NCT00667992|7268163|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1
4473475|NCT00667992|7268162|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1
4473476|NCT00667992|7268163|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0
4473477|NCT00667992|7268162|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0
4473478|NCT00667992|7268163|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1
4473479|NCT00667992|7268162|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1
4473480|NCT00667992|7268163|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0
4473481|NCT00667992|7268162|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2
4473482|NCT00667992|7268163|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3
4473483|NCT00667992|7268162|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0
4473484|NCT00667992|7268163|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1
4473485|NCT00667992|7268162|FG000|Wash-out|Not within one doubling dilution|4
4473486|NCT00667992|7268163|FG001|Wash-out|Not within one doubling dilution|3
4473487|NCT00667992|7268162|FG000|Wash-out|Failure to wash-out|2
4473488|NCT00667992|7268163|FG001|Wash-out|Failure to wash-out|2
4473489|NCT00667992|7268162|FG000|Wash-out|Withdrawal by Subject|1
4473490|NCT00667992|7268163|FG001|Wash-out|Withdrawal by Subject|0
4473491|NCT00667992|7268162|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1
4518755|NCT00976209|7331019|FG000|Wash-out Period|Other|1
4473492|NCT00667992|7268163|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0
4473493|NCT00667992|7268162|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0
4473494|NCT00667992|7268163|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1
4473495|NCT00668148|7268179|FG000|Overall Study|Adverse Event|5
4473496|NCT00668148|7268179|FG000|Overall Study|Subject Non-compliance|1
4473497|NCT00668148|7268179|FG000|Overall Study|Progressive Disease Before Treatment|2
4473498|NCT00668148|7268179|FG000|Overall Study|Withdrawal of Consent|2
4473499|NCT00668200|7268194|FG000|Overall Study|Withdrawal by Subject|2
4473500|NCT00668200|7268194|FG000|Overall Study|Lost to Follow-up|1
4473501|NCT00668317|7268198|FG000|Overall Study|Adverse Event|2
4473502|NCT00668395|7268209|FG000|Overall Study|Withdrawal by Subject|4
4473503|NCT00668395|7268210|FG001|Overall Study|Withdrawal by Subject|4
4473504|NCT00668395|7268211|FG002|Overall Study|Withdrawal by Subject|1
4473505|NCT00668395|7268209|FG000|Overall Study|Adverse Event|1
4473506|NCT00668395|7268210|FG001|Overall Study|Adverse Event|1
4473507|NCT00668395|7268211|FG002|Overall Study|Adverse Event|0
4473508|NCT00668395|7268209|FG000|Overall Study|Physician Decision|1
4473509|NCT00668395|7268210|FG001|Overall Study|Physician Decision|1
4473510|NCT00668395|7268211|FG002|Overall Study|Physician Decision|0
4473511|NCT00668707|7268247|FG000|Overall Study|Cancer Recurrence|58
4473512|NCT00668707|7268248|FG001|Overall Study|Cancer Recurrence|58
4473513|NCT00668707|7268247|FG000|Overall Study|Withdrawal by Subject|117
4473514|NCT00668707|7268248|FG001|Overall Study|Withdrawal by Subject|100
4473515|NCT00668707|7268247|FG000|Overall Study|Lost to Follow-up|3
4473516|NCT00668707|7268248|FG001|Overall Study|Lost to Follow-up|6
4473517|NCT00668707|7268247|FG000|Overall Study|Protocol Violation|10
4473518|NCT00668707|7268248|FG001|Overall Study|Protocol Violation|12
4473519|NCT00668707|7268247|FG000|Overall Study|Death|11
4473520|NCT00668707|7268248|FG001|Overall Study|Death|4
4473521|NCT00668733|7268261|FG000|Overall Study|Lost to Follow-up|2
4473522|NCT00668733|7268262|FG001|Overall Study|Lost to Follow-up|3
4473523|NCT00668733|7268261|FG000|Overall Study|Withdrawal by Subject|0
4473524|NCT00668733|7268262|FG001|Overall Study|Withdrawal by Subject|4
4473525|NCT00668746|7268270|FG000|Overall Study|Lost to Follow-up|2
4473526|NCT00668746|7268271|FG001|Overall Study|Lost to Follow-up|1
4473527|NCT00668863|7268291|FG000|Overall Study|Objective Progression or Relapse|42
4473528|NCT00668863|7268291|FG000|Overall Study|Adverse Event|13
4473529|NCT00668863|7268291|FG000|Overall Study|Study Terminated by Sponsor|8
4473530|NCT00668863|7268291|FG000|Overall Study|Global Deterioration of Health Status|4
4473531|NCT00668863|7268291|FG000|Overall Study|Withdrawal by Subject|1
4473532|NCT00668863|7268291|FG000|Overall Study|Surgery|1
4473533|NCT00668863|7268291|FG000|Overall Study|Subject's work scheduling problem|1
4473534|NCT00668863|7268291|FG000|Overall Study|Physician Decision|1
4473535|NCT00669032|7268314|FG000|Overall Study|Lost to Follow-up|6
4473536|NCT00669032|7268315|FG001|Overall Study|Lost to Follow-up|5
4473537|NCT00669032|7268314|FG000|Overall Study|Lack of Efficacy|8
4473538|NCT00669032|7268315|FG001|Overall Study|Lack of Efficacy|19
4473539|NCT00669032|7268314|FG000|Overall Study|Withdrawal by Subject|12
4473540|NCT00669032|7268315|FG001|Overall Study|Withdrawal by Subject|13
4473541|NCT00669032|7268314|FG000|Overall Study|Adverse Event|12
4473542|NCT00669032|7268315|FG001|Overall Study|Adverse Event|16
4473543|NCT00669032|7268314|FG000|Overall Study|Physician Decision|1
4473544|NCT00669032|7268315|FG001|Overall Study|Physician Decision|1
4473545|NCT00669032|7268314|FG000|Overall Study|No fulfilment of the selection criteria|5
4473546|NCT00669032|7268315|FG001|Overall Study|No fulfilment of the selection criteria|5
4473547|NCT00669071|7268321|FG000|Overall Study|Lost to Follow-up|3
4473548|NCT00669071|7268321|FG000|Overall Study|Final visit 40 days out of window|1
4473549|NCT00669110|7268329|FG000|Overall Study|Adverse Event|4
4473550|NCT00669110|7268330|FG001|Overall Study|Adverse Event|3
4473551|NCT00669110|7268329|FG000|Overall Study|Caregiver request|3
4473552|NCT00669110|7268330|FG001|Overall Study|Caregiver request|2
4473553|NCT00669110|7268329|FG000|Overall Study|Physician Decision|0
4473554|NCT00669110|7268330|FG001|Overall Study|Physician Decision|1
4473555|NCT00669110|7268329|FG000|Overall Study|Lost to Follow-up|1
4473556|NCT00669110|7268330|FG001|Overall Study|Lost to Follow-up|0
4473557|NCT00669110|7268329|FG000|Overall Study|Protocol Violation|0
4473558|NCT00669110|7268330|FG001|Overall Study|Protocol Violation|5
4473559|NCT00669110|7268329|FG000|Overall Study|Withdrawal by Subject|0
4473560|NCT00669110|7268330|FG001|Overall Study|Withdrawal by Subject|2
4473561|NCT00669162|7268336|FG000|Overall Study|Withdrawal by Subject|1
4473562|NCT00669240|7268353|FG000|Overall Study|Lack of Efficacy|33
4473563|NCT00669240|7268353|FG000|Overall Study|Withdrawal by Subject|42
4473564|NCT00669240|7268353|FG000|Overall Study|Lost to Follow-up|34
4473565|NCT00669240|7268353|FG000|Overall Study|Adverse Event|21
4473566|NCT00669240|7268353|FG000|Overall Study|Other|19
4473567|NCT00669240|7268353|FG000|Overall Study|Enrolled but not treated|15
4473568|NCT00669240|7268353|FG000|Overall Study|Enrolled but no dosing record|1
4473569|NCT00669318|7268366|FG000|Overall Study|Withdrawal by Subject|2
4473570|NCT00669331|7268372|FG000|Randomisation to First Dose|Adverse Event|1
4473571|NCT00669331|7268373|FG001|Randomisation to First Dose|Adverse Event|0
4473572|NCT00669331|7268372|FG000|Randomisation to First Dose|Protocol Violation|1
4473573|NCT00669331|7268373|FG001|Randomisation to First Dose|Protocol Violation|0
4473574|NCT00669331|7268372|FG000|Randomisation to First Dose|Withdrawal by Subject|3
4473575|NCT00669331|7268373|FG001|Randomisation to First Dose|Withdrawal by Subject|2
4473576|NCT00669331|7268372|FG000|Randomisation to First Dose|Lost to Follow-up|2
4473577|NCT00669331|7268373|FG001|Randomisation to First Dose|Lost to Follow-up|0
4473578|NCT00669331|7268372|FG000|Randomisation to First Dose|Death|1
4473579|NCT00669331|7268373|FG001|Randomisation to First Dose|Death|0
4473580|NCT00669331|7268372|FG000|Randomisation to First Dose|Sponsor decision|0
4473581|NCT00669331|7268373|FG001|Randomisation to First Dose|Sponsor decision|1
4473582|NCT00669331|7268372|FG000|Randomisation to First Dose|Randomised in error|3
4473583|NCT00669331|7268373|FG001|Randomisation to First Dose|Randomised in error|10
4473584|NCT00669331|7268372|FG000|Blinded Treatment Period|Adverse Event|16
4473585|NCT00669331|7268373|FG001|Blinded Treatment Period|Adverse Event|10
4473586|NCT00669331|7268372|FG000|Blinded Treatment Period|Protocol Violation|1
4473587|NCT00669331|7268373|FG001|Blinded Treatment Period|Protocol Violation|1
4473588|NCT00669331|7268372|FG000|Blinded Treatment Period|Withdrawal by Subject|17
4473589|NCT00669331|7268373|FG001|Blinded Treatment Period|Withdrawal by Subject|19
4473590|NCT00669331|7268372|FG000|Blinded Treatment Period|Lost to Follow-up|3
4473591|NCT00669331|7268373|FG001|Blinded Treatment Period|Lost to Follow-up|2
4473592|NCT00669331|7268372|FG000|Blinded Treatment Period|Death|0
4473593|NCT00669331|7268373|FG001|Blinded Treatment Period|Death|2
4473594|NCT00669331|7268372|FG000|Blinded Treatment Period|Physician Decision|3
4473595|NCT00669331|7268373|FG001|Blinded Treatment Period|Physician Decision|3
4473596|NCT00669331|7268372|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2
4473597|NCT00669331|7268373|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2
4473598|NCT00669396|7268392|FG000|Overall Study|Lost to Follow-up|10
4473599|NCT00669396|7268393|FG001|Overall Study|Lost to Follow-up|12
4473600|NCT00669409|7268405|FG000|Part 2|Withdrawal by Subject|0
4473601|NCT00669409|7268406|FG001|Part 2|Withdrawal by Subject|0
4473602|NCT00669409|7268407|FG002|Part 2|Withdrawal by Subject|0
4473603|NCT00669409|7268408|FG003|Part 2|Withdrawal by Subject|0
4473604|NCT00669409|7268409|FG004|Part 2|Withdrawal by Subject|0
4473605|NCT00669409|7268410|FG005|Part 2|Withdrawal by Subject|0
4473606|NCT00669409|7268411|FG006|Part 2|Withdrawal by Subject|0
4473607|NCT00669409|7268412|FG007|Part 2|Withdrawal by Subject|0
4473608|NCT00669409|7268413|FG008|Part 2|Withdrawal by Subject|0
4473609|NCT00669409|7268414|FG009|Part 2|Withdrawal by Subject|1
4473610|NCT00669409|7268415|FG010|Part 2|Withdrawal by Subject|0
4516600|NCT00960661|7328028|FG000|Interventional Phase|entry criteria not met|0
4516601|NCT00960661|7328029|FG001|Interventional Phase|entry criteria not met|3
4516602|NCT00960661|7328030|FG002|Interventional Phase|entry criteria not met|0
4516603|NCT00960661|7328028|FG000|Interventional Phase|Protocol Violation|0
4516604|NCT00960661|7328029|FG001|Interventional Phase|Protocol Violation|7
4516605|NCT00960661|7328030|FG002|Interventional Phase|Protocol Violation|2
4516606|NCT00960661|7328028|FG000|Interventional Phase|Withdrawal by Subject|0
4516607|NCT00960661|7328029|FG001|Interventional Phase|Withdrawal by Subject|18
4516608|NCT00960661|7328030|FG002|Interventional Phase|Withdrawal by Subject|29
4516609|NCT00960661|7328028|FG000|Interventional Phase|Physician Decision|0
4516610|NCT00960661|7328029|FG001|Interventional Phase|Physician Decision|3
4516611|NCT00960661|7328030|FG002|Interventional Phase|Physician Decision|5
4516612|NCT00960661|7328028|FG000|Interventional Phase|sponsor decision|0
4516613|NCT00960661|7328029|FG001|Interventional Phase|sponsor decision|1
4516614|NCT00960661|7328030|FG002|Interventional Phase|sponsor decision|0
4516615|NCT00960661|7328028|FG000|Interventional Phase|Lack of Efficacy|0
4516616|NCT00960661|7328029|FG001|Interventional Phase|Lack of Efficacy|2
4516617|NCT00960661|7328030|FG002|Interventional Phase|Lack of Efficacy|0
4516618|NCT00960687|7328036|FG000|Washout Period of 7 Days|Adverse Event|3
4516619|NCT00960687|7328037|FG001|Washout Period of 7 Days|Adverse Event|2
4516620|NCT00960687|7328036|FG000|Washout Period of 7 Days|Withdrawal by Subject|1
4516621|NCT00960687|7328037|FG001|Washout Period of 7 Days|Withdrawal by Subject|1
4516622|NCT00960804|7328055|FG000|Overall Study|Adverse Event|1
4516623|NCT00960804|7328056|FG001|Overall Study|Adverse Event|0
4516624|NCT00960804|7328057|FG002|Overall Study|Adverse Event|0
4516625|NCT00960804|7328055|FG000|Overall Study|Withdrawal by Subject|1
4516626|NCT00960804|7328056|FG001|Overall Study|Withdrawal by Subject|0
4516627|NCT00960804|7328057|FG002|Overall Study|Withdrawal by Subject|0
4516628|NCT00960804|7328055|FG000|Overall Study|Study terminated by the sponsor|5
4516629|NCT00960804|7328056|FG001|Overall Study|Study terminated by the sponsor|4
4516630|NCT00960804|7328057|FG002|Overall Study|Study terminated by the sponsor|10
4516631|NCT00960843|7328067|FG000|Overall Study|Lost to Follow-up|2
4516632|NCT00960843|7328068|FG001|Overall Study|Lost to Follow-up|0
4516633|NCT00960843|7328067|FG000|Overall Study|Protocol Violation|0
4516634|NCT00960843|7328068|FG001|Overall Study|Protocol Violation|4
4516635|NCT00960843|7328067|FG000|Overall Study|Repeated needle dislodgment|0
4516636|NCT00960843|7328068|FG001|Overall Study|Repeated needle dislodgment|1
4516637|NCT00960856|7328074|FG000|Washout Period of 7 Days|Withdrawal by Subject|0
4516638|NCT00960856|7328075|FG001|Washout Period of 7 Days|Withdrawal by Subject|2
4516639|NCT00960856|7328076|FG002|Washout Period of 7 Days|Withdrawal by Subject|0
4516640|NCT00960856|7328077|FG003|Washout Period of 7 Days|Withdrawal by Subject|0
4516641|NCT00960856|7328074|FG000|Washout Period of 7 Days|Adverse Event|0
4516642|NCT00960856|7328075|FG001|Washout Period of 7 Days|Adverse Event|0
4516643|NCT00960856|7328076|FG002|Washout Period of 7 Days|Adverse Event|1
4473611|NCT00669617|7268465|FG000|Period 1|Withdrawal by Subject|0
4473612|NCT00669617|7268466|FG001|Period 1|Withdrawal by Subject|0
4473613|NCT00669617|7268467|FG002|Period 1|Withdrawal by Subject|1
4473614|NCT00669617|7268468|FG003|Period 1|Withdrawal by Subject|0
4473615|NCT00669617|7268469|FG004|Period 1|Withdrawal by Subject|0
4473616|NCT00669617|7268465|FG000|Period 1|Protocol Deviation|0
4473617|NCT00669617|7268466|FG001|Period 1|Protocol Deviation|0
4473618|NCT00669617|7268467|FG002|Period 1|Protocol Deviation|0
4473619|NCT00669617|7268468|FG003|Period 1|Protocol Deviation|0
4473620|NCT00669617|7268469|FG004|Period 1|Protocol Deviation|1
4473621|NCT00669617|7268465|FG000|Period 3|Lost to Follow-up|1
4473622|NCT00669617|7268466|FG001|Period 3|Lost to Follow-up|0
4473623|NCT00669617|7268467|FG002|Period 3|Lost to Follow-up|0
4473624|NCT00669617|7268468|FG003|Period 3|Lost to Follow-up|0
4473625|NCT00669617|7268469|FG004|Period 3|Lost to Follow-up|0
4473626|NCT00669864|7268486|FG000|Overall Study|Lost to Follow-up|2
4473627|NCT00669864|7268486|FG000|Overall Study|Protocol Violation|2
4473628|NCT00669864|7268486|FG000|Overall Study|Withdrawal by Subject|3
4473629|NCT00669864|7268486|FG000|Overall Study|Other|2
4473630|NCT00669877|7268490|FG000|Overall Study|Disease Progression/Death|4
4473631|NCT00669903|7268498|FG000|Overall Study|Adverse Event|0
4473632|NCT00669903|7268499|FG001|Overall Study|Adverse Event|1
4473633|NCT00669903|7268500|FG002|Overall Study|Adverse Event|3
4473634|NCT00669903|7268501|FG003|Overall Study|Adverse Event|1
4473635|NCT00669903|7268498|FG000|Overall Study|Withdrawal by Subject|0
4473636|NCT00669903|7268499|FG001|Overall Study|Withdrawal by Subject|2
4473637|NCT00669903|7268500|FG002|Overall Study|Withdrawal by Subject|2
4473638|NCT00669903|7268501|FG003|Overall Study|Withdrawal by Subject|2
4473639|NCT00669903|7268498|FG000|Overall Study|Lost to Follow-up|1
4473640|NCT00669903|7268499|FG001|Overall Study|Lost to Follow-up|1
4473641|NCT00669903|7268500|FG002|Overall Study|Lost to Follow-up|0
4473642|NCT00669903|7268501|FG003|Overall Study|Lost to Follow-up|1
4626384|NCT01839487|7491905|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0
4473643|NCT00669903|7268498|FG000|Overall Study|Protocol Violation|0
4473644|NCT00669903|7268499|FG001|Overall Study|Protocol Violation|1
4473645|NCT00669903|7268500|FG002|Overall Study|Protocol Violation|0
4473646|NCT00669903|7268501|FG003|Overall Study|Protocol Violation|0
4473647|NCT00669942|7268532|FG000|Parts 2 and 3|Adverse Event|0
4473648|NCT00669942|7268533|FG001|Parts 2 and 3|Adverse Event|0
4473649|NCT00669942|7268534|FG002|Parts 2 and 3|Adverse Event|0
4473650|NCT00669942|7268535|FG003|Parts 2 and 3|Adverse Event|0
4473651|NCT00669942|7268536|FG004|Parts 2 and 3|Adverse Event|0
4473652|NCT00669942|7268537|FG005|Parts 2 and 3|Adverse Event|0
4473653|NCT00669942|7268538|FG006|Parts 2 and 3|Adverse Event|0
4473654|NCT00669942|7268539|FG007|Parts 2 and 3|Adverse Event|2
4473655|NCT00669942|7268540|FG008|Parts 2 and 3|Adverse Event|1
4473656|NCT00669942|7268541|FG009|Parts 2 and 3|Adverse Event|0
4473657|NCT00669942|7268542|FG010|Parts 2 and 3|Adverse Event|0
4473658|NCT00669942|7268543|FG011|Parts 2 and 3|Adverse Event|0
4473659|NCT00669942|7268532|FG000|Parts 2 and 3|Withdrawal by Subject|0
4473660|NCT00669942|7268533|FG001|Parts 2 and 3|Withdrawal by Subject|0
4473661|NCT00669942|7268534|FG002|Parts 2 and 3|Withdrawal by Subject|0
4473662|NCT00669942|7268535|FG003|Parts 2 and 3|Withdrawal by Subject|0
4473663|NCT00669942|7268536|FG004|Parts 2 and 3|Withdrawal by Subject|0
4473664|NCT00669942|7268537|FG005|Parts 2 and 3|Withdrawal by Subject|1
4473665|NCT00669942|7268538|FG006|Parts 2 and 3|Withdrawal by Subject|0
4473666|NCT00669942|7268539|FG007|Parts 2 and 3|Withdrawal by Subject|0
4473667|NCT00669942|7268540|FG008|Parts 2 and 3|Withdrawal by Subject|2
4473668|NCT00669942|7268541|FG009|Parts 2 and 3|Withdrawal by Subject|0
4473669|NCT00669942|7268542|FG010|Parts 2 and 3|Withdrawal by Subject|0
4473670|NCT00669942|7268543|FG011|Parts 2 and 3|Withdrawal by Subject|0
4473671|NCT00669942|7268532|FG000|Parts 2 and 3|Protocol Violation|0
4473672|NCT00669942|7268533|FG001|Parts 2 and 3|Protocol Violation|0
4473673|NCT00669942|7268534|FG002|Parts 2 and 3|Protocol Violation|0
4473674|NCT00669942|7268535|FG003|Parts 2 and 3|Protocol Violation|0
4473675|NCT00669942|7268536|FG004|Parts 2 and 3|Protocol Violation|0
4473676|NCT00669942|7268537|FG005|Parts 2 and 3|Protocol Violation|1
4473677|NCT00669942|7268538|FG006|Parts 2 and 3|Protocol Violation|0
4473678|NCT00669942|7268539|FG007|Parts 2 and 3|Protocol Violation|0
4473679|NCT00669942|7268540|FG008|Parts 2 and 3|Protocol Violation|0
4473680|NCT00669942|7268541|FG009|Parts 2 and 3|Protocol Violation|0
4473681|NCT00669942|7268542|FG010|Parts 2 and 3|Protocol Violation|0
4473682|NCT00669942|7268543|FG011|Parts 2 and 3|Protocol Violation|0
4473683|NCT00669955|7268568|FG000|Overall Study|Adverse Event|3
4473684|NCT00669955|7268569|FG001|Overall Study|Adverse Event|5
4473685|NCT00669955|7268568|FG000|Overall Study|Death|0
4473686|NCT00669955|7268569|FG001|Overall Study|Death|1
4473687|NCT00669955|7268568|FG000|Overall Study|Withdrawal by Subject|2
4473688|NCT00669955|7268569|FG001|Overall Study|Withdrawal by Subject|3
4473689|NCT00669955|7268568|FG000|Overall Study|Lost to Follow-up|5
4473690|NCT00669955|7268569|FG001|Overall Study|Lost to Follow-up|7
4473691|NCT00669955|7268568|FG000|Overall Study|Protocol Violation|2
4473692|NCT00669955|7268569|FG001|Overall Study|Protocol Violation|7
4473693|NCT00669955|7268568|FG000|Overall Study|Investigator Sponsor Judgement|0
4473694|NCT00669955|7268569|FG001|Overall Study|Investigator Sponsor Judgement|1
4473695|NCT00669955|7268568|FG000|Overall Study|not compliant with study drug/visit|2
4473696|NCT00669955|7268569|FG001|Overall Study|not compliant with study drug/visit|3
4473697|NCT00670007|7268575|FG000|Overall Study|Drug abuse|1
4473698|NCT00670007|7268575|FG000|Overall Study|Lung transplant|1
4473699|NCT00670007|7268575|FG000|Overall Study|Travel/Vacation|1
4473700|NCT00670007|7268575|FG000|Overall Study|Adverse event, serious fatal|1
4473701|NCT00670007|7268575|FG000|Overall Study|Adverse Event|1
4473702|NCT00670007|7268575|FG000|Overall Study|Withdrawal by Subject|4
4473703|NCT00670046|7268582|FG000|Overall Study|Lost to Follow-up|1
4473704|NCT00670046|7268583|FG001|Overall Study|Lost to Follow-up|1
4473705|NCT00670046|7268582|FG000|Overall Study|Withdrawal by Subject|0
4473706|NCT00670046|7268583|FG001|Overall Study|Withdrawal by Subject|1
4473707|NCT00670111|7268592|FG000|Enrollment to One Month|Testing Failure|0
4473708|NCT00670111|7268593|FG001|Enrollment to One Month|Testing Failure|0
4473709|NCT00670111|7268594|FG002|Enrollment to One Month|Testing Failure|13
4473710|NCT00670111|7268592|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0
4473711|NCT00670111|7268593|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0
4699077|NCT02678676|7614270|FG000|Overall Study|Lost to Follow-up|171
4699078|NCT02678676|7614271|FG001|Overall Study|Lost to Follow-up|151
4699079|NCT02678676|7614270|FG000|Overall Study|Unconfirmed for lost to follow-up|85
4699080|NCT02678676|7614271|FG001|Overall Study|Unconfirmed for lost to follow-up|67
4699081|NCT02678923|7614279|FG000|Overall Study|Protocol Deviation (Not Dosed)|1
4699082|NCT02678923|7614280|FG001|Overall Study|Protocol Deviation (Not Dosed)|3
4699083|NCT02678923|7614279|FG000|Overall Study|Withdrawal by Subject|3
4699084|NCT02678923|7614280|FG001|Overall Study|Withdrawal by Subject|2
4699085|NCT02678923|7614279|FG000|Overall Study|Lost to Follow-up|1
4699086|NCT02678923|7614280|FG001|Overall Study|Lost to Follow-up|0
4699087|NCT02678923|7614279|FG000|Overall Study|Did Not Return for Study Visits|1
4699088|NCT02678923|7614280|FG001|Overall Study|Did Not Return for Study Visits|0
4699089|NCT02679079|7614289|FG000|Overall Study|Adverse Event|2
4699090|NCT02679079|7614290|FG001|Overall Study|Adverse Event|0
4699091|NCT02679079|7614291|FG002|Overall Study|Adverse Event|2
4699092|NCT02679079|7614289|FG000|Overall Study|Protocol Violation|0
4699093|NCT02679079|7614290|FG001|Overall Study|Protocol Violation|1
4699094|NCT02679079|7614291|FG002|Overall Study|Protocol Violation|0
4699095|NCT02679079|7614289|FG000|Overall Study|Withdrawal by Subject|2
4699096|NCT02679079|7614290|FG001|Overall Study|Withdrawal by Subject|1
4699097|NCT02679079|7614291|FG002|Overall Study|Withdrawal by Subject|0
4699098|NCT02679222|7614299|FG000|Overall Study|No time for project|1
4699099|NCT02679235|7614311|FG000|Overall Study|Withdrawal by Subject|3
4699100|NCT02679235|7614311|FG000|Overall Study|Adverse Event|1
4699101|NCT02679274|7614317|FG000|Overall Study|Withdrawal by Subject|1
4699102|NCT02679274|7614318|FG001|Overall Study|Withdrawal by Subject|0
4699103|NCT02679287|7614326|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2
4699104|NCT02679287|7614327|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1
4699105|NCT02679287|7614326|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2
4699106|NCT02679287|7614327|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3
4699107|NCT02679287|7614326|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0
4699108|NCT02679287|7614327|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1
4699109|NCT02679287|7614326|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0
4699110|NCT02679287|7614327|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1
4699111|NCT02679287|7614326|FG000|Period 2|Work/Scheduling Conflict|1
4699112|NCT02679287|7614327|FG001|Period 2|Work/Scheduling Conflict|0
4699113|NCT02679287|7614326|FG000|Period 2|Disliked Mobile System|2
4699114|NCT02679287|7614327|FG001|Period 2|Disliked Mobile System|0
4699115|NCT02679287|7614326|FG000|Period 3|Work/Scheduling Conflict|0
4699116|NCT02679287|7614327|FG001|Period 3|Work/Scheduling Conflict|1
4699117|NCT02679573|7614345|FG000|Overall Study|Adverse Event|13
4699118|NCT02679573|7614346|FG001|Overall Study|Adverse Event|6
4699119|NCT02679573|7614345|FG000|Overall Study|Lack of Efficacy|12
4699120|NCT02679573|7614346|FG001|Overall Study|Lack of Efficacy|15
4699121|NCT02679573|7614345|FG000|Overall Study|Could not complete required study visits|6
4699122|NCT02679573|7614346|FG001|Overall Study|Could not complete required study visits|2
4699123|NCT02679573|7614345|FG000|Overall Study|Withdrawal by Subject|2
4699124|NCT02679573|7614346|FG001|Overall Study|Withdrawal by Subject|9
4699125|NCT02679573|7614345|FG000|Overall Study|Death|2
4699126|NCT02679573|7614346|FG001|Overall Study|Death|0
4699127|NCT02679573|7614345|FG000|Overall Study|Physician Decision|2
4699128|NCT02679573|7614346|FG001|Overall Study|Physician Decision|4
4473712|NCT00670111|7268594|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6
4473713|NCT00670111|7268592|FG000|Enrollment to One Month|Physician Decision|1
4473714|NCT00670111|7268593|FG001|Enrollment to One Month|Physician Decision|0
4473715|NCT00670111|7268594|FG002|Enrollment to One Month|Physician Decision|0
4699129|NCT02679573|7614345|FG000|Overall Study|Lost to Follow-up|0
4699130|NCT02679573|7614346|FG001|Overall Study|Lost to Follow-up|3
4699131|NCT02679729|7614367|FG000|Overall Study|Lost to Follow-up|0
4699132|NCT02679729|7614368|FG001|Overall Study|Lost to Follow-up|1
4699133|NCT02679729|7614369|FG002|Overall Study|Lost to Follow-up|0
4699134|NCT02679729|7614370|FG003|Overall Study|Lost to Follow-up|0
4699135|NCT02679729|7614371|FG004|Overall Study|Lost to Follow-up|1
4473716|NCT00670228|7268613|FG000|Overall Study|Adverse Event|1
4473717|NCT00670228|7268614|FG001|Overall Study|Adverse Event|0
4473718|NCT00670228|7268613|FG000|Overall Study|Death or MACE|0
4473719|NCT00670228|7268614|FG001|Overall Study|Death or MACE|1
4473720|NCT00670228|7268613|FG000|Overall Study|Not treated|2
4473721|NCT00670228|7268614|FG001|Overall Study|Not treated|2
4473722|NCT00670228|7268613|FG000|Overall Study|Not meeting the selection criteria|2
4473723|NCT00670228|7268614|FG001|Overall Study|Not meeting the selection criteria|0
4473724|NCT00670306|7268639|FG000|Overall Study|Adverse Event|8
4473725|NCT00670306|7268639|FG000|Overall Study|Lack of Efficacy|10
4473726|NCT00670306|7268639|FG000|Overall Study|Withdrawal by Subject|9
4473727|NCT00670306|7268639|FG000|Overall Study|Physician Decision|1
4473728|NCT00670306|7268639|FG000|Overall Study|Lost to Follow-up|8
4473729|NCT00670306|7268639|FG000|Overall Study|incl/excl criterias did not meet|19
4473730|NCT00670449|7268647|FG000|Overall Study|Adverse Event|6
4473731|NCT00670449|7268648|FG001|Overall Study|Adverse Event|2
4473732|NCT00670449|7268649|FG002|Overall Study|Adverse Event|8
4473733|NCT00670449|7268650|FG003|Overall Study|Adverse Event|5
4473734|NCT00670449|7268647|FG000|Overall Study|Protocol Deviation|1
4473735|NCT00670449|7268648|FG001|Overall Study|Protocol Deviation|2
4473736|NCT00670449|7268649|FG002|Overall Study|Protocol Deviation|0
4473737|NCT00670449|7268650|FG003|Overall Study|Protocol Deviation|1
4473738|NCT00670449|7268647|FG000|Overall Study|Administrative Problems|0
4473739|NCT00670449|7268648|FG001|Overall Study|Administrative Problems|2
4473740|NCT00670449|7268649|FG002|Overall Study|Administrative Problems|0
4473741|NCT00670449|7268650|FG003|Overall Study|Administrative Problems|1
4473742|NCT00670449|7268647|FG000|Overall Study|Subject Withdrew Consent|0
4473743|NCT00670449|7268648|FG001|Overall Study|Subject Withdrew Consent|2
4473744|NCT00670449|7268649|FG002|Overall Study|Subject Withdrew Consent|0
4473745|NCT00670449|7268650|FG003|Overall Study|Subject Withdrew Consent|1
4473746|NCT00670449|7268647|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2
4473747|NCT00670449|7268648|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0
4473748|NCT00670449|7268649|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1
4473749|NCT00670449|7268650|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0
4473750|NCT00670449|7268647|FG000|Overall Study|Abnormal Laboratory Value(s)|0
4473751|NCT00670449|7268648|FG001|Overall Study|Abnormal Laboratory Value(s)|2
4473752|NCT00670449|7268649|FG002|Overall Study|Abnormal Laboratory Value(s)|0
4473753|NCT00670449|7268650|FG003|Overall Study|Abnormal Laboratory Value(s)|0
4473754|NCT00670488|7268680|FG000|Overall Study|Adverse Event|0
4473755|NCT00670488|7268681|FG001|Overall Study|Adverse Event|7
4473756|NCT00670488|7268682|FG002|Overall Study|Adverse Event|0
4473757|NCT00670488|7268683|FG003|Overall Study|Adverse Event|3
4473758|NCT00670488|7268684|FG004|Overall Study|Adverse Event|1
4473759|NCT00670488|7268685|FG005|Overall Study|Adverse Event|1
4473760|NCT00670488|7268686|FG006|Overall Study|Adverse Event|5
4473761|NCT00670488|7268687|FG007|Overall Study|Adverse Event|1
4473762|NCT00670488|7268688|FG008|Overall Study|Adverse Event|0
4473763|NCT00670488|7268689|FG009|Overall Study|Adverse Event|1
4473764|NCT00670488|7268680|FG000|Overall Study|Physician Decision|1
4473765|NCT00670488|7268681|FG001|Overall Study|Physician Decision|9
4473766|NCT00670488|7268682|FG002|Overall Study|Physician Decision|0
4473767|NCT00670488|7268683|FG003|Overall Study|Physician Decision|1
4473768|NCT00670488|7268684|FG004|Overall Study|Physician Decision|0
4473769|NCT00670488|7268685|FG005|Overall Study|Physician Decision|0
4473770|NCT00670488|7268686|FG006|Overall Study|Physician Decision|0
4473771|NCT00670488|7268687|FG007|Overall Study|Physician Decision|0
4473772|NCT00670488|7268688|FG008|Overall Study|Physician Decision|0
4473773|NCT00670488|7268689|FG009|Overall Study|Physician Decision|0
4473774|NCT00670488|7268680|FG000|Overall Study|Progressive Disease|2
4473775|NCT00670488|7268681|FG001|Overall Study|Progressive Disease|41
4473776|NCT00670488|7268682|FG002|Overall Study|Progressive Disease|3
4473777|NCT00670488|7268683|FG003|Overall Study|Progressive Disease|2
4473778|NCT00670488|7268684|FG004|Overall Study|Progressive Disease|2
4473779|NCT00670488|7268685|FG005|Overall Study|Progressive Disease|4
4473780|NCT00670488|7268686|FG006|Overall Study|Progressive Disease|11
4473781|NCT00670488|7268687|FG007|Overall Study|Progressive Disease|2
4473782|NCT00670488|7268688|FG008|Overall Study|Progressive Disease|2
4473783|NCT00670488|7268689|FG009|Overall Study|Progressive Disease|1
4473784|NCT00670488|7268680|FG000|Overall Study|Withdrawal by Subject|0
4473785|NCT00670488|7268681|FG001|Overall Study|Withdrawal by Subject|1
4473786|NCT00670488|7268682|FG002|Overall Study|Withdrawal by Subject|0
4473787|NCT00670488|7268683|FG003|Overall Study|Withdrawal by Subject|1
4473788|NCT00670488|7268684|FG004|Overall Study|Withdrawal by Subject|0
4473789|NCT00670488|7268685|FG005|Overall Study|Withdrawal by Subject|0
4473790|NCT00670488|7268686|FG006|Overall Study|Withdrawal by Subject|1
4473791|NCT00670488|7268687|FG007|Overall Study|Withdrawal by Subject|0
4473792|NCT00670488|7268688|FG008|Overall Study|Withdrawal by Subject|1
4473793|NCT00670488|7268689|FG009|Overall Study|Withdrawal by Subject|0
4473794|NCT00670540|7268711|FG000|Overall Study|ineligible|17
4473795|NCT00670540|7268711|FG000|Overall Study|not living in France|348
4473796|NCT00670540|7268711|FG000|Overall Study|refused to participate|189
4473797|NCT00670540|7268711|FG000|Overall Study|controls randomised for no follow up|2770
4473798|NCT00670540|7268711|FG000|Overall Study|missing information inclusion criteria|1
4473799|NCT00670748|7268728|FG000|Overall Study|Death during treatment|1
4473800|NCT00670748|7268729|FG001|Overall Study|Death during treatment|1
4473801|NCT00670748|7268730|FG002|Overall Study|Death during treatment|1
4473802|NCT00670748|7268731|FG003|Overall Study|Death during treatment|0
4473803|NCT00670748|7268728|FG000|Overall Study|Not off study|2
4473804|NCT00670748|7268729|FG001|Overall Study|Not off study|1
4473805|NCT00670748|7268730|FG002|Overall Study|Not off study|1
4473806|NCT00670748|7268731|FG003|Overall Study|Not off study|1
4473807|NCT00670800|7268747|FG000|Overall Study|2 controls were insulin resistant|0
4473808|NCT00670800|7268748|FG001|Overall Study|2 controls were insulin resistant|2
4473809|NCT00670930|7268758|FG000|Overall Study|Adminstrative Problem|0
4473810|NCT00670930|7268759|FG001|Overall Study|Adminstrative Problem|1
4473811|NCT00670930|7268758|FG000|Overall Study|Lost to Follow-up|1
4473812|NCT00670930|7268759|FG001|Overall Study|Lost to Follow-up|0
4473813|NCT00671034|7268780|FG000|Overall Study|Adverse Event|5
4473814|NCT00671034|7268781|FG001|Overall Study|Adverse Event|7
4473815|NCT00671034|7268782|FG002|Overall Study|Adverse Event|1
4473816|NCT00671034|7268780|FG000|Overall Study|Death|3
4473817|NCT00671034|7268781|FG001|Overall Study|Death|2
4473818|NCT00671034|7268782|FG002|Overall Study|Death|1
4473819|NCT00671034|7268780|FG000|Overall Study|Physician Decision|12
4473820|NCT00671034|7268781|FG001|Overall Study|Physician Decision|4
4473821|NCT00671034|7268782|FG002|Overall Study|Physician Decision|5
4473822|NCT00671034|7268780|FG000|Overall Study|VHR ALL feature|8
4473823|NCT00671034|7268781|FG001|Overall Study|VHR ALL feature|3
4473824|NCT00671034|7268782|FG002|Overall Study|VHR ALL feature|5
4473825|NCT00671034|7268780|FG000|Overall Study|Refusal|5
4473826|NCT00671034|7268781|FG001|Overall Study|Refusal|3
4473827|NCT00671034|7268782|FG002|Overall Study|Refusal|5
4473828|NCT00671034|7268780|FG000|Overall Study|includes Alternative therapy, etc.|6
4473829|NCT00671034|7268781|FG001|Overall Study|includes Alternative therapy, etc.|1
4473830|NCT00671034|7268782|FG002|Overall Study|includes Alternative therapy, etc.|7
4473831|NCT00671060|7268793|FG000|Overall Study|Protocol Violation|1
4473832|NCT00671060|7268794|FG001|Overall Study|Protocol Violation|0
4473833|NCT00671060|7268793|FG000|Overall Study|Physician Decision|0
4473834|NCT00671060|7268794|FG001|Overall Study|Physician Decision|1
4473835|NCT00671437|7268809|FG000|Overall Study|Progressive disease before C1 week 8|8
4473836|NCT00671437|7268809|FG000|Overall Study|Cutaneous SCC of head and neck|3
4473837|NCT00671437|7268809|FG000|Overall Study|Adverse Event|3
4473838|NCT00671437|7268809|FG000|Overall Study|Ineligible post-hoc|1
4473839|NCT00671554|7268838|FG000|Overall Study|Disease progression|3
4473840|NCT00671658|7268843|FG000|Overall Study|Physician Decision|5
4473841|NCT00671749|7268870|FG000|Overall Study|Adverse Event|2
4473842|NCT00671749|7268870|FG000|Overall Study|Withdrawal by Subject|4
4473843|NCT00671749|7268870|FG000|Overall Study|Protocol Violation|1
4473844|NCT00671749|7268870|FG000|Overall Study|Lost to Follow-up|1
4473845|NCT00671788|7268874|FG000|Overall Study|Adverse Event|8
4473846|NCT00671788|7268874|FG000|Overall Study|Refused further treatment|3
4473847|NCT00671788|7268874|FG000|Overall Study|Ineligible|1
4473848|NCT00671788|7268874|FG000|Overall Study|MD Decision|1
4473849|NCT00671788|7268874|FG000|Overall Study|Other|1
4473850|NCT00671853|7268880|FG000|Overall Study|Lack of Efficacy|3
4473851|NCT00671853|7268881|FG001|Overall Study|Lack of Efficacy|7
4473852|NCT00671853|7268880|FG000|Overall Study|Adverse Event|7
4473853|NCT00671853|7268881|FG001|Overall Study|Adverse Event|1
4473854|NCT00671853|7268880|FG000|Overall Study|Withdrawal by Subject|1
4473855|NCT00671853|7268881|FG001|Overall Study|Withdrawal by Subject|5
4473856|NCT00671853|7268880|FG000|Overall Study|Lost to Follow-up|8
4473857|NCT00671853|7268881|FG001|Overall Study|Lost to Follow-up|8
4473858|NCT00671853|7268880|FG000|Overall Study|Physician Decision|0
4473859|NCT00671853|7268881|FG001|Overall Study|Physician Decision|2
4473860|NCT00671853|7268880|FG000|Overall Study|Non-adherence with study procedures|1
4473861|NCT00671853|7268881|FG001|Overall Study|Non-adherence with study procedures|4
4473862|NCT00671879|7268892|FG000|Overall Study|Withdrawal by Subject|0
4473863|NCT00671879|7268893|FG001|Overall Study|Withdrawal by Subject|4
4699136|NCT02679729|7614372|FG005|Overall Study|Lost to Follow-up|0
4699137|NCT02679729|7614373|FG006|Overall Study|Lost to Follow-up|0
4699138|NCT02679729|7614374|FG007|Overall Study|Lost to Follow-up|0
4699139|NCT02679729|7614375|FG008|Overall Study|Lost to Follow-up|0
4699140|NCT02679729|7614367|FG000|Overall Study|Participant decision|0
4699141|NCT02679729|7614368|FG001|Overall Study|Participant decision|1
4699142|NCT02679729|7614369|FG002|Overall Study|Participant decision|0
4699143|NCT02679729|7614370|FG003|Overall Study|Participant decision|0
4699144|NCT02679729|7614371|FG004|Overall Study|Participant decision|0
4699145|NCT02679729|7614372|FG005|Overall Study|Participant decision|0
4473864|NCT00671879|7268894|FG002|Overall Study|Withdrawal by Subject|6
4473865|NCT00671931|7268913|FG000|Overall Study|Physician Decision|1
4473866|NCT00671931|7268914|FG001|Overall Study|Physician Decision|0
4473867|NCT00671931|7268915|FG002|Overall Study|Physician Decision|0
4473868|NCT00671931|7268916|FG003|Overall Study|Physician Decision|2
4473869|NCT00671931|7268917|FG004|Overall Study|Physician Decision|1
4473870|NCT00672139|7268969|FG000|Overall Study|Death|14
4473871|NCT00672139|7268970|FG001|Overall Study|Death|23
4699146|NCT02679729|7614373|FG006|Overall Study|Participant decision|1
4473872|NCT00672139|7268969|FG000|Overall Study|Withdrawal by Subject|2
4473873|NCT00672139|7268970|FG001|Overall Study|Withdrawal by Subject|11
4473874|NCT00672139|7268969|FG000|Overall Study|Adverse Event|4
4473875|NCT00672139|7268970|FG001|Overall Study|Adverse Event|7
4473876|NCT00672139|7268969|FG000|Overall Study|Physician Decision|2
4473877|NCT00672139|7268970|FG001|Overall Study|Physician Decision|0
4473878|NCT00672139|7268969|FG000|Overall Study|Lack of Efficacy|4
4473879|NCT00672139|7268970|FG001|Overall Study|Lack of Efficacy|1
4473880|NCT00672139|7268969|FG000|Overall Study|Protocol Violation|1
4473881|NCT00672139|7268970|FG001|Overall Study|Protocol Violation|1
4473882|NCT00672139|7268969|FG000|Overall Study|hospice discharge, caregiver requests|3
4473883|NCT00672139|7268970|FG001|Overall Study|hospice discharge, caregiver requests|2
4473884|NCT00672256|7268985|FG000|Overall Study|PI dropped, bad data|44
4473885|NCT00672477|7269009|FG000|Overall Study|Adverse Event|10
4473886|NCT00672477|7269010|FG001|Overall Study|Adverse Event|7
4473887|NCT00672477|7269009|FG000|Overall Study|Death|7
4473888|NCT00672477|7269010|FG001|Overall Study|Death|11
4473889|NCT00672477|7269009|FG000|Overall Study|Physician Decision|2
4473890|NCT00672477|7269010|FG001|Overall Study|Physician Decision|0
4473891|NCT00672477|7269009|FG000|Overall Study|Protocol Violation|1
4473892|NCT00672477|7269010|FG001|Overall Study|Protocol Violation|1
4473893|NCT00672477|7269009|FG000|Overall Study|Withdrawal by Subject|5
4473894|NCT00672477|7269010|FG001|Overall Study|Withdrawal by Subject|3
4473895|NCT00672477|7269009|FG000|Overall Study|Lack of Efficacy|1
4473896|NCT00672477|7269010|FG001|Overall Study|Lack of Efficacy|1
4473897|NCT00672477|7269009|FG000|Overall Study|no study drug for low GFR, health cond.|1
4473898|NCT00672477|7269010|FG001|Overall Study|no study drug for low GFR, health cond.|3
4473899|NCT00672490|7269018|FG000|Overall Study|Withdrawal by Subject|8
4473900|NCT00672490|7269019|FG001|Overall Study|Withdrawal by Subject|8
4473901|NCT00672490|7269018|FG000|Overall Study|Lack of Compliance|2
4473902|NCT00672490|7269019|FG001|Overall Study|Lack of Compliance|7
4473903|NCT00672490|7269018|FG000|Overall Study|Mismatch Include/Exclude Criteria|1
4473904|NCT00672490|7269019|FG001|Overall Study|Mismatch Include/Exclude Criteria|0
4473905|NCT00672490|7269018|FG000|Overall Study|Adverse Event|5
4473906|NCT00672490|7269019|FG001|Overall Study|Adverse Event|8
4473907|NCT00672490|7269018|FG000|Overall Study|Violation of Concomitant Medicine|1
4473908|NCT00672490|7269019|FG001|Overall Study|Violation of Concomitant Medicine|0
4473909|NCT00672490|7269018|FG000|Overall Study|Intolerance|0
4473910|NCT00672490|7269019|FG001|Overall Study|Intolerance|2
4473911|NCT00672490|7269018|FG000|Overall Study|Lost to Follow-up|1
4473912|NCT00672490|7269019|FG001|Overall Study|Lost to Follow-up|5
4473913|NCT00672490|7269018|FG000|Overall Study|No reason was provided|6
4473914|NCT00672490|7269019|FG001|Overall Study|No reason was provided|2
4473915|NCT00672555|7269025|FG000|Overall Study|Lost to Follow-up|4
4473916|NCT00672555|7269025|FG000|Overall Study|Did not want to answer questionnaire|2
4473917|NCT00672620|7269037|FG000|Overall Study|Adverse Event|7
4589138|NCT01508702|7434152|FG000|Overall Study|Adverse Event|7
4589139|NCT01508702|7434153|FG001|Overall Study|Adverse Event|3
4589140|NCT01508702|7434152|FG000|Overall Study|Gout flare|2
4589141|NCT01508702|7434153|FG001|Overall Study|Gout flare|0
4473918|NCT00672620|7269038|FG001|Overall Study|Adverse Event|7
4473919|NCT00672620|7269039|FG002|Overall Study|Adverse Event|12
4473920|NCT00672620|7269040|FG003|Overall Study|Adverse Event|17
4473921|NCT00672620|7269037|FG000|Overall Study|Lack of Efficacy|1
4473922|NCT00672620|7269038|FG001|Overall Study|Lack of Efficacy|2
4473923|NCT00672620|7269039|FG002|Overall Study|Lack of Efficacy|2
4473924|NCT00672620|7269040|FG003|Overall Study|Lack of Efficacy|0
4473925|NCT00672620|7269037|FG000|Overall Study|Noncompliance with Study Drug|3
4473926|NCT00672620|7269038|FG001|Overall Study|Noncompliance with Study Drug|4
4473927|NCT00672620|7269039|FG002|Overall Study|Noncompliance with Study Drug|0
4473928|NCT00672620|7269040|FG003|Overall Study|Noncompliance with Study Drug|2
4473929|NCT00672620|7269037|FG000|Overall Study|Protocol Deviations|5
4473930|NCT00672620|7269038|FG001|Overall Study|Protocol Deviations|7
4473931|NCT00672620|7269039|FG002|Overall Study|Protocol Deviations|2
4473932|NCT00672620|7269040|FG003|Overall Study|Protocol Deviations|5
4473933|NCT00672620|7269037|FG000|Overall Study|Withdrawal of Consent|6
4473934|NCT00672620|7269038|FG001|Overall Study|Withdrawal of Consent|12
4473935|NCT00672620|7269039|FG002|Overall Study|Withdrawal of Consent|5
4473936|NCT00672620|7269040|FG003|Overall Study|Withdrawal of Consent|6
4473937|NCT00672620|7269037|FG000|Overall Study|Lost to Follow-up|8
4473938|NCT00672620|7269038|FG001|Overall Study|Lost to Follow-up|19
4473939|NCT00672620|7269039|FG002|Overall Study|Lost to Follow-up|8
4473940|NCT00672620|7269040|FG003|Overall Study|Lost to Follow-up|11
4473941|NCT00672620|7269037|FG000|Overall Study|Reason not Specified|3
4473942|NCT00672620|7269038|FG001|Overall Study|Reason not Specified|3
4473943|NCT00672620|7269039|FG002|Overall Study|Reason not Specified|2
4589142|NCT01508702|7434152|FG000|Overall Study|Protocol Violation|2
4473944|NCT00672620|7269040|FG003|Overall Study|Reason not Specified|1
4473945|NCT00672633|7269052|FG000|Overall Study|Withdrawal by Subject|0
4473946|NCT00672633|7269053|FG001|Overall Study|Withdrawal by Subject|1
4473947|NCT00672646|7269062|FG000|Overall Study|Lost to Follow-up|0
4473948|NCT00672646|7269063|FG001|Overall Study|Lost to Follow-up|1
4473949|NCT00672646|7269064|FG002|Overall Study|Lost to Follow-up|2
4473950|NCT00672646|7269062|FG000|Overall Study|Withdrawal by Subject|0
4473951|NCT00672646|7269063|FG001|Overall Study|Withdrawal by Subject|0
4473952|NCT00672646|7269064|FG002|Overall Study|Withdrawal by Subject|1
4589143|NCT01508702|7434153|FG001|Overall Study|Protocol Violation|1
4589144|NCT01508702|7434152|FG000|Overall Study|Lost to Follow-up|1
4473953|NCT00672841|7269079|FG000|Overall Study|Comfort care|1
4473954|NCT00672841|7269080|FG001|Overall Study|Comfort care|4
4473955|NCT00672841|7269079|FG000|Overall Study|icteric specimens|0
4473956|NCT00672841|7269080|FG001|Overall Study|icteric specimens|3
4473957|NCT00672841|7269079|FG000|Overall Study|Antifungal therapy, negative glucan|0
4473958|NCT00672841|7269080|FG001|Overall Study|Antifungal therapy, negative glucan|4
4473959|NCT00672841|7269079|FG000|Overall Study|Adverse Event|0
4473960|NCT00672841|7269080|FG001|Overall Study|Adverse Event|3
4589145|NCT01508702|7434153|FG001|Overall Study|Lost to Follow-up|2
4589146|NCT01508702|7434152|FG000|Overall Study|Withdrawal by Subject|11
4589147|NCT01508702|7434153|FG001|Overall Study|Withdrawal by Subject|7
4589148|NCT01508910|7434171|FG000|Treatment|Death|2
4589149|NCT01508910|7434172|FG001|Treatment|Death|3
4589150|NCT01508910|7434173|FG002|Treatment|Death|2
4589151|NCT01508910|7434174|FG003|Treatment|Death|0
4589152|NCT01508910|7434171|FG000|Treatment|Lost to Follow-up|0
4589153|NCT01508910|7434172|FG001|Treatment|Lost to Follow-up|0
4589154|NCT01508910|7434173|FG002|Treatment|Lost to Follow-up|2
4589155|NCT01508910|7434174|FG003|Treatment|Lost to Follow-up|1
4589156|NCT01508910|7434171|FG000|Treatment|Withdrawal by Subject|0
4589157|NCT01508910|7434172|FG001|Treatment|Withdrawal by Subject|1
4589158|NCT01508910|7434173|FG002|Treatment|Withdrawal by Subject|6
4589159|NCT01508910|7434174|FG003|Treatment|Withdrawal by Subject|1
4589160|NCT01508910|7434171|FG000|Treatment|Sponsor Decision|0
4589161|NCT01508910|7434172|FG001|Treatment|Sponsor Decision|0
4589162|NCT01508910|7434173|FG002|Treatment|Sponsor Decision|0
4589163|NCT01508910|7434174|FG003|Treatment|Sponsor Decision|1
4589164|NCT01508936|7434188|FG000|Overall Study|Adverse Event|11
4473961|NCT00672841|7269079|FG000|Overall Study|Pregnancy|0
4473962|NCT00672841|7269080|FG001|Overall Study|Pregnancy|1
4473963|NCT00672958|7269111|FG000|Overall Study|Adverse Event|11
4473964|NCT00672958|7269112|FG001|Overall Study|Adverse Event|9
4473965|NCT00672958|7269111|FG000|Overall Study|Lack of Efficacy|6
4473966|NCT00672958|7269112|FG001|Overall Study|Lack of Efficacy|11
4473967|NCT00672958|7269111|FG000|Overall Study|Non-compliance with study drug|2
4473968|NCT00672958|7269112|FG001|Overall Study|Non-compliance with study drug|3
4473969|NCT00672958|7269111|FG000|Overall Study|Protocol deviations|11
4473970|NCT00672958|7269112|FG001|Overall Study|Protocol deviations|5
4473971|NCT00672958|7269111|FG000|Overall Study|Voluntary withdrawal|12
4473972|NCT00672958|7269112|FG001|Overall Study|Voluntary withdrawal|8
4473973|NCT00672958|7269111|FG000|Overall Study|Lost to Follow-up|22
4473974|NCT00672958|7269112|FG001|Overall Study|Lost to Follow-up|17
4473975|NCT00672958|7269111|FG000|Overall Study|Reason not specified|0
4473976|NCT00672958|7269112|FG001|Overall Study|Reason not specified|3
4473977|NCT00672984|7269121|FG000|First Intervention|Adverse Event|5
4473978|NCT00672984|7269122|FG001|First Intervention|Adverse Event|0
4473979|NCT00672984|7269123|FG002|First Intervention|Adverse Event|0
4473980|NCT00672984|7269121|FG000|First Intervention|Withdrawal by Subject|1
4473981|NCT00672984|7269122|FG001|First Intervention|Withdrawal by Subject|2
4473982|NCT00672984|7269123|FG002|First Intervention|Withdrawal by Subject|2
4473983|NCT00672984|7269121|FG000|First Intervention|Sponsor decision|3
4473984|NCT00672984|7269122|FG001|First Intervention|Sponsor decision|0
4473985|NCT00672984|7269123|FG002|First Intervention|Sponsor decision|0
4473986|NCT00672984|7269121|FG000|Second Intervention|Non-compliance with facility policies|0
4473987|NCT00672984|7269122|FG001|Second Intervention|Non-compliance with facility policies|2
4473988|NCT00672984|7269123|FG002|Second Intervention|Non-compliance with facility policies|0
4473989|NCT00672984|7269121|FG000|Second Intervention|Withdrawal by Subject|0
4473990|NCT00672984|7269122|FG001|Second Intervention|Withdrawal by Subject|3
4473991|NCT00672984|7269123|FG002|Second Intervention|Withdrawal by Subject|0
4473992|NCT00672984|7269121|FG000|Second Intervention|Protocol Violation|0
4473993|NCT00672984|7269122|FG001|Second Intervention|Protocol Violation|1
4473994|NCT00672984|7269123|FG002|Second Intervention|Protocol Violation|1
4473995|NCT00672984|7269121|FG000|Third Intervention|Adverse Event|1
4473996|NCT00672984|7269122|FG001|Third Intervention|Adverse Event|0
4473997|NCT00672984|7269123|FG002|Third Intervention|Adverse Event|1
4473998|NCT00673049|7269135|FG000|Before Progression on Erlotinib|Randomized but not treated|3
4473999|NCT00673049|7269136|FG001|Before Progression on Erlotinib|Randomized but not treated|1
4474000|NCT00673049|7269137|FG002|Before Progression on Erlotinib|Randomized but not treated|0
4474001|NCT00673049|7269138|FG003|Before Progression on Erlotinib|Randomized but not treated|0
4474002|NCT00673049|7269135|FG000|Before Progression on Erlotinib|Death|235
4474003|NCT00673049|7269136|FG001|Before Progression on Erlotinib|Death|167
4474004|NCT00673049|7269137|FG002|Before Progression on Erlotinib|Death|1
4474005|NCT00673049|7269138|FG003|Before Progression on Erlotinib|Death|0
4474006|NCT00673049|7269135|FG000|Before Progression on Erlotinib|Lost to Follow-up|9
4474007|NCT00673049|7269136|FG001|Before Progression on Erlotinib|Lost to Follow-up|5
4474008|NCT00673049|7269137|FG002|Before Progression on Erlotinib|Lost to Follow-up|0
4474009|NCT00673049|7269138|FG003|Before Progression on Erlotinib|Lost to Follow-up|0
4589165|NCT01508936|7434189|FG001|Overall Study|Adverse Event|32
4474010|NCT00673049|7269135|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26
4589166|NCT01508936|7434188|FG000|Overall Study|Lack of Efficacy|0
4589167|NCT01508936|7434189|FG001|Overall Study|Lack of Efficacy|1
4589168|NCT01508936|7434188|FG000|Overall Study|Withdrawal by Subject|4
4474011|NCT00673049|7269136|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18
4474012|NCT00673049|7269137|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0
4474013|NCT00673049|7269138|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0
4474014|NCT00673049|7269135|FG000|Before Progression on Erlotinib|Other|1
4474015|NCT00673049|7269136|FG001|Before Progression on Erlotinib|Other|2
4699147|NCT02679729|7614374|FG007|Overall Study|Participant decision|0
4699148|NCT02679729|7614375|FG008|Overall Study|Participant decision|0
4699149|NCT02679755|7614409|FG000|Overall Study|Death|0
4699150|NCT02679755|7614410|FG001|Overall Study|Death|3
4699151|NCT02679755|7614409|FG000|Overall Study|Global deterioration of health status|1
4699152|NCT02679755|7614410|FG001|Overall Study|Global deterioration of health status|8
4699153|NCT02679755|7614409|FG000|Overall Study|Lost to Follow-up|1
4699154|NCT02679755|7614410|FG001|Overall Study|Lost to Follow-up|0
4699155|NCT02679755|7614409|FG000|Overall Study|Objective progression or relapse|24
4699156|NCT02679755|7614410|FG001|Overall Study|Objective progression or relapse|83
4699157|NCT02679755|7614409|FG000|Overall Study|Not defined|0
4699158|NCT02679755|7614410|FG001|Overall Study|Not defined|2
4699159|NCT02679755|7614409|FG000|Overall Study|Withdrawal by participant|6
4474016|NCT00673049|7269137|FG002|Before Progression on Erlotinib|Other|0
4474017|NCT00673049|7269138|FG003|Before Progression on Erlotinib|Other|0
4474018|NCT00673049|7269135|FG000|Before Progression on Erlotinib|study terminated by sponsor|18
4474019|NCT00673049|7269136|FG001|Before Progression on Erlotinib|study terminated by sponsor|14
4474020|NCT00673049|7269137|FG002|Before Progression on Erlotinib|study terminated by sponsor|0
4474021|NCT00673049|7269138|FG003|Before Progression on Erlotinib|study terminated by sponsor|0
4474022|NCT00673049|7269135|FG000|Before Progression on Erlotinib|Switched to figitumumab|0
4474023|NCT00673049|7269136|FG001|Before Progression on Erlotinib|Switched to figitumumab|83
4474024|NCT00673049|7269137|FG002|Before Progression on Erlotinib|Switched to figitumumab|0
4474025|NCT00673049|7269138|FG003|Before Progression on Erlotinib|Switched to figitumumab|0
4474026|NCT00673049|7269135|FG000|After Progression on Erlotinib|Death|0
4474027|NCT00673049|7269136|FG001|After Progression on Erlotinib|Death|0
4474028|NCT00673049|7269137|FG002|After Progression on Erlotinib|Death|0
4474029|NCT00673049|7269138|FG003|After Progression on Erlotinib|Death|71
4474030|NCT00673049|7269135|FG000|After Progression on Erlotinib|Lost to Follow-up|0
4474031|NCT00673049|7269136|FG001|After Progression on Erlotinib|Lost to Follow-up|0
4474032|NCT00673049|7269137|FG002|After Progression on Erlotinib|Lost to Follow-up|0
4474033|NCT00673049|7269138|FG003|After Progression on Erlotinib|Lost to Follow-up|3
4474034|NCT00673049|7269135|FG000|After Progression on Erlotinib|Withdrawal by Subject|0
4474035|NCT00673049|7269136|FG001|After Progression on Erlotinib|Withdrawal by Subject|0
4474036|NCT00673049|7269137|FG002|After Progression on Erlotinib|Withdrawal by Subject|0
4474037|NCT00673049|7269138|FG003|After Progression on Erlotinib|Withdrawal by Subject|5
4474038|NCT00673049|7269135|FG000|After Progression on Erlotinib|study terminated by sponsor|0
4474039|NCT00673049|7269136|FG001|After Progression on Erlotinib|study terminated by sponsor|0
4474040|NCT00673049|7269137|FG002|After Progression on Erlotinib|study terminated by sponsor|0
4474041|NCT00673049|7269138|FG003|After Progression on Erlotinib|study terminated by sponsor|4
4474042|NCT00673231|7269174|FG000|Overall Study|Withdrawal by Subject|14
4474043|NCT00673231|7269175|FG001|Overall Study|Withdrawal by Subject|10
4474044|NCT00673231|7269176|FG002|Overall Study|Withdrawal by Subject|8
4474045|NCT00673231|7269177|FG003|Overall Study|Withdrawal by Subject|6
4474046|NCT00673231|7269174|FG000|Overall Study|Adverse Event|6
4474047|NCT00673231|7269175|FG001|Overall Study|Adverse Event|5
4474048|NCT00673231|7269176|FG002|Overall Study|Adverse Event|9
4474049|NCT00673231|7269177|FG003|Overall Study|Adverse Event|6
4474050|NCT00673231|7269174|FG000|Overall Study|Lost to Follow-up|1
4474051|NCT00673231|7269175|FG001|Overall Study|Lost to Follow-up|2
4474052|NCT00673231|7269176|FG002|Overall Study|Lost to Follow-up|1
4474053|NCT00673231|7269177|FG003|Overall Study|Lost to Follow-up|2
4474054|NCT00673231|7269174|FG000|Overall Study|Death|0
4474055|NCT00673231|7269175|FG001|Overall Study|Death|0
4474056|NCT00673231|7269176|FG002|Overall Study|Death|1
4474057|NCT00673231|7269177|FG003|Overall Study|Death|0
4474058|NCT00673231|7269174|FG000|Overall Study|Study criteria,compliance,safety, other|8
4474059|NCT00673231|7269175|FG001|Overall Study|Study criteria,compliance,safety, other|5
4474060|NCT00673231|7269176|FG002|Overall Study|Study criteria,compliance,safety, other|7
4474061|NCT00673231|7269177|FG003|Overall Study|Study criteria,compliance,safety, other|4
4474062|NCT00673257|7269196|FG000|Overall Study|Withdrawal by Subject|4
4474063|NCT00673257|7269196|FG000|Overall Study|Unable to obtain specimen|1
4474064|NCT00673387|7269208|FG000|Overall Study|Withdrawal by Subject|15
4474065|NCT00673387|7269209|FG001|Overall Study|Withdrawal by Subject|16
4474066|NCT00673387|7269210|FG002|Overall Study|Withdrawal by Subject|20
4474067|NCT00673387|7269211|FG003|Overall Study|Withdrawal by Subject|16
4474068|NCT00673387|7269212|FG004|Overall Study|Withdrawal by Subject|18
4474069|NCT00673387|7269213|FG005|Overall Study|Withdrawal by Subject|21
4474070|NCT00673387|7269214|FG006|Overall Study|Withdrawal by Subject|15
4699160|NCT02679755|7614410|FG001|Overall Study|Withdrawal by participant|3
4474071|NCT00673387|7269215|FG007|Overall Study|Withdrawal by Subject|21
4474072|NCT00673387|7269208|FG000|Overall Study|Adverse Event|3
4474073|NCT00673387|7269209|FG001|Overall Study|Adverse Event|1
4699161|NCT02679755|7614409|FG000|Overall Study|Adverse Event|1
4474074|NCT00673387|7269210|FG002|Overall Study|Adverse Event|5
4474075|NCT00673387|7269211|FG003|Overall Study|Adverse Event|2
4474076|NCT00673387|7269212|FG004|Overall Study|Adverse Event|6
4474077|NCT00673387|7269213|FG005|Overall Study|Adverse Event|2
4474078|NCT00673387|7269214|FG006|Overall Study|Adverse Event|5
4474079|NCT00673387|7269215|FG007|Overall Study|Adverse Event|5
4474080|NCT00673387|7269208|FG000|Overall Study|Physician Decision|0
4474081|NCT00673387|7269209|FG001|Overall Study|Physician Decision|0
4474082|NCT00673387|7269210|FG002|Overall Study|Physician Decision|0
4474083|NCT00673387|7269211|FG003|Overall Study|Physician Decision|0
4474084|NCT00673387|7269212|FG004|Overall Study|Physician Decision|0
4474085|NCT00673387|7269213|FG005|Overall Study|Physician Decision|5
4474086|NCT00673387|7269214|FG006|Overall Study|Physician Decision|1
4474087|NCT00673387|7269215|FG007|Overall Study|Physician Decision|1
4474088|NCT00673387|7269208|FG000|Overall Study|Protocol Violation|3
4474089|NCT00673387|7269209|FG001|Overall Study|Protocol Violation|0
4474090|NCT00673387|7269210|FG002|Overall Study|Protocol Violation|1
4474091|NCT00673387|7269211|FG003|Overall Study|Protocol Violation|2
4474092|NCT00673387|7269212|FG004|Overall Study|Protocol Violation|0
4474093|NCT00673387|7269213|FG005|Overall Study|Protocol Violation|1
4474094|NCT00673387|7269214|FG006|Overall Study|Protocol Violation|1
4474095|NCT00673387|7269215|FG007|Overall Study|Protocol Violation|3
4474096|NCT00673387|7269208|FG000|Overall Study|Lost to Follow-up|8
4474097|NCT00673387|7269209|FG001|Overall Study|Lost to Follow-up|6
4474098|NCT00673387|7269210|FG002|Overall Study|Lost to Follow-up|5
4474099|NCT00673387|7269211|FG003|Overall Study|Lost to Follow-up|6
4474100|NCT00673387|7269212|FG004|Overall Study|Lost to Follow-up|6
4474101|NCT00673387|7269213|FG005|Overall Study|Lost to Follow-up|5
4474102|NCT00673387|7269214|FG006|Overall Study|Lost to Follow-up|8
4474103|NCT00673387|7269215|FG007|Overall Study|Lost to Follow-up|5
4474104|NCT00673452|7269260|FG000|Acute Double-Blind Phase|Adverse Event|41
4474105|NCT00673452|7269261|FG001|Acute Double-Blind Phase|Adverse Event|24
4474106|NCT00673452|7269260|FG000|Acute Double-Blind Phase|Lack of Efficacy|9
4474107|NCT00673452|7269261|FG001|Acute Double-Blind Phase|Lack of Efficacy|14
4474108|NCT00673452|7269260|FG000|Acute Double-Blind Phase|Lost to Follow-up|16
4474109|NCT00673452|7269261|FG001|Acute Double-Blind Phase|Lost to Follow-up|19
4474110|NCT00673452|7269260|FG000|Acute Double-Blind Phase|Physician Decision|0
4474111|NCT00673452|7269261|FG001|Acute Double-Blind Phase|Physician Decision|6
4474112|NCT00673452|7269260|FG000|Acute Double-Blind Phase|Protocol Violation|5
4474113|NCT00673452|7269261|FG001|Acute Double-Blind Phase|Protocol Violation|3
4474114|NCT00673452|7269260|FG000|Acute Double-Blind Phase|Sponsor Decision|0
4474115|NCT00673452|7269261|FG001|Acute Double-Blind Phase|Sponsor Decision|1
4474116|NCT00673452|7269260|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16
4474117|NCT00673452|7269261|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13
4474118|NCT00673452|7269260|FG000|Continuation Double-Blind Phase|Adverse Event|5
4474119|NCT00673452|7269261|FG001|Continuation Double-Blind Phase|Adverse Event|13
4474120|NCT00673452|7269260|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9
4474121|NCT00673452|7269261|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5
4474122|NCT00673452|7269260|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4
4474123|NCT00673452|7269261|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5
4474124|NCT00673452|7269260|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2
4474125|NCT00673452|7269261|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5
4474126|NCT00673452|7269260|FG000|Continuation Double-Blind Phase|Protocol Violation|2
4474127|NCT00673452|7269261|FG001|Continuation Double-Blind Phase|Protocol Violation|3
4474128|NCT00673452|7269260|FG000|Continuation Double-Blind Phase|Sponsor Decision|0
4474129|NCT00673452|7269261|FG001|Continuation Double-Blind Phase|Sponsor Decision|3
4474130|NCT00673452|7269260|FG000|Continuation Double-Blind Phase|Physician Decision|2
4474131|NCT00673452|7269261|FG001|Continuation Double-Blind Phase|Physician Decision|0
4474132|NCT00673452|7269260|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1
4474133|NCT00673452|7269261|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0
4474134|NCT00673465|7269267|FG000|Part 1/Period 1 (United States)|Protocol Violation|0
4474135|NCT00673465|7269268|FG001|Part 1/Period 1 (United States)|Protocol Violation|0
4474136|NCT00673465|7269269|FG002|Part 1/Period 1 (United States)|Protocol Violation|0
4474137|NCT00673465|7269270|FG003|Part 1/Period 1 (United States)|Protocol Violation|0
4474138|NCT00673465|7269271|FG004|Part 1/Period 1 (United States)|Protocol Violation|1
4474139|NCT00673465|7269272|FG005|Part 1/Period 1 (United States)|Protocol Violation|1
4474140|NCT00673465|7269273|FG006|Part 1/Period 1 (United States)|Protocol Violation|0
4474141|NCT00673465|7269274|FG007|Part 1/Period 1 (United States)|Protocol Violation|0
4474142|NCT00673465|7269275|FG008|Part 1/Period 1 (United States)|Protocol Violation|0
4474143|NCT00673465|7269276|FG009|Part 1/Period 1 (United States)|Protocol Violation|0
4474144|NCT00673465|7269277|FG010|Part 1/Period 1 (United States)|Protocol Violation|0
4474145|NCT00673465|7269278|FG011|Part 1/Period 1 (United States)|Protocol Violation|0
4474146|NCT00673465|7269267|FG000|Part 1/Period 2 (United States)|Protocol Violation|0
4474147|NCT00673465|7269268|FG001|Part 1/Period 2 (United States)|Protocol Violation|0
4474148|NCT00673465|7269269|FG002|Part 1/Period 2 (United States)|Protocol Violation|0
4474149|NCT00673465|7269270|FG003|Part 1/Period 2 (United States)|Protocol Violation|0
4474150|NCT00673465|7269271|FG004|Part 1/Period 2 (United States)|Protocol Violation|1
4474151|NCT00673465|7269272|FG005|Part 1/Period 2 (United States)|Protocol Violation|0
4474152|NCT00673465|7269273|FG006|Part 1/Period 2 (United States)|Protocol Violation|0
4474153|NCT00673465|7269274|FG007|Part 1/Period 2 (United States)|Protocol Violation|0
4474154|NCT00673465|7269275|FG008|Part 1/Period 2 (United States)|Protocol Violation|0
4474155|NCT00673465|7269276|FG009|Part 1/Period 2 (United States)|Protocol Violation|0
4474156|NCT00673465|7269277|FG010|Part 1/Period 2 (United States)|Protocol Violation|0
4474157|NCT00673465|7269278|FG011|Part 1/Period 2 (United States)|Protocol Violation|0
4474158|NCT00673660|7269286|FG000|Overall Study|Lost to Follow-up|107
4474159|NCT00673673|7269295|FG000|Overall Study|Progressive disease|27
4474160|NCT00673673|7269295|FG000|Overall Study|Adverse Event|4
4474161|NCT00673673|7269295|FG000|Overall Study|Withdrawal by Subject|3
4474162|NCT00673673|7269295|FG000|Overall Study|Investigators' discretion|2
4474163|NCT00673790|7269322|FG000|Overall Study|Adverse Event|23
4474164|NCT00673790|7269323|FG001|Overall Study|Adverse Event|14
4474165|NCT00673790|7269324|FG002|Overall Study|Adverse Event|2
4474166|NCT00673790|7269322|FG000|Overall Study|Lack of Efficacy|2
4474167|NCT00673790|7269323|FG001|Overall Study|Lack of Efficacy|2
4474168|NCT00673790|7269324|FG002|Overall Study|Lack of Efficacy|2
4474169|NCT00673790|7269322|FG000|Overall Study|Protocol Violation|6
4474170|NCT00673790|7269323|FG001|Overall Study|Protocol Violation|9
4474171|NCT00673790|7269324|FG002|Overall Study|Protocol Violation|1
4474172|NCT00673790|7269322|FG000|Overall Study|Withdrawal by Subject|7
4474173|NCT00673790|7269323|FG001|Overall Study|Withdrawal by Subject|4
4474174|NCT00673790|7269324|FG002|Overall Study|Withdrawal by Subject|1
4474175|NCT00673790|7269322|FG000|Overall Study|Lost to Follow-up|6
4474176|NCT00673790|7269323|FG001|Overall Study|Lost to Follow-up|6
4474177|NCT00673790|7269324|FG002|Overall Study|Lost to Follow-up|5
4474178|NCT00673790|7269322|FG000|Overall Study|Sponsor Terminated due to PI oversight|0
4474179|NCT00673790|7269323|FG001|Overall Study|Sponsor Terminated due to PI oversight|1
4474180|NCT00673790|7269324|FG002|Overall Study|Sponsor Terminated due to PI oversight|0
4474181|NCT00673790|7269322|FG000|Overall Study|Poor compliance|1
4474182|NCT00673790|7269323|FG001|Overall Study|Poor compliance|0
4474183|NCT00673790|7269324|FG002|Overall Study|Poor compliance|0
4474184|NCT00673790|7269322|FG000|Overall Study|Participated in two Nebivolol studies|0
4474185|NCT00673790|7269323|FG001|Overall Study|Participated in two Nebivolol studies|0
4474186|NCT00673790|7269324|FG002|Overall Study|Participated in two Nebivolol studies|1
4474187|NCT00673790|7269322|FG000|Overall Study|Unconfirmed pregnancy|0
4474188|NCT00673790|7269323|FG001|Overall Study|Unconfirmed pregnancy|1
4474189|NCT00673790|7269324|FG002|Overall Study|Unconfirmed pregnancy|0
4474190|NCT00673790|7269322|FG000|Overall Study|Randomization criteria not met|0
4474191|NCT00673790|7269323|FG001|Overall Study|Randomization criteria not met|1
4474192|NCT00673790|7269324|FG002|Overall Study|Randomization criteria not met|0
4474193|NCT00673816|7269333|FG000|Overall Study|Adverse Event|1
4474194|NCT00673816|7269333|FG000|Overall Study|Withdrawal by Subject|1
4474195|NCT00673881|7269345|FG000|Overall Study|Withdrawal by Subject|1
4474196|NCT00673894|7269351|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1
4474197|NCT00673894|7269352|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0
4474198|NCT00673894|7269351|FG000|First Intervention 4 Weeks|Adverse Event|1
4474199|NCT00673894|7269352|FG001|First Intervention 4 Weeks|Adverse Event|0
4474200|NCT00673920|7269366|FG000|Baseline up to Week 48|Withdrew consent|1
4474201|NCT00673920|7269367|FG001|Baseline up to Week 48|Withdrew consent|0
4474202|NCT00673920|7269368|FG002|Baseline up to Week 48|Withdrew consent|2
4474203|NCT00673920|7269369|FG003|Baseline up to Week 48|Withdrew consent|0
4474204|NCT00673920|7269370|FG004|Baseline up to Week 48|Withdrew consent|0
4474205|NCT00673920|7269371|FG005|Baseline up to Week 48|Withdrew consent|0
4474206|NCT00673920|7269372|FG006|Baseline up to Week 48|Withdrew consent|0
4474207|NCT00673920|7269373|FG007|Baseline up to Week 48|Withdrew consent|0
4474208|NCT00673920|7269366|FG000|Baseline up to Week 48|Refused treatment|1
4474209|NCT00673920|7269367|FG001|Baseline up to Week 48|Refused treatment|0
4474210|NCT00673920|7269368|FG002|Baseline up to Week 48|Refused treatment|0
4474211|NCT00673920|7269369|FG003|Baseline up to Week 48|Refused treatment|0
4474212|NCT00673920|7269370|FG004|Baseline up to Week 48|Refused treatment|0
4474213|NCT00673920|7269371|FG005|Baseline up to Week 48|Refused treatment|0
4474214|NCT00673920|7269372|FG006|Baseline up to Week 48|Refused treatment|0
4474215|NCT00673920|7269373|FG007|Baseline up to Week 48|Refused treatment|0
4474216|NCT00673920|7269366|FG000|Baseline up to Week 48|Insufficient therapeutic response|2
4474217|NCT00673920|7269367|FG001|Baseline up to Week 48|Insufficient therapeutic response|1
4474218|NCT00673920|7269368|FG002|Baseline up to Week 48|Insufficient therapeutic response|0
4474219|NCT00673920|7269369|FG003|Baseline up to Week 48|Insufficient therapeutic response|0
4474220|NCT00673920|7269370|FG004|Baseline up to Week 48|Insufficient therapeutic response|0
4474221|NCT00673920|7269371|FG005|Baseline up to Week 48|Insufficient therapeutic response|0
4474222|NCT00673920|7269372|FG006|Baseline up to Week 48|Insufficient therapeutic response|0
4474223|NCT00673920|7269373|FG007|Baseline up to Week 48|Insufficient therapeutic response|0
4474224|NCT00673920|7269366|FG000|Baseline up to Week 48|Protocol Violation|0
4474225|NCT00673920|7269367|FG001|Baseline up to Week 48|Protocol Violation|0
4474226|NCT00673920|7269368|FG002|Baseline up to Week 48|Protocol Violation|1
4474227|NCT00673920|7269369|FG003|Baseline up to Week 48|Protocol Violation|0
4474228|NCT00673920|7269370|FG004|Baseline up to Week 48|Protocol Violation|0
4474229|NCT00673920|7269371|FG005|Baseline up to Week 48|Protocol Violation|0
4474230|NCT00673920|7269372|FG006|Baseline up to Week 48|Protocol Violation|0
4474231|NCT00673920|7269373|FG007|Baseline up to Week 48|Protocol Violation|0
4474232|NCT00673920|7269366|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0
4474233|NCT00673920|7269367|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0
4474234|NCT00673920|7269368|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1
4474235|NCT00673920|7269369|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0
4474236|NCT00673920|7269370|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0
4474237|NCT00673920|7269371|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0
4474238|NCT00673920|7269372|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0
4589169|NCT01508936|7434189|FG001|Overall Study|Withdrawal by Subject|18
4589170|NCT01508936|7434188|FG000|Overall Study|Protocol Violation|2
4474239|NCT00673920|7269373|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0
4474240|NCT00673920|7269366|FG000|Baseline up to Week 48|Administrative/Other|0
4474241|NCT00673920|7269367|FG001|Baseline up to Week 48|Administrative/Other|1
4474242|NCT00673920|7269368|FG002|Baseline up to Week 48|Administrative/Other|2
4474243|NCT00673920|7269369|FG003|Baseline up to Week 48|Administrative/Other|0
4474244|NCT00673920|7269370|FG004|Baseline up to Week 48|Administrative/Other|0
4474245|NCT00673920|7269371|FG005|Baseline up to Week 48|Administrative/Other|0
4474246|NCT00673920|7269372|FG006|Baseline up to Week 48|Administrative/Other|0
4474247|NCT00673920|7269373|FG007|Baseline up to Week 48|Administrative/Other|0
4474248|NCT00673920|7269366|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0
4474249|NCT00673920|7269367|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1
4589171|NCT01508936|7434189|FG001|Overall Study|Protocol Violation|3
4589172|NCT01508936|7434188|FG000|Overall Study|Lost to Follow-up|2
4589173|NCT01508936|7434189|FG001|Overall Study|Lost to Follow-up|9
4589174|NCT01508936|7434188|FG000|Overall Study|Other|0
4474250|NCT00673920|7269368|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1
4474251|NCT00673920|7269369|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0
4474252|NCT00673920|7269370|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0
4474253|NCT00673920|7269371|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0
4474254|NCT00673920|7269372|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0
4474255|NCT00673920|7269373|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0
4474256|NCT00673920|7269366|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0
4474257|NCT00673920|7269367|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0
4474258|NCT00673920|7269368|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0
4474259|NCT00673920|7269369|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0
4474260|NCT00673920|7269370|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0
4474261|NCT00673920|7269371|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0
4474262|NCT00673920|7269372|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1
4474263|NCT00673920|7269373|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0
4474264|NCT00673920|7269366|FG000|Week 24 to Week 48|Failure to return|0
4474265|NCT00673920|7269367|FG001|Week 24 to Week 48|Failure to return|0
4474266|NCT00673920|7269368|FG002|Week 24 to Week 48|Failure to return|0
4474267|NCT00673920|7269369|FG003|Week 24 to Week 48|Failure to return|0
4474268|NCT00673920|7269370|FG004|Week 24 to Week 48|Failure to return|0
4474269|NCT00673920|7269371|FG005|Week 24 to Week 48|Failure to return|1
4474270|NCT00673920|7269372|FG006|Week 24 to Week 48|Failure to return|0
4474271|NCT00673920|7269373|FG007|Week 24 to Week 48|Failure to return|0
4474272|NCT00673920|7269366|FG000|Week 24 to Week 48|Insufficient therapeutic response|0
4474273|NCT00673920|7269367|FG001|Week 24 to Week 48|Insufficient therapeutic response|0
4474274|NCT00673920|7269368|FG002|Week 24 to Week 48|Insufficient therapeutic response|0
4474275|NCT00673920|7269369|FG003|Week 24 to Week 48|Insufficient therapeutic response|0
4474276|NCT00673920|7269370|FG004|Week 24 to Week 48|Insufficient therapeutic response|0
4474277|NCT00673920|7269371|FG005|Week 24 to Week 48|Insufficient therapeutic response|1
4474278|NCT00673920|7269372|FG006|Week 24 to Week 48|Insufficient therapeutic response|0
4474279|NCT00673920|7269373|FG007|Week 24 to Week 48|Insufficient therapeutic response|0
4474280|NCT00673920|7269366|FG000|Week 24 to Week 48|Death|0
4474281|NCT00673920|7269367|FG001|Week 24 to Week 48|Death|0
4474282|NCT00673920|7269368|FG002|Week 24 to Week 48|Death|0
4474283|NCT00673920|7269369|FG003|Week 24 to Week 48|Death|0
4474284|NCT00673920|7269370|FG004|Week 24 to Week 48|Death|0
4474285|NCT00673920|7269371|FG005|Week 24 to Week 48|Death|1
4474286|NCT00673920|7269372|FG006|Week 24 to Week 48|Death|0
4474287|NCT00673920|7269373|FG007|Week 24 to Week 48|Death|0
4474288|NCT00673920|7269366|FG000|Week 24 to Week 48|Adminstrative/Other|0
4474289|NCT00673920|7269367|FG001|Week 24 to Week 48|Adminstrative/Other|0
4474290|NCT00673920|7269368|FG002|Week 24 to Week 48|Adminstrative/Other|0
4474291|NCT00673920|7269369|FG003|Week 24 to Week 48|Adminstrative/Other|1
4474292|NCT00673920|7269370|FG004|Week 24 to Week 48|Adminstrative/Other|0
4474293|NCT00673920|7269371|FG005|Week 24 to Week 48|Adminstrative/Other|0
4474294|NCT00673920|7269372|FG006|Week 24 to Week 48|Adminstrative/Other|0
4589175|NCT01508936|7434189|FG001|Overall Study|Other|5
4589176|NCT01508936|7434188|FG000|Overall Study|Data from 2 sites deemed invalid|4
4589177|NCT01508936|7434189|FG001|Overall Study|Data from 2 sites deemed invalid|11
4589178|NCT01509079|7434217|FG000|Overall Study|Lack of Efficacy|0
4589179|NCT01509079|7434218|FG001|Overall Study|Lack of Efficacy|2
4474295|NCT00673920|7269373|FG007|Week 24 to Week 48|Adminstrative/Other|0
4474296|NCT00673933|7269395|FG000|Overall Study|Withdrawal by Subject|2
4474297|NCT00673933|7269395|FG000|Overall Study|Lost to Follow-up|1
4474298|NCT00674128|7269422|FG000|Overall Study|Withdrawal by Subject|25
4474299|NCT00674128|7269423|FG001|Overall Study|Withdrawal by Subject|23
4474300|NCT00674154|7269431|FG000|Overall Study|Withdrawal by Subject|3
4474301|NCT00674154|7269432|FG001|Overall Study|Withdrawal by Subject|1
4474302|NCT00674154|7269431|FG000|Overall Study|Did not want parathyroidectomy|0
4474303|NCT00674154|7269432|FG001|Overall Study|Did not want parathyroidectomy|2
4474304|NCT00674323|7269464|FG000|Overall Study|Adverse Event|0
4474305|NCT00674323|7269465|FG001|Overall Study|Adverse Event|1
4474306|NCT00674323|7269466|FG002|Overall Study|Adverse Event|0
4474307|NCT00674323|7269464|FG000|Overall Study|Protocol Violation|1
4474308|NCT00674323|7269465|FG001|Overall Study|Protocol Violation|0
4474309|NCT00674323|7269466|FG002|Overall Study|Protocol Violation|0
4516644|NCT00960856|7328077|FG003|Washout Period of 7 Days|Adverse Event|0
4516645|NCT00960869|7328089|FG000|Overall Study|Adverse Event|17
4516646|NCT00960869|7328090|FG001|Overall Study|Adverse Event|26
4516647|NCT00960869|7328089|FG000|Overall Study|Withdrawal by Subject|16
4516648|NCT00960869|7328090|FG001|Overall Study|Withdrawal by Subject|14
4516649|NCT00960869|7328089|FG000|Overall Study|Lost to Follow-up|1
4516650|NCT00960869|7328090|FG001|Overall Study|Lost to Follow-up|4
4516651|NCT00960869|7328089|FG000|Overall Study|Misc|19
4516652|NCT00960869|7328090|FG001|Overall Study|Misc|18
4516653|NCT00960934|7328102|FG000|Overall Study|Adverse Event|2
4516654|NCT00960934|7328103|FG001|Overall Study|Adverse Event|3
4516655|NCT00960934|7328104|FG002|Overall Study|Adverse Event|3
4516656|NCT00960934|7328105|FG003|Overall Study|Adverse Event|2
4516657|NCT00960934|7328106|FG004|Overall Study|Adverse Event|4
4516658|NCT00960934|7328107|FG005|Overall Study|Adverse Event|3
4516659|NCT00960934|7328102|FG000|Overall Study|Lack of Efficacy|1
4516660|NCT00960934|7328103|FG001|Overall Study|Lack of Efficacy|0
4516661|NCT00960934|7328104|FG002|Overall Study|Lack of Efficacy|0
4516662|NCT00960934|7328105|FG003|Overall Study|Lack of Efficacy|0
4516663|NCT00960934|7328106|FG004|Overall Study|Lack of Efficacy|0
4516664|NCT00960934|7328107|FG005|Overall Study|Lack of Efficacy|0
4516665|NCT00960934|7328102|FG000|Overall Study|Lost to Follow-up|0
4516666|NCT00960934|7328103|FG001|Overall Study|Lost to Follow-up|1
4516667|NCT00960934|7328104|FG002|Overall Study|Lost to Follow-up|0
4516668|NCT00960934|7328105|FG003|Overall Study|Lost to Follow-up|0
4516669|NCT00960934|7328106|FG004|Overall Study|Lost to Follow-up|0
4516670|NCT00960934|7328107|FG005|Overall Study|Lost to Follow-up|0
4516671|NCT00960934|7328102|FG000|Overall Study|Other|2
4516672|NCT00960934|7328103|FG001|Overall Study|Other|1
4516673|NCT00960934|7328104|FG002|Overall Study|Other|5
4516674|NCT00960934|7328105|FG003|Overall Study|Other|4
4699162|NCT02679755|7614410|FG001|Overall Study|Adverse Event|4
4699163|NCT02679755|7614409|FG000|Overall Study|Adverse events not related to study drug|1
4699164|NCT02679755|7614410|FG001|Overall Study|Adverse events not related to study drug|2
4589180|NCT01509079|7434217|FG000|Overall Study|started an excluded medication|0
4589181|NCT01509079|7434218|FG001|Overall Study|started an excluded medication|1
4593672|NCT01554241|7442217|FG002|Overall Study|protocol specified renal stone|0
4593673|NCT01554241|7442218|FG003|Overall Study|protocol specified renal stone|1
4593674|NCT01554241|7442215|FG000|Overall Study|protocol specified change in eGFR|0
4593675|NCT01554241|7442216|FG001|Overall Study|protocol specified change in eGFR|0
4516675|NCT00960934|7328106|FG004|Overall Study|Other|2
4516676|NCT00960934|7328107|FG005|Overall Study|Other|2
4516677|NCT00960934|7328102|FG000|Overall Study|Physician Decision|0
4516678|NCT00960934|7328103|FG001|Overall Study|Physician Decision|1
4516679|NCT00960934|7328104|FG002|Overall Study|Physician Decision|0
4516680|NCT00960934|7328105|FG003|Overall Study|Physician Decision|0
4516681|NCT00960934|7328106|FG004|Overall Study|Physician Decision|0
4516682|NCT00960934|7328107|FG005|Overall Study|Physician Decision|0
4516683|NCT00960934|7328102|FG000|Overall Study|Progressive Disease|1
4516684|NCT00960934|7328103|FG001|Overall Study|Progressive Disease|1
4516685|NCT00960934|7328104|FG002|Overall Study|Progressive Disease|0
4516686|NCT00960934|7328105|FG003|Overall Study|Progressive Disease|0
4516687|NCT00960934|7328106|FG004|Overall Study|Progressive Disease|1
4516688|NCT00960934|7328107|FG005|Overall Study|Progressive Disease|1
4516689|NCT00960934|7328102|FG000|Overall Study|Protocol Violation|3
4516690|NCT00960934|7328103|FG001|Overall Study|Protocol Violation|4
4516691|NCT00960934|7328104|FG002|Overall Study|Protocol Violation|0
4516692|NCT00960934|7328105|FG003|Overall Study|Protocol Violation|3
4516693|NCT00960934|7328106|FG004|Overall Study|Protocol Violation|3
4516694|NCT00960934|7328107|FG005|Overall Study|Protocol Violation|2
4516695|NCT00960934|7328102|FG000|Overall Study|Withdrawal by Subject|5
4516696|NCT00960934|7328103|FG001|Overall Study|Withdrawal by Subject|6
4516697|NCT00960934|7328104|FG002|Overall Study|Withdrawal by Subject|4
4516698|NCT00960934|7328105|FG003|Overall Study|Withdrawal by Subject|5
4516699|NCT00960934|7328106|FG004|Overall Study|Withdrawal by Subject|5
4516700|NCT00960934|7328107|FG005|Overall Study|Withdrawal by Subject|7
4516701|NCT00960934|7328102|FG000|Overall Study|Study Terminated by Sponsor|50
4516702|NCT00960934|7328103|FG001|Overall Study|Study Terminated by Sponsor|46
4516703|NCT00960934|7328104|FG002|Overall Study|Study Terminated by Sponsor|52
4516704|NCT00960934|7328105|FG003|Overall Study|Study Terminated by Sponsor|50
4699165|NCT02680002|7614444|FG000|Overall Study|Lost to Follow-up|5
4699166|NCT02680002|7614445|FG001|Overall Study|Lost to Follow-up|1
4699167|NCT02680002|7614446|FG002|Overall Study|Lost to Follow-up|4
4699168|NCT02680002|7614447|FG003|Overall Study|Lost to Follow-up|2
4699169|NCT02680002|7614448|FG004|Overall Study|Lost to Follow-up|0
4699170|NCT02680002|7614449|FG005|Overall Study|Lost to Follow-up|2
4699171|NCT02680002|7614444|FG000|Overall Study|Physician Decision|5
4699172|NCT02680002|7614445|FG001|Overall Study|Physician Decision|1
4699173|NCT02680002|7614446|FG002|Overall Study|Physician Decision|1
4699174|NCT02680002|7614447|FG003|Overall Study|Physician Decision|1
4699175|NCT02680002|7614448|FG004|Overall Study|Physician Decision|1
4474310|NCT00674362|7269476|FG000|Double Blind|Adverse Event|6
4474311|NCT00674362|7269477|FG001|Double Blind|Adverse Event|6
4474312|NCT00674362|7269476|FG000|Double Blind|Lack of Efficacy|2
4474313|NCT00674362|7269477|FG001|Double Blind|Lack of Efficacy|6
4474314|NCT00674362|7269476|FG000|Double Blind|Loss of efficacy|0
4474315|NCT00674362|7269477|FG001|Double Blind|Loss of efficacy|1
4474316|NCT00674362|7269476|FG000|Double Blind|Withdrawal by Subject|4
4474317|NCT00674362|7269477|FG001|Double Blind|Withdrawal by Subject|3
4474318|NCT00674362|7269476|FG000|Double Blind|Other: Loss of Patient Compliance|0
4474319|NCT00674362|7269477|FG001|Double Blind|Other: Loss of Patient Compliance|1
4474320|NCT00674362|7269476|FG000|Double Blind|Other: Surgery|0
4474321|NCT00674362|7269477|FG001|Double Blind|Other: Surgery|1
4474322|NCT00674362|7269476|FG000|Open Label|Adverse Event|1
4474323|NCT00674362|7269477|FG001|Open Label|Adverse Event|0
4474324|NCT00674362|7269476|FG000|Open Label|Other: Subject moved to extension study|1
4474325|NCT00674362|7269477|FG001|Open Label|Other: Subject moved to extension study|0
4474326|NCT00674570|7269508|FG000|Overall Study|Withdrawal by Subject|0
4474327|NCT00674570|7269509|FG001|Overall Study|Withdrawal by Subject|2
4474328|NCT00674570|7269510|FG002|Overall Study|Withdrawal by Subject|0
4474329|NCT00674661|7269559|FG000|Overall Study|Other|5
4474330|NCT00674661|7269560|FG001|Overall Study|Other|7
4474331|NCT00674661|7269559|FG000|Overall Study|Lost to Follow-up|6
4474332|NCT00674661|7269560|FG001|Overall Study|Lost to Follow-up|3
4474333|NCT00674661|7269559|FG000|Overall Study|Withdrawal by Subject|0
4474334|NCT00674661|7269560|FG001|Overall Study|Withdrawal by Subject|5
4474335|NCT00674700|7269569|FG000|Year 1|Adverse Event|17
4474336|NCT00674700|7269570|FG001|Year 1|Adverse Event|20
4474337|NCT00674700|7269571|FG002|Year 1|Adverse Event|5
4474338|NCT00674700|7269569|FG000|Year 1|Withdrawal by Subject|7
4474339|NCT00674700|7269570|FG001|Year 1|Withdrawal by Subject|7
4474340|NCT00674700|7269571|FG002|Year 1|Withdrawal by Subject|6
4474341|NCT00674700|7269569|FG000|Year 1|Any other reason not above-mentioned|7
4474342|NCT00674700|7269570|FG001|Year 1|Any other reason not above-mentioned|7
4474343|NCT00674700|7269571|FG002|Year 1|Any other reason not above-mentioned|6
4474344|NCT00674700|7269569|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0
4474345|NCT00674700|7269570|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1
4474346|NCT00674700|7269571|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1
4474347|NCT00674700|7269569|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1
4474348|NCT00674700|7269570|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1
4474349|NCT00674700|7269571|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4
4474350|NCT00674700|7269569|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5
4474351|NCT00674700|7269570|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10
4474352|NCT00674700|7269571|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7
4474353|NCT00674817|7269601|FG000|Period 1|Withdrawal by Subject|2
4474354|NCT00674817|7269601|FG000|Period 1|Protocol Violation|1
4474355|NCT00674817|7269601|FG000|Period 3|Adverse Event|1
4474356|NCT00674817|7269601|FG000|Period 3|Protocol Violation|1
4474357|NCT00674817|7269601|FG000|Period 4|Adverse Event|1
4474358|NCT00674973|7269617|FG000|Overall Study|Insufficient Therapeutic Response|77
4474359|NCT00674973|7269618|FG001|Overall Study|Insufficient Therapeutic Response|72
4474360|NCT00674973|7269617|FG000|Overall Study|Refused Treatment|1
4474361|NCT00674973|7269618|FG001|Overall Study|Refused Treatment|5
4474362|NCT00674973|7269617|FG000|Overall Study|Failure to Return|1
4474363|NCT00674973|7269618|FG001|Overall Study|Failure to Return|0
4474364|NCT00674973|7269617|FG000|Overall Study|Adverse Event|2
4474365|NCT00674973|7269618|FG001|Overall Study|Adverse Event|9
4474366|NCT00674973|7269617|FG000|Overall Study|Death|19
4474367|NCT00674973|7269618|FG001|Overall Study|Death|15
4699176|NCT02680002|7614449|FG005|Overall Study|Physician Decision|1
4474368|NCT00674973|7269617|FG000|Overall Study|Protocol Violation|0
4474369|NCT00674973|7269618|FG001|Overall Study|Protocol Violation|1
4474370|NCT00674986|7269626|FG000|Overall Study|Adverse Event|2
4474371|NCT00674986|7269627|FG001|Overall Study|Adverse Event|1
4474372|NCT00674986|7269626|FG000|Overall Study|Subject withdrew consent|12
4474373|NCT00674986|7269627|FG001|Overall Study|Subject withdrew consent|19
4474374|NCT00674986|7269626|FG000|Overall Study|Lost to Follow-up|25
4474375|NCT00674986|7269627|FG001|Overall Study|Lost to Follow-up|53
4474376|NCT00674986|7269626|FG000|Overall Study|Other reasons|4
4474377|NCT00674986|7269627|FG001|Overall Study|Other reasons|8
4474378|NCT00675025|7269636|FG000|Overall Study|Study Terminated by Sponsor|38
4474379|NCT00675025|7269637|FG001|Overall Study|Study Terminated by Sponsor|42
4474380|NCT00675025|7269636|FG000|Overall Study|Adverse Event|6
4699177|NCT02680002|7614444|FG000|Overall Study|Protocol Violation|1
4474381|NCT00675025|7269637|FG001|Overall Study|Adverse Event|11
4474382|NCT00675025|7269636|FG000|Overall Study|Lost to Follow-up|6
4474383|NCT00675025|7269637|FG001|Overall Study|Lost to Follow-up|4
4474384|NCT00675025|7269636|FG000|Overall Study|Withdrawal by Subject|4
4474385|NCT00675025|7269637|FG001|Overall Study|Withdrawal by Subject|6
4474386|NCT00675103|7269643|FG000|Overall Study|Lack of Efficacy|2
4474387|NCT00675103|7269643|FG000|Overall Study|Adverse Event|1
4474388|NCT00675428|7269666|FG000|Overall Study|Disease Progression|2
4474389|NCT00675428|7269667|FG001|Overall Study|Disease Progression|2
4474390|NCT00675428|7269666|FG000|Overall Study|No Disease Response After Cycle 6|0
4474391|NCT00675428|7269667|FG001|Overall Study|No Disease Response After Cycle 6|1
4474392|NCT00675428|7269666|FG000|Overall Study|Physician Decision|1
4474393|NCT00675428|7269667|FG001|Overall Study|Physician Decision|0
4474394|NCT00675441|7269673|FG000|Overall Study|Withdrawal by Subject|2
4474395|NCT00675441|7269673|FG000|Overall Study|Death|1
4474396|NCT00675506|7269679|FG000|Overall Study|Lost to Follow-up|1
4474397|NCT00675506|7269680|FG001|Overall Study|Lost to Follow-up|5
4474398|NCT00675506|7269679|FG000|Overall Study|Lost interest|3
4474399|NCT00675506|7269680|FG001|Overall Study|Lost interest|5
4474400|NCT00675506|7269679|FG000|Overall Study|Elevated fasting glucose|2
4474401|NCT00675506|7269680|FG001|Overall Study|Elevated fasting glucose|1
4474402|NCT00675506|7269679|FG000|Overall Study|Elevated IGF-1 prior to treatment|1
4474403|NCT00675506|7269680|FG001|Overall Study|Elevated IGF-1 prior to treatment|0
4474404|NCT00675506|7269679|FG000|Overall Study|Elevated IGF-1|2
4474405|NCT00675506|7269680|FG001|Overall Study|Elevated IGF-1|0
4474406|NCT00675506|7269679|FG000|Overall Study|Hypersensitivity Reaction|1
4474407|NCT00675506|7269680|FG001|Overall Study|Hypersensitivity Reaction|0
4474408|NCT00675506|7269679|FG000|Overall Study|Disclosed history of cancer|1
4474409|NCT00675506|7269680|FG001|Overall Study|Disclosed history of cancer|0
4474410|NCT00675506|7269679|FG000|Overall Study|Declined participation|1
4474411|NCT00675506|7269680|FG001|Overall Study|Declined participation|0
4474412|NCT00675506|7269679|FG000|Overall Study|Schedule conflict|0
4474413|NCT00675506|7269680|FG001|Overall Study|Schedule conflict|1
4474414|NCT00675597|7269709|FG000|Overall Study|Withdrawal by Subject|3
4474415|NCT00675766|7269717|FG000|Overall Study|Lost to Follow-up|6
4474416|NCT00675766|7269718|FG001|Overall Study|Lost to Follow-up|5
4474417|NCT00675766|7269719|FG002|Overall Study|Lost to Follow-up|21
4474418|NCT00675766|7269720|FG003|Overall Study|Lost to Follow-up|26
4474419|NCT00675948|7269759|FG000|Overall Study|Adverse Event|23
4474420|NCT00675948|7269760|FG001|Overall Study|Adverse Event|1
4474421|NCT00675948|7269759|FG000|Overall Study|Lack of Efficacy|3
4474422|NCT00675948|7269760|FG001|Overall Study|Lack of Efficacy|0
4474423|NCT00675948|7269759|FG000|Overall Study|Withdrawal by Subject|7
4474424|NCT00675948|7269760|FG001|Overall Study|Withdrawal by Subject|0
4474425|NCT00675948|7269759|FG000|Overall Study|Lost to Follow-up|2
4474426|NCT00675948|7269760|FG001|Overall Study|Lost to Follow-up|0
4474427|NCT00675948|7269759|FG000|Overall Study|Protocol Violation|1
4474428|NCT00675948|7269760|FG001|Overall Study|Protocol Violation|0
4474429|NCT00675948|7269759|FG000|Overall Study|Pain under control|1
4474430|NCT00675948|7269760|FG001|Overall Study|Pain under control|0
4474431|NCT00675948|7269759|FG000|Overall Study|Sponsor decision|0
4474432|NCT00675948|7269760|FG001|Overall Study|Sponsor decision|1
4474433|NCT00675948|7269759|FG000|Overall Study|Patient died|1
4474434|NCT00675948|7269760|FG001|Overall Study|Patient died|0
4474435|NCT00675948|7269759|FG000|Overall Study|Patient unable to comply with diaries|1
4474436|NCT00675948|7269760|FG001|Overall Study|Patient unable to comply with diaries|0
4474437|NCT00675948|7269759|FG000|Overall Study|Patient feels unable to take medication|0
4474438|NCT00675948|7269760|FG001|Overall Study|Patient feels unable to take medication|1
4474439|NCT00676052|7269791|FG000|Overall Study|Adverse Event|0
4474440|NCT00676052|7269792|FG001|Overall Study|Adverse Event|1
4474441|NCT00676052|7269793|FG002|Overall Study|Adverse Event|1
4474442|NCT00676052|7269794|FG003|Overall Study|Adverse Event|2
4474443|NCT00676052|7269795|FG004|Overall Study|Adverse Event|2
4474444|NCT00676052|7269796|FG005|Overall Study|Adverse Event|2
4474445|NCT00676052|7269791|FG000|Overall Study|Lack of Efficacy|2
4474446|NCT00676052|7269792|FG001|Overall Study|Lack of Efficacy|2
4474447|NCT00676052|7269793|FG002|Overall Study|Lack of Efficacy|1
4474448|NCT00676052|7269794|FG003|Overall Study|Lack of Efficacy|1
4474449|NCT00676052|7269795|FG004|Overall Study|Lack of Efficacy|2
4474450|NCT00676052|7269796|FG005|Overall Study|Lack of Efficacy|1
4474451|NCT00676052|7269791|FG000|Overall Study|Protocol Violation|5
4474452|NCT00676052|7269792|FG001|Overall Study|Protocol Violation|3
4474453|NCT00676052|7269793|FG002|Overall Study|Protocol Violation|2
4474454|NCT00676052|7269794|FG003|Overall Study|Protocol Violation|2
4474455|NCT00676052|7269795|FG004|Overall Study|Protocol Violation|1
4474456|NCT00676052|7269796|FG005|Overall Study|Protocol Violation|2
4474457|NCT00676052|7269791|FG000|Overall Study|Lost to Follow-up|0
4474458|NCT00676052|7269792|FG001|Overall Study|Lost to Follow-up|0
4474459|NCT00676052|7269793|FG002|Overall Study|Lost to Follow-up|0
4474460|NCT00676052|7269794|FG003|Overall Study|Lost to Follow-up|0
4474461|NCT00676052|7269795|FG004|Overall Study|Lost to Follow-up|1
4474462|NCT00676052|7269796|FG005|Overall Study|Lost to Follow-up|0
4474463|NCT00676052|7269791|FG000|Overall Study|Physician Decision|1
4474464|NCT00676052|7269792|FG001|Overall Study|Physician Decision|1
4474465|NCT00676052|7269793|FG002|Overall Study|Physician Decision|1
4474466|NCT00676052|7269794|FG003|Overall Study|Physician Decision|0
4474467|NCT00676052|7269795|FG004|Overall Study|Physician Decision|0
4699178|NCT02680002|7614445|FG001|Overall Study|Protocol Violation|0
4699179|NCT02680002|7614446|FG002|Overall Study|Protocol Violation|1
4699180|NCT02680002|7614447|FG003|Overall Study|Protocol Violation|0
4699181|NCT02680002|7614448|FG004|Overall Study|Protocol Violation|1
4699182|NCT02680002|7614449|FG005|Overall Study|Protocol Violation|2
4699183|NCT02680002|7614444|FG000|Overall Study|Withdrawal by Subject|0
4699184|NCT02680002|7614445|FG001|Overall Study|Withdrawal by Subject|0
4699185|NCT02680002|7614446|FG002|Overall Study|Withdrawal by Subject|1
4699186|NCT02680002|7614447|FG003|Overall Study|Withdrawal by Subject|0
4699187|NCT02680002|7614448|FG004|Overall Study|Withdrawal by Subject|2
4699188|NCT02680002|7614449|FG005|Overall Study|Withdrawal by Subject|2
4474468|NCT00676052|7269796|FG005|Overall Study|Physician Decision|1
4474469|NCT00676052|7269791|FG000|Overall Study|Withdrawal by Subject|1
4474470|NCT00676052|7269792|FG001|Overall Study|Withdrawal by Subject|0
4474471|NCT00676052|7269793|FG002|Overall Study|Withdrawal by Subject|1
4474472|NCT00676052|7269794|FG003|Overall Study|Withdrawal by Subject|0
4474473|NCT00676052|7269795|FG004|Overall Study|Withdrawal by Subject|0
4474474|NCT00676052|7269796|FG005|Overall Study|Withdrawal by Subject|0
4474475|NCT00676091|7269825|FG000|Infant Series|Parent or legal guardian request|10
4474476|NCT00676091|7269826|FG001|Infant Series|Parent or legal guardian request|8
4474477|NCT00676091|7269825|FG000|Infant Series|Protocol Violation|6
4474478|NCT00676091|7269826|FG001|Infant Series|Protocol Violation|3
4474479|NCT00676091|7269825|FG000|Infant Series|Adverse Event|2
4474480|NCT00676091|7269826|FG001|Infant Series|Adverse Event|3
4474481|NCT00676091|7269825|FG000|Infant Series|Failed to return|1
4474482|NCT00676091|7269826|FG001|Infant Series|Failed to return|3
4474483|NCT00676091|7269825|FG000|Infant Series|Lost to Follow-up|1
4589182|NCT01509547|7434250|FG000|Overall Study|Lost to Follow-up|24
4589183|NCT01509547|7434251|FG001|Overall Study|Lost to Follow-up|14
4474484|NCT00676091|7269826|FG001|Infant Series|Lost to Follow-up|0
4474485|NCT00676091|7269825|FG000|Infant Series|Died prior to receiving 7vPnC|0
4474486|NCT00676091|7269826|FG001|Infant Series|Died prior to receiving 7vPnC|1
4474487|NCT00676091|7269825|FG000|After Infant Series|Adverse Event|0
4474488|NCT00676091|7269826|FG001|After Infant Series|Adverse Event|1
4474489|NCT00676091|7269825|FG000|After Infant Series|Protocol Violation|0
4474490|NCT00676091|7269826|FG001|After Infant Series|Protocol Violation|1
4474491|NCT00676091|7269825|FG000|After Infant Series|Failed to return|1
4474492|NCT00676091|7269826|FG001|After Infant Series|Failed to return|1
4474493|NCT00676091|7269825|FG000|Toddler Dose|Failed to return|2
4474494|NCT00676091|7269826|FG001|Toddler Dose|Failed to return|0
4474495|NCT00676091|7269825|FG000|Toddler Dose|Parent or legal guardian request|1
4474496|NCT00676091|7269826|FG001|Toddler Dose|Parent or legal guardian request|0
4474497|NCT00676130|7269838|FG000|Overall Study|Lost to Follow-up|0
4474498|NCT00676130|7269839|FG001|Overall Study|Lost to Follow-up|1
4474499|NCT00676130|7269838|FG000|Overall Study|Found ineligible|3
4474500|NCT00676130|7269839|FG001|Overall Study|Found ineligible|2
4474501|NCT00676130|7269838|FG000|Overall Study|Withdrawal by Subject|0
4474502|NCT00676130|7269839|FG001|Overall Study|Withdrawal by Subject|1
4474503|NCT00676143|7269847|FG000|Overall Study|Adverse Event|34
4474504|NCT00676143|7269848|FG001|Overall Study|Adverse Event|60
4474505|NCT00676143|7269847|FG000|Overall Study|Death|4
4474506|NCT00676143|7269848|FG001|Overall Study|Death|4
4474507|NCT00676143|7269847|FG000|Overall Study|Lack of Efficacy|0
4474508|NCT00676143|7269848|FG001|Overall Study|Lack of Efficacy|6
4474509|NCT00676143|7269847|FG000|Overall Study|Lost to Follow-up|0
4474510|NCT00676143|7269848|FG001|Overall Study|Lost to Follow-up|13
4474511|NCT00676143|7269847|FG000|Overall Study|Physician Decision|5
4474512|NCT00676143|7269848|FG001|Overall Study|Physician Decision|8
4474513|NCT00676143|7269847|FG000|Overall Study|Protocol Violation|4
4474514|NCT00676143|7269848|FG001|Overall Study|Protocol Violation|8
4474515|NCT00676143|7269847|FG000|Overall Study|Withdrawal by Subject|24
4474516|NCT00676143|7269848|FG001|Overall Study|Withdrawal by Subject|42
4474517|NCT00676143|7269847|FG000|Overall Study|Discontinuation of study by sponsor|65
4474518|NCT00676143|7269848|FG001|Overall Study|Discontinuation of study by sponsor|88
4474519|NCT00676143|7269847|FG000|Overall Study|Failed to return|2
4474520|NCT00676143|7269848|FG001|Overall Study|Failed to return|1
4474521|NCT00676143|7269847|FG000|Overall Study|Loss of caregiver|5
4474522|NCT00676143|7269848|FG001|Overall Study|Loss of caregiver|3
4589184|NCT01509547|7434250|FG000|Overall Study|Withdrawal by Subject|11
4589185|NCT01509547|7434251|FG001|Overall Study|Withdrawal by Subject|24
4589186|NCT01509547|7434250|FG000|Overall Study|Physician Decision|0
4699189|NCT02680002|7614444|FG000|Overall Study|Missed Visit 8 (Day 201)|2
4474523|NCT00676143|7269847|FG000|Overall Study|Other|11
4474524|NCT00676143|7269848|FG001|Overall Study|Other|20
4474525|NCT00676143|7269847|FG000|Overall Study|Participant participation unknown|1
4474526|NCT00676143|7269848|FG001|Overall Study|Participant participation unknown|4
4474527|NCT00676143|7269847|FG000|Overall Study|Vasogenic edema recurrence|1
4474528|NCT00676143|7269848|FG001|Overall Study|Vasogenic edema recurrence|3
4474529|NCT00676195|7269867|FG000|Overall Study|Lost to Follow-up|1
4474530|NCT00676195|7269867|FG000|Overall Study|Adverse Event|1
4474531|NCT00676195|7269867|FG000|Overall Study|Physician Decision|1
4474532|NCT00676208|7269874|FG000|Overall Study|Lost to Follow-up|0
4589187|NCT01509547|7434251|FG001|Overall Study|Physician Decision|1
4589188|NCT01509664|7434306|FG000|Overall Study|Lost to Follow-up|15
4474533|NCT00676208|7269875|FG001|Overall Study|Lost to Follow-up|2
4474534|NCT00676208|7269874|FG000|Overall Study|Incomplete data|2
4474535|NCT00676208|7269875|FG001|Overall Study|Incomplete data|4
4474536|NCT00676338|7269887|FG000|Overall Study|Adverse Event|6
4474537|NCT00676338|7269888|FG001|Overall Study|Adverse Event|6
4474538|NCT00676338|7269889|FG002|Overall Study|Adverse Event|5
4474539|NCT00676338|7269890|FG003|Overall Study|Adverse Event|1
4474540|NCT00676338|7269887|FG000|Overall Study|Lost to Follow-up|4
4474541|NCT00676338|7269888|FG001|Overall Study|Lost to Follow-up|1
4474542|NCT00676338|7269889|FG002|Overall Study|Lost to Follow-up|3
4474543|NCT00676338|7269890|FG003|Overall Study|Lost to Follow-up|4
4474544|NCT00676338|7269887|FG000|Overall Study|Physician Decision|3
4589189|NCT01509664|7434307|FG001|Overall Study|Lost to Follow-up|21
4589190|NCT01509846|7434336|FG000|Received Vaccination 2|Withdrawal by Subject|0
4589191|NCT01509846|7434337|FG001|Received Vaccination 2|Withdrawal by Subject|0
4589192|NCT01509846|7434338|FG002|Received Vaccination 2|Withdrawal by Subject|1
4589193|NCT01509846|7434339|FG003|Received Vaccination 2|Withdrawal by Subject|0
4474545|NCT00676338|7269888|FG001|Overall Study|Physician Decision|3
4474546|NCT00676338|7269889|FG002|Overall Study|Physician Decision|2
4474547|NCT00676338|7269890|FG003|Overall Study|Physician Decision|3
4474548|NCT00676338|7269887|FG000|Overall Study|Protocol Violation|5
4474549|NCT00676338|7269888|FG001|Overall Study|Protocol Violation|9
4474550|NCT00676338|7269889|FG002|Overall Study|Protocol Violation|2
4474551|NCT00676338|7269890|FG003|Overall Study|Protocol Violation|5
4474552|NCT00676338|7269887|FG000|Overall Study|Withdrawal by Subject|17
4474553|NCT00676338|7269888|FG001|Overall Study|Withdrawal by Subject|9
4474554|NCT00676338|7269889|FG002|Overall Study|Withdrawal by Subject|12
4474555|NCT00676338|7269890|FG003|Overall Study|Withdrawal by Subject|6
4474556|NCT00676338|7269887|FG000|Overall Study|Entry Criteria Not Met|0
4474557|NCT00676338|7269888|FG001|Overall Study|Entry Criteria Not Met|2
4474558|NCT00676338|7269889|FG002|Overall Study|Entry Criteria Not Met|1
4474559|NCT00676338|7269890|FG003|Overall Study|Entry Criteria Not Met|1
4474560|NCT00676338|7269887|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
4474561|NCT00676338|7269888|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
4474562|NCT00676338|7269889|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5
4474563|NCT00676338|7269890|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
4474564|NCT00676403|7269917|FG000|Overall Study|Adverse Event|1
4474565|NCT00676403|7269918|FG001|Overall Study|Adverse Event|2
4474566|NCT00676403|7269919|FG002|Overall Study|Adverse Event|0
4474567|NCT00676403|7269920|FG003|Overall Study|Adverse Event|5
4474568|NCT00676403|7269921|FG004|Overall Study|Adverse Event|1
4474569|NCT00676403|7269922|FG005|Overall Study|Adverse Event|2
4474570|NCT00676403|7269917|FG000|Overall Study|Lost to Follow-up|0
4474571|NCT00676403|7269918|FG001|Overall Study|Lost to Follow-up|0
4474572|NCT00676403|7269919|FG002|Overall Study|Lost to Follow-up|0
4474573|NCT00676403|7269920|FG003|Overall Study|Lost to Follow-up|0
4474574|NCT00676403|7269921|FG004|Overall Study|Lost to Follow-up|0
4474575|NCT00676403|7269922|FG005|Overall Study|Lost to Follow-up|1
4474576|NCT00676403|7269917|FG000|Overall Study|Reason Unspecified|1
4474577|NCT00676403|7269918|FG001|Overall Study|Reason Unspecified|0
4474578|NCT00676403|7269919|FG002|Overall Study|Reason Unspecified|1
4474579|NCT00676403|7269920|FG003|Overall Study|Reason Unspecified|0
4474580|NCT00676403|7269921|FG004|Overall Study|Reason Unspecified|0
4474581|NCT00676403|7269922|FG005|Overall Study|Reason Unspecified|1
4474582|NCT00676403|7269917|FG000|Overall Study|Withdrawal by Subject|0
4474583|NCT00676403|7269918|FG001|Overall Study|Withdrawal by Subject|0
4474584|NCT00676403|7269919|FG002|Overall Study|Withdrawal by Subject|0
4474585|NCT00676403|7269920|FG003|Overall Study|Withdrawal by Subject|0
4474586|NCT00676403|7269921|FG004|Overall Study|Withdrawal by Subject|0
4474587|NCT00676403|7269922|FG005|Overall Study|Withdrawal by Subject|1
4474588|NCT00676520|7269942|FG000|Overall Study|Withdrawal by Subject|163
4474589|NCT00676520|7269942|FG000|Overall Study|Lost to Follow-up|162
4474590|NCT00676520|7269942|FG000|Overall Study|Death|159
4474591|NCT00676520|7269942|FG000|Overall Study|Physician Decision|20
4474592|NCT00676520|7269942|FG000|Overall Study|Ineligible for Randomization to DAPT|209
4474593|NCT00676520|7269942|FG000|Overall Study|Other Reason|18
4474594|NCT00676650|7269971|FG000|Overall Study|Death|45
4474595|NCT00676650|7269972|FG001|Overall Study|Death|14
4474596|NCT00676650|7269971|FG000|Overall Study|Adverse Event|159
4474597|NCT00676650|7269972|FG001|Overall Study|Adverse Event|21
4474598|NCT00676650|7269971|FG000|Overall Study|Global deterioration of health status|66
4474599|NCT00676650|7269972|FG001|Overall Study|Global deterioration of health status|31
4589194|NCT01509846|7434340|FG004|Received Vaccination 2|Withdrawal by Subject|0
4474600|NCT00676650|7269971|FG000|Overall Study|Lost to Follow-up|0
4474601|NCT00676650|7269972|FG001|Overall Study|Lost to Follow-up|1
4474602|NCT00676650|7269971|FG000|Overall Study|Objective progression or relapse|189
4474603|NCT00676650|7269972|FG001|Overall Study|Objective progression or relapse|140
4474604|NCT00676650|7269971|FG000|Overall Study|Other|14
4474605|NCT00676650|7269972|FG001|Overall Study|Other|10
4474606|NCT00676650|7269971|FG000|Overall Study|Protocol Violation|3
4474607|NCT00676650|7269972|FG001|Overall Study|Protocol Violation|1
4474608|NCT00676650|7269971|FG000|Overall Study|Study terminated by sponsor|57
4474609|NCT00676650|7269972|FG001|Overall Study|Study terminated by sponsor|43
4474610|NCT00676650|7269971|FG000|Overall Study|Withdrawal by Subject|48
4474611|NCT00676650|7269972|FG001|Overall Study|Withdrawal by Subject|24
4474612|NCT00676650|7269971|FG000|Overall Study|Randomized but not treated|3
4474613|NCT00676650|7269972|FG001|Overall Study|Randomized but not treated|4
4474614|NCT00676663|7269980|FG000|Overall Study|Death|43
4474615|NCT00676663|7269981|FG001|Overall Study|Death|27
4474616|NCT00676663|7269980|FG000|Overall Study|Withdrew Consent|1
4474617|NCT00676663|7269981|FG001|Overall Study|Withdrew Consent|8
4474618|NCT00676663|7269980|FG000|Overall Study|Lost to Follow-up|1
4474619|NCT00676663|7269981|FG001|Overall Study|Lost to Follow-up|3
4474620|NCT00676689|7269993|FG000|Overall Study|Screen Failure|2
4474621|NCT00676689|7269993|FG000|Overall Study|Death|2
4474622|NCT00676689|7269993|FG000|Overall Study|Lost to Follow-up|4
4474623|NCT00676689|7269993|FG000|Overall Study|Physician Decision|1
4474624|NCT00676689|7269993|FG000|Overall Study|Withdrawal by Subject|3
4474625|NCT00676689|7269993|FG000|Overall Study|Continuing FU|49
4474626|NCT00677014|7270033|FG000|Overall Study|Lost to Follow-up|20
4474627|NCT00677014|7270034|FG001|Overall Study|Lost to Follow-up|12
4474628|NCT00677014|7270035|FG002|Overall Study|Lost to Follow-up|24
4474629|NCT00677014|7270033|FG000|Overall Study|Death|6
4474630|NCT00677014|7270034|FG001|Overall Study|Death|15
4474631|NCT00677014|7270035|FG002|Overall Study|Death|7
4474632|NCT00677014|7270033|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18
4474633|NCT00677014|7270034|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14
4474634|NCT00677014|7270035|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18
4474635|NCT00677092|7270048|FG000|Overall Study|Adverse Event|1
4474636|NCT00677092|7270048|FG000|Overall Study|Lost to Follow-up|1
4474637|NCT00677092|7270048|FG000|Overall Study|Withdrawal by Subject|3
4474638|NCT00677092|7270048|FG000|Overall Study|Death Prior to Receiving Treatment|1
4474639|NCT00677235|7270055|FG000|Overall Study|Withdrawal by Subject|1
4474640|NCT00677235|7270056|FG001|Overall Study|Withdrawal by Subject|1
4474641|NCT00677235|7270055|FG000|Overall Study|Lost to Follow-up|2
4474642|NCT00677235|7270056|FG001|Overall Study|Lost to Follow-up|1
4474643|NCT00677235|7270055|FG000|Overall Study|Death|37
4699190|NCT02680002|7614445|FG001|Overall Study|Missed Visit 8 (Day 201)|1
4699191|NCT02680002|7614446|FG002|Overall Study|Missed Visit 8 (Day 201)|3
4699192|NCT02680002|7614447|FG003|Overall Study|Missed Visit 8 (Day 201)|1
4699193|NCT02680002|7614448|FG004|Overall Study|Missed Visit 8 (Day 201)|5
4699194|NCT02680002|7614449|FG005|Overall Study|Missed Visit 8 (Day 201)|0
4699195|NCT02680002|7614444|FG000|Overall Study|Other|0
4699196|NCT02680002|7614445|FG001|Overall Study|Other|1
4474644|NCT00677235|7270056|FG001|Overall Study|Death|36
4474645|NCT00677235|7270055|FG000|Overall Study|Adverse Experience|1
4474646|NCT00677235|7270056|FG001|Overall Study|Adverse Experience|0
4474647|NCT00677352|7270064|FG000|Treatment Phase|Adverse Event|14
4474648|NCT00677352|7270065|FG001|Treatment Phase|Adverse Event|22
4474649|NCT00677352|7270064|FG000|Treatment Phase|Lack of Efficacy|2
4474650|NCT00677352|7270065|FG001|Treatment Phase|Lack of Efficacy|3
4474651|NCT00677352|7270064|FG000|Treatment Phase|Lost to Follow-up|0
4474652|NCT00677352|7270065|FG001|Treatment Phase|Lost to Follow-up|1
4474653|NCT00677352|7270064|FG000|Treatment Phase|Withdrawal by Subject|7
4474654|NCT00677352|7270065|FG001|Treatment Phase|Withdrawal by Subject|7
4474655|NCT00677352|7270064|FG000|Treatment Phase|Physician Decision|1
4474656|NCT00677352|7270065|FG001|Treatment Phase|Physician Decision|0
4474657|NCT00677352|7270064|FG000|Treatment Phase|Pregnancy|0
4474658|NCT00677352|7270065|FG001|Treatment Phase|Pregnancy|1
4474659|NCT00677352|7270064|FG000|Treatment Phase|Protocol Violation|1
4474660|NCT00677352|7270065|FG001|Treatment Phase|Protocol Violation|1
4474661|NCT00677352|7270064|FG000|Treatment Phase|Transference or work related matter|0
4474662|NCT00677352|7270065|FG001|Treatment Phase|Transference or work related matter|5
4474663|NCT00677352|7270064|FG000|Treatment Phase|Not treated|0
4474664|NCT00677352|7270065|FG001|Treatment Phase|Not treated|2
4474665|NCT00677352|7270064|FG000|Tapering Phase|Adverse Event|1
4474666|NCT00677352|7270065|FG001|Tapering Phase|Adverse Event|5
4474667|NCT00677352|7270064|FG000|Tapering Phase|Withdrawal by Subject|5
4474668|NCT00677352|7270065|FG001|Tapering Phase|Withdrawal by Subject|3
4474669|NCT00677352|7270064|FG000|Tapering Phase|Pregnancy|0
4474670|NCT00677352|7270065|FG001|Tapering Phase|Pregnancy|1
4474671|NCT00677352|7270064|FG000|Tapering Phase|Job transfer|0
4474672|NCT00677352|7270065|FG001|Tapering Phase|Job transfer|1
4474673|NCT00677365|7270075|FG000|Overall Study|Adverse Event|2
4474674|NCT00677365|7270076|FG001|Overall Study|Adverse Event|1
4474675|NCT00677365|7270077|FG002|Overall Study|Adverse Event|1
4474676|NCT00677365|7270078|FG003|Overall Study|Adverse Event|2
4474677|NCT00677365|7270075|FG000|Overall Study|Withdrawal by Subject|0
4474678|NCT00677365|7270076|FG001|Overall Study|Withdrawal by Subject|0
4474679|NCT00677365|7270077|FG002|Overall Study|Withdrawal by Subject|1
4474680|NCT00677365|7270078|FG003|Overall Study|Withdrawal by Subject|0
4474681|NCT00677365|7270075|FG000|Overall Study|Other reason|0
4474682|NCT00677365|7270076|FG001|Overall Study|Other reason|0
4474683|NCT00677365|7270077|FG002|Overall Study|Other reason|0
4474684|NCT00677365|7270078|FG003|Overall Study|Other reason|1
4474685|NCT00677534|7270088|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1
4474686|NCT00677534|7270088|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1
4699197|NCT02680002|7614446|FG002|Overall Study|Other|0
4474687|NCT00677534|7270088|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1
4474688|NCT00677807|7270104|FG000|Overall Study|Adverse Event|4
4474689|NCT00677807|7270105|FG001|Overall Study|Adverse Event|1
4474690|NCT00677807|7270106|FG002|Overall Study|Adverse Event|6
4474691|NCT00677807|7270104|FG000|Overall Study|Lack of Efficacy|0
4474692|NCT00677807|7270105|FG001|Overall Study|Lack of Efficacy|0
4474693|NCT00677807|7270106|FG002|Overall Study|Lack of Efficacy|2
4474694|NCT00677807|7270104|FG000|Overall Study|Participant no longer needs study drug|0
4474695|NCT00677807|7270105|FG001|Overall Study|Participant no longer needs study drug|0
4474696|NCT00677807|7270106|FG002|Overall Study|Participant no longer needs study drug|1
4474697|NCT00677807|7270104|FG000|Overall Study|Withdrawal by Subject|10
4474698|NCT00677807|7270105|FG001|Overall Study|Withdrawal by Subject|3
4474699|NCT00677807|7270106|FG002|Overall Study|Withdrawal by Subject|6
4474700|NCT00677807|7270104|FG000|Overall Study|Lost to Follow-up|2
4474701|NCT00677807|7270105|FG001|Overall Study|Lost to Follow-up|2
4474702|NCT00677807|7270106|FG002|Overall Study|Lost to Follow-up|2
4386330|NCT00027027|7164766|FG002|Overall Study|PD Requiring Surgery|1
4386331|NCT00027027|7164767|FG003|Overall Study|PD Requiring Surgery|0
4386332|NCT00027027|7164768|FG004|Overall Study|PD Requiring Surgery|0
4386333|NCT00027027|7164764|FG000|Overall Study|Physician Decision Due To PD|2
4386334|NCT00027027|7164765|FG001|Overall Study|Physician Decision Due To PD|3
4386335|NCT00027027|7164766|FG002|Overall Study|Physician Decision Due To PD|2
4386336|NCT00027027|7164767|FG003|Overall Study|Physician Decision Due To PD|3
4386337|NCT00027027|7164768|FG004|Overall Study|Physician Decision Due To PD|5
4386338|NCT00027027|7164764|FG000|Overall Study|Withdrawal by Subject|0
4386339|NCT00027027|7164765|FG001|Overall Study|Withdrawal by Subject|0
4386340|NCT00027027|7164766|FG002|Overall Study|Withdrawal by Subject|0
4386341|NCT00027027|7164767|FG003|Overall Study|Withdrawal by Subject|0
4386342|NCT00027027|7164768|FG004|Overall Study|Withdrawal by Subject|1
4386343|NCT00027378|7164786|FG000|Overall Study|Physician Decision|0
4386344|NCT00027378|7164787|FG001|Overall Study|Physician Decision|3
4589195|NCT01509846|7434336|FG000|Received Vaccination 2|Illness|0
4589196|NCT01509846|7434337|FG001|Received Vaccination 2|Illness|0
4589197|NCT01509846|7434338|FG002|Received Vaccination 2|Illness|0
4386345|NCT00027560|7164793|FG000|Overall Study|Withdrawal by Subject|1
4386346|NCT00027846|7164802|FG000|Overall Study|Lost to Follow-up|0
4386347|NCT00027846|7164803|FG001|Overall Study|Lost to Follow-up|41
4386348|NCT00027846|7164804|FG002|Overall Study|Lost to Follow-up|9
4386349|NCT00027846|7164802|FG000|Overall Study|Withdrawal by Subject|0
4386350|NCT00027846|7164803|FG001|Overall Study|Withdrawal by Subject|14
4386351|NCT00027846|7164804|FG002|Overall Study|Withdrawal by Subject|7
4386352|NCT00027846|7164802|FG000|Overall Study|Ineligible for study|2
4386353|NCT00027846|7164803|FG001|Overall Study|Ineligible for study|6
4386354|NCT00027846|7164804|FG002|Overall Study|Ineligible for study|14
4386355|NCT00027846|7164802|FG000|Overall Study|Entry into another COG therapeutic study|0
4386356|NCT00027846|7164803|FG001|Overall Study|Entry into another COG therapeutic study|5
4386357|NCT00027846|7164804|FG002|Overall Study|Entry into another COG therapeutic study|2
4386358|NCT00027846|7164802|FG000|Overall Study|Neuraxis dissemination during/after ther|0
4386359|NCT00027846|7164803|FG001|Overall Study|Neuraxis dissemination during/after ther|2
4386360|NCT00027846|7164804|FG002|Overall Study|Neuraxis dissemination during/after ther|5
4386361|NCT00028002|7164814|FG000|Overall Study|Withdrawal by Subject|3
4386362|NCT00028002|7164814|FG000|Overall Study|Ineligible|8
4386363|NCT00028769|7164832|FG000|Overall Study|Adverse Event|2
4386364|NCT00028769|7164832|FG000|Overall Study|Refusal Unrelated to Adverse Events|1
4386365|NCT00028769|7164832|FG000|Overall Study|Progression or Death|31
4474703|NCT00677807|7270104|FG000|Overall Study|Administrative problems|1
4474704|NCT00677807|7270105|FG001|Overall Study|Administrative problems|1
4474705|NCT00677807|7270106|FG002|Overall Study|Administrative problems|2
4474706|NCT00677807|7270104|FG000|Overall Study|Death|0
4474707|NCT00677807|7270105|FG001|Overall Study|Death|1
4474708|NCT00677807|7270106|FG002|Overall Study|Death|1
4474709|NCT00677807|7270104|FG000|Overall Study|Protocol Deviation|1
4474710|NCT00677807|7270105|FG001|Overall Study|Protocol Deviation|3
4474711|NCT00677807|7270106|FG002|Overall Study|Protocol Deviation|0
4474712|NCT00677820|7270116|FG000|Overall Study|Lost to Follow-up|1
4474713|NCT00677820|7270117|FG001|Overall Study|Lost to Follow-up|0
4474714|NCT00677833|7270127|FG000|Overall Study|Withdrawal by Subject|4
4474715|NCT00677833|7270128|FG001|Overall Study|Withdrawal by Subject|0
4474716|NCT00677833|7270129|FG002|Overall Study|Withdrawal by Subject|1
4474717|NCT00677833|7270130|FG003|Overall Study|Withdrawal by Subject|3
4474718|NCT00677833|7270127|FG000|Overall Study|Lost to Follow-up|0
4474719|NCT00677833|7270128|FG001|Overall Study|Lost to Follow-up|0
4474720|NCT00677833|7270129|FG002|Overall Study|Lost to Follow-up|1
4474721|NCT00677833|7270130|FG003|Overall Study|Lost to Follow-up|0
4474722|NCT00678080|7270162|FG000|Overall Study|Physician Decision|2
4474723|NCT00678080|7270163|FG001|Overall Study|Physician Decision|0
4474724|NCT00678080|7270162|FG000|Overall Study|Lost to Follow-up|1
4474725|NCT00678080|7270163|FG001|Overall Study|Lost to Follow-up|0
4474726|NCT00678080|7270162|FG000|Overall Study|Withdrawal by Subject|0
4474727|NCT00678080|7270163|FG001|Overall Study|Withdrawal by Subject|1
4474728|NCT00678210|7270173|FG000|Overall Study|Adverse Event|1
4474729|NCT00678210|7270174|FG001|Overall Study|Adverse Event|2
4589198|NCT01509846|7434339|FG003|Received Vaccination 2|Illness|0
4474730|NCT00678210|7270175|FG002|Overall Study|Adverse Event|3
4474731|NCT00678210|7270176|FG003|Overall Study|Adverse Event|3
4474732|NCT00678210|7270173|FG000|Overall Study|Lack of Efficacy|2
4474733|NCT00678210|7270174|FG001|Overall Study|Lack of Efficacy|3
4474734|NCT00678210|7270175|FG002|Overall Study|Lack of Efficacy|1
4474735|NCT00678210|7270176|FG003|Overall Study|Lack of Efficacy|9
4474736|NCT00678210|7270173|FG000|Overall Study|Lost to Follow-up|4
4474737|NCT00678210|7270174|FG001|Overall Study|Lost to Follow-up|2
4474738|NCT00678210|7270175|FG002|Overall Study|Lost to Follow-up|0
4474739|NCT00678210|7270176|FG003|Overall Study|Lost to Follow-up|1
4474740|NCT00678210|7270173|FG000|Overall Study|Withdrawal by Subject|3
4474741|NCT00678210|7270174|FG001|Overall Study|Withdrawal by Subject|4
4474742|NCT00678210|7270175|FG002|Overall Study|Withdrawal by Subject|1
4474743|NCT00678210|7270176|FG003|Overall Study|Withdrawal by Subject|7
4474744|NCT00678210|7270173|FG000|Overall Study|Other|1
4474745|NCT00678210|7270174|FG001|Overall Study|Other|0
4474746|NCT00678210|7270175|FG002|Overall Study|Other|1
4474747|NCT00678210|7270176|FG003|Overall Study|Other|0
4474748|NCT00678301|7270201|FG000|Overall Study|Non-compliance with study procedures|0
4474749|NCT00678301|7270202|FG001|Overall Study|Non-compliance with study procedures|1
4474750|NCT00678301|7270201|FG000|Overall Study|Adverse Event|1
4474751|NCT00678301|7270202|FG001|Overall Study|Adverse Event|0
4474752|NCT00678301|7270201|FG000|Overall Study|Withdrawal by Subject|4
4474753|NCT00678301|7270202|FG001|Overall Study|Withdrawal by Subject|0
4474754|NCT00678301|7270201|FG000|Overall Study|Lost to Follow-up|3
4474755|NCT00678301|7270202|FG001|Overall Study|Lost to Follow-up|1
4474756|NCT00678379|7270211|FG000|Overall Study|Injection performed after tonsillectomy|2
4474757|NCT00678379|7270212|FG001|Overall Study|Injection performed after tonsillectomy|0
4474758|NCT00678379|7270213|FG002|Overall Study|Injection performed after tonsillectomy|1
4474759|NCT00678379|7270211|FG000|Overall Study|Incomplete Data|4
4474760|NCT00678379|7270212|FG001|Overall Study|Incomplete Data|3
4474761|NCT00678379|7270213|FG002|Overall Study|Incomplete Data|3
4474762|NCT00678392|7270223|FG000|Overall Study|Adverse Event|0
4474763|NCT00678392|7270224|FG001|Overall Study|Adverse Event|6
4474764|NCT00678392|7270223|FG000|Overall Study|Death|280
4474765|NCT00678392|7270224|FG001|Overall Study|Death|269
4474766|NCT00678392|7270223|FG000|Overall Study|Lost to Follow-up|15
4474767|NCT00678392|7270224|FG001|Overall Study|Lost to Follow-up|13
4589199|NCT01509846|7434340|FG004|Received Vaccination 2|Illness|1
4589200|NCT01509846|7434336|FG000|Received Vaccination 2|Not vaccinated per protocol|5
4589201|NCT01509846|7434337|FG001|Received Vaccination 2|Not vaccinated per protocol|0
4589202|NCT01509846|7434338|FG002|Received Vaccination 2|Not vaccinated per protocol|0
4626385|NCT01839487|7491906|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0
4626386|NCT01839487|7491907|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1
4626387|NCT01839487|7491908|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3
4626388|NCT01839487|7491909|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2
4626389|NCT01839487|7491910|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1
4626390|NCT01839656|7491941|FG000|Overall Study|Withdrawal by Subject|1
4474768|NCT00678392|7270223|FG000|Overall Study|Objective Progression or Relapse|3
4474769|NCT00678392|7270224|FG001|Overall Study|Objective Progression or Relapse|8
4474770|NCT00678392|7270223|FG000|Overall Study|Sponsor's Decision|1
4474771|NCT00678392|7270224|FG001|Overall Study|Sponsor's Decision|2
4474772|NCT00678392|7270223|FG000|Overall Study|Withdrawal by Subject|4
4474773|NCT00678392|7270224|FG001|Overall Study|Withdrawal by Subject|4
4474774|NCT00678392|7270223|FG000|Overall Study|Randomized But Not Treated|2
4474775|NCT00678392|7270224|FG001|Overall Study|Randomized But Not Treated|7
4474776|NCT00678392|7270223|FG000|Overall Study|Other|56
4474777|NCT00678392|7270224|FG001|Overall Study|Other|53
4474778|NCT00678561|7270280|FG000|Overall Study|Adverse Event|0
4474779|NCT00678561|7270281|FG001|Overall Study|Adverse Event|1
4474780|NCT00678561|7270282|FG002|Overall Study|Adverse Event|1
4474781|NCT00678561|7270283|FG003|Overall Study|Adverse Event|0
4474782|NCT00678561|7270284|FG004|Overall Study|Adverse Event|1
4474783|NCT00678561|7270285|FG005|Overall Study|Adverse Event|0
4474784|NCT00678561|7270286|FG006|Overall Study|Adverse Event|0
4474785|NCT00678561|7270287|FG007|Overall Study|Adverse Event|0
4474786|NCT00678561|7270280|FG000|Overall Study|Protocol Violation|0
4474787|NCT00678561|7270281|FG001|Overall Study|Protocol Violation|0
4474788|NCT00678561|7270282|FG002|Overall Study|Protocol Violation|0
4474789|NCT00678561|7270283|FG003|Overall Study|Protocol Violation|0
4474790|NCT00678561|7270284|FG004|Overall Study|Protocol Violation|1
4474791|NCT00678561|7270285|FG005|Overall Study|Protocol Violation|1
4589203|NCT01509846|7434339|FG003|Received Vaccination 2|Not vaccinated per protocol|0
4589204|NCT01509846|7434340|FG004|Received Vaccination 2|Not vaccinated per protocol|2
4589205|NCT01509846|7434336|FG000|Received Vaccination 3|Withdrawal by Subject|0
4589206|NCT01509846|7434337|FG001|Received Vaccination 3|Withdrawal by Subject|1
4589207|NCT01509846|7434338|FG002|Received Vaccination 3|Withdrawal by Subject|0
4589208|NCT01509846|7434339|FG003|Received Vaccination 3|Withdrawal by Subject|0
4589209|NCT01509846|7434340|FG004|Received Vaccination 3|Withdrawal by Subject|0
4589210|NCT01509846|7434336|FG000|Received Vaccination 3|Pregnancy|0
4589211|NCT01509846|7434337|FG001|Received Vaccination 3|Pregnancy|0
4589212|NCT01509846|7434338|FG002|Received Vaccination 3|Pregnancy|0
4474792|NCT00678561|7270286|FG006|Overall Study|Protocol Violation|0
4474793|NCT00678561|7270287|FG007|Overall Study|Protocol Violation|0
4474794|NCT00678561|7270280|FG000|Overall Study|Withdrawal by Subject|0
4474795|NCT00678561|7270281|FG001|Overall Study|Withdrawal by Subject|0
4474796|NCT00678561|7270282|FG002|Overall Study|Withdrawal by Subject|0
4474797|NCT00678561|7270283|FG003|Overall Study|Withdrawal by Subject|0
4474798|NCT00678561|7270284|FG004|Overall Study|Withdrawal by Subject|0
4474799|NCT00678561|7270285|FG005|Overall Study|Withdrawal by Subject|0
4474800|NCT00678561|7270286|FG006|Overall Study|Withdrawal by Subject|0
4474801|NCT00678561|7270287|FG007|Overall Study|Withdrawal by Subject|1
4474802|NCT00678587|7270314|FG000|Overall Study|Adverse Event|3
4474803|NCT00678587|7270315|FG001|Overall Study|Adverse Event|3
4474804|NCT00678587|7270314|FG000|Overall Study|Lack of Efficacy|1
4474805|NCT00678587|7270315|FG001|Overall Study|Lack of Efficacy|0
4474806|NCT00678587|7270314|FG000|Overall Study|Protocol Violation|2
4474807|NCT00678587|7270315|FG001|Overall Study|Protocol Violation|1
4474808|NCT00678587|7270314|FG000|Overall Study|Study Closed/Terminated|1
4474809|NCT00678587|7270315|FG001|Overall Study|Study Closed/Terminated|0
4474810|NCT00678587|7270314|FG000|Overall Study|Lost to Follow-up|3
4474811|NCT00678587|7270315|FG001|Overall Study|Lost to Follow-up|5
4474812|NCT00678587|7270314|FG000|Overall Study|Investigator Discretion|2
4474813|NCT00678587|7270315|FG001|Overall Study|Investigator Discretion|6
4474814|NCT00678587|7270314|FG000|Overall Study|Withdrew Consent|8
4474815|NCT00678587|7270315|FG001|Overall Study|Withdrew Consent|3
4474816|NCT00678639|7270324|FG000|Overall Study|Lost to Follow-up at 30 days|2
4474817|NCT00678639|7270325|FG001|Overall Study|Lost to Follow-up at 30 days|0
4474818|NCT00678652|7270336|FG000|Overall Study|Protocol Violation|2
4474819|NCT00678652|7270337|FG001|Overall Study|Protocol Violation|0
4474820|NCT00678652|7270338|FG002|Overall Study|Protocol Violation|0
4474821|NCT00678652|7270339|FG003|Overall Study|Protocol Violation|0
4474822|NCT00678652|7270336|FG000|Overall Study|Pregnancy|0
4474823|NCT00678652|7270337|FG001|Overall Study|Pregnancy|0
4474824|NCT00678652|7270338|FG002|Overall Study|Pregnancy|1
4474825|NCT00678652|7270339|FG003|Overall Study|Pregnancy|0
4474826|NCT00678652|7270336|FG000|Overall Study|Relocation|1
4474827|NCT00678652|7270337|FG001|Overall Study|Relocation|0
4474828|NCT00678652|7270338|FG002|Overall Study|Relocation|0
4474829|NCT00678652|7270339|FG003|Overall Study|Relocation|0
4474830|NCT00678691|7270351|FG000|Overall Study|Adverse Event|6
4474831|NCT00678691|7270352|FG001|Overall Study|Adverse Event|4
4474832|NCT00678795|7270360|FG000|Overall Study|Adverse Event|7
4474833|NCT00678795|7270361|FG001|Overall Study|Adverse Event|3
4474834|NCT00678795|7270360|FG000|Overall Study|Withdrawal by Subject|3
4474835|NCT00678795|7270361|FG001|Overall Study|Withdrawal by Subject|0
4474836|NCT00678795|7270360|FG000|Overall Study|Protocol Violation|0
4474837|NCT00678795|7270361|FG001|Overall Study|Protocol Violation|1
4474838|NCT00678795|7270360|FG000|Overall Study|Lost to Follow-up|0
4474839|NCT00678795|7270361|FG001|Overall Study|Lost to Follow-up|1
4474840|NCT00678795|7270360|FG000|Overall Study|Lack of Efficacy|1
4474841|NCT00678795|7270361|FG001|Overall Study|Lack of Efficacy|1
4474842|NCT00678886|7270392|FG000|Overall Study|Withdrawal by Subject|0
4474843|NCT00678886|7270393|FG001|Overall Study|Withdrawal by Subject|0
4474844|NCT00678886|7270394|FG002|Overall Study|Withdrawal by Subject|4
4474845|NCT00678886|7270395|FG003|Overall Study|Withdrawal by Subject|6
4474846|NCT00678886|7270392|FG000|Overall Study|Physician Decision|0
4474847|NCT00678886|7270393|FG001|Overall Study|Physician Decision|0
4474848|NCT00678886|7270394|FG002|Overall Study|Physician Decision|1
4474849|NCT00678886|7270395|FG003|Overall Study|Physician Decision|1
4474850|NCT00678886|7270392|FG000|Overall Study|Lost to Follow-up|0
4474851|NCT00678886|7270393|FG001|Overall Study|Lost to Follow-up|0
4474852|NCT00678886|7270394|FG002|Overall Study|Lost to Follow-up|3
4474853|NCT00678886|7270395|FG003|Overall Study|Lost to Follow-up|2
4474854|NCT00678886|7270392|FG000|Overall Study|Other|0
4474855|NCT00678886|7270393|FG001|Overall Study|Other|0
4474856|NCT00678886|7270394|FG002|Overall Study|Other|1
4474857|NCT00678886|7270395|FG003|Overall Study|Other|0
4474858|NCT00678899|7270404|FG000|Overall Study|Adverse Event|1
4474859|NCT00679029|7270409|FG000|Overall Study|Adverse Event|3
4474860|NCT00679029|7270409|FG000|Overall Study|Withdrawal by Subject|1
4474861|NCT00679029|7270409|FG000|Overall Study|Lost to Follow-up|1
4474862|NCT00679042|7270413|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2
4474863|NCT00679042|7270413|FG000|5-Year Follow Up|In follow-up (ongoing)|6
4474864|NCT00679042|7270413|FG000|5-Year Follow Up|Death|1
4474865|NCT00679042|7270413|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7
4474866|NCT00679042|7270413|FG000|10-Year Follow Up|In follow-up (ongoing)|5
4474867|NCT00679055|7270419|FG000|Overall Study|Adverse Event|0
4474868|NCT00679055|7270420|FG001|Overall Study|Adverse Event|1
4474869|NCT00679055|7270419|FG000|Overall Study|Other|0
4474870|NCT00679055|7270420|FG001|Overall Study|Other|3
4474871|NCT00679055|7270419|FG000|Overall Study|Study Terminated|2
4474872|NCT00679055|7270420|FG001|Overall Study|Study Terminated|1
4474873|NCT00679081|7270426|FG000|Overall Study|Lost to Follow-up|1
4474874|NCT00679172|7270439|FG000|Overall Study|Non-compliance|1
4474875|NCT00679172|7270440|FG001|Overall Study|Non-compliance|1
4474876|NCT00679172|7270441|FG002|Overall Study|Non-compliance|0
4474877|NCT00679172|7270442|FG003|Overall Study|Non-compliance|1
4474878|NCT00679172|7270443|FG004|Overall Study|Non-compliance|0
4474879|NCT00679172|7270439|FG000|Overall Study|Other not specified|0
4474880|NCT00679172|7270440|FG001|Overall Study|Other not specified|0
4474881|NCT00679172|7270441|FG002|Overall Study|Other not specified|1
4474882|NCT00679172|7270442|FG003|Overall Study|Other not specified|0
4474883|NCT00679172|7270443|FG004|Overall Study|Other not specified|0
4474884|NCT00679211|7270458|FG000|Overall Study|Progressive disease|82
4474885|NCT00679211|7270458|FG000|Overall Study|Adverse Event|7
4474886|NCT00679211|7270458|FG000|Overall Study|Withdrawal by Subject|2
4474887|NCT00679211|7270458|FG000|Overall Study|Physician Decision|5
4474888|NCT00679211|7270458|FG000|Overall Study|Refused to undergo protocol procedures|1
4474889|NCT00679211|7270458|FG000|Overall Study|Transferred to extension study TDM4529g|12
4474890|NCT00679211|7270458|FG000|Overall Study|Other|1
4474891|NCT00679263|7270467|FG000|Visit 2/Dose 1|Adverse Event|1
4474892|NCT00679263|7270468|FG001|Visit 2/Dose 1|Adverse Event|0
4474893|NCT00679263|7270469|FG002|Visit 2/Dose 1|Adverse Event|0
4474894|NCT00679263|7270467|FG000|Visit 2/Dose 1|subject not compliance|1
4474895|NCT00679263|7270468|FG001|Visit 2/Dose 1|subject not compliance|1
4474896|NCT00679263|7270469|FG002|Visit 2/Dose 1|subject not compliance|0
4474897|NCT00679289|7270480|FG000|Overall Study|Progressive disease|4
4474898|NCT00679289|7270481|FG001|Overall Study|Progressive disease|5
4474899|NCT00679289|7270482|FG002|Overall Study|Progressive disease|18
4474900|NCT00679289|7270480|FG000|Overall Study|Withdrawal by Subject|0
4474901|NCT00679289|7270481|FG001|Overall Study|Withdrawal by Subject|1
4474902|NCT00679289|7270482|FG002|Overall Study|Withdrawal by Subject|1
4474903|NCT00679289|7270480|FG000|Overall Study|Adverse Event|0
4474904|NCT00679289|7270481|FG001|Overall Study|Adverse Event|0
4474905|NCT00679289|7270482|FG002|Overall Study|Adverse Event|3
4474906|NCT00679289|7270480|FG000|Overall Study|Physician Decision|1
4474907|NCT00679289|7270481|FG001|Overall Study|Physician Decision|0
4474908|NCT00679289|7270482|FG002|Overall Study|Physician Decision|1
4474909|NCT00679302|7270494|FG000|Overall Study|Lost to Follow-up|8
4474910|NCT00679302|7270495|FG001|Overall Study|Lost to Follow-up|4
4474911|NCT00679341|7270503|FG000|Overall Study|Disease progression|42
4474912|NCT00679341|7270504|FG001|Overall Study|Disease progression|36
4474913|NCT00679341|7270503|FG000|Overall Study|Adverse Event|5
4474914|NCT00679341|7270504|FG001|Overall Study|Adverse Event|6
4474915|NCT00679341|7270503|FG000|Overall Study|Subject/guardian decision to discontinue|3
4474916|NCT00679341|7270504|FG001|Overall Study|Subject/guardian decision to discontinue|0
4474917|NCT00679341|7270503|FG000|Overall Study|Death|1
4474918|NCT00679341|7270504|FG001|Overall Study|Death|1
4474919|NCT00679341|7270503|FG000|Overall Study|Other|1
4474920|NCT00679341|7270504|FG001|Overall Study|Other|0
4474921|NCT00679341|7270503|FG000|Overall Study|Physician Decision|1
4474922|NCT00679341|7270504|FG001|Overall Study|Physician Decision|0
4474923|NCT00679341|7270503|FG000|Overall Study|Not treated|0
4474924|NCT00679341|7270504|FG001|Overall Study|Not treated|2
4474925|NCT00679341|7270503|FG000|Overall Study|Physician/patient decision to withdraw|0
4474926|NCT00679341|7270504|FG001|Overall Study|Physician/patient decision to withdraw|6
4474927|NCT00679354|7270511|FG000|Overall Study|Death|3
4474928|NCT00679354|7270511|FG000|Overall Study|Lack of Efficacy|22
4474929|NCT00679354|7270511|FG000|Overall Study|Physician Decision|4
4474930|NCT00679354|7270511|FG000|Overall Study|Ineligible|1
4474931|NCT00679367|7270516|FG000|Overall Study|Adverse Event|7
4474932|NCT00679367|7270516|FG000|Overall Study|inability to swallow oral drugs|1
4474933|NCT00679367|7270516|FG000|Overall Study|Lack of Efficacy|3
4474934|NCT00679367|7270516|FG000|Overall Study|Withdrawal by Subject|1
4516705|NCT00960934|7328106|FG004|Overall Study|Study Terminated by Sponsor|49
4516706|NCT00960934|7328107|FG005|Overall Study|Study Terminated by Sponsor|49
4516707|NCT00960986|7328125|FG000|Period 1 (Screening and Washout)|Adverse Event|1
4516708|NCT00960986|7328126|FG001|Period 1 (Screening and Washout)|Adverse Event|2
4516709|NCT00960986|7328127|FG002|Period 1 (Screening and Washout)|Adverse Event|1
4516710|NCT00960986|7328128|FG003|Period 1 (Screening and Washout)|Adverse Event|1
4516711|NCT00960986|7328125|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0
4516712|NCT00960986|7328126|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0
4516713|NCT00960986|7328127|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2
4516714|NCT00960986|7328128|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1
4516715|NCT00960986|7328125|FG000|Period 1 (Screening and Washout)|Protocol Violation|1
4516716|NCT00960986|7328126|FG001|Period 1 (Screening and Washout)|Protocol Violation|0
4516717|NCT00960986|7328127|FG002|Period 1 (Screening and Washout)|Protocol Violation|0
4516718|NCT00960986|7328128|FG003|Period 1 (Screening and Washout)|Protocol Violation|0
4516719|NCT00960986|7328125|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1
4516720|NCT00960986|7328126|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2
4516721|NCT00960986|7328127|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1
4516722|NCT00960986|7328128|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1
4516723|NCT00960986|7328125|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17
4516724|NCT00960986|7328126|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15
4516725|NCT00960986|7328127|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10
4516726|NCT00960986|7328128|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12
4516727|NCT00960986|7328125|FG000|Period 3 (7-week Therapy Period)|Death|0
4516728|NCT00960986|7328126|FG001|Period 3 (7-week Therapy Period)|Death|0
4516729|NCT00960986|7328127|FG002|Period 3 (7-week Therapy Period)|Death|1
4474935|NCT00679432|7270542|FG000|Overall Study|Adverse Event|5
4474936|NCT00679432|7270543|FG001|Overall Study|Adverse Event|6
4474937|NCT00679432|7270544|FG002|Overall Study|Adverse Event|10
4474938|NCT00679432|7270545|FG003|Overall Study|Adverse Event|7
4474939|NCT00679432|7270542|FG000|Overall Study|Protocol Violation|1
4474940|NCT00679432|7270543|FG001|Overall Study|Protocol Violation|1
4474941|NCT00679432|7270544|FG002|Overall Study|Protocol Violation|2
4474942|NCT00679432|7270545|FG003|Overall Study|Protocol Violation|1
4474943|NCT00679432|7270542|FG000|Overall Study|Withdrawal by Subject|8
4474944|NCT00679432|7270543|FG001|Overall Study|Withdrawal by Subject|11
4474945|NCT00679432|7270544|FG002|Overall Study|Withdrawal by Subject|10
4474946|NCT00679432|7270545|FG003|Overall Study|Withdrawal by Subject|9
4474947|NCT00679432|7270542|FG000|Overall Study|Lost to Follow-up|1
4474948|NCT00679432|7270543|FG001|Overall Study|Lost to Follow-up|5
4474949|NCT00679432|7270544|FG002|Overall Study|Lost to Follow-up|4
4474950|NCT00679432|7270545|FG003|Overall Study|Lost to Follow-up|2
4474951|NCT00679432|7270542|FG000|Overall Study|Physician Decision|3
4474952|NCT00679432|7270543|FG001|Overall Study|Physician Decision|2
4474953|NCT00679432|7270544|FG002|Overall Study|Physician Decision|2
4474954|NCT00679432|7270545|FG003|Overall Study|Physician Decision|2
4474955|NCT00679432|7270542|FG000|Overall Study|Sponsor decision|1
4474956|NCT00679432|7270543|FG001|Overall Study|Sponsor decision|0
4474957|NCT00679432|7270544|FG002|Overall Study|Sponsor decision|0
4474958|NCT00679432|7270545|FG003|Overall Study|Sponsor decision|0
4474959|NCT00679432|7270542|FG000|Overall Study|Lack of Efficacy|13
4474960|NCT00679432|7270543|FG001|Overall Study|Lack of Efficacy|9
4474961|NCT00679432|7270544|FG002|Overall Study|Lack of Efficacy|14
4474962|NCT00679432|7270545|FG003|Overall Study|Lack of Efficacy|8
4474963|NCT00679432|7270542|FG000|Overall Study|Infectious colitis, normal histology|5
4474964|NCT00679432|7270543|FG001|Overall Study|Infectious colitis, normal histology|4
4474965|NCT00679432|7270544|FG002|Overall Study|Infectious colitis, normal histology|8
4474966|NCT00679432|7270545|FG003|Overall Study|Infectious colitis, normal histology|3
4474967|NCT00679432|7270542|FG000|Overall Study|Randomization error, return to prior Rx|0
4474968|NCT00679432|7270543|FG001|Overall Study|Randomization error, return to prior Rx|0
4474969|NCT00679432|7270544|FG002|Overall Study|Randomization error, return to prior Rx|3
4474970|NCT00679432|7270545|FG003|Overall Study|Randomization error, return to prior Rx|0
4474971|NCT00679549|7270557|FG000|Overall Study|dropout|2
4474972|NCT00679549|7270558|FG001|Overall Study|dropout|4
4474973|NCT00679549|7270557|FG000|Overall Study|missing outcome echocardiograms|4
4474974|NCT00679549|7270558|FG001|Overall Study|missing outcome echocardiograms|5
4474975|NCT00679627|7270566|FG000|Overall Study|Death|41
4474976|NCT00679627|7270567|FG001|Overall Study|Death|29
4474977|NCT00679627|7270566|FG000|Overall Study|Adverse Event|43
4474978|NCT00679627|7270567|FG001|Overall Study|Adverse Event|53
4474979|NCT00679627|7270566|FG000|Overall Study|Withdrawal by Subject|168
4474980|NCT00679627|7270567|FG001|Overall Study|Withdrawal by Subject|172
4474981|NCT00679627|7270566|FG000|Overall Study|Lost to Follow-up|22
4474982|NCT00679627|7270567|FG001|Overall Study|Lost to Follow-up|26
4474983|NCT00679627|7270566|FG000|Overall Study|Early Study Closure|425
4474984|NCT00679627|7270567|FG001|Overall Study|Early Study Closure|405
4474985|NCT00679913|7270575|FG000|Overall Study|Protocol Violation|18
4474986|NCT00679913|7270576|FG001|Overall Study|Protocol Violation|13
4474987|NCT00679939|7270585|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17
4474988|NCT00679939|7270586|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13
4474989|NCT00679939|7270585|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14
4474990|NCT00679939|7270586|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12
4474991|NCT00679939|7270585|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5
4474992|NCT00679939|7270586|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0
4474993|NCT00679939|7270585|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1
4474994|NCT00679939|7270586|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0
4474995|NCT00679939|7270585|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
4474996|NCT00679939|7270586|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2
4474997|NCT00679939|7270585|FG000|24-Week Open-Label (OL) Period|Adverse Event|0
4474998|NCT00679939|7270586|FG001|24-Week Open-Label (OL) Period|Adverse Event|1
4474999|NCT00679939|7270585|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1
4475000|NCT00679939|7270586|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1
4475001|NCT00679939|7270585|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3
4475002|NCT00679939|7270586|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1
4475003|NCT00679939|7270585|FG000|24-Week Open-Label (OL) Period|Physician Decision|1
4475004|NCT00679939|7270586|FG001|24-Week Open-Label (OL) Period|Physician Decision|0
4475005|NCT00679939|7270585|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2
4475006|NCT00679939|7270586|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1
4475007|NCT00680017|7270607|FG000|Overall Study|Adverse Event|13
4475008|NCT00680017|7270608|FG001|Overall Study|Adverse Event|7
4475009|NCT00680017|7270607|FG000|Overall Study|Withdrawal by Subject|2
4475010|NCT00680017|7270608|FG001|Overall Study|Withdrawal by Subject|5
4475011|NCT00680017|7270607|FG000|Overall Study|Lost to Follow-up|2
4475012|NCT00680017|7270608|FG001|Overall Study|Lost to Follow-up|0
4475013|NCT00680043|7270617|FG000|Overall Study|Withdrawal by Subject|1
4475014|NCT00680043|7270618|FG001|Overall Study|Withdrawal by Subject|0
4475015|NCT00680043|7270619|FG002|Overall Study|Withdrawal by Subject|0
4475016|NCT00680043|7270617|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0
4475017|NCT00680043|7270618|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1
4475018|NCT00680043|7270619|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0
4475019|NCT00680043|7270617|FG000|Overall Study|Renal Transplant|1
4475020|NCT00680043|7270618|FG001|Overall Study|Renal Transplant|0
4475021|NCT00680043|7270619|FG002|Overall Study|Renal Transplant|4
4475022|NCT00680056|7270629|FG000|First Intervention|Mainly Exacerbation of COPD|1
4475023|NCT00680056|7270630|FG001|First Intervention|Mainly Exacerbation of COPD|2
4475024|NCT00680056|7270629|FG000|Second Intervention|Protocol Violation|3
4475025|NCT00680056|7270630|FG001|Second Intervention|Protocol Violation|1
4475026|NCT00680121|7270639|FG000|Overall Study|Lost to Follow-up|27
4475027|NCT00680121|7270640|FG001|Overall Study|Lost to Follow-up|23
4475028|NCT00680186|7270648|FG000|Overall Study|Adverse Event|47
4475029|NCT00680186|7270649|FG001|Overall Study|Adverse Event|44
4475030|NCT00680186|7270648|FG000|Overall Study|Protocol Violation|31
4475031|NCT00680186|7270649|FG001|Overall Study|Protocol Violation|26
4475032|NCT00680186|7270648|FG000|Overall Study|Lost to Follow-up|11
4475033|NCT00680186|7270649|FG001|Overall Study|Lost to Follow-up|6
4475034|NCT00680186|7270648|FG000|Overall Study|Withdrawal by Subject|32
4475035|NCT00680186|7270649|FG001|Overall Study|Withdrawal by Subject|39
4475036|NCT00680186|7270648|FG000|Overall Study|Other|4
4475037|NCT00680186|7270649|FG001|Overall Study|Other|1
4475038|NCT00680368|7270659|FG000|Overall Study|not supervised, not eligible|15
4475039|NCT00680407|7270668|FG000|Overall Study|Lost to Follow-up|3
4475040|NCT00680407|7270669|FG001|Overall Study|Lost to Follow-up|3
4475041|NCT00680407|7270670|FG002|Overall Study|Lost to Follow-up|1
4475042|NCT00680407|7270668|FG000|Overall Study|Withdrawal by Subject|5
4475043|NCT00680407|7270669|FG001|Overall Study|Withdrawal by Subject|2
4475044|NCT00680407|7270670|FG002|Overall Study|Withdrawal by Subject|2
4475045|NCT00680745|7270713|FG000|Overall Study|Withdrawal by Subject|8
4475046|NCT00680745|7270714|FG001|Overall Study|Withdrawal by Subject|3
4475047|NCT00680745|7270715|FG002|Overall Study|Withdrawal by Subject|2
4475048|NCT00680745|7270716|FG003|Overall Study|Withdrawal by Subject|8
4475049|NCT00680745|7270713|FG000|Overall Study|Lost to Follow-up|0
4475050|NCT00680745|7270714|FG001|Overall Study|Lost to Follow-up|1
4475051|NCT00680745|7270715|FG002|Overall Study|Lost to Follow-up|1
4475052|NCT00680745|7270716|FG003|Overall Study|Lost to Follow-up|0
4475053|NCT00680745|7270713|FG000|Overall Study|Death|1
4475054|NCT00680745|7270714|FG001|Overall Study|Death|0
4475055|NCT00680745|7270715|FG002|Overall Study|Death|1
4475056|NCT00680745|7270716|FG003|Overall Study|Death|0
4475057|NCT00680745|7270713|FG000|Overall Study|Adverse Event|5
4475058|NCT00680745|7270714|FG001|Overall Study|Adverse Event|3
4475059|NCT00680745|7270715|FG002|Overall Study|Adverse Event|3
4475060|NCT00680745|7270716|FG003|Overall Study|Adverse Event|3
4475061|NCT00680745|7270713|FG000|Overall Study|Poor/Non-compliance|0
4475062|NCT00680745|7270714|FG001|Overall Study|Poor/Non-compliance|3
4475063|NCT00680745|7270715|FG002|Overall Study|Poor/Non-compliance|0
4475064|NCT00680745|7270716|FG003|Overall Study|Poor/Non-compliance|0
4475065|NCT00680745|7270713|FG000|Overall Study|Subject No Longer Meets Study Criteria|0
4475066|NCT00680745|7270714|FG001|Overall Study|Subject No Longer Meets Study Criteria|2
4475067|NCT00680745|7270715|FG002|Overall Study|Subject No Longer Meets Study Criteria|0
4475068|NCT00680745|7270716|FG003|Overall Study|Subject No Longer Meets Study Criteria|2
4475069|NCT00680745|7270713|FG000|Overall Study|False Treatment|0
4475070|NCT00680745|7270714|FG001|Overall Study|False Treatment|1
4475071|NCT00680745|7270715|FG002|Overall Study|False Treatment|3
4475072|NCT00680745|7270716|FG003|Overall Study|False Treatment|0
4475073|NCT00680771|7270729|FG000|Overall Study|Withdrawal by Subject|1
4475074|NCT00680771|7270730|FG001|Overall Study|Withdrawal by Subject|0
4475075|NCT00680771|7270729|FG000|Overall Study|Sleep Apnea suspected after PSG|1
4475076|NCT00680771|7270730|FG001|Overall Study|Sleep Apnea suspected after PSG|0
4475077|NCT00680771|7270729|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4
4475078|NCT00680771|7270730|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2
4475079|NCT00680836|7270768|FG000|Overall Study|Withdrawal by Subject|3
4475080|NCT00680836|7270769|FG001|Overall Study|Withdrawal by Subject|0
4475081|NCT00680836|7270768|FG000|Overall Study|Lost to Follow-up|3
4475082|NCT00680836|7270769|FG001|Overall Study|Lost to Follow-up|1
4475083|NCT00680836|7270768|FG000|Overall Study|Physician Decision|2
4475084|NCT00680836|7270769|FG001|Overall Study|Physician Decision|1
4475085|NCT00680914|7270782|FG000|Overall Study|Consent withdrawal|6
4475086|NCT00680914|7270783|FG001|Overall Study|Consent withdrawal|3
4475087|NCT00680914|7270782|FG000|Overall Study|Lost to Follow-up|4
4475088|NCT00680914|7270783|FG001|Overall Study|Lost to Follow-up|0
4475089|NCT00680914|7270782|FG000|Overall Study|serious adverse event (SAE)|0
4475090|NCT00680914|7270783|FG001|Overall Study|serious adverse event (SAE)|1
4475091|NCT00680992|7270805|FG000|Overall Study|Complete Resection (as per protocol)|25
4475092|NCT00680992|7270806|FG001|Overall Study|Complete Resection (as per protocol)|121
4475093|NCT00680992|7270807|FG002|Overall Study|Complete Resection (as per protocol)|0
4475094|NCT00680992|7270805|FG000|Overall Study|Administrative Decision|83
4475095|NCT00680992|7270806|FG001|Overall Study|Administrative Decision|42
4475096|NCT00680992|7270807|FG002|Overall Study|Administrative Decision|5
4475097|NCT00680992|7270805|FG000|Overall Study|End of Trial|32
4475098|NCT00680992|7270806|FG001|Overall Study|End of Trial|12
4475099|NCT00680992|7270807|FG002|Overall Study|End of Trial|3
4475100|NCT00680992|7270805|FG000|Overall Study|Withdrawal by Subject|33
4475101|NCT00680992|7270806|FG001|Overall Study|Withdrawal by Subject|11
4475102|NCT00680992|7270807|FG002|Overall Study|Withdrawal by Subject|1
4475103|NCT00680992|7270805|FG000|Overall Study|Adverse Event|21
4475104|NCT00680992|7270806|FG001|Overall Study|Adverse Event|19
4475105|NCT00680992|7270807|FG002|Overall Study|Adverse Event|1
4475106|NCT00680992|7270805|FG000|Overall Study|Other|19
4475107|NCT00680992|7270806|FG001|Overall Study|Other|14
4475108|NCT00680992|7270807|FG002|Overall Study|Other|1
4475109|NCT00680992|7270805|FG000|Overall Study|Disease Progression|21
4475110|NCT00680992|7270806|FG001|Overall Study|Disease Progression|9
4475111|NCT00680992|7270807|FG002|Overall Study|Disease Progression|0
4475112|NCT00680992|7270805|FG000|Overall Study|Lost to Follow-up|12
4475113|NCT00680992|7270806|FG001|Overall Study|Lost to Follow-up|14
4475114|NCT00680992|7270807|FG002|Overall Study|Lost to Follow-up|0
4475115|NCT00680992|7270805|FG000|Overall Study|Noncompliance|4
4475116|NCT00680992|7270806|FG001|Overall Study|Noncompliance|6
4475117|NCT00680992|7270807|FG002|Overall Study|Noncompliance|0
4475118|NCT00680992|7270805|FG000|Overall Study|Requirement for Alternative Therapy|8
4475119|NCT00680992|7270806|FG001|Overall Study|Requirement for Alternative Therapy|2
4475120|NCT00680992|7270807|FG002|Overall Study|Requirement for Alternative Therapy|0
4475121|NCT00680992|7270805|FG000|Overall Study|Pregnancy|5
4475122|NCT00680992|7270806|FG001|Overall Study|Pregnancy|0
4475123|NCT00680992|7270807|FG002|Overall Study|Pregnancy|1
4475124|NCT00680992|7270805|FG000|Overall Study|Death|5
4475125|NCT00680992|7270806|FG001|Overall Study|Death|1
4475126|NCT00680992|7270807|FG002|Overall Study|Death|0
4475127|NCT00680992|7270805|FG000|Overall Study|Ineligibility Determined|0
4475128|NCT00680992|7270806|FG001|Overall Study|Ineligibility Determined|1
4475129|NCT00680992|7270807|FG002|Overall Study|Ineligibility Determined|0
4475130|NCT00681109|7270830|FG000|Overall Study|Lost to Follow-up|2
4475131|NCT00681109|7270831|FG001|Overall Study|Lost to Follow-up|6
4475132|NCT00681109|7270832|FG002|Overall Study|Lost to Follow-up|0
4475133|NCT00681187|7270845|FG000|Overall Study|Withdrawal by Subject|1
4475134|NCT00681187|7270846|FG001|Overall Study|Withdrawal by Subject|0
4475135|NCT00681187|7270845|FG000|Overall Study|Death|0
4475136|NCT00681187|7270846|FG001|Overall Study|Death|1
4475137|NCT00681187|7270845|FG000|Overall Study|Adverse Event|0
4475138|NCT00681187|7270846|FG001|Overall Study|Adverse Event|1
4475139|NCT00681564|7270895|FG000|Overall Study|Lost to Follow-up|6
4475140|NCT00681564|7270896|FG001|Overall Study|Lost to Follow-up|6
4475141|NCT00681564|7270895|FG000|Overall Study|Withdrawal by Subject|0
4475142|NCT00681564|7270896|FG001|Overall Study|Withdrawal by Subject|1
4475143|NCT00681564|7270895|FG000|Overall Study|Death|0
4475144|NCT00681564|7270896|FG001|Overall Study|Death|1
4475145|NCT00681590|7270904|FG000|Overall Study|Withdrawal by Subject|2
4475146|NCT00681590|7270905|FG001|Overall Study|Withdrawal by Subject|12
4475147|NCT00681668|7270911|FG000|Overall Study|Protocol Violation|1
4475148|NCT00681668|7270911|FG000|Overall Study|Withdrawal by Subject|1
4475149|NCT00681811|7270917|FG000|Overall Study|Adverse Event|1
4475150|NCT00681811|7270918|FG001|Overall Study|Adverse Event|1
4475151|NCT00681811|7270917|FG000|Overall Study|Withdrawal by Subject|2
4475152|NCT00681811|7270918|FG001|Overall Study|Withdrawal by Subject|2
4475153|NCT00681811|7270917|FG000|Overall Study|Non-compliance|0
4475154|NCT00681811|7270918|FG001|Overall Study|Non-compliance|1
4475155|NCT00681824|7270938|FG000|Overall Study|withdrawn by investigator|0
4475156|NCT00681824|7270939|FG001|Overall Study|withdrawn by investigator|0
4475157|NCT00681824|7270940|FG002|Overall Study|withdrawn by investigator|1
4475158|NCT00681824|7270938|FG000|Overall Study|scheduling conflict|1
4475159|NCT00681824|7270939|FG001|Overall Study|scheduling conflict|0
4475160|NCT00681824|7270940|FG002|Overall Study|scheduling conflict|0
4475161|NCT00681824|7270938|FG000|Overall Study|Death|0
4475162|NCT00681824|7270939|FG001|Overall Study|Death|1
4475163|NCT00681824|7270940|FG002|Overall Study|Death|0
4475164|NCT00681863|7270948|FG000|Overall Study|Adverse Event|1
4475165|NCT00681863|7270948|FG000|Overall Study|Lost to Follow-up|2
4475166|NCT00681863|7270948|FG000|Overall Study|Lack of Efficacy|2
4475167|NCT00681863|7270948|FG000|Overall Study|Other|18
4475168|NCT00682435|7270969|FG000|Overall Study|Insufficient data|5
4475169|NCT00682435|7270969|FG000|Overall Study|Erroneously enrolled twice|2
4475170|NCT00682448|7270975|FG000|Overall Study|Adverse Event|1
4475171|NCT00682448|7270976|FG001|Overall Study|Adverse Event|2
4475172|NCT00682448|7270975|FG000|Overall Study|Lack of Efficacy|1
4475173|NCT00682448|7270976|FG001|Overall Study|Lack of Efficacy|0
4475174|NCT00682448|7270975|FG000|Overall Study|Lost to Follow-up|1
4475175|NCT00682448|7270976|FG001|Overall Study|Lost to Follow-up|3
4475176|NCT00682448|7270975|FG000|Overall Study|Pregnancy|0
4475177|NCT00682448|7270976|FG001|Overall Study|Pregnancy|1
4475178|NCT00682448|7270975|FG000|Overall Study|Withdrawal by Subject|2
4475179|NCT00682448|7270976|FG001|Overall Study|Withdrawal by Subject|0
4475180|NCT00682461|7270984|FG000|Overall Study|Adverse Event|5
4475181|NCT00682461|7270985|FG001|Overall Study|Adverse Event|7
4475182|NCT00682461|7270984|FG000|Overall Study|Lost to Follow-up|8
4475183|NCT00682461|7270985|FG001|Overall Study|Lost to Follow-up|5
4475184|NCT00682461|7270984|FG000|Overall Study|Withdrawal by Subject|12
4475185|NCT00682461|7270985|FG001|Overall Study|Withdrawal by Subject|19
4475186|NCT00682539|7270995|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3
4475187|NCT00682539|7270996|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1
4475188|NCT00682539|7270997|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0
4475189|NCT00682539|7270995|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0
4475190|NCT00682539|7270996|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3
4475191|NCT00682539|7270997|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8
4475192|NCT00682643|7271030|FG000|Overall Study|Adverse Event|12
4475193|NCT00682643|7271031|FG001|Overall Study|Adverse Event|23
4475194|NCT00682643|7271030|FG000|Overall Study|Lack of Efficacy|2
4475195|NCT00682643|7271031|FG001|Overall Study|Lack of Efficacy|0
4475196|NCT00682643|7271030|FG000|Overall Study|Protocol Violation|38
4475197|NCT00682643|7271031|FG001|Overall Study|Protocol Violation|76
4475198|NCT00682643|7271030|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3
4475199|NCT00682643|7271031|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4
4475200|NCT00682643|7271030|FG000|Overall Study|Lost to Follow-up|1
4475201|NCT00682643|7271031|FG001|Overall Study|Lost to Follow-up|6
4475202|NCT00682643|7271030|FG000|Overall Study|Physician Decision|2
4475203|NCT00682643|7271031|FG001|Overall Study|Physician Decision|6
4475204|NCT00682643|7271030|FG000|Overall Study|Withdrawal by Subject|19
4475205|NCT00682643|7271031|FG001|Overall Study|Withdrawal by Subject|53
4475206|NCT00682643|7271030|FG000|Overall Study|Did Not Receive Study Drug|1
4475207|NCT00682643|7271031|FG001|Overall Study|Did Not Receive Study Drug|1
4475208|NCT00682786|7271053|FG000|Overall Study|Withdrawal by Subject|2
4475209|NCT00682786|7271054|FG001|Overall Study|Withdrawal by Subject|2
4475210|NCT00682786|7271053|FG000|Overall Study|Did not receive irinotecan|0
4475211|NCT00682786|7271054|FG001|Overall Study|Did not receive irinotecan|1
4475212|NCT00682890|7271094|FG000|Overall Study|Lost to Follow-up|1
4475213|NCT00682890|7271095|FG001|Overall Study|Lost to Follow-up|1
4475214|NCT00682890|7271094|FG000|Overall Study|subject moved away|0
4475215|NCT00682890|7271095|FG001|Overall Study|subject moved away|1
4475216|NCT00682890|7271094|FG000|Overall Study|heavy menstrual bleeding|1
4475217|NCT00682890|7271095|FG001|Overall Study|heavy menstrual bleeding|0
4475218|NCT00682929|7271104|FG000|Overall Study|Adverse Event|4
4475219|NCT00682929|7271105|FG001|Overall Study|Adverse Event|1
4475220|NCT00682929|7271106|FG002|Overall Study|Adverse Event|1
4475221|NCT00682929|7271104|FG000|Overall Study|Withdrawal by Subject|1
4475222|NCT00682929|7271105|FG001|Overall Study|Withdrawal by Subject|2
4475223|NCT00682929|7271106|FG002|Overall Study|Withdrawal by Subject|1
4475224|NCT00682929|7271104|FG000|Overall Study|dosing compliance < 80%|0
4475225|NCT00682929|7271105|FG001|Overall Study|dosing compliance < 80%|2
4475226|NCT00682929|7271106|FG002|Overall Study|dosing compliance < 80%|0
4475227|NCT00682929|7271104|FG000|Overall Study|lag in DEA renewal|1
4475228|NCT00682929|7271105|FG001|Overall Study|lag in DEA renewal|0
4475229|NCT00682929|7271106|FG002|Overall Study|lag in DEA renewal|0
4475230|NCT00683293|7271142|FG000|Overall Study|Withdrawal by Subject|2
4475231|NCT00683293|7271143|FG001|Overall Study|Withdrawal by Subject|3
4475232|NCT00683384|7271153|FG000|Overall Study|Death|1
4475233|NCT00683384|7271153|FG000|Overall Study|Adverse Event|1
4475234|NCT00683449|7271166|FG000|Overall Study|Lost to Follow-up|0
4475235|NCT00683449|7271167|FG001|Overall Study|Lost to Follow-up|1
4475236|NCT00683449|7271168|FG002|Overall Study|Lost to Follow-up|0
4475237|NCT00683449|7271169|FG003|Overall Study|Lost to Follow-up|0
4475238|NCT00683449|7271170|FG004|Overall Study|Lost to Follow-up|0
4475239|NCT00683475|7271189|FG000|Overall Study|Withdrawal by Subject|1
4475240|NCT00683475|7271190|FG001|Overall Study|Withdrawal by Subject|0
4475241|NCT00683475|7271189|FG000|Overall Study|Never Treated: Adverse Event|2
4475242|NCT00683475|7271190|FG001|Overall Study|Never Treated: Adverse Event|3
4475243|NCT00683475|7271189|FG000|Overall Study|Never Treated: Progressive Disease|1
4475244|NCT00683475|7271190|FG001|Overall Study|Never Treated: Progressive Disease|0
4475245|NCT00683592|7271199|FG000|Overall Study|Adverse Event|12
4475246|NCT00683592|7271200|FG001|Overall Study|Adverse Event|4
4475247|NCT00683592|7271199|FG000|Overall Study|Withdrawal by Subject|11
4475248|NCT00683592|7271200|FG001|Overall Study|Withdrawal by Subject|11
4475249|NCT00683592|7271199|FG000|Overall Study|Lost to Follow-up|17
4475250|NCT00683592|7271200|FG001|Overall Study|Lost to Follow-up|17
4475251|NCT00683592|7271199|FG000|Overall Study|Lack of Efficacy|3
4475252|NCT00683592|7271200|FG001|Overall Study|Lack of Efficacy|7
4475253|NCT00683592|7271199|FG000|Overall Study|Physician Decision|0
4475254|NCT00683592|7271200|FG001|Overall Study|Physician Decision|1
4475255|NCT00683592|7271199|FG000|Overall Study|Non-compliance|3
4475256|NCT00683592|7271200|FG001|Overall Study|Non-compliance|5
4475257|NCT00683592|7271199|FG000|Overall Study|Other|1
4475258|NCT00683592|7271200|FG001|Overall Study|Other|1
4475259|NCT00683618|7271209|FG000|Randomised Treatment Period|Withdrawal by Subject|4
4475260|NCT00683618|7271210|FG001|Randomised Treatment Period|Withdrawal by Subject|1
4475261|NCT00683618|7271211|FG002|Randomised Treatment Period|Withdrawal by Subject|2
4475262|NCT00683618|7271209|FG000|Randomised Treatment Period|Protocol Violation|0
4475263|NCT00683618|7271210|FG001|Randomised Treatment Period|Protocol Violation|1
4475264|NCT00683618|7271211|FG002|Randomised Treatment Period|Protocol Violation|0
4475265|NCT00683618|7271209|FG000|Randomised Treatment Period|Adverse Event|2
4475266|NCT00683618|7271210|FG001|Randomised Treatment Period|Adverse Event|0
4475267|NCT00683618|7271211|FG002|Randomised Treatment Period|Adverse Event|2
4475268|NCT00683618|7271209|FG000|Randomised Treatment Period|Reason not provided|0
4475269|NCT00683618|7271210|FG001|Randomised Treatment Period|Reason not provided|0
4475270|NCT00683618|7271211|FG002|Randomised Treatment Period|Reason not provided|2
4475271|NCT00683618|7271209|FG000|Extension Treatment Period|Withdrawal by Subject|1
4475272|NCT00683618|7271210|FG001|Extension Treatment Period|Withdrawal by Subject|0
4475273|NCT00683618|7271211|FG002|Extension Treatment Period|Withdrawal by Subject|0
4475274|NCT00683618|7271209|FG000|Extension Treatment Period|Adverse Event|1
4475275|NCT00683618|7271210|FG001|Extension Treatment Period|Adverse Event|0
4475276|NCT00683618|7271211|FG002|Extension Treatment Period|Adverse Event|0
4475277|NCT00683618|7271209|FG000|Extension Treatment Period|Protocol Violation|1
4475278|NCT00683618|7271210|FG001|Extension Treatment Period|Protocol Violation|0
4475279|NCT00683618|7271211|FG002|Extension Treatment Period|Protocol Violation|0
4475280|NCT00683644|7271223|FG000|Overall Study|Withdrawal by Subject|4
4475281|NCT00683644|7271224|FG001|Overall Study|Withdrawal by Subject|2
4475282|NCT00683644|7271223|FG000|Overall Study|Lost to Follow-up|1
4475283|NCT00683644|7271224|FG001|Overall Study|Lost to Follow-up|4
4475284|NCT00683644|7271223|FG000|Overall Study|Adverse Event|1
4475285|NCT00683644|7271224|FG001|Overall Study|Adverse Event|2
4475286|NCT00683644|7271223|FG000|Overall Study|Low copper, other health problems,|7
4475287|NCT00683644|7271224|FG001|Overall Study|Low copper, other health problems,|6
4475288|NCT00683657|7271236|FG000|Overall Study|Adverse Event|0
4475289|NCT00683657|7271237|FG001|Overall Study|Adverse Event|1
4475290|NCT00683657|7271236|FG000|Overall Study|Subject Withdrew Consent|1
4475291|NCT00683657|7271237|FG001|Overall Study|Subject Withdrew Consent|0
4475292|NCT00683696|7271245|FG000|Overall Study|Withdrawn due to study closure|337
4475293|NCT00683696|7271246|FG001|Overall Study|Withdrawn due to study closure|338
4475294|NCT00683696|7271245|FG000|Overall Study|Withdrawn prior to study closure|13
4475295|NCT00683696|7271246|FG001|Overall Study|Withdrawn prior to study closure|28
4475296|NCT00683696|7271245|FG000|Overall Study|Lost to Follow-up|5
4475297|NCT00683696|7271246|FG001|Overall Study|Lost to Follow-up|6
4475298|NCT00683696|7271245|FG000|Overall Study|Vital status follow-up only|3
4475299|NCT00683696|7271246|FG001|Overall Study|Vital status follow-up only|3
4475300|NCT00683696|7271245|FG000|Overall Study|Death|46
4475301|NCT00683696|7271246|FG001|Overall Study|Death|30
4475302|NCT00683774|7271255|FG000|Overall Study|Withdrawal by Subject|0
4475303|NCT00683774|7271256|FG001|Overall Study|Withdrawal by Subject|1
4475304|NCT00683774|7271255|FG000|Overall Study|Physician Decision|3
4475305|NCT00683774|7271256|FG001|Overall Study|Physician Decision|0
4475306|NCT00683800|7271264|FG000|Overall Study|Adverse Event|195
4475307|NCT00683800|7271265|FG001|Overall Study|Adverse Event|102
4475308|NCT00683800|7271264|FG000|Overall Study|Death|0
4475309|NCT00683800|7271265|FG001|Overall Study|Death|1
4475310|NCT00683800|7271264|FG000|Overall Study|Lost to Follow-up|57
4475311|NCT00683800|7271265|FG001|Overall Study|Lost to Follow-up|44
4475312|NCT00683800|7271264|FG000|Overall Study|Other|5
4475313|NCT00683800|7271265|FG001|Overall Study|Other|2
4475314|NCT00683800|7271264|FG000|Overall Study|Protocol Violation|13
4475315|NCT00683800|7271265|FG001|Overall Study|Protocol Violation|16
4475316|NCT00683800|7271264|FG000|Overall Study|Withdrawal by Subject|66
4475317|NCT00683800|7271265|FG001|Overall Study|Withdrawal by Subject|64
4475318|NCT00683800|7271264|FG000|Overall Study|Lack of Efficacy|61
4475319|NCT00683800|7271265|FG001|Overall Study|Lack of Efficacy|104
4475320|NCT00683800|7271264|FG000|Overall Study|Randomized, not treated|35
4475321|NCT00683800|7271265|FG001|Overall Study|Randomized, not treated|33
4475322|NCT00683878|7271304|FG000|Overall Study|Lack of Efficacy|3
4475323|NCT00683878|7271305|FG001|Overall Study|Lack of Efficacy|0
4475324|NCT00683878|7271306|FG002|Overall Study|Lack of Efficacy|1
4475325|NCT00683878|7271304|FG000|Overall Study|Adverse Event|4
4475326|NCT00683878|7271305|FG001|Overall Study|Adverse Event|3
4475327|NCT00683878|7271306|FG002|Overall Study|Adverse Event|3
4475328|NCT00683878|7271304|FG000|Overall Study|Withdrawal by Subject|9
4475329|NCT00683878|7271305|FG001|Overall Study|Withdrawal by Subject|8
4475330|NCT00683878|7271306|FG002|Overall Study|Withdrawal by Subject|6
4475331|NCT00683878|7271304|FG000|Overall Study|Death|0
4475332|NCT00683878|7271305|FG001|Overall Study|Death|1
4475333|NCT00683878|7271306|FG002|Overall Study|Death|0
4475334|NCT00683878|7271304|FG000|Overall Study|Lost to Follow-up|4
4475335|NCT00683878|7271305|FG001|Overall Study|Lost to Follow-up|2
4475336|NCT00683878|7271306|FG002|Overall Study|Lost to Follow-up|4
4475337|NCT00683878|7271304|FG000|Overall Study|Non-compliance, not met criteria etc.|3
4475338|NCT00683878|7271305|FG001|Overall Study|Non-compliance, not met criteria etc.|2
4475339|NCT00683878|7271306|FG002|Overall Study|Non-compliance, not met criteria etc.|0
4475340|NCT00683904|7271316|FG000|Dose Level 1|Disease progression|2
4475341|NCT00683904|7271317|FG001|Dose Level 1|Disease progression|0
4475342|NCT00683904|7271316|FG000|Dose Level 1|Adverse Event|1
4475343|NCT00683904|7271317|FG001|Dose Level 1|Adverse Event|0
4475344|NCT00683904|7271316|FG000|Dose Level 2|Adverse Event|0
4475345|NCT00683904|7271317|FG001|Dose Level 2|Adverse Event|2
4475346|NCT00684021|7271347|FG000|Overall Study|MRI Contraindicated|1
4475347|NCT00684021|7271348|FG001|Overall Study|MRI Contraindicated|1
4475348|NCT00684021|7271349|FG002|Overall Study|MRI Contraindicated|1
4475349|NCT00684021|7271350|FG003|Overall Study|MRI Contraindicated|0
4475350|NCT00684021|7271347|FG000|Overall Study|MRI not performed|0
4475351|NCT00684021|7271348|FG001|Overall Study|MRI not performed|1
4475352|NCT00684021|7271349|FG002|Overall Study|MRI not performed|1
4475353|NCT00684021|7271350|FG003|Overall Study|MRI not performed|2
4475354|NCT00684021|7271347|FG000|Overall Study|Death|1
4475355|NCT00684021|7271348|FG001|Overall Study|Death|0
4475356|NCT00684021|7271349|FG002|Overall Study|Death|0
4475357|NCT00684021|7271350|FG003|Overall Study|Death|0
4475358|NCT00684060|7271375|FG000|Overall Study|Lost to Follow-up|1
4475359|NCT00684060|7271376|FG001|Overall Study|Lost to Follow-up|0
4475360|NCT00684060|7271375|FG000|Overall Study|New stenosis identified|1
4475361|NCT00684060|7271376|FG001|Overall Study|New stenosis identified|0
4475362|NCT00684060|7271375|FG000|Overall Study|Unable to collect MRI|1
4475363|NCT00684060|7271376|FG001|Overall Study|Unable to collect MRI|2
4475364|NCT00684060|7271375|FG000|Overall Study|Death|0
4475365|NCT00684060|7271376|FG001|Overall Study|Death|1
4475366|NCT00684073|7271382|FG000|Selection|Selection/non-selection criteria|3
4475367|NCT00684073|7271382|FG000|Selection|Death|1
4475368|NCT00684073|7271382|FG000|Selection|noncompliance|1
4475369|NCT00684073|7271382|FG000|Selection|Lost to Follow-up|1
4475370|NCT00684073|7271382|FG000|Selection|request of the sponsor|1
4475371|NCT00684073|7271382|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1
4475372|NCT00684177|7271403|FG000|Overall Study|Adverse Event|4
4475373|NCT00684177|7271404|FG001|Overall Study|Adverse Event|3
4475374|NCT00684177|7271403|FG000|Overall Study|Lack of Efficacy|10
4475375|NCT00684177|7271404|FG001|Overall Study|Lack of Efficacy|15
4475376|NCT00684177|7271403|FG000|Overall Study|Protocol Violation|1
4475377|NCT00684177|7271404|FG001|Overall Study|Protocol Violation|0
4475378|NCT00684177|7271403|FG000|Overall Study|Lost to Follow-up|2
4475379|NCT00684177|7271404|FG001|Overall Study|Lost to Follow-up|1
4475380|NCT00684177|7271403|FG000|Overall Study|Physician Decision|2
4475381|NCT00684177|7271404|FG001|Overall Study|Physician Decision|0
4475382|NCT00684177|7271403|FG000|Overall Study|Withdrawal by Subject|1
4475383|NCT00684177|7271404|FG001|Overall Study|Withdrawal by Subject|2
4475384|NCT00684177|7271403|FG000|Overall Study|Other|1
4475385|NCT00684177|7271404|FG001|Overall Study|Other|2
4475386|NCT00684203|7271416|FG000|Overall Study|Adverse Event|6
4475387|NCT00684203|7271417|FG001|Overall Study|Adverse Event|4
4475388|NCT00684203|7271418|FG002|Overall Study|Adverse Event|8
4475389|NCT00684203|7271419|FG003|Overall Study|Adverse Event|0
4475390|NCT00684203|7271420|FG004|Overall Study|Adverse Event|0
4475391|NCT00684203|7271421|FG005|Overall Study|Adverse Event|0
4475392|NCT00684203|7271416|FG000|Overall Study|Protocol-defined clinical event|3
4475393|NCT00684203|7271417|FG001|Overall Study|Protocol-defined clinical event|1
4475394|NCT00684203|7271418|FG002|Overall Study|Protocol-defined clinical event|0
4475395|NCT00684203|7271419|FG003|Overall Study|Protocol-defined clinical event|0
4475396|NCT00684203|7271420|FG004|Overall Study|Protocol-defined clinical event|0
4475397|NCT00684203|7271421|FG005|Overall Study|Protocol-defined clinical event|0
4475398|NCT00684203|7271416|FG000|Overall Study|Withdrawal by Subject|0
4475399|NCT00684203|7271417|FG001|Overall Study|Withdrawal by Subject|2
4475400|NCT00684203|7271418|FG002|Overall Study|Withdrawal by Subject|1
4475401|NCT00684203|7271419|FG003|Overall Study|Withdrawal by Subject|0
4475402|NCT00684203|7271420|FG004|Overall Study|Withdrawal by Subject|0
4475403|NCT00684203|7271421|FG005|Overall Study|Withdrawal by Subject|0
4475404|NCT00684203|7271416|FG000|Overall Study|Did not meet protocol eligibility|0
4475405|NCT00684203|7271417|FG001|Overall Study|Did not meet protocol eligibility|1
4475406|NCT00684203|7271418|FG002|Overall Study|Did not meet protocol eligibility|0
4475407|NCT00684203|7271419|FG003|Overall Study|Did not meet protocol eligibility|0
4475408|NCT00684203|7271420|FG004|Overall Study|Did not meet protocol eligibility|0
4475409|NCT00684203|7271421|FG005|Overall Study|Did not meet protocol eligibility|0
4475410|NCT00684307|7271451|FG000|Overall Study|Adverse Event|11
4475411|NCT00684307|7271452|FG001|Overall Study|Adverse Event|6
4475412|NCT00684307|7271453|FG002|Overall Study|Adverse Event|15
4475413|NCT00684307|7271454|FG003|Overall Study|Adverse Event|16
4475414|NCT00684307|7271455|FG004|Overall Study|Adverse Event|8
4475415|NCT00684307|7271451|FG000|Overall Study|Development of increasing Liver Function|0
4699198|NCT02680002|7614447|FG003|Overall Study|Other|0
4699199|NCT02680002|7614448|FG004|Overall Study|Other|1
4699200|NCT02680002|7614449|FG005|Overall Study|Other|0
4699201|NCT02680002|7614444|FG000|Overall Study|Adverse Event|0
4699202|NCT02680002|7614445|FG001|Overall Study|Adverse Event|0
4475416|NCT00684307|7271452|FG001|Overall Study|Development of increasing Liver Function|2
4475417|NCT00684307|7271453|FG002|Overall Study|Development of increasing Liver Function|0
4475418|NCT00684307|7271454|FG003|Overall Study|Development of increasing Liver Function|1
4475419|NCT00684307|7271455|FG004|Overall Study|Development of increasing Liver Function|0
4475420|NCT00684307|7271451|FG000|Overall Study|Fullfillment of exclusion criteria|1
4475421|NCT00684307|7271452|FG001|Overall Study|Fullfillment of exclusion criteria|0
4475422|NCT00684307|7271453|FG002|Overall Study|Fullfillment of exclusion criteria|0
4475423|NCT00684307|7271454|FG003|Overall Study|Fullfillment of exclusion criteria|3
4475424|NCT00684307|7271455|FG004|Overall Study|Fullfillment of exclusion criteria|1
4475425|NCT00684307|7271451|FG000|Overall Study|Incorrect enrolment or randomization|4
4475426|NCT00684307|7271452|FG001|Overall Study|Incorrect enrolment or randomization|0
4475427|NCT00684307|7271453|FG002|Overall Study|Incorrect enrolment or randomization|0
4475428|NCT00684307|7271454|FG003|Overall Study|Incorrect enrolment or randomization|0
4475429|NCT00684307|7271455|FG004|Overall Study|Incorrect enrolment or randomization|0
4475430|NCT00684307|7271451|FG000|Overall Study|Interupted IP for more than 7 days|0
4386366|NCT00028769|7164832|FG000|Overall Study|Other - Not Protocol Specified|1
4386367|NCT00028769|7164832|FG000|Overall Study|Ineligible|5
4386368|NCT00028769|7164832|FG000|Overall Study|Not Analyzable|1
4386369|NCT00029146|7164847|FG000|Overall Study|Lost to Follow-up|2
4386370|NCT00029146|7164848|FG001|Overall Study|Lost to Follow-up|1
4386371|NCT00030823|7164898|FG000|Overall Study|Withdrawal by Subject|1
4386372|NCT00030901|7164904|FG000|Initial Registration|Ineligible|167
4386373|NCT00030901|7164905|FG001|Initial Registration|Ineligible|0
4386374|NCT00030901|7164906|FG002|Initial Registration|Ineligible|0
4386375|NCT00030901|7164904|FG000|Randomization|Adverse Event|0
4386376|NCT00030901|7164905|FG001|Randomization|Adverse Event|11
4386377|NCT00030901|7164906|FG002|Randomization|Adverse Event|7
4386378|NCT00030901|7164904|FG000|Randomization|Refusal Unrelated to Adverse Event|0
4386379|NCT00030901|7164905|FG001|Randomization|Refusal Unrelated to Adverse Event|16
4386380|NCT00030901|7164906|FG002|Randomization|Refusal Unrelated to Adverse Event|10
4386381|NCT00030901|7164904|FG000|Randomization|Progression/Relapse|0
4386382|NCT00030901|7164905|FG001|Randomization|Progression/Relapse|22
4386383|NCT00030901|7164906|FG002|Randomization|Progression/Relapse|21
4386384|NCT00030901|7164904|FG000|Randomization|Death|0
4386385|NCT00030901|7164905|FG001|Randomization|Death|1
4386386|NCT00030901|7164906|FG002|Randomization|Death|3
4386387|NCT00030901|7164904|FG000|Randomization|Other|0
4386388|NCT00030901|7164905|FG001|Randomization|Other|36
4386389|NCT00030901|7164906|FG002|Randomization|Other|33
4386390|NCT00030901|7164904|FG000|Randomization|Ineligible|0
4386391|NCT00030901|7164905|FG001|Randomization|Ineligible|15
4386392|NCT00030901|7164906|FG002|Randomization|Ineligible|14
4386393|NCT00031447|7164918|FG000|Overall Study|Lost to Follow-up|0
4386394|NCT00031447|7164919|FG001|Overall Study|Lost to Follow-up|1
4386395|NCT00031447|7164918|FG000|Overall Study|Non-compliant|1
4386396|NCT00031447|7164919|FG001|Overall Study|Non-compliant|1
4386397|NCT00031447|7164918|FG000|Overall Study|Re-activation of Disease|2
4386398|NCT00031447|7164919|FG001|Overall Study|Re-activation of Disease|1
4386399|NCT00031447|7164918|FG000|Overall Study|Disruption of blinded study drug supply|7
4386400|NCT00031447|7164919|FG001|Overall Study|Disruption of blinded study drug supply|4
4386401|NCT00031460|7164927|FG000|Overall Study|Lost to Follow-up|0
4386402|NCT00031460|7164928|FG001|Overall Study|Lost to Follow-up|1
4386403|NCT00031460|7164927|FG000|Overall Study|Withdrawal by Subject|1
4386404|NCT00031460|7164928|FG001|Overall Study|Withdrawal by Subject|1
4386405|NCT00031460|7164927|FG000|Overall Study|Non-Compliant|1
4386406|NCT00031460|7164928|FG001|Overall Study|Non-Compliant|1
4386407|NCT00031460|7164927|FG000|Overall Study|Death|0
4386408|NCT00031460|7164928|FG001|Overall Study|Death|1
4386409|NCT00031460|7164927|FG000|Overall Study|Reactivation of Disease|5
4386410|NCT00031460|7164928|FG001|Overall Study|Reactivation of Disease|9
4386411|NCT00031460|7164927|FG000|Overall Study|Disruption of blinded drug supply|2
4386412|NCT00031460|7164928|FG001|Overall Study|Disruption of blinded drug supply|0
4386413|NCT00031460|7164927|FG000|Overall Study|Confirmed unevaluable|0
4386414|NCT00031460|7164928|FG001|Overall Study|Confirmed unevaluable|1
4386415|NCT00031486|7164936|FG000|Overall Study|Adverse Event|1
4386416|NCT00031486|7164937|FG001|Overall Study|Adverse Event|0
4386417|NCT00031486|7164936|FG000|Overall Study|Lost to Follow-up|0
4386418|NCT00031486|7164937|FG001|Overall Study|Lost to Follow-up|1
4386419|NCT00031486|7164936|FG000|Overall Study|Withdrawal by Subject|3
4386420|NCT00031486|7164937|FG001|Overall Study|Withdrawal by Subject|2
4386421|NCT00031486|7164936|FG000|Overall Study|Death|0
4386422|NCT00031486|7164937|FG001|Overall Study|Death|3
4386423|NCT00031486|7164936|FG000|Overall Study|Non-compliant|0
4386424|NCT00031486|7164937|FG001|Overall Study|Non-compliant|4
4386425|NCT00031486|7164936|FG000|Overall Study|Did not meet eligibility requirement|2
4386426|NCT00031486|7164937|FG001|Overall Study|Did not meet eligibility requirement|1
4386427|NCT00031486|7164936|FG000|Overall Study|Other|1
4386428|NCT00031486|7164937|FG001|Overall Study|Other|1
4386429|NCT00031551|7164947|FG000|Overall Study|Withdrew due to chemotherapy effects|2
4386430|NCT00031551|7164948|FG001|Overall Study|Withdrew due to chemotherapy effects|0
4386431|NCT00031590|7164958|FG000|Overall Study|Adverse Event|1
4386432|NCT00031590|7164958|FG000|Overall Study|Withdrawal by parents|2
4386433|NCT00031694|7164963|FG000|Overall Study|Adverse Event|12
4386434|NCT00031694|7164963|FG000|Overall Study|Death|2
4386435|NCT00031694|7164963|FG000|Overall Study|Withdrawal by Subject|5
4386436|NCT00032487|7164970|FG000|Overall Study|Withdrawal by Subject|67
4386437|NCT00032487|7164971|FG001|Overall Study|Withdrawal by Subject|43
4386438|NCT00032487|7164970|FG000|Overall Study|Adverse Event|3
4386439|NCT00032487|7164971|FG001|Overall Study|Adverse Event|7
4386440|NCT00032487|7164970|FG000|Overall Study|Lost to Follow-up|57
4386441|NCT00032487|7164971|FG001|Overall Study|Lost to Follow-up|58
4386442|NCT00032487|7164970|FG000|Overall Study|Had other reason|12
4386443|NCT00032487|7164971|FG001|Overall Study|Had other reason|12
4475431|NCT00684307|7271452|FG001|Overall Study|Interupted IP for more than 7 days|4
4475432|NCT00684307|7271453|FG002|Overall Study|Interupted IP for more than 7 days|1
4475433|NCT00684307|7271454|FG003|Overall Study|Interupted IP for more than 7 days|3
4475434|NCT00684307|7271455|FG004|Overall Study|Interupted IP for more than 7 days|3
4475435|NCT00684307|7271451|FG000|Overall Study|Severe non compliance to protocol|1
4516730|NCT00960986|7328128|FG003|Period 3 (7-week Therapy Period)|Death|0
4386444|NCT00033371|7164997|FG000|Overall Study|Adverse Event|1
4386445|NCT00033371|7164998|FG001|Overall Study|Adverse Event|5
4386446|NCT00033371|7164997|FG000|Overall Study|Lost to Follow-up|2
4386447|NCT00033371|7164998|FG001|Overall Study|Lost to Follow-up|1
4386448|NCT00033371|7164997|FG000|Overall Study|Withdrawal by Subject|3
4386449|NCT00033371|7164998|FG001|Overall Study|Withdrawal by Subject|3
4386450|NCT00033371|7164997|FG000|Overall Study|Disease Progression|0
4386451|NCT00033371|7164998|FG001|Overall Study|Disease Progression|1
4386452|NCT00033514|7165010|FG000|Overall Study|Lost to Follow-up|1
4386453|NCT00033514|7165011|FG001|Overall Study|Lost to Follow-up|1
4386454|NCT00033514|7165010|FG000|Overall Study|Withdrawal by Subject|0
4386455|NCT00033514|7165011|FG001|Overall Study|Withdrawal by Subject|3
4386456|NCT00033540|7165018|FG000|Overall Study|Adverse Event|14
4386457|NCT00033540|7165018|FG000|Overall Study|Death|1
4386458|NCT00033540|7165018|FG000|Overall Study|Progression|26
4386459|NCT00033540|7165018|FG000|Overall Study|Withdrawal by Subject|6
4386460|NCT00033540|7165018|FG000|Overall Study|Other|5
4386461|NCT00033540|7165018|FG000|Overall Study|Ineligible|3
4386462|NCT00033540|7165018|FG000|Overall Study|Never received treatment|2
4386463|NCT00033631|7165025|FG000|Overall Study|Protocol Violation|14
4386464|NCT00033631|7165026|FG001|Overall Study|Protocol Violation|11
4386465|NCT00033631|7165025|FG000|Overall Study|Withdrawal by Subject|4
4386466|NCT00033631|7165026|FG001|Overall Study|Withdrawal by Subject|4
4699203|NCT02680002|7614446|FG002|Overall Study|Adverse Event|0
4699204|NCT02680002|7614447|FG003|Overall Study|Adverse Event|0
4699205|NCT02680002|7614448|FG004|Overall Study|Adverse Event|1
4699206|NCT02680002|7614449|FG005|Overall Study|Adverse Event|2
4735311|NCT03526861|7683206|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0
4386467|NCT00033657|7165035|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1
4386468|NCT00033657|7165036|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2
4386469|NCT00033657|7165035|FG000|Neoadjuvant Chemotherapy|Adverse Event|0
4386470|NCT00033657|7165036|FG001|Neoadjuvant Chemotherapy|Adverse Event|2
4386471|NCT00033657|7165035|FG000|Neoadjuvant Chemotherapy|Death|1
4386472|NCT00033657|7165036|FG001|Neoadjuvant Chemotherapy|Death|1
4386473|NCT00033657|7165035|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1
4386474|NCT00033657|7165036|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0
4386475|NCT00033657|7165035|FG000|Neoadjuvant Chemotherapy|other complicating disease|0
4386476|NCT00033657|7165036|FG001|Neoadjuvant Chemotherapy|other complicating disease|1
4386477|NCT00033657|7165035|FG000|Neoadjuvant Chemotherapy|Ineligible|8
4386478|NCT00033657|7165036|FG001|Neoadjuvant Chemotherapy|Ineligible|4
4386479|NCT00033657|7165035|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3
4386480|NCT00033657|7165036|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1
4386481|NCT00033657|7165035|FG000|Surgical Resection|not complete resection|0
4386482|NCT00033657|7165036|FG001|Surgical Resection|not complete resection|3
4386483|NCT00033657|7165035|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3
4386484|NCT00033657|7165036|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1
4386485|NCT00033657|7165035|FG000|Adjuvant Chemotherapy|Adverse Event|7
4386486|NCT00033657|7165036|FG001|Adjuvant Chemotherapy|Adverse Event|10
4386487|NCT00033657|7165035|FG000|Adjuvant Chemotherapy|Death|2
4386488|NCT00033657|7165036|FG001|Adjuvant Chemotherapy|Death|1
4386489|NCT00033657|7165035|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5
4386490|NCT00033657|7165036|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3
4386491|NCT00033657|7165035|FG000|Adjuvant Chemotherapy|alternative therapy|1
4386492|NCT00033657|7165036|FG001|Adjuvant Chemotherapy|alternative therapy|0
4386493|NCT00033657|7165035|FG000|Adjuvant Chemotherapy|Other|0
4386494|NCT00033657|7165036|FG001|Adjuvant Chemotherapy|Other|2
4386495|NCT00035555|7165060|FG000|Overall Study|Adverse Event|5
4386496|NCT00035555|7165061|FG001|Overall Study|Adverse Event|8
4386497|NCT00035555|7165062|FG002|Overall Study|Adverse Event|9
4386498|NCT00035555|7165060|FG000|Overall Study|Allograft loss|1
4386499|NCT00035555|7165061|FG001|Overall Study|Allograft loss|1
4386500|NCT00035555|7165062|FG002|Overall Study|Allograft loss|2
4386501|NCT00035555|7165060|FG000|Overall Study|Death|0
4386502|NCT00035555|7165061|FG001|Overall Study|Death|0
4386503|NCT00035555|7165062|FG002|Overall Study|Death|2
4386504|NCT00035555|7165060|FG000|Overall Study|Lost to Follow-up|0
4386505|NCT00035555|7165061|FG001|Overall Study|Lost to Follow-up|0
4386506|NCT00035555|7165062|FG002|Overall Study|Lost to Follow-up|1
4386507|NCT00035555|7165060|FG000|Overall Study|Noncompliance|0
4735312|NCT03526861|7683207|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6
4771207|NCT04250077|7748050|FG001|Overall Study|Withdrawal by Subject|1
4386508|NCT00035555|7165061|FG001|Overall Study|Noncompliance|1
4386509|NCT00035555|7165062|FG002|Overall Study|Noncompliance|1
4386510|NCT00035555|7165060|FG000|Overall Study|Prohibited medication|1
4386511|NCT00035555|7165061|FG001|Overall Study|Prohibited medication|1
4386512|NCT00035555|7165062|FG002|Overall Study|Prohibited medication|0
4386513|NCT00035555|7165060|FG000|Overall Study|Treatment failure/lack of efficacy|7
4386514|NCT00035555|7165061|FG001|Overall Study|Treatment failure/lack of efficacy|5
4386515|NCT00035555|7165062|FG002|Overall Study|Treatment failure/lack of efficacy|3
4386516|NCT00035555|7165060|FG000|Overall Study|Withdrawal by Subject|2
4386517|NCT00035555|7165061|FG001|Overall Study|Withdrawal by Subject|0
4386518|NCT00035555|7165062|FG002|Overall Study|Withdrawal by Subject|2
4386519|NCT00035555|7165060|FG000|Overall Study|Investigator deemed not a good candidate|0
4386520|NCT00035555|7165061|FG001|Overall Study|Investigator deemed not a good candidate|0
4386521|NCT00035555|7165062|FG002|Overall Study|Investigator deemed not a good candidate|1
4386522|NCT00035555|7165060|FG000|Overall Study|Received cyclosporin in error|0
4386523|NCT00035555|7165061|FG001|Overall Study|Received cyclosporin in error|0
4386524|NCT00035555|7165062|FG002|Overall Study|Received cyclosporin in error|1
4386525|NCT00035815|7165073|FG000|Overall Study|Withdrawal by Subject|17
4386526|NCT00035815|7165074|FG001|Overall Study|Withdrawal by Subject|11
4386527|NCT00035932|7165083|FG000|Overall Study|Adverse Event|10
4386528|NCT00035932|7165084|FG001|Overall Study|Adverse Event|9
4386529|NCT00035932|7165085|FG002|Overall Study|Adverse Event|9
4386530|NCT00035932|7165083|FG000|Overall Study|Death|0
4386531|NCT00035932|7165084|FG001|Overall Study|Death|0
4386532|NCT00035932|7165085|FG002|Overall Study|Death|1
4386533|NCT00035932|7165083|FG000|Overall Study|Disease Progression / Relapse|1
4386534|NCT00035932|7165084|FG001|Overall Study|Disease Progression / Relapse|1
4386535|NCT00035932|7165085|FG002|Overall Study|Disease Progression / Relapse|0
4386536|NCT00035932|7165083|FG000|Overall Study|Lost to Follow-up|4
4386537|NCT00035932|7165084|FG001|Overall Study|Lost to Follow-up|4
4475436|NCT00684307|7271452|FG001|Overall Study|Severe non compliance to protocol|0
4475437|NCT00684307|7271453|FG002|Overall Study|Severe non compliance to protocol|0
4475438|NCT00684307|7271454|FG003|Overall Study|Severe non compliance to protocol|1
4475439|NCT00684307|7271455|FG004|Overall Study|Severe non compliance to protocol|2
4475440|NCT00684307|7271451|FG000|Overall Study|Participant not willing to continue|7
4475441|NCT00684307|7271452|FG001|Overall Study|Participant not willing to continue|10
4475442|NCT00684307|7271453|FG002|Overall Study|Participant not willing to continue|11
4475443|NCT00684307|7271454|FG003|Overall Study|Participant not willing to continue|5
4475444|NCT00684307|7271455|FG004|Overall Study|Participant not willing to continue|8
4475445|NCT00684307|7271451|FG000|Overall Study|Criteria from the CSR|0
4475446|NCT00684307|7271452|FG001|Overall Study|Criteria from the CSR|0
4475447|NCT00684307|7271453|FG002|Overall Study|Criteria from the CSR|1
4475448|NCT00684307|7271454|FG003|Overall Study|Criteria from the CSR|3
4475449|NCT00684307|7271455|FG004|Overall Study|Criteria from the CSR|3
4475450|NCT00684411|7271476|FG000|Overall Study|New Primary Cancer|1
4475451|NCT00684411|7271476|FG000|Overall Study|Disease Progression|10
4475452|NCT00684411|7271476|FG000|Overall Study|Adverse Event|1
4475453|NCT00684424|7271480|FG000|Overall Study|Adverse Event|1
4475454|NCT00684424|7271480|FG000|Overall Study|Lost to Follow-up|2
4475455|NCT00684424|7271480|FG000|Overall Study|Other|2
4589213|NCT01509846|7434339|FG003|Received Vaccination 3|Pregnancy|1
4589214|NCT01509846|7434340|FG004|Received Vaccination 3|Pregnancy|0
4475456|NCT00684515|7271488|FG000|Overall Study|Adverse Event|3
4475457|NCT00684515|7271489|FG001|Overall Study|Adverse Event|3
4475458|NCT00684515|7271490|FG002|Overall Study|Adverse Event|1
4475459|NCT00684515|7271488|FG000|Overall Study|Protocol-Defined Clinical Event|1
4475460|NCT00684515|7271489|FG001|Overall Study|Protocol-Defined Clinical Event|0
4475461|NCT00684515|7271490|FG002|Overall Study|Protocol-Defined Clinical Event|0
4475462|NCT00684567|7271517|FG000|Concomitant Radiotherapy Period|Adverse Event|2
4475463|NCT00684567|7271517|FG000|Monotherapy Period|Adverse Event|2
4475464|NCT00684567|7271517|FG000|Monotherapy Period|Death|1
4475465|NCT00684567|7271517|FG000|Monotherapy Period|Progression of primary disease|11
4475466|NCT00684593|7271523|FG000|Overall Study|Adverse Event|0
4475467|NCT00684593|7271524|FG001|Overall Study|Adverse Event|2
4475468|NCT00684645|7271530|FG000|Overall Study|Death|2
4475469|NCT00684645|7271530|FG000|Overall Study|Progressive disease|67
4475470|NCT00684645|7271530|FG000|Overall Study|Adverse Event|27
4475471|NCT00684645|7271530|FG000|Overall Study|Lost to Follow-up|3
4475472|NCT00684645|7271530|FG000|Overall Study|Other|15
4475473|NCT00684671|7271537|FG000|Overall Study|Adverse Event|1
4475474|NCT00684671|7271538|FG001|Overall Study|Adverse Event|0
4475475|NCT00684671|7271539|FG002|Overall Study|Adverse Event|0
4475476|NCT00684671|7271537|FG000|Overall Study|Lost to Follow-up|1
4475477|NCT00684671|7271538|FG001|Overall Study|Lost to Follow-up|0
4475478|NCT00684671|7271539|FG002|Overall Study|Lost to Follow-up|0
4475479|NCT00684671|7271537|FG000|Overall Study|Alcoholic dependance|1
4475480|NCT00684671|7271538|FG001|Overall Study|Alcoholic dependance|0
4475481|NCT00684671|7271539|FG002|Overall Study|Alcoholic dependance|0
4516731|NCT00960986|7328125|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
4516732|NCT00960986|7328126|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
4516733|NCT00960986|7328127|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1
4516734|NCT00960986|7328128|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
4516735|NCT00960986|7328125|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10
4516736|NCT00960986|7328126|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4
4516737|NCT00960986|7328127|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3
4516738|NCT00960986|7328128|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11
4516739|NCT00960986|7328125|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
4516740|NCT00960986|7328126|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
4516741|NCT00960986|7328127|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4
4516742|NCT00960986|7328128|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
4516743|NCT00960986|7328125|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1
4516744|NCT00960986|7328126|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2
4475482|NCT00684762|7271558|FG000|Washout Period of 7 Days|Withdrawal by Subject|2
4475483|NCT00684762|7271559|FG001|Washout Period of 7 Days|Withdrawal by Subject|2
4475484|NCT00684814|7271597|FG000|Washout Period of 7 Days|Adverse Event|1
4475485|NCT00684814|7271598|FG001|Washout Period of 7 Days|Adverse Event|2
4475486|NCT00684814|7271597|FG000|Washout Period of 7 Days|Withdrawal by Subject|1
4475487|NCT00684814|7271598|FG001|Washout Period of 7 Days|Withdrawal by Subject|2
4475488|NCT00684814|7271597|FG000|Second Intervention|Adverse Event|1
4475489|NCT00684814|7271598|FG001|Second Intervention|Adverse Event|0
4475490|NCT00684996|7271615|FG000|Overall Study|Adverse Event|1
4475491|NCT00684996|7271615|FG000|Overall Study|Refusal unrelated to adverse event|1
4475492|NCT00684996|7271615|FG000|Overall Study|Progression/relapse|2
4475493|NCT00684996|7271615|FG000|Overall Study|Other reasons not protocol specified|1
4475494|NCT00685035|7271622|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1
4475495|NCT00685035|7271623|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0
4475496|NCT00685165|7271654|FG000|Washout Period of 14 Days|Adverse Event|1
4475497|NCT00685165|7271655|FG001|Washout Period of 14 Days|Adverse Event|0
4475498|NCT00685178|7271665|FG000|Overall Study|Adverse Event|1
4475499|NCT00685178|7271666|FG001|Overall Study|Adverse Event|5
4475500|NCT00685178|7271667|FG002|Overall Study|Adverse Event|2
4475501|NCT00685178|7271668|FG003|Overall Study|Adverse Event|4
4475502|NCT00685178|7271665|FG000|Overall Study|missed 3 consecutive methadone clin days|7
4475503|NCT00685178|7271666|FG001|Overall Study|missed 3 consecutive methadone clin days|5
4475504|NCT00685178|7271667|FG002|Overall Study|missed 3 consecutive methadone clin days|2
4475505|NCT00685178|7271668|FG003|Overall Study|missed 3 consecutive methadone clin days|6
4475506|NCT00685178|7271665|FG000|Overall Study|voluntary study discharge|4
4475507|NCT00685178|7271666|FG001|Overall Study|voluntary study discharge|5
4475508|NCT00685178|7271667|FG002|Overall Study|voluntary study discharge|1
4386538|NCT00035932|7165085|FG002|Overall Study|Lost to Follow-up|3
4386539|NCT00035932|7165083|FG000|Overall Study|Noncompliance|6
4386540|NCT00035932|7165084|FG001|Overall Study|Noncompliance|7
4386541|NCT00035932|7165085|FG002|Overall Study|Noncompliance|6
4386542|NCT00035932|7165083|FG000|Overall Study|Protocol Violation While on Study|0
4386543|NCT00035932|7165084|FG001|Overall Study|Protocol Violation While on Study|1
4386544|NCT00035932|7165085|FG002|Overall Study|Protocol Violation While on Study|2
4386545|NCT00035932|7165083|FG000|Overall Study|Withdrawal by Subject|1
4386546|NCT00035932|7165084|FG001|Overall Study|Withdrawal by Subject|5
4386547|NCT00035932|7165085|FG002|Overall Study|Withdrawal by Subject|0
4386548|NCT00035932|7165083|FG000|Overall Study|Study Termination by Sponsor|1
4386549|NCT00035932|7165084|FG001|Overall Study|Study Termination by Sponsor|0
4386550|NCT00035932|7165085|FG002|Overall Study|Study Termination by Sponsor|0
4386551|NCT00035932|7165083|FG000|Overall Study|Lack of Efficacy|33
4386552|NCT00035932|7165084|FG001|Overall Study|Lack of Efficacy|33
4386553|NCT00035932|7165085|FG002|Overall Study|Lack of Efficacy|28
4386554|NCT00036270|7165100|FG000|Randomized to Study Treatment|Withdrawal by Subject|6
4386555|NCT00036270|7165101|FG001|Randomized to Study Treatment|Withdrawal by Subject|7
4386556|NCT00036270|7165100|FG000|Study Treatment to 5 Year Report|Ongoing|1081
4386557|NCT00036270|7165101|FG001|Study Treatment to 5 Year Report|Ongoing|736
4386558|NCT00036270|7165100|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507
4386559|NCT00036270|7165101|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447
4386560|NCT00036270|7165100|FG000|Study Treatment to 5 Year Report|Adverse Event|501
4386561|NCT00036270|7165101|FG001|Study Treatment to 5 Year Report|Adverse Event|782
4386562|NCT00036270|7165100|FG000|Study Treatment to 5 Year Report|Other|277
4386563|NCT00036270|7165101|FG001|Study Treatment to 5 Year Report|Other|288
4386564|NCT00036270|7165100|FG000|Study Treatment to 5 Year Report|Treatment refusal|113
4386565|NCT00036270|7165101|FG001|Study Treatment to 5 Year Report|Treatment refusal|208
4386566|NCT00036270|7165100|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46
4386567|NCT00036270|7165101|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54
4386568|NCT00036270|7165100|FG000|Study Treatment to 5 Year Report|Protocol Violation|23
4386569|NCT00036270|7165101|FG001|Study Treatment to 5 Year Report|Protocol Violation|91
4386570|NCT00036270|7165100|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17
4386571|NCT00036270|7165101|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29
4386572|NCT00036270|7165100|FG000|Study Treatment to 5 Year Report|Too early switch|0
4386573|NCT00036270|7165101|FG001|Study Treatment to 5 Year Report|Too early switch|103
4386574|NCT00036270|7165100|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0
4386575|NCT00036270|7165101|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750
4386576|NCT00037830|7165120|FG000|Overall Study|Adverse Event|2
4386577|NCT00037830|7165121|FG001|Overall Study|Adverse Event|0
4386578|NCT00037830|7165122|FG002|Overall Study|Adverse Event|0
4386579|NCT00037830|7165120|FG000|Overall Study|Withdrawal by Subject|4
4386580|NCT00037830|7165121|FG001|Overall Study|Withdrawal by Subject|5
4386581|NCT00037830|7165122|FG002|Overall Study|Withdrawal by Subject|1
4386582|NCT00037830|7165120|FG000|Overall Study|Protocol Violation|2
4386583|NCT00037830|7165121|FG001|Overall Study|Protocol Violation|2
4386584|NCT00037830|7165122|FG002|Overall Study|Protocol Violation|0
4386585|NCT00037830|7165120|FG000|Overall Study|Unrelated Medical Problem|2
4475509|NCT00685178|7271668|FG003|Overall Study|voluntary study discharge|1
4475510|NCT00685178|7271665|FG000|Overall Study|incarcerated|1
4386586|NCT00037830|7165121|FG001|Overall Study|Unrelated Medical Problem|0
4386587|NCT00037830|7165122|FG002|Overall Study|Unrelated Medical Problem|0
4386588|NCT00038103|7165132|FG000|Overall Study|Adverse Event|5
4386589|NCT00038103|7165133|FG001|Overall Study|Adverse Event|6
4386590|NCT00038103|7165132|FG000|Overall Study|Lack of Efficacy|48
4386591|NCT00038103|7165133|FG001|Overall Study|Lack of Efficacy|41
4386592|NCT00038103|7165132|FG000|Overall Study|Withdrawal by Subject|0
4386593|NCT00038103|7165133|FG001|Overall Study|Withdrawal by Subject|3
4386594|NCT00038103|7165132|FG000|Overall Study|Lost to Follow-up|0
4475511|NCT00685178|7271666|FG001|Overall Study|incarcerated|3
4475512|NCT00685178|7271667|FG002|Overall Study|incarcerated|7
4475513|NCT00685178|7271668|FG003|Overall Study|incarcerated|0
4475514|NCT00685178|7271665|FG000|Overall Study|administrative (disciplinary) discharge|0
4475515|NCT00685178|7271666|FG001|Overall Study|administrative (disciplinary) discharge|1
4475516|NCT00685178|7271667|FG002|Overall Study|administrative (disciplinary) discharge|0
4475517|NCT00685178|7271668|FG003|Overall Study|administrative (disciplinary) discharge|2
4475518|NCT00685178|7271665|FG000|Overall Study|Pregnancy|0
4475519|NCT00685178|7271666|FG001|Overall Study|Pregnancy|0
4475520|NCT00685178|7271667|FG002|Overall Study|Pregnancy|0
4475521|NCT00685178|7271668|FG003|Overall Study|Pregnancy|1
4475522|NCT00685334|7271691|FG000|Overall Study|Withdrawal by Subject|5
4475523|NCT00685334|7271692|FG001|Overall Study|Withdrawal by Subject|6
4475524|NCT00685334|7271691|FG000|Overall Study|Lost to Follow-up|4
4475525|NCT00685334|7271692|FG001|Overall Study|Lost to Follow-up|0
4475526|NCT00685334|7271691|FG000|Overall Study|Chose to enter hospital|1
4475527|NCT00685334|7271692|FG001|Overall Study|Chose to enter hospital|1
4475528|NCT00685373|7271698|FG000|Overall Study|Adverse Event|3
4475529|NCT00685373|7271698|FG000|Overall Study|Withdrawal by Subject|5
4475530|NCT00685373|7271698|FG000|Overall Study|Lack of Efficacy|3
4475531|NCT00685373|7271698|FG000|Overall Study|Condition no longer requires study drug|1
4475532|NCT00685373|7271698|FG000|Overall Study|Lost to Follow-up|2
4475533|NCT00685373|7271698|FG000|Overall Study|Protocol Violation|1
4475534|NCT00685399|7271709|FG000|Treatment Period 1|Withdrawal by Subject|2
4475535|NCT00685399|7271710|FG001|Treatment Period 1|Withdrawal by Subject|0
4475536|NCT00685399|7271711|FG002|Treatment Period 1|Withdrawal by Subject|0
4475537|NCT00685399|7271712|FG003|Treatment Period 1|Withdrawal by Subject|0
4475538|NCT00685399|7271713|FG004|Treatment Period 1|Withdrawal by Subject|0
4475539|NCT00685399|7271714|FG005|Treatment Period 1|Withdrawal by Subject|0
4475540|NCT00685399|7271715|FG006|Treatment Period 1|Withdrawal by Subject|0
4475541|NCT00685399|7271716|FG007|Treatment Period 1|Withdrawal by Subject|0
4475542|NCT00685399|7271709|FG000|Treatment Period 1|Protocol Violation|1
4475543|NCT00685399|7271710|FG001|Treatment Period 1|Protocol Violation|0
4475544|NCT00685399|7271711|FG002|Treatment Period 1|Protocol Violation|0
4475545|NCT00685399|7271712|FG003|Treatment Period 1|Protocol Violation|0
4475546|NCT00685399|7271713|FG004|Treatment Period 1|Protocol Violation|0
4475547|NCT00685399|7271714|FG005|Treatment Period 1|Protocol Violation|0
4475548|NCT00685399|7271715|FG006|Treatment Period 1|Protocol Violation|0
4475549|NCT00685399|7271716|FG007|Treatment Period 1|Protocol Violation|0
4475550|NCT00685399|7271709|FG000|Treatment Period 1|Administrative|2
4475551|NCT00685399|7271710|FG001|Treatment Period 1|Administrative|0
4475552|NCT00685399|7271711|FG002|Treatment Period 1|Administrative|0
4475553|NCT00685399|7271712|FG003|Treatment Period 1|Administrative|0
4475554|NCT00685399|7271713|FG004|Treatment Period 1|Administrative|0
4475555|NCT00685399|7271714|FG005|Treatment Period 1|Administrative|0
4475556|NCT00685399|7271715|FG006|Treatment Period 1|Administrative|0
4475557|NCT00685399|7271716|FG007|Treatment Period 1|Administrative|0
4475558|NCT00685399|7271709|FG000|Treatment Period 1|Lack of Efficacy|1
4475559|NCT00685399|7271710|FG001|Treatment Period 1|Lack of Efficacy|0
4475560|NCT00685399|7271711|FG002|Treatment Period 1|Lack of Efficacy|0
4475561|NCT00685399|7271712|FG003|Treatment Period 1|Lack of Efficacy|0
4475562|NCT00685399|7271713|FG004|Treatment Period 1|Lack of Efficacy|0
4475563|NCT00685399|7271714|FG005|Treatment Period 1|Lack of Efficacy|0
4475564|NCT00685399|7271715|FG006|Treatment Period 1|Lack of Efficacy|0
4475565|NCT00685399|7271716|FG007|Treatment Period 1|Lack of Efficacy|0
4589215|NCT01509846|7434336|FG000|Received Vaccination 3|Lost to Follow-up|0
4475566|NCT00685399|7271709|FG000|Treatment Period 2|Administrative Problems|0
4475567|NCT00685399|7271710|FG001|Treatment Period 2|Administrative Problems|2
4475568|NCT00685399|7271711|FG002|Treatment Period 2|Administrative Problems|1
4475569|NCT00685399|7271712|FG003|Treatment Period 2|Administrative Problems|0
4475570|NCT00685399|7271713|FG004|Treatment Period 2|Administrative Problems|0
4475571|NCT00685399|7271714|FG005|Treatment Period 2|Administrative Problems|0
4475572|NCT00685399|7271715|FG006|Treatment Period 2|Administrative Problems|0
4475573|NCT00685399|7271716|FG007|Treatment Period 2|Administrative Problems|0
4475574|NCT00685399|7271709|FG000|Treatment Period 2|Withdrawal by Subject|0
4475575|NCT00685399|7271710|FG001|Treatment Period 2|Withdrawal by Subject|0
4475576|NCT00685399|7271711|FG002|Treatment Period 2|Withdrawal by Subject|0
4475577|NCT00685399|7271712|FG003|Treatment Period 2|Withdrawal by Subject|0
4475578|NCT00685399|7271713|FG004|Treatment Period 2|Withdrawal by Subject|0
4475579|NCT00685399|7271714|FG005|Treatment Period 2|Withdrawal by Subject|0
4475580|NCT00685399|7271715|FG006|Treatment Period 2|Withdrawal by Subject|0
4475581|NCT00685399|7271716|FG007|Treatment Period 2|Withdrawal by Subject|2
4589216|NCT01509846|7434337|FG001|Received Vaccination 3|Lost to Follow-up|0
4475582|NCT00685399|7271709|FG000|Treatment Period 2|Adverse Event|0
4475583|NCT00685399|7271710|FG001|Treatment Period 2|Adverse Event|0
4475584|NCT00685399|7271711|FG002|Treatment Period 2|Adverse Event|0
4475585|NCT00685399|7271712|FG003|Treatment Period 2|Adverse Event|0
4475586|NCT00685399|7271713|FG004|Treatment Period 2|Adverse Event|0
4475587|NCT00685399|7271714|FG005|Treatment Period 2|Adverse Event|1
4475588|NCT00685399|7271715|FG006|Treatment Period 2|Adverse Event|0
4475589|NCT00685399|7271716|FG007|Treatment Period 2|Adverse Event|0
4475590|NCT00685399|7271709|FG000|Treatment Period 2|Lack of Efficacy|0
4475591|NCT00685399|7271710|FG001|Treatment Period 2|Lack of Efficacy|10
4475592|NCT00685399|7271711|FG002|Treatment Period 2|Lack of Efficacy|2
4475593|NCT00685399|7271712|FG003|Treatment Period 2|Lack of Efficacy|0
4475594|NCT00685399|7271713|FG004|Treatment Period 2|Lack of Efficacy|0
4475595|NCT00685399|7271714|FG005|Treatment Period 2|Lack of Efficacy|1
4475596|NCT00685399|7271715|FG006|Treatment Period 2|Lack of Efficacy|0
4475597|NCT00685399|7271716|FG007|Treatment Period 2|Lack of Efficacy|0
4475598|NCT00685399|7271709|FG000|Extension|Administrative Issues|0
4475599|NCT00685399|7271710|FG001|Extension|Administrative Issues|0
4475600|NCT00685399|7271711|FG002|Extension|Administrative Issues|0
4475601|NCT00685399|7271712|FG003|Extension|Administrative Issues|1
4475602|NCT00685399|7271713|FG004|Extension|Administrative Issues|0
4475603|NCT00685399|7271714|FG005|Extension|Administrative Issues|0
4475604|NCT00685399|7271715|FG006|Extension|Administrative Issues|0
4475605|NCT00685399|7271716|FG007|Extension|Administrative Issues|0
4475606|NCT00685399|7271709|FG000|Extension|Withdrawal by Subject|0
4475607|NCT00685399|7271710|FG001|Extension|Withdrawal by Subject|0
4475608|NCT00685399|7271711|FG002|Extension|Withdrawal by Subject|0
4475609|NCT00685399|7271712|FG003|Extension|Withdrawal by Subject|1
4475610|NCT00685399|7271713|FG004|Extension|Withdrawal by Subject|0
4475611|NCT00685399|7271714|FG005|Extension|Withdrawal by Subject|0
4475612|NCT00685399|7271715|FG006|Extension|Withdrawal by Subject|0
4475613|NCT00685399|7271716|FG007|Extension|Withdrawal by Subject|0
4475614|NCT00685399|7271709|FG000|Extension|Protocol Violation|0
4475615|NCT00685399|7271710|FG001|Extension|Protocol Violation|0
4475616|NCT00685399|7271711|FG002|Extension|Protocol Violation|0
4475617|NCT00685399|7271712|FG003|Extension|Protocol Violation|1
4475618|NCT00685399|7271713|FG004|Extension|Protocol Violation|0
4475619|NCT00685399|7271714|FG005|Extension|Protocol Violation|0
4475620|NCT00685399|7271715|FG006|Extension|Protocol Violation|0
4475621|NCT00685399|7271716|FG007|Extension|Protocol Violation|0
4475622|NCT00685399|7271709|FG000|Extension|Lack of Efficacy|0
4475623|NCT00685399|7271710|FG001|Extension|Lack of Efficacy|0
4475624|NCT00685399|7271711|FG002|Extension|Lack of Efficacy|0
4475625|NCT00685399|7271712|FG003|Extension|Lack of Efficacy|2
4475626|NCT00685399|7271713|FG004|Extension|Lack of Efficacy|0
4475627|NCT00685399|7271714|FG005|Extension|Lack of Efficacy|0
4475628|NCT00685399|7271715|FG006|Extension|Lack of Efficacy|0
4475629|NCT00685399|7271716|FG007|Extension|Lack of Efficacy|0
4475630|NCT00685399|7271709|FG000|Extension|Adverse Event|0
4475631|NCT00685399|7271710|FG001|Extension|Adverse Event|0
4475632|NCT00685399|7271711|FG002|Extension|Adverse Event|0
4475633|NCT00685399|7271712|FG003|Extension|Adverse Event|2
4475634|NCT00685399|7271713|FG004|Extension|Adverse Event|0
4475635|NCT00685399|7271714|FG005|Extension|Adverse Event|0
4475636|NCT00685399|7271715|FG006|Extension|Adverse Event|0
4475637|NCT00685399|7271716|FG007|Extension|Adverse Event|0
4475638|NCT00685685|7271786|FG000|Washout Period of 7 Days|Adverse Event|2
4475639|NCT00685685|7271787|FG001|Washout Period of 7 Days|Adverse Event|0
4475640|NCT00685685|7271786|FG000|Washout Period of 7 Days|Withdrawal by Subject|0
4475641|NCT00685685|7271787|FG001|Washout Period of 7 Days|Withdrawal by Subject|1
4475642|NCT00685698|7271793|FG000|Overall Study|Withdrawal by Subject|1
4475643|NCT00685698|7271793|FG000|Overall Study|Protocol Violation|6
4475644|NCT00685698|7271793|FG000|Overall Study|Adverse Event|3
4475645|NCT00685698|7271793|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1
4475646|NCT00685698|7271793|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1
4475647|NCT00685698|7271793|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1
4589217|NCT01509846|7434338|FG002|Received Vaccination 3|Lost to Follow-up|1
4589218|NCT01509846|7434339|FG003|Received Vaccination 3|Lost to Follow-up|0
4475648|NCT00685750|7271816|FG000|Overall Study|Tumor sampling failure|0
4475649|NCT00685750|7271817|FG001|Overall Study|Tumor sampling failure|0
4475650|NCT00685750|7271818|FG002|Overall Study|Tumor sampling failure|1
4475651|NCT00685750|7271819|FG003|Overall Study|Tumor sampling failure|0
4475652|NCT00685750|7271820|FG004|Overall Study|Tumor sampling failure|0
4475653|NCT00685750|7271821|FG005|Overall Study|Tumor sampling failure|0
4475654|NCT00685750|7271822|FG006|Overall Study|Tumor sampling failure|0
4475655|NCT00685750|7271816|FG000|Overall Study|Patient didn't receive the treatment|0
4475656|NCT00685750|7271817|FG001|Overall Study|Patient didn't receive the treatment|0
4475657|NCT00685750|7271818|FG002|Overall Study|Patient didn't receive the treatment|0
4475658|NCT00685750|7271819|FG003|Overall Study|Patient didn't receive the treatment|0
4475659|NCT00685750|7271820|FG004|Overall Study|Patient didn't receive the treatment|0
4475660|NCT00685750|7271821|FG005|Overall Study|Patient didn't receive the treatment|0
4475661|NCT00685750|7271822|FG006|Overall Study|Patient didn't receive the treatment|1
4475662|NCT00685750|7271816|FG000|Overall Study|Eligibility criteria not fulfilled|0
4475663|NCT00685750|7271817|FG001|Overall Study|Eligibility criteria not fulfilled|0
4475664|NCT00685750|7271818|FG002|Overall Study|Eligibility criteria not fulfilled|1
4475665|NCT00685750|7271819|FG003|Overall Study|Eligibility criteria not fulfilled|0
4475666|NCT00685750|7271820|FG004|Overall Study|Eligibility criteria not fulfilled|0
4475667|NCT00685750|7271821|FG005|Overall Study|Eligibility criteria not fulfilled|0
4475668|NCT00685750|7271822|FG006|Overall Study|Eligibility criteria not fulfilled|0
4475669|NCT00685763|7271842|FG000|Overall Study|Intercurrent death-incomplete treatment|1
4475670|NCT00685763|7271842|FG000|Overall Study|Protocol Violation|1
4475671|NCT00685802|7271846|FG000|Washout Period of 7 Days|Protocol Violation|2
4475672|NCT00685802|7271847|FG001|Washout Period of 7 Days|Protocol Violation|0
4475673|NCT00685802|7271846|FG000|Washout Period of 7 Days|Withdrawal by Subject|0
4475674|NCT00685802|7271847|FG001|Washout Period of 7 Days|Withdrawal by Subject|1
4475675|NCT00685945|7271862|FG000|L-NMMA + Bradykinin|Physician Decision|1
4475676|NCT00686075|7271882|FG000|Overall Study|Withdrawal by Subject|4
4475677|NCT00686075|7271883|FG001|Overall Study|Withdrawal by Subject|3
4475678|NCT00686075|7271884|FG002|Overall Study|Withdrawal by Subject|3
4475679|NCT00686075|7271885|FG003|Overall Study|Withdrawal by Subject|7
4475680|NCT00686075|7271886|FG004|Overall Study|Withdrawal by Subject|1
4475681|NCT00686075|7271887|FG005|Overall Study|Withdrawal by Subject|0
4475682|NCT00686075|7271888|FG006|Overall Study|Withdrawal by Subject|0
4475683|NCT00686075|7271889|FG007|Overall Study|Withdrawal by Subject|2
4475684|NCT00686075|7271890|FG008|Overall Study|Withdrawal by Subject|4
4475685|NCT00686075|7271891|FG009|Overall Study|Withdrawal by Subject|6
4475686|NCT00686075|7271882|FG000|Overall Study|Lost to Follow-up|3
4699207|NCT02680041|7614466|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8
4699208|NCT02680041|7614466|FG000|Overall Study|Lost to Follow-up|2
4699209|NCT02680639|7614523|FG000|Screening Period|Screen Failure|7
4699210|NCT02680639|7614524|FG001|Screening Period|Screen Failure|0
4699211|NCT02680639|7614525|FG002|Screening Period|Screen Failure|0
4699212|NCT02680665|7614535|FG000|Overall Study|No visit after the first prescription|5
4699213|NCT02680756|7614541|FG000|Overall Study|Adverse Event|10
4475687|NCT00686075|7271883|FG001|Overall Study|Lost to Follow-up|6
4475688|NCT00686075|7271884|FG002|Overall Study|Lost to Follow-up|3
4475689|NCT00686075|7271885|FG003|Overall Study|Lost to Follow-up|2
4589219|NCT01509846|7434340|FG004|Received Vaccination 3|Lost to Follow-up|0
4589220|NCT01510028|7434384|FG000|Overall Study|Lack of Efficacy|1
4589221|NCT01510028|7434385|FG001|Overall Study|Lack of Efficacy|0
4589222|NCT01510028|7434386|FG002|Overall Study|Lack of Efficacy|0
4589223|NCT01510028|7434387|FG003|Overall Study|Lack of Efficacy|0
4589224|NCT01510145|7434399|FG000|Overall Study|Adverse Event|6
4589225|NCT01510145|7434399|FG000|Overall Study|Lost to Follow-up|5
4589226|NCT01510145|7434399|FG000|Overall Study|Withdrawal by Subject|6
4475690|NCT00686075|7271886|FG004|Overall Study|Lost to Follow-up|3
4475691|NCT00686075|7271887|FG005|Overall Study|Lost to Follow-up|3
4475692|NCT00686075|7271888|FG006|Overall Study|Lost to Follow-up|0
4475693|NCT00686075|7271889|FG007|Overall Study|Lost to Follow-up|0
4475694|NCT00686075|7271890|FG008|Overall Study|Lost to Follow-up|2
4475695|NCT00686075|7271891|FG009|Overall Study|Lost to Follow-up|3
4475696|NCT00686075|7271882|FG000|Overall Study|Other|1
4475697|NCT00686075|7271883|FG001|Overall Study|Other|1
4475698|NCT00686075|7271884|FG002|Overall Study|Other|0
4475699|NCT00686075|7271885|FG003|Overall Study|Other|0
4475700|NCT00686075|7271886|FG004|Overall Study|Other|0
4475701|NCT00686075|7271887|FG005|Overall Study|Other|0
4475702|NCT00686075|7271888|FG006|Overall Study|Other|0
4589227|NCT01510145|7434399|FG000|Overall Study|Relative reported subject withdrew|1
4589228|NCT01510158|7434406|FG000|Overall Study|Adverse Event|7
4589229|NCT01510158|7434407|FG001|Overall Study|Adverse Event|8
4589230|NCT01510158|7434408|FG002|Overall Study|Adverse Event|5
4589231|NCT01510158|7434406|FG000|Overall Study|Gout flare|1
4589232|NCT01510158|7434407|FG001|Overall Study|Gout flare|0
4589233|NCT01510158|7434408|FG002|Overall Study|Gout flare|0
4589234|NCT01510158|7434406|FG000|Overall Study|Protocol Violation|17
4589235|NCT01510158|7434407|FG001|Overall Study|Protocol Violation|16
4589236|NCT01510158|7434408|FG002|Overall Study|Protocol Violation|24
4589237|NCT01510158|7434406|FG000|Overall Study|Sponsor terminated study.|2
4589238|NCT01510158|7434407|FG001|Overall Study|Sponsor terminated study.|0
4589239|NCT01510158|7434408|FG002|Overall Study|Sponsor terminated study.|2
4589240|NCT01510158|7434406|FG000|Overall Study|Lost to Follow-up|13
4589241|NCT01510158|7434407|FG001|Overall Study|Lost to Follow-up|16
4589242|NCT01510158|7434408|FG002|Overall Study|Lost to Follow-up|9
4589243|NCT01510158|7434406|FG000|Overall Study|Withdrawal by Subject|10
4589244|NCT01510158|7434407|FG001|Overall Study|Withdrawal by Subject|13
4475703|NCT00686075|7271889|FG007|Overall Study|Other|0
4475704|NCT00686075|7271890|FG008|Overall Study|Other|0
4589245|NCT01510158|7434408|FG002|Overall Study|Withdrawal by Subject|10
4589246|NCT01510158|7434406|FG000|Overall Study|Death|1
4589247|NCT01510158|7434407|FG001|Overall Study|Death|0
4475705|NCT00686075|7271891|FG009|Overall Study|Other|1
4475706|NCT00686127|7271915|FG000|Overall Study|Withdrawal by Subject|14
4475707|NCT00686127|7271916|FG001|Overall Study|Withdrawal by Subject|6
4475708|NCT00686166|7271922|FG000|Overall Study|Adverse Event|7
4475709|NCT00686166|7271922|FG000|Overall Study|Withdrawal by Subject|1
4475710|NCT00686166|7271922|FG000|Overall Study|Progression/Relapse|1
4475711|NCT00686166|7271922|FG000|Overall Study|Death|1
4699214|NCT02680756|7614542|FG001|Overall Study|Adverse Event|2
4589248|NCT01510158|7434408|FG002|Overall Study|Death|0
4589249|NCT01510717|7434474|FG000|Overall Study|Adverse Event|1
4589250|NCT01510717|7434475|FG001|Overall Study|Adverse Event|2
4589251|NCT01510717|7434474|FG000|Overall Study|Death|1
4589252|NCT01510717|7434475|FG001|Overall Study|Death|0
4589253|NCT01510717|7434474|FG000|Overall Study|Lost to Follow-up|0
4589254|NCT01510717|7434475|FG001|Overall Study|Lost to Follow-up|1
4589255|NCT01510717|7434474|FG000|Overall Study|Withdrawal by Subject|0
4589256|NCT01510717|7434475|FG001|Overall Study|Withdrawal by Subject|2
4589257|NCT01510769|7434485|FG000|Overall Study|Adverse Event|7
4589258|NCT01510769|7434486|FG001|Overall Study|Adverse Event|6
4475712|NCT00686166|7271922|FG000|Overall Study|Not Protocol Specified|1
4475713|NCT00686166|7271922|FG000|Overall Study|Ineligible|5
4475714|NCT00686166|7271922|FG000|Overall Study|Did not begin protocol therapy|4
4475715|NCT00686205|7271933|FG000|Overall Study|Protocol Violation|127
4475716|NCT00686205|7271934|FG001|Overall Study|Protocol Violation|0
4475717|NCT00686205|7271933|FG000|Overall Study|Withdrawal by Subject|2
4475718|NCT00686205|7271934|FG001|Overall Study|Withdrawal by Subject|0
4475719|NCT00686205|7271933|FG000|Overall Study|Specimen handling procedure altered|5878
4475720|NCT00686205|7271934|FG001|Overall Study|Specimen handling procedure altered|0
4475721|NCT00686205|7271933|FG000|Overall Study|Specimens not confirmed HIV positive|0
4475722|NCT00686205|7271934|FG001|Overall Study|Specimens not confirmed HIV positive|981
4475723|NCT00686335|7271964|FG000|Run-in Period|Adverse Event|1
4475724|NCT00686335|7271964|FG000|Run-in Period|asthma exacerbation|1
4475725|NCT00686335|7271964|FG000|Run-in Period|violation of inclusion/exclusion criteri|3
4475726|NCT00686517|7271973|FG000|Treatment|Serious Adverse Event|1
4475727|NCT00686517|7271974|FG001|Treatment|Serious Adverse Event|2
4475728|NCT00686517|7271975|FG002|Treatment|Serious Adverse Event|1
4475729|NCT00686517|7271973|FG000|Treatment|Adverse Event|2
4475730|NCT00686517|7271974|FG001|Treatment|Adverse Event|0
4475731|NCT00686517|7271975|FG002|Treatment|Adverse Event|0
4475732|NCT00686517|7271973|FG000|Treatment|Poor Protocol Compliance|1
4475733|NCT00686517|7271974|FG001|Treatment|Poor Protocol Compliance|0
4475734|NCT00686517|7271975|FG002|Treatment|Poor Protocol Compliance|0
4475735|NCT00686517|7271973|FG000|Treatment|Protocol Violation|2
4475736|NCT00686517|7271974|FG001|Treatment|Protocol Violation|1
4475737|NCT00686517|7271975|FG002|Treatment|Protocol Violation|0
4475738|NCT00686543|7271987|FG000|Overall Study|Adverse Event|9
4475739|NCT00686543|7271988|FG001|Overall Study|Adverse Event|1
4475740|NCT00686543|7271989|FG002|Overall Study|Adverse Event|3
4475741|NCT00686543|7271990|FG003|Overall Study|Adverse Event|2
4475742|NCT00686543|7271987|FG000|Overall Study|Withdrawal by Subject|2
4475743|NCT00686543|7271988|FG001|Overall Study|Withdrawal by Subject|0
4475744|NCT00686543|7271989|FG002|Overall Study|Withdrawal by Subject|0
4475745|NCT00686543|7271990|FG003|Overall Study|Withdrawal by Subject|0
4475746|NCT00686543|7271987|FG000|Overall Study|Protocol Violation|3
4475747|NCT00686543|7271988|FG001|Overall Study|Protocol Violation|0
4475748|NCT00686543|7271989|FG002|Overall Study|Protocol Violation|2
4475749|NCT00686543|7271990|FG003|Overall Study|Protocol Violation|1
4589259|NCT01510769|7434487|FG002|Overall Study|Adverse Event|4
4589260|NCT01510769|7434485|FG000|Overall Study|Gout Flare|0
4589261|NCT01510769|7434486|FG001|Overall Study|Gout Flare|3
4589262|NCT01510769|7434487|FG002|Overall Study|Gout Flare|1
4589263|NCT01510769|7434485|FG000|Overall Study|Protocol Violation|11
4589264|NCT01510769|7434486|FG001|Overall Study|Protocol Violation|10
4589265|NCT01510769|7434487|FG002|Overall Study|Protocol Violation|9
4589266|NCT01510769|7434485|FG000|Overall Study|Lost to Follow-up|5
4589267|NCT01510769|7434486|FG001|Overall Study|Lost to Follow-up|1
4589268|NCT01510769|7434487|FG002|Overall Study|Lost to Follow-up|5
4589269|NCT01510769|7434485|FG000|Overall Study|Withdrawal by Subject|3
4589270|NCT01510769|7434486|FG001|Overall Study|Withdrawal by Subject|4
4589271|NCT01510769|7434487|FG002|Overall Study|Withdrawal by Subject|3
4589272|NCT01510769|7434485|FG000|Overall Study|Death|1
4589273|NCT01510769|7434486|FG001|Overall Study|Death|1
4589274|NCT01510769|7434487|FG002|Overall Study|Death|0
4589275|NCT01510912|7434502|FG000|Overall Study|Adverse Event|99
4589276|NCT01510912|7434502|FG000|Overall Study|Lack of Efficacy|12
4589277|NCT01510912|7434502|FG000|Overall Study|Non-compliance with trial drug|23
4589278|NCT01510912|7434502|FG000|Overall Study|Withdrawal by Subject|49
4589279|NCT01510912|7434502|FG000|Overall Study|Physician Decision|1
4589280|NCT01510912|7434502|FG000|Overall Study|Protocol Violation|27
4589281|NCT01510912|7434502|FG000|Overall Study|Lost to Follow-up|26
4589282|NCT01510912|7434502|FG000|Overall Study|Other, including joint replacement|5
4589283|NCT01511055|7434516|FG000|Overall Study|Withdrawal by Subject|6
4589284|NCT01511107|7434526|FG000|Overall Study|Ineligible|3
4589285|NCT01511107|7434527|FG001|Overall Study|Ineligible|2
4589286|NCT01511107|7434526|FG000|Overall Study|Lost to Follow-up|10
4589287|NCT01511107|7434527|FG001|Overall Study|Lost to Follow-up|19
4589288|NCT01511107|7434526|FG000|Overall Study|Withdrawal by Subject|9
4475750|NCT00686595|7272011|FG000|Overall Study|Adverse Event|3
4475751|NCT00686595|7272011|FG000|Overall Study|Protocol Violation|1
4475752|NCT00686595|7272011|FG000|Overall Study|Lost to Follow-up|1
4475753|NCT00686595|7272011|FG000|Overall Study|Lack of Efficacy|1
4475754|NCT00686595|7272011|FG000|Overall Study|Poor Compliance|1
4475755|NCT00686634|7272015|FG000|Overall Study|Protocol Violation|6
4475756|NCT00686647|7272020|FG000|Overall Study|Lost to Follow-up|1
4589289|NCT01511107|7434527|FG001|Overall Study|Withdrawal by Subject|20
4589290|NCT01511250|7434543|FG000|Overall Study|Withdrawal of Consent|1
4589291|NCT01511250|7434544|FG001|Overall Study|Withdrawal of Consent|0
4589292|NCT01511250|7434545|FG002|Overall Study|Withdrawal of Consent|0
4589293|NCT01511250|7434546|FG003|Overall Study|Withdrawal of Consent|0
4589294|NCT01511250|7434547|FG004|Overall Study|Withdrawal of Consent|0
4589295|NCT01511250|7434548|FG005|Overall Study|Withdrawal of Consent|0
4589296|NCT01511250|7434549|FG006|Overall Study|Withdrawal of Consent|0
4589297|NCT01511250|7434550|FG007|Overall Study|Withdrawal of Consent|1
4589298|NCT01511250|7434551|FG008|Overall Study|Withdrawal of Consent|1
4589299|NCT01511250|7434552|FG009|Overall Study|Withdrawal of Consent|0
4589300|NCT01511250|7434543|FG000|Overall Study|Sponsor/Investigator Decision|1
4475757|NCT00686647|7272020|FG000|Overall Study|Death|1
4475758|NCT00686686|7272025|FG000|Overall Study|Non-compliance|1
4475759|NCT00686686|7272025|FG000|Overall Study|Adverse Event|2
4475760|NCT00686686|7272025|FG000|Overall Study|Lost to Follow-up|3
4475761|NCT00686699|7272031|FG000|Treatment Period 1|Adverse Event|0
4475762|NCT00686699|7272032|FG001|Treatment Period 1|Adverse Event|2
4475763|NCT00686712|7272041|FG000|Overall Study|Protocol Violation|8
4475764|NCT00686712|7272042|FG001|Overall Study|Protocol Violation|8
4475765|NCT00686712|7272043|FG002|Overall Study|Protocol Violation|10
4475766|NCT00686712|7272041|FG000|Overall Study|Lost to Follow-up|1
4475767|NCT00686712|7272042|FG001|Overall Study|Lost to Follow-up|2
4475768|NCT00686712|7272043|FG002|Overall Study|Lost to Follow-up|3
4475769|NCT00686712|7272041|FG000|Overall Study|Adverse Event|1
4475770|NCT00686712|7272042|FG001|Overall Study|Adverse Event|1
4475771|NCT00686712|7272043|FG002|Overall Study|Adverse Event|0
4475772|NCT00686725|7272056|FG000|Overall Study|Adverse Event|1
4475773|NCT00686725|7272057|FG001|Overall Study|Adverse Event|1
4475774|NCT00686725|7272056|FG000|Overall Study|Progressive Disease|17
4475775|NCT00686725|7272057|FG001|Overall Study|Progressive Disease|23
4475776|NCT00686725|7272056|FG000|Overall Study|Lost to Follow-up|7
4475777|NCT00686725|7272057|FG001|Overall Study|Lost to Follow-up|5
4475778|NCT00686725|7272056|FG000|Overall Study|Death|6
4475779|NCT00686725|7272057|FG001|Overall Study|Death|3
4475780|NCT00686725|7272056|FG000|Overall Study|Withdrawal by Subject|13
4475781|NCT00686725|7272057|FG001|Overall Study|Withdrawal by Subject|4
4475782|NCT00686725|7272056|FG000|Overall Study|Protocol Violation|1
4475783|NCT00686725|7272057|FG001|Overall Study|Protocol Violation|3
4475784|NCT00686725|7272056|FG000|Overall Study|Other|1
4475785|NCT00686725|7272057|FG001|Overall Study|Other|3
4475786|NCT00686777|7272063|FG000|Overall Study|Adverse Event|2
4475787|NCT00686777|7272063|FG000|Overall Study|Pregnancy|1
4475788|NCT00686777|7272063|FG000|Overall Study|Withdrawal by Subject|2
4475789|NCT00686777|7272063|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4
4475790|NCT00686777|7272063|FG000|Overall Study|No Visit|1
4475791|NCT00686790|7272067|FG000|Overall Study|Adverse Event|2
4475792|NCT00686790|7272067|FG000|Overall Study|Withdrawal by Subject|1
4475793|NCT00686790|7272067|FG000|Overall Study|Death|1
4475794|NCT00686790|7272067|FG000|Overall Study|Lost to Follow-up|12
4475795|NCT00686829|7272084|FG000|Overall Study|Adverse Event|5
4475796|NCT00686829|7272084|FG000|Overall Study|Lack of Efficacy|6
4475797|NCT00686829|7272084|FG000|Overall Study|Lost to Follow-up|4
4475798|NCT00686829|7272084|FG000|Overall Study|Withdrawal by Subject|14
4475799|NCT00686829|7272084|FG000|Overall Study|Protocol Violation|3
4475800|NCT00686829|7272084|FG000|Overall Study|Sponsor discontinued VCV|47
4475801|NCT00686855|7272094|FG000|Overall Study|Lost to Follow-up|1
4475802|NCT00686855|7272095|FG001|Overall Study|Lost to Follow-up|0
4475803|NCT00686855|7272094|FG000|Overall Study|Progressive GVHD|0
4475804|NCT00686855|7272095|FG001|Overall Study|Progressive GVHD|1
4475805|NCT00686881|7272103|FG000|Overall Study|Withdrawal by Subject|11
4475806|NCT00686881|7272104|FG001|Overall Study|Withdrawal by Subject|18
4475807|NCT00686881|7272103|FG000|Overall Study|Lost to Follow-up|0
4475808|NCT00686881|7272104|FG001|Overall Study|Lost to Follow-up|1
4475809|NCT00686881|7272103|FG000|Overall Study|Treatment-related adverse event|10
4475810|NCT00686881|7272104|FG001|Overall Study|Treatment-related adverse event|9
4475811|NCT00686881|7272103|FG000|Overall Study|Met discontinuation criteria|5
4475812|NCT00686881|7272104|FG001|Overall Study|Met discontinuation criteria|0
4475813|NCT00686881|7272103|FG000|Overall Study|Onset of malignant tumor|11
4475814|NCT00686881|7272104|FG001|Overall Study|Onset of malignant tumor|11
4475815|NCT00686881|7272103|FG000|Overall Study|Lack of Efficacy|4
4475816|NCT00686881|7272104|FG001|Overall Study|Lack of Efficacy|3
4475817|NCT00686881|7272103|FG000|Overall Study|Physician Decision|1
4475818|NCT00686881|7272104|FG001|Overall Study|Physician Decision|0
4475819|NCT00686881|7272103|FG000|Overall Study|Circumstances of site|1
4475820|NCT00686881|7272104|FG001|Overall Study|Circumstances of site|1
4475821|NCT00686881|7272103|FG000|Overall Study|Did not meet protocol eligibility|1
4475822|NCT00686881|7272104|FG001|Overall Study|Did not meet protocol eligibility|0
4475823|NCT00686881|7272103|FG000|Overall Study|Irregular visits|1
4475824|NCT00686881|7272104|FG001|Overall Study|Irregular visits|0
4475825|NCT00686881|7272103|FG000|Overall Study|Study discontinuation|35
4475826|NCT00686881|7272104|FG001|Overall Study|Study discontinuation|32
4475827|NCT00686881|7272103|FG000|Overall Study|Never received study drug|2
4475828|NCT00686881|7272104|FG001|Overall Study|Never received study drug|6
4475829|NCT00686894|7272112|FG000|Overall Study|Relapse|2
4475830|NCT00686894|7272112|FG000|Overall Study|Protocol Violation|4
4475831|NCT00686920|7272118|FG000|Overall Study|Death|45
4475832|NCT00686920|7272119|FG001|Overall Study|Death|14
4475833|NCT00686920|7272118|FG000|Overall Study|Liver Transplant|23
4475834|NCT00686920|7272119|FG001|Overall Study|Liver Transplant|8
4475835|NCT00686920|7272118|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1
4475836|NCT00686920|7272119|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2
4475837|NCT00686920|7272118|FG000|Overall Study|Withdrawal by Subject|23
4475838|NCT00686920|7272119|FG001|Overall Study|Withdrawal by Subject|5
4475839|NCT00686920|7272118|FG000|Overall Study|Protocol Violation|2
4475840|NCT00686920|7272119|FG001|Overall Study|Protocol Violation|1
4475841|NCT00686920|7272118|FG000|Overall Study|Adverse Event|10
4475842|NCT00686920|7272119|FG001|Overall Study|Adverse Event|2
4475843|NCT00686920|7272118|FG000|Overall Study|Personal Reason|0
4475844|NCT00686920|7272119|FG001|Overall Study|Personal Reason|1
4475845|NCT00686920|7272118|FG000|Overall Study|Lost to Follow-up|15
4475846|NCT00686920|7272119|FG001|Overall Study|Lost to Follow-up|3
4475847|NCT00686920|7272118|FG000|Overall Study|Moved to Another State|1
4475848|NCT00686920|7272119|FG001|Overall Study|Moved to Another State|0
4475849|NCT00686920|7272118|FG000|Overall Study|Transferred to Nursing Home|1
4475850|NCT00686920|7272119|FG001|Overall Study|Transferred to Nursing Home|0
4475851|NCT00686920|7272118|FG000|Overall Study|Noncompliance|9
4475852|NCT00686920|7272119|FG001|Overall Study|Noncompliance|0
4475853|NCT00686920|7272118|FG000|Overall Study|Principal Investigator Decision|2
4475854|NCT00686920|7272119|FG001|Overall Study|Principal Investigator Decision|0
4475855|NCT00686959|7272127|FG000|Overall Study|Participants censored (no death events)|124
4475856|NCT00686959|7272128|FG001|Overall Study|Participants censored (no death events)|117
4475857|NCT00686998|7272137|FG000|Overall Study|Adverse Event|3
4475858|NCT00686998|7272138|FG001|Overall Study|Adverse Event|2
4475859|NCT00686998|7272139|FG002|Overall Study|Adverse Event|1
4475860|NCT00686998|7272137|FG000|Overall Study|Withdrawal by Subject|2
4475861|NCT00686998|7272138|FG001|Overall Study|Withdrawal by Subject|1
4475862|NCT00686998|7272139|FG002|Overall Study|Withdrawal by Subject|2
4475863|NCT00686998|7272137|FG000|Overall Study|Lack of Efficacy|7
4475864|NCT00686998|7272138|FG001|Overall Study|Lack of Efficacy|5
4475865|NCT00686998|7272139|FG002|Overall Study|Lack of Efficacy|0
4475866|NCT00686998|7272137|FG000|Overall Study|Other|0
4475867|NCT00686998|7272138|FG001|Overall Study|Other|0
4475868|NCT00686998|7272139|FG002|Overall Study|Other|1
4475869|NCT00686998|7272137|FG000|Overall Study|Safety Reasons|1
4475870|NCT00686998|7272138|FG001|Overall Study|Safety Reasons|0
4475871|NCT00686998|7272139|FG002|Overall Study|Safety Reasons|0
4475872|NCT00687193|7272178|FG000|Overall Study|Adverse Event|0
4475873|NCT00687193|7272179|FG001|Overall Study|Adverse Event|1
4475874|NCT00687193|7272180|FG002|Overall Study|Adverse Event|2
4589301|NCT01511250|7434544|FG001|Overall Study|Sponsor/Investigator Decision|0
4589302|NCT01511250|7434545|FG002|Overall Study|Sponsor/Investigator Decision|0
4589303|NCT01511250|7434546|FG003|Overall Study|Sponsor/Investigator Decision|0
4589304|NCT01511250|7434547|FG004|Overall Study|Sponsor/Investigator Decision|0
4589305|NCT01511250|7434548|FG005|Overall Study|Sponsor/Investigator Decision|0
4589306|NCT01511250|7434549|FG006|Overall Study|Sponsor/Investigator Decision|0
4589307|NCT01511250|7434550|FG007|Overall Study|Sponsor/Investigator Decision|0
4589308|NCT01511250|7434551|FG008|Overall Study|Sponsor/Investigator Decision|0
4589309|NCT01511250|7434552|FG009|Overall Study|Sponsor/Investigator Decision|0
4589310|NCT01511250|7434543|FG000|Overall Study|Lost to Follow-up|7
4589311|NCT01511250|7434544|FG001|Overall Study|Lost to Follow-up|3
4475875|NCT00687193|7272181|FG003|Overall Study|Adverse Event|3
4475876|NCT00687193|7272182|FG004|Overall Study|Adverse Event|0
4475877|NCT00687193|7272183|FG005|Overall Study|Adverse Event|2
4475878|NCT00687193|7272178|FG000|Overall Study|Lack of Efficacy|1
4475879|NCT00687193|7272179|FG001|Overall Study|Lack of Efficacy|1
4475880|NCT00687193|7272180|FG002|Overall Study|Lack of Efficacy|0
4475881|NCT00687193|7272181|FG003|Overall Study|Lack of Efficacy|0
4475882|NCT00687193|7272182|FG004|Overall Study|Lack of Efficacy|0
4475883|NCT00687193|7272183|FG005|Overall Study|Lack of Efficacy|2
4475884|NCT00687193|7272178|FG000|Overall Study|Protocol Violation|1
4475885|NCT00687193|7272179|FG001|Overall Study|Protocol Violation|2
4475886|NCT00687193|7272180|FG002|Overall Study|Protocol Violation|0
4475887|NCT00687193|7272181|FG003|Overall Study|Protocol Violation|1
4475888|NCT00687193|7272182|FG004|Overall Study|Protocol Violation|2
4475889|NCT00687193|7272183|FG005|Overall Study|Protocol Violation|0
4475890|NCT00687219|7272200|FG000|Overall Study|Adverse Event|8
4475891|NCT00687219|7272200|FG000|Overall Study|Discontinuance criteria met|7
4475892|NCT00687219|7272200|FG000|Overall Study|HCV-RNA positive conversion|34
4475893|NCT00687219|7272200|FG000|Overall Study|Withdrawal by Subject|1
4475894|NCT00687219|7272200|FG000|Overall Study|Lack of Efficacy|1
4475895|NCT00687271|7272208|FG000|Overall Study|Adverse Event|1
4475896|NCT00687271|7272209|FG001|Overall Study|Adverse Event|3
4475897|NCT00687271|7272210|FG002|Overall Study|Adverse Event|1
4475898|NCT00687271|7272211|FG003|Overall Study|Adverse Event|0
4475899|NCT00687271|7272208|FG000|Overall Study|Lost to Follow-up|0
4475900|NCT00687271|7272209|FG001|Overall Study|Lost to Follow-up|1
4475901|NCT00687271|7272210|FG002|Overall Study|Lost to Follow-up|0
4475902|NCT00687271|7272211|FG003|Overall Study|Lost to Follow-up|0
4589312|NCT01511250|7434545|FG002|Overall Study|Lost to Follow-up|3
4475903|NCT00687271|7272208|FG000|Overall Study|Protocol Violation|2
4475904|NCT00687271|7272209|FG001|Overall Study|Protocol Violation|1
4475905|NCT00687271|7272210|FG002|Overall Study|Protocol Violation|1
4475906|NCT00687271|7272211|FG003|Overall Study|Protocol Violation|0
4475907|NCT00687271|7272208|FG000|Overall Study|Withdrawal by Subject|0
4475908|NCT00687271|7272209|FG001|Overall Study|Withdrawal by Subject|1
4475909|NCT00687271|7272210|FG002|Overall Study|Withdrawal by Subject|3
4475910|NCT00687271|7272211|FG003|Overall Study|Withdrawal by Subject|0
4475911|NCT00687297|7272223|FG000|Randomization|Withdrawal by Subject|2
4475912|NCT00687297|7272224|FG001|Randomization|Withdrawal by Subject|0
4475913|NCT00687297|7272223|FG000|Randomization|Withdrew before treatment, ineligible|1
4475914|NCT00687297|7272224|FG001|Randomization|Withdrew before treatment, ineligible|1
4475915|NCT00687297|7272223|FG000|Induction|Withdrawal by Subject|4
4475916|NCT00687297|7272224|FG001|Induction|Withdrawal by Subject|4
4475917|NCT00687297|7272223|FG000|Induction|Adverse Event|16
4475918|NCT00687297|7272224|FG001|Induction|Adverse Event|15
4475919|NCT00687297|7272223|FG000|Induction|Death|7
4475920|NCT00687297|7272224|FG001|Induction|Death|11
4475921|NCT00687297|7272223|FG000|Induction|Lack of Efficacy|17
4475922|NCT00687297|7272224|FG001|Induction|Lack of Efficacy|21
4475923|NCT00687297|7272223|FG000|Induction|Ineligible|0
4475924|NCT00687297|7272224|FG001|Induction|Ineligible|1
4475925|NCT00687297|7272223|FG000|Induction|Patient Noncompliance|1
4475926|NCT00687297|7272224|FG001|Induction|Patient Noncompliance|0
4475927|NCT00687297|7272223|FG000|Induction|Physician Decision|0
4475928|NCT00687297|7272224|FG001|Induction|Physician Decision|2
4475929|NCT00687297|7272223|FG000|Induction|Other|0
4475930|NCT00687297|7272224|FG001|Induction|Other|1
4475931|NCT00687323|7272232|FG000|Overall Study|Death|25
4475932|NCT00687323|7272232|FG000|Overall Study|Withdrawal by Subject|1
4475933|NCT00687323|7272232|FG000|Overall Study|Excluded from efficacy evaluations|6
4475934|NCT00687323|7272232|FG000|Overall Study|Screen failure|148
4475935|NCT00687362|7272236|FG000|Overall Study|Protocol Violation|2
4475936|NCT00687362|7272236|FG000|Overall Study|Withdrawal by Subject|1
4475937|NCT00687401|7272240|FG000|Overall Study|Protocol Violation|7
4475938|NCT00687401|7272240|FG000|Overall Study|Adverse Event|6
4475939|NCT00687401|7272240|FG000|Overall Study|Lack of Efficacy|6
4475940|NCT00687401|7272240|FG000|Overall Study|Withdrawal by Subject|4
4475941|NCT00687401|7272240|FG000|Overall Study|Did not return for visit|3
4475942|NCT00687401|7272240|FG000|Overall Study|For reasons different from those above|4
4475943|NCT00687440|7272245|FG000|Overall Study|Adverse Event|3
4475944|NCT00687440|7272245|FG000|Overall Study|Lost to Follow-up|3
4475945|NCT00687440|7272245|FG000|Overall Study|Lack of Efficacy|2
4475946|NCT00687440|7272245|FG000|Overall Study|Death|2
4475947|NCT00687440|7272245|FG000|Overall Study|Other|1
4475948|NCT00687440|7272245|FG000|Overall Study|Missing|1
4475949|NCT00687609|7272262|FG000|Overall Study|Physician Decision|1
4475950|NCT00687609|7272262|FG000|Overall Study|Withdrawal by Subject|2
4475951|NCT00687739|7272285|FG000|Overall Study|Lost to Follow-up|2
4475952|NCT00687739|7272286|FG001|Overall Study|Lost to Follow-up|2
4475953|NCT00687739|7272287|FG002|Overall Study|Lost to Follow-up|1
4475954|NCT00687739|7272288|FG003|Overall Study|Lost to Follow-up|2
4475955|NCT00687739|7272285|FG000|Overall Study|Adverse Event|0
4475956|NCT00687739|7272286|FG001|Overall Study|Adverse Event|1
4475957|NCT00687739|7272287|FG002|Overall Study|Adverse Event|1
4475958|NCT00687739|7272288|FG003|Overall Study|Adverse Event|0
4475959|NCT00687804|7272303|FG000|Core Study|Adverse Event|5
4475960|NCT00687804|7272304|FG001|Core Study|Adverse Event|3
4475961|NCT00687804|7272305|FG002|Core Study|Adverse Event|3
4475962|NCT00687804|7272303|FG000|Core Study|Abnormal laboratory value(s)|1
4475963|NCT00687804|7272304|FG001|Core Study|Abnormal laboratory value(s)|0
4475964|NCT00687804|7272305|FG002|Core Study|Abnormal laboratory value(s)|0
4475965|NCT00687804|7272303|FG000|Core Study|Lack of Efficacy|1
4475966|NCT00687804|7272304|FG001|Core Study|Lack of Efficacy|1
4475967|NCT00687804|7272305|FG002|Core Study|Lack of Efficacy|1
4475968|NCT00687804|7272303|FG000|Core Study|Withdrawal by Subject|4
4475969|NCT00687804|7272304|FG001|Core Study|Withdrawal by Subject|7
4475970|NCT00687804|7272305|FG002|Core Study|Withdrawal by Subject|7
4475971|NCT00687804|7272303|FG000|Core Study|Lost to Follow-up|0
4475972|NCT00687804|7272304|FG001|Core Study|Lost to Follow-up|1
4475973|NCT00687804|7272305|FG002|Core Study|Lost to Follow-up|0
4475974|NCT00687804|7272303|FG000|Core Study|Death|2
4475975|NCT00687804|7272304|FG001|Core Study|Death|2
4475976|NCT00687804|7272305|FG002|Core Study|Death|2
4475977|NCT00687804|7272303|FG000|Core Study|Protocol Violation|1
4475978|NCT00687804|7272304|FG001|Core Study|Protocol Violation|1
4475979|NCT00687804|7272305|FG002|Core Study|Protocol Violation|0
4475980|NCT00687804|7272303|FG000|Open-Label Extension Study|Adverse Event|2
4475981|NCT00687804|7272304|FG001|Open-Label Extension Study|Adverse Event|2
4475982|NCT00687804|7272305|FG002|Open-Label Extension Study|Adverse Event|2
4475983|NCT00687804|7272303|FG000|Open-Label Extension Study|Subject withdrew consent|3
4475984|NCT00687804|7272304|FG001|Open-Label Extension Study|Subject withdrew consent|4
4475985|NCT00687804|7272305|FG002|Open-Label Extension Study|Subject withdrew consent|4
4475986|NCT00687804|7272303|FG000|Open-Label Extension Study|Lost to Follow-up|2
4475987|NCT00687804|7272304|FG001|Open-Label Extension Study|Lost to Follow-up|1
4475988|NCT00687804|7272305|FG002|Open-Label Extension Study|Lost to Follow-up|2
4518756|NCT00976209|7331020|FG001|Wash-out Period|Other|0
4475989|NCT00687804|7272303|FG000|Open-Label Extension Study|Administrative problems|1
4475990|NCT00687804|7272304|FG001|Open-Label Extension Study|Administrative problems|1
4475991|NCT00687804|7272305|FG002|Open-Label Extension Study|Administrative problems|0
4475992|NCT00687804|7272303|FG000|Open-Label Extension Study|Death|2
4475993|NCT00687804|7272304|FG001|Open-Label Extension Study|Death|3
4475994|NCT00687804|7272305|FG002|Open-Label Extension Study|Death|3
4475995|NCT00687973|7272343|FG000|Overall Study|Adverse Event|18
4589313|NCT01511250|7434546|FG003|Overall Study|Lost to Follow-up|3
4589314|NCT01511250|7434547|FG004|Overall Study|Lost to Follow-up|0
4589315|NCT01511250|7434548|FG005|Overall Study|Lost to Follow-up|0
4589316|NCT01511250|7434549|FG006|Overall Study|Lost to Follow-up|2
4589317|NCT01511250|7434550|FG007|Overall Study|Lost to Follow-up|3
4589318|NCT01511250|7434551|FG008|Overall Study|Lost to Follow-up|13
4589319|NCT01511250|7434552|FG009|Overall Study|Lost to Follow-up|5
4589320|NCT01511250|7434543|FG000|Overall Study|Protocol Violation|0
4589321|NCT01511250|7434544|FG001|Overall Study|Protocol Violation|2
4589322|NCT01511250|7434545|FG002|Overall Study|Protocol Violation|1
4589323|NCT01511250|7434546|FG003|Overall Study|Protocol Violation|0
4589324|NCT01511250|7434547|FG004|Overall Study|Protocol Violation|0
4589325|NCT01511250|7434548|FG005|Overall Study|Protocol Violation|0
4589326|NCT01511250|7434549|FG006|Overall Study|Protocol Violation|0
4589327|NCT01511250|7434550|FG007|Overall Study|Protocol Violation|0
4589328|NCT01511250|7434551|FG008|Overall Study|Protocol Violation|0
4589329|NCT01511250|7434552|FG009|Overall Study|Protocol Violation|0
4589330|NCT01511419|7434580|FG000|Dose 2|Physician Decision|1
4589331|NCT01511419|7434581|FG001|Dose 2|Physician Decision|0
4589332|NCT01511445|7434613|FG000|Overall Study|Lost to Follow-up|3
4589333|NCT01511445|7434614|FG001|Overall Study|Lost to Follow-up|1
4589334|NCT01511445|7434613|FG000|Overall Study|Protocol Violation|1
4475996|NCT00687973|7272344|FG001|Overall Study|Adverse Event|28
4475997|NCT00687973|7272343|FG000|Overall Study|Lack of Efficacy|2
4475998|NCT00687973|7272344|FG001|Overall Study|Lack of Efficacy|3
4475999|NCT00687973|7272343|FG000|Overall Study|Protocol Violation|1
4476000|NCT00687973|7272344|FG001|Overall Study|Protocol Violation|2
4476001|NCT00687973|7272343|FG000|Overall Study|Administrative Reasons|0
4476002|NCT00687973|7272344|FG001|Overall Study|Administrative Reasons|2
4476003|NCT00687973|7272343|FG000|Overall Study|Withdrawal by Subject|3
4476004|NCT00687973|7272344|FG001|Overall Study|Withdrawal by Subject|3
4476005|NCT00688064|7272353|FG000|Overall Study|Protocol Violation|0
4476006|NCT00688064|7272354|FG001|Overall Study|Protocol Violation|1
4476007|NCT00688064|7272353|FG000|Overall Study|Adverse Event|2
4476008|NCT00688064|7272354|FG001|Overall Study|Adverse Event|4
4476009|NCT00688064|7272353|FG000|Overall Study|Withdrawal by Subject|7
4476010|NCT00688064|7272354|FG001|Overall Study|Withdrawal by Subject|7
4476011|NCT00688064|7272353|FG000|Overall Study|Lost to Follow-up|10
4476012|NCT00688064|7272354|FG001|Overall Study|Lost to Follow-up|10
4476013|NCT00688064|7272353|FG000|Overall Study|Lack of Efficacy|0
4476014|NCT00688064|7272354|FG001|Overall Study|Lack of Efficacy|1
4476015|NCT00688064|7272353|FG000|Overall Study|Pregnancy|1
4476016|NCT00688064|7272354|FG001|Overall Study|Pregnancy|0
4476017|NCT00688064|7272353|FG000|Overall Study|Any other reasons|1
4476018|NCT00688064|7272354|FG001|Overall Study|Any other reasons|3
4476019|NCT00688103|7272362|FG000|Overall Study|Adverse Event|4
4476020|NCT00688103|7272363|FG001|Overall Study|Adverse Event|1
4476021|NCT00688103|7272362|FG000|Overall Study|Lack of Efficacy|11
4476022|NCT00688103|7272363|FG001|Overall Study|Lack of Efficacy|1
4476023|NCT00688103|7272362|FG000|Overall Study|Withdrawal by Subject|4
4476024|NCT00688103|7272363|FG001|Overall Study|Withdrawal by Subject|2
4476025|NCT00688103|7272362|FG000|Overall Study|complex reasons|11
4476026|NCT00688103|7272363|FG001|Overall Study|complex reasons|9
4476027|NCT00688155|7272375|FG000|Overall Study|Withdrawal by Subject|2
4476028|NCT00688155|7272376|FG001|Overall Study|Withdrawal by Subject|2
4476029|NCT00688155|7272377|FG002|Overall Study|Withdrawal by Subject|1
4476030|NCT00688155|7272378|FG003|Overall Study|Withdrawal by Subject|1
4476031|NCT00688181|7272388|FG000|Overall Study|Lost to Follow-up|17
4476032|NCT00688181|7272388|FG000|Overall Study|Unknown Reason|4
4476033|NCT00688181|7272388|FG000|Overall Study|Non-clinical Reason|2
4476034|NCT00688259|7272396|FG000|Overall Study|Lost to Follow-up|2
4476035|NCT00688259|7272397|FG001|Overall Study|Lost to Follow-up|4
4476036|NCT00688259|7272396|FG000|Overall Study|Physician Decision|1
4476037|NCT00688259|7272397|FG001|Overall Study|Physician Decision|0
4476038|NCT00688259|7272396|FG000|Overall Study|Withdrawal by Subject|2
4476039|NCT00688259|7272397|FG001|Overall Study|Withdrawal by Subject|0
4476040|NCT00688259|7272396|FG000|Overall Study|Declined Interview|2
4476041|NCT00688259|7272397|FG001|Overall Study|Declined Interview|3
4589335|NCT01511445|7434614|FG001|Overall Study|Protocol Violation|3
4589336|NCT01511445|7434613|FG000|Overall Study|Protocol Violation|1
4589337|NCT01511445|7434614|FG001|Overall Study|Protocol Violation|0
4589338|NCT01511536|7434623|FG000|Phase 1|Other|0
4589339|NCT01511536|7434624|FG001|Phase 1|Other|1
4589340|NCT01511536|7434625|FG002|Phase 1|Other|0
4476042|NCT00688259|7272396|FG000|Overall Study|Hospitalized at Follow-up|0
4476043|NCT00688259|7272397|FG001|Overall Study|Hospitalized at Follow-up|1
4476044|NCT00688324|7272403|FG000|Overall Study|Withdrawal by Subject|2
4476045|NCT00688324|7272403|FG000|Overall Study|Physician Decision|5
4589341|NCT01511536|7434623|FG000|Phase 2|Other|0
4589342|NCT01511536|7434624|FG001|Phase 2|Other|0
4476046|NCT00688324|7272403|FG000|Overall Study|Lost to Follow-up|1
4476047|NCT00688467|7272410|FG000|Treatment Period 1|Adverse Event|2
4476048|NCT00688467|7272411|FG001|Treatment Period 1|Adverse Event|1
4476049|NCT00688467|7272410|FG000|Treatment Period 1|Did not meet protocol eligibility|0
4476050|NCT00688467|7272411|FG001|Treatment Period 1|Did not meet protocol eligibility|1
4476051|NCT00688467|7272410|FG000|Treatment Period 2|Protocol Violation|0
4476052|NCT00688467|7272411|FG001|Treatment Period 2|Protocol Violation|1
4476053|NCT00688467|7272410|FG000|Treatment Period 2|Adverse Event|0
4476054|NCT00688467|7272411|FG001|Treatment Period 2|Adverse Event|1
4476055|NCT00688519|7272419|FG000|Overall Study|Adverse Event|2
4476056|NCT00688519|7272420|FG001|Overall Study|Adverse Event|3
4476057|NCT00688519|7272419|FG000|Overall Study|Lost to Follow-up|3
4476058|NCT00688519|7272420|FG001|Overall Study|Lost to Follow-up|3
4476059|NCT00688519|7272419|FG000|Overall Study|Lack of Efficacy|3
4476060|NCT00688519|7272420|FG001|Overall Study|Lack of Efficacy|1
4476061|NCT00688519|7272419|FG000|Overall Study|Withdrawal by Subject|7
4476062|NCT00688519|7272420|FG001|Overall Study|Withdrawal by Subject|6
4476063|NCT00688519|7272419|FG000|Overall Study|Prohibited medication|1
4476064|NCT00688519|7272420|FG001|Overall Study|Prohibited medication|0
4476065|NCT00688519|7272419|FG000|Overall Study|Non-compliance|0
4476066|NCT00688519|7272420|FG001|Overall Study|Non-compliance|1
4476067|NCT00688519|7272419|FG000|Overall Study|Subject moved out of state|1
4476068|NCT00688519|7272420|FG001|Overall Study|Subject moved out of state|0
4476069|NCT00688519|7272419|FG000|Overall Study|Investigator decision|1
4476070|NCT00688519|7272420|FG001|Overall Study|Investigator decision|0
4476071|NCT00688519|7272419|FG000|Overall Study|Subject moved out of area|1
4476072|NCT00688519|7272420|FG001|Overall Study|Subject moved out of area|0
4476073|NCT00688519|7272419|FG000|Overall Study|Pregnancy|0
4476074|NCT00688519|7272420|FG001|Overall Study|Pregnancy|1
4476075|NCT00688545|7272428|FG000|Overall Study|Lost to Follow-up|1
4476076|NCT00688545|7272429|FG001|Overall Study|Lost to Follow-up|4
4476077|NCT00688545|7272428|FG000|Overall Study|Insurance/cost of drug|0
4476078|NCT00688545|7272429|FG001|Overall Study|Insurance/cost of drug|1
4476079|NCT00688545|7272428|FG000|Overall Study|Withdrawal by Subject|2
4476080|NCT00688545|7272429|FG001|Overall Study|Withdrawal by Subject|3
4476081|NCT00688545|7272428|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2
4589343|NCT01511536|7434625|FG002|Phase 2|Other|9
4589344|NCT01511939|7434662|FG000|Overall Study|Withdrawal by Subject|2
4589345|NCT01511939|7434663|FG001|Overall Study|Withdrawal by Subject|1
4589346|NCT01511939|7434664|FG002|Overall Study|Withdrawal by Subject|0
4589347|NCT01512108|7434685|FG000|Overall Study|Adverse Event|9
4589348|NCT01512108|7434686|FG001|Overall Study|Adverse Event|4
4589349|NCT01512108|7434685|FG000|Overall Study|Protocol Violation|1
4589350|NCT01512108|7434686|FG001|Overall Study|Protocol Violation|2
4589351|NCT01512108|7434685|FG000|Overall Study|Withdrawal Criteria|1
4589352|NCT01512108|7434686|FG001|Overall Study|Withdrawal Criteria|0
4589353|NCT01512108|7434685|FG000|Overall Study|Unclassified|11
4589354|NCT01512108|7434686|FG001|Overall Study|Unclassified|3
4589355|NCT01512160|7434696|FG000|Overall Study|Lost to Follow-up|1
4589356|NCT01512160|7434697|FG001|Overall Study|Lost to Follow-up|0
4589357|NCT01512160|7434698|FG002|Overall Study|Lost to Follow-up|0
4589358|NCT01512160|7434699|FG003|Overall Study|Lost to Follow-up|0
4589359|NCT01512160|7434696|FG000|Overall Study|Withdrawal by Subject|1
4589360|NCT01512160|7434697|FG001|Overall Study|Withdrawal by Subject|0
4589361|NCT01512160|7434698|FG002|Overall Study|Withdrawal by Subject|0
4589362|NCT01512160|7434699|FG003|Overall Study|Withdrawal by Subject|1
4589363|NCT01512264|7434735|FG000|Overall Study|Lost to Follow-up|0
4589364|NCT01512264|7434736|FG001|Overall Study|Lost to Follow-up|0
4589365|NCT01512264|7434737|FG002|Overall Study|Lost to Follow-up|0
4589366|NCT01512264|7434738|FG003|Overall Study|Lost to Follow-up|1
4589367|NCT01512368|7434748|FG000|Overall Study|Protocol Violation|3
4589368|NCT01512693|7434772|FG000|Overall Study|Withdrawal by Subject|0
4589369|NCT01512693|7434773|FG001|Overall Study|Withdrawal by Subject|1
4589370|NCT01512745|7434781|FG000|Overall Study|Adverse Event|22
4589371|NCT01512745|7434782|FG001|Overall Study|Adverse Event|3
4589372|NCT01512745|7434781|FG000|Overall Study|Death|9
4589373|NCT01512745|7434782|FG001|Overall Study|Death|13
4589374|NCT01512745|7434781|FG000|Overall Study|Withdrawal by Subject|2
4589375|NCT01512745|7434782|FG001|Overall Study|Withdrawal by Subject|2
4589376|NCT01512745|7434781|FG000|Overall Study|Lost to Follow-up|4
4589377|NCT01512745|7434782|FG001|Overall Study|Lost to Follow-up|0
4589378|NCT01512745|7434781|FG000|Overall Study|Lack of Efficacy|2
4476082|NCT00688545|7272429|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7
4476083|NCT00688597|7272440|FG000|Overall Study|Adverse Event|2
4476084|NCT00688597|7272441|FG001|Overall Study|Adverse Event|0
4476085|NCT00688597|7272442|FG002|Overall Study|Adverse Event|0
4476086|NCT00688597|7272440|FG000|Overall Study|Physician Decision|1
4589379|NCT01512745|7434782|FG001|Overall Study|Lack of Efficacy|2
4589380|NCT01512745|7434781|FG000|Overall Study|Protocol Violation|1
4589381|NCT01512745|7434782|FG001|Overall Study|Protocol Violation|0
4589382|NCT01512979|7434824|FG000|Overall Study|Adverse Event|2
4589383|NCT01512979|7434825|FG001|Overall Study|Adverse Event|2
4476087|NCT00688597|7272441|FG001|Overall Study|Physician Decision|0
4476088|NCT00688597|7272442|FG002|Overall Study|Physician Decision|0
4589384|NCT01512979|7434824|FG000|Overall Study|Protocol Violation|1
4476089|NCT00688623|7272450|FG000|Overall Study|Adverse Event|22
4476090|NCT00688623|7272450|FG000|Overall Study|abnormal lab value|1
4476091|NCT00688623|7272450|FG000|Overall Study|Withdrawal by Subject|4
4476092|NCT00688623|7272450|FG000|Overall Study|Death|3
4476093|NCT00688623|7272450|FG000|Overall Study|disease progression|23
4476094|NCT00688623|7272450|FG000|Overall Study|Protocol Violation|2
4476095|NCT00688636|7272456|FG000|Overall Study|Adverse Event|2
4476096|NCT00688636|7272457|FG001|Overall Study|Adverse Event|1
4476097|NCT00688688|7272476|FG000|Overall Study|Eligibility criterion not met|7
4476098|NCT00688688|7272477|FG001|Overall Study|Eligibility criterion not met|7
4476099|NCT00688688|7272478|FG002|Overall Study|Eligibility criterion not met|10
4476100|NCT00688688|7272476|FG000|Overall Study|Adverse Event|52
4476101|NCT00688688|7272477|FG001|Overall Study|Adverse Event|51
4476102|NCT00688688|7272478|FG002|Overall Study|Adverse Event|50
4476103|NCT00688688|7272476|FG000|Overall Study|Lack of Efficacy|34
4476104|NCT00688688|7272477|FG001|Overall Study|Lack of Efficacy|25
4476105|NCT00688688|7272478|FG002|Overall Study|Lack of Efficacy|45
4476106|NCT00688688|7272476|FG000|Overall Study|Withdrawal by Subject|66
4476107|NCT00688688|7272477|FG001|Overall Study|Withdrawal by Subject|75
4476108|NCT00688688|7272478|FG002|Overall Study|Withdrawal by Subject|65
4476109|NCT00688688|7272476|FG000|Overall Study|Lost to Follow-up|14
4476110|NCT00688688|7272477|FG001|Overall Study|Lost to Follow-up|7
4476111|NCT00688688|7272478|FG002|Overall Study|Lost to Follow-up|7
4476112|NCT00688688|7272476|FG000|Overall Study|Protocol Violation|6
4476113|NCT00688688|7272477|FG001|Overall Study|Protocol Violation|9
4476114|NCT00688688|7272478|FG002|Overall Study|Protocol Violation|11
4476115|NCT00688688|7272476|FG000|Overall Study|Randomized but never received study drug|1
4476116|NCT00688688|7272477|FG001|Overall Study|Randomized but never received study drug|0
4476117|NCT00688688|7272478|FG002|Overall Study|Randomized but never received study drug|0
4476118|NCT00688688|7272476|FG000|Overall Study|Non-compliance with study procedures|5
4476119|NCT00688688|7272477|FG001|Overall Study|Non-compliance with study procedures|3
4476120|NCT00688688|7272478|FG002|Overall Study|Non-compliance with study procedures|4
4476121|NCT00688688|7272476|FG000|Overall Study|Taking exclusionary medications|1
4476122|NCT00688688|7272477|FG001|Overall Study|Taking exclusionary medications|0
4476123|NCT00688688|7272478|FG002|Overall Study|Taking exclusionary medications|0
4476124|NCT00688688|7272476|FG000|Overall Study|Site closure|0
4476125|NCT00688688|7272477|FG001|Overall Study|Site closure|1
4476126|NCT00688688|7272478|FG002|Overall Study|Site closure|0
4476127|NCT00688688|7272476|FG000|Overall Study|Violation of exclusion criterion|0
4476128|NCT00688688|7272477|FG001|Overall Study|Violation of exclusion criterion|1
4476129|NCT00688688|7272478|FG002|Overall Study|Violation of exclusion criterion|0
4476130|NCT00688701|7272489|FG000|Overall Study|Adverse Event|1
4476131|NCT00688701|7272490|FG001|Overall Study|Adverse Event|0
4476132|NCT00688701|7272491|FG002|Overall Study|Adverse Event|5
4476133|NCT00688701|7272492|FG003|Overall Study|Adverse Event|3
4476134|NCT00688701|7272489|FG000|Overall Study|Lack of Efficacy|0
4476135|NCT00688701|7272490|FG001|Overall Study|Lack of Efficacy|1
4476136|NCT00688701|7272491|FG002|Overall Study|Lack of Efficacy|0
4476137|NCT00688701|7272492|FG003|Overall Study|Lack of Efficacy|0
4476138|NCT00688701|7272489|FG000|Overall Study|Withdrawal by Subject|3
4476139|NCT00688701|7272490|FG001|Overall Study|Withdrawal by Subject|3
4476140|NCT00688701|7272491|FG002|Overall Study|Withdrawal by Subject|4
4476141|NCT00688701|7272492|FG003|Overall Study|Withdrawal by Subject|8
4476142|NCT00688701|7272489|FG000|Overall Study|Poor compliance to protocol|0
4476143|NCT00688701|7272490|FG001|Overall Study|Poor compliance to protocol|1
4476144|NCT00688701|7272491|FG002|Overall Study|Poor compliance to protocol|1
4476145|NCT00688701|7272492|FG003|Overall Study|Poor compliance to protocol|0
4476146|NCT00688740|7272505|FG000|Overall Study|Adverse Event|45
4476147|NCT00688740|7272506|FG001|Overall Study|Adverse Event|8
4476148|NCT00688740|7272505|FG000|Overall Study|Death|2
4476149|NCT00688740|7272506|FG001|Overall Study|Death|2
4476150|NCT00688740|7272505|FG000|Overall Study|Lost to Follow-up|0
4476151|NCT00688740|7272506|FG001|Overall Study|Lost to Follow-up|1
4476152|NCT00688740|7272505|FG000|Overall Study|Consent Withdrawn|17
4476153|NCT00688740|7272506|FG001|Overall Study|Consent Withdrawn|17
4476154|NCT00688740|7272505|FG000|Overall Study|Breast Cancer Relapse|1
4476155|NCT00688740|7272506|FG001|Overall Study|Breast Cancer Relapse|4
4476156|NCT00688740|7272505|FG000|Overall Study|Violation of Inclusion Criteria|1
4476157|NCT00688740|7272506|FG001|Overall Study|Violation of Inclusion Criteria|3
4476158|NCT00688753|7272512|FG000|Overall Study|Disease progression|55
4476159|NCT00688753|7272512|FG000|Overall Study|Missing|1
4476160|NCT00688753|7272512|FG000|Overall Study|Death|9
4476161|NCT00688753|7272512|FG000|Overall Study|Withdrawal by Subject|3
4476162|NCT00688753|7272512|FG000|Overall Study|Adverse Event|20
4476163|NCT00688753|7272512|FG000|Overall Study|Protocol Violation|1
4476164|NCT00688753|7272512|FG000|Overall Study|Lost to Follow-up|3
4476165|NCT00688844|7272516|FG000|Overall Study|Lost to Follow-up|10
4476166|NCT00688870|7272522|FG000|Infant Series|Parent or legal guardian request|4
4476167|NCT00688870|7272523|FG001|Infant Series|Parent or legal guardian request|0
4476168|NCT00688909|7272533|FG000|Overall Study|Adverse Event|28
4476169|NCT00688909|7272533|FG000|Overall Study|Patient withdrew consent|2
4476170|NCT00688909|7272533|FG000|Overall Study|Administrative problems|1
4476171|NCT00688909|7272533|FG000|Overall Study|Protocol Violation|2
4476172|NCT00689026|7272540|FG000|Overall Study|Withdrawal by Subject|13
4476173|NCT00689026|7272541|FG001|Overall Study|Withdrawal by Subject|6
4476174|NCT00689104|7272581|FG000|Overall Study|Eligibility criterion not met|5
4476175|NCT00689104|7272582|FG001|Overall Study|Eligibility criterion not met|8
4476176|NCT00689104|7272583|FG002|Overall Study|Eligibility criterion not met|0
4476177|NCT00689104|7272584|FG003|Overall Study|Eligibility criterion not met|4
4476178|NCT00689104|7272581|FG000|Overall Study|Adverse Event|13
4476179|NCT00689104|7272582|FG001|Overall Study|Adverse Event|25
4476180|NCT00689104|7272583|FG002|Overall Study|Adverse Event|16
4476181|NCT00689104|7272584|FG003|Overall Study|Adverse Event|24
4476182|NCT00689104|7272581|FG000|Overall Study|Lack of Efficacy|5
4476183|NCT00689104|7272582|FG001|Overall Study|Lack of Efficacy|6
4476184|NCT00689104|7272583|FG002|Overall Study|Lack of Efficacy|2
4476185|NCT00689104|7272584|FG003|Overall Study|Lack of Efficacy|3
4476186|NCT00689104|7272581|FG000|Overall Study|Withdrawal by Subject|12
4476187|NCT00689104|7272582|FG001|Overall Study|Withdrawal by Subject|11
4476188|NCT00689104|7272583|FG002|Overall Study|Withdrawal by Subject|18
4476189|NCT00689104|7272584|FG003|Overall Study|Withdrawal by Subject|11
4476190|NCT00689104|7272581|FG000|Overall Study|Lost to Follow-up|4
4476191|NCT00689104|7272582|FG001|Overall Study|Lost to Follow-up|3
4476192|NCT00689104|7272583|FG002|Overall Study|Lost to Follow-up|2
4476193|NCT00689104|7272584|FG003|Overall Study|Lost to Follow-up|5
4476194|NCT00689104|7272581|FG000|Overall Study|Protocol Violation|2
4476195|NCT00689104|7272582|FG001|Overall Study|Protocol Violation|3
4476196|NCT00689104|7272583|FG002|Overall Study|Protocol Violation|5
4476197|NCT00689104|7272584|FG003|Overall Study|Protocol Violation|3
4476198|NCT00689104|7272581|FG000|Overall Study|Randomized but never received study drug|2
4476199|NCT00689104|7272582|FG001|Overall Study|Randomized but never received study drug|1
4476200|NCT00689104|7272583|FG002|Overall Study|Randomized but never received study drug|1
4476201|NCT00689104|7272584|FG003|Overall Study|Randomized but never received study drug|0
4476202|NCT00689104|7272581|FG000|Overall Study|Physician Decision|1
4476203|NCT00689104|7272582|FG001|Overall Study|Physician Decision|0
4476204|NCT00689104|7272583|FG002|Overall Study|Physician Decision|0
4476205|NCT00689104|7272584|FG003|Overall Study|Physician Decision|0
4476206|NCT00689104|7272581|FG000|Overall Study|Non-compliance with study procedures|0
4476207|NCT00689104|7272582|FG001|Overall Study|Non-compliance with study procedures|0
4476208|NCT00689104|7272583|FG002|Overall Study|Non-compliance with study procedures|1
4476209|NCT00689104|7272584|FG003|Overall Study|Non-compliance with study procedures|0
4476210|NCT00689117|7272598|FG000|Overall Study|Adverse Event|6
4476211|NCT00689117|7272599|FG001|Overall Study|Adverse Event|0
4476212|NCT00689117|7272600|FG002|Overall Study|Adverse Event|5
4476213|NCT00689117|7272601|FG003|Overall Study|Adverse Event|0
4476214|NCT00689117|7272598|FG000|Overall Study|Lost to Follow-up|26
4476215|NCT00689117|7272599|FG001|Overall Study|Lost to Follow-up|19
4476216|NCT00689117|7272600|FG002|Overall Study|Lost to Follow-up|17
4476217|NCT00689117|7272601|FG003|Overall Study|Lost to Follow-up|11
4476218|NCT00689117|7272598|FG000|Overall Study|Lack of Efficacy|1
4476219|NCT00689117|7272599|FG001|Overall Study|Lack of Efficacy|2
4476220|NCT00689117|7272600|FG002|Overall Study|Lack of Efficacy|2
4476221|NCT00689117|7272601|FG003|Overall Study|Lack of Efficacy|2
4476222|NCT00689117|7272598|FG000|Overall Study|Non-Compliance with Study Treatment|3
4476223|NCT00689117|7272599|FG001|Overall Study|Non-Compliance with Study Treatment|3
4476224|NCT00689117|7272600|FG002|Overall Study|Non-Compliance with Study Treatment|3
4476225|NCT00689117|7272601|FG003|Overall Study|Non-Compliance with Study Treatment|1
4476226|NCT00689117|7272598|FG000|Overall Study|Withdrawal by Subject|19
4476227|NCT00689117|7272599|FG001|Overall Study|Withdrawal by Subject|18
4476228|NCT00689117|7272600|FG002|Overall Study|Withdrawal by Subject|26
4476229|NCT00689117|7272601|FG003|Overall Study|Withdrawal by Subject|13
4476230|NCT00689117|7272598|FG000|Overall Study|Unable to Comply with Visit Schedule|0
4476231|NCT00689117|7272599|FG001|Overall Study|Unable to Comply with Visit Schedule|0
4476232|NCT00689117|7272600|FG002|Overall Study|Unable to Comply with Visit Schedule|1
4476233|NCT00689117|7272601|FG003|Overall Study|Unable to Comply with Visit Schedule|1
4476234|NCT00689117|7272598|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1
4476235|NCT00689117|7272599|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2
4476236|NCT00689117|7272600|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0
4476237|NCT00689117|7272601|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0
4476238|NCT00689117|7272598|FG000|Overall Study|Non-compliance with Treatment Regimen|0
4476239|NCT00689117|7272599|FG001|Overall Study|Non-compliance with Treatment Regimen|1
4476240|NCT00689117|7272600|FG002|Overall Study|Non-compliance with Treatment Regimen|0
4476241|NCT00689117|7272601|FG003|Overall Study|Non-compliance with Treatment Regimen|0
4476242|NCT00689117|7272598|FG000|Overall Study|Change/Discontinuation of Birth Control|1
4476243|NCT00689117|7272599|FG001|Overall Study|Change/Discontinuation of Birth Control|1
4476244|NCT00689117|7272600|FG002|Overall Study|Change/Discontinuation of Birth Control|1
4476245|NCT00689117|7272601|FG003|Overall Study|Change/Discontinuation of Birth Control|0
4476246|NCT00689117|7272598|FG000|Overall Study|Use of Prohibitive Medication|2
4476247|NCT00689117|7272599|FG001|Overall Study|Use of Prohibitive Medication|1
4476248|NCT00689117|7272600|FG002|Overall Study|Use of Prohibitive Medication|3
4476249|NCT00689117|7272601|FG003|Overall Study|Use of Prohibitive Medication|0
4476250|NCT00689117|7272598|FG000|Overall Study|Pregnancy|0
4476251|NCT00689117|7272599|FG001|Overall Study|Pregnancy|2
4476252|NCT00689117|7272600|FG002|Overall Study|Pregnancy|0
4476253|NCT00689117|7272601|FG003|Overall Study|Pregnancy|2
4476254|NCT00689117|7272598|FG000|Overall Study|Incarceration|2
4476255|NCT00689117|7272599|FG001|Overall Study|Incarceration|0
4476256|NCT00689117|7272600|FG002|Overall Study|Incarceration|0
4476257|NCT00689117|7272601|FG003|Overall Study|Incarceration|0
4476258|NCT00689117|7272598|FG000|Overall Study|Fear of Birth Defects|0
4476259|NCT00689117|7272599|FG001|Overall Study|Fear of Birth Defects|0
4476260|NCT00689117|7272600|FG002|Overall Study|Fear of Birth Defects|1
4476261|NCT00689117|7272601|FG003|Overall Study|Fear of Birth Defects|0
4476262|NCT00689117|7272598|FG000|Overall Study|Transportation|1
4476263|NCT00689117|7272599|FG001|Overall Study|Transportation|0
4476264|NCT00689117|7272600|FG002|Overall Study|Transportation|0
4476265|NCT00689117|7272601|FG003|Overall Study|Transportation|0
4476266|NCT00689117|7272598|FG000|Overall Study|Patient Withdrew from Study|0
4476267|NCT00689117|7272599|FG001|Overall Study|Patient Withdrew from Study|0
4476268|NCT00689117|7272600|FG002|Overall Study|Patient Withdrew from Study|0
4476269|NCT00689117|7272601|FG003|Overall Study|Patient Withdrew from Study|1
4476270|NCT00689117|7272598|FG000|Overall Study|Personal Reason|0
4476271|NCT00689117|7272599|FG001|Overall Study|Personal Reason|1
4476272|NCT00689117|7272600|FG002|Overall Study|Personal Reason|0
4476273|NCT00689117|7272601|FG003|Overall Study|Personal Reason|0
4476274|NCT00689117|7272598|FG000|Overall Study|Dispensing Error|0
4476275|NCT00689117|7272599|FG001|Overall Study|Dispensing Error|1
4476276|NCT00689117|7272600|FG002|Overall Study|Dispensing Error|0
4476277|NCT00689117|7272601|FG003|Overall Study|Dispensing Error|0
4476278|NCT00689221|7272613|FG000|Overall Study|Ongoing at cut-off date|39
4476279|NCT00689221|7272614|FG001|Overall Study|Ongoing at cut-off date|36
4516745|NCT00960986|7328127|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1
4516746|NCT00960986|7328128|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0
4516747|NCT00960999|7328140|FG000|Overall Study|Withdrawal by Subject|1
4516748|NCT00960999|7328141|FG001|Overall Study|Withdrawal by Subject|0
4516749|NCT00960999|7328140|FG000|Overall Study|Protocol Violation|5
4516750|NCT00960999|7328141|FG001|Overall Study|Protocol Violation|2
4516751|NCT00960999|7328140|FG000|Overall Study|RT dose constraints not met|2
4516752|NCT00960999|7328141|FG001|Overall Study|RT dose constraints not met|0
4516753|NCT00961116|7328156|FG000|Washout Period of 7 Days|Adverse Event|1
4516754|NCT00961116|7328157|FG001|Washout Period of 7 Days|Adverse Event|1
4516755|NCT00961116|7328156|FG000|Washout Period of 7 Days|Withdrawal by Subject|1
4516756|NCT00961116|7328157|FG001|Washout Period of 7 Days|Withdrawal by Subject|1
4516757|NCT00961116|7328156|FG000|Washout Period of 7 Days|Protocol Violation|0
4516758|NCT00961116|7328157|FG001|Washout Period of 7 Days|Protocol Violation|1
4516759|NCT00961181|7328164|FG000|Overall Study|Death|2
4589385|NCT01512979|7434825|FG001|Overall Study|Protocol Violation|4
4589386|NCT01512979|7434824|FG000|Overall Study|Lost to Follow-up|2
4589387|NCT01512979|7434825|FG001|Overall Study|Lost to Follow-up|5
4516760|NCT00961181|7328164|FG000|Overall Study|Withdrawal by Subject|2
4516761|NCT00961181|7328164|FG000|Overall Study|Lost to Follow-up|1
4516762|NCT00961220|7328168|FG000|Overall Study|Adverse Event|3
4516763|NCT00961220|7328168|FG000|Overall Study|Lack of Efficacy|1
4516764|NCT00961220|7328168|FG000|Overall Study|No IV access for O6BG|1
4516765|NCT00961220|7328168|FG000|Overall Study|O6BG no longer supplied|1
4516766|NCT00961220|7328168|FG000|Overall Study|Complete Response prior to 12 courses|1
4516767|NCT00961259|7328185|FG000|Washout Period of 7 Days|due to concomitant medication used|0
4516768|NCT00961259|7328186|FG001|Washout Period of 7 Days|due to concomitant medication used|1
4516769|NCT00961259|7328187|FG002|Washout Period of 7 Days|due to concomitant medication used|0
4516770|NCT00961298|7328196|FG000|Two Week Placebo Run in|Withdrawal by Subject|1
4516771|NCT00961298|7328196|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2
4516772|NCT00961298|7328196|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1
4516773|NCT00961350|7328206|FG000|Overall Study|Adverse Event|18
4516774|NCT00961350|7328207|FG001|Overall Study|Adverse Event|33
4516775|NCT00961350|7328206|FG000|Overall Study|Withdrawal by Subject|10
4516776|NCT00961350|7328207|FG001|Overall Study|Withdrawal by Subject|10
4516777|NCT00961350|7328206|FG000|Overall Study|Lost to Follow-up|3
4516778|NCT00961350|7328207|FG001|Overall Study|Lost to Follow-up|3
4516779|NCT00961350|7328206|FG000|Overall Study|Misc|16
4516780|NCT00961350|7328207|FG001|Overall Study|Misc|21
4516781|NCT00961415|7328224|FG000|Induction Treatment Phase|Withdrawal by Subject|11
4516782|NCT00961415|7328225|FG001|Induction Treatment Phase|Withdrawal by Subject|0
4516783|NCT00961415|7328226|FG002|Induction Treatment Phase|Withdrawal by Subject|0
4516784|NCT00961415|7328224|FG000|Induction Treatment Phase|Death|77
4516785|NCT00961415|7328225|FG001|Induction Treatment Phase|Death|0
4516786|NCT00961415|7328226|FG002|Induction Treatment Phase|Death|0
4516787|NCT00961415|7328224|FG000|Induction Treatment Phase|Protocol Violation|1
4516788|NCT00961415|7328225|FG001|Induction Treatment Phase|Protocol Violation|0
4516789|NCT00961415|7328226|FG002|Induction Treatment Phase|Protocol Violation|0
4516790|NCT00961415|7328224|FG000|Induction Treatment Phase|Physician Decision|2
4516791|NCT00961415|7328225|FG001|Induction Treatment Phase|Physician Decision|0
4516792|NCT00961415|7328226|FG002|Induction Treatment Phase|Physician Decision|0
4516793|NCT00961415|7328224|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27
4516794|NCT00961415|7328225|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0
4476280|NCT00689273|7272634|FG000|Overall Study|Adverse Event|3
4476281|NCT00689273|7272635|FG001|Overall Study|Adverse Event|1
4476282|NCT00689273|7272634|FG000|Overall Study|Lack of Efficacy|3
4476283|NCT00689273|7272635|FG001|Overall Study|Lack of Efficacy|0
4476284|NCT00689273|7272634|FG000|Overall Study|Lost to Follow-up|0
4476285|NCT00689273|7272635|FG001|Overall Study|Lost to Follow-up|2
4476286|NCT00689273|7272634|FG000|Overall Study|Other|6
4476287|NCT00689273|7272635|FG001|Overall Study|Other|2
4476288|NCT00689273|7272634|FG000|Overall Study|Randomized but not Treated|1
4589388|NCT01512979|7434824|FG000|Overall Study|Withdrawal by Subject|1
4589389|NCT01512979|7434825|FG001|Overall Study|Withdrawal by Subject|2
4589390|NCT01512979|7434824|FG000|Overall Study|Reason other than stated above|13
4589391|NCT01512979|7434825|FG001|Overall Study|Reason other than stated above|9
4476289|NCT00689273|7272635|FG001|Overall Study|Randomized but not Treated|0
4476290|NCT00689299|7272644|FG000|Overall Study|Adverse Event|2
4476291|NCT00689299|7272645|FG001|Overall Study|Adverse Event|1
4476292|NCT00689299|7272646|FG002|Overall Study|Adverse Event|1
4476293|NCT00689299|7272644|FG000|Overall Study|Lost to Follow-up|0
4476294|NCT00689299|7272645|FG001|Overall Study|Lost to Follow-up|1
4476295|NCT00689299|7272646|FG002|Overall Study|Lost to Follow-up|1
4476296|NCT00689299|7272644|FG000|Overall Study|Withdrawal by Subject|4
4476297|NCT00689299|7272645|FG001|Overall Study|Withdrawal by Subject|1
4476298|NCT00689299|7272646|FG002|Overall Study|Withdrawal by Subject|3
4476299|NCT00689299|7272644|FG000|Overall Study|Protocol Violation|1
4476300|NCT00689299|7272645|FG001|Overall Study|Protocol Violation|0
4476301|NCT00689299|7272646|FG002|Overall Study|Protocol Violation|0
4476302|NCT00689338|7272654|FG000|Overall Study|Death|65
4476303|NCT00689338|7272654|FG000|Overall Study|Adverse Event|13
4476304|NCT00689338|7272654|FG000|Overall Study|Insufficient Clinical Response|1
4476305|NCT00689338|7272654|FG000|Overall Study|Lack of Efficacy|6
4476306|NCT00689338|7272654|FG000|Overall Study|Other|8
4476307|NCT00689338|7272654|FG000|Overall Study|Did not Meet Entrance Criteria|27
4476308|NCT00689338|7272654|FG000|Overall Study|Lost to Follow-up|5
4476309|NCT00689338|7272654|FG000|Overall Study|Withdrawal by Subject|3
4476310|NCT00689338|7272654|FG000|Overall Study|Protocol Violation|15
4476311|NCT00689351|7272660|FG000|Infant Series of Dosing|Parent/legal guardian request|5
4476312|NCT00689351|7272661|FG001|Infant Series of Dosing|Parent/legal guardian request|0
4476313|NCT00689351|7272660|FG000|Infant Series of Dosing|Adverse Event|1
4476314|NCT00689351|7272661|FG001|Infant Series of Dosing|Adverse Event|0
4476315|NCT00689351|7272660|FG000|Infant Series of Dosing|Lost to Follow-up|0
4476316|NCT00689351|7272661|FG001|Infant Series of Dosing|Lost to Follow-up|1
4476317|NCT00689351|7272660|FG000|After Infant Series|Parent/legal guardian request|1
4476318|NCT00689351|7272661|FG001|After Infant Series|Parent/legal guardian request|0
4476319|NCT00689390|7272673|FG000|Overall Study|Adverse Event|19
4476320|NCT00689390|7272674|FG001|Overall Study|Adverse Event|0
4476321|NCT00689390|7272673|FG000|Overall Study|Lost to Follow-up|179
4476322|NCT00689390|7272674|FG001|Overall Study|Lost to Follow-up|7
4476323|NCT00689390|7272673|FG000|Overall Study|Withdrawal by Subject|117
4476324|NCT00689390|7272674|FG001|Overall Study|Withdrawal by Subject|3
4476325|NCT00689390|7272673|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52
4476326|NCT00689390|7272674|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0
4476327|NCT00689390|7272673|FG000|Overall Study|Non-Compliance With Protocol|21
4476328|NCT00689390|7272674|FG001|Overall Study|Non-Compliance With Protocol|0
4476329|NCT00689390|7272673|FG000|Overall Study|Did Not Meet Protocol Eligibility|1
4476330|NCT00689390|7272674|FG001|Overall Study|Did Not Meet Protocol Eligibility|0
4476331|NCT00689390|7272673|FG000|Overall Study|Administrative|37
4476332|NCT00689390|7272674|FG001|Overall Study|Administrative|0
4476333|NCT00689481|7272687|FG000|Overall Study|Adverse Event|7
4476334|NCT00689481|7272688|FG001|Overall Study|Adverse Event|1
4476335|NCT00689481|7272687|FG000|Overall Study|Lost to Follow-up|4
4476336|NCT00689481|7272688|FG001|Overall Study|Lost to Follow-up|3
4476337|NCT00689481|7272687|FG000|Overall Study|Lack of Efficacy|4
4476338|NCT00689481|7272688|FG001|Overall Study|Lack of Efficacy|3
4476339|NCT00689481|7272687|FG000|Overall Study|Non-compliance with study treatment|1
4476340|NCT00689481|7272688|FG001|Overall Study|Non-compliance with study treatment|1
4476341|NCT00689481|7272687|FG000|Overall Study|Withdrawal by Subject|8
4476342|NCT00689481|7272688|FG001|Overall Study|Withdrawal by Subject|4
4476343|NCT00689481|7272687|FG000|Overall Study|Excluded medication started during study|0
4476344|NCT00689481|7272688|FG001|Overall Study|Excluded medication started during study|1
4476345|NCT00689481|7272687|FG000|Overall Study|Subject early term, left on vacation|0
4476346|NCT00689481|7272688|FG001|Overall Study|Subject early term, left on vacation|1
4476347|NCT00689611|7272705|FG000|Overall Study|Death|6
4476348|NCT00689611|7272706|FG001|Overall Study|Death|9
4476349|NCT00689611|7272705|FG000|Overall Study|Withdrawal by Subject|8
4476350|NCT00689611|7272706|FG001|Overall Study|Withdrawal by Subject|9
4476351|NCT00689611|7272705|FG000|Overall Study|Lost to Follow-up|27
4476352|NCT00689611|7272706|FG001|Overall Study|Lost to Follow-up|28
4476353|NCT00689728|7272715|FG000|Double-Blind Treatment|Adverse Event|1
4476354|NCT00689728|7272716|FG001|Double-Blind Treatment|Adverse Event|0
4476355|NCT00689728|7272717|FG002|Double-Blind Treatment|Adverse Event|0
4476356|NCT00689728|7272715|FG000|Double-Blind Treatment|Protocol Violation|0
4476357|NCT00689728|7272716|FG001|Double-Blind Treatment|Protocol Violation|0
4476358|NCT00689728|7272717|FG002|Double-Blind Treatment|Protocol Violation|1
4476359|NCT00689728|7272715|FG000|Double-Blind Treatment|Withdrawal by Subject|3
4476360|NCT00689728|7272716|FG001|Double-Blind Treatment|Withdrawal by Subject|3
4476361|NCT00689728|7272717|FG002|Double-Blind Treatment|Withdrawal by Subject|2
4476362|NCT00689728|7272715|FG000|Double-Blind Treatment|Lack of Efficacy|0
4476363|NCT00689728|7272716|FG001|Double-Blind Treatment|Lack of Efficacy|1
4476364|NCT00689728|7272717|FG002|Double-Blind Treatment|Lack of Efficacy|2
4476365|NCT00689728|7272715|FG000|Rescue|Adverse Event|0
4476366|NCT00689728|7272716|FG001|Rescue|Adverse Event|1
4476367|NCT00689728|7272717|FG002|Rescue|Adverse Event|0
4476368|NCT00689728|7272715|FG000|Rescue|Withdrawal by Subject|1
4476369|NCT00689728|7272716|FG001|Rescue|Withdrawal by Subject|1
4476370|NCT00689728|7272717|FG002|Rescue|Withdrawal by Subject|1
4476371|NCT00689728|7272715|FG000|Optional Follow-Up|Adverse Event|1
4476372|NCT00689728|7272716|FG001|Optional Follow-Up|Adverse Event|0
4476373|NCT00689728|7272717|FG002|Optional Follow-Up|Adverse Event|0
4476374|NCT00689728|7272715|FG000|Optional Follow-Up|Lack of Efficacy|0
4476375|NCT00689728|7272716|FG001|Optional Follow-Up|Lack of Efficacy|1
4476376|NCT00689728|7272717|FG002|Optional Follow-Up|Lack of Efficacy|1
4476377|NCT00689728|7272715|FG000|Optional Follow-Up|Lost to Follow-up|0
4476378|NCT00689728|7272716|FG001|Optional Follow-Up|Lost to Follow-up|1
4476379|NCT00689728|7272717|FG002|Optional Follow-Up|Lost to Follow-up|1
4476380|NCT00689728|7272715|FG000|Optional Follow-Up|Protocol Violation|0
4476381|NCT00689728|7272716|FG001|Optional Follow-Up|Protocol Violation|0
4476382|NCT00689728|7272717|FG002|Optional Follow-Up|Protocol Violation|1
4476383|NCT00689728|7272715|FG000|Optional Follow-Up|Withdrawal by Subject|2
4476384|NCT00689728|7272716|FG001|Optional Follow-Up|Withdrawal by Subject|4
4476385|NCT00689728|7272717|FG002|Optional Follow-Up|Withdrawal by Subject|3
4476386|NCT00689793|7272748|FG000|Overall Study|Lost to Follow-up|4
4476387|NCT00689793|7272749|FG001|Overall Study|Lost to Follow-up|5
4476388|NCT00689871|7272770|FG000|Overall Study|Lost to Follow-up|123
4476389|NCT00689871|7272771|FG001|Overall Study|Lost to Follow-up|13
4476390|NCT00689871|7272772|FG002|Overall Study|Lost to Follow-up|37
4476391|NCT00689871|7272773|FG003|Overall Study|Lost to Follow-up|1
4476392|NCT00689871|7272770|FG000|Overall Study|Explanted of All Study Devices|36
4476393|NCT00689871|7272771|FG001|Overall Study|Explanted of All Study Devices|25
4476394|NCT00689871|7272772|FG002|Overall Study|Explanted of All Study Devices|29
4476395|NCT00689871|7272773|FG003|Overall Study|Explanted of All Study Devices|3
4476396|NCT00689871|7272770|FG000|Overall Study|Withdrawal by Subject|13
4476397|NCT00689871|7272771|FG001|Overall Study|Withdrawal by Subject|3
4699215|NCT02680756|7614541|FG000|Overall Study|Lost to Follow-up|7
4699216|NCT02680756|7614542|FG001|Overall Study|Lost to Follow-up|6
4699217|NCT02680756|7614541|FG000|Overall Study|Withdrawal by Subject|5
4699218|NCT02680756|7614542|FG001|Overall Study|Withdrawal by Subject|5
4699219|NCT02680756|7614541|FG000|Overall Study|Physician Decision|4
4699220|NCT02680756|7614542|FG001|Overall Study|Physician Decision|1
4699221|NCT02680756|7614541|FG000|Overall Study|Hb ≤7.5 g/dL|0
4476398|NCT00689871|7272772|FG002|Overall Study|Withdrawal by Subject|4
4476399|NCT00689871|7272773|FG003|Overall Study|Withdrawal by Subject|1
4476400|NCT00689871|7272770|FG000|Overall Study|Death|1
4476401|NCT00689871|7272771|FG001|Overall Study|Death|10
4476402|NCT00689871|7272772|FG002|Overall Study|Death|2
4476403|NCT00689871|7272773|FG003|Overall Study|Death|2
4476404|NCT00689871|7272770|FG000|Overall Study|Physician Decision|2
4476405|NCT00689871|7272771|FG001|Overall Study|Physician Decision|1
4476406|NCT00689871|7272772|FG002|Overall Study|Physician Decision|1
4476407|NCT00689871|7272773|FG003|Overall Study|Physician Decision|0
4476408|NCT00689936|7272786|FG000|Active Treatment Phase|Adverse Event|68
4476409|NCT00689936|7272787|FG001|Active Treatment Phase|Adverse Event|71
4476410|NCT00689936|7272788|FG002|Active Treatment Phase|Adverse Event|76
4476411|NCT00689936|7272786|FG000|Active Treatment Phase|Disease Progression|273
4476412|NCT00689936|7272787|FG001|Active Treatment Phase|Disease Progression|362
4476413|NCT00689936|7272788|FG002|Active Treatment Phase|Disease Progression|339
4476414|NCT00689936|7272786|FG000|Active Treatment Phase|Withdrawal by Subject|16
4476415|NCT00689936|7272787|FG001|Active Treatment Phase|Withdrawal by Subject|16
4476416|NCT00689936|7272788|FG002|Active Treatment Phase|Withdrawal by Subject|21
4476417|NCT00689936|7272786|FG000|Active Treatment Phase|Death|60
4476418|NCT00689936|7272787|FG001|Active Treatment Phase|Death|28
4476419|NCT00689936|7272788|FG002|Active Treatment Phase|Death|37
4476420|NCT00689936|7272786|FG000|Active Treatment Phase|Lost to Follow-up|0
4476421|NCT00689936|7272787|FG001|Active Treatment Phase|Lost to Follow-up|2
4476422|NCT00689936|7272788|FG002|Active Treatment Phase|Lost to Follow-up|2
4476423|NCT00689936|7272786|FG000|Active Treatment Phase|Protocol Violation|2
4699222|NCT02680756|7614542|FG001|Overall Study|Hb ≤7.5 g/dL|2
4699223|NCT02680756|7614541|FG000|Overall Study|Blood transfusion for any reason|0
4476424|NCT00689936|7272787|FG001|Active Treatment Phase|Protocol Violation|2
4476425|NCT00689936|7272788|FG002|Active Treatment Phase|Protocol Violation|4
4476426|NCT00689936|7272786|FG000|Active Treatment Phase|Study Close Out|64
4476427|NCT00689936|7272787|FG001|Active Treatment Phase|Study Close Out|26
4476428|NCT00689936|7272788|FG002|Active Treatment Phase|Study Close Out|21
4476429|NCT00689936|7272786|FG000|Active Treatment Phase|Miscellaneous|52
4476430|NCT00689936|7272787|FG001|Active Treatment Phase|Miscellaneous|34
4699224|NCT02680756|7614542|FG001|Overall Study|Blood transfusion for any reason|1
4476431|NCT00689936|7272788|FG002|Active Treatment Phase|Miscellaneous|47
4476432|NCT00689936|7272786|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127
4476433|NCT00689936|7272787|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188
4476434|NCT00689936|7272788|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144
4476435|NCT00690378|7272842|FG000|Overall Study|Adverse Event|1
4476436|NCT00690378|7272843|FG001|Overall Study|Adverse Event|0
4476437|NCT00690378|7272842|FG000|Overall Study|Withdrawal by Subject|2
4476438|NCT00690378|7272843|FG001|Overall Study|Withdrawal by Subject|0
4476439|NCT00690378|7272842|FG000|Overall Study|Protocol Violation|1
4476440|NCT00690378|7272843|FG001|Overall Study|Protocol Violation|0
4476441|NCT00690378|7272842|FG000|Overall Study|Lost to Follow-up|2
4476442|NCT00690378|7272843|FG001|Overall Study|Lost to Follow-up|3
4476443|NCT00690378|7272842|FG000|Overall Study|Did not meet inc/exc criteria|13
4476444|NCT00690378|7272843|FG001|Overall Study|Did not meet inc/exc criteria|11
4476445|NCT00690378|7272842|FG000|Overall Study|Social problem|1
4476446|NCT00690378|7272843|FG001|Overall Study|Social problem|0
4476447|NCT00690430|7272851|FG000|Core Phase|Abnormal Laboratory value|0
4476448|NCT00690430|7272852|FG001|Core Phase|Abnormal Laboratory value|1
4476449|NCT00690430|7272853|FG002|Core Phase|Abnormal Laboratory value|0
4476450|NCT00690430|7272851|FG000|Core Phase|Adverse Event|5
4476451|NCT00690430|7272852|FG001|Core Phase|Adverse Event|1
4476452|NCT00690430|7272853|FG002|Core Phase|Adverse Event|0
4476453|NCT00690430|7272851|FG000|Core Phase|Death|0
4476454|NCT00690430|7272852|FG001|Core Phase|Death|2
4476455|NCT00690430|7272853|FG002|Core Phase|Death|0
4476456|NCT00690430|7272851|FG000|Core Phase|Protocol Violation|1
4476457|NCT00690430|7272852|FG001|Core Phase|Protocol Violation|0
4476458|NCT00690430|7272853|FG002|Core Phase|Protocol Violation|0
4476459|NCT00690430|7272851|FG000|Core Phase|Withdrawal by Subject|3
4476460|NCT00690430|7272852|FG001|Core Phase|Withdrawal by Subject|3
4476461|NCT00690430|7272853|FG002|Core Phase|Withdrawal by Subject|0
4476462|NCT00690430|7272851|FG000|Core Phase|Subject no longer requires study drug|1
4476463|NCT00690430|7272852|FG001|Core Phase|Subject no longer requires study drug|0
4476464|NCT00690430|7272853|FG002|Core Phase|Subject no longer requires study drug|0
4476465|NCT00690430|7272851|FG000|Core Phase|Lack of Efficacy|8
4476466|NCT00690430|7272852|FG001|Core Phase|Lack of Efficacy|10
4476467|NCT00690430|7272853|FG002|Core Phase|Lack of Efficacy|0
4476468|NCT00690430|7272851|FG000|Core Phase|Administrative Problems|0
4476469|NCT00690430|7272852|FG001|Core Phase|Administrative Problems|1
4476470|NCT00690430|7272853|FG002|Core Phase|Administrative Problems|0
4476471|NCT00690430|7272851|FG000|Core Phase|Early Termination|0
4476472|NCT00690430|7272852|FG001|Core Phase|Early Termination|5
4476473|NCT00690430|7272853|FG002|Core Phase|Early Termination|0
4476474|NCT00690430|7272851|FG000|Extension Phase|Lack of Efficacy|3
4476475|NCT00690430|7272852|FG001|Extension Phase|Lack of Efficacy|1
4476476|NCT00690430|7272853|FG002|Extension Phase|Lack of Efficacy|4
4476477|NCT00690430|7272851|FG000|Extension Phase|Abnormal Lab Values|1
4476478|NCT00690430|7272852|FG001|Extension Phase|Abnormal Lab Values|0
4476479|NCT00690430|7272853|FG002|Extension Phase|Abnormal Lab Values|0
4476480|NCT00690430|7272851|FG000|Extension Phase|Abnormal test procedure results|1
4476481|NCT00690430|7272852|FG001|Extension Phase|Abnormal test procedure results|0
4476482|NCT00690430|7272853|FG002|Extension Phase|Abnormal test procedure results|0
4476483|NCT00690430|7272851|FG000|Extension Phase|Administrative Problems|0
4476484|NCT00690430|7272852|FG001|Extension Phase|Administrative Problems|1
4476485|NCT00690430|7272853|FG002|Extension Phase|Administrative Problems|1
4476486|NCT00690430|7272851|FG000|Extension Phase|Adverse Event|2
4476487|NCT00690430|7272852|FG001|Extension Phase|Adverse Event|1
4476488|NCT00690430|7272853|FG002|Extension Phase|Adverse Event|2
4476489|NCT00690430|7272851|FG000|Extension Phase|Death|1
4476490|NCT00690430|7272852|FG001|Extension Phase|Death|1
4589392|NCT01513148|7434842|FG000|Overall Study|Protocol Violation|2
4476491|NCT00690430|7272853|FG002|Extension Phase|Death|1
4476492|NCT00690430|7272851|FG000|Extension Phase|Withdrawal by Subject|0
4476493|NCT00690430|7272852|FG001|Extension Phase|Withdrawal by Subject|0
4476494|NCT00690430|7272853|FG002|Extension Phase|Withdrawal by Subject|2
4476495|NCT00690430|7272851|FG000|Extension Phase|Early Termination|10
4476496|NCT00690430|7272852|FG001|Extension Phase|Early Termination|1
4476497|NCT00690430|7272853|FG002|Extension Phase|Early Termination|3
4476498|NCT00690443|7272864|FG000|Overall Study|Adverse Event|1
4476499|NCT00690443|7272865|FG001|Overall Study|Adverse Event|2
4476500|NCT00690482|7272873|FG000|Overall Study|Adverse Event|2
4476501|NCT00690482|7272874|FG001|Overall Study|Adverse Event|1
4476502|NCT00690482|7272873|FG000|Overall Study|Incorrect enrolment|0
4476503|NCT00690482|7272874|FG001|Overall Study|Incorrect enrolment|1
4476504|NCT00690482|7272873|FG000|Overall Study|Study-specific discontinuation criteria|1
4476505|NCT00690482|7272874|FG001|Overall Study|Study-specific discontinuation criteria|0
4476506|NCT00690482|7272873|FG000|Overall Study|Intake of prohibited medicine|1
4476507|NCT00690482|7272874|FG001|Overall Study|Intake of prohibited medicine|0
4476508|NCT00690482|7272873|FG000|Overall Study|withdrew consent at rand.day|0
4476509|NCT00690482|7272874|FG001|Overall Study|withdrew consent at rand.day|1
4476510|NCT00690573|7272889|FG000|Overall Study|Lack of Efficacy|8
4476511|NCT00690573|7272889|FG000|Overall Study|Withdrawal by Subject|1
4476512|NCT00690612|7272893|FG000|Overall Study|Adverse Event|1
4476513|NCT00690612|7272893|FG000|Overall Study|Withdrawal by Subject|2
4476514|NCT00690755|7272904|FG000|Overall Study|Physician Decision|2
4476515|NCT00690755|7272905|FG001|Overall Study|Physician Decision|0
4476516|NCT00690755|7272906|FG002|Overall Study|Physician Decision|46
4476517|NCT00690755|7272907|FG003|Overall Study|Physician Decision|5
4476518|NCT00690755|7272908|FG004|Overall Study|Physician Decision|0
4476519|NCT00690755|7272909|FG005|Overall Study|Physician Decision|4
4476520|NCT00690755|7272910|FG006|Overall Study|Physician Decision|0
4476521|NCT00690794|7272928|FG000|Overall Study|Adverse Event|12
4476522|NCT00690794|7272929|FG001|Overall Study|Adverse Event|10
4476523|NCT00690794|7272928|FG000|Overall Study|Lost to Follow-up|1
4476524|NCT00690794|7272929|FG001|Overall Study|Lost to Follow-up|4
4476525|NCT00690794|7272928|FG000|Overall Study|Withdrawal by Subject|0
4476526|NCT00690794|7272929|FG001|Overall Study|Withdrawal by Subject|9
4476527|NCT00690794|7272928|FG000|Overall Study|Protocol Violation|6
4476528|NCT00690794|7272929|FG001|Overall Study|Protocol Violation|7
4476529|NCT00690794|7272928|FG000|Overall Study|Noncompliance|1
4476530|NCT00690794|7272929|FG001|Overall Study|Noncompliance|2
4476531|NCT00690794|7272928|FG000|Overall Study|Other not specified|1
4476532|NCT00690794|7272929|FG001|Overall Study|Other not specified|3
4476533|NCT00690820|7272937|FG000|Period 1|Withdrawal by Subject|0
4476534|NCT00690820|7272938|FG001|Period 1|Withdrawal by Subject|1
4476535|NCT00690898|7272948|FG000|SCREENING|Screen failure|18
4476536|NCT00690898|7272948|FG000|TREATMENT|Adverse Event|3
4476537|NCT00690898|7272948|FG000|TREATMENT|Lack of Efficacy|18
4476538|NCT00690898|7272948|FG000|TREATMENT|Withdrawal by Subject|4
4476539|NCT00690898|7272948|FG000|TREATMENT|Other (not otherwise specified)|1
4476540|NCT00691015|7272975|FG000|Overall Study|Refused further treatment|1
4476541|NCT00691028|7272982|FG000|Open-label Period|Adverse Event|0
4476542|NCT00691028|7272983|FG001|Open-label Period|Adverse Event|0
4476543|NCT00691028|7272984|FG002|Open-label Period|Adverse Event|0
4476544|NCT00691028|7272985|FG003|Open-label Period|Adverse Event|16
4476545|NCT00691028|7272982|FG000|Open-label Period|Withdrawal by Subject|0
4476546|NCT00691028|7272983|FG001|Open-label Period|Withdrawal by Subject|0
4476547|NCT00691028|7272984|FG002|Open-label Period|Withdrawal by Subject|0
4476548|NCT00691028|7272985|FG003|Open-label Period|Withdrawal by Subject|3
4589393|NCT01513148|7434843|FG001|Overall Study|Protocol Violation|2
4589394|NCT01513239|7434892|FG000|Period 1: Main Phase|Adverse Event|1
4589395|NCT01513239|7434893|FG001|Period 1: Main Phase|Adverse Event|1
4589396|NCT01513239|7434894|FG002|Period 1: Main Phase|Adverse Event|2
4589397|NCT01513239|7434895|FG003|Period 1: Main Phase|Adverse Event|0
4589398|NCT01513239|7434896|FG004|Period 1: Main Phase|Adverse Event|0
4476549|NCT00691028|7272982|FG000|Open-label Period|not come to a hospital|0
4476550|NCT00691028|7272983|FG001|Open-label Period|not come to a hospital|0
4476551|NCT00691028|7272984|FG002|Open-label Period|not come to a hospital|0
4476552|NCT00691028|7272985|FG003|Open-label Period|not come to a hospital|1
4476553|NCT00691028|7272982|FG000|Double-blind Period|Adverse Event|8
4476554|NCT00691028|7272983|FG001|Double-blind Period|Adverse Event|9
4476555|NCT00691028|7272984|FG002|Double-blind Period|Adverse Event|6
4476556|NCT00691028|7272985|FG003|Double-blind Period|Adverse Event|0
4476557|NCT00691028|7272982|FG000|Double-blind Period|Lack of Efficacy|4
4476558|NCT00691028|7272983|FG001|Double-blind Period|Lack of Efficacy|3
4476559|NCT00691028|7272984|FG002|Double-blind Period|Lack of Efficacy|2
4476560|NCT00691028|7272985|FG003|Double-blind Period|Lack of Efficacy|0
4476561|NCT00691028|7272982|FG000|Double-blind Period|Withdrawal by Subject|1
4476562|NCT00691028|7272983|FG001|Double-blind Period|Withdrawal by Subject|0
4476563|NCT00691028|7272984|FG002|Double-blind Period|Withdrawal by Subject|1
4476564|NCT00691028|7272985|FG003|Double-blind Period|Withdrawal by Subject|0
4476565|NCT00691028|7272982|FG000|Double-blind Period|not come to a hospital.|0
4476566|NCT00691028|7272983|FG001|Double-blind Period|not come to a hospital.|1
4476567|NCT00691028|7272984|FG002|Double-blind Period|not come to a hospital.|0
4476568|NCT00691028|7272985|FG003|Double-blind Period|not come to a hospital.|0
4476569|NCT00691054|7272997|FG000|Overall Study|Withdrawal by Subject|1
4476570|NCT00691093|7273003|FG000|Overall Study|Adverse Event|1
4476571|NCT00691093|7273003|FG000|Overall Study|Lost to Follow-up|1
4476572|NCT00691093|7273003|FG000|Overall Study|Lack of Efficacy|1
4476573|NCT00691093|7273003|FG000|Overall Study|Ongoing at Date of Cut-Off|4
4476574|NCT00691132|7273014|FG000|Overall Study|Adverse Event|2
4476575|NCT00691132|7273015|FG001|Overall Study|Adverse Event|3
4476576|NCT00691132|7273014|FG000|Overall Study|Withdrawal by Subject|10
4476577|NCT00691132|7273015|FG001|Overall Study|Withdrawal by Subject|10
4476578|NCT00691210|7273048|FG000|Overall Study|Progression of Disease|0
4476579|NCT00691210|7273049|FG001|Overall Study|Progression of Disease|0
4476580|NCT00691210|7273050|FG002|Overall Study|Progression of Disease|0
4476581|NCT00691210|7273051|FG003|Overall Study|Progression of Disease|2
4476582|NCT00691210|7273052|FG004|Overall Study|Progression of Disease|0
4476583|NCT00691210|7273053|FG005|Overall Study|Progression of Disease|0
4476584|NCT00691210|7273054|FG006|Overall Study|Progression of Disease|0
4476585|NCT00691210|7273055|FG007|Overall Study|Progression of Disease|0
4476586|NCT00691210|7273048|FG000|Overall Study|Lack of Efficacy|0
4476587|NCT00691210|7273049|FG001|Overall Study|Lack of Efficacy|0
4476588|NCT00691210|7273050|FG002|Overall Study|Lack of Efficacy|0
4476589|NCT00691210|7273051|FG003|Overall Study|Lack of Efficacy|1
4476590|NCT00691210|7273052|FG004|Overall Study|Lack of Efficacy|0
4476591|NCT00691210|7273053|FG005|Overall Study|Lack of Efficacy|1
4476592|NCT00691210|7273054|FG006|Overall Study|Lack of Efficacy|0
4476593|NCT00691210|7273055|FG007|Overall Study|Lack of Efficacy|0
4476594|NCT00691301|7273073|FG000|Overall Study|Adverse Event|10
4476595|NCT00691301|7273073|FG000|Overall Study|Death|2
4476596|NCT00691301|7273073|FG000|Overall Study|Lack of Efficacy|32
4476597|NCT00691301|7273073|FG000|Overall Study|Withdrawal by Subject|4
4476598|NCT00691301|7273073|FG000|Overall Study|Concurrent illness|2
4476599|NCT00691301|7273073|FG000|Overall Study|other reason|3
4476600|NCT00691301|7273073|FG000|Overall Study|Did not initiate study treatment|1
4476601|NCT00691483|7273094|FG000|Overall Study|Adverse Event|14
4476602|NCT00691483|7273095|FG001|Overall Study|Adverse Event|6
4476603|NCT00691483|7273094|FG000|Overall Study|Lost to Follow-up|17
4476604|NCT00691483|7273095|FG001|Overall Study|Lost to Follow-up|10
4476605|NCT00691483|7273094|FG000|Overall Study|Withdrawal by Subject|24
4476606|NCT00691483|7273095|FG001|Overall Study|Withdrawal by Subject|7
4476607|NCT00691483|7273094|FG000|Overall Study|Other known cause|6
4476608|NCT00691483|7273095|FG001|Overall Study|Other known cause|1
4476609|NCT00691483|7273094|FG000|Overall Study|Randomized by not treated|7
4476610|NCT00691483|7273095|FG001|Overall Study|Randomized by not treated|1
4476611|NCT00691704|7273119|FG000|Induction Therapy|Disease Progression|1
4476612|NCT00691704|7273119|FG000|Induction Therapy|Active Hepatitis|1
4476613|NCT00691704|7273119|FG000|Two Years of Maintenance Therapy|Disease Progression|8
4476614|NCT00691704|7273119|FG000|Two Years of Maintenance Therapy|Physician Decision|4
4476615|NCT00691704|7273119|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1
4476616|NCT00691938|7273143|FG000|Overall Study|QTc prolongation|1
4476617|NCT00691938|7273144|FG001|Overall Study|QTc prolongation|0
4476618|NCT00691938|7273145|FG002|Overall Study|QTc prolongation|0
4476619|NCT00691938|7273146|FG003|Overall Study|QTc prolongation|0
4476620|NCT00691938|7273147|FG004|Overall Study|QTc prolongation|0
4476621|NCT00691938|7273148|FG005|Overall Study|QTc prolongation|0
4476622|NCT00691938|7273149|FG006|Overall Study|QTc prolongation|0
4476623|NCT00692237|7273192|FG000|Overall Study|Withdrawal by Subject|1
4476624|NCT00692237|7273193|FG001|Overall Study|Withdrawal by Subject|3
4476625|NCT00692237|7273192|FG000|Overall Study|Adverse Event|0
4476626|NCT00692237|7273193|FG001|Overall Study|Adverse Event|1
4476627|NCT00692406|7273221|FG000|Overall Study|PI dropped, bad data|57
4476628|NCT00692770|7273247|FG000|Overall Study|Protocol Violation|2
4476629|NCT00692770|7273248|FG001|Overall Study|Protocol Violation|7
4476630|NCT00692770|7273247|FG000|Overall Study|Withdrawal by Subject|97
4476631|NCT00692770|7273248|FG001|Overall Study|Withdrawal by Subject|36
4476632|NCT00692770|7273247|FG000|Overall Study|Adverse Event|136
4476633|NCT00692770|7273248|FG001|Overall Study|Adverse Event|41
4476634|NCT00692770|7273247|FG000|Overall Study|Death|10
4476635|NCT00692770|7273248|FG001|Overall Study|Death|5
4476636|NCT00692770|7273247|FG000|Overall Study|Lost to Follow-up|7
4476637|NCT00692770|7273248|FG001|Overall Study|Lost to Follow-up|3
4476638|NCT00692770|7273247|FG000|Overall Study|Non-compliant with study medication|11
4476639|NCT00692770|7273248|FG001|Overall Study|Non-compliant with study medication|5
4476640|NCT00692770|7273247|FG000|Overall Study|Progression by clinical judgment|2
4476641|NCT00692770|7273248|FG001|Overall Study|Progression by clinical judgment|3
4476642|NCT00692770|7273247|FG000|Overall Study|Physician decision not protocol driven|10
4476643|NCT00692770|7273248|FG001|Overall Study|Physician decision not protocol driven|14
4476644|NCT00692770|7273247|FG000|Overall Study|Disease progression, recurrence/relapse|170
4476645|NCT00692770|7273248|FG001|Overall Study|Disease progression, recurrence/relapse|279
4476646|NCT00692770|7273247|FG000|Overall Study|Protocol driven decision point|3
4476647|NCT00692770|7273248|FG001|Overall Study|Protocol driven decision point|7
4476648|NCT00692770|7273247|FG000|Overall Study|Completed all planned assessments|79
4476649|NCT00692770|7273248|FG001|Overall Study|Completed all planned assessments|101
4476650|NCT00692770|7273247|FG000|Overall Study|Radiological and clinical progression|8
4476651|NCT00692770|7273248|FG001|Overall Study|Radiological and clinical progression|8
4476652|NCT00692770|7273247|FG000|Overall Study|Clinical endpoint reached|16
4476653|NCT00692770|7273248|FG001|Overall Study|Clinical endpoint reached|43
4476654|NCT00692770|7273247|FG000|Overall Study|Study terminated by sponsor|2
4476655|NCT00692770|7273248|FG001|Overall Study|Study terminated by sponsor|2
4476656|NCT00692770|7273247|FG000|Overall Study|Randomized but not treated|3
4476657|NCT00692770|7273248|FG001|Overall Study|Randomized but not treated|4
4476658|NCT00693225|7273292|FG000|Overall Study|Lost to Follow-up|1
4476659|NCT00693225|7273293|FG001|Overall Study|Lost to Follow-up|2
4476660|NCT00693225|7273292|FG000|Overall Study|Adverse Event|1
4476661|NCT00693225|7273293|FG001|Overall Study|Adverse Event|3
4476662|NCT00693420|7273305|FG000|Overall Study|Adverse Event|4
4476663|NCT00693420|7273306|FG001|Overall Study|Adverse Event|4
4476664|NCT00693420|7273305|FG000|Overall Study|Lost to Follow-up|0
4476665|NCT00693420|7273306|FG001|Overall Study|Lost to Follow-up|3
4476666|NCT00693420|7273305|FG000|Overall Study|Withdrawal by Subject|1
4476667|NCT00693420|7273306|FG001|Overall Study|Withdrawal by Subject|0
4476668|NCT00693420|7273305|FG000|Overall Study|Protocol Violation|0
4476669|NCT00693420|7273306|FG001|Overall Study|Protocol Violation|2
4476670|NCT00693420|7273305|FG000|Overall Study|Sponsor Request - Conflict of Interest|0
4476671|NCT00693420|7273306|FG001|Overall Study|Sponsor Request - Conflict of Interest|2
4476672|NCT00693420|7273305|FG000|Overall Study|Personal Reasons|1
4476673|NCT00693420|7273306|FG001|Overall Study|Personal Reasons|4
4699225|NCT02680756|7614541|FG000|Overall Study|Death|1
4699226|NCT02680756|7614542|FG001|Overall Study|Death|0
4699227|NCT02680756|7614541|FG000|Overall Study|Protocol Violation|1
4699228|NCT02680756|7614542|FG001|Overall Study|Protocol Violation|0
4699229|NCT02680756|7614541|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1
4699230|NCT02680756|7614542|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0
4699231|NCT02680756|7614541|FG000|Overall Study|None of above or not recorded|3
4699232|NCT02680756|7614542|FG001|Overall Study|None of above or not recorded|2
4699233|NCT02680834|7614550|FG000|Overall Study|Physician Decision|5
4476674|NCT00693472|7273316|FG000|Part 1|Adverse Event|1
4476675|NCT00693472|7273317|FG001|Part 1|Adverse Event|1
4476676|NCT00693472|7273318|FG002|Part 1|Adverse Event|0
4476677|NCT00693472|7273319|FG003|Part 1|Adverse Event|0
4476678|NCT00693472|7273316|FG000|Part 1|Lost to Follow-up|0
4476679|NCT00693472|7273317|FG001|Part 1|Lost to Follow-up|1
4476680|NCT00693472|7273318|FG002|Part 1|Lost to Follow-up|0
4476681|NCT00693472|7273319|FG003|Part 1|Lost to Follow-up|0
4476682|NCT00693472|7273316|FG000|Part 1|Withdrew - reason unrelated to treatment|5
4476683|NCT00693472|7273317|FG001|Part 1|Withdrew - reason unrelated to treatment|2
4476684|NCT00693472|7273318|FG002|Part 1|Withdrew - reason unrelated to treatment|0
4476685|NCT00693472|7273319|FG003|Part 1|Withdrew - reason unrelated to treatment|0
4476686|NCT00693472|7273316|FG000|Part 2|Adverse Event|0
4476687|NCT00693472|7273317|FG001|Part 2|Adverse Event|0
4476688|NCT00693472|7273318|FG002|Part 2|Adverse Event|1
4589399|NCT01513239|7434897|FG005|Period 1: Main Phase|Adverse Event|0
4589400|NCT01513239|7434892|FG000|Period 1: Main Phase|Death|29
4589401|NCT01513239|7434893|FG001|Period 1: Main Phase|Death|22
4589402|NCT01513239|7434894|FG002|Period 1: Main Phase|Death|32
4589403|NCT01513239|7434895|FG003|Period 1: Main Phase|Death|0
4589404|NCT01513239|7434896|FG004|Period 1: Main Phase|Death|0
4589405|NCT01513239|7434897|FG005|Period 1: Main Phase|Death|0
4589406|NCT01513239|7434892|FG000|Period 1: Main Phase|Lost to Follow-up|11
4589407|NCT01513239|7434893|FG001|Period 1: Main Phase|Lost to Follow-up|10
4589408|NCT01513239|7434894|FG002|Period 1: Main Phase|Lost to Follow-up|6
4589409|NCT01513239|7434895|FG003|Period 1: Main Phase|Lost to Follow-up|0
4589410|NCT01513239|7434896|FG004|Period 1: Main Phase|Lost to Follow-up|0
4589411|NCT01513239|7434897|FG005|Period 1: Main Phase|Lost to Follow-up|0
4589412|NCT01513239|7434892|FG000|Period 1: Main Phase|Physician Decision|4
4589413|NCT01513239|7434893|FG001|Period 1: Main Phase|Physician Decision|4
4589414|NCT01513239|7434894|FG002|Period 1: Main Phase|Physician Decision|4
4589415|NCT01513239|7434895|FG003|Period 1: Main Phase|Physician Decision|0
4589416|NCT01513239|7434896|FG004|Period 1: Main Phase|Physician Decision|0
4476689|NCT00693472|7273319|FG003|Part 2|Adverse Event|0
4476690|NCT00693472|7273316|FG000|Part 2|Withdrew - reason unrelated to treatment|0
4476691|NCT00693472|7273317|FG001|Part 2|Withdrew - reason unrelated to treatment|0
4476692|NCT00693472|7273318|FG002|Part 2|Withdrew - reason unrelated to treatment|1
4476693|NCT00693472|7273319|FG003|Part 2|Withdrew - reason unrelated to treatment|2
4476694|NCT00693693|7273364|FG000|Overall Study|Lost to Follow-up|1
4476695|NCT00693693|7273365|FG001|Overall Study|Lost to Follow-up|1
4476696|NCT00693693|7273366|FG002|Overall Study|Lost to Follow-up|2
4476697|NCT00693706|7273376|FG000|Overall Study|Protocol Violation|0
4476698|NCT00693706|7273377|FG001|Overall Study|Protocol Violation|1
4476699|NCT00693784|7273387|FG000|Overall Study|Lost to Follow-up|2
4476700|NCT00693784|7273387|FG000|Overall Study|Withdrawal by Subject|2
4476701|NCT00694096|7273413|FG000|Overall Study|Withdrawal by Subject|5
4476702|NCT00694109|7273417|FG000|Overall Study|Physician Decision|3
4476703|NCT00694109|7273417|FG000|Overall Study|Adverse Event|74
4476704|NCT00694109|7273417|FG000|Overall Study|Not consent of more 2 years of treatment|18
4476705|NCT00694109|7273417|FG000|Overall Study|Lack of Efficacy|2
4476706|NCT00694109|7273417|FG000|Overall Study|Withdrawal by Subject|13
4476707|NCT00694109|7273417|FG000|Overall Study|Pregnancy|1
4476708|NCT00694109|7273417|FG000|Overall Study|Enrolled but not treated|1
4476709|NCT00694109|7273417|FG000|Overall Study|Other|2
4476710|NCT00694109|7273417|FG000|Overall Study|Consented but no additional treatment|3
4476711|NCT00694122|7273422|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7
4476712|NCT00694122|7273423|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0
4476713|NCT00694122|7273422|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1
4476714|NCT00694122|7273423|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1
4476715|NCT00694122|7273422|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2
4476716|NCT00694122|7273423|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1
4476717|NCT00694161|7273434|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1
4476718|NCT00694161|7273434|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1
4476719|NCT00694161|7273434|FG000|Part 2 (After Week 6 up to Month 12)|Death|1
4476720|NCT00694304|7273438|FG000|Overall Study|Adverse Event|42
4589417|NCT01513239|7434897|FG005|Period 1: Main Phase|Physician Decision|0
4589418|NCT01513239|7434892|FG000|Period 1: Main Phase|Protocol Violation|2
4699234|NCT02680834|7614551|FG001|Overall Study|Physician Decision|2
4699235|NCT02680834|7614550|FG000|Overall Study|Withdrawal by Subject|6
4476721|NCT00694304|7273438|FG000|Overall Study|Lack of Efficacy|35
4476722|NCT00694304|7273438|FG000|Overall Study|Non-compliance With Study Product|16
4476723|NCT00694304|7273438|FG000|Overall Study|Protocol Violation|6
4476724|NCT00694304|7273438|FG000|Overall Study|Withdrawal of Consent|61
4476725|NCT00694304|7273438|FG000|Overall Study|Lost to Follow-up|15
4476726|NCT00694304|7273438|FG000|Overall Study|Administrative or Other Reasons|32
4476727|NCT00694356|7273445|FG000|Overall Study|Adverse Event|1
4476728|NCT00694356|7273446|FG001|Overall Study|Adverse Event|0
4476729|NCT00694356|7273447|FG002|Overall Study|Adverse Event|0
4476730|NCT00694356|7273445|FG000|Overall Study|Progressive Disease|2
4476731|NCT00694356|7273446|FG001|Overall Study|Progressive Disease|6
4476732|NCT00694356|7273447|FG002|Overall Study|Progressive Disease|6
4476733|NCT00694551|7273462|FG000|Overall Study|Disease Progression|1
4476734|NCT00694551|7273463|FG001|Overall Study|Disease Progression|0
4476735|NCT00694551|7273464|FG002|Overall Study|Disease Progression|1
4476736|NCT00694707|7273486|FG000|Overall Study|Did Not Receive Treatment|0
4476737|NCT00694707|7273487|FG001|Overall Study|Did Not Receive Treatment|0
4476738|NCT00694707|7273488|FG002|Overall Study|Did Not Receive Treatment|1
4476739|NCT00694707|7273489|FG003|Overall Study|Did Not Receive Treatment|1
4476740|NCT00694707|7273490|FG004|Overall Study|Did Not Receive Treatment|1
4476741|NCT00694707|7273486|FG000|Overall Study|Adverse Event|22
4476742|NCT00694707|7273487|FG001|Overall Study|Adverse Event|14
4476743|NCT00694707|7273488|FG002|Overall Study|Adverse Event|8
4476744|NCT00694707|7273489|FG003|Overall Study|Adverse Event|12
4476745|NCT00694707|7273490|FG004|Overall Study|Adverse Event|13
4476746|NCT00694707|7273486|FG000|Overall Study|Insufficient Therapeutic Response|33
4476747|NCT00694707|7273487|FG001|Overall Study|Insufficient Therapeutic Response|18
4476748|NCT00694707|7273488|FG002|Overall Study|Insufficient Therapeutic Response|17
4476749|NCT00694707|7273489|FG003|Overall Study|Insufficient Therapeutic Response|15
4476750|NCT00694707|7273490|FG004|Overall Study|Insufficient Therapeutic Response|10
4476751|NCT00694707|7273486|FG000|Overall Study|Protocol Violation|1
4476752|NCT00694707|7273487|FG001|Overall Study|Protocol Violation|2
4476753|NCT00694707|7273488|FG002|Overall Study|Protocol Violation|1
4476754|NCT00694707|7273489|FG003|Overall Study|Protocol Violation|3
4476755|NCT00694707|7273490|FG004|Overall Study|Protocol Violation|1
4476756|NCT00694707|7273486|FG000|Overall Study|Withdrawal of Consent|14
4476757|NCT00694707|7273487|FG001|Overall Study|Withdrawal of Consent|18
4476758|NCT00694707|7273488|FG002|Overall Study|Withdrawal of Consent|22
4476759|NCT00694707|7273489|FG003|Overall Study|Withdrawal of Consent|16
4476760|NCT00694707|7273490|FG004|Overall Study|Withdrawal of Consent|15
4476761|NCT00694707|7273486|FG000|Overall Study|Lost to Follow-up|0
4476762|NCT00694707|7273487|FG001|Overall Study|Lost to Follow-up|1
4476763|NCT00694707|7273488|FG002|Overall Study|Lost to Follow-up|2
4476764|NCT00694707|7273489|FG003|Overall Study|Lost to Follow-up|0
4476765|NCT00694707|7273490|FG004|Overall Study|Lost to Follow-up|0
4476766|NCT00694707|7273486|FG000|Overall Study|Jeopardizing Parole Status|1
4476767|NCT00694707|7273487|FG001|Overall Study|Jeopardizing Parole Status|0
4476768|NCT00694707|7273488|FG002|Overall Study|Jeopardizing Parole Status|0
4476769|NCT00694707|7273489|FG003|Overall Study|Jeopardizing Parole Status|0
4476770|NCT00694707|7273490|FG004|Overall Study|Jeopardizing Parole Status|0
4476771|NCT00694707|7273486|FG000|Overall Study|Death in the Family|1
4476772|NCT00694707|7273487|FG001|Overall Study|Death in the Family|0
4476773|NCT00694707|7273488|FG002|Overall Study|Death in the Family|0
4476774|NCT00694707|7273489|FG003|Overall Study|Death in the Family|0
4476775|NCT00694707|7273490|FG004|Overall Study|Death in the Family|0
4476776|NCT00694707|7273486|FG000|Overall Study|Arrest by Police|0
4476777|NCT00694707|7273487|FG001|Overall Study|Arrest by Police|1
4476778|NCT00694707|7273488|FG002|Overall Study|Arrest by Police|0
4476779|NCT00694707|7273489|FG003|Overall Study|Arrest by Police|0
4476780|NCT00694707|7273490|FG004|Overall Study|Arrest by Police|0
4476781|NCT00694707|7273486|FG000|Overall Study|Administrative Reasons|0
4476782|NCT00694707|7273487|FG001|Overall Study|Administrative Reasons|1
4476783|NCT00694707|7273488|FG002|Overall Study|Administrative Reasons|0
4476784|NCT00694707|7273489|FG003|Overall Study|Administrative Reasons|2
4476785|NCT00694707|7273490|FG004|Overall Study|Administrative Reasons|0
4476786|NCT00694707|7273486|FG000|Overall Study|Notification of Past Head Injury|0
4476787|NCT00694707|7273487|FG001|Overall Study|Notification of Past Head Injury|0
4476788|NCT00694707|7273488|FG002|Overall Study|Notification of Past Head Injury|0
4476789|NCT00694707|7273489|FG003|Overall Study|Notification of Past Head Injury|1
4476790|NCT00694707|7273490|FG004|Overall Study|Notification of Past Head Injury|0
4476791|NCT00695019|7273505|FG000|Overall Study|Withdrawal by Subject|8
4476792|NCT00695019|7273506|FG001|Overall Study|Withdrawal by Subject|6
4476793|NCT00695019|7273507|FG002|Overall Study|Withdrawal by Subject|4
4476794|NCT00695019|7273505|FG000|Overall Study|Protocol Violation|1
4476795|NCT00695019|7273506|FG001|Overall Study|Protocol Violation|3
4476796|NCT00695019|7273507|FG002|Overall Study|Protocol Violation|1
4476797|NCT00695019|7273505|FG000|Overall Study|Lack of Efficacy|0
4476798|NCT00695019|7273506|FG001|Overall Study|Lack of Efficacy|0
4476799|NCT00695019|7273507|FG002|Overall Study|Lack of Efficacy|1
4476800|NCT00695019|7273505|FG000|Overall Study|Various|4
4476801|NCT00695019|7273506|FG001|Overall Study|Various|5
4476802|NCT00695019|7273507|FG002|Overall Study|Various|4
4476803|NCT00695110|7273524|FG000|Treatment Period 1|Adverse Event|1
4476804|NCT00695110|7273524|FG000|Treatment Period 1|Withdrawal by Subject|2
4476805|NCT00695110|7273524|FG000|Treatment Period 3|Withdrawal by Subject|1
4476806|NCT00695110|7273524|FG000|Treatment Period 4|Adverse Event|1
4476807|NCT00695136|7273531|FG000|Overall Study|Withdrawal by Subject|1
4476808|NCT00695136|7273531|FG000|Overall Study|unrelated adverse event|1
4386595|NCT00038103|7165133|FG001|Overall Study|Lost to Follow-up|3
4386596|NCT00038103|7165132|FG000|Overall Study|Protocol Violation|0
4386597|NCT00038103|7165133|FG001|Overall Study|Protocol Violation|2
4386598|NCT00038103|7165132|FG000|Overall Study|Sponsor Decision|0
4386599|NCT00038103|7165133|FG001|Overall Study|Sponsor Decision|1
4386600|NCT00038103|7165132|FG000|Overall Study|Randomized/never treated|2
4386601|NCT00038103|7165133|FG001|Overall Study|Randomized/never treated|0
4386602|NCT00038467|7165141|FG000|Overall Study|Adverse Event|170
4386603|NCT00038467|7165142|FG001|Overall Study|Adverse Event|145
4386604|NCT00038467|7165141|FG000|Overall Study|Withdrawal by Subject|150
4386605|NCT00038467|7165142|FG001|Overall Study|Withdrawal by Subject|107
4386606|NCT00038467|7165141|FG000|Overall Study|Protocol Violation|19
4386607|NCT00038467|7165142|FG001|Overall Study|Protocol Violation|22
4386608|NCT00038467|7165141|FG000|Overall Study|Death|22
4386609|NCT00038467|7165142|FG001|Overall Study|Death|16
4386610|NCT00038467|7165141|FG000|Overall Study|Lost to Follow-up|15
4386611|NCT00038467|7165142|FG001|Overall Study|Lost to Follow-up|10
4386612|NCT00038467|7165141|FG000|Overall Study|Recurrence|109
4386613|NCT00038467|7165142|FG001|Overall Study|Recurrence|179
4386614|NCT00038467|7165141|FG000|Overall Study|Randomized, but not treated|31
4386615|NCT00038467|7165142|FG001|Overall Study|Randomized, but not treated|35
4386616|NCT00038467|7165141|FG000|Overall Study|Other|26
4386617|NCT00038467|7165142|FG001|Overall Study|Other|28
4386618|NCT00038649|7165152|FG000|Overall Study|Adverse Event|9
4386619|NCT00038948|7165162|FG000|Overall Study|Adverse Event|131
4386620|NCT00038948|7165163|FG001|Overall Study|Adverse Event|43
4476809|NCT00695318|7273555|FG000|Overall Study|Lost to Follow-up|1
4476810|NCT00695318|7273556|FG001|Overall Study|Lost to Follow-up|0
4476811|NCT00695318|7273555|FG000|Overall Study|Withdrawal by Subject|2
4476812|NCT00695318|7273556|FG001|Overall Study|Withdrawal by Subject|0
4476813|NCT00695318|7273555|FG000|Overall Study|Death|1
4476814|NCT00695318|7273556|FG001|Overall Study|Death|1
4476815|NCT00695318|7273555|FG000|Overall Study|Study Terminated|1
4476816|NCT00695318|7273556|FG001|Overall Study|Study Terminated|0
4476817|NCT00695396|7273570|FG000|Overall Study|Study Closed Prematurely|5
4476818|NCT00695396|7273571|FG001|Overall Study|Study Closed Prematurely|6
4476819|NCT00695396|7273572|FG002|Overall Study|Study Closed Prematurely|8
4476820|NCT00695396|7273570|FG000|Overall Study|Withdrawal by Subject|2
4476821|NCT00695396|7273571|FG001|Overall Study|Withdrawal by Subject|2
4476822|NCT00695396|7273572|FG002|Overall Study|Withdrawal by Subject|0
4476823|NCT00695565|7273606|FG000|Overall Study|Lost to Follow-up|4
4476824|NCT00695565|7273607|FG001|Overall Study|Lost to Follow-up|4
4476825|NCT00695565|7273606|FG000|Overall Study|Adverse Event|3
4476826|NCT00695565|7273607|FG001|Overall Study|Adverse Event|1
4476827|NCT00695565|7273606|FG000|Overall Study|Protocol Violation|3
4476828|NCT00695565|7273607|FG001|Overall Study|Protocol Violation|1
4476829|NCT00695565|7273606|FG000|Overall Study|Withdrawal by Subject|1
4476830|NCT00695565|7273607|FG001|Overall Study|Withdrawal by Subject|1
4476831|NCT00695565|7273606|FG000|Overall Study|Lack of Efficacy|1
4476832|NCT00695565|7273607|FG001|Overall Study|Lack of Efficacy|1
4476833|NCT00695565|7273606|FG000|Overall Study|Subject did not follow instructions|1
4476834|NCT00695565|7273607|FG001|Overall Study|Subject did not follow instructions|1
4476835|NCT00695669|7273626|FG000|Overall Study|Adverse Event|0
4476836|NCT00695669|7273627|FG001|Overall Study|Adverse Event|0
4476837|NCT00695669|7273628|FG002|Overall Study|Adverse Event|2
4476838|NCT00695669|7273629|FG003|Overall Study|Adverse Event|0
4476839|NCT00695669|7273626|FG000|Overall Study|Lost to Follow-up|4
4476840|NCT00695669|7273627|FG001|Overall Study|Lost to Follow-up|4
4476841|NCT00695669|7273628|FG002|Overall Study|Lost to Follow-up|1
4476842|NCT00695669|7273629|FG003|Overall Study|Lost to Follow-up|4
4476843|NCT00695786|7273646|FG000|Overall Study|Adverse Event|0
4476844|NCT00695786|7273647|FG001|Overall Study|Adverse Event|3
4476845|NCT00695786|7273648|FG002|Overall Study|Adverse Event|4
4476846|NCT00695786|7273649|FG003|Overall Study|Adverse Event|2
4476847|NCT00695786|7273646|FG000|Overall Study|Lost to Follow-up|0
4476848|NCT00695786|7273647|FG001|Overall Study|Lost to Follow-up|5
4476849|NCT00695786|7273648|FG002|Overall Study|Lost to Follow-up|1
4476850|NCT00695786|7273649|FG003|Overall Study|Lost to Follow-up|1
4386621|NCT00038948|7165162|FG000|Overall Study|Lost to Follow-up|4
4386622|NCT00038948|7165163|FG001|Overall Study|Lost to Follow-up|4
4386623|NCT00038948|7165162|FG000|Overall Study|Nonmedical event|5
4386624|NCT00038948|7165163|FG001|Overall Study|Nonmedical event|7
4386625|NCT00038948|7165162|FG000|Overall Study|Withdrawal by Subject|23
4476851|NCT00695786|7273646|FG000|Overall Study|Withdrawal by Subject|0
4476852|NCT00695786|7273647|FG001|Overall Study|Withdrawal by Subject|4
4476853|NCT00695786|7273648|FG002|Overall Study|Withdrawal by Subject|3
4476854|NCT00695786|7273649|FG003|Overall Study|Withdrawal by Subject|1
4476855|NCT00695786|7273646|FG000|Overall Study|Deemed Ineligible|1
4476856|NCT00695786|7273647|FG001|Overall Study|Deemed Ineligible|0
4476857|NCT00695786|7273648|FG002|Overall Study|Deemed Ineligible|0
4476858|NCT00695786|7273649|FG003|Overall Study|Deemed Ineligible|0
4476859|NCT00695786|7273646|FG000|Overall Study|Lack of Efficacy|0
4476860|NCT00695786|7273647|FG001|Overall Study|Lack of Efficacy|0
4386626|NCT00038948|7165163|FG001|Overall Study|Withdrawal by Subject|10
4386627|NCT00038948|7165162|FG000|Overall Study|Protocol Violation|3
4476861|NCT00695786|7273648|FG002|Overall Study|Lack of Efficacy|0
4476862|NCT00695786|7273649|FG003|Overall Study|Lack of Efficacy|4
4476863|NCT00695864|7273659|FG000|Placebo|Withdrawal by Subject|1
4476864|NCT00695864|7273659|FG000|Placebo|Physician Decision|4
4476865|NCT00695903|7273667|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0
4476866|NCT00695903|7273668|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2
4476867|NCT00695903|7273667|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9
4476868|NCT00695903|7273668|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9
4476869|NCT00695903|7273667|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1
4476870|NCT00695903|7273668|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0
4476871|NCT00695903|7273667|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1
4476872|NCT00695903|7273668|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1
4476873|NCT00695903|7273667|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0
4476874|NCT00695903|7273668|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1
4476875|NCT00695903|7273667|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1
4476876|NCT00695903|7273668|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2
4476877|NCT00695903|7273667|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1
4476878|NCT00695903|7273668|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0
4476879|NCT00695903|7273667|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1
4476880|NCT00695903|7273668|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0
4476881|NCT00695903|7273667|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0
4476882|NCT00695903|7273668|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1
4476883|NCT00695955|7273674|FG000|Cohort 1|Adverse Event|26
4476884|NCT00695955|7273674|FG000|Cohort 1|Protocol Violation|2
4476885|NCT00695955|7273674|FG000|Cohort 1|Lost to Follow-up|30
4476886|NCT00695955|7273674|FG000|Cohort 1|Withdrawal by Subject|25
4476887|NCT00695955|7273674|FG000|Cohort 1|Lack of Efficacy|3
4476888|NCT00695955|7273674|FG000|Cohort 1|Other|16
4476889|NCT00695955|7273674|FG000|Cohort 2|Adverse Event|24
4476890|NCT00695955|7273674|FG000|Cohort 2|Protocol Violation|5
4476891|NCT00695955|7273674|FG000|Cohort 2|Lost to Follow-up|38
4589419|NCT01513239|7434893|FG001|Period 1: Main Phase|Protocol Violation|2
4589420|NCT01513239|7434894|FG002|Period 1: Main Phase|Protocol Violation|2
4589421|NCT01513239|7434895|FG003|Period 1: Main Phase|Protocol Violation|0
4589422|NCT01513239|7434896|FG004|Period 1: Main Phase|Protocol Violation|0
4589423|NCT01513239|7434897|FG005|Period 1: Main Phase|Protocol Violation|0
4589424|NCT01513239|7434892|FG000|Period 1: Main Phase|Technical Problems|1
4589425|NCT01513239|7434893|FG001|Period 1: Main Phase|Technical Problems|2
4589426|NCT01513239|7434894|FG002|Period 1: Main Phase|Technical Problems|0
4589427|NCT01513239|7434895|FG003|Period 1: Main Phase|Technical Problems|0
4589428|NCT01513239|7434896|FG004|Period 1: Main Phase|Technical Problems|0
4589429|NCT01513239|7434897|FG005|Period 1: Main Phase|Technical Problems|0
4589430|NCT01513239|7434892|FG000|Period 1: Main Phase|Withdrawal by Subject|27
4589431|NCT01513239|7434893|FG001|Period 1: Main Phase|Withdrawal by Subject|29
4589432|NCT01513239|7434894|FG002|Period 1: Main Phase|Withdrawal by Subject|42
4589433|NCT01513239|7434895|FG003|Period 1: Main Phase|Withdrawal by Subject|0
4589434|NCT01513239|7434896|FG004|Period 1: Main Phase|Withdrawal by Subject|0
4589435|NCT01513239|7434897|FG005|Period 1: Main Phase|Withdrawal by Subject|0
4589436|NCT01513239|7434892|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
4589437|NCT01513239|7434893|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
4589438|NCT01513239|7434894|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
4476892|NCT00695955|7273674|FG000|Cohort 2|Withdrawal by Subject|28
4476893|NCT00695955|7273674|FG000|Cohort 2|Lack of Efficacy|4
4476894|NCT00695955|7273674|FG000|Cohort 2|Other|5
4476895|NCT00696020|7273684|FG000|Overall Study|Adverse Event|3
4476896|NCT00696020|7273685|FG001|Overall Study|Adverse Event|1
4476897|NCT00696020|7273686|FG002|Overall Study|Adverse Event|2
4476898|NCT00696020|7273687|FG003|Overall Study|Adverse Event|1
4476899|NCT00696020|7273684|FG000|Overall Study|Lack of Efficacy|1
4476900|NCT00696020|7273685|FG001|Overall Study|Lack of Efficacy|0
4476901|NCT00696020|7273686|FG002|Overall Study|Lack of Efficacy|0
4476902|NCT00696020|7273687|FG003|Overall Study|Lack of Efficacy|0
4476903|NCT00696020|7273684|FG000|Overall Study|Protocol Violation|0
4476904|NCT00696020|7273685|FG001|Overall Study|Protocol Violation|0
4476905|NCT00696020|7273686|FG002|Overall Study|Protocol Violation|0
4476906|NCT00696020|7273687|FG003|Overall Study|Protocol Violation|1
4476907|NCT00696020|7273684|FG000|Overall Study|Withdrawal by Subject|0
4476908|NCT00696020|7273685|FG001|Overall Study|Withdrawal by Subject|1
4476909|NCT00696020|7273686|FG002|Overall Study|Withdrawal by Subject|0
4476910|NCT00696020|7273687|FG003|Overall Study|Withdrawal by Subject|1
4476911|NCT00696020|7273684|FG000|Overall Study|Other not stated above|0
4476912|NCT00696020|7273685|FG001|Overall Study|Other not stated above|0
4476913|NCT00696020|7273686|FG002|Overall Study|Other not stated above|1
4476914|NCT00696020|7273687|FG003|Overall Study|Other not stated above|1
4476915|NCT00696072|7273701|FG000|Overall Study|continuing active treatment|10
4476916|NCT00696072|7273702|FG001|Overall Study|continuing active treatment|13
4476917|NCT00696072|7273701|FG000|Overall Study|Adverse Event|10
4476918|NCT00696072|7273702|FG001|Overall Study|Adverse Event|6
4476919|NCT00696072|7273701|FG000|Overall Study|Patient Request|3
4589439|NCT01513239|7434895|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5
4476920|NCT00696072|7273702|FG001|Overall Study|Patient Request|7
4476921|NCT00696072|7273701|FG000|Overall Study|Investigator Request|1
4476922|NCT00696072|7273702|FG001|Overall Study|Investigator Request|4
4476923|NCT00696072|7273701|FG000|Overall Study|Sponsor Request|0
4476924|NCT00696072|7273702|FG001|Overall Study|Sponsor Request|1
4476925|NCT00696072|7273701|FG000|Overall Study|Disease Progression|32
4476926|NCT00696072|7273702|FG001|Overall Study|Disease Progression|30
4476927|NCT00696072|7273701|FG000|Overall Study|Non-specified|1
4476928|NCT00696072|7273702|FG001|Overall Study|Non-specified|2
4476929|NCT00696137|7273709|FG000|Overall Study|Withdrawal by Subject|2
4476930|NCT00696241|7273718|FG000|Overall Study|Adverse Event|11
4476931|NCT00696241|7273719|FG001|Overall Study|Adverse Event|3
4476932|NCT00696241|7273720|FG002|Overall Study|Adverse Event|6
4476933|NCT00696241|7273721|FG003|Overall Study|Adverse Event|4
4476934|NCT00696241|7273722|FG004|Overall Study|Adverse Event|5
4476935|NCT00696241|7273718|FG000|Overall Study|Protocol Violation|1
4476936|NCT00696241|7273719|FG001|Overall Study|Protocol Violation|1
4476937|NCT00696241|7273720|FG002|Overall Study|Protocol Violation|2
4476938|NCT00696241|7273721|FG003|Overall Study|Protocol Violation|0
4476939|NCT00696241|7273722|FG004|Overall Study|Protocol Violation|3
4476940|NCT00696241|7273718|FG000|Overall Study|Lost to Follow-up|1
4476941|NCT00696241|7273719|FG001|Overall Study|Lost to Follow-up|4
4476942|NCT00696241|7273720|FG002|Overall Study|Lost to Follow-up|1
4476943|NCT00696241|7273721|FG003|Overall Study|Lost to Follow-up|2
4476944|NCT00696241|7273722|FG004|Overall Study|Lost to Follow-up|0
4476945|NCT00696241|7273718|FG000|Overall Study|Withdrawal by Subject|4
4476946|NCT00696241|7273719|FG001|Overall Study|Withdrawal by Subject|8
4476947|NCT00696241|7273720|FG002|Overall Study|Withdrawal by Subject|6
4476948|NCT00696241|7273721|FG003|Overall Study|Withdrawal by Subject|1
4476949|NCT00696241|7273722|FG004|Overall Study|Withdrawal by Subject|0
4476950|NCT00696241|7273718|FG000|Overall Study|Lack of Efficacy|1
4476951|NCT00696241|7273719|FG001|Overall Study|Lack of Efficacy|5
4476952|NCT00696241|7273720|FG002|Overall Study|Lack of Efficacy|4
4476953|NCT00696241|7273721|FG003|Overall Study|Lack of Efficacy|5
4476954|NCT00696241|7273722|FG004|Overall Study|Lack of Efficacy|3
4476955|NCT00696241|7273718|FG000|Overall Study|Other|6
4476956|NCT00696241|7273719|FG001|Overall Study|Other|1
4476957|NCT00696241|7273720|FG002|Overall Study|Other|5
4476958|NCT00696241|7273721|FG003|Overall Study|Other|2
4476959|NCT00696241|7273722|FG004|Overall Study|Other|1
4476960|NCT00696384|7273739|FG000|Open Label Phase|Adverse Event|27
4476961|NCT00696384|7273740|FG001|Open Label Phase|Adverse Event|0
4476962|NCT00696384|7273741|FG002|Open Label Phase|Adverse Event|0
4476963|NCT00696384|7273739|FG000|Open Label Phase|Protocol Violation|18
4476964|NCT00696384|7273740|FG001|Open Label Phase|Protocol Violation|0
4699236|NCT02680834|7614551|FG001|Overall Study|Withdrawal by Subject|0
4699237|NCT02680834|7614550|FG000|Overall Study|Lost to Follow-up|0
4699238|NCT02680834|7614551|FG001|Overall Study|Lost to Follow-up|1
4699239|NCT02680847|7614560|FG000|Overall Study|Other|2
4699240|NCT02680847|7614561|FG001|Overall Study|Other|0
4699241|NCT02680847|7614562|FG002|Overall Study|Other|0
4699242|NCT02680847|7614560|FG000|Overall Study|No longer met eligibility criteria|2
4699243|NCT02680847|7614561|FG001|Overall Study|No longer met eligibility criteria|2
4699244|NCT02680847|7614562|FG002|Overall Study|No longer met eligibility criteria|0
4699245|NCT02680847|7614560|FG000|Overall Study|Unwilling to participate in study|1
4699246|NCT02680847|7614561|FG001|Overall Study|Unwilling to participate in study|1
4699247|NCT02680847|7614562|FG002|Overall Study|Unwilling to participate in study|0
4699248|NCT02680847|7614560|FG000|Overall Study|Lack of Efficacy|0
4699249|NCT02680847|7614561|FG001|Overall Study|Lack of Efficacy|0
4699250|NCT02680847|7614562|FG002|Overall Study|Lack of Efficacy|2
4699251|NCT02680847|7614560|FG000|Overall Study|Adverse Event|0
4699252|NCT02680847|7614561|FG001|Overall Study|Adverse Event|0
4699253|NCT02680847|7614562|FG002|Overall Study|Adverse Event|1
4699254|NCT02681094|7614573|FG000|1 -Modified Enrolled Participants Set|Participant decision|7
4699255|NCT02681094|7614574|FG001|1 -Modified Enrolled Participants Set|Participant decision|10
4699256|NCT02681094|7614575|FG002|1 -Modified Enrolled Participants Set|Participant decision|9
4699257|NCT02681094|7614573|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10
4699258|NCT02681094|7614574|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4
4699259|NCT02681094|7614575|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1
4699260|NCT02681094|7614573|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2
4699261|NCT02681094|7614574|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0
4699262|NCT02681094|7614575|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1
4476965|NCT00696384|7273741|FG002|Open Label Phase|Protocol Violation|0
4476966|NCT00696384|7273739|FG000|Open Label Phase|Lost to Follow-up|24
4476967|NCT00696384|7273740|FG001|Open Label Phase|Lost to Follow-up|0
4476968|NCT00696384|7273741|FG002|Open Label Phase|Lost to Follow-up|0
4476969|NCT00696384|7273739|FG000|Open Label Phase|Withdrawal by Subject|37
4476970|NCT00696384|7273740|FG001|Open Label Phase|Withdrawal by Subject|0
4699263|NCT02681094|7614573|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1
4699264|NCT02681094|7614574|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5
4699265|NCT02681094|7614575|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14
4771208|NCT04250077|7748051|FG002|Overall Study|Withdrawal by Subject|0
4476971|NCT00696384|7273741|FG002|Open Label Phase|Withdrawal by Subject|0
4476972|NCT00696384|7273739|FG000|Open Label Phase|Other|6
4476973|NCT00696384|7273740|FG001|Open Label Phase|Other|0
4476974|NCT00696384|7273741|FG002|Open Label Phase|Other|0
4476975|NCT00696384|7273739|FG000|Open Label Phase|Lack of Efficacy|3
4476976|NCT00696384|7273740|FG001|Open Label Phase|Lack of Efficacy|0
4476977|NCT00696384|7273741|FG002|Open Label Phase|Lack of Efficacy|0
4476978|NCT00696384|7273739|FG000|Open Label Phase|Physician Decision|4
4476979|NCT00696384|7273740|FG001|Open Label Phase|Physician Decision|0
4476980|NCT00696384|7273741|FG002|Open Label Phase|Physician Decision|0
4476981|NCT00696384|7273739|FG000|Double Blind Phase|Adverse Event|0
4476982|NCT00696384|7273740|FG001|Double Blind Phase|Adverse Event|2
4476983|NCT00696384|7273741|FG002|Double Blind Phase|Adverse Event|2
4476984|NCT00696384|7273739|FG000|Double Blind Phase|Lost to Follow-up|0
4476985|NCT00696384|7273740|FG001|Double Blind Phase|Lost to Follow-up|2
4476986|NCT00696384|7273741|FG002|Double Blind Phase|Lost to Follow-up|1
4476987|NCT00696384|7273739|FG000|Double Blind Phase|Withdrawal by Subject|0
4476988|NCT00696384|7273740|FG001|Double Blind Phase|Withdrawal by Subject|4
4476989|NCT00696384|7273741|FG002|Double Blind Phase|Withdrawal by Subject|3
4476990|NCT00696384|7273739|FG000|Double Blind Phase|Lack of Efficacy|0
4476991|NCT00696384|7273740|FG001|Double Blind Phase|Lack of Efficacy|1
4476992|NCT00696384|7273741|FG002|Double Blind Phase|Lack of Efficacy|0
4476993|NCT00696384|7273739|FG000|Double Blind Phase|Physician Decision|0
4476994|NCT00696384|7273740|FG001|Double Blind Phase|Physician Decision|2
4476995|NCT00696384|7273741|FG002|Double Blind Phase|Physician Decision|0
4476996|NCT00696410|7273752|FG000|Overall Study|Lost to Follow-up|2
4476997|NCT00696410|7273753|FG001|Overall Study|Lost to Follow-up|0
4476998|NCT00696410|7273752|FG000|Overall Study|Withdrawal by Subject|8
4476999|NCT00696410|7273753|FG001|Overall Study|Withdrawal by Subject|0
4477000|NCT00696410|7273752|FG000|Overall Study|Physician Decision|3
4477001|NCT00696410|7273753|FG001|Overall Study|Physician Decision|0
4477002|NCT00696423|7273766|FG000|Overall Study|Lost to Follow-up|0
4477003|NCT00696423|7273767|FG001|Overall Study|Lost to Follow-up|5
4477004|NCT00696436|7273778|FG000|Overall Study|Adverse Event|7
4477005|NCT00696436|7273779|FG001|Overall Study|Adverse Event|9
4477006|NCT00696436|7273780|FG002|Overall Study|Adverse Event|8
4477007|NCT00696436|7273781|FG003|Overall Study|Adverse Event|6
4477008|NCT00696436|7273782|FG004|Overall Study|Adverse Event|4
4477009|NCT00696436|7273778|FG000|Overall Study|Protocol Violation|3
4477010|NCT00696436|7273779|FG001|Overall Study|Protocol Violation|2
4477011|NCT00696436|7273780|FG002|Overall Study|Protocol Violation|2
4477012|NCT00696436|7273781|FG003|Overall Study|Protocol Violation|0
4477013|NCT00696436|7273782|FG004|Overall Study|Protocol Violation|1
4477014|NCT00696436|7273778|FG000|Overall Study|Lost to Follow-up|1
4477015|NCT00696436|7273779|FG001|Overall Study|Lost to Follow-up|6
4477016|NCT00696436|7273780|FG002|Overall Study|Lost to Follow-up|2
4477017|NCT00696436|7273781|FG003|Overall Study|Lost to Follow-up|4
4477018|NCT00696436|7273782|FG004|Overall Study|Lost to Follow-up|3
4477019|NCT00696436|7273778|FG000|Overall Study|Withdrawal by Subject|4
4477020|NCT00696436|7273779|FG001|Overall Study|Withdrawal by Subject|11
4477021|NCT00696436|7273780|FG002|Overall Study|Withdrawal by Subject|5
4477022|NCT00696436|7273781|FG003|Overall Study|Withdrawal by Subject|7
4477023|NCT00696436|7273782|FG004|Overall Study|Withdrawal by Subject|1
4477024|NCT00696436|7273778|FG000|Overall Study|Lack of Efficacy|3
4477025|NCT00696436|7273779|FG001|Overall Study|Lack of Efficacy|1
4477026|NCT00696436|7273780|FG002|Overall Study|Lack of Efficacy|5
4477027|NCT00696436|7273781|FG003|Overall Study|Lack of Efficacy|2
4477028|NCT00696436|7273782|FG004|Overall Study|Lack of Efficacy|4
4477029|NCT00696436|7273778|FG000|Overall Study|Participant Unavailability|2
4477030|NCT00696436|7273779|FG001|Overall Study|Participant Unavailability|0
4477031|NCT00696436|7273780|FG002|Overall Study|Participant Unavailability|2
4477032|NCT00696436|7273781|FG003|Overall Study|Participant Unavailability|1
4477033|NCT00696436|7273782|FG004|Overall Study|Participant Unavailability|0
4477034|NCT00696436|7273778|FG000|Overall Study|Administrative Error|2
4477035|NCT00696436|7273779|FG001|Overall Study|Administrative Error|0
4477036|NCT00696436|7273780|FG002|Overall Study|Administrative Error|2
4477037|NCT00696436|7273781|FG003|Overall Study|Administrative Error|0
4477038|NCT00696436|7273782|FG004|Overall Study|Administrative Error|0
4477039|NCT00696436|7273778|FG000|Overall Study|Participant Non-compliance|0
4477040|NCT00696436|7273779|FG001|Overall Study|Participant Non-compliance|0
4477041|NCT00696436|7273780|FG002|Overall Study|Participant Non-compliance|1
4477042|NCT00696436|7273781|FG003|Overall Study|Participant Non-compliance|2
4477043|NCT00696436|7273782|FG004|Overall Study|Participant Non-compliance|0
4477044|NCT00696436|7273778|FG000|Overall Study|Administrative Decision|1
4477045|NCT00696436|7273779|FG001|Overall Study|Administrative Decision|0
4477046|NCT00696436|7273780|FG002|Overall Study|Administrative Decision|0
4477047|NCT00696436|7273781|FG003|Overall Study|Administrative Decision|0
4477048|NCT00696436|7273782|FG004|Overall Study|Administrative Decision|0
4477049|NCT00696436|7273778|FG000|Overall Study|Missing|0
4477050|NCT00696436|7273779|FG001|Overall Study|Missing|1
4477051|NCT00696436|7273780|FG002|Overall Study|Missing|1
4477052|NCT00696436|7273781|FG003|Overall Study|Missing|0
4477053|NCT00696436|7273782|FG004|Overall Study|Missing|0
4477054|NCT00696657|7273837|FG000|Overall Study|Protocol Violation|0
4477055|NCT00696657|7273838|FG001|Overall Study|Protocol Violation|0
4477056|NCT00696657|7273839|FG002|Overall Study|Protocol Violation|0
4477057|NCT00696657|7273840|FG003|Overall Study|Protocol Violation|0
4477058|NCT00696657|7273841|FG004|Overall Study|Protocol Violation|0
4477059|NCT00696657|7273842|FG005|Overall Study|Protocol Violation|1
4477060|NCT00696657|7273843|FG006|Overall Study|Protocol Violation|0
4477061|NCT00696657|7273844|FG007|Overall Study|Protocol Violation|0
4477062|NCT00696657|7273845|FG008|Overall Study|Protocol Violation|1
4477063|NCT00696657|7273837|FG000|Overall Study|Lack of Efficacy|0
4477064|NCT00696657|7273838|FG001|Overall Study|Lack of Efficacy|1
4477065|NCT00696657|7273839|FG002|Overall Study|Lack of Efficacy|0
4477066|NCT00696657|7273840|FG003|Overall Study|Lack of Efficacy|0
4477067|NCT00696657|7273841|FG004|Overall Study|Lack of Efficacy|0
4477068|NCT00696657|7273842|FG005|Overall Study|Lack of Efficacy|0
4477069|NCT00696657|7273843|FG006|Overall Study|Lack of Efficacy|0
4589440|NCT01513239|7434896|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3
4589441|NCT01513239|7434897|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2
4589442|NCT01513239|7434892|FG000|Period 2: 9 Month Extension Phase|Death|0
4589443|NCT01513239|7434893|FG001|Period 2: 9 Month Extension Phase|Death|0
4589444|NCT01513239|7434894|FG002|Period 2: 9 Month Extension Phase|Death|0
4589445|NCT01513239|7434895|FG003|Period 2: 9 Month Extension Phase|Death|2
4589446|NCT01513239|7434896|FG004|Period 2: 9 Month Extension Phase|Death|5
4589447|NCT01513239|7434897|FG005|Period 2: 9 Month Extension Phase|Death|2
4477070|NCT00696657|7273844|FG007|Overall Study|Lack of Efficacy|0
4477071|NCT00696657|7273845|FG008|Overall Study|Lack of Efficacy|0
4477072|NCT00696657|7273837|FG000|Overall Study|Withdrawal criteria|1
4477073|NCT00696657|7273838|FG001|Overall Study|Withdrawal criteria|3
4477074|NCT00696657|7273839|FG002|Overall Study|Withdrawal criteria|2
4477075|NCT00696657|7273840|FG003|Overall Study|Withdrawal criteria|2
4477076|NCT00696657|7273841|FG004|Overall Study|Withdrawal criteria|0
4477077|NCT00696657|7273842|FG005|Overall Study|Withdrawal criteria|0
4477078|NCT00696657|7273843|FG006|Overall Study|Withdrawal criteria|1
4477079|NCT00696657|7273844|FG007|Overall Study|Withdrawal criteria|1
4477080|NCT00696657|7273845|FG008|Overall Study|Withdrawal criteria|2
4477081|NCT00696657|7273837|FG000|Overall Study|Unclassified|0
4477082|NCT00696657|7273838|FG001|Overall Study|Unclassified|1
4477083|NCT00696657|7273839|FG002|Overall Study|Unclassified|3
4477084|NCT00696657|7273840|FG003|Overall Study|Unclassified|2
4477085|NCT00696657|7273841|FG004|Overall Study|Unclassified|4
4477086|NCT00696657|7273842|FG005|Overall Study|Unclassified|2
4477087|NCT00696657|7273843|FG006|Overall Study|Unclassified|0
4477088|NCT00696657|7273844|FG007|Overall Study|Unclassified|0
4477089|NCT00696657|7273845|FG008|Overall Study|Unclassified|1
4477090|NCT00696657|7273837|FG000|Overall Study|Adverse Event|0
4477091|NCT00696657|7273838|FG001|Overall Study|Adverse Event|0
4477092|NCT00696657|7273839|FG002|Overall Study|Adverse Event|3
4477093|NCT00696657|7273840|FG003|Overall Study|Adverse Event|7
4477094|NCT00696657|7273841|FG004|Overall Study|Adverse Event|6
4477095|NCT00696657|7273842|FG005|Overall Study|Adverse Event|9
4477096|NCT00696657|7273843|FG006|Overall Study|Adverse Event|14
4477097|NCT00696657|7273844|FG007|Overall Study|Adverse Event|2
4477098|NCT00696657|7273845|FG008|Overall Study|Adverse Event|5
4477099|NCT00696696|7273865|FG000|Overall Study|Adverse Event|5
4477100|NCT00696696|7273865|FG000|Overall Study|Withdrawal by Subject|8
4477101|NCT00696696|7273865|FG000|Overall Study|Physician Decision|2
4477102|NCT00696696|7273865|FG000|Overall Study|Death|3
4477103|NCT00696709|7273874|FG000|Overall Study|Withdrawal by Subject|1
4477104|NCT00696709|7273875|FG001|Overall Study|Withdrawal by Subject|2
4477105|NCT00696709|7273876|FG002|Overall Study|Withdrawal by Subject|1
4477106|NCT00696709|7273877|FG003|Overall Study|Withdrawal by Subject|4
4477107|NCT00696709|7273878|FG004|Overall Study|Withdrawal by Subject|3
4477108|NCT00696709|7273874|FG000|Overall Study|Protocol Violation|1
4477109|NCT00696709|7273875|FG001|Overall Study|Protocol Violation|0
4477110|NCT00696709|7273876|FG002|Overall Study|Protocol Violation|0
4477111|NCT00696709|7273877|FG003|Overall Study|Protocol Violation|0
4477112|NCT00696709|7273878|FG004|Overall Study|Protocol Violation|0
4477113|NCT00696709|7273874|FG000|Overall Study|Lost to Follow-up|1
4477114|NCT00696709|7273875|FG001|Overall Study|Lost to Follow-up|1
4477115|NCT00696709|7273876|FG002|Overall Study|Lost to Follow-up|0
4477116|NCT00696709|7273877|FG003|Overall Study|Lost to Follow-up|0
4477117|NCT00696709|7273878|FG004|Overall Study|Lost to Follow-up|0
4477118|NCT00696709|7273874|FG000|Overall Study|Adverse Event|0
4477119|NCT00696709|7273875|FG001|Overall Study|Adverse Event|0
4477120|NCT00696709|7273876|FG002|Overall Study|Adverse Event|0
4477121|NCT00696709|7273877|FG003|Overall Study|Adverse Event|1
4477122|NCT00696709|7273878|FG004|Overall Study|Adverse Event|0
4477123|NCT00696774|7273922|FG000|Period II|Adverse Event|0
4477124|NCT00696774|7273923|FG001|Period II|Adverse Event|0
4477125|NCT00696774|7273924|FG002|Period II|Adverse Event|15
4477126|NCT00696774|7273922|FG000|Period II|Lost to Follow-up|0
4477127|NCT00696774|7273923|FG001|Period II|Lost to Follow-up|0
4477128|NCT00696774|7273924|FG002|Period II|Lost to Follow-up|4
4477129|NCT00696774|7273922|FG000|Period II|Protocol Violation|0
4477130|NCT00696774|7273923|FG001|Period II|Protocol Violation|0
4477131|NCT00696774|7273924|FG002|Period II|Protocol Violation|11
4589448|NCT01513239|7434892|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
4589449|NCT01513239|7434893|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
4477132|NCT00696774|7273922|FG000|Period II|Withdrawal by Subject|0
4477133|NCT00696774|7273923|FG001|Period II|Withdrawal by Subject|0
4477134|NCT00696774|7273924|FG002|Period II|Withdrawal by Subject|4
4477135|NCT00696774|7273922|FG000|Period II|Sponsor Decision|0
4477136|NCT00696774|7273923|FG001|Period II|Sponsor Decision|0
4477137|NCT00696774|7273924|FG002|Period II|Sponsor Decision|0
4477138|NCT00696774|7273922|FG000|Period II|Lack of Efficacy|0
4477139|NCT00696774|7273923|FG001|Period II|Lack of Efficacy|0
4477140|NCT00696774|7273924|FG002|Period II|Lack of Efficacy|2
4477141|NCT00696774|7273922|FG000|Period III|Adverse Event|1
4477142|NCT00696774|7273923|FG001|Period III|Adverse Event|1
4477143|NCT00696774|7273924|FG002|Period III|Adverse Event|0
4477144|NCT00696774|7273922|FG000|Period III|Lost to Follow-up|2
4477145|NCT00696774|7273923|FG001|Period III|Lost to Follow-up|1
4477146|NCT00696774|7273924|FG002|Period III|Lost to Follow-up|0
4477147|NCT00696774|7273922|FG000|Period III|Protocol Violation|1
4477148|NCT00696774|7273923|FG001|Period III|Protocol Violation|1
4477149|NCT00696774|7273924|FG002|Period III|Protocol Violation|0
4477150|NCT00696774|7273922|FG000|Period III|Withdrawal by Subject|1
4477151|NCT00696774|7273923|FG001|Period III|Withdrawal by Subject|2
4477152|NCT00696774|7273924|FG002|Period III|Withdrawal by Subject|0
4477153|NCT00696774|7273922|FG000|Period III|Sponsor Decision|2
4477154|NCT00696774|7273923|FG001|Period III|Sponsor Decision|0
4477155|NCT00696774|7273924|FG002|Period III|Sponsor Decision|0
4477156|NCT00696774|7273922|FG000|Period III|Lack of Efficacy|0
4477157|NCT00696774|7273923|FG001|Period III|Lack of Efficacy|2
4477158|NCT00696774|7273924|FG002|Period III|Lack of Efficacy|0
4477159|NCT00696787|7273935|FG000|Overall Study|Adverse Event|1
4477160|NCT00696787|7273936|FG001|Overall Study|Adverse Event|0
4477161|NCT00696787|7273937|FG002|Overall Study|Adverse Event|6
4477162|NCT00696787|7273935|FG000|Overall Study|Discontinuation by Sponsor|9
4477163|NCT00696787|7273936|FG001|Overall Study|Discontinuation by Sponsor|13
4477164|NCT00696787|7273937|FG002|Overall Study|Discontinuation by Sponsor|14
4477165|NCT00696787|7273935|FG000|Overall Study|Lack of Efficacy|0
4477166|NCT00696787|7273936|FG001|Overall Study|Lack of Efficacy|1
4477167|NCT00696787|7273937|FG002|Overall Study|Lack of Efficacy|0
4477168|NCT00696787|7273935|FG000|Overall Study|Lost to Follow-up|4
4477169|NCT00696787|7273936|FG001|Overall Study|Lost to Follow-up|0
4477170|NCT00696787|7273937|FG002|Overall Study|Lost to Follow-up|3
4477171|NCT00696787|7273935|FG000|Overall Study|Withdrawal by Subject|0
4477172|NCT00696787|7273936|FG001|Overall Study|Withdrawal by Subject|3
4477173|NCT00696787|7273937|FG002|Overall Study|Withdrawal by Subject|2
4477174|NCT00696787|7273935|FG000|Overall Study|Failed to return|1
4477175|NCT00696787|7273936|FG001|Overall Study|Failed to return|3
4477176|NCT00696787|7273937|FG002|Overall Study|Failed to return|1
4477177|NCT00697073|7273945|FG000|Overall Study|Withdrawal by Subject|2
4477178|NCT00697073|7273945|FG000|Overall Study|Pregnancy|1
4477179|NCT00697073|7273945|FG000|Overall Study|non compliance and other|6
4477180|NCT00697112|7273949|FG000|Overall Study|Adverse Event|8
4477181|NCT00697112|7273949|FG000|Overall Study|Lost to Follow-up|1
4477182|NCT00697112|7273949|FG000|Overall Study|Did not meet inclusion criteria|1
4477183|NCT00697346|7273984|FG000|Overall Study|Adverse Event|4
4477184|NCT00697346|7273985|FG001|Overall Study|Adverse Event|5
4477185|NCT00697346|7273986|FG002|Overall Study|Adverse Event|0
4477186|NCT00697346|7273984|FG000|Overall Study|Progressive Disease|19
4477187|NCT00697346|7273985|FG001|Overall Study|Progressive Disease|18
4477188|NCT00697346|7273986|FG002|Overall Study|Progressive Disease|0
4477189|NCT00697346|7273984|FG000|Overall Study|Symptomatic Deterioration|0
4477190|NCT00697346|7273985|FG001|Overall Study|Symptomatic Deterioration|1
4477191|NCT00697346|7273986|FG002|Overall Study|Symptomatic Deterioration|0
4477192|NCT00697346|7273984|FG000|Overall Study|Withdrawal by Subject|2
4477193|NCT00697346|7273985|FG001|Overall Study|Withdrawal by Subject|2
4477194|NCT00697346|7273986|FG002|Overall Study|Withdrawal by Subject|0
4477195|NCT00697346|7273984|FG000|Overall Study|Reason not Specified|3
4477196|NCT00697346|7273985|FG001|Overall Study|Reason not Specified|0
4477197|NCT00697346|7273986|FG002|Overall Study|Reason not Specified|1
4477198|NCT00697463|7274013|FG000|Overall Study|Withdrawal by Subject|1
4477199|NCT00697515|7274017|FG000|Dose Optimization Period|Adverse Event|4
4477200|NCT00697515|7274018|FG001|Dose Optimization Period|Adverse Event|0
4477201|NCT00697515|7274017|FG000|Dose Optimization Period|Withdrawal by Subject|5
4477202|NCT00697515|7274018|FG001|Dose Optimization Period|Withdrawal by Subject|0
4477203|NCT00697515|7274017|FG000|Dose Optimization Period|Lost to Follow-up|2
4477204|NCT00697515|7274018|FG001|Dose Optimization Period|Lost to Follow-up|0
4477205|NCT00697515|7274017|FG000|Dose Optimization Period|sponsor request|2
4477206|NCT00697515|7274018|FG001|Dose Optimization Period|sponsor request|0
4477207|NCT00697515|7274017|FG000|Dose Optimization Period|called to active duty|1
4477208|NCT00697515|7274018|FG001|Dose Optimization Period|called to active duty|0
4477209|NCT00697515|7274017|FG000|Dose Optimization Period|elevated QTc|1
4477210|NCT00697515|7274018|FG001|Dose Optimization Period|elevated QTc|0
4477211|NCT00697515|7274017|FG000|First Intervention (Crossover Period)|Natural disaster|8
4477212|NCT00697515|7274018|FG001|First Intervention (Crossover Period)|Natural disaster|9
4477213|NCT00697515|7274017|FG000|First Intervention (Crossover Period)|Adverse Event|0
4477214|NCT00697515|7274018|FG001|First Intervention (Crossover Period)|Adverse Event|2
4477215|NCT00697515|7274017|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2
4477216|NCT00697515|7274018|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1
4477217|NCT00697515|7274017|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1
4477218|NCT00697515|7274018|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1
4477219|NCT00697593|7274034|FG000|Overall Study|Adverse Event|3
4477220|NCT00697593|7274034|FG000|Overall Study|Protocol Violation|1
4477221|NCT00697593|7274034|FG000|Overall Study|Lack of Efficacy|3
4477222|NCT00697593|7274034|FG000|Overall Study|Suspension of the study by sponsor|12
4477223|NCT00697619|7274040|FG000|Overall Study|Lack of Efficacy|2
4477224|NCT00697619|7274041|FG001|Overall Study|Lack of Efficacy|2
4477225|NCT00697619|7274040|FG000|Overall Study|Adverse Event|4
4477226|NCT00697619|7274041|FG001|Overall Study|Adverse Event|6
4477227|NCT00697788|7274056|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
4477228|NCT00697788|7274057|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2
4477229|NCT00697788|7274058|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
4477230|NCT00697788|7274059|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
4477231|NCT00697788|7274060|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
4477232|NCT00697788|7274061|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
4477233|NCT00697788|7274062|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
4477234|NCT00697788|7274063|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
4477235|NCT00697788|7274056|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
4477236|NCT00697788|7274057|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
4477237|NCT00697788|7274058|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
4477238|NCT00697788|7274059|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
4477239|NCT00697788|7274060|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1
4477240|NCT00697788|7274061|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
4477241|NCT00697788|7274062|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
4477242|NCT00697788|7274063|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
4477243|NCT00697827|7274105|FG000|Overall Study|enrolled but not treated|2
4477244|NCT00697827|7274106|FG001|Overall Study|enrolled but not treated|1
4477245|NCT00698204|7274139|FG000|Overall Study|Withdrawal by Subject|1
4477246|NCT00698204|7274140|FG001|Overall Study|Withdrawal by Subject|0
4477247|NCT00698451|7274148|FG000|Overall Study|Adverse Event|22
4477248|NCT00698451|7274148|FG000|Overall Study|Physician Decision|2
4477249|NCT00698451|7274148|FG000|Overall Study|Protocol Violation|6
4477250|NCT00698451|7274148|FG000|Overall Study|Withdrawal by Subject|6
4477251|NCT00698451|7274148|FG000|Overall Study|Disease progression|3
4477252|NCT00698516|7274152|FG000|Overall Study|Study Termination|2
4477253|NCT00698516|7274152|FG000|Overall Study|Withdrawal by Subject|3
4477254|NCT00698581|7274162|FG000|Overall Study|Lack of Efficacy|23
4477255|NCT00698581|7274163|FG001|Overall Study|Lack of Efficacy|11
4477256|NCT00698581|7274162|FG000|Overall Study|Withdrawal by Subject|6
4477257|NCT00698581|7274163|FG001|Overall Study|Withdrawal by Subject|0
4477258|NCT00698581|7274162|FG000|Overall Study|Other reason|9
4477259|NCT00698581|7274163|FG001|Overall Study|Other reason|1
4477260|NCT00698581|7274162|FG000|Overall Study|SAE, non-fatal|1
4477261|NCT00698581|7274163|FG001|Overall Study|SAE, non-fatal|0
4477262|NCT00698581|7274162|FG000|Overall Study|AE, non-serious non-fatal|4
4477263|NCT00698581|7274163|FG001|Overall Study|AE, non-serious non-fatal|0
4477264|NCT00698581|7274162|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
4477265|NCT00698581|7274163|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
4477266|NCT00698581|7274162|FG000|Overall Study|AE of unknown type|1
4477267|NCT00698581|7274163|FG001|Overall Study|AE of unknown type|0
4477268|NCT00698646|7274173|FG000|Overall Study|Adverse Event|8
4477269|NCT00698646|7274174|FG001|Overall Study|Adverse Event|7
4477270|NCT00698646|7274175|FG002|Overall Study|Adverse Event|8
4477271|NCT00698646|7274173|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11
4477272|NCT00698646|7274174|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11
4477273|NCT00698646|7274175|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7
4477274|NCT00698646|7274173|FG000|Overall Study|Protocol Deviation|6
4477275|NCT00698646|7274174|FG001|Overall Study|Protocol Deviation|2
4477276|NCT00698646|7274175|FG002|Overall Study|Protocol Deviation|3
4477277|NCT00698646|7274173|FG000|Overall Study|Withdrawal by Subject|10
4477278|NCT00698646|7274174|FG001|Overall Study|Withdrawal by Subject|11
4477279|NCT00698646|7274175|FG002|Overall Study|Withdrawal by Subject|8
4477280|NCT00698646|7274173|FG000|Overall Study|Lost to Follow-up|0
4477281|NCT00698646|7274174|FG001|Overall Study|Lost to Follow-up|0
4477282|NCT00698646|7274175|FG002|Overall Study|Lost to Follow-up|2
4477283|NCT00698646|7274173|FG000|Overall Study|Administrative problems|1
4477284|NCT00698646|7274174|FG001|Overall Study|Administrative problems|0
4477285|NCT00698646|7274175|FG002|Overall Study|Administrative problems|1
4477286|NCT00698685|7274183|FG000|Overall Study|Sister withdrew as donor|1
4477287|NCT00698685|7274183|FG000|Overall Study|Off study pre transplant by clinic MD|1
4477288|NCT00698841|7274187|FG000|Overall Study|Withdrawal by Subject|2
4477289|NCT00698841|7274187|FG000|Overall Study|Adverse Event|3
4477290|NCT00698841|7274187|FG000|Overall Study|Disease progression|7
4477291|NCT00698841|7274187|FG000|Overall Study|Failure to meet eligibility criteria|2
4477292|NCT00698841|7274187|FG000|Overall Study|Study drug toxicity|2
4477293|NCT00698841|7274187|FG000|Overall Study|Other|2
4477294|NCT00698932|7274197|FG000|Overall Study|Adverse Event|0
4477295|NCT00698932|7274198|FG001|Overall Study|Adverse Event|2
4477296|NCT00698932|7274197|FG000|Overall Study|Incorrect enrollment|0
4477297|NCT00698932|7274198|FG001|Overall Study|Incorrect enrollment|2
4477298|NCT00698932|7274197|FG000|Overall Study|Study specific discontinuation criteria|3
4477299|NCT00698932|7274198|FG001|Overall Study|Study specific discontinuation criteria|4
4477300|NCT00698932|7274197|FG000|Overall Study|Withdrawal by Subject|11
4477301|NCT00698932|7274198|FG001|Overall Study|Withdrawal by Subject|23
4477302|NCT00698932|7274197|FG000|Overall Study|Lost to Follow-up|6
4477303|NCT00698932|7274198|FG001|Overall Study|Lost to Follow-up|1
4477304|NCT00698932|7274197|FG000|Overall Study|Severe non-compliance to protocol|1
4477305|NCT00698932|7274198|FG001|Overall Study|Severe non-compliance to protocol|2
4477306|NCT00698932|7274197|FG000|Overall Study|Safety reasons|0
4477307|NCT00698932|7274198|FG001|Overall Study|Safety reasons|2
4477308|NCT00698932|7274197|FG000|Overall Study|Death|1
4477309|NCT00698932|7274198|FG001|Overall Study|Death|0
4477310|NCT00698997|7274206|FG000|Overall Study|Lost to Follow-up|3
4477311|NCT00698997|7274207|FG001|Overall Study|Lost to Follow-up|0
4477312|NCT00698997|7274206|FG000|Overall Study|Withdrawal by Subject|7
4477313|NCT00698997|7274207|FG001|Overall Study|Withdrawal by Subject|27
4477314|NCT00699153|7274233|FG000|Overall Study|Lost to Follow-up|1
4477315|NCT00699153|7274234|FG001|Overall Study|Lost to Follow-up|0
4477316|NCT00699153|7274233|FG000|Overall Study|Adverse Event|0
4477317|NCT00699153|7274234|FG001|Overall Study|Adverse Event|2
4477318|NCT00699153|7274233|FG000|Overall Study|Protocol Violation|1
4477319|NCT00699153|7274234|FG001|Overall Study|Protocol Violation|0
4477320|NCT00699153|7274233|FG000|Overall Study|Travel Problem|1
4477321|NCT00699153|7274234|FG001|Overall Study|Travel Problem|0
4477322|NCT00699192|7274243|FG000|Overall Study|Missing|1
4477323|NCT00699192|7274244|FG001|Overall Study|Missing|1
4477324|NCT00699192|7274245|FG002|Overall Study|Missing|1
4477325|NCT00699192|7274243|FG000|Overall Study|Adverse Event|9
4477326|NCT00699192|7274244|FG001|Overall Study|Adverse Event|4
4477327|NCT00699192|7274245|FG002|Overall Study|Adverse Event|3
4477328|NCT00699192|7274243|FG000|Overall Study|Abnormal test procedure result(s)|0
4477329|NCT00699192|7274244|FG001|Overall Study|Abnormal test procedure result(s)|0
4477330|NCT00699192|7274245|FG002|Overall Study|Abnormal test procedure result(s)|1
4477331|NCT00699192|7274243|FG000|Overall Study|Lack of Efficacy|0
4477332|NCT00699192|7274244|FG001|Overall Study|Lack of Efficacy|0
4477333|NCT00699192|7274245|FG002|Overall Study|Lack of Efficacy|1
4477334|NCT00699192|7274243|FG000|Overall Study|Withdrawal by Subject|3
4477335|NCT00699192|7274244|FG001|Overall Study|Withdrawal by Subject|2
4477336|NCT00699192|7274245|FG002|Overall Study|Withdrawal by Subject|4
4477337|NCT00699192|7274243|FG000|Overall Study|Administrative problems|1
4477338|NCT00699192|7274244|FG001|Overall Study|Administrative problems|3
4477339|NCT00699192|7274245|FG002|Overall Study|Administrative problems|1
4477340|NCT00699192|7274243|FG000|Overall Study|Protocol Violation|2
4477341|NCT00699192|7274244|FG001|Overall Study|Protocol Violation|2
4477342|NCT00699192|7274245|FG002|Overall Study|Protocol Violation|0
4477343|NCT00699283|7274259|FG000|Overall Study|Lack of Efficacy|15
4477344|NCT00699283|7274260|FG001|Overall Study|Lack of Efficacy|5
4477345|NCT00699283|7274259|FG000|Overall Study|Lost to Follow-up|2
4477346|NCT00699283|7274260|FG001|Overall Study|Lost to Follow-up|0
4477347|NCT00699283|7274259|FG000|Overall Study|Withdrawal by Subject|1
4477348|NCT00699283|7274260|FG001|Overall Study|Withdrawal by Subject|0
4477349|NCT00699283|7274259|FG000|Overall Study|Other Reason|5
4477350|NCT00699283|7274260|FG001|Overall Study|Other Reason|1
4477351|NCT00699283|7274259|FG000|Overall Study|SAE, non-fatal|1
4477352|NCT00699283|7274260|FG001|Overall Study|SAE, non-fatal|1
4477353|NCT00699283|7274259|FG000|Overall Study|AE, non-serious non-fatal|8
4477354|NCT00699283|7274260|FG001|Overall Study|AE, non-serious non-fatal|1
4477355|NCT00699283|7274259|FG000|Overall Study|AE of unknown type|1
4477356|NCT00699283|7274260|FG001|Overall Study|AE of unknown type|0
4477357|NCT00699335|7274265|FG000|Overall Study|Combination of multiple reasons|176
4477358|NCT00699335|7274265|FG000|Overall Study|Missing data|52
4477359|NCT00699348|7274272|FG000|Overall Study|Death|6
4477360|NCT00699348|7274272|FG000|Overall Study|Adverse Event|15
4477361|NCT00699348|7274272|FG000|Overall Study|Withdrawal by Subject|11
4477362|NCT00699348|7274272|FG000|Overall Study|Protocol Violation|10
4477363|NCT00699348|7274272|FG000|Overall Study|Lack of Efficacy|8
4477364|NCT00699348|7274272|FG000|Overall Study|Failure to return|1
4477365|NCT00699348|7274272|FG000|Overall Study|Blood transfusion|24
4477366|NCT00699348|7274272|FG000|Overall Study|Renal transplantation|10
4477367|NCT00699348|7274272|FG000|Overall Study|Other|5
4477368|NCT00699374|7274278|FG000|Overall Study|Death|93
4477369|NCT00699374|7274279|FG001|Overall Study|Death|83
4477370|NCT00699374|7274278|FG000|Overall Study|Adverse Event|70
4477371|NCT00699374|7274279|FG001|Overall Study|Adverse Event|67
4477372|NCT00699374|7274278|FG000|Overall Study|Global deterioration of health status|7
4477373|NCT00699374|7274279|FG001|Overall Study|Global deterioration of health status|8
4477374|NCT00699374|7274278|FG000|Overall Study|Lost to Follow-up|3
4477375|NCT00699374|7274279|FG001|Overall Study|Lost to Follow-up|5
4477376|NCT00699374|7274278|FG000|Overall Study|Withdrawal by Subject|34
4477377|NCT00699374|7274279|FG001|Overall Study|Withdrawal by Subject|44
4477378|NCT00699374|7274278|FG000|Overall Study|Objective progression or relapse|281
4477379|NCT00699374|7274279|FG001|Overall Study|Objective progression or relapse|277
4477380|NCT00699374|7274278|FG000|Overall Study|Other|18
4477381|NCT00699374|7274279|FG001|Overall Study|Other|15
4477382|NCT00699374|7274278|FG000|Overall Study|Protocol Violation|2
4477383|NCT00699374|7274279|FG001|Overall Study|Protocol Violation|6
4477384|NCT00699374|7274278|FG000|Overall Study|Study terminated by sponsor|13
4477385|NCT00699374|7274279|FG001|Overall Study|Study terminated by sponsor|28
4477386|NCT00699374|7274278|FG000|Overall Study|Randomized but not treated|4
4477387|NCT00699374|7274279|FG001|Overall Study|Randomized but not treated|2
4477388|NCT00699374|7274278|FG000|Overall Study|Died 28 days after last dose|5
4477389|NCT00699374|7274279|FG001|Overall Study|Died 28 days after last dose|9
4477390|NCT00699582|7274337|FG000|Overall Study|Adverse Event|4
4477391|NCT00699582|7274338|FG001|Overall Study|Adverse Event|11
4477392|NCT00699582|7274339|FG002|Overall Study|Adverse Event|23
4477393|NCT00699582|7274337|FG000|Overall Study|Withdrawal by Subject|6
4477394|NCT00699582|7274338|FG001|Overall Study|Withdrawal by Subject|7
4477395|NCT00699582|7274339|FG002|Overall Study|Withdrawal by Subject|4
4477396|NCT00699582|7274337|FG000|Overall Study|Lack of Efficacy|1
4477397|NCT00699582|7274338|FG001|Overall Study|Lack of Efficacy|0
4477398|NCT00699582|7274339|FG002|Overall Study|Lack of Efficacy|1
4477399|NCT00699582|7274337|FG000|Overall Study|Progressive Disease|1
4477400|NCT00699582|7274338|FG001|Overall Study|Progressive Disease|0
4477401|NCT00699582|7274339|FG002|Overall Study|Progressive Disease|0
4477402|NCT00699582|7274337|FG000|Overall Study|Administrative/Other|4
4477403|NCT00699582|7274338|FG001|Overall Study|Administrative/Other|3
4477404|NCT00699582|7274339|FG002|Overall Study|Administrative/Other|0
4477405|NCT00699582|7274337|FG000|Overall Study|Randomized, Not Treated|2
4477406|NCT00699582|7274338|FG001|Overall Study|Randomized, Not Treated|1
4477407|NCT00699582|7274339|FG002|Overall Study|Randomized, Not Treated|0
4477408|NCT00699608|7274347|FG000|First Intervention|Withdrawal by Subject|0
4477409|NCT00699608|7274348|FG001|First Intervention|Withdrawal by Subject|0
4477410|NCT00699608|7274349|FG002|First Intervention|Withdrawal by Subject|1
4477411|NCT00699608|7274350|FG003|First Intervention|Withdrawal by Subject|0
4477412|NCT00699608|7274351|FG004|First Intervention|Withdrawal by Subject|0
4477413|NCT00699608|7274352|FG005|First Intervention|Withdrawal by Subject|0
4477414|NCT00699608|7274347|FG000|First Intervention|Protocol Violation|0
4477415|NCT00699608|7274348|FG001|First Intervention|Protocol Violation|0
4477416|NCT00699608|7274349|FG002|First Intervention|Protocol Violation|0
4477417|NCT00699608|7274350|FG003|First Intervention|Protocol Violation|0
4477418|NCT00699608|7274351|FG004|First Intervention|Protocol Violation|1
4477419|NCT00699608|7274352|FG005|First Intervention|Protocol Violation|0
4477420|NCT00699608|7274347|FG000|Second Intervention|Adverse Event|0
4477421|NCT00699608|7274348|FG001|Second Intervention|Adverse Event|0
4477422|NCT00699608|7274349|FG002|Second Intervention|Adverse Event|1
4477423|NCT00699608|7274350|FG003|Second Intervention|Adverse Event|0
4477424|NCT00699608|7274351|FG004|Second Intervention|Adverse Event|0
4477425|NCT00699608|7274352|FG005|Second Intervention|Adverse Event|0
4477426|NCT00699608|7274347|FG000|Second Intervention|Withdrawal by Subject|0
4477427|NCT00699608|7274348|FG001|Second Intervention|Withdrawal by Subject|0
4477428|NCT00699608|7274349|FG002|Second Intervention|Withdrawal by Subject|0
4477429|NCT00699608|7274350|FG003|Second Intervention|Withdrawal by Subject|1
4477430|NCT00699608|7274351|FG004|Second Intervention|Withdrawal by Subject|0
4477431|NCT00699608|7274352|FG005|Second Intervention|Withdrawal by Subject|0
4477432|NCT00699660|7274362|FG000|Overall Study|Lost to Follow-up|4
4477433|NCT00699660|7274363|FG001|Overall Study|Lost to Follow-up|2
4477434|NCT00699660|7274362|FG000|Overall Study|missing reports and recording failures|10
4477435|NCT00699660|7274363|FG001|Overall Study|missing reports and recording failures|6
4477436|NCT00699699|7274369|FG000|Overall Study|Adverse Event|36
4477437|NCT00699699|7274369|FG000|Overall Study|Individual different reasons|21
4477438|NCT00699751|7274375|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27
4477439|NCT00699751|7274376|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27
4477440|NCT00699751|7274375|FG000|Period 1: Without/Before Drug Switch|Death|28
4477441|NCT00699751|7274376|FG001|Period 1: Without/Before Drug Switch|Death|29
4477442|NCT00699751|7274375|FG000|Period 1: Without/Before Drug Switch|Subject Request|43
4477443|NCT00699751|7274376|FG001|Period 1: Without/Before Drug Switch|Subject Request|23
4477444|NCT00699751|7274375|FG000|Period 1: Without/Before Drug Switch|Other|30
4477445|NCT00699751|7274376|FG001|Period 1: Without/Before Drug Switch|Other|20
4477446|NCT00699751|7274375|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97
4477447|NCT00699751|7274376|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63
4477448|NCT00699751|7274375|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0
4477449|NCT00699751|7274376|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4
4477450|NCT00699751|7274375|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0
4477451|NCT00699751|7274376|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1
4477452|NCT00699751|7274375|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0
4477453|NCT00699751|7274376|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4
4477454|NCT00699816|7274394|FG000|Overall Study|Protocol Violation|1
4477455|NCT00699816|7274395|FG001|Overall Study|Protocol Violation|3
4477456|NCT00699907|7274404|FG000|Overall Study|Withdrawal by Subject|2
4477457|NCT00699907|7274405|FG001|Overall Study|Withdrawal by Subject|1
4477458|NCT00699907|7274406|FG002|Overall Study|Withdrawal by Subject|0
4477459|NCT00699907|7274404|FG000|Overall Study|No usable sample|0
4477460|NCT00699907|7274405|FG001|Overall Study|No usable sample|9
4477461|NCT00699907|7274406|FG002|Overall Study|No usable sample|8
4477462|NCT00699972|7274417|FG000|Overall Study|Adverse Event|7
4477463|NCT00699972|7274418|FG001|Overall Study|Adverse Event|9
4477464|NCT00699972|7274419|FG002|Overall Study|Adverse Event|24
4477465|NCT00699972|7274417|FG000|Overall Study|Lost to Follow-up|0
4477466|NCT00699972|7274418|FG001|Overall Study|Lost to Follow-up|2
4477467|NCT00699972|7274419|FG002|Overall Study|Lost to Follow-up|0
4477468|NCT00699972|7274417|FG000|Overall Study|Withdrawal by Subject|3
4477469|NCT00699972|7274418|FG001|Overall Study|Withdrawal by Subject|7
4477470|NCT00699972|7274419|FG002|Overall Study|Withdrawal by Subject|4
4477471|NCT00699972|7274417|FG000|Overall Study|Lack of Efficacy|2
4477472|NCT00699972|7274418|FG001|Overall Study|Lack of Efficacy|0
4477473|NCT00699972|7274419|FG002|Overall Study|Lack of Efficacy|2
4477474|NCT00699972|7274417|FG000|Overall Study|Administrative/Other|3
4477475|NCT00699972|7274418|FG001|Overall Study|Administrative/Other|1
4477476|NCT00699972|7274419|FG002|Overall Study|Administrative/Other|4
4477477|NCT00699972|7274417|FG000|Overall Study|Randomized, Not Treated|1
4477478|NCT00699972|7274418|FG001|Overall Study|Randomized, Not Treated|0
4477479|NCT00699972|7274419|FG002|Overall Study|Randomized, Not Treated|1
4477480|NCT00699998|7274431|FG000|Overall Study|Withdrawal by Subject|194
4477481|NCT00699998|7274432|FG001|Overall Study|Withdrawal by Subject|83
4477482|NCT00699998|7274433|FG002|Overall Study|Withdrawal by Subject|202
4477483|NCT00699998|7274434|FG003|Overall Study|Withdrawal by Subject|80
4477484|NCT00699998|7274431|FG000|Overall Study|Physician Decision|3
4477485|NCT00699998|7274432|FG001|Overall Study|Physician Decision|2
4477486|NCT00699998|7274433|FG002|Overall Study|Physician Decision|1
4477487|NCT00699998|7274434|FG003|Overall Study|Physician Decision|1
4477488|NCT00699998|7274431|FG000|Overall Study|Lost to Follow-up|2
4477489|NCT00699998|7274432|FG001|Overall Study|Lost to Follow-up|1
4477490|NCT00699998|7274433|FG002|Overall Study|Lost to Follow-up|3
4477491|NCT00699998|7274434|FG003|Overall Study|Lost to Follow-up|1
4477492|NCT00700011|7274451|FG000|Overall Study|Death|0
4477493|NCT00700011|7274452|FG001|Overall Study|Death|1
4477494|NCT00700102|7274493|FG000|Overall Study|Died|394
4477495|NCT00700102|7274494|FG001|Overall Study|Died|385
4477496|NCT00700102|7274493|FG000|Overall Study|Lost to Follow-up|8
4477497|NCT00700102|7274494|FG001|Overall Study|Lost to Follow-up|10
4477498|NCT00700115|7274502|FG000|Overall Study|Withdrawal by Subject|1
4477499|NCT00700115|7274503|FG001|Overall Study|Withdrawal by Subject|0
4477500|NCT00700115|7274502|FG000|Overall Study|Lost to Follow-up|0
4477501|NCT00700115|7274503|FG001|Overall Study|Lost to Follow-up|1
4477502|NCT00700180|7274515|FG000|Overall Study|Death|99
4477503|NCT00700180|7274516|FG001|Overall Study|Death|114
4477504|NCT00700180|7274515|FG000|Overall Study|Alive on treatment|5
4477505|NCT00700180|7274516|FG001|Overall Study|Alive on treatment|3
4477506|NCT00700180|7274515|FG000|Overall Study|Alive in follow-up|46
4477507|NCT00700180|7274516|FG001|Overall Study|Alive in follow-up|27
4477508|NCT00700180|7274515|FG000|Overall Study|Lost to Follow-up|4
4477509|NCT00700180|7274516|FG001|Overall Study|Lost to Follow-up|5
4477510|NCT00700271|7274524|FG000|Overall Study|Adverse Event|4
4699266|NCT02681094|7614573|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11
4699267|NCT02681094|7614574|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13
4699268|NCT02681094|7614575|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20
4699269|NCT02681094|7614573|FG000|1 -Modified Enrolled Participants Set|Other|6
4699270|NCT02681094|7614574|FG001|1 -Modified Enrolled Participants Set|Other|6
4699271|NCT02681094|7614575|FG002|1 -Modified Enrolled Participants Set|Other|7
4699272|NCT02681094|7614573|FG000|1 -Modified Enrolled Participants Set|No treatment given|0
4699273|NCT02681094|7614574|FG001|1 -Modified Enrolled Participants Set|No treatment given|1
4699274|NCT02681094|7614575|FG002|1 -Modified Enrolled Participants Set|No treatment given|1
4699275|NCT02681094|7614573|FG000|2 - Enrolled Participants Set|Participant decision|7
4699276|NCT02681094|7614574|FG001|2 - Enrolled Participants Set|Participant decision|10
4699277|NCT02681094|7614575|FG002|2 - Enrolled Participants Set|Participant decision|9
4699278|NCT02681094|7614573|FG000|2 - Enrolled Participants Set|Adverse Event|10
4699279|NCT02681094|7614574|FG001|2 - Enrolled Participants Set|Adverse Event|4
4699280|NCT02681094|7614575|FG002|2 - Enrolled Participants Set|Adverse Event|1
4477511|NCT00700271|7274525|FG001|Overall Study|Adverse Event|6
4477512|NCT00700271|7274524|FG000|Overall Study|Protocol Violation|1
4477513|NCT00700271|7274525|FG001|Overall Study|Protocol Violation|0
4477514|NCT00700271|7274524|FG000|Overall Study|Administrative Reasons|1
4477515|NCT00700271|7274525|FG001|Overall Study|Administrative Reasons|0
4477516|NCT00700271|7274524|FG000|Overall Study|Withdrawal by Subject|6
4477517|NCT00700271|7274525|FG001|Overall Study|Withdrawal by Subject|4
4477518|NCT00700271|7274524|FG000|Overall Study|Lost to Follow-up|2
4477519|NCT00700271|7274525|FG001|Overall Study|Lost to Follow-up|2
4477520|NCT00700310|7274535|FG000|Overall Study|Adverse Event|6
4477521|NCT00700310|7274536|FG001|Overall Study|Adverse Event|10
4477522|NCT00700310|7274537|FG002|Overall Study|Adverse Event|5
4477523|NCT00700310|7274538|FG003|Overall Study|Adverse Event|11
4477524|NCT00700310|7274535|FG000|Overall Study|Lost to Follow-up|4
4477525|NCT00700310|7274536|FG001|Overall Study|Lost to Follow-up|1
4477526|NCT00700310|7274537|FG002|Overall Study|Lost to Follow-up|0
4477527|NCT00700310|7274538|FG003|Overall Study|Lost to Follow-up|1
4477528|NCT00700310|7274535|FG000|Overall Study|Withdrawal by Subject|8
4477529|NCT00700310|7274536|FG001|Overall Study|Withdrawal by Subject|9
4477530|NCT00700310|7274537|FG002|Overall Study|Withdrawal by Subject|8
4477531|NCT00700310|7274538|FG003|Overall Study|Withdrawal by Subject|8
4477532|NCT00700310|7274535|FG000|Overall Study|Lack of Efficacy|0
4477533|NCT00700310|7274536|FG001|Overall Study|Lack of Efficacy|3
4477534|NCT00700310|7274537|FG002|Overall Study|Lack of Efficacy|0
4477535|NCT00700310|7274538|FG003|Overall Study|Lack of Efficacy|1
4477536|NCT00700310|7274535|FG000|Overall Study|Administrative/Other|1
4477537|NCT00700310|7274536|FG001|Overall Study|Administrative/Other|3
4477538|NCT00700310|7274537|FG002|Overall Study|Administrative/Other|1
4477539|NCT00700310|7274538|FG003|Overall Study|Administrative/Other|3
4477540|NCT00700310|7274535|FG000|Overall Study|Randomized, Not Treated|2
4477541|NCT00700310|7274536|FG001|Overall Study|Randomized, Not Treated|0
4477542|NCT00700310|7274537|FG002|Overall Study|Randomized, Not Treated|2
4477543|NCT00700310|7274538|FG003|Overall Study|Randomized, Not Treated|2
4477544|NCT00700401|7274569|FG000|Overall Study|Detectable HCV RNA after Week 4|82
4477545|NCT00700401|7274569|FG000|Overall Study|Adverse Event|5
4477546|NCT00700401|7274569|FG000|Overall Study|Refused Treatment|2
4477547|NCT00700401|7274569|FG000|Overall Study|Lost to Follow-up|1
4477548|NCT00700401|7274569|FG000|Overall Study|Treatment never started|1
4477549|NCT00700401|7274569|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1
4477550|NCT00700401|7274569|FG000|Overall Study|Withdrawal by Subject|2
4477551|NCT00700427|7274573|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298
4477552|NCT00700427|7274574|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
4477553|NCT00700427|7274575|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
4477554|NCT00700427|7274576|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
4477555|NCT00700427|7274577|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
4477556|NCT00700427|7274573|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173
4477557|NCT00700427|7274574|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
4477558|NCT00700427|7274575|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
4477559|NCT00700427|7274576|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
4477560|NCT00700427|7274577|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
4477561|NCT00700427|7274573|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164
4477562|NCT00700427|7274574|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
4477563|NCT00700427|7274575|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
4477564|NCT00700427|7274576|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
4477565|NCT00700427|7274577|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
4477566|NCT00700427|7274573|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161
4477567|NCT00700427|7274574|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
4477568|NCT00700427|7274575|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
4477569|NCT00700427|7274576|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
4477570|NCT00700427|7274577|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
4477571|NCT00700427|7274573|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108
4477572|NCT00700427|7274574|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
4477573|NCT00700427|7274575|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
4477574|NCT00700427|7274576|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
4477575|NCT00700427|7274577|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
4477576|NCT00700427|7274573|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90
4477577|NCT00700427|7274574|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
4477578|NCT00700427|7274575|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
4477579|NCT00700427|7274576|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
4477580|NCT00700427|7274577|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
4477581|NCT00700427|7274573|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8
4477582|NCT00700427|7274574|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
4477583|NCT00700427|7274575|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
4477584|NCT00700427|7274576|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
4477585|NCT00700427|7274577|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
4477586|NCT00700427|7274573|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7
4477587|NCT00700427|7274574|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
4477588|NCT00700427|7274575|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
4477589|NCT00700427|7274576|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
4477590|NCT00700427|7274577|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
4477591|NCT00700427|7274573|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2
4477592|NCT00700427|7274574|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
4477593|NCT00700427|7274575|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
4477594|NCT00700427|7274576|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
4477595|NCT00700427|7274577|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
4699281|NCT02681094|7614573|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2
4699282|NCT02681094|7614574|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0
4699283|NCT02681094|7614575|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1
4477596|NCT00700427|7274573|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0
4477597|NCT00700427|7274574|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50
4477598|NCT00700427|7274575|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0
4477599|NCT00700427|7274576|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0
4477600|NCT00700427|7274577|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0
4477601|NCT00700427|7274573|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
4477602|NCT00700427|7274574|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162
4477603|NCT00700427|7274575|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
4477604|NCT00700427|7274576|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
4477605|NCT00700427|7274577|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
4477606|NCT00700427|7274573|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
4477607|NCT00700427|7274574|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81
4699284|NCT02681094|7614573|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1
4699285|NCT02681094|7614574|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5
4699286|NCT02681094|7614575|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14
4699287|NCT02681094|7614573|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14
4699288|NCT02681094|7614574|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15
4477608|NCT00700427|7274575|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
4477609|NCT00700427|7274576|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
4477610|NCT00700427|7274577|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
4477611|NCT00700427|7274573|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
4477612|NCT00700427|7274574|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56
4477613|NCT00700427|7274575|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
4477614|NCT00700427|7274576|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
4477615|NCT00700427|7274577|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
4477616|NCT00700427|7274573|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
4477617|NCT00700427|7274574|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49
4477618|NCT00700427|7274575|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
4477619|NCT00700427|7274576|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
4477620|NCT00700427|7274577|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
4477621|NCT00700427|7274573|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
4477622|NCT00700427|7274574|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41
4477623|NCT00700427|7274575|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
4477624|NCT00700427|7274576|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
4477625|NCT00700427|7274577|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
4477626|NCT00700427|7274573|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
4477627|NCT00700427|7274574|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32
4477628|NCT00700427|7274575|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
4477629|NCT00700427|7274576|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
4477630|NCT00700427|7274577|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
4477631|NCT00700427|7274573|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
4589450|NCT01513239|7434894|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
4589451|NCT01513239|7434895|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2
4589452|NCT01513239|7434896|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1
4589453|NCT01513239|7434897|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
4589454|NCT01513239|7434892|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0
4589455|NCT01513239|7434893|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0
4589456|NCT01513239|7434894|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0
4589457|NCT01513239|7434895|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1
4589458|NCT01513239|7434896|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0
4589459|NCT01513239|7434897|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0
4589460|NCT01513239|7434892|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0
4589461|NCT01513239|7434893|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0
4589462|NCT01513239|7434894|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0
4589463|NCT01513239|7434895|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0
4589464|NCT01513239|7434896|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1
4477632|NCT00700427|7274574|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3
4477633|NCT00700427|7274575|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
4477634|NCT00700427|7274576|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
4477635|NCT00700427|7274577|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
4477636|NCT00700427|7274573|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0
4477637|NCT00700427|7274574|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2
4477638|NCT00700427|7274575|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0
4477639|NCT00700427|7274576|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0
4477640|NCT00700427|7274577|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0
4477641|NCT00700427|7274573|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
4589465|NCT01513239|7434897|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1
4589466|NCT01513291|7434911|FG000|Treatment Period|Adverse Event|8
4589467|NCT01513291|7434912|FG001|Treatment Period|Adverse Event|4
4589468|NCT01513291|7434913|FG002|Treatment Period|Adverse Event|0
4477642|NCT00700427|7274574|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5
4477643|NCT00700427|7274575|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
4477644|NCT00700427|7274576|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
4477645|NCT00700427|7274577|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
4477646|NCT00700427|7274573|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
4477647|NCT00700427|7274574|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
4477648|NCT00700427|7274575|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8
4477649|NCT00700427|7274576|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5
4477650|NCT00700427|7274577|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
4477651|NCT00700427|7274573|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
4477652|NCT00700427|7274574|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
4477653|NCT00700427|7274575|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25
4477654|NCT00700427|7274576|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34
4699289|NCT02681094|7614575|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21
4699290|NCT02681094|7614573|FG000|2 - Enrolled Participants Set|Other|6
4699291|NCT02681094|7614574|FG001|2 - Enrolled Participants Set|Other|6
4699292|NCT02681094|7614575|FG002|2 - Enrolled Participants Set|Other|7
4699293|NCT02681094|7614573|FG000|2 - Enrolled Participants Set|No treatment given|0
4699294|NCT02681094|7614574|FG001|2 - Enrolled Participants Set|No treatment given|1
4699295|NCT02681094|7614575|FG002|2 - Enrolled Participants Set|No treatment given|1
4699296|NCT02681510|7614597|FG000|Overall Study|Withdrawal by Subject|1
4699297|NCT02681510|7614597|FG000|Overall Study|Lost to Follow-up|9
4699298|NCT02681523|7614601|FG000|Overall Study|Adverse Event|1
4699299|NCT02681523|7614601|FG000|Overall Study|Patient Non-compliance|1
4699300|NCT02682264|7614656|FG000|Overall Study|Withdrawal by Subject|56
4699301|NCT02682264|7614657|FG001|Overall Study|Withdrawal by Subject|45
4699302|NCT02682264|7614656|FG000|Overall Study|Lost to Follow-up|49
4699303|NCT02682264|7614657|FG001|Overall Study|Lost to Follow-up|41
4699304|NCT02682264|7614656|FG000|Overall Study|Lack of Efficacy|14
4699305|NCT02682264|7614657|FG001|Overall Study|Lack of Efficacy|16
4699306|NCT02682264|7614656|FG000|Overall Study|Withdrawal by Parent|6
4699307|NCT02682264|7614657|FG001|Overall Study|Withdrawal by Parent|7
4699308|NCT02682264|7614656|FG000|Overall Study|Adverse Event|9
4699309|NCT02682264|7614657|FG001|Overall Study|Adverse Event|0
4699310|NCT02682264|7614656|FG000|Overall Study|Noncompliance with study drug|1
4699311|NCT02682264|7614657|FG001|Overall Study|Noncompliance with study drug|4
4699312|NCT02682264|7614656|FG000|Overall Study|Pregnancy|1
4699313|NCT02682264|7614657|FG001|Overall Study|Pregnancy|2
4699314|NCT02682264|7614656|FG000|Overall Study|Recovery|1
4699315|NCT02682264|7614657|FG001|Overall Study|Recovery|2
4699316|NCT02682264|7614656|FG000|Overall Study|Progressive Disease|1
4699317|NCT02682264|7614657|FG001|Overall Study|Progressive Disease|0
4699318|NCT02682264|7614656|FG000|Overall Study|Technical Problems|0
4699319|NCT02682264|7614657|FG001|Overall Study|Technical Problems|1
4699320|NCT02682264|7614656|FG000|Overall Study|Moved abroad and unable to continue|0
4699321|NCT02682264|7614657|FG001|Overall Study|Moved abroad and unable to continue|3
4699322|NCT02682264|7614656|FG000|Overall Study|Stopped test article application|0
4699323|NCT02682264|7614657|FG001|Overall Study|Stopped test article application|1
4699324|NCT02682602|7614708|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1
4699325|NCT02682602|7614709|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0
4699326|NCT02682602|7614708|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3
4699327|NCT02682602|7614709|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0
4699328|NCT02682784|7614723|FG000|Overall Study|Withdrawal by Subject|0
4699329|NCT02682784|7614724|FG001|Overall Study|Withdrawal by Subject|2
4699330|NCT02682784|7614725|FG002|Overall Study|Withdrawal by Subject|1
4699331|NCT02682784|7614726|FG003|Overall Study|Withdrawal by Subject|2
4699332|NCT02682784|7614723|FG000|Overall Study|Physician Decision|1
4699333|NCT02682784|7614724|FG001|Overall Study|Physician Decision|0
4699334|NCT02682784|7614725|FG002|Overall Study|Physician Decision|1
4699335|NCT02682784|7614726|FG003|Overall Study|Physician Decision|1
4699336|NCT02682823|7614741|FG000|Overall Study|Withdrawal by Subject|0
4699337|NCT02682823|7614742|FG001|Overall Study|Withdrawal by Subject|0
4699338|NCT02682823|7614743|FG002|Overall Study|Withdrawal by Subject|1
4699339|NCT02682823|7614744|FG003|Overall Study|Withdrawal by Subject|0
4699340|NCT02682823|7614745|FG004|Overall Study|Withdrawal by Subject|1
4699341|NCT02682823|7614741|FG000|Overall Study|Protocol Deviation|0
4699342|NCT02682823|7614742|FG001|Overall Study|Protocol Deviation|1
4699343|NCT02682823|7614743|FG002|Overall Study|Protocol Deviation|0
4699344|NCT02682823|7614744|FG003|Overall Study|Protocol Deviation|0
4699345|NCT02682823|7614745|FG004|Overall Study|Protocol Deviation|0
4699346|NCT02682823|7614741|FG000|Overall Study|Adverse Event|0
4699347|NCT02682823|7614742|FG001|Overall Study|Adverse Event|0
4699348|NCT02682823|7614743|FG002|Overall Study|Adverse Event|0
4699349|NCT02682823|7614744|FG003|Overall Study|Adverse Event|1
4699350|NCT02682823|7614745|FG004|Overall Study|Adverse Event|0
4699351|NCT02683109|7614763|FG000|Overall Study|Adverse Event|1
4699352|NCT02683109|7614764|FG001|Overall Study|Adverse Event|0
4699353|NCT02683187|7614780|FG000|Overall Study|Failed IV access|3
4699354|NCT02683187|7614780|FG000|Overall Study|Withdrawal by Subject|5
4477655|NCT00700427|7274577|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
4477656|NCT00700427|7274573|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
4477657|NCT00700427|7274574|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
4477658|NCT00700427|7274575|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23
4477659|NCT00700427|7274576|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25
4477660|NCT00700427|7274577|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
4477661|NCT00700427|7274573|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
4477662|NCT00700427|7274574|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
4477663|NCT00700427|7274575|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19
4477664|NCT00700427|7274576|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9
4477665|NCT00700427|7274577|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
4477666|NCT00700427|7274573|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
4477667|NCT00700427|7274574|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
4477668|NCT00700427|7274575|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3
4386628|NCT00038948|7165163|FG001|Overall Study|Protocol Violation|7
4386629|NCT00038948|7165162|FG000|Overall Study|Lack of Efficacy|3
4386630|NCT00038948|7165163|FG001|Overall Study|Lack of Efficacy|6
4386631|NCT00039130|7165175|FG000|Overall Study|Adverse Event|11
4386632|NCT00039130|7165175|FG000|Overall Study|Death|9
4386633|NCT00039130|7165175|FG000|Overall Study|Withdrawal by Subject|3
4386634|NCT00039130|7165175|FG000|Overall Study|Progression|2
4386635|NCT00039130|7165175|FG000|Overall Study|Subsequent treatment|2
4386636|NCT00039130|7165175|FG000|Overall Study|Physician Decision|3
4386637|NCT00039377|7165183|FG000|Initial Registration|Adverse Event|2
4386638|NCT00039377|7165184|FG001|Initial Registration|Adverse Event|0
4386639|NCT00039377|7165185|FG002|Initial Registration|Adverse Event|0
4477669|NCT00700427|7274576|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11
4477670|NCT00700427|7274577|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
4477671|NCT00700427|7274573|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
4477672|NCT00700427|7274574|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
4477673|NCT00700427|7274575|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
4477674|NCT00700427|7274576|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5
4477675|NCT00700427|7274577|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
4477676|NCT00700427|7274573|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
4477677|NCT00700427|7274574|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
4477678|NCT00700427|7274575|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
4477679|NCT00700427|7274576|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3
4477680|NCT00700427|7274577|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
4477681|NCT00700427|7274573|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0
4477682|NCT00700427|7274574|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0
4477683|NCT00700427|7274575|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1
4477684|NCT00700427|7274576|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1
4477685|NCT00700427|7274577|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0
4477686|NCT00700427|7274573|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
4477687|NCT00700427|7274574|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
4477688|NCT00700427|7274575|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2
4477689|NCT00700427|7274576|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
4477690|NCT00700427|7274577|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
4477691|NCT00700427|7274573|FG000|Study Period 3B (Randomized Withdrawal)|Death|0
4477692|NCT00700427|7274574|FG001|Study Period 3B (Randomized Withdrawal)|Death|0
4477693|NCT00700427|7274575|FG002|Study Period 3B (Randomized Withdrawal)|Death|1
4477694|NCT00700427|7274576|FG003|Study Period 3B (Randomized Withdrawal)|Death|0
4477695|NCT00700427|7274577|FG004|Study Period 3B (Randomized Withdrawal)|Death|0
4477696|NCT00700427|7274573|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0
4477697|NCT00700427|7274574|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0
4477698|NCT00700427|7274575|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0
4477699|NCT00700427|7274576|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0
4477700|NCT00700427|7274577|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16
4477701|NCT00700427|7274573|FG000|Study Period 4 (Open-Label Extension)|Death|0
4477702|NCT00700427|7274574|FG001|Study Period 4 (Open-Label Extension)|Death|0
4477703|NCT00700427|7274575|FG002|Study Period 4 (Open-Label Extension)|Death|0
4477704|NCT00700427|7274576|FG003|Study Period 4 (Open-Label Extension)|Death|0
4477705|NCT00700427|7274577|FG004|Study Period 4 (Open-Label Extension)|Death|1
4477706|NCT00700427|7274573|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0
4477707|NCT00700427|7274574|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0
4477708|NCT00700427|7274575|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0
4477709|NCT00700427|7274576|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0
4477710|NCT00700427|7274577|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12
4477711|NCT00700427|7274573|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
4477712|NCT00700427|7274574|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
4477713|NCT00700427|7274575|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
4477714|NCT00700427|7274576|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
4477715|NCT00700427|7274577|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38
4477716|NCT00700427|7274573|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0
4477717|NCT00700427|7274574|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0
4477718|NCT00700427|7274575|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0
4477719|NCT00700427|7274576|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0
4477720|NCT00700427|7274577|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2
4477721|NCT00700427|7274573|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
4477722|NCT00700427|7274574|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
4477723|NCT00700427|7274575|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
4477724|NCT00700427|7274576|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
4477725|NCT00700427|7274577|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2
4477726|NCT00700427|7274573|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
4477727|NCT00700427|7274574|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
4477728|NCT00700427|7274575|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
4477729|NCT00700427|7274576|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
4477730|NCT00700427|7274577|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1
4477731|NCT00700427|7274573|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
4477732|NCT00700427|7274574|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
4477733|NCT00700427|7274575|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
4477734|NCT00700427|7274576|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
4477735|NCT00700427|7274577|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11
4477736|NCT00700427|7274573|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
4477737|NCT00700427|7274574|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
4477738|NCT00700427|7274575|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
4477739|NCT00700427|7274576|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
4477740|NCT00700427|7274577|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1
4477741|NCT00700570|7274591|FG000|Overall Study|Adverse Event|2
4477742|NCT00700570|7274592|FG001|Overall Study|Adverse Event|6
4477743|NCT00700570|7274591|FG000|Overall Study|Discretion of Investigator or Sponsor|0
4477744|NCT00700570|7274592|FG001|Overall Study|Discretion of Investigator or Sponsor|3
4477745|NCT00700570|7274591|FG000|Overall Study|Disease Progression|8
4477746|NCT00700570|7274592|FG001|Overall Study|Disease Progression|11
4477747|NCT00700570|7274591|FG000|Overall Study|Withdrawal by Subject|1
4477748|NCT00700570|7274592|FG001|Overall Study|Withdrawal by Subject|6
4477749|NCT00700622|7274600|FG000|Overall Study|Adverse Event|4
4477750|NCT00700622|7274601|FG001|Overall Study|Adverse Event|0
4477751|NCT00700622|7274600|FG000|Overall Study|Lost to Follow-up|0
4477752|NCT00700622|7274601|FG001|Overall Study|Lost to Follow-up|1
4477753|NCT00700622|7274600|FG000|Overall Study|Physician Decision|2
4477754|NCT00700622|7274601|FG001|Overall Study|Physician Decision|1
4477755|NCT00700622|7274600|FG000|Overall Study|Protocol Violation|0
4477756|NCT00700622|7274601|FG001|Overall Study|Protocol Violation|1
4477757|NCT00700622|7274600|FG000|Overall Study|Withdrawal by Subject|4
4477758|NCT00700622|7274601|FG001|Overall Study|Withdrawal by Subject|1
4477759|NCT00700622|7274600|FG000|Overall Study|Other|3
4477760|NCT00700622|7274601|FG001|Overall Study|Other|1
4477761|NCT00700635|7274610|FG000|Overall Study|Adverse Event|1
4477762|NCT00700635|7274611|FG001|Overall Study|Adverse Event|0
4477763|NCT00700635|7274612|FG002|Overall Study|Adverse Event|0
4477764|NCT00700635|7274610|FG000|Overall Study|Lost to Follow-up|1
4477765|NCT00700635|7274611|FG001|Overall Study|Lost to Follow-up|3
4477766|NCT00700635|7274612|FG002|Overall Study|Lost to Follow-up|0
4477767|NCT00700635|7274610|FG000|Overall Study|Protocol Violation|2
4477768|NCT00700635|7274611|FG001|Overall Study|Protocol Violation|2
4477769|NCT00700635|7274612|FG002|Overall Study|Protocol Violation|0
4477770|NCT00700635|7274610|FG000|Overall Study|Withdrawal by Subject|7
4477771|NCT00700635|7274611|FG001|Overall Study|Withdrawal by Subject|3
4477772|NCT00700635|7274612|FG002|Overall Study|Withdrawal by Subject|1
4477773|NCT00700713|7274623|FG000|Overall Study|Protocol Violation|1
4477774|NCT00700713|7274624|FG001|Overall Study|Protocol Violation|0
4477775|NCT00700713|7274625|FG002|Overall Study|Protocol Violation|1
4477776|NCT00700713|7274623|FG000|Overall Study|Withdrawal by Subject|0
4477777|NCT00700713|7274624|FG001|Overall Study|Withdrawal by Subject|0
4477778|NCT00700713|7274625|FG002|Overall Study|Withdrawal by Subject|1
4589469|NCT01513291|7434914|FG003|Treatment Period|Adverse Event|0
4589470|NCT01513291|7434915|FG004|Treatment Period|Adverse Event|0
4589471|NCT01513291|7434911|FG000|Treatment Period|Lack of Efficacy|3
4589472|NCT01513291|7434912|FG001|Treatment Period|Lack of Efficacy|0
4589473|NCT01513291|7434913|FG002|Treatment Period|Lack of Efficacy|0
4589474|NCT01513291|7434914|FG003|Treatment Period|Lack of Efficacy|0
4589475|NCT01513291|7434915|FG004|Treatment Period|Lack of Efficacy|0
4589476|NCT01513291|7434911|FG000|Treatment Period|Lost to Follow-up|2
4589477|NCT01513291|7434912|FG001|Treatment Period|Lost to Follow-up|3
4589478|NCT01513291|7434913|FG002|Treatment Period|Lost to Follow-up|0
4589479|NCT01513291|7434914|FG003|Treatment Period|Lost to Follow-up|0
4589480|NCT01513291|7434915|FG004|Treatment Period|Lost to Follow-up|0
4477779|NCT00700739|7274635|FG000|Overall Study|Lost to Follow-up|4
4477780|NCT00700739|7274636|FG001|Overall Study|Lost to Follow-up|4
4477781|NCT00700752|7274643|FG000|First Intervention|Withdrawal by Subject|0
4477782|NCT00700752|7274644|FG001|First Intervention|Withdrawal by Subject|2
4477783|NCT00700804|7274652|FG000|Overall Study|Withdrawal by Subject|1
4477784|NCT00700804|7274653|FG001|Overall Study|Withdrawal by Subject|2
4477785|NCT00700804|7274652|FG000|Overall Study|Protocol Violation|1
4477786|NCT00700804|7274653|FG001|Overall Study|Protocol Violation|1
4477787|NCT00700804|7274652|FG000|Overall Study|Loose Stools|1
4477788|NCT00700804|7274653|FG001|Overall Study|Loose Stools|1
4477789|NCT00700817|7274664|FG000|Week 0-26 (Main Period)|Adverse Event|14
4477790|NCT00700817|7274665|FG001|Week 0-26 (Main Period)|Adverse Event|15
4477791|NCT00700817|7274666|FG002|Week 0-26 (Main Period)|Adverse Event|4
4477792|NCT00700817|7274667|FG003|Week 0-26 (Main Period)|Adverse Event|0
4477793|NCT00700817|7274668|FG004|Week 0-26 (Main Period)|Adverse Event|0
4477794|NCT00700817|7274664|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4
4477795|NCT00700817|7274665|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0
4477796|NCT00700817|7274666|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4
4477797|NCT00700817|7274667|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0
4477798|NCT00700817|7274668|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0
4477799|NCT00700817|7274664|FG000|Week 0-26 (Main Period)|Protocol Violation|14
4477800|NCT00700817|7274665|FG001|Week 0-26 (Main Period)|Protocol Violation|4
4477801|NCT00700817|7274666|FG002|Week 0-26 (Main Period)|Protocol Violation|4
4477802|NCT00700817|7274667|FG003|Week 0-26 (Main Period)|Protocol Violation|0
4477803|NCT00700817|7274668|FG004|Week 0-26 (Main Period)|Protocol Violation|0
4477804|NCT00700817|7274664|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10
4477805|NCT00700817|7274665|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7
4477806|NCT00700817|7274666|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5
4477807|NCT00700817|7274667|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0
4477808|NCT00700817|7274668|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0
4477809|NCT00700817|7274664|FG000|Week 0-26 (Main Period)|Unclassified|14
4477810|NCT00700817|7274665|FG001|Week 0-26 (Main Period)|Unclassified|4
4477811|NCT00700817|7274666|FG002|Week 0-26 (Main Period)|Unclassified|8
4477812|NCT00700817|7274667|FG003|Week 0-26 (Main Period)|Unclassified|0
4477813|NCT00700817|7274668|FG004|Week 0-26 (Main Period)|Unclassified|0
4477814|NCT00700817|7274664|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5
4477815|NCT00700817|7274665|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10
4477816|NCT00700817|7274666|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3
4477817|NCT00700817|7274667|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0
4477818|NCT00700817|7274668|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0
4477819|NCT00700817|7274664|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3
4477820|NCT00700817|7274665|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2
4477821|NCT00700817|7274666|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2
4477822|NCT00700817|7274667|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0
4477823|NCT00700817|7274668|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0
4477824|NCT00700817|7274664|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2
4477825|NCT00700817|7274665|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3
4477826|NCT00700817|7274666|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7
4477827|NCT00700817|7274667|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0
4477828|NCT00700817|7274668|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0
4477829|NCT00700817|7274664|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6
4477830|NCT00700817|7274665|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8
4477831|NCT00700817|7274666|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2
4477832|NCT00700817|7274667|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0
4477833|NCT00700817|7274668|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0
4477834|NCT00700817|7274664|FG000|Week 26-52 (Extension Period 1)|Unclassified|4
4477835|NCT00700817|7274665|FG001|Week 26-52 (Extension Period 1)|Unclassified|3
4477836|NCT00700817|7274666|FG002|Week 26-52 (Extension Period 1)|Unclassified|1
4477837|NCT00700817|7274667|FG003|Week 26-52 (Extension Period 1)|Unclassified|0
4477838|NCT00700817|7274668|FG004|Week 26-52 (Extension Period 1)|Unclassified|0
4477839|NCT00700817|7274664|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0
4477840|NCT00700817|7274665|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3
4477841|NCT00700817|7274666|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0
4477842|NCT00700817|7274667|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6
4477843|NCT00700817|7274668|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0
4477844|NCT00700817|7274664|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1
4477845|NCT00700817|7274665|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2
4477846|NCT00700817|7274666|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0
4477847|NCT00700817|7274667|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1
4386640|NCT00039377|7165186|FG003|Initial Registration|Adverse Event|0
4386641|NCT00039377|7165183|FG000|Initial Registration|Relapsed|6
4386642|NCT00039377|7165184|FG001|Initial Registration|Relapsed|0
4386643|NCT00039377|7165185|FG002|Initial Registration|Relapsed|0
4386644|NCT00039377|7165186|FG003|Initial Registration|Relapsed|0
4386645|NCT00039377|7165183|FG000|Initial Registration|Received non-protocol therapy|11
4386646|NCT00039377|7165184|FG001|Initial Registration|Received non-protocol therapy|0
4386647|NCT00039377|7165185|FG002|Initial Registration|Received non-protocol therapy|0
4386648|NCT00039377|7165186|FG003|Initial Registration|Received non-protocol therapy|0
4386649|NCT00039377|7165183|FG000|Initial Registration|Withdrawal by Subject|3
4386650|NCT00039377|7165184|FG001|Initial Registration|Withdrawal by Subject|0
4386651|NCT00039377|7165185|FG002|Initial Registration|Withdrawal by Subject|0
4386652|NCT00039377|7165186|FG003|Initial Registration|Withdrawal by Subject|0
4386653|NCT00039741|7165198|FG000|Overall Study|Death|0
4386654|NCT00039741|7165199|FG001|Overall Study|Death|1
4386655|NCT00039741|7165200|FG002|Overall Study|Death|0
4386656|NCT00039741|7165201|FG003|Overall Study|Death|0
4386657|NCT00039741|7165198|FG000|Overall Study|Lost to Follow-up|3
4386658|NCT00039741|7165199|FG001|Overall Study|Lost to Follow-up|1
4386659|NCT00039741|7165200|FG002|Overall Study|Lost to Follow-up|5
4477848|NCT00700817|7274668|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1
4477849|NCT00700817|7274664|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3
4477850|NCT00700817|7274665|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3
4477851|NCT00700817|7274666|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
4477852|NCT00700817|7274667|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
4477853|NCT00700817|7274668|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
4477854|NCT00700817|7274664|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4
4477855|NCT00700817|7274665|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3
4477856|NCT00700817|7274666|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0
4477857|NCT00700817|7274667|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1
4477858|NCT00700817|7274668|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3
4477859|NCT00700817|7274664|FG000|Week 52-78 (Extension Period 2)|Unclassified|2
4477860|NCT00700817|7274665|FG001|Week 52-78 (Extension Period 2)|Unclassified|4
4477861|NCT00700817|7274666|FG002|Week 52-78 (Extension Period 2)|Unclassified|0
4477862|NCT00700817|7274667|FG003|Week 52-78 (Extension Period 2)|Unclassified|0
4477863|NCT00700817|7274668|FG004|Week 52-78 (Extension Period 2)|Unclassified|1
4477864|NCT00700882|7274678|FG000|Overall Study|Never received treatment|6
4477865|NCT00700882|7274678|FG000|Overall Study|Ineligible|2
4477866|NCT00700882|7274678|FG000|Overall Study|No KIT mutation|51
4477867|NCT00700999|7274693|FG000|Overall Study|Lost to Follow-up|7
4477868|NCT00700999|7274694|FG001|Overall Study|Lost to Follow-up|7
4477869|NCT00700999|7274693|FG000|Overall Study|Excluded - did not meet study criteria|0
4477870|NCT00700999|7274694|FG001|Overall Study|Excluded - did not meet study criteria|1
4477871|NCT00700999|7274693|FG000|Overall Study|Withdrawal by Subject|8
4477872|NCT00700999|7274694|FG001|Overall Study|Withdrawal by Subject|1
4477873|NCT00701038|7274702|FG000|Overall Study|study amended pilot group of patients|4
4477874|NCT00701038|7274703|FG001|Overall Study|study amended pilot group of patients|4
4477875|NCT00701051|7274711|FG000|Screening|Failed Screening|40
4477876|NCT00701051|7274712|FG001|Screening|Failed Screening|0
4477877|NCT00701051|7274713|FG002|Screening|Failed Screening|0
4477878|NCT00701051|7274711|FG000|Screening|Time conflicts|19
4477879|NCT00701051|7274712|FG001|Screening|Time conflicts|0
4477880|NCT00701051|7274713|FG002|Screening|Time conflicts|0
4477881|NCT00701051|7274711|FG000|Exercise Intervention|time conflict; non-study related illness|0
4477882|NCT00701051|7274712|FG001|Exercise Intervention|time conflict; non-study related illness|5
4477883|NCT00701051|7274713|FG002|Exercise Intervention|time conflict; non-study related illness|3
4477884|NCT00701064|7274721|FG000|Overall Study|Protocol Violation|1
4477885|NCT00701064|7274722|FG001|Overall Study|Protocol Violation|1
4477886|NCT00701064|7274721|FG000|Overall Study|Withdrawal by Subject|1
4477887|NCT00701064|7274722|FG001|Overall Study|Withdrawal by Subject|1
4477888|NCT00701064|7274721|FG000|Overall Study|initiated other PTSD treatment|2
4477889|NCT00701064|7274722|FG001|Overall Study|initiated other PTSD treatment|2
4477890|NCT00701090|7274730|FG000|Overall Study|Adverse Event|11
4477891|NCT00701090|7274731|FG001|Overall Study|Adverse Event|2
4477892|NCT00701090|7274730|FG000|Overall Study|Death|0
4477893|NCT00701090|7274731|FG001|Overall Study|Death|1
4477894|NCT00701090|7274730|FG000|Overall Study|Lack of Efficacy|5
4477895|NCT00701090|7274731|FG001|Overall Study|Lack of Efficacy|4
4477896|NCT00701090|7274730|FG000|Overall Study|Lost to Follow-up|9
4477897|NCT00701090|7274731|FG001|Overall Study|Lost to Follow-up|9
4477898|NCT00701090|7274730|FG000|Overall Study|Physician Decision|3
4477899|NCT00701090|7274731|FG001|Overall Study|Physician Decision|4
4477900|NCT00701090|7274730|FG000|Overall Study|Protocol Violation|2
4477901|NCT00701090|7274731|FG001|Overall Study|Protocol Violation|3
4477902|NCT00701090|7274730|FG000|Overall Study|Withdrawal by Subject|11
4477903|NCT00701090|7274731|FG001|Overall Study|Withdrawal by Subject|16
4477904|NCT00701090|7274730|FG000|Overall Study|Other|7
4477905|NCT00701090|7274731|FG001|Overall Study|Other|12
4477906|NCT00701103|7274748|FG000|Overall Study|Adverse Event|0
4477907|NCT00701103|7274749|FG001|Overall Study|Adverse Event|0
4477908|NCT00701103|7274750|FG002|Overall Study|Adverse Event|1
4477909|NCT00701103|7274751|FG003|Overall Study|Adverse Event|1
4477910|NCT00701103|7274752|FG004|Overall Study|Adverse Event|0
4477911|NCT00701103|7274753|FG005|Overall Study|Adverse Event|1
4477912|NCT00701103|7274754|FG006|Overall Study|Adverse Event|1
4477913|NCT00701103|7274755|FG007|Overall Study|Adverse Event|0
4477914|NCT00701103|7274756|FG008|Overall Study|Adverse Event|0
4477915|NCT00701103|7274757|FG009|Overall Study|Adverse Event|2
4477916|NCT00701103|7274758|FG010|Overall Study|Adverse Event|0
4477917|NCT00701103|7274748|FG000|Overall Study|Progressive Disease|5
4386660|NCT00039741|7165201|FG003|Overall Study|Lost to Follow-up|2
4477918|NCT00701103|7274749|FG001|Overall Study|Progressive Disease|2
4477919|NCT00701103|7274750|FG002|Overall Study|Progressive Disease|6
4477920|NCT00701103|7274751|FG003|Overall Study|Progressive Disease|5
4477921|NCT00701103|7274752|FG004|Overall Study|Progressive Disease|6
4477922|NCT00701103|7274753|FG005|Overall Study|Progressive Disease|5
4477923|NCT00701103|7274754|FG006|Overall Study|Progressive Disease|7
4477924|NCT00701103|7274755|FG007|Overall Study|Progressive Disease|7
4477925|NCT00701103|7274756|FG008|Overall Study|Progressive Disease|8
4477926|NCT00701103|7274757|FG009|Overall Study|Progressive Disease|8
4477927|NCT00701103|7274758|FG010|Overall Study|Progressive Disease|11
4477928|NCT00701103|7274748|FG000|Overall Study|Withdrawal by Subject|0
4477929|NCT00701103|7274749|FG001|Overall Study|Withdrawal by Subject|1
4477930|NCT00701103|7274750|FG002|Overall Study|Withdrawal by Subject|1
4477931|NCT00701103|7274751|FG003|Overall Study|Withdrawal by Subject|0
4477932|NCT00701103|7274752|FG004|Overall Study|Withdrawal by Subject|0
4477933|NCT00701103|7274753|FG005|Overall Study|Withdrawal by Subject|0
4477934|NCT00701103|7274754|FG006|Overall Study|Withdrawal by Subject|0
4477935|NCT00701103|7274755|FG007|Overall Study|Withdrawal by Subject|0
4477936|NCT00701103|7274756|FG008|Overall Study|Withdrawal by Subject|0
4477937|NCT00701103|7274757|FG009|Overall Study|Withdrawal by Subject|0
4477938|NCT00701103|7274758|FG010|Overall Study|Withdrawal by Subject|0
4477939|NCT00701103|7274748|FG000|Overall Study|Other|0
4477940|NCT00701103|7274749|FG001|Overall Study|Other|0
4477941|NCT00701103|7274750|FG002|Overall Study|Other|0
4477942|NCT00701103|7274751|FG003|Overall Study|Other|0
4477943|NCT00701103|7274752|FG004|Overall Study|Other|0
4477944|NCT00701103|7274753|FG005|Overall Study|Other|0
4477945|NCT00701103|7274754|FG006|Overall Study|Other|0
4477946|NCT00701103|7274755|FG007|Overall Study|Other|0
4477947|NCT00701103|7274756|FG008|Overall Study|Other|1
4477948|NCT00701103|7274757|FG009|Overall Study|Other|1
4477949|NCT00701103|7274758|FG010|Overall Study|Other|0
4477950|NCT00701129|7274786|FG000|Overall Study|Death|2
4477951|NCT00701311|7274790|FG000|Overall Study|Lack of Efficacy|3
4477952|NCT00701311|7274790|FG000|Overall Study|Adverse Event|3
4477953|NCT00701311|7274790|FG000|Overall Study|Withdrawal by Subject|2
4516795|NCT00961415|7328226|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0
4516796|NCT00961415|7328224|FG000|Induction Treatment Phase|Other Reason|5
4516797|NCT00961415|7328225|FG001|Induction Treatment Phase|Other Reason|0
4516798|NCT00961415|7328226|FG002|Induction Treatment Phase|Other Reason|0
4516799|NCT00961415|7328224|FG000|Maintenance Treatment Phase|Death|0
4516800|NCT00961415|7328225|FG001|Maintenance Treatment Phase|Death|42
4516801|NCT00961415|7328226|FG002|Maintenance Treatment Phase|Death|34
4516802|NCT00961415|7328224|FG000|Maintenance Treatment Phase|Investigators decision|0
4516803|NCT00961415|7328225|FG001|Maintenance Treatment Phase|Investigators decision|2
4516804|NCT00961415|7328226|FG002|Maintenance Treatment Phase|Investigators decision|0
4516805|NCT00961415|7328224|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0
4516806|NCT00961415|7328225|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3
4516807|NCT00961415|7328226|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8
4516808|NCT00961415|7328224|FG000|Maintenance Treatment Phase|Other reason|0
4516809|NCT00961415|7328225|FG001|Maintenance Treatment Phase|Other reason|1
4516810|NCT00961415|7328226|FG002|Maintenance Treatment Phase|Other reason|3
4516811|NCT00961571|7328253|FG000|Overall Study|Physician Decision|39
4516812|NCT00961636|7328260|FG000|Overall Study|Adverse Event|35
4516813|NCT00961636|7328261|FG001|Overall Study|Adverse Event|54
4516814|NCT00961636|7328262|FG002|Overall Study|Adverse Event|13
4516815|NCT00961636|7328260|FG000|Overall Study|Flushing Symptoms|29
4516816|NCT00961636|7328261|FG001|Overall Study|Flushing Symptoms|46
4516817|NCT00961636|7328262|FG002|Overall Study|Flushing Symptoms|3
4516818|NCT00961636|7328260|FG000|Overall Study|Lost to Follow-up|2
4516819|NCT00961636|7328261|FG001|Overall Study|Lost to Follow-up|3
4516820|NCT00961636|7328262|FG002|Overall Study|Lost to Follow-up|1
4516821|NCT00961636|7328260|FG000|Overall Study|Physician Decision|3
4516822|NCT00961636|7328261|FG001|Overall Study|Physician Decision|1
4516823|NCT00961636|7328262|FG002|Overall Study|Physician Decision|1
4516824|NCT00961636|7328260|FG000|Overall Study|Protocol Violation|9
4516825|NCT00961636|7328261|FG001|Overall Study|Protocol Violation|5
4516826|NCT00961636|7328262|FG002|Overall Study|Protocol Violation|1
4516827|NCT00961636|7328260|FG000|Overall Study|Withdrawal by Subject|29
4516828|NCT00961636|7328261|FG001|Overall Study|Withdrawal by Subject|22
4516829|NCT00961636|7328262|FG002|Overall Study|Withdrawal by Subject|13
4516830|NCT00961649|7328274|FG000|Overall Study|Adverse Event|4
4516831|NCT00961649|7328275|FG001|Overall Study|Adverse Event|0
4516832|NCT00961649|7328276|FG002|Overall Study|Adverse Event|0
4516833|NCT00961649|7328277|FG003|Overall Study|Adverse Event|2
4516834|NCT00961649|7328274|FG000|Overall Study|Inadequate control of IOP|0
4516835|NCT00961649|7328275|FG001|Overall Study|Inadequate control of IOP|0
4516836|NCT00961649|7328276|FG002|Overall Study|Inadequate control of IOP|0
4516837|NCT00961649|7328277|FG003|Overall Study|Inadequate control of IOP|1
4516838|NCT00961649|7328274|FG000|Overall Study|Patient has travel plans during holidays|0
4516839|NCT00961649|7328275|FG001|Overall Study|Patient has travel plans during holidays|0
4516840|NCT00961649|7328276|FG002|Overall Study|Patient has travel plans during holidays|1
4516841|NCT00961649|7328277|FG003|Overall Study|Patient has travel plans during holidays|0
4516842|NCT00961649|7328274|FG000|Overall Study|Patient left to Mexico-family emergency|1
4477954|NCT00701363|7274798|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4
4477955|NCT00701363|7274799|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
4477956|NCT00701363|7274800|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
4477957|NCT00701363|7274801|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
4477958|NCT00701363|7274798|FG000|Treatment Phase 1|Does not meet entry Criteria|1
4477959|NCT00701363|7274799|FG001|Treatment Phase 1|Does not meet entry Criteria|0
4589481|NCT01513291|7434911|FG000|Treatment Period|Physician Decision|1
4589482|NCT01513291|7434912|FG001|Treatment Period|Physician Decision|0
4589483|NCT01513291|7434913|FG002|Treatment Period|Physician Decision|0
4589484|NCT01513291|7434914|FG003|Treatment Period|Physician Decision|0
4589485|NCT01513291|7434915|FG004|Treatment Period|Physician Decision|0
4589486|NCT01513291|7434911|FG000|Treatment Period|Protocol Violation|1
4589487|NCT01513291|7434912|FG001|Treatment Period|Protocol Violation|2
4589488|NCT01513291|7434913|FG002|Treatment Period|Protocol Violation|0
4589489|NCT01513291|7434914|FG003|Treatment Period|Protocol Violation|0
4589490|NCT01513291|7434915|FG004|Treatment Period|Protocol Violation|0
4589491|NCT01513291|7434911|FG000|Treatment Period|Withdrawal by Subject|8
4589492|NCT01513291|7434912|FG001|Treatment Period|Withdrawal by Subject|5
4589493|NCT01513291|7434913|FG002|Treatment Period|Withdrawal by Subject|0
4589494|NCT01513291|7434914|FG003|Treatment Period|Withdrawal by Subject|0
4589495|NCT01513291|7434915|FG004|Treatment Period|Withdrawal by Subject|0
4589496|NCT01513291|7434911|FG000|Treatment Period|Randomized not treated|0
4589497|NCT01513291|7434912|FG001|Treatment Period|Randomized not treated|2
4589498|NCT01513291|7434913|FG002|Treatment Period|Randomized not treated|0
4589499|NCT01513291|7434914|FG003|Treatment Period|Randomized not treated|0
4589500|NCT01513291|7434915|FG004|Treatment Period|Randomized not treated|0
4589501|NCT01513291|7434911|FG000|Run-out Period|Lost to Follow-up|0
4477960|NCT00701363|7274800|FG002|Treatment Phase 1|Does not meet entry Criteria|0
4477961|NCT00701363|7274801|FG003|Treatment Phase 1|Does not meet entry Criteria|0
4477962|NCT00701363|7274798|FG000|Treatment Phase 1|Adverse Event|7
4477963|NCT00701363|7274799|FG001|Treatment Phase 1|Adverse Event|0
4477964|NCT00701363|7274800|FG002|Treatment Phase 1|Adverse Event|0
4477965|NCT00701363|7274801|FG003|Treatment Phase 1|Adverse Event|0
4477966|NCT00701363|7274798|FG000|Treatment Phase 1|Protocol Violation|1
4477967|NCT00701363|7274799|FG001|Treatment Phase 1|Protocol Violation|0
4477968|NCT00701363|7274800|FG002|Treatment Phase 1|Protocol Violation|0
4477969|NCT00701363|7274801|FG003|Treatment Phase 1|Protocol Violation|0
4477970|NCT00701363|7274798|FG000|Treatment Phase 1|Withdrawal by Subject|5
4477971|NCT00701363|7274799|FG001|Treatment Phase 1|Withdrawal by Subject|0
4477972|NCT00701363|7274800|FG002|Treatment Phase 1|Withdrawal by Subject|0
4477973|NCT00701363|7274801|FG003|Treatment Phase 1|Withdrawal by Subject|0
4477974|NCT00701363|7274798|FG000|Treatment Phase 1|Lack of Efficacy|1
4477975|NCT00701363|7274799|FG001|Treatment Phase 1|Lack of Efficacy|0
4477976|NCT00701363|7274800|FG002|Treatment Phase 1|Lack of Efficacy|0
4477977|NCT00701363|7274801|FG003|Treatment Phase 1|Lack of Efficacy|0
4477978|NCT00701363|7274798|FG000|Treatment Phase 2|Adverse Event|0
4477979|NCT00701363|7274799|FG001|Treatment Phase 2|Adverse Event|0
4477980|NCT00701363|7274800|FG002|Treatment Phase 2|Adverse Event|1
4477981|NCT00701363|7274801|FG003|Treatment Phase 2|Adverse Event|0
4477982|NCT00701363|7274798|FG000|Treatment Phase 2|Withdrawal by Subject|0
4477983|NCT00701363|7274799|FG001|Treatment Phase 2|Withdrawal by Subject|0
4477984|NCT00701363|7274800|FG002|Treatment Phase 2|Withdrawal by Subject|1
4477985|NCT00701363|7274801|FG003|Treatment Phase 2|Withdrawal by Subject|0
4477986|NCT00701415|7274845|FG000|Overall Study|Adverse Event|0
4477987|NCT00701415|7274846|FG001|Overall Study|Adverse Event|1
4477988|NCT00701415|7274845|FG000|Overall Study|Social/family issues and needle phobia|1
4477989|NCT00701415|7274846|FG001|Overall Study|Social/family issues and needle phobia|0
4477990|NCT00701441|7274854|FG000|Overall Study|failure in cpap compliance|0
4477991|NCT00701441|7274855|FG001|Overall Study|failure in cpap compliance|4
4477992|NCT00701558|7274865|FG000|Overall Study|Death|7
4477993|NCT00701558|7274865|FG000|Overall Study|Lost to Follow-up|8
4477994|NCT00701662|7274877|FG000|Overall Study|Lack of Efficacy|1
4477995|NCT00701701|7274896|FG000|Overall Study|Withdrawal by Subject|0
4477996|NCT00701701|7274897|FG001|Overall Study|Withdrawal by Subject|1
4477997|NCT00701701|7274896|FG000|Overall Study|Adverse Event|0
4477998|NCT00701701|7274897|FG001|Overall Study|Adverse Event|1
4477999|NCT00701727|7274917|FG000|First Treatment Period|Adverse Event|0
4478000|NCT00701727|7274918|FG001|First Treatment Period|Adverse Event|0
4478001|NCT00701727|7274917|FG000|First Treatment Period|Withdrawal by Subject|1
4478002|NCT00701727|7274918|FG001|First Treatment Period|Withdrawal by Subject|0
4478003|NCT00701727|7274917|FG000|First Treatment Period|sponsor decision|0
4478004|NCT00701727|7274918|FG001|First Treatment Period|sponsor decision|1
4478005|NCT00701727|7274917|FG000|First Treatment Period|Lost to Follow-up|0
4478006|NCT00701727|7274918|FG001|First Treatment Period|Lost to Follow-up|1
4478007|NCT00701727|7274917|FG000|Second Treatment Period|Withdrawal by Subject|2
4478008|NCT00701727|7274918|FG001|Second Treatment Period|Withdrawal by Subject|0
4478009|NCT00701779|7274924|FG000|Overall Study|Adverse Event|6
4478010|NCT00701779|7274924|FG000|Overall Study|Lost to Follow-up|1
4478011|NCT00701779|7274924|FG000|Overall Study|Withdrawal by Subject|2
4478012|NCT00701805|7274932|FG000|Overall Study|Withdrawal by Subject|3
4478013|NCT00701805|7274933|FG001|Overall Study|Withdrawal by Subject|1
4478014|NCT00701805|7274934|FG002|Overall Study|Withdrawal by Subject|4
4478015|NCT00701805|7274935|FG003|Overall Study|Withdrawal by Subject|3
4478016|NCT00701805|7274932|FG000|Overall Study|Adverse Event|0
4478017|NCT00701805|7274933|FG001|Overall Study|Adverse Event|1
4478018|NCT00701805|7274934|FG002|Overall Study|Adverse Event|1
4478019|NCT00701805|7274935|FG003|Overall Study|Adverse Event|0
4478020|NCT00701805|7274932|FG000|Overall Study|Missed 7 consecutive doses|0
4478021|NCT00701805|7274933|FG001|Overall Study|Missed 7 consecutive doses|1
4478022|NCT00701805|7274934|FG002|Overall Study|Missed 7 consecutive doses|0
4478023|NCT00701805|7274935|FG003|Overall Study|Missed 7 consecutive doses|0
4478024|NCT00701805|7274932|FG000|Overall Study|Admitted to hospital for 2 weeks|0
4478025|NCT00701805|7274933|FG001|Overall Study|Admitted to hospital for 2 weeks|0
4478026|NCT00701805|7274934|FG002|Overall Study|Admitted to hospital for 2 weeks|1
4478027|NCT00701805|7274935|FG003|Overall Study|Admitted to hospital for 2 weeks|0
4478028|NCT00701805|7274932|FG000|Overall Study|Physician decision, change of therapy|0
4478029|NCT00701805|7274933|FG001|Overall Study|Physician decision, change of therapy|0
4478030|NCT00701805|7274934|FG002|Overall Study|Physician decision, change of therapy|0
4478031|NCT00701805|7274935|FG003|Overall Study|Physician decision, change of therapy|1
4478032|NCT00701805|7274932|FG000|Overall Study|Difficult to travel to dialysis site|0
4478033|NCT00701805|7274933|FG001|Overall Study|Difficult to travel to dialysis site|0
4478034|NCT00701805|7274934|FG002|Overall Study|Difficult to travel to dialysis site|1
4478035|NCT00701805|7274935|FG003|Overall Study|Difficult to travel to dialysis site|0
4478036|NCT00701805|7274932|FG000|Overall Study|Resumption criteria were not met|0
4478037|NCT00701805|7274933|FG001|Overall Study|Resumption criteria were not met|1
4478038|NCT00701805|7274934|FG002|Overall Study|Resumption criteria were not met|0
4478039|NCT00701805|7274935|FG003|Overall Study|Resumption criteria were not met|0
4478040|NCT00702052|7274963|FG000|Overall Study|Adverse Event|23
4478041|NCT00702052|7274963|FG000|Overall Study|Disease Progression|30
4478042|NCT00702052|7274963|FG000|Overall Study|Withdrawal by Subject|5
4478043|NCT00702143|7274970|FG000|Overall Study|Lost to Follow-up|0
4478044|NCT00702143|7274971|FG001|Overall Study|Lost to Follow-up|0
4478045|NCT00702143|7274972|FG002|Overall Study|Lost to Follow-up|1
4478046|NCT00702208|7274978|FG000|Overall Study|Lost to Follow-up|28
4478047|NCT00702208|7274978|FG000|Overall Study|Did not self-lavage|1
4478048|NCT00702208|7274978|FG000|Overall Study|Unsatisfactory colposcopy|2
4478049|NCT00702221|7274985|FG000|Overall Study|Adverse Event|4
4478050|NCT00702221|7274986|FG001|Overall Study|Adverse Event|3
4478051|NCT00702325|7275001|FG000|Overall Study|Adverse Event|1
4478052|NCT00702325|7275002|FG001|Overall Study|Adverse Event|0
4478053|NCT00702325|7275001|FG000|Overall Study|Withdrawal by Subject|7
4478054|NCT00702325|7275002|FG001|Overall Study|Withdrawal by Subject|7
4589502|NCT01513291|7434912|FG001|Run-out Period|Lost to Follow-up|0
4589503|NCT01513291|7434913|FG002|Run-out Period|Lost to Follow-up|0
4478055|NCT00702325|7275001|FG000|Overall Study|Lost to Follow-up|3
4478056|NCT00702325|7275002|FG001|Overall Study|Lost to Follow-up|4
4478057|NCT00702325|7275001|FG000|Overall Study|Incorrect enrollment|5
4478058|NCT00702325|7275002|FG001|Overall Study|Incorrect enrollment|7
4478059|NCT00702325|7275001|FG000|Overall Study|Developed study discontinuation criteria|18
4478060|NCT00702325|7275002|FG001|Overall Study|Developed study discontinuation criteria|28
4478061|NCT00702325|7275001|FG000|Overall Study|Severe noncompliance to protocol|3
4478062|NCT00702325|7275002|FG001|Overall Study|Severe noncompliance to protocol|3
4478063|NCT00702325|7275001|FG000|Overall Study|Termination due to lab results|1
4478064|NCT00702325|7275002|FG001|Overall Study|Termination due to lab results|0
4478065|NCT00702325|7275001|FG000|Overall Study|Didn't follow study medication dosage|0
4478066|NCT00702325|7275002|FG001|Overall Study|Didn't follow study medication dosage|2
4478067|NCT00702325|7275001|FG000|Overall Study|Withdrew consent|0
4478068|NCT00702325|7275002|FG001|Overall Study|Withdrew consent|1
4478069|NCT00702325|7275001|FG000|Overall Study|Incorrectly Discontinued|0
4478070|NCT00702325|7275002|FG001|Overall Study|Incorrectly Discontinued|1
4478071|NCT00702403|7275026|FG000|From Consent to Engraftment|Progressive leukemia|6
4478072|NCT00702403|7275026|FG000|From Consent to Engraftment|Critically ill|2
4589504|NCT01513291|7434914|FG003|Run-out Period|Lost to Follow-up|1
4386661|NCT00039741|7165198|FG000|Overall Study|Confounding medical condition|1
4386662|NCT00039741|7165199|FG001|Overall Study|Confounding medical condition|0
4386663|NCT00039741|7165200|FG002|Overall Study|Confounding medical condition|0
4386664|NCT00039741|7165201|FG003|Overall Study|Confounding medical condition|0
4386665|NCT00039741|7165198|FG000|Overall Study|Not able to get to clinic|5
4386666|NCT00039741|7165199|FG001|Overall Study|Not able to get to clinic|2
4386667|NCT00039741|7165200|FG002|Overall Study|Not able to get to clinic|0
4386668|NCT00039741|7165201|FG003|Overall Study|Not able to get to clinic|3
4386669|NCT00039741|7165198|FG000|Overall Study|Moved|3
4386670|NCT00039741|7165199|FG001|Overall Study|Moved|2
4386671|NCT00039741|7165200|FG002|Overall Study|Moved|3
4386672|NCT00039741|7165201|FG003|Overall Study|Moved|6
4386673|NCT00039741|7165198|FG000|Overall Study|Non-compliance with protocol|1
4386674|NCT00039741|7165199|FG001|Overall Study|Non-compliance with protocol|0
4386675|NCT00039741|7165200|FG002|Overall Study|Non-compliance with protocol|1
4386676|NCT00039741|7165201|FG003|Overall Study|Non-compliance with protocol|0
4386677|NCT00039741|7165198|FG000|Overall Study|Withdrew consent|0
4386678|NCT00039741|7165199|FG001|Overall Study|Withdrew consent|5
4699355|NCT02683525|7614805|FG000|Overall Study|Lost to Follow-up|1
4699356|NCT02683525|7614805|FG000|Overall Study|Physician Decision|1
4699357|NCT02683525|7614805|FG000|Overall Study|Disease Progression|6
4699358|NCT02683668|7614824|FG000|Period 2|Withdrawal by Subject|0
4699359|NCT02683668|7614825|FG001|Period 2|Withdrawal by Subject|1
4699360|NCT02683668|7614826|FG002|Period 2|Withdrawal by Subject|0
4699361|NCT02683746|7614843|FG000|Overall Study|Adverse Event|3
4699362|NCT02683746|7614844|FG001|Overall Study|Adverse Event|2
4699363|NCT02683746|7614843|FG000|Overall Study|Lost to Follow-up|5
4699364|NCT02683746|7614844|FG001|Overall Study|Lost to Follow-up|6
4699365|NCT02683746|7614843|FG000|Overall Study|Withdrawal by Subject|6
4699366|NCT02683746|7614844|FG001|Overall Study|Withdrawal by Subject|5
4699367|NCT02683746|7614843|FG000|Overall Study|Physician Decision|2
4699368|NCT02683746|7614844|FG001|Overall Study|Physician Decision|1
4699369|NCT02683785|7614863|FG000|Overall Study|Withdrawal by Subject|1
4699370|NCT02683785|7614864|FG001|Overall Study|Withdrawal by Subject|1
4699371|NCT02683785|7614863|FG000|Overall Study|Lost to Follow-up|0
4699372|NCT02683785|7614864|FG001|Overall Study|Lost to Follow-up|1
4699373|NCT02683785|7614863|FG000|Overall Study|Adverse Event|0
4699374|NCT02683785|7614864|FG001|Overall Study|Adverse Event|2
4699375|NCT02683876|7614874|FG000|Overall Study|samples damaged during shipping|2
4699376|NCT02683876|7614875|FG001|Overall Study|samples damaged during shipping|0
4699377|NCT02683941|7614894|FG000|Double-blind Phase|Adverse Event|0
4699378|NCT02683941|7614895|FG001|Double-blind Phase|Adverse Event|1
4699379|NCT02683941|7614894|FG000|Double-blind Phase|Withdrawal by Subject|4
4699380|NCT02683941|7614895|FG001|Double-blind Phase|Withdrawal by Subject|2
4699381|NCT02683941|7614894|FG000|Double-blind Phase|Lost to Follow-up|1
4699382|NCT02683941|7614895|FG001|Double-blind Phase|Lost to Follow-up|0
4699383|NCT02683941|7614894|FG000|Double-blind Phase|Disease Progression|5
4699384|NCT02683941|7614895|FG001|Double-blind Phase|Disease Progression|2
4699385|NCT02683941|7614894|FG000|Open-label Treatment Phase|Withdrawal by Subject|0
4699386|NCT02683941|7614895|FG001|Open-label Treatment Phase|Withdrawal by Subject|2
4699387|NCT02683941|7614894|FG000|Open-label Treatment Phase|Disease Progression|1
4699388|NCT02683941|7614895|FG001|Open-label Treatment Phase|Disease Progression|2
4699389|NCT02683941|7614894|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18
4699390|NCT02683941|7614895|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9
4699391|NCT02683941|7614894|FG000|Open-label Treatment Phase|Other|1
4699392|NCT02683941|7614895|FG001|Open-label Treatment Phase|Other|0
4699393|NCT02683941|7614894|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3
4699394|NCT02683941|7614895|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3
4699395|NCT02683941|7614894|FG000|Open-label Follow-up Phase|Lost to Follow-up|1
4699396|NCT02683941|7614895|FG001|Open-label Follow-up Phase|Lost to Follow-up|0
4699397|NCT02683941|7614894|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6
4699398|NCT02683941|7614895|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4
4699399|NCT02683941|7614894|FG000|Open-label Follow-up Phase|Other|8
4699400|NCT02683941|7614895|FG001|Open-label Follow-up Phase|Other|1
4699401|NCT02684097|7614916|FG000|Overall Study|Lack of Efficacy|13
4699402|NCT02684097|7614917|FG001|Overall Study|Lack of Efficacy|6
4699403|NCT02684279|7614942|FG000|Overall Study|Adverse Event|87
4699404|NCT02684279|7614942|FG000|Overall Study|Lack of Efficacy|4
4699405|NCT02684279|7614942|FG000|Overall Study|Lost to Follow-up|61
4699406|NCT02684279|7614942|FG000|Overall Study|Protocol Violation|6
4699407|NCT02684279|7614942|FG000|Overall Study|Pregnancy|8
4699408|NCT02684279|7614942|FG000|Overall Study|Withdrawal by Subject|92
4699409|NCT02684279|7614942|FG000|Overall Study|non-compliance with study drug|9
4699410|NCT02684279|7614942|FG000|Overall Study|non compliance with study visits|2
4699411|NCT02684279|7614942|FG000|Overall Study|subject to have surgery|1
4699412|NCT02684279|7614942|FG000|Overall Study|family emergency|1
4699413|NCT02684279|7614942|FG000|Overall Study|Site closures|7
4699414|NCT02684279|7614942|FG000|Overall Study|Physician Decision|1
4699415|NCT02684344|7614948|FG000|Overall Study|Withdrawal by Subject|0
4699416|NCT02684344|7614949|FG001|Overall Study|Withdrawal by Subject|1
4699417|NCT02684357|7614958|FG000|Part A|Adverse Event (Worsening of Disease)|1
4699418|NCT02684357|7614959|FG001|Part A|Adverse Event (Worsening of Disease)|0
4699419|NCT02684357|7614960|FG002|Part A|Adverse Event (Worsening of Disease)|0
4699420|NCT02684357|7614961|FG003|Part A|Adverse Event (Worsening of Disease)|0
4699421|NCT02684357|7614962|FG004|Part A|Adverse Event (Worsening of Disease)|0
4699422|NCT02684357|7614963|FG005|Part A|Adverse Event (Worsening of Disease)|0
4699423|NCT02684357|7614958|FG000|Part A|Lost to Follow-up|0
4699424|NCT02684357|7614959|FG001|Part A|Lost to Follow-up|2
4699425|NCT02684357|7614960|FG002|Part A|Lost to Follow-up|2
4699426|NCT02684357|7614961|FG003|Part A|Lost to Follow-up|0
4699427|NCT02684357|7614962|FG004|Part A|Lost to Follow-up|0
4699428|NCT02684357|7614963|FG005|Part A|Lost to Follow-up|0
4699429|NCT02684357|7614958|FG000|Part A|Withdrawal by Subject|3
4699430|NCT02684357|7614959|FG001|Part A|Withdrawal by Subject|0
4699431|NCT02684357|7614960|FG002|Part A|Withdrawal by Subject|0
4699432|NCT02684357|7614961|FG003|Part A|Withdrawal by Subject|0
4699433|NCT02684357|7614962|FG004|Part A|Withdrawal by Subject|0
4699434|NCT02684357|7614963|FG005|Part A|Withdrawal by Subject|0
4699435|NCT02684357|7614958|FG000|Part A|Other|0
4699436|NCT02684357|7614959|FG001|Part A|Other|1
4699437|NCT02684357|7614960|FG002|Part A|Other|0
4699438|NCT02684357|7614961|FG003|Part A|Other|0
4699439|NCT02684357|7614962|FG004|Part A|Other|0
4699440|NCT02684357|7614963|FG005|Part A|Other|0
4699441|NCT02684357|7614958|FG000|Part B|Adverse Event (Other)|0
4699442|NCT02684357|7614959|FG001|Part B|Adverse Event (Other)|0
4699443|NCT02684357|7614960|FG002|Part B|Adverse Event (Other)|0
4699444|NCT02684357|7614961|FG003|Part B|Adverse Event (Other)|1
4699445|NCT02684357|7614962|FG004|Part B|Adverse Event (Other)|1
4699446|NCT02684357|7614963|FG005|Part B|Adverse Event (Other)|1
4699447|NCT02684357|7614958|FG000|Part B|Lost to Follow-up|0
4699448|NCT02684357|7614959|FG001|Part B|Lost to Follow-up|0
4699449|NCT02684357|7614960|FG002|Part B|Lost to Follow-up|0
4699450|NCT02684357|7614961|FG003|Part B|Lost to Follow-up|1
4699451|NCT02684357|7614962|FG004|Part B|Lost to Follow-up|1
4699452|NCT02684357|7614963|FG005|Part B|Lost to Follow-up|7
4699453|NCT02684357|7614958|FG000|Part B|Withdrawal by Subject|0
4699454|NCT02684357|7614959|FG001|Part B|Withdrawal by Subject|0
4699455|NCT02684357|7614960|FG002|Part B|Withdrawal by Subject|0
4699456|NCT02684357|7614961|FG003|Part B|Withdrawal by Subject|0
4699457|NCT02684357|7614962|FG004|Part B|Withdrawal by Subject|2
4699458|NCT02684357|7614963|FG005|Part B|Withdrawal by Subject|4
4699459|NCT02684357|7614958|FG000|Part B|Other|0
4699460|NCT02684357|7614959|FG001|Part B|Other|0
4699461|NCT02684357|7614960|FG002|Part B|Other|0
4699462|NCT02684357|7614961|FG003|Part B|Other|1
4699463|NCT02684357|7614962|FG004|Part B|Other|0
4699464|NCT02684357|7614963|FG005|Part B|Other|1
4699465|NCT02684370|7614979|FG000|Part A|Adverse Event|2
4699466|NCT02684370|7614980|FG001|Part A|Adverse Event|0
4699467|NCT02684370|7614981|FG002|Part A|Adverse Event|1
4699468|NCT02684370|7614982|FG003|Part A|Adverse Event|0
4699469|NCT02684370|7614983|FG004|Part A|Adverse Event|0
4699470|NCT02684370|7614984|FG005|Part A|Adverse Event|0
4699471|NCT02684370|7614979|FG000|Part A|Lost to Follow-up|1
4699472|NCT02684370|7614980|FG001|Part A|Lost to Follow-up|1
4699473|NCT02684370|7614981|FG002|Part A|Lost to Follow-up|0
4699474|NCT02684370|7614982|FG003|Part A|Lost to Follow-up|0
4699475|NCT02684370|7614983|FG004|Part A|Lost to Follow-up|0
4699476|NCT02684370|7614984|FG005|Part A|Lost to Follow-up|0
4699477|NCT02684370|7614979|FG000|Part A|Subject Withdrawal|1
4699478|NCT02684370|7614980|FG001|Part A|Subject Withdrawal|0
4699479|NCT02684370|7614981|FG002|Part A|Subject Withdrawal|3
4699480|NCT02684370|7614982|FG003|Part A|Subject Withdrawal|0
4699481|NCT02684370|7614983|FG004|Part A|Subject Withdrawal|0
4699482|NCT02684370|7614984|FG005|Part A|Subject Withdrawal|0
4699483|NCT02684370|7614979|FG000|Part A|Other|0
4699484|NCT02684370|7614980|FG001|Part A|Other|0
4699485|NCT02684370|7614981|FG002|Part A|Other|1
4699486|NCT02684370|7614982|FG003|Part A|Other|0
4699487|NCT02684370|7614983|FG004|Part A|Other|0
4699488|NCT02684370|7614984|FG005|Part A|Other|0
4699489|NCT02684370|7614979|FG000|Part B|Adverse Event|0
4699490|NCT02684370|7614980|FG001|Part B|Adverse Event|0
4699491|NCT02684370|7614981|FG002|Part B|Adverse Event|0
4699492|NCT02684370|7614982|FG003|Part B|Adverse Event|0
4699493|NCT02684370|7614983|FG004|Part B|Adverse Event|2
4699494|NCT02684370|7614984|FG005|Part B|Adverse Event|1
4699495|NCT02684370|7614979|FG000|Part B|Lost to Follow-up|0
4699496|NCT02684370|7614980|FG001|Part B|Lost to Follow-up|0
4699497|NCT02684370|7614981|FG002|Part B|Lost to Follow-up|0
4699498|NCT02684370|7614982|FG003|Part B|Lost to Follow-up|1
4699499|NCT02684370|7614983|FG004|Part B|Lost to Follow-up|2
4699500|NCT02684370|7614984|FG005|Part B|Lost to Follow-up|5
4699501|NCT02684370|7614979|FG000|Part B|Subject Withdrawal|0
4699502|NCT02684370|7614980|FG001|Part B|Subject Withdrawal|0
4699503|NCT02684370|7614981|FG002|Part B|Subject Withdrawal|0
4699504|NCT02684370|7614982|FG003|Part B|Subject Withdrawal|1
4699505|NCT02684370|7614983|FG004|Part B|Subject Withdrawal|1
4699506|NCT02684370|7614984|FG005|Part B|Subject Withdrawal|2
4699507|NCT02684617|7615048|FG000|Overall Study|Adverse Event|1
4699508|NCT02684617|7615049|FG001|Overall Study|Adverse Event|0
4699509|NCT02684617|7615050|FG002|Overall Study|Adverse Event|1
4699510|NCT02684617|7615048|FG000|Overall Study|Death|8
4699511|NCT02684617|7615049|FG001|Overall Study|Death|16
4699512|NCT02684617|7615050|FG002|Overall Study|Death|28
4699513|NCT02684617|7615048|FG000|Overall Study|Withdrawal by Subject|2
4699514|NCT02684617|7615049|FG001|Overall Study|Withdrawal by Subject|0
4699515|NCT02684617|7615050|FG002|Overall Study|Withdrawal by Subject|4
4699516|NCT02684617|7615048|FG000|Overall Study|Screen Failure|1
4699517|NCT02684617|7615049|FG001|Overall Study|Screen Failure|0
4699518|NCT02684617|7615050|FG002|Overall Study|Screen Failure|2
4699519|NCT02684617|7615048|FG000|Overall Study|Study Terminated by Sponsor|6
4699520|NCT02684617|7615049|FG001|Overall Study|Study Terminated by Sponsor|1
4699521|NCT02684617|7615050|FG002|Overall Study|Study Terminated by Sponsor|5
4699522|NCT02684981|7615088|FG000|Overall Study|Permanently discontinued the treatment|157
4699523|NCT02684981|7615089|FG001|Overall Study|Permanently discontinued the treatment|161
4699524|NCT02684981|7615090|FG002|Overall Study|Permanently discontinued the treatment|110
4699525|NCT02684981|7615088|FG000|Overall Study|Other|83
4699526|NCT02684981|7615089|FG001|Overall Study|Other|49
4699527|NCT02684981|7615090|FG002|Overall Study|Other|17
4699528|NCT02685033|7615110|FG000|Overall Study|Withdrawal of Consent|0
4699529|NCT02685033|7615111|FG001|Overall Study|Withdrawal of Consent|1
4699530|NCT02685033|7615110|FG000|Overall Study|Lost to Follow-up|2
4699531|NCT02685033|7615111|FG001|Overall Study|Lost to Follow-up|1
4699532|NCT02685033|7615110|FG000|Overall Study|Adverse Event|1
4699533|NCT02685033|7615111|FG001|Overall Study|Adverse Event|0
4699534|NCT02685072|7615119|FG000|Treatment Period|Lost to Follow-up|12
4699535|NCT02685072|7615120|FG001|Treatment Period|Lost to Follow-up|6
4699536|NCT02685072|7615119|FG000|Treatment Period|Withdrawal by Subject|1
4699537|NCT02685072|7615120|FG001|Treatment Period|Withdrawal by Subject|3
4699538|NCT02685072|7615119|FG000|1-Month Follow-Up|Withdrawal by Subject|1
4386679|NCT00039741|7165200|FG002|Overall Study|Withdrew consent|0
4386680|NCT00039741|7165201|FG003|Overall Study|Withdrew consent|1
4386681|NCT00039741|7165198|FG000|Overall Study|Missed final visit|2
4386682|NCT00039741|7165199|FG001|Overall Study|Missed final visit|1
4386683|NCT00039741|7165200|FG002|Overall Study|Missed final visit|2
4699539|NCT02685072|7615120|FG001|1-Month Follow-Up|Withdrawal by Subject|0
4699540|NCT02685488|7615149|FG000|Overall Study|Withdrawal by Subject|0
4699541|NCT02685488|7615150|FG001|Overall Study|Withdrawal by Subject|1
4699542|NCT02685826|7615168|FG000|Overall Study|Adverse Event|2
4699543|NCT02685826|7615169|FG001|Overall Study|Adverse Event|0
4699544|NCT02685826|7615170|FG002|Overall Study|Adverse Event|1
4699545|NCT02685826|7615168|FG000|Overall Study|Progressive Disease|2
4699546|NCT02685826|7615169|FG001|Overall Study|Progressive Disease|1
4699547|NCT02685826|7615170|FG002|Overall Study|Progressive Disease|0
4699548|NCT02685826|7615168|FG000|Overall Study|Withdrawal by Subject|2
4699549|NCT02685826|7615169|FG001|Overall Study|Withdrawal by Subject|0
4699550|NCT02685826|7615170|FG002|Overall Study|Withdrawal by Subject|0
4699551|NCT02685826|7615168|FG000|Overall Study|Full Clinical Hold by FDA|19
4699552|NCT02685826|7615169|FG001|Overall Study|Full Clinical Hold by FDA|9
4699553|NCT02685826|7615170|FG002|Overall Study|Full Clinical Hold by FDA|20
4699554|NCT02685995|7615191|FG000|Overall Study|Insertion of immediately puncturable graft.|1
4699555|NCT02685995|7615192|FG001|Overall Study|Insertion of immediately puncturable graft.|1
4699556|NCT02686034|7615200|FG000|Run-In Period 1|Eligibility|12
4699557|NCT02686034|7615201|FG001|Run-In Period 1|Eligibility|10
4699558|NCT02686034|7615200|FG000|Run-In Period 1|Withdrawal by Subject|4
4699559|NCT02686034|7615201|FG001|Run-In Period 1|Withdrawal by Subject|3
4699560|NCT02686034|7615200|FG000|Run-In Period 1|Lost to Follow-up|4
4699561|NCT02686034|7615201|FG001|Run-In Period 1|Lost to Follow-up|4
4699562|NCT02686034|7615200|FG000|Randomized Controlled Period 2|Lost to Follow-up|1
4699563|NCT02686034|7615201|FG001|Randomized Controlled Period 2|Lost to Follow-up|2
4699564|NCT02686034|7615200|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3
4699565|NCT02686034|7615201|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0
4699566|NCT02686034|7615200|FG000|Randomized Controlled Period 2|Adverse Event|0
4699567|NCT02686034|7615201|FG001|Randomized Controlled Period 2|Adverse Event|2
4699568|NCT02686034|7615200|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1
4699569|NCT02686034|7615201|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0
4699570|NCT02686034|7615200|FG000|Open Label Period 3|Lost to Follow-up|0
4699571|NCT02686034|7615201|FG001|Open Label Period 3|Lost to Follow-up|1
4699572|NCT02686164|7615216|FG000|Overall Study|Adverse Event|1
4699573|NCT02686164|7615216|FG000|Overall Study|Withdrawal of consent|1
4699574|NCT02686164|7615216|FG000|Overall Study|Clinical progression|1
4699575|NCT02687035|7615232|FG000|Overall Study|Withdrawal by Subject|1
4699576|NCT02687035|7615232|FG000|Overall Study|Death|87
4699577|NCT02687035|7615232|FG000|Overall Study|Lost to Follow-up|1
4699578|NCT02687035|7615232|FG000|Overall Study|Missed Visit|87
4699579|NCT02687035|7615232|FG000|Overall Study|Did not receive Study Device|8
4699580|NCT02687191|7615253|FG000|Overall Study|Death|0
4699581|NCT02687191|7615254|FG001|Overall Study|Death|1
4699582|NCT02687191|7615255|FG002|Overall Study|Death|1
4699583|NCT02687191|7615256|FG003|Overall Study|Death|0
4699584|NCT02687191|7615257|FG004|Overall Study|Death|1
4699585|NCT02687191|7615258|FG005|Overall Study|Death|1
4699586|NCT02687191|7615253|FG000|Overall Study|Withdrawal by Subject|0
4699587|NCT02687191|7615254|FG001|Overall Study|Withdrawal by Subject|0
4699588|NCT02687191|7615255|FG002|Overall Study|Withdrawal by Subject|0
4699589|NCT02687191|7615256|FG003|Overall Study|Withdrawal by Subject|1
4699590|NCT02687191|7615257|FG004|Overall Study|Withdrawal by Subject|0
4699591|NCT02687191|7615258|FG005|Overall Study|Withdrawal by Subject|0
4386684|NCT00039741|7165201|FG003|Overall Study|Missed final visit|2
4386685|NCT00039871|7165211|FG000|Overall Study|Adverse Event|165
4386686|NCT00039871|7165211|FG000|Overall Study|Lost to Follow-up|18
4386687|NCT00039871|7165211|FG000|Overall Study|Protocol Violation|24
4699592|NCT02687451|7615296|FG000|Overall Study|Withdrawal by Subject|1
4699593|NCT02687451|7615297|FG001|Overall Study|Withdrawal by Subject|0
4699594|NCT02687451|7615298|FG002|Overall Study|Withdrawal by Subject|0
4699595|NCT02687451|7615299|FG003|Overall Study|Withdrawal by Subject|0
4699596|NCT02687451|7615300|FG004|Overall Study|Withdrawal by Subject|0
4699597|NCT02687451|7615301|FG005|Overall Study|Withdrawal by Subject|1
4699598|NCT02687542|7615331|FG000|Overall Study|Medication error without associated AEs|0
4699599|NCT02687542|7615332|FG001|Overall Study|Medication error without associated AEs|0
4699600|NCT02687542|7615333|FG002|Overall Study|Medication error without associated AEs|0
4699601|NCT02687542|7615334|FG003|Overall Study|Medication error without associated AEs|0
4699602|NCT02687542|7615335|FG004|Overall Study|Medication error without associated AEs|1
4699603|NCT02687542|7615331|FG000|Overall Study|Lost to Follow-up|0
4699604|NCT02687542|7615332|FG001|Overall Study|Lost to Follow-up|0
4386688|NCT00039871|7165211|FG000|Overall Study|Withdrawal by Subject|97
4386689|NCT00039871|7165211|FG000|Overall Study|Did not meet eligibility criteria|11
4386690|NCT00039871|7165211|FG000|Overall Study|Administrative|1
4386691|NCT00039871|7165211|FG000|Overall Study|Discontinued at Week 12 per protocol|1061
4386692|NCT00039871|7165211|FG000|Overall Study|Never entered follow-up|7
4386693|NCT00040365|7165215|FG000|Overall Study|Death|1
4386694|NCT00040365|7165215|FG000|Overall Study|Progressive disease|7
4386695|NCT00040365|7165215|FG000|Overall Study|Lost to Follow-up|3
4386696|NCT00040664|7165228|FG000|Overall Study|Adverse Event|12
4386697|NCT00040664|7165229|FG001|Overall Study|Adverse Event|3
4386698|NCT00040664|7165230|FG002|Overall Study|Adverse Event|2
4386699|NCT00040664|7165231|FG003|Overall Study|Adverse Event|7
4386700|NCT00040664|7165228|FG000|Overall Study|Lack of Efficacy|9
4386701|NCT00040664|7165229|FG001|Overall Study|Lack of Efficacy|2
4386702|NCT00040664|7165230|FG002|Overall Study|Lack of Efficacy|3
4386703|NCT00040664|7165231|FG003|Overall Study|Lack of Efficacy|4
4386704|NCT00040664|7165228|FG000|Overall Study|Insufficient CD4 response|1
4386705|NCT00040664|7165229|FG001|Overall Study|Insufficient CD4 response|0
4386706|NCT00040664|7165230|FG002|Overall Study|Insufficient CD4 response|1
4386707|NCT00040664|7165231|FG003|Overall Study|Insufficient CD4 response|0
4386708|NCT00040664|7165228|FG000|Overall Study|Lost to Follow-up|4
4386709|NCT00040664|7165229|FG001|Overall Study|Lost to Follow-up|2
4386710|NCT00040664|7165230|FG002|Overall Study|Lost to Follow-up|0
4386711|NCT00040664|7165231|FG003|Overall Study|Lost to Follow-up|2
4386712|NCT00040664|7165228|FG000|Overall Study|Protocol Violation|2
4386713|NCT00040664|7165229|FG001|Overall Study|Protocol Violation|1
4386714|NCT00040664|7165230|FG002|Overall Study|Protocol Violation|0
4386715|NCT00040664|7165231|FG003|Overall Study|Protocol Violation|1
4386716|NCT00040664|7165228|FG000|Overall Study|Withdrawal by Subject|7
4386717|NCT00040664|7165229|FG001|Overall Study|Withdrawal by Subject|0
4478073|NCT00702403|7275026|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2
4478074|NCT00702403|7275026|FG000|From Consent to Engraftment|Myocardial infarction|1
4478075|NCT00702403|7275026|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4
4478076|NCT00702403|7275026|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2
4478077|NCT00702403|7275026|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11
4478078|NCT00702403|7275026|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4
4478079|NCT00702403|7275026|FG000|From Engraftment to Study Completion|Non-compliance|2
4478080|NCT00702403|7275026|FG000|From Engraftment to Study Completion|Adenocarcinoma|1
4478081|NCT00702403|7275026|FG000|From Engraftment to Study Completion|Liver GVHD|1
4478082|NCT00702403|7275026|FG000|From Engraftment to Study Completion|Suicide|1
4478083|NCT00702403|7275026|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1
4478084|NCT00702403|7275026|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1
4478085|NCT00702403|7275026|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5
4478086|NCT00702507|7275042|FG000|Initial Treatment Phase|Adverse Event|2
4478087|NCT00702507|7275042|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3
4478088|NCT00702507|7275042|FG000|Initial Treatment Phase|Lost to Follow-up|2
4478089|NCT00702507|7275042|FG000|Initial Treatment Phase|Negative Candida Culture|34
4478090|NCT00702507|7275042|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1
4478091|NCT00702507|7275042|FG000|Follow-up Phase|Protocol Violation|2
4478092|NCT00702507|7275042|FG000|Follow-up Phase|Lost to Follow-up|23
4478093|NCT00702507|7275042|FG000|Follow-up Phase|Late Enrollment|1
4478094|NCT00702650|7275047|FG000|Overall Study|Withdrawal by Subject|9
4478095|NCT00702650|7275047|FG000|Overall Study|Non-Compliance of Study Drug|3
4478096|NCT00702650|7275047|FG000|Overall Study|Lost to Follow-up|2
4478097|NCT00702650|7275047|FG000|Overall Study|Non-Compliance with Site Directives|1
4478098|NCT00702650|7275047|FG000|Overall Study|Sponsor Request|1
4478099|NCT00702650|7275047|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1
4478100|NCT00702650|7275047|FG000|Overall Study|Adverse Event|3
4478101|NCT00702689|7275051|FG000|Overall Study|Withdrawal by Subject|4
4478102|NCT00702689|7275051|FG000|Overall Study|Recurrent malignancy|1
4478103|NCT00702689|7275051|FG000|Overall Study|Adverse Event|1
4478104|NCT00702715|7275057|FG000|Overall Study|Lost to Follow-up|1
4478105|NCT00702715|7275058|FG001|Overall Study|Lost to Follow-up|0
4478106|NCT00702923|7275084|FG000|Overall Study|Adverse Event|1
4478107|NCT00702949|7275092|FG000|Overall Study|Refusal|3
4478108|NCT00702949|7275093|FG001|Overall Study|Refusal|2
4478109|NCT00702949|7275094|FG002|Overall Study|Refusal|2
4478110|NCT00702949|7275092|FG000|Overall Study|Adverse Event|1
4478111|NCT00702949|7275093|FG001|Overall Study|Adverse Event|6
4478112|NCT00702949|7275094|FG002|Overall Study|Adverse Event|3
4478113|NCT00702949|7275092|FG000|Overall Study|Other Medical Reason/unknown|1
4478114|NCT00702949|7275093|FG001|Overall Study|Other Medical Reason/unknown|1
4478115|NCT00702949|7275094|FG002|Overall Study|Other Medical Reason/unknown|3
4478116|NCT00703118|7275146|FG000|Overall Study|Adverse Event|1
4478117|NCT00703118|7275147|FG001|Overall Study|Adverse Event|2
4478118|NCT00703118|7275148|FG002|Overall Study|Adverse Event|2
4478119|NCT00703118|7275146|FG000|Overall Study|Subject Ineligible To Continue The Trial|6
4478120|NCT00703118|7275147|FG001|Overall Study|Subject Ineligible To Continue The Trial|3
4478121|NCT00703118|7275148|FG002|Overall Study|Subject Ineligible To Continue The Trial|2
4478122|NCT00703118|7275146|FG000|Overall Study|Lost to Follow-up|6
4478123|NCT00703118|7275147|FG001|Overall Study|Lost to Follow-up|4
4478124|NCT00703118|7275148|FG002|Overall Study|Lost to Follow-up|4
4478125|NCT00703118|7275146|FG000|Overall Study|Withdrawal by Subject|8
4478126|NCT00703118|7275147|FG001|Overall Study|Withdrawal by Subject|7
4478127|NCT00703118|7275148|FG002|Overall Study|Withdrawal by Subject|13
4478128|NCT00703118|7275146|FG000|Overall Study|Other|0
4478129|NCT00703118|7275147|FG001|Overall Study|Other|0
4478130|NCT00703118|7275148|FG002|Overall Study|Other|1
4478131|NCT00703157|7275161|FG000|Overall Study|Lost to Follow-up|0
4478132|NCT00703157|7275162|FG001|Overall Study|Lost to Follow-up|1
4478133|NCT00703157|7275161|FG000|Overall Study|source data permanently lost/ other|4
4478134|NCT00703157|7275162|FG001|Overall Study|source data permanently lost/ other|1
4478135|NCT00703677|7275208|FG000|Overall Study|Dropout-withdrawal not related to drug|3
4478136|NCT00703781|7275223|FG000|Overall Study|Withdrawal by Subject|1
4478137|NCT00703781|7275224|FG001|Overall Study|Withdrawal by Subject|2
4478138|NCT00703781|7275223|FG000|Overall Study|Cancelled surgery|1
4478139|NCT00703781|7275224|FG001|Overall Study|Cancelled surgery|0
4478140|NCT00703820|7275232|FG000|Overall Study|Adverse Event|12
4478141|NCT00703820|7275233|FG001|Overall Study|Adverse Event|17
4478142|NCT00703820|7275232|FG000|Overall Study|Death|5
4478143|NCT00703820|7275233|FG001|Overall Study|Death|0
4478144|NCT00703820|7275232|FG000|Overall Study|Lack of Efficacy|11
4478145|NCT00703820|7275233|FG001|Overall Study|Lack of Efficacy|11
4478146|NCT00703820|7275232|FG000|Overall Study|Received non-protocol therapy|1
4478147|NCT00703820|7275233|FG001|Overall Study|Received non-protocol therapy|0
4478148|NCT00703820|7275232|FG000|Overall Study|Physician Decision|4
4478149|NCT00703820|7275233|FG001|Overall Study|Physician Decision|5
4478150|NCT00703820|7275232|FG000|Overall Study|Withdrawal by Subject|2
4478151|NCT00703820|7275233|FG001|Overall Study|Withdrawal by Subject|1
4478152|NCT00703846|7275241|FG000|Overall Study|Adverse Event|8
4478153|NCT00703846|7275241|FG000|Overall Study|Lost to Follow-up|55
4478154|NCT00703846|7275241|FG000|Overall Study|Lack of Efficacy|15
4478155|NCT00703846|7275241|FG000|Overall Study|Noncompliance with Study Treatment|2
4478156|NCT00703846|7275241|FG000|Overall Study|Withdrawal by Subject|40
4478157|NCT00703846|7275241|FG000|Overall Study|Death|1
4478158|NCT00703846|7275241|FG000|Overall Study|Other|14
4478159|NCT00703846|7275241|FG000|Overall Study|Did Not Receive Study Drug|2
4478160|NCT00703911|7275245|FG000|Overall Study|Death|1
4478161|NCT00703911|7275245|FG000|Overall Study|Physician Decision|6
4478162|NCT00703911|7275245|FG000|Overall Study|Lost to Follow-up|1
4478163|NCT00703911|7275245|FG000|Overall Study|Withdrawal by Subject|2
4478164|NCT00703924|7275251|FG000|Overall Study|Withdrawal by Subject|1
4478165|NCT00703924|7275252|FG001|Overall Study|Withdrawal by Subject|1
4478166|NCT00703963|7275273|FG000|Overall Study|Withdrawal by Subject|7
4478167|NCT00703963|7275274|FG001|Overall Study|Withdrawal by Subject|13
4478168|NCT00703963|7275273|FG000|Overall Study|Physician Decision|0
4478169|NCT00703963|7275274|FG001|Overall Study|Physician Decision|1
4478170|NCT00704132|7275302|FG000|Overall Study|Clinical Adverse Experience|1
4478171|NCT00704132|7275303|FG001|Overall Study|Clinical Adverse Experience|0
4478172|NCT00704132|7275302|FG000|Overall Study|Lack of Efficacy|0
4478173|NCT00704132|7275303|FG001|Overall Study|Lack of Efficacy|1
4478174|NCT00704132|7275302|FG000|Overall Study|Withdrawal by Subject|0
4478175|NCT00704132|7275303|FG001|Overall Study|Withdrawal by Subject|1
4478176|NCT00704171|7275311|FG000|Overall Study|Withdrawal by Subject|1
4478177|NCT00704171|7275312|FG001|Overall Study|Withdrawal by Subject|0
4478178|NCT00704184|7275323|FG000|Double-Blind Treatment|Withdrawal by Subject|1
4478179|NCT00704184|7275324|FG001|Double-Blind Treatment|Withdrawal by Subject|0
4478180|NCT00704184|7275325|FG002|Double-Blind Treatment|Withdrawal by Subject|0
4478181|NCT00704184|7275326|FG003|Double-Blind Treatment|Withdrawal by Subject|0
4478182|NCT00704184|7275327|FG004|Double-Blind Treatment|Withdrawal by Subject|0
4478183|NCT00704184|7275323|FG000|Open-Label Treatment|Adverse Event|0
4478184|NCT00704184|7275324|FG001|Open-Label Treatment|Adverse Event|0
4478185|NCT00704184|7275325|FG002|Open-Label Treatment|Adverse Event|2
4478186|NCT00704184|7275326|FG003|Open-Label Treatment|Adverse Event|0
4478187|NCT00704184|7275327|FG004|Open-Label Treatment|Adverse Event|1
4478188|NCT00704184|7275323|FG000|Open-Label Treatment|Lack of Efficacy|0
4478189|NCT00704184|7275324|FG001|Open-Label Treatment|Lack of Efficacy|2
4478190|NCT00704184|7275325|FG002|Open-Label Treatment|Lack of Efficacy|2
4478191|NCT00704184|7275326|FG003|Open-Label Treatment|Lack of Efficacy|2
4478192|NCT00704184|7275327|FG004|Open-Label Treatment|Lack of Efficacy|1
4478193|NCT00704184|7275323|FG000|Open-Label Treatment|Physician Decision|0
4478194|NCT00704184|7275324|FG001|Open-Label Treatment|Physician Decision|0
4478195|NCT00704184|7275325|FG002|Open-Label Treatment|Physician Decision|0
4478196|NCT00704184|7275326|FG003|Open-Label Treatment|Physician Decision|0
4478197|NCT00704184|7275327|FG004|Open-Label Treatment|Physician Decision|1
4478198|NCT00704184|7275323|FG000|Open-Label Treatment|Withdrawal by Subject|1
4478199|NCT00704184|7275324|FG001|Open-Label Treatment|Withdrawal by Subject|0
4478200|NCT00704184|7275325|FG002|Open-Label Treatment|Withdrawal by Subject|0
4478201|NCT00704184|7275326|FG003|Open-Label Treatment|Withdrawal by Subject|3
4478202|NCT00704184|7275327|FG004|Open-Label Treatment|Withdrawal by Subject|0
4478203|NCT00704340|7275345|FG000|Overall Study|Lost to Follow-up|2
4478204|NCT00704340|7275346|FG001|Overall Study|Lost to Follow-up|1
4478205|NCT00704340|7275345|FG000|Overall Study|Death|0
4478206|NCT00704340|7275346|FG001|Overall Study|Death|1
4478207|NCT00704405|7275377|FG000|Overall Study (NC Population)|Adverse Event|1
4478208|NCT00704405|7275378|FG001|Overall Study (NC Population)|Adverse Event|0
4478209|NCT00704405|7275379|FG002|Overall Study (NC Population)|Adverse Event|0
4478210|NCT00704405|7275380|FG003|Overall Study (NC Population)|Adverse Event|0
4478211|NCT00704405|7275381|FG004|Overall Study (NC Population)|Adverse Event|0
4478212|NCT00704405|7275377|FG000|Overall Study (NC Population)|Lost to Follow-up|2
4478213|NCT00704405|7275378|FG001|Overall Study (NC Population)|Lost to Follow-up|1
4478214|NCT00704405|7275379|FG002|Overall Study (NC Population)|Lost to Follow-up|1
4478215|NCT00704405|7275380|FG003|Overall Study (NC Population)|Lost to Follow-up|2
4478216|NCT00704405|7275381|FG004|Overall Study (NC Population)|Lost to Follow-up|2
4478217|NCT00704405|7275377|FG000|Overall Study (NC Population)|Withdrawal by Subject|2
4478218|NCT00704405|7275378|FG001|Overall Study (NC Population)|Withdrawal by Subject|3
4478219|NCT00704405|7275379|FG002|Overall Study (NC Population)|Withdrawal by Subject|2
4478220|NCT00704405|7275380|FG003|Overall Study (NC Population)|Withdrawal by Subject|2
4478221|NCT00704405|7275381|FG004|Overall Study (NC Population)|Withdrawal by Subject|2
4478222|NCT00704405|7275377|FG000|Overall Study (NC Population)|Other|0
4478223|NCT00704405|7275378|FG001|Overall Study (NC Population)|Other|0
4478224|NCT00704405|7275379|FG002|Overall Study (NC Population)|Other|0
4478225|NCT00704405|7275380|FG003|Overall Study (NC Population)|Other|0
4478226|NCT00704405|7275381|FG004|Overall Study (NC Population)|Other|1
4478227|NCT00704405|7275377|FG000|Overall Study (C Population)|Withdrawal by Subject|1
4478228|NCT00704405|7275378|FG001|Overall Study (C Population)|Withdrawal by Subject|1
4478229|NCT00704405|7275379|FG002|Overall Study (C Population)|Withdrawal by Subject|1
4478230|NCT00704405|7275380|FG003|Overall Study (C Population)|Withdrawal by Subject|1
4478231|NCT00704405|7275381|FG004|Overall Study (C Population)|Withdrawal by Subject|0
4478232|NCT00704405|7275377|FG000|Overall Study (C Population)|Lost to Follow-up|0
4478233|NCT00704405|7275378|FG001|Overall Study (C Population)|Lost to Follow-up|2
4478234|NCT00704405|7275379|FG002|Overall Study (C Population)|Lost to Follow-up|0
4478235|NCT00704405|7275380|FG003|Overall Study (C Population)|Lost to Follow-up|0
4478236|NCT00704405|7275381|FG004|Overall Study (C Population)|Lost to Follow-up|0
4478237|NCT00704418|7275401|FG000|Overall Study|Withdrawal by Subject|2
4478238|NCT00704418|7275402|FG001|Overall Study|Withdrawal by Subject|0
4478239|NCT00704418|7275401|FG000|Overall Study|Over-enrolled/surgery postponed|3
4478240|NCT00704418|7275402|FG001|Overall Study|Over-enrolled/surgery postponed|6
4478241|NCT00704522|7275410|FG000|Overall Study|Lack of Efficacy|65
4478242|NCT00704522|7275411|FG001|Overall Study|Lack of Efficacy|17
4478243|NCT00704522|7275410|FG000|Overall Study|Failure to appear again at hospital|56
4589505|NCT01513291|7434915|FG004|Run-out Period|Lost to Follow-up|0
4478244|NCT00704522|7275411|FG001|Overall Study|Failure to appear again at hospital|10
4478245|NCT00704522|7275410|FG000|Overall Study|Withdrawal by Subject|17
4589506|NCT01513291|7434911|FG000|Run-out Period|Withdrawal by Subject|0
4589507|NCT01513291|7434912|FG001|Run-out Period|Withdrawal by Subject|0
4589508|NCT01513291|7434913|FG002|Run-out Period|Withdrawal by Subject|0
4589509|NCT01513291|7434914|FG003|Run-out Period|Withdrawal by Subject|1
4589510|NCT01513291|7434915|FG004|Run-out Period|Withdrawal by Subject|0
4589511|NCT01513317|7434929|FG000|Overall Study|Withdrawal by Subject|15
4589512|NCT01513317|7434930|FG001|Overall Study|Withdrawal by Subject|4
4589513|NCT01513317|7434929|FG000|Overall Study|Death|1
4589514|NCT01513317|7434930|FG001|Overall Study|Death|1
4589515|NCT01513317|7434929|FG000|Overall Study|Study terminated by sponsor|18
4478246|NCT00704522|7275411|FG001|Overall Study|Withdrawal by Subject|8
4478247|NCT00704522|7275410|FG000|Overall Study|Adverse Event|9
4478248|NCT00704522|7275411|FG001|Overall Study|Adverse Event|1
4478249|NCT00704522|7275410|FG000|Overall Study|Undefined causes|9
4478250|NCT00704522|7275411|FG001|Overall Study|Undefined causes|7
4478251|NCT00704522|7275410|FG000|Overall Study|No information on therapy end|27
4478252|NCT00704522|7275411|FG001|Overall Study|No information on therapy end|2
4478253|NCT00704730|7275422|FG000|Overall Study|Adverse Event|35
4478254|NCT00704730|7275423|FG001|Overall Study|Adverse Event|9
4478255|NCT00704730|7275422|FG000|Overall Study|Death|11
4478256|NCT00704730|7275423|FG001|Overall Study|Death|5
4478257|NCT00704730|7275422|FG000|Overall Study|Physician Decision|2
4478258|NCT00704730|7275423|FG001|Overall Study|Physician Decision|0
4478259|NCT00704730|7275422|FG000|Overall Study|Did not receive drug|5
4478260|NCT00704730|7275423|FG001|Overall Study|Did not receive drug|2
4478261|NCT00704730|7275422|FG000|Overall Study|Disease progression per PI|58
4478262|NCT00704730|7275423|FG001|Overall Study|Disease progression per PI|67
4478263|NCT00704730|7275422|FG000|Overall Study|data unavailable|1
4478264|NCT00704730|7275423|FG001|Overall Study|data unavailable|0
4478265|NCT00704730|7275422|FG000|Overall Study|Withdrawal by Subject|9
4478266|NCT00704730|7275423|FG001|Overall Study|Withdrawal by Subject|13
4478267|NCT00704808|7275430|FG000|Overall Study|Discontinued prior to starting treatment|14
4478268|NCT00704808|7275430|FG000|Overall Study|Death|7
4478269|NCT00704808|7275430|FG000|Overall Study|Tumor progression|80
4478270|NCT00704808|7275430|FG000|Overall Study|Patient's decision|11
4478271|NCT00704808|7275430|FG000|Overall Study|Early therapy discontinuation|16
4478272|NCT00704808|7275430|FG000|Overall Study|Adverse Event|1
4478273|NCT00704808|7275430|FG000|Overall Study|Lost to Follow-up|1
4589516|NCT01513317|7434930|FG001|Overall Study|Study terminated by sponsor|18
4478274|NCT00704808|7275430|FG000|Overall Study|Treatment change|1
4478275|NCT00704964|7275465|FG000|Overall Study|Not completed on time|328
4478276|NCT00705016|7275486|FG000|Overall Study|Adverse Event|6
4478277|NCT00705016|7275487|FG001|Overall Study|Adverse Event|11
4478278|NCT00705016|7275488|FG002|Overall Study|Adverse Event|10
4478279|NCT00705016|7275486|FG000|Overall Study|Death|5
4478280|NCT00705016|7275487|FG001|Overall Study|Death|7
4478281|NCT00705016|7275488|FG002|Overall Study|Death|5
4478282|NCT00705016|7275486|FG000|Overall Study|Protocol Violation|0
4478283|NCT00705016|7275487|FG001|Overall Study|Protocol Violation|1
4478284|NCT00705016|7275488|FG002|Overall Study|Protocol Violation|1
4478285|NCT00705016|7275486|FG000|Overall Study|Withdrawal by Subject|4
4478286|NCT00705016|7275487|FG001|Overall Study|Withdrawal by Subject|3
4478287|NCT00705016|7275488|FG002|Overall Study|Withdrawal by Subject|2
4478288|NCT00705016|7275486|FG000|Overall Study|Progressive Disease|33
4478289|NCT00705016|7275487|FG001|Overall Study|Progressive Disease|29
4478290|NCT00705016|7275488|FG002|Overall Study|Progressive Disease|33
4478291|NCT00705016|7275486|FG000|Overall Study|Symptomatic Deterioration|3
4478292|NCT00705016|7275487|FG001|Overall Study|Symptomatic Deterioration|1
4478293|NCT00705016|7275488|FG002|Overall Study|Symptomatic Deterioration|1
4478294|NCT00705016|7275486|FG000|Overall Study|Other|9
4478295|NCT00705016|7275487|FG001|Overall Study|Other|6
4478296|NCT00705016|7275488|FG002|Overall Study|Other|6
4478297|NCT00705146|7275506|FG000|Overall Study|Lost to Follow-up|1
4478298|NCT00705146|7275507|FG001|Overall Study|Lost to Follow-up|1
4478299|NCT00705159|7275517|FG000|Overall Study|Withdrawal by Subject|0
4478300|NCT00705159|7275518|FG001|Overall Study|Withdrawal by Subject|1
4478301|NCT00705159|7275519|FG002|Overall Study|Withdrawal by Subject|1
4478302|NCT00705159|7275520|FG003|Overall Study|Withdrawal by Subject|1
4478303|NCT00705159|7275517|FG000|Overall Study|Protocol Violation|0
4478304|NCT00705159|7275518|FG001|Overall Study|Protocol Violation|1
4478305|NCT00705159|7275519|FG002|Overall Study|Protocol Violation|0
4478306|NCT00705159|7275520|FG003|Overall Study|Protocol Violation|0
4478307|NCT00705159|7275517|FG000|Overall Study|Adverse Event|0
4478308|NCT00705159|7275518|FG001|Overall Study|Adverse Event|0
4478309|NCT00705159|7275519|FG002|Overall Study|Adverse Event|1
4478310|NCT00705159|7275520|FG003|Overall Study|Adverse Event|0
4478311|NCT00705159|7275517|FG000|Overall Study|Lost to Follow-up|0
4478312|NCT00705159|7275518|FG001|Overall Study|Lost to Follow-up|0
4699605|NCT02687542|7615333|FG002|Overall Study|Lost to Follow-up|0
4699606|NCT02687542|7615334|FG003|Overall Study|Lost to Follow-up|0
4699607|NCT02687542|7615335|FG004|Overall Study|Lost to Follow-up|1
4699608|NCT02687542|7615331|FG000|Overall Study|Protocol Violation|0
4699609|NCT02687542|7615332|FG001|Overall Study|Protocol Violation|1
4699610|NCT02687542|7615333|FG002|Overall Study|Protocol Violation|0
4699611|NCT02687542|7615334|FG003|Overall Study|Protocol Violation|0
4699612|NCT02687542|7615335|FG004|Overall Study|Protocol Violation|0
4699613|NCT02687542|7615331|FG000|Overall Study|Other|5
4699614|NCT02687542|7615332|FG001|Overall Study|Other|9
4699615|NCT02687542|7615333|FG002|Overall Study|Other|10
4699616|NCT02687542|7615334|FG003|Overall Study|Other|6
4699617|NCT02687542|7615335|FG004|Overall Study|Other|5
4699618|NCT02687542|7615331|FG000|Overall Study|Adverse Event|3
4699619|NCT02687542|7615332|FG001|Overall Study|Adverse Event|1
4699620|NCT02687542|7615333|FG002|Overall Study|Adverse Event|3
4699621|NCT02687542|7615334|FG003|Overall Study|Adverse Event|2
4699622|NCT02687542|7615335|FG004|Overall Study|Adverse Event|9
4699623|NCT02687542|7615331|FG000|Overall Study|Withdrawal by Subject|0
4699624|NCT02687542|7615332|FG001|Overall Study|Withdrawal by Subject|1
4699625|NCT02687542|7615333|FG002|Overall Study|Withdrawal by Subject|1
4699626|NCT02687542|7615334|FG003|Overall Study|Withdrawal by Subject|2
4699627|NCT02687542|7615335|FG004|Overall Study|Withdrawal by Subject|4
4699628|NCT02687711|7615347|FG000|Overall Study|Adverse Event|89
4699629|NCT02687711|7615347|FG000|Overall Study|Lack of Efficacy|70
4699630|NCT02687711|7615347|FG000|Overall Study|Lost to Follow-up|20
4699631|NCT02687711|7615347|FG000|Overall Study|Consent withdrawn|15
4699632|NCT02687711|7615347|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1
4699633|NCT02687711|7615347|FG000|Overall Study|Too expensive|4
4699634|NCT02687711|7615347|FG000|Overall Study|Participant moved abroad|1
4699635|NCT02687711|7615347|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1
4699636|NCT02687711|7615347|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1
4478313|NCT00705159|7275519|FG002|Overall Study|Lost to Follow-up|3
4478314|NCT00705159|7275520|FG003|Overall Study|Lost to Follow-up|2
4589517|NCT01513317|7434929|FG000|Overall Study|Other|0
4699637|NCT02687711|7615347|FG000|Overall Study|Disliked taste|1
4699638|NCT02687711|7615347|FG000|Overall Study|Low mood|1
4478315|NCT00705159|7275517|FG000|Overall Study|Screen Failure|0
4478316|NCT00705159|7275518|FG001|Overall Study|Screen Failure|0
4478317|NCT00705159|7275519|FG002|Overall Study|Screen Failure|0
4478318|NCT00705159|7275520|FG003|Overall Study|Screen Failure|1
4478319|NCT00705224|7275530|FG000|Overall Study|Adverse Event|1
4478320|NCT00705224|7275530|FG000|Overall Study|Lack of Efficacy|2
4478321|NCT00705224|7275530|FG000|Overall Study|Withdrawal by Subject|3
4699639|NCT02687711|7615347|FG000|Overall Study|Side effects|1
4699640|NCT02687711|7615347|FG000|Overall Study|Change of Hospital|1
4699641|NCT02687711|7615347|FG000|Overall Study|Liver Encephalopathy|1
4478322|NCT00705224|7275530|FG000|Overall Study|Lost to Follow-up|5
4478323|NCT00705250|7275537|FG000|Overall Study|Withdrawal by Subject|1
4478324|NCT00705250|7275537|FG000|Overall Study|Patient died in car accident|1
4478325|NCT00705263|7275541|FG000|Overall Study|Withdrawal by Subject|2
4478326|NCT00705289|7275545|FG000|Overall Study|Subject or treating physician's choice|131
4478327|NCT00705341|7275568|FG000|Phase 2: Trial|Withdrawal by Subject|0
4478328|NCT00705341|7275569|FG001|Phase 2: Trial|Withdrawal by Subject|0
4478329|NCT00705341|7275570|FG002|Phase 2: Trial|Withdrawal by Subject|6
4478330|NCT00705341|7275571|FG003|Phase 2: Trial|Withdrawal by Subject|4
4478331|NCT00705341|7275568|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0
4478332|NCT00705341|7275569|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0
4478333|NCT00705341|7275570|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1
4478334|NCT00705341|7275571|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0
4478335|NCT00705367|7275581|FG000|Long-term Extension Period|Adverse Event|2
4478336|NCT00705367|7275582|FG001|Long-term Extension Period|Adverse Event|0
4478337|NCT00705367|7275581|FG000|Long-term Extension Period|Withdrawal by Subject|2
4478338|NCT00705367|7275582|FG001|Long-term Extension Period|Withdrawal by Subject|0
4478339|NCT00705367|7275581|FG000|Long-term Extension Period|Lack of Efficacy|1
4478340|NCT00705367|7275582|FG001|Long-term Extension Period|Lack of Efficacy|0
4478341|NCT00705367|7275581|FG000|Long-term Extension Period|No longer met study criteria|1
4478342|NCT00705367|7275582|FG001|Long-term Extension Period|No longer met study criteria|0
4478343|NCT00705367|7275581|FG000|Long-term Extension Period|Administrative reason by sponsor|3
4478344|NCT00705367|7275582|FG001|Long-term Extension Period|Administrative reason by sponsor|0
4478345|NCT00705406|7275592|FG000|Overall Study|Lost to Follow-up|3
4478346|NCT00705406|7275593|FG001|Overall Study|Lost to Follow-up|3
4478347|NCT00705406|7275592|FG000|Overall Study|Did not receive study drug|1
4478348|NCT00705406|7275593|FG001|Overall Study|Did not receive study drug|2
4478349|NCT00705432|7275606|FG000|Treatment Period|Adverse Event|45
4478350|NCT00705432|7275607|FG001|Treatment Period|Adverse Event|37
4478351|NCT00705432|7275608|FG002|Treatment Period|Adverse Event|51
4478352|NCT00705432|7275609|FG003|Treatment Period|Adverse Event|12
4478353|NCT00705432|7275610|FG004|Treatment Period|Adverse Event|8
4478354|NCT00705432|7275611|FG005|Treatment Period|Adverse Event|9
4478355|NCT00705432|7275606|FG000|Treatment Period|Treatment failure|92
4478356|NCT00705432|7275607|FG001|Treatment Period|Treatment failure|42
4478357|NCT00705432|7275608|FG002|Treatment Period|Treatment failure|33
4478358|NCT00705432|7275609|FG003|Treatment Period|Treatment failure|25
4478359|NCT00705432|7275610|FG004|Treatment Period|Treatment failure|13
4478360|NCT00705432|7275611|FG005|Treatment Period|Treatment failure|14
4478361|NCT00705432|7275606|FG000|Treatment Period|Non medical reason|26
4478362|NCT00705432|7275607|FG001|Treatment Period|Non medical reason|32
4478363|NCT00705432|7275608|FG002|Treatment Period|Non medical reason|37
4478364|NCT00705432|7275609|FG003|Treatment Period|Non medical reason|4
4478365|NCT00705432|7275610|FG004|Treatment Period|Non medical reason|7
4478366|NCT00705432|7275611|FG005|Treatment Period|Non medical reason|7
4478367|NCT00705432|7275606|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2
4478368|NCT00705432|7275607|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1
4478369|NCT00705432|7275608|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1
4478370|NCT00705432|7275609|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0
4478371|NCT00705432|7275610|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0
4478372|NCT00705432|7275611|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0
4478373|NCT00705432|7275606|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69
4478374|NCT00705432|7275607|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42
4478375|NCT00705432|7275608|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24
4478376|NCT00705432|7275609|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14
4478377|NCT00705432|7275610|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6
4478378|NCT00705432|7275611|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7
4478379|NCT00705484|7275624|FG000|Overall Study|Adverse Event|28
4478380|NCT00705484|7275625|FG001|Overall Study|Adverse Event|27
4478381|NCT00705484|7275624|FG000|Overall Study|Lost to Follow-up|169
4478382|NCT00705484|7275625|FG001|Overall Study|Lost to Follow-up|250
4478383|NCT00705484|7275624|FG000|Overall Study|Withdrawal by Subject|96
4478384|NCT00705484|7275625|FG001|Overall Study|Withdrawal by Subject|72
4478385|NCT00705484|7275624|FG000|Overall Study|Administrative|89
4478386|NCT00705484|7275625|FG001|Overall Study|Administrative|59
4478387|NCT00705523|7275635|FG000|Overall Study|Lost to Follow-up|2
4478388|NCT00705523|7275636|FG001|Overall Study|Lost to Follow-up|3
4478389|NCT00705536|7275644|FG000|Start Period 1|Withdrawal by Subject|0
4478390|NCT00705536|7275645|FG001|Start Period 1|Withdrawal by Subject|0
4478391|NCT00705536|7275646|FG002|Start Period 1|Withdrawal by Subject|0
4478392|NCT00705536|7275647|FG003|Start Period 1|Withdrawal by Subject|1
4478393|NCT00705575|7275668|FG000|Overall Study|Abnormal laboratory value(s)|0
4478394|NCT00705575|7275669|FG001|Overall Study|Abnormal laboratory value(s)|3
4478395|NCT00705575|7275668|FG000|Overall Study|Abnormal test procedure result(s)|2
4478396|NCT00705575|7275669|FG001|Overall Study|Abnormal test procedure result(s)|12
4478397|NCT00705575|7275668|FG000|Overall Study|Adverse Event|11
4478398|NCT00705575|7275669|FG001|Overall Study|Adverse Event|15
4478399|NCT00705575|7275668|FG000|Overall Study|Lost to Follow-up|3
4478400|NCT00705575|7275669|FG001|Overall Study|Lost to Follow-up|4
4478401|NCT00705575|7275668|FG000|Overall Study|Protocol Violation|2
4478402|NCT00705575|7275669|FG001|Overall Study|Protocol Violation|2
4589518|NCT01513317|7434930|FG001|Overall Study|Other|1
4589519|NCT01513330|7434936|FG000|SenSura Mio First,|Adverse Event|2
4699642|NCT02687711|7615347|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1
4699643|NCT02687711|7615347|FG000|Overall Study|Withdrawn due to intake interruption|1
4478403|NCT00705575|7275668|FG000|Overall Study|Withdrawal by Subject|5
4478404|NCT00705575|7275669|FG001|Overall Study|Withdrawal by Subject|10
4478405|NCT00705614|7275677|FG000|Initial Intervention|Adverse Event|40
4478406|NCT00705614|7275678|FG001|Initial Intervention|Adverse Event|21
4478407|NCT00705614|7275677|FG000|Initial Intervention|Lost to Follow-up|310
4478408|NCT00705614|7275678|FG001|Initial Intervention|Lost to Follow-up|191
4699644|NCT02687711|7615347|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1
4699645|NCT02687711|7615347|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1
4699646|NCT02687711|7615347|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1
4699647|NCT02687815|7615353|FG000|Overall Study|Lost to Follow-up|2
4699648|NCT02687815|7615354|FG001|Overall Study|Lost to Follow-up|4
4699649|NCT02687815|7615353|FG000|Overall Study|Withdrawal by Subject|2
4478409|NCT00705614|7275677|FG000|Initial Intervention|Withdrawal by Subject|114
4478410|NCT00705614|7275678|FG001|Initial Intervention|Withdrawal by Subject|71
4478411|NCT00705614|7275677|FG000|Initial Intervention|Administrative Reason|51
4478412|NCT00705614|7275678|FG001|Initial Intervention|Administrative Reason|38
4478413|NCT00705614|7275677|FG000|Initial Intervention|Status completion unknown|3
4478414|NCT00705614|7275678|FG001|Initial Intervention|Status completion unknown|0
4478415|NCT00705614|7275677|FG000|Switch to Remicade|Adverse Event|0
4478416|NCT00705614|7275678|FG001|Switch to Remicade|Adverse Event|5
4478417|NCT00705614|7275677|FG000|Switch to Remicade|Lost to Follow-up|0
4478418|NCT00705614|7275678|FG001|Switch to Remicade|Lost to Follow-up|23
4478419|NCT00705614|7275677|FG000|Switch to Remicade|Withdrawal by Subject|0
4478420|NCT00705614|7275678|FG001|Switch to Remicade|Withdrawal by Subject|12
4478421|NCT00705614|7275677|FG000|Switch to Remicade|Administrative Reason|0
4478422|NCT00705614|7275678|FG001|Switch to Remicade|Administrative Reason|9
4478423|NCT00705666|7275690|FG000|Overall Study|No post-treatment questionnaire|279
4478424|NCT00705666|7275690|FG000|Overall Study|Withdrawal by Subject|21
4478425|NCT00705666|7275690|FG000|Overall Study|Physician Decision|7
4478426|NCT00705666|7275690|FG000|Overall Study|Lost to Follow-up|5
4478427|NCT00705666|7275690|FG000|Overall Study|Death|1
4478428|NCT00705666|7275690|FG000|Overall Study|Adverse Event|4
4478429|NCT00705666|7275690|FG000|Overall Study|Other|12
4478430|NCT00705666|7275690|FG000|Overall Study|Other|2
4478431|NCT00705666|7275690|FG000|Overall Study|Lack of data|3
4699650|NCT02687815|7615354|FG001|Overall Study|Withdrawal by Subject|4
4699651|NCT02687919|7615362|FG000|Overall Study|Withdrawal by Subject|6
4699652|NCT02687919|7615363|FG001|Overall Study|Withdrawal by Subject|6
4699653|NCT02687919|7615362|FG000|Overall Study|Protocol Violation|2
4699654|NCT02687919|7615363|FG001|Overall Study|Protocol Violation|0
4699655|NCT02688153|7615371|FG000|Overall Study|Death|7
4699656|NCT02688153|7615372|FG001|Overall Study|Death|5
4699657|NCT02688153|7615371|FG000|Overall Study|Withdrawal by Subject|4
4699658|NCT02688153|7615372|FG001|Overall Study|Withdrawal by Subject|2
4699659|NCT02688153|7615371|FG000|Overall Study|Valve Explant|1
4699660|NCT02688153|7615372|FG001|Overall Study|Valve Explant|0
4699661|NCT02688153|7615371|FG000|Overall Study|Conversion to Commercial Valve|3
4699662|NCT02688153|7615372|FG001|Overall Study|Conversion to Commercial Valve|0
4699663|NCT02688192|7615381|FG000|Overall Study|Lost to Follow-up|11
4699664|NCT02688192|7615382|FG001|Overall Study|Lost to Follow-up|5
4699665|NCT02688192|7615381|FG000|Overall Study|Physician Decision|1
4699666|NCT02688192|7615382|FG001|Overall Study|Physician Decision|0
4699667|NCT02688387|7615402|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
4699668|NCT02688387|7615403|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
4699669|NCT02688387|7615404|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1
4699670|NCT02688387|7615405|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
4699671|NCT02688387|7615406|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
4699672|NCT02688387|7615407|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
4699673|NCT02688387|7615408|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
4699674|NCT02688387|7615409|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
4699675|NCT02688387|7615410|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
4699676|NCT02688387|7615411|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
4699677|NCT02688387|7615412|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
4699678|NCT02688387|7615413|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
4699679|NCT02688387|7615414|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
4699680|NCT02688387|7615415|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
4699681|NCT02688387|7615416|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
4699682|NCT02688387|7615417|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
4478432|NCT00705666|7275690|FG000|Overall Study|Untreated|5
4478433|NCT00705679|7275699|FG000|Overall Study|Adverse Event|1
4478434|NCT00705679|7275700|FG001|Overall Study|Adverse Event|1
4478435|NCT00705679|7275701|FG002|Overall Study|Adverse Event|0
4478436|NCT00705679|7275702|FG003|Overall Study|Adverse Event|0
4589520|NCT01513330|7434937|FG001|SenSura Mio First,|Adverse Event|0
4478437|NCT00705679|7275703|FG004|Overall Study|Adverse Event|0
4478438|NCT00705679|7275699|FG000|Overall Study|Death|0
4478439|NCT00705679|7275700|FG001|Overall Study|Death|0
4478440|NCT00705679|7275701|FG002|Overall Study|Death|3
4478441|NCT00705679|7275702|FG003|Overall Study|Death|2
4478442|NCT00705679|7275703|FG004|Overall Study|Death|1
4478443|NCT00705679|7275699|FG000|Overall Study|Lost to Follow-up|32
4478444|NCT00705679|7275700|FG001|Overall Study|Lost to Follow-up|60
4478445|NCT00705679|7275701|FG002|Overall Study|Lost to Follow-up|44
4478446|NCT00705679|7275702|FG003|Overall Study|Lost to Follow-up|30
4478447|NCT00705679|7275703|FG004|Overall Study|Lost to Follow-up|35
4478448|NCT00705679|7275699|FG000|Overall Study|Physician Decision|0
4478449|NCT00705679|7275700|FG001|Overall Study|Physician Decision|1
4478450|NCT00705679|7275701|FG002|Overall Study|Physician Decision|0
4478451|NCT00705679|7275702|FG003|Overall Study|Physician Decision|1
4478452|NCT00705679|7275703|FG004|Overall Study|Physician Decision|0
4478453|NCT00705679|7275699|FG000|Overall Study|Withdrawal by Subject|32
4478454|NCT00705679|7275700|FG001|Overall Study|Withdrawal by Subject|77
4478455|NCT00705679|7275701|FG002|Overall Study|Withdrawal by Subject|68
4478456|NCT00705679|7275702|FG003|Overall Study|Withdrawal by Subject|47
4478457|NCT00705679|7275703|FG004|Overall Study|Withdrawal by Subject|33
4478458|NCT00705718|7275722|FG000|Overall Study|Death|6
4478459|NCT00705718|7275723|FG001|Overall Study|Death|6
4478460|NCT00705718|7275722|FG000|Overall Study|Not due for Visit|0
4478461|NCT00705718|7275723|FG001|Overall Study|Not due for Visit|12
4478462|NCT00705718|7275722|FG000|Overall Study|Follow up not done|1
4478463|NCT00705718|7275723|FG001|Overall Study|Follow up not done|4
4478464|NCT00705757|7275732|FG000|Overall Study|Lack of Efficacy|5
4478465|NCT00705757|7275733|FG001|Overall Study|Lack of Efficacy|1
4478466|NCT00705757|7275734|FG002|Overall Study|Lack of Efficacy|3
4478467|NCT00705757|7275732|FG000|Overall Study|Lost to Follow-up|7
4478468|NCT00705757|7275733|FG001|Overall Study|Lost to Follow-up|6
4478469|NCT00705757|7275734|FG002|Overall Study|Lost to Follow-up|6
4478470|NCT00705757|7275732|FG000|Overall Study|Withdrawal by Subject|1
4478471|NCT00705757|7275733|FG001|Overall Study|Withdrawal by Subject|1
4478472|NCT00705757|7275734|FG002|Overall Study|Withdrawal by Subject|2
4478473|NCT00705783|7275744|FG000|Conversion Phase|Sponsor Discontinued Study|54
4478474|NCT00705783|7275745|FG001|Conversion Phase|Sponsor Discontinued Study|0
4478475|NCT00705783|7275746|FG002|Conversion Phase|Sponsor Discontinued Study|0
4478476|NCT00705783|7275744|FG000|Conversion Phase|Lost to Follow-up|13
4478477|NCT00705783|7275745|FG001|Conversion Phase|Lost to Follow-up|0
4478478|NCT00705783|7275746|FG002|Conversion Phase|Lost to Follow-up|0
4478479|NCT00705783|7275744|FG000|Conversion Phase|Met Withdrawal Criteria|4
4478480|NCT00705783|7275745|FG001|Conversion Phase|Met Withdrawal Criteria|0
4478481|NCT00705783|7275746|FG002|Conversion Phase|Met Withdrawal Criteria|0
4478482|NCT00705783|7275744|FG000|Conversion Phase|Withdrawn by Investigator|4
4478483|NCT00705783|7275745|FG001|Conversion Phase|Withdrawn by Investigator|0
4478484|NCT00705783|7275746|FG002|Conversion Phase|Withdrawn by Investigator|0
4478485|NCT00705783|7275744|FG000|Conversion Phase|Withdrew Consent|24
4478486|NCT00705783|7275745|FG001|Conversion Phase|Withdrew Consent|0
4478487|NCT00705783|7275746|FG002|Conversion Phase|Withdrew Consent|0
4478488|NCT00705783|7275744|FG000|Conversion Phase|Protocol Deviation|2
4478489|NCT00705783|7275745|FG001|Conversion Phase|Protocol Deviation|0
4478490|NCT00705783|7275746|FG002|Conversion Phase|Protocol Deviation|0
4478491|NCT00705783|7275744|FG000|Conversion Phase|Adverse Event|11
4478492|NCT00705783|7275745|FG001|Conversion Phase|Adverse Event|0
4478493|NCT00705783|7275746|FG002|Conversion Phase|Adverse Event|0
4478494|NCT00705783|7275744|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13
4478495|NCT00705783|7275745|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0
4478496|NCT00705783|7275746|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0
4478497|NCT00705783|7275744|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8
4478498|NCT00705783|7275745|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0
4478499|NCT00705783|7275746|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0
4478500|NCT00705783|7275744|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42
4478501|NCT00705783|7275745|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0
4478502|NCT00705783|7275746|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0
4478503|NCT00705783|7275744|FG000|Oral Stabilization Phase|Lost to Follow-up|7
4478504|NCT00705783|7275745|FG001|Oral Stabilization Phase|Lost to Follow-up|0
4478505|NCT00705783|7275746|FG002|Oral Stabilization Phase|Lost to Follow-up|0
4478506|NCT00705783|7275744|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19
4478507|NCT00705783|7275745|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0
4478508|NCT00705783|7275746|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0
4478509|NCT00705783|7275744|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12
4478510|NCT00705783|7275745|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0
4478511|NCT00705783|7275746|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0
4478512|NCT00705783|7275744|FG000|Oral Stabilization Phase|Withdrew Consent|29
4478513|NCT00705783|7275745|FG001|Oral Stabilization Phase|Withdrew Consent|0
4478514|NCT00705783|7275746|FG002|Oral Stabilization Phase|Withdrew Consent|0
4478515|NCT00705783|7275744|FG000|Oral Stabilization Phase|Adverse Event|14
4478516|NCT00705783|7275745|FG001|Oral Stabilization Phase|Adverse Event|0
4478517|NCT00705783|7275746|FG002|Oral Stabilization Phase|Adverse Event|0
4478518|NCT00705783|7275744|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7
4478519|NCT00705783|7275745|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
4478520|NCT00705783|7275746|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
4478521|NCT00705783|7275744|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4
4478522|NCT00705783|7275745|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
4478523|NCT00705783|7275746|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
4478524|NCT00705783|7275744|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86
4478525|NCT00705783|7275745|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0
4478526|NCT00705783|7275746|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0
4478527|NCT00705783|7275744|FG000|Depot Stabilization Phase|Lost to Follow-up|11
4478528|NCT00705783|7275745|FG001|Depot Stabilization Phase|Lost to Follow-up|0
4478529|NCT00705783|7275746|FG002|Depot Stabilization Phase|Lost to Follow-up|0
4478530|NCT00705783|7275744|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8
4478531|NCT00705783|7275745|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0
4478532|NCT00705783|7275746|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0
4478533|NCT00705783|7275744|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9
4478534|NCT00705783|7275745|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0
4478535|NCT00705783|7275746|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0
4478536|NCT00705783|7275744|FG000|Depot Stabilization Phase|Withdrew Consent|29
4478537|NCT00705783|7275745|FG001|Depot Stabilization Phase|Withdrew Consent|0
4478538|NCT00705783|7275746|FG002|Depot Stabilization Phase|Withdrew Consent|0
4478539|NCT00705783|7275744|FG000|Depot Stabilization Phase|Adverse Event|17
4478540|NCT00705783|7275745|FG001|Depot Stabilization Phase|Adverse Event|0
4478541|NCT00705783|7275746|FG002|Depot Stabilization Phase|Adverse Event|0
4478542|NCT00705783|7275744|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12
4478543|NCT00705783|7275745|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0
4478544|NCT00705783|7275746|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0
4478545|NCT00705783|7275744|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1
4478546|NCT00705783|7275745|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0
4478547|NCT00705783|7275746|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0
4478548|NCT00705783|7275744|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0
4478549|NCT00705783|7275745|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179
4478550|NCT00705783|7275746|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58
4478551|NCT00705783|7275744|FG000|Depot Maintenance Phase|Lost to Follow-up|0
4478552|NCT00705783|7275745|FG001|Depot Maintenance Phase|Lost to Follow-up|5
4478553|NCT00705783|7275746|FG002|Depot Maintenance Phase|Lost to Follow-up|3
4699683|NCT02688387|7615418|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
4699684|NCT02688387|7615419|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
4699685|NCT02688387|7615420|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
4699686|NCT02688387|7615421|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
4699687|NCT02688387|7615422|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
4699688|NCT02688387|7615423|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
4699689|NCT02688387|7615402|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4699690|NCT02688387|7615403|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4386718|NCT00040664|7165230|FG002|Overall Study|Withdrawal by Subject|3
4386719|NCT00040664|7165231|FG003|Overall Study|Withdrawal by Subject|4
4386720|NCT00040664|7165228|FG000|Overall Study|Pregnancy|3
4386721|NCT00040664|7165229|FG001|Overall Study|Pregnancy|0
4386722|NCT00040664|7165230|FG002|Overall Study|Pregnancy|0
4386723|NCT00040664|7165231|FG003|Overall Study|Pregnancy|3
4386724|NCT00040664|7165228|FG000|Overall Study|Medication adherence/compliance problems|8
4386725|NCT00040664|7165229|FG001|Overall Study|Medication adherence/compliance problems|2
4386726|NCT00040664|7165230|FG002|Overall Study|Medication adherence/compliance problems|1
4386727|NCT00040664|7165231|FG003|Overall Study|Medication adherence/compliance problems|5
4386728|NCT00040664|7165228|FG000|Overall Study|Poor taste|2
4386729|NCT00040664|7165229|FG001|Overall Study|Poor taste|0
4386730|NCT00040664|7165230|FG002|Overall Study|Poor taste|2
4386731|NCT00040664|7165231|FG003|Overall Study|Poor taste|0
4386732|NCT00040664|7165228|FG000|Overall Study|Pharmacokinetic target not achieved|2
4386733|NCT00040664|7165229|FG001|Overall Study|Pharmacokinetic target not achieved|1
4386734|NCT00040664|7165230|FG002|Overall Study|Pharmacokinetic target not achieved|0
4386735|NCT00040664|7165231|FG003|Overall Study|Pharmacokinetic target not achieved|1
4386736|NCT00040664|7165228|FG000|Overall Study|Change of formulation|2
4386737|NCT00040664|7165229|FG001|Overall Study|Change of formulation|2
4386738|NCT00040664|7165230|FG002|Overall Study|Change of formulation|0
4386739|NCT00040664|7165231|FG003|Overall Study|Change of formulation|0
4386740|NCT00040664|7165228|FG000|Overall Study|Non-viability of oral suspension|1
4386741|NCT00040664|7165229|FG001|Overall Study|Non-viability of oral suspension|0
4386742|NCT00040664|7165230|FG002|Overall Study|Non-viability of oral suspension|1
4386743|NCT00040664|7165231|FG003|Overall Study|Non-viability of oral suspension|0
4386744|NCT00040742|7165253|FG000|Overall Study|Death|0
4386745|NCT00040742|7165254|FG001|Overall Study|Death|0
4386746|NCT00040742|7165255|FG002|Overall Study|Death|1
4386747|NCT00040742|7165256|FG003|Overall Study|Death|0
4386748|NCT00040742|7165253|FG000|Overall Study|Adverse Event|15
4386749|NCT00040742|7165254|FG001|Overall Study|Adverse Event|16
4386750|NCT00040742|7165255|FG002|Overall Study|Adverse Event|21
4386751|NCT00040742|7165256|FG003|Overall Study|Adverse Event|9
4386752|NCT00040742|7165253|FG000|Overall Study|Withdrawal by Subject|7
4386753|NCT00040742|7165254|FG001|Overall Study|Withdrawal by Subject|15
4386754|NCT00040742|7165255|FG002|Overall Study|Withdrawal by Subject|10
4386755|NCT00040742|7165256|FG003|Overall Study|Withdrawal by Subject|13
4386756|NCT00040742|7165253|FG000|Overall Study|Chemotoxicity|4
4386757|NCT00040742|7165254|FG001|Overall Study|Chemotoxicity|3
4478554|NCT00705783|7275744|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0
4478555|NCT00705783|7275745|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2
4478556|NCT00705783|7275746|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2
4589521|NCT01513330|7434936|FG000|SenSura Mio First,|Lack of Efficacy|0
4589522|NCT01513330|7434937|FG001|SenSura Mio First,|Lack of Efficacy|1
4699691|NCT02688387|7615404|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4478557|NCT00705783|7275744|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0
4478558|NCT00705783|7275745|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8
4478559|NCT00705783|7275746|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6
4478560|NCT00705783|7275744|FG000|Depot Maintenance Phase|Withdrew Consent|0
4478561|NCT00705783|7275745|FG001|Depot Maintenance Phase|Withdrew Consent|14
4478562|NCT00705783|7275746|FG002|Depot Maintenance Phase|Withdrew Consent|4
4478563|NCT00705783|7275744|FG000|Depot Maintenance Phase|Protocol Deviation|0
4478564|NCT00705783|7275745|FG001|Depot Maintenance Phase|Protocol Deviation|2
4478565|NCT00705783|7275746|FG002|Depot Maintenance Phase|Protocol Deviation|0
4478566|NCT00705783|7275744|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0
4478567|NCT00705783|7275745|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9
4478568|NCT00705783|7275746|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5
4478569|NCT00705783|7275744|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0
4478570|NCT00705783|7275745|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11
4478571|NCT00705783|7275746|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13
4478572|NCT00705783|7275744|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0
4478573|NCT00705783|7275745|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16
4478574|NCT00705783|7275746|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40
4478575|NCT00705939|7275787|FG000|Overall Study|Protocol Violation|0
4478576|NCT00705939|7275788|FG001|Overall Study|Protocol Violation|0
4478577|NCT00705939|7275789|FG002|Overall Study|Protocol Violation|1
4478578|NCT00705939|7275787|FG000|Overall Study|Withdrawal by Subject|0
4478579|NCT00705939|7275788|FG001|Overall Study|Withdrawal by Subject|1
4478580|NCT00705939|7275789|FG002|Overall Study|Withdrawal by Subject|3
4478581|NCT00705939|7275787|FG000|Overall Study|Physician Decision|0
4478582|NCT00705939|7275788|FG001|Overall Study|Physician Decision|1
4478583|NCT00705939|7275789|FG002|Overall Study|Physician Decision|0
4478584|NCT00706004|7275798|FG000|Overall Study|Did not meet eligibility criteria|2
4478585|NCT00706030|7275807|FG000|Overall Study|Disease Progression|4
4478586|NCT00706030|7275808|FG001|Overall Study|Disease Progression|6
4478587|NCT00706030|7275809|FG002|Overall Study|Disease Progression|46
4478588|NCT00706030|7275810|FG003|Overall Study|Disease Progression|12
4478589|NCT00706030|7275807|FG000|Overall Study|Adverse Event|1
4478590|NCT00706030|7275808|FG001|Overall Study|Adverse Event|0
4478591|NCT00706030|7275809|FG002|Overall Study|Adverse Event|4
4478592|NCT00706030|7275810|FG003|Overall Study|Adverse Event|2
4478593|NCT00706030|7275807|FG000|Overall Study|Withdrawal by Subject|1
4478594|NCT00706030|7275808|FG001|Overall Study|Withdrawal by Subject|0
4478595|NCT00706030|7275809|FG002|Overall Study|Withdrawal by Subject|2
4478596|NCT00706030|7275810|FG003|Overall Study|Withdrawal by Subject|0
4478597|NCT00706030|7275807|FG000|Overall Study|Physician Decision|0
4699692|NCT02688387|7615405|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1
4699693|NCT02688387|7615406|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4699694|NCT02688387|7615407|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4699695|NCT02688387|7615408|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4699696|NCT02688387|7615409|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4699697|NCT02688387|7615410|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4699698|NCT02688387|7615411|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4699699|NCT02688387|7615412|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4699700|NCT02688387|7615413|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4699701|NCT02688387|7615414|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4699702|NCT02688387|7615415|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4699703|NCT02688387|7615416|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4699704|NCT02688387|7615417|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4699705|NCT02688387|7615418|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4699706|NCT02688387|7615419|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4771209|NCT04250077|7748049|FG000|Overall Study|Lost to Follow-up|2
4478598|NCT00706030|7275808|FG001|Overall Study|Physician Decision|0
4386758|NCT00040742|7165255|FG002|Overall Study|Chemotoxicity|5
4386759|NCT00040742|7165256|FG003|Overall Study|Chemotoxicity|2
4386760|NCT00040742|7165253|FG000|Overall Study|Incomplete Forms|6
4478599|NCT00706030|7275809|FG002|Overall Study|Physician Decision|2
4478600|NCT00706030|7275810|FG003|Overall Study|Physician Decision|0
4478601|NCT00706030|7275807|FG000|Overall Study|Not recorded|0
4478602|NCT00706030|7275808|FG001|Overall Study|Not recorded|0
4478603|NCT00706030|7275809|FG002|Overall Study|Not recorded|2
4478604|NCT00706030|7275810|FG003|Overall Study|Not recorded|0
4478605|NCT00706030|7275807|FG000|Overall Study|Protocol Violation|0
4478606|NCT00706030|7275808|FG001|Overall Study|Protocol Violation|0
4478607|NCT00706030|7275809|FG002|Overall Study|Protocol Violation|1
4478608|NCT00706030|7275810|FG003|Overall Study|Protocol Violation|1
4478609|NCT00706030|7275807|FG000|Overall Study|Failed to return|0
4478610|NCT00706030|7275808|FG001|Overall Study|Failed to return|0
4478611|NCT00706030|7275809|FG002|Overall Study|Failed to return|1
4478612|NCT00706030|7275810|FG003|Overall Study|Failed to return|0
4478613|NCT00706030|7275807|FG000|Overall Study|Symptomatic Deterioration|0
4478614|NCT00706030|7275808|FG001|Overall Study|Symptomatic Deterioration|0
4478615|NCT00706030|7275809|FG002|Overall Study|Symptomatic Deterioration|1
4478616|NCT00706030|7275810|FG003|Overall Study|Symptomatic Deterioration|0
4478617|NCT00706030|7275807|FG000|Overall Study|No treatment received|0
4478618|NCT00706030|7275808|FG001|Overall Study|No treatment received|0
4478619|NCT00706030|7275809|FG002|Overall Study|No treatment received|0
4478620|NCT00706030|7275810|FG003|Overall Study|No treatment received|1
4478621|NCT00706030|7275807|FG000|Overall Study|Death|0
4478622|NCT00706030|7275808|FG001|Overall Study|Death|0
4478623|NCT00706030|7275809|FG002|Overall Study|Death|1
4478624|NCT00706030|7275810|FG003|Overall Study|Death|0
4478625|NCT00706095|7275824|FG000|Overall Study|Progressive Disease|4
4478626|NCT00706095|7275825|FG001|Overall Study|Progressive Disease|5
4478627|NCT00706095|7275826|FG002|Overall Study|Progressive Disease|3
4478628|NCT00706095|7275824|FG000|Overall Study|Clinical Progression|1
4478629|NCT00706095|7275825|FG001|Overall Study|Clinical Progression|2
4478630|NCT00706095|7275826|FG002|Overall Study|Clinical Progression|2
4478631|NCT00706095|7275824|FG000|Overall Study|Withdrawal by Subject|1
4478632|NCT00706095|7275825|FG001|Overall Study|Withdrawal by Subject|0
4478633|NCT00706095|7275826|FG002|Overall Study|Withdrawal by Subject|0
4516843|NCT00961649|7328275|FG001|Overall Study|Patient left to Mexico-family emergency|0
4516844|NCT00961649|7328276|FG002|Overall Study|Patient left to Mexico-family emergency|0
4516845|NCT00961649|7328277|FG003|Overall Study|Patient left to Mexico-family emergency|0
4516846|NCT00961649|7328274|FG000|Overall Study|Study terminated by sponsor|4
4516847|NCT00961649|7328275|FG001|Overall Study|Study terminated by sponsor|4
4589523|NCT01513330|7434936|FG000|SenSura Mio First,|Withdrawal by Subject|1
4516848|NCT00961649|7328276|FG002|Overall Study|Study terminated by sponsor|4
4516849|NCT00961649|7328277|FG003|Overall Study|Study terminated by sponsor|1
4516850|NCT00961896|7328303|FG000|Overall Study|Abnormal laboratory value|0
4516851|NCT00961896|7328304|FG001|Overall Study|Abnormal laboratory value|0
4516852|NCT00961896|7328305|FG002|Overall Study|Abnormal laboratory value|1
4516853|NCT00961961|7328320|FG000|Phase I|Withdrawal by Subject|7
4516854|NCT00961961|7328321|FG001|Phase I|Withdrawal by Subject|0
4589524|NCT01513330|7434937|FG001|SenSura Mio First,|Withdrawal by Subject|1
4589525|NCT01513330|7434936|FG000|SenSura Mio First,|Other|1
4589526|NCT01513330|7434937|FG001|SenSura Mio First,|Other|0
4589527|NCT01513330|7434936|FG000|Standard Care First,|Lack of Efficacy|2
4699707|NCT02688387|7615420|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4516855|NCT00961961|7328322|FG002|Phase I|Withdrawal by Subject|0
4516856|NCT00961961|7328323|FG003|Phase I|Withdrawal by Subject|0
4516857|NCT00961961|7328320|FG000|Phase I|Lost to Follow-up|10
4516858|NCT00961961|7328321|FG001|Phase I|Lost to Follow-up|0
4516859|NCT00961961|7328322|FG002|Phase I|Lost to Follow-up|0
4516860|NCT00961961|7328323|FG003|Phase I|Lost to Follow-up|0
4516861|NCT00961961|7328320|FG000|Phase I|Lack of Efficacy|94
4516862|NCT00961961|7328321|FG001|Phase I|Lack of Efficacy|0
4516863|NCT00961961|7328322|FG002|Phase I|Lack of Efficacy|0
4516864|NCT00961961|7328323|FG003|Phase I|Lack of Efficacy|0
4516865|NCT00961961|7328320|FG000|Phase I|Adverse Event|7
4516866|NCT00961961|7328321|FG001|Phase I|Adverse Event|0
4516867|NCT00961961|7328322|FG002|Phase I|Adverse Event|0
4516868|NCT00961961|7328323|FG003|Phase I|Adverse Event|0
4699708|NCT02688387|7615421|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4699709|NCT02688387|7615422|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4699710|NCT02688387|7615423|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4699711|NCT02688387|7615402|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
4699712|NCT02688387|7615403|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1
4699713|NCT02688387|7615404|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
4516869|NCT00961961|7328320|FG000|Phase I|Physician Decision|8
4516870|NCT00961961|7328321|FG001|Phase I|Physician Decision|0
4589528|NCT01513330|7434937|FG001|Standard Care First,|Lack of Efficacy|2
4589529|NCT01513330|7434936|FG000|Standard Care First,|Withdrawal by Subject|1
4516871|NCT00961961|7328322|FG002|Phase I|Physician Decision|0
4516872|NCT00961961|7328323|FG003|Phase I|Physician Decision|0
4516873|NCT00961961|7328320|FG000|Phase II|Lost to Follow-up|0
4516874|NCT00961961|7328321|FG001|Phase II|Lost to Follow-up|0
4516875|NCT00961961|7328322|FG002|Phase II|Lost to Follow-up|10
4516876|NCT00961961|7328323|FG003|Phase II|Lost to Follow-up|7
4516877|NCT00961961|7328320|FG000|Phase II|Adverse Event|0
4516878|NCT00961961|7328321|FG001|Phase II|Adverse Event|0
4478634|NCT00706134|7275863|FG000|Overall Study|Adverse Event|8
4478635|NCT00706134|7275864|FG001|Overall Study|Adverse Event|7
4478636|NCT00706134|7275865|FG002|Overall Study|Adverse Event|2
4478637|NCT00706134|7275866|FG003|Overall Study|Adverse Event|3
4478638|NCT00706134|7275863|FG000|Overall Study|Lost to Follow-up|0
4478639|NCT00706134|7275864|FG001|Overall Study|Lost to Follow-up|1
4478640|NCT00706134|7275865|FG002|Overall Study|Lost to Follow-up|0
4478641|NCT00706134|7275866|FG003|Overall Study|Lost to Follow-up|0
4478642|NCT00706134|7275863|FG000|Overall Study|Protocol Violation|0
4478643|NCT00706134|7275864|FG001|Overall Study|Protocol Violation|6
4478644|NCT00706134|7275865|FG002|Overall Study|Protocol Violation|0
4478645|NCT00706134|7275866|FG003|Overall Study|Protocol Violation|3
4478646|NCT00706134|7275863|FG000|Overall Study|Withdrawal by Subject|1
4589530|NCT01513330|7434937|FG001|Standard Care First,|Withdrawal by Subject|2
4589531|NCT01513330|7434936|FG000|Standard Care First,|Other|1
4478647|NCT00706134|7275864|FG001|Overall Study|Withdrawal by Subject|2
4478648|NCT00706134|7275865|FG002|Overall Study|Withdrawal by Subject|1
4478649|NCT00706134|7275866|FG003|Overall Study|Withdrawal by Subject|0
4386761|NCT00040742|7165254|FG001|Overall Study|Incomplete Forms|10
4386762|NCT00040742|7165255|FG002|Overall Study|Incomplete Forms|4
4386763|NCT00040742|7165256|FG003|Overall Study|Incomplete Forms|5
4386764|NCT00040742|7165253|FG000|Overall Study|Other medical|7
4386765|NCT00040742|7165254|FG001|Overall Study|Other medical|5
4386766|NCT00040742|7165255|FG002|Overall Study|Other medical|5
4386767|NCT00040742|7165256|FG003|Overall Study|Other medical|5
4386768|NCT00041067|7165298|FG000|Overall Study|Adverse Event|20
4386769|NCT00041067|7165298|FG000|Overall Study|Progression|19
4386770|NCT00041067|7165298|FG000|Overall Study|Patient refusal|12
4386771|NCT00041067|7165298|FG000|Overall Study|Other reasons|23
4386772|NCT00041067|7165298|FG000|Overall Study|Ineligible|2
4386773|NCT00041080|7165305|FG000|Overall Study|Adverse Event|21
4386774|NCT00041080|7165306|FG001|Overall Study|Adverse Event|1
4386775|NCT00041080|7165305|FG000|Overall Study|Withdrawal by Subject|6
4386776|NCT00041080|7165306|FG001|Overall Study|Withdrawal by Subject|6
4478650|NCT00706134|7275863|FG000|Overall Study|Unsatisfactory therapeutic effect|9
4478651|NCT00706134|7275864|FG001|Overall Study|Unsatisfactory therapeutic effect|3
4478652|NCT00706134|7275865|FG002|Overall Study|Unsatisfactory therapeutic effect|3
4478653|NCT00706134|7275866|FG003|Overall Study|Unsatisfactory therapeutic effect|5
4478654|NCT00706134|7275863|FG000|Overall Study|Did not meet study criteria|2
4478655|NCT00706134|7275864|FG001|Overall Study|Did not meet study criteria|0
4478656|NCT00706134|7275865|FG002|Overall Study|Did not meet study criteria|0
4478657|NCT00706134|7275866|FG003|Overall Study|Did not meet study criteria|0
4478658|NCT00706238|7275876|FG000|Overall Study|Disease progression|4
4478659|NCT00706238|7275876|FG000|Overall Study|Other|1
4478660|NCT00706342|7275891|FG000|Overall Study|Adverse Event|3
4478661|NCT00706342|7275891|FG000|Overall Study|Not responding to treatment|2
4478662|NCT00706342|7275891|FG000|Overall Study|Withdrawn due to failure to respond|1
4478663|NCT00706342|7275891|FG000|Overall Study|Death|1
4478664|NCT00706342|7275891|FG000|Overall Study|Withdrew from the study on his own.|1
4478665|NCT00706342|7275891|FG000|Overall Study|Investigator discretion|2
4478666|NCT00706342|7275891|FG000|Overall Study|Non-responder Week 12|1
4478667|NCT00706342|7275891|FG000|Overall Study|Ongoing|6
4478668|NCT00706342|7275891|FG000|Overall Study|WIthdrawal of consent|1
4478669|NCT00706355|7275899|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1
4478670|NCT00706355|7275900|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
4478671|NCT00706355|7275901|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
4478672|NCT00706355|7275902|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
4478673|NCT00706355|7275899|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2
4478674|NCT00706355|7275900|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
4478675|NCT00706355|7275901|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
4478676|NCT00706355|7275902|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
4478677|NCT00706355|7275899|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
4478678|NCT00706355|7275900|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1
4478679|NCT00706355|7275901|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
4478680|NCT00706355|7275902|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
4478681|NCT00706355|7275899|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
4478682|NCT00706355|7275900|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1
4478683|NCT00706355|7275901|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
4478684|NCT00706355|7275902|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
4478685|NCT00706355|7275899|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
4478686|NCT00706355|7275900|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5
4478687|NCT00706355|7275901|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
4478688|NCT00706355|7275902|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
4589532|NCT01513330|7434937|FG001|Standard Care First,|Other|0
4478689|NCT00706355|7275899|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0
4478690|NCT00706355|7275900|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0
4478691|NCT00706355|7275901|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1
4478692|NCT00706355|7275902|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0
4589533|NCT01513460|7434955|FG000|Overall Study|Death|0
4478693|NCT00706355|7275899|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
4478694|NCT00706355|7275900|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
4478695|NCT00706355|7275901|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1
4478696|NCT00706355|7275902|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
4478697|NCT00706355|7275899|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0
4386777|NCT00041080|7165305|FG000|Overall Study|Concommitant Illness/Other|1
4386778|NCT00041080|7165306|FG001|Overall Study|Concommitant Illness/Other|2
4386779|NCT00041080|7165305|FG000|Overall Study|Did not start therapy|1
4386780|NCT00041080|7165306|FG001|Overall Study|Did not start therapy|1
4386781|NCT00041080|7165305|FG000|Overall Study|Ineligible|1
4386782|NCT00041080|7165306|FG001|Overall Study|Ineligible|0
4386783|NCT00041132|7165333|FG000|Overall Study|Adverse Event|19
4386784|NCT00041132|7165333|FG000|Overall Study|Death|1
4589534|NCT01513460|7434956|FG001|Overall Study|Death|0
4589535|NCT01513460|7434957|FG002|Overall Study|Death|1
4699714|NCT02688387|7615405|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
4699715|NCT02688387|7615406|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
4699716|NCT02688387|7615407|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
4699717|NCT02688387|7615408|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
4699718|NCT02688387|7615409|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
4699719|NCT02688387|7615410|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
4699720|NCT02688387|7615411|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
4699721|NCT02688387|7615412|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
4699722|NCT02688387|7615413|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
4699723|NCT02688387|7615414|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
4699724|NCT02688387|7615415|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
4699725|NCT02688387|7615416|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
4699726|NCT02688387|7615417|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
4699727|NCT02688387|7615418|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
4699728|NCT02688387|7615419|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
4699729|NCT02688387|7615420|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
4699730|NCT02688387|7615421|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
4699731|NCT02688387|7615422|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
4699732|NCT02688387|7615423|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
4699733|NCT02688387|7615402|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
4386785|NCT00041132|7165333|FG000|Overall Study|Not Eligible|7
4386786|NCT00041132|7165333|FG000|Overall Study|Withdrawal by Subject|1
4386787|NCT00041132|7165333|FG000|Overall Study|Physician Decision|2
4386788|NCT00041470|7165346|FG000|Overall Study|Loss of Funding|38
4386789|NCT00041756|7165364|FG000|Overall Study|Adverse Event|4
4386790|NCT00041756|7165365|FG001|Overall Study|Adverse Event|10
4386791|NCT00041756|7165366|FG002|Overall Study|Adverse Event|6
4699734|NCT02688387|7615403|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
4699735|NCT02688387|7615404|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1
4699736|NCT02688387|7615405|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
4699737|NCT02688387|7615406|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1
4699738|NCT02688387|7615407|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
4699739|NCT02688387|7615408|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
4699740|NCT02688387|7615409|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
4699741|NCT02688387|7615410|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
4699742|NCT02688387|7615411|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
4699743|NCT02688387|7615412|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
4699744|NCT02688387|7615413|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
4699745|NCT02688387|7615414|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
4699746|NCT02688387|7615415|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
4699747|NCT02688387|7615416|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
4699748|NCT02688387|7615417|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
4699749|NCT02688387|7615418|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
4699750|NCT02688387|7615419|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
4699751|NCT02688387|7615420|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
4699752|NCT02688387|7615421|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
4699753|NCT02688387|7615422|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
4699754|NCT02688387|7615423|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
4699755|NCT02688387|7615402|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1
4699756|NCT02688387|7615403|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
4386792|NCT00041756|7165367|FG003|Overall Study|Adverse Event|11
4386793|NCT00041756|7165368|FG004|Overall Study|Adverse Event|34
4386794|NCT00041756|7165364|FG000|Overall Study|Protocol Violation|1
4386795|NCT00041756|7165365|FG001|Overall Study|Protocol Violation|1
4386796|NCT00041756|7165366|FG002|Overall Study|Protocol Violation|2
4386797|NCT00041756|7165367|FG003|Overall Study|Protocol Violation|2
4386798|NCT00041756|7165368|FG004|Overall Study|Protocol Violation|1
4386799|NCT00041756|7165364|FG000|Overall Study|Withdrawal by Subject|3
4386800|NCT00041756|7165365|FG001|Overall Study|Withdrawal by Subject|3
4386801|NCT00041756|7165366|FG002|Overall Study|Withdrawal by Subject|4
4386802|NCT00041756|7165367|FG003|Overall Study|Withdrawal by Subject|2
4386803|NCT00041756|7165368|FG004|Overall Study|Withdrawal by Subject|3
4386804|NCT00041756|7165364|FG000|Overall Study|Lost to Follow-up|0
4386805|NCT00041756|7165365|FG001|Overall Study|Lost to Follow-up|1
4386806|NCT00041756|7165366|FG002|Overall Study|Lost to Follow-up|0
4386807|NCT00041756|7165367|FG003|Overall Study|Lost to Follow-up|1
4386808|NCT00041756|7165368|FG004|Overall Study|Lost to Follow-up|0
4386809|NCT00041756|7165364|FG000|Overall Study|Unable to meet protocol criteria|0
4386810|NCT00041756|7165365|FG001|Overall Study|Unable to meet protocol criteria|0
4386811|NCT00041756|7165366|FG002|Overall Study|Unable to meet protocol criteria|1
4386812|NCT00041756|7165367|FG003|Overall Study|Unable to meet protocol criteria|0
4386813|NCT00041756|7165368|FG004|Overall Study|Unable to meet protocol criteria|1
4386814|NCT00041756|7165364|FG000|Overall Study|Data Monitoring Committee Recommendation|0
4386815|NCT00041756|7165365|FG001|Overall Study|Data Monitoring Committee Recommendation|0
4478698|NCT00706355|7275900|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0
4478699|NCT00706355|7275901|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0
4478700|NCT00706355|7275902|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2
4478701|NCT00706355|7275899|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
4478702|NCT00706355|7275900|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
4478703|NCT00706355|7275901|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
4478704|NCT00706355|7275902|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2
4478705|NCT00706381|7275918|FG000|Overall Study|Lost to Follow-up|0
4478706|NCT00706381|7275919|FG001|Overall Study|Lost to Follow-up|1
4478707|NCT00706381|7275920|FG002|Overall Study|Lost to Follow-up|1
4478708|NCT00706381|7275921|FG003|Overall Study|Lost to Follow-up|0
4478709|NCT00706433|7275951|FG000|Overall Study|Lost to Follow-up|3
4478710|NCT00706433|7275952|FG001|Overall Study|Lost to Follow-up|1
4478711|NCT00706433|7275953|FG002|Overall Study|Lost to Follow-up|6
4478712|NCT00706433|7275954|FG003|Overall Study|Lost to Follow-up|0
4478713|NCT00706433|7275951|FG000|Overall Study|Withdrawal by Subject|1
4478714|NCT00706433|7275952|FG001|Overall Study|Withdrawal by Subject|2
4478715|NCT00706433|7275953|FG002|Overall Study|Withdrawal by Subject|3
4478716|NCT00706433|7275954|FG003|Overall Study|Withdrawal by Subject|1
4478717|NCT00706433|7275951|FG000|Overall Study|Adverse Event|0
4478718|NCT00706433|7275952|FG001|Overall Study|Adverse Event|0
4478719|NCT00706433|7275953|FG002|Overall Study|Adverse Event|1
4478720|NCT00706433|7275954|FG003|Overall Study|Adverse Event|0
4478721|NCT00706433|7275951|FG000|Overall Study|Protocol Violation|1
4478722|NCT00706433|7275952|FG001|Overall Study|Protocol Violation|0
4478723|NCT00706433|7275953|FG002|Overall Study|Protocol Violation|0
4699757|NCT02688387|7615404|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
4699758|NCT02688387|7615405|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
4699759|NCT02688387|7615406|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
4699760|NCT02688387|7615407|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
4699761|NCT02688387|7615408|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
4699762|NCT02688387|7615409|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
4699763|NCT02688387|7615410|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
4699764|NCT02688387|7615411|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
4699765|NCT02688387|7615412|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
4699766|NCT02688387|7615413|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
4699767|NCT02688387|7615414|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
4699768|NCT02688387|7615415|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
4699769|NCT02688387|7615416|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
4699770|NCT02688387|7615417|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
4478724|NCT00706433|7275954|FG003|Overall Study|Protocol Violation|0
4478725|NCT00706433|7275951|FG000|Overall Study|new job|0
4478726|NCT00706433|7275952|FG001|Overall Study|new job|0
4478727|NCT00706433|7275953|FG002|Overall Study|new job|0
4478728|NCT00706433|7275954|FG003|Overall Study|new job|1
4478729|NCT00706511|7275997|FG000|Overall Study|Withdrawal by Subject|1
4478730|NCT00706511|7275998|FG001|Overall Study|Withdrawal by Subject|0
4478731|NCT00706511|7275999|FG002|Overall Study|Withdrawal by Subject|0
4478732|NCT00706511|7276000|FG003|Overall Study|Withdrawal by Subject|0
4478733|NCT00706628|7276040|FG000|Overall Study|Other Adverse Event|16
4386816|NCT00041756|7165366|FG002|Overall Study|Data Monitoring Committee Recommendation|0
4386817|NCT00041756|7165367|FG003|Overall Study|Data Monitoring Committee Recommendation|0
4386818|NCT00041756|7165368|FG004|Overall Study|Data Monitoring Committee Recommendation|21
4386819|NCT00042432|7165400|FG000|Overall Study|Adverse Event|4
4386820|NCT00042432|7165401|FG001|Overall Study|Adverse Event|1
4386821|NCT00042432|7165400|FG000|Overall Study|Withdrawal by Subject|1
4386822|NCT00042432|7165401|FG001|Overall Study|Withdrawal by Subject|3
4386823|NCT00042432|7165400|FG000|Overall Study|Death|0
4478734|NCT00706628|7276041|FG001|Overall Study|Other Adverse Event|5
4478735|NCT00706628|7276042|FG002|Overall Study|Other Adverse Event|5
4478736|NCT00706628|7276043|FG003|Overall Study|Other Adverse Event|2
4478737|NCT00706628|7276040|FG000|Overall Study|Non compliant with protocol|0
4478738|NCT00706628|7276041|FG001|Overall Study|Non compliant with protocol|1
4478739|NCT00706628|7276042|FG002|Overall Study|Non compliant with protocol|0
4478740|NCT00706628|7276043|FG003|Overall Study|Non compliant with protocol|0
4478741|NCT00706628|7276040|FG000|Overall Study|Consent withdrawn|6
4478742|NCT00706628|7276041|FG001|Overall Study|Consent withdrawn|1
4478743|NCT00706628|7276042|FG002|Overall Study|Consent withdrawn|3
4478744|NCT00706628|7276043|FG003|Overall Study|Consent withdrawn|0
4478745|NCT00706628|7276040|FG000|Overall Study|Progressive disease|20
4478746|NCT00706628|7276041|FG001|Overall Study|Progressive disease|13
4478747|NCT00706628|7276042|FG002|Overall Study|Progressive disease|8
4478748|NCT00706628|7276043|FG003|Overall Study|Progressive disease|1
4478749|NCT00706628|7276040|FG000|Overall Study|Other than those stated above|4
4478750|NCT00706628|7276041|FG001|Overall Study|Other than those stated above|0
4478751|NCT00706628|7276042|FG002|Overall Study|Other than those stated above|0
4478752|NCT00706628|7276043|FG003|Overall Study|Other than those stated above|0
4478753|NCT00706628|7276040|FG000|Overall Study|Not treated|1
4478754|NCT00706628|7276041|FG001|Overall Study|Not treated|1
4478755|NCT00706628|7276042|FG002|Overall Study|Not treated|0
4478756|NCT00706628|7276043|FG003|Overall Study|Not treated|0
4478757|NCT00706641|7276056|FG000|Dasatinib Administration|Withdrawal by Subject|1
4478758|NCT00706641|7276056|FG000|Dasatinib Administration|Ineligible after start of therapy|1
4478759|NCT00706641|7276056|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1
4478760|NCT00706654|7276063|FG000|Conversion Phase|Lost to Follow-up|4
4478761|NCT00706654|7276064|FG001|Conversion Phase|Lost to Follow-up|0
4478762|NCT00706654|7276065|FG002|Conversion Phase|Lost to Follow-up|0
4478763|NCT00706654|7276066|FG003|Conversion Phase|Lost to Follow-up|0
4478764|NCT00706654|7276063|FG000|Conversion Phase|Sponsor Discontinued Trial|8
4478765|NCT00706654|7276064|FG001|Conversion Phase|Sponsor Discontinued Trial|0
4478766|NCT00706654|7276065|FG002|Conversion Phase|Sponsor Discontinued Trial|0
4699771|NCT02688387|7615418|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
4699772|NCT02688387|7615419|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
4699773|NCT02688387|7615420|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
4699774|NCT02688387|7615421|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
4699775|NCT02688387|7615422|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
4699776|NCT02688387|7615423|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
4699777|NCT02688387|7615402|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
4699778|NCT02688387|7615403|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
4699779|NCT02688387|7615404|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
4699780|NCT02688387|7615405|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
4699781|NCT02688387|7615406|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
4699782|NCT02688387|7615407|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
4699783|NCT02688387|7615408|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
4699784|NCT02688387|7615409|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
4699785|NCT02688387|7615410|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
4699786|NCT02688387|7615411|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
4699787|NCT02688387|7615412|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1
4699788|NCT02688387|7615413|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
4699789|NCT02688387|7615414|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
4699790|NCT02688387|7615415|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
4699791|NCT02688387|7615416|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
4699792|NCT02688387|7615417|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
4699793|NCT02688387|7615418|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
4699794|NCT02688387|7615419|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
4699795|NCT02688387|7615420|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
4699796|NCT02688387|7615421|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
4699797|NCT02688387|7615422|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
4699798|NCT02688387|7615423|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
4699799|NCT02688387|7615402|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4699800|NCT02688387|7615403|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4699801|NCT02688387|7615404|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4699802|NCT02688387|7615405|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4699803|NCT02688387|7615406|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4699804|NCT02688387|7615407|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4699805|NCT02688387|7615408|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4699806|NCT02688387|7615409|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4699807|NCT02688387|7615410|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4699808|NCT02688387|7615411|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4699809|NCT02688387|7615412|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4771210|NCT04250077|7748050|FG001|Overall Study|Lost to Follow-up|3
4478767|NCT00706654|7276066|FG003|Conversion Phase|Sponsor Discontinued Trial|0
4478768|NCT00706654|7276063|FG000|Conversion Phase|Met Withdrawal Criteria|2
4478769|NCT00706654|7276064|FG001|Conversion Phase|Met Withdrawal Criteria|0
4478770|NCT00706654|7276065|FG002|Conversion Phase|Met Withdrawal Criteria|0
4478771|NCT00706654|7276066|FG003|Conversion Phase|Met Withdrawal Criteria|0
4478772|NCT00706654|7276063|FG000|Conversion Phase|Withdrawn by Investigator|14
4478773|NCT00706654|7276064|FG001|Conversion Phase|Withdrawn by Investigator|0
4478774|NCT00706654|7276065|FG002|Conversion Phase|Withdrawn by Investigator|0
4478775|NCT00706654|7276066|FG003|Conversion Phase|Withdrawn by Investigator|0
4478776|NCT00706654|7276063|FG000|Conversion Phase|Withdrew Consent|38
4478777|NCT00706654|7276064|FG001|Conversion Phase|Withdrew Consent|0
4478778|NCT00706654|7276065|FG002|Conversion Phase|Withdrew Consent|0
4478779|NCT00706654|7276066|FG003|Conversion Phase|Withdrew Consent|0
4478780|NCT00706654|7276063|FG000|Conversion Phase|Adverse Event|18
4478781|NCT00706654|7276064|FG001|Conversion Phase|Adverse Event|0
4478782|NCT00706654|7276065|FG002|Conversion Phase|Adverse Event|0
4478783|NCT00706654|7276066|FG003|Conversion Phase|Adverse Event|0
4478784|NCT00706654|7276063|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9
4478785|NCT00706654|7276064|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0
4478786|NCT00706654|7276065|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0
4478787|NCT00706654|7276066|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0
4478788|NCT00706654|7276063|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2
4478789|NCT00706654|7276064|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0
4478790|NCT00706654|7276065|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0
4478791|NCT00706654|7276066|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0
4478792|NCT00706654|7276063|FG000|Oral Stabilization Phase|Lost to Follow-up|17
4589536|NCT01513460|7434955|FG000|Overall Study|Lost to Follow-up|0
4589537|NCT01513460|7434956|FG001|Overall Study|Lost to Follow-up|0
4478793|NCT00706654|7276064|FG001|Oral Stabilization Phase|Lost to Follow-up|0
4478794|NCT00706654|7276065|FG002|Oral Stabilization Phase|Lost to Follow-up|0
4478795|NCT00706654|7276066|FG003|Oral Stabilization Phase|Lost to Follow-up|0
4478796|NCT00706654|7276063|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19
4478797|NCT00706654|7276064|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0
4478798|NCT00706654|7276065|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0
4478799|NCT00706654|7276066|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0
4478800|NCT00706654|7276063|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15
4478801|NCT00706654|7276064|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0
4478802|NCT00706654|7276065|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0
4478803|NCT00706654|7276066|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0
4478804|NCT00706654|7276063|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21
4478805|NCT00706654|7276064|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0
4478806|NCT00706654|7276065|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0
4478807|NCT00706654|7276066|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0
4478808|NCT00706654|7276063|FG000|Oral Stabilization Phase|Withdrew consent|55
4478809|NCT00706654|7276064|FG001|Oral Stabilization Phase|Withdrew consent|0
4478810|NCT00706654|7276065|FG002|Oral Stabilization Phase|Withdrew consent|0
4478811|NCT00706654|7276066|FG003|Oral Stabilization Phase|Withdrew consent|0
4478812|NCT00706654|7276063|FG000|Oral Stabilization Phase|Protocol Deviation|2
4478813|NCT00706654|7276064|FG001|Oral Stabilization Phase|Protocol Deviation|0
4478814|NCT00706654|7276065|FG002|Oral Stabilization Phase|Protocol Deviation|0
4478815|NCT00706654|7276066|FG003|Oral Stabilization Phase|Protocol Deviation|0
4478816|NCT00706654|7276063|FG000|Oral Stabilization Phase|Adverse Event|21
4478817|NCT00706654|7276064|FG001|Oral Stabilization Phase|Adverse Event|0
4478818|NCT00706654|7276065|FG002|Oral Stabilization Phase|Adverse Event|0
4478819|NCT00706654|7276066|FG003|Oral Stabilization Phase|Adverse Event|0
4478820|NCT00706654|7276063|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20
4478821|NCT00706654|7276064|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
4478822|NCT00706654|7276065|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
4478823|NCT00706654|7276066|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
4478824|NCT00706654|7276063|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10
4478825|NCT00706654|7276064|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
4478826|NCT00706654|7276065|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
4478827|NCT00706654|7276066|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
4478828|NCT00706654|7276063|FG000|Depot Maintenance Phase|Lost to Follow-up|0
4478829|NCT00706654|7276064|FG001|Depot Maintenance Phase|Lost to Follow-up|4
4478830|NCT00706654|7276065|FG002|Depot Maintenance Phase|Lost to Follow-up|10
4478831|NCT00706654|7276066|FG003|Depot Maintenance Phase|Lost to Follow-up|6
4478832|NCT00706654|7276063|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0
4478833|NCT00706654|7276064|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4
4589538|NCT01513460|7434957|FG002|Overall Study|Lost to Follow-up|2
4699810|NCT02688387|7615413|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4699811|NCT02688387|7615414|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4699812|NCT02688387|7615415|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4699813|NCT02688387|7615416|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1
4699814|NCT02688387|7615417|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4699815|NCT02688387|7615418|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4699816|NCT02688387|7615419|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4699817|NCT02688387|7615420|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4589539|NCT01513460|7434955|FG000|Overall Study|Abnormal laboratory value|1
4589540|NCT01513460|7434956|FG001|Overall Study|Abnormal laboratory value|0
4478834|NCT00706654|7276065|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6
4478835|NCT00706654|7276066|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5
4478836|NCT00706654|7276063|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0
4589541|NCT01513460|7434957|FG002|Overall Study|Abnormal laboratory value|1
4589542|NCT01513460|7434955|FG000|Overall Study|Lack of Efficacy|1
4589543|NCT01513460|7434956|FG001|Overall Study|Lack of Efficacy|2
4589544|NCT01513460|7434957|FG002|Overall Study|Lack of Efficacy|5
4589545|NCT01513460|7434955|FG000|Overall Study|Protocol deviations|3
4589546|NCT01513460|7434956|FG001|Overall Study|Protocol deviations|4
4589547|NCT01513460|7434957|FG002|Overall Study|Protocol deviations|3
4478837|NCT00706654|7276064|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8
4478838|NCT00706654|7276065|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12
4478839|NCT00706654|7276066|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8
4478840|NCT00706654|7276063|FG000|Depot Maintenance Phase|Withdrew Consent|0
4478841|NCT00706654|7276064|FG001|Depot Maintenance Phase|Withdrew Consent|21
4478842|NCT00706654|7276065|FG002|Depot Maintenance Phase|Withdrew Consent|29
4478843|NCT00706654|7276066|FG003|Depot Maintenance Phase|Withdrew Consent|14
4386824|NCT00042432|7165401|FG001|Overall Study|Death|2
4386825|NCT00042432|7165400|FG000|Overall Study|Ineligibility determined|1
4386826|NCT00042432|7165401|FG001|Overall Study|Ineligibility determined|0
4386827|NCT00042432|7165400|FG000|Overall Study|Initiation of maintenance dialysis|1
4386828|NCT00042432|7165401|FG001|Overall Study|Initiation of maintenance dialysis|1
4386829|NCT00042432|7165400|FG000|Overall Study|Other|2
4386830|NCT00042432|7165401|FG001|Overall Study|Other|0
4386831|NCT00042666|7165407|FG000|Overall Study|Adverse Event|2
4478844|NCT00706654|7276063|FG000|Depot Maintenance Phase|Protocol Deviation|0
4478845|NCT00706654|7276064|FG001|Depot Maintenance Phase|Protocol Deviation|2
4478846|NCT00706654|7276065|FG002|Depot Maintenance Phase|Protocol Deviation|3
4478847|NCT00706654|7276066|FG003|Depot Maintenance Phase|Protocol Deviation|1
4478848|NCT00706654|7276063|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0
4478849|NCT00706654|7276064|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8
4478850|NCT00706654|7276065|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7
4478851|NCT00706654|7276066|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7
4478852|NCT00706654|7276063|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0
4478853|NCT00706654|7276064|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13
4478854|NCT00706654|7276065|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12
4478855|NCT00706654|7276066|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17
4478856|NCT00706654|7276063|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0
4478857|NCT00706654|7276064|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9
4478858|NCT00706654|7276065|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9
4478859|NCT00706654|7276066|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12
4478860|NCT00706706|7276076|FG000|Overall Study|Death|53
4478861|NCT00706706|7276076|FG000|Overall Study|Lost to Follow-up|7
4478862|NCT00706706|7276076|FG000|Overall Study|Study endpoint had reached|45
4478863|NCT00706849|7276125|FG000|Treatment Period|Adverse Event|0
4478864|NCT00706849|7276126|FG001|Treatment Period|Adverse Event|9
4478865|NCT00706849|7276125|FG000|Treatment Period|Other|0
4478866|NCT00706849|7276126|FG001|Treatment Period|Other|1
4478867|NCT00706849|7276125|FG000|Follow-up Period|Withdrawal by Subject|0
4478868|NCT00706849|7276126|FG001|Follow-up Period|Withdrawal by Subject|2
4478869|NCT00706849|7276125|FG000|Follow-up Period|Protocol non-compliance|0
4478870|NCT00706849|7276126|FG001|Follow-up Period|Protocol non-compliance|1
4478871|NCT00706901|7276135|FG000|Overall Study|Lost to Follow-up|2
4478872|NCT00706901|7276136|FG001|Overall Study|Lost to Follow-up|3
4478873|NCT00706901|7276137|FG002|Overall Study|Lost to Follow-up|2
4478874|NCT00706901|7276135|FG000|Overall Study|Withdrawal by Subject|4
4478875|NCT00706901|7276136|FG001|Overall Study|Withdrawal by Subject|2
4478876|NCT00706901|7276137|FG002|Overall Study|Withdrawal by Subject|5
4478877|NCT00706901|7276135|FG000|Overall Study|In Jail|1
4478878|NCT00706901|7276136|FG001|Overall Study|In Jail|0
4478879|NCT00706901|7276137|FG002|Overall Study|In Jail|1
4478880|NCT00706901|7276135|FG000|Overall Study|Death|1
4589548|NCT01513460|7434955|FG000|Overall Study|Withdrawal by Subject|7
4589549|NCT01513460|7434956|FG001|Overall Study|Withdrawal by Subject|8
4589550|NCT01513460|7434957|FG002|Overall Study|Withdrawal by Subject|21
4589551|NCT01513460|7434955|FG000|Overall Study|Adverse Event|16
4589552|NCT01513460|7434956|FG001|Overall Study|Adverse Event|18
4589553|NCT01513460|7434957|FG002|Overall Study|Adverse Event|23
4589554|NCT01513460|7434955|FG000|Overall Study|Abnormal test procedure|1
4589555|NCT01513460|7434956|FG001|Overall Study|Abnormal test procedure|0
4589556|NCT01513460|7434957|FG002|Overall Study|Abnormal test procedure|0
4589557|NCT01513473|7434969|FG000|Main Trial (26 Weeks)|Adverse Event|0
4589558|NCT01513473|7434970|FG001|Main Trial (26 Weeks)|Adverse Event|2
4589559|NCT01513473|7434969|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4
4589560|NCT01513473|7434970|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7
4386832|NCT00042666|7165407|FG000|Overall Study|Death|4
4386833|NCT00042666|7165407|FG000|Overall Study|Protocol Violation|1
4386834|NCT00042666|7165407|FG000|Overall Study|Participant/Physician Perception|1
4478881|NCT00706901|7276136|FG001|Overall Study|Death|0
4478882|NCT00706901|7276137|FG002|Overall Study|Death|0
4478883|NCT00706914|7276149|FG000|Overall Study|Lack of Efficacy|0
4478884|NCT00706914|7276150|FG001|Overall Study|Lack of Efficacy|1
4478885|NCT00706914|7276151|FG002|Overall Study|Lack of Efficacy|0
4478886|NCT00706914|7276149|FG000|Overall Study|Lost to Follow-up|1
4478887|NCT00706914|7276150|FG001|Overall Study|Lost to Follow-up|0
4478888|NCT00706914|7276151|FG002|Overall Study|Lost to Follow-up|0
4478889|NCT00706914|7276149|FG000|Overall Study|Adverse Event|2
4478890|NCT00706914|7276150|FG001|Overall Study|Adverse Event|2
4478891|NCT00706914|7276151|FG002|Overall Study|Adverse Event|0
4478892|NCT00706914|7276149|FG000|Overall Study|Protocol Violation|3
4478893|NCT00706914|7276150|FG001|Overall Study|Protocol Violation|1
4478894|NCT00706914|7276151|FG002|Overall Study|Protocol Violation|1
4478895|NCT00706966|7276159|FG000|Overall Study|Adverse Event|1
4478896|NCT00706992|7276207|FG000|Overall Study|Study termination|5
4386835|NCT00042666|7165407|FG000|Overall Study|Progressive Disease|41
4386836|NCT00042666|7165407|FG000|Overall Study|Other|1
4386837|NCT00042666|7165407|FG000|Overall Study|Other|4
4386838|NCT00042939|7165414|FG000|Overall Study|Adverse Event|6
4386839|NCT00042939|7165415|FG001|Overall Study|Adverse Event|7
4386840|NCT00042939|7165414|FG000|Overall Study|Death|3
4386841|NCT00042939|7165415|FG001|Overall Study|Death|2
4386842|NCT00042939|7165414|FG000|Overall Study|Withdrawal by Subject|3
4386843|NCT00042939|7165415|FG001|Overall Study|Withdrawal by Subject|4
4386844|NCT00042939|7165414|FG000|Overall Study|Other disease|1
4386845|NCT00042939|7165415|FG001|Overall Study|Other disease|0
4386846|NCT00042939|7165414|FG000|Overall Study|Ineligible|2
4386847|NCT00042939|7165415|FG001|Overall Study|Ineligible|2
4386848|NCT00042939|7165414|FG000|Overall Study|Deterioration of health|3
4386849|NCT00042939|7165415|FG001|Overall Study|Deterioration of health|4
4386850|NCT00042939|7165414|FG000|Overall Study|QOL diminished|1
4386851|NCT00042939|7165415|FG001|Overall Study|QOL diminished|0
4386852|NCT00042939|7165414|FG000|Overall Study|Rising ca 19-9|1
4386853|NCT00042939|7165415|FG001|Overall Study|Rising ca 19-9|0
4386854|NCT00042939|7165414|FG000|Overall Study|Patient non-compliance|1
4386855|NCT00042939|7165415|FG001|Overall Study|Patient non-compliance|0
4386856|NCT00042939|7165414|FG000|Overall Study|Still on treatment|1
4386857|NCT00042939|7165415|FG001|Overall Study|Still on treatment|0
4386858|NCT00042939|7165414|FG000|Overall Study|Treatment break > 4 weeks|0
4478897|NCT00706992|7276208|FG001|Overall Study|Study termination|5
4478898|NCT00706992|7276209|FG002|Overall Study|Study termination|6
4478899|NCT00706992|7276210|FG003|Overall Study|Study termination|2
4478900|NCT00706992|7276211|FG004|Overall Study|Study termination|3
4478901|NCT00706992|7276212|FG005|Overall Study|Study termination|2
4478902|NCT00706992|7276213|FG006|Overall Study|Study termination|3
4478903|NCT00706992|7276207|FG000|Overall Study|Disease progression before treatment|0
4478904|NCT00706992|7276208|FG001|Overall Study|Disease progression before treatment|0
4478905|NCT00706992|7276209|FG002|Overall Study|Disease progression before treatment|0
4478906|NCT00706992|7276210|FG003|Overall Study|Disease progression before treatment|0
4478907|NCT00706992|7276211|FG004|Overall Study|Disease progression before treatment|1
4478908|NCT00706992|7276212|FG005|Overall Study|Disease progression before treatment|0
4478909|NCT00706992|7276213|FG006|Overall Study|Disease progression before treatment|0
4478910|NCT00707031|7276232|FG000|Overall Study|Adverse Event|45
4478911|NCT00707031|7276233|FG001|Overall Study|Adverse Event|45
4478912|NCT00707031|7276232|FG000|Overall Study|Lack of Efficacy|19
4478913|NCT00707031|7276233|FG001|Overall Study|Lack of Efficacy|6
4478914|NCT00707031|7276232|FG000|Overall Study|Lost to Follow-up|2
4478915|NCT00707031|7276233|FG001|Overall Study|Lost to Follow-up|1
4478916|NCT00707031|7276232|FG000|Overall Study|Protocol Violation|1
4478917|NCT00707031|7276233|FG001|Overall Study|Protocol Violation|0
4478918|NCT00707031|7276232|FG000|Overall Study|Withdrawal by Subject|7
4478919|NCT00707031|7276233|FG001|Overall Study|Withdrawal by Subject|8
4478920|NCT00707031|7276232|FG000|Overall Study|Poor Compliance to Protocol|7
4478921|NCT00707031|7276233|FG001|Overall Study|Poor Compliance to Protocol|13
4478922|NCT00707031|7276232|FG000|Overall Study|Familial or Personal Reasons|12
4478923|NCT00707031|7276233|FG001|Overall Study|Familial or Personal Reasons|15
4478924|NCT00707031|7276232|FG000|Overall Study|Serious Noncompliance|2
4478925|NCT00707031|7276233|FG001|Overall Study|Serious Noncompliance|3
4478926|NCT00707031|7276232|FG000|Overall Study|Sponsor Decision|9
4478927|NCT00707031|7276233|FG001|Overall Study|Sponsor Decision|8
4478928|NCT00707057|7276242|FG000|Overall Study|Withdrawal by Subject|8
4478929|NCT00707057|7276243|FG001|Overall Study|Withdrawal by Subject|3
4478930|NCT00707057|7276242|FG000|Overall Study|Dosed incorrectly|0
4478931|NCT00707057|7276243|FG001|Overall Study|Dosed incorrectly|1
4478932|NCT00707174|7276251|FG000|Overall Study|Adverse Event|1
4478933|NCT00707174|7276252|FG001|Overall Study|Adverse Event|6
4478934|NCT00707174|7276251|FG000|Overall Study|Withdrawal by Subject|4
4478935|NCT00707174|7276252|FG001|Overall Study|Withdrawal by Subject|1
4478936|NCT00707239|7276261|FG000|Overall Study|Adverse Event|5
4478937|NCT00707239|7276262|FG001|Overall Study|Adverse Event|3
4478938|NCT00707239|7276263|FG002|Overall Study|Adverse Event|2
4478939|NCT00707239|7276261|FG000|Overall Study|Death|3
4478940|NCT00707239|7276262|FG001|Overall Study|Death|1
4478941|NCT00707239|7276263|FG002|Overall Study|Death|3
4478942|NCT00707239|7276261|FG000|Overall Study|Physician Decision|1
4478943|NCT00707239|7276262|FG001|Overall Study|Physician Decision|1
4478944|NCT00707239|7276263|FG002|Overall Study|Physician Decision|2
4478945|NCT00707239|7276261|FG000|Overall Study|Protocol Violation|0
4478946|NCT00707239|7276262|FG001|Overall Study|Protocol Violation|0
4478947|NCT00707239|7276263|FG002|Overall Study|Protocol Violation|1
4478948|NCT00707239|7276261|FG000|Overall Study|Lack of Efficacy|1
4478949|NCT00707239|7276262|FG001|Overall Study|Lack of Efficacy|2
4478950|NCT00707239|7276263|FG002|Overall Study|Lack of Efficacy|0
4478951|NCT00707239|7276261|FG000|Overall Study|Randomized, but not treated|1
4478952|NCT00707239|7276262|FG001|Overall Study|Randomized, but not treated|1
4478953|NCT00707239|7276263|FG002|Overall Study|Randomized, but not treated|1
4478954|NCT00707239|7276261|FG000|Overall Study|Other|8
4478955|NCT00707239|7276262|FG001|Overall Study|Other|3
4478956|NCT00707239|7276263|FG002|Overall Study|Other|5
4478957|NCT00707486|7276287|FG000|Overall Study|Withdrawal by Subject|1
4478958|NCT00707577|7276295|FG000|Overall Study|Withdrawal by Subject|3
4478959|NCT00707577|7276296|FG001|Overall Study|Withdrawal by Subject|2
4478960|NCT00707577|7276295|FG000|Overall Study|Lost to Follow-up|34
4478961|NCT00707577|7276296|FG001|Overall Study|Lost to Follow-up|25
4589561|NCT01513473|7434969|FG000|Main Trial (26 Weeks)|Unclassified|0
4589562|NCT01513473|7434970|FG001|Main Trial (26 Weeks)|Unclassified|2
4589563|NCT01513473|7434969|FG000|Extension Trial (26 Weeks)|Adverse Event|0
4589564|NCT01513473|7434970|FG001|Extension Trial (26 Weeks)|Adverse Event|1
4589565|NCT01513473|7434969|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1
4589566|NCT01513473|7434970|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5
4589567|NCT01513551|7434983|FG000|Overall Study|Death|0
4589568|NCT01513551|7434984|FG001|Overall Study|Death|1
4589569|NCT01513551|7434985|FG002|Overall Study|Death|0
4589570|NCT01513551|7434983|FG000|Overall Study|Lost to Follow-up|3
4478962|NCT00707577|7276295|FG000|Overall Study|Left employment|13
4478963|NCT00707577|7276296|FG001|Overall Study|Left employment|10
4478964|NCT00707577|7276295|FG000|Overall Study|Pregnancy|4
4478965|NCT00707577|7276296|FG001|Overall Study|Pregnancy|1
4478966|NCT00707746|7276315|FG000|Treatment Period|Adverse Event|2
4478967|NCT00707746|7276316|FG001|Treatment Period|Adverse Event|4
4478968|NCT00707746|7276315|FG000|Treatment Period|Ineligibility|0
4478969|NCT00707746|7276316|FG001|Treatment Period|Ineligibility|1
4478970|NCT00707954|7276349|FG000|Overall Study|Physician Decision|0
4478971|NCT00707954|7276350|FG001|Overall Study|Physician Decision|0
4478972|NCT00707954|7276351|FG002|Overall Study|Physician Decision|0
4478973|NCT00707954|7276352|FG003|Overall Study|Physician Decision|0
4478974|NCT00707954|7276353|FG004|Overall Study|Physician Decision|1
4478975|NCT00707980|7276378|FG000|Overall Study|Adverse Event|49
4478976|NCT00707980|7276378|FG000|Overall Study|Lack of Efficacy|35
4478977|NCT00707980|7276378|FG000|Overall Study|Non-Compliance with Study Drug|28
4478978|NCT00707980|7276378|FG000|Overall Study|Protocol Deviations|19
4478979|NCT00707980|7276378|FG000|Overall Study|Withdrawal of Consent|81
4478980|NCT00707980|7276378|FG000|Overall Study|Lost to Follow-up|59
4478981|NCT00707980|7276378|FG000|Overall Study|Other|39
4478982|NCT00707993|7276384|FG000|Overall Study|Adverse Event|16
4478983|NCT00707993|7276385|FG001|Overall Study|Adverse Event|20
4478984|NCT00707993|7276384|FG000|Overall Study|Protocol Violation|4
4478985|NCT00707993|7276385|FG001|Overall Study|Protocol Violation|7
4478986|NCT00707993|7276384|FG000|Overall Study|Lost to Follow-up|0
4478987|NCT00707993|7276385|FG001|Overall Study|Lost to Follow-up|4
4478988|NCT00707993|7276384|FG000|Overall Study|Withdrawal by Subject|12
4478989|NCT00707993|7276385|FG001|Overall Study|Withdrawal by Subject|16
4478990|NCT00707993|7276384|FG000|Overall Study|Hyperglycemic Rescue|55
4478991|NCT00707993|7276385|FG001|Overall Study|Hyperglycemic Rescue|47
4478992|NCT00707993|7276384|FG000|Overall Study|Other|2
4478993|NCT00707993|7276385|FG001|Overall Study|Other|0
4478994|NCT00708032|7276402|FG000|Overall Study|Adverse Event|0
4478995|NCT00708032|7276403|FG001|Overall Study|Adverse Event|2
4478996|NCT00708032|7276402|FG000|Overall Study|Lost to Follow-up|1
4478997|NCT00708032|7276403|FG001|Overall Study|Lost to Follow-up|2
4478998|NCT00708032|7276402|FG000|Overall Study|Pregnancy|0
4478999|NCT00708032|7276403|FG001|Overall Study|Pregnancy|1
4479000|NCT00708032|7276402|FG000|Overall Study|Poor vision|0
4479001|NCT00708032|7276403|FG001|Overall Study|Poor vision|6
4479002|NCT00708032|7276402|FG000|Overall Study|Visit out of range at month 12|4
4479003|NCT00708032|7276403|FG001|Overall Study|Visit out of range at month 12|1
4589571|NCT01513551|7434984|FG001|Overall Study|Lost to Follow-up|5
4589572|NCT01513551|7434985|FG002|Overall Study|Lost to Follow-up|2
4479004|NCT00708032|7276402|FG000|Overall Study|Did not meet protocol criteria|1
4479005|NCT00708032|7276403|FG001|Overall Study|Did not meet protocol criteria|2
4479006|NCT00708032|7276402|FG000|Overall Study|Protocol Violation|4
4479007|NCT00708032|7276403|FG001|Overall Study|Protocol Violation|1
4479008|NCT00708032|7276402|FG000|Overall Study|Withdrawal by Subject|0
4479009|NCT00708032|7276403|FG001|Overall Study|Withdrawal by Subject|1
4589573|NCT01513551|7434983|FG000|Overall Study|Withdrawal by Subject|1
4589574|NCT01513551|7434984|FG001|Overall Study|Withdrawal by Subject|0
4479010|NCT00708097|7276443|FG000|Period 1|Protocol Violation|0
4479011|NCT00708097|7276444|FG001|Period 1|Protocol Violation|1
4479012|NCT00708097|7276445|FG002|Period 1|Protocol Violation|0
4479013|NCT00708097|7276446|FG003|Period 1|Protocol Violation|2
4479014|NCT00708097|7276447|FG004|Period 1|Protocol Violation|0
4479015|NCT00708097|7276443|FG000|Period 1|Other Reason|0
4479016|NCT00708097|7276444|FG001|Period 1|Other Reason|0
4479017|NCT00708097|7276445|FG002|Period 1|Other Reason|0
4479018|NCT00708097|7276446|FG003|Period 1|Other Reason|0
4479019|NCT00708097|7276447|FG004|Period 1|Other Reason|1
4479020|NCT00708097|7276443|FG000|Period 2|Protocol Violation|0
4479021|NCT00708097|7276444|FG001|Period 2|Protocol Violation|1
4479022|NCT00708097|7276445|FG002|Period 2|Protocol Violation|1
4386859|NCT00042939|7165415|FG001|Overall Study|Treatment break > 4 weeks|1
4386860|NCT00042939|7165414|FG000|Overall Study|Did not start treatment|2
4386861|NCT00042939|7165415|FG001|Overall Study|Did not start treatment|1
4386862|NCT00042991|7165428|FG000|Overall Study|Adverse Event|1
4386863|NCT00042991|7165429|FG001|Overall Study|Adverse Event|4
4386864|NCT00042991|7165430|FG002|Overall Study|Adverse Event|2
4386865|NCT00042991|7165431|FG003|Overall Study|Adverse Event|0
4386866|NCT00042991|7165432|FG004|Overall Study|Adverse Event|0
4386867|NCT00042991|7165433|FG005|Overall Study|Adverse Event|1
4386868|NCT00042991|7165434|FG006|Overall Study|Adverse Event|0
4386869|NCT00042991|7165428|FG000|Overall Study|Withdrawal by Subject|0
4386870|NCT00042991|7165429|FG001|Overall Study|Withdrawal by Subject|7
4386871|NCT00042991|7165430|FG002|Overall Study|Withdrawal by Subject|2
4386872|NCT00042991|7165431|FG003|Overall Study|Withdrawal by Subject|0
4386873|NCT00042991|7165432|FG004|Overall Study|Withdrawal by Subject|1
4386874|NCT00042991|7165433|FG005|Overall Study|Withdrawal by Subject|0
4479023|NCT00708097|7276446|FG003|Period 2|Protocol Violation|1
4479024|NCT00708097|7276447|FG004|Period 2|Protocol Violation|0
4479025|NCT00708123|7276481|FG000|Period 1|Protocol Violation|0
4479026|NCT00708123|7276482|FG001|Period 1|Protocol Violation|1
4479027|NCT00708123|7276483|FG002|Period 1|Protocol Violation|0
4479028|NCT00708123|7276484|FG003|Period 1|Protocol Violation|1
4479029|NCT00708123|7276485|FG004|Period 1|Protocol Violation|0
4589575|NCT01513551|7434985|FG002|Overall Study|Withdrawal by Subject|2
4589576|NCT01513551|7434983|FG000|Overall Study|Randomized but not vaccinated|0
4589577|NCT01513551|7434984|FG001|Overall Study|Randomized but not vaccinated|0
4589578|NCT01513551|7434985|FG002|Overall Study|Randomized but not vaccinated|1
4589579|NCT01513590|7434995|FG000|Overall Study|Adverse Event|2
4589580|NCT01513590|7434996|FG001|Overall Study|Adverse Event|3
4589581|NCT01513590|7434995|FG000|Overall Study|Withdrawal Criteria|3
4589582|NCT01513590|7434996|FG001|Overall Study|Withdrawal Criteria|0
4589583|NCT01513590|7434995|FG000|Overall Study|Unclassified|5
4589584|NCT01513590|7434996|FG001|Overall Study|Unclassified|10
4589585|NCT01513759|7435002|FG000|Overall Study|Protocol Violation|4
4589586|NCT01513759|7435002|FG000|Overall Study|Death during catheter placement|1
4589587|NCT01513967|7435027|FG000|Overall Study|Pregnancy|0
4589588|NCT01513967|7435028|FG001|Overall Study|Pregnancy|0
4589589|NCT01513967|7435029|FG002|Overall Study|Pregnancy|0
4589590|NCT01513967|7435030|FG003|Overall Study|Pregnancy|0
4589591|NCT01513967|7435031|FG004|Overall Study|Pregnancy|0
4589592|NCT01513967|7435032|FG005|Overall Study|Pregnancy|0
4589593|NCT01513967|7435033|FG006|Overall Study|Pregnancy|1
4589594|NCT01513967|7435034|FG007|Overall Study|Pregnancy|0
4589595|NCT01513967|7435027|FG000|Overall Study|missed a study visit|0
4589596|NCT01513967|7435028|FG001|Overall Study|missed a study visit|0
4479030|NCT00708123|7276481|FG000|Period 1|Adverse Event|0
4479031|NCT00708123|7276482|FG001|Period 1|Adverse Event|0
4479032|NCT00708123|7276483|FG002|Period 1|Adverse Event|1
4479033|NCT00708123|7276484|FG003|Period 1|Adverse Event|0
4479034|NCT00708123|7276485|FG004|Period 1|Adverse Event|0
4479035|NCT00708123|7276481|FG000|Period 2|Protocol Violation|0
4479036|NCT00708123|7276482|FG001|Period 2|Protocol Violation|0
4479037|NCT00708123|7276483|FG002|Period 2|Protocol Violation|0
4479038|NCT00708123|7276484|FG003|Period 2|Protocol Violation|1
4479039|NCT00708123|7276485|FG004|Period 2|Protocol Violation|0
4479040|NCT00708123|7276481|FG000|Period 2|Other Reason|1
4589597|NCT01513967|7435029|FG002|Overall Study|missed a study visit|0
4589598|NCT01513967|7435030|FG003|Overall Study|missed a study visit|0
4589599|NCT01513967|7435031|FG004|Overall Study|missed a study visit|0
4589600|NCT01513967|7435032|FG005|Overall Study|missed a study visit|0
4589601|NCT01513967|7435033|FG006|Overall Study|missed a study visit|1
4589602|NCT01513967|7435034|FG007|Overall Study|missed a study visit|0
4589603|NCT01513967|7435027|FG000|Overall Study|excluded due to positive drug screen|0
4479041|NCT00708123|7276482|FG001|Period 2|Other Reason|0
4479042|NCT00708123|7276483|FG002|Period 2|Other Reason|0
4479043|NCT00708123|7276484|FG003|Period 2|Other Reason|0
4479044|NCT00708123|7276485|FG004|Period 2|Other Reason|0
4479045|NCT00708123|7276481|FG000|Period 3|Lost to Follow-up|0
4479046|NCT00708123|7276482|FG001|Period 3|Lost to Follow-up|0
4589604|NCT01513967|7435028|FG001|Overall Study|excluded due to positive drug screen|0
4589605|NCT01513967|7435029|FG002|Overall Study|excluded due to positive drug screen|0
4589606|NCT01513967|7435030|FG003|Overall Study|excluded due to positive drug screen|0
4479047|NCT00708123|7276483|FG002|Period 3|Lost to Follow-up|1
4589607|NCT01513967|7435031|FG004|Overall Study|excluded due to positive drug screen|0
4386875|NCT00042991|7165434|FG006|Overall Study|Withdrawal by Subject|0
4386876|NCT00042991|7165428|FG000|Overall Study|Disease Progression|5
4386877|NCT00042991|7165429|FG001|Overall Study|Disease Progression|29
4479048|NCT00708123|7276484|FG003|Period 3|Lost to Follow-up|1
4479049|NCT00708123|7276485|FG004|Period 3|Lost to Follow-up|0
4479050|NCT00708123|7276481|FG000|Period 4|Protocol Violation|0
4479051|NCT00708123|7276482|FG001|Period 4|Protocol Violation|1
4479052|NCT00708123|7276483|FG002|Period 4|Protocol Violation|0
4479053|NCT00708123|7276484|FG003|Period 4|Protocol Violation|0
4479054|NCT00708123|7276485|FG004|Period 4|Protocol Violation|0
4479055|NCT00708162|7276503|FG000|Randomized Phase|Randomized but Not Treated|7
4479056|NCT00708162|7276504|FG001|Randomized Phase|Randomized but Not Treated|5
4479057|NCT00708162|7276503|FG000|Randomized Phase|Participant Noncompliance|40
4479058|NCT00708162|7276504|FG001|Randomized Phase|Participant Noncompliance|32
4479059|NCT00708162|7276503|FG000|Randomized Phase|Lost to Follow-up|34
4479060|NCT00708162|7276504|FG001|Randomized Phase|Lost to Follow-up|34
4479061|NCT00708162|7276503|FG000|Randomized Phase|Withdrew Consent|31
4479062|NCT00708162|7276504|FG001|Randomized Phase|Withdrew Consent|22
4479063|NCT00708162|7276503|FG000|Randomized Phase|Lack of Efficacy|14
4479064|NCT00708162|7276504|FG001|Randomized Phase|Lack of Efficacy|19
4479065|NCT00708162|7276503|FG000|Randomized Phase|Protocol Violation|10
4479066|NCT00708162|7276504|FG001|Randomized Phase|Protocol Violation|11
4479067|NCT00708162|7276503|FG000|Randomized Phase|Adverse Event|8
4479068|NCT00708162|7276504|FG001|Randomized Phase|Adverse Event|12
4699818|NCT02688387|7615421|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4699819|NCT02688387|7615422|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4699820|NCT02688387|7615423|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4699821|NCT02688387|7615402|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
4699822|NCT02688387|7615403|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
4699823|NCT02688387|7615404|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
4699824|NCT02688387|7615405|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
4699825|NCT02688387|7615406|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
4699826|NCT02688387|7615407|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
4699827|NCT02688387|7615408|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
4699828|NCT02688387|7615409|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
4699829|NCT02688387|7615410|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
4699830|NCT02688387|7615411|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
4699831|NCT02688387|7615412|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
4479069|NCT00708162|7276503|FG000|Randomized Phase|Investigator's Discretion|7
4479070|NCT00708162|7276504|FG001|Randomized Phase|Investigator's Discretion|10
4479071|NCT00708162|7276503|FG000|Randomized Phase|Death|2
4479072|NCT00708162|7276504|FG001|Randomized Phase|Death|9
4479073|NCT00708162|7276503|FG000|Randomized Phase|Pregnancy|3
4479074|NCT00708162|7276504|FG001|Randomized Phase|Pregnancy|0
4479075|NCT00708162|7276503|FG000|Open-Label Phase|Lost to Follow-up|10
4479076|NCT00708162|7276504|FG001|Open-Label Phase|Lost to Follow-up|8
4479077|NCT00708162|7276503|FG000|Open-Label Phase|Withdrew Consent|12
4479078|NCT00708162|7276504|FG001|Open-Label Phase|Withdrew Consent|6
4479079|NCT00708162|7276503|FG000|Open-Label Phase|Participant Noncompliance|7
4479080|NCT00708162|7276504|FG001|Open-Label Phase|Participant Noncompliance|7
4479081|NCT00708162|7276503|FG000|Open-Label Phase|Lack of Efficacy|7
4479082|NCT00708162|7276504|FG001|Open-Label Phase|Lack of Efficacy|4
4479083|NCT00708162|7276503|FG000|Open-Label Phase|Investigator's Discretion|3
4479084|NCT00708162|7276504|FG001|Open-Label Phase|Investigator's Discretion|2
4479085|NCT00708162|7276503|FG000|Open-Label Phase|Death|3
4479086|NCT00708162|7276504|FG001|Open-Label Phase|Death|1
4479087|NCT00708162|7276503|FG000|Open-Label Phase|Adverse Event|1
4479088|NCT00708162|7276504|FG001|Open-Label Phase|Adverse Event|2
4479089|NCT00708162|7276503|FG000|Open-Label Phase|Other|1
4479090|NCT00708162|7276504|FG001|Open-Label Phase|Other|0
4479091|NCT00708175|7276513|FG000|Overall Study|Adverse Event|4
4479092|NCT00708175|7276514|FG001|Overall Study|Adverse Event|5
4479093|NCT00708175|7276513|FG000|Overall Study|Protocol Violation|2
4479094|NCT00708175|7276514|FG001|Overall Study|Protocol Violation|3
4479095|NCT00708175|7276513|FG000|Overall Study|Lost to Follow-up|5
4479096|NCT00708175|7276514|FG001|Overall Study|Lost to Follow-up|3
4479097|NCT00708175|7276513|FG000|Overall Study|Withdrawal by Subject|5
4479098|NCT00708175|7276514|FG001|Overall Study|Withdrawal by Subject|7
4479099|NCT00708175|7276513|FG000|Overall Study|BMD loss >7%|2
4479100|NCT00708175|7276514|FG001|Overall Study|BMD loss >7%|3
4479101|NCT00708201|7276522|FG000|Overall Study|Adverse Event|4
4479102|NCT00708201|7276523|FG001|Overall Study|Adverse Event|4
4479103|NCT00708201|7276522|FG000|Overall Study|Withdrawal by Subject|1
4479104|NCT00708201|7276523|FG001|Overall Study|Withdrawal by Subject|1
4479105|NCT00708201|7276522|FG000|Overall Study|Lost to Follow-up|2
4479106|NCT00708201|7276523|FG001|Overall Study|Lost to Follow-up|0
4479107|NCT00708201|7276522|FG000|Overall Study|Protocol Violation|0
4479108|NCT00708201|7276523|FG001|Overall Study|Protocol Violation|1
4479109|NCT00708214|7276532|FG000|Overall Study|Other Adverse Event|3
4479110|NCT00708214|7276533|FG001|Overall Study|Other Adverse Event|6
4479111|NCT00708214|7276534|FG002|Overall Study|Other Adverse Event|2
4479112|NCT00708214|7276532|FG000|Overall Study|Other|0
4479113|NCT00708214|7276533|FG001|Overall Study|Other|1
4479114|NCT00708214|7276534|FG002|Overall Study|Other|1
4479115|NCT00708214|7276532|FG000|Overall Study|Progressive Disease|4
4479116|NCT00708214|7276533|FG001|Overall Study|Progressive Disease|6
4479117|NCT00708214|7276534|FG002|Overall Study|Progressive Disease|5
4479118|NCT00708227|7276551|FG000|Overall Study|Physician Decision|0
4479119|NCT00708227|7276552|FG001|Overall Study|Physician Decision|3
4479120|NCT00708227|7276553|FG002|Overall Study|Physician Decision|1
4479121|NCT00708227|7276554|FG003|Overall Study|Physician Decision|2
4479122|NCT00708227|7276551|FG000|Overall Study|Withdrawal by Subject|1
4479123|NCT00708227|7276552|FG001|Overall Study|Withdrawal by Subject|2
4479124|NCT00708227|7276553|FG002|Overall Study|Withdrawal by Subject|0
4479125|NCT00708227|7276554|FG003|Overall Study|Withdrawal by Subject|1
4479126|NCT00708305|7276584|FG000|Period 1|Protocol Violation|1
4479127|NCT00708305|7276585|FG001|Period 1|Protocol Violation|0
4479128|NCT00708305|7276586|FG002|Period 1|Protocol Violation|1
4479129|NCT00708305|7276587|FG003|Period 1|Protocol Violation|0
4479130|NCT00708305|7276584|FG000|Period 1|Other Reason|0
4479131|NCT00708305|7276585|FG001|Period 1|Other Reason|0
4479132|NCT00708305|7276586|FG002|Period 1|Other Reason|0
4479133|NCT00708305|7276587|FG003|Period 1|Other Reason|2
4479134|NCT00708305|7276584|FG000|Period 2|Lost to Follow-up|0
4479135|NCT00708305|7276585|FG001|Period 2|Lost to Follow-up|1
4479136|NCT00708305|7276586|FG002|Period 2|Lost to Follow-up|0
4479137|NCT00708305|7276587|FG003|Period 2|Lost to Follow-up|0
4479138|NCT00708305|7276584|FG000|Period 2|Protocol Violation|0
4479139|NCT00708305|7276585|FG001|Period 2|Protocol Violation|1
4479140|NCT00708305|7276586|FG002|Period 2|Protocol Violation|0
4479141|NCT00708305|7276587|FG003|Period 2|Protocol Violation|0
4479142|NCT00708305|7276584|FG000|Period 2|Other Reason|1
4479143|NCT00708305|7276585|FG001|Period 2|Other Reason|0
4479144|NCT00708305|7276586|FG002|Period 2|Other Reason|0
4479145|NCT00708305|7276587|FG003|Period 2|Other Reason|1
4479146|NCT00708305|7276584|FG000|Period 3|Protocol Violation|0
4479147|NCT00708305|7276585|FG001|Period 3|Protocol Violation|2
4479148|NCT00708305|7276586|FG002|Period 3|Protocol Violation|0
4479149|NCT00708305|7276587|FG003|Period 3|Protocol Violation|0
4479150|NCT00708305|7276584|FG000|Period 3|Other Reason|1
4479151|NCT00708305|7276585|FG001|Period 3|Other Reason|0
4479152|NCT00708305|7276586|FG002|Period 3|Other Reason|0
4479153|NCT00708305|7276587|FG003|Period 3|Other Reason|0
4479154|NCT00708422|7276602|FG000|Overall Study|Adverse Event|3
4479155|NCT00708422|7276603|FG001|Overall Study|Adverse Event|1
4479156|NCT00708422|7276602|FG000|Overall Study|Withdrawal by Subject|1
4479157|NCT00708422|7276603|FG001|Overall Study|Withdrawal by Subject|0
4479158|NCT00708435|7276611|FG000|Overall Study|Death / Serious Adverse Event|10
4479159|NCT00708435|7276612|FG001|Overall Study|Death / Serious Adverse Event|5
4479160|NCT00708435|7276611|FG000|Overall Study|Lost to Follow-up|9
4479161|NCT00708435|7276612|FG001|Overall Study|Lost to Follow-up|4
4479162|NCT00708435|7276611|FG000|Overall Study|Withdrawal by Subject|3
4479163|NCT00708435|7276612|FG001|Overall Study|Withdrawal by Subject|7
4479164|NCT00708435|7276611|FG000|Overall Study|Adverse Event|1
4479165|NCT00708435|7276612|FG001|Overall Study|Adverse Event|0
4479166|NCT00708435|7276611|FG000|Overall Study|Protocol Violation|0
4479167|NCT00708435|7276612|FG001|Overall Study|Protocol Violation|1
4479168|NCT00708435|7276611|FG000|Overall Study|Intervention by primary care physician|1
4479169|NCT00708435|7276612|FG001|Overall Study|Intervention by primary care physician|0
4479170|NCT00708435|7276611|FG000|Overall Study|Refused hospitalization|1
4479171|NCT00708435|7276612|FG001|Overall Study|Refused hospitalization|0
4479172|NCT00708461|7276622|FG000|Overall Study|Lost to Follow-up|18
4479173|NCT00708461|7276623|FG001|Overall Study|Lost to Follow-up|11
4479174|NCT00708461|7276622|FG000|Overall Study|Withdrawal by Subject|8
4479175|NCT00708461|7276623|FG001|Overall Study|Withdrawal by Subject|9
4479176|NCT00708461|7276622|FG000|Overall Study|left workforce|115
4479177|NCT00708461|7276623|FG001|Overall Study|left workforce|180
4479178|NCT00708500|7276632|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1
4479179|NCT00708500|7276633|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3
4479180|NCT00708500|7276634|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1
4479181|NCT00708500|7276632|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1
4479182|NCT00708500|7276633|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0
4479183|NCT00708500|7276634|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0
4479184|NCT00708500|7276632|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0
4479185|NCT00708500|7276633|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1
4479186|NCT00708500|7276634|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0
4479187|NCT00708500|7276632|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0
4479188|NCT00708500|7276633|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2
4479189|NCT00708500|7276634|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0
4479190|NCT00708500|7276632|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0
4479191|NCT00708500|7276633|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0
4479192|NCT00708500|7276634|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1
4479193|NCT00708500|7276632|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1
4479194|NCT00708500|7276633|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10
4479195|NCT00708500|7276634|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19
4479196|NCT00708500|7276632|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49
4479197|NCT00708500|7276633|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36
4479198|NCT00708500|7276634|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29
4479199|NCT00708500|7276632|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0
4479200|NCT00708500|7276633|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1
4479201|NCT00708500|7276634|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0
4479202|NCT00708500|7276632|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3
4479203|NCT00708500|7276633|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1
4479204|NCT00708500|7276634|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4
4479205|NCT00708500|7276632|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2
4479206|NCT00708500|7276633|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0
4479207|NCT00708500|7276634|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1
4479208|NCT00708500|7276632|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0
4479209|NCT00708500|7276633|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2
4479210|NCT00708500|7276634|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1
4479211|NCT00708500|7276632|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0
4479212|NCT00708500|7276633|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1
4479213|NCT00708500|7276634|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1
4479214|NCT00708500|7276632|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0
4479215|NCT00708500|7276633|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1
4479216|NCT00708500|7276634|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0
4479217|NCT00708500|7276632|FG000|FOLLOWUP|Adverse Event|0
4479218|NCT00708500|7276633|FG001|FOLLOWUP|Adverse Event|1
4479219|NCT00708500|7276634|FG002|FOLLOWUP|Adverse Event|0
4479220|NCT00708500|7276632|FG000|FOLLOWUP|Lost to Follow-up|1
4479221|NCT00708500|7276633|FG001|FOLLOWUP|Lost to Follow-up|6
4479222|NCT00708500|7276634|FG002|FOLLOWUP|Lost to Follow-up|4
4479223|NCT00708500|7276632|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3
4479224|NCT00708500|7276633|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4
4479225|NCT00708500|7276634|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5
4479226|NCT00708500|7276632|FG000|FOLLOWUP|Subject withdrew consent|31
4479227|NCT00708500|7276633|FG001|FOLLOWUP|Subject withdrew consent|4
4479228|NCT00708500|7276634|FG002|FOLLOWUP|Subject withdrew consent|5
4479229|NCT00708500|7276632|FG000|FOLLOWUP|Non-compliance with protocol|5
4479230|NCT00708500|7276633|FG001|FOLLOWUP|Non-compliance with protocol|0
4479231|NCT00708500|7276634|FG002|FOLLOWUP|Non-compliance with protocol|1
4479232|NCT00708552|7276655|FG000|Overall Study|Adverse Event|10
4479233|NCT00708552|7276656|FG001|Overall Study|Adverse Event|3
4479234|NCT00708552|7276657|FG002|Overall Study|Adverse Event|4
4479235|NCT00708552|7276658|FG003|Overall Study|Adverse Event|6
4479236|NCT00708552|7276655|FG000|Overall Study|Lack of Efficacy|0
4479237|NCT00708552|7276656|FG001|Overall Study|Lack of Efficacy|4
4479238|NCT00708552|7276657|FG002|Overall Study|Lack of Efficacy|1
4479239|NCT00708552|7276658|FG003|Overall Study|Lack of Efficacy|0
4479240|NCT00708552|7276655|FG000|Overall Study|Protocol Violation|0
4479241|NCT00708552|7276656|FG001|Overall Study|Protocol Violation|0
4479242|NCT00708552|7276657|FG002|Overall Study|Protocol Violation|2
4479243|NCT00708552|7276658|FG003|Overall Study|Protocol Violation|4
4479244|NCT00708552|7276655|FG000|Overall Study|Lost to Follow-up|4
4479245|NCT00708552|7276656|FG001|Overall Study|Lost to Follow-up|2
4479246|NCT00708552|7276657|FG002|Overall Study|Lost to Follow-up|0
4699832|NCT02688387|7615413|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
4699833|NCT02688387|7615414|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
4699834|NCT02688387|7615415|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
4699835|NCT02688387|7615416|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
4699836|NCT02688387|7615417|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
4699837|NCT02688387|7615418|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
4699838|NCT02688387|7615419|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
4699839|NCT02688387|7615420|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
4699840|NCT02688387|7615421|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
4699841|NCT02688387|7615422|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1
4699842|NCT02688387|7615423|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
4699843|NCT02688387|7615402|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
4699844|NCT02688387|7615403|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
4699845|NCT02688387|7615404|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
4699846|NCT02688387|7615405|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
4699847|NCT02688387|7615406|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
4699848|NCT02688387|7615407|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
4699849|NCT02688387|7615408|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
4699850|NCT02688387|7615409|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
4699851|NCT02688387|7615410|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
4699852|NCT02688387|7615411|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
4699853|NCT02688387|7615412|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
4699854|NCT02688387|7615413|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
4699855|NCT02688387|7615414|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
4699856|NCT02688387|7615415|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
4699857|NCT02688387|7615416|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
4699858|NCT02688387|7615417|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
4699859|NCT02688387|7615418|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
4479247|NCT00708552|7276658|FG003|Overall Study|Lost to Follow-up|1
4479248|NCT00708552|7276655|FG000|Overall Study|Physician Decision|1
4479249|NCT00708552|7276656|FG001|Overall Study|Physician Decision|2
4479250|NCT00708552|7276657|FG002|Overall Study|Physician Decision|0
4479251|NCT00708552|7276658|FG003|Overall Study|Physician Decision|0
4479252|NCT00708552|7276655|FG000|Overall Study|Withdrawal by Subject|12
4479253|NCT00708552|7276656|FG001|Overall Study|Withdrawal by Subject|7
4479254|NCT00708552|7276657|FG002|Overall Study|Withdrawal by Subject|8
4479255|NCT00708552|7276658|FG003|Overall Study|Withdrawal by Subject|10
4479256|NCT00708643|7276674|FG000|Overall Study|Adverse Event|0
4479257|NCT00708643|7276675|FG001|Overall Study|Adverse Event|1
4479258|NCT00708682|7276681|FG000|Infant Series|Adverse Event|1
4479259|NCT00708682|7276681|FG000|Infant Series|Lost to Follow-up|4
4479260|NCT00708682|7276681|FG000|Infant Series|Protocol Violation|1
4479261|NCT00708682|7276681|FG000|Infant Series|Parent/legal guardian request|6
4479262|NCT00708682|7276681|FG000|Infant Series|Failed to return|2
4479263|NCT00708682|7276681|FG000|Infant Series|Other|19
4479264|NCT00708682|7276681|FG000|After Infant Series|Parent/Legal Guardian Request|1
4479265|NCT00708682|7276681|FG000|Toddler Dose|Parent/Legal Guardian Request|1
4479266|NCT00708682|7276681|FG000|Toddler Dose|Lost to Follow-up|3
4479267|NCT00708682|7276681|FG000|Toddler Dose|Failed to Return|4
4479268|NCT00708708|7276687|FG000|Overall Study|Another therapy instead of Enbrel|141
4479269|NCT00708708|7276687|FG000|Overall Study|Lost to Follow-up|52
4479270|NCT00708708|7276687|FG000|Overall Study|Withdrawal by Subject|51
4479271|NCT00708708|7276687|FG000|Overall Study|Intolerance|42
4479272|NCT00708708|7276687|FG000|Overall Study|Another therapy along with Enbrel|15
4479273|NCT00708708|7276687|FG000|Overall Study|Other unspecified|11
4479274|NCT00708708|7276687|FG000|Overall Study|Good effectiveness|9
4479275|NCT00708708|7276687|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9
4479276|NCT00708708|7276687|FG000|Overall Study|Administrative reasons|7
4479277|NCT00708708|7276687|FG000|Overall Study|Lack of effectiveness|4
4479278|NCT00708708|7276687|FG000|Overall Study|Lack of compliance|3
4479279|NCT00708708|7276687|FG000|Overall Study|Pregnancy|3
4479280|NCT00708708|7276687|FG000|Overall Study|Adverse Event|3
4479281|NCT00708708|7276687|FG000|Overall Study|Missing values|392
4479282|NCT00709059|7276739|FG000|Overall Study|Lost to Follow-up|34
4479283|NCT00709059|7276739|FG000|Overall Study|Withdrawal by Subject|19
4479284|NCT00709059|7276739|FG000|Overall Study|Physician Decision|7
4479285|NCT00709059|7276739|FG000|Overall Study|Disease complication|3
4479286|NCT00709059|7276739|FG000|Overall Study|Side effects|20
4479287|NCT00709059|7276739|FG000|Overall Study|Serious side effects|11
4479288|NCT00709098|7276746|FG000|Double-blind Period|Withdrawal of consent|3
4479289|NCT00709098|7276747|FG001|Double-blind Period|Withdrawal of consent|3
4479290|NCT00709098|7276748|FG002|Double-blind Period|Withdrawal of consent|0
4479291|NCT00709098|7276746|FG000|Double-blind Period|Administrative reason|1
4479292|NCT00709098|7276747|FG001|Double-blind Period|Administrative reason|3
4479293|NCT00709098|7276748|FG002|Double-blind Period|Administrative reason|0
4479294|NCT00709098|7276746|FG000|Double-blind Period|Death|1
4479295|NCT00709098|7276747|FG001|Double-blind Period|Death|1
4479296|NCT00709098|7276748|FG002|Double-blind Period|Death|0
4479297|NCT00709098|7276746|FG000|Double-blind Period|Lost to Follow-up|1
4479298|NCT00709098|7276747|FG001|Double-blind Period|Lost to Follow-up|1
4479299|NCT00709098|7276748|FG002|Double-blind Period|Lost to Follow-up|0
4479300|NCT00709098|7276746|FG000|Open-label Period|Withdrawal of consent|0
4479301|NCT00709098|7276747|FG001|Open-label Period|Withdrawal of consent|0
4479302|NCT00709098|7276748|FG002|Open-label Period|Withdrawal of consent|7
4479303|NCT00709098|7276746|FG000|Open-label Period|Administrative reason|0
4479304|NCT00709098|7276747|FG001|Open-label Period|Administrative reason|0
4479305|NCT00709098|7276748|FG002|Open-label Period|Administrative reason|5
4479306|NCT00709098|7276746|FG000|Open-label Period|Death|0
4479307|NCT00709098|7276747|FG001|Open-label Period|Death|0
4479308|NCT00709098|7276748|FG002|Open-label Period|Death|1
4479309|NCT00709098|7276746|FG000|Open-label Period|Lost to Follow-up|0
4479310|NCT00709098|7276747|FG001|Open-label Period|Lost to Follow-up|0
4479311|NCT00709098|7276748|FG002|Open-label Period|Lost to Follow-up|1
4479312|NCT00709111|7276757|FG000|Overall Study|Withdrawal by Subject|1
4479313|NCT00709111|7276757|FG000|Overall Study|Unable to attend clinic visits|1
4479314|NCT00709124|7276763|FG000|Overall Study|Death|3
4479315|NCT00709124|7276764|FG001|Overall Study|Death|1
4479316|NCT00709124|7276763|FG000|Overall Study|encephalopathy; can't do assessment|1
4479317|NCT00709124|7276764|FG001|Overall Study|encephalopathy; can't do assessment|0
4479318|NCT00709202|7276776|FG000|Overall Study|Withdrawal by Subject|6
4479319|NCT00709202|7276777|FG001|Overall Study|Withdrawal by Subject|6
4479320|NCT00709228|7276784|FG000|Overall Study|Not treated|14
4479321|NCT00709228|7276784|FG000|Overall Study|Eligibility criteria not met|281
4479322|NCT00709228|7276784|FG000|Overall Study|Adverse events|2
4479323|NCT00709228|7276784|FG000|Overall Study|Discontinued treatment|14
4479324|NCT00709228|7276784|FG000|Overall Study|Did not enter follow-up|4
4479325|NCT00709228|7276784|FG000|Overall Study|Discontinued follow-up|5
4479326|NCT00709228|7276784|FG000|Overall Study|Disease progression|1
4479327|NCT00709228|7276784|FG000|Overall Study|Lost to Follow-up|6
4479328|NCT00709228|7276784|FG000|Overall Study|Non-compliance|5
4479329|NCT00709319|7276805|FG000|Overall Study|Death|4
4479330|NCT00709319|7276805|FG000|Overall Study|Withdrawal by Subject|2
4479331|NCT00709592|7276811|FG000|Overall Study|Unable to proceed to transplant|0
4479332|NCT00709592|7276812|FG001|Overall Study|Unable to proceed to transplant|1
4479333|NCT00709618|7276818|FG000|Overall Study|Withdrawal by Subject|4
4479334|NCT00709618|7276818|FG000|Overall Study|Lost to Follow-up|1
4479335|NCT00709618|7276818|FG000|Overall Study|Study Closed/Terminated|25
4479336|NCT00709722|7276831|FG000|Overall Study|Adverse Event|1
4479337|NCT00709735|7276837|FG000|Overall Study|Lost to Follow-up|1
4479338|NCT00709735|7276838|FG001|Overall Study|Lost to Follow-up|1
4479339|NCT00709735|7276837|FG000|Overall Study|Relapse into Opioid Abuse|0
4479340|NCT00709735|7276838|FG001|Overall Study|Relapse into Opioid Abuse|1
4479341|NCT00709735|7276837|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2
4479342|NCT00709735|7276838|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0
4479343|NCT00709761|7276844|FG000|Overall Study|Withdrawal by Subject|8
4479344|NCT00709761|7276844|FG000|Overall Study|study closed/terminated|17
4479345|NCT00709761|7276844|FG000|Overall Study|Lost to Follow-up|2
4479346|NCT00709852|7276857|FG000|Period 1|Adverse Event|2
4479347|NCT00709852|7276858|FG001|Period 1|Adverse Event|0
4479348|NCT00709852|7276857|FG000|Period 1|Withdrawal by Subject|4
4479349|NCT00709852|7276858|FG001|Period 1|Withdrawal by Subject|2
4479350|NCT00709852|7276857|FG000|Period 1|Protocol Violation|1
4699860|NCT02688387|7615419|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
4699861|NCT02688387|7615420|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1
4699862|NCT02688387|7615421|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
4699863|NCT02688387|7615422|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1
4699864|NCT02688387|7615423|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
4699865|NCT02688387|7615402|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
4699866|NCT02688387|7615403|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
4699867|NCT02688387|7615404|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
4699868|NCT02688387|7615405|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
4699869|NCT02688387|7615406|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
4699870|NCT02688387|7615407|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
4699871|NCT02688387|7615408|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
4699872|NCT02688387|7615409|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
4699873|NCT02688387|7615410|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
4699874|NCT02688387|7615411|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
4699875|NCT02688387|7615412|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
4699876|NCT02688387|7615413|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
4699877|NCT02688387|7615414|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
4699878|NCT02688387|7615415|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
4699879|NCT02688387|7615416|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
4699880|NCT02688387|7615417|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
4699881|NCT02688387|7615418|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
4699882|NCT02688387|7615419|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
4699883|NCT02688387|7615420|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
4699884|NCT02688387|7615421|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1
4699885|NCT02688387|7615422|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
4699886|NCT02688387|7615423|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
4699887|NCT02688621|7615480|FG000|Overall Study|Pregnancy|1
4699888|NCT02688621|7615481|FG001|Overall Study|Pregnancy|3
4699889|NCT02688621|7615480|FG000|Overall Study|Lost to Follow-up|38
4699890|NCT02688621|7615481|FG001|Overall Study|Lost to Follow-up|15
4699891|NCT02688621|7615480|FG000|Overall Study|Withdrawal by Subject|1
4699892|NCT02688621|7615481|FG001|Overall Study|Withdrawal by Subject|0
4699893|NCT02688764|7615492|FG000|Overall Study|Adverse Event|3
4699894|NCT02688764|7615493|FG001|Overall Study|Adverse Event|3
4699895|NCT02688764|7615492|FG000|Overall Study|AE/Kidney transplant|1
4699896|NCT02688764|7615493|FG001|Overall Study|AE/Kidney transplant|0
4699897|NCT02688764|7615492|FG000|Overall Study|AE/Lack of efficacy|1
4699898|NCT02688764|7615493|FG001|Overall Study|AE/Lack of efficacy|0
4699899|NCT02688764|7615492|FG000|Overall Study|AE/Non-compl.|1
4699900|NCT02688764|7615493|FG001|Overall Study|AE/Non-compl.|0
4699901|NCT02688764|7615492|FG000|Overall Study|AE/Non-compl./Withd. parent|0
4699902|NCT02688764|7615493|FG001|Overall Study|AE/Non-compl./Withd. parent|1
4699903|NCT02688764|7615492|FG000|Overall Study|AE/Other|0
4699904|NCT02688764|7615493|FG001|Overall Study|AE/Other|1
4699905|NCT02688764|7615492|FG000|Overall Study|AE/Physician decision|1
4699906|NCT02688764|7615493|FG001|Overall Study|AE/Physician decision|0
4699907|NCT02688764|7615492|FG000|Overall Study|AE/Withd. parent|3
4699908|NCT02688764|7615493|FG001|Overall Study|AE/Withd. parent|0
4699909|NCT02688764|7615492|FG000|Overall Study|AE/Withd. parent/Withd. subject|1
4699910|NCT02688764|7615493|FG001|Overall Study|AE/Withd. parent/Withd. subject|1
4479351|NCT00709852|7276858|FG001|Period 1|Protocol Violation|0
4479352|NCT00709852|7276857|FG000|Period 1|Defective scanner|0
4479353|NCT00709852|7276858|FG001|Period 1|Defective scanner|1
4479354|NCT00709852|7276857|FG000|Period 1|Lost to Follow-up|1
4479355|NCT00709852|7276858|FG001|Period 1|Lost to Follow-up|0
4479356|NCT00709852|7276857|FG000|Period 2|Protocol Violation|4
4699911|NCT02688764|7615492|FG000|Overall Study|AE/Withd. subject|1
4699912|NCT02688764|7615493|FG001|Overall Study|AE/Withd. subject|0
4479357|NCT00709852|7276858|FG001|Period 2|Protocol Violation|1
4479358|NCT00709852|7276857|FG000|Period 2|Adverse Event|1
4479359|NCT00709852|7276858|FG001|Period 2|Adverse Event|1
4479360|NCT00709852|7276857|FG000|Period 2|Lost to Follow-up|1
4479361|NCT00709852|7276858|FG001|Period 2|Lost to Follow-up|0
4479362|NCT00709852|7276857|FG000|Period 2|No 72-hour follow-up|3
4479363|NCT00709852|7276858|FG001|Period 2|No 72-hour follow-up|0
4479364|NCT00709956|7276896|FG000|Overall Study|Withdrawal by Subject|1
4479365|NCT00709956|7276897|FG001|Overall Study|Withdrawal by Subject|1
4479366|NCT00709956|7276896|FG000|Overall Study|Inclusion/exclusion criteria violation|2
4479367|NCT00709956|7276897|FG001|Overall Study|Inclusion/exclusion criteria violation|3
4479368|NCT00709995|7276907|FG000|Overall Study|Adverse Event|4
4479369|NCT00709995|7276908|FG001|Overall Study|Adverse Event|2
4479370|NCT00709995|7276907|FG000|Overall Study|Withdrawal by Subject|1
4479371|NCT00709995|7276908|FG001|Overall Study|Withdrawal by Subject|3
4479372|NCT00710021|7276920|FG000|Overall Study|Lost to Follow-up|1
4479373|NCT00710021|7276921|FG001|Overall Study|Lost to Follow-up|0
4479374|NCT00710021|7276922|FG002|Overall Study|Lost to Follow-up|0
4479375|NCT00710021|7276920|FG000|Overall Study|Subject's Decision|0
4479376|NCT00710021|7276921|FG001|Overall Study|Subject's Decision|1
4479377|NCT00710021|7276922|FG002|Overall Study|Subject's Decision|0
4479378|NCT00710021|7276920|FG000|Overall Study|Subject misrandomized|0
4479379|NCT00710021|7276921|FG001|Overall Study|Subject misrandomized|1
4479380|NCT00710021|7276922|FG002|Overall Study|Subject misrandomized|1
4479381|NCT00710021|7276920|FG000|Overall Study|Physician Decision|0
4479382|NCT00710021|7276921|FG001|Overall Study|Physician Decision|1
4479383|NCT00710021|7276922|FG002|Overall Study|Physician Decision|0
4479384|NCT00710034|7276933|FG000|Completed 6 Weeks of Treatment|Adverse Event|5
4479385|NCT00710034|7276934|FG001|Completed 6 Weeks of Treatment|Adverse Event|12
4479386|NCT00710034|7276933|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12
4479387|NCT00710034|7276934|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8
4479388|NCT00710034|7276933|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15
4479389|NCT00710034|7276934|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17
4479390|NCT00710034|7276933|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2
4479391|NCT00710034|7276934|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6
4479392|NCT00710034|7276933|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6
4479393|NCT00710034|7276934|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4
4479394|NCT00710034|7276933|FG000|Completed 6 Weeks of Treatment|Physician Decision|1
4479395|NCT00710034|7276934|FG001|Completed 6 Weeks of Treatment|Physician Decision|0
4479396|NCT00710034|7276933|FG000|Completed 12 Weeks of Treatment|Adverse Event|0
4479397|NCT00710034|7276934|FG001|Completed 12 Weeks of Treatment|Adverse Event|1
4479398|NCT00710034|7276933|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0
4479399|NCT00710034|7276934|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2
4479400|NCT00710034|7276933|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5
4479401|NCT00710034|7276934|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5
4479402|NCT00710034|7276933|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0
4479403|NCT00710034|7276934|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1
4479404|NCT00710034|7276933|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8
4479405|NCT00710034|7276934|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2
4479406|NCT00710385|7276950|FG000|Overall Study|Did not qualify|1
4479407|NCT00710385|7276950|FG000|Overall Study|Withdrawal by Subject|1
4479408|NCT00710385|7276950|FG000|Overall Study|Undisclosed back pain|1
4479409|NCT00710385|7276950|FG000|Overall Study|Physician Decision|1
4479410|NCT00710385|7276950|FG000|Overall Study|Undisclosed excessive methadone use|1
4479411|NCT00710424|7276962|FG000|Overall Study|Adverse Event|30
4479412|NCT00710424|7276963|FG001|Overall Study|Adverse Event|12
4479413|NCT00710424|7276962|FG000|Overall Study|Lack of Efficacy|4
4479414|NCT00710424|7276963|FG001|Overall Study|Lack of Efficacy|5
4479415|NCT00710424|7276962|FG000|Overall Study|Withdrawal by Subject|5
4479416|NCT00710424|7276963|FG001|Overall Study|Withdrawal by Subject|3
4479417|NCT00710424|7276962|FG000|Overall Study|Lost to Follow-up|0
4699913|NCT02688764|7615492|FG000|Overall Study|Kidney transplant|10
4699914|NCT02688764|7615493|FG001|Overall Study|Kidney transplant|4
4699915|NCT02688764|7615492|FG000|Overall Study|Lack of Efficacy|3
4699916|NCT02688764|7615493|FG001|Overall Study|Lack of Efficacy|2
4699917|NCT02688764|7615492|FG000|Overall Study|Lack of efficacy/Physician decision|0
4699918|NCT02688764|7615493|FG001|Overall Study|Lack of efficacy/Physician decision|1
4699919|NCT02688764|7615492|FG000|Overall Study|Non-compliance with study drug|4
4699920|NCT02688764|7615493|FG001|Overall Study|Non-compliance with study drug|0
4699921|NCT02688764|7615492|FG000|Overall Study|Non-compl./Physician decision|2
4699922|NCT02688764|7615493|FG001|Overall Study|Non-compl./Physician decision|0
4479418|NCT00710424|7276963|FG001|Overall Study|Lost to Follow-up|1
4479419|NCT00710424|7276962|FG000|Overall Study|Refused medication, no side effects|1
4479420|NCT00710424|7276963|FG001|Overall Study|Refused medication, no side effects|0
4479421|NCT00710424|7276962|FG000|Overall Study|Non-compliance with stable analgesia|1
4479422|NCT00710424|7276963|FG001|Overall Study|Non-compliance with stable analgesia|0
4479423|NCT00710424|7276962|FG000|Overall Study|Did not meet entry criteria at visit 1|1
4699923|NCT02688764|7615492|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1
4699924|NCT02688764|7615493|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1
4479424|NCT00710424|7276963|FG001|Overall Study|Did not meet entry criteria at visit 1|0
4479425|NCT00710424|7276962|FG000|Overall Study|Subject thought medication changed|1
4479426|NCT00710424|7276963|FG001|Overall Study|Subject thought medication changed|0
4479427|NCT00710424|7276962|FG000|Overall Study|Ceased treatment due to travel|1
4479428|NCT00710424|7276963|FG001|Overall Study|Ceased treatment due to travel|0
4479429|NCT00710424|7276962|FG000|Overall Study|Subject preferred paracetamol|0
4479430|NCT00710424|7276963|FG001|Overall Study|Subject preferred paracetamol|1
4479431|NCT00710424|7276962|FG000|Overall Study|Felt good so stopped treatment|0
4479432|NCT00710424|7276963|FG001|Overall Study|Felt good so stopped treatment|1
4479433|NCT00710554|7276971|FG000|Overall Study|Adverse Event|24
4479434|NCT00710554|7276972|FG001|Overall Study|Adverse Event|7
4479435|NCT00710554|7276971|FG000|Overall Study|Withdrawal by Subject|7
4479436|NCT00710554|7276972|FG001|Overall Study|Withdrawal by Subject|3
4479437|NCT00710554|7276971|FG000|Overall Study|Lost to Follow-up|7
4479438|NCT00710554|7276972|FG001|Overall Study|Lost to Follow-up|1
4479439|NCT00710554|7276971|FG000|Overall Study|Lack of Efficacy|11
4479440|NCT00710554|7276972|FG001|Overall Study|Lack of Efficacy|12
4589608|NCT01513967|7435032|FG005|Overall Study|excluded due to positive drug screen|0
4589609|NCT01513967|7435033|FG006|Overall Study|excluded due to positive drug screen|0
4589610|NCT01513967|7435034|FG007|Overall Study|excluded due to positive drug screen|2
4589611|NCT01513967|7435027|FG000|Overall Study|Physician Decision|0
4479441|NCT00710554|7276971|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0
4479442|NCT00710554|7276972|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1
4479443|NCT00710593|7276980|FG000|Overall Study|Incarceration|1
4479444|NCT00710593|7276981|FG001|Overall Study|Incarceration|0
4479445|NCT00710593|7276980|FG000|Overall Study|Unable to complete Wk 48 within window|2
4479446|NCT00710593|7276981|FG001|Overall Study|Unable to complete Wk 48 within window|0
4479447|NCT00710593|7276980|FG000|Overall Study|Lost to Follow-up|3
4479448|NCT00710593|7276981|FG001|Overall Study|Lost to Follow-up|1
4479449|NCT00710593|7276980|FG000|Overall Study|Moved out of area|1
4479450|NCT00710593|7276981|FG001|Overall Study|Moved out of area|0
4479451|NCT00710593|7276980|FG000|Overall Study|Failure to adhere or complete study eval|1
4479452|NCT00710593|7276981|FG001|Overall Study|Failure to adhere or complete study eval|1
4479453|NCT00710593|7276980|FG000|Overall Study|Protocol Violation|1
4479454|NCT00710593|7276981|FG001|Overall Study|Protocol Violation|1
4479455|NCT00710593|7276980|FG000|Overall Study|Prem disc vaccine, completed all visits|6
4479456|NCT00710593|7276981|FG001|Overall Study|Prem disc vaccine, completed all visits|2
4516879|NCT00961961|7328322|FG002|Phase II|Adverse Event|0
4516880|NCT00961961|7328323|FG003|Phase II|Adverse Event|1
4516881|NCT00961961|7328320|FG000|Phase II|Physician Decision|0
4516882|NCT00961961|7328321|FG001|Phase II|Physician Decision|0
4516883|NCT00961961|7328322|FG002|Phase II|Physician Decision|1
4516884|NCT00961961|7328323|FG003|Phase II|Physician Decision|0
4516885|NCT00961961|7328320|FG000|Phase II|Withdrawal by Subject|0
4516886|NCT00961961|7328321|FG001|Phase II|Withdrawal by Subject|0
4516887|NCT00961961|7328322|FG002|Phase II|Withdrawal by Subject|1
4516888|NCT00961961|7328323|FG003|Phase II|Withdrawal by Subject|0
4516889|NCT00962013|7328350|FG000|Overall Study|Did not have surgery|1
4516890|NCT00962013|7328350|FG000|Overall Study|Death|8
4516891|NCT00962013|7328350|FG000|Overall Study|Lost to Follow-up|12
4516892|NCT00962013|7328350|FG000|Overall Study|Unable/Unwilling to return|6
4516893|NCT00962013|7328350|FG000|Overall Study|Withdrawal by Subject|8
4516894|NCT00962013|7328350|FG000|Overall Study|Removal of study device|3
4516895|NCT00962013|7328350|FG000|Overall Study|Site Termination|24
4516896|NCT00962013|7328350|FG000|Overall Study|No 5 year evaluation|6
4516897|NCT00962091|7328392|FG000|Overall Study|Withdrawal by Subject|1
4516898|NCT00962091|7328393|FG001|Overall Study|Withdrawal by Subject|2
4516899|NCT00962091|7328394|FG002|Overall Study|Withdrawal by Subject|1
4516900|NCT00962091|7328395|FG003|Overall Study|Withdrawal by Subject|1
4516901|NCT00962091|7328396|FG004|Overall Study|Withdrawal by Subject|0
4516902|NCT00962091|7328397|FG005|Overall Study|Withdrawal by Subject|1
4516903|NCT00962091|7328398|FG006|Overall Study|Withdrawal by Subject|0
4516904|NCT00962091|7328392|FG000|Overall Study|Adverse Event|0
4516905|NCT00962091|7328393|FG001|Overall Study|Adverse Event|0
4516906|NCT00962091|7328394|FG002|Overall Study|Adverse Event|0
4516907|NCT00962091|7328395|FG003|Overall Study|Adverse Event|0
4516908|NCT00962091|7328396|FG004|Overall Study|Adverse Event|0
4516909|NCT00962091|7328397|FG005|Overall Study|Adverse Event|0
4589612|NCT01513967|7435028|FG001|Overall Study|Physician Decision|0
4516910|NCT00962091|7328398|FG006|Overall Study|Adverse Event|1
4516911|NCT00962104|7328424|FG000|Overall Study|Adverse Event|10
4516912|NCT00962104|7328425|FG001|Overall Study|Adverse Event|3
4516913|NCT00962104|7328424|FG000|Overall Study|Entry Criteria Not Met|1
4516914|NCT00962104|7328425|FG001|Overall Study|Entry Criteria Not Met|2
4516915|NCT00962104|7328424|FG000|Overall Study|Lack of Efficacy|0
4516916|NCT00962104|7328425|FG001|Overall Study|Lack of Efficacy|1
4516917|NCT00962104|7328424|FG000|Overall Study|Lost to Follow-up|10
4516918|NCT00962104|7328425|FG001|Overall Study|Lost to Follow-up|4
4516919|NCT00962104|7328424|FG000|Overall Study|Physician Decision|1
4516920|NCT00962104|7328425|FG001|Overall Study|Physician Decision|0
4516921|NCT00962104|7328424|FG000|Overall Study|Protocol Violation|6
4516922|NCT00962104|7328425|FG001|Overall Study|Protocol Violation|8
4479457|NCT00710606|7277005|FG000|Overall Study|Adverse Event|0
4479458|NCT00710606|7277006|FG001|Overall Study|Adverse Event|2
4479459|NCT00710684|7277017|FG000|Overall Study|Adverse Event|11
4479460|NCT00710684|7277018|FG001|Overall Study|Adverse Event|19
4479461|NCT00710684|7277019|FG002|Overall Study|Adverse Event|16
4479462|NCT00710684|7277017|FG000|Overall Study|Lack of Efficacy|4
4479463|NCT00710684|7277018|FG001|Overall Study|Lack of Efficacy|3
4479464|NCT00710684|7277019|FG002|Overall Study|Lack of Efficacy|5
4479465|NCT00710684|7277017|FG000|Overall Study|Protocol Violation|5
4479466|NCT00710684|7277018|FG001|Overall Study|Protocol Violation|5
4479467|NCT00710684|7277019|FG002|Overall Study|Protocol Violation|5
4479468|NCT00710684|7277017|FG000|Overall Study|Lost to Follow-up|4
4479469|NCT00710684|7277018|FG001|Overall Study|Lost to Follow-up|6
4479470|NCT00710684|7277019|FG002|Overall Study|Lost to Follow-up|7
4479471|NCT00710684|7277017|FG000|Overall Study|Physician Decision|0
4479472|NCT00710684|7277018|FG001|Overall Study|Physician Decision|2
4479473|NCT00710684|7277019|FG002|Overall Study|Physician Decision|4
4479474|NCT00710684|7277017|FG000|Overall Study|Withdrawal by Subject|24
4479475|NCT00710684|7277018|FG001|Overall Study|Withdrawal by Subject|18
4479476|NCT00710684|7277019|FG002|Overall Study|Withdrawal by Subject|11
4479477|NCT00710684|7277017|FG000|Overall Study|Missing|1
4479478|NCT00710684|7277018|FG001|Overall Study|Missing|0
4479479|NCT00710684|7277019|FG002|Overall Study|Missing|0
4479480|NCT00710684|7277017|FG000|Overall Study|Did not continue after week 24|25
4479481|NCT00710684|7277018|FG001|Overall Study|Did not continue after week 24|21
4479482|NCT00710684|7277019|FG002|Overall Study|Did not continue after week 24|16
4479483|NCT00710749|7277033|FG000|First Intervention|Withdrawal by Subject|1
4479484|NCT00710749|7277034|FG001|First Intervention|Withdrawal by Subject|0
4479485|NCT00710762|7277044|FG000|Overall Study|Progressive disease|27
4479486|NCT00710762|7277045|FG001|Overall Study|Progressive disease|30
4479487|NCT00710762|7277044|FG000|Overall Study|Adverse Event other disease worsening|2
4479488|NCT00710762|7277045|FG001|Overall Study|Adverse Event other disease worsening|1
4479489|NCT00710762|7277044|FG000|Overall Study|Other Adverse Event|7
4479490|NCT00710762|7277045|FG001|Overall Study|Other Adverse Event|7
4479491|NCT00710762|7277044|FG000|Overall Study|Lost to Follow-up|1
4479492|NCT00710762|7277045|FG001|Overall Study|Lost to Follow-up|0
4479493|NCT00710762|7277044|FG000|Overall Study|Reason other than listed above|2
4479494|NCT00710762|7277045|FG001|Overall Study|Reason other than listed above|2
4479495|NCT00710866|7277071|FG000|Overall Study|Protocol Violation|5
4479496|NCT00710866|7277072|FG001|Overall Study|Protocol Violation|4
4479497|NCT00710866|7277071|FG000|Overall Study|Withdrawal by Subject|2
4479498|NCT00710866|7277072|FG001|Overall Study|Withdrawal by Subject|1
4479499|NCT00710866|7277071|FG000|Overall Study|Lost to Follow-up|1
4479500|NCT00710866|7277072|FG001|Overall Study|Lost to Follow-up|0
4479501|NCT00710866|7277071|FG000|Overall Study|Failed to meet eligibility|1
4479502|NCT00710866|7277072|FG001|Overall Study|Failed to meet eligibility|1
4479503|NCT00710879|7277080|FG000|Overall Study|Lost to Follow-up|2
4479504|NCT00710879|7277081|FG001|Overall Study|Lost to Follow-up|1
4479505|NCT00710879|7277080|FG000|Overall Study|Protocol Violation|0
4479506|NCT00710879|7277081|FG001|Overall Study|Protocol Violation|3
4479507|NCT00711009|7277123|FG000|Overall Study|Adverse Event/HIV-Related Event|4
4479508|NCT00711009|7277124|FG001|Overall Study|Adverse Event/HIV-Related Event|5
4479509|NCT00711009|7277123|FG000|Overall Study|Withdrawal by Subject|4
4479510|NCT00711009|7277124|FG001|Overall Study|Withdrawal by Subject|2
4479511|NCT00711009|7277123|FG000|Overall Study|Lost to Follow-up|3
4479512|NCT00711009|7277124|FG001|Overall Study|Lost to Follow-up|9
4479513|NCT00711009|7277123|FG000|Overall Study|Participant Noncompliant|0
4479514|NCT00711009|7277124|FG001|Overall Study|Participant Noncompliant|1
4479515|NCT00711009|7277123|FG000|Overall Study|Virologic Failure|2
4479516|NCT00711009|7277124|FG001|Overall Study|Virologic Failure|1
4479517|NCT00711009|7277123|FG000|Overall Study|Pregnancy|1
4479518|NCT00711009|7277124|FG001|Overall Study|Pregnancy|0
4479519|NCT00711009|7277123|FG000|Overall Study|Site closing|0
4479520|NCT00711009|7277124|FG001|Overall Study|Site closing|1
4479521|NCT00711009|7277123|FG000|Overall Study|Dose adjustment|1
4479522|NCT00711009|7277124|FG001|Overall Study|Dose adjustment|0
4479523|NCT00711100|7277134|FG000|Overall Study|Lack of Efficacy|5
4589613|NCT01513967|7435029|FG002|Overall Study|Physician Decision|0
4589614|NCT01513967|7435030|FG003|Overall Study|Physician Decision|0
4589615|NCT01513967|7435031|FG004|Overall Study|Physician Decision|0
4589616|NCT01513967|7435032|FG005|Overall Study|Physician Decision|1
4589617|NCT01513967|7435033|FG006|Overall Study|Physician Decision|0
4589618|NCT01513967|7435034|FG007|Overall Study|Physician Decision|0
4589619|NCT01514136|7435054|FG000|Test Period 1; Test A|Protocol Violation|1
4589620|NCT01514136|7435055|FG001|Test Period 1; Test A|Protocol Violation|0
4589621|NCT01514136|7435056|FG002|Test Period 1; Test A|Protocol Violation|0
4589622|NCT01514136|7435057|FG003|Test Period 1; Test A|Protocol Violation|0
4479524|NCT00711100|7277134|FG000|Overall Study|Withdrawal by Subject|8
4479525|NCT00711113|7277150|FG000|Overall Study|Lost to Follow-up|9
4479526|NCT00711113|7277150|FG000|Overall Study|Implant lost|2
4479527|NCT00711191|7277157|FG000|Overall Study|Adverse Event|1
4589623|NCT01514136|7435058|FG004|Test Period 1; Test A|Protocol Violation|0
4589624|NCT01514136|7435059|FG005|Test Period 1; Test A|Protocol Violation|0
4479528|NCT00711191|7277158|FG001|Overall Study|Adverse Event|1
4479529|NCT00711191|7277159|FG002|Overall Study|Adverse Event|2
4479530|NCT00711191|7277157|FG000|Overall Study|Objective progression or relapse|2
4479531|NCT00711191|7277158|FG001|Overall Study|Objective progression or relapse|3
4479532|NCT00711191|7277159|FG002|Overall Study|Objective progression or relapse|7
4479533|NCT00711191|7277157|FG000|Overall Study|Withdrawal by Subject|0
4479534|NCT00711191|7277158|FG001|Overall Study|Withdrawal by Subject|1
4479535|NCT00711191|7277159|FG002|Overall Study|Withdrawal by Subject|3
4479536|NCT00711243|7277176|FG000|Registed and Started Treatment|Withdrawal by Subject|0
4479537|NCT00711243|7277177|FG001|Registed and Started Treatment|Withdrawal by Subject|0
4479538|NCT00711243|7277178|FG002|Registed and Started Treatment|Withdrawal by Subject|0
4479539|NCT00711243|7277179|FG003|Registed and Started Treatment|Withdrawal by Subject|0
4479540|NCT00711243|7277180|FG004|Registed and Started Treatment|Withdrawal by Subject|0
4479541|NCT00711243|7277181|FG005|Registed and Started Treatment|Withdrawal by Subject|1
4479542|NCT00711243|7277176|FG000|Reached First Response/4 Cycles|Death|0
4479543|NCT00711243|7277177|FG001|Reached First Response/4 Cycles|Death|0
4479544|NCT00711243|7277178|FG002|Reached First Response/4 Cycles|Death|0
4479545|NCT00711243|7277179|FG003|Reached First Response/4 Cycles|Death|0
4479546|NCT00711243|7277180|FG004|Reached First Response/4 Cycles|Death|0
4479547|NCT00711243|7277181|FG005|Reached First Response/4 Cycles|Death|2
4479548|NCT00711243|7277176|FG000|Reached First Response/4 Cycles|Progressive disease|0
4479549|NCT00711243|7277177|FG001|Reached First Response/4 Cycles|Progressive disease|0
4479550|NCT00711243|7277178|FG002|Reached First Response/4 Cycles|Progressive disease|0
4479551|NCT00711243|7277179|FG003|Reached First Response/4 Cycles|Progressive disease|1
4479552|NCT00711243|7277180|FG004|Reached First Response/4 Cycles|Progressive disease|0
4479553|NCT00711243|7277181|FG005|Reached First Response/4 Cycles|Progressive disease|0
4479554|NCT00711243|7277176|FG000|Treated Cycle 5 After First Response|Progressive disease|1
4479555|NCT00711243|7277177|FG001|Treated Cycle 5 After First Response|Progressive disease|2
4479556|NCT00711243|7277178|FG002|Treated Cycle 5 After First Response|Progressive disease|0
4479557|NCT00711243|7277179|FG003|Treated Cycle 5 After First Response|Progressive disease|0
4479558|NCT00711243|7277180|FG004|Treated Cycle 5 After First Response|Progressive disease|1
4479559|NCT00711243|7277181|FG005|Treated Cycle 5 After First Response|Progressive disease|1
4479560|NCT00711243|7277176|FG000|Treated Cycle 5 After First Response|Death|0
4479561|NCT00711243|7277177|FG001|Treated Cycle 5 After First Response|Death|0
4479562|NCT00711243|7277178|FG002|Treated Cycle 5 After First Response|Death|0
4479563|NCT00711243|7277179|FG003|Treated Cycle 5 After First Response|Death|0
4479564|NCT00711243|7277180|FG004|Treated Cycle 5 After First Response|Death|0
4479565|NCT00711243|7277181|FG005|Treated Cycle 5 After First Response|Death|2
4479566|NCT00711243|7277176|FG000|Treated Cycle 5 After First Response|Decline in performance status|0
4479567|NCT00711243|7277177|FG001|Treated Cycle 5 After First Response|Decline in performance status|0
4479568|NCT00711243|7277178|FG002|Treated Cycle 5 After First Response|Decline in performance status|0
4479569|NCT00711243|7277179|FG003|Treated Cycle 5 After First Response|Decline in performance status|0
4479570|NCT00711243|7277180|FG004|Treated Cycle 5 After First Response|Decline in performance status|0
4479571|NCT00711243|7277181|FG005|Treated Cycle 5 After First Response|Decline in performance status|1
4479572|NCT00711243|7277176|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0
4479573|NCT00711243|7277177|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0
4479574|NCT00711243|7277178|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0
4479575|NCT00711243|7277179|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0
4479576|NCT00711243|7277180|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0
4479577|NCT00711243|7277181|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2
4479578|NCT00711412|7277206|FG000|Induction Treatment|Death|2
4479579|NCT00711412|7277206|FG000|Induction Treatment|Adverse Event|1
4479580|NCT00711412|7277206|FG000|Induction Treatment|Other|1
4479581|NCT00711412|7277206|FG000|Evaluated for Combination Treatment|Adverse Event|2
4386878|NCT00042991|7165430|FG002|Overall Study|Disease Progression|2
4386879|NCT00042991|7165431|FG003|Overall Study|Disease Progression|2
4386880|NCT00042991|7165432|FG004|Overall Study|Disease Progression|1
4386881|NCT00042991|7165433|FG005|Overall Study|Disease Progression|4
4386882|NCT00042991|7165434|FG006|Overall Study|Disease Progression|2
4386883|NCT00042991|7165428|FG000|Overall Study|Alternative Therapy|0
4386884|NCT00042991|7165429|FG001|Overall Study|Alternative Therapy|0
4386885|NCT00042991|7165430|FG002|Overall Study|Alternative Therapy|0
4386886|NCT00042991|7165431|FG003|Overall Study|Alternative Therapy|0
4386887|NCT00042991|7165432|FG004|Overall Study|Alternative Therapy|1
4386888|NCT00042991|7165433|FG005|Overall Study|Alternative Therapy|0
4386889|NCT00042991|7165434|FG006|Overall Study|Alternative Therapy|0
4386890|NCT00043186|7165461|FG000|Overall Study|Physician Decision|0
4386891|NCT00043186|7165462|FG001|Overall Study|Physician Decision|0
4386892|NCT00043186|7165463|FG002|Overall Study|Physician Decision|3
4386893|NCT00043186|7165464|FG003|Overall Study|Physician Decision|0
4386894|NCT00043186|7165465|FG004|Overall Study|Physician Decision|1
4386895|NCT00043186|7165466|FG005|Overall Study|Physician Decision|0
4386896|NCT00043186|7165467|FG006|Overall Study|Physician Decision|0
4386897|NCT00043186|7165468|FG007|Overall Study|Physician Decision|1
4386898|NCT00043186|7165469|FG008|Overall Study|Physician Decision|1
4386899|NCT00043186|7165461|FG000|Overall Study|Adverse Event|2
4386900|NCT00043186|7165462|FG001|Overall Study|Adverse Event|2
4386901|NCT00043186|7165463|FG002|Overall Study|Adverse Event|2
4479582|NCT00711412|7277206|FG000|Evaluated for Combination Treatment|Death|1
4479583|NCT00711412|7277206|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1
4479584|NCT00711412|7277206|FG000|Evaluated for Combination Treatment|Progressive disease|2
4479585|NCT00711412|7277206|FG000|Combination Treatment|Progressive Disease|1
4479586|NCT00711412|7277206|FG000|Evaluation for Response and Surgery|Progressive Disease|2
4479587|NCT00711412|7277206|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2
4479588|NCT00711412|7277206|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1
4479589|NCT00711412|7277206|FG000|Evaluation for Response and Surgery|Death|1
4479590|NCT00711412|7277206|FG000|Survival Follow up Until Death|Other|12
4479591|NCT00711425|7277211|FG000|Overall Study|Protocol Violation|1
4479592|NCT00711425|7277211|FG000|Overall Study|Death|2
4479593|NCT00711425|7277211|FG000|Overall Study|Lost to Follow-up|1
4479594|NCT00711477|7277227|FG000|Overall Study|Adverse Event|3
4479595|NCT00711477|7277228|FG001|Overall Study|Adverse Event|1
4479596|NCT00711477|7277227|FG000|Overall Study|Lost to Follow-up|0
4479597|NCT00711477|7277228|FG001|Overall Study|Lost to Follow-up|1
4479598|NCT00711477|7277227|FG000|Overall Study|Noncompliance|0
4479599|NCT00711477|7277228|FG001|Overall Study|Noncompliance|1
4479600|NCT00711516|7277243|FG000|Overall Study|Adverse Event|1
4479601|NCT00711516|7277244|FG001|Overall Study|Adverse Event|1
4479602|NCT00711516|7277243|FG000|Overall Study|Withdrawal by Subject|0
4479603|NCT00711516|7277244|FG001|Overall Study|Withdrawal by Subject|1
4479604|NCT00711516|7277243|FG000|Overall Study|Protocol Violation|0
4479605|NCT00711516|7277244|FG001|Overall Study|Protocol Violation|1
4479606|NCT00711529|7277252|FG000|Overall Study|Protocol Violation|2
4479607|NCT00711529|7277253|FG001|Overall Study|Protocol Violation|0
4479608|NCT00711529|7277252|FG000|Overall Study|Withdrawal by Subject|2
4479609|NCT00711529|7277253|FG001|Overall Study|Withdrawal by Subject|6
4479610|NCT00711594|7277263|FG000|Overall Study|Progressive disease|2
4479611|NCT00711594|7277264|FG001|Overall Study|Progressive disease|2
4479612|NCT00711594|7277265|FG002|Overall Study|Progressive disease|6
4479613|NCT00711594|7277266|FG003|Overall Study|Progressive disease|44
4479614|NCT00711594|7277263|FG000|Overall Study|Other Adverse Event|1
4479615|NCT00711594|7277264|FG001|Overall Study|Other Adverse Event|0
4479616|NCT00711594|7277265|FG002|Overall Study|Other Adverse Event|0
4479617|NCT00711594|7277266|FG003|Overall Study|Other Adverse Event|16
4589625|NCT01514136|7435060|FG006|Test Period 1; Test A|Protocol Violation|0
4589626|NCT01514136|7435061|FG007|Test Period 1; Test A|Protocol Violation|0
4589627|NCT01514136|7435054|FG000|Test Period 1; Test A|Break from study holiday|2
4589628|NCT01514136|7435055|FG001|Test Period 1; Test A|Break from study holiday|0
4589629|NCT01514136|7435056|FG002|Test Period 1; Test A|Break from study holiday|0
4589630|NCT01514136|7435057|FG003|Test Period 1; Test A|Break from study holiday|0
4589631|NCT01514136|7435058|FG004|Test Period 1; Test A|Break from study holiday|0
4589632|NCT01514136|7435059|FG005|Test Period 1; Test A|Break from study holiday|0
4589633|NCT01514136|7435060|FG006|Test Period 1; Test A|Break from study holiday|0
4589634|NCT01514136|7435061|FG007|Test Period 1; Test A|Break from study holiday|0
4479618|NCT00711594|7277263|FG000|Overall Study|Withdrawal by Subject|0
4479619|NCT00711594|7277264|FG001|Overall Study|Withdrawal by Subject|1
4479620|NCT00711594|7277265|FG002|Overall Study|Withdrawal by Subject|0
4479621|NCT00711594|7277266|FG003|Overall Study|Withdrawal by Subject|2
4479622|NCT00711646|7277280|FG000|Overall Study|Adverse Event|6
4479623|NCT00711646|7277281|FG001|Overall Study|Adverse Event|1
4479624|NCT00711646|7277280|FG000|Overall Study|Withdrawal by Subject|4
4479625|NCT00711646|7277281|FG001|Overall Study|Withdrawal by Subject|0
4479626|NCT00711646|7277280|FG000|Overall Study|Protocol Violation|0
4479627|NCT00711646|7277281|FG001|Overall Study|Protocol Violation|1
4479628|NCT00711646|7277280|FG000|Overall Study|Lost to Follow-up|1
4479629|NCT00711646|7277281|FG001|Overall Study|Lost to Follow-up|0
4479630|NCT00711646|7277280|FG000|Overall Study|administrative decision|0
4479631|NCT00711646|7277281|FG001|Overall Study|administrative decision|1
4479632|NCT00711646|7277280|FG000|Overall Study|patient non-compliance|1
4479633|NCT00711646|7277281|FG001|Overall Study|patient non-compliance|0
4479634|NCT00711802|7277306|FG000|Overall Study|Not treated (no further detail)|2
4479635|NCT00711802|7277307|FG001|Overall Study|Not treated (no further detail)|1
4479636|NCT00711802|7277308|FG002|Overall Study|Not treated (no further detail)|2
4479637|NCT00711802|7277309|FG003|Overall Study|Not treated (no further detail)|0
4479638|NCT00711802|7277310|FG004|Overall Study|Not treated (no further detail)|2
4479639|NCT00711802|7277311|FG005|Overall Study|Not treated (no further detail)|0
4479640|NCT00711802|7277312|FG006|Overall Study|Not treated (no further detail)|0
4479641|NCT00711802|7277313|FG007|Overall Study|Not treated (no further detail)|0
4479642|NCT00711802|7277306|FG000|Overall Study|Adverse Event|0
4479643|NCT00711802|7277307|FG001|Overall Study|Adverse Event|0
4479644|NCT00711802|7277308|FG002|Overall Study|Adverse Event|0
4479645|NCT00711802|7277309|FG003|Overall Study|Adverse Event|0
4479646|NCT00711802|7277310|FG004|Overall Study|Adverse Event|1
4479647|NCT00711802|7277311|FG005|Overall Study|Adverse Event|1
4479648|NCT00711802|7277312|FG006|Overall Study|Adverse Event|0
4479649|NCT00711802|7277313|FG007|Overall Study|Adverse Event|0
4479650|NCT00711802|7277306|FG000|Overall Study|Microbiological failure|0
4479651|NCT00711802|7277307|FG001|Overall Study|Microbiological failure|1
4479652|NCT00711802|7277308|FG002|Overall Study|Microbiological failure|0
4589635|NCT01514136|7435054|FG000|Test Period 1; Test B|Withdrawal by Subject|0
4479653|NCT00711802|7277309|FG003|Overall Study|Microbiological failure|0
4479654|NCT00711802|7277310|FG004|Overall Study|Microbiological failure|0
4479655|NCT00711802|7277311|FG005|Overall Study|Microbiological failure|1
4479656|NCT00711802|7277312|FG006|Overall Study|Microbiological failure|0
4479657|NCT00711802|7277313|FG007|Overall Study|Microbiological failure|0
4479658|NCT00711802|7277306|FG000|Overall Study|Protocol Violation|0
4479659|NCT00711802|7277307|FG001|Overall Study|Protocol Violation|0
4479660|NCT00711802|7277308|FG002|Overall Study|Protocol Violation|0
4479661|NCT00711802|7277309|FG003|Overall Study|Protocol Violation|1
4479662|NCT00711802|7277310|FG004|Overall Study|Protocol Violation|0
4479663|NCT00711802|7277311|FG005|Overall Study|Protocol Violation|0
4479664|NCT00711802|7277312|FG006|Overall Study|Protocol Violation|0
4479665|NCT00711802|7277313|FG007|Overall Study|Protocol Violation|0
4479666|NCT00711802|7277306|FG000|Overall Study|Physician Decision|0
4479667|NCT00711802|7277307|FG001|Overall Study|Physician Decision|2
4699925|NCT02688764|7615492|FG000|Overall Study|Non-compl./Withd. subject|0
4699926|NCT02688764|7615493|FG001|Overall Study|Non-compl./Withd. subject|2
4699927|NCT02688764|7615492|FG000|Overall Study|Phosphorus level outside safe range|0
4699928|NCT02688764|7615493|FG001|Overall Study|Phosphorus level outside safe range|1
4699929|NCT02688764|7615492|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1
4699930|NCT02688764|7615493|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0
4699931|NCT02688764|7615492|FG000|Overall Study|Study drug taste/Withd. parent|1
4699932|NCT02688764|7615493|FG001|Overall Study|Study drug taste/Withd. parent|0
4699933|NCT02688764|7615492|FG000|Overall Study|Subject moving out|2
4699934|NCT02688764|7615493|FG001|Overall Study|Subject moving out|0
4699935|NCT02688764|7615492|FG000|Overall Study|Subject taken off dialysis|1
4699936|NCT02688764|7615493|FG001|Overall Study|Subject taken off dialysis|0
4699937|NCT02688764|7615492|FG000|Overall Study|Withdrawal by parent|3
4699938|NCT02688764|7615493|FG001|Overall Study|Withdrawal by parent|0
4479668|NCT00711802|7277308|FG002|Overall Study|Physician Decision|0
4479669|NCT00711802|7277309|FG003|Overall Study|Physician Decision|0
4479670|NCT00711802|7277310|FG004|Overall Study|Physician Decision|0
4479671|NCT00711802|7277311|FG005|Overall Study|Physician Decision|0
4479672|NCT00711802|7277312|FG006|Overall Study|Physician Decision|0
4479673|NCT00711802|7277313|FG007|Overall Study|Physician Decision|0
4479674|NCT00711802|7277306|FG000|Overall Study|Withdrawal by Subject|0
4479675|NCT00711802|7277307|FG001|Overall Study|Withdrawal by Subject|1
4479676|NCT00711802|7277308|FG002|Overall Study|Withdrawal by Subject|0
4479677|NCT00711802|7277309|FG003|Overall Study|Withdrawal by Subject|1
4479678|NCT00711802|7277310|FG004|Overall Study|Withdrawal by Subject|0
4479679|NCT00711802|7277311|FG005|Overall Study|Withdrawal by Subject|0
4479680|NCT00711802|7277312|FG006|Overall Study|Withdrawal by Subject|0
4479681|NCT00711802|7277313|FG007|Overall Study|Withdrawal by Subject|0
4479682|NCT00711802|7277306|FG000|Overall Study|Lost to Follow-up|0
4479683|NCT00711802|7277307|FG001|Overall Study|Lost to Follow-up|0
4479684|NCT00711802|7277308|FG002|Overall Study|Lost to Follow-up|3
4479685|NCT00711802|7277309|FG003|Overall Study|Lost to Follow-up|1
4479686|NCT00711802|7277310|FG004|Overall Study|Lost to Follow-up|10
4479687|NCT00711802|7277311|FG005|Overall Study|Lost to Follow-up|6
4479688|NCT00711802|7277312|FG006|Overall Study|Lost to Follow-up|4
4479689|NCT00711802|7277313|FG007|Overall Study|Lost to Follow-up|2
4479690|NCT00711802|7277306|FG000|Overall Study|Reason not reported|0
4479691|NCT00711802|7277307|FG001|Overall Study|Reason not reported|1
4479692|NCT00711802|7277308|FG002|Overall Study|Reason not reported|1
4479693|NCT00711802|7277309|FG003|Overall Study|Reason not reported|0
4479694|NCT00711802|7277310|FG004|Overall Study|Reason not reported|1
4479695|NCT00711802|7277311|FG005|Overall Study|Reason not reported|0
4479696|NCT00711802|7277312|FG006|Overall Study|Reason not reported|1
4479697|NCT00711802|7277313|FG007|Overall Study|Reason not reported|0
4479698|NCT00711880|7277349|FG000|Overall Study|Adverse Event|11
4479699|NCT00711880|7277350|FG001|Overall Study|Adverse Event|2
4479700|NCT00711880|7277349|FG000|Overall Study|Patient non-compliance|1
4479701|NCT00711880|7277350|FG001|Overall Study|Patient non-compliance|0
4479702|NCT00711880|7277349|FG000|Overall Study|Lack of Efficacy|1
4479703|NCT00711880|7277350|FG001|Overall Study|Lack of Efficacy|5
4479704|NCT00711958|7277358|FG000|Overall Study|Withdrawal by Subject|6
4479705|NCT00711958|7277359|FG001|Overall Study|Withdrawal by Subject|8
4479706|NCT00711958|7277358|FG000|Overall Study|Lack of Efficacy|3
4479707|NCT00711958|7277359|FG001|Overall Study|Lack of Efficacy|1
4735313|NCT03526861|7683208|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5
4735314|NCT03526861|7683209|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4
4735315|NCT03526861|7683210|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5
4735316|NCT03526861|7683211|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2
4735317|NCT03526861|7683212|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0
4737567|NCT03614078|7687792|FG002|Overall Study|Participant Did Not Return for Visit|0
4479708|NCT00711958|7277358|FG000|Overall Study|Clinical deterioration|1
4479709|NCT00711958|7277359|FG001|Overall Study|Clinical deterioration|0
4479710|NCT00711958|7277358|FG000|Overall Study|Adverse Event|9
4479711|NCT00711958|7277359|FG001|Overall Study|Adverse Event|7
4479712|NCT00711958|7277358|FG000|Overall Study|Protocol Violation|1
4479713|NCT00711958|7277359|FG001|Overall Study|Protocol Violation|0
4479714|NCT00711958|7277358|FG000|Overall Study|Lost to Follow-up|2
4479715|NCT00711958|7277359|FG001|Overall Study|Lost to Follow-up|2
4479716|NCT00711958|7277358|FG000|Overall Study|Death|10
4479717|NCT00711958|7277359|FG001|Overall Study|Death|5
4479718|NCT00711958|7277358|FG000|Overall Study|Progression of disease|1
4479719|NCT00711958|7277359|FG001|Overall Study|Progression of disease|0
4479720|NCT00711971|7277368|FG000|Overall Study|Lost to Follow-up|3
4479721|NCT00711971|7277369|FG001|Overall Study|Lost to Follow-up|4
4479722|NCT00711971|7277370|FG002|Overall Study|Lost to Follow-up|1
4479723|NCT00712010|7277393|FG000|Washout (7 Days)|Withdrawal by Subject|1
4479724|NCT00712166|7277424|FG000|Overall Study|Noncompliance|0
4479725|NCT00712166|7277425|FG001|Overall Study|Noncompliance|1
4479726|NCT00712270|7277457|FG000|Overall Study|Withdrawal by Subject|11
4479727|NCT00712270|7277457|FG000|Overall Study|Screen Failure|3
4479728|NCT00712335|7277511|FG000|Overall Study|Withdrawal by Subject|0
4479729|NCT00712335|7277512|FG001|Overall Study|Withdrawal by Subject|7
4479730|NCT00712335|7277513|FG002|Overall Study|Withdrawal by Subject|2
4479731|NCT00712335|7277514|FG003|Overall Study|Withdrawal by Subject|3
4479732|NCT00712335|7277515|FG004|Overall Study|Withdrawal by Subject|0
4479733|NCT00712335|7277511|FG000|Overall Study|Lost to Follow-up|2
4479734|NCT00712335|7277512|FG001|Overall Study|Lost to Follow-up|5
4479735|NCT00712335|7277513|FG002|Overall Study|Lost to Follow-up|0
4479736|NCT00712335|7277514|FG003|Overall Study|Lost to Follow-up|1
4479737|NCT00712335|7277515|FG004|Overall Study|Lost to Follow-up|0
4479738|NCT00712335|7277511|FG000|Overall Study|Protocol Violation|1
4479739|NCT00712335|7277512|FG001|Overall Study|Protocol Violation|2
4479740|NCT00712335|7277513|FG002|Overall Study|Protocol Violation|1
4479741|NCT00712335|7277514|FG003|Overall Study|Protocol Violation|0
4479742|NCT00712335|7277515|FG004|Overall Study|Protocol Violation|0
4479743|NCT00712335|7277511|FG000|Overall Study|Lack of Efficacy|0
4479744|NCT00712335|7277512|FG001|Overall Study|Lack of Efficacy|0
4479745|NCT00712335|7277513|FG002|Overall Study|Lack of Efficacy|1
4479746|NCT00712335|7277514|FG003|Overall Study|Lack of Efficacy|1
4479747|NCT00712335|7277515|FG004|Overall Study|Lack of Efficacy|0
4479748|NCT00712335|7277511|FG000|Overall Study|Other Reason|0
4479749|NCT00712335|7277512|FG001|Overall Study|Other Reason|3
4479750|NCT00712335|7277513|FG002|Overall Study|Other Reason|1
4479751|NCT00712335|7277514|FG003|Overall Study|Other Reason|0
4479752|NCT00712335|7277515|FG004|Overall Study|Other Reason|0
4479753|NCT00712348|7277527|FG000|Overall Study|Withdrawal by Subject|1
4479754|NCT00712543|7277546|FG000|Day 8-14|Lost to Follow-up|0
4479755|NCT00712543|7277547|FG001|Day 8-14|Lost to Follow-up|2
4479756|NCT00712673|7277556|FG000|Overall Study|Adverse Event|3
4479757|NCT00712673|7277557|FG001|Overall Study|Adverse Event|3
4479758|NCT00712673|7277558|FG002|Overall Study|Adverse Event|21
4479759|NCT00712673|7277559|FG003|Overall Study|Adverse Event|26
4479760|NCT00712673|7277556|FG000|Overall Study|Lack of Efficacy|2
4479761|NCT00712673|7277557|FG001|Overall Study|Lack of Efficacy|8
4479762|NCT00712673|7277558|FG002|Overall Study|Lack of Efficacy|8
4479763|NCT00712673|7277559|FG003|Overall Study|Lack of Efficacy|6
4479764|NCT00712673|7277556|FG000|Overall Study|Poor Compliance to Protocol|3
4479765|NCT00712673|7277557|FG001|Overall Study|Poor Compliance to Protocol|3
4479766|NCT00712673|7277558|FG002|Overall Study|Poor Compliance to Protocol|4
4479767|NCT00712673|7277559|FG003|Overall Study|Poor Compliance to Protocol|16
4479768|NCT00712673|7277556|FG000|Overall Study|Lost to Follow-up|1
4479769|NCT00712673|7277557|FG001|Overall Study|Lost to Follow-up|0
4479770|NCT00712673|7277558|FG002|Overall Study|Lost to Follow-up|2
4479771|NCT00712673|7277559|FG003|Overall Study|Lost to Follow-up|0
4479772|NCT00712673|7277556|FG000|Overall Study|Withdrawal by Subject|6
4479773|NCT00712673|7277557|FG001|Overall Study|Withdrawal by Subject|7
4479774|NCT00712673|7277558|FG002|Overall Study|Withdrawal by Subject|15
4479775|NCT00712673|7277559|FG003|Overall Study|Withdrawal by Subject|20
4479776|NCT00712673|7277556|FG000|Overall Study|Familial and Personal Reasons|5
4479777|NCT00712673|7277557|FG001|Overall Study|Familial and Personal Reasons|0
4479778|NCT00712673|7277558|FG002|Overall Study|Familial and Personal Reasons|5
4479779|NCT00712673|7277559|FG003|Overall Study|Familial and Personal Reasons|2
4479780|NCT00712673|7277556|FG000|Overall Study|Investigator's Decision|1
4479781|NCT00712673|7277557|FG001|Overall Study|Investigator's Decision|0
4479782|NCT00712673|7277558|FG002|Overall Study|Investigator's Decision|0
4479783|NCT00712673|7277559|FG003|Overall Study|Investigator's Decision|0
4479784|NCT00712673|7277556|FG000|Overall Study|Protocol Violation|0
4479785|NCT00712673|7277557|FG001|Overall Study|Protocol Violation|0
4479786|NCT00712673|7277558|FG002|Overall Study|Protocol Violation|2
4479787|NCT00712673|7277559|FG003|Overall Study|Protocol Violation|0
4479788|NCT00712712|7277578|FG000|Overall Study|Protocol Violation|11
4479789|NCT00712712|7277578|FG000|Overall Study|Radiofrequency not done|3
4479790|NCT00712712|7277578|FG000|Overall Study|Death|8
4479791|NCT00712712|7277578|FG000|Overall Study|Withdrawal by Subject|1
4479792|NCT00712725|7277590|FG000|Overall Study|Adverse Event|1
4479793|NCT00712725|7277591|FG001|Overall Study|Adverse Event|0
4479794|NCT00712725|7277592|FG002|Overall Study|Adverse Event|0
4479795|NCT00712725|7277593|FG003|Overall Study|Adverse Event|1
4479796|NCT00712725|7277594|FG004|Overall Study|Adverse Event|0
4479797|NCT00712725|7277595|FG005|Overall Study|Adverse Event|0
4479798|NCT00712725|7277596|FG006|Overall Study|Adverse Event|0
4479799|NCT00712725|7277597|FG007|Overall Study|Adverse Event|0
4479800|NCT00712725|7277590|FG000|Overall Study|Lost to Follow-up|3
4479801|NCT00712725|7277591|FG001|Overall Study|Lost to Follow-up|2
4479802|NCT00712725|7277592|FG002|Overall Study|Lost to Follow-up|1
4479803|NCT00712725|7277593|FG003|Overall Study|Lost to Follow-up|1
4479804|NCT00712725|7277594|FG004|Overall Study|Lost to Follow-up|2
4479805|NCT00712725|7277595|FG005|Overall Study|Lost to Follow-up|2
4479806|NCT00712725|7277596|FG006|Overall Study|Lost to Follow-up|3
4479807|NCT00712725|7277597|FG007|Overall Study|Lost to Follow-up|1
4479808|NCT00712725|7277590|FG000|Overall Study|Physician Decision|2
4479809|NCT00712725|7277591|FG001|Overall Study|Physician Decision|0
4479810|NCT00712725|7277592|FG002|Overall Study|Physician Decision|0
4479811|NCT00712725|7277593|FG003|Overall Study|Physician Decision|0
4479812|NCT00712725|7277594|FG004|Overall Study|Physician Decision|1
4479813|NCT00712725|7277595|FG005|Overall Study|Physician Decision|0
4479814|NCT00712725|7277596|FG006|Overall Study|Physician Decision|2
4479815|NCT00712725|7277597|FG007|Overall Study|Physician Decision|0
4479816|NCT00712725|7277590|FG000|Overall Study|Pregnancy|0
4479817|NCT00712725|7277591|FG001|Overall Study|Pregnancy|1
4479818|NCT00712725|7277592|FG002|Overall Study|Pregnancy|0
4479819|NCT00712725|7277593|FG003|Overall Study|Pregnancy|0
4479820|NCT00712725|7277594|FG004|Overall Study|Pregnancy|1
4479821|NCT00712725|7277595|FG005|Overall Study|Pregnancy|0
4479822|NCT00712725|7277596|FG006|Overall Study|Pregnancy|2
4479823|NCT00712725|7277597|FG007|Overall Study|Pregnancy|0
4479824|NCT00712725|7277590|FG000|Overall Study|Protocol Violation|2
4479825|NCT00712725|7277591|FG001|Overall Study|Protocol Violation|0
4479826|NCT00712725|7277592|FG002|Overall Study|Protocol Violation|1
4479827|NCT00712725|7277593|FG003|Overall Study|Protocol Violation|3
4479828|NCT00712725|7277594|FG004|Overall Study|Protocol Violation|2
4479829|NCT00712725|7277595|FG005|Overall Study|Protocol Violation|0
4479830|NCT00712725|7277596|FG006|Overall Study|Protocol Violation|1
4479831|NCT00712725|7277597|FG007|Overall Study|Protocol Violation|1
4479832|NCT00712725|7277590|FG000|Overall Study|Withdrawal by Subject|2
4699939|NCT02689076|7615534|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172
4699940|NCT02689076|7615535|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213
4699941|NCT02689076|7615536|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0
4699942|NCT02689076|7615534|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3
4699943|NCT02689076|7615535|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1
4699944|NCT02689076|7615536|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0
4699945|NCT02689076|7615534|FG000|Overall Study|Did not have an HIE match|2
4699946|NCT02689076|7615535|FG001|Overall Study|Did not have an HIE match|0
4699947|NCT02689076|7615536|FG002|Overall Study|Did not have an HIE match|0
4699948|NCT02689076|7615534|FG000|Overall Study|Death during non-VA encounter|2
4699949|NCT02689076|7615535|FG001|Overall Study|Death during non-VA encounter|5
4699950|NCT02689076|7615536|FG002|Overall Study|Death during non-VA encounter|0
4699951|NCT02689076|7615534|FG000|Overall Study|Provider declined to participate after participant assignment|1
4699952|NCT02689076|7615535|FG001|Overall Study|Provider declined to participate after participant assignment|1
4699953|NCT02689076|7615536|FG002|Overall Study|Provider declined to participate after participant assignment|0
4699954|NCT02689076|7615534|FG000|Overall Study|Participant no longer active in VA system|1
4699955|NCT02689076|7615535|FG001|Overall Study|Participant no longer active in VA system|0
4699956|NCT02689076|7615536|FG002|Overall Study|Participant no longer active in VA system|0
4699957|NCT02689076|7615534|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0
4699958|NCT02689076|7615535|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2
4699959|NCT02689076|7615536|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0
4699960|NCT02689206|7615553|FG000|Overall Study|Adverse Event|0
4699961|NCT02689206|7615554|FG001|Overall Study|Adverse Event|0
4699962|NCT02689206|7615555|FG002|Overall Study|Adverse Event|1
4699963|NCT02689206|7615556|FG003|Overall Study|Adverse Event|0
4699964|NCT02689206|7615557|FG004|Overall Study|Adverse Event|2
4699965|NCT02689206|7615553|FG000|Overall Study|Protocol Violation|1
4699966|NCT02689206|7615554|FG001|Overall Study|Protocol Violation|0
4699967|NCT02689206|7615555|FG002|Overall Study|Protocol Violation|0
4699968|NCT02689206|7615556|FG003|Overall Study|Protocol Violation|1
4699969|NCT02689206|7615557|FG004|Overall Study|Protocol Violation|2
4699970|NCT02689206|7615553|FG000|Overall Study|Other: Reached stopping criteria|0
4699971|NCT02689206|7615554|FG001|Overall Study|Other: Reached stopping criteria|1
4699972|NCT02689206|7615555|FG002|Overall Study|Other: Reached stopping criteria|2
4699973|NCT02689206|7615556|FG003|Overall Study|Other: Reached stopping criteria|3
4479833|NCT00712725|7277591|FG001|Overall Study|Withdrawal by Subject|1
4479834|NCT00712725|7277592|FG002|Overall Study|Withdrawal by Subject|1
4479835|NCT00712725|7277593|FG003|Overall Study|Withdrawal by Subject|2
4479836|NCT00712725|7277594|FG004|Overall Study|Withdrawal by Subject|1
4479837|NCT00712725|7277595|FG005|Overall Study|Withdrawal by Subject|1
4479838|NCT00712725|7277596|FG006|Overall Study|Withdrawal by Subject|1
4699974|NCT02689206|7615557|FG004|Overall Study|Other: Reached stopping criteria|4
4699975|NCT02689206|7615553|FG000|Overall Study|Physician Decision|1
4699976|NCT02689206|7615554|FG001|Overall Study|Physician Decision|0
4699977|NCT02689206|7615555|FG002|Overall Study|Physician Decision|0
4479839|NCT00712725|7277597|FG007|Overall Study|Withdrawal by Subject|2
4479840|NCT00712725|7277590|FG000|Overall Study|Lack of Qualifying Event|16
4479841|NCT00712725|7277591|FG001|Overall Study|Lack of Qualifying Event|2
4479842|NCT00712725|7277592|FG002|Overall Study|Lack of Qualifying Event|6
4479843|NCT00712725|7277593|FG003|Overall Study|Lack of Qualifying Event|8
4479844|NCT00712725|7277594|FG004|Overall Study|Lack of Qualifying Event|11
4479845|NCT00712725|7277595|FG005|Overall Study|Lack of Qualifying Event|13
4479846|NCT00712725|7277596|FG006|Overall Study|Lack of Qualifying Event|11
4479847|NCT00712725|7277597|FG007|Overall Study|Lack of Qualifying Event|6
4479848|NCT00712725|7277590|FG000|Overall Study|Protocol Specified Criteria|3
4479849|NCT00712725|7277591|FG001|Overall Study|Protocol Specified Criteria|0
4479850|NCT00712725|7277592|FG002|Overall Study|Protocol Specified Criteria|1
4479851|NCT00712725|7277593|FG003|Overall Study|Protocol Specified Criteria|2
4479852|NCT00712725|7277594|FG004|Overall Study|Protocol Specified Criteria|1
4479853|NCT00712725|7277595|FG005|Overall Study|Protocol Specified Criteria|0
4479854|NCT00712725|7277596|FG006|Overall Study|Protocol Specified Criteria|2
4479855|NCT00712725|7277597|FG007|Overall Study|Protocol Specified Criteria|1
4479856|NCT00712920|7277618|FG000|Overall Study|Adverse Event|3
4479857|NCT00712920|7277619|FG001|Overall Study|Adverse Event|4
4479858|NCT00712920|7277620|FG002|Overall Study|Adverse Event|7
4479859|NCT00712920|7277618|FG000|Overall Study|Withdrawal by Subject|4
4479860|NCT00712920|7277619|FG001|Overall Study|Withdrawal by Subject|2
4479861|NCT00712920|7277620|FG002|Overall Study|Withdrawal by Subject|1
4479862|NCT00712920|7277618|FG000|Overall Study|Lost to Follow-up|1
4479863|NCT00712920|7277619|FG001|Overall Study|Lost to Follow-up|4
4479864|NCT00712920|7277620|FG002|Overall Study|Lost to Follow-up|0
4479865|NCT00712920|7277618|FG000|Overall Study|Lack of Efficacy|1
4479866|NCT00712920|7277619|FG001|Overall Study|Lack of Efficacy|0
4479867|NCT00712920|7277620|FG002|Overall Study|Lack of Efficacy|1
4479868|NCT00712920|7277618|FG000|Overall Study|Other|5
4479869|NCT00712920|7277619|FG001|Overall Study|Other|7
4479870|NCT00712920|7277620|FG002|Overall Study|Other|3
4479871|NCT00712920|7277618|FG000|Overall Study|Non-compliance|3
4479872|NCT00712920|7277619|FG001|Overall Study|Non-compliance|0
4479873|NCT00712920|7277620|FG002|Overall Study|Non-compliance|0
4479874|NCT00712959|7277630|FG000|Overall Study|Protocol Violation|3
4479875|NCT00712959|7277631|FG001|Overall Study|Protocol Violation|1
4479876|NCT00712959|7277630|FG000|Overall Study|Lost to Follow-up|13
4479877|NCT00712959|7277631|FG001|Overall Study|Lost to Follow-up|2
4479878|NCT00712959|7277630|FG000|Overall Study|Withdrawal by Subject|3
4479879|NCT00712959|7277631|FG001|Overall Study|Withdrawal by Subject|0
4479880|NCT00712985|7277637|FG000|Overall Study|1 withdrew prior to start of drug|1
4479881|NCT00712985|7277637|FG000|Overall Study|1 patient moved out of state|1
4479882|NCT00712985|7277637|FG000|Overall Study|Lack of Efficacy|3
4479883|NCT00713219|7277641|FG000|Overall Study|Death|1
4479884|NCT00713219|7277641|FG000|Overall Study|Protocol Violation|1
4479885|NCT00713310|7277651|FG000|Overall Study|Adverse Event|5
4479886|NCT00713310|7277652|FG001|Overall Study|Adverse Event|2
4479887|NCT00713310|7277651|FG000|Overall Study|Lack of Efficacy|0
4479888|NCT00713310|7277652|FG001|Overall Study|Lack of Efficacy|2
4479889|NCT00713310|7277651|FG000|Overall Study|Withdrawal by Subject|0
4479890|NCT00713310|7277652|FG001|Overall Study|Withdrawal by Subject|2
4479891|NCT00713323|7277658|FG000|Overall Study|Adverse Event|75
4479892|NCT00713323|7277658|FG000|Overall Study|Withdrawal by Subject|15
4479893|NCT00713323|7277658|FG000|Overall Study|Lost to Follow-up|11
4479894|NCT00713323|7277658|FG000|Overall Study|Lack of Efficacy|36
4479895|NCT00713323|7277658|FG000|Overall Study|Low creatine clearance at screening|1
4479896|NCT00713323|7277658|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1
4479897|NCT00713323|7277658|FG000|Overall Study|Surgery cured allodynic pain|1
4479898|NCT00713323|7277658|FG000|Overall Study|Pain free|1
4479899|NCT00713323|7277658|FG000|Overall Study|Non-compliance|1
4479900|NCT00713323|7277658|FG000|Overall Study|Pain resolved|1
4479901|NCT00713323|7277658|FG000|Overall Study|Subject travelling to USA|1
4479902|NCT00713323|7277658|FG000|Overall Study|Subject travelling to Dominica Republic|1
4479903|NCT00713323|7277658|FG000|Overall Study|Treatment that may interact with Sativex|1
4479904|NCT00713349|7277662|FG000|Overall Study|Protocol Violation|1
4479905|NCT00713544|7277687|FG000|Overall Study|Adverse Event|5
4479906|NCT00713544|7277688|FG001|Overall Study|Adverse Event|3
4479907|NCT00713544|7277689|FG002|Overall Study|Adverse Event|7
4479908|NCT00713544|7277690|FG003|Overall Study|Adverse Event|7
4699978|NCT02689206|7615556|FG003|Overall Study|Physician Decision|0
4699979|NCT02689206|7615557|FG004|Overall Study|Physician Decision|0
4699980|NCT02689206|7615553|FG000|Overall Study|Withdrawal by Subject|1
4699981|NCT02689206|7615554|FG001|Overall Study|Withdrawal by Subject|0
4699982|NCT02689206|7615555|FG002|Overall Study|Withdrawal by Subject|1
4699983|NCT02689206|7615556|FG003|Overall Study|Withdrawal by Subject|0
4699984|NCT02689206|7615557|FG004|Overall Study|Withdrawal by Subject|0
4699985|NCT02689219|7615575|FG000|Overall Study|Death|1
4699986|NCT02689219|7615576|FG001|Overall Study|Death|1
4699987|NCT02689219|7615575|FG000|Overall Study|Disease Progression|10
4699988|NCT02689219|7615576|FG001|Overall Study|Disease Progression|6
4699989|NCT02689492|7615582|FG000|Overall Study|Lost to Follow-up|61
4479909|NCT00713544|7277691|FG004|Overall Study|Adverse Event|3
4479910|NCT00713544|7277692|FG005|Overall Study|Adverse Event|5
4699990|NCT02689492|7615582|FG000|Overall Study|Withdrawal by Subject|11
4699991|NCT02689492|7615582|FG000|Overall Study|Death|9
4479911|NCT00713544|7277687|FG000|Overall Study|Withdrawal by Subject|2
4479912|NCT00713544|7277688|FG001|Overall Study|Withdrawal by Subject|0
4479913|NCT00713544|7277689|FG002|Overall Study|Withdrawal by Subject|3
4479914|NCT00713544|7277690|FG003|Overall Study|Withdrawal by Subject|2
4479915|NCT00713544|7277691|FG004|Overall Study|Withdrawal by Subject|3
4479916|NCT00713544|7277692|FG005|Overall Study|Withdrawal by Subject|1
4479917|NCT00713544|7277687|FG000|Overall Study|Protocol Violation|0
4699992|NCT02689492|7615582|FG000|Overall Study|Physician Decision|2
4699993|NCT02689492|7615582|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1
4699994|NCT02689492|7615582|FG000|Overall Study|Withdrawal/ Physician's Decision|1
4699995|NCT02689492|7615582|FG000|Overall Study|Other than listed|1
4699996|NCT02689804|7615591|FG000|Overall Study|Withdrawal by Subject|2
4699997|NCT02689804|7615592|FG001|Overall Study|Withdrawal by Subject|0
4699998|NCT02690194|7615652|FG000|Overall Study|Withdrawal by Subject|1
4699999|NCT02690194|7615653|FG001|Overall Study|Withdrawal by Subject|4
4700000|NCT02690194|7615654|FG002|Overall Study|Withdrawal by Subject|0
4700001|NCT02690207|7615662|FG000|Overall Study|Lost to Follow-up|48
4700002|NCT02690207|7615662|FG000|Overall Study|Withdrawal by Subject|46
4700003|NCT02690207|7615662|FG000|Overall Study|Protocol Violation|2
4700004|NCT02690207|7615662|FG000|Overall Study|Serious adverse event|110
4700005|NCT02690207|7615662|FG000|Overall Study|Non-serious Adverse Event|18
4700006|NCT02690207|7615662|FG000|Overall Study|Migrated/moved from study area|5
4700007|NCT02690207|7615662|FG000|Overall Study|Suspected HZ Episode|1
4700008|NCT02690207|7615662|FG000|Overall Study|Other reasons for withdrawal|23
4700009|NCT02690649|7615672|FG000|Overall Study|Withdrawal by Subject|1
4700010|NCT02690649|7615673|FG001|Overall Study|Withdrawal by Subject|1
4700011|NCT02690649|7615672|FG000|Overall Study|Protocol Violation|0
4700012|NCT02690649|7615673|FG001|Overall Study|Protocol Violation|3
4700013|NCT02690701|7615683|FG000|Treatment Period 1|Adverse Event|2
4700014|NCT02690701|7615684|FG001|Treatment Period 1|Adverse Event|2
4700015|NCT02690701|7615683|FG000|Treatment Period 1|Withdrawal by Subject|0
4700016|NCT02690701|7615684|FG001|Treatment Period 1|Withdrawal by Subject|1
4700017|NCT02690701|7615683|FG000|Treatment Period 2|Adverse Event|2
4700018|NCT02690701|7615684|FG001|Treatment Period 2|Adverse Event|0
4700019|NCT02690701|7615683|FG000|Treatment Period 2|Lack of Efficacy|1
4700020|NCT02690701|7615684|FG001|Treatment Period 2|Lack of Efficacy|0
4700021|NCT02690701|7615683|FG000|Treatment Period 2|Lost to Follow-up|0
4700022|NCT02690701|7615684|FG001|Treatment Period 2|Lost to Follow-up|2
4700023|NCT02690701|7615683|FG000|Treatment Period 2|Withdrawal by Subject|0
4700024|NCT02690701|7615684|FG001|Treatment Period 2|Withdrawal by Subject|2
4700025|NCT02690701|7615683|FG000|Treatment Period 2|Protocol Violation|0
4700026|NCT02690701|7615684|FG001|Treatment Period 2|Protocol Violation|1
4700027|NCT02690714|7615691|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1
4700028|NCT02690714|7615691|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1
4700029|NCT02690727|7615699|FG000|Overall Study|Adverse Event|2
4700030|NCT02690727|7615700|FG001|Overall Study|Adverse Event|2
4700031|NCT02690974|7615726|FG000|Overall Study|Adverse Event|16
4700032|NCT02690974|7615726|FG000|Overall Study|Death|9
4700033|NCT02690974|7615726|FG000|Overall Study|Subject/guardian decision|4
4700034|NCT02690974|7615726|FG000|Overall Study|Lost to Follow-up|3
4700035|NCT02690974|7615726|FG000|Overall Study|Withdrawal of Informed Consent|3
4700036|NCT02690974|7615726|FG000|Overall Study|Physician Decision|2
4700037|NCT02690974|7615726|FG000|Overall Study|Non-compliance with study treatment|1
4700038|NCT02690974|7615726|FG000|Overall Study|Protocol-defined stopping criteria|1
4700039|NCT02690974|7615726|FG000|Overall Study|Protocol Deviation|1
4700040|NCT02691247|7615742|FG000|Overall Study|Withdrawal by Subject|1
4700041|NCT02691247|7615743|FG001|Overall Study|Withdrawal by Subject|2
4700042|NCT02691247|7615744|FG002|Overall Study|Withdrawal by Subject|2
4700043|NCT02691247|7615742|FG000|Overall Study|Lost to Follow-up|2
4700044|NCT02691247|7615743|FG001|Overall Study|Lost to Follow-up|0
4700045|NCT02691247|7615744|FG002|Overall Study|Lost to Follow-up|1
4700046|NCT02691455|7615784|FG000|Overall Study|Withdrawal by Subject|1
4700047|NCT02691455|7615785|FG001|Overall Study|Withdrawal by Subject|2
4700048|NCT02691455|7615784|FG000|Overall Study|Lost to Follow-up|15
4700049|NCT02691455|7615785|FG001|Overall Study|Lost to Follow-up|15
4700050|NCT02691468|7615793|FG000|Overall Study|Bronchial blocker use|2
4700051|NCT02691468|7615794|FG001|Overall Study|Bronchial blocker use|1
4700052|NCT02691468|7615793|FG000|Overall Study|Lost to Follow-up|2
4700053|NCT02691468|7615794|FG001|Overall Study|Lost to Follow-up|1
4700054|NCT02691468|7615793|FG000|Overall Study|Failure to advance FOB|2
4700055|NCT02691468|7615794|FG001|Overall Study|Failure to advance FOB|0
4700056|NCT02691494|7615803|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1
4700057|NCT02691494|7615804|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2
4700058|NCT02691494|7615805|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8
4700059|NCT02691494|7615803|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2
4700060|NCT02691494|7615804|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3
4700061|NCT02691494|7615805|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4
4700062|NCT02691494|7615803|FG000|Post-Treatment Follow-Up Period|Other|2
4700063|NCT02691494|7615804|FG001|Post-Treatment Follow-Up Period|Other|1
4700064|NCT02691494|7615805|FG002|Post-Treatment Follow-Up Period|Other|1
4700065|NCT02691494|7615803|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0
4479918|NCT00713544|7277688|FG001|Overall Study|Protocol Violation|0
4479919|NCT00713544|7277689|FG002|Overall Study|Protocol Violation|0
4479920|NCT00713544|7277690|FG003|Overall Study|Protocol Violation|0
4479921|NCT00713544|7277691|FG004|Overall Study|Protocol Violation|0
4479922|NCT00713544|7277692|FG005|Overall Study|Protocol Violation|1
4479923|NCT00713544|7277687|FG000|Overall Study|Physician Decision|0
4479924|NCT00713544|7277688|FG001|Overall Study|Physician Decision|0
4479925|NCT00713544|7277689|FG002|Overall Study|Physician Decision|0
4479926|NCT00713544|7277690|FG003|Overall Study|Physician Decision|0
4479927|NCT00713544|7277691|FG004|Overall Study|Physician Decision|0
4479928|NCT00713544|7277692|FG005|Overall Study|Physician Decision|2
4479929|NCT00713544|7277687|FG000|Overall Study|Lack of Efficacy|0
4479930|NCT00713544|7277688|FG001|Overall Study|Lack of Efficacy|1
4479931|NCT00713544|7277689|FG002|Overall Study|Lack of Efficacy|0
4479932|NCT00713544|7277690|FG003|Overall Study|Lack of Efficacy|1
4479933|NCT00713544|7277691|FG004|Overall Study|Lack of Efficacy|1
4479934|NCT00713544|7277692|FG005|Overall Study|Lack of Efficacy|0
4479935|NCT00713544|7277687|FG000|Overall Study|Lost to Follow-up|0
4479936|NCT00713544|7277688|FG001|Overall Study|Lost to Follow-up|0
4479937|NCT00713544|7277689|FG002|Overall Study|Lost to Follow-up|1
4479938|NCT00713544|7277690|FG003|Overall Study|Lost to Follow-up|0
4700066|NCT02691494|7615804|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0
4700067|NCT02691494|7615805|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3
4700068|NCT02691494|7615803|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0
4700069|NCT02691494|7615804|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1
4700070|NCT02691494|7615805|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1
4700071|NCT02691507|7615815|FG000|Overall Study|Missed Visit 3|0
4700072|NCT02691507|7615816|FG001|Overall Study|Missed Visit 3|1
4700073|NCT02691572|7615824|FG000|Overall Study|Withdrawal by Subject|1
4700074|NCT02691572|7615825|FG001|Overall Study|Withdrawal by Subject|0
4700075|NCT02691572|7615824|FG000|Overall Study|Protocol Violation|0
4700076|NCT02691572|7615825|FG001|Overall Study|Protocol Violation|1
4700077|NCT02691702|7615842|FG000|Overall Study|Adverse Event|1
4700078|NCT02691702|7615843|FG001|Overall Study|Adverse Event|0
4700079|NCT02691702|7615844|FG002|Overall Study|Adverse Event|0
4700080|NCT02691702|7615845|FG003|Overall Study|Adverse Event|0
4700081|NCT02691702|7615846|FG004|Overall Study|Adverse Event|0
4700082|NCT02691702|7615847|FG005|Overall Study|Adverse Event|0
4700083|NCT02691702|7615848|FG006|Overall Study|Adverse Event|0
4700084|NCT02691702|7615849|FG007|Overall Study|Adverse Event|0
4700085|NCT02691702|7615850|FG008|Overall Study|Adverse Event|1
4700086|NCT02691702|7615851|FG009|Overall Study|Adverse Event|0
4700087|NCT02691702|7615852|FG010|Overall Study|Adverse Event|1
4700088|NCT02691702|7615842|FG000|Overall Study|Lost to Follow-up|0
4700089|NCT02691702|7615843|FG001|Overall Study|Lost to Follow-up|0
4700090|NCT02691702|7615844|FG002|Overall Study|Lost to Follow-up|1
4700091|NCT02691702|7615845|FG003|Overall Study|Lost to Follow-up|0
4700092|NCT02691702|7615846|FG004|Overall Study|Lost to Follow-up|0
4700093|NCT02691702|7615847|FG005|Overall Study|Lost to Follow-up|2
4700094|NCT02691702|7615848|FG006|Overall Study|Lost to Follow-up|0
4700095|NCT02691702|7615849|FG007|Overall Study|Lost to Follow-up|0
4700096|NCT02691702|7615850|FG008|Overall Study|Lost to Follow-up|0
4700097|NCT02691702|7615851|FG009|Overall Study|Lost to Follow-up|0
4700098|NCT02691702|7615852|FG010|Overall Study|Lost to Follow-up|1
4700099|NCT02691702|7615842|FG000|Overall Study|Withdrawal by Subject|1
4700100|NCT02691702|7615843|FG001|Overall Study|Withdrawal by Subject|1
4700101|NCT02691702|7615844|FG002|Overall Study|Withdrawal by Subject|0
4700102|NCT02691702|7615845|FG003|Overall Study|Withdrawal by Subject|0
4700103|NCT02691702|7615846|FG004|Overall Study|Withdrawal by Subject|0
4700104|NCT02691702|7615847|FG005|Overall Study|Withdrawal by Subject|1
4700105|NCT02691702|7615848|FG006|Overall Study|Withdrawal by Subject|2
4700106|NCT02691702|7615849|FG007|Overall Study|Withdrawal by Subject|0
4700107|NCT02691702|7615850|FG008|Overall Study|Withdrawal by Subject|0
4700108|NCT02691702|7615851|FG009|Overall Study|Withdrawal by Subject|0
4700109|NCT02691702|7615852|FG010|Overall Study|Withdrawal by Subject|0
4700110|NCT02691702|7615842|FG000|Overall Study|Other|0
4700111|NCT02691702|7615843|FG001|Overall Study|Other|0
4700112|NCT02691702|7615844|FG002|Overall Study|Other|0
4700113|NCT02691702|7615845|FG003|Overall Study|Other|0
4700114|NCT02691702|7615846|FG004|Overall Study|Other|0
4700115|NCT02691702|7615847|FG005|Overall Study|Other|0
4700116|NCT02691702|7615848|FG006|Overall Study|Other|1
4700117|NCT02691702|7615849|FG007|Overall Study|Other|0
4700118|NCT02691702|7615850|FG008|Overall Study|Other|1
4700119|NCT02691702|7615851|FG009|Overall Study|Other|0
4700120|NCT02691702|7615852|FG010|Overall Study|Other|0
4700121|NCT02691702|7615842|FG000|Overall Study|Protocol Violation|0
4700122|NCT02691702|7615843|FG001|Overall Study|Protocol Violation|0
4479939|NCT00713544|7277691|FG004|Overall Study|Lost to Follow-up|0
4479940|NCT00713544|7277692|FG005|Overall Study|Lost to Follow-up|0
4700123|NCT02691702|7615844|FG002|Overall Study|Protocol Violation|0
4700124|NCT02691702|7615845|FG003|Overall Study|Protocol Violation|0
4700125|NCT02691702|7615846|FG004|Overall Study|Protocol Violation|0
4700126|NCT02691702|7615847|FG005|Overall Study|Protocol Violation|0
4700127|NCT02691702|7615848|FG006|Overall Study|Protocol Violation|0
4700128|NCT02691702|7615849|FG007|Overall Study|Protocol Violation|0
4700129|NCT02691702|7615850|FG008|Overall Study|Protocol Violation|0
4479941|NCT00713544|7277687|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0
4479942|NCT00713544|7277688|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1
4479943|NCT00713544|7277689|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0
4479944|NCT00713544|7277690|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0
4479945|NCT00713544|7277691|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0
4479946|NCT00713544|7277692|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0
4479947|NCT00713544|7277687|FG000|Overall Study|Incorrect enrollment|0
4479948|NCT00713544|7277688|FG001|Overall Study|Incorrect enrollment|1
4479949|NCT00713544|7277689|FG002|Overall Study|Incorrect enrollment|0
4479950|NCT00713544|7277690|FG003|Overall Study|Incorrect enrollment|0
4479951|NCT00713544|7277691|FG004|Overall Study|Incorrect enrollment|0
4479952|NCT00713544|7277692|FG005|Overall Study|Incorrect enrollment|0
4479953|NCT00713544|7277687|FG000|Overall Study|Hepatotoxicity - not an AE|0
4479954|NCT00713544|7277688|FG001|Overall Study|Hepatotoxicity - not an AE|0
4479955|NCT00713544|7277689|FG002|Overall Study|Hepatotoxicity - not an AE|0
4479956|NCT00713544|7277690|FG003|Overall Study|Hepatotoxicity - not an AE|0
4479957|NCT00713544|7277691|FG004|Overall Study|Hepatotoxicity - not an AE|1
4479958|NCT00713544|7277692|FG005|Overall Study|Hepatotoxicity - not an AE|0
4479959|NCT00713609|7277721|FG000|Overall Study|Adverse Event|2
4479960|NCT00713609|7277722|FG001|Overall Study|Adverse Event|0
4479961|NCT00713609|7277723|FG002|Overall Study|Adverse Event|2
4479962|NCT00713609|7277724|FG003|Overall Study|Adverse Event|2
4479963|NCT00713609|7277725|FG004|Overall Study|Adverse Event|3
4479964|NCT00713609|7277726|FG005|Overall Study|Adverse Event|1
4479965|NCT00713609|7277721|FG000|Overall Study|Lost to Follow-up|5
4479966|NCT00713609|7277722|FG001|Overall Study|Lost to Follow-up|7
4479967|NCT00713609|7277723|FG002|Overall Study|Lost to Follow-up|5
4479968|NCT00713609|7277724|FG003|Overall Study|Lost to Follow-up|5
4700130|NCT02691702|7615851|FG009|Overall Study|Protocol Violation|2
4700131|NCT02691702|7615852|FG010|Overall Study|Protocol Violation|0
4700132|NCT02691741|7615886|FG000|Overall Study|Adverse Event|0
4700133|NCT02691741|7615887|FG001|Overall Study|Adverse Event|2
4700134|NCT02691741|7615886|FG000|Overall Study|Lost to Follow-up|1
4700135|NCT02691741|7615887|FG001|Overall Study|Lost to Follow-up|0
4700136|NCT02691741|7615886|FG000|Overall Study|Physician Decision|0
4700137|NCT02691741|7615887|FG001|Overall Study|Physician Decision|1
4700138|NCT02691741|7615886|FG000|Overall Study|Withdrawal by Subject|0
4700139|NCT02691741|7615887|FG001|Overall Study|Withdrawal by Subject|4
4700140|NCT02691936|7615900|FG000|Overall Study|Withdrawal by Subject|2
4700141|NCT02691936|7615901|FG001|Overall Study|Withdrawal by Subject|5
4700142|NCT02692040|7615929|FG000|Overall Study|Protocol Violation|0
4700143|NCT02692040|7615930|FG001|Overall Study|Protocol Violation|0
4700144|NCT02692040|7615931|FG002|Overall Study|Protocol Violation|0
4700145|NCT02692040|7615932|FG003|Overall Study|Protocol Violation|0
4700146|NCT02692040|7615933|FG004|Overall Study|Protocol Violation|0
4700147|NCT02692040|7615934|FG005|Overall Study|Protocol Violation|0
4700148|NCT02692040|7615935|FG006|Overall Study|Protocol Violation|0
4700149|NCT02692040|7615936|FG007|Overall Study|Protocol Violation|0
4700150|NCT02692040|7615937|FG008|Overall Study|Protocol Violation|0
4700151|NCT02692040|7615938|FG009|Overall Study|Protocol Violation|0
4700152|NCT02692040|7615939|FG010|Overall Study|Protocol Violation|0
4700153|NCT02692040|7615940|FG011|Overall Study|Protocol Violation|0
4700154|NCT02692040|7615941|FG012|Overall Study|Protocol Violation|1
4700155|NCT02692040|7615942|FG013|Overall Study|Protocol Violation|0
4700156|NCT02692040|7615943|FG014|Overall Study|Protocol Violation|0
4700157|NCT02692040|7615944|FG015|Overall Study|Protocol Violation|0
4700158|NCT02692040|7615945|FG016|Overall Study|Protocol Violation|0
4700159|NCT02692040|7615929|FG000|Overall Study|Adverse Event|0
4700160|NCT02692040|7615930|FG001|Overall Study|Adverse Event|0
4700161|NCT02692040|7615931|FG002|Overall Study|Adverse Event|0
4700162|NCT02692040|7615932|FG003|Overall Study|Adverse Event|0
4700163|NCT02692040|7615933|FG004|Overall Study|Adverse Event|0
4700164|NCT02692040|7615934|FG005|Overall Study|Adverse Event|0
4700165|NCT02692040|7615935|FG006|Overall Study|Adverse Event|0
4700166|NCT02692040|7615936|FG007|Overall Study|Adverse Event|0
4700167|NCT02692040|7615937|FG008|Overall Study|Adverse Event|0
4700168|NCT02692040|7615938|FG009|Overall Study|Adverse Event|0
4700169|NCT02692040|7615939|FG010|Overall Study|Adverse Event|0
4700170|NCT02692040|7615940|FG011|Overall Study|Adverse Event|0
4700171|NCT02692040|7615941|FG012|Overall Study|Adverse Event|0
4700172|NCT02692040|7615942|FG013|Overall Study|Adverse Event|3
4700173|NCT02692040|7615943|FG014|Overall Study|Adverse Event|1
4700174|NCT02692040|7615944|FG015|Overall Study|Adverse Event|1
4700175|NCT02692040|7615945|FG016|Overall Study|Adverse Event|0
4700176|NCT02692235|7616030|FG000|Overall Study|Withdrawal by Subject|2
4700177|NCT02692235|7616031|FG001|Overall Study|Withdrawal by Subject|1
4700178|NCT02692235|7616030|FG000|Overall Study|Adverse Event|1
4700179|NCT02692235|7616031|FG001|Overall Study|Adverse Event|2
4700180|NCT02692417|7616048|FG000|Overall Study|Withdrawal by Subject|5
4700181|NCT02692417|7616049|FG001|Overall Study|Withdrawal by Subject|1
4700182|NCT02692417|7616048|FG000|Overall Study|Adverse Event|1
4700183|NCT02692417|7616049|FG001|Overall Study|Adverse Event|0
4700184|NCT02692482|7616057|FG000|Overall Study|Death|2
4700185|NCT02692482|7616058|FG001|Overall Study|Death|2
4700186|NCT02692482|7616057|FG000|Overall Study|Withdrawal by Subject|1
4479969|NCT00713609|7277725|FG004|Overall Study|Lost to Follow-up|7
4479970|NCT00713609|7277726|FG005|Overall Study|Lost to Follow-up|0
4479971|NCT00713609|7277721|FG000|Overall Study|Lack of Efficacy|1
4479972|NCT00713609|7277722|FG001|Overall Study|Lack of Efficacy|3
4479973|NCT00713609|7277723|FG002|Overall Study|Lack of Efficacy|0
4479974|NCT00713609|7277724|FG003|Overall Study|Lack of Efficacy|0
4479975|NCT00713609|7277725|FG004|Overall Study|Lack of Efficacy|1
4479976|NCT00713609|7277726|FG005|Overall Study|Lack of Efficacy|0
4479977|NCT00713609|7277721|FG000|Overall Study|Non-Compliance with Study Treatment|1
4479978|NCT00713609|7277722|FG001|Overall Study|Non-Compliance with Study Treatment|1
4479979|NCT00713609|7277723|FG002|Overall Study|Non-Compliance with Study Treatment|2
4479980|NCT00713609|7277724|FG003|Overall Study|Non-Compliance with Study Treatment|0
4479981|NCT00713609|7277725|FG004|Overall Study|Non-Compliance with Study Treatment|1
4479982|NCT00713609|7277726|FG005|Overall Study|Non-Compliance with Study Treatment|0
4479983|NCT00713609|7277721|FG000|Overall Study|Withdrawal by Subject|6
4479984|NCT00713609|7277722|FG001|Overall Study|Withdrawal by Subject|1
4479985|NCT00713609|7277723|FG002|Overall Study|Withdrawal by Subject|5
4479986|NCT00713609|7277724|FG003|Overall Study|Withdrawal by Subject|1
4479987|NCT00713609|7277725|FG004|Overall Study|Withdrawal by Subject|5
4479988|NCT00713609|7277726|FG005|Overall Study|Withdrawal by Subject|7
4479989|NCT00713609|7277721|FG000|Overall Study|Protocol Violation|6
4479990|NCT00713609|7277722|FG001|Overall Study|Protocol Violation|3
4479991|NCT00713609|7277723|FG002|Overall Study|Protocol Violation|1
4479992|NCT00713609|7277724|FG003|Overall Study|Protocol Violation|1
4479993|NCT00713609|7277725|FG004|Overall Study|Protocol Violation|2
4479994|NCT00713609|7277726|FG005|Overall Study|Protocol Violation|0
4479995|NCT00713648|7277740|FG000|Overall Study|Adverse Event|1
4479996|NCT00713648|7277740|FG000|Overall Study|Unclassified|2
4479997|NCT00713648|7277740|FG000|Overall Study|According to Protocol|2
4700187|NCT02692482|7616058|FG001|Overall Study|Withdrawal by Subject|2
4700188|NCT02692560|7616080|FG000|Overall Study|Withdrawal by Subject|0
4700189|NCT02692560|7616081|FG001|Overall Study|Withdrawal by Subject|6
4700190|NCT02692586|7616087|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1
4700191|NCT02692586|7616087|FG000|Overall Study|Received adjunctive thrombolytics|2
4700192|NCT02692703|7616091|FG000|Overall Study|Lost to Follow-up|1
4700193|NCT02692703|7616091|FG000|Overall Study|Other|1
4700194|NCT02692716|7616097|FG000|Overall Study|Lost to Follow-up|2
4700195|NCT02692716|7616098|FG001|Overall Study|Lost to Follow-up|5
4700196|NCT02692716|7616097|FG000|Overall Study|Withdrawal by Subject|3
4700197|NCT02692716|7616098|FG001|Overall Study|Withdrawal by Subject|1
4700198|NCT02693106|7616118|FG000|Overall Study|No time|3
4700199|NCT02693119|7616130|FG000|Open-Label Period|Withdrawal by Subject|0
4700200|NCT02693119|7616131|FG001|Open-Label Period|Withdrawal by Subject|1
4700201|NCT02693418|7616192|FG000|Overall Study|Lost to Follow-up|1
4700202|NCT02693418|7616193|FG001|Overall Study|Lost to Follow-up|2
4700203|NCT02693418|7616194|FG002|Overall Study|Lost to Follow-up|0
4700204|NCT02693418|7616195|FG003|Overall Study|Lost to Follow-up|0
4700205|NCT02693418|7616196|FG004|Overall Study|Lost to Follow-up|0
4700206|NCT02693418|7616192|FG000|Overall Study|Menses during study period|0
4700207|NCT02693418|7616193|FG001|Overall Study|Menses during study period|0
4700208|NCT02693418|7616194|FG002|Overall Study|Menses during study period|2
4700209|NCT02693418|7616195|FG003|Overall Study|Menses during study period|0
4700210|NCT02693418|7616196|FG004|Overall Study|Menses during study period|0
4700211|NCT02693834|7616225|FG000|Baseline Measurement|Withdrawal by Subject|1
4700212|NCT02693834|7616226|FG001|Baseline Measurement|Withdrawal by Subject|0
4700213|NCT02693834|7616225|FG000|Baseline Measurement|Adverse Event|1
4700214|NCT02693834|7616226|FG001|Baseline Measurement|Adverse Event|0
4700215|NCT02693834|7616225|FG000|Week 2 Practice|Adverse Event|0
4700216|NCT02693834|7616226|FG001|Week 2 Practice|Adverse Event|1
4700217|NCT02694328|7616255|FG000|Overall Study|Adverse Event|27
4700218|NCT02694328|7616256|FG001|Overall Study|Adverse Event|33
4700219|NCT02694328|7616255|FG000|Overall Study|Withdrawal by Subject|27
4700220|NCT02694328|7616256|FG001|Overall Study|Withdrawal by Subject|23
4700221|NCT02694328|7616255|FG000|Overall Study|Lost to Follow-up|26
4700222|NCT02694328|7616256|FG001|Overall Study|Lost to Follow-up|22
4700223|NCT02694328|7616255|FG000|Overall Study|Noncompliant with study drug|11
4700224|NCT02694328|7616256|FG001|Overall Study|Noncompliant with study drug|8
4700225|NCT02694328|7616255|FG000|Overall Study|Incarceration|1
4700226|NCT02694328|7616256|FG001|Overall Study|Incarceration|1
4700227|NCT02694328|7616255|FG000|Overall Study|Lack of Efficacy|1
4700228|NCT02694328|7616256|FG001|Overall Study|Lack of Efficacy|2
4700229|NCT02694328|7616255|FG000|Overall Study|Pregnancy|1
4700230|NCT02694328|7616256|FG001|Overall Study|Pregnancy|1
4700231|NCT02694328|7616255|FG000|Overall Study|Protocol Violation|6
4700232|NCT02694328|7616256|FG001|Overall Study|Protocol Violation|5
4700233|NCT02694328|7616255|FG000|Overall Study|Abnormal Laboratory Value|0
4700234|NCT02694328|7616256|FG001|Overall Study|Abnormal Laboratory Value|3
4700235|NCT02694523|7616268|FG000|Part A|Adverse Event|7
4700236|NCT02694523|7616269|FG001|Part A|Adverse Event|3
4700237|NCT02694523|7616270|FG002|Part A|Adverse Event|0
4479998|NCT00713648|7277740|FG000|Overall Study|Development of antibodies|3
4479999|NCT00713700|7277761|FG000|Overall Study|Lost to Follow-up|3
4480000|NCT00713700|7277761|FG000|Overall Study|Withdrawal by Subject|1
4480001|NCT00713830|7277776|FG000|Overall Study|Adverse Event|23
4480002|NCT00713830|7277777|FG001|Overall Study|Adverse Event|71
4480003|NCT00713830|7277776|FG000|Overall Study|Lack of Efficacy|24
4480004|NCT00713830|7277777|FG001|Overall Study|Lack of Efficacy|16
4480005|NCT00713830|7277776|FG000|Overall Study|Lost to Follow-up|2
4480006|NCT00713830|7277777|FG001|Overall Study|Lost to Follow-up|9
4480007|NCT00713830|7277776|FG000|Overall Study|Withdrawal by Subject|13
4480008|NCT00713830|7277777|FG001|Overall Study|Withdrawal by Subject|23
4480009|NCT00713830|7277776|FG000|Overall Study|Poor Compliance to Protocol|7
4480010|NCT00713830|7277777|FG001|Overall Study|Poor Compliance to Protocol|14
4480011|NCT00713830|7277776|FG000|Overall Study|Familial and Personal Reasons|9
4480012|NCT00713830|7277777|FG001|Overall Study|Familial and Personal Reasons|34
4480013|NCT00713830|7277776|FG000|Overall Study|Sponsor Decision|4
4480014|NCT00713830|7277777|FG001|Overall Study|Sponsor Decision|10
4480015|NCT00714051|7277785|FG000|Overall Study|Withdrawal by Subject|1
4480016|NCT00714051|7277786|FG001|Overall Study|Withdrawal by Subject|0
4480017|NCT00714051|7277785|FG000|Overall Study|Death|0
4480018|NCT00714051|7277786|FG001|Overall Study|Death|1
4480019|NCT00714168|7277794|FG000|Overall Study|Pregnancy|5
4480020|NCT00714168|7277795|FG001|Overall Study|Pregnancy|4
4480021|NCT00714168|7277794|FG000|Overall Study|Lost to Follow-up|32
4480022|NCT00714168|7277795|FG001|Overall Study|Lost to Follow-up|50
4480023|NCT00714168|7277794|FG000|Overall Study|Relocation|4
4480024|NCT00714168|7277795|FG001|Overall Study|Relocation|3
4480025|NCT00714168|7277794|FG000|Overall Study|Non-study medical condition|3
4480026|NCT00714168|7277795|FG001|Overall Study|Non-study medical condition|2
4480027|NCT00714259|7277823|FG000|Overall Study|Death|2
4480028|NCT00714285|7277840|FG000|Overall Study|Lost to Follow-up|0
4480029|NCT00714285|7277841|FG001|Overall Study|Lost to Follow-up|2
4480030|NCT00714285|7277842|FG002|Overall Study|Lost to Follow-up|0
4480031|NCT00714285|7277843|FG003|Overall Study|Lost to Follow-up|1
4480032|NCT00714285|7277840|FG000|Overall Study|Migrated/moved from study area|0
4700238|NCT02694523|7616271|FG003|Part A|Adverse Event|0
4700239|NCT02694523|7616272|FG004|Part A|Adverse Event|0
4700240|NCT02694523|7616273|FG005|Part A|Adverse Event|0
4700241|NCT02694523|7616274|FG006|Part A|Adverse Event|0
4700242|NCT02694523|7616268|FG000|Part A|Protocol Violation|1
4700243|NCT02694523|7616269|FG001|Part A|Protocol Violation|0
4700244|NCT02694523|7616270|FG002|Part A|Protocol Violation|0
4700245|NCT02694523|7616271|FG003|Part A|Protocol Violation|0
4700246|NCT02694523|7616272|FG004|Part A|Protocol Violation|0
4700247|NCT02694523|7616273|FG005|Part A|Protocol Violation|0
4700248|NCT02694523|7616274|FG006|Part A|Protocol Violation|0
4700249|NCT02694523|7616268|FG000|Part A|Lost to Follow-up|1
4700250|NCT02694523|7616269|FG001|Part A|Lost to Follow-up|2
4700251|NCT02694523|7616270|FG002|Part A|Lost to Follow-up|0
4700252|NCT02694523|7616271|FG003|Part A|Lost to Follow-up|0
4700253|NCT02694523|7616272|FG004|Part A|Lost to Follow-up|0
4700254|NCT02694523|7616273|FG005|Part A|Lost to Follow-up|0
4700255|NCT02694523|7616274|FG006|Part A|Lost to Follow-up|0
4700256|NCT02694523|7616268|FG000|Part A|Withdrawal by Subject|3
4700257|NCT02694523|7616269|FG001|Part A|Withdrawal by Subject|1
4700258|NCT02694523|7616270|FG002|Part A|Withdrawal by Subject|0
4700259|NCT02694523|7616271|FG003|Part A|Withdrawal by Subject|0
4700260|NCT02694523|7616272|FG004|Part A|Withdrawal by Subject|0
4700261|NCT02694523|7616273|FG005|Part A|Withdrawal by Subject|0
4700262|NCT02694523|7616274|FG006|Part A|Withdrawal by Subject|0
4700263|NCT02694523|7616268|FG000|Part A|Other|1
4700264|NCT02694523|7616269|FG001|Part A|Other|1
4700265|NCT02694523|7616270|FG002|Part A|Other|0
4700266|NCT02694523|7616271|FG003|Part A|Other|0
4700267|NCT02694523|7616272|FG004|Part A|Other|0
4700268|NCT02694523|7616273|FG005|Part A|Other|0
4700269|NCT02694523|7616274|FG006|Part A|Other|0
4700270|NCT02694523|7616268|FG000|Part B|Adverse Event|0
4700271|NCT02694523|7616269|FG001|Part B|Adverse Event|0
4700272|NCT02694523|7616270|FG002|Part B|Adverse Event|7
4700273|NCT02694523|7616271|FG003|Part B|Adverse Event|1
4700274|NCT02694523|7616272|FG004|Part B|Adverse Event|1
4700275|NCT02694523|7616273|FG005|Part B|Adverse Event|2
4700276|NCT02694523|7616274|FG006|Part B|Adverse Event|0
4700277|NCT02694523|7616268|FG000|Part B|Protocol Violation|0
4480033|NCT00714285|7277841|FG001|Overall Study|Migrated/moved from study area|1
4480034|NCT00714285|7277842|FG002|Overall Study|Migrated/moved from study area|0
4700278|NCT02694523|7616269|FG001|Part B|Protocol Violation|0
4700279|NCT02694523|7616270|FG002|Part B|Protocol Violation|1
4700280|NCT02694523|7616271|FG003|Part B|Protocol Violation|0
4700281|NCT02694523|7616272|FG004|Part B|Protocol Violation|0
4700282|NCT02694523|7616273|FG005|Part B|Protocol Violation|0
4700283|NCT02694523|7616274|FG006|Part B|Protocol Violation|0
4700284|NCT02694523|7616268|FG000|Part B|Lost to Follow-up|0
4700285|NCT02694523|7616269|FG001|Part B|Lost to Follow-up|0
4480035|NCT00714285|7277843|FG003|Overall Study|Migrated/moved from study area|0
4480036|NCT00714415|7277870|FG000|Overall Study|Lack of Efficacy|1
4480037|NCT00714415|7277871|FG001|Overall Study|Lack of Efficacy|0
4700286|NCT02694523|7616270|FG002|Part B|Lost to Follow-up|2
4700287|NCT02694523|7616271|FG003|Part B|Lost to Follow-up|3
4700288|NCT02694523|7616272|FG004|Part B|Lost to Follow-up|2
4700289|NCT02694523|7616273|FG005|Part B|Lost to Follow-up|0
4700290|NCT02694523|7616274|FG006|Part B|Lost to Follow-up|1
4700291|NCT02694523|7616268|FG000|Part B|Withdrawal by Subject|0
4700292|NCT02694523|7616269|FG001|Part B|Withdrawal by Subject|0
4700293|NCT02694523|7616270|FG002|Part B|Withdrawal by Subject|9
4480038|NCT00714415|7277870|FG000|Overall Study|Death|1
4480039|NCT00714415|7277871|FG001|Overall Study|Death|0
4480040|NCT00714493|7277877|FG000|Overall Study|Adverse Event|11
4480041|NCT00714493|7277877|FG000|Overall Study|Death|3
4480042|NCT00714493|7277877|FG000|Overall Study|Lack of Efficacy|10
4480043|NCT00714493|7277877|FG000|Overall Study|Lost to Follow-up|3
4480044|NCT00714493|7277877|FG000|Overall Study|Protocol Violation|12
4480045|NCT00714493|7277877|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8
4480046|NCT00714493|7277877|FG000|Overall Study|OTHER|2
4480047|NCT00714688|7277909|FG000|Overall Study|Lack of Efficacy|14
4480048|NCT00714688|7277910|FG001|Overall Study|Lack of Efficacy|1
4480049|NCT00714688|7277911|FG002|Overall Study|Lack of Efficacy|4
4480050|NCT00714688|7277909|FG000|Overall Study|Withdrawal by Subject|4
4480051|NCT00714688|7277910|FG001|Overall Study|Withdrawal by Subject|3
4480052|NCT00714688|7277911|FG002|Overall Study|Withdrawal by Subject|3
4480053|NCT00714688|7277909|FG000|Overall Study|Lost to Follow-up|5
4480054|NCT00714688|7277910|FG001|Overall Study|Lost to Follow-up|2
4480055|NCT00714688|7277911|FG002|Overall Study|Lost to Follow-up|0
4480056|NCT00714688|7277909|FG000|Overall Study|Adverse Event|2
4480057|NCT00714688|7277910|FG001|Overall Study|Adverse Event|15
4480058|NCT00714688|7277911|FG002|Overall Study|Adverse Event|19
4480059|NCT00714688|7277909|FG000|Overall Study|Subject Non-compliant|3
4480060|NCT00714688|7277910|FG001|Overall Study|Subject Non-compliant|5
4480061|NCT00714688|7277911|FG002|Overall Study|Subject Non-compliant|5
4480062|NCT00714688|7277909|FG000|Overall Study|Ineligible to Continue the Study|0
4480063|NCT00714688|7277910|FG001|Overall Study|Ineligible to Continue the Study|1
4480064|NCT00714688|7277911|FG002|Overall Study|Ineligible to Continue the Study|1
4700294|NCT02694523|7616271|FG003|Part B|Withdrawal by Subject|0
4700295|NCT02694523|7616272|FG004|Part B|Withdrawal by Subject|1
4700296|NCT02694523|7616273|FG005|Part B|Withdrawal by Subject|3
4589636|NCT01514136|7435055|FG001|Test Period 1; Test B|Withdrawal by Subject|1
4589637|NCT01514136|7435056|FG002|Test Period 1; Test B|Withdrawal by Subject|0
4589638|NCT01514136|7435057|FG003|Test Period 1; Test B|Withdrawal by Subject|0
4589639|NCT01514136|7435058|FG004|Test Period 1; Test B|Withdrawal by Subject|0
4589640|NCT01514136|7435059|FG005|Test Period 1; Test B|Withdrawal by Subject|0
4700297|NCT02694523|7616274|FG006|Part B|Withdrawal by Subject|0
4480065|NCT00714688|7277909|FG000|Overall Study|Sponsor's Decision|0
4480066|NCT00714688|7277910|FG001|Overall Study|Sponsor's Decision|2
4480067|NCT00714688|7277911|FG002|Overall Study|Sponsor's Decision|0
4480068|NCT00714688|7277909|FG000|Overall Study|Other|1
4480069|NCT00714688|7277910|FG001|Overall Study|Other|6
4480070|NCT00714688|7277911|FG002|Overall Study|Other|5
4480071|NCT00714714|7277919|FG000|Overall Study|Adverse Event|1
4480072|NCT00714870|7277940|FG000|Overall Study|Lost to Follow-up|22
4480073|NCT00714870|7277941|FG001|Overall Study|Lost to Follow-up|5
4480074|NCT00714870|7277940|FG000|Overall Study|patient unable to come b/c back pain|1
4700298|NCT02694523|7616268|FG000|Part B|Other|0
4700299|NCT02694523|7616269|FG001|Part B|Other|0
4700300|NCT02694523|7616270|FG002|Part B|Other|1
4700301|NCT02694523|7616271|FG003|Part B|Other|0
4700302|NCT02694523|7616272|FG004|Part B|Other|0
4700303|NCT02694523|7616273|FG005|Part B|Other|0
4700304|NCT02694523|7616274|FG006|Part B|Other|1
4700305|NCT02694536|7616286|FG000|Overall Study|Progressive Disease|40
4700306|NCT02694536|7616286|FG000|Overall Study|Lost to Follow-up|1
4700307|NCT02694536|7616286|FG000|Overall Study|Study Drug-Related Adverse Event|1
4700308|NCT02694536|7616286|FG000|Overall Study|Withdrawal by Subject|8
4700309|NCT02694536|7616286|FG000|Overall Study|Death|8
4700310|NCT02694536|7616286|FG000|Overall Study|Other|22
4700311|NCT02694549|7616290|FG000|Overall Study|screen failures|2
4700312|NCT02694562|7616294|FG000|Overall Study|Death|8
4700313|NCT02694562|7616294|FG000|Overall Study|Protocol Violation|4
4700314|NCT02694562|7616294|FG000|Overall Study|Lost to Follow-up|3
4700315|NCT02694562|7616294|FG000|Overall Study|Screen Failure|2
4700316|NCT02694562|7616294|FG000|Overall Study|Physician Decision|1
4700317|NCT02694718|7616302|FG000|Overall Study|Death|1
4700318|NCT02694718|7616302|FG000|Overall Study|Withdrawal by Subject|1
4700319|NCT02694744|7616308|FG000|Overall Study|Adverse Event|2
4700320|NCT02694744|7616309|FG001|Overall Study|Adverse Event|1
4700321|NCT02694744|7616308|FG000|Overall Study|Withdrawal by Subject|2
4700322|NCT02694744|7616309|FG001|Overall Study|Withdrawal by Subject|1
4700323|NCT02694744|7616308|FG000|Overall Study|Physician Decision|1
4700324|NCT02694744|7616309|FG001|Overall Study|Physician Decision|2
4700325|NCT02694744|7616308|FG000|Overall Study|Lost to Follow-up|1
4700326|NCT02694744|7616309|FG001|Overall Study|Lost to Follow-up|0
4700327|NCT02694744|7616308|FG000|Overall Study|Taking potassium supplement: exclusion 6|0
4700328|NCT02694744|7616309|FG001|Overall Study|Taking potassium supplement: exclusion 6|1
4700329|NCT02694978|7616328|FG000|Overall Study|Adverse Event|10
4700330|NCT02694978|7616329|FG001|Overall Study|Adverse Event|9
4700331|NCT02694978|7616328|FG000|Overall Study|Withdrawal by Subject|22
4700332|NCT02694978|7616329|FG001|Overall Study|Withdrawal by Subject|19
4700333|NCT02694978|7616328|FG000|Overall Study|Lost to Follow-up|14
4480075|NCT00714870|7277941|FG001|Overall Study|patient unable to come b/c back pain|0
4480076|NCT00714870|7277940|FG000|Overall Study|did not attend minimum of 4 sessions|4
4700334|NCT02694978|7616329|FG001|Overall Study|Lost to Follow-up|17
4700335|NCT02694978|7616328|FG000|Overall Study|Death|4
4480077|NCT00714870|7277941|FG001|Overall Study|did not attend minimum of 4 sessions|0
4480078|NCT00715026|7277947|FG000|Overall Study|Withdrawal by Subject|5
4480079|NCT00715026|7277947|FG000|Overall Study|Lost to Follow-up|3
4480080|NCT00715026|7277947|FG000|Overall Study|Protocol Violation|1
4480081|NCT00715026|7277947|FG000|Overall Study|Surgery done on non-study consented hip|1
4480082|NCT00715078|7277954|FG000|Overall Study|Death|29
4480083|NCT00715078|7277955|FG001|Overall Study|Death|36
4480084|NCT00715078|7277956|FG002|Overall Study|Death|36
4480085|NCT00715078|7277954|FG000|Overall Study|Withdrawal by Subject|1
4480086|NCT00715078|7277955|FG001|Overall Study|Withdrawal by Subject|0
4480087|NCT00715078|7277956|FG002|Overall Study|Withdrawal by Subject|1
4480088|NCT00715078|7277954|FG000|Overall Study|Unable to start due to disease prog.|0
4480089|NCT00715078|7277955|FG001|Overall Study|Unable to start due to disease prog.|0
4480090|NCT00715078|7277956|FG002|Overall Study|Unable to start due to disease prog.|1
4480091|NCT00715117|7278013|FG000|Overall Study|Crohn's flare and rescue with steroids|0
4480092|NCT00715117|7278014|FG001|Overall Study|Crohn's flare and rescue with steroids|1
4480093|NCT00715208|7278027|FG000|Overall Study|Withdrawal by Subject|1
4480094|NCT00715208|7278028|FG001|Overall Study|Withdrawal by Subject|1
4480095|NCT00715208|7278027|FG000|Overall Study|Adverse Event|0
4480096|NCT00715208|7278028|FG001|Overall Study|Adverse Event|6
4480097|NCT00715208|7278027|FG000|Overall Study|Lack of Efficacy|0
4480098|NCT00715208|7278028|FG001|Overall Study|Lack of Efficacy|2
4480099|NCT00715299|7278034|FG000|Overall Study|Withdrawal by Subject|1
4480100|NCT00715299|7278034|FG000|Overall Study|Adverse Event|3
4480101|NCT00715299|7278034|FG000|Overall Study|failed the pre-screen exercise test|2
4480102|NCT00715403|7278049|FG000|Overall Study|Progressive disease|0
4700336|NCT02694978|7616329|FG001|Overall Study|Death|1
4480103|NCT00715403|7278050|FG001|Overall Study|Progressive disease|1
4480104|NCT00715403|7278051|FG002|Overall Study|Progressive disease|3
4480105|NCT00715403|7278052|FG003|Overall Study|Progressive disease|9
4700337|NCT02694978|7616328|FG000|Overall Study|Other-Decision of Participant|6
4700338|NCT02694978|7616329|FG001|Overall Study|Other-Decision of Participant|1
4700339|NCT02694978|7616328|FG000|Overall Study|Other-Investigator's decision|1
4700340|NCT02694978|7616329|FG001|Overall Study|Other-Investigator's decision|0
4700341|NCT02694978|7616328|FG000|Overall Study|Other-Unable to be reached|0
4700342|NCT02694978|7616329|FG001|Overall Study|Other-Unable to be reached|1
4700343|NCT02694978|7616328|FG000|Overall Study|Other-Protocol noncompliant|2
4700344|NCT02694978|7616329|FG001|Overall Study|Other-Protocol noncompliant|1
4700345|NCT02694978|7616328|FG000|Overall Study|Other-Personal reasons|3
4700346|NCT02694978|7616329|FG001|Overall Study|Other-Personal reasons|3
4700347|NCT02694978|7616328|FG000|Overall Study|Other-Withdrew prior to dosing|9
4700348|NCT02694978|7616329|FG001|Overall Study|Other-Withdrew prior to dosing|8
4700349|NCT02695329|7616341|FG000|Overall Study|Adverse Event|1
4700350|NCT02695329|7616342|FG001|Overall Study|Adverse Event|0
4700351|NCT02695329|7616341|FG000|Overall Study|Poor X-ray quality for measurement|4
4700352|NCT02695329|7616342|FG001|Overall Study|Poor X-ray quality for measurement|5
4700353|NCT02695420|7616352|FG000|Overall Study|Death|0
4700354|NCT02695420|7616353|FG001|Overall Study|Death|1
4700355|NCT02695420|7616354|FG002|Overall Study|Death|0
4700356|NCT02695420|7616355|FG003|Overall Study|Death|0
4700357|NCT02695524|7616374|FG000|Overall Study|Lost to Follow-up|3
4700358|NCT02695524|7616375|FG001|Overall Study|Lost to Follow-up|2
4700359|NCT02695524|7616374|FG000|Overall Study|Death|0
4700360|NCT02695524|7616375|FG001|Overall Study|Death|1
4700361|NCT02695537|7616381|FG000|Overall Study|Adverse Event|3
4700362|NCT02695537|7616381|FG000|Overall Study|Lack of Efficacy|28
4700363|NCT02695537|7616381|FG000|Overall Study|Withdrawal by Subject|4
4700364|NCT02695537|7616381|FG000|Overall Study|Protocol Violation|3
4700365|NCT02695628|7616385|FG000|Overall Study|Withdrawal by Subject|1
4700366|NCT02695719|7616391|FG000|Overall Study|Pretreatment Event/Adverse Event|2
4700367|NCT02695719|7616392|FG001|Overall Study|Pretreatment Event/Adverse Event|9
4700368|NCT02695719|7616391|FG000|Overall Study|Significant Protocol Deviation|0
4700369|NCT02695719|7616392|FG001|Overall Study|Significant Protocol Deviation|1
4700370|NCT02695719|7616391|FG000|Overall Study|Voluntary Withdrawal|1
4700371|NCT02695719|7616392|FG001|Overall Study|Voluntary Withdrawal|0
4771211|NCT04250077|7748051|FG002|Overall Study|Lost to Follow-up|0
4480106|NCT00715403|7278053|FG004|Overall Study|Progressive disease|5
4480107|NCT00715403|7278054|FG005|Overall Study|Progressive disease|14
4480108|NCT00715403|7278055|FG006|Overall Study|Progressive disease|1
4480109|NCT00715403|7278049|FG000|Overall Study|Dose limiting Toxicity (DLT)|0
4480110|NCT00715403|7278050|FG001|Overall Study|Dose limiting Toxicity (DLT)|0
4771212|NCT03296553|7748104|FG000|Overall Study|Withdrawal by Subject|1
4771213|NCT03296553|7748105|FG001|Overall Study|Withdrawal by Subject|1
4771214|NCT03296553|7748104|FG000|Overall Study|Death|1
4771215|NCT03296553|7748105|FG001|Overall Study|Death|0
4771216|NCT03148795|7748111|FG000|Overall Study|Death|6
4771217|NCT03148795|7748111|FG000|Overall Study|Adverse Event|5
4771218|NCT03148795|7748111|FG000|Overall Study|Other|15
4771219|NCT03148795|7748111|FG000|Overall Study|No Longer Clinically Benefitting|2
4771220|NCT03148795|7748111|FG000|Overall Study|Global Deterioration Of Health Status|6
4771221|NCT03148795|7748111|FG000|Overall Study|Withdrawal by Subject|2
4771222|NCT03148795|7748111|FG000|Overall Study|Progressive Disease|62
4771223|NCT03148795|7748111|FG000|Overall Study|Ongoing|30
4771224|NCT03000569|7748117|FG000|Overall Study|Withdrawal by Subject|1
4771225|NCT03000569|7748118|FG001|Overall Study|Withdrawal by Subject|0
4771226|NCT03000530|7748135|FG000|Overall Study|Adverse Event|0
4771227|NCT03000530|7748136|FG001|Overall Study|Adverse Event|0
4771228|NCT03000530|7748137|FG002|Overall Study|Adverse Event|2
4771229|NCT03000530|7748135|FG000|Overall Study|Lost to Follow-up|0
4771230|NCT03000530|7748136|FG001|Overall Study|Lost to Follow-up|3
4771231|NCT03000530|7748137|FG002|Overall Study|Lost to Follow-up|1
4771232|NCT03000530|7748135|FG000|Overall Study|Withdrawal by Subject|0
4771233|NCT03000530|7748136|FG001|Overall Study|Withdrawal by Subject|2
4700411|NCT02696317|7616448|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2
4700412|NCT02696317|7616449|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4
4700413|NCT02696317|7616448|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1
4700414|NCT02696317|7616449|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0
4700415|NCT02696434|7616459|FG000|Overall Study|Adverse Event|3
4700416|NCT02696434|7616460|FG001|Overall Study|Adverse Event|1
4700417|NCT02696434|7616459|FG000|Overall Study|Lost to Follow-up|5
4700418|NCT02696434|7616460|FG001|Overall Study|Lost to Follow-up|4
4700419|NCT02696434|7616459|FG000|Overall Study|Withdrawal by Subject|14
4700420|NCT02696434|7616460|FG001|Overall Study|Withdrawal by Subject|12
4700421|NCT02696434|7616459|FG000|Overall Study|Physician Decision|0
4700422|NCT02696434|7616460|FG001|Overall Study|Physician Decision|1
4700423|NCT02696785|7616470|FG000|Blinded Treatment Period|Adverse Event|0
4700424|NCT02696785|7616471|FG001|Blinded Treatment Period|Adverse Event|1
4700425|NCT02696785|7616472|FG002|Blinded Treatment Period|Adverse Event|3
4700426|NCT02696785|7616473|FG003|Blinded Treatment Period|Adverse Event|0
4700427|NCT02696785|7616470|FG000|Blinded Treatment Period|Withdrawal by Subject|0
4700428|NCT02696785|7616471|FG001|Blinded Treatment Period|Withdrawal by Subject|1
4700429|NCT02696785|7616472|FG002|Blinded Treatment Period|Withdrawal by Subject|1
4700430|NCT02696785|7616473|FG003|Blinded Treatment Period|Withdrawal by Subject|2
4700431|NCT02696785|7616470|FG000|Blinded Treatment Period|Lack of Efficacy|0
4700432|NCT02696785|7616471|FG001|Blinded Treatment Period|Lack of Efficacy|0
4700433|NCT02696785|7616472|FG002|Blinded Treatment Period|Lack of Efficacy|0
4700434|NCT02696785|7616473|FG003|Blinded Treatment Period|Lack of Efficacy|1
4700435|NCT02696785|7616470|FG000|Blinded Treatment Period|Screen Failure|1
4700436|NCT02696785|7616471|FG001|Blinded Treatment Period|Screen Failure|0
4700437|NCT02696785|7616472|FG002|Blinded Treatment Period|Screen Failure|0
4700438|NCT02696785|7616473|FG003|Blinded Treatment Period|Screen Failure|0
4700439|NCT02696785|7616470|FG000|Washout Period|Withdrawal by Subject|0
4700440|NCT02696785|7616471|FG001|Washout Period|Withdrawal by Subject|1
4700441|NCT02696785|7616472|FG002|Washout Period|Withdrawal by Subject|0
4700442|NCT02696785|7616473|FG003|Washout Period|Withdrawal by Subject|0
4700443|NCT02696785|7616470|FG000|Washout Period|Lack of Efficacy|0
4700444|NCT02696785|7616471|FG001|Washout Period|Lack of Efficacy|1
4700445|NCT02696785|7616472|FG002|Washout Period|Lack of Efficacy|0
4700446|NCT02696785|7616473|FG003|Washout Period|Lack of Efficacy|0
4700447|NCT02696785|7616470|FG000|Extended Treatment Period|Adverse Event|2
4700448|NCT02696785|7616471|FG001|Extended Treatment Period|Adverse Event|3
4700449|NCT02696785|7616472|FG002|Extended Treatment Period|Adverse Event|2
4700450|NCT02696785|7616473|FG003|Extended Treatment Period|Adverse Event|1
4700451|NCT02696785|7616470|FG000|Extended Treatment Period|Lack of Efficacy|0
4700452|NCT02696785|7616471|FG001|Extended Treatment Period|Lack of Efficacy|1
4700453|NCT02696785|7616472|FG002|Extended Treatment Period|Lack of Efficacy|0
4700454|NCT02696785|7616473|FG003|Extended Treatment Period|Lack of Efficacy|0
4700455|NCT02696785|7616470|FG000|Extended Treatment Period|Withdrawal by Subject|1
4700456|NCT02696785|7616471|FG001|Extended Treatment Period|Withdrawal by Subject|2
4700457|NCT02696785|7616472|FG002|Extended Treatment Period|Withdrawal by Subject|3
4700458|NCT02696785|7616473|FG003|Extended Treatment Period|Withdrawal by Subject|5
4700459|NCT02696785|7616470|FG000|Follow-up Period|Adverse Event|0
4700460|NCT02696785|7616471|FG001|Follow-up Period|Adverse Event|0
4700461|NCT02696785|7616472|FG002|Follow-up Period|Adverse Event|8
4700462|NCT02696785|7616473|FG003|Follow-up Period|Adverse Event|2
4700463|NCT02696785|7616470|FG000|Follow-up Period|Lost to Follow-up|0
4700464|NCT02696785|7616471|FG001|Follow-up Period|Lost to Follow-up|0
4700465|NCT02696785|7616472|FG002|Follow-up Period|Lost to Follow-up|0
4700466|NCT02696785|7616473|FG003|Follow-up Period|Lost to Follow-up|1
4700467|NCT02696785|7616470|FG000|Follow-up Period|Lack of Efficacy|0
4700468|NCT02696785|7616471|FG001|Follow-up Period|Lack of Efficacy|0
4700469|NCT02696785|7616472|FG002|Follow-up Period|Lack of Efficacy|0
4700470|NCT02696785|7616473|FG003|Follow-up Period|Lack of Efficacy|1
4480111|NCT00715403|7278051|FG002|Overall Study|Dose limiting Toxicity (DLT)|0
4480112|NCT00715403|7278052|FG003|Overall Study|Dose limiting Toxicity (DLT)|0
4480113|NCT00715403|7278053|FG004|Overall Study|Dose limiting Toxicity (DLT)|0
4480114|NCT00715403|7278054|FG005|Overall Study|Dose limiting Toxicity (DLT)|1
4480115|NCT00715403|7278055|FG006|Overall Study|Dose limiting Toxicity (DLT)|0
4480116|NCT00715403|7278049|FG000|Overall Study|Other Adverse Event than DLT|1
4480117|NCT00715403|7278050|FG001|Overall Study|Other Adverse Event than DLT|0
4480118|NCT00715403|7278051|FG002|Overall Study|Other Adverse Event than DLT|0
4480119|NCT00715403|7278052|FG003|Overall Study|Other Adverse Event than DLT|0
4480120|NCT00715403|7278053|FG004|Overall Study|Other Adverse Event than DLT|0
4480121|NCT00715403|7278054|FG005|Overall Study|Other Adverse Event than DLT|2
4480122|NCT00715403|7278055|FG006|Overall Study|Other Adverse Event than DLT|0
4480123|NCT00715403|7278049|FG000|Overall Study|Protocol Violation|0
4480124|NCT00715403|7278050|FG001|Overall Study|Protocol Violation|0
4480125|NCT00715403|7278051|FG002|Overall Study|Protocol Violation|0
4480126|NCT00715403|7278052|FG003|Overall Study|Protocol Violation|0
4480127|NCT00715403|7278053|FG004|Overall Study|Protocol Violation|0
4480128|NCT00715403|7278054|FG005|Overall Study|Protocol Violation|1
4480129|NCT00715403|7278055|FG006|Overall Study|Protocol Violation|0
4480130|NCT00715403|7278049|FG000|Overall Study|Other reason not defined above|0
4480131|NCT00715403|7278050|FG001|Overall Study|Other reason not defined above|0
4480132|NCT00715403|7278051|FG002|Overall Study|Other reason not defined above|1
4480133|NCT00715403|7278052|FG003|Overall Study|Other reason not defined above|0
4480134|NCT00715403|7278053|FG004|Overall Study|Other reason not defined above|1
4480135|NCT00715403|7278054|FG005|Overall Study|Other reason not defined above|1
4480136|NCT00715403|7278055|FG006|Overall Study|Other reason not defined above|0
4480137|NCT00715429|7278073|FG000|Overall Study|Did not complete the study diary|0
4480138|NCT00715429|7278074|FG001|Overall Study|Did not complete the study diary|1
4480139|NCT00715520|7278083|FG000|Overall Study|Screen failure|8
4480140|NCT00715520|7278084|FG001|Overall Study|Screen failure|1
4480141|NCT00715520|7278085|FG002|Overall Study|Screen failure|1
4480142|NCT00715520|7278083|FG000|Overall Study|Withdrawal by Subject|2
4480143|NCT00715520|7278084|FG001|Overall Study|Withdrawal by Subject|0
4480144|NCT00715520|7278085|FG002|Overall Study|Withdrawal by Subject|1
4700471|NCT02696785|7616470|FG000|Follow-up Period|Withdrawal by Subject|1
4700472|NCT02696785|7616471|FG001|Follow-up Period|Withdrawal by Subject|0
4700473|NCT02696785|7616472|FG002|Follow-up Period|Withdrawal by Subject|5
4700474|NCT02696785|7616473|FG003|Follow-up Period|Withdrawal by Subject|4
4700475|NCT02696798|7616504|FG000|Blinded Treatment Dosing Period|Adverse Event|2
4700476|NCT02696798|7616505|FG001|Blinded Treatment Dosing Period|Adverse Event|9
4700477|NCT02696798|7616506|FG002|Blinded Treatment Dosing Period|Adverse Event|2
4700478|NCT02696798|7616504|FG000|Blinded Treatment Dosing Period|Death|0
4700479|NCT02696798|7616505|FG001|Blinded Treatment Dosing Period|Death|0
4700480|NCT02696798|7616506|FG002|Blinded Treatment Dosing Period|Death|1
4700481|NCT02696798|7616504|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2
4700482|NCT02696798|7616505|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1
4700483|NCT02696798|7616506|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1
4700484|NCT02696798|7616504|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0
4700485|NCT02696798|7616505|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1
4700486|NCT02696798|7616506|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0
4700487|NCT02696798|7616504|FG000|Blinded Treatment Dosing Period|Physician Decision|0
4700488|NCT02696798|7616505|FG001|Blinded Treatment Dosing Period|Physician Decision|1
4700489|NCT02696798|7616506|FG002|Blinded Treatment Dosing Period|Physician Decision|0
4700490|NCT02696798|7616504|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7
4700491|NCT02696798|7616505|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3
4700492|NCT02696798|7616506|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4
4700493|NCT02696798|7616504|FG000|Extended Treatment Period|Adverse Event|1
4700494|NCT02696798|7616505|FG001|Extended Treatment Period|Adverse Event|4
4700495|NCT02696798|7616506|FG002|Extended Treatment Period|Adverse Event|5
4700496|NCT02696798|7616504|FG000|Extended Treatment Period|Lack of Efficacy|7
4700497|NCT02696798|7616505|FG001|Extended Treatment Period|Lack of Efficacy|2
4700498|NCT02696798|7616506|FG002|Extended Treatment Period|Lack of Efficacy|2
4700499|NCT02696798|7616504|FG000|Extended Treatment Period|Lost to Follow-up|1
4700500|NCT02696798|7616505|FG001|Extended Treatment Period|Lost to Follow-up|0
4700501|NCT02696798|7616506|FG002|Extended Treatment Period|Lost to Follow-up|0
4700502|NCT02696798|7616504|FG000|Extended Treatment Period|Physician Decision|0
4700503|NCT02696798|7616505|FG001|Extended Treatment Period|Physician Decision|1
4700504|NCT02696798|7616506|FG002|Extended Treatment Period|Physician Decision|0
4700505|NCT02696798|7616504|FG000|Extended Treatment Period|Withdrawal by Subject|3
4700506|NCT02696798|7616505|FG001|Extended Treatment Period|Withdrawal by Subject|2
4700507|NCT02696798|7616506|FG002|Extended Treatment Period|Withdrawal by Subject|3
4480145|NCT00715559|7278093|FG000|Overall Study|medication not tolerated - nausea|1
4480146|NCT00715624|7278099|FG000|Overall Study|Adverse Event|12
4480147|NCT00715624|7278100|FG001|Overall Study|Adverse Event|37
4480148|NCT00715624|7278099|FG000|Overall Study|Lack of Efficacy|11
4480149|NCT00715624|7278100|FG001|Overall Study|Lack of Efficacy|11
4480150|NCT00715624|7278099|FG000|Overall Study|Lost to Follow-up|1
4480151|NCT00715624|7278100|FG001|Overall Study|Lost to Follow-up|2
4480152|NCT00715624|7278099|FG000|Overall Study|Protocol Violation|1
4480153|NCT00715624|7278100|FG001|Overall Study|Protocol Violation|0
4480154|NCT00715624|7278099|FG000|Overall Study|Withdrawal by Subject|11
4480155|NCT00715624|7278100|FG001|Overall Study|Withdrawal by Subject|25
4480156|NCT00715624|7278099|FG000|Overall Study|Familial and personal reasons|10
4480157|NCT00715624|7278100|FG001|Overall Study|Familial and personal reasons|22
4480158|NCT00715624|7278099|FG000|Overall Study|Poor compliance|6
4480159|NCT00715624|7278100|FG001|Overall Study|Poor compliance|13
4480160|NCT00715624|7278099|FG000|Overall Study|Sponsor decision|0
4480161|NCT00715624|7278100|FG001|Overall Study|Sponsor decision|4
4480162|NCT00715624|7278099|FG000|Overall Study|Incorrect randomization (not treated)|0
4480163|NCT00715624|7278100|FG001|Overall Study|Incorrect randomization (not treated)|1
4480164|NCT00715624|7278099|FG000|Overall Study|Other|0
4480165|NCT00715624|7278100|FG001|Overall Study|Other|1
4480166|NCT00715676|7278118|FG000|Overall Study|Adverse Event|3
4480167|NCT00715676|7278119|FG001|Overall Study|Adverse Event|5
4480168|NCT00715676|7278120|FG002|Overall Study|Adverse Event|21
4480169|NCT00715676|7278118|FG000|Overall Study|Withdrawal by Subject|1
4480170|NCT00715676|7278119|FG001|Overall Study|Withdrawal by Subject|3
4480171|NCT00715676|7278120|FG002|Overall Study|Withdrawal by Subject|8
4480172|NCT00715676|7278118|FG000|Overall Study|Lost to Follow-up|1
4480173|NCT00715676|7278119|FG001|Overall Study|Lost to Follow-up|2
4480174|NCT00715676|7278120|FG002|Overall Study|Lost to Follow-up|1
4480175|NCT00715676|7278118|FG000|Overall Study|Terminated by Sponsor|1
4480176|NCT00715676|7278119|FG001|Overall Study|Terminated by Sponsor|0
4480177|NCT00715676|7278120|FG002|Overall Study|Terminated by Sponsor|0
4480178|NCT00715676|7278118|FG000|Overall Study|Did Not Meet Entry Criteria|0
4480179|NCT00715676|7278119|FG001|Overall Study|Did Not Meet Entry Criteria|0
4480180|NCT00715676|7278120|FG002|Overall Study|Did Not Meet Entry Criteria|1
4480181|NCT00715676|7278118|FG000|Overall Study|Use of Exclusionary Medication|0
4700508|NCT02696798|7616504|FG000|Post-treatment Follow-up Period|Adverse Event|2
4700509|NCT02696798|7616505|FG001|Post-treatment Follow-up Period|Adverse Event|12
4700510|NCT02696798|7616506|FG002|Post-treatment Follow-up Period|Adverse Event|6
4700511|NCT02696798|7616504|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0
4700512|NCT02696798|7616505|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1
4700513|NCT02696798|7616506|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1
4700514|NCT02696798|7616504|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1
4700515|NCT02696798|7616505|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2
4700516|NCT02696798|7616506|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0
4700517|NCT02696798|7616504|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2
4700518|NCT02696798|7616505|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8
4700519|NCT02696798|7616506|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12
4700520|NCT02696798|7616504|FG000|Post-treatment Follow-up Period|Physician Decision|0
4700521|NCT02696798|7616505|FG001|Post-treatment Follow-up Period|Physician Decision|2
4700522|NCT02696798|7616506|FG002|Post-treatment Follow-up Period|Physician Decision|0
4700523|NCT02696798|7616504|FG000|Post-treatment Follow-up Period|No progressive improvement|0
4700524|NCT02696798|7616505|FG001|Post-treatment Follow-up Period|No progressive improvement|1
4700525|NCT02696798|7616506|FG002|Post-treatment Follow-up Period|No progressive improvement|0
4700526|NCT02696850|7616530|FG000|Overall Study|Withdrawal by Subject|3
4700527|NCT02696850|7616531|FG001|Overall Study|Withdrawal by Subject|3
4700528|NCT02696850|7616530|FG000|Overall Study|Lost to Follow-up|8
4700529|NCT02696850|7616531|FG001|Overall Study|Lost to Follow-up|5
4700530|NCT02696902|7616540|FG000|Overall Study|Lost to Follow-up|0
4700531|NCT02696902|7616541|FG001|Overall Study|Lost to Follow-up|1
4700532|NCT02696902|7616542|FG002|Overall Study|Lost to Follow-up|1
4700533|NCT02696902|7616540|FG000|Overall Study|Withdrawal by Subject|0
4700534|NCT02696902|7616541|FG001|Overall Study|Withdrawal by Subject|0
4700535|NCT02696902|7616542|FG002|Overall Study|Withdrawal by Subject|1
4700536|NCT02696902|7616540|FG000|Overall Study|Death|19
4700537|NCT02696902|7616541|FG001|Overall Study|Death|3
4700538|NCT02696902|7616542|FG002|Overall Study|Death|24
4700539|NCT02696902|7616540|FG000|Overall Study|Participant not fit post-randomization|0
4700540|NCT02696902|7616541|FG001|Overall Study|Participant not fit post-randomization|0
4700541|NCT02696902|7616542|FG002|Overall Study|Participant not fit post-randomization|1
4700542|NCT02696902|7616540|FG000|Overall Study|Participant not eligible (negative PCR)|0
4700543|NCT02696902|7616541|FG001|Overall Study|Participant not eligible (negative PCR)|0
4700544|NCT02696902|7616542|FG002|Overall Study|Participant not eligible (negative PCR)|1
4700545|NCT02696902|7616540|FG000|Overall Study|Principal investigator's decision|1
4700546|NCT02696902|7616541|FG001|Overall Study|Principal investigator's decision|0
4700547|NCT02696902|7616542|FG002|Overall Study|Principal investigator's decision|0
4700548|NCT02696902|7616540|FG000|Overall Study|Sponsor's decision|1
4700549|NCT02696902|7616541|FG001|Overall Study|Sponsor's decision|0
4700550|NCT02696902|7616542|FG002|Overall Study|Sponsor's decision|0
4480182|NCT00715676|7278119|FG001|Overall Study|Use of Exclusionary Medication|0
4480183|NCT00715676|7278120|FG002|Overall Study|Use of Exclusionary Medication|1
4480184|NCT00715676|7278118|FG000|Overall Study|Elevated Blood Glucose|0
4480185|NCT00715676|7278119|FG001|Overall Study|Elevated Blood Glucose|1
4480186|NCT00715676|7278120|FG002|Overall Study|Elevated Blood Glucose|0
4516923|NCT00962104|7328424|FG000|Overall Study|Sponsor Decision|0
4480187|NCT00715793|7278160|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1
4480188|NCT00715793|7278161|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0
4480189|NCT00715793|7278160|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0
4480190|NCT00715793|7278161|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2
4480191|NCT00715910|7278181|FG000|Booster and ESFU Phase|Lost to Follow-up|0
4480192|NCT00715910|7278182|FG001|Booster and ESFU Phase|Lost to Follow-up|0
4480193|NCT00715910|7278183|FG002|Booster and ESFU Phase|Lost to Follow-up|0
4480194|NCT00715910|7278184|FG003|Booster and ESFU Phase|Lost to Follow-up|6
4480195|NCT00715910|7278185|FG004|Booster and ESFU Phase|Lost to Follow-up|1
4480196|NCT00715910|7278186|FG005|Booster and ESFU Phase|Lost to Follow-up|13
4480197|NCT00715910|7278181|FG000|Booster and ESFU Phase|Other|0
4480198|NCT00715910|7278182|FG001|Booster and ESFU Phase|Other|0
4480199|NCT00715910|7278183|FG002|Booster and ESFU Phase|Other|0
4480200|NCT00715910|7278184|FG003|Booster and ESFU Phase|Other|5
4480201|NCT00715910|7278185|FG004|Booster and ESFU Phase|Other|1
4480202|NCT00715910|7278186|FG005|Booster and ESFU Phase|Other|0
4480203|NCT00715949|7278202|FG000|Overall Study|could not finish first test|4
4480204|NCT00716092|7278228|FG000|Overall Study|Other incl. Lack of Efficacy|2
4480205|NCT00716092|7278229|FG001|Overall Study|Other incl. Lack of Efficacy|1
4480206|NCT00716092|7278230|FG002|Overall Study|Other incl. Lack of Efficacy|0
4480207|NCT00716144|7278242|FG000|Overall Study|Withdrawal by Subject|4
4480208|NCT00716144|7278243|FG001|Overall Study|Withdrawal by Subject|2
4700551|NCT02696902|7616540|FG000|Overall Study|Transferred to other hospital|1
4700552|NCT02696902|7616541|FG001|Overall Study|Transferred to other hospital|0
4700553|NCT02696902|7616542|FG002|Overall Study|Transferred to other hospital|0
4700554|NCT02697435|7616621|FG000|Overall Study|Withdrawal by Subject|1
4700555|NCT02697435|7616622|FG001|Overall Study|Withdrawal by Subject|0
4700556|NCT02697435|7616621|FG000|Overall Study|Physician Decision|0
4700557|NCT02697435|7616622|FG001|Overall Study|Physician Decision|4
4700558|NCT02697591|7616639|FG000|Overall Study|Lost to Follow-up|0
4700559|NCT02697591|7616640|FG001|Overall Study|Lost to Follow-up|0
4700560|NCT02697591|7616641|FG002|Overall Study|Lost to Follow-up|0
4700561|NCT02697591|7616642|FG003|Overall Study|Lost to Follow-up|0
4700562|NCT02697591|7616643|FG004|Overall Study|Lost to Follow-up|0
4700563|NCT02697591|7616644|FG005|Overall Study|Lost to Follow-up|1
4700564|NCT02697591|7616645|FG006|Overall Study|Lost to Follow-up|1
4700565|NCT02697591|7616646|FG007|Overall Study|Lost to Follow-up|0
4700566|NCT02697591|7616647|FG008|Overall Study|Lost to Follow-up|0
4700567|NCT02697591|7616648|FG009|Overall Study|Lost to Follow-up|1
4700568|NCT02697591|7616639|FG000|Overall Study|Withdrawal by Subject|1
4700569|NCT02697591|7616640|FG001|Overall Study|Withdrawal by Subject|1
4700570|NCT02697591|7616641|FG002|Overall Study|Withdrawal by Subject|2
4700571|NCT02697591|7616642|FG003|Overall Study|Withdrawal by Subject|1
4700572|NCT02697591|7616643|FG004|Overall Study|Withdrawal by Subject|7
4700573|NCT02697591|7616644|FG005|Overall Study|Withdrawal by Subject|6
4700574|NCT02697591|7616645|FG006|Overall Study|Withdrawal by Subject|9
4700575|NCT02697591|7616646|FG007|Overall Study|Withdrawal by Subject|1
4700576|NCT02697591|7616647|FG008|Overall Study|Withdrawal by Subject|6
4700577|NCT02697591|7616648|FG009|Overall Study|Withdrawal by Subject|10
4700578|NCT02697591|7616639|FG000|Overall Study|Physician Decision|1
4700579|NCT02697591|7616640|FG001|Overall Study|Physician Decision|0
4700580|NCT02697591|7616641|FG002|Overall Study|Physician Decision|0
4700581|NCT02697591|7616642|FG003|Overall Study|Physician Decision|0
4700582|NCT02697591|7616643|FG004|Overall Study|Physician Decision|1
4700583|NCT02697591|7616644|FG005|Overall Study|Physician Decision|2
4700584|NCT02697591|7616645|FG006|Overall Study|Physician Decision|0
4700585|NCT02697591|7616646|FG007|Overall Study|Physician Decision|0
4700586|NCT02697591|7616647|FG008|Overall Study|Physician Decision|1
4700587|NCT02697591|7616648|FG009|Overall Study|Physician Decision|1
4700588|NCT02697591|7616639|FG000|Overall Study|Death|2
4700589|NCT02697591|7616640|FG001|Overall Study|Death|3
4700590|NCT02697591|7616641|FG002|Overall Study|Death|1
4700591|NCT02697591|7616642|FG003|Overall Study|Death|1
4700592|NCT02697591|7616643|FG004|Overall Study|Death|4
4700593|NCT02697591|7616644|FG005|Overall Study|Death|5
4700594|NCT02697591|7616645|FG006|Overall Study|Death|3
4700595|NCT02697591|7616646|FG007|Overall Study|Death|1
4700596|NCT02697591|7616647|FG008|Overall Study|Death|1
4700597|NCT02697591|7616648|FG009|Overall Study|Death|5
4700598|NCT02697591|7616639|FG000|Overall Study|Reason not Specified|0
4700599|NCT02697591|7616640|FG001|Overall Study|Reason not Specified|0
4700600|NCT02697591|7616641|FG002|Overall Study|Reason not Specified|0
4700601|NCT02697591|7616642|FG003|Overall Study|Reason not Specified|1
4700602|NCT02697591|7616643|FG004|Overall Study|Reason not Specified|1
4700603|NCT02697591|7616644|FG005|Overall Study|Reason not Specified|2
4700604|NCT02697591|7616645|FG006|Overall Study|Reason not Specified|3
4480209|NCT00716144|7278244|FG002|Overall Study|Withdrawal by Subject|6
4480210|NCT00716144|7278245|FG003|Overall Study|Withdrawal by Subject|6
4480211|NCT00716144|7278242|FG000|Overall Study|Lost to Follow-up|2
4480212|NCT00716144|7278243|FG001|Overall Study|Lost to Follow-up|2
4700605|NCT02697591|7616646|FG007|Overall Study|Reason not Specified|1
4700606|NCT02697591|7616647|FG008|Overall Study|Reason not Specified|1
4700607|NCT02697591|7616648|FG009|Overall Study|Reason not Specified|3
4700608|NCT02697617|7616671|FG000|Overall Study|Withdrawal by Subject|0
4480213|NCT00716144|7278244|FG002|Overall Study|Lost to Follow-up|1
4589641|NCT01514136|7435060|FG006|Test Period 1; Test B|Withdrawal by Subject|0
4589642|NCT01514136|7435061|FG007|Test Period 1; Test B|Withdrawal by Subject|0
4589643|NCT01514136|7435054|FG000|Test Period 1; Test D|Subject took a break due to holiday|0
4589644|NCT01514136|7435055|FG001|Test Period 1; Test D|Subject took a break due to holiday|0
4589645|NCT01514136|7435056|FG002|Test Period 1; Test D|Subject took a break due to holiday|0
4700609|NCT02697617|7616672|FG001|Overall Study|Withdrawal by Subject|2
4700610|NCT02697617|7616671|FG000|Overall Study|Pregnancy|1
4700611|NCT02697617|7616672|FG001|Overall Study|Pregnancy|0
4700612|NCT02697734|7616684|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4
4700613|NCT02697734|7616685|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0
4700614|NCT02697734|7616684|FG000|Core Phase - up to Week 48|Adverse Event|1
4700615|NCT02697734|7616685|FG001|Core Phase - up to Week 48|Adverse Event|2
4700616|NCT02697734|7616684|FG000|Core Phase - up to Week 48|Physician Decision|1
4700617|NCT02697734|7616685|FG001|Core Phase - up to Week 48|Physician Decision|0
4700618|NCT02697734|7616684|FG000|Optional Extension Phase|Adverse Event|5
4700619|NCT02697734|7616685|FG001|Optional Extension Phase|Adverse Event|1
4700620|NCT02697734|7616684|FG000|Optional Extension Phase|Physician Decision|0
4700621|NCT02697734|7616685|FG001|Optional Extension Phase|Physician Decision|1
4700622|NCT02697773|7616702|FG000|Overall Study|Adverse Event|2
4700623|NCT02697773|7616703|FG001|Overall Study|Adverse Event|1
4700624|NCT02697773|7616704|FG002|Overall Study|Adverse Event|2
4700625|NCT02697773|7616702|FG000|Overall Study|Death|0
4700626|NCT02697773|7616703|FG001|Overall Study|Death|0
4700627|NCT02697773|7616704|FG002|Overall Study|Death|2
4589646|NCT01514136|7435057|FG003|Test Period 1; Test D|Subject took a break due to holiday|2
4589647|NCT01514136|7435058|FG004|Test Period 1; Test D|Subject took a break due to holiday|0
4700628|NCT02697773|7616702|FG000|Overall Study|Lack of Efficacy|4
4700629|NCT02697773|7616703|FG001|Overall Study|Lack of Efficacy|6
4700630|NCT02697773|7616704|FG002|Overall Study|Lack of Efficacy|6
4700631|NCT02697773|7616702|FG000|Overall Study|Lost to Follow-up|5
4700632|NCT02697773|7616703|FG001|Overall Study|Lost to Follow-up|5
4700633|NCT02697773|7616704|FG002|Overall Study|Lost to Follow-up|7
4700634|NCT02697773|7616702|FG000|Overall Study|Other|15
4700635|NCT02697773|7616703|FG001|Overall Study|Other|11
4700636|NCT02697773|7616704|FG002|Overall Study|Other|10
4700637|NCT02697773|7616702|FG000|Overall Study|Protocol Violation|1
4700638|NCT02697773|7616703|FG001|Overall Study|Protocol Violation|1
4700639|NCT02697773|7616704|FG002|Overall Study|Protocol Violation|0
4700640|NCT02697773|7616702|FG000|Overall Study|Withdrawal by Subject|10
4700641|NCT02697773|7616703|FG001|Overall Study|Withdrawal by Subject|13
4700642|NCT02697773|7616704|FG002|Overall Study|Withdrawal by Subject|13
4700643|NCT02697773|7616702|FG000|Overall Study|Randomized but not treated|1
4700644|NCT02697773|7616703|FG001|Overall Study|Randomized but not treated|1
4700645|NCT02697773|7616704|FG002|Overall Study|Randomized but not treated|0
4700646|NCT02697916|7616723|FG000|Overall Study|Death|357
4700647|NCT02697916|7616724|FG001|Overall Study|Death|315
4700648|NCT02697916|7616723|FG000|Overall Study|Withdrawal by Subject|221
4700649|NCT02697916|7616724|FG001|Overall Study|Withdrawal by Subject|393
4735318|NCT03526861|7683204|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
4735319|NCT03526861|7683205|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
4735320|NCT03526861|7683206|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
4735321|NCT03526861|7683207|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1
4735322|NCT03526861|7683208|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
4735323|NCT03526861|7683209|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
4735324|NCT03526861|7683210|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
4735325|NCT03526861|7683211|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
4735326|NCT03526861|7683212|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
4735327|NCT03526861|7683204|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
4735328|NCT03526861|7683205|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
4589648|NCT01514136|7435059|FG005|Test Period 1; Test D|Subject took a break due to holiday|0
4589649|NCT01514136|7435060|FG006|Test Period 1; Test D|Subject took a break due to holiday|0
4589650|NCT01514136|7435061|FG007|Test Period 1; Test D|Subject took a break due to holiday|0
4589651|NCT01514136|7435054|FG000|Test Period 2; Test A*|Adverse Event|0
4589652|NCT01514136|7435055|FG001|Test Period 2; Test A*|Adverse Event|0
4589653|NCT01514136|7435056|FG002|Test Period 2; Test A*|Adverse Event|0
4589654|NCT01514136|7435057|FG003|Test Period 2; Test A*|Adverse Event|0
4589655|NCT01514136|7435058|FG004|Test Period 2; Test A*|Adverse Event|1
4589656|NCT01514136|7435059|FG005|Test Period 2; Test A*|Adverse Event|0
4589657|NCT01514136|7435060|FG006|Test Period 2; Test A*|Adverse Event|0
4589658|NCT01514136|7435061|FG007|Test Period 2; Test A*|Adverse Event|0
4589659|NCT01514136|7435054|FG000|Test Period 2; Test A*|Holiday|0
4589660|NCT01514136|7435055|FG001|Test Period 2; Test A*|Holiday|0
4589661|NCT01514136|7435056|FG002|Test Period 2; Test A*|Holiday|0
4589662|NCT01514136|7435057|FG003|Test Period 2; Test A*|Holiday|0
4589663|NCT01514136|7435058|FG004|Test Period 2; Test A*|Holiday|1
4589664|NCT01514136|7435059|FG005|Test Period 2; Test A*|Holiday|0
4589665|NCT01514136|7435060|FG006|Test Period 2; Test A*|Holiday|0
4589666|NCT01514136|7435061|FG007|Test Period 2; Test A*|Holiday|0
4589667|NCT01514136|7435054|FG000|Test Period 2; Test B*|Withdrawal by Subject|0
4589668|NCT01514136|7435055|FG001|Test Period 2; Test B*|Withdrawal by Subject|0
4589669|NCT01514136|7435056|FG002|Test Period 2; Test B*|Withdrawal by Subject|0
4589670|NCT01514136|7435057|FG003|Test Period 2; Test B*|Withdrawal by Subject|0
4700650|NCT02698176|7616737|FG000|Overall Study|Progressive disease|4
4700651|NCT02698176|7616738|FG001|Overall Study|Progressive disease|3
4480214|NCT00716144|7278245|FG003|Overall Study|Lost to Follow-up|2
4480215|NCT00716144|7278242|FG000|Overall Study|Adverse Event|0
4480216|NCT00716144|7278243|FG001|Overall Study|Adverse Event|0
4480217|NCT00716144|7278244|FG002|Overall Study|Adverse Event|0
4480218|NCT00716144|7278245|FG003|Overall Study|Adverse Event|2
4480219|NCT00716144|7278242|FG000|Overall Study|Non-compliance|1
4480220|NCT00716144|7278243|FG001|Overall Study|Non-compliance|0
4480221|NCT00716144|7278244|FG002|Overall Study|Non-compliance|0
4480222|NCT00716144|7278245|FG003|Overall Study|Non-compliance|0
4480223|NCT00716144|7278242|FG000|Overall Study|Protocol Violation|2
4480224|NCT00716144|7278243|FG001|Overall Study|Protocol Violation|0
4480225|NCT00716144|7278244|FG002|Overall Study|Protocol Violation|1
4480226|NCT00716144|7278245|FG003|Overall Study|Protocol Violation|0
4480227|NCT00716144|7278242|FG000|Overall Study|Physician Decision|0
4480228|NCT00716144|7278243|FG001|Overall Study|Physician Decision|1
4480229|NCT00716144|7278244|FG002|Overall Study|Physician Decision|2
4480230|NCT00716144|7278245|FG003|Overall Study|Physician Decision|2
4480231|NCT00716144|7278242|FG000|Overall Study|Intercurrent illness|0
4480232|NCT00716144|7278243|FG001|Overall Study|Intercurrent illness|0
4700652|NCT02698176|7616739|FG002|Overall Study|Progressive disease|1
4700653|NCT02698176|7616740|FG003|Overall Study|Progressive disease|0
4700654|NCT02698176|7616737|FG000|Overall Study|Adverse Event|2
4700655|NCT02698176|7616738|FG001|Overall Study|Adverse Event|0
4700656|NCT02698176|7616739|FG002|Overall Study|Adverse Event|0
4700657|NCT02698176|7616740|FG003|Overall Study|Adverse Event|0
4700658|NCT02698176|7616737|FG000|Overall Study|Clinical progression|3
4700659|NCT02698176|7616738|FG001|Overall Study|Clinical progression|0
4700660|NCT02698176|7616739|FG002|Overall Study|Clinical progression|0
4700661|NCT02698176|7616740|FG003|Overall Study|Clinical progression|0
4700662|NCT02698189|7616753|FG000|Overall Study|Progressive disease|3
4700663|NCT02698189|7616754|FG001|Overall Study|Progressive disease|5
4700664|NCT02698189|7616753|FG000|Overall Study|Still ongoing in the study|0
4700665|NCT02698189|7616754|FG001|Overall Study|Still ongoing in the study|1
4700666|NCT02698241|7616771|FG000|Overall Study|Inclusion/exclusion criteria not met|4
4700667|NCT02698241|7616771|FG000|Overall Study|Screening not met|7
4700668|NCT02698241|7616771|FG000|Overall Study|Withdrawal by Subject|7
4700669|NCT02698241|7616771|FG000|Overall Study|Physician Decision|2
4700670|NCT02698241|7616771|FG000|Overall Study|Subject underwent system modification|2
4700671|NCT02698241|7616771|FG000|Overall Study|Lost to Follow-up|3
4700672|NCT02698241|7616771|FG000|Overall Study|Subject on inodrip not safe to continue|6
4700673|NCT02698241|7616771|FG000|Overall Study|geographic and licensing issue|1
4700674|NCT02698241|7616771|FG000|Overall Study|Death|2
4700675|NCT02698371|7616775|FG000|All Participants Flow|Lost to Follow-up|3
4700676|NCT02698371|7616775|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3
4700677|NCT02698371|7616775|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3
4700678|NCT02698371|7616775|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3
4700679|NCT02698371|7616775|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3
4700680|NCT02698371|7616775|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3
4700681|NCT02698371|7616775|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2
4700682|NCT02698410|7616791|FG000|Overall Study|Adverse Event|2
4700683|NCT02698410|7616791|FG000|Overall Study|Withdrawal by Subject|1
4700684|NCT02698410|7616791|FG000|Overall Study|Other|1
4700685|NCT02698423|7616797|FG000|Overall Study|Lost to Follow-up|19
4700686|NCT02698423|7616798|FG001|Overall Study|Lost to Follow-up|24
4700687|NCT02698436|7616808|FG000|Overall Study|Adverse Event|1
4700688|NCT02698436|7616809|FG001|Overall Study|Adverse Event|0
4700689|NCT02698436|7616808|FG000|Overall Study|Withdrawal by Subject|3
4700690|NCT02698436|7616809|FG001|Overall Study|Withdrawal by Subject|3
4700691|NCT02698436|7616808|FG000|Overall Study|Lost to Follow-up|2
4700692|NCT02698436|7616809|FG001|Overall Study|Lost to Follow-up|4
4700693|NCT02698436|7616808|FG000|Overall Study|Non-compliance with study regimen|1
4700694|NCT02698436|7616809|FG001|Overall Study|Non-compliance with study regimen|0
4700695|NCT02698475|7616815|FG000|Main Study Period|Lack of Efficacy|1
4480233|NCT00716144|7278244|FG002|Overall Study|Intercurrent illness|1
4480234|NCT00716144|7278245|FG003|Overall Study|Intercurrent illness|0
4480235|NCT00716144|7278242|FG000|Overall Study|Withdrew consent, allowed use of data|0
4480236|NCT00716144|7278243|FG001|Overall Study|Withdrew consent, allowed use of data|0
4480237|NCT00716144|7278244|FG002|Overall Study|Withdrew consent, allowed use of data|1
4480238|NCT00716144|7278245|FG003|Overall Study|Withdrew consent, allowed use of data|0
4516924|NCT00962104|7328425|FG001|Overall Study|Sponsor Decision|1
4480239|NCT00716144|7278242|FG000|Overall Study|Adverse event: left foot pain|0
4480240|NCT00716144|7278243|FG001|Overall Study|Adverse event: left foot pain|1
4480241|NCT00716144|7278244|FG002|Overall Study|Adverse event: left foot pain|0
4480242|NCT00716144|7278245|FG003|Overall Study|Adverse event: left foot pain|0
4480243|NCT00716144|7278242|FG000|Overall Study|Clinical Depression|0
4480244|NCT00716144|7278243|FG001|Overall Study|Clinical Depression|1
4480245|NCT00716144|7278244|FG002|Overall Study|Clinical Depression|0
4480246|NCT00716144|7278245|FG003|Overall Study|Clinical Depression|0
4480247|NCT00716274|7278258|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2
4480248|NCT00716274|7278259|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0
4480249|NCT00716274|7278260|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0
4589671|NCT01514136|7435058|FG004|Test Period 2; Test B*|Withdrawal by Subject|0
4589672|NCT01514136|7435059|FG005|Test Period 2; Test B*|Withdrawal by Subject|2
4589673|NCT01514136|7435060|FG006|Test Period 2; Test B*|Withdrawal by Subject|0
4700696|NCT02698475|7616815|FG000|Main Study Period|Protocol Violation|2
4700697|NCT02698475|7616815|FG000|Long-Term Extension Period|Lost to Follow-up|1
4700698|NCT02698475|7616815|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1
4700699|NCT02698475|7616815|FG000|Long-Term Extension Period|Withdrawal by Subject|3
4700700|NCT02698475|7616815|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22
4700701|NCT02698475|7616815|FG000|Long-Term Extension Period|Other|1
4700702|NCT02698787|7616839|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0
4700703|NCT02698787|7616840|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1
4700704|NCT02699099|7616857|FG000|Overall Study|Adverse Event|1
4700705|NCT02699099|7616858|FG001|Overall Study|Adverse Event|0
4700706|NCT02699099|7616859|FG002|Overall Study|Adverse Event|2
4700707|NCT02699099|7616857|FG000|Overall Study|Lost to Follow-up|0
4700708|NCT02699099|7616858|FG001|Overall Study|Lost to Follow-up|1
4700709|NCT02699099|7616859|FG002|Overall Study|Lost to Follow-up|0
4700710|NCT02699099|7616857|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7
4700711|NCT02699099|7616858|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2
4700712|NCT02699099|7616859|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4
4700713|NCT02699125|7616869|FG000|Placebo|Lost to Follow-up|2
4700714|NCT02699125|7616870|FG001|Placebo|Lost to Follow-up|0
4700715|NCT02699125|7616869|FG000|Placebo|Protocol Violation|1
4700716|NCT02699125|7616870|FG001|Placebo|Protocol Violation|0
4700717|NCT02699125|7616869|FG000|Placebo|Withdrawal by Subject|0
4700718|NCT02699125|7616870|FG001|Placebo|Withdrawal by Subject|4
4700719|NCT02699125|7616869|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7
4700720|NCT02699125|7616870|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2
4700721|NCT02699450|7616883|FG000|Overall Study|Death|2
4700722|NCT02699450|7616884|FG001|Overall Study|Death|1
4700723|NCT02699450|7616885|FG002|Overall Study|Death|2
4700724|NCT02699450|7616883|FG000|Overall Study|Met Criteria for Study Exit|0
4700725|NCT02699450|7616884|FG001|Overall Study|Met Criteria for Study Exit|0
4700726|NCT02699450|7616885|FG002|Overall Study|Met Criteria for Study Exit|1
4700727|NCT02699450|7616883|FG000|Overall Study|Protocol Violation|4
4700728|NCT02699450|7616884|FG001|Overall Study|Protocol Violation|3
4700729|NCT02699450|7616885|FG002|Overall Study|Protocol Violation|5
4700730|NCT02699450|7616883|FG000|Overall Study|Lost to Follow-up|3
4700731|NCT02699450|7616884|FG001|Overall Study|Lost to Follow-up|0
4700732|NCT02699450|7616885|FG002|Overall Study|Lost to Follow-up|5
4700733|NCT02699450|7616883|FG000|Overall Study|Physician Decision|2
4700734|NCT02699450|7616884|FG001|Overall Study|Physician Decision|0
4700735|NCT02699450|7616885|FG002|Overall Study|Physician Decision|0
4700736|NCT02699450|7616883|FG000|Overall Study|Withdrawal by Subject|3
4700737|NCT02699450|7616884|FG001|Overall Study|Withdrawal by Subject|1
4700738|NCT02699450|7616885|FG002|Overall Study|Withdrawal by Subject|2
4700739|NCT02699450|7616883|FG000|Overall Study|Adverse Event|1
4700740|NCT02699450|7616884|FG001|Overall Study|Adverse Event|0
4700741|NCT02699450|7616885|FG002|Overall Study|Adverse Event|0
4700742|NCT02699463|7616896|FG000|Overall Study|Lost to Follow-up|11
4589674|NCT01514136|7435061|FG007|Test Period 2; Test B*|Withdrawal by Subject|0
4589675|NCT01514136|7435054|FG000|Test Period 2; Test C*|Withdrawal by Subject|0
4589676|NCT01514136|7435055|FG001|Test Period 2; Test C*|Withdrawal by Subject|0
4589677|NCT01514136|7435056|FG002|Test Period 2; Test C*|Withdrawal by Subject|0
4589678|NCT01514136|7435057|FG003|Test Period 2; Test C*|Withdrawal by Subject|0
4589679|NCT01514136|7435058|FG004|Test Period 2; Test C*|Withdrawal by Subject|0
4589680|NCT01514136|7435059|FG005|Test Period 2; Test C*|Withdrawal by Subject|0
4589681|NCT01514136|7435060|FG006|Test Period 2; Test C*|Withdrawal by Subject|1
4589682|NCT01514136|7435061|FG007|Test Period 2; Test C*|Withdrawal by Subject|0
4700743|NCT02699463|7616897|FG001|Overall Study|Lost to Follow-up|8
4700744|NCT02699463|7616896|FG000|Overall Study|Withdrawal by Subject|4
4700745|NCT02699463|7616897|FG001|Overall Study|Withdrawal by Subject|1
4700746|NCT02699593|7616903|FG000|Period 1|Unsatisfactory Visual Response|0
4700747|NCT02699593|7616904|FG001|Period 1|Unsatisfactory Visual Response|1
4480250|NCT00716274|7278261|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0
4480251|NCT00716274|7278262|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0
4700748|NCT02699593|7616903|FG000|Period 1|Torn Contact Len|4
4700749|NCT02699593|7616904|FG001|Period 1|Torn Contact Len|3
4700750|NCT02699593|7616903|FG000|Period 1|Protocol Violation|0
4700751|NCT02699593|7616904|FG001|Period 1|Protocol Violation|1
4480252|NCT00716274|7278263|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0
4480253|NCT00716274|7278258|FG000|Study Period II (16-Weeks)|Protocol Violation|0
4480254|NCT00716274|7278259|FG001|Study Period II (16-Weeks)|Protocol Violation|3
4480255|NCT00716274|7278260|FG002|Study Period II (16-Weeks)|Protocol Violation|0
4480256|NCT00716274|7278261|FG003|Study Period II (16-Weeks)|Protocol Violation|0
4480257|NCT00716274|7278262|FG004|Study Period II (16-Weeks)|Protocol Violation|0
4480258|NCT00716274|7278263|FG005|Study Period II (16-Weeks)|Protocol Violation|1
4480259|NCT00716274|7278258|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1
4480260|NCT00716274|7278259|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0
4480261|NCT00716274|7278260|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0
4480262|NCT00716274|7278261|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0
4480263|NCT00716274|7278262|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0
4480264|NCT00716274|7278263|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0
4480265|NCT00716274|7278258|FG000|Study Period II (16-Weeks)|Physician Decision|3
4480266|NCT00716274|7278259|FG001|Study Period II (16-Weeks)|Physician Decision|1
4480267|NCT00716274|7278260|FG002|Study Period II (16-Weeks)|Physician Decision|0
4480268|NCT00716274|7278261|FG003|Study Period II (16-Weeks)|Physician Decision|0
4480269|NCT00716274|7278262|FG004|Study Period II (16-Weeks)|Physician Decision|0
4480270|NCT00716274|7278263|FG005|Study Period II (16-Weeks)|Physician Decision|1
4480271|NCT00716274|7278258|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3
4480272|NCT00716274|7278259|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3
4480273|NCT00716274|7278260|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
4480274|NCT00716274|7278261|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
4480275|NCT00716274|7278262|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
4480276|NCT00716274|7278263|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
4480277|NCT00716274|7278258|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0
4480278|NCT00716274|7278259|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2
4480279|NCT00716274|7278260|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0
4480280|NCT00716274|7278261|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0
4480281|NCT00716274|7278262|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0
4480282|NCT00716274|7278263|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0
4480283|NCT00716274|7278258|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0
4480284|NCT00716274|7278259|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0
4480285|NCT00716274|7278260|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2
4480286|NCT00716274|7278261|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0
4480287|NCT00716274|7278262|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0
4480288|NCT00716274|7278263|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0
4480289|NCT00716274|7278258|FG000|Study Period III (16-Weeks)|Physician Decision|0
4480290|NCT00716274|7278259|FG001|Study Period III (16-Weeks)|Physician Decision|0
4480291|NCT00716274|7278260|FG002|Study Period III (16-Weeks)|Physician Decision|0
4480292|NCT00716274|7278261|FG003|Study Period III (16-Weeks)|Physician Decision|0
4480293|NCT00716274|7278262|FG004|Study Period III (16-Weeks)|Physician Decision|1
4480294|NCT00716274|7278263|FG005|Study Period III (16-Weeks)|Physician Decision|0
4480295|NCT00716274|7278258|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0
4480296|NCT00716274|7278259|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0
4480297|NCT00716274|7278260|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0
4480298|NCT00716274|7278261|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1
4480299|NCT00716274|7278262|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1
4480300|NCT00716274|7278263|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0
4480301|NCT00716274|7278258|FG000|Study Period III (16-Weeks)|Adverse Event|0
4480302|NCT00716274|7278259|FG001|Study Period III (16-Weeks)|Adverse Event|0
4480303|NCT00716274|7278260|FG002|Study Period III (16-Weeks)|Adverse Event|0
4480304|NCT00716274|7278261|FG003|Study Period III (16-Weeks)|Adverse Event|0
4480305|NCT00716274|7278262|FG004|Study Period III (16-Weeks)|Adverse Event|1
4480306|NCT00716274|7278263|FG005|Study Period III (16-Weeks)|Adverse Event|0
4480307|NCT00716417|7278290|FG000|Overall Study|Adverse Event|0
4480308|NCT00716417|7278291|FG001|Overall Study|Adverse Event|0
4480309|NCT00716417|7278292|FG002|Overall Study|Adverse Event|2
4480310|NCT00716417|7278293|FG003|Overall Study|Adverse Event|1
4480311|NCT00716417|7278294|FG004|Overall Study|Adverse Event|0
4480312|NCT00716417|7278295|FG005|Overall Study|Adverse Event|0
4480313|NCT00716417|7278296|FG006|Overall Study|Adverse Event|3
4480314|NCT00716417|7278297|FG007|Overall Study|Adverse Event|1
4480315|NCT00716417|7278298|FG008|Overall Study|Adverse Event|0
4480316|NCT00716417|7278299|FG009|Overall Study|Adverse Event|3
4480317|NCT00716417|7278290|FG000|Overall Study|Withdrawal by Subject|0
4480318|NCT00716417|7278291|FG001|Overall Study|Withdrawal by Subject|1
4480319|NCT00716417|7278292|FG002|Overall Study|Withdrawal by Subject|0
4480320|NCT00716417|7278293|FG003|Overall Study|Withdrawal by Subject|2
4480321|NCT00716417|7278294|FG004|Overall Study|Withdrawal by Subject|0
4480322|NCT00716417|7278295|FG005|Overall Study|Withdrawal by Subject|0
4480323|NCT00716417|7278296|FG006|Overall Study|Withdrawal by Subject|1
4480324|NCT00716417|7278297|FG007|Overall Study|Withdrawal by Subject|0
4480325|NCT00716417|7278298|FG008|Overall Study|Withdrawal by Subject|0
4480326|NCT00716417|7278299|FG009|Overall Study|Withdrawal by Subject|0
4480327|NCT00716417|7278290|FG000|Overall Study|Progressive disease|3
4480328|NCT00716417|7278291|FG001|Overall Study|Progressive disease|5
4480329|NCT00716417|7278292|FG002|Overall Study|Progressive disease|3
4480330|NCT00716417|7278293|FG003|Overall Study|Progressive disease|8
4480331|NCT00716417|7278294|FG004|Overall Study|Progressive disease|0
4480332|NCT00716417|7278295|FG005|Overall Study|Progressive disease|3
4480333|NCT00716417|7278296|FG006|Overall Study|Progressive disease|3
4480334|NCT00716417|7278297|FG007|Overall Study|Progressive disease|1
4480335|NCT00716417|7278298|FG008|Overall Study|Progressive disease|5
4480336|NCT00716417|7278299|FG009|Overall Study|Progressive disease|0
4480337|NCT00716417|7278290|FG000|Overall Study|Dose limiting toxicity (DLT)|0
4480338|NCT00716417|7278291|FG001|Overall Study|Dose limiting toxicity (DLT)|0
4480339|NCT00716417|7278292|FG002|Overall Study|Dose limiting toxicity (DLT)|0
4480340|NCT00716417|7278293|FG003|Overall Study|Dose limiting toxicity (DLT)|0
4480341|NCT00716417|7278294|FG004|Overall Study|Dose limiting toxicity (DLT)|1
4480342|NCT00716417|7278295|FG005|Overall Study|Dose limiting toxicity (DLT)|0
4480343|NCT00716417|7278296|FG006|Overall Study|Dose limiting toxicity (DLT)|0
4480344|NCT00716417|7278297|FG007|Overall Study|Dose limiting toxicity (DLT)|0
4480345|NCT00716417|7278298|FG008|Overall Study|Dose limiting toxicity (DLT)|0
4480346|NCT00716417|7278299|FG009|Overall Study|Dose limiting toxicity (DLT)|0
4480347|NCT00716417|7278290|FG000|Overall Study|On patient request due to toxicities|0
4480348|NCT00716417|7278291|FG001|Overall Study|On patient request due to toxicities|0
4480349|NCT00716417|7278292|FG002|Overall Study|On patient request due to toxicities|0
4480350|NCT00716417|7278293|FG003|Overall Study|On patient request due to toxicities|0
4480351|NCT00716417|7278294|FG004|Overall Study|On patient request due to toxicities|0
4480352|NCT00716417|7278295|FG005|Overall Study|On patient request due to toxicities|0
4480353|NCT00716417|7278296|FG006|Overall Study|On patient request due to toxicities|0
4480354|NCT00716417|7278297|FG007|Overall Study|On patient request due to toxicities|1
4480355|NCT00716417|7278298|FG008|Overall Study|On patient request due to toxicities|0
4480356|NCT00716417|7278299|FG009|Overall Study|On patient request due to toxicities|0
4480357|NCT00716456|7278331|FG000|Overall Study|Adverse Event|0
4480358|NCT00716456|7278332|FG001|Overall Study|Adverse Event|2
4480359|NCT00716456|7278333|FG002|Overall Study|Adverse Event|0
4480360|NCT00716482|7278341|FG000|Overall Study|Lost to Follow-up|6
4480361|NCT00716482|7278341|FG000|Overall Study|Inadequate acquisition or analysis|50
4480362|NCT00716482|7278341|FG000|Overall Study|no pathology obtained|10
4480363|NCT00716482|7278341|FG000|Overall Study|technical/machine error|28
4480364|NCT00716482|7278341|FG000|Overall Study|inclusion/exclusion criteria not met|25
4480365|NCT00716625|7278356|FG000|Overall Study|Safety was not Assessable|1
4480366|NCT00716859|7278414|FG000|Overall Study|Adverse Event|4
4480367|NCT00716859|7278415|FG001|Overall Study|Adverse Event|1
4480368|NCT00716859|7278414|FG000|Overall Study|Lack of Efficacy|3
4480369|NCT00716859|7278415|FG001|Overall Study|Lack of Efficacy|0
4480370|NCT00716859|7278414|FG000|Overall Study|Withdrawal by Subject|1
4480371|NCT00716859|7278415|FG001|Overall Study|Withdrawal by Subject|3
4480372|NCT00716859|7278414|FG000|Overall Study|Not treated|1
4480373|NCT00716859|7278415|FG001|Overall Study|Not treated|1
4480374|NCT00716976|7278436|FG000|Overall Study|Adverse Event|2
4480375|NCT00716976|7278437|FG001|Overall Study|Adverse Event|0
4480376|NCT00716976|7278436|FG000|Overall Study|Death|1
4480377|NCT00716976|7278437|FG001|Overall Study|Death|0
4480378|NCT00716976|7278436|FG000|Overall Study|Physician Decision|2
4480379|NCT00716976|7278437|FG001|Overall Study|Physician Decision|2
4480380|NCT00716976|7278436|FG000|Overall Study|Withdrawal by Subject|5
4480381|NCT00716976|7278437|FG001|Overall Study|Withdrawal by Subject|1
4480382|NCT00716976|7278436|FG000|Overall Study|Premature discontinuation cisplatin|5
4480383|NCT00716976|7278437|FG001|Overall Study|Premature discontinuation cisplatin|4
4480384|NCT00716976|7278436|FG000|Overall Study|Radiation during protocol|1
4480385|NCT00716976|7278437|FG001|Overall Study|Radiation during protocol|0
4480386|NCT00716976|7278436|FG000|Overall Study|Ineligibles|4
4480387|NCT00716976|7278437|FG001|Overall Study|Ineligibles|2
4480388|NCT00717067|7278466|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
4480389|NCT00717067|7278467|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
4480390|NCT00717067|7278468|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1
4480391|NCT00717067|7278469|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
4480392|NCT00717067|7278470|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
4480393|NCT00717093|7278494|FG000|Overall Study|Adverse Event|19
4480394|NCT00717093|7278495|FG001|Overall Study|Adverse Event|9
4480395|NCT00717093|7278494|FG000|Overall Study|Lack of Efficacy|3
4480396|NCT00717093|7278495|FG001|Overall Study|Lack of Efficacy|13
4480397|NCT00717093|7278494|FG000|Overall Study|Lost to Follow-up|9
4480398|NCT00717093|7278495|FG001|Overall Study|Lost to Follow-up|6
4480399|NCT00717093|7278494|FG000|Overall Study|Withdrawal by Subject|12
4480400|NCT00717093|7278495|FG001|Overall Study|Withdrawal by Subject|19
4480401|NCT00717093|7278494|FG000|Overall Study|Other|0
4480402|NCT00717093|7278495|FG001|Overall Study|Other|1
4480403|NCT00717093|7278494|FG000|Overall Study|Randomized but not treated|1
4480404|NCT00717093|7278495|FG001|Overall Study|Randomized but not treated|0
4480405|NCT00717197|7278501|FG000|Overall Study|Unable to purchase study drug|5
4480406|NCT00717197|7278501|FG000|Overall Study|Tumor Progression|1
4480407|NCT00717197|7278501|FG000|Overall Study|Physician Decision|1
4480408|NCT00717236|7278507|FG000|Double-Blind Period|Adverse Event|33
4480409|NCT00717236|7278508|FG001|Double-Blind Period|Adverse Event|6
4480410|NCT00717236|7278507|FG000|Double-Blind Period|Lack of Efficacy|6
4480411|NCT00717236|7278508|FG001|Double-Blind Period|Lack of Efficacy|6
4480412|NCT00717236|7278507|FG000|Double-Blind Period|Lost to Follow-up|3
4480413|NCT00717236|7278508|FG001|Double-Blind Period|Lost to Follow-up|5
4480414|NCT00717236|7278507|FG000|Double-Blind Period|Withdrawal by Subject|10
4480415|NCT00717236|7278508|FG001|Double-Blind Period|Withdrawal by Subject|2
4480416|NCT00717236|7278507|FG000|Double-Blind Period|Loss of efficacy|3
4480417|NCT00717236|7278508|FG001|Double-Blind Period|Loss of efficacy|0
4480418|NCT00717236|7278507|FG000|Double-Blind Period|Other: Death|1
4480419|NCT00717236|7278508|FG001|Double-Blind Period|Other: Death|0
4480420|NCT00717236|7278507|FG000|Double-Blind Period|Other: Pregnancy|1
4480421|NCT00717236|7278508|FG001|Double-Blind Period|Other: Pregnancy|0
4480422|NCT00717236|7278507|FG000|Double-Blind Period|Other: Protocol Violation|2
4480423|NCT00717236|7278508|FG001|Double-Blind Period|Other: Protocol Violation|0
4480424|NCT00717236|7278507|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6
4480425|NCT00717236|7278508|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2
4480426|NCT00717236|7278507|FG000|Double-Blind Period|Other: Site withdrew|2
4480427|NCT00717236|7278508|FG001|Double-Blind Period|Other: Site withdrew|0
4386902|NCT00043186|7165464|FG003|Overall Study|Adverse Event|3
4386903|NCT00043186|7165465|FG004|Overall Study|Adverse Event|2
4386904|NCT00043186|7165466|FG005|Overall Study|Adverse Event|1
4386905|NCT00043186|7165467|FG006|Overall Study|Adverse Event|2
4480428|NCT00717236|7278507|FG000|Double-Blind Period|Other: Screening failure|1
4480429|NCT00717236|7278508|FG001|Double-Blind Period|Other: Screening failure|0
4480430|NCT00717236|7278507|FG000|Double-Blind Period|Other: subject withdrew consent|1
4480431|NCT00717236|7278508|FG001|Double-Blind Period|Other: subject withdrew consent|1
4480432|NCT00717236|7278507|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2
4480433|NCT00717236|7278508|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1
4480434|NCT00717236|7278507|FG000|Double-Blind Period|Other: History of adenoid grown|1
4480435|NCT00717236|7278508|FG001|Double-Blind Period|Other: History of adenoid grown|0
4480436|NCT00717236|7278507|FG000|Double-Blind Period|Other: History of cancer|1
4480437|NCT00717236|7278508|FG001|Double-Blind Period|Other: History of cancer|0
4480438|NCT00717236|7278507|FG000|Double-Blind Period|Other: Sponsor request|1
4480439|NCT00717236|7278508|FG001|Double-Blind Period|Other: Sponsor request|0
4480440|NCT00717236|7278507|FG000|Double-Blind Period|Other: Inappropriate randomization|1
4480441|NCT00717236|7278508|FG001|Double-Blind Period|Other: Inappropriate randomization|0
4480442|NCT00717236|7278507|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1
4480443|NCT00717236|7278508|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0
4480444|NCT00717236|7278507|FG000|Double-Blind Period|Other: Subject moved|1
4480445|NCT00717236|7278508|FG001|Double-Blind Period|Other: Subject moved|1
4480446|NCT00717236|7278507|FG000|Double-Blind Period|Other: Stopped taking DMARD|1
4480447|NCT00717236|7278508|FG001|Double-Blind Period|Other: Stopped taking DMARD|0
4480448|NCT00717236|7278507|FG000|Double-Blind Period|Other: Prohibited medication taken|2
4480449|NCT00717236|7278508|FG001|Double-Blind Period|Other: Prohibited medication taken|2
4480450|NCT00717236|7278507|FG000|Double-Blind Period|Other: Transportation problems|0
4480451|NCT00717236|7278508|FG001|Double-Blind Period|Other: Transportation problems|1
4480452|NCT00717236|7278507|FG000|Double-Blind Period|Other: Investigator Decision|0
4480453|NCT00717236|7278508|FG001|Double-Blind Period|Other: Investigator Decision|1
4480454|NCT00717236|7278507|FG000|Open-Label Period|Adverse Event|29
4480455|NCT00717236|7278508|FG001|Open-Label Period|Adverse Event|4
4480456|NCT00717236|7278507|FG000|Open-Label Period|Lack of Efficacy|30
4480457|NCT00717236|7278508|FG001|Open-Label Period|Lack of Efficacy|8
4480458|NCT00717236|7278507|FG000|Open-Label Period|Lost to Follow-up|28
4480459|NCT00717236|7278508|FG001|Open-Label Period|Lost to Follow-up|4
4480460|NCT00717236|7278507|FG000|Open-Label Period|Withdrawal by Subject|20
4480461|NCT00717236|7278508|FG001|Open-Label Period|Withdrawal by Subject|2
4480462|NCT00717236|7278507|FG000|Open-Label Period|Loss of Efficacy|6
4480463|NCT00717236|7278508|FG001|Open-Label Period|Loss of Efficacy|1
4480464|NCT00717236|7278507|FG000|Open-Label Period|Other: Peripheral Neuropathy|0
4480465|NCT00717236|7278508|FG001|Open-Label Period|Other: Peripheral Neuropathy|1
4386906|NCT00043186|7165468|FG007|Overall Study|Adverse Event|1
4386907|NCT00043186|7165469|FG008|Overall Study|Adverse Event|3
4386908|NCT00043186|7165461|FG000|Overall Study|Withdrawal by Subject|11
4386909|NCT00043186|7165462|FG001|Overall Study|Withdrawal by Subject|8
4386910|NCT00043186|7165463|FG002|Overall Study|Withdrawal by Subject|11
4386911|NCT00043186|7165464|FG003|Overall Study|Withdrawal by Subject|13
4386912|NCT00043186|7165465|FG004|Overall Study|Withdrawal by Subject|14
4386913|NCT00043186|7165466|FG005|Overall Study|Withdrawal by Subject|6
4386914|NCT00043186|7165467|FG006|Overall Study|Withdrawal by Subject|12
4386915|NCT00043186|7165468|FG007|Overall Study|Withdrawal by Subject|9
4386916|NCT00043186|7165469|FG008|Overall Study|Withdrawal by Subject|10
4386917|NCT00043186|7165461|FG000|Overall Study|Death|0
4386918|NCT00043186|7165462|FG001|Overall Study|Death|0
4386919|NCT00043186|7165463|FG002|Overall Study|Death|1
4386920|NCT00043186|7165464|FG003|Overall Study|Death|0
4386921|NCT00043186|7165465|FG004|Overall Study|Death|0
4386922|NCT00043186|7165466|FG005|Overall Study|Death|0
4386923|NCT00043186|7165467|FG006|Overall Study|Death|2
4386924|NCT00043186|7165468|FG007|Overall Study|Death|0
4480466|NCT00717236|7278507|FG000|Open-Label Period|Other: Lack of Compliance|1
4480467|NCT00717236|7278508|FG001|Open-Label Period|Other: Lack of Compliance|1
4480468|NCT00717236|7278507|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1
4480469|NCT00717236|7278508|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0
4480470|NCT00717236|7278507|FG000|Open-Label Period|Other: Moved|1
4480471|NCT00717236|7278508|FG001|Open-Label Period|Other: Moved|0
4480472|NCT00717236|7278507|FG000|Open-Label Period|Other: Investigator Decision|1
4480473|NCT00717236|7278508|FG001|Open-Label Period|Other: Investigator Decision|0
4480474|NCT00717236|7278507|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1
4480475|NCT00717236|7278508|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0
4480476|NCT00717236|7278507|FG000|Open-Label Period|Other: Sponsor Request|3
4480477|NCT00717236|7278508|FG001|Open-Label Period|Other: Sponsor Request|0
4480478|NCT00717236|7278507|FG000|Open-Label Period|Other: Cataract Surgery|1
4480479|NCT00717236|7278508|FG001|Open-Label Period|Other: Cataract Surgery|0
4480480|NCT00717236|7278507|FG000|Open-Label Period|Other: Administration of Golimumab|1
4480481|NCT00717236|7278508|FG001|Open-Label Period|Other: Administration of Golimumab|0
4480482|NCT00717236|7278507|FG000|Open-Label Period|Other: Completion Accidently Performed|1
4480483|NCT00717236|7278508|FG001|Open-Label Period|Other: Completion Accidently Performed|0
4480484|NCT00717236|7278507|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1
4480485|NCT00717236|7278508|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0
4480486|NCT00717249|7278518|FG000|Overall Study|Lens Discomfort|4
4480487|NCT00717249|7278519|FG001|Overall Study|Lens Discomfort|1
4480488|NCT00717249|7278518|FG000|Overall Study|Unsatisfactory visual Response|0
4480489|NCT00717249|7278519|FG001|Overall Study|Unsatisfactory visual Response|2
4480490|NCT00717249|7278518|FG000|Overall Study|Adverse Event|4
4480491|NCT00717249|7278519|FG001|Overall Study|Adverse Event|2
4480492|NCT00717249|7278518|FG000|Overall Study|Lost to Follow-up|2
4386925|NCT00043186|7165469|FG008|Overall Study|Death|0
4386926|NCT00043186|7165461|FG000|Overall Study|Disease progression|1
4386927|NCT00043186|7165462|FG001|Overall Study|Disease progression|0
4386928|NCT00043186|7165463|FG002|Overall Study|Disease progression|0
4386929|NCT00043186|7165464|FG003|Overall Study|Disease progression|3
4386930|NCT00043186|7165465|FG004|Overall Study|Disease progression|0
4386931|NCT00043186|7165466|FG005|Overall Study|Disease progression|0
4386932|NCT00043186|7165467|FG006|Overall Study|Disease progression|0
4386933|NCT00043186|7165468|FG007|Overall Study|Disease progression|4
4386934|NCT00043186|7165469|FG008|Overall Study|Disease progression|0
4386935|NCT00043186|7165461|FG000|Overall Study|Ineligibility determined|0
4386936|NCT00043186|7165462|FG001|Overall Study|Ineligibility determined|0
4386937|NCT00043186|7165463|FG002|Overall Study|Ineligibility determined|0
4386938|NCT00043186|7165464|FG003|Overall Study|Ineligibility determined|0
4386939|NCT00043186|7165465|FG004|Overall Study|Ineligibility determined|0
4386940|NCT00043186|7165466|FG005|Overall Study|Ineligibility determined|0
4480493|NCT00717249|7278519|FG001|Overall Study|Lost to Follow-up|0
4480494|NCT00717249|7278518|FG000|Overall Study|Withdrawal by Subject|1
4480495|NCT00717249|7278519|FG001|Overall Study|Withdrawal by Subject|2
4480496|NCT00717249|7278518|FG000|Overall Study|Pregnancy|6
4480497|NCT00717249|7278519|FG001|Overall Study|Pregnancy|3
4480498|NCT00717249|7278518|FG000|Overall Study|Protocol Violation|0
4480499|NCT00717249|7278519|FG001|Overall Study|Protocol Violation|2
4480500|NCT00717249|7278518|FG000|Overall Study|Subject became Ineligible|1
4480501|NCT00717249|7278519|FG001|Overall Study|Subject became Ineligible|1
4480502|NCT00717249|7278518|FG000|Overall Study|Unsatisfactory Physiological Response|0
4480503|NCT00717249|7278519|FG001|Overall Study|Unsatisfactory Physiological Response|1
4700752|NCT02699593|7616903|FG000|Period 1|Withdrawal by Subject|0
4700753|NCT02699593|7616904|FG001|Period 1|Withdrawal by Subject|1
4700754|NCT02699593|7616903|FG000|Period 1|Adverse Event|1
4700755|NCT02699593|7616904|FG001|Period 1|Adverse Event|1
4700756|NCT02699593|7616903|FG000|Period 2|Adverse Event|1
4700757|NCT02699593|7616904|FG001|Period 2|Adverse Event|1
4700758|NCT02699593|7616903|FG000|Period 2|Lost Contact Lens|0
4700759|NCT02699593|7616904|FG001|Period 2|Lost Contact Lens|1
4480504|NCT00717249|7278518|FG000|Overall Study|Gastric Surgery|0
4480505|NCT00717249|7278519|FG001|Overall Study|Gastric Surgery|1
4480506|NCT00717249|7278518|FG000|Overall Study|Diagnosed with Diabetes|1
4480507|NCT00717249|7278519|FG001|Overall Study|Diagnosed with Diabetes|0
4480508|NCT00717249|7278518|FG000|Overall Study|Diagnosed with Multiple Scletosis|1
4480509|NCT00717249|7278519|FG001|Overall Study|Diagnosed with Multiple Scletosis|0
4480510|NCT00717249|7278518|FG000|Overall Study|Subject relocated|1
4480511|NCT00717249|7278519|FG001|Overall Study|Subject relocated|0
4480512|NCT00717249|7278518|FG000|Overall Study|Headaches|1
4480513|NCT00717249|7278519|FG001|Overall Study|Headaches|0
4480514|NCT00717314|7278546|FG000|Overall Study|Adverse Event|3
4480515|NCT00717314|7278547|FG001|Overall Study|Adverse Event|2
4480516|NCT00717314|7278546|FG000|Overall Study|Protocol Violation|1
4700760|NCT02699593|7616903|FG000|Period 2|Torn Contact Lens|1
4480517|NCT00717314|7278547|FG001|Overall Study|Protocol Violation|0
4480518|NCT00717314|7278546|FG000|Overall Study|Lost to Follow-up|1
4480519|NCT00717314|7278547|FG001|Overall Study|Lost to Follow-up|5
4480520|NCT00717314|7278546|FG000|Overall Study|Withdrawal by Subject|1
4480521|NCT00717314|7278547|FG001|Overall Study|Withdrawal by Subject|3
4480522|NCT00717366|7278555|FG000|Core Study Period (20 Weeks)|Renal transplant|4
4700761|NCT02699593|7616904|FG001|Period 2|Torn Contact Lens|0
4480523|NCT00717366|7278556|FG001|Core Study Period (20 Weeks)|Renal transplant|9
4480524|NCT00717366|7278555|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0
4480525|NCT00717366|7278556|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2
4480526|NCT00717366|7278555|FG000|Core Study Period (20 Weeks)|Death|0
4480527|NCT00717366|7278556|FG001|Core Study Period (20 Weeks)|Death|1
4480528|NCT00717366|7278555|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0
4480529|NCT00717366|7278556|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1
4480530|NCT00717366|7278555|FG000|Extension Period (52 Weeks)|Renal transplant|3
4480531|NCT00717366|7278556|FG001|Extension Period (52 Weeks)|Renal transplant|13
4480532|NCT00717366|7278555|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0
4480533|NCT00717366|7278556|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2
4480534|NCT00717366|7278555|FG000|Extension Period (52 Weeks)|Withdrew consent|1
4480535|NCT00717366|7278556|FG001|Extension Period (52 Weeks)|Withdrew consent|1
4480536|NCT00717522|7278577|FG000|Overall Study|Disease Progression|5
4480537|NCT00717522|7278577|FG000|Overall Study|Adverse Event|1
4480538|NCT00717522|7278577|FG000|Overall Study|Death|1
4480539|NCT00717756|7278594|FG000|Overall Study|Withdrawal by Subject|1
4480540|NCT00717769|7278601|FG000|Overall Study|Adverse Event|9
4480541|NCT00717769|7278602|FG001|Overall Study|Adverse Event|6
4480542|NCT00717769|7278603|FG002|Overall Study|Adverse Event|1
4480543|NCT00717769|7278601|FG000|Overall Study|Lack of compliance|0
4480544|NCT00717769|7278602|FG001|Overall Study|Lack of compliance|2
4480545|NCT00717769|7278603|FG002|Overall Study|Lack of compliance|0
4480546|NCT00717769|7278601|FG000|Overall Study|Lost to Follow-up|3
4480547|NCT00717769|7278602|FG001|Overall Study|Lost to Follow-up|4
4480548|NCT00717769|7278603|FG002|Overall Study|Lost to Follow-up|0
4480549|NCT00717769|7278601|FG000|Overall Study|Lack of Efficacy|1
4480550|NCT00717769|7278602|FG001|Overall Study|Lack of Efficacy|2
4480551|NCT00717769|7278603|FG002|Overall Study|Lack of Efficacy|0
4480552|NCT00717769|7278601|FG000|Overall Study|Protocol Violation|0
4480553|NCT00717769|7278602|FG001|Overall Study|Protocol Violation|2
4480554|NCT00717769|7278603|FG002|Overall Study|Protocol Violation|0
4480555|NCT00717769|7278601|FG000|Overall Study|Sponsor decision|1
4480556|NCT00717769|7278602|FG001|Overall Study|Sponsor decision|0
4480557|NCT00717769|7278603|FG002|Overall Study|Sponsor decision|10
4480558|NCT00717769|7278601|FG000|Overall Study|Withdrew consent|2
4480559|NCT00717769|7278602|FG001|Overall Study|Withdrew consent|2
4480560|NCT00717769|7278603|FG002|Overall Study|Withdrew consent|0
4480561|NCT00717860|7278615|FG000|Overall Study|Clinical adverse experience|5
4480562|NCT00717860|7278616|FG001|Overall Study|Clinical adverse experience|9
4480563|NCT00717860|7278615|FG000|Overall Study|Laboratory adverse experience|2
4480564|NCT00717860|7278616|FG001|Overall Study|Laboratory adverse experience|2
4480565|NCT00717860|7278615|FG000|Overall Study|Lack of Efficacy|7
4480566|NCT00717860|7278616|FG001|Overall Study|Lack of Efficacy|13
4480567|NCT00717860|7278615|FG000|Overall Study|Discontinued for other reason|6
4480568|NCT00717860|7278616|FG001|Overall Study|Discontinued for other reason|1
4480569|NCT00717860|7278615|FG000|Overall Study|Withdrew consent|7
4480570|NCT00717860|7278616|FG001|Overall Study|Withdrew consent|3
4480571|NCT00717886|7278631|FG000|Overall Study|Withdrawal by Subject|3
4480572|NCT00717886|7278631|FG000|Overall Study|Treatment Failure|1
4480573|NCT00718042|7278659|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
4480574|NCT00718042|7278660|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
4480575|NCT00718042|7278661|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
4480576|NCT00718042|7278662|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
4480577|NCT00718042|7278663|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2
4480578|NCT00718042|7278664|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
4480579|NCT00718042|7278659|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64
4480580|NCT00718042|7278660|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0
4480581|NCT00718042|7278661|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0
4480582|NCT00718042|7278662|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0
4480583|NCT00718042|7278663|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36
4480584|NCT00718042|7278664|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0
4480585|NCT00718042|7278659|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0
4480586|NCT00718042|7278660|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1
4480587|NCT00718042|7278661|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1
4480588|NCT00718042|7278662|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0
4480589|NCT00718042|7278663|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0
4480590|NCT00718042|7278664|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0
4480591|NCT00718042|7278659|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
4480592|NCT00718042|7278660|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1
4480593|NCT00718042|7278661|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
4480594|NCT00718042|7278662|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
4589683|NCT01514136|7435054|FG000|Test Period 2; Test C*|holiday|0
4589684|NCT01514136|7435055|FG001|Test Period 2; Test C*|holiday|0
4589685|NCT01514136|7435056|FG002|Test Period 2; Test C*|holiday|0
4589686|NCT01514136|7435057|FG003|Test Period 2; Test C*|holiday|0
4589687|NCT01514136|7435058|FG004|Test Period 2; Test C*|holiday|0
4589688|NCT01514136|7435059|FG005|Test Period 2; Test C*|holiday|0
4589689|NCT01514136|7435060|FG006|Test Period 2; Test C*|holiday|1
4589690|NCT01514136|7435061|FG007|Test Period 2; Test C*|holiday|0
4480595|NCT00718042|7278663|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
4480596|NCT00718042|7278664|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
4480597|NCT00718042|7278659|FG000|Donor Follow-up|Lost to Follow-up|13
4480598|NCT00718042|7278660|FG001|Donor Follow-up|Lost to Follow-up|0
4480599|NCT00718042|7278661|FG002|Donor Follow-up|Lost to Follow-up|0
4480600|NCT00718042|7278662|FG003|Donor Follow-up|Lost to Follow-up|0
4480601|NCT00718042|7278663|FG004|Donor Follow-up|Lost to Follow-up|19
4480602|NCT00718042|7278664|FG005|Donor Follow-up|Lost to Follow-up|0
4480603|NCT00718081|7278679|FG000|Overall Study|Adverse Event|0
4480604|NCT00718081|7278680|FG001|Overall Study|Adverse Event|1
4480605|NCT00718081|7278681|FG002|Overall Study|Adverse Event|0
4480606|NCT00718081|7278679|FG000|Overall Study|Lack of Efficacy|7
4480607|NCT00718081|7278680|FG001|Overall Study|Lack of Efficacy|3
4480608|NCT00718081|7278681|FG002|Overall Study|Lack of Efficacy|21
4480609|NCT00718159|7278714|FG000|Overall Study|Progressive Disease|3
4480610|NCT00718159|7278715|FG001|Overall Study|Progressive Disease|3
4480611|NCT00718159|7278716|FG002|Overall Study|Progressive Disease|2
4480612|NCT00718159|7278717|FG003|Overall Study|Progressive Disease|0
4480613|NCT00718159|7278718|FG004|Overall Study|Progressive Disease|6
4480614|NCT00718159|7278719|FG005|Overall Study|Progressive Disease|0
4480615|NCT00718159|7278720|FG006|Overall Study|Progressive Disease|0
4480616|NCT00718159|7278714|FG000|Overall Study|Death due to Adverse Event|0
4480617|NCT00718159|7278715|FG001|Overall Study|Death due to Adverse Event|0
4480618|NCT00718159|7278716|FG002|Overall Study|Death due to Adverse Event|0
4480619|NCT00718159|7278717|FG003|Overall Study|Death due to Adverse Event|2
4480620|NCT00718159|7278718|FG004|Overall Study|Death due to Adverse Event|2
4480621|NCT00718159|7278719|FG005|Overall Study|Death due to Adverse Event|0
4480622|NCT00718159|7278720|FG006|Overall Study|Death due to Adverse Event|0
4480623|NCT00718159|7278714|FG000|Overall Study|Death due to Study Drug Toxicity|0
4480624|NCT00718159|7278715|FG001|Overall Study|Death due to Study Drug Toxicity|0
4480625|NCT00718159|7278716|FG002|Overall Study|Death due to Study Drug Toxicity|1
4480626|NCT00718159|7278717|FG003|Overall Study|Death due to Study Drug Toxicity|2
4480627|NCT00718159|7278718|FG004|Overall Study|Death due to Study Drug Toxicity|0
4480628|NCT00718159|7278719|FG005|Overall Study|Death due to Study Drug Toxicity|0
4480629|NCT00718159|7278720|FG006|Overall Study|Death due to Study Drug Toxicity|0
4480630|NCT00718159|7278714|FG000|Overall Study|Investigator Decision|0
4480631|NCT00718159|7278715|FG001|Overall Study|Investigator Decision|0
4480632|NCT00718159|7278716|FG002|Overall Study|Investigator Decision|0
4480633|NCT00718159|7278717|FG003|Overall Study|Investigator Decision|0
4480634|NCT00718159|7278718|FG004|Overall Study|Investigator Decision|0
4480635|NCT00718159|7278719|FG005|Overall Study|Investigator Decision|1
4480636|NCT00718159|7278720|FG006|Overall Study|Investigator Decision|1
4589691|NCT01514136|7435054|FG000|Test Period 2; Test C*|Protocol Violation|0
4480637|NCT00718237|7278738|FG000|Overall Study|Adverse Event|1
4480638|NCT00718237|7278739|FG001|Overall Study|Adverse Event|3
4480639|NCT00718237|7278738|FG000|Overall Study|Lost to Follow-up|2
4480640|NCT00718237|7278739|FG001|Overall Study|Lost to Follow-up|2
4480641|NCT00718237|7278738|FG000|Overall Study|Physician Decision|1
4480642|NCT00718237|7278739|FG001|Overall Study|Physician Decision|0
4480643|NCT00718237|7278738|FG000|Overall Study|Withdrawal by Subject|9
4480644|NCT00718237|7278739|FG001|Overall Study|Withdrawal by Subject|10
4480645|NCT00718315|7278761|FG000|Overall Study|Adverse Event|1
4480646|NCT00718315|7278762|FG001|Overall Study|Adverse Event|2
4480647|NCT00718315|7278763|FG002|Overall Study|Adverse Event|3
4480648|NCT00718315|7278761|FG000|Overall Study|Death|6
4480649|NCT00718315|7278762|FG001|Overall Study|Death|6
4480650|NCT00718315|7278763|FG002|Overall Study|Death|5
4480651|NCT00718315|7278761|FG000|Overall Study|Lost to Follow-up|2
4480652|NCT00718315|7278762|FG001|Overall Study|Lost to Follow-up|3
4480653|NCT00718315|7278763|FG002|Overall Study|Lost to Follow-up|4
4480654|NCT00718315|7278761|FG000|Overall Study|Protocol Violation|5
4480655|NCT00718315|7278762|FG001|Overall Study|Protocol Violation|5
4480656|NCT00718315|7278763|FG002|Overall Study|Protocol Violation|3
4480657|NCT00718315|7278761|FG000|Overall Study|Erlotinib dose decreased|4
4480658|NCT00718315|7278762|FG001|Overall Study|Erlotinib dose decreased|3
4480659|NCT00718315|7278763|FG002|Overall Study|Erlotinib dose decreased|1
4480660|NCT00718315|7278761|FG000|Overall Study|Use of Minocyclin|1
4480661|NCT00718315|7278762|FG001|Overall Study|Use of Minocyclin|1
4480662|NCT00718315|7278763|FG002|Overall Study|Use of Minocyclin|1
4480663|NCT00718315|7278761|FG000|Overall Study|Disease progression|0
4480664|NCT00718315|7278762|FG001|Overall Study|Disease progression|1
4480665|NCT00718315|7278763|FG002|Overall Study|Disease progression|1
4480666|NCT00718315|7278761|FG000|Overall Study|Other|0
4480667|NCT00718315|7278762|FG001|Overall Study|Other|0
4480668|NCT00718315|7278763|FG002|Overall Study|Other|1
4480669|NCT00718315|7278761|FG000|Overall Study|Use of ATB and Corticoids|0
4480670|NCT00718315|7278762|FG001|Overall Study|Use of ATB and Corticoids|1
4480671|NCT00718315|7278763|FG002|Overall Study|Use of ATB and Corticoids|2
4480672|NCT00718328|7278773|FG000|Overall Study|Lost to Follow-up|1
4480673|NCT00718328|7278774|FG001|Overall Study|Lost to Follow-up|0
4480674|NCT00718419|7278782|FG000|Overall Study|Adverse Event|2
4480675|NCT00718419|7278783|FG001|Overall Study|Adverse Event|1
4626391|NCT01839656|7491942|FG001|Overall Study|Withdrawal by Subject|1
4480676|NCT00718419|7278782|FG000|Overall Study|Physician Decision|1
4480677|NCT00718419|7278783|FG001|Overall Study|Physician Decision|6
4480678|NCT00718419|7278782|FG000|Overall Study|Sponsor decision|0
4480679|NCT00718419|7278783|FG001|Overall Study|Sponsor decision|1
4480680|NCT00718419|7278782|FG000|Overall Study|Withdrawal by Subject|0
4480681|NCT00718419|7278783|FG001|Overall Study|Withdrawal by Subject|5
4480682|NCT00718419|7278782|FG000|Overall Study|Progressive Disease|7
4480683|NCT00718419|7278783|FG001|Overall Study|Progressive Disease|25
4480684|NCT00718419|7278782|FG000|Overall Study|Death Due to Progressive Disease|2
4480685|NCT00718419|7278783|FG001|Overall Study|Death Due to Progressive Disease|0
4480686|NCT00718419|7278782|FG000|Overall Study|Death Due to Study Drug Related|0
4480687|NCT00718419|7278783|FG001|Overall Study|Death Due to Study Drug Related|1
4480688|NCT00718419|7278782|FG000|Overall Study|Death Due to Adverse Events|1
4480689|NCT00718419|7278783|FG001|Overall Study|Death Due to Adverse Events|0
4480690|NCT00718510|7278791|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0
4480691|NCT00718510|7278792|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1
4480692|NCT00718510|7278791|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1
4480693|NCT00718510|7278792|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0
4480694|NCT00718523|7278800|FG000|Overall Study|Withdrawal by Subject|5
4480695|NCT00718523|7278801|FG001|Overall Study|Withdrawal by Subject|7
4480696|NCT00718523|7278800|FG000|Overall Study|Death|13
4480697|NCT00718523|7278801|FG001|Overall Study|Death|17
4480698|NCT00718549|7278807|FG000|Induction Phase|Disease Progression|1
4480699|NCT00718549|7278808|FG001|Induction Phase|Disease Progression|0
4480700|NCT00718549|7278809|FG002|Induction Phase|Disease Progression|0
4480701|NCT00718549|7278807|FG000|Induction Phase|Eligibility Criteria Violation|2
4480702|NCT00718549|7278808|FG001|Induction Phase|Eligibility Criteria Violation|0
4480703|NCT00718549|7278809|FG002|Induction Phase|Eligibility Criteria Violation|0
4480704|NCT00718549|7278807|FG000|Induction Phase|Early Termination - No Additional Info|59
4480705|NCT00718549|7278808|FG001|Induction Phase|Early Termination - No Additional Info|0
4480706|NCT00718549|7278809|FG002|Induction Phase|Early Termination - No Additional Info|0
4480707|NCT00718549|7278807|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0
4480708|NCT00718549|7278808|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15
4480709|NCT00718549|7278809|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8
4480710|NCT00718549|7278807|FG000|Maintenance/ Observation Phase|Death|0
4480711|NCT00718549|7278808|FG001|Maintenance/ Observation Phase|Death|1
4480712|NCT00718549|7278809|FG002|Maintenance/ Observation Phase|Death|2
4480713|NCT00718549|7278807|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0
4480714|NCT00718549|7278808|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4
4480715|NCT00718549|7278809|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4
4480716|NCT00718549|7278807|FG000|Maintenance/ Observation Phase|Progression|0
4480717|NCT00718549|7278808|FG001|Maintenance/ Observation Phase|Progression|5
4480718|NCT00718549|7278809|FG002|Maintenance/ Observation Phase|Progression|14
4480719|NCT00718549|7278807|FG000|Maintenance/ Observation Phase|Relapse|0
4480720|NCT00718549|7278808|FG001|Maintenance/ Observation Phase|Relapse|3
4480721|NCT00718549|7278809|FG002|Maintenance/ Observation Phase|Relapse|2
4480722|NCT00718666|7278825|FG000|Booster Phase Year 5|No active participation request|0
4480723|NCT00718666|7278826|FG001|Booster Phase Year 5|No active participation request|0
4480724|NCT00718666|7278827|FG002|Booster Phase Year 5|No active participation request|1
4480725|NCT00718666|7278825|FG000|Booster Phase Year 5|Declined v-4 serology|1
4480726|NCT00718666|7278826|FG001|Booster Phase Year 5|Declined v-4 serology|0
4480727|NCT00718666|7278827|FG002|Booster Phase Year 5|Declined v-4 serology|0
4480728|NCT00718666|7278825|FG000|Booster Phase Year 5|Withdrawal by Subject|0
4480729|NCT00718666|7278826|FG001|Booster Phase Year 5|Withdrawal by Subject|0
4480730|NCT00718666|7278827|FG002|Booster Phase Year 5|Withdrawal by Subject|1
4480731|NCT00718666|7278825|FG000|Booster Phase Year 5|Lost to Follow-up|1
4480732|NCT00718666|7278826|FG001|Booster Phase Year 5|Lost to Follow-up|0
4480733|NCT00718666|7278827|FG002|Booster Phase Year 5|Lost to Follow-up|4
4480734|NCT00718718|7278852|FG000|Prior to Week 12|Adverse Event|0
4480735|NCT00718718|7278853|FG001|Prior to Week 12|Adverse Event|0
4480736|NCT00718718|7278854|FG002|Prior to Week 12|Adverse Event|0
4480737|NCT00718718|7278855|FG003|Prior to Week 12|Adverse Event|0
4480738|NCT00718718|7278856|FG004|Prior to Week 12|Adverse Event|0
4480739|NCT00718718|7278857|FG005|Prior to Week 12|Adverse Event|0
4480740|NCT00718718|7278858|FG006|Prior to Week 12|Adverse Event|0
4480741|NCT00718718|7278859|FG007|Prior to Week 12|Adverse Event|1
4480742|NCT00718718|7278860|FG008|Prior to Week 12|Adverse Event|1
4480743|NCT00718718|7278861|FG009|Prior to Week 12|Adverse Event|0
4480744|NCT00718718|7278852|FG000|Prior to Week 12|Withdrawal by Subject|0
4480745|NCT00718718|7278853|FG001|Prior to Week 12|Withdrawal by Subject|0
4480746|NCT00718718|7278854|FG002|Prior to Week 12|Withdrawal by Subject|0
4480747|NCT00718718|7278855|FG003|Prior to Week 12|Withdrawal by Subject|0
4480748|NCT00718718|7278856|FG004|Prior to Week 12|Withdrawal by Subject|3
4480749|NCT00718718|7278857|FG005|Prior to Week 12|Withdrawal by Subject|0
4480750|NCT00718718|7278858|FG006|Prior to Week 12|Withdrawal by Subject|1
4480751|NCT00718718|7278859|FG007|Prior to Week 12|Withdrawal by Subject|1
4480752|NCT00718718|7278860|FG008|Prior to Week 12|Withdrawal by Subject|1
4480753|NCT00718718|7278861|FG009|Prior to Week 12|Withdrawal by Subject|0
4480754|NCT00718718|7278852|FG000|Prior to Week 12|Other|1
4480755|NCT00718718|7278853|FG001|Prior to Week 12|Other|0
4480756|NCT00718718|7278854|FG002|Prior to Week 12|Other|1
4480757|NCT00718718|7278855|FG003|Prior to Week 12|Other|0
4480758|NCT00718718|7278856|FG004|Prior to Week 12|Other|0
4480759|NCT00718718|7278857|FG005|Prior to Week 12|Other|0
4480760|NCT00718718|7278858|FG006|Prior to Week 12|Other|0
4480761|NCT00718718|7278859|FG007|Prior to Week 12|Other|0
4480762|NCT00718718|7278860|FG008|Prior to Week 12|Other|0
4480763|NCT00718718|7278861|FG009|Prior to Week 12|Other|0
4480764|NCT00718718|7278852|FG000|Week 12 to End of Study|Adverse Event|0
4480765|NCT00718718|7278853|FG001|Week 12 to End of Study|Adverse Event|0
4480766|NCT00718718|7278854|FG002|Week 12 to End of Study|Adverse Event|0
4480767|NCT00718718|7278855|FG003|Week 12 to End of Study|Adverse Event|0
4480768|NCT00718718|7278856|FG004|Week 12 to End of Study|Adverse Event|0
4480769|NCT00718718|7278857|FG005|Week 12 to End of Study|Adverse Event|0
4480770|NCT00718718|7278858|FG006|Week 12 to End of Study|Adverse Event|0
4480771|NCT00718718|7278859|FG007|Week 12 to End of Study|Adverse Event|1
4480772|NCT00718718|7278860|FG008|Week 12 to End of Study|Adverse Event|0
4480773|NCT00718718|7278861|FG009|Week 12 to End of Study|Adverse Event|0
4480774|NCT00718718|7278852|FG000|Week 12 to End of Study|Death|0
4480775|NCT00718718|7278853|FG001|Week 12 to End of Study|Death|0
4480776|NCT00718718|7278854|FG002|Week 12 to End of Study|Death|0
4480777|NCT00718718|7278855|FG003|Week 12 to End of Study|Death|0
4480778|NCT00718718|7278856|FG004|Week 12 to End of Study|Death|0
4480779|NCT00718718|7278857|FG005|Week 12 to End of Study|Death|1
4480780|NCT00718718|7278858|FG006|Week 12 to End of Study|Death|0
4480781|NCT00718718|7278859|FG007|Week 12 to End of Study|Death|0
4480782|NCT00718718|7278860|FG008|Week 12 to End of Study|Death|0
4480783|NCT00718718|7278861|FG009|Week 12 to End of Study|Death|0
4480784|NCT00718718|7278852|FG000|Week 12 to End of Study|Withdrawal by Subject|0
4480785|NCT00718718|7278853|FG001|Week 12 to End of Study|Withdrawal by Subject|0
4480786|NCT00718718|7278854|FG002|Week 12 to End of Study|Withdrawal by Subject|0
4480787|NCT00718718|7278855|FG003|Week 12 to End of Study|Withdrawal by Subject|0
4480788|NCT00718718|7278856|FG004|Week 12 to End of Study|Withdrawal by Subject|0
4480789|NCT00718718|7278857|FG005|Week 12 to End of Study|Withdrawal by Subject|2
4480790|NCT00718718|7278858|FG006|Week 12 to End of Study|Withdrawal by Subject|1
4480791|NCT00718718|7278859|FG007|Week 12 to End of Study|Withdrawal by Subject|0
4480792|NCT00718718|7278860|FG008|Week 12 to End of Study|Withdrawal by Subject|0
4480793|NCT00718718|7278861|FG009|Week 12 to End of Study|Withdrawal by Subject|0
4480794|NCT00718718|7278852|FG000|Week 12 to End of Study|Lost to Follow-up|0
4480795|NCT00718718|7278853|FG001|Week 12 to End of Study|Lost to Follow-up|0
4480796|NCT00718718|7278854|FG002|Week 12 to End of Study|Lost to Follow-up|0
4480797|NCT00718718|7278855|FG003|Week 12 to End of Study|Lost to Follow-up|0
4480798|NCT00718718|7278856|FG004|Week 12 to End of Study|Lost to Follow-up|0
4480799|NCT00718718|7278857|FG005|Week 12 to End of Study|Lost to Follow-up|0
4480800|NCT00718718|7278858|FG006|Week 12 to End of Study|Lost to Follow-up|0
4480801|NCT00718718|7278859|FG007|Week 12 to End of Study|Lost to Follow-up|0
4480802|NCT00718718|7278860|FG008|Week 12 to End of Study|Lost to Follow-up|1
4480803|NCT00718718|7278861|FG009|Week 12 to End of Study|Lost to Follow-up|0
4480804|NCT00718718|7278852|FG000|Week 12 to End of Study|Other|0
4480805|NCT00718718|7278853|FG001|Week 12 to End of Study|Other|1
4480806|NCT00718718|7278854|FG002|Week 12 to End of Study|Other|0
4480807|NCT00718718|7278855|FG003|Week 12 to End of Study|Other|1
4480808|NCT00718718|7278856|FG004|Week 12 to End of Study|Other|0
4480809|NCT00718718|7278857|FG005|Week 12 to End of Study|Other|0
4480810|NCT00718718|7278858|FG006|Week 12 to End of Study|Other|1
4480811|NCT00718718|7278859|FG007|Week 12 to End of Study|Other|0
4480812|NCT00718718|7278860|FG008|Week 12 to End of Study|Other|0
4480813|NCT00718718|7278861|FG009|Week 12 to End of Study|Other|0
4480814|NCT00718770|7278887|FG000|Overall Study|Adverse Event|1
4480815|NCT00718770|7278887|FG000|Overall Study|Lack of Efficacy|1
4480816|NCT00718770|7278887|FG000|Overall Study|Lack of Efficacy|1
4480817|NCT00718770|7278887|FG000|Overall Study|Adverse Event|1
4480818|NCT00718770|7278887|FG000|Overall Study|Lack of Efficacy|1
4480819|NCT00718770|7278887|FG000|Overall Study|Adverse Event|1
4480820|NCT00718770|7278887|FG000|Overall Study|Lack of Efficacy|1
4480821|NCT00718770|7278887|FG000|Overall Study|Adverse Event|1
4480822|NCT00718809|7278893|FG000|Overall Study|Disease progression|9
4480823|NCT00718809|7278894|FG001|Overall Study|Disease progression|7
4480824|NCT00718809|7278893|FG000|Overall Study|Adverse Event|1
4480825|NCT00718809|7278894|FG001|Overall Study|Adverse Event|1
4480826|NCT00718809|7278893|FG000|Overall Study|Withdrawal by Subject|0
4480827|NCT00718809|7278894|FG001|Overall Study|Withdrawal by Subject|1
4480828|NCT00718809|7278893|FG000|Overall Study|Lost to Follow-up|1
4480829|NCT00718809|7278894|FG001|Overall Study|Lost to Follow-up|0
4480830|NCT00718809|7278893|FG000|Overall Study|Noncompliance|1
4480831|NCT00718809|7278894|FG001|Overall Study|Noncompliance|0
4480832|NCT00718861|7278902|FG000|Overall Study|Withdrawal by Subject|15
4480833|NCT00718861|7278903|FG001|Overall Study|Withdrawal by Subject|10
4480834|NCT00718861|7278902|FG000|Overall Study|Adverse Event|2
4480835|NCT00718861|7278903|FG001|Overall Study|Adverse Event|1
4480836|NCT00718861|7278902|FG000|Overall Study|Lost to Follow-up|2
4480837|NCT00718861|7278903|FG001|Overall Study|Lost to Follow-up|1
4480838|NCT00718861|7278902|FG000|Overall Study|Administrative Problems|1
4480839|NCT00718861|7278903|FG001|Overall Study|Administrative Problems|1
4480840|NCT00718861|7278902|FG000|Overall Study|Death|1
4480841|NCT00718861|7278903|FG001|Overall Study|Death|5
4480842|NCT00718887|7278911|FG000|Overall Study|Withdrawal by Subject|3
4480843|NCT00718887|7278912|FG001|Overall Study|Withdrawal by Subject|2
4480844|NCT00718887|7278911|FG000|Overall Study|Not identified|2
4480845|NCT00718887|7278912|FG001|Overall Study|Not identified|7
4480846|NCT00719043|7278931|FG000|Overall Study|Adverse Event|5
4480847|NCT00719043|7278932|FG001|Overall Study|Adverse Event|1
4480848|NCT00719043|7278933|FG002|Overall Study|Adverse Event|2
4480849|NCT00719043|7278934|FG003|Overall Study|Adverse Event|2
4480850|NCT00719043|7278935|FG004|Overall Study|Adverse Event|1
4480851|NCT00719043|7278936|FG005|Overall Study|Adverse Event|4
4480852|NCT00719043|7278937|FG006|Overall Study|Adverse Event|4
4480853|NCT00719043|7278931|FG000|Overall Study|Lost to Follow-up|14
4480854|NCT00719043|7278932|FG001|Overall Study|Lost to Follow-up|10
4480855|NCT00719043|7278933|FG002|Overall Study|Lost to Follow-up|8
4480856|NCT00719043|7278934|FG003|Overall Study|Lost to Follow-up|9
4480857|NCT00719043|7278935|FG004|Overall Study|Lost to Follow-up|10
4480858|NCT00719043|7278936|FG005|Overall Study|Lost to Follow-up|9
4480859|NCT00719043|7278937|FG006|Overall Study|Lost to Follow-up|9
4480860|NCT00719043|7278931|FG000|Overall Study|Protocol Violation|0
4480861|NCT00719043|7278932|FG001|Overall Study|Protocol Violation|0
4480862|NCT00719043|7278933|FG002|Overall Study|Protocol Violation|0
4480863|NCT00719043|7278934|FG003|Overall Study|Protocol Violation|0
4480864|NCT00719043|7278935|FG004|Overall Study|Protocol Violation|0
4480865|NCT00719043|7278936|FG005|Overall Study|Protocol Violation|1
4480866|NCT00719043|7278937|FG006|Overall Study|Protocol Violation|0
4480867|NCT00719043|7278931|FG000|Overall Study|Other|1
4480868|NCT00719043|7278932|FG001|Overall Study|Other|0
4480869|NCT00719043|7278933|FG002|Overall Study|Other|1
4480870|NCT00719043|7278934|FG003|Overall Study|Other|2
4480871|NCT00719043|7278935|FG004|Overall Study|Other|0
4480872|NCT00719043|7278936|FG005|Overall Study|Other|2
4480873|NCT00719043|7278937|FG006|Overall Study|Other|1
4480874|NCT00719043|7278931|FG000|Overall Study|Withdrawal by Subject|12
4480875|NCT00719043|7278932|FG001|Overall Study|Withdrawal by Subject|14
4480876|NCT00719043|7278933|FG002|Overall Study|Withdrawal by Subject|9
4480877|NCT00719043|7278934|FG003|Overall Study|Withdrawal by Subject|10
4480878|NCT00719043|7278935|FG004|Overall Study|Withdrawal by Subject|16
4480879|NCT00719043|7278936|FG005|Overall Study|Withdrawal by Subject|18
4480880|NCT00719043|7278937|FG006|Overall Study|Withdrawal by Subject|14
4480881|NCT00719212|7278987|FG000|Overall Study|Death|41
4480882|NCT00719212|7278987|FG000|Overall Study|Lost to Follow-up|2
4480883|NCT00719212|7278987|FG000|Overall Study|Withdrawal by Subject|1
4480884|NCT00719264|7278993|FG000|Overall Study|Adverse Event|41
4480885|NCT00719264|7278994|FG001|Overall Study|Adverse Event|49
4480886|NCT00719264|7278993|FG000|Overall Study|Death|13
4480887|NCT00719264|7278994|FG001|Overall Study|Death|10
4480888|NCT00719264|7278993|FG000|Overall Study|Administrative Problems|6
4480889|NCT00719264|7278994|FG001|Overall Study|Administrative Problems|4
4480890|NCT00719264|7278993|FG000|Overall Study|Lost to Follow-up|1
4480891|NCT00719264|7278994|FG001|Overall Study|Lost to Follow-up|1
4480892|NCT00719264|7278993|FG000|Overall Study|Withdrawal by Subject|12
4480893|NCT00719264|7278994|FG001|Overall Study|Withdrawal by Subject|7
4480894|NCT00719264|7278993|FG000|Overall Study|Protocol Deviation|1
4480895|NCT00719264|7278994|FG001|Overall Study|Protocol Deviation|3
4480896|NCT00719264|7278993|FG000|Overall Study|New Cancer Therapy|4
4480897|NCT00719264|7278994|FG001|Overall Study|New Cancer Therapy|2
4480898|NCT00719264|7278993|FG000|Overall Study|Disease Progression|104
4480899|NCT00719264|7278994|FG001|Overall Study|Disease Progression|107
4480900|NCT00719355|7279018|FG000|Overall Study|Death|0
4480901|NCT00719355|7279019|FG001|Overall Study|Death|1
4480902|NCT00719355|7279018|FG000|Overall Study|Medical|14
4480903|NCT00719355|7279019|FG001|Overall Study|Medical|5
4480904|NCT00719355|7279018|FG000|Overall Study|Compliance|4
4480905|NCT00719355|7279019|FG001|Overall Study|Compliance|6
4480906|NCT00719355|7279018|FG000|Overall Study|Moved|0
4480907|NCT00719355|7279019|FG001|Overall Study|Moved|1
4480908|NCT00719472|7279025|FG000|Enrolled in Study|Physician decision to withdraw patient|1
4480909|NCT00719472|7279025|FG000|Enrolled in Study|Subject decision to withdraw|8
4480910|NCT00719472|7279025|FG000|Enrolled in Study|Various Reasons|17
4480911|NCT00719472|7279025|FG000|Received Cycle 1 Treatment|Adverse Event|8
4480912|NCT00719472|7279025|FG000|Received Cycle 1 Treatment|Death|5
4480913|NCT00719472|7279025|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11
4480914|NCT00719472|7279025|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7
4480915|NCT00719472|7279025|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9
4480916|NCT00719472|7279025|FG000|Received Cycle 1 Treatment|Various Reasons|13
4480917|NCT00719472|7279025|FG000|Received Cycle 2 Treatment|Adverse Event|12
4480918|NCT00719472|7279025|FG000|Received Cycle 2 Treatment|Death|6
4480919|NCT00719472|7279025|FG000|Received Cycle 2 Treatment|Disease progression|3
4480920|NCT00719472|7279025|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3
4480921|NCT00719472|7279025|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13
4480922|NCT00719472|7279025|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6
4480923|NCT00719472|7279025|FG000|Received Cycle 2 Treatment|Various Reasons|25
4480924|NCT00719537|7279031|FG000|Overall Study|Withdrawal by Subject|1
4480925|NCT00719537|7279032|FG001|Overall Study|Withdrawal by Subject|0
4480926|NCT00719537|7279031|FG000|Overall Study|Lost to Follow-up|0
4480927|NCT00719537|7279032|FG001|Overall Study|Lost to Follow-up|1
4480928|NCT00719563|7279040|FG000|Overall Study|Adverse Event|16
4480929|NCT00719563|7279041|FG001|Overall Study|Adverse Event|13
4480930|NCT00719563|7279040|FG000|Overall Study|Medical condition changed|3
4480931|NCT00719563|7279041|FG001|Overall Study|Medical condition changed|5
4480932|NCT00719563|7279040|FG000|Overall Study|Lack of Efficacy|3
4480933|NCT00719563|7279041|FG001|Overall Study|Lack of Efficacy|7
4480934|NCT00719563|7279040|FG000|Overall Study|Personal reasons|6
4480935|NCT00719563|7279041|FG001|Overall Study|Personal reasons|7
4480936|NCT00719563|7279040|FG000|Overall Study|Unknown reasons|4
4480937|NCT00719563|7279041|FG001|Overall Study|Unknown reasons|6
4480938|NCT00719563|7279040|FG000|Overall Study|Noncompliant|1
4480939|NCT00719563|7279041|FG001|Overall Study|Noncompliant|1
4480940|NCT00719563|7279040|FG000|Overall Study|Lost to Follow-up|5
4480941|NCT00719563|7279041|FG001|Overall Study|Lost to Follow-up|3
4480942|NCT00719680|7279072|FG000|Overall Study|Adverse Event|1
4480943|NCT00719680|7279072|FG000|Overall Study|Lost to Follow-up|1
4480944|NCT00719680|7279072|FG000|Overall Study|Withdrawal by Subject|3
4480945|NCT00719706|7279078|FG000|Overall Study|Adverse Event|5
4480946|NCT00719706|7279079|FG001|Overall Study|Adverse Event|4
4480947|NCT00719706|7279078|FG000|Overall Study|Withdrawal by Subject|1
4480948|NCT00719706|7279079|FG001|Overall Study|Withdrawal by Subject|2
4480949|NCT00719706|7279078|FG000|Overall Study|Protocol Violation|3
4480950|NCT00719706|7279079|FG001|Overall Study|Protocol Violation|0
4480951|NCT00719732|7279085|FG000|Overall Study|Lost to Follow-up|20
4480952|NCT00719732|7279085|FG000|Overall Study|Unilateral (not bilateral) implantation|1
4480953|NCT00719732|7279085|FG000|Overall Study|Illness not associated with device|1
4480954|NCT00719810|7279092|FG000|Overall Study|Adverse Event|0
4480955|NCT00719810|7279093|FG001|Overall Study|Adverse Event|2
4480956|NCT00719810|7279094|FG002|Overall Study|Adverse Event|3
4480957|NCT00719810|7279092|FG000|Overall Study|Lost to Follow-up|2
4480958|NCT00719810|7279093|FG001|Overall Study|Lost to Follow-up|0
4480959|NCT00719810|7279094|FG002|Overall Study|Lost to Follow-up|3
4480960|NCT00719810|7279092|FG000|Overall Study|Physician Decision|0
4480961|NCT00719810|7279093|FG001|Overall Study|Physician Decision|1
4480962|NCT00719810|7279094|FG002|Overall Study|Physician Decision|0
4480963|NCT00719810|7279092|FG000|Overall Study|Withdrawal by Subject|1
4480964|NCT00719810|7279093|FG001|Overall Study|Withdrawal by Subject|1
4480965|NCT00719810|7279094|FG002|Overall Study|Withdrawal by Subject|2
4480966|NCT00719849|7279104|FG000|Overall Study|Death|0
4480967|NCT00719849|7279105|FG001|Overall Study|Death|1
4480968|NCT00719862|7279113|FG000|Overall Study|Adverse Event|1
4480969|NCT00719862|7279114|FG001|Overall Study|Adverse Event|2
4480970|NCT00719862|7279113|FG000|Overall Study|Lack of Efficacy|3
4480971|NCT00719862|7279114|FG001|Overall Study|Lack of Efficacy|0
4480972|NCT00719862|7279113|FG000|Overall Study|Non-Compliance|1
4480973|NCT00719862|7279114|FG001|Overall Study|Non-Compliance|0
4480974|NCT00719862|7279113|FG000|Overall Study|Withdrawal by Subject|1
4480975|NCT00719862|7279114|FG001|Overall Study|Withdrawal by Subject|0
4480976|NCT00719862|7279113|FG000|Overall Study|Lost to Follow-up|0
4480977|NCT00719862|7279114|FG001|Overall Study|Lost to Follow-up|1
4480978|NCT00719862|7279113|FG000|Overall Study|Other|2
4480979|NCT00719862|7279114|FG001|Overall Study|Other|3
4480980|NCT00719901|7279120|FG000|Overall Study|Adverse Event|5
4480981|NCT00719901|7279120|FG000|Overall Study|Withdrawal by Subject|1
4480982|NCT00719901|7279120|FG000|Overall Study|Alternate Treatment|1
4480983|NCT00719901|7279120|FG000|Overall Study|Disease Progression|3
4480984|NCT00719901|7279120|FG000|Overall Study|Availability of Study Drug|1
4480985|NCT00719953|7279124|FG000|Overall Study|Adverse Event|4
4480986|NCT00720057|7279130|FG000|Overall Study|Lost to Follow-up|0
4480987|NCT00720057|7279131|FG001|Overall Study|Lost to Follow-up|2
4480988|NCT00720057|7279130|FG000|Overall Study|Protocol Violation|1
4480989|NCT00720057|7279131|FG001|Overall Study|Protocol Violation|0
4480990|NCT00720057|7279130|FG000|Overall Study|Withdrawal by Subject|0
4480991|NCT00720057|7279131|FG001|Overall Study|Withdrawal by Subject|1
4480992|NCT00720096|7279139|FG000|Overall Study|Withdrawal by Subject|0
4480993|NCT00720096|7279140|FG001|Overall Study|Withdrawal by Subject|2
4480994|NCT00720109|7279146|FG000|Induction Period|Did not meet eligibility criteria|3
4480995|NCT00720109|7279147|FG001|Induction Period|Did not meet eligibility criteria|0
4480996|NCT00720109|7279148|FG002|Induction Period|Did not meet eligibility criteria|0
4480997|NCT00720109|7279146|FG000|Induction Period|Bone Marrow Transplant|2
4480998|NCT00720109|7279147|FG001|Induction Period|Bone Marrow Transplant|0
4480999|NCT00720109|7279148|FG002|Induction Period|Bone Marrow Transplant|0
4481000|NCT00720109|7279146|FG000|Induction Period|Physician Decision|1
4481001|NCT00720109|7279147|FG001|Induction Period|Physician Decision|0
4481002|NCT00720109|7279148|FG002|Induction Period|Physician Decision|0
4481003|NCT00720109|7279146|FG000|Risk Stratification Period|Adverse Event|0
4481004|NCT00720109|7279147|FG001|Risk Stratification Period|Adverse Event|1
4481005|NCT00720109|7279148|FG002|Risk Stratification Period|Adverse Event|0
4481006|NCT00720109|7279146|FG000|Risk Stratification Period|Physician Decision|0
4481007|NCT00720109|7279147|FG001|Risk Stratification Period|Physician Decision|2
4481008|NCT00720109|7279148|FG002|Risk Stratification Period|Physician Decision|1
4481009|NCT00720109|7279146|FG000|Risk Stratification Period|Bone marrow transplant|0
4481010|NCT00720109|7279147|FG001|Risk Stratification Period|Bone marrow transplant|9
4481011|NCT00720109|7279148|FG002|Risk Stratification Period|Bone marrow transplant|7
4481012|NCT00720109|7279146|FG000|Risk Stratification Period|Disease progression or relapse|0
4481013|NCT00720109|7279147|FG001|Risk Stratification Period|Disease progression or relapse|2
4481014|NCT00720109|7279148|FG002|Risk Stratification Period|Disease progression or relapse|0
4481015|NCT00720109|7279146|FG000|Risk Stratification Period|Development of second malignant neoplasm|0
4481016|NCT00720109|7279147|FG001|Risk Stratification Period|Development of second malignant neoplasm|1
4481017|NCT00720109|7279148|FG002|Risk Stratification Period|Development of second malignant neoplasm|0
4481018|NCT00720122|7279157|FG000|Overall Study|Lost to Follow-up|1
4481019|NCT00720122|7279157|FG000|Overall Study|Physician Decision|1
4481020|NCT00720122|7279157|FG000|Overall Study|Withdrawal by Subject|7
4481021|NCT00720213|7279161|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7
4481022|NCT00720213|7279162|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0
4481023|NCT00720213|7279163|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0
4481024|NCT00720226|7279173|FG000|Overall Study|Withdrawal by Subject|7
4481025|NCT00720226|7279174|FG001|Overall Study|Withdrawal by Subject|4
4481026|NCT00720278|7279183|FG000|Overall Study|Adverse Event|5
4481027|NCT00720278|7279184|FG001|Overall Study|Adverse Event|3
4481028|NCT00720278|7279185|FG002|Overall Study|Adverse Event|4
4481029|NCT00720278|7279183|FG000|Overall Study|Withdrawal by Subject|0
4481030|NCT00720278|7279184|FG001|Overall Study|Withdrawal by Subject|1
4481031|NCT00720278|7279185|FG002|Overall Study|Withdrawal by Subject|0
4481032|NCT00720278|7279183|FG000|Overall Study|Lost to Follow-up|0
4481033|NCT00720278|7279184|FG001|Overall Study|Lost to Follow-up|0
4481034|NCT00720278|7279185|FG002|Overall Study|Lost to Follow-up|1
4481035|NCT00720278|7279183|FG000|Overall Study|Non-compliance|1
4481036|NCT00720278|7279184|FG001|Overall Study|Non-compliance|0
4481037|NCT00720278|7279185|FG002|Overall Study|Non-compliance|0
4481038|NCT00720278|7279183|FG000|Overall Study|eligibility criteria violation|1
4481039|NCT00720278|7279184|FG001|Overall Study|eligibility criteria violation|0
4481040|NCT00720278|7279185|FG002|Overall Study|eligibility criteria violation|1
4481041|NCT00720356|7279206|FG000|Registration to Study|Determined to have methylated MGMT|67
4481042|NCT00720356|7279206|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1
4481043|NCT00720356|7279206|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1
4481044|NCT00720356|7279206|FG000|Went on to be Treated Cycle 3|Adverse Event|1
4481045|NCT00720356|7279206|FG000|Went on to be Treated Cycle 3|Physician Decision|1
4481046|NCT00720356|7279206|FG000|Follow up Until Death|Withdrawal by Subject|1
4481047|NCT00720356|7279206|FG000|Follow up Until Death|Alive at last data collection|4
4481048|NCT00720382|7279223|FG000|Overall Study|Adverse Event|54
4481049|NCT00720382|7279224|FG001|Overall Study|Adverse Event|17
4481050|NCT00720382|7279223|FG000|Overall Study|Lack of Efficacy|18
4481051|NCT00720382|7279224|FG001|Overall Study|Lack of Efficacy|7
4481052|NCT00720382|7279223|FG000|Overall Study|Non-Compliance|15
4481053|NCT00720382|7279224|FG001|Overall Study|Non-Compliance|5
4481054|NCT00720382|7279223|FG000|Overall Study|Withdrawal by Subject|47
4481055|NCT00720382|7279224|FG001|Overall Study|Withdrawal by Subject|11
4481056|NCT00720382|7279223|FG000|Overall Study|Lost to Follow-up|28
4481057|NCT00720382|7279224|FG001|Overall Study|Lost to Follow-up|14
4481058|NCT00720382|7279223|FG000|Overall Study|administrative|14
4481059|NCT00720382|7279224|FG001|Overall Study|administrative|5
4481060|NCT00720434|7279234|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
4481061|NCT00720434|7279235|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1
4481062|NCT00720434|7279236|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
4481063|NCT00720434|7279237|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
4481064|NCT00720434|7279234|FG000|Open-Label Period (Week 5-72)|Adverse Event|0
4481065|NCT00720434|7279235|FG001|Open-Label Period (Week 5-72)|Adverse Event|0
4481066|NCT00720434|7279236|FG002|Open-Label Period (Week 5-72)|Adverse Event|0
4481067|NCT00720434|7279237|FG003|Open-Label Period (Week 5-72)|Adverse Event|2
4481068|NCT00720434|7279234|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1
4481069|NCT00720434|7279235|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0
4481070|NCT00720434|7279236|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0
4481071|NCT00720434|7279237|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0
4481072|NCT00720434|7279234|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1
4481073|NCT00720434|7279235|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0
4700762|NCT02699684|7616917|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1
4700763|NCT02699684|7616918|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0
4700764|NCT02699749|7616939|FG000|Overall Study|Other|0
4700765|NCT02699749|7616940|FG001|Overall Study|Other|0
4700766|NCT02699749|7616941|FG002|Overall Study|Other|2
4700767|NCT02699749|7616942|FG003|Overall Study|Other|0
4700768|NCT02699749|7616943|FG004|Overall Study|Other|0
4481074|NCT00720434|7279236|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1
4481075|NCT00720434|7279237|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0
4481076|NCT00720434|7279234|FG000|Open-Label Period (Week 5-72)|Other|4
4481077|NCT00720434|7279235|FG001|Open-Label Period (Week 5-72)|Other|3
4481078|NCT00720434|7279236|FG002|Open-Label Period (Week 5-72)|Other|3
4481079|NCT00720434|7279237|FG003|Open-Label Period (Week 5-72)|Other|2
4481080|NCT00720499|7279257|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2
4700769|NCT02699749|7616944|FG005|Overall Study|Other|1
4481081|NCT00720499|7279258|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0
4481082|NCT00720499|7279257|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1
4481083|NCT00720499|7279258|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2
4481084|NCT00720499|7279257|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2
4481085|NCT00720499|7279258|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3
4481086|NCT00720759|7279275|FG000|Overall Study|Lost to Follow-up|0
4481087|NCT00720759|7279276|FG001|Overall Study|Lost to Follow-up|1
4481088|NCT00720759|7279277|FG002|Overall Study|Lost to Follow-up|1
4481089|NCT00720759|7279278|FG003|Overall Study|Lost to Follow-up|0
4481090|NCT00720798|7279288|FG000|Overall Study|Adverse Event|304
4481091|NCT00720798|7279288|FG000|Overall Study|Death|39
4481092|NCT00720798|7279288|FG000|Overall Study|Insufficient Therapeutic Response|129
4481093|NCT00720798|7279288|FG000|Overall Study|Protocol Violation|4
4481094|NCT00720798|7279288|FG000|Overall Study|Refused Treatment|151
4481095|NCT00720798|7279288|FG000|Overall Study|Failure to Return|46
4481096|NCT00720798|7279288|FG000|Overall Study|Reason not Specified|83
4516925|NCT00962104|7328424|FG000|Overall Study|Withdrawal by Subject|10
4516926|NCT00962104|7328425|FG001|Overall Study|Withdrawal by Subject|6
4516927|NCT00962104|7328424|FG000|Overall Study|Other|2
4516928|NCT00962104|7328425|FG001|Overall Study|Other|0
4516929|NCT00962208|7328433|FG000|Overall Study|Could not achieve good vision|9
4516930|NCT00962208|7328434|FG001|Overall Study|Could not achieve good vision|0
4516931|NCT00962208|7328433|FG000|Overall Study|Contraindicated to continue study|5
4516932|NCT00962208|7328434|FG001|Overall Study|Contraindicated to continue study|1
4516933|NCT00962208|7328433|FG000|Overall Study|Lost to Follow-up|0
4516934|NCT00962208|7328434|FG001|Overall Study|Lost to Follow-up|9
4516935|NCT00962247|7328440|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4
4516936|NCT00962247|7328440|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1
4516937|NCT00962390|7328450|FG000|Overall Study|Adverse Event|0
4516938|NCT00962390|7328451|FG001|Overall Study|Adverse Event|0
4516939|NCT00962390|7328452|FG002|Overall Study|Adverse Event|3
4516940|NCT00962390|7328453|FG003|Overall Study|Adverse Event|1
4516941|NCT00962390|7328450|FG000|Overall Study|Lost to Follow-up|2
4516942|NCT00962390|7328451|FG001|Overall Study|Lost to Follow-up|2
4516943|NCT00962390|7328452|FG002|Overall Study|Lost to Follow-up|0
4516944|NCT00962390|7328453|FG003|Overall Study|Lost to Follow-up|0
4516945|NCT00962390|7328450|FG000|Overall Study|Protocol Violation|1
4516946|NCT00962390|7328451|FG001|Overall Study|Protocol Violation|0
4516947|NCT00962390|7328452|FG002|Overall Study|Protocol Violation|0
4516948|NCT00962390|7328453|FG003|Overall Study|Protocol Violation|0
4516949|NCT00962390|7328450|FG000|Overall Study|Withdrawal by Subject|1
4516950|NCT00962390|7328451|FG001|Overall Study|Withdrawal by Subject|1
4516951|NCT00962390|7328452|FG002|Overall Study|Withdrawal by Subject|1
4516952|NCT00962390|7328453|FG003|Overall Study|Withdrawal by Subject|0
4516953|NCT00962585|7328467|FG000|Overall Study|Adverse Event|0
4516954|NCT00962585|7328468|FG001|Overall Study|Adverse Event|2
4516955|NCT00962585|7328469|FG002|Overall Study|Adverse Event|1
4516956|NCT00962585|7328470|FG003|Overall Study|Adverse Event|0
4516957|NCT00962585|7328467|FG000|Overall Study|Lost to Follow-up|3
4516958|NCT00962585|7328468|FG001|Overall Study|Lost to Follow-up|0
4516959|NCT00962585|7328469|FG002|Overall Study|Lost to Follow-up|1
4516960|NCT00962585|7328470|FG003|Overall Study|Lost to Follow-up|0
4516961|NCT00962585|7328467|FG000|Overall Study|Protocol Violation|0
4516962|NCT00962585|7328468|FG001|Overall Study|Protocol Violation|0
4516963|NCT00962585|7328469|FG002|Overall Study|Protocol Violation|1
4516964|NCT00962585|7328470|FG003|Overall Study|Protocol Violation|0
4516965|NCT00962585|7328467|FG000|Overall Study|Withdrawal by Subject|1
4516966|NCT00962585|7328468|FG001|Overall Study|Withdrawal by Subject|0
4516967|NCT00962585|7328469|FG002|Overall Study|Withdrawal by Subject|0
4516968|NCT00962585|7328470|FG003|Overall Study|Withdrawal by Subject|0
4516969|NCT00962585|7328467|FG000|Overall Study|Withdrew Consent|2
4516970|NCT00962585|7328468|FG001|Overall Study|Withdrew Consent|0
4516971|NCT00962585|7328469|FG002|Overall Study|Withdrew Consent|0
4516972|NCT00962585|7328470|FG003|Overall Study|Withdrew Consent|0
4516973|NCT00962650|7328491|FG000|Overall Study|Transgastric DP was not completed|2
4516974|NCT00962741|7328495|FG000|Overall Study|Failed to return|3
4700770|NCT02699749|7616945|FG006|Overall Study|Other|1
4700771|NCT02699749|7616946|FG007|Overall Study|Other|0
4516975|NCT00962741|7328495|FG000|Overall Study|Lost to Follow-up|2
4516976|NCT00962741|7328495|FG000|Overall Study|Withdrawal by Subject|1
4516977|NCT00962741|7328495|FG000|Overall Study|Lack of Efficacy|1
4516978|NCT00962741|7328495|FG000|Overall Study|drug ineffective+prohibited drug taken|1
4633401|NCT01911819|7503581|FG001|Overall Study|Adverse Event|1
4700772|NCT02699749|7616947|FG008|Overall Study|Other|0
4516979|NCT00962780|7328514|FG000|Overall Study|Death|0
4516980|NCT00962780|7328515|FG001|Overall Study|Death|1
4516981|NCT00962780|7328514|FG000|Overall Study|Protocol Violation|9
4516982|NCT00962780|7328515|FG001|Overall Study|Protocol Violation|4
4700773|NCT02699749|7616948|FG009|Overall Study|Other|0
4516983|NCT00962780|7328514|FG000|Overall Study|Withdrawal by Subject|1
4516984|NCT00962780|7328515|FG001|Overall Study|Withdrawal by Subject|8
4516985|NCT00962780|7328514|FG000|Overall Study|Other|0
4516986|NCT00962780|7328515|FG001|Overall Study|Other|1
4516987|NCT00963235|7328587|FG000|Overall Study|Withdrawal by Subject|22
4516988|NCT00963235|7328587|FG000|Overall Study|Lost to Follow-up|14
4481097|NCT00720876|7279292|FG000|Overall Study|found to be ineligible after starting tx|2
4481098|NCT00720941|7279298|FG000|Overall Study|Death|334
4481099|NCT00720941|7279299|FG001|Overall Study|Death|335
4481100|NCT00720941|7279298|FG000|Overall Study|Protocol Violation|0
4481101|NCT00720941|7279299|FG001|Overall Study|Protocol Violation|2
4481102|NCT00720941|7279298|FG000|Overall Study|Lost to Follow-up|17
4481103|NCT00720941|7279299|FG001|Overall Study|Lost to Follow-up|15
4481104|NCT00720941|7279298|FG000|Overall Study|Physician Decision|1
4481105|NCT00720941|7279299|FG001|Overall Study|Physician Decision|5
4481106|NCT00720941|7279298|FG000|Overall Study|Withdrawal by Subject|27
4481107|NCT00720941|7279299|FG001|Overall Study|Withdrawal by Subject|35
4481108|NCT00720941|7279298|FG000|Overall Study|Ongoing|34
4481109|NCT00720941|7279299|FG001|Overall Study|Ongoing|23
4481110|NCT00721110|7279309|FG000|Overall Study|Ultram use|1
4481111|NCT00721110|7279310|FG001|Overall Study|Ultram use|0
4481112|NCT00721110|7279311|FG002|Overall Study|Ultram use|0
4481113|NCT00721110|7279312|FG003|Overall Study|Ultram use|0
4481114|NCT00721110|7279309|FG000|Overall Study|vertical incision|0
4481115|NCT00721110|7279310|FG001|Overall Study|vertical incision|0
4481116|NCT00721110|7279311|FG002|Overall Study|vertical incision|1
4481117|NCT00721110|7279312|FG003|Overall Study|vertical incision|0
4481118|NCT00721123|7279322|FG000|Overall Study|Adverse Event|96
4481119|NCT00721123|7279322|FG000|Overall Study|Death|10
4589692|NCT01514136|7435055|FG001|Test Period 2; Test C*|Protocol Violation|0
4589693|NCT01514136|7435056|FG002|Test Period 2; Test C*|Protocol Violation|0
4481120|NCT00721123|7279322|FG000|Overall Study|Insufficient Therapeutic Response|21
4481121|NCT00721123|7279322|FG000|Overall Study|Protocol Violation|1
4481122|NCT00721123|7279322|FG000|Overall Study|Refused Treatment|41
4481123|NCT00721123|7279322|FG000|Overall Study|Failure to Return|9
4481124|NCT00721123|7279322|FG000|Overall Study|Withdrawal by Subject|5
4481125|NCT00721149|7279363|FG000|Overall Study|Physician Decision|1
4481126|NCT00721214|7279384|FG000|Overall Study|Chose another center for transplant|1
4481127|NCT00721214|7279384|FG000|Overall Study|Death|3
4481128|NCT00721227|7279390|FG000|Overall Study|Lost to Follow-up|3
4481129|NCT00721227|7279391|FG001|Overall Study|Lost to Follow-up|0
4481130|NCT00721227|7279390|FG000|Overall Study|Noncompliance with scheduled visits.|1
4481131|NCT00721227|7279391|FG001|Overall Study|Noncompliance with scheduled visits.|0
4481132|NCT00721279|7279409|FG000|Overall Study|Lack of Efficacy|6
4481133|NCT00721279|7279410|FG001|Overall Study|Lack of Efficacy|3
4481134|NCT00721279|7279409|FG000|Overall Study|Tolerability insufficient|5
4481135|NCT00721279|7279410|FG001|Overall Study|Tolerability insufficient|2
4481136|NCT00721279|7279409|FG000|Overall Study|Withdrawal by Subject|13
4481137|NCT00721279|7279410|FG001|Overall Study|Withdrawal by Subject|3
4481138|NCT00721279|7279409|FG000|Overall Study|Other|12
4481139|NCT00721279|7279410|FG001|Overall Study|Other|16
4481140|NCT00721396|7279432|FG000|Overall Study|Adverse Event|4
4481141|NCT00721396|7279433|FG001|Overall Study|Adverse Event|7
4481142|NCT00721396|7279434|FG002|Overall Study|Adverse Event|2
4481143|NCT00721396|7279435|FG003|Overall Study|Adverse Event|0
4481144|NCT00721396|7279432|FG000|Overall Study|Withdrawal by Subject|12
4481145|NCT00721396|7279433|FG001|Overall Study|Withdrawal by Subject|15
4481146|NCT00721396|7279434|FG002|Overall Study|Withdrawal by Subject|3
4481147|NCT00721396|7279435|FG003|Overall Study|Withdrawal by Subject|7
4481148|NCT00721396|7279432|FG000|Overall Study|Lost to Follow-up|7
4481149|NCT00721396|7279433|FG001|Overall Study|Lost to Follow-up|9
4481150|NCT00721396|7279434|FG002|Overall Study|Lost to Follow-up|3
4481151|NCT00721396|7279435|FG003|Overall Study|Lost to Follow-up|3
4481152|NCT00721396|7279432|FG000|Overall Study|Protocol Violation|4
4481153|NCT00721396|7279433|FG001|Overall Study|Protocol Violation|3
4481154|NCT00721396|7279434|FG002|Overall Study|Protocol Violation|1
4481155|NCT00721396|7279435|FG003|Overall Study|Protocol Violation|0
4481156|NCT00721396|7279432|FG000|Overall Study|Inappropriate enrollment|0
4481157|NCT00721396|7279433|FG001|Overall Study|Inappropriate enrollment|2
4481158|NCT00721396|7279434|FG002|Overall Study|Inappropriate enrollment|0
4481159|NCT00721396|7279435|FG003|Overall Study|Inappropriate enrollment|0
4481160|NCT00721396|7279432|FG000|Overall Study|Administrative reason|3
4589694|NCT01514136|7435057|FG003|Test Period 2; Test C*|Protocol Violation|0
4481161|NCT00721396|7279433|FG001|Overall Study|Administrative reason|0
4481162|NCT00721396|7279434|FG002|Overall Study|Administrative reason|1
4481163|NCT00721396|7279435|FG003|Overall Study|Administrative reason|0
4481164|NCT00721409|7279453|FG000|Overall Study|Global deterioration of health status|2
4481165|NCT00721409|7279454|FG001|Overall Study|Global deterioration of health status|6
4481166|NCT00721409|7279455|FG002|Overall Study|Global deterioration of health status|3
4481167|NCT00721409|7279453|FG000|Overall Study|Death|0
4481168|NCT00721409|7279454|FG001|Overall Study|Death|1
4481169|NCT00721409|7279455|FG002|Overall Study|Death|0
4481170|NCT00721409|7279453|FG000|Overall Study|Randomized not Treated|0
4481171|NCT00721409|7279454|FG001|Overall Study|Randomized not Treated|1
4481172|NCT00721409|7279455|FG002|Overall Study|Randomized not Treated|4
4481173|NCT00721409|7279453|FG000|Overall Study|Reason not specified|1
4481174|NCT00721409|7279454|FG001|Overall Study|Reason not specified|0
4481175|NCT00721409|7279455|FG002|Overall Study|Reason not specified|2
4481176|NCT00721409|7279453|FG000|Overall Study|Adverse Event|0
4481177|NCT00721409|7279454|FG001|Overall Study|Adverse Event|13
4481178|NCT00721409|7279455|FG002|Overall Study|Adverse Event|2
4481179|NCT00721409|7279453|FG000|Overall Study|Lost to Follow-up|0
4481180|NCT00721409|7279454|FG001|Overall Study|Lost to Follow-up|0
4481181|NCT00721409|7279455|FG002|Overall Study|Lost to Follow-up|1
4481182|NCT00721409|7279453|FG000|Overall Study|Withdrawal by Subject|1
4481183|NCT00721409|7279454|FG001|Overall Study|Withdrawal by Subject|6
4481184|NCT00721409|7279455|FG002|Overall Study|Withdrawal by Subject|5
4481185|NCT00721409|7279453|FG000|Overall Study|Objective progression or relapse|8
4481186|NCT00721409|7279454|FG001|Overall Study|Objective progression or relapse|55
4481187|NCT00721409|7279455|FG002|Overall Study|Objective progression or relapse|62
4481188|NCT00721578|7279502|FG000|Overall Study|Death|1
4481189|NCT00721578|7279503|FG001|Overall Study|Death|1
4481190|NCT00721578|7279502|FG000|Overall Study|Withdrawal by Subject|1
4481191|NCT00721578|7279503|FG001|Overall Study|Withdrawal by Subject|1
4481192|NCT00721630|7279514|FG000|Overall Study|Participant found to be ineligible|1
4481193|NCT00721734|7279523|FG000|Overall Study|Progressive Disease|3
4481194|NCT00721734|7279524|FG001|Overall Study|Progressive Disease|10
4481195|NCT00721734|7279525|FG002|Overall Study|Progressive Disease|4
4481196|NCT00721734|7279526|FG003|Overall Study|Progressive Disease|5
4481197|NCT00721734|7279527|FG004|Overall Study|Progressive Disease|2
4481198|NCT00721734|7279523|FG000|Overall Study|Adverse Event|3
4481199|NCT00721734|7279524|FG001|Overall Study|Adverse Event|1
4481200|NCT00721734|7279525|FG002|Overall Study|Adverse Event|4
4481201|NCT00721734|7279526|FG003|Overall Study|Adverse Event|0
4481202|NCT00721734|7279527|FG004|Overall Study|Adverse Event|3
4481203|NCT00721734|7279523|FG000|Overall Study|Withdrawal by Subject|2
4481204|NCT00721734|7279524|FG001|Overall Study|Withdrawal by Subject|1
4481205|NCT00721734|7279525|FG002|Overall Study|Withdrawal by Subject|0
4481206|NCT00721734|7279526|FG003|Overall Study|Withdrawal by Subject|0
4481207|NCT00721734|7279527|FG004|Overall Study|Withdrawal by Subject|1
4481208|NCT00721734|7279523|FG000|Overall Study|Other|0
4481209|NCT00721734|7279524|FG001|Overall Study|Other|0
4481210|NCT00721734|7279525|FG002|Overall Study|Other|0
4481211|NCT00721734|7279526|FG003|Overall Study|Other|1
4481212|NCT00721734|7279527|FG004|Overall Study|Other|0
4481213|NCT00721799|7279539|FG000|Overall Study|Withdrawal by Subject|7
4481214|NCT00721799|7279539|FG000|Overall Study|withdraw by subject after scan 1|1
4481215|NCT00721955|7279546|FG000|Overall Study|Adverse Event|0
4481216|NCT00721955|7279547|FG001|Overall Study|Adverse Event|0
4481217|NCT00721955|7279548|FG002|Overall Study|Adverse Event|2
4481218|NCT00721968|7279558|FG000|Overall Study|Lost to Follow-up|2
4481219|NCT00721968|7279559|FG001|Overall Study|Lost to Follow-up|0
4481220|NCT00722137|7279609|FG000|Overall Study|Overt Disease Progression|5
4481221|NCT00722137|7279610|FG001|Overall Study|Overt Disease Progression|4
4481222|NCT00722137|7279609|FG000|Overall Study|Adverse Event|17
4481223|NCT00722137|7279610|FG001|Overall Study|Adverse Event|21
4481224|NCT00722137|7279609|FG000|Overall Study|Death|12
4481225|NCT00722137|7279610|FG001|Overall Study|Death|7
4481226|NCT00722137|7279609|FG000|Overall Study|Withdrawal by Subject|6
4481227|NCT00722137|7279610|FG001|Overall Study|Withdrawal by Subject|9
4481228|NCT00722137|7279609|FG000|Overall Study|Other Reason Unknown|3
4481229|NCT00722137|7279610|FG001|Overall Study|Other Reason Unknown|4
4481230|NCT00722137|7279609|FG000|Overall Study|Randomized But Not Treated|2
4481231|NCT00722137|7279610|FG001|Overall Study|Randomized But Not Treated|3
4481232|NCT00722371|7279623|FG000|Overall Study|Adverse Event|6
4481233|NCT00722371|7279624|FG001|Overall Study|Adverse Event|13
4481234|NCT00722371|7279625|FG002|Overall Study|Adverse Event|9
4481235|NCT00722371|7279626|FG003|Overall Study|Adverse Event|10
4481236|NCT00722371|7279627|FG004|Overall Study|Adverse Event|6
4481237|NCT00722371|7279628|FG005|Overall Study|Adverse Event|8
4481238|NCT00722371|7279629|FG006|Overall Study|Adverse Event|4
4481239|NCT00722371|7279623|FG000|Overall Study|Contraindication|0
4481240|NCT00722371|7279624|FG001|Overall Study|Contraindication|0
4589695|NCT01514136|7435058|FG004|Test Period 2; Test C*|Protocol Violation|0
4589696|NCT01514136|7435059|FG005|Test Period 2; Test C*|Protocol Violation|0
4481241|NCT00722371|7279625|FG002|Overall Study|Contraindication|1
4481242|NCT00722371|7279626|FG003|Overall Study|Contraindication|0
4481243|NCT00722371|7279627|FG004|Overall Study|Contraindication|0
4481244|NCT00722371|7279628|FG005|Overall Study|Contraindication|0
4481245|NCT00722371|7279629|FG006|Overall Study|Contraindication|0
4481246|NCT00722371|7279623|FG000|Overall Study|Creatinine / Creatinine clearance|2
4481247|NCT00722371|7279624|FG001|Overall Study|Creatinine / Creatinine clearance|1
4481248|NCT00722371|7279625|FG002|Overall Study|Creatinine / Creatinine clearance|2
4481249|NCT00722371|7279626|FG003|Overall Study|Creatinine / Creatinine clearance|3
4481250|NCT00722371|7279627|FG004|Overall Study|Creatinine / Creatinine clearance|2
4481251|NCT00722371|7279628|FG005|Overall Study|Creatinine / Creatinine clearance|1
4481252|NCT00722371|7279629|FG006|Overall Study|Creatinine / Creatinine clearance|1
4481253|NCT00722371|7279623|FG000|Overall Study|Excluded medication|0
4481254|NCT00722371|7279624|FG001|Overall Study|Excluded medication|1
4481255|NCT00722371|7279625|FG002|Overall Study|Excluded medication|1
4481256|NCT00722371|7279626|FG003|Overall Study|Excluded medication|0
4481257|NCT00722371|7279627|FG004|Overall Study|Excluded medication|0
4481258|NCT00722371|7279628|FG005|Overall Study|Excluded medication|0
4481259|NCT00722371|7279629|FG006|Overall Study|Excluded medication|1
4481260|NCT00722371|7279623|FG000|Overall Study|Hyperglycemia|2
4481261|NCT00722371|7279624|FG001|Overall Study|Hyperglycemia|6
4481262|NCT00722371|7279625|FG002|Overall Study|Hyperglycemia|4
4481263|NCT00722371|7279626|FG003|Overall Study|Hyperglycemia|2
4481264|NCT00722371|7279627|FG004|Overall Study|Hyperglycemia|5
4481265|NCT00722371|7279628|FG005|Overall Study|Hyperglycemia|1
4481266|NCT00722371|7279629|FG006|Overall Study|Hyperglycemia|1
4481267|NCT00722371|7279623|FG000|Overall Study|Hypoglycemia|1
4481268|NCT00722371|7279624|FG001|Overall Study|Hypoglycemia|0
4481269|NCT00722371|7279625|FG002|Overall Study|Hypoglycemia|0
4481270|NCT00722371|7279626|FG003|Overall Study|Hypoglycemia|0
4481271|NCT00722371|7279627|FG004|Overall Study|Hypoglycemia|0
4481272|NCT00722371|7279628|FG005|Overall Study|Hypoglycemia|0
4481273|NCT00722371|7279629|FG006|Overall Study|Hypoglycemia|0
4481274|NCT00722371|7279623|FG000|Overall Study|Lack of Efficacy|4
4481275|NCT00722371|7279624|FG001|Overall Study|Lack of Efficacy|6
4481276|NCT00722371|7279625|FG002|Overall Study|Lack of Efficacy|6
4481277|NCT00722371|7279626|FG003|Overall Study|Lack of Efficacy|6
4481278|NCT00722371|7279627|FG004|Overall Study|Lack of Efficacy|2
4481279|NCT00722371|7279628|FG005|Overall Study|Lack of Efficacy|3
4481280|NCT00722371|7279629|FG006|Overall Study|Lack of Efficacy|0
4481281|NCT00722371|7279623|FG000|Overall Study|Lost to Follow-up|11
4481282|NCT00722371|7279624|FG001|Overall Study|Lost to Follow-up|14
4481283|NCT00722371|7279625|FG002|Overall Study|Lost to Follow-up|21
4481284|NCT00722371|7279626|FG003|Overall Study|Lost to Follow-up|13
4481285|NCT00722371|7279627|FG004|Overall Study|Lost to Follow-up|8
4481286|NCT00722371|7279628|FG005|Overall Study|Lost to Follow-up|16
4481287|NCT00722371|7279629|FG006|Overall Study|Lost to Follow-up|13
4481288|NCT00722371|7279623|FG000|Overall Study|Physician Decision|5
4481289|NCT00722371|7279624|FG001|Overall Study|Physician Decision|2
4481290|NCT00722371|7279625|FG002|Overall Study|Physician Decision|2
4481291|NCT00722371|7279626|FG003|Overall Study|Physician Decision|5
4481292|NCT00722371|7279627|FG004|Overall Study|Physician Decision|2
4481293|NCT00722371|7279628|FG005|Overall Study|Physician Decision|3
4481294|NCT00722371|7279629|FG006|Overall Study|Physician Decision|4
4481295|NCT00722371|7279623|FG000|Overall Study|Pregnancy|1
4481296|NCT00722371|7279624|FG001|Overall Study|Pregnancy|1
4481297|NCT00722371|7279625|FG002|Overall Study|Pregnancy|0
4481298|NCT00722371|7279626|FG003|Overall Study|Pregnancy|0
4481299|NCT00722371|7279627|FG004|Overall Study|Pregnancy|0
4481300|NCT00722371|7279628|FG005|Overall Study|Pregnancy|1
4481301|NCT00722371|7279629|FG006|Overall Study|Pregnancy|0
4481302|NCT00722371|7279623|FG000|Overall Study|Protocol Violation|6
4481303|NCT00722371|7279624|FG001|Overall Study|Protocol Violation|1
4481304|NCT00722371|7279625|FG002|Overall Study|Protocol Violation|0
4481305|NCT00722371|7279626|FG003|Overall Study|Protocol Violation|1
4481306|NCT00722371|7279627|FG004|Overall Study|Protocol Violation|4
4481307|NCT00722371|7279628|FG005|Overall Study|Protocol Violation|2
4481308|NCT00722371|7279629|FG006|Overall Study|Protocol Violation|1
4481309|NCT00722371|7279623|FG000|Overall Study|Withdrawal by Subject|18
4481310|NCT00722371|7279624|FG001|Overall Study|Withdrawal by Subject|27
4481311|NCT00722371|7279625|FG002|Overall Study|Withdrawal by Subject|19
4481312|NCT00722371|7279626|FG003|Overall Study|Withdrawal by Subject|23
4481313|NCT00722371|7279627|FG004|Overall Study|Withdrawal by Subject|19
4481314|NCT00722371|7279628|FG005|Overall Study|Withdrawal by Subject|18
4481315|NCT00722371|7279629|FG006|Overall Study|Withdrawal by Subject|26
4481316|NCT00722423|7279647|FG000|Overall Study|Protocol Violation|0
4481317|NCT00722423|7279648|FG001|Overall Study|Protocol Violation|1
4481318|NCT00722761|7279697|FG000|Overall Study|Lost to Follow-up|1
4481319|NCT00722761|7279698|FG001|Overall Study|Lost to Follow-up|4
4481320|NCT00722761|7279697|FG000|Overall Study|Withdrawal by Subject|5
4481321|NCT00722761|7279698|FG001|Overall Study|Withdrawal by Subject|2
4481322|NCT00722800|7279706|FG000|Overall Study|Withdrawal by Subject|1
4481323|NCT00722800|7279707|FG001|Overall Study|Withdrawal by Subject|0
4481324|NCT00722800|7279706|FG000|Overall Study|Physician Decision|1
4481325|NCT00722800|7279707|FG001|Overall Study|Physician Decision|0
4481326|NCT00723008|7279719|FG000|Enrollment|Lost to Follow-up|1
4481327|NCT00723008|7279720|FG001|Enrollment|Lost to Follow-up|0
4481328|NCT00723008|7279719|FG000|4-Week Double Blinded|Lack of Efficacy|0
4481329|NCT00723008|7279720|FG001|4-Week Double Blinded|Lack of Efficacy|1
4481330|NCT00723008|7279719|FG000|4-Week Double Blinded|Withdrawal by Subject|1
4481331|NCT00723008|7279720|FG001|4-Week Double Blinded|Withdrawal by Subject|1
4481332|NCT00723008|7279719|FG000|4-Week Double Blinded|Lost to Follow-up|4
4481333|NCT00723008|7279720|FG001|4-Week Double Blinded|Lost to Follow-up|3
4481334|NCT00723008|7279719|FG000|4-Week Unblinded Treatment|Adverse Event|1
4481335|NCT00723008|7279720|FG001|4-Week Unblinded Treatment|Adverse Event|0
4481336|NCT00723008|7279719|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0
4481337|NCT00723008|7279720|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1
4481338|NCT00723021|7279734|FG000|Intervention Period 4|Adverse Event|0
4481339|NCT00723021|7279735|FG001|Intervention Period 4|Adverse Event|0
4481340|NCT00723021|7279736|FG002|Intervention Period 4|Adverse Event|0
4481341|NCT00723021|7279737|FG003|Intervention Period 4|Adverse Event|0
4481342|NCT00723021|7279738|FG004|Intervention Period 4|Adverse Event|1
4481343|NCT00723125|7279773|FG000|Overall Study|Met Dx|1
4481344|NCT00723125|7279774|FG001|Overall Study|Met Dx|0
4481345|NCT00723125|7279773|FG000|Overall Study|Withdrawal by Subject|15
4481346|NCT00723125|7279774|FG001|Overall Study|Withdrawal by Subject|6
4481347|NCT00723125|7279773|FG000|Overall Study|Adverse Event|2
4481348|NCT00723125|7279774|FG001|Overall Study|Adverse Event|0
4481349|NCT00723190|7279799|FG000|Overall Study|Withdrawal by Subject|45
4481350|NCT00723190|7279799|FG000|Overall Study|Lost to Follow-up|37
4481351|NCT00723190|7279799|FG000|Overall Study|Adverse Event|18
4481352|NCT00723190|7279799|FG000|Overall Study|Lack of Efficacy|16
4481353|NCT00723190|7279799|FG000|Overall Study|Protocol Violation|15
4481354|NCT00723190|7279799|FG000|Overall Study|Other-Premature Discontinuation|9
4481355|NCT00723190|7279799|FG000|Overall Study|Other-Not included in safety population|2
4481356|NCT00723203|7279803|FG000|Overall Study|Withdrawal by Subject|3
4481357|NCT00723229|7279809|FG000|First Intervention|Lost to Follow-up|7
4481358|NCT00723229|7279810|FG001|First Intervention|Lost to Follow-up|3
4481359|NCT00723255|7279816|FG000|Overall Study|Ineligible: Inadequate pathology|1
4481360|NCT00723255|7279816|FG000|Overall Study|Ineligible: Second primary|1
4481361|NCT00723255|7279816|FG000|Overall Study|Ineligible: Wrong Primary|2
4481362|NCT00723294|7279832|FG000|Overall Study|Lobular histology|2
4481363|NCT00723294|7279832|FG000|Overall Study|>25% intraductal component|1
4481364|NCT00723294|7279832|FG000|Overall Study|No MRI tumor enhancement|1
4481365|NCT00723294|7279832|FG000|Overall Study|1.0-Tesla MRI|1
4481366|NCT00723294|7279832|FG000|Overall Study|No cryoabalation|2
4481367|NCT00723294|7279832|FG000|Overall Study|Did not undergo surgery|1
4481368|NCT00723294|7279832|FG000|Overall Study|Treated prior to registration|1
4481369|NCT00723294|7279832|FG000|Overall Study|Treated by non-credentialed surgeon|1
4481370|NCT00723294|7279832|FG000|Overall Study|Benign lesion|1
4481371|NCT00723294|7279832|FG000|Overall Study|Withdrawal by Subject|1
4481372|NCT00723294|7279832|FG000|Overall Study|No treatment due to probe failure|1
4481373|NCT00723398|7279841|FG000|Overall Study|Withdrawal by Subject|2
4481374|NCT00723398|7279842|FG001|Overall Study|Withdrawal by Subject|6
4481375|NCT00723398|7279843|FG002|Overall Study|Withdrawal by Subject|4
4481376|NCT00723398|7279844|FG003|Overall Study|Withdrawal by Subject|4
4481377|NCT00723398|7279845|FG004|Overall Study|Withdrawal by Subject|4
4481378|NCT00723398|7279841|FG000|Overall Study|Protocol Violation|2
4481379|NCT00723398|7279842|FG001|Overall Study|Protocol Violation|1
4481380|NCT00723398|7279843|FG002|Overall Study|Protocol Violation|5
4481381|NCT00723398|7279844|FG003|Overall Study|Protocol Violation|0
4481382|NCT00723398|7279845|FG004|Overall Study|Protocol Violation|0
4481383|NCT00723398|7279841|FG000|Overall Study|Physician Decision|2
4481384|NCT00723398|7279842|FG001|Overall Study|Physician Decision|2
4481385|NCT00723398|7279843|FG002|Overall Study|Physician Decision|5
4481386|NCT00723398|7279844|FG003|Overall Study|Physician Decision|0
4481387|NCT00723398|7279845|FG004|Overall Study|Physician Decision|1
4481388|NCT00723398|7279841|FG000|Overall Study|Adverse Event|0
4481389|NCT00723398|7279842|FG001|Overall Study|Adverse Event|5
4481390|NCT00723398|7279843|FG002|Overall Study|Adverse Event|3
4481391|NCT00723398|7279844|FG003|Overall Study|Adverse Event|1
4481392|NCT00723398|7279845|FG004|Overall Study|Adverse Event|4
4481393|NCT00723398|7279841|FG000|Overall Study|Lost to Follow-up|0
4481394|NCT00723398|7279842|FG001|Overall Study|Lost to Follow-up|1
4481395|NCT00723398|7279843|FG002|Overall Study|Lost to Follow-up|0
4481396|NCT00723398|7279844|FG003|Overall Study|Lost to Follow-up|0
4481397|NCT00723398|7279845|FG004|Overall Study|Lost to Follow-up|0
4481398|NCT00723450|7279859|FG000|Open-Label Phase|Adverse Event|26
4481399|NCT00723450|7279860|FG001|Open-Label Phase|Adverse Event|0
4481400|NCT00723450|7279861|FG002|Open-Label Phase|Adverse Event|0
4481401|NCT00723450|7279859|FG000|Open-Label Phase|Lack of Efficacy|18
4481402|NCT00723450|7279860|FG001|Open-Label Phase|Lack of Efficacy|0
4481403|NCT00723450|7279861|FG002|Open-Label Phase|Lack of Efficacy|0
4481404|NCT00723450|7279859|FG000|Open-Label Phase|Protocol Violation|35
4481405|NCT00723450|7279860|FG001|Open-Label Phase|Protocol Violation|0
4481406|NCT00723450|7279861|FG002|Open-Label Phase|Protocol Violation|0
4481407|NCT00723450|7279859|FG000|Open-Label Phase|Lost to Follow-up|7
4481408|NCT00723450|7279860|FG001|Open-Label Phase|Lost to Follow-up|0
4481409|NCT00723450|7279861|FG002|Open-Label Phase|Lost to Follow-up|0
4481410|NCT00723450|7279859|FG000|Open-Label Phase|Physician Decision|2
4481411|NCT00723450|7279860|FG001|Open-Label Phase|Physician Decision|0
4481412|NCT00723450|7279861|FG002|Open-Label Phase|Physician Decision|0
4481413|NCT00723450|7279859|FG000|Open-Label Phase|Withdrawal by Subject|37
4481414|NCT00723450|7279860|FG001|Open-Label Phase|Withdrawal by Subject|0
4481415|NCT00723450|7279861|FG002|Open-Label Phase|Withdrawal by Subject|0
4481416|NCT00723450|7279859|FG000|Randomized Phase|Adverse Event|0
4481417|NCT00723450|7279860|FG001|Randomized Phase|Adverse Event|26
4481418|NCT00723450|7279861|FG002|Randomized Phase|Adverse Event|17
4481419|NCT00723450|7279859|FG000|Randomized Phase|Lack of Efficacy|0
4481420|NCT00723450|7279860|FG001|Randomized Phase|Lack of Efficacy|11
4481421|NCT00723450|7279861|FG002|Randomized Phase|Lack of Efficacy|11
4481422|NCT00723450|7279859|FG000|Randomized Phase|Protocol Violation|0
4481423|NCT00723450|7279860|FG001|Randomized Phase|Protocol Violation|9
4481424|NCT00723450|7279861|FG002|Randomized Phase|Protocol Violation|13
4481425|NCT00723450|7279859|FG000|Randomized Phase|Lost to Follow-up|0
4481426|NCT00723450|7279860|FG001|Randomized Phase|Lost to Follow-up|2
4481427|NCT00723450|7279861|FG002|Randomized Phase|Lost to Follow-up|3
4481428|NCT00723450|7279859|FG000|Randomized Phase|Physician Decision|0
4481429|NCT00723450|7279860|FG001|Randomized Phase|Physician Decision|3
4481430|NCT00723450|7279861|FG002|Randomized Phase|Physician Decision|1
4481431|NCT00723450|7279859|FG000|Randomized Phase|Withdrawal by Subject|0
4481432|NCT00723450|7279860|FG001|Randomized Phase|Withdrawal by Subject|14
4481433|NCT00723450|7279861|FG002|Randomized Phase|Withdrawal by Subject|22
4481434|NCT00723489|7279874|FG000|Overall Study|Physician Decision|0
4481435|NCT00723489|7279875|FG001|Overall Study|Physician Decision|1
4481436|NCT00723489|7279876|FG002|Overall Study|Physician Decision|0
4481437|NCT00723489|7279877|FG003|Overall Study|Physician Decision|0
4481438|NCT00723489|7279874|FG000|Overall Study|Pregnancy|0
4481439|NCT00723489|7279875|FG001|Overall Study|Pregnancy|0
4481440|NCT00723489|7279876|FG002|Overall Study|Pregnancy|0
4481441|NCT00723489|7279877|FG003|Overall Study|Pregnancy|1
4481442|NCT00723489|7279874|FG000|Overall Study|Withdrawal by Subject|0
4481443|NCT00723489|7279875|FG001|Overall Study|Withdrawal by Subject|0
4481444|NCT00723489|7279876|FG002|Overall Study|Withdrawal by Subject|0
4481445|NCT00723489|7279877|FG003|Overall Study|Withdrawal by Subject|1
4481446|NCT00723489|7279874|FG000|Overall Study|Seropositive at baseline|1
4481447|NCT00723489|7279875|FG001|Overall Study|Seropositive at baseline|0
4481448|NCT00723489|7279876|FG002|Overall Study|Seropositive at baseline|0
4481449|NCT00723489|7279877|FG003|Overall Study|Seropositive at baseline|0
4481450|NCT00723489|7279874|FG000|Overall Study|Prohibited Medication|0
4481451|NCT00723489|7279875|FG001|Overall Study|Prohibited Medication|0
4481452|NCT00723489|7279876|FG002|Overall Study|Prohibited Medication|0
4481453|NCT00723489|7279877|FG003|Overall Study|Prohibited Medication|1
4481454|NCT00723489|7279874|FG000|Overall Study|Samples Collected Out of Window|0
4481455|NCT00723489|7279875|FG001|Overall Study|Samples Collected Out of Window|3
4481456|NCT00723489|7279876|FG002|Overall Study|Samples Collected Out of Window|0
4481457|NCT00723489|7279877|FG003|Overall Study|Samples Collected Out of Window|0
4481458|NCT00723528|7279890|FG000|Period 1: Controlled Period (CP)|Adverse Event|0
4481459|NCT00723528|7279891|FG001|Period 1: Controlled Period (CP)|Adverse Event|0
4481460|NCT00723528|7279892|FG002|Period 1: Controlled Period (CP)|Adverse Event|1
4481461|NCT00723528|7279893|FG003|Period 1: Controlled Period (CP)|Adverse Event|0
4481462|NCT00723528|7279894|FG004|Period 1: Controlled Period (CP)|Adverse Event|0
4481463|NCT00723528|7279895|FG005|Period 1: Controlled Period (CP)|Adverse Event|0
4481464|NCT00723528|7279896|FG006|Period 1: Controlled Period (CP)|Adverse Event|0
4481465|NCT00723528|7279890|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2
4481466|NCT00723528|7279891|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
4481467|NCT00723528|7279892|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
4481468|NCT00723528|7279893|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
4481469|NCT00723528|7279894|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
4481470|NCT00723528|7279895|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
4481471|NCT00723528|7279896|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
4481472|NCT00723528|7279890|FG000|Period 1: Controlled Period (CP)|Physician Decision|0
4481473|NCT00723528|7279891|FG001|Period 1: Controlled Period (CP)|Physician Decision|0
4481474|NCT00723528|7279892|FG002|Period 1: Controlled Period (CP)|Physician Decision|1
4481475|NCT00723528|7279893|FG003|Period 1: Controlled Period (CP)|Physician Decision|0
4481476|NCT00723528|7279894|FG004|Period 1: Controlled Period (CP)|Physician Decision|0
4481477|NCT00723528|7279895|FG005|Period 1: Controlled Period (CP)|Physician Decision|0
4481478|NCT00723528|7279896|FG006|Period 1: Controlled Period (CP)|Physician Decision|0
4481479|NCT00723528|7279890|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
4481480|NCT00723528|7279891|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
4481481|NCT00723528|7279892|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1
4481482|NCT00723528|7279893|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
4481483|NCT00723528|7279894|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
4481484|NCT00723528|7279895|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
4481485|NCT00723528|7279896|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
4481486|NCT00723528|7279890|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2
4481487|NCT00723528|7279891|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
4481488|NCT00723528|7279892|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1
4481489|NCT00723528|7279893|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
4481490|NCT00723528|7279894|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
4481491|NCT00723528|7279895|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
4481492|NCT00723528|7279896|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
4481493|NCT00723528|7279890|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0
4481494|NCT00723528|7279891|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0
4481495|NCT00723528|7279892|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0
4481496|NCT00723528|7279893|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1
4481497|NCT00723528|7279894|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0
4481498|NCT00723528|7279895|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1
4481499|NCT00723528|7279896|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1
4481500|NCT00723528|7279890|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0
4481501|NCT00723528|7279891|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0
4481502|NCT00723528|7279892|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0
4516989|NCT00963235|7328587|FG000|Overall Study|Failed to return|9
4481503|NCT00723528|7279893|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0
4481504|NCT00723528|7279894|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0
4481505|NCT00723528|7279895|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1
4481506|NCT00723528|7279896|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0
4481507|NCT00723528|7279890|FG000|Period 2: After Controlled Period|Other|0
4481508|NCT00723528|7279891|FG001|Period 2: After Controlled Period|Other|0
4481509|NCT00723528|7279892|FG002|Period 2: After Controlled Period|Other|0
4481510|NCT00723528|7279893|FG003|Period 2: After Controlled Period|Other|0
4481511|NCT00723528|7279894|FG004|Period 2: After Controlled Period|Other|1
4481512|NCT00723528|7279895|FG005|Period 2: After Controlled Period|Other|4
4481513|NCT00723528|7279896|FG006|Period 2: After Controlled Period|Other|0
4481514|NCT00723528|7279890|FG000|Period 2: After Controlled Period|Adverse Event|0
4481515|NCT00723528|7279891|FG001|Period 2: After Controlled Period|Adverse Event|0
4481516|NCT00723528|7279892|FG002|Period 2: After Controlled Period|Adverse Event|0
4481517|NCT00723528|7279893|FG003|Period 2: After Controlled Period|Adverse Event|0
4481518|NCT00723528|7279894|FG004|Period 2: After Controlled Period|Adverse Event|1
4481519|NCT00723528|7279895|FG005|Period 2: After Controlled Period|Adverse Event|0
4481520|NCT00723528|7279896|FG006|Period 2: After Controlled Period|Adverse Event|1
4481521|NCT00723528|7279890|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
4481522|NCT00723528|7279891|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
4481523|NCT00723528|7279892|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
4481524|NCT00723528|7279893|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
4481525|NCT00723528|7279894|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
4481526|NCT00723528|7279895|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
4481527|NCT00723528|7279896|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1
4481528|NCT00723528|7279890|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
4481529|NCT00723528|7279891|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
4481530|NCT00723528|7279892|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
4481531|NCT00723528|7279893|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
4481532|NCT00723528|7279894|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
4481533|NCT00723528|7279895|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
4481534|NCT00723528|7279896|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1
4481535|NCT00723554|7279912|FG000|Overall Study|Adverse Event|12
4481536|NCT00723554|7279912|FG000|Overall Study|Investigator's judgement|5
4481537|NCT00723554|7279912|FG000|Overall Study|Inhaled medication other than iloprost|4
4481538|NCT00723554|7279912|FG000|Overall Study|Withdrawal of consent|3
4481539|NCT00723554|7279912|FG000|Overall Study|Other|3
4481540|NCT00723554|7279912|FG000|Overall Study|Lost to Follow-up|1
4481541|NCT00723554|7279912|FG000|Overall Study|Non-compliance|1
4481542|NCT00723606|7279924|FG000|Overall Study|Adverse Event|2
4481543|NCT00723606|7279925|FG001|Overall Study|Adverse Event|5
4481544|NCT00723606|7279924|FG000|Overall Study|Other|2
4481545|NCT00723606|7279925|FG001|Overall Study|Other|0
4481546|NCT00723606|7279924|FG000|Overall Study|Withdrawal by Subject|0
4481547|NCT00723606|7279925|FG001|Overall Study|Withdrawal by Subject|2
4481548|NCT00723697|7279939|FG000|Overall Study|Physician questionnaires not received|2
4481549|NCT00723697|7279939|FG000|Overall Study|Missing Informed Consent Form|10
4481550|NCT00723697|7279939|FG000|Overall Study|Other exclusion criteria applied|6
4481551|NCT00723710|7279946|FG000|Overall Study|Disease progression|48
4481552|NCT00723710|7279946|FG000|Overall Study|Adverse Event|88
4481553|NCT00723710|7279946|FG000|Overall Study|Withdrawal by Subject|36
4481554|NCT00723710|7279946|FG000|Overall Study|Physician Decision|2
4481555|NCT00723801|7279962|FG000|Overall Study|Lost to Follow-up|1
4481556|NCT00723801|7279963|FG001|Overall Study|Lost to Follow-up|2
4481557|NCT00723801|7279962|FG000|Overall Study|Protocol Violation|2
4481558|NCT00723801|7279963|FG001|Overall Study|Protocol Violation|1
4481559|NCT00723840|7279973|FG000|Overall Study|Lost to Follow-up|2
4481560|NCT00723840|7279973|FG000|Overall Study|Failure to return|18
4481561|NCT00723840|7279973|FG000|Overall Study|Withdrawal by Subject|55
4481562|NCT00723840|7279973|FG000|Overall Study|Serious Adverse Events|3
4481563|NCT00723840|7279973|FG000|Overall Study|Other Medical Event|2
4481564|NCT00723840|7279973|FG000|Overall Study|Unspecified reason|2
4481565|NCT00723892|7279986|FG000|Overall Study|Participant not tracked|33
4481566|NCT00723892|7279987|FG001|Overall Study|Participant not tracked|35
4481567|NCT00723892|7279986|FG000|Overall Study|Virological criterion|24
4481568|NCT00723892|7279987|FG001|Overall Study|Virological criterion|9
4481569|NCT00723892|7279986|FG000|Overall Study|Withdrawal by Subject|6
4481570|NCT00723892|7279987|FG001|Overall Study|Withdrawal by Subject|9
4481571|NCT00723892|7279986|FG000|Overall Study|End planned|11
4481572|NCT00723892|7279987|FG001|Overall Study|End planned|7
4481573|NCT00723892|7279986|FG000|Overall Study|Bad tolerance|5
4481574|NCT00723892|7279987|FG001|Overall Study|Bad tolerance|5
4481575|NCT00723892|7279986|FG000|Overall Study|Multiple reasons|17
4481576|NCT00723892|7279987|FG001|Overall Study|Multiple reasons|12
4481577|NCT00723892|7279986|FG000|Overall Study|Other|6
4481578|NCT00723892|7279987|FG001|Overall Study|Other|3
4481579|NCT00723892|7279986|FG000|Overall Study|Study end|1
4481580|NCT00723892|7279987|FG001|Overall Study|Study end|3
4481581|NCT00723892|7279986|FG000|Overall Study|Weight loss|1
4481582|NCT00723892|7279987|FG001|Overall Study|Weight loss|3
4481583|NCT00723892|7279986|FG000|Overall Study|Alcohol abuse|0
4481584|NCT00723892|7279987|FG001|Overall Study|Alcohol abuse|1
4481585|NCT00723892|7279986|FG000|Overall Study|Intercurrent infection|2
4481586|NCT00723892|7279987|FG001|Overall Study|Intercurrent infection|0
4481587|NCT00723892|7279986|FG000|Overall Study|Drug addiction|1
4481588|NCT00723892|7279987|FG001|Overall Study|Drug addiction|0
4481589|NCT00723957|7279999|FG000|Overall Study|Adverse event unrelated to study drug|1
4481590|NCT00723957|7280000|FG001|Overall Study|Adverse event unrelated to study drug|4
4481591|NCT00723957|7279999|FG000|Overall Study|Death|3
4481592|NCT00723957|7280000|FG001|Overall Study|Death|4
4481593|NCT00723957|7279999|FG000|Overall Study|Disease progression|27
4481594|NCT00723957|7280000|FG001|Overall Study|Disease progression|25
4481595|NCT00723957|7279999|FG000|Overall Study|Maximum clinical benefit|4
4481596|NCT00723957|7280000|FG001|Overall Study|Maximum clinical benefit|5
4481597|NCT00723957|7279999|FG000|Overall Study|Investigator decision|1
4481598|NCT00723957|7280000|FG001|Overall Study|Investigator decision|1
4481599|NCT00723957|7279999|FG000|Overall Study|Study drug toxicity|4
4481600|NCT00723957|7280000|FG001|Overall Study|Study drug toxicity|6
4481601|NCT00723957|7279999|FG000|Overall Study|Withdrawal by Subject|7
4481602|NCT00723957|7280000|FG001|Overall Study|Withdrawal by Subject|5
4481603|NCT00723957|7279999|FG000|Overall Study|Reason not analyzed|1
4481604|NCT00723957|7280000|FG001|Overall Study|Reason not analyzed|0
4481605|NCT00723957|7279999|FG000|Overall Study|Never received treatment|3
4481606|NCT00723957|7280000|FG001|Overall Study|Never received treatment|3
4481607|NCT00724061|7280010|FG000|Dose Escalation Phase|Adverse Event|2
4481608|NCT00724061|7280010|FG000|Dose Escalation Phase|Disease Progression|3
4481609|NCT00724126|7280016|FG000|Overall Study|Adverse Event|2
4481610|NCT00724126|7280017|FG001|Overall Study|Adverse Event|0
4481611|NCT00724126|7280016|FG000|Overall Study|Withdrawal by Subject|8
4481612|NCT00724126|7280017|FG001|Overall Study|Withdrawal by Subject|6
4481613|NCT00724126|7280016|FG000|Overall Study|Lost to Follow-up|6
4481614|NCT00724126|7280017|FG001|Overall Study|Lost to Follow-up|6
4481615|NCT00724126|7280016|FG000|Overall Study|Noncompliance|2
4481616|NCT00724126|7280017|FG001|Overall Study|Noncompliance|1
4481617|NCT00724126|7280016|FG000|Overall Study|Subject randomized although ineligible|1
4481618|NCT00724126|7280017|FG001|Overall Study|Subject randomized although ineligible|1
4481619|NCT00724126|7280016|FG000|Overall Study|Subject had to leave vicinity of site|0
4481620|NCT00724126|7280017|FG001|Overall Study|Subject had to leave vicinity of site|1
4481621|NCT00724152|7280028|FG000|Two-arm Study Period|Withdrawal by Subject|3
4481622|NCT00724152|7280029|FG001|Two-arm Study Period|Withdrawal by Subject|2
4481623|NCT00724152|7280030|FG002|Two-arm Study Period|Withdrawal by Subject|0
4481624|NCT00724152|7280028|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1
4481625|NCT00724152|7280029|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2
4481626|NCT00724152|7280030|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1
4481627|NCT00724243|7280040|FG000|Overall Study|Lack of Efficacy|10
4481628|NCT00724243|7280040|FG000|Overall Study|Adverse Event|5
4481629|NCT00724373|7280057|FG000|Overall Study|Adverse Event|41
4481630|NCT00724373|7280057|FG000|Overall Study|Lack of Efficacy|82
4481631|NCT00724373|7280057|FG000|Overall Study|Lost to Follow-up|7
4481632|NCT00724373|7280057|FG000|Overall Study|Non-compliance|2
4481633|NCT00724373|7280057|FG000|Overall Study|HCV RNA negative after 4 weeks|9
4481634|NCT00724373|7280057|FG000|Overall Study|Participant moved away|1
4481635|NCT00724373|7280057|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2
4481636|NCT00724373|7280057|FG000|Overall Study|Only to have 24 week regimen|1
4481637|NCT00724373|7280057|FG000|Overall Study|Viral Relapse|1
4481638|NCT00724373|7280057|FG000|Overall Study|Acute HCV infection|1
4481639|NCT00724373|7280057|FG000|Overall Study|Drug Relapse|1
4481640|NCT00724373|7280057|FG000|Overall Study|Tolerability|23
4481641|NCT00724451|7280061|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7
4481642|NCT00724451|7280061|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3
4481643|NCT00724451|7280061|FG000|Overall Study|Not Eligible for Treatment|431
4481644|NCT00724451|7280061|FG000|Overall Study|Participant Refused Treatment|89
4481645|NCT00724451|7280061|FG000|Overall Study|Never Started Treatment|89
4481646|NCT00724451|7280061|FG000|Overall Study|Unknown; No Data Sources Available|9
4481647|NCT00724451|7280061|FG000|Overall Study|Physician Decision|116
4481648|NCT00724451|7280061|FG000|Overall Study|Withdrawal by Subject|45
4589697|NCT01514136|7435060|FG006|Test Period 2; Test C*|Protocol Violation|1
4481649|NCT00724451|7280061|FG000|Overall Study|Investigator + Participant Decision|13
4481650|NCT00724503|7280072|FG000|Overall Study|Lost to Follow-up|4
4481651|NCT00724503|7280073|FG001|Overall Study|Lost to Follow-up|8
4481652|NCT00724503|7280072|FG000|Overall Study|Withdrawal by Subject|11
4481653|NCT00724503|7280073|FG001|Overall Study|Withdrawal by Subject|23
4481654|NCT00724503|7280072|FG000|Overall Study|Death|190
4481655|NCT00724503|7280073|FG001|Overall Study|Death|182
4481656|NCT00724503|7280072|FG000|Overall Study|Adverse Event|1
4481657|NCT00724503|7280073|FG001|Overall Study|Adverse Event|0
4481658|NCT00724503|7280072|FG000|Overall Study|Not otherwise specified|4
4589698|NCT01514136|7435061|FG007|Test Period 2; Test C*|Protocol Violation|0
4481659|NCT00724503|7280073|FG001|Overall Study|Not otherwise specified|7
4700774|NCT02699749|7616949|FG010|Overall Study|Other|1
4700775|NCT02699749|7616950|FG011|Overall Study|Other|0
4700776|NCT02699749|7616951|FG012|Overall Study|Other|0
4700777|NCT02699749|7616952|FG013|Overall Study|Other|0
4700778|NCT02699749|7616939|FG000|Overall Study|Progressive Disease|3
4700779|NCT02699749|7616940|FG001|Overall Study|Progressive Disease|3
4700780|NCT02699749|7616941|FG002|Overall Study|Progressive Disease|14
4700781|NCT02699749|7616942|FG003|Overall Study|Progressive Disease|3
4700782|NCT02699749|7616943|FG004|Overall Study|Progressive Disease|3
4700783|NCT02699749|7616944|FG005|Overall Study|Progressive Disease|7
4700784|NCT02699749|7616945|FG006|Overall Study|Progressive Disease|5
4700785|NCT02699749|7616946|FG007|Overall Study|Progressive Disease|5
4481660|NCT00724711|7280120|FG000|Overall Study|Adverse Event|7
4481661|NCT00724711|7280121|FG001|Overall Study|Adverse Event|3
4481662|NCT00724711|7280120|FG000|Overall Study|Pregnancy|0
4481663|NCT00724711|7280121|FG001|Overall Study|Pregnancy|1
4481664|NCT00724711|7280120|FG000|Overall Study|Lack of Efficacy|0
4481665|NCT00724711|7280121|FG001|Overall Study|Lack of Efficacy|1
4481666|NCT00724711|7280120|FG000|Overall Study|Physician Decision|0
4481667|NCT00724711|7280121|FG001|Overall Study|Physician Decision|3
4481668|NCT00724711|7280120|FG000|Overall Study|Withdrawal by Subject|5
4481669|NCT00724711|7280121|FG001|Overall Study|Withdrawal by Subject|4
4481670|NCT00724711|7280120|FG000|Overall Study|Lost to Follow-up|4
4481671|NCT00724711|7280121|FG001|Overall Study|Lost to Follow-up|5
4481672|NCT00724711|7280120|FG000|Overall Study|Protocol Violation|1
4481673|NCT00724711|7280121|FG001|Overall Study|Protocol Violation|0
4481674|NCT00724815|7280138|FG000|Overall Study|Randomized, not treated|31
4481675|NCT00724815|7280139|FG001|Overall Study|Randomized, not treated|30
4481676|NCT00724815|7280138|FG000|Overall Study|Adverse Event|5
4481677|NCT00724815|7280139|FG001|Overall Study|Adverse Event|3
4481678|NCT00724815|7280138|FG000|Overall Study|Lost to Follow-up|4
4481679|NCT00724815|7280139|FG001|Overall Study|Lost to Follow-up|1
4481680|NCT00724815|7280138|FG000|Overall Study|Other Various|3
4481681|NCT00724815|7280139|FG001|Overall Study|Other Various|5
4481682|NCT00724854|7280147|FG000|Overall Study|Lack of Efficacy|187
4481683|NCT00724854|7280148|FG001|Overall Study|Lack of Efficacy|13
4481684|NCT00724854|7280147|FG000|Overall Study|Lost to Follow-up|87
4481685|NCT00724854|7280148|FG001|Overall Study|Lost to Follow-up|10
4481686|NCT00724854|7280147|FG000|Overall Study|Adverse Event|62
4481687|NCT00724854|7280148|FG001|Overall Study|Adverse Event|4
4481688|NCT00724854|7280147|FG000|Overall Study|Other|42
4481689|NCT00724854|7280148|FG001|Overall Study|Other|3
4481690|NCT00724854|7280147|FG000|Overall Study|Death|11
4481691|NCT00724854|7280148|FG001|Overall Study|Death|0
4481692|NCT00724854|7280147|FG000|Overall Study|Change of treatment|7
4481693|NCT00724854|7280148|FG001|Overall Study|Change of treatment|0
4481694|NCT00724854|7280147|FG000|Overall Study|Withdrawal by Subject|5
4481695|NCT00724854|7280148|FG001|Overall Study|Withdrawal by Subject|0
4481696|NCT00724854|7280147|FG000|Overall Study|Adverse event + lack of efficacy|2
4481697|NCT00724854|7280148|FG001|Overall Study|Adverse event + lack of efficacy|1
4481698|NCT00724867|7280155|FG000|Overall Study|Adverse Event|25
4481699|NCT00724867|7280155|FG000|Overall Study|Lack of Efficacy|14
4481700|NCT00724867|7280155|FG000|Overall Study|Lost to Follow-up|12
4481701|NCT00724867|7280155|FG000|Overall Study|Non-compliance with study drug|6
4481702|NCT00724867|7280155|FG000|Overall Study|Physician Decision|17
4481703|NCT00724867|7280155|FG000|Overall Study|Protocol Violation|1
4481704|NCT00724867|7280155|FG000|Overall Study|Withdrawal by Subject|31
4481705|NCT00724867|7280155|FG000|Overall Study|Sponsor decision to end study|14
4481706|NCT00724867|7280155|FG000|Overall Study|Subject incarcerated|1
4481707|NCT00724867|7280155|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4
4481708|NCT00724867|7280155|FG000|Overall Study|Subject moved out of state|1
4481709|NCT00724867|7280155|FG000|Overall Study|Elected to exit due to site closure|2
4481710|NCT00724893|7280164|FG000|Overall Study|Adverse Event|76
4481711|NCT00724893|7280165|FG001|Overall Study|Adverse Event|142
4481712|NCT00724893|7280164|FG000|Overall Study|Withdrawal by Subject|0
4481713|NCT00724893|7280165|FG001|Overall Study|Withdrawal by Subject|1
4481714|NCT00724893|7280164|FG000|Overall Study|Lack of virologic response|94
4481715|NCT00724893|7280165|FG001|Overall Study|Lack of virologic response|202
4481716|NCT00724893|7280164|FG000|Overall Study|Reason not specified|193
4481717|NCT00724893|7280165|FG001|Overall Study|Reason not specified|7
4481718|NCT00724893|7280164|FG000|Overall Study|Patient choice|0
4481719|NCT00724893|7280165|FG001|Overall Study|Patient choice|26
4481720|NCT00724893|7280164|FG000|Overall Study|Geographic reasons|0
4481721|NCT00724893|7280165|FG001|Overall Study|Geographic reasons|11
4481722|NCT00724893|7280164|FG000|Overall Study|Incarceration|0
4481723|NCT00724893|7280165|FG001|Overall Study|Incarceration|9
4481724|NCT00724893|7280164|FG000|Overall Study|Substance abuse|0
4481725|NCT00724893|7280165|FG001|Overall Study|Substance abuse|3
4481726|NCT00724893|7280164|FG000|Overall Study|Financial reasons|0
4481727|NCT00724893|7280165|FG001|Overall Study|Financial reasons|2
4700786|NCT02699749|7616947|FG008|Overall Study|Progressive Disease|6
4700787|NCT02699749|7616948|FG009|Overall Study|Progressive Disease|6
4481728|NCT00724893|7280164|FG000|Overall Study|Assigned shorter treatment|0
4481729|NCT00724893|7280165|FG001|Overall Study|Assigned shorter treatment|2
4481730|NCT00724893|7280164|FG000|Overall Study|Lost to Follow-up|0
4481731|NCT00724893|7280165|FG001|Overall Study|Lost to Follow-up|52
4700788|NCT02699749|7616949|FG010|Overall Study|Progressive Disease|5
4481732|NCT00724893|7280164|FG000|Overall Study|Unknown, missing data|1
4481733|NCT00724893|7280165|FG001|Overall Study|Unknown, missing data|1
4481734|NCT00724932|7280188|FG000|Overall Study|Lost to Follow-up|1
4481735|NCT00724932|7280189|FG001|Overall Study|Lost to Follow-up|0
4481736|NCT00724932|7280188|FG000|Overall Study|Not treated|4
4481737|NCT00724932|7280189|FG001|Overall Study|Not treated|3
4481738|NCT00724945|7280197|FG000|Period 1|non-compliance|1
4481739|NCT00724945|7280198|FG001|Period 1|non-compliance|0
4481740|NCT00724945|7280197|FG000|Period 1|Adverse Event|1
4481741|NCT00724945|7280198|FG001|Period 1|Adverse Event|1
4481742|NCT00724945|7280197|FG000|Period 1|Lost to Follow-up|1
4481743|NCT00724945|7280198|FG001|Period 1|Lost to Follow-up|0
4481744|NCT00724945|7280197|FG000|Period 2|lens comfort issue|3
4481745|NCT00724945|7280198|FG001|Period 2|lens comfort issue|0
4481746|NCT00724945|7280197|FG000|Period 2|lens physiology issue|1
4481747|NCT00724945|7280198|FG001|Period 2|lens physiology issue|0
4481748|NCT00724958|7280204|FG000|Overall Study|Adverse Event|28
4481749|NCT00724958|7280204|FG000|Overall Study|Loss of Response|40
4481750|NCT00724958|7280204|FG000|Overall Study|No Response|18
4481751|NCT00724958|7280204|FG000|Overall Study|Remission|7
4481752|NCT00724958|7280204|FG000|Overall Study|Other Reason|76
4481753|NCT00724958|7280204|FG000|Overall Study|No documentation for end of therapy|13
4481754|NCT00724971|7280208|FG000|Overall Study|Adverse Event|5
4481755|NCT00724971|7280208|FG000|Overall Study|Withdrawal by Subject|1
4481756|NCT00725010|7280237|FG000|Overall Study|Toxicity|9
4481757|NCT00725010|7280237|FG000|Overall Study|Tumor Progression|7
4481758|NCT00725010|7280237|FG000|Overall Study|Withdrawal by Subject|2
4481759|NCT00725010|7280237|FG000|Overall Study|Death|1
4481760|NCT00725010|7280237|FG000|Overall Study|Lost to Follow-up|1
4481761|NCT00725010|7280237|FG000|Overall Study|Hepatopathy probably not Temodal-related|1
4481762|NCT00725010|7280237|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1
4481763|NCT00725010|7280237|FG000|Overall Study|No further documentation|1
4481764|NCT00725010|7280237|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2
4481765|NCT00725075|7280246|FG000|Overall Study|Use of Excluded Medication|0
4481766|NCT00725075|7280247|FG001|Overall Study|Use of Excluded Medication|1
4481767|NCT00725075|7280248|FG002|Overall Study|Use of Excluded Medication|0
4481768|NCT00725075|7280246|FG000|Overall Study|Protocol Violation|0
4481769|NCT00725075|7280247|FG001|Overall Study|Protocol Violation|0
4481770|NCT00725075|7280248|FG002|Overall Study|Protocol Violation|1
4481771|NCT00725075|7280246|FG000|Overall Study|Lost to Follow-up|1
4481772|NCT00725075|7280247|FG001|Overall Study|Lost to Follow-up|0
4481773|NCT00725075|7280248|FG002|Overall Study|Lost to Follow-up|0
4481774|NCT00725075|7280246|FG000|Overall Study|Withdrawal by Subject|4
4481775|NCT00725075|7280247|FG001|Overall Study|Withdrawal by Subject|5
4481776|NCT00725075|7280248|FG002|Overall Study|Withdrawal by Subject|4
4481777|NCT00725075|7280246|FG000|Overall Study|Adverse Event|2
4481778|NCT00725075|7280247|FG001|Overall Study|Adverse Event|1
4481779|NCT00725075|7280248|FG002|Overall Study|Adverse Event|1
4481780|NCT00725075|7280246|FG000|Overall Study|Worsening of Disease|2
4481781|NCT00725075|7280247|FG001|Overall Study|Worsening of Disease|1
4481782|NCT00725075|7280248|FG002|Overall Study|Worsening of Disease|2
4481783|NCT00725075|7280246|FG000|Overall Study|Inclusion/Exclusion Criteria|1
4481784|NCT00725075|7280247|FG001|Overall Study|Inclusion/Exclusion Criteria|0
4481785|NCT00725075|7280248|FG002|Overall Study|Inclusion/Exclusion Criteria|1
4481786|NCT00725075|7280246|FG000|Overall Study|Other|1
4481787|NCT00725075|7280247|FG001|Overall Study|Other|0
4481788|NCT00725075|7280248|FG002|Overall Study|Other|0
4481789|NCT00725101|7280256|FG000|Overall Study|Death|3
4481790|NCT00725101|7280256|FG000|Overall Study|Lost to Follow-up|353
4481791|NCT00725101|7280256|FG000|Overall Study|Protocol Violation|1
4481792|NCT00725101|7280256|FG000|Overall Study|Withdrawal by Subject|127
4481793|NCT00725101|7280256|FG000|Overall Study|not specified/no reason given|11
4481794|NCT00725205|7280267|FG000|Overall Study|Adverse Event|22
4481795|NCT00725205|7280267|FG000|Overall Study|Investigator Discontinued|1
4481796|NCT00725205|7280267|FG000|Overall Study|Non-compliance With Protocol|14
4481797|NCT00725205|7280267|FG000|Overall Study|Other|8
4481798|NCT00725205|7280267|FG000|Overall Study|Protocol Defined Clinical Event|1
4481799|NCT00725205|7280267|FG000|Overall Study|Treatment Failure|41
4516990|NCT00963235|7328587|FG000|Overall Study|Protocol Violation|7
4516991|NCT00963235|7328587|FG000|Overall Study|Adverse Event|5
4516992|NCT00963235|7328587|FG000|Overall Study|Physician Decision|2
4516993|NCT00963235|7328587|FG000|Overall Study|Other|1
4516994|NCT00963547|7328625|FG000|Overall Study|Adverse Event|0
4516995|NCT00963547|7328626|FG001|Overall Study|Adverse Event|1
4516996|NCT00963547|7328627|FG002|Overall Study|Adverse Event|0
4516997|NCT00963547|7328628|FG003|Overall Study|Adverse Event|1
4516998|NCT00963547|7328629|FG004|Overall Study|Adverse Event|0
4516999|NCT00963547|7328630|FG005|Overall Study|Adverse Event|0
4517000|NCT00963547|7328631|FG006|Overall Study|Adverse Event|0
4517001|NCT00963547|7328625|FG000|Overall Study|Physician Decision|1
4517002|NCT00963547|7328626|FG001|Overall Study|Physician Decision|1
4517003|NCT00963547|7328627|FG002|Overall Study|Physician Decision|0
4517004|NCT00963547|7328628|FG003|Overall Study|Physician Decision|0
4517005|NCT00963547|7328629|FG004|Overall Study|Physician Decision|0
4517006|NCT00963547|7328630|FG005|Overall Study|Physician Decision|0
4517007|NCT00963547|7328631|FG006|Overall Study|Physician Decision|0
4481800|NCT00725283|7280280|FG000|Overall Study|Missing Code|3
4481801|NCT00725283|7280280|FG000|Overall Study|Death|5
4481802|NCT00725283|7280280|FG000|Overall Study|Other|6
4481803|NCT00725283|7280280|FG000|Overall Study|Withdrawal by Subject|10
4481804|NCT00725296|7280284|FG000|Overall Study|Adverse Event|11
4481805|NCT00725296|7280284|FG000|Overall Study|Lack of Efficacy|7
4481806|NCT00725296|7280284|FG000|Overall Study|Withdrawal by Subject|3
4481807|NCT00725296|7280284|FG000|Overall Study|Non-Compliance|2
4481808|NCT00725296|7280284|FG000|Overall Study|Lost to Follow-up|1
4481809|NCT00725296|7280284|FG000|Overall Study|Other|38
4481810|NCT00725322|7280291|FG000|Washout (28 Days)|Withdrawal by Subject|2
4481811|NCT00725322|7280292|FG001|Washout (28 Days)|Withdrawal by Subject|0
4481812|NCT00725322|7280291|FG000|Washout (28 Days)|Protocol Violation|0
4481813|NCT00725322|7280292|FG001|Washout (28 Days)|Protocol Violation|1
4481814|NCT00725452|7280302|FG000|Overall Study|Adverse Event|3
4481815|NCT00725452|7280302|FG000|Overall Study|Lack of Efficacy|2
4481816|NCT00725452|7280302|FG000|Overall Study|Reason not specified|1
4481817|NCT00725452|7280302|FG000|Overall Study|Physician Decision|1
4481818|NCT00725452|7280302|FG000|Overall Study|Withdrawal by Subject|3
4481819|NCT00725452|7280302|FG000|Overall Study|Lost to Follow-up|1
4481820|NCT00725543|7280320|FG000|Overall Study|Adverse Event|10
4481821|NCT00725543|7280320|FG000|Overall Study|Lack of Efficacy|3
4481822|NCT00725543|7280320|FG000|Overall Study|Withdrawal by Subject|10
4481823|NCT00725543|7280320|FG000|Overall Study|Physician Decision|5
4481824|NCT00725543|7280320|FG000|Overall Study|Lost to Follow-up|4
4481825|NCT00725543|7280320|FG000|Overall Study|Non-compliance|2
4481826|NCT00725543|7280320|FG000|Overall Study|Other|119
4481827|NCT00725608|7280324|FG000|Overall Study|Lost to Follow-up|60
4481828|NCT00725608|7280324|FG000|Overall Study|Adverse Event|14
4481829|NCT00725608|7280324|FG000|Overall Study|Individual reasons|86
4481830|NCT00725608|7280324|FG000|Overall Study|Other|7
4481831|NCT00725621|7280328|FG000|Overall Study|Adverse Event|25
4481832|NCT00725621|7280328|FG000|Overall Study|Lack of Efficacy|46
4481833|NCT00725621|7280328|FG000|Overall Study|Withdrawal by Subject|57
4481834|NCT00725621|7280328|FG000|Overall Study|Physician Decision|19
4481835|NCT00725621|7280328|FG000|Overall Study|Lost to Follow-up|52
4481836|NCT00725621|7280328|FG000|Overall Study|Non-compliance|8
4481837|NCT00725621|7280328|FG000|Overall Study|Continued treatment by other physician|6
4481838|NCT00725621|7280328|FG000|Overall Study|Switched to other study|1
4481839|NCT00725621|7280328|FG000|Overall Study|Switched to other drug|1
4481840|NCT00725621|7280328|FG000|Overall Study|Prepared for elective surgery|1
4481841|NCT00725621|7280328|FG000|Overall Study|Reason not specified|55
4481842|NCT00725712|7280338|FG000|Overall Study|Withdrawal by Subject|2
4481843|NCT00725712|7280339|FG001|Overall Study|Withdrawal by Subject|1
4589699|NCT01514201|7435116|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1
4481844|NCT00725712|7280338|FG000|Overall Study|Protocol Violation|1
4481845|NCT00725712|7280339|FG001|Overall Study|Protocol Violation|0
4481846|NCT00725712|7280338|FG000|Overall Study|Progressive disease|37
4481847|NCT00725712|7280339|FG001|Overall Study|Progressive disease|16
4481848|NCT00725712|7280338|FG000|Overall Study|Clinical progression not based on RECIST|0
4481849|NCT00725712|7280339|FG001|Overall Study|Clinical progression not based on RECIST|3
4481850|NCT00725712|7280338|FG000|Overall Study|Adverse Event|5
4481851|NCT00725712|7280339|FG001|Overall Study|Adverse Event|5
4481852|NCT00725712|7280338|FG000|Overall Study|Death|2
4481853|NCT00725712|7280339|FG001|Overall Study|Death|0
4481854|NCT00725712|7280338|FG000|Overall Study|Other: Death|1
4481855|NCT00725712|7280339|FG001|Overall Study|Other: Death|0
4481856|NCT00725712|7280338|FG000|Overall Study|Hospitalized, unable to continue|0
4481857|NCT00725712|7280339|FG001|Overall Study|Hospitalized, unable to continue|1
4481858|NCT00725725|7280352|FG000|Overall Study|Adverse Event|1
4481859|NCT00725725|7280353|FG001|Overall Study|Adverse Event|3
4481860|NCT00725725|7280354|FG002|Overall Study|Adverse Event|2
4481861|NCT00725725|7280352|FG000|Overall Study|Lost to Follow-up|2
4481862|NCT00725725|7280353|FG001|Overall Study|Lost to Follow-up|0
4481863|NCT00725725|7280354|FG002|Overall Study|Lost to Follow-up|2
4481864|NCT00725725|7280352|FG000|Overall Study|Withdrawal by Subject|1
4481865|NCT00725725|7280353|FG001|Overall Study|Withdrawal by Subject|0
4481866|NCT00725725|7280354|FG002|Overall Study|Withdrawal by Subject|1
4481867|NCT00725725|7280352|FG000|Overall Study|Protocol Violation|0
4481868|NCT00725725|7280353|FG001|Overall Study|Protocol Violation|1
4481869|NCT00725725|7280354|FG002|Overall Study|Protocol Violation|0
4481870|NCT00725764|7280372|FG000|Overall Study|Withdrawal by Subject|2
4481871|NCT00725764|7280372|FG000|Overall Study|Physician Decision|1
4481872|NCT00725764|7280372|FG000|Overall Study|Progressive Disease|7
4481873|NCT00725764|7280372|FG000|Overall Study|Lost to Follow-up|1
4481874|NCT00725764|7280372|FG000|Overall Study|Death|1
4481875|NCT00725764|7280372|FG000|Overall Study|Participant non compliant with protocol|1
4481876|NCT00725764|7280372|FG000|Overall Study|Decline in performance status|1
4481877|NCT00725842|7280377|FG000|Overall Study|Lost to Follow-up|19
4593796|NCT01555125|7442334|FG003|Extension|Technical Problems|1
4481878|NCT00725842|7280377|FG000|Overall Study|Death|1
4481879|NCT00725842|7280377|FG000|Overall Study|Positive HCV-RNA at Visit 2|13
4481880|NCT00725842|7280377|FG000|Overall Study|Consent date prior to study start date|5
4481881|NCT00725842|7280377|FG000|Overall Study|Inclusion criterion not met|1
4481882|NCT00725842|7280377|FG000|Overall Study|No Visit 1 data|1
4481883|NCT00725920|7280383|FG000|Overall Study|Lack of Efficacy|3
4481884|NCT00725920|7280384|FG001|Overall Study|Lack of Efficacy|6
4481885|NCT00726232|7280405|FG000|Initial Phase (Dose-finding)|Death|0
4481886|NCT00726232|7280406|FG001|Initial Phase (Dose-finding)|Death|0
4481887|NCT00726232|7280407|FG002|Initial Phase (Dose-finding)|Death|0
4481888|NCT00726232|7280408|FG003|Initial Phase (Dose-finding)|Death|0
4481889|NCT00726232|7280409|FG004|Initial Phase (Dose-finding)|Death|1
4481890|NCT00726232|7280410|FG005|Initial Phase (Dose-finding)|Death|0
4481891|NCT00726232|7280411|FG006|Initial Phase (Dose-finding)|Death|0
4481892|NCT00726232|7280412|FG007|Initial Phase (Dose-finding)|Death|0
4481893|NCT00726232|7280405|FG000|Initial Phase (Dose-finding)|Adverse Event|2
4481894|NCT00726232|7280406|FG001|Initial Phase (Dose-finding)|Adverse Event|2
4481895|NCT00726232|7280407|FG002|Initial Phase (Dose-finding)|Adverse Event|2
4481896|NCT00726232|7280408|FG003|Initial Phase (Dose-finding)|Adverse Event|1
4481897|NCT00726232|7280409|FG004|Initial Phase (Dose-finding)|Adverse Event|7
4481898|NCT00726232|7280410|FG005|Initial Phase (Dose-finding)|Adverse Event|3
4481899|NCT00726232|7280411|FG006|Initial Phase (Dose-finding)|Adverse Event|0
4481900|NCT00726232|7280412|FG007|Initial Phase (Dose-finding)|Adverse Event|0
4481901|NCT00726232|7280405|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2
4481902|NCT00726232|7280406|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0
4481903|NCT00726232|7280407|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0
4386941|NCT00043186|7165467|FG006|Overall Study|Ineligibility determined|0
4386942|NCT00043186|7165468|FG007|Overall Study|Ineligibility determined|0
4481904|NCT00726232|7280408|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1
4481905|NCT00726232|7280409|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0
4589700|NCT01514201|7435117|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0
4589701|NCT01514201|7435118|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0
4589702|NCT01514201|7435119|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0
4589703|NCT01514201|7435116|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0
4589704|NCT01514201|7435117|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1
4589705|NCT01514201|7435118|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1
4589706|NCT01514201|7435119|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0
4589707|NCT01514201|7435116|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4
4589708|NCT01514201|7435117|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4
4589709|NCT01514201|7435118|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5
4481906|NCT00726232|7280410|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2
4481907|NCT00726232|7280411|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0
4481908|NCT00726232|7280412|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0
4481909|NCT00726232|7280405|FG000|Initial Phase (Dose-finding)|Disease progression|3
4481910|NCT00726232|7280406|FG001|Initial Phase (Dose-finding)|Disease progression|1
4481911|NCT00726232|7280407|FG002|Initial Phase (Dose-finding)|Disease progression|0
4481912|NCT00726232|7280408|FG003|Initial Phase (Dose-finding)|Disease progression|0
4481913|NCT00726232|7280409|FG004|Initial Phase (Dose-finding)|Disease progression|0
4481914|NCT00726232|7280410|FG005|Initial Phase (Dose-finding)|Disease progression|0
4481915|NCT00726232|7280411|FG006|Initial Phase (Dose-finding)|Disease progression|0
4481916|NCT00726232|7280412|FG007|Initial Phase (Dose-finding)|Disease progression|0
4481917|NCT00726232|7280405|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4
4481918|NCT00726232|7280406|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3
4481919|NCT00726232|7280407|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3
4589710|NCT01514201|7435119|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
4589711|NCT01514201|7435116|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1
4589712|NCT01514201|7435117|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1
4589713|NCT01514201|7435118|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
4386943|NCT00043186|7165469|FG008|Overall Study|Ineligibility determined|1
4386944|NCT00043186|7165461|FG000|Overall Study|Lost to Follow-up|3
4386945|NCT00043186|7165462|FG001|Overall Study|Lost to Follow-up|5
4386946|NCT00043186|7165463|FG002|Overall Study|Lost to Follow-up|1
4386947|NCT00043186|7165464|FG003|Overall Study|Lost to Follow-up|1
4386948|NCT00043186|7165465|FG004|Overall Study|Lost to Follow-up|1
4386949|NCT00043186|7165466|FG005|Overall Study|Lost to Follow-up|1
4386950|NCT00043186|7165467|FG006|Overall Study|Lost to Follow-up|1
4386951|NCT00043186|7165468|FG007|Overall Study|Lost to Follow-up|1
4386952|NCT00043186|7165469|FG008|Overall Study|Lost to Follow-up|2
4386953|NCT00043186|7165461|FG000|Overall Study|Noncompliance|0
4386954|NCT00043186|7165462|FG001|Overall Study|Noncompliance|0
4386955|NCT00043186|7165463|FG002|Overall Study|Noncompliance|1
4386956|NCT00043186|7165464|FG003|Overall Study|Noncompliance|1
4386957|NCT00043186|7165465|FG004|Overall Study|Noncompliance|0
4386958|NCT00043186|7165466|FG005|Overall Study|Noncompliance|0
4386959|NCT00043186|7165467|FG006|Overall Study|Noncompliance|0
4386960|NCT00043186|7165468|FG007|Overall Study|Noncompliance|0
4386961|NCT00043186|7165469|FG008|Overall Study|Noncompliance|0
4386962|NCT00043186|7165461|FG000|Overall Study|Other|0
4386963|NCT00043186|7165462|FG001|Overall Study|Other|0
4386964|NCT00043186|7165463|FG002|Overall Study|Other|1
4386965|NCT00043186|7165464|FG003|Overall Study|Other|1
4386966|NCT00043186|7165465|FG004|Overall Study|Other|0
4481920|NCT00726232|7280408|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4
4481921|NCT00726232|7280409|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9
4481922|NCT00726232|7280410|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3
4481923|NCT00726232|7280411|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0
4481924|NCT00726232|7280412|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0
4481925|NCT00726232|7280405|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1
4481926|NCT00726232|7280406|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
4481927|NCT00726232|7280407|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
4481928|NCT00726232|7280408|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2
4481929|NCT00726232|7280409|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4
4481930|NCT00726232|7280410|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1
4481931|NCT00726232|7280411|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
4481932|NCT00726232|7280412|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
4481933|NCT00726232|7280405|FG000|Initial Phase (Dose-finding)|Unspecified reason|1
4481934|NCT00726232|7280406|FG001|Initial Phase (Dose-finding)|Unspecified reason|0
4481935|NCT00726232|7280407|FG002|Initial Phase (Dose-finding)|Unspecified reason|0
4481936|NCT00726232|7280408|FG003|Initial Phase (Dose-finding)|Unspecified reason|0
4481937|NCT00726232|7280409|FG004|Initial Phase (Dose-finding)|Unspecified reason|0
4481938|NCT00726232|7280410|FG005|Initial Phase (Dose-finding)|Unspecified reason|0
4481939|NCT00726232|7280411|FG006|Initial Phase (Dose-finding)|Unspecified reason|0
4481940|NCT00726232|7280412|FG007|Initial Phase (Dose-finding)|Unspecified reason|0
4481941|NCT00726232|7280405|FG000|Expansion Phase|Death|0
4481942|NCT00726232|7280406|FG001|Expansion Phase|Death|0
4481943|NCT00726232|7280407|FG002|Expansion Phase|Death|0
4481944|NCT00726232|7280408|FG003|Expansion Phase|Death|0
4481945|NCT00726232|7280409|FG004|Expansion Phase|Death|0
4481946|NCT00726232|7280410|FG005|Expansion Phase|Death|0
4481947|NCT00726232|7280411|FG006|Expansion Phase|Death|0
4481948|NCT00726232|7280412|FG007|Expansion Phase|Death|1
4481949|NCT00726232|7280405|FG000|Expansion Phase|Adverse Event|0
4481950|NCT00726232|7280406|FG001|Expansion Phase|Adverse Event|0
4481951|NCT00726232|7280407|FG002|Expansion Phase|Adverse Event|0
4481952|NCT00726232|7280408|FG003|Expansion Phase|Adverse Event|0
4481953|NCT00726232|7280409|FG004|Expansion Phase|Adverse Event|0
4481954|NCT00726232|7280410|FG005|Expansion Phase|Adverse Event|0
4481955|NCT00726232|7280411|FG006|Expansion Phase|Adverse Event|6
4481956|NCT00726232|7280412|FG007|Expansion Phase|Adverse Event|11
4481957|NCT00726232|7280405|FG000|Expansion Phase|Withdrawal by Subject|0
4481958|NCT00726232|7280406|FG001|Expansion Phase|Withdrawal by Subject|0
4481959|NCT00726232|7280407|FG002|Expansion Phase|Withdrawal by Subject|0
4481960|NCT00726232|7280408|FG003|Expansion Phase|Withdrawal by Subject|0
4481961|NCT00726232|7280409|FG004|Expansion Phase|Withdrawal by Subject|0
4481962|NCT00726232|7280410|FG005|Expansion Phase|Withdrawal by Subject|0
4481963|NCT00726232|7280411|FG006|Expansion Phase|Withdrawal by Subject|2
4481964|NCT00726232|7280412|FG007|Expansion Phase|Withdrawal by Subject|3
4481965|NCT00726232|7280405|FG000|Expansion Phase|Disease progression|0
4481966|NCT00726232|7280406|FG001|Expansion Phase|Disease progression|0
4481967|NCT00726232|7280407|FG002|Expansion Phase|Disease progression|0
4481968|NCT00726232|7280408|FG003|Expansion Phase|Disease progression|0
4481969|NCT00726232|7280409|FG004|Expansion Phase|Disease progression|0
4481970|NCT00726232|7280410|FG005|Expansion Phase|Disease progression|0
4481971|NCT00726232|7280411|FG006|Expansion Phase|Disease progression|4
4481972|NCT00726232|7280412|FG007|Expansion Phase|Disease progression|0
4481973|NCT00726232|7280405|FG000|Expansion Phase|Termination of the trial by sponsor|0
4481974|NCT00726232|7280406|FG001|Expansion Phase|Termination of the trial by sponsor|0
4481975|NCT00726232|7280407|FG002|Expansion Phase|Termination of the trial by sponsor|0
4481976|NCT00726232|7280408|FG003|Expansion Phase|Termination of the trial by sponsor|0
4481977|NCT00726232|7280409|FG004|Expansion Phase|Termination of the trial by sponsor|0
4481978|NCT00726232|7280410|FG005|Expansion Phase|Termination of the trial by sponsor|0
4481979|NCT00726232|7280411|FG006|Expansion Phase|Termination of the trial by sponsor|10
4481980|NCT00726232|7280412|FG007|Expansion Phase|Termination of the trial by sponsor|16
4481981|NCT00726232|7280405|FG000|Expansion Phase|Per Investigator: lack of response|0
4481982|NCT00726232|7280406|FG001|Expansion Phase|Per Investigator: lack of response|0
4481983|NCT00726232|7280407|FG002|Expansion Phase|Per Investigator: lack of response|0
4481984|NCT00726232|7280408|FG003|Expansion Phase|Per Investigator: lack of response|0
4481985|NCT00726232|7280409|FG004|Expansion Phase|Per Investigator: lack of response|0
4481986|NCT00726232|7280410|FG005|Expansion Phase|Per Investigator: lack of response|0
4481987|NCT00726232|7280411|FG006|Expansion Phase|Per Investigator: lack of response|1
4481988|NCT00726232|7280412|FG007|Expansion Phase|Per Investigator: lack of response|7
4700789|NCT02699749|7616950|FG011|Overall Study|Progressive Disease|4
4481989|NCT00726232|7280405|FG000|Expansion Phase|Unspecified reason|0
4481990|NCT00726232|7280406|FG001|Expansion Phase|Unspecified reason|0
4481991|NCT00726232|7280407|FG002|Expansion Phase|Unspecified reason|0
4481992|NCT00726232|7280408|FG003|Expansion Phase|Unspecified reason|0
4481993|NCT00726232|7280409|FG004|Expansion Phase|Unspecified reason|0
4481994|NCT00726232|7280410|FG005|Expansion Phase|Unspecified reason|0
4481995|NCT00726232|7280411|FG006|Expansion Phase|Unspecified reason|1
4481996|NCT00726232|7280412|FG007|Expansion Phase|Unspecified reason|0
4481997|NCT00726323|7280433|FG000|Overall Study|Withdrawal by Subject|3
4481998|NCT00726323|7280434|FG001|Overall Study|Withdrawal by Subject|1
4481999|NCT00726323|7280433|FG000|Overall Study|Physician Decision|1
4482000|NCT00726323|7280434|FG001|Overall Study|Physician Decision|0
4482001|NCT00726323|7280433|FG000|Overall Study|Progressive disease|23
4482002|NCT00726323|7280434|FG001|Overall Study|Progressive disease|16
4482003|NCT00726323|7280433|FG000|Overall Study|Clinical progression|0
4482004|NCT00726323|7280434|FG001|Overall Study|Clinical progression|3
4482005|NCT00726323|7280433|FG000|Overall Study|Adverse Event|9
4482006|NCT00726323|7280434|FG001|Overall Study|Adverse Event|9
4482007|NCT00726323|7280433|FG000|Overall Study|Death|1
4482008|NCT00726323|7280434|FG001|Overall Study|Death|0
4482009|NCT00726323|7280433|FG000|Overall Study|Participant wished to discontinue|0
4482010|NCT00726323|7280434|FG001|Overall Study|Participant wished to discontinue|1
4482011|NCT00726323|7280433|FG000|Overall Study|Metastatic lesions inferred cyst|0
4482012|NCT00726323|7280434|FG001|Overall Study|Metastatic lesions inferred cyst|1
4482013|NCT00726388|7280444|FG000|Overall Study|Withdrawal by Subject|5
4482014|NCT00726388|7280444|FG000|Overall Study|Adverse Event|3
4482015|NCT00726388|7280444|FG000|Overall Study|Lost to Follow-up|10
4482016|NCT00726388|7280444|FG000|Overall Study|Participants Non-compliant With Study Procedures|5
4482017|NCT00726388|7280444|FG000|Overall Study|Other|5
4482018|NCT00726388|7280444|FG000|Overall Study|Enrolled, Not Treated|79
4482019|NCT00726453|7280457|FG000|Primary Enrollment Group|Death|18
4482020|NCT00726453|7280458|FG001|Primary Enrollment Group|Death|0
4482021|NCT00726453|7280457|FG000|Primary Enrollment Group|Withdrawal by Subject|13
4482022|NCT00726453|7280458|FG001|Primary Enrollment Group|Withdrawal by Subject|0
4482023|NCT00726453|7280457|FG000|38 mm Length Group|Death|0
4482024|NCT00726453|7280458|FG001|38 mm Length Group|Death|3
4482025|NCT00726557|7280463|FG000|Overall Study|Screening failure|4
4482026|NCT00726557|7280463|FG000|Overall Study|No end of treatment documentation|37
4482027|NCT00726557|7280463|FG000|Overall Study|No follow-up documentation available|55
4482028|NCT00726557|7280463|FG000|Overall Study|Treatment less than 3 months|17
4482029|NCT00726557|7280463|FG000|Overall Study|Inclusion criteria not met|15
4482030|NCT00726609|7280468|FG000|Overall Study|Adverse Event|10
4482031|NCT00726609|7280468|FG000|Overall Study|Withdrawal by Subject|2
4482032|NCT00726609|7280468|FG000|Overall Study|Lack of Efficacy|25
4482033|NCT00726609|7280468|FG000|Overall Study|Other|16
4482034|NCT00726609|7280468|FG000|Overall Study|Missing|42
4482035|NCT00726609|7280468|FG000|Overall Study|Other|3
4482036|NCT00726622|7280474|FG000|Overall Study|Withdrawal by Subject|16
4482037|NCT00726622|7280475|FG001|Overall Study|Withdrawal by Subject|2
4482038|NCT00726622|7280474|FG000|Overall Study|Physician Decision|0
4482039|NCT00726622|7280475|FG001|Overall Study|Physician Decision|1
4482040|NCT00726622|7280474|FG000|Overall Study|Metastasis|2
4482041|NCT00726622|7280475|FG001|Overall Study|Metastasis|0
4482042|NCT00726661|7280483|FG000|Overall Study|Lost to Follow-up|36
4482043|NCT00726661|7280484|FG001|Overall Study|Lost to Follow-up|11
4482044|NCT00726661|7280483|FG000|Overall Study|Withdrawal by Subject|17
4482045|NCT00726661|7280484|FG001|Overall Study|Withdrawal by Subject|13
4482046|NCT00726661|7280483|FG000|Overall Study|Trial terminated by sponsor|214
4482047|NCT00726661|7280484|FG001|Overall Study|Trial terminated by sponsor|187
4482048|NCT00726661|7280483|FG000|Overall Study|Death|475
4482049|NCT00726661|7280484|FG001|Overall Study|Death|159
4482050|NCT00726661|7280483|FG000|Overall Study|Physician Decision|25
4482051|NCT00726661|7280484|FG001|Overall Study|Physician Decision|13
4482052|NCT00726661|7280483|FG000|Overall Study|Other|47
4482053|NCT00726661|7280484|FG001|Overall Study|Other|35
4482054|NCT00726752|7280511|FG000|Overall Study|Lack of Efficacy|6
4482055|NCT00726882|7280515|FG000|Overall Study|Withdrawal by Subject|5
4482056|NCT00726882|7280515|FG000|Overall Study|Lost to Follow-up|7
4482057|NCT00726882|7280515|FG000|Overall Study|Other|10
4482058|NCT00726895|7280521|FG000|Washout Period of 7 Days|Withdrawal by Subject|0
4482059|NCT00726895|7280522|FG001|Washout Period of 7 Days|Withdrawal by Subject|1
4482060|NCT00726986|7280529|FG000|Induction Phase|Adverse Event|4
4482061|NCT00726986|7280529|FG000|Induction Phase|Withdrawal by Subject|2
4482062|NCT00726986|7280529|FG000|Induction Phase|Death|2
4482063|NCT00726986|7280529|FG000|Induction Phase|Lack of Efficacy|5
4482064|NCT00726986|7280529|FG000|Induction Phase|Secondary Disease|2
4482065|NCT00726986|7280529|FG000|Maintenance Phase|Adverse Event|1
4482066|NCT00726986|7280529|FG000|Maintenance Phase|Lack of Efficacy|2
4482067|NCT00726999|7280535|FG000|Overall Study|Physician Decision|0
4482068|NCT00726999|7280536|FG001|Overall Study|Physician Decision|1
4482069|NCT00726999|7280535|FG000|Overall Study|Withdrawal by Subject|2
4482070|NCT00726999|7280536|FG001|Overall Study|Withdrawal by Subject|0
4482071|NCT00726999|7280535|FG000|Overall Study|Protocol Violation|1
4589714|NCT01514201|7435119|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
4482072|NCT00726999|7280536|FG001|Overall Study|Protocol Violation|0
4482073|NCT00727025|7280544|FG000|Overall Study|Physician Decision|23
4482074|NCT00727194|7280561|FG000|Screening Period|Low QMG scores|0
4482075|NCT00727194|7280562|FG001|Screening Period|Low QMG scores|0
4482076|NCT00727194|7280563|FG002|Screening Period|Low QMG scores|6
4482077|NCT00727194|7280561|FG000|Screening Period|Lacked AChR antibodies|0
4482078|NCT00727194|7280562|FG001|Screening Period|Lacked AChR antibodies|0
4482079|NCT00727194|7280563|FG002|Screening Period|Lacked AChR antibodies|5
4482080|NCT00727194|7280561|FG000|Screening Period|Not stable on concomitant MG therapy|0
4482081|NCT00727194|7280562|FG001|Screening Period|Not stable on concomitant MG therapy|0
4482082|NCT00727194|7280563|FG002|Screening Period|Not stable on concomitant MG therapy|2
4482083|NCT00727194|7280561|FG000|Screening Period|Severe infections|0
4482084|NCT00727194|7280562|FG001|Screening Period|Severe infections|0
4482085|NCT00727194|7280563|FG002|Screening Period|Severe infections|2
4482086|NCT00727194|7280561|FG000|Screening Period|History of thymoma|0
4482087|NCT00727194|7280562|FG001|Screening Period|History of thymoma|0
4482088|NCT00727194|7280563|FG002|Screening Period|History of thymoma|1
4482089|NCT00727194|7280561|FG000|Treatment Period 2|Lack of Efficacy|0
4482090|NCT00727194|7280562|FG001|Treatment Period 2|Lack of Efficacy|1
4482091|NCT00727194|7280563|FG002|Treatment Period 2|Lack of Efficacy|0
4482092|NCT00727246|7280590|FG000|Overall Study|could not complete MRI|0
4482093|NCT00727246|7280591|FG001|Overall Study|could not complete MRI|1
4482094|NCT00727246|7280592|FG002|Overall Study|could not complete MRI|0
4482095|NCT00727246|7280593|FG003|Overall Study|could not complete MRI|1
4482096|NCT00727246|7280590|FG000|Overall Study|incidental finding|0
4482097|NCT00727246|7280591|FG001|Overall Study|incidental finding|0
4482098|NCT00727246|7280592|FG002|Overall Study|incidental finding|0
4482099|NCT00727246|7280593|FG003|Overall Study|incidental finding|1
4482100|NCT00727246|7280590|FG000|Overall Study|withdrawn|0
4700790|NCT02699749|7616951|FG012|Overall Study|Progressive Disease|3
4700791|NCT02699749|7616952|FG013|Overall Study|Progressive Disease|5
4700792|NCT02699749|7616939|FG000|Overall Study|Death|0
4700793|NCT02699749|7616940|FG001|Overall Study|Death|0
4700794|NCT02699749|7616941|FG002|Overall Study|Death|0
4700795|NCT02699749|7616942|FG003|Overall Study|Death|0
4700796|NCT02699749|7616943|FG004|Overall Study|Death|0
4771234|NCT03000530|7748137|FG002|Overall Study|Withdrawal by Subject|1
4482101|NCT00727246|7280591|FG001|Overall Study|withdrawn|0
4482102|NCT00727246|7280592|FG002|Overall Study|withdrawn|1
4482103|NCT00727246|7280593|FG003|Overall Study|withdrawn|0
4482104|NCT00727259|7280603|FG000|Overall Study|Not all questionnaires completed|1055
4482105|NCT00727272|7280608|FG000|Washout Period A|Adverse Event|0
4482106|NCT00727272|7280609|FG001|Washout Period A|Adverse Event|0
4482107|NCT00727272|7280610|FG002|Washout Period A|Adverse Event|1
4482108|NCT00727272|7280608|FG000|Washout Period B|Withdrawal by Subject|0
4482109|NCT00727272|7280609|FG001|Washout Period B|Withdrawal by Subject|0
4482110|NCT00727272|7280610|FG002|Washout Period B|Withdrawal by Subject|1
4482111|NCT00727311|7280624|FG000|Overall Study|Did not receive drug|316
4482112|NCT00727311|7280624|FG000|Overall Study|Missing end of therapy data|205
4482113|NCT00727311|7280624|FG000|Overall Study|Adverse Event|58
4482114|NCT00727311|7280624|FG000|Overall Study|Lack of Efficacy|242
4482115|NCT00727311|7280624|FG000|Overall Study|Lost to Follow-up|73
4482116|NCT00727311|7280624|FG000|Overall Study|Withdrawal by Subject|77
4482117|NCT00727311|7280624|FG000|Overall Study|Other|97
4482118|NCT00727311|7280624|FG000|Overall Study|Multiple reasons|39
4482119|NCT00727402|7280650|FG000|Overall Study|Physician Decision|116
4482120|NCT00727415|7280654|FG000|Phase I|Dose Limiting Toxicity|2
4482121|NCT00727441|7280661|FG000|Overall Study|Disease Progression|11
4482122|NCT00727441|7280662|FG001|Overall Study|Disease Progression|14
4482123|NCT00727441|7280663|FG002|Overall Study|Disease Progression|17
4482124|NCT00727441|7280661|FG000|Overall Study|Eligibility|7
4482125|NCT00727441|7280662|FG001|Overall Study|Eligibility|5
4482126|NCT00727441|7280663|FG002|Overall Study|Eligibility|7
4482127|NCT00727441|7280661|FG000|Overall Study|Death|0
4482128|NCT00727441|7280662|FG001|Overall Study|Death|1
4482129|NCT00727441|7280663|FG002|Overall Study|Death|1
4482130|NCT00727441|7280661|FG000|Overall Study|Physician Decision|0
4482131|NCT00727441|7280662|FG001|Overall Study|Physician Decision|1
4482132|NCT00727441|7280663|FG002|Overall Study|Physician Decision|0
4482133|NCT00727441|7280661|FG000|Overall Study|Withdrawal by Subject|0
4482134|NCT00727441|7280662|FG001|Overall Study|Withdrawal by Subject|1
4482135|NCT00727441|7280663|FG002|Overall Study|Withdrawal by Subject|0
4482136|NCT00727506|7280680|FG000|Overall Study|Adverse Event|0
4482137|NCT00727506|7280681|FG001|Overall Study|Adverse Event|0
4482138|NCT00727506|7280682|FG002|Overall Study|Adverse Event|4
4482139|NCT00727506|7280683|FG003|Overall Study|Adverse Event|4
4482140|NCT00727506|7280684|FG004|Overall Study|Adverse Event|1
4482141|NCT00727506|7280685|FG005|Overall Study|Adverse Event|8
4482142|NCT00727506|7280680|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2
4482143|NCT00727506|7280681|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0
4482144|NCT00727506|7280682|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2
4482145|NCT00727506|7280683|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0
4482146|NCT00727506|7280684|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0
4482147|NCT00727506|7280685|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0
4482148|NCT00727506|7280680|FG000|Overall Study|Progressive disease|4
4482149|NCT00727506|7280681|FG001|Overall Study|Progressive disease|7
4482150|NCT00727506|7280682|FG002|Overall Study|Progressive disease|9
4482151|NCT00727506|7280683|FG003|Overall Study|Progressive disease|28
4700797|NCT02699749|7616944|FG005|Overall Study|Death|0
4700798|NCT02699749|7616945|FG006|Overall Study|Death|0
4700799|NCT02699749|7616946|FG007|Overall Study|Death|0
4700800|NCT02699749|7616947|FG008|Overall Study|Death|0
4700801|NCT02699749|7616948|FG009|Overall Study|Death|0
4700802|NCT02699749|7616949|FG010|Overall Study|Death|0
4700803|NCT02699749|7616950|FG011|Overall Study|Death|0
4700804|NCT02699749|7616951|FG012|Overall Study|Death|0
4700805|NCT02699749|7616952|FG013|Overall Study|Death|1
4700806|NCT02699749|7616939|FG000|Overall Study|Lost to Follow-up|0
4700807|NCT02699749|7616940|FG001|Overall Study|Lost to Follow-up|0
4700808|NCT02699749|7616941|FG002|Overall Study|Lost to Follow-up|0
4482152|NCT00727506|7280684|FG004|Overall Study|Progressive disease|38
4482153|NCT00727506|7280685|FG005|Overall Study|Progressive disease|28
4482154|NCT00727506|7280680|FG000|Overall Study|Refused to continue medication|0
4482155|NCT00727506|7280681|FG001|Overall Study|Refused to continue medication|1
4482156|NCT00727506|7280682|FG002|Overall Study|Refused to continue medication|2
4482157|NCT00727506|7280683|FG003|Overall Study|Refused to continue medication|3
4482158|NCT00727506|7280684|FG004|Overall Study|Refused to continue medication|1
4482159|NCT00727506|7280685|FG005|Overall Study|Refused to continue medication|2
4482160|NCT00727506|7280680|FG000|Overall Study|Other reason not described above|0
4482161|NCT00727506|7280681|FG001|Overall Study|Other reason not described above|0
4482162|NCT00727506|7280682|FG002|Overall Study|Other reason not described above|1
4482163|NCT00727506|7280683|FG003|Overall Study|Other reason not described above|4
4482164|NCT00727506|7280684|FG004|Overall Study|Other reason not described above|1
4482165|NCT00727506|7280685|FG005|Overall Study|Other reason not described above|1
4482166|NCT00727532|7280705|FG000|Overall Study|Adverse Event|1
4482167|NCT00727532|7280705|FG000|Overall Study|Withdrawal by Subject|1
4482168|NCT00727558|7280711|FG000|Overall Study|Lens issue|0
4482169|NCT00727558|7280712|FG001|Overall Study|Lens issue|1
4482170|NCT00727558|7280711|FG000|Overall Study|Adverse Event|0
4482171|NCT00727558|7280712|FG001|Overall Study|Adverse Event|1
4482172|NCT00727558|7280711|FG000|Overall Study|Subject unable to return for follow-up|1
4482173|NCT00727558|7280712|FG001|Overall Study|Subject unable to return for follow-up|1
4482174|NCT00727558|7280711|FG000|Overall Study|Lost to Follow-up|1
4482175|NCT00727558|7280712|FG001|Overall Study|Lost to Follow-up|0
4482176|NCT00727571|7280722|FG000|Overall Study|Ineligibility determined|1
4482177|NCT00727571|7280723|FG001|Overall Study|Ineligibility determined|1
4482178|NCT00727571|7280724|FG002|Overall Study|Ineligibility determined|1
4482179|NCT00727571|7280725|FG003|Overall Study|Ineligibility determined|0
4482180|NCT00727571|7280722|FG000|Overall Study|Death|0
4482181|NCT00727571|7280723|FG001|Overall Study|Death|19
4482182|NCT00727571|7280724|FG002|Overall Study|Death|5
4482183|NCT00727571|7280725|FG003|Overall Study|Death|1
4482184|NCT00727571|7280722|FG000|Overall Study|Physician Decision|0
4482185|NCT00727571|7280723|FG001|Overall Study|Physician Decision|5
4482186|NCT00727571|7280724|FG002|Overall Study|Physician Decision|0
4482187|NCT00727571|7280725|FG003|Overall Study|Physician Decision|0
4482188|NCT00727571|7280722|FG000|Overall Study|Withdrawal by Subject|0
4482189|NCT00727571|7280723|FG001|Overall Study|Withdrawal by Subject|10
4482190|NCT00727571|7280724|FG002|Overall Study|Withdrawal by Subject|11
4482191|NCT00727571|7280725|FG003|Overall Study|Withdrawal by Subject|0
4482192|NCT00727571|7280722|FG000|Overall Study|Subject Non Compliance|0
4482193|NCT00727571|7280723|FG001|Overall Study|Subject Non Compliance|6
4482194|NCT00727571|7280724|FG002|Overall Study|Subject Non Compliance|0
4482195|NCT00727571|7280725|FG003|Overall Study|Subject Non Compliance|4
4482196|NCT00727571|7280722|FG000|Overall Study|Dismissed from nursing home|0
4482197|NCT00727571|7280723|FG001|Overall Study|Dismissed from nursing home|9
4482198|NCT00727571|7280724|FG002|Overall Study|Dismissed from nursing home|5
4482199|NCT00727571|7280725|FG003|Overall Study|Dismissed from nursing home|0
4482200|NCT00727571|7280722|FG000|Overall Study|Hospitalization|0
4482201|NCT00727571|7280723|FG001|Overall Study|Hospitalization|1
4482202|NCT00727571|7280724|FG002|Overall Study|Hospitalization|0
4589715|NCT01514201|7435116|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0
4482203|NCT00727571|7280725|FG003|Overall Study|Hospitalization|1
4482204|NCT00727571|7280722|FG000|Overall Study|AE not leading to hospitalization|0
4482205|NCT00727571|7280723|FG001|Overall Study|AE not leading to hospitalization|0
4482206|NCT00727571|7280724|FG002|Overall Study|AE not leading to hospitalization|2
4482207|NCT00727571|7280725|FG003|Overall Study|AE not leading to hospitalization|0
4482208|NCT00727571|7280722|FG000|Overall Study|Other|0
4482209|NCT00727571|7280723|FG001|Overall Study|Other|4
4482210|NCT00727571|7280724|FG002|Overall Study|Other|6
4482211|NCT00727571|7280725|FG003|Overall Study|Other|0
4482212|NCT00727649|7280755|FG000|First Intervention (4-weeks)|Lost to Follow-up|1
4482213|NCT00727649|7280756|FG001|First Intervention (4-weeks)|Lost to Follow-up|2
4482214|NCT00727649|7280755|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2
4482215|NCT00727649|7280756|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1
4482216|NCT00727649|7280755|FG000|Wash-out (2-weeks)|Lost to Follow-up|3
4482217|NCT00727649|7280756|FG001|Wash-out (2-weeks)|Lost to Follow-up|1
4482218|NCT00727649|7280755|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1
4482219|NCT00727649|7280756|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2
4482220|NCT00727649|7280755|FG000|Second Intervention (4-weeks)|Death|1
4482221|NCT00727649|7280756|FG001|Second Intervention (4-weeks)|Death|0
4482222|NCT00727649|7280755|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0
4700809|NCT02699749|7616942|FG003|Overall Study|Lost to Follow-up|0
4700810|NCT02699749|7616943|FG004|Overall Study|Lost to Follow-up|0
4482223|NCT00727649|7280756|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1
4482224|NCT00727649|7280755|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0
4482225|NCT00727649|7280756|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2
4482226|NCT00727714|7280764|FG000|Overall Study|Lost to Follow-up|2
4482227|NCT00727844|7280779|FG000|Initial Randomization|Physician Decision|2
4482228|NCT00727844|7280780|FG001|Initial Randomization|Physician Decision|0
4482229|NCT00727844|7280781|FG002|Initial Randomization|Physician Decision|0
4482230|NCT00727844|7280782|FG003|Initial Randomization|Physician Decision|0
4482231|NCT00727909|7280801|FG000|Overall Study|Withdrawal by Subject|5
4482232|NCT00727909|7280802|FG001|Overall Study|Withdrawal by Subject|11
4482233|NCT00727909|7280803|FG002|Overall Study|Withdrawal by Subject|8
4482234|NCT00727909|7280804|FG003|Overall Study|Withdrawal by Subject|5
4482235|NCT00727909|7280801|FG000|Overall Study|Death|0
4482236|NCT00727909|7280802|FG001|Overall Study|Death|0
4482237|NCT00727909|7280803|FG002|Overall Study|Death|1
4482238|NCT00727909|7280804|FG003|Overall Study|Death|0
4482239|NCT00727961|7280808|FG000|Overall Study|Lost to Follow-up|1
4482240|NCT00727961|7280808|FG000|Overall Study|Adverse Event|4
4482241|NCT00727961|7280808|FG000|Overall Study|Patient's refusal|2
4482242|NCT00727961|7280808|FG000|Overall Study|Progression|30
4482243|NCT00728130|7280812|FG000|Overall Study|Withdrawal by Subject|1
4482244|NCT00728130|7280812|FG000|Overall Study|Paperwork not completed in time|1
4482245|NCT00728130|7280812|FG000|Overall Study|Physician Decision|1
4482246|NCT00728182|7280818|FG000|Overall Study|Adverse Event|1
4482247|NCT00728182|7280819|FG001|Overall Study|Adverse Event|0
4482248|NCT00728182|7280818|FG000|Overall Study|Lost to Follow-up|2
4482249|NCT00728182|7280819|FG001|Overall Study|Lost to Follow-up|0
4482250|NCT00728182|7280818|FG000|Overall Study|Death|0
4482251|NCT00728182|7280819|FG001|Overall Study|Death|2
4482252|NCT00728182|7280818|FG000|Overall Study|Protocol Noncompliance|0
4482253|NCT00728182|7280819|FG001|Overall Study|Protocol Noncompliance|1
4482254|NCT00728468|7280831|FG000|Overall Study|Enrolled but not treated|1
4482255|NCT00728468|7280831|FG000|Overall Study|Death|1
4482256|NCT00728468|7280831|FG000|Overall Study|Protocol Violation|4
4482257|NCT00728468|7280831|FG000|Overall Study|Objective progression or relapse|9
4482258|NCT00728468|7280831|FG000|Overall Study|Study terminated by sponsor|1
4482259|NCT00728481|7280837|FG000|Overall Study|Withdrawal by Subject|0
4482260|NCT00728481|7280838|FG001|Overall Study|Withdrawal by Subject|1
4482261|NCT00728481|7280837|FG000|Overall Study|Adverse Event|0
4482262|NCT00728481|7280838|FG001|Overall Study|Adverse Event|1
4482263|NCT00728481|7280837|FG000|Overall Study|Study medication non-compliance|0
4482264|NCT00728481|7280838|FG001|Overall Study|Study medication non-compliance|2
4482265|NCT00728481|7280837|FG000|Overall Study|Incorrectly assigned to opposite arm|1
4482266|NCT00728481|7280838|FG001|Overall Study|Incorrectly assigned to opposite arm|0
4482267|NCT00728494|7280846|FG000|Overall Study|Adverse Event|7
4482268|NCT00728494|7280847|FG001|Overall Study|Adverse Event|0
4482269|NCT00728494|7280846|FG000|Overall Study|Withdrawal by Subject|0
4386967|NCT00043186|7165466|FG005|Overall Study|Other|0
4386968|NCT00043186|7165467|FG006|Overall Study|Other|0
4386969|NCT00043186|7165468|FG007|Overall Study|Other|0
4386970|NCT00043186|7165469|FG008|Overall Study|Other|0
4386971|NCT00043550|7165493|FG000|Overall Study|Withdrawal by Subject|22
4386972|NCT00043550|7165494|FG001|Overall Study|Withdrawal by Subject|12
4386973|NCT00043550|7165495|FG002|Overall Study|Withdrawal by Subject|20
4386974|NCT00043979|7165505|FG000|Period 1|recipient with progressive disease|7
4386975|NCT00043979|7165506|FG001|Period 1|recipient with progressive disease|4
4386976|NCT00043979|7165507|FG002|Period 1|recipient with progressive disease|3
4386977|NCT00044083|7165549|FG000|First Intervention (One Week)- HV's|Adverse Event|1
4386978|NCT00044083|7165550|FG001|First Intervention (One Week)- HV's|Adverse Event|0
4386979|NCT00044083|7165549|FG000|First Intervention (One Week)- HV's|Not follow directions|2
4482270|NCT00728494|7280847|FG001|Overall Study|Withdrawal by Subject|2
4482271|NCT00728494|7280846|FG000|Overall Study|Lack of Efficacy|2
4482272|NCT00728494|7280847|FG001|Overall Study|Lack of Efficacy|4
4482273|NCT00728494|7280846|FG000|Overall Study|No data available|0
4482274|NCT00728494|7280847|FG001|Overall Study|No data available|1
4482275|NCT00728689|7280864|FG000|Washout Period (Days 4 - 10)|Death in family|1
4482276|NCT00728689|7280865|FG001|Washout Period (Days 4 - 10)|Death in family|0
4482277|NCT00728936|7280912|FG000|Overall Study|Withdrawal by Subject|0
4482278|NCT00728936|7280913|FG001|Overall Study|Withdrawal by Subject|0
4482279|NCT00728936|7280914|FG002|Overall Study|Withdrawal by Subject|0
4482280|NCT00728936|7280915|FG003|Overall Study|Withdrawal by Subject|0
4482281|NCT00728936|7280916|FG004|Overall Study|Withdrawal by Subject|0
4482282|NCT00728936|7280917|FG005|Overall Study|Withdrawal by Subject|1
4482283|NCT00728936|7280918|FG006|Overall Study|Withdrawal by Subject|0
4482284|NCT00728949|7280936|FG000|Overall Study|Adverse Event|8
4589716|NCT01514201|7435117|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0
4482285|NCT00728949|7280937|FG001|Overall Study|Adverse Event|0
4482286|NCT00728949|7280936|FG000|Overall Study|Withdrawal by Subject|2
4386980|NCT00044083|7165550|FG001|First Intervention (One Week)- HV's|Not follow directions|2
4386981|NCT00044083|7165549|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5
4386982|NCT00044083|7165550|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3
4482287|NCT00728949|7280937|FG001|Overall Study|Withdrawal by Subject|2
4482288|NCT00728949|7280936|FG000|Overall Study|Abnormal Lab Results|0
4482289|NCT00728949|7280937|FG001|Overall Study|Abnormal Lab Results|2
4482290|NCT00728949|7280936|FG000|Overall Study|On treatment at cutoff date|1
4482291|NCT00728949|7280937|FG001|Overall Study|On treatment at cutoff date|0
4482292|NCT00728988|7280945|FG000|Overall Study|Not Treated|2
4482293|NCT00728988|7280946|FG001|Overall Study|Not Treated|2
4482294|NCT00728988|7280945|FG000|Overall Study|Death|1
4482295|NCT00728988|7280946|FG001|Overall Study|Death|1
4482296|NCT00728988|7280945|FG000|Overall Study|Adverse Event|3
4482297|NCT00728988|7280946|FG001|Overall Study|Adverse Event|2
4482298|NCT00728988|7280945|FG000|Overall Study|Other|85
4482299|NCT00728988|7280946|FG001|Overall Study|Other|77
4482300|NCT00728988|7280945|FG000|Overall Study|Withdrawal by Subject|2
4482301|NCT00728988|7280946|FG001|Overall Study|Withdrawal by Subject|6
4482302|NCT00729157|7280970|FG000|Overall Study|Withdrawal by Subject|1
4482303|NCT00729183|7280976|FG000|Overall Study|Adverse Event|11
4482304|NCT00729183|7280977|FG001|Overall Study|Adverse Event|5
4482305|NCT00729183|7280976|FG000|Overall Study|Lack of Efficacy|0
4482306|NCT00729183|7280977|FG001|Overall Study|Lack of Efficacy|1
4482307|NCT00729183|7280976|FG000|Overall Study|Lost to Follow-up|3
4482308|NCT00729183|7280977|FG001|Overall Study|Lost to Follow-up|1
4482309|NCT00729183|7280976|FG000|Overall Study|Physician Decision|1
4482310|NCT00729183|7280977|FG001|Overall Study|Physician Decision|1
4482311|NCT00729183|7280976|FG000|Overall Study|Protocol Violation|1
4482312|NCT00729183|7280977|FG001|Overall Study|Protocol Violation|0
4482313|NCT00729183|7280976|FG000|Overall Study|Withdrawal by Subject|9
4482314|NCT00729183|7280977|FG001|Overall Study|Withdrawal by Subject|7
4482315|NCT00729248|7280983|FG000|Overall Study|Physician Decision|2
4482316|NCT00729326|7280990|FG000|Overall Study|Lost to Follow-up|2
4482317|NCT00729326|7280991|FG001|Overall Study|Lost to Follow-up|0
4482318|NCT00729326|7280990|FG000|Overall Study|Physician Decision|0
4482319|NCT00729326|7280991|FG001|Overall Study|Physician Decision|1
4482320|NCT00729326|7280990|FG000|Overall Study|Protocol Violation|3
4482321|NCT00729326|7280991|FG001|Overall Study|Protocol Violation|2
4482322|NCT00729326|7280990|FG000|Overall Study|Subject Decision|4
4482323|NCT00729326|7280991|FG001|Overall Study|Subject Decision|4
4482324|NCT00729326|7280990|FG000|Overall Study|Sponsor Decision|1
4482325|NCT00729326|7280991|FG001|Overall Study|Sponsor Decision|2
4482326|NCT00729378|7280999|FG000|Baseline|Did not complete study measurements|72
4482327|NCT00729378|7281000|FG001|Baseline|Did not complete study measurements|33
4482328|NCT00729378|7280999|FG000|Baseline|Withdrawal by Subject|66
4482329|NCT00729378|7281000|FG001|Baseline|Withdrawal by Subject|59
4482330|NCT00729378|7280999|FG000|12-months|Lost to Follow-up|100
4482331|NCT00729378|7281000|FG001|12-months|Lost to Follow-up|65
4482332|NCT00729378|7280999|FG000|24-months|Lost to Follow-up|72
4482333|NCT00729378|7281000|FG001|24-months|Lost to Follow-up|51
4482334|NCT00729378|7280999|FG000|36-months|Lost to Follow-up|15
4482335|NCT00729378|7281000|FG001|36-months|Lost to Follow-up|6
4482336|NCT00729469|7281021|FG000|Overall Study|Adverse Event|14
4482337|NCT00729469|7281022|FG001|Overall Study|Adverse Event|25
4482338|NCT00729469|7281021|FG000|Overall Study|Lost to Follow-up|9
4482339|NCT00729469|7281022|FG001|Overall Study|Lost to Follow-up|9
4482340|NCT00729469|7281021|FG000|Overall Study|Protocol Violation|2
4482341|NCT00729469|7281022|FG001|Overall Study|Protocol Violation|1
4482342|NCT00729469|7281021|FG000|Overall Study|Withdrawal by Subject|19
4700811|NCT02699749|7616944|FG005|Overall Study|Lost to Follow-up|1
4700812|NCT02699749|7616945|FG006|Overall Study|Lost to Follow-up|0
4700813|NCT02699749|7616946|FG007|Overall Study|Lost to Follow-up|1
4700814|NCT02699749|7616947|FG008|Overall Study|Lost to Follow-up|0
4700815|NCT02699749|7616948|FG009|Overall Study|Lost to Follow-up|0
4700816|NCT02699749|7616949|FG010|Overall Study|Lost to Follow-up|0
4700817|NCT02699749|7616950|FG011|Overall Study|Lost to Follow-up|0
4700818|NCT02699749|7616951|FG012|Overall Study|Lost to Follow-up|0
4700819|NCT02699749|7616952|FG013|Overall Study|Lost to Follow-up|0
4700820|NCT02699866|7616982|FG000|Overall Study|Withdrawal by Subject|3
4700821|NCT02699866|7616982|FG000|Overall Study|Physician Decision|2
4700822|NCT02699866|7616982|FG000|Overall Study|Adverse Event|3
4700823|NCT02699892|7616986|FG000|Overall Study|Other|36
4700824|NCT02699983|7616997|FG000|Overall Study|Withdrawal by Subject|1
4700825|NCT02699983|7616998|FG001|Overall Study|Withdrawal by Subject|0
4700826|NCT02699996|7617010|FG000|Overall Study|Withdrawal by Subject|5
4700827|NCT02699996|7617011|FG001|Overall Study|Withdrawal by Subject|2
4482343|NCT00729469|7281022|FG001|Overall Study|Withdrawal by Subject|8
4482344|NCT00729469|7281021|FG000|Overall Study|Other-Not mentioned|9
4482345|NCT00729469|7281022|FG001|Overall Study|Other-Not mentioned|4
4482346|NCT00729586|7281047|FG000|Overall Study|Ineligible|0
4700828|NCT02700412|7617032|FG000|Overall Study|Adverse Event|6
4700829|NCT02700412|7617032|FG000|Overall Study|Death|1
4700830|NCT02700412|7617032|FG000|Overall Study|Lack of Efficacy|19
4700831|NCT02700412|7617032|FG000|Overall Study|Protocol Violation|5
4700832|NCT02700412|7617032|FG000|Overall Study|Withdrawal by Subject|2
4482347|NCT00729586|7281048|FG001|Overall Study|Ineligible|1
4482348|NCT00729586|7281047|FG000|Overall Study|never treated|1
4482349|NCT00729586|7281048|FG001|Overall Study|never treated|0
4482350|NCT00729612|7281055|FG000|Overall Study|Non evaluable for response|10
4482351|NCT00729690|7281073|FG000|Overall Study|IT Catheter Malfunction|0
4700833|NCT02700815|7617049|FG000|Overall Study|Adverse Event|0
4700834|NCT02700815|7617050|FG001|Overall Study|Adverse Event|6
4482352|NCT00729690|7281074|FG001|Overall Study|IT Catheter Malfunction|2
4482353|NCT00729690|7281075|FG002|Overall Study|IT Catheter Malfunction|2
4482354|NCT00729833|7281091|FG000|Overall Study|Death|5
4482355|NCT00729833|7281092|FG001|Overall Study|Death|1
4482356|NCT00729833|7281093|FG002|Overall Study|Death|3
4482357|NCT00729833|7281094|FG003|Overall Study|Death|5
4482358|NCT00729833|7281091|FG000|Overall Study|Study Terminated by Sponsor|0
4482359|NCT00729833|7281092|FG001|Overall Study|Study Terminated by Sponsor|0
4482360|NCT00729833|7281093|FG002|Overall Study|Study Terminated by Sponsor|1
4482361|NCT00729833|7281094|FG003|Overall Study|Study Terminated by Sponsor|0
4482362|NCT00729833|7281091|FG000|Overall Study|Lost to Follow-up|1
4482363|NCT00729833|7281092|FG001|Overall Study|Lost to Follow-up|0
4482364|NCT00729833|7281093|FG002|Overall Study|Lost to Follow-up|0
4482365|NCT00729833|7281094|FG003|Overall Study|Lost to Follow-up|0
4482366|NCT00729833|7281091|FG000|Overall Study|Withdrawal by Subject|3
4482367|NCT00729833|7281092|FG001|Overall Study|Withdrawal by Subject|1
4482368|NCT00729833|7281093|FG002|Overall Study|Withdrawal by Subject|3
4482369|NCT00729833|7281094|FG003|Overall Study|Withdrawal by Subject|0
4482370|NCT00729833|7281091|FG000|Overall Study|Unspecified Reasons|11
4482371|NCT00729833|7281092|FG001|Overall Study|Unspecified Reasons|5
4482372|NCT00729833|7281093|FG002|Overall Study|Unspecified Reasons|5
4482373|NCT00729833|7281094|FG003|Overall Study|Unspecified Reasons|1
4482374|NCT00729859|7281117|FG000|Overall Study|Adverse Event|0
4482375|NCT00729859|7281118|FG001|Overall Study|Adverse Event|1
4482376|NCT00729859|7281119|FG002|Overall Study|Adverse Event|0
4482377|NCT00729859|7281117|FG000|Overall Study|Withdrawal by Subject|0
4482378|NCT00729859|7281118|FG001|Overall Study|Withdrawal by Subject|1
4482379|NCT00729859|7281119|FG002|Overall Study|Withdrawal by Subject|0
4482380|NCT00729937|7281148|FG000|Overall Study|Lost to Follow-up|49
4482381|NCT00729937|7281149|FG001|Overall Study|Lost to Follow-up|58
4482382|NCT00729937|7281150|FG002|Overall Study|Lost to Follow-up|18
4482383|NCT00729937|7281151|FG003|Overall Study|Lost to Follow-up|33
4482384|NCT00729937|7281152|FG004|Overall Study|Lost to Follow-up|18
4482385|NCT00729937|7281153|FG005|Overall Study|Lost to Follow-up|23
4482386|NCT00729937|7281148|FG000|Overall Study|Physician Decision|7
4482387|NCT00729937|7281149|FG001|Overall Study|Physician Decision|16
4482388|NCT00729937|7281150|FG002|Overall Study|Physician Decision|2
4482389|NCT00729937|7281151|FG003|Overall Study|Physician Decision|0
4482390|NCT00729937|7281152|FG004|Overall Study|Physician Decision|5
4482391|NCT00729937|7281153|FG005|Overall Study|Physician Decision|8
4482392|NCT00729937|7281148|FG000|Overall Study|Death|1
4482393|NCT00729937|7281149|FG001|Overall Study|Death|0
4482394|NCT00729937|7281150|FG002|Overall Study|Death|1
4482395|NCT00729937|7281151|FG003|Overall Study|Death|0
4482396|NCT00729937|7281152|FG004|Overall Study|Death|0
4482397|NCT00729937|7281153|FG005|Overall Study|Death|1
4482398|NCT00729937|7281148|FG000|Overall Study|Withdrawal by Subject|3
4482399|NCT00729937|7281149|FG001|Overall Study|Withdrawal by Subject|5
4482400|NCT00729937|7281150|FG002|Overall Study|Withdrawal by Subject|6
4482401|NCT00729937|7281151|FG003|Overall Study|Withdrawal by Subject|0
4482402|NCT00729937|7281152|FG004|Overall Study|Withdrawal by Subject|4
4482403|NCT00729937|7281153|FG005|Overall Study|Withdrawal by Subject|2
4482404|NCT00729937|7281148|FG000|Overall Study|Randomized but not treated|12
4482405|NCT00729937|7281149|FG001|Overall Study|Randomized but not treated|6
4482406|NCT00729937|7281150|FG002|Overall Study|Randomized but not treated|1
4482407|NCT00729937|7281151|FG003|Overall Study|Randomized but not treated|0
4482408|NCT00729937|7281152|FG004|Overall Study|Randomized but not treated|1
4482409|NCT00729937|7281153|FG005|Overall Study|Randomized but not treated|3
4482410|NCT00729937|7281148|FG000|Overall Study|Did not meet eligibility criteria|2
4482411|NCT00729937|7281149|FG001|Overall Study|Did not meet eligibility criteria|1
4482412|NCT00729937|7281150|FG002|Overall Study|Did not meet eligibility criteria|0
4482413|NCT00729937|7281151|FG003|Overall Study|Did not meet eligibility criteria|0
4482414|NCT00729937|7281152|FG004|Overall Study|Did not meet eligibility criteria|0
4482415|NCT00729937|7281153|FG005|Overall Study|Did not meet eligibility criteria|0
4482416|NCT00729937|7281148|FG000|Overall Study|Incarcerated|0
4482417|NCT00729937|7281149|FG001|Overall Study|Incarcerated|2
4482418|NCT00729937|7281150|FG002|Overall Study|Incarcerated|1
4482419|NCT00729937|7281151|FG003|Overall Study|Incarcerated|1
4482420|NCT00729937|7281152|FG004|Overall Study|Incarcerated|0
4482421|NCT00729937|7281153|FG005|Overall Study|Incarcerated|0
4482422|NCT00730015|7281170|FG000|Overall Study|Adverse Event|11
4482423|NCT00730015|7281171|FG001|Overall Study|Adverse Event|10
4482424|NCT00730015|7281172|FG002|Overall Study|Adverse Event|8
4482425|NCT00730015|7281170|FG000|Overall Study|Protocol Violation|2
4482426|NCT00730015|7281171|FG001|Overall Study|Protocol Violation|6
4482427|NCT00730015|7281172|FG002|Overall Study|Protocol Violation|4
4482428|NCT00730015|7281170|FG000|Overall Study|Withdrawal by Subject|12
4482429|NCT00730015|7281171|FG001|Overall Study|Withdrawal by Subject|12
4482430|NCT00730015|7281172|FG002|Overall Study|Withdrawal by Subject|8
4482431|NCT00730015|7281170|FG000|Overall Study|Lost to Follow-up|4
4482432|NCT00730015|7281171|FG001|Overall Study|Lost to Follow-up|10
4482433|NCT00730015|7281172|FG002|Overall Study|Lost to Follow-up|3
4482434|NCT00730015|7281170|FG000|Overall Study|Lack of Efficacy|1
4482435|NCT00730015|7281171|FG001|Overall Study|Lack of Efficacy|2
4482436|NCT00730015|7281172|FG002|Overall Study|Lack of Efficacy|8
4482437|NCT00730015|7281170|FG000|Overall Study|Other Reason|1
4482438|NCT00730015|7281171|FG001|Overall Study|Other Reason|0
4482439|NCT00730015|7281172|FG002|Overall Study|Other Reason|1
4482440|NCT00730028|7281190|FG000|Overall Study|Adverse Event|23
4482441|NCT00730028|7281191|FG001|Overall Study|Adverse Event|26
4482442|NCT00730028|7281192|FG002|Overall Study|Adverse Event|16
4482443|NCT00730028|7281193|FG003|Overall Study|Adverse Event|20
4482444|NCT00730028|7281194|FG004|Overall Study|Adverse Event|43
4482445|NCT00730028|7281190|FG000|Overall Study|Lost to Follow-up|13
4482446|NCT00730028|7281191|FG001|Overall Study|Lost to Follow-up|26
4482447|NCT00730028|7281192|FG002|Overall Study|Lost to Follow-up|22
4482448|NCT00730028|7281193|FG003|Overall Study|Lost to Follow-up|26
4482449|NCT00730028|7281194|FG004|Overall Study|Lost to Follow-up|25
4482450|NCT00730028|7281190|FG000|Overall Study|Protocol Violation|6
4482451|NCT00730028|7281191|FG001|Overall Study|Protocol Violation|1
4482452|NCT00730028|7281192|FG002|Overall Study|Protocol Violation|1
4482453|NCT00730028|7281193|FG003|Overall Study|Protocol Violation|2
4482454|NCT00730028|7281194|FG004|Overall Study|Protocol Violation|0
4482455|NCT00730028|7281190|FG000|Overall Study|Withdrawal by Subject|9
4482456|NCT00730028|7281191|FG001|Overall Study|Withdrawal by Subject|5
4482457|NCT00730028|7281192|FG002|Overall Study|Withdrawal by Subject|4
4482458|NCT00730028|7281193|FG003|Overall Study|Withdrawal by Subject|5
4482459|NCT00730028|7281194|FG004|Overall Study|Withdrawal by Subject|9
4482460|NCT00730028|7281190|FG000|Overall Study|Physician Decision|3
4482461|NCT00730028|7281191|FG001|Overall Study|Physician Decision|3
4482462|NCT00730028|7281192|FG002|Overall Study|Physician Decision|2
4482463|NCT00730028|7281193|FG003|Overall Study|Physician Decision|3
4482464|NCT00730028|7281194|FG004|Overall Study|Physician Decision|2
4482465|NCT00730028|7281190|FG000|Overall Study|Treatment Failure|5
4482466|NCT00730028|7281191|FG001|Overall Study|Treatment Failure|5
4482467|NCT00730028|7281192|FG002|Overall Study|Treatment Failure|0
4482468|NCT00730028|7281193|FG003|Overall Study|Treatment Failure|0
4482469|NCT00730028|7281194|FG004|Overall Study|Treatment Failure|1
4482470|NCT00730028|7281190|FG000|Overall Study|Randomization Error|1
4482471|NCT00730028|7281191|FG001|Overall Study|Randomization Error|0
4482472|NCT00730028|7281192|FG002|Overall Study|Randomization Error|0
4482473|NCT00730028|7281193|FG003|Overall Study|Randomization Error|0
4482474|NCT00730028|7281194|FG004|Overall Study|Randomization Error|2
4482475|NCT00730041|7281208|FG000|Overall Study|Lost to Follow-up|0
4482476|NCT00730041|7281209|FG001|Overall Study|Lost to Follow-up|2
4517008|NCT00963547|7328625|FG000|Overall Study|Progressive Disease|3
4517009|NCT00963547|7328626|FG001|Overall Study|Progressive Disease|8
4517010|NCT00963547|7328627|FG002|Overall Study|Progressive Disease|9
4517011|NCT00963547|7328628|FG003|Overall Study|Progressive Disease|5
4517012|NCT00963547|7328629|FG004|Overall Study|Progressive Disease|0
4517013|NCT00963547|7328630|FG005|Overall Study|Progressive Disease|0
4517014|NCT00963547|7328631|FG006|Overall Study|Progressive Disease|0
4517015|NCT00963547|7328625|FG000|Overall Study|Withdrawal by Subject|0
4517016|NCT00963547|7328626|FG001|Overall Study|Withdrawal by Subject|0
4517017|NCT00963547|7328627|FG002|Overall Study|Withdrawal by Subject|3
4517018|NCT00963547|7328628|FG003|Overall Study|Withdrawal by Subject|0
4517019|NCT00963547|7328629|FG004|Overall Study|Withdrawal by Subject|0
4517020|NCT00963547|7328630|FG005|Overall Study|Withdrawal by Subject|0
4517021|NCT00963547|7328631|FG006|Overall Study|Withdrawal by Subject|0
4517022|NCT00963547|7328625|FG000|Overall Study|Reason Unknown|0
4517023|NCT00963547|7328626|FG001|Overall Study|Reason Unknown|1
4517024|NCT00963547|7328627|FG002|Overall Study|Reason Unknown|0
4517025|NCT00963547|7328628|FG003|Overall Study|Reason Unknown|0
4517026|NCT00963547|7328629|FG004|Overall Study|Reason Unknown|0
4517027|NCT00963547|7328630|FG005|Overall Study|Reason Unknown|0
4517028|NCT00963547|7328631|FG006|Overall Study|Reason Unknown|0
4518653|NCT00975481|7330836|FG000|Second Intervention Period|Withdrawal by Subject|0
4518654|NCT00975481|7330837|FG001|Second Intervention Period|Withdrawal by Subject|0
4518655|NCT00975481|7330838|FG002|Second Intervention Period|Withdrawal by Subject|1
4518656|NCT00975481|7330839|FG003|Second Intervention Period|Withdrawal by Subject|0
4518657|NCT00975481|7330840|FG004|Second Intervention Period|Withdrawal by Subject|0
4518658|NCT00975481|7330841|FG005|Second Intervention Period|Withdrawal by Subject|0
4518659|NCT00975481|7330836|FG000|Fourth Intervention Period|Withdrawal by Subject|0
4518660|NCT00975481|7330837|FG001|Fourth Intervention Period|Withdrawal by Subject|0
4518661|NCT00975481|7330838|FG002|Fourth Intervention Period|Withdrawal by Subject|1
4518662|NCT00975481|7330839|FG003|Fourth Intervention Period|Withdrawal by Subject|1
4518663|NCT00975481|7330840|FG004|Fourth Intervention Period|Withdrawal by Subject|0
4518664|NCT00975481|7330841|FG005|Fourth Intervention Period|Withdrawal by Subject|0
4518665|NCT00975481|7330836|FG000|Fifth Intervention Period|Withdrawal by Subject|0
4518666|NCT00975481|7330837|FG001|Fifth Intervention Period|Withdrawal by Subject|0
4518667|NCT00975481|7330838|FG002|Fifth Intervention Period|Withdrawal by Subject|0
4518668|NCT00975481|7330839|FG003|Fifth Intervention Period|Withdrawal by Subject|0
4518669|NCT00975481|7330840|FG004|Fifth Intervention Period|Withdrawal by Subject|1
4518670|NCT00975481|7330841|FG005|Fifth Intervention Period|Withdrawal by Subject|0
4518671|NCT00975507|7330861|FG000|Overall Study|Adverse Event|1
4518672|NCT00975507|7330862|FG001|Overall Study|Adverse Event|0
4518673|NCT00975507|7330861|FG000|Overall Study|Lost to Follow-up|7
4518674|NCT00975507|7330862|FG001|Overall Study|Lost to Follow-up|1
4518675|NCT00975507|7330861|FG000|Overall Study|Protocol Violation|2
4518676|NCT00975507|7330862|FG001|Overall Study|Protocol Violation|0
4482477|NCT00730158|7281217|FG000|Overall Study|Withdrawal by Subject|1
4482478|NCT00730158|7281218|FG001|Overall Study|Withdrawal by Subject|1
4482479|NCT00730171|7281228|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5
4482480|NCT00730171|7281228|FG000|Overall Study|Adverse Event|193
4482481|NCT00730171|7281228|FG000|Overall Study|Protocol Violation|48
4482482|NCT00730171|7281228|FG000|Overall Study|Withdrawal by Subject|202
4482483|NCT00730171|7281228|FG000|Overall Study|Lost to Follow-up|121
4482484|NCT00730171|7281228|FG000|Overall Study|Insufficient Therapeutic Response|141
4482485|NCT00730171|7281228|FG000|Overall Study|Other|61
4482486|NCT00730236|7281236|FG000|Overall Study|Adverse Event|4
4482487|NCT00730236|7281236|FG000|Overall Study|Withdrawal by Subject|1
4482488|NCT00730236|7281236|FG000|Overall Study|Non-compliance|1
4482489|NCT00730275|7281244|FG000|Overall Study|Withdrawal by Subject|0
4482490|NCT00730275|7281245|FG001|Overall Study|Withdrawal by Subject|0
4482491|NCT00730275|7281246|FG002|Overall Study|Withdrawal by Subject|0
4482492|NCT00730275|7281247|FG003|Overall Study|Withdrawal by Subject|1
4482493|NCT00730327|7281260|FG000|Overall Study|Lost to Follow-up|14
4482494|NCT00730327|7281261|FG001|Overall Study|Lost to Follow-up|16
4482495|NCT00730327|7281260|FG000|Overall Study|Adverse Event|8
4482496|NCT00730327|7281261|FG001|Overall Study|Adverse Event|1
4482497|NCT00730327|7281260|FG000|Overall Study|Withdrawal by Subject|3
4482498|NCT00730327|7281261|FG001|Overall Study|Withdrawal by Subject|13
4482499|NCT00730327|7281260|FG000|Overall Study|Subject withdrew (reason not specified)|2
4482500|NCT00730327|7281261|FG001|Overall Study|Subject withdrew (reason not specified)|7
4482501|NCT00730405|7281276|FG000|Overall Study-Treatment Phase|Adverse Event|5
4482502|NCT00730405|7281277|FG001|Overall Study-Treatment Phase|Adverse Event|10
4482503|NCT00730405|7281278|FG002|Overall Study-Treatment Phase|Adverse Event|4
4482504|NCT00730405|7281279|FG003|Overall Study-Treatment Phase|Adverse Event|8
4482505|NCT00730405|7281280|FG004|Overall Study-Treatment Phase|Adverse Event|4
4482506|NCT00730405|7281276|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4
4482507|NCT00730405|7281277|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5
4482508|NCT00730405|7281278|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6
4482509|NCT00730405|7281279|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4
4482510|NCT00730405|7281280|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4
4482511|NCT00730405|7281276|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1
4482512|NCT00730405|7281277|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0
4482513|NCT00730405|7281278|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5
4482514|NCT00730405|7281279|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0
4482515|NCT00730405|7281280|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1
4482516|NCT00730405|7281276|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7
4482517|NCT00730405|7281277|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1
4482518|NCT00730405|7281278|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2
4482519|NCT00730405|7281279|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5
4482520|NCT00730405|7281280|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8
4482521|NCT00730405|7281276|FG000|Overall Study-Treatment Phase|Did not met eligibility|0
4482522|NCT00730405|7281277|FG001|Overall Study-Treatment Phase|Did not met eligibility|0
4482523|NCT00730405|7281278|FG002|Overall Study-Treatment Phase|Did not met eligibility|1
4482524|NCT00730405|7281279|FG003|Overall Study-Treatment Phase|Did not met eligibility|0
4482525|NCT00730405|7281280|FG004|Overall Study-Treatment Phase|Did not met eligibility|0
4482526|NCT00730405|7281276|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0
4482527|NCT00730405|7281277|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0
4482528|NCT00730405|7281278|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1
4482529|NCT00730405|7281279|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0
4482530|NCT00730405|7281280|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0
4482531|NCT00730405|7281276|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1
4482532|NCT00730405|7281277|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0
4482533|NCT00730405|7281278|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0
4482534|NCT00730405|7281279|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0
4482535|NCT00730405|7281280|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0
4482536|NCT00730405|7281276|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0
4482537|NCT00730405|7281277|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1
4482538|NCT00730405|7281278|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0
4482539|NCT00730405|7281279|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0
4482540|NCT00730405|7281280|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0
4482541|NCT00730405|7281276|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0
4482542|NCT00730405|7281277|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1
4482543|NCT00730405|7281278|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0
4482544|NCT00730405|7281279|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0
4482545|NCT00730405|7281280|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2
4482546|NCT00730405|7281276|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
4482547|NCT00730405|7281277|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
4482548|NCT00730405|7281278|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1
4482549|NCT00730405|7281279|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
4482550|NCT00730405|7281280|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
4482551|NCT00730405|7281276|FG000|Overall Study-Treatment Phase|Misrandomized|0
4482552|NCT00730405|7281277|FG001|Overall Study-Treatment Phase|Misrandomized|1
4482553|NCT00730405|7281278|FG002|Overall Study-Treatment Phase|Misrandomized|0
4482554|NCT00730405|7281279|FG003|Overall Study-Treatment Phase|Misrandomized|0
4482555|NCT00730405|7281280|FG004|Overall Study-Treatment Phase|Misrandomized|0
4482556|NCT00730405|7281276|FG000|Overall Study-Treatment Phase|Study drug interrupted|0
4482557|NCT00730405|7281277|FG001|Overall Study-Treatment Phase|Study drug interrupted|1
4482558|NCT00730405|7281278|FG002|Overall Study-Treatment Phase|Study drug interrupted|0
4482559|NCT00730405|7281279|FG003|Overall Study-Treatment Phase|Study drug interrupted|0
4482560|NCT00730405|7281280|FG004|Overall Study-Treatment Phase|Study drug interrupted|0
4482561|NCT00730405|7281276|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
4482562|NCT00730405|7281277|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
4482563|NCT00730405|7281278|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
4482564|NCT00730405|7281279|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1
4482565|NCT00730405|7281280|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
4482566|NCT00730405|7281276|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
4482567|NCT00730405|7281277|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
4482568|NCT00730405|7281278|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1
4482569|NCT00730405|7281279|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
4482570|NCT00730405|7281280|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
4482571|NCT00730405|7281276|FG000|Overall Study-Treatment Phase|Change of location|0
4482572|NCT00730405|7281277|FG001|Overall Study-Treatment Phase|Change of location|0
4482573|NCT00730405|7281278|FG002|Overall Study-Treatment Phase|Change of location|0
4482574|NCT00730405|7281279|FG003|Overall Study-Treatment Phase|Change of location|1
4482575|NCT00730405|7281280|FG004|Overall Study-Treatment Phase|Change of location|0
4482576|NCT00730405|7281276|FG000|Overall Study-Treatment Phase|Pregnancy|0
4482577|NCT00730405|7281277|FG001|Overall Study-Treatment Phase|Pregnancy|1
4482578|NCT00730405|7281278|FG002|Overall Study-Treatment Phase|Pregnancy|0
4482579|NCT00730405|7281279|FG003|Overall Study-Treatment Phase|Pregnancy|0
4482580|NCT00730405|7281280|FG004|Overall Study-Treatment Phase|Pregnancy|0
4482581|NCT00730405|7281276|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
4482582|NCT00730405|7281277|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
4482583|NCT00730405|7281278|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
4482584|NCT00730405|7281279|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
4482585|NCT00730405|7281280|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1
4482586|NCT00730405|7281276|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1
4482587|NCT00730405|7281277|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0
4482588|NCT00730405|7281278|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0
4482589|NCT00730405|7281279|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0
4482590|NCT00730405|7281280|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0
4482591|NCT00730405|7281276|FG000|Overall Study-follow-up Phase|Adverse Event|2
4482592|NCT00730405|7281277|FG001|Overall Study-follow-up Phase|Adverse Event|6
4482593|NCT00730405|7281278|FG002|Overall Study-follow-up Phase|Adverse Event|2
4482594|NCT00730405|7281279|FG003|Overall Study-follow-up Phase|Adverse Event|3
4482595|NCT00730405|7281280|FG004|Overall Study-follow-up Phase|Adverse Event|4
4482596|NCT00730405|7281276|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7
4482597|NCT00730405|7281277|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6
4482598|NCT00730405|7281278|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8
4482599|NCT00730405|7281279|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4
4482600|NCT00730405|7281280|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6
4482601|NCT00730405|7281276|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7
4482602|NCT00730405|7281277|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3
4482603|NCT00730405|7281278|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3
4482604|NCT00730405|7281279|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6
4482605|NCT00730405|7281280|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10
4482606|NCT00730405|7281276|FG000|Overall Study-follow-up Phase|Death|0
4482607|NCT00730405|7281277|FG001|Overall Study-follow-up Phase|Death|1
4482608|NCT00730405|7281278|FG002|Overall Study-follow-up Phase|Death|0
4386983|NCT00044083|7165549|FG000|First Intervention (One Week)- HV's|Pregnancy|1
4386984|NCT00044083|7165550|FG001|First Intervention (One Week)- HV's|Pregnancy|0
4386985|NCT00044083|7165549|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1
4386986|NCT00044083|7165550|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0
4386987|NCT00044083|7165549|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0
4386988|NCT00044083|7165550|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1
4386989|NCT00044083|7165549|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0
4386990|NCT00044083|7165550|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1
4386991|NCT00044083|7165549|FG000|First Intervention (One Week) Patients|Not follow directions|0
4386992|NCT00044083|7165550|FG001|First Intervention (One Week) Patients|Not follow directions|2
4482609|NCT00730405|7281279|FG003|Overall Study-follow-up Phase|Death|1
4482610|NCT00730405|7281280|FG004|Overall Study-follow-up Phase|Death|0
4482611|NCT00730405|7281276|FG000|Overall Study-follow-up Phase|Change of location|1
4482612|NCT00730405|7281277|FG001|Overall Study-follow-up Phase|Change of location|1
4482613|NCT00730405|7281278|FG002|Overall Study-follow-up Phase|Change of location|0
4482614|NCT00730405|7281279|FG003|Overall Study-follow-up Phase|Change of location|1
4482615|NCT00730405|7281280|FG004|Overall Study-follow-up Phase|Change of location|0
4482616|NCT00730405|7281276|FG000|Overall Study-follow-up Phase|Did not met eligibility|0
4482617|NCT00730405|7281277|FG001|Overall Study-follow-up Phase|Did not met eligibility|0
4482618|NCT00730405|7281278|FG002|Overall Study-follow-up Phase|Did not met eligibility|1
4482619|NCT00730405|7281279|FG003|Overall Study-follow-up Phase|Did not met eligibility|0
4482620|NCT00730405|7281280|FG004|Overall Study-follow-up Phase|Did not met eligibility|0
4482621|NCT00730405|7281276|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0
4482622|NCT00730405|7281277|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0
4482623|NCT00730405|7281278|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1
4482624|NCT00730405|7281279|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0
4482625|NCT00730405|7281280|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0
4482626|NCT00730405|7281276|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
4482627|NCT00730405|7281277|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
4482628|NCT00730405|7281278|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1
4482629|NCT00730405|7281279|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
4482630|NCT00730405|7281280|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
4482631|NCT00730405|7281276|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
4482632|NCT00730405|7281277|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
4482633|NCT00730405|7281278|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
4482634|NCT00730405|7281279|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
4482635|NCT00730405|7281280|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1
4482636|NCT00730405|7281276|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1
4482637|NCT00730405|7281277|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0
4482638|NCT00730405|7281278|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0
4482639|NCT00730405|7281279|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0
4482640|NCT00730405|7281280|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0
4482641|NCT00730405|7281276|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0
4482642|NCT00730405|7281277|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0
4482643|NCT00730405|7281278|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0
4482644|NCT00730405|7281279|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1
4482645|NCT00730405|7281280|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0
4482646|NCT00730405|7281276|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
4482647|NCT00730405|7281277|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1
4482648|NCT00730405|7281278|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1
4482649|NCT00730405|7281279|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
4482650|NCT00730405|7281280|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
4482651|NCT00730405|7281276|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1
4482652|NCT00730405|7281277|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1
4482653|NCT00730405|7281278|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0
4482654|NCT00730405|7281279|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0
4482655|NCT00730405|7281280|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0
4482656|NCT00730405|7281276|FG000|Overall Study-follow-up Phase|Use of restricted medication|0
4482657|NCT00730405|7281277|FG001|Overall Study-follow-up Phase|Use of restricted medication|1
4482658|NCT00730405|7281278|FG002|Overall Study-follow-up Phase|Use of restricted medication|0
4482659|NCT00730405|7281279|FG003|Overall Study-follow-up Phase|Use of restricted medication|0
4482660|NCT00730405|7281280|FG004|Overall Study-follow-up Phase|Use of restricted medication|0
4482661|NCT00730405|7281276|FG000|Overall Study-follow-up Phase|Non-compliance|1
4482662|NCT00730405|7281277|FG001|Overall Study-follow-up Phase|Non-compliance|0
4482663|NCT00730405|7281278|FG002|Overall Study-follow-up Phase|Non-compliance|2
4482664|NCT00730405|7281279|FG003|Overall Study-follow-up Phase|Non-compliance|0
4482665|NCT00730405|7281280|FG004|Overall Study-follow-up Phase|Non-compliance|0
4482666|NCT00730405|7281276|FG000|Overall Study-follow-up Phase|Missing|0
4482667|NCT00730405|7281277|FG001|Overall Study-follow-up Phase|Missing|0
4482668|NCT00730405|7281278|FG002|Overall Study-follow-up Phase|Missing|2
4482669|NCT00730405|7281279|FG003|Overall Study-follow-up Phase|Missing|0
4482670|NCT00730405|7281280|FG004|Overall Study-follow-up Phase|Missing|0
4482671|NCT00730405|7281276|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0
4482672|NCT00730405|7281277|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0
4482673|NCT00730405|7281278|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0
4482674|NCT00730405|7281279|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0
4482675|NCT00730405|7281280|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1
4482676|NCT00730405|7281276|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
4482677|NCT00730405|7281277|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
4482678|NCT00730405|7281278|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1
4482679|NCT00730405|7281279|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
4482680|NCT00730405|7281280|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
4482681|NCT00730405|7281276|FG000|Overall Study-follow-up Phase|Mis-randomized|0
4482682|NCT00730405|7281277|FG001|Overall Study-follow-up Phase|Mis-randomized|1
4482683|NCT00730405|7281278|FG002|Overall Study-follow-up Phase|Mis-randomized|0
4482684|NCT00730405|7281279|FG003|Overall Study-follow-up Phase|Mis-randomized|0
4482685|NCT00730405|7281280|FG004|Overall Study-follow-up Phase|Mis-randomized|0
4482686|NCT00730405|7281276|FG000|Overall Study-follow-up Phase|Other Protocol violation|0
4482687|NCT00730405|7281277|FG001|Overall Study-follow-up Phase|Other Protocol violation|0
4482688|NCT00730405|7281278|FG002|Overall Study-follow-up Phase|Other Protocol violation|1
4482689|NCT00730405|7281279|FG003|Overall Study-follow-up Phase|Other Protocol violation|0
4482690|NCT00730405|7281280|FG004|Overall Study-follow-up Phase|Other Protocol violation|0
4482691|NCT00730405|7281276|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
4482692|NCT00730405|7281277|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
4482693|NCT00730405|7281278|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
4482694|NCT00730405|7281279|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1
4482695|NCT00730405|7281280|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
4482696|NCT00730405|7281276|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1
4482697|NCT00730405|7281277|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0
4482698|NCT00730405|7281278|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0
4482699|NCT00730405|7281279|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0
4482700|NCT00730405|7281280|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0
4482701|NCT00730691|7281315|FG000|Overall Study|Adverse Event|4
4482702|NCT00730691|7281316|FG001|Overall Study|Adverse Event|8
4482703|NCT00730691|7281317|FG002|Overall Study|Adverse Event|11
4482704|NCT00730691|7281318|FG003|Overall Study|Adverse Event|11
4482705|NCT00730691|7281319|FG004|Overall Study|Adverse Event|23
4482706|NCT00730691|7281315|FG000|Overall Study|Lack of Efficacy|4
4482707|NCT00730691|7281316|FG001|Overall Study|Lack of Efficacy|4
4482708|NCT00730691|7281317|FG002|Overall Study|Lack of Efficacy|2
4482709|NCT00730691|7281318|FG003|Overall Study|Lack of Efficacy|1
4482710|NCT00730691|7281319|FG004|Overall Study|Lack of Efficacy|1
4482711|NCT00730691|7281315|FG000|Overall Study|Non-compliance with Study Drug|6
4482712|NCT00730691|7281316|FG001|Overall Study|Non-compliance with Study Drug|1
4482713|NCT00730691|7281317|FG002|Overall Study|Non-compliance with Study Drug|6
4482714|NCT00730691|7281318|FG003|Overall Study|Non-compliance with Study Drug|3
4482715|NCT00730691|7281319|FG004|Overall Study|Non-compliance with Study Drug|3
4482716|NCT00730691|7281315|FG000|Overall Study|Protocol Deviations|3
4482717|NCT00730691|7281316|FG001|Overall Study|Protocol Deviations|5
4482718|NCT00730691|7281317|FG002|Overall Study|Protocol Deviations|3
4482719|NCT00730691|7281318|FG003|Overall Study|Protocol Deviations|7
4482720|NCT00730691|7281319|FG004|Overall Study|Protocol Deviations|5
4482721|NCT00730691|7281315|FG000|Overall Study|Withdrawal of Consent|7
4482722|NCT00730691|7281316|FG001|Overall Study|Withdrawal of Consent|9
4482723|NCT00730691|7281317|FG002|Overall Study|Withdrawal of Consent|3
4482724|NCT00730691|7281318|FG003|Overall Study|Withdrawal of Consent|6
4482725|NCT00730691|7281319|FG004|Overall Study|Withdrawal of Consent|3
4482726|NCT00730691|7281315|FG000|Overall Study|Lost to Follow-up|11
4482727|NCT00730691|7281316|FG001|Overall Study|Lost to Follow-up|8
4482728|NCT00730691|7281317|FG002|Overall Study|Lost to Follow-up|13
4482729|NCT00730691|7281318|FG003|Overall Study|Lost to Follow-up|15
4482730|NCT00730691|7281319|FG004|Overall Study|Lost to Follow-up|13
4482731|NCT00730691|7281315|FG000|Overall Study|Other|1
4482732|NCT00730691|7281316|FG001|Overall Study|Other|1
4482733|NCT00730691|7281317|FG002|Overall Study|Other|1
4482734|NCT00730691|7281318|FG003|Overall Study|Other|2
4482735|NCT00730691|7281319|FG004|Overall Study|Other|2
4482736|NCT00730756|7281337|FG000|Overall Study|Adverse Event|2
4482737|NCT00730756|7281338|FG001|Overall Study|Adverse Event|0
4482738|NCT00730756|7281337|FG000|Overall Study|Lack of Efficacy|1
4482739|NCT00730756|7281338|FG001|Overall Study|Lack of Efficacy|1
4482740|NCT00730756|7281337|FG000|Overall Study|Protocol Deviation|1
4482741|NCT00730756|7281338|FG001|Overall Study|Protocol Deviation|2
4482742|NCT00730756|7281337|FG000|Overall Study|Lost to Follow-up|0
4482743|NCT00730756|7281338|FG001|Overall Study|Lost to Follow-up|1
4482744|NCT00730756|7281337|FG000|Overall Study|Withdrew Consent|0
4482745|NCT00730756|7281338|FG001|Overall Study|Withdrew Consent|1
4482746|NCT00730847|7281344|FG000|Overall Study|Adverse Event|1
4482747|NCT00730847|7281344|FG000|Overall Study|Protocol Violation|2
4482748|NCT00730847|7281344|FG000|Overall Study|Withdrawal by Subject|16
4482749|NCT00730847|7281344|FG000|Overall Study|Lost to Follow-up|67
4482750|NCT00730847|7281344|FG000|Overall Study|Unknown completion status|21
4482751|NCT00730847|7281344|FG000|Overall Study|Other|24
4482752|NCT00730912|7281351|FG000|Overall Study|Discontinued|0
4482753|NCT00730912|7281352|FG001|Overall Study|Discontinued|0
4482754|NCT00730912|7281353|FG002|Overall Study|Discontinued|1
4482755|NCT00730925|7281361|FG000|Overall Study|Progressive Disease|21
4482756|NCT00730925|7281361|FG000|Overall Study|Dose reducing Event|2
4482757|NCT00730925|7281361|FG000|Overall Study|Other Averse Event|7
4482758|NCT00730925|7281361|FG000|Overall Study|Protocol Violation|1
4482759|NCT00730925|7281361|FG000|Overall Study|Withdrawal by Subject|1
4482760|NCT00730925|7281361|FG000|Overall Study|Switch to combination therapy|8
4482761|NCT00730925|7281361|FG000|Overall Study|Other|1
4482762|NCT00731042|7281372|FG000|Second Intervention|Did not meet inclusion criteria|0
4482763|NCT00731042|7281373|FG001|Second Intervention|Did not meet inclusion criteria|2
4482764|NCT00731120|7281398|FG000|Overall Study|Adverse Event|7
4482765|NCT00731120|7281399|FG001|Overall Study|Adverse Event|6
4482766|NCT00731120|7281400|FG002|Overall Study|Adverse Event|8
4482767|NCT00731120|7281398|FG000|Overall Study|Lack of Efficacy|4
4482768|NCT00731120|7281399|FG001|Overall Study|Lack of Efficacy|5
4482769|NCT00731120|7281400|FG002|Overall Study|Lack of Efficacy|4
4482770|NCT00731120|7281398|FG000|Overall Study|Noncompliance with Study Drug|3
4482771|NCT00731120|7281399|FG001|Overall Study|Noncompliance with Study Drug|3
4482772|NCT00731120|7281400|FG002|Overall Study|Noncompliance with Study Drug|1
4482773|NCT00731120|7281398|FG000|Overall Study|Protocol Deviations|1
4482774|NCT00731120|7281399|FG001|Overall Study|Protocol Deviations|6
4482775|NCT00731120|7281400|FG002|Overall Study|Protocol Deviations|1
4482776|NCT00731120|7281398|FG000|Overall Study|Withdrawal of Consent|13
4482777|NCT00731120|7281399|FG001|Overall Study|Withdrawal of Consent|8
4482778|NCT00731120|7281400|FG002|Overall Study|Withdrawal of Consent|4
4482779|NCT00731120|7281398|FG000|Overall Study|Lost to Follow-up|10
4482780|NCT00731120|7281399|FG001|Overall Study|Lost to Follow-up|15
4482781|NCT00731120|7281400|FG002|Overall Study|Lost to Follow-up|17
4482782|NCT00731120|7281398|FG000|Overall Study|Other|4
4482783|NCT00731120|7281399|FG001|Overall Study|Other|0
4482784|NCT00731120|7281400|FG002|Overall Study|Other|1
4482785|NCT00731133|7281408|FG000|Overall Study|Withdrawal by Subject|10
4482786|NCT00731549|7281433|FG000|Overall Study|Lost to Follow-up|19
4482787|NCT00731549|7281433|FG000|Overall Study|Met withdrawal criteria|24
4482788|NCT00731549|7281433|FG000|Overall Study|Physician Decision|16
4482789|NCT00731549|7281433|FG000|Overall Study|Withdrawal by Subject|89
4482790|NCT00731549|7281433|FG000|Overall Study|Protocol deviation|1
4482791|NCT00731549|7281433|FG000|Overall Study|Adverse Event|31
4482792|NCT00731549|7281433|FG000|Overall Study|Lack of efficacy with AE|37
4482793|NCT00731549|7281433|FG000|Overall Study|Lack of efficacy without AE|6
4482794|NCT00731666|7281469|FG000|Overall Study|Adverse Event|2
4482795|NCT00731666|7281469|FG000|Overall Study|Lost to Follow-up|8
4482796|NCT00731666|7281469|FG000|Overall Study|Withdrawal by Subject|2
4482797|NCT00731679|7281475|FG000|Overall Study|Adverse Event|7
4482798|NCT00731679|7281476|FG001|Overall Study|Adverse Event|8
4482799|NCT00731679|7281475|FG000|Overall Study|Withdrawal by Subject|8
4482800|NCT00731679|7281476|FG001|Overall Study|Withdrawal by Subject|8
4482801|NCT00731679|7281475|FG000|Overall Study|Lost to Follow-up|7
4482802|NCT00731679|7281476|FG001|Overall Study|Lost to Follow-up|8
4482803|NCT00731679|7281475|FG000|Overall Study|Noncompliance|0
4482804|NCT00731679|7281476|FG001|Overall Study|Noncompliance|1
4482805|NCT00731679|7281475|FG000|Overall Study|Pregnancy|0
4482806|NCT00731679|7281476|FG001|Overall Study|Pregnancy|1
4482807|NCT00731692|7281485|FG000|Core Study (36 Months)|Lack of Efficacy|11
4482808|NCT00731692|7281486|FG001|Core Study (36 Months)|Lack of Efficacy|23
4482809|NCT00731692|7281487|FG002|Core Study (36 Months)|Lack of Efficacy|64
4482810|NCT00731692|7281485|FG000|Core Study (36 Months)|Physician Decision|1
4482811|NCT00731692|7281486|FG001|Core Study (36 Months)|Physician Decision|0
4482812|NCT00731692|7281487|FG002|Core Study (36 Months)|Physician Decision|2
4482813|NCT00731692|7281485|FG000|Core Study (36 Months)|Death|2
4482814|NCT00731692|7281486|FG001|Core Study (36 Months)|Death|1
4482815|NCT00731692|7281487|FG002|Core Study (36 Months)|Death|2
4482816|NCT00731692|7281485|FG000|Core Study (36 Months)|Lost to Follow-up|1
4482817|NCT00731692|7281486|FG001|Core Study (36 Months)|Lost to Follow-up|3
4482818|NCT00731692|7281487|FG002|Core Study (36 Months)|Lost to Follow-up|3
4482819|NCT00731692|7281485|FG000|Core Study (36 Months)|Administrative|2
4482820|NCT00731692|7281486|FG001|Core Study (36 Months)|Administrative|2
4482821|NCT00731692|7281487|FG002|Core Study (36 Months)|Administrative|6
4482822|NCT00731692|7281485|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4
4482823|NCT00731692|7281486|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3
4482824|NCT00731692|7281487|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5
4482825|NCT00731692|7281485|FG000|Core Study (36 Months)|Protocol Violation|4
4482826|NCT00731692|7281486|FG001|Core Study (36 Months)|Protocol Violation|5
4482827|NCT00731692|7281487|FG002|Core Study (36 Months)|Protocol Violation|8
4482828|NCT00731692|7281485|FG000|Core Study (36 Months)|Abnormal Lab values|6
4482829|NCT00731692|7281486|FG001|Core Study (36 Months)|Abnormal Lab values|19
4482830|NCT00731692|7281487|FG002|Core Study (36 Months)|Abnormal Lab values|5
4482831|NCT00731692|7281485|FG000|Core Study (36 Months)|Adverse Event|25
4482832|NCT00731692|7281486|FG001|Core Study (36 Months)|Adverse Event|28
4482833|NCT00731692|7281487|FG002|Core Study (36 Months)|Adverse Event|29
4482834|NCT00731692|7281485|FG000|Core Study (36 Months)|Withdrawal by Subject|12
4482835|NCT00731692|7281486|FG001|Core Study (36 Months)|Withdrawal by Subject|32
4482836|NCT00731692|7281487|FG002|Core Study (36 Months)|Withdrawal by Subject|46
4482837|NCT00731692|7281485|FG000|Extension Phase|Admin Problems: Terminated # patients|69
4482838|NCT00731692|7281486|FG001|Extension Phase|Admin Problems: Terminated # patients|189
4482839|NCT00731692|7281487|FG002|Extension Phase|Admin Problems: Terminated # patients|277
4482840|NCT00731692|7281485|FG000|Extension Phase|Abnormal test procedure|0
4482841|NCT00731692|7281486|FG001|Extension Phase|Abnormal test procedure|0
4482842|NCT00731692|7281487|FG002|Extension Phase|Abnormal test procedure|1
4482843|NCT00731692|7281485|FG000|Extension Phase|Abnormal lab values|0
4482844|NCT00731692|7281486|FG001|Extension Phase|Abnormal lab values|0
4482845|NCT00731692|7281487|FG002|Extension Phase|Abnormal lab values|1
4482846|NCT00731692|7281485|FG000|Extension Phase|Lost to Follow-up|0
4482847|NCT00731692|7281486|FG001|Extension Phase|Lost to Follow-up|1
4482848|NCT00731692|7281487|FG002|Extension Phase|Lost to Follow-up|4
4482849|NCT00731692|7281485|FG000|Extension Phase|Withdrawal by Subject|4
4482850|NCT00731692|7281486|FG001|Extension Phase|Withdrawal by Subject|5
4482851|NCT00731692|7281487|FG002|Extension Phase|Withdrawal by Subject|3
4482852|NCT00731692|7281485|FG000|Extension Phase|Adverse Event|1
4482853|NCT00731692|7281486|FG001|Extension Phase|Adverse Event|1
4482854|NCT00731692|7281487|FG002|Extension Phase|Adverse Event|15
4482855|NCT00731783|7281505|FG000|One Month Follow-Up Visit|Lost to Follow-up|14
4482856|NCT00731783|7281506|FG001|One Month Follow-Up Visit|Lost to Follow-up|22
4482857|NCT00731783|7281505|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7
4482858|NCT00731783|7281506|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16
4482859|NCT00731783|7281505|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6
4482860|NCT00731783|7281506|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3
4482861|NCT00731783|7281505|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6
4482862|NCT00731783|7281506|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7
4482863|NCT00731822|7281514|FG000|Overall Study|Adverse Event|2
4482864|NCT00731822|7281515|FG001|Overall Study|Adverse Event|1
4482865|NCT00731822|7281514|FG000|Overall Study|Protocol Violation|1
4482866|NCT00731822|7281515|FG001|Overall Study|Protocol Violation|0
4482867|NCT00731822|7281514|FG000|Overall Study|Lost to Follow-up|1
4482868|NCT00731822|7281515|FG001|Overall Study|Lost to Follow-up|0
4482869|NCT00731939|7281530|FG000|Overall Study|Adverse Event|6
4482870|NCT00731939|7281530|FG000|Overall Study|Lost to Follow-up|15
4482871|NCT00731939|7281530|FG000|Overall Study|Not implanted with study device|9
4482872|NCT00731939|7281530|FG000|Overall Study|Withdrawal by Subject|2
4482873|NCT00731939|7281530|FG000|Overall Study|Did not meet enrollment criteria|2
4482874|NCT00732069|7281538|FG000|Washout After First Study Drug|Adverse Event|1
4482875|NCT00732069|7281539|FG001|Washout After First Study Drug|Adverse Event|0
4482876|NCT00732069|7281540|FG002|Washout After First Study Drug|Adverse Event|0
4482877|NCT00732069|7281541|FG003|Washout After First Study Drug|Adverse Event|0
4482878|NCT00732069|7281542|FG004|Washout After First Study Drug|Adverse Event|0
4482879|NCT00732069|7281543|FG005|Washout After First Study Drug|Adverse Event|0
4482880|NCT00732160|7281555|FG000|Overall Study|Adverse Event|1
4482881|NCT00732160|7281556|FG001|Overall Study|Adverse Event|0
4482882|NCT00732160|7281557|FG002|Overall Study|Adverse Event|1
4482883|NCT00732160|7281558|FG003|Overall Study|Adverse Event|1
4482884|NCT00732160|7281555|FG000|Overall Study|scheduling|4
4482885|NCT00732160|7281556|FG001|Overall Study|scheduling|4
4482886|NCT00732160|7281557|FG002|Overall Study|scheduling|2
4482887|NCT00732160|7281558|FG003|Overall Study|scheduling|1
4482888|NCT00732199|7281570|FG000|Overall Study|Withdrawal by Subject|25
4482889|NCT00732199|7281571|FG001|Overall Study|Withdrawal by Subject|18
4482890|NCT00732199|7281570|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9
4482891|NCT00732199|7281571|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8
4482892|NCT00732238|7281638|FG000|Overall Study|Bacteremia|4
4482893|NCT00732238|7281639|FG001|Overall Study|Bacteremia|1
4482894|NCT00732238|7281638|FG000|Overall Study|Asymptomatic bacteriuria|1
4482895|NCT00732238|7281639|FG001|Overall Study|Asymptomatic bacteriuria|0
4482896|NCT00732251|7281647|FG000|Overall Study|Lost to Follow-up|3
4482897|NCT00732251|7281647|FG000|Overall Study|Withdrawal by Subject|3
4482898|NCT00732251|7281647|FG000|Overall Study|Early Term due to Site Closure|1
4482899|NCT00732303|7281651|FG000|Overall Study|Study Terminated|2
4482900|NCT00732472|7281659|FG000|Overall Study|Adverse Event|0
4482901|NCT00732472|7281660|FG001|Overall Study|Adverse Event|1
4482902|NCT00732472|7281661|FG002|Overall Study|Adverse Event|1
4482903|NCT00732472|7281662|FG003|Overall Study|Adverse Event|1
4482904|NCT00732472|7281659|FG000|Overall Study|Protocol Violation|0
4482905|NCT00732472|7281660|FG001|Overall Study|Protocol Violation|0
4482906|NCT00732472|7281661|FG002|Overall Study|Protocol Violation|0
4482907|NCT00732472|7281662|FG003|Overall Study|Protocol Violation|1
4482908|NCT00732472|7281659|FG000|Overall Study|Withdrawal by Subject|0
4482909|NCT00732472|7281660|FG001|Overall Study|Withdrawal by Subject|2
4482910|NCT00732472|7281661|FG002|Overall Study|Withdrawal by Subject|0
4482911|NCT00732472|7281662|FG003|Overall Study|Withdrawal by Subject|1
4482912|NCT00732498|7281673|FG000|Overall Study|Ineligible|1
4482913|NCT00732498|7281673|FG000|Overall Study|Adverse Event|2
4482914|NCT00732498|7281673|FG000|Overall Study|Physician Decision|3
4482915|NCT00732615|7281679|FG000|Overall Study|Withdrawal by Subject|3
4482916|NCT00732615|7281680|FG001|Overall Study|Withdrawal by Subject|1
4482917|NCT00732615|7281679|FG000|Overall Study|Lost to Follow-up|0
4482918|NCT00732615|7281680|FG001|Overall Study|Lost to Follow-up|1
4482919|NCT00732615|7281679|FG000|Overall Study|Adverse Event|0
4482920|NCT00732615|7281680|FG001|Overall Study|Adverse Event|2
4482921|NCT00732615|7281679|FG000|Overall Study|Physician Decision|3
4482922|NCT00732615|7281680|FG001|Overall Study|Physician Decision|0
4482923|NCT00732615|7281679|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1
4482924|NCT00732615|7281680|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1
4482925|NCT00732641|7281689|FG000|Overall Study|Relapse or Progressive Disease|65
4482926|NCT00732641|7281690|FG001|Overall Study|Relapse or Progressive Disease|101
4482927|NCT00732641|7281689|FG000|Overall Study|Serious Adverse Events|12
4482928|NCT00732641|7281690|FG001|Overall Study|Serious Adverse Events|3
4482929|NCT00732641|7281689|FG000|Overall Study|Physician Decision|6
4482930|NCT00732641|7281690|FG001|Overall Study|Physician Decision|0
4482931|NCT00732641|7281689|FG000|Overall Study|Withdrawal by Subject|4
4482932|NCT00732641|7281690|FG001|Overall Study|Withdrawal by Subject|2
4482933|NCT00732641|7281689|FG000|Overall Study|Unable to Complete|1
4482934|NCT00732641|7281690|FG001|Overall Study|Unable to Complete|1
4482935|NCT00732641|7281689|FG000|Overall Study|Other|18
4482936|NCT00732641|7281690|FG001|Overall Study|Other|5
4482937|NCT00732758|7281711|FG000|Overall Study|Lost to Follow-up|8
4482938|NCT00732758|7281712|FG001|Overall Study|Lost to Follow-up|16
4482939|NCT00732875|7281718|FG000|Overall Study|Adverse Event|16
4482940|NCT00732875|7281718|FG000|Overall Study|Withdrawal by Subject|6
4482941|NCT00732875|7281718|FG000|Overall Study|Lack of Efficacy|13
4482942|NCT00732940|7281733|FG000|Overall Study|Withdrawal by Subject|1
4482943|NCT00732940|7281734|FG001|Overall Study|Withdrawal by Subject|2
4482944|NCT00732940|7281733|FG000|Overall Study|Adverse Event|0
4482945|NCT00732940|7281734|FG001|Overall Study|Adverse Event|1
4482946|NCT00732940|7281733|FG000|Overall Study|Lost to Follow-up|1
4482947|NCT00732940|7281734|FG001|Overall Study|Lost to Follow-up|0
4482948|NCT00732992|7281742|FG000|Overall Study|Adverse Event|1
4482949|NCT00732992|7281743|FG001|Overall Study|Adverse Event|1
4482950|NCT00732992|7281742|FG000|Overall Study|Objective Progression or Relapse|3
4482951|NCT00732992|7281743|FG001|Overall Study|Objective Progression or Relapse|5
4482952|NCT00732992|7281742|FG000|Overall Study|Global Deterioration of Health Status|1
4482953|NCT00732992|7281743|FG001|Overall Study|Global Deterioration of Health Status|0
4482954|NCT00732992|7281742|FG000|Overall Study|Withdrawal by Subject|1
4482955|NCT00732992|7281743|FG001|Overall Study|Withdrawal by Subject|0
4482956|NCT00733226|7281771|FG000|Overall Study|Withdrawal by Subject|1
4482957|NCT00733226|7281772|FG001|Overall Study|Withdrawal by Subject|0
4482958|NCT00733226|7281771|FG000|Overall Study|Lost to Follow-up|2
4482959|NCT00733226|7281772|FG001|Overall Study|Lost to Follow-up|0
4386993|NCT00044083|7165549|FG000|First Intervention (One Week) Patients|Used illegal drug|1
4386994|NCT00044083|7165550|FG001|First Intervention (One Week) Patients|Used illegal drug|0
4386995|NCT00044083|7165549|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0
4386996|NCT00044083|7165550|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1
4386997|NCT00044213|7165587|FG000|Overall Study|Withdrawal by Subject|50
4386998|NCT00044213|7165588|FG001|Overall Study|Withdrawal by Subject|65
4386999|NCT00044213|7165589|FG002|Overall Study|Withdrawal by Subject|91
4387000|NCT00044213|7165590|FG003|Overall Study|Withdrawal by Subject|83
4387001|NCT00044213|7165587|FG000|Overall Study|Death|42
4387002|NCT00044213|7165588|FG001|Overall Study|Death|42
4387003|NCT00044213|7165589|FG002|Overall Study|Death|42
4387004|NCT00044213|7165590|FG003|Overall Study|Death|49
4387005|NCT00044213|7165587|FG000|Overall Study|Lost to Follow-up|8
4387006|NCT00044213|7165588|FG001|Overall Study|Lost to Follow-up|5
4387007|NCT00044213|7165589|FG002|Overall Study|Lost to Follow-up|5
4387008|NCT00044213|7165590|FG003|Overall Study|Lost to Follow-up|4
4387009|NCT00044512|7165600|FG000|Follow Up|Lost to Follow-up|2
4387010|NCT00045032|7165616|FG000|Overall Study|Adverse Event/Intercurrent Illness|2
4387011|NCT00045032|7165617|FG001|Overall Study|Adverse Event/Intercurrent Illness|2
4387012|NCT00045032|7165618|FG002|Overall Study|Adverse Event/Intercurrent Illness|7
4387013|NCT00045032|7165616|FG000|Overall Study|Death|22
4387014|NCT00045032|7165617|FG001|Overall Study|Death|24
4387015|NCT00045032|7165618|FG002|Overall Study|Death|17
4387016|NCT00045032|7165616|FG000|Overall Study|Insufficient Therapeutic Response|542
4387017|NCT00045032|7165617|FG001|Overall Study|Insufficient Therapeutic Response|437
4387018|NCT00045032|7165618|FG002|Overall Study|Insufficient Therapeutic Response|445
4387019|NCT00045032|7165616|FG000|Overall Study|Violation of Selection Criteria at Entry|3
4387020|NCT00045032|7165617|FG001|Overall Study|Violation of Selection Criteria at Entry|6
4387021|NCT00045032|7165618|FG002|Overall Study|Violation of Selection Criteria at Entry|6
4387022|NCT00045032|7165616|FG000|Overall Study|Other Protocol Violation|2
4387023|NCT00045032|7165617|FG001|Overall Study|Other Protocol Violation|0
4387024|NCT00045032|7165618|FG002|Overall Study|Other Protocol Violation|1
4387025|NCT00045032|7165616|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142
4482960|NCT00733226|7281771|FG000|Overall Study|moved to another place|2
4482961|NCT00733226|7281772|FG001|Overall Study|moved to another place|0
4482962|NCT00733291|7281785|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1
4482963|NCT00733291|7281786|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
4482964|NCT00733291|7281787|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
4482965|NCT00733291|7281788|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
4482966|NCT00733304|7281802|FG000|Overall Study|Adverse Event|3
4482967|NCT00733304|7281803|FG001|Overall Study|Adverse Event|0
4482968|NCT00733304|7281804|FG002|Overall Study|Adverse Event|0
4482969|NCT00733304|7281802|FG000|Overall Study|Lack of Efficacy|0
4482970|NCT00733304|7281803|FG001|Overall Study|Lack of Efficacy|0
4482971|NCT00733304|7281804|FG002|Overall Study|Lack of Efficacy|2
4482972|NCT00733304|7281802|FG000|Overall Study|Lost to Follow-up|0
4482973|NCT00733304|7281803|FG001|Overall Study|Lost to Follow-up|1
4482974|NCT00733304|7281804|FG002|Overall Study|Lost to Follow-up|0
4482975|NCT00733304|7281802|FG000|Overall Study|Physician Decision|3
4482976|NCT00733304|7281803|FG001|Overall Study|Physician Decision|1
4482977|NCT00733304|7281804|FG002|Overall Study|Physician Decision|3
4482978|NCT00733304|7281802|FG000|Overall Study|Withdrawal by Subject|1
4482979|NCT00733304|7281803|FG001|Overall Study|Withdrawal by Subject|1
4482980|NCT00733304|7281804|FG002|Overall Study|Withdrawal by Subject|0
4482981|NCT00733369|7281839|FG000|Overall Study|Lost to Follow-up|2
4482982|NCT00733369|7281840|FG001|Overall Study|Lost to Follow-up|1
4482983|NCT00733369|7281839|FG000|Overall Study|Adverse Event|4
4482984|NCT00733369|7281840|FG001|Overall Study|Adverse Event|4
4482985|NCT00733369|7281839|FG000|Overall Study|Protocol Violation|4
4482986|NCT00733369|7281840|FG001|Overall Study|Protocol Violation|4
4482987|NCT00733408|7281846|FG000|Overall Study|Adverse Event|4
4482988|NCT00733421|7281852|FG000|Overall Study|Withdrawal by Subject|1
4482989|NCT00733421|7281853|FG001|Overall Study|Withdrawal by Subject|1
4482990|NCT00733499|7281861|FG000|Pre-operative|Protocol Violation|0
4482991|NCT00733499|7281862|FG001|Pre-operative|Protocol Violation|1
4482992|NCT00733499|7281861|FG000|3 Months Follow-up|Death|1
4482993|NCT00733499|7281862|FG001|3 Months Follow-up|Death|2
4482994|NCT00733499|7281861|FG000|6 Months Follow-up|Death|0
4482995|NCT00733499|7281862|FG001|6 Months Follow-up|Death|2
4482996|NCT00733499|7281861|FG000|6 Months Follow-up|Adverse Event|0
4482997|NCT00733499|7281862|FG001|6 Months Follow-up|Adverse Event|1
4482998|NCT00733499|7281861|FG000|12 Months Follow-up|Death|2
4482999|NCT00733499|7281862|FG001|12 Months Follow-up|Death|1
4483000|NCT00733499|7281861|FG000|24 Months Follow-up|Death|0
4483001|NCT00733499|7281862|FG001|24 Months Follow-up|Death|1
4483002|NCT00733499|7281861|FG000|5 Year Followup|Adverse Event|2
4483003|NCT00733499|7281862|FG001|5 Year Followup|Adverse Event|2
4483004|NCT00733499|7281861|FG000|5 Year Followup|Non device related AE|0
4483005|NCT00733499|7281862|FG001|5 Year Followup|Non device related AE|1
4483006|NCT00733499|7281861|FG000|5 Year Followup|Revision of Study Implant|0
4483007|NCT00733499|7281862|FG001|5 Year Followup|Revision of Study Implant|1
4483008|NCT00733499|7281861|FG000|5 Year Followup|Lost to Follow-up|2
4483009|NCT00733499|7281862|FG001|5 Year Followup|Lost to Follow-up|0
4483010|NCT00733499|7281861|FG000|5 Year Followup|Death|13
4483011|NCT00733499|7281862|FG001|5 Year Followup|Death|19
4483012|NCT00733499|7281861|FG000|5 Year Followup|missing, unable to locate|0
4483013|NCT00733499|7281862|FG001|5 Year Followup|missing, unable to locate|1
4483014|NCT00733499|7281861|FG000|5 Year Followup|Withdrawal by Subject|4
4483015|NCT00733499|7281862|FG001|5 Year Followup|Withdrawal by Subject|1
4483016|NCT00733499|7281861|FG000|10 Year Followup|Death|9
4483017|NCT00733499|7281862|FG001|10 Year Followup|Death|7
4483018|NCT00733499|7281861|FG000|10 Year Followup|Adverse Event|3
4483019|NCT00733499|7281862|FG001|10 Year Followup|Adverse Event|3
4483020|NCT00733499|7281861|FG000|10 Year Followup|Lost to Follow-up|3
4483021|NCT00733499|7281862|FG001|10 Year Followup|Lost to Follow-up|2
4483022|NCT00733499|7281861|FG000|10 Year Followup|Withdrawal by Subject|5
4483023|NCT00733499|7281862|FG001|10 Year Followup|Withdrawal by Subject|5
4483024|NCT00733499|7281861|FG000|10 Year Followup|missing, unable to locate|0
4387026|NCT00045032|7165617|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93
4387027|NCT00045032|7165618|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84
4387028|NCT00045032|7165616|FG000|Overall Study|Failure to Return|57
4387029|NCT00045032|7165617|FG001|Overall Study|Failure to Return|62
4387030|NCT00045032|7165618|FG002|Overall Study|Failure to Return|61
4387031|NCT00045032|7165616|FG000|Overall Study|Other|93
4387032|NCT00045032|7165617|FG001|Overall Study|Other|84
4387033|NCT00045032|7165618|FG002|Overall Study|Other|105
4387034|NCT00045110|7165631|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0
4387035|NCT00045110|7165632|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2
4387036|NCT00045110|7165633|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1
4483025|NCT00733499|7281862|FG001|10 Year Followup|missing, unable to locate|2
4483026|NCT00733746|7281872|FG000|Overall Study|Ineligible|5
4483027|NCT00733824|7281881|FG000|Phase I|Withdrawal by Subject|1
4483028|NCT00733824|7281882|FG001|Phase I|Withdrawal by Subject|0
4483029|NCT00733824|7281883|FG002|Phase I|Withdrawal by Subject|0
4483030|NCT00733824|7281884|FG003|Phase I|Withdrawal by Subject|0
4483031|NCT00733824|7281885|FG004|Phase I|Withdrawal by Subject|0
4483032|NCT00733902|7281903|FG000|Overall Study|Death|0
4483033|NCT00733902|7281904|FG001|Overall Study|Death|0
4483034|NCT00733902|7281905|FG002|Overall Study|Death|0
4483035|NCT00733902|7281906|FG003|Overall Study|Death|1
4483036|NCT00733902|7281903|FG000|Overall Study|Adverse Event|3
4483037|NCT00733902|7281904|FG001|Overall Study|Adverse Event|4
4483038|NCT00733902|7281905|FG002|Overall Study|Adverse Event|7
4483039|NCT00733902|7281906|FG003|Overall Study|Adverse Event|11
4483040|NCT00733902|7281903|FG000|Overall Study|Lack of Efficacy|56
4483041|NCT00733902|7281904|FG001|Overall Study|Lack of Efficacy|21
4483042|NCT00733902|7281905|FG002|Overall Study|Lack of Efficacy|34
4483043|NCT00733902|7281906|FG003|Overall Study|Lack of Efficacy|23
4483044|NCT00733902|7281903|FG000|Overall Study|Protocol Violation|4
4483045|NCT00733902|7281904|FG001|Overall Study|Protocol Violation|6
4483046|NCT00733902|7281905|FG002|Overall Study|Protocol Violation|3
4483047|NCT00733902|7281906|FG003|Overall Study|Protocol Violation|3
4483048|NCT00733902|7281903|FG000|Overall Study|Withdrawal by Subject|10
4483049|NCT00733902|7281904|FG001|Overall Study|Withdrawal by Subject|5
4483050|NCT00733902|7281905|FG002|Overall Study|Withdrawal by Subject|4
4483051|NCT00733902|7281906|FG003|Overall Study|Withdrawal by Subject|16
4700835|NCT02700815|7617051|FG002|Overall Study|Adverse Event|2
4700836|NCT02700815|7617052|FG003|Overall Study|Adverse Event|3
4700837|NCT02700815|7617049|FG000|Overall Study|Lack of Efficacy|0
4700838|NCT02700815|7617050|FG001|Overall Study|Lack of Efficacy|0
4700839|NCT02700815|7617051|FG002|Overall Study|Lack of Efficacy|1
4700840|NCT02700815|7617052|FG003|Overall Study|Lack of Efficacy|2
4700841|NCT02700815|7617049|FG000|Overall Study|Lost to Follow-up|1
4387037|NCT00045110|7165631|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0
4700842|NCT02700815|7617050|FG001|Overall Study|Lost to Follow-up|0
4700843|NCT02700815|7617051|FG002|Overall Study|Lost to Follow-up|0
4700844|NCT02700815|7617052|FG003|Overall Study|Lost to Follow-up|1
4700845|NCT02700815|7617049|FG000|Overall Study|Refusal to continue medication|0
4700846|NCT02700815|7617050|FG001|Overall Study|Refusal to continue medication|1
4700847|NCT02700815|7617051|FG002|Overall Study|Refusal to continue medication|0
4700848|NCT02700815|7617052|FG003|Overall Study|Refusal to continue medication|1
4483052|NCT00733902|7281903|FG000|Overall Study|Entered extension study|89
4483053|NCT00733902|7281904|FG001|Overall Study|Entered extension study|124
4483054|NCT00733902|7281905|FG002|Overall Study|Entered extension study|111
4483055|NCT00733902|7281906|FG003|Overall Study|Entered extension study|109
4483056|NCT00733902|7281903|FG000|Overall Study|Randomized but not treated|2
4483057|NCT00733902|7281904|FG001|Overall Study|Randomized but not treated|2
4483058|NCT00733902|7281905|FG002|Overall Study|Randomized but not treated|2
4483059|NCT00733902|7281906|FG003|Overall Study|Randomized but not treated|1
4483060|NCT00733954|7281918|FG000|Overall Study|Lost to Follow-up|5
4483061|NCT00733954|7281919|FG001|Overall Study|Lost to Follow-up|2
4483062|NCT00733954|7281918|FG000|Overall Study|Protocol Violation|1
4483063|NCT00733954|7281919|FG001|Overall Study|Protocol Violation|0
4483064|NCT00733954|7281918|FG000|Overall Study|Withdrawal by Subject|2
4483065|NCT00733954|7281919|FG001|Overall Study|Withdrawal by Subject|0
4483066|NCT00733980|7281927|FG000|Overall Study|Adverse Event|5
4483067|NCT00733980|7281928|FG001|Overall Study|Adverse Event|2
4483068|NCT00733980|7281927|FG000|Overall Study|Lack of Efficacy|0
4483069|NCT00733980|7281928|FG001|Overall Study|Lack of Efficacy|1
4483070|NCT00733980|7281927|FG000|Overall Study|Protocol Violation|2
4483071|NCT00733980|7281928|FG001|Overall Study|Protocol Violation|1
4589717|NCT01514201|7435118|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0
4589718|NCT01514201|7435119|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1
4589719|NCT01514201|7435116|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0
4589720|NCT01514201|7435117|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0
4589721|NCT01514201|7435118|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0
4589722|NCT01514201|7435119|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2
4700849|NCT02700815|7617049|FG000|Overall Study|Withdrawal by Subject|0
4700850|NCT02700815|7617050|FG001|Overall Study|Withdrawal by Subject|0
4700851|NCT02700815|7617051|FG002|Overall Study|Withdrawal by Subject|1
4700852|NCT02700815|7617052|FG003|Overall Study|Withdrawal by Subject|0
4387038|NCT00045110|7165632|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4
4387039|NCT00045110|7165633|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0
4387040|NCT00045110|7165631|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0
4387041|NCT00045110|7165632|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0
4387042|NCT00045110|7165633|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1
4387043|NCT00045162|7165652|FG000|Overall Study|Ineligible|12
4387044|NCT00045162|7165653|FG001|Overall Study|Ineligible|8
4387045|NCT00045162|7165652|FG000|Overall Study|Not treated|7
4387046|NCT00045162|7165653|FG001|Overall Study|Not treated|2
4387047|NCT00045162|7165652|FG000|Overall Study|Adverse Event|55
4387048|NCT00045162|7165653|FG001|Overall Study|Adverse Event|50
4387049|NCT00045162|7165652|FG000|Overall Study|Lack of Efficacy|32
4387050|NCT00045162|7165653|FG001|Overall Study|Lack of Efficacy|29
4387051|NCT00045162|7165652|FG000|Overall Study|Death|10
4387052|NCT00045162|7165653|FG001|Overall Study|Death|10
4387053|NCT00045162|7165652|FG000|Overall Study|Withdrawal by Subject|5
4387054|NCT00045162|7165653|FG001|Overall Study|Withdrawal by Subject|3
4387055|NCT00045162|7165652|FG000|Overall Study|Other|21
4387056|NCT00045162|7165653|FG001|Overall Study|Other|16
4387057|NCT00045305|7165659|FG000|Overall Study|Lack of Efficacy|6
4387058|NCT00045305|7165659|FG000|Overall Study|Adverse Event|3
4387059|NCT00045305|7165659|FG000|Overall Study|Death|3
4387060|NCT00045305|7165659|FG000|Overall Study|site error|2
4387061|NCT00045630|7165671|FG000|Overall Study|Adverse Event|1
4387062|NCT00045630|7165671|FG000|Overall Study|Refusal unrelated to adverse event|1
4387063|NCT00045630|7165671|FG000|Overall Study|Progression/relapse|1
4387064|NCT00045630|7165671|FG000|Overall Study|Death|1
4387065|NCT00045630|7165671|FG000|Overall Study|Ineligible|2
4387066|NCT00045708|7165678|FG000|Phase 1|early progressive disease|0
4483072|NCT00733980|7281927|FG000|Overall Study|Protocol defined stopping criteria reach|1
4483073|NCT00733980|7281928|FG001|Overall Study|Protocol defined stopping criteria reach|1
4483074|NCT00733980|7281927|FG000|Overall Study|Lost to Follow-up|6
4483075|NCT00733980|7281928|FG001|Overall Study|Lost to Follow-up|11
4483076|NCT00733980|7281927|FG000|Overall Study|Physician Decision|2
4483077|NCT00733980|7281928|FG001|Overall Study|Physician Decision|3
4483078|NCT00733980|7281927|FG000|Overall Study|Withdrawal by Subject|6
4483079|NCT00733980|7281928|FG001|Overall Study|Withdrawal by Subject|2
4483080|NCT00734032|7281953|FG000|Overall Study|Adverse Event|0
4483081|NCT00734032|7281954|FG001|Overall Study|Adverse Event|1
4483082|NCT00734032|7281955|FG002|Overall Study|Adverse Event|0
4483083|NCT00734032|7281956|FG003|Overall Study|Adverse Event|0
4483084|NCT00734071|7281968|FG000|Overall Study|Adverse Event|4
4483085|NCT00734071|7281969|FG001|Overall Study|Adverse Event|3
4483086|NCT00734071|7281968|FG000|Overall Study|Lack of Efficacy|3
4483087|NCT00734071|7281969|FG001|Overall Study|Lack of Efficacy|1
4483088|NCT00734071|7281968|FG000|Overall Study|Noncompliance|2
4483089|NCT00734071|7281969|FG001|Overall Study|Noncompliance|2
4483090|NCT00734071|7281968|FG000|Overall Study|Protocol Deviations|3
4483091|NCT00734071|7281969|FG001|Overall Study|Protocol Deviations|4
4483092|NCT00734071|7281968|FG000|Overall Study|Voluntary Withdrawal|9
4483093|NCT00734071|7281969|FG001|Overall Study|Voluntary Withdrawal|7
4483094|NCT00734071|7281968|FG000|Overall Study|Lost to Follow-up|16
4483095|NCT00734071|7281969|FG001|Overall Study|Lost to Follow-up|8
4483096|NCT00734071|7281968|FG000|Overall Study|Other|1
4483097|NCT00734071|7281969|FG001|Overall Study|Other|2
4483098|NCT00734097|7281975|FG000|Screening|Protocol Violation|12
4483099|NCT00734097|7281975|FG000|Screening|Withdrawal by Subject|5
4483100|NCT00734097|7281975|FG000|Screening|Lost to Follow-up|2
4483101|NCT00734097|7281975|FG000|Screening|Unconfirmed pregnancy|1
4483102|NCT00734097|7281975|FG000|Open Label|Lost to Follow-up|7
4483103|NCT00734097|7281975|FG000|Open Label|Withdrawal by Subject|5
4483104|NCT00734097|7281975|FG000|Open Label|Protocol Violation|4
4483105|NCT00734149|7281979|FG000|Overall Study|Withdrawal by Subject|1
4483106|NCT00734162|7281989|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0
4483107|NCT00734162|7281990|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1
4483108|NCT00734162|7281991|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0
4483109|NCT00734162|7281992|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2
4483110|NCT00734162|7281989|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
4483111|NCT00734162|7281990|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
4483112|NCT00734162|7281991|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
4483113|NCT00734162|7281992|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2
4700853|NCT02700919|7617065|FG000|Overall Study|Physician Decision|1
4700854|NCT02700919|7617066|FG001|Overall Study|Physician Decision|0
4700855|NCT02700919|7617067|FG002|Overall Study|Physician Decision|0
4700856|NCT02700919|7617065|FG000|Overall Study|Protocol Violation|1
4700857|NCT02700919|7617066|FG001|Overall Study|Protocol Violation|0
4700858|NCT02700919|7617067|FG002|Overall Study|Protocol Violation|0
4700859|NCT02700919|7617065|FG000|Overall Study|Adverse Event|1
4700860|NCT02700919|7617066|FG001|Overall Study|Adverse Event|3
4700861|NCT02700919|7617067|FG002|Overall Study|Adverse Event|1
4700862|NCT02700919|7617065|FG000|Overall Study|Withdrawal by Subject|5
4700863|NCT02700919|7617066|FG001|Overall Study|Withdrawal by Subject|8
4700864|NCT02700919|7617067|FG002|Overall Study|Withdrawal by Subject|2
4700865|NCT02700919|7617065|FG000|Overall Study|Lost to Follow-up|2
4700866|NCT02700919|7617066|FG001|Overall Study|Lost to Follow-up|0
4700867|NCT02700919|7617067|FG002|Overall Study|Lost to Follow-up|0
4700868|NCT02700919|7617065|FG000|Overall Study|Other|2
4700869|NCT02700919|7617066|FG001|Overall Study|Other|1
4700870|NCT02700919|7617067|FG002|Overall Study|Other|1
4700871|NCT02700984|7617077|FG000|Overall Study|Death|2
4700872|NCT02700984|7617078|FG001|Overall Study|Death|1
4700873|NCT02700984|7617077|FG000|Overall Study|Lost to Follow-up|2
4700874|NCT02700984|7617078|FG001|Overall Study|Lost to Follow-up|1
4483114|NCT00734162|7281989|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1
4483115|NCT00734162|7281990|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
4483116|NCT00734162|7281991|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
4483117|NCT00734162|7281992|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
4483118|NCT00734162|7281989|FG000|Open-Label Phase|Withdrew Consent|1
4589723|NCT01514201|7435116|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0
4589724|NCT01514201|7435117|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0
4589725|NCT01514201|7435118|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0
4700875|NCT02700984|7617077|FG000|Overall Study|Physician Decision|0
4483119|NCT00734162|7281990|FG001|Open-Label Phase|Withdrew Consent|0
4589726|NCT01514201|7435119|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1
4589727|NCT01514201|7435116|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0
4589728|NCT01514201|7435117|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0
4483120|NCT00734162|7281991|FG002|Open-Label Phase|Withdrew Consent|1
4483121|NCT00734162|7281992|FG003|Open-Label Phase|Withdrew Consent|1
4483122|NCT00734162|7281989|FG000|Open-Label Phase|Lost to Follow-up|1
4700876|NCT02700984|7617078|FG001|Overall Study|Physician Decision|1
4483123|NCT00734162|7281990|FG001|Open-Label Phase|Lost to Follow-up|2
4483124|NCT00734162|7281991|FG002|Open-Label Phase|Lost to Follow-up|0
4483125|NCT00734162|7281992|FG003|Open-Label Phase|Lost to Follow-up|1
4483126|NCT00734162|7281989|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0
4483127|NCT00734162|7281990|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0
4483128|NCT00734162|7281991|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0
4483129|NCT00734162|7281992|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1
4483130|NCT00734214|7282008|FG000|Overall Study|Withdrawal by Subject|3
4483131|NCT00734214|7282009|FG001|Overall Study|Withdrawal by Subject|4
4483132|NCT00734214|7282008|FG000|Overall Study|MD withdrawal|1
4483133|NCT00734214|7282009|FG001|Overall Study|MD withdrawal|0
4483134|NCT00734474|7282070|FG000|Overall Study|Entry Criteria Not Met|0
4483135|NCT00734474|7282071|FG001|Overall Study|Entry Criteria Not Met|0
4483136|NCT00734474|7282072|FG002|Overall Study|Entry Criteria Not Met|5
4483137|NCT00734474|7282073|FG003|Overall Study|Entry Criteria Not Met|0
4483138|NCT00734474|7282074|FG004|Overall Study|Entry Criteria Not Met|3
4483139|NCT00734474|7282075|FG005|Overall Study|Entry Criteria Not Met|1
4483140|NCT00734474|7282076|FG006|Overall Study|Entry Criteria Not Met|0
4483141|NCT00734474|7282077|FG007|Overall Study|Entry Criteria Not Met|1
4483142|NCT00734474|7282078|FG008|Overall Study|Entry Criteria Not Met|1
4483143|NCT00734474|7282070|FG000|Overall Study|Lost to Follow-up|1
4483144|NCT00734474|7282071|FG001|Overall Study|Lost to Follow-up|0
4483145|NCT00734474|7282072|FG002|Overall Study|Lost to Follow-up|13
4483146|NCT00734474|7282073|FG003|Overall Study|Lost to Follow-up|0
4483147|NCT00734474|7282074|FG004|Overall Study|Lost to Follow-up|11
4483148|NCT00734474|7282075|FG005|Overall Study|Lost to Follow-up|1
4483149|NCT00734474|7282076|FG006|Overall Study|Lost to Follow-up|0
4483150|NCT00734474|7282077|FG007|Overall Study|Lost to Follow-up|9
4483151|NCT00734474|7282078|FG008|Overall Study|Lost to Follow-up|4
4483152|NCT00734474|7282070|FG000|Overall Study|Withdrawal by Subject|2
4483153|NCT00734474|7282071|FG001|Overall Study|Withdrawal by Subject|1
4483154|NCT00734474|7282072|FG002|Overall Study|Withdrawal by Subject|18
4483155|NCT00734474|7282073|FG003|Overall Study|Withdrawal by Subject|0
4483156|NCT00734474|7282074|FG004|Overall Study|Withdrawal by Subject|24
4483157|NCT00734474|7282075|FG005|Overall Study|Withdrawal by Subject|2
4483158|NCT00734474|7282076|FG006|Overall Study|Withdrawal by Subject|0
4483159|NCT00734474|7282077|FG007|Overall Study|Withdrawal by Subject|36
4483160|NCT00734474|7282078|FG008|Overall Study|Withdrawal by Subject|21
4483161|NCT00734474|7282070|FG000|Overall Study|Physician Decision|0
4483162|NCT00734474|7282071|FG001|Overall Study|Physician Decision|0
4483163|NCT00734474|7282072|FG002|Overall Study|Physician Decision|4
4483164|NCT00734474|7282073|FG003|Overall Study|Physician Decision|1
4483165|NCT00734474|7282074|FG004|Overall Study|Physician Decision|11
4483166|NCT00734474|7282075|FG005|Overall Study|Physician Decision|0
4483167|NCT00734474|7282076|FG006|Overall Study|Physician Decision|0
4483168|NCT00734474|7282077|FG007|Overall Study|Physician Decision|9
4483169|NCT00734474|7282078|FG008|Overall Study|Physician Decision|9
4483170|NCT00734474|7282070|FG000|Overall Study|Adverse Event|4
4483171|NCT00734474|7282071|FG001|Overall Study|Adverse Event|4
4483172|NCT00734474|7282072|FG002|Overall Study|Adverse Event|63
4483173|NCT00734474|7282073|FG003|Overall Study|Adverse Event|1
4483174|NCT00734474|7282074|FG004|Overall Study|Adverse Event|64
4483175|NCT00734474|7282075|FG005|Overall Study|Adverse Event|0
4483176|NCT00734474|7282076|FG006|Overall Study|Adverse Event|1
4483177|NCT00734474|7282077|FG007|Overall Study|Adverse Event|65
4483178|NCT00734474|7282078|FG008|Overall Study|Adverse Event|39
4483179|NCT00734474|7282070|FG000|Overall Study|Protocol Violation|0
4483180|NCT00734474|7282071|FG001|Overall Study|Protocol Violation|0
4483181|NCT00734474|7282072|FG002|Overall Study|Protocol Violation|4
4483182|NCT00734474|7282073|FG003|Overall Study|Protocol Violation|0
4483183|NCT00734474|7282074|FG004|Overall Study|Protocol Violation|3
4483184|NCT00734474|7282075|FG005|Overall Study|Protocol Violation|0
4483185|NCT00734474|7282076|FG006|Overall Study|Protocol Violation|0
4483186|NCT00734474|7282077|FG007|Overall Study|Protocol Violation|3
4483187|NCT00734474|7282078|FG008|Overall Study|Protocol Violation|1
4483188|NCT00734474|7282070|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8
4483189|NCT00734474|7282071|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25
4483190|NCT00734474|7282072|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0
4483191|NCT00734474|7282073|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8
4483192|NCT00734474|7282074|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0
4483193|NCT00734474|7282075|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21
4483194|NCT00734474|7282076|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23
4483195|NCT00734474|7282077|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0
4483196|NCT00734474|7282078|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0
4483197|NCT00734474|7282070|FG000|Overall Study|Sponsor Decision|0
4483198|NCT00734474|7282071|FG001|Overall Study|Sponsor Decision|0
4483199|NCT00734474|7282072|FG002|Overall Study|Sponsor Decision|0
4483200|NCT00734474|7282073|FG003|Overall Study|Sponsor Decision|0
4483201|NCT00734474|7282074|FG004|Overall Study|Sponsor Decision|2
4483202|NCT00734474|7282075|FG005|Overall Study|Sponsor Decision|0
4483203|NCT00734474|7282076|FG006|Overall Study|Sponsor Decision|0
4483204|NCT00734474|7282077|FG007|Overall Study|Sponsor Decision|0
4483205|NCT00734474|7282078|FG008|Overall Study|Sponsor Decision|0
4483206|NCT00734474|7282070|FG000|Overall Study|Death|0
4483207|NCT00734474|7282071|FG001|Overall Study|Death|0
4483208|NCT00734474|7282072|FG002|Overall Study|Death|1
4483209|NCT00734474|7282073|FG003|Overall Study|Death|0
4483210|NCT00734474|7282074|FG004|Overall Study|Death|0
4483211|NCT00734474|7282075|FG005|Overall Study|Death|0
4483212|NCT00734474|7282076|FG006|Overall Study|Death|0
4483213|NCT00734474|7282077|FG007|Overall Study|Death|2
4483214|NCT00734474|7282078|FG008|Overall Study|Death|1
4483215|NCT00734474|7282070|FG000|Overall Study|Lack of Efficacy|0
4483216|NCT00734474|7282071|FG001|Overall Study|Lack of Efficacy|0
4483217|NCT00734474|7282072|FG002|Overall Study|Lack of Efficacy|4
4483218|NCT00734474|7282073|FG003|Overall Study|Lack of Efficacy|0
4483219|NCT00734474|7282074|FG004|Overall Study|Lack of Efficacy|0
4483220|NCT00734474|7282075|FG005|Overall Study|Lack of Efficacy|0
4483221|NCT00734474|7282076|FG006|Overall Study|Lack of Efficacy|0
4483222|NCT00734474|7282077|FG007|Overall Study|Lack of Efficacy|4
4483223|NCT00734474|7282078|FG008|Overall Study|Lack of Efficacy|6
4483224|NCT00734539|7282110|FG000|Main Study|Death|33
4483225|NCT00734539|7282111|FG001|Main Study|Death|32
4483226|NCT00734539|7282110|FG000|Main Study|Physician Decision|2
4483227|NCT00734539|7282111|FG001|Main Study|Physician Decision|0
4483228|NCT00734539|7282110|FG000|Main Study|Withdrawal by Subject|1
4483229|NCT00734539|7282111|FG001|Main Study|Withdrawal by Subject|3
4483230|NCT00734539|7282110|FG000|Main Study|Enrolled in error; ineligible|1
4483231|NCT00734539|7282111|FG001|Main Study|Enrolled in error; ineligible|0
4483232|NCT00734578|7282123|FG000|Overall Study|Adverse Event|4
4483233|NCT00734578|7282124|FG001|Overall Study|Adverse Event|6
4483234|NCT00734578|7282125|FG002|Overall Study|Adverse Event|1
4483235|NCT00734578|7282123|FG000|Overall Study|Protocol Violation|8
4483236|NCT00734578|7282124|FG001|Overall Study|Protocol Violation|6
4483237|NCT00734578|7282125|FG002|Overall Study|Protocol Violation|3
4483238|NCT00734578|7282123|FG000|Overall Study|Withdrawal by Subject|7
4483239|NCT00734578|7282124|FG001|Overall Study|Withdrawal by Subject|8
4483240|NCT00734578|7282125|FG002|Overall Study|Withdrawal by Subject|11
4483241|NCT00734578|7282123|FG000|Overall Study|Lost to Follow-up|9
4483242|NCT00734578|7282124|FG001|Overall Study|Lost to Follow-up|3
4483243|NCT00734578|7282125|FG002|Overall Study|Lost to Follow-up|5
4483244|NCT00734578|7282123|FG000|Overall Study|Lack of Efficacy|3
4483245|NCT00734578|7282124|FG001|Overall Study|Lack of Efficacy|2
4483246|NCT00734578|7282125|FG002|Overall Study|Lack of Efficacy|5
4483247|NCT00734578|7282123|FG000|Overall Study|Randomized in error|1
4483248|NCT00734578|7282124|FG001|Overall Study|Randomized in error|0
4483249|NCT00734578|7282125|FG002|Overall Study|Randomized in error|0
4483250|NCT00734578|7282123|FG000|Overall Study|Exclusion criteria|1
4483251|NCT00734578|7282124|FG001|Overall Study|Exclusion criteria|0
4483252|NCT00734578|7282125|FG002|Overall Study|Exclusion criteria|0
4483253|NCT00734591|7282135|FG000|Screening for Prospective Period|Site did not participate|1604
4483254|NCT00734591|7282136|FG001|Screening for Prospective Period|Site did not participate|1488
4483255|NCT00734591|7282135|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913
4483256|NCT00734591|7282136|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803
4483257|NCT00734591|7282135|FG000|Prospective Period|Withdrawal by Subject|11
4483258|NCT00734591|7282136|FG001|Prospective Period|Withdrawal by Subject|9
4483259|NCT00734591|7282135|FG000|Prospective Period|Lost to Follow-up|37
4483260|NCT00734591|7282136|FG001|Prospective Period|Lost to Follow-up|33
4483261|NCT00734591|7282135|FG000|Prospective Period|Study Terminated|1
4483262|NCT00734591|7282136|FG001|Prospective Period|Study Terminated|0
4483263|NCT00734591|7282135|FG000|Prospective Period|Other|2
4483264|NCT00734591|7282136|FG001|Prospective Period|Other|2
4483265|NCT00734604|7282148|FG000|Overall Study|Adverse Event|0
4483266|NCT00734604|7282149|FG001|Overall Study|Adverse Event|2
4483267|NCT00734604|7282150|FG002|Overall Study|Adverse Event|0
4483268|NCT00734604|7282151|FG003|Overall Study|Adverse Event|2
4483269|NCT00734604|7282152|FG004|Overall Study|Adverse Event|1
4483270|NCT00734604|7282153|FG005|Overall Study|Adverse Event|1
4483271|NCT00734604|7282148|FG000|Overall Study|Serious Adverse Event|1
4483272|NCT00734604|7282149|FG001|Overall Study|Serious Adverse Event|0
4483273|NCT00734604|7282150|FG002|Overall Study|Serious Adverse Event|1
4483274|NCT00734604|7282151|FG003|Overall Study|Serious Adverse Event|2
4483275|NCT00734604|7282152|FG004|Overall Study|Serious Adverse Event|0
4483276|NCT00734604|7282153|FG005|Overall Study|Serious Adverse Event|1
4483277|NCT00734604|7282148|FG000|Overall Study|Lost to Follow-up|1
4483278|NCT00734604|7282149|FG001|Overall Study|Lost to Follow-up|2
4483279|NCT00734604|7282150|FG002|Overall Study|Lost to Follow-up|2
4483280|NCT00734604|7282151|FG003|Overall Study|Lost to Follow-up|4
4483281|NCT00734604|7282152|FG004|Overall Study|Lost to Follow-up|2
4483282|NCT00734604|7282153|FG005|Overall Study|Lost to Follow-up|3
4483283|NCT00734604|7282148|FG000|Overall Study|Physician Decision|0
4483284|NCT00734604|7282149|FG001|Overall Study|Physician Decision|1
4483285|NCT00734604|7282150|FG002|Overall Study|Physician Decision|1
4483286|NCT00734604|7282151|FG003|Overall Study|Physician Decision|0
4483287|NCT00734604|7282152|FG004|Overall Study|Physician Decision|0
4483288|NCT00734604|7282153|FG005|Overall Study|Physician Decision|0
4483289|NCT00734604|7282148|FG000|Overall Study|Protocol Violation|0
4483290|NCT00734604|7282149|FG001|Overall Study|Protocol Violation|2
4483291|NCT00734604|7282150|FG002|Overall Study|Protocol Violation|0
4483292|NCT00734604|7282151|FG003|Overall Study|Protocol Violation|0
4483293|NCT00734604|7282152|FG004|Overall Study|Protocol Violation|1
4483294|NCT00734604|7282153|FG005|Overall Study|Protocol Violation|0
4483295|NCT00734604|7282148|FG000|Overall Study|Sponsor Decision|1
4483296|NCT00734604|7282149|FG001|Overall Study|Sponsor Decision|2
4483297|NCT00734604|7282150|FG002|Overall Study|Sponsor Decision|1
4483298|NCT00734604|7282151|FG003|Overall Study|Sponsor Decision|0
4483299|NCT00734604|7282152|FG004|Overall Study|Sponsor Decision|2
4483300|NCT00734604|7282153|FG005|Overall Study|Sponsor Decision|0
4483301|NCT00734604|7282148|FG000|Overall Study|Withdrawal by Subject|0
4483302|NCT00734604|7282149|FG001|Overall Study|Withdrawal by Subject|2
4483303|NCT00734604|7282150|FG002|Overall Study|Withdrawal by Subject|0
4483304|NCT00734604|7282151|FG003|Overall Study|Withdrawal by Subject|1
4483305|NCT00734604|7282152|FG004|Overall Study|Withdrawal by Subject|2
4483306|NCT00734604|7282153|FG005|Overall Study|Withdrawal by Subject|1
4483307|NCT00734604|7282148|FG000|Overall Study|Lack of Efficacy|0
4483308|NCT00734604|7282149|FG001|Overall Study|Lack of Efficacy|1
4483309|NCT00734604|7282150|FG002|Overall Study|Lack of Efficacy|1
4483310|NCT00734604|7282151|FG003|Overall Study|Lack of Efficacy|0
4483311|NCT00734604|7282152|FG004|Overall Study|Lack of Efficacy|0
4483312|NCT00734604|7282153|FG005|Overall Study|Lack of Efficacy|0
4483313|NCT00734617|7282166|FG000|Overall Study|Adverse Event|4
4483314|NCT00734617|7282167|FG001|Overall Study|Adverse Event|7
4483315|NCT00734617|7282166|FG000|Overall Study|Withdrawal by Subject|103
4483316|NCT00734617|7282167|FG001|Overall Study|Withdrawal by Subject|95
4483317|NCT00734630|7282175|FG000|Overall Study|Lack of Efficacy|4
4483318|NCT00734630|7282176|FG001|Overall Study|Lack of Efficacy|4
4483319|NCT00734630|7282175|FG000|Overall Study|Withdrawal by Subject|7
4483320|NCT00734630|7282176|FG001|Overall Study|Withdrawal by Subject|9
4483321|NCT00734630|7282175|FG000|Overall Study|Lost to Follow-up|13
4483322|NCT00734630|7282176|FG001|Overall Study|Lost to Follow-up|7
4483323|NCT00734630|7282175|FG000|Overall Study|Protocol Violation|0
4483324|NCT00734630|7282176|FG001|Overall Study|Protocol Violation|3
4483325|NCT00734630|7282175|FG000|Overall Study|Inclusion/Exclusion criteria not met|0
4483326|NCT00734630|7282176|FG001|Overall Study|Inclusion/Exclusion criteria not met|1
4483327|NCT00734630|7282175|FG000|Overall Study|Adverse Event|3
4483328|NCT00734630|7282176|FG001|Overall Study|Adverse Event|6
4483329|NCT00734630|7282175|FG000|Overall Study|Randomized in Error|0
4483330|NCT00734630|7282176|FG001|Overall Study|Randomized in Error|1
4483331|NCT00734630|7282175|FG000|Overall Study|Tested Positive for Illegal Drug Use|1
4483332|NCT00734630|7282176|FG001|Overall Study|Tested Positive for Illegal Drug Use|1
4483333|NCT00734630|7282175|FG000|Overall Study|Poor Compliance|1
4483334|NCT00734630|7282176|FG001|Overall Study|Poor Compliance|1
4483335|NCT00734656|7282182|FG000|Lab Session 1|Withdrawal by Subject|2
4483336|NCT00734656|7282183|FG001|Lab Session 1|Withdrawal by Subject|0
4483337|NCT00734656|7282184|FG002|Lab Session 1|Withdrawal by Subject|0
4483338|NCT00734656|7282185|FG003|Lab Session 1|Withdrawal by Subject|0
4483339|NCT00734656|7282182|FG000|Washout 1|Withdrawal by Subject|1
4483340|NCT00734656|7282183|FG001|Washout 1|Withdrawal by Subject|5
4483341|NCT00734656|7282184|FG002|Washout 1|Withdrawal by Subject|2
4700877|NCT02700984|7617077|FG000|Overall Study|Withdrawal by Subject|8
4700878|NCT02700984|7617078|FG001|Overall Study|Withdrawal by Subject|9
4700879|NCT02700984|7617077|FG000|Overall Study|Reason not specified|3
4700880|NCT02700984|7617078|FG001|Overall Study|Reason not specified|2
4700881|NCT02700997|7617094|FG000|Overall Study|Did not undergo CT imaging|1
4483342|NCT00734656|7282185|FG003|Washout 1|Withdrawal by Subject|3
4483343|NCT00734656|7282182|FG000|Lab Session 2|Withdrawal by Subject|1
4483344|NCT00734656|7282183|FG001|Lab Session 2|Withdrawal by Subject|0
4483345|NCT00734656|7282184|FG002|Lab Session 2|Withdrawal by Subject|0
4483346|NCT00734656|7282185|FG003|Lab Session 2|Withdrawal by Subject|1
4483347|NCT00734656|7282182|FG000|Washout 2|Withdrawal by Subject|1
4483348|NCT00734656|7282183|FG001|Washout 2|Withdrawal by Subject|1
4483349|NCT00734656|7282184|FG002|Washout 2|Withdrawal by Subject|1
4483350|NCT00734656|7282185|FG003|Washout 2|Withdrawal by Subject|0
4483351|NCT00734656|7282182|FG000|Washout 3|Withdrawal by Subject|1
4483352|NCT00734656|7282183|FG001|Washout 3|Withdrawal by Subject|0
4483353|NCT00734656|7282184|FG002|Washout 3|Withdrawal by Subject|0
4483354|NCT00734656|7282185|FG003|Washout 3|Withdrawal by Subject|1
4483355|NCT00734656|7282182|FG000|Lab Session 4|Withdrawal by Subject|0
4483356|NCT00734656|7282183|FG001|Lab Session 4|Withdrawal by Subject|0
4483357|NCT00734656|7282184|FG002|Lab Session 4|Withdrawal by Subject|0
4483358|NCT00734656|7282185|FG003|Lab Session 4|Withdrawal by Subject|1
4483359|NCT00734747|7282200|FG000|SRS Procedure|No staples placed|3
4483360|NCT00734747|7282200|FG000|6 Month Follow-up|Did not meet inclusion criteria|3
4483361|NCT00734851|7282213|FG000|Overall Study|Withdrawal by Subject|2
4483362|NCT00734851|7282213|FG000|Overall Study|Lost to Follow-up|1
4483363|NCT00734851|7282213|FG000|Overall Study|Physician Decision|18
4483364|NCT00734929|7282228|FG000|Overall Study|Lost to Follow-up|1
4483365|NCT00734929|7282229|FG001|Overall Study|Lost to Follow-up|2
4483366|NCT00734929|7282228|FG000|Overall Study|No intervention/ screen fail|5
4483367|NCT00734929|7282229|FG001|Overall Study|No intervention/ screen fail|3
4517029|NCT00963807|7328675|FG000|Overall Study|Physician Decision|2
4517030|NCT00963807|7328675|FG000|Overall Study|Reaction to study chemotherapy regimen|1
4517031|NCT00963807|7328675|FG000|Overall Study|Disease progression|15
4517032|NCT00963820|7328681|FG000|Dose Escalation Phase|Progressive Disease|3
4517033|NCT00963820|7328682|FG001|Dose Escalation Phase|Progressive Disease|3
4483368|NCT00734994|7282246|FG000|Overall Study|Withdrawal by Subject|1
4483369|NCT00735007|7282251|FG000|Overall Study|Adverse Event|4
4483370|NCT00735007|7282251|FG000|Overall Study|Protocol Violation|1
4483371|NCT00735072|7282257|FG000|Overall Study|interrupted study med during ARV change|1
4483372|NCT00735072|7282258|FG001|Overall Study|interrupted study med during ARV change|0
4483373|NCT00735072|7282257|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0
4483374|NCT00735072|7282258|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1
4483375|NCT00735371|7282275|FG000|Overall Study|Adverse Event|3
4483376|NCT00735371|7282276|FG001|Overall Study|Adverse Event|3
4483377|NCT00735371|7282277|FG002|Overall Study|Adverse Event|4
4387067|NCT00045708|7165679|FG001|Phase 1|early progressive disease|1
4387068|NCT00045708|7165680|FG002|Phase 1|early progressive disease|0
4387069|NCT00045734|7165697|FG000|Overall Study|Protocol Violation|1
4387070|NCT00045942|7165710|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1
4387071|NCT00045942|7165711|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0
4387072|NCT00045942|7165712|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0
4387073|NCT00045942|7165713|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0
4387074|NCT00045942|7165714|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0
4387075|NCT00045942|7165715|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0
4483378|NCT00735371|7282278|FG003|Overall Study|Adverse Event|1
4483379|NCT00735371|7282275|FG000|Overall Study|Protocol Violation|2
4483380|NCT00735371|7282276|FG001|Overall Study|Protocol Violation|2
4483381|NCT00735371|7282277|FG002|Overall Study|Protocol Violation|0
4483382|NCT00735371|7282278|FG003|Overall Study|Protocol Violation|3
4483383|NCT00735371|7282275|FG000|Overall Study|Withdrawal by Subject|0
4483384|NCT00735371|7282276|FG001|Overall Study|Withdrawal by Subject|2
4700882|NCT02700997|7617094|FG000|Overall Study|No CT measurement - pelvic calcification|1
4700883|NCT02701296|7617178|FG000|Overall Study|Incomplete Data|0
4483385|NCT00735371|7282277|FG002|Overall Study|Withdrawal by Subject|2
4483386|NCT00735371|7282278|FG003|Overall Study|Withdrawal by Subject|0
4483387|NCT00735371|7282275|FG000|Overall Study|Lost to Follow-up|1
4483388|NCT00735371|7282276|FG001|Overall Study|Lost to Follow-up|1
4483389|NCT00735371|7282277|FG002|Overall Study|Lost to Follow-up|3
4483390|NCT00735371|7282278|FG003|Overall Study|Lost to Follow-up|1
4483391|NCT00735371|7282275|FG000|Overall Study|Lack of Efficacy|4
4483392|NCT00735371|7282276|FG001|Overall Study|Lack of Efficacy|2
4483393|NCT00735371|7282277|FG002|Overall Study|Lack of Efficacy|0
4483394|NCT00735371|7282278|FG003|Overall Study|Lack of Efficacy|4
4483395|NCT00735371|7282275|FG000|Overall Study|Sponsor Decision|3
4483396|NCT00735371|7282276|FG001|Overall Study|Sponsor Decision|1
4483397|NCT00735371|7282277|FG002|Overall Study|Sponsor Decision|0
4483398|NCT00735371|7282278|FG003|Overall Study|Sponsor Decision|1
4483399|NCT00735371|7282275|FG000|Overall Study|Protocol Violation|0
4483400|NCT00735371|7282276|FG001|Overall Study|Protocol Violation|1
4483401|NCT00735371|7282277|FG002|Overall Study|Protocol Violation|2
4483402|NCT00735371|7282278|FG003|Overall Study|Protocol Violation|0
4483403|NCT00735371|7282275|FG000|Overall Study|Prior Vyvanse Exposure|1
4483404|NCT00735371|7282276|FG001|Overall Study|Prior Vyvanse Exposure|1
4483405|NCT00735371|7282277|FG002|Overall Study|Prior Vyvanse Exposure|0
4483406|NCT00735371|7282278|FG003|Overall Study|Prior Vyvanse Exposure|0
4483407|NCT00735371|7282275|FG000|Overall Study|Exclusion criteria|1
4483408|NCT00735371|7282276|FG001|Overall Study|Exclusion criteria|0
4483409|NCT00735371|7282277|FG002|Overall Study|Exclusion criteria|0
4483410|NCT00735371|7282278|FG003|Overall Study|Exclusion criteria|0
4483411|NCT00735397|7282288|FG000|Overall Study|Adverse Event|194
4483412|NCT00735397|7282288|FG000|Overall Study|Lost to Follow-up|33
4483413|NCT00735397|7282288|FG000|Overall Study|Participant choice|252
4483414|NCT00735397|7282288|FG000|Overall Study|Inadequate therapeutic effect|202
4483415|NCT00735397|7282288|FG000|Overall Study|Administrative/Other|502
4483416|NCT00735475|7282324|FG000|Overall Study|Adverse Event|0
4483417|NCT00735475|7282325|FG001|Overall Study|Adverse Event|1
4483418|NCT00735475|7282324|FG000|Overall Study|Death|1
4483419|NCT00735475|7282325|FG001|Overall Study|Death|1
4483420|NCT00735475|7282324|FG000|Overall Study|Lost to Follow-up|3
4483421|NCT00735475|7282325|FG001|Overall Study|Lost to Follow-up|3
4483422|NCT00735475|7282324|FG000|Overall Study|Physician Decision|0
4483423|NCT00735475|7282325|FG001|Overall Study|Physician Decision|1
4483424|NCT00735475|7282324|FG000|Overall Study|Withdrawal by Subject|4
4483425|NCT00735475|7282325|FG001|Overall Study|Withdrawal by Subject|5
4483426|NCT00735644|7282340|FG000|Overall Study|Did not receive study vaccine|0
4483427|NCT00735644|7282341|FG001|Overall Study|Did not receive study vaccine|1
4483428|NCT00735644|7282342|FG002|Overall Study|Did not receive study vaccine|0
4483429|NCT00735644|7282343|FG003|Overall Study|Did not receive study vaccine|0
4483430|NCT00735644|7282344|FG004|Overall Study|Did not receive study vaccine|0
4483431|NCT00735644|7282340|FG000|Overall Study|Withdrawal by Subject|0
4483432|NCT00735644|7282341|FG001|Overall Study|Withdrawal by Subject|1
4483433|NCT00735644|7282342|FG002|Overall Study|Withdrawal by Subject|1
4483434|NCT00735644|7282343|FG003|Overall Study|Withdrawal by Subject|1
4483435|NCT00735644|7282344|FG004|Overall Study|Withdrawal by Subject|0
4483436|NCT00735696|7282372|FG000|Overall Study|Withdrawal by Subject|1
4483437|NCT00735696|7282372|FG000|Overall Study|Enrolled but never Treated|1
4483438|NCT00735709|7282380|FG000|Overall Study|Adverse Event|2
4700884|NCT02701296|7617179|FG001|Overall Study|Incomplete Data|2
4483439|NCT00735709|7282381|FG001|Overall Study|Adverse Event|3
4483440|NCT00735709|7282382|FG002|Overall Study|Adverse Event|1
4483441|NCT00735709|7282383|FG003|Overall Study|Adverse Event|5
4483442|NCT00735709|7282380|FG000|Overall Study|Lack of Efficacy|8
4483443|NCT00735709|7282381|FG001|Overall Study|Lack of Efficacy|4
4483444|NCT00735709|7282382|FG002|Overall Study|Lack of Efficacy|2
4483445|NCT00735709|7282383|FG003|Overall Study|Lack of Efficacy|3
4483446|NCT00735709|7282380|FG000|Overall Study|Noncompliance|0
4483447|NCT00735709|7282381|FG001|Overall Study|Noncompliance|0
4483448|NCT00735709|7282382|FG002|Overall Study|Noncompliance|1
4483449|NCT00735709|7282383|FG003|Overall Study|Noncompliance|0
4483450|NCT00735709|7282380|FG000|Overall Study|Protocol deviations|1
4483451|NCT00735709|7282381|FG001|Overall Study|Protocol deviations|2
4483452|NCT00735709|7282382|FG002|Overall Study|Protocol deviations|1
4483453|NCT00735709|7282383|FG003|Overall Study|Protocol deviations|1
4483454|NCT00735709|7282380|FG000|Overall Study|Voluntary Withdrawal|1
4483455|NCT00735709|7282381|FG001|Overall Study|Voluntary Withdrawal|3
4483456|NCT00735709|7282382|FG002|Overall Study|Voluntary Withdrawal|5
4483457|NCT00735709|7282383|FG003|Overall Study|Voluntary Withdrawal|7
4483458|NCT00735709|7282380|FG000|Overall Study|Lost to Follow-up|0
4483459|NCT00735709|7282381|FG001|Overall Study|Lost to Follow-up|1
4483460|NCT00735709|7282382|FG002|Overall Study|Lost to Follow-up|1
4483461|NCT00735709|7282383|FG003|Overall Study|Lost to Follow-up|1
4483462|NCT00735709|7282380|FG000|Overall Study|Excluded medication|1
4483463|NCT00735709|7282381|FG001|Overall Study|Excluded medication|0
4483464|NCT00735709|7282382|FG002|Overall Study|Excluded medication|0
4483465|NCT00735709|7282383|FG003|Overall Study|Excluded medication|1
4483466|NCT00735878|7282420|FG000|Phase I- Dose Determination|Withdrawal by Subject|0
4483467|NCT00735878|7282421|FG001|Phase I- Dose Determination|Withdrawal by Subject|0
4483468|NCT00735878|7282422|FG002|Phase I- Dose Determination|Withdrawal by Subject|1
4483469|NCT00735904|7282433|FG000|Overall Study|Adverse Event|3
4483470|NCT00735904|7282433|FG000|Overall Study|Death|20
4483471|NCT00735904|7282433|FG000|Overall Study|Protocol Violation|1
4483472|NCT00735904|7282433|FG000|Overall Study|Withdrawal by Subject|1
4589729|NCT01514201|7435118|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0
4589730|NCT01514201|7435119|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2
4589731|NCT01514201|7435116|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0
4589732|NCT01514201|7435117|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0
4589733|NCT01514201|7435118|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0
4589734|NCT01514201|7435119|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6
4589735|NCT01514201|7435116|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0
4589736|NCT01514201|7435117|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0
4589737|NCT01514201|7435118|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0
4589738|NCT01514201|7435119|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4
4589739|NCT01514201|7435116|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
4589740|NCT01514201|7435117|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
4589741|NCT01514201|7435118|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
4589742|NCT01514201|7435119|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7
4589743|NCT01514201|7435116|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
4589744|NCT01514201|7435117|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
4589745|NCT01514201|7435118|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
4589746|NCT01514201|7435119|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22
4589747|NCT01514240|7435141|FG000|Overall Study|Adverse Event|4
4589748|NCT01514240|7435142|FG001|Overall Study|Adverse Event|4
4589749|NCT01514240|7435141|FG000|Overall Study|Subject Decision|2
4589750|NCT01514240|7435142|FG001|Overall Study|Subject Decision|7
4589751|NCT01514357|7435171|FG000|Overall Study|Screen failure|2
4589752|NCT01514357|7435172|FG001|Overall Study|Screen failure|0
4589753|NCT01514357|7435171|FG000|Overall Study|Withdrawal by Subject|2
4589754|NCT01514357|7435172|FG001|Overall Study|Withdrawal by Subject|0
4589755|NCT01514370|7435180|FG000|Overall Study|Protocol Violation|2
4589756|NCT01514370|7435181|FG001|Overall Study|Protocol Violation|3
4589757|NCT01514370|7435180|FG000|Overall Study|Lost to Follow-up|0
4589758|NCT01514370|7435181|FG001|Overall Study|Lost to Follow-up|2
4483473|NCT00735904|7282433|FG000|Overall Study|Study Terminated by Sponsor|5
4483474|NCT00735904|7282433|FG000|Overall Study|Other|8
4483475|NCT00735943|7282441|FG000|Overall Study|Lost to Follow-up|1
4483476|NCT00735943|7282441|FG000|Overall Study|Adverse Event|1
4483477|NCT00736034|7282449|FG000|Overall Study|Adverse Event|2
4483478|NCT00736099|7282465|FG000|Overall Study|Adverse Event|61
4483479|NCT00736099|7282466|FG001|Overall Study|Adverse Event|18
4483480|NCT00736099|7282465|FG000|Overall Study|Protocol Violation|10
4483481|NCT00736099|7282466|FG001|Overall Study|Protocol Violation|4
4483482|NCT00736099|7282465|FG000|Overall Study|Lost to Follow-up|12
4483483|NCT00736099|7282466|FG001|Overall Study|Lost to Follow-up|5
4483484|NCT00736099|7282465|FG000|Overall Study|Withdrawal by Subject|42
4483485|NCT00736099|7282466|FG001|Overall Study|Withdrawal by Subject|13
4483486|NCT00736099|7282465|FG000|Overall Study|Lack of Efficacy|15
4483487|NCT00736099|7282466|FG001|Overall Study|Lack of Efficacy|8
4483488|NCT00736099|7282465|FG000|Overall Study|Other reason|43
4483489|NCT00736099|7282466|FG001|Overall Study|Other reason|10
4483490|NCT00736190|7282481|FG000|Overall Study|Pregnancy|1
4483491|NCT00736190|7282481|FG000|Overall Study|Withdrawal by Subject|1
4483492|NCT00736190|7282481|FG000|Overall Study|Adverse Event|1
4700885|NCT02701361|7617188|FG000|Overall Study|Lost to Follow-up|5
4700886|NCT02701361|7617189|FG001|Overall Study|Lost to Follow-up|2
4700887|NCT02701361|7617190|FG002|Overall Study|Lost to Follow-up|1
4700888|NCT02701361|7617188|FG000|Overall Study|Withdrawal by Subject|4
4700889|NCT02701361|7617189|FG001|Overall Study|Withdrawal by Subject|0
4483493|NCT00736255|7282505|FG000|Overall Study|Adverse Event|1
4483494|NCT00736255|7282506|FG001|Overall Study|Adverse Event|0
4483495|NCT00736255|7282505|FG000|Overall Study|Physician Decision|1
4483496|NCT00736255|7282506|FG001|Overall Study|Physician Decision|0
4483497|NCT00736255|7282505|FG000|Overall Study|Non-compliance|1
4483498|NCT00736255|7282506|FG001|Overall Study|Non-compliance|1
4483499|NCT00736333|7282512|FG000|Overall Study|Did Not Receive Drug or Not Documented|7
4483500|NCT00736333|7282512|FG000|Overall Study|Data Missing|2
4483501|NCT00736333|7282512|FG000|Overall Study|Tumor Progression|75
4483502|NCT00736333|7282512|FG000|Overall Study|Toxicity|6
4483503|NCT00736333|7282512|FG000|Overall Study|Withdrawal by Subject|10
4483504|NCT00736333|7282512|FG000|Overall Study|Death|7
4483505|NCT00736333|7282512|FG000|Overall Study|Other|4
4483506|NCT00736450|7282516|FG000|Overall Study|Not ABC gene eligible|19
4483507|NCT00736450|7282516|FG000|Overall Study|Withdrawal by Subject|5
4483508|NCT00736450|7282516|FG000|Overall Study|Physician Decision|1
4483509|NCT00736476|7282522|FG000|Overall Study|Adverse Event|1
4483510|NCT00736476|7282523|FG001|Overall Study|Adverse Event|0
4483511|NCT00736489|7282535|FG000|Period 1|Lost to Follow-up|1
4483512|NCT00736489|7282536|FG001|Period 1|Lost to Follow-up|0
4483513|NCT00736489|7282537|FG002|Period 1|Lost to Follow-up|0
4483514|NCT00736489|7282538|FG003|Period 1|Lost to Follow-up|0
4483515|NCT00736489|7282539|FG004|Period 1|Lost to Follow-up|0
4483516|NCT00736489|7282540|FG005|Period 1|Lost to Follow-up|0
4483517|NCT00736489|7282535|FG000|Period 1|Withdrawal by Subject|0
4483518|NCT00736489|7282536|FG001|Period 1|Withdrawal by Subject|0
4483519|NCT00736489|7282537|FG002|Period 1|Withdrawal by Subject|0
4483520|NCT00736489|7282538|FG003|Period 1|Withdrawal by Subject|0
4483521|NCT00736489|7282539|FG004|Period 1|Withdrawal by Subject|0
4483522|NCT00736489|7282540|FG005|Period 1|Withdrawal by Subject|1
4483523|NCT00736502|7282554|FG000|Overall Study|Adverse Event|22
4483524|NCT00736502|7282554|FG000|Overall Study|Lack of Efficacy|16
4483525|NCT00736502|7282554|FG000|Overall Study|Lost to Follow-up|27
4483526|NCT00736645|7282582|FG000|Overall Study|Adverse Event|0
4483527|NCT00736645|7282583|FG001|Overall Study|Adverse Event|2
4483528|NCT00736645|7282584|FG002|Overall Study|Adverse Event|0
4483529|NCT00736645|7282585|FG003|Overall Study|Adverse Event|0
4483530|NCT00736723|7282597|FG000|Overall Study|Withdrawal by Subject|4
4483531|NCT00736723|7282598|FG001|Overall Study|Withdrawal by Subject|3
4483532|NCT00736840|7282604|FG000|Overall Study|Lost to Follow-up|13
4483533|NCT00736853|7282608|FG000|Open-Label Period|Physician Decision|2
4483534|NCT00736853|7282609|FG001|Open-Label Period|Physician Decision|0
4483535|NCT00736853|7282610|FG002|Open-Label Period|Physician Decision|0
4483536|NCT00736853|7282608|FG000|Open-Label Period|Adverse Event|31
4483537|NCT00736853|7282609|FG001|Open-Label Period|Adverse Event|0
4483538|NCT00736853|7282610|FG002|Open-Label Period|Adverse Event|0
4483539|NCT00736853|7282608|FG000|Open-Label Period|Withdrawal by Subject|16
4483540|NCT00736853|7282609|FG001|Open-Label Period|Withdrawal by Subject|0
4483541|NCT00736853|7282610|FG002|Open-Label Period|Withdrawal by Subject|0
4483542|NCT00736853|7282608|FG000|Open-Label Period|Started but not treated|42
4483543|NCT00736853|7282609|FG001|Open-Label Period|Started but not treated|0
4483544|NCT00736853|7282610|FG002|Open-Label Period|Started but not treated|0
4483545|NCT00736853|7282608|FG000|Open-Label Period|Failed to meet the transfer criteria|40
4483546|NCT00736853|7282609|FG001|Open-Label Period|Failed to meet the transfer criteria|0
4483547|NCT00736853|7282610|FG002|Open-Label Period|Failed to meet the transfer criteria|0
4483548|NCT00736853|7282608|FG000|Open-Label Period|Unable to attend hospital appointments|1
4483549|NCT00736853|7282609|FG001|Open-Label Period|Unable to attend hospital appointments|0
4483550|NCT00736853|7282610|FG002|Open-Label Period|Unable to attend hospital appointments|0
4483551|NCT00736853|7282608|FG000|Double-Blind Period|Lack of Efficacy|0
4483552|NCT00736853|7282609|FG001|Double-Blind Period|Lack of Efficacy|19
4483553|NCT00736853|7282610|FG002|Double-Blind Period|Lack of Efficacy|42
4483554|NCT00736853|7282608|FG000|Double-Blind Period|Adverse Event|0
4483555|NCT00736853|7282609|FG001|Double-Blind Period|Adverse Event|3
4483556|NCT00736853|7282610|FG002|Double-Blind Period|Adverse Event|2
4483557|NCT00736853|7282608|FG000|Double-Blind Period|Withdrawal by Subject|0
4483558|NCT00736853|7282609|FG001|Double-Blind Period|Withdrawal by Subject|1
4700890|NCT02701361|7617190|FG002|Overall Study|Withdrawal by Subject|0
4700891|NCT02701361|7617188|FG000|Overall Study|timed out in rehab center|0
4483559|NCT00736853|7282610|FG002|Double-Blind Period|Withdrawal by Subject|4
4483560|NCT00736853|7282608|FG000|Double-Blind Period|Ineligible to participate the study|0
4483561|NCT00736853|7282609|FG001|Double-Blind Period|Ineligible to participate the study|1
4483562|NCT00736853|7282610|FG002|Double-Blind Period|Ineligible to participate the study|0
4483563|NCT00736879|7282623|FG000|Double Blind Treatment Period|Lack of Efficacy|1
4483564|NCT00736879|7282624|FG001|Double Blind Treatment Period|Lack of Efficacy|0
4483565|NCT00736879|7282625|FG002|Double Blind Treatment Period|Lack of Efficacy|0
4517034|NCT00963820|7328683|FG002|Dose Escalation Phase|Progressive Disease|3
4483566|NCT00736879|7282626|FG003|Double Blind Treatment Period|Lack of Efficacy|0
4483567|NCT00736879|7282623|FG000|Double Blind Treatment Period|Adverse Event|0
4483568|NCT00736879|7282624|FG001|Double Blind Treatment Period|Adverse Event|1
4483569|NCT00736879|7282625|FG002|Double Blind Treatment Period|Adverse Event|1
4483570|NCT00736879|7282626|FG003|Double Blind Treatment Period|Adverse Event|0
4483571|NCT00736879|7282623|FG000|Double Blind Treatment Period|Withdrawal by Subject|2
4483572|NCT00736879|7282624|FG001|Double Blind Treatment Period|Withdrawal by Subject|1
4483573|NCT00736879|7282625|FG002|Double Blind Treatment Period|Withdrawal by Subject|3
4483574|NCT00736879|7282626|FG003|Double Blind Treatment Period|Withdrawal by Subject|3
4483575|NCT00736879|7282623|FG000|Double Blind Treatment Period|Lost to Follow-up|0
4483576|NCT00736879|7282624|FG001|Double Blind Treatment Period|Lost to Follow-up|0
4483577|NCT00736879|7282625|FG002|Double Blind Treatment Period|Lost to Follow-up|2
4700892|NCT02701361|7617189|FG001|Overall Study|timed out in rehab center|1
4700893|NCT02701361|7617190|FG002|Overall Study|timed out in rehab center|0
4700894|NCT02701361|7617188|FG000|Overall Study|incarceration|0
4483578|NCT00736879|7282626|FG003|Double Blind Treatment Period|Lost to Follow-up|1
4483579|NCT00736879|7282623|FG000|Double Blind Treatment Period|Poor non-compliance|0
4483580|NCT00736879|7282624|FG001|Double Blind Treatment Period|Poor non-compliance|0
4483581|NCT00736879|7282625|FG002|Double Blind Treatment Period|Poor non-compliance|1
4483582|NCT00736879|7282626|FG003|Double Blind Treatment Period|Poor non-compliance|1
4483583|NCT00736879|7282623|FG000|Double Blind Treatment Period|No longer met criteria|0
4483584|NCT00736879|7282624|FG001|Double Blind Treatment Period|No longer met criteria|1
4483585|NCT00736879|7282625|FG002|Double Blind Treatment Period|No longer met criteria|0
4483586|NCT00736879|7282626|FG003|Double Blind Treatment Period|No longer met criteria|0
4483587|NCT00736879|7282623|FG000|Double Blind Treatment Period|non-specified|0
4483588|NCT00736879|7282624|FG001|Double Blind Treatment Period|non-specified|1
4483589|NCT00736879|7282625|FG002|Double Blind Treatment Period|non-specified|0
4483590|NCT00736879|7282626|FG003|Double Blind Treatment Period|non-specified|0
4483591|NCT00736879|7282623|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
4483592|NCT00736879|7282624|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1
4483593|NCT00736879|7282625|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
4589759|NCT01514370|7435180|FG000|Overall Study|Withdrawal by Subject|2
4589760|NCT01514370|7435181|FG001|Overall Study|Withdrawal by Subject|1
4589761|NCT01514370|7435180|FG000|Overall Study|Adverse Event|1
4589762|NCT01514370|7435181|FG001|Overall Study|Adverse Event|3
4589763|NCT01514370|7435180|FG000|Overall Study|Other|6
4589764|NCT01514370|7435181|FG001|Overall Study|Other|7
4589765|NCT01514422|7435198|FG000|Overall Study|Lost to Follow-up|1
4589766|NCT01514448|7435204|FG000|Overall Study|Death|7
4483594|NCT00736879|7282626|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
4483595|NCT00736879|7282623|FG000|Follow up Period - No Drug Treatment|non-specified|1
4483596|NCT00736879|7282624|FG001|Follow up Period - No Drug Treatment|non-specified|2
4483597|NCT00736879|7282625|FG002|Follow up Period - No Drug Treatment|non-specified|0
4483598|NCT00736879|7282626|FG003|Follow up Period - No Drug Treatment|non-specified|0
4483599|NCT00736944|7282639|FG000|Induction|Death|1
4483600|NCT00736944|7282639|FG000|Definitive Treatment|Physician Decision|1
4483601|NCT00736957|7282646|FG000|Overall Study|Adverse Event|43
4483602|NCT00736957|7282646|FG000|Overall Study|Withdrawal by Subject|49
4483603|NCT00736957|7282646|FG000|Overall Study|violation of eligibility criteria|2
4483604|NCT00736957|7282646|FG000|Overall Study|did not attend hospital appointments|1
4483605|NCT00736957|7282646|FG000|Overall Study|not eligible for Treatment Period I|22
4483606|NCT00736957|7282646|FG000|Overall Study|Physician Decision|5
4483607|NCT00736996|7282653|FG000|Overall Study|Lost to Follow-up|1
4483608|NCT00736996|7282654|FG001|Overall Study|Lost to Follow-up|9
4483609|NCT00736996|7282655|FG002|Overall Study|Lost to Follow-up|2
4483610|NCT00737048|7282666|FG000|Overall Study|Physician Decision|0
4483611|NCT00737048|7282667|FG001|Overall Study|Physician Decision|0
4483612|NCT00737048|7282668|FG002|Overall Study|Physician Decision|1
4483613|NCT00737048|7282666|FG000|Overall Study|Adverse Event|0
4483614|NCT00737048|7282667|FG001|Overall Study|Adverse Event|1
4483615|NCT00737048|7282668|FG002|Overall Study|Adverse Event|0
4483616|NCT00737048|7282666|FG000|Overall Study|Worsening of the symptoms|3
4483617|NCT00737048|7282667|FG001|Overall Study|Worsening of the symptoms|5
4483618|NCT00737048|7282668|FG002|Overall Study|Worsening of the symptoms|3
4483619|NCT00737061|7282676|FG000|Waiting Period|Lost to Follow-up|6
4483620|NCT00737061|7282676|FG000|Waiting Period|Withdrawal by Subject|1
4483621|NCT00737061|7282676|FG000|Waiting Period|Bilateral placement failure|34
4483622|NCT00737061|7282676|FG000|Waiting Period|Deemed patent following HSG|26
4483623|NCT00737061|7282676|FG000|Waiting Period|Alternative contraception failure|3
4483624|NCT00737061|7282676|FG000|Waiting Period|Elected surgical tubal ligation|5
4483625|NCT00737061|7282676|FG000|1 Year Wearing Period|Lost to Follow-up|11
4483626|NCT00737061|7282676|FG000|1 Year Wearing Period|Withdrawal by Subject|2
4483627|NCT00737061|7282676|FG000|1 Year Wearing Period|Discontinued reilance|3
4483628|NCT00737061|7282676|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1
4483629|NCT00737100|7282683|FG000|Overall Study|Adverse Event|6
4483630|NCT00737100|7282684|FG001|Overall Study|Adverse Event|5
4589767|NCT01514448|7435205|FG001|Overall Study|Death|8
4700895|NCT02701361|7617189|FG001|Overall Study|incarceration|0
4483631|NCT00737100|7282685|FG002|Overall Study|Adverse Event|3
4483632|NCT00737100|7282683|FG000|Overall Study|Lost to Follow-up|0
4483633|NCT00737100|7282684|FG001|Overall Study|Lost to Follow-up|1
4483634|NCT00737100|7282685|FG002|Overall Study|Lost to Follow-up|0
4483635|NCT00737100|7282683|FG000|Overall Study|Withdrawal by Subject|0
4483636|NCT00737100|7282684|FG001|Overall Study|Withdrawal by Subject|0
4483637|NCT00737100|7282685|FG002|Overall Study|Withdrawal by Subject|3
4483638|NCT00737100|7282683|FG000|Overall Study|Reason discontinued not explained above|1
4589768|NCT01514448|7435204|FG000|Overall Study|Withdrawal by Subject|2
4589769|NCT01514448|7435205|FG001|Overall Study|Withdrawal by Subject|0
4589770|NCT01514448|7435204|FG000|Overall Study|Lost to Follow-up|2
4589771|NCT01514448|7435205|FG001|Overall Study|Lost to Follow-up|0
4589772|NCT01514448|7435204|FG000|Overall Study|New Cancer Therapy|1
4589773|NCT01514448|7435205|FG001|Overall Study|New Cancer Therapy|0
4589774|NCT01514461|7435215|FG000|Overall Study|Adverse Event|2
4589775|NCT01514461|7435216|FG001|Overall Study|Adverse Event|1
4589776|NCT01514461|7435217|FG002|Overall Study|Adverse Event|3
4589777|NCT01514461|7435215|FG000|Overall Study|Physician Decision|1
4483639|NCT00737100|7282684|FG001|Overall Study|Reason discontinued not explained above|1
4483640|NCT00737100|7282685|FG002|Overall Study|Reason discontinued not explained above|1
4483641|NCT00737438|7282723|FG000|Overall Study|Withdrawal by Subject|2
4483642|NCT00737438|7282723|FG000|Overall Study|Patient ineligible|1
4483643|NCT00737464|7282727|FG000|Overall Study|Adverse Event|1
4483644|NCT00737464|7282727|FG000|Overall Study|Death|6
4483645|NCT00737464|7282727|FG000|Overall Study|Other - Failure to Return|1
4483646|NCT00737464|7282727|FG000|Overall Study|Refused Treatment / Withdrew Consent|6
4483647|NCT00737464|7282727|FG000|Overall Study|Other reasons|4
4483648|NCT00737477|7282731|FG000|Overall Study|Adverse Event|9
4483649|NCT00737477|7282731|FG000|Overall Study|Death|9
4483650|NCT00737477|7282731|FG000|Overall Study|Treatment Refusal|1
4483651|NCT00737477|7282731|FG000|Overall Study|Withdrawal by Subject|1
4483652|NCT00737477|7282731|FG000|Overall Study|Renal Transplantation|10
4483653|NCT00737477|7282731|FG000|Overall Study|Other|4
4483654|NCT00737529|7282735|FG000|Overall Study|Disease Progression|95
4483655|NCT00737529|7282735|FG000|Overall Study|Adverse Event|24
4483656|NCT00737529|7282735|FG000|Overall Study|Withdrawal by Subject|5
4483657|NCT00737529|7282735|FG000|Overall Study|Death|4
4483658|NCT00737529|7282735|FG000|Overall Study|Protocol Violation|1
4483659|NCT00737529|7282735|FG000|Overall Study|Other|4
4483660|NCT00737568|7282741|FG000|Treatment Period Through Week 240|Investigator's Discretion|6
4483661|NCT00737568|7282742|FG001|Treatment Period Through Week 240|Investigator's Discretion|5
4483662|NCT00737568|7282741|FG000|Treatment Period Through Week 240|Withdrew Consent|5
4483663|NCT00737568|7282742|FG001|Treatment Period Through Week 240|Withdrew Consent|6
4483664|NCT00737568|7282741|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3
4483665|NCT00737568|7282742|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4
4483666|NCT00737568|7282741|FG000|Treatment Period Through Week 240|Lost to Follow-up|3
4483667|NCT00737568|7282742|FG001|Treatment Period Through Week 240|Lost to Follow-up|3
4483668|NCT00737568|7282741|FG000|Treatment Period Through Week 240|Protocol Violation|2
4483669|NCT00737568|7282742|FG001|Treatment Period Through Week 240|Protocol Violation|3
4483670|NCT00737568|7282741|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1
4483671|NCT00737568|7282742|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0
4483672|NCT00737568|7282741|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25
4483673|NCT00737568|7282742|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17
4483674|NCT00737568|7282741|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0
4483675|NCT00737568|7282742|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1
4483676|NCT00737568|7282741|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1
4483677|NCT00737568|7282742|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0
4483678|NCT00737633|7282750|FG000|Overall Study|Study terminated by sponsor|44
4483679|NCT00737633|7282751|FG001|Overall Study|Study terminated by sponsor|55
4483680|NCT00737633|7282750|FG000|Overall Study|Lost to Follow-up|0
4483681|NCT00737633|7282751|FG001|Overall Study|Lost to Follow-up|1
4483682|NCT00737633|7282750|FG000|Overall Study|protocol non-compliance|0
4483683|NCT00737633|7282751|FG001|Overall Study|protocol non-compliance|1
4483684|NCT00737672|7282759|FG000|Overall Study|Graft Abandonment|48
4483685|NCT00737672|7282760|FG001|Overall Study|Graft Abandonment|56
4483686|NCT00737672|7282759|FG000|Overall Study|Death|23
4483687|NCT00737672|7282760|FG001|Overall Study|Death|22
4483688|NCT00737672|7282759|FG000|Overall Study|Withdrawal by Subject|1
4483689|NCT00737672|7282760|FG001|Overall Study|Withdrawal by Subject|2
4589778|NCT01514461|7435216|FG001|Overall Study|Physician Decision|1
4589779|NCT01514461|7435217|FG002|Overall Study|Physician Decision|0
4483690|NCT00737672|7282759|FG000|Overall Study|Lost to Follow-up|1
4483691|NCT00737672|7282760|FG001|Overall Study|Lost to Follow-up|0
4483692|NCT00737672|7282759|FG000|Overall Study|Miscellaneous|7
4483693|NCT00737672|7282760|FG001|Overall Study|Miscellaneous|1
4483694|NCT00737672|7282759|FG000|Overall Study|Physician Decision|0
4483695|NCT00737672|7282760|FG001|Overall Study|Physician Decision|2
4483696|NCT00737698|7282769|FG000|Overall Study|Withdrawal by Subject|6
4483697|NCT00737698|7282770|FG001|Overall Study|Withdrawal by Subject|5
4483698|NCT00737698|7282771|FG002|Overall Study|Withdrawal by Subject|3
4483699|NCT00737698|7282769|FG000|Overall Study|Death|0
4483700|NCT00737698|7282770|FG001|Overall Study|Death|0
4483701|NCT00737698|7282771|FG002|Overall Study|Death|1
4483702|NCT00737711|7282779|FG000|Overall Study|Adverse Event|2
4483703|NCT00737711|7282779|FG000|Overall Study|Death|8
4483704|NCT00737711|7282779|FG000|Overall Study|Failure to return|4
4483705|NCT00737711|7282779|FG000|Overall Study|Protocol Violation|1
4483706|NCT00737711|7282779|FG000|Overall Study|Withdrawal by Subject|5
4387076|NCT00045942|7165716|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0
4387077|NCT00045942|7165717|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0
4387078|NCT00045942|7165718|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0
4387079|NCT00045942|7165710|FG000|PKC412A2104 (Core)|Adverse Event|5
4387080|NCT00045942|7165711|FG001|PKC412A2104 (Core)|Adverse Event|0
4387081|NCT00045942|7165712|FG002|PKC412A2104 (Core)|Adverse Event|0
4483707|NCT00737711|7282779|FG000|Overall Study|Blood transfusion|6
4483708|NCT00737711|7282779|FG000|Overall Study|Other|5
4483709|NCT00738062|7282829|FG000|Open Label Treatment|Lack of Efficacy|5
4483710|NCT00738062|7282830|FG001|Open Label Treatment|Lack of Efficacy|0
4483711|NCT00738062|7282831|FG002|Open Label Treatment|Lack of Efficacy|0
4483712|NCT00738062|7282829|FG000|Open Label Treatment|Adverse Event|11
4589780|NCT01514461|7435215|FG000|Overall Study|Patient/guardian decision|1
4589781|NCT01514461|7435216|FG001|Overall Study|Patient/guardian decision|1
4483713|NCT00738062|7282830|FG001|Open Label Treatment|Adverse Event|0
4483714|NCT00738062|7282831|FG002|Open Label Treatment|Adverse Event|0
4483715|NCT00738062|7282829|FG000|Open Label Treatment|Protocol Violation|2
4483716|NCT00738062|7282830|FG001|Open Label Treatment|Protocol Violation|0
4483717|NCT00738062|7282831|FG002|Open Label Treatment|Protocol Violation|0
4483718|NCT00738062|7282829|FG000|Open Label Treatment|Withdrawal by Subject|9
4483719|NCT00738062|7282830|FG001|Open Label Treatment|Withdrawal by Subject|0
4483720|NCT00738062|7282831|FG002|Open Label Treatment|Withdrawal by Subject|0
4483721|NCT00738062|7282829|FG000|Open Label Treatment|Investigator Decision|1
4483722|NCT00738062|7282830|FG001|Open Label Treatment|Investigator Decision|0
4483723|NCT00738062|7282831|FG002|Open Label Treatment|Investigator Decision|0
4483724|NCT00738062|7282829|FG000|Open-Label Extension|Adverse Event|5
4483725|NCT00738062|7282830|FG001|Open-Label Extension|Adverse Event|0
4483726|NCT00738062|7282831|FG002|Open-Label Extension|Adverse Event|0
4483727|NCT00738062|7282829|FG000|Open-Label Extension|Physician Decision|1
4483728|NCT00738062|7282830|FG001|Open-Label Extension|Physician Decision|0
4483729|NCT00738062|7282831|FG002|Open-Label Extension|Physician Decision|0
4483730|NCT00738062|7282829|FG000|Open-Label Extension|Lack of Efficacy|2
4483731|NCT00738062|7282830|FG001|Open-Label Extension|Lack of Efficacy|0
4483732|NCT00738062|7282831|FG002|Open-Label Extension|Lack of Efficacy|0
4483733|NCT00738062|7282829|FG000|Open-Label Extension|Withdrawal by Subject|6
4483734|NCT00738062|7282830|FG001|Open-Label Extension|Withdrawal by Subject|0
4483735|NCT00738062|7282831|FG002|Open-Label Extension|Withdrawal by Subject|0
4483736|NCT00738062|7282829|FG000|Open-Label Extension|Protocol Violation|1
4483737|NCT00738062|7282830|FG001|Open-Label Extension|Protocol Violation|0
4483738|NCT00738062|7282831|FG002|Open-Label Extension|Protocol Violation|0
4483739|NCT00738062|7282829|FG000|Open-Label Extension|Study Terminated|2
4483740|NCT00738062|7282830|FG001|Open-Label Extension|Study Terminated|0
4483741|NCT00738062|7282831|FG002|Open-Label Extension|Study Terminated|0
4483742|NCT00738101|7282840|FG000|Overall Study|Physician Decision|5
4483743|NCT00738101|7282840|FG000|Overall Study|Death|1
4483744|NCT00738101|7282840|FG000|Overall Study|Repeat enrollment|1
4483745|NCT00738283|7282844|FG000|Overall Study|Death|1
4483746|NCT00738283|7282844|FG000|Overall Study|Transfer to another facility|2
4483747|NCT00738283|7282844|FG000|Overall Study|Discharge home prior to end of study|1
4483748|NCT00738374|7282856|FG000|Induction Treatment Phase|Adverse Event|14
4483749|NCT00738374|7282857|FG001|Induction Treatment Phase|Adverse Event|0
4483750|NCT00738374|7282858|FG002|Induction Treatment Phase|Adverse Event|0
4483751|NCT00738374|7282859|FG003|Induction Treatment Phase|Adverse Event|0
4483752|NCT00738374|7282856|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4
4483753|NCT00738374|7282857|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0
4483754|NCT00738374|7282858|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0
4483755|NCT00738374|7282859|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0
4483756|NCT00738374|7282856|FG000|Induction Treatment Phase|Physician Decision|2
4483757|NCT00738374|7282857|FG001|Induction Treatment Phase|Physician Decision|0
4483758|NCT00738374|7282858|FG002|Induction Treatment Phase|Physician Decision|0
4483759|NCT00738374|7282859|FG003|Induction Treatment Phase|Physician Decision|0
4483760|NCT00738374|7282856|FG000|Induction Treatment Phase|Protocol Violation|2
4387082|NCT00045942|7165713|FG003|PKC412A2104 (Core)|Adverse Event|0
4387083|NCT00045942|7165714|FG004|PKC412A2104 (Core)|Adverse Event|0
4387084|NCT00045942|7165715|FG005|PKC412A2104 (Core)|Adverse Event|0
4387085|NCT00045942|7165716|FG006|PKC412A2104 (Core)|Adverse Event|0
4387086|NCT00045942|7165717|FG007|PKC412A2104 (Core)|Adverse Event|0
4387087|NCT00045942|7165718|FG008|PKC412A2104 (Core)|Adverse Event|0
4387088|NCT00045942|7165710|FG000|PKC412A2104 (Core)|Lack of Efficacy|13
4387089|NCT00045942|7165711|FG001|PKC412A2104 (Core)|Lack of Efficacy|0
4387090|NCT00045942|7165712|FG002|PKC412A2104 (Core)|Lack of Efficacy|0
4387091|NCT00045942|7165713|FG003|PKC412A2104 (Core)|Lack of Efficacy|0
4387092|NCT00045942|7165714|FG004|PKC412A2104 (Core)|Lack of Efficacy|0
4483761|NCT00738374|7282857|FG001|Induction Treatment Phase|Protocol Violation|0
4483762|NCT00738374|7282858|FG002|Induction Treatment Phase|Protocol Violation|0
4483763|NCT00738374|7282859|FG003|Induction Treatment Phase|Protocol Violation|0
4483764|NCT00738374|7282856|FG000|Induction Treatment Phase|Non-compliance|1
4483765|NCT00738374|7282857|FG001|Induction Treatment Phase|Non-compliance|0
4483766|NCT00738374|7282858|FG002|Induction Treatment Phase|Non-compliance|0
4483767|NCT00738374|7282859|FG003|Induction Treatment Phase|Non-compliance|0
4483768|NCT00738374|7282856|FG000|Induction Treatment Phase|Withdrawal by Subject|1
4483769|NCT00738374|7282857|FG001|Induction Treatment Phase|Withdrawal by Subject|0
4483770|NCT00738374|7282858|FG002|Induction Treatment Phase|Withdrawal by Subject|0
4483771|NCT00738374|7282859|FG003|Induction Treatment Phase|Withdrawal by Subject|0
4483772|NCT00738374|7282856|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0
4483773|NCT00738374|7282857|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1
4483774|NCT00738374|7282858|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2
4483775|NCT00738374|7282859|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0
4483776|NCT00738374|7282856|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0
4483777|NCT00738374|7282857|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4
4483778|NCT00738374|7282858|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5
4483779|NCT00738374|7282859|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11
4483780|NCT00738374|7282856|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
4483781|NCT00738374|7282857|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
4483782|NCT00738374|7282858|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
4483783|NCT00738374|7282859|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1
4483784|NCT00738374|7282856|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0
4483785|NCT00738374|7282857|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1
4483786|NCT00738374|7282858|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0
4483787|NCT00738374|7282859|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0
4483788|NCT00738374|7282856|FG000|Maintenance Treatment/Observation Phase|Other|0
4483789|NCT00738374|7282857|FG001|Maintenance Treatment/Observation Phase|Other|1
4483790|NCT00738374|7282858|FG002|Maintenance Treatment/Observation Phase|Other|0
4483791|NCT00738374|7282859|FG003|Maintenance Treatment/Observation Phase|Other|0
4483792|NCT00738400|7282870|FG000|Overall Study|Adverse Event|3
4483793|NCT00738400|7282871|FG001|Overall Study|Adverse Event|1
4483794|NCT00738400|7282870|FG000|Overall Study|Withdrawal by Subject|0
4483795|NCT00738400|7282871|FG001|Overall Study|Withdrawal by Subject|1
4483796|NCT00738400|7282870|FG000|Overall Study|Lack of Efficacy|0
4483797|NCT00738400|7282871|FG001|Overall Study|Lack of Efficacy|1
4483798|NCT00738400|7282870|FG000|Overall Study|Lost to Follow-up|0
4483799|NCT00738400|7282871|FG001|Overall Study|Lost to Follow-up|3
4483800|NCT00738400|7282870|FG000|Overall Study|Protocol Violation|1
4483801|NCT00738400|7282871|FG001|Overall Study|Protocol Violation|0
4483802|NCT00738400|7282870|FG000|Overall Study|Non-compliant with study medication|0
4483803|NCT00738400|7282871|FG001|Overall Study|Non-compliant with study medication|1
4483804|NCT00738530|7282888|FG000|Overall Study|Death|220
4483805|NCT00738530|7282889|FG001|Overall Study|Death|224
4483806|NCT00738530|7282888|FG000|Overall Study|Lost to Follow-up|8
4483807|NCT00738530|7282889|FG001|Overall Study|Lost to Follow-up|6
4483808|NCT00738530|7282888|FG000|Overall Study|Withdrawal by Subject|6
4483809|NCT00738530|7282889|FG001|Overall Study|Withdrawal by Subject|8
4483810|NCT00738673|7282901|FG000|Overall Study|Adverse Event|1
4483811|NCT00738673|7282902|FG001|Overall Study|Adverse Event|0
4483812|NCT00738673|7282901|FG000|Overall Study|Lack of Efficacy|19
4483813|NCT00738673|7282902|FG001|Overall Study|Lack of Efficacy|8
4483814|NCT00738673|7282901|FG000|Overall Study|Protocol Violation|1
4483815|NCT00738673|7282902|FG001|Overall Study|Protocol Violation|2
4483816|NCT00738673|7282901|FG000|Overall Study|Withdrawal by Subject|3
4483817|NCT00738673|7282902|FG001|Overall Study|Withdrawal by Subject|1
4483818|NCT00738699|7282910|FG000|Overall Study|Withdrawal by Subject|5
4483819|NCT00738699|7282911|FG001|Overall Study|Withdrawal by Subject|0
4483820|NCT00738699|7282910|FG000|Overall Study|Lost to Follow-up|1
4483821|NCT00738699|7282911|FG001|Overall Study|Lost to Follow-up|0
4483822|NCT00738699|7282910|FG000|Overall Study|Death|144
4483823|NCT00738699|7282911|FG001|Overall Study|Death|68
4483824|NCT00738699|7282910|FG000|Overall Study|Discontinuation of study by Sponsor|123
4483825|NCT00738699|7282911|FG001|Overall Study|Discontinuation of study by Sponsor|72
4483826|NCT00738699|7282910|FG000|Overall Study|Other|2
4483827|NCT00738699|7282911|FG001|Overall Study|Other|0
4483828|NCT00738881|7282919|FG000|Overall Study|Withdrawal by Subject|0
4483829|NCT00738881|7282920|FG001|Overall Study|Withdrawal by Subject|2
4483830|NCT00738894|7282928|FG000|Overall Study|Lost to Follow-up|23
4483831|NCT00738894|7282929|FG001|Overall Study|Lost to Follow-up|13
4483832|NCT00738894|7282928|FG000|Overall Study|Withdrawal by Subject|10
4483833|NCT00738894|7282929|FG001|Overall Study|Withdrawal by Subject|15
4483834|NCT00738894|7282928|FG000|Overall Study|Physician Decision|4
4483835|NCT00738894|7282929|FG001|Overall Study|Physician Decision|5
4483836|NCT00738894|7282928|FG000|Overall Study|Death|2
4483837|NCT00738894|7282929|FG001|Overall Study|Death|0
4483838|NCT00739102|7282935|FG000|Overall Study|Death|5
4483839|NCT00739102|7282935|FG000|Overall Study|Withdrawal by Subject|10
4483840|NCT00739297|7282939|FG000|First Washout Period of 4-7 Days|Adverse Event|0
4483841|NCT00739297|7282940|FG001|First Washout Period of 4-7 Days|Adverse Event|0
4483842|NCT00739297|7282941|FG002|First Washout Period of 4-7 Days|Adverse Event|0
4483843|NCT00739297|7282942|FG003|First Washout Period of 4-7 Days|Adverse Event|2
4483844|NCT00739297|7282943|FG004|First Washout Period of 4-7 Days|Adverse Event|0
4483845|NCT00739297|7282944|FG005|First Washout Period of 4-7 Days|Adverse Event|0
4483846|NCT00739297|7282945|FG006|First Washout Period of 4-7 Days|Adverse Event|2
4483847|NCT00739297|7282939|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
4483848|NCT00739297|7282940|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
4483849|NCT00739297|7282941|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
4483850|NCT00739297|7282942|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
4483851|NCT00739297|7282943|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
4483852|NCT00739297|7282944|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1
4483853|NCT00739297|7282945|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1
4483854|NCT00739310|7282961|FG000|Overall Study|Poor adherance to prescribed therapy|4
4483855|NCT00739310|7282961|FG000|Overall Study|Withdrawal by Subject|1
4483856|NCT00739310|7282961|FG000|Overall Study|Lost to Follow-up|2
4483857|NCT00739596|7282986|FG000|Overall Study|Adverse Event|12
4483858|NCT00739596|7282987|FG001|Overall Study|Adverse Event|6
4483859|NCT00739596|7282986|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4
4483860|NCT00739596|7282987|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0
4483861|NCT00739596|7282986|FG000|Overall Study|Patient Withdrew Consent|8
4483862|NCT00739596|7282987|FG001|Overall Study|Patient Withdrew Consent|8
4483863|NCT00739596|7282986|FG000|Overall Study|Lost to Follow-up|0
4483864|NCT00739596|7282987|FG001|Overall Study|Lost to Follow-up|2
4483865|NCT00739596|7282986|FG000|Overall Study|Protocol Deviation|1
4483866|NCT00739596|7282987|FG001|Overall Study|Protocol Deviation|1
4483867|NCT00739648|7282995|FG000|Overall Study|Adverse Event|3
4483868|NCT00739648|7282996|FG001|Overall Study|Adverse Event|15
4483869|NCT00739648|7282995|FG000|Overall Study|Withdrawal by Subject|13
4483870|NCT00739648|7282996|FG001|Overall Study|Withdrawal by Subject|25
4483871|NCT00739648|7282995|FG000|Overall Study|Lost to Follow-up|4
4483872|NCT00739648|7282996|FG001|Overall Study|Lost to Follow-up|7
4483873|NCT00739648|7282995|FG000|Overall Study|Death|2
4483874|NCT00739648|7282996|FG001|Overall Study|Death|0
4483875|NCT00739648|7282995|FG000|Overall Study|Do not know|4
4483876|NCT00739648|7282996|FG001|Overall Study|Do not know|6
4483877|NCT00739661|7283008|FG000|Overall Study|Adverse Event|2
4483878|NCT00739661|7283009|FG001|Overall Study|Adverse Event|0
4483879|NCT00739661|7283008|FG000|Overall Study|Physician decision to withdraw patient|1
4483880|NCT00739661|7283009|FG001|Overall Study|Physician decision to withdraw patient|0
4483881|NCT00739661|7283008|FG000|Overall Study|Patient decision to withdraw|9
4483882|NCT00739661|7283009|FG001|Overall Study|Patient decision to withdraw|4
4483883|NCT00739661|7283008|FG000|Overall Study|Disease progression, radiographic|33
4483884|NCT00739661|7283009|FG001|Overall Study|Disease progression, radiographic|37
4483885|NCT00739661|7283008|FG000|Overall Study|Reason for discontinuation not available|1
4483886|NCT00739661|7283009|FG001|Overall Study|Reason for discontinuation not available|1
4483887|NCT00739908|7283055|FG000|Overall Study|Adverse Event|5
4483888|NCT00739908|7283056|FG001|Overall Study|Adverse Event|6
4483889|NCT00739908|7283055|FG000|Overall Study|Withdrawal by Subject|4
4483890|NCT00739908|7283056|FG001|Overall Study|Withdrawal by Subject|2
4483891|NCT00739908|7283055|FG000|Overall Study|Lost to Follow-up|14
4483892|NCT00739908|7283056|FG001|Overall Study|Lost to Follow-up|9
4483893|NCT00739908|7283055|FG000|Overall Study|Non-Compliance With Study Procedures|2
4483894|NCT00739908|7283056|FG001|Overall Study|Non-Compliance With Study Procedures|3
4483895|NCT00739908|7283055|FG000|Overall Study|Non-Compliance With Study Medication|0
4483896|NCT00739908|7283056|FG001|Overall Study|Non-Compliance With Study Medication|3
4483897|NCT00739908|7283055|FG000|Overall Study|Lack of Efficacy|0
4483898|NCT00739908|7283056|FG001|Overall Study|Lack of Efficacy|1
4483899|NCT00739908|7283055|FG000|Overall Study|Relocation|0
4483900|NCT00739908|7283056|FG001|Overall Study|Relocation|1
4483901|NCT00739934|7283064|FG000|Voriconazole IV|Adverse Event|6
4483902|NCT00739934|7283064|FG000|Voriconazole Oral|Other|3
4483903|NCT00739973|7283086|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35
4483904|NCT00739973|7283087|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
4483905|NCT00739973|7283088|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
4483906|NCT00739973|7283089|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
4483907|NCT00739973|7283090|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
4483908|NCT00739973|7283091|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
4483909|NCT00739973|7283092|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
4483910|NCT00739973|7283093|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
4483911|NCT00739973|7283094|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
4483912|NCT00739973|7283086|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38
4483913|NCT00739973|7283087|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
4483914|NCT00739973|7283088|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
4483915|NCT00739973|7283089|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
4483916|NCT00739973|7283090|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
4483917|NCT00739973|7283091|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
4483918|NCT00739973|7283092|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
4483919|NCT00739973|7283093|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
4483920|NCT00739973|7283094|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
4483921|NCT00739973|7283086|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810
4483922|NCT00739973|7283087|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
4483923|NCT00739973|7283088|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
4483924|NCT00739973|7283089|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
4483925|NCT00739973|7283090|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
4483926|NCT00739973|7283091|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
4483927|NCT00739973|7283092|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
4483928|NCT00739973|7283093|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
4483929|NCT00739973|7283094|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
4483930|NCT00739973|7283086|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86
4483931|NCT00739973|7283087|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
4483932|NCT00739973|7283088|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
4483933|NCT00739973|7283089|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
4483934|NCT00739973|7283090|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
4483935|NCT00739973|7283091|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
4483936|NCT00739973|7283092|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
4483937|NCT00739973|7283093|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
4483938|NCT00739973|7283094|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
4483939|NCT00739973|7283086|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17
4483940|NCT00739973|7283087|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
4483941|NCT00739973|7283088|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
4483942|NCT00739973|7283089|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
4483943|NCT00739973|7283090|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
4483944|NCT00739973|7283091|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
4483945|NCT00739973|7283092|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
4483946|NCT00739973|7283093|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
4483947|NCT00739973|7283094|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
4483948|NCT00739973|7283086|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12
4483949|NCT00739973|7283087|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
4483950|NCT00739973|7283088|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
4483951|NCT00739973|7283089|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
4483952|NCT00739973|7283090|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
4483953|NCT00739973|7283091|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
4483954|NCT00739973|7283092|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
4483955|NCT00739973|7283093|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
4483956|NCT00739973|7283094|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
4483957|NCT00739973|7283086|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11
4483958|NCT00739973|7283087|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
4483959|NCT00739973|7283088|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
4483960|NCT00739973|7283089|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
4483961|NCT00739973|7283090|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
4483962|NCT00739973|7283091|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
4483963|NCT00739973|7283092|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
4483964|NCT00739973|7283093|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
4483965|NCT00739973|7283094|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
4483966|NCT00739973|7283086|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
4483967|NCT00739973|7283087|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
4483968|NCT00739973|7283088|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1
4483969|NCT00739973|7283089|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2
4483970|NCT00739973|7283090|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7
4483971|NCT00739973|7283091|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
4483972|NCT00739973|7283092|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4
4483973|NCT00739973|7283093|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1
4483974|NCT00739973|7283094|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4
4483975|NCT00739973|7283086|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
4483976|NCT00739973|7283087|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
4483977|NCT00739973|7283088|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
4483978|NCT00739973|7283089|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
4700896|NCT02701361|7617190|FG002|Overall Study|incarceration|1
4700897|NCT02701413|7617217|FG000|Overall Study|Withdrawal by Subject|7
4700898|NCT02701413|7617218|FG001|Overall Study|Withdrawal by Subject|11
4483979|NCT00739973|7283090|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1
4483980|NCT00739973|7283091|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
4483981|NCT00739973|7283092|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
4483982|NCT00739973|7283093|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1
4483983|NCT00739973|7283094|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
4483984|NCT00739973|7283086|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1
4483985|NCT00739973|7283087|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1
4483986|NCT00739973|7283088|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
4483987|NCT00739973|7283089|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
4483988|NCT00739973|7283090|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
4483989|NCT00739973|7283091|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
4483990|NCT00739973|7283092|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
4483991|NCT00739973|7283093|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
4483992|NCT00739973|7283094|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
4483993|NCT00739973|7283086|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17
4483994|NCT00739973|7283087|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8
4483995|NCT00739973|7283088|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8
4483996|NCT00739973|7283089|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4
4483997|NCT00739973|7283090|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
4483998|NCT00739973|7283091|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
4483999|NCT00739973|7283092|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1
4484000|NCT00739973|7283093|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1
4484001|NCT00739973|7283094|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
4484002|NCT00739973|7283086|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
4484003|NCT00739973|7283087|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
4484004|NCT00739973|7283088|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1
4484005|NCT00739973|7283089|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
4484006|NCT00739973|7283090|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
4484007|NCT00739973|7283091|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
4484008|NCT00739973|7283092|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
4484009|NCT00739973|7283093|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
4484010|NCT00739973|7283094|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
4484011|NCT00739973|7283086|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
4484012|NCT00739973|7283087|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2
4484013|NCT00739973|7283088|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
4484014|NCT00739973|7283089|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3
4484015|NCT00739973|7283090|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
4484016|NCT00739973|7283091|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
4484017|NCT00739973|7283092|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3
4484018|NCT00739973|7283093|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2
4484019|NCT00739973|7283094|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
4484020|NCT00739973|7283086|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0
4484021|NCT00739973|7283087|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
4484022|NCT00739973|7283088|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4
4484023|NCT00739973|7283089|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1
4484024|NCT00739973|7283090|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
4484025|NCT00739973|7283091|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
4484026|NCT00739973|7283092|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0
4484027|NCT00739973|7283093|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3
4484028|NCT00739973|7283094|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1
4484029|NCT00739973|7283086|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
4484030|NCT00739973|7283087|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
4484031|NCT00739973|7283088|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
4484032|NCT00739973|7283089|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
4484033|NCT00739973|7283090|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
4484034|NCT00739973|7283091|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
4484035|NCT00739973|7283092|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1
4484036|NCT00739973|7283093|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
4484037|NCT00739973|7283094|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
4700899|NCT02701634|7617237|FG000|Overall Study|Adverse Event|2
4700900|NCT02701634|7617238|FG001|Overall Study|Adverse Event|3
4700901|NCT02701634|7617237|FG000|Overall Study|Death|1
4484038|NCT00739973|7283086|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5
4484039|NCT00739973|7283087|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
4484040|NCT00739973|7283088|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1
4484041|NCT00739973|7283089|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
4484042|NCT00739973|7283090|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
4484043|NCT00739973|7283091|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1
4484044|NCT00739973|7283092|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
4484045|NCT00739973|7283093|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
4484046|NCT00739973|7283094|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
4484047|NCT00739973|7283086|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
4484048|NCT00739973|7283087|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1
4484049|NCT00739973|7283088|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
4484050|NCT00739973|7283089|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
4484051|NCT00739973|7283090|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
4484052|NCT00739973|7283091|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
4484053|NCT00739973|7283092|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2
4484054|NCT00739973|7283093|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
4484055|NCT00739973|7283094|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
4484056|NCT00740051|7283138|FG000|Overall Study|Lack of Efficacy|2
4484057|NCT00740051|7283139|FG001|Overall Study|Lack of Efficacy|5
4484058|NCT00740051|7283138|FG000|Overall Study|Adverse Event|1
4484059|NCT00740051|7283139|FG001|Overall Study|Adverse Event|4
4484060|NCT00740051|7283138|FG000|Overall Study|Protocol Violation|2
4484061|NCT00740051|7283139|FG001|Overall Study|Protocol Violation|6
4484062|NCT00740051|7283138|FG000|Overall Study|Lost to Follow-up|3
4484063|NCT00740051|7283139|FG001|Overall Study|Lost to Follow-up|8
4484064|NCT00740051|7283138|FG000|Overall Study|Withdrawal by Subject|6
4484065|NCT00740051|7283139|FG001|Overall Study|Withdrawal by Subject|8
4484066|NCT00740051|7283138|FG000|Overall Study|Other reason (not specified)|4
4484067|NCT00740051|7283139|FG001|Overall Study|Other reason (not specified)|1
4484068|NCT00740220|7283164|FG000|Overall Study|screen failures (non-COPD patients)|9
4517035|NCT00963820|7328684|FG003|Dose Escalation Phase|Progressive Disease|3
4517036|NCT00963820|7328685|FG004|Dose Escalation Phase|Progressive Disease|4
4517037|NCT00963820|7328686|FG005|Dose Escalation Phase|Progressive Disease|3
4517038|NCT00963820|7328687|FG006|Dose Escalation Phase|Progressive Disease|3
4517039|NCT00963820|7328688|FG007|Dose Escalation Phase|Progressive Disease|2
4517040|NCT00963820|7328689|FG008|Dose Escalation Phase|Progressive Disease|0
4517041|NCT00963820|7328690|FG009|Dose Escalation Phase|Progressive Disease|0
4517042|NCT00963820|7328691|FG010|Dose Escalation Phase|Progressive Disease|0
4517043|NCT00963820|7328692|FG011|Dose Escalation Phase|Progressive Disease|0
4517044|NCT00963820|7328681|FG000|Dose Escalation Phase|Adverse Event|0
4517045|NCT00963820|7328682|FG001|Dose Escalation Phase|Adverse Event|0
4517046|NCT00963820|7328683|FG002|Dose Escalation Phase|Adverse Event|0
4517047|NCT00963820|7328684|FG003|Dose Escalation Phase|Adverse Event|0
4517048|NCT00963820|7328685|FG004|Dose Escalation Phase|Adverse Event|0
4517049|NCT00963820|7328686|FG005|Dose Escalation Phase|Adverse Event|0
4517050|NCT00963820|7328687|FG006|Dose Escalation Phase|Adverse Event|3
4517051|NCT00963820|7328688|FG007|Dose Escalation Phase|Adverse Event|1
4517052|NCT00963820|7328689|FG008|Dose Escalation Phase|Adverse Event|0
4517053|NCT00963820|7328690|FG009|Dose Escalation Phase|Adverse Event|0
4517054|NCT00963820|7328691|FG010|Dose Escalation Phase|Adverse Event|0
4517055|NCT00963820|7328692|FG011|Dose Escalation Phase|Adverse Event|0
4517056|NCT00963820|7328681|FG000|Dose Escalation Phase|Withdrawal by Subject|0
4517057|NCT00963820|7328682|FG001|Dose Escalation Phase|Withdrawal by Subject|0
4517058|NCT00963820|7328683|FG002|Dose Escalation Phase|Withdrawal by Subject|0
4517059|NCT00963820|7328684|FG003|Dose Escalation Phase|Withdrawal by Subject|0
4517060|NCT00963820|7328685|FG004|Dose Escalation Phase|Withdrawal by Subject|0
4517061|NCT00963820|7328686|FG005|Dose Escalation Phase|Withdrawal by Subject|0
4517062|NCT00963820|7328687|FG006|Dose Escalation Phase|Withdrawal by Subject|1
4517063|NCT00963820|7328688|FG007|Dose Escalation Phase|Withdrawal by Subject|2
4517064|NCT00963820|7328689|FG008|Dose Escalation Phase|Withdrawal by Subject|0
4517065|NCT00963820|7328690|FG009|Dose Escalation Phase|Withdrawal by Subject|0
4517066|NCT00963820|7328691|FG010|Dose Escalation Phase|Withdrawal by Subject|0
4517067|NCT00963820|7328692|FG011|Dose Escalation Phase|Withdrawal by Subject|0
4517068|NCT00963820|7328681|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
4517069|NCT00963820|7328682|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
4517070|NCT00963820|7328683|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
4517071|NCT00963820|7328684|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
4517072|NCT00963820|7328685|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
4517073|NCT00963820|7328686|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
4517074|NCT00963820|7328687|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1
4517075|NCT00963820|7328688|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
4517076|NCT00963820|7328689|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
4484069|NCT00740584|7283177|FG000|Overall Study|Withdrawal by Subject|1
4484070|NCT00740636|7283184|FG000|Overall Study|Adverse Event|0
4484071|NCT00740636|7283185|FG001|Overall Study|Adverse Event|2
4484072|NCT00740636|7283184|FG000|Overall Study|Patient Ineligible|0
4484073|NCT00740636|7283185|FG001|Overall Study|Patient Ineligible|1
4484074|NCT00740636|7283184|FG000|Overall Study|Patient Not Treated|0
4484075|NCT00740636|7283185|FG001|Overall Study|Patient Not Treated|1
4484076|NCT00740636|7283184|FG000|Overall Study|Progressive Disease|1
4484077|NCT00740636|7283185|FG001|Overall Study|Progressive Disease|0
4484078|NCT00740636|7283184|FG000|Overall Study|Death|1
4484079|NCT00740636|7283185|FG001|Overall Study|Death|0
4484080|NCT00740714|7283194|FG000|Overall Study|Withdrawal by Subject|17
4484081|NCT00740714|7283195|FG001|Overall Study|Withdrawal by Subject|19
4484082|NCT00740714|7283196|FG002|Overall Study|Withdrawal by Subject|29
4484083|NCT00740779|7283207|FG000|Overall Study|Adverse Event|4
4484084|NCT00740779|7283208|FG001|Overall Study|Adverse Event|6
4484085|NCT00740779|7283209|FG002|Overall Study|Adverse Event|3
4484086|NCT00740779|7283207|FG000|Overall Study|Protocol Violation|1
4484087|NCT00740779|7283208|FG001|Overall Study|Protocol Violation|1
4484088|NCT00740779|7283209|FG002|Overall Study|Protocol Violation|1
4484089|NCT00740779|7283207|FG000|Overall Study|Lack of Efficacy|0
4484090|NCT00740779|7283208|FG001|Overall Study|Lack of Efficacy|0
4484091|NCT00740779|7283209|FG002|Overall Study|Lack of Efficacy|2
4484092|NCT00740779|7283207|FG000|Overall Study|Withdrawal by Subject|2
4484093|NCT00740779|7283208|FG001|Overall Study|Withdrawal by Subject|4
4484094|NCT00740779|7283209|FG002|Overall Study|Withdrawal by Subject|2
4484095|NCT00740779|7283207|FG000|Overall Study|Lost to Follow-up|2
4484096|NCT00740779|7283208|FG001|Overall Study|Lost to Follow-up|3
4484097|NCT00740779|7283209|FG002|Overall Study|Lost to Follow-up|5
4484098|NCT00740792|7283221|FG000|Overall Study|Adverse Event|3
4484099|NCT00740792|7283222|FG001|Overall Study|Adverse Event|1
4484100|NCT00740792|7283223|FG002|Overall Study|Adverse Event|1
4484101|NCT00740792|7283224|FG003|Overall Study|Adverse Event|3
4484102|NCT00740792|7283221|FG000|Overall Study|Lack of Efficacy|1
4484103|NCT00740792|7283222|FG001|Overall Study|Lack of Efficacy|1
4484104|NCT00740792|7283223|FG002|Overall Study|Lack of Efficacy|0
4484105|NCT00740792|7283224|FG003|Overall Study|Lack of Efficacy|3
4484106|NCT00740792|7283221|FG000|Overall Study|Lost to Follow-up|2
4484107|NCT00740792|7283222|FG001|Overall Study|Lost to Follow-up|1
4484108|NCT00740792|7283223|FG002|Overall Study|Lost to Follow-up|0
4484109|NCT00740792|7283224|FG003|Overall Study|Lost to Follow-up|0
4484110|NCT00740792|7283221|FG000|Overall Study|Protocol Violation|0
4484111|NCT00740792|7283222|FG001|Overall Study|Protocol Violation|1
4484112|NCT00740792|7283223|FG002|Overall Study|Protocol Violation|0
4484113|NCT00740792|7283224|FG003|Overall Study|Protocol Violation|2
4484114|NCT00740792|7283221|FG000|Overall Study|Withdrawal by Subject|1
4484115|NCT00740792|7283222|FG001|Overall Study|Withdrawal by Subject|1
4484116|NCT00740792|7283223|FG002|Overall Study|Withdrawal by Subject|0
4484117|NCT00740792|7283224|FG003|Overall Study|Withdrawal by Subject|0
4484118|NCT00740792|7283221|FG000|Overall Study|administrative|3
4484119|NCT00740792|7283222|FG001|Overall Study|administrative|3
4484120|NCT00740792|7283223|FG002|Overall Study|administrative|8
4484121|NCT00740792|7283224|FG003|Overall Study|administrative|2
4484122|NCT00740857|7283250|FG000|Overall Study|Withdrawal by Subject|1
4484123|NCT00740857|7283251|FG001|Overall Study|Withdrawal by Subject|0
4484124|NCT00740857|7283252|FG002|Overall Study|Withdrawal by Subject|0
4484125|NCT00740870|7283260|FG000|Overall Study|Not Catheterized|4
4484126|NCT00740870|7283260|FG000|Overall Study|Further testing contraindicated implant|17
4484127|NCT00741013|7283270|FG000|Overall Study|Adverse Event|1
4484128|NCT00741013|7283271|FG001|Overall Study|Adverse Event|0
4484129|NCT00741013|7283272|FG002|Overall Study|Adverse Event|0
4484130|NCT00741013|7283270|FG000|Overall Study|Withdrawal by Subject|0
4484131|NCT00741013|7283271|FG001|Overall Study|Withdrawal by Subject|0
4484132|NCT00741013|7283272|FG002|Overall Study|Withdrawal by Subject|1
4484133|NCT00741013|7283270|FG000|Overall Study|Discovered failed screen after enrolled|0
4484134|NCT00741013|7283271|FG001|Overall Study|Discovered failed screen after enrolled|2
4484135|NCT00741013|7283272|FG002|Overall Study|Discovered failed screen after enrolled|0
4484136|NCT00741039|7283288|FG000|Overall Study|Patient non-compliance|2
4484137|NCT00741039|7283289|FG001|Overall Study|Patient non-compliance|0
4484138|NCT00741091|7283295|FG000|Overall Study|Death|13
4484139|NCT00741091|7283295|FG000|Overall Study|Lost to Follow-up|16
4484140|NCT00741091|7283295|FG000|Overall Study|Withdrawal by Subject|6
4484141|NCT00741091|7283295|FG000|Overall Study|Missed Visit|22
4484142|NCT00741260|7283325|FG000|Overall Study|Disease Progression|3
4484143|NCT00741260|7283326|FG001|Overall Study|Disease Progression|5
4484144|NCT00741260|7283327|FG002|Overall Study|Disease Progression|3
4484145|NCT00741260|7283328|FG003|Overall Study|Disease Progression|3
4484146|NCT00741260|7283329|FG004|Overall Study|Disease Progression|5
4484147|NCT00741260|7283330|FG005|Overall Study|Disease Progression|37
4484148|NCT00741260|7283331|FG006|Overall Study|Disease Progression|4
4484149|NCT00741260|7283325|FG000|Overall Study|Death|0
4484150|NCT00741260|7283326|FG001|Overall Study|Death|1
4484151|NCT00741260|7283327|FG002|Overall Study|Death|0
4484152|NCT00741260|7283328|FG003|Overall Study|Death|1
4484153|NCT00741260|7283329|FG004|Overall Study|Death|2
4484154|NCT00741260|7283330|FG005|Overall Study|Death|2
4484155|NCT00741260|7283331|FG006|Overall Study|Death|1
4484156|NCT00741260|7283325|FG000|Overall Study|Withdrawal by Subject|0
4484157|NCT00741260|7283326|FG001|Overall Study|Withdrawal by Subject|0
4484158|NCT00741260|7283327|FG002|Overall Study|Withdrawal by Subject|0
4484159|NCT00741260|7283328|FG003|Overall Study|Withdrawal by Subject|0
4484160|NCT00741260|7283329|FG004|Overall Study|Withdrawal by Subject|1
4484161|NCT00741260|7283330|FG005|Overall Study|Withdrawal by Subject|3
4484162|NCT00741260|7283331|FG006|Overall Study|Withdrawal by Subject|1
4484163|NCT00741260|7283325|FG000|Overall Study|Physician Decision|1
4484164|NCT00741260|7283326|FG001|Overall Study|Physician Decision|1
4484165|NCT00741260|7283327|FG002|Overall Study|Physician Decision|0
4484166|NCT00741260|7283328|FG003|Overall Study|Physician Decision|0
4484167|NCT00741260|7283329|FG004|Overall Study|Physician Decision|0
4484168|NCT00741260|7283330|FG005|Overall Study|Physician Decision|0
4484169|NCT00741260|7283331|FG006|Overall Study|Physician Decision|0
4484170|NCT00741260|7283325|FG000|Overall Study|Other|2
4484171|NCT00741260|7283326|FG001|Overall Study|Other|1
4484172|NCT00741260|7283327|FG002|Overall Study|Other|1
4484173|NCT00741260|7283328|FG003|Overall Study|Other|2
4484174|NCT00741260|7283329|FG004|Overall Study|Other|1
4484175|NCT00741260|7283330|FG005|Overall Study|Other|3
4484176|NCT00741260|7283331|FG006|Overall Study|Other|1
4484177|NCT00741286|7283367|FG000|Overall Study|Lost to Follow-up|15
4484178|NCT00741286|7283368|FG001|Overall Study|Lost to Follow-up|10
4484179|NCT00741286|7283367|FG000|Overall Study|Adverse Event|1
4484180|NCT00741286|7283368|FG001|Overall Study|Adverse Event|6
4484181|NCT00741286|7283367|FG000|Overall Study|Protocol Violation|3
4484182|NCT00741286|7283368|FG001|Overall Study|Protocol Violation|2
4484183|NCT00741286|7283367|FG000|Overall Study|Primary Outcome|1
4484184|NCT00741286|7283368|FG001|Overall Study|Primary Outcome|1
4484185|NCT00741338|7283376|FG000|Overall Study|Adverse Event|0
4484186|NCT00741338|7283377|FG001|Overall Study|Adverse Event|1
4484187|NCT00741598|7283419|FG000|Overall Study|Lost to Follow-up|3
4484188|NCT00741598|7283420|FG001|Overall Study|Lost to Follow-up|4
4484189|NCT00741598|7283419|FG000|Overall Study|Lack of Efficacy|1
4484190|NCT00741598|7283420|FG001|Overall Study|Lack of Efficacy|2
4484191|NCT00741598|7283419|FG000|Overall Study|Physician Decision|1
4484192|NCT00741598|7283420|FG001|Overall Study|Physician Decision|1
4484193|NCT00741598|7283419|FG000|Overall Study|Pregnancy|1
4484194|NCT00741598|7283420|FG001|Overall Study|Pregnancy|0
4484195|NCT00741598|7283419|FG000|Overall Study|Withdrawal by Subject|3
4484196|NCT00741598|7283420|FG001|Overall Study|Withdrawal by Subject|2
4484197|NCT00741611|7283430|FG000|Overall Study|Death|0
4484198|NCT00741611|7283431|FG001|Overall Study|Death|0
4589782|NCT01514461|7435217|FG002|Overall Study|Patient/guardian decision|1
4589783|NCT01514461|7435215|FG000|Overall Study|Death|1
4589784|NCT01514461|7435216|FG001|Overall Study|Death|0
4589785|NCT01514461|7435217|FG002|Overall Study|Death|0
4589786|NCT01514760|7435245|FG000|Overall Study|Lost to Follow-up|2
4589787|NCT01514864|7435260|FG000|Overall Study|Disease progression|7
4700902|NCT02701634|7617238|FG001|Overall Study|Death|0
4700903|NCT02701634|7617237|FG000|Overall Study|Investigator's Discretion|7
4700904|NCT02701634|7617238|FG001|Overall Study|Investigator's Discretion|4
4700905|NCT02701634|7617237|FG000|Overall Study|Study terminated by Sponsor|15
4700906|NCT02701634|7617238|FG001|Overall Study|Study terminated by Sponsor|17
4700907|NCT02701634|7617237|FG000|Overall Study|Withdrew Consent|6
4700908|NCT02701634|7617238|FG001|Overall Study|Withdrew Consent|7
4700909|NCT02701634|7617237|FG000|Overall Study|Randomized but not treated|1
4589788|NCT01514864|7435261|FG001|Overall Study|Disease progression|5
4589789|NCT01514864|7435260|FG000|Overall Study|Study drug toxicity|2
4589790|NCT01514864|7435261|FG001|Overall Study|Study drug toxicity|0
4589791|NCT01515189|7435308|FG000|Induction|Disease Progression|109
4589792|NCT01515189|7435309|FG001|Induction|Disease Progression|155
4589793|NCT01515189|7435308|FG000|Induction|Study drug toxicity|86
4589794|NCT01515189|7435309|FG001|Induction|Study drug toxicity|36
4589795|NCT01515189|7435308|FG000|Induction|Death|24
4589796|NCT01515189|7435309|FG001|Induction|Death|17
4589797|NCT01515189|7435308|FG000|Induction|Adverse Event|14
4589798|NCT01515189|7435309|FG001|Induction|Adverse Event|9
4589799|NCT01515189|7435308|FG000|Induction|Withdrawal by Subject|3
4589800|NCT01515189|7435309|FG001|Induction|Withdrawal by Subject|9
4589801|NCT01515189|7435308|FG000|Induction|No longer meets study criteria|0
4700910|NCT02701634|7617238|FG001|Overall Study|Randomized but not treated|0
4700911|NCT02701764|7617266|FG000|Overall Study|Lost to Follow-up|0
4700912|NCT02701764|7617267|FG001|Overall Study|Lost to Follow-up|1
4700913|NCT02701985|7617289|FG000|Overall Study|Withdrawal by Subject|1
4700914|NCT02701985|7617290|FG001|Overall Study|Withdrawal by Subject|1
4700915|NCT02701985|7617289|FG000|Overall Study|Lost to Follow-up|1
4484199|NCT00741611|7283432|FG002|Overall Study|Death|1
4484200|NCT00741611|7283430|FG000|Overall Study|Withdrawal by Subject|0
4484201|NCT00741611|7283431|FG001|Overall Study|Withdrawal by Subject|2
4484202|NCT00741611|7283432|FG002|Overall Study|Withdrawal by Subject|2
4484203|NCT00741819|7283441|FG000|Overall Study|Adverse Event|3
4484204|NCT00741819|7283441|FG000|Overall Study|Withdrawal by Subject|3
4484205|NCT00741819|7283441|FG000|Overall Study|Death|1
4484206|NCT00741819|7283441|FG000|Overall Study|Disease progression|1
4484207|NCT00741936|7283458|FG000|Overall Study|Lost to Follow-up|1
4589802|NCT01515189|7435309|FG001|Induction|No longer meets study criteria|2
4589803|NCT01515189|7435308|FG000|Induction|Lost to Follow-up|1
4589804|NCT01515189|7435309|FG001|Induction|Lost to Follow-up|0
4589805|NCT01515189|7435308|FG000|Induction|Other|0
4589806|NCT01515189|7435309|FG001|Induction|Other|4
4589807|NCT01515189|7435308|FG000|First Re-Induction Phase|Disease progression|6
4589808|NCT01515189|7435309|FG001|First Re-Induction Phase|Disease progression|14
4589809|NCT01515189|7435308|FG000|First Re-Induction Phase|Study drug toxicity|5
4589810|NCT01515189|7435309|FG001|First Re-Induction Phase|Study drug toxicity|0
4589811|NCT01515189|7435308|FG000|First Re-Induction Phase|Withdrawal by Subject|1
4589812|NCT01515189|7435309|FG001|First Re-Induction Phase|Withdrawal by Subject|1
4589813|NCT01515189|7435308|FG000|First Re-Induction Phase|No longer meets study criteria|1
4589814|NCT01515189|7435309|FG001|First Re-Induction Phase|No longer meets study criteria|0
4589815|NCT01515189|7435308|FG000|First Re-Induction Phase|Other|1
4589816|NCT01515189|7435309|FG001|First Re-Induction Phase|Other|0
4589817|NCT01515319|7435325|FG000|Overall Study|Withdrawal by Subject|0
4589818|NCT01515319|7435326|FG001|Overall Study|Withdrawal by Subject|0
4589819|NCT01515319|7435327|FG002|Overall Study|Withdrawal by Subject|0
4589820|NCT01515319|7435328|FG003|Overall Study|Withdrawal by Subject|0
4589821|NCT01515319|7435329|FG004|Overall Study|Withdrawal by Subject|0
4589822|NCT01515319|7435330|FG005|Overall Study|Withdrawal by Subject|0
4589823|NCT01515319|7435331|FG006|Overall Study|Withdrawal by Subject|1
4589824|NCT01515319|7435332|FG007|Overall Study|Withdrawal by Subject|0
4589825|NCT01515319|7435333|FG008|Overall Study|Withdrawal by Subject|0
4589826|NCT01515319|7435334|FG009|Overall Study|Withdrawal by Subject|0
4589827|NCT01515319|7435325|FG000|Overall Study|Adverse Event|0
4589828|NCT01515319|7435326|FG001|Overall Study|Adverse Event|0
4589829|NCT01515319|7435327|FG002|Overall Study|Adverse Event|0
4589830|NCT01515319|7435328|FG003|Overall Study|Adverse Event|0
4589831|NCT01515319|7435329|FG004|Overall Study|Adverse Event|0
4589832|NCT01515319|7435330|FG005|Overall Study|Adverse Event|0
4589833|NCT01515319|7435331|FG006|Overall Study|Adverse Event|0
4589834|NCT01515319|7435332|FG007|Overall Study|Adverse Event|0
4589835|NCT01515319|7435333|FG008|Overall Study|Adverse Event|3
4589836|NCT01515319|7435334|FG009|Overall Study|Adverse Event|0
4589837|NCT01515319|7435325|FG000|Overall Study|Protocol Violation|0
4589838|NCT01515319|7435326|FG001|Overall Study|Protocol Violation|0
4589839|NCT01515319|7435327|FG002|Overall Study|Protocol Violation|0
4589840|NCT01515319|7435328|FG003|Overall Study|Protocol Violation|0
4589841|NCT01515319|7435329|FG004|Overall Study|Protocol Violation|0
4589842|NCT01515319|7435330|FG005|Overall Study|Protocol Violation|0
4589843|NCT01515319|7435331|FG006|Overall Study|Protocol Violation|0
4589844|NCT01515319|7435332|FG007|Overall Study|Protocol Violation|0
4589845|NCT01515319|7435333|FG008|Overall Study|Protocol Violation|2
4589846|NCT01515319|7435334|FG009|Overall Study|Protocol Violation|0
4589847|NCT01515423|7435374|FG000|Open Label Phase|Adverse Event|57
4589848|NCT01515423|7435375|FG001|Open Label Phase|Adverse Event|0
4589849|NCT01515423|7435376|FG002|Open Label Phase|Adverse Event|0
4589850|NCT01515423|7435374|FG000|Open Label Phase|Death|2
4589851|NCT01515423|7435375|FG001|Open Label Phase|Death|0
4589852|NCT01515423|7435376|FG002|Open Label Phase|Death|0
4589853|NCT01515423|7435374|FG000|Open Label Phase|Lack of Efficacy|117
4589854|NCT01515423|7435375|FG001|Open Label Phase|Lack of Efficacy|0
4589855|NCT01515423|7435376|FG002|Open Label Phase|Lack of Efficacy|0
4589856|NCT01515423|7435374|FG000|Open Label Phase|Lost to Follow-up|21
4589857|NCT01515423|7435375|FG001|Open Label Phase|Lost to Follow-up|0
4589858|NCT01515423|7435376|FG002|Open Label Phase|Lost to Follow-up|0
4589859|NCT01515423|7435374|FG000|Open Label Phase|Withdrawal by Subject|118
4589860|NCT01515423|7435375|FG001|Open Label Phase|Withdrawal by Subject|0
4589861|NCT01515423|7435376|FG002|Open Label Phase|Withdrawal by Subject|0
4589862|NCT01515423|7435374|FG000|Open Label Phase|excluded from DB Phase|70
4589863|NCT01515423|7435375|FG001|Open Label Phase|excluded from DB Phase|0
4589864|NCT01515423|7435376|FG002|Open Label Phase|excluded from DB Phase|0
4589865|NCT01515423|7435374|FG000|Open Label Phase|Other|28
4589866|NCT01515423|7435375|FG001|Open Label Phase|Other|0
4589867|NCT01515423|7435376|FG002|Open Label Phase|Other|0
4589868|NCT01515423|7435374|FG000|DOUBLE BLIND|Adverse Event|0
4589869|NCT01515423|7435375|FG001|DOUBLE BLIND|Adverse Event|15
4589870|NCT01515423|7435376|FG002|DOUBLE BLIND|Adverse Event|13
4589871|NCT01515423|7435374|FG000|DOUBLE BLIND|Death|0
4589872|NCT01515423|7435375|FG001|DOUBLE BLIND|Death|1
4589873|NCT01515423|7435376|FG002|DOUBLE BLIND|Death|2
4589874|NCT01515423|7435374|FG000|DOUBLE BLIND|Lost to Follow-up|0
4589875|NCT01515423|7435375|FG001|DOUBLE BLIND|Lost to Follow-up|7
4589876|NCT01515423|7435376|FG002|DOUBLE BLIND|Lost to Follow-up|12
4589877|NCT01515423|7435374|FG000|DOUBLE BLIND|Pregnancy|0
4589878|NCT01515423|7435375|FG001|DOUBLE BLIND|Pregnancy|2
4589879|NCT01515423|7435376|FG002|DOUBLE BLIND|Pregnancy|0
4589880|NCT01515423|7435374|FG000|DOUBLE BLIND|Withdrawal by Subject|0
4589881|NCT01515423|7435375|FG001|DOUBLE BLIND|Withdrawal by Subject|50
4589882|NCT01515423|7435376|FG002|DOUBLE BLIND|Withdrawal by Subject|53
4589883|NCT01515423|7435374|FG000|DOUBLE BLIND|Other|0
4589884|NCT01515423|7435375|FG001|DOUBLE BLIND|Other|6
4589885|NCT01515423|7435376|FG002|DOUBLE BLIND|Other|12
4589886|NCT01515423|7435374|FG000|DOUBLE BLIND|Blind broken by investigator|0
4589887|NCT01515423|7435375|FG001|DOUBLE BLIND|Blind broken by investigator|1
4589888|NCT01515423|7435376|FG002|DOUBLE BLIND|Blind broken by investigator|0
4589889|NCT01515475|7435387|FG000|Overall Study|Lost to Follow-up|20
4589890|NCT01515475|7435388|FG001|Overall Study|Lost to Follow-up|15
4589891|NCT01515475|7435389|FG002|Overall Study|Lost to Follow-up|12
4589892|NCT01515475|7435390|FG003|Overall Study|Lost to Follow-up|12
4593676|NCT01554241|7442217|FG002|Overall Study|protocol specified change in eGFR|1
4593677|NCT01554241|7442218|FG003|Overall Study|protocol specified change in eGFR|0
4593678|NCT01554241|7442215|FG000|Overall Study|Withdrawal by Subject|0
4593679|NCT01554241|7442216|FG001|Overall Study|Withdrawal by Subject|0
4593680|NCT01554241|7442217|FG002|Overall Study|Withdrawal by Subject|2
4593681|NCT01554241|7442218|FG003|Overall Study|Withdrawal by Subject|0
4593682|NCT01554514|7442253|FG000|Overall Study|1 patient ineligible with congenital TTP|1
4593683|NCT01554514|7442253|FG000|Overall Study|Physician Decision|1
4593684|NCT01554527|7442260|FG000|Overall Study|Withdrawal by Subject|1
4593685|NCT01554527|7442261|FG001|Overall Study|Withdrawal by Subject|0
4593686|NCT01554527|7442262|FG002|Overall Study|Withdrawal by Subject|3
4593687|NCT01554527|7442260|FG000|Overall Study|Lost to Follow-up|0
4593688|NCT01554527|7442261|FG001|Overall Study|Lost to Follow-up|0
4593689|NCT01554527|7442262|FG002|Overall Study|Lost to Follow-up|4
4593690|NCT01554527|7442260|FG000|Overall Study|Physician Decision|0
4593691|NCT01554527|7442261|FG001|Overall Study|Physician Decision|0
4593692|NCT01554527|7442262|FG002|Overall Study|Physician Decision|1
4593797|NCT01555125|7442335|FG004|Extension|Technical Problems|0
4593798|NCT01555125|7442331|FG000|Follow-Up Period|Lost to Follow-up|1
4593799|NCT01555125|7442332|FG001|Follow-Up Period|Lost to Follow-up|0
4593800|NCT01555125|7442333|FG002|Follow-Up Period|Lost to Follow-up|0
4593801|NCT01555125|7442334|FG003|Follow-Up Period|Lost to Follow-up|0
4593802|NCT01555125|7442335|FG004|Follow-Up Period|Lost to Follow-up|0
4593803|NCT01555125|7442331|FG000|Follow-Up Period|Subject / guardian decision|3
4593804|NCT01555125|7442332|FG001|Follow-Up Period|Subject / guardian decision|1
4593805|NCT01555125|7442333|FG002|Follow-Up Period|Subject / guardian decision|1
4593806|NCT01555125|7442334|FG003|Follow-Up Period|Subject / guardian decision|1
4593807|NCT01555125|7442335|FG004|Follow-Up Period|Subject / guardian decision|0
4593808|NCT01555138|7442352|FG000|Overall Study|Death|0
4593809|NCT01555138|7442353|FG001|Overall Study|Death|1
4593810|NCT01555138|7442352|FG000|Overall Study|Lost to Follow-up|1
4593811|NCT01555138|7442353|FG001|Overall Study|Lost to Follow-up|0
4593812|NCT01555138|7442352|FG000|Overall Study|Abnormal Lab reults|1
4593813|NCT01555138|7442353|FG001|Overall Study|Abnormal Lab reults|3
4593814|NCT01555138|7442352|FG000|Overall Study|Lack of Efficacy|2
4593815|NCT01555138|7442353|FG001|Overall Study|Lack of Efficacy|2
4593816|NCT01555138|7442352|FG000|Overall Study|Protocol Violation|5
4593817|NCT01555138|7442353|FG001|Overall Study|Protocol Violation|3
4593818|NCT01555138|7442352|FG000|Overall Study|Administrative problems|8
4593819|NCT01555138|7442353|FG001|Overall Study|Administrative problems|0
4593820|NCT01555138|7442352|FG000|Overall Study|Withdrawal by Subject|16
4593821|NCT01555138|7442353|FG001|Overall Study|Withdrawal by Subject|15
4593822|NCT01555138|7442352|FG000|Overall Study|Adverse Event|14
4593823|NCT01555138|7442353|FG001|Overall Study|Adverse Event|14
4593824|NCT01555151|7442363|FG000|Overall Study|Withdrawal by Subject|6
4593825|NCT01555151|7442364|FG001|Overall Study|Withdrawal by Subject|2
4593826|NCT01555151|7442365|FG002|Overall Study|Withdrawal by Subject|0
4593827|NCT01555151|7442366|FG003|Overall Study|Withdrawal by Subject|2
4593828|NCT01555151|7442363|FG000|Overall Study|Administrative|3
4593829|NCT01555151|7442364|FG001|Overall Study|Administrative|1
4593830|NCT01555151|7442365|FG002|Overall Study|Administrative|2
4593831|NCT01555151|7442366|FG003|Overall Study|Administrative|0
4593832|NCT01555151|7442363|FG000|Overall Study|Protocol Violation|3
4593833|NCT01555151|7442364|FG001|Overall Study|Protocol Violation|3
4700916|NCT02701985|7617290|FG001|Overall Study|Lost to Follow-up|0
4484208|NCT00741936|7283459|FG001|Overall Study|Lost to Follow-up|1
4484209|NCT00741936|7283458|FG000|Overall Study|Adverse Event|3
4484210|NCT00741936|7283459|FG001|Overall Study|Adverse Event|4
4484211|NCT00741936|7283458|FG000|Overall Study|Pregnancy|0
4484212|NCT00741936|7283459|FG001|Overall Study|Pregnancy|1
4484213|NCT00741936|7283458|FG000|Overall Study|Protocol Violation|2
4484214|NCT00741936|7283459|FG001|Overall Study|Protocol Violation|0
4484215|NCT00741936|7283458|FG000|Overall Study|Lack of Efficacy|0
4484216|NCT00741936|7283459|FG001|Overall Study|Lack of Efficacy|2
4484217|NCT00741936|7283458|FG000|Overall Study|Low compliance|3
4484218|NCT00741936|7283459|FG001|Overall Study|Low compliance|0
4593834|NCT01555151|7442365|FG002|Overall Study|Protocol Violation|3
4593835|NCT01555151|7442366|FG003|Overall Study|Protocol Violation|5
4593836|NCT01555151|7442363|FG000|Overall Study|Adverse Event|1
4593837|NCT01555151|7442364|FG001|Overall Study|Adverse Event|2
4593838|NCT01555151|7442365|FG002|Overall Study|Adverse Event|1
4593839|NCT01555151|7442366|FG003|Overall Study|Adverse Event|2
4593840|NCT01555151|7442363|FG000|Overall Study|Lost to Follow-up|0
4593841|NCT01555151|7442364|FG001|Overall Study|Lost to Follow-up|0
4593842|NCT01555151|7442365|FG002|Overall Study|Lost to Follow-up|0
4593843|NCT01555151|7442366|FG003|Overall Study|Lost to Follow-up|1
4484219|NCT00742001|7283468|FG000|Overall Study|Withdrawn; health exclusion (flu)|0
4484220|NCT00742001|7283469|FG001|Overall Study|Withdrawn; health exclusion (flu)|0
4593844|NCT01555164|7442379|FG000|Overall Study|Adverse Event|5
4593845|NCT01555164|7442380|FG001|Overall Study|Adverse Event|7
4593846|NCT01555164|7442379|FG000|Overall Study|Hyperglycemia|0
4484221|NCT00742001|7283470|FG002|Overall Study|Withdrawn; health exclusion (flu)|1
4484222|NCT00742027|7283481|FG000|Overall Study|Disease Progression|76
4484223|NCT00742027|7283481|FG000|Overall Study|New Cancer Therapy|19
4484224|NCT00742027|7283481|FG000|Overall Study|Withdrawal by Subject|18
4484225|NCT00742027|7283481|FG000|Overall Study|Death|7
4484226|NCT00742027|7283481|FG000|Overall Study|Lost to Follow-up|4
4484227|NCT00742027|7283481|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2
4484228|NCT00742027|7283481|FG000|Overall Study|Missing|2
4484229|NCT00742027|7283481|FG000|Overall Study|Administrative Problems|1
4484230|NCT00742079|7283491|FG000|Overall Study|Lost to Follow-up|0
4484231|NCT00742079|7283492|FG001|Overall Study|Lost to Follow-up|1
4484232|NCT00742183|7283509|FG000|Overall Study|Adverse Event|2
4484233|NCT00742183|7283510|FG001|Overall Study|Adverse Event|2
4484234|NCT00742183|7283509|FG000|Overall Study|Death|1
4484235|NCT00742183|7283510|FG001|Overall Study|Death|0
4484236|NCT00742183|7283509|FG000|Overall Study|Physician Decision|0
4484237|NCT00742183|7283510|FG001|Overall Study|Physician Decision|2
4484238|NCT00742183|7283509|FG000|Overall Study|Lost to Follow-up|4
4484239|NCT00742183|7283510|FG001|Overall Study|Lost to Follow-up|4
4484240|NCT00742183|7283509|FG000|Overall Study|Required skin-graft|1
4484241|NCT00742183|7283510|FG001|Overall Study|Required skin-graft|1
4484242|NCT00742183|7283509|FG000|Overall Study|Withdrawal by Subject|1
4484243|NCT00742183|7283510|FG001|Overall Study|Withdrawal by Subject|0
4484244|NCT00742183|7283509|FG000|Overall Study|Lack of Efficacy|0
4484245|NCT00742183|7283510|FG001|Overall Study|Lack of Efficacy|3
4484246|NCT00742209|7283521|FG000|Overall Study|Adverse Event|11
4484247|NCT00742209|7283522|FG001|Overall Study|Adverse Event|4
4484248|NCT00742209|7283523|FG002|Overall Study|Adverse Event|17
4484249|NCT00742209|7283524|FG003|Overall Study|Adverse Event|16
4484250|NCT00742209|7283525|FG004|Overall Study|Adverse Event|13
4484251|NCT00742209|7283521|FG000|Overall Study|Participant Withdrew Consent|8
4484252|NCT00742209|7283522|FG001|Overall Study|Participant Withdrew Consent|4
4484253|NCT00742209|7283523|FG002|Overall Study|Participant Withdrew Consent|14
4484254|NCT00742209|7283524|FG003|Overall Study|Participant Withdrew Consent|7
4484255|NCT00742209|7283525|FG004|Overall Study|Participant Withdrew Consent|4
4484256|NCT00742209|7283521|FG000|Overall Study|Protocol Violation|6
4484257|NCT00742209|7283522|FG001|Overall Study|Protocol Violation|5
4484258|NCT00742209|7283523|FG002|Overall Study|Protocol Violation|4
4484259|NCT00742209|7283524|FG003|Overall Study|Protocol Violation|5
4484260|NCT00742209|7283525|FG004|Overall Study|Protocol Violation|3
4484261|NCT00742209|7283521|FG000|Overall Study|Lost to Follow-up|3
4484262|NCT00742209|7283522|FG001|Overall Study|Lost to Follow-up|4
4484263|NCT00742209|7283523|FG002|Overall Study|Lost to Follow-up|5
4484264|NCT00742209|7283524|FG003|Overall Study|Lost to Follow-up|5
4484265|NCT00742209|7283525|FG004|Overall Study|Lost to Follow-up|3
4484266|NCT00742209|7283521|FG000|Overall Study|Lack of Efficacy|6
4484267|NCT00742209|7283522|FG001|Overall Study|Lack of Efficacy|1
4484268|NCT00742209|7283523|FG002|Overall Study|Lack of Efficacy|1
4484269|NCT00742209|7283524|FG003|Overall Study|Lack of Efficacy|3
4484270|NCT00742209|7283525|FG004|Overall Study|Lack of Efficacy|1
4484271|NCT00742209|7283521|FG000|Overall Study|Investigator Discretion|0
4484272|NCT00742209|7283522|FG001|Overall Study|Investigator Discretion|0
4484273|NCT00742209|7283523|FG002|Overall Study|Investigator Discretion|5
4484274|NCT00742209|7283524|FG003|Overall Study|Investigator Discretion|1
4484275|NCT00742209|7283525|FG004|Overall Study|Investigator Discretion|1
4484276|NCT00742235|7283540|FG000|Overall Study|Lost to Follow-up|0
4484277|NCT00742235|7283541|FG001|Overall Study|Lost to Follow-up|31
4484278|NCT00742274|7283549|FG000|Overall Study|Death|1
4484279|NCT00742274|7283550|FG001|Overall Study|Death|0
4484280|NCT00742274|7283549|FG000|Overall Study|Withdrawal by Subject|1
4484281|NCT00742274|7283550|FG001|Overall Study|Withdrawal by Subject|2
4484282|NCT00742274|7283549|FG000|Overall Study|Removed for medical reasons|1
4484283|NCT00742274|7283550|FG001|Overall Study|Removed for medical reasons|1
4484284|NCT00742326|7283567|FG000|Overall Study|Physician Decision|0
4484285|NCT00742326|7283568|FG001|Overall Study|Physician Decision|1
4484286|NCT00742391|7283576|FG000|Overall Study|Adverse Event|2
4484287|NCT00742391|7283577|FG001|Overall Study|Adverse Event|1
4484288|NCT00742391|7283576|FG000|Overall Study|Lost to Follow-up|1
4484289|NCT00742391|7283577|FG001|Overall Study|Lost to Follow-up|0
4484290|NCT00742391|7283576|FG000|Overall Study|Protocol Violation|1
4484291|NCT00742391|7283577|FG001|Overall Study|Protocol Violation|0
4484292|NCT00742417|7283585|FG000|Randomized|Withdrawal by legal representative|0
4484293|NCT00742417|7283586|FG001|Randomized|Withdrawal by legal representative|1
4484294|NCT00742417|7283585|FG000|Randomized|Withdrawal by Subject|1
4484295|NCT00742417|7283586|FG001|Randomized|Withdrawal by Subject|0
4484296|NCT00742417|7283585|FG000|Randomized|Physician Decision|1
4484297|NCT00742417|7283586|FG001|Randomized|Physician Decision|0
4484298|NCT00742417|7283585|FG000|Intensive Period|Withdrawal by Subject|1
4484299|NCT00742417|7283586|FG001|Intensive Period|Withdrawal by Subject|1
4484300|NCT00742417|7283585|FG000|Intensive Period|Adverse Event|2
4484301|NCT00742417|7283586|FG001|Intensive Period|Adverse Event|0
4484302|NCT00742508|7283605|FG000|8-Week Primary Evaluation Period|Adverse Event|2
4484303|NCT00742508|7283606|FG001|8-Week Primary Evaluation Period|Adverse Event|4
4484304|NCT00742508|7283605|FG000|8-Week Primary Evaluation Period|Protocol Violation|1
4484305|NCT00742508|7283606|FG001|8-Week Primary Evaluation Period|Protocol Violation|0
4484306|NCT00742508|7283605|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8
4484307|NCT00742508|7283606|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5
4484308|NCT00742508|7283605|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0
4484309|NCT00742508|7283606|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2
4484310|NCT00742508|7283605|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0
4484311|NCT00742508|7283606|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1
4484312|NCT00742560|7283617|FG000|Overall Study|Adverse Event|0
4484313|NCT00742560|7283618|FG001|Overall Study|Adverse Event|0
4484314|NCT00742560|7283619|FG002|Overall Study|Adverse Event|1
4484315|NCT00742560|7283620|FG003|Overall Study|Adverse Event|1
4484316|NCT00742560|7283621|FG004|Overall Study|Adverse Event|1
4484317|NCT00742560|7283617|FG000|Overall Study|Death|0
4484318|NCT00742560|7283618|FG001|Overall Study|Death|2
4484319|NCT00742560|7283619|FG002|Overall Study|Death|0
4484320|NCT00742560|7283620|FG003|Overall Study|Death|2
4484321|NCT00742560|7283621|FG004|Overall Study|Death|3
4484322|NCT00742560|7283617|FG000|Overall Study|Subject's Decision|1
4484323|NCT00742560|7283618|FG001|Overall Study|Subject's Decision|0
4484324|NCT00742560|7283619|FG002|Overall Study|Subject's Decision|2
4484325|NCT00742560|7283620|FG003|Overall Study|Subject's Decision|3
4484326|NCT00742560|7283621|FG004|Overall Study|Subject's Decision|3
4484327|NCT00742560|7283617|FG000|Overall Study|Investigator's Decision|0
4484328|NCT00742560|7283618|FG001|Overall Study|Investigator's Decision|0
4484329|NCT00742560|7283619|FG002|Overall Study|Investigator's Decision|4
4484330|NCT00742560|7283620|FG003|Overall Study|Investigator's Decision|1
4484331|NCT00742560|7283621|FG004|Overall Study|Investigator's Decision|0
4484332|NCT00742560|7283617|FG000|Overall Study|Disease Progression|1
4484333|NCT00742560|7283618|FG001|Overall Study|Disease Progression|0
4484334|NCT00742560|7283619|FG002|Overall Study|Disease Progression|5
4484335|NCT00742560|7283620|FG003|Overall Study|Disease Progression|17
4484336|NCT00742560|7283621|FG004|Overall Study|Disease Progression|16
4484337|NCT00742560|7283617|FG000|Overall Study|New Multiple Myeloma Therapy|1
4484338|NCT00742560|7283618|FG001|Overall Study|New Multiple Myeloma Therapy|0
4484339|NCT00742560|7283619|FG002|Overall Study|New Multiple Myeloma Therapy|2
4484340|NCT00742560|7283620|FG003|Overall Study|New Multiple Myeloma Therapy|3
4484341|NCT00742560|7283621|FG004|Overall Study|New Multiple Myeloma Therapy|4
4484342|NCT00742560|7283617|FG000|Overall Study|Other|0
4484343|NCT00742560|7283618|FG001|Overall Study|Other|1
4484344|NCT00742560|7283619|FG002|Overall Study|Other|8
4484345|NCT00742560|7283620|FG003|Overall Study|Other|9
4484346|NCT00742560|7283621|FG004|Overall Study|Other|9
4484347|NCT00742560|7283617|FG000|Overall Study|MIssing|0
4484348|NCT00742560|7283618|FG001|Overall Study|MIssing|0
4484349|NCT00742560|7283619|FG002|Overall Study|MIssing|0
4484350|NCT00742560|7283620|FG003|Overall Study|MIssing|0
4484351|NCT00742560|7283621|FG004|Overall Study|MIssing|1
4484352|NCT00742625|7283661|FG000|Remission Induction|Progression|6
4484353|NCT00742625|7283661|FG000|Remission Induction|Failed induction|8
4484354|NCT00742625|7283661|FG000|Remission Induction|Adverse Event|3
4484355|NCT00742625|7283661|FG000|Remission Induction|Death|10
4484356|NCT00742625|7283661|FG000|Remission Induction|Refusal|5
4484357|NCT00742625|7283661|FG000|Remission Induction|Non protocol treatment|17
4484358|NCT00742625|7283661|FG000|Remission Induction|Other, not specified|5
4484359|NCT00742625|7283661|FG000|Consolidation|Progression|5
4484360|NCT00742625|7283661|FG000|Consolidation|Adverse Event|1
4484361|NCT00742625|7283661|FG000|Consolidation|Death|1
4484362|NCT00742625|7283661|FG000|Consolidation|Refused|1
4484363|NCT00742625|7283661|FG000|Consolidation|Non protocol therapy|13
4484364|NCT00742781|7283668|FG000|Overall Study|Withdrawal by Subject|3
4484365|NCT00742859|7283677|FG000|Overall Study|Adverse Event|5
4484366|NCT00742859|7283678|FG001|Overall Study|Adverse Event|6
4484367|NCT00742859|7283679|FG002|Overall Study|Adverse Event|3
4484368|NCT00742859|7283680|FG003|Overall Study|Adverse Event|1
4484369|NCT00742859|7283677|FG000|Overall Study|Death|1
4484370|NCT00742859|7283678|FG001|Overall Study|Death|0
4484371|NCT00742859|7283679|FG002|Overall Study|Death|0
4484372|NCT00742859|7283680|FG003|Overall Study|Death|1
4484373|NCT00742859|7283677|FG000|Overall Study|Physician Decision|1
4484374|NCT00742859|7283678|FG001|Overall Study|Physician Decision|2
4484375|NCT00742859|7283679|FG002|Overall Study|Physician Decision|0
4484376|NCT00742859|7283680|FG003|Overall Study|Physician Decision|0
4484377|NCT00742859|7283677|FG000|Overall Study|Withdrawal by Subject|4
4484378|NCT00742859|7283678|FG001|Overall Study|Withdrawal by Subject|2
4484379|NCT00742859|7283679|FG002|Overall Study|Withdrawal by Subject|4
4484380|NCT00742859|7283680|FG003|Overall Study|Withdrawal by Subject|1
4484381|NCT00742859|7283677|FG000|Overall Study|Endpoint|0
4484382|NCT00742859|7283678|FG001|Overall Study|Endpoint|1
4484383|NCT00742859|7283679|FG002|Overall Study|Endpoint|1
4484384|NCT00742859|7283680|FG003|Overall Study|Endpoint|2
4484385|NCT00742859|7283677|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0
4484386|NCT00742859|7283678|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1
4484387|NCT00742859|7283679|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1
4484388|NCT00742859|7283680|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0
4484389|NCT00742859|7283677|FG000|Overall Study|Sponsor req visit schedule noncompliance|0
4518677|NCT00975507|7330861|FG000|Overall Study|Withdrawal by Subject|10
4484390|NCT00742859|7283678|FG001|Overall Study|Sponsor req visit schedule noncompliance|0
4484391|NCT00742859|7283679|FG002|Overall Study|Sponsor req visit schedule noncompliance|0
4484392|NCT00742859|7283680|FG003|Overall Study|Sponsor req visit schedule noncompliance|1
4484393|NCT00742859|7283677|FG000|Overall Study|Sponsor request patient out of town|0
4484394|NCT00742859|7283678|FG001|Overall Study|Sponsor request patient out of town|0
4484395|NCT00742859|7283679|FG002|Overall Study|Sponsor request patient out of town|1
4484396|NCT00742859|7283680|FG003|Overall Study|Sponsor request patient out of town|1
4484397|NCT00742859|7283677|FG000|Overall Study|Site error|0
4484398|NCT00742859|7283678|FG001|Overall Study|Site error|0
4484399|NCT00742859|7283679|FG002|Overall Study|Site error|1
4484400|NCT00742859|7283680|FG003|Overall Study|Site error|1
4484401|NCT00742885|7283701|FG000|Overall Study|Lost to Follow-up|1
4484402|NCT00742885|7283702|FG001|Overall Study|Lost to Follow-up|0
4484403|NCT00742924|7283715|FG000|Overall Study|Adverse Event|0
4484404|NCT00742924|7283716|FG001|Overall Study|Adverse Event|0
4484405|NCT00742924|7283717|FG002|Overall Study|Adverse Event|1
4484406|NCT00742924|7283718|FG003|Overall Study|Adverse Event|1
4484407|NCT00742924|7283715|FG000|Overall Study|Lack of Efficacy|5
4484408|NCT00742924|7283716|FG001|Overall Study|Lack of Efficacy|1
4484409|NCT00742924|7283717|FG002|Overall Study|Lack of Efficacy|2
4484410|NCT00742924|7283718|FG003|Overall Study|Lack of Efficacy|4
4484411|NCT00742924|7283715|FG000|Overall Study|Physician Decision|0
4484412|NCT00742924|7283716|FG001|Overall Study|Physician Decision|0
4484413|NCT00742924|7283717|FG002|Overall Study|Physician Decision|0
4484414|NCT00742924|7283718|FG003|Overall Study|Physician Decision|1
4484415|NCT00742924|7283715|FG000|Overall Study|Withdrawal by Subject|0
4484416|NCT00742924|7283716|FG001|Overall Study|Withdrawal by Subject|1
4484417|NCT00742924|7283717|FG002|Overall Study|Withdrawal by Subject|1
4484418|NCT00742924|7283718|FG003|Overall Study|Withdrawal by Subject|0
4484419|NCT00743106|7283743|FG000|Overall Study|Met intraoperative exclusion criterion|8
4484420|NCT00743106|7283744|FG001|Overall Study|Met intraoperative exclusion criterion|5
4484421|NCT00743119|7283750|FG000|Overall Study|unreliable|3
4484422|NCT00743119|7283750|FG000|Overall Study|Withdrawal by Subject|1
4484423|NCT00743145|7283762|FG000|Overall Study|Withdrawal by Subject|1
4484424|NCT00743145|7283762|FG000|Overall Study|Adverse Event|2
4484425|NCT00743145|7283762|FG000|Overall Study|Pregnancy|1
4484426|NCT00743249|7283778|FG000|Overall Study|Adverse Event|0
4484427|NCT00743249|7283779|FG001|Overall Study|Adverse Event|4
4484428|NCT00743249|7283778|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0
4484429|NCT00743249|7283779|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1
4484430|NCT00743249|7283778|FG000|Overall Study|Unsuccessful insertion of stent|2
4484431|NCT00743249|7283779|FG001|Overall Study|Unsuccessful insertion of stent|1
4484432|NCT00743275|7283791|FG000|Overall Study|Protocol Violation|0
4484433|NCT00743275|7283792|FG001|Overall Study|Protocol Violation|1
4484434|NCT00743288|7283798|FG000|Overall Study|Adverse Event|1
4484435|NCT00743288|7283799|FG001|Overall Study|Adverse Event|1
4484436|NCT00743288|7283800|FG002|Overall Study|Adverse Event|2
4484437|NCT00743288|7283801|FG003|Overall Study|Adverse Event|2
4484438|NCT00743288|7283802|FG004|Overall Study|Adverse Event|1
4484439|NCT00743288|7283803|FG005|Overall Study|Adverse Event|1
4484440|NCT00743288|7283804|FG006|Overall Study|Adverse Event|2
4484441|NCT00743288|7283798|FG000|Overall Study|Withdrawal by Subject|0
4484442|NCT00743288|7283799|FG001|Overall Study|Withdrawal by Subject|0
4484443|NCT00743288|7283800|FG002|Overall Study|Withdrawal by Subject|1
4484444|NCT00743288|7283801|FG003|Overall Study|Withdrawal by Subject|0
4484445|NCT00743288|7283802|FG004|Overall Study|Withdrawal by Subject|0
4484446|NCT00743288|7283803|FG005|Overall Study|Withdrawal by Subject|1
4484447|NCT00743288|7283804|FG006|Overall Study|Withdrawal by Subject|1
4484448|NCT00743288|7283798|FG000|Overall Study|Progressive disease (PD)|2
4484449|NCT00743288|7283799|FG001|Overall Study|Progressive disease (PD)|0
4484450|NCT00743288|7283800|FG002|Overall Study|Progressive disease (PD)|1
4484451|NCT00743288|7283801|FG003|Overall Study|Progressive disease (PD)|4
4484452|NCT00743288|7283802|FG004|Overall Study|Progressive disease (PD)|5
4484453|NCT00743288|7283803|FG005|Overall Study|Progressive disease (PD)|3
4484454|NCT00743288|7283804|FG006|Overall Study|Progressive disease (PD)|6
4484455|NCT00743288|7283798|FG000|Overall Study|Worsening of condition (Not PD)|0
4484456|NCT00743288|7283799|FG001|Overall Study|Worsening of condition (Not PD)|2
4484457|NCT00743288|7283800|FG002|Overall Study|Worsening of condition (Not PD)|1
4484458|NCT00743288|7283801|FG003|Overall Study|Worsening of condition (Not PD)|1
4484459|NCT00743288|7283802|FG004|Overall Study|Worsening of condition (Not PD)|0
4484460|NCT00743288|7283803|FG005|Overall Study|Worsening of condition (Not PD)|0
4484461|NCT00743288|7283804|FG006|Overall Study|Worsening of condition (Not PD)|0
4484462|NCT00743340|7283815|FG000|Overall Study|Study medication non-compliance|1
4484463|NCT00743340|7283815|FG000|Overall Study|Lost to Follow-up|1
4484464|NCT00743340|7283815|FG000|Overall Study|Withdrawal from the Study|5
4484465|NCT00743340|7283815|FG000|Overall Study|Protocol Violation|1
4484466|NCT00743340|7283815|FG000|Overall Study|Virologic failure|8
4484467|NCT00743340|7283815|FG000|Overall Study|Pregnancy|1
4484468|NCT00743340|7283815|FG000|Overall Study|Rolled over to other Gilead Study|23
4484469|NCT00743340|7283815|FG000|Overall Study|Participant Relocated|1
4484470|NCT00743366|7283819|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3
4484471|NCT00743366|7283820|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3
4484472|NCT00743431|7283826|FG000|Overall Study|Toxicity|6
4484473|NCT00743431|7283826|FG000|Overall Study|Tumor progression|56
4484474|NCT00743431|7283826|FG000|Overall Study|Withdrawal by Subject|13
4484475|NCT00743431|7283826|FG000|Overall Study|Death|9
4484476|NCT00743431|7283826|FG000|Overall Study|Reason for discontinuation not specified|29
4484477|NCT00743431|7283826|FG000|Overall Study|No documentation available|13
4484478|NCT00743444|7283830|FG000|First Intervention|Catheter placement problems|0
4484479|NCT00743444|7283831|FG001|First Intervention|Catheter placement problems|1
4484480|NCT00743444|7283830|FG000|Washout Period|Adverse Event|0
4484481|NCT00743444|7283831|FG001|Washout Period|Adverse Event|1
4484482|NCT00743483|7283837|FG000|Baseline Period|Physician Decision|1
4484483|NCT00743483|7283837|FG000|Treatment Period|Adverse Event|1
4484484|NCT00743509|7283841|FG000|Overall Study|Withdrawal by Subject|2
4484485|NCT00743652|7283854|FG000|Overall Study|Parent/Legal Guardian Request|3
4484486|NCT00743652|7283855|FG001|Overall Study|Parent/Legal Guardian Request|2
4484487|NCT00743652|7283856|FG002|Overall Study|Parent/Legal Guardian Request|2
4484488|NCT00743652|7283857|FG003|Overall Study|Parent/Legal Guardian Request|2
4484489|NCT00743652|7283858|FG004|Overall Study|Parent/Legal Guardian Request|0
4484490|NCT00743652|7283854|FG000|Overall Study|Adverse Event|3
4484491|NCT00743652|7283855|FG001|Overall Study|Adverse Event|0
4484492|NCT00743652|7283856|FG002|Overall Study|Adverse Event|0
4484493|NCT00743652|7283857|FG003|Overall Study|Adverse Event|0
4484494|NCT00743652|7283858|FG004|Overall Study|Adverse Event|0
4484495|NCT00743652|7283854|FG000|Overall Study|Death|2
4484496|NCT00743652|7283855|FG001|Overall Study|Death|0
4484497|NCT00743652|7283856|FG002|Overall Study|Death|0
4484498|NCT00743652|7283857|FG003|Overall Study|Death|0
4484499|NCT00743652|7283858|FG004|Overall Study|Death|0
4484500|NCT00743652|7283854|FG000|Overall Study|Investigator Request|0
4484501|NCT00743652|7283855|FG001|Overall Study|Investigator Request|0
4484502|NCT00743652|7283856|FG002|Overall Study|Investigator Request|0
4484503|NCT00743652|7283857|FG003|Overall Study|Investigator Request|2
4484504|NCT00743652|7283858|FG004|Overall Study|Investigator Request|0
4484505|NCT00743652|7283854|FG000|Overall Study|Other|1
4484506|NCT00743652|7283855|FG001|Overall Study|Other|1
4484507|NCT00743652|7283856|FG002|Overall Study|Other|0
4484508|NCT00743652|7283857|FG003|Overall Study|Other|0
4484509|NCT00743652|7283858|FG004|Overall Study|Other|0
4484510|NCT00743652|7283854|FG000|Overall Study|Lost to Follow-up|1
4484511|NCT00743652|7283855|FG001|Overall Study|Lost to Follow-up|0
4484512|NCT00743652|7283856|FG002|Overall Study|Lost to Follow-up|0
4589893|NCT01515865|7435446|FG000|Part A (Open-label)|Other|3
4484513|NCT00743652|7283857|FG003|Overall Study|Lost to Follow-up|0
4484514|NCT00743652|7283858|FG004|Overall Study|Lost to Follow-up|0
4484515|NCT00744042|7283900|FG000|Overall Study|Withdrawal by Subject|1
4484516|NCT00744055|7283912|FG000|Overall Study|Withdrawal by Subject|6
4484517|NCT00744055|7283913|FG001|Overall Study|Withdrawal by Subject|9
4484518|NCT00744055|7283912|FG000|Overall Study|Lack of Efficacy|0
4484519|NCT00744055|7283913|FG001|Overall Study|Lack of Efficacy|1
4484520|NCT00744055|7283912|FG000|Overall Study|Physician Decision|0
4484521|NCT00744055|7283913|FG001|Overall Study|Physician Decision|2
4484522|NCT00744055|7283912|FG000|Overall Study|Protocol Violation|1
4484523|NCT00744055|7283913|FG001|Overall Study|Protocol Violation|1
4484524|NCT00744055|7283912|FG000|Overall Study|Lost to Follow-up|0
4484525|NCT00744055|7283913|FG001|Overall Study|Lost to Follow-up|1
4484526|NCT00744237|7283938|FG000|Overall Study|Lack of Efficacy|1
4484527|NCT00744237|7283939|FG001|Overall Study|Lack of Efficacy|1
4484528|NCT00744237|7283940|FG002|Overall Study|Lack of Efficacy|0
4484529|NCT00744237|7283938|FG000|Overall Study|Withdrawal by Subject|9
4484530|NCT00744237|7283939|FG001|Overall Study|Withdrawal by Subject|5
4484531|NCT00744237|7283940|FG002|Overall Study|Withdrawal by Subject|3
4484532|NCT00744237|7283938|FG000|Overall Study|Lost to Follow-up|1
4484533|NCT00744237|7283939|FG001|Overall Study|Lost to Follow-up|1
4484534|NCT00744237|7283940|FG002|Overall Study|Lost to Follow-up|1
4484535|NCT00744237|7283938|FG000|Overall Study|Protocol Violation|3
4484536|NCT00744237|7283939|FG001|Overall Study|Protocol Violation|4
4484537|NCT00744237|7283940|FG002|Overall Study|Protocol Violation|3
4484538|NCT00744237|7283938|FG000|Overall Study|Inclusion/Exclusion criteria not met|1
4484539|NCT00744237|7283939|FG001|Overall Study|Inclusion/Exclusion criteria not met|0
4484540|NCT00744237|7283940|FG002|Overall Study|Inclusion/Exclusion criteria not met|0
4484541|NCT00744237|7283938|FG000|Overall Study|Dosing Error|1
4484542|NCT00744237|7283939|FG001|Overall Study|Dosing Error|0
4484543|NCT00744237|7283940|FG002|Overall Study|Dosing Error|1
4484544|NCT00744237|7283938|FG000|Overall Study|Study Drug Error|1
4484545|NCT00744237|7283939|FG001|Overall Study|Study Drug Error|0
4484546|NCT00744237|7283940|FG002|Overall Study|Study Drug Error|0
4484547|NCT00744237|7283938|FG000|Overall Study|Prohibited Concomitant Medication|0
4484548|NCT00744237|7283939|FG001|Overall Study|Prohibited Concomitant Medication|0
4484549|NCT00744237|7283940|FG002|Overall Study|Prohibited Concomitant Medication|1
4484550|NCT00744237|7283938|FG000|Overall Study|Poor Compliance|0
4484551|NCT00744237|7283939|FG001|Overall Study|Poor Compliance|2
4484552|NCT00744237|7283940|FG002|Overall Study|Poor Compliance|0
4484553|NCT00744237|7283938|FG000|Overall Study|Administrative. Site Closed|1
4484554|NCT00744237|7283939|FG001|Overall Study|Administrative. Site Closed|1
4484555|NCT00744237|7283940|FG002|Overall Study|Administrative. Site Closed|1
4484556|NCT00744237|7283938|FG000|Overall Study|Adverse Event|9
4484557|NCT00744237|7283939|FG001|Overall Study|Adverse Event|13
4484558|NCT00744237|7283940|FG002|Overall Study|Adverse Event|5
4484559|NCT00744263|7283950|FG000|Overall Study|Death|3006
4484560|NCT00744263|7283951|FG001|Overall Study|Death|3005
4484561|NCT00744263|7283950|FG000|Overall Study|Lost to Follow-up|2038
4484562|NCT00744263|7283951|FG001|Overall Study|Lost to Follow-up|2135
4484563|NCT00744263|7283950|FG000|Overall Study|Withdrawal by Subject|166
4484564|NCT00744263|7283951|FG001|Overall Study|Withdrawal by Subject|150
4484565|NCT00744263|7283950|FG000|Overall Study|Physician Decision|20
4484566|NCT00744263|7283951|FG001|Overall Study|Physician Decision|23
4589894|NCT01515865|7435447|FG001|Part A (Open-label)|Other|0
4589895|NCT01515865|7435448|FG002|Part A (Open-label)|Other|0
4589896|NCT01515865|7435446|FG000|Part B (Open-label)|Withdrawal by Subject|1
4589897|NCT01515865|7435447|FG001|Part B (Open-label)|Withdrawal by Subject|0
4589898|NCT01515865|7435448|FG002|Part B (Open-label)|Withdrawal by Subject|0
4589899|NCT01515865|7435446|FG000|Part B (Open-label)|Other|1
4589900|NCT01515865|7435447|FG001|Part B (Open-label)|Other|0
4589901|NCT01515865|7435448|FG002|Part B (Open-label)|Other|0
4589902|NCT01516008|7435492|FG000|Overall Study|Adverse Event|0
4589903|NCT01516008|7435493|FG001|Overall Study|Adverse Event|2
4589904|NCT01516008|7435494|FG002|Overall Study|Adverse Event|7
4589905|NCT01516008|7435492|FG000|Overall Study|Lack of Efficacy|44
4589906|NCT01516008|7435493|FG001|Overall Study|Lack of Efficacy|14
4589907|NCT01516008|7435494|FG002|Overall Study|Lack of Efficacy|10
4589908|NCT01516008|7435492|FG000|Overall Study|Protocol Violation|1
4589909|NCT01516008|7435493|FG001|Overall Study|Protocol Violation|0
4589910|NCT01516008|7435494|FG002|Overall Study|Protocol Violation|0
4589911|NCT01516008|7435492|FG000|Overall Study|Reason not specified|0
4484567|NCT00744263|7283950|FG000|Overall Study|Protocol Violation|3
4484568|NCT00744263|7283951|FG001|Overall Study|Protocol Violation|5
4484569|NCT00744263|7283950|FG000|Overall Study|Adverse Event|1
4484570|NCT00744263|7283951|FG001|Overall Study|Adverse Event|0
4484571|NCT00744263|7283950|FG000|Overall Study|Other|2
4484572|NCT00744263|7283951|FG001|Overall Study|Other|2
4484573|NCT00744328|7283962|FG000|Overall Study|Lost to Follow-up|2
4484574|NCT00744328|7283963|FG001|Overall Study|Lost to Follow-up|5
4484575|NCT00744328|7283964|FG002|Overall Study|Lost to Follow-up|3
4484576|NCT00744328|7283962|FG000|Overall Study|Withdrawal by Subject|5
4484577|NCT00744328|7283963|FG001|Overall Study|Withdrawal by Subject|3
4484578|NCT00744328|7283964|FG002|Overall Study|Withdrawal by Subject|4
4484579|NCT00744328|7283962|FG000|Overall Study|Found ineligible after randomization|0
4484580|NCT00744328|7283963|FG001|Overall Study|Found ineligible after randomization|0
4484581|NCT00744328|7283964|FG002|Overall Study|Found ineligible after randomization|1
4484582|NCT00744471|7283986|FG000|Overall Study|Randomized but not treated|1
4484583|NCT00744471|7283987|FG001|Overall Study|Randomized but not treated|1
4484584|NCT00744471|7283988|FG002|Overall Study|Randomized but not treated|4
4484585|NCT00744471|7283989|FG003|Overall Study|Randomized but not treated|0
4484586|NCT00744471|7283986|FG000|Overall Study|Death|0
4484587|NCT00744471|7283987|FG001|Overall Study|Death|0
4484588|NCT00744471|7283988|FG002|Overall Study|Death|0
4484589|NCT00744471|7283989|FG003|Overall Study|Death|1
4484590|NCT00744471|7283986|FG000|Overall Study|Adverse Event|6
4484591|NCT00744471|7283987|FG001|Overall Study|Adverse Event|7
4484592|NCT00744471|7283988|FG002|Overall Study|Adverse Event|5
4484593|NCT00744471|7283989|FG003|Overall Study|Adverse Event|9
4484594|NCT00744471|7283986|FG000|Overall Study|Withdrawal by Subject|9
4484595|NCT00744471|7283987|FG001|Overall Study|Withdrawal by Subject|9
4484596|NCT00744471|7283988|FG002|Overall Study|Withdrawal by Subject|15
4484597|NCT00744471|7283989|FG003|Overall Study|Withdrawal by Subject|12
4484598|NCT00744471|7283986|FG000|Overall Study|Protocol Violation|1
4484599|NCT00744471|7283987|FG001|Overall Study|Protocol Violation|4
4484600|NCT00744471|7283988|FG002|Overall Study|Protocol Violation|1
4484601|NCT00744471|7283989|FG003|Overall Study|Protocol Violation|2
4484602|NCT00744471|7283986|FG000|Overall Study|Entered extension study|41
4484603|NCT00744471|7283987|FG001|Overall Study|Entered extension study|84
4484604|NCT00744471|7283988|FG002|Overall Study|Entered extension study|100
4484605|NCT00744471|7283989|FG003|Overall Study|Entered extension study|91
4589912|NCT01516008|7435493|FG001|Overall Study|Reason not specified|0
4589913|NCT01516008|7435494|FG002|Overall Study|Reason not specified|1
4589914|NCT01516437|7435524|FG000|Overall Study|Reason not specified|0
4589915|NCT01516437|7435525|FG001|Overall Study|Reason not specified|0
4484606|NCT00744471|7283986|FG000|Overall Study|Other|2
4484607|NCT00744471|7283987|FG001|Overall Study|Other|3
4484608|NCT00744471|7283988|FG002|Overall Study|Other|6
4484609|NCT00744471|7283989|FG003|Overall Study|Other|2
4484610|NCT00744471|7283986|FG000|Overall Study|Lack of Efficacy|83
4484611|NCT00744471|7283987|FG001|Overall Study|Lack of Efficacy|37
4484612|NCT00744471|7283988|FG002|Overall Study|Lack of Efficacy|19
4484613|NCT00744471|7283989|FG003|Overall Study|Lack of Efficacy|31
4484614|NCT00744471|7283986|FG000|Overall Study|Lost to Follow-up|0
4484615|NCT00744471|7283987|FG001|Overall Study|Lost to Follow-up|0
4484616|NCT00744471|7283988|FG002|Overall Study|Lost to Follow-up|2
4484617|NCT00744471|7283989|FG003|Overall Study|Lost to Follow-up|0
4484618|NCT00744497|7284001|FG000|Overall Study|Withdrawal by Subject|21
4484619|NCT00744497|7284002|FG001|Overall Study|Withdrawal by Subject|18
4484620|NCT00744497|7284001|FG000|Overall Study|Death|11
4484621|NCT00744497|7284002|FG001|Overall Study|Death|9
4484622|NCT00744497|7284001|FG000|Overall Study|Lost to Follow-up|4
4484623|NCT00744497|7284002|FG001|Overall Study|Lost to Follow-up|2
4484624|NCT00744497|7284001|FG000|Overall Study|Poor compliance/noncompliance|9
4484625|NCT00744497|7284002|FG001|Overall Study|Poor compliance/noncompliance|5
4484626|NCT00744497|7284001|FG000|Overall Study|No longer meets study criteria|7
4484627|NCT00744497|7284002|FG001|Overall Study|No longer meets study criteria|3
4484628|NCT00744497|7284001|FG000|Overall Study|Administrative Reason By Sponsor|25
4484629|NCT00744497|7284002|FG001|Overall Study|Administrative Reason By Sponsor|8
4484630|NCT00744497|7284001|FG000|Overall Study|Disease progression|312
4484631|NCT00744497|7284002|FG001|Overall Study|Disease progression|219
4484632|NCT00744497|7284001|FG000|Overall Study|Study drug toxicity|68
4484633|NCT00744497|7284002|FG001|Overall Study|Study drug toxicity|141
4484634|NCT00744497|7284001|FG000|Overall Study|Adverse event unrelated to study drug|78
4484635|NCT00744497|7284002|FG001|Overall Study|Adverse event unrelated to study drug|122
4484636|NCT00744497|7284001|FG000|Overall Study|Patient requested to stop study drug|65
4484637|NCT00744497|7284002|FG001|Overall Study|Patient requested to stop study drug|80
4484638|NCT00744497|7284001|FG000|Overall Study|Maximum clinical benefit|141
4484639|NCT00744497|7284002|FG001|Overall Study|Maximum clinical benefit|142
4484640|NCT00744497|7284001|FG000|Overall Study|Not defined|19
4484641|NCT00744497|7284002|FG001|Overall Study|Not defined|13
4484642|NCT00744523|7284010|FG000|30 Days After the Procedure|Insufficient follow-up|0
4484643|NCT00744523|7284011|FG001|30 Days After the Procedure|Insufficient follow-up|5
4484644|NCT00744627|7284021|FG000|Overall Study|Adverse Event|6
4484645|NCT00744627|7284022|FG001|Overall Study|Adverse Event|9
4484646|NCT00744627|7284021|FG000|Overall Study|Lack of Efficacy|7
4484647|NCT00744627|7284022|FG001|Overall Study|Lack of Efficacy|3
4484648|NCT00744627|7284021|FG000|Overall Study|Noncompliance|0
4484649|NCT00744627|7284022|FG001|Overall Study|Noncompliance|1
4484650|NCT00744627|7284021|FG000|Overall Study|Protocol Deviations|0
4484651|NCT00744627|7284022|FG001|Overall Study|Protocol Deviations|2
4484652|NCT00744627|7284021|FG000|Overall Study|Voluntary Withdrawal|9
4484653|NCT00744627|7284022|FG001|Overall Study|Voluntary Withdrawal|6
4484654|NCT00744627|7284021|FG000|Overall Study|Lost to Follow-up|2
4484655|NCT00744627|7284022|FG001|Overall Study|Lost to Follow-up|1
4484656|NCT00744627|7284021|FG000|Overall Study|Other|1
4484657|NCT00744627|7284022|FG001|Overall Study|Other|0
4484658|NCT00744653|7284028|FG000|Overall Study|antineoplastic treatment|11
4484659|NCT00744653|7284028|FG000|Overall Study|Death|1
4484660|NCT00744653|7284028|FG000|Overall Study|Lost to Follow-up|1
4484661|NCT00744653|7284028|FG000|Overall Study|Physician Decision|3
4484662|NCT00744757|7284037|FG000|Overall Study|Objective disease progression|7
4484663|NCT00744757|7284037|FG000|Overall Study|Physician Decision|5
4484664|NCT00744757|7284037|FG000|Overall Study|Withdrawal by Subject|1
4484665|NCT00744757|7284037|FG000|Overall Study|Death|6
4484666|NCT00744757|7284037|FG000|Overall Study|Adverse Event|2
4484667|NCT00744796|7284041|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12
4484668|NCT00744861|7284058|FG000|Feasibility Stage 1|Withdrawal by Subject|1
4484669|NCT00744861|7284059|FG001|Feasibility Stage 1|Withdrawal by Subject|1
4484670|NCT00744861|7284060|FG002|Feasibility Stage 1|Withdrawal by Subject|0
4484671|NCT00744861|7284061|FG003|Feasibility Stage 1|Withdrawal by Subject|0
4484672|NCT00744861|7284058|FG000|Feasibility Stage 1|Pregnancy|0
4484673|NCT00744861|7284059|FG001|Feasibility Stage 1|Pregnancy|1
4484674|NCT00744861|7284060|FG002|Feasibility Stage 1|Pregnancy|0
4484675|NCT00744861|7284061|FG003|Feasibility Stage 1|Pregnancy|0
4484676|NCT00744861|7284058|FG000|Pivotal Stage 2|Adverse Event|0
4484677|NCT00744861|7284059|FG001|Pivotal Stage 2|Adverse Event|0
4484678|NCT00744861|7284060|FG002|Pivotal Stage 2|Adverse Event|6
4484679|NCT00744861|7284061|FG003|Pivotal Stage 2|Adverse Event|11
4484680|NCT00744861|7284058|FG000|Pivotal Stage 2|Death|0
4484681|NCT00744861|7284059|FG001|Pivotal Stage 2|Death|0
4484682|NCT00744861|7284060|FG002|Pivotal Stage 2|Death|0
4484683|NCT00744861|7284061|FG003|Pivotal Stage 2|Death|1
4484684|NCT00744861|7284058|FG000|Pivotal Stage 2|Lost to Follow-up|0
4484685|NCT00744861|7284059|FG001|Pivotal Stage 2|Lost to Follow-up|0
4484686|NCT00744861|7284060|FG002|Pivotal Stage 2|Lost to Follow-up|13
4484687|NCT00744861|7284061|FG003|Pivotal Stage 2|Lost to Follow-up|14
4484688|NCT00744861|7284058|FG000|Pivotal Stage 2|Physician Decision|0
4484689|NCT00744861|7284059|FG001|Pivotal Stage 2|Physician Decision|0
4484690|NCT00744861|7284060|FG002|Pivotal Stage 2|Physician Decision|3
4484691|NCT00744861|7284061|FG003|Pivotal Stage 2|Physician Decision|1
4484692|NCT00744861|7284058|FG000|Pivotal Stage 2|Protocol Violation|0
4484693|NCT00744861|7284059|FG001|Pivotal Stage 2|Protocol Violation|0
4484694|NCT00744861|7284060|FG002|Pivotal Stage 2|Protocol Violation|0
4484695|NCT00744861|7284061|FG003|Pivotal Stage 2|Protocol Violation|1
4484696|NCT00744861|7284058|FG000|Pivotal Stage 2|Withdrawal by Subject|0
4484697|NCT00744861|7284059|FG001|Pivotal Stage 2|Withdrawal by Subject|0
4484698|NCT00744861|7284060|FG002|Pivotal Stage 2|Withdrawal by Subject|20
4484699|NCT00744861|7284061|FG003|Pivotal Stage 2|Withdrawal by Subject|14
4484700|NCT00744861|7284058|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0
4484701|NCT00744861|7284059|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0
4484702|NCT00744861|7284060|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60
4484703|NCT00744861|7284061|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63
4387093|NCT00045942|7165715|FG005|PKC412A2104 (Core)|Lack of Efficacy|0
4387094|NCT00045942|7165716|FG006|PKC412A2104 (Core)|Lack of Efficacy|0
4387095|NCT00045942|7165717|FG007|PKC412A2104 (Core)|Lack of Efficacy|0
4387096|NCT00045942|7165718|FG008|PKC412A2104 (Core)|Lack of Efficacy|0
4387097|NCT00045942|7165710|FG000|PKC412A2104 (Core)|Death|1
4387098|NCT00045942|7165711|FG001|PKC412A2104 (Core)|Death|0
4387099|NCT00045942|7165712|FG002|PKC412A2104 (Core)|Death|0
4387100|NCT00045942|7165713|FG003|PKC412A2104 (Core)|Death|0
4387101|NCT00045942|7165714|FG004|PKC412A2104 (Core)|Death|0
4387102|NCT00045942|7165715|FG005|PKC412A2104 (Core)|Death|0
4387103|NCT00045942|7165716|FG006|PKC412A2104 (Core)|Death|0
4387104|NCT00045942|7165717|FG007|PKC412A2104 (Core)|Death|0
4387105|NCT00045942|7165718|FG008|PKC412A2104 (Core)|Death|0
4387106|NCT00045942|7165710|FG000|PKC412A2104E1|Withdrawal by Subject|0
4387107|NCT00045942|7165711|FG001|PKC412A2104E1|Withdrawal by Subject|0
4387108|NCT00045942|7165712|FG002|PKC412A2104E1|Withdrawal by Subject|2
4387109|NCT00045942|7165713|FG003|PKC412A2104E1|Withdrawal by Subject|5
4387110|NCT00045942|7165714|FG004|PKC412A2104E1|Withdrawal by Subject|2
4387111|NCT00045942|7165715|FG005|PKC412A2104E1|Withdrawal by Subject|0
4387112|NCT00045942|7165716|FG006|PKC412A2104E1|Withdrawal by Subject|0
4387113|NCT00045942|7165717|FG007|PKC412A2104E1|Withdrawal by Subject|0
4387114|NCT00045942|7165718|FG008|PKC412A2104E1|Withdrawal by Subject|0
4387115|NCT00045942|7165710|FG000|PKC412A2104E1|Condition no longer requires study drug|0
4387116|NCT00045942|7165711|FG001|PKC412A2104E1|Condition no longer requires study drug|1
4387117|NCT00045942|7165712|FG002|PKC412A2104E1|Condition no longer requires study drug|1
4387118|NCT00045942|7165713|FG003|PKC412A2104E1|Condition no longer requires study drug|0
4387119|NCT00045942|7165714|FG004|PKC412A2104E1|Condition no longer requires study drug|1
4387120|NCT00045942|7165715|FG005|PKC412A2104E1|Condition no longer requires study drug|0
4387121|NCT00045942|7165716|FG006|PKC412A2104E1|Condition no longer requires study drug|0
4387122|NCT00045942|7165717|FG007|PKC412A2104E1|Condition no longer requires study drug|0
4387123|NCT00045942|7165718|FG008|PKC412A2104E1|Condition no longer requires study drug|0
4387124|NCT00045942|7165710|FG000|PKC412A2104E1|Lack of Efficacy|0
4387125|NCT00045942|7165711|FG001|PKC412A2104E1|Lack of Efficacy|11
4387126|NCT00045942|7165712|FG002|PKC412A2104E1|Lack of Efficacy|11
4387127|NCT00045942|7165713|FG003|PKC412A2104E1|Lack of Efficacy|23
4387128|NCT00045942|7165714|FG004|PKC412A2104E1|Lack of Efficacy|17
4387129|NCT00045942|7165715|FG005|PKC412A2104E1|Lack of Efficacy|0
4387130|NCT00045942|7165716|FG006|PKC412A2104E1|Lack of Efficacy|0
4387131|NCT00045942|7165717|FG007|PKC412A2104E1|Lack of Efficacy|0
4387132|NCT00045942|7165718|FG008|PKC412A2104E1|Lack of Efficacy|0
4387133|NCT00045942|7165710|FG000|PKC412A2104E1|Abnormal laboratory value|0
4387134|NCT00045942|7165711|FG001|PKC412A2104E1|Abnormal laboratory value|1
4387135|NCT00045942|7165712|FG002|PKC412A2104E1|Abnormal laboratory value|0
4387136|NCT00045942|7165713|FG003|PKC412A2104E1|Abnormal laboratory value|0
4387137|NCT00045942|7165714|FG004|PKC412A2104E1|Abnormal laboratory value|0
4387138|NCT00045942|7165715|FG005|PKC412A2104E1|Abnormal laboratory value|0
4387139|NCT00045942|7165716|FG006|PKC412A2104E1|Abnormal laboratory value|0
4387140|NCT00045942|7165717|FG007|PKC412A2104E1|Abnormal laboratory value|0
4387141|NCT00045942|7165718|FG008|PKC412A2104E1|Abnormal laboratory value|0
4387142|NCT00045942|7165710|FG000|PKC412A2104E1|Adverse Event|0
4387143|NCT00045942|7165711|FG001|PKC412A2104E1|Adverse Event|1
4387144|NCT00045942|7165712|FG002|PKC412A2104E1|Adverse Event|1
4387145|NCT00045942|7165713|FG003|PKC412A2104E1|Adverse Event|3
4387146|NCT00045942|7165714|FG004|PKC412A2104E1|Adverse Event|6
4387147|NCT00045942|7165715|FG005|PKC412A2104E1|Adverse Event|0
4387148|NCT00045942|7165716|FG006|PKC412A2104E1|Adverse Event|0
4387149|NCT00045942|7165717|FG007|PKC412A2104E1|Adverse Event|0
4387150|NCT00045942|7165718|FG008|PKC412A2104E1|Adverse Event|0
4387151|NCT00045942|7165710|FG000|PKC412A2104E1|Death|0
4387152|NCT00045942|7165711|FG001|PKC412A2104E1|Death|4
4387153|NCT00045942|7165712|FG002|PKC412A2104E1|Death|1
4387154|NCT00045942|7165713|FG003|PKC412A2104E1|Death|1
4387155|NCT00045942|7165714|FG004|PKC412A2104E1|Death|1
4387156|NCT00045942|7165715|FG005|PKC412A2104E1|Death|0
4387157|NCT00045942|7165716|FG006|PKC412A2104E1|Death|0
4387158|NCT00045942|7165717|FG007|PKC412A2104E1|Death|0
4387159|NCT00045942|7165718|FG008|PKC412A2104E1|Death|0
4387160|NCT00045942|7165710|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0
4387161|NCT00045942|7165711|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0
4387162|NCT00045942|7165712|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1
4387163|NCT00045942|7165713|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1
4387164|NCT00045942|7165714|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0
4387165|NCT00045942|7165715|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0
4387166|NCT00045942|7165716|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0
4387167|NCT00045942|7165717|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0
4387168|NCT00045942|7165718|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0
4387169|NCT00045942|7165710|FG000|PKC412A2104E2|Lost to Follow-up|0
4387170|NCT00045942|7165711|FG001|PKC412A2104E2|Lost to Follow-up|0
4387171|NCT00045942|7165712|FG002|PKC412A2104E2|Lost to Follow-up|0
4387172|NCT00045942|7165713|FG003|PKC412A2104E2|Lost to Follow-up|0
4387173|NCT00045942|7165714|FG004|PKC412A2104E2|Lost to Follow-up|0
4387174|NCT00045942|7165715|FG005|PKC412A2104E2|Lost to Follow-up|0
4484704|NCT00744874|7284069|FG000|Overall Study|Lost to Follow-up|1
4484705|NCT00744874|7284069|FG000|Overall Study|Withdrawal by Subject|1
4484706|NCT00744874|7284069|FG000|Overall Study|Study Device not available at procedure|1
4700917|NCT02701985|7617289|FG000|Overall Study|Death|1
4700918|NCT02701985|7617290|FG001|Overall Study|Death|0
4700919|NCT02701985|7617289|FG000|Overall Study|Adverse Event|0
4700920|NCT02701985|7617290|FG001|Overall Study|Adverse Event|5
4700921|NCT02702011|7617301|FG000|Overall Study|Withdrawal by Subject|0
4700922|NCT02702011|7617302|FG001|Overall Study|Withdrawal by Subject|1
4700923|NCT02702011|7617303|FG002|Overall Study|Withdrawal by Subject|0
4700924|NCT02702011|7617304|FG003|Overall Study|Withdrawal by Subject|0
4700925|NCT02702193|7617316|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1
4700926|NCT02702193|7617317|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0
4700927|NCT02702193|7617316|FG000|4 Month Follow up|Withdrawal by Subject|1
4700928|NCT02702193|7617317|FG001|4 Month Follow up|Withdrawal by Subject|0
4700929|NCT02702193|7617316|FG000|4 Month Follow up|Lost to Follow-up|17
4700930|NCT02702193|7617317|FG001|4 Month Follow up|Lost to Follow-up|18
4700931|NCT02702193|7617316|FG000|8 Month Follow up|Withdrawal by Subject|1
4700932|NCT02702193|7617317|FG001|8 Month Follow up|Withdrawal by Subject|0
4700933|NCT02702193|7617316|FG000|8 Month Follow up|Lost to Follow-up|14
4700934|NCT02702193|7617317|FG001|8 Month Follow up|Lost to Follow-up|18
4700935|NCT02702193|7617316|FG000|12 Month Follow up|Withdrawal by Subject|1
4700936|NCT02702193|7617317|FG001|12 Month Follow up|Withdrawal by Subject|0
4700937|NCT02702193|7617316|FG000|12 Month Follow up|Lost to Follow-up|16
4700938|NCT02702193|7617317|FG001|12 Month Follow up|Lost to Follow-up|18
4700939|NCT02702388|7617325|FG000|Overall Study|Disease Progression|18
4700940|NCT02702388|7617326|FG001|Overall Study|Disease Progression|25
4700941|NCT02702388|7617325|FG000|Overall Study|Withdrawal by Subject|9
4700942|NCT02702388|7617326|FG001|Overall Study|Withdrawal by Subject|7
4700943|NCT02702388|7617325|FG000|Overall Study|Adverse Event|11
4700944|NCT02702388|7617326|FG001|Overall Study|Adverse Event|15
4700945|NCT02702388|7617325|FG000|Overall Study|Other|2
4700946|NCT02702388|7617326|FG001|Overall Study|Other|4
4700947|NCT02702401|7617343|FG000|Overall Study|Death|180
4700948|NCT02702401|7617344|FG001|Overall Study|Death|101
4700949|NCT02702401|7617343|FG000|Overall Study|Withdrawal by Subject|4
4700950|NCT02702401|7617344|FG001|Overall Study|Withdrawal by Subject|0
4700951|NCT02702401|7617343|FG000|Overall Study|Ongoing in study|94
4700952|NCT02702401|7617344|FG001|Overall Study|Ongoing in study|34
4700953|NCT02702518|7617352|FG000|Overall Study|Lost to Follow-up|3
4700954|NCT02702518|7617353|FG001|Overall Study|Lost to Follow-up|4
4700955|NCT02702609|7617361|FG000|Overall Study|Lost to Follow-up|8
4700956|NCT02702609|7617362|FG001|Overall Study|Lost to Follow-up|4
4700957|NCT02702609|7617361|FG000|Overall Study|Physician Decision|1
4700958|NCT02702609|7617362|FG001|Overall Study|Physician Decision|0
4700959|NCT02703259|7617388|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1
4700960|NCT02703259|7617389|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4
4700961|NCT02703259|7617388|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1
4700962|NCT02703259|7617389|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2
4700963|NCT02703259|7617388|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10
4700964|NCT02703259|7617389|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10
4700965|NCT02703311|7617395|FG000|Overall Study|Death|5
4700966|NCT02703311|7617395|FG000|Overall Study|Withdrawal by Subject|3
4700967|NCT02703324|7617399|FG000|Period Two|Withdrawal by Subject|0
4700968|NCT02703324|7617400|FG001|Period Two|Withdrawal by Subject|0
4700969|NCT02703324|7617401|FG002|Period Two|Withdrawal by Subject|1
4700970|NCT02703324|7617402|FG003|Period Two|Withdrawal by Subject|0
4700971|NCT02703324|7617403|FG004|Period Two|Withdrawal by Subject|0
4700972|NCT02703324|7617404|FG005|Period Two|Withdrawal by Subject|0
4700973|NCT02703337|7617413|FG000|Period One (Part A)|Withdrawal by Subject|0
4700974|NCT02703337|7617414|FG001|Period One (Part A)|Withdrawal by Subject|0
4700975|NCT02703337|7617415|FG002|Period One (Part A)|Withdrawal by Subject|0
4700976|NCT02703337|7617416|FG003|Period One (Part A)|Withdrawal by Subject|0
4700977|NCT02703337|7617417|FG004|Period One (Part A)|Withdrawal by Subject|1
4700978|NCT02703337|7617418|FG005|Period One (Part A)|Withdrawal by Subject|0
4700979|NCT02703337|7617419|FG006|Period One (Part A)|Withdrawal by Subject|0
4700980|NCT02703337|7617420|FG007|Period One (Part A)|Withdrawal by Subject|0
4700981|NCT02703454|7617465|FG000|Overall Study|Not treated|1
4700982|NCT02703454|7617466|FG001|Overall Study|Not treated|3
4700983|NCT02703454|7617465|FG000|Overall Study|Withdrawal by Subject|4
4700984|NCT02703454|7617466|FG001|Overall Study|Withdrawal by Subject|3
4700985|NCT02703454|7617465|FG000|Overall Study|Lost to Follow-up|1
4700986|NCT02703454|7617466|FG001|Overall Study|Lost to Follow-up|2
4700987|NCT02703454|7617465|FG000|Overall Study|Study discontinuation|5
4700988|NCT02703454|7617466|FG001|Overall Study|Study discontinuation|8
4700989|NCT02703532|7617493|FG000|Overall Study|Withdrawal by Subject|0
4700990|NCT02703532|7617494|FG001|Overall Study|Withdrawal by Subject|1
4700991|NCT02703532|7617495|FG002|Overall Study|Withdrawal by Subject|0
4700992|NCT02703532|7617496|FG003|Overall Study|Withdrawal by Subject|1
4700993|NCT02703532|7617493|FG000|Overall Study|Lost to Follow-up|2
4700994|NCT02703532|7617494|FG001|Overall Study|Lost to Follow-up|0
4700995|NCT02703532|7617495|FG002|Overall Study|Lost to Follow-up|2
4700996|NCT02703532|7617496|FG003|Overall Study|Lost to Follow-up|0
4700997|NCT02703636|7617506|FG000|Overall Study|Adverse Event|14
4700998|NCT02703636|7617506|FG000|Overall Study|Study stopped by sponsor|1
4700999|NCT02703636|7617506|FG000|Overall Study|Withdrawal by Subject|1
4701000|NCT02704091|7617553|FG000|Overall Study|Adverse Event|4
4701001|NCT02704091|7617554|FG001|Overall Study|Adverse Event|3
4701002|NCT02704091|7617553|FG000|Overall Study|Protocol Violation|5
4701003|NCT02704091|7617554|FG001|Overall Study|Protocol Violation|3
4701004|NCT02704091|7617553|FG000|Overall Study|Consent withdrawn|4
4701005|NCT02704091|7617554|FG001|Overall Study|Consent withdrawn|4
4701006|NCT02704091|7617553|FG000|Overall Study|Lost to Follow-up|13
4701007|NCT02704091|7617554|FG001|Overall Study|Lost to Follow-up|5
4589916|NCT01516437|7435526|FG002|Overall Study|Reason not specified|1
4589917|NCT01516437|7435527|FG003|Overall Study|Reason not specified|1
4589918|NCT01516736|7435563|FG000|Overall Study|Withdrawal by Subject|10
4589919|NCT01516736|7435564|FG001|Overall Study|Withdrawal by Subject|4
4589920|NCT01516736|7435563|FG000|Overall Study|Adverse Event|4
4589921|NCT01516736|7435564|FG001|Overall Study|Adverse Event|5
4589922|NCT01516736|7435563|FG000|Overall Study|Death|3
4589923|NCT01516736|7435564|FG001|Overall Study|Death|1
4589924|NCT01516736|7435563|FG000|Overall Study|Physician Decision|2
4589925|NCT01516736|7435564|FG001|Overall Study|Physician Decision|1
4589926|NCT01516736|7435563|FG000|Overall Study|Lack of Efficacy|1
4701008|NCT02704091|7617553|FG000|Overall Study|Other|2
4701009|NCT02704091|7617554|FG001|Overall Study|Other|8
4701010|NCT02704143|7617568|FG000|Overall Study|disease progression|10
4701011|NCT02704689|7617581|FG000|Overall Study|Physician Decision|1
4701012|NCT02704689|7617581|FG000|Overall Study|Study device not implanted|2
4701013|NCT02705105|7617622|FG000|Treatment|Objective Disease Progression|1
4701014|NCT02705105|7617623|FG001|Treatment|Objective Disease Progression|50
4701015|NCT02705105|7617622|FG000|Treatment|Withdrawal by Subject|3
4701016|NCT02705105|7617623|FG001|Treatment|Withdrawal by Subject|5
4701017|NCT02705105|7617622|FG000|Treatment|Adverse Event|0
4701018|NCT02705105|7617623|FG001|Treatment|Adverse Event|17
4701019|NCT02705105|7617622|FG000|Treatment|Clinical Disease Progression|0
4701020|NCT02705105|7617623|FG001|Treatment|Clinical Disease Progression|32
4701021|NCT02705105|7617622|FG000|Treatment|Physician Decision|0
4701022|NCT02705105|7617623|FG001|Treatment|Physician Decision|3
4701023|NCT02705105|7617622|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0
4701024|NCT02705105|7617623|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2
4701025|NCT02705105|7617622|FG000|Follow-Up|Death|3
4701026|NCT02705105|7617623|FG001|Follow-Up|Death|68
4701027|NCT02705105|7617622|FG000|Follow-Up|Withdrawal by Subject|1
4701028|NCT02705105|7617623|FG001|Follow-Up|Withdrawal by Subject|14
4701029|NCT02705105|7617622|FG000|Follow-Up|Study Terminated|0
4701030|NCT02705105|7617623|FG001|Follow-Up|Study Terminated|26
4701031|NCT02705105|7617622|FG000|Follow-Up|Discontinued per Amendment 3|0
4701032|NCT02705105|7617623|FG001|Follow-Up|Discontinued per Amendment 3|2
4701033|NCT02705586|7617659|FG000|Overall Study|Health Issues|2
4701034|NCT02705586|7617659|FG000|Overall Study|Transportation Difficulties|5
4589927|NCT01516736|7435564|FG001|Overall Study|Lack of Efficacy|0
4701035|NCT02705586|7617659|FG000|Overall Study|Vacation/Planned Absence|1
4701036|NCT02705625|7617666|FG000|Overall Study|Protocol Violation|1
4701037|NCT02705625|7617667|FG001|Overall Study|Protocol Violation|0
4701038|NCT02705625|7617668|FG002|Overall Study|Protocol Violation|0
4701039|NCT02705625|7617666|FG000|Overall Study|Adverse Event|6
4701040|NCT02705625|7617667|FG001|Overall Study|Adverse Event|5
4701041|NCT02705625|7617668|FG002|Overall Study|Adverse Event|2
4701042|NCT02705625|7617666|FG000|Overall Study|Death|0
4518678|NCT00975507|7330862|FG001|Overall Study|Withdrawal by Subject|3
4589928|NCT01516736|7435563|FG000|Overall Study|Protocol Violation|0
4701043|NCT02705625|7617667|FG001|Overall Study|Death|0
4701044|NCT02705625|7617668|FG002|Overall Study|Death|1
4701045|NCT02705625|7617666|FG000|Overall Study|Withdrawal by Subject|1
4701046|NCT02705625|7617667|FG001|Overall Study|Withdrawal by Subject|4
4701047|NCT02705625|7617668|FG002|Overall Study|Withdrawal by Subject|5
4701048|NCT02705625|7617666|FG000|Overall Study|Lost to Follow-up|0
4701049|NCT02705625|7617667|FG001|Overall Study|Lost to Follow-up|0
4701050|NCT02705625|7617668|FG002|Overall Study|Lost to Follow-up|1
4701051|NCT02705625|7617666|FG000|Overall Study|Non-compliance|0
4701052|NCT02705625|7617667|FG001|Overall Study|Non-compliance|1
4701053|NCT02705625|7617668|FG002|Overall Study|Non-compliance|1
4701054|NCT02705625|7617666|FG000|Overall Study|Overdosing|0
4701055|NCT02705625|7617667|FG001|Overall Study|Overdosing|0
4701056|NCT02705625|7617668|FG002|Overall Study|Overdosing|1
4701057|NCT02705716|7617678|FG000|Overall Study|Adverse Event|0
4701058|NCT02705716|7617679|FG001|Overall Study|Adverse Event|1
4701059|NCT02705716|7617678|FG000|Overall Study|Protocol Violation|3
4701060|NCT02705716|7617679|FG001|Overall Study|Protocol Violation|0
4701061|NCT02705716|7617678|FG000|Overall Study|Withdrawal of Consent|1
4701062|NCT02705716|7617679|FG001|Overall Study|Withdrawal of Consent|1
4701063|NCT02706327|7617712|FG000|Overall Study|Lost to Follow-up|1
4701064|NCT02706327|7617713|FG001|Overall Study|Lost to Follow-up|1
4701065|NCT02706327|7617714|FG002|Overall Study|Lost to Follow-up|2
4701066|NCT02706483|7617722|FG000|Overall Study|Adverse Event|97
4701067|NCT02706483|7617722|FG000|Overall Study|Death|1
4701068|NCT02706483|7617722|FG000|Overall Study|Lack of Efficacy|39
4701069|NCT02706483|7617722|FG000|Overall Study|Lost to Follow-up|101
4701070|NCT02706483|7617722|FG000|Overall Study|Non-compliance with study drug|15
4701071|NCT02706483|7617722|FG000|Overall Study|Physician Decision|6
4701072|NCT02706483|7617722|FG000|Overall Study|Pregnancy|6
4701073|NCT02706483|7617722|FG000|Overall Study|Protocol Violation|18
4701074|NCT02706483|7617722|FG000|Overall Study|Withdrawal by Subject|136
4701075|NCT02706483|7617722|FG000|Overall Study|Non-compliance with visits|6
4701076|NCT02706483|7617722|FG000|Overall Study|Site closure|4
4701077|NCT02706483|7617722|FG000|Overall Study|Subject moved|1
4701078|NCT02706717|7617728|FG000|Overall Study|Withdrawal by Subject|1
4701079|NCT02706717|7617729|FG001|Overall Study|Withdrawal by Subject|8
4701080|NCT02706717|7617728|FG000|Overall Study|Lost to Follow-up|0
4701081|NCT02706717|7617729|FG001|Overall Study|Lost to Follow-up|1
4701082|NCT02706717|7617728|FG000|Overall Study|Physician Decision|0
4701083|NCT02706717|7617729|FG001|Overall Study|Physician Decision|1
4701084|NCT02706717|7617728|FG000|Overall Study|Death|0
4701085|NCT02706717|7617729|FG001|Overall Study|Death|1
4701086|NCT02706834|7617746|FG000|Overall Study|Pretreatment Event/Adverse Event|0
4701087|NCT02706834|7617747|FG001|Overall Study|Pretreatment Event/Adverse Event|1
4701088|NCT02706834|7617748|FG002|Overall Study|Pretreatment Event/Adverse Event|0
4701089|NCT02706834|7617749|FG003|Overall Study|Pretreatment Event/Adverse Event|0
4701090|NCT02706834|7617750|FG004|Overall Study|Pretreatment Event/Adverse Event|0
4701091|NCT02706834|7617751|FG005|Overall Study|Pretreatment Event/Adverse Event|0
4701092|NCT02706834|7617752|FG006|Overall Study|Pretreatment Event/Adverse Event|0
4701093|NCT02706834|7617753|FG007|Overall Study|Pretreatment Event/Adverse Event|0
4701094|NCT02706834|7617754|FG008|Overall Study|Pretreatment Event/Adverse Event|0
4701095|NCT02706834|7617755|FG009|Overall Study|Pretreatment Event/Adverse Event|0
4701096|NCT02706834|7617756|FG010|Overall Study|Pretreatment Event/Adverse Event|1
4701097|NCT02706834|7617746|FG000|Overall Study|Lost to Follow-up|0
4701098|NCT02706834|7617747|FG001|Overall Study|Lost to Follow-up|0
4701099|NCT02706834|7617748|FG002|Overall Study|Lost to Follow-up|1
4701100|NCT02706834|7617749|FG003|Overall Study|Lost to Follow-up|0
4701101|NCT02706834|7617750|FG004|Overall Study|Lost to Follow-up|0
4701102|NCT02706834|7617751|FG005|Overall Study|Lost to Follow-up|0
4701103|NCT02706834|7617752|FG006|Overall Study|Lost to Follow-up|0
4701104|NCT02706834|7617753|FG007|Overall Study|Lost to Follow-up|0
4701105|NCT02706834|7617754|FG008|Overall Study|Lost to Follow-up|0
4701106|NCT02706834|7617755|FG009|Overall Study|Lost to Follow-up|0
4701107|NCT02706834|7617756|FG010|Overall Study|Lost to Follow-up|0
4701108|NCT02706834|7617746|FG000|Overall Study|Voluntary Withdrawal|1
4701109|NCT02706834|7617747|FG001|Overall Study|Voluntary Withdrawal|0
4701110|NCT02706834|7617748|FG002|Overall Study|Voluntary Withdrawal|0
4701111|NCT02706834|7617749|FG003|Overall Study|Voluntary Withdrawal|0
4701112|NCT02706834|7617750|FG004|Overall Study|Voluntary Withdrawal|0
4701113|NCT02706834|7617751|FG005|Overall Study|Voluntary Withdrawal|0
4701114|NCT02706834|7617752|FG006|Overall Study|Voluntary Withdrawal|0
4701115|NCT02706834|7617753|FG007|Overall Study|Voluntary Withdrawal|0
4701116|NCT02706834|7617754|FG008|Overall Study|Voluntary Withdrawal|0
4701117|NCT02706834|7617755|FG009|Overall Study|Voluntary Withdrawal|1
4701118|NCT02706834|7617756|FG010|Overall Study|Voluntary Withdrawal|0
4701119|NCT02706834|7617746|FG000|Overall Study|Other Reason Not Specified|1
4701120|NCT02706834|7617747|FG001|Overall Study|Other Reason Not Specified|0
4701121|NCT02706834|7617748|FG002|Overall Study|Other Reason Not Specified|0
4701122|NCT02706834|7617749|FG003|Overall Study|Other Reason Not Specified|0
4701123|NCT02706834|7617750|FG004|Overall Study|Other Reason Not Specified|1
4701124|NCT02706834|7617751|FG005|Overall Study|Other Reason Not Specified|0
4701125|NCT02706834|7617752|FG006|Overall Study|Other Reason Not Specified|0
4701126|NCT02706834|7617753|FG007|Overall Study|Other Reason Not Specified|0
4701127|NCT02706834|7617754|FG008|Overall Study|Other Reason Not Specified|0
4701128|NCT02706834|7617755|FG009|Overall Study|Other Reason Not Specified|0
4701129|NCT02706834|7617756|FG010|Overall Study|Other Reason Not Specified|0
4701130|NCT02706873|7617805|FG000|Overall Study|Adverse Event|13
4701131|NCT02706873|7617806|FG001|Overall Study|Adverse Event|3
4701132|NCT02706873|7617807|FG002|Overall Study|Adverse Event|13
4701133|NCT02706873|7617808|FG003|Overall Study|Adverse Event|12
4701134|NCT02706873|7617805|FG000|Overall Study|Withdrawal by Subject|15
4771235|NCT02978781|7748151|FG000|Part A|Adverse Event|1
4701135|NCT02706873|7617806|FG001|Overall Study|Withdrawal by Subject|0
4701136|NCT02706873|7617807|FG002|Overall Study|Withdrawal by Subject|8
4701137|NCT02706873|7617808|FG003|Overall Study|Withdrawal by Subject|11
4701138|NCT02706873|7617805|FG000|Overall Study|Lost to Follow-up|3
4701139|NCT02706873|7617806|FG001|Overall Study|Lost to Follow-up|0
4701140|NCT02706873|7617807|FG002|Overall Study|Lost to Follow-up|4
4701141|NCT02706873|7617808|FG003|Overall Study|Lost to Follow-up|2
4701142|NCT02706873|7617805|FG000|Overall Study|Lack of Efficacy|10
4701143|NCT02706873|7617806|FG001|Overall Study|Lack of Efficacy|0
4701144|NCT02706873|7617807|FG002|Overall Study|Lack of Efficacy|0
4701145|NCT02706873|7617808|FG003|Overall Study|Lack of Efficacy|3
4701146|NCT02706873|7617805|FG000|Overall Study|Other|5
4701147|NCT02706873|7617806|FG001|Overall Study|Other|1
4701148|NCT02706873|7617807|FG002|Overall Study|Other|2
4701149|NCT02706873|7617808|FG003|Overall Study|Other|3
4701150|NCT02706873|7617805|FG000|Overall Study|Not Dosed|1
4701151|NCT02706873|7617806|FG001|Overall Study|Not Dosed|0
4701152|NCT02706873|7617807|FG002|Overall Study|Not Dosed|0
4701153|NCT02706873|7617808|FG003|Overall Study|Not Dosed|1
4701154|NCT02706873|7617805|FG000|Overall Study|Ongoing|0
4701155|NCT02706873|7617806|FG001|Overall Study|Ongoing|0
4701156|NCT02706873|7617807|FG002|Overall Study|Ongoing|0
4701157|NCT02706873|7617808|FG003|Overall Study|Ongoing|1
4701158|NCT02706886|7617829|FG000|Part A: SAD Period|Withdrawal by Subject|0
4701159|NCT02706886|7617830|FG001|Part A: SAD Period|Withdrawal by Subject|0
4701160|NCT02706886|7617831|FG002|Part A: SAD Period|Withdrawal by Subject|0
4701161|NCT02706886|7617832|FG003|Part A: SAD Period|Withdrawal by Subject|2
4701162|NCT02706886|7617833|FG004|Part A: SAD Period|Withdrawal by Subject|0
4701163|NCT02706886|7617834|FG005|Part A: SAD Period|Withdrawal by Subject|0
4701164|NCT02706886|7617835|FG006|Part A: SAD Period|Withdrawal by Subject|0
4701165|NCT02706886|7617836|FG007|Part A: SAD Period|Withdrawal by Subject|0
4701166|NCT02706886|7617837|FG008|Part A: SAD Period|Withdrawal by Subject|0
4701167|NCT02706899|7617882|FG000|Overall Study|Withdrawal by Subject|1
4701168|NCT02706899|7617883|FG001|Overall Study|Withdrawal by Subject|0
4701169|NCT02706899|7617882|FG000|Overall Study|Death|8
4701170|NCT02706899|7617883|FG001|Overall Study|Death|0
4701171|NCT02706899|7617882|FG000|Overall Study|Study Termination by Sponsor|4
4701172|NCT02706899|7617883|FG001|Overall Study|Study Termination by Sponsor|6
4701173|NCT02706938|7617936|FG000|First Period, 6 Weeks|Adverse Event|8
4701174|NCT02706938|7617937|FG001|First Period, 6 Weeks|Adverse Event|0
4701175|NCT02706938|7617936|FG000|First Period, 6 Weeks|Lost to Follow-up|2
4701176|NCT02706938|7617937|FG001|First Period, 6 Weeks|Lost to Follow-up|2
4701177|NCT02706938|7617936|FG000|First Period, 6 Weeks|Withdrawal by Subject|1
4701178|NCT02706938|7617937|FG001|First Period, 6 Weeks|Withdrawal by Subject|0
4701179|NCT02706938|7617936|FG000|Second Period, 6 Weeks|Adverse Event|0
4701180|NCT02706938|7617937|FG001|Second Period, 6 Weeks|Adverse Event|7
4701181|NCT02706938|7617936|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0
4701182|NCT02706938|7617937|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3
4701183|NCT02706951|7617947|FG000|Overall Study|Adverse Event|1
4701184|NCT02706951|7617948|FG001|Overall Study|Adverse Event|5
4701185|NCT02706951|7617949|FG002|Overall Study|Adverse Event|3
4701186|NCT02706951|7617947|FG000|Overall Study|Withdrawal by Subject|11
4701187|NCT02706951|7617948|FG001|Overall Study|Withdrawal by Subject|6
4701188|NCT02706951|7617949|FG002|Overall Study|Withdrawal by Subject|6
4701189|NCT02706951|7617947|FG000|Overall Study|Lost to Follow-up|0
4701190|NCT02706951|7617948|FG001|Overall Study|Lost to Follow-up|4
4701191|NCT02706951|7617949|FG002|Overall Study|Lost to Follow-up|1
4701192|NCT02706951|7617947|FG000|Overall Study|Other|2
4701193|NCT02706951|7617948|FG001|Overall Study|Other|1
4701194|NCT02706951|7617949|FG002|Overall Study|Other|0
4735329|NCT03526861|7683206|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
4735330|NCT03526861|7683207|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
4735331|NCT03526861|7683208|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
4735332|NCT03526861|7683209|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
4735333|NCT03526861|7683210|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
4735334|NCT03526861|7683211|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0
4735335|NCT03526861|7683212|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19
4735336|NCT03526861|7683204|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0
4735337|NCT03526861|7683205|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0
4735338|NCT03526861|7683206|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0
4735339|NCT03526861|7683207|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0
4735340|NCT03526861|7683208|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0
4735341|NCT03526861|7683209|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0
4735342|NCT03526861|7683210|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0
4735343|NCT03526861|7683211|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0
4735344|NCT03526861|7683212|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1
4735345|NCT03526861|7683204|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
4735346|NCT03526861|7683205|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
4735347|NCT03526861|7683206|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
4735348|NCT03526861|7683207|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
4735349|NCT03526861|7683208|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
4735350|NCT03526861|7683209|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
4735351|NCT03526861|7683210|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
4701195|NCT02707601|7617995|FG000|Overall Study|Death|0
4701196|NCT02707601|7617996|FG001|Overall Study|Death|1
4701197|NCT02707601|7617995|FG000|Overall Study|Lack of Efficacy|0
4701198|NCT02707601|7617996|FG001|Overall Study|Lack of Efficacy|1
4701199|NCT02707601|7617995|FG000|Overall Study|Investigator's Discretion|1
4701200|NCT02707601|7617996|FG001|Overall Study|Investigator's Discretion|0
4701201|NCT02707601|7617995|FG000|Overall Study|Withdrew Consent|0
4701202|NCT02707601|7617996|FG001|Overall Study|Withdrew Consent|1
4701203|NCT02707601|7617995|FG000|Overall Study|Lost to Follow-up|1
4701204|NCT02707601|7617996|FG001|Overall Study|Lost to Follow-up|1
4701205|NCT02707601|7617995|FG000|Overall Study|Participants Randomized but Not Treated|2
4701206|NCT02707601|7617996|FG001|Overall Study|Participants Randomized but Not Treated|0
4701207|NCT02707640|7618008|FG000|Overall Study|Adverse Event|4
4701208|NCT02707640|7618009|FG001|Overall Study|Adverse Event|2
4701209|NCT02707640|7618008|FG000|Overall Study|Death|1
4701210|NCT02707640|7618009|FG001|Overall Study|Death|2
4701211|NCT02707640|7618008|FG000|Overall Study|Physician Decision|2
4701212|NCT02707640|7618009|FG001|Overall Study|Physician Decision|0
4701213|NCT02707640|7618008|FG000|Overall Study|Withdrawal by Subject|0
4701214|NCT02707640|7618009|FG001|Overall Study|Withdrawal by Subject|1
4701215|NCT02707640|7618008|FG000|Overall Study|Participant's Personal Decision|1
4701216|NCT02707640|7618009|FG001|Overall Study|Participant's Personal Decision|2
4701217|NCT02707640|7618008|FG000|Overall Study|Sponsor Discretion|1
4701218|NCT02707640|7618009|FG001|Overall Study|Sponsor Discretion|0
4701219|NCT02707757|7618017|FG000|Overall Study|Protocol Violation|3
4701220|NCT02707757|7618018|FG001|Overall Study|Protocol Violation|2
4701221|NCT02707757|7618017|FG000|Overall Study|Withdrawal by Subject|2
4701222|NCT02707757|7618018|FG001|Overall Study|Withdrawal by Subject|0
4701223|NCT02707757|7618017|FG000|Overall Study|Death|0
4701224|NCT02707757|7618018|FG001|Overall Study|Death|1
4701225|NCT02707757|7618017|FG000|Overall Study|Adverse Event|6
4701226|NCT02707757|7618018|FG001|Overall Study|Adverse Event|4
4701227|NCT02707757|7618017|FG000|Overall Study|Renal transplant/elective operation|1
4701228|NCT02707757|7618018|FG001|Overall Study|Renal transplant/elective operation|5
4701229|NCT02707861|7618037|FG000|Overall Study|Went onto commercial drug|30
4701230|NCT02707861|7618038|FG001|Overall Study|Went onto commercial drug|23
4701231|NCT02707861|7618037|FG000|Overall Study|Adverse Event|2
4701232|NCT02707861|7618038|FG001|Overall Study|Adverse Event|3
4701233|NCT02707861|7618037|FG000|Overall Study|Death|5
4701234|NCT02707861|7618038|FG001|Overall Study|Death|2
4701235|NCT02707861|7618037|FG000|Overall Study|Lack of Efficacy|0
4701236|NCT02707861|7618038|FG001|Overall Study|Lack of Efficacy|2
4701237|NCT02707861|7618037|FG000|Overall Study|Physician Decision|1
4701238|NCT02707861|7618038|FG001|Overall Study|Physician Decision|4
4701239|NCT02707861|7618037|FG000|Overall Study|Withdrawal by Subject|2
4484707|NCT00744874|7284069|FG000|Overall Study|Unable to accomodate schedule|1
4484708|NCT00744939|7284084|FG000|Overall Study|Withdrawal by Subject|9
4484709|NCT00744939|7284084|FG000|Overall Study|Protocol Violation|13
4484710|NCT00744939|7284084|FG000|Overall Study|Death|24
4484711|NCT00744939|7284084|FG000|Overall Study|distance|4
4484712|NCT00744939|7284084|FG000|Overall Study|Lost to Follow-up|12
4484713|NCT00744939|7284084|FG000|Overall Study|Medical history exclusionary|1
4484714|NCT00744939|7284084|FG000|Overall Study|Did not receive Magnevist|7
4484715|NCT00744939|7284084|FG000|Overall Study|Failed inclusion/exclusion criteria|19
4484716|NCT00744939|7284084|FG000|Overall Study|coma|1
4484717|NCT00744939|7284084|FG000|Overall Study|incorrect race|1
4484718|NCT00744978|7284107|FG000|Period 1|Lost to Follow-up|1
4484719|NCT00744978|7284108|FG001|Period 1|Lost to Follow-up|0
4484720|NCT00744978|7284107|FG000|Period 1|Withdrawal by Subject|0
4484721|NCT00744978|7284108|FG001|Period 1|Withdrawal by Subject|2
4484722|NCT00744978|7284107|FG000|Period 1|Other|0
4484723|NCT00744978|7284108|FG001|Period 1|Other|2
4484724|NCT00744978|7284107|FG000|Period 1|Adverse Event|4
4484725|NCT00744978|7284108|FG001|Period 1|Adverse Event|0
4484726|NCT00744978|7284107|FG000|Period 1|Randomized but not Treated|1
4484727|NCT00744978|7284108|FG001|Period 1|Randomized but not Treated|1
4484728|NCT00744978|7284107|FG000|Period 2|Adverse Event|0
4484729|NCT00744978|7284108|FG001|Period 2|Adverse Event|1
4484730|NCT00744991|7284114|FG000|Overall Study|Progressive Disease|11
4484731|NCT00744991|7284114|FG000|Overall Study|Withdrawal by Subject|8
4484732|NCT00744991|7284114|FG000|Overall Study|Physician Decision|3
4484733|NCT00744991|7284114|FG000|Overall Study|Adverse Event|2
4701240|NCT02707861|7618038|FG001|Overall Study|Withdrawal by Subject|1
4701241|NCT02707861|7618037|FG000|Overall Study|Lost to Follow-up|1
4701242|NCT02707861|7618038|FG001|Overall Study|Lost to Follow-up|3
4701243|NCT02707952|7618048|FG000|Overall Study|Adverse Event|1
4484734|NCT00744991|7284114|FG000|Overall Study|Protocol Entry Criteria Unmet|1
4484735|NCT00745095|7284127|FG000|Overall Study|Declined to participate|1
4701244|NCT02707952|7618049|FG001|Overall Study|Adverse Event|0
4484736|NCT00745095|7284128|FG001|Overall Study|Declined to participate|0
4484737|NCT00745095|7284129|FG002|Overall Study|Declined to participate|0
4484738|NCT00745095|7284130|FG003|Overall Study|Declined to participate|0
4484739|NCT00745095|7284131|FG004|Overall Study|Declined to participate|92
4701245|NCT02707952|7618050|FG002|Overall Study|Adverse Event|0
4701246|NCT02707952|7618051|FG003|Overall Study|Adverse Event|0
4701247|NCT02707952|7618048|FG000|Overall Study|Lost to Follow-up|1
4484740|NCT00745095|7284132|FG005|Overall Study|Declined to participate|95
4484741|NCT00745095|7284127|FG000|Overall Study|Ineligible due to GFR criteria|0
4484742|NCT00745095|7284128|FG001|Overall Study|Ineligible due to GFR criteria|2
4484743|NCT00745095|7284129|FG002|Overall Study|Ineligible due to GFR criteria|3
4484744|NCT00745095|7284130|FG003|Overall Study|Ineligible due to GFR criteria|3
4484745|NCT00745095|7284131|FG004|Overall Study|Ineligible due to GFR criteria|30
4484746|NCT00745095|7284132|FG005|Overall Study|Ineligible due to GFR criteria|28
4484747|NCT00745121|7284151|FG000|Overall Study|Death|3
4484748|NCT00745121|7284152|FG001|Overall Study|Death|0
4484749|NCT00745121|7284151|FG000|Overall Study|Adverse Event|1
4484750|NCT00745121|7284152|FG001|Overall Study|Adverse Event|0
4484751|NCT00745121|7284151|FG000|Overall Study|Lost to Follow-up|1
4484752|NCT00745121|7284152|FG001|Overall Study|Lost to Follow-up|0
4484753|NCT00745121|7284151|FG000|Overall Study|Withdrawal by Subject|4
4484754|NCT00745121|7284152|FG001|Overall Study|Withdrawal by Subject|2
4484755|NCT00745251|7284160|FG000|Overall Study|Adverse Event|1
4484756|NCT00745251|7284161|FG001|Overall Study|Adverse Event|2
4484757|NCT00745251|7284160|FG000|Overall Study|Withdrawal by Subject|1
4484758|NCT00745251|7284161|FG001|Overall Study|Withdrawal by Subject|1
4484759|NCT00745368|7284176|FG000|Overall Study|Unable to provide sample|3
4484760|NCT00745420|7284180|FG000|Overall Study|Ineligible|1
4484761|NCT00745498|7284187|FG000|Overall Study|Lost to Follow-up|1
4484762|NCT00745498|7284188|FG001|Overall Study|Lost to Follow-up|1
4484763|NCT00745498|7284189|FG002|Overall Study|Lost to Follow-up|3
4484764|NCT00745498|7284187|FG000|Overall Study|Injection of intravitreal silicone oil o|3
4484765|NCT00745498|7284188|FG001|Overall Study|Injection of intravitreal silicone oil o|4
4484766|NCT00745498|7284189|FG002|Overall Study|Injection of intravitreal silicone oil o|4
4484767|NCT00745498|7284187|FG000|Overall Study|Non-PDR related VH|0
4484768|NCT00745498|7284188|FG001|Overall Study|Non-PDR related VH|1
4484769|NCT00745498|7284189|FG002|Overall Study|Non-PDR related VH|1
4484770|NCT00745498|7284187|FG000|Overall Study|Edophthalmitis after preoperative IVB|1
4484771|NCT00745498|7284188|FG001|Overall Study|Edophthalmitis after preoperative IVB|0
4484772|NCT00745498|7284189|FG002|Overall Study|Edophthalmitis after preoperative IVB|0
4484773|NCT00745615|7284201|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3
4484774|NCT00745615|7284202|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1
4484775|NCT00745615|7284203|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0
4484776|NCT00745615|7284204|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4
4484777|NCT00745615|7284205|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0
4484778|NCT00745615|7284206|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0
4484779|NCT00745615|7284201|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0
4484780|NCT00745615|7284202|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1
4484781|NCT00745615|7284203|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0
4484782|NCT00745615|7284204|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0
4484783|NCT00745615|7284205|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0
4484784|NCT00745615|7284206|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0
4484785|NCT00745615|7284201|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2
4484786|NCT00745615|7284202|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3
4484787|NCT00745615|7284203|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1
4484788|NCT00745615|7284204|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1
4484789|NCT00745615|7284205|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0
4484790|NCT00745615|7284206|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0
4484791|NCT00745615|7284201|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0
4484792|NCT00745615|7284202|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1
4484793|NCT00745615|7284203|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0
4484794|NCT00745615|7284204|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0
4484795|NCT00745615|7284205|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0
4484796|NCT00745615|7284206|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0
4484797|NCT00745615|7284201|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0
4484798|NCT00745615|7284202|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1
4484799|NCT00745615|7284203|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0
4484800|NCT00745615|7284204|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0
4484801|NCT00745615|7284205|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0
4484802|NCT00745615|7284206|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0
4484803|NCT00745615|7284201|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
4484804|NCT00745615|7284202|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
4484805|NCT00745615|7284203|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
4484806|NCT00745615|7284204|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
4484807|NCT00745615|7284205|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50
4484808|NCT00745615|7284206|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50
4484809|NCT00745615|7284201|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
4484810|NCT00745615|7284202|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
4484811|NCT00745615|7284203|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
4484812|NCT00745615|7284204|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
4484813|NCT00745615|7284205|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19
4589929|NCT01516736|7435564|FG001|Overall Study|Protocol Violation|1
4589930|NCT01516736|7435563|FG000|Overall Study|Other (not specified)|0
4701248|NCT02707952|7618049|FG001|Overall Study|Lost to Follow-up|0
4701249|NCT02707952|7618050|FG002|Overall Study|Lost to Follow-up|0
4701250|NCT02707952|7618051|FG003|Overall Study|Lost to Follow-up|0
4701251|NCT02707952|7618048|FG000|Overall Study|Withdrawal by Subject|0
4484814|NCT00745615|7284206|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19
4484815|NCT00745615|7284201|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
4484816|NCT00745615|7284202|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
4484817|NCT00745615|7284203|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
4484818|NCT00745615|7284204|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
4484819|NCT00745615|7284205|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9
4484820|NCT00745615|7284206|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11
4484821|NCT00745615|7284201|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
4484822|NCT00745615|7284202|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
4484823|NCT00745615|7284203|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
4484824|NCT00745615|7284204|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
4484825|NCT00745615|7284205|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2
4484826|NCT00745615|7284206|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8
4484827|NCT00745615|7284201|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
4484828|NCT00745615|7284202|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
4484829|NCT00745615|7284203|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
4484830|NCT00745615|7284204|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
4484831|NCT00745615|7284205|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2
4484832|NCT00745615|7284206|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5
4484833|NCT00745615|7284201|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
4484834|NCT00745615|7284202|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
4484835|NCT00745615|7284203|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
4484836|NCT00745615|7284204|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
4484837|NCT00745615|7284205|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1
4484838|NCT00745615|7284206|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3
4484839|NCT00745615|7284201|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
4484840|NCT00745615|7284202|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
4484841|NCT00745615|7284203|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
4484842|NCT00745615|7284204|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
4484843|NCT00745615|7284205|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
4484844|NCT00745615|7284206|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1
4484845|NCT00745615|7284201|FG000|Open-Label (up to Approx 10.5 Years)|Death|0
4484846|NCT00745615|7284202|FG001|Open-Label (up to Approx 10.5 Years)|Death|0
4484847|NCT00745615|7284203|FG002|Open-Label (up to Approx 10.5 Years)|Death|0
4484848|NCT00745615|7284204|FG003|Open-Label (up to Approx 10.5 Years)|Death|0
4484849|NCT00745615|7284205|FG004|Open-Label (up to Approx 10.5 Years)|Death|0
4484850|NCT00745615|7284206|FG005|Open-Label (up to Approx 10.5 Years)|Death|1
4484851|NCT00745615|7284201|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
4484852|NCT00745615|7284202|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
4484853|NCT00745615|7284203|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
4484854|NCT00745615|7284204|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
4484855|NCT00745615|7284205|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8
4484856|NCT00745615|7284206|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10
4484857|NCT00745823|7284220|FG000|Overall Study|Adverse Event|5
4484858|NCT00745823|7284221|FG001|Overall Study|Adverse Event|3
4484859|NCT00745823|7284220|FG000|Overall Study|Lack of Efficacy|20
4484860|NCT00745823|7284221|FG001|Overall Study|Lack of Efficacy|6
4484861|NCT00745823|7284220|FG000|Overall Study|Lost to Follow-up|10
4484862|NCT00745823|7284221|FG001|Overall Study|Lost to Follow-up|11
4484863|NCT00745823|7284220|FG000|Overall Study|Physician Decision|10
4484864|NCT00745823|7284221|FG001|Overall Study|Physician Decision|5
4484865|NCT00745823|7284220|FG000|Overall Study|Pregnancy|0
4484866|NCT00745823|7284221|FG001|Overall Study|Pregnancy|4
4484867|NCT00745823|7284220|FG000|Overall Study|Withdrawal by Subject|14
4484868|NCT00745823|7284221|FG001|Overall Study|Withdrawal by Subject|8
4484869|NCT00745823|7284220|FG000|Overall Study|Study Terminated by Sponsor|326
4484870|NCT00745823|7284221|FG001|Overall Study|Study Terminated by Sponsor|349
4484871|NCT00745849|7284229|FG000|First Intervention|Withdrawal by Subject|0
4484872|NCT00745849|7284230|FG001|First Intervention|Withdrawal by Subject|1
4484873|NCT00745849|7284229|FG000|First Intervention|Lost to Follow-up|1
4484874|NCT00745849|7284230|FG001|First Intervention|Lost to Follow-up|1
4484875|NCT00745849|7284229|FG000|Second Intervention|Lost to Follow-up|2
4484876|NCT00745849|7284230|FG001|Second Intervention|Lost to Follow-up|1
4517077|NCT00963820|7328690|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
4517078|NCT00963820|7328691|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
4517079|NCT00963820|7328692|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
4517080|NCT00963820|7328681|FG000|Expansion Phase|Progressive Disease|0
4517081|NCT00963820|7328682|FG001|Expansion Phase|Progressive Disease|0
4517082|NCT00963820|7328683|FG002|Expansion Phase|Progressive Disease|0
4484877|NCT00745875|7284238|FG000|Overall Study|Continuing study treatment|4
4589931|NCT01516736|7435564|FG001|Overall Study|Other (not specified)|1
4589932|NCT01516749|7435570|FG000|Active Therapy|Lost to Follow-up|1
4589933|NCT01516749|7435570|FG000|Follow-up Off Therapy|Lost to Follow-up|1
4589934|NCT01516879|7435576|FG000|Overall Study|Withdrawal by Subject|9
4484878|NCT00745875|7284239|FG001|Overall Study|Continuing study treatment|4
4484879|NCT00745901|7284247|FG000|Overall Study|Adverse Event|3
4484880|NCT00745901|7284248|FG001|Overall Study|Adverse Event|4
4484881|NCT00745901|7284247|FG000|Overall Study|Protocol Violation|0
4484882|NCT00745901|7284248|FG001|Overall Study|Protocol Violation|1
4484883|NCT00745901|7284247|FG000|Overall Study|Withdrawal by Subject|1
4484884|NCT00745901|7284248|FG001|Overall Study|Withdrawal by Subject|0
4484885|NCT00745901|7284247|FG000|Overall Study|Lost to Follow-up|7
4484886|NCT00745901|7284248|FG001|Overall Study|Lost to Follow-up|4
4484887|NCT00745901|7284247|FG000|Overall Study|Pregnancy|2
4484888|NCT00745901|7284248|FG001|Overall Study|Pregnancy|4
4484889|NCT00745901|7284247|FG000|Overall Study|Lack of compliance|2
4484890|NCT00745901|7284248|FG001|Overall Study|Lack of compliance|2
4484891|NCT00745901|7284247|FG000|Overall Study|Patient's next menses did not start with|1
4484892|NCT00745901|7284248|FG001|Overall Study|Patient's next menses did not start with|0
4484893|NCT00745901|7284247|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0
4484894|NCT00745901|7284248|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2
4484895|NCT00745901|7284247|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1
4484896|NCT00745901|7284248|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1
4484897|NCT00745901|7284247|FG000|Overall Study|Patient didn't take any study medication|7
4484898|NCT00745901|7284248|FG001|Overall Study|Patient didn't take any study medication|3
4484899|NCT00746096|7284265|FG000|Overall Study|Adverse Event|1
4484900|NCT00746096|7284266|FG001|Overall Study|Adverse Event|0
4484901|NCT00746096|7284265|FG000|Overall Study|Withdrawal by Subject|5
4484902|NCT00746096|7284266|FG001|Overall Study|Withdrawal by Subject|1
4484903|NCT00746096|7284265|FG000|Overall Study|Lost to Follow-up|2
4484904|NCT00746096|7284266|FG001|Overall Study|Lost to Follow-up|1
4484905|NCT00746096|7284265|FG000|Overall Study|Protocol Violation|1
4484906|NCT00746096|7284266|FG001|Overall Study|Protocol Violation|0
4484907|NCT00746096|7284265|FG000|Overall Study|No study drug treatment|1
4484908|NCT00746096|7284266|FG001|Overall Study|No study drug treatment|1
4484909|NCT00746252|7284292|FG000|Overall Study|weight gain >7.5 %|1
4484910|NCT00746252|7284293|FG001|Overall Study|weight gain >7.5 %|2
4484911|NCT00746330|7284303|FG000|Period 1|Abnormal test procedure result|0
4484912|NCT00746330|7284304|FG001|Period 1|Abnormal test procedure result|0
4484913|NCT00746330|7284305|FG002|Period 1|Abnormal test procedure result|1
4484914|NCT00746330|7284306|FG003|Period 1|Abnormal test procedure result|0
4589935|NCT01516879|7435577|FG001|Overall Study|Withdrawal by Subject|11
4589936|NCT01516879|7435576|FG000|Overall Study|Death|0
4589937|NCT01516879|7435577|FG001|Overall Study|Death|2
4589938|NCT01516879|7435576|FG000|Overall Study|Lost to Follow-up|2
4589939|NCT01516879|7435577|FG001|Overall Study|Lost to Follow-up|11
4589940|NCT01516879|7435576|FG000|Overall Study|Other|5
4589941|NCT01516879|7435577|FG001|Overall Study|Other|10
4589942|NCT01516892|7435583|FG000|Overall Study|Adverse Event|25
4589943|NCT01516892|7435583|FG000|Overall Study|Lack of Efficacy|35
4589944|NCT01516892|7435583|FG000|Overall Study|Pregnancy|5
4589945|NCT01516892|7435583|FG000|Overall Study|Lost to Follow-up|82
4701252|NCT02707952|7618049|FG001|Overall Study|Withdrawal by Subject|1
4484915|NCT00746356|7284317|FG000|Overall Study|Withdrawal by Subject|2
4484916|NCT00746356|7284318|FG001|Overall Study|Withdrawal by Subject|3
4484917|NCT00746356|7284317|FG000|Overall Study|Death|7
4484918|NCT00746356|7284318|FG001|Overall Study|Death|3
4484919|NCT00746356|7284317|FG000|Overall Study|Lost to Follow-up|1
4484920|NCT00746356|7284318|FG001|Overall Study|Lost to Follow-up|0
4484921|NCT00746356|7284317|FG000|Overall Study|Removal of Device|0
4484922|NCT00746356|7284318|FG001|Overall Study|Removal of Device|1
4484923|NCT00746356|7284317|FG000|Overall Study|Patient relocated|1
4484924|NCT00746356|7284318|FG001|Overall Study|Patient relocated|0
4484925|NCT00746551|7284363|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2
4484926|NCT00746551|7284364|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4
4484927|NCT00746551|7284363|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9
4484928|NCT00746551|7284364|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7
4484929|NCT00746551|7284363|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6
4484930|NCT00746551|7284364|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8
4484931|NCT00746564|7284370|FG000|Overall Study|Required Pacemaker/ICD Implant|2
4484932|NCT00746733|7284399|FG000|Second Intervention|Adverse Event|1
4589946|NCT01516892|7435583|FG000|Overall Study|Subject Withdrew Consent|92
4589947|NCT01516892|7435583|FG000|Overall Study|Protocol Violation|60
4589948|NCT01516892|7435583|FG000|Overall Study|Other Miscellaneous Reasons|43
4589949|NCT01516892|7435583|FG000|Overall Study|Missing|1
4589950|NCT01516970|7435604|FG000|Overall Study|Lost to Follow-up|7
4484933|NCT00746733|7284400|FG001|Second Intervention|Adverse Event|0
4484934|NCT00746733|7284399|FG000|Third Intervention|Withdrawal by Subject|1
4484935|NCT00746733|7284400|FG001|Third Intervention|Withdrawal by Subject|1
4484936|NCT00746785|7284416|FG000|Overall Study|Lost to Follow-up|29
4484937|NCT00746785|7284417|FG001|Overall Study|Lost to Follow-up|25
4484938|NCT00746785|7284418|FG002|Overall Study|Lost to Follow-up|27
4484939|NCT00746798|7284430|FG000|Overall Study|Protocol Violation|0
4484940|NCT00746798|7284431|FG001|Overall Study|Protocol Violation|1
4484941|NCT00746798|7284432|FG002|Overall Study|Protocol Violation|0
4484942|NCT00746798|7284433|FG003|Overall Study|Protocol Violation|0
4484943|NCT00746798|7284430|FG000|Overall Study|Withdrawal by Subject|0
4484944|NCT00746798|7284431|FG001|Overall Study|Withdrawal by Subject|1
4484945|NCT00746798|7284432|FG002|Overall Study|Withdrawal by Subject|1
4484946|NCT00746798|7284433|FG003|Overall Study|Withdrawal by Subject|0
4484947|NCT00746798|7284430|FG000|Overall Study|Death|0
4484948|NCT00746798|7284431|FG001|Overall Study|Death|0
4484949|NCT00746798|7284432|FG002|Overall Study|Death|2
4484950|NCT00746798|7284433|FG003|Overall Study|Death|0
4484951|NCT00746798|7284430|FG000|Overall Study|Participant unable to return for visit|1
4484952|NCT00746798|7284431|FG001|Overall Study|Participant unable to return for visit|0
4484953|NCT00746798|7284432|FG002|Overall Study|Participant unable to return for visit|0
4484954|NCT00746798|7284433|FG003|Overall Study|Participant unable to return for visit|0
4484955|NCT00746941|7284467|FG000|Overall Study|Death|2
4484956|NCT00746941|7284468|FG001|Overall Study|Death|0
4484957|NCT00746941|7284469|FG002|Overall Study|Death|0
4484958|NCT00746941|7284470|FG003|Overall Study|Death|6
4484959|NCT00746941|7284467|FG000|Overall Study|Physician Decision|0
4484960|NCT00746941|7284468|FG001|Overall Study|Physician Decision|0
4484961|NCT00746941|7284469|FG002|Overall Study|Physician Decision|2
4484962|NCT00746941|7284470|FG003|Overall Study|Physician Decision|0
4484963|NCT00746941|7284467|FG000|Overall Study|Withdrawal by Subject|3
4484964|NCT00746941|7284468|FG001|Overall Study|Withdrawal by Subject|0
4484965|NCT00746941|7284469|FG002|Overall Study|Withdrawal by Subject|0
4484966|NCT00746941|7284470|FG003|Overall Study|Withdrawal by Subject|2
4484967|NCT00746941|7284467|FG000|Overall Study|Other, reason not provided|2
4484968|NCT00746941|7284468|FG001|Overall Study|Other, reason not provided|4
4484969|NCT00746941|7284469|FG002|Overall Study|Other, reason not provided|0
4484970|NCT00746941|7284470|FG003|Overall Study|Other, reason not provided|4
4484971|NCT00746941|7284467|FG000|Overall Study|Adverse Event|0
4484972|NCT00746941|7284468|FG001|Overall Study|Adverse Event|0
4484973|NCT00746941|7284469|FG002|Overall Study|Adverse Event|0
4484974|NCT00746941|7284470|FG003|Overall Study|Adverse Event|1
4484975|NCT00747006|7284490|FG000|Overall Study|Adverse Event|1
4484976|NCT00747006|7284491|FG001|Overall Study|Adverse Event|0
4484977|NCT00747006|7284492|FG002|Overall Study|Adverse Event|0
4484978|NCT00747006|7284490|FG000|Overall Study|Lost to Follow-up|0
4484979|NCT00747006|7284491|FG001|Overall Study|Lost to Follow-up|1
4484980|NCT00747006|7284492|FG002|Overall Study|Lost to Follow-up|0
4484981|NCT00747006|7284490|FG000|Overall Study|Physician Decision|2
4484982|NCT00747006|7284491|FG001|Overall Study|Physician Decision|0
4484983|NCT00747006|7284492|FG002|Overall Study|Physician Decision|1
4484984|NCT00747149|7284505|FG000|Overall Study|Adverse Event|0
4484985|NCT00747149|7284506|FG001|Overall Study|Adverse Event|15
4484986|NCT00747149|7284505|FG000|Overall Study|Lost to Follow-up|0
4484987|NCT00747149|7284506|FG001|Overall Study|Lost to Follow-up|10
4484988|NCT00747149|7284505|FG000|Overall Study|Withdrawal by Subject|0
4484989|NCT00747149|7284506|FG001|Overall Study|Withdrawal by Subject|6
4484990|NCT00747149|7284505|FG000|Overall Study|Did not receive treatment|0
4484991|NCT00747149|7284506|FG001|Overall Study|Did not receive treatment|1
4484992|NCT00747149|7284505|FG000|Overall Study|Incorrect enrollment|0
4484993|NCT00747149|7284506|FG001|Overall Study|Incorrect enrollment|6
4484994|NCT00747149|7284505|FG000|Overall Study|Severe non-compliance to protocol|0
4484995|NCT00747149|7284506|FG001|Overall Study|Severe non-compliance to protocol|1
4484996|NCT00747149|7284505|FG000|Overall Study|Not reported|1
4484997|NCT00747149|7284506|FG001|Overall Study|Not reported|4
4484998|NCT00747227|7284529|FG000|Overall Study|Death|3
4484999|NCT00747227|7284530|FG001|Overall Study|Death|1
4485000|NCT00747227|7284529|FG000|Overall Study|Withdrawal by Subject|1
4485001|NCT00747227|7284530|FG001|Overall Study|Withdrawal by Subject|0
4485002|NCT00747227|7284529|FG000|Overall Study|Lost to Follow-up|1
4485003|NCT00747227|7284530|FG001|Overall Study|Lost to Follow-up|2
4485004|NCT00747227|7284529|FG000|Overall Study|Illness|1
4485005|NCT00747227|7284530|FG001|Overall Study|Illness|1
4485006|NCT00747344|7284538|FG000|Controlled Period|Adverse Event|3
4485007|NCT00747344|7284539|FG001|Controlled Period|Adverse Event|0
4485008|NCT00747344|7284540|FG002|Controlled Period|Adverse Event|0
4485009|NCT00747344|7284541|FG003|Controlled Period|Adverse Event|0
4485010|NCT00747344|7284538|FG000|Controlled Period|Lack of Efficacy|2
4485011|NCT00747344|7284539|FG001|Controlled Period|Lack of Efficacy|1
4485012|NCT00747344|7284540|FG002|Controlled Period|Lack of Efficacy|0
4485013|NCT00747344|7284541|FG003|Controlled Period|Lack of Efficacy|0
4485014|NCT00747344|7284538|FG000|Controlled Period|Other|0
4485015|NCT00747344|7284539|FG001|Controlled Period|Other|3
4485016|NCT00747344|7284540|FG002|Controlled Period|Other|0
4485017|NCT00747344|7284541|FG003|Controlled Period|Other|0
4485018|NCT00747344|7284538|FG000|After Controlled Period|Adverse Event|0
4485019|NCT00747344|7284539|FG001|After Controlled Period|Adverse Event|0
4485020|NCT00747344|7284540|FG002|After Controlled Period|Adverse Event|0
4485021|NCT00747344|7284541|FG003|After Controlled Period|Adverse Event|1
4485022|NCT00747435|7284549|FG000|Overall Study|Lost to Follow-up|2
4485023|NCT00747435|7284549|FG000|Overall Study|Withdrawal by Subject|3
4485024|NCT00747435|7284549|FG000|Overall Study|Still undergoing follow up|1
4485025|NCT00747474|7284553|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
4485026|NCT00747474|7284554|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
4485027|NCT00747474|7284555|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
4485028|NCT00747474|7284556|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
4485029|NCT00747474|7284557|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
4485030|NCT00747474|7284558|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
4485031|NCT00747474|7284559|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
4485032|NCT00747474|7284560|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1
4485033|NCT00747474|7284561|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
4485034|NCT00747474|7284562|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
4485035|NCT00747474|7284563|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
4485036|NCT00747474|7284564|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
4485037|NCT00747565|7284575|FG000|Overall Study|Withdrawal by Subject|10
4485038|NCT00747565|7284576|FG001|Overall Study|Withdrawal by Subject|6
4485039|NCT00747565|7284575|FG000|Overall Study|Lost to Follow-up|4
4485040|NCT00747565|7284576|FG001|Overall Study|Lost to Follow-up|1
4485041|NCT00747617|7284584|FG000|Overall Study|Lost to Follow-up|3
4485042|NCT00747617|7284585|FG001|Overall Study|Lost to Follow-up|1
4485043|NCT00747643|7284593|FG000|Overall Study|Withdrawal by Subject|36
4485044|NCT00747643|7284594|FG001|Overall Study|Withdrawal by Subject|27
4485045|NCT00747812|7284615|FG000|Overall Study|Research Site Staff Relocation|5
4485046|NCT00747812|7284616|FG001|Overall Study|Research Site Staff Relocation|3
4485047|NCT00748033|7284624|FG000|Overall Study|Adverse Event|0
4485048|NCT00748033|7284625|FG001|Overall Study|Adverse Event|1
4485049|NCT00748098|7284648|FG000|First Treatment Intervention Period|Adverse Event|1
4485050|NCT00748098|7284649|FG001|First Treatment Intervention Period|Adverse Event|1
4485051|NCT00748098|7284648|FG000|First Treatment Intervention Period|Protocol Violation|1
4485052|NCT00748098|7284649|FG001|First Treatment Intervention Period|Protocol Violation|0
4485053|NCT00748098|7284648|FG000|First Treatment Intervention Period|Lost to Follow-up|1
4485054|NCT00748098|7284649|FG001|First Treatment Intervention Period|Lost to Follow-up|0
4485055|NCT00748098|7284648|FG000|First Treatment Intervention Period|Withdrawal by Subject|2
4485056|NCT00748098|7284649|FG001|First Treatment Intervention Period|Withdrawal by Subject|0
4485057|NCT00748098|7284648|FG000|First Taper Period|Protocol Violation|1
4485058|NCT00748098|7284649|FG001|First Taper Period|Protocol Violation|0
4485059|NCT00748098|7284648|FG000|First Taper Period|Withdrawal by Subject|2
4485060|NCT00748098|7284649|FG001|First Taper Period|Withdrawal by Subject|0
4485061|NCT00748098|7284648|FG000|First Taper Period|Protocol Stopping Criteria Met|0
4485062|NCT00748098|7284649|FG001|First Taper Period|Protocol Stopping Criteria Met|1
4485063|NCT00748098|7284648|FG000|1-Week Washout Period|Adverse Event|0
4485064|NCT00748098|7284649|FG001|1-Week Washout Period|Adverse Event|1
4485065|NCT00748098|7284648|FG000|1-Week Washout Period|Withdrawal by Subject|2
4485066|NCT00748098|7284649|FG001|1-Week Washout Period|Withdrawal by Subject|0
4485067|NCT00748098|7284648|FG000|Second Treatment Intervention Period|Adverse Event|4
4485068|NCT00748098|7284649|FG001|Second Treatment Intervention Period|Adverse Event|1
4485069|NCT00748098|7284648|FG000|Second Treatment Intervention Period|Lost to Follow-up|1
4485070|NCT00748098|7284649|FG001|Second Treatment Intervention Period|Lost to Follow-up|1
4485071|NCT00748098|7284648|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1
4485072|NCT00748098|7284649|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1
4485073|NCT00748189|7284658|FG000|Overall Study|Death|99
4485074|NCT00748189|7284659|FG001|Overall Study|Death|84
4485075|NCT00748189|7284658|FG000|Overall Study|Withdrawal by Subject|23
4485076|NCT00748189|7284659|FG001|Overall Study|Withdrawal by Subject|29
4485077|NCT00748189|7284658|FG000|Overall Study|Physician Decision|16
4485078|NCT00748189|7284659|FG001|Overall Study|Physician Decision|5
4485079|NCT00748189|7284658|FG000|Overall Study|Lost to Follow-up|8
4485080|NCT00748189|7284659|FG001|Overall Study|Lost to Follow-up|15
4485081|NCT00748189|7284658|FG000|Overall Study|Study terminated by Sponsor|70
4485082|NCT00748189|7284659|FG001|Overall Study|Study terminated by Sponsor|79
4485083|NCT00748215|7284672|FG000|Overall Study|Withdrawal by Subject|7
4485084|NCT00748215|7284673|FG001|Overall Study|Withdrawal by Subject|7
4485085|NCT00748215|7284672|FG000|Overall Study|Treatment change|2
4485086|NCT00748215|7284673|FG001|Overall Study|Treatment change|1
4485087|NCT00748215|7284672|FG000|Overall Study|Change in patient condition|0
4485088|NCT00748215|7284673|FG001|Overall Study|Change in patient condition|3
4485089|NCT00748215|7284672|FG000|Overall Study|Non-compliant|0
4485090|NCT00748215|7284673|FG001|Overall Study|Non-compliant|2
4485091|NCT00748215|7284672|FG000|Overall Study|Adverse Event|0
4485092|NCT00748215|7284673|FG001|Overall Study|Adverse Event|5
4485093|NCT00748241|7284679|FG000|Overall Study|Implant failure|1
4485094|NCT00748241|7284679|FG000|Overall Study|Lost to Follow-up|5
4485095|NCT00748241|7284679|FG000|Overall Study|Death|2
4485096|NCT00748540|7284692|FG000|Overall Study|Physician Decision|1
4485097|NCT00748553|7284698|FG000|Overall Study|Adverse Event|0
4485098|NCT00748553|7284699|FG001|Overall Study|Adverse Event|1
4485099|NCT00748553|7284698|FG000|Overall Study|disease progression|2
4485100|NCT00748553|7284699|FG001|Overall Study|disease progression|0
4485101|NCT00748553|7284698|FG000|Overall Study|noncompliance|1
4485102|NCT00748553|7284699|FG001|Overall Study|noncompliance|0
4485103|NCT00748566|7284704|FG000|Overall Study|Adverse Event|49
4485104|NCT00748566|7284704|FG000|Overall Study|Death|1
4485105|NCT00748566|7284704|FG000|Overall Study|Lack of Efficacy|12
4485106|NCT00748566|7284704|FG000|Overall Study|Lost to Follow-up|1
4485107|NCT00748566|7284704|FG000|Overall Study|Protocol Violation|13
4485108|NCT00748566|7284704|FG000|Overall Study|Withdrawal by Subject|22
4485109|NCT00748566|7284704|FG000|Overall Study|Study terminated by sponsor|5
4485110|NCT00748566|7284704|FG000|Overall Study|Other|9
4485111|NCT00748709|7284718|FG000|Overall Study|Progressive disease|15
4485112|NCT00748709|7284718|FG000|Overall Study|Drug reducing Toxity|2
4485113|NCT00748709|7284718|FG000|Overall Study|Other Adverse Event|1
4485114|NCT00748709|7284718|FG000|Overall Study|Withdrawal by Subject|1
4485115|NCT00748709|7284718|FG000|Overall Study|Other Reasons|1
4485116|NCT00748969|7284748|FG000|Overall Study|Withdrawal by Subject|1
4485117|NCT00748969|7284749|FG001|Overall Study|Withdrawal by Subject|0
4485118|NCT00748969|7284748|FG000|Overall Study|Withdrawal by Subject|0
4485119|NCT00748969|7284749|FG001|Overall Study|Withdrawal by Subject|1
4485120|NCT00749190|7284785|FG000|Overall Study|Adverse Event|0
4485121|NCT00749190|7284786|FG001|Overall Study|Adverse Event|2
4485122|NCT00749190|7284787|FG002|Overall Study|Adverse Event|0
4485123|NCT00749190|7284788|FG003|Overall Study|Adverse Event|4
4485124|NCT00749190|7284789|FG004|Overall Study|Adverse Event|0
4485125|NCT00749190|7284790|FG005|Overall Study|Adverse Event|3
4485126|NCT00749190|7284791|FG006|Overall Study|Adverse Event|0
4485127|NCT00749190|7284785|FG000|Overall Study|Lack of Efficacy|3
4485128|NCT00749190|7284786|FG001|Overall Study|Lack of Efficacy|1
4485129|NCT00749190|7284787|FG002|Overall Study|Lack of Efficacy|1
4485130|NCT00749190|7284788|FG003|Overall Study|Lack of Efficacy|0
4485131|NCT00749190|7284789|FG004|Overall Study|Lack of Efficacy|0
4485132|NCT00749190|7284790|FG005|Overall Study|Lack of Efficacy|1
4485133|NCT00749190|7284791|FG006|Overall Study|Lack of Efficacy|0
4485134|NCT00749190|7284785|FG000|Overall Study|Withdrawal by Subject|2
4485135|NCT00749190|7284786|FG001|Overall Study|Withdrawal by Subject|1
4485136|NCT00749190|7284787|FG002|Overall Study|Withdrawal by Subject|0
4485137|NCT00749190|7284788|FG003|Overall Study|Withdrawal by Subject|0
4485138|NCT00749190|7284789|FG004|Overall Study|Withdrawal by Subject|0
4485139|NCT00749190|7284790|FG005|Overall Study|Withdrawal by Subject|1
4485140|NCT00749190|7284791|FG006|Overall Study|Withdrawal by Subject|0
4485141|NCT00749190|7284785|FG000|Overall Study|Protocol Violation|0
4485142|NCT00749190|7284786|FG001|Overall Study|Protocol Violation|1
4485143|NCT00749190|7284787|FG002|Overall Study|Protocol Violation|0
4485144|NCT00749190|7284788|FG003|Overall Study|Protocol Violation|0
4485145|NCT00749190|7284789|FG004|Overall Study|Protocol Violation|0
4485146|NCT00749190|7284790|FG005|Overall Study|Protocol Violation|0
4485147|NCT00749190|7284791|FG006|Overall Study|Protocol Violation|1
4485148|NCT00749190|7284785|FG000|Overall Study|Other reason not defined above|0
4485149|NCT00749190|7284786|FG001|Overall Study|Other reason not defined above|0
4485150|NCT00749190|7284787|FG002|Overall Study|Other reason not defined above|0
4485151|NCT00749190|7284788|FG003|Overall Study|Other reason not defined above|1
4485152|NCT00749190|7284789|FG004|Overall Study|Other reason not defined above|0
4485153|NCT00749190|7284790|FG005|Overall Study|Other reason not defined above|0
4485154|NCT00749190|7284791|FG006|Overall Study|Other reason not defined above|0
4485155|NCT00749203|7284814|FG000|no Infusion at Week 1|Lost to Follow-up|0
4485156|NCT00749203|7284815|FG001|no Infusion at Week 1|Lost to Follow-up|1
4485157|NCT00749203|7284814|FG000|no Infusion at Week 1|Withdrawal by Subject|0
4485158|NCT00749203|7284815|FG001|no Infusion at Week 1|Withdrawal by Subject|1
4485159|NCT00749203|7284814|FG000|no Infusion at Week 1|delayed-onset sedation|0
4485160|NCT00749203|7284815|FG001|no Infusion at Week 1|delayed-onset sedation|1
4485161|NCT00749203|7284814|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0
4485162|NCT00749203|7284815|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1
4485163|NCT00749203|7284814|FG000|Second Infusion at 2 Weeks|Protocol Violation|0
4485164|NCT00749203|7284815|FG001|Second Infusion at 2 Weeks|Protocol Violation|1
4485165|NCT00749203|7284814|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0
4485166|NCT00749203|7284815|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1
4485167|NCT00749398|7284836|FG000|Overall Study|Lack of Efficacy|7
4485168|NCT00749398|7284836|FG000|Overall Study|Adverse Event|4
4485169|NCT00749398|7284836|FG000|Overall Study|Serious adverse event|11
4485170|NCT00749398|7284836|FG000|Overall Study|Withdrawal by Subject|17
4485171|NCT00749398|7284836|FG000|Overall Study|Lost to Follow-up|11
4485172|NCT00749398|7284836|FG000|Overall Study|Reason not specified|2
4485173|NCT00749398|7284836|FG000|Overall Study|Unknown reason|1
4485174|NCT00749411|7284842|FG000|Overall Study|Adverse Event|0
4485175|NCT00749411|7284843|FG001|Overall Study|Adverse Event|2
4485176|NCT00749411|7284842|FG000|Overall Study|Lack of Efficacy|0
4485177|NCT00749411|7284843|FG001|Overall Study|Lack of Efficacy|1
4485178|NCT00749411|7284842|FG000|Overall Study|Protocol Violation|1
4485179|NCT00749411|7284843|FG001|Overall Study|Protocol Violation|1
4485180|NCT00749411|7284842|FG000|Overall Study|Protocol-defined stopping criteria|0
4485181|NCT00749411|7284843|FG001|Overall Study|Protocol-defined stopping criteria|1
4485182|NCT00749463|7284852|FG000|Overall Study|Adverse Event|0
4485183|NCT00749463|7284853|FG001|Overall Study|Adverse Event|4
4485184|NCT00749463|7284854|FG002|Overall Study|Adverse Event|1
4485185|NCT00749463|7284852|FG000|Overall Study|Withdrawal by Subject|1
4485186|NCT00749463|7284853|FG001|Overall Study|Withdrawal by Subject|0
4485187|NCT00749463|7284854|FG002|Overall Study|Withdrawal by Subject|0
4485188|NCT00749580|7284873|FG000|Overall Study|Lost to Follow-up|4
4485189|NCT00749580|7284874|FG001|Overall Study|Lost to Follow-up|8
4485190|NCT00749580|7284873|FG000|Overall Study|Adverse Event|0
4485191|NCT00749580|7284874|FG001|Overall Study|Adverse Event|1
4485192|NCT00749684|7284902|FG000|Overall Study|Death|1
4485193|NCT00749684|7284902|FG000|Overall Study|Adverse Event|27
4485194|NCT00749684|7284902|FG000|Overall Study|Participant's Wish|10
4485195|NCT00749684|7284902|FG000|Overall Study|Not Documented|1
4485196|NCT00749684|7284902|FG000|Overall Study|Progressive Desease|31
4485197|NCT00749684|7284902|FG000|Overall Study|Therapy according to protocol + AE|2
4485198|NCT00749684|7284902|FG000|Overall Study|AE+discontinuation on participants wish|1
4485199|NCT00749684|7284902|FG000|Overall Study|Missing|9
4485200|NCT00749775|7284915|FG000|Overall Study|Protocol Violation|24
4485201|NCT00749775|7284915|FG000|Overall Study|Lost to Follow-up|36
4485202|NCT00749775|7284915|FG000|Overall Study|No visit after first day of treatment|44
4485203|NCT00749775|7284915|FG000|Overall Study|No drug administration|3
4485204|NCT00749892|7284941|FG000|Overall Study|Withdrawal by Subject|3
4485205|NCT00749944|7284958|FG000|Overall Study|Lost to Follow-up|2
4485206|NCT00749944|7284959|FG001|Overall Study|Lost to Follow-up|1
4485207|NCT00749944|7284958|FG000|Overall Study|Other|1
4485208|NCT00749944|7284959|FG001|Overall Study|Other|0
4485209|NCT00749944|7284958|FG000|Overall Study|Withdrawal by Subject|2
4485210|NCT00749944|7284959|FG001|Overall Study|Withdrawal by Subject|0
4485211|NCT00749996|7284978|FG000|Overall Study|Lost to Follow-up|7
4485212|NCT00749996|7284979|FG001|Overall Study|Lost to Follow-up|4
4485213|NCT00749996|7284978|FG000|Overall Study|Withdrawal by Subject|5
4485214|NCT00749996|7284979|FG001|Overall Study|Withdrawal by Subject|4
4485215|NCT00749996|7284978|FG000|Overall Study|Protocol Violation|2
4485216|NCT00749996|7284979|FG001|Overall Study|Protocol Violation|3
4485217|NCT00749996|7284978|FG000|Overall Study|Physician Decision|2
4485218|NCT00749996|7284979|FG001|Overall Study|Physician Decision|0
4485219|NCT00749996|7284978|FG000|Overall Study|Pregnancy|0
4485220|NCT00749996|7284979|FG001|Overall Study|Pregnancy|2
4485221|NCT00749996|7284978|FG000|Overall Study|Adverse Event|1
4485222|NCT00749996|7284979|FG001|Overall Study|Adverse Event|0
4485223|NCT00749996|7284978|FG000|Overall Study|Death|1
4485224|NCT00749996|7284979|FG001|Overall Study|Death|0
4485225|NCT00750061|7284987|FG000|Overall Study|Adverse Event|2
4485226|NCT00750061|7284988|FG001|Overall Study|Adverse Event|0
4485227|NCT00750061|7284987|FG000|Overall Study|Withdrawal by Subject|0
4485228|NCT00750061|7284988|FG001|Overall Study|Withdrawal by Subject|1
4485229|NCT00750061|7284987|FG000|Overall Study|Physician Decision|0
4485230|NCT00750061|7284988|FG001|Overall Study|Physician Decision|1
4485231|NCT00750139|7284998|FG000|Overall Study|Adverse Event|1
4485232|NCT00750139|7284999|FG001|Overall Study|Adverse Event|2
4485233|NCT00750139|7285000|FG002|Overall Study|Adverse Event|0
4485234|NCT00750139|7285001|FG003|Overall Study|Adverse Event|1
4485235|NCT00750139|7284998|FG000|Overall Study|Lost to Follow-up|17
4485236|NCT00750139|7284999|FG001|Overall Study|Lost to Follow-up|12
4485237|NCT00750139|7285000|FG002|Overall Study|Lost to Follow-up|15
4485238|NCT00750139|7285001|FG003|Overall Study|Lost to Follow-up|6
4485239|NCT00750139|7284998|FG000|Overall Study|Withdrawal by Subject|3
4485240|NCT00750139|7284999|FG001|Overall Study|Withdrawal by Subject|2
4485241|NCT00750139|7285000|FG002|Overall Study|Withdrawal by Subject|6
4485242|NCT00750139|7285001|FG003|Overall Study|Withdrawal by Subject|2
4485243|NCT00750139|7284998|FG000|Overall Study|Physician Decision|1
4485244|NCT00750139|7284999|FG001|Overall Study|Physician Decision|1
4485245|NCT00750139|7285000|FG002|Overall Study|Physician Decision|0
4485246|NCT00750139|7285001|FG003|Overall Study|Physician Decision|0
4485247|NCT00750139|7284998|FG000|Overall Study|Non-compliance|1
4485248|NCT00750139|7284999|FG001|Overall Study|Non-compliance|0
4485249|NCT00750139|7285000|FG002|Overall Study|Non-compliance|1
4485250|NCT00750139|7285001|FG003|Overall Study|Non-compliance|3
4485251|NCT00750139|7284998|FG000|Overall Study|Termination by sponsor|4
4485252|NCT00750139|7284999|FG001|Overall Study|Termination by sponsor|0
4485253|NCT00750139|7285000|FG002|Overall Study|Termination by sponsor|0
4485254|NCT00750139|7285001|FG003|Overall Study|Termination by sponsor|1
4485255|NCT00750139|7284998|FG000|Overall Study|Non-specific|62
4485256|NCT00750139|7284999|FG001|Overall Study|Non-specific|42
4485257|NCT00750139|7285000|FG002|Overall Study|Non-specific|79
4485258|NCT00750139|7285001|FG003|Overall Study|Non-specific|33
4485259|NCT00750152|7285015|FG000|Overall Study|Adverse Event|2
4485260|NCT00750152|7285016|FG001|Overall Study|Adverse Event|1
4485261|NCT00750152|7285015|FG000|Overall Study|Lost to Follow-up|8
4485262|NCT00750152|7285016|FG001|Overall Study|Lost to Follow-up|13
4485263|NCT00750152|7285015|FG000|Overall Study|Withdrawal by Subject|3
4485264|NCT00750152|7285016|FG001|Overall Study|Withdrawal by Subject|3
4485265|NCT00750152|7285015|FG000|Overall Study|Physician Decision|1
4485266|NCT00750152|7285016|FG001|Overall Study|Physician Decision|1
4485267|NCT00750152|7285015|FG000|Overall Study|Non-compliance|0
4485268|NCT00750152|7285016|FG001|Overall Study|Non-compliance|1
4485269|NCT00750152|7285015|FG000|Overall Study|Termination by sponsor|1
4485270|NCT00750152|7285016|FG001|Overall Study|Termination by sponsor|0
4485271|NCT00750152|7285015|FG000|Overall Study|Other|7
4485272|NCT00750152|7285016|FG001|Overall Study|Other|8
4485273|NCT00750269|7285040|FG000|Overall Study|Protocol Violation|0
4485274|NCT00750269|7285041|FG001|Overall Study|Protocol Violation|1
4485275|NCT00750269|7285042|FG002|Overall Study|Protocol Violation|1
4485276|NCT00750269|7285043|FG003|Overall Study|Protocol Violation|2
4485277|NCT00750269|7285044|FG004|Overall Study|Protocol Violation|4
4485278|NCT00750269|7285040|FG000|Overall Study|Withdrawal by Subject|0
4485279|NCT00750269|7285041|FG001|Overall Study|Withdrawal by Subject|0
4485280|NCT00750269|7285042|FG002|Overall Study|Withdrawal by Subject|2
4485281|NCT00750269|7285043|FG003|Overall Study|Withdrawal by Subject|2
4485282|NCT00750269|7285044|FG004|Overall Study|Withdrawal by Subject|2
4485283|NCT00750269|7285040|FG000|Overall Study|Physician Decision|0
4485284|NCT00750269|7285041|FG001|Overall Study|Physician Decision|0
4485285|NCT00750269|7285042|FG002|Overall Study|Physician Decision|0
4485286|NCT00750269|7285043|FG003|Overall Study|Physician Decision|0
4485287|NCT00750269|7285044|FG004|Overall Study|Physician Decision|2
4485288|NCT00750269|7285040|FG000|Overall Study|Patient too large for positioning|0
4485289|NCT00750269|7285041|FG001|Overall Study|Patient too large for positioning|0
4485290|NCT00750269|7285042|FG002|Overall Study|Patient too large for positioning|1
4485291|NCT00750269|7285043|FG003|Overall Study|Patient too large for positioning|0
4485292|NCT00750269|7285044|FG004|Overall Study|Patient too large for positioning|0
4485293|NCT00750269|7285040|FG000|Overall Study|Site error|0
4485294|NCT00750269|7285041|FG001|Overall Study|Site error|0
4485295|NCT00750269|7285042|FG002|Overall Study|Site error|0
4485296|NCT00750269|7285043|FG003|Overall Study|Site error|1
4485297|NCT00750269|7285044|FG004|Overall Study|Site error|0
4485298|NCT00750269|7285040|FG000|Overall Study|SBRT plan could not be drawn|0
4485299|NCT00750269|7285041|FG001|Overall Study|SBRT plan could not be drawn|0
4485300|NCT00750269|7285042|FG002|Overall Study|SBRT plan could not be drawn|0
4485301|NCT00750269|7285043|FG003|Overall Study|SBRT plan could not be drawn|0
4485302|NCT00750269|7285044|FG004|Overall Study|SBRT plan could not be drawn|1
4485303|NCT00750269|7285040|FG000|Overall Study|Fiducials could not be placed|0
4485304|NCT00750269|7285041|FG001|Overall Study|Fiducials could not be placed|0
4485305|NCT00750269|7285042|FG002|Overall Study|Fiducials could not be placed|0
4485306|NCT00750269|7285043|FG003|Overall Study|Fiducials could not be placed|0
4485307|NCT00750269|7285044|FG004|Overall Study|Fiducials could not be placed|1
4485308|NCT00750308|7285094|FG000|First Treatment|Adverse Event|0
4485309|NCT00750308|7285095|FG001|First Treatment|Adverse Event|1
4485310|NCT00750308|7285096|FG002|First Treatment|Adverse Event|0
4485311|NCT00750308|7285097|FG003|First Treatment|Adverse Event|0
4485312|NCT00750308|7285098|FG004|First Treatment|Adverse Event|0
4485313|NCT00750308|7285099|FG005|First Treatment|Adverse Event|0
4485314|NCT00750308|7285100|FG006|First Treatment|Adverse Event|0
4485315|NCT00750308|7285101|FG007|First Treatment|Adverse Event|0
4485316|NCT00750308|7285102|FG008|First Treatment|Adverse Event|0
4485317|NCT00750308|7285103|FG009|First Treatment|Adverse Event|0
4485318|NCT00750308|7285104|FG010|First Treatment|Adverse Event|1
4485319|NCT00750308|7285105|FG011|First Treatment|Adverse Event|1
4485320|NCT00750308|7285094|FG000|First Treatment|Withdrawal by Subject|0
4485321|NCT00750308|7285095|FG001|First Treatment|Withdrawal by Subject|0
4485322|NCT00750308|7285096|FG002|First Treatment|Withdrawal by Subject|0
4485323|NCT00750308|7285097|FG003|First Treatment|Withdrawal by Subject|1
4485324|NCT00750308|7285098|FG004|First Treatment|Withdrawal by Subject|0
4485325|NCT00750308|7285099|FG005|First Treatment|Withdrawal by Subject|0
4485326|NCT00750308|7285100|FG006|First Treatment|Withdrawal by Subject|0
4485327|NCT00750308|7285101|FG007|First Treatment|Withdrawal by Subject|1
4485328|NCT00750308|7285102|FG008|First Treatment|Withdrawal by Subject|0
4485329|NCT00750308|7285103|FG009|First Treatment|Withdrawal by Subject|0
4485330|NCT00750308|7285104|FG010|First Treatment|Withdrawal by Subject|0
4485331|NCT00750308|7285105|FG011|First Treatment|Withdrawal by Subject|0
4485332|NCT00750308|7285094|FG000|Second Treatment|Adverse Event|0
4485333|NCT00750308|7285095|FG001|Second Treatment|Adverse Event|0
4485334|NCT00750308|7285096|FG002|Second Treatment|Adverse Event|0
4485335|NCT00750308|7285097|FG003|Second Treatment|Adverse Event|0
4485336|NCT00750308|7285098|FG004|Second Treatment|Adverse Event|0
4485337|NCT00750308|7285099|FG005|Second Treatment|Adverse Event|1
4485338|NCT00750308|7285100|FG006|Second Treatment|Adverse Event|0
4485339|NCT00750308|7285101|FG007|Second Treatment|Adverse Event|0
4485340|NCT00750308|7285102|FG008|Second Treatment|Adverse Event|1
4485341|NCT00750308|7285103|FG009|Second Treatment|Adverse Event|0
4485342|NCT00750308|7285104|FG010|Second Treatment|Adverse Event|0
4485343|NCT00750308|7285105|FG011|Second Treatment|Adverse Event|0
4485344|NCT00750308|7285094|FG000|Second Treatment|Withdrawal by Subject|0
4485345|NCT00750308|7285095|FG001|Second Treatment|Withdrawal by Subject|0
4485346|NCT00750308|7285096|FG002|Second Treatment|Withdrawal by Subject|0
4485347|NCT00750308|7285097|FG003|Second Treatment|Withdrawal by Subject|0
4485348|NCT00750308|7285098|FG004|Second Treatment|Withdrawal by Subject|1
4485349|NCT00750308|7285099|FG005|Second Treatment|Withdrawal by Subject|0
4485350|NCT00750308|7285100|FG006|Second Treatment|Withdrawal by Subject|0
4485351|NCT00750308|7285101|FG007|Second Treatment|Withdrawal by Subject|0
4485352|NCT00750308|7285102|FG008|Second Treatment|Withdrawal by Subject|0
4485353|NCT00750308|7285103|FG009|Second Treatment|Withdrawal by Subject|0
4485354|NCT00750308|7285104|FG010|Second Treatment|Withdrawal by Subject|0
4485355|NCT00750308|7285105|FG011|Second Treatment|Withdrawal by Subject|0
4485356|NCT00750308|7285094|FG000|Third Treatment|Withdrawal by Subject|0
4485357|NCT00750308|7285095|FG001|Third Treatment|Withdrawal by Subject|1
4485358|NCT00750308|7285096|FG002|Third Treatment|Withdrawal by Subject|0
4485359|NCT00750308|7285097|FG003|Third Treatment|Withdrawal by Subject|0
4485360|NCT00750308|7285098|FG004|Third Treatment|Withdrawal by Subject|0
4485361|NCT00750308|7285099|FG005|Third Treatment|Withdrawal by Subject|0
4485362|NCT00750308|7285100|FG006|Third Treatment|Withdrawal by Subject|0
4485363|NCT00750308|7285101|FG007|Third Treatment|Withdrawal by Subject|0
4485364|NCT00750308|7285102|FG008|Third Treatment|Withdrawal by Subject|0
4485365|NCT00750308|7285103|FG009|Third Treatment|Withdrawal by Subject|0
4485366|NCT00750308|7285104|FG010|Third Treatment|Withdrawal by Subject|0
4485367|NCT00750308|7285105|FG011|Third Treatment|Withdrawal by Subject|0
4485368|NCT00750438|7285161|FG000|Overall Study|Protocol Violation|4
4485369|NCT00750438|7285162|FG001|Overall Study|Protocol Violation|1
4485370|NCT00750438|7285161|FG000|Overall Study|Physician Decision|2
4485371|NCT00750438|7285162|FG001|Overall Study|Physician Decision|2
4485372|NCT00750438|7285161|FG000|Overall Study|Withdrawal by Subject|1
4485373|NCT00750438|7285162|FG001|Overall Study|Withdrawal by Subject|1
4485374|NCT00750737|7285170|FG000|Overall Study|Withdrawal by Subject|3
4485375|NCT00750737|7285171|FG001|Overall Study|Withdrawal by Subject|3
4485376|NCT00750867|7285190|FG000|Overall Study|Adverse Event|2
4485377|NCT00750880|7285194|FG000|Overall Study|Adverse Event|76
4485378|NCT00750880|7285194|FG000|Overall Study|Death|4
4485379|NCT00750880|7285194|FG000|Overall Study|Lack of Efficacy|46
4485380|NCT00750880|7285194|FG000|Overall Study|Lost to Follow-up|10
4485381|NCT00750880|7285194|FG000|Overall Study|Protocol Violation|15
4485382|NCT00750880|7285194|FG000|Overall Study|Withdrawal by Subject|33
4485383|NCT00750880|7285194|FG000|Overall Study|Physician Decision|20
4485384|NCT00750880|7285194|FG000|Overall Study|Administrative|11
4485385|NCT00750893|7285199|FG000|Overall Study|Adverse Event|5
4485386|NCT00750893|7285199|FG000|Overall Study|Withdrawal by Subject|10
4485387|NCT00750893|7285199|FG000|Overall Study|Lost to Follow-up|510
4485388|NCT00750893|7285199|FG000|Overall Study|Other|17
4485389|NCT00750919|7285203|FG000|Overall Study|Adverse Event|9
4485390|NCT00750919|7285203|FG000|Overall Study|Withdrawal by Subject|1
4485391|NCT00750919|7285203|FG000|Overall Study|Lack of Efficacy|8
4485392|NCT00750919|7285203|FG000|Overall Study|Could not cooperate, unrelated to trial|4
4485393|NCT00750919|7285203|FG000|Overall Study|Other|36
4485394|NCT00751023|7285209|FG000|Overall Study|Lost to Follow-up|11
4485395|NCT00751023|7285210|FG001|Overall Study|Lost to Follow-up|7
4485396|NCT00751036|7285218|FG000|Overall Study|Disease Progression|28
4485397|NCT00751036|7285219|FG001|Overall Study|Disease Progression|29
4485398|NCT00751036|7285218|FG000|Overall Study|Adverse Event|6
4485399|NCT00751036|7285219|FG001|Overall Study|Adverse Event|4
4485400|NCT00751036|7285218|FG000|Overall Study|Administrative Problems|3
4485401|NCT00751036|7285219|FG001|Overall Study|Administrative Problems|4
4485402|NCT00751036|7285218|FG000|Overall Study|Withdrawal by Subject|5
4485403|NCT00751036|7285219|FG001|Overall Study|Withdrawal by Subject|2
4485404|NCT00751036|7285218|FG000|Overall Study|Death|3
4485405|NCT00751036|7285219|FG001|Overall Study|Death|3
4485406|NCT00751036|7285218|FG000|Overall Study|Lost to Follow-up|0
4485407|NCT00751036|7285219|FG001|Overall Study|Lost to Follow-up|1
4485408|NCT00751036|7285218|FG000|Overall Study|Protocol Violation|1
4485409|NCT00751036|7285219|FG001|Overall Study|Protocol Violation|0
4485410|NCT00751036|7285218|FG000|Overall Study|Missing end of Treatment Page|2
4485411|NCT00751036|7285219|FG001|Overall Study|Missing end of Treatment Page|3
4485412|NCT00751101|7285227|FG000|Overall Study|Withdrawal by Subject|1
4485413|NCT00751101|7285228|FG001|Overall Study|Withdrawal by Subject|0
4485414|NCT00751101|7285227|FG000|Overall Study|No HFS / Never Started Patch/|0
4485415|NCT00751101|7285228|FG001|Overall Study|No HFS / Never Started Patch/|4
4485416|NCT00751101|7285227|FG000|Overall Study|Never began capecitabine|1
4485417|NCT00751101|7285228|FG001|Overall Study|Never began capecitabine|0
4485418|NCT00751101|7285227|FG000|Overall Study|Physician Decision|0
4485419|NCT00751101|7285228|FG001|Overall Study|Physician Decision|1
4485420|NCT00751114|7285240|FG000|Overall Study|Adverse Event|2
4485421|NCT00751114|7285241|FG001|Overall Study|Adverse Event|4
4485422|NCT00751114|7285240|FG000|Overall Study|Protocol Violation|8
4485423|NCT00751114|7285241|FG001|Overall Study|Protocol Violation|9
4485424|NCT00751114|7285240|FG000|Overall Study|Withdrawal by Subject|9
4485425|NCT00751114|7285241|FG001|Overall Study|Withdrawal by Subject|4
4485426|NCT00751114|7285240|FG000|Overall Study|Lost to Follow-up|4
4485427|NCT00751114|7285241|FG001|Overall Study|Lost to Follow-up|7
4485428|NCT00751114|7285240|FG000|Overall Study|Lack of Efficacy|0
4485429|NCT00751114|7285241|FG001|Overall Study|Lack of Efficacy|7
4485430|NCT00751114|7285240|FG000|Overall Study|Not Treated|13
4485431|NCT00751114|7285241|FG001|Overall Study|Not Treated|1
4485432|NCT00751114|7285240|FG000|Overall Study|Out of country for 2 months|1
4485433|NCT00751114|7285241|FG001|Overall Study|Out of country for 2 months|0
4485434|NCT00751114|7285240|FG000|Overall Study|Move to another city|1
4485435|NCT00751114|7285241|FG001|Overall Study|Move to another city|0
4485436|NCT00751140|7285247|FG000|Overall Study|benign angioma excluded from analysis|1
4485437|NCT00751296|7285265|FG000|Overall Study|Adverse Event|2
4485438|NCT00751348|7285271|FG000|Overall Study|Withdrawal by Subject|5
4485439|NCT00751348|7285272|FG001|Overall Study|Withdrawal by Subject|2
4485440|NCT00751348|7285271|FG000|Overall Study|Migration from study area|1
4485441|NCT00751348|7285272|FG001|Overall Study|Migration from study area|0
4485442|NCT00751400|7285278|FG000|Overall Study|Lost to Follow-up|10
4517083|NCT00963820|7328684|FG003|Expansion Phase|Progressive Disease|0
4517084|NCT00963820|7328685|FG004|Expansion Phase|Progressive Disease|0
4517085|NCT00963820|7328686|FG005|Expansion Phase|Progressive Disease|0
4517086|NCT00963820|7328687|FG006|Expansion Phase|Progressive Disease|0
4517087|NCT00963820|7328688|FG007|Expansion Phase|Progressive Disease|0
4517088|NCT00963820|7328689|FG008|Expansion Phase|Progressive Disease|8
4517089|NCT00963820|7328690|FG009|Expansion Phase|Progressive Disease|6
4517090|NCT00963820|7328691|FG010|Expansion Phase|Progressive Disease|4
4517091|NCT00963820|7328692|FG011|Expansion Phase|Progressive Disease|2
4517092|NCT00963820|7328681|FG000|Expansion Phase|Adverse Event|0
4517093|NCT00963820|7328682|FG001|Expansion Phase|Adverse Event|0
4517094|NCT00963820|7328683|FG002|Expansion Phase|Adverse Event|0
4517095|NCT00963820|7328684|FG003|Expansion Phase|Adverse Event|0
4517096|NCT00963820|7328685|FG004|Expansion Phase|Adverse Event|0
4517097|NCT00963820|7328686|FG005|Expansion Phase|Adverse Event|0
4517098|NCT00963820|7328687|FG006|Expansion Phase|Adverse Event|0
4517099|NCT00963820|7328688|FG007|Expansion Phase|Adverse Event|0
4517100|NCT00963820|7328689|FG008|Expansion Phase|Adverse Event|1
4517101|NCT00963820|7328690|FG009|Expansion Phase|Adverse Event|3
4517102|NCT00963820|7328691|FG010|Expansion Phase|Adverse Event|0
4517103|NCT00963820|7328692|FG011|Expansion Phase|Adverse Event|0
4517104|NCT00963820|7328681|FG000|Expansion Phase|Withdrawal by Subject|0
4517105|NCT00963820|7328682|FG001|Expansion Phase|Withdrawal by Subject|0
4517106|NCT00963820|7328683|FG002|Expansion Phase|Withdrawal by Subject|0
4517107|NCT00963820|7328684|FG003|Expansion Phase|Withdrawal by Subject|0
4517108|NCT00963820|7328685|FG004|Expansion Phase|Withdrawal by Subject|0
4517109|NCT00963820|7328686|FG005|Expansion Phase|Withdrawal by Subject|0
4517110|NCT00963820|7328687|FG006|Expansion Phase|Withdrawal by Subject|0
4517111|NCT00963820|7328688|FG007|Expansion Phase|Withdrawal by Subject|0
4517112|NCT00963820|7328689|FG008|Expansion Phase|Withdrawal by Subject|1
4517113|NCT00963820|7328690|FG009|Expansion Phase|Withdrawal by Subject|0
4517114|NCT00963820|7328691|FG010|Expansion Phase|Withdrawal by Subject|1
4517115|NCT00963820|7328692|FG011|Expansion Phase|Withdrawal by Subject|1
4517116|NCT00963820|7328681|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0
4517117|NCT00963820|7328682|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0
4517118|NCT00963820|7328683|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0
4517119|NCT00963820|7328684|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0
4517120|NCT00963820|7328685|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0
4517121|NCT00963820|7328686|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0
4517122|NCT00963820|7328687|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0
4517123|NCT00963820|7328688|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0
4517124|NCT00963820|7328689|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0
4517125|NCT00963820|7328690|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0
4517126|NCT00963820|7328691|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0
4517127|NCT00963820|7328692|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1
4517128|NCT00963924|7328728|FG000|Overall Study|Adverse Event|1
4517129|NCT00963924|7328729|FG001|Overall Study|Adverse Event|0
4517130|NCT00963924|7328728|FG000|Overall Study|Withdrawal by Subject|0
4517131|NCT00963924|7328729|FG001|Overall Study|Withdrawal by Subject|1
4517132|NCT00963924|7328728|FG000|Overall Study|Changed antipsychotic|0
4517133|NCT00963924|7328729|FG001|Overall Study|Changed antipsychotic|1
4517134|NCT00963924|7328728|FG000|Overall Study|Lost to Follow-up|0
4517135|NCT00963924|7328729|FG001|Overall Study|Lost to Follow-up|1
4517136|NCT00963937|7328740|FG000|Overall Study|Protocol Violation|1
4517137|NCT00963937|7328741|FG001|Overall Study|Protocol Violation|1
4517138|NCT00963937|7328742|FG002|Overall Study|Protocol Violation|0
4517139|NCT00963937|7328740|FG000|Overall Study|Physician Decision|18
4517140|NCT00963937|7328741|FG001|Overall Study|Physician Decision|10
4517141|NCT00963937|7328742|FG002|Overall Study|Physician Decision|4
4517142|NCT00964028|7328759|FG000|Overall Study|Withdrawal by Subject|0
4517143|NCT00964028|7328760|FG001|Overall Study|Withdrawal by Subject|1
4517144|NCT00964158|7328773|FG000|Overall Study|Lost to Follow-up|0
4517145|NCT00964158|7328774|FG001|Overall Study|Lost to Follow-up|1
4517146|NCT00964158|7328775|FG002|Overall Study|Lost to Follow-up|2
4517147|NCT00964158|7328773|FG000|Overall Study|Withdrawal by Subject|0
4517148|NCT00964158|7328774|FG001|Overall Study|Withdrawal by Subject|0
4517149|NCT00964158|7328775|FG002|Overall Study|Withdrawal by Subject|6
4517150|NCT00964223|7328786|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1
4517151|NCT00964366|7328802|FG000|Overall Study|Did not qualify at Day 1|1
4517152|NCT00964366|7328803|FG001|Overall Study|Did not qualify at Day 1|0
4517153|NCT00964366|7328802|FG000|Overall Study|Withdrawal by Subject|0
4517154|NCT00964366|7328803|FG001|Overall Study|Withdrawal by Subject|1
4517155|NCT00964392|7328811|FG000|Overall Study|Withdrawal by Subject|4
4517156|NCT00964392|7328812|FG001|Overall Study|Withdrawal by Subject|6
4517157|NCT00964392|7328811|FG000|Overall Study|Lost to Follow-up|4
4517158|NCT00964392|7328812|FG001|Overall Study|Lost to Follow-up|10
4517159|NCT00964392|7328811|FG000|Overall Study|Early Termination, non-study arrhythmia|1
4485443|NCT00751621|7285291|FG000|Overall Study|Adverse Event|1
4485444|NCT00751621|7285291|FG000|Overall Study|Withdrawal by Subject|1
4485445|NCT00751621|7285291|FG000|Overall Study|Subject moved to another country|1
4485446|NCT00751621|7285291|FG000|Overall Study|Poor adherence to asthma treatment|1
4485447|NCT00751790|7285311|FG000|Overall Study|Lost to Follow-up|1
4485448|NCT00751790|7285311|FG000|Overall Study|Death|3
4485449|NCT00751790|7285311|FG000|Overall Study|Withdrawal by Subject|1
4485450|NCT00751881|7285318|FG000|Core Treatment Period|Not treated|1
4485451|NCT00751881|7285319|FG001|Core Treatment Period|Not treated|1
4485452|NCT00751881|7285320|FG002|Core Treatment Period|Not treated|2
4485453|NCT00751881|7285318|FG000|Core Treatment Period|Adverse Event|26
4485454|NCT00751881|7285319|FG001|Core Treatment Period|Adverse Event|54
4485455|NCT00751881|7285320|FG002|Core Treatment Period|Adverse Event|58
4485456|NCT00751881|7285318|FG000|Core Treatment Period|Lack of Efficacy|37
4485457|NCT00751881|7285319|FG001|Core Treatment Period|Lack of Efficacy|30
4485458|NCT00751881|7285320|FG002|Core Treatment Period|Lack of Efficacy|20
4485459|NCT00751881|7285318|FG000|Core Treatment Period|Poor compliance to protocol|15
4485460|NCT00751881|7285319|FG001|Core Treatment Period|Poor compliance to protocol|3
4485461|NCT00751881|7285320|FG002|Core Treatment Period|Poor compliance to protocol|4
4485462|NCT00751881|7285318|FG000|Core Treatment Period|Lost to Follow-up|6
4485463|NCT00751881|7285319|FG001|Core Treatment Period|Lost to Follow-up|4
4485464|NCT00751881|7285320|FG002|Core Treatment Period|Lost to Follow-up|3
4485465|NCT00751881|7285318|FG000|Core Treatment Period|Other: protocol deviation|3
4485466|NCT00751881|7285319|FG001|Core Treatment Period|Other: protocol deviation|3
4485467|NCT00751881|7285320|FG002|Core Treatment Period|Other: protocol deviation|7
4485468|NCT00751881|7285318|FG000|Core Treatment Period|Other: wish to parent|5
4485469|NCT00751881|7285319|FG001|Core Treatment Period|Other: wish to parent|7
4485470|NCT00751881|7285320|FG002|Core Treatment Period|Other: wish to parent|4
4485471|NCT00751881|7285318|FG000|Core Treatment Period|Other: personal/family constraints|6
4485472|NCT00751881|7285319|FG001|Core Treatment Period|Other: personal/family constraints|7
4485473|NCT00751881|7285320|FG002|Core Treatment Period|Other: personal/family constraints|10
4485474|NCT00751881|7285318|FG000|Core Treatment Period|Other: MS treatment change|6
4485475|NCT00751881|7285319|FG001|Core Treatment Period|Other: MS treatment change|4
4485476|NCT00751881|7285320|FG002|Core Treatment Period|Other: MS treatment change|4
4485477|NCT00751881|7285318|FG000|Core Treatment Period|Other: tolerability complaints|2
4485478|NCT00751881|7285319|FG001|Core Treatment Period|Other: tolerability complaints|0
4485479|NCT00751881|7285320|FG002|Core Treatment Period|Other: tolerability complaints|0
4485480|NCT00751881|7285318|FG000|Core Treatment Period|Other:participant's decision/unspecified|19
4485481|NCT00751881|7285319|FG001|Core Treatment Period|Other:participant's decision/unspecified|22
4485482|NCT00751881|7285320|FG002|Core Treatment Period|Other:participant's decision/unspecified|16
4485483|NCT00751881|7285318|FG000|Extension Study Period|Adverse Event|18
4485484|NCT00751881|7285319|FG001|Extension Study Period|Adverse Event|20
4485485|NCT00751881|7285320|FG002|Extension Study Period|Adverse Event|21
4485486|NCT00751881|7285318|FG000|Extension Study Period|Lack of Efficacy|14
4485487|NCT00751881|7285319|FG001|Extension Study Period|Lack of Efficacy|10
4485488|NCT00751881|7285320|FG002|Extension Study Period|Lack of Efficacy|20
4485489|NCT00751881|7285318|FG000|Extension Study Period|Lost to Follow-up|4
4485490|NCT00751881|7285319|FG001|Extension Study Period|Lost to Follow-up|9
4485491|NCT00751881|7285320|FG002|Extension Study Period|Lost to Follow-up|6
4485492|NCT00751881|7285318|FG000|Extension Study Period|Poor Compliance to Protocol|3
4485493|NCT00751881|7285319|FG001|Extension Study Period|Poor Compliance to Protocol|2
4485494|NCT00751881|7285320|FG002|Extension Study Period|Poor Compliance to Protocol|1
4485495|NCT00751881|7285318|FG000|Extension Study Period|Other than specified above|26
4485496|NCT00751881|7285319|FG001|Extension Study Period|Other than specified above|30
4485497|NCT00751881|7285320|FG002|Extension Study Period|Other than specified above|18
4485498|NCT00751998|7285342|FG000|Overall Study|Lost to Follow-up|7
4485499|NCT00751998|7285342|FG000|Overall Study|Death|11
4485500|NCT00751998|7285342|FG000|Overall Study|Withdrawal by Subject|2
4485501|NCT00752089|7285346|FG000|Overall Study|Adverse Event|1
4485502|NCT00752089|7285346|FG000|Overall Study|Protocol Deviation|2
4485503|NCT00752089|7285346|FG000|Overall Study|Could not attend visit 9|1
4485504|NCT00752089|7285346|FG000|Overall Study|Not capable of wearing partial denture|1
4485505|NCT00752089|7285346|FG000|Overall Study|Cannot continue the study|1
4485506|NCT00752128|7285366|FG000|Overall Study|Withdrawal by Subject|4
4485507|NCT00752206|7285373|FG000|Overall Study|Disease progression|8
4485508|NCT00752206|7285374|FG001|Overall Study|Disease progression|11
4485509|NCT00752206|7285373|FG000|Overall Study|Pregnancy|1
4485510|NCT00752206|7285374|FG001|Overall Study|Pregnancy|0
4485511|NCT00752219|7285382|FG000|Overall Study|Clinical failure|0
4485512|NCT00752219|7285383|FG001|Overall Study|Clinical failure|1
4485513|NCT00752219|7285382|FG000|Overall Study|Adverse Event|5
4485514|NCT00752219|7285383|FG001|Overall Study|Adverse Event|3
4485515|NCT00752219|7285382|FG000|Overall Study|Protocol deviation|1
4485516|NCT00752219|7285383|FG001|Overall Study|Protocol deviation|0
4485517|NCT00752219|7285382|FG000|Overall Study|Lost to Follow-up|1
4485518|NCT00752219|7285383|FG001|Overall Study|Lost to Follow-up|2
4485519|NCT00752219|7285382|FG000|Overall Study|Randomized but not treated|1
4485520|NCT00752219|7285383|FG001|Overall Study|Randomized but not treated|0
4485521|NCT00752219|7285382|FG000|Overall Study|Other|3
4485522|NCT00752219|7285383|FG001|Overall Study|Other|0
4485523|NCT00752232|7285396|FG000|Overall Study|Protocol Violation|0
4485524|NCT00752232|7285397|FG001|Overall Study|Protocol Violation|0
4485525|NCT00752232|7285398|FG002|Overall Study|Protocol Violation|0
4485526|NCT00752232|7285399|FG003|Overall Study|Protocol Violation|0
4485527|NCT00752232|7285400|FG004|Overall Study|Protocol Violation|0
4485528|NCT00752232|7285401|FG005|Overall Study|Protocol Violation|1
4485529|NCT00752232|7285402|FG006|Overall Study|Protocol Violation|0
4485530|NCT00752232|7285396|FG000|Overall Study|Caregiver request|2
4485531|NCT00752232|7285397|FG001|Overall Study|Caregiver request|0
4485532|NCT00752232|7285398|FG002|Overall Study|Caregiver request|0
4485533|NCT00752232|7285399|FG003|Overall Study|Caregiver request|0
4485534|NCT00752232|7285400|FG004|Overall Study|Caregiver request|1
4485535|NCT00752232|7285401|FG005|Overall Study|Caregiver request|0
4485536|NCT00752232|7285402|FG006|Overall Study|Caregiver request|0
4485537|NCT00752232|7285396|FG000|Overall Study|Investigator request|0
4485538|NCT00752232|7285397|FG001|Overall Study|Investigator request|0
4485539|NCT00752232|7285398|FG002|Overall Study|Investigator request|0
4485540|NCT00752232|7285399|FG003|Overall Study|Investigator request|0
4485541|NCT00752232|7285400|FG004|Overall Study|Investigator request|1
4485542|NCT00752232|7285401|FG005|Overall Study|Investigator request|0
4485543|NCT00752232|7285402|FG006|Overall Study|Investigator request|0
4485544|NCT00752232|7285396|FG000|Overall Study|Subject request|0
4485545|NCT00752232|7285397|FG001|Overall Study|Subject request|0
4485546|NCT00752232|7285398|FG002|Overall Study|Subject request|1
4485547|NCT00752232|7285399|FG003|Overall Study|Subject request|0
4485548|NCT00752232|7285400|FG004|Overall Study|Subject request|0
4485549|NCT00752232|7285401|FG005|Overall Study|Subject request|0
4485550|NCT00752232|7285402|FG006|Overall Study|Subject request|0
4485551|NCT00752232|7285396|FG000|Overall Study|Group home admission|0
4485552|NCT00752232|7285397|FG001|Overall Study|Group home admission|0
4485553|NCT00752232|7285398|FG002|Overall Study|Group home admission|0
4485554|NCT00752232|7285399|FG003|Overall Study|Group home admission|1
4485555|NCT00752232|7285400|FG004|Overall Study|Group home admission|0
4485556|NCT00752232|7285401|FG005|Overall Study|Group home admission|0
4485557|NCT00752232|7285402|FG006|Overall Study|Group home admission|0
4485558|NCT00752232|7285396|FG000|Overall Study|Caregiver could not attend the subject|0
4485559|NCT00752232|7285397|FG001|Overall Study|Caregiver could not attend the subject|0
4485560|NCT00752232|7285398|FG002|Overall Study|Caregiver could not attend the subject|0
4485561|NCT00752232|7285399|FG003|Overall Study|Caregiver could not attend the subject|0
4485562|NCT00752232|7285400|FG004|Overall Study|Caregiver could not attend the subject|1
4485563|NCT00752232|7285401|FG005|Overall Study|Caregiver could not attend the subject|0
4485564|NCT00752232|7285402|FG006|Overall Study|Caregiver could not attend the subject|0
4485565|NCT00752557|7285422|FG000|Overall Study|Withdrawal by Subject|4
4485566|NCT00752557|7285423|FG001|Overall Study|Withdrawal by Subject|3
4485567|NCT00752557|7285424|FG002|Overall Study|Withdrawal by Subject|3
4485568|NCT00752557|7285422|FG000|Overall Study|Unspecified resaons|0
4485569|NCT00752557|7285423|FG001|Overall Study|Unspecified resaons|2
4485570|NCT00752557|7285424|FG002|Overall Study|Unspecified resaons|2
4485571|NCT00752557|7285422|FG000|Overall Study|Lost to Follow-up|1
4485572|NCT00752557|7285423|FG001|Overall Study|Lost to Follow-up|0
4485573|NCT00752557|7285424|FG002|Overall Study|Lost to Follow-up|1
4485574|NCT00752609|7285436|FG000|Overall Study|Adverse Event|2
4485575|NCT00752609|7285437|FG001|Overall Study|Adverse Event|2
4485576|NCT00752609|7285436|FG000|Overall Study|Withdrawal by Subject|3
4485577|NCT00752609|7285437|FG001|Overall Study|Withdrawal by Subject|0
4485578|NCT00752609|7285436|FG000|Overall Study|Physician Decision|1
4485579|NCT00752609|7285437|FG001|Overall Study|Physician Decision|0
4485580|NCT00752609|7285436|FG000|Overall Study|Death|1
4485581|NCT00752609|7285437|FG001|Overall Study|Death|0
4485582|NCT00752609|7285436|FG000|Overall Study|Met exclusion criteria|1
4485583|NCT00752609|7285437|FG001|Overall Study|Met exclusion criteria|0
4485584|NCT00752609|7285436|FG000|Overall Study|Received Aranesp in error|1
4485585|NCT00752609|7285437|FG001|Overall Study|Received Aranesp in error|0
4485586|NCT00752622|7285446|FG000|Induction Phase|Adverse Event|3
4485587|NCT00752622|7285446|FG000|Induction Phase|Other|3
4485588|NCT00752622|7285446|FG000|Induction Phase|Non-responder|14
4485589|NCT00752622|7285446|FG000|Induction Phase|Withdrawal by Subject|1
4485590|NCT00752622|7285446|FG000|Induction Phase|Premature study termination|14
4485591|NCT00752622|7285446|FG000|Observational Phase|Premature Study Termination|36
4485592|NCT00752622|7285446|FG000|Observational Phase|Non-responder|2
4485593|NCT00752622|7285446|FG000|Observational Phase|Withdrawal by Subject|2
4485594|NCT00752622|7285446|FG000|Observational Phase|Adverse Event|1
4485595|NCT00752622|7285446|FG000|Observational Phase|Other|2
4485596|NCT00752622|7285446|FG000|Interventional Phase|Non-responder|2
4485597|NCT00752622|7285446|FG000|Interventional Phase|Physician Decision|1
4485598|NCT00752622|7285446|FG000|Interventional Phase|Premature Study Termination|5
4485599|NCT00752726|7285453|FG000|Overall Study|Lost to Follow-up|2
4485600|NCT00752726|7285454|FG001|Overall Study|Lost to Follow-up|1
4485601|NCT00752726|7285453|FG000|Overall Study|Adverse Event|3
4485602|NCT00752726|7285454|FG001|Overall Study|Adverse Event|0
4485603|NCT00752726|7285453|FG000|Overall Study|Withdrawal by Subject|5
4485604|NCT00752726|7285454|FG001|Overall Study|Withdrawal by Subject|10
4485605|NCT00752726|7285453|FG000|Overall Study|Other Reason|1
4485606|NCT00752726|7285454|FG001|Overall Study|Other Reason|2
4485607|NCT00752791|7285460|FG000|Overall Study|Adverse Event|7
4485608|NCT00752791|7285460|FG000|Overall Study|Withdrawal by Subject|1
4485609|NCT00752791|7285460|FG000|Overall Study|Physician Decision|1
4485610|NCT00752791|7285460|FG000|Overall Study|Death|1
4485611|NCT00752791|7285460|FG000|Overall Study|Renal transplant|3
4485612|NCT00752791|7285460|FG000|Overall Study|Switched to hemodialysis|2
4485613|NCT00752791|7285460|FG000|Overall Study|Protocol deviation|1
4485614|NCT00752856|7285466|FG000|Overall Study|randomized but did not do viral kinetics|0
4485615|NCT00752856|7285467|FG001|Overall Study|randomized but did not do viral kinetics|1
4701253|NCT02707952|7618050|FG002|Overall Study|Withdrawal by Subject|2
4701254|NCT02707952|7618051|FG003|Overall Study|Withdrawal by Subject|0
4701255|NCT02707965|7618072|FG000|Overall Study|Withdrawal by Subject|0
4701256|NCT02707965|7618073|FG001|Overall Study|Withdrawal by Subject|0
4701257|NCT02707965|7618074|FG002|Overall Study|Withdrawal by Subject|1
4701258|NCT02707965|7618075|FG003|Overall Study|Withdrawal by Subject|0
4485616|NCT00752895|7285475|FG000|Overall Study|Withdrawal by Subject|8
4485617|NCT00752895|7285476|FG001|Overall Study|Withdrawal by Subject|3
4485618|NCT00753012|7285499|FG000|Overall Study|Ineligible, abnormal cardiac histo|1
4485619|NCT00753012|7285500|FG001|Overall Study|Ineligible, abnormal cardiac histo|0
4485620|NCT00753012|7285499|FG000|Overall Study|Adverse Event|2
4485621|NCT00753012|7285500|FG001|Overall Study|Adverse Event|0
4485622|NCT00753012|7285499|FG000|Overall Study|Withdrawal by Subject|0
4485623|NCT00753012|7285500|FG001|Overall Study|Withdrawal by Subject|1
4485624|NCT00753012|7285499|FG000|Overall Study|Lost to Follow-up|4
4485625|NCT00753012|7285500|FG001|Overall Study|Lost to Follow-up|0
4485626|NCT00753012|7285499|FG000|Overall Study|Confounded endpoint data|1
4485627|NCT00753012|7285500|FG001|Overall Study|Confounded endpoint data|0
4485628|NCT00753272|7285526|FG000|Overall Study|Adverse Event|878
4485629|NCT00753272|7285527|FG001|Overall Study|Adverse Event|869
4485630|NCT00753272|7285526|FG000|Overall Study|Protocol Violation|28
4485631|NCT00753272|7285527|FG001|Overall Study|Protocol Violation|46
4485632|NCT00753272|7285526|FG000|Overall Study|Withdrawal by Subject|2481
4485633|NCT00753272|7285527|FG001|Overall Study|Withdrawal by Subject|2407
4485634|NCT00753272|7285526|FG000|Overall Study|Lost to Follow-up|491
4485635|NCT00753272|7285527|FG001|Overall Study|Lost to Follow-up|497
4485636|NCT00753272|7285526|FG000|Overall Study|Other|1104
4485637|NCT00753272|7285527|FG001|Overall Study|Other|1088
4485638|NCT00753415|7285564|FG000|Part A|Disease progression|1
4485639|NCT00753415|7285565|FG001|Part A|Disease progression|0
4485640|NCT00753415|7285566|FG002|Part A|Disease progression|1
4485641|NCT00753415|7285567|FG003|Part A|Disease progression|2
4485642|NCT00753415|7285568|FG004|Part A|Disease progression|0
4485643|NCT00753415|7285569|FG005|Part A|Disease progression|0
4485644|NCT00753415|7285570|FG006|Part A|Disease progression|0
4485645|NCT00753415|7285571|FG007|Part A|Disease progression|0
4485646|NCT00753415|7285572|FG008|Part A|Disease progression|0
4485647|NCT00753415|7285573|FG009|Part A|Disease progression|0
4701259|NCT02707965|7618076|FG004|Overall Study|Withdrawal by Subject|0
4701260|NCT02707965|7618077|FG005|Overall Study|Withdrawal by Subject|0
4701261|NCT02707965|7618078|FG006|Overall Study|Withdrawal by Subject|0
4701262|NCT02707965|7618079|FG007|Overall Study|Withdrawal by Subject|2
4701263|NCT02707965|7618080|FG008|Overall Study|Withdrawal by Subject|0
4701264|NCT02707965|7618081|FG009|Overall Study|Withdrawal by Subject|0
4701265|NCT02707965|7618082|FG010|Overall Study|Withdrawal by Subject|0
4701266|NCT02707965|7618083|FG011|Overall Study|Withdrawal by Subject|0
4701267|NCT02707965|7618084|FG012|Overall Study|Withdrawal by Subject|0
4701268|NCT02707965|7618085|FG013|Overall Study|Withdrawal by Subject|0
4701269|NCT02707965|7618086|FG014|Overall Study|Withdrawal by Subject|0
4701270|NCT02707965|7618087|FG015|Overall Study|Withdrawal by Subject|0
4701271|NCT02707965|7618072|FG000|Overall Study|PI decisions|0
4701272|NCT02707965|7618073|FG001|Overall Study|PI decisions|0
4701273|NCT02707965|7618074|FG002|Overall Study|PI decisions|0
4701274|NCT02707965|7618075|FG003|Overall Study|PI decisions|0
4701275|NCT02707965|7618076|FG004|Overall Study|PI decisions|0
4701276|NCT02707965|7618077|FG005|Overall Study|PI decisions|0
4701277|NCT02707965|7618078|FG006|Overall Study|PI decisions|0
4701278|NCT02707965|7618079|FG007|Overall Study|PI decisions|0
4701279|NCT02707965|7618080|FG008|Overall Study|PI decisions|0
4701280|NCT02707965|7618081|FG009|Overall Study|PI decisions|0
4701281|NCT02707965|7618082|FG010|Overall Study|PI decisions|0
4701282|NCT02707965|7618083|FG011|Overall Study|PI decisions|0
4701283|NCT02707965|7618084|FG012|Overall Study|PI decisions|0
4701284|NCT02707965|7618085|FG013|Overall Study|PI decisions|0
4701285|NCT02707965|7618086|FG014|Overall Study|PI decisions|2
4701286|NCT02707965|7618087|FG015|Overall Study|PI decisions|0
4701287|NCT02707965|7618072|FG000|Overall Study|Protocol deviation|1
4701288|NCT02707965|7618073|FG001|Overall Study|Protocol deviation|1
4701289|NCT02707965|7618074|FG002|Overall Study|Protocol deviation|0
4701290|NCT02707965|7618075|FG003|Overall Study|Protocol deviation|0
4701291|NCT02707965|7618076|FG004|Overall Study|Protocol deviation|0
4485648|NCT00753415|7285564|FG000|Part A|Withdrawal by Subject|0
4485649|NCT00753415|7285565|FG001|Part A|Withdrawal by Subject|0
4485650|NCT00753415|7285566|FG002|Part A|Withdrawal by Subject|1
4485651|NCT00753415|7285567|FG003|Part A|Withdrawal by Subject|0
4701292|NCT02707965|7618077|FG005|Overall Study|Protocol deviation|0
4485652|NCT00753415|7285568|FG004|Part A|Withdrawal by Subject|0
4485653|NCT00753415|7285569|FG005|Part A|Withdrawal by Subject|0
4485654|NCT00753415|7285570|FG006|Part A|Withdrawal by Subject|0
4485655|NCT00753415|7285571|FG007|Part A|Withdrawal by Subject|0
4485656|NCT00753415|7285572|FG008|Part A|Withdrawal by Subject|0
4485657|NCT00753415|7285573|FG009|Part A|Withdrawal by Subject|0
4485658|NCT00753415|7285564|FG000|Part B|Lost to Follow-up|0
4485659|NCT00753415|7285565|FG001|Part B|Lost to Follow-up|0
4485660|NCT00753415|7285566|FG002|Part B|Lost to Follow-up|0
4485661|NCT00753415|7285567|FG003|Part B|Lost to Follow-up|0
4485662|NCT00753415|7285568|FG004|Part B|Lost to Follow-up|0
4485663|NCT00753415|7285569|FG005|Part B|Lost to Follow-up|0
4485664|NCT00753415|7285570|FG006|Part B|Lost to Follow-up|0
4485665|NCT00753415|7285571|FG007|Part B|Lost to Follow-up|1
4485666|NCT00753415|7285572|FG008|Part B|Lost to Follow-up|1
4485667|NCT00753415|7285573|FG009|Part B|Lost to Follow-up|0
4485668|NCT00753415|7285564|FG000|Part B|Disease progression|0
4485669|NCT00753415|7285565|FG001|Part B|Disease progression|0
4485670|NCT00753415|7285566|FG002|Part B|Disease progression|0
4485671|NCT00753415|7285567|FG003|Part B|Disease progression|0
4485672|NCT00753415|7285568|FG004|Part B|Disease progression|0
4485673|NCT00753415|7285569|FG005|Part B|Disease progression|0
4485674|NCT00753415|7285570|FG006|Part B|Disease progression|0
4485675|NCT00753415|7285571|FG007|Part B|Disease progression|0
4485676|NCT00753415|7285572|FG008|Part B|Disease progression|2
4485677|NCT00753415|7285573|FG009|Part B|Disease progression|1
4485678|NCT00753454|7285597|FG000|Overall Study|Adverse Event|4
4485679|NCT00753454|7285597|FG000|Overall Study|Lack of Efficacy|1
4485680|NCT00753454|7285597|FG000|Overall Study|Lost to Follow-up|3
4485681|NCT00753454|7285597|FG000|Overall Study|Withdrawal by Subject|5
4485682|NCT00753454|7285597|FG000|Overall Study|Investigator Decision|1
4485683|NCT00753506|7285603|FG000|Overall Study|Withdrawal by Subject|4
4485684|NCT00753506|7285604|FG001|Overall Study|Withdrawal by Subject|1
4485685|NCT00753506|7285603|FG000|Overall Study|Lost to Follow-up|2
4485686|NCT00753506|7285604|FG001|Overall Study|Lost to Follow-up|0
4485687|NCT00753506|7285603|FG000|Overall Study|Other reason|1
4485688|NCT00753506|7285604|FG001|Overall Study|Other reason|1
4485689|NCT00753519|7285612|FG000|Overall Study|Withdrawal by Subject|0
4485690|NCT00753519|7285613|FG001|Overall Study|Withdrawal by Subject|2
4485691|NCT00753623|7285623|FG000|Phase I (14 Days)|Withdrawal by Subject|1
4485692|NCT00753623|7285624|FG001|Phase I (14 Days)|Withdrawal by Subject|1
4485693|NCT00753623|7285623|FG000|Phase I (14 Days)|Physician Decision|1
4485694|NCT00753623|7285624|FG001|Phase I (14 Days)|Physician Decision|2
4485695|NCT00753623|7285623|FG000|Phase I (14 Days)|Adverse Event|0
4485696|NCT00753623|7285624|FG001|Phase I (14 Days)|Adverse Event|1
4485697|NCT00753623|7285623|FG000|Washout (7 Days)|Physician Decision|1
4485698|NCT00753623|7285624|FG001|Washout (7 Days)|Physician Decision|0
4485699|NCT00753623|7285623|FG000|Phase II (14 Days)|Physician Decision|0
4485700|NCT00753623|7285624|FG001|Phase II (14 Days)|Physician Decision|1
4485701|NCT00753649|7285636|FG000|Overall Study|Migrated/moved from study area|1
4485702|NCT00753649|7285637|FG001|Overall Study|Migrated/moved from study area|0
4485703|NCT00753649|7285636|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3
4485704|NCT00753649|7285637|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0
4485705|NCT00753649|7285636|FG000|Overall Study|Lost to follow-up-complete vaccination|1
4485706|NCT00753649|7285637|FG001|Overall Study|Lost to follow-up-complete vaccination|0
4485707|NCT00753649|7285636|FG000|Overall Study|Protocol Violation|2
4485708|NCT00753649|7285637|FG001|Overall Study|Protocol Violation|0
4485709|NCT00753675|7285646|FG000|Overall Study|other reason|11
4485710|NCT00753675|7285647|FG001|Overall Study|other reason|12
4485711|NCT00753675|7285648|FG002|Overall Study|other reason|13
4485712|NCT00753675|7285646|FG000|Overall Study|Death|1
4485713|NCT00753675|7285647|FG001|Overall Study|Death|2
4485714|NCT00753675|7285648|FG002|Overall Study|Death|4
4485715|NCT00753675|7285646|FG000|Overall Study|Adverse Event|11
4485716|NCT00753675|7285647|FG001|Overall Study|Adverse Event|9
4485717|NCT00753675|7285648|FG002|Overall Study|Adverse Event|4
4485718|NCT00753675|7285646|FG000|Overall Study|Objective progression of disease|35
4485719|NCT00753675|7285647|FG001|Overall Study|Objective progression of disease|35
4485720|NCT00753675|7285648|FG002|Overall Study|Objective progression of disease|35
4485721|NCT00753675|7285646|FG000|Overall Study|Withdrawal by Subject|0
4485722|NCT00753675|7285647|FG001|Overall Study|Withdrawal by Subject|1
4485723|NCT00753675|7285648|FG002|Overall Study|Withdrawal by Subject|0
4485724|NCT00753675|7285646|FG000|Overall Study|Lost to Follow-up|1
4485725|NCT00753675|7285647|FG001|Overall Study|Lost to Follow-up|0
4485726|NCT00753675|7285648|FG002|Overall Study|Lost to Follow-up|0
4485727|NCT00753688|7285658|FG000|Overall Study|Death|102
4485728|NCT00753688|7285659|FG001|Overall Study|Death|203
4485729|NCT00753688|7285658|FG000|Overall Study|Missing|4
4485730|NCT00753688|7285659|FG001|Overall Study|Missing|9
4485731|NCT00753688|7285658|FG000|Overall Study|Participant Withdrew Consent|2
4485732|NCT00753688|7285659|FG001|Overall Study|Participant Withdrew Consent|2
4485733|NCT00753688|7285658|FG000|Overall Study|Ongoing - in Follow-up|15
4485734|NCT00753688|7285659|FG001|Overall Study|Ongoing - in Follow-up|31
4485735|NCT00753688|7285658|FG000|Overall Study|Adverse Event|0
4485736|NCT00753688|7285659|FG001|Overall Study|Adverse Event|1
4485737|NCT00753714|7285667|FG000|Overall Study|Lack of Efficacy|21
4485738|NCT00753714|7285668|FG001|Overall Study|Lack of Efficacy|34
4485739|NCT00753714|7285667|FG000|Overall Study|Adverse Event|26
4485740|NCT00753714|7285668|FG001|Overall Study|Adverse Event|18
4485741|NCT00753714|7285667|FG000|Overall Study|Protocol Violation|1
4485742|NCT00753714|7285668|FG001|Overall Study|Protocol Violation|0
4485743|NCT00753714|7285667|FG000|Overall Study|Lost to Follow-up|0
4485744|NCT00753714|7285668|FG001|Overall Study|Lost to Follow-up|1
4485745|NCT00753714|7285667|FG000|Overall Study|Withdrawal by Subject|2
4485746|NCT00753714|7285668|FG001|Overall Study|Withdrawal by Subject|1
4485747|NCT00753714|7285667|FG000|Overall Study|Death|3
4485748|NCT00753714|7285668|FG001|Overall Study|Death|3
4485749|NCT00753714|7285667|FG000|Overall Study|Other|7
4485750|NCT00753714|7285668|FG001|Overall Study|Other|5
4485751|NCT00753766|7285679|FG000|Overall Study|Physician Decision|1
4485752|NCT00753766|7285680|FG001|Overall Study|Physician Decision|0
4485753|NCT00753896|7285687|FG000|Overall Study|Adverse Event|4
4485754|NCT00753896|7285687|FG000|Overall Study|Death|1
4485755|NCT00753896|7285687|FG000|Overall Study|Lost to Follow-up|2
4485756|NCT00753896|7285687|FG000|Overall Study|Protocol Violation|1
4485757|NCT00753896|7285687|FG000|Overall Study|Withdrawal by Subject|4
4485758|NCT00753896|7285687|FG000|Overall Study|Entry Criteria Not Met|4
4485759|NCT00753922|7285695|FG000|Overall Study|Lost to Follow-up|155
4485760|NCT00753922|7285696|FG001|Overall Study|Lost to Follow-up|24
4485761|NCT00753922|7285697|FG002|Overall Study|Lost to Follow-up|28
4485762|NCT00753922|7285698|FG003|Overall Study|Lost to Follow-up|5
4485763|NCT00753922|7285695|FG000|Overall Study|Withdrawal by Subject|9
4485764|NCT00753922|7285696|FG001|Overall Study|Withdrawal by Subject|11
4485765|NCT00753922|7285697|FG002|Overall Study|Withdrawal by Subject|4
4485766|NCT00753922|7285698|FG003|Overall Study|Withdrawal by Subject|2
4485767|NCT00753922|7285695|FG000|Overall Study|Patient Non-compliance|55
4485768|NCT00753922|7285696|FG001|Overall Study|Patient Non-compliance|22
4485769|NCT00753922|7285697|FG002|Overall Study|Patient Non-compliance|14
4485770|NCT00753922|7285698|FG003|Overall Study|Patient Non-compliance|11
4485771|NCT00753922|7285695|FG000|Overall Study|Patients Not Completing Visit|11
4485772|NCT00753922|7285696|FG001|Overall Study|Patients Not Completing Visit|0
4485773|NCT00753922|7285697|FG002|Overall Study|Patients Not Completing Visit|1
4485774|NCT00753922|7285698|FG003|Overall Study|Patients Not Completing Visit|0
4485775|NCT00753922|7285695|FG000|Overall Study|Death|2
4485776|NCT00753922|7285696|FG001|Overall Study|Death|23
4485777|NCT00753922|7285697|FG002|Overall Study|Death|2
4485778|NCT00753922|7285698|FG003|Overall Study|Death|1
4485779|NCT00753922|7285695|FG000|Overall Study|Discontinuation Due to Explantation|14
4485780|NCT00753922|7285696|FG001|Overall Study|Discontinuation Due to Explantation|14
4485781|NCT00753922|7285697|FG002|Overall Study|Discontinuation Due to Explantation|14
4485782|NCT00753922|7285698|FG003|Overall Study|Discontinuation Due to Explantation|4
4485783|NCT00754065|7285732|FG000|Overall Study|Never received treatment|12
4589951|NCT01516970|7435605|FG001|Overall Study|Lost to Follow-up|8
4589952|NCT01516970|7435604|FG000|Overall Study|Adverse Event|1
4589953|NCT01516970|7435605|FG001|Overall Study|Adverse Event|5
4485784|NCT00754065|7285733|FG001|Overall Study|Never received treatment|2
4485785|NCT00754065|7285732|FG000|Overall Study|Adverse Event|19
4485786|NCT00754065|7285733|FG001|Overall Study|Adverse Event|25
4485787|NCT00754065|7285732|FG000|Overall Study|Lost to Follow-up|7
4485788|NCT00754065|7285733|FG001|Overall Study|Lost to Follow-up|11
4485789|NCT00754065|7285732|FG000|Overall Study|Protocol Violation|12
4485790|NCT00754065|7285733|FG001|Overall Study|Protocol Violation|10
4485791|NCT00754065|7285732|FG000|Overall Study|Withdrawal by Subject|4
4485792|NCT00754065|7285733|FG001|Overall Study|Withdrawal by Subject|5
4485793|NCT00754065|7285732|FG000|Overall Study|Pregnancy|6
4485794|NCT00754065|7285733|FG001|Overall Study|Pregnancy|0
4485795|NCT00754065|7285732|FG000|Overall Study|Reason not specified or unknown, etc.|21
4485796|NCT00754065|7285733|FG001|Overall Study|Reason not specified or unknown, etc.|27
4485797|NCT00754234|7285786|FG000|Overall Study|Withdrawal by Subject|3
4485798|NCT00754325|7285805|FG000|Initial Treatment|Continuing Active Treatment|4
4485799|NCT00754325|7285806|FG001|Initial Treatment|Continuing Active Treatment|5
4485800|NCT00754325|7285805|FG000|Initial Treatment|Adverse Event|7
4485801|NCT00754325|7285806|FG001|Initial Treatment|Adverse Event|6
4485802|NCT00754325|7285805|FG000|Initial Treatment|Withdrawal by Subject|2
4485803|NCT00754325|7285806|FG001|Initial Treatment|Withdrawal by Subject|2
4485804|NCT00754325|7285805|FG000|Initial Treatment|Physician Decision|2
4485805|NCT00754325|7285806|FG001|Initial Treatment|Physician Decision|0
4485806|NCT00754325|7285805|FG000|Initial Treatment|Sponsor Request|0
4485807|NCT00754325|7285806|FG001|Initial Treatment|Sponsor Request|1
4485808|NCT00754325|7285805|FG000|Initial Treatment|Disease Progression|35
4485809|NCT00754325|7285806|FG001|Initial Treatment|Disease Progression|35
4485810|NCT00754338|7285817|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0
4485811|NCT00754338|7285818|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3
4485812|NCT00754338|7285819|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3
4485813|NCT00754338|7285820|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0
4485814|NCT00754338|7285817|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0
4485815|NCT00754338|7285818|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1
4485816|NCT00754338|7285819|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0
4485817|NCT00754338|7285820|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1
4485818|NCT00754390|7285843|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3
4485819|NCT00754390|7285843|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2
4485820|NCT00754390|7285843|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1
4485821|NCT00754390|7285843|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1
4485822|NCT00754442|7285852|FG000|Overall Study|Withdrawal by Subject|5
4485823|NCT00754442|7285853|FG001|Overall Study|Withdrawal by Subject|3
4485824|NCT00754559|7285894|FG000|Overall Study|Adverse Event|15
4485825|NCT00754559|7285894|FG000|Overall Study|Protocol Violation|11
4485826|NCT00754559|7285894|FG000|Overall Study|Lack of Efficacy|10
4485827|NCT00754559|7285894|FG000|Overall Study|Lost to Follow-up|2
4485828|NCT00754559|7285894|FG000|Overall Study|Administrative reason|1
4485829|NCT00754559|7285894|FG000|Overall Study|Other|5
4485830|NCT00754559|7285894|FG000|Overall Study|Withdrawal by Subject|3
4485831|NCT00754572|7285901|FG000|Overall Study|Adverse Event|19
4485832|NCT00754572|7285901|FG000|Overall Study|Other|39
4485833|NCT00754572|7285901|FG000|Overall Study|Protocol Violation|3
4485834|NCT00754572|7285901|FG000|Overall Study|Withdrawal by Subject|3
4485835|NCT00754572|7285901|FG000|Overall Study|Lack of Efficacy|2
4485836|NCT00754572|7285901|FG000|Overall Study|Death|1
4485837|NCT00754572|7285901|FG000|Overall Study|Administrative Reason|3
4485838|NCT00754572|7285901|FG000|Overall Study|Lost to Follow-up|1
4485839|NCT00754624|7285905|FG000|Overall Study|Adverse Event|16
4485840|NCT00754624|7285905|FG000|Overall Study|Death|1
4485841|NCT00754624|7285905|FG000|Overall Study|Physician Decision|8
4485842|NCT00754624|7285905|FG000|Overall Study|Protocol Violation|1
4485843|NCT00754624|7285905|FG000|Overall Study|Withdrawal by Subject|28
4485844|NCT00754624|7285905|FG000|Overall Study|Various|12
4485845|NCT00754624|7285905|FG000|Overall Study|Lost to Follow-up|3
4485846|NCT00754650|7285909|FG000|Overall Study|Disease Progression|2
4485847|NCT00754741|7285916|FG000|Overall Study|Died or disenrolled|57
4485848|NCT00754741|7285917|FG001|Overall Study|Died or disenrolled|69
4485849|NCT00754741|7285918|FG002|Overall Study|Died or disenrolled|54
4485850|NCT00754936|7285948|FG000|Overall Study|Lost to Follow-up|3
4485851|NCT00754936|7285948|FG000|Overall Study|Physician Decision|1
4485852|NCT00754936|7285948|FG000|Overall Study|Withdrawal by Subject|2
4485853|NCT00754936|7285948|FG000|Overall Study|Side Effects|3
4485854|NCT00754936|7285948|FG000|Overall Study|Inter-current medical events|3
4485855|NCT00755079|7285963|FG000|Overall Study|Lost to Follow-up|1
4485856|NCT00755079|7285964|FG001|Overall Study|Lost to Follow-up|3
4485857|NCT00755079|7285963|FG000|Overall Study|Adverse Event|0
4485858|NCT00755079|7285964|FG001|Overall Study|Adverse Event|1
4485859|NCT00755079|7285963|FG000|Overall Study|Withdrawal by Subject|0
4485860|NCT00755079|7285964|FG001|Overall Study|Withdrawal by Subject|2
4485861|NCT00755105|7285973|FG000|Overall Study|Withdrawal by Subject|9
4485862|NCT00755105|7285974|FG001|Overall Study|Withdrawal by Subject|11
4485863|NCT00755105|7285975|FG002|Overall Study|Withdrawal by Subject|4
4485864|NCT00755183|7285994|FG000|Overall Study|Adverse Event|5
4485865|NCT00755183|7285995|FG001|Overall Study|Adverse Event|2
4485866|NCT00755183|7285994|FG000|Overall Study|Protocol Violation|0
4485867|NCT00755183|7285995|FG001|Overall Study|Protocol Violation|1
4485868|NCT00755183|7285994|FG000|Overall Study|Withdrawal by Subject|0
4485869|NCT00755183|7285995|FG001|Overall Study|Withdrawal by Subject|2
4485870|NCT00755183|7285994|FG000|Overall Study|Administrative|2
4485871|NCT00755183|7285995|FG001|Overall Study|Administrative|1
4485872|NCT00755196|7286003|FG000|Overall Study|Lost to Follow-up|1
4485873|NCT00755196|7286003|FG000|Overall Study|Lack of Efficiency|1
4485874|NCT00755222|7286010|FG000|Overall Study|Withdrawal by Subject|4
4485875|NCT00755222|7286011|FG001|Overall Study|Withdrawal by Subject|2
4485876|NCT00755222|7286010|FG000|Overall Study|Adverse Event|2
4485877|NCT00755222|7286011|FG001|Overall Study|Adverse Event|0
4485878|NCT00755222|7286010|FG000|Overall Study|Protocol Violation|2
4485879|NCT00755222|7286011|FG001|Overall Study|Protocol Violation|0
4485880|NCT00755326|7286037|FG000|Overall Study|Lost to Follow-up|2
4485881|NCT00755326|7286038|FG001|Overall Study|Lost to Follow-up|3
4485882|NCT00755417|7286048|FG000|Overall Study|Adverse Event|28
4485883|NCT00755417|7286049|FG001|Overall Study|Adverse Event|20
4485884|NCT00755417|7286050|FG002|Overall Study|Adverse Event|7
4485885|NCT00755417|7286048|FG000|Overall Study|Lack of Efficacy|8
4485886|NCT00755417|7286049|FG001|Overall Study|Lack of Efficacy|4
4485887|NCT00755417|7286050|FG002|Overall Study|Lack of Efficacy|9
4485888|NCT00755417|7286048|FG000|Overall Study|Protocol Violation|2
4485889|NCT00755417|7286049|FG001|Overall Study|Protocol Violation|1
4485890|NCT00755417|7286050|FG002|Overall Study|Protocol Violation|1
4485891|NCT00755417|7286048|FG000|Overall Study|Lost to Follow-up|3
4485892|NCT00755417|7286049|FG001|Overall Study|Lost to Follow-up|0
4485893|NCT00755417|7286050|FG002|Overall Study|Lost to Follow-up|1
4485894|NCT00755417|7286048|FG000|Overall Study|Withdrawal by Subject|12
4485895|NCT00755417|7286049|FG001|Overall Study|Withdrawal by Subject|12
4485896|NCT00755417|7286050|FG002|Overall Study|Withdrawal by Subject|12
4485897|NCT00755417|7286048|FG000|Overall Study|Not specified or missing data|9
4485898|NCT00755417|7286049|FG001|Overall Study|Not specified or missing data|18
4485899|NCT00755417|7286050|FG002|Overall Study|Not specified or missing data|12
4485900|NCT00755716|7286061|FG000|Overall Study|Adverse Event|1
4485901|NCT00755716|7286062|FG001|Overall Study|Adverse Event|4
4485902|NCT00755716|7286063|FG002|Overall Study|Adverse Event|1
4485903|NCT00755716|7286061|FG000|Overall Study|Lack of Efficacy|2
4485904|NCT00755716|7286062|FG001|Overall Study|Lack of Efficacy|0
4485905|NCT00755716|7286063|FG002|Overall Study|Lack of Efficacy|0
4485906|NCT00755716|7286061|FG000|Overall Study|Lost to Follow-up|5
4485907|NCT00755716|7286062|FG001|Overall Study|Lost to Follow-up|3
4485908|NCT00755716|7286063|FG002|Overall Study|Lost to Follow-up|1
4485909|NCT00755716|7286061|FG000|Overall Study|work schedule issues|0
4485910|NCT00755716|7286062|FG001|Overall Study|work schedule issues|1
4485911|NCT00755716|7286063|FG002|Overall Study|work schedule issues|1
4485912|NCT00755807|7286086|FG000|Acute Phase|Adverse Event|16
4485913|NCT00755807|7286087|FG001|Acute Phase|Adverse Event|5
4485914|NCT00755807|7286086|FG000|Acute Phase|Protocol Violation|1
4485915|NCT00755807|7286087|FG001|Acute Phase|Protocol Violation|3
4485916|NCT00755807|7286086|FG000|Acute Phase|Withdrawal by Subject|1
4485917|NCT00755807|7286087|FG001|Acute Phase|Withdrawal by Subject|2
4485918|NCT00755807|7286086|FG000|Acute Phase|Lack of Efficacy|0
4485919|NCT00755807|7286087|FG001|Acute Phase|Lack of Efficacy|1
4485920|NCT00755807|7286086|FG000|Acute Phase|Physician Decision|0
4485921|NCT00755807|7286087|FG001|Acute Phase|Physician Decision|1
4485922|NCT00755807|7286086|FG000|Open-label Extension Phase|Adverse Event|7
4485923|NCT00755807|7286087|FG001|Open-label Extension Phase|Adverse Event|7
4485924|NCT00755807|7286086|FG000|Open-label Extension Phase|Protocol Violation|5
4485925|NCT00755807|7286087|FG001|Open-label Extension Phase|Protocol Violation|2
4485926|NCT00755807|7286086|FG000|Open-label Extension Phase|Lack of Efficacy|3
4485927|NCT00755807|7286087|FG001|Open-label Extension Phase|Lack of Efficacy|3
4485928|NCT00755807|7286086|FG000|Open-label Extension Phase|Withdrawal by Subject|1
4485929|NCT00755807|7286087|FG001|Open-label Extension Phase|Withdrawal by Subject|3
4485930|NCT00755807|7286086|FG000|Open-label Extension Phase|Lost to Follow-up|2
4485931|NCT00755807|7286087|FG001|Open-label Extension Phase|Lost to Follow-up|0
4485932|NCT00755807|7286086|FG000|Open-label Extension Phase|Sponsor Decision|0
4485933|NCT00755807|7286087|FG001|Open-label Extension Phase|Sponsor Decision|1
4485934|NCT00755846|7286103|FG000|Overall Study|Adverse Event|0
4485935|NCT00755846|7286104|FG001|Overall Study|Adverse Event|0
4485936|NCT00755846|7286105|FG002|Overall Study|Adverse Event|0
4485937|NCT00755846|7286106|FG003|Overall Study|Adverse Event|1
4485938|NCT00755846|7286107|FG004|Overall Study|Adverse Event|3
4485939|NCT00755846|7286108|FG005|Overall Study|Adverse Event|2
4485940|NCT00755846|7286103|FG000|Overall Study|Protocol Violation|1
4485941|NCT00755846|7286104|FG001|Overall Study|Protocol Violation|1
4485942|NCT00755846|7286105|FG002|Overall Study|Protocol Violation|1
4485943|NCT00755846|7286106|FG003|Overall Study|Protocol Violation|1
4485944|NCT00755846|7286107|FG004|Overall Study|Protocol Violation|1
4485945|NCT00755846|7286108|FG005|Overall Study|Protocol Violation|1
4485946|NCT00755846|7286103|FG000|Overall Study|Lost to Follow-up|0
4485947|NCT00755846|7286104|FG001|Overall Study|Lost to Follow-up|2
4485948|NCT00755846|7286105|FG002|Overall Study|Lost to Follow-up|1
4485949|NCT00755846|7286106|FG003|Overall Study|Lost to Follow-up|0
4485950|NCT00755846|7286107|FG004|Overall Study|Lost to Follow-up|4
4485951|NCT00755846|7286108|FG005|Overall Study|Lost to Follow-up|2
4485952|NCT00755846|7286103|FG000|Overall Study|Withdrawal by Subject|2
4485953|NCT00755846|7286104|FG001|Overall Study|Withdrawal by Subject|3
4485954|NCT00755846|7286105|FG002|Overall Study|Withdrawal by Subject|5
4485955|NCT00755846|7286106|FG003|Overall Study|Withdrawal by Subject|2
4485956|NCT00755846|7286107|FG004|Overall Study|Withdrawal by Subject|0
4485957|NCT00755846|7286108|FG005|Overall Study|Withdrawal by Subject|1
4485958|NCT00755846|7286103|FG000|Overall Study|Hyperglycemic Rescue|21
4485959|NCT00755846|7286104|FG001|Overall Study|Hyperglycemic Rescue|7
4485960|NCT00755846|7286105|FG002|Overall Study|Hyperglycemic Rescue|5
4485961|NCT00755846|7286106|FG003|Overall Study|Hyperglycemic Rescue|8
4485962|NCT00755846|7286107|FG004|Overall Study|Hyperglycemic Rescue|8
4485963|NCT00755846|7286108|FG005|Overall Study|Hyperglycemic Rescue|7
4485964|NCT00755846|7286103|FG000|Overall Study|Physician Decision|1
4485965|NCT00755846|7286104|FG001|Overall Study|Physician Decision|3
4485966|NCT00755846|7286105|FG002|Overall Study|Physician Decision|0
4485967|NCT00755846|7286106|FG003|Overall Study|Physician Decision|1
4485968|NCT00755846|7286107|FG004|Overall Study|Physician Decision|0
4485969|NCT00755846|7286108|FG005|Overall Study|Physician Decision|1
4485970|NCT00755846|7286103|FG000|Overall Study|Administrative Error|0
4485971|NCT00755846|7286104|FG001|Overall Study|Administrative Error|1
4485972|NCT00755846|7286105|FG002|Overall Study|Administrative Error|0
4485973|NCT00755846|7286106|FG003|Overall Study|Administrative Error|0
4485974|NCT00755846|7286107|FG004|Overall Study|Administrative Error|0
4485975|NCT00755846|7286108|FG005|Overall Study|Administrative Error|0
4485976|NCT00755846|7286103|FG000|Overall Study|Participant Non-compliance|0
4485977|NCT00755846|7286104|FG001|Overall Study|Participant Non-compliance|0
4485978|NCT00755846|7286105|FG002|Overall Study|Participant Non-compliance|0
4485979|NCT00755846|7286106|FG003|Overall Study|Participant Non-compliance|0
4485980|NCT00755846|7286107|FG004|Overall Study|Participant Non-compliance|1
4485981|NCT00755846|7286108|FG005|Overall Study|Participant Non-compliance|0
4485982|NCT00755937|7286131|FG000|Recruitment|Unknown if infliximab received|164
4485983|NCT00755937|7286131|FG000|Observational Follow-up|Lost to Follow-up|148
4485984|NCT00756002|7286137|FG000|Double-Blind Treatment Period|Lack of Efficacy|1
4485985|NCT00756002|7286138|FG001|Double-Blind Treatment Period|Lack of Efficacy|1
4485986|NCT00756002|7286137|FG000|Double-Blind Treatment Period|Lost to Follow-up|0
4485987|NCT00756002|7286138|FG001|Double-Blind Treatment Period|Lost to Follow-up|1
4485988|NCT00756002|7286137|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6
4485989|NCT00756002|7286138|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6
4485990|NCT00756002|7286137|FG000|Double-Blind Treatment Period|Protocol Violation|6
4485991|NCT00756002|7286138|FG001|Double-Blind Treatment Period|Protocol Violation|5
4485992|NCT00756002|7286137|FG000|Double-Blind Treatment Period|Other|2
4485993|NCT00756002|7286138|FG001|Double-Blind Treatment Period|Other|2
4485994|NCT00756275|7286176|FG000|Overall Study|Lost to Follow-up|25
4485995|NCT00756275|7286177|FG001|Overall Study|Lost to Follow-up|21
4485996|NCT00756275|7286176|FG000|Overall Study|Withdrawal by Subject|4
4485997|NCT00756275|7286177|FG001|Overall Study|Withdrawal by Subject|7
4485998|NCT00756314|7286185|FG000|Overall Study|Lost to Follow-up|2
4485999|NCT00756314|7286186|FG001|Overall Study|Lost to Follow-up|59
4486000|NCT00756444|7286194|FG000|Overall Study|Adverse Event|1
4486001|NCT00756444|7286195|FG001|Overall Study|Adverse Event|1
4486002|NCT00756444|7286194|FG000|Overall Study|Withdrawal by Subject|6
4486003|NCT00756444|7286195|FG001|Overall Study|Withdrawal by Subject|8
4486004|NCT00756444|7286194|FG000|Overall Study|Lost to Follow-up|0
4486005|NCT00756444|7286195|FG001|Overall Study|Lost to Follow-up|1
4486006|NCT00756444|7286194|FG000|Overall Study|Death|5
4486007|NCT00756444|7286195|FG001|Overall Study|Death|4
4486008|NCT00756444|7286194|FG000|Overall Study|Disease Progression|2
4486009|NCT00756444|7286195|FG001|Overall Study|Disease Progression|7
4486010|NCT00756444|7286194|FG000|Overall Study|Ineligibility Determined|1
4486011|NCT00756444|7286195|FG001|Overall Study|Ineligibility Determined|0
4486012|NCT00756457|7286204|FG000|Overall Study|Lost to Follow-up|1
4486013|NCT00756457|7286205|FG001|Overall Study|Lost to Follow-up|2
4486014|NCT00756470|7286227|FG000|Overall Study|Withdrawal by Subject|1
4486015|NCT00756470|7286227|FG000|Overall Study|Adverse Event|4
4486016|NCT00756652|7286274|FG000|Original Phase|Withdrawal by Subject|864
4486017|NCT00756652|7286275|FG001|Original Phase|Withdrawal by Subject|23
4486018|NCT00756652|7286274|FG000|Original Phase|Lost to Follow-up|601
4486019|NCT00756652|7286275|FG001|Original Phase|Lost to Follow-up|0
4486020|NCT00756652|7286274|FG000|Original Phase|Other Discontinuation|797
4486021|NCT00756652|7286275|FG001|Original Phase|Other Discontinuation|5
4486022|NCT00756652|7286274|FG000|Original Phase|Participant Noncompliance|18622
4486023|NCT00756652|7286275|FG001|Original Phase|Participant Noncompliance|424
4486024|NCT00756652|7286274|FG000|Original Phase|Unknown Discontinuation Reason|2
4486025|NCT00756652|7286275|FG001|Original Phase|Unknown Discontinuation Reason|0
4486026|NCT00756652|7286274|FG000|Original Phase|Participants without data|3259
4486027|NCT00756652|7286275|FG001|Original Phase|Participants without data|466
4486028|NCT00756652|7286274|FG000|Original Phase|Death|168
4486029|NCT00756652|7286275|FG001|Original Phase|Death|1
4486030|NCT00756652|7286274|FG000|Original Phase|Not due for F/U at Phase One closure|11076
4589954|NCT01516970|7435604|FG000|Overall Study|Withdrawal by Subject|1
4589955|NCT01516970|7435605|FG001|Overall Study|Withdrawal by Subject|1
4589956|NCT01516970|7435604|FG000|Overall Study|Other|9
4589957|NCT01516970|7435605|FG001|Overall Study|Other|7
4589958|NCT01517178|7435620|FG000|Period 1|Adverse Event|1
4589959|NCT01517178|7435621|FG001|Period 1|Adverse Event|2
4589960|NCT01517178|7435620|FG000|Period 1|Lack of Efficacy|0
4589961|NCT01517178|7435621|FG001|Period 1|Lack of Efficacy|1
4589962|NCT01517178|7435620|FG000|Period 1|E.g. study termination|3
4589963|NCT01517178|7435621|FG001|Period 1|E.g. study termination|1
4589964|NCT01517178|7435620|FG000|Period 1|Withdrawal by Subject|0
4589965|NCT01517178|7435621|FG001|Period 1|Withdrawal by Subject|1
4589966|NCT01517178|7435620|FG000|Period 2|Adverse Event|1
4589967|NCT01517178|7435621|FG001|Period 2|Adverse Event|0
4486031|NCT00756652|7286275|FG001|Original Phase|Not due for F/U at Phase One closure|2
4486032|NCT00756652|7286274|FG000|Re-Op Phase|Withdrawal by Subject|62
4486033|NCT00756652|7286275|FG001|Re-Op Phase|Withdrawal by Subject|0
4486034|NCT00756652|7286274|FG000|Re-Op Phase|Death|6
4486035|NCT00756652|7286275|FG001|Re-Op Phase|Death|0
4486036|NCT00756652|7286274|FG000|Re-Op Phase|Lost to Follow-up|340
4486037|NCT00756652|7286275|FG001|Re-Op Phase|Lost to Follow-up|0
4486038|NCT00756652|7286274|FG000|Re-Op Phase|Site Closed|2454
4486039|NCT00756652|7286275|FG001|Re-Op Phase|Site Closed|0
4486040|NCT00756652|7286274|FG000|Re-Op Phase|Withdrawn after explant|14
4486041|NCT00756652|7286275|FG001|Re-Op Phase|Withdrawn after explant|0
4517160|NCT00964392|7328812|FG001|Overall Study|Early Termination, non-study arrhythmia|6
4517161|NCT00964392|7328811|FG000|Overall Study|Not completed|44
4517162|NCT00964392|7328812|FG001|Overall Study|Not completed|168
4517163|NCT00964678|7328857|FG000|Overall Study|Physician Decision|4
4517164|NCT00964743|7328862|FG000|Overall Study|Neither patient completed 8 weeks of tre|2
4517165|NCT00964782|7328868|FG000|Overall Study|Lost to Follow-up|1
4517166|NCT00964782|7328869|FG001|Overall Study|Lost to Follow-up|0
4517167|NCT00964795|7328877|FG000|Overall Study|Withdrawal by Subject|79
4517168|NCT00964795|7328877|FG000|Overall Study|Adverse Event|12
4589968|NCT01517178|7435620|FG000|Period 2|Withdrawal by Subject|3
4589969|NCT01517178|7435621|FG001|Period 2|Withdrawal by Subject|0
4589970|NCT01517178|7435620|FG000|Period 2|E.g. study termination|2
4589971|NCT01517178|7435621|FG001|Period 2|E.g. study termination|2
4589972|NCT01517282|7435631|FG000|Overall Study|Consent withdrawn|0
4486042|NCT00756717|7286284|FG000|Overall Study|Withdrawal by Subject|2
4486043|NCT00756730|7286290|FG000|Overall Study|discontinued due to rash prior to week 4|0
4486044|NCT00756730|7286291|FG001|Overall Study|discontinued due to rash prior to week 4|1
4486045|NCT00756730|7286290|FG000|Overall Study|persistent low-level viremmia|0
4486046|NCT00756730|7286291|FG001|Overall Study|persistent low-level viremmia|1
4486047|NCT00756886|7286299|FG000|Overall Study|Lost to Follow-up|1
4486048|NCT00756886|7286300|FG001|Overall Study|Lost to Follow-up|0
4486049|NCT00756886|7286299|FG000|Overall Study|Adverse Event|0
4486050|NCT00756886|7286300|FG001|Overall Study|Adverse Event|3
4486051|NCT00756886|7286299|FG000|Overall Study|Lack of Efficacy|1
4486052|NCT00756886|7286300|FG001|Overall Study|Lack of Efficacy|0
4486053|NCT00756886|7286299|FG000|Overall Study|Ineligible|9
4486054|NCT00756886|7286300|FG001|Overall Study|Ineligible|4
4486055|NCT00757003|7286324|FG000|Overall Study|Death|33
4486056|NCT00757003|7286324|FG000|Overall Study|Lost to Follow-up|9
4486057|NCT00757003|7286324|FG000|Overall Study|Withdrawal by Subject|4
4486058|NCT00757003|7286324|FG000|Overall Study|Surgically explanted|2
4486059|NCT00757003|7286324|FG000|Overall Study|Not implanted|1
4486060|NCT00757172|7286329|FG000|Overall Study|Withdrawal by Subject|4
4486061|NCT00757172|7286329|FG000|Overall Study|Physician Decision|3
4486062|NCT00757172|7286329|FG000|Overall Study|Progression|4
4486063|NCT00757237|7286335|FG000|Overall Study|Lost to Follow-up|0
4486064|NCT00757237|7286336|FG001|Overall Study|Lost to Follow-up|1
4486065|NCT00757237|7286335|FG000|Overall Study|Protocol Violation|0
4486066|NCT00757237|7286336|FG001|Overall Study|Protocol Violation|2
4486067|NCT00757237|7286335|FG000|Overall Study|Physician Decision|2
4486068|NCT00757237|7286336|FG001|Overall Study|Physician Decision|3
4486069|NCT00757237|7286335|FG000|Overall Study|Withdrawal by Subject|8
4486070|NCT00757237|7286336|FG001|Overall Study|Withdrawal by Subject|12
4486071|NCT00757237|7286335|FG000|Overall Study|Safety or Tolerability|3
4486072|NCT00757237|7286336|FG001|Overall Study|Safety or Tolerability|5
4486073|NCT00757237|7286335|FG000|Overall Study|Other|0
4486074|NCT00757237|7286336|FG001|Overall Study|Other|2
4486075|NCT00757588|7286350|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3
4486076|NCT00757588|7286351|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2
4486077|NCT00757588|7286350|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6
4486078|NCT00757588|7286351|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3
4486079|NCT00757588|7286350|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13
4486080|NCT00757588|7286351|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5
4486081|NCT00757588|7286350|FG000|Period 1: Short-term (24-week) Phase|Death|1
4486082|NCT00757588|7286351|FG001|Period 1: Short-term (24-week) Phase|Death|0
4486083|NCT00757588|7286350|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3
4486084|NCT00757588|7286351|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5
4486085|NCT00757588|7286350|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5
4486086|NCT00757588|7286351|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1
4486087|NCT00757588|7286350|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5
4486088|NCT00757588|7286351|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0
4486089|NCT00757588|7286350|FG000|Period 1: Short-term (24-week) Phase|Other|0
4486090|NCT00757588|7286351|FG001|Period 1: Short-term (24-week) Phase|Other|1
4486091|NCT00757588|7286350|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1
4486092|NCT00757588|7286351|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0
4486093|NCT00757588|7286350|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4
4486094|NCT00757588|7286351|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0
4486095|NCT00757588|7286350|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4
4486096|NCT00757588|7286351|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2
4486097|NCT00757588|7286350|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1
4486098|NCT00757588|7286351|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1
4486099|NCT00757588|7286350|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5
4486100|NCT00757588|7286351|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2
4486101|NCT00757588|7286350|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1
4486102|NCT00757588|7286351|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0
4486103|NCT00757588|7286350|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5
4486104|NCT00757588|7286351|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4
4486105|NCT00757588|7286350|FG000|Period 2: Long-term (52-week) Phase|Other|1
4486106|NCT00757588|7286351|FG001|Period 2: Long-term (52-week) Phase|Other|0
4486107|NCT00757705|7286411|FG000|Overall Study|Adverse Event|19
4486108|NCT00757705|7286411|FG000|Overall Study|Lost to Follow-up|16
4486109|NCT00757705|7286411|FG000|Overall Study|Withdrawal by Subject|25
4486110|NCT00757705|7286411|FG000|Overall Study|Insufficient Response|26
4486111|NCT00757705|7286411|FG000|Overall Study|Ineligible to continue|8
4486112|NCT00757705|7286411|FG000|Overall Study|Non-compliant|9
4486113|NCT00757705|7286411|FG000|Overall Study|Other|18
4486114|NCT00757783|7286417|FG000|Overall Study|Adverse Event|0
4486115|NCT00757783|7286418|FG001|Overall Study|Adverse Event|2
4486116|NCT00757783|7286417|FG000|Overall Study|Lost to Follow-up|1
4486117|NCT00757783|7286418|FG001|Overall Study|Lost to Follow-up|1
4486118|NCT00757783|7286417|FG000|Overall Study|Protocol Violation|1
4486119|NCT00757783|7286418|FG001|Overall Study|Protocol Violation|0
4486120|NCT00757783|7286417|FG000|Overall Study|Withdrawal by Subject|2
4486121|NCT00757783|7286418|FG001|Overall Study|Withdrawal by Subject|1
4486122|NCT00757783|7286417|FG000|Overall Study|Other|1
4486123|NCT00757783|7286418|FG001|Overall Study|Other|2
4486124|NCT00757848|7286438|FG000|Overall Study|Voluntary discontinuation|1
4486125|NCT00757848|7286439|FG001|Overall Study|Voluntary discontinuation|0
4486126|NCT00757848|7286438|FG000|Overall Study|Adverse Event|1
4486127|NCT00757848|7286439|FG001|Overall Study|Adverse Event|2
4486128|NCT00757848|7286438|FG000|Overall Study|Incorrect enrolment|1
4486129|NCT00757848|7286439|FG001|Overall Study|Incorrect enrolment|0
4486130|NCT00758043|7286449|FG000|Overall Study|Adverse Event|1
4486131|NCT00758043|7286450|FG001|Overall Study|Adverse Event|20
4486132|NCT00758043|7286451|FG002|Overall Study|Adverse Event|12
4486133|NCT00758043|7286452|FG003|Overall Study|Adverse Event|62
4486134|NCT00758043|7286449|FG000|Overall Study|Lack of Efficacy|0
4486135|NCT00758043|7286450|FG001|Overall Study|Lack of Efficacy|6
4486136|NCT00758043|7286451|FG002|Overall Study|Lack of Efficacy|18
4486137|NCT00758043|7286452|FG003|Overall Study|Lack of Efficacy|12
4486138|NCT00758043|7286449|FG000|Overall Study|Refused Further Treatment|0
4486139|NCT00758043|7286450|FG001|Overall Study|Refused Further Treatment|11
4486140|NCT00758043|7286451|FG002|Overall Study|Refused Further Treatment|5
4486141|NCT00758043|7286452|FG003|Overall Study|Refused Further Treatment|8
4486142|NCT00758043|7286449|FG000|Overall Study|Lost to Follow-up|0
4486143|NCT00758043|7286450|FG001|Overall Study|Lost to Follow-up|2
4486144|NCT00758043|7286451|FG002|Overall Study|Lost to Follow-up|2
4486145|NCT00758043|7286452|FG003|Overall Study|Lost to Follow-up|5
4486146|NCT00758043|7286449|FG000|Overall Study|Withdrawal by Subject|0
4486147|NCT00758043|7286450|FG001|Overall Study|Withdrawal by Subject|1
4486148|NCT00758043|7286451|FG002|Overall Study|Withdrawal by Subject|1
4486149|NCT00758043|7286452|FG003|Overall Study|Withdrawal by Subject|4
4486150|NCT00758043|7286449|FG000|Overall Study|Required Prohibited Medication|0
4486151|NCT00758043|7286450|FG001|Overall Study|Required Prohibited Medication|0
4486152|NCT00758043|7286451|FG002|Overall Study|Required Prohibited Medication|1
4486153|NCT00758043|7286452|FG003|Overall Study|Required Prohibited Medication|3
4486154|NCT00758043|7286449|FG000|Overall Study|Non-Compliant With study Drug|0
4486155|NCT00758043|7286450|FG001|Overall Study|Non-Compliant With study Drug|0
4486156|NCT00758043|7286451|FG002|Overall Study|Non-Compliant With study Drug|0
4486157|NCT00758043|7286452|FG003|Overall Study|Non-Compliant With study Drug|1
4486158|NCT00758043|7286449|FG000|Overall Study|Other Reasons|0
4486159|NCT00758043|7286450|FG001|Overall Study|Other Reasons|1
4486160|NCT00758043|7286451|FG002|Overall Study|Other Reasons|0
4589973|NCT01517282|7435632|FG001|Overall Study|Consent withdrawn|1
4589974|NCT01517282|7435633|FG002|Overall Study|Consent withdrawn|1
4589975|NCT01517282|7435634|FG003|Overall Study|Consent withdrawn|1
4589976|NCT01517282|7435631|FG000|Overall Study|Physician Decision|1
4589977|NCT01517282|7435632|FG001|Overall Study|Physician Decision|0
4589978|NCT01517282|7435633|FG002|Overall Study|Physician Decision|0
4589979|NCT01517282|7435634|FG003|Overall Study|Physician Decision|0
4589980|NCT01517295|7435646|FG000|Overall Study|Physician Decision|1
4589981|NCT01517295|7435647|FG001|Overall Study|Physician Decision|0
4589982|NCT01517373|7435658|FG000|Run-in Period|Death|1
4589983|NCT01517373|7435659|FG001|Run-in Period|Death|0
4589984|NCT01517373|7435660|FG002|Run-in Period|Death|0
4589985|NCT01517373|7435661|FG003|Run-in Period|Death|0
4589986|NCT01517373|7435662|FG004|Run-in Period|Death|0
4589987|NCT01517373|7435663|FG005|Run-in Period|Death|0
4486161|NCT00758043|7286452|FG003|Overall Study|Other Reasons|5
4486162|NCT00758069|7286471|FG000|Overall Study|Lack of Efficacy|0
4486163|NCT00758069|7286472|FG001|Overall Study|Lack of Efficacy|0
4486164|NCT00758069|7286473|FG002|Overall Study|Lack of Efficacy|1
4486165|NCT00758069|7286471|FG000|Overall Study|Incorrect Study Drug|1
4486166|NCT00758069|7286472|FG001|Overall Study|Incorrect Study Drug|0
4486167|NCT00758069|7286473|FG002|Overall Study|Incorrect Study Drug|0
4486168|NCT00758160|7286481|FG000|Overall Study|No Longer Requires Study Medication|4
4486169|NCT00758160|7286481|FG000|Overall Study|Administration Problems|3
4486170|NCT00758160|7286481|FG000|Overall Study|Adverse Event|15
4486171|NCT00758160|7286481|FG000|Overall Study|Lack of Efficacy|10
4486172|NCT00758160|7286481|FG000|Overall Study|Lost to Follow-up|14
4589988|NCT01517373|7435658|FG000|Run-in Period|Adverse Event|5
4589989|NCT01517373|7435659|FG001|Run-in Period|Adverse Event|0
4589990|NCT01517373|7435660|FG002|Run-in Period|Adverse Event|0
4589991|NCT01517373|7435661|FG003|Run-in Period|Adverse Event|0
4486173|NCT00758160|7286481|FG000|Overall Study|Protocol Violation|12
4486174|NCT00758160|7286481|FG000|Overall Study|Withdrawal by Subject|8
4486175|NCT00758264|7286492|FG000|Active Phase|Withdrawal by Subject|0
4486176|NCT00758264|7286493|FG001|Active Phase|Withdrawal by Subject|0
4486177|NCT00758264|7286494|FG002|Active Phase|Withdrawal by Subject|1
4486178|NCT00758264|7286492|FG000|Active Phase|Lost to Follow-up|1
4486179|NCT00758264|7286493|FG001|Active Phase|Lost to Follow-up|0
4486180|NCT00758264|7286494|FG002|Active Phase|Lost to Follow-up|0
4486181|NCT00758264|7286492|FG000|Active Phase|Other|0
4486182|NCT00758264|7286493|FG001|Active Phase|Other|0
4486183|NCT00758264|7286494|FG002|Active Phase|Other|4
4486184|NCT00758394|7286515|FG000|2nd Intervention Order|Lost to Follow-up|0
4486185|NCT00758394|7286516|FG001|2nd Intervention Order|Lost to Follow-up|1
4486186|NCT00758394|7286517|FG002|2nd Intervention Order|Lost to Follow-up|0
4589992|NCT01517373|7435662|FG004|Run-in Period|Adverse Event|0
4589993|NCT01517373|7435663|FG005|Run-in Period|Adverse Event|0
4589994|NCT01517373|7435658|FG000|Run-in Period|Did not meet eligibility criteria|34
4486187|NCT00758394|7286518|FG003|2nd Intervention Order|Lost to Follow-up|0
4486188|NCT00758394|7286515|FG000|3rd Intervention|Lost to Follow-up|1
4486189|NCT00758394|7286516|FG001|3rd Intervention|Lost to Follow-up|0
4486190|NCT00758394|7286517|FG002|3rd Intervention|Lost to Follow-up|0
4486191|NCT00758394|7286518|FG003|3rd Intervention|Lost to Follow-up|1
4486192|NCT00758459|7286539|FG000|Overall Study|Adverse Event|3
4486193|NCT00758459|7286540|FG001|Overall Study|Adverse Event|2
4486194|NCT00758459|7286539|FG000|Overall Study|Protocol Violation|0
4486195|NCT00758459|7286540|FG001|Overall Study|Protocol Violation|1
4486196|NCT00758459|7286539|FG000|Overall Study|Withdrawal by Subject|0
4486197|NCT00758459|7286540|FG001|Overall Study|Withdrawal by Subject|1
4486198|NCT00758485|7286548|FG000|Overall Study|Lost to Follow-up|0
4486199|NCT00758485|7286549|FG001|Overall Study|Lost to Follow-up|1
4486200|NCT00758485|7286548|FG000|Overall Study|Not Treated|1
4486201|NCT00758485|7286549|FG001|Overall Study|Not Treated|2
4486202|NCT00758498|7286559|FG000|Overall Study|Adverse Event|2
4486203|NCT00758498|7286560|FG001|Overall Study|Adverse Event|2
4486204|NCT00758498|7286561|FG002|Overall Study|Adverse Event|3
4486205|NCT00758498|7286559|FG000|Overall Study|Subject legally detained out of state|1
4486206|NCT00758498|7286560|FG001|Overall Study|Subject legally detained out of state|0
4486207|NCT00758498|7286561|FG002|Overall Study|Subject legally detained out of state|0
4486208|NCT00758498|7286559|FG000|Overall Study|Withdrawal by Subject|0
4486209|NCT00758498|7286560|FG001|Overall Study|Withdrawal by Subject|0
4486210|NCT00758498|7286561|FG002|Overall Study|Withdrawal by Subject|1
4486211|NCT00758498|7286559|FG000|Overall Study|Noncompliance to study procedures|0
4486212|NCT00758498|7286560|FG001|Overall Study|Noncompliance to study procedures|0
4486213|NCT00758498|7286561|FG002|Overall Study|Noncompliance to study procedures|1
4486214|NCT00758524|7286575|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3
4486215|NCT00758524|7286576|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2
4486216|NCT00758524|7286577|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4
4486217|NCT00758524|7286578|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
4486218|NCT00758524|7286579|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3
4486219|NCT00758524|7286580|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5
4486220|NCT00758524|7286581|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
4486221|NCT00758524|7286582|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
4486222|NCT00758524|7286583|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
4486223|NCT00758524|7286584|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
4486224|NCT00758524|7286585|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
4486225|NCT00758524|7286586|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
4486226|NCT00758524|7286587|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
4486227|NCT00758524|7286588|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
4486228|NCT00758524|7286589|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
4486229|NCT00758524|7286590|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
4486230|NCT00758524|7286591|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0
4486231|NCT00758524|7286575|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3
4486232|NCT00758524|7286576|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
4486233|NCT00758524|7286577|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2
4486234|NCT00758524|7286578|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3
4486235|NCT00758524|7286579|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1
4486236|NCT00758524|7286580|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3
4486237|NCT00758524|7286581|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
4486238|NCT00758524|7286582|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
4486239|NCT00758524|7286583|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
4486240|NCT00758524|7286584|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
4486241|NCT00758524|7286585|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
4486242|NCT00758524|7286586|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
4486243|NCT00758524|7286587|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
4486244|NCT00758524|7286588|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
4486245|NCT00758524|7286589|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
4486246|NCT00758524|7286590|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
4486247|NCT00758524|7286591|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0
4486248|NCT00758524|7286575|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2
4486249|NCT00758524|7286576|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1
4486250|NCT00758524|7286577|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1
4486251|NCT00758524|7286578|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3
4486252|NCT00758524|7286579|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2
4486253|NCT00758524|7286580|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1
4486254|NCT00758524|7286581|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0
4486255|NCT00758524|7286582|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0
4486256|NCT00758524|7286583|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0
4486257|NCT00758524|7286584|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0
4589995|NCT01517373|7435659|FG001|Run-in Period|Did not meet eligibility criteria|0
4486258|NCT00758524|7286585|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0
4486259|NCT00758524|7286586|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0
4486260|NCT00758524|7286587|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0
4486261|NCT00758524|7286588|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0
4486262|NCT00758524|7286589|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0
4486263|NCT00758524|7286590|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0
4486264|NCT00758524|7286591|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0
4486265|NCT00758524|7286575|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
4486266|NCT00758524|7286576|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2
4486267|NCT00758524|7286577|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1
4486268|NCT00758524|7286578|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
4486269|NCT00758524|7286579|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2
4486270|NCT00758524|7286580|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1
4486271|NCT00758524|7286581|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
4486272|NCT00758524|7286582|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
4486273|NCT00758524|7286583|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
4486274|NCT00758524|7286584|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
4486275|NCT00758524|7286585|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
4486276|NCT00758524|7286586|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
4486277|NCT00758524|7286587|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
4486278|NCT00758524|7286588|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
4486279|NCT00758524|7286589|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
4486280|NCT00758524|7286590|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
4486281|NCT00758524|7286591|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0
4486282|NCT00758524|7286575|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0
4486283|NCT00758524|7286576|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0
4486284|NCT00758524|7286577|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1
4486285|NCT00758524|7286578|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1
4486286|NCT00758524|7286579|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0
4486287|NCT00758524|7286580|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0
4486288|NCT00758524|7286581|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0
4486289|NCT00758524|7286582|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0
4486290|NCT00758524|7286583|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0
4486291|NCT00758524|7286584|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0
4486292|NCT00758524|7286585|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0
4486293|NCT00758524|7286586|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0
4486294|NCT00758524|7286587|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0
4486295|NCT00758524|7286588|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0
4486296|NCT00758524|7286589|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0
4486297|NCT00758524|7286590|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0
4486298|NCT00758524|7286591|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0
4486299|NCT00758524|7286575|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
4486300|NCT00758524|7286576|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
4486301|NCT00758524|7286577|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
4486302|NCT00758524|7286578|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
4486303|NCT00758524|7286579|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1
4486304|NCT00758524|7286580|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
4486305|NCT00758524|7286581|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
4486306|NCT00758524|7286582|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
4486307|NCT00758524|7286583|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
4486308|NCT00758524|7286584|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
4486309|NCT00758524|7286585|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
4486310|NCT00758524|7286586|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
4486311|NCT00758524|7286587|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
4486312|NCT00758524|7286588|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
4486313|NCT00758524|7286589|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
4486314|NCT00758524|7286590|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
4486315|NCT00758524|7286591|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0
4486316|NCT00758524|7286575|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
4486317|NCT00758524|7286576|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1
4486318|NCT00758524|7286577|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
4486319|NCT00758524|7286578|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
4486320|NCT00758524|7286579|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
4486321|NCT00758524|7286580|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
4486322|NCT00758524|7286581|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
4486323|NCT00758524|7286582|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
4486324|NCT00758524|7286583|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
4486325|NCT00758524|7286584|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
4486326|NCT00758524|7286585|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
4486327|NCT00758524|7286586|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
4486328|NCT00758524|7286587|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
4486329|NCT00758524|7286588|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
4486330|NCT00758524|7286589|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
4486331|NCT00758524|7286590|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
4486332|NCT00758524|7286591|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0
4486333|NCT00758524|7286575|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0
4486334|NCT00758524|7286576|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1
4486335|NCT00758524|7286577|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0
4486336|NCT00758524|7286578|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0
4486337|NCT00758524|7286579|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0
4486338|NCT00758524|7286580|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0
4486339|NCT00758524|7286581|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0
4486340|NCT00758524|7286582|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0
4486341|NCT00758524|7286583|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0
4486342|NCT00758524|7286584|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0
4486343|NCT00758524|7286585|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0
4486344|NCT00758524|7286586|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0
4486345|NCT00758524|7286587|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0
4486346|NCT00758524|7286588|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0
4486347|NCT00758524|7286589|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0
4486348|NCT00758524|7286590|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0
4486349|NCT00758524|7286591|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0
4486350|NCT00758524|7286575|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
4486351|NCT00758524|7286576|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
4486352|NCT00758524|7286577|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
4486353|NCT00758524|7286578|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
4486354|NCT00758524|7286579|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
4486355|NCT00758524|7286580|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
4486356|NCT00758524|7286581|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
4486357|NCT00758524|7286582|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
4486358|NCT00758524|7286583|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2
4486359|NCT00758524|7286584|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
4486360|NCT00758524|7286585|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
4486361|NCT00758524|7286586|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
4486362|NCT00758524|7286587|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
4486363|NCT00758524|7286588|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
4486364|NCT00758524|7286589|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
4486365|NCT00758524|7286590|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
4486366|NCT00758524|7286591|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0
4486367|NCT00758524|7286575|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
4486368|NCT00758524|7286576|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
4486369|NCT00758524|7286577|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
4486370|NCT00758524|7286578|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
4486371|NCT00758524|7286579|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
4486372|NCT00758524|7286580|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
4486373|NCT00758524|7286581|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1
4486374|NCT00758524|7286582|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
4486375|NCT00758524|7286583|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
4486376|NCT00758524|7286584|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
4486377|NCT00758524|7286585|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
4486378|NCT00758524|7286586|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
4486379|NCT00758524|7286587|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
4486380|NCT00758524|7286588|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
4486381|NCT00758524|7286589|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
4486382|NCT00758524|7286590|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
4486383|NCT00758524|7286591|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0
4486384|NCT00758589|7286646|FG000|Overall Study|Adverse Event|3
4486385|NCT00758589|7286647|FG001|Overall Study|Adverse Event|2
4486386|NCT00758589|7286648|FG002|Overall Study|Adverse Event|5
4486387|NCT00758589|7286649|FG003|Overall Study|Adverse Event|4
4486388|NCT00758589|7286646|FG000|Overall Study|Withdrawal by Subject|0
4486389|NCT00758589|7286647|FG001|Overall Study|Withdrawal by Subject|1
4486390|NCT00758589|7286648|FG002|Overall Study|Withdrawal by Subject|1
4589996|NCT01517373|7435660|FG002|Run-in Period|Did not meet eligibility criteria|0
4589997|NCT01517373|7435661|FG003|Run-in Period|Did not meet eligibility criteria|0
4589998|NCT01517373|7435662|FG004|Run-in Period|Did not meet eligibility criteria|0
4589999|NCT01517373|7435663|FG005|Run-in Period|Did not meet eligibility criteria|0
4590000|NCT01517373|7435658|FG000|Run-in Period|Lost to Follow-up|1
4590001|NCT01517373|7435659|FG001|Run-in Period|Lost to Follow-up|0
4590002|NCT01517373|7435660|FG002|Run-in Period|Lost to Follow-up|0
4486391|NCT00758589|7286649|FG003|Overall Study|Withdrawal by Subject|1
4486392|NCT00758589|7286646|FG000|Overall Study|Palm stopped to work|0
4486393|NCT00758589|7286647|FG001|Overall Study|Palm stopped to work|0
4486394|NCT00758589|7286648|FG002|Overall Study|Palm stopped to work|0
4486395|NCT00758589|7286649|FG003|Overall Study|Palm stopped to work|1
4486396|NCT00758602|7286661|FG000|Overall Study|Adverse Event|11
4486397|NCT00758602|7286662|FG001|Overall Study|Adverse Event|10
4486398|NCT00758602|7286661|FG000|Overall Study|Lost to Follow-up|4
4486399|NCT00758602|7286662|FG001|Overall Study|Lost to Follow-up|3
4486400|NCT00758602|7286661|FG000|Overall Study|Withdrawal by Subject|1
4486401|NCT00758602|7286662|FG001|Overall Study|Withdrawal by Subject|3
4486402|NCT00758602|7286661|FG000|Overall Study|Protocol Violation|0
4486403|NCT00758602|7286662|FG001|Overall Study|Protocol Violation|2
4486404|NCT00758602|7286661|FG000|Overall Study|Death|0
4486405|NCT00758602|7286662|FG001|Overall Study|Death|1
4486406|NCT00758602|7286661|FG000|Overall Study|Reason not specified|3
4486407|NCT00758602|7286662|FG001|Overall Study|Reason not specified|3
4486408|NCT00758680|7286679|FG000|Overall Study|Adverse Event|0
4486409|NCT00758680|7286680|FG001|Overall Study|Adverse Event|0
4486410|NCT00758680|7286681|FG002|Overall Study|Adverse Event|0
4486411|NCT00758680|7286682|FG003|Overall Study|Adverse Event|0
4486412|NCT00758680|7286683|FG004|Overall Study|Adverse Event|0
4486413|NCT00758680|7286684|FG005|Overall Study|Adverse Event|0
4486414|NCT00758680|7286685|FG006|Overall Study|Adverse Event|0
4486415|NCT00758680|7286686|FG007|Overall Study|Adverse Event|1
4486416|NCT00758680|7286687|FG008|Overall Study|Adverse Event|0
4486417|NCT00758680|7286688|FG009|Overall Study|Adverse Event|1
4486418|NCT00758680|7286679|FG000|Overall Study|Laboratory Adverse Event|0
4486419|NCT00758680|7286680|FG001|Overall Study|Laboratory Adverse Event|0
4486420|NCT00758680|7286681|FG002|Overall Study|Laboratory Adverse Event|0
4486421|NCT00758680|7286682|FG003|Overall Study|Laboratory Adverse Event|0
4486422|NCT00758680|7286683|FG004|Overall Study|Laboratory Adverse Event|0
4486423|NCT00758680|7286684|FG005|Overall Study|Laboratory Adverse Event|0
4486424|NCT00758680|7286685|FG006|Overall Study|Laboratory Adverse Event|0
4486425|NCT00758680|7286686|FG007|Overall Study|Laboratory Adverse Event|0
4486426|NCT00758680|7286687|FG008|Overall Study|Laboratory Adverse Event|1
4486427|NCT00758680|7286688|FG009|Overall Study|Laboratory Adverse Event|0
4486428|NCT00758680|7286679|FG000|Overall Study|Withdrawal by Subject|0
4486429|NCT00758680|7286680|FG001|Overall Study|Withdrawal by Subject|0
4486430|NCT00758680|7286681|FG002|Overall Study|Withdrawal by Subject|0
4486431|NCT00758680|7286682|FG003|Overall Study|Withdrawal by Subject|0
4486432|NCT00758680|7286683|FG004|Overall Study|Withdrawal by Subject|0
4486433|NCT00758680|7286684|FG005|Overall Study|Withdrawal by Subject|0
4486434|NCT00758680|7286685|FG006|Overall Study|Withdrawal by Subject|1
4486435|NCT00758680|7286686|FG007|Overall Study|Withdrawal by Subject|0
4486436|NCT00758680|7286687|FG008|Overall Study|Withdrawal by Subject|1
4486437|NCT00758680|7286688|FG009|Overall Study|Withdrawal by Subject|0
4486438|NCT00758706|7286713|FG000|Overall Study|Adverse Event|4
4486439|NCT00758706|7286714|FG001|Overall Study|Adverse Event|4
4486440|NCT00758771|7286772|FG000|Overall Study|Withdrawal by Subject|1
4486441|NCT00758771|7286773|FG001|Overall Study|Withdrawal by Subject|1
4486442|NCT00758771|7286772|FG000|Overall Study|Did not meet eligibility criteria|2
4590003|NCT01517373|7435661|FG003|Run-in Period|Lost to Follow-up|0
4590004|NCT01517373|7435662|FG004|Run-in Period|Lost to Follow-up|0
4590005|NCT01517373|7435663|FG005|Run-in Period|Lost to Follow-up|0
4590006|NCT01517373|7435658|FG000|Run-in Period|Withdrawal by Subject|12
4590007|NCT01517373|7435659|FG001|Run-in Period|Withdrawal by Subject|0
4590008|NCT01517373|7435660|FG002|Run-in Period|Withdrawal by Subject|0
4590009|NCT01517373|7435661|FG003|Run-in Period|Withdrawal by Subject|0
4590010|NCT01517373|7435662|FG004|Run-in Period|Withdrawal by Subject|0
4590011|NCT01517373|7435663|FG005|Run-in Period|Withdrawal by Subject|0
4590012|NCT01517373|7435658|FG000|Run-in Period|Sponsor Decision|3
4590013|NCT01517373|7435659|FG001|Run-in Period|Sponsor Decision|0
4590014|NCT01517373|7435660|FG002|Run-in Period|Sponsor Decision|0
4590015|NCT01517373|7435661|FG003|Run-in Period|Sponsor Decision|0
4590016|NCT01517373|7435662|FG004|Run-in Period|Sponsor Decision|0
4590017|NCT01517373|7435663|FG005|Run-in Period|Sponsor Decision|0
4590018|NCT01517373|7435658|FG000|Run-in Period|Other|1
4590019|NCT01517373|7435659|FG001|Run-in Period|Other|0
4590020|NCT01517373|7435660|FG002|Run-in Period|Other|0
4590021|NCT01517373|7435661|FG003|Run-in Period|Other|0
4590022|NCT01517373|7435662|FG004|Run-in Period|Other|0
4590023|NCT01517373|7435663|FG005|Run-in Period|Other|0
4590024|NCT01517373|7435658|FG000|Treatment Period|Adverse Event|0
4590025|NCT01517373|7435659|FG001|Treatment Period|Adverse Event|0
4486443|NCT00758771|7286773|FG001|Overall Study|Did not meet eligibility criteria|4
4486444|NCT00759031|7286806|FG000|First Intervention (1 Day)|Physician Decision|1
4590026|NCT01517373|7435660|FG002|Treatment Period|Adverse Event|0
4590027|NCT01517373|7435661|FG003|Treatment Period|Adverse Event|0
4590028|NCT01517373|7435662|FG004|Treatment Period|Adverse Event|0
4590029|NCT01517373|7435663|FG005|Treatment Period|Adverse Event|2
4590030|NCT01517373|7435658|FG000|Treatment Period|Lost to Follow-up|0
4590031|NCT01517373|7435659|FG001|Treatment Period|Lost to Follow-up|0
4590032|NCT01517373|7435660|FG002|Treatment Period|Lost to Follow-up|1
4590033|NCT01517373|7435661|FG003|Treatment Period|Lost to Follow-up|1
4590034|NCT01517373|7435662|FG004|Treatment Period|Lost to Follow-up|0
4590035|NCT01517373|7435663|FG005|Treatment Period|Lost to Follow-up|0
4590036|NCT01517373|7435658|FG000|Treatment Period|Withdrawal by Subject|0
4590037|NCT01517373|7435659|FG001|Treatment Period|Withdrawal by Subject|3
4590038|NCT01517373|7435660|FG002|Treatment Period|Withdrawal by Subject|2
4590039|NCT01517373|7435661|FG003|Treatment Period|Withdrawal by Subject|2
4590040|NCT01517373|7435662|FG004|Treatment Period|Withdrawal by Subject|2
4590041|NCT01517373|7435663|FG005|Treatment Period|Withdrawal by Subject|3
4590042|NCT01517373|7435658|FG000|Treatment Period|Other|0
4590043|NCT01517373|7435659|FG001|Treatment Period|Other|0
4590044|NCT01517373|7435660|FG002|Treatment Period|Other|0
4590045|NCT01517373|7435661|FG003|Treatment Period|Other|0
4590046|NCT01517373|7435662|FG004|Treatment Period|Other|1
4590047|NCT01517373|7435663|FG005|Treatment Period|Other|0
4590048|NCT01517373|7435658|FG000|Treatment Period|Protocol Violation|0
4590049|NCT01517373|7435659|FG001|Treatment Period|Protocol Violation|0
4590050|NCT01517373|7435660|FG002|Treatment Period|Protocol Violation|0
4590051|NCT01517373|7435661|FG003|Treatment Period|Protocol Violation|0
4590052|NCT01517373|7435662|FG004|Treatment Period|Protocol Violation|1
4590053|NCT01517373|7435663|FG005|Treatment Period|Protocol Violation|0
4590054|NCT01517373|7435658|FG000|Treatment Period|Lack of Efficacy|0
4590055|NCT01517373|7435659|FG001|Treatment Period|Lack of Efficacy|1
4590056|NCT01517373|7435660|FG002|Treatment Period|Lack of Efficacy|1
4590057|NCT01517373|7435661|FG003|Treatment Period|Lack of Efficacy|3
4590058|NCT01517373|7435662|FG004|Treatment Period|Lack of Efficacy|2
4590059|NCT01517373|7435663|FG005|Treatment Period|Lack of Efficacy|0
4590060|NCT01517373|7435658|FG000|Treatment Period|Medication error without AEs|0
4590061|NCT01517373|7435659|FG001|Treatment Period|Medication error without AEs|0
4590062|NCT01517373|7435660|FG002|Treatment Period|Medication error without AEs|2
4590063|NCT01517373|7435661|FG003|Treatment Period|Medication error without AEs|1
4590064|NCT01517373|7435662|FG004|Treatment Period|Medication error without AEs|0
4590065|NCT01517373|7435663|FG005|Treatment Period|Medication error without AEs|2
4590066|NCT01517412|7435678|FG000|Overall Study|Adverse Event|10
4590067|NCT01517412|7435679|FG001|Overall Study|Adverse Event|11
4590068|NCT01517412|7435678|FG000|Overall Study|Lack of Efficacy|10
4590069|NCT01517412|7435679|FG001|Overall Study|Lack of Efficacy|5
4590070|NCT01517412|7435678|FG000|Overall Study|Poor compliance to protocol|8
4590071|NCT01517412|7435679|FG001|Overall Study|Poor compliance to protocol|3
4590072|NCT01517412|7435678|FG000|Overall Study|Other than specified above|8
4590073|NCT01517412|7435679|FG001|Overall Study|Other than specified above|5
4590074|NCT01517750|7435693|FG000|Overall Study|Lost to Follow-up|1
4590075|NCT01517750|7435694|FG001|Overall Study|Lost to Follow-up|2
4590076|NCT01517750|7435695|FG002|Overall Study|Lost to Follow-up|4
4590077|NCT01517750|7435696|FG003|Overall Study|Lost to Follow-up|1
4590078|NCT01517867|7435712|FG000|Overall Study|never started treatment|29
4590079|NCT01517867|7435713|FG001|Overall Study|never started treatment|32
4590080|NCT01517867|7435712|FG000|Overall Study|Withdrawal by Subject|34
4590081|NCT01517867|7435713|FG001|Overall Study|Withdrawal by Subject|30
4590082|NCT01517867|7435712|FG000|Overall Study|Still in treatment at study end|0
4590083|NCT01517867|7435713|FG001|Overall Study|Still in treatment at study end|3
4590084|NCT01517893|7435721|FG000|Overall Study|Withdrawal by Subject|3
4590085|NCT01517893|7435722|FG001|Overall Study|Withdrawal by Subject|0
4590086|NCT01517984|7435731|FG000|Overall Study|Lost to Follow-up|0
4590087|NCT01517984|7435732|FG001|Overall Study|Lost to Follow-up|1
4590088|NCT01517984|7435733|FG002|Overall Study|Lost to Follow-up|0
4590089|NCT01517984|7435734|FG003|Overall Study|Lost to Follow-up|0
4590090|NCT01517984|7435731|FG000|Overall Study|Withdrawal by Subject|1
4590091|NCT01517984|7435732|FG001|Overall Study|Withdrawal by Subject|8
4590092|NCT01517984|7435733|FG002|Overall Study|Withdrawal by Subject|4
4590093|NCT01517984|7435734|FG003|Overall Study|Withdrawal by Subject|1
4590094|NCT01517984|7435731|FG000|Overall Study|Screen Failure|4
4590095|NCT01517984|7435732|FG001|Overall Study|Screen Failure|0
4590096|NCT01517984|7435733|FG002|Overall Study|Screen Failure|0
4590097|NCT01517984|7435734|FG003|Overall Study|Screen Failure|0
4590098|NCT01517984|7435731|FG000|Overall Study|Ineligible for randomization|0
4590099|NCT01517984|7435732|FG001|Overall Study|Ineligible for randomization|14
4590100|NCT01517984|7435733|FG002|Overall Study|Ineligible for randomization|0
4590101|NCT01517984|7435734|FG003|Overall Study|Ineligible for randomization|0
4593693|NCT01554579|7442273|FG000|Overall Study|Adverse Event|6
4593694|NCT01554579|7442274|FG001|Overall Study|Adverse Event|25
4593695|NCT01554579|7442273|FG000|Overall Study|Lack of Efficacy|2
4593696|NCT01554579|7442274|FG001|Overall Study|Lack of Efficacy|1
4593697|NCT01554579|7442273|FG000|Overall Study|Withdrawal by Subject|2
4593698|NCT01554579|7442274|FG001|Overall Study|Withdrawal by Subject|1
4593699|NCT01554618|7442283|FG000|Randomized Through Start of Treatment|Adverse Event|1
4593700|NCT01554618|7442284|FG001|Randomized Through Start of Treatment|Adverse Event|0
4593701|NCT01554618|7442283|FG000|Controlled Assessment Period|Lost to Follow-up|2
4593702|NCT01554618|7442284|FG001|Controlled Assessment Period|Lost to Follow-up|1
4593703|NCT01554618|7442283|FG000|Controlled Assessment Period|Withdrawal by Subject|6
4593704|NCT01554618|7442284|FG001|Controlled Assessment Period|Withdrawal by Subject|0
4590102|NCT01518153|7435741|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5
4590103|NCT01518153|7435742|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0
4590104|NCT01518153|7435743|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0
4590105|NCT01518153|7435741|FG000|Stem Cell Transplant|Death|2
4590106|NCT01518153|7435742|FG001|Stem Cell Transplant|Death|0
4590107|NCT01518153|7435743|FG002|Stem Cell Transplant|Death|0
4590108|NCT01518153|7435741|FG000|Stem Cell Transplant|Secondary graft failure|1
4590109|NCT01518153|7435742|FG001|Stem Cell Transplant|Secondary graft failure|0
4590110|NCT01518153|7435743|FG002|Stem Cell Transplant|Secondary graft failure|0
4590111|NCT01518153|7435741|FG000|Stem Cell Transplant|Adverse Event|1
4590112|NCT01518153|7435742|FG001|Stem Cell Transplant|Adverse Event|0
4701293|NCT02707965|7618078|FG006|Overall Study|Protocol deviation|0
4701294|NCT02707965|7618079|FG007|Overall Study|Protocol deviation|1
4701295|NCT02707965|7618080|FG008|Overall Study|Protocol deviation|0
4701296|NCT02707965|7618081|FG009|Overall Study|Protocol deviation|0
4701297|NCT02707965|7618082|FG010|Overall Study|Protocol deviation|0
4701298|NCT02707965|7618083|FG011|Overall Study|Protocol deviation|0
4701299|NCT02707965|7618084|FG012|Overall Study|Protocol deviation|0
4701300|NCT02707965|7618085|FG013|Overall Study|Protocol deviation|0
4486445|NCT00759031|7286807|FG001|First Intervention (1 Day)|Physician Decision|0
4486446|NCT00759031|7286806|FG000|First Intervention (1 Day)|Withdrawal by Subject|0
4486447|NCT00759031|7286807|FG001|First Intervention (1 Day)|Withdrawal by Subject|1
4486448|NCT00759031|7286806|FG000|First Intervention (1 Day)|Screening failure|1
4486449|NCT00759031|7286807|FG001|First Intervention (1 Day)|Screening failure|0
4486450|NCT00759109|7286819|FG000|Overall Study|Adverse Event|17
4486451|NCT00759109|7286820|FG001|Overall Study|Adverse Event|12
4486452|NCT00759109|7286819|FG000|Overall Study|Inability to comply|1
4486453|NCT00759109|7286820|FG001|Overall Study|Inability to comply|1
4486454|NCT00759109|7286819|FG000|Overall Study|Withdrawal by Subject|9
4486455|NCT00759109|7286820|FG001|Overall Study|Withdrawal by Subject|5
4486456|NCT00759109|7286819|FG000|Overall Study|Death|4
4486457|NCT00759109|7286820|FG001|Overall Study|Death|3
4486458|NCT00759109|7286819|FG000|Overall Study|Lost to Follow-up|4
4486459|NCT00759109|7286820|FG001|Overall Study|Lost to Follow-up|6
4486460|NCT00759109|7286819|FG000|Overall Study|Started new therapy|2
4486461|NCT00759109|7286820|FG001|Overall Study|Started new therapy|6
4486462|NCT00759109|7286819|FG000|Overall Study|HCV RNA negative|1
4486463|NCT00759109|7286820|FG001|Overall Study|HCV RNA negative|0
4486464|NCT00759109|7286819|FG000|Overall Study|Participant moved to a different city|0
4486465|NCT00759109|7286820|FG001|Overall Study|Participant moved to a different city|1
4486466|NCT00759109|7286819|FG000|Overall Study|Participant had a liver transplant|0
4486467|NCT00759109|7286820|FG001|Overall Study|Participant had a liver transplant|1
4486468|NCT00759109|7286819|FG000|Overall Study|Lost during study|1
4486469|NCT00759109|7286820|FG001|Overall Study|Lost during study|0
4486470|NCT00759148|7286828|FG000|Overall Study|Adverse Event|1
4486471|NCT00759148|7286829|FG001|Overall Study|Adverse Event|6
4486472|NCT00759148|7286828|FG000|Overall Study|Withdrawal by Subject|3
4486473|NCT00759148|7286829|FG001|Overall Study|Withdrawal by Subject|7
4486474|NCT00759148|7286828|FG000|Overall Study|Lost to Follow-up|3
4486475|NCT00759148|7286829|FG001|Overall Study|Lost to Follow-up|9
4486476|NCT00759148|7286828|FG000|Overall Study|Treatment Failure|6
4486477|NCT00759148|7286829|FG001|Overall Study|Treatment Failure|10
4486478|NCT00759148|7286828|FG000|Overall Study|Reason not given|1
4486479|NCT00759148|7286829|FG001|Overall Study|Reason not given|0
4486480|NCT00759174|7286844|FG000|Overall Study|Other|0
4486481|NCT00759174|7286845|FG001|Overall Study|Other|2
4486482|NCT00759356|7286885|FG000|Overall Study|Adverse Event|0
4486483|NCT00759356|7286886|FG001|Overall Study|Adverse Event|1
4486484|NCT00759356|7286885|FG000|Overall Study|Withdrawal by Subject|0
4486485|NCT00759356|7286886|FG001|Overall Study|Withdrawal by Subject|2
4486486|NCT00759356|7286885|FG000|Overall Study|Subject was unable to return|1
4486487|NCT00759356|7286886|FG001|Overall Study|Subject was unable to return|0
4486488|NCT00759395|7286894|FG000|Overall Study|Adverse Event|1
4486489|NCT00759395|7286895|FG001|Overall Study|Adverse Event|0
4486490|NCT00759395|7286894|FG000|Overall Study|Withdrawal by Subject|1
4486491|NCT00759395|7286895|FG001|Overall Study|Withdrawal by Subject|0
4486492|NCT00759395|7286894|FG000|Overall Study|Lack of Efficacy|0
4486493|NCT00759395|7286895|FG001|Overall Study|Lack of Efficacy|2
4486494|NCT00759564|7286938|FG000|Washout Period (at Least 14 Days)|Adverse Event|0
4486495|NCT00759564|7286939|FG001|Washout Period (at Least 14 Days)|Adverse Event|0
4486496|NCT00759564|7286940|FG002|Washout Period (at Least 14 Days)|Adverse Event|0
4486497|NCT00759564|7286941|FG003|Washout Period (at Least 14 Days)|Adverse Event|0
4486498|NCT00759564|7286942|FG004|Washout Period (at Least 14 Days)|Adverse Event|1
4486499|NCT00759655|7286982|FG000|Overall Study|Termination of the study by sponsor|1
4590113|NCT01518153|7435743|FG002|Stem Cell Transplant|Adverse Event|0
4590114|NCT01518153|7435741|FG000|Donor Lymphocyte Infusion|Death|0
4486500|NCT00759681|7286997|FG000|Overall Study|Death|2
4486501|NCT00759681|7286998|FG001|Overall Study|Death|5
4486502|NCT00759681|7286997|FG000|Overall Study|Lost to Follow-up|8
4486503|NCT00759681|7286998|FG001|Overall Study|Lost to Follow-up|5
4486504|NCT00759759|7287011|FG000|Overall Study|didn't return for period 2|1
4486505|NCT00759759|7287012|FG001|Overall Study|didn't return for period 2|0
4517169|NCT00964795|7328877|FG000|Overall Study|Death|14
4486506|NCT00759759|7287011|FG000|Overall Study|Didn't receive drug in period 2|1
4486507|NCT00759759|7287012|FG001|Overall Study|Didn't receive drug in period 2|0
4486508|NCT00759759|7287011|FG000|Overall Study|Withdrawal by Subject|2
4486509|NCT00759759|7287012|FG001|Overall Study|Withdrawal by Subject|1
4486510|NCT00759785|7287029|FG000|Overall Study|Participant sample not evaluable|11
4486511|NCT00759785|7287030|FG001|Overall Study|Participant sample not evaluable|2
4486512|NCT00759785|7287029|FG000|Overall Study|Participant sample lost|0
4486513|NCT00759785|7287030|FG001|Overall Study|Participant sample lost|1
4486514|NCT00759785|7287029|FG000|Overall Study|Protocol Violation|1
4486515|NCT00759785|7287030|FG001|Overall Study|Protocol Violation|0
4486516|NCT00759785|7287029|FG000|Overall Study|Physician Decision|0
4486517|NCT00759785|7287030|FG001|Overall Study|Physician Decision|1
4486518|NCT00759785|7287029|FG000|Overall Study|Withdrawal by Subject|0
4486519|NCT00759785|7287030|FG001|Overall Study|Withdrawal by Subject|1
4486520|NCT00759863|7287051|FG000|Overall Study|Death, moved, or lost contact|20
4486521|NCT00759863|7287052|FG001|Overall Study|Death, moved, or lost contact|18
4701301|NCT02707965|7618086|FG014|Overall Study|Protocol deviation|0
4701302|NCT02707965|7618087|FG015|Overall Study|Protocol deviation|0
4486522|NCT00759876|7287058|FG000|Overall Study|Sponsor terminated study early|36
4486523|NCT00759902|7287064|FG000|Overall Study|Adverse Event|0
4486524|NCT00759902|7287065|FG001|Overall Study|Adverse Event|1
4486525|NCT00759915|7287073|FG000|Overall Study|Withdrawal by Subject|1
4486526|NCT00759915|7287074|FG001|Overall Study|Withdrawal by Subject|0
4486527|NCT00759915|7287073|FG000|Overall Study|Adverse Event|0
4486528|NCT00759915|7287074|FG001|Overall Study|Adverse Event|1
4486529|NCT00759941|7287082|FG000|Overall Study|Use of medication|1
4486530|NCT00759941|7287083|FG001|Overall Study|Use of medication|0
4486531|NCT00759941|7287082|FG000|Overall Study|Adverse Event|1
4486532|NCT00759941|7287083|FG001|Overall Study|Adverse Event|0
4486533|NCT00759941|7287082|FG000|Overall Study|Exited in error by site|1
4486534|NCT00759941|7287083|FG001|Overall Study|Exited in error by site|1
4486535|NCT00759954|7287091|FG000|Overall Study|Personal reason|1
4486536|NCT00759954|7287092|FG001|Overall Study|Personal reason|0
4486537|NCT00759954|7287091|FG000|Overall Study|Adverse Event|1
4486538|NCT00759954|7287092|FG001|Overall Study|Adverse Event|2
4486539|NCT00760084|7287129|FG000|Overall Study|Physician Decision|5
4486540|NCT00760084|7287129|FG000|Overall Study|Withdrawal by Subject|2
4486541|NCT00760084|7287129|FG000|Overall Study|Progressive Disease|3
4486542|NCT00760214|7287136|FG000|Overall Study|Adverse Event|8
4486543|NCT00760214|7287137|FG001|Overall Study|Adverse Event|9
4486544|NCT00760214|7287138|FG002|Overall Study|Adverse Event|12
4486545|NCT00760214|7287136|FG000|Overall Study|Protocol Violation|3
4486546|NCT00760214|7287137|FG001|Overall Study|Protocol Violation|0
4486547|NCT00760214|7287138|FG002|Overall Study|Protocol Violation|3
4486548|NCT00760214|7287136|FG000|Overall Study|Lost to Follow-up|0
4486549|NCT00760214|7287137|FG001|Overall Study|Lost to Follow-up|0
4486550|NCT00760214|7287138|FG002|Overall Study|Lost to Follow-up|1
4486551|NCT00760214|7287136|FG000|Overall Study|Withdrawal by Subject|12
4486552|NCT00760214|7287137|FG001|Overall Study|Withdrawal by Subject|14
4486553|NCT00760214|7287138|FG002|Overall Study|Withdrawal by Subject|13
4486554|NCT00760214|7287136|FG000|Overall Study|Lack of Efficacy|3
4486555|NCT00760214|7287137|FG001|Overall Study|Lack of Efficacy|2
4486556|NCT00760214|7287138|FG002|Overall Study|Lack of Efficacy|4
4486557|NCT00760214|7287136|FG000|Overall Study|Pregnancy|0
4486558|NCT00760214|7287137|FG001|Overall Study|Pregnancy|0
4486559|NCT00760214|7287138|FG002|Overall Study|Pregnancy|1
4486560|NCT00760214|7287136|FG000|Overall Study|Physician Decision|1
4486561|NCT00760214|7287137|FG001|Overall Study|Physician Decision|1
4486562|NCT00760214|7287138|FG002|Overall Study|Physician Decision|1
4486563|NCT00760214|7287136|FG000|Overall Study|Other|3
4486564|NCT00760214|7287137|FG001|Overall Study|Other|4
4486565|NCT00760214|7287138|FG002|Overall Study|Other|6
4486566|NCT00760266|7287148|FG000|Overall Study|Adverse Event|13
4486567|NCT00760266|7287149|FG001|Overall Study|Adverse Event|7
4486568|NCT00760266|7287148|FG000|Overall Study|Abnormal laboratory value(s)|1
4486569|NCT00760266|7287149|FG001|Overall Study|Abnormal laboratory value(s)|0
4486570|NCT00760266|7287148|FG000|Overall Study|Abnormal test procedure result(s)|1
4486571|NCT00760266|7287149|FG001|Overall Study|Abnormal test procedure result(s)|0
4486572|NCT00760266|7287148|FG000|Overall Study|Lack of Efficacy|2
4486573|NCT00760266|7287149|FG001|Overall Study|Lack of Efficacy|2
4486574|NCT00760266|7287148|FG000|Overall Study|Protocol deviation|2
4486575|NCT00760266|7287149|FG001|Overall Study|Protocol deviation|4
4486576|NCT00760266|7287148|FG000|Overall Study|Patient withdrew consent|3
4486577|NCT00760266|7287149|FG001|Overall Study|Patient withdrew consent|3
4486578|NCT00760266|7287148|FG000|Overall Study|Lost to Follow-up|2
4486579|NCT00760266|7287149|FG001|Overall Study|Lost to Follow-up|1
4486580|NCT00760266|7287148|FG000|Overall Study|Administrative Problems|0
4486581|NCT00760266|7287149|FG001|Overall Study|Administrative Problems|1
4486582|NCT00760383|7287157|FG000|Overall Study|moved away; withdrew; medical reasons|5
4486583|NCT00760383|7287158|FG001|Overall Study|moved away; withdrew; medical reasons|7
4486584|NCT00760474|7287173|FG000|Period 1 (P1)|Discontinued then re-entered|1
4486585|NCT00760474|7287174|FG001|Period 1 (P1)|Discontinued then re-entered|1
4486586|NCT00760474|7287173|FG000|Placebo Washout Period|Other|0
4486587|NCT00760474|7287174|FG001|Placebo Washout Period|Other|1
4486588|NCT00760474|7287173|FG000|Period 2 (P2)|Lost to Follow-up|1
4486589|NCT00760474|7287174|FG001|Period 2 (P2)|Lost to Follow-up|0
4486590|NCT00760474|7287173|FG000|Period 2 (P2)|Adverse Event|0
4486591|NCT00760474|7287174|FG001|Period 2 (P2)|Adverse Event|1
4486592|NCT00760487|7287181|FG000|Overall Study|Unilateral implantation|3
4486593|NCT00760513|7287187|FG000|Overall Study|Withdrawal by Subject|5
4486594|NCT00760513|7287188|FG001|Overall Study|Withdrawal by Subject|7
4486595|NCT00760552|7287214|FG000|Overall Study|Death|2
4486596|NCT00760552|7287215|FG001|Overall Study|Death|0
4486597|NCT00760552|7287214|FG000|Overall Study|Lost to Follow-up|11
4486598|NCT00760552|7287215|FG001|Overall Study|Lost to Follow-up|10
4486599|NCT00760617|7287246|FG000|Overall Study|Adverse Event|5
4486600|NCT00760617|7287247|FG001|Overall Study|Adverse Event|2
4486601|NCT00760617|7287248|FG002|Overall Study|Adverse Event|0
4486602|NCT00760617|7287246|FG000|Overall Study|Lost to Follow-up|0
4486603|NCT00760617|7287247|FG001|Overall Study|Lost to Follow-up|0
4486604|NCT00760617|7287248|FG002|Overall Study|Lost to Follow-up|5
4486605|NCT00760669|7287256|FG000|Overall Study|Not assessed for overall improvement|18
4486606|NCT00760669|7287256|FG000|Overall Study|Participants missing efficacy assessment|6
4486607|NCT00760669|7287256|FG000|Overall Study|Participants with overlapping cases|1
4486608|NCT00760669|7287256|FG000|Overall Study|Took drug before entering in contract|5
4486609|NCT00760747|7287262|FG000|Study Period II|Adverse Event|3
4486610|NCT00760747|7287263|FG001|Study Period II|Adverse Event|4
4486611|NCT00760747|7287262|FG000|Study Period II|Lack of Efficacy|0
4486612|NCT00760747|7287263|FG001|Study Period II|Lack of Efficacy|6
4486613|NCT00760747|7287262|FG000|Study Period II|Parent/Caregiver Decision|3
4486614|NCT00760747|7287263|FG001|Study Period II|Parent/Caregiver Decision|0
4486615|NCT00760747|7287262|FG000|Study Period II|Protocol Violation|6
4486616|NCT00760747|7287263|FG001|Study Period II|Protocol Violation|3
4486617|NCT00760747|7287262|FG000|Study Period II|Withdrawal by Subject|1
4486618|NCT00760747|7287263|FG001|Study Period II|Withdrawal by Subject|0
4486619|NCT00760747|7287262|FG000|Study Period II|No drug administered|0
4486620|NCT00760747|7287263|FG001|Study Period II|No drug administered|1
4486621|NCT00760747|7287262|FG000|Study Period III|Adverse Event|1
4486622|NCT00760747|7287263|FG001|Study Period III|Adverse Event|0
4486623|NCT00760747|7287262|FG000|Study Period III|Lack of Efficacy|1
4486624|NCT00760747|7287263|FG001|Study Period III|Lack of Efficacy|0
4486625|NCT00760747|7287262|FG000|Study Period III|Parent/Caregiver Decision|0
4486626|NCT00760747|7287263|FG001|Study Period III|Parent/Caregiver Decision|1
4486627|NCT00760747|7287262|FG000|Study Period III|Protocol Violation|1
4486628|NCT00760747|7287263|FG001|Study Period III|Protocol Violation|1
4486629|NCT00760747|7287262|FG000|Study Period III|Physician Decision|0
4486630|NCT00760747|7287263|FG001|Study Period III|Physician Decision|1
4486631|NCT00760838|7287271|FG000|Overall Study|Adverse Event|1
4486632|NCT00760838|7287272|FG001|Overall Study|Adverse Event|1
4486633|NCT00760838|7287271|FG000|Overall Study|Lack of Efficacy|1
4486634|NCT00760838|7287272|FG001|Overall Study|Lack of Efficacy|0
4486635|NCT00760838|7287271|FG000|Overall Study|Lost to Follow-up|2
4486636|NCT00760838|7287272|FG001|Overall Study|Lost to Follow-up|0
4486637|NCT00760838|7287271|FG000|Overall Study|Withdrawal by Subject|1
4486638|NCT00760838|7287272|FG001|Overall Study|Withdrawal by Subject|1
4486639|NCT00760877|7287280|FG000|Overall Study|Protocol Violation|1
4486640|NCT00760877|7287281|FG001|Overall Study|Protocol Violation|0
4486641|NCT00760877|7287280|FG000|Overall Study|Non-compliance with protocol treatment|2
4486642|NCT00760877|7287281|FG001|Overall Study|Non-compliance with protocol treatment|1
4486643|NCT00760877|7287280|FG000|Overall Study|Pregnancy|1
4486644|NCT00760877|7287281|FG001|Overall Study|Pregnancy|4
4486645|NCT00760877|7287280|FG000|Overall Study|Death|2
4486646|NCT00760877|7287281|FG001|Overall Study|Death|1
4486647|NCT00760877|7287280|FG000|Overall Study|Withdrawal by Subject|7
4486648|NCT00760877|7287281|FG001|Overall Study|Withdrawal by Subject|3
4486649|NCT00760877|7287280|FG000|Overall Study|Adverse Event|19
4486650|NCT00760877|7287281|FG001|Overall Study|Adverse Event|12
4486651|NCT00760877|7287280|FG000|Overall Study|Participant diagnosed with AML|0
4486652|NCT00760877|7287281|FG001|Overall Study|Participant diagnosed with AML|1
4486653|NCT00760877|7287280|FG000|Overall Study|Participant not eligible to cross-over|0
4486654|NCT00760877|7287281|FG001|Overall Study|Participant not eligible to cross-over|1
4486655|NCT00760877|7287280|FG000|Overall Study|Physician Decision|1
4486656|NCT00760877|7287281|FG001|Overall Study|Physician Decision|2
4486657|NCT00760877|7287280|FG000|Overall Study|Participants transferred to AMN107A2408|11
4486658|NCT00760877|7287281|FG001|Overall Study|Participants transferred to AMN107A2408|1
4486659|NCT00760877|7287280|FG000|Overall Study|Treatment failure|1
4486660|NCT00760877|7287281|FG001|Overall Study|Treatment failure|0
4486661|NCT00760929|7287292|FG000|Overall Study|Adverse Event|2
4486662|NCT00760929|7287293|FG001|Overall Study|Adverse Event|0
4486663|NCT00760929|7287294|FG002|Overall Study|Adverse Event|6
4486664|NCT00760929|7287295|FG003|Overall Study|Adverse Event|10
4486665|NCT00760929|7287292|FG000|Overall Study|Lack of Efficacy|0
4486666|NCT00760929|7287293|FG001|Overall Study|Lack of Efficacy|2
4486667|NCT00760929|7287294|FG002|Overall Study|Lack of Efficacy|1
4486668|NCT00760929|7287295|FG003|Overall Study|Lack of Efficacy|0
4486669|NCT00760929|7287292|FG000|Overall Study|Withdrawal by Subject|1
4486670|NCT00760929|7287293|FG001|Overall Study|Withdrawal by Subject|0
4486671|NCT00760929|7287294|FG002|Overall Study|Withdrawal by Subject|9
4486672|NCT00760929|7287295|FG003|Overall Study|Withdrawal by Subject|1
4486673|NCT00760929|7287292|FG000|Overall Study|Lost to Follow-up|0
4486674|NCT00760929|7287293|FG001|Overall Study|Lost to Follow-up|0
4486675|NCT00760929|7287294|FG002|Overall Study|Lost to Follow-up|1
4486676|NCT00760929|7287295|FG003|Overall Study|Lost to Follow-up|0
4486677|NCT00760929|7287292|FG000|Overall Study|Progression of Disease|21
4486678|NCT00760929|7287293|FG001|Overall Study|Progression of Disease|26
4486679|NCT00760929|7287294|FG002|Overall Study|Progression of Disease|38
4486680|NCT00760929|7287295|FG003|Overall Study|Progression of Disease|42
4486681|NCT00760929|7287292|FG000|Overall Study|Other|2
4486682|NCT00760929|7287293|FG001|Overall Study|Other|0
4486683|NCT00760929|7287294|FG002|Overall Study|Other|2
4486684|NCT00760929|7287295|FG003|Overall Study|Other|1
4486685|NCT00760929|7287292|FG000|Overall Study|Death|0
4486686|NCT00760929|7287293|FG001|Overall Study|Death|0
4486687|NCT00760929|7287294|FG002|Overall Study|Death|1
4486688|NCT00760929|7287295|FG003|Overall Study|Death|0
4486689|NCT00760929|7287292|FG000|Overall Study|Violation of Selection Criteria at Entry|0
4486690|NCT00760929|7287293|FG001|Overall Study|Violation of Selection Criteria at Entry|0
4486691|NCT00760929|7287294|FG002|Overall Study|Violation of Selection Criteria at Entry|0
4486692|NCT00760929|7287295|FG003|Overall Study|Violation of Selection Criteria at Entry|1
4486693|NCT00760994|7287307|FG000|Overall Study|Lost to Follow-up|4
4486694|NCT00760994|7287308|FG001|Overall Study|Lost to Follow-up|4
4486695|NCT00760994|7287309|FG002|Overall Study|Lost to Follow-up|3
4486696|NCT00761150|7287363|FG000|Open-label Period|Adverse Event|36
4486697|NCT00761150|7287364|FG001|Open-label Period|Adverse Event|0
4486698|NCT00761150|7287365|FG002|Open-label Period|Adverse Event|0
4486699|NCT00761150|7287363|FG000|Open-label Period|Did not meet DB randomization criteria|11
4486700|NCT00761150|7287364|FG001|Open-label Period|Did not meet DB randomization criteria|0
4486701|NCT00761150|7287365|FG002|Open-label Period|Did not meet DB randomization criteria|0
4486702|NCT00761150|7287363|FG000|Open-label Period|Lost to Follow-up|7
4486703|NCT00761150|7287364|FG001|Open-label Period|Lost to Follow-up|0
4486704|NCT00761150|7287365|FG002|Open-label Period|Lost to Follow-up|0
4486705|NCT00761150|7287363|FG000|Open-label Period|Lack of Efficacy|4
4486706|NCT00761150|7287364|FG001|Open-label Period|Lack of Efficacy|0
4486707|NCT00761150|7287365|FG002|Open-label Period|Lack of Efficacy|0
4486708|NCT00761150|7287363|FG000|Open-label Period|Withdrawal by Subject|5
4486709|NCT00761150|7287364|FG001|Open-label Period|Withdrawal by Subject|0
4486710|NCT00761150|7287365|FG002|Open-label Period|Withdrawal by Subject|0
4486711|NCT00761150|7287363|FG000|Open-label Period|Noncompliance|2
4486712|NCT00761150|7287364|FG001|Open-label Period|Noncompliance|0
4486713|NCT00761150|7287365|FG002|Open-label Period|Noncompliance|0
4486714|NCT00761150|7287363|FG000|Open-label Period|Other|5
4486715|NCT00761150|7287364|FG001|Open-label Period|Other|0
4486716|NCT00761150|7287365|FG002|Open-label Period|Other|0
4486717|NCT00761150|7287363|FG000|Double-blind Period|Lack of Efficacy|0
4486718|NCT00761150|7287364|FG001|Double-blind Period|Lack of Efficacy|2
4486719|NCT00761150|7287365|FG002|Double-blind Period|Lack of Efficacy|19
4486720|NCT00761150|7287363|FG000|Double-blind Period|Adverse Event|0
4486721|NCT00761150|7287364|FG001|Double-blind Period|Adverse Event|3
4486722|NCT00761150|7287365|FG002|Double-blind Period|Adverse Event|3
4486723|NCT00761150|7287363|FG000|Double-blind Period|Withdrawal by Subject|0
4486724|NCT00761150|7287364|FG001|Double-blind Period|Withdrawal by Subject|3
4486725|NCT00761150|7287365|FG002|Double-blind Period|Withdrawal by Subject|2
4486726|NCT00761150|7287363|FG000|Double-blind Period|Lost to Follow-up|0
4486727|NCT00761150|7287364|FG001|Double-blind Period|Lost to Follow-up|2
4486728|NCT00761150|7287365|FG002|Double-blind Period|Lost to Follow-up|1
4486729|NCT00761150|7287363|FG000|Double-blind Period|Did not meet DB randomization criteria|0
4486730|NCT00761150|7287364|FG001|Double-blind Period|Did not meet DB randomization criteria|0
4486731|NCT00761150|7287365|FG002|Double-blind Period|Did not meet DB randomization criteria|1
4486732|NCT00761150|7287363|FG000|Double-blind Period|Noncompliance|0
4486733|NCT00761150|7287364|FG001|Double-blind Period|Noncompliance|1
4486734|NCT00761150|7287365|FG002|Double-blind Period|Noncompliance|0
4486735|NCT00761150|7287363|FG000|Double-blind Period|Other|0
4486736|NCT00761150|7287364|FG001|Double-blind Period|Other|3
4486737|NCT00761150|7287365|FG002|Double-blind Period|Other|3
4486738|NCT00761189|7287372|FG000|Overall Study|Adverse Event|42
4486739|NCT00761189|7287372|FG000|Overall Study|Lack of Efficacy|45
4486740|NCT00761189|7287372|FG000|Overall Study|Lost to Follow-up|36
4486741|NCT00761189|7287372|FG000|Overall Study|Withdrawal by Subject|49
4486742|NCT00761189|7287372|FG000|Overall Study|Other|13
4486743|NCT00761215|7287388|FG000|Overall Study|Randomized but didn't receive drug|1
4486744|NCT00761215|7287389|FG001|Overall Study|Randomized but didn't receive drug|1
4486745|NCT00761215|7287390|FG002|Overall Study|Randomized but didn't receive drug|2
4486746|NCT00761215|7287388|FG000|Overall Study|Lost to Follow-up|6
4701303|NCT02707991|7618122|FG000|Overall Study|Protocol Violation|1
4701304|NCT02707991|7618123|FG001|Overall Study|Protocol Violation|0
4701305|NCT02707991|7618122|FG000|Overall Study|Became ineligible|0
4701306|NCT02707991|7618123|FG001|Overall Study|Became ineligible|1
4701307|NCT02708095|7618132|FG000|Overall Study|Adverse Event|4
4486747|NCT00761215|7287389|FG001|Overall Study|Lost to Follow-up|3
4486748|NCT00761215|7287390|FG002|Overall Study|Lost to Follow-up|6
4701308|NCT02708095|7618133|FG001|Overall Study|Adverse Event|10
4486749|NCT00761215|7287388|FG000|Overall Study|Withdrawal by Subject|1
4486750|NCT00761215|7287389|FG001|Overall Study|Withdrawal by Subject|0
4486751|NCT00761215|7287390|FG002|Overall Study|Withdrawal by Subject|0
4486752|NCT00761215|7287388|FG000|Overall Study|Bacteremia|1
4486753|NCT00761215|7287389|FG001|Overall Study|Bacteremia|0
4486754|NCT00761215|7287390|FG002|Overall Study|Bacteremia|0
4517170|NCT00964795|7328877|FG000|Overall Study|Lost to Follow-up|7
4517171|NCT00964795|7328877|FG000|Overall Study|Termination of Study by Sponsor|169
4517172|NCT00964795|7328877|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3
4517173|NCT00964795|7328877|FG000|Overall Study|Other|23
4517174|NCT00964860|7328884|FG000|Overall Study|Withdrawal by Subject|0
4517175|NCT00964860|7328885|FG001|Overall Study|Withdrawal by Subject|1
4517176|NCT00964886|7328895|FG000|Overall Study|Lost to Follow-up|2
4517177|NCT00964886|7328896|FG001|Overall Study|Lost to Follow-up|2
4517178|NCT00964886|7328897|FG002|Overall Study|Lost to Follow-up|6
4517179|NCT00964886|7328898|FG003|Overall Study|Lost to Follow-up|4
4517180|NCT00964886|7328895|FG000|Overall Study|Withdrawal by Subject|6
4517181|NCT00964886|7328896|FG001|Overall Study|Withdrawal by Subject|2
4517182|NCT00964886|7328897|FG002|Overall Study|Withdrawal by Subject|5
4517183|NCT00964886|7328898|FG003|Overall Study|Withdrawal by Subject|3
4517184|NCT00964886|7328895|FG000|Overall Study|Adverse Event|3
4517185|NCT00964886|7328896|FG001|Overall Study|Adverse Event|1
4517186|NCT00964886|7328897|FG002|Overall Study|Adverse Event|5
4517187|NCT00964886|7328898|FG003|Overall Study|Adverse Event|2
4517188|NCT00964886|7328895|FG000|Overall Study|Protocol Violation|0
4517189|NCT00964886|7328896|FG001|Overall Study|Protocol Violation|2
4517190|NCT00964886|7328897|FG002|Overall Study|Protocol Violation|0
4517191|NCT00964886|7328898|FG003|Overall Study|Protocol Violation|0
4517192|NCT00965081|7328914|FG000|Overall Study|Adverse Event|14
4517193|NCT00965081|7328915|FG001|Overall Study|Adverse Event|9
4517194|NCT00965081|7328914|FG000|Overall Study|Lack of Efficacy|2
4517195|NCT00965081|7328915|FG001|Overall Study|Lack of Efficacy|5
4517196|NCT00965081|7328914|FG000|Overall Study|Lost to Follow-up|4
4517197|NCT00965081|7328915|FG001|Overall Study|Lost to Follow-up|5
4517198|NCT00965081|7328914|FG000|Overall Study|Physician Decision|2
4517199|NCT00965081|7328915|FG001|Overall Study|Physician Decision|0
4517200|NCT00965081|7328914|FG000|Overall Study|Protocol Violation|2
4517201|NCT00965081|7328915|FG001|Overall Study|Protocol Violation|5
4517202|NCT00965081|7328914|FG000|Overall Study|Sponsor Decision|1
4517203|NCT00965081|7328915|FG001|Overall Study|Sponsor Decision|0
4517204|NCT00965081|7328914|FG000|Overall Study|Withdrawal by Subject|4
4517205|NCT00965081|7328915|FG001|Overall Study|Withdrawal by Subject|7
4517206|NCT00965081|7328914|FG000|Overall Study|Switched to Rescue Arm|5
4517207|NCT00965081|7328915|FG001|Overall Study|Switched to Rescue Arm|12
4517208|NCT00965094|7328924|FG000|Overall Study|Adverse Event|5
4517209|NCT00965094|7328925|FG001|Overall Study|Adverse Event|0
4517210|NCT00965094|7328924|FG000|Overall Study|Lost to Follow-up|0
4517211|NCT00965094|7328925|FG001|Overall Study|Lost to Follow-up|1
4517212|NCT00965185|7328934|FG000|Overall Study|Lost to Follow-up|2
4517213|NCT00965185|7328935|FG001|Overall Study|Lost to Follow-up|0
4517214|NCT00965185|7328934|FG000|Overall Study|Withdrawal by Subject|0
4517215|NCT00965185|7328935|FG001|Overall Study|Withdrawal by Subject|1
4517216|NCT00965263|7328961|FG000|Overall Study|Physician Decision|2
4517217|NCT00965263|7328962|FG001|Overall Study|Physician Decision|0
4517218|NCT00965263|7328961|FG000|Overall Study|Family emergency|0
4517219|NCT00965263|7328962|FG001|Overall Study|Family emergency|1
4517220|NCT00965263|7328961|FG000|Overall Study|Protocol Violation|0
4517221|NCT00965263|7328962|FG001|Overall Study|Protocol Violation|2
4517222|NCT00965341|7328988|FG000|Overall Study|Withdrew consent|1
4517223|NCT00965341|7328989|FG001|Overall Study|Withdrew consent|5
4517224|NCT00965341|7328988|FG000|Overall Study|Lost to Follow-up|1
4517225|NCT00965341|7328989|FG001|Overall Study|Lost to Follow-up|0
4517226|NCT00965341|7328988|FG000|Overall Study|Transportation issues|4
4517227|NCT00965341|7328989|FG001|Overall Study|Transportation issues|3
4517228|NCT00965419|7328995|FG000|Open Label Treatment for Responders|Adverse Event|33
4517229|NCT00965419|7328995|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1
4517230|NCT00965419|7328995|FG000|Open Label Treatment for Responders|Protocol Violation|21
4517231|NCT00965419|7328995|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27
4517232|NCT00965419|7328995|FG000|Open Label Treatment for Responders|Physician Decision|6
4517233|NCT00965419|7328995|FG000|Open Label Treatment for Responders|Sponsor Decision|5
4517234|NCT00965419|7328995|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41
4517235|NCT00965419|7328995|FG000|Open Label Treatment for Responders|Lack of Efficacy|67
4517236|NCT00965419|7328995|FG000|Open Label Treatment for Responders|Lost to Follow-up|46
4517237|NCT00965419|7328995|FG000|Follow-up Phase|Adverse Event|9
4517238|NCT00965419|7328995|FG000|Follow-up Phase|Protocol Violation|4
4517239|NCT00965419|7328995|FG000|Follow-up Phase|Withdrawal by Subject|8
4517240|NCT00965419|7328995|FG000|Follow-up Phase|Physician Decision|4
4517241|NCT00965419|7328995|FG000|Follow-up Phase|Parent/Caregiver Decision|9
4517242|NCT00965419|7328995|FG000|Follow-up Phase|Lack of Efficacy|28
4517243|NCT00965458|7329002|FG000|Overall Study|Adverse Event|1
4517244|NCT00965458|7329003|FG001|Overall Study|Adverse Event|0
4517245|NCT00965458|7329002|FG000|Overall Study|Lost to Follow-up|1
4517246|NCT00965458|7329003|FG001|Overall Study|Lost to Follow-up|3
4517247|NCT00965458|7329002|FG000|Overall Study|Withdrawal by Subject|0
4486755|NCT00761267|7287404|FG000|Overall Study|Death|1
4486756|NCT00761267|7287405|FG001|Overall Study|Death|2
4486757|NCT00761267|7287406|FG002|Overall Study|Death|5
4486758|NCT00761267|7287404|FG000|Overall Study|Lost to Follow-up|0
4486759|NCT00761267|7287405|FG001|Overall Study|Lost to Follow-up|0
4486760|NCT00761267|7287406|FG002|Overall Study|Lost to Follow-up|1
4486761|NCT00761267|7287404|FG000|Overall Study|Randomized but not treated|1
4486762|NCT00761267|7287405|FG001|Overall Study|Randomized but not treated|1
4486763|NCT00761267|7287406|FG002|Overall Study|Randomized but not treated|0
4486764|NCT00761267|7287404|FG000|Overall Study|Withdrawal by Subject|0
4486765|NCT00761267|7287405|FG001|Overall Study|Withdrawal by Subject|1
4486766|NCT00761267|7287406|FG002|Overall Study|Withdrawal by Subject|0
4486767|NCT00761280|7287427|FG000|Randomization to First Dose|Withdrawal by Subject|0
4486768|NCT00761280|7287428|FG001|Randomization to First Dose|Withdrawal by Subject|2
4486769|NCT00761280|7287427|FG000|Randomization to First Dose|Sponsor decision|1
4486770|NCT00761280|7287428|FG001|Randomization to First Dose|Sponsor decision|0
4486771|NCT00761280|7287427|FG000|Randomization to First Dose|Other|1
4486772|NCT00761280|7287428|FG001|Randomization to First Dose|Other|0
4486773|NCT00761280|7287427|FG000|First Dose to End of Study|End of trial|5
4486774|NCT00761280|7287428|FG001|First Dose to End of Study|End of trial|5
4486775|NCT00761280|7287427|FG000|First Dose to End of Study|Progressive disease|5
4486776|NCT00761280|7287428|FG001|First Dose to End of Study|Progressive disease|3
4486777|NCT00761280|7287427|FG000|First Dose to End of Study|Sponsor decision|1
4486778|NCT00761280|7287428|FG001|First Dose to End of Study|Sponsor decision|2
4486779|NCT00761280|7287427|FG000|First Dose to End of Study|Death|1
4486780|NCT00761280|7287428|FG001|First Dose to End of Study|Death|0
4486781|NCT00761280|7287427|FG000|First Dose to End of Study|Lost to Follow-up|0
4486782|NCT00761280|7287428|FG001|First Dose to End of Study|Lost to Follow-up|1
4486783|NCT00761306|7287434|FG000|Overall Study|Adverse Event|5
4486784|NCT00761306|7287434|FG000|Overall Study|Lack of Efficacy|4
4486785|NCT00761306|7287434|FG000|Overall Study|Protocol Violation|2
4486786|NCT00761306|7287434|FG000|Overall Study|Withdrawal of Consent|3
4486787|NCT00761306|7287434|FG000|Overall Study|Lost to Follow-up|1
4486788|NCT00761306|7287434|FG000|Overall Study|Administrative or Other Reasons|5
4486789|NCT00761319|7287440|FG000|Overall Study|Protocol Violation|21
4486790|NCT00761319|7287441|FG001|Overall Study|Protocol Violation|14
4486791|NCT00761319|7287440|FG000|Overall Study|Adverse Event|11
4486792|NCT00761319|7287441|FG001|Overall Study|Adverse Event|7
4486793|NCT00761319|7287440|FG000|Overall Study|Withdrawal by Subject|8
4486794|NCT00761319|7287441|FG001|Overall Study|Withdrawal by Subject|7
4486795|NCT00761319|7287440|FG000|Overall Study|Noncompliance|4
4486796|NCT00761319|7287441|FG001|Overall Study|Noncompliance|3
4486797|NCT00761319|7287440|FG000|Overall Study|Lost to Follow-up|1
4486798|NCT00761319|7287441|FG001|Overall Study|Lost to Follow-up|1
4590115|NCT01518153|7435742|FG001|Donor Lymphocyte Infusion|Death|2
4590116|NCT01518153|7435743|FG002|Donor Lymphocyte Infusion|Death|1
4590117|NCT01518192|7435754|FG000|Overall Study|Lost to Follow-up|29
4590118|NCT01518192|7435755|FG001|Overall Study|Lost to Follow-up|26
4590119|NCT01518192|7435756|FG002|Overall Study|Lost to Follow-up|35
4590120|NCT01518244|7435770|FG000|Overall Study|Adverse Event|3
4590121|NCT01518257|7435776|FG000|Overall Study|Lost to Follow-up|1
4590122|NCT01518257|7435777|FG001|Overall Study|Lost to Follow-up|0
4590123|NCT01518257|7435776|FG000|Overall Study|Other Miscellaneous Reason|1
4590124|NCT01518257|7435777|FG001|Overall Study|Other Miscellaneous Reason|0
4590125|NCT01518309|7435787|FG000|Overall Study|Adverse Event|6
4590126|NCT01518309|7435787|FG000|Overall Study|Death|6
4590127|NCT01518309|7435787|FG000|Overall Study|Lack of Efficacy|7
4590128|NCT01518309|7435787|FG000|Overall Study|Withdrawal by Subject|6
4590129|NCT01518309|7435787|FG000|Overall Study|Physician Decision|3
4590130|NCT01518309|7435787|FG000|Overall Study|Sponsor Decision|2
4590131|NCT01518309|7435787|FG000|Overall Study|Not in Predefined Categories|9
4590132|NCT01518322|7435791|FG000|Overall Study|FeNO measurement was missing|13
4590133|NCT01518374|7435800|FG000|Overall Study|Withdrawal by Subject|2
4590134|NCT01518374|7435800|FG000|Overall Study|Protocol Violation|3
4590135|NCT01518374|7435800|FG000|Overall Study|Lost to Follow-up|2
4590136|NCT01518699|7435814|FG000|Period 2|Protocol Violation|1
4590137|NCT01518699|7435815|FG001|Period 2|Protocol Violation|1
4486799|NCT00761319|7287440|FG000|Overall Study|Nonspecified|2
4486800|NCT00761319|7287441|FG001|Overall Study|Nonspecified|2
4486801|NCT00761319|7287440|FG000|Overall Study|Missing|1
4486802|NCT00761319|7287441|FG001|Overall Study|Missing|0
4486803|NCT00761462|7287453|FG000|Treatment|Subjects never received study medication|23
4486804|NCT00761462|7287454|FG001|Treatment|Subjects never received study medication|12
4486805|NCT00761462|7287453|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4
4486806|NCT00761462|7287454|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0
4486807|NCT00761462|7287453|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75
4486808|NCT00761462|7287454|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30
4486809|NCT00761462|7287453|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75
4486810|NCT00761462|7287454|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21
4486811|NCT00761514|7287460|FG000|Overall Study|Adverse Event|1
4590138|NCT01518699|7435816|FG002|Period 2|Protocol Violation|0
4590139|NCT01518699|7435817|FG003|Period 2|Protocol Violation|0
4486812|NCT00761514|7287460|FG000|Overall Study|Withdrawal by Subject|2
4486813|NCT00761514|7287460|FG000|Overall Study|Lost to Follow-up|1
4486814|NCT00761514|7287460|FG000|Overall Study|Health insurance didn't cover study drug|1
4486815|NCT00761514|7287460|FG000|Overall Study|Problem complying with study visit|1
4486816|NCT00761514|7287460|FG000|Overall Study|Unable to pay for medications|1
4486817|NCT00761579|7287464|FG000|Overall Study|Adverse Event|10
4486818|NCT00761579|7287464|FG000|Overall Study|Death|2
4486819|NCT00761579|7287464|FG000|Overall Study|Lack of Efficacy|21
4486820|NCT00761579|7287464|FG000|Overall Study|Lost to Follow-up|16
4486821|NCT00761579|7287464|FG000|Overall Study|Pregnancy|1
4486822|NCT00761579|7287464|FG000|Overall Study|Withdrawal by Subject|34
4486823|NCT00761579|7287464|FG000|Overall Study|Lack of compliance|2
4486824|NCT00761579|7287464|FG000|Overall Study|Protocol deviation|1
4486825|NCT00761579|7287464|FG000|Overall Study|Drug overdose|1
4486826|NCT00761579|7287464|FG000|Overall Study|Aggravation of depression|1
4486827|NCT00761579|7287464|FG000|Overall Study|Aggravation of symptoms by changing drug|1
4486828|NCT00761579|7287464|FG000|Overall Study|Lost survey form|1
4486829|NCT00761579|7287464|FG000|Overall Study|Intake of prohibited concomitant drug|1
4486830|NCT00761605|7287479|FG000|Overall Study|Adverse Event|26
4486831|NCT00761605|7287479|FG000|Overall Study|Death|2
4486832|NCT00761605|7287479|FG000|Overall Study|Lack of Efficacy|26
4486833|NCT00761605|7287479|FG000|Overall Study|Lost to Follow-up|29
4486834|NCT00761605|7287479|FG000|Overall Study|Withdrawal by Subject|37
4486835|NCT00761605|7287479|FG000|Overall Study|Other|21
4486836|NCT00761631|7287491|FG000|Overall Study|Parent/legal guardian request|8
4486837|NCT00761631|7287492|FG001|Overall Study|Parent/legal guardian request|3
4486838|NCT00761631|7287493|FG002|Overall Study|Parent/legal guardian request|8
4486839|NCT00761631|7287494|FG003|Overall Study|Parent/legal guardian request|0
4486840|NCT00761631|7287495|FG004|Overall Study|Parent/legal guardian request|5
4486841|NCT00761631|7287496|FG005|Overall Study|Parent/legal guardian request|0
4486842|NCT00761631|7287491|FG000|Overall Study|Lost to Follow-up|2
4486843|NCT00761631|7287492|FG001|Overall Study|Lost to Follow-up|4
4486844|NCT00761631|7287493|FG002|Overall Study|Lost to Follow-up|7
4486845|NCT00761631|7287494|FG003|Overall Study|Lost to Follow-up|1
4486846|NCT00761631|7287495|FG004|Overall Study|Lost to Follow-up|6
4486847|NCT00761631|7287496|FG005|Overall Study|Lost to Follow-up|1
4486848|NCT00761631|7287491|FG000|Overall Study|Protocol Violation|2
4486849|NCT00761631|7287492|FG001|Overall Study|Protocol Violation|0
4486850|NCT00761631|7287493|FG002|Overall Study|Protocol Violation|0
4486851|NCT00761631|7287494|FG003|Overall Study|Protocol Violation|1
4486852|NCT00761631|7287495|FG004|Overall Study|Protocol Violation|5
4486853|NCT00761631|7287496|FG005|Overall Study|Protocol Violation|1
4486854|NCT00761631|7287491|FG000|Overall Study|Randomized, not treated|1
4486855|NCT00761631|7287492|FG001|Overall Study|Randomized, not treated|0
4486856|NCT00761631|7287493|FG002|Overall Study|Randomized, not treated|0
4486857|NCT00761631|7287494|FG003|Overall Study|Randomized, not treated|0
4486858|NCT00761631|7287495|FG004|Overall Study|Randomized, not treated|0
4486859|NCT00761631|7287496|FG005|Overall Study|Randomized, not treated|0
4486860|NCT00761631|7287491|FG000|Overall Study|Failed to return|1
4486861|NCT00761631|7287492|FG001|Overall Study|Failed to return|0
4486862|NCT00761631|7287493|FG002|Overall Study|Failed to return|1
4486863|NCT00761631|7287494|FG003|Overall Study|Failed to return|1
4486864|NCT00761631|7287495|FG004|Overall Study|Failed to return|5
4486865|NCT00761631|7287496|FG005|Overall Study|Failed to return|2
4486866|NCT00761631|7287491|FG000|Overall Study|Physician Decision|1
4486867|NCT00761631|7287492|FG001|Overall Study|Physician Decision|0
4486868|NCT00761631|7287493|FG002|Overall Study|Physician Decision|0
4486869|NCT00761631|7287494|FG003|Overall Study|Physician Decision|0
4486870|NCT00761631|7287495|FG004|Overall Study|Physician Decision|0
4486871|NCT00761631|7287496|FG005|Overall Study|Physician Decision|0
4486872|NCT00761631|7287491|FG000|Overall Study|Other|0
4486873|NCT00761631|7287492|FG001|Overall Study|Other|0
4486874|NCT00761631|7287493|FG002|Overall Study|Other|0
4486875|NCT00761631|7287494|FG003|Overall Study|Other|0
4486876|NCT00761631|7287495|FG004|Overall Study|Other|1
4486877|NCT00761631|7287496|FG005|Overall Study|Other|1
4486878|NCT00761657|7287528|FG000|Part 1 (up to Day 57)|Adverse Event|0
4486879|NCT00761657|7287529|FG001|Part 1 (up to Day 57)|Adverse Event|0
4486880|NCT00761657|7287530|FG002|Part 1 (up to Day 57)|Adverse Event|0
4486881|NCT00761657|7287531|FG003|Part 1 (up to Day 57)|Adverse Event|1
4486882|NCT00761657|7287532|FG004|Part 1 (up to Day 57)|Adverse Event|0
4486883|NCT00761657|7287533|FG005|Part 1 (up to Day 57)|Adverse Event|0
4486884|NCT00761657|7287534|FG006|Part 1 (up to Day 57)|Adverse Event|0
4486885|NCT00761657|7287535|FG007|Part 1 (up to Day 57)|Adverse Event|0
4486886|NCT00761657|7287536|FG008|Part 1 (up to Day 57)|Adverse Event|0
4486887|NCT00761657|7287528|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0
4486888|NCT00761657|7287529|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0
4486889|NCT00761657|7287530|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1
4486890|NCT00761657|7287531|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1
4486891|NCT00761657|7287532|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0
4486892|NCT00761657|7287533|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0
4486893|NCT00761657|7287534|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0
4486894|NCT00761657|7287535|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0
4486895|NCT00761657|7287536|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0
4486896|NCT00761657|7287528|FG000|Part 1 (up to Day 57)|Sponsor Decision|0
4486897|NCT00761657|7287529|FG001|Part 1 (up to Day 57)|Sponsor Decision|0
4486898|NCT00761657|7287530|FG002|Part 1 (up to Day 57)|Sponsor Decision|3
4486899|NCT00761657|7287531|FG003|Part 1 (up to Day 57)|Sponsor Decision|4
4486900|NCT00761657|7287532|FG004|Part 1 (up to Day 57)|Sponsor Decision|0
4486901|NCT00761657|7287533|FG005|Part 1 (up to Day 57)|Sponsor Decision|0
4486902|NCT00761657|7287534|FG006|Part 1 (up to Day 57)|Sponsor Decision|1
4486903|NCT00761657|7287535|FG007|Part 1 (up to Day 57)|Sponsor Decision|1
4486904|NCT00761657|7287536|FG008|Part 1 (up to Day 57)|Sponsor Decision|1
4486905|NCT00761657|7287528|FG000|Part 2 (up to Day 114)|Adverse Event|0
4486906|NCT00761657|7287529|FG001|Part 2 (up to Day 114)|Adverse Event|0
4486907|NCT00761657|7287530|FG002|Part 2 (up to Day 114)|Adverse Event|0
4486908|NCT00761657|7287531|FG003|Part 2 (up to Day 114)|Adverse Event|0
4486909|NCT00761657|7287532|FG004|Part 2 (up to Day 114)|Adverse Event|0
4486910|NCT00761657|7287533|FG005|Part 2 (up to Day 114)|Adverse Event|0
4701309|NCT02708095|7618134|FG002|Overall Study|Adverse Event|11
4486911|NCT00761657|7287534|FG006|Part 2 (up to Day 114)|Adverse Event|0
4486912|NCT00761657|7287535|FG007|Part 2 (up to Day 114)|Adverse Event|0
4486913|NCT00761657|7287536|FG008|Part 2 (up to Day 114)|Adverse Event|1
4486914|NCT00761735|7287566|FG000|Overall Study|Lost to Follow-up|6
4486915|NCT00761735|7287566|FG000|Overall Study|Withdrawal by Subject|6
4486916|NCT00761735|7287566|FG000|Overall Study|Non-compliance with protocol|1
4486917|NCT00761735|7287566|FG000|Overall Study|Administrative|1
4486918|NCT00761748|7287574|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3
4486919|NCT00761748|7287575|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0
4486920|NCT00761748|7287574|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0
4486921|NCT00761748|7287575|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3
4486922|NCT00761761|7287583|FG000|Overall Study|Lost to Follow-up|3
4486923|NCT00761761|7287584|FG001|Overall Study|Lost to Follow-up|1
4486924|NCT00761761|7287583|FG000|Overall Study|Withdrawal by Subject|3
4486925|NCT00761761|7287584|FG001|Overall Study|Withdrawal by Subject|0
4486926|NCT00761774|7287592|FG000|Overall Study|Adverse Event|17
4486927|NCT00761774|7287592|FG000|Overall Study|Lack of Efficacy|37
4486928|NCT00761774|7287592|FG000|Overall Study|Lost to Follow-up|2
4486929|NCT00761774|7287592|FG000|Overall Study|Withdrawal by Subject|9
4486930|NCT00761774|7287592|FG000|Overall Study|Non-compliance|4
4486931|NCT00761774|7287592|FG000|Overall Study|End of study|2
4486932|NCT00761774|7287592|FG000|Overall Study|Reclassification of seizures|1
4486933|NCT00761774|7287592|FG000|Overall Study|Medical decision to read SUSAR reports|1
4486934|NCT00761774|7287592|FG000|Overall Study|Sponsor decision|1
4486935|NCT00761774|7287592|FG000|Overall Study|Investigator clinical judgement|1
4486936|NCT00761774|7287592|FG000|Overall Study|Patient moved out of study area|1
4486937|NCT00761774|7287592|FG000|Overall Study|Coordinator leaving site|1
4486938|NCT00761774|7287592|FG000|Overall Study|Subject IP non-compliance|1
4486939|NCT00761774|7287592|FG000|Overall Study|IP stopped by hospital physician|1
4486940|NCT00761865|7287609|FG000|Overall Study|Lost to Follow-up|8
4486941|NCT00761865|7287610|FG001|Overall Study|Lost to Follow-up|7
4486942|NCT00761891|7287616|FG000|Overall Study|Withdrawal by Subject|10
4486943|NCT00761956|7287636|FG000|Overall Study|Lost to Follow-up|6
4486944|NCT00761956|7287637|FG001|Overall Study|Lost to Follow-up|11
4486945|NCT00761956|7287636|FG000|Overall Study|Withdrawal by Subject|3
4486946|NCT00761956|7287637|FG001|Overall Study|Withdrawal by Subject|8
4486947|NCT00761956|7287636|FG000|Overall Study|Death|0
4486948|NCT00761956|7287637|FG001|Overall Study|Death|1
4486949|NCT00761956|7287636|FG000|Overall Study|Adverse Event|26
4486950|NCT00761956|7287637|FG001|Overall Study|Adverse Event|34
4486951|NCT00761969|7287645|FG000|Overall Study|Death|112
4486952|NCT00761969|7287646|FG001|Overall Study|Death|47
4486953|NCT00761969|7287645|FG000|Overall Study|Lost to Follow-up|88
4486954|NCT00761969|7287646|FG001|Overall Study|Lost to Follow-up|93
4486955|NCT00762034|7287663|FG000|Induction Period|Protocol Violation|1
4486956|NCT00762034|7287664|FG001|Induction Period|Protocol Violation|2
4486957|NCT00762034|7287663|FG000|Induction Period|Entry Criterion Not Met|12
4486958|NCT00762034|7287664|FG001|Induction Period|Entry Criterion Not Met|11
4486959|NCT00762034|7287663|FG000|Induction Period|Adverse Event|27
4486960|NCT00762034|7287664|FG001|Induction Period|Adverse Event|38
4486961|NCT00762034|7287663|FG000|Induction Period|Lost to Follow-up|1
4486962|NCT00762034|7287664|FG001|Induction Period|Lost to Follow-up|1
4486963|NCT00762034|7287663|FG000|Induction Period|Progressive Disease|73
4486964|NCT00762034|7287664|FG001|Induction Period|Progressive Disease|55
4486965|NCT00762034|7287663|FG000|Induction Period|Physician Decision|21
4701310|NCT02708095|7618132|FG000|Overall Study|Lack of Efficacy|9
4486966|NCT00762034|7287664|FG001|Induction Period|Physician Decision|20
4486967|NCT00762034|7287663|FG000|Induction Period|Withdrawal by Subject|15
4486968|NCT00762034|7287664|FG001|Induction Period|Withdrawal by Subject|19
4486969|NCT00762034|7287663|FG000|Induction Period|Deaths Not Due to Study Disease|19
4486970|NCT00762034|7287664|FG001|Induction Period|Deaths Not Due to Study Disease|14
4486971|NCT00762034|7287663|FG000|Induction Period|Deaths Due to Study Disease|9
4486972|NCT00762034|7287664|FG001|Induction Period|Deaths Due to Study Disease|9
4486973|NCT00762034|7287663|FG000|Maintenance Period|Protocol Violation|1
4486974|NCT00762034|7287664|FG001|Maintenance Period|Protocol Violation|3
4486975|NCT00762034|7287663|FG000|Maintenance Period|Entry Criterion Not Met|0
4486976|NCT00762034|7287664|FG001|Maintenance Period|Entry Criterion Not Met|2
4486977|NCT00762034|7287663|FG000|Maintenance Period|Adverse Event|42
4486978|NCT00762034|7287664|FG001|Maintenance Period|Adverse Event|26
4486979|NCT00762034|7287663|FG000|Maintenance Period|Progressive Disease|186
4486980|NCT00762034|7287664|FG001|Maintenance Period|Progressive Disease|224
4486981|NCT00762034|7287663|FG000|Maintenance Period|Physician Decision|25
4486982|NCT00762034|7287664|FG001|Maintenance Period|Physician Decision|20
4486983|NCT00762034|7287663|FG000|Maintenance Period|Withdrawal by Subject|34
4486984|NCT00762034|7287664|FG001|Maintenance Period|Withdrawal by Subject|14
4486985|NCT00762034|7287663|FG000|Maintenance Period|Death not due to study disease|2
4486986|NCT00762034|7287664|FG001|Maintenance Period|Death not due to study disease|5
4486987|NCT00762034|7287663|FG000|Maintenance Period|Death due to study disease|3
4486988|NCT00762034|7287664|FG001|Maintenance Period|Death due to study disease|3
4486989|NCT00762034|7287663|FG000|Maintenance Period|Other|1
4486990|NCT00762034|7287664|FG001|Maintenance Period|Other|1
4486991|NCT00762073|7287682|FG000|Overall Study|Lack of Efficacy|1
4486992|NCT00762073|7287683|FG001|Overall Study|Lack of Efficacy|1
4486993|NCT00762073|7287684|FG002|Overall Study|Lack of Efficacy|0
4486994|NCT00762073|7287685|FG003|Overall Study|Lack of Efficacy|0
4486995|NCT00762073|7287682|FG000|Overall Study|Adverse Event|1
4486996|NCT00762073|7287683|FG001|Overall Study|Adverse Event|0
4486997|NCT00762073|7287684|FG002|Overall Study|Adverse Event|1
4486998|NCT00762073|7287685|FG003|Overall Study|Adverse Event|1
4486999|NCT00762073|7287682|FG000|Overall Study|Significant Subject Noncompliance|0
4487000|NCT00762073|7287683|FG001|Overall Study|Significant Subject Noncompliance|1
4487001|NCT00762073|7287684|FG002|Overall Study|Significant Subject Noncompliance|0
4487002|NCT00762073|7287685|FG003|Overall Study|Significant Subject Noncompliance|1
4487003|NCT00762073|7287682|FG000|Overall Study|Withdrawal by Subject|1
4487004|NCT00762073|7287683|FG001|Overall Study|Withdrawal by Subject|2
4487005|NCT00762073|7287684|FG002|Overall Study|Withdrawal by Subject|1
4487006|NCT00762073|7287685|FG003|Overall Study|Withdrawal by Subject|1
4487007|NCT00762073|7287682|FG000|Overall Study|Not on treatment for >/= 77 days|1
4487008|NCT00762073|7287683|FG001|Overall Study|Not on treatment for >/= 77 days|0
4487009|NCT00762073|7287684|FG002|Overall Study|Not on treatment for >/= 77 days|0
4487010|NCT00762073|7287685|FG003|Overall Study|Not on treatment for >/= 77 days|0
4487011|NCT00762086|7287704|FG000|Overall Study|Adverse Event|2
4487012|NCT00762086|7287705|FG001|Overall Study|Adverse Event|0
4487013|NCT00762086|7287704|FG000|Overall Study|Lost to Follow-up|0
4487014|NCT00762086|7287705|FG001|Overall Study|Lost to Follow-up|2
4487015|NCT00762086|7287704|FG000|Overall Study|Non compliance|1
4487016|NCT00762086|7287705|FG001|Overall Study|Non compliance|0
4487017|NCT00762086|7287704|FG000|Overall Study|Withdrawal by Subject|2
4487018|NCT00762086|7287705|FG001|Overall Study|Withdrawal by Subject|2
4487019|NCT00762086|7287704|FG000|Overall Study|Ineligible to participate in the study|1
4487020|NCT00762086|7287705|FG001|Overall Study|Ineligible to participate in the study|0
4487021|NCT00762164|7287713|FG000|Overall Study|Lost to Follow-up|1
4487022|NCT00762164|7287714|FG001|Overall Study|Lost to Follow-up|1
4487023|NCT00762164|7287713|FG000|Overall Study|Discontinued medication|2
4487024|NCT00762164|7287714|FG001|Overall Study|Discontinued medication|0
4487025|NCT00762164|7287713|FG000|Overall Study|Withdrawal by Subject|0
4487026|NCT00762164|7287714|FG001|Overall Study|Withdrawal by Subject|1
4487027|NCT00762229|7287742|FG000|Overall Study|Lost to Follow-up|1
4487028|NCT00762229|7287743|FG001|Overall Study|Lost to Follow-up|1
4487029|NCT00762229|7287742|FG000|Overall Study|did not recveive intervention|0
4487030|NCT00762229|7287743|FG001|Overall Study|did not recveive intervention|1
4487031|NCT00762268|7287751|FG000|Overall Study|Withdrawal by Subject|3
4487032|NCT00762268|7287752|FG001|Overall Study|Withdrawal by Subject|3
4487033|NCT00762359|7287797|FG000|Overall Study|Adverse Event|20
4487034|NCT00762359|7287798|FG001|Overall Study|Adverse Event|23
4487035|NCT00762359|7287797|FG000|Overall Study|Protocol Violation|21
4487036|NCT00762359|7287798|FG001|Overall Study|Protocol Violation|13
4487037|NCT00762359|7287797|FG000|Overall Study|Withdrawal by Subject|13
4487038|NCT00762359|7287798|FG001|Overall Study|Withdrawal by Subject|10
4487039|NCT00762359|7287797|FG000|Overall Study|Lack of Efficacy|0
4487040|NCT00762359|7287798|FG001|Overall Study|Lack of Efficacy|4
4487041|NCT00762359|7287797|FG000|Overall Study|Institution closed|2
4487042|NCT00762359|7287798|FG001|Overall Study|Institution closed|3
4487043|NCT00762359|7287797|FG000|Overall Study|Physician Decision|2
4487044|NCT00762359|7287798|FG001|Overall Study|Physician Decision|3
4487045|NCT00762359|7287797|FG000|Overall Study|Removal|0
4487046|NCT00762359|7287798|FG001|Overall Study|Removal|1
4487047|NCT00762359|7287797|FG000|Overall Study|Withdrew consent|1
4487048|NCT00762359|7287798|FG001|Overall Study|Withdrew consent|0
4487049|NCT00762372|7287807|FG000|Overall Study|Adverse Event|1
4487050|NCT00762372|7287808|FG001|Overall Study|Adverse Event|0
4487051|NCT00762372|7287809|FG002|Overall Study|Adverse Event|0
4487052|NCT00762385|7287823|FG000|First Intervention|Lens Issue|1
4487053|NCT00762385|7287824|FG001|First Intervention|Lens Issue|1
4487054|NCT00762385|7287823|FG000|First Intervention|Lost to Follow-up|0
4487055|NCT00762385|7287824|FG001|First Intervention|Lost to Follow-up|2
4487056|NCT00762385|7287823|FG000|First Intervention|Ineligible|1
4487057|NCT00762385|7287824|FG001|First Intervention|Ineligible|0
4487058|NCT00762385|7287823|FG000|First Intervention|Protocol Violation|0
4487059|NCT00762385|7287824|FG001|First Intervention|Protocol Violation|1
4487060|NCT00762385|7287823|FG000|Second Intervention|Protocol Violation|3
4487061|NCT00762385|7287824|FG001|Second Intervention|Protocol Violation|3
4487062|NCT00762411|7287835|FG000|Initial Treatment|Death|7
4487063|NCT00762411|7287836|FG001|Initial Treatment|Death|6
4487064|NCT00762411|7287835|FG000|Initial Treatment|Adverse Event|132
4487065|NCT00762411|7287836|FG001|Initial Treatment|Adverse Event|40
4487066|NCT00762411|7287835|FG000|Initial Treatment|Protocol Violation|4
4487067|NCT00762411|7287836|FG001|Initial Treatment|Protocol Violation|1
4487068|NCT00762411|7287835|FG000|Initial Treatment|Withdrawal by Subject|65
4487069|NCT00762411|7287836|FG001|Initial Treatment|Withdrawal by Subject|52
4487070|NCT00762411|7287835|FG000|Initial Treatment|Physician Decision|1
4487071|NCT00762411|7287836|FG001|Initial Treatment|Physician Decision|0
4487072|NCT00762411|7287835|FG000|Initial Treatment|Sponsor Decision|293
4487073|NCT00762411|7287836|FG001|Initial Treatment|Sponsor Decision|401
4487074|NCT00762411|7287835|FG000|Initial Treatment|Lost to Follow-up|5
4487075|NCT00762411|7287836|FG001|Initial Treatment|Lost to Follow-up|0
4487076|NCT00762411|7287835|FG000|Initial Treatment|Caregiver Decision|21
4487077|NCT00762411|7287836|FG001|Initial Treatment|Caregiver Decision|16
4487078|NCT00762411|7287835|FG000|Initial Treatment|Abnormal Lab/ECG Result|6
4487079|NCT00762411|7287836|FG001|Initial Treatment|Abnormal Lab/ECG Result|4
4487080|NCT00762411|7287835|FG000|Initial Treatment|Entry Criteria Exclusion|0
4487081|NCT00762411|7287836|FG001|Initial Treatment|Entry Criteria Exclusion|1
4487082|NCT00762411|7287835|FG000|Delayed Start|Adverse Event|0
4487083|NCT00762411|7287836|FG001|Delayed Start|Adverse Event|4
4487084|NCT00762411|7287835|FG000|Delayed Start|Protocol Violation|0
4487085|NCT00762411|7287836|FG001|Delayed Start|Protocol Violation|1
4487086|NCT00762411|7287835|FG000|Delayed Start|Sponsor Decision|16
4487087|NCT00762411|7287836|FG001|Delayed Start|Sponsor Decision|20
4487088|NCT00762411|7287835|FG000|Delayed Start|Caregiver Decision|1
4487089|NCT00762411|7287836|FG001|Delayed Start|Caregiver Decision|1
4487090|NCT00762411|7287835|FG000|Safety Follow Up (SFU)-Optional|Death|1
4487091|NCT00762411|7287836|FG001|Safety Follow Up (SFU)-Optional|Death|8
4487092|NCT00762411|7287835|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0
4487093|NCT00762411|7287836|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1
4487094|NCT00762411|7287835|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21
4487095|NCT00762411|7287836|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46
4487096|NCT00762411|7287835|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6
4487097|NCT00762411|7287836|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1
4487098|NCT00762411|7287835|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8
4487099|NCT00762411|7287836|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8
4487100|NCT00762411|7287835|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48
4487101|NCT00762411|7287836|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54
4487102|NCT00762463|7287870|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2
4487103|NCT00762463|7287871|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2
4487104|NCT00762463|7287872|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0
4487105|NCT00762463|7287873|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0
4487106|NCT00762463|7287870|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3
4487107|NCT00762463|7287871|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4
4487108|NCT00762463|7287872|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0
4487109|NCT00762463|7287873|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0
4487110|NCT00762463|7287870|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2
4487111|NCT00762463|7287871|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4
4487112|NCT00762463|7287872|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0
4487113|NCT00762463|7287873|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0
4487114|NCT00762463|7287870|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4
4487115|NCT00762463|7287871|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1
4487116|NCT00762463|7287872|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0
4487117|NCT00762463|7287873|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0
4487118|NCT00762463|7287870|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1
4487119|NCT00762463|7287871|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0
4487120|NCT00762463|7287872|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1
4487121|NCT00762463|7287873|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0
4487122|NCT00762463|7287870|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
4487123|NCT00762463|7287871|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
4487124|NCT00762463|7287872|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0
4487125|NCT00762463|7287873|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
4487126|NCT00762463|7287870|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1
4487127|NCT00762463|7287871|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0
4487128|NCT00762463|7287872|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3
4487129|NCT00762463|7287873|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0
4487130|NCT00762463|7287870|FG000|Extension Phase (Week 6 to Week 12)|Other|0
4487131|NCT00762463|7287871|FG001|Extension Phase (Week 6 to Week 12)|Other|0
4487132|NCT00762463|7287872|FG002|Extension Phase (Week 6 to Week 12)|Other|0
4487133|NCT00762463|7287873|FG003|Extension Phase (Week 6 to Week 12)|Other|1
4487134|NCT00762476|7287888|FG000|Overall Study|Adverse Event|7
4487135|NCT00762476|7287889|FG001|Overall Study|Adverse Event|1
4487136|NCT00762476|7287888|FG000|Overall Study|Lost to Follow-up|2
4487137|NCT00762476|7287889|FG001|Overall Study|Lost to Follow-up|0
4487138|NCT00762476|7287888|FG000|Overall Study|Protocol Violation|5
4487139|NCT00762476|7287889|FG001|Overall Study|Protocol Violation|6
4487140|NCT00762476|7287888|FG000|Overall Study|Physician Decision|2
4487141|NCT00762476|7287889|FG001|Overall Study|Physician Decision|14
4487142|NCT00762476|7287888|FG000|Overall Study|Withdrawal by Subject|6
4487143|NCT00762476|7287889|FG001|Overall Study|Withdrawal by Subject|12
4487144|NCT00762476|7287888|FG000|Overall Study|antibiotic use|0
4487145|NCT00762476|7287889|FG001|Overall Study|antibiotic use|1
4487146|NCT00762476|7287888|FG000|Overall Study|non-compliance with study visits|0
4487147|NCT00762476|7287889|FG001|Overall Study|non-compliance with study visits|2
4487148|NCT00762476|7287888|FG000|Overall Study|Seasonal allergies|1
4487149|NCT00762476|7287889|FG001|Overall Study|Seasonal allergies|0
4487150|NCT00762502|7287899|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4
4487151|NCT00762502|7287900|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3
4487152|NCT00762502|7287901|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6
4487153|NCT00762502|7287899|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6
4487154|NCT00762502|7287900|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3
4487155|NCT00762502|7287901|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13
4487156|NCT00762502|7287899|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0
4487157|NCT00762502|7287900|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1
4487158|NCT00762502|7287901|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0
4487159|NCT00762606|7287927|FG000|Overall Study|Lost to Follow-up|18
4487160|NCT00762606|7287928|FG001|Overall Study|Lost to Follow-up|13
4487161|NCT00762762|7287965|FG000|Overall Study|Did not report for appointments|8
4487162|NCT00762762|7287966|FG001|Overall Study|Did not report for appointments|10
4487163|NCT00762788|7287978|FG000|Overall Study|Lost to Follow-up|26
4487164|NCT00762788|7287979|FG001|Overall Study|Lost to Follow-up|37
4487165|NCT00762788|7287980|FG002|Overall Study|Lost to Follow-up|21
4487166|NCT00762788|7287981|FG003|Overall Study|Lost to Follow-up|26
4487167|NCT00762788|7287982|FG004|Overall Study|Lost to Follow-up|13
4487168|NCT00762788|7287983|FG005|Overall Study|Lost to Follow-up|21
4487169|NCT00762892|7288008|FG000|Overall Study|Lost to Follow-up|2
4487170|NCT00762892|7288009|FG001|Overall Study|Lost to Follow-up|5
4487171|NCT00762892|7288008|FG000|Overall Study|Withdrawal by Subject|0
4487172|NCT00762892|7288009|FG001|Overall Study|Withdrawal by Subject|1
4487173|NCT00762892|7288008|FG000|Overall Study|Death|1
4487174|NCT00762892|7288009|FG001|Overall Study|Death|0
4487175|NCT00762892|7288008|FG000|Overall Study|Pregnancy|1
4487176|NCT00762892|7288009|FG001|Overall Study|Pregnancy|0
4487177|NCT00762892|7288008|FG000|Overall Study|Incarceration|1
4487178|NCT00762892|7288009|FG001|Overall Study|Incarceration|0
4487179|NCT00762970|7288022|FG000|Overall Study|Withdrawal by Subject|7
4487180|NCT00762970|7288023|FG001|Overall Study|Withdrawal by Subject|4
4487181|NCT00762970|7288024|FG002|Overall Study|Withdrawal by Subject|0
4487182|NCT00762970|7288022|FG000|Overall Study|Protocol Violation|3
4487183|NCT00762970|7288023|FG001|Overall Study|Protocol Violation|1
4487184|NCT00762970|7288024|FG002|Overall Study|Protocol Violation|1
4487185|NCT00762970|7288022|FG000|Overall Study|Lost to Follow-up|1
4487186|NCT00762970|7288023|FG001|Overall Study|Lost to Follow-up|2
4487187|NCT00762970|7288024|FG002|Overall Study|Lost to Follow-up|0
4487188|NCT00762970|7288022|FG000|Overall Study|Difficulty of handling lens|1
4487189|NCT00762970|7288023|FG001|Overall Study|Difficulty of handling lens|2
4487190|NCT00762970|7288024|FG002|Overall Study|Difficulty of handling lens|0
4487191|NCT00762996|7288032|FG000|Period One|Protocol Violation|0
4487192|NCT00762996|7288033|FG001|Period One|Protocol Violation|0
4487193|NCT00762996|7288034|FG002|Period One|Protocol Violation|1
4487194|NCT00762996|7288035|FG003|Period One|Protocol Violation|0
4487195|NCT00762996|7288032|FG000|Period One|ineligible|0
4487196|NCT00762996|7288033|FG001|Period One|ineligible|0
4487197|NCT00762996|7288034|FG002|Period One|ineligible|1
4487198|NCT00762996|7288035|FG003|Period One|ineligible|1
4487199|NCT00762996|7288032|FG000|Period One|Adverse Event|0
4487200|NCT00762996|7288033|FG001|Period One|Adverse Event|0
4487201|NCT00762996|7288034|FG002|Period One|Adverse Event|1
4487202|NCT00762996|7288035|FG003|Period One|Adverse Event|0
4487203|NCT00762996|7288032|FG000|Period One|Withdrawal by Subject|0
4487204|NCT00762996|7288033|FG001|Period One|Withdrawal by Subject|0
4487205|NCT00762996|7288034|FG002|Period One|Withdrawal by Subject|1
4487206|NCT00762996|7288035|FG003|Period One|Withdrawal by Subject|0
4487207|NCT00763035|7288043|FG000|First Intervention|Did not meeting inclusion/exclusion|1
4487208|NCT00763035|7288044|FG001|First Intervention|Did not meeting inclusion/exclusion|0
4487209|NCT00763035|7288043|FG000|First Intervention|Adverse Event|0
4487210|NCT00763035|7288044|FG001|First Intervention|Adverse Event|1
4487211|NCT00763035|7288043|FG000|Second Intervention|Adverse Event|1
4487212|NCT00763035|7288044|FG001|Second Intervention|Adverse Event|0
4487213|NCT00763035|7288043|FG000|Second Intervention|Physician Decision|2
4487214|NCT00763035|7288044|FG001|Second Intervention|Physician Decision|0
4487215|NCT00763139|7288068|FG000|Overall Study|Adverse Event|4
4487216|NCT00763139|7288069|FG001|Overall Study|Adverse Event|2
4487217|NCT00763139|7288068|FG000|Overall Study|Withdrawal by Subject|0
4487218|NCT00763139|7288069|FG001|Overall Study|Withdrawal by Subject|1
4487219|NCT00763139|7288068|FG000|Overall Study|med change not allowed by protocol|1
4487220|NCT00763139|7288069|FG001|Overall Study|med change not allowed by protocol|0
4487221|NCT00763256|7288094|FG000|Overall Study|Didn't return for appointments|7
4487222|NCT00763256|7288095|FG001|Overall Study|Didn't return for appointments|10
4487223|NCT00763269|7288103|FG000|Overall Study|Lost to Follow-up|12
4487224|NCT00763269|7288104|FG001|Overall Study|Lost to Follow-up|13
4487225|NCT00763282|7288112|FG000|Overall Study|Withdrawal by Subject|6
4487226|NCT00763282|7288113|FG001|Overall Study|Withdrawal by Subject|5
4487227|NCT00763282|7288112|FG000|Overall Study|Death|4
4487228|NCT00763282|7288113|FG001|Overall Study|Death|3
4487229|NCT00763282|7288112|FG000|Overall Study|Lost to Follow-up|22
4487230|NCT00763282|7288113|FG001|Overall Study|Lost to Follow-up|26
4487231|NCT00763321|7288124|FG000|Open-label Period|Adverse Event|24
4487232|NCT00763321|7288125|FG001|Open-label Period|Adverse Event|0
4487233|NCT00763321|7288126|FG002|Open-label Period|Adverse Event|0
4487234|NCT00763321|7288124|FG000|Open-label Period|Lost to Follow-up|14
4487235|NCT00763321|7288125|FG001|Open-label Period|Lost to Follow-up|0
4487236|NCT00763321|7288126|FG002|Open-label Period|Lost to Follow-up|0
4487237|NCT00763321|7288124|FG000|Open-label Period|Withdrawal by Subject|7
4487238|NCT00763321|7288125|FG001|Open-label Period|Withdrawal by Subject|0
4487239|NCT00763321|7288126|FG002|Open-label Period|Withdrawal by Subject|0
4487240|NCT00763321|7288124|FG000|Open-label Period|Subject noncompliant|7
4487241|NCT00763321|7288125|FG001|Open-label Period|Subject noncompliant|0
4487242|NCT00763321|7288126|FG002|Open-label Period|Subject noncompliant|0
4487243|NCT00763321|7288124|FG000|Open-label Period|Did not meet DB randomization criteria|5
4487244|NCT00763321|7288125|FG001|Open-label Period|Did not meet DB randomization criteria|0
4487245|NCT00763321|7288126|FG002|Open-label Period|Did not meet DB randomization criteria|0
4487246|NCT00763321|7288124|FG000|Open-label Period|Lack of Efficacy|2
4487247|NCT00763321|7288125|FG001|Open-label Period|Lack of Efficacy|0
4487248|NCT00763321|7288126|FG002|Open-label Period|Lack of Efficacy|0
4487249|NCT00763321|7288124|FG000|Open-label Period|Other|4
4487250|NCT00763321|7288125|FG001|Open-label Period|Other|0
4487251|NCT00763321|7288126|FG002|Open-label Period|Other|0
4487252|NCT00763321|7288124|FG000|Double-blind Period|Lack of Efficacy|0
4487253|NCT00763321|7288125|FG001|Double-blind Period|Lack of Efficacy|9
4487254|NCT00763321|7288126|FG002|Double-blind Period|Lack of Efficacy|17
4487255|NCT00763321|7288124|FG000|Double-blind Period|Adverse Event|0
4487256|NCT00763321|7288125|FG001|Double-blind Period|Adverse Event|4
4487257|NCT00763321|7288126|FG002|Double-blind Period|Adverse Event|4
4487258|NCT00763321|7288124|FG000|Double-blind Period|Lost to Follow-up|0
4487259|NCT00763321|7288125|FG001|Double-blind Period|Lost to Follow-up|4
4487260|NCT00763321|7288126|FG002|Double-blind Period|Lost to Follow-up|2
4487261|NCT00763321|7288124|FG000|Double-blind Period|Withdrawal by Subject|0
4487262|NCT00763321|7288125|FG001|Double-blind Period|Withdrawal by Subject|2
4487263|NCT00763321|7288126|FG002|Double-blind Period|Withdrawal by Subject|3
4487264|NCT00763321|7288124|FG000|Double-blind Period|Other|0
4487265|NCT00763321|7288125|FG001|Double-blind Period|Other|2
4487266|NCT00763321|7288126|FG002|Double-blind Period|Other|3
4487267|NCT00763386|7288148|FG000|Overall Study|Adverse Event|43
4487268|NCT00763386|7288149|FG001|Overall Study|Adverse Event|33
4487269|NCT00763386|7288148|FG000|Overall Study|Death|1
4487270|NCT00763386|7288149|FG001|Overall Study|Death|2
4487271|NCT00763386|7288148|FG000|Overall Study|Lost to Follow-up|3
4487272|NCT00763386|7288149|FG001|Overall Study|Lost to Follow-up|3
4487273|NCT00763386|7288148|FG000|Overall Study|Withdrawal by Subject|0
4487274|NCT00763386|7288149|FG001|Overall Study|Withdrawal by Subject|1
4487275|NCT00763386|7288148|FG000|Overall Study|CRF missing|0
4487276|NCT00763386|7288149|FG001|Overall Study|CRF missing|1
4487277|NCT00763386|7288148|FG000|Overall Study|Study Prosthesis Removed|1
4487278|NCT00763386|7288149|FG001|Overall Study|Study Prosthesis Removed|0
4487279|NCT00763451|7288168|FG000|Overall Study|Adverse Event|4
4487280|NCT00763451|7288169|FG001|Overall Study|Adverse Event|6
4487281|NCT00763451|7288170|FG002|Overall Study|Adverse Event|19
4487282|NCT00763451|7288171|FG003|Overall Study|Adverse Event|14
4487283|NCT00763451|7288168|FG000|Overall Study|Lack of Efficacy|1
4487284|NCT00763451|7288169|FG001|Overall Study|Lack of Efficacy|4
4487285|NCT00763451|7288170|FG002|Overall Study|Lack of Efficacy|3
4487286|NCT00763451|7288171|FG003|Overall Study|Lack of Efficacy|2
4487287|NCT00763451|7288168|FG000|Overall Study|Withdrawal by Subject|1
4487288|NCT00763451|7288169|FG001|Overall Study|Withdrawal by Subject|6
4487289|NCT00763451|7288170|FG002|Overall Study|Withdrawal by Subject|9
4487290|NCT00763451|7288171|FG003|Overall Study|Withdrawal by Subject|7
4487291|NCT00763451|7288168|FG000|Overall Study|Protocol Violation|0
4487292|NCT00763451|7288169|FG001|Overall Study|Protocol Violation|0
4487293|NCT00763451|7288170|FG002|Overall Study|Protocol Violation|1
4487294|NCT00763451|7288171|FG003|Overall Study|Protocol Violation|0
4487295|NCT00763451|7288168|FG000|Overall Study|Poor Compliance to Protocol|1
4487296|NCT00763451|7288169|FG001|Overall Study|Poor Compliance to Protocol|1
4487297|NCT00763451|7288170|FG002|Overall Study|Poor Compliance to Protocol|2
4487298|NCT00763451|7288171|FG003|Overall Study|Poor Compliance to Protocol|2
4487299|NCT00763451|7288168|FG000|Overall Study|Familial and Personal Reasons|5
4487300|NCT00763451|7288169|FG001|Overall Study|Familial and Personal Reasons|3
4487301|NCT00763451|7288170|FG002|Overall Study|Familial and Personal Reasons|5
4487302|NCT00763451|7288171|FG003|Overall Study|Familial and Personal Reasons|4
4487303|NCT00763451|7288168|FG000|Overall Study|Randomized but not Treated|1
4487304|NCT00763451|7288169|FG001|Overall Study|Randomized but not Treated|1
4487305|NCT00763451|7288170|FG002|Overall Study|Randomized but not Treated|0
4487306|NCT00763451|7288171|FG003|Overall Study|Randomized but not Treated|0
4487307|NCT00763451|7288168|FG000|Overall Study|Study Site Reason|0
4487308|NCT00763451|7288169|FG001|Overall Study|Study Site Reason|1
4487309|NCT00763451|7288170|FG002|Overall Study|Study Site Reason|1
4487310|NCT00763451|7288171|FG003|Overall Study|Study Site Reason|1
4487311|NCT00763698|7288186|FG000|Overall Study|Unsuccessful Implant|5
4487312|NCT00763698|7288186|FG000|Overall Study|Death|4
4487313|NCT00763698|7288186|FG000|Overall Study|Withdrawal by Subject|1
4487314|NCT00763815|7288197|FG000|Overall Study|Adverse Event|14
4487315|NCT00763815|7288198|FG001|Overall Study|Adverse Event|29
4487316|NCT00763815|7288197|FG000|Overall Study|Lack of Efficacy|10
4487317|NCT00763815|7288198|FG001|Overall Study|Lack of Efficacy|11
4487318|NCT00763815|7288197|FG000|Overall Study|Poor Compliance to Protocol|6
4487319|NCT00763815|7288198|FG001|Overall Study|Poor Compliance to Protocol|6
4487320|NCT00763815|7288197|FG000|Overall Study|Lost to Follow-up|2
4487321|NCT00763815|7288198|FG001|Overall Study|Lost to Follow-up|4
4487322|NCT00763815|7288197|FG000|Overall Study|Early Termination|1
4487323|NCT00763815|7288198|FG001|Overall Study|Early Termination|0
4487324|NCT00763815|7288197|FG000|Overall Study|Familial and Personal Reasons|9
4487325|NCT00763815|7288198|FG001|Overall Study|Familial and Personal Reasons|16
4487326|NCT00763815|7288197|FG000|Overall Study|Physician Decision|1
4487327|NCT00763815|7288198|FG001|Overall Study|Physician Decision|0
4487328|NCT00763815|7288197|FG000|Overall Study|Withdrawal by Subject|7
4487329|NCT00763815|7288198|FG001|Overall Study|Withdrawal by Subject|12
4487330|NCT00763815|7288197|FG000|Overall Study|Protocol Violation|2
4487331|NCT00763815|7288198|FG001|Overall Study|Protocol Violation|5
4487332|NCT00763815|7288197|FG000|Overall Study|Sponsor's Decision|0
4487333|NCT00763815|7288198|FG001|Overall Study|Sponsor's Decision|1
4487334|NCT00763958|7288219|FG000|Overall Study|did not meet final criteria|4
4487335|NCT00763958|7288220|FG001|Overall Study|did not meet final criteria|4
4487336|NCT00763958|7288219|FG000|Overall Study|Lost to Follow-up|10
4487337|NCT00763958|7288220|FG001|Overall Study|Lost to Follow-up|2
4487338|NCT00763958|7288219|FG000|Overall Study|Believed they were receiving placebo|0
4487339|NCT00763958|7288220|FG001|Overall Study|Believed they were receiving placebo|5
4487340|NCT00763971|7288230|FG000|Overall Study|Adverse Event|5
4487341|NCT00763971|7288231|FG001|Overall Study|Adverse Event|2
4487342|NCT00763971|7288232|FG002|Overall Study|Adverse Event|4
4487343|NCT00763971|7288230|FG000|Overall Study|Protocol Violation|3
4487344|NCT00763971|7288231|FG001|Overall Study|Protocol Violation|3
4487345|NCT00763971|7288232|FG002|Overall Study|Protocol Violation|2
4487346|NCT00763971|7288230|FG000|Overall Study|Withdrawal by Subject|4
4487347|NCT00763971|7288231|FG001|Overall Study|Withdrawal by Subject|5
4487348|NCT00763971|7288232|FG002|Overall Study|Withdrawal by Subject|5
4487349|NCT00763971|7288230|FG000|Overall Study|Lost to Follow-up|0
4701311|NCT02708095|7618133|FG001|Overall Study|Lack of Efficacy|3
4701312|NCT02708095|7618134|FG002|Overall Study|Lack of Efficacy|0
4701313|NCT02708095|7618132|FG000|Overall Study|Lost to Follow-up|2
4701314|NCT02708095|7618133|FG001|Overall Study|Lost to Follow-up|0
4701315|NCT02708095|7618134|FG002|Overall Study|Lost to Follow-up|0
4701316|NCT02708095|7618132|FG000|Overall Study|Physician Decision|2
4701317|NCT02708095|7618133|FG001|Overall Study|Physician Decision|3
4701318|NCT02708095|7618134|FG002|Overall Study|Physician Decision|2
4701319|NCT02708095|7618132|FG000|Overall Study|Protocol Violation|0
4701320|NCT02708095|7618133|FG001|Overall Study|Protocol Violation|0
4701321|NCT02708095|7618134|FG002|Overall Study|Protocol Violation|1
4701322|NCT02708095|7618132|FG000|Overall Study|Withdrawal by Subject|5
4701323|NCT02708095|7618133|FG001|Overall Study|Withdrawal by Subject|3
4701324|NCT02708095|7618134|FG002|Overall Study|Withdrawal by Subject|4
4701325|NCT02708121|7618146|FG000|Overall Study|Withdrawn by Study Team|1
4701326|NCT02708121|7618147|FG001|Overall Study|Withdrawn by Study Team|1
4701327|NCT02708121|7618146|FG000|Overall Study|Withdrawal by Subject|0
4701328|NCT02708121|7618147|FG001|Overall Study|Withdrawal by Subject|4
4701329|NCT02708277|7618190|FG000|Overall Study|Lost to Follow-up|7
4701330|NCT02708277|7618191|FG001|Overall Study|Lost to Follow-up|4
4701331|NCT02708355|7618209|FG000|Overall Study|Adverse Event|1
4701332|NCT02708355|7618210|FG001|Overall Study|Adverse Event|0
4701333|NCT02708355|7618211|FG002|Overall Study|Adverse Event|0
4701334|NCT02708485|7618228|FG000|Overall Study|Withdrawal by Subject|3
4487350|NCT00763971|7288231|FG001|Overall Study|Lost to Follow-up|1
4487351|NCT00763971|7288232|FG002|Overall Study|Lost to Follow-up|0
4487352|NCT00763971|7288230|FG000|Overall Study|Lack of Efficacy|11
4487353|NCT00763971|7288231|FG001|Overall Study|Lack of Efficacy|22
4487354|NCT00763971|7288232|FG002|Overall Study|Lack of Efficacy|54
4487355|NCT00763971|7288230|FG000|Overall Study|Unable to swallow capsule|2
4487356|NCT00763971|7288231|FG001|Overall Study|Unable to swallow capsule|1
4487357|NCT00763971|7288232|FG002|Overall Study|Unable to swallow capsule|1
4487358|NCT00763971|7288230|FG000|Overall Study|Personal reason|3
4487359|NCT00763971|7288231|FG001|Overall Study|Personal reason|0
4487360|NCT00763971|7288232|FG002|Overall Study|Personal reason|0
4701335|NCT02708485|7618229|FG001|Overall Study|Withdrawal by Subject|2
4701336|NCT02708498|7618243|FG000|Overall Study|Death|20
4701337|NCT02708498|7618244|FG001|Overall Study|Death|19
4701338|NCT02708498|7618245|FG002|Overall Study|Death|0
4487361|NCT00763971|7288230|FG000|Overall Study|Exclusion criteria met|1
4487362|NCT00763971|7288231|FG001|Overall Study|Exclusion criteria met|0
4487363|NCT00763971|7288232|FG002|Overall Study|Exclusion criteria met|0
4487364|NCT00763971|7288230|FG000|Overall Study|Sponsor decision|1
4487365|NCT00763971|7288231|FG001|Overall Study|Sponsor decision|0
4487366|NCT00763971|7288232|FG002|Overall Study|Sponsor decision|0
4487367|NCT00763971|7288230|FG000|Overall Study|Due to holiday season|2
4487368|NCT00763971|7288231|FG001|Overall Study|Due to holiday season|0
4487369|NCT00763971|7288232|FG002|Overall Study|Due to holiday season|1
4487370|NCT00763971|7288230|FG000|Overall Study|Randomization error|0
4487371|NCT00763971|7288231|FG001|Overall Study|Randomization error|0
4487372|NCT00763971|7288232|FG002|Overall Study|Randomization error|1
4487373|NCT00763971|7288230|FG000|Overall Study|Medical monitor decision|0
4487374|NCT00763971|7288231|FG001|Overall Study|Medical monitor decision|0
4487375|NCT00763971|7288232|FG002|Overall Study|Medical monitor decision|1
4487376|NCT00763971|7288230|FG000|Overall Study|Moved to another country|0
4487377|NCT00763971|7288231|FG001|Overall Study|Moved to another country|1
4487378|NCT00763971|7288232|FG002|Overall Study|Moved to another country|0
4487379|NCT00763971|7288230|FG000|Overall Study|Subject wanted dose reduction|0
4487380|NCT00763971|7288231|FG001|Overall Study|Subject wanted dose reduction|1
4487381|NCT00763971|7288232|FG002|Overall Study|Subject wanted dose reduction|0
4487382|NCT00763971|7288230|FG000|Overall Study|Lack of availability|0
4487383|NCT00763971|7288231|FG001|Overall Study|Lack of availability|1
4487384|NCT00763971|7288232|FG002|Overall Study|Lack of availability|0
4487385|NCT00763971|7288230|FG000|Overall Study|Performed final visit on phone|0
4487386|NCT00763971|7288231|FG001|Overall Study|Performed final visit on phone|1
4487387|NCT00763971|7288232|FG002|Overall Study|Performed final visit on phone|0
4487388|NCT00763971|7288230|FG000|Overall Study|Participation in 489-326 required|1
4487389|NCT00763971|7288231|FG001|Overall Study|Participation in 489-326 required|0
4487390|NCT00763971|7288232|FG002|Overall Study|Participation in 489-326 required|0
4487391|NCT00764322|7288246|FG000|Overall Study|Withdrawal by Subject|11
4487392|NCT00764322|7288246|FG000|Overall Study|No CYP2D6 genotyping|9
4487393|NCT00764361|7288265|FG000|Overall Study|Withdrawal by Subject|2
4487394|NCT00764361|7288266|FG001|Overall Study|Withdrawal by Subject|3
4487395|NCT00764361|7288265|FG000|Overall Study|Adverse Event|0
4487396|NCT00764361|7288266|FG001|Overall Study|Adverse Event|1
4487397|NCT00764465|7288278|FG000|Overall Study|Adverse Event|2
4487398|NCT00764465|7288279|FG001|Overall Study|Adverse Event|0
4487399|NCT00764465|7288280|FG002|Overall Study|Adverse Event|0
4487400|NCT00764465|7288281|FG003|Overall Study|Adverse Event|1
4487401|NCT00764465|7288282|FG004|Overall Study|Adverse Event|1
4701339|NCT02708498|7618246|FG003|Overall Study|Death|0
4701340|NCT02708498|7618247|FG004|Overall Study|Death|1
4701341|NCT02708498|7618248|FG005|Overall Study|Death|0
4701342|NCT02708498|7618249|FG006|Overall Study|Death|0
4701343|NCT02708498|7618250|FG007|Overall Study|Death|0
4701344|NCT02708498|7618243|FG000|Overall Study|Unknown reason, missing data|0
4701345|NCT02708498|7618244|FG001|Overall Study|Unknown reason, missing data|0
4701346|NCT02708498|7618245|FG002|Overall Study|Unknown reason, missing data|62
4701347|NCT02708498|7618246|FG003|Overall Study|Unknown reason, missing data|51
4701348|NCT02708498|7618247|FG004|Overall Study|Unknown reason, missing data|195
4701349|NCT02708498|7618248|FG005|Overall Study|Unknown reason, missing data|132
4701350|NCT02708498|7618249|FG006|Overall Study|Unknown reason, missing data|0
4701351|NCT02708498|7618250|FG007|Overall Study|Unknown reason, missing data|0
4701352|NCT02708524|7618270|FG000|Overall Study|Adverse Event|0
4701353|NCT02708524|7618271|FG001|Overall Study|Adverse Event|1
4701354|NCT02708524|7618272|FG002|Overall Study|Adverse Event|0
4701355|NCT02708524|7618273|FG003|Overall Study|Adverse Event|0
4701356|NCT02708524|7618270|FG000|Overall Study|Lens Discomfort|1
4701357|NCT02708524|7618271|FG001|Overall Study|Lens Discomfort|0
4701358|NCT02708524|7618272|FG002|Overall Study|Lens Discomfort|1
4701359|NCT02708524|7618273|FG003|Overall Study|Lens Discomfort|0
4701360|NCT02708524|7618270|FG000|Overall Study|Lost to Follow-up|1
4701361|NCT02708524|7618271|FG001|Overall Study|Lost to Follow-up|1
4701362|NCT02708524|7618272|FG002|Overall Study|Lost to Follow-up|1
4701363|NCT02708524|7618273|FG003|Overall Study|Lost to Follow-up|0
4701364|NCT02708524|7618270|FG000|Overall Study|Protocol Violation|0
4701365|NCT02708524|7618271|FG001|Overall Study|Protocol Violation|1
4701366|NCT02708524|7618272|FG002|Overall Study|Protocol Violation|0
4701367|NCT02708524|7618273|FG003|Overall Study|Protocol Violation|0
4701368|NCT02708524|7618270|FG000|Overall Study|Withdrawal by Subject|1
4701369|NCT02708524|7618271|FG001|Overall Study|Withdrawal by Subject|1
4487402|NCT00764465|7288283|FG005|Overall Study|Adverse Event|1
4487403|NCT00764465|7288278|FG000|Overall Study|Withdrawal by Subject|0
4487404|NCT00764465|7288279|FG001|Overall Study|Withdrawal by Subject|1
4487405|NCT00764465|7288280|FG002|Overall Study|Withdrawal by Subject|1
4487406|NCT00764465|7288281|FG003|Overall Study|Withdrawal by Subject|0
4487407|NCT00764465|7288282|FG004|Overall Study|Withdrawal by Subject|0
4487408|NCT00764465|7288283|FG005|Overall Study|Withdrawal by Subject|0
4701370|NCT02708524|7618272|FG002|Overall Study|Withdrawal by Subject|0
4701371|NCT02708524|7618273|FG003|Overall Study|Withdrawal by Subject|0
4487409|NCT00764491|7288302|FG000|Overall Study|Lost to Follow-up|35
4487410|NCT00764491|7288303|FG001|Overall Study|Lost to Follow-up|17
4487411|NCT00764504|7288312|FG000|Overall Study|Death|12
4487412|NCT00764504|7288313|FG001|Overall Study|Death|6
4487413|NCT00764504|7288314|FG002|Overall Study|Death|13
4487414|NCT00764504|7288312|FG000|Overall Study|Revision of Device|12
4487415|NCT00764504|7288313|FG001|Overall Study|Revision of Device|23
4487416|NCT00764504|7288314|FG002|Overall Study|Revision of Device|14
4487417|NCT00764504|7288312|FG000|Overall Study|Physician Decision|1
4487418|NCT00764504|7288313|FG001|Overall Study|Physician Decision|0
4487419|NCT00764504|7288314|FG002|Overall Study|Physician Decision|0
4487420|NCT00764504|7288312|FG000|Overall Study|Withdrawal by Subject|1
4487421|NCT00764504|7288313|FG001|Overall Study|Withdrawal by Subject|7
4487422|NCT00764504|7288314|FG002|Overall Study|Withdrawal by Subject|4
4487423|NCT00764504|7288312|FG000|Overall Study|Lost to Follow-up|40
4487424|NCT00764504|7288313|FG001|Overall Study|Lost to Follow-up|34
4487425|NCT00764504|7288314|FG002|Overall Study|Lost to Follow-up|72
4487426|NCT00764517|7288324|FG000|Overall Study|Adverse Event|9
4487427|NCT00764517|7288325|FG001|Overall Study|Adverse Event|3
4487428|NCT00764517|7288324|FG000|Overall Study|Death|3
4487429|NCT00764517|7288325|FG001|Overall Study|Death|11
4487430|NCT00764517|7288324|FG000|Overall Study|Physician Decision|3
4487431|NCT00764517|7288325|FG001|Overall Study|Physician Decision|0
4487432|NCT00764660|7288333|FG000|Overall Study|Adverse Event|6
4487433|NCT00764660|7288334|FG001|Overall Study|Adverse Event|3
4487434|NCT00764660|7288333|FG000|Overall Study|Lost to Follow-up|3
4487435|NCT00764660|7288334|FG001|Overall Study|Lost to Follow-up|4
4487436|NCT00764660|7288333|FG000|Overall Study|Withdrawal by Subject|7
4487437|NCT00764660|7288334|FG001|Overall Study|Withdrawal by Subject|3
4487438|NCT00764660|7288333|FG000|Overall Study|Noncompliance With Protocol|5
4487439|NCT00764660|7288334|FG001|Overall Study|Noncompliance With Protocol|1
4487440|NCT00764660|7288333|FG000|Overall Study|Did Not Meet Protocol Eligibility|1
4487441|NCT00764660|7288334|FG001|Overall Study|Did Not Meet Protocol Eligibility|0
4487442|NCT00764673|7288340|FG000|Overall Study|Death|1
4487443|NCT00764673|7288340|FG000|Overall Study|Lost to Follow-up|3
4487444|NCT00764673|7288340|FG000|Overall Study|Withdrawal by Subject|6
4487445|NCT00764673|7288340|FG000|Overall Study|Revision of Device|2
4487446|NCT00764751|7288363|FG000|Overall Study|Adverse Event|1
4487447|NCT00764751|7288364|FG001|Overall Study|Adverse Event|1
4487448|NCT00764751|7288363|FG000|Overall Study|Psoriasis flare up on the scalp|1
4487449|NCT00764751|7288364|FG001|Overall Study|Psoriasis flare up on the scalp|0
4487450|NCT00764790|7288378|FG000|Overall Study|Protocol Violation|0
4487451|NCT00764790|7288379|FG001|Overall Study|Protocol Violation|0
4487452|NCT00764790|7288380|FG002|Overall Study|Protocol Violation|1
4487453|NCT00764790|7288378|FG000|Overall Study|Withdrawal by Subject|10
4487454|NCT00764790|7288379|FG001|Overall Study|Withdrawal by Subject|12
4487455|NCT00764790|7288380|FG002|Overall Study|Withdrawal by Subject|6
4487456|NCT00764790|7288378|FG000|Overall Study|Lost to Follow-up|28
4487457|NCT00764790|7288379|FG001|Overall Study|Lost to Follow-up|29
4487458|NCT00764790|7288380|FG002|Overall Study|Lost to Follow-up|23
4487459|NCT00764868|7288388|FG000|Overall Study|Adverse Event|18
4487460|NCT00764868|7288388|FG000|Overall Study|Withdrawal by Subject|31
4487461|NCT00764868|7288388|FG000|Overall Study|Non-compliance|16
4487462|NCT00764868|7288388|FG000|Overall Study|Lost to Follow-up|25
4487463|NCT00764868|7288388|FG000|Overall Study|Lack of Efficacy|5
4487464|NCT00764868|7288388|FG000|Overall Study|Subject moved|7
4487465|NCT00764868|7288388|FG000|Overall Study|Pregnancy|3
4487466|NCT00764868|7288388|FG000|Overall Study|Prohibited medication|1
4487467|NCT00764868|7288388|FG000|Overall Study|Out of town|1
4487468|NCT00764868|7288388|FG000|Overall Study|Misuse and compliance of study drug|1
4487469|NCT00764868|7288388|FG000|Overall Study|Subject sent to boarding school|1
4487470|NCT00764868|7288388|FG000|Overall Study|Met an exclusion criteria|1
4487471|NCT00764868|7288388|FG000|Overall Study|Positive drug screen|2
4487472|NCT00764868|7288388|FG000|Overall Study|Sponsor requested withdrawal|1
4487473|NCT00764881|7288394|FG000|Overall Study|Adverse Event|5
4487474|NCT00764881|7288395|FG001|Overall Study|Adverse Event|1
4487475|NCT00764881|7288394|FG000|Overall Study|Withdrawal by Subject|1
4487476|NCT00764881|7288395|FG001|Overall Study|Withdrawal by Subject|3
4701372|NCT02708524|7618270|FG000|Overall Study|Dispensed incorrect study lens|0
4701373|NCT02708524|7618271|FG001|Overall Study|Dispensed incorrect study lens|1
4701374|NCT02708524|7618272|FG002|Overall Study|Dispensed incorrect study lens|1
4701375|NCT02708524|7618273|FG003|Overall Study|Dispensed incorrect study lens|0
4487477|NCT00764881|7288394|FG000|Overall Study|Protocol Violation|2
4487478|NCT00764881|7288395|FG001|Overall Study|Protocol Violation|2
4487479|NCT00764881|7288394|FG000|Overall Study|Lost to Follow-up|2
4487480|NCT00764881|7288395|FG001|Overall Study|Lost to Follow-up|0
4487481|NCT00764881|7288394|FG000|Overall Study|Noncompliant|1
4487482|NCT00764881|7288395|FG001|Overall Study|Noncompliant|0
4487483|NCT00764881|7288394|FG000|Overall Study|Accidentally discontinued study drug|1
4487484|NCT00764881|7288395|FG001|Overall Study|Accidentally discontinued study drug|0
4487485|NCT00764881|7288394|FG000|Overall Study|Wished to become pregnant|1
4487486|NCT00764881|7288395|FG001|Overall Study|Wished to become pregnant|0
4487487|NCT00764881|7288394|FG000|Overall Study|Carcinoma detected|1
4487488|NCT00764881|7288395|FG001|Overall Study|Carcinoma detected|0
4737568|NCT03614078|7687790|FG000|Overall Study|High Neutrophils|0
4487489|NCT00764881|7288394|FG000|Overall Study|Possibly noncompliant (study drug)|0
4590140|NCT01518699|7435818|FG004|Period 2|Protocol Violation|0
4590141|NCT01518699|7435819|FG005|Period 2|Protocol Violation|0
4590142|NCT01518699|7435814|FG000|Period 2|Lost to Follow-up|0
4590143|NCT01518699|7435815|FG001|Period 2|Lost to Follow-up|1
4590144|NCT01518699|7435816|FG002|Period 2|Lost to Follow-up|0
4590145|NCT01518699|7435817|FG003|Period 2|Lost to Follow-up|0
4590146|NCT01518699|7435818|FG004|Period 2|Lost to Follow-up|0
4590147|NCT01518699|7435819|FG005|Period 2|Lost to Follow-up|0
4590148|NCT01518699|7435814|FG000|Period 2|Adverse Event|1
4590149|NCT01518699|7435815|FG001|Period 2|Adverse Event|0
4590150|NCT01518699|7435816|FG002|Period 2|Adverse Event|0
4590151|NCT01518699|7435817|FG003|Period 2|Adverse Event|0
4590152|NCT01518699|7435818|FG004|Period 2|Adverse Event|0
4701376|NCT02708524|7618270|FG000|Overall Study|Did not wear lens at final visit|0
4701377|NCT02708524|7618271|FG001|Overall Study|Did not wear lens at final visit|1
4701378|NCT02708524|7618272|FG002|Overall Study|Did not wear lens at final visit|0
4701379|NCT02708524|7618273|FG003|Overall Study|Did not wear lens at final visit|0
4487490|NCT00764881|7288395|FG001|Overall Study|Possibly noncompliant (study drug)|2
4590153|NCT01518699|7435819|FG005|Period 2|Adverse Event|0
4590154|NCT01518946|7435836|FG000|Open-label Phase|Other|4
4590155|NCT01518946|7435837|FG001|Open-label Phase|Other|0
4590156|NCT01518946|7435838|FG002|Open-label Phase|Other|0
4590157|NCT01518946|7435836|FG000|Randomized Phase (First Intervention)|Other|0
4590158|NCT01518946|7435837|FG001|Randomized Phase (First Intervention)|Other|1
4590159|NCT01518946|7435838|FG002|Randomized Phase (First Intervention)|Other|0
4590160|NCT01518972|7435847|FG000|Overall Study|Lost to Follow-up|2
4590161|NCT01518972|7435848|FG001|Overall Study|Lost to Follow-up|1
4590162|NCT01518972|7435847|FG000|Overall Study|Withdrawal by Subject|1
4590163|NCT01518972|7435848|FG001|Overall Study|Withdrawal by Subject|0
4590164|NCT01518972|7435847|FG000|Overall Study|Moved from area|1
4590165|NCT01518972|7435848|FG001|Overall Study|Moved from area|0
4590166|NCT01518972|7435847|FG000|Overall Study|Transportation problems|1
4590167|NCT01518972|7435848|FG001|Overall Study|Transportation problems|0
4590168|NCT01518972|7435847|FG000|Overall Study|Exclusionary medical condition|1
4590169|NCT01518972|7435848|FG001|Overall Study|Exclusionary medical condition|0
4590170|NCT01518972|7435847|FG000|Overall Study|Missed safety visits|0
4590171|NCT01518972|7435848|FG001|Overall Study|Missed safety visits|1
4590172|NCT01518972|7435847|FG000|Overall Study|Exclusionary medication|0
4590173|NCT01518972|7435848|FG001|Overall Study|Exclusionary medication|1
4590174|NCT01518972|7435847|FG000|Overall Study|Declined medication starting on day 12|0
4590175|NCT01518972|7435848|FG001|Overall Study|Declined medication starting on day 12|1
4590176|NCT01519089|7435865|FG000|Overall Study|Adverse Event|4
4590177|NCT01519089|7435866|FG001|Overall Study|Adverse Event|4
4590178|NCT01519089|7435865|FG000|Overall Study|Lack of Efficacy|0
4590179|NCT01519089|7435866|FG001|Overall Study|Lack of Efficacy|2
4590180|NCT01519089|7435865|FG000|Overall Study|Lost to Follow-up|1
4590181|NCT01519089|7435866|FG001|Overall Study|Lost to Follow-up|0
4590182|NCT01519089|7435865|FG000|Overall Study|Withdrawal by Subject|0
4590183|NCT01519089|7435866|FG001|Overall Study|Withdrawal by Subject|2
4590184|NCT01519089|7435865|FG000|Overall Study|Other|2
4590185|NCT01519089|7435866|FG001|Overall Study|Other|6
4590186|NCT01519089|7435865|FG000|Overall Study|Not received study drug|0
4590187|NCT01519089|7435866|FG001|Overall Study|Not received study drug|1
4590188|NCT01519167|7435876|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0
4590189|NCT01519167|7435877|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3
4487491|NCT00764881|7288394|FG000|Overall Study|no treatment or no observation|2
4487492|NCT00764881|7288395|FG001|Overall Study|no treatment or no observation|2
4487493|NCT00764946|7288404|FG000|Overall Study|Lack of Efficacy|1
4487494|NCT00764946|7288405|FG001|Overall Study|Lack of Efficacy|0
4487495|NCT00764946|7288406|FG002|Overall Study|Lack of Efficacy|0
4487496|NCT00764946|7288404|FG000|Overall Study|Lost to Follow-up|3
4487497|NCT00764946|7288405|FG001|Overall Study|Lost to Follow-up|4
4487498|NCT00764946|7288406|FG002|Overall Study|Lost to Follow-up|0
4487499|NCT00764946|7288404|FG000|Overall Study|Physician Decision|2
4487500|NCT00764946|7288405|FG001|Overall Study|Physician Decision|4
4487501|NCT00764946|7288406|FG002|Overall Study|Physician Decision|0
4487502|NCT00764946|7288404|FG000|Overall Study|Adverse Event|3
4487503|NCT00764946|7288405|FG001|Overall Study|Adverse Event|2
4487504|NCT00764946|7288406|FG002|Overall Study|Adverse Event|1
4590190|NCT01519167|7435876|FG000|Overall Study|Adverse Event|0
4590191|NCT01519167|7435877|FG001|Overall Study|Adverse Event|1
4590192|NCT01519167|7435876|FG000|Overall Study|Lack of Efficacy|0
4590193|NCT01519167|7435877|FG001|Overall Study|Lack of Efficacy|1
4590194|NCT01519167|7435876|FG000|Overall Study|Medical condition changes&deep sedation|0
4626392|NCT01839656|7491941|FG000|Overall Study|Adverse event, serious fatal|1
4701380|NCT02708524|7618270|FG000|Overall Study|Subject lost study lens|1
4590195|NCT01519167|7435877|FG001|Overall Study|Medical condition changes&deep sedation|2
4487505|NCT00764946|7288404|FG000|Overall Study|Withdrawal by Subject|3
4487506|NCT00764946|7288405|FG001|Overall Study|Withdrawal by Subject|6
4590196|NCT01519167|7435876|FG000|Overall Study|Physician Decision|0
4590197|NCT01519167|7435877|FG001|Overall Study|Physician Decision|1
4590198|NCT01519206|7435883|FG000|Overall Study|Lost to Follow-up|3
4590199|NCT01519206|7435883|FG000|Overall Study|Missed Visit|2
4487507|NCT00764946|7288406|FG002|Overall Study|Withdrawal by Subject|2
4487508|NCT00764946|7288404|FG000|Overall Study|Never Treated|1
4487509|NCT00764946|7288405|FG001|Overall Study|Never Treated|1
4487510|NCT00764946|7288406|FG002|Overall Study|Never Treated|1
4487511|NCT00765037|7288420|FG000|Overall Study|Lost to Follow-up|5
4487512|NCT00765037|7288420|FG000|Overall Study|Adverse Event|1
4487513|NCT00765063|7288424|FG000|Overall Study|Lack of Efficacy|5
4487514|NCT00765063|7288424|FG000|Overall Study|Withdrawal by Subject|1
4487515|NCT00765063|7288424|FG000|Overall Study|Other|16
4487516|NCT00765063|7288424|FG000|Overall Study|Protocol Violation|6
4487517|NCT00765063|7288424|FG000|Overall Study|Adverse Event|4
4487518|NCT00765076|7288431|FG000|Overall Study|Adverse Event|1
4487519|NCT00765076|7288432|FG001|Overall Study|Adverse Event|0
4487520|NCT00765076|7288433|FG002|Overall Study|Adverse Event|0
4487521|NCT00765076|7288431|FG000|Overall Study|Withdrawal by Subject|0
4487522|NCT00765076|7288432|FG001|Overall Study|Withdrawal by Subject|0
4487523|NCT00765076|7288433|FG002|Overall Study|Withdrawal by Subject|1
4487524|NCT00765102|7288441|FG000|Overall Study|Progressive disease|18
4487525|NCT00765102|7288441|FG000|Overall Study|Adverse Event|6
4487526|NCT00765102|7288441|FG000|Overall Study|Physician Decision|4
4487527|NCT00765102|7288441|FG000|Overall Study|Withdrawal by Subject|2
4487528|NCT00765102|7288441|FG000|Overall Study|Protocol Violation|1
4487529|NCT00765245|7288481|FG000|Overall Study|disease progression|3
4487530|NCT00765245|7288482|FG001|Overall Study|disease progression|2
4487531|NCT00765245|7288481|FG000|Overall Study|Withdrawal by Subject|3
4487532|NCT00765245|7288482|FG001|Overall Study|Withdrawal by Subject|0
4487533|NCT00765245|7288481|FG000|Overall Study|Adverse Event|5
4487534|NCT00765245|7288482|FG001|Overall Study|Adverse Event|0
4487535|NCT00765245|7288481|FG000|Overall Study|Physician Decision|1
4487536|NCT00765245|7288482|FG001|Overall Study|Physician Decision|0
4487537|NCT00765245|7288481|FG000|Overall Study|Death|1
4487538|NCT00765245|7288482|FG001|Overall Study|Death|0
4517248|NCT00965458|7329003|FG001|Overall Study|Withdrawal by Subject|1
4517249|NCT00965484|7329011|FG000|Overall Study|Protocol Violation|1
4517250|NCT00965484|7329011|FG000|Overall Study|Withdrawal by Subject|1
4517251|NCT00965497|7329015|FG000|Overall Study|Physician Decision|1
4517252|NCT00965523|7329019|FG000|Study 221|Progressive Disease|4
4517253|NCT00965523|7329019|FG000|Study 221|Physician Decision|3
4517254|NCT00965523|7329019|FG000|Study 224|Progressive Disease|5
4517255|NCT00965523|7329019|FG000|Study 224|Physician Decision|1
4517256|NCT00965562|7329026|FG000|Overall Study|Lost to Follow-up|1
4517257|NCT00965562|7329027|FG001|Overall Study|Lost to Follow-up|2
4517258|NCT00965562|7329028|FG002|Overall Study|Lost to Follow-up|3
4517259|NCT00965562|7329026|FG000|Overall Study|Withdrawal by Subject|2
4517260|NCT00965562|7329027|FG001|Overall Study|Withdrawal by Subject|2
4517261|NCT00965562|7329028|FG002|Overall Study|Withdrawal by Subject|0
4517262|NCT00965575|7329039|FG000|Overall Study|subject unwillingness to swallow study c|1
4517263|NCT00965575|7329040|FG001|Overall Study|subject unwillingness to swallow study c|0
4517264|NCT00965718|7329048|FG000|Overall Study|Withdrawal by Subject|4
4517265|NCT00965731|7329054|FG000|Overall Study|Death|0
4517266|NCT00965731|7329055|FG001|Overall Study|Death|4
4517267|NCT00965731|7329054|FG000|Overall Study|Withdrawal by Subject|0
4517268|NCT00965731|7329055|FG001|Overall Study|Withdrawal by Subject|1
4517269|NCT00965731|7329054|FG000|Overall Study|Other|7
4517270|NCT00965731|7329055|FG001|Overall Study|Other|15
4517271|NCT00965848|7329066|FG000|Overall Study|Protocol Violation|3
4517272|NCT00965848|7329067|FG001|Overall Study|Protocol Violation|0
4517273|NCT00965848|7329068|FG002|Overall Study|Protocol Violation|1
4517274|NCT00965848|7329066|FG000|Overall Study|Death|11
4517275|NCT00965848|7329067|FG001|Overall Study|Death|1
4517276|NCT00965848|7329068|FG002|Overall Study|Death|5
4517277|NCT00965848|7329066|FG000|Overall Study|Lost to Follow-up|0
4517278|NCT00965848|7329067|FG001|Overall Study|Lost to Follow-up|0
4517279|NCT00965848|7329068|FG002|Overall Study|Lost to Follow-up|1
4517280|NCT00965848|7329066|FG000|Overall Study|Withdrawal by Subject|1
4517281|NCT00965848|7329067|FG001|Overall Study|Withdrawal by Subject|0
4517282|NCT00965848|7329068|FG002|Overall Study|Withdrawal by Subject|0
4517283|NCT00965848|7329066|FG000|Overall Study|Indeterminate Clinical Outcome|2
4517284|NCT00965848|7329067|FG001|Overall Study|Indeterminate Clinical Outcome|0
4517285|NCT00965848|7329068|FG002|Overall Study|Indeterminate Clinical Outcome|1
4517286|NCT00965848|7329066|FG000|Overall Study|Not Clinically Evaluable|7
4517287|NCT00965848|7329067|FG001|Overall Study|Not Clinically Evaluable|1
4517288|NCT00965848|7329068|FG002|Overall Study|Not Clinically Evaluable|1
4517289|NCT00965848|7329066|FG000|Overall Study|Other|5
4517290|NCT00965848|7329067|FG001|Overall Study|Other|0
4517291|NCT00965848|7329068|FG002|Overall Study|Other|1
4517292|NCT00966264|7329112|FG000|Overall Study|Lost to Follow-up|4
4517293|NCT00966264|7329113|FG001|Overall Study|Lost to Follow-up|3
4517294|NCT00966277|7329121|FG000|Overall Study|Withdrawal by Subject|3
4517295|NCT00966277|7329122|FG001|Overall Study|Withdrawal by Subject|0
4517296|NCT00966277|7329121|FG000|Overall Study|Ineligible|1
4517297|NCT00966277|7329122|FG001|Overall Study|Ineligible|3
4517298|NCT00966277|7329121|FG000|Overall Study|Treatment Plan Changed|0
4517299|NCT00966277|7329122|FG001|Overall Study|Treatment Plan Changed|1
4517300|NCT00966355|7329131|FG000|Overall Study|non-variceal bleeding on endoscopy|68
4517301|NCT00966355|7329132|FG001|Overall Study|non-variceal bleeding on endoscopy|70
4487539|NCT00765336|7288490|FG000|Overall Study|Protocol Violation|4
4487540|NCT00765336|7288491|FG001|Overall Study|Protocol Violation|2
4487541|NCT00765336|7288490|FG000|Overall Study|Withdrawal by Subject|6
4487542|NCT00765336|7288491|FG001|Overall Study|Withdrawal by Subject|4
4487543|NCT00765336|7288490|FG000|Overall Study|Lost to Follow-up|7
4487544|NCT00765336|7288491|FG001|Overall Study|Lost to Follow-up|9
4487545|NCT00765336|7288490|FG000|Overall Study|Adverse Event|2
4487546|NCT00765336|7288491|FG001|Overall Study|Adverse Event|1
4487547|NCT00765362|7288497|FG000|Overall Study|Death|9
4487548|NCT00765362|7288497|FG000|Overall Study|Adverse Event|2
4487549|NCT00765362|7288497|FG000|Overall Study|Protocol Violation|18
4487550|NCT00765362|7288497|FG000|Overall Study|Withdrawal by Subject|13
4487551|NCT00765362|7288497|FG000|Overall Study|Lost to Follow-up|95
4487552|NCT00765388|7288507|FG000|Period 1|Lack of Efficacy|1
4487553|NCT00765388|7288508|FG001|Period 1|Lack of Efficacy|2
4487554|NCT00765388|7288507|FG000|Period 1|Lost to Follow-up|0
4487555|NCT00765388|7288508|FG001|Period 1|Lost to Follow-up|1
4487556|NCT00765388|7288507|FG000|Period 1|Herpes Zoster|0
4487557|NCT00765388|7288508|FG001|Period 1|Herpes Zoster|1
4487558|NCT00765388|7288507|FG000|Period 1|Hip operation|0
4487559|NCT00765388|7288508|FG001|Period 1|Hip operation|1
4487560|NCT00765674|7288545|FG000|Overall Study|Adverse Event|7
4487561|NCT00765674|7288546|FG001|Overall Study|Adverse Event|2
4487562|NCT00765674|7288547|FG002|Overall Study|Adverse Event|8
4487563|NCT00765674|7288548|FG003|Overall Study|Adverse Event|11
4487564|NCT00765674|7288545|FG000|Overall Study|Abnormal Laboratory Value(s)|0
4487565|NCT00765674|7288546|FG001|Overall Study|Abnormal Laboratory Value(s)|0
4487566|NCT00765674|7288547|FG002|Overall Study|Abnormal Laboratory Value(s)|1
4487567|NCT00765674|7288548|FG003|Overall Study|Abnormal Laboratory Value(s)|0
4487568|NCT00765674|7288545|FG000|Overall Study|Abnormal Test Procedure Result(s)|1
4487569|NCT00765674|7288546|FG001|Overall Study|Abnormal Test Procedure Result(s)|3
4487570|NCT00765674|7288547|FG002|Overall Study|Abnormal Test Procedure Result(s)|1
4487571|NCT00765674|7288548|FG003|Overall Study|Abnormal Test Procedure Result(s)|2
4487572|NCT00765674|7288545|FG000|Overall Study|Lack of Efficacy|2
4487573|NCT00765674|7288546|FG001|Overall Study|Lack of Efficacy|3
4487574|NCT00765674|7288547|FG002|Overall Study|Lack of Efficacy|1
4487575|NCT00765674|7288548|FG003|Overall Study|Lack of Efficacy|2
4487576|NCT00765674|7288545|FG000|Overall Study|Protocol Violation|2
4487577|NCT00765674|7288546|FG001|Overall Study|Protocol Violation|0
4487578|NCT00765674|7288547|FG002|Overall Study|Protocol Violation|1
4487579|NCT00765674|7288548|FG003|Overall Study|Protocol Violation|0
4487580|NCT00765674|7288545|FG000|Overall Study|Withdrawal by Subject|5
4487581|NCT00765674|7288546|FG001|Overall Study|Withdrawal by Subject|7
4487582|NCT00765674|7288547|FG002|Overall Study|Withdrawal by Subject|3
4487583|NCT00765674|7288548|FG003|Overall Study|Withdrawal by Subject|8
4487584|NCT00765674|7288545|FG000|Overall Study|Lost to Follow-up|4
4487585|NCT00765674|7288546|FG001|Overall Study|Lost to Follow-up|6
4487586|NCT00765674|7288547|FG002|Overall Study|Lost to Follow-up|2
4487587|NCT00765674|7288548|FG003|Overall Study|Lost to Follow-up|1
4701381|NCT02708524|7618271|FG001|Overall Study|Subject lost study lens|0
4701382|NCT02708524|7618272|FG002|Overall Study|Subject lost study lens|0
4701383|NCT02708524|7618273|FG003|Overall Study|Subject lost study lens|0
4701384|NCT02708966|7618315|FG000|Overall Study|Lost to Follow-up|2
4701385|NCT02708966|7618316|FG001|Overall Study|Lost to Follow-up|2
4701386|NCT02709005|7618324|FG000|Overall Study|Lost to Follow-up|1
4701387|NCT02709005|7618325|FG001|Overall Study|Lost to Follow-up|1
4701388|NCT02709005|7618324|FG000|Overall Study|Withdrawal by Subject|3
4487588|NCT00765674|7288545|FG000|Overall Study|Randomized in Error - No Study Drug|0
4487589|NCT00765674|7288546|FG001|Overall Study|Randomized in Error - No Study Drug|1
4487590|NCT00765674|7288547|FG002|Overall Study|Randomized in Error - No Study Drug|0
4487591|NCT00765674|7288548|FG003|Overall Study|Randomized in Error - No Study Drug|1
4487592|NCT00765726|7288558|FG000|Overall Study|Withdrawal by Subject|1
4487593|NCT00765726|7288558|FG000|Overall Study|Discontinuation of study by sponsor|8
4487594|NCT00765817|7288564|FG000|Overall Study|Adverse Event|13
4487595|NCT00765817|7288565|FG001|Overall Study|Adverse Event|1
4487596|NCT00765817|7288564|FG000|Overall Study|Death|0
4487597|NCT00765817|7288565|FG001|Overall Study|Death|1
4487598|NCT00765817|7288564|FG000|Overall Study|Entry criteria not met|2
4701389|NCT02709005|7618325|FG001|Overall Study|Withdrawal by Subject|0
4701390|NCT02709096|7618344|FG000|Overall Study|non-compliance|1
4701391|NCT02709096|7618345|FG001|Overall Study|non-compliance|1
4701392|NCT02709109|7618355|FG000|Treatment Period 1 (28 Days)|Adverse Event|3
4701393|NCT02709109|7618356|FG001|Treatment Period 1 (28 Days)|Adverse Event|3
4701394|NCT02709109|7618357|FG002|Treatment Period 1 (28 Days)|Adverse Event|1
4701395|NCT02709109|7618358|FG003|Treatment Period 1 (28 Days)|Adverse Event|0
4701396|NCT02709109|7618355|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0
4701397|NCT02709109|7618356|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2
4737569|NCT03614078|7687791|FG001|Overall Study|High Neutrophils|0
4487599|NCT00765817|7288565|FG001|Overall Study|Entry criteria not met|2
4487600|NCT00765817|7288564|FG000|Overall Study|Loss of glucose control|0
4487601|NCT00765817|7288565|FG001|Overall Study|Loss of glucose control|2
4487602|NCT00765817|7288564|FG000|Overall Study|Lost to Follow-up|1
4487603|NCT00765817|7288565|FG001|Overall Study|Lost to Follow-up|3
4487604|NCT00765817|7288564|FG000|Overall Study|Physician Decision|2
4701398|NCT02709109|7618357|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0
4701399|NCT02709109|7618358|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0
4701400|NCT02709109|7618355|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1
4701401|NCT02709109|7618356|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0
4701402|NCT02709109|7618357|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0
4701403|NCT02709109|7618358|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0
4701404|NCT02709109|7618355|FG000|Washout Period (28 Days)|Other|2
4701405|NCT02709109|7618356|FG001|Washout Period (28 Days)|Other|2
4701406|NCT02709109|7618357|FG002|Washout Period (28 Days)|Other|3
4701407|NCT02709109|7618358|FG003|Washout Period (28 Days)|Other|0
4701408|NCT02709109|7618355|FG000|Treatment Period 2 (28 Days)|Adverse Event|2
4701409|NCT02709109|7618356|FG001|Treatment Period 2 (28 Days)|Adverse Event|3
4701410|NCT02709109|7618357|FG002|Treatment Period 2 (28 Days)|Adverse Event|0
4701411|NCT02709109|7618358|FG003|Treatment Period 2 (28 Days)|Adverse Event|0
4701412|NCT02709109|7618355|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0
4701413|NCT02709109|7618356|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1
4701414|NCT02709109|7618357|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1
4701415|NCT02709109|7618358|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0
4701416|NCT02709109|7618355|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0
4701417|NCT02709109|7618356|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0
4701418|NCT02709109|7618357|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1
4487605|NCT00765817|7288565|FG001|Overall Study|Physician Decision|1
4487606|NCT00765817|7288564|FG000|Overall Study|Protocol Violation|1
4487607|NCT00765817|7288565|FG001|Overall Study|Protocol Violation|1
4487608|NCT00765817|7288564|FG000|Overall Study|Subject decision|7
4487609|NCT00765817|7288565|FG001|Overall Study|Subject decision|11
4487610|NCT00765843|7288574|FG000|Overall Study|Lost to Follow-up|1
4487611|NCT00765843|7288575|FG001|Overall Study|Lost to Follow-up|3
4487612|NCT00765843|7288576|FG002|Overall Study|Lost to Follow-up|2
4487613|NCT00765843|7288574|FG000|Overall Study|did not return to receive intervention|0
4487614|NCT00765843|7288575|FG001|Overall Study|did not return to receive intervention|1
4487615|NCT00765843|7288576|FG002|Overall Study|did not return to receive intervention|0
4487616|NCT00765843|7288574|FG000|Overall Study|Adverse Event|0
4487617|NCT00765843|7288575|FG001|Overall Study|Adverse Event|0
4487618|NCT00765843|7288576|FG002|Overall Study|Adverse Event|1
4487619|NCT00765882|7288594|FG000|Overall Study|Adverse Event|10
4487620|NCT00765882|7288595|FG001|Overall Study|Adverse Event|21
4487621|NCT00765882|7288596|FG002|Overall Study|Adverse Event|20
4487622|NCT00765882|7288594|FG000|Overall Study|Lack of Efficacy|4
4487623|NCT00765882|7288595|FG001|Overall Study|Lack of Efficacy|0
4487624|NCT00765882|7288596|FG002|Overall Study|Lack of Efficacy|1
4487625|NCT00765882|7288594|FG000|Overall Study|Protocol Violation|4
4487626|NCT00765882|7288595|FG001|Overall Study|Protocol Violation|3
4487627|NCT00765882|7288596|FG002|Overall Study|Protocol Violation|1
4487628|NCT00765882|7288594|FG000|Overall Study|Withdrawal by Subject|2
4487629|NCT00765882|7288595|FG001|Overall Study|Withdrawal by Subject|6
4487630|NCT00765882|7288596|FG002|Overall Study|Withdrawal by Subject|6
4487631|NCT00765882|7288594|FG000|Overall Study|Lost to Follow-up|1
4487632|NCT00765882|7288595|FG001|Overall Study|Lost to Follow-up|9
4487633|NCT00765882|7288596|FG002|Overall Study|Lost to Follow-up|6
4487634|NCT00765882|7288594|FG000|Overall Study|Other Reason|3
4487635|NCT00765882|7288595|FG001|Overall Study|Other Reason|1
4487636|NCT00765882|7288596|FG002|Overall Study|Other Reason|2
4487637|NCT00765999|7288619|FG000|Overall Study|Adverse Event|203
4487638|NCT00765999|7288619|FG000|Overall Study|Insufficient Therapeutic Response|100
4487639|NCT00765999|7288619|FG000|Overall Study|Protocol Violation|95
4487640|NCT00765999|7288619|FG000|Overall Study|Consent Withdrawn|202
4487641|NCT00765999|7288619|FG000|Overall Study|Lost to Follow-up|131
4487642|NCT00765999|7288619|FG000|Overall Study|Study Terminated by Sponsor|2
4487643|NCT00765999|7288619|FG000|Overall Study|Other Miscellaneous Reasons|51
4487644|NCT00766038|7288627|FG000|Overall Study|Lost to Follow-up|15
4487645|NCT00766038|7288628|FG001|Overall Study|Lost to Follow-up|14
4487646|NCT00766051|7288638|FG000|Overall Study|Withdrawal by Subject|2
4487647|NCT00766051|7288639|FG001|Overall Study|Withdrawal by Subject|0
4487648|NCT00766090|7288649|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0
4487649|NCT00766090|7288650|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0
4487650|NCT00766090|7288651|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0
4487651|NCT00766090|7288652|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0
4487652|NCT00766090|7288653|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0
4487653|NCT00766090|7288654|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0
4487654|NCT00766090|7288655|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0
4487655|NCT00766090|7288656|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0
4487656|NCT00766090|7288657|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1
4487657|NCT00766090|7288658|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0
4487658|NCT00766090|7288659|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0
4487659|NCT00766090|7288660|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0
4487660|NCT00766090|7288649|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2
4487661|NCT00766090|7288650|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0
4487662|NCT00766090|7288651|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0
4487663|NCT00766090|7288652|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0
4487664|NCT00766090|7288653|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0
4487665|NCT00766090|7288654|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0
4487666|NCT00766090|7288655|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0
4487667|NCT00766090|7288656|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0
4487668|NCT00766090|7288657|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0
4487669|NCT00766090|7288658|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0
4487670|NCT00766090|7288659|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0
4487671|NCT00766090|7288660|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0
4487672|NCT00766090|7288649|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
4487673|NCT00766090|7288650|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4626393|NCT01839656|7491942|FG001|Overall Study|Adverse event, serious fatal|4
4626394|NCT01839656|7491941|FG000|Overall Study|Early study closure|0
4701419|NCT02709109|7618358|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0
4487674|NCT00766090|7288651|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4487675|NCT00766090|7288652|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
4487676|NCT00766090|7288653|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4487677|NCT00766090|7288654|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4487678|NCT00766090|7288655|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4487679|NCT00766090|7288656|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4487680|NCT00766090|7288657|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4487681|NCT00766090|7288658|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4487682|NCT00766090|7288659|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4487683|NCT00766090|7288660|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4487684|NCT00766090|7288649|FG000|Washout Period 1 (14 Days)|Protocol Violation|0
4487685|NCT00766090|7288650|FG001|Washout Period 1 (14 Days)|Protocol Violation|0
4487686|NCT00766090|7288651|FG002|Washout Period 1 (14 Days)|Protocol Violation|1
4487687|NCT00766090|7288652|FG003|Washout Period 1 (14 Days)|Protocol Violation|0
4487688|NCT00766090|7288653|FG004|Washout Period 1 (14 Days)|Protocol Violation|0
4487689|NCT00766090|7288654|FG005|Washout Period 1 (14 Days)|Protocol Violation|0
4487690|NCT00766090|7288655|FG006|Washout Period 1 (14 Days)|Protocol Violation|0
4487691|NCT00766090|7288656|FG007|Washout Period 1 (14 Days)|Protocol Violation|0
4487692|NCT00766090|7288657|FG008|Washout Period 1 (14 Days)|Protocol Violation|0
4487693|NCT00766090|7288658|FG009|Washout Period 1 (14 Days)|Protocol Violation|0
4487694|NCT00766090|7288659|FG010|Washout Period 1 (14 Days)|Protocol Violation|0
4487695|NCT00766090|7288660|FG011|Washout Period 1 (14 Days)|Protocol Violation|0
4487696|NCT00766090|7288649|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0
4487697|NCT00766090|7288650|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0
4487698|NCT00766090|7288651|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0
4487699|NCT00766090|7288652|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0
4487700|NCT00766090|7288653|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2
4487701|NCT00766090|7288654|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0
4487702|NCT00766090|7288655|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0
4487703|NCT00766090|7288656|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0
4487704|NCT00766090|7288657|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0
4487705|NCT00766090|7288658|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0
4487706|NCT00766090|7288659|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0
4487707|NCT00766090|7288660|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0
4487708|NCT00766090|7288649|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0
4487709|NCT00766090|7288650|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0
4487710|NCT00766090|7288651|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1
4487711|NCT00766090|7288652|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0
4487712|NCT00766090|7288653|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0
4487713|NCT00766090|7288654|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0
4487714|NCT00766090|7288655|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0
4487715|NCT00766090|7288656|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0
4487716|NCT00766090|7288657|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0
4487717|NCT00766090|7288658|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0
4487718|NCT00766090|7288659|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0
4626395|NCT01839656|7491942|FG001|Overall Study|Early study closure|11
4626396|NCT01839656|7491941|FG000|Overall Study|Adverse Event|1
4701420|NCT02709109|7618355|FG000|Treatment Period 2 (28 Days)|Other|0
4701421|NCT02709109|7618356|FG001|Treatment Period 2 (28 Days)|Other|0
4701422|NCT02709109|7618357|FG002|Treatment Period 2 (28 Days)|Other|1
4701423|NCT02709109|7618358|FG003|Treatment Period 2 (28 Days)|Other|0
4701424|NCT02709330|7618369|FG000|Overall Study|Death|5
4701425|NCT02709330|7618370|FG001|Overall Study|Death|0
4701426|NCT02709330|7618369|FG000|Overall Study|Lost to Follow-up|2
4626397|NCT01839656|7491942|FG001|Overall Study|Adverse Event|0
4626398|NCT01839916|7491970|FG000|Overall Study|Death|9
4626399|NCT01839916|7491970|FG000|Overall Study|Physician Decision|17
4626400|NCT01839916|7491970|FG000|Overall Study|Relapse|12
4626401|NCT01839916|7491970|FG000|Overall Study|GVHD|2
4626402|NCT01839916|7491970|FG000|Overall Study|Graft Failure|1
4626403|NCT01840163|7491987|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19
4626404|NCT01840163|7491988|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16
4487719|NCT00766090|7288660|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0
4487720|NCT00766090|7288649|FG000|Washout Period 2 (14 Days)|Physician Decision|0
4487721|NCT00766090|7288650|FG001|Washout Period 2 (14 Days)|Physician Decision|0
4487722|NCT00766090|7288651|FG002|Washout Period 2 (14 Days)|Physician Decision|1
4487723|NCT00766090|7288652|FG003|Washout Period 2 (14 Days)|Physician Decision|0
4487724|NCT00766090|7288653|FG004|Washout Period 2 (14 Days)|Physician Decision|0
4487725|NCT00766090|7288654|FG005|Washout Period 2 (14 Days)|Physician Decision|0
4487726|NCT00766090|7288655|FG006|Washout Period 2 (14 Days)|Physician Decision|0
4487727|NCT00766090|7288656|FG007|Washout Period 2 (14 Days)|Physician Decision|0
4487728|NCT00766090|7288657|FG008|Washout Period 2 (14 Days)|Physician Decision|0
4487729|NCT00766090|7288658|FG009|Washout Period 2 (14 Days)|Physician Decision|0
4487730|NCT00766090|7288659|FG010|Washout Period 2 (14 Days)|Physician Decision|0
4487731|NCT00766090|7288660|FG011|Washout Period 2 (14 Days)|Physician Decision|0
4387175|NCT00045942|7165716|FG006|PKC412A2104E2|Lost to Follow-up|0
4387176|NCT00045942|7165717|FG007|PKC412A2104E2|Lost to Follow-up|3
4387177|NCT00045942|7165718|FG008|PKC412A2104E2|Lost to Follow-up|0
4387178|NCT00045942|7165710|FG000|PKC412A2104E2|Withdrawal by Subject|0
4387179|NCT00045942|7165711|FG001|PKC412A2104E2|Withdrawal by Subject|0
4387180|NCT00045942|7165712|FG002|PKC412A2104E2|Withdrawal by Subject|0
4387181|NCT00045942|7165713|FG003|PKC412A2104E2|Withdrawal by Subject|0
4387182|NCT00045942|7165714|FG004|PKC412A2104E2|Withdrawal by Subject|0
4387183|NCT00045942|7165715|FG005|PKC412A2104E2|Withdrawal by Subject|1
4387184|NCT00045942|7165716|FG006|PKC412A2104E2|Withdrawal by Subject|0
4387185|NCT00045942|7165717|FG007|PKC412A2104E2|Withdrawal by Subject|1
4387186|NCT00045942|7165718|FG008|PKC412A2104E2|Withdrawal by Subject|0
4387187|NCT00045942|7165710|FG000|PKC412A2104E2|Lack of Efficacy|0
4387188|NCT00045942|7165711|FG001|PKC412A2104E2|Lack of Efficacy|0
4387189|NCT00045942|7165712|FG002|PKC412A2104E2|Lack of Efficacy|0
4387190|NCT00045942|7165713|FG003|PKC412A2104E2|Lack of Efficacy|0
4387191|NCT00045942|7165714|FG004|PKC412A2104E2|Lack of Efficacy|0
4387192|NCT00045942|7165715|FG005|PKC412A2104E2|Lack of Efficacy|3
4387193|NCT00045942|7165716|FG006|PKC412A2104E2|Lack of Efficacy|2
4387194|NCT00045942|7165717|FG007|PKC412A2104E2|Lack of Efficacy|2
4387195|NCT00045942|7165718|FG008|PKC412A2104E2|Lack of Efficacy|6
4387196|NCT00045942|7165710|FG000|PKC412A2104E2|Adverse Event|0
4387197|NCT00045942|7165711|FG001|PKC412A2104E2|Adverse Event|0
4387198|NCT00045942|7165712|FG002|PKC412A2104E2|Adverse Event|0
4701427|NCT02709330|7618370|FG001|Overall Study|Lost to Follow-up|0
4701428|NCT02709330|7618369|FG000|Overall Study|Physician Decision|2
4701429|NCT02709330|7618370|FG001|Overall Study|Physician Decision|0
4701430|NCT02709330|7618369|FG000|Overall Study|Withdrawal by Subject|4
4701431|NCT02709330|7618370|FG001|Overall Study|Withdrawal by Subject|0
4701432|NCT02709369|7618376|FG000|Overall Study|Lost to Follow-up|15
4701433|NCT02709369|7618376|FG000|Overall Study|Withdrawal by Subject|10
4701434|NCT02709369|7618376|FG000|Overall Study|Did not received intervention|2
4701435|NCT02709486|7618383|FG000|Overall Study|Adverse Event|2
4701436|NCT02709486|7618384|FG001|Overall Study|Adverse Event|5
4701437|NCT02709486|7618385|FG002|Overall Study|Adverse Event|3
4701438|NCT02709486|7618383|FG000|Overall Study|Death|0
4387199|NCT00045942|7165713|FG003|PKC412A2104E2|Adverse Event|0
4387200|NCT00045942|7165714|FG004|PKC412A2104E2|Adverse Event|0
4387201|NCT00045942|7165715|FG005|PKC412A2104E2|Adverse Event|4
4387202|NCT00045942|7165716|FG006|PKC412A2104E2|Adverse Event|3
4387203|NCT00045942|7165717|FG007|PKC412A2104E2|Adverse Event|1
4387204|NCT00045942|7165718|FG008|PKC412A2104E2|Adverse Event|0
4487732|NCT00766090|7288649|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0
4487733|NCT00766090|7288650|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0
4487734|NCT00766090|7288651|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0
4487735|NCT00766090|7288652|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0
4701439|NCT02709486|7618384|FG001|Overall Study|Death|0
4701440|NCT02709486|7618385|FG002|Overall Study|Death|2
4701441|NCT02709486|7618383|FG000|Overall Study|Insufficient clinical response|7
4701442|NCT02709486|7618384|FG001|Overall Study|Insufficient clinical response|3
4701443|NCT02709486|7618385|FG002|Overall Study|Insufficient clinical response|3
4701444|NCT02709486|7618383|FG000|Overall Study|Lost to Follow-up|3
4701445|NCT02709486|7618384|FG001|Overall Study|Lost to Follow-up|2
4701446|NCT02709486|7618385|FG002|Overall Study|Lost to Follow-up|2
4701447|NCT02709486|7618383|FG000|Overall Study|Other|0
4701448|NCT02709486|7618384|FG001|Overall Study|Other|2
4701449|NCT02709486|7618385|FG002|Overall Study|Other|3
4701450|NCT02709486|7618383|FG000|Overall Study|Withdrawal by Subject|32
4387205|NCT00045942|7165710|FG000|PKC412A2104E2|Death|0
4387206|NCT00045942|7165711|FG001|PKC412A2104E2|Death|0
4387207|NCT00045942|7165712|FG002|PKC412A2104E2|Death|0
4387208|NCT00045942|7165713|FG003|PKC412A2104E2|Death|0
4387209|NCT00045942|7165714|FG004|PKC412A2104E2|Death|0
4387210|NCT00045942|7165715|FG005|PKC412A2104E2|Death|1
4387211|NCT00045942|7165716|FG006|PKC412A2104E2|Death|2
4701451|NCT02709486|7618384|FG001|Overall Study|Withdrawal by Subject|22
4701452|NCT02709486|7618385|FG002|Overall Study|Withdrawal by Subject|32
4701453|NCT02709538|7618396|FG000|Overall Study|Adverse Event|13
4701454|NCT02709538|7618397|FG001|Overall Study|Adverse Event|2
4701455|NCT02709538|7618398|FG002|Overall Study|Adverse Event|3
4701456|NCT02709538|7618396|FG000|Overall Study|Lack of Efficacy|1
4487736|NCT00766090|7288653|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0
4487737|NCT00766090|7288654|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1
4487738|NCT00766090|7288655|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0
4487739|NCT00766090|7288656|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0
4487740|NCT00766090|7288657|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0
4487741|NCT00766090|7288658|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0
4487742|NCT00766090|7288659|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0
4487743|NCT00766090|7288660|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0
4487744|NCT00766090|7288649|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0
4487745|NCT00766090|7288650|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1
4487746|NCT00766090|7288651|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0
4487747|NCT00766090|7288652|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1
4487748|NCT00766090|7288653|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0
4487749|NCT00766090|7288654|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0
4487750|NCT00766090|7288655|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0
4487751|NCT00766090|7288656|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0
4487752|NCT00766090|7288657|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0
4487753|NCT00766090|7288658|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0
4487754|NCT00766090|7288659|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0
4487755|NCT00766090|7288660|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1
4487756|NCT00766090|7288649|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0
4487757|NCT00766090|7288650|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0
4487758|NCT00766090|7288651|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0
4487759|NCT00766090|7288652|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0
4487760|NCT00766090|7288653|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1
4487761|NCT00766090|7288654|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0
4487762|NCT00766090|7288655|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0
4487763|NCT00766090|7288656|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0
4487764|NCT00766090|7288657|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0
4487765|NCT00766090|7288658|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0
4487766|NCT00766090|7288659|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0
4487767|NCT00766090|7288660|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0
4487768|NCT00766142|7288681|FG000|Overall Study|Protocol Violation|4
4487769|NCT00766363|7288689|FG000|Overall Study|Withdrawal by Subject|1
4487770|NCT00766363|7288690|FG001|Overall Study|Withdrawal by Subject|0
4487771|NCT00766363|7288691|FG002|Overall Study|Withdrawal by Subject|0
4487772|NCT00766363|7288692|FG003|Overall Study|Withdrawal by Subject|0
4487773|NCT00766363|7288689|FG000|Overall Study|Adverse Event Prior to Randomization|0
4487774|NCT00766363|7288690|FG001|Overall Study|Adverse Event Prior to Randomization|1
4487775|NCT00766363|7288691|FG002|Overall Study|Adverse Event Prior to Randomization|0
4487776|NCT00766363|7288692|FG003|Overall Study|Adverse Event Prior to Randomization|0
4487777|NCT00766376|7288703|FG000|Overall Study|Withdrawal by Subject|27
4487778|NCT00766415|7288709|FG000|Overall Study|Withdrawal by Subject|0
4487779|NCT00766415|7288710|FG001|Overall Study|Withdrawal by Subject|1
4487780|NCT00766467|7288718|FG000|Overall Study|Withdrawal by Subject|7
4487781|NCT00766467|7288719|FG001|Overall Study|Withdrawal by Subject|2
4487782|NCT00766467|7288718|FG000|Overall Study|Adverse Event|1
4487783|NCT00766467|7288719|FG001|Overall Study|Adverse Event|1
4487784|NCT00766467|7288718|FG000|Overall Study|Protocol Violation|2
4487785|NCT00766467|7288719|FG001|Overall Study|Protocol Violation|4
4487786|NCT00766467|7288718|FG000|Overall Study|Tumor Progression on Study|0
4487787|NCT00766467|7288719|FG001|Overall Study|Tumor Progression on Study|1
4487788|NCT00766467|7288718|FG000|Overall Study|Physician Decision|1
4487789|NCT00766467|7288719|FG001|Overall Study|Physician Decision|0
4487790|NCT00766493|7288725|FG000|30 Days Post-Procedure|Discontinued|7
4487791|NCT00766493|7288725|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4
4487792|NCT00766493|7288725|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1
4487793|NCT00766506|7288731|FG000|Overall Study|Use rescue medication after 3 hours|3
4487794|NCT00766506|7288732|FG001|Overall Study|Use rescue medication after 3 hours|0
4487795|NCT00766506|7288731|FG000|Overall Study|Other|2
4487796|NCT00766506|7288732|FG001|Overall Study|Other|2
4487797|NCT00766532|7288738|FG000|Overall Study|Protocol Violation|2
4487798|NCT00766597|7288742|FG000|Overall Study|Unexpected closure of study|4
4487799|NCT00766597|7288742|FG000|Overall Study|Without CCR5-tropic virus|5
4487800|NCT00766675|7288752|FG000|Overall Study|Adverse Event|16
4487801|NCT00766675|7288752|FG000|Overall Study|Lost to Follow-up|2
4487802|NCT00766675|7288752|FG000|Overall Study|Withdrawal by Subject|11
4487803|NCT00766675|7288752|FG000|Overall Study|Protocol Violation|8
4487804|NCT00766675|7288752|FG000|Overall Study|Participant took prohibited medication|1
4487805|NCT00766675|7288752|FG000|Overall Study|Receive other anti-neoplastic treatment|1
4487806|NCT00766675|7288752|FG000|Overall Study|Insufficient therapy|1
4487807|NCT00766831|7288772|FG000|Overall Study|Withdrawal by Subject|4
4487808|NCT00766831|7288772|FG000|Overall Study|Lost to Follow-up|3
4487809|NCT00766831|7288772|FG000|Overall Study|Adverse Event|20
4487810|NCT00766831|7288772|FG000|Overall Study|Protocol Violation|15
4487811|NCT00766831|7288772|FG000|Overall Study|Physician Decision|5
4487812|NCT00766831|7288772|FG000|Overall Study|Withdrawal of consent|26
4487813|NCT00766831|7288772|FG000|Overall Study|Non cooperation by participants|14
4487814|NCT00766831|7288772|FG000|Overall Study|Other|28
4487815|NCT00767000|7288781|FG000|54-week Study|Adverse Event|4
4487816|NCT00767000|7288782|FG001|54-week Study|Adverse Event|6
4487817|NCT00767000|7288783|FG002|54-week Study|Adverse Event|6
4487818|NCT00767000|7288784|FG003|54-week Study|Adverse Event|8
4487819|NCT00767000|7288785|FG004|54-week Study|Adverse Event|4
4487820|NCT00767000|7288781|FG000|54-week Study|Creaninine/creatinine clearance|2
4487821|NCT00767000|7288782|FG001|54-week Study|Creaninine/creatinine clearance|1
4487822|NCT00767000|7288783|FG002|54-week Study|Creaninine/creatinine clearance|2
4487823|NCT00767000|7288784|FG003|54-week Study|Creaninine/creatinine clearance|2
4487824|NCT00767000|7288785|FG004|54-week Study|Creaninine/creatinine clearance|4
4487825|NCT00767000|7288781|FG000|54-week Study|Hyperglycemia|0
4487826|NCT00767000|7288782|FG001|54-week Study|Hyperglycemia|0
4487827|NCT00767000|7288783|FG002|54-week Study|Hyperglycemia|1
4487828|NCT00767000|7288784|FG003|54-week Study|Hyperglycemia|0
4487829|NCT00767000|7288785|FG004|54-week Study|Hyperglycemia|1
4487830|NCT00767000|7288781|FG000|54-week Study|Hypoglycemia|0
4487831|NCT00767000|7288782|FG001|54-week Study|Hypoglycemia|1
4487832|NCT00767000|7288783|FG002|54-week Study|Hypoglycemia|0
4487833|NCT00767000|7288784|FG003|54-week Study|Hypoglycemia|0
4487834|NCT00767000|7288785|FG004|54-week Study|Hypoglycemia|0
4487835|NCT00767000|7288781|FG000|54-week Study|Interruption of study medication|0
4487836|NCT00767000|7288782|FG001|54-week Study|Interruption of study medication|0
4487837|NCT00767000|7288783|FG002|54-week Study|Interruption of study medication|1
4487838|NCT00767000|7288784|FG003|54-week Study|Interruption of study medication|0
4487839|NCT00767000|7288785|FG004|54-week Study|Interruption of study medication|0
4487840|NCT00767000|7288781|FG000|54-week Study|Lack of Efficacy|2
4487841|NCT00767000|7288782|FG001|54-week Study|Lack of Efficacy|0
4487842|NCT00767000|7288783|FG002|54-week Study|Lack of Efficacy|1
4487843|NCT00767000|7288784|FG003|54-week Study|Lack of Efficacy|0
4487844|NCT00767000|7288785|FG004|54-week Study|Lack of Efficacy|5
4626405|NCT01840163|7491987|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48
4626406|NCT01840163|7491988|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40
4487845|NCT00767000|7288781|FG000|54-week Study|Lost to Follow-up|4
4487846|NCT00767000|7288782|FG001|54-week Study|Lost to Follow-up|0
4487847|NCT00767000|7288783|FG002|54-week Study|Lost to Follow-up|1
4487848|NCT00767000|7288784|FG003|54-week Study|Lost to Follow-up|4
4487849|NCT00767000|7288785|FG004|54-week Study|Lost to Follow-up|2
4487850|NCT00767000|7288781|FG000|54-week Study|Physician Decision|4
4487851|NCT00767000|7288782|FG001|54-week Study|Physician Decision|0
4487852|NCT00767000|7288783|FG002|54-week Study|Physician Decision|1
4487853|NCT00767000|7288784|FG003|54-week Study|Physician Decision|1
4487854|NCT00767000|7288785|FG004|54-week Study|Physician Decision|1
4487855|NCT00767000|7288781|FG000|54-week Study|Progressive disease|0
4487856|NCT00767000|7288782|FG001|54-week Study|Progressive disease|0
4487857|NCT00767000|7288783|FG002|54-week Study|Progressive disease|1
4487858|NCT00767000|7288784|FG003|54-week Study|Progressive disease|0
4487859|NCT00767000|7288785|FG004|54-week Study|Progressive disease|0
4487860|NCT00767000|7288781|FG000|54-week Study|Protocol Violation|0
4487861|NCT00767000|7288782|FG001|54-week Study|Protocol Violation|0
4487862|NCT00767000|7288783|FG002|54-week Study|Protocol Violation|1
4487863|NCT00767000|7288784|FG003|54-week Study|Protocol Violation|2
4487864|NCT00767000|7288785|FG004|54-week Study|Protocol Violation|0
4487865|NCT00767000|7288781|FG000|54-week Study|Withdrawal by Subject|2
4487866|NCT00767000|7288782|FG001|54-week Study|Withdrawal by Subject|3
4626407|NCT01840163|7491987|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43
4626408|NCT01840163|7491988|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35
4626409|NCT01840228|7491996|FG000|Overall Study|Lost to Follow-up|1
4626410|NCT01840228|7491997|FG001|Overall Study|Lost to Follow-up|1
4626411|NCT01840410|7492017|FG000|Overall Study|Physician Decision|1
4626412|NCT01840410|7492018|FG001|Overall Study|Physician Decision|2
4626413|NCT01840410|7492017|FG000|Overall Study|Pregnancy|1
4626414|NCT01840410|7492018|FG001|Overall Study|Pregnancy|0
4626415|NCT01840410|7492017|FG000|Overall Study|Protocol deviation|1
4626416|NCT01840410|7492018|FG001|Overall Study|Protocol deviation|0
4626417|NCT01840410|7492017|FG000|Overall Study|Lost to Follow-up|1
4487867|NCT00767000|7288783|FG002|54-week Study|Withdrawal by Subject|5
4487868|NCT00767000|7288784|FG003|54-week Study|Withdrawal by Subject|11
4487869|NCT00767000|7288785|FG004|54-week Study|Withdrawal by Subject|13
4487870|NCT00767000|7288781|FG000|54-week Study|Study terminated by sponsor|90
4487871|NCT00767000|7288782|FG001|54-week Study|Study terminated by sponsor|102
4487872|NCT00767000|7288783|FG002|54-week Study|Study terminated by sponsor|89
4487873|NCT00767000|7288784|FG003|54-week Study|Study terminated by sponsor|196
4487874|NCT00767000|7288785|FG004|54-week Study|Study terminated by sponsor|194
4487875|NCT00767000|7288781|FG000|54-week Study|Reason not reported|0
4626418|NCT01840410|7492018|FG001|Overall Study|Lost to Follow-up|0
4487876|NCT00767000|7288782|FG001|54-week Study|Reason not reported|0
4487877|NCT00767000|7288783|FG002|54-week Study|Reason not reported|0
4487878|NCT00767000|7288784|FG003|54-week Study|Reason not reported|1
4487879|NCT00767000|7288785|FG004|54-week Study|Reason not reported|0
4518679|NCT00975585|7330872|FG000|Overall Study|Adverse Event|0
4626419|NCT01840410|7492017|FG000|Overall Study|Withdrawal by Subject|2
4626420|NCT01840410|7492018|FG001|Overall Study|Withdrawal by Subject|1
4626421|NCT01840410|7492017|FG000|Overall Study|Adverse Event|1
4487880|NCT00767000|7288781|FG000|Optional 104-week Extension|Study terminated by sponsor|7
4487881|NCT00767000|7288782|FG001|Optional 104-week Extension|Study terminated by sponsor|3
4487882|NCT00767000|7288783|FG002|Optional 104-week Extension|Study terminated by sponsor|7
4487883|NCT00767000|7288784|FG003|Optional 104-week Extension|Study terminated by sponsor|2
4487884|NCT00767000|7288785|FG004|Optional 104-week Extension|Study terminated by sponsor|4
4487885|NCT00767039|7288799|FG000|Overall Study|Death|5
4487886|NCT00767039|7288800|FG001|Overall Study|Death|2
4487887|NCT00767104|7288808|FG000|Overall Study|Lost to Follow-up|1
4487888|NCT00767104|7288809|FG001|Overall Study|Lost to Follow-up|2
4487889|NCT00767325|7288817|FG000|Overall Study|Lack of Efficacy|2
4487890|NCT00767325|7288817|FG000|Overall Study|Adverse Event|7
4487891|NCT00767325|7288817|FG000|Overall Study|Lost to Follow-up|3
4487892|NCT00767325|7288817|FG000|Overall Study|No longer met study criteria|2
4487893|NCT00767325|7288817|FG000|Overall Study|Missed visit due to family reasons|1
4487894|NCT00767455|7288847|FG000|Overall Study|Investigator error|19
4487895|NCT00767520|7288879|FG000|Overall Study|Participants still on treatment|11
4487896|NCT00767520|7288880|FG001|Overall Study|Participants still on treatment|15
4626422|NCT01840410|7492018|FG001|Overall Study|Adverse Event|1
4626423|NCT01840579|7492036|FG000|Overall Study|Status not recorded|0
4626424|NCT01840579|7492037|FG001|Overall Study|Status not recorded|0
4626425|NCT01840579|7492038|FG002|Overall Study|Status not recorded|2
4626426|NCT01840579|7492039|FG003|Overall Study|Status not recorded|3
4626427|NCT01840579|7492040|FG004|Overall Study|Status not recorded|4
4626428|NCT01840579|7492041|FG005|Overall Study|Status not recorded|3
4626429|NCT01840579|7492042|FG006|Overall Study|Status not recorded|0
4626430|NCT01840579|7492043|FG007|Overall Study|Status not recorded|3
4701457|NCT02709538|7618397|FG001|Overall Study|Lack of Efficacy|0
4701458|NCT02709538|7618398|FG002|Overall Study|Lack of Efficacy|0
4701459|NCT02709538|7618396|FG000|Overall Study|Lost to Follow-up|24
4701460|NCT02709538|7618397|FG001|Overall Study|Lost to Follow-up|8
4701461|NCT02709538|7618398|FG002|Overall Study|Lost to Follow-up|4
4701462|NCT02709538|7618396|FG000|Overall Study|Physician Decision|1
4701463|NCT02709538|7618397|FG001|Overall Study|Physician Decision|0
4701464|NCT02709538|7618398|FG002|Overall Study|Physician Decision|0
4701465|NCT02709538|7618396|FG000|Overall Study|Withdrawal by Subject|40
4701466|NCT02709538|7618397|FG001|Overall Study|Withdrawal by Subject|7
4701467|NCT02709538|7618398|FG002|Overall Study|Withdrawal by Subject|4
4701468|NCT02709538|7618396|FG000|Overall Study|Non-compliance with study procedures|5
4701469|NCT02709538|7618397|FG001|Overall Study|Non-compliance with study procedures|0
4701470|NCT02709538|7618398|FG002|Overall Study|Non-compliance with study procedures|0
4701471|NCT02709538|7618396|FG000|Overall Study|Non-compliance with study drug|2
4701472|NCT02709538|7618397|FG001|Overall Study|Non-compliance with study drug|0
4487897|NCT00767520|7288879|FG000|Overall Study|Randomized in error and Never treated|0
4487898|NCT00767520|7288880|FG001|Overall Study|Randomized in error and Never treated|2
4487899|NCT00767676|7288901|FG000|Overall Study|Investigator error|54
4487900|NCT00767806|7288928|FG000|Overall Study|Adverse Event|30
4487901|NCT00767806|7288929|FG001|Overall Study|Adverse Event|11
4487902|NCT00767806|7288928|FG000|Overall Study|Withdrawal by Subject|8
4487903|NCT00767806|7288929|FG001|Overall Study|Withdrawal by Subject|13
4487904|NCT00767806|7288928|FG000|Overall Study|Protocol Violation|6
4487905|NCT00767806|7288929|FG001|Overall Study|Protocol Violation|5
4487906|NCT00767806|7288928|FG000|Overall Study|Lack of Efficacy|1
4487907|NCT00767806|7288929|FG001|Overall Study|Lack of Efficacy|9
4487908|NCT00767806|7288928|FG000|Overall Study|Physician Decision|4
4487909|NCT00767806|7288929|FG001|Overall Study|Physician Decision|3
4487910|NCT00767806|7288928|FG000|Overall Study|Lost to Follow-up|1
4487911|NCT00767806|7288929|FG001|Overall Study|Lost to Follow-up|4
4487912|NCT00767806|7288928|FG000|Overall Study|Entry Criteria Not Met|1
4487913|NCT00767806|7288929|FG001|Overall Study|Entry Criteria Not Met|1
4487914|NCT00767806|7288928|FG000|Overall Study|Sponsor Decision|0
4487915|NCT00767806|7288929|FG001|Overall Study|Sponsor Decision|1
4487916|NCT00767819|7288938|FG000|Overall Study|Unsatisfactory therapeutic effect|18
4487917|NCT00767819|7288939|FG001|Overall Study|Unsatisfactory therapeutic effect|14
4487918|NCT00767819|7288940|FG002|Overall Study|Unsatisfactory therapeutic effect|0
4487919|NCT00767819|7288938|FG000|Overall Study|Withdrawal by Subject|1
4487920|NCT00767819|7288939|FG001|Overall Study|Withdrawal by Subject|1
4487921|NCT00767819|7288940|FG002|Overall Study|Withdrawal by Subject|0
4487922|NCT00767819|7288938|FG000|Overall Study|Administrative problems|0
4487923|NCT00767819|7288939|FG001|Overall Study|Administrative problems|1
4626431|NCT01840579|7492044|FG008|Overall Study|Status not recorded|3
4626432|NCT01840579|7492045|FG009|Overall Study|Status not recorded|3
4487924|NCT00767819|7288940|FG002|Overall Study|Administrative problems|0
4487925|NCT00767819|7288938|FG000|Overall Study|Death|2
4487926|NCT00767819|7288939|FG001|Overall Study|Death|3
4487927|NCT00767819|7288940|FG002|Overall Study|Death|0
4487928|NCT00767819|7288938|FG000|Overall Study|Adverse Event|2
4487929|NCT00767819|7288939|FG001|Overall Study|Adverse Event|0
4487930|NCT00767819|7288940|FG002|Overall Study|Adverse Event|0
4626433|NCT01840579|7492036|FG000|Overall Study|Progressive disease|3
4626434|NCT01840579|7492037|FG001|Overall Study|Progressive disease|5
4626435|NCT01840579|7492038|FG002|Overall Study|Progressive disease|0
4701473|NCT02709538|7618398|FG002|Overall Study|Non-compliance with study drug|0
4701474|NCT02709538|7618396|FG000|Overall Study|Protocol deviation|10
4487931|NCT00767819|7288938|FG000|Overall Study|Abnormal lab values|1
4487932|NCT00767819|7288939|FG001|Overall Study|Abnormal lab values|0
4487933|NCT00767819|7288940|FG002|Overall Study|Abnormal lab values|0
4487934|NCT00767819|7288938|FG000|Overall Study|Lost to Follow-up|1
4487935|NCT00767819|7288939|FG001|Overall Study|Lost to Follow-up|0
4487936|NCT00767819|7288940|FG002|Overall Study|Lost to Follow-up|0
4487937|NCT00768053|7288948|FG000|Overall Study|Adverse Event|10
4487938|NCT00768053|7288948|FG000|Overall Study|Lost to Follow-up|1
4487939|NCT00768066|7288955|FG000|Overall Study|Did not receive study product injection.|3
4487940|NCT00768066|7288956|FG001|Overall Study|Did not receive study product injection.|3
4487941|NCT00768066|7288957|FG002|Overall Study|Did not receive study product injection.|0
4487942|NCT00768079|7288968|FG000|Overall Study|Lost to Follow-up|2
4487943|NCT00768079|7288969|FG001|Overall Study|Lost to Follow-up|0
4487944|NCT00768079|7288970|FG002|Overall Study|Lost to Follow-up|4
4487945|NCT00768079|7288968|FG000|Overall Study|Participant incarcerated|0
4487946|NCT00768079|7288969|FG001|Overall Study|Participant incarcerated|1
4487947|NCT00768079|7288970|FG002|Overall Study|Participant incarcerated|0
4487948|NCT00768144|7288984|FG000|Overall Study|Adverse Event|13
4487949|NCT00768144|7288984|FG000|Overall Study|Progressive Disease|21
4487950|NCT00768144|7288984|FG000|Overall Study|Patient or MD Decision to End Treatment|1
4487951|NCT00768144|7288984|FG000|Overall Study|Pt Withdrew Consent|1
4487952|NCT00768222|7288990|FG000|Overall Study|Lost to Follow-up|1
4487953|NCT00768222|7288991|FG001|Overall Study|Lost to Follow-up|1
4487954|NCT00768222|7288990|FG000|Overall Study|Withdrawal by Subject|3
4487955|NCT00768222|7288991|FG001|Overall Study|Withdrawal by Subject|1
4487956|NCT00768222|7288990|FG000|Overall Study|Protocol Violation|0
4487957|NCT00768222|7288991|FG001|Overall Study|Protocol Violation|2
4487958|NCT00768300|7289036|FG000|Overall Study|Randomized but not treated|1
4487959|NCT00768300|7289037|FG001|Overall Study|Randomized but not treated|1
4487960|NCT00768300|7289036|FG000|Overall Study|Adverse Event|10
4487961|NCT00768300|7289037|FG001|Overall Study|Adverse Event|2
4487962|NCT00768300|7289036|FG000|Overall Study|Protocol Violation|6
4487963|NCT00768300|7289037|FG001|Overall Study|Protocol Violation|1
4487964|NCT00768300|7289036|FG000|Overall Study|Withdrawal by Subject|13
4487965|NCT00768300|7289037|FG001|Overall Study|Withdrawal by Subject|7
4487966|NCT00768300|7289036|FG000|Overall Study|Physician Decision|2
4487967|NCT00768300|7289037|FG001|Overall Study|Physician Decision|3
4487968|NCT00768300|7289036|FG000|Overall Study|Study discontinued by Sponsor|271
4487969|NCT00768300|7289037|FG001|Overall Study|Study discontinued by Sponsor|140
4487970|NCT00768300|7289036|FG000|Overall Study|Death|21
4487971|NCT00768300|7289037|FG001|Overall Study|Death|5
4487972|NCT00768300|7289036|FG000|Overall Study|Subject moved to pursue lung transplant|1
4487973|NCT00768300|7289037|FG001|Overall Study|Subject moved to pursue lung transplant|1
4487974|NCT00768300|7289036|FG000|Overall Study|Screen failure following randomization|1
4487975|NCT00768300|7289037|FG001|Overall Study|Screen failure following randomization|0
4487976|NCT00768300|7289036|FG000|Overall Study|Received lung transplant|1
4487977|NCT00768300|7289037|FG001|Overall Study|Received lung transplant|1
4487978|NCT00768300|7289036|FG000|Overall Study|Lost to Follow-up|0
4487979|NCT00768300|7289037|FG001|Overall Study|Lost to Follow-up|1
4487980|NCT00768300|7289036|FG000|Overall Study|Began prohibited concomitant medication|0
4487981|NCT00768300|7289037|FG001|Overall Study|Began prohibited concomitant medication|1
4487982|NCT00768300|7289036|FG000|Overall Study|Treated but never dosed with Study drug|1
4487983|NCT00768300|7289037|FG001|Overall Study|Treated but never dosed with Study drug|0
4487984|NCT00768300|7289036|FG000|Overall Study|Missing data|1
4487985|NCT00768300|7289037|FG001|Overall Study|Missing data|0
4487986|NCT00768430|7289045|FG000|7 Day Endpoint|Withdrawal by Subject|2
4487987|NCT00768430|7289046|FG001|7 Day Endpoint|Withdrawal by Subject|3
4487988|NCT00768469|7289054|FG000|Overall Study|Adverse Event|0
4487989|NCT00768469|7289055|FG001|Overall Study|Adverse Event|2
4487990|NCT00768469|7289054|FG000|Overall Study|Disease Progression|3
4487991|NCT00768469|7289055|FG001|Overall Study|Disease Progression|4
4487992|NCT00768469|7289054|FG000|Overall Study|Withdrawal by Subject|0
4487993|NCT00768469|7289055|FG001|Overall Study|Withdrawal by Subject|1
4487994|NCT00768560|7289075|FG000|Intervention Set 1|Adverse Event|0
4487995|NCT00768560|7289076|FG001|Intervention Set 1|Adverse Event|1
4487996|NCT00768560|7289077|FG002|Intervention Set 1|Adverse Event|0
4487997|NCT00768560|7289078|FG003|Intervention Set 1|Adverse Event|0
4487998|NCT00768560|7289079|FG004|Intervention Set 1|Adverse Event|0
4487999|NCT00768560|7289080|FG005|Intervention Set 1|Adverse Event|0
4488000|NCT00768651|7289101|FG000|Overall Study|Withdrawal by Subject|1
4488001|NCT00768664|7289106|FG000|Overall Study|Death|57
4701475|NCT02709538|7618397|FG001|Overall Study|Protocol deviation|4
4701476|NCT02709538|7618398|FG002|Overall Study|Protocol deviation|4
4701477|NCT02709538|7618396|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1
4701478|NCT02709538|7618397|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0
4701479|NCT02709538|7618398|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0
4701480|NCT02709538|7618396|FG000|Overall Study|Other|16
4701481|NCT02709538|7618397|FG001|Overall Study|Other|7
4701482|NCT02709538|7618398|FG002|Overall Study|Other|5
4488002|NCT00768664|7289106|FG000|Overall Study|Lost to Follow-up|2
4488003|NCT00768664|7289106|FG000|Overall Study|Other|9
4488004|NCT00768664|7289106|FG000|Overall Study|Participant refused|1
4488005|NCT00768755|7289126|FG000|Phase 1|Death|6
4488006|NCT00768755|7289127|FG001|Phase 1|Death|0
4488007|NCT00768755|7289128|FG002|Phase 1|Death|0
4488008|NCT00768755|7289129|FG003|Phase 1|Death|0
4488009|NCT00768755|7289126|FG000|Phase 1|Other|4
4488010|NCT00768755|7289127|FG001|Phase 1|Other|0
4488011|NCT00768755|7289128|FG002|Phase 1|Other|0
4488012|NCT00768755|7289129|FG003|Phase 1|Other|0
4488013|NCT00768755|7289126|FG000|Phase 2|Death|0
4488014|NCT00768755|7289127|FG001|Phase 2|Death|37
4488015|NCT00768755|7289128|FG002|Phase 2|Death|48
4488016|NCT00768755|7289129|FG003|Phase 2|Death|31
4488017|NCT00768755|7289126|FG000|Phase 2|Protocol Violation|0
4488018|NCT00768755|7289127|FG001|Phase 2|Protocol Violation|2
4488019|NCT00768755|7289128|FG002|Phase 2|Protocol Violation|0
4488020|NCT00768755|7289129|FG003|Phase 2|Protocol Violation|1
4488021|NCT00768755|7289126|FG000|Phase 2|Lost to Follow-up|0
4488022|NCT00768755|7289127|FG001|Phase 2|Lost to Follow-up|1
4488023|NCT00768755|7289128|FG002|Phase 2|Lost to Follow-up|1
4488024|NCT00768755|7289129|FG003|Phase 2|Lost to Follow-up|4
4488025|NCT00768755|7289126|FG000|Phase 2|Withdrawal by Subject|0
4488026|NCT00768755|7289127|FG001|Phase 2|Withdrawal by Subject|1
4488027|NCT00768755|7289128|FG002|Phase 2|Withdrawal by Subject|0
4488028|NCT00768755|7289129|FG003|Phase 2|Withdrawal by Subject|1
4488029|NCT00768755|7289126|FG000|Phase 2|Other|0
4488030|NCT00768755|7289127|FG001|Phase 2|Other|1
4488031|NCT00768755|7289128|FG002|Phase 2|Other|2
4488032|NCT00768755|7289129|FG003|Phase 2|Other|4
4488033|NCT00768755|7289126|FG000|Phase 2|Study Terminated by Sponsor|0
4488034|NCT00768755|7289127|FG001|Phase 2|Study Terminated by Sponsor|13
4488035|NCT00768755|7289128|FG002|Phase 2|Study Terminated by Sponsor|7
4488036|NCT00768755|7289129|FG003|Phase 2|Study Terminated by Sponsor|14
4488037|NCT00768755|7289126|FG000|Phase 2|Randomized but not treated|0
4488038|NCT00768755|7289127|FG001|Phase 2|Randomized but not treated|0
4488039|NCT00768755|7289128|FG002|Phase 2|Randomized but not treated|0
4488040|NCT00768755|7289129|FG003|Phase 2|Randomized but not treated|2
4488041|NCT00768898|7289138|FG000|Overall Study|Unrelated injury|1
4488042|NCT00768898|7289138|FG000|Overall Study|Headache|1
4488043|NCT00768989|7289149|FG000|Prior to Week 24|Withdrawal by Subject|1
4488044|NCT00768989|7289150|FG001|Prior to Week 24|Withdrawal by Subject|0
4488045|NCT00768989|7289149|FG000|Prior to Week 24|Adverse Event|3
4488046|NCT00768989|7289150|FG001|Prior to Week 24|Adverse Event|0
4488047|NCT00768989|7289149|FG000|Prior to Week 24|Lost to Follow-up|0
4488048|NCT00768989|7289150|FG001|Prior to Week 24|Lost to Follow-up|1
4488049|NCT00768989|7289149|FG000|Prior to Week 24|Protocol Violation|0
4488050|NCT00768989|7289150|FG001|Prior to Week 24|Protocol Violation|2
4488051|NCT00768989|7289149|FG000|Week 24 to Prior to Week 36|Adverse Event|1
4488052|NCT00768989|7289150|FG001|Week 24 to Prior to Week 36|Adverse Event|0
4488053|NCT00768989|7289149|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6
4488054|NCT00768989|7289150|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0
4488055|NCT00768989|7289149|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1
4488056|NCT00768989|7289150|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0
4488057|NCT00768989|7289149|FG000|On or After Week 36|Lack of Efficacy|1
4488058|NCT00768989|7289150|FG001|On or After Week 36|Lack of Efficacy|0
4488059|NCT00768989|7289149|FG000|On or After Week 36|Adverse Event|0
4488060|NCT00768989|7289150|FG001|On or After Week 36|Adverse Event|1
4488061|NCT00768989|7289149|FG000|On or After Week 36|Lost to Follow-up|1
4488062|NCT00768989|7289150|FG001|On or After Week 36|Lost to Follow-up|0
4488063|NCT00768989|7289149|FG000|On or After Week 36|Poor Compliance|1
4488064|NCT00768989|7289150|FG001|On or After Week 36|Poor Compliance|0
4488065|NCT00768989|7289149|FG000|On or After Week 36|Protocol Violation|1
4488066|NCT00768989|7289150|FG001|On or After Week 36|Protocol Violation|0
4488067|NCT00768989|7289149|FG000|On or After Week 36|Did not attend termination visit|2
4488068|NCT00768989|7289150|FG001|On or After Week 36|Did not attend termination visit|0
4488069|NCT00768989|7289149|FG000|On or After Week 36|Sponsor Termination|45
4488070|NCT00768989|7289150|FG001|On or After Week 36|Sponsor Termination|26
4488071|NCT00769067|7289169|FG000|Overall Study|Death|89
4488072|NCT00769067|7289170|FG001|Overall Study|Death|86
4488073|NCT00769067|7289169|FG000|Overall Study|Lost to Follow-up|3
4488074|NCT00769067|7289170|FG001|Overall Study|Lost to Follow-up|1
4488075|NCT00769067|7289169|FG000|Overall Study|Study terminated by sponsor|1
4488076|NCT00769067|7289170|FG001|Overall Study|Study terminated by sponsor|3
4488077|NCT00769067|7289169|FG000|Overall Study|Other|1
4488078|NCT00769067|7289170|FG001|Overall Study|Other|3
4488079|NCT00769067|7289169|FG000|Overall Study|Withdrawal by Subject|0
4488080|NCT00769067|7289170|FG001|Overall Study|Withdrawal by Subject|1
4488081|NCT00769119|7289179|FG000|Overall Study|Voluntary discontinuation|0
4488082|NCT00769119|7289180|FG001|Overall Study|Voluntary discontinuation|2
4488083|NCT00769119|7289179|FG000|Overall Study|Adverse Event|1
4488084|NCT00769119|7289180|FG001|Overall Study|Adverse Event|1
4488085|NCT00769119|7289179|FG000|Overall Study|Disallowed medication|1
4488086|NCT00769119|7289180|FG001|Overall Study|Disallowed medication|0
4488087|NCT00769132|7289186|FG000|Period 1|Adverse Event|1
4488088|NCT00769132|7289187|FG001|Period 1|Adverse Event|0
4488089|NCT00769132|7289188|FG002|Period 1|Adverse Event|0
4488090|NCT00769132|7289189|FG003|Period 1|Adverse Event|1
4488091|NCT00769132|7289186|FG000|Period 2|Withdrawal by Subject|0
4488092|NCT00769132|7289187|FG001|Period 2|Withdrawal by Subject|0
4488093|NCT00769132|7289188|FG002|Period 2|Withdrawal by Subject|0
4488094|NCT00769132|7289189|FG003|Period 2|Withdrawal by Subject|1
4488095|NCT00769132|7289186|FG000|Period 3|Withdrawal by Subject|1
4488096|NCT00769132|7289187|FG001|Period 3|Withdrawal by Subject|0
4488097|NCT00769132|7289188|FG002|Period 3|Withdrawal by Subject|0
4488098|NCT00769132|7289189|FG003|Period 3|Withdrawal by Subject|0
4488099|NCT00769132|7289186|FG000|Period 4|Withdrawal by Subject|0
4488100|NCT00769132|7289187|FG001|Period 4|Withdrawal by Subject|1
4488101|NCT00769132|7289188|FG002|Period 4|Withdrawal by Subject|0
4701483|NCT02709577|7618408|FG000|Overall Study|non-accommodating anatomy|0
4701484|NCT02709577|7618409|FG001|Overall Study|non-accommodating anatomy|1
4701485|NCT02709577|7618410|FG002|Overall Study|non-accommodating anatomy|0
4701486|NCT02709577|7618411|FG003|Overall Study|non-accommodating anatomy|0
4701487|NCT02709577|7618408|FG000|Overall Study|procedural complication|0
4701488|NCT02709577|7618409|FG001|Overall Study|procedural complication|1
4701489|NCT02709577|7618410|FG002|Overall Study|procedural complication|0
4701490|NCT02709577|7618411|FG003|Overall Study|procedural complication|0
4701491|NCT02709577|7618408|FG000|Overall Study|Withdrawal by Subject|2
4701492|NCT02709577|7618409|FG001|Overall Study|Withdrawal by Subject|3
4701493|NCT02709577|7618410|FG002|Overall Study|Withdrawal by Subject|2
4488102|NCT00769132|7289189|FG003|Period 4|Withdrawal by Subject|0
4488103|NCT00769184|7289199|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1
4488104|NCT00769184|7289200|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0
4488105|NCT00769184|7289199|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0
4488106|NCT00769184|7289200|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1
4488107|NCT00769184|7289199|FG000|No Treatment (6 Weeks)|Adverse Event|1
4488108|NCT00769184|7289200|FG001|No Treatment (6 Weeks)|Adverse Event|1
4488109|NCT00769483|7289227|FG000|Overall Study|Withdrawal by Subject|0
4488110|NCT00769483|7289228|FG001|Overall Study|Withdrawal by Subject|1
4488111|NCT00769483|7289229|FG002|Overall Study|Withdrawal by Subject|0
4488112|NCT00769483|7289230|FG003|Overall Study|Withdrawal by Subject|0
4488113|NCT00769483|7289231|FG004|Overall Study|Withdrawal by Subject|1
4488114|NCT00769483|7289232|FG005|Overall Study|Withdrawal by Subject|0
4488115|NCT00769561|7289250|FG000|Overall Study|Withdrawal by Subject|2
4488116|NCT00769561|7289251|FG001|Overall Study|Withdrawal by Subject|2
4488117|NCT00769561|7289250|FG000|Overall Study|Lost to Follow-up|1
4488118|NCT00769561|7289251|FG001|Overall Study|Lost to Follow-up|3
4626436|NCT01840579|7492039|FG003|Overall Study|Progressive disease|0
4626437|NCT01840579|7492040|FG004|Overall Study|Progressive disease|0
4626438|NCT01840579|7492041|FG005|Overall Study|Progressive disease|0
4626439|NCT01840579|7492042|FG006|Overall Study|Progressive disease|0
4626440|NCT01840579|7492043|FG007|Overall Study|Progressive disease|0
4626441|NCT01840579|7492044|FG008|Overall Study|Progressive disease|0
4626442|NCT01840579|7492045|FG009|Overall Study|Progressive disease|0
4626443|NCT01840579|7492036|FG000|Overall Study|Ongoing in study|0
4626444|NCT01840579|7492037|FG001|Overall Study|Ongoing in study|1
4488119|NCT00769704|7289271|FG000|Overall Study|Lost to Follow-up|3
4488120|NCT00769704|7289272|FG001|Overall Study|Lost to Follow-up|2
4626445|NCT01840579|7492038|FG002|Overall Study|Ongoing in study|0
4626446|NCT01840579|7492039|FG003|Overall Study|Ongoing in study|0
4626447|NCT01840579|7492040|FG004|Overall Study|Ongoing in study|0
4626448|NCT01840579|7492041|FG005|Overall Study|Ongoing in study|0
4626449|NCT01840579|7492042|FG006|Overall Study|Ongoing in study|0
4701494|NCT02709577|7618411|FG003|Overall Study|Withdrawal by Subject|0
4488121|NCT00769704|7289271|FG000|Overall Study|Death|95
4488122|NCT00769704|7289272|FG001|Overall Study|Death|190
4488123|NCT00769704|7289271|FG000|Overall Study|Withdrawal by Subject|12
4488124|NCT00769704|7289272|FG001|Overall Study|Withdrawal by Subject|5
4488125|NCT00769704|7289271|FG000|Overall Study|Other|1
4488126|NCT00769704|7289272|FG001|Overall Study|Other|2
4488127|NCT00769860|7289285|FG000|Overall Study|Withdrawal by Subject|2
4488128|NCT00769860|7289286|FG001|Overall Study|Withdrawal by Subject|0
4488129|NCT00770029|7289311|FG000|Overall Study|Lost to Follow-up|2
4488130|NCT00770029|7289312|FG001|Overall Study|Lost to Follow-up|0
4488131|NCT00770029|7289311|FG000|Overall Study|Withdrawal by Subject|3
4488132|NCT00770029|7289312|FG001|Overall Study|Withdrawal by Subject|3
4488133|NCT00770029|7289311|FG000|Overall Study|Adverse Event|1
4488134|NCT00770029|7289312|FG001|Overall Study|Adverse Event|0
4488135|NCT00770120|7289318|FG000|Overall Study|Progression|31
4488136|NCT00770120|7289318|FG000|Overall Study|Adverse Event|11
4488137|NCT00770120|7289318|FG000|Overall Study|Not Protocol Specified|11
4488138|NCT00770120|7289318|FG000|Overall Study|Death|3
4488139|NCT00770120|7289318|FG000|Overall Study|Withdrawal by Subject|2
4488140|NCT00770120|7289318|FG000|Overall Study|Ineligible|1
4488141|NCT00770120|7289318|FG000|Overall Study|Never Received Treatment/Not Analyzable|1
4488142|NCT00770120|7289318|FG000|Overall Study|Reason under Review|1
4488143|NCT00770146|7289342|FG000|Treatment Period|Withdrawal by Subject|6
4488144|NCT00770146|7289343|FG001|Treatment Period|Withdrawal by Subject|13
4488145|NCT00770146|7289342|FG000|Treatment Period|Adverse Event|2
4488146|NCT00770146|7289343|FG001|Treatment Period|Adverse Event|26
4488147|NCT00770146|7289342|FG000|Treatment Period|Other|1
4488148|NCT00770146|7289343|FG001|Treatment Period|Other|5
4626450|NCT01840579|7492043|FG007|Overall Study|Ongoing in study|0
4626451|NCT01840579|7492044|FG008|Overall Study|Ongoing in study|0
4626452|NCT01840579|7492045|FG009|Overall Study|Ongoing in study|0
4626453|NCT01840579|7492036|FG000|Overall Study|Death|0
4488149|NCT00770146|7289342|FG000|Treatment Period|Protocol non-compliance|0
4488150|NCT00770146|7289343|FG001|Treatment Period|Protocol non-compliance|1
4488151|NCT00770146|7289342|FG000|Follow-up Period|Withdrawal by Subject|7
4488152|NCT00770146|7289343|FG001|Follow-up Period|Withdrawal by Subject|13
4488153|NCT00770146|7289342|FG000|Follow-up Period|Adverse Event|0
4488154|NCT00770146|7289343|FG001|Follow-up Period|Adverse Event|2
4488155|NCT00770146|7289342|FG000|Follow-up Period|Other|4
4488156|NCT00770146|7289343|FG001|Follow-up Period|Other|5
4488157|NCT00770211|7289351|FG000|Overall Study|Lost to Follow-up|1
4488158|NCT00770211|7289352|FG001|Overall Study|Lost to Follow-up|0
4488159|NCT00770211|7289351|FG000|Overall Study|Withdrawal by Subject|0
4488160|NCT00770211|7289352|FG001|Overall Study|Withdrawal by Subject|2
4488161|NCT00770224|7289358|FG000|Step 1: Induction|Adverse Event|3
4488162|NCT00770224|7289359|FG001|Step 1: Induction|Adverse Event|0
4488163|NCT00770224|7289358|FG000|Step 1: Induction|Refusal unrelated to adverse event|6
4488164|NCT00770224|7289359|FG001|Step 1: Induction|Refusal unrelated to adverse event|0
4488165|NCT00770224|7289358|FG000|Step 1: Induction|Other reason not protocol specified|2
4626454|NCT01840579|7492037|FG001|Overall Study|Death|0
4626455|NCT01840579|7492038|FG002|Overall Study|Death|0
4626456|NCT01840579|7492039|FG003|Overall Study|Death|0
4626457|NCT01840579|7492040|FG004|Overall Study|Death|0
4626458|NCT01840579|7492041|FG005|Overall Study|Death|1
4626459|NCT01840579|7492042|FG006|Overall Study|Death|0
4626460|NCT01840579|7492043|FG007|Overall Study|Death|0
4626461|NCT01840579|7492044|FG008|Overall Study|Death|0
4626462|NCT01840579|7492045|FG009|Overall Study|Death|0
4626463|NCT01840579|7492036|FG000|Overall Study|Adverse Event|0
4626464|NCT01840579|7492037|FG001|Overall Study|Adverse Event|1
4626465|NCT01840579|7492038|FG002|Overall Study|Adverse Event|0
4626466|NCT01840579|7492039|FG003|Overall Study|Adverse Event|0
4626467|NCT01840579|7492040|FG004|Overall Study|Adverse Event|0
4488166|NCT00770224|7289359|FG001|Step 1: Induction|Other reason not protocol specified|0
4488167|NCT00770224|7289358|FG000|Step 1: Induction|Ineligible|2
4488168|NCT00770224|7289359|FG001|Step 1: Induction|Ineligible|0
4488169|NCT00770224|7289358|FG000|Step 1: Induction|No protocol treatment given|1
4488170|NCT00770224|7289359|FG001|Step 1: Induction|No protocol treatment given|0
4488171|NCT00770224|7289358|FG000|Step 2: Maintenance|Adverse Event|0
4488172|NCT00770224|7289359|FG001|Step 2: Maintenance|Adverse Event|10
4488173|NCT00770224|7289358|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0
4488174|NCT00770224|7289359|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8
4488175|NCT00770224|7289358|FG000|Step 2: Maintenance|Progression/relapse|0
4488176|NCT00770224|7289359|FG001|Step 2: Maintenance|Progression/relapse|1
4488177|NCT00770224|7289358|FG000|Step 2: Maintenance|Death|0
4488178|NCT00770224|7289359|FG001|Step 2: Maintenance|Death|2
4488179|NCT00770224|7289358|FG000|Step 2: Maintenance|Other reason not protocol specified|0
4488180|NCT00770224|7289359|FG001|Step 2: Maintenance|Other reason not protocol specified|7
4488181|NCT00770224|7289358|FG000|Step 2: Maintenance|Ineligible|0
4488182|NCT00770224|7289359|FG001|Step 2: Maintenance|Ineligible|2
4488183|NCT00770289|7289366|FG000|Overall Study|Other|6
4488184|NCT00770315|7289379|FG000|Overall Study|Adverse Event|11
4488185|NCT00770315|7289380|FG001|Overall Study|Adverse Event|17
4488186|NCT00770315|7289381|FG002|Overall Study|Adverse Event|16
4488187|NCT00770315|7289382|FG003|Overall Study|Adverse Event|6
4488188|NCT00770315|7289379|FG000|Overall Study|Lost to Follow-up|9
4488189|NCT00770315|7289380|FG001|Overall Study|Lost to Follow-up|5
4488190|NCT00770315|7289381|FG002|Overall Study|Lost to Follow-up|10
4488191|NCT00770315|7289382|FG003|Overall Study|Lost to Follow-up|3
4488192|NCT00770315|7289379|FG000|Overall Study|Withdrawal by Subject|13
4488193|NCT00770315|7289380|FG001|Overall Study|Withdrawal by Subject|17
4488194|NCT00770315|7289381|FG002|Overall Study|Withdrawal by Subject|24
4488195|NCT00770315|7289382|FG003|Overall Study|Withdrawal by Subject|20
4488196|NCT00770315|7289379|FG000|Overall Study|Noncompliance with Protocol|7
4488197|NCT00770315|7289380|FG001|Overall Study|Noncompliance with Protocol|4
4488198|NCT00770315|7289381|FG002|Overall Study|Noncompliance with Protocol|7
4488199|NCT00770315|7289382|FG003|Overall Study|Noncompliance with Protocol|9
4488200|NCT00770328|7289394|FG000|Overall Study|Adverse Event|11
4488201|NCT00770328|7289395|FG001|Overall Study|Adverse Event|2
4488202|NCT00770328|7289394|FG000|Overall Study|Lost to Follow-up|2
4488203|NCT00770328|7289395|FG001|Overall Study|Lost to Follow-up|2
4488204|NCT00770341|7289404|FG000|Overall Study|Did not meet eligibility criteria|1
4488205|NCT00770341|7289405|FG001|Overall Study|Did not meet eligibility criteria|0
4488206|NCT00770341|7289406|FG002|Overall Study|Did not meet eligibility criteria|0
4488207|NCT00770341|7289404|FG000|Overall Study|Withdrawal by Subject|0
4488208|NCT00770341|7289405|FG001|Overall Study|Withdrawal by Subject|1
4488209|NCT00770341|7289406|FG002|Overall Study|Withdrawal by Subject|0
4488210|NCT00770341|7289404|FG000|Overall Study|Clinical Adverse Event|3
4488211|NCT00770341|7289405|FG001|Overall Study|Clinical Adverse Event|1
4626468|NCT01840579|7492041|FG005|Overall Study|Adverse Event|0
4626469|NCT01840579|7492042|FG006|Overall Study|Adverse Event|0
4626470|NCT01840579|7492043|FG007|Overall Study|Adverse Event|0
4626471|NCT01840579|7492044|FG008|Overall Study|Adverse Event|0
4626472|NCT01840579|7492045|FG009|Overall Study|Adverse Event|0
4626473|NCT01840579|7492036|FG000|Overall Study|Follow-up ended by Sponsor|0
4626474|NCT01840579|7492037|FG001|Overall Study|Follow-up ended by Sponsor|0
4488212|NCT00770341|7289406|FG002|Overall Study|Clinical Adverse Event|2
4488213|NCT00770341|7289404|FG000|Overall Study|Laboratory adverse event|3
4488214|NCT00770341|7289405|FG001|Overall Study|Laboratory adverse event|3
4488215|NCT00770341|7289406|FG002|Overall Study|Laboratory adverse event|0
4488216|NCT00770341|7289404|FG000|Overall Study|Lack of Efficacy|3
4488217|NCT00770341|7289405|FG001|Overall Study|Lack of Efficacy|0
4488218|NCT00770341|7289406|FG002|Overall Study|Lack of Efficacy|1
4488219|NCT00770341|7289404|FG000|Overall Study|Other|1
4488220|NCT00770341|7289405|FG001|Overall Study|Other|0
4488221|NCT00770341|7289406|FG002|Overall Study|Other|0
4488222|NCT00770341|7289404|FG000|Overall Study|Not treated|1
4488223|NCT00770341|7289405|FG001|Overall Study|Not treated|0
4488224|NCT00770341|7289406|FG002|Overall Study|Not treated|0
4488225|NCT00770367|7289417|FG000|First Intervention|Withdrawal by Subject|0
4488226|NCT00770367|7289418|FG001|First Intervention|Withdrawal by Subject|2
4488227|NCT00770367|7289417|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0
4488228|NCT00770367|7289418|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1
4488229|NCT00770367|7289417|FG000|Second Intervention|Lost to Follow-up|2
4488230|NCT00770367|7289418|FG001|Second Intervention|Lost to Follow-up|0
4488231|NCT00770432|7289428|FG000|Overall Study|Other|4
4488232|NCT00770432|7289429|FG001|Overall Study|Other|6
4488233|NCT00770432|7289428|FG000|Overall Study|Non-compliance|0
4488234|NCT00770432|7289429|FG001|Overall Study|Non-compliance|1
4488235|NCT00770484|7289437|FG000|Overall Study|Withdrawal by Subject|1
4701495|NCT02709746|7618441|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4
4701496|NCT02709746|7618442|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0
4701497|NCT02709746|7618443|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0
4701498|NCT02709746|7618444|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0
4701499|NCT02709746|7618445|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0
4701500|NCT02709746|7618441|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14
4701501|NCT02709746|7618442|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0
4701502|NCT02709746|7618443|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0
4701503|NCT02709746|7618444|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0
4701504|NCT02709746|7618445|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0
4701505|NCT02709746|7618441|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12
4701506|NCT02709746|7618442|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0
4701507|NCT02709746|7618443|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0
4701508|NCT02709746|7618444|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0
4701509|NCT02709746|7618445|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0
4701510|NCT02709746|7618441|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7
4701511|NCT02709746|7618442|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0
4701512|NCT02709746|7618443|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0
4701513|NCT02709746|7618444|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0
4701514|NCT02709746|7618445|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0
4701515|NCT02709746|7618441|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2
4701516|NCT02709746|7618442|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0
4701517|NCT02709746|7618443|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0
4701518|NCT02709746|7618444|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0
4701519|NCT02709746|7618445|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0
4701520|NCT02709746|7618441|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12
4701521|NCT02709746|7618442|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0
4701522|NCT02709746|7618443|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0
4701523|NCT02709746|7618444|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0
4701524|NCT02709746|7618445|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0
4701525|NCT02709746|7618441|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7
4701526|NCT02709746|7618442|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0
4701527|NCT02709746|7618443|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0
4701528|NCT02709746|7618444|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0
4701529|NCT02709746|7618445|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0
4701530|NCT02709746|7618441|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7
4701531|NCT02709746|7618442|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0
4701532|NCT02709746|7618443|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0
4488236|NCT00770484|7289438|FG001|Overall Study|Withdrawal by Subject|0
4488237|NCT00770510|7289444|FG000|Overall Study|Lost to Follow-up|2
4488238|NCT00770510|7289444|FG000|Overall Study|Pregnancy|1
4488239|NCT00770510|7289444|FG000|Overall Study|Withdrawal by Subject|2
4488240|NCT00770562|7289458|FG000|Overall Study|Did not take treatment|1
4488241|NCT00770562|7289459|FG001|Overall Study|Did not take treatment|1
4488242|NCT00770588|7289468|FG000|Overall Study|Adverse Event|9
4488243|NCT00770588|7289469|FG001|Overall Study|Adverse Event|2
4488244|NCT00770588|7289468|FG000|Overall Study|Death caused by progression of disease|70
4488245|NCT00770588|7289469|FG001|Overall Study|Death caused by progression of disease|91
4488246|NCT00770588|7289468|FG000|Overall Study|Lost to Follow-up|1
4488247|NCT00770588|7289469|FG001|Overall Study|Lost to Follow-up|1
4488248|NCT00770588|7289468|FG000|Overall Study|Withdrawal by Subject|1
4488249|NCT00770588|7289469|FG001|Overall Study|Withdrawal by Subject|1
4488250|NCT00770601|7289476|FG000|Overall Study|Withdrawal by Subject|1
4517302|NCT00966355|7329133|FG002|Overall Study|non-variceal bleeding on endoscopy|71
4517303|NCT00966355|7329131|FG000|Overall Study|newly diagnosed advanced HCC|11
4517304|NCT00966355|7329132|FG001|Overall Study|newly diagnosed advanced HCC|12
4517305|NCT00966355|7329133|FG002|Overall Study|newly diagnosed advanced HCC|10
4517306|NCT00966355|7329131|FG000|Overall Study|Lost to Follow-up|5
4517307|NCT00966355|7329132|FG001|Overall Study|Lost to Follow-up|4
4517308|NCT00966355|7329133|FG002|Overall Study|Lost to Follow-up|3
4517309|NCT00966693|7329189|FG000|Overall Study|Adverse Event|0
4517310|NCT00966693|7329190|FG001|Overall Study|Adverse Event|0
4517311|NCT00966693|7329191|FG002|Overall Study|Adverse Event|1
4517312|NCT00966693|7329192|FG003|Overall Study|Adverse Event|2
4517313|NCT00966693|7329189|FG000|Overall Study|Death|0
4517314|NCT00966693|7329190|FG001|Overall Study|Death|0
4517315|NCT00966693|7329191|FG002|Overall Study|Death|1
4517316|NCT00966693|7329192|FG003|Overall Study|Death|0
4517317|NCT00966693|7329189|FG000|Overall Study|Withdrawal by Subject|1
4517318|NCT00966693|7329190|FG001|Overall Study|Withdrawal by Subject|0
4517319|NCT00966693|7329191|FG002|Overall Study|Withdrawal by Subject|0
4517320|NCT00966693|7329192|FG003|Overall Study|Withdrawal by Subject|5
4517321|NCT00966693|7329189|FG000|Overall Study|Disease Progression|0
4517322|NCT00966693|7329190|FG001|Overall Study|Disease Progression|0
4517323|NCT00966693|7329191|FG002|Overall Study|Disease Progression|1
4517324|NCT00966693|7329192|FG003|Overall Study|Disease Progression|16
4517325|NCT00966719|7329204|FG000|Overall Study|Lost to Follow-up|6
4517326|NCT00966719|7329205|FG001|Overall Study|Lost to Follow-up|11
4517327|NCT00966875|7329237|FG000|Part A|Adverse Event|2
4517328|NCT00966875|7329238|FG001|Part A|Adverse Event|1
4517329|NCT00966875|7329239|FG002|Part A|Adverse Event|0
4517330|NCT00966875|7329240|FG003|Part A|Adverse Event|1
4517331|NCT00966875|7329241|FG004|Part A|Adverse Event|0
4517332|NCT00966875|7329242|FG005|Part A|Adverse Event|1
4517333|NCT00966875|7329243|FG006|Part A|Adverse Event|0
4517334|NCT00966875|7329244|FG007|Part A|Adverse Event|3
4517335|NCT00966875|7329245|FG008|Part A|Adverse Event|3
4517336|NCT00966875|7329237|FG000|Part A|Entry Criteria|0
4517337|NCT00966875|7329238|FG001|Part A|Entry Criteria|0
4517338|NCT00966875|7329239|FG002|Part A|Entry Criteria|0
4517339|NCT00966875|7329240|FG003|Part A|Entry Criteria|0
4517340|NCT00966875|7329241|FG004|Part A|Entry Criteria|0
4517341|NCT00966875|7329242|FG005|Part A|Entry Criteria|2
4517342|NCT00966875|7329243|FG006|Part A|Entry Criteria|0
4517343|NCT00966875|7329244|FG007|Part A|Entry Criteria|0
4517344|NCT00966875|7329245|FG008|Part A|Entry Criteria|0
4517345|NCT00966875|7329237|FG000|Part A|Lack of Efficacy|0
4517346|NCT00966875|7329238|FG001|Part A|Lack of Efficacy|1
4517347|NCT00966875|7329239|FG002|Part A|Lack of Efficacy|0
4517348|NCT00966875|7329240|FG003|Part A|Lack of Efficacy|0
4517349|NCT00966875|7329241|FG004|Part A|Lack of Efficacy|0
4517350|NCT00966875|7329242|FG005|Part A|Lack of Efficacy|0
4517351|NCT00966875|7329243|FG006|Part A|Lack of Efficacy|4
4517352|NCT00966875|7329244|FG007|Part A|Lack of Efficacy|0
4517353|NCT00966875|7329245|FG008|Part A|Lack of Efficacy|0
4517354|NCT00966875|7329237|FG000|Part A|Lost to Follow-up|2
4701533|NCT02709746|7618444|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0
4701534|NCT02709746|7618445|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0
4701535|NCT02709746|7618441|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103
4701536|NCT02709746|7618442|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0
4701537|NCT02709746|7618443|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0
4701538|NCT02709746|7618444|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0
4701539|NCT02709746|7618445|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0
4701540|NCT02709746|7618441|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0
4701541|NCT02709746|7618442|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1
4701542|NCT02709746|7618443|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0
4701543|NCT02709746|7618444|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0
4517355|NCT00966875|7329238|FG001|Part A|Lost to Follow-up|0
4517356|NCT00966875|7329239|FG002|Part A|Lost to Follow-up|0
4517357|NCT00966875|7329240|FG003|Part A|Lost to Follow-up|0
4517358|NCT00966875|7329241|FG004|Part A|Lost to Follow-up|0
4517359|NCT00966875|7329242|FG005|Part A|Lost to Follow-up|1
4517360|NCT00966875|7329243|FG006|Part A|Lost to Follow-up|0
4517361|NCT00966875|7329244|FG007|Part A|Lost to Follow-up|0
4517362|NCT00966875|7329245|FG008|Part A|Lost to Follow-up|0
4517363|NCT00966875|7329237|FG000|Part A|Parent/Caregiver Decision|0
4517364|NCT00966875|7329238|FG001|Part A|Parent/Caregiver Decision|0
4517365|NCT00966875|7329239|FG002|Part A|Parent/Caregiver Decision|0
4517366|NCT00966875|7329240|FG003|Part A|Parent/Caregiver Decision|1
4517367|NCT00966875|7329241|FG004|Part A|Parent/Caregiver Decision|0
4517368|NCT00966875|7329242|FG005|Part A|Parent/Caregiver Decision|0
4517369|NCT00966875|7329243|FG006|Part A|Parent/Caregiver Decision|0
4517370|NCT00966875|7329244|FG007|Part A|Parent/Caregiver Decision|0
4517371|NCT00966875|7329245|FG008|Part A|Parent/Caregiver Decision|0
4517372|NCT00966875|7329237|FG000|Part A|Physician Decision|0
4517373|NCT00966875|7329238|FG001|Part A|Physician Decision|0
4488251|NCT00770653|7289482|FG000|Overall Study|Adverse Event|13
4488252|NCT00770653|7289483|FG001|Overall Study|Adverse Event|5
4488253|NCT00770653|7289482|FG000|Overall Study|Protocol Violation|8
4488254|NCT00770653|7289483|FG001|Overall Study|Protocol Violation|6
4488255|NCT00770653|7289482|FG000|Overall Study|Withdrawal by Subject|4
4488256|NCT00770653|7289483|FG001|Overall Study|Withdrawal by Subject|7
4488257|NCT00770653|7289482|FG000|Overall Study|Lack of Compliance|1
4488258|NCT00770653|7289483|FG001|Overall Study|Lack of Compliance|4
4488259|NCT00770653|7289482|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2
4488260|NCT00770653|7289483|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2
4488261|NCT00770653|7289482|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2
4488262|NCT00770653|7289483|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1
4488263|NCT00770653|7289482|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0
4488264|NCT00770653|7289483|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2
4488265|NCT00770653|7289482|FG000|Overall Study|Lost to Follow-up|1
4488266|NCT00770653|7289483|FG001|Overall Study|Lost to Follow-up|2
4488267|NCT00770653|7289482|FG000|Overall Study|Physician Decision|1
4488268|NCT00770653|7289483|FG001|Overall Study|Physician Decision|0
4488269|NCT00770679|7289489|FG000|Overall Study|Lost to Follow-up|3
4488270|NCT00770679|7289489|FG000|Overall Study|Follow-up LDL measurement not collected|3
4488271|NCT00770692|7289497|FG000|Overall Study|Withdrawal by Subject|7
4488272|NCT00770692|7289498|FG001|Overall Study|Withdrawal by Subject|9
4488273|NCT00770692|7289499|FG002|Overall Study|Withdrawal by Subject|9
4488274|NCT00770692|7289500|FG003|Overall Study|Withdrawal by Subject|6
4488275|NCT00770692|7289497|FG000|Overall Study|Adverse Event|3
4488276|NCT00770692|7289498|FG001|Overall Study|Adverse Event|0
4488277|NCT00770692|7289499|FG002|Overall Study|Adverse Event|4
4488278|NCT00770692|7289500|FG003|Overall Study|Adverse Event|4
4488279|NCT00770692|7289497|FG000|Overall Study|Investigator judgment|2
4488280|NCT00770692|7289498|FG001|Overall Study|Investigator judgment|0
4488281|NCT00770692|7289499|FG002|Overall Study|Investigator judgment|1
4488282|NCT00770692|7289500|FG003|Overall Study|Investigator judgment|1
4488283|NCT00770770|7289516|FG000|Overall Study|Lost to Follow-up|1
4488284|NCT00770770|7289517|FG001|Overall Study|Lost to Follow-up|0
4488285|NCT00770770|7289516|FG000|Overall Study|Withdrawal by Subject|1
4488286|NCT00770770|7289517|FG001|Overall Study|Withdrawal by Subject|0
4488287|NCT00770770|7289516|FG000|Overall Study|Death|0
4488288|NCT00770770|7289517|FG001|Overall Study|Death|1
4488289|NCT00770770|7289516|FG000|Overall Study|Study Terminated|8
4488290|NCT00770770|7289517|FG001|Overall Study|Study Terminated|0
4488291|NCT00770913|7289544|FG000|Overall Study|Adverse Event|1
4488292|NCT00770913|7289545|FG001|Overall Study|Adverse Event|3
4488293|NCT00770913|7289546|FG002|Overall Study|Adverse Event|6
4488294|NCT00770913|7289544|FG000|Overall Study|Refusal to continue participation|6
4488295|NCT00770913|7289545|FG001|Overall Study|Refusal to continue participation|4
4488296|NCT00770913|7289546|FG002|Overall Study|Refusal to continue participation|5
4488297|NCT00770913|7289544|FG000|Overall Study|Physician Decision|0
4488298|NCT00770913|7289545|FG001|Overall Study|Physician Decision|1
4488299|NCT00770913|7289546|FG002|Overall Study|Physician Decision|1
4488300|NCT00770913|7289544|FG000|Overall Study|Protocol Violation|3
4488301|NCT00770913|7289545|FG001|Overall Study|Protocol Violation|0
4488302|NCT00770913|7289546|FG002|Overall Study|Protocol Violation|1
4488303|NCT00770913|7289544|FG000|Overall Study|Incorrect drug was allocated|1
4488304|NCT00770913|7289545|FG001|Overall Study|Incorrect drug was allocated|0
4488305|NCT00770913|7289546|FG002|Overall Study|Incorrect drug was allocated|0
4488306|NCT00770991|7289556|FG000|Overall Study|Physician Decision|2
4488307|NCT00770991|7289557|FG001|Overall Study|Physician Decision|0
4488308|NCT00770991|7289556|FG000|Overall Study|Withdrawal by Subject|1
4488309|NCT00770991|7289557|FG001|Overall Study|Withdrawal by Subject|0
4626475|NCT01840579|7492038|FG002|Overall Study|Follow-up ended by Sponsor|0
4626476|NCT01840579|7492039|FG003|Overall Study|Follow-up ended by Sponsor|0
4626477|NCT01840579|7492040|FG004|Overall Study|Follow-up ended by Sponsor|0
4626478|NCT01840579|7492041|FG005|Overall Study|Follow-up ended by Sponsor|0
4626479|NCT01840579|7492042|FG006|Overall Study|Follow-up ended by Sponsor|2
4626480|NCT01840579|7492043|FG007|Overall Study|Follow-up ended by Sponsor|0
4626481|NCT01840579|7492044|FG008|Overall Study|Follow-up ended by Sponsor|0
4626482|NCT01840579|7492045|FG009|Overall Study|Follow-up ended by Sponsor|0
4626483|NCT01840605|7492081|FG000|Overall Study|Adverse Event|0
4626484|NCT01840605|7492082|FG001|Overall Study|Adverse Event|1
4488310|NCT00770991|7289556|FG000|Overall Study|Adverse Event|1
4488311|NCT00770991|7289557|FG001|Overall Study|Adverse Event|5
4488312|NCT00770991|7289556|FG000|Overall Study|Pregnancy|1
4488313|NCT00770991|7289557|FG001|Overall Study|Pregnancy|0
4488314|NCT00771030|7289575|FG000|Overall Study|Adverse Event|0
4488315|NCT00771030|7289576|FG001|Overall Study|Adverse Event|1
4488316|NCT00771030|7289577|FG002|Overall Study|Adverse Event|0
4488317|NCT00771030|7289578|FG003|Overall Study|Adverse Event|0
4488318|NCT00771030|7289579|FG004|Overall Study|Adverse Event|0
4488319|NCT00771030|7289580|FG005|Overall Study|Adverse Event|0
4488320|NCT00771030|7289581|FG006|Overall Study|Adverse Event|0
4488321|NCT00771472|7289646|FG000|Overall Study|Physician Decision|2
4626485|NCT01840605|7492081|FG000|Overall Study|Physician Decision|2
4626486|NCT01840605|7492082|FG001|Overall Study|Physician Decision|1
4626487|NCT01840943|7492099|FG000|Overall Study|Withdrawal by Subject|5
4488322|NCT00771472|7289647|FG001|Overall Study|Physician Decision|3
4488323|NCT00771472|7289646|FG000|Overall Study|Progressive Disease|3
4488324|NCT00771472|7289647|FG001|Overall Study|Progressive Disease|1
4488325|NCT00771472|7289646|FG000|Overall Study|Protocol Violation|1
4488326|NCT00771472|7289647|FG001|Overall Study|Protocol Violation|0
4488327|NCT00771615|7289718|FG000|Overall Study|Withdrawal by Subject|0
4488328|NCT00771615|7289719|FG001|Overall Study|Withdrawal by Subject|1
4488329|NCT00771615|7289720|FG002|Overall Study|Withdrawal by Subject|0
4488330|NCT00771615|7289721|FG003|Overall Study|Withdrawal by Subject|0
4488331|NCT00771615|7289722|FG004|Overall Study|Withdrawal by Subject|0
4488332|NCT00771615|7289723|FG005|Overall Study|Withdrawal by Subject|0
4488333|NCT00771615|7289724|FG006|Overall Study|Withdrawal by Subject|0
4488334|NCT00771615|7289725|FG007|Overall Study|Withdrawal by Subject|1
4488335|NCT00771615|7289726|FG008|Overall Study|Withdrawal by Subject|0
4488336|NCT00771615|7289718|FG000|Overall Study|Lost to Follow-up|1
4488337|NCT00771615|7289719|FG001|Overall Study|Lost to Follow-up|1
4488338|NCT00771615|7289720|FG002|Overall Study|Lost to Follow-up|1
4488339|NCT00771615|7289721|FG003|Overall Study|Lost to Follow-up|1
4488340|NCT00771615|7289722|FG004|Overall Study|Lost to Follow-up|0
4488341|NCT00771615|7289723|FG005|Overall Study|Lost to Follow-up|1
4488342|NCT00771615|7289724|FG006|Overall Study|Lost to Follow-up|1
4488343|NCT00771615|7289725|FG007|Overall Study|Lost to Follow-up|0
4488344|NCT00771615|7289726|FG008|Overall Study|Lost to Follow-up|0
4488345|NCT00771667|7289759|FG000|Induction Phase|Adverse Event|5
4488346|NCT00771667|7289760|FG001|Induction Phase|Adverse Event|2
4488347|NCT00771667|7289761|FG002|Induction Phase|Adverse Event|4
4488348|NCT00771667|7289762|FG003|Induction Phase|Adverse Event|1
4488349|NCT00771667|7289763|FG004|Induction Phase|Adverse Event|0
4488350|NCT00771667|7289764|FG005|Induction Phase|Adverse Event|0
4488351|NCT00771667|7289765|FG006|Induction Phase|Adverse Event|0
4488352|NCT00771667|7289766|FG007|Induction Phase|Adverse Event|0
4488353|NCT00771667|7289767|FG008|Induction Phase|Adverse Event|0
4488354|NCT00771667|7289768|FG009|Induction Phase|Adverse Event|0
4488355|NCT00771667|7289759|FG000|Induction Phase|Lack of Efficacy|9
4488356|NCT00771667|7289760|FG001|Induction Phase|Lack of Efficacy|2
4488357|NCT00771667|7289761|FG002|Induction Phase|Lack of Efficacy|4
4488358|NCT00771667|7289762|FG003|Induction Phase|Lack of Efficacy|3
4488359|NCT00771667|7289763|FG004|Induction Phase|Lack of Efficacy|0
4488360|NCT00771667|7289764|FG005|Induction Phase|Lack of Efficacy|0
4488361|NCT00771667|7289765|FG006|Induction Phase|Lack of Efficacy|0
4488362|NCT00771667|7289766|FG007|Induction Phase|Lack of Efficacy|0
4488363|NCT00771667|7289767|FG008|Induction Phase|Lack of Efficacy|0
4488364|NCT00771667|7289768|FG009|Induction Phase|Lack of Efficacy|0
4488365|NCT00771667|7289759|FG000|Induction Phase|Lost to Follow-up|1
4488366|NCT00771667|7289760|FG001|Induction Phase|Lost to Follow-up|0
4488367|NCT00771667|7289761|FG002|Induction Phase|Lost to Follow-up|1
4488368|NCT00771667|7289762|FG003|Induction Phase|Lost to Follow-up|0
4488369|NCT00771667|7289763|FG004|Induction Phase|Lost to Follow-up|0
4488370|NCT00771667|7289764|FG005|Induction Phase|Lost to Follow-up|0
4488371|NCT00771667|7289765|FG006|Induction Phase|Lost to Follow-up|0
4488372|NCT00771667|7289766|FG007|Induction Phase|Lost to Follow-up|0
4488373|NCT00771667|7289767|FG008|Induction Phase|Lost to Follow-up|0
4488374|NCT00771667|7289768|FG009|Induction Phase|Lost to Follow-up|0
4488375|NCT00771667|7289759|FG000|Induction Phase|Other|4
4488376|NCT00771667|7289760|FG001|Induction Phase|Other|6
4488377|NCT00771667|7289761|FG002|Induction Phase|Other|3
4488378|NCT00771667|7289762|FG003|Induction Phase|Other|4
4488379|NCT00771667|7289763|FG004|Induction Phase|Other|0
4488380|NCT00771667|7289764|FG005|Induction Phase|Other|0
4488381|NCT00771667|7289765|FG006|Induction Phase|Other|0
4488382|NCT00771667|7289766|FG007|Induction Phase|Other|0
4488383|NCT00771667|7289767|FG008|Induction Phase|Other|0
4488384|NCT00771667|7289768|FG009|Induction Phase|Other|0
4488385|NCT00771667|7289759|FG000|Maintenance Phase|Adverse Event|0
4488386|NCT00771667|7289760|FG001|Maintenance Phase|Adverse Event|0
4488387|NCT00771667|7289761|FG002|Maintenance Phase|Adverse Event|0
4488388|NCT00771667|7289762|FG003|Maintenance Phase|Adverse Event|0
4488389|NCT00771667|7289763|FG004|Maintenance Phase|Adverse Event|1
4488390|NCT00771667|7289764|FG005|Maintenance Phase|Adverse Event|3
4488391|NCT00771667|7289765|FG006|Maintenance Phase|Adverse Event|5
4488392|NCT00771667|7289766|FG007|Maintenance Phase|Adverse Event|1
4488393|NCT00771667|7289767|FG008|Maintenance Phase|Adverse Event|8
4488394|NCT00771667|7289768|FG009|Maintenance Phase|Adverse Event|7
4488395|NCT00771667|7289759|FG000|Maintenance Phase|Lack of Efficacy|0
4488396|NCT00771667|7289760|FG001|Maintenance Phase|Lack of Efficacy|0
4488397|NCT00771667|7289761|FG002|Maintenance Phase|Lack of Efficacy|0
4488398|NCT00771667|7289762|FG003|Maintenance Phase|Lack of Efficacy|0
4488399|NCT00771667|7289763|FG004|Maintenance Phase|Lack of Efficacy|1
4488400|NCT00771667|7289764|FG005|Maintenance Phase|Lack of Efficacy|3
4488401|NCT00771667|7289765|FG006|Maintenance Phase|Lack of Efficacy|3
4488402|NCT00771667|7289766|FG007|Maintenance Phase|Lack of Efficacy|2
4488403|NCT00771667|7289767|FG008|Maintenance Phase|Lack of Efficacy|11
4488404|NCT00771667|7289768|FG009|Maintenance Phase|Lack of Efficacy|7
4488405|NCT00771667|7289759|FG000|Maintenance Phase|Other|0
4488406|NCT00771667|7289760|FG001|Maintenance Phase|Other|0
4488407|NCT00771667|7289761|FG002|Maintenance Phase|Other|0
4488408|NCT00771667|7289762|FG003|Maintenance Phase|Other|0
4488409|NCT00771667|7289763|FG004|Maintenance Phase|Other|0
4488410|NCT00771667|7289764|FG005|Maintenance Phase|Other|1
4488411|NCT00771667|7289765|FG006|Maintenance Phase|Other|2
4488412|NCT00771667|7289766|FG007|Maintenance Phase|Other|2
4488413|NCT00771667|7289767|FG008|Maintenance Phase|Other|3
4488414|NCT00771667|7289768|FG009|Maintenance Phase|Other|3
4488415|NCT00771758|7289798|FG000|Overall Study|Adverse Event|2
4488416|NCT00771758|7289799|FG001|Overall Study|Adverse Event|8
4488417|NCT00771758|7289800|FG002|Overall Study|Adverse Event|1
4488418|NCT00771758|7289798|FG000|Overall Study|Lack of Efficacy|0
4488419|NCT00771758|7289799|FG001|Overall Study|Lack of Efficacy|2
4488420|NCT00771758|7289800|FG002|Overall Study|Lack of Efficacy|1
4488421|NCT00771758|7289798|FG000|Overall Study|Lost to Follow-up|1
4488422|NCT00771758|7289799|FG001|Overall Study|Lost to Follow-up|0
4488423|NCT00771758|7289800|FG002|Overall Study|Lost to Follow-up|0
4488424|NCT00771758|7289798|FG000|Overall Study|Protocol Violation|1
4488425|NCT00771758|7289799|FG001|Overall Study|Protocol Violation|0
4488426|NCT00771758|7289800|FG002|Overall Study|Protocol Violation|0
4488427|NCT00771758|7289798|FG000|Overall Study|Withdrawal by Subject|1
4488428|NCT00771758|7289799|FG001|Overall Study|Withdrawal by Subject|0
4488429|NCT00771758|7289800|FG002|Overall Study|Withdrawal by Subject|0
4488430|NCT00771758|7289798|FG000|Overall Study|Other|3
4488431|NCT00771758|7289799|FG001|Overall Study|Other|2
4488432|NCT00771758|7289800|FG002|Overall Study|Other|0
4488433|NCT00771810|7289828|FG000|Overall Study|Adverse Event|3
4488434|NCT00771810|7289829|FG001|Overall Study|Adverse Event|0
4488435|NCT00771810|7289830|FG002|Overall Study|Adverse Event|2
4488436|NCT00771810|7289828|FG000|Overall Study|Lost to Follow-up|0
4488437|NCT00771810|7289829|FG001|Overall Study|Lost to Follow-up|0
4488438|NCT00771810|7289830|FG002|Overall Study|Lost to Follow-up|1
4488439|NCT00771810|7289828|FG000|Overall Study|Physician Decision|1
4488440|NCT00771810|7289829|FG001|Overall Study|Physician Decision|2
4488441|NCT00771810|7289830|FG002|Overall Study|Physician Decision|2
4488442|NCT00771810|7289828|FG000|Overall Study|Protocol Violation|0
4488443|NCT00771810|7289829|FG001|Overall Study|Protocol Violation|1
4488444|NCT00771810|7289830|FG002|Overall Study|Protocol Violation|1
4488445|NCT00771810|7289828|FG000|Overall Study|Withdrawal by Subject|1
4488446|NCT00771810|7289829|FG001|Overall Study|Withdrawal by Subject|2
4488447|NCT00771810|7289830|FG002|Overall Study|Withdrawal by Subject|0
4626488|NCT01840943|7492100|FG001|Overall Study|Withdrawal by Subject|6
4626489|NCT01840943|7492099|FG000|Overall Study|Physician Decision|4
4626490|NCT01840943|7492100|FG001|Overall Study|Physician Decision|2
4626491|NCT01840943|7492099|FG000|Overall Study|Lost to Follow-up|4
4626492|NCT01840943|7492100|FG001|Overall Study|Lost to Follow-up|4
4626493|NCT01841060|7492114|FG000|Overall Study|Protocol Violation|10
4626494|NCT01841073|7492120|FG000|Overall Study|Adverse Event|1
4626495|NCT01841073|7492121|FG001|Overall Study|Adverse Event|1
4626496|NCT01841073|7492120|FG000|Overall Study|Physician Decision|1
4626497|NCT01841073|7492121|FG001|Overall Study|Physician Decision|0
4626498|NCT01841073|7492120|FG000|Overall Study|Lost to Follow-up|0
4626499|NCT01841073|7492121|FG001|Overall Study|Lost to Follow-up|2
4626500|NCT01841554|7492159|FG000|Overall Study|Death|7
4626501|NCT01841554|7492159|FG000|Overall Study|No Implantation|1
4626502|NCT01841554|7492159|FG000|Overall Study|Discontinued Follow Up|5
4626503|NCT01841554|7492159|FG000|Overall Study|Study exit due to secondary intervention|6
4488448|NCT00771810|7289828|FG000|Overall Study|Other|0
4488449|NCT00771810|7289829|FG001|Overall Study|Other|0
4488450|NCT00771810|7289830|FG002|Overall Study|Other|1
4488451|NCT00771849|7289841|FG000|Overall Study|Lost to Follow-up|1
4488452|NCT00771849|7289842|FG001|Overall Study|Lost to Follow-up|2
4488453|NCT00771849|7289841|FG000|Overall Study|Withdrawal by Subject|1
4488454|NCT00771849|7289842|FG001|Overall Study|Withdrawal by Subject|1
4488455|NCT00771849|7289841|FG000|Overall Study|Not vaccinated|0
4488456|NCT00771849|7289842|FG001|Overall Study|Not vaccinated|1
4488457|NCT00771901|7289864|FG000|Overall Study|Dissat w/# of study medication (40/day)|0
4488458|NCT00771901|7289865|FG001|Overall Study|Dissat w/# of study medication (40/day)|0
4488459|NCT00771901|7289866|FG002|Overall Study|Dissat w/# of study medication (40/day)|4
4488460|NCT00771914|7289878|FG000|Overall Study|Physician Decision|0
4488461|NCT00771914|7289879|FG001|Overall Study|Physician Decision|0
4488462|NCT00771914|7289880|FG002|Overall Study|Physician Decision|0
4488463|NCT00771914|7289881|FG003|Overall Study|Physician Decision|1
4488464|NCT00771914|7289878|FG000|Overall Study|Lost to Follow-up|0
4488465|NCT00771914|7289879|FG001|Overall Study|Lost to Follow-up|0
4488466|NCT00771914|7289880|FG002|Overall Study|Lost to Follow-up|0
4488467|NCT00771914|7289881|FG003|Overall Study|Lost to Follow-up|1
4488468|NCT00771927|7289893|FG000|Overall Study|Adverse Event|100
4488469|NCT00771927|7289894|FG001|Overall Study|Adverse Event|105
4488470|NCT00771927|7289893|FG000|Overall Study|Lack of Efficacy|70
4488471|NCT00771927|7289894|FG001|Overall Study|Lack of Efficacy|42
4488472|NCT00771927|7289893|FG000|Overall Study|Lost to Follow-up|46
4488473|NCT00771927|7289894|FG001|Overall Study|Lost to Follow-up|46
4488474|NCT00771927|7289893|FG000|Overall Study|Withdrawal by Subject|16
4488475|NCT00771927|7289894|FG001|Overall Study|Withdrawal by Subject|17
4488476|NCT00771927|7289893|FG000|Overall Study|Other reason|23
4626504|NCT01841567|7492163|FG000|Overall Study|Adverse Event|3
4626505|NCT01841593|7492169|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0
4626506|NCT01841593|7492170|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1
4488477|NCT00771927|7289894|FG001|Overall Study|Other reason|27
4488478|NCT00771953|7289902|FG000|Overall Study|Adverse Event|5
4488479|NCT00771953|7289903|FG001|Overall Study|Adverse Event|3
4488480|NCT00771953|7289902|FG000|Overall Study|Death|2
4488481|NCT00771953|7289903|FG001|Overall Study|Death|2
4488482|NCT00771953|7289902|FG000|Overall Study|Progression before active Tx|1
4488483|NCT00771953|7289903|FG001|Overall Study|Progression before active Tx|2
4488484|NCT00771953|7289902|FG000|Overall Study|Sponsor decision|1
4488485|NCT00771953|7289903|FG001|Overall Study|Sponsor decision|0
4488486|NCT00771953|7289902|FG000|Overall Study|Other complicating disease|1
4488487|NCT00771953|7289903|FG001|Overall Study|Other complicating disease|0
4488488|NCT00771953|7289902|FG000|Overall Study|Withdrawal by Subject|0
4488489|NCT00771953|7289903|FG001|Overall Study|Withdrawal by Subject|3
4488490|NCT00772005|7289915|FG000|Overall Study|Adverse Event|9
4488491|NCT00772005|7289916|FG001|Overall Study|Adverse Event|14
4488492|NCT00772005|7289917|FG002|Overall Study|Adverse Event|10
4488493|NCT00772005|7289918|FG003|Overall Study|Adverse Event|13
4488494|NCT00772005|7289915|FG000|Overall Study|Lack of Efficacy|0
4488495|NCT00772005|7289916|FG001|Overall Study|Lack of Efficacy|1
4488496|NCT00772005|7289917|FG002|Overall Study|Lack of Efficacy|0
4488497|NCT00772005|7289918|FG003|Overall Study|Lack of Efficacy|0
4488498|NCT00772005|7289915|FG000|Overall Study|Withdrawal by Subject|3
4488499|NCT00772005|7289916|FG001|Overall Study|Withdrawal by Subject|7
4488500|NCT00772005|7289917|FG002|Overall Study|Withdrawal by Subject|10
4488501|NCT00772005|7289918|FG003|Overall Study|Withdrawal by Subject|2
4488502|NCT00772005|7289915|FG000|Overall Study|Protocol Violation|2
4488503|NCT00772005|7289916|FG001|Overall Study|Protocol Violation|4
4488504|NCT00772005|7289917|FG002|Overall Study|Protocol Violation|1
4488505|NCT00772005|7289918|FG003|Overall Study|Protocol Violation|6
4488506|NCT00772005|7289915|FG000|Overall Study|Lost to Follow-up|7
4488507|NCT00772005|7289916|FG001|Overall Study|Lost to Follow-up|3
4488508|NCT00772005|7289917|FG002|Overall Study|Lost to Follow-up|6
4488509|NCT00772005|7289918|FG003|Overall Study|Lost to Follow-up|3
4488510|NCT00772005|7289915|FG000|Overall Study|Non-compliance with study procedures|1
4488511|NCT00772005|7289916|FG001|Overall Study|Non-compliance with study procedures|1
4488512|NCT00772005|7289917|FG002|Overall Study|Non-compliance with study procedures|0
4488513|NCT00772005|7289918|FG003|Overall Study|Non-compliance with study procedures|1
4488514|NCT00772005|7289915|FG000|Overall Study|Non-compliance with drug administration|3
4488515|NCT00772005|7289916|FG001|Overall Study|Non-compliance with drug administration|0
4488516|NCT00772005|7289917|FG002|Overall Study|Non-compliance with drug administration|1
4488517|NCT00772005|7289918|FG003|Overall Study|Non-compliance with drug administration|1
4488518|NCT00772031|7289930|FG000|Overall Study|Early termination of trial|12
4488519|NCT00772031|7289931|FG001|Overall Study|Early termination of trial|10
4488520|NCT00772031|7289930|FG000|Overall Study|Lost to Follow-up|20
4488521|NCT00772031|7289931|FG001|Overall Study|Lost to Follow-up|33
4488522|NCT00772070|7289945|FG000|Overall Study|Lost to Follow-up|0
4488523|NCT00772070|7289946|FG001|Overall Study|Lost to Follow-up|8
4488524|NCT00772070|7289945|FG000|Overall Study|Withdrawal by Subject|0
4488525|NCT00772070|7289946|FG001|Overall Study|Withdrawal by Subject|2
4488526|NCT00772070|7289945|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2
4488527|NCT00772070|7289946|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0
4488528|NCT00772109|7289956|FG000|Overall Study|Serious adverse event|1
4488529|NCT00772109|7289957|FG001|Overall Study|Serious adverse event|0
4488530|NCT00772109|7289958|FG002|Overall Study|Serious adverse event|1
4488531|NCT00772109|7289959|FG003|Overall Study|Serious adverse event|0
4488532|NCT00772109|7289956|FG000|Overall Study|Protocol Violation|5
4488533|NCT00772109|7289957|FG001|Overall Study|Protocol Violation|8
4488534|NCT00772109|7289958|FG002|Overall Study|Protocol Violation|7
4488535|NCT00772109|7289959|FG003|Overall Study|Protocol Violation|6
4488536|NCT00772109|7289956|FG000|Overall Study|Lost to Follow-up|7
4488537|NCT00772109|7289957|FG001|Overall Study|Lost to Follow-up|3
4488538|NCT00772109|7289958|FG002|Overall Study|Lost to Follow-up|5
4590200|NCT01519245|7435896|FG000|Overall Study|Met exclusion criteria, not analysed|1
4590201|NCT01519245|7435897|FG001|Overall Study|Met exclusion criteria, not analysed|2
4488539|NCT00772109|7289959|FG003|Overall Study|Lost to Follow-up|9
4488540|NCT00772109|7289956|FG000|Overall Study|Withdrawal by Subject|8
4488541|NCT00772109|7289957|FG001|Overall Study|Withdrawal by Subject|8
4488542|NCT00772109|7289958|FG002|Overall Study|Withdrawal by Subject|6
4488543|NCT00772109|7289959|FG003|Overall Study|Withdrawal by Subject|16
4488544|NCT00772148|7289971|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3
4488545|NCT00772148|7289972|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1
4488546|NCT00772148|7289971|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3
4488547|NCT00772148|7289972|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5
4488548|NCT00772148|7289971|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2
4488549|NCT00772148|7289972|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0
4488550|NCT00772148|7289971|FG000|Maintenance Phase (Week 52)|Death|2
4488551|NCT00772148|7289972|FG001|Maintenance Phase (Week 52)|Death|2
4488552|NCT00772148|7289971|FG000|Maintenance Phase (Week 52)|Adverse Event|1
4488553|NCT00772148|7289972|FG001|Maintenance Phase (Week 52)|Adverse Event|0
4488554|NCT00772148|7289971|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0
4626507|NCT01841593|7492169|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1
4488555|NCT00772148|7289972|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1
4488556|NCT00772148|7289971|FG000|Maintenance Phase (Week 52)|Administrative/other|1
4488557|NCT00772148|7289972|FG001|Maintenance Phase (Week 52)|Administrative/other|2
4488558|NCT00772330|7289982|FG000|Overall Study|Lost to Follow-up|3
4488559|NCT00772369|7289989|FG000|Overall Study|Did not return record release form|1
4488560|NCT00772382|7289993|FG000|Overall Study|Adverse Event|19
4488561|NCT00772382|7289993|FG000|Overall Study|Death|6
4488562|NCT00772382|7289993|FG000|Overall Study|Lack of Efficacy|4
4488563|NCT00772382|7289993|FG000|Overall Study|Physician Decision|5
4488564|NCT00772382|7289993|FG000|Overall Study|Protocol Violation|1
4488565|NCT00772382|7289993|FG000|Overall Study|Withdrawal by Subject|10
4488566|NCT00772382|7289993|FG000|Overall Study|Other Reasons|10
4488567|NCT00772447|7289999|FG000|Overall Study|Withdrawal by Subject|9
4488568|NCT00772447|7290000|FG001|Overall Study|Withdrawal by Subject|5
4488569|NCT00772447|7289999|FG000|Overall Study|Physician Decision|4
4488570|NCT00772447|7290000|FG001|Overall Study|Physician Decision|8
4488571|NCT00772447|7289999|FG000|Overall Study|Lost to Follow-up|2
4488572|NCT00772447|7290000|FG001|Overall Study|Lost to Follow-up|4
4488573|NCT00772447|7289999|FG000|Overall Study|incorrect enrolment|3
4488574|NCT00772447|7290000|FG001|Overall Study|incorrect enrolment|4
4488575|NCT00772447|7289999|FG000|Overall Study|Protocol Violation|0
4488576|NCT00772447|7290000|FG001|Overall Study|Protocol Violation|1
4488577|NCT00772447|7289999|FG000|Overall Study|all others|2
4488578|NCT00772447|7290000|FG001|Overall Study|all others|2
4488579|NCT00772538|7290009|FG000|Overall Study|Adverse Event|6
4488580|NCT00772538|7290010|FG001|Overall Study|Adverse Event|6
4488581|NCT00772538|7290009|FG000|Overall Study|Protocol Violation|3
4488582|NCT00772538|7290010|FG001|Overall Study|Protocol Violation|3
4626508|NCT01841593|7492170|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0
4626509|NCT01841697|7492199|FG000|Overall Study|Death|0
4626510|NCT01841697|7492200|FG001|Overall Study|Death|1
4626511|NCT01841697|7492199|FG000|Overall Study|Lost to Follow-up|4
4626512|NCT01841697|7492200|FG001|Overall Study|Lost to Follow-up|1
4488583|NCT00772538|7290009|FG000|Overall Study|Lost to Follow-up|1
4488584|NCT00772538|7290010|FG001|Overall Study|Lost to Follow-up|1
4488585|NCT00772538|7290009|FG000|Overall Study|Withdrawal by Subject|3
4488586|NCT00772538|7290010|FG001|Overall Study|Withdrawal by Subject|8
4488587|NCT00772538|7290009|FG000|Overall Study|Lack of Efficacy|0
4488588|NCT00772538|7290010|FG001|Overall Study|Lack of Efficacy|1
4488589|NCT00772538|7290009|FG000|Overall Study|Other|7
4488590|NCT00772538|7290010|FG001|Overall Study|Other|7
4488591|NCT00772577|7290018|FG000|Overall Study|Adverse Event|6
4488592|NCT00772577|7290019|FG001|Overall Study|Adverse Event|3
4488593|NCT00772577|7290018|FG000|Overall Study|Abnormal laboratory values|0
4488594|NCT00772577|7290019|FG001|Overall Study|Abnormal laboratory values|1
4488595|NCT00772577|7290018|FG000|Overall Study|Unsatisfactory therapeutic effect|0
4488596|NCT00772577|7290019|FG001|Overall Study|Unsatisfactory therapeutic effect|8
4488597|NCT00772577|7290018|FG000|Overall Study|Patient withdrew consent|8
4488598|NCT00772577|7290019|FG001|Overall Study|Patient withdrew consent|5
4488599|NCT00772577|7290018|FG000|Overall Study|Lost to Follow-up|4
4488600|NCT00772577|7290019|FG001|Overall Study|Lost to Follow-up|3
4488601|NCT00772577|7290018|FG000|Overall Study|Administrative problems|2
4488602|NCT00772577|7290019|FG001|Overall Study|Administrative problems|1
4488603|NCT00772577|7290018|FG000|Overall Study|Protocol Deviation|3
4488604|NCT00772577|7290019|FG001|Overall Study|Protocol Deviation|2
4488605|NCT00772603|7290045|FG000|Overall Study|Withdrawal by Subject|11
4488606|NCT00772603|7290046|FG001|Overall Study|Withdrawal by Subject|10
4488607|NCT00772603|7290047|FG002|Overall Study|Withdrawal by Subject|6
4488608|NCT00772603|7290045|FG000|Overall Study|Adverse Event|37
4488609|NCT00772603|7290046|FG001|Overall Study|Adverse Event|18
4488610|NCT00772603|7290047|FG002|Overall Study|Adverse Event|10
4488611|NCT00772603|7290045|FG000|Overall Study|Subject Non-compliance|1
4488612|NCT00772603|7290046|FG001|Overall Study|Subject Non-compliance|6
4488613|NCT00772603|7290047|FG002|Overall Study|Subject Non-compliance|4
4488614|NCT00772603|7290045|FG000|Overall Study|Protocol Violation|0
4488615|NCT00772603|7290046|FG001|Overall Study|Protocol Violation|1
4488616|NCT00772603|7290047|FG002|Overall Study|Protocol Violation|1
4488617|NCT00772603|7290045|FG000|Overall Study|Lost to Follow-up|1
4488618|NCT00772603|7290046|FG001|Overall Study|Lost to Follow-up|5
4488619|NCT00772603|7290047|FG002|Overall Study|Lost to Follow-up|2
4488620|NCT00772603|7290045|FG000|Overall Study|Physician Decision|0
4488621|NCT00772603|7290046|FG001|Overall Study|Physician Decision|0
4488622|NCT00772603|7290047|FG002|Overall Study|Physician Decision|1
4488623|NCT00772603|7290045|FG000|Overall Study|Other|2
4488624|NCT00772603|7290046|FG001|Overall Study|Other|0
4488625|NCT00772603|7290047|FG002|Overall Study|Other|2
4488626|NCT00772629|7290060|FG000|Overall Study|Subject was not vaccinated|1
4488627|NCT00772629|7290061|FG001|Overall Study|Subject was not vaccinated|0
4488628|NCT00772668|7290067|FG000|Overall Study|Physician Decision|3
4488629|NCT00772707|7290072|FG000|Overall Study|Withdrawn|3
4488630|NCT00772889|7290084|FG000|Overall Study|Adverse Event|7
4488631|NCT00772889|7290085|FG001|Overall Study|Adverse Event|4
4488632|NCT00772889|7290086|FG002|Overall Study|Adverse Event|0
4488633|NCT00772889|7290084|FG000|Overall Study|Withdrawal by Subject|9
4488634|NCT00772889|7290085|FG001|Overall Study|Withdrawal by Subject|8
4488635|NCT00772889|7290086|FG002|Overall Study|Withdrawal by Subject|9
4488636|NCT00772889|7290084|FG000|Overall Study|Lost to Follow-up|6
4488637|NCT00772889|7290085|FG001|Overall Study|Lost to Follow-up|6
4488638|NCT00772889|7290086|FG002|Overall Study|Lost to Follow-up|7
4488639|NCT00772928|7290100|FG000|Overall Study|Lost to Follow-up|9
4488640|NCT00772928|7290101|FG001|Overall Study|Lost to Follow-up|6
4488641|NCT00772928|7290100|FG000|Overall Study|Protocol Violation|10
4488642|NCT00772928|7290101|FG001|Overall Study|Protocol Violation|12
4488643|NCT00772928|7290100|FG000|Overall Study|Withdrawal by Subject|25
4488644|NCT00772928|7290101|FG001|Overall Study|Withdrawal by Subject|22
4488645|NCT00772928|7290100|FG000|Overall Study|Did not receive vaccine|0
4488646|NCT00772928|7290101|FG001|Overall Study|Did not receive vaccine|1
4488647|NCT00772941|7290107|FG000|Overall Study|CRFs not available|195
4488648|NCT00772941|7290107|FG000|Overall Study|Study not completed|16
4488649|NCT00772941|7290107|FG000|Overall Study|Missed Visits|374
4488650|NCT00772941|7290107|FG000|Overall Study|Poor Compliance|7
4488651|NCT00772941|7290107|FG000|Overall Study|GPSP Violation|90
4488652|NCT00772954|7290137|FG000|Overall Study|Adverse Event|0
4488653|NCT00772954|7290138|FG001|Overall Study|Adverse Event|0
4488654|NCT00772954|7290139|FG002|Overall Study|Adverse Event|1
4488655|NCT00772967|7290147|FG000|Crossover Treatment 1|Adverse Event (Pain)|0
4488656|NCT00772967|7290148|FG001|Crossover Treatment 1|Adverse Event (Pain)|0
4488657|NCT00772967|7290149|FG002|Crossover Treatment 1|Adverse Event (Pain)|0
4488658|NCT00772967|7290150|FG003|Crossover Treatment 1|Adverse Event (Pain)|1
4488659|NCT00772967|7290151|FG004|Crossover Treatment 1|Adverse Event (Pain)|0
4488660|NCT00772967|7290152|FG005|Crossover Treatment 1|Adverse Event (Pain)|0
4488661|NCT00772967|7290147|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0
4488662|NCT00772967|7290148|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1
4488663|NCT00772967|7290149|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0
4488664|NCT00772967|7290150|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0
4488665|NCT00772967|7290151|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0
4488666|NCT00772967|7290152|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0
4488667|NCT00772967|7290147|FG000|Crossover Treatment 3|Adverse Event|0
4488668|NCT00772967|7290148|FG001|Crossover Treatment 3|Adverse Event|0
4488669|NCT00772967|7290149|FG002|Crossover Treatment 3|Adverse Event|0
4488670|NCT00772967|7290150|FG003|Crossover Treatment 3|Adverse Event|0
4488671|NCT00772967|7290151|FG004|Crossover Treatment 3|Adverse Event|1
4488672|NCT00772967|7290152|FG005|Crossover Treatment 3|Adverse Event|0
4488673|NCT00773097|7290160|FG000|Overall Study|Withdrawal by Subject|1
4488674|NCT00773097|7290160|FG000|Overall Study|Physician Decision|6
4488675|NCT00773136|7290164|FG000|Overall Study|Physician Decision|2
4488676|NCT00773175|7290171|FG000|Overall Study|Adverse Event|2
4488677|NCT00773175|7290172|FG001|Overall Study|Adverse Event|0
4488678|NCT00773175|7290171|FG000|Overall Study|Consent Withdrawn|0
4488679|NCT00773175|7290172|FG001|Overall Study|Consent Withdrawn|2
4488680|NCT00773253|7290185|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0
4488681|NCT00773253|7290186|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1
4488682|NCT00773279|7290194|FG000|Period 1|Adverse Event|2
4488683|NCT00773279|7290195|FG001|Period 1|Adverse Event|1
4488684|NCT00773279|7290194|FG000|Period 1|Lack of Efficacy|0
4488685|NCT00773279|7290195|FG001|Period 1|Lack of Efficacy|2
4488686|NCT00773279|7290194|FG000|Period 1|Unclassified|5
4488687|NCT00773279|7290195|FG001|Period 1|Unclassified|1
4488688|NCT00773279|7290194|FG000|Period 2|Adverse Event|0
4488689|NCT00773279|7290195|FG001|Period 2|Adverse Event|1
4488690|NCT00773279|7290194|FG000|Period 2|Lack of Efficacy|1
4488691|NCT00773279|7290195|FG001|Period 2|Lack of Efficacy|0
4488692|NCT00773279|7290194|FG000|Period 2|Protocol Violation|0
4488693|NCT00773279|7290195|FG001|Period 2|Protocol Violation|3
4488694|NCT00773279|7290194|FG000|Period 2|Unclassified|2
4488695|NCT00773279|7290195|FG001|Period 2|Unclassified|2
4488696|NCT00773292|7290202|FG000|Treatment 48 Weeks|Adverse Event|1
4488697|NCT00773292|7290202|FG000|Treatment 48 Weeks|Lack of Efficacy|1
4488698|NCT00773383|7290215|FG000|Overall Study|Adverse Event|4
4488699|NCT00773383|7290215|FG000|Overall Study|Death|1
4488700|NCT00773383|7290215|FG000|Overall Study|Progression of Disease|23
4488701|NCT00773383|7290215|FG000|Overall Study|Other|2
4488702|NCT00773383|7290215|FG000|Overall Study|No study dose received|1
4488703|NCT00773461|7290238|FG000|Overall Study|Adverse Event|1
4488704|NCT00773461|7290239|FG001|Overall Study|Adverse Event|3
4488705|NCT00773461|7290238|FG000|Overall Study|Withdrawal by Subject|4
4488706|NCT00773461|7290239|FG001|Overall Study|Withdrawal by Subject|1
4590202|NCT01519323|7435937|FG000|Overall Study|Death|3
4488707|NCT00773513|7290252|FG000|Overall Study|Renal Transplant|254
4488708|NCT00773513|7290253|FG001|Overall Study|Renal Transplant|263
4488709|NCT00773513|7290252|FG000|Overall Study|Adverse Event / Intercurrent Illness|40
4488710|NCT00773513|7290253|FG001|Overall Study|Adverse Event / Intercurrent Illness|48
4488711|NCT00773513|7290252|FG000|Overall Study|Withdrew Consent|68
4488712|NCT00773513|7290253|FG001|Overall Study|Withdrew Consent|69
4488713|NCT00773513|7290252|FG000|Overall Study|Refused Treatment / Did not Cooperate|26
4488714|NCT00773513|7290253|FG001|Overall Study|Refused Treatment / Did not Cooperate|32
4488715|NCT00773513|7290252|FG000|Overall Study|Failure to Return|22
4488716|NCT00773513|7290253|FG001|Overall Study|Failure to Return|8
4488717|NCT00773513|7290252|FG000|Overall Study|Insufficient Therapeutic Response|1
4488718|NCT00773513|7290253|FG001|Overall Study|Insufficient Therapeutic Response|18
4488719|NCT00773513|7290252|FG000|Overall Study|Reason Not Specified|159
4488720|NCT00773513|7290253|FG001|Overall Study|Reason Not Specified|126
4488721|NCT00773513|7290252|FG000|Overall Study|Death|531
4488722|NCT00773513|7290253|FG001|Overall Study|Death|545
4488723|NCT00773734|7290267|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5
4488724|NCT00773734|7290268|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1
4488725|NCT00773734|7290269|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8
4488726|NCT00773734|7290270|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10
4488727|NCT00773734|7290271|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0
4488728|NCT00773734|7290272|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0
4488729|NCT00773734|7290267|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4
4701544|NCT02709746|7618445|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2
4701545|NCT02709746|7618441|FG000|Phase B (Double-blind Treatment Period)|Other|0
4701546|NCT02709746|7618442|FG001|Phase B (Double-blind Treatment Period)|Other|6
4701547|NCT02709746|7618443|FG002|Phase B (Double-blind Treatment Period)|Other|5
4701548|NCT02709746|7618444|FG003|Phase B (Double-blind Treatment Period)|Other|6
4701549|NCT02709746|7618445|FG004|Phase B (Double-blind Treatment Period)|Other|7
4701550|NCT02709746|7618441|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0
4701551|NCT02709746|7618442|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1
4701552|NCT02709746|7618443|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4
4701553|NCT02709746|7618444|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1
4701554|NCT02709746|7618445|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0
4701555|NCT02709746|7618441|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0
4701556|NCT02709746|7618442|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3
4701557|NCT02709746|7618443|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0
4701558|NCT02709746|7618444|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1
4701559|NCT02709746|7618445|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2
4701560|NCT02709746|7618441|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0
4701561|NCT02709746|7618442|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4
4701562|NCT02709746|7618443|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8
4701563|NCT02709746|7618444|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5
4701564|NCT02709746|7618445|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2
4701565|NCT02709746|7618441|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0
4701566|NCT02709746|7618442|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2
4701567|NCT02709746|7618443|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2
4701568|NCT02709746|7618444|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2
4701569|NCT02709746|7618445|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1
4701570|NCT02709746|7618441|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0
4701571|NCT02709746|7618442|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0
4701572|NCT02709746|7618443|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1
4701573|NCT02709746|7618444|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0
4701574|NCT02709746|7618445|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0
4701575|NCT02709746|7618441|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0
4701576|NCT02709746|7618442|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4
4701577|NCT02709746|7618443|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2
4387212|NCT00045942|7165717|FG007|PKC412A2104E2|Death|0
4387213|NCT00045942|7165718|FG008|PKC412A2104E2|Death|0
4387214|NCT00046839|7165785|FG000|Overall Study|Ineligible / No protocol treatment|0
4387215|NCT00046839|7165786|FG001|Overall Study|Ineligible / No protocol treatment|2
4701578|NCT02709746|7618444|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0
4701579|NCT02709746|7618445|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2
4701580|NCT02709785|7618460|FG000|Overall Study|Withdrawal by Subject|1
4701581|NCT02709785|7618461|FG001|Overall Study|Withdrawal by Subject|2
4701582|NCT02709785|7618462|FG002|Overall Study|Withdrawal by Subject|1
4701583|NCT02709889|7618478|FG000|Overall Study|Withdrawal by Subject|11
4701584|NCT02709889|7618479|FG001|Overall Study|Withdrawal by Subject|10
4701585|NCT02709889|7618480|FG002|Overall Study|Withdrawal by Subject|2
4701586|NCT02709889|7618481|FG003|Overall Study|Withdrawal by Subject|12
4701587|NCT02709889|7618478|FG000|Overall Study|Death|25
4701588|NCT02709889|7618479|FG001|Overall Study|Death|38
4701589|NCT02709889|7618480|FG002|Overall Study|Death|4
4701590|NCT02709889|7618481|FG003|Overall Study|Death|44
4701591|NCT02709889|7618478|FG000|Overall Study|Physician Decision|1
4701592|NCT02709889|7618479|FG001|Overall Study|Physician Decision|2
4701593|NCT02709889|7618480|FG002|Overall Study|Physician Decision|3
4701594|NCT02709889|7618481|FG003|Overall Study|Physician Decision|5
4701595|NCT02709889|7618478|FG000|Overall Study|Lost to Follow-up|2
4701596|NCT02709889|7618479|FG001|Overall Study|Lost to Follow-up|0
4701597|NCT02709889|7618480|FG002|Overall Study|Lost to Follow-up|0
4701598|NCT02709889|7618481|FG003|Overall Study|Lost to Follow-up|4
4701599|NCT02709889|7618478|FG000|Overall Study|Study Terminated by Sponsor|4
4701600|NCT02709889|7618479|FG001|Overall Study|Study Terminated by Sponsor|6
4387216|NCT00046839|7165785|FG000|Overall Study|Withdrawal of consent|1
4387217|NCT00046839|7165786|FG001|Overall Study|Withdrawal of consent|0
4488730|NCT00773734|7290268|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3
4488731|NCT00773734|7290269|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2
4488732|NCT00773734|7290270|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2
4488733|NCT00773734|7290271|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0
4488734|NCT00773734|7290272|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0
4488735|NCT00773734|7290267|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2
4488736|NCT00773734|7290268|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2
4488737|NCT00773734|7290269|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6
4488738|NCT00773734|7290270|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4
4488739|NCT00773734|7290271|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0
4488740|NCT00773734|7290272|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0
4488741|NCT00773734|7290267|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1
4488742|NCT00773734|7290268|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0
4488743|NCT00773734|7290269|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0
4488744|NCT00773734|7290270|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0
4488745|NCT00773734|7290271|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0
4488746|NCT00773734|7290272|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0
4488747|NCT00773734|7290267|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2
4488748|NCT00773734|7290268|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
4488749|NCT00773734|7290269|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
4488750|NCT00773734|7290270|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1
4488751|NCT00773734|7290271|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
4488752|NCT00773734|7290272|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
4488753|NCT00773734|7290267|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1
4488754|NCT00773734|7290268|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3
4488755|NCT00773734|7290269|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4
4488756|NCT00773734|7290270|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
4488757|NCT00773734|7290271|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
4488758|NCT00773734|7290272|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
4488759|NCT00773734|7290267|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1
4488760|NCT00773734|7290268|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1
4488761|NCT00773734|7290269|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1
4488762|NCT00773734|7290270|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1
4488763|NCT00773734|7290271|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0
4626513|NCT01841697|7492199|FG000|Overall Study|Withdrawal by Subject|16
4626514|NCT01841697|7492200|FG001|Overall Study|Withdrawal by Subject|16
4626515|NCT01841762|7492206|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51
4626516|NCT01841762|7492206|FG000|Treatment Period|Adverse Event|16
4626517|NCT01841762|7492206|FG000|Treatment Period|Death|1
4626518|NCT01841762|7492206|FG000|Treatment Period|Withdrawal by Subject|7
4626519|NCT01841762|7492206|FG000|Treatment Period|Lost to Follow-up|1
4626520|NCT01841762|7492206|FG000|Treatment Period|Physician Decision|2
4626521|NCT01841762|7492206|FG000|Treatment Period|Other, including non-compliance|5
4626522|NCT01841762|7492206|FG000|Post-Treatment Safety Follow-Up Period|Death|1
4626523|NCT01841762|7492206|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7
4626524|NCT01841762|7492206|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6
4626525|NCT01841762|7492206|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1
4626526|NCT01841970|7492210|FG000|Overall Study|Withdrawal by Subject|1
4626527|NCT01841970|7492210|FG000|Overall Study|Physician Decision|2
4626528|NCT01841970|7492210|FG000|Overall Study|Lost to Follow-up|8
4488764|NCT00773734|7290272|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0
4488765|NCT00773734|7290267|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0
4488766|NCT00773734|7290268|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4
4488767|NCT00773734|7290269|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0
4488768|NCT00773734|7290270|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0
4488769|NCT00773734|7290271|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1
4488770|NCT00773734|7290272|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2
4488771|NCT00773734|7290267|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
4488772|NCT00773734|7290268|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4
4488773|NCT00773734|7290269|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4
4488774|NCT00773734|7290270|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1
4488775|NCT00773734|7290271|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
4488776|NCT00773734|7290272|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
4488777|NCT00773734|7290267|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
4488778|NCT00773734|7290268|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1
4488779|NCT00773734|7290269|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1
4488780|NCT00773734|7290270|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
4488781|NCT00773734|7290271|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
4488782|NCT00773734|7290272|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2
4488783|NCT00773734|7290267|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
4488784|NCT00773734|7290268|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1
4488785|NCT00773734|7290269|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1
4488786|NCT00773734|7290270|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
4488787|NCT00773734|7290271|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
4488788|NCT00773734|7290272|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
4488789|NCT00773734|7290267|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0
4488790|NCT00773734|7290268|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
4488791|NCT00773734|7290269|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
4488792|NCT00773734|7290270|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
4488793|NCT00773734|7290271|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0
4488794|NCT00773734|7290272|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
4488795|NCT00773734|7290267|FG000|Core: Active Treatment Phase Week 16-24|Other|0
4488796|NCT00773734|7290268|FG001|Core: Active Treatment Phase Week 16-24|Other|1
4488797|NCT00773734|7290269|FG002|Core: Active Treatment Phase Week 16-24|Other|0
4488798|NCT00773734|7290270|FG003|Core: Active Treatment Phase Week 16-24|Other|0
4488799|NCT00773734|7290271|FG004|Core: Active Treatment Phase Week 16-24|Other|0
4488800|NCT00773734|7290272|FG005|Core: Active Treatment Phase Week 16-24|Other|0
4488801|NCT00773734|7290267|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0
4488802|NCT00773734|7290268|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0
4488803|NCT00773734|7290269|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0
4488804|NCT00773734|7290270|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0
4488805|NCT00773734|7290271|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2
4488806|NCT00773734|7290272|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1
4488807|NCT00773734|7290267|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0
4488808|NCT00773734|7290268|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8
4488809|NCT00773734|7290269|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10
4488810|NCT00773734|7290270|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3
4488811|NCT00773734|7290271|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1
4701601|NCT02709889|7618480|FG002|Overall Study|Study Terminated by Sponsor|2
4701602|NCT02709889|7618481|FG003|Overall Study|Study Terminated by Sponsor|17
4701603|NCT02709889|7618478|FG000|Overall Study|Other, Not Specified|0
4701604|NCT02709889|7618479|FG001|Overall Study|Other, Not Specified|1
4701605|NCT02709889|7618480|FG002|Overall Study|Other, Not Specified|1
4701606|NCT02709889|7618481|FG003|Overall Study|Other, Not Specified|6
4701607|NCT02710045|7618529|FG000|Overall Study|Death|1
4701608|NCT02710045|7618530|FG001|Overall Study|Death|2
4701609|NCT02710045|7618531|FG002|Overall Study|Death|0
4701610|NCT02710045|7618529|FG000|Overall Study|Withdrawal by Subject|6
4701611|NCT02710045|7618530|FG001|Overall Study|Withdrawal by Subject|6
4701612|NCT02710045|7618531|FG002|Overall Study|Withdrawal by Subject|2
4701613|NCT02710045|7618529|FG000|Overall Study|Protocol Violation|1
4701614|NCT02710045|7618530|FG001|Overall Study|Protocol Violation|2
4701615|NCT02710045|7618531|FG002|Overall Study|Protocol Violation|3
4701616|NCT02710045|7618529|FG000|Overall Study|Lost to Follow-up|3
4701617|NCT02710045|7618530|FG001|Overall Study|Lost to Follow-up|6
4701618|NCT02710045|7618531|FG002|Overall Study|Lost to Follow-up|7
4701619|NCT02710045|7618529|FG000|Overall Study|Physician Decision|0
4701620|NCT02710045|7618530|FG001|Overall Study|Physician Decision|0
4701621|NCT02710045|7618531|FG002|Overall Study|Physician Decision|1
4701622|NCT02710045|7618529|FG000|Overall Study|Poor Attendance|0
4701623|NCT02710045|7618530|FG001|Overall Study|Poor Attendance|1
4701624|NCT02710045|7618531|FG002|Overall Study|Poor Attendance|0
4701625|NCT02710071|7618541|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3
4701626|NCT02710071|7618542|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4
4701627|NCT02710071|7618541|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1
4701628|NCT02710071|7618542|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2
4701629|NCT02710136|7618551|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1
4701630|NCT02710136|7618552|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0
4701631|NCT02710214|7618561|FG000|Overall Study|Lost to Follow-up|1
4701632|NCT02710214|7618562|FG001|Overall Study|Lost to Follow-up|0
4701633|NCT02710214|7618561|FG000|Overall Study|Lack of Efficacy|0
4701634|NCT02710214|7618562|FG001|Overall Study|Lack of Efficacy|1
4701635|NCT02710214|7618561|FG000|Overall Study|Death|0
4701636|NCT02710214|7618562|FG001|Overall Study|Death|1
4701637|NCT02710292|7618572|FG000|Period 1, First 10 Days of Wear|Adverse Event|0
4701638|NCT02710292|7618573|FG001|Period 1, First 10 Days of Wear|Adverse Event|1
4701639|NCT02710292|7618572|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1
4701640|NCT02710292|7618573|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2
4701641|NCT02710422|7618582|FG000|Overall Study|Termination of study|9
4701642|NCT02710422|7618583|FG001|Overall Study|Termination of study|9
4701643|NCT02710669|7618657|FG000|Overall Study|Physician Decision|2
4701644|NCT02710669|7618658|FG001|Overall Study|Physician Decision|1
4701645|NCT02710669|7618659|FG002|Overall Study|Physician Decision|0
4701646|NCT02710669|7618657|FG000|Overall Study|Institutional delays (including COVID)|2
4701647|NCT02710669|7618658|FG001|Overall Study|Institutional delays (including COVID)|2
4701648|NCT02710669|7618659|FG002|Overall Study|Institutional delays (including COVID)|0
4701649|NCT02710669|7618657|FG000|Overall Study|arrived in afib/aflutter|10
4701650|NCT02710669|7618658|FG001|Overall Study|arrived in afib/aflutter|8
4701651|NCT02710669|7618659|FG002|Overall Study|arrived in afib/aflutter|2
4701652|NCT02711306|7618687|FG000|Overall Study|Withdrawal by Subject|2
4488812|NCT00773734|7290272|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2
4488813|NCT00773734|7290267|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0
4488814|NCT00773734|7290268|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3
4488815|NCT00773734|7290269|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1
4488816|NCT00773734|7290270|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2
4488817|NCT00773734|7290271|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2
4488818|NCT00773734|7290272|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3
4488819|NCT00773734|7290267|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0
4488820|NCT00773734|7290268|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2
4488821|NCT00773734|7290269|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5
4488822|NCT00773734|7290270|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3
4488823|NCT00773734|7290271|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0
4488824|NCT00773734|7290272|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1
4488825|NCT00773734|7290267|FG000|Extension: Active Treatment Week 24-52|Other|0
4488826|NCT00773734|7290268|FG001|Extension: Active Treatment Week 24-52|Other|0
4488827|NCT00773734|7290269|FG002|Extension: Active Treatment Week 24-52|Other|1
4488828|NCT00773734|7290270|FG003|Extension: Active Treatment Week 24-52|Other|2
4488829|NCT00773734|7290271|FG004|Extension: Active Treatment Week 24-52|Other|0
4488830|NCT00773734|7290272|FG005|Extension: Active Treatment Week 24-52|Other|1
4488831|NCT00773734|7290267|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0
4488832|NCT00773734|7290268|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0
4488833|NCT00773734|7290269|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0
4488834|NCT00773734|7290270|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1
4488835|NCT00773734|7290271|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0
4488836|NCT00773734|7290272|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0
4488837|NCT00773734|7290267|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
4488838|NCT00773734|7290268|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
4488839|NCT00773734|7290269|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2
4488840|NCT00773734|7290270|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4
4488841|NCT00773734|7290271|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
4488842|NCT00773734|7290272|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
4488843|NCT00773734|7290267|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
4488844|NCT00773734|7290268|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
4488845|NCT00773734|7290269|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6
4488846|NCT00773734|7290270|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3
4626529|NCT01842308|7492231|FG000|Overall Study|Withdrawal by Subject|0
4626530|NCT01842308|7492232|FG001|Overall Study|Withdrawal by Subject|0
4626531|NCT01842308|7492233|FG002|Overall Study|Withdrawal by Subject|0
4626532|NCT01842308|7492234|FG003|Overall Study|Withdrawal by Subject|0
4626533|NCT01842308|7492235|FG004|Overall Study|Withdrawal by Subject|1
4626534|NCT01842334|7492250|FG000|Overall Study|Withdrawal by Subject|3
4626535|NCT01842334|7492251|FG001|Overall Study|Withdrawal by Subject|3
4626536|NCT01842334|7492250|FG000|Overall Study|Moved away mid-study|0
4626537|NCT01842334|7492251|FG001|Overall Study|Moved away mid-study|1
4488847|NCT00773734|7290271|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
4488848|NCT00773734|7290272|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
4488849|NCT00773734|7290267|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
4626538|NCT01842438|7492259|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6
4626539|NCT01842438|7492260|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8
4701653|NCT02711306|7618688|FG001|Overall Study|Withdrawal by Subject|2
4701654|NCT02711345|7618704|FG000|Overall Study|Adverse Event|0
4701655|NCT02711345|7618705|FG001|Overall Study|Adverse Event|0
4701656|NCT02711345|7618706|FG002|Overall Study|Adverse Event|0
4701657|NCT02711345|7618707|FG003|Overall Study|Adverse Event|1
4701658|NCT02711345|7618708|FG004|Overall Study|Adverse Event|1
4701659|NCT02711345|7618709|FG005|Overall Study|Adverse Event|2
4701660|NCT02711345|7618710|FG006|Overall Study|Adverse Event|1
4701661|NCT02711345|7618711|FG007|Overall Study|Adverse Event|0
4701662|NCT02711345|7618712|FG008|Overall Study|Adverse Event|0
4701663|NCT02711345|7618713|FG009|Overall Study|Adverse Event|2
4701664|NCT02711345|7618704|FG000|Overall Study|Physician Decision|0
4701665|NCT02711345|7618705|FG001|Overall Study|Physician Decision|0
4701666|NCT02711345|7618706|FG002|Overall Study|Physician Decision|1
4701667|NCT02711345|7618707|FG003|Overall Study|Physician Decision|0
4701668|NCT02711345|7618708|FG004|Overall Study|Physician Decision|0
4701669|NCT02711345|7618709|FG005|Overall Study|Physician Decision|0
4701670|NCT02711345|7618710|FG006|Overall Study|Physician Decision|0
4701671|NCT02711345|7618711|FG007|Overall Study|Physician Decision|0
4701672|NCT02711345|7618712|FG008|Overall Study|Physician Decision|1
4701673|NCT02711345|7618713|FG009|Overall Study|Physician Decision|0
4701674|NCT02711345|7618704|FG000|Overall Study|Progressive disease|1
4701675|NCT02711345|7618705|FG001|Overall Study|Progressive disease|3
4701676|NCT02711345|7618706|FG002|Overall Study|Progressive disease|5
4701677|NCT02711345|7618707|FG003|Overall Study|Progressive disease|3
4488850|NCT00773734|7290268|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
4488851|NCT00773734|7290269|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4
4488852|NCT00773734|7290270|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4
4488853|NCT00773734|7290271|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
4488854|NCT00773734|7290272|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
4488855|NCT00773747|7290331|FG000|Overall Study|Lack of Efficacy|112
4488856|NCT00773747|7290332|FG001|Overall Study|Lack of Efficacy|144
4488857|NCT00773747|7290331|FG000|Overall Study|Physician Decision|26
4488858|NCT00773747|7290332|FG001|Overall Study|Physician Decision|18
4488859|NCT00773747|7290331|FG000|Overall Study|Lost to Follow-up|0
4488860|NCT00773747|7290332|FG001|Overall Study|Lost to Follow-up|1
4488861|NCT00773747|7290331|FG000|Overall Study|Protocol Violation|2
4488862|NCT00773747|7290332|FG001|Overall Study|Protocol Violation|2
4488863|NCT00773747|7290331|FG000|Overall Study|Withdrawal by Subject|89
4488864|NCT00773747|7290332|FG001|Overall Study|Withdrawal by Subject|61
4488865|NCT00773747|7290331|FG000|Overall Study|Adverse Event|61
4488866|NCT00773747|7290332|FG001|Overall Study|Adverse Event|62
4488867|NCT00773747|7290331|FG000|Overall Study|Death|5
4488868|NCT00773747|7290332|FG001|Overall Study|Death|8
4488869|NCT00773747|7290331|FG000|Overall Study|Not Treated|2
4488870|NCT00773747|7290332|FG001|Overall Study|Not Treated|0
4488871|NCT00773838|7290346|FG000|Overall Study|Adverse Event|29
4488872|NCT00773838|7290346|FG000|Overall Study|Lost to Follow-up|1
4488873|NCT00773838|7290346|FG000|Overall Study|Physician Decision|8
4488874|NCT00773838|7290346|FG000|Overall Study|Progressive Disease|82
4488875|NCT00773838|7290346|FG000|Overall Study|Protocol Violation|2
4488876|NCT00773838|7290346|FG000|Overall Study|Withdrawal by Subject|21
4488877|NCT00773968|7290354|FG000|Overall Study|Adverse Event|2
4488878|NCT00773968|7290354|FG000|Overall Study|Death|1
4488879|NCT00773968|7290354|FG000|Overall Study|Failure to Return|2
4488880|NCT00773968|7290354|FG000|Overall Study|Lack of Efficacy|3
4488881|NCT00773968|7290354|FG000|Overall Study|Protocol Violation|1
4488882|NCT00773968|7290354|FG000|Overall Study|Withdrawal by Subject|11
4488883|NCT00773968|7290354|FG000|Overall Study|Screen Failure|17
4488884|NCT00773968|7290354|FG000|Overall Study|Other|8
4488885|NCT00774046|7290358|FG000|Screening|Not eligible|56
4488886|NCT00774046|7290358|FG000|Enrollment|Desired other therapy/refused|28
4488887|NCT00774046|7290358|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3
4488888|NCT00774397|7290408|FG000|Overall Study|Adverse Event|1
4488889|NCT00774397|7290409|FG001|Overall Study|Adverse Event|3
4488890|NCT00774397|7290410|FG002|Overall Study|Adverse Event|16
4488891|NCT00774397|7290411|FG003|Overall Study|Adverse Event|8
4488892|NCT00774397|7290412|FG004|Overall Study|Adverse Event|8
4488893|NCT00774397|7290413|FG005|Overall Study|Adverse Event|3
4488894|NCT00774397|7290414|FG006|Overall Study|Adverse Event|16
4488895|NCT00774397|7290408|FG000|Overall Study|Lack of Efficacy|11
4488896|NCT00774397|7290409|FG001|Overall Study|Lack of Efficacy|4
4488897|NCT00774397|7290410|FG002|Overall Study|Lack of Efficacy|5
4488898|NCT00774397|7290411|FG003|Overall Study|Lack of Efficacy|3
4488899|NCT00774397|7290412|FG004|Overall Study|Lack of Efficacy|27
4488900|NCT00774397|7290413|FG005|Overall Study|Lack of Efficacy|15
4488901|NCT00774397|7290414|FG006|Overall Study|Lack of Efficacy|9
4488902|NCT00774397|7290408|FG000|Overall Study|Protocol Violation|0
4488903|NCT00774397|7290409|FG001|Overall Study|Protocol Violation|1
4488904|NCT00774397|7290410|FG002|Overall Study|Protocol Violation|3
4488905|NCT00774397|7290411|FG003|Overall Study|Protocol Violation|1
4488906|NCT00774397|7290412|FG004|Overall Study|Protocol Violation|2
4488907|NCT00774397|7290413|FG005|Overall Study|Protocol Violation|1
4488908|NCT00774397|7290414|FG006|Overall Study|Protocol Violation|0
4488909|NCT00774397|7290408|FG000|Overall Study|Lost to Follow-up|0
4488910|NCT00774397|7290409|FG001|Overall Study|Lost to Follow-up|1
4488911|NCT00774397|7290410|FG002|Overall Study|Lost to Follow-up|1
4488912|NCT00774397|7290411|FG003|Overall Study|Lost to Follow-up|1
4488913|NCT00774397|7290412|FG004|Overall Study|Lost to Follow-up|0
4488914|NCT00774397|7290413|FG005|Overall Study|Lost to Follow-up|1
4488915|NCT00774397|7290414|FG006|Overall Study|Lost to Follow-up|0
4488916|NCT00774397|7290408|FG000|Overall Study|Refused to continue trial medication|1
4488917|NCT00774397|7290409|FG001|Overall Study|Refused to continue trial medication|3
4488918|NCT00774397|7290410|FG002|Overall Study|Refused to continue trial medication|2
4488919|NCT00774397|7290411|FG003|Overall Study|Refused to continue trial medication|2
4488920|NCT00774397|7290412|FG004|Overall Study|Refused to continue trial medication|6
4488921|NCT00774397|7290413|FG005|Overall Study|Refused to continue trial medication|2
4488922|NCT00774397|7290414|FG006|Overall Study|Refused to continue trial medication|3
4488923|NCT00774397|7290408|FG000|Overall Study|Not treated|0
4488924|NCT00774397|7290409|FG001|Overall Study|Not treated|0
4488925|NCT00774397|7290410|FG002|Overall Study|Not treated|0
4488926|NCT00774397|7290411|FG003|Overall Study|Not treated|0
4488927|NCT00774397|7290412|FG004|Overall Study|Not treated|1
4488928|NCT00774397|7290413|FG005|Overall Study|Not treated|0
4488929|NCT00774397|7290414|FG006|Overall Study|Not treated|1
4488930|NCT00774397|7290408|FG000|Overall Study|Other than those stated above|1
4488931|NCT00774397|7290409|FG001|Overall Study|Other than those stated above|1
4488932|NCT00774397|7290410|FG002|Overall Study|Other than those stated above|3
4488933|NCT00774397|7290411|FG003|Overall Study|Other than those stated above|2
4488934|NCT00774397|7290412|FG004|Overall Study|Other than those stated above|2
4488935|NCT00774397|7290413|FG005|Overall Study|Other than those stated above|0
4488936|NCT00774397|7290414|FG006|Overall Study|Other than those stated above|1
4488937|NCT00774566|7290439|FG000|Overall Study|Protocol Violation|18
4488938|NCT00774566|7290440|FG001|Overall Study|Protocol Violation|15
4488939|NCT00774748|7290455|FG000|Overall Study|Lost to Follow-up|3
4488940|NCT00774787|7290463|FG000|Overall Study|Lost to Follow-up|1
4488941|NCT00774800|7290467|FG000|Intervention 4|Withdrawal by Subject|1
4488942|NCT00774852|7290479|FG000|Overall Study|Adverse Event|9
4488943|NCT00774852|7290480|FG001|Overall Study|Adverse Event|6
4488944|NCT00774852|7290479|FG000|Overall Study|Death|2
4488945|NCT00774852|7290480|FG001|Overall Study|Death|1
4488946|NCT00774852|7290479|FG000|Overall Study|Lack of Efficacy|3
4488947|NCT00774852|7290480|FG001|Overall Study|Lack of Efficacy|7
4488948|NCT00774852|7290479|FG000|Overall Study|Lost to Follow-up|9
4488949|NCT00774852|7290480|FG001|Overall Study|Lost to Follow-up|5
4488950|NCT00774852|7290479|FG000|Overall Study|Physician Decision|2
4488951|NCT00774852|7290480|FG001|Overall Study|Physician Decision|6
4488952|NCT00774852|7290479|FG000|Overall Study|Pregnancy|1
4488953|NCT00774852|7290480|FG001|Overall Study|Pregnancy|2
4488954|NCT00774852|7290479|FG000|Overall Study|Withdrawal by Subject|2
4488955|NCT00774852|7290480|FG001|Overall Study|Withdrawal by Subject|2
4488956|NCT00774852|7290479|FG000|Overall Study|Non-responder|15
4488957|NCT00774852|7290480|FG001|Overall Study|Non-responder|11
4488958|NCT00774852|7290479|FG000|Overall Study|Subject non-compliance|0
4488959|NCT00774852|7290480|FG001|Overall Study|Subject non-compliance|1
4488960|NCT00774852|7290479|FG000|Overall Study|Protocol Violation|1
4488961|NCT00774852|7290480|FG001|Overall Study|Protocol Violation|0
4488962|NCT00774852|7290479|FG000|Overall Study|Subject received prohibited medication|1
4488963|NCT00774852|7290480|FG001|Overall Study|Subject received prohibited medication|0
4488964|NCT00774930|7290498|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11
4488965|NCT00774930|7290499|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12
4488966|NCT00774930|7290498|FG000|DB Phase|Adverse Event|1
4488967|NCT00774930|7290499|FG001|DB Phase|Adverse Event|2
4488968|NCT00774930|7290498|FG000|DB Phase|Subject Decision|1
4488969|NCT00774930|7290499|FG001|DB Phase|Subject Decision|5
4488970|NCT00774930|7290498|FG000|DB Phase|Sponsor Decision|0
4590203|NCT01519323|7435938|FG001|Overall Study|Death|2
4590204|NCT01519323|7435937|FG000|Overall Study|Study terminated by sponsor|0
4590205|NCT01519323|7435938|FG001|Overall Study|Study terminated by sponsor|1
4590206|NCT01519427|7435959|FG000|Overall Study|disease progression|2
4488971|NCT00774930|7290499|FG001|DB Phase|Sponsor Decision|1
4701678|NCT02711345|7618708|FG004|Overall Study|Progressive disease|7
4701679|NCT02711345|7618709|FG005|Overall Study|Progressive disease|2
4701680|NCT02711345|7618710|FG006|Overall Study|Progressive disease|8
4701681|NCT02711345|7618711|FG007|Overall Study|Progressive disease|4
4488972|NCT00774930|7290498|FG000|DB Phase|Disease Progression|1
4701682|NCT02711345|7618712|FG008|Overall Study|Progressive disease|5
4701683|NCT02711345|7618713|FG009|Overall Study|Progressive disease|6
4701684|NCT02711345|7618704|FG000|Overall Study|Subject/guardian decision|0
4701685|NCT02711345|7618705|FG001|Overall Study|Subject/guardian decision|0
4701686|NCT02711345|7618706|FG002|Overall Study|Subject/guardian decision|0
4701687|NCT02711345|7618707|FG003|Overall Study|Subject/guardian decision|0
4701688|NCT02711345|7618708|FG004|Overall Study|Subject/guardian decision|0
4701689|NCT02711345|7618709|FG005|Overall Study|Subject/guardian decision|2
4701690|NCT02711345|7618710|FG006|Overall Study|Subject/guardian decision|3
4701691|NCT02711345|7618711|FG007|Overall Study|Subject/guardian decision|1
4701692|NCT02711345|7618712|FG008|Overall Study|Subject/guardian decision|0
4701693|NCT02711345|7618713|FG009|Overall Study|Subject/guardian decision|4
4701694|NCT02711345|7618704|FG000|Overall Study|Death|1
4701695|NCT02711345|7618705|FG001|Overall Study|Death|0
4701696|NCT02711345|7618706|FG002|Overall Study|Death|0
4701697|NCT02711345|7618707|FG003|Overall Study|Death|0
4701698|NCT02711345|7618708|FG004|Overall Study|Death|0
4701699|NCT02711345|7618709|FG005|Overall Study|Death|0
4701700|NCT02711345|7618710|FG006|Overall Study|Death|0
4701701|NCT02711345|7618711|FG007|Overall Study|Death|1
4701702|NCT02711345|7618712|FG008|Overall Study|Death|0
4701703|NCT02711345|7618713|FG009|Overall Study|Death|0
4701704|NCT02711553|7618744|FG000|Overall Study|Withdrawal by Subject|2
4701705|NCT02711553|7618745|FG001|Overall Study|Withdrawal by Subject|1
4701706|NCT02711553|7618746|FG002|Overall Study|Withdrawal by Subject|1
4701707|NCT02711553|7618747|FG003|Overall Study|Withdrawal by Subject|0
4488973|NCT00774930|7290499|FG001|DB Phase|Disease Progression|1
4590207|NCT01519518|7435983|FG000|Overall Study|Consent not available|7
4590208|NCT01519518|7435984|FG001|Overall Study|Consent not available|10
4488974|NCT00774930|7290498|FG000|DB Phase|Started Nonprotocol Radiation therapy|0
4488975|NCT00774930|7290499|FG001|DB Phase|Started Nonprotocol Radiation therapy|1
4488976|NCT00774930|7290498|FG000|IOL Phase|Adverse Event|1
4488977|NCT00774930|7290499|FG001|IOL Phase|Adverse Event|1
4701708|NCT02711553|7618744|FG000|Overall Study|Lost to Follow-up|3
4701709|NCT02711553|7618745|FG001|Overall Study|Lost to Follow-up|3
4701710|NCT02711553|7618746|FG002|Overall Study|Lost to Follow-up|6
4701711|NCT02711553|7618747|FG003|Overall Study|Lost to Follow-up|3
4701712|NCT02711553|7618744|FG000|Overall Study|On Study Treatment at Study Conclusion|1
4701713|NCT02711553|7618745|FG001|Overall Study|On Study Treatment at Study Conclusion|1
4701714|NCT02711553|7618746|FG002|Overall Study|On Study Treatment at Study Conclusion|3
4488978|NCT00774930|7290498|FG000|IOL Phase|Subject Decision|4
4488979|NCT00774930|7290499|FG001|IOL Phase|Subject Decision|3
4488980|NCT00774930|7290498|FG000|IOL Phase|Physician Decision|3
4488981|NCT00774930|7290499|FG001|IOL Phase|Physician Decision|2
4488982|NCT00774930|7290498|FG000|IOL Phase|Sponsor Decision|1
4488983|NCT00774930|7290499|FG001|IOL Phase|Sponsor Decision|0
4488984|NCT00774930|7290498|FG000|IOL Phase|Disease Progression|2
4488985|NCT00774930|7290499|FG001|IOL Phase|Disease Progression|1
4488986|NCT00774930|7290498|FG000|IOL Phase|Subject Consumed Prohibited Medication|1
4488987|NCT00774930|7290499|FG001|IOL Phase|Subject Consumed Prohibited Medication|0
4488988|NCT00774930|7290498|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0
4488989|NCT00774930|7290499|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1
4488990|NCT00774930|7290498|FG000|IOL Phase|Other|1
4488991|NCT00774930|7290499|FG001|IOL Phase|Other|0
4488992|NCT00774930|7290498|FG000|IOL Phase|Brain radiation|0
4488993|NCT00774930|7290499|FG001|IOL Phase|Brain radiation|1
4488994|NCT00774930|7290498|FG000|LTOLE Phase|Adverse Event|7
4488995|NCT00774930|7290499|FG001|LTOLE Phase|Adverse Event|3
4488996|NCT00774930|7290498|FG000|LTOLE Phase|Subject decision|0
4488997|NCT00774930|7290499|FG001|LTOLE Phase|Subject decision|5
4488998|NCT00774930|7290498|FG000|LTOLE Phase|Physician Decision|4
4488999|NCT00774930|7290499|FG001|LTOLE Phase|Physician Decision|1
4489000|NCT00774930|7290498|FG000|LTOLE Phase|Sponsor decision|2
4489001|NCT00774930|7290499|FG001|LTOLE Phase|Sponsor decision|1
4489002|NCT00774930|7290498|FG000|LTOLE Phase|Disease Progression|2
4489003|NCT00774930|7290499|FG001|LTOLE Phase|Disease Progression|5
4489004|NCT00774930|7290498|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0
4489005|NCT00774930|7290499|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1
4489006|NCT00774930|7290498|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0
4489007|NCT00774930|7290499|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1
4489008|NCT00774995|7290511|FG000|Overall Study|Protocol Violation|0
4489009|NCT00774995|7290512|FG001|Overall Study|Protocol Violation|0
4489010|NCT00774995|7290513|FG002|Overall Study|Protocol Violation|1
4489011|NCT00774995|7290514|FG003|Overall Study|Protocol Violation|0
4489012|NCT00775021|7290524|FG000|First Intervention|Lost to Follow-up|1
4489013|NCT00775021|7290525|FG001|First Intervention|Lost to Follow-up|0
4489014|NCT00775021|7290524|FG000|Second Intervention|Adverse Event|0
4489015|NCT00775021|7290525|FG001|Second Intervention|Adverse Event|1
4489016|NCT00775138|7290535|FG000|Overall Study|Withdrawal by Subject|0
4489017|NCT00775138|7290536|FG001|Overall Study|Withdrawal by Subject|0
4489018|NCT00775138|7290537|FG002|Overall Study|Withdrawal by Subject|2
4489019|NCT00775138|7290538|FG003|Overall Study|Withdrawal by Subject|2
4489020|NCT00775138|7290535|FG000|Overall Study|Adverse Event|0
4489021|NCT00775138|7290536|FG001|Overall Study|Adverse Event|0
4489022|NCT00775138|7290537|FG002|Overall Study|Adverse Event|1
4489023|NCT00775138|7290538|FG003|Overall Study|Adverse Event|0
4489024|NCT00775203|7290552|FG000|Overall Study|Adverse Event|25
4489025|NCT00775203|7290553|FG001|Overall Study|Adverse Event|6
4489026|NCT00775203|7290552|FG000|Overall Study|Lack of Efficacy|8
4489027|NCT00775203|7290553|FG001|Overall Study|Lack of Efficacy|9
4489028|NCT00775203|7290552|FG000|Overall Study|Withdrawal by Subject|11
4489029|NCT00775203|7290553|FG001|Overall Study|Withdrawal by Subject|9
4489030|NCT00775203|7290552|FG000|Overall Study|Lost to Follow-up|11
4489031|NCT00775203|7290553|FG001|Overall Study|Lost to Follow-up|15
4489032|NCT00775203|7290552|FG000|Overall Study|Administrative reason|2
4489033|NCT00775203|7290553|FG001|Overall Study|Administrative reason|0
4489034|NCT00775203|7290552|FG000|Overall Study|Noncompliance|4
4489035|NCT00775203|7290553|FG001|Overall Study|Noncompliance|2
4489036|NCT00775203|7290552|FG000|Overall Study|Protocol Violation|0
4489037|NCT00775203|7290553|FG001|Overall Study|Protocol Violation|1
4489038|NCT00775203|7290552|FG000|Overall Study|Entered other study|1
4489039|NCT00775203|7290553|FG001|Overall Study|Entered other study|0
4489040|NCT00775203|7290552|FG000|Overall Study|Physician Decision|0
4489041|NCT00775203|7290553|FG001|Overall Study|Physician Decision|1
4489042|NCT00775268|7290570|FG000|Baseline|Drug not synthesize dose|1
4489043|NCT00775268|7290571|FG001|Baseline|Drug not synthesize dose|0
4489044|NCT00775268|7290570|FG000|Baseline|Not treated-ineligible per CT|0
4489045|NCT00775268|7290571|FG001|Baseline|Not treated-ineligible per CT|1
4489046|NCT00775268|7290570|FG000|After 2 Cycles|Participant refused to be scanned further|1
4489047|NCT00775268|7290571|FG001|After 2 Cycles|Participant refused to be scanned further|0
4489048|NCT00775268|7290570|FG000|After Completion|Participant missed scan appointment|1
4489049|NCT00775268|7290571|FG001|After Completion|Participant missed scan appointment|0
4489050|NCT00775437|7290596|FG000|Overall Study|Loss of efficacy|2
4489051|NCT00775437|7290596|FG000|Overall Study|Withdrawal by Subject|3
4489052|NCT00775437|7290596|FG000|Overall Study|Lost to Follow-up|1
4489053|NCT00775450|7290605|FG000|Overall Study|Serious Adverse Event|2
4489054|NCT00775450|7290606|FG001|Overall Study|Serious Adverse Event|0
4489055|NCT00775450|7290607|FG002|Overall Study|Serious Adverse Event|0
4489056|NCT00775450|7290608|FG003|Overall Study|Serious Adverse Event|0
4489057|NCT00775450|7290609|FG004|Overall Study|Serious Adverse Event|0
4489058|NCT00775450|7290605|FG000|Overall Study|Protocol Violation|0
4489059|NCT00775450|7290606|FG001|Overall Study|Protocol Violation|0
4489060|NCT00775450|7290607|FG002|Overall Study|Protocol Violation|0
4489061|NCT00775450|7290608|FG003|Overall Study|Protocol Violation|0
4489062|NCT00775450|7290609|FG004|Overall Study|Protocol Violation|1
4489063|NCT00775450|7290605|FG000|Overall Study|Withdrawal by Subject|1
4489064|NCT00775450|7290606|FG001|Overall Study|Withdrawal by Subject|0
4489065|NCT00775450|7290607|FG002|Overall Study|Withdrawal by Subject|0
4489066|NCT00775450|7290608|FG003|Overall Study|Withdrawal by Subject|0
4489067|NCT00775450|7290609|FG004|Overall Study|Withdrawal by Subject|1
4489068|NCT00775463|7290623|FG000|Overall Study|Withdrawal by Subject|0
4489069|NCT00775463|7290624|FG001|Overall Study|Withdrawal by Subject|1
4489070|NCT00775463|7290623|FG000|Overall Study|Adverse Event|7
4489071|NCT00775463|7290624|FG001|Overall Study|Adverse Event|9
4489072|NCT00775463|7290623|FG000|Overall Study|Protocol Violation|2
4489073|NCT00775463|7290624|FG001|Overall Study|Protocol Violation|2
4489074|NCT00775463|7290623|FG000|Overall Study|Lost to Follow-up|1
4489075|NCT00775463|7290624|FG001|Overall Study|Lost to Follow-up|0
4489076|NCT00775463|7290623|FG000|Overall Study|Lack of Efficacy|1
4489077|NCT00775463|7290624|FG001|Overall Study|Lack of Efficacy|1
4489078|NCT00775528|7290637|FG000|Overall Study|Protocol Violation|1
4489079|NCT00775593|7290641|FG000|Overall Study|Unmet eligibility criteria|6
4489080|NCT00775593|7290641|FG000|Overall Study|Death|1
4489081|NCT00775606|7290647|FG000|Overall Study|Study sponsor terminated funding|3
4489082|NCT00775606|7290648|FG001|Overall Study|Study sponsor terminated funding|0
4517374|NCT00966875|7329239|FG002|Part A|Physician Decision|0
4517375|NCT00966875|7329240|FG003|Part A|Physician Decision|0
4517376|NCT00966875|7329241|FG004|Part A|Physician Decision|1
4517377|NCT00966875|7329242|FG005|Part A|Physician Decision|0
4517378|NCT00966875|7329243|FG006|Part A|Physician Decision|1
4517379|NCT00966875|7329244|FG007|Part A|Physician Decision|0
4517380|NCT00966875|7329245|FG008|Part A|Physician Decision|2
4517381|NCT00966875|7329237|FG000|Part A|Sponsor Decision|0
4517382|NCT00966875|7329238|FG001|Part A|Sponsor Decision|0
4517383|NCT00966875|7329239|FG002|Part A|Sponsor Decision|1
4517384|NCT00966875|7329240|FG003|Part A|Sponsor Decision|0
4517385|NCT00966875|7329241|FG004|Part A|Sponsor Decision|1
4517386|NCT00966875|7329242|FG005|Part A|Sponsor Decision|0
4517387|NCT00966875|7329243|FG006|Part A|Sponsor Decision|0
4517388|NCT00966875|7329244|FG007|Part A|Sponsor Decision|2
4517389|NCT00966875|7329245|FG008|Part A|Sponsor Decision|1
4517390|NCT00966875|7329237|FG000|Part A|Withdrawal by Subject|2
4517391|NCT00966875|7329238|FG001|Part A|Withdrawal by Subject|2
4517392|NCT00966875|7329239|FG002|Part A|Withdrawal by Subject|1
4517393|NCT00966875|7329240|FG003|Part A|Withdrawal by Subject|1
4517394|NCT00966875|7329241|FG004|Part A|Withdrawal by Subject|3
4517395|NCT00966875|7329242|FG005|Part A|Withdrawal by Subject|0
4517396|NCT00966875|7329243|FG006|Part A|Withdrawal by Subject|5
4517397|NCT00966875|7329244|FG007|Part A|Withdrawal by Subject|1
4517398|NCT00966875|7329245|FG008|Part A|Withdrawal by Subject|1
4517399|NCT00966875|7329237|FG000|Part A|Protocol Violation|0
4517400|NCT00966875|7329238|FG001|Part A|Protocol Violation|0
4517401|NCT00966875|7329239|FG002|Part A|Protocol Violation|0
4517402|NCT00966875|7329240|FG003|Part A|Protocol Violation|0
4517403|NCT00966875|7329241|FG004|Part A|Protocol Violation|0
4517404|NCT00966875|7329242|FG005|Part A|Protocol Violation|0
4701715|NCT02711553|7618747|FG003|Overall Study|On Study Treatment at Study Conclusion|1
4701716|NCT02711800|7618759|FG000|Overall Study|Lost to Follow-up|1
4701717|NCT02711800|7618759|FG000|Overall Study|Withdrawal by Subject|1
4701718|NCT02711956|7618787|FG000|Overall Study|Adverse Event|0
4701719|NCT02711956|7618788|FG001|Overall Study|Adverse Event|0
4701720|NCT02711956|7618789|FG002|Overall Study|Adverse Event|0
4701721|NCT02711956|7618790|FG003|Overall Study|Adverse Event|1
4701722|NCT02711956|7618791|FG004|Overall Study|Adverse Event|2
4701723|NCT02711956|7618792|FG005|Overall Study|Adverse Event|0
4701724|NCT02711956|7618793|FG006|Overall Study|Adverse Event|0
4701725|NCT02711956|7618794|FG007|Overall Study|Adverse Event|1
4701726|NCT02711956|7618795|FG008|Overall Study|Adverse Event|1
4701727|NCT02711956|7618796|FG009|Overall Study|Adverse Event|1
4701728|NCT02711956|7618797|FG010|Overall Study|Adverse Event|1
4701729|NCT02711956|7618798|FG011|Overall Study|Adverse Event|0
4701730|NCT02711956|7618799|FG012|Overall Study|Adverse Event|0
4701731|NCT02711956|7618800|FG013|Overall Study|Adverse Event|0
4701732|NCT02711956|7618801|FG014|Overall Study|Adverse Event|2
4701733|NCT02711956|7618787|FG000|Overall Study|Physician Decision|0
4701734|NCT02711956|7618788|FG001|Overall Study|Physician Decision|0
4701735|NCT02711956|7618789|FG002|Overall Study|Physician Decision|0
4701736|NCT02711956|7618790|FG003|Overall Study|Physician Decision|2
4701737|NCT02711956|7618791|FG004|Overall Study|Physician Decision|0
4701738|NCT02711956|7618792|FG005|Overall Study|Physician Decision|0
4701739|NCT02711956|7618793|FG006|Overall Study|Physician Decision|0
4701740|NCT02711956|7618794|FG007|Overall Study|Physician Decision|0
4701741|NCT02711956|7618795|FG008|Overall Study|Physician Decision|0
4701742|NCT02711956|7618796|FG009|Overall Study|Physician Decision|0
4701743|NCT02711956|7618797|FG010|Overall Study|Physician Decision|0
4517405|NCT00966875|7329243|FG006|Part A|Protocol Violation|2
4517406|NCT00966875|7329244|FG007|Part A|Protocol Violation|1
4517407|NCT00966875|7329245|FG008|Part A|Protocol Violation|1
4517408|NCT00966875|7329237|FG000|Part B|Adverse Event|0
4517409|NCT00966875|7329238|FG001|Part B|Adverse Event|1
4517410|NCT00966875|7329239|FG002|Part B|Adverse Event|1
4701744|NCT02711956|7618798|FG011|Overall Study|Physician Decision|0
4701745|NCT02711956|7618799|FG012|Overall Study|Physician Decision|0
4701746|NCT02711956|7618800|FG013|Overall Study|Physician Decision|0
4489083|NCT00775983|7290731|FG000|Overall Study|Protocol Violation|1
4489084|NCT00775983|7290732|FG001|Overall Study|Protocol Violation|2
4489085|NCT00776009|7290744|FG000|Period 1: First Intervention|Withdrawal by Subject|0
4489086|NCT00776009|7290745|FG001|Period 1: First Intervention|Withdrawal by Subject|0
4489087|NCT00776009|7290746|FG002|Period 1: First Intervention|Withdrawal by Subject|1
4489088|NCT00776009|7290747|FG003|Period 1: First Intervention|Withdrawal by Subject|0
4489089|NCT00776009|7290748|FG004|Period 1: First Intervention|Withdrawal by Subject|1
4626540|NCT01842438|7492259|FG000|T2: 6month Follow-up|Withdrawal by Subject|4
4489090|NCT00776009|7290749|FG005|Period 1: First Intervention|Withdrawal by Subject|0
4489091|NCT00776009|7290744|FG000|Period 1: First Intervention|Protocol Violation|0
4489092|NCT00776009|7290745|FG001|Period 1: First Intervention|Protocol Violation|1
4489093|NCT00776009|7290746|FG002|Period 1: First Intervention|Protocol Violation|0
4489094|NCT00776009|7290747|FG003|Period 1: First Intervention|Protocol Violation|0
4489095|NCT00776009|7290748|FG004|Period 1: First Intervention|Protocol Violation|1
4489096|NCT00776009|7290749|FG005|Period 1: First Intervention|Protocol Violation|0
4489097|NCT00776009|7290744|FG000|Period 2: Second Intervention|Withdrawal by Subject|0
4489098|NCT00776009|7290745|FG001|Period 2: Second Intervention|Withdrawal by Subject|0
4489099|NCT00776009|7290746|FG002|Period 2: Second Intervention|Withdrawal by Subject|0
4489100|NCT00776009|7290747|FG003|Period 2: Second Intervention|Withdrawal by Subject|0
4489101|NCT00776009|7290748|FG004|Period 2: Second Intervention|Withdrawal by Subject|0
4489102|NCT00776009|7290749|FG005|Period 2: Second Intervention|Withdrawal by Subject|1
4489103|NCT00776009|7290744|FG000|Period 2: Second Intervention|Protocol Violation|1
4489104|NCT00776009|7290745|FG001|Period 2: Second Intervention|Protocol Violation|0
4489105|NCT00776009|7290746|FG002|Period 2: Second Intervention|Protocol Violation|1
4489106|NCT00776009|7290747|FG003|Period 2: Second Intervention|Protocol Violation|0
4489107|NCT00776009|7290748|FG004|Period 2: Second Intervention|Protocol Violation|0
4489108|NCT00776009|7290749|FG005|Period 2: Second Intervention|Protocol Violation|0
4489109|NCT00776009|7290744|FG000|Period 3: Third Intervention|Withdrawal by Subject|1
4489110|NCT00776009|7290745|FG001|Period 3: Third Intervention|Withdrawal by Subject|0
4489111|NCT00776009|7290746|FG002|Period 3: Third Intervention|Withdrawal by Subject|0
4489112|NCT00776009|7290747|FG003|Period 3: Third Intervention|Withdrawal by Subject|0
4489113|NCT00776009|7290748|FG004|Period 3: Third Intervention|Withdrawal by Subject|0
4489114|NCT00776009|7290749|FG005|Period 3: Third Intervention|Withdrawal by Subject|0
4489115|NCT00776230|7290760|FG000|Overall Study|Lost to Follow-up|2
4489116|NCT00776230|7290761|FG001|Overall Study|Lost to Follow-up|1
4489117|NCT00776230|7290762|FG002|Overall Study|Lost to Follow-up|5
4489118|NCT00776230|7290760|FG000|Overall Study|Not vaccinated at Day 0|1
4489119|NCT00776230|7290761|FG001|Overall Study|Not vaccinated at Day 0|0
4489120|NCT00776230|7290762|FG002|Overall Study|Not vaccinated at Day 0|0
4489121|NCT00776230|7290760|FG000|Overall Study|Withdrawal by Subject|0
4489122|NCT00776230|7290761|FG001|Overall Study|Withdrawal by Subject|1
4489123|NCT00776230|7290762|FG002|Overall Study|Withdrawal by Subject|0
4489124|NCT00776230|7290760|FG000|Overall Study|Subject missed Visit 4|0
4489125|NCT00776230|7290761|FG001|Overall Study|Subject missed Visit 4|1
4489126|NCT00776230|7290762|FG002|Overall Study|Subject missed Visit 4|0
4489127|NCT00776659|7290785|FG000|Overall Study|Lost to Follow-up|15
4489128|NCT00776659|7290785|FG000|Overall Study|Withdrawal by Subject|10
4489129|NCT00776659|7290785|FG000|Overall Study|Study Terminated by Sponsor|1
4626541|NCT01842438|7492260|FG001|T2: 6month Follow-up|Withdrawal by Subject|3
4626542|NCT01842438|7492259|FG000|T2: 6month Follow-up|Death|0
4626543|NCT01842438|7492260|FG001|T2: 6month Follow-up|Death|1
4701747|NCT02711956|7618801|FG014|Overall Study|Physician Decision|0
4701748|NCT02711956|7618787|FG000|Overall Study|Withdrawal by Subject|0
4701749|NCT02711956|7618788|FG001|Overall Study|Withdrawal by Subject|0
4701750|NCT02711956|7618789|FG002|Overall Study|Withdrawal by Subject|0
4701751|NCT02711956|7618790|FG003|Overall Study|Withdrawal by Subject|0
4701752|NCT02711956|7618791|FG004|Overall Study|Withdrawal by Subject|0
4701753|NCT02711956|7618792|FG005|Overall Study|Withdrawal by Subject|0
4701754|NCT02711956|7618793|FG006|Overall Study|Withdrawal by Subject|1
4701755|NCT02711956|7618794|FG007|Overall Study|Withdrawal by Subject|0
4701756|NCT02711956|7618795|FG008|Overall Study|Withdrawal by Subject|0
4701757|NCT02711956|7618796|FG009|Overall Study|Withdrawal by Subject|0
4701758|NCT02711956|7618797|FG010|Overall Study|Withdrawal by Subject|0
4701759|NCT02711956|7618798|FG011|Overall Study|Withdrawal by Subject|1
4701760|NCT02711956|7618799|FG012|Overall Study|Withdrawal by Subject|6
4701761|NCT02711956|7618800|FG013|Overall Study|Withdrawal by Subject|0
4701762|NCT02711956|7618801|FG014|Overall Study|Withdrawal by Subject|1
4701763|NCT02711956|7618787|FG000|Overall Study|Clinical progression|1
4701764|NCT02711956|7618788|FG001|Overall Study|Clinical progression|0
4626544|NCT01842581|7492277|FG000|Overall Study|Adverse Event|6
4626545|NCT01842581|7492278|FG001|Overall Study|Adverse Event|4
4626546|NCT01842581|7492277|FG000|Overall Study|HE breakthrough|26
4626547|NCT01842581|7492278|FG001|Overall Study|HE breakthrough|13
4626548|NCT01842581|7492277|FG000|Overall Study|Liver transplant|2
4626549|NCT01842581|7492278|FG001|Overall Study|Liver transplant|0
4626550|NCT01842581|7492277|FG000|Overall Study|Lost to Follow-up|2
4626551|NCT01842581|7492278|FG001|Overall Study|Lost to Follow-up|5
4626552|NCT01842581|7492277|FG000|Overall Study|Withdrawal by Subject|5
4489130|NCT00776789|7290791|FG000|Overall Study|Consent refusal|2
4489131|NCT00776789|7290792|FG001|Overall Study|Consent refusal|2
4489132|NCT00776789|7290791|FG000|Overall Study|Poor quality video|1
4489133|NCT00776789|7290792|FG001|Overall Study|Poor quality video|1
4489134|NCT00776919|7290804|FG000|Overall Study|Withdrawal by Subject|16
4489135|NCT00776919|7290805|FG001|Overall Study|Withdrawal by Subject|14
4489136|NCT00776919|7290806|FG002|Overall Study|Withdrawal by Subject|15
4489137|NCT00776919|7290807|FG003|Overall Study|Withdrawal by Subject|26
4489138|NCT00776919|7290804|FG000|Overall Study|Lost to Follow-up|8
4489139|NCT00776919|7290805|FG001|Overall Study|Lost to Follow-up|12
4489140|NCT00776919|7290806|FG002|Overall Study|Lost to Follow-up|11
4489141|NCT00776919|7290807|FG003|Overall Study|Lost to Follow-up|8
4489142|NCT00776919|7290804|FG000|Overall Study|Adverse Event|1
4489143|NCT00776919|7290805|FG001|Overall Study|Adverse Event|0
4489144|NCT00776919|7290806|FG002|Overall Study|Adverse Event|2
4489145|NCT00776919|7290807|FG003|Overall Study|Adverse Event|2
4489146|NCT00776919|7290804|FG000|Overall Study|Protocol Violation|1
4489147|NCT00776919|7290805|FG001|Overall Study|Protocol Violation|2
4489148|NCT00776919|7290806|FG002|Overall Study|Protocol Violation|0
4626553|NCT01842581|7492278|FG001|Overall Study|Withdrawal by Subject|7
4626554|NCT01842581|7492277|FG000|Overall Study|Other than specified|3
4626555|NCT01842581|7492278|FG001|Overall Study|Other than specified|1
4626556|NCT01842607|7492288|FG000|Overall Study|Adverse Event|11
4626557|NCT01842607|7492288|FG000|Overall Study|Lack of Efficacy|19
4626558|NCT01842607|7492288|FG000|Overall Study|Protocol Violation|8
4626559|NCT01842607|7492288|FG000|Overall Study|Protocol defined stopping criteria|2
4626560|NCT01842607|7492288|FG000|Overall Study|Lost to Follow-up|3
4626561|NCT01842607|7492288|FG000|Overall Study|Physician Decision|9
4626562|NCT01842607|7492288|FG000|Overall Study|Withdrawal by Subject|14
4626563|NCT01842620|7492292|FG000|Period 1|Withdrawal by Subject|1
4701765|NCT02711956|7618789|FG002|Overall Study|Clinical progression|0
4701766|NCT02711956|7618790|FG003|Overall Study|Clinical progression|0
4701767|NCT02711956|7618791|FG004|Overall Study|Clinical progression|0
4701768|NCT02711956|7618792|FG005|Overall Study|Clinical progression|0
4701769|NCT02711956|7618793|FG006|Overall Study|Clinical progression|1
4701770|NCT02711956|7618794|FG007|Overall Study|Clinical progression|0
4701771|NCT02711956|7618795|FG008|Overall Study|Clinical progression|1
4701772|NCT02711956|7618796|FG009|Overall Study|Clinical progression|0
4701773|NCT02711956|7618797|FG010|Overall Study|Clinical progression|0
4701774|NCT02711956|7618798|FG011|Overall Study|Clinical progression|2
4701775|NCT02711956|7618799|FG012|Overall Study|Clinical progression|4
4701776|NCT02711956|7618800|FG013|Overall Study|Clinical progression|1
4701777|NCT02711956|7618801|FG014|Overall Study|Clinical progression|1
4701778|NCT02711956|7618787|FG000|Overall Study|Radiographic progression|1
4701779|NCT02711956|7618788|FG001|Overall Study|Radiographic progression|1
4701780|NCT02711956|7618789|FG002|Overall Study|Radiographic progression|2
4701781|NCT02711956|7618790|FG003|Overall Study|Radiographic progression|0
4701782|NCT02711956|7618791|FG004|Overall Study|Radiographic progression|1
4701783|NCT02711956|7618792|FG005|Overall Study|Radiographic progression|0
4701784|NCT02711956|7618793|FG006|Overall Study|Radiographic progression|0
4701785|NCT02711956|7618794|FG007|Overall Study|Radiographic progression|0
4701786|NCT02711956|7618795|FG008|Overall Study|Radiographic progression|2
4701787|NCT02711956|7618796|FG009|Overall Study|Radiographic progression|1
4701788|NCT02711956|7618797|FG010|Overall Study|Radiographic progression|0
4701789|NCT02711956|7618798|FG011|Overall Study|Radiographic progression|5
4701790|NCT02711956|7618799|FG012|Overall Study|Radiographic progression|3
4701791|NCT02711956|7618800|FG013|Overall Study|Radiographic progression|0
4701792|NCT02711956|7618801|FG014|Overall Study|Radiographic progression|1
4701793|NCT02711956|7618787|FG000|Overall Study|PSA progression with clinical progression|0
4701794|NCT02711956|7618788|FG001|Overall Study|PSA progression with clinical progression|0
4701795|NCT02711956|7618789|FG002|Overall Study|PSA progression with clinical progression|0
4701796|NCT02711956|7618790|FG003|Overall Study|PSA progression with clinical progression|0
4701797|NCT02711956|7618791|FG004|Overall Study|PSA progression with clinical progression|1
4701798|NCT02711956|7618792|FG005|Overall Study|PSA progression with clinical progression|0
4701799|NCT02711956|7618793|FG006|Overall Study|PSA progression with clinical progression|0
4701800|NCT02711956|7618794|FG007|Overall Study|PSA progression with clinical progression|0
4701801|NCT02711956|7618795|FG008|Overall Study|PSA progression with clinical progression|0
4701802|NCT02711956|7618796|FG009|Overall Study|PSA progression with clinical progression|0
4701803|NCT02711956|7618797|FG010|Overall Study|PSA progression with clinical progression|0
4701804|NCT02711956|7618798|FG011|Overall Study|PSA progression with clinical progression|0
4701805|NCT02711956|7618799|FG012|Overall Study|PSA progression with clinical progression|1
4489149|NCT00776919|7290807|FG003|Overall Study|Protocol Violation|1
4626564|NCT01842620|7492293|FG001|Period 1|Withdrawal by Subject|0
4626565|NCT01842633|7492302|FG000|Overall Study|Screen Failure|1
4701806|NCT02711956|7618800|FG013|Overall Study|PSA progression with clinical progression|1
4701807|NCT02711956|7618801|FG014|Overall Study|PSA progression with clinical progression|0
4489150|NCT00776919|7290804|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1
4626566|NCT01842633|7492303|FG001|Overall Study|Screen Failure|0
4701808|NCT02711956|7618787|FG000|Overall Study|PSA progression with radiographic progression|0
4701809|NCT02711956|7618788|FG001|Overall Study|PSA progression with radiographic progression|1
4489151|NCT00776919|7290805|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5
4489152|NCT00776919|7290806|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4
4489153|NCT00776919|7290807|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2
4489154|NCT00776984|7290819|FG000|Overall Study|Adverse Event|8
4489155|NCT00776984|7290820|FG001|Overall Study|Adverse Event|2
4489156|NCT00776984|7290819|FG000|Overall Study|Protocol Violation|4
4489157|NCT00776984|7290820|FG001|Overall Study|Protocol Violation|2
4489158|NCT00776984|7290819|FG000|Overall Study|Lost to Follow-up|2
4489159|NCT00776984|7290820|FG001|Overall Study|Lost to Follow-up|0
4626567|NCT01842633|7492304|FG002|Overall Study|Screen Failure|0
4701810|NCT02711956|7618789|FG002|Overall Study|PSA progression with radiographic progression|0
4489160|NCT00776984|7290819|FG000|Overall Study|Withdrawal by Subject|12
4489161|NCT00776984|7290820|FG001|Overall Study|Withdrawal by Subject|7
4489162|NCT00776984|7290819|FG000|Overall Study|Lack of Efficacy|0
4489163|NCT00776984|7290820|FG001|Overall Study|Lack of Efficacy|1
4489164|NCT00776984|7290819|FG000|Overall Study|Other|5
4489165|NCT00776984|7290820|FG001|Overall Study|Other|9
4489166|NCT00776997|7290826|FG000|Overall Study|Adverse Event|2
4489167|NCT00777023|7290833|FG000|Overall Study|Adverse Event|15
4489168|NCT00777023|7290834|FG001|Overall Study|Adverse Event|21
4489169|NCT00777023|7290835|FG002|Overall Study|Adverse Event|8
4489170|NCT00777023|7290833|FG000|Overall Study|Lack of Efficacy|1
4489171|NCT00777023|7290834|FG001|Overall Study|Lack of Efficacy|0
4489172|NCT00777023|7290835|FG002|Overall Study|Lack of Efficacy|14
4489173|NCT00777023|7290833|FG000|Overall Study|Protocol Violation|2
4489174|NCT00777023|7290834|FG001|Overall Study|Protocol Violation|1
4489175|NCT00777023|7290835|FG002|Overall Study|Protocol Violation|1
4489176|NCT00777023|7290833|FG000|Overall Study|Lost to Follow-up|2
4489177|NCT00777023|7290834|FG001|Overall Study|Lost to Follow-up|3
4489178|NCT00777023|7290835|FG002|Overall Study|Lost to Follow-up|3
4489179|NCT00777023|7290833|FG000|Overall Study|Death|0
4489180|NCT00777023|7290834|FG001|Overall Study|Death|1
4489181|NCT00777023|7290835|FG002|Overall Study|Death|0
4489182|NCT00777023|7290833|FG000|Overall Study|Withdrawal by Subject|7
4489183|NCT00777023|7290834|FG001|Overall Study|Withdrawal by Subject|7
4489184|NCT00777023|7290835|FG002|Overall Study|Withdrawal by Subject|8
4489185|NCT00777023|7290833|FG000|Overall Study|Missing data|1
4489186|NCT00777023|7290834|FG001|Overall Study|Missing data|1
4489187|NCT00777023|7290835|FG002|Overall Study|Missing data|0
4489188|NCT00777023|7290833|FG000|Overall Study|Reasons not specified|4
4489189|NCT00777023|7290834|FG001|Overall Study|Reasons not specified|4
4489190|NCT00777023|7290835|FG002|Overall Study|Reasons not specified|2
4489191|NCT00777023|7290833|FG000|Overall Study|Last dose date unknown|3
4489192|NCT00777023|7290834|FG001|Overall Study|Last dose date unknown|3
4489193|NCT00777023|7290835|FG002|Overall Study|Last dose date unknown|1
4489194|NCT00777049|7290845|FG000|Overall Study|Withdrawal by Subject|1
4489195|NCT00777049|7290846|FG001|Overall Study|Withdrawal by Subject|0
4489196|NCT00777049|7290845|FG000|Overall Study|No treatment (elevated liver enzymes)|0
4489197|NCT00777049|7290846|FG001|Overall Study|No treatment (elevated liver enzymes)|1
4489198|NCT00777088|7290861|FG000|Overall Study|PED Treatment not attempted|1
4489199|NCT00777101|7290868|FG000|Overall Study|Death|48
4489200|NCT00777101|7290869|FG001|Overall Study|Death|43
4489201|NCT00777101|7290868|FG000|Overall Study|Withdrawal by Subject|11
4489202|NCT00777101|7290869|FG001|Overall Study|Withdrawal by Subject|6
4489203|NCT00777101|7290868|FG000|Overall Study|Lost to Follow-up|2
4489204|NCT00777101|7290869|FG001|Overall Study|Lost to Follow-up|1
4489205|NCT00777101|7290868|FG000|Overall Study|Discontinuation of Study by Sponsor|1
4489206|NCT00777101|7290869|FG001|Overall Study|Discontinuation of Study by Sponsor|0
4489207|NCT00777101|7290868|FG000|Overall Study|Failed to Return|0
4489208|NCT00777101|7290869|FG001|Overall Study|Failed to Return|1
4701811|NCT02711956|7618790|FG003|Overall Study|PSA progression with radiographic progression|0
4701812|NCT02711956|7618791|FG004|Overall Study|PSA progression with radiographic progression|0
4701813|NCT02711956|7618792|FG005|Overall Study|PSA progression with radiographic progression|2
4701814|NCT02711956|7618793|FG006|Overall Study|PSA progression with radiographic progression|2
4771236|NCT02978781|7748152|FG001|Part A|Adverse Event|1
4771237|NCT02978781|7748153|FG002|Part A|Adverse Event|0
4771238|NCT02978781|7748154|FG003|Part A|Adverse Event|0
4771239|NCT02978781|7748155|FG004|Part A|Adverse Event|0
4771240|NCT02978781|7748151|FG000|Part A|Withdrawal by Subject|0
4771241|NCT02978781|7748152|FG001|Part A|Withdrawal by Subject|1
4771242|NCT02978781|7748153|FG002|Part A|Withdrawal by Subject|0
4771243|NCT02978781|7748154|FG003|Part A|Withdrawal by Subject|0
4489209|NCT00777153|7290879|FG000|Overall Study|Lost to Follow-up|1
4489210|NCT00777153|7290880|FG001|Overall Study|Lost to Follow-up|1
4489211|NCT00777153|7290881|FG002|Overall Study|Lost to Follow-up|0
4489212|NCT00777153|7290879|FG000|Overall Study|Death|85
4489213|NCT00777153|7290880|FG001|Overall Study|Death|73
4489214|NCT00777153|7290881|FG002|Overall Study|Death|33
4489215|NCT00777153|7290879|FG000|Overall Study|Withdrawal by Subject|3
4489216|NCT00777153|7290880|FG001|Overall Study|Withdrawal by Subject|4
4489217|NCT00777153|7290881|FG002|Overall Study|Withdrawal by Subject|3
4626568|NCT01842633|7492302|FG000|Overall Study|Adverse Event|1
4771244|NCT02978781|7748155|FG004|Part A|Withdrawal by Subject|0
4771245|NCT02978781|7748151|FG000|Part B|Withdrawal by Subject|0
4489218|NCT00777153|7290879|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1
4489219|NCT00777153|7290880|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5
4489220|NCT00777153|7290881|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1
4489221|NCT00777205|7290904|FG000|Overall Study|Lost to Follow-up|25
4489222|NCT00777205|7290905|FG001|Overall Study|Lost to Follow-up|9
4489223|NCT00777205|7290904|FG000|Overall Study|Withdrawal by Subject|6
4489224|NCT00777205|7290905|FG001|Overall Study|Withdrawal by Subject|4
4489225|NCT00777205|7290904|FG000|Overall Study|Death|0
4489226|NCT00777205|7290905|FG001|Overall Study|Death|2
4489227|NCT00777205|7290904|FG000|Overall Study|Protocol Violation|0
4489228|NCT00777205|7290905|FG001|Overall Study|Protocol Violation|56
4489229|NCT00777257|7290916|FG000|Overall Study|Adverse Event|3
4489230|NCT00777257|7290917|FG001|Overall Study|Adverse Event|1
4489231|NCT00777257|7290918|FG002|Overall Study|Adverse Event|0
4489232|NCT00777257|7290916|FG000|Overall Study|Lost to Follow-up|3
4489233|NCT00777257|7290917|FG001|Overall Study|Lost to Follow-up|3
4489234|NCT00777257|7290918|FG002|Overall Study|Lost to Follow-up|2
4489235|NCT00777257|7290916|FG000|Overall Study|Protocol Violation|2
4489236|NCT00777257|7290917|FG001|Overall Study|Protocol Violation|2
4489237|NCT00777257|7290918|FG002|Overall Study|Protocol Violation|2
4489238|NCT00777257|7290916|FG000|Overall Study|Withdrawal by Subject|3
4489239|NCT00777257|7290917|FG001|Overall Study|Withdrawal by Subject|6
4489240|NCT00777257|7290918|FG002|Overall Study|Withdrawal by Subject|5
4489241|NCT00777296|7290930|FG000|Overall Study|Adverse Event|0
4489242|NCT00777296|7290931|FG001|Overall Study|Adverse Event|1
4489243|NCT00777296|7290932|FG002|Overall Study|Adverse Event|0
4489244|NCT00777296|7290933|FG003|Overall Study|Adverse Event|1
4489245|NCT00777296|7290930|FG000|Overall Study|Withdrawal by Subject|1
4489246|NCT00777296|7290931|FG001|Overall Study|Withdrawal by Subject|0
4489247|NCT00777296|7290932|FG002|Overall Study|Withdrawal by Subject|0
4489248|NCT00777296|7290933|FG003|Overall Study|Withdrawal by Subject|0
4489249|NCT00777296|7290930|FG000|Overall Study|CRF form not completed|0
4489250|NCT00777296|7290931|FG001|Overall Study|CRF form not completed|0
4489251|NCT00777296|7290932|FG002|Overall Study|CRF form not completed|2
4489252|NCT00777296|7290933|FG003|Overall Study|CRF form not completed|0
4489253|NCT00777491|7290966|FG000|Overall Study|Protocol Violation|0
4489254|NCT00777491|7290967|FG001|Overall Study|Protocol Violation|2
4489255|NCT00777491|7290966|FG000|Overall Study|Did not receive any protocol treatment|2
4489256|NCT00777491|7290967|FG001|Overall Study|Did not receive any protocol treatment|0
4489257|NCT00777556|7290973|FG000|Overall Study|Inappropriate self-selection|34
4489258|NCT00777556|7290973|FG000|Overall Study|Dispensed but did not use product|12
4489259|NCT00777556|7290973|FG000|Overall Study|Did not complete all 3 follow-up visits|20
4489260|NCT00777608|7290979|FG000|Overall Study|Lost to Follow-up|1
4489261|NCT00777608|7290980|FG001|Overall Study|Lost to Follow-up|1
4489262|NCT00777608|7290979|FG000|Overall Study|Withdrawal by Subject|1
4489263|NCT00777608|7290980|FG001|Overall Study|Withdrawal by Subject|3
4489264|NCT00777608|7290979|FG000|Overall Study|Protocol Violation|1
4489265|NCT00777608|7290980|FG001|Overall Study|Protocol Violation|0
4489266|NCT00777608|7290979|FG000|Overall Study|Investigator Decision|1
4489267|NCT00777608|7290980|FG001|Overall Study|Investigator Decision|2
4489268|NCT00777803|7291021|FG000|Overall Study|Lost to Follow-up|12
4489269|NCT00777803|7291022|FG001|Overall Study|Lost to Follow-up|5
4489270|NCT00777803|7291021|FG000|Overall Study|Adverse Event|1
4489271|NCT00777803|7291022|FG001|Overall Study|Adverse Event|0
4489272|NCT00777803|7291021|FG000|Overall Study|Non-compliance|2
4489273|NCT00777803|7291022|FG001|Overall Study|Non-compliance|2
4489274|NCT00777829|7291028|FG000|Overall Study|Withdrawal by Subject|0
4489275|NCT00777829|7291029|FG001|Overall Study|Withdrawal by Subject|2
4489276|NCT00777920|7291043|FG000|Overall Study|Adverse Event|39
4489277|NCT00777920|7291043|FG000|Overall Study|Withdrawal of Consent|4
4489278|NCT00777920|7291043|FG000|Overall Study|Lost to Follow-up|1
4489279|NCT00777920|7291043|FG000|Overall Study|Investigator's discretion|1
4701815|NCT02711956|7618794|FG007|Overall Study|PSA progression with radiographic progression|1
4701816|NCT02711956|7618795|FG008|Overall Study|PSA progression with radiographic progression|0
4701817|NCT02711956|7618796|FG009|Overall Study|PSA progression with radiographic progression|1
4701818|NCT02711956|7618797|FG010|Overall Study|PSA progression with radiographic progression|0
4701819|NCT02711956|7618798|FG011|Overall Study|PSA progression with radiographic progression|1
4701820|NCT02711956|7618799|FG012|Overall Study|PSA progression with radiographic progression|2
4701821|NCT02711956|7618800|FG013|Overall Study|PSA progression with radiographic progression|3
4701822|NCT02711956|7618801|FG014|Overall Study|PSA progression with radiographic progression|3
4701823|NCT02711995|7618842|FG000|Washout (90 Days)|Conflicting medication|1
4701824|NCT02712008|7618851|FG000|Baseline (Day 1) up to Week 12|Death|3
4701825|NCT02712008|7618852|FG001|Baseline (Day 1) up to Week 12|Death|0
4701826|NCT02712008|7618853|FG002|Baseline (Day 1) up to Week 12|Death|0
4489280|NCT00777920|7291043|FG000|Overall Study|Clinical status did not improve|1
4489281|NCT00777920|7291043|FG000|Overall Study|Other, not specified|4
4489282|NCT00777946|7291050|FG000|Overall Study|Adverse Event|11
4489283|NCT00777946|7291051|FG001|Overall Study|Adverse Event|1
4489284|NCT00777946|7291052|FG002|Overall Study|Adverse Event|3
4489285|NCT00777946|7291050|FG000|Overall Study|Lack of Efficacy|0
4489286|NCT00777946|7291051|FG001|Overall Study|Lack of Efficacy|0
4489287|NCT00777946|7291052|FG002|Overall Study|Lack of Efficacy|9
4489288|NCT00777946|7291050|FG000|Overall Study|Condition no longer required study drug|1
4489289|NCT00777946|7291051|FG001|Overall Study|Condition no longer required study drug|0
4489290|NCT00777946|7291052|FG002|Overall Study|Condition no longer required study drug|0
4489291|NCT00777946|7291050|FG000|Overall Study|Patient withdrew consent|3
4489292|NCT00777946|7291051|FG001|Overall Study|Patient withdrew consent|2
4489293|NCT00777946|7291052|FG002|Overall Study|Patient withdrew consent|3
4489294|NCT00777946|7291050|FG000|Overall Study|Lost to Follow-up|3
4626569|NCT01842633|7492303|FG001|Overall Study|Adverse Event|1
4626570|NCT01842633|7492304|FG002|Overall Study|Adverse Event|0
4626571|NCT01842633|7492302|FG000|Overall Study|Withdrawal by Subject|0
4626572|NCT01842633|7492303|FG001|Overall Study|Withdrawal by Subject|1
4626573|NCT01842633|7492304|FG002|Overall Study|Withdrawal by Subject|0
4626574|NCT01842633|7492302|FG000|Overall Study|Technical issues|1
4626575|NCT01842633|7492303|FG001|Overall Study|Technical issues|0
4489295|NCT00777946|7291051|FG001|Overall Study|Lost to Follow-up|1
4489296|NCT00777946|7291052|FG002|Overall Study|Lost to Follow-up|0
4489297|NCT00777946|7291050|FG000|Overall Study|Protocol deviation|2
4489298|NCT00777946|7291051|FG001|Overall Study|Protocol deviation|1
4489299|NCT00777946|7291052|FG002|Overall Study|Protocol deviation|1
4489300|NCT00777946|7291050|FG000|Overall Study|Randomized in error|1
4489301|NCT00777946|7291051|FG001|Overall Study|Randomized in error|1
4489302|NCT00777946|7291052|FG002|Overall Study|Randomized in error|0
4489303|NCT00778102|7291062|FG000|Overall Study|Adverse Event|8
4489304|NCT00778102|7291063|FG001|Overall Study|Adverse Event|5
4489305|NCT00778102|7291062|FG000|Overall Study|Death|1
4489306|NCT00778102|7291063|FG001|Overall Study|Death|1
4489307|NCT00778102|7291062|FG000|Overall Study|Lost to Follow-up|1
4489308|NCT00778102|7291063|FG001|Overall Study|Lost to Follow-up|0
4489309|NCT00778102|7291062|FG000|Overall Study|Violation of Selection Criteria|1
4489310|NCT00778102|7291063|FG001|Overall Study|Violation of Selection Criteria|1
4489311|NCT00778102|7291062|FG000|Overall Study|Protocol Violation|0
4489312|NCT00778102|7291063|FG001|Overall Study|Protocol Violation|1
4489313|NCT00778102|7291062|FG000|Overall Study|Refused Treatment|2
4489314|NCT00778102|7291063|FG001|Overall Study|Refused Treatment|3
4489315|NCT00778102|7291062|FG000|Overall Study|Withdrawal by Subject|1
4489316|NCT00778102|7291063|FG001|Overall Study|Withdrawal by Subject|1
4489317|NCT00778102|7291062|FG000|Overall Study|Administrative Reason|7
4489318|NCT00778102|7291063|FG001|Overall Study|Administrative Reason|10
4489319|NCT00778258|7291091|FG000|Overall Study|Adverse Event|1
4489320|NCT00778258|7291092|FG001|Overall Study|Adverse Event|0
4489321|NCT00778258|7291093|FG002|Overall Study|Adverse Event|0
4489322|NCT00778258|7291094|FG003|Overall Study|Adverse Event|0
4489323|NCT00778258|7291095|FG004|Overall Study|Adverse Event|0
4489324|NCT00778258|7291096|FG005|Overall Study|Adverse Event|1
4489325|NCT00778258|7291097|FG006|Overall Study|Adverse Event|0
4489326|NCT00778258|7291098|FG007|Overall Study|Adverse Event|0
4489327|NCT00778258|7291099|FG008|Overall Study|Adverse Event|0
4489328|NCT00778258|7291091|FG000|Overall Study|Lost to Follow-up|0
4489329|NCT00778258|7291092|FG001|Overall Study|Lost to Follow-up|0
4489330|NCT00778258|7291093|FG002|Overall Study|Lost to Follow-up|2
4489331|NCT00778258|7291094|FG003|Overall Study|Lost to Follow-up|0
4489332|NCT00778258|7291095|FG004|Overall Study|Lost to Follow-up|0
4489333|NCT00778258|7291096|FG005|Overall Study|Lost to Follow-up|3
4489334|NCT00778258|7291097|FG006|Overall Study|Lost to Follow-up|2
4489335|NCT00778258|7291098|FG007|Overall Study|Lost to Follow-up|2
4489336|NCT00778258|7291099|FG008|Overall Study|Lost to Follow-up|0
4489337|NCT00778258|7291091|FG000|Overall Study|Withdrawal by Subject|6
4489338|NCT00778258|7291092|FG001|Overall Study|Withdrawal by Subject|2
4489339|NCT00778258|7291093|FG002|Overall Study|Withdrawal by Subject|8
4489340|NCT00778258|7291094|FG003|Overall Study|Withdrawal by Subject|2
4489341|NCT00778258|7291095|FG004|Overall Study|Withdrawal by Subject|0
4489342|NCT00778258|7291096|FG005|Overall Study|Withdrawal by Subject|6
4489343|NCT00778258|7291097|FG006|Overall Study|Withdrawal by Subject|12
4489344|NCT00778258|7291098|FG007|Overall Study|Withdrawal by Subject|12
4489345|NCT00778258|7291099|FG008|Overall Study|Withdrawal by Subject|4
4489346|NCT00778258|7291091|FG000|Overall Study|New Contraindication|0
4489347|NCT00778258|7291092|FG001|Overall Study|New Contraindication|0
4489348|NCT00778258|7291093|FG002|Overall Study|New Contraindication|0
4489349|NCT00778258|7291094|FG003|Overall Study|New Contraindication|0
4489350|NCT00778258|7291095|FG004|Overall Study|New Contraindication|0
4489351|NCT00778258|7291096|FG005|Overall Study|New Contraindication|0
4489352|NCT00778258|7291097|FG006|Overall Study|New Contraindication|0
4489353|NCT00778258|7291098|FG007|Overall Study|New Contraindication|1
4489354|NCT00778258|7291099|FG008|Overall Study|New Contraindication|0
4489355|NCT00778258|7291091|FG000|Overall Study|Non-compliance|0
4590209|NCT01519635|7436001|FG000|Overall Study|Withdrawal by Subject|0
4590210|NCT01519635|7436002|FG001|Overall Study|Withdrawal by Subject|1
4590211|NCT01519635|7436001|FG000|Overall Study|No possibility to put a catheter|1
4590212|NCT01519635|7436002|FG001|Overall Study|No possibility to put a catheter|2
4590213|NCT01519661|7436017|FG000|Overall Study|Protocol deviation|6
4590214|NCT01519661|7436017|FG000|Overall Study|Lost to Follow-up|3
4590215|NCT01519661|7436017|FG000|Overall Study|Withdrawal by Subject|17
4489356|NCT00778258|7291092|FG001|Overall Study|Non-compliance|0
4489357|NCT00778258|7291093|FG002|Overall Study|Non-compliance|0
4489358|NCT00778258|7291094|FG003|Overall Study|Non-compliance|1
4489359|NCT00778258|7291095|FG004|Overall Study|Non-compliance|0
4489360|NCT00778258|7291096|FG005|Overall Study|Non-compliance|0
4489361|NCT00778258|7291097|FG006|Overall Study|Non-compliance|0
4489362|NCT00778258|7291098|FG007|Overall Study|Non-compliance|0
4489363|NCT00778258|7291099|FG008|Overall Study|Non-compliance|0
4489364|NCT00778258|7291091|FG000|Overall Study|Other|0
4489365|NCT00778258|7291092|FG001|Overall Study|Other|0
4489366|NCT00778258|7291093|FG002|Overall Study|Other|0
4489367|NCT00778258|7291094|FG003|Overall Study|Other|0
4489368|NCT00778258|7291095|FG004|Overall Study|Other|0
4489369|NCT00778258|7291096|FG005|Overall Study|Other|0
4489370|NCT00778258|7291097|FG006|Overall Study|Other|1
4489371|NCT00778258|7291098|FG007|Overall Study|Other|0
4489372|NCT00778258|7291099|FG008|Overall Study|Other|0
4489373|NCT00778336|7291140|FG000|Index Procedure-Discharge|Death|6
4489374|NCT00778336|7291141|FG001|Index Procedure-Discharge|Death|3
4489375|NCT00778336|7291142|FG002|Index Procedure-Discharge|Death|2
4489376|NCT00778336|7291143|FG003|Index Procedure-Discharge|Death|0
4489377|NCT00778336|7291140|FG000|3 Month Follow Up|Lost to Follow-up|15
4489378|NCT00778336|7291141|FG001|3 Month Follow Up|Lost to Follow-up|20
4489379|NCT00778336|7291142|FG002|3 Month Follow Up|Lost to Follow-up|3
4489380|NCT00778336|7291143|FG003|3 Month Follow Up|Lost to Follow-up|0
4489381|NCT00778336|7291140|FG000|3 Month Follow Up|Death|8
4489382|NCT00778336|7291141|FG001|3 Month Follow Up|Death|3
4489383|NCT00778336|7291142|FG002|3 Month Follow Up|Death|2
4489384|NCT00778336|7291143|FG003|3 Month Follow Up|Death|0
4489385|NCT00778375|7291153|FG000|Overall Study|Ineligible|3
4489386|NCT00778622|7291162|FG000|Overall Study|Adverse Event|5
4489387|NCT00778622|7291163|FG001|Overall Study|Adverse Event|4
4489388|NCT00778622|7291164|FG002|Overall Study|Adverse Event|7
4489389|NCT00778622|7291162|FG000|Overall Study|Withdrawal by Subject|4
4489390|NCT00778622|7291163|FG001|Overall Study|Withdrawal by Subject|5
4489391|NCT00778622|7291164|FG002|Overall Study|Withdrawal by Subject|5
4489392|NCT00778622|7291162|FG000|Overall Study|Lost to Follow-up|3
4489393|NCT00778622|7291163|FG001|Overall Study|Lost to Follow-up|3
4489394|NCT00778622|7291164|FG002|Overall Study|Lost to Follow-up|2
4489395|NCT00778622|7291162|FG000|Overall Study|Protocol Violation|0
4489396|NCT00778622|7291163|FG001|Overall Study|Protocol Violation|3
4489397|NCT00778622|7291164|FG002|Overall Study|Protocol Violation|0
4489398|NCT00778622|7291162|FG000|Overall Study|Lack of Efficacy|2
4489399|NCT00778622|7291163|FG001|Overall Study|Lack of Efficacy|0
4489400|NCT00778622|7291164|FG002|Overall Study|Lack of Efficacy|0
4489401|NCT00778622|7291162|FG000|Overall Study|immigration|1
4489402|NCT00778622|7291163|FG001|Overall Study|immigration|0
4701827|NCT02712008|7618854|FG003|Baseline (Day 1) up to Week 12|Death|0
4701828|NCT02712008|7618855|FG004|Baseline (Day 1) up to Week 12|Death|0
4701829|NCT02712008|7618856|FG005|Baseline (Day 1) up to Week 12|Death|0
4701830|NCT02712008|7618857|FG006|Baseline (Day 1) up to Week 12|Death|0
4701831|NCT02712008|7618858|FG007|Baseline (Day 1) up to Week 12|Death|0
4701832|NCT02712008|7618851|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
4701833|NCT02712008|7618852|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2
4701834|NCT02712008|7618853|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1
4701835|NCT02712008|7618854|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
4701836|NCT02712008|7618855|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
4701837|NCT02712008|7618856|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
4701838|NCT02712008|7618857|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
4701839|NCT02712008|7618858|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
4701840|NCT02712008|7618851|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1
4701841|NCT02712008|7618852|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
4701842|NCT02712008|7618853|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2
4701843|NCT02712008|7618854|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
4701844|NCT02712008|7618855|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
4701845|NCT02712008|7618856|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
4701846|NCT02712008|7618857|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
4701847|NCT02712008|7618858|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
4701848|NCT02712008|7618851|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0
4701849|NCT02712008|7618852|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0
4701850|NCT02712008|7618853|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1
4701851|NCT02712008|7618854|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0
4701852|NCT02712008|7618855|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0
4701853|NCT02712008|7618856|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0
4489403|NCT00778622|7291164|FG002|Overall Study|immigration|0
4489404|NCT00778622|7291162|FG000|Overall Study|Other|1
4489405|NCT00778622|7291163|FG001|Overall Study|Other|0
4489406|NCT00778622|7291164|FG002|Overall Study|Other|1
4489407|NCT00778817|7291185|FG000|Overall Study|Adverse Event|2
4489408|NCT00778817|7291185|FG000|Overall Study|Withdrawal by Subject|2
4489409|NCT00778830|7291191|FG000|Overall Study|Ongoing at data cut-off|0
4489410|NCT00778830|7291192|FG001|Overall Study|Ongoing at data cut-off|1
4489411|NCT00778895|7291205|FG000|Active Phase|Adverse Event|3
4489412|NCT00778895|7291206|FG001|Active Phase|Adverse Event|1
4489413|NCT00778895|7291207|FG002|Active Phase|Adverse Event|0
4489414|NCT00778895|7291205|FG000|Active Phase|Withdrawal by Subject|1
4489415|NCT00778895|7291206|FG001|Active Phase|Withdrawal by Subject|4
4489416|NCT00778895|7291207|FG002|Active Phase|Withdrawal by Subject|0
4489417|NCT00778895|7291205|FG000|Active Phase|Lost to Follow-up|1
4489418|NCT00778895|7291206|FG001|Active Phase|Lost to Follow-up|1
4489419|NCT00778895|7291207|FG002|Active Phase|Lost to Follow-up|0
4489420|NCT00778895|7291205|FG000|Active Phase|Other|2
4489421|NCT00778895|7291206|FG001|Active Phase|Other|0
4489422|NCT00778895|7291207|FG002|Active Phase|Other|0
4489423|NCT00778895|7291205|FG000|ESFU Phase|Adverse Event|2
4489424|NCT00778895|7291206|FG001|ESFU Phase|Adverse Event|1
4489425|NCT00778895|7291207|FG002|ESFU Phase|Adverse Event|0
4489426|NCT00778895|7291205|FG000|ESFU Phase|Withdrawal by Subject|1
4489427|NCT00778895|7291206|FG001|ESFU Phase|Withdrawal by Subject|4
4489428|NCT00778895|7291207|FG002|ESFU Phase|Withdrawal by Subject|0
4489429|NCT00778895|7291205|FG000|ESFU Phase|Lost to Follow-up|6
4489430|NCT00778895|7291206|FG001|ESFU Phase|Lost to Follow-up|7
4489431|NCT00778895|7291207|FG002|ESFU Phase|Lost to Follow-up|2
4489432|NCT00778895|7291205|FG000|ESFU Phase|Other|2
4489433|NCT00778895|7291206|FG001|ESFU Phase|Other|0
4489434|NCT00778895|7291207|FG002|ESFU Phase|Other|0
4489435|NCT00778921|7291219|FG000|Overall Study|Adverse Event|9
4489436|NCT00778921|7291220|FG001|Overall Study|Adverse Event|10
4489437|NCT00778921|7291221|FG002|Overall Study|Adverse Event|14
4489438|NCT00778921|7291219|FG000|Overall Study|Abnormal Laboratory Value(s)|1
4489439|NCT00778921|7291220|FG001|Overall Study|Abnormal Laboratory Value(s)|0
4489440|NCT00778921|7291221|FG002|Overall Study|Abnormal Laboratory Value(s)|0
4489441|NCT00778921|7291219|FG000|Overall Study|Abnormal Test Procedure Result(s)|0
4489442|NCT00778921|7291220|FG001|Overall Study|Abnormal Test Procedure Result(s)|0
4489443|NCT00778921|7291221|FG002|Overall Study|Abnormal Test Procedure Result(s)|2
4701854|NCT02712008|7618857|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0
4701855|NCT02712008|7618858|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0
4489444|NCT00778921|7291219|FG000|Overall Study|Unsatisfactory therapeutic response|1
4626576|NCT01842633|7492304|FG002|Overall Study|Technical issues|0
4701856|NCT02712008|7618851|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0
4701857|NCT02712008|7618852|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1
4701858|NCT02712008|7618853|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0
4701859|NCT02712008|7618854|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0
4701860|NCT02712008|7618855|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0
4701861|NCT02712008|7618856|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0
4701862|NCT02712008|7618857|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0
4701863|NCT02712008|7618858|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0
4701864|NCT02712008|7618851|FG000|From Week 12 up to Week 36|Adverse Event|0
4701865|NCT02712008|7618852|FG001|From Week 12 up to Week 36|Adverse Event|0
4701866|NCT02712008|7618853|FG002|From Week 12 up to Week 36|Adverse Event|0
4701867|NCT02712008|7618854|FG003|From Week 12 up to Week 36|Adverse Event|0
4701868|NCT02712008|7618855|FG004|From Week 12 up to Week 36|Adverse Event|1
4701869|NCT02712008|7618856|FG005|From Week 12 up to Week 36|Adverse Event|0
4701870|NCT02712008|7618857|FG006|From Week 12 up to Week 36|Adverse Event|0
4701871|NCT02712008|7618858|FG007|From Week 12 up to Week 36|Adverse Event|2
4701872|NCT02712008|7618851|FG000|From Week 12 up to Week 36|Death|1
4701873|NCT02712008|7618852|FG001|From Week 12 up to Week 36|Death|0
4701874|NCT02712008|7618853|FG002|From Week 12 up to Week 36|Death|0
4701875|NCT02712008|7618854|FG003|From Week 12 up to Week 36|Death|0
4701876|NCT02712008|7618855|FG004|From Week 12 up to Week 36|Death|0
4701877|NCT02712008|7618856|FG005|From Week 12 up to Week 36|Death|0
4701878|NCT02712008|7618857|FG006|From Week 12 up to Week 36|Death|1
4701879|NCT02712008|7618858|FG007|From Week 12 up to Week 36|Death|0
4701880|NCT02712008|7618851|FG000|From Week 12 up to Week 36|Lost to Follow-up|0
4701881|NCT02712008|7618852|FG001|From Week 12 up to Week 36|Lost to Follow-up|0
4701882|NCT02712008|7618853|FG002|From Week 12 up to Week 36|Lost to Follow-up|0
4701883|NCT02712008|7618854|FG003|From Week 12 up to Week 36|Lost to Follow-up|1
4489445|NCT00778921|7291220|FG001|Overall Study|Unsatisfactory therapeutic response|1
4489446|NCT00778921|7291221|FG002|Overall Study|Unsatisfactory therapeutic response|1
4489447|NCT00778921|7291219|FG000|Overall Study|Patient No Longer Requires Study Drug|0
4489448|NCT00778921|7291220|FG001|Overall Study|Patient No Longer Requires Study Drug|1
4489449|NCT00778921|7291221|FG002|Overall Study|Patient No Longer Requires Study Drug|0
4489450|NCT00778921|7291219|FG000|Overall Study|Patient withdrew request|3
4626577|NCT01842958|7492348|FG000|Overall Study|Lost to Follow-up|1
4626578|NCT01842958|7492349|FG001|Overall Study|Lost to Follow-up|1
4626579|NCT01843023|7492357|FG000|Overall Study|Death|1
4626580|NCT01843023|7492358|FG001|Overall Study|Death|0
4626581|NCT01843023|7492357|FG000|Overall Study|Lost to Follow-up|24
4626582|NCT01843023|7492358|FG001|Overall Study|Lost to Follow-up|29
4626583|NCT01843023|7492357|FG000|Overall Study|Withdrawal by Subject|8
4626584|NCT01843023|7492358|FG001|Overall Study|Withdrawal by Subject|6
4626585|NCT01843062|7492366|FG000|Overall Study|Protocol Violation|1
4626586|NCT01843062|7492367|FG001|Overall Study|Protocol Violation|0
4626587|NCT01843062|7492366|FG000|Overall Study|New treatment following progression|2
4626588|NCT01843062|7492367|FG001|Overall Study|New treatment following progression|0
4626589|NCT01843062|7492366|FG000|Overall Study|Pregnancy|1
4626590|NCT01843062|7492367|FG001|Overall Study|Pregnancy|0
4701884|NCT02712008|7618855|FG004|From Week 12 up to Week 36|Lost to Follow-up|0
4701885|NCT02712008|7618856|FG005|From Week 12 up to Week 36|Lost to Follow-up|0
4701886|NCT02712008|7618857|FG006|From Week 12 up to Week 36|Lost to Follow-up|1
4701887|NCT02712008|7618858|FG007|From Week 12 up to Week 36|Lost to Follow-up|0
4701888|NCT02712008|7618851|FG000|From Week 12 up to Week 36|Physician Decision|0
4701889|NCT02712008|7618852|FG001|From Week 12 up to Week 36|Physician Decision|0
4701890|NCT02712008|7618853|FG002|From Week 12 up to Week 36|Physician Decision|0
4701891|NCT02712008|7618854|FG003|From Week 12 up to Week 36|Physician Decision|1
4489451|NCT00778921|7291220|FG001|Overall Study|Patient withdrew request|1
4489452|NCT00778921|7291221|FG002|Overall Study|Patient withdrew request|6
4489453|NCT00778921|7291219|FG000|Overall Study|Lost to Follow-up|0
4489454|NCT00778921|7291220|FG001|Overall Study|Lost to Follow-up|2
4489455|NCT00778921|7291221|FG002|Overall Study|Lost to Follow-up|1
4701892|NCT02712008|7618855|FG004|From Week 12 up to Week 36|Physician Decision|1
4701893|NCT02712008|7618856|FG005|From Week 12 up to Week 36|Physician Decision|0
4701894|NCT02712008|7618857|FG006|From Week 12 up to Week 36|Physician Decision|0
4701895|NCT02712008|7618858|FG007|From Week 12 up to Week 36|Physician Decision|0
4701896|NCT02712008|7618851|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0
4701897|NCT02712008|7618852|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0
4701898|NCT02712008|7618853|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0
4701899|NCT02712008|7618854|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0
4701900|NCT02712008|7618855|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0
4701901|NCT02712008|7618856|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0
4701902|NCT02712008|7618857|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3
4701903|NCT02712008|7618858|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2
4701904|NCT02712320|7618888|FG000|Overall Study|Lost to Follow-up|1
4701905|NCT02712320|7618888|FG000|Overall Study|Withdrawal by Subject|1
4701906|NCT02712320|7618888|FG000|Overall Study|Transferred to another facility|1
4701907|NCT02712320|7618888|FG000|Overall Study|Treating with the prohibited medications|2
4701908|NCT02712333|7618894|FG000|First Period|Withdrawal by Subject|3
4701909|NCT02712333|7618895|FG001|First Period|Withdrawal by Subject|2
4701910|NCT02712398|7618923|FG000|Overall Study|Withdrawal by Subject|6
4701911|NCT02712398|7618923|FG000|Overall Study|Lost to Follow-up|6
4701912|NCT02712398|7618923|FG000|Overall Study|Sponsor Decision|1
4701913|NCT02712398|7618923|FG000|Overall Study|Physician Decision|1
4701914|NCT02712398|7618923|FG000|Overall Study|Death|2
4701915|NCT02712398|7618923|FG000|Overall Study|Re-operation|21
4701916|NCT02712424|7618929|FG000|Overall Study|Lost to Follow-up|34
4701917|NCT02712424|7618930|FG001|Overall Study|Lost to Follow-up|32
4701918|NCT02712554|7618938|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0
4701919|NCT02712554|7618939|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13
4701920|NCT02712554|7618938|FG000|Part B: Qualification Phase|Sponsor Decision|0
4701921|NCT02712554|7618939|FG001|Part B: Qualification Phase|Sponsor Decision|4
4701922|NCT02712554|7618938|FG000|Part B: Qualification Phase|Withdrawal by Subject|0
4701923|NCT02712554|7618939|FG001|Part B: Qualification Phase|Withdrawal by Subject|3
4701924|NCT02712554|7618938|FG000|Part B: Qualification Phase|Adverse Event|0
4701925|NCT02712554|7618939|FG001|Part B: Qualification Phase|Adverse Event|1
4701926|NCT02712554|7618938|FG000|Part B: Treatment Phase|Adverse Event|0
4701927|NCT02712554|7618939|FG001|Part B: Treatment Phase|Adverse Event|1
4701928|NCT02712554|7618938|FG000|Part B: Treatment Phase|Withdrawal by Subject|0
4701929|NCT02712554|7618939|FG001|Part B: Treatment Phase|Withdrawal by Subject|1
4701930|NCT02712554|7618938|FG000|Part B: Treatment Phase|Other|0
4701931|NCT02712554|7618939|FG001|Part B: Treatment Phase|Other|1
4701932|NCT02712788|7618964|FG000|Overall Study|Physician Decision|1
4701933|NCT02712788|7618965|FG001|Overall Study|Physician Decision|0
4701934|NCT02712788|7618964|FG000|Overall Study|Protocol Violation|1
4701935|NCT02712788|7618965|FG001|Overall Study|Protocol Violation|0
4701936|NCT02712983|7618980|FG000|Treatment Phase|Adverse Event|3
4701937|NCT02712983|7618981|FG001|Treatment Phase|Adverse Event|1
4701938|NCT02712983|7618982|FG002|Treatment Phase|Adverse Event|1
4701939|NCT02712983|7618983|FG003|Treatment Phase|Adverse Event|4
4701940|NCT02712983|7618984|FG004|Treatment Phase|Adverse Event|3
4701941|NCT02712983|7618985|FG005|Treatment Phase|Adverse Event|0
4701942|NCT02712983|7618986|FG006|Treatment Phase|Adverse Event|6
4701943|NCT02712983|7618987|FG007|Treatment Phase|Adverse Event|6
4701944|NCT02712983|7618988|FG008|Treatment Phase|Adverse Event|1
4701945|NCT02712983|7618980|FG000|Treatment Phase|Protocol Deviation|0
4701946|NCT02712983|7618981|FG001|Treatment Phase|Protocol Deviation|0
4701947|NCT02712983|7618982|FG002|Treatment Phase|Protocol Deviation|0
4701948|NCT02712983|7618983|FG003|Treatment Phase|Protocol Deviation|2
4701949|NCT02712983|7618984|FG004|Treatment Phase|Protocol Deviation|0
4701950|NCT02712983|7618985|FG005|Treatment Phase|Protocol Deviation|0
4701951|NCT02712983|7618986|FG006|Treatment Phase|Protocol Deviation|1
4701952|NCT02712983|7618987|FG007|Treatment Phase|Protocol Deviation|0
4701953|NCT02712983|7618988|FG008|Treatment Phase|Protocol Deviation|0
4701954|NCT02712983|7618980|FG000|Treatment Phase|Technical Problems|0
4489456|NCT00778921|7291219|FG000|Overall Study|Administrative Problems|1
4701955|NCT02712983|7618981|FG001|Treatment Phase|Technical Problems|0
4701956|NCT02712983|7618982|FG002|Treatment Phase|Technical Problems|0
4701957|NCT02712983|7618983|FG003|Treatment Phase|Technical Problems|0
4701958|NCT02712983|7618984|FG004|Treatment Phase|Technical Problems|0
4489457|NCT00778921|7291220|FG001|Overall Study|Administrative Problems|2
4489458|NCT00778921|7291221|FG002|Overall Study|Administrative Problems|0
4489459|NCT00778921|7291219|FG000|Overall Study|Protocol Violation|3
4489460|NCT00778921|7291220|FG001|Overall Study|Protocol Violation|0
4489461|NCT00778921|7291221|FG002|Overall Study|Protocol Violation|2
4489462|NCT00778921|7291219|FG000|Overall Study|Not treated|0
4489463|NCT00778921|7291220|FG001|Overall Study|Not treated|2
4489464|NCT00778921|7291221|FG002|Overall Study|Not treated|2
4489465|NCT00779025|7291229|FG000|Overall Study|Withdrawal by Subject|1
4489466|NCT00779142|7291242|FG000|Overall Study|Screen Failures|3
4489467|NCT00779246|7291258|FG000|Overall Study|Missing sufficient data for analysis|33
4489468|NCT00779246|7291259|FG001|Overall Study|Missing sufficient data for analysis|53
4489469|NCT00779259|7291265|FG000|Quinine Alone|Adverse Event|2
4489470|NCT00779324|7291310|FG000|Overall Study|Lost to Follow-up|2
4489471|NCT00779324|7291311|FG001|Overall Study|Lost to Follow-up|1
4489472|NCT00779324|7291310|FG000|Overall Study|Withdrawal by Subject|4
4489473|NCT00779324|7291311|FG001|Overall Study|Withdrawal by Subject|2
4489474|NCT00779324|7291310|FG000|Overall Study|Missed visit|1
4489475|NCT00779324|7291311|FG001|Overall Study|Missed visit|1
4489476|NCT00779402|7291319|FG000|Treatment Phase 1|Disease Progression|1
4489477|NCT00779402|7291320|FG001|Treatment Phase 1|Disease Progression|0
4489478|NCT00779402|7291319|FG000|Treatment Phase 1|Adverse Event|2
4489479|NCT00779402|7291320|FG001|Treatment Phase 1|Adverse Event|0
4489480|NCT00779402|7291319|FG000|Treatment Phase 1|Protocol Violation|1
4489481|NCT00779402|7291320|FG001|Treatment Phase 1|Protocol Violation|0
4489482|NCT00779402|7291319|FG000|Treatment Phase 1|Patient Refused to Continue|17
4489483|NCT00779402|7291320|FG001|Treatment Phase 1|Patient Refused to Continue|2
4489484|NCT00779402|7291319|FG000|Treatment Phase 1|Lost to Follow-up|0
4489485|NCT00779402|7291320|FG001|Treatment Phase 1|Lost to Follow-up|1
4489486|NCT00779402|7291319|FG000|Treatment Phase 1|Death|0
4489487|NCT00779402|7291320|FG001|Treatment Phase 1|Death|1
4489488|NCT00779402|7291319|FG000|Treatment Phase 1|Intercurrent Illness|1
4489489|NCT00779402|7291320|FG001|Treatment Phase 1|Intercurrent Illness|1
4489490|NCT00779402|7291319|FG000|Treatment Phase 1|Withdrawal by Subject|1
4489491|NCT00779402|7291320|FG001|Treatment Phase 1|Withdrawal by Subject|0
4489492|NCT00779402|7291319|FG000|Treatment Phase 1|Other|4
4489493|NCT00779402|7291320|FG001|Treatment Phase 1|Other|2
4489494|NCT00779402|7291319|FG000|Treatment Phase 1|Closure of Study|3
4489495|NCT00779402|7291320|FG001|Treatment Phase 1|Closure of Study|2
4489496|NCT00779402|7291319|FG000|Treatment Phase 1|Completed Protocol Visits|3
4489497|NCT00779402|7291320|FG001|Treatment Phase 1|Completed Protocol Visits|6
4489498|NCT00779402|7291319|FG000|Surveillance Phase|Protocol Violation|0
4489499|NCT00779402|7291320|FG001|Surveillance Phase|Protocol Violation|1
4489500|NCT00779402|7291319|FG000|Surveillance Phase|Patient refused to continue|22
4489501|NCT00779402|7291320|FG001|Surveillance Phase|Patient refused to continue|14
4489502|NCT00779402|7291319|FG000|Surveillance Phase|Lost to Follow-up|2
4489503|NCT00779402|7291320|FG001|Surveillance Phase|Lost to Follow-up|1
4489504|NCT00779402|7291319|FG000|Surveillance Phase|Death|0
4701959|NCT02712983|7618985|FG005|Treatment Phase|Technical Problems|0
4701960|NCT02712983|7618986|FG006|Treatment Phase|Technical Problems|1
4701961|NCT02712983|7618987|FG007|Treatment Phase|Technical Problems|0
4701962|NCT02712983|7618988|FG008|Treatment Phase|Technical Problems|0
4701963|NCT02712983|7618980|FG000|Treatment Phase|Physician Decision|0
4701964|NCT02712983|7618981|FG001|Treatment Phase|Physician Decision|0
4701965|NCT02712983|7618982|FG002|Treatment Phase|Physician Decision|0
4701966|NCT02712983|7618983|FG003|Treatment Phase|Physician Decision|0
4701967|NCT02712983|7618984|FG004|Treatment Phase|Physician Decision|0
4701968|NCT02712983|7618985|FG005|Treatment Phase|Physician Decision|0
4701969|NCT02712983|7618986|FG006|Treatment Phase|Physician Decision|0
4701970|NCT02712983|7618987|FG007|Treatment Phase|Physician Decision|1
4701971|NCT02712983|7618988|FG008|Treatment Phase|Physician Decision|1
4701972|NCT02712983|7618980|FG000|Treatment Phase|Subject Decision|2
4701973|NCT02712983|7618981|FG001|Treatment Phase|Subject Decision|0
4701974|NCT02712983|7618982|FG002|Treatment Phase|Subject Decision|0
4701975|NCT02712983|7618983|FG003|Treatment Phase|Subject Decision|2
4701976|NCT02712983|7618984|FG004|Treatment Phase|Subject Decision|1
4701977|NCT02712983|7618985|FG005|Treatment Phase|Subject Decision|0
4701978|NCT02712983|7618986|FG006|Treatment Phase|Subject Decision|1
4701979|NCT02712983|7618987|FG007|Treatment Phase|Subject Decision|2
4701980|NCT02712983|7618988|FG008|Treatment Phase|Subject Decision|0
4701981|NCT02712983|7618980|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
4701982|NCT02712983|7618981|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1
4701983|NCT02712983|7618982|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
4489505|NCT00779402|7291320|FG001|Surveillance Phase|Death|1
4489506|NCT00779402|7291319|FG000|Surveillance Phase|Intercurrent Illness|2
4489507|NCT00779402|7291320|FG001|Surveillance Phase|Intercurrent Illness|0
4489508|NCT00779402|7291319|FG000|Surveillance Phase|Other|5
4489509|NCT00779402|7291320|FG001|Surveillance Phase|Other|5
4489510|NCT00779402|7291319|FG000|Surveillance Phase|Withdrawal by Subject|4
4489511|NCT00779402|7291320|FG001|Surveillance Phase|Withdrawal by Subject|1
4701984|NCT02712983|7618983|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
4701985|NCT02712983|7618984|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
4701986|NCT02712983|7618985|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
4489512|NCT00779402|7291319|FG000|Surveillance Phase|Closure of study|5
4489513|NCT00779402|7291320|FG001|Surveillance Phase|Closure of study|6
4489514|NCT00779402|7291319|FG000|Surveillance Phase|Completed Protocol Visits|3
4489515|NCT00779402|7291320|FG001|Surveillance Phase|Completed Protocol Visits|2
4489516|NCT00779402|7291319|FG000|Long-term Follow-up|Patient refused to continue|2
4489517|NCT00779402|7291320|FG001|Long-term Follow-up|Patient refused to continue|0
4489518|NCT00779402|7291319|FG000|Long-term Follow-up|Other|5
4489519|NCT00779402|7291320|FG001|Long-term Follow-up|Other|0
4489520|NCT00779402|7291319|FG000|Long-term Follow-up|Closure of Study|8
4489521|NCT00779402|7291320|FG001|Long-term Follow-up|Closure of Study|4
4489522|NCT00779402|7291319|FG000|Long-term Follow-up|Completed Protocol Visits|6
4489523|NCT00779402|7291320|FG001|Long-term Follow-up|Completed Protocol Visits|2
4489524|NCT00779467|7291330|FG000|Overall Study|Lack of Efficacy|11
4489525|NCT00779467|7291331|FG001|Overall Study|Lack of Efficacy|2
4489526|NCT00779467|7291332|FG002|Overall Study|Lack of Efficacy|6
4489527|NCT00779467|7291333|FG003|Overall Study|Lack of Efficacy|11
4489528|NCT00779467|7291330|FG000|Overall Study|failed inclusion criteria|3
4489529|NCT00779467|7291331|FG001|Overall Study|failed inclusion criteria|3
4489530|NCT00779467|7291332|FG002|Overall Study|failed inclusion criteria|1
4489531|NCT00779467|7291333|FG003|Overall Study|failed inclusion criteria|2
4489532|NCT00779467|7291330|FG000|Overall Study|missing data|1
4701987|NCT02712983|7618986|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1
4701988|NCT02712983|7618987|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1
4701989|NCT02712983|7618988|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
4701990|NCT02712983|7618980|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
4701991|NCT02712983|7618981|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
4701992|NCT02712983|7618982|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
4701993|NCT02712983|7618983|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1
4701994|NCT02712983|7618984|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
4701995|NCT02712983|7618985|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
4701996|NCT02712983|7618986|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
4701997|NCT02712983|7618987|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
4701998|NCT02712983|7618988|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
4701999|NCT02712983|7618980|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0
4702000|NCT02712983|7618981|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0
4702001|NCT02712983|7618982|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0
4702002|NCT02712983|7618983|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0
4702003|NCT02712983|7618984|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2
4702004|NCT02712983|7618985|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1
4702005|NCT02712983|7618986|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1
4702006|NCT02712983|7618987|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2
4702007|NCT02712983|7618988|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0
4702008|NCT02712996|7619010|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0
4702009|NCT02712996|7619011|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1
4702010|NCT02713204|7619035|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1
4702011|NCT02713204|7619036|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0
4702012|NCT02713204|7619037|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1
4702013|NCT02713204|7619038|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0
4702014|NCT02713204|7619039|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0
4702015|NCT02713204|7619040|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0
4702016|NCT02713204|7619041|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0
4702017|NCT02713204|7619042|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0
4702018|NCT02713204|7619035|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
4702019|NCT02713204|7619036|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
4702020|NCT02713204|7619037|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1
4702021|NCT02713204|7619038|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
4702022|NCT02713204|7619039|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
4702023|NCT02713204|7619040|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
4702024|NCT02713204|7619041|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
4702025|NCT02713204|7619042|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
4702026|NCT02713204|7619035|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
4702027|NCT02713204|7619036|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1
4702028|NCT02713204|7619037|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
4702029|NCT02713204|7619038|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
4702030|NCT02713204|7619039|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
4702031|NCT02713204|7619040|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
4702032|NCT02713204|7619041|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
4702033|NCT02713204|7619042|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
4702034|NCT02713204|7619035|FG000|From Week 12 up to Week 36|Adverse Event|1
4702035|NCT02713204|7619036|FG001|From Week 12 up to Week 36|Adverse Event|0
4702036|NCT02713204|7619037|FG002|From Week 12 up to Week 36|Adverse Event|0
4702037|NCT02713204|7619038|FG003|From Week 12 up to Week 36|Adverse Event|1
4702038|NCT02713204|7619039|FG004|From Week 12 up to Week 36|Adverse Event|1
4702039|NCT02713204|7619040|FG005|From Week 12 up to Week 36|Adverse Event|0
4702040|NCT02713204|7619041|FG006|From Week 12 up to Week 36|Adverse Event|2
4489533|NCT00779467|7291331|FG001|Overall Study|missing data|0
4489534|NCT00779467|7291332|FG002|Overall Study|missing data|1
4489535|NCT00779467|7291333|FG003|Overall Study|missing data|4
4489536|NCT00779467|7291330|FG000|Overall Study|technical issue|0
4489537|NCT00779467|7291331|FG001|Overall Study|technical issue|0
4489538|NCT00779467|7291332|FG002|Overall Study|technical issue|2
4489539|NCT00779467|7291333|FG003|Overall Study|technical issue|1
4489540|NCT00779467|7291330|FG000|Overall Study|unavailable research staff|0
4489541|NCT00779467|7291331|FG001|Overall Study|unavailable research staff|0
4489542|NCT00779467|7291332|FG002|Overall Study|unavailable research staff|0
4489543|NCT00779467|7291333|FG003|Overall Study|unavailable research staff|1
4489544|NCT00779506|7291343|FG000|Overall Study|Screening Failed|2
4489545|NCT00779506|7291343|FG000|Overall Study|Adverse Event|4
4489546|NCT00779506|7291343|FG000|Overall Study|Lack of Efficacy|11
4489547|NCT00779506|7291343|FG000|Overall Study|Protocol Violation|5
4489548|NCT00779506|7291343|FG000|Overall Study|Withdrawal by Subject|6
4489549|NCT00779506|7291343|FG000|Overall Study|Lost to Follow-up|1
4489550|NCT00779584|7291365|FG000|Overall Study|Protocol Violation|0
4489551|NCT00779584|7291366|FG001|Overall Study|Protocol Violation|0
4489552|NCT00779584|7291367|FG002|Overall Study|Protocol Violation|0
4489553|NCT00779584|7291368|FG003|Overall Study|Protocol Violation|0
4489554|NCT00779584|7291369|FG004|Overall Study|Protocol Violation|0
4489555|NCT00779584|7291370|FG005|Overall Study|Protocol Violation|1
4489556|NCT00779584|7291371|FG006|Overall Study|Protocol Violation|0
4489557|NCT00779584|7291372|FG007|Overall Study|Protocol Violation|0
4489558|NCT00779584|7291373|FG008|Overall Study|Protocol Violation|0
4489559|NCT00779584|7291365|FG000|Overall Study|Withdrawal by Subject|1
4489560|NCT00779584|7291366|FG001|Overall Study|Withdrawal by Subject|1
4489561|NCT00779584|7291367|FG002|Overall Study|Withdrawal by Subject|2
4489562|NCT00779584|7291368|FG003|Overall Study|Withdrawal by Subject|0
4489563|NCT00779584|7291369|FG004|Overall Study|Withdrawal by Subject|0
4489564|NCT00779584|7291370|FG005|Overall Study|Withdrawal by Subject|2
4489565|NCT00779584|7291371|FG006|Overall Study|Withdrawal by Subject|1
4489566|NCT00779584|7291372|FG007|Overall Study|Withdrawal by Subject|0
4489567|NCT00779584|7291373|FG008|Overall Study|Withdrawal by Subject|0
4489568|NCT00779584|7291365|FG000|Overall Study|Lost to Follow-up|0
4489569|NCT00779584|7291366|FG001|Overall Study|Lost to Follow-up|0
4489570|NCT00779584|7291367|FG002|Overall Study|Lost to Follow-up|0
4489571|NCT00779584|7291368|FG003|Overall Study|Lost to Follow-up|0
4489572|NCT00779584|7291369|FG004|Overall Study|Lost to Follow-up|1
4489573|NCT00779584|7291370|FG005|Overall Study|Lost to Follow-up|0
4489574|NCT00779584|7291371|FG006|Overall Study|Lost to Follow-up|0
4702041|NCT02713204|7619042|FG007|From Week 12 up to Week 36|Adverse Event|1
4702042|NCT02713204|7619035|FG000|From Week 12 up to Week 36|Death|0
4702043|NCT02713204|7619036|FG001|From Week 12 up to Week 36|Death|0
4702044|NCT02713204|7619037|FG002|From Week 12 up to Week 36|Death|0
4702045|NCT02713204|7619038|FG003|From Week 12 up to Week 36|Death|1
4702046|NCT02713204|7619039|FG004|From Week 12 up to Week 36|Death|0
4702047|NCT02713204|7619040|FG005|From Week 12 up to Week 36|Death|1
4702048|NCT02713204|7619041|FG006|From Week 12 up to Week 36|Death|0
4702049|NCT02713204|7619042|FG007|From Week 12 up to Week 36|Death|3
4702050|NCT02713204|7619035|FG000|From Week 12 up to Week 36|Lost to Follow-up|0
4702051|NCT02713204|7619036|FG001|From Week 12 up to Week 36|Lost to Follow-up|0
4702052|NCT02713204|7619037|FG002|From Week 12 up to Week 36|Lost to Follow-up|0
4702053|NCT02713204|7619038|FG003|From Week 12 up to Week 36|Lost to Follow-up|2
4702054|NCT02713204|7619039|FG004|From Week 12 up to Week 36|Lost to Follow-up|0
4702055|NCT02713204|7619040|FG005|From Week 12 up to Week 36|Lost to Follow-up|0
4702056|NCT02713204|7619041|FG006|From Week 12 up to Week 36|Lost to Follow-up|0
4702057|NCT02713204|7619042|FG007|From Week 12 up to Week 36|Lost to Follow-up|0
4702058|NCT02713204|7619035|FG000|From Week 12 up to Week 36|Participant Re-located|0
4702059|NCT02713204|7619036|FG001|From Week 12 up to Week 36|Participant Re-located|0
4702060|NCT02713204|7619037|FG002|From Week 12 up to Week 36|Participant Re-located|0
4702061|NCT02713204|7619038|FG003|From Week 12 up to Week 36|Participant Re-located|0
4702062|NCT02713204|7619039|FG004|From Week 12 up to Week 36|Participant Re-located|1
4702063|NCT02713204|7619040|FG005|From Week 12 up to Week 36|Participant Re-located|0
4702064|NCT02713204|7619041|FG006|From Week 12 up to Week 36|Participant Re-located|0
4702065|NCT02713204|7619042|FG007|From Week 12 up to Week 36|Participant Re-located|0
4702066|NCT02713243|7619073|FG000|Overall Study|Abnormal laboratory value(s)#|1
4702067|NCT02713243|7619074|FG001|Overall Study|Abnormal laboratory value(s)#|0
4702068|NCT02713243|7619073|FG000|Overall Study|Administrative problems|0
4489575|NCT00779584|7291372|FG007|Overall Study|Lost to Follow-up|0
4489576|NCT00779584|7291373|FG008|Overall Study|Lost to Follow-up|0
4489577|NCT00779584|7291365|FG000|Overall Study|Progression of Disease|0
4489578|NCT00779584|7291366|FG001|Overall Study|Progression of Disease|1
4489579|NCT00779584|7291367|FG002|Overall Study|Progression of Disease|2
4489580|NCT00779584|7291368|FG003|Overall Study|Progression of Disease|6
4489581|NCT00779584|7291369|FG004|Overall Study|Progression of Disease|5
4702069|NCT02713243|7619074|FG001|Overall Study|Administrative problems|1
4702070|NCT02713243|7619073|FG000|Overall Study|Protocol deviation|0
4702071|NCT02713243|7619074|FG001|Overall Study|Protocol deviation|1
4489582|NCT00779584|7291370|FG005|Overall Study|Progression of Disease|1
4489583|NCT00779584|7291371|FG006|Overall Study|Progression of Disease|4
4489584|NCT00779584|7291372|FG007|Overall Study|Progression of Disease|2
4489585|NCT00779584|7291373|FG008|Overall Study|Progression of Disease|1
4489586|NCT00779584|7291365|FG000|Overall Study|Adverse Event|1
4489587|NCT00779584|7291366|FG001|Overall Study|Adverse Event|0
4489588|NCT00779584|7291367|FG002|Overall Study|Adverse Event|2
4489589|NCT00779584|7291368|FG003|Overall Study|Adverse Event|0
4489590|NCT00779584|7291369|FG004|Overall Study|Adverse Event|0
4489591|NCT00779584|7291370|FG005|Overall Study|Adverse Event|0
4489592|NCT00779584|7291371|FG006|Overall Study|Adverse Event|2
4489593|NCT00779584|7291372|FG007|Overall Study|Adverse Event|1
4489594|NCT00779584|7291373|FG008|Overall Study|Adverse Event|1
4489595|NCT00779584|7291365|FG000|Overall Study|Symptomatic Deterioration|1
4489596|NCT00779584|7291366|FG001|Overall Study|Symptomatic Deterioration|1
4489597|NCT00779584|7291367|FG002|Overall Study|Symptomatic Deterioration|1
4489598|NCT00779584|7291368|FG003|Overall Study|Symptomatic Deterioration|0
4489599|NCT00779584|7291369|FG004|Overall Study|Symptomatic Deterioration|0
4489600|NCT00779584|7291370|FG005|Overall Study|Symptomatic Deterioration|1
4489601|NCT00779584|7291371|FG006|Overall Study|Symptomatic Deterioration|1
4489602|NCT00779584|7291372|FG007|Overall Study|Symptomatic Deterioration|0
4489603|NCT00779584|7291373|FG008|Overall Study|Symptomatic Deterioration|0
4489604|NCT00779584|7291365|FG000|Overall Study|Ongoing in Study|0
4489605|NCT00779584|7291366|FG001|Overall Study|Ongoing in Study|0
4489606|NCT00779584|7291367|FG002|Overall Study|Ongoing in Study|0
4489607|NCT00779584|7291368|FG003|Overall Study|Ongoing in Study|0
4489608|NCT00779584|7291369|FG004|Overall Study|Ongoing in Study|1
4489609|NCT00779584|7291370|FG005|Overall Study|Ongoing in Study|1
4489610|NCT00779584|7291371|FG006|Overall Study|Ongoing in Study|0
4489611|NCT00779584|7291372|FG007|Overall Study|Ongoing in Study|0
4489612|NCT00779584|7291373|FG008|Overall Study|Ongoing in Study|0
4702072|NCT02713490|7619090|FG000|Overall Study|Withdrawal by Subject|2
4702073|NCT02713490|7619091|FG001|Overall Study|Withdrawal by Subject|1
4702074|NCT02713490|7619090|FG000|Overall Study|Did not receive study drug|1
4702075|NCT02713490|7619091|FG001|Overall Study|Did not receive study drug|0
4702076|NCT02713490|7619090|FG000|Overall Study|Met exclusion criteria|0
4702077|NCT02713490|7619091|FG001|Overall Study|Met exclusion criteria|1
4702078|NCT02713529|7619104|FG000|Overall Study|Withdrawal by Subject|3
4702079|NCT02713529|7619105|FG001|Overall Study|Withdrawal by Subject|1
4702080|NCT02713529|7619106|FG002|Overall Study|Withdrawal by Subject|4
4702081|NCT02713529|7619107|FG003|Overall Study|Withdrawal by Subject|2
4702082|NCT02713529|7619108|FG004|Overall Study|Withdrawal by Subject|0
4702083|NCT02713529|7619109|FG005|Overall Study|Withdrawal by Subject|1
4702084|NCT02713529|7619110|FG006|Overall Study|Withdrawal by Subject|1
4702085|NCT02713529|7619104|FG000|Overall Study|Lost to Follow-up|1
4702086|NCT02713529|7619105|FG001|Overall Study|Lost to Follow-up|0
4702087|NCT02713529|7619106|FG002|Overall Study|Lost to Follow-up|1
4702088|NCT02713529|7619107|FG003|Overall Study|Lost to Follow-up|0
4702089|NCT02713529|7619108|FG004|Overall Study|Lost to Follow-up|0
4702090|NCT02713529|7619109|FG005|Overall Study|Lost to Follow-up|0
4702091|NCT02713529|7619110|FG006|Overall Study|Lost to Follow-up|0
4702092|NCT02713529|7619104|FG000|Overall Study|Death|3
4702093|NCT02713529|7619105|FG001|Overall Study|Death|3
4702094|NCT02713529|7619106|FG002|Overall Study|Death|26
4702095|NCT02713529|7619107|FG003|Overall Study|Death|27
4702096|NCT02713529|7619108|FG004|Overall Study|Death|3
4702097|NCT02713529|7619109|FG005|Overall Study|Death|13
4626591|NCT01843062|7492366|FG000|Overall Study|Adverse Event|2
4626592|NCT01843062|7492367|FG001|Overall Study|Adverse Event|0
4626593|NCT01843062|7492366|FG000|Overall Study|Incorrect randomisation|1
4626594|NCT01843062|7492367|FG001|Overall Study|Incorrect randomisation|0
4626595|NCT01843062|7492366|FG000|Overall Study|Withdrawal by Subject|12
4626596|NCT01843062|7492367|FG001|Overall Study|Withdrawal by Subject|3
4626597|NCT01843062|7492366|FG000|Overall Study|Death|1
4626598|NCT01843062|7492367|FG001|Overall Study|Death|2
4626599|NCT01843062|7492366|FG000|Overall Study|Lost to Follow-up|2
4626600|NCT01843062|7492367|FG001|Overall Study|Lost to Follow-up|4
4626601|NCT01843192|7492376|FG000|Overall Study|Intra-operative exclusions per protocol|2
4626602|NCT01843192|7492377|FG001|Overall Study|Intra-operative exclusions per protocol|6
4626603|NCT01843192|7492378|FG002|Overall Study|Intra-operative exclusions per protocol|2
4626604|NCT01843205|7492386|FG000|First Treatment (11 Days)|Withdrawal by Subject|1
4626605|NCT01843205|7492387|FG001|First Treatment (11 Days)|Withdrawal by Subject|0
4626606|NCT01843348|7492396|FG000|Overall Study|Withdrawal by Subject|4
4702098|NCT02713529|7619110|FG006|Overall Study|Death|3
4702099|NCT02713542|7619132|FG000|Overall Study|Use of prohibited medication|14
4702100|NCT02713542|7619133|FG001|Overall Study|Use of prohibited medication|5
4702101|NCT02713542|7619132|FG000|Overall Study|Withdrawal by Subject|4
4626607|NCT01843348|7492397|FG001|Overall Study|Withdrawal by Subject|16
4626608|NCT01843348|7492398|FG002|Overall Study|Withdrawal by Subject|18
4626609|NCT01843348|7492396|FG000|Overall Study|Lost to Follow-up|5
4626610|NCT01843348|7492397|FG001|Overall Study|Lost to Follow-up|4
4702102|NCT02713542|7619133|FG001|Overall Study|Withdrawal by Subject|1
4702103|NCT02713594|7619141|FG000|Overall Study|Withdrawal by Subject|32
4702104|NCT02713594|7619142|FG001|Overall Study|Withdrawal by Subject|22
4489613|NCT00779675|7291393|FG000|Treatment Period|Adverse Event|87
4489614|NCT00779675|7291393|FG000|Treatment Period|Treatment Failure|80
4702105|NCT02713594|7619141|FG000|Overall Study|Lost to Follow-up|358
4489615|NCT00779675|7291393|FG000|Treatment Period|Transferred to Another Study|38
4489616|NCT00779675|7291393|FG000|Treatment Period|Lost to Follow-up|23
4489617|NCT00779675|7291393|FG000|Treatment Period|Withdrawal by Subject|46
4626611|NCT01843348|7492398|FG002|Overall Study|Lost to Follow-up|2
4626612|NCT01843348|7492396|FG000|Overall Study|Death|5
4626613|NCT01843348|7492397|FG001|Overall Study|Death|3
4626614|NCT01843348|7492398|FG002|Overall Study|Death|4
4626615|NCT01843348|7492396|FG000|Overall Study|Graft loss/retransplantation|5
4626616|NCT01843348|7492397|FG001|Overall Study|Graft loss/retransplantation|8
4626617|NCT01843348|7492398|FG002|Overall Study|Graft loss/retransplantation|11
4626618|NCT01843348|7492396|FG000|Overall Study|Various reasons|4
4626619|NCT01843348|7492397|FG001|Overall Study|Various reasons|9
4626620|NCT01843348|7492398|FG002|Overall Study|Various reasons|6
4626621|NCT01843660|7492424|FG000|Overall Study|Other|30
4626622|NCT01843673|7492428|FG000|Overall Study|Lack of Efficacy|2
4626623|NCT01843673|7492428|FG000|Overall Study|Withdrawal by Subject|4
4626624|NCT01843777|7492445|FG000|Overall Study|Withdrawal by Subject|1
4626625|NCT01843777|7492446|FG001|Overall Study|Withdrawal by Subject|0
4626626|NCT01843803|7492454|FG000|Overall Study|not a Veteran, did not see provider|1
4626627|NCT01843803|7492455|FG001|Overall Study|not a Veteran, did not see provider|3
4626628|NCT01843842|7492463|FG000|Overall Study|Do not meet inclusion criteria|1
4626629|NCT01843842|7492464|FG001|Overall Study|Do not meet inclusion criteria|1
4626630|NCT01843933|7492481|FG000|Overall Study|Data lost|6
4626631|NCT01843933|7492482|FG001|Overall Study|Data lost|4
4633232|NCT01909804|7503303|FG007|Overall Study|Randomized but Never Treated|0
4702106|NCT02713594|7619142|FG001|Overall Study|Lost to Follow-up|374
4702107|NCT02713789|7619191|FG000|Overall Study|Lost to Follow-up|0
4702108|NCT02713789|7619192|FG001|Overall Study|Lost to Follow-up|1
4702109|NCT02713789|7619193|FG002|Overall Study|Lost to Follow-up|1
4702110|NCT02713828|7619203|FG000|Overall Study|Death|2
4702111|NCT02713828|7619204|FG001|Overall Study|Death|0
4702112|NCT02713828|7619203|FG000|Overall Study|Withdrawal by Subject|1
4702113|NCT02713828|7619204|FG001|Overall Study|Withdrawal by Subject|0
4702114|NCT02713828|7619203|FG000|Overall Study|study terminated but patient allowed to|2
4702115|NCT02713828|7619204|FG001|Overall Study|study terminated but patient allowed to|0
4702116|NCT02714153|7619209|FG000|Overall Study|Death|1
4702117|NCT02714426|7619235|FG000|Overall Study|Withdrawal by Subject|2
4702118|NCT02714426|7619236|FG001|Overall Study|Withdrawal by Subject|2
4702119|NCT02714569|7619262|FG000|Part A Second Intervention|Withdrawal by Subject|0
4702120|NCT02714569|7619263|FG001|Part A Second Intervention|Withdrawal by Subject|1
4702121|NCT02714569|7619264|FG002|Part A Second Intervention|Withdrawal by Subject|0
4702122|NCT02714569|7619265|FG003|Part A Second Intervention|Withdrawal by Subject|0
4702123|NCT02714569|7619266|FG004|Part A Second Intervention|Withdrawal by Subject|0
4702124|NCT02714569|7619267|FG005|Part A Second Intervention|Withdrawal by Subject|0
4702125|NCT02714569|7619268|FG006|Part A Second Intervention|Withdrawal by Subject|0
4702126|NCT02714569|7619269|FG007|Part A Second Intervention|Withdrawal by Subject|0
4702127|NCT02714569|7619270|FG008|Part A Second Intervention|Withdrawal by Subject|0
4702128|NCT02714569|7619271|FG009|Part A Second Intervention|Withdrawal by Subject|0
4702129|NCT02714569|7619272|FG010|Part A Second Intervention|Withdrawal by Subject|0
4702130|NCT02714569|7619262|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
4702131|NCT02714569|7619263|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
4702132|NCT02714569|7619264|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
4702133|NCT02714569|7619265|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1
4702134|NCT02714569|7619266|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
4702135|NCT02714569|7619267|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
4702136|NCT02714569|7619268|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
4387218|NCT00046891|7165795|FG000|Overall Study|Cancels|5
4387219|NCT00046891|7165796|FG001|Overall Study|Cancels|9
4387220|NCT00046891|7165795|FG000|Overall Study|Ineligible|1
4387221|NCT00046891|7165796|FG001|Overall Study|Ineligible|1
4387222|NCT00046891|7165795|FG000|Overall Study|Withdrawal by Subject|18
4702137|NCT02714569|7619269|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
4702138|NCT02714569|7619270|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
4702139|NCT02714569|7619271|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
4737570|NCT03614078|7687792|FG002|Overall Study|High Neutrophils|2
4387223|NCT00046891|7165796|FG001|Overall Study|Withdrawal by Subject|15
4387224|NCT00046891|7165795|FG000|Overall Study|Adverse Event|5
4387225|NCT00046891|7165796|FG001|Overall Study|Adverse Event|5
4387226|NCT00046930|7165812|FG000|Overall Study|Ineligible|12
4387227|NCT00046930|7165813|FG001|Overall Study|Ineligible|4
4387228|NCT00047008|7165824|FG000|Overall Study|Withdrawn consent|2
4387229|NCT00047008|7165825|FG001|Overall Study|Withdrawn consent|3
4387230|NCT00047008|7165824|FG000|Overall Study|Ineligible|9
4387231|NCT00047008|7165825|FG001|Overall Study|Ineligible|8
4387232|NCT00047320|7165835|FG000|Overall Study|Lack of Efficacy|8
4387233|NCT00047320|7165835|FG000|Overall Study|Lost to Follow-up|1
4387234|NCT00047320|7165835|FG000|Overall Study|Physician Decision|8
4387235|NCT00047320|7165835|FG000|Overall Study|Withdrawal by Subject|9
4387236|NCT00047320|7165835|FG000|Overall Study|Ineligible|2
4387237|NCT00047385|7165841|FG000|Overall Study|Death before any screening|2
4387238|NCT00047385|7165842|FG001|Overall Study|Death before any screening|5
4489618|NCT00779675|7291393|FG000|Treatment Period|Protocol Violation|54
4489619|NCT00779675|7291393|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1
4489620|NCT00779675|7291393|FG000|Treatment Period|Administrative|3
4489621|NCT00779675|7291393|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9
4489622|NCT00779675|7291393|FG000|Extended Treatment Period|Protocol Violation|13
4489623|NCT00779675|7291393|FG000|Extended Treatment Period|Adverse Event|6
4489624|NCT00779675|7291393|FG000|Extended Treatment Period|Treatment Failure|11
4489625|NCT00779675|7291393|FG000|Extended Treatment Period|Protocol defined clinical event|1
4489626|NCT00779675|7291393|FG000|Extended Treatment Period|Lost to Follow-up|6
4489627|NCT00779766|7291407|FG000|Month 24|Serious Adverse Event|2
4489628|NCT00779766|7291408|FG001|Month 24|Serious Adverse Event|3
4489629|NCT00779766|7291407|FG000|Month 24|Adverse Event|3
4489630|NCT00779766|7291408|FG001|Month 24|Adverse Event|3
4702140|NCT02714569|7619272|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0
4702141|NCT02714569|7619262|FG000|Part A Third Intervention|Adverse Event|0
4702142|NCT02714569|7619263|FG001|Part A Third Intervention|Adverse Event|0
4702143|NCT02714569|7619264|FG002|Part A Third Intervention|Adverse Event|1
4702144|NCT02714569|7619265|FG003|Part A Third Intervention|Adverse Event|0
4702145|NCT02714569|7619266|FG004|Part A Third Intervention|Adverse Event|0
4702146|NCT02714569|7619267|FG005|Part A Third Intervention|Adverse Event|0
4702147|NCT02714569|7619268|FG006|Part A Third Intervention|Adverse Event|0
4702148|NCT02714569|7619269|FG007|Part A Third Intervention|Adverse Event|0
4702149|NCT02714569|7619270|FG008|Part A Third Intervention|Adverse Event|0
4702150|NCT02714569|7619271|FG009|Part A Third Intervention|Adverse Event|0
4702151|NCT02714569|7619272|FG010|Part A Third Intervention|Adverse Event|0
4702152|NCT02714569|7619262|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1
4702153|NCT02714569|7619263|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
4702154|NCT02714569|7619264|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
4702155|NCT02714569|7619265|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
4702156|NCT02714569|7619266|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
4702157|NCT02714569|7619267|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1
4702158|NCT02714569|7619268|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
4702159|NCT02714569|7619269|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
4702160|NCT02714569|7619270|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
4702161|NCT02714569|7619271|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
4702162|NCT02714569|7619272|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0
4702163|NCT02714569|7619262|FG000|Part B (Overall)|Lost to Follow-up|0
4702164|NCT02714569|7619263|FG001|Part B (Overall)|Lost to Follow-up|0
4702165|NCT02714569|7619264|FG002|Part B (Overall)|Lost to Follow-up|0
4702166|NCT02714569|7619265|FG003|Part B (Overall)|Lost to Follow-up|0
4702167|NCT02714569|7619266|FG004|Part B (Overall)|Lost to Follow-up|0
4702168|NCT02714569|7619267|FG005|Part B (Overall)|Lost to Follow-up|0
4702169|NCT02714569|7619268|FG006|Part B (Overall)|Lost to Follow-up|1
4702170|NCT02714569|7619269|FG007|Part B (Overall)|Lost to Follow-up|0
4702171|NCT02714569|7619270|FG008|Part B (Overall)|Lost to Follow-up|0
4702172|NCT02714569|7619271|FG009|Part B (Overall)|Lost to Follow-up|0
4702173|NCT02714569|7619272|FG010|Part B (Overall)|Lost to Follow-up|0
4702174|NCT02714569|7619262|FG000|Part B (Overall)|Withdrawal by Subject|0
4702175|NCT02714569|7619263|FG001|Part B (Overall)|Withdrawal by Subject|0
4702176|NCT02714569|7619264|FG002|Part B (Overall)|Withdrawal by Subject|0
4702177|NCT02714569|7619265|FG003|Part B (Overall)|Withdrawal by Subject|0
4702178|NCT02714569|7619266|FG004|Part B (Overall)|Withdrawal by Subject|0
4702179|NCT02714569|7619267|FG005|Part B (Overall)|Withdrawal by Subject|0
4702180|NCT02714569|7619268|FG006|Part B (Overall)|Withdrawal by Subject|0
4702181|NCT02714569|7619269|FG007|Part B (Overall)|Withdrawal by Subject|1
4702182|NCT02714569|7619270|FG008|Part B (Overall)|Withdrawal by Subject|0
4702183|NCT02714569|7619271|FG009|Part B (Overall)|Withdrawal by Subject|1
4702184|NCT02714569|7619272|FG010|Part B (Overall)|Withdrawal by Subject|0
4702185|NCT02714569|7619262|FG000|Part B (Overall)|Adverse Event|0
4702186|NCT02714569|7619263|FG001|Part B (Overall)|Adverse Event|0
4702187|NCT02714569|7619264|FG002|Part B (Overall)|Adverse Event|0
4702188|NCT02714569|7619265|FG003|Part B (Overall)|Adverse Event|0
4702189|NCT02714569|7619266|FG004|Part B (Overall)|Adverse Event|0
4702190|NCT02714569|7619267|FG005|Part B (Overall)|Adverse Event|0
4702191|NCT02714569|7619268|FG006|Part B (Overall)|Adverse Event|0
4702192|NCT02714569|7619269|FG007|Part B (Overall)|Adverse Event|0
4702193|NCT02714569|7619270|FG008|Part B (Overall)|Adverse Event|0
4702194|NCT02714569|7619271|FG009|Part B (Overall)|Adverse Event|1
4702195|NCT02714569|7619272|FG010|Part B (Overall)|Adverse Event|0
4702196|NCT02714595|7619334|FG000|Overall Study|Lost to Follow-up|1
4702197|NCT02714595|7619335|FG001|Overall Study|Lost to Follow-up|0
4702198|NCT02714595|7619334|FG000|Overall Study|Withdrawal by Subject|1
4702199|NCT02714595|7619335|FG001|Overall Study|Withdrawal by Subject|2
4702200|NCT02714595|7619334|FG000|Overall Study|Lack of Efficacy|0
4702201|NCT02714595|7619335|FG001|Overall Study|Lack of Efficacy|1
4702202|NCT02714595|7619334|FG000|Overall Study|Death|30
4702203|NCT02714595|7619335|FG001|Overall Study|Death|9
4702204|NCT02714595|7619334|FG000|Overall Study|Other-Miscellaneous|0
4489631|NCT00779766|7291407|FG000|Month 24|Protocol Violation|3
4489632|NCT00779766|7291408|FG001|Month 24|Protocol Violation|1
4489633|NCT00779766|7291407|FG000|Month 24|Withdrawal by Subject|159
4489634|NCT00779766|7291408|FG001|Month 24|Withdrawal by Subject|127
4489635|NCT00779766|7291407|FG000|Month 24|Migrated/moved from study area|138
4489636|NCT00779766|7291408|FG001|Month 24|Migrated/moved from study area|162
4489637|NCT00779766|7291407|FG000|Month 24|Lost to Follow-up|9
4489638|NCT00779766|7291408|FG001|Month 24|Lost to Follow-up|9
4489639|NCT00779766|7291407|FG000|Month 24|Other|18
4489640|NCT00779766|7291408|FG001|Month 24|Other|27
4489641|NCT00779766|7291407|FG000|Month 48|Withdrawal by Subject|68
4489642|NCT00779766|7291408|FG001|Month 48|Withdrawal by Subject|63
4489643|NCT00779766|7291407|FG000|Month 48|Migrated/moved from study area|76
4489644|NCT00779766|7291408|FG001|Month 48|Migrated/moved from study area|75
4489645|NCT00779766|7291407|FG000|Month 48|Lost to Follow-up|29
4489646|NCT00779766|7291408|FG001|Month 48|Lost to Follow-up|30
4489647|NCT00779766|7291407|FG000|Month 48|Other|1
4702205|NCT02714595|7619335|FG001|Overall Study|Other-Miscellaneous|1
4702206|NCT02714868|7619361|FG000|Overall Study|Withdrawal by Subject|3
4702207|NCT02714868|7619362|FG001|Overall Study|Withdrawal by Subject|0
4702208|NCT02714868|7619361|FG000|Overall Study|PI withdrawal safety risk self/others|1
4702209|NCT02714868|7619362|FG001|Overall Study|PI withdrawal safety risk self/others|0
4702210|NCT02714868|7619361|FG000|Overall Study|PI withdraw did not meet inclusion|1
4702211|NCT02714868|7619362|FG001|Overall Study|PI withdraw did not meet inclusion|0
4702212|NCT02715258|7619396|FG000|Overall Study|Withdrawal by Subject|6
4702213|NCT02715258|7619397|FG001|Overall Study|Withdrawal by Subject|1
4702214|NCT02715258|7619396|FG000|Overall Study|Lost to Follow-up|7
4702215|NCT02715258|7619397|FG001|Overall Study|Lost to Follow-up|1
4702216|NCT02715258|7619396|FG000|Overall Study|Terminated by Sponsor|0
4702217|NCT02715258|7619397|FG001|Overall Study|Terminated by Sponsor|1
4702218|NCT02715258|7619396|FG000|Overall Study|Death|0
4702219|NCT02715258|7619397|FG001|Overall Study|Death|1
4702220|NCT02715258|7619396|FG000|Overall Study|Subject non-compliant|1
4702221|NCT02715258|7619397|FG001|Overall Study|Subject non-compliant|1
4702222|NCT02715258|7619396|FG000|Overall Study|GCP violation|2
4702223|NCT02715258|7619397|FG001|Overall Study|GCP violation|1
4702224|NCT02715726|7619413|FG000|Overall Study|Adverse Event|2
4702225|NCT02715726|7619414|FG001|Overall Study|Adverse Event|6
4702226|NCT02715726|7619413|FG000|Overall Study|Protocol Violation|1
4702227|NCT02715726|7619414|FG001|Overall Study|Protocol Violation|0
4702228|NCT02715726|7619413|FG000|Overall Study|Death|2
4702229|NCT02715726|7619414|FG001|Overall Study|Death|1
4702230|NCT02715726|7619413|FG000|Overall Study|Participant moved|1
4702231|NCT02715726|7619414|FG001|Overall Study|Participant moved|3
4702232|NCT02715726|7619413|FG000|Overall Study|Other than specified above|11
4702233|NCT02715726|7619414|FG001|Overall Study|Other than specified above|15
4702234|NCT02715726|7619413|FG000|Overall Study|Randomized but not treated|1
4702235|NCT02715726|7619414|FG001|Overall Study|Randomized but not treated|2
4702236|NCT02715804|7619422|FG000|Overall Study|Death|222
4702237|NCT02715804|7619423|FG001|Overall Study|Death|106
4702238|NCT02715804|7619422|FG000|Overall Study|Withdrawal by Subject|5
4702239|NCT02715804|7619423|FG001|Overall Study|Withdrawal by Subject|4
4702240|NCT02715804|7619422|FG000|Overall Study|Other than specified|2
4702241|NCT02715804|7619423|FG001|Overall Study|Other than specified|3
4702242|NCT02716194|7619432|FG000|Period 1 - ADVATE|Withdrawal by Subject|1
4702243|NCT02716194|7619433|FG001|Period 1 - ADVATE|Withdrawal by Subject|1
4702244|NCT02716194|7619434|FG002|Period 1 - ADVATE|Withdrawal by Subject|0
4702245|NCT02716298|7619455|FG000|First Intervention (1 Month)|Lens discomfort|1
4702246|NCT02716298|7619456|FG001|First Intervention (1 Month)|Lens discomfort|1
4735352|NCT03526861|7683211|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0
4735353|NCT03526861|7683212|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8
4735354|NCT03527160|7683234|FG000|Overall Study|No urine collected|13
4735355|NCT03527160|7683234|FG000|Overall Study|No clinical serum creatinine collected|6
4735356|NCT03527160|7683234|FG000|Overall Study|Did not meet inclusion|2
4735357|NCT03527173|7683243|FG000|Overall Study|Lost to Follow-up|4
4735358|NCT03527173|7683244|FG001|Overall Study|Lost to Follow-up|2
4735359|NCT03527173|7683243|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1
4735360|NCT03527173|7683244|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0
4735361|NCT03527173|7683243|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1
4735362|NCT03527173|7683244|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5
4735363|NCT03527173|7683243|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1
4735364|NCT03527173|7683244|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
4735365|NCT03527550|7683252|FG000|Overall Study|Lost to Follow-up|4
4735366|NCT03527550|7683253|FG001|Overall Study|Lost to Follow-up|2
4735367|NCT03527550|7683252|FG000|Overall Study|Withdrawal by Subject|4
4735368|NCT03527550|7683253|FG001|Overall Study|Withdrawal by Subject|1
4735369|NCT03527550|7683252|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1
4735370|NCT03527550|7683253|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0
4735371|NCT03527745|7683287|FG000|Overall Study|Lost to Follow-up|3
4735372|NCT03527745|7683288|FG001|Overall Study|Lost to Follow-up|6
4735373|NCT03527745|7683289|FG002|Overall Study|Lost to Follow-up|7
4489648|NCT00779766|7291408|FG001|Month 48|Other|0
4489649|NCT00779766|7291407|FG000|Month 72|Withdrawal by Subject|55
4489650|NCT00779766|7291408|FG001|Month 72|Withdrawal by Subject|71
4489651|NCT00779766|7291407|FG000|Month 72|Migrated/moved from study area|124
4489652|NCT00779766|7291408|FG001|Month 72|Migrated/moved from study area|109
4489653|NCT00779766|7291407|FG000|Month 72|Lost to Follow-up|6
4489654|NCT00779766|7291408|FG001|Month 72|Lost to Follow-up|8
4489655|NCT00779766|7291407|FG000|Month 72|Other|0
4489656|NCT00779766|7291408|FG001|Month 72|Other|1
4489657|NCT00779779|7291415|FG000|Overall Study|Adverse Event|1
4489658|NCT00779779|7291415|FG000|Overall Study|Protocol Violation|14
4489659|NCT00779779|7291415|FG000|Overall Study|Withdrawal by Subject|4
4489660|NCT00779779|7291415|FG000|Overall Study|Lost to Follow-up|5
4489661|NCT00779857|7291419|FG000|Overall Study|Death|1
4489662|NCT00779857|7291419|FG000|Overall Study|Withdrawal by Subject|3
4489663|NCT00779857|7291419|FG000|Overall Study|Missed Visit|2
4702247|NCT02716584|7619482|FG000|Overall Study|Lost to Follow-up|8
4702248|NCT02716584|7619483|FG001|Overall Study|Lost to Follow-up|5
4702249|NCT02716779|7619514|FG000|Monotherapy|Adverse Event|0
4702250|NCT02716779|7619515|FG001|Monotherapy|Adverse Event|1
4702251|NCT02716779|7619516|FG002|Monotherapy|Adverse Event|1
4702252|NCT02716779|7619514|FG000|Combination Therapy|Adverse Event|0
4702253|NCT02716779|7619515|FG001|Combination Therapy|Adverse Event|2
4702254|NCT02716779|7619516|FG002|Combination Therapy|Adverse Event|1
4702255|NCT02716805|7619530|FG000|Overall Study|Progressive disease|2
4702256|NCT02716805|7619531|FG001|Overall Study|Progressive disease|0
4702257|NCT02716805|7619532|FG002|Overall Study|Progressive disease|0
4702258|NCT02716805|7619533|FG003|Overall Study|Progressive disease|0
4702259|NCT02716896|7619570|FG000|Overall Study|Physician Decision|0
4702260|NCT02716896|7619571|FG001|Overall Study|Physician Decision|1
4702261|NCT02716987|7619583|FG000|Overall Study|Ligand synthesis failure|0
4702262|NCT02716987|7619584|FG001|Overall Study|Ligand synthesis failure|0
4702263|NCT02716987|7619585|FG002|Overall Study|Ligand synthesis failure|1
4702264|NCT02716987|7619586|FG003|Overall Study|Ligand synthesis failure|0
4702265|NCT02716987|7619587|FG004|Overall Study|Ligand synthesis failure|0
4702266|NCT02716987|7619588|FG005|Overall Study|Ligand synthesis failure|0
4702267|NCT02716987|7619583|FG000|Overall Study|Withdrawal by Subject|0
4702268|NCT02716987|7619584|FG001|Overall Study|Withdrawal by Subject|0
4702269|NCT02716987|7619585|FG002|Overall Study|Withdrawal by Subject|0
4702270|NCT02716987|7619586|FG003|Overall Study|Withdrawal by Subject|0
4702271|NCT02716987|7619587|FG004|Overall Study|Withdrawal by Subject|1
4702272|NCT02716987|7619588|FG005|Overall Study|Withdrawal by Subject|1
4702273|NCT02717195|7619617|FG000|Prospective Confirmation (PC) Period|Adverse Event|19
4702274|NCT02717195|7619618|FG001|Prospective Confirmation (PC) Period|Adverse Event|7
4702275|NCT02717195|7619619|FG002|Prospective Confirmation (PC) Period|Adverse Event|0
4702276|NCT02717195|7619620|FG003|Prospective Confirmation (PC) Period|Adverse Event|0
4702277|NCT02717195|7619621|FG004|Prospective Confirmation (PC) Period|Adverse Event|0
4702278|NCT02717195|7619617|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2
4702279|NCT02717195|7619618|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1
4702280|NCT02717195|7619619|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0
4702281|NCT02717195|7619620|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0
4702282|NCT02717195|7619621|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0
4702283|NCT02717195|7619617|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7
4702284|NCT02717195|7619618|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1
4702285|NCT02717195|7619619|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0
4702286|NCT02717195|7619620|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0
4702287|NCT02717195|7619621|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0
4702288|NCT02717195|7619617|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3
4702289|NCT02717195|7619618|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1
4702290|NCT02717195|7619619|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0
4702291|NCT02717195|7619620|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0
4702292|NCT02717195|7619621|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0
4702293|NCT02717195|7619617|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43
4702294|NCT02717195|7619618|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12
4702295|NCT02717195|7619619|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
4702296|NCT02717195|7619620|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
4702297|NCT02717195|7619621|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
4702298|NCT02717195|7619617|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9
4702299|NCT02717195|7619618|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4
4702300|NCT02717195|7619619|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0
4702301|NCT02717195|7619620|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0
4702302|NCT02717195|7619621|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0
4702303|NCT02717195|7619617|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189
4702304|NCT02717195|7619618|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75
4702305|NCT02717195|7619619|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0
4489664|NCT00779909|7291440|FG000|Overall Study|Lost to Follow-up|1
4489665|NCT00779909|7291441|FG001|Overall Study|Lost to Follow-up|0
4489666|NCT00779909|7291442|FG002|Overall Study|Lost to Follow-up|0
4489667|NCT00779909|7291443|FG003|Overall Study|Lost to Follow-up|1
4489668|NCT00779909|7291440|FG000|Overall Study|Withdrawal by Subject|0
4489669|NCT00779909|7291441|FG001|Overall Study|Withdrawal by Subject|1
4489670|NCT00779909|7291442|FG002|Overall Study|Withdrawal by Subject|0
4489671|NCT00779909|7291443|FG003|Overall Study|Withdrawal by Subject|0
4489672|NCT00780143|7291469|FG000|Overall Study|Progressive disease|1
4489673|NCT00780143|7291469|FG000|Overall Study|Toxicity|1
4702306|NCT02717195|7619620|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0
4702307|NCT02717195|7619621|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0
4702308|NCT02717195|7619617|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3
4702309|NCT02717195|7619618|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3
4702310|NCT02717195|7619619|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0
4702311|NCT02717195|7619620|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0
4702312|NCT02717195|7619621|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0
4702313|NCT02717195|7619617|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1
4702314|NCT02717195|7619618|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
4702315|NCT02717195|7619619|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
4702316|NCT02717195|7619620|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
4702317|NCT02717195|7619621|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
4702318|NCT02717195|7619617|FG000|Prospective Confirmation (PC) Period|Technical error|1
4702319|NCT02717195|7619618|FG001|Prospective Confirmation (PC) Period|Technical error|0
4702320|NCT02717195|7619619|FG002|Prospective Confirmation (PC) Period|Technical error|0
4702321|NCT02717195|7619620|FG003|Prospective Confirmation (PC) Period|Technical error|0
4702322|NCT02717195|7619621|FG004|Prospective Confirmation (PC) Period|Technical error|0
4702323|NCT02717195|7619617|FG000|Prospective Confirmation (PC) Period|Patient decision|5
4702324|NCT02717195|7619618|FG001|Prospective Confirmation (PC) Period|Patient decision|2
4702325|NCT02717195|7619619|FG002|Prospective Confirmation (PC) Period|Patient decision|0
4702326|NCT02717195|7619620|FG003|Prospective Confirmation (PC) Period|Patient decision|0
4702327|NCT02717195|7619621|FG004|Prospective Confirmation (PC) Period|Patient decision|0
4702328|NCT02717195|7619617|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1
4702329|NCT02717195|7619618|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
4702330|NCT02717195|7619619|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
4702331|NCT02717195|7619620|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
4702332|NCT02717195|7619621|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
4702333|NCT02717195|7619617|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1
4702334|NCT02717195|7619618|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0
4702335|NCT02717195|7619619|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0
4702336|NCT02717195|7619620|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0
4702337|NCT02717195|7619621|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0
4702338|NCT02717195|7619617|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
4702339|NCT02717195|7619618|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1
4702340|NCT02717195|7619619|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
4702341|NCT02717195|7619620|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
4702342|NCT02717195|7619621|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
4702343|NCT02717195|7619617|FG000|Prospective Confirmation (PC) Period|Investigator decision|2
4702344|NCT02717195|7619618|FG001|Prospective Confirmation (PC) Period|Investigator decision|1
4702345|NCT02717195|7619619|FG002|Prospective Confirmation (PC) Period|Investigator decision|0
4702346|NCT02717195|7619620|FG003|Prospective Confirmation (PC) Period|Investigator decision|0
4702347|NCT02717195|7619621|FG004|Prospective Confirmation (PC) Period|Investigator decision|0
4702348|NCT02717195|7619617|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
4702349|NCT02717195|7619618|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1
4702350|NCT02717195|7619619|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
4702351|NCT02717195|7619620|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
4702352|NCT02717195|7619621|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
4702353|NCT02717195|7619617|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1
4702354|NCT02717195|7619618|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
4702355|NCT02717195|7619619|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
4702356|NCT02717195|7619620|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
4702357|NCT02717195|7619621|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
4702358|NCT02717195|7619617|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
4702359|NCT02717195|7619618|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1
4702360|NCT02717195|7619619|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
4702361|NCT02717195|7619620|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
4702362|NCT02717195|7619621|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
4735374|NCT03527745|7683290|FG003|Overall Study|Lost to Follow-up|9
4489674|NCT00780143|7291469|FG000|Overall Study|Adverse Event|1
4489675|NCT00780273|7291486|FG000|Overall Study|Death|1
4489676|NCT00780273|7291486|FG000|Overall Study|Lost to Follow-up|1
4489677|NCT00780416|7291506|FG000|Overall Study|Physician Decision|3
4489678|NCT00780416|7291507|FG001|Overall Study|Physician Decision|3
4702363|NCT02717195|7619617|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1
4702364|NCT02717195|7619618|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0
4702365|NCT02717195|7619619|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0
4702366|NCT02717195|7619620|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0
4702367|NCT02717195|7619621|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0
4702368|NCT02717195|7619617|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0
4702369|NCT02717195|7619618|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1
4702370|NCT02717195|7619619|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0
4702371|NCT02717195|7619620|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0
4702372|NCT02717195|7619621|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0
4702373|NCT02717195|7619617|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1
4702374|NCT02717195|7619618|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0
4702375|NCT02717195|7619619|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0
4702376|NCT02717195|7619620|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0
4702377|NCT02717195|7619621|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0
4702378|NCT02717195|7619617|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1
4702379|NCT02717195|7619618|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
4702380|NCT02717195|7619619|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
4702381|NCT02717195|7619620|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
4702382|NCT02717195|7619621|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
4702383|NCT02717195|7619617|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0
4702384|NCT02717195|7619618|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0
4702385|NCT02717195|7619619|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10
4702386|NCT02717195|7619620|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11
4702387|NCT02717195|7619621|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8
4702388|NCT02717195|7619617|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0
4702389|NCT02717195|7619618|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0
4702390|NCT02717195|7619619|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6
4702391|NCT02717195|7619620|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9
4702392|NCT02717195|7619621|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2
4702393|NCT02717195|7619617|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0
4702394|NCT02717195|7619618|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0
4702395|NCT02717195|7619619|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4
4702396|NCT02717195|7619620|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3
4702397|NCT02717195|7619621|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2
4702398|NCT02717195|7619617|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0
4702399|NCT02717195|7619618|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0
4702400|NCT02717195|7619619|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1
4702401|NCT02717195|7619620|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0
4702402|NCT02717195|7619621|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1
4702403|NCT02717195|7619617|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0
4702404|NCT02717195|7619618|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0
4702405|NCT02717195|7619619|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14
4702406|NCT02717195|7619620|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13
4702407|NCT02717195|7619621|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8
4702408|NCT02717195|7619617|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0
4702409|NCT02717195|7619618|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0
4702410|NCT02717195|7619619|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0
4702411|NCT02717195|7619620|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3
4702412|NCT02717195|7619621|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2
4702413|NCT02717195|7619617|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
4702414|NCT02717195|7619618|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
4702415|NCT02717195|7619619|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1
4702416|NCT02717195|7619620|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
4702417|NCT02717195|7619621|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
4702418|NCT02717195|7619617|FG000|Double-blind Treatment (DBT) Period|Patient decision|0
4702419|NCT02717195|7619618|FG001|Double-blind Treatment (DBT) Period|Patient decision|0
4702420|NCT02717195|7619619|FG002|Double-blind Treatment (DBT) Period|Patient decision|0
4702421|NCT02717195|7619620|FG003|Double-blind Treatment (DBT) Period|Patient decision|2
4702422|NCT02717195|7619621|FG004|Double-blind Treatment (DBT) Period|Patient decision|2
4702423|NCT02717195|7619617|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0
4702424|NCT02717195|7619618|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0
4702425|NCT02717195|7619619|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0
4702426|NCT02717195|7619620|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1
4702427|NCT02717195|7619621|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1
4489679|NCT00780416|7291506|FG000|Overall Study|Protocol Violation|1
4489680|NCT00780416|7291507|FG001|Overall Study|Protocol Violation|0
4489681|NCT00780416|7291506|FG000|Overall Study|Withdrawal by Subject|8
4702428|NCT02717195|7619617|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0
4702429|NCT02717195|7619618|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0
4702430|NCT02717195|7619619|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0
4702431|NCT02717195|7619620|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0
4702432|NCT02717195|7619621|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1
4702433|NCT02717195|7619617|FG000|Double-blind Treatment (DBT) Period|Change of residence|0
4702434|NCT02717195|7619618|FG001|Double-blind Treatment (DBT) Period|Change of residence|0
4702435|NCT02717195|7619619|FG002|Double-blind Treatment (DBT) Period|Change of residence|0
4702436|NCT02717195|7619620|FG003|Double-blind Treatment (DBT) Period|Change of residence|1
4702437|NCT02717195|7619621|FG004|Double-blind Treatment (DBT) Period|Change of residence|1
4702438|NCT02717195|7619617|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
4702439|NCT02717195|7619618|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
4702440|NCT02717195|7619619|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
4702441|NCT02717195|7619620|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
4702442|NCT02717195|7619621|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1
4702443|NCT02717195|7619617|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0
4702444|NCT02717195|7619618|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0
4702445|NCT02717195|7619619|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1
4702446|NCT02717195|7619620|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0
4702447|NCT02717195|7619621|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0
4702448|NCT02717195|7619617|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0
4702449|NCT02717195|7619618|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0
4702450|NCT02717195|7619619|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0
4702451|NCT02717195|7619620|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1
4702452|NCT02717195|7619621|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1
4702453|NCT02717494|7619646|FG000|First Intervention (Step 1)|Lost to Follow-up|4
4702454|NCT02717494|7619647|FG001|First Intervention (Step 1)|Lost to Follow-up|7
4702455|NCT02717494|7619648|FG002|First Intervention (Step 1)|Lost to Follow-up|3
4702456|NCT02717494|7619646|FG000|First Intervention (Step 1)|Withdrawal by Subject|2
4702457|NCT02717494|7619647|FG001|First Intervention (Step 1)|Withdrawal by Subject|0
4702458|NCT02717494|7619648|FG002|First Intervention (Step 1)|Withdrawal by Subject|1
4702459|NCT02717494|7619646|FG000|First Intervention (Step 1)|Death|0
4702460|NCT02717494|7619647|FG001|First Intervention (Step 1)|Death|0
4702461|NCT02717494|7619648|FG002|First Intervention (Step 1)|Death|1
4702462|NCT02717494|7619646|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0
4702463|NCT02717494|7619647|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0
4702464|NCT02717494|7619648|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4
4702465|NCT02717546|7619674|FG000|Overall Study|Lost to Follow-up|12
4702466|NCT02717754|7619684|FG000|Overall Study|Incorrect Infusion Duration|0
4702467|NCT02717754|7619685|FG001|Overall Study|Incorrect Infusion Duration|0
4702468|NCT02717754|7619686|FG002|Overall Study|Incorrect Infusion Duration|0
4702469|NCT02717754|7619687|FG003|Overall Study|Incorrect Infusion Duration|10
4702470|NCT02717754|7619688|FG004|Overall Study|Incorrect Infusion Duration|20
4702471|NCT02717754|7619689|FG005|Overall Study|Incorrect Infusion Duration|20
4702472|NCT02718131|7619714|FG000|Overall Study|Withdrawal by Subject|1
4702473|NCT02718131|7619715|FG001|Overall Study|Withdrawal by Subject|0
4702474|NCT02718131|7619714|FG000|Overall Study|Adverse Event|1
4702475|NCT02718131|7619715|FG001|Overall Study|Adverse Event|0
4702476|NCT02718131|7619714|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1
4702477|NCT02718131|7619715|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0
4702478|NCT02718326|7619734|FG000|Overall Study|Adverse Event|4
4702479|NCT02718326|7619735|FG001|Overall Study|Adverse Event|9
4702480|NCT02718326|7619736|FG002|Overall Study|Adverse Event|0
4702481|NCT02718326|7619734|FG000|Overall Study|Death|8
4702482|NCT02718326|7619735|FG001|Overall Study|Death|1
4702483|NCT02718326|7619736|FG002|Overall Study|Death|2
4702484|NCT02718326|7619734|FG000|Overall Study|Withdrawal by Subject|4
4702485|NCT02718326|7619735|FG001|Overall Study|Withdrawal by Subject|9
4702486|NCT02718326|7619736|FG002|Overall Study|Withdrawal by Subject|6
4702487|NCT02718326|7619734|FG000|Overall Study|Lost to Follow-up|18
4702488|NCT02718326|7619735|FG001|Overall Study|Lost to Follow-up|5
4702489|NCT02718326|7619736|FG002|Overall Study|Lost to Follow-up|14
4702490|NCT02718326|7619734|FG000|Overall Study|Protocol Deviation|1
4702491|NCT02718326|7619735|FG001|Overall Study|Protocol Deviation|0
4702492|NCT02718326|7619736|FG002|Overall Study|Protocol Deviation|0
4702493|NCT02718326|7619734|FG000|Overall Study|Pregnancy|1
4702494|NCT02718326|7619735|FG001|Overall Study|Pregnancy|0
4702495|NCT02718326|7619736|FG002|Overall Study|Pregnancy|0
4702496|NCT02718417|7619749|FG000|Chemotherapy Phase (CP)|Adverse Event|9
4702497|NCT02718417|7619750|FG001|Chemotherapy Phase (CP)|Adverse Event|14
4702498|NCT02718417|7619751|FG002|Chemotherapy Phase (CP)|Adverse Event|13
4702499|NCT02718417|7619749|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5
4702500|NCT02718417|7619750|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4
4489682|NCT00780416|7291507|FG001|Overall Study|Withdrawal by Subject|6
4489683|NCT00780559|7291528|FG000|Overall Study|Lost to Follow-up|2
4489684|NCT00780559|7291529|FG001|Overall Study|Lost to Follow-up|7
4489685|NCT00780559|7291528|FG000|Overall Study|Death|1
4489686|NCT00780559|7291529|FG001|Overall Study|Death|0
4489687|NCT00780910|7291588|FG000|Overall Study|Adverse Event|2
4489688|NCT00780975|7291601|FG000|Overall Study|Progressive disease|3
4489689|NCT00780975|7291601|FG000|Overall Study|Toxicity|5
4489690|NCT00781274|7291614|FG000|Overall Study|Withdrawal by Subject|2
4489691|NCT00781326|7291618|FG000|Phase I|Adverse Event|1
4489692|NCT00781326|7291618|FG000|Phase I|Withdrawal by Subject|1
4489693|NCT00781326|7291618|FG000|Phase I|Physician Decision|2
4489694|NCT00781365|7291624|FG000|Overall Study|Withdrawal by Subject|13
4489695|NCT00781365|7291625|FG001|Overall Study|Withdrawal by Subject|8
4489696|NCT00781365|7291624|FG000|Overall Study|Did Not Attend Visit|20
4489697|NCT00781365|7291625|FG001|Overall Study|Did Not Attend Visit|28
4489698|NCT00781365|7291624|FG000|Overall Study|Language barrier|1
4489699|NCT00781365|7291625|FG001|Overall Study|Language barrier|0
4489700|NCT00781391|7291634|FG000|Overall Study|never received study drug|24
4489701|NCT00781391|7291635|FG001|Overall Study|never received study drug|23
4489702|NCT00781391|7291636|FG002|Overall Study|never received study drug|32
4489703|NCT00781391|7291634|FG000|Overall Study|Protocol Violation|19
4489704|NCT00781391|7291635|FG001|Overall Study|Protocol Violation|17
4489705|NCT00781391|7291636|FG002|Overall Study|Protocol Violation|20
4489706|NCT00781391|7291634|FG000|Overall Study|Death|789
4489707|NCT00781391|7291635|FG001|Overall Study|Death|730
4489708|NCT00781391|7291636|FG002|Overall Study|Death|706
4489709|NCT00781391|7291634|FG000|Overall Study|Withdrawal by Subject|47
4489710|NCT00781391|7291635|FG001|Overall Study|Withdrawal by Subject|37
4489711|NCT00781391|7291636|FG002|Overall Study|Withdrawal by Subject|25
4489712|NCT00781391|7291634|FG000|Overall Study|Lost to Follow-up|0
4489713|NCT00781391|7291635|FG001|Overall Study|Lost to Follow-up|0
4489714|NCT00781391|7291636|FG002|Overall Study|Lost to Follow-up|1
4489715|NCT00781456|7291646|FG000|Overall Study|Adverse Event|3
4626632|NCT01843972|7492498|FG000|Overall Study|Withdrawal by Subject|0
4702501|NCT02718417|7619751|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1
4702502|NCT02718417|7619749|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3
4702503|NCT02718417|7619750|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2
4702504|NCT02718417|7619751|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1
4702505|NCT02718417|7619749|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4
4702506|NCT02718417|7619750|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2
4702507|NCT02718417|7619751|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1
4702508|NCT02718417|7619749|FG000|Chemotherapy Phase (CP)|Physician's decision|5
4702509|NCT02718417|7619750|FG001|Chemotherapy Phase (CP)|Physician's decision|0
4702510|NCT02718417|7619751|FG002|Chemotherapy Phase (CP)|Physician's decision|4
4702511|NCT02718417|7619749|FG000|Chemotherapy Phase (CP)|Progressive disease|11
4702512|NCT02718417|7619750|FG001|Chemotherapy Phase (CP)|Progressive disease|7
4702513|NCT02718417|7619751|FG002|Chemotherapy Phase (CP)|Progressive disease|10
4702514|NCT02718417|7619749|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13
4702515|NCT02718417|7619750|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8
4702516|NCT02718417|7619751|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15
4702517|NCT02718417|7619749|FG000|Chemotherapy Phase (CP)|Other|2
4702518|NCT02718417|7619750|FG001|Chemotherapy Phase (CP)|Other|0
4626633|NCT01843972|7492499|FG001|Overall Study|Withdrawal by Subject|0
4626634|NCT01843972|7492500|FG002|Overall Study|Withdrawal by Subject|0
4626635|NCT01843972|7492501|FG003|Overall Study|Withdrawal by Subject|0
4626636|NCT01843972|7492502|FG004|Overall Study|Withdrawal by Subject|1
4626637|NCT01843972|7492503|FG005|Overall Study|Withdrawal by Subject|0
4626638|NCT01843972|7492504|FG006|Overall Study|Withdrawal by Subject|0
4702519|NCT02718417|7619751|FG002|Chemotherapy Phase (CP)|Other|1
4702520|NCT02718417|7619749|FG000|Maintenance Phase (MP)|Adverse Event|21
4702521|NCT02718417|7619750|FG001|Maintenance Phase (MP)|Adverse Event|26
4702522|NCT02718417|7619751|FG002|Maintenance Phase (MP)|Adverse Event|0
4702523|NCT02718417|7619749|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1
4702524|NCT02718417|7619750|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1
4702525|NCT02718417|7619751|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0
4702526|NCT02718417|7619749|FG000|Maintenance Phase (MP)|Global deterioration of health status|5
4702527|NCT02718417|7619750|FG001|Maintenance Phase (MP)|Global deterioration of health status|3
4702528|NCT02718417|7619751|FG002|Maintenance Phase (MP)|Global deterioration of health status|0
4702529|NCT02718417|7619749|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0
4702530|NCT02718417|7619750|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1
4702531|NCT02718417|7619751|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0
4702532|NCT02718417|7619749|FG000|Maintenance Phase (MP)|Physician's decision|6
4702533|NCT02718417|7619750|FG001|Maintenance Phase (MP)|Physician's decision|7
4702534|NCT02718417|7619751|FG002|Maintenance Phase (MP)|Physician's decision|0
4702535|NCT02718417|7619749|FG000|Maintenance Phase (MP)|Progressive disease|100
4489716|NCT00781456|7291647|FG001|Overall Study|Adverse Event|3
4626639|NCT01843972|7492505|FG007|Overall Study|Withdrawal by Subject|0
4626640|NCT01843972|7492506|FG008|Overall Study|Withdrawal by Subject|0
4626641|NCT01843972|7492507|FG009|Overall Study|Withdrawal by Subject|0
4626642|NCT01844076|7492547|FG000|Overall Study|Adverse Event|1
4626643|NCT01844076|7492548|FG001|Overall Study|Adverse Event|0
4626644|NCT01844076|7492549|FG002|Overall Study|Adverse Event|0
4626645|NCT01844076|7492550|FG003|Overall Study|Adverse Event|0
4626646|NCT01844076|7492547|FG000|Overall Study|Withdrawal by Subject|1
4626647|NCT01844076|7492548|FG001|Overall Study|Withdrawal by Subject|0
4626648|NCT01844076|7492549|FG002|Overall Study|Withdrawal by Subject|0
4626649|NCT01844076|7492550|FG003|Overall Study|Withdrawal by Subject|0
4626650|NCT01844115|7492562|FG000|Overall Study|Adverse Event|4
4626651|NCT01844115|7492563|FG001|Overall Study|Adverse Event|22
4626652|NCT01844115|7492562|FG000|Overall Study|Lack of Efficacy|1
4626653|NCT01844115|7492563|FG001|Overall Study|Lack of Efficacy|4
4626654|NCT01844115|7492562|FG000|Overall Study|Protocol Violation|12
4626655|NCT01844115|7492563|FG001|Overall Study|Protocol Violation|10
4626656|NCT01844115|7492562|FG000|Overall Study|Withdrawal by Subject|11
4626657|NCT01844115|7492563|FG001|Overall Study|Withdrawal by Subject|11
4626658|NCT01844115|7492562|FG000|Overall Study|Lost to Follow-up|11
4626659|NCT01844115|7492563|FG001|Overall Study|Lost to Follow-up|10
4626660|NCT01844115|7492562|FG000|Overall Study|Pregnancy|0
4626661|NCT01844115|7492563|FG001|Overall Study|Pregnancy|1
4626662|NCT01844284|7492580|FG000|Overall Study|Lost to Follow-up|12
4626663|NCT01844284|7492581|FG001|Overall Study|Lost to Follow-up|7
4626664|NCT01844375|7492589|FG000|Overall Study|Protocol Violation|1
4626665|NCT01844375|7492590|FG001|Overall Study|Protocol Violation|1
4626666|NCT01844531|7492617|FG000|Overall Study|Withdrawal by Subject|0
4626667|NCT01844531|7492618|FG001|Overall Study|Withdrawal by Subject|1
4626668|NCT01844531|7492619|FG002|Overall Study|Withdrawal by Subject|0
4702536|NCT02718417|7619750|FG001|Maintenance Phase (MP)|Progressive disease|88
4702537|NCT02718417|7619751|FG002|Maintenance Phase (MP)|Progressive disease|0
4702538|NCT02718417|7619749|FG000|Maintenance Phase (MP)|Other|2
4702539|NCT02718417|7619750|FG001|Maintenance Phase (MP)|Other|1
4702540|NCT02718417|7619751|FG002|Maintenance Phase (MP)|Other|0
4702541|NCT02718417|7619749|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17
4702542|NCT02718417|7619750|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20
4702543|NCT02718417|7619751|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0
4702544|NCT02718417|7619749|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114
4702545|NCT02718417|7619750|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140
4702546|NCT02718417|7619751|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0
4702547|NCT02718417|7619749|FG000|Observation Phase (OP)|Adverse Event|0
4702548|NCT02718417|7619750|FG001|Observation Phase (OP)|Adverse Event|0
4702549|NCT02718417|7619751|FG002|Observation Phase (OP)|Adverse Event|1
4702550|NCT02718417|7619749|FG000|Observation Phase (OP)|Death leading to discontinuation|0
4702551|NCT02718417|7619750|FG001|Observation Phase (OP)|Death leading to discontinuation|0
4702552|NCT02718417|7619751|FG002|Observation Phase (OP)|Death leading to discontinuation|2
4702553|NCT02718417|7619749|FG000|Observation Phase (OP)|Lost to Follow-up|0
4702554|NCT02718417|7619750|FG001|Observation Phase (OP)|Lost to Follow-up|0
4702555|NCT02718417|7619751|FG002|Observation Phase (OP)|Lost to Follow-up|1
4702556|NCT02718417|7619749|FG000|Observation Phase (OP)|Physician Decision|0
4702557|NCT02718417|7619750|FG001|Observation Phase (OP)|Physician Decision|0
4702558|NCT02718417|7619751|FG002|Observation Phase (OP)|Physician Decision|9
4702559|NCT02718417|7619749|FG000|Observation Phase (OP)|Progressive disease|0
4702560|NCT02718417|7619750|FG001|Observation Phase (OP)|Progressive disease|0
4702561|NCT02718417|7619751|FG002|Observation Phase (OP)|Progressive disease|92
4702562|NCT02718417|7619749|FG000|Observation Phase (OP)|Study terminated by sponsor|0
4702563|NCT02718417|7619750|FG001|Observation Phase (OP)|Study terminated by sponsor|0
4702564|NCT02718417|7619751|FG002|Observation Phase (OP)|Study terminated by sponsor|135
4702565|NCT02718417|7619749|FG000|Observation Phase (OP)|Withdrawal by Subject|0
4702566|NCT02718417|7619750|FG001|Observation Phase (OP)|Withdrawal by Subject|0
4702567|NCT02718417|7619751|FG002|Observation Phase (OP)|Withdrawal by Subject|34
4702568|NCT02718417|7619749|FG000|Observation Phase (OP)|Global deterioration of health status|0
4702569|NCT02718417|7619750|FG001|Observation Phase (OP)|Global deterioration of health status|0
4702570|NCT02718417|7619751|FG002|Observation Phase (OP)|Global deterioration of health status|1
4702571|NCT02718417|7619749|FG000|Observation Phase (OP)|Other|0
4702572|NCT02718417|7619750|FG001|Observation Phase (OP)|Other|0
4702573|NCT02718417|7619751|FG002|Observation Phase (OP)|Other|7
4702574|NCT02718417|7619749|FG000|Follow-up Phase|Adverse Event|3
4702575|NCT02718417|7619750|FG001|Follow-up Phase|Adverse Event|1
4702576|NCT02718417|7619751|FG002|Follow-up Phase|Adverse Event|1
4702577|NCT02718417|7619749|FG000|Follow-up Phase|Other|4
4626669|NCT01844531|7492620|FG003|Overall Study|Withdrawal by Subject|0
4626670|NCT01844583|7492632|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8
4702578|NCT02718417|7619750|FG001|Follow-up Phase|Other|6
4702579|NCT02718417|7619751|FG002|Follow-up Phase|Other|4
4626671|NCT01844583|7492633|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10
4626672|NCT01844687|7492644|FG000|Visit 1|Protocol Violation|3
4626673|NCT01844687|7492644|FG000|Visit 1|Lost to Follow-up|5
4626674|NCT01844687|7492644|FG000|Visit 2|Withdrawal by Subject|1
4626675|NCT01844687|7492644|FG000|Visit 2|Protocol Violation|1
4626676|NCT01844687|7492644|FG000|Visit 3|Lost to Follow-up|1
4626677|NCT01844687|7492644|FG000|Visit 3|Withdrawal by Subject|3
4702580|NCT02718417|7619749|FG000|Follow-up Phase|Withdrawal by Subject|19
4702581|NCT02718417|7619750|FG001|Follow-up Phase|Withdrawal by Subject|17
4702582|NCT02718417|7619751|FG002|Follow-up Phase|Withdrawal by Subject|5
4702583|NCT02718417|7619749|FG000|Follow-up Phase|Study terminated by sponsor|100
4702584|NCT02718417|7619750|FG001|Follow-up Phase|Study terminated by sponsor|138
4702585|NCT02718417|7619751|FG002|Follow-up Phase|Study terminated by sponsor|6
4702586|NCT02718417|7619749|FG000|Follow-up Phase|Lost to Follow-up|2
4702587|NCT02718417|7619750|FG001|Follow-up Phase|Lost to Follow-up|3
4702588|NCT02718417|7619751|FG002|Follow-up Phase|Lost to Follow-up|0
4702589|NCT02718417|7619749|FG000|Follow-up Phase|Death leading to discontinuation|7
4702590|NCT02718417|7619750|FG001|Follow-up Phase|Death leading to discontinuation|7
4702591|NCT02718417|7619751|FG002|Follow-up Phase|Death leading to discontinuation|3
4702592|NCT02718417|7619749|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20
4489717|NCT00781456|7291646|FG000|Overall Study|Withdrawal by Subject|3
4489718|NCT00781456|7291647|FG001|Overall Study|Withdrawal by Subject|5
4489719|NCT00781456|7291646|FG000|Overall Study|Protocol Violation|4
4489720|NCT00781456|7291647|FG001|Overall Study|Protocol Violation|1
4489721|NCT00781456|7291646|FG000|Overall Study|Noncompliance With Protocol|1
4489722|NCT00781456|7291647|FG001|Overall Study|Noncompliance With Protocol|1
4489723|NCT00781456|7291646|FG000|Overall Study|Lost to Follow-up|10
4489724|NCT00781456|7291647|FG001|Overall Study|Lost to Follow-up|5
4489725|NCT00781456|7291646|FG000|Overall Study|Other Reason, Unknown|0
4489726|NCT00781456|7291647|FG001|Overall Study|Other Reason, Unknown|1
4489727|NCT00781599|7291666|FG000|Overall Study|Lost to Follow-up|7
4489728|NCT00781599|7291667|FG001|Overall Study|Lost to Follow-up|4
4489729|NCT00781768|7291675|FG000|Overall Study|Not transplanted.|0
4489730|NCT00781768|7291676|FG001|Overall Study|Not transplanted.|2
4489731|NCT00781859|7291684|FG000|Overall Study|Adverse Event|2
4489732|NCT00781859|7291685|FG001|Overall Study|Adverse Event|2
4489733|NCT00781859|7291684|FG000|Overall Study|Withdrawal by Subject|8
4489734|NCT00781859|7291685|FG001|Overall Study|Withdrawal by Subject|4
4489735|NCT00781859|7291684|FG000|Overall Study|Lost to Follow-up|6
4489736|NCT00781859|7291685|FG001|Overall Study|Lost to Follow-up|3
4489737|NCT00781859|7291684|FG000|Overall Study|Death|3
4489738|NCT00781859|7291685|FG001|Overall Study|Death|0
4489739|NCT00781885|7291691|FG000|Overall Study|Physician Decision|1
4489740|NCT00781911|7291706|FG000|Overall Study|Adverse Event|4
4489741|NCT00781911|7291707|FG001|Overall Study|Adverse Event|4
4489742|NCT00781911|7291706|FG000|Overall Study|Withdrawal by Subject|1
4489743|NCT00781911|7291707|FG001|Overall Study|Withdrawal by Subject|2
4489744|NCT00781911|7291706|FG000|Overall Study|Physician Decision|0
4489745|NCT00781911|7291707|FG001|Overall Study|Physician Decision|2
4489746|NCT00781911|7291706|FG000|Overall Study|Sponsor Decision|1
4489747|NCT00781911|7291707|FG001|Overall Study|Sponsor Decision|0
4517411|NCT00966875|7329240|FG003|Part B|Adverse Event|0
4517412|NCT00966875|7329241|FG004|Part B|Adverse Event|1
4517413|NCT00966875|7329242|FG005|Part B|Adverse Event|0
4517414|NCT00966875|7329243|FG006|Part B|Adverse Event|5
4517415|NCT00966875|7329244|FG007|Part B|Adverse Event|2
4517416|NCT00966875|7329245|FG008|Part B|Adverse Event|2
4517417|NCT00966875|7329237|FG000|Part B|Death|0
4517418|NCT00966875|7329238|FG001|Part B|Death|0
4517419|NCT00966875|7329239|FG002|Part B|Death|1
4517420|NCT00966875|7329240|FG003|Part B|Death|0
4517421|NCT00966875|7329241|FG004|Part B|Death|0
4517422|NCT00966875|7329242|FG005|Part B|Death|0
4517423|NCT00966875|7329243|FG006|Part B|Death|0
4517424|NCT00966875|7329244|FG007|Part B|Death|1
4517425|NCT00966875|7329245|FG008|Part B|Death|0
4517426|NCT00966875|7329237|FG000|Part B|Lack of Efficacy|2
4517427|NCT00966875|7329238|FG001|Part B|Lack of Efficacy|1
4517428|NCT00966875|7329239|FG002|Part B|Lack of Efficacy|1
4517429|NCT00966875|7329240|FG003|Part B|Lack of Efficacy|1
4517430|NCT00966875|7329241|FG004|Part B|Lack of Efficacy|2
4517431|NCT00966875|7329242|FG005|Part B|Lack of Efficacy|3
4517432|NCT00966875|7329243|FG006|Part B|Lack of Efficacy|12
4517433|NCT00966875|7329244|FG007|Part B|Lack of Efficacy|9
4517434|NCT00966875|7329245|FG008|Part B|Lack of Efficacy|6
4517435|NCT00966875|7329237|FG000|Part B|Lost to Follow-up|0
4517436|NCT00966875|7329238|FG001|Part B|Lost to Follow-up|0
4517437|NCT00966875|7329239|FG002|Part B|Lost to Follow-up|0
4517438|NCT00966875|7329240|FG003|Part B|Lost to Follow-up|1
4517439|NCT00966875|7329241|FG004|Part B|Lost to Follow-up|0
4517440|NCT00966875|7329242|FG005|Part B|Lost to Follow-up|0
4517441|NCT00966875|7329243|FG006|Part B|Lost to Follow-up|0
4517442|NCT00966875|7329244|FG007|Part B|Lost to Follow-up|0
4517443|NCT00966875|7329245|FG008|Part B|Lost to Follow-up|1
4517444|NCT00966875|7329237|FG000|Part B|Physician Decision|0
4702593|NCT02718417|7619750|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17
4517445|NCT00966875|7329238|FG001|Part B|Physician Decision|0
4517446|NCT00966875|7329239|FG002|Part B|Physician Decision|1
4517447|NCT00966875|7329240|FG003|Part B|Physician Decision|0
4517448|NCT00966875|7329241|FG004|Part B|Physician Decision|2
4517449|NCT00966875|7329242|FG005|Part B|Physician Decision|1
4517450|NCT00966875|7329243|FG006|Part B|Physician Decision|0
4517451|NCT00966875|7329244|FG007|Part B|Physician Decision|0
4517452|NCT00966875|7329245|FG008|Part B|Physician Decision|2
4517453|NCT00966875|7329237|FG000|Part B|Sponsor Decision|1
4517454|NCT00966875|7329238|FG001|Part B|Sponsor Decision|0
4517455|NCT00966875|7329239|FG002|Part B|Sponsor Decision|0
4590216|NCT01519661|7436017|FG000|Overall Study|Lack of Efficacy|6
4590217|NCT01519661|7436017|FG000|Overall Study|Adverse Event|29
4590218|NCT01519674|7436025|FG000|Overall Study|Adverse Event|3
4590219|NCT01519674|7436026|FG001|Overall Study|Adverse Event|3
4590220|NCT01519674|7436027|FG002|Overall Study|Adverse Event|0
4590221|NCT01519674|7436025|FG000|Overall Study|Lack of Efficacy|1
4590222|NCT01519674|7436026|FG001|Overall Study|Lack of Efficacy|1
4590223|NCT01519674|7436027|FG002|Overall Study|Lack of Efficacy|1
4590224|NCT01519674|7436025|FG000|Overall Study|Protocol Violation|0
4590225|NCT01519674|7436026|FG001|Overall Study|Protocol Violation|3
4590226|NCT01519674|7436027|FG002|Overall Study|Protocol Violation|1
4590227|NCT01519674|7436025|FG000|Overall Study|Withdrawal Criteria|7
4590228|NCT01519674|7436026|FG001|Overall Study|Withdrawal Criteria|2
4590229|NCT01519674|7436027|FG002|Overall Study|Withdrawal Criteria|7
4590230|NCT01519674|7436025|FG000|Overall Study|Unsclassified|10
4590231|NCT01519674|7436026|FG001|Overall Study|Unsclassified|4
4590232|NCT01519674|7436027|FG002|Overall Study|Unsclassified|3
4590233|NCT01519700|7436039|FG000|Overall Study|Death|1
4489748|NCT00781937|7291717|FG000|Main Trial Period Through Week 56|Adverse Event|18
4489749|NCT00781937|7291718|FG001|Main Trial Period Through Week 56|Adverse Event|18
4489750|NCT00781937|7291717|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0
4489751|NCT00781937|7291718|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2
4489752|NCT00781937|7291717|FG000|Main Trial Period Through Week 56|Protocol Violation|8
4489753|NCT00781937|7291718|FG001|Main Trial Period Through Week 56|Protocol Violation|5
4489754|NCT00781937|7291717|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17
4489755|NCT00781937|7291718|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24
4489756|NCT00781937|7291717|FG000|Main Trial Period Through Week 56|Unclassified|10
4489757|NCT00781937|7291718|FG001|Main Trial Period Through Week 56|Unclassified|15
4489758|NCT00781937|7291717|FG000|Follow up Period (Week 56-68)|Protocol Violation|1
4489759|NCT00781937|7291718|FG001|Follow up Period (Week 56-68)|Protocol Violation|1
4489760|NCT00781937|7291717|FG000|Follow up Period (Week 56-68)|Unclassified|5
4489761|NCT00781937|7291718|FG001|Follow up Period (Week 56-68)|Unclassified|4
4489762|NCT00781963|7291736|FG000|Overall Study|Death|3
4489763|NCT00781963|7291737|FG001|Overall Study|Death|0
4489764|NCT00781963|7291736|FG000|Overall Study|Lost to Follow-up|2
4489765|NCT00781963|7291737|FG001|Overall Study|Lost to Follow-up|1
4489766|NCT00781963|7291736|FG000|Overall Study|Withdrawal by Subject|3
4489767|NCT00781963|7291737|FG001|Overall Study|Withdrawal by Subject|1
4489768|NCT00781963|7291736|FG000|Overall Study|Refused follow-up|9
4489769|NCT00781963|7291737|FG001|Overall Study|Refused follow-up|0
4489770|NCT00782067|7291743|FG000|Overall Study|Adverse Event|35
4489771|NCT00782067|7291743|FG000|Overall Study|Subject withdrew consent|11
4489772|NCT00782067|7291743|FG000|Overall Study|Lost to Follow-up|2
4489773|NCT00782067|7291743|FG000|Overall Study|Administrative problems|14
4489774|NCT00782067|7291743|FG000|Overall Study|Death|9
4489775|NCT00782067|7291743|FG000|Overall Study|Disease progression|43
4489776|NCT00782067|7291743|FG000|Overall Study|Protocol deviation|2
4489777|NCT00782171|7291749|FG000|Overall Study|Lost to Follow-up|2
4489778|NCT00782171|7291750|FG001|Overall Study|Lost to Follow-up|2
4489779|NCT00782171|7291749|FG000|Overall Study|Withdrawal by Subject|2
4489780|NCT00782171|7291750|FG001|Overall Study|Withdrawal by Subject|1
4489781|NCT00782171|7291749|FG000|Overall Study|complications|3
4489782|NCT00782171|7291750|FG001|Overall Study|complications|1
4489783|NCT00782171|7291749|FG000|Overall Study|others|7
4489784|NCT00782171|7291750|FG001|Overall Study|others|9
4489785|NCT00782171|7291749|FG000|Overall Study|not eligible|8
4489786|NCT00782171|7291750|FG001|Overall Study|not eligible|6
4489787|NCT00782210|7291759|FG000|Overall Study|Adverse Event|21
4489788|NCT00782210|7291760|FG001|Overall Study|Adverse Event|17
4489789|NCT00782210|7291761|FG002|Overall Study|Adverse Event|16
4489790|NCT00782210|7291759|FG000|Overall Study|Lost to Follow-up|2
4489791|NCT00782210|7291760|FG001|Overall Study|Lost to Follow-up|1
4489792|NCT00782210|7291761|FG002|Overall Study|Lost to Follow-up|2
4489793|NCT00782210|7291759|FG000|Overall Study|Withdrawal by Subject|11
4489794|NCT00782210|7291760|FG001|Overall Study|Withdrawal by Subject|8
4489795|NCT00782210|7291761|FG002|Overall Study|Withdrawal by Subject|11
4489796|NCT00782210|7291759|FG000|Overall Study|Non compliance with protocol|0
4489797|NCT00782210|7291760|FG001|Overall Study|Non compliance with protocol|3
4489798|NCT00782210|7291761|FG002|Overall Study|Non compliance with protocol|2
4489799|NCT00782210|7291759|FG000|Overall Study|Lack of Efficacy|13
4489800|NCT00782210|7291760|FG001|Overall Study|Lack of Efficacy|4
4489801|NCT00782210|7291761|FG002|Overall Study|Lack of Efficacy|1
4489802|NCT00782210|7291759|FG000|Overall Study|Other reason not described above|3
4489803|NCT00782210|7291760|FG001|Overall Study|Other reason not described above|2
4489804|NCT00782210|7291761|FG002|Overall Study|Other reason not described above|3
4489805|NCT00782275|7291778|FG000|Overall Study|Adverse Event|11
4489806|NCT00782275|7291778|FG000|Overall Study|Withdrawal by Subject|1
4489807|NCT00782275|7291778|FG000|Overall Study|Progressive Disease|21
4590234|NCT01519700|7436040|FG001|Overall Study|Death|0
4590235|NCT01519700|7436041|FG002|Overall Study|Death|0
4489808|NCT00782275|7291778|FG000|Overall Study|Physician Decision|4
4489809|NCT00782275|7291778|FG000|Overall Study|Not started treatment|1
4489810|NCT00782275|7291778|FG000|Overall Study|Other|3
4590236|NCT01519700|7436042|FG003|Overall Study|Death|0
4489811|NCT00782340|7291785|FG000|Open Label Titration|Adverse Event|12
4489812|NCT00782340|7291786|FG001|Open Label Titration|Adverse Event|0
4489813|NCT00782340|7291787|FG002|Open Label Titration|Adverse Event|0
4489814|NCT00782340|7291785|FG000|Open Label Titration|Treatment failure|50
4489815|NCT00782340|7291786|FG001|Open Label Titration|Treatment failure|0
4489816|NCT00782340|7291787|FG002|Open Label Titration|Treatment failure|0
4489817|NCT00782340|7291785|FG000|Open Label Titration|Protocol Violation|5
4489818|NCT00782340|7291786|FG001|Open Label Titration|Protocol Violation|0
4489819|NCT00782340|7291787|FG002|Open Label Titration|Protocol Violation|0
4489820|NCT00782340|7291785|FG000|Open Label Titration|Withdrawal by Subject|5
4489821|NCT00782340|7291786|FG001|Open Label Titration|Withdrawal by Subject|0
4489822|NCT00782340|7291787|FG002|Open Label Titration|Withdrawal by Subject|0
4489823|NCT00782340|7291785|FG000|Open Label Titration|Enrollment capped|16
4489824|NCT00782340|7291786|FG001|Open Label Titration|Enrollment capped|0
4489825|NCT00782340|7291787|FG002|Open Label Titration|Enrollment capped|0
4489826|NCT00782340|7291785|FG000|Open Label Titration|Did not meet responder criteria|2
4489827|NCT00782340|7291786|FG001|Open Label Titration|Did not meet responder criteria|0
4489828|NCT00782340|7291787|FG002|Open Label Titration|Did not meet responder criteria|0
4489829|NCT00782340|7291785|FG000|Open Label Titration|Lost to Follow-up|5
4489830|NCT00782340|7291786|FG001|Open Label Titration|Lost to Follow-up|0
4489831|NCT00782340|7291787|FG002|Open Label Titration|Lost to Follow-up|0
4489832|NCT00782340|7291785|FG000|Open Label Titration|Randomized in error|6
4489833|NCT00782340|7291786|FG001|Open Label Titration|Randomized in error|0
4489834|NCT00782340|7291787|FG002|Open Label Titration|Randomized in error|0
4517456|NCT00966875|7329240|FG003|Part B|Sponsor Decision|0
4517457|NCT00966875|7329241|FG004|Part B|Sponsor Decision|0
4517458|NCT00966875|7329242|FG005|Part B|Sponsor Decision|1
4517459|NCT00966875|7329243|FG006|Part B|Sponsor Decision|0
4517460|NCT00966875|7329244|FG007|Part B|Sponsor Decision|2
4517461|NCT00966875|7329245|FG008|Part B|Sponsor Decision|1
4517462|NCT00966875|7329237|FG000|Part B|Withdrawal by Subject|2
4517463|NCT00966875|7329238|FG001|Part B|Withdrawal by Subject|1
4517464|NCT00966875|7329239|FG002|Part B|Withdrawal by Subject|2
4517465|NCT00966875|7329240|FG003|Part B|Withdrawal by Subject|1
4517466|NCT00966875|7329241|FG004|Part B|Withdrawal by Subject|2
4517467|NCT00966875|7329242|FG005|Part B|Withdrawal by Subject|1
4517468|NCT00966875|7329243|FG006|Part B|Withdrawal by Subject|4
4517469|NCT00966875|7329244|FG007|Part B|Withdrawal by Subject|5
4517470|NCT00966875|7329245|FG008|Part B|Withdrawal by Subject|5
4517471|NCT00966875|7329237|FG000|Part B|Entry Criteria|0
4517472|NCT00966875|7329238|FG001|Part B|Entry Criteria|0
4517473|NCT00966875|7329239|FG002|Part B|Entry Criteria|0
4517474|NCT00966875|7329240|FG003|Part B|Entry Criteria|0
4517475|NCT00966875|7329241|FG004|Part B|Entry Criteria|0
4517476|NCT00966875|7329242|FG005|Part B|Entry Criteria|0
4517477|NCT00966875|7329243|FG006|Part B|Entry Criteria|1
4517478|NCT00966875|7329244|FG007|Part B|Entry Criteria|0
4517479|NCT00966875|7329245|FG008|Part B|Entry Criteria|1
4517480|NCT00966940|7329320|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2
4517481|NCT00966940|7329321|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0
4517482|NCT00966940|7329320|FG000|Period 1, First 6 Weeks|Protocol Violation|1
4517483|NCT00966940|7329321|FG001|Period 1, First 6 Weeks|Protocol Violation|0
4517484|NCT00967005|7329329|FG000|Overall Study|Lost to Follow-up|7
4517485|NCT00967005|7329330|FG001|Overall Study|Lost to Follow-up|10
4517486|NCT00967018|7329336|FG000|Overall Study|Adverse Event|2
4517487|NCT00967018|7329336|FG000|Overall Study|Physician Decision|7
4517488|NCT00967018|7329336|FG000|Overall Study|Lost to Follow-up|2
4517489|NCT00967018|7329336|FG000|Overall Study|Withdrawal by Subject|1
4517490|NCT00967018|7329336|FG000|Overall Study|Miscellaneous Reasons|9
4517491|NCT00967226|7329346|FG000|Overall Study|Adverse Event|0
4517492|NCT00967226|7329347|FG001|Overall Study|Adverse Event|5
4517493|NCT00967226|7329346|FG000|Overall Study|Protocol Violation|2
4517494|NCT00967226|7329347|FG001|Overall Study|Protocol Violation|0
4517495|NCT00967226|7329346|FG000|Overall Study|Physician Decision|0
4517496|NCT00967226|7329347|FG001|Overall Study|Physician Decision|1
4517497|NCT00967330|7329379|FG000|Overall Study|Protocol Violation|3
4517498|NCT00967330|7329380|FG001|Overall Study|Protocol Violation|4
4517499|NCT00967330|7329379|FG000|Overall Study|Regular|10
4517500|NCT00967330|7329380|FG001|Overall Study|Regular|3
4517501|NCT00967330|7329379|FG000|Overall Study|Withdrawal by Subject|6
4517502|NCT00967330|7329380|FG001|Overall Study|Withdrawal by Subject|0
4517503|NCT00967330|7329379|FG000|Overall Study|Lost to Follow-up|1
4517504|NCT00967330|7329380|FG001|Overall Study|Lost to Follow-up|1
4517505|NCT00967330|7329379|FG000|Overall Study|Death|102
4517506|NCT00967330|7329380|FG001|Overall Study|Death|51
4517507|NCT00967330|7329379|FG000|Overall Study|Severe protocol deviation|0
4517508|NCT00967330|7329380|FG001|Overall Study|Severe protocol deviation|1
4517509|NCT00967343|7329386|FG000|Overall Study|Study termination by sponsor|12
4517510|NCT00967343|7329386|FG000|Overall Study|Death|24
4517511|NCT00967343|7329386|FG000|Overall Study|Relapse|1
4517512|NCT00967343|7329386|FG000|Overall Study|Lost to Follow-up|1
4517513|NCT00967499|7329414|FG000|Overall Study|Adverse Event|0
4517514|NCT00967499|7329415|FG001|Overall Study|Adverse Event|1
4517515|NCT00967499|7329414|FG000|Overall Study|Protocol Violation|1
4517516|NCT00967499|7329415|FG001|Overall Study|Protocol Violation|0
4517517|NCT00967499|7329414|FG000|Overall Study|Sponsor Decision|1
4590237|NCT01519700|7436039|FG000|Overall Study|Lost to Follow-up|0
4489835|NCT00782418|7291798|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1
4489836|NCT00782418|7291799|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0
4489837|NCT00782418|7291800|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0
4489838|NCT00782418|7291801|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0
4489839|NCT00782418|7291802|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0
4489840|NCT00782418|7291803|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0
4489841|NCT00782418|7291804|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0
4489842|NCT00782418|7291798|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
4489843|NCT00782418|7291799|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
4489844|NCT00782418|7291800|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
4489845|NCT00782418|7291801|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
4489846|NCT00782418|7291802|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
4489847|NCT00782418|7291803|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
4489848|NCT00782418|7291804|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
4489849|NCT00782496|7291820|FG000|Overall Study|Lost to Follow-up|14
4489850|NCT00782496|7291821|FG001|Overall Study|Lost to Follow-up|15
4489851|NCT00782509|7291831|FG000|Overall Study|Adverse Event|20
4489852|NCT00782509|7291832|FG001|Overall Study|Adverse Event|10
4489853|NCT00782509|7291833|FG002|Overall Study|Adverse Event|20
4489854|NCT00782509|7291831|FG000|Overall Study|Lost to Follow-up|1
4489855|NCT00782509|7291832|FG001|Overall Study|Lost to Follow-up|2
4489856|NCT00782509|7291833|FG002|Overall Study|Lost to Follow-up|3
4489857|NCT00782509|7291831|FG000|Overall Study|Withdrawal by Subject|3
4489858|NCT00782509|7291832|FG001|Overall Study|Withdrawal by Subject|5
4489859|NCT00782509|7291833|FG002|Overall Study|Withdrawal by Subject|8
4489860|NCT00782509|7291831|FG000|Overall Study|Non compliance with protocol|2
4489861|NCT00782509|7291832|FG001|Overall Study|Non compliance with protocol|0
4489862|NCT00782509|7291833|FG002|Overall Study|Non compliance with protocol|0
4489863|NCT00782509|7291831|FG000|Overall Study|Other reasons not stated above|5
4489864|NCT00782509|7291832|FG001|Overall Study|Other reasons not stated above|2
4489865|NCT00782509|7291833|FG002|Overall Study|Other reasons not stated above|3
4489866|NCT00782509|7291831|FG000|Overall Study|Lack of Efficacy|10
4489867|NCT00782509|7291832|FG001|Overall Study|Lack of Efficacy|5
4489868|NCT00782509|7291833|FG002|Overall Study|Lack of Efficacy|2
4489869|NCT00782626|7291848|FG000|Overall Study|Adverse Event|1
4489870|NCT00782626|7291848|FG000|Overall Study|Progressive Disease|5
4489871|NCT00782626|7291848|FG000|Overall Study|Other Complicating Disease|1
4489872|NCT00782717|7291865|FG000|Overall Study|Adverse Event|2
4489873|NCT00782717|7291866|FG001|Overall Study|Adverse Event|5
4489874|NCT00782717|7291865|FG000|Overall Study|Patient decision unrelated to AE|6
4489875|NCT00782717|7291866|FG001|Overall Study|Patient decision unrelated to AE|3
4489876|NCT00782717|7291865|FG000|Overall Study|Noncompliance|2
4489877|NCT00782717|7291866|FG001|Overall Study|Noncompliance|1
4489878|NCT00782717|7291865|FG000|Overall Study|Treatment failure|3
4489879|NCT00782717|7291866|FG001|Overall Study|Treatment failure|14
4489880|NCT00782717|7291865|FG000|Overall Study|Enrollment close prior to surgery|1
4489881|NCT00782717|7291866|FG001|Overall Study|Enrollment close prior to surgery|0
4489882|NCT00782717|7291865|FG000|Overall Study|Did not meet entrance criteria|1
4489883|NCT00782717|7291866|FG001|Overall Study|Did not meet entrance criteria|3
4489884|NCT00782717|7291865|FG000|Overall Study|Exited in error|0
4489885|NCT00782717|7291866|FG001|Overall Study|Exited in error|2
4489886|NCT00782795|7291878|FG000|Overall Study|Withdrawal by Subject|1
4489887|NCT00782795|7291879|FG001|Overall Study|Withdrawal by Subject|2
4489888|NCT00782834|7291909|FG000|Treatment Phase|fibrous tumor not GIST|1
4489889|NCT00783094|7291916|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4
4489890|NCT00783094|7291917|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5
4626678|NCT01844687|7492644|FG000|Visit 3|child care problems|1
4489891|NCT00783094|7291918|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5
4489892|NCT00783094|7291916|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0
4489893|NCT00783094|7291917|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2
4590238|NCT01519700|7436040|FG001|Overall Study|Lost to Follow-up|0
4590239|NCT01519700|7436041|FG002|Overall Study|Lost to Follow-up|1
4590240|NCT01519700|7436042|FG003|Overall Study|Lost to Follow-up|1
4590241|NCT01519700|7436039|FG000|Overall Study|Physician Decision|1
4590242|NCT01519700|7436040|FG001|Overall Study|Physician Decision|1
4590243|NCT01519700|7436041|FG002|Overall Study|Physician Decision|3
4590244|NCT01519700|7436042|FG003|Overall Study|Physician Decision|0
4590245|NCT01519700|7436039|FG000|Overall Study|Withdrawal by Subject|5
4590246|NCT01519700|7436040|FG001|Overall Study|Withdrawal by Subject|3
4489894|NCT00783094|7291918|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1
4489895|NCT00783094|7291916|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0
4489896|NCT00783094|7291917|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2
4489897|NCT00783094|7291918|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0
4489898|NCT00783094|7291916|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1
4489899|NCT00783094|7291917|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2
4590247|NCT01519700|7436041|FG002|Overall Study|Withdrawal by Subject|3
4489900|NCT00783094|7291918|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1
4489901|NCT00783094|7291916|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2
4489902|NCT00783094|7291917|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1
4489903|NCT00783094|7291918|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2
4489904|NCT00783094|7291916|FG000|Open-Label Extension Period|Adverse Event|12
4489905|NCT00783094|7291917|FG001|Open-Label Extension Period|Adverse Event|7
4489906|NCT00783094|7291918|FG002|Open-Label Extension Period|Adverse Event|16
4489907|NCT00783094|7291916|FG000|Open-Label Extension Period|Death|0
4489908|NCT00783094|7291917|FG001|Open-Label Extension Period|Death|0
4489909|NCT00783094|7291918|FG002|Open-Label Extension Period|Death|1
4702594|NCT02718417|7619751|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11
4702595|NCT02718417|7619749|FG000|Long-term Follow-up Phase|Lost to Follow-up|8
4702596|NCT02718417|7619750|FG001|Long-term Follow-up Phase|Lost to Follow-up|4
4702597|NCT02718417|7619751|FG002|Long-term Follow-up Phase|Lost to Follow-up|3
4702598|NCT02718417|7619749|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105
4702599|NCT02718417|7619750|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80
4702600|NCT02718417|7619751|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112
4702601|NCT02718417|7619749|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6
4702602|NCT02718417|7619750|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9
4702603|NCT02718417|7619751|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9
4702604|NCT02718417|7619749|FG000|Long-term Follow-up Phase|Other|0
4702605|NCT02718417|7619750|FG001|Long-term Follow-up Phase|Other|2
4702606|NCT02718417|7619751|FG002|Long-term Follow-up Phase|Other|0
4702607|NCT02718625|7619768|FG000|Overall Study|Adverse Event|0
4702608|NCT02718625|7619769|FG001|Overall Study|Adverse Event|1
4702609|NCT02718625|7619768|FG000|Overall Study|Termination of Study by Sponsor|0
4702610|NCT02718625|7619769|FG001|Overall Study|Termination of Study by Sponsor|1
4702611|NCT02718898|7619777|FG000|Blinded Treatment Period|Adverse Event|5
4702612|NCT02718898|7619778|FG001|Blinded Treatment Period|Adverse Event|1
4702613|NCT02718898|7619779|FG002|Blinded Treatment Period|Adverse Event|0
4702614|NCT02718898|7619780|FG003|Blinded Treatment Period|Adverse Event|0
4702615|NCT02718898|7619781|FG004|Blinded Treatment Period|Adverse Event|0
4702616|NCT02718898|7619782|FG005|Blinded Treatment Period|Adverse Event|0
4702617|NCT02718898|7619783|FG006|Blinded Treatment Period|Adverse Event|0
4702618|NCT02718898|7619777|FG000|Blinded Treatment Period|Physician Decision|1
4702619|NCT02718898|7619778|FG001|Blinded Treatment Period|Physician Decision|0
4489910|NCT00783094|7291916|FG000|Open-Label Extension Period|Protocol Violation|4
4489911|NCT00783094|7291917|FG001|Open-Label Extension Period|Protocol Violation|5
4489912|NCT00783094|7291918|FG002|Open-Label Extension Period|Protocol Violation|7
4489913|NCT00783094|7291916|FG000|Open-Label Extension Period|Withdrawal by Subject|1
4489914|NCT00783094|7291917|FG001|Open-Label Extension Period|Withdrawal by Subject|1
4489915|NCT00783094|7291918|FG002|Open-Label Extension Period|Withdrawal by Subject|3
4489916|NCT00783094|7291916|FG000|Open-Label Extension Period|Physician Decision|4
4489917|NCT00783094|7291917|FG001|Open-Label Extension Period|Physician Decision|2
4489918|NCT00783094|7291918|FG002|Open-Label Extension Period|Physician Decision|3
4489919|NCT00783094|7291916|FG000|Open-Label Extension Period|Lack of Efficacy|1
4489920|NCT00783094|7291917|FG001|Open-Label Extension Period|Lack of Efficacy|4
4489921|NCT00783094|7291918|FG002|Open-Label Extension Period|Lack of Efficacy|0
4489922|NCT00783198|7291932|FG000|Overall Study|Adverse Event|15
4489923|NCT00783198|7291933|FG001|Overall Study|Adverse Event|19
4489924|NCT00783198|7291934|FG002|Overall Study|Adverse Event|3
4489925|NCT00783198|7291932|FG000|Overall Study|Lost to Follow-up|11
4489926|NCT00783198|7291933|FG001|Overall Study|Lost to Follow-up|1
4489927|NCT00783198|7291934|FG002|Overall Study|Lost to Follow-up|7
4489928|NCT00783198|7291932|FG000|Overall Study|Withdrawal by Subject|22
4489929|NCT00783198|7291933|FG001|Overall Study|Withdrawal by Subject|14
4489930|NCT00783198|7291934|FG002|Overall Study|Withdrawal by Subject|20
4489931|NCT00783198|7291932|FG000|Overall Study|Noncompliance with protocol|7
4489932|NCT00783198|7291933|FG001|Overall Study|Noncompliance with protocol|7
4489933|NCT00783198|7291934|FG002|Overall Study|Noncompliance with protocol|10
4489934|NCT00783198|7291932|FG000|Overall Study|Did not meet protocol eligibility|0
4489935|NCT00783198|7291933|FG001|Overall Study|Did not meet protocol eligibility|1
4489936|NCT00783198|7291934|FG002|Overall Study|Did not meet protocol eligibility|0
4489937|NCT00783198|7291932|FG000|Overall Study|Administrative|2
4489938|NCT00783198|7291933|FG001|Overall Study|Administrative|1
4489939|NCT00783198|7291934|FG002|Overall Study|Administrative|2
4489940|NCT00783289|7291946|FG000|Overall Study|Protocol Violation|0
4489941|NCT00783289|7291947|FG001|Overall Study|Protocol Violation|1
4489942|NCT00783289|7291948|FG002|Overall Study|Protocol Violation|0
4489943|NCT00783289|7291949|FG003|Overall Study|Protocol Violation|0
4489944|NCT00783302|7291962|FG000|Overall Study|Lost to Follow-up|17
4489945|NCT00783302|7291962|FG000|Overall Study|Technical Problems|11
4489946|NCT00783302|7291962|FG000|Overall Study|Protocol Violation|3
4489947|NCT00783302|7291962|FG000|Overall Study|Physician Decision|1
4489948|NCT00783302|7291962|FG000|Overall Study|Withdrawal by Subject|3
4489949|NCT00783432|7291991|FG000|Overall Study|Adverse Event|22
4489950|NCT00783432|7291992|FG001|Overall Study|Adverse Event|17
4489951|NCT00783432|7291991|FG000|Overall Study|Lack of Efficacy|20
4489952|NCT00783432|7291992|FG001|Overall Study|Lack of Efficacy|21
4489953|NCT00783432|7291991|FG000|Overall Study|Lost to Follow-up|11
4489954|NCT00783432|7291992|FG001|Overall Study|Lost to Follow-up|6
4489955|NCT00783432|7291991|FG000|Overall Study|Withdrawal by Subject|23
4489956|NCT00783432|7291992|FG001|Overall Study|Withdrawal by Subject|20
4489957|NCT00783432|7291991|FG000|Overall Study|subject moved|3
4489958|NCT00783432|7291992|FG001|Overall Study|subject moved|5
4489959|NCT00783432|7291991|FG000|Overall Study|Protocol Violation|6
4489960|NCT00783432|7291992|FG001|Overall Study|Protocol Violation|9
4489961|NCT00783692|7292018|FG000|Induction Phase|Adverse Event|7
4489962|NCT00783692|7292019|FG001|Induction Phase|Adverse Event|9
4489963|NCT00783692|7292020|FG002|Induction Phase|Adverse Event|24
4489964|NCT00783692|7292021|FG003|Induction Phase|Adverse Event|0
4489965|NCT00783692|7292022|FG004|Induction Phase|Adverse Event|0
4489966|NCT00783692|7292023|FG005|Induction Phase|Adverse Event|0
4489967|NCT00783692|7292024|FG006|Induction Phase|Adverse Event|0
4489968|NCT00783692|7292018|FG000|Induction Phase|Protocol Violation|0
4489969|NCT00783692|7292019|FG001|Induction Phase|Protocol Violation|0
4489970|NCT00783692|7292020|FG002|Induction Phase|Protocol Violation|1
4489971|NCT00783692|7292021|FG003|Induction Phase|Protocol Violation|0
4489972|NCT00783692|7292022|FG004|Induction Phase|Protocol Violation|0
4489973|NCT00783692|7292023|FG005|Induction Phase|Protocol Violation|0
4489974|NCT00783692|7292024|FG006|Induction Phase|Protocol Violation|0
4489975|NCT00783692|7292018|FG000|Induction Phase|Lack of Efficacy|1
4489976|NCT00783692|7292019|FG001|Induction Phase|Lack of Efficacy|3
4489977|NCT00783692|7292020|FG002|Induction Phase|Lack of Efficacy|28
4489978|NCT00783692|7292021|FG003|Induction Phase|Lack of Efficacy|0
4489979|NCT00783692|7292022|FG004|Induction Phase|Lack of Efficacy|0
4489980|NCT00783692|7292023|FG005|Induction Phase|Lack of Efficacy|0
4489981|NCT00783692|7292024|FG006|Induction Phase|Lack of Efficacy|0
4489982|NCT00783692|7292018|FG000|Induction Phase|Withdrawal by Subject|3
4489983|NCT00783692|7292019|FG001|Induction Phase|Withdrawal by Subject|9
4489984|NCT00783692|7292020|FG002|Induction Phase|Withdrawal by Subject|16
4489985|NCT00783692|7292021|FG003|Induction Phase|Withdrawal by Subject|0
4489986|NCT00783692|7292022|FG004|Induction Phase|Withdrawal by Subject|0
4489987|NCT00783692|7292023|FG005|Induction Phase|Withdrawal by Subject|0
4489988|NCT00783692|7292024|FG006|Induction Phase|Withdrawal by Subject|0
4489989|NCT00783692|7292018|FG000|Induction Phase|Lost to Follow-up|0
4489990|NCT00783692|7292019|FG001|Induction Phase|Lost to Follow-up|0
4489991|NCT00783692|7292020|FG002|Induction Phase|Lost to Follow-up|3
4489992|NCT00783692|7292021|FG003|Induction Phase|Lost to Follow-up|0
4489993|NCT00783692|7292022|FG004|Induction Phase|Lost to Follow-up|0
4489994|NCT00783692|7292023|FG005|Induction Phase|Lost to Follow-up|0
4489995|NCT00783692|7292024|FG006|Induction Phase|Lost to Follow-up|0
4489996|NCT00783692|7292018|FG000|Induction Phase|Other|0
4489997|NCT00783692|7292019|FG001|Induction Phase|Other|0
4489998|NCT00783692|7292020|FG002|Induction Phase|Other|2
4489999|NCT00783692|7292021|FG003|Induction Phase|Other|0
4490000|NCT00783692|7292022|FG004|Induction Phase|Other|0
4490001|NCT00783692|7292023|FG005|Induction Phase|Other|0
4490002|NCT00783692|7292024|FG006|Induction Phase|Other|0
4490003|NCT00783692|7292018|FG000|Maintenance Phase|Adverse Event|7
4490004|NCT00783692|7292019|FG001|Maintenance Phase|Adverse Event|0
4490005|NCT00783692|7292020|FG002|Maintenance Phase|Adverse Event|0
4490006|NCT00783692|7292021|FG003|Maintenance Phase|Adverse Event|15
4490007|NCT00783692|7292022|FG004|Maintenance Phase|Adverse Event|12
4490008|NCT00783692|7292023|FG005|Maintenance Phase|Adverse Event|9
4490009|NCT00783692|7292024|FG006|Maintenance Phase|Adverse Event|38
4490010|NCT00783692|7292018|FG000|Maintenance Phase|Protocol Violation|0
4490011|NCT00783692|7292019|FG001|Maintenance Phase|Protocol Violation|0
4490012|NCT00783692|7292020|FG002|Maintenance Phase|Protocol Violation|0
4490013|NCT00783692|7292021|FG003|Maintenance Phase|Protocol Violation|1
4490014|NCT00783692|7292022|FG004|Maintenance Phase|Protocol Violation|2
4490015|NCT00783692|7292023|FG005|Maintenance Phase|Protocol Violation|3
4490016|NCT00783692|7292024|FG006|Maintenance Phase|Protocol Violation|4
4490017|NCT00783692|7292018|FG000|Maintenance Phase|Lack of Efficacy|79
4490018|NCT00783692|7292019|FG001|Maintenance Phase|Lack of Efficacy|0
4490019|NCT00783692|7292020|FG002|Maintenance Phase|Lack of Efficacy|0
4490020|NCT00783692|7292021|FG003|Maintenance Phase|Lack of Efficacy|64
4490021|NCT00783692|7292022|FG004|Maintenance Phase|Lack of Efficacy|58
4490022|NCT00783692|7292023|FG005|Maintenance Phase|Lack of Efficacy|48
4490023|NCT00783692|7292024|FG006|Maintenance Phase|Lack of Efficacy|177
4490024|NCT00783692|7292018|FG000|Maintenance Phase|Withdrawal by Subject|7
4702620|NCT02718898|7619779|FG002|Blinded Treatment Period|Physician Decision|0
4702621|NCT02718898|7619780|FG003|Blinded Treatment Period|Physician Decision|0
4702622|NCT02718898|7619781|FG004|Blinded Treatment Period|Physician Decision|0
4702623|NCT02718898|7619782|FG005|Blinded Treatment Period|Physician Decision|0
4702624|NCT02718898|7619783|FG006|Blinded Treatment Period|Physician Decision|0
4702625|NCT02718898|7619777|FG000|Blinded Treatment Period|Lack of Efficacy|1
4702626|NCT02718898|7619778|FG001|Blinded Treatment Period|Lack of Efficacy|0
4702627|NCT02718898|7619779|FG002|Blinded Treatment Period|Lack of Efficacy|0
4702628|NCT02718898|7619780|FG003|Blinded Treatment Period|Lack of Efficacy|0
4702629|NCT02718898|7619781|FG004|Blinded Treatment Period|Lack of Efficacy|0
4490025|NCT00783692|7292019|FG001|Maintenance Phase|Withdrawal by Subject|0
4490026|NCT00783692|7292020|FG002|Maintenance Phase|Withdrawal by Subject|0
4490027|NCT00783692|7292021|FG003|Maintenance Phase|Withdrawal by Subject|7
4702630|NCT02718898|7619782|FG005|Blinded Treatment Period|Lack of Efficacy|0
4702631|NCT02718898|7619783|FG006|Blinded Treatment Period|Lack of Efficacy|0
4702632|NCT02718898|7619777|FG000|Blinded Treatment Period|Lost to Follow-up|2
4702633|NCT02718898|7619778|FG001|Blinded Treatment Period|Lost to Follow-up|0
4702634|NCT02718898|7619779|FG002|Blinded Treatment Period|Lost to Follow-up|0
4702635|NCT02718898|7619780|FG003|Blinded Treatment Period|Lost to Follow-up|0
4702636|NCT02718898|7619781|FG004|Blinded Treatment Period|Lost to Follow-up|0
4702637|NCT02718898|7619782|FG005|Blinded Treatment Period|Lost to Follow-up|0
4702638|NCT02718898|7619783|FG006|Blinded Treatment Period|Lost to Follow-up|0
4702639|NCT02718898|7619777|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0
4702640|NCT02718898|7619778|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0
4702641|NCT02718898|7619779|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1
4702642|NCT02718898|7619780|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1
4702643|NCT02718898|7619781|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0
4702644|NCT02718898|7619782|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0
4702645|NCT02718898|7619783|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0
4702646|NCT02718898|7619777|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
4702647|NCT02718898|7619778|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
4702648|NCT02718898|7619779|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
4702649|NCT02718898|7619780|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2
4702650|NCT02718898|7619781|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
4702651|NCT02718898|7619782|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
4702652|NCT02718898|7619783|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
4702653|NCT02718898|7619777|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
4702654|NCT02718898|7619778|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
4702655|NCT02718898|7619779|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1
4702656|NCT02718898|7619780|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3
4702657|NCT02718898|7619781|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
4702658|NCT02718898|7619782|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
4702659|NCT02718898|7619783|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
4702660|NCT02718898|7619777|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
4702661|NCT02718898|7619778|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
4702662|NCT02718898|7619779|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1
4702663|NCT02718898|7619780|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2
4702664|NCT02718898|7619781|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
4702665|NCT02718898|7619782|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
4702666|NCT02718898|7619783|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
4702667|NCT02718898|7619777|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
4702668|NCT02718898|7619778|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
4702669|NCT02718898|7619779|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
4702670|NCT02718898|7619780|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1
4702671|NCT02718898|7619781|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
4702672|NCT02718898|7619782|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
4702673|NCT02718898|7619783|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
4702674|NCT02718898|7619777|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
4702675|NCT02718898|7619778|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
4702676|NCT02718898|7619779|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
4702677|NCT02718898|7619780|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1
4702678|NCT02718898|7619781|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
4702679|NCT02718898|7619782|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
4702680|NCT02718898|7619783|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
4702681|NCT02718898|7619777|FG000|Post Treatment Follow-up Period|Adverse Event|0
4702682|NCT02718898|7619778|FG001|Post Treatment Follow-up Period|Adverse Event|0
4702683|NCT02718898|7619779|FG002|Post Treatment Follow-up Period|Adverse Event|0
4702684|NCT02718898|7619780|FG003|Post Treatment Follow-up Period|Adverse Event|0
4702685|NCT02718898|7619781|FG004|Post Treatment Follow-up Period|Adverse Event|0
4702686|NCT02718898|7619782|FG005|Post Treatment Follow-up Period|Adverse Event|1
4702687|NCT02718898|7619783|FG006|Post Treatment Follow-up Period|Adverse Event|1
4702688|NCT02718898|7619777|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0
4702689|NCT02718898|7619778|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0
4702690|NCT02718898|7619779|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0
4702691|NCT02718898|7619780|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0
4702692|NCT02718898|7619781|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1
4702693|NCT02718898|7619782|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5
4702694|NCT02718898|7619783|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1
4702695|NCT02718898|7619777|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0
4702696|NCT02718898|7619778|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0
4702697|NCT02718898|7619779|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0
4702698|NCT02718898|7619780|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0
4771246|NCT02978781|7748152|FG001|Part B|Withdrawal by Subject|0
4626679|NCT01844687|7492644|FG000|Visit 4|Pregnancy|1
4702699|NCT02718898|7619781|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0
4702700|NCT02718898|7619782|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5
4702701|NCT02718898|7619783|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3
4702702|NCT02719028|7619809|FG000|Overall Study|Adverse Event|2
4702703|NCT02719028|7619810|FG001|Overall Study|Adverse Event|1
4702704|NCT02719028|7619811|FG002|Overall Study|Adverse Event|4
4702705|NCT02719028|7619812|FG003|Overall Study|Adverse Event|8
4702706|NCT02719028|7619809|FG000|Overall Study|Physician Decision|0
4702707|NCT02719028|7619810|FG001|Overall Study|Physician Decision|1
4702708|NCT02719028|7619811|FG002|Overall Study|Physician Decision|1
4702709|NCT02719028|7619812|FG003|Overall Study|Physician Decision|1
4702710|NCT02719028|7619809|FG000|Overall Study|Use of prohibited medication|0
4702711|NCT02719028|7619810|FG001|Overall Study|Use of prohibited medication|0
4702712|NCT02719028|7619811|FG002|Overall Study|Use of prohibited medication|1
4702713|NCT02719028|7619812|FG003|Overall Study|Use of prohibited medication|0
4702714|NCT02719028|7619809|FG000|Overall Study|Protocol Violation|0
4702715|NCT02719028|7619810|FG001|Overall Study|Protocol Violation|0
4702716|NCT02719028|7619811|FG002|Overall Study|Protocol Violation|0
4702717|NCT02719028|7619812|FG003|Overall Study|Protocol Violation|1
4702718|NCT02719171|7619840|FG000|Overall Study|Adverse Event|1
4702719|NCT02719171|7619841|FG001|Overall Study|Adverse Event|2
4702720|NCT02719171|7619842|FG002|Overall Study|Adverse Event|0
4702721|NCT02719171|7619843|FG003|Overall Study|Adverse Event|0
4702722|NCT02719171|7619844|FG004|Overall Study|Adverse Event|2
4702723|NCT02719171|7619840|FG000|Overall Study|Lost to Follow-up|0
4702724|NCT02719171|7619841|FG001|Overall Study|Lost to Follow-up|0
4702725|NCT02719171|7619842|FG002|Overall Study|Lost to Follow-up|1
4702726|NCT02719171|7619843|FG003|Overall Study|Lost to Follow-up|0
4702727|NCT02719171|7619844|FG004|Overall Study|Lost to Follow-up|0
4702728|NCT02719171|7619840|FG000|Overall Study|Subject Withdrawal|0
4702729|NCT02719171|7619841|FG001|Overall Study|Subject Withdrawal|2
4702730|NCT02719171|7619842|FG002|Overall Study|Subject Withdrawal|2
4702731|NCT02719171|7619843|FG003|Overall Study|Subject Withdrawal|1
4702732|NCT02719171|7619844|FG004|Overall Study|Subject Withdrawal|0
4702733|NCT02719171|7619840|FG000|Overall Study|Other|0
4702734|NCT02719171|7619841|FG001|Overall Study|Other|0
4702735|NCT02719171|7619842|FG002|Overall Study|Other|0
4702736|NCT02719171|7619843|FG003|Overall Study|Other|1
4702737|NCT02719171|7619844|FG004|Overall Study|Other|0
4702738|NCT02719353|7619859|FG000|First Intervention|Physician Decision|0
4702739|NCT02719353|7619860|FG001|First Intervention|Physician Decision|1
4702740|NCT02719743|7619888|FG000|Overall Study|Consent withdrawal|0
4702741|NCT02719743|7619889|FG001|Overall Study|Consent withdrawal|2
4702742|NCT02719743|7619890|FG002|Overall Study|Consent withdrawal|0
4702743|NCT02719743|7619891|FG003|Overall Study|Consent withdrawal|1
4702744|NCT02719743|7619892|FG004|Overall Study|Consent withdrawal|0
4702745|NCT02719743|7619888|FG000|Overall Study|Migrated/moved from study area|0
4702746|NCT02719743|7619889|FG001|Overall Study|Migrated/moved from study area|0
4702747|NCT02719743|7619890|FG002|Overall Study|Migrated/moved from study area|0
4702748|NCT02719743|7619891|FG003|Overall Study|Migrated/moved from study area|0
4702749|NCT02719743|7619892|FG004|Overall Study|Migrated/moved from study area|2
4702750|NCT02719743|7619888|FG000|Overall Study|Lost to Follow-up|1
4702751|NCT02719743|7619889|FG001|Overall Study|Lost to Follow-up|1
4702752|NCT02719743|7619890|FG002|Overall Study|Lost to Follow-up|0
4702753|NCT02719743|7619891|FG003|Overall Study|Lost to Follow-up|0
4702754|NCT02719743|7619892|FG004|Overall Study|Lost to Follow-up|0
4702755|NCT02720042|7619913|FG000|Overall Study|Death|3
4702756|NCT02720042|7619913|FG000|Overall Study|Lost to Follow-up|4
4702757|NCT02720042|7619913|FG000|Overall Study|Withdrawal by Subject|1
4702758|NCT02720042|7619913|FG000|Overall Study|Physician Decision|3
4702759|NCT02720042|7619913|FG000|Overall Study|Phasix Mesh explanted|1
4702760|NCT02720042|7619913|FG000|Overall Study|unable due to non-study-related illness|3
4702761|NCT02720081|7619919|FG000|Overall Study|Adverse Event|0
4702762|NCT02720081|7619920|FG001|Overall Study|Adverse Event|3
4702763|NCT02720081|7619919|FG000|Overall Study|Protocol Violation|4
4702764|NCT02720081|7619920|FG001|Overall Study|Protocol Violation|1
4702765|NCT02720198|7619932|FG000|Overall Study|Withdrawal by Subject|0
4702766|NCT02720198|7619933|FG001|Overall Study|Withdrawal by Subject|1
4702767|NCT02720484|7619943|FG000|Treatment on Study|Adverse Event|1
4702768|NCT02720484|7619943|FG000|Treatment on Study|Withdrawal by Subject|1
4702769|NCT02720484|7619943|FG000|Treatment on Study|Progressive Disease|4
4702770|NCT02720484|7619943|FG000|Follow Up for 2 Years|Withdrawal by Subject|1
4702771|NCT02720484|7619943|FG000|Follow Up for 2 Years|Death|3
4626680|NCT01844687|7492644|FG000|Visit 4|Lost to Follow-up|1
4626681|NCT01844687|7492644|FG000|Visit 4|Withdrawal by Subject|2
4626682|NCT01844700|7492668|FG000|Overall Study|Lack of Efficacy|1
4626683|NCT01844700|7492669|FG001|Overall Study|Lack of Efficacy|0
4626684|NCT01844700|7492668|FG000|Overall Study|refused medication switch|1
4626685|NCT01844700|7492669|FG001|Overall Study|refused medication switch|0
4626686|NCT01844700|7492668|FG000|Overall Study|Withdrawal by Subject|1
4626687|NCT01844700|7492669|FG001|Overall Study|Withdrawal by Subject|0
4702772|NCT02720484|7619943|FG000|Follow Up for 2 Years|Lost to Follow-up|2
4702773|NCT02720523|7619951|FG000|Period 1: Placebo-controlled Period|Adverse Event|0
4702774|NCT02720523|7619952|FG001|Period 1: Placebo-controlled Period|Adverse Event|0
4702775|NCT02720523|7619953|FG002|Period 1: Placebo-controlled Period|Adverse Event|1
4702776|NCT02720523|7619954|FG003|Period 1: Placebo-controlled Period|Adverse Event|5
4702777|NCT02720523|7619955|FG004|Period 1: Placebo-controlled Period|Adverse Event|0
4702778|NCT02720523|7619956|FG005|Period 1: Placebo-controlled Period|Adverse Event|0
4702779|NCT02720523|7619957|FG006|Period 1: Placebo-controlled Period|Adverse Event|0
4702780|NCT02720523|7619951|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1
4702781|NCT02720523|7619952|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
4702782|NCT02720523|7619953|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
4702783|NCT02720523|7619954|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
4702784|NCT02720523|7619955|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
4702785|NCT02720523|7619956|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
4702786|NCT02720523|7619957|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
4702787|NCT02720523|7619951|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1
4702788|NCT02720523|7619952|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0
4702789|NCT02720523|7619953|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0
4702790|NCT02720523|7619954|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0
4702791|NCT02720523|7619955|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0
4702792|NCT02720523|7619956|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0
4702793|NCT02720523|7619957|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0
4702794|NCT02720523|7619951|FG000|Period 1: Placebo-controlled Period|Other|0
4702795|NCT02720523|7619952|FG001|Period 1: Placebo-controlled Period|Other|0
4702796|NCT02720523|7619953|FG002|Period 1: Placebo-controlled Period|Other|1
4702797|NCT02720523|7619954|FG003|Period 1: Placebo-controlled Period|Other|1
4702798|NCT02720523|7619955|FG004|Period 1: Placebo-controlled Period|Other|0
4702799|NCT02720523|7619956|FG005|Period 1: Placebo-controlled Period|Other|0
4702800|NCT02720523|7619957|FG006|Period 1: Placebo-controlled Period|Other|0
4702801|NCT02720523|7619951|FG000|Period 2: Long-term Extension Period|Ongoing|0
4702802|NCT02720523|7619952|FG001|Period 2: Long-term Extension Period|Ongoing|0
4702803|NCT02720523|7619953|FG002|Period 2: Long-term Extension Period|Ongoing|0
4702804|NCT02720523|7619954|FG003|Period 2: Long-term Extension Period|Ongoing|0
4702805|NCT02720523|7619955|FG004|Period 2: Long-term Extension Period|Ongoing|57
4702806|NCT02720523|7619956|FG005|Period 2: Long-term Extension Period|Ongoing|54
4702807|NCT02720523|7619957|FG006|Period 2: Long-term Extension Period|Ongoing|45
4702808|NCT02720523|7619951|FG000|Period 2: Long-term Extension Period|Adverse Event|0
4702809|NCT02720523|7619952|FG001|Period 2: Long-term Extension Period|Adverse Event|0
4702810|NCT02720523|7619953|FG002|Period 2: Long-term Extension Period|Adverse Event|0
4702811|NCT02720523|7619954|FG003|Period 2: Long-term Extension Period|Adverse Event|0
4702812|NCT02720523|7619955|FG004|Period 2: Long-term Extension Period|Adverse Event|4
4702813|NCT02720523|7619956|FG005|Period 2: Long-term Extension Period|Adverse Event|7
4702814|NCT02720523|7619957|FG006|Period 2: Long-term Extension Period|Adverse Event|11
4702815|NCT02720523|7619951|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0
4702816|NCT02720523|7619952|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0
4702817|NCT02720523|7619953|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0
4702818|NCT02720523|7619954|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0
4702819|NCT02720523|7619955|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2
4702820|NCT02720523|7619956|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1
4702821|NCT02720523|7619957|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1
4702822|NCT02720523|7619951|FG000|Period 2: Long-term Extension Period|Other|0
4702823|NCT02720523|7619952|FG001|Period 2: Long-term Extension Period|Other|0
4702824|NCT02720523|7619953|FG002|Period 2: Long-term Extension Period|Other|0
4702825|NCT02720523|7619954|FG003|Period 2: Long-term Extension Period|Other|0
4702826|NCT02720523|7619955|FG004|Period 2: Long-term Extension Period|Other|2
4702827|NCT02720523|7619956|FG005|Period 2: Long-term Extension Period|Other|0
4702828|NCT02720523|7619957|FG006|Period 2: Long-term Extension Period|Other|3
4702829|NCT02720536|7619970|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11
4702830|NCT02720536|7619970|FG000|Overall Study|PR - pregnancy|2
4702831|NCT02720536|7619970|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2
4702832|NCT02720536|7619970|FG000|Overall Study|PR - death|1
4702833|NCT02720536|7619970|FG000|Overall Study|PR - adverse event|1
4702834|NCT02720536|7619970|FG000|Overall Study|PR - abnormal lab value(s)|1
4702835|NCT02720536|7619970|FG000|Overall Study|PR- unwilling to comply with procedures|1
4702836|NCT02720757|7619984|FG000|Overall Study|Other reason|5
4702837|NCT02720757|7619984|FG000|Overall Study|Loss of contact|4
4702838|NCT02720757|7619984|FG000|Overall Study|Informed consent withdrawal|1
4702839|NCT02720757|7619984|FG000|Overall Study|Patients wish to withdraw|2
4702840|NCT02720757|7619984|FG000|Overall Study|Missing|3
4702841|NCT02720757|7619984|FG000|Overall Study|General exclusion|3
4702842|NCT02721147|7620010|FG000|Overall Study|Lost to Follow-up|2
4702843|NCT02721147|7620011|FG001|Overall Study|Lost to Follow-up|0
4702844|NCT02721147|7620012|FG002|Overall Study|Lost to Follow-up|0
4702845|NCT02721251|7620023|FG000|Overall Study|Withdrawal by Subject|8
4702846|NCT02721251|7620024|FG001|Overall Study|Withdrawal by Subject|7
4702847|NCT02721251|7620025|FG002|Overall Study|Withdrawal by Subject|9
4702848|NCT02721251|7620023|FG000|Overall Study|poor adherence|2
4702849|NCT02721251|7620024|FG001|Overall Study|poor adherence|2
4702850|NCT02721251|7620025|FG002|Overall Study|poor adherence|2
4702851|NCT02721355|7620036|FG000|Overall Study|Lost to Follow-up|6
4702852|NCT02721355|7620037|FG001|Overall Study|Lost to Follow-up|1
4702853|NCT02721875|7620049|FG000|Overall Study|Progressive disease/relapse|1
4702854|NCT02721875|7620050|FG001|Overall Study|Progressive disease/relapse|0
4702855|NCT02721966|7620059|FG000|Overall Study|Protocol Violation|1
4702856|NCT02721966|7620060|FG001|Overall Study|Protocol Violation|0
4702857|NCT02721966|7620061|FG002|Overall Study|Protocol Violation|0
4702858|NCT02721966|7620062|FG003|Overall Study|Protocol Violation|0
4702859|NCT02721966|7620063|FG004|Overall Study|Protocol Violation|0
4702860|NCT02721966|7620059|FG000|Overall Study|Withdrawal by Subject|9
4702861|NCT02721966|7620060|FG001|Overall Study|Withdrawal by Subject|2
4702862|NCT02721966|7620061|FG002|Overall Study|Withdrawal by Subject|3
4702863|NCT02721966|7620062|FG003|Overall Study|Withdrawal by Subject|7
4702864|NCT02721966|7620063|FG004|Overall Study|Withdrawal by Subject|0
4702865|NCT02721966|7620059|FG000|Overall Study|Adverse Event|4
4702866|NCT02721966|7620060|FG001|Overall Study|Adverse Event|4
4702867|NCT02721966|7620061|FG002|Overall Study|Adverse Event|3
4702868|NCT02721966|7620062|FG003|Overall Study|Adverse Event|0
4702869|NCT02721966|7620063|FG004|Overall Study|Adverse Event|0
4702870|NCT02721966|7620059|FG000|Overall Study|Death|1
4702871|NCT02721966|7620060|FG001|Overall Study|Death|0
4702872|NCT02721966|7620061|FG002|Overall Study|Death|0
4702873|NCT02721966|7620062|FG003|Overall Study|Death|0
4702874|NCT02721966|7620063|FG004|Overall Study|Death|0
4702875|NCT02721966|7620059|FG000|Overall Study|Lack of Efficacy|7
4702876|NCT02721966|7620060|FG001|Overall Study|Lack of Efficacy|4
4702877|NCT02721966|7620061|FG002|Overall Study|Lack of Efficacy|0
4702878|NCT02721966|7620062|FG003|Overall Study|Lack of Efficacy|0
4702879|NCT02721966|7620063|FG004|Overall Study|Lack of Efficacy|0
4702880|NCT02721966|7620059|FG000|Overall Study|Lost to Follow-up|0
4702881|NCT02721966|7620060|FG001|Overall Study|Lost to Follow-up|0
4702882|NCT02721966|7620061|FG002|Overall Study|Lost to Follow-up|3
4702883|NCT02721966|7620062|FG003|Overall Study|Lost to Follow-up|0
4702884|NCT02721966|7620063|FG004|Overall Study|Lost to Follow-up|0
4702885|NCT02721966|7620059|FG000|Overall Study|Physician Decision|1
4702886|NCT02721966|7620060|FG001|Overall Study|Physician Decision|1
4702887|NCT02721966|7620061|FG002|Overall Study|Physician Decision|0
4702888|NCT02721966|7620062|FG003|Overall Study|Physician Decision|0
4702889|NCT02721966|7620063|FG004|Overall Study|Physician Decision|0
4702890|NCT02721966|7620059|FG000|Overall Study|Pregnancy|1
4702891|NCT02721966|7620060|FG001|Overall Study|Pregnancy|0
4702892|NCT02721966|7620061|FG002|Overall Study|Pregnancy|0
4702893|NCT02721966|7620062|FG003|Overall Study|Pregnancy|0
4702894|NCT02721966|7620063|FG004|Overall Study|Pregnancy|0
4702895|NCT02721966|7620059|FG000|Overall Study|Did not continue to period 2|5
4702896|NCT02721966|7620060|FG001|Overall Study|Did not continue to period 2|12
4702897|NCT02721966|7620061|FG002|Overall Study|Did not continue to period 2|0
4702898|NCT02721966|7620062|FG003|Overall Study|Did not continue to period 2|0
4702899|NCT02721966|7620063|FG004|Overall Study|Did not continue to period 2|5
4702900|NCT02722044|7620071|FG000|Overall Study|Adverse Event|2
4702901|NCT02722044|7620071|FG000|Overall Study|Physician Decision|1
4702902|NCT02722044|7620071|FG000|Overall Study|Withdrawal by Subject|1
4702903|NCT02722044|7620071|FG000|Overall Study|Did Not Meet Criteria at Week 14|1
4702904|NCT02722148|7620076|FG000|Overall Study|Lost to Follow-up|2
4702905|NCT02722148|7620076|FG000|Overall Study|Non compliant with treatment regimen|3
4702906|NCT02722278|7620092|FG000|Overall Study|Withdrawal by Subject|5
4702907|NCT02722278|7620093|FG001|Overall Study|Withdrawal by Subject|3
4702908|NCT02722278|7620092|FG000|Overall Study|Adverse Event|4
4702909|NCT02722278|7620093|FG001|Overall Study|Adverse Event|1
4702910|NCT02722278|7620092|FG000|Overall Study|Lost to Follow-up|2
4702911|NCT02722278|7620093|FG001|Overall Study|Lost to Follow-up|0
4702912|NCT02722278|7620092|FG000|Overall Study|Protocol Violation|1
4702913|NCT02722278|7620093|FG001|Overall Study|Protocol Violation|0
4702914|NCT02722278|7620092|FG000|Overall Study|High PSA pre-study/ not eligible|0
4702915|NCT02722278|7620093|FG001|Overall Study|High PSA pre-study/ not eligible|1
4702916|NCT02722278|7620092|FG000|Overall Study|Subject declined after tx assignment|0
4702917|NCT02722278|7620093|FG001|Overall Study|Subject declined after tx assignment|1
4702918|NCT02722278|7620092|FG000|Overall Study|Site closure not study related|0
4702919|NCT02722278|7620093|FG001|Overall Study|Site closure not study related|1
4702920|NCT02722304|7620106|FG000|Overall Study|Study Terminated by Sponsor|1
4702921|NCT02722304|7620107|FG001|Overall Study|Study Terminated by Sponsor|0
4702922|NCT02722304|7620108|FG002|Overall Study|Study Terminated by Sponsor|2
4702923|NCT02722304|7620109|FG003|Overall Study|Study Terminated by Sponsor|1
4702924|NCT02722304|7620110|FG004|Overall Study|Study Terminated by Sponsor|1
4702925|NCT02722304|7620106|FG000|Overall Study|Other|0
4702926|NCT02722304|7620107|FG001|Overall Study|Other|0
4702927|NCT02722304|7620108|FG002|Overall Study|Other|0
4702928|NCT02722304|7620109|FG003|Overall Study|Other|1
4702929|NCT02722304|7620110|FG004|Overall Study|Other|1
4702930|NCT02722499|7620137|FG000|Overall Study|Lost to Follow-up|2
4702931|NCT02722499|7620138|FG001|Overall Study|Lost to Follow-up|0
4702932|NCT02722499|7620139|FG002|Overall Study|Lost to Follow-up|1
4490028|NCT00783692|7292022|FG004|Maintenance Phase|Withdrawal by Subject|6
4490029|NCT00783692|7292023|FG005|Maintenance Phase|Withdrawal by Subject|9
4490030|NCT00783692|7292024|FG006|Maintenance Phase|Withdrawal by Subject|24
4490031|NCT00783692|7292018|FG000|Maintenance Phase|Lost to Follow-up|2
4490032|NCT00783692|7292019|FG001|Maintenance Phase|Lost to Follow-up|0
4490033|NCT00783692|7292020|FG002|Maintenance Phase|Lost to Follow-up|0
4490034|NCT00783692|7292021|FG003|Maintenance Phase|Lost to Follow-up|1
4490035|NCT00783692|7292022|FG004|Maintenance Phase|Lost to Follow-up|3
4490036|NCT00783692|7292023|FG005|Maintenance Phase|Lost to Follow-up|2
4490037|NCT00783692|7292024|FG006|Maintenance Phase|Lost to Follow-up|5
4490038|NCT00783692|7292018|FG000|Maintenance Phase|Other|0
4490039|NCT00783692|7292019|FG001|Maintenance Phase|Other|0
4490040|NCT00783692|7292020|FG002|Maintenance Phase|Other|0
4490041|NCT00783692|7292021|FG003|Maintenance Phase|Other|1
4490042|NCT00783692|7292022|FG004|Maintenance Phase|Other|0
4490043|NCT00783692|7292023|FG005|Maintenance Phase|Other|1
4490044|NCT00783692|7292024|FG006|Maintenance Phase|Other|1
4490045|NCT00783705|7292039|FG000|Overall Study|Adverse Event|2
4490046|NCT00783705|7292040|FG001|Overall Study|Adverse Event|0
4490047|NCT00783705|7292039|FG000|Overall Study|Withdrawal by Subject|3
4490048|NCT00783705|7292040|FG001|Overall Study|Withdrawal by Subject|2
4490049|NCT00783705|7292039|FG000|Overall Study|Lost to Follow-up|1
4490050|NCT00783705|7292040|FG001|Overall Study|Lost to Follow-up|3
4490051|NCT00783718|7292049|FG000|Induction Phase|Adverse Event|4
4490052|NCT00783718|7292050|FG001|Induction Phase|Adverse Event|0
4490053|NCT00783718|7292051|FG002|Induction Phase|Adverse Event|7
4490054|NCT00783718|7292052|FG003|Induction Phase|Adverse Event|0
4490055|NCT00783718|7292053|FG004|Induction Phase|Adverse Event|0
4490056|NCT00783718|7292054|FG005|Induction Phase|Adverse Event|0
4490057|NCT00783718|7292055|FG006|Induction Phase|Adverse Event|0
4490058|NCT00783718|7292049|FG000|Induction Phase|Protocol Violation|1
4490059|NCT00783718|7292050|FG001|Induction Phase|Protocol Violation|1
4490060|NCT00783718|7292051|FG002|Induction Phase|Protocol Violation|6
4626688|NCT01844700|7492668|FG000|Overall Study|stopped taking meds|0
4626689|NCT01844700|7492669|FG001|Overall Study|stopped taking meds|1
4626690|NCT01844765|7492677|FG000|Overall Study|Adverse Event|6
4626691|NCT01844765|7492678|FG001|Overall Study|Adverse Event|8
4626692|NCT01844765|7492677|FG000|Overall Study|Withdrawal by Subject|2
4626693|NCT01844765|7492678|FG001|Overall Study|Withdrawal by Subject|3
4626694|NCT01844765|7492677|FG000|Overall Study|Disease progression|1
4626695|NCT01844765|7492678|FG001|Overall Study|Disease progression|0
4626696|NCT01844765|7492677|FG000|Overall Study|Administrative problems|3
4626697|NCT01844765|7492678|FG001|Overall Study|Administrative problems|4
4626698|NCT01844765|7492677|FG000|Overall Study|Protocol deviation|2
4626699|NCT01844765|7492678|FG001|Overall Study|Protocol deviation|0
4626700|NCT01844765|7492677|FG000|Overall Study|Untreated|1
4626701|NCT01844765|7492678|FG001|Overall Study|Untreated|0
4626702|NCT01844778|7492692|FG000|Overall Study|Protocol deviation|0
4626703|NCT01844778|7492693|FG001|Overall Study|Protocol deviation|1
4626704|NCT01844778|7492694|FG002|Overall Study|Protocol deviation|2
4626705|NCT01844778|7492692|FG000|Overall Study|Withdrawal by Subject|2
4626706|NCT01844778|7492693|FG001|Overall Study|Withdrawal by Subject|0
4626707|NCT01844778|7492694|FG002|Overall Study|Withdrawal by Subject|0
4626708|NCT01844778|7492692|FG000|Overall Study|Adverse Event|0
4626709|NCT01844778|7492693|FG001|Overall Study|Adverse Event|2
4626710|NCT01844778|7492694|FG002|Overall Study|Adverse Event|2
4626711|NCT01844817|7492708|FG000|Enrolled and Randomized|Withdrawal by Subject|2
4626712|NCT01844817|7492709|FG001|Enrolled and Randomized|Withdrawal by Subject|3
4626713|NCT01844817|7492708|FG000|Treatment|Progressive Disease|27
4626714|NCT01844817|7492709|FG001|Treatment|Progressive Disease|36
4626715|NCT01844817|7492708|FG000|Treatment|Adverse Event|17
4626716|NCT01844817|7492709|FG001|Treatment|Adverse Event|9
4626717|NCT01844817|7492708|FG000|Treatment|Withdrawal by Subject|10
4626718|NCT01844817|7492709|FG001|Treatment|Withdrawal by Subject|6
4626719|NCT01844817|7492708|FG000|Treatment|Death|10
4626720|NCT01844817|7492709|FG001|Treatment|Death|8
4626721|NCT01844817|7492708|FG000|Treatment|Lost to Follow-up|0
4626722|NCT01844817|7492709|FG001|Treatment|Lost to Follow-up|1
4490061|NCT00783718|7292052|FG003|Induction Phase|Protocol Violation|0
4490062|NCT00783718|7292053|FG004|Induction Phase|Protocol Violation|0
4490063|NCT00783718|7292054|FG005|Induction Phase|Protocol Violation|0
4490064|NCT00783718|7292055|FG006|Induction Phase|Protocol Violation|0
4626723|NCT01844817|7492708|FG000|Treatment|Other|0
4626724|NCT01844817|7492709|FG001|Treatment|Other|3
4626725|NCT01844830|7492718|FG000|Overall Study|Withdrawal by Subject|1
4626726|NCT01844830|7492719|FG001|Overall Study|Withdrawal by Subject|0
4626727|NCT01844895|7492725|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1
4626728|NCT01844895|7492725|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1
4626729|NCT01844895|7492725|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1
4626730|NCT01844895|7492725|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1
4626731|NCT01844895|7492725|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1
4626732|NCT01844895|7492725|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3
4626733|NCT01844895|7492725|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1
4626734|NCT01845025|7492740|FG000|Overall Study|Adverse Event|6
4702933|NCT02722928|7620166|FG000|Overall Study|Standard CT was not as required per prot|5
4702934|NCT02722928|7620167|FG001|Overall Study|Standard CT was not as required per prot|13
4702935|NCT02722928|7620166|FG000|Overall Study|Required Intraoperative MRI|5
4702936|NCT02722928|7620167|FG001|Overall Study|Required Intraoperative MRI|7
4702937|NCT02722967|7620180|FG000|Overall Study|Adverse Event|1
4702938|NCT02722967|7620181|FG001|Overall Study|Adverse Event|0
4702939|NCT02722967|7620182|FG002|Overall Study|Adverse Event|0
4702940|NCT02722967|7620180|FG000|Overall Study|Lost to Follow-up|0
4702941|NCT02722967|7620181|FG001|Overall Study|Lost to Follow-up|1
4702942|NCT02722967|7620182|FG002|Overall Study|Lost to Follow-up|0
4702943|NCT02722967|7620180|FG000|Overall Study|Non-compliance with patch wearing|2
4702944|NCT02722967|7620181|FG001|Overall Study|Non-compliance with patch wearing|1
4702945|NCT02722967|7620182|FG002|Overall Study|Non-compliance with patch wearing|1
4702946|NCT02722967|7620180|FG000|Overall Study|Withdrawal by Subject|1
4702947|NCT02722967|7620181|FG001|Overall Study|Withdrawal by Subject|0
4702948|NCT02722967|7620182|FG002|Overall Study|Withdrawal by Subject|1
4702949|NCT02722967|7620180|FG000|Overall Study|Physician Decision|1
4702950|NCT02722967|7620181|FG001|Overall Study|Physician Decision|0
4702951|NCT02722967|7620182|FG002|Overall Study|Physician Decision|0
4702952|NCT02722967|7620180|FG000|Overall Study|Non-adherence of the patch to the skin|0
4490065|NCT00783718|7292049|FG000|Induction Phase|Lack of Efficacy|5
4626735|NCT01845025|7492741|FG001|Overall Study|Adverse Event|3
4626736|NCT01845025|7492740|FG000|Overall Study|Unsatisfactory therapeutic effect|4
4626737|NCT01845025|7492741|FG001|Overall Study|Unsatisfactory therapeutic effect|2
4626738|NCT01845025|7492740|FG000|Overall Study|Withdrawal by Subject|48
4626739|NCT01845025|7492741|FG001|Overall Study|Withdrawal by Subject|44
4626740|NCT01845025|7492740|FG000|Overall Study|Lost to Follow-up|13
4626741|NCT01845025|7492741|FG001|Overall Study|Lost to Follow-up|13
4626742|NCT01845025|7492740|FG000|Overall Study|Administrative problems|8
4626743|NCT01845025|7492741|FG001|Overall Study|Administrative problems|8
4626744|NCT01845025|7492740|FG000|Overall Study|Death|2
4626745|NCT01845025|7492741|FG001|Overall Study|Death|0
4626746|NCT01845025|7492740|FG000|Overall Study|Protocol deviation|3
4626747|NCT01845025|7492741|FG001|Overall Study|Protocol deviation|6
4626748|NCT01845025|7492740|FG000|Overall Study|Missing|1
4626749|NCT01845025|7492741|FG001|Overall Study|Missing|1
4626750|NCT01845077|7492750|FG000|Washout Period|Lost to Follow-up|0
4626751|NCT01845077|7492751|FG001|Washout Period|Lost to Follow-up|1
4626752|NCT01845077|7492752|FG002|Washout Period|Lost to Follow-up|0
4626753|NCT01845077|7492753|FG003|Washout Period|Lost to Follow-up|1
4702953|NCT02722967|7620181|FG001|Overall Study|Non-adherence of the patch to the skin|0
4702954|NCT02722967|7620182|FG002|Overall Study|Non-adherence of the patch to the skin|2
4490066|NCT00783718|7292050|FG001|Induction Phase|Lack of Efficacy|2
4490067|NCT00783718|7292051|FG002|Induction Phase|Lack of Efficacy|14
4490068|NCT00783718|7292052|FG003|Induction Phase|Lack of Efficacy|0
4490069|NCT00783718|7292053|FG004|Induction Phase|Lack of Efficacy|0
4490070|NCT00783718|7292054|FG005|Induction Phase|Lack of Efficacy|0
4490071|NCT00783718|7292055|FG006|Induction Phase|Lack of Efficacy|0
4490072|NCT00783718|7292049|FG000|Induction Phase|Withdrawal by Subject|3
4490073|NCT00783718|7292050|FG001|Induction Phase|Withdrawal by Subject|4
4490074|NCT00783718|7292051|FG002|Induction Phase|Withdrawal by Subject|8
4490075|NCT00783718|7292052|FG003|Induction Phase|Withdrawal by Subject|0
4490076|NCT00783718|7292053|FG004|Induction Phase|Withdrawal by Subject|0
4490077|NCT00783718|7292054|FG005|Induction Phase|Withdrawal by Subject|0
4490078|NCT00783718|7292055|FG006|Induction Phase|Withdrawal by Subject|0
4490079|NCT00783718|7292049|FG000|Induction Phase|Lost to Follow-up|1
4490080|NCT00783718|7292050|FG001|Induction Phase|Lost to Follow-up|0
4490081|NCT00783718|7292051|FG002|Induction Phase|Lost to Follow-up|1
4490082|NCT00783718|7292052|FG003|Induction Phase|Lost to Follow-up|0
4490083|NCT00783718|7292053|FG004|Induction Phase|Lost to Follow-up|0
4490084|NCT00783718|7292054|FG005|Induction Phase|Lost to Follow-up|0
4490085|NCT00783718|7292055|FG006|Induction Phase|Lost to Follow-up|0
4490086|NCT00783718|7292049|FG000|Maintenance Phase|Adverse Event|12
4490087|NCT00783718|7292050|FG001|Maintenance Phase|Adverse Event|0
4490088|NCT00783718|7292051|FG002|Maintenance Phase|Adverse Event|0
4490089|NCT00783718|7292052|FG003|Maintenance Phase|Adverse Event|15
4490090|NCT00783718|7292053|FG004|Maintenance Phase|Adverse Event|7
4490091|NCT00783718|7292054|FG005|Maintenance Phase|Adverse Event|6
4490092|NCT00783718|7292055|FG006|Maintenance Phase|Adverse Event|16
4490093|NCT00783718|7292049|FG000|Maintenance Phase|Protocol Violation|1
4490094|NCT00783718|7292050|FG001|Maintenance Phase|Protocol Violation|0
4490095|NCT00783718|7292051|FG002|Maintenance Phase|Protocol Violation|0
4490096|NCT00783718|7292052|FG003|Maintenance Phase|Protocol Violation|0
4490097|NCT00783718|7292053|FG004|Maintenance Phase|Protocol Violation|0
4490098|NCT00783718|7292054|FG005|Maintenance Phase|Protocol Violation|0
4490099|NCT00783718|7292055|FG006|Maintenance Phase|Protocol Violation|2
4490100|NCT00783718|7292049|FG000|Maintenance Phase|Lack of Efficacy|83
4490101|NCT00783718|7292050|FG001|Maintenance Phase|Lack of Efficacy|0
4490102|NCT00783718|7292051|FG002|Maintenance Phase|Lack of Efficacy|0
4626754|NCT01845077|7492754|FG004|Washout Period|Lost to Follow-up|0
4626755|NCT01845077|7492755|FG005|Washout Period|Lost to Follow-up|1
4626756|NCT01845077|7492750|FG000|Washout Period|Adverse Event|1
4626757|NCT01845077|7492751|FG001|Washout Period|Adverse Event|0
4626758|NCT01845077|7492752|FG002|Washout Period|Adverse Event|0
4490103|NCT00783718|7292052|FG003|Maintenance Phase|Lack of Efficacy|61
4490104|NCT00783718|7292053|FG004|Maintenance Phase|Lack of Efficacy|31
4490105|NCT00783718|7292054|FG005|Maintenance Phase|Lack of Efficacy|33
4490106|NCT00783718|7292055|FG006|Maintenance Phase|Lack of Efficacy|155
4490107|NCT00783718|7292049|FG000|Maintenance Phase|Withdrawal by Subject|6
4490108|NCT00783718|7292050|FG001|Maintenance Phase|Withdrawal by Subject|0
4490109|NCT00783718|7292051|FG002|Maintenance Phase|Withdrawal by Subject|0
4490110|NCT00783718|7292052|FG003|Maintenance Phase|Withdrawal by Subject|2
4490111|NCT00783718|7292053|FG004|Maintenance Phase|Withdrawal by Subject|5
4490112|NCT00783718|7292054|FG005|Maintenance Phase|Withdrawal by Subject|2
4490113|NCT00783718|7292055|FG006|Maintenance Phase|Withdrawal by Subject|20
4490114|NCT00783718|7292049|FG000|Maintenance Phase|Lost to Follow-up|3
4490115|NCT00783718|7292050|FG001|Maintenance Phase|Lost to Follow-up|0
4490116|NCT00783718|7292051|FG002|Maintenance Phase|Lost to Follow-up|0
4490117|NCT00783718|7292052|FG003|Maintenance Phase|Lost to Follow-up|0
4490118|NCT00783718|7292053|FG004|Maintenance Phase|Lost to Follow-up|2
4490119|NCT00783718|7292054|FG005|Maintenance Phase|Lost to Follow-up|0
4490120|NCT00783718|7292055|FG006|Maintenance Phase|Lost to Follow-up|2
4490121|NCT00783796|7292065|FG000|Overall Study|Did not receive any stent|4
4490122|NCT00783796|7292065|FG000|Overall Study|Received non-XIENCE V stent|1
4490123|NCT00783796|7292065|FG000|Overall Study|Received commercial XIENCE V stent|1
4490124|NCT00783835|7292071|FG000|Overall Study|Adverse Event|3
4490125|NCT00783835|7292071|FG000|Overall Study|Medical Criteria|1
4490126|NCT00783835|7292071|FG000|Overall Study|Withdrawal by Subject|2
4490127|NCT00783835|7292071|FG000|Overall Study|Lost to Follow-up|1
4490128|NCT00783835|7292071|FG000|Overall Study|Participant not Adherent|3
4490129|NCT00784134|7292116|FG000|Overall Study|Lost to Follow-up|3
4490130|NCT00784134|7292117|FG001|Overall Study|Lost to Follow-up|6
4490131|NCT00784147|7292125|FG000|Overall Study|Lost to Follow-up|2
4490132|NCT00784147|7292126|FG001|Overall Study|Lost to Follow-up|4
4490133|NCT00784147|7292125|FG000|Overall Study|Withdrawal by Subject|1
4490134|NCT00784147|7292126|FG001|Overall Study|Withdrawal by Subject|3
4490135|NCT00784147|7292125|FG000|Overall Study|Physician Decision|2
4490136|NCT00784147|7292126|FG001|Overall Study|Physician Decision|1
4490137|NCT00784147|7292125|FG000|Overall Study|Protocol Violation|1
4490138|NCT00784147|7292126|FG001|Overall Study|Protocol Violation|1
4490139|NCT00784147|7292125|FG000|Overall Study|Death|2
4490140|NCT00784147|7292126|FG001|Overall Study|Death|0
4490141|NCT00784238|7292153|FG000|Overall Study|Adverse Event|14
4490142|NCT00784238|7292153|FG000|Overall Study|Death|2
4490143|NCT00784238|7292153|FG000|Overall Study|Lack of Efficacy|33
4490144|NCT00784238|7292153|FG000|Overall Study|Lost to Follow-up|29
4490145|NCT00784238|7292153|FG000|Overall Study|Pregnancy|1
4490146|NCT00784238|7292153|FG000|Overall Study|Withdrawal by Subject|26
4490147|NCT00784238|7292153|FG000|Overall Study|Other|14
4490148|NCT00784277|7292164|FG000|IR Treatment|Adverse Event|4
4490149|NCT00784277|7292165|FG001|IR Treatment|Adverse Event|8
4490150|NCT00784277|7292166|FG002|IR Treatment|Adverse Event|19
4490151|NCT00784277|7292167|FG003|IR Treatment|Adverse Event|35
4490152|NCT00784277|7292168|FG004|IR Treatment|Adverse Event|0
4490153|NCT00784277|7292169|FG005|IR Treatment|Adverse Event|0
4490154|NCT00784277|7292170|FG006|IR Treatment|Adverse Event|0
4490155|NCT00784277|7292164|FG000|IR Treatment|Lack of Efficacy|4
4490156|NCT00784277|7292165|FG001|IR Treatment|Lack of Efficacy|4
4490157|NCT00784277|7292166|FG002|IR Treatment|Lack of Efficacy|1
4490158|NCT00784277|7292167|FG003|IR Treatment|Lack of Efficacy|0
4490159|NCT00784277|7292168|FG004|IR Treatment|Lack of Efficacy|0
4490160|NCT00784277|7292169|FG005|IR Treatment|Lack of Efficacy|0
4490161|NCT00784277|7292170|FG006|IR Treatment|Lack of Efficacy|0
4490162|NCT00784277|7292164|FG000|IR Treatment|Lost to Follow-up|1
4490163|NCT00784277|7292165|FG001|IR Treatment|Lost to Follow-up|0
4490164|NCT00784277|7292166|FG002|IR Treatment|Lost to Follow-up|1
4490165|NCT00784277|7292167|FG003|IR Treatment|Lost to Follow-up|0
4490166|NCT00784277|7292168|FG004|IR Treatment|Lost to Follow-up|0
4490167|NCT00784277|7292169|FG005|IR Treatment|Lost to Follow-up|0
4490168|NCT00784277|7292170|FG006|IR Treatment|Lost to Follow-up|0
4490169|NCT00784277|7292164|FG000|IR Treatment|Withdrawal by Subject|5
4490170|NCT00784277|7292165|FG001|IR Treatment|Withdrawal by Subject|1
4490171|NCT00784277|7292166|FG002|IR Treatment|Withdrawal by Subject|4
4490172|NCT00784277|7292167|FG003|IR Treatment|Withdrawal by Subject|6
4490173|NCT00784277|7292168|FG004|IR Treatment|Withdrawal by Subject|0
4490174|NCT00784277|7292169|FG005|IR Treatment|Withdrawal by Subject|0
4490175|NCT00784277|7292170|FG006|IR Treatment|Withdrawal by Subject|0
4490176|NCT00784277|7292164|FG000|IR Treatment|Resolution Of Pain|0
4490177|NCT00784277|7292165|FG001|IR Treatment|Resolution Of Pain|1
4490178|NCT00784277|7292166|FG002|IR Treatment|Resolution Of Pain|0
4490179|NCT00784277|7292167|FG003|IR Treatment|Resolution Of Pain|0
4490180|NCT00784277|7292168|FG004|IR Treatment|Resolution Of Pain|0
4490181|NCT00784277|7292169|FG005|IR Treatment|Resolution Of Pain|0
4490182|NCT00784277|7292170|FG006|IR Treatment|Resolution Of Pain|0
4490183|NCT00784277|7292164|FG000|IR Treatment|Other|2
4490184|NCT00784277|7292165|FG001|IR Treatment|Other|3
4490185|NCT00784277|7292166|FG002|IR Treatment|Other|3
4490186|NCT00784277|7292167|FG003|IR Treatment|Other|2
4626759|NCT01845077|7492753|FG003|Washout Period|Adverse Event|0
4490187|NCT00784277|7292168|FG004|IR Treatment|Other|0
4490188|NCT00784277|7292169|FG005|IR Treatment|Other|0
4490189|NCT00784277|7292170|FG006|IR Treatment|Other|0
4490190|NCT00784277|7292164|FG000|ER Treatment|Adverse Event|0
4490191|NCT00784277|7292165|FG001|ER Treatment|Adverse Event|0
4490192|NCT00784277|7292166|FG002|ER Treatment|Adverse Event|0
4490193|NCT00784277|7292167|FG003|ER Treatment|Adverse Event|0
4490194|NCT00784277|7292168|FG004|ER Treatment|Adverse Event|1
4490195|NCT00784277|7292169|FG005|ER Treatment|Adverse Event|7
4490196|NCT00784277|7292170|FG006|ER Treatment|Adverse Event|7
4490197|NCT00784277|7292164|FG000|ER Treatment|Lack of Efficacy|0
4490198|NCT00784277|7292165|FG001|ER Treatment|Lack of Efficacy|0
4490199|NCT00784277|7292166|FG002|ER Treatment|Lack of Efficacy|0
4490200|NCT00784277|7292167|FG003|ER Treatment|Lack of Efficacy|0
4490201|NCT00784277|7292168|FG004|ER Treatment|Lack of Efficacy|3
4490202|NCT00784277|7292169|FG005|ER Treatment|Lack of Efficacy|4
4490203|NCT00784277|7292170|FG006|ER Treatment|Lack of Efficacy|0
4490204|NCT00784277|7292164|FG000|ER Treatment|Lost to Follow-up|0
4490205|NCT00784277|7292165|FG001|ER Treatment|Lost to Follow-up|0
4490206|NCT00784277|7292166|FG002|ER Treatment|Lost to Follow-up|0
4490207|NCT00784277|7292167|FG003|ER Treatment|Lost to Follow-up|0
4490208|NCT00784277|7292168|FG004|ER Treatment|Lost to Follow-up|0
4490209|NCT00784277|7292169|FG005|ER Treatment|Lost to Follow-up|2
4490210|NCT00784277|7292170|FG006|ER Treatment|Lost to Follow-up|0
4490211|NCT00784277|7292164|FG000|ER Treatment|Withdrawal by Subject|0
4490212|NCT00784277|7292165|FG001|ER Treatment|Withdrawal by Subject|0
4490213|NCT00784277|7292166|FG002|ER Treatment|Withdrawal by Subject|0
4490214|NCT00784277|7292167|FG003|ER Treatment|Withdrawal by Subject|0
4490215|NCT00784277|7292168|FG004|ER Treatment|Withdrawal by Subject|2
4490216|NCT00784277|7292169|FG005|ER Treatment|Withdrawal by Subject|5
4490217|NCT00784277|7292170|FG006|ER Treatment|Withdrawal by Subject|3
4490218|NCT00784277|7292164|FG000|ER Treatment|Study Medication Non-Compliant|0
4490219|NCT00784277|7292165|FG001|ER Treatment|Study Medication Non-Compliant|0
4490220|NCT00784277|7292166|FG002|ER Treatment|Study Medication Non-Compliant|0
4490221|NCT00784277|7292167|FG003|ER Treatment|Study Medication Non-Compliant|0
4490222|NCT00784277|7292168|FG004|ER Treatment|Study Medication Non-Compliant|2
4490223|NCT00784277|7292169|FG005|ER Treatment|Study Medication Non-Compliant|3
4490224|NCT00784277|7292170|FG006|ER Treatment|Study Medication Non-Compliant|3
4490225|NCT00784277|7292164|FG000|ER Treatment|Other|0
4490226|NCT00784277|7292165|FG001|ER Treatment|Other|0
4490227|NCT00784277|7292166|FG002|ER Treatment|Other|0
4490228|NCT00784277|7292167|FG003|ER Treatment|Other|0
4490229|NCT00784277|7292168|FG004|ER Treatment|Other|1
4490230|NCT00784277|7292169|FG005|ER Treatment|Other|3
4490231|NCT00784277|7292170|FG006|ER Treatment|Other|2
4490232|NCT00784368|7292196|FG000|Overall Study|Physician Decision|0
4490233|NCT00784368|7292197|FG001|Overall Study|Physician Decision|0
4490234|NCT00784368|7292198|FG002|Overall Study|Physician Decision|6
4490235|NCT00784368|7292196|FG000|Overall Study|Lack of Efficacy|2
4490236|NCT00784368|7292197|FG001|Overall Study|Lack of Efficacy|0
4490237|NCT00784368|7292198|FG002|Overall Study|Lack of Efficacy|1
4490238|NCT00784368|7292196|FG000|Overall Study|Adverse Event|6
4490239|NCT00784368|7292197|FG001|Overall Study|Adverse Event|9
4490240|NCT00784368|7292198|FG002|Overall Study|Adverse Event|2
4490241|NCT00784368|7292196|FG000|Overall Study|Diagnosis of fever|0
4490242|NCT00784368|7292197|FG001|Overall Study|Diagnosis of fever|0
4490243|NCT00784368|7292198|FG002|Overall Study|Diagnosis of fever|1
4490244|NCT00784368|7292196|FG000|Overall Study|Worsening of complications|0
4490245|NCT00784368|7292197|FG001|Overall Study|Worsening of complications|0
4490246|NCT00784368|7292198|FG002|Overall Study|Worsening of complications|1
4490247|NCT00784368|7292196|FG000|Overall Study|Worsening of symptoms|0
4490248|NCT00784368|7292197|FG001|Overall Study|Worsening of symptoms|1
4490249|NCT00784368|7292198|FG002|Overall Study|Worsening of symptoms|0
4490250|NCT00784368|7292196|FG000|Overall Study|Withdrawal of informed consent|0
4490251|NCT00784368|7292197|FG001|Overall Study|Withdrawal of informed consent|1
4490252|NCT00784368|7292198|FG002|Overall Study|Withdrawal of informed consent|0
4490253|NCT00784459|7292211|FG000|Overall Study|Adverse Event|0
4490254|NCT00784459|7292212|FG001|Overall Study|Adverse Event|2
4490255|NCT00784550|7292224|FG000|Overall Study|Adverse Event|12
4490256|NCT00784550|7292225|FG001|Overall Study|Adverse Event|10
4490257|NCT00784550|7292224|FG000|Overall Study|Lack of Efficacy|0
4490258|NCT00784550|7292225|FG001|Overall Study|Lack of Efficacy|1
4490259|NCT00784550|7292224|FG000|Overall Study|Protocol Violation|10
4490260|NCT00784550|7292225|FG001|Overall Study|Protocol Violation|10
4590248|NCT01519700|7436042|FG003|Overall Study|Withdrawal by Subject|2
4490261|NCT00784550|7292224|FG000|Overall Study|Lost to Follow-up|8
4490262|NCT00784550|7292225|FG001|Overall Study|Lost to Follow-up|5
4490263|NCT00784550|7292224|FG000|Overall Study|Physician Decision|2
4490264|NCT00784550|7292225|FG001|Overall Study|Physician Decision|3
4490265|NCT00784550|7292224|FG000|Overall Study|Withdrawal by Subject|4
4490266|NCT00784550|7292225|FG001|Overall Study|Withdrawal by Subject|13
4490267|NCT00784563|7292234|FG000|Years 1 & 2|Withdrawal by Subject|3
4490268|NCT00784563|7292235|FG001|Years 1 & 2|Withdrawal by Subject|2
4490269|NCT00784563|7292236|FG002|Years 1 & 2|Withdrawal by Subject|0
4490270|NCT00784563|7292234|FG000|Years 1 & 2|Adverse Event|0
4490271|NCT00784563|7292235|FG001|Years 1 & 2|Adverse Event|3
4490272|NCT00784563|7292236|FG002|Years 1 & 2|Adverse Event|0
4490273|NCT00784563|7292234|FG000|Year 3|Withdrawal by Subject|0
4490274|NCT00784563|7292235|FG001|Year 3|Withdrawal by Subject|0
4490275|NCT00784563|7292236|FG002|Year 3|Withdrawal by Subject|2
4490276|NCT00784563|7292234|FG000|Year 3|Adverse Event|0
4490277|NCT00784563|7292235|FG001|Year 3|Adverse Event|0
4490278|NCT00784563|7292236|FG002|Year 3|Adverse Event|1
4490279|NCT00784654|7292255|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44
4490280|NCT00784654|7292256|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0
4490281|NCT00784654|7292257|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0
4490282|NCT00784654|7292255|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22
4490283|NCT00784654|7292256|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0
4490284|NCT00784654|7292257|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0
4490285|NCT00784654|7292255|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21
4490286|NCT00784654|7292256|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0
4490287|NCT00784654|7292257|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0
4490288|NCT00784654|7292255|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11
4490289|NCT00784654|7292256|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0
4490290|NCT00784654|7292257|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0
4490291|NCT00784654|7292255|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7
4490292|NCT00784654|7292256|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0
4490293|NCT00784654|7292257|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0
4490294|NCT00784654|7292255|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1
4490295|NCT00784654|7292256|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0
4490296|NCT00784654|7292257|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0
4490297|NCT00784654|7292255|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1
4490298|NCT00784654|7292256|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0
4490299|NCT00784654|7292257|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0
4490300|NCT00784654|7292255|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1
4490301|NCT00784654|7292256|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0
4490302|NCT00784654|7292257|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0
4490303|NCT00784654|7292255|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1
4490304|NCT00784654|7292256|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0
4490305|NCT00784654|7292257|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0
4490306|NCT00784654|7292255|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1
4490307|NCT00784654|7292256|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0
4490308|NCT00784654|7292257|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0
4490309|NCT00784654|7292255|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1
4490310|NCT00784654|7292256|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0
4490311|NCT00784654|7292257|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0
4490312|NCT00784654|7292255|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0
4490313|NCT00784654|7292256|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8
4490314|NCT00784654|7292257|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35
4490315|NCT00784654|7292255|FG000|Randomized Withdrawal Period|Lack of Efficacy|0
4490316|NCT00784654|7292256|FG001|Randomized Withdrawal Period|Lack of Efficacy|5
4490317|NCT00784654|7292257|FG002|Randomized Withdrawal Period|Lack of Efficacy|18
4490318|NCT00784654|7292255|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0
4490319|NCT00784654|7292256|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1
4490320|NCT00784654|7292257|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7
4490321|NCT00784654|7292255|FG000|Randomized Withdrawal Period|Protocol Violation|0
4490322|NCT00784654|7292256|FG001|Randomized Withdrawal Period|Protocol Violation|2
4490323|NCT00784654|7292257|FG002|Randomized Withdrawal Period|Protocol Violation|1
4490324|NCT00784654|7292255|FG000|Randomized Withdrawal Period|Adverse Event|0
4490325|NCT00784654|7292256|FG001|Randomized Withdrawal Period|Adverse Event|1
4490326|NCT00784654|7292257|FG002|Randomized Withdrawal Period|Adverse Event|1
4490327|NCT00784654|7292255|FG000|Randomized Withdrawal Period|Did not complete a visit|0
4490328|NCT00784654|7292256|FG001|Randomized Withdrawal Period|Did not complete a visit|1
4490329|NCT00784654|7292257|FG002|Randomized Withdrawal Period|Did not complete a visit|0
4490330|NCT00784654|7292255|FG000|Randomized Withdrawal Period|Family reasons|0
4490331|NCT00784654|7292256|FG001|Randomized Withdrawal Period|Family reasons|0
4490332|NCT00784654|7292257|FG002|Randomized Withdrawal Period|Family reasons|1
4490333|NCT00784693|7292270|FG000|Overall Study|Lost to Follow-up|0
4490334|NCT00784693|7292271|FG001|Overall Study|Lost to Follow-up|1
4490335|NCT00784693|7292270|FG000|Overall Study|Lack of Efficacy|1
4490336|NCT00784693|7292271|FG001|Overall Study|Lack of Efficacy|1
4490337|NCT00784693|7292270|FG000|Overall Study|Withdrawal by Subject|0
4490338|NCT00784693|7292271|FG001|Overall Study|Withdrawal by Subject|4
4490339|NCT00784693|7292270|FG000|Overall Study|Randomized but not Treated|1
4490340|NCT00784693|7292271|FG001|Overall Study|Randomized but not Treated|0
4490341|NCT00784693|7292270|FG000|Overall Study|Other|1
4490342|NCT00784693|7292271|FG001|Overall Study|Other|0
4490343|NCT00784719|7292284|FG000|Overall Study|Adverse Event|0
4490344|NCT00784719|7292285|FG001|Overall Study|Adverse Event|2
4490345|NCT00784719|7292286|FG002|Overall Study|Adverse Event|0
4490346|NCT00784719|7292287|FG003|Overall Study|Adverse Event|0
4490347|NCT00784719|7292288|FG004|Overall Study|Adverse Event|1
4490348|NCT00784719|7292289|FG005|Overall Study|Adverse Event|1
4490349|NCT00784719|7292290|FG006|Overall Study|Adverse Event|1
4490350|NCT00784719|7292284|FG000|Overall Study|Lost to Follow-up|0
4490351|NCT00784719|7292285|FG001|Overall Study|Lost to Follow-up|0
4490352|NCT00784719|7292286|FG002|Overall Study|Lost to Follow-up|0
4490353|NCT00784719|7292287|FG003|Overall Study|Lost to Follow-up|0
4490354|NCT00784719|7292288|FG004|Overall Study|Lost to Follow-up|1
4490355|NCT00784719|7292289|FG005|Overall Study|Lost to Follow-up|1
4490356|NCT00784719|7292290|FG006|Overall Study|Lost to Follow-up|0
4490357|NCT00784719|7292284|FG000|Overall Study|Other|2
4490358|NCT00784719|7292285|FG001|Overall Study|Other|1
4702955|NCT02723006|7620193|FG000|Overall Study|Withdrawal by Subject|0
4702956|NCT02723006|7620194|FG001|Overall Study|Withdrawal by Subject|1
4702957|NCT02723006|7620195|FG002|Overall Study|Withdrawal by Subject|1
4702958|NCT02723006|7620193|FG000|Overall Study|Study Terminated by Sponsor|1
4702959|NCT02723006|7620194|FG001|Overall Study|Study Terminated by Sponsor|6
4702960|NCT02723006|7620195|FG002|Overall Study|Study Terminated by Sponsor|6
4702961|NCT02723084|7620205|FG000|Overall Study|Withdrawal by Subject|1
4702962|NCT02723084|7620206|FG001|Overall Study|Withdrawal by Subject|1
4702963|NCT02723084|7620205|FG000|Overall Study|Lost to Follow-up|3
4702964|NCT02723084|7620206|FG001|Overall Study|Lost to Follow-up|0
4702965|NCT02723175|7620214|FG000|Overall Study|Lost to 1 Month Follow Up|3
4702966|NCT02723175|7620215|FG001|Overall Study|Lost to 1 Month Follow Up|2
4702967|NCT02723175|7620214|FG000|Overall Study|Lost to 3 Month Follow Up|1
4702968|NCT02723175|7620215|FG001|Overall Study|Lost to 3 Month Follow Up|1
4702969|NCT02723188|7620224|FG000|Overall Study|Withdrawal by Subject|1
4702970|NCT02723188|7620225|FG001|Overall Study|Withdrawal by Subject|0
4702971|NCT02723188|7620226|FG002|Overall Study|Withdrawal by Subject|0
4702972|NCT02723201|7620237|FG000|Second Intervention Period|Protocol Violation|1
4490359|NCT00784719|7292286|FG002|Overall Study|Other|1
4490360|NCT00784719|7292287|FG003|Overall Study|Other|0
4490361|NCT00784719|7292288|FG004|Overall Study|Other|2
4490362|NCT00784719|7292289|FG005|Overall Study|Other|1
4490363|NCT00784719|7292290|FG006|Overall Study|Other|3
4490364|NCT00784719|7292284|FG000|Overall Study|Withdrawal by Subject|1
4490365|NCT00784719|7292285|FG001|Overall Study|Withdrawal by Subject|0
4490366|NCT00784719|7292286|FG002|Overall Study|Withdrawal by Subject|0
4490367|NCT00784719|7292287|FG003|Overall Study|Withdrawal by Subject|0
4490368|NCT00784719|7292288|FG004|Overall Study|Withdrawal by Subject|2
4490369|NCT00784719|7292289|FG005|Overall Study|Withdrawal by Subject|0
4490370|NCT00784719|7292290|FG006|Overall Study|Withdrawal by Subject|1
4490371|NCT00784758|7292308|FG000|Overall Study|Withdrawal by Subject|3
4490372|NCT00784758|7292309|FG001|Overall Study|Withdrawal by Subject|0
4490373|NCT00784758|7292308|FG000|Overall Study|Adverse Event|1
4490374|NCT00784758|7292309|FG001|Overall Study|Adverse Event|0
4490375|NCT00784784|7292319|FG000|Overall Study|Withdrawal by Subject|2
4490376|NCT00784784|7292320|FG001|Overall Study|Withdrawal by Subject|2
4490377|NCT00784810|7292328|FG000|Overall Study|Adverse Event|32
4490378|NCT00784810|7292329|FG001|Overall Study|Adverse Event|20
4490379|NCT00784810|7292328|FG000|Overall Study|Lack of Efficacy|14
4490380|NCT00784810|7292329|FG001|Overall Study|Lack of Efficacy|11
4490381|NCT00784810|7292328|FG000|Overall Study|Withdrawal by Subject|11
4490382|NCT00784810|7292329|FG001|Overall Study|Withdrawal by Subject|9
4490383|NCT00784810|7292328|FG000|Overall Study|Administrative|5
4490384|NCT00784810|7292329|FG001|Overall Study|Administrative|8
4490385|NCT00784810|7292328|FG000|Overall Study|Lost to Follow-up|1
4490386|NCT00784810|7292329|FG001|Overall Study|Lost to Follow-up|1
4490387|NCT00784836|7292335|FG000|Overall Study|Early Study Termination|3
4490388|NCT00784875|7292347|FG000|Period A - Baseline|Entry Criteria Not Met|0
4490389|NCT00784875|7292348|FG001|Period A - Baseline|Entry Criteria Not Met|0
4490390|NCT00784875|7292349|FG002|Period A - Baseline|Entry Criteria Not Met|0
4490391|NCT00784875|7292350|FG003|Period A - Baseline|Entry Criteria Not Met|5
4490392|NCT00784875|7292347|FG000|Period A - Baseline|Adverse Event|0
4490393|NCT00784875|7292348|FG001|Period A - Baseline|Adverse Event|0
4490394|NCT00784875|7292349|FG002|Period A - Baseline|Adverse Event|0
4490395|NCT00784875|7292350|FG003|Period A - Baseline|Adverse Event|8
4490396|NCT00784875|7292347|FG000|Period A - Baseline|Protocol Violation|0
4490397|NCT00784875|7292348|FG001|Period A - Baseline|Protocol Violation|0
4490398|NCT00784875|7292349|FG002|Period A - Baseline|Protocol Violation|0
4490399|NCT00784875|7292350|FG003|Period A - Baseline|Protocol Violation|25
4490400|NCT00784875|7292347|FG000|Period A - Baseline|Withdrawal by Subject|0
4490401|NCT00784875|7292348|FG001|Period A - Baseline|Withdrawal by Subject|0
4490402|NCT00784875|7292349|FG002|Period A - Baseline|Withdrawal by Subject|0
4590249|NCT01519700|7436039|FG000|Overall Study|Other Reason|2
4590250|NCT01519700|7436040|FG001|Overall Study|Other Reason|2
4490403|NCT00784875|7292350|FG003|Period A - Baseline|Withdrawal by Subject|27
4490404|NCT00784875|7292347|FG000|Period A - Baseline|Physician Decision|0
4490405|NCT00784875|7292348|FG001|Period A - Baseline|Physician Decision|0
4490406|NCT00784875|7292349|FG002|Period A - Baseline|Physician Decision|0
4490407|NCT00784875|7292350|FG003|Period A - Baseline|Physician Decision|2
4490408|NCT00784875|7292347|FG000|Period A - Baseline|Sponsor Decision|0
4490409|NCT00784875|7292348|FG001|Period A - Baseline|Sponsor Decision|0
4490410|NCT00784875|7292349|FG002|Period A - Baseline|Sponsor Decision|0
4490411|NCT00784875|7292350|FG003|Period A - Baseline|Sponsor Decision|113
4490412|NCT00784875|7292347|FG000|Period A - Baseline|Lost to Follow-up|0
4490413|NCT00784875|7292348|FG001|Period A - Baseline|Lost to Follow-up|0
4490414|NCT00784875|7292349|FG002|Period A - Baseline|Lost to Follow-up|0
4490415|NCT00784875|7292350|FG003|Period A - Baseline|Lost to Follow-up|2
4490416|NCT00784875|7292347|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0
4490417|NCT00784875|7292348|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0
4490418|NCT00784875|7292349|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2
4490419|NCT00784875|7292350|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1
4490420|NCT00784875|7292347|FG000|Period B - Efficacy Endpoint|Adverse Event|0
4490421|NCT00784875|7292348|FG001|Period B - Efficacy Endpoint|Adverse Event|3
4490422|NCT00784875|7292349|FG002|Period B - Efficacy Endpoint|Adverse Event|2
4490423|NCT00784875|7292350|FG003|Period B - Efficacy Endpoint|Adverse Event|1
4490424|NCT00784875|7292347|FG000|Period B - Efficacy Endpoint|Protocol Violation|1
4490425|NCT00784875|7292348|FG001|Period B - Efficacy Endpoint|Protocol Violation|1
4490426|NCT00784875|7292349|FG002|Period B - Efficacy Endpoint|Protocol Violation|2
4490427|NCT00784875|7292350|FG003|Period B - Efficacy Endpoint|Protocol Violation|3
4490428|NCT00784875|7292347|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0
4490429|NCT00784875|7292348|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1
4490430|NCT00784875|7292349|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0
4490431|NCT00784875|7292350|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0
4490432|NCT00784875|7292347|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4
4490433|NCT00784875|7292348|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1
4490434|NCT00784875|7292349|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1
4490435|NCT00784875|7292350|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2
4490436|NCT00784875|7292347|FG000|Period B - Efficacy Endpoint|Physician Decision|0
4490437|NCT00784875|7292348|FG001|Period B - Efficacy Endpoint|Physician Decision|0
4490438|NCT00784875|7292349|FG002|Period B - Efficacy Endpoint|Physician Decision|1
4490439|NCT00784875|7292350|FG003|Period B - Efficacy Endpoint|Physician Decision|0
4490440|NCT00784875|7292347|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9
4490441|NCT00784875|7292348|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6
4490442|NCT00784875|7292349|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12
4490443|NCT00784875|7292350|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12
4490444|NCT00784875|7292347|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0
4490445|NCT00784875|7292348|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0
4490446|NCT00784875|7292349|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1
4490447|NCT00784875|7292350|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0
4490448|NCT00784875|7292347|FG000|Period C|Adverse Event|1
4490449|NCT00784875|7292348|FG001|Period C|Adverse Event|0
4490450|NCT00784875|7292349|FG002|Period C|Adverse Event|4
4490451|NCT00784875|7292350|FG003|Period C|Adverse Event|2
4490452|NCT00784875|7292347|FG000|Period C|Protocol Violation|0
4490453|NCT00784875|7292348|FG001|Period C|Protocol Violation|0
4490454|NCT00784875|7292349|FG002|Period C|Protocol Violation|1
4490455|NCT00784875|7292350|FG003|Period C|Protocol Violation|2
4490456|NCT00784875|7292347|FG000|Period C|Lack of Efficacy|0
4490457|NCT00784875|7292348|FG001|Period C|Lack of Efficacy|0
4490458|NCT00784875|7292349|FG002|Period C|Lack of Efficacy|1
4490459|NCT00784875|7292350|FG003|Period C|Lack of Efficacy|0
4490460|NCT00784875|7292347|FG000|Period C|Withdrawal by Subject|1
4490461|NCT00784875|7292348|FG001|Period C|Withdrawal by Subject|1
4490462|NCT00784875|7292349|FG002|Period C|Withdrawal by Subject|2
4490463|NCT00784875|7292350|FG003|Period C|Withdrawal by Subject|0
4490464|NCT00784875|7292347|FG000|Period C|Physician Decision|0
4490465|NCT00784875|7292348|FG001|Period C|Physician Decision|0
4490466|NCT00784875|7292349|FG002|Period C|Physician Decision|1
4490467|NCT00784875|7292350|FG003|Period C|Physician Decision|1
4490468|NCT00784875|7292347|FG000|Period C|Sponsor Decision|5
4490469|NCT00784875|7292348|FG001|Period C|Sponsor Decision|5
4490470|NCT00784875|7292349|FG002|Period C|Sponsor Decision|4
4490471|NCT00784875|7292350|FG003|Period C|Sponsor Decision|2
4490472|NCT00784875|7292347|FG000|Period D|Adverse Event|0
4490473|NCT00784875|7292348|FG001|Period D|Adverse Event|2
4490474|NCT00784875|7292349|FG002|Period D|Adverse Event|2
4490475|NCT00784875|7292350|FG003|Period D|Adverse Event|0
4490476|NCT00784875|7292347|FG000|Period D|Protocol Violation|1
4490477|NCT00784875|7292348|FG001|Period D|Protocol Violation|0
4490478|NCT00784875|7292349|FG002|Period D|Protocol Violation|0
4490479|NCT00784875|7292350|FG003|Period D|Protocol Violation|0
4490480|NCT00784875|7292347|FG000|Period D|Withdrawal by Subject|2
4490481|NCT00784875|7292348|FG001|Period D|Withdrawal by Subject|0
4490482|NCT00784875|7292349|FG002|Period D|Withdrawal by Subject|2
4490483|NCT00784875|7292350|FG003|Period D|Withdrawal by Subject|0
4490484|NCT00784875|7292347|FG000|Period D|Physician Decision|0
4490485|NCT00784875|7292348|FG001|Period D|Physician Decision|1
4490486|NCT00784875|7292349|FG002|Period D|Physician Decision|0
4490487|NCT00784875|7292350|FG003|Period D|Physician Decision|0
4490488|NCT00784875|7292347|FG000|Period D|Sponsor Decision|1
4490489|NCT00784875|7292348|FG001|Period D|Sponsor Decision|1
4490490|NCT00784875|7292349|FG002|Period D|Sponsor Decision|1
4490491|NCT00784875|7292350|FG003|Period D|Sponsor Decision|0
4490492|NCT00784875|7292347|FG000|Period D|Lost to Follow-up|1
4490493|NCT00784875|7292348|FG001|Period D|Lost to Follow-up|0
4490494|NCT00784875|7292349|FG002|Period D|Lost to Follow-up|1
4490495|NCT00784875|7292350|FG003|Period D|Lost to Follow-up|1
4490496|NCT00784927|7292373|FG000|Overall Study|Cancel Prior to Initiating Treatment|1
4490497|NCT00784927|7292373|FG000|Overall Study|Protocol Violation|1
4490498|NCT00784927|7292373|FG000|Overall Study|Ineligible|1
4490499|NCT00784979|7292378|FG000|Overall Study|incomplete data|6
4490500|NCT00785044|7292382|FG000|Overall Study|Dosed at non-participating sites|152
4490501|NCT00785044|7292382|FG000|Overall Study|Death|77
4490502|NCT00785044|7292382|FG000|Overall Study|Lost to Follow-up|266
4490503|NCT00785044|7292382|FG000|Overall Study|Withdrawal by Subject|1
4490504|NCT00785213|7292387|FG000|Quinine Sulfate Alone|Adverse Event|4
4490505|NCT00785213|7292387|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1
4490506|NCT00785486|7292394|FG000|Midazolam Alone|Withdrawal by Subject|1
4490507|NCT00785512|7292417|FG000|Overall Study|Inclusion/Exclusion not meet|0
4490508|NCT00785512|7292418|FG001|Overall Study|Inclusion/Exclusion not meet|0
4490509|NCT00785512|7292417|FG000|Overall Study|Adverse Event|0
4490510|NCT00785512|7292418|FG001|Overall Study|Adverse Event|0
4490511|NCT00785512|7292417|FG000|Overall Study|Lack of Efficacy|0
4490512|NCT00785512|7292418|FG001|Overall Study|Lack of Efficacy|2
4490513|NCT00785512|7292417|FG000|Overall Study|Withdrawal by Subject|0
4490514|NCT00785512|7292418|FG001|Overall Study|Withdrawal by Subject|1
4490515|NCT00785512|7292417|FG000|Overall Study|Lost to Follow-up|3
4490516|NCT00785512|7292418|FG001|Overall Study|Lost to Follow-up|0
4590251|NCT01519700|7436041|FG002|Overall Study|Other Reason|0
4590252|NCT01519700|7436042|FG003|Overall Study|Other Reason|4
4590253|NCT01519765|7436073|FG000|Overall Study|Adverse Event|0
4590254|NCT01519765|7436074|FG001|Overall Study|Adverse Event|1
4626760|NCT01845077|7492754|FG004|Washout Period|Adverse Event|0
4626761|NCT01845077|7492755|FG005|Washout Period|Adverse Event|0
4626762|NCT01845077|7492750|FG000|Washout Period|elevated lab values (not clinic. sign.)|0
4626763|NCT01845077|7492751|FG001|Washout Period|elevated lab values (not clinic. sign.)|0
4626764|NCT01845077|7492752|FG002|Washout Period|elevated lab values (not clinic. sign.)|1
4626765|NCT01845077|7492753|FG003|Washout Period|elevated lab values (not clinic. sign.)|0
4626766|NCT01845077|7492754|FG004|Washout Period|elevated lab values (not clinic. sign.)|0
4626767|NCT01845077|7492755|FG005|Washout Period|elevated lab values (not clinic. sign.)|0
4626768|NCT01845077|7492750|FG000|Washout Period|Protocol Violation|0
4626769|NCT01845077|7492751|FG001|Washout Period|Protocol Violation|0
4626770|NCT01845077|7492752|FG002|Washout Period|Protocol Violation|0
4626771|NCT01845077|7492753|FG003|Washout Period|Protocol Violation|1
4626772|NCT01845077|7492754|FG004|Washout Period|Protocol Violation|1
4626773|NCT01845077|7492755|FG005|Washout Period|Protocol Violation|0
4626774|NCT01845818|7492805|FG000|Overall Study|Withdrawal by Subject|0
4626775|NCT01845818|7492806|FG001|Overall Study|Withdrawal by Subject|1
4626776|NCT01845818|7492805|FG000|Overall Study|Lost to Follow-up|7
4626777|NCT01845818|7492806|FG001|Overall Study|Lost to Follow-up|5
4626778|NCT01845818|7492805|FG000|Overall Study|Administrative Reasons|3
4626779|NCT01845818|7492806|FG001|Overall Study|Administrative Reasons|1
4626780|NCT01845818|7492805|FG000|Overall Study|Serious Adverse Event|1
4626781|NCT01845818|7492806|FG001|Overall Study|Serious Adverse Event|1
4626782|NCT01845818|7492805|FG000|Overall Study|Other|25
4626783|NCT01845818|7492806|FG001|Overall Study|Other|8
4626784|NCT01845818|7492805|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5
4626785|NCT01845818|7492806|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0
4626786|NCT01845818|7492805|FG000|Overall Study|No Follow-Up Data Available|4
4626787|NCT01845818|7492806|FG001|Overall Study|No Follow-Up Data Available|1
4626788|NCT01845831|7492816|FG000|Inpatient Phase|Withdrawal by Subject|1
4626789|NCT01845831|7492817|FG001|Inpatient Phase|Withdrawal by Subject|1
4626790|NCT01845831|7492818|FG002|Inpatient Phase|Withdrawal by Subject|0
4626791|NCT01845831|7492819|FG003|Inpatient Phase|Withdrawal by Subject|0
4626792|NCT01845831|7492820|FG004|Inpatient Phase|Withdrawal by Subject|0
4626793|NCT01845974|7492833|FG000|Overall Study|screen failure|1
4490517|NCT00785512|7292417|FG000|Overall Study|Precedure Refused|0
4490518|NCT00785512|7292418|FG001|Overall Study|Precedure Refused|0
4490519|NCT00785512|7292417|FG000|Overall Study|IVRS Programing Error|0
4590255|NCT01519765|7436073|FG000|Overall Study|Lack of Efficacy|2
4590256|NCT01519765|7436074|FG001|Overall Study|Lack of Efficacy|0
4590257|NCT01519765|7436073|FG000|Overall Study|Protocol Violation|1
4590258|NCT01519765|7436074|FG001|Overall Study|Protocol Violation|0
4590259|NCT01519765|7436073|FG000|Overall Study|Withdrawal by Subject|0
4626794|NCT01845974|7492834|FG001|Overall Study|screen failure|0
4626795|NCT01846039|7492840|FG000|Overall Study|Protocol Violation|1
4626796|NCT01846039|7492840|FG000|Overall Study|Subject Withdrew Consent|1
4626797|NCT01846104|7492844|FG000|Overall Study|Withdrawal by Subject|1
4626798|NCT01846208|7492851|FG000|Overall Study|Withdrew prior to treatment|1
4490520|NCT00785512|7292418|FG001|Overall Study|IVRS Programing Error|0
4490521|NCT00785512|7292417|FG000|Overall Study|Physician Decision|0
4490522|NCT00785512|7292418|FG001|Overall Study|Physician Decision|0
4490523|NCT00785512|7292417|FG000|Overall Study|Lack of compliance|0
4626799|NCT01846208|7492852|FG001|Overall Study|Withdrew prior to treatment|1
4626800|NCT01846208|7492853|FG002|Overall Study|Withdrew prior to treatment|1
4626801|NCT01846208|7492851|FG000|Overall Study|Dosing Symptoms|1
4490524|NCT00785512|7292418|FG001|Overall Study|Lack of compliance|1
4490525|NCT00785538|7292429|FG000|Treatment Period|Adverse Event|1
4490526|NCT00785538|7292430|FG001|Treatment Period|Adverse Event|2
4490527|NCT00785538|7292431|FG002|Treatment Period|Adverse Event|2
4490528|NCT00785538|7292432|FG003|Treatment Period|Adverse Event|0
4490529|NCT00785538|7292429|FG000|Treatment Period|Withdrawal by Subject|0
4490530|NCT00785538|7292430|FG001|Treatment Period|Withdrawal by Subject|0
4490531|NCT00785538|7292431|FG002|Treatment Period|Withdrawal by Subject|0
4490532|NCT00785538|7292432|FG003|Treatment Period|Withdrawal by Subject|1
4490533|NCT00785577|7292448|FG000|Study Period 2: Therapy Phase|Adverse Event|5
4490534|NCT00785577|7292449|FG001|Study Period 2: Therapy Phase|Adverse Event|7
4490535|NCT00785577|7292450|FG002|Study Period 2: Therapy Phase|Adverse Event|14
4490536|NCT00785577|7292451|FG003|Study Period 2: Therapy Phase|Adverse Event|10
4490537|NCT00785577|7292452|FG004|Study Period 2: Therapy Phase|Adverse Event|17
4490538|NCT00785577|7292448|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0
4490539|NCT00785577|7292449|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0
4490540|NCT00785577|7292450|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0
4490541|NCT00785577|7292451|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0
4490542|NCT00785577|7292452|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1
4490543|NCT00785577|7292448|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0
4490544|NCT00785577|7292449|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0
4490545|NCT00785577|7292450|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0
4490546|NCT00785577|7292451|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1
4490547|NCT00785577|7292452|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0
4490548|NCT00785577|7292448|FG000|Study Period 2: Therapy Phase|Physician Decision|1
4490549|NCT00785577|7292449|FG001|Study Period 2: Therapy Phase|Physician Decision|0
4490550|NCT00785577|7292450|FG002|Study Period 2: Therapy Phase|Physician Decision|0
4490551|NCT00785577|7292451|FG003|Study Period 2: Therapy Phase|Physician Decision|0
4490552|NCT00785577|7292452|FG004|Study Period 2: Therapy Phase|Physician Decision|0
4490553|NCT00785577|7292448|FG000|Study Period 2: Therapy Phase|Protocol Violation|1
4490554|NCT00785577|7292449|FG001|Study Period 2: Therapy Phase|Protocol Violation|1
4490555|NCT00785577|7292450|FG002|Study Period 2: Therapy Phase|Protocol Violation|1
4490556|NCT00785577|7292451|FG003|Study Period 2: Therapy Phase|Protocol Violation|0
4490557|NCT00785577|7292452|FG004|Study Period 2: Therapy Phase|Protocol Violation|1
4490558|NCT00785577|7292448|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2
4490559|NCT00785577|7292449|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1
4490560|NCT00785577|7292450|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1
4490561|NCT00785577|7292451|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0
4490562|NCT00785577|7292452|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1
4490563|NCT00785577|7292448|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
4490564|NCT00785577|7292449|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0
4490565|NCT00785577|7292450|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
4490566|NCT00785577|7292451|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
4490567|NCT00785577|7292452|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0
4490568|NCT00785577|7292448|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1
4490569|NCT00785577|7292449|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0
4490570|NCT00785577|7292450|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1
4490571|NCT00785577|7292451|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1
4490572|NCT00785577|7292452|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0
4490573|NCT00785577|7292448|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0
4490574|NCT00785577|7292449|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0
4490575|NCT00785577|7292450|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0
4490576|NCT00785577|7292451|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1
4490577|NCT00785577|7292452|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0
4490578|NCT00785577|7292448|FG000|Study Period 3: 1-Week Washout Phase|Death|0
4490579|NCT00785577|7292449|FG001|Study Period 3: 1-Week Washout Phase|Death|0
4490580|NCT00785577|7292450|FG002|Study Period 3: 1-Week Washout Phase|Death|0
4490581|NCT00785577|7292451|FG003|Study Period 3: 1-Week Washout Phase|Death|0
4490582|NCT00785577|7292452|FG004|Study Period 3: 1-Week Washout Phase|Death|1
4490583|NCT00785629|7292478|FG000|Overall Study|Adverse Event|2
4490584|NCT00785629|7292479|FG001|Overall Study|Adverse Event|1
4490585|NCT00785629|7292480|FG002|Overall Study|Adverse Event|1
4490586|NCT00785629|7292481|FG003|Overall Study|Adverse Event|5
4490587|NCT00785629|7292478|FG000|Overall Study|Protocol Violation|1
4490588|NCT00785629|7292479|FG001|Overall Study|Protocol Violation|2
4490589|NCT00785629|7292480|FG002|Overall Study|Protocol Violation|4
4490590|NCT00785629|7292481|FG003|Overall Study|Protocol Violation|5
4490591|NCT00785629|7292478|FG000|Overall Study|administrative decision|5
4490592|NCT00785629|7292479|FG001|Overall Study|administrative decision|1
4490593|NCT00785629|7292480|FG002|Overall Study|administrative decision|3
4490594|NCT00785629|7292481|FG003|Overall Study|administrative decision|4
4490595|NCT00785629|7292478|FG000|Overall Study|Withdrawal by Subject|0
4490596|NCT00785629|7292479|FG001|Overall Study|Withdrawal by Subject|1
4490597|NCT00785629|7292480|FG002|Overall Study|Withdrawal by Subject|2
4490598|NCT00785629|7292481|FG003|Overall Study|Withdrawal by Subject|2
4490599|NCT00785707|7292489|FG000|Overall Study|Lost to Follow-up|7
4517518|NCT00967499|7329415|FG001|Overall Study|Sponsor Decision|0
4490600|NCT00785785|7292499|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3
4490601|NCT00785785|7292500|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4
4490602|NCT00785785|7292499|FG000|Core Phase up to 36 Months|Adverse Event|31
4490603|NCT00785785|7292500|FG001|Core Phase up to 36 Months|Adverse Event|21
4490604|NCT00785785|7292499|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1
4490605|NCT00785785|7292500|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0
4490606|NCT00785785|7292499|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2
4490607|NCT00785785|7292500|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2
4490608|NCT00785785|7292499|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16
4490609|NCT00785785|7292500|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17
4490610|NCT00785785|7292499|FG000|Core Phase up to 36 Months|Lost to Follow-up|3
4490611|NCT00785785|7292500|FG001|Core Phase up to 36 Months|Lost to Follow-up|7
4490612|NCT00785785|7292499|FG000|Core Phase up to 36 Months|Administrative problems|3
4490613|NCT00785785|7292500|FG001|Core Phase up to 36 Months|Administrative problems|3
4490614|NCT00785785|7292499|FG000|Core Phase up to 36 Months|Death|5
4490615|NCT00785785|7292500|FG001|Core Phase up to 36 Months|Death|8
4490616|NCT00785785|7292499|FG000|Core Phase up to 36 Months|Disease progression|139
4490617|NCT00785785|7292500|FG001|Core Phase up to 36 Months|Disease progression|119
4490618|NCT00785785|7292499|FG000|Core Phase up to 36 Months|Protocol deviation|5
4490619|NCT00785785|7292500|FG001|Core Phase up to 36 Months|Protocol deviation|6
4626802|NCT01846208|7492852|FG001|Overall Study|Dosing Symptoms|2
4626803|NCT01846208|7492853|FG002|Overall Study|Dosing Symptoms|6
4626804|NCT01846208|7492851|FG000|Overall Study|Withdrawal by Subject|5
4626805|NCT01846208|7492852|FG001|Overall Study|Withdrawal by Subject|0
4702973|NCT02723201|7620238|FG001|Second Intervention Period|Protocol Violation|0
4702974|NCT02723201|7620239|FG002|Second Intervention Period|Protocol Violation|0
4490620|NCT00785785|7292499|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116
4490621|NCT00785785|7292500|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133
4490622|NCT00785785|7292499|FG000|Optional Extension Phase|Adverse Event|4
4490623|NCT00785785|7292500|FG001|Optional Extension Phase|Adverse Event|5
4490624|NCT00785785|7292499|FG000|Optional Extension Phase|Withdrawal by Subject|6
4490625|NCT00785785|7292500|FG001|Optional Extension Phase|Withdrawal by Subject|6
4490626|NCT00785785|7292499|FG000|Optional Extension Phase|Lost to Follow-up|1
4490627|NCT00785785|7292500|FG001|Optional Extension Phase|Lost to Follow-up|0
4490628|NCT00785785|7292499|FG000|Optional Extension Phase|Administrative problems|2
4490629|NCT00785785|7292500|FG001|Optional Extension Phase|Administrative problems|0
4490630|NCT00785785|7292499|FG000|Optional Extension Phase|Death|1
4490631|NCT00785785|7292500|FG001|Optional Extension Phase|Death|5
4490632|NCT00785785|7292499|FG000|Optional Extension Phase|Disease progression|22
4490633|NCT00785785|7292500|FG001|Optional Extension Phase|Disease progression|70
4490634|NCT00785785|7292499|FG000|Optional Extension Phase|Protocol deviation|0
4490635|NCT00785785|7292500|FG001|Optional Extension Phase|Protocol deviation|2
4490636|NCT00785785|7292499|FG000|Optional Extension Phase|Study terminated by sponsor|3
4490637|NCT00785785|7292500|FG001|Optional Extension Phase|Study terminated by sponsor|37
4490638|NCT00785928|7292515|FG000|Treatment Phase|Adverse Event|1
4490639|NCT00785928|7292516|FG001|Treatment Phase|Adverse Event|1
4490640|NCT00785928|7292517|FG002|Treatment Phase|Adverse Event|2
4490641|NCT00785928|7292518|FG003|Treatment Phase|Adverse Event|0
4490642|NCT00785928|7292519|FG004|Treatment Phase|Adverse Event|0
4490643|NCT00785928|7292520|FG005|Treatment Phase|Adverse Event|0
4490644|NCT00785928|7292521|FG006|Treatment Phase|Adverse Event|2
4490645|NCT00785928|7292515|FG000|Treatment Phase|Inadequate Response|0
4490646|NCT00785928|7292516|FG001|Treatment Phase|Inadequate Response|1
4490647|NCT00785928|7292517|FG002|Treatment Phase|Inadequate Response|0
4490648|NCT00785928|7292518|FG003|Treatment Phase|Inadequate Response|0
4490649|NCT00785928|7292519|FG004|Treatment Phase|Inadequate Response|0
4490650|NCT00785928|7292520|FG005|Treatment Phase|Inadequate Response|0
4490651|NCT00785928|7292521|FG006|Treatment Phase|Inadequate Response|0
4626806|NCT01846208|7492853|FG002|Overall Study|Withdrawal by Subject|0
4626807|NCT01846208|7492851|FG000|Overall Study|Non-compliance|1
4702975|NCT02723201|7620237|FG000|Second Intervention Period|Adverse Event|1
4702976|NCT02723201|7620238|FG001|Second Intervention Period|Adverse Event|0
4702977|NCT02723201|7620239|FG002|Second Intervention Period|Adverse Event|0
4702978|NCT02723344|7620255|FG000|Overall Study|Lost to Follow-up|0
4702979|NCT02723344|7620256|FG001|Overall Study|Lost to Follow-up|4
4702980|NCT02723591|7620264|FG000|Overall Study|Adverse Event|48
4702981|NCT02723591|7620265|FG001|Overall Study|Adverse Event|40
4702982|NCT02723591|7620264|FG000|Overall Study|Death|2
4702983|NCT02723591|7620265|FG001|Overall Study|Death|2
4702984|NCT02723591|7620264|FG000|Overall Study|Lack of Efficacy|4
4702985|NCT02723591|7620265|FG001|Overall Study|Lack of Efficacy|3
4490652|NCT00785928|7292515|FG000|Treatment Phase|Lack of Efficacy|0
4490653|NCT00785928|7292516|FG001|Treatment Phase|Lack of Efficacy|1
4590260|NCT01519765|7436074|FG001|Overall Study|Withdrawal by Subject|1
4626808|NCT01846208|7492852|FG001|Overall Study|Non-compliance|1
4626809|NCT01846208|7492853|FG002|Overall Study|Non-compliance|0
4626810|NCT01846208|7492851|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1
4702986|NCT02723591|7620264|FG000|Overall Study|Lost to Follow-up|1
4702987|NCT02723591|7620265|FG001|Overall Study|Lost to Follow-up|7
4490654|NCT00785928|7292517|FG002|Treatment Phase|Lack of Efficacy|1
4490655|NCT00785928|7292518|FG003|Treatment Phase|Lack of Efficacy|0
4490656|NCT00785928|7292519|FG004|Treatment Phase|Lack of Efficacy|0
4490657|NCT00785928|7292520|FG005|Treatment Phase|Lack of Efficacy|0
4490658|NCT00785928|7292521|FG006|Treatment Phase|Lack of Efficacy|0
4490659|NCT00785928|7292515|FG000|Treatment Phase|Physician Decision|0
4490660|NCT00785928|7292516|FG001|Treatment Phase|Physician Decision|0
4490661|NCT00785928|7292517|FG002|Treatment Phase|Physician Decision|0
4490662|NCT00785928|7292518|FG003|Treatment Phase|Physician Decision|0
4490663|NCT00785928|7292519|FG004|Treatment Phase|Physician Decision|1
4490664|NCT00785928|7292520|FG005|Treatment Phase|Physician Decision|0
4490665|NCT00785928|7292521|FG006|Treatment Phase|Physician Decision|0
4490666|NCT00785928|7292515|FG000|Treatment Phase|Sponsor Decision|1
4490667|NCT00785928|7292516|FG001|Treatment Phase|Sponsor Decision|0
4490668|NCT00785928|7292517|FG002|Treatment Phase|Sponsor Decision|0
4490669|NCT00785928|7292518|FG003|Treatment Phase|Sponsor Decision|0
4490670|NCT00785928|7292519|FG004|Treatment Phase|Sponsor Decision|0
4490671|NCT00785928|7292520|FG005|Treatment Phase|Sponsor Decision|0
4490672|NCT00785928|7292521|FG006|Treatment Phase|Sponsor Decision|1
4490673|NCT00785928|7292515|FG000|Treatment Phase|Withdrawal by Subject|1
4490674|NCT00785928|7292516|FG001|Treatment Phase|Withdrawal by Subject|2
4626811|NCT01846208|7492852|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0
4626812|NCT01846208|7492853|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0
4626813|NCT01846208|7492851|FG000|Overall Study|Refused SU OFC|0
4626814|NCT01846208|7492852|FG001|Overall Study|Refused SU OFC|0
4626815|NCT01846208|7492853|FG002|Overall Study|Refused SU OFC|1
4490675|NCT00785928|7292517|FG002|Treatment Phase|Withdrawal by Subject|0
4490676|NCT00785928|7292518|FG003|Treatment Phase|Withdrawal by Subject|0
4490677|NCT00785928|7292519|FG004|Treatment Phase|Withdrawal by Subject|1
4490678|NCT00785928|7292520|FG005|Treatment Phase|Withdrawal by Subject|0
4490679|NCT00785928|7292521|FG006|Treatment Phase|Withdrawal by Subject|0
4490680|NCT00785980|7292559|FG000|7 Day Washout Period|Protocol Violation|3
4490681|NCT00786032|7292577|FG000|Overall Study|Death|4
4490682|NCT00786032|7292577|FG000|Overall Study|Withdrawal by Subject|14
4490683|NCT00786032|7292577|FG000|Overall Study|Did not complete in the timeframe|6
4490684|NCT00786188|7292585|FG000|Overall Study|Adverse Event|3
4490685|NCT00786188|7292586|FG001|Overall Study|Adverse Event|1
4490686|NCT00786188|7292585|FG000|Overall Study|Withdrawal by Subject|2
4490687|NCT00786188|7292586|FG001|Overall Study|Withdrawal by Subject|0
4490688|NCT00786409|7292594|FG000|Overall Study|Withdrawal by Subject|2
4490689|NCT00786409|7292594|FG000|Overall Study|Adverse Event|2
4490690|NCT00786409|7292594|FG000|Overall Study|Pregnancy|2
4490691|NCT00786409|7292594|FG000|Overall Study|Lost to Follow-up|1
4490692|NCT00786422|7292598|FG000|Rivaroxaban Treatment|Death|2
4490693|NCT00786422|7292598|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3
4490694|NCT00786422|7292598|FG000|Rivaroxaban Treatment|Lack of Efficacy|1
4490695|NCT00786422|7292598|FG000|Rivaroxaban Treatment|Physician Decision|1
4490696|NCT00786422|7292598|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1
4490697|NCT00786422|7292598|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1
4490698|NCT00786422|7292598|FG000|Rivaroxaban Treatment|Adverse Event|2
4490699|NCT00786422|7292598|FG000|Follow-up Period|Death|1
4490700|NCT00786422|7292598|FG000|Follow-up Period|End-of-study done up to 4 days early|2
4490701|NCT00786474|7292606|FG000|Overall Study|Death|5
4490702|NCT00786474|7292607|FG001|Overall Study|Death|4
4490703|NCT00786474|7292606|FG000|Overall Study|Withdrawal by Subject|23
4490704|NCT00786474|7292607|FG001|Overall Study|Withdrawal by Subject|31
4490705|NCT00786474|7292606|FG000|Overall Study|Lost to Follow-up|3
4490706|NCT00786474|7292607|FG001|Overall Study|Lost to Follow-up|3
4490707|NCT00786474|7292606|FG000|Overall Study|Physician Decision|2
4490708|NCT00786474|7292607|FG001|Overall Study|Physician Decision|1
4490709|NCT00786474|7292606|FG000|Overall Study|Other|4
4490710|NCT00786474|7292607|FG001|Overall Study|Other|4
4490711|NCT00786565|7292630|FG000|Enrollment Prior to Surgery|Site Closed|3
4490712|NCT00786565|7292630|FG000|Enrollment Prior to Surgery|Protocol Violation|3
4490713|NCT00786565|7292630|FG000|Post Surgery|Abnormal macular pucker|1
4490714|NCT00786565|7292630|FG000|Post Surgery|Adapt AO implanted posterior side up|1
4490715|NCT00786799|7292647|FG000|Overall Study|Lost to Follow-up|1
4490716|NCT00786799|7292648|FG001|Overall Study|Lost to Follow-up|1
4490717|NCT00786838|7292668|FG000|Overall Study|Physician Decision|4
4490718|NCT00786838|7292668|FG000|Overall Study|Death|4
4490719|NCT00786838|7292668|FG000|Overall Study|Adverse Event|6
4490720|NCT00786838|7292668|FG000|Overall Study|Progressive disease|31
4490721|NCT00786838|7292668|FG000|Overall Study|Withdrawal by Subject|4
4490722|NCT00786864|7292679|FG000|Overall Study|Lost to Follow-up|0
4490723|NCT00786864|7292680|FG001|Overall Study|Lost to Follow-up|1
4490724|NCT00786864|7292679|FG000|Overall Study|Sustained serious back injury|1
4490725|NCT00786864|7292680|FG001|Overall Study|Sustained serious back injury|0
4490726|NCT00787137|7292727|FG000|Overall Study|Study Termination|0
4490727|NCT00787137|7292728|FG001|Overall Study|Study Termination|0
4490728|NCT00787137|7292729|FG002|Overall Study|Study Termination|1
4490729|NCT00787150|7292740|FG000|Overall Study|Adverse Event|4
4490730|NCT00787150|7292741|FG001|Overall Study|Adverse Event|4
4490731|NCT00787150|7292742|FG002|Overall Study|Adverse Event|4
4490732|NCT00787150|7292740|FG000|Overall Study|Physician Decision|1
4490733|NCT00787150|7292741|FG001|Overall Study|Physician Decision|2
4490734|NCT00787150|7292742|FG002|Overall Study|Physician Decision|1
4490735|NCT00787150|7292740|FG000|Overall Study|Withdrawal by Subject|2
4490736|NCT00787150|7292741|FG001|Overall Study|Withdrawal by Subject|1
4490737|NCT00787150|7292742|FG002|Overall Study|Withdrawal by Subject|0
4490738|NCT00787150|7292740|FG000|Overall Study|Dosing incorrect study durg|2
4490739|NCT00787150|7292741|FG001|Overall Study|Dosing incorrect study durg|0
4490740|NCT00787150|7292742|FG002|Overall Study|Dosing incorrect study durg|0
4490741|NCT00787189|7292754|FG000|Overall Study|Lost to Follow-up|2
4490742|NCT00787189|7292755|FG001|Overall Study|Lost to Follow-up|2
4490743|NCT00787202|7292766|FG000|Overall Study|Adverse Event|3
4490744|NCT00787202|7292767|FG001|Overall Study|Adverse Event|2
4490745|NCT00787202|7292768|FG002|Overall Study|Adverse Event|0
4490746|NCT00787202|7292769|FG003|Overall Study|Adverse Event|0
4490747|NCT00787202|7292770|FG004|Overall Study|Adverse Event|2
4490748|NCT00787202|7292766|FG000|Overall Study|Lack of Efficacy|5
4490749|NCT00787202|7292767|FG001|Overall Study|Lack of Efficacy|6
4490750|NCT00787202|7292768|FG002|Overall Study|Lack of Efficacy|5
4490751|NCT00787202|7292769|FG003|Overall Study|Lack of Efficacy|2
4490752|NCT00787202|7292770|FG004|Overall Study|Lack of Efficacy|1
4490753|NCT00787202|7292766|FG000|Overall Study|Lost to Follow-up|1
4490754|NCT00787202|7292767|FG001|Overall Study|Lost to Follow-up|0
4490755|NCT00787202|7292768|FG002|Overall Study|Lost to Follow-up|0
4490756|NCT00787202|7292769|FG003|Overall Study|Lost to Follow-up|0
4490757|NCT00787202|7292770|FG004|Overall Study|Lost to Follow-up|0
4490758|NCT00787202|7292766|FG000|Overall Study|Withdrawal by Subject|2
4490759|NCT00787202|7292767|FG001|Overall Study|Withdrawal by Subject|2
4490760|NCT00787202|7292768|FG002|Overall Study|Withdrawal by Subject|2
4490761|NCT00787202|7292769|FG003|Overall Study|Withdrawal by Subject|0
4490762|NCT00787202|7292770|FG004|Overall Study|Withdrawal by Subject|0
4490763|NCT00787202|7292766|FG000|Overall Study|Protocol Violation|2
4490764|NCT00787202|7292767|FG001|Overall Study|Protocol Violation|1
4490765|NCT00787202|7292768|FG002|Overall Study|Protocol Violation|0
4490766|NCT00787202|7292769|FG003|Overall Study|Protocol Violation|0
4490767|NCT00787202|7292770|FG004|Overall Study|Protocol Violation|1
4490768|NCT00787202|7292766|FG000|Overall Study|Randomized, not treated|1
4490769|NCT00787202|7292767|FG001|Overall Study|Randomized, not treated|0
4490770|NCT00787202|7292768|FG002|Overall Study|Randomized, not treated|0
4490771|NCT00787202|7292769|FG003|Overall Study|Randomized, not treated|0
4490772|NCT00787202|7292770|FG004|Overall Study|Randomized, not treated|0
4490773|NCT00787254|7292801|FG000|Overall Study|Adverse Event|24
4490774|NCT00787254|7292802|FG001|Overall Study|Adverse Event|23
4490775|NCT00787254|7292801|FG000|Overall Study|Protocol Violation|26
4490776|NCT00787254|7292802|FG001|Overall Study|Protocol Violation|23
4490777|NCT00787254|7292801|FG000|Overall Study|Withdrawal by Subject|16
4490778|NCT00787254|7292802|FG001|Overall Study|Withdrawal by Subject|11
4490779|NCT00787254|7292801|FG000|Overall Study|Lack of Efficacy|4
4490780|NCT00787254|7292802|FG001|Overall Study|Lack of Efficacy|15
4490781|NCT00787254|7292801|FG000|Overall Study|NSAIDs discontinuation|1
4490782|NCT00787254|7292802|FG001|Overall Study|NSAIDs discontinuation|2
4490783|NCT00787254|7292801|FG000|Overall Study|Institution closed|1
4490784|NCT00787254|7292802|FG001|Overall Study|Institution closed|0
4490785|NCT00787254|7292801|FG000|Overall Study|Physician Decision|4
4490786|NCT00787254|7292802|FG001|Overall Study|Physician Decision|8
4490787|NCT00787267|7292808|FG000|Overall Study|Screen failure/Ineligible|10
4490788|NCT00787267|7292808|FG000|Overall Study|No Reason Provided|1
4490789|NCT00787267|7292808|FG000|Overall Study|Withdrawal by Subject|1
4490790|NCT00787319|7292812|FG000|Overall Study|Lost to Follow-up|2
4490791|NCT00787319|7292812|FG000|Overall Study|Withdrawal by Subject|15
4490792|NCT00787319|7292812|FG000|Overall Study|Adverse Event|3
4490793|NCT00787319|7292812|FG000|Overall Study|Objective progression or relapse|30
4490794|NCT00787319|7292812|FG000|Overall Study|Lack of Efficacy|1
4490795|NCT00787319|7292812|FG000|Overall Study|Budget exhausted/exceeded|1
4490796|NCT00787319|7292812|FG000|Overall Study|Unresponsiveness to visit invitation|1
4490797|NCT00787319|7292812|FG000|Overall Study|No health insurance reimbursement|2
4490798|NCT00787319|7292812|FG000|Overall Study|Stabilized disease findings|3
4490799|NCT00787319|7292812|FG000|Overall Study|Inactive disease|5
4490800|NCT00787527|7292825|FG000|Overall Study|Toxicity|3
4490801|NCT00787566|7292836|FG000|Overall Study|AE related to chemotherapy|0
4490802|NCT00787566|7292837|FG001|Overall Study|AE related to chemotherapy|1
4490803|NCT00787566|7292838|FG002|Overall Study|AE related to chemotherapy|0
4490804|NCT00787605|7292848|FG000|Overall Study|Administrative Problems|3
4490805|NCT00787605|7292849|FG001|Overall Study|Administrative Problems|0
4490806|NCT00787605|7292848|FG000|Overall Study|Adverse Event|14
4490807|NCT00787605|7292849|FG001|Overall Study|Adverse Event|25
4490808|NCT00787605|7292848|FG000|Overall Study|Lost to Follow-up|3
4490809|NCT00787605|7292849|FG001|Overall Study|Lost to Follow-up|6
4490810|NCT00787605|7292848|FG000|Overall Study|Protocol Violation|7
4490811|NCT00787605|7292849|FG001|Overall Study|Protocol Violation|3
4490812|NCT00787605|7292848|FG000|Overall Study|Withdrawal by Subject|6
4490813|NCT00787605|7292849|FG001|Overall Study|Withdrawal by Subject|13
4490814|NCT00787605|7292848|FG000|Overall Study|Lack of Efficacy|13
4490815|NCT00787605|7292849|FG001|Overall Study|Lack of Efficacy|9
4490816|NCT00787644|7292857|FG000|Overall Study|Lost to Follow-up|1
4490817|NCT00787644|7292858|FG001|Overall Study|Lost to Follow-up|1
4490818|NCT00787644|7292857|FG000|Overall Study|Withdrawal by Subject|1
4490819|NCT00787644|7292858|FG001|Overall Study|Withdrawal by Subject|1
4517519|NCT00967499|7329414|FG000|Overall Study|Randomized but not treated|63
4517520|NCT00967499|7329415|FG001|Overall Study|Randomized but not treated|59
4517521|NCT00967616|7329432|FG000|Overall Study|Adverse Event or Serious Adverse Event|2
4590261|NCT01519778|7436081|FG000|Overall Study|Withdrawal by Subject|3
4590262|NCT01519778|7436081|FG000|Overall Study|Lost to Follow-up|10
4590263|NCT01519778|7436081|FG000|Overall Study|Physician Decision|1
4590264|NCT01519791|7436087|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2
4590265|NCT01519791|7436088|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1
4590266|NCT01519791|7436087|FG000|Overall Study|Protocol Violation|6
4590267|NCT01519791|7436088|FG001|Overall Study|Protocol Violation|19
4590268|NCT01519791|7436087|FG000|Overall Study|Other Reason|87
4590269|NCT01519791|7436088|FG001|Overall Study|Other Reason|222
4590270|NCT01519791|7436087|FG000|Overall Study|subjects randomized in error|2
4590271|NCT01519791|7436088|FG001|Overall Study|subjects randomized in error|0
4590272|NCT01519791|7436087|FG000|Overall Study|Lack of Efficacy|16
4590273|NCT01519791|7436088|FG001|Overall Study|Lack of Efficacy|20
4517522|NCT00967616|7329433|FG001|Overall Study|Adverse Event or Serious Adverse Event|17
4517523|NCT00967616|7329432|FG000|Overall Study|Death|0
4517524|NCT00967616|7329433|FG001|Overall Study|Death|3
4517525|NCT00967616|7329432|FG000|Overall Study|Withdrawal by Subject|8
4517526|NCT00967616|7329433|FG001|Overall Study|Withdrawal by Subject|4
4517527|NCT00967616|7329432|FG000|Overall Study|Progressive Disease|31
4517528|NCT00967616|7329433|FG001|Overall Study|Progressive Disease|18
4517529|NCT00967616|7329432|FG000|Overall Study|Other|8
4517530|NCT00967616|7329433|FG001|Overall Study|Other|8
4517531|NCT00967616|7329432|FG000|Overall Study|Protocol Violation|1
4517532|NCT00967616|7329433|FG001|Overall Study|Protocol Violation|0
4517533|NCT00967668|7329442|FG000|Overall Study|Withdrawal by Subject|13
4517534|NCT00967668|7329443|FG001|Overall Study|Withdrawal by Subject|8
4517535|NCT00967668|7329444|FG002|Overall Study|Withdrawal by Subject|8
4517536|NCT00967668|7329442|FG000|Overall Study|Death|0
4517537|NCT00967668|7329443|FG001|Overall Study|Death|2
4517538|NCT00967668|7329444|FG002|Overall Study|Death|4
4517539|NCT00967668|7329442|FG000|Overall Study|Removed due to behavior|1
4517540|NCT00967668|7329443|FG001|Overall Study|Removed due to behavior|1
4517541|NCT00967668|7329444|FG002|Overall Study|Removed due to behavior|2
4517542|NCT00967668|7329442|FG000|Overall Study|Refused Year 2|11
4517543|NCT00967668|7329443|FG001|Overall Study|Refused Year 2|6
4517544|NCT00967668|7329444|FG002|Overall Study|Refused Year 2|4
4517545|NCT00967668|7329442|FG000|Overall Study|Lost to follow-up at 12-mo|27
4517546|NCT00967668|7329443|FG001|Overall Study|Lost to follow-up at 12-mo|29
4517547|NCT00967668|7329444|FG002|Overall Study|Lost to follow-up at 12-mo|26
4517548|NCT00967668|7329442|FG000|Overall Study|Lost to Follow-up|15
4517549|NCT00967668|7329443|FG001|Overall Study|Lost to Follow-up|9
4517550|NCT00967668|7329444|FG002|Overall Study|Lost to Follow-up|16
4517551|NCT00967668|7329442|FG000|Overall Study|Refused 12-mo assessment|3
4517552|NCT00967668|7329443|FG001|Overall Study|Refused 12-mo assessment|1
4517553|NCT00967668|7329444|FG002|Overall Study|Refused 12-mo assessment|9
4517554|NCT00967668|7329442|FG000|Overall Study|Pregnancy|1
4517555|NCT00967668|7329443|FG001|Overall Study|Pregnancy|0
4517556|NCT00967668|7329444|FG002|Overall Study|Pregnancy|0
4517557|NCT00967694|7329455|FG000|Overall Study|Withdrawal by Subject|6
4517558|NCT00967798|7329461|FG000|Overall Study|Withdrawal by Subject|5
4517559|NCT00967798|7329462|FG001|Overall Study|Withdrawal by Subject|2
4517560|NCT00967798|7329461|FG000|Overall Study|Lost to Follow-up|4
4517561|NCT00967798|7329462|FG001|Overall Study|Lost to Follow-up|1
4517562|NCT00968253|7329504|FG000|Overall Study|Death|0
4517563|NCT00968253|7329505|FG001|Overall Study|Death|0
4517564|NCT00968253|7329506|FG002|Overall Study|Death|2
4517565|NCT00968253|7329504|FG000|Overall Study|Withdrawal by Subject|0
4517566|NCT00968253|7329505|FG001|Overall Study|Withdrawal by Subject|0
4517567|NCT00968253|7329506|FG002|Overall Study|Withdrawal by Subject|1
4517568|NCT00968253|7329504|FG000|Overall Study|Disease Progression|0
4517569|NCT00968253|7329505|FG001|Overall Study|Disease Progression|3
4517570|NCT00968253|7329506|FG002|Overall Study|Disease Progression|3
4590274|NCT01519791|7436087|FG000|Overall Study|SAE, non-fatal|6
4590275|NCT01519791|7436088|FG001|Overall Study|SAE, non-fatal|22
4590276|NCT01519791|7436087|FG000|Overall Study|AE, serious fatal|0
4517571|NCT00968253|7329504|FG000|Overall Study|Adverse Event|0
4517572|NCT00968253|7329505|FG001|Overall Study|Adverse Event|0
4517573|NCT00968253|7329506|FG002|Overall Study|Adverse Event|1
4517574|NCT00968526|7329526|FG000|Overall Study|Adverse Event|2
4517575|NCT00968526|7329527|FG001|Overall Study|Adverse Event|0
4517576|NCT00968526|7329526|FG000|Overall Study|Migrated/moved from study area|1
4517577|NCT00968526|7329527|FG001|Overall Study|Migrated/moved from study area|0
4590277|NCT01519791|7436088|FG001|Overall Study|AE, serious fatal|1
4517578|NCT00968539|7329544|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1
4517579|NCT00968539|7329545|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0
4517580|NCT00968617|7329552|FG000|Overall Study|Study terminated by sponsor|6
4517581|NCT00968669|7329560|FG000|Overall Study|Lost to Follow-up|5
4517582|NCT00968669|7329561|FG001|Overall Study|Lost to Follow-up|2
4517583|NCT00968669|7329562|FG002|Overall Study|Lost to Follow-up|1
4517584|NCT00968669|7329563|FG003|Overall Study|Lost to Follow-up|4
4490820|NCT00787787|7292875|FG000|Overall Study|Lack of Efficacy|4
4490821|NCT00787787|7292875|FG000|Overall Study|Adverse Event|3
4490822|NCT00787800|7292881|FG000|Overall Study|Withdrawal by Subject|3
4490823|NCT00787800|7292882|FG001|Overall Study|Withdrawal by Subject|5
4490824|NCT00787800|7292881|FG000|Overall Study|Death|0
4490825|NCT00787800|7292882|FG001|Overall Study|Death|2
4490826|NCT00787839|7292889|FG000|Overall Study|Failure to have the OGTT was most common|404
4490827|NCT00787891|7292921|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1
4490828|NCT00787891|7292922|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2
4490829|NCT00787891|7292921|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2
4490830|NCT00787891|7292922|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2
4490831|NCT00787891|7292921|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0
4490832|NCT00787891|7292922|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1
4490833|NCT00787891|7292921|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1
4490834|NCT00787891|7292922|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0
4490835|NCT00787891|7292921|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6
4490836|NCT00787891|7292922|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2
4490837|NCT00787891|7292921|FG000|Short-term Double-blind Phase (Part 1)|Other|0
4490838|NCT00787891|7292922|FG001|Short-term Double-blind Phase (Part 1)|Other|2
4490839|NCT00787891|7292921|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0
4490840|NCT00787891|7292922|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1
4490841|NCT00787891|7292921|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1
4490842|NCT00787891|7292922|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1
4490843|NCT00787891|7292921|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1
4490844|NCT00787891|7292922|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3
4490845|NCT00787891|7292921|FG000|Maintenance Double-blind Phase (Part 2)|Other|5
4490846|NCT00787891|7292922|FG001|Maintenance Double-blind Phase (Part 2)|Other|2
4490847|NCT00787930|7292939|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3
4490848|NCT00788073|7292968|FG000|STX209 Then Placebo|Adverse Event|1
4490849|NCT00788073|7292969|FG001|STX209 Then Placebo|Adverse Event|0
4490850|NCT00788073|7292968|FG000|STX209 Then Placebo|Lost to Follow-up|0
4490851|NCT00788073|7292969|FG001|STX209 Then Placebo|Lost to Follow-up|1
4490852|NCT00788073|7292968|FG000|STX209 Then Placebo|Withdrawal by Subject|0
4490853|NCT00788073|7292969|FG001|STX209 Then Placebo|Withdrawal by Subject|1
4490854|NCT00788073|7292968|FG000|STX209 Then Placebo|unable to return due to travel|0
4490855|NCT00788073|7292969|FG001|STX209 Then Placebo|unable to return due to travel|1
4490856|NCT00788073|7292968|FG000|Placebo Then STX209|Adverse Event|2
4490857|NCT00788073|7292969|FG001|Placebo Then STX209|Adverse Event|0
4490858|NCT00788073|7292968|FG000|Placebo Then STX209|Protocol Violation|0
4490859|NCT00788073|7292969|FG001|Placebo Then STX209|Protocol Violation|1
4490860|NCT00788372|7292982|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18
4490861|NCT00788372|7292982|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9
4490862|NCT00788372|7292982|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4
4490863|NCT00788372|7292982|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13
4490864|NCT00788372|7292982|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9
4490865|NCT00788372|7292982|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9
4490866|NCT00788372|7292982|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1
4490867|NCT00788593|7292986|FG000|Placebo Run-in Phase|Adverse Event|2
4490868|NCT00788593|7292987|FG001|Placebo Run-in Phase|Adverse Event|0
4490869|NCT00788593|7292988|FG002|Placebo Run-in Phase|Adverse Event|0
4626816|NCT01846221|7492863|FG000|Overall Study|Catheter Failure|2
4702988|NCT02723591|7620264|FG000|Overall Study|Protocol Violation|20
4490870|NCT00788593|7292986|FG000|Placebo Run-in Phase|Withdrawal by Subject|2
4490871|NCT00788593|7292987|FG001|Placebo Run-in Phase|Withdrawal by Subject|0
4490872|NCT00788593|7292988|FG002|Placebo Run-in Phase|Withdrawal by Subject|0
4490873|NCT00788593|7292986|FG000|Placebo Run-in Phase|Protocol Violation|2
4490874|NCT00788593|7292987|FG001|Placebo Run-in Phase|Protocol Violation|0
4702989|NCT02723591|7620265|FG001|Overall Study|Protocol Violation|23
4702990|NCT02723591|7620264|FG000|Overall Study|Withdrawal by Subject|4
4490875|NCT00788593|7292988|FG002|Placebo Run-in Phase|Protocol Violation|0
4490876|NCT00788593|7292986|FG000|First Intervention Period|Adverse Event|0
4490877|NCT00788593|7292987|FG001|First Intervention Period|Adverse Event|1
4490878|NCT00788593|7292988|FG002|First Intervention Period|Adverse Event|0
4490879|NCT00788593|7292986|FG000|Second Intervention Period|Lost to Follow-up|0
4490880|NCT00788593|7292987|FG001|Second Intervention Period|Lost to Follow-up|1
4490881|NCT00788593|7292988|FG002|Second Intervention Period|Lost to Follow-up|0
4490882|NCT00788593|7292986|FG000|Second Intervention Period|Other|0
4490883|NCT00788593|7292987|FG001|Second Intervention Period|Other|0
4626817|NCT01846221|7492864|FG001|Overall Study|Catheter Failure|0
4626818|NCT01846221|7492863|FG000|Overall Study|Age Exclusion|1
4626819|NCT01846221|7492864|FG001|Overall Study|Age Exclusion|0
4626820|NCT01846299|7492872|FG000|Overall Study|Physician Decision|4
4626821|NCT01846299|7492873|FG001|Overall Study|Physician Decision|2
4626822|NCT01846299|7492872|FG000|Overall Study|Protocol deviation|1
4626823|NCT01846299|7492873|FG001|Overall Study|Protocol deviation|0
4626824|NCT01846299|7492872|FG000|Overall Study|Death|1
4626825|NCT01846299|7492873|FG001|Overall Study|Death|2
4626826|NCT01846299|7492872|FG000|Overall Study|Lost to Follow-up|3
4626827|NCT01846299|7492873|FG001|Overall Study|Lost to Follow-up|0
4490884|NCT00788593|7292988|FG002|Second Intervention Period|Other|1
4490885|NCT00788697|7292998|FG000|Overall Study|No study drug administered|12
4490886|NCT00788697|7292998|FG000|Overall Study|Training Patients|74
4490887|NCT00788697|7292998|FG000|Overall Study|no truth standard procedure available|5
4490888|NCT00788697|7292998|FG000|Overall Study|Technically inadequate truth standard|1
4490889|NCT00788697|7292998|FG000|Overall Study|Indeterminate diagnosis from truth stand|17
4490890|NCT00788775|7293012|FG000|Overall Study|Progressive Disease|8
4490891|NCT00788775|7293013|FG001|Overall Study|Progressive Disease|6
4490892|NCT00788775|7293012|FG000|Overall Study|Withdrawal by Subject|0
4490893|NCT00788775|7293013|FG001|Overall Study|Withdrawal by Subject|2
4490894|NCT00788775|7293012|FG000|Overall Study|Patient Non-Compliance|1
4490895|NCT00788775|7293013|FG001|Overall Study|Patient Non-Compliance|0
4490896|NCT00788775|7293012|FG000|Overall Study|Patient's measurable disease resected.|1
4490897|NCT00788775|7293013|FG001|Overall Study|Patient's measurable disease resected.|0
4490898|NCT00788827|7293019|FG000|Overall Study|Lack of Efficacy|2
4490899|NCT00788957|7293038|FG000|Part 1|Death|8
4490900|NCT00788957|7293039|FG001|Part 1|Death|0
4490901|NCT00788957|7293040|FG002|Part 1|Death|0
4490902|NCT00788957|7293041|FG003|Part 1|Death|0
4490903|NCT00788957|7293042|FG004|Part 1|Death|0
4490904|NCT00788957|7293043|FG005|Part 1|Death|0
4490905|NCT00788957|7293038|FG000|Part 1|Lost to Follow-up|1
4490906|NCT00788957|7293039|FG001|Part 1|Lost to Follow-up|0
4490907|NCT00788957|7293040|FG002|Part 1|Lost to Follow-up|0
4490908|NCT00788957|7293041|FG003|Part 1|Lost to Follow-up|0
4490909|NCT00788957|7293042|FG004|Part 1|Lost to Follow-up|0
4490910|NCT00788957|7293043|FG005|Part 1|Lost to Follow-up|0
4490911|NCT00788957|7293038|FG000|Part 2|Withdrawal by Subject|0
4490912|NCT00788957|7293039|FG001|Part 2|Withdrawal by Subject|9
4490913|NCT00788957|7293040|FG002|Part 2|Withdrawal by Subject|5
4490914|NCT00788957|7293041|FG003|Part 2|Withdrawal by Subject|3
4490915|NCT00788957|7293042|FG004|Part 2|Withdrawal by Subject|0
4490916|NCT00788957|7293043|FG005|Part 2|Withdrawal by Subject|0
4490917|NCT00788957|7293038|FG000|Part 2|Death|0
4490918|NCT00788957|7293039|FG001|Part 2|Death|32
4490919|NCT00788957|7293040|FG002|Part 2|Death|35
4490920|NCT00788957|7293041|FG003|Part 2|Death|37
4490921|NCT00788957|7293042|FG004|Part 2|Death|0
4490922|NCT00788957|7293043|FG005|Part 2|Death|0
4490923|NCT00788957|7293038|FG000|Part 2|Lost to Follow-up|0
4490924|NCT00788957|7293039|FG001|Part 2|Lost to Follow-up|0
4490925|NCT00788957|7293040|FG002|Part 2|Lost to Follow-up|3
4490926|NCT00788957|7293041|FG003|Part 2|Lost to Follow-up|0
4490927|NCT00788957|7293042|FG004|Part 2|Lost to Follow-up|0
4490928|NCT00788957|7293043|FG005|Part 2|Lost to Follow-up|0
4490929|NCT00788957|7293038|FG000|Part 2|On-study at time of data cut-off|0
4490930|NCT00788957|7293039|FG001|Part 2|On-study at time of data cut-off|1
4490931|NCT00788957|7293040|FG002|Part 2|On-study at time of data cut-off|1
4490932|NCT00788957|7293041|FG003|Part 2|On-study at time of data cut-off|1
4490933|NCT00788957|7293042|FG004|Part 2|On-study at time of data cut-off|0
4490934|NCT00788957|7293043|FG005|Part 2|On-study at time of data cut-off|0
4490935|NCT00788957|7293038|FG000|Part 3|Withdrawal by Subject|0
4490936|NCT00788957|7293039|FG001|Part 3|Withdrawal by Subject|0
4490937|NCT00788957|7293040|FG002|Part 3|Withdrawal by Subject|0
4490938|NCT00788957|7293041|FG003|Part 3|Withdrawal by Subject|0
4490939|NCT00788957|7293042|FG004|Part 3|Withdrawal by Subject|0
4490940|NCT00788957|7293043|FG005|Part 3|Withdrawal by Subject|2
4490941|NCT00788957|7293038|FG000|Part 3|Death|0
4490942|NCT00788957|7293039|FG001|Part 3|Death|0
4490943|NCT00788957|7293040|FG002|Part 3|Death|0
4490944|NCT00788957|7293041|FG003|Part 3|Death|0
4490945|NCT00788957|7293042|FG004|Part 3|Death|8
4490946|NCT00788957|7293043|FG005|Part 3|Death|9
4490947|NCT00788957|7293038|FG000|Part 3|On-study at time of data cut-off|0
4490948|NCT00788957|7293039|FG001|Part 3|On-study at time of data cut-off|0
4490949|NCT00788957|7293040|FG002|Part 3|On-study at time of data cut-off|0
4490950|NCT00788957|7293041|FG003|Part 3|On-study at time of data cut-off|0
4490951|NCT00788957|7293042|FG004|Part 3|On-study at time of data cut-off|1
4490952|NCT00788957|7293043|FG005|Part 3|On-study at time of data cut-off|0
4490953|NCT00789035|7293065|FG000|Overall Study|Adverse Event|0
4490954|NCT00789035|7293066|FG001|Overall Study|Adverse Event|2
4490955|NCT00789035|7293067|FG002|Overall Study|Adverse Event|0
4490956|NCT00789035|7293068|FG003|Overall Study|Adverse Event|1
4490957|NCT00789035|7293069|FG004|Overall Study|Adverse Event|3
4490958|NCT00789035|7293065|FG000|Overall Study|Lack of Efficacy|3
4490959|NCT00789035|7293066|FG001|Overall Study|Lack of Efficacy|0
4490960|NCT00789035|7293067|FG002|Overall Study|Lack of Efficacy|0
4490961|NCT00789035|7293068|FG003|Overall Study|Lack of Efficacy|0
4490962|NCT00789035|7293069|FG004|Overall Study|Lack of Efficacy|2
4590278|NCT01519791|7436087|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0
4490963|NCT00789035|7293065|FG000|Overall Study|Protocol Violation|1
4490964|NCT00789035|7293066|FG001|Overall Study|Protocol Violation|0
4490965|NCT00789035|7293067|FG002|Overall Study|Protocol Violation|0
4490966|NCT00789035|7293068|FG003|Overall Study|Protocol Violation|0
4490967|NCT00789035|7293069|FG004|Overall Study|Protocol Violation|0
4490968|NCT00789035|7293065|FG000|Overall Study|Withdrawal by Subject|0
4490969|NCT00789035|7293066|FG001|Overall Study|Withdrawal by Subject|2
4490970|NCT00789035|7293067|FG002|Overall Study|Withdrawal by Subject|0
4490971|NCT00789035|7293068|FG003|Overall Study|Withdrawal by Subject|0
4490972|NCT00789035|7293069|FG004|Overall Study|Withdrawal by Subject|0
4490973|NCT00789035|7293065|FG000|Overall Study|Other reason not defined above|2
4490974|NCT00789035|7293066|FG001|Overall Study|Other reason not defined above|3
4490975|NCT00789035|7293067|FG002|Overall Study|Other reason not defined above|1
4490976|NCT00789035|7293068|FG003|Overall Study|Other reason not defined above|0
4490977|NCT00789035|7293069|FG004|Overall Study|Other reason not defined above|1
4490978|NCT00789191|7293103|FG000|Overall Study|Adverse Event|2
4490979|NCT00789191|7293104|FG001|Overall Study|Adverse Event|4
4490980|NCT00789191|7293103|FG000|Overall Study|Lack of Efficacy|0
4490981|NCT00789191|7293104|FG001|Overall Study|Lack of Efficacy|5
4490982|NCT00789191|7293103|FG000|Overall Study|Protocol Violation|5
4490983|NCT00789191|7293104|FG001|Overall Study|Protocol Violation|3
4490984|NCT00789191|7293103|FG000|Overall Study|Withdrawal Criteria|2
4490985|NCT00789191|7293104|FG001|Overall Study|Withdrawal Criteria|4
4490986|NCT00789191|7293103|FG000|Overall Study|Unclassified|5
4490987|NCT00789191|7293104|FG001|Overall Study|Unclassified|3
4490988|NCT00789321|7293124|FG000|Overall Study|Adverse Event|0
4490989|NCT00789321|7293125|FG001|Overall Study|Adverse Event|1
4490990|NCT00789360|7293133|FG000|Overall Study|Protocol Violation|3
4490991|NCT00789360|7293134|FG001|Overall Study|Protocol Violation|1
4490992|NCT00789373|7293141|FG000|Induction|Adverse Event|64
4490993|NCT00789373|7293142|FG001|Induction|Adverse Event|0
4490994|NCT00789373|7293143|FG002|Induction|Adverse Event|0
4490995|NCT00789373|7293141|FG000|Induction|Death Due to study disease|24
4490996|NCT00789373|7293142|FG001|Induction|Death Due to study disease|0
4490997|NCT00789373|7293143|FG002|Induction|Death Due to study disease|0
4490998|NCT00789373|7293141|FG000|Induction|Death due to adverse event|19
4490999|NCT00789373|7293142|FG001|Induction|Death due to adverse event|0
4491000|NCT00789373|7293143|FG002|Induction|Death due to adverse event|0
4491001|NCT00789373|7293141|FG000|Induction|Death due to toxicity|11
4491002|NCT00789373|7293142|FG001|Induction|Death due to toxicity|0
4491003|NCT00789373|7293143|FG002|Induction|Death due to toxicity|0
4491004|NCT00789373|7293141|FG000|Induction|Death due to procedure|1
4491005|NCT00789373|7293142|FG001|Induction|Death due to procedure|0
4491006|NCT00789373|7293143|FG002|Induction|Death due to procedure|0
4491007|NCT00789373|7293141|FG000|Induction|Investigator decision|7
4491008|NCT00789373|7293142|FG001|Induction|Investigator decision|0
4491009|NCT00789373|7293143|FG002|Induction|Investigator decision|0
4491010|NCT00789373|7293141|FG000|Induction|Protocol entry criteria not met|9
4491011|NCT00789373|7293142|FG001|Induction|Protocol entry criteria not met|0
4491012|NCT00789373|7293143|FG002|Induction|Protocol entry criteria not met|0
4491013|NCT00789373|7293141|FG000|Induction|Lost to Follow-up|6
4491014|NCT00789373|7293142|FG001|Induction|Lost to Follow-up|0
4491015|NCT00789373|7293143|FG002|Induction|Lost to Follow-up|0
4491016|NCT00789373|7293141|FG000|Induction|Protocol Violation|1
4491017|NCT00789373|7293142|FG001|Induction|Protocol Violation|0
4491018|NCT00789373|7293143|FG002|Induction|Protocol Violation|0
4491019|NCT00789373|7293141|FG000|Induction|Progressive Disease|220
4491020|NCT00789373|7293142|FG001|Induction|Progressive Disease|0
4491021|NCT00789373|7293143|FG002|Induction|Progressive Disease|0
4491022|NCT00789373|7293141|FG000|Induction|Withdrawal by Subject|37
4491023|NCT00789373|7293142|FG001|Induction|Withdrawal by Subject|0
4491024|NCT00789373|7293143|FG002|Induction|Withdrawal by Subject|0
4491025|NCT00789373|7293141|FG000|Maintenance|Adverse Event|0
4491026|NCT00789373|7293142|FG001|Maintenance|Adverse Event|65
4491027|NCT00789373|7293143|FG002|Maintenance|Adverse Event|12
4491028|NCT00789373|7293141|FG000|Maintenance|Death due to study disease|0
4491029|NCT00789373|7293142|FG001|Maintenance|Death due to study disease|3
4491030|NCT00789373|7293143|FG002|Maintenance|Death due to study disease|1
4491031|NCT00789373|7293141|FG000|Maintenance|Death due to adverse event|0
4491032|NCT00789373|7293142|FG001|Maintenance|Death due to adverse event|4
4491033|NCT00789373|7293143|FG002|Maintenance|Death due to adverse event|1
4491034|NCT00789373|7293141|FG000|Maintenance|Death due to toxicity|0
4491035|NCT00789373|7293142|FG001|Maintenance|Death due to toxicity|1
4491036|NCT00789373|7293143|FG002|Maintenance|Death due to toxicity|2
4491037|NCT00789373|7293141|FG000|Maintenance|Investigator Decision|0
4491038|NCT00789373|7293142|FG001|Maintenance|Investigator Decision|4
4491039|NCT00789373|7293143|FG002|Maintenance|Investigator Decision|2
4491040|NCT00789373|7293141|FG000|Maintenance|Protocol entry criteria not met|0
4491041|NCT00789373|7293142|FG001|Maintenance|Protocol entry criteria not met|2
4491042|NCT00789373|7293143|FG002|Maintenance|Protocol entry criteria not met|0
4491043|NCT00789373|7293141|FG000|Maintenance|Lost to Follow-up|0
4491044|NCT00789373|7293142|FG001|Maintenance|Lost to Follow-up|2
4491045|NCT00789373|7293143|FG002|Maintenance|Lost to Follow-up|0
4491046|NCT00789373|7293141|FG000|Maintenance|Progressive Disease|0
4491047|NCT00789373|7293142|FG001|Maintenance|Progressive Disease|253
4491048|NCT00789373|7293143|FG002|Maintenance|Progressive Disease|152
4491049|NCT00789373|7293141|FG000|Maintenance|Withdrawal by Subject|0
4491050|NCT00789373|7293142|FG001|Maintenance|Withdrawal by Subject|21
4491051|NCT00789373|7293143|FG002|Maintenance|Withdrawal by Subject|8
4491052|NCT00789373|7293141|FG000|Maintenance|Sponsor Decision|0
4491053|NCT00789373|7293142|FG001|Maintenance|Sponsor Decision|0
4491054|NCT00789373|7293143|FG002|Maintenance|Sponsor Decision|2
4491055|NCT00789373|7293141|FG000|Maintenance|Participants On-Going at Data Cut-Off|0
4702991|NCT02723591|7620265|FG001|Overall Study|Withdrawal by Subject|8
4702992|NCT02723591|7620264|FG000|Overall Study|Randomized but Never Received StudyDrug|12
4702993|NCT02723591|7620265|FG001|Overall Study|Randomized but Never Received StudyDrug|12
4491056|NCT00789373|7293142|FG001|Maintenance|Participants On-Going at Data Cut-Off|4
4491057|NCT00789373|7293143|FG002|Maintenance|Participants On-Going at Data Cut-Off|0
4491058|NCT00789477|7293172|FG000|Overall Study|Withdrawal by Subject|2
4491059|NCT00789477|7293173|FG001|Overall Study|Withdrawal by Subject|1
4491060|NCT00789477|7293174|FG002|Overall Study|Withdrawal by Subject|3
4491061|NCT00789477|7293175|FG003|Overall Study|Withdrawal by Subject|2
4491062|NCT00789477|7293176|FG004|Overall Study|Withdrawal by Subject|3
4491063|NCT00789477|7293172|FG000|Overall Study|Protocol Violation|1
4491064|NCT00789477|7293173|FG001|Overall Study|Protocol Violation|0
4491065|NCT00789477|7293174|FG002|Overall Study|Protocol Violation|0
4491066|NCT00789477|7293175|FG003|Overall Study|Protocol Violation|1
4491067|NCT00789477|7293176|FG004|Overall Study|Protocol Violation|0
4491068|NCT00789477|7293172|FG000|Overall Study|Adverse Event|3
4491069|NCT00789477|7293173|FG001|Overall Study|Adverse Event|3
4491070|NCT00789477|7293174|FG002|Overall Study|Adverse Event|1
4491071|NCT00789477|7293175|FG003|Overall Study|Adverse Event|0
4491072|NCT00789477|7293176|FG004|Overall Study|Adverse Event|0
4491073|NCT00789477|7293172|FG000|Overall Study|Death|1
4491074|NCT00789477|7293173|FG001|Overall Study|Death|1
4491075|NCT00789477|7293174|FG002|Overall Study|Death|2
4491076|NCT00789477|7293175|FG003|Overall Study|Death|2
4491077|NCT00789477|7293176|FG004|Overall Study|Death|0
4491078|NCT00789477|7293172|FG000|Overall Study|Lost to Follow-up|0
4491079|NCT00789477|7293173|FG001|Overall Study|Lost to Follow-up|1
4491080|NCT00789477|7293174|FG002|Overall Study|Lost to Follow-up|4
4491081|NCT00789477|7293175|FG003|Overall Study|Lost to Follow-up|2
4491082|NCT00789477|7293176|FG004|Overall Study|Lost to Follow-up|4
4491083|NCT00789477|7293172|FG000|Overall Study|Lack of Efficacy|2
4491084|NCT00789477|7293173|FG001|Overall Study|Lack of Efficacy|0
4491085|NCT00789477|7293174|FG002|Overall Study|Lack of Efficacy|0
4491086|NCT00789477|7293175|FG003|Overall Study|Lack of Efficacy|0
4491087|NCT00789477|7293176|FG004|Overall Study|Lack of Efficacy|0
4491088|NCT00789477|7293172|FG000|Overall Study|Other|2
4491089|NCT00789477|7293173|FG001|Overall Study|Other|0
4491090|NCT00789477|7293174|FG002|Overall Study|Other|1
4491091|NCT00789477|7293175|FG003|Overall Study|Other|3
4491092|NCT00789477|7293176|FG004|Overall Study|Other|0
4491093|NCT00789529|7293192|FG000|Overall Study|Withdrawal by Subject|0
4491094|NCT00789529|7293193|FG001|Overall Study|Withdrawal by Subject|1
4491095|NCT00789529|7293192|FG000|Overall Study|Other Reason|1
4491096|NCT00789529|7293193|FG001|Overall Study|Other Reason|0
4491097|NCT00789555|7293202|FG000|Overall Study|Protocol Amendment|78
4491098|NCT00789555|7293203|FG001|Overall Study|Protocol Amendment|76
4491099|NCT00789555|7293204|FG002|Overall Study|Protocol Amendment|80
4491100|NCT00789555|7293202|FG000|Overall Study|Adverse Event|17
4491101|NCT00789555|7293203|FG001|Overall Study|Adverse Event|7
4491102|NCT00789555|7293204|FG002|Overall Study|Adverse Event|10
4491103|NCT00789555|7293202|FG000|Overall Study|Lost to Follow-up|9
4491104|NCT00789555|7293203|FG001|Overall Study|Lost to Follow-up|10
4491105|NCT00789555|7293204|FG002|Overall Study|Lost to Follow-up|18
4491106|NCT00789555|7293202|FG000|Overall Study|Patient decision unnrelated to adv event|38
4491107|NCT00789555|7293203|FG001|Overall Study|Patient decision unnrelated to adv event|29
4491108|NCT00789555|7293204|FG002|Overall Study|Patient decision unnrelated to adv event|26
4491109|NCT00789555|7293202|FG000|Overall Study|Treatment failure|11
4491110|NCT00789555|7293203|FG001|Overall Study|Treatment failure|8
4491111|NCT00789555|7293204|FG002|Overall Study|Treatment failure|12
4491112|NCT00789555|7293202|FG000|Overall Study|Protocol Violation|6
4491113|NCT00789555|7293203|FG001|Overall Study|Protocol Violation|9
4491114|NCT00789555|7293204|FG002|Overall Study|Protocol Violation|13
4491115|NCT00789581|7293214|FG000|AC Therapy|Adverse Event|2
4491116|NCT00789581|7293215|FG001|AC Therapy|Adverse Event|3
4491117|NCT00789581|7293214|FG000|AC Therapy|Withdrawal by Subject|4
4491118|NCT00789581|7293215|FG001|AC Therapy|Withdrawal by Subject|7
4491119|NCT00789581|7293214|FG000|AC Therapy|Disease recurrence|3
4491120|NCT00789581|7293215|FG001|AC Therapy|Disease recurrence|1
4491121|NCT00789581|7293214|FG000|AC Therapy|Intercurrent Illness|1
4491122|NCT00789581|7293215|FG001|AC Therapy|Intercurrent Illness|0
4491123|NCT00789581|7293214|FG000|AC Therapy|Never Treated|1
4491124|NCT00789581|7293215|FG001|AC Therapy|Never Treated|4
4491125|NCT00789581|7293214|FG000|AC Therapy|Other|0
4491126|NCT00789581|7293215|FG001|AC Therapy|Other|2
4491127|NCT00789581|7293214|FG000|Adjuvant Therapy|Never treated|2
4491128|NCT00789581|7293215|FG001|Adjuvant Therapy|Never treated|2
4491129|NCT00789581|7293214|FG000|Adjuvant Therapy|Adverse Event|20
4491130|NCT00789581|7293215|FG001|Adjuvant Therapy|Adverse Event|44
4491131|NCT00789581|7293214|FG000|Adjuvant Therapy|Withdrawal by Subject|14
4702994|NCT02723591|7620264|FG000|Overall Study|Miscellaneous|5
4491132|NCT00789581|7293215|FG001|Adjuvant Therapy|Withdrawal by Subject|5
4491133|NCT00789581|7293214|FG000|Adjuvant Therapy|Disease recurrence|2
4491134|NCT00789581|7293215|FG001|Adjuvant Therapy|Disease recurrence|1
4491135|NCT00789581|7293214|FG000|Adjuvant Therapy|Intercurrent Illness|1
4491136|NCT00789581|7293215|FG001|Adjuvant Therapy|Intercurrent Illness|3
4491137|NCT00789581|7293214|FG000|Adjuvant Therapy|Protocol Violation|1
4491138|NCT00789581|7293215|FG001|Adjuvant Therapy|Protocol Violation|1
4491139|NCT00789581|7293214|FG000|Adjuvant Therapy|Other|0
4491140|NCT00789581|7293215|FG001|Adjuvant Therapy|Other|1
4491141|NCT00789698|7293239|FG000|Overall Study|Lack of Efficacy|10
4491142|NCT00789698|7293240|FG001|Overall Study|Lack of Efficacy|4
4491143|NCT00789698|7293241|FG002|Overall Study|Lack of Efficacy|5
4491144|NCT00789698|7293242|FG003|Overall Study|Lack of Efficacy|18
4491145|NCT00789698|7293239|FG000|Overall Study|Adverse Event|5
4491146|NCT00789698|7293240|FG001|Overall Study|Adverse Event|5
4491147|NCT00789698|7293241|FG002|Overall Study|Adverse Event|3
4491148|NCT00789698|7293242|FG003|Overall Study|Adverse Event|4
4491149|NCT00789698|7293239|FG000|Overall Study|Lost to Follow-up|5
4491150|NCT00789698|7293240|FG001|Overall Study|Lost to Follow-up|5
4491151|NCT00789698|7293241|FG002|Overall Study|Lost to Follow-up|2
4491152|NCT00789698|7293242|FG003|Overall Study|Lost to Follow-up|9
4491153|NCT00789698|7293239|FG000|Overall Study|Protocol Violation|6
4491154|NCT00789698|7293240|FG001|Overall Study|Protocol Violation|1
4491155|NCT00789698|7293241|FG002|Overall Study|Protocol Violation|2
4491156|NCT00789698|7293242|FG003|Overall Study|Protocol Violation|1
4491157|NCT00789698|7293239|FG000|Overall Study|Withdrawal by Subject|14
4491158|NCT00789698|7293240|FG001|Overall Study|Withdrawal by Subject|15
4491159|NCT00789698|7293241|FG002|Overall Study|Withdrawal by Subject|12
4491160|NCT00789698|7293242|FG003|Overall Study|Withdrawal by Subject|19
4491161|NCT00789698|7293239|FG000|Overall Study|Administrative|0
4491162|NCT00789698|7293240|FG001|Overall Study|Administrative|3
4491163|NCT00789698|7293241|FG002|Overall Study|Administrative|3
4491164|NCT00789698|7293242|FG003|Overall Study|Administrative|1
4491165|NCT00789737|7293262|FG000|Overall Study|Withdrawal by Subject|13
4491166|NCT00789737|7293263|FG001|Overall Study|Withdrawal by Subject|22
4491167|NCT00789737|7293262|FG000|Overall Study|Lost to Follow-up|10
4491168|NCT00789737|7293263|FG001|Overall Study|Lost to Follow-up|14
4491169|NCT00789737|7293262|FG000|Overall Study|Adverse Event|8
4491170|NCT00789737|7293263|FG001|Overall Study|Adverse Event|8
4491171|NCT00789737|7293262|FG000|Overall Study|Protocol Violation|3
4491172|NCT00789737|7293263|FG001|Overall Study|Protocol Violation|0
4491173|NCT00789737|7293262|FG000|Overall Study|Lack of Efficacy|3
4491174|NCT00789737|7293263|FG001|Overall Study|Lack of Efficacy|0
4491175|NCT00789737|7293262|FG000|Overall Study|hyperglycemia that met protocol-specifie|0
4491176|NCT00789737|7293263|FG001|Overall Study|hyperglycemia that met protocol-specifie|4
4491177|NCT00789737|7293262|FG000|Overall Study|Other|11
4491178|NCT00789737|7293263|FG001|Overall Study|Other|7
4491179|NCT00789815|7293305|FG000|Overall Study|Protocol Violation|6
4491180|NCT00789815|7293306|FG001|Overall Study|Protocol Violation|1
4491181|NCT00789815|7293305|FG000|Overall Study|Intubation due to massive bleeding|1
4491182|NCT00789815|7293306|FG001|Overall Study|Intubation due to massive bleeding|0
4491183|NCT00789828|7293314|FG000|Core Period (48 Weeks)|Administrative problems|0
4491184|NCT00789828|7293315|FG001|Core Period (48 Weeks)|Administrative problems|1
4491185|NCT00789828|7293314|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0
4491186|NCT00789828|7293315|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4
4491187|NCT00789828|7293314|FG000|Core Period (48 Weeks)|Lost to Follow-up|0
4491188|NCT00789828|7293315|FG001|Core Period (48 Weeks)|Lost to Follow-up|1
4491189|NCT00789828|7293314|FG000|Open-label Extension Period (4 Years)|Adverse Event|10
4491190|NCT00789828|7293315|FG001|Open-label Extension Period (4 Years)|Adverse Event|0
4491191|NCT00789828|7293314|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6
4491192|NCT00789828|7293315|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0
4491193|NCT00789828|7293314|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3
4491194|NCT00789828|7293315|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0
4491195|NCT00789828|7293314|FG000|Open-label Extension Period (4 Years)|Administrative problems|7
4491196|NCT00789828|7293315|FG001|Open-label Extension Period (4 Years)|Administrative problems|0
4491197|NCT00789828|7293314|FG000|Open-label Extension Period (4 Years)|Death|1
4491198|NCT00789828|7293315|FG001|Open-label Extension Period (4 Years)|Death|0
4491199|NCT00789828|7293314|FG000|Open-label Extension Period (4 Years)|Disease progression|1
4491200|NCT00789828|7293315|FG001|Open-label Extension Period (4 Years)|Disease progression|0
4491201|NCT00789828|7293314|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1
4491202|NCT00789828|7293315|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0
4491203|NCT00789854|7293327|FG000|Overall Study|Adverse Event|28
4491204|NCT00789854|7293328|FG001|Overall Study|Adverse Event|23
4491205|NCT00789854|7293329|FG002|Overall Study|Adverse Event|18
4491206|NCT00789854|7293327|FG000|Overall Study|Lost to Follow-up|1
4491207|NCT00789854|7293328|FG001|Overall Study|Lost to Follow-up|1
4491208|NCT00789854|7293329|FG002|Overall Study|Lost to Follow-up|4
4491209|NCT00789854|7293327|FG000|Overall Study|Withdrawal by Subject|9
4491210|NCT00789854|7293328|FG001|Overall Study|Withdrawal by Subject|6
4491211|NCT00789854|7293329|FG002|Overall Study|Withdrawal by Subject|17
4491212|NCT00789854|7293327|FG000|Overall Study|Eligibility criteria not fulfilled|2
4491213|NCT00789854|7293328|FG001|Overall Study|Eligibility criteria not fulfilled|5
4491214|NCT00789854|7293329|FG002|Overall Study|Eligibility criteria not fulfilled|1
4491215|NCT00789854|7293327|FG000|Overall Study|Severe non-compliance to the protocol|3
4491216|NCT00789854|7293328|FG001|Overall Study|Severe non-compliance to the protocol|0
4491217|NCT00789854|7293329|FG002|Overall Study|Severe non-compliance to the protocol|0
4491218|NCT00789854|7293327|FG000|Overall Study|Safety reasons|0
4491219|NCT00789854|7293328|FG001|Overall Study|Safety reasons|0
4491220|NCT00789854|7293329|FG002|Overall Study|Safety reasons|2
4491221|NCT00789854|7293327|FG000|Overall Study|Other|6
4491222|NCT00789854|7293328|FG001|Overall Study|Other|0
4702995|NCT02723591|7620265|FG001|Overall Study|Miscellaneous|6
4491223|NCT00789854|7293329|FG002|Overall Study|Other|5
4491224|NCT00789880|7293357|FG000|Overall Study|Adverse Event|0
4491225|NCT00789880|7293358|FG001|Overall Study|Adverse Event|0
4491226|NCT00789880|7293359|FG002|Overall Study|Adverse Event|0
4491227|NCT00789880|7293360|FG003|Overall Study|Adverse Event|0
4491228|NCT00789880|7293361|FG004|Overall Study|Adverse Event|1
4491229|NCT00789880|7293362|FG005|Overall Study|Adverse Event|0
4491230|NCT00789880|7293357|FG000|Overall Study|Protocol Violation|0
4491231|NCT00789880|7293358|FG001|Overall Study|Protocol Violation|1
4491232|NCT00789880|7293359|FG002|Overall Study|Protocol Violation|0
4491233|NCT00789880|7293360|FG003|Overall Study|Protocol Violation|1
4491234|NCT00789880|7293361|FG004|Overall Study|Protocol Violation|0
4491235|NCT00789880|7293362|FG005|Overall Study|Protocol Violation|0
4491236|NCT00789880|7293357|FG000|Overall Study|Withdrawal by Subject|1
4491237|NCT00789880|7293358|FG001|Overall Study|Withdrawal by Subject|0
4491238|NCT00789880|7293359|FG002|Overall Study|Withdrawal by Subject|0
4491239|NCT00789880|7293360|FG003|Overall Study|Withdrawal by Subject|0
4491240|NCT00789880|7293361|FG004|Overall Study|Withdrawal by Subject|2
4491241|NCT00789880|7293362|FG005|Overall Study|Withdrawal by Subject|0
4491242|NCT00789958|7293376|FG000|Overall Study|Adverse Event|3
4491243|NCT00789958|7293376|FG000|Overall Study|Withdrawal by Subject|4
4491244|NCT00789958|7293376|FG000|Overall Study|Progression|3
4491245|NCT00789958|7293376|FG000|Overall Study|not protocol specified|1
4491246|NCT00789958|7293376|FG000|Overall Study|Not eligible/not analyzable|26
4491247|NCT00790023|7293394|FG000|Overall Study|Adverse Event|2
4491248|NCT00790023|7293395|FG001|Overall Study|Adverse Event|1
4491249|NCT00790023|7293396|FG002|Overall Study|Adverse Event|4
4491250|NCT00790023|7293394|FG000|Overall Study|Protocol Violation|2
4491251|NCT00790023|7293395|FG001|Overall Study|Protocol Violation|4
4491252|NCT00790023|7293396|FG002|Overall Study|Protocol Violation|2
4491253|NCT00790023|7293394|FG000|Overall Study|Withdrawal by Subject|2
4491254|NCT00790023|7293395|FG001|Overall Study|Withdrawal by Subject|0
4491255|NCT00790023|7293396|FG002|Overall Study|Withdrawal by Subject|6
4491256|NCT00790023|7293394|FG000|Overall Study|Lost to Follow-up|0
4491257|NCT00790023|7293395|FG001|Overall Study|Lost to Follow-up|0
4491258|NCT00790023|7293396|FG002|Overall Study|Lost to Follow-up|1
4491259|NCT00790023|7293394|FG000|Overall Study|Other|5
4491260|NCT00790023|7293395|FG001|Overall Study|Other|5
4491261|NCT00790023|7293396|FG002|Overall Study|Other|8
4491262|NCT00790036|7293407|FG000|Overall Study|Abnormal lab values|3
4491263|NCT00790036|7293408|FG001|Overall Study|Abnormal lab values|2
4491264|NCT00790036|7293407|FG000|Overall Study|Administrative problems|5
4491265|NCT00790036|7293408|FG001|Overall Study|Administrative problems|9
4491266|NCT00790036|7293407|FG000|Overall Study|Adverse Event|113
4491267|NCT00790036|7293408|FG001|Overall Study|Adverse Event|44
4491268|NCT00790036|7293407|FG000|Overall Study|Death|1
4491269|NCT00790036|7293408|FG001|Overall Study|Death|0
4491270|NCT00790036|7293407|FG000|Overall Study|Disease progression|24
4491271|NCT00790036|7293408|FG001|Overall Study|Disease progression|48
4491272|NCT00790036|7293407|FG000|Overall Study|Lost to Follow-up|1
4491273|NCT00790036|7293408|FG001|Overall Study|Lost to Follow-up|2
4491274|NCT00790036|7293407|FG000|Overall Study|Protocol Violation|10
4491275|NCT00790036|7293408|FG001|Overall Study|Protocol Violation|2
4491276|NCT00790036|7293407|FG000|Overall Study|Withdrawal by Subject|18
4491277|NCT00790036|7293408|FG001|Overall Study|Withdrawal by Subject|7
4491278|NCT00790036|7293407|FG000|Overall Study|Subject/guardian decision|20
4491279|NCT00790036|7293408|FG001|Overall Study|Subject/guardian decision|7
4491280|NCT00790088|7293437|FG000|Overall Study|Protocol Violation|11
4491281|NCT00790088|7293437|FG000|Overall Study|Withdrawal by Subject|17
4491282|NCT00790088|7293437|FG000|Overall Study|Lost to Follow-up|7
4491283|NCT00790088|7293437|FG000|Overall Study|Physician Decision|4
4491284|NCT00790205|7293462|FG000|Overall Study|Lost to Follow-up|61
4491285|NCT00790205|7293463|FG001|Overall Study|Lost to Follow-up|71
4491286|NCT00790205|7293462|FG000|Overall Study|Withdrawal by Subject|299
4491287|NCT00790205|7293463|FG001|Overall Study|Withdrawal by Subject|363
4491288|NCT00790218|7293469|FG000|Overall Study|Death|1
4491289|NCT00790218|7293470|FG001|Overall Study|Death|0
4491290|NCT00790218|7293471|FG002|Overall Study|Death|0
4491291|NCT00790296|7293494|FG000|Overall Study|Did not meet study eligibility criteria|1
4491292|NCT00790296|7293495|FG001|Overall Study|Did not meet study eligibility criteria|1
4491293|NCT00790296|7293494|FG000|Overall Study|Adverse Event|0
4491294|NCT00790296|7293495|FG001|Overall Study|Adverse Event|1
4491295|NCT00790400|7293512|FG000|Double-blind Period (Core Phase)|Protocol Violation|1
4590279|NCT01519791|7436088|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1
4491296|NCT00790400|7293513|FG001|Double-blind Period (Core Phase)|Protocol Violation|0
4491297|NCT00790400|7293512|FG000|Double-blind Period (Core Phase)|Progressive disease|0
4491298|NCT00790400|7293513|FG001|Double-blind Period (Core Phase)|Progressive disease|9
4491299|NCT00790400|7293512|FG000|Double-blind Period (Core Phase)|Adverse Event|2
4491300|NCT00790400|7293513|FG001|Double-blind Period (Core Phase)|Adverse Event|4
4491301|NCT00790400|7293512|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1
4702996|NCT02723630|7620277|FG000|Intervention Period 1|Adverse Event|1
4491302|NCT00790400|7293513|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0
4491303|NCT00790400|7293512|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1
4491304|NCT00790400|7293513|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0
4491305|NCT00790400|7293512|FG000|Double-blind Period (Core Phase)|Administrative problems|1
4491306|NCT00790400|7293513|FG001|Double-blind Period (Core Phase)|Administrative problems|0
4491307|NCT00790400|7293512|FG000|Double-blind Period (Core Phase)|Death|1
4491308|NCT00790400|7293513|FG001|Double-blind Period (Core Phase)|Death|0
4491309|NCT00790400|7293512|FG000|Everolimus Period (Core or Extension)|Adverse Event|9
4491310|NCT00790400|7293513|FG001|Everolimus Period (Core or Extension)|Adverse Event|0
4491311|NCT00790400|7293512|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1
4491312|NCT00790400|7293513|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0
4491313|NCT00790400|7293512|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7
4491314|NCT00790400|7293513|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0
4491315|NCT00790400|7293512|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1
4491316|NCT00790400|7293513|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0
4491317|NCT00790400|7293512|FG000|Everolimus Period (Core or Extension)|Administrative problems|2
4491318|NCT00790400|7293513|FG001|Everolimus Period (Core or Extension)|Administrative problems|0
4491319|NCT00790400|7293512|FG000|Everolimus Period (Core or Extension)|Death|1
4491320|NCT00790400|7293513|FG001|Everolimus Period (Core or Extension)|Death|0
4491321|NCT00790400|7293512|FG000|Everolimus Period (Core or Extension)|Disease progression|5
4491322|NCT00790400|7293513|FG001|Everolimus Period (Core or Extension)|Disease progression|0
4491323|NCT00790400|7293512|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1
4491324|NCT00790400|7293513|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0
4491325|NCT00790400|7293512|FG000|Everolimus Period (Core or Extension)|New treatment|2
4491326|NCT00790400|7293513|FG001|Everolimus Period (Core or Extension)|New treatment|0
4491327|NCT00790556|7293522|FG000|Treatment Period 1|Physician Decision|1
4491328|NCT00790556|7293523|FG001|Treatment Period 1|Physician Decision|0
4491329|NCT00790556|7293522|FG000|Treatment Period 1|Withdrawal by Subject|1
4491330|NCT00790556|7293523|FG001|Treatment Period 1|Withdrawal by Subject|0
4491331|NCT00790569|7293532|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20
4491332|NCT00790569|7293533|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8
4491333|NCT00790569|7293534|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20
4491334|NCT00790569|7293532|FG000|End of Treatment (6 Month Interview)|Death|0
4491335|NCT00790569|7293533|FG001|End of Treatment (6 Month Interview)|Death|2
4491336|NCT00790569|7293534|FG002|End of Treatment (6 Month Interview)|Death|1
4491337|NCT00790569|7293532|FG000|End of Treatment (6 Month Interview)|Hospitalized|2
4491338|NCT00790569|7293533|FG001|End of Treatment (6 Month Interview)|Hospitalized|0
4491339|NCT00790569|7293534|FG002|End of Treatment (6 Month Interview)|Hospitalized|0
4491340|NCT00790569|7293532|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0
4491341|NCT00790569|7293533|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0
4491342|NCT00790569|7293534|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2
4491343|NCT00790569|7293532|FG000|End of Treatment (6 Month Interview)|Incarcerated|0
4491344|NCT00790569|7293533|FG001|End of Treatment (6 Month Interview)|Incarcerated|0
4491345|NCT00790569|7293534|FG002|End of Treatment (6 Month Interview)|Incarcerated|3
4491346|NCT00790569|7293532|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66
4491347|NCT00790569|7293533|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19
4491348|NCT00790569|7293534|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50
4491349|NCT00790582|7293544|FG000|Overall Study|Death|14
4491350|NCT00790582|7293545|FG001|Overall Study|Death|32
4491351|NCT00790582|7293544|FG000|Overall Study|Physician Decision|7
4491352|NCT00790582|7293545|FG001|Overall Study|Physician Decision|1
4491353|NCT00790582|7293544|FG000|Overall Study|Lost to Follow-up|3
4491354|NCT00790582|7293545|FG001|Overall Study|Lost to Follow-up|3
4491355|NCT00790582|7293544|FG000|Overall Study|Withdrawal by Subject|7
4491356|NCT00790582|7293545|FG001|Overall Study|Withdrawal by Subject|51
4491357|NCT00790647|7293553|FG000|Overall Study|Adverse Event|1
4491358|NCT00790751|7293600|FG000|Overall Study|Protocol non-compliance|16
4491359|NCT00790751|7293601|FG001|Overall Study|Protocol non-compliance|16
4491360|NCT00790751|7293602|FG002|Overall Study|Protocol non-compliance|10
4491361|NCT00790751|7293603|FG003|Overall Study|Protocol non-compliance|11
4491362|NCT00790751|7293600|FG000|Overall Study|Lost to Follow-up|4
4491363|NCT00790751|7293601|FG001|Overall Study|Lost to Follow-up|9
4491364|NCT00790751|7293602|FG002|Overall Study|Lost to Follow-up|4
4491365|NCT00790751|7293603|FG003|Overall Study|Lost to Follow-up|5
4491366|NCT00790751|7293600|FG000|Overall Study|Adverse Event|5
4491367|NCT00790751|7293601|FG001|Overall Study|Adverse Event|3
4491368|NCT00790751|7293602|FG002|Overall Study|Adverse Event|5
4491369|NCT00790751|7293603|FG003|Overall Study|Adverse Event|4
4491370|NCT00790751|7293600|FG000|Overall Study|Requirement for restricted medication|0
4491371|NCT00790751|7293601|FG001|Overall Study|Requirement for restricted medication|2
4491372|NCT00790751|7293602|FG002|Overall Study|Requirement for restricted medication|0
4491373|NCT00790751|7293603|FG003|Overall Study|Requirement for restricted medication|0
4491374|NCT00790751|7293600|FG000|Overall Study|Death|0
4491375|NCT00790751|7293601|FG001|Overall Study|Death|0
4491376|NCT00790751|7293602|FG002|Overall Study|Death|1
4491377|NCT00790751|7293603|FG003|Overall Study|Death|0
4491378|NCT00790751|7293600|FG000|Overall Study|Physician Decision|0
4491379|NCT00790751|7293601|FG001|Overall Study|Physician Decision|0
4491380|NCT00790751|7293602|FG002|Overall Study|Physician Decision|0
4491381|NCT00790751|7293603|FG003|Overall Study|Physician Decision|1
4491382|NCT00790790|7293616|FG000|Study Period 2: Therapy Phase|Adverse Event|3
4491383|NCT00790790|7293617|FG001|Study Period 2: Therapy Phase|Adverse Event|16
4491384|NCT00790790|7293618|FG002|Study Period 2: Therapy Phase|Adverse Event|16
4491385|NCT00790790|7293616|FG000|Study Period 2: Therapy Phase|Protocol Violation|1
4491386|NCT00790790|7293617|FG001|Study Period 2: Therapy Phase|Protocol Violation|1
4491387|NCT00790790|7293618|FG002|Study Period 2: Therapy Phase|Protocol Violation|0
4491388|NCT00790790|7293616|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7
4491389|NCT00790790|7293617|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0
4491390|NCT00790790|7293618|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2
4491391|NCT00790790|7293616|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1
4491392|NCT00790790|7293617|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0
4491393|NCT00790790|7293618|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3
4491394|NCT00790790|7293616|FG000|Study Period 2: Therapy Phase|Physician Decision|0
4491395|NCT00790790|7293617|FG001|Study Period 2: Therapy Phase|Physician Decision|1
4491396|NCT00790790|7293618|FG002|Study Period 2: Therapy Phase|Physician Decision|0
4491397|NCT00790842|7293634|FG000|Dose Level 1|Adverse Event|1
4491398|NCT00790842|7293635|FG001|Dose Level 1|Adverse Event|0
4491399|NCT00790842|7293636|FG002|Dose Level 1|Adverse Event|0
4491400|NCT00790842|7293637|FG003|Dose Level 1|Adverse Event|2
4491401|NCT00790842|7293638|FG004|Dose Level 1|Adverse Event|0
4491402|NCT00790842|7293639|FG005|Dose Level 1|Adverse Event|0
4491403|NCT00790842|7293640|FG006|Dose Level 1|Adverse Event|0
4491404|NCT00790842|7293641|FG007|Dose Level 1|Adverse Event|1
4491405|NCT00790842|7293642|FG008|Dose Level 1|Adverse Event|0
4491406|NCT00790842|7293643|FG009|Dose Level 1|Adverse Event|0
4491407|NCT00790842|7293644|FG010|Dose Level 1|Adverse Event|0
4491408|NCT00790842|7293634|FG000|Dose Level 1|Physician Decision|1
4491409|NCT00790842|7293635|FG001|Dose Level 1|Physician Decision|0
4491410|NCT00790842|7293636|FG002|Dose Level 1|Physician Decision|0
4491411|NCT00790842|7293637|FG003|Dose Level 1|Physician Decision|0
4491412|NCT00790842|7293638|FG004|Dose Level 1|Physician Decision|0
4491413|NCT00790842|7293639|FG005|Dose Level 1|Physician Decision|0
4491414|NCT00790842|7293640|FG006|Dose Level 1|Physician Decision|0
4491415|NCT00790842|7293641|FG007|Dose Level 1|Physician Decision|1
4491416|NCT00790842|7293642|FG008|Dose Level 1|Physician Decision|0
4491417|NCT00790842|7293643|FG009|Dose Level 1|Physician Decision|0
4491418|NCT00790842|7293644|FG010|Dose Level 1|Physician Decision|0
4491419|NCT00790842|7293634|FG000|Dose Level 1|Withdrawal by Subject|1
4491420|NCT00790842|7293635|FG001|Dose Level 1|Withdrawal by Subject|0
4491421|NCT00790842|7293636|FG002|Dose Level 1|Withdrawal by Subject|0
4491422|NCT00790842|7293637|FG003|Dose Level 1|Withdrawal by Subject|0
4491423|NCT00790842|7293638|FG004|Dose Level 1|Withdrawal by Subject|0
4491424|NCT00790842|7293639|FG005|Dose Level 1|Withdrawal by Subject|0
4491425|NCT00790842|7293640|FG006|Dose Level 1|Withdrawal by Subject|0
4491426|NCT00790842|7293641|FG007|Dose Level 1|Withdrawal by Subject|0
4491427|NCT00790842|7293642|FG008|Dose Level 1|Withdrawal by Subject|0
4491428|NCT00790842|7293643|FG009|Dose Level 1|Withdrawal by Subject|0
4491429|NCT00790842|7293644|FG010|Dose Level 1|Withdrawal by Subject|0
4491430|NCT00790842|7293634|FG000|Dose Level 2|Death|0
4491431|NCT00790842|7293635|FG001|Dose Level 2|Death|1
4491432|NCT00790842|7293636|FG002|Dose Level 2|Death|0
4491433|NCT00790842|7293637|FG003|Dose Level 2|Death|0
4491434|NCT00790842|7293638|FG004|Dose Level 2|Death|1
4491435|NCT00790842|7293639|FG005|Dose Level 2|Death|0
4491436|NCT00790842|7293640|FG006|Dose Level 2|Death|0
4491437|NCT00790842|7293641|FG007|Dose Level 2|Death|0
4491438|NCT00790842|7293642|FG008|Dose Level 2|Death|0
4491439|NCT00790842|7293643|FG009|Dose Level 2|Death|0
4491440|NCT00790842|7293644|FG010|Dose Level 2|Death|0
4491441|NCT00790842|7293634|FG000|Dose Level 2|Physician Decision|0
4491442|NCT00790842|7293635|FG001|Dose Level 2|Physician Decision|1
4491443|NCT00790842|7293636|FG002|Dose Level 2|Physician Decision|0
4491444|NCT00790842|7293637|FG003|Dose Level 2|Physician Decision|0
4491445|NCT00790842|7293638|FG004|Dose Level 2|Physician Decision|0
4491446|NCT00790842|7293639|FG005|Dose Level 2|Physician Decision|0
4491447|NCT00790842|7293640|FG006|Dose Level 2|Physician Decision|0
4491448|NCT00790842|7293641|FG007|Dose Level 2|Physician Decision|0
4491449|NCT00790842|7293642|FG008|Dose Level 2|Physician Decision|0
4491450|NCT00790842|7293643|FG009|Dose Level 2|Physician Decision|0
4491451|NCT00790842|7293644|FG010|Dose Level 2|Physician Decision|0
4491452|NCT00790842|7293634|FG000|Dose Level 2|Withdrawal by Subject|0
4491453|NCT00790842|7293635|FG001|Dose Level 2|Withdrawal by Subject|1
4491454|NCT00790842|7293636|FG002|Dose Level 2|Withdrawal by Subject|0
4491455|NCT00790842|7293637|FG003|Dose Level 2|Withdrawal by Subject|0
4491456|NCT00790842|7293638|FG004|Dose Level 2|Withdrawal by Subject|0
4491457|NCT00790842|7293639|FG005|Dose Level 2|Withdrawal by Subject|0
4491458|NCT00790842|7293640|FG006|Dose Level 2|Withdrawal by Subject|0
4491459|NCT00790842|7293641|FG007|Dose Level 2|Withdrawal by Subject|0
4491460|NCT00790842|7293642|FG008|Dose Level 2|Withdrawal by Subject|0
4491461|NCT00790842|7293643|FG009|Dose Level 2|Withdrawal by Subject|0
4491462|NCT00790842|7293644|FG010|Dose Level 2|Withdrawal by Subject|0
4491463|NCT00790842|7293634|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0
4491464|NCT00790842|7293635|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0
4491465|NCT00790842|7293636|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0
4491466|NCT00790842|7293637|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0
4491467|NCT00790842|7293638|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0
4491468|NCT00790842|7293639|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0
4491469|NCT00790842|7293640|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0
4491470|NCT00790842|7293641|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0
4491471|NCT00790842|7293642|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2
4491472|NCT00790842|7293643|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0
4491473|NCT00790842|7293644|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0
4491474|NCT00790842|7293634|FG000|Dose Level 3|Adverse Event|0
4491475|NCT00790842|7293635|FG001|Dose Level 3|Adverse Event|0
4491476|NCT00790842|7293636|FG002|Dose Level 3|Adverse Event|1
4491477|NCT00790842|7293637|FG003|Dose Level 3|Adverse Event|0
4491478|NCT00790842|7293638|FG004|Dose Level 3|Adverse Event|0
4491479|NCT00790842|7293639|FG005|Dose Level 3|Adverse Event|0
4491480|NCT00790842|7293640|FG006|Dose Level 3|Adverse Event|0
4491481|NCT00790842|7293641|FG007|Dose Level 3|Adverse Event|0
4491482|NCT00790842|7293642|FG008|Dose Level 3|Adverse Event|0
4491483|NCT00790842|7293643|FG009|Dose Level 3|Adverse Event|0
4491484|NCT00790842|7293644|FG010|Dose Level 3|Adverse Event|0
4491485|NCT00790842|7293634|FG000|Dose Level 3|Withdrawal by Subject|0
4491486|NCT00790842|7293635|FG001|Dose Level 3|Withdrawal by Subject|0
4491487|NCT00790842|7293636|FG002|Dose Level 3|Withdrawal by Subject|3
4491488|NCT00790842|7293637|FG003|Dose Level 3|Withdrawal by Subject|0
4491489|NCT00790842|7293638|FG004|Dose Level 3|Withdrawal by Subject|0
4491490|NCT00790842|7293639|FG005|Dose Level 3|Withdrawal by Subject|0
4491491|NCT00790842|7293640|FG006|Dose Level 3|Withdrawal by Subject|0
4491492|NCT00790842|7293641|FG007|Dose Level 3|Withdrawal by Subject|0
4491493|NCT00790842|7293642|FG008|Dose Level 3|Withdrawal by Subject|0
4491494|NCT00790842|7293643|FG009|Dose Level 3|Withdrawal by Subject|2
4491495|NCT00790842|7293644|FG010|Dose Level 3|Withdrawal by Subject|0
4491496|NCT00790842|7293634|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
4491497|NCT00790842|7293635|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
4491498|NCT00790842|7293636|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
4491499|NCT00790842|7293637|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
4491500|NCT00790842|7293638|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
4491501|NCT00790842|7293639|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1
4491502|NCT00790842|7293640|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
4491503|NCT00790842|7293641|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
4491504|NCT00790842|7293642|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
4491505|NCT00790842|7293643|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
4491506|NCT00790842|7293644|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
4491507|NCT00790842|7293634|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0
4491508|NCT00790842|7293635|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0
4491509|NCT00790842|7293636|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1
4491510|NCT00790842|7293637|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0
4491511|NCT00790842|7293638|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0
4491512|NCT00790842|7293639|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0
4491513|NCT00790842|7293640|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0
4491514|NCT00790842|7293641|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0
4491515|NCT00790842|7293642|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0
4491516|NCT00790842|7293643|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0
4491517|NCT00790842|7293644|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0
4491518|NCT00790842|7293634|FG000|Dose Level 4|Adverse Event|0
4491519|NCT00790842|7293635|FG001|Dose Level 4|Adverse Event|0
4491520|NCT00790842|7293636|FG002|Dose Level 4|Adverse Event|0
4491521|NCT00790842|7293637|FG003|Dose Level 4|Adverse Event|0
4491522|NCT00790842|7293638|FG004|Dose Level 4|Adverse Event|0
4491523|NCT00790842|7293639|FG005|Dose Level 4|Adverse Event|0
4491524|NCT00790842|7293640|FG006|Dose Level 4|Adverse Event|1
4491525|NCT00790842|7293641|FG007|Dose Level 4|Adverse Event|0
4491526|NCT00790842|7293642|FG008|Dose Level 4|Adverse Event|0
4491527|NCT00790842|7293643|FG009|Dose Level 4|Adverse Event|0
4491528|NCT00790842|7293644|FG010|Dose Level 4|Adverse Event|0
4491529|NCT00790842|7293634|FG000|Dose Level 4|Physician Decision|0
4491530|NCT00790842|7293635|FG001|Dose Level 4|Physician Decision|0
4491531|NCT00790842|7293636|FG002|Dose Level 4|Physician Decision|0
4491532|NCT00790842|7293637|FG003|Dose Level 4|Physician Decision|0
4491533|NCT00790842|7293638|FG004|Dose Level 4|Physician Decision|0
4491534|NCT00790842|7293639|FG005|Dose Level 4|Physician Decision|0
4491535|NCT00790842|7293640|FG006|Dose Level 4|Physician Decision|1
4491536|NCT00790842|7293641|FG007|Dose Level 4|Physician Decision|0
4491537|NCT00790842|7293642|FG008|Dose Level 4|Physician Decision|0
4491538|NCT00790842|7293643|FG009|Dose Level 4|Physician Decision|0
4491539|NCT00790842|7293644|FG010|Dose Level 4|Physician Decision|1
4491540|NCT00790842|7293634|FG000|Dose Level 4|Withdrawal by Subject|0
4491541|NCT00790842|7293635|FG001|Dose Level 4|Withdrawal by Subject|0
4491542|NCT00790842|7293636|FG002|Dose Level 4|Withdrawal by Subject|0
4491543|NCT00790842|7293637|FG003|Dose Level 4|Withdrawal by Subject|0
4491544|NCT00790842|7293638|FG004|Dose Level 4|Withdrawal by Subject|0
4491545|NCT00790842|7293639|FG005|Dose Level 4|Withdrawal by Subject|0
4491546|NCT00790842|7293640|FG006|Dose Level 4|Withdrawal by Subject|0
4491547|NCT00790842|7293641|FG007|Dose Level 4|Withdrawal by Subject|0
4491548|NCT00790842|7293642|FG008|Dose Level 4|Withdrawal by Subject|0
4491549|NCT00790842|7293643|FG009|Dose Level 4|Withdrawal by Subject|0
4491550|NCT00790842|7293644|FG010|Dose Level 4|Withdrawal by Subject|1
4491551|NCT00790842|7293634|FG000|Expansion Cohort|Adverse Event|0
4491552|NCT00790842|7293635|FG001|Expansion Cohort|Adverse Event|0
4491553|NCT00790842|7293636|FG002|Expansion Cohort|Adverse Event|0
4590280|NCT01519791|7436087|FG000|Overall Study|AE, non-serious non-fatal|12
4590281|NCT01519791|7436088|FG001|Overall Study|AE, non-serious non-fatal|31
4590282|NCT01519791|7436087|FG000|Overall Study|Withdrawal by Subject|15
4590283|NCT01519791|7436088|FG001|Overall Study|Withdrawal by Subject|37
4590284|NCT01519791|7436087|FG000|Overall Study|Lost to Follow-up|6
4590285|NCT01519791|7436088|FG001|Overall Study|Lost to Follow-up|14
4491554|NCT00790842|7293637|FG003|Expansion Cohort|Adverse Event|0
4491555|NCT00790842|7293638|FG004|Expansion Cohort|Adverse Event|0
4491556|NCT00790842|7293639|FG005|Expansion Cohort|Adverse Event|0
4491557|NCT00790842|7293640|FG006|Expansion Cohort|Adverse Event|1
4491558|NCT00790842|7293641|FG007|Expansion Cohort|Adverse Event|0
4491559|NCT00790842|7293642|FG008|Expansion Cohort|Adverse Event|0
4491560|NCT00790842|7293643|FG009|Expansion Cohort|Adverse Event|0
4491561|NCT00790842|7293644|FG010|Expansion Cohort|Adverse Event|0
4491562|NCT00790842|7293634|FG000|Expansion Cohort|Death|0
4491563|NCT00790842|7293635|FG001|Expansion Cohort|Death|0
4491564|NCT00790842|7293636|FG002|Expansion Cohort|Death|2
4491565|NCT00790842|7293637|FG003|Expansion Cohort|Death|0
4491566|NCT00790842|7293638|FG004|Expansion Cohort|Death|0
4491567|NCT00790842|7293639|FG005|Expansion Cohort|Death|0
4491568|NCT00790842|7293640|FG006|Expansion Cohort|Death|0
4491569|NCT00790842|7293641|FG007|Expansion Cohort|Death|0
4491570|NCT00790842|7293642|FG008|Expansion Cohort|Death|0
4491571|NCT00790842|7293643|FG009|Expansion Cohort|Death|0
4491572|NCT00790842|7293644|FG010|Expansion Cohort|Death|0
4491573|NCT00790842|7293634|FG000|Expansion Cohort|Physician Decision|0
4491574|NCT00790842|7293635|FG001|Expansion Cohort|Physician Decision|0
4491575|NCT00790842|7293636|FG002|Expansion Cohort|Physician Decision|1
4491576|NCT00790842|7293637|FG003|Expansion Cohort|Physician Decision|0
4491577|NCT00790842|7293638|FG004|Expansion Cohort|Physician Decision|0
4491578|NCT00790842|7293639|FG005|Expansion Cohort|Physician Decision|0
4491579|NCT00790842|7293640|FG006|Expansion Cohort|Physician Decision|0
4491580|NCT00790842|7293641|FG007|Expansion Cohort|Physician Decision|0
4491581|NCT00790842|7293642|FG008|Expansion Cohort|Physician Decision|0
4491582|NCT00790842|7293643|FG009|Expansion Cohort|Physician Decision|0
4491583|NCT00790842|7293644|FG010|Expansion Cohort|Physician Decision|0
4491584|NCT00790842|7293634|FG000|Expansion Cohort|Withdrawal by Subject|0
4491585|NCT00790842|7293635|FG001|Expansion Cohort|Withdrawal by Subject|0
4491586|NCT00790842|7293636|FG002|Expansion Cohort|Withdrawal by Subject|3
4491587|NCT00790842|7293637|FG003|Expansion Cohort|Withdrawal by Subject|0
4491588|NCT00790842|7293638|FG004|Expansion Cohort|Withdrawal by Subject|0
4491589|NCT00790842|7293639|FG005|Expansion Cohort|Withdrawal by Subject|0
4491590|NCT00790842|7293640|FG006|Expansion Cohort|Withdrawal by Subject|0
4491591|NCT00790842|7293641|FG007|Expansion Cohort|Withdrawal by Subject|0
4491592|NCT00790842|7293642|FG008|Expansion Cohort|Withdrawal by Subject|0
4491593|NCT00790842|7293643|FG009|Expansion Cohort|Withdrawal by Subject|0
4491594|NCT00790842|7293644|FG010|Expansion Cohort|Withdrawal by Subject|0
4491595|NCT00790842|7293634|FG000|Expansion Cohort|Study Closure|0
4491596|NCT00790842|7293635|FG001|Expansion Cohort|Study Closure|0
4491597|NCT00790842|7293636|FG002|Expansion Cohort|Study Closure|1
4491598|NCT00790842|7293637|FG003|Expansion Cohort|Study Closure|0
4491599|NCT00790842|7293638|FG004|Expansion Cohort|Study Closure|0
4491600|NCT00790842|7293639|FG005|Expansion Cohort|Study Closure|0
4491601|NCT00790842|7293640|FG006|Expansion Cohort|Study Closure|0
4491602|NCT00790842|7293641|FG007|Expansion Cohort|Study Closure|0
4491603|NCT00790842|7293642|FG008|Expansion Cohort|Study Closure|0
4491604|NCT00790842|7293643|FG009|Expansion Cohort|Study Closure|0
4491605|NCT00790842|7293644|FG010|Expansion Cohort|Study Closure|0
4491606|NCT00790868|7293699|FG000|Overall Study|Withdrawal by Subject|4
4491607|NCT00790868|7293700|FG001|Overall Study|Withdrawal by Subject|5
4491608|NCT00790868|7293699|FG000|Overall Study|Lost to Follow-up|2
4491609|NCT00790868|7293700|FG001|Overall Study|Lost to Follow-up|12
4491610|NCT00790907|7293711|FG000|Overall Study|Adverse Event|9
4491611|NCT00790907|7293712|FG001|Overall Study|Adverse Event|7
4491612|NCT00790907|7293713|FG002|Overall Study|Adverse Event|6
4491613|NCT00790907|7293711|FG000|Overall Study|Physician Decision|304
4491614|NCT00790907|7293712|FG001|Overall Study|Physician Decision|271
4491615|NCT00790907|7293713|FG002|Overall Study|Physician Decision|255
4590286|NCT01519817|7436096|FG000|Overall Study|Withdrawal by Subject|1
4491616|NCT00790907|7293711|FG000|Overall Study|Withdrawal by Subject|1
4491617|NCT00790907|7293712|FG001|Overall Study|Withdrawal by Subject|7
4491618|NCT00790907|7293713|FG002|Overall Study|Withdrawal by Subject|5
4491619|NCT00790907|7293711|FG000|Overall Study|Bleeding Event|11
4491620|NCT00790907|7293712|FG001|Overall Study|Bleeding Event|16
4491621|NCT00790907|7293713|FG002|Overall Study|Bleeding Event|21
4491622|NCT00790907|7293711|FG000|Overall Study|Required Protocol-prohibited Therapy|17
4491623|NCT00790907|7293712|FG001|Overall Study|Required Protocol-prohibited Therapy|5
4491624|NCT00790907|7293713|FG002|Overall Study|Required Protocol-prohibited Therapy|7
4491625|NCT00790907|7293711|FG000|Overall Study|Qualifying Condition Not Present|29
4491626|NCT00790907|7293712|FG001|Overall Study|Qualifying Condition Not Present|14
4491627|NCT00790907|7293713|FG002|Overall Study|Qualifying Condition Not Present|16
4491628|NCT00790907|7293711|FG000|Overall Study|Verbatim Reason on the Case Report Form|74
4491629|NCT00790907|7293712|FG001|Overall Study|Verbatim Reason on the Case Report Form|20
4491630|NCT00790907|7293713|FG002|Overall Study|Verbatim Reason on the Case Report Form|29
4491631|NCT00790907|7293711|FG000|Overall Study|Did Not Receive Study Drug|10
4491632|NCT00790907|7293712|FG001|Overall Study|Did Not Receive Study Drug|0
4491633|NCT00790907|7293713|FG002|Overall Study|Did Not Receive Study Drug|0
4491634|NCT00790933|7293725|FG000|Overall Study|Adverse Event|94
4626828|NCT01846299|7492872|FG000|Overall Study|Withdrawal by Subject|1
4626829|NCT01846299|7492873|FG001|Overall Study|Withdrawal by Subject|6
4626830|NCT01846299|7492872|FG000|Overall Study|Adverse Event|2
4626831|NCT01846299|7492873|FG001|Overall Study|Adverse Event|0
4626832|NCT01846416|7492884|FG000|Treatment Phase|Death|2
4626833|NCT01846416|7492885|FG001|Treatment Phase|Death|9
4626834|NCT01846416|7492886|FG002|Treatment Phase|Death|1
4626835|NCT01846416|7492884|FG000|Treatment Phase|Withdrawal by Subject|2
4626836|NCT01846416|7492885|FG001|Treatment Phase|Withdrawal by Subject|4
4626837|NCT01846416|7492886|FG002|Treatment Phase|Withdrawal by Subject|2
4626838|NCT01846416|7492884|FG000|Treatment Phase|Other|1
4626839|NCT01846416|7492885|FG001|Treatment Phase|Other|5
4626840|NCT01846416|7492886|FG002|Treatment Phase|Other|1
4626841|NCT01846416|7492884|FG000|Treatment Phase|Physician Decision|1
4626842|NCT01846416|7492885|FG001|Treatment Phase|Physician Decision|2
4626843|NCT01846416|7492886|FG002|Treatment Phase|Physician Decision|0
4626844|NCT01846416|7492884|FG000|Treatment Phase|Adverse Event|3
4626845|NCT01846416|7492885|FG001|Treatment Phase|Adverse Event|4
4626846|NCT01846416|7492886|FG002|Treatment Phase|Adverse Event|0
4626847|NCT01846416|7492884|FG000|Treatment Phase|Non-compliance|0
4626848|NCT01846416|7492885|FG001|Treatment Phase|Non-compliance|2
4626849|NCT01846416|7492886|FG002|Treatment Phase|Non-compliance|0
4626850|NCT01846416|7492884|FG000|Treatment Phase|Study Terminated by Sponsor|1
4626851|NCT01846416|7492885|FG001|Treatment Phase|Study Terminated by Sponsor|4
4626852|NCT01846416|7492886|FG002|Treatment Phase|Study Terminated by Sponsor|0
4626853|NCT01846416|7492884|FG000|Treatment Phase|Progressive Disease|21
4626854|NCT01846416|7492885|FG001|Treatment Phase|Progressive Disease|63
4626855|NCT01846416|7492886|FG002|Treatment Phase|Progressive Disease|9
4626856|NCT01846416|7492884|FG000|Survival Follow-up|Death|21
4626857|NCT01846416|7492885|FG001|Survival Follow-up|Death|62
4626858|NCT01846416|7492886|FG002|Survival Follow-up|Death|9
4626859|NCT01846416|7492884|FG000|Survival Follow-up|Lost to Follow-up|0
4626860|NCT01846416|7492885|FG001|Survival Follow-up|Lost to Follow-up|2
4626861|NCT01846416|7492886|FG002|Survival Follow-up|Lost to Follow-up|2
4626862|NCT01846416|7492884|FG000|Survival Follow-up|Withdrawal by Subject|2
4626863|NCT01846416|7492885|FG001|Survival Follow-up|Withdrawal by Subject|7
4626864|NCT01846416|7492886|FG002|Survival Follow-up|Withdrawal by Subject|0
4626865|NCT01846416|7492884|FG000|Survival Follow-up|Study Terminated by Sponsor|2
4626866|NCT01846416|7492885|FG001|Survival Follow-up|Study Terminated by Sponsor|8
4702997|NCT02723630|7620278|FG001|Intervention Period 1|Adverse Event|0
4491635|NCT00790933|7293726|FG001|Overall Study|Adverse Event|119
4491636|NCT00790933|7293727|FG002|Overall Study|Adverse Event|65
4491637|NCT00790933|7293728|FG003|Overall Study|Adverse Event|5
4491638|NCT00790933|7293729|FG004|Overall Study|Adverse Event|69
4491639|NCT00790933|7293725|FG000|Overall Study|Protocol Violation(s)|8
4491640|NCT00790933|7293726|FG001|Overall Study|Protocol Violation(s)|18
4491641|NCT00790933|7293727|FG002|Overall Study|Protocol Violation(s)|7
4491642|NCT00790933|7293728|FG003|Overall Study|Protocol Violation(s)|0
4491643|NCT00790933|7293729|FG004|Overall Study|Protocol Violation(s)|12
4491644|NCT00790933|7293725|FG000|Overall Study|Lack of Efficacy|192
4491645|NCT00790933|7293726|FG001|Overall Study|Lack of Efficacy|176
4491646|NCT00790933|7293727|FG002|Overall Study|Lack of Efficacy|130
4491647|NCT00790933|7293728|FG003|Overall Study|Lack of Efficacy|1
4491648|NCT00790933|7293729|FG004|Overall Study|Lack of Efficacy|121
4491649|NCT00790933|7293725|FG000|Overall Study|Study Terminated by Sponsor|0
4491650|NCT00790933|7293726|FG001|Overall Study|Study Terminated by Sponsor|0
4491651|NCT00790933|7293727|FG002|Overall Study|Study Terminated by Sponsor|1
4491652|NCT00790933|7293728|FG003|Overall Study|Study Terminated by Sponsor|0
4491653|NCT00790933|7293729|FG004|Overall Study|Study Terminated by Sponsor|0
4491654|NCT00790933|7293725|FG000|Overall Study|Withdrawal by Subject|123
4626867|NCT01846416|7492886|FG002|Survival Follow-up|Study Terminated by Sponsor|0
4626868|NCT01846416|7492884|FG000|Survival Follow-up|Other|3
4626869|NCT01846416|7492885|FG001|Survival Follow-up|Other|1
4626870|NCT01846416|7492886|FG002|Survival Follow-up|Other|1
4626871|NCT01846442|7492899|FG000|Overall Study|Adverse Event|2
4626872|NCT01846442|7492900|FG001|Overall Study|Adverse Event|4
4626873|NCT01846442|7492901|FG002|Overall Study|Adverse Event|2
4491655|NCT00790933|7293726|FG001|Overall Study|Withdrawal by Subject|120
4491656|NCT00790933|7293727|FG002|Overall Study|Withdrawal by Subject|52
4491657|NCT00790933|7293728|FG003|Overall Study|Withdrawal by Subject|6
4491658|NCT00790933|7293729|FG004|Overall Study|Withdrawal by Subject|50
4491659|NCT00790933|7293725|FG000|Overall Study|Lost to Follow-up|13
4491660|NCT00790933|7293726|FG001|Overall Study|Lost to Follow-up|31
4491661|NCT00790933|7293727|FG002|Overall Study|Lost to Follow-up|10
4491662|NCT00790933|7293728|FG003|Overall Study|Lost to Follow-up|1
4491663|NCT00790933|7293729|FG004|Overall Study|Lost to Follow-up|15
4491664|NCT00790933|7293725|FG000|Overall Study|Reason Not Specified|8
4491665|NCT00790933|7293726|FG001|Overall Study|Reason Not Specified|16
4491666|NCT00790933|7293727|FG002|Overall Study|Reason Not Specified|4
4491667|NCT00790933|7293728|FG003|Overall Study|Reason Not Specified|1
4491668|NCT00790933|7293729|FG004|Overall Study|Reason Not Specified|9
4491669|NCT00791128|7293767|FG000|Overall Study|Adverse Event|4
4491670|NCT00791128|7293767|FG000|Overall Study|Device migration|2
4491671|NCT00791128|7293767|FG000|Overall Study|non-compliance by subject|2
4491672|NCT00791128|7293767|FG000|Overall Study|abdominal tumor, unrelated to device|1
4491673|NCT00791258|7293784|FG000|Overall Study|Adverse Event|87
4491674|NCT00791258|7293784|FG000|Overall Study|Lost to Follow-up|18
4491675|NCT00791258|7293784|FG000|Overall Study|Protocol Violation|109
4491676|NCT00791258|7293784|FG000|Overall Study|Withdrawal by Subject|40
4491677|NCT00791258|7293784|FG000|Overall Study|Did not take medication for >3 days|1
4491678|NCT00791258|7293784|FG000|Overall Study|subject left area|2
4491679|NCT00791258|7293784|FG000|Overall Study|non-compliance|3
4491680|NCT00791258|7293784|FG000|Overall Study|Subject incarcerated|1
4491681|NCT00791258|7293784|FG000|Overall Study|Subject required restricted medication|1
4491682|NCT00791258|7293784|FG000|Overall Study|Lack of Efficacy|1
4491683|NCT00791388|7293802|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
4491684|NCT00791388|7293803|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1
4491685|NCT00791388|7293804|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
4491686|NCT00791388|7293805|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
4491687|NCT00791388|7293806|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
4491688|NCT00791388|7293802|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1
4491689|NCT00791388|7293803|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
4491690|NCT00791388|7293804|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
4491691|NCT00791388|7293805|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
4491692|NCT00791388|7293806|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
4491693|NCT00791388|7293802|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0
4491694|NCT00791388|7293803|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0
4491695|NCT00791388|7293804|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0
4491696|NCT00791388|7293805|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0
4491697|NCT00791388|7293806|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4
4491698|NCT00791479|7293824|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0
4491699|NCT00791479|7293825|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0
4491700|NCT00791479|7293826|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0
4491701|NCT00791479|7293827|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0
4491702|NCT00791479|7293828|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3
4491703|NCT00791479|7293829|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0
4491704|NCT00791479|7293824|FG000|Overall Study|Adverse Event|0
4491705|NCT00791479|7293825|FG001|Overall Study|Adverse Event|1
4491706|NCT00791479|7293826|FG002|Overall Study|Adverse Event|0
4491707|NCT00791479|7293827|FG003|Overall Study|Adverse Event|2
4491708|NCT00791479|7293828|FG004|Overall Study|Adverse Event|0
4491709|NCT00791479|7293829|FG005|Overall Study|Adverse Event|1
4491710|NCT00791479|7293824|FG000|Overall Study|Lost to Follow-up|0
4491711|NCT00791479|7293825|FG001|Overall Study|Lost to Follow-up|1
4491712|NCT00791479|7293826|FG002|Overall Study|Lost to Follow-up|0
4491713|NCT00791479|7293827|FG003|Overall Study|Lost to Follow-up|0
4491714|NCT00791479|7293828|FG004|Overall Study|Lost to Follow-up|0
4491715|NCT00791479|7293829|FG005|Overall Study|Lost to Follow-up|1
4491716|NCT00791479|7293824|FG000|Overall Study|Protocol Violation|2
4491717|NCT00791479|7293825|FG001|Overall Study|Protocol Violation|1
4491718|NCT00791479|7293826|FG002|Overall Study|Protocol Violation|0
4491719|NCT00791479|7293827|FG003|Overall Study|Protocol Violation|1
4491720|NCT00791479|7293828|FG004|Overall Study|Protocol Violation|0
4491721|NCT00791479|7293829|FG005|Overall Study|Protocol Violation|0
4491722|NCT00791479|7293824|FG000|Overall Study|Withdrawal by Subject|0
4491723|NCT00791479|7293825|FG001|Overall Study|Withdrawal by Subject|0
4491724|NCT00791479|7293826|FG002|Overall Study|Withdrawal by Subject|0
4491725|NCT00791479|7293827|FG003|Overall Study|Withdrawal by Subject|1
4491726|NCT00791479|7293828|FG004|Overall Study|Withdrawal by Subject|0
4491727|NCT00791479|7293829|FG005|Overall Study|Withdrawal by Subject|1
4491728|NCT00791492|7293852|FG000|Overall Study|Withdrawal by Subject|1
4491729|NCT00791492|7293853|FG001|Overall Study|Withdrawal by Subject|2
4491730|NCT00791492|7293852|FG000|Overall Study|Liver transplantation|5
4491731|NCT00791492|7293853|FG001|Overall Study|Liver transplantation|1
4491732|NCT00791518|7293859|FG000|Overall Study|Protocol Violation|93
4491733|NCT00791557|7293878|FG000|Overall Study|Adverse Event|1
4491734|NCT00791648|7293884|FG000|Overall Study|Physician Decision|0
4491735|NCT00791648|7293885|FG001|Overall Study|Physician Decision|1
4491736|NCT00791648|7293884|FG000|Overall Study|Withdrawal by Subject|0
4491737|NCT00791648|7293885|FG001|Overall Study|Withdrawal by Subject|1
4491738|NCT00791661|7293894|FG000|7 Day Wash-out|Adverse Event|0
4491739|NCT00791661|7293895|FG001|7 Day Wash-out|Adverse Event|0
4491740|NCT00791661|7293896|FG002|7 Day Wash-out|Adverse Event|1
4491741|NCT00791661|7293894|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0
4491742|NCT00791661|7293895|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0
4491743|NCT00791661|7293896|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1
4491744|NCT00791700|7293924|FG000|Overall Study|Insufficient clinical response|1
4491745|NCT00791700|7293925|FG001|Overall Study|Insufficient clinical response|4
4491746|NCT00791700|7293926|FG002|Overall Study|Insufficient clinical response|1
4491747|NCT00791700|7293927|FG003|Overall Study|Insufficient clinical response|8
4491748|NCT00791700|7293924|FG000|Overall Study|No longer willing to participate|1
4491749|NCT00791700|7293925|FG001|Overall Study|No longer willing to participate|1
4491750|NCT00791700|7293926|FG002|Overall Study|No longer willing to participate|0
4491751|NCT00791700|7293927|FG003|Overall Study|No longer willing to participate|8
4491752|NCT00791700|7293924|FG000|Overall Study|Non-compliance with study treatment|0
4491753|NCT00791700|7293925|FG001|Overall Study|Non-compliance with study treatment|2
4491754|NCT00791700|7293926|FG002|Overall Study|Non-compliance with study treatment|0
4491755|NCT00791700|7293927|FG003|Overall Study|Non-compliance with study treatment|4
4491756|NCT00791700|7293924|FG000|Overall Study|Withdrawn due to pregnancy|0
4491757|NCT00791700|7293925|FG001|Overall Study|Withdrawn due to pregnancy|0
4491758|NCT00791700|7293926|FG002|Overall Study|Withdrawn due to pregnancy|0
4491759|NCT00791700|7293927|FG003|Overall Study|Withdrawn due to pregnancy|1
4491760|NCT00791700|7293924|FG000|Overall Study|Other|0
4491761|NCT00791700|7293925|FG001|Overall Study|Other|1
4491762|NCT00791700|7293926|FG002|Overall Study|Other|0
4491763|NCT00791700|7293927|FG003|Overall Study|Other|1
4491764|NCT00791700|7293924|FG000|Overall Study|Death|0
4491765|NCT00791700|7293925|FG001|Overall Study|Death|0
4491766|NCT00791700|7293926|FG002|Overall Study|Death|0
4491767|NCT00791700|7293927|FG003|Overall Study|Death|1
4491768|NCT00791700|7293924|FG000|Overall Study|Lost to Follow-up|4
4491769|NCT00791700|7293925|FG001|Overall Study|Lost to Follow-up|3
4491770|NCT00791700|7293926|FG002|Overall Study|Lost to Follow-up|4
4491771|NCT00791700|7293927|FG003|Overall Study|Lost to Follow-up|6
4491772|NCT00791700|7293924|FG000|Overall Study|Adverse Event|0
4491773|NCT00791700|7293925|FG001|Overall Study|Adverse Event|0
4491774|NCT00791700|7293926|FG002|Overall Study|Adverse Event|1
4491775|NCT00791700|7293927|FG003|Overall Study|Adverse Event|1
4491776|NCT00791765|7293950|FG000|Weeks 1 to 12|Adverse Event|0
4491777|NCT00791765|7293951|FG001|Weeks 1 to 12|Adverse Event|1
4491778|NCT00791765|7293950|FG000|Weeks 1 to 12|Lost to Follow-up|1
4491779|NCT00791765|7293951|FG001|Weeks 1 to 12|Lost to Follow-up|0
4491780|NCT00791765|7293950|FG000|Weeks 1 to 12|Withdrawal by Subject|3
4491781|NCT00791765|7293951|FG001|Weeks 1 to 12|Withdrawal by Subject|0
4491782|NCT00791765|7293950|FG000|Weeks 1 to 12|Physician Decision|1
4491783|NCT00791765|7293951|FG001|Weeks 1 to 12|Physician Decision|0
4491784|NCT00791765|7293950|FG000|Weeks 1 to 12|Disease progression|3
4491785|NCT00791765|7293951|FG001|Weeks 1 to 12|Disease progression|0
4491786|NCT00791765|7293950|FG000|Weeks 1 to 12|Ineligibility determined|0
4491787|NCT00791765|7293951|FG001|Weeks 1 to 12|Ineligibility determined|3
4491788|NCT00791765|7293950|FG000|Weeks 13 to 24|Protocol deviation|2
4491789|NCT00791765|7293951|FG001|Weeks 13 to 24|Protocol deviation|0
4491790|NCT00791765|7293950|FG000|Weeks 13 to 24|Adverse Event|0
4491791|NCT00791765|7293951|FG001|Weeks 13 to 24|Adverse Event|3
4491792|NCT00791765|7293950|FG000|Weeks 13 to 24|Withdrawal by Subject|2
4491793|NCT00791765|7293951|FG001|Weeks 13 to 24|Withdrawal by Subject|1
4491794|NCT00791765|7293950|FG000|Weeks 13 to 24|Disease progression|0
4491795|NCT00791765|7293951|FG001|Weeks 13 to 24|Disease progression|1
4491796|NCT00791765|7293950|FG000|Weeks 13 to 24|Lost to Follow-up|1
4491797|NCT00791765|7293951|FG001|Weeks 13 to 24|Lost to Follow-up|2
4491798|NCT00791765|7293950|FG000|Weeks 13 to 24|Other|0
4491799|NCT00791765|7293951|FG001|Weeks 13 to 24|Other|1
4491800|NCT00791778|7293959|FG000|Double-blind Treatment|Adverse Event|49
4491801|NCT00791778|7293960|FG001|Double-blind Treatment|Adverse Event|9
4491802|NCT00791778|7293959|FG000|Double-blind Treatment|Physician Decision|6
4491803|NCT00791778|7293960|FG001|Double-blind Treatment|Physician Decision|26
4491804|NCT00791778|7293959|FG000|Double-blind Treatment|Protocol Violation|0
4491805|NCT00791778|7293960|FG001|Double-blind Treatment|Protocol Violation|4
4491806|NCT00791778|7293959|FG000|Double-blind Treatment|Withdrawal by Subject|20
4491807|NCT00791778|7293960|FG001|Double-blind Treatment|Withdrawal by Subject|9
4491808|NCT00791778|7293959|FG000|Double-blind Treatment|Non-compliant with study medication|2
4491809|NCT00791778|7293960|FG001|Double-blind Treatment|Non-compliant with study medication|0
4491810|NCT00791778|7293959|FG000|Follow-up|Withdrawal by Subject|3
4491811|NCT00791778|7293960|FG001|Follow-up|Withdrawal by Subject|0
4491812|NCT00791778|7293959|FG000|Follow-up|Lost to Follow-up|2
4491813|NCT00791778|7293960|FG001|Follow-up|Lost to Follow-up|1
4491814|NCT00791921|7293985|FG000|Overall Study|Protocol planed|24
4491815|NCT00791921|7293986|FG001|Overall Study|Protocol planed|88
4491816|NCT00791921|7293985|FG000|Overall Study|Withdrawal by Subject|1
4491817|NCT00791921|7293986|FG001|Overall Study|Withdrawal by Subject|2
4491818|NCT00791921|7293985|FG000|Overall Study|Adverse Event|8
4491819|NCT00791921|7293986|FG001|Overall Study|Adverse Event|2
4491820|NCT00791921|7293985|FG000|Overall Study|Lack of Efficacy|0
4491821|NCT00791921|7293986|FG001|Overall Study|Lack of Efficacy|2
4491822|NCT00791921|7293985|FG000|Overall Study|Lack of study drug administration|1
4491823|NCT00791921|7293986|FG001|Overall Study|Lack of study drug administration|1
4491824|NCT00791921|7293985|FG000|Overall Study|Reason other than those above|0
4491825|NCT00791921|7293986|FG001|Overall Study|Reason other than those above|1
4491826|NCT00791934|7293992|FG000|Overall Study|Withdrawal by Subject|2
4491827|NCT00791934|7293992|FG000|Overall Study|Did not consent for extended follow-up|13
4491828|NCT00791999|7294009|FG000|Overall Study|Protocol planed withdrawal|14
4491829|NCT00791999|7294010|FG001|Overall Study|Protocol planed withdrawal|11
4491830|NCT00791999|7294011|FG002|Overall Study|Protocol planed withdrawal|11
4491831|NCT00791999|7294012|FG003|Overall Study|Protocol planed withdrawal|45
4491832|NCT00791999|7294009|FG000|Overall Study|Withdrawal by Subject|0
4491833|NCT00791999|7294010|FG001|Overall Study|Withdrawal by Subject|1
4491834|NCT00791999|7294011|FG002|Overall Study|Withdrawal by Subject|0
4491835|NCT00791999|7294012|FG003|Overall Study|Withdrawal by Subject|2
4491836|NCT00791999|7294009|FG000|Overall Study|Protocol Violation|3
4491837|NCT00791999|7294010|FG001|Overall Study|Protocol Violation|0
4491838|NCT00791999|7294011|FG002|Overall Study|Protocol Violation|1
4491839|NCT00791999|7294012|FG003|Overall Study|Protocol Violation|0
4491840|NCT00791999|7294009|FG000|Overall Study|Adverse Event|3
4491841|NCT00791999|7294010|FG001|Overall Study|Adverse Event|3
4491842|NCT00791999|7294011|FG002|Overall Study|Adverse Event|7
4491843|NCT00791999|7294012|FG003|Overall Study|Adverse Event|3
4491844|NCT00791999|7294009|FG000|Overall Study|Lack of Efficacy|0
4491845|NCT00791999|7294010|FG001|Overall Study|Lack of Efficacy|1
4491846|NCT00791999|7294011|FG002|Overall Study|Lack of Efficacy|0
4491847|NCT00791999|7294012|FG003|Overall Study|Lack of Efficacy|2
4491848|NCT00791999|7294009|FG000|Overall Study|Reason other than those above|1
4491849|NCT00791999|7294010|FG001|Overall Study|Reason other than those above|0
4491850|NCT00791999|7294011|FG002|Overall Study|Reason other than those above|1
4491851|NCT00791999|7294012|FG003|Overall Study|Reason other than those above|0
4491852|NCT00792103|7294026|FG000|Overall Study|Enrolled, not treated|15
4491853|NCT00792103|7294026|FG000|Overall Study|Lost to Follow-up|17
4491854|NCT00792103|7294026|FG000|Overall Study|Adverse Event|25
4491855|NCT00792103|7294026|FG000|Overall Study|Withdrawal by Subject|52
4491856|NCT00792103|7294026|FG000|Overall Study|Protocol Violation|10
4491857|NCT00792103|7294026|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14
4491858|NCT00792298|7294034|FG000|Treatment Period 1|Adverse Event|0
4491859|NCT00792298|7294035|FG001|Treatment Period 1|Adverse Event|1
4491860|NCT00792298|7294036|FG002|Treatment Period 1|Adverse Event|0
4491861|NCT00792298|7294037|FG003|Treatment Period 1|Adverse Event|1
4491862|NCT00792298|7294038|FG004|Treatment Period 1|Adverse Event|0
4491863|NCT00792298|7294039|FG005|Treatment Period 1|Adverse Event|1
4491864|NCT00792298|7294040|FG006|Treatment Period 1|Adverse Event|1
4491865|NCT00792298|7294041|FG007|Treatment Period 1|Adverse Event|0
4491866|NCT00792298|7294034|FG000|Treatment Period 1|Lack of Efficacy|0
4491867|NCT00792298|7294035|FG001|Treatment Period 1|Lack of Efficacy|0
4491868|NCT00792298|7294036|FG002|Treatment Period 1|Lack of Efficacy|1
4491869|NCT00792298|7294037|FG003|Treatment Period 1|Lack of Efficacy|0
4491870|NCT00792298|7294038|FG004|Treatment Period 1|Lack of Efficacy|0
4491871|NCT00792298|7294039|FG005|Treatment Period 1|Lack of Efficacy|0
4491872|NCT00792298|7294040|FG006|Treatment Period 1|Lack of Efficacy|0
4491873|NCT00792298|7294041|FG007|Treatment Period 1|Lack of Efficacy|0
4491874|NCT00792298|7294034|FG000|Treatment Period 1|Withdrawal by Subject|1
4491875|NCT00792298|7294035|FG001|Treatment Period 1|Withdrawal by Subject|0
4491876|NCT00792298|7294036|FG002|Treatment Period 1|Withdrawal by Subject|1
4491877|NCT00792298|7294037|FG003|Treatment Period 1|Withdrawal by Subject|2
4491878|NCT00792298|7294038|FG004|Treatment Period 1|Withdrawal by Subject|0
4491879|NCT00792298|7294039|FG005|Treatment Period 1|Withdrawal by Subject|2
4491880|NCT00792298|7294040|FG006|Treatment Period 1|Withdrawal by Subject|1
4491881|NCT00792298|7294041|FG007|Treatment Period 1|Withdrawal by Subject|0
4491882|NCT00792298|7294034|FG000|Treatment Period 1|Lost to Follow-up|0
4491883|NCT00792298|7294035|FG001|Treatment Period 1|Lost to Follow-up|0
4491884|NCT00792298|7294036|FG002|Treatment Period 1|Lost to Follow-up|0
4491885|NCT00792298|7294037|FG003|Treatment Period 1|Lost to Follow-up|0
4491886|NCT00792298|7294038|FG004|Treatment Period 1|Lost to Follow-up|0
4491887|NCT00792298|7294039|FG005|Treatment Period 1|Lost to Follow-up|0
4491888|NCT00792298|7294040|FG006|Treatment Period 1|Lost to Follow-up|1
4491889|NCT00792298|7294041|FG007|Treatment Period 1|Lost to Follow-up|0
4491890|NCT00792298|7294034|FG000|Treatment Period 1|Physician Decision|0
4491891|NCT00792298|7294035|FG001|Treatment Period 1|Physician Decision|0
4491892|NCT00792298|7294036|FG002|Treatment Period 1|Physician Decision|0
4491893|NCT00792298|7294037|FG003|Treatment Period 1|Physician Decision|1
4491894|NCT00792298|7294038|FG004|Treatment Period 1|Physician Decision|0
4491895|NCT00792298|7294039|FG005|Treatment Period 1|Physician Decision|0
4491896|NCT00792298|7294040|FG006|Treatment Period 1|Physician Decision|1
4491897|NCT00792298|7294041|FG007|Treatment Period 1|Physician Decision|0
4491898|NCT00792298|7294034|FG000|Treatment Period 1|Protocol Violation|0
4491899|NCT00792298|7294035|FG001|Treatment Period 1|Protocol Violation|0
4491900|NCT00792298|7294036|FG002|Treatment Period 1|Protocol Violation|0
4491901|NCT00792298|7294037|FG003|Treatment Period 1|Protocol Violation|0
4491902|NCT00792298|7294038|FG004|Treatment Period 1|Protocol Violation|0
4491903|NCT00792298|7294039|FG005|Treatment Period 1|Protocol Violation|0
4491904|NCT00792298|7294040|FG006|Treatment Period 1|Protocol Violation|0
4491905|NCT00792298|7294041|FG007|Treatment Period 1|Protocol Violation|1
4491906|NCT00792298|7294034|FG000|Washout|Adverse Event|0
4491907|NCT00792298|7294035|FG001|Washout|Adverse Event|0
4491908|NCT00792298|7294036|FG002|Washout|Adverse Event|0
4491909|NCT00792298|7294037|FG003|Washout|Adverse Event|0
4491910|NCT00792298|7294038|FG004|Washout|Adverse Event|0
4491911|NCT00792298|7294039|FG005|Washout|Adverse Event|1
4491912|NCT00792298|7294040|FG006|Washout|Adverse Event|0
4491913|NCT00792298|7294041|FG007|Washout|Adverse Event|0
4491914|NCT00792298|7294034|FG000|Washout|Withdrawal by Subject|0
4491915|NCT00792298|7294035|FG001|Washout|Withdrawal by Subject|0
4491916|NCT00792298|7294036|FG002|Washout|Withdrawal by Subject|1
4491917|NCT00792298|7294037|FG003|Washout|Withdrawal by Subject|0
4491918|NCT00792298|7294038|FG004|Washout|Withdrawal by Subject|0
4491919|NCT00792298|7294039|FG005|Washout|Withdrawal by Subject|1
4491920|NCT00792298|7294040|FG006|Washout|Withdrawal by Subject|0
4491921|NCT00792298|7294041|FG007|Washout|Withdrawal by Subject|0
4491922|NCT00792298|7294034|FG000|Treatment Period 2|Lack of Efficacy|0
4491923|NCT00792298|7294035|FG001|Treatment Period 2|Lack of Efficacy|0
4491924|NCT00792298|7294036|FG002|Treatment Period 2|Lack of Efficacy|0
4491925|NCT00792298|7294037|FG003|Treatment Period 2|Lack of Efficacy|0
4491926|NCT00792298|7294038|FG004|Treatment Period 2|Lack of Efficacy|1
4491927|NCT00792298|7294039|FG005|Treatment Period 2|Lack of Efficacy|0
4491928|NCT00792298|7294040|FG006|Treatment Period 2|Lack of Efficacy|0
4491929|NCT00792298|7294041|FG007|Treatment Period 2|Lack of Efficacy|0
4491930|NCT00792298|7294034|FG000|Treatment Period 2|Physician Decision|0
4491931|NCT00792298|7294035|FG001|Treatment Period 2|Physician Decision|0
4491932|NCT00792298|7294036|FG002|Treatment Period 2|Physician Decision|0
4491933|NCT00792298|7294037|FG003|Treatment Period 2|Physician Decision|0
4491934|NCT00792298|7294038|FG004|Treatment Period 2|Physician Decision|0
4491935|NCT00792298|7294039|FG005|Treatment Period 2|Physician Decision|0
4491936|NCT00792298|7294040|FG006|Treatment Period 2|Physician Decision|1
4491937|NCT00792298|7294041|FG007|Treatment Period 2|Physician Decision|0
4491938|NCT00792298|7294034|FG000|Treatment Period 2|Pregnancy|0
4491939|NCT00792298|7294035|FG001|Treatment Period 2|Pregnancy|0
4491940|NCT00792298|7294036|FG002|Treatment Period 2|Pregnancy|1
4491941|NCT00792298|7294037|FG003|Treatment Period 2|Pregnancy|0
4491942|NCT00792298|7294038|FG004|Treatment Period 2|Pregnancy|0
4491943|NCT00792298|7294039|FG005|Treatment Period 2|Pregnancy|0
4491944|NCT00792298|7294040|FG006|Treatment Period 2|Pregnancy|0
4491945|NCT00792298|7294041|FG007|Treatment Period 2|Pregnancy|0
4491946|NCT00792298|7294034|FG000|Treatment Period 2|Withdrawal by Subject|1
4491947|NCT00792298|7294035|FG001|Treatment Period 2|Withdrawal by Subject|1
4491948|NCT00792298|7294036|FG002|Treatment Period 2|Withdrawal by Subject|0
4491949|NCT00792298|7294037|FG003|Treatment Period 2|Withdrawal by Subject|2
4491950|NCT00792298|7294038|FG004|Treatment Period 2|Withdrawal by Subject|1
4491951|NCT00792298|7294039|FG005|Treatment Period 2|Withdrawal by Subject|0
4491952|NCT00792298|7294040|FG006|Treatment Period 2|Withdrawal by Subject|0
4491953|NCT00792298|7294041|FG007|Treatment Period 2|Withdrawal by Subject|2
4517585|NCT00968669|7329560|FG000|Overall Study|Withdrawal by Subject|9
4517586|NCT00968669|7329561|FG001|Overall Study|Withdrawal by Subject|7
4517587|NCT00968669|7329562|FG002|Overall Study|Withdrawal by Subject|5
4517588|NCT00968669|7329563|FG003|Overall Study|Withdrawal by Subject|3
4517589|NCT00968669|7329560|FG000|Overall Study|Pregnancy|0
4517590|NCT00968669|7329561|FG001|Overall Study|Pregnancy|0
4517591|NCT00968669|7329562|FG002|Overall Study|Pregnancy|2
4517592|NCT00968669|7329563|FG003|Overall Study|Pregnancy|0
4517593|NCT00968669|7329560|FG000|Overall Study|AE|1
4517594|NCT00968669|7329561|FG001|Overall Study|AE|0
4517595|NCT00968669|7329562|FG002|Overall Study|AE|0
4517596|NCT00968669|7329563|FG003|Overall Study|AE|0
4517597|NCT00968669|7329560|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
4517598|NCT00968669|7329561|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
4517599|NCT00968669|7329562|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
4517600|NCT00968669|7329563|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1
4517601|NCT00968669|7329560|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1
4517602|NCT00968669|7329561|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
4517603|NCT00968669|7329562|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
4517604|NCT00968669|7329563|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
4517605|NCT00968669|7329560|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1
4517606|NCT00968669|7329561|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
4517607|NCT00968669|7329562|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
4517608|NCT00968669|7329563|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
4517609|NCT00968669|7329560|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
4517610|NCT00968669|7329561|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
4517611|NCT00968669|7329562|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1
4517612|NCT00968669|7329563|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
4517613|NCT00968669|7329560|FG000|Overall Study|EARLY WITHDRAWAL|0
4517614|NCT00968669|7329561|FG001|Overall Study|EARLY WITHDRAWAL|1
4491954|NCT00792467|7294067|FG000|Overall Study|progression of disease|17
4491955|NCT00792467|7294067|FG000|Overall Study|Adverse Event|1
4491956|NCT00792467|7294067|FG000|Overall Study|patient request|1
4491957|NCT00792467|7294067|FG000|Overall Study|Lost to Follow-up|1
4491958|NCT00792467|7294067|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1
4491959|NCT00792467|7294067|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1
4491960|NCT00792571|7294072|FG000|Overall Study|Death|1
4491961|NCT00792571|7294072|FG000|Overall Study|Adverse Event|4
4491962|NCT00792571|7294072|FG000|Overall Study|Withdrawal by Subject|1
4491963|NCT00792571|7294072|FG000|Overall Study|Other|4
4491964|NCT00792623|7294080|FG000|Overall Study|Adverse Event|2
4491965|NCT00792623|7294080|FG000|Overall Study|Withdrawal by Subject|5
4491966|NCT00792636|7294088|FG000|Overall Study|Protocol Violation|17
4491967|NCT00792636|7294089|FG001|Overall Study|Protocol Violation|23
4491968|NCT00792636|7294090|FG002|Overall Study|Protocol Violation|20
4491969|NCT00792636|7294088|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19
4491970|NCT00792636|7294089|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20
4491971|NCT00792636|7294090|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20
4491972|NCT00792636|7294088|FG000|Overall Study|Lost to Follow-up|13
4491973|NCT00792636|7294089|FG001|Overall Study|Lost to Follow-up|19
4491974|NCT00792636|7294090|FG002|Overall Study|Lost to Follow-up|14
4491975|NCT00792636|7294088|FG000|Overall Study|Withdrew Consent|10
4491976|NCT00792636|7294089|FG001|Overall Study|Withdrew Consent|13
4491977|NCT00792636|7294090|FG002|Overall Study|Withdrew Consent|9
4491978|NCT00792636|7294088|FG000|Overall Study|Lack of Efficacy|3
4491979|NCT00792636|7294089|FG001|Overall Study|Lack of Efficacy|4
4491980|NCT00792636|7294090|FG002|Overall Study|Lack of Efficacy|13
4491981|NCT00792636|7294088|FG000|Overall Study|Adverse Event|4
4491982|NCT00792636|7294089|FG001|Overall Study|Adverse Event|2
4491983|NCT00792636|7294090|FG002|Overall Study|Adverse Event|3
4491984|NCT00792636|7294088|FG000|Overall Study|Investigator Discretion|2
4491985|NCT00792636|7294089|FG001|Overall Study|Investigator Discretion|0
4491986|NCT00792636|7294090|FG002|Overall Study|Investigator Discretion|2
4491987|NCT00792701|7294115|FG000|Overall Study|Adverse Event|0
4491988|NCT00792701|7294116|FG001|Overall Study|Adverse Event|22
4491989|NCT00792701|7294115|FG000|Overall Study|Ineligible|1
4491990|NCT00792701|7294116|FG001|Overall Study|Ineligible|3
4491991|NCT00792701|7294115|FG000|Overall Study|Withdrawal by Subject|1
4491992|NCT00792701|7294116|FG001|Overall Study|Withdrawal by Subject|19
4491993|NCT00792701|7294115|FG000|Overall Study|Not protocol specified|17
4491994|NCT00792701|7294116|FG001|Overall Study|Not protocol specified|0
4491995|NCT00792805|7294127|FG000|Overall Study|Adverse Event|12
4491996|NCT00792805|7294128|FG001|Overall Study|Adverse Event|10
4491997|NCT00792805|7294129|FG002|Overall Study|Adverse Event|10
4491998|NCT00792805|7294127|FG000|Overall Study|Subject withdrew consent|5
4491999|NCT00792805|7294128|FG001|Overall Study|Subject withdrew consent|6
4492000|NCT00792805|7294129|FG002|Overall Study|Subject withdrew consent|5
4492001|NCT00792805|7294127|FG000|Overall Study|Administrative problems|2
4492002|NCT00792805|7294128|FG001|Overall Study|Administrative problems|0
4492003|NCT00792805|7294129|FG002|Overall Study|Administrative problems|4
4492004|NCT00792805|7294127|FG000|Overall Study|Abnormal test procedure result(s)|1
4492005|NCT00792805|7294128|FG001|Overall Study|Abnormal test procedure result(s)|2
4492006|NCT00792805|7294129|FG002|Overall Study|Abnormal test procedure result(s)|0
4492007|NCT00792805|7294127|FG000|Overall Study|Unsatisfactory therapeutic effect|1
4492008|NCT00792805|7294128|FG001|Overall Study|Unsatisfactory therapeutic effect|6
4492009|NCT00792805|7294129|FG002|Overall Study|Unsatisfactory therapeutic effect|6
4492010|NCT00792805|7294127|FG000|Overall Study|Lost to Follow-up|1
4492011|NCT00792805|7294128|FG001|Overall Study|Lost to Follow-up|1
4492012|NCT00792805|7294129|FG002|Overall Study|Lost to Follow-up|6
4492013|NCT00792805|7294127|FG000|Overall Study|Abnormal laboratory value(s)|0
4492014|NCT00792805|7294128|FG001|Overall Study|Abnormal laboratory value(s)|0
4492015|NCT00792805|7294129|FG002|Overall Study|Abnormal laboratory value(s)|1
4492016|NCT00792805|7294127|FG000|Overall Study|Protocol deviation|0
4492017|NCT00792805|7294128|FG001|Overall Study|Protocol deviation|1
4492018|NCT00792805|7294129|FG002|Overall Study|Protocol deviation|1
4492019|NCT00792909|7294140|FG000|Overall Study|Withdrawal by Subject|0
4492020|NCT00792909|7294141|FG001|Overall Study|Withdrawal by Subject|1
4492021|NCT00792909|7294142|FG002|Overall Study|Withdrawal by Subject|0
4492022|NCT00792935|7294174|FG000|Overall Study|Adverse Event|2
4492023|NCT00792935|7294175|FG001|Overall Study|Adverse Event|1
4492024|NCT00792935|7294174|FG000|Overall Study|Lost to Follow-up|0
4492025|NCT00792935|7294175|FG001|Overall Study|Lost to Follow-up|1
4492026|NCT00792935|7294174|FG000|Overall Study|Protocol Violation|2
4492027|NCT00792935|7294175|FG001|Overall Study|Protocol Violation|0
4492028|NCT00792935|7294174|FG000|Overall Study|Withdrawal by Subject|0
4492029|NCT00792935|7294175|FG001|Overall Study|Withdrawal by Subject|1
4492030|NCT00793104|7294181|FG000|Overall Study|Lost to Follow-up|1
4492031|NCT00793182|7294187|FG000|Overall Study|Adverse Event|0
4492032|NCT00793182|7294188|FG001|Overall Study|Adverse Event|1
4492033|NCT00793325|7294194|FG000|Overall Study|Protocol Violation|18
4492034|NCT00793325|7294194|FG000|Overall Study|Lost to Follow-up|1
4492035|NCT00793403|7294217|FG000|Overall Study|Other|73
4492036|NCT00793546|7294233|FG000|Overall Study|Death|3
4492037|NCT00793546|7294234|FG001|Overall Study|Death|0
4492038|NCT00793546|7294233|FG000|Overall Study|Lost to Follow-up|1
4492039|NCT00793546|7294234|FG001|Overall Study|Lost to Follow-up|0
4492040|NCT00793546|7294233|FG000|Overall Study|Withdrawal by Subject|1
4492041|NCT00793546|7294234|FG001|Overall Study|Withdrawal by Subject|1
4492042|NCT00793546|7294233|FG000|Overall Study|Study Terminated by Sponsor|8
4492043|NCT00793546|7294234|FG001|Overall Study|Study Terminated by Sponsor|27
4492044|NCT00793546|7294233|FG000|Overall Study|Other|1
4492045|NCT00793546|7294234|FG001|Overall Study|Other|0
4492046|NCT00793585|7294248|FG000|Overall Study|Adverse Event|1
4492047|NCT00793585|7294249|FG001|Overall Study|Adverse Event|1
4492048|NCT00793585|7294248|FG000|Overall Study|Protocol Violation|1
4492049|NCT00793585|7294249|FG001|Overall Study|Protocol Violation|2
4626874|NCT01846442|7492902|FG003|Overall Study|Adverse Event|1
4626875|NCT01846442|7492899|FG000|Overall Study|Lost to Follow-up|0
4626876|NCT01846442|7492900|FG001|Overall Study|Lost to Follow-up|0
4626877|NCT01846442|7492901|FG002|Overall Study|Lost to Follow-up|1
4626878|NCT01846442|7492902|FG003|Overall Study|Lost to Follow-up|0
4626879|NCT01846442|7492899|FG000|Overall Study|Withdrawal by Subject|3
4626880|NCT01846442|7492900|FG001|Overall Study|Withdrawal by Subject|2
4626881|NCT01846442|7492901|FG002|Overall Study|Withdrawal by Subject|0
4626882|NCT01846442|7492902|FG003|Overall Study|Withdrawal by Subject|1
4492050|NCT00793598|7294260|FG000|Overall Study|Patient Request|0
4492051|NCT00793598|7294261|FG001|Overall Study|Patient Request|1
4492052|NCT00793598|7294262|FG002|Overall Study|Patient Request|0
4492053|NCT00793598|7294263|FG003|Overall Study|Patient Request|0
4492054|NCT00793598|7294264|FG004|Overall Study|Patient Request|0
4492055|NCT00793598|7294265|FG005|Overall Study|Patient Request|0
4492056|NCT00793598|7294266|FG006|Overall Study|Patient Request|0
4492057|NCT00793598|7294267|FG007|Overall Study|Patient Request|0
4492058|NCT00793598|7294260|FG000|Overall Study|Protocol Violation|0
4492059|NCT00793598|7294261|FG001|Overall Study|Protocol Violation|0
4492060|NCT00793598|7294262|FG002|Overall Study|Protocol Violation|0
4492061|NCT00793598|7294263|FG003|Overall Study|Protocol Violation|0
4492062|NCT00793598|7294264|FG004|Overall Study|Protocol Violation|0
4492063|NCT00793598|7294265|FG005|Overall Study|Protocol Violation|0
4492064|NCT00793598|7294266|FG006|Overall Study|Protocol Violation|0
4492065|NCT00793598|7294267|FG007|Overall Study|Protocol Violation|1
4492066|NCT00793598|7294260|FG000|Overall Study|Subject not dosed|0
4492067|NCT00793598|7294261|FG001|Overall Study|Subject not dosed|0
4492068|NCT00793598|7294262|FG002|Overall Study|Subject not dosed|0
4492069|NCT00793598|7294263|FG003|Overall Study|Subject not dosed|0
4492070|NCT00793598|7294264|FG004|Overall Study|Subject not dosed|0
4492071|NCT00793598|7294265|FG005|Overall Study|Subject not dosed|1
4492072|NCT00793598|7294266|FG006|Overall Study|Subject not dosed|0
4492073|NCT00793598|7294267|FG007|Overall Study|Subject not dosed|0
4492074|NCT00793624|7294302|FG000|Overall Study|Adverse Event|18
4492075|NCT00793624|7294303|FG001|Overall Study|Adverse Event|16
4492076|NCT00793624|7294304|FG002|Overall Study|Adverse Event|15
4492077|NCT00793624|7294305|FG003|Overall Study|Adverse Event|20
4492078|NCT00793624|7294302|FG000|Overall Study|Lost to Follow-up|2
4492079|NCT00793624|7294303|FG001|Overall Study|Lost to Follow-up|2
4492080|NCT00793624|7294304|FG002|Overall Study|Lost to Follow-up|4
4492081|NCT00793624|7294305|FG003|Overall Study|Lost to Follow-up|0
4492082|NCT00793624|7294302|FG000|Overall Study|Withdrawal by Subject|20
4492083|NCT00793624|7294303|FG001|Overall Study|Withdrawal by Subject|9
4492084|NCT00793624|7294304|FG002|Overall Study|Withdrawal by Subject|11
4492085|NCT00793624|7294305|FG003|Overall Study|Withdrawal by Subject|14
4492086|NCT00793624|7294302|FG000|Overall Study|Lack of Efficacy|9
4492087|NCT00793624|7294303|FG001|Overall Study|Lack of Efficacy|2
4492088|NCT00793624|7294304|FG002|Overall Study|Lack of Efficacy|1
4492089|NCT00793624|7294305|FG003|Overall Study|Lack of Efficacy|3
4492090|NCT00793624|7294302|FG000|Overall Study|Non compliance with protocol|2
4492091|NCT00793624|7294303|FG001|Overall Study|Non compliance with protocol|3
4492092|NCT00793624|7294304|FG002|Overall Study|Non compliance with protocol|2
4492093|NCT00793624|7294305|FG003|Overall Study|Non compliance with protocol|3
4492094|NCT00793624|7294302|FG000|Overall Study|Other reason not described above|6
4492095|NCT00793624|7294303|FG001|Overall Study|Other reason not described above|4
4492096|NCT00793624|7294304|FG002|Overall Study|Other reason not described above|6
4492097|NCT00793624|7294305|FG003|Overall Study|Other reason not described above|3
4626883|NCT01846442|7492899|FG000|Overall Study|Left the city/Lost medication|1
4626884|NCT01846442|7492900|FG001|Overall Study|Left the city/Lost medication|0
4492098|NCT00793780|7294336|FG000|Overall Study|Withdrawal by Subject|2
4492099|NCT00793780|7294337|FG001|Overall Study|Withdrawal by Subject|1
4492100|NCT00793793|7294355|FG000|Overall Study|Adverse Event|0
4492101|NCT00793793|7294356|FG001|Overall Study|Adverse Event|0
4492102|NCT00793793|7294357|FG002|Overall Study|Adverse Event|1
4492103|NCT00793793|7294358|FG003|Overall Study|Adverse Event|1
4492104|NCT00793793|7294359|FG004|Overall Study|Adverse Event|0
4492105|NCT00793793|7294360|FG005|Overall Study|Adverse Event|1
4492106|NCT00793793|7294361|FG006|Overall Study|Adverse Event|2
4492107|NCT00793793|7294362|FG007|Overall Study|Adverse Event|0
4492108|NCT00793793|7294363|FG008|Overall Study|Adverse Event|0
4492109|NCT00793793|7294364|FG009|Overall Study|Adverse Event|0
4492110|NCT00793793|7294365|FG010|Overall Study|Adverse Event|0
4492111|NCT00793793|7294366|FG011|Overall Study|Adverse Event|2
4492112|NCT00793793|7294355|FG000|Overall Study|Protocol Violation|0
4492113|NCT00793793|7294356|FG001|Overall Study|Protocol Violation|0
4492114|NCT00793793|7294357|FG002|Overall Study|Protocol Violation|0
4492115|NCT00793793|7294358|FG003|Overall Study|Protocol Violation|1
4492116|NCT00793793|7294359|FG004|Overall Study|Protocol Violation|0
4492117|NCT00793793|7294360|FG005|Overall Study|Protocol Violation|0
4492118|NCT00793793|7294361|FG006|Overall Study|Protocol Violation|0
4492119|NCT00793793|7294362|FG007|Overall Study|Protocol Violation|0
4492120|NCT00793793|7294363|FG008|Overall Study|Protocol Violation|0
4492121|NCT00793793|7294364|FG009|Overall Study|Protocol Violation|0
4492122|NCT00793793|7294365|FG010|Overall Study|Protocol Violation|0
4492123|NCT00793793|7294366|FG011|Overall Study|Protocol Violation|0
4492124|NCT00793793|7294355|FG000|Overall Study|Lost to Follow-up|0
4492125|NCT00793793|7294356|FG001|Overall Study|Lost to Follow-up|0
4492126|NCT00793793|7294357|FG002|Overall Study|Lost to Follow-up|1
4492127|NCT00793793|7294358|FG003|Overall Study|Lost to Follow-up|0
4492128|NCT00793793|7294359|FG004|Overall Study|Lost to Follow-up|0
4492129|NCT00793793|7294360|FG005|Overall Study|Lost to Follow-up|0
4492130|NCT00793793|7294361|FG006|Overall Study|Lost to Follow-up|0
4492131|NCT00793793|7294362|FG007|Overall Study|Lost to Follow-up|0
4492132|NCT00793793|7294363|FG008|Overall Study|Lost to Follow-up|1
4492133|NCT00793793|7294364|FG009|Overall Study|Lost to Follow-up|3
4492134|NCT00793793|7294365|FG010|Overall Study|Lost to Follow-up|1
4492135|NCT00793793|7294366|FG011|Overall Study|Lost to Follow-up|0
4492136|NCT00793793|7294355|FG000|Overall Study|Withdrawal by Subject|0
4492137|NCT00793793|7294356|FG001|Overall Study|Withdrawal by Subject|0
4492138|NCT00793793|7294357|FG002|Overall Study|Withdrawal by Subject|0
4492139|NCT00793793|7294358|FG003|Overall Study|Withdrawal by Subject|0
4492140|NCT00793793|7294359|FG004|Overall Study|Withdrawal by Subject|1
4492141|NCT00793793|7294360|FG005|Overall Study|Withdrawal by Subject|0
4492142|NCT00793793|7294361|FG006|Overall Study|Withdrawal by Subject|0
4492143|NCT00793793|7294362|FG007|Overall Study|Withdrawal by Subject|0
4492144|NCT00793793|7294363|FG008|Overall Study|Withdrawal by Subject|1
4492145|NCT00793793|7294364|FG009|Overall Study|Withdrawal by Subject|0
4492146|NCT00793793|7294365|FG010|Overall Study|Withdrawal by Subject|0
4492147|NCT00793793|7294366|FG011|Overall Study|Withdrawal by Subject|0
4492148|NCT00793793|7294355|FG000|Overall Study|reason not specified|0
4492149|NCT00793793|7294356|FG001|Overall Study|reason not specified|1
4492150|NCT00793793|7294357|FG002|Overall Study|reason not specified|0
4492151|NCT00793793|7294358|FG003|Overall Study|reason not specified|1
4492152|NCT00793793|7294359|FG004|Overall Study|reason not specified|1
4492153|NCT00793793|7294360|FG005|Overall Study|reason not specified|1
4492154|NCT00793793|7294361|FG006|Overall Study|reason not specified|2
4492155|NCT00793793|7294362|FG007|Overall Study|reason not specified|0
4492156|NCT00793793|7294363|FG008|Overall Study|reason not specified|7
4492157|NCT00793793|7294364|FG009|Overall Study|reason not specified|6
4492158|NCT00793793|7294365|FG010|Overall Study|reason not specified|2
4492159|NCT00793793|7294366|FG011|Overall Study|reason not specified|4
4492160|NCT00793819|7294414|FG000|Overall Study|Adverse Event|8
4492161|NCT00793819|7294415|FG001|Overall Study|Adverse Event|4
4492162|NCT00793819|7294414|FG000|Overall Study|Lack of Efficacy|1
4492163|NCT00793819|7294415|FG001|Overall Study|Lack of Efficacy|1
4492164|NCT00793819|7294414|FG000|Overall Study|Withdrawal by Subject|4
4492165|NCT00793819|7294415|FG001|Overall Study|Withdrawal by Subject|3
4492166|NCT00793819|7294414|FG000|Overall Study|Lost to Follow-up|1
4492167|NCT00793819|7294415|FG001|Overall Study|Lost to Follow-up|1
4492168|NCT00793871|7294421|FG000|Overall Study|Death|50
4492169|NCT00793871|7294421|FG000|Overall Study|Lost to Follow-up|3
4492170|NCT00793871|7294421|FG000|Overall Study|Study terminated by the Sponsor|7
4492171|NCT00793910|7294427|FG000|Overall Study|discarded study pills|0
4492172|NCT00793910|7294428|FG001|Overall Study|discarded study pills|1
4492173|NCT00793910|7294427|FG000|Overall Study|did not pick up medications|1
4492174|NCT00793910|7294428|FG001|Overall Study|did not pick up medications|1
4492175|NCT00793910|7294427|FG000|Overall Study|ineligible based on entry criteria|2
4492176|NCT00793910|7294428|FG001|Overall Study|ineligible based on entry criteria|3
4492177|NCT00793910|7294427|FG000|Overall Study|decided to undergo LASIK instead of PRK|2
4492178|NCT00793910|7294428|FG001|Overall Study|decided to undergo LASIK instead of PRK|1
4492179|NCT00793910|7294427|FG000|Overall Study|Withdrawal by Subject|0
4492180|NCT00793910|7294428|FG001|Overall Study|Withdrawal by Subject|1
4492181|NCT00794040|7294436|FG000|Overall Study|Withdrawal by Subject|3
4492182|NCT00794040|7294437|FG001|Overall Study|Withdrawal by Subject|4
4492183|NCT00794040|7294436|FG000|Overall Study|Physician Decision|0
4492184|NCT00794040|7294437|FG001|Overall Study|Physician Decision|1
4492185|NCT00794118|7294443|FG000|Overall Study|Lost to Follow-up|16
4492186|NCT00794118|7294443|FG000|Overall Study|Withdrawal by Subject|9
4492187|NCT00794118|7294443|FG000|Overall Study|Changed hospital center|2
4492188|NCT00794157|7294459|FG000|Overall Study|Adverse Event|4
4492189|NCT00794157|7294460|FG001|Overall Study|Adverse Event|1
4492190|NCT00794157|7294461|FG002|Overall Study|Adverse Event|8
4492191|NCT00794157|7294459|FG000|Overall Study|Subject withdrew consent|2
4492192|NCT00794157|7294460|FG001|Overall Study|Subject withdrew consent|0
4492193|NCT00794157|7294461|FG002|Overall Study|Subject withdrew consent|3
4492194|NCT00794157|7294459|FG000|Overall Study|Lost to Follow-up|2
4492195|NCT00794157|7294460|FG001|Overall Study|Lost to Follow-up|0
4492196|NCT00794157|7294461|FG002|Overall Study|Lost to Follow-up|1
4492197|NCT00794157|7294459|FG000|Overall Study|Unsatisfactory therapeutic effect|1
4492198|NCT00794157|7294460|FG001|Overall Study|Unsatisfactory therapeutic effect|0
4492199|NCT00794157|7294461|FG002|Overall Study|Unsatisfactory therapeutic effect|2
4492200|NCT00794157|7294459|FG000|Overall Study|Administrative problems|1
4492201|NCT00794157|7294460|FG001|Overall Study|Administrative problems|7
4626885|NCT01846442|7492901|FG002|Overall Study|Left the city/Lost medication|1
4626886|NCT01846442|7492902|FG003|Overall Study|Left the city/Lost medication|1
4626887|NCT01846507|7492942|FG000|Overall Study|Lost to Follow-up|4
4626888|NCT01846507|7492942|FG000|Overall Study|Protocol Violation|1
4626889|NCT01846507|7492942|FG000|Overall Study|Missing data|2
4626890|NCT01846611|7492950|FG000|Overall Study|Lost to Follow-up|4
4626891|NCT01846611|7492951|FG001|Overall Study|Lost to Follow-up|6
4626892|NCT01846611|7492950|FG000|Overall Study|Withdrawal by Subject|15
4626893|NCT01846611|7492951|FG001|Overall Study|Withdrawal by Subject|19
4626894|NCT01846611|7492950|FG000|Overall Study|Other|19
4626895|NCT01846611|7492951|FG001|Overall Study|Other|18
4626896|NCT01846624|7492957|FG000|Overall Study|Died during induction, no midostaurin|1
4492202|NCT00794157|7294461|FG002|Overall Study|Administrative problems|4
4492203|NCT00794157|7294459|FG000|Overall Study|Abnormal test procedure result(s)|0
4492204|NCT00794157|7294460|FG001|Overall Study|Abnormal test procedure result(s)|1
4492205|NCT00794157|7294461|FG002|Overall Study|Abnormal test procedure result(s)|0
4492206|NCT00794157|7294459|FG000|Overall Study|Protocol deviation|0
4492207|NCT00794157|7294460|FG001|Overall Study|Protocol deviation|1
4492208|NCT00794157|7294461|FG002|Overall Study|Protocol deviation|1
4492209|NCT00794196|7294480|FG000|Overall Study|Lost to Follow-up|5
4492210|NCT00794196|7294481|FG001|Overall Study|Lost to Follow-up|23
4492211|NCT00794339|7294500|FG000|Overall Study|Withdrawal by Subject|3
4492212|NCT00794339|7294500|FG000|Overall Study|Ineligible|4
4492213|NCT00794339|7294500|FG000|Overall Study|Tx prior to ATSM|3
4492214|NCT00794339|7294500|FG000|Overall Study|ATSM imaging not complete or inadequate|3
4492215|NCT00794339|7294500|FG000|Overall Study|Tx not per protocol|1
4492216|NCT00794365|7294521|FG000|Overall Study|Lost to Follow-up|38
4492217|NCT00794365|7294521|FG000|Overall Study|Other|17
4492218|NCT00794365|7294521|FG000|Overall Study|Poor Compliance|11
4492219|NCT00794365|7294521|FG000|Overall Study|Adverse Event|10
4492220|NCT00794365|7294521|FG000|Overall Study|Lack of Efficacy|3
4492221|NCT00794417|7294529|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0
4492222|NCT00794417|7294530|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0
4492223|NCT00794417|7294531|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2
4492224|NCT00794417|7294532|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0
4492225|NCT00794417|7294529|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3
4492226|NCT00794417|7294530|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3
4492227|NCT00794417|7294531|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1
4492228|NCT00794417|7294532|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0
4492229|NCT00794417|7294529|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0
4492230|NCT00794417|7294530|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0
4492231|NCT00794417|7294531|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0
4492232|NCT00794417|7294532|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7
4492233|NCT00794417|7294529|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0
4492234|NCT00794417|7294530|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0
4492235|NCT00794417|7294531|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0
4492236|NCT00794417|7294532|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11
4492237|NCT00794417|7294529|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0
4492238|NCT00794417|7294530|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0
4492239|NCT00794417|7294531|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0
4492240|NCT00794417|7294532|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4
4492241|NCT00794417|7294529|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0
4492242|NCT00794417|7294530|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0
4492243|NCT00794417|7294531|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0
4492244|NCT00794417|7294532|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13
4492245|NCT00794573|7294576|FG000|Overall Study|Death|3
4492246|NCT00794573|7294577|FG001|Overall Study|Death|0
4492247|NCT00794573|7294576|FG000|Overall Study|Withdrawal by Subject|9
4492248|NCT00794573|7294577|FG001|Overall Study|Withdrawal by Subject|12
4492249|NCT00794573|7294576|FG000|Overall Study|Lost to Follow-up|26
4626897|NCT01846741|7493002|FG000|Baseline Visit|Subject did not meet entry criteria|2
4626898|NCT01847092|7493091|FG000|Overall Study|Adverse Event|12
4626899|NCT01847092|7493092|FG001|Overall Study|Adverse Event|3
4626900|NCT01847092|7493091|FG000|Overall Study|Withdrawal by Subject|5
4626901|NCT01847092|7493092|FG001|Overall Study|Withdrawal by Subject|5
4492250|NCT00794573|7294577|FG001|Overall Study|Lost to Follow-up|33
4492251|NCT00794664|7294585|FG000|Treatment Period|Withdrawal by Subject|0
4492252|NCT00794664|7294586|FG001|Treatment Period|Withdrawal by Subject|2
4492253|NCT00794664|7294585|FG000|Treatment Period|Protocol non-compliance|0
4492254|NCT00794664|7294586|FG001|Treatment Period|Protocol non-compliance|1
4492255|NCT00794664|7294585|FG000|Treatment Period|Other|0
4492256|NCT00794664|7294586|FG001|Treatment Period|Other|1
4492257|NCT00794664|7294585|FG000|Treatment Period|Adverse Event|1
4492258|NCT00794664|7294586|FG001|Treatment Period|Adverse Event|8
4492259|NCT00794664|7294585|FG000|Follow-up Period|Other|1
4492260|NCT00794664|7294586|FG001|Follow-up Period|Other|2
4492261|NCT00794664|7294585|FG000|Follow-up Period|Withdrawal by Subject|0
4492262|NCT00794664|7294586|FG001|Follow-up Period|Withdrawal by Subject|2
4492263|NCT00794664|7294585|FG000|Follow-up Period|Protocol non-compliance|0
4492264|NCT00794664|7294586|FG001|Follow-up Period|Protocol non-compliance|1
4492265|NCT00794820|7294592|FG000|Overall Study|Adverse Event|11
4492266|NCT00794820|7294592|FG000|Overall Study|Secondary Malignancies|2
4492267|NCT00794820|7294592|FG000|Overall Study|Resistant Disease|2
4492268|NCT00794820|7294592|FG000|Overall Study|Ineligible/Screen Failure|1
4492269|NCT00794950|7294596|FG000|BCG Induction|Withdrawal by Subject|2
4492270|NCT00794950|7294596|FG000|BCG Induction|ineligible|3
4492271|NCT00794950|7294596|FG000|BCG Induction|noncompliant w. BCG|1
4492272|NCT00794950|7294596|FG000|BCG Induction|Adverse Event|1
4492273|NCT00794950|7294596|FG000|Beginning Sunitinib Treatment|cystectomy|5
4492274|NCT00794950|7294596|FG000|Beginning Sunitinib Treatment|Physician Decision|5
4492275|NCT00794950|7294596|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1
4492276|NCT00794950|7294596|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1
4492277|NCT00794963|7294603|FG000|Overall Study|Withdrawal by Subject|1
4492278|NCT00794963|7294604|FG001|Overall Study|Withdrawal by Subject|4
4492279|NCT00795132|7294619|FG000|Overall Study|Death|1
4492280|NCT00795132|7294619|FG000|Overall Study|Relapse|2
4492281|NCT00795184|7294666|FG000|Overall Study|Tissue sampling incomplete/conclusive|8
4492282|NCT00795184|7294667|FG001|Overall Study|Tissue sampling incomplete/conclusive|13
4492283|NCT00795509|7294729|FG000|Overall Study|Protocol Violation|31
4492284|NCT00795535|7294733|FG000|Overall Study|incomplete data and technical problems|20
4492285|NCT00795600|7294739|FG000|Overall Study|Adverse Event|1
4492286|NCT00795600|7294740|FG001|Overall Study|Adverse Event|1
4492287|NCT00795600|7294739|FG000|Overall Study|Protocol Violation|1
4492288|NCT00795600|7294740|FG001|Overall Study|Protocol Violation|2
4492289|NCT00795600|7294739|FG000|Overall Study|Withdrawal by Subject|1
4492290|NCT00795600|7294740|FG001|Overall Study|Withdrawal by Subject|0
4492291|NCT00795600|7294739|FG000|Overall Study|Unclassified|1
4492292|NCT00795600|7294740|FG001|Overall Study|Unclassified|1
4492293|NCT00795639|7294748|FG000|Overall Study|Death|1
4492294|NCT00795639|7294749|FG001|Overall Study|Death|6
4492295|NCT00795639|7294748|FG000|Overall Study|Withdrawal by Subject|1
4492296|NCT00795639|7294749|FG001|Overall Study|Withdrawal by Subject|3
4492297|NCT00795639|7294748|FG000|Overall Study|Pregnancy|1
4492298|NCT00795639|7294749|FG001|Overall Study|Pregnancy|0
4492299|NCT00795639|7294748|FG000|Overall Study|Adverse Event|5
4492300|NCT00795639|7294749|FG001|Overall Study|Adverse Event|2
4492301|NCT00795639|7294748|FG000|Overall Study|Other|0
4492302|NCT00795639|7294749|FG001|Overall Study|Other|2
4492303|NCT00795639|7294748|FG000|Overall Study|Terminated by sponsor|13
4492304|NCT00795639|7294749|FG001|Overall Study|Terminated by sponsor|12
4492305|NCT00795639|7294748|FG000|Overall Study|Randomized and not treated|0
4702998|NCT02723630|7620279|FG002|Intervention Period 1|Adverse Event|0
4702999|NCT02723630|7620280|FG003|Intervention Period 1|Adverse Event|0
4703000|NCT02723630|7620281|FG004|Intervention Period 1|Adverse Event|0
4703001|NCT02723630|7620282|FG005|Intervention Period 1|Adverse Event|0
4492306|NCT00795639|7294749|FG001|Overall Study|Randomized and not treated|1
4492307|NCT00795704|7294757|FG000|Overall Study|Withdrawal by Subject|3
4492308|NCT00795704|7294758|FG001|Overall Study|Withdrawal by Subject|2
4492309|NCT00795704|7294757|FG000|Overall Study|Adverse Event|1
4492310|NCT00795704|7294758|FG001|Overall Study|Adverse Event|1
4492311|NCT00795717|7294766|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1
4492312|NCT00795717|7294767|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0
4492313|NCT00795717|7294766|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1
4492314|NCT00795717|7294767|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1
4492315|NCT00795717|7294766|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0
4492316|NCT00795717|7294767|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1
4492317|NCT00795717|7294766|FG000|Phase II|too busy|0
4492318|NCT00795717|7294767|FG001|Phase II|too busy|1
4492319|NCT00795821|7294780|FG000|Acute Treatment Phase|Adverse Event|23
4492320|NCT00795821|7294781|FG001|Acute Treatment Phase|Adverse Event|4
4492321|NCT00795821|7294780|FG000|Acute Treatment Phase|Death|1
4492322|NCT00795821|7294781|FG001|Acute Treatment Phase|Death|0
4492323|NCT00795821|7294780|FG000|Acute Treatment Phase|Lack of Efficacy|5
4492324|NCT00795821|7294781|FG001|Acute Treatment Phase|Lack of Efficacy|2
4492325|NCT00795821|7294780|FG000|Acute Treatment Phase|Lost to Follow-up|9
4492326|NCT00795821|7294781|FG001|Acute Treatment Phase|Lost to Follow-up|12
4492327|NCT00795821|7294780|FG000|Acute Treatment Phase|Physician Decision|1
4492328|NCT00795821|7294781|FG001|Acute Treatment Phase|Physician Decision|1
4703002|NCT02723630|7620277|FG000|Intervention Period 3|consumption of restricted item|0
4735375|NCT03527745|7683291|FG004|Overall Study|Lost to Follow-up|0
4492329|NCT00795821|7294780|FG000|Acute Treatment Phase|Protocol Violation|1
4492330|NCT00795821|7294781|FG001|Acute Treatment Phase|Protocol Violation|2
4492331|NCT00795821|7294780|FG000|Acute Treatment Phase|Withdrawal by Subject|16
4492332|NCT00795821|7294781|FG001|Acute Treatment Phase|Withdrawal by Subject|10
4492333|NCT00795821|7294780|FG000|Long-term Extension Phase|Adverse Event|25
4492334|NCT00795821|7294781|FG001|Long-term Extension Phase|Adverse Event|32
4492335|NCT00795821|7294780|FG000|Long-term Extension Phase|Lack of Efficacy|16
4492336|NCT00795821|7294781|FG001|Long-term Extension Phase|Lack of Efficacy|12
4492337|NCT00795821|7294780|FG000|Long-term Extension Phase|Lost to Follow-up|20
4492338|NCT00795821|7294781|FG001|Long-term Extension Phase|Lost to Follow-up|16
4492339|NCT00795821|7294780|FG000|Long-term Extension Phase|Physician Decision|1
4492340|NCT00795821|7294781|FG001|Long-term Extension Phase|Physician Decision|2
4492341|NCT00795821|7294780|FG000|Long-term Extension Phase|Protocol Violation|3
4492342|NCT00795821|7294781|FG001|Long-term Extension Phase|Protocol Violation|5
4492343|NCT00795821|7294780|FG000|Long-term Extension Phase|Withdrawal by Subject|25
4492344|NCT00795821|7294781|FG001|Long-term Extension Phase|Withdrawal by Subject|25
4492345|NCT00795821|7294780|FG000|Taper Phase|Adverse Event|2
4492346|NCT00795821|7294781|FG001|Taper Phase|Adverse Event|0
4492347|NCT00795821|7294780|FG000|Taper Phase|Lost to Follow-up|1
4492348|NCT00795821|7294781|FG001|Taper Phase|Lost to Follow-up|0
4492349|NCT00795821|7294780|FG000|Taper Phase|Physician Decision|2
4492350|NCT00795821|7294781|FG001|Taper Phase|Physician Decision|0
4492351|NCT00795821|7294780|FG000|Taper Phase|Withdrawal by Subject|4
4492352|NCT00795821|7294781|FG001|Taper Phase|Withdrawal by Subject|0
4492353|NCT00795886|7294797|FG000|Overall Study|Death|10
4492354|NCT00795951|7294802|FG000|Overall Study|Lost to Follow-up|1
4492355|NCT00795951|7294802|FG000|Overall Study|Withdrawal by Subject|1
4492356|NCT00796003|7294809|FG000|Overall Study|Disease Progression|2
4492357|NCT00796003|7294810|FG001|Overall Study|Disease Progression|13
4492358|NCT00796003|7294809|FG000|Overall Study|Adverse Event|1
4492359|NCT00796003|7294810|FG001|Overall Study|Adverse Event|7
4492360|NCT00796003|7294809|FG000|Overall Study|Specified organ function not met|0
4492361|NCT00796003|7294810|FG001|Overall Study|Specified organ function not met|1
4492362|NCT00796003|7294809|FG000|Overall Study|Physician Decision|0
4492363|NCT00796003|7294810|FG001|Overall Study|Physician Decision|4
4492364|NCT00796003|7294809|FG000|Overall Study|Withdrawal by Subject|0
4492365|NCT00796003|7294810|FG001|Overall Study|Withdrawal by Subject|1
4492366|NCT00796003|7294809|FG000|Overall Study|Other|0
4492367|NCT00796003|7294810|FG001|Overall Study|Other|1
4492368|NCT00796003|7294809|FG000|Overall Study|Participants Not treated|0
4492369|NCT00796003|7294810|FG001|Overall Study|Participants Not treated|2
4492370|NCT00796120|7294821|FG000|Overall Study|Death|3
4492371|NCT00796120|7294822|FG001|Overall Study|Death|0
4492372|NCT00796120|7294821|FG000|Overall Study|Adverse Event|11
4492373|NCT00796120|7294822|FG001|Overall Study|Adverse Event|6
4492374|NCT00796120|7294821|FG000|Overall Study|Progressive disease|22
4492375|NCT00796120|7294822|FG001|Overall Study|Progressive disease|13
4492376|NCT00796120|7294821|FG000|Overall Study|Participant refusal|3
4492377|NCT00796120|7294822|FG001|Overall Study|Participant refusal|4
4492378|NCT00796120|7294821|FG000|Overall Study|Other|6
4492379|NCT00796120|7294822|FG001|Overall Study|Other|17
4492380|NCT00796120|7294821|FG000|Overall Study|Physician Decision|16
4492381|NCT00796120|7294822|FG001|Overall Study|Physician Decision|17
4492382|NCT00796120|7294821|FG000|Overall Study|Randomized but not treated|0
4492383|NCT00796120|7294822|FG001|Overall Study|Randomized but not treated|3
4492384|NCT00796224|7294830|FG000|Overall Study|Adverse Event|1
4492385|NCT00796224|7294831|FG001|Overall Study|Adverse Event|0
4492386|NCT00796224|7294830|FG000|Overall Study|Protocol Violation|0
4492387|NCT00796224|7294831|FG001|Overall Study|Protocol Violation|1
4492388|NCT00796315|7294849|FG000|Overall Study|Protocol Violation|0
4492389|NCT00796315|7294850|FG001|Overall Study|Protocol Violation|1
4492390|NCT00796315|7294851|FG002|Overall Study|Protocol Violation|0
4492391|NCT00796328|7294862|FG000|Overall Study|experienced hypotension requiring tx|6
4492392|NCT00796367|7294869|FG000|Overall Study|Adverse Event|6
4492393|NCT00796367|7294870|FG001|Overall Study|Adverse Event|4
4492394|NCT00796367|7294871|FG002|Overall Study|Adverse Event|7
4492395|NCT00796367|7294869|FG000|Overall Study|Lost to Follow-up|5
4492396|NCT00796367|7294870|FG001|Overall Study|Lost to Follow-up|4
4626902|NCT01847092|7493091|FG000|Overall Study|Protocol Specified|8
4626903|NCT01847092|7493092|FG001|Overall Study|Protocol Specified|0
4626904|NCT01847092|7493091|FG000|Overall Study|Physician Decision|1
4626905|NCT01847092|7493092|FG001|Overall Study|Physician Decision|1
4626906|NCT01847092|7493091|FG000|Overall Study|Protocol Violation|0
4626907|NCT01847092|7493092|FG001|Overall Study|Protocol Violation|2
4492397|NCT00796367|7294871|FG002|Overall Study|Lost to Follow-up|21
4492398|NCT00796367|7294869|FG000|Overall Study|Withdrawal by Subject|9
4492399|NCT00796367|7294870|FG001|Overall Study|Withdrawal by Subject|11
4492400|NCT00796367|7294871|FG002|Overall Study|Withdrawal by Subject|12
4492401|NCT00796367|7294869|FG000|Overall Study|Lack of Efficacy|2
4492402|NCT00796367|7294870|FG001|Overall Study|Lack of Efficacy|1
4492403|NCT00796367|7294871|FG002|Overall Study|Lack of Efficacy|0
4492404|NCT00796367|7294869|FG000|Overall Study|non compliance|3
4492405|NCT00796367|7294870|FG001|Overall Study|non compliance|1
4492406|NCT00796367|7294871|FG002|Overall Study|non compliance|1
4492407|NCT00796367|7294869|FG000|Overall Study|Pregnancy|1
4492408|NCT00796367|7294870|FG001|Overall Study|Pregnancy|0
4492409|NCT00796367|7294871|FG002|Overall Study|Pregnancy|1
4492410|NCT00796367|7294869|FG000|Overall Study|Requirement for restricted medication|2
4492411|NCT00796367|7294870|FG001|Overall Study|Requirement for restricted medication|0
4492412|NCT00796367|7294871|FG002|Overall Study|Requirement for restricted medication|2
4626908|NCT01847209|7493111|FG000|Overall Study|Withdrawal by Subject|1
4626909|NCT01847209|7493111|FG000|Overall Study|No lung nodule found on intraop CT scan|1
4626910|NCT01847313|7493117|FG000|Overall Study|Death|0
4626911|NCT01847313|7493118|FG001|Overall Study|Death|1
4626912|NCT01847313|7493117|FG000|Overall Study|Withdrawal by Subject|0
4492413|NCT00796367|7294869|FG000|Overall Study|other|2
4492414|NCT00796367|7294870|FG001|Overall Study|other|4
4492415|NCT00796367|7294871|FG002|Overall Study|other|3
4492416|NCT00796419|7294881|FG000|Overall Study|Death|0
4492417|NCT00796419|7294882|FG001|Overall Study|Death|1
4492418|NCT00796445|7294890|FG000|Overall Study|Protocol Violation|5
4492419|NCT00796445|7294891|FG001|Overall Study|Protocol Violation|3
4492420|NCT00796445|7294890|FG000|Overall Study|Adverse event, serious fatal|10
4492421|NCT00796445|7294891|FG001|Overall Study|Adverse event, serious fatal|5
4492422|NCT00796445|7294890|FG000|Overall Study|Adverse event, non-fatal|4
4492423|NCT00796445|7294891|FG001|Overall Study|Adverse event, non-fatal|0
4492424|NCT00796445|7294890|FG000|Overall Study|Disease progression/recurrence|537
4492425|NCT00796445|7294891|FG001|Overall Study|Disease progression/recurrence|268
4492426|NCT00796445|7294890|FG000|Overall Study|Other|10
4492427|NCT00796445|7294891|FG001|Overall Study|Other|7
4492428|NCT00796445|7294890|FG000|Overall Study|Withdrawal by Subject|18
4492429|NCT00796445|7294891|FG001|Overall Study|Withdrawal by Subject|9
4492430|NCT00796445|7294890|FG000|Overall Study|Invalid Informed Consent Form|1
4492431|NCT00796445|7294891|FG001|Overall Study|Invalid Informed Consent Form|0
4492432|NCT00796549|7294905|FG000|Overall Study|Adverse Event|11
4492433|NCT00796549|7294905|FG000|Overall Study|not entered|149
4492434|NCT00796549|7294905|FG000|Overall Study|Other|2
4492435|NCT00796549|7294905|FG000|Overall Study|Progressive disease|56
4492436|NCT00796562|7294911|FG000|Overall Study|Death|49
4492437|NCT00796614|7294919|FG000|Overall Study|Adverse Event|1
4492438|NCT00796614|7294920|FG001|Overall Study|Adverse Event|2
4492439|NCT00796614|7294921|FG002|Overall Study|Adverse Event|0
4492440|NCT00796614|7294922|FG003|Overall Study|Adverse Event|0
4492441|NCT00796614|7294919|FG000|Overall Study|Protocol Violation|0
4492442|NCT00796614|7294920|FG001|Overall Study|Protocol Violation|0
4492443|NCT00796614|7294921|FG002|Overall Study|Protocol Violation|2
4492444|NCT00796614|7294922|FG003|Overall Study|Protocol Violation|0
4492445|NCT00796614|7294919|FG000|Overall Study|Lost to Follow-up|2
4492446|NCT00796614|7294920|FG001|Overall Study|Lost to Follow-up|2
4492447|NCT00796614|7294921|FG002|Overall Study|Lost to Follow-up|1
4492448|NCT00796614|7294922|FG003|Overall Study|Lost to Follow-up|0
4492449|NCT00796614|7294919|FG000|Overall Study|Withdrawal by Subject|1
4492450|NCT00796614|7294920|FG001|Overall Study|Withdrawal by Subject|0
4492451|NCT00796614|7294921|FG002|Overall Study|Withdrawal by Subject|0
4492452|NCT00796614|7294922|FG003|Overall Study|Withdrawal by Subject|1
4492453|NCT00796614|7294919|FG000|Overall Study|Other than stated|1
4492454|NCT00796614|7294920|FG001|Overall Study|Other than stated|0
4492455|NCT00796614|7294921|FG002|Overall Study|Other than stated|0
4492456|NCT00796614|7294922|FG003|Overall Study|Other than stated|0
4492457|NCT00796653|7294945|FG000|Overall Study|Adverse Event|19
4492458|NCT00796653|7294946|FG001|Overall Study|Adverse Event|16
4492459|NCT00796653|7294947|FG002|Overall Study|Adverse Event|16
4492460|NCT00796653|7294948|FG003|Overall Study|Adverse Event|16
4492461|NCT00796653|7294945|FG000|Overall Study|Lost to Follow-up|2
4492462|NCT00796653|7294946|FG001|Overall Study|Lost to Follow-up|1
4492463|NCT00796653|7294947|FG002|Overall Study|Lost to Follow-up|2
4492464|NCT00796653|7294948|FG003|Overall Study|Lost to Follow-up|3
4492465|NCT00796653|7294945|FG000|Overall Study|Withdrawal by Subject|16
4492466|NCT00796653|7294946|FG001|Overall Study|Withdrawal by Subject|8
4492467|NCT00796653|7294947|FG002|Overall Study|Withdrawal by Subject|8
4492468|NCT00796653|7294948|FG003|Overall Study|Withdrawal by Subject|13
4492469|NCT00796653|7294945|FG000|Overall Study|Lack of Efficacy|8
4492470|NCT00796653|7294946|FG001|Overall Study|Lack of Efficacy|1
4492471|NCT00796653|7294947|FG002|Overall Study|Lack of Efficacy|3
4492472|NCT00796653|7294948|FG003|Overall Study|Lack of Efficacy|2
4492473|NCT00796653|7294945|FG000|Overall Study|Non compliance with protocol|2
4492474|NCT00796653|7294946|FG001|Overall Study|Non compliance with protocol|2
4492475|NCT00796653|7294947|FG002|Overall Study|Non compliance with protocol|0
4492476|NCT00796653|7294948|FG003|Overall Study|Non compliance with protocol|2
4492477|NCT00796653|7294945|FG000|Overall Study|Other reason not described above|4
4492478|NCT00796653|7294946|FG001|Overall Study|Other reason not described above|9
4492479|NCT00796653|7294947|FG002|Overall Study|Other reason not described above|7
4492480|NCT00796653|7294948|FG003|Overall Study|Other reason not described above|4
4492481|NCT00796666|7294968|FG000|Overall Study|Death|2
4492482|NCT00796666|7294969|FG001|Overall Study|Death|4
4492483|NCT00796666|7294968|FG000|Overall Study|Withdrawal by Subject|2
4492484|NCT00796666|7294969|FG001|Overall Study|Withdrawal by Subject|0
4492485|NCT00796666|7294968|FG000|Overall Study|Adverse Event|7
4492486|NCT00796666|7294969|FG001|Overall Study|Adverse Event|5
4492487|NCT00796666|7294968|FG000|Overall Study|Protocol Violation|1
4492488|NCT00796666|7294969|FG001|Overall Study|Protocol Violation|0
4492489|NCT00796666|7294968|FG000|Overall Study|Other|1
4492490|NCT00796666|7294969|FG001|Overall Study|Other|0
4492491|NCT00796666|7294968|FG000|Overall Study|Terminated by sponsor|53
4492492|NCT00796666|7294969|FG001|Overall Study|Terminated by sponsor|55
4492493|NCT00796666|7294968|FG000|Overall Study|Randomized and not treated|1
4492494|NCT00796666|7294969|FG001|Overall Study|Randomized and not treated|0
4492495|NCT00796718|7294994|FG000|Overall Study|Adverse Event|2
4492496|NCT00796718|7294994|FG000|Overall Study|Exclusion Criteria|1
4492497|NCT00796718|7294994|FG000|Overall Study|Lost to Follow-up|5
4492498|NCT00796718|7294994|FG000|Overall Study|Withdrawal by Informed Consent|1
4492499|NCT00796757|7295013|FG000|Overall Study|Withdrawal by Subject|14
4492500|NCT00796757|7295013|FG000|Overall Study|Death|61
4492501|NCT00796757|7295013|FG000|Overall Study|Protocol Violation|1
4492502|NCT00796757|7295013|FG000|Overall Study|Participant noncompliance|1
4492503|NCT00796757|7295013|FG000|Overall Study|Investigator's decision|2
4492504|NCT00796757|7295013|FG000|Overall Study|Other|7
4492505|NCT00796822|7295019|FG000|Overall Study|Lost to Follow-up|2
4492506|NCT00796822|7295020|FG001|Overall Study|Lost to Follow-up|0
4492507|NCT00796822|7295019|FG000|Overall Study|Adverse Event|1
4492508|NCT00796822|7295020|FG001|Overall Study|Adverse Event|0
4492509|NCT00796978|7295035|FG000|Overall Study|Cardiac adverse event|5
4492510|NCT00796978|7295035|FG000|Overall Study|Adverse Event|4
4492511|NCT00796978|7295035|FG000|Overall Study|Withdrawal by Subject|3
4492512|NCT00796991|7295042|FG000|Overall Study|Adverse Event|0
4492513|NCT00796991|7295043|FG001|Overall Study|Adverse Event|0
4492514|NCT00796991|7295044|FG002|Overall Study|Adverse Event|1
4492515|NCT00796991|7295042|FG000|Overall Study|Death|2
4492516|NCT00796991|7295043|FG001|Overall Study|Death|0
4492517|NCT00796991|7295044|FG002|Overall Study|Death|0
4492518|NCT00796991|7295042|FG000|Overall Study|Disease Progression|10
4492519|NCT00796991|7295043|FG001|Overall Study|Disease Progression|9
4492520|NCT00796991|7295044|FG002|Overall Study|Disease Progression|7
4492521|NCT00796991|7295042|FG000|Overall Study|Study Drug Toxicity|3
4492522|NCT00796991|7295043|FG001|Overall Study|Study Drug Toxicity|3
4492523|NCT00796991|7295044|FG002|Overall Study|Study Drug Toxicity|5
4492524|NCT00796991|7295042|FG000|Overall Study|Withdrawal by Subject|0
4492525|NCT00796991|7295043|FG001|Overall Study|Withdrawal by Subject|0
4492526|NCT00796991|7295044|FG002|Overall Study|Withdrawal by Subject|1
4492527|NCT00797108|7295055|FG000|Overall Study|Adverse Event|1
4492528|NCT00797108|7295056|FG001|Overall Study|Adverse Event|0
4492529|NCT00797108|7295057|FG002|Overall Study|Adverse Event|3
4492530|NCT00797108|7295055|FG000|Overall Study|Did Not Meet Entrance Criteria|0
4492531|NCT00797108|7295056|FG001|Overall Study|Did Not Meet Entrance Criteria|1
4492532|NCT00797108|7295057|FG002|Overall Study|Did Not Meet Entrance Criteria|0
4492533|NCT00797108|7295055|FG000|Overall Study|Global Deterioration of Health Status|0
4492534|NCT00797108|7295056|FG001|Overall Study|Global Deterioration of Health Status|1
4492535|NCT00797108|7295057|FG002|Overall Study|Global Deterioration of Health Status|0
4492536|NCT00797108|7295055|FG000|Overall Study|Lack of Efficacy|1
4492537|NCT00797108|7295056|FG001|Overall Study|Lack of Efficacy|0
4492538|NCT00797108|7295057|FG002|Overall Study|Lack of Efficacy|1
4492539|NCT00797108|7295055|FG000|Overall Study|Other|0
4492540|NCT00797108|7295056|FG001|Overall Study|Other|0
4492541|NCT00797108|7295057|FG002|Overall Study|Other|2
4492542|NCT00797108|7295055|FG000|Overall Study|Randomized but not Treated|2
4492543|NCT00797108|7295056|FG001|Overall Study|Randomized but not Treated|0
4492544|NCT00797108|7295057|FG002|Overall Study|Randomized but not Treated|0
4492545|NCT00797225|7295073|FG000|Weeks 1 to 12|Adverse Event|0
4492546|NCT00797225|7295074|FG001|Weeks 1 to 12|Adverse Event|0
4492547|NCT00797225|7295075|FG002|Weeks 1 to 12|Adverse Event|1
4492548|NCT00797225|7295076|FG003|Weeks 1 to 12|Adverse Event|0
4492549|NCT00797225|7295077|FG004|Weeks 1 to 12|Adverse Event|0
4492550|NCT00797225|7295078|FG005|Weeks 1 to 12|Adverse Event|0
4492551|NCT00797225|7295079|FG006|Weeks 1 to 12|Adverse Event|0
4492552|NCT00797225|7295080|FG007|Weeks 1 to 12|Adverse Event|0
4492553|NCT00797225|7295073|FG000|Weeks 1 to 12|Non-compliance|0
4492554|NCT00797225|7295074|FG001|Weeks 1 to 12|Non-compliance|1
4703003|NCT02723630|7620278|FG001|Intervention Period 3|consumption of restricted item|1
4703004|NCT02723630|7620279|FG002|Intervention Period 3|consumption of restricted item|0
4703005|NCT02723630|7620280|FG003|Intervention Period 3|consumption of restricted item|0
4703006|NCT02723630|7620281|FG004|Intervention Period 3|consumption of restricted item|0
4703007|NCT02723630|7620282|FG005|Intervention Period 3|consumption of restricted item|0
4492555|NCT00797225|7295075|FG002|Weeks 1 to 12|Non-compliance|0
4492556|NCT00797225|7295076|FG003|Weeks 1 to 12|Non-compliance|0
4492557|NCT00797225|7295077|FG004|Weeks 1 to 12|Non-compliance|0
4492558|NCT00797225|7295078|FG005|Weeks 1 to 12|Non-compliance|0
4492559|NCT00797225|7295079|FG006|Weeks 1 to 12|Non-compliance|0
4492560|NCT00797225|7295080|FG007|Weeks 1 to 12|Non-compliance|0
4492561|NCT00797225|7295073|FG000|Weeks 1 to 12|Lack of Efficacy|1
4492562|NCT00797225|7295074|FG001|Weeks 1 to 12|Lack of Efficacy|0
4492563|NCT00797225|7295075|FG002|Weeks 1 to 12|Lack of Efficacy|0
4492564|NCT00797225|7295076|FG003|Weeks 1 to 12|Lack of Efficacy|0
4492565|NCT00797225|7295077|FG004|Weeks 1 to 12|Lack of Efficacy|0
4492566|NCT00797225|7295078|FG005|Weeks 1 to 12|Lack of Efficacy|0
4492567|NCT00797225|7295079|FG006|Weeks 1 to 12|Lack of Efficacy|0
4492568|NCT00797225|7295080|FG007|Weeks 1 to 12|Lack of Efficacy|0
4492569|NCT00797225|7295073|FG000|Weeks 1 to 12|Sponsor Decision|1
4492570|NCT00797225|7295074|FG001|Weeks 1 to 12|Sponsor Decision|0
4492571|NCT00797225|7295075|FG002|Weeks 1 to 12|Sponsor Decision|0
4492572|NCT00797225|7295076|FG003|Weeks 1 to 12|Sponsor Decision|0
4492573|NCT00797225|7295077|FG004|Weeks 1 to 12|Sponsor Decision|0
4492574|NCT00797225|7295078|FG005|Weeks 1 to 12|Sponsor Decision|0
4492575|NCT00797225|7295079|FG006|Weeks 1 to 12|Sponsor Decision|0
4492576|NCT00797225|7295080|FG007|Weeks 1 to 12|Sponsor Decision|0
4492577|NCT00797225|7295073|FG000|Weeks 13 to 24|Non-compliance|0
4492578|NCT00797225|7295074|FG001|Weeks 13 to 24|Non-compliance|2
4492579|NCT00797225|7295075|FG002|Weeks 13 to 24|Non-compliance|0
4492580|NCT00797225|7295076|FG003|Weeks 13 to 24|Non-compliance|0
4492581|NCT00797225|7295077|FG004|Weeks 13 to 24|Non-compliance|0
4492582|NCT00797225|7295078|FG005|Weeks 13 to 24|Non-compliance|0
4492583|NCT00797225|7295079|FG006|Weeks 13 to 24|Non-compliance|0
4492584|NCT00797225|7295080|FG007|Weeks 13 to 24|Non-compliance|0
4492585|NCT00797225|7295073|FG000|Weeks 13 to 24|Withdrawal by Subject|0
4626913|NCT01847313|7493118|FG001|Overall Study|Withdrawal by Subject|1
4626914|NCT01847443|7493128|FG000|Study Period 1|Withdrawal by Subject|0
4626915|NCT01847443|7493129|FG001|Study Period 1|Withdrawal by Subject|1
4626916|NCT01847443|7493130|FG002|Study Period 1|Withdrawal by Subject|0
4626917|NCT01847443|7493131|FG003|Study Period 1|Withdrawal by Subject|0
4626918|NCT01847443|7493128|FG000|Washout Period Before Study Period 2|Adverse Event|1
4626919|NCT01847443|7493129|FG001|Washout Period Before Study Period 2|Adverse Event|1
4626920|NCT01847443|7493130|FG002|Washout Period Before Study Period 2|Adverse Event|0
4626921|NCT01847443|7493131|FG003|Washout Period Before Study Period 2|Adverse Event|0
4626922|NCT01847443|7493128|FG000|Washout Period Before Study Period 2|Other reason|1
4626923|NCT01847443|7493129|FG001|Washout Period Before Study Period 2|Other reason|0
4626924|NCT01847443|7493130|FG002|Washout Period Before Study Period 2|Other reason|0
4626925|NCT01847443|7493131|FG003|Washout Period Before Study Period 2|Other reason|0
4626926|NCT01847443|7493128|FG000|Washout Period Before Study Period 3|Other reason|1
4703008|NCT02723786|7620295|FG000|Overall Study|Lost to Follow-up|1
4703009|NCT02724020|7620322|FG000|Overall Study|Death|16
4492586|NCT00797225|7295074|FG001|Weeks 13 to 24|Withdrawal by Subject|1
4492587|NCT00797225|7295075|FG002|Weeks 13 to 24|Withdrawal by Subject|1
4492588|NCT00797225|7295076|FG003|Weeks 13 to 24|Withdrawal by Subject|0
4492589|NCT00797225|7295077|FG004|Weeks 13 to 24|Withdrawal by Subject|0
4492590|NCT00797225|7295078|FG005|Weeks 13 to 24|Withdrawal by Subject|0
4492591|NCT00797225|7295079|FG006|Weeks 13 to 24|Withdrawal by Subject|0
4492592|NCT00797225|7295080|FG007|Weeks 13 to 24|Withdrawal by Subject|0
4492593|NCT00797225|7295073|FG000|Weeks 13 to 24|Lost to Follow-up|0
4492594|NCT00797225|7295074|FG001|Weeks 13 to 24|Lost to Follow-up|0
4492595|NCT00797225|7295075|FG002|Weeks 13 to 24|Lost to Follow-up|1
4492596|NCT00797225|7295076|FG003|Weeks 13 to 24|Lost to Follow-up|0
4492597|NCT00797225|7295077|FG004|Weeks 13 to 24|Lost to Follow-up|1
4492598|NCT00797225|7295078|FG005|Weeks 13 to 24|Lost to Follow-up|0
4492599|NCT00797225|7295079|FG006|Weeks 13 to 24|Lost to Follow-up|0
4492600|NCT00797225|7295080|FG007|Weeks 13 to 24|Lost to Follow-up|0
4492601|NCT00797225|7295073|FG000|Weeks 13 to 24|Adverse Event|0
4492602|NCT00797225|7295074|FG001|Weeks 13 to 24|Adverse Event|1
4492603|NCT00797225|7295075|FG002|Weeks 13 to 24|Adverse Event|0
4492604|NCT00797225|7295076|FG003|Weeks 13 to 24|Adverse Event|0
4492605|NCT00797225|7295077|FG004|Weeks 13 to 24|Adverse Event|0
4492606|NCT00797225|7295078|FG005|Weeks 13 to 24|Adverse Event|0
4492607|NCT00797225|7295079|FG006|Weeks 13 to 24|Adverse Event|1
4492608|NCT00797225|7295080|FG007|Weeks 13 to 24|Adverse Event|0
4492609|NCT00797225|7295073|FG000|Weeks 13 to 24|Sponsor Decision|0
4492610|NCT00797225|7295074|FG001|Weeks 13 to 24|Sponsor Decision|0
4492611|NCT00797225|7295075|FG002|Weeks 13 to 24|Sponsor Decision|0
4492612|NCT00797225|7295076|FG003|Weeks 13 to 24|Sponsor Decision|0
4492613|NCT00797225|7295077|FG004|Weeks 13 to 24|Sponsor Decision|0
4492614|NCT00797225|7295078|FG005|Weeks 13 to 24|Sponsor Decision|0
4492615|NCT00797225|7295079|FG006|Weeks 13 to 24|Sponsor Decision|1
4492616|NCT00797225|7295080|FG007|Weeks 13 to 24|Sponsor Decision|0
4703010|NCT02724020|7620323|FG001|Overall Study|Death|18
4703011|NCT02724020|7620324|FG002|Overall Study|Death|19
4703012|NCT02724020|7620322|FG000|Overall Study|Lost to Follow-up|0
4703013|NCT02724020|7620323|FG001|Overall Study|Lost to Follow-up|3
4703014|NCT02724020|7620324|FG002|Overall Study|Lost to Follow-up|0
4703015|NCT02724020|7620322|FG000|Overall Study|Site Terminated by Sponsor|15
4703016|NCT02724020|7620323|FG001|Overall Study|Site Terminated by Sponsor|8
4703017|NCT02724020|7620324|FG002|Overall Study|Site Terminated by Sponsor|8
4703018|NCT02724020|7620322|FG000|Overall Study|Withdrawal by Subject|1
4703019|NCT02724020|7620323|FG001|Overall Study|Withdrawal by Subject|3
4703020|NCT02724020|7620324|FG002|Overall Study|Withdrawal by Subject|5
4703021|NCT02724111|7620347|FG000|Overall Study|Protocol Violation|2
4703022|NCT02724111|7620348|FG001|Overall Study|Protocol Violation|5
4703023|NCT02724462|7620365|FG000|3 Month Follow-up Survey|Lost to Follow-up|171
4703024|NCT02724462|7620366|FG001|3 Month Follow-up Survey|Lost to Follow-up|151
4703025|NCT02724462|7620365|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40
4735376|NCT03527745|7683292|FG005|Overall Study|Lost to Follow-up|2
4492617|NCT00797316|7295108|FG000|Overall Study|Administrative problems|1
4492618|NCT00797316|7295109|FG001|Overall Study|Administrative problems|0
4492619|NCT00797316|7295108|FG000|Overall Study|Adverse Event|5
4492620|NCT00797316|7295109|FG001|Overall Study|Adverse Event|3
4492621|NCT00797316|7295108|FG000|Overall Study|Lost to Follow-up|4
4492622|NCT00797316|7295109|FG001|Overall Study|Lost to Follow-up|8
4492623|NCT00797316|7295108|FG000|Overall Study|Protocol Deviation|1
4492624|NCT00797316|7295109|FG001|Overall Study|Protocol Deviation|2
4492625|NCT00797316|7295108|FG000|Overall Study|Patient withdrew consent|12
4492626|NCT00797316|7295109|FG001|Overall Study|Patient withdrew consent|6
4492627|NCT00797316|7295108|FG000|Overall Study|Unsatisfactory therapeutic effect|0
4492628|NCT00797316|7295109|FG001|Overall Study|Unsatisfactory therapeutic effect|13
4492629|NCT00797511|7295123|FG000|Overall Study|Withdrawal by Subject|1
4492630|NCT00797563|7295128|FG000|Overall Study|Adverse Event|1
4492631|NCT00797667|7295135|FG000|Overall Study|Lack of Efficacy|0
4492632|NCT00797667|7295136|FG001|Overall Study|Lack of Efficacy|1
4492633|NCT00797667|7295137|FG002|Overall Study|Lack of Efficacy|0
4492634|NCT00797667|7295135|FG000|Overall Study|Lost to Follow-up|8
4492635|NCT00797667|7295136|FG001|Overall Study|Lost to Follow-up|12
4492636|NCT00797667|7295137|FG002|Overall Study|Lost to Follow-up|2
4492637|NCT00797667|7295135|FG000|Overall Study|Physician Decision|3
4492638|NCT00797667|7295136|FG001|Overall Study|Physician Decision|1
4492639|NCT00797667|7295137|FG002|Overall Study|Physician Decision|0
4492640|NCT00797667|7295135|FG000|Overall Study|Pregnancy|2
4492641|NCT00797667|7295136|FG001|Overall Study|Pregnancy|0
4492642|NCT00797667|7295137|FG002|Overall Study|Pregnancy|0
4492643|NCT00797667|7295135|FG000|Overall Study|Protocol Violation|2
4492644|NCT00797667|7295136|FG001|Overall Study|Protocol Violation|7
4492645|NCT00797667|7295137|FG002|Overall Study|Protocol Violation|0
4492646|NCT00797667|7295135|FG000|Overall Study|Study Terminated by Sponsor|217
4492647|NCT00797667|7295136|FG001|Overall Study|Study Terminated by Sponsor|216
4492648|NCT00797667|7295137|FG002|Overall Study|Study Terminated by Sponsor|115
4492649|NCT00797667|7295135|FG000|Overall Study|Withdrawal by Subject|9
4492650|NCT00797667|7295136|FG001|Overall Study|Withdrawal by Subject|14
4492651|NCT00797667|7295137|FG002|Overall Study|Withdrawal by Subject|2
4492652|NCT00797667|7295135|FG000|Overall Study|Adverse Event|19
4492653|NCT00797667|7295136|FG001|Overall Study|Adverse Event|8
4626927|NCT01847443|7493129|FG001|Washout Period Before Study Period 3|Other reason|0
4626928|NCT01847443|7493130|FG002|Washout Period Before Study Period 3|Other reason|0
4626929|NCT01847443|7493131|FG003|Washout Period Before Study Period 3|Other reason|0
4703026|NCT02724462|7620366|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48
4492654|NCT00797667|7295137|FG002|Overall Study|Adverse Event|8
4492655|NCT00797732|7295147|FG000|Overall Study|Withdrawal by Subject|3
4492656|NCT00797732|7295148|FG001|Overall Study|Withdrawal by Subject|3
4492657|NCT00797732|7295149|FG002|Overall Study|Withdrawal by Subject|0
4492658|NCT00797732|7295147|FG000|Overall Study|Lost to Follow-up|1
4492659|NCT00797732|7295148|FG001|Overall Study|Lost to Follow-up|0
4492660|NCT00797732|7295149|FG002|Overall Study|Lost to Follow-up|0
4492661|NCT00797732|7295147|FG000|Overall Study|Death|1
4492662|NCT00797732|7295148|FG001|Overall Study|Death|0
4492663|NCT00797732|7295149|FG002|Overall Study|Death|0
4492664|NCT00797732|7295147|FG000|Overall Study|Not meet inclusion criteria|0
4492665|NCT00797732|7295148|FG001|Overall Study|Not meet inclusion criteria|0
4492666|NCT00797732|7295149|FG002|Overall Study|Not meet inclusion criteria|7
4492667|NCT00797732|7295147|FG000|Overall Study|Excluded due to time constraints|0
4492668|NCT00797732|7295148|FG001|Overall Study|Excluded due to time constraints|0
4492669|NCT00797732|7295149|FG002|Overall Study|Excluded due to time constraints|24
4492670|NCT00797732|7295147|FG000|Overall Study|Refused to Participate|0
4492671|NCT00797732|7295148|FG001|Overall Study|Refused to Participate|0
4492672|NCT00797732|7295149|FG002|Overall Study|Refused to Participate|123
4517615|NCT00968669|7329562|FG002|Overall Study|EARLY WITHDRAWAL|0
4517616|NCT00968669|7329563|FG003|Overall Study|EARLY WITHDRAWAL|0
4517617|NCT00968669|7329560|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0
4517618|NCT00968669|7329561|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0
4703027|NCT02724462|7620365|FG000|6 Month Follow-up Survey|Lost to Follow-up|156
4703028|NCT02724462|7620366|FG001|6 Month Follow-up Survey|Lost to Follow-up|123
4517619|NCT00968669|7329562|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1
4517620|NCT00968669|7329563|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0
4517621|NCT00968669|7329560|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1
4517622|NCT00968669|7329561|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0
4517623|NCT00968669|7329562|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0
4517624|NCT00968669|7329563|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0
4517625|NCT00968669|7329560|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
4517626|NCT00968669|7329561|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1
4517627|NCT00968669|7329562|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
4517628|NCT00968669|7329563|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
4517629|NCT00968669|7329560|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
4517630|NCT00968669|7329561|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1
4517631|NCT00968669|7329562|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
4517632|NCT00968669|7329563|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
4517633|NCT00968669|7329560|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
4517634|NCT00968669|7329561|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1
4517635|NCT00968669|7329562|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
4517636|NCT00968669|7329563|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
4633402|NCT01911819|7503582|FG002|Overall Study|Adverse Event|0
4517637|NCT00968669|7329560|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0
4517638|NCT00968669|7329561|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1
4517639|NCT00968669|7329562|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0
4492673|NCT00797823|7295167|FG000|First Period (Initial Randomization)|Physician Decision|1
4492674|NCT00797823|7295168|FG001|First Period (Initial Randomization)|Physician Decision|0
4492675|NCT00797823|7295169|FG002|First Period (Initial Randomization)|Physician Decision|0
4492676|NCT00797862|7295179|FG000|Overall Study|Adverse Event|86
4492677|NCT00797862|7295180|FG001|Overall Study|Adverse Event|44
4492678|NCT00797862|7295181|FG002|Overall Study|Adverse Event|58
4492679|NCT00797862|7295179|FG000|Overall Study|Abnormal Test Procedure Result|0
4492680|NCT00797862|7295180|FG001|Overall Study|Abnormal Test Procedure Result|1
4492681|NCT00797862|7295181|FG002|Overall Study|Abnormal Test Procedure Result|1
4492682|NCT00797862|7295179|FG000|Overall Study|Lack of Efficacy|1
4492683|NCT00797862|7295180|FG001|Overall Study|Lack of Efficacy|7
4492684|NCT00797862|7295181|FG002|Overall Study|Lack of Efficacy|6
4492685|NCT00797862|7295179|FG000|Overall Study|No longer required study medication|1
4492686|NCT00797862|7295180|FG001|Overall Study|No longer required study medication|0
4492687|NCT00797862|7295181|FG002|Overall Study|No longer required study medication|0
4492688|NCT00797862|7295179|FG000|Overall Study|Withdrawal by Subject|14
4492689|NCT00797862|7295180|FG001|Overall Study|Withdrawal by Subject|7
4492690|NCT00797862|7295181|FG002|Overall Study|Withdrawal by Subject|7
4492691|NCT00797862|7295179|FG000|Overall Study|Lost to Follow-up|11
4492692|NCT00797862|7295180|FG001|Overall Study|Lost to Follow-up|0
4492693|NCT00797862|7295181|FG002|Overall Study|Lost to Follow-up|5
4492694|NCT00797862|7295179|FG000|Overall Study|Administrative Problem|4
4492695|NCT00797862|7295180|FG001|Overall Study|Administrative Problem|0
4492696|NCT00797862|7295181|FG002|Overall Study|Administrative Problem|0
4492697|NCT00797862|7295179|FG000|Overall Study|Protocol Violation|4
4492698|NCT00797862|7295180|FG001|Overall Study|Protocol Violation|6
4492699|NCT00797862|7295181|FG002|Overall Study|Protocol Violation|8
4492700|NCT00797862|7295179|FG000|Overall Study|Mis-randomized|3
4492701|NCT00797862|7295180|FG001|Overall Study|Mis-randomized|3
4492702|NCT00797862|7295181|FG002|Overall Study|Mis-randomized|1
4492703|NCT00797966|7295193|FG000|Phase A|Lost to Follow-up|0
4492704|NCT00797966|7295194|FG001|Phase A|Lost to Follow-up|0
4492705|NCT00797966|7295195|FG002|Phase A|Lost to Follow-up|0
4492706|NCT00797966|7295196|FG003|Phase A|Lost to Follow-up|0
4492707|NCT00797966|7295197|FG004|Phase A|Lost to Follow-up|33
4492708|NCT00797966|7295198|FG005|Phase A|Lost to Follow-up|0
4492709|NCT00797966|7295193|FG000|Phase A|Adverse Event|0
4492710|NCT00797966|7295194|FG001|Phase A|Adverse Event|0
4492711|NCT00797966|7295195|FG002|Phase A|Adverse Event|0
4492712|NCT00797966|7295196|FG003|Phase A|Adverse Event|0
4492713|NCT00797966|7295197|FG004|Phase A|Adverse Event|46
4492714|NCT00797966|7295198|FG005|Phase A|Adverse Event|0
4492715|NCT00797966|7295193|FG000|Phase A|Met withdrawal criteria|0
4492716|NCT00797966|7295194|FG001|Phase A|Met withdrawal criteria|0
4492717|NCT00797966|7295195|FG002|Phase A|Met withdrawal criteria|0
4492718|NCT00797966|7295196|FG003|Phase A|Met withdrawal criteria|0
4492719|NCT00797966|7295197|FG004|Phase A|Met withdrawal criteria|4
4492720|NCT00797966|7295198|FG005|Phase A|Met withdrawal criteria|0
4492721|NCT00797966|7295193|FG000|Phase A|Physician Decision|0
4492722|NCT00797966|7295194|FG001|Phase A|Physician Decision|0
4492723|NCT00797966|7295195|FG002|Phase A|Physician Decision|0
4492724|NCT00797966|7295196|FG003|Phase A|Physician Decision|0
4626930|NCT01847443|7493128|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1
4492725|NCT00797966|7295197|FG004|Phase A|Physician Decision|13
4492726|NCT00797966|7295198|FG005|Phase A|Physician Decision|0
4492727|NCT00797966|7295193|FG000|Phase A|Withdrawal by Subject|0
4492728|NCT00797966|7295194|FG001|Phase A|Withdrawal by Subject|0
4492729|NCT00797966|7295195|FG002|Phase A|Withdrawal by Subject|0
4492730|NCT00797966|7295196|FG003|Phase A|Withdrawal by Subject|0
4492731|NCT00797966|7295197|FG004|Phase A|Withdrawal by Subject|33
4492732|NCT00797966|7295198|FG005|Phase A|Withdrawal by Subject|0
4492733|NCT00797966|7295193|FG000|Phase A|Protocol deviation|0
4492734|NCT00797966|7295194|FG001|Phase A|Protocol deviation|0
4492735|NCT00797966|7295195|FG002|Phase A|Protocol deviation|0
4492736|NCT00797966|7295196|FG003|Phase A|Protocol deviation|0
4492737|NCT00797966|7295197|FG004|Phase A|Protocol deviation|56
4626931|NCT01847443|7493129|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0
4626932|NCT01847443|7493130|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0
4633403|NCT01911819|7503580|FG000|Overall Study|Withdrawal by Subject|1
4492738|NCT00797966|7295198|FG005|Phase A|Protocol deviation|0
4492739|NCT00797966|7295193|FG000|Phase B|Lost to Follow-up|0
4492740|NCT00797966|7295194|FG001|Phase B|Lost to Follow-up|1
4492741|NCT00797966|7295195|FG002|Phase B|Lost to Follow-up|3
4492742|NCT00797966|7295196|FG003|Phase B|Lost to Follow-up|0
4492743|NCT00797966|7295197|FG004|Phase B|Lost to Follow-up|0
4492744|NCT00797966|7295198|FG005|Phase B|Lost to Follow-up|0
4492745|NCT00797966|7295193|FG000|Phase B|Adverse Event|2
4492746|NCT00797966|7295194|FG001|Phase B|Adverse Event|1
4492747|NCT00797966|7295195|FG002|Phase B|Adverse Event|3
4492748|NCT00797966|7295196|FG003|Phase B|Adverse Event|1
4492749|NCT00797966|7295197|FG004|Phase B|Adverse Event|0
4492750|NCT00797966|7295198|FG005|Phase B|Adverse Event|0
4492751|NCT00797966|7295193|FG000|Phase B|Met Withdrawal Criteria|3
4492752|NCT00797966|7295194|FG001|Phase B|Met Withdrawal Criteria|3
4492753|NCT00797966|7295195|FG002|Phase B|Met Withdrawal Criteria|6
4492754|NCT00797966|7295196|FG003|Phase B|Met Withdrawal Criteria|1
4492755|NCT00797966|7295197|FG004|Phase B|Met Withdrawal Criteria|0
4492756|NCT00797966|7295198|FG005|Phase B|Met Withdrawal Criteria|0
4492757|NCT00797966|7295193|FG000|Phase B|Physician Decision|1
4492758|NCT00797966|7295194|FG001|Phase B|Physician Decision|0
4492759|NCT00797966|7295195|FG002|Phase B|Physician Decision|3
4492760|NCT00797966|7295196|FG003|Phase B|Physician Decision|1
4492761|NCT00797966|7295197|FG004|Phase B|Physician Decision|0
4492762|NCT00797966|7295198|FG005|Phase B|Physician Decision|0
4492763|NCT00797966|7295193|FG000|Phase B|Withdrawal by Subject|1
4492764|NCT00797966|7295194|FG001|Phase B|Withdrawal by Subject|4
4492765|NCT00797966|7295195|FG002|Phase B|Withdrawal by Subject|3
4492766|NCT00797966|7295196|FG003|Phase B|Withdrawal by Subject|3
4492767|NCT00797966|7295197|FG004|Phase B|Withdrawal by Subject|0
4492768|NCT00797966|7295198|FG005|Phase B|Withdrawal by Subject|0
4492769|NCT00797966|7295193|FG000|Phase B|Protocol Deviation|4
4492770|NCT00797966|7295194|FG001|Phase B|Protocol Deviation|8
4492771|NCT00797966|7295195|FG002|Phase B|Protocol Deviation|2
4492772|NCT00797966|7295196|FG003|Phase B|Protocol Deviation|6
4492773|NCT00797966|7295197|FG004|Phase B|Protocol Deviation|0
4492774|NCT00797966|7295198|FG005|Phase B|Protocol Deviation|0
4492775|NCT00797966|7295193|FG000|Phase B|Lack of Efficacy|0
4492776|NCT00797966|7295194|FG001|Phase B|Lack of Efficacy|1
4492777|NCT00797966|7295195|FG002|Phase B|Lack of Efficacy|1
4492778|NCT00797966|7295196|FG003|Phase B|Lack of Efficacy|4
4492779|NCT00797966|7295197|FG004|Phase B|Lack of Efficacy|0
4492780|NCT00797966|7295198|FG005|Phase B|Lack of Efficacy|0
4492781|NCT00797966|7295193|FG000|Phase A+|Lost to Follow-up|0
4492782|NCT00797966|7295194|FG001|Phase A+|Lost to Follow-up|0
4492783|NCT00797966|7295195|FG002|Phase A+|Lost to Follow-up|0
4492784|NCT00797966|7295196|FG003|Phase A+|Lost to Follow-up|0
4492785|NCT00797966|7295197|FG004|Phase A+|Lost to Follow-up|0
4492786|NCT00797966|7295198|FG005|Phase A+|Lost to Follow-up|9
4492787|NCT00797966|7295193|FG000|Phase A+|Met withdrawal criteria|0
4492788|NCT00797966|7295194|FG001|Phase A+|Met withdrawal criteria|0
4492789|NCT00797966|7295195|FG002|Phase A+|Met withdrawal criteria|0
4492790|NCT00797966|7295196|FG003|Phase A+|Met withdrawal criteria|0
4492791|NCT00797966|7295197|FG004|Phase A+|Met withdrawal criteria|0
4492792|NCT00797966|7295198|FG005|Phase A+|Met withdrawal criteria|5
4492793|NCT00797966|7295193|FG000|Phase A+|Withdrawal by Subject|0
4492794|NCT00797966|7295194|FG001|Phase A+|Withdrawal by Subject|0
4492795|NCT00797966|7295195|FG002|Phase A+|Withdrawal by Subject|0
4492796|NCT00797966|7295196|FG003|Phase A+|Withdrawal by Subject|0
4492797|NCT00797966|7295197|FG004|Phase A+|Withdrawal by Subject|0
4492798|NCT00797966|7295198|FG005|Phase A+|Withdrawal by Subject|6
4492799|NCT00797966|7295193|FG000|Phase A+|Adverse Event|0
4492800|NCT00797966|7295194|FG001|Phase A+|Adverse Event|0
4492801|NCT00797966|7295195|FG002|Phase A+|Adverse Event|0
4492802|NCT00797966|7295196|FG003|Phase A+|Adverse Event|0
4492803|NCT00797966|7295197|FG004|Phase A+|Adverse Event|0
4492804|NCT00797966|7295198|FG005|Phase A+|Adverse Event|4
4492805|NCT00797966|7295193|FG000|Phase A+|Protocol deviation|0
4492806|NCT00797966|7295194|FG001|Phase A+|Protocol deviation|0
4492807|NCT00797966|7295195|FG002|Phase A+|Protocol deviation|0
4492808|NCT00797966|7295196|FG003|Phase A+|Protocol deviation|0
4492809|NCT00797966|7295197|FG004|Phase A+|Protocol deviation|0
4492810|NCT00797966|7295198|FG005|Phase A+|Protocol deviation|4
4492811|NCT00798096|7295227|FG000|Overall Study|Ongoing|2
4492812|NCT00798135|7295231|FG000|Overall Study|Disease progression, relapse|11
4492813|NCT00798135|7295231|FG000|Overall Study|Disease progression, refractory|1
4492814|NCT00798135|7295231|FG000|Overall Study|Physician Decision|1
4492815|NCT00798161|7295242|FG000|Overall Study|Adverse Event|3
4492816|NCT00798161|7295243|FG001|Overall Study|Adverse Event|4
4492817|NCT00798161|7295244|FG002|Overall Study|Adverse Event|6
4492818|NCT00798161|7295245|FG003|Overall Study|Adverse Event|6
4492819|NCT00798161|7295246|FG004|Overall Study|Adverse Event|5
4492820|NCT00798161|7295247|FG005|Overall Study|Adverse Event|2
4492821|NCT00798161|7295248|FG006|Overall Study|Adverse Event|4
4492822|NCT00798161|7295242|FG000|Overall Study|Protocol Violation|2
4492823|NCT00798161|7295243|FG001|Overall Study|Protocol Violation|1
4492824|NCT00798161|7295244|FG002|Overall Study|Protocol Violation|3
4492825|NCT00798161|7295245|FG003|Overall Study|Protocol Violation|3
4492826|NCT00798161|7295246|FG004|Overall Study|Protocol Violation|3
4492827|NCT00798161|7295247|FG005|Overall Study|Protocol Violation|2
4492828|NCT00798161|7295248|FG006|Overall Study|Protocol Violation|0
4492829|NCT00798161|7295242|FG000|Overall Study|Lost to Follow-up|1
4492830|NCT00798161|7295243|FG001|Overall Study|Lost to Follow-up|3
4492831|NCT00798161|7295244|FG002|Overall Study|Lost to Follow-up|4
4492832|NCT00798161|7295245|FG003|Overall Study|Lost to Follow-up|3
4492833|NCT00798161|7295246|FG004|Overall Study|Lost to Follow-up|4
4492834|NCT00798161|7295247|FG005|Overall Study|Lost to Follow-up|0
4492835|NCT00798161|7295248|FG006|Overall Study|Lost to Follow-up|0
4492836|NCT00798161|7295242|FG000|Overall Study|Withdrawal by Subject|5
4492837|NCT00798161|7295243|FG001|Overall Study|Withdrawal by Subject|4
4492838|NCT00798161|7295244|FG002|Overall Study|Withdrawal by Subject|5
4492839|NCT00798161|7295245|FG003|Overall Study|Withdrawal by Subject|4
4492840|NCT00798161|7295246|FG004|Overall Study|Withdrawal by Subject|2
4492841|NCT00798161|7295247|FG005|Overall Study|Withdrawal by Subject|3
4492842|NCT00798161|7295248|FG006|Overall Study|Withdrawal by Subject|1
4492843|NCT00798161|7295242|FG000|Overall Study|Other reason (incl. lack of efficacy)|7
4492844|NCT00798161|7295243|FG001|Overall Study|Other reason (incl. lack of efficacy)|5
4492845|NCT00798161|7295244|FG002|Overall Study|Other reason (incl. lack of efficacy)|3
4492846|NCT00798161|7295245|FG003|Overall Study|Other reason (incl. lack of efficacy)|5
4492847|NCT00798161|7295246|FG004|Overall Study|Other reason (incl. lack of efficacy)|2
4492848|NCT00798161|7295247|FG005|Overall Study|Other reason (incl. lack of efficacy)|4
4492849|NCT00798161|7295248|FG006|Overall Study|Other reason (incl. lack of efficacy)|5
4492850|NCT00798174|7295264|FG000|Overall Study|inability to implant azygos coil|3
4492851|NCT00798174|7295265|FG001|Overall Study|inability to implant azygos coil|3
4492852|NCT00798174|7295264|FG000|Overall Study|Inability to sedate for DFT testing|1
4492853|NCT00798174|7295265|FG001|Overall Study|Inability to sedate for DFT testing|0
4492854|NCT00798304|7295272|FG000|Overall Study|Adverse Event|0
4492855|NCT00798304|7295273|FG001|Overall Study|Adverse Event|1
4492856|NCT00798304|7295274|FG002|Overall Study|Adverse Event|1
4492857|NCT00798304|7295272|FG000|Overall Study|Discontinuation by Sponsor|14
4492858|NCT00798304|7295273|FG001|Overall Study|Discontinuation by Sponsor|21
4492859|NCT00798304|7295274|FG002|Overall Study|Discontinuation by Sponsor|9
4492860|NCT00798317|7295284|FG000|Overall Study|Physician Decision|0
4492861|NCT00798317|7295285|FG001|Overall Study|Physician Decision|1
4492862|NCT00798317|7295284|FG000|Overall Study|Withdrawal by Subject|5
4492863|NCT00798317|7295285|FG001|Overall Study|Withdrawal by Subject|4
4492864|NCT00798317|7295284|FG000|Overall Study|Lost to Follow-up|2
4492865|NCT00798317|7295285|FG001|Overall Study|Lost to Follow-up|2
4492866|NCT00798317|7295284|FG000|Overall Study|Adverse Event|2
4492867|NCT00798317|7295285|FG001|Overall Study|Adverse Event|0
4492868|NCT00798317|7295284|FG000|Overall Study|Death|1
4492869|NCT00798317|7295285|FG001|Overall Study|Death|0
4492870|NCT00798369|7295297|FG000|Overall Study|Subject withdrew consent|0
4492871|NCT00798369|7295298|FG001|Overall Study|Subject withdrew consent|0
4492872|NCT00798369|7295299|FG002|Overall Study|Subject withdrew consent|1
4492873|NCT00798369|7295300|FG003|Overall Study|Subject withdrew consent|1
4492874|NCT00798369|7295301|FG004|Overall Study|Subject withdrew consent|0
4492875|NCT00798369|7295302|FG005|Overall Study|Subject withdrew consent|2
4492876|NCT00798369|7295297|FG000|Overall Study|Lost to Follow-up|1
4492877|NCT00798369|7295298|FG001|Overall Study|Lost to Follow-up|1
4492878|NCT00798369|7295299|FG002|Overall Study|Lost to Follow-up|1
4492879|NCT00798369|7295300|FG003|Overall Study|Lost to Follow-up|0
4492880|NCT00798369|7295301|FG004|Overall Study|Lost to Follow-up|1
4492881|NCT00798369|7295302|FG005|Overall Study|Lost to Follow-up|0
4492882|NCT00798369|7295297|FG000|Overall Study|Adminstrative problems|0
4492883|NCT00798369|7295298|FG001|Overall Study|Adminstrative problems|0
4492884|NCT00798369|7295299|FG002|Overall Study|Adminstrative problems|0
4492885|NCT00798369|7295300|FG003|Overall Study|Adminstrative problems|0
4492886|NCT00798369|7295301|FG004|Overall Study|Adminstrative problems|0
4492887|NCT00798369|7295302|FG005|Overall Study|Adminstrative problems|1
4492888|NCT00798434|7295319|FG000|Double-Blind|Adverse Event|22
4492889|NCT00798434|7295320|FG001|Double-Blind|Adverse Event|46
4492890|NCT00798434|7295319|FG000|Double-Blind|Death|0
4492891|NCT00798434|7295320|FG001|Double-Blind|Death|1
4492892|NCT00798434|7295319|FG000|Double-Blind|Lost to Follow-up|1
4492893|NCT00798434|7295320|FG001|Double-Blind|Lost to Follow-up|0
4492894|NCT00798434|7295319|FG000|Double-Blind|Lack of Efficacy|8
4492895|NCT00798434|7295320|FG001|Double-Blind|Lack of Efficacy|12
4492896|NCT00798434|7295319|FG000|Double-Blind|Withdrawal by Subject|17
4492897|NCT00798434|7295320|FG001|Double-Blind|Withdrawal by Subject|14
4492898|NCT00798434|7295319|FG000|Double-Blind|Protocol Violation|1
4492899|NCT00798434|7295320|FG001|Double-Blind|Protocol Violation|4
4492900|NCT00798434|7295319|FG000|Double-Blind|Did Not Meet Entrance Criteria|2
4492901|NCT00798434|7295320|FG001|Double-Blind|Did Not Meet Entrance Criteria|1
4492902|NCT00798434|7295319|FG000|Double-Blind|Other|1
4492903|NCT00798434|7295320|FG001|Double-Blind|Other|0
4492904|NCT00798434|7295319|FG000|Double-Blind|Not Treated|3
4492905|NCT00798434|7295320|FG001|Double-Blind|Not Treated|6
4492906|NCT00798434|7295319|FG000|Open-Label|Adverse Event|33
4492907|NCT00798434|7295320|FG001|Open-Label|Adverse Event|11
4492908|NCT00798434|7295319|FG000|Open-Label|Lack of Efficacy|5
4492909|NCT00798434|7295320|FG001|Open-Label|Lack of Efficacy|11
4492910|NCT00798434|7295319|FG000|Open-Label|Withdrawal by Subject|2
4492911|NCT00798434|7295320|FG001|Open-Label|Withdrawal by Subject|7
4492912|NCT00798434|7295319|FG000|Open-Label|Protocol Violation|1
4492913|NCT00798434|7295320|FG001|Open-Label|Protocol Violation|0
4492914|NCT00798434|7295319|FG000|Open-Label|Other|1
4492915|NCT00798434|7295320|FG001|Open-Label|Other|2
4492916|NCT00798434|7295319|FG000|Open-Label|Not Treated|0
4492917|NCT00798434|7295320|FG001|Open-Label|Not Treated|1
4492918|NCT00798603|7295344|FG000|Overall Study|Still on treatment as of 11/6/2012|1
4492919|NCT00798603|7295344|FG000|Overall Study|Withdrawal by Subject|10
4492920|NCT00798603|7295344|FG000|Overall Study|Adverse Event|22
4492921|NCT00798603|7295344|FG000|Overall Study|Physician Decision|1
4492922|NCT00798603|7295344|FG000|Overall Study|Lack of insurance coverage|1
4492923|NCT00798655|7295348|FG000|Overall Study|Did not receive at least one dose of pan|2
4492924|NCT00798694|7295354|FG000|Overall Study|Lost to Follow-up|1
4492925|NCT00798694|7295355|FG001|Overall Study|Lost to Follow-up|1
4492926|NCT00798694|7295354|FG000|Overall Study|Physician Decision|1
4492927|NCT00798694|7295355|FG001|Overall Study|Physician Decision|0
4492928|NCT00798707|7295370|FG000|Overall Study|Adverse Event|6
4492929|NCT00798707|7295371|FG001|Overall Study|Adverse Event|8
4492930|NCT00798707|7295372|FG002|Overall Study|Adverse Event|8
4492931|NCT00798707|7295370|FG000|Overall Study|Failed to return|2
4492932|NCT00798707|7295371|FG001|Overall Study|Failed to return|2
4492933|NCT00798707|7295372|FG002|Overall Study|Failed to return|0
4492934|NCT00798707|7295370|FG000|Overall Study|Investigator|0
4492935|NCT00798707|7295371|FG001|Overall Study|Investigator|1
4492936|NCT00798707|7295372|FG002|Overall Study|Investigator|2
4492937|NCT00798707|7295370|FG000|Overall Study|Lack of Efficacy|2
4492938|NCT00798707|7295371|FG001|Overall Study|Lack of Efficacy|2
4492939|NCT00798707|7295372|FG002|Overall Study|Lack of Efficacy|1
4492940|NCT00798707|7295370|FG000|Overall Study|Lost to Follow-up|5
4492941|NCT00798707|7295371|FG001|Overall Study|Lost to Follow-up|6
4492942|NCT00798707|7295372|FG002|Overall Study|Lost to Follow-up|6
4492943|NCT00798707|7295370|FG000|Overall Study|Other|0
4492944|NCT00798707|7295371|FG001|Overall Study|Other|1
4492945|NCT00798707|7295372|FG002|Overall Study|Other|0
4492946|NCT00798707|7295370|FG000|Overall Study|Protocol Violation|4
4492947|NCT00798707|7295371|FG001|Overall Study|Protocol Violation|0
4492948|NCT00798707|7295372|FG002|Overall Study|Protocol Violation|2
4492949|NCT00798707|7295370|FG000|Overall Study|Withdrawal by Subject|3
4492950|NCT00798707|7295371|FG001|Overall Study|Withdrawal by Subject|8
4492951|NCT00798707|7295372|FG002|Overall Study|Withdrawal by Subject|2
4492952|NCT00798707|7295370|FG000|Overall Study|Randomized not treated|4
4492953|NCT00798707|7295371|FG001|Overall Study|Randomized not treated|5
4492954|NCT00798707|7295372|FG002|Overall Study|Randomized not treated|1
4492955|NCT00798759|7295386|FG000|Overall Study|Adverse Event|3
4492956|NCT00798759|7295387|FG001|Overall Study|Adverse Event|3
4492957|NCT00798759|7295386|FG000|Overall Study|Lost to Follow-up|1
4492958|NCT00798759|7295387|FG001|Overall Study|Lost to Follow-up|1
4492959|NCT00798759|7295386|FG000|Overall Study|Protocol Violation|4
4492960|NCT00798759|7295387|FG001|Overall Study|Protocol Violation|8
4492961|NCT00798759|7295386|FG000|Overall Study|Other|0
4492962|NCT00798759|7295387|FG001|Overall Study|Other|1
4492963|NCT00798889|7295393|FG000|Overall Study|Adverse Event|53
4492964|NCT00798889|7295393|FG000|Overall Study|Protocol Violation|2
4492965|NCT00798889|7295393|FG000|Overall Study|Withdrawal by Subject|31
4492966|NCT00798889|7295393|FG000|Overall Study|Lost to Follow-up|1
4492967|NCT00798889|7295393|FG000|Overall Study|Lack of Efficacy|213
4492968|NCT00798889|7295393|FG000|Overall Study|Decision of Sponsor|11
4492969|NCT00798889|7295393|FG000|Overall Study|Enrolled, Not treated|3
4492970|NCT00798967|7295399|FG000|Overall Study|Adverse Event|2
4492971|NCT00798967|7295400|FG001|Overall Study|Adverse Event|3
4492972|NCT00798967|7295399|FG000|Overall Study|Withdrawal by Subject|0
4492973|NCT00798967|7295400|FG001|Overall Study|Withdrawal by Subject|1
4492974|NCT00798967|7295399|FG000|Overall Study|Physician Decision|1
4492975|NCT00798967|7295400|FG001|Overall Study|Physician Decision|0
4492976|NCT00798967|7295399|FG000|Overall Study|Randomized in error by site|1
4492977|NCT00798967|7295400|FG001|Overall Study|Randomized in error by site|0
4492978|NCT00799383|7295413|FG000|Overall Study|Protocol Violation|1
4492979|NCT00799383|7295414|FG001|Overall Study|Protocol Violation|1
4492980|NCT00799383|7295413|FG000|Overall Study|Adverse Event|0
4492981|NCT00799383|7295414|FG001|Overall Study|Adverse Event|1
4492982|NCT00799383|7295413|FG000|Overall Study|Lost to Follow-up|1
4492983|NCT00799383|7295414|FG001|Overall Study|Lost to Follow-up|2
4492984|NCT00799383|7295413|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1
4492985|NCT00799383|7295414|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1
4492986|NCT00799383|7295413|FG000|Overall Study|Withdrawal by Subject|0
4492987|NCT00799383|7295414|FG001|Overall Study|Withdrawal by Subject|1
4492988|NCT00799409|7295423|FG000|Overall Study|Withdrawal by Subject|1
4492989|NCT00799409|7295424|FG001|Overall Study|Withdrawal by Subject|0
4492990|NCT00799409|7295425|FG002|Overall Study|Withdrawal by Subject|0
4492991|NCT00799409|7295423|FG000|Overall Study|Lost to Follow-up|1
4492992|NCT00799409|7295424|FG001|Overall Study|Lost to Follow-up|0
4492993|NCT00799409|7295425|FG002|Overall Study|Lost to Follow-up|0
4492994|NCT00799409|7295423|FG000|Overall Study|Optimal Dose Not Achieved|2
4492995|NCT00799409|7295424|FG001|Overall Study|Optimal Dose Not Achieved|0
4492996|NCT00799409|7295425|FG002|Overall Study|Optimal Dose Not Achieved|0
4492997|NCT00799409|7295423|FG000|Overall Study|Failure to follow study protocol)|1
4492998|NCT00799409|7295424|FG001|Overall Study|Failure to follow study protocol)|0
4492999|NCT00799409|7295425|FG002|Overall Study|Failure to follow study protocol)|0
4493000|NCT00799409|7295423|FG000|Overall Study|Did not attend lab school day 1|1
4493001|NCT00799409|7295424|FG001|Overall Study|Did not attend lab school day 1|0
4493002|NCT00799409|7295425|FG002|Overall Study|Did not attend lab school day 1|0
4493003|NCT00799409|7295423|FG000|Overall Study|medication compliance|1
4493004|NCT00799409|7295424|FG001|Overall Study|medication compliance|0
4493005|NCT00799409|7295425|FG002|Overall Study|medication compliance|0
4493006|NCT00799422|7295433|FG000|First Week of Wear|Lost to Follow-up|0
4493007|NCT00799422|7295434|FG001|First Week of Wear|Lost to Follow-up|0
4493008|NCT00799422|7295435|FG002|First Week of Wear|Lost to Follow-up|1
4493009|NCT00799422|7295436|FG003|First Week of Wear|Lost to Follow-up|0
4493010|NCT00799422|7295437|FG004|First Week of Wear|Lost to Follow-up|0
4493011|NCT00799422|7295438|FG005|First Week of Wear|Lost to Follow-up|0
4493012|NCT00799422|7295433|FG000|First Week of Wear|Adverse Event|0
4493013|NCT00799422|7295434|FG001|First Week of Wear|Adverse Event|0
4493014|NCT00799422|7295435|FG002|First Week of Wear|Adverse Event|0
4493015|NCT00799422|7295436|FG003|First Week of Wear|Adverse Event|1
4493016|NCT00799422|7295437|FG004|First Week of Wear|Adverse Event|0
4493017|NCT00799422|7295438|FG005|First Week of Wear|Adverse Event|0
4493018|NCT00799487|7295462|FG000|Dose Adjustment Period|Lost to Follow-up|1
4493019|NCT00799487|7295463|FG001|Dose Adjustment Period|Lost to Follow-up|0
4493020|NCT00799487|7295464|FG002|Dose Adjustment Period|Lost to Follow-up|0
4493021|NCT00799487|7295462|FG000|Dose Adjustment Period|Adverse Event|2
4493022|NCT00799487|7295463|FG001|Dose Adjustment Period|Adverse Event|0
4493023|NCT00799487|7295464|FG002|Dose Adjustment Period|Adverse Event|0
4493024|NCT00799487|7295462|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8
4493025|NCT00799487|7295463|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0
4493026|NCT00799487|7295464|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0
4493027|NCT00799487|7295462|FG000|Dose Adjustment Period|Investigator Discretion|2
4493028|NCT00799487|7295463|FG001|Dose Adjustment Period|Investigator Discretion|0
4493029|NCT00799487|7295464|FG002|Dose Adjustment Period|Investigator Discretion|0
4493030|NCT00799487|7295462|FG000|Dose Adjustment Period|Withdrawal by Subject|3
4493031|NCT00799487|7295463|FG001|Dose Adjustment Period|Withdrawal by Subject|0
4493032|NCT00799487|7295464|FG002|Dose Adjustment Period|Withdrawal by Subject|0
4493033|NCT00799487|7295462|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1
4493034|NCT00799487|7295463|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0
4493035|NCT00799487|7295464|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0
4493036|NCT00799487|7295462|FG000|Dose Adjustment Period|Child too young (exclusion)|1
4493037|NCT00799487|7295463|FG001|Dose Adjustment Period|Child too young (exclusion)|0
4493038|NCT00799487|7295464|FG002|Dose Adjustment Period|Child too young (exclusion)|0
4493039|NCT00799487|7295462|FG000|Dose Adjustment Period|Missed laboratory day 1|1
4493040|NCT00799487|7295463|FG001|Dose Adjustment Period|Missed laboratory day 1|0
4493041|NCT00799487|7295464|FG002|Dose Adjustment Period|Missed laboratory day 1|0
4493042|NCT00799487|7295462|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2
4493043|NCT00799487|7295463|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0
4493044|NCT00799487|7295464|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0
4493045|NCT00799487|7295462|FG000|Double-Blind Assessment Period|Lost to Follow-up|0
4493046|NCT00799487|7295463|FG001|Double-Blind Assessment Period|Lost to Follow-up|0
4493047|NCT00799487|7295464|FG002|Double-Blind Assessment Period|Lost to Follow-up|1
4493048|NCT00799487|7295462|FG000|Double-Blind Assessment Period|Subject was out of the state|0
4493049|NCT00799487|7295463|FG001|Double-Blind Assessment Period|Subject was out of the state|0
4493050|NCT00799487|7295464|FG002|Double-Blind Assessment Period|Subject was out of the state|1
4493051|NCT00799487|7295462|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0
4493052|NCT00799487|7295463|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1
4493053|NCT00799487|7295464|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0
4493054|NCT00799591|7295479|FG000|Overall Study|De-escalation of doses|20
4493055|NCT00799591|7295479|FG000|Overall Study|Death|14
4493056|NCT00799591|7295479|FG000|Overall Study|Technical failure|12
4493057|NCT00799591|7295479|FG000|Overall Study|Resistant germ|11
4493058|NCT00799591|7295479|FG000|Overall Study|New infection|4
4493059|NCT00799591|7295479|FG000|Overall Study|Resistance germ and technical failure|2
4493060|NCT00799591|7295479|FG000|Overall Study|Persistance of fever undetermined origin|1
4493061|NCT00799591|7295479|FG000|Overall Study|Antibiotic changed, no apparent reason|1
4493062|NCT00799591|7295479|FG000|Overall Study|Infectious origin not probable|1
4493063|NCT00799617|7295498|FG000|Main Testosterone Trial|Randomized in error|1
4493064|NCT00799617|7295499|FG001|Main Testosterone Trial|Randomized in error|1
4493065|NCT00799617|7295498|FG000|Main Testosterone Trial|Lost to Follow-up|18
4493066|NCT00799617|7295499|FG001|Main Testosterone Trial|Lost to Follow-up|20
4493067|NCT00799617|7295498|FG000|Sexual Funtion Trial|Lost to Follow-up|12
4493068|NCT00799617|7295499|FG001|Sexual Funtion Trial|Lost to Follow-up|14
4493069|NCT00799617|7295498|FG000|Sexual Funtion Trial|No Baseline Data|4
4493070|NCT00799617|7295499|FG001|Sexual Funtion Trial|No Baseline Data|7
4493071|NCT00799617|7295498|FG000|Physical Function Trial|Lost to Follow-up|6
4493072|NCT00799617|7295499|FG001|Physical Function Trial|Lost to Follow-up|11
4493073|NCT00799617|7295498|FG000|Vitality Trial|Lost to Follow-up|7
4493074|NCT00799617|7295499|FG001|Vitality Trial|Lost to Follow-up|22
4493075|NCT00799617|7295498|FG000|Cardiovascular Trial|Month 12 scan not available|15
4493076|NCT00799617|7295499|FG001|Cardiovascular Trial|Month 12 scan not available|15
4493077|NCT00799617|7295498|FG000|Cardiovascular Trial|Baseline scan not analyzable|0
4493078|NCT00799617|7295499|FG001|Cardiovascular Trial|Baseline scan not analyzable|2
4493079|NCT00799617|7295498|FG000|Bone Trial|Month 12 scan not available|6
4493080|NCT00799617|7295499|FG001|Bone Trial|Month 12 scan not available|16
4493081|NCT00799617|7295498|FG000|Cognitive Function Trial|Lost to Follow-up|0
4493082|NCT00799617|7295499|FG001|Cognitive Function Trial|Lost to Follow-up|1
4493083|NCT00799617|7295498|FG000|Anemia Trial|Withdrawal by Subject|3
4493084|NCT00799617|7295499|FG001|Anemia Trial|Withdrawal by Subject|3
4493085|NCT00799708|7295518|FG000|Overall Study|non-compliance|1
4493086|NCT00799708|7295519|FG001|Overall Study|non-compliance|0
4493087|NCT00799708|7295520|FG002|Overall Study|non-compliance|0
4493088|NCT00799825|7295542|FG000|Overall Study|Adverse Event|1
4493089|NCT00799825|7295542|FG000|Overall Study|Withdrawal by Subject|6
4493090|NCT00799825|7295542|FG000|Overall Study|Lost to Follow-up|38
4493091|NCT00799825|7295542|FG000|Overall Study|Pregnancy|3
4493092|NCT00799903|7295548|FG000|Overall Study|Investigator Site Closed|25
4493093|NCT00799903|7295549|FG001|Overall Study|Investigator Site Closed|23
4493094|NCT00799903|7295548|FG000|Overall Study|Withdrawal by Subject|179
4493095|NCT00799903|7295549|FG001|Overall Study|Withdrawal by Subject|175
4493096|NCT00799903|7295548|FG000|Overall Study|Lost to Follow-up|69
4493097|NCT00799903|7295549|FG001|Overall Study|Lost to Follow-up|80
4493098|NCT00800176|7295575|FG000|Overall Study|Adverse Event|2
4493099|NCT00800176|7295576|FG001|Overall Study|Adverse Event|1
4493100|NCT00800176|7295577|FG002|Overall Study|Adverse Event|0
4493101|NCT00800176|7295578|FG003|Overall Study|Adverse Event|2
4493102|NCT00800176|7295579|FG004|Overall Study|Adverse Event|1
4493103|NCT00800176|7295580|FG005|Overall Study|Adverse Event|1
4493104|NCT00800176|7295575|FG000|Overall Study|Refused treatment|3
4493105|NCT00800176|7295576|FG001|Overall Study|Refused treatment|2
4493106|NCT00800176|7295577|FG002|Overall Study|Refused treatment|0
4493107|NCT00800176|7295578|FG003|Overall Study|Refused treatment|0
4493108|NCT00800176|7295579|FG004|Overall Study|Refused treatment|1
4493109|NCT00800176|7295580|FG005|Overall Study|Refused treatment|4
4493110|NCT00800176|7295575|FG000|Overall Study|Failure to return|3
4493111|NCT00800176|7295576|FG001|Overall Study|Failure to return|3
4493112|NCT00800176|7295577|FG002|Overall Study|Failure to return|0
4493113|NCT00800176|7295578|FG003|Overall Study|Failure to return|2
4493114|NCT00800176|7295579|FG004|Overall Study|Failure to return|0
4493115|NCT00800176|7295580|FG005|Overall Study|Failure to return|0
4493116|NCT00800176|7295575|FG000|Overall Study|Other|1
4493117|NCT00800176|7295576|FG001|Overall Study|Other|0
4493118|NCT00800176|7295577|FG002|Overall Study|Other|0
4493119|NCT00800176|7295578|FG003|Overall Study|Other|0
4493120|NCT00800176|7295579|FG004|Overall Study|Other|2
4493121|NCT00800176|7295580|FG005|Overall Study|Other|0
4493122|NCT00800202|7295596|FG000|Overall Study|Adverse Event|7
4493123|NCT00800202|7295597|FG001|Overall Study|Adverse Event|6
4493124|NCT00800202|7295596|FG000|Overall Study|Death|1
4493125|NCT00800202|7295597|FG001|Overall Study|Death|0
4493126|NCT00800202|7295596|FG000|Overall Study|Other|5
4493127|NCT00800202|7295597|FG001|Overall Study|Other|0
4493128|NCT00800202|7295596|FG000|Overall Study|Disease Progression|54
4493129|NCT00800202|7295597|FG001|Overall Study|Disease Progression|18
4493130|NCT00800384|7295618|FG000|Overall Study|Withdrawal by Subject|24
4493131|NCT00800384|7295619|FG001|Overall Study|Withdrawal by Subject|17
4493132|NCT00800384|7295618|FG000|Overall Study|Lost to Follow-up|17
4493133|NCT00800384|7295619|FG001|Overall Study|Lost to Follow-up|26
4493134|NCT00800436|7295633|FG000|Overall Study|Withdrawal by Subject|0
4493135|NCT00800436|7295634|FG001|Overall Study|Withdrawal by Subject|0
4493136|NCT00800436|7295635|FG002|Overall Study|Withdrawal by Subject|1
4493137|NCT00800436|7295636|FG003|Overall Study|Withdrawal by Subject|1
4493138|NCT00800436|7295637|FG004|Overall Study|Withdrawal by Subject|0
4493139|NCT00800436|7295638|FG005|Overall Study|Withdrawal by Subject|0
4493140|NCT00800436|7295639|FG006|Overall Study|Withdrawal by Subject|0
4493141|NCT00800540|7295655|FG000|Period One: 6 Weeks|Noncompliance|1
4493142|NCT00800540|7295656|FG001|Period One: 6 Weeks|Noncompliance|0
4493143|NCT00800540|7295655|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0
4493144|NCT00800540|7295656|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1
4493145|NCT00800540|7295655|FG000|Period 2: 6 Weeks|Adverse Event|0
4493146|NCT00800540|7295656|FG001|Period 2: 6 Weeks|Adverse Event|1
4493147|NCT00800683|7295664|FG000|Overall Study|Adverse Event|11
4493148|NCT00800683|7295665|FG001|Overall Study|Adverse Event|8
4493149|NCT00800683|7295664|FG000|Overall Study|Lost to Follow-up|3
4493150|NCT00800683|7295665|FG001|Overall Study|Lost to Follow-up|1
4493151|NCT00800683|7295664|FG000|Overall Study|Withdrawal by Subject|1
4493152|NCT00800683|7295665|FG001|Overall Study|Withdrawal by Subject|7
4493153|NCT00800683|7295664|FG000|Overall Study|Lack of Efficacy|1
4493154|NCT00800683|7295665|FG001|Overall Study|Lack of Efficacy|1
4493155|NCT00800683|7295664|FG000|Overall Study|Other|1
4493156|NCT00800683|7295665|FG001|Overall Study|Other|2
4493157|NCT00800735|7295671|FG000|Overall Study|Administrative/Other|2
4703029|NCT02724462|7620365|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40
4703030|NCT02724462|7620366|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48
4703031|NCT02724462|7620365|FG000|12 Month Follow-up Survey|Lost to Follow-up|174
4703032|NCT02724462|7620366|FG001|12 Month Follow-up Survey|Lost to Follow-up|134
4703033|NCT02724462|7620365|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40
4703034|NCT02724462|7620366|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48
4703035|NCT02724592|7620374|FG000|Overall Study|Lost to Follow-up|4
4703036|NCT02724592|7620375|FG001|Overall Study|Lost to Follow-up|1
4493158|NCT00800735|7295671|FG000|Overall Study|Insufficient Therapeutic Response|2
4493159|NCT00800735|7295671|FG000|Overall Study|Violation of Selection Criteria at Entry|7
4493160|NCT00800735|7295671|FG000|Overall Study|Withdrew Consent|3
4493161|NCT00800982|7295690|FG000|Overall Study|Lost to Follow-up|1
4493162|NCT00800982|7295691|FG001|Overall Study|Lost to Follow-up|2
4493163|NCT00800982|7295690|FG000|Overall Study|Withdrawal by Subject|0
4493164|NCT00800982|7295691|FG001|Overall Study|Withdrawal by Subject|1
4493165|NCT00800982|7295690|FG000|Overall Study|Patient moved out of state|1
4493166|NCT00800982|7295691|FG001|Overall Study|Patient moved out of state|0
4493167|NCT00801099|7295697|FG000|Overall Study|Lost to Follow-up|101
4493168|NCT00801229|7295720|FG000|Signed Consent|Withdrawal by Subject|2
4493169|NCT00801229|7295721|FG001|Signed Consent|Withdrawal by Subject|2
4493170|NCT00801229|7295720|FG000|Signed Consent|Found Ineligible|1
4493171|NCT00801229|7295721|FG001|Signed Consent|Found Ineligible|1
4493172|NCT00801229|7295720|FG000|Received Study Drug/Placebo|Elevated SGOT level|1
4703037|NCT02724644|7620383|FG000|Overall Study|Adverse Event|7
4493173|NCT00801229|7295721|FG001|Received Study Drug/Placebo|Elevated SGOT level|0
4493174|NCT00801229|7295720|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0
4493175|NCT00801229|7295721|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1
4493176|NCT00801229|7295720|FG000|Received Study Drug/Placebo|Simulator sickness|1
4493177|NCT00801229|7295721|FG001|Received Study Drug/Placebo|Simulator sickness|1
4493178|NCT00801229|7295720|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1
4493179|NCT00801229|7295721|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0
4493180|NCT00801229|7295720|FG000|Received Study Drug/Placebo|Lost to Follow-up|0
4493181|NCT00801229|7295721|FG001|Received Study Drug/Placebo|Lost to Follow-up|1
4493182|NCT00801229|7295720|FG000|Received Study Drug/Placebo|Adverse Event|1
4493183|NCT00801229|7295721|FG001|Received Study Drug/Placebo|Adverse Event|1
4493184|NCT00801242|7295727|FG000|Overall Study|Adverse Event|10
4493185|NCT00801242|7295727|FG000|Overall Study|Withdrawal by Subject|13
4493186|NCT00801242|7295727|FG000|Overall Study|Protocol Violation|5
4493187|NCT00801242|7295727|FG000|Overall Study|Physician Decision|3
4493188|NCT00801242|7295727|FG000|Overall Study|Lost to Follow-up|1
4493189|NCT00801242|7295727|FG000|Overall Study|Miscellaneous reasons|20
4493190|NCT00801632|7295770|FG000|Overall Study|Re-transplant|1
4493191|NCT00801892|7295811|FG000|Main Study Period|Withdrawal by Subject|0
4493192|NCT00801892|7295812|FG001|Main Study Period|Withdrawal by Subject|1
4493193|NCT00801892|7295811|FG000|Sham Crossover Period|Lost to Follow-up|0
4493194|NCT00801892|7295812|FG001|Sham Crossover Period|Lost to Follow-up|2
4493195|NCT00801983|7295822|FG000|Period 1|Lost to Follow-up|2
4493196|NCT00801983|7295823|FG001|Period 1|Lost to Follow-up|0
4493197|NCT00801983|7295822|FG000|Period 1|Withdrawal by Subject|2
4493198|NCT00801983|7295823|FG001|Period 1|Withdrawal by Subject|8
4493199|NCT00801983|7295822|FG000|Period 2|Withdrawal by Subject|2
4493200|NCT00801983|7295823|FG001|Period 2|Withdrawal by Subject|1
4493201|NCT00802074|7295835|FG000|Overall Study|Adverse Event|1
4493202|NCT00802074|7295836|FG001|Overall Study|Adverse Event|1
4493203|NCT00802074|7295837|FG002|Overall Study|Adverse Event|1
4493204|NCT00802074|7295838|FG003|Overall Study|Adverse Event|0
4493205|NCT00802074|7295839|FG004|Overall Study|Adverse Event|0
4493206|NCT00802074|7295840|FG005|Overall Study|Adverse Event|0
4493207|NCT00802074|7295835|FG000|Overall Study|Withdrawal by Subject|1
4493208|NCT00802074|7295836|FG001|Overall Study|Withdrawal by Subject|0
4493209|NCT00802074|7295837|FG002|Overall Study|Withdrawal by Subject|0
4493210|NCT00802074|7295838|FG003|Overall Study|Withdrawal by Subject|0
4493211|NCT00802074|7295839|FG004|Overall Study|Withdrawal by Subject|0
4493212|NCT00802074|7295840|FG005|Overall Study|Withdrawal by Subject|0
4493213|NCT00802178|7295880|FG000|Overall Study|Lack of Efficacy|36
4493214|NCT00802178|7295880|FG000|Overall Study|Insufficient tolerability (IT)|17
4493215|NCT00802178|7295880|FG000|Overall Study|Withdrawal by Subject|18
4493216|NCT00802178|7295880|FG000|Overall Study|Other|32
4493217|NCT00802178|7295880|FG000|Overall Study|Lack of efficacy and patient wish|1
4493218|NCT00802178|7295880|FG000|Overall Study|IT and patient wish|8
4493219|NCT00802178|7295880|FG000|Overall Study|Patients wish and other reason|1
4493220|NCT00802360|7295900|FG000|Overall Study|Stimulation failure|4
4493221|NCT00802360|7295901|FG001|Overall Study|Stimulation failure|0
4493222|NCT00802360|7295902|FG002|Overall Study|Stimulation failure|3
4493223|NCT00802360|7295903|FG003|Overall Study|Stimulation failure|3
4493224|NCT00802360|7295900|FG000|Overall Study|Inadequate number of oocytes retrieved|0
4493225|NCT00802360|7295901|FG001|Overall Study|Inadequate number of oocytes retrieved|0
4493226|NCT00802360|7295902|FG002|Overall Study|Inadequate number of oocytes retrieved|0
4493227|NCT00802360|7295903|FG003|Overall Study|Inadequate number of oocytes retrieved|1
4493228|NCT00802360|7295900|FG000|Overall Study|Cycle cancelled|0
4493229|NCT00802360|7295901|FG001|Overall Study|Cycle cancelled|1
4493230|NCT00802360|7295902|FG002|Overall Study|Cycle cancelled|1
4493231|NCT00802360|7295903|FG003|Overall Study|Cycle cancelled|1
4493232|NCT00802360|7295900|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0
4493233|NCT00802360|7295901|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0
4493234|NCT00802360|7295902|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0
4493235|NCT00802360|7295903|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1
4493236|NCT00802360|7295900|FG000|Overall Study|No positive serum pregnancy|17
4493237|NCT00802360|7295901|FG001|Overall Study|No positive serum pregnancy|20
4493238|NCT00802360|7295902|FG002|Overall Study|No positive serum pregnancy|14
4493239|NCT00802360|7295903|FG003|Overall Study|No positive serum pregnancy|10
4493240|NCT00802360|7295900|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1
4493241|NCT00802360|7295901|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0
4493242|NCT00802360|7295902|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1
4493243|NCT00802360|7295903|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0
4493244|NCT00802360|7295900|FG000|Overall Study|Pregnancy loss/miscarriage|0
4703038|NCT02724644|7620384|FG001|Overall Study|Adverse Event|1
4626933|NCT01847443|7493131|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0
4626934|NCT01847443|7493128|FG000|Washout Period Before Study Period 4|Positive alcohol test|1
4626935|NCT01847443|7493129|FG001|Washout Period Before Study Period 4|Positive alcohol test|0
4626936|NCT01847443|7493130|FG002|Washout Period Before Study Period 4|Positive alcohol test|0
4626937|NCT01847443|7493131|FG003|Washout Period Before Study Period 4|Positive alcohol test|0
4626938|NCT01847755|7493232|FG000|Overall Study|Adverse Event|2
4493245|NCT00802360|7295901|FG001|Overall Study|Pregnancy loss/miscarriage|2
4493246|NCT00802360|7295902|FG002|Overall Study|Pregnancy loss/miscarriage|0
4493247|NCT00802360|7295903|FG003|Overall Study|Pregnancy loss/miscarriage|3
4493248|NCT00802360|7295900|FG000|Overall Study|Other|2
4493249|NCT00802360|7295901|FG001|Overall Study|Other|3
4493250|NCT00802360|7295902|FG002|Overall Study|Other|6
4493251|NCT00802360|7295903|FG003|Overall Study|Other|3
4493252|NCT00802438|7295924|FG000|Overall Study|Screen Failure|20
4493253|NCT00802438|7295924|FG000|Overall Study|Withdrawal by Subject|7
4493254|NCT00802438|7295924|FG000|Overall Study|Physician Decision|1
4493255|NCT00802464|7295932|FG000|Month 0 - Month 8|Adverse Event|0
4493256|NCT00802464|7295933|FG001|Month 0 - Month 8|Adverse Event|1
4493257|NCT00802464|7295934|FG002|Month 0 - Month 8|Adverse Event|1
4493258|NCT00802464|7295935|FG003|Month 0 - Month 8|Adverse Event|2
4493259|NCT00802464|7295932|FG000|Month 0 - Month 8|Protocol Violation|0
4493260|NCT00802464|7295933|FG001|Month 0 - Month 8|Protocol Violation|0
4493261|NCT00802464|7295934|FG002|Month 0 - Month 8|Protocol Violation|1
4493262|NCT00802464|7295935|FG003|Month 0 - Month 8|Protocol Violation|0
4493263|NCT00802464|7295932|FG000|Month 0 - Month 8|Withdrawal by Subject|0
4493264|NCT00802464|7295933|FG001|Month 0 - Month 8|Withdrawal by Subject|1
4493265|NCT00802464|7295934|FG002|Month 0 - Month 8|Withdrawal by Subject|2
4493266|NCT00802464|7295935|FG003|Month 0 - Month 8|Withdrawal by Subject|5
4493267|NCT00802464|7295932|FG000|Month 0 - Month 8|Lost to Follow-up|0
4493268|NCT00802464|7295933|FG001|Month 0 - Month 8|Lost to Follow-up|1
4493269|NCT00802464|7295934|FG002|Month 0 - Month 8|Lost to Follow-up|2
4493270|NCT00802464|7295935|FG003|Month 0 - Month 8|Lost to Follow-up|2
4493271|NCT00802464|7295932|FG000|Month 0 - Month 8|Other|0
4493272|NCT00802464|7295933|FG001|Month 0 - Month 8|Other|0
4493273|NCT00802464|7295934|FG002|Month 0 - Month 8|Other|1
4493274|NCT00802464|7295935|FG003|Month 0 - Month 8|Other|0
4493275|NCT00802464|7295932|FG000|Month 8 - Month 14|Adverse Event|0
4493276|NCT00802464|7295933|FG001|Month 8 - Month 14|Adverse Event|1
4493277|NCT00802464|7295934|FG002|Month 8 - Month 14|Adverse Event|0
4493278|NCT00802464|7295935|FG003|Month 8 - Month 14|Adverse Event|0
4493279|NCT00802464|7295932|FG000|Month 8 - Month 14|Withdrawal by Subject|1
4493280|NCT00802464|7295933|FG001|Month 8 - Month 14|Withdrawal by Subject|1
4493281|NCT00802464|7295934|FG002|Month 8 - Month 14|Withdrawal by Subject|0
4493282|NCT00802464|7295935|FG003|Month 8 - Month 14|Withdrawal by Subject|0
4493283|NCT00802464|7295932|FG000|Month 8 - Month 14|Lost to Follow-up|0
4493284|NCT00802464|7295933|FG001|Month 8 - Month 14|Lost to Follow-up|0
4493285|NCT00802464|7295934|FG002|Month 8 - Month 14|Lost to Follow-up|1
4493286|NCT00802464|7295935|FG003|Month 8 - Month 14|Lost to Follow-up|0
4493287|NCT00802529|7295962|FG000|Overall Study|Lost to Follow-up|0
4493288|NCT00802529|7295963|FG001|Overall Study|Lost to Follow-up|1
4493289|NCT00802672|7295981|FG000|Overall Study|Lack of fungal pathogen at baseline|56
4493290|NCT00802672|7295982|FG001|Overall Study|Lack of fungal pathogen at baseline|43
4493291|NCT00802672|7295983|FG002|Overall Study|Lack of fungal pathogen at baseline|25
4493292|NCT00802672|7295981|FG000|Overall Study|Adverse Event|1
4493293|NCT00802672|7295982|FG001|Overall Study|Adverse Event|1
4493294|NCT00802672|7295983|FG002|Overall Study|Adverse Event|1
4493295|NCT00802672|7295981|FG000|Overall Study|Protocol Violation|2
4493296|NCT00802672|7295982|FG001|Overall Study|Protocol Violation|1
4493297|NCT00802672|7295983|FG002|Overall Study|Protocol Violation|1
4493298|NCT00802672|7295981|FG000|Overall Study|Lost to Follow-up|5
4493299|NCT00802672|7295982|FG001|Overall Study|Lost to Follow-up|5
4493300|NCT00802672|7295983|FG002|Overall Study|Lost to Follow-up|3
4493301|NCT00802672|7295981|FG000|Overall Study|Withdrawal by Subject|1
4493302|NCT00802672|7295982|FG001|Overall Study|Withdrawal by Subject|1
4493303|NCT00802672|7295983|FG002|Overall Study|Withdrawal by Subject|2
4493304|NCT00802672|7295981|FG000|Overall Study|other|3
4493305|NCT00802672|7295982|FG001|Overall Study|other|1
4493306|NCT00802672|7295983|FG002|Overall Study|other|2
4493307|NCT00802737|7296003|FG000|Overall Study|Withdrawn due to Disease Progression|9
4493308|NCT00802737|7296004|FG001|Overall Study|Withdrawn due to Disease Progression|3
4493309|NCT00802737|7296005|FG002|Overall Study|Withdrawn due to Disease Progression|0
4493310|NCT00802737|7296003|FG000|Overall Study|Death|6
4493311|NCT00802737|7296004|FG001|Overall Study|Death|5
4493312|NCT00802737|7296005|FG002|Overall Study|Death|1
4493313|NCT00802737|7296003|FG000|Overall Study|Adverse Event|1
4493314|NCT00802737|7296004|FG001|Overall Study|Adverse Event|0
4493315|NCT00802737|7296005|FG002|Overall Study|Adverse Event|0
4493316|NCT00802737|7296003|FG000|Overall Study|Received Prohibited Therapy|1
4493317|NCT00802737|7296004|FG001|Overall Study|Received Prohibited Therapy|0
4493318|NCT00802737|7296005|FG002|Overall Study|Received Prohibited Therapy|0
4493319|NCT00802737|7296003|FG000|Overall Study|Ongoing CLL-Treatment|0
4493320|NCT00802737|7296004|FG001|Overall Study|Ongoing CLL-Treatment|1
4493321|NCT00802737|7296005|FG002|Overall Study|Ongoing CLL-Treatment|0
4493322|NCT00802737|7296003|FG000|Overall Study|Participant too Unwell|0
4493323|NCT00802737|7296004|FG001|Overall Study|Participant too Unwell|2
4493324|NCT00802737|7296005|FG002|Overall Study|Participant too Unwell|0
4493325|NCT00802841|7296016|FG000|Overall Study|Administrative problems|1
4493326|NCT00802841|7296017|FG001|Overall Study|Administrative problems|0
4493327|NCT00802841|7296016|FG000|Overall Study|Lost to Follow-up|2
4493328|NCT00802841|7296017|FG001|Overall Study|Lost to Follow-up|1
4493329|NCT00802841|7296016|FG000|Overall Study|Death|1
4493330|NCT00802841|7296017|FG001|Overall Study|Death|2
4493331|NCT00802841|7296016|FG000|Overall Study|Adverse Event|8
4493332|NCT00802841|7296017|FG001|Overall Study|Adverse Event|2
4493333|NCT00802841|7296016|FG000|Overall Study|Disease progression|7
4493334|NCT00802841|7296017|FG001|Overall Study|Disease progression|3
4493335|NCT00802841|7296016|FG000|Overall Study|Withdrawal by Subject|9
4493336|NCT00802841|7296017|FG001|Overall Study|Withdrawal by Subject|5
4493337|NCT00802841|7296016|FG000|Overall Study|Protocol deviation|2
4493338|NCT00802841|7296017|FG001|Overall Study|Protocol deviation|6
4493339|NCT00802841|7296016|FG000|Overall Study|Treatment duration completed|66
4493340|NCT00802841|7296017|FG001|Overall Study|Treatment duration completed|76
4493341|NCT00802867|7296029|FG000|Overall Study|Lost to Follow-up|6
4493342|NCT00802867|7296029|FG000|Overall Study|Protocol Violation|6
4493343|NCT00802867|7296029|FG000|Overall Study|Withdrawal by Subject|1
4493344|NCT00802945|7296053|FG000|Overall Study|Death|27
4493345|NCT00802945|7296054|FG001|Overall Study|Death|23
4493346|NCT00802945|7296053|FG000|Overall Study|Terminated by sponsor|8
4493347|NCT00802945|7296054|FG001|Overall Study|Terminated by sponsor|12
4493348|NCT00803023|7296084|FG000|Overall Study|Adverse Event|5
4493349|NCT00803023|7296085|FG001|Overall Study|Adverse Event|4
4493350|NCT00803023|7296086|FG002|Overall Study|Adverse Event|8
4493351|NCT00803023|7296087|FG003|Overall Study|Adverse Event|6
4493352|NCT00803023|7296084|FG000|Overall Study|Withdrawal by Subject|0
4493353|NCT00803023|7296085|FG001|Overall Study|Withdrawal by Subject|2
4493354|NCT00803023|7296086|FG002|Overall Study|Withdrawal by Subject|0
4493355|NCT00803023|7296087|FG003|Overall Study|Withdrawal by Subject|0
4493356|NCT00803023|7296084|FG000|Overall Study|Lost to Follow-up|0
4493357|NCT00803023|7296085|FG001|Overall Study|Lost to Follow-up|1
4493358|NCT00803023|7296086|FG002|Overall Study|Lost to Follow-up|2
4493359|NCT00803023|7296087|FG003|Overall Study|Lost to Follow-up|1
4493360|NCT00803023|7296084|FG000|Overall Study|Lack of Efficacy|0
4493361|NCT00803023|7296085|FG001|Overall Study|Lack of Efficacy|1
4493362|NCT00803023|7296086|FG002|Overall Study|Lack of Efficacy|1
4493363|NCT00803023|7296087|FG003|Overall Study|Lack of Efficacy|1
4493364|NCT00803049|7296101|FG000|Overall Study|Adverse Event|21
4493365|NCT00803049|7296102|FG001|Overall Study|Adverse Event|33
4493366|NCT00803049|7296103|FG002|Overall Study|Adverse Event|13
4493367|NCT00803049|7296104|FG003|Overall Study|Adverse Event|27
4493368|NCT00803049|7296101|FG000|Overall Study|Lack of Efficacy|10
4493369|NCT00803049|7296102|FG001|Overall Study|Lack of Efficacy|19
4493370|NCT00803049|7296103|FG002|Overall Study|Lack of Efficacy|6
4493371|NCT00803049|7296104|FG003|Overall Study|Lack of Efficacy|13
4493372|NCT00803049|7296101|FG000|Overall Study|Lost to Follow-up|0
4493373|NCT00803049|7296102|FG001|Overall Study|Lost to Follow-up|2
4493374|NCT00803049|7296103|FG002|Overall Study|Lost to Follow-up|0
4493375|NCT00803049|7296104|FG003|Overall Study|Lost to Follow-up|3
4493376|NCT00803049|7296101|FG000|Overall Study|Death|2
4493377|NCT00803049|7296102|FG001|Overall Study|Death|1
4493378|NCT00803049|7296103|FG002|Overall Study|Death|0
4493379|NCT00803049|7296104|FG003|Overall Study|Death|2
4493380|NCT00803049|7296101|FG000|Overall Study|Progressive Disease|6
4493381|NCT00803049|7296102|FG001|Overall Study|Progressive Disease|10
4493382|NCT00803049|7296103|FG002|Overall Study|Progressive Disease|6
4493383|NCT00803049|7296104|FG003|Overall Study|Progressive Disease|6
4493384|NCT00803049|7296101|FG000|Overall Study|Withdrawal by Subject|19
4493385|NCT00803049|7296102|FG001|Overall Study|Withdrawal by Subject|43
4493386|NCT00803049|7296103|FG002|Overall Study|Withdrawal by Subject|16
4493387|NCT00803049|7296104|FG003|Overall Study|Withdrawal by Subject|44
4493388|NCT00803049|7296101|FG000|Overall Study|Protocol Violation|0
4493389|NCT00803049|7296102|FG001|Overall Study|Protocol Violation|1
4493390|NCT00803049|7296103|FG002|Overall Study|Protocol Violation|1
4493391|NCT00803049|7296104|FG003|Overall Study|Protocol Violation|0
4493392|NCT00803049|7296101|FG000|Overall Study|Randomized and Not Treated|0
4493393|NCT00803049|7296102|FG001|Overall Study|Randomized and Not Treated|0
4493394|NCT00803049|7296103|FG002|Overall Study|Randomized and Not Treated|0
4493395|NCT00803049|7296104|FG003|Overall Study|Randomized and Not Treated|2
4493396|NCT00803049|7296101|FG000|Overall Study|Other than Specified Above|3
4493397|NCT00803049|7296102|FG001|Overall Study|Other than Specified Above|9
4493398|NCT00803049|7296103|FG002|Overall Study|Other than Specified Above|2
4493399|NCT00803049|7296104|FG003|Overall Study|Other than Specified Above|5
4493400|NCT00803101|7296133|FG000|Overall Study|Death / Serious Adverse Event|4
4493401|NCT00803101|7296134|FG001|Overall Study|Death / Serious Adverse Event|6
4493402|NCT00803101|7296133|FG000|Overall Study|Withdrawal by Subject|6
4493403|NCT00803101|7296134|FG001|Overall Study|Withdrawal by Subject|4
4493404|NCT00803101|7296133|FG000|Overall Study|Lost to Follow-up|2
4493405|NCT00803101|7296134|FG001|Overall Study|Lost to Follow-up|2
4493406|NCT00803101|7296133|FG000|Overall Study|Protocol Violation|1
4493407|NCT00803101|7296134|FG001|Overall Study|Protocol Violation|7
4493408|NCT00803101|7296133|FG000|Overall Study|Surgery finished outside protocol window|1
4493409|NCT00803101|7296134|FG001|Overall Study|Surgery finished outside protocol window|1
4493410|NCT00803101|7296133|FG000|Overall Study|Patient died outside SAE report period|1
4493411|NCT00803101|7296134|FG001|Overall Study|Patient died outside SAE report period|0
4493412|NCT00803101|7296133|FG000|Overall Study|Patient did not attend scheduled visit|2
4493413|NCT00803101|7296134|FG001|Overall Study|Patient did not attend scheduled visit|1
4493414|NCT00803101|7296133|FG000|Overall Study|Patient did not have surgery|1
4493415|NCT00803101|7296134|FG001|Overall Study|Patient did not have surgery|1
4493416|NCT00803205|7296142|FG000|Overall Study|Adverse Event|7
4493417|NCT00803205|7296143|FG001|Overall Study|Adverse Event|2
4493418|NCT00803205|7296142|FG000|Overall Study|Lost to Follow-up|1
4493419|NCT00803205|7296143|FG001|Overall Study|Lost to Follow-up|0
4493420|NCT00803205|7296142|FG000|Overall Study|Withdrawal by Subject|9
4493421|NCT00803205|7296143|FG001|Overall Study|Withdrawal by Subject|9
4493422|NCT00803205|7296142|FG000|Overall Study|Physician Decision|1
4493423|NCT00803205|7296143|FG001|Overall Study|Physician Decision|0
4493424|NCT00803205|7296142|FG000|Overall Study|Protocol Violation|1
4493425|NCT00803205|7296143|FG001|Overall Study|Protocol Violation|1
4493426|NCT00803205|7296142|FG000|Overall Study|Medical Monitor Decision|1
4493427|NCT00803205|7296143|FG001|Overall Study|Medical Monitor Decision|0
4493428|NCT00803205|7296142|FG000|Overall Study|Acquired a Lung Infection|0
4493429|NCT00803205|7296143|FG001|Overall Study|Acquired a Lung Infection|1
4493430|NCT00803205|7296142|FG000|Overall Study|Sponsor Decision|0
4493431|NCT00803205|7296143|FG001|Overall Study|Sponsor Decision|1
4493432|NCT00803244|7296151|FG000|Overall Study|Adverse Event|1
4493433|NCT00803244|7296152|FG001|Overall Study|Adverse Event|2
4493434|NCT00803244|7296151|FG000|Overall Study|Withdrawal by Subject|2
4493435|NCT00803244|7296152|FG001|Overall Study|Withdrawal by Subject|3
4493436|NCT00803244|7296151|FG000|Overall Study|Any other reason not above-mentioned|4
4493437|NCT00803244|7296152|FG001|Overall Study|Any other reason not above-mentioned|10
4493438|NCT00803270|7296160|FG000|Overall Study|Lost to Follow-up|1
4493439|NCT00803270|7296161|FG001|Overall Study|Lost to Follow-up|2
4493440|NCT00803361|7296169|FG000|Overall Study|Adverse Event|13
4493441|NCT00803361|7296170|FG001|Overall Study|Adverse Event|3
4493442|NCT00803361|7296169|FG000|Overall Study|Lack of Efficacy|4
4493443|NCT00803361|7296170|FG001|Overall Study|Lack of Efficacy|13
4493444|NCT00803361|7296169|FG000|Overall Study|Lost to Follow-up|1
4493445|NCT00803361|7296170|FG001|Overall Study|Lost to Follow-up|2
4493446|NCT00803361|7296169|FG000|Overall Study|Physician Decision|1
4493447|NCT00803361|7296170|FG001|Overall Study|Physician Decision|0
4493448|NCT00803361|7296169|FG000|Overall Study|Protocol Violation|2
4493449|NCT00803361|7296170|FG001|Overall Study|Protocol Violation|4
4493450|NCT00803361|7296169|FG000|Overall Study|Withdrawal by Subject|5
4493451|NCT00803361|7296170|FG001|Overall Study|Withdrawal by Subject|6
4493452|NCT00803452|7296188|FG000|Overall Study|Adverse Event|0
4493453|NCT00803452|7296189|FG001|Overall Study|Adverse Event|2
4493454|NCT00803452|7296188|FG000|Overall Study|Lost to Follow-up|0
4493455|NCT00803452|7296189|FG001|Overall Study|Lost to Follow-up|3
4493456|NCT00803569|7296204|FG000|Overall Study|Progressive Disease|3
4493457|NCT00803569|7296204|FG000|Overall Study|Noncompliance|1
4493458|NCT00803595|7296211|FG000|Overall Study|Adverse Event|3
4493459|NCT00803595|7296212|FG001|Overall Study|Adverse Event|4
4493460|NCT00803595|7296213|FG002|Overall Study|Adverse Event|1
4493461|NCT00803595|7296211|FG000|Overall Study|Protocol Violation|7
4493462|NCT00803595|7296212|FG001|Overall Study|Protocol Violation|2
4493463|NCT00803595|7296213|FG002|Overall Study|Protocol Violation|12
4493464|NCT00803595|7296211|FG000|Overall Study|Withdrawal by Subject|5
4493465|NCT00803595|7296212|FG001|Overall Study|Withdrawal by Subject|2
4493466|NCT00803595|7296213|FG002|Overall Study|Withdrawal by Subject|3
4493467|NCT00803634|7296223|FG000|Overall Study|Withdrew Consent|1
4493468|NCT00803634|7296224|FG001|Overall Study|Withdrew Consent|0
4493469|NCT00803634|7296223|FG000|Overall Study|Lost to Follow-up|2
4493470|NCT00803634|7296224|FG001|Overall Study|Lost to Follow-up|3
4493471|NCT00803634|7296223|FG000|Overall Study|Death|3
4493472|NCT00803634|7296224|FG001|Overall Study|Death|2
4517640|NCT00968669|7329563|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0
4517641|NCT00968669|7329560|FG000|Overall Study|SPONSOR DECISION|0
4517642|NCT00968669|7329561|FG001|Overall Study|SPONSOR DECISION|1
4517643|NCT00968669|7329562|FG002|Overall Study|SPONSOR DECISION|0
4517644|NCT00968669|7329563|FG003|Overall Study|SPONSOR DECISION|0
4517645|NCT00968669|7329560|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
4517646|NCT00968669|7329561|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
4517647|NCT00968669|7329562|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1
4626939|NCT01847755|7493232|FG000|Overall Study|Withdrawal by Subject|2
4517648|NCT00968669|7329563|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
4517649|NCT00968669|7329560|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
4517650|NCT00968669|7329561|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1
4517651|NCT00968669|7329562|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
4517652|NCT00968669|7329563|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
4517653|NCT00968669|7329560|FG000|Overall Study|SUBJECT INCARCERATED|0
4517654|NCT00968669|7329561|FG001|Overall Study|SUBJECT INCARCERATED|1
4517655|NCT00968669|7329562|FG002|Overall Study|SUBJECT INCARCERATED|0
4703039|NCT02724644|7620383|FG000|Overall Study|Lost to Follow-up|6
4703040|NCT02724644|7620384|FG001|Overall Study|Lost to Follow-up|2
4703041|NCT02724644|7620383|FG000|Overall Study|Withdrawal by Subject|7
4703042|NCT02724644|7620384|FG001|Overall Study|Withdrawal by Subject|1
4703043|NCT02724644|7620383|FG000|Overall Study|Administrative|1
4703044|NCT02724644|7620384|FG001|Overall Study|Administrative|0
4703045|NCT02724839|7620406|FG000|Overall Study|Withdrawal by Subject|1
4703046|NCT02724839|7620407|FG001|Overall Study|Withdrawal by Subject|1
4703047|NCT02724839|7620408|FG002|Overall Study|Withdrawal by Subject|0
4703048|NCT02724839|7620406|FG000|Overall Study|Lost to Follow-up|0
4703049|NCT02724839|7620407|FG001|Overall Study|Lost to Follow-up|3
4703050|NCT02724839|7620408|FG002|Overall Study|Lost to Follow-up|2
4703051|NCT02724839|7620406|FG000|Overall Study|Physician Decision|0
4703052|NCT02724839|7620407|FG001|Overall Study|Physician Decision|0
4703053|NCT02724839|7620408|FG002|Overall Study|Physician Decision|3
4703054|NCT02724956|7620425|FG000|Overall Study|Physician Decision|1
4703055|NCT02724956|7620426|FG001|Overall Study|Physician Decision|0
4703056|NCT02724956|7620425|FG000|Overall Study|Lack of Efficacy|0
4703057|NCT02724956|7620426|FG001|Overall Study|Lack of Efficacy|1
4703058|NCT02724956|7620425|FG000|Overall Study|Withdrawal by Subject|0
4703059|NCT02724956|7620426|FG001|Overall Study|Withdrawal by Subject|1
4703060|NCT02725008|7620434|FG000|Overall Study|Lost to Follow-up|7
4703061|NCT02725008|7620435|FG001|Overall Study|Lost to Follow-up|9
4703062|NCT02725008|7620434|FG000|Overall Study|Withdrawal by Subject|2
4703063|NCT02725008|7620435|FG001|Overall Study|Withdrawal by Subject|2
4703064|NCT02725008|7620434|FG000|Overall Study|Admitted to hospital|0
4703065|NCT02725008|7620435|FG001|Overall Study|Admitted to hospital|1
4703066|NCT02725268|7620445|FG000|Overall Study|Death|58
4703067|NCT02725268|7620446|FG001|Overall Study|Death|59
4703068|NCT02725268|7620447|FG002|Overall Study|Death|30
4703069|NCT02725268|7620448|FG003|Overall Study|Death|16
4703070|NCT02725268|7620445|FG000|Overall Study|Lost to Follow-up|4
4703071|NCT02725268|7620446|FG001|Overall Study|Lost to Follow-up|3
4703072|NCT02725268|7620447|FG002|Overall Study|Lost to Follow-up|0
4703073|NCT02725268|7620448|FG003|Overall Study|Lost to Follow-up|1
4703074|NCT02725268|7620445|FG000|Overall Study|Site Terminated by Sponsor|0
4703075|NCT02725268|7620446|FG001|Overall Study|Site Terminated by Sponsor|1
4703076|NCT02725268|7620447|FG002|Overall Study|Site Terminated by Sponsor|0
4703077|NCT02725268|7620448|FG003|Overall Study|Site Terminated by Sponsor|0
4703078|NCT02725268|7620445|FG000|Overall Study|Withdrawal by Subject|8
4703079|NCT02725268|7620446|FG001|Overall Study|Withdrawal by Subject|6
4703080|NCT02725268|7620447|FG002|Overall Study|Withdrawal by Subject|8
4703081|NCT02725268|7620448|FG003|Overall Study|Withdrawal by Subject|1
4703082|NCT02725268|7620445|FG000|Overall Study|Reason not Specified|2
4703083|NCT02725268|7620446|FG001|Overall Study|Reason not Specified|1
4703084|NCT02725268|7620447|FG002|Overall Study|Reason not Specified|0
4703085|NCT02725268|7620448|FG003|Overall Study|Reason not Specified|0
4703086|NCT02725411|7620461|FG000|Treatment Period (56 Weeks)|Adverse Event|3
4703087|NCT02725411|7620462|FG001|Treatment Period (56 Weeks)|Adverse Event|5
4703088|NCT02725411|7620463|FG002|Treatment Period (56 Weeks)|Adverse Event|4
4703089|NCT02725411|7620461|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1
4703090|NCT02725411|7620462|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4
4703091|NCT02725411|7620463|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1
4703092|NCT02725411|7620461|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0
4703093|NCT02725411|7620462|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1
4703094|NCT02725411|7620463|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0
4703095|NCT02725411|7620461|FG000|Treatment Period (56 Weeks)|Other|1
4703096|NCT02725411|7620462|FG001|Treatment Period (56 Weeks)|Other|4
4703097|NCT02725411|7620463|FG002|Treatment Period (56 Weeks)|Other|5
4703098|NCT02725411|7620461|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0
4703099|NCT02725411|7620462|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1
4703100|NCT02725411|7620463|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4
4703101|NCT02725411|7620461|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25
4703102|NCT02725411|7620462|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35
4703103|NCT02725411|7620463|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35
4703104|NCT02725411|7620461|FG000|Follow-up Period (24 Weeks)|Adverse Event|1
4703105|NCT02725411|7620462|FG001|Follow-up Period (24 Weeks)|Adverse Event|1
4703106|NCT02725411|7620463|FG002|Follow-up Period (24 Weeks)|Adverse Event|0
4703107|NCT02725411|7620461|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0
4703108|NCT02725411|7620462|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2
4703109|NCT02725411|7620463|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0
4703110|NCT02725411|7620461|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1
4703111|NCT02725411|7620462|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1
4703112|NCT02725411|7620463|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0
4703113|NCT02725411|7620461|FG000|Follow-up Period (24 Weeks)|Other|1
4703114|NCT02725411|7620462|FG001|Follow-up Period (24 Weeks)|Other|4
4703115|NCT02725411|7620463|FG002|Follow-up Period (24 Weeks)|Other|2
4703116|NCT02725411|7620461|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1
4703117|NCT02725411|7620462|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3
4703118|NCT02725411|7620463|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3
4703119|NCT02725476|7620473|FG000|Overall Study|Physician Decision|2
4703120|NCT02725476|7620474|FG001|Overall Study|Physician Decision|0
4703121|NCT02725476|7620473|FG000|Overall Study|Adverse Event|1
4703122|NCT02725476|7620474|FG001|Overall Study|Adverse Event|1
4703123|NCT02725515|7620482|FG000|Overall Study|Refused infusion (no study treatment)|1
4703124|NCT02725515|7620483|FG001|Overall Study|Refused infusion (no study treatment)|0
4703125|NCT02725515|7620482|FG000|Overall Study|Loss of Improvement per Protocol|14
4703126|NCT02725515|7620483|FG001|Overall Study|Loss of Improvement per Protocol|25
4703127|NCT02725515|7620482|FG000|Overall Study|Withdrawal by Subject|2
4703128|NCT02725515|7620483|FG001|Overall Study|Withdrawal by Subject|1
4703129|NCT02725515|7620482|FG000|Overall Study|Non-Compliance With Study Drug|0
4703130|NCT02725515|7620483|FG001|Overall Study|Non-Compliance With Study Drug|3
4703131|NCT02725515|7620482|FG000|Overall Study|Lost to Follow-up|1
4703132|NCT02725515|7620483|FG001|Overall Study|Lost to Follow-up|1
4703133|NCT02725515|7620482|FG000|Overall Study|Adverse Event|7
4703134|NCT02725515|7620483|FG001|Overall Study|Adverse Event|2
4703135|NCT02725515|7620482|FG000|Overall Study|No Documented Disease Improvement|0
4703136|NCT02725515|7620483|FG001|Overall Study|No Documented Disease Improvement|1
4703137|NCT02725515|7620482|FG000|Overall Study|Completed Study Under Original Protocol|0
4703138|NCT02725515|7620483|FG001|Overall Study|Completed Study Under Original Protocol|1
4703139|NCT02725515|7620482|FG000|Overall Study|Lack of Response|0
4703140|NCT02725515|7620483|FG001|Overall Study|Lack of Response|1
4703141|NCT02725710|7620495|FG000|Overall Study|Lost to Follow-up|1
4703142|NCT02725710|7620496|FG001|Overall Study|Lost to Follow-up|0
4703143|NCT02725788|7620504|FG000|Overall Study|Lost to Follow-up|1
4703144|NCT02725788|7620505|FG001|Overall Study|Lost to Follow-up|1
4703145|NCT02725788|7620504|FG000|Overall Study|Protocol Violation|0
4703146|NCT02725788|7620505|FG001|Overall Study|Protocol Violation|1
4703147|NCT02725866|7620520|FG000|Overall Study|Failure to return|6
4703148|NCT02725866|7620520|FG000|Overall Study|Withdrew consent|3
4703149|NCT02725866|7620520|FG000|Overall Study|Insufficient virological response|1
4703150|NCT02725866|7620520|FG000|Overall Study|Other, not specified|4
4703151|NCT02726022|7620524|FG000|Overall Study|Adverse Event|14
4703152|NCT02726022|7620524|FG000|Overall Study|Treatment Failure|8
4703153|NCT02726022|7620524|FG000|Overall Study|Poor Compliance|13
4703154|NCT02726022|7620524|FG000|Overall Study|Treatment Failure and Poor Compliance|1
4703155|NCT02726074|7620528|FG000|Overall Study|Withdrawal by Subject|4
4703156|NCT02726074|7620528|FG000|Overall Study|Adverse Event|14
4703157|NCT02726074|7620528|FG000|Overall Study|Protocol Violation|3
4703158|NCT02726074|7620528|FG000|Overall Study|Lost to Follow-up|2
4703159|NCT02726074|7620528|FG000|Overall Study|Others|3
4735377|NCT03527745|7683293|FG006|Overall Study|Lost to Follow-up|3
4735378|NCT03527745|7683294|FG007|Overall Study|Lost to Follow-up|2
4735379|NCT03527745|7683295|FG008|Overall Study|Lost to Follow-up|3
4735380|NCT03527745|7683296|FG009|Overall Study|Lost to Follow-up|2
4735381|NCT03527745|7683297|FG010|Overall Study|Lost to Follow-up|1
4735382|NCT03527745|7683298|FG011|Overall Study|Lost to Follow-up|1
4735383|NCT03527745|7683299|FG012|Overall Study|Lost to Follow-up|0
4735384|NCT03527745|7683300|FG013|Overall Study|Lost to Follow-up|0
4735385|NCT03527745|7683301|FG014|Overall Study|Lost to Follow-up|0
4735386|NCT03527745|7683302|FG015|Overall Study|Lost to Follow-up|0
4735387|NCT03527745|7683303|FG016|Overall Study|Lost to Follow-up|1
4735388|NCT03527745|7683304|FG017|Overall Study|Lost to Follow-up|0
4735389|NCT03527745|7683305|FG018|Overall Study|Lost to Follow-up|0
4735390|NCT03527745|7683306|FG019|Overall Study|Lost to Follow-up|1
4735391|NCT03527745|7683307|FG020|Overall Study|Lost to Follow-up|1
4735392|NCT03527745|7683308|FG021|Overall Study|Lost to Follow-up|5
4735393|NCT03527745|7683309|FG022|Overall Study|Lost to Follow-up|6
4735394|NCT03527745|7683310|FG023|Overall Study|Lost to Follow-up|8
4735395|NCT03527745|7683311|FG024|Overall Study|Lost to Follow-up|1
4735396|NCT03527745|7683312|FG025|Overall Study|Lost to Follow-up|3
4735397|NCT03527966|7683370|FG000|Overall Study|Lost to Follow-up|3
4735398|NCT03527966|7683371|FG001|Overall Study|Lost to Follow-up|0
4735399|NCT03528174|7683377|FG000|Overall Study|Adverse Event|1
4735400|NCT03528174|7683377|FG000|Overall Study|sensors dislodged|1
4735401|NCT03528369|7683384|FG000|Overall Study|Withdrawal by Subject|2
4735402|NCT03528369|7683385|FG001|Overall Study|Withdrawal by Subject|0
4735403|NCT03528369|7683386|FG002|Overall Study|Withdrawal by Subject|0
4735404|NCT03528369|7683384|FG000|Overall Study|Lost to Follow-up|1
4735405|NCT03528369|7683385|FG001|Overall Study|Lost to Follow-up|0
4735406|NCT03528369|7683386|FG002|Overall Study|Lost to Follow-up|0
4735407|NCT03528369|7683384|FG000|Overall Study|Adverse Event|0
4735408|NCT03528369|7683385|FG001|Overall Study|Adverse Event|1
4735409|NCT03528369|7683386|FG002|Overall Study|Adverse Event|0
4735410|NCT03528551|7683406|FG000|Overall Study|Lost to Follow-up|0
4735411|NCT03528551|7683407|FG001|Overall Study|Lost to Follow-up|1
4735412|NCT03528551|7683408|FG002|Overall Study|Lost to Follow-up|0
4735413|NCT03528551|7683406|FG000|Overall Study|Transferred to other arm/group|2
4735414|NCT03528551|7683407|FG001|Overall Study|Transferred to other arm/group|3
4735415|NCT03528551|7683408|FG002|Overall Study|Transferred to other arm/group|0
4735416|NCT03528551|7683406|FG000|Overall Study|Withdrawal by parent/guardian|0
4735417|NCT03528551|7683407|FG001|Overall Study|Withdrawal by parent/guardian|5
4735418|NCT03528551|7683408|FG002|Overall Study|Withdrawal by parent/guardian|0
4735419|NCT03528551|7683406|FG000|Overall Study|Protocol Violation|0
4735420|NCT03528551|7683407|FG001|Overall Study|Protocol Violation|3
4703160|NCT02726113|7620534|FG000|Total Enrollment|Physician Decision|0
4703161|NCT02726113|7620535|FG001|Total Enrollment|Physician Decision|1
4703162|NCT02726113|7620534|FG000|Total Enrollment|Protocol Violation|1
4703163|NCT02726113|7620535|FG001|Total Enrollment|Protocol Violation|0
4703164|NCT02726113|7620534|FG000|Total Enrollment|Withdrawal by Subject|2
4703165|NCT02726113|7620535|FG001|Total Enrollment|Withdrawal by Subject|1
4703166|NCT02726113|7620534|FG000|Total Enrollment|Insurance non-coverage for surgery|1
4703167|NCT02726113|7620535|FG001|Total Enrollment|Insurance non-coverage for surgery|1
4703168|NCT02726113|7620534|FG000|Genomic Analysis|Protocol Violation|1
4703169|NCT02726113|7620535|FG001|Genomic Analysis|Protocol Violation|0
4703170|NCT02726113|7620534|FG000|Genomic Analysis|Withdrawal by Subject|2
4703171|NCT02726113|7620535|FG001|Genomic Analysis|Withdrawal by Subject|1
4703172|NCT02726113|7620534|FG000|Genomic Analysis|Insurance non-coverage for surgery|1
4703173|NCT02726113|7620535|FG001|Genomic Analysis|Insurance non-coverage for surgery|1
4703174|NCT02726945|7620588|FG000|Overall Study|Withdrawal by Subject|0
4703175|NCT02726945|7620589|FG001|Overall Study|Withdrawal by Subject|0
4703176|NCT02726945|7620590|FG002|Overall Study|Withdrawal by Subject|1
4703177|NCT02726945|7620588|FG000|Overall Study|Elected to have total knee replacement|0
4703178|NCT02726945|7620589|FG001|Overall Study|Elected to have total knee replacement|1
4493473|NCT00803712|7296256|FG000|Overall Study|Noncompliance|3
4493474|NCT00803712|7296257|FG001|Overall Study|Noncompliance|0
4493475|NCT00803712|7296256|FG000|Overall Study|Adverse Event|5
4493476|NCT00803712|7296257|FG001|Overall Study|Adverse Event|0
4493477|NCT00803712|7296256|FG000|Overall Study|Death|8
4493478|NCT00803712|7296257|FG001|Overall Study|Death|7
4493479|NCT00803712|7296256|FG000|Overall Study|Lost to Follow-up|3
4493480|NCT00803712|7296257|FG001|Overall Study|Lost to Follow-up|1
4493481|NCT00803712|7296256|FG000|Overall Study|Withdrawal by Subject|2
4493482|NCT00803712|7296257|FG001|Overall Study|Withdrawal by Subject|4
4493483|NCT00803712|7296256|FG000|Overall Study|"Other in electronic Case Report Form"|0
4493484|NCT00803712|7296257|FG001|Overall Study|"Other in electronic Case Report Form"|1
4493485|NCT00803712|7296256|FG000|Overall Study|Protocol criteria (other)|0
4493486|NCT00803712|7296257|FG001|Overall Study|Protocol criteria (other)|2
4493487|NCT00803712|7296256|FG000|Overall Study|Protocol criteria (renal transplant)|12
4493488|NCT00803712|7296257|FG001|Overall Study|Protocol criteria (renal transplant)|8
4493489|NCT00803712|7296256|FG000|Overall Study|Administrative decision|2
4493490|NCT00803712|7296257|FG001|Overall Study|Administrative decision|3
4493491|NCT00803712|7296256|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1
4493492|NCT00803712|7296257|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1
4493493|NCT00803738|7296265|FG000|Overall Study|Adverse Event|3
4493494|NCT00803738|7296266|FG001|Overall Study|Adverse Event|5
4493495|NCT00803738|7296265|FG000|Overall Study|Lost to Follow-up|4
4493496|NCT00803738|7296266|FG001|Overall Study|Lost to Follow-up|4
4493497|NCT00803738|7296265|FG000|Overall Study|Protocol Violation|18
4493498|NCT00803738|7296266|FG001|Overall Study|Protocol Violation|10
4493499|NCT00803738|7296265|FG000|Overall Study|Withdrawal by Subject|1
4493500|NCT00803738|7296266|FG001|Overall Study|Withdrawal by Subject|4
4493501|NCT00803738|7296265|FG000|Overall Study|Lack of Efficacy|10
4493502|NCT00803738|7296266|FG001|Overall Study|Lack of Efficacy|16
4493503|NCT00803738|7296265|FG000|Overall Study|Negative Baseline Culture of Candida|56
4493504|NCT00803738|7296266|FG001|Overall Study|Negative Baseline Culture of Candida|63
4493505|NCT00803738|7296265|FG000|Overall Study|Positive Results for STD or abnormal PAP|2
4493506|NCT00803738|7296266|FG001|Overall Study|Positive Results for STD or abnormal PAP|8
4493507|NCT00804141|7296294|FG000|Overall Study|Adverse Event|157
4493508|NCT00804141|7296294|FG000|Overall Study|Death|4
4493509|NCT00804141|7296294|FG000|Overall Study|Failed to return|96
4493510|NCT00804141|7296294|FG000|Overall Study|Investigator request|8
4493511|NCT00804141|7296294|FG000|Overall Study|Protocol Violation|85
4493512|NCT00804141|7296294|FG000|Overall Study|Withdrawal by Subject|131
4493513|NCT00804141|7296294|FG000|Overall Study|Lack of Efficacy|46
4493514|NCT00804141|7296294|FG000|Overall Study|Other than specified|30
4493515|NCT00804141|7296294|FG000|Overall Study|Enrolled but not treated|6
4493516|NCT00804193|7296301|FG000|Overall Study|Lack of baseline fungus|32
4493517|NCT00804193|7296302|FG001|Overall Study|Lack of baseline fungus|31
4493518|NCT00804193|7296303|FG002|Overall Study|Lack of baseline fungus|19
4493519|NCT00804193|7296301|FG000|Overall Study|Adverse Event|0
4493520|NCT00804193|7296302|FG001|Overall Study|Adverse Event|0
4493521|NCT00804193|7296303|FG002|Overall Study|Adverse Event|2
4493522|NCT00804193|7296301|FG000|Overall Study|Lack of Efficacy|1
4493523|NCT00804193|7296302|FG001|Overall Study|Lack of Efficacy|1
4493524|NCT00804193|7296303|FG002|Overall Study|Lack of Efficacy|3
4493525|NCT00804193|7296301|FG000|Overall Study|Protocol Violation|0
4493526|NCT00804193|7296302|FG001|Overall Study|Protocol Violation|8
4493527|NCT00804193|7296303|FG002|Overall Study|Protocol Violation|2
4493528|NCT00804193|7296301|FG000|Overall Study|Lost to Follow-up|3
4493529|NCT00804193|7296302|FG001|Overall Study|Lost to Follow-up|3
4493530|NCT00804193|7296303|FG002|Overall Study|Lost to Follow-up|4
4493531|NCT00804193|7296301|FG000|Overall Study|Withdrawal by Subject|3
4493532|NCT00804193|7296302|FG001|Overall Study|Withdrawal by Subject|1
4493533|NCT00804193|7296303|FG002|Overall Study|Withdrawal by Subject|2
4703179|NCT02726945|7620590|FG002|Overall Study|Elected to have total knee replacement|0
4493534|NCT00804570|7296313|FG000|Overall Study|Adverse Event|14
4493535|NCT00804570|7296314|FG001|Overall Study|Adverse Event|7
4493536|NCT00804570|7296313|FG000|Overall Study|Lack of Efficacy|0
4493537|NCT00804570|7296314|FG001|Overall Study|Lack of Efficacy|1
4493538|NCT00804570|7296313|FG000|Overall Study|Lost to Follow-up|18
4493539|NCT00804570|7296314|FG001|Overall Study|Lost to Follow-up|21
4493540|NCT00804570|7296313|FG000|Overall Study|Entry criteria not met|5
4493541|NCT00804570|7296314|FG001|Overall Study|Entry criteria not met|5
4493542|NCT00804570|7296313|FG000|Overall Study|Protocol Violation|12
4493543|NCT00804570|7296314|FG001|Overall Study|Protocol Violation|16
4493544|NCT00804570|7296313|FG000|Overall Study|Physician Decision|1
4493545|NCT00804570|7296314|FG001|Overall Study|Physician Decision|2
4493546|NCT00804570|7296313|FG000|Overall Study|Sponsor decision|1
4493547|NCT00804570|7296314|FG001|Overall Study|Sponsor decision|4
4493548|NCT00804570|7296313|FG000|Overall Study|Withdrawal by Subject|21
4493549|NCT00804570|7296314|FG001|Overall Study|Withdrawal by Subject|38
4493550|NCT00804687|7296347|FG000|Period 3: Treatment Period|Positive Drug screen|0
4493551|NCT00804687|7296348|FG001|Period 3: Treatment Period|Positive Drug screen|0
4493552|NCT00804687|7296349|FG002|Period 3: Treatment Period|Positive Drug screen|0
4493553|NCT00804687|7296350|FG003|Period 3: Treatment Period|Positive Drug screen|1
4493554|NCT00804687|7296351|FG004|Period 3: Treatment Period|Positive Drug screen|0
4493555|NCT00804687|7296352|FG005|Period 3: Treatment Period|Positive Drug screen|0
4493556|NCT00804687|7296347|FG000|Period 5: Treatment Period|Withdrawal by Subject|0
4493557|NCT00804687|7296348|FG001|Period 5: Treatment Period|Withdrawal by Subject|0
4493558|NCT00804687|7296349|FG002|Period 5: Treatment Period|Withdrawal by Subject|0
4493559|NCT00804687|7296350|FG003|Period 5: Treatment Period|Withdrawal by Subject|0
4493560|NCT00804687|7296351|FG004|Period 5: Treatment Period|Withdrawal by Subject|1
4493561|NCT00804687|7296352|FG005|Period 5: Treatment Period|Withdrawal by Subject|0
4493562|NCT00804687|7296347|FG000|Period 5: Treatment Period|Positive drugs of abuse|0
4493563|NCT00804687|7296348|FG001|Period 5: Treatment Period|Positive drugs of abuse|0
4493564|NCT00804687|7296349|FG002|Period 5: Treatment Period|Positive drugs of abuse|1
4493565|NCT00804687|7296350|FG003|Period 5: Treatment Period|Positive drugs of abuse|0
4493566|NCT00804687|7296351|FG004|Period 5: Treatment Period|Positive drugs of abuse|0
4493567|NCT00804687|7296352|FG005|Period 5: Treatment Period|Positive drugs of abuse|0
4493568|NCT00804687|7296347|FG000|Period 5: Treatment Period|Positive drug test|1
4493569|NCT00804687|7296348|FG001|Period 5: Treatment Period|Positive drug test|0
4493570|NCT00804687|7296349|FG002|Period 5: Treatment Period|Positive drug test|0
4493571|NCT00804687|7296350|FG003|Period 5: Treatment Period|Positive drug test|0
4493572|NCT00804687|7296351|FG004|Period 5: Treatment Period|Positive drug test|0
4626940|NCT01847755|7493232|FG000|Overall Study|Physician Decision|1
4626941|NCT01847885|7493238|FG000|Initial Enrollment (Consented)|Protocol Violation|1
4626942|NCT01847885|7493239|FG001|Initial Enrollment (Consented)|Protocol Violation|0
4493573|NCT00804687|7296352|FG005|Period 5: Treatment Period|Positive drug test|0
4493574|NCT00804843|7296362|FG000|Overall Study|Protocol Violation|1
4493575|NCT00804843|7296363|FG001|Overall Study|Protocol Violation|0
4493576|NCT00804843|7296362|FG000|Overall Study|Adverse Event|8
4493577|NCT00804843|7296363|FG001|Overall Study|Adverse Event|5
4493578|NCT00804843|7296362|FG000|Overall Study|Withdrawal by Subject|1
4493579|NCT00804843|7296363|FG001|Overall Study|Withdrawal by Subject|2
4493580|NCT00804908|7296373|FG000|Overall Study|Other|115
4493581|NCT00804908|7296374|FG001|Overall Study|Other|116
4493582|NCT00804908|7296375|FG002|Overall Study|Other|114
4493583|NCT00804986|7296402|FG000|Overall Study|Adverse Event|0
4493584|NCT00804986|7296403|FG001|Overall Study|Adverse Event|1
4493585|NCT00804986|7296404|FG002|Overall Study|Adverse Event|2
4493586|NCT00804986|7296405|FG003|Overall Study|Adverse Event|1
4493587|NCT00804986|7296406|FG004|Overall Study|Adverse Event|3
4493588|NCT00804986|7296407|FG005|Overall Study|Adverse Event|0
4493589|NCT00804986|7296402|FG000|Overall Study|Lack of Efficacy|0
4493590|NCT00804986|7296403|FG001|Overall Study|Lack of Efficacy|0
4493591|NCT00804986|7296404|FG002|Overall Study|Lack of Efficacy|0
4493592|NCT00804986|7296405|FG003|Overall Study|Lack of Efficacy|1
4493593|NCT00804986|7296406|FG004|Overall Study|Lack of Efficacy|0
4493594|NCT00804986|7296407|FG005|Overall Study|Lack of Efficacy|3
4493595|NCT00804986|7296402|FG000|Overall Study|Lost to Follow-up|0
4493596|NCT00804986|7296403|FG001|Overall Study|Lost to Follow-up|0
4493597|NCT00804986|7296404|FG002|Overall Study|Lost to Follow-up|0
4493598|NCT00804986|7296405|FG003|Overall Study|Lost to Follow-up|1
4493599|NCT00804986|7296406|FG004|Overall Study|Lost to Follow-up|1
4493600|NCT00804986|7296407|FG005|Overall Study|Lost to Follow-up|3
4493601|NCT00804986|7296402|FG000|Overall Study|Protocol Violation|0
4493602|NCT00804986|7296403|FG001|Overall Study|Protocol Violation|1
4493603|NCT00804986|7296404|FG002|Overall Study|Protocol Violation|0
4493604|NCT00804986|7296405|FG003|Overall Study|Protocol Violation|1
4493605|NCT00804986|7296406|FG004|Overall Study|Protocol Violation|0
4493606|NCT00804986|7296407|FG005|Overall Study|Protocol Violation|0
4493607|NCT00804986|7296402|FG000|Overall Study|Withdrawal by Subject|0
4493608|NCT00804986|7296403|FG001|Overall Study|Withdrawal by Subject|3
4493609|NCT00804986|7296404|FG002|Overall Study|Withdrawal by Subject|0
4493610|NCT00804986|7296405|FG003|Overall Study|Withdrawal by Subject|3
4493611|NCT00804986|7296406|FG004|Overall Study|Withdrawal by Subject|5
4493612|NCT00804986|7296407|FG005|Overall Study|Withdrawal by Subject|3
4493613|NCT00804986|7296402|FG000|Overall Study|Inclusion/Exclusion criteria not met|0
4493614|NCT00804986|7296403|FG001|Overall Study|Inclusion/Exclusion criteria not met|2
4493615|NCT00804986|7296404|FG002|Overall Study|Inclusion/Exclusion criteria not met|0
4493616|NCT00804986|7296405|FG003|Overall Study|Inclusion/Exclusion criteria not met|1
4493617|NCT00804986|7296406|FG004|Overall Study|Inclusion/Exclusion criteria not met|0
4493618|NCT00804986|7296407|FG005|Overall Study|Inclusion/Exclusion criteria not met|1
4493619|NCT00804986|7296402|FG000|Overall Study|Sponsor Decision|0
4493620|NCT00804986|7296403|FG001|Overall Study|Sponsor Decision|1
4493621|NCT00804986|7296404|FG002|Overall Study|Sponsor Decision|0
4493622|NCT00804986|7296405|FG003|Overall Study|Sponsor Decision|0
4493623|NCT00804986|7296406|FG004|Overall Study|Sponsor Decision|0
4493624|NCT00804986|7296407|FG005|Overall Study|Sponsor Decision|0
4493625|NCT00804986|7296402|FG000|Overall Study|Physician Decision|1
4493626|NCT00804986|7296403|FG001|Overall Study|Physician Decision|0
4493627|NCT00804986|7296404|FG002|Overall Study|Physician Decision|0
4493628|NCT00804986|7296405|FG003|Overall Study|Physician Decision|0
4493629|NCT00804986|7296406|FG004|Overall Study|Physician Decision|0
4493630|NCT00804986|7296407|FG005|Overall Study|Physician Decision|0
4493631|NCT00805025|7296438|FG000|Overall Study|Screened but not enrolled/treated|42
4493632|NCT00805025|7296438|FG000|Overall Study|Adverse Event|4
4493633|NCT00805025|7296438|FG000|Overall Study|Withdrawal by Subject|2
4493634|NCT00805025|7296438|FG000|Overall Study|Physician Decision|1
4626943|NCT01847885|7493240|FG002|Initial Enrollment (Consented)|Protocol Violation|0
4626944|NCT01847885|7493238|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2
4493635|NCT00805142|7296453|FG000|Titration Period|Adverse Event|3
4493636|NCT00805142|7296454|FG001|Titration Period|Adverse Event|3
4493637|NCT00805142|7296453|FG000|Titration Period|Lack of Efficacy|1
4493638|NCT00805142|7296454|FG001|Titration Period|Lack of Efficacy|1
4493639|NCT00805142|7296453|FG000|Titration Period|Lost to Follow-up|0
4493640|NCT00805142|7296454|FG001|Titration Period|Lost to Follow-up|1
4703180|NCT02727192|7620609|FG000|Overall Study|Lost to Follow-up|1
4703181|NCT02727192|7620610|FG001|Overall Study|Lost to Follow-up|0
4703182|NCT02727192|7620611|FG002|Overall Study|Lost to Follow-up|0
4703183|NCT02727322|7620620|FG000|Overall Study|Withdrawal by Subject|1
4703184|NCT02727322|7620621|FG001|Overall Study|Withdrawal by Subject|1
4703185|NCT02727322|7620620|FG000|Overall Study|Protocol Violation|1
4703186|NCT02727322|7620621|FG001|Overall Study|Protocol Violation|0
4703187|NCT02727660|7620634|FG000|Overall Study|Lack of Efficacy|40
4703188|NCT02727660|7620635|FG001|Overall Study|Lack of Efficacy|40
4703189|NCT02727660|7620636|FG002|Overall Study|Lack of Efficacy|70
4703190|NCT02727660|7620634|FG000|Overall Study|Adverse Event|28
4703191|NCT02727660|7620635|FG001|Overall Study|Adverse Event|21
4703192|NCT02727660|7620636|FG002|Overall Study|Adverse Event|32
4703193|NCT02727660|7620634|FG000|Overall Study|Withdrawal by Subject|26
4703194|NCT02727660|7620635|FG001|Overall Study|Withdrawal by Subject|25
4703195|NCT02727660|7620636|FG002|Overall Study|Withdrawal by Subject|30
4703196|NCT02727660|7620634|FG000|Overall Study|Physician Decision|3
4703197|NCT02727660|7620635|FG001|Overall Study|Physician Decision|8
4703198|NCT02727660|7620636|FG002|Overall Study|Physician Decision|14
4493641|NCT00805142|7296453|FG000|Titration Period|Disease Progression|2
4493642|NCT00805142|7296454|FG001|Titration Period|Disease Progression|1
4493643|NCT00805142|7296453|FG000|Titration Period|Withdrawal of consent|0
4493644|NCT00805142|7296454|FG001|Titration Period|Withdrawal of consent|1
4493645|NCT00805142|7296453|FG000|Titration Period|Other|0
4493646|NCT00805142|7296454|FG001|Titration Period|Other|3
4493647|NCT00805142|7296453|FG000|Maintenance Period|Adverse Event|0
4493648|NCT00805142|7296454|FG001|Maintenance Period|Adverse Event|1
4493649|NCT00805142|7296453|FG000|Maintenance Period|Other|0
4493650|NCT00805142|7296454|FG001|Maintenance Period|Other|1
4493651|NCT00805194|7296469|FG000|Overall Study|Progressive disease (modified RECIST)|404
4493652|NCT00805194|7296470|FG001|Overall Study|Progressive disease (modified RECIST)|435
4493653|NCT00805194|7296469|FG000|Overall Study|Worsening or AE of underlying disease|64
4493654|NCT00805194|7296470|FG001|Overall Study|Worsening or AE of underlying disease|70
4493655|NCT00805194|7296469|FG000|Overall Study|Other AE|84
4493656|NCT00805194|7296470|FG001|Overall Study|Other AE|73
4493657|NCT00805194|7296469|FG000|Overall Study|Protocol Violation|9
4493658|NCT00805194|7296470|FG001|Overall Study|Protocol Violation|9
4493659|NCT00805194|7296469|FG000|Overall Study|Lost to Follow-up|5
4493660|NCT00805194|7296470|FG001|Overall Study|Lost to Follow-up|5
4493661|NCT00805194|7296469|FG000|Overall Study|Withdrawal by Subject|60
4626945|NCT01847885|7493239|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0
4626946|NCT01847885|7493240|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0
4626947|NCT01847885|7493238|FG000|Initial Enrollment (Consented)|Screen failure|39
4626948|NCT01847885|7493239|FG001|Initial Enrollment (Consented)|Screen failure|0
4626949|NCT01847885|7493240|FG002|Initial Enrollment (Consented)|Screen failure|0
4626950|NCT01847885|7493238|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6
4626951|NCT01847885|7493239|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0
4626952|NCT01847885|7493240|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0
4626953|NCT01847885|7493238|FG000|Randomization|Protocol Violation|0
4626954|NCT01847885|7493239|FG001|Randomization|Protocol Violation|1
4626955|NCT01847885|7493240|FG002|Randomization|Protocol Violation|0
4626956|NCT01847885|7493238|FG000|Randomization|Withdrawal by Subject|0
4493662|NCT00805194|7296470|FG001|Overall Study|Withdrawal by Subject|42
4493663|NCT00805194|7296469|FG000|Overall Study|Not treated|3
4493664|NCT00805194|7296470|FG001|Overall Study|Not treated|4
4493665|NCT00805194|7296469|FG000|Overall Study|Reasons other than stated above|20
4493666|NCT00805194|7296470|FG001|Overall Study|Reasons other than stated above|16
4493667|NCT00805207|7296490|FG000|Overall Study|Protocol Violation|0
4703199|NCT02727660|7620634|FG000|Overall Study|Lost to Follow-up|5
4703200|NCT02727660|7620635|FG001|Overall Study|Lost to Follow-up|9
4703201|NCT02727660|7620636|FG002|Overall Study|Lost to Follow-up|8
4703202|NCT02727660|7620634|FG000|Overall Study|Protocol Violation|7
4703203|NCT02727660|7620635|FG001|Overall Study|Protocol Violation|5
4703204|NCT02727660|7620636|FG002|Overall Study|Protocol Violation|5
4703205|NCT02727660|7620634|FG000|Overall Study|Protocol Specified Disc. Criteria|5
4703206|NCT02727660|7620635|FG001|Overall Study|Protocol Specified Disc. Criteria|5
4703207|NCT02727660|7620636|FG002|Overall Study|Protocol Specified Disc. Criteria|2
4703208|NCT02727660|7620634|FG000|Overall Study|Administrative Reasons|2
4703209|NCT02727660|7620635|FG001|Overall Study|Administrative Reasons|3
4703210|NCT02727660|7620636|FG002|Overall Study|Administrative Reasons|4
4703211|NCT02727699|7620646|FG000|Overall Study|Adverse Event|2
4703212|NCT02727699|7620647|FG001|Overall Study|Adverse Event|0
4703213|NCT02727699|7620646|FG000|Overall Study|Withdrawal by Subject|5
4703214|NCT02727699|7620647|FG001|Overall Study|Withdrawal by Subject|3
4703215|NCT02727699|7620646|FG000|Overall Study|Protocol Violation|0
4703216|NCT02727699|7620647|FG001|Overall Study|Protocol Violation|1
4703217|NCT02727699|7620646|FG000|Overall Study|Physician Decision|0
4703218|NCT02727699|7620647|FG001|Overall Study|Physician Decision|1
4703219|NCT02727699|7620646|FG000|Overall Study|Lost to Follow-up|1
4703220|NCT02727699|7620647|FG001|Overall Study|Lost to Follow-up|0
4703221|NCT02727699|7620646|FG000|Overall Study|Sponsor Decision|1
4703222|NCT02727699|7620647|FG001|Overall Study|Sponsor Decision|0
4703223|NCT02727777|7620660|FG000|Overall Study|Screen Failure|2
4703224|NCT02727777|7620661|FG001|Overall Study|Screen Failure|0
4703225|NCT02727777|7620662|FG002|Overall Study|Screen Failure|0
4703226|NCT02727777|7620660|FG000|Overall Study|Progressive disease|2
4703227|NCT02727777|7620661|FG001|Overall Study|Progressive disease|0
4703228|NCT02727777|7620662|FG002|Overall Study|Progressive disease|0
4703229|NCT02728089|7620706|FG000|Overall Study|Physician Decision|2
4703230|NCT02728089|7620706|FG000|Overall Study|Withdrawal by Subject|1
4703231|NCT02728102|7620713|FG000|Overall Study|Death|1
4703232|NCT02728102|7620714|FG001|Overall Study|Death|0
4703233|NCT02728102|7620715|FG002|Overall Study|Death|0
4703234|NCT02728102|7620713|FG000|Overall Study|Withdrawal by Subject|0
4703235|NCT02728102|7620714|FG001|Overall Study|Withdrawal by Subject|2
4703236|NCT02728102|7620715|FG002|Overall Study|Withdrawal by Subject|2
4703237|NCT02728206|7620722|FG000|Overall Study|Death|1
4703238|NCT02728830|7620726|FG000|Overall Study|Exclusionary Surgery|9
4703239|NCT02728830|7620726|FG000|Overall Study|Exclusionary Pathology|6
4703240|NCT02728830|7620726|FG000|Overall Study|Physician Decision|3
4703241|NCT02728830|7620726|FG000|Overall Study|Withdrawal by Subject|2
4703242|NCT02728830|7620726|FG000|Overall Study|Lost to Follow-up|1
4703243|NCT02728830|7620726|FG000|Overall Study|Exclusionary Lab Values|1
4703244|NCT02728830|7620726|FG000|Overall Study|Contraindicated Illness|1
4703245|NCT02728830|7620726|FG000|Overall Study|Language Barrier|1
4703246|NCT02728895|7620732|FG000|Overall Study|Other|1
4703247|NCT02728895|7620733|FG001|Overall Study|Other|2
4703248|NCT02728895|7620732|FG000|Overall Study|Withdrawal by Subject|0
4387239|NCT00047385|7165841|FG000|Overall Study|Lung Cancer diagnosed before screening|5
4387240|NCT00047385|7165842|FG001|Overall Study|Lung Cancer diagnosed before screening|3
4703249|NCT02728895|7620733|FG001|Overall Study|Withdrawal by Subject|3
4703250|NCT02729025|7620741|FG000|Overall Study|Sponsor Decision|0
4703251|NCT02729025|7620742|FG001|Overall Study|Sponsor Decision|1
4703252|NCT02729051|7620774|FG000|Overall Study|Adverse Event|21
4703253|NCT02729051|7620775|FG001|Overall Study|Adverse Event|11
4703254|NCT02729051|7620774|FG000|Overall Study|Lack of Efficacy|1
4703255|NCT02729051|7620775|FG001|Overall Study|Lack of Efficacy|1
4703256|NCT02729051|7620774|FG000|Overall Study|Lost to Follow-up|1
4703257|NCT02729051|7620775|FG001|Overall Study|Lost to Follow-up|2
4703258|NCT02729051|7620774|FG000|Overall Study|Physician Decision|1
4703259|NCT02729051|7620775|FG001|Overall Study|Physician Decision|1
4703260|NCT02729051|7620774|FG000|Overall Study|Withdrawal by Subject|6
4703261|NCT02729051|7620775|FG001|Overall Study|Withdrawal by Subject|17
4703262|NCT02729194|7620781|FG000|Overall Study|Withdrawal by Subject|3
4703263|NCT02729545|7620787|FG000|Overall Study|Pregnancy|1
4703264|NCT02729545|7620788|FG001|Overall Study|Pregnancy|1
4703265|NCT02729545|7620787|FG000|Overall Study|Lost to Follow-up|0
4703266|NCT02729545|7620788|FG001|Overall Study|Lost to Follow-up|1
4387241|NCT00047385|7165841|FG000|Overall Study|Eligible for screening but had no screen|260
4703267|NCT02729545|7620787|FG000|Overall Study|Withdrawal by Subject|2
4703268|NCT02729545|7620788|FG001|Overall Study|Withdrawal by Subject|3
4703269|NCT02729740|7620794|FG000|Overall Study|Early Termination|130
4703270|NCT02729740|7620794|FG000|Overall Study|Other|1
4703271|NCT02729831|7620802|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38
4703272|NCT02729831|7620803|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23
4703273|NCT02729831|7620804|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18
4493668|NCT00805207|7296491|FG001|Overall Study|Protocol Violation|0
4493669|NCT00805207|7296492|FG002|Overall Study|Protocol Violation|1
4493670|NCT00805207|7296493|FG003|Overall Study|Protocol Violation|0
4493671|NCT00805207|7296494|FG004|Overall Study|Protocol Violation|0
4493672|NCT00805207|7296495|FG005|Overall Study|Protocol Violation|0
4493673|NCT00805207|7296496|FG006|Overall Study|Protocol Violation|0
4493674|NCT00805207|7296497|FG007|Overall Study|Protocol Violation|0
4493675|NCT00805207|7296498|FG008|Overall Study|Protocol Violation|0
4493676|NCT00805207|7296490|FG000|Overall Study|Physician Decision|0
4493677|NCT00805207|7296491|FG001|Overall Study|Physician Decision|1
4493678|NCT00805207|7296492|FG002|Overall Study|Physician Decision|0
4493679|NCT00805207|7296493|FG003|Overall Study|Physician Decision|0
4493680|NCT00805207|7296494|FG004|Overall Study|Physician Decision|0
4493681|NCT00805207|7296495|FG005|Overall Study|Physician Decision|1
4493682|NCT00805207|7296496|FG006|Overall Study|Physician Decision|0
4493683|NCT00805207|7296497|FG007|Overall Study|Physician Decision|0
4493684|NCT00805207|7296498|FG008|Overall Study|Physician Decision|0
4493685|NCT00805207|7296490|FG000|Overall Study|Withdrawal by Subject|0
4493686|NCT00805207|7296491|FG001|Overall Study|Withdrawal by Subject|1
4493687|NCT00805207|7296492|FG002|Overall Study|Withdrawal by Subject|0
4493688|NCT00805207|7296493|FG003|Overall Study|Withdrawal by Subject|0
4493689|NCT00805207|7296494|FG004|Overall Study|Withdrawal by Subject|1
4493690|NCT00805207|7296495|FG005|Overall Study|Withdrawal by Subject|2
4493691|NCT00805207|7296496|FG006|Overall Study|Withdrawal by Subject|0
4493692|NCT00805207|7296497|FG007|Overall Study|Withdrawal by Subject|0
4493693|NCT00805207|7296498|FG008|Overall Study|Withdrawal by Subject|0
4493694|NCT00805285|7296522|FG000|Overall Study|Lack of Efficacy|1
4493695|NCT00805389|7296531|FG000|Overall Study|Adverse Event|0
4493696|NCT00805389|7296532|FG001|Overall Study|Adverse Event|0
4493697|NCT00805389|7296533|FG002|Overall Study|Adverse Event|1
4493698|NCT00805389|7296534|FG003|Overall Study|Adverse Event|2
4493699|NCT00805389|7296535|FG004|Overall Study|Adverse Event|0
4493700|NCT00805389|7296531|FG000|Overall Study|Lost to Follow-up|4
4493701|NCT00805389|7296532|FG001|Overall Study|Lost to Follow-up|3
4493702|NCT00805389|7296533|FG002|Overall Study|Lost to Follow-up|6
4493703|NCT00805389|7296534|FG003|Overall Study|Lost to Follow-up|10
4493704|NCT00805389|7296535|FG004|Overall Study|Lost to Follow-up|9
4493705|NCT00805389|7296531|FG000|Overall Study|Protocol Violation|0
4493706|NCT00805389|7296532|FG001|Overall Study|Protocol Violation|0
4493707|NCT00805389|7296533|FG002|Overall Study|Protocol Violation|1
4493708|NCT00805389|7296534|FG003|Overall Study|Protocol Violation|0
4493709|NCT00805389|7296535|FG004|Overall Study|Protocol Violation|0
4493710|NCT00805389|7296531|FG000|Overall Study|Withdrawal by Subject|3
4493711|NCT00805389|7296532|FG001|Overall Study|Withdrawal by Subject|2
4493712|NCT00805389|7296533|FG002|Overall Study|Withdrawal by Subject|4
4493713|NCT00805389|7296534|FG003|Overall Study|Withdrawal by Subject|5
4493714|NCT00805389|7296535|FG004|Overall Study|Withdrawal by Subject|4
4493715|NCT00805441|7296559|FG000|Overall Study|Adverse Event|5
4493716|NCT00805441|7296560|FG001|Overall Study|Adverse Event|2
4493717|NCT00805441|7296559|FG000|Overall Study|Lack of Efficacy|0
4493718|NCT00805441|7296560|FG001|Overall Study|Lack of Efficacy|2
4493719|NCT00805441|7296559|FG000|Overall Study|Protocol Violation|4
4493720|NCT00805441|7296560|FG001|Overall Study|Protocol Violation|8
4493721|NCT00805441|7296559|FG000|Overall Study|Lost to Follow-up|10
4493722|NCT00805441|7296560|FG001|Overall Study|Lost to Follow-up|13
4493723|NCT00805441|7296559|FG000|Overall Study|Withdrawal by Subject|15
4493724|NCT00805441|7296560|FG001|Overall Study|Withdrawal by Subject|9
4493725|NCT00805441|7296559|FG000|Overall Study|Physician Decision|0
4493726|NCT00805441|7296560|FG001|Overall Study|Physician Decision|1
4493727|NCT00805441|7296559|FG000|Overall Study|Acute Alcohol Withdrawal|0
4493728|NCT00805441|7296560|FG001|Overall Study|Acute Alcohol Withdrawal|1
4493729|NCT00805467|7296570|FG000|Overall Study|Lack of Efficacy|0
4703274|NCT02729831|7620805|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17
4703275|NCT02729831|7620802|FG000|1 Week Post-visit|Lost to Follow-up|43
4703276|NCT02729831|7620803|FG001|1 Week Post-visit|Lost to Follow-up|40
4703277|NCT02729831|7620804|FG002|1 Week Post-visit|Lost to Follow-up|38
4703278|NCT02729831|7620805|FG003|1 Week Post-visit|Lost to Follow-up|36
4703279|NCT02729831|7620802|FG000|6 Month Follow-up|Lost to Follow-up|54
4703280|NCT02729831|7620803|FG001|6 Month Follow-up|Lost to Follow-up|51
4703281|NCT02729831|7620804|FG002|6 Month Follow-up|Lost to Follow-up|48
4703282|NCT02729831|7620805|FG003|6 Month Follow-up|Lost to Follow-up|42
4703283|NCT02729831|7620802|FG000|6 Month Follow-up|Death|1
4703284|NCT02729831|7620803|FG001|6 Month Follow-up|Death|3
4703285|NCT02729831|7620804|FG002|6 Month Follow-up|Death|0
4703286|NCT02729831|7620805|FG003|6 Month Follow-up|Death|1
4703287|NCT02729896|7620818|FG000|Overall Study|Death|0
4703288|NCT02729896|7620819|FG001|Overall Study|Death|2
4703289|NCT02729896|7620820|FG002|Overall Study|Death|13
4703290|NCT02729896|7620818|FG000|Overall Study|Lost to Follow-up|0
4703291|NCT02729896|7620819|FG001|Overall Study|Lost to Follow-up|2
4703292|NCT02729896|7620820|FG002|Overall Study|Lost to Follow-up|3
4703293|NCT02729896|7620818|FG000|Overall Study|Other|0
4703294|NCT02729896|7620819|FG001|Overall Study|Other|2
4493730|NCT00805467|7296571|FG001|Overall Study|Lack of Efficacy|8
4493731|NCT00805467|7296572|FG002|Overall Study|Lack of Efficacy|13
4493732|NCT00805467|7296573|FG003|Overall Study|Lack of Efficacy|86
4703295|NCT02729896|7620820|FG002|Overall Study|Other|0
4703296|NCT02729896|7620818|FG000|Overall Study|Physician Decision|1
4703297|NCT02729896|7620819|FG001|Overall Study|Physician Decision|2
4703298|NCT02729896|7620820|FG002|Overall Study|Physician Decision|3
4703299|NCT02729896|7620818|FG000|Overall Study|Progressive Disease|0
4703300|NCT02729896|7620819|FG001|Overall Study|Progressive Disease|1
4493733|NCT00805467|7296570|FG000|Overall Study|Lost to Follow-up|0
4493734|NCT00805467|7296571|FG001|Overall Study|Lost to Follow-up|1
4493735|NCT00805467|7296572|FG002|Overall Study|Lost to Follow-up|7
4493736|NCT00805467|7296573|FG003|Overall Study|Lost to Follow-up|21
4493737|NCT00805467|7296570|FG000|Overall Study|Withdrawal by Subject|0
4493738|NCT00805467|7296571|FG001|Overall Study|Withdrawal by Subject|6
4493739|NCT00805467|7296572|FG002|Overall Study|Withdrawal by Subject|45
4493740|NCT00805467|7296573|FG003|Overall Study|Withdrawal by Subject|50
4493741|NCT00805467|7296570|FG000|Overall Study|Protocol Violation|0
4493742|NCT00805467|7296571|FG001|Overall Study|Protocol Violation|3
4493743|NCT00805467|7296572|FG002|Overall Study|Protocol Violation|0
4493744|NCT00805467|7296573|FG003|Overall Study|Protocol Violation|5
4493745|NCT00805467|7296570|FG000|Overall Study|Adverse Event|0
4493746|NCT00805467|7296571|FG001|Overall Study|Adverse Event|13
4493747|NCT00805467|7296572|FG002|Overall Study|Adverse Event|26
4493748|NCT00805467|7296573|FG003|Overall Study|Adverse Event|57
4493749|NCT00805467|7296570|FG000|Overall Study|Death|0
4493750|NCT00805467|7296571|FG001|Overall Study|Death|2
4493751|NCT00805467|7296572|FG002|Overall Study|Death|7
4493752|NCT00805467|7296573|FG003|Overall Study|Death|5
4493753|NCT00805467|7296570|FG000|Overall Study|Physician Decision|0
4493754|NCT00805467|7296571|FG001|Overall Study|Physician Decision|1
4493755|NCT00805467|7296572|FG002|Overall Study|Physician Decision|2
4493756|NCT00805467|7296573|FG003|Overall Study|Physician Decision|6
4493757|NCT00805467|7296570|FG000|Overall Study|Not reported|0
4493758|NCT00805467|7296571|FG001|Overall Study|Not reported|0
4493759|NCT00805467|7296572|FG002|Overall Study|Not reported|3
4493760|NCT00805467|7296573|FG003|Overall Study|Not reported|7
4493761|NCT00805480|7296587|FG000|Overall Study|Withdrawal by Subject|13
4493762|NCT00805480|7296588|FG001|Overall Study|Withdrawal by Subject|5
4493763|NCT00805480|7296589|FG002|Overall Study|Withdrawal by Subject|11
4493764|NCT00805480|7296590|FG003|Overall Study|Withdrawal by Subject|5
4493765|NCT00805480|7296587|FG000|Overall Study|Lost to Follow-up|1
4493766|NCT00805480|7296588|FG001|Overall Study|Lost to Follow-up|2
4493767|NCT00805480|7296589|FG002|Overall Study|Lost to Follow-up|0
4493768|NCT00805480|7296590|FG003|Overall Study|Lost to Follow-up|0
4493769|NCT00805480|7296587|FG000|Overall Study|Adverse Event|0
4493770|NCT00805480|7296588|FG001|Overall Study|Adverse Event|0
4493771|NCT00805480|7296589|FG002|Overall Study|Adverse Event|1
4493772|NCT00805480|7296590|FG003|Overall Study|Adverse Event|0
4493773|NCT00805532|7296618|FG000|Overall Study|invalid data|0
4493774|NCT00805532|7296619|FG001|Overall Study|invalid data|1
4493775|NCT00805545|7296629|FG000|Overall Study|Protocol Violation|3
4493776|NCT00805545|7296630|FG001|Overall Study|Protocol Violation|2
4493777|NCT00805545|7296629|FG000|Overall Study|Protocol Violation|3
4493778|NCT00805545|7296630|FG001|Overall Study|Protocol Violation|1
4493779|NCT00805675|7296639|FG000|Overall Study|Adverse Event|0
4493780|NCT00805675|7296640|FG001|Overall Study|Adverse Event|0
4493781|NCT00805675|7296641|FG002|Overall Study|Adverse Event|1
4493782|NCT00805740|7296651|FG000|Overall Study|Death|7
4493783|NCT00805740|7296652|FG001|Overall Study|Death|4
4493784|NCT00805740|7296651|FG000|Overall Study|Withdrawal by Subject|1
4493785|NCT00805740|7296652|FG001|Overall Study|Withdrawal by Subject|0
4493786|NCT00805740|7296651|FG000|Overall Study|Lost to Follow-up|1
4493787|NCT00805740|7296652|FG001|Overall Study|Lost to Follow-up|0
4493788|NCT00805740|7296651|FG000|Overall Study|Randomized, but not treated|2
4493789|NCT00805740|7296652|FG001|Overall Study|Randomized, but not treated|0
4493790|NCT00805766|7296658|FG000|Screening Period|Adverse Event|1
4493791|NCT00805766|7296658|FG000|Screening Period|Lack of Efficacy|2
4493792|NCT00805766|7296658|FG000|Screening Period|Pregnancy|1
4493793|NCT00805766|7296658|FG000|Screening Period|Responder|2
4493794|NCT00805766|7296658|FG000|Increased Dose Period|Adverse Event|4
4493795|NCT00805766|7296658|FG000|Increased Dose Period|Lack of Efficacy|7
4493796|NCT00805766|7296658|FG000|Increased Dose Period|Pregnancy|1
4493797|NCT00805766|7296658|FG000|Increased Dose Period|Withdrawal by Subject|1
4493798|NCT00805792|7296666|FG000|Overall Study|Death|3
4493799|NCT00805792|7296666|FG000|Overall Study|Lost to Follow-up|2
4493800|NCT00805935|7296683|FG000|Overall Study|Stimulation Failure|1
4493801|NCT00805935|7296684|FG001|Overall Study|Stimulation Failure|5
4493802|NCT00805935|7296685|FG002|Overall Study|Stimulation Failure|2
4493803|NCT00805935|7296686|FG003|Overall Study|Stimulation Failure|2
4493804|NCT00805935|7296683|FG000|Overall Study|Cycle cancelled|0
4493805|NCT00805935|7296684|FG001|Overall Study|Cycle cancelled|0
4493806|NCT00805935|7296685|FG002|Overall Study|Cycle cancelled|2
4493807|NCT00805935|7296686|FG003|Overall Study|Cycle cancelled|0
4493808|NCT00805935|7296683|FG000|Overall Study|Cycle cancellation for risk of OHSS|1
4703301|NCT02729896|7620820|FG002|Overall Study|Progressive Disease|0
4493809|NCT00805935|7296684|FG001|Overall Study|Cycle cancellation for risk of OHSS|0
4703302|NCT02729896|7620818|FG000|Overall Study|Withdrawal by Subject|1
4493810|NCT00805935|7296685|FG002|Overall Study|Cycle cancellation for risk of OHSS|1
4493811|NCT00805935|7296686|FG003|Overall Study|Cycle cancellation for risk of OHSS|0
4493812|NCT00805935|7296683|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
4493813|NCT00805935|7296684|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
4493814|NCT00805935|7296685|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
4493815|NCT00805935|7296686|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1
4493816|NCT00805935|7296683|FG000|Overall Study|Lost to Follow-up|1
4493817|NCT00805935|7296684|FG001|Overall Study|Lost to Follow-up|0
4493818|NCT00805935|7296685|FG002|Overall Study|Lost to Follow-up|0
4493819|NCT00805935|7296686|FG003|Overall Study|Lost to Follow-up|0
4493820|NCT00805935|7296683|FG000|Overall Study|No positive serum pregnancy|8
4493821|NCT00805935|7296684|FG001|Overall Study|No positive serum pregnancy|7
4493822|NCT00805935|7296685|FG002|Overall Study|No positive serum pregnancy|6
4493823|NCT00805935|7296686|FG003|Overall Study|No positive serum pregnancy|5
4493824|NCT00805935|7296683|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0
4493825|NCT00805935|7296684|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0
4493826|NCT00805935|7296685|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0
4493827|NCT00805935|7296686|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1
4493828|NCT00805935|7296683|FG000|Overall Study|Pregnancy loss/miscarriage|2
4493829|NCT00805935|7296684|FG001|Overall Study|Pregnancy loss/miscarriage|0
4493830|NCT00805935|7296685|FG002|Overall Study|Pregnancy loss/miscarriage|0
4493831|NCT00805935|7296686|FG003|Overall Study|Pregnancy loss/miscarriage|0
4493832|NCT00805935|7296683|FG000|Overall Study|Biochemical pregnancy|0
4493833|NCT00805935|7296684|FG001|Overall Study|Biochemical pregnancy|1
4493834|NCT00805935|7296685|FG002|Overall Study|Biochemical pregnancy|0
4493835|NCT00805935|7296686|FG003|Overall Study|Biochemical pregnancy|0
4493836|NCT00805935|7296683|FG000|Overall Study|Chemical pregnancy|0
4493837|NCT00805935|7296684|FG001|Overall Study|Chemical pregnancy|5
4493838|NCT00805935|7296685|FG002|Overall Study|Chemical pregnancy|3
4493839|NCT00805935|7296686|FG003|Overall Study|Chemical pregnancy|2
4493840|NCT00805935|7296683|FG000|Overall Study|Ectopic pregnancy|0
4493841|NCT00805935|7296684|FG001|Overall Study|Ectopic pregnancy|0
4493842|NCT00805935|7296685|FG002|Overall Study|Ectopic pregnancy|1
4493843|NCT00805935|7296686|FG003|Overall Study|Ectopic pregnancy|0
4493844|NCT00805935|7296683|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0
4493845|NCT00805935|7296684|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1
4493846|NCT00805935|7296685|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0
4493847|NCT00805935|7296686|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0
4493848|NCT00806026|7296714|FG000|Overall Study|Death|0
4493849|NCT00806026|7296715|FG001|Overall Study|Death|0
4493850|NCT00806026|7296716|FG002|Overall Study|Death|0
4493851|NCT00806026|7296717|FG003|Overall Study|Death|1
4493852|NCT00806026|7296718|FG004|Overall Study|Death|0
4493853|NCT00806026|7296719|FG005|Overall Study|Death|0
4493854|NCT00806026|7296714|FG000|Overall Study|Did not meet entrance criteria|4
4493855|NCT00806026|7296715|FG001|Overall Study|Did not meet entrance criteria|1
4493856|NCT00806026|7296716|FG002|Overall Study|Did not meet entrance criteria|2
4493857|NCT00806026|7296717|FG003|Overall Study|Did not meet entrance criteria|1
4493858|NCT00806026|7296718|FG004|Overall Study|Did not meet entrance criteria|0
4493859|NCT00806026|7296719|FG005|Overall Study|Did not meet entrance criteria|0
4493860|NCT00806026|7296714|FG000|Overall Study|Lack of Efficacy|5
4493861|NCT00806026|7296715|FG001|Overall Study|Lack of Efficacy|18
4493862|NCT00806026|7296716|FG002|Overall Study|Lack of Efficacy|13
4493863|NCT00806026|7296717|FG003|Overall Study|Lack of Efficacy|4
4493864|NCT00806026|7296718|FG004|Overall Study|Lack of Efficacy|8
4493865|NCT00806026|7296719|FG005|Overall Study|Lack of Efficacy|7
4493866|NCT00806026|7296714|FG000|Overall Study|Lost to Follow-up|8
4493867|NCT00806026|7296715|FG001|Overall Study|Lost to Follow-up|15
4493868|NCT00806026|7296716|FG002|Overall Study|Lost to Follow-up|8
4493869|NCT00806026|7296717|FG003|Overall Study|Lost to Follow-up|2
4493870|NCT00806026|7296718|FG004|Overall Study|Lost to Follow-up|6
4493871|NCT00806026|7296719|FG005|Overall Study|Lost to Follow-up|6
4493872|NCT00806026|7296714|FG000|Overall Study|Withdrawal by Subject|14
4493873|NCT00806026|7296715|FG001|Overall Study|Withdrawal by Subject|17
4493874|NCT00806026|7296716|FG002|Overall Study|Withdrawal by Subject|9
4493875|NCT00806026|7296717|FG003|Overall Study|Withdrawal by Subject|2
4493876|NCT00806026|7296718|FG004|Overall Study|Withdrawal by Subject|5
4493877|NCT00806026|7296719|FG005|Overall Study|Withdrawal by Subject|3
4493878|NCT00806026|7296714|FG000|Overall Study|Other|3
4493879|NCT00806026|7296715|FG001|Overall Study|Other|6
4493880|NCT00806026|7296716|FG002|Overall Study|Other|8
4493881|NCT00806026|7296717|FG003|Overall Study|Other|2
4493882|NCT00806026|7296718|FG004|Overall Study|Other|0
4493883|NCT00806026|7296719|FG005|Overall Study|Other|4
4493884|NCT00806026|7296714|FG000|Overall Study|Protocol Violation|6
4493885|NCT00806026|7296715|FG001|Overall Study|Protocol Violation|9
4493886|NCT00806026|7296716|FG002|Overall Study|Protocol Violation|9
4493887|NCT00806026|7296717|FG003|Overall Study|Protocol Violation|0
4493888|NCT00806026|7296718|FG004|Overall Study|Protocol Violation|2
4493889|NCT00806026|7296719|FG005|Overall Study|Protocol Violation|3
4493890|NCT00806026|7296714|FG000|Overall Study|Adverse Event|52
4493891|NCT00806026|7296715|FG001|Overall Study|Adverse Event|35
4493892|NCT00806026|7296716|FG002|Overall Study|Adverse Event|44
4493893|NCT00806026|7296717|FG003|Overall Study|Adverse Event|17
4493894|NCT00806026|7296718|FG004|Overall Study|Adverse Event|9
4493895|NCT00806026|7296719|FG005|Overall Study|Adverse Event|9
4493896|NCT00806156|7296742|FG000|Overall Study|Death|35
4493897|NCT00806156|7296743|FG001|Overall Study|Death|95
4493898|NCT00806156|7296742|FG000|Overall Study|Did not meet eligibility criteria|1
4493899|NCT00806156|7296743|FG001|Overall Study|Did not meet eligibility criteria|0
4493900|NCT00806156|7296742|FG000|Overall Study|Study terminated by Sponsor|2
4493901|NCT00806156|7296743|FG001|Overall Study|Study terminated by Sponsor|40
4493902|NCT00806156|7296742|FG000|Overall Study|Consent withdrawn by subject|1
4493903|NCT00806156|7296743|FG001|Overall Study|Consent withdrawn by subject|3
4493904|NCT00806156|7296742|FG000|Overall Study|Lost to Follow-up|0
4493905|NCT00806156|7296743|FG001|Overall Study|Lost to Follow-up|1
4703303|NCT02729896|7620819|FG001|Overall Study|Withdrawal by Subject|0
4703304|NCT02729896|7620820|FG002|Overall Study|Withdrawal by Subject|3
4703305|NCT02729909|7620831|FG000|Overall Study|Lost to Follow-up|0
4703306|NCT02729909|7620832|FG001|Overall Study|Lost to Follow-up|1
4703307|NCT02729909|7620831|FG000|Overall Study|Lack of Efficacy|0
4703308|NCT02729909|7620832|FG001|Overall Study|Lack of Efficacy|2
4703309|NCT02729909|7620831|FG000|Overall Study|Significant Protocol Deviation|0
4703310|NCT02729909|7620832|FG001|Overall Study|Significant Protocol Deviation|2
4703311|NCT02729909|7620831|FG000|Overall Study|Voluntary Withdrawal|1
4703312|NCT02729909|7620832|FG001|Overall Study|Voluntary Withdrawal|0
4493906|NCT00806195|7296765|FG000|Overall Study|Death|6
4493907|NCT00806195|7296766|FG001|Overall Study|Death|0
4493908|NCT00806195|7296767|FG002|Overall Study|Death|1
4493909|NCT00806195|7296768|FG003|Overall Study|Death|0
4493910|NCT00806195|7296765|FG000|Overall Study|Adverse Event|25
4493911|NCT00806195|7296766|FG001|Overall Study|Adverse Event|5
4493912|NCT00806195|7296767|FG002|Overall Study|Adverse Event|11
4493913|NCT00806195|7296768|FG003|Overall Study|Adverse Event|2
4493914|NCT00806195|7296765|FG000|Overall Study|Withdrawal by Subject|119
4493915|NCT00806195|7296766|FG001|Overall Study|Withdrawal by Subject|31
4493916|NCT00806195|7296767|FG002|Overall Study|Withdrawal by Subject|76
4493917|NCT00806195|7296768|FG003|Overall Study|Withdrawal by Subject|35
4493918|NCT00806195|7296765|FG000|Overall Study|Lost to Follow-up|217
4493919|NCT00806195|7296766|FG001|Overall Study|Lost to Follow-up|66
4493920|NCT00806195|7296767|FG002|Overall Study|Lost to Follow-up|90
4493921|NCT00806195|7296768|FG003|Overall Study|Lost to Follow-up|34
4493922|NCT00806195|7296765|FG000|Overall Study|Inappropriate Enrollment|0
4493923|NCT00806195|7296766|FG001|Overall Study|Inappropriate Enrollment|1
4493924|NCT00806195|7296767|FG002|Overall Study|Inappropriate Enrollment|0
4493925|NCT00806195|7296768|FG003|Overall Study|Inappropriate Enrollment|0
4493926|NCT00806195|7296765|FG000|Overall Study|Administrative Reason|113
4493927|NCT00806195|7296766|FG001|Overall Study|Administrative Reason|35
4493928|NCT00806195|7296767|FG002|Overall Study|Administrative Reason|66
4493929|NCT00806195|7296768|FG003|Overall Study|Administrative Reason|26
4493930|NCT00806195|7296765|FG000|Overall Study|Protocol Violation|34
4493931|NCT00806195|7296766|FG001|Overall Study|Protocol Violation|24
4493932|NCT00806195|7296767|FG002|Overall Study|Protocol Violation|26
4493933|NCT00806195|7296768|FG003|Overall Study|Protocol Violation|9
4493934|NCT00806260|7296803|FG000|Period 1 (1 Day)|Adverse Event|0
4493935|NCT00806260|7296804|FG001|Period 1 (1 Day)|Adverse Event|0
4493936|NCT00806260|7296805|FG002|Period 1 (1 Day)|Adverse Event|0
4493937|NCT00806260|7296806|FG003|Period 1 (1 Day)|Adverse Event|0
4493938|NCT00806260|7296807|FG004|Period 1 (1 Day)|Adverse Event|3
4493939|NCT00806260|7296808|FG005|Period 1 (1 Day)|Adverse Event|0
4493940|NCT00806260|7296803|FG000|Period 2|Adverse Event|0
4493941|NCT00806260|7296804|FG001|Period 2|Adverse Event|0
4493942|NCT00806260|7296805|FG002|Period 2|Adverse Event|0
4493943|NCT00806260|7296806|FG003|Period 2|Adverse Event|1
4493944|NCT00806260|7296807|FG004|Period 2|Adverse Event|0
4493945|NCT00806260|7296808|FG005|Period 2|Adverse Event|0
4493946|NCT00806260|7296803|FG000|Period 2|Protocol Violation|1
4493947|NCT00806260|7296804|FG001|Period 2|Protocol Violation|0
4493948|NCT00806260|7296805|FG002|Period 2|Protocol Violation|1
4493949|NCT00806260|7296806|FG003|Period 2|Protocol Violation|0
4493950|NCT00806260|7296807|FG004|Period 2|Protocol Violation|0
4493951|NCT00806260|7296808|FG005|Period 2|Protocol Violation|0
4493952|NCT00806260|7296803|FG000|Period 2|Need to take concomitant medication|1
4493953|NCT00806260|7296804|FG001|Period 2|Need to take concomitant medication|0
4493954|NCT00806260|7296805|FG002|Period 2|Need to take concomitant medication|0
4493955|NCT00806260|7296806|FG003|Period 2|Need to take concomitant medication|0
4493956|NCT00806260|7296807|FG004|Period 2|Need to take concomitant medication|0
4493957|NCT00806260|7296808|FG005|Period 2|Need to take concomitant medication|0
4493958|NCT00806260|7296803|FG000|Period 2|sponsor request|0
4493959|NCT00806260|7296804|FG001|Period 2|sponsor request|0
4493960|NCT00806260|7296805|FG002|Period 2|sponsor request|1
4493961|NCT00806260|7296806|FG003|Period 2|sponsor request|1
4493962|NCT00806260|7296807|FG004|Period 2|sponsor request|0
4493963|NCT00806260|7296808|FG005|Period 2|sponsor request|0
4493964|NCT00806260|7296803|FG000|Period 3|Protocol Violation|0
4493965|NCT00806260|7296804|FG001|Period 3|Protocol Violation|1
4493966|NCT00806260|7296805|FG002|Period 3|Protocol Violation|1
4493967|NCT00806260|7296806|FG003|Period 3|Protocol Violation|0
4493968|NCT00806260|7296807|FG004|Period 3|Protocol Violation|0
4703313|NCT02730169|7620842|FG000|Overall Study|Protocol Violation|1
4703314|NCT02730169|7620843|FG001|Overall Study|Protocol Violation|0
4703315|NCT02730169|7620844|FG002|Overall Study|Protocol Violation|0
4703316|NCT02730169|7620845|FG003|Overall Study|Protocol Violation|1
4703317|NCT02730169|7620842|FG000|Overall Study|Adverse Event|2
4703318|NCT02730169|7620843|FG001|Overall Study|Adverse Event|3
4703319|NCT02730169|7620844|FG002|Overall Study|Adverse Event|3
4703320|NCT02730169|7620845|FG003|Overall Study|Adverse Event|0
4703321|NCT02730169|7620842|FG000|Overall Study|Adverse Event of Special Interest|0
4703322|NCT02730169|7620843|FG001|Overall Study|Adverse Event of Special Interest|1
4703323|NCT02730169|7620844|FG002|Overall Study|Adverse Event of Special Interest|2
4703324|NCT02730169|7620845|FG003|Overall Study|Adverse Event of Special Interest|0
4703325|NCT02730169|7620842|FG000|Overall Study|Withdrawal by Subject|6
4703326|NCT02730169|7620843|FG001|Overall Study|Withdrawal by Subject|11
4703327|NCT02730169|7620844|FG002|Overall Study|Withdrawal by Subject|6
4703328|NCT02730169|7620845|FG003|Overall Study|Withdrawal by Subject|8
4703329|NCT02730169|7620842|FG000|Overall Study|Lost to Follow-up|5
4703330|NCT02730169|7620843|FG001|Overall Study|Lost to Follow-up|6
4703331|NCT02730169|7620844|FG002|Overall Study|Lost to Follow-up|5
4703332|NCT02730169|7620845|FG003|Overall Study|Lost to Follow-up|6
4703333|NCT02730169|7620842|FG000|Overall Study|Other|0
4703334|NCT02730169|7620843|FG001|Overall Study|Other|0
4703335|NCT02730169|7620844|FG002|Overall Study|Other|1
4703336|NCT02730169|7620845|FG003|Overall Study|Other|1
4703337|NCT02730195|7620855|FG000|Overall Study|Withdrawal by Subject|1
4703338|NCT02730208|7620861|FG000|Overall Study|Withdrawal of consent (not due to AE)|0
4703339|NCT02730208|7620862|FG001|Overall Study|Withdrawal of consent (not due to AE)|1
4703340|NCT02730351|7620885|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1
4703341|NCT02730351|7620886|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0
4703342|NCT02730351|7620885|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0
4703343|NCT02730351|7620886|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1
4703344|NCT02730351|7620885|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1
4703345|NCT02730351|7620886|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0
4703346|NCT02730351|7620885|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1
4703347|NCT02730351|7620886|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0
4703348|NCT02730351|7620885|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1
4703349|NCT02730351|7620886|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0
4703350|NCT02730377|7620894|FG000|Overall Study|Other|5
4703351|NCT02730377|7620895|FG001|Overall Study|Other|4
4703352|NCT02730377|7620894|FG000|Overall Study|Death|1
4703353|NCT02730377|7620895|FG001|Overall Study|Death|8
4703354|NCT02730377|7620894|FG000|Overall Study|Inadequate glycaemic control|368
4703355|NCT02730377|7620895|FG001|Overall Study|Inadequate glycaemic control|473
4703356|NCT02730377|7620894|FG000|Overall Study|Adverse Event|79
4703357|NCT02730377|7620895|FG001|Overall Study|Adverse Event|41
4703358|NCT02730377|7620894|FG000|Overall Study|Protocol Violation|23
4703359|NCT02730377|7620895|FG001|Overall Study|Protocol Violation|30
4703360|NCT02730377|7620894|FG000|Overall Study|Lack of Efficacy|4
4703361|NCT02730377|7620895|FG001|Overall Study|Lack of Efficacy|13
4703362|NCT02730377|7620894|FG000|Overall Study|Pregnancy|0
4703363|NCT02730377|7620895|FG001|Overall Study|Pregnancy|1
4703364|NCT02730377|7620894|FG000|Overall Study|Withdrawal by Subject|45
4703365|NCT02730377|7620895|FG001|Overall Study|Withdrawal by Subject|42
4703366|NCT02730377|7620894|FG000|Overall Study|Lost to Follow-up|25
4703367|NCT02730377|7620895|FG001|Overall Study|Lost to Follow-up|21
4703368|NCT02730455|7620909|FG000|Overall Study|Death|5
4703369|NCT02730455|7620910|FG001|Overall Study|Death|6
4703370|NCT02730455|7620911|FG002|Overall Study|Death|4
4493969|NCT00806260|7296808|FG005|Period 3|Protocol Violation|0
4493970|NCT00806260|7296803|FG000|Period 3|Pregnancy|1
4493971|NCT00806260|7296804|FG001|Period 3|Pregnancy|0
4493972|NCT00806260|7296805|FG002|Period 3|Pregnancy|0
4493973|NCT00806260|7296806|FG003|Period 3|Pregnancy|0
4493974|NCT00806260|7296807|FG004|Period 3|Pregnancy|0
4493975|NCT00806260|7296808|FG005|Period 3|Pregnancy|0
4493976|NCT00806286|7296823|FG000|Overall Study|Adverse Event|5
4493977|NCT00806286|7296824|FG001|Overall Study|Adverse Event|2
4493978|NCT00806286|7296825|FG002|Overall Study|Adverse Event|0
4493979|NCT00806286|7296823|FG000|Overall Study|Disease progression|31
4493980|NCT00806286|7296824|FG001|Overall Study|Disease progression|38
4493981|NCT00806286|7296825|FG002|Overall Study|Disease progression|1
4493982|NCT00806286|7296823|FG000|Overall Study|Death|1
4493983|NCT00806286|7296824|FG001|Overall Study|Death|6
4493984|NCT00806286|7296825|FG002|Overall Study|Death|0
4493985|NCT00806286|7296823|FG000|Overall Study|Lost to Follow-up|0
4493986|NCT00806286|7296824|FG001|Overall Study|Lost to Follow-up|1
4493987|NCT00806286|7296825|FG002|Overall Study|Lost to Follow-up|0
4493988|NCT00806286|7296823|FG000|Overall Study|Withdrawal by Subject|8
4493989|NCT00806286|7296824|FG001|Overall Study|Withdrawal by Subject|3
4493990|NCT00806286|7296825|FG002|Overall Study|Withdrawal by Subject|1
4493991|NCT00806286|7296823|FG000|Overall Study|Physician Decision|2
4493992|NCT00806286|7296824|FG001|Overall Study|Physician Decision|2
4493993|NCT00806286|7296825|FG002|Overall Study|Physician Decision|0
4493994|NCT00806286|7296823|FG000|Overall Study|Due to a variety of reasons|7
4703371|NCT02730455|7620909|FG000|Overall Study|Consent withdrawn|2
4703372|NCT02730455|7620910|FG001|Overall Study|Consent withdrawn|4
4493995|NCT00806286|7296824|FG001|Overall Study|Due to a variety of reasons|2
4493996|NCT00806286|7296825|FG002|Overall Study|Due to a variety of reasons|1
4493997|NCT00806351|7296835|FG000|Overall Study|Death|5
4493998|NCT00806351|7296836|FG001|Overall Study|Death|4
4493999|NCT00806442|7296842|FG000|Overall Study|Lost to Follow-up|3
4494000|NCT00806442|7296843|FG001|Overall Study|Lost to Follow-up|2
4494001|NCT00806442|7296842|FG000|Overall Study|Withdrawal by Subject|1
4494002|NCT00806442|7296843|FG001|Overall Study|Withdrawal by Subject|5
4494003|NCT00806494|7296851|FG000|Overall Study|Adverse Event|29
4494004|NCT00806494|7296851|FG000|Overall Study|Lack of Efficacy|6
4494005|NCT00806494|7296851|FG000|Overall Study|Lost to Follow-up|10
4494006|NCT00806494|7296851|FG000|Overall Study|Other|30
4494007|NCT00806494|7296851|FG000|Overall Study|Withdrawal by Subject|5
4494008|NCT00806546|7296856|FG000|Overall Study|Enrolled, not treated|35
4494009|NCT00806546|7296856|FG000|Overall Study|Lost to Follow-up|32
4494010|NCT00806546|7296856|FG000|Overall Study|Adverse Event|74
4494011|NCT00806546|7296856|FG000|Overall Study|Withdrawal by Subject|75
4494012|NCT00806546|7296856|FG000|Overall Study|Protocol Violation|49
4494013|NCT00806546|7296856|FG000|Overall Study|Various|42
4494014|NCT00806585|7296865|FG000|Overall Study|Study terminated by Sponsor|0
4494015|NCT00806585|7296866|FG001|Overall Study|Study terminated by Sponsor|0
4494016|NCT00806585|7296867|FG002|Overall Study|Study terminated by Sponsor|1
4494017|NCT00806585|7296868|FG003|Overall Study|Study terminated by Sponsor|2
4494018|NCT00806585|7296869|FG004|Overall Study|Study terminated by Sponsor|0
4494019|NCT00806585|7296865|FG000|Overall Study|Protocol Violation|3
4494020|NCT00806585|7296866|FG001|Overall Study|Protocol Violation|1
4494021|NCT00806585|7296867|FG002|Overall Study|Protocol Violation|2
4494022|NCT00806585|7296868|FG003|Overall Study|Protocol Violation|0
4494023|NCT00806585|7296869|FG004|Overall Study|Protocol Violation|0
4494024|NCT00806585|7296865|FG000|Overall Study|Physician Decision|0
4494025|NCT00806585|7296866|FG001|Overall Study|Physician Decision|2
4494026|NCT00806585|7296867|FG002|Overall Study|Physician Decision|3
4494027|NCT00806585|7296868|FG003|Overall Study|Physician Decision|0
4494028|NCT00806585|7296869|FG004|Overall Study|Physician Decision|1
4494029|NCT00806585|7296865|FG000|Overall Study|Lost to Follow-up|2
4494030|NCT00806585|7296866|FG001|Overall Study|Lost to Follow-up|1
4494031|NCT00806585|7296867|FG002|Overall Study|Lost to Follow-up|2
4494032|NCT00806585|7296868|FG003|Overall Study|Lost to Follow-up|2
4494033|NCT00806585|7296869|FG004|Overall Study|Lost to Follow-up|5
4494034|NCT00806585|7296865|FG000|Overall Study|Lack of Efficacy|1
4494035|NCT00806585|7296866|FG001|Overall Study|Lack of Efficacy|0
4494036|NCT00806585|7296867|FG002|Overall Study|Lack of Efficacy|0
4494037|NCT00806585|7296868|FG003|Overall Study|Lack of Efficacy|0
4494038|NCT00806585|7296869|FG004|Overall Study|Lack of Efficacy|0
4494039|NCT00806585|7296865|FG000|Overall Study|Adverse Event|1
4494040|NCT00806585|7296866|FG001|Overall Study|Adverse Event|5
4494041|NCT00806585|7296867|FG002|Overall Study|Adverse Event|3
4494042|NCT00806585|7296868|FG003|Overall Study|Adverse Event|4
4494043|NCT00806585|7296869|FG004|Overall Study|Adverse Event|2
4494044|NCT00806585|7296865|FG000|Overall Study|Withdrawal by Subject|10
4494045|NCT00806585|7296866|FG001|Overall Study|Withdrawal by Subject|8
4494046|NCT00806585|7296867|FG002|Overall Study|Withdrawal by Subject|9
4494047|NCT00806585|7296868|FG003|Overall Study|Withdrawal by Subject|3
4494048|NCT00806585|7296869|FG004|Overall Study|Withdrawal by Subject|11
4494049|NCT00806585|7296865|FG000|Overall Study|Completion status unknown|15
4494050|NCT00806585|7296866|FG001|Overall Study|Completion status unknown|14
4494051|NCT00806585|7296867|FG002|Overall Study|Completion status unknown|12
4494052|NCT00806585|7296868|FG003|Overall Study|Completion status unknown|4
4494053|NCT00806585|7296869|FG004|Overall Study|Completion status unknown|12
4494054|NCT00806624|7296888|FG000|Overall Study|Adverse Event|2
4494055|NCT00806624|7296889|FG001|Overall Study|Adverse Event|8
4494056|NCT00806624|7296890|FG002|Overall Study|Adverse Event|0
4494057|NCT00806624|7296888|FG000|Overall Study|Death|0
4494058|NCT00806624|7296889|FG001|Overall Study|Death|1
4494059|NCT00806624|7296890|FG002|Overall Study|Death|1
4494060|NCT00806624|7296888|FG000|Overall Study|Lost to Follow-up|1
4494061|NCT00806624|7296889|FG001|Overall Study|Lost to Follow-up|0
4494062|NCT00806624|7296890|FG002|Overall Study|Lost to Follow-up|1
4494063|NCT00806624|7296888|FG000|Overall Study|Withdrawal by Subject|6
4494064|NCT00806624|7296889|FG001|Overall Study|Withdrawal by Subject|3
4494065|NCT00806624|7296890|FG002|Overall Study|Withdrawal by Subject|3
4494066|NCT00806624|7296888|FG000|Overall Study|discontinued before start of treatment|0
4494067|NCT00806624|7296889|FG001|Overall Study|discontinued before start of treatment|0
4494068|NCT00806624|7296890|FG002|Overall Study|discontinued before start of treatment|1
4494069|NCT00806819|7296914|FG000|Overall Study|progressive disease (modified RECIST )|217
4494070|NCT00806819|7296915|FG001|Overall Study|progressive disease (modified RECIST )|216
4494071|NCT00806819|7296914|FG000|Overall Study|Worsening or AE of underlying disease|18
4494072|NCT00806819|7296915|FG001|Overall Study|Worsening or AE of underlying disease|25
4494073|NCT00806819|7296914|FG000|Overall Study|Other AE|38
4494074|NCT00806819|7296915|FG001|Overall Study|Other AE|40
4494075|NCT00806819|7296914|FG000|Overall Study|Protocol Violation|9
4494076|NCT00806819|7296915|FG001|Overall Study|Protocol Violation|4
4494077|NCT00806819|7296914|FG000|Overall Study|Lost to Follow-up|1
4494078|NCT00806819|7296915|FG001|Overall Study|Lost to Follow-up|0
4494079|NCT00806819|7296914|FG000|Overall Study|Withdrawal by Subject|32
4494080|NCT00806819|7296915|FG001|Overall Study|Withdrawal by Subject|29
4494081|NCT00806819|7296914|FG000|Overall Study|Not treated|6
4494082|NCT00806819|7296915|FG001|Overall Study|Not treated|3
4494083|NCT00806819|7296914|FG000|Overall Study|Reasons other than stated above|25
4494084|NCT00806819|7296915|FG001|Overall Study|Reasons other than stated above|41
4494085|NCT00806988|7296924|FG000|Overall Study|Death|15
4494086|NCT00806988|7296925|FG001|Overall Study|Death|16
4494087|NCT00806988|7296924|FG000|Overall Study|Withdrawal by Subject|8
4494088|NCT00806988|7296925|FG001|Overall Study|Withdrawal by Subject|8
4494089|NCT00806988|7296924|FG000|Overall Study|Lost to Follow-up|4
4494090|NCT00806988|7296925|FG001|Overall Study|Lost to Follow-up|19
4494091|NCT00807001|7296936|FG000|Overall Study|Non-compliance|0
4494092|NCT00807001|7296937|FG001|Overall Study|Non-compliance|1
4494093|NCT00807001|7296938|FG002|Overall Study|Non-compliance|0
4494094|NCT00807001|7296939|FG003|Overall Study|Non-compliance|0
4494095|NCT00807001|7296940|FG004|Overall Study|Non-compliance|0
4494096|NCT00807014|7296954|FG000|Overall Study|Participant Considered Disease Cured|13
4494097|NCT00807014|7296955|FG001|Overall Study|Participant Considered Disease Cured|2
4494098|NCT00807014|7296954|FG000|Overall Study|Participant Considered Disease Not Cured|2
4494099|NCT00807014|7296955|FG001|Overall Study|Participant Considered Disease Not Cured|7
4494100|NCT00807014|7296954|FG000|Overall Study|Protocol Violation|2
4494101|NCT00807014|7296955|FG001|Overall Study|Protocol Violation|8
4494102|NCT00807014|7296954|FG000|Overall Study|Adverse Event|0
4494103|NCT00807014|7296955|FG001|Overall Study|Adverse Event|2
4494104|NCT00807014|7296954|FG000|Overall Study|Lost to Follow-up|9
4494105|NCT00807014|7296955|FG001|Overall Study|Lost to Follow-up|7
4494106|NCT00807014|7296954|FG000|Overall Study|Recovery|1
4494107|NCT00807014|7296955|FG001|Overall Study|Recovery|0
4494108|NCT00807014|7296954|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0
4494109|NCT00807014|7296955|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1
4494110|NCT00807040|7296963|FG000|Overall Study|Death|24
4494111|NCT00807040|7296964|FG001|Overall Study|Death|29
4494112|NCT00807040|7296963|FG000|Overall Study|Withdrawal by Subject|8
4494113|NCT00807040|7296964|FG001|Overall Study|Withdrawal by Subject|6
4494114|NCT00807040|7296963|FG000|Overall Study|Lost to Follow-up|4
4494115|NCT00807040|7296964|FG001|Overall Study|Lost to Follow-up|6
4494116|NCT00807092|7296972|FG000|Overall Study|Adverse Event|0
4494117|NCT00807092|7296973|FG001|Overall Study|Adverse Event|1
4494118|NCT00807092|7296972|FG000|Overall Study|Protocol Violation|0
4494119|NCT00807092|7296973|FG001|Overall Study|Protocol Violation|2
4494120|NCT00807092|7296972|FG000|Overall Study|Withdrawal by Subject|1
4494121|NCT00807092|7296973|FG001|Overall Study|Withdrawal by Subject|0
4494122|NCT00807092|7296972|FG000|Overall Study|CGMS data collection failed|0
4494123|NCT00807092|7296973|FG001|Overall Study|CGMS data collection failed|1
4494124|NCT00807144|7296981|FG000|Overall Study|Lost to Follow-up|0
4494125|NCT00807144|7296982|FG001|Overall Study|Lost to Follow-up|1
4494126|NCT00807235|7297003|FG000|Overall Study|Adverse Event|1
4494127|NCT00807235|7297004|FG001|Overall Study|Adverse Event|0
4494128|NCT00807248|7297014|FG000|Overall Study|Adverse Event|1
4494129|NCT00807248|7297015|FG001|Overall Study|Adverse Event|2
4494130|NCT00807248|7297016|FG002|Overall Study|Adverse Event|2
4494131|NCT00807248|7297017|FG003|Overall Study|Adverse Event|6
4494132|NCT00807248|7297014|FG000|Overall Study|Lack of Efficacy|14
4494133|NCT00807248|7297015|FG001|Overall Study|Lack of Efficacy|4
4494134|NCT00807248|7297016|FG002|Overall Study|Lack of Efficacy|8
4494135|NCT00807248|7297017|FG003|Overall Study|Lack of Efficacy|3
4494136|NCT00807248|7297014|FG000|Overall Study|Protocol Violation|0
4494137|NCT00807248|7297015|FG001|Overall Study|Protocol Violation|1
4494138|NCT00807248|7297016|FG002|Overall Study|Protocol Violation|1
4494139|NCT00807248|7297017|FG003|Overall Study|Protocol Violation|0
4494140|NCT00807248|7297014|FG000|Overall Study|Withdrawal of Consent|5
4494141|NCT00807248|7297015|FG001|Overall Study|Withdrawal of Consent|5
4494142|NCT00807248|7297016|FG002|Overall Study|Withdrawal of Consent|5
4494143|NCT00807248|7297017|FG003|Overall Study|Withdrawal of Consent|5
4494144|NCT00807248|7297014|FG000|Overall Study|Lost to Follow-up|1
4494145|NCT00807248|7297015|FG001|Overall Study|Lost to Follow-up|0
4494146|NCT00807248|7297016|FG002|Overall Study|Lost to Follow-up|0
4494147|NCT00807248|7297017|FG003|Overall Study|Lost to Follow-up|0
4494148|NCT00807248|7297014|FG000|Overall Study|Other Reason|0
4494149|NCT00807248|7297015|FG001|Overall Study|Other Reason|0
4494150|NCT00807248|7297016|FG002|Overall Study|Other Reason|2
4494151|NCT00807248|7297017|FG003|Overall Study|Other Reason|0
4494152|NCT00807495|7297036|FG000|Overall Study|Adverse Event|6
4494153|NCT00807495|7297037|FG001|Overall Study|Adverse Event|3
4494154|NCT00807495|7297038|FG002|Overall Study|Adverse Event|1
4494155|NCT00807495|7297039|FG003|Overall Study|Adverse Event|1
4494156|NCT00807495|7297040|FG004|Overall Study|Adverse Event|2
4494157|NCT00807495|7297036|FG000|Overall Study|Withdrawal by Patient|2
4494158|NCT00807495|7297037|FG001|Overall Study|Withdrawal by Patient|0
4494159|NCT00807495|7297038|FG002|Overall Study|Withdrawal by Patient|1
4494160|NCT00807495|7297039|FG003|Overall Study|Withdrawal by Patient|0
4494161|NCT00807495|7297040|FG004|Overall Study|Withdrawal by Patient|0
4494162|NCT00807495|7297036|FG000|Overall Study|Reason Not Specified|0
4494163|NCT00807495|7297037|FG001|Overall Study|Reason Not Specified|3
4494164|NCT00807495|7297038|FG002|Overall Study|Reason Not Specified|2
4494165|NCT00807495|7297039|FG003|Overall Study|Reason Not Specified|0
4494166|NCT00807495|7297040|FG004|Overall Study|Reason Not Specified|3
4494167|NCT00807573|7297061|FG000|Overall Study|Withdrawal by Subject|1
4494168|NCT00807573|7297061|FG000|Overall Study|Adverse Event|1
4494169|NCT00807599|7297076|FG000|Overall Study|Not treated on protocol study|0
4494170|NCT00807599|7297077|FG001|Overall Study|Not treated on protocol study|0
4494171|NCT00807599|7297078|FG002|Overall Study|Not treated on protocol study|2
4494172|NCT00807599|7297076|FG000|Overall Study|Adverse Event|0
4494173|NCT00807599|7297077|FG001|Overall Study|Adverse Event|0
4494174|NCT00807599|7297078|FG002|Overall Study|Adverse Event|5
4494175|NCT00807599|7297076|FG000|Overall Study|Inadequate response to induction|0
4494176|NCT00807599|7297077|FG001|Overall Study|Inadequate response to induction|0
4494177|NCT00807599|7297078|FG002|Overall Study|Inadequate response to induction|9
4494178|NCT00807599|7297076|FG000|Overall Study|Withdrawal by Subject|0
4494179|NCT00807599|7297077|FG001|Overall Study|Withdrawal by Subject|0
4494180|NCT00807599|7297078|FG002|Overall Study|Withdrawal by Subject|1
4494181|NCT00807742|7297096|FG000|Overall Study|Death|9
4494182|NCT00807742|7297097|FG001|Overall Study|Death|2
4494183|NCT00807742|7297096|FG000|Overall Study|Withdrawal by Subject|2
4494184|NCT00807742|7297097|FG001|Overall Study|Withdrawal by Subject|1
4494185|NCT00807742|7297096|FG000|Overall Study|Lost to Follow-up|35
4494186|NCT00807742|7297097|FG001|Overall Study|Lost to Follow-up|51
4494187|NCT00807846|7297114|FG000|Overall Study|Adverse Event|5
4494188|NCT00807846|7297115|FG001|Overall Study|Adverse Event|0
4494189|NCT00807846|7297114|FG000|Overall Study|Lack of Efficacy|2
4494190|NCT00807846|7297115|FG001|Overall Study|Lack of Efficacy|0
4494191|NCT00807846|7297114|FG000|Overall Study|Protocol Violation|2
4494192|NCT00807846|7297115|FG001|Overall Study|Protocol Violation|1
4494193|NCT00807846|7297114|FG000|Overall Study|Withdrawal by Subject|2
4494194|NCT00807846|7297115|FG001|Overall Study|Withdrawal by Subject|1
4494195|NCT00807846|7297114|FG000|Overall Study|Other|1
4494196|NCT00807846|7297115|FG001|Overall Study|Other|2
4494197|NCT00807885|7297130|FG000|Overall Study|Lost to Follow-up|0
4494198|NCT00807885|7297131|FG001|Overall Study|Lost to Follow-up|0
4494199|NCT00807885|7297132|FG002|Overall Study|Lost to Follow-up|0
4494200|NCT00807885|7297133|FG003|Overall Study|Lost to Follow-up|0
4494201|NCT00807885|7297134|FG004|Overall Study|Lost to Follow-up|0
4494202|NCT00807885|7297135|FG005|Overall Study|Lost to Follow-up|1
4494203|NCT00807885|7297136|FG006|Overall Study|Lost to Follow-up|0
4494204|NCT00807885|7297137|FG007|Overall Study|Lost to Follow-up|0
4494205|NCT00807885|7297138|FG008|Overall Study|Lost to Follow-up|0
4494206|NCT00807937|7297162|FG000|Overall Study|Adverse Event|12
4494207|NCT00807937|7297163|FG001|Overall Study|Adverse Event|12
4494208|NCT00807937|7297164|FG002|Overall Study|Adverse Event|5
4494209|NCT00807937|7297165|FG003|Overall Study|Adverse Event|4
4494210|NCT00807937|7297162|FG000|Overall Study|Protocol Violation|4
4494211|NCT00807937|7297163|FG001|Overall Study|Protocol Violation|5
4494212|NCT00807937|7297164|FG002|Overall Study|Protocol Violation|3
4494213|NCT00807937|7297165|FG003|Overall Study|Protocol Violation|3
4494214|NCT00807937|7297162|FG000|Overall Study|Withdrawal by Subject|5
4494215|NCT00807937|7297163|FG001|Overall Study|Withdrawal by Subject|4
4494216|NCT00807937|7297164|FG002|Overall Study|Withdrawal by Subject|1
4494217|NCT00807937|7297165|FG003|Overall Study|Withdrawal by Subject|4
4494218|NCT00807937|7297162|FG000|Overall Study|Lost to Follow-up|4
4494219|NCT00807937|7297163|FG001|Overall Study|Lost to Follow-up|0
4494220|NCT00807937|7297164|FG002|Overall Study|Lost to Follow-up|2
4494221|NCT00807937|7297165|FG003|Overall Study|Lost to Follow-up|1
4494222|NCT00807937|7297162|FG000|Overall Study|Lack of Efficacy|0
4494223|NCT00807937|7297163|FG001|Overall Study|Lack of Efficacy|0
4494224|NCT00807937|7297164|FG002|Overall Study|Lack of Efficacy|1
4494225|NCT00807937|7297165|FG003|Overall Study|Lack of Efficacy|2
4494226|NCT00807937|7297162|FG000|Overall Study|Intake of prohibited medicine|0
4494227|NCT00807937|7297163|FG001|Overall Study|Intake of prohibited medicine|0
4494228|NCT00807937|7297164|FG002|Overall Study|Intake of prohibited medicine|2
4494229|NCT00807937|7297165|FG003|Overall Study|Intake of prohibited medicine|0
4494230|NCT00807937|7297162|FG000|Overall Study|All other reasons (not provided)|2
4494231|NCT00807937|7297163|FG001|Overall Study|All other reasons (not provided)|4
4494232|NCT00807937|7297164|FG002|Overall Study|All other reasons (not provided)|0
4494233|NCT00807937|7297165|FG003|Overall Study|All other reasons (not provided)|1
4494234|NCT00808015|7297184|FG000|Overall Study|Death|1
4494235|NCT00808015|7297184|FG000|Overall Study|Lack of Efficacy|58
4494236|NCT00808015|7297184|FG000|Overall Study|Lost to Follow-up|76
4494237|NCT00808015|7297184|FG000|Overall Study|Participants not willing to participate|158
4590287|NCT01519817|7436097|FG001|Overall Study|Withdrawal by Subject|0
4590288|NCT01519817|7436098|FG002|Overall Study|Withdrawal by Subject|0
4590289|NCT01519817|7436099|FG003|Overall Study|Withdrawal by Subject|0
4590290|NCT01519817|7436096|FG000|Overall Study|Off study due to infection|0
4590291|NCT01519817|7436097|FG001|Overall Study|Off study due to infection|0
4590292|NCT01519817|7436098|FG002|Overall Study|Off study due to infection|0
4494238|NCT00808015|7297184|FG000|Overall Study|Adverse Event|22
4494239|NCT00808015|7297184|FG000|Overall Study|Other|25
4494240|NCT00808015|7297184|FG000|Overall Study|Enrolled but not treated|4
4494241|NCT00808028|7297192|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3
4494242|NCT00808028|7297193|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0
4590293|NCT01519817|7436099|FG003|Overall Study|Off study due to infection|1
4494243|NCT00808028|7297194|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2
4494244|NCT00808028|7297195|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5
4494245|NCT00808028|7297192|FG000|Stage 1 (6 Months)|Other|1
4494246|NCT00808028|7297193|FG001|Stage 1 (6 Months)|Other|0
4494247|NCT00808028|7297194|FG002|Stage 1 (6 Months)|Other|2
4494248|NCT00808028|7297195|FG003|Stage 1 (6 Months)|Other|4
4494249|NCT00808028|7297192|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0
4494250|NCT00808028|7297193|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1
4494251|NCT00808028|7297194|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1
4494252|NCT00808028|7297195|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3
4494253|NCT00808028|7297192|FG000|Stage 1 (6 Months)|Adverse Event|0
4494254|NCT00808028|7297193|FG001|Stage 1 (6 Months)|Adverse Event|0
4494255|NCT00808028|7297194|FG002|Stage 1 (6 Months)|Adverse Event|1
4494256|NCT00808028|7297195|FG003|Stage 1 (6 Months)|Adverse Event|2
4494257|NCT00808028|7297192|FG000|Stage 1 (6 Months)|Lost to Follow-up|1
4494258|NCT00808028|7297193|FG001|Stage 1 (6 Months)|Lost to Follow-up|0
4494259|NCT00808028|7297194|FG002|Stage 1 (6 Months)|Lost to Follow-up|1
4494260|NCT00808028|7297195|FG003|Stage 1 (6 Months)|Lost to Follow-up|0
4494261|NCT00808028|7297192|FG000|Stage 1 (6 Months)|Protocol Violation|0
4494262|NCT00808028|7297193|FG001|Stage 1 (6 Months)|Protocol Violation|0
4494263|NCT00808028|7297194|FG002|Stage 1 (6 Months)|Protocol Violation|0
4494264|NCT00808028|7297195|FG003|Stage 1 (6 Months)|Protocol Violation|1
4494265|NCT00808028|7297192|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6
4494266|NCT00808028|7297193|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0
4494267|NCT00808028|7297194|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9
4494268|NCT00808028|7297195|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11
4494269|NCT00808028|7297192|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
4494270|NCT00808028|7297193|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
4494271|NCT00808028|7297194|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1
4494272|NCT00808028|7297195|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
4494273|NCT00808028|7297192|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2
4494274|NCT00808028|7297193|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0
4494275|NCT00808028|7297194|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8
4494276|NCT00808028|7297195|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7
4494277|NCT00808028|7297192|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2
4494278|NCT00808028|7297193|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0
4494279|NCT00808028|7297194|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5
4494280|NCT00808028|7297195|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4
4494281|NCT00808028|7297192|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1
4494282|NCT00808028|7297193|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0
4494283|NCT00808028|7297194|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1
4494284|NCT00808028|7297195|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0
4494285|NCT00808028|7297192|FG000|Stage 2 (Followed up to 48 Months )|Other|0
4494286|NCT00808028|7297193|FG001|Stage 2 (Followed up to 48 Months )|Other|0
4494287|NCT00808028|7297194|FG002|Stage 2 (Followed up to 48 Months )|Other|1
4494288|NCT00808028|7297195|FG003|Stage 2 (Followed up to 48 Months )|Other|1
4494289|NCT00808028|7297192|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
4494290|NCT00808028|7297193|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
4494291|NCT00808028|7297194|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2
4494292|NCT00808028|7297195|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
4494293|NCT00808028|7297192|FG000|Stage 2 (Followed up to 48 Months )|Death|0
4494294|NCT00808028|7297193|FG001|Stage 2 (Followed up to 48 Months )|Death|0
4494295|NCT00808028|7297194|FG002|Stage 2 (Followed up to 48 Months )|Death|1
4494296|NCT00808028|7297195|FG003|Stage 2 (Followed up to 48 Months )|Death|0
4494297|NCT00808028|7297192|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0
4494298|NCT00808028|7297193|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0
4494299|NCT00808028|7297194|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1
4494300|NCT00808028|7297195|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0
4494301|NCT00808067|7297217|FG000|Overall Study|Major/minor bleed|30
4494302|NCT00808067|7297218|FG001|Overall Study|Major/minor bleed|44
4494303|NCT00808067|7297217|FG000|Overall Study|Outcome event - other|33
4494304|NCT00808067|7297218|FG001|Overall Study|Outcome event - other|25
4494305|NCT00808067|7297217|FG000|Overall Study|Adverse Event|111
4494306|NCT00808067|7297218|FG001|Overall Study|Adverse Event|121
4494307|NCT00808067|7297217|FG000|Overall Study|Hospitalization (not including surgery)|18
4494308|NCT00808067|7297218|FG001|Overall Study|Hospitalization (not including surgery)|17
4494309|NCT00808067|7297217|FG000|Overall Study|Hospitalization due to surgery|37
4494310|NCT00808067|7297218|FG001|Overall Study|Hospitalization due to surgery|40
4494311|NCT00808067|7297217|FG000|Overall Study|Reduced creatinine clearance|53
4494312|NCT00808067|7297218|FG001|Overall Study|Reduced creatinine clearance|55
4494313|NCT00808067|7297217|FG000|Overall Study|Elevated LFT results|7
4494314|NCT00808067|7297218|FG001|Overall Study|Elevated LFT results|3
4494315|NCT00808067|7297217|FG000|Overall Study|Patient refused to take study medication|65
4494316|NCT00808067|7297218|FG001|Overall Study|Patient refused to take study medication|76
4494317|NCT00808067|7297217|FG000|Overall Study|Missing|1
4494318|NCT00808067|7297218|FG001|Overall Study|Missing|0
4494319|NCT00808067|7297217|FG000|Overall Study|Death|1
4494320|NCT00808067|7297218|FG001|Overall Study|Death|1
4494321|NCT00808067|7297217|FG000|Overall Study|Procedure|6
4494322|NCT00808067|7297218|FG001|Overall Study|Procedure|7
4494323|NCT00808067|7297217|FG000|Overall Study|Withdrawal by Subject|21
4494324|NCT00808067|7297218|FG001|Overall Study|Withdrawal by Subject|25
4494325|NCT00808067|7297217|FG000|Overall Study|Site closed|4
4494326|NCT00808067|7297218|FG001|Overall Study|Site closed|3
4494327|NCT00808067|7297217|FG000|Overall Study|Physician Decision|47
4494328|NCT00808067|7297218|FG001|Overall Study|Physician Decision|38
4494329|NCT00808067|7297217|FG000|Overall Study|Protocol Violation|3
4494330|NCT00808067|7297218|FG001|Overall Study|Protocol Violation|11
4494331|NCT00808067|7297217|FG000|Overall Study|Patient elected|7
4494332|NCT00808067|7297218|FG001|Overall Study|Patient elected|9
4494333|NCT00808067|7297217|FG000|Overall Study|Site closed for cause|19
4494334|NCT00808067|7297218|FG001|Overall Study|Site closed for cause|19
4494335|NCT00808067|7297217|FG000|Overall Study|Other reason not defined above|5
4494336|NCT00808067|7297218|FG001|Overall Study|Other reason not defined above|5
4494337|NCT00808067|7297217|FG000|Overall Study|Excluded from analysis|13
4494338|NCT00808067|7297218|FG001|Overall Study|Excluded from analysis|19
4494339|NCT00808132|7297229|FG000|Overall Study|Adverse Event|34
4494340|NCT00808132|7297230|FG001|Overall Study|Adverse Event|33
4494341|NCT00808132|7297231|FG002|Overall Study|Adverse Event|16
4494342|NCT00808132|7297232|FG003|Overall Study|Adverse Event|31
4494343|NCT00808132|7297233|FG004|Overall Study|Adverse Event|33
4494344|NCT00808132|7297229|FG000|Overall Study|Death|0
4494345|NCT00808132|7297230|FG001|Overall Study|Death|0
4494346|NCT00808132|7297231|FG002|Overall Study|Death|0
4494347|NCT00808132|7297232|FG003|Overall Study|Death|0
4494348|NCT00808132|7297233|FG004|Overall Study|Death|1
4494349|NCT00808132|7297229|FG000|Overall Study|Physician Decision|0
4494350|NCT00808132|7297230|FG001|Overall Study|Physician Decision|1
4494351|NCT00808132|7297231|FG002|Overall Study|Physician Decision|0
4494352|NCT00808132|7297232|FG003|Overall Study|Physician Decision|0
4494353|NCT00808132|7297233|FG004|Overall Study|Physician Decision|0
4494354|NCT00808132|7297229|FG000|Overall Study|Lost to Follow-up|8
4494355|NCT00808132|7297230|FG001|Overall Study|Lost to Follow-up|10
4494356|NCT00808132|7297231|FG002|Overall Study|Lost to Follow-up|11
4494357|NCT00808132|7297232|FG003|Overall Study|Lost to Follow-up|8
4494358|NCT00808132|7297233|FG004|Overall Study|Lost to Follow-up|9
4494359|NCT00808132|7297229|FG000|Overall Study|Protocol Violation|8
4494360|NCT00808132|7297230|FG001|Overall Study|Protocol Violation|9
4494361|NCT00808132|7297231|FG002|Overall Study|Protocol Violation|4
4494362|NCT00808132|7297232|FG003|Overall Study|Protocol Violation|9
4494363|NCT00808132|7297233|FG004|Overall Study|Protocol Violation|5
4494364|NCT00808132|7297229|FG000|Overall Study|Withdrawal by Subject|27
4494365|NCT00808132|7297230|FG001|Overall Study|Withdrawal by Subject|18
4494366|NCT00808132|7297231|FG002|Overall Study|Withdrawal by Subject|2
4494367|NCT00808132|7297232|FG003|Overall Study|Withdrawal by Subject|7
4494368|NCT00808132|7297233|FG004|Overall Study|Withdrawal by Subject|16
4494369|NCT00808132|7297229|FG000|Overall Study|Other|6
4494370|NCT00808132|7297230|FG001|Overall Study|Other|4
4494371|NCT00808132|7297231|FG002|Overall Study|Other|6
4494372|NCT00808132|7297232|FG003|Overall Study|Other|2
4494373|NCT00808132|7297233|FG004|Overall Study|Other|15
4494374|NCT00808132|7297229|FG000|Overall Study|Randomized, but not treated|10
4494375|NCT00808132|7297230|FG001|Overall Study|Randomized, but not treated|7
4494376|NCT00808132|7297231|FG002|Overall Study|Randomized, but not treated|9
4494377|NCT00808132|7297232|FG003|Overall Study|Randomized, but not treated|8
4494378|NCT00808132|7297233|FG004|Overall Study|Randomized, but not treated|9
4494379|NCT00808132|7297229|FG000|Overall Study|Unsatisfactory response|5
4494380|NCT00808132|7297230|FG001|Overall Study|Unsatisfactory response|6
4494381|NCT00808132|7297231|FG002|Overall Study|Unsatisfactory response|6
4494382|NCT00808132|7297232|FG003|Overall Study|Unsatisfactory response|4
4494383|NCT00808132|7297233|FG004|Overall Study|Unsatisfactory response|12
4494384|NCT00808210|7297247|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3
4494385|NCT00808210|7297248|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7
4494386|NCT00808210|7297247|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6
4494387|NCT00808210|7297248|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2
4494388|NCT00808210|7297247|FG000|Double-Blind TX Period|Adverse Event|0
4494389|NCT00808210|7297248|FG001|Double-Blind TX Period|Adverse Event|1
4494390|NCT00808210|7297247|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1
4494391|NCT00808210|7297248|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1
4494392|NCT00808210|7297247|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1
4494393|NCT00808210|7297248|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1
4494394|NCT00808210|7297247|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9
4494395|NCT00808210|7297248|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4
4494396|NCT00808236|7297256|FG000|Overall Study|Was not resuscitated|50
4494397|NCT00808236|7297257|FG001|Overall Study|Was not resuscitated|56
4494398|NCT00808236|7297256|FG000|Overall Study|Pre-defined exclusion|13
4494399|NCT00808236|7297257|FG001|Overall Study|Pre-defined exclusion|3
4494400|NCT00808236|7297256|FG000|Overall Study|Lost to Follow-up|1
4494401|NCT00808236|7297257|FG001|Overall Study|Lost to Follow-up|1
4494402|NCT00808236|7297256|FG000|Overall Study|Physician Decision|0
4494403|NCT00808236|7297257|FG001|Overall Study|Physician Decision|1
4494404|NCT00808236|7297256|FG000|Overall Study|Death|18
4494405|NCT00808236|7297257|FG001|Overall Study|Death|30
4494406|NCT00808249|7297267|FG000|Overall Study|Adverse Event|4
4494407|NCT00808249|7297268|FG001|Overall Study|Adverse Event|7
4494408|NCT00808249|7297269|FG002|Overall Study|Adverse Event|10
4494409|NCT00808249|7297270|FG003|Overall Study|Adverse Event|6
4494410|NCT00808249|7297267|FG000|Overall Study|Lost to Follow-up|2
4494411|NCT00808249|7297268|FG001|Overall Study|Lost to Follow-up|3
4494412|NCT00808249|7297269|FG002|Overall Study|Lost to Follow-up|3
4494413|NCT00808249|7297270|FG003|Overall Study|Lost to Follow-up|5
4494414|NCT00808249|7297267|FG000|Overall Study|Withdrawal by Subject|4
4494415|NCT00808249|7297268|FG001|Overall Study|Withdrawal by Subject|0
4494416|NCT00808249|7297269|FG002|Overall Study|Withdrawal by Subject|2
4494417|NCT00808249|7297270|FG003|Overall Study|Withdrawal by Subject|4
4494418|NCT00808249|7297267|FG000|Overall Study|Protocol Violation|3
4494419|NCT00808249|7297268|FG001|Overall Study|Protocol Violation|3
4494420|NCT00808249|7297269|FG002|Overall Study|Protocol Violation|3
4494421|NCT00808249|7297270|FG003|Overall Study|Protocol Violation|0
4494422|NCT00808249|7297267|FG000|Overall Study|Lack of Efficacy|1
4494423|NCT00808249|7297268|FG001|Overall Study|Lack of Efficacy|1
4494424|NCT00808249|7297269|FG002|Overall Study|Lack of Efficacy|0
4494425|NCT00808249|7297270|FG003|Overall Study|Lack of Efficacy|0
4494426|NCT00808249|7297267|FG000|Overall Study|study specific discontinuation criteria|1
4494427|NCT00808249|7297268|FG001|Overall Study|study specific discontinuation criteria|0
4494428|NCT00808249|7297269|FG002|Overall Study|study specific discontinuation criteria|1
4494429|NCT00808249|7297270|FG003|Overall Study|study specific discontinuation criteria|0
4494430|NCT00808249|7297267|FG000|Overall Study|All other reasons|2
4494431|NCT00808249|7297268|FG001|Overall Study|All other reasons|1
4494432|NCT00808249|7297269|FG002|Overall Study|All other reasons|3
4494433|NCT00808249|7297270|FG003|Overall Study|All other reasons|1
4494434|NCT00808444|7297304|FG000|Overall Study|Withdrawal by Subject|1
4494435|NCT00808444|7297305|FG001|Overall Study|Withdrawal by Subject|0
4494436|NCT00808444|7297304|FG000|Overall Study|Lost to Follow-up|0
4494437|NCT00808444|7297305|FG001|Overall Study|Lost to Follow-up|1
4494438|NCT00808483|7297326|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1
4494439|NCT00808483|7297327|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1
4494440|NCT00808483|7297326|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1
4494441|NCT00808483|7297327|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0
4494442|NCT00808483|7297326|FG000|From 5 Months to 12 Months|Lack of Efficacy|1
4494443|NCT00808483|7297327|FG001|From 5 Months to 12 Months|Lack of Efficacy|0
4494444|NCT00808509|7297342|FG000|Randomized Phase|Did not meet eligibility criteria|1
4494445|NCT00808509|7297343|FG001|Randomized Phase|Did not meet eligibility criteria|0
4494446|NCT00808509|7297342|FG000|Randomized Phase|Reduced methotrexate dose|1
4494447|NCT00808509|7297343|FG001|Randomized Phase|Reduced methotrexate dose|2
4494448|NCT00808509|7297342|FG000|Randomized Phase|Patient refused rescue therapy|0
4494449|NCT00808509|7297343|FG001|Randomized Phase|Patient refused rescue therapy|3
4494450|NCT00808639|7297351|FG000|Overall Study|Disease progression before surgery.|1
4494451|NCT00808665|7297357|FG000|Overall Study|Withdrawal by Subject|1
4494452|NCT00808665|7297358|FG001|Overall Study|Withdrawal by Subject|0
4494453|NCT00808665|7297357|FG000|Overall Study|only required minimally invasive surgery|1
4494454|NCT00808665|7297358|FG001|Overall Study|only required minimally invasive surgery|0
4494455|NCT00808665|7297357|FG000|Overall Study|surgery cancelled|1
4494456|NCT00808665|7297358|FG001|Overall Study|surgery cancelled|0
4494457|NCT00808665|7297357|FG000|Overall Study|required an additional procedure|0
4494458|NCT00808665|7297358|FG001|Overall Study|required an additional procedure|1
4494459|NCT00808665|7297357|FG000|Overall Study|Physician Decision|3
4494460|NCT00808665|7297358|FG001|Overall Study|Physician Decision|1
4494461|NCT00808665|7297357|FG000|Overall Study|Medication stopped by resident|0
4494462|NCT00808665|7297358|FG001|Overall Study|Medication stopped by resident|1
4494463|NCT00808808|7297367|FG000|Overall Study|Vaccinated; survey not completed|131
4494464|NCT00808808|7297368|FG001|Overall Study|Vaccinated; survey not completed|169
4494465|NCT00808808|7297369|FG002|Overall Study|Vaccinated; survey not completed|302
4494466|NCT00808808|7297367|FG000|Overall Study|Employee was not vaccinated.|2686
4494467|NCT00808808|7297368|FG001|Overall Study|Employee was not vaccinated.|2268
4494468|NCT00808808|7297369|FG002|Overall Study|Employee was not vaccinated.|2255
4494469|NCT00809094|7297401|FG000|Overall Study|Lost to Follow-up|0
4494470|NCT00809094|7297402|FG001|Overall Study|Lost to Follow-up|1
4494471|NCT00809133|7297422|FG000|Overall Study|Progressive disease|2
4494472|NCT00809133|7297423|FG001|Overall Study|Progressive disease|5
4494473|NCT00809133|7297424|FG002|Overall Study|Progressive disease|5
4494474|NCT00809133|7297425|FG003|Overall Study|Progressive disease|3
4494475|NCT00809133|7297426|FG004|Overall Study|Progressive disease|4
4494476|NCT00809133|7297427|FG005|Overall Study|Progressive disease|1
4494477|NCT00809133|7297428|FG006|Overall Study|Progressive disease|3
4494478|NCT00809133|7297429|FG007|Overall Study|Progressive disease|3
4494479|NCT00809133|7297430|FG008|Overall Study|Progressive disease|3
4494480|NCT00809133|7297431|FG009|Overall Study|Progressive disease|9
4494481|NCT00809133|7297432|FG010|Overall Study|Progressive disease|5
4494482|NCT00809133|7297433|FG011|Overall Study|Progressive disease|7
4494483|NCT00809133|7297434|FG012|Overall Study|Progressive disease|5
4494484|NCT00809133|7297435|FG013|Overall Study|Progressive disease|4
4494485|NCT00809133|7297422|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0
4494486|NCT00809133|7297423|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0
4494487|NCT00809133|7297424|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0
4494488|NCT00809133|7297425|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0
4494489|NCT00809133|7297426|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0
4494490|NCT00809133|7297427|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1
4494491|NCT00809133|7297428|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1
4494492|NCT00809133|7297429|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1
4494493|NCT00809133|7297430|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0
4494494|NCT00809133|7297431|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0
4494495|NCT00809133|7297432|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0
4494496|NCT00809133|7297433|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0
4494497|NCT00809133|7297434|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0
4494498|NCT00809133|7297435|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2
4494499|NCT00809133|7297422|FG000|Overall Study|Other adverse event|1
4494500|NCT00809133|7297423|FG001|Overall Study|Other adverse event|1
4494501|NCT00809133|7297424|FG002|Overall Study|Other adverse event|1
4494502|NCT00809133|7297425|FG003|Overall Study|Other adverse event|0
4494503|NCT00809133|7297426|FG004|Overall Study|Other adverse event|0
4494504|NCT00809133|7297427|FG005|Overall Study|Other adverse event|3
4494505|NCT00809133|7297428|FG006|Overall Study|Other adverse event|2
4494506|NCT00809133|7297429|FG007|Overall Study|Other adverse event|4
4494507|NCT00809133|7297430|FG008|Overall Study|Other adverse event|0
4494508|NCT00809133|7297431|FG009|Overall Study|Other adverse event|0
4494509|NCT00809133|7297432|FG010|Overall Study|Other adverse event|1
4494510|NCT00809133|7297433|FG011|Overall Study|Other adverse event|1
4494511|NCT00809133|7297434|FG012|Overall Study|Other adverse event|0
4494512|NCT00809133|7297435|FG013|Overall Study|Other adverse event|1
4494513|NCT00809133|7297422|FG000|Overall Study|Lost to Follow-up|0
4494514|NCT00809133|7297423|FG001|Overall Study|Lost to Follow-up|0
4494515|NCT00809133|7297424|FG002|Overall Study|Lost to Follow-up|0
4494516|NCT00809133|7297425|FG003|Overall Study|Lost to Follow-up|0
4494517|NCT00809133|7297426|FG004|Overall Study|Lost to Follow-up|0
4494518|NCT00809133|7297427|FG005|Overall Study|Lost to Follow-up|1
4494519|NCT00809133|7297428|FG006|Overall Study|Lost to Follow-up|0
4494520|NCT00809133|7297429|FG007|Overall Study|Lost to Follow-up|0
4494521|NCT00809133|7297430|FG008|Overall Study|Lost to Follow-up|0
4494522|NCT00809133|7297431|FG009|Overall Study|Lost to Follow-up|0
4494523|NCT00809133|7297432|FG010|Overall Study|Lost to Follow-up|0
4494524|NCT00809133|7297433|FG011|Overall Study|Lost to Follow-up|0
4494525|NCT00809133|7297434|FG012|Overall Study|Lost to Follow-up|0
4494526|NCT00809133|7297435|FG013|Overall Study|Lost to Follow-up|0
4494527|NCT00809133|7297422|FG000|Overall Study|Consent withdrawn|0
4494528|NCT00809133|7297423|FG001|Overall Study|Consent withdrawn|0
4494529|NCT00809133|7297424|FG002|Overall Study|Consent withdrawn|0
4494530|NCT00809133|7297425|FG003|Overall Study|Consent withdrawn|0
4494531|NCT00809133|7297426|FG004|Overall Study|Consent withdrawn|1
4494532|NCT00809133|7297427|FG005|Overall Study|Consent withdrawn|0
4494533|NCT00809133|7297428|FG006|Overall Study|Consent withdrawn|0
4494534|NCT00809133|7297429|FG007|Overall Study|Consent withdrawn|0
4494535|NCT00809133|7297430|FG008|Overall Study|Consent withdrawn|0
4494536|NCT00809133|7297431|FG009|Overall Study|Consent withdrawn|0
4494537|NCT00809133|7297432|FG010|Overall Study|Consent withdrawn|0
4494538|NCT00809133|7297433|FG011|Overall Study|Consent withdrawn|0
4494539|NCT00809133|7297434|FG012|Overall Study|Consent withdrawn|0
4494540|NCT00809133|7297435|FG013|Overall Study|Consent withdrawn|0
4494541|NCT00809133|7297422|FG000|Overall Study|Other not mentioned above|0
4494542|NCT00809133|7297423|FG001|Overall Study|Other not mentioned above|1
4494543|NCT00809133|7297424|FG002|Overall Study|Other not mentioned above|0
4494544|NCT00809133|7297425|FG003|Overall Study|Other not mentioned above|0
4494545|NCT00809133|7297426|FG004|Overall Study|Other not mentioned above|0
4494546|NCT00809133|7297427|FG005|Overall Study|Other not mentioned above|1
4494547|NCT00809133|7297428|FG006|Overall Study|Other not mentioned above|0
4494548|NCT00809133|7297429|FG007|Overall Study|Other not mentioned above|0
4494549|NCT00809133|7297430|FG008|Overall Study|Other not mentioned above|0
4494550|NCT00809133|7297431|FG009|Overall Study|Other not mentioned above|0
4494551|NCT00809133|7297432|FG010|Overall Study|Other not mentioned above|0
4494552|NCT00809133|7297433|FG011|Overall Study|Other not mentioned above|0
4494553|NCT00809133|7297434|FG012|Overall Study|Other not mentioned above|0
4494554|NCT00809133|7297435|FG013|Overall Study|Other not mentioned above|0
4494555|NCT00809159|7297491|FG000|Part 1|Adverse Event|1
4494556|NCT00809159|7297492|FG001|Part 1|Adverse Event|1
4494557|NCT00809159|7297493|FG002|Part 1|Adverse Event|0
4494558|NCT00809159|7297494|FG003|Part 1|Adverse Event|0
4494559|NCT00809159|7297495|FG004|Part 1|Adverse Event|0
4494560|NCT00809159|7297496|FG005|Part 1|Adverse Event|0
4494561|NCT00809159|7297491|FG000|Part 1|Lost to Follow-up|1
4494562|NCT00809159|7297492|FG001|Part 1|Lost to Follow-up|0
4494563|NCT00809159|7297493|FG002|Part 1|Lost to Follow-up|0
4494564|NCT00809159|7297494|FG003|Part 1|Lost to Follow-up|0
4494565|NCT00809159|7297495|FG004|Part 1|Lost to Follow-up|0
4494566|NCT00809159|7297496|FG005|Part 1|Lost to Follow-up|0
4494567|NCT00809159|7297491|FG000|Part 1|Withdrawal by Subject|3
4494568|NCT00809159|7297492|FG001|Part 1|Withdrawal by Subject|1
4494569|NCT00809159|7297493|FG002|Part 1|Withdrawal by Subject|0
4494570|NCT00809159|7297494|FG003|Part 1|Withdrawal by Subject|0
4494571|NCT00809159|7297495|FG004|Part 1|Withdrawal by Subject|0
4494572|NCT00809159|7297496|FG005|Part 1|Withdrawal by Subject|0
4494573|NCT00809159|7297491|FG000|Part 1|Unsatisfactory therapeutic effect|3
4494574|NCT00809159|7297492|FG001|Part 1|Unsatisfactory therapeutic effect|1
4494575|NCT00809159|7297493|FG002|Part 1|Unsatisfactory therapeutic effect|0
4494576|NCT00809159|7297494|FG003|Part 1|Unsatisfactory therapeutic effect|0
4494577|NCT00809159|7297495|FG004|Part 1|Unsatisfactory therapeutic effect|0
4494578|NCT00809159|7297496|FG005|Part 1|Unsatisfactory therapeutic effect|0
4494579|NCT00809159|7297491|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0
4494580|NCT00809159|7297492|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0
4494581|NCT00809159|7297493|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4
4494582|NCT00809159|7297494|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3
4494583|NCT00809159|7297495|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5
4494584|NCT00809159|7297496|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1
4494585|NCT00809159|7297491|FG000|Part 1 and 2|Administrative problems|0
4494586|NCT00809159|7297492|FG001|Part 1 and 2|Administrative problems|0
4494587|NCT00809159|7297493|FG002|Part 1 and 2|Administrative problems|0
4494588|NCT00809159|7297494|FG003|Part 1 and 2|Administrative problems|1
4494589|NCT00809159|7297495|FG004|Part 1 and 2|Administrative problems|0
4494590|NCT00809159|7297496|FG005|Part 1 and 2|Administrative problems|0
4494591|NCT00809159|7297491|FG000|Part 1 and 2|Adverse Event|0
4494592|NCT00809159|7297492|FG001|Part 1 and 2|Adverse Event|0
4494593|NCT00809159|7297493|FG002|Part 1 and 2|Adverse Event|1
4494594|NCT00809159|7297494|FG003|Part 1 and 2|Adverse Event|0
4494595|NCT00809159|7297495|FG004|Part 1 and 2|Adverse Event|1
4494596|NCT00809159|7297496|FG005|Part 1 and 2|Adverse Event|1
4494597|NCT00809159|7297491|FG000|Part 1 and 2|Lost to Follow-up|0
4494598|NCT00809159|7297492|FG001|Part 1 and 2|Lost to Follow-up|0
4494599|NCT00809159|7297493|FG002|Part 1 and 2|Lost to Follow-up|1
4494600|NCT00809159|7297494|FG003|Part 1 and 2|Lost to Follow-up|1
4494601|NCT00809159|7297495|FG004|Part 1 and 2|Lost to Follow-up|0
4494602|NCT00809159|7297496|FG005|Part 1 and 2|Lost to Follow-up|0
4494603|NCT00809159|7297491|FG000|Part 1 and 2|Withdrawal by Subject|0
4494604|NCT00809159|7297492|FG001|Part 1 and 2|Withdrawal by Subject|0
4494605|NCT00809159|7297493|FG002|Part 1 and 2|Withdrawal by Subject|4
4494606|NCT00809159|7297494|FG003|Part 1 and 2|Withdrawal by Subject|0
4494607|NCT00809159|7297495|FG004|Part 1 and 2|Withdrawal by Subject|0
4494608|NCT00809159|7297496|FG005|Part 1 and 2|Withdrawal by Subject|1
4517656|NCT00968669|7329563|FG003|Overall Study|SUBJECT INCARCERATED|0
4517657|NCT00968669|7329560|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
4517658|NCT00968669|7329561|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1
4517659|NCT00968669|7329562|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
4517660|NCT00968669|7329563|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
4517661|NCT00968669|7329560|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
4517662|NCT00968669|7329561|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
4517663|NCT00968669|7329562|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
4517664|NCT00968669|7329563|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1
4517665|NCT00968708|7329575|FG000|Overall Study|Adverse Event|169
4517666|NCT00968708|7329576|FG001|Overall Study|Adverse Event|150
4517667|NCT00968708|7329575|FG000|Overall Study|Major Protocol Deviation|0
4517668|NCT00968708|7329576|FG001|Overall Study|Major Protocol Deviation|1
4517669|NCT00968708|7329575|FG000|Overall Study|Lost to Follow-up|19
4517670|NCT00968708|7329576|FG001|Overall Study|Lost to Follow-up|11
4517671|NCT00968708|7329575|FG000|Overall Study|Voluntary Withdrawal|104
4517672|NCT00968708|7329576|FG001|Overall Study|Voluntary Withdrawal|101
4517673|NCT00968708|7329575|FG000|Overall Study|Investigator Discretion|0
4517674|NCT00968708|7329576|FG001|Overall Study|Investigator Discretion|1
4517675|NCT00968708|7329575|FG000|Overall Study|Other|26
4517676|NCT00968708|7329576|FG001|Overall Study|Other|34
4517677|NCT00968799|7329582|FG000|Overall Study|Advanced disease, HIPEC not applicable|2
4517678|NCT00968812|7329589|FG000|Overall Study|Adverse Event|30
4517679|NCT00968812|7329590|FG001|Overall Study|Adverse Event|46
4517680|NCT00968812|7329591|FG002|Overall Study|Adverse Event|33
4517681|NCT00968812|7329589|FG000|Overall Study|Death|2
4517682|NCT00968812|7329590|FG001|Overall Study|Death|2
4517683|NCT00968812|7329591|FG002|Overall Study|Death|1
4517684|NCT00968812|7329589|FG000|Overall Study|Lack of Efficacy|9
4517685|NCT00968812|7329590|FG001|Overall Study|Lack of Efficacy|7
4517686|NCT00968812|7329591|FG002|Overall Study|Lack of Efficacy|16
4517687|NCT00968812|7329589|FG000|Overall Study|Lost to Follow-up|17
4517688|NCT00968812|7329590|FG001|Overall Study|Lost to Follow-up|12
4517689|NCT00968812|7329591|FG002|Overall Study|Lost to Follow-up|11
4517690|NCT00968812|7329589|FG000|Overall Study|Physician Decision|8
4517691|NCT00968812|7329590|FG001|Overall Study|Physician Decision|5
4517692|NCT00968812|7329591|FG002|Overall Study|Physician Decision|9
4517693|NCT00968812|7329589|FG000|Overall Study|Protocol Violation|7
4517694|NCT00968812|7329590|FG001|Overall Study|Protocol Violation|4
4517695|NCT00968812|7329591|FG002|Overall Study|Protocol Violation|3
4517696|NCT00968812|7329589|FG000|Overall Study|Withdrawal by Subject|17
4517697|NCT00968812|7329590|FG001|Overall Study|Withdrawal by Subject|23
4517698|NCT00968812|7329591|FG002|Overall Study|Withdrawal by Subject|25
4517699|NCT00968812|7329589|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9
4494609|NCT00809328|7297519|FG000|Overall Study|Lack of Efficacy|18
4494610|NCT00809328|7297519|FG000|Overall Study|Adverse Event|6
4494611|NCT00809328|7297519|FG000|Overall Study|Protocol Violation|3
4494612|NCT00809328|7297519|FG000|Overall Study|Withdrawal by Subject|2
4494613|NCT00809354|7297533|FG000|Overall Study|Adverse Event|32
4494614|NCT00809354|7297534|FG001|Overall Study|Adverse Event|45
4494615|NCT00809354|7297535|FG002|Overall Study|Adverse Event|37
4494616|NCT00809354|7297536|FG003|Overall Study|Adverse Event|53
4494617|NCT00809354|7297537|FG004|Overall Study|Adverse Event|26
4494618|NCT00809354|7297538|FG005|Overall Study|Adverse Event|33
4494619|NCT00809354|7297539|FG006|Overall Study|Adverse Event|44
4494620|NCT00809354|7297540|FG007|Overall Study|Adverse Event|40
4494621|NCT00809354|7297541|FG008|Overall Study|Adverse Event|46
4494622|NCT00809354|7297542|FG009|Overall Study|Adverse Event|26
4494623|NCT00809354|7297533|FG000|Overall Study|Lack of Efficacy|23
4494624|NCT00809354|7297534|FG001|Overall Study|Lack of Efficacy|23
4494625|NCT00809354|7297535|FG002|Overall Study|Lack of Efficacy|22
4494626|NCT00809354|7297536|FG003|Overall Study|Lack of Efficacy|15
4494627|NCT00809354|7297537|FG004|Overall Study|Lack of Efficacy|40
4494628|NCT00809354|7297538|FG005|Overall Study|Lack of Efficacy|19
4494629|NCT00809354|7297539|FG006|Overall Study|Lack of Efficacy|21
4494630|NCT00809354|7297540|FG007|Overall Study|Lack of Efficacy|15
4494631|NCT00809354|7297541|FG008|Overall Study|Lack of Efficacy|18
4494632|NCT00809354|7297542|FG009|Overall Study|Lack of Efficacy|38
4494633|NCT00809354|7297533|FG000|Overall Study|Lost to Follow-up|10
4494634|NCT00809354|7297534|FG001|Overall Study|Lost to Follow-up|11
4494635|NCT00809354|7297535|FG002|Overall Study|Lost to Follow-up|8
4494636|NCT00809354|7297536|FG003|Overall Study|Lost to Follow-up|13
4494637|NCT00809354|7297537|FG004|Overall Study|Lost to Follow-up|6
4494638|NCT00809354|7297538|FG005|Overall Study|Lost to Follow-up|2
4494639|NCT00809354|7297539|FG006|Overall Study|Lost to Follow-up|0
4494640|NCT00809354|7297540|FG007|Overall Study|Lost to Follow-up|5
4494641|NCT00809354|7297541|FG008|Overall Study|Lost to Follow-up|4
4494642|NCT00809354|7297542|FG009|Overall Study|Lost to Follow-up|0
4494643|NCT00809354|7297533|FG000|Overall Study|Protocol Violation|7
4494644|NCT00809354|7297534|FG001|Overall Study|Protocol Violation|14
4494645|NCT00809354|7297535|FG002|Overall Study|Protocol Violation|14
4494646|NCT00809354|7297536|FG003|Overall Study|Protocol Violation|12
4494647|NCT00809354|7297537|FG004|Overall Study|Protocol Violation|14
4494648|NCT00809354|7297538|FG005|Overall Study|Protocol Violation|6
4494649|NCT00809354|7297539|FG006|Overall Study|Protocol Violation|4
4494650|NCT00809354|7297540|FG007|Overall Study|Protocol Violation|6
4494651|NCT00809354|7297541|FG008|Overall Study|Protocol Violation|9
4494652|NCT00809354|7297542|FG009|Overall Study|Protocol Violation|3
4494653|NCT00809354|7297533|FG000|Overall Study|Withdrawal by Subject|32
4494654|NCT00809354|7297534|FG001|Overall Study|Withdrawal by Subject|27
4494655|NCT00809354|7297535|FG002|Overall Study|Withdrawal by Subject|31
4494656|NCT00809354|7297536|FG003|Overall Study|Withdrawal by Subject|33
4494657|NCT00809354|7297537|FG004|Overall Study|Withdrawal by Subject|34
4494658|NCT00809354|7297538|FG005|Overall Study|Withdrawal by Subject|29
4494659|NCT00809354|7297539|FG006|Overall Study|Withdrawal by Subject|27
4494660|NCT00809354|7297540|FG007|Overall Study|Withdrawal by Subject|19
4494661|NCT00809354|7297541|FG008|Overall Study|Withdrawal by Subject|18
4494662|NCT00809354|7297542|FG009|Overall Study|Withdrawal by Subject|20
4494663|NCT00809354|7297533|FG000|Overall Study|Other|10
4494664|NCT00809354|7297534|FG001|Overall Study|Other|2
4494665|NCT00809354|7297535|FG002|Overall Study|Other|7
4494666|NCT00809354|7297536|FG003|Overall Study|Other|10
4494667|NCT00809354|7297537|FG004|Overall Study|Other|5
4494668|NCT00809354|7297538|FG005|Overall Study|Other|3
4494669|NCT00809354|7297539|FG006|Overall Study|Other|2
4494670|NCT00809354|7297540|FG007|Overall Study|Other|3
4494671|NCT00809354|7297541|FG008|Overall Study|Other|4
4494672|NCT00809354|7297542|FG009|Overall Study|Other|3
4494673|NCT00809354|7297533|FG000|Overall Study|Study terminated by sponsor|138
4494674|NCT00809354|7297534|FG001|Overall Study|Study terminated by sponsor|134
4494675|NCT00809354|7297535|FG002|Overall Study|Study terminated by sponsor|129
4494676|NCT00809354|7297536|FG003|Overall Study|Study terminated by sponsor|120
4494677|NCT00809354|7297537|FG004|Overall Study|Study terminated by sponsor|126
4494678|NCT00809354|7297538|FG005|Overall Study|Study terminated by sponsor|133
4494679|NCT00809354|7297539|FG006|Overall Study|Study terminated by sponsor|124
4494680|NCT00809354|7297540|FG007|Overall Study|Study terminated by sponsor|148
4494681|NCT00809354|7297541|FG008|Overall Study|Study terminated by sponsor|127
4494682|NCT00809354|7297542|FG009|Overall Study|Study terminated by sponsor|135
4494683|NCT00809354|7297533|FG000|Overall Study|Withdrawn due to pregnancy|0
4494684|NCT00809354|7297534|FG001|Overall Study|Withdrawn due to pregnancy|1
4494685|NCT00809354|7297535|FG002|Overall Study|Withdrawn due to pregnancy|0
4494686|NCT00809354|7297536|FG003|Overall Study|Withdrawn due to pregnancy|0
4494687|NCT00809354|7297537|FG004|Overall Study|Withdrawn due to pregnancy|0
4494688|NCT00809354|7297538|FG005|Overall Study|Withdrawn due to pregnancy|0
4494689|NCT00809354|7297539|FG006|Overall Study|Withdrawn due to pregnancy|0
4494690|NCT00809354|7297540|FG007|Overall Study|Withdrawn due to pregnancy|0
4494691|NCT00809354|7297541|FG008|Overall Study|Withdrawn due to pregnancy|0
4494692|NCT00809354|7297542|FG009|Overall Study|Withdrawn due to pregnancy|0
4494693|NCT00809354|7297533|FG000|Overall Study|Randomized but not Treated|3
4494694|NCT00809354|7297534|FG001|Overall Study|Randomized but not Treated|1
4494695|NCT00809354|7297535|FG002|Overall Study|Randomized but not Treated|6
4494696|NCT00809354|7297536|FG003|Overall Study|Randomized but not Treated|0
4494697|NCT00809354|7297537|FG004|Overall Study|Randomized but not Treated|5
4494698|NCT00809354|7297538|FG005|Overall Study|Randomized but not Treated|0
4494699|NCT00809354|7297539|FG006|Overall Study|Randomized but not Treated|1
4494700|NCT00809354|7297540|FG007|Overall Study|Randomized but not Treated|1
4494701|NCT00809354|7297541|FG008|Overall Study|Randomized but not Treated|2
4494702|NCT00809354|7297542|FG009|Overall Study|Randomized but not Treated|1
4494703|NCT00809354|7297533|FG000|Overall Study|Death|0
4494704|NCT00809354|7297534|FG001|Overall Study|Death|0
4494705|NCT00809354|7297535|FG002|Overall Study|Death|0
4494706|NCT00809354|7297536|FG003|Overall Study|Death|0
4494707|NCT00809354|7297537|FG004|Overall Study|Death|0
4494708|NCT00809354|7297538|FG005|Overall Study|Death|0
4494709|NCT00809354|7297539|FG006|Overall Study|Death|0
4494710|NCT00809354|7297540|FG007|Overall Study|Death|1
4494711|NCT00809354|7297541|FG008|Overall Study|Death|0
4494712|NCT00809354|7297542|FG009|Overall Study|Death|0
4494713|NCT00809445|7297572|FG000|1 Month Follow-up|Lost contact|1
4494714|NCT00809445|7297573|FG001|1 Month Follow-up|Lost contact|2
4494715|NCT00809445|7297574|FG002|1 Month Follow-up|Lost contact|1
4494716|NCT00809445|7297572|FG000|1 Month Follow-up|Withdrew consent|1
4494717|NCT00809445|7297573|FG001|1 Month Follow-up|Withdrew consent|1
4494718|NCT00809445|7297574|FG002|1 Month Follow-up|Withdrew consent|1
4494719|NCT00809445|7297572|FG000|1 Month Follow-up|Death|0
4494720|NCT00809445|7297573|FG001|1 Month Follow-up|Death|1
4494721|NCT00809445|7297574|FG002|1 Month Follow-up|Death|1
4494722|NCT00809445|7297572|FG000|1 Month Follow-up|Incarcerated|0
4494723|NCT00809445|7297573|FG001|1 Month Follow-up|Incarcerated|0
4494724|NCT00809445|7297574|FG002|1 Month Follow-up|Incarcerated|1
4494725|NCT00809445|7297572|FG000|6 Month Follow-up|Lost contact|16
4494726|NCT00809445|7297573|FG001|6 Month Follow-up|Lost contact|14
4494727|NCT00809445|7297574|FG002|6 Month Follow-up|Lost contact|14
4494728|NCT00809445|7297572|FG000|6 Month Follow-up|Death|2
4494729|NCT00809445|7297573|FG001|6 Month Follow-up|Death|1
4494730|NCT00809445|7297574|FG002|6 Month Follow-up|Death|1
4494731|NCT00809445|7297572|FG000|6 Month Follow-up|Incarcerated|6
4494732|NCT00809445|7297573|FG001|6 Month Follow-up|Incarcerated|8
4494733|NCT00809445|7297574|FG002|6 Month Follow-up|Incarcerated|8
4494734|NCT00809445|7297572|FG000|6 Month Follow-up|Withdrew consent|0
4494735|NCT00809445|7297573|FG001|6 Month Follow-up|Withdrew consent|0
4494736|NCT00809445|7297574|FG002|6 Month Follow-up|Withdrew consent|1
4494737|NCT00809471|7297585|FG000|Overall Study|Protocol non-compliance|15
4494738|NCT00809471|7297586|FG001|Overall Study|Protocol non-compliance|15
4494739|NCT00809471|7297587|FG002|Overall Study|Protocol non-compliance|6
4494740|NCT00809471|7297585|FG000|Overall Study|Lost to Follow-up|4
4494741|NCT00809471|7297586|FG001|Overall Study|Lost to Follow-up|2
4494742|NCT00809471|7297587|FG002|Overall Study|Lost to Follow-up|9
4494743|NCT00809471|7297585|FG000|Overall Study|Adverse Event|0
4494744|NCT00809471|7297586|FG001|Overall Study|Adverse Event|2
4494745|NCT00809471|7297587|FG002|Overall Study|Adverse Event|2
4494746|NCT00809471|7297585|FG000|Overall Study|Requirement for restricted medication|1
4494747|NCT00809471|7297586|FG001|Overall Study|Requirement for restricted medication|1
4494748|NCT00809471|7297587|FG002|Overall Study|Requirement for restricted medication|0
4494749|NCT00809614|7297606|FG000|Overall Study|Lack of Efficacy|2
4494750|NCT00809614|7297607|FG001|Overall Study|Lack of Efficacy|3
4494751|NCT00809614|7297606|FG000|Overall Study|Withdrawal by Subject|1
4494752|NCT00809614|7297607|FG001|Overall Study|Withdrawal by Subject|1
4494753|NCT00809757|7297616|FG000|Overall Study|Adverse Event|2
4494754|NCT00809757|7297617|FG001|Overall Study|Adverse Event|3
4494755|NCT00809757|7297618|FG002|Overall Study|Adverse Event|3
4494756|NCT00809757|7297616|FG000|Overall Study|Lost to Follow-up|0
4494757|NCT00809757|7297617|FG001|Overall Study|Lost to Follow-up|0
4494758|NCT00809757|7297618|FG002|Overall Study|Lost to Follow-up|1
4494759|NCT00809757|7297616|FG000|Overall Study|Protocol Violation|1
4494760|NCT00809757|7297617|FG001|Overall Study|Protocol Violation|1
4494761|NCT00809757|7297618|FG002|Overall Study|Protocol Violation|1
4494762|NCT00809757|7297616|FG000|Overall Study|Withdrawal by Subject|2
4494763|NCT00809757|7297617|FG001|Overall Study|Withdrawal by Subject|1
4494764|NCT00809757|7297618|FG002|Overall Study|Withdrawal by Subject|3
4494765|NCT00809757|7297616|FG000|Overall Study|Subject Uncooperative|1
4494766|NCT00809757|7297617|FG001|Overall Study|Subject Uncooperative|0
4494767|NCT00809757|7297618|FG002|Overall Study|Subject Uncooperative|2
4494768|NCT00809757|7297616|FG000|Overall Study|Noncompliance with Medication|0
4494769|NCT00809757|7297617|FG001|Overall Study|Noncompliance with Medication|0
4494770|NCT00809757|7297618|FG002|Overall Study|Noncompliance with Medication|1
4494771|NCT00809783|7297635|FG000|Overall Study|Death|1
4494772|NCT00809783|7297636|FG001|Overall Study|Death|0
4494773|NCT00809783|7297637|FG002|Overall Study|Death|0
4494774|NCT00809783|7297635|FG000|Overall Study|Adverse Event|34
4494775|NCT00809783|7297636|FG001|Overall Study|Adverse Event|52
4494776|NCT00809783|7297637|FG002|Overall Study|Adverse Event|71
4494777|NCT00809783|7297635|FG000|Overall Study|Lack of Efficacy|39
4494778|NCT00809783|7297636|FG001|Overall Study|Lack of Efficacy|52
4494779|NCT00809783|7297637|FG002|Overall Study|Lack of Efficacy|63
4494780|NCT00809783|7297635|FG000|Overall Study|Lost to Follow-up|0
4494781|NCT00809783|7297636|FG001|Overall Study|Lost to Follow-up|3
4494782|NCT00809783|7297637|FG002|Overall Study|Lost to Follow-up|4
4494783|NCT00809783|7297635|FG000|Overall Study|Withdrawal by Subject|47
4494784|NCT00809783|7297636|FG001|Overall Study|Withdrawal by Subject|72
4494785|NCT00809783|7297637|FG002|Overall Study|Withdrawal by Subject|64
4494786|NCT00809783|7297635|FG000|Overall Study|Protocol Violation|2
4494787|NCT00809783|7297636|FG001|Overall Study|Protocol Violation|6
4494788|NCT00809783|7297637|FG002|Overall Study|Protocol Violation|5
4494789|NCT00809783|7297635|FG000|Overall Study|Randomized, but not treated|3
4494790|NCT00809783|7297636|FG001|Overall Study|Randomized, but not treated|0
4494791|NCT00809783|7297637|FG002|Overall Study|Randomized, but not treated|2
4494792|NCT00809783|7297635|FG000|Overall Study|Study Terminated by Sponsor|378
4494793|NCT00809783|7297636|FG001|Overall Study|Study Terminated by Sponsor|626
4494794|NCT00809783|7297637|FG002|Overall Study|Study Terminated by Sponsor|565
4494795|NCT00809783|7297635|FG000|Overall Study|Other|21
4494796|NCT00809783|7297636|FG001|Overall Study|Other|21
4494797|NCT00809783|7297637|FG002|Overall Study|Other|16
4494798|NCT00809835|7297658|FG000|Overall Study|Lost to Follow-up|7
4494799|NCT00809835|7297659|FG001|Overall Study|Lost to Follow-up|6
4494800|NCT00809835|7297660|FG002|Overall Study|Lost to Follow-up|10
4494801|NCT00809835|7297661|FG003|Overall Study|Lost to Follow-up|2
4494802|NCT00809835|7297658|FG000|Overall Study|Withdrawal by Subject|1
4494803|NCT00809835|7297659|FG001|Overall Study|Withdrawal by Subject|1
4494804|NCT00809835|7297660|FG002|Overall Study|Withdrawal by Subject|1
4494805|NCT00809835|7297661|FG003|Overall Study|Withdrawal by Subject|0
4494806|NCT00809926|7297695|FG000|Overall Study|Adverse Event|18
4494807|NCT00809926|7297696|FG001|Overall Study|Adverse Event|10
4494808|NCT00809926|7297695|FG000|Overall Study|Unsatisfactory therapeutic effect|3
4494809|NCT00809926|7297696|FG001|Overall Study|Unsatisfactory therapeutic effect|3
4494810|NCT00809926|7297695|FG000|Overall Study|Patient withdrew consent|8
4494811|NCT00809926|7297696|FG001|Overall Study|Patient withdrew consent|6
4494812|NCT00809926|7297695|FG000|Overall Study|Lost to Follow-up|2
4494813|NCT00809926|7297696|FG001|Overall Study|Lost to Follow-up|1
4494814|NCT00809926|7297695|FG000|Overall Study|Administrative Problems|0
4494815|NCT00809926|7297696|FG001|Overall Study|Administrative Problems|1
4494816|NCT00809926|7297695|FG000|Overall Study|Protocol deviation|0
4494817|NCT00809926|7297696|FG001|Overall Study|Protocol deviation|2
4494818|NCT00809965|7297705|FG000|Overall Study|Death|194
4494819|NCT00809965|7297706|FG001|Overall Study|Death|147
4494820|NCT00809965|7297707|FG002|Overall Study|Death|196
4494821|NCT00809965|7297705|FG000|Overall Study|Lost to Follow-up|17
4494822|NCT00809965|7297706|FG001|Overall Study|Lost to Follow-up|10
4494823|NCT00809965|7297707|FG002|Overall Study|Lost to Follow-up|18
4494824|NCT00809965|7297705|FG000|Overall Study|Withdrawal by Subject|405
4494825|NCT00809965|7297706|FG001|Overall Study|Withdrawal by Subject|448
4494826|NCT00809965|7297707|FG002|Overall Study|Withdrawal by Subject|441
4494827|NCT00809965|7297705|FG000|Overall Study|Other Reason|167
4494828|NCT00809965|7297706|FG001|Overall Study|Other Reason|170
4494829|NCT00809965|7297707|FG002|Overall Study|Other Reason|189
4494830|NCT00810043|7297717|FG000|Overall Study|Withdrawal by Subject|1
4494831|NCT00810043|7297718|FG001|Overall Study|Withdrawal by Subject|0
4494832|NCT00810043|7297719|FG002|Overall Study|Withdrawal by Subject|2
4494833|NCT00810043|7297717|FG000|Overall Study|Lost to Follow-up|1
4494834|NCT00810043|7297718|FG001|Overall Study|Lost to Follow-up|0
4494835|NCT00810043|7297719|FG002|Overall Study|Lost to Follow-up|0
4494836|NCT00810043|7297717|FG000|Overall Study|Physician Decision|0
4494837|NCT00810043|7297718|FG001|Overall Study|Physician Decision|0
4494838|NCT00810043|7297719|FG002|Overall Study|Physician Decision|2
4494839|NCT00810043|7297717|FG000|Overall Study|Death|2
4494840|NCT00810043|7297718|FG001|Overall Study|Death|0
4626957|NCT01847885|7493239|FG001|Randomization|Withdrawal by Subject|0
4626958|NCT01847885|7493240|FG002|Randomization|Withdrawal by Subject|2
4626959|NCT01847885|7493238|FG000|Randomization|Screen Failure|0
4626960|NCT01847885|7493239|FG001|Randomization|Screen Failure|3
4626961|NCT01847885|7493240|FG002|Randomization|Screen Failure|0
4626962|NCT01848145|7493285|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1
4626963|NCT01848145|7493285|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1
4626964|NCT01848145|7493285|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1
4626965|NCT01848145|7493285|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1
4626966|NCT01848145|7493285|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6
4626967|NCT01848145|7493285|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3
4626968|NCT01848145|7493285|FG000|Subsequent Infusions: Weeks 3-8|Death|1
4494841|NCT00810043|7297719|FG002|Overall Study|Death|0
4494842|NCT00810043|7297717|FG000|Overall Study|Unrelated medical problem|0
4494843|NCT00810043|7297718|FG001|Overall Study|Unrelated medical problem|1
4494844|NCT00810043|7297719|FG002|Overall Study|Unrelated medical problem|0
4494845|NCT00810043|7297717|FG000|Overall Study|Non-medical problem|0
4494846|NCT00810043|7297718|FG001|Overall Study|Non-medical problem|0
4494847|NCT00810043|7297719|FG002|Overall Study|Non-medical problem|1
4494848|NCT00810043|7297717|FG000|Overall Study|No longer met enrollment criteria|0
4494849|NCT00810043|7297718|FG001|Overall Study|No longer met enrollment criteria|0
4494850|NCT00810043|7297719|FG002|Overall Study|No longer met enrollment criteria|3
4494851|NCT00810069|7297730|FG000|Lead-in Period I|Adverse Event|43
4494852|NCT00810069|7297731|FG001|Lead-in Period I|Adverse Event|0
4494853|NCT00810069|7297732|FG002|Lead-in Period I|Adverse Event|0
4494854|NCT00810069|7297730|FG000|Lead-in Period I|Lack of Efficacy|1
4494855|NCT00810069|7297731|FG001|Lead-in Period I|Lack of Efficacy|0
4703373|NCT02730455|7620911|FG002|Overall Study|Consent withdrawn|1
4703374|NCT02730455|7620909|FG000|Overall Study|Lost to Follow-up|3
4703375|NCT02730455|7620910|FG001|Overall Study|Lost to Follow-up|1
4703376|NCT02730455|7620911|FG002|Overall Study|Lost to Follow-up|4
4703377|NCT02730455|7620909|FG000|Overall Study|Other|1
4703378|NCT02730455|7620910|FG001|Overall Study|Other|1
4703379|NCT02730455|7620911|FG002|Overall Study|Other|2
4703380|NCT02730455|7620909|FG000|Overall Study|Other|2
4703381|NCT02730455|7620910|FG001|Overall Study|Other|2
4703382|NCT02730455|7620911|FG002|Overall Study|Other|0
4703383|NCT02730598|7620921|FG000|Overall Study|Withdrawal by Subject|3
4703384|NCT02730598|7620922|FG001|Overall Study|Withdrawal by Subject|3
4703385|NCT02730598|7620921|FG000|Overall Study|Protocol Violation|0
4703386|NCT02730598|7620922|FG001|Overall Study|Protocol Violation|1
4703387|NCT02730598|7620921|FG000|Overall Study|Unrelated Injury affecting outcomes.|1
4703388|NCT02730598|7620922|FG001|Overall Study|Unrelated Injury affecting outcomes.|0
4703389|NCT02730728|7620935|FG000|Overall Study|Withdrawal by Subject|0
4626969|NCT01848210|7493310|FG000|Overall Study|Informed Consent Form Withdrawal|28
4626970|NCT01848210|7493311|FG001|Overall Study|Informed Consent Form Withdrawal|24
4626971|NCT01848210|7493310|FG000|Overall Study|Lost to Follow-up|24
4703390|NCT02730728|7620936|FG001|Overall Study|Withdrawal by Subject|1
4703391|NCT02730728|7620937|FG002|Overall Study|Withdrawal by Subject|0
4703392|NCT02730728|7620935|FG000|Overall Study|Lack of Efficacy|0
4703393|NCT02730728|7620936|FG001|Overall Study|Lack of Efficacy|1
4703394|NCT02730728|7620937|FG002|Overall Study|Lack of Efficacy|1
4703395|NCT02730819|7620945|FG000|Overall Study|Lost to Follow-up|9
4703396|NCT02730871|7620951|FG000|Overall Study|Adverse Event|6
4703397|NCT02730871|7620952|FG001|Overall Study|Adverse Event|0
4703398|NCT02731131|7620982|FG000|Overall Study|Psychiatric Disorder|0
4703399|NCT02731131|7620983|FG001|Overall Study|Psychiatric Disorder|1
4703400|NCT02731131|7620982|FG000|Overall Study|Refused Therapy|0
4703401|NCT02731131|7620983|FG001|Overall Study|Refused Therapy|1
4703402|NCT02731157|7620989|FG000|First Rejuvenated RCE|Withdrawal by Subject|1
4494856|NCT00810069|7297732|FG002|Lead-in Period I|Lack of Efficacy|0
4494857|NCT00810069|7297730|FG000|Lead-in Period I|Lost to Follow-up|19
4494858|NCT00810069|7297731|FG001|Lead-in Period I|Lost to Follow-up|0
4494859|NCT00810069|7297732|FG002|Lead-in Period I|Lost to Follow-up|0
4494860|NCT00810069|7297730|FG000|Lead-in Period I|Physician Decision|1
4494861|NCT00810069|7297731|FG001|Lead-in Period I|Physician Decision|0
4494862|NCT00810069|7297732|FG002|Lead-in Period I|Physician Decision|0
4494863|NCT00810069|7297730|FG000|Lead-in Period I|Protocol Violation|1
4494864|NCT00810069|7297731|FG001|Lead-in Period I|Protocol Violation|0
4494865|NCT00810069|7297732|FG002|Lead-in Period I|Protocol Violation|0
4494866|NCT00810069|7297730|FG000|Lead-in Period I|Withdrawal by Subject|46
4494867|NCT00810069|7297731|FG001|Lead-in Period I|Withdrawal by Subject|0
4494868|NCT00810069|7297732|FG002|Lead-in Period I|Withdrawal by Subject|0
4494869|NCT00810069|7297730|FG000|Lead-in Period I|Protocol entry criterion not met|5
4494870|NCT00810069|7297731|FG001|Lead-in Period I|Protocol entry criterion not met|0
4494871|NCT00810069|7297732|FG002|Lead-in Period I|Protocol entry criterion not met|0
4494872|NCT00810069|7297730|FG000|Lead-in Period I|Randomization criteria not met|158
4494873|NCT00810069|7297731|FG001|Lead-in Period I|Randomization criteria not met|0
4494874|NCT00810069|7297732|FG002|Lead-in Period I|Randomization criteria not met|0
4494875|NCT00810069|7297730|FG000|Double-Blind Period II|Adverse Event|0
4494876|NCT00810069|7297731|FG001|Double-Blind Period II|Adverse Event|9
4494877|NCT00810069|7297732|FG002|Double-Blind Period II|Adverse Event|8
4494878|NCT00810069|7297730|FG000|Double-Blind Period II|Lack of Efficacy|0
4494879|NCT00810069|7297731|FG001|Double-Blind Period II|Lack of Efficacy|7
4494880|NCT00810069|7297732|FG002|Double-Blind Period II|Lack of Efficacy|12
4494881|NCT00810069|7297730|FG000|Double-Blind Period II|Lost to Follow-up|0
4494882|NCT00810069|7297731|FG001|Double-Blind Period II|Lost to Follow-up|9
4494883|NCT00810069|7297732|FG002|Double-Blind Period II|Lost to Follow-up|9
4494884|NCT00810069|7297730|FG000|Double-Blind Period II|Physician Decision|0
4494885|NCT00810069|7297731|FG001|Double-Blind Period II|Physician Decision|0
4494886|NCT00810069|7297732|FG002|Double-Blind Period II|Physician Decision|1
4494887|NCT00810069|7297730|FG000|Double-Blind Period II|Withdrawal by Subject|0
4494888|NCT00810069|7297731|FG001|Double-Blind Period II|Withdrawal by Subject|21
4494889|NCT00810069|7297732|FG002|Double-Blind Period II|Withdrawal by Subject|35
4494890|NCT00810069|7297730|FG000|Double-Blind Period II|Protocol entry criterion not met|0
4494891|NCT00810069|7297731|FG001|Double-Blind Period II|Protocol entry criterion not met|0
4494892|NCT00810069|7297732|FG002|Double-Blind Period II|Protocol entry criterion not met|1
4494893|NCT00810069|7297730|FG000|Double-Blind Period II|Clinical relapse|0
4703403|NCT02731638|7621055|FG000|Overall Study|Lost to Follow-up|6
4494894|NCT00810069|7297731|FG001|Double-Blind Period II|Clinical relapse|3
4494895|NCT00810069|7297732|FG002|Double-Blind Period II|Clinical relapse|0
4494896|NCT00810069|7297730|FG000|Double-Blind Period II|Protocol Violation|0
4494897|NCT00810069|7297731|FG001|Double-Blind Period II|Protocol Violation|7
4494898|NCT00810069|7297732|FG002|Double-Blind Period II|Protocol Violation|6
4703404|NCT02731638|7621056|FG001|Overall Study|Lost to Follow-up|9
4703405|NCT02731690|7621062|FG000|Overall Study|Adverse Event|1
4494899|NCT00810082|7297743|FG000|Overall Study|Lost to Follow-up|0
4494900|NCT00810082|7297744|FG001|Overall Study|Lost to Follow-up|4
4494901|NCT00810108|7297756|FG000|Overall Study|Withdrawal by Subject|1
4494902|NCT00810108|7297757|FG001|Overall Study|Withdrawal by Subject|0
4494903|NCT00810199|7297764|FG000|Overall Study|Adverse Event|24
4494904|NCT00810199|7297765|FG001|Overall Study|Adverse Event|26
4494905|NCT00810199|7297764|FG000|Overall Study|Death|4
4494906|NCT00810199|7297765|FG001|Overall Study|Death|6
4494907|NCT00810199|7297764|FG000|Overall Study|Withdrew consent|9
4494908|NCT00810199|7297765|FG001|Overall Study|Withdrew consent|12
4494909|NCT00810199|7297764|FG000|Overall Study|Insufficient therapeutic response|5
4494910|NCT00810199|7297765|FG001|Overall Study|Insufficient therapeutic response|14
4494911|NCT00810199|7297764|FG000|Overall Study|Refused treatment/Did not cooperate|7
4494912|NCT00810199|7297765|FG001|Overall Study|Refused treatment/Did not cooperate|7
4494913|NCT00810199|7297764|FG000|Overall Study|Administrative/Other|5
4494914|NCT00810199|7297765|FG001|Overall Study|Administrative/Other|6
4494915|NCT00810199|7297764|FG000|Overall Study|Protocol Violation|2
4494916|NCT00810199|7297765|FG001|Overall Study|Protocol Violation|6
4494917|NCT00810199|7297764|FG000|Overall Study|Failure to return|1
4494918|NCT00810199|7297765|FG001|Overall Study|Failure to return|4
4494919|NCT00810199|7297764|FG000|Overall Study|Did not receive study drug|2
4494920|NCT00810199|7297765|FG001|Overall Study|Did not receive study drug|1
4494921|NCT00810264|7297777|FG000|Overall Study|Lost to Follow-up|191
4494922|NCT00810264|7297777|FG000|Overall Study|Withdrawal by subject or physician|721
4494923|NCT00810264|7297777|FG000|Overall Study|Death|641
4494924|NCT00810277|7297785|FG000|Overall Study|Adverse Event|1
4494925|NCT00810342|7297799|FG000|Month 1 Follow-up|Lost to Follow-up|4
4494926|NCT00810342|7297800|FG001|Month 1 Follow-up|Lost to Follow-up|2
4494927|NCT00810342|7297799|FG000|Month 1 Follow-up|Pregnancy|1
4494928|NCT00810342|7297800|FG001|Month 1 Follow-up|Pregnancy|0
4494929|NCT00810342|7297799|FG000|6-month Follow-up|Lost to Follow-up|18
4494930|NCT00810342|7297800|FG001|6-month Follow-up|Lost to Follow-up|6
4494931|NCT00810342|7297799|FG000|6-month Follow-up|Pregnancy|6
4494932|NCT00810342|7297800|FG001|6-month Follow-up|Pregnancy|2
4494933|NCT00810342|7297799|FG000|12-month Followup|Pregnancy|9
4494934|NCT00810342|7297800|FG001|12-month Followup|Pregnancy|10
4494935|NCT00810342|7297799|FG000|12-month Followup|Lost to Follow-up|3
4494936|NCT00810342|7297800|FG001|12-month Followup|Lost to Follow-up|1
4494937|NCT00810355|7297811|FG000|Overall Study|Lost to Follow-up|13
4494938|NCT00810355|7297812|FG001|Overall Study|Lost to Follow-up|17
4494939|NCT00810355|7297813|FG002|Overall Study|Lost to Follow-up|11
4494940|NCT00810355|7297811|FG000|Overall Study|Withdrawal by Subject|1
4494941|NCT00810355|7297812|FG001|Overall Study|Withdrawal by Subject|0
4494942|NCT00810355|7297813|FG002|Overall Study|Withdrawal by Subject|0
4494943|NCT00810368|7297823|FG000|Overall Study|Lost to Follow-up|4
4494944|NCT00810368|7297824|FG001|Overall Study|Lost to Follow-up|2
4494945|NCT00810368|7297823|FG000|Overall Study|Lack of Efficacy|2
4494946|NCT00810368|7297824|FG001|Overall Study|Lack of Efficacy|0
4494947|NCT00810394|7297832|FG000|Overall Study|Withdrawal by Subject|3
4494948|NCT00810407|7297836|FG000|Overall Study|Protocol Violation|3
4494949|NCT00810407|7297836|FG000|Overall Study|No Visit After First Day of Treatment|3
4494950|NCT00810511|7297857|FG000|Overall Study|Protocol Violation|0
4494951|NCT00810511|7297858|FG001|Overall Study|Protocol Violation|1
4494952|NCT00810511|7297857|FG000|Overall Study|Lack of Efficacy|9
4494953|NCT00810511|7297858|FG001|Overall Study|Lack of Efficacy|1
4494954|NCT00810511|7297857|FG000|Overall Study|death in the family|0
4494955|NCT00810511|7297858|FG001|Overall Study|death in the family|1
4494956|NCT00810511|7297857|FG000|Overall Study|Lost to Follow-up|1
4494957|NCT00810511|7297858|FG001|Overall Study|Lost to Follow-up|0
4494958|NCT00810511|7297857|FG000|Overall Study|deposits on contact lens|0
4494959|NCT00810511|7297858|FG001|Overall Study|deposits on contact lens|1
4494960|NCT00810602|7297868|FG000|Overall Study|Withdrawal by Subject|8
4494961|NCT00810602|7297869|FG001|Overall Study|Withdrawal by Subject|3
4703406|NCT02731690|7621062|FG000|Overall Study|Withdrawal by Subject|3
4703407|NCT02731690|7621062|FG000|Overall Study|Discontinuation of Study by Sponsor|26
4626972|NCT01848210|7493311|FG001|Overall Study|Lost to Follow-up|12
4626973|NCT01848210|7493310|FG000|Overall Study|Protocol Violation|3
4494962|NCT00810615|7297875|FG000|Overall Study|Withdrawal by Subject|1
4494963|NCT00810615|7297876|FG001|Overall Study|Withdrawal by Subject|1
4494964|NCT00810641|7297897|FG000|Overall Study|Withdrawal by Subject|0
4494965|NCT00810641|7297898|FG001|Overall Study|Withdrawal by Subject|1
4494966|NCT00810641|7297899|FG002|Overall Study|Withdrawal by Subject|2
4494967|NCT00810693|7297910|FG000|Treatment Period|Adverse Event|8
4494968|NCT00810693|7297911|FG001|Treatment Period|Adverse Event|1
4494969|NCT00810693|7297912|FG002|Treatment Period|Adverse Event|7
4494970|NCT00810693|7297910|FG000|Treatment Period|Death|0
4494971|NCT00810693|7297911|FG001|Treatment Period|Death|1
4494972|NCT00810693|7297912|FG002|Treatment Period|Death|2
4494973|NCT00810693|7297910|FG000|Treatment Period|Lack of Efficacy|0
4494974|NCT00810693|7297911|FG001|Treatment Period|Lack of Efficacy|0
4494975|NCT00810693|7297912|FG002|Treatment Period|Lack of Efficacy|1
4494976|NCT00810693|7297910|FG000|Treatment Period|Lost to Follow-up|1
4626974|NCT01848210|7493311|FG001|Overall Study|Protocol Violation|5
4494977|NCT00810693|7297911|FG001|Treatment Period|Lost to Follow-up|0
4494978|NCT00810693|7297912|FG002|Treatment Period|Lost to Follow-up|0
4494979|NCT00810693|7297910|FG000|Treatment Period|Non-compliance|1
4494980|NCT00810693|7297911|FG001|Treatment Period|Non-compliance|0
4494981|NCT00810693|7297912|FG002|Treatment Period|Non-compliance|0
4494982|NCT00810693|7297910|FG000|Treatment Period|Protocol Violation|1
4494983|NCT00810693|7297911|FG001|Treatment Period|Protocol Violation|2
4494984|NCT00810693|7297912|FG002|Treatment Period|Protocol Violation|2
4494985|NCT00810693|7297910|FG000|Treatment Period|Withdrawal by Subject|6
4494986|NCT00810693|7297911|FG001|Treatment Period|Withdrawal by Subject|2
4494987|NCT00810693|7297912|FG002|Treatment Period|Withdrawal by Subject|3
4494988|NCT00810693|7297910|FG000|Treatment Period|Not treated|0
4494989|NCT00810693|7297911|FG001|Treatment Period|Not treated|1
4494990|NCT00810693|7297912|FG002|Treatment Period|Not treated|1
4494991|NCT00810693|7297910|FG000|Follow-up Period (FUP)|Adverse Event|3
4494992|NCT00810693|7297911|FG001|Follow-up Period (FUP)|Adverse Event|1
4494993|NCT00810693|7297912|FG002|Follow-up Period (FUP)|Adverse Event|1
4494994|NCT00810693|7297910|FG000|Follow-up Period (FUP)|Death|2
4494995|NCT00810693|7297911|FG001|Follow-up Period (FUP)|Death|0
4494996|NCT00810693|7297912|FG002|Follow-up Period (FUP)|Death|1
4494997|NCT00810693|7297910|FG000|Follow-up Period (FUP)|Lost to Follow-up|1
4494998|NCT00810693|7297911|FG001|Follow-up Period (FUP)|Lost to Follow-up|0
4494999|NCT00810693|7297912|FG002|Follow-up Period (FUP)|Lost to Follow-up|2
4495000|NCT00810693|7297910|FG000|Follow-up Period (FUP)|Protocol Violation|0
4495001|NCT00810693|7297911|FG001|Follow-up Period (FUP)|Protocol Violation|1
4495002|NCT00810693|7297912|FG002|Follow-up Period (FUP)|Protocol Violation|0
4495003|NCT00810693|7297910|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2
4495004|NCT00810693|7297911|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1
4495005|NCT00810693|7297912|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0
4495006|NCT00810810|7297947|FG000|Overall Study|Withdrawal by Subject|0
4495007|NCT00810810|7297948|FG001|Overall Study|Withdrawal by Subject|8
4495008|NCT00810810|7297949|FG002|Overall Study|Withdrawal by Subject|10
4495009|NCT00810810|7297950|FG003|Overall Study|Withdrawal by Subject|8
4495010|NCT00810810|7297947|FG000|Overall Study|Physician Decision|0
4495011|NCT00810810|7297948|FG001|Overall Study|Physician Decision|3
4495012|NCT00810810|7297949|FG002|Overall Study|Physician Decision|1
4495013|NCT00810810|7297950|FG003|Overall Study|Physician Decision|5
4495014|NCT00810901|7297975|FG000|Overall Study|Lost to Follow-up|88
4495015|NCT00810901|7297976|FG001|Overall Study|Lost to Follow-up|58
4495016|NCT00811018|7297982|FG000|Overall Study|Additional Chronic Treatment|31
4495017|NCT00811018|7297982|FG000|Overall Study|Adverse Event|79
4495018|NCT00811018|7297982|FG000|Overall Study|Death|147
4495019|NCT00811018|7297982|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4
4495020|NCT00811018|7297982|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70
4495021|NCT00811018|7297982|FG000|Overall Study|Investigator Decision|57
4495022|NCT00811018|7297982|FG000|Overall Study|Lost to Follow-up|19
4495023|NCT00811018|7297982|FG000|Overall Study|Pregnancy|6
4495024|NCT00811018|7297982|FG000|Overall Study|Sponsor Decision|450
4495025|NCT00811018|7297982|FG000|Overall Study|Withdrawal by Subject|70
4495026|NCT00811018|7297982|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9
4495027|NCT00811018|7297982|FG000|Overall Study|Other|26
4495028|NCT00811057|7297989|FG000|Overall Study|Protocol Violation|5
4495029|NCT00811057|7297990|FG001|Overall Study|Protocol Violation|10
4495030|NCT00811057|7297991|FG002|Overall Study|Protocol Violation|10
4495031|NCT00811070|7298005|FG000|Overall Study|Death|0
4495032|NCT00811070|7298006|FG001|Overall Study|Death|0
4495033|NCT00811070|7298007|FG002|Overall Study|Death|0
4495034|NCT00811070|7298008|FG003|Overall Study|Death|2
4495035|NCT00811070|7298009|FG004|Overall Study|Death|5
4495036|NCT00811070|7298010|FG005|Overall Study|Death|0
4495037|NCT00811070|7298005|FG000|Overall Study|Other|1
4495038|NCT00811070|7298006|FG001|Overall Study|Other|0
4495039|NCT00811070|7298007|FG002|Overall Study|Other|0
4495040|NCT00811070|7298008|FG003|Overall Study|Other|0
4495041|NCT00811070|7298009|FG004|Overall Study|Other|0
4495042|NCT00811070|7298010|FG005|Overall Study|Other|0
4495043|NCT00811070|7298005|FG000|Overall Study|Withdrawal by Subject|0
4495044|NCT00811070|7298006|FG001|Overall Study|Withdrawal by Subject|1
4495045|NCT00811070|7298007|FG002|Overall Study|Withdrawal by Subject|0
4495046|NCT00811070|7298008|FG003|Overall Study|Withdrawal by Subject|0
4495047|NCT00811070|7298009|FG004|Overall Study|Withdrawal by Subject|0
4495048|NCT00811070|7298010|FG005|Overall Study|Withdrawal by Subject|0
4495049|NCT00811070|7298005|FG000|Overall Study|Physician Decision|0
4495050|NCT00811070|7298006|FG001|Overall Study|Physician Decision|0
4495051|NCT00811070|7298007|FG002|Overall Study|Physician Decision|0
4495052|NCT00811070|7298008|FG003|Overall Study|Physician Decision|0
4495053|NCT00811070|7298009|FG004|Overall Study|Physician Decision|0
4495054|NCT00811070|7298010|FG005|Overall Study|Physician Decision|1
4495055|NCT00811135|7298026|FG000|Overall Study|Adverse Event/Intercurrent Illness|8
4495056|NCT00811135|7298026|FG000|Overall Study|Death|3
4495057|NCT00811135|7298026|FG000|Overall Study|Protocol Violation|2
4495058|NCT00811135|7298026|FG000|Overall Study|Violation of Selection Criteria|1
4495059|NCT00811135|7298026|FG000|Overall Study|Refused Treatment|1
4495060|NCT00811135|7298026|FG000|Overall Study|Withdrawal by Subject|3
4495061|NCT00811135|7298026|FG000|Overall Study|Administrative/Other Unspecified|11
4495062|NCT00811135|7298026|FG000|Overall Study|Ongoing|59
4495063|NCT00811174|7298030|FG000|Overall Study|Protocol Violation|2
4495064|NCT00811174|7298030|FG000|Overall Study|Sponsors Decision|1
4495065|NCT00811187|7298036|FG000|Overall Study|Unable to place device / procedure abort|3
4495066|NCT00811187|7298037|FG001|Overall Study|Unable to place device / procedure abort|3
4495067|NCT00811252|7298046|FG000|Overall Study|Adverse Event|6
4495068|NCT00811252|7298047|FG001|Overall Study|Adverse Event|10
4495069|NCT00811252|7298048|FG002|Overall Study|Adverse Event|15
4495070|NCT00811252|7298046|FG000|Overall Study|Lack of Efficacy|7
4495071|NCT00811252|7298047|FG001|Overall Study|Lack of Efficacy|2
4495072|NCT00811252|7298048|FG002|Overall Study|Lack of Efficacy|0
4495073|NCT00811252|7298046|FG000|Overall Study|Protocol Violation|3
4495074|NCT00811252|7298047|FG001|Overall Study|Protocol Violation|3
4495075|NCT00811252|7298048|FG002|Overall Study|Protocol Violation|2
4495076|NCT00811252|7298046|FG000|Overall Study|Withdrawal of Consent|1
4495077|NCT00811252|7298047|FG001|Overall Study|Withdrawal of Consent|2
4495078|NCT00811252|7298048|FG002|Overall Study|Withdrawal of Consent|2
4495079|NCT00811252|7298046|FG000|Overall Study|Lost to Follow-up|0
4495080|NCT00811252|7298047|FG001|Overall Study|Lost to Follow-up|0
4495081|NCT00811252|7298048|FG002|Overall Study|Lost to Follow-up|2
4495082|NCT00811252|7298046|FG000|Overall Study|Administrative or Other Reasons|0
4495083|NCT00811252|7298047|FG001|Overall Study|Administrative or Other Reasons|3
4495084|NCT00811252|7298048|FG002|Overall Study|Administrative or Other Reasons|2
4495085|NCT00811395|7298077|FG000|Extension Treatment|Adverse Event|1
4495086|NCT00811395|7298078|FG001|Extension Treatment|Adverse Event|2
4495087|NCT00811395|7298079|FG002|Extension Treatment|Adverse Event|2
4495088|NCT00811395|7298080|FG003|Extension Treatment|Adverse Event|2
4495089|NCT00811395|7298081|FG004|Extension Treatment|Adverse Event|0
4495090|NCT00811395|7298082|FG005|Extension Treatment|Adverse Event|1
4495091|NCT00811395|7298077|FG000|Extension Treatment|Progressive disease|1
4495092|NCT00811395|7298078|FG001|Extension Treatment|Progressive disease|1
4495093|NCT00811395|7298079|FG002|Extension Treatment|Progressive disease|0
4495094|NCT00811395|7298080|FG003|Extension Treatment|Progressive disease|0
4495095|NCT00811395|7298081|FG004|Extension Treatment|Progressive disease|0
4495096|NCT00811395|7298082|FG005|Extension Treatment|Progressive disease|0
4495097|NCT00811395|7298077|FG000|Extension Treatment|Participant did not wish to continue|0
4495098|NCT00811395|7298078|FG001|Extension Treatment|Participant did not wish to continue|3
4495099|NCT00811395|7298079|FG002|Extension Treatment|Participant did not wish to continue|0
4495100|NCT00811395|7298080|FG003|Extension Treatment|Participant did not wish to continue|1
4495101|NCT00811395|7298081|FG004|Extension Treatment|Participant did not wish to continue|0
4495102|NCT00811395|7298082|FG005|Extension Treatment|Participant did not wish to continue|1
4495103|NCT00811395|7298077|FG000|Extension Treatment|Other than above|0
4495104|NCT00811395|7298078|FG001|Extension Treatment|Other than above|0
4495105|NCT00811395|7298079|FG002|Extension Treatment|Other than above|1
4703408|NCT02731729|7621068|FG000|Overall Study|Death|2
4703409|NCT02731729|7621069|FG001|Overall Study|Death|2
4703410|NCT02731729|7621068|FG000|Overall Study|Study terminated by Sponsor|6
4703411|NCT02731729|7621069|FG001|Overall Study|Study terminated by Sponsor|6
4703412|NCT02731729|7621068|FG000|Overall Study|Withdrawal by Subject|1
4703413|NCT02731729|7621069|FG001|Overall Study|Withdrawal by Subject|0
4703414|NCT02731742|7621079|FG000|Overall Study|Death|1
4703415|NCT02731742|7621080|FG001|Overall Study|Death|2
4703416|NCT02731742|7621081|FG002|Overall Study|Death|5
4703417|NCT02731742|7621082|FG003|Overall Study|Death|0
4703418|NCT02731742|7621079|FG000|Overall Study|Physician Decision|0
4703419|NCT02731742|7621080|FG001|Overall Study|Physician Decision|0
4703420|NCT02731742|7621081|FG002|Overall Study|Physician Decision|0
4703421|NCT02731742|7621082|FG003|Overall Study|Physician Decision|1
4703422|NCT02731742|7621079|FG000|Overall Study|Study Terminated by Sponsor|2
4703423|NCT02731742|7621080|FG001|Overall Study|Study Terminated by Sponsor|1
4703424|NCT02731742|7621081|FG002|Overall Study|Study Terminated by Sponsor|1
4703425|NCT02731742|7621082|FG003|Overall Study|Study Terminated by Sponsor|1
4703426|NCT02731755|7621092|FG000|First Intervention|Withdrawal by Subject|0
4703427|NCT02731755|7621093|FG001|First Intervention|Withdrawal by Subject|2
4703428|NCT02732015|7621119|FG000|Overall Study|Lost to Follow-up|0
4703429|NCT02732015|7621120|FG001|Overall Study|Lost to Follow-up|1
4703430|NCT02732119|7621131|FG000|Phase I|Adverse Event|1
4703431|NCT02732119|7621132|FG001|Phase I|Adverse Event|3
4703432|NCT02732119|7621133|FG002|Phase I|Adverse Event|1
4703433|NCT02732119|7621134|FG003|Phase I|Adverse Event|0
4703434|NCT02732119|7621135|FG004|Phase I|Adverse Event|0
4703435|NCT02732119|7621131|FG000|Phase I|Progressive disease|7
4703436|NCT02732119|7621132|FG001|Phase I|Progressive disease|3
4703437|NCT02732119|7621133|FG002|Phase I|Progressive disease|2
4703438|NCT02732119|7621134|FG003|Phase I|Progressive disease|0
4703439|NCT02732119|7621135|FG004|Phase I|Progressive disease|0
4703440|NCT02732119|7621131|FG000|Phase I|Protocol deviation|0
4703441|NCT02732119|7621132|FG001|Phase I|Protocol deviation|1
4495106|NCT00811395|7298080|FG003|Extension Treatment|Other than above|0
4495107|NCT00811395|7298081|FG004|Extension Treatment|Other than above|0
4495108|NCT00811395|7298082|FG005|Extension Treatment|Other than above|0
4703442|NCT02732119|7621133|FG002|Phase I|Protocol deviation|0
4495109|NCT00811473|7298109|FG000|Overall Study|Adverse Event|3
4703443|NCT02732119|7621134|FG003|Phase I|Protocol deviation|0
4703444|NCT02732119|7621135|FG004|Phase I|Protocol deviation|0
4703445|NCT02732119|7621131|FG000|Phase I|Physician Decision|0
4495110|NCT00811473|7298110|FG001|Overall Study|Adverse Event|12
4495111|NCT00811473|7298109|FG000|Overall Study|Lost to Follow-up|5
4495112|NCT00811473|7298110|FG001|Overall Study|Lost to Follow-up|1
4495113|NCT00811473|7298109|FG000|Overall Study|Withdrawal by Subject|2
4495114|NCT00811473|7298110|FG001|Overall Study|Withdrawal by Subject|4
4495115|NCT00811473|7298109|FG000|Overall Study|Severe non-compliance to protocol|2
4495116|NCT00811473|7298110|FG001|Overall Study|Severe non-compliance to protocol|4
4495117|NCT00811473|7298109|FG000|Overall Study|Lack of therapeutic response|4
4495118|NCT00811473|7298110|FG001|Overall Study|Lack of therapeutic response|1
4495119|NCT00811473|7298109|FG000|Overall Study|Condition under investigation worsened|1
4495120|NCT00811473|7298110|FG001|Overall Study|Condition under investigation worsened|3
4495121|NCT00811473|7298109|FG000|Overall Study|Other 2|4
4495122|NCT00811473|7298110|FG001|Overall Study|Other 2|1
4495123|NCT00811473|7298109|FG000|Overall Study|Incorrect Enrollment|1
4495124|NCT00811473|7298110|FG001|Overall Study|Incorrect Enrollment|0
4495125|NCT00811473|7298109|FG000|Overall Study|Safety Reasons|1
4495126|NCT00811473|7298110|FG001|Overall Study|Safety Reasons|0
4495127|NCT00811577|7298127|FG000|Overall Study|Lost to Follow-up|7
4495128|NCT00811577|7298128|FG001|Overall Study|Lost to Follow-up|1
4495129|NCT00811577|7298127|FG000|Overall Study|Withdrawal by Subject|3
4495130|NCT00811577|7298128|FG001|Overall Study|Withdrawal by Subject|0
4495131|NCT00811642|7298177|FG000|Overall Study|Adverse Event|3
4495132|NCT00811642|7298177|FG000|Overall Study|Protocol Violation|1
4495133|NCT00811642|7298177|FG000|Overall Study|Death|2
4495134|NCT00811642|7298177|FG000|Overall Study|Withdrawal by Subject|7
4495135|NCT00811642|7298177|FG000|Overall Study|Cumulative use of antifungal agent|2
4495136|NCT00811655|7298181|FG000|Overall Study|Physician Decision|1
4495137|NCT00811720|7298187|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2
4495138|NCT00811720|7298188|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4
4703446|NCT02732119|7621132|FG001|Phase I|Physician Decision|3
4703447|NCT02732119|7621133|FG002|Phase I|Physician Decision|4
4626975|NCT01848210|7493310|FG000|Overall Study|Use of Forbidden Drugs|9
4626976|NCT01848210|7493311|FG001|Overall Study|Use of Forbidden Drugs|10
4626977|NCT01848210|7493310|FG000|Overall Study|Impedition Condition|5
4626978|NCT01848210|7493311|FG001|Overall Study|Impedition Condition|9
4495139|NCT00811720|7298187|FG000|All Treated Patients|Adverse Event|20
4495140|NCT00811720|7298188|FG001|All Treated Patients|Adverse Event|62
4495141|NCT00811720|7298187|FG000|All Treated Patients|Lack of Efficacy|22
4495142|NCT00811720|7298188|FG001|All Treated Patients|Lack of Efficacy|18
4495143|NCT00811720|7298187|FG000|All Treated Patients|Non-compliance|0
4495144|NCT00811720|7298188|FG001|All Treated Patients|Non-compliance|14
4495145|NCT00811720|7298187|FG000|All Treated Patients|Protocol Violation|9
4495146|NCT00811720|7298188|FG001|All Treated Patients|Protocol Violation|16
4495147|NCT00811720|7298187|FG000|All Treated Patients|Withdrawal by Subject|28
4495148|NCT00811720|7298188|FG001|All Treated Patients|Withdrawal by Subject|34
4495149|NCT00811720|7298187|FG000|All Treated Patients|Lost to Follow-up|10
4495150|NCT00811720|7298188|FG001|All Treated Patients|Lost to Follow-up|16
4495151|NCT00811720|7298187|FG000|All Treated Patients|Other Reason|7
4495152|NCT00811720|7298188|FG001|All Treated Patients|Other Reason|4
4495153|NCT00811733|7298196|FG000|Overall Study|Investigator Discretion|10
4495154|NCT00811733|7298197|FG001|Overall Study|Investigator Discretion|8
4495155|NCT00811733|7298196|FG000|Overall Study|Withdrawal by Subject|1
4495156|NCT00811733|7298197|FG001|Overall Study|Withdrawal by Subject|2
4495157|NCT00811928|7298215|FG000|Overall Study|AEs and SAEs Including Death|7
4495158|NCT00811928|7298216|FG001|Overall Study|AEs and SAEs Including Death|11
4495159|NCT00811928|7298215|FG000|Overall Study|Withdrawal by Subject|18
4495160|NCT00811928|7298216|FG001|Overall Study|Withdrawal by Subject|12
4495161|NCT00811928|7298215|FG000|Overall Study|Did Not Take Study Drug|3
4495162|NCT00811928|7298216|FG001|Overall Study|Did Not Take Study Drug|0
4495163|NCT00811928|7298215|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7
4495164|NCT00811928|7298216|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4
4495165|NCT00811928|7298215|FG000|Overall Study|Investigator Decision|2
4495166|NCT00811928|7298216|FG001|Overall Study|Investigator Decision|1
4495167|NCT00811928|7298215|FG000|Overall Study|Poor Compliance|2
4495168|NCT00811928|7298216|FG001|Overall Study|Poor Compliance|5
4495169|NCT00811941|7298224|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2
4495170|NCT00811941|7298225|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8
4626979|NCT01848210|7493310|FG000|Overall Study|Adverse Event|7
4626980|NCT01848210|7493311|FG001|Overall Study|Adverse Event|9
4626981|NCT01848210|7493310|FG000|Overall Study|Discontinuation Criterion|5
4495171|NCT00811941|7298224|FG000|All Treated Patients|Adverse Event|2
4495172|NCT00811941|7298225|FG001|All Treated Patients|Adverse Event|43
4495173|NCT00811941|7298224|FG000|All Treated Patients|Lack of Efficacy|2
4495174|NCT00811941|7298225|FG001|All Treated Patients|Lack of Efficacy|3
4495175|NCT00811941|7298224|FG000|All Treated Patients|Non-compliance|1
4495176|NCT00811941|7298225|FG001|All Treated Patients|Non-compliance|8
4495177|NCT00811941|7298224|FG000|All Treated Patients|Protocol Violation|5
4626982|NCT01848210|7493311|FG001|Overall Study|Discontinuation Criterion|7
4626983|NCT01848210|7493310|FG000|Overall Study|Hypesensitivity|1
4495178|NCT00811941|7298225|FG001|All Treated Patients|Protocol Violation|17
4495179|NCT00811941|7298224|FG000|All Treated Patients|Withdrawal by Subject|35
4703448|NCT02732119|7621134|FG003|Phase I|Physician Decision|0
4703449|NCT02732119|7621135|FG004|Phase I|Physician Decision|0
4495180|NCT00811941|7298225|FG001|All Treated Patients|Withdrawal by Subject|94
4495181|NCT00811941|7298224|FG000|All Treated Patients|Lost to Follow-up|3
4495182|NCT00811941|7298225|FG001|All Treated Patients|Lost to Follow-up|12
4495183|NCT00811941|7298224|FG000|All Treated Patients|Other Reason|4
4495184|NCT00811941|7298225|FG001|All Treated Patients|Other Reason|14
4495185|NCT00811954|7298234|FG000|Overall Study|Death|10
4495186|NCT00811954|7298235|FG001|Overall Study|Death|6
4495187|NCT00811954|7298236|FG002|Overall Study|Death|13
4495188|NCT00811954|7298234|FG000|Overall Study|Lost to Follow-up|29
4495189|NCT00811954|7298235|FG001|Overall Study|Lost to Follow-up|23
4495190|NCT00811954|7298236|FG002|Overall Study|Lost to Follow-up|34
4495191|NCT00811954|7298234|FG000|Overall Study|Not able to get to clinic|28
4495192|NCT00811954|7298235|FG001|Overall Study|Not able to get to clinic|35
4495193|NCT00811954|7298236|FG002|Overall Study|Not able to get to clinic|30
4495194|NCT00811954|7298234|FG000|Overall Study|Not willing to adhere to requirements|12
4495195|NCT00811954|7298235|FG001|Overall Study|Not willing to adhere to requirements|2
4495196|NCT00811954|7298236|FG002|Overall Study|Not willing to adhere to requirements|16
4495197|NCT00811954|7298234|FG000|Overall Study|Withdraw consent prior study completion|4
4495198|NCT00811954|7298235|FG001|Overall Study|Withdraw consent prior study completion|6
4495199|NCT00811954|7298236|FG002|Overall Study|Withdraw consent prior study completion|5
4495200|NCT00811954|7298234|FG000|Overall Study|Site Closure|4
4495201|NCT00811954|7298235|FG001|Overall Study|Site Closure|0
4495202|NCT00811954|7298236|FG002|Overall Study|Site Closure|1
4495203|NCT00811954|7298234|FG000|Overall Study|Severe Debilitation|2
4495204|NCT00811954|7298235|FG001|Overall Study|Severe Debilitation|0
4495205|NCT00811954|7298236|FG002|Overall Study|Severe Debilitation|1
4495206|NCT00811954|7298234|FG000|Overall Study|Complete Protocol: No follow-up|0
4495207|NCT00811954|7298235|FG001|Overall Study|Complete Protocol: No follow-up|0
4495208|NCT00811954|7298236|FG002|Overall Study|Complete Protocol: No follow-up|1
4495209|NCT00812097|7298248|FG000|Overall Study|Death|3
4495210|NCT00812097|7298249|FG001|Overall Study|Death|10
4495211|NCT00812097|7298250|FG002|Overall Study|Death|3
4495212|NCT00812097|7298251|FG003|Overall Study|Death|3
4495213|NCT00812097|7298248|FG000|Overall Study|Withdrawal by Subject|14
4495214|NCT00812097|7298249|FG001|Overall Study|Withdrawal by Subject|12
4495215|NCT00812097|7298250|FG002|Overall Study|Withdrawal by Subject|8
4495216|NCT00812097|7298251|FG003|Overall Study|Withdrawal by Subject|2
4495217|NCT00812097|7298248|FG000|Overall Study|Lost to Follow-up|90
4495218|NCT00812097|7298249|FG001|Overall Study|Lost to Follow-up|14
4495219|NCT00812097|7298250|FG002|Overall Study|Lost to Follow-up|17
4495220|NCT00812097|7298251|FG003|Overall Study|Lost to Follow-up|5
4495221|NCT00812097|7298248|FG000|Overall Study|Explantation of study device(s)|27
4495222|NCT00812097|7298249|FG001|Overall Study|Explantation of study device(s)|29
4495223|NCT00812097|7298250|FG002|Overall Study|Explantation of study device(s)|14
4495224|NCT00812097|7298251|FG003|Overall Study|Explantation of study device(s)|20
4495225|NCT00812097|7298248|FG000|Overall Study|Unknown reasons and patient/doctor moves|111
4495226|NCT00812097|7298249|FG001|Overall Study|Unknown reasons and patient/doctor moves|24
4495227|NCT00812097|7298250|FG002|Overall Study|Unknown reasons and patient/doctor moves|15
4495228|NCT00812097|7298251|FG003|Overall Study|Unknown reasons and patient/doctor moves|5
4495229|NCT00812253|7298267|FG000|Overall Study|Withdrawal by Subject|3
4495230|NCT00812253|7298268|FG001|Overall Study|Withdrawal by Subject|2
4495231|NCT00812253|7298267|FG000|Overall Study|Protocol Violation|1
4495232|NCT00812253|7298268|FG001|Overall Study|Protocol Violation|1
4495233|NCT00812253|7298267|FG000|Overall Study|Lost to Follow-up|2
4495234|NCT00812253|7298268|FG001|Overall Study|Lost to Follow-up|0
4495235|NCT00812331|7298279|FG000|Overall Study|Adverse Event|1
4495236|NCT00812331|7298280|FG001|Overall Study|Adverse Event|0
4495237|NCT00812331|7298281|FG002|Overall Study|Adverse Event|0
4495238|NCT00812331|7298282|FG003|Overall Study|Adverse Event|0
4495239|NCT00812331|7298283|FG004|Overall Study|Adverse Event|0
4495240|NCT00812461|7298293|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23
4495241|NCT00812461|7298294|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17
4495242|NCT00812461|7298293|FG000|All Treated Patients|Adverse Event|8
4495243|NCT00812461|7298294|FG001|All Treated Patients|Adverse Event|15
4495244|NCT00812461|7298293|FG000|All Treated Patients|Lack of Efficacy|13
4495245|NCT00812461|7298294|FG001|All Treated Patients|Lack of Efficacy|7
4495246|NCT00812461|7298293|FG000|All Treated Patients|Non-compliance|6
4495247|NCT00812461|7298294|FG001|All Treated Patients|Non-compliance|9
4495248|NCT00812461|7298293|FG000|All Treated Patients|Protocol Violation|36
4495249|NCT00812461|7298294|FG001|All Treated Patients|Protocol Violation|27
4495250|NCT00812461|7298293|FG000|All Treated Patients|Withdrawal by Subject|45
4495251|NCT00812461|7298294|FG001|All Treated Patients|Withdrawal by Subject|54
4495252|NCT00812461|7298293|FG000|All Treated Patients|Lost to Follow-up|11
4495253|NCT00812461|7298294|FG001|All Treated Patients|Lost to Follow-up|14
4495254|NCT00812461|7298293|FG000|All Treated Patients|Other Reason|13
4495255|NCT00812461|7298294|FG001|All Treated Patients|Other Reason|21
4495256|NCT00812487|7298302|FG000|Overall Study|Lost to Follow-up|2
4495257|NCT00812487|7298303|FG001|Overall Study|Lost to Follow-up|0
4495258|NCT00812487|7298302|FG000|Overall Study|Withdrawal by Subject|3
4703450|NCT02732119|7621131|FG000|Phase II|Adverse Event|0
4495259|NCT00812487|7298303|FG001|Overall Study|Withdrawal by Subject|2
4495260|NCT00812487|7298302|FG000|Overall Study|Transfer to ICU prior to intervention|1
4495261|NCT00812487|7298303|FG001|Overall Study|Transfer to ICU prior to intervention|0
4495262|NCT00812487|7298302|FG000|Overall Study|Protocol Violation|0
4495263|NCT00812487|7298303|FG001|Overall Study|Protocol Violation|1
4495264|NCT00812565|7298317|FG000|Overall Study|Did Not Receive Study Medication|1
4495265|NCT00812565|7298318|FG001|Overall Study|Did Not Receive Study Medication|1
4495266|NCT00812565|7298319|FG002|Overall Study|Did Not Receive Study Medication|0
4495267|NCT00812565|7298320|FG003|Overall Study|Did Not Receive Study Medication|0
4495268|NCT00812565|7298321|FG004|Overall Study|Did Not Receive Study Medication|0
4495269|NCT00812565|7298322|FG005|Overall Study|Did Not Receive Study Medication|0
4495270|NCT00812565|7298323|FG006|Overall Study|Did Not Receive Study Medication|0
4495271|NCT00812565|7298324|FG007|Overall Study|Did Not Receive Study Medication|0
4495272|NCT00812565|7298317|FG000|Overall Study|Adverse Event|0
4495273|NCT00812565|7298318|FG001|Overall Study|Adverse Event|0
4495274|NCT00812565|7298319|FG002|Overall Study|Adverse Event|0
4495275|NCT00812565|7298320|FG003|Overall Study|Adverse Event|2
4495276|NCT00812565|7298321|FG004|Overall Study|Adverse Event|0
4495277|NCT00812565|7298322|FG005|Overall Study|Adverse Event|0
4495278|NCT00812565|7298323|FG006|Overall Study|Adverse Event|0
4495279|NCT00812565|7298324|FG007|Overall Study|Adverse Event|1
4495280|NCT00812565|7298317|FG000|Overall Study|Did Not Come to Study Visit|1
4495281|NCT00812565|7298318|FG001|Overall Study|Did Not Come to Study Visit|0
4495282|NCT00812565|7298319|FG002|Overall Study|Did Not Come to Study Visit|0
4495283|NCT00812565|7298320|FG003|Overall Study|Did Not Come to Study Visit|0
4495284|NCT00812565|7298321|FG004|Overall Study|Did Not Come to Study Visit|0
4495285|NCT00812565|7298322|FG005|Overall Study|Did Not Come to Study Visit|0
4495286|NCT00812565|7298323|FG006|Overall Study|Did Not Come to Study Visit|0
4495287|NCT00812565|7298324|FG007|Overall Study|Did Not Come to Study Visit|0
4495288|NCT00812565|7298317|FG000|Overall Study|Withdrawal of Consent|1
4495289|NCT00812565|7298318|FG001|Overall Study|Withdrawal of Consent|0
4495290|NCT00812565|7298319|FG002|Overall Study|Withdrawal of Consent|0
4495291|NCT00812565|7298320|FG003|Overall Study|Withdrawal of Consent|0
4495292|NCT00812565|7298321|FG004|Overall Study|Withdrawal of Consent|1
4495293|NCT00812565|7298322|FG005|Overall Study|Withdrawal of Consent|0
4495294|NCT00812565|7298323|FG006|Overall Study|Withdrawal of Consent|0
4495295|NCT00812565|7298324|FG007|Overall Study|Withdrawal of Consent|0
4495296|NCT00812565|7298317|FG000|Overall Study|Reason Not Specified|0
4495297|NCT00812565|7298318|FG001|Overall Study|Reason Not Specified|0
4495298|NCT00812565|7298319|FG002|Overall Study|Reason Not Specified|0
4495299|NCT00812565|7298320|FG003|Overall Study|Reason Not Specified|0
4495300|NCT00812565|7298321|FG004|Overall Study|Reason Not Specified|0
4495301|NCT00812565|7298322|FG005|Overall Study|Reason Not Specified|1
4495302|NCT00812565|7298323|FG006|Overall Study|Reason Not Specified|0
4495303|NCT00812565|7298324|FG007|Overall Study|Reason Not Specified|0
4495304|NCT00812812|7298353|FG000|Overall Study|Adverse Event|2
4495305|NCT00812812|7298354|FG001|Overall Study|Adverse Event|1
4495306|NCT00812812|7298353|FG000|Overall Study|Lack of Efficacy|1
4495307|NCT00812812|7298354|FG001|Overall Study|Lack of Efficacy|0
4495308|NCT00812812|7298353|FG000|Overall Study|Lost to Follow-up|0
4495309|NCT00812812|7298354|FG001|Overall Study|Lost to Follow-up|1
4495310|NCT00812812|7298353|FG000|Overall Study|Withdrawal by Subject|0
4495311|NCT00812812|7298354|FG001|Overall Study|Withdrawal by Subject|2
4495312|NCT00812929|7298388|FG000|Washout Period 1 (7 Days)|Physician Decision|0
4495313|NCT00812929|7298389|FG001|Washout Period 1 (7 Days)|Physician Decision|0
4495314|NCT00812929|7298390|FG002|Washout Period 1 (7 Days)|Physician Decision|1
4495315|NCT00812929|7298391|FG003|Washout Period 1 (7 Days)|Physician Decision|0
4495316|NCT00812929|7298392|FG004|Washout Period 1 (7 Days)|Physician Decision|0
4495317|NCT00812929|7298393|FG005|Washout Period 1 (7 Days)|Physician Decision|0
4495318|NCT00812929|7298394|FG006|Washout Period 1 (7 Days)|Physician Decision|0
4495319|NCT00812929|7298395|FG007|Washout Period 1 (7 Days)|Physician Decision|0
4495320|NCT00812929|7298396|FG008|Washout Period 1 (7 Days)|Physician Decision|0
4495321|NCT00812929|7298397|FG009|Washout Period 1 (7 Days)|Physician Decision|0
4495322|NCT00812929|7298388|FG000|Washout Period 2 (7 Days)|Physician Decision|0
4495323|NCT00812929|7298389|FG001|Washout Period 2 (7 Days)|Physician Decision|0
4495324|NCT00812929|7298390|FG002|Washout Period 2 (7 Days)|Physician Decision|0
4495325|NCT00812929|7298391|FG003|Washout Period 2 (7 Days)|Physician Decision|0
4495326|NCT00812929|7298392|FG004|Washout Period 2 (7 Days)|Physician Decision|0
4495327|NCT00812929|7298393|FG005|Washout Period 2 (7 Days)|Physician Decision|0
4495328|NCT00812929|7298394|FG006|Washout Period 2 (7 Days)|Physician Decision|0
4495329|NCT00812929|7298395|FG007|Washout Period 2 (7 Days)|Physician Decision|0
4495330|NCT00812929|7298396|FG008|Washout Period 2 (7 Days)|Physician Decision|0
4495331|NCT00812929|7298397|FG009|Washout Period 2 (7 Days)|Physician Decision|1
4495332|NCT00812929|7298388|FG000|Washout Period 3 (7 Days)|Adverse Event|0
4495333|NCT00812929|7298389|FG001|Washout Period 3 (7 Days)|Adverse Event|0
4495334|NCT00812929|7298390|FG002|Washout Period 3 (7 Days)|Adverse Event|0
4495335|NCT00812929|7298391|FG003|Washout Period 3 (7 Days)|Adverse Event|0
4495336|NCT00812929|7298392|FG004|Washout Period 3 (7 Days)|Adverse Event|0
4495337|NCT00812929|7298393|FG005|Washout Period 3 (7 Days)|Adverse Event|1
4495338|NCT00812929|7298394|FG006|Washout Period 3 (7 Days)|Adverse Event|0
4495339|NCT00812929|7298395|FG007|Washout Period 3 (7 Days)|Adverse Event|0
4495340|NCT00812929|7298396|FG008|Washout Period 3 (7 Days)|Adverse Event|0
4495341|NCT00812929|7298397|FG009|Washout Period 3 (7 Days)|Adverse Event|0
4495342|NCT00812955|7298418|FG000|Overall Study|Adverse Event|7
4495343|NCT00812955|7298419|FG001|Overall Study|Adverse Event|6
4495344|NCT00812955|7298420|FG002|Overall Study|Adverse Event|3
4495345|NCT00812955|7298421|FG003|Overall Study|Adverse Event|4
4495346|NCT00812955|7298418|FG000|Overall Study|Lost to Follow-up|2
4495347|NCT00812955|7298419|FG001|Overall Study|Lost to Follow-up|1
4495348|NCT00812955|7298420|FG002|Overall Study|Lost to Follow-up|1
4495349|NCT00812955|7298421|FG003|Overall Study|Lost to Follow-up|2
4495350|NCT00812955|7298418|FG000|Overall Study|Withdrawal by Subject|1
4495351|NCT00812955|7298419|FG001|Overall Study|Withdrawal by Subject|0
4495352|NCT00812955|7298420|FG002|Overall Study|Withdrawal by Subject|1
4495353|NCT00812955|7298421|FG003|Overall Study|Withdrawal by Subject|2
4495354|NCT00812955|7298418|FG000|Overall Study|randomized in error|0
4495355|NCT00812955|7298419|FG001|Overall Study|randomized in error|0
4495356|NCT00812955|7298420|FG002|Overall Study|randomized in error|1
4495357|NCT00812955|7298421|FG003|Overall Study|randomized in error|0
4495358|NCT00812968|7298435|FG000|Overall Study|Relapse after erythroid response|6
4495359|NCT00812968|7298435|FG000|Overall Study|Disease progression|1
4495360|NCT00812968|7298435|FG000|Overall Study|No further treatment required|1
4495361|NCT00812968|7298435|FG000|Overall Study|Study closed due to marketing approval|3
4495362|NCT00812981|7298443|FG000|Overall Study|Other|0
4495363|NCT00812981|7298444|FG001|Overall Study|Other|1
4495364|NCT00813098|7298453|FG000|Overall Study|Adverse Event|2
4495365|NCT00813098|7298454|FG001|Overall Study|Adverse Event|4
4495366|NCT00813098|7298455|FG002|Overall Study|Adverse Event|1
4495367|NCT00813098|7298453|FG000|Overall Study|Withdrawal by Subject|0
4495368|NCT00813098|7298454|FG001|Overall Study|Withdrawal by Subject|1
4495369|NCT00813098|7298455|FG002|Overall Study|Withdrawal by Subject|0
4495370|NCT00813098|7298453|FG000|Overall Study|Inability to complete study procedures|1
4495371|NCT00813098|7298454|FG001|Overall Study|Inability to complete study procedures|0
4495372|NCT00813098|7298455|FG002|Overall Study|Inability to complete study procedures|0
4495373|NCT00813098|7298453|FG000|Overall Study|Lost to Follow-up|0
4495374|NCT00813098|7298454|FG001|Overall Study|Lost to Follow-up|1
4495375|NCT00813098|7298455|FG002|Overall Study|Lost to Follow-up|0
4495376|NCT00813098|7298453|FG000|Overall Study|Protocol Violation|0
4495377|NCT00813098|7298454|FG001|Overall Study|Protocol Violation|0
4495378|NCT00813098|7298455|FG002|Overall Study|Protocol Violation|1
4495379|NCT00813098|7298453|FG000|Overall Study|Principal Investigator decision|0
4495380|NCT00813098|7298454|FG001|Overall Study|Principal Investigator decision|1
4495381|NCT00813098|7298455|FG002|Overall Study|Principal Investigator decision|0
4495382|NCT00813098|7298453|FG000|Overall Study|Withdrew Consent|0
4495383|NCT00813098|7298454|FG001|Overall Study|Withdrew Consent|1
4495384|NCT00813098|7298455|FG002|Overall Study|Withdrew Consent|0
4495385|NCT00813124|7298472|FG000|Overall Study|Death|2
4495386|NCT00813124|7298472|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9
4495387|NCT00813124|7298472|FG000|Overall Study|Withdrawal by Subject|1
4495388|NCT00813150|7298478|FG000|Treatment Period|Adverse Event|16
4495389|NCT00813150|7298479|FG001|Treatment Period|Adverse Event|15
4495390|NCT00813150|7298478|FG000|Treatment Period|Death|2
4495391|NCT00813150|7298479|FG001|Treatment Period|Death|0
4495392|NCT00813150|7298478|FG000|Treatment Period|Progressive disease|1
4495393|NCT00813150|7298479|FG001|Treatment Period|Progressive disease|0
4495394|NCT00813150|7298478|FG000|Treatment Period|Complete response|0
4495395|NCT00813150|7298479|FG001|Treatment Period|Complete response|1
4495396|NCT00813150|7298478|FG000|Treatment Period|Stable disease|1
4495397|NCT00813150|7298479|FG001|Treatment Period|Stable disease|2
4495398|NCT00813150|7298478|FG000|Treatment Period|Protocol Violation|3
4495399|NCT00813150|7298479|FG001|Treatment Period|Protocol Violation|4
4495400|NCT00813150|7298478|FG000|Treatment Period|Withdrawal by Subject|5
4495401|NCT00813150|7298479|FG001|Treatment Period|Withdrawal by Subject|3
4495402|NCT00813150|7298478|FG000|Treatment Period|Non compliance|0
4495403|NCT00813150|7298479|FG001|Treatment Period|Non compliance|1
4495404|NCT00813150|7298478|FG000|Treatment Period|Reason not specified|3
4495405|NCT00813150|7298479|FG001|Treatment Period|Reason not specified|4
4495406|NCT00813150|7298478|FG000|Treatment Period|Data not available|1
4495407|NCT00813150|7298479|FG001|Treatment Period|Data not available|2
4495408|NCT00813150|7298478|FG000|Long Term Follow-up|Death|0
4495409|NCT00813150|7298479|FG001|Long Term Follow-up|Death|4
4495410|NCT00813150|7298478|FG000|Long Term Follow-up|Other|0
4495411|NCT00813150|7298479|FG001|Long Term Follow-up|Other|3
4495412|NCT00813150|7298478|FG000|Long Term Follow-up|Lost to Follow-up|2
4495413|NCT00813150|7298479|FG001|Long Term Follow-up|Lost to Follow-up|0
4495414|NCT00813150|7298478|FG000|Long Term Follow-up|Progression/Relapse|22
4495415|NCT00813150|7298479|FG001|Long Term Follow-up|Progression/Relapse|24
4495416|NCT00813293|7298498|FG000|Overall Study|Intercurrent illness|1
4495417|NCT00813293|7298499|FG001|Overall Study|Intercurrent illness|0
4495418|NCT00813293|7298498|FG000|Overall Study|Adverse Event|0
4495419|NCT00813293|7298499|FG001|Overall Study|Adverse Event|1
4495420|NCT00813358|7298514|FG000|Overall Study|Death|32
4495421|NCT00813358|7298514|FG000|Overall Study|Lost to Follow-up|12
4495422|NCT00813358|7298514|FG000|Overall Study|other endpoints|5
4495423|NCT00813358|7298514|FG000|Overall Study|Withdrawal by Subject|20
4495424|NCT00813488|7298518|FG000|Titration Period 1|Adverse Event|6
4495425|NCT00813488|7298519|FG001|Titration Period 1|Adverse Event|1
4495426|NCT00813488|7298518|FG000|Titration Period 1|Lack of Efficacy|9
4495427|NCT00813488|7298519|FG001|Titration Period 1|Lack of Efficacy|7
4495428|NCT00813488|7298518|FG000|Titration Period 1|Withdrawal by Subject|2
4495429|NCT00813488|7298519|FG001|Titration Period 1|Withdrawal by Subject|2
4495430|NCT00813488|7298518|FG000|Titration Period 1|Protocol Violation|4
4495431|NCT00813488|7298519|FG001|Titration Period 1|Protocol Violation|3
4495432|NCT00813488|7298518|FG000|Titration Period 1|Non-compliance to study medication|4
4495433|NCT00813488|7298519|FG001|Titration Period 1|Non-compliance to study medication|1
4495434|NCT00813488|7298518|FG000|Titration Period 1|Non-compliance to study procedures|2
4495435|NCT00813488|7298519|FG001|Titration Period 1|Non-compliance to study procedures|2
4495436|NCT00813488|7298518|FG000|Titration Period 1|Technical Difficulties|0
4495437|NCT00813488|7298519|FG001|Titration Period 1|Technical Difficulties|1
4495438|NCT00813488|7298518|FG000|Titration Period 2|Adverse Event|2
4495439|NCT00813488|7298519|FG001|Titration Period 2|Adverse Event|3
4495440|NCT00813488|7298518|FG000|Titration Period 2|Lack of Efficacy|8
4495441|NCT00813488|7298519|FG001|Titration Period 2|Lack of Efficacy|4
4495442|NCT00813488|7298518|FG000|Titration Period 2|Protocol Violation|3
4495443|NCT00813488|7298519|FG001|Titration Period 2|Protocol Violation|2
4495444|NCT00813488|7298518|FG000|Titration Period 2|Lost to Follow-up|1
4495445|NCT00813488|7298519|FG001|Titration Period 2|Lost to Follow-up|0
4495446|NCT00813488|7298518|FG000|Titration Period 2|Non-compliance with study procedures|2
4495447|NCT00813488|7298519|FG001|Titration Period 2|Non-compliance with study procedures|1
4495448|NCT00813488|7298518|FG000|Double-blind Treatment Period 1|Adverse Event|1
4495449|NCT00813488|7298519|FG001|Double-blind Treatment Period 1|Adverse Event|1
4495450|NCT00813488|7298518|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0
4495451|NCT00813488|7298519|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1
4495452|NCT00813488|7298518|FG000|Double-blind Treatment Period 1|Protocol Violation|0
4495453|NCT00813488|7298519|FG001|Double-blind Treatment Period 1|Protocol Violation|2
4495454|NCT00813488|7298518|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0
4495455|NCT00813488|7298519|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1
4495456|NCT00813488|7298518|FG000|Double-blind Treatment Period 2|Adverse Event|1
4495457|NCT00813488|7298519|FG001|Double-blind Treatment Period 2|Adverse Event|0
4495458|NCT00813488|7298518|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1
4495459|NCT00813488|7298519|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1
4495460|NCT00813488|7298518|FG000|Double-blind Treatment Period 2|Protocol Violation|2
4495461|NCT00813488|7298519|FG001|Double-blind Treatment Period 2|Protocol Violation|0
4495462|NCT00813488|7298518|FG000|Double-blind Treatment Period 2|Other|1
4495463|NCT00813488|7298519|FG001|Double-blind Treatment Period 2|Other|0
4495464|NCT00813488|7298518|FG000|Open-label Extension|Adverse Event|1
4495465|NCT00813488|7298519|FG001|Open-label Extension|Adverse Event|2
4495466|NCT00813488|7298518|FG000|Open-label Extension|Lack of Efficacy|3
4495467|NCT00813488|7298519|FG001|Open-label Extension|Lack of Efficacy|0
4495468|NCT00813488|7298518|FG000|Open-label Extension|Withdrawal by Subject|0
4495469|NCT00813488|7298519|FG001|Open-label Extension|Withdrawal by Subject|2
4495470|NCT00813488|7298518|FG000|Open-label Extension|Protocol Violation|1
4495471|NCT00813488|7298519|FG001|Open-label Extension|Protocol Violation|2
4495472|NCT00813488|7298518|FG000|Open-label Extension|Non-compliance study medication|4
4495473|NCT00813488|7298519|FG001|Open-label Extension|Non-compliance study medication|0
4495474|NCT00813488|7298518|FG000|Open-label Extension|Non-compliance study procedures|2
4495475|NCT00813488|7298519|FG001|Open-label Extension|Non-compliance study procedures|1
4495476|NCT00813488|7298518|FG000|Open-label Extension|Other|1
4495477|NCT00813488|7298519|FG001|Open-label Extension|Other|0
4495478|NCT00813592|7298529|FG000|Overall Study|Disease assessment was not completed per|2
4495479|NCT00813709|7298537|FG000|Double Blind Period|Adverse Event|4
4495480|NCT00813709|7298538|FG001|Double Blind Period|Adverse Event|1
4495481|NCT00813709|7298539|FG002|Double Blind Period|Adverse Event|4
4495482|NCT00813709|7298540|FG003|Double Blind Period|Adverse Event|0
4495483|NCT00813709|7298541|FG004|Double Blind Period|Adverse Event|0
4495484|NCT00813709|7298542|FG005|Double Blind Period|Adverse Event|0
4495485|NCT00813709|7298537|FG000|Double Blind Period|Lost to Follow-up|3
4495486|NCT00813709|7298538|FG001|Double Blind Period|Lost to Follow-up|2
4495487|NCT00813709|7298539|FG002|Double Blind Period|Lost to Follow-up|2
4495488|NCT00813709|7298540|FG003|Double Blind Period|Lost to Follow-up|0
4495489|NCT00813709|7298541|FG004|Double Blind Period|Lost to Follow-up|0
4495490|NCT00813709|7298542|FG005|Double Blind Period|Lost to Follow-up|0
4495491|NCT00813709|7298537|FG000|Double Blind Period|Switched to open label phase|9
4495492|NCT00813709|7298538|FG001|Double Blind Period|Switched to open label phase|26
4495493|NCT00813709|7298539|FG002|Double Blind Period|Switched to open label phase|18
4495494|NCT00813709|7298540|FG003|Double Blind Period|Switched to open label phase|0
4495495|NCT00813709|7298541|FG004|Double Blind Period|Switched to open label phase|0
4495496|NCT00813709|7298542|FG005|Double Blind Period|Switched to open label phase|0
4495497|NCT00813709|7298537|FG000|Double Blind Period|Randomized but not treated|1
4495498|NCT00813709|7298538|FG001|Double Blind Period|Randomized but not treated|3
4495499|NCT00813709|7298539|FG002|Double Blind Period|Randomized but not treated|1
4495500|NCT00813709|7298540|FG003|Double Blind Period|Randomized but not treated|0
4495501|NCT00813709|7298541|FG004|Double Blind Period|Randomized but not treated|0
4495502|NCT00813709|7298542|FG005|Double Blind Period|Randomized but not treated|0
4495503|NCT00813709|7298537|FG000|Double Blind Period|Other|14
4495504|NCT00813709|7298538|FG001|Double Blind Period|Other|9
4495505|NCT00813709|7298539|FG002|Double Blind Period|Other|6
4495506|NCT00813709|7298540|FG003|Double Blind Period|Other|0
4495507|NCT00813709|7298541|FG004|Double Blind Period|Other|0
4495508|NCT00813709|7298542|FG005|Double Blind Period|Other|0
4495509|NCT00813709|7298537|FG000|Open Label Period|Adverse Event|0
4495510|NCT00813709|7298538|FG001|Open Label Period|Adverse Event|0
4495511|NCT00813709|7298539|FG002|Open Label Period|Adverse Event|0
4495512|NCT00813709|7298540|FG003|Open Label Period|Adverse Event|5
4495513|NCT00813709|7298541|FG004|Open Label Period|Adverse Event|4
4495514|NCT00813709|7298542|FG005|Open Label Period|Adverse Event|3
4495515|NCT00813709|7298537|FG000|Open Label Period|Lack of Efficacy|0
4495516|NCT00813709|7298538|FG001|Open Label Period|Lack of Efficacy|0
4495517|NCT00813709|7298539|FG002|Open Label Period|Lack of Efficacy|0
4495518|NCT00813709|7298540|FG003|Open Label Period|Lack of Efficacy|3
4495519|NCT00813709|7298541|FG004|Open Label Period|Lack of Efficacy|1
4495520|NCT00813709|7298542|FG005|Open Label Period|Lack of Efficacy|1
4495521|NCT00813709|7298537|FG000|Open Label Period|Randomized but not treated|0
4495522|NCT00813709|7298538|FG001|Open Label Period|Randomized but not treated|0
4495523|NCT00813709|7298539|FG002|Open Label Period|Randomized but not treated|0
4495524|NCT00813709|7298540|FG003|Open Label Period|Randomized but not treated|1
4495525|NCT00813709|7298541|FG004|Open Label Period|Randomized but not treated|0
4495526|NCT00813709|7298542|FG005|Open Label Period|Randomized but not treated|1
4495527|NCT00813709|7298537|FG000|Open Label Period|Other|0
4495528|NCT00813709|7298538|FG001|Open Label Period|Other|0
4495529|NCT00813709|7298539|FG002|Open Label Period|Other|0
4495530|NCT00813709|7298540|FG003|Open Label Period|Other|11
4495531|NCT00813709|7298541|FG004|Open Label Period|Other|5
4495532|NCT00813709|7298542|FG005|Open Label Period|Other|6
4495533|NCT00813748|7298573|FG000|Skin Test Substudy|Physician Decision|0
4495534|NCT00813748|7298574|FG001|Skin Test Substudy|Physician Decision|1
4495535|NCT00813761|7298584|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2
4495536|NCT00813761|7298585|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
4495537|NCT00813761|7298586|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
4495538|NCT00813761|7298587|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
4495539|NCT00813761|7298584|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0
4495540|NCT00813761|7298585|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0
4495541|NCT00813761|7298586|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3
4495542|NCT00813761|7298587|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1
4495543|NCT00813761|7298584|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
4495544|NCT00813761|7298585|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
4495545|NCT00813761|7298586|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
4495546|NCT00813761|7298587|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0
4495547|NCT00813761|7298584|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0
4495548|NCT00813761|7298585|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0
4495549|NCT00813761|7298586|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3
4495550|NCT00813761|7298587|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0
4495551|NCT00813761|7298584|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
4495552|NCT00813761|7298585|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
4495553|NCT00813761|7298586|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5
4495554|NCT00813761|7298587|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
4495555|NCT00813761|7298584|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
4495556|NCT00813761|7298585|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1
4495557|NCT00813761|7298586|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
4495558|NCT00813761|7298587|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
4495559|NCT00813761|7298584|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2
4495560|NCT00813761|7298585|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3
4495561|NCT00813761|7298586|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0
4495562|NCT00813761|7298587|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0
4495563|NCT00813761|7298584|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3
4495564|NCT00813761|7298585|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0
4495565|NCT00813761|7298586|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2
4495566|NCT00813761|7298587|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1
4495567|NCT00813761|7298584|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0
4495568|NCT00813761|7298585|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1
4495569|NCT00813761|7298586|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0
4495570|NCT00813761|7298587|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1
4495571|NCT00813761|7298584|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
4495572|NCT00813761|7298585|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
4495573|NCT00813761|7298586|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
4495574|NCT00813761|7298587|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0
4495575|NCT00813761|7298584|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1
4495576|NCT00813761|7298585|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4
4495577|NCT00813761|7298586|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0
4495578|NCT00813761|7298587|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3
4495579|NCT00813761|7298584|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9
4703451|NCT02732119|7621132|FG001|Phase II|Adverse Event|0
4703452|NCT02732119|7621133|FG002|Phase II|Adverse Event|0
4703453|NCT02732119|7621134|FG003|Phase II|Adverse Event|3
4703454|NCT02732119|7621135|FG004|Phase II|Adverse Event|3
4703455|NCT02732119|7621131|FG000|Phase II|Death|0
4703456|NCT02732119|7621132|FG001|Phase II|Death|0
4703457|NCT02732119|7621133|FG002|Phase II|Death|0
4703458|NCT02732119|7621134|FG003|Phase II|Death|1
4703459|NCT02732119|7621135|FG004|Phase II|Death|0
4703460|NCT02732119|7621131|FG000|Phase II|Progressive dissease|0
4703461|NCT02732119|7621132|FG001|Phase II|Progressive dissease|0
4703462|NCT02732119|7621133|FG002|Phase II|Progressive dissease|0
4703463|NCT02732119|7621134|FG003|Phase II|Progressive dissease|30
4703464|NCT02732119|7621135|FG004|Phase II|Progressive dissease|23
4703465|NCT02732119|7621131|FG000|Phase II|Study terminated by sponsor|0
4703466|NCT02732119|7621132|FG001|Phase II|Study terminated by sponsor|0
4703467|NCT02732119|7621133|FG002|Phase II|Study terminated by sponsor|0
4703468|NCT02732119|7621134|FG003|Phase II|Study terminated by sponsor|2
4703469|NCT02732119|7621135|FG004|Phase II|Study terminated by sponsor|2
4495580|NCT00813761|7298585|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0
4495581|NCT00813761|7298586|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6
4495582|NCT00813761|7298587|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0
4495583|NCT00813800|7298603|FG000|Overall Study|Screen Failure after Consent|2
4495584|NCT00813800|7298603|FG000|Overall Study|Adverse Event|1
4495585|NCT00813800|7298603|FG000|Overall Study|Worsening of depression|2
4495586|NCT00813800|7298603|FG000|Overall Study|Physician Decision|1
4495587|NCT00813813|7298609|FG000|Overall Study|Withdrawal by Subject|1
4495588|NCT00813813|7298610|FG001|Overall Study|Withdrawal by Subject|1
4495589|NCT00813813|7298609|FG000|Overall Study|Lost to Follow-up|2
4495590|NCT00813813|7298610|FG001|Overall Study|Lost to Follow-up|7
4495591|NCT00813813|7298609|FG000|Overall Study|Other|0
4495592|NCT00813813|7298610|FG001|Overall Study|Other|1
4495593|NCT00813865|7298616|FG000|Overall Study|Failure to Respond|3
4495594|NCT00813865|7298616|FG000|Overall Study|Lost to Follow-up|3
4495595|NCT00813865|7298616|FG000|Overall Study|Withdrawal by Subject|1
4495596|NCT00813904|7298620|FG000|Overall Study|Death|1
4495597|NCT00813917|7298626|FG000|Overall Study|Adverse Event|0
4495598|NCT00813917|7298627|FG001|Overall Study|Adverse Event|1
4495599|NCT00813917|7298626|FG000|Overall Study|Withdrawal by Subject|3
4495600|NCT00813917|7298627|FG001|Overall Study|Withdrawal by Subject|4
4495601|NCT00813917|7298626|FG000|Overall Study|Lost to Follow-up|3
4495602|NCT00813917|7298627|FG001|Overall Study|Lost to Follow-up|1
4517700|NCT00968812|7329590|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13
4517701|NCT00968812|7329591|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7
4517702|NCT00968812|7329589|FG000|Overall Study|Noncompliance with study drug|4
4517703|NCT00968812|7329590|FG001|Overall Study|Noncompliance with study drug|1
4517704|NCT00968812|7329591|FG002|Overall Study|Noncompliance with study drug|6
4517705|NCT00968812|7329589|FG000|Overall Study|Unable to take rescue therapy|12
4517706|NCT00968812|7329590|FG001|Overall Study|Unable to take rescue therapy|12
4517707|NCT00968812|7329591|FG002|Overall Study|Unable to take rescue therapy|17
4517708|NCT00968812|7329589|FG000|Overall Study|Other|25
4517709|NCT00968812|7329590|FG001|Overall Study|Other|37
4517710|NCT00968812|7329591|FG002|Overall Study|Other|40
4517711|NCT00968968|7329622|FG000|Overall Study|Study closed/terminated|10
4517712|NCT00968968|7329623|FG001|Overall Study|Study closed/terminated|10
4517713|NCT00968968|7329622|FG000|Overall Study|Protocol defined stopping criteria|3
4517714|NCT00968968|7329623|FG001|Overall Study|Protocol defined stopping criteria|1
4517715|NCT00968968|7329622|FG000|Overall Study|Withdrawal by Subject|2
4517716|NCT00968968|7329623|FG001|Overall Study|Withdrawal by Subject|0
4517717|NCT00968968|7329622|FG000|Overall Study|Physician Decision|1
4517718|NCT00968968|7329623|FG001|Overall Study|Physician Decision|2
4517719|NCT00968968|7329622|FG000|Overall Study|Lost to Follow-up|0
4517720|NCT00968968|7329623|FG001|Overall Study|Lost to Follow-up|1
4517721|NCT00968981|7329633|FG000|Overall Study|Adverse Event|2
4517722|NCT00968981|7329634|FG001|Overall Study|Adverse Event|0
4517723|NCT00968981|7329635|FG002|Overall Study|Adverse Event|0
4517724|NCT00968981|7329633|FG000|Overall Study|Disease Progression|14
4517725|NCT00968981|7329634|FG001|Overall Study|Disease Progression|16
4517726|NCT00968981|7329635|FG002|Overall Study|Disease Progression|13
4517727|NCT00968981|7329633|FG000|Overall Study|Lost to Follow-up|0
4517728|NCT00968981|7329634|FG001|Overall Study|Lost to Follow-up|0
4517729|NCT00968981|7329635|FG002|Overall Study|Lost to Follow-up|1
4517730|NCT00968981|7329633|FG000|Overall Study|Physician Decision|5
4517731|NCT00968981|7329634|FG001|Overall Study|Physician Decision|3
4517732|NCT00968981|7329635|FG002|Overall Study|Physician Decision|5
4517733|NCT00968981|7329633|FG000|Overall Study|Withdrawal by Subject|1
4517734|NCT00968981|7329634|FG001|Overall Study|Withdrawal by Subject|3
4517735|NCT00968981|7329635|FG002|Overall Study|Withdrawal by Subject|3
4517736|NCT00969124|7329644|FG000|Overall Study|Protocol Violation|2
4517737|NCT00969124|7329644|FG000|Overall Study|Inadequate bowel preparation|15
4703470|NCT02732119|7621131|FG000|Phase II|Other|0
4703471|NCT02732119|7621132|FG001|Phase II|Other|0
4703472|NCT02732119|7621133|FG002|Phase II|Other|0
4703473|NCT02732119|7621134|FG003|Phase II|Other|2
4703474|NCT02732119|7621135|FG004|Phase II|Other|0
4703475|NCT02732119|7621131|FG000|Phase II|Physician Decision|0
4495603|NCT00813943|7298636|FG000|Overall Study|Ongoing at cut-off date|5
4495604|NCT00813943|7298637|FG001|Overall Study|Ongoing at cut-off date|5
4495605|NCT00813943|7298638|FG002|Overall Study|Ongoing at cut-off date|3
4495606|NCT00813995|7298655|FG000|Overall Study|Clinical adverse event|9
4495607|NCT00813995|7298656|FG001|Overall Study|Clinical adverse event|3
4495608|NCT00813995|7298655|FG000|Overall Study|Laboratory adverse event|0
4495609|NCT00813995|7298656|FG001|Overall Study|Laboratory adverse event|2
4495610|NCT00813995|7298655|FG000|Overall Study|Lack of Efficacy|1
4495611|NCT00813995|7298656|FG001|Overall Study|Lack of Efficacy|0
4495612|NCT00813995|7298655|FG000|Overall Study|Lost to Follow-up|4
4495613|NCT00813995|7298656|FG001|Overall Study|Lost to Follow-up|2
4495614|NCT00813995|7298655|FG000|Overall Study|Other reason|2
4495615|NCT00813995|7298656|FG001|Overall Study|Other reason|2
4495616|NCT00813995|7298655|FG000|Overall Study|Protocol Violation|3
4495617|NCT00813995|7298656|FG001|Overall Study|Protocol Violation|2
4495618|NCT00813995|7298655|FG000|Overall Study|Subject moved|4
4495619|NCT00813995|7298656|FG001|Overall Study|Subject moved|0
4495620|NCT00813995|7298655|FG000|Overall Study|Withdrawal by Subject|0
4495621|NCT00813995|7298656|FG001|Overall Study|Withdrawal by Subject|5
4495622|NCT00814164|7298677|FG000|Overall Study|Progression|7
4495623|NCT00814164|7298677|FG000|Overall Study|not stated|7
4495624|NCT00814164|7298677|FG000|Overall Study|Death|5
4495625|NCT00814307|7298710|FG000|Overall Study|Randomized but not treated|1
4495626|NCT00814307|7298711|FG001|Overall Study|Randomized but not treated|0
4495627|NCT00814307|7298712|FG002|Overall Study|Randomized but not treated|0
4495628|NCT00814307|7298713|FG003|Overall Study|Randomized but not treated|0
4495629|NCT00814307|7298710|FG000|Overall Study|Adverse Event|3
4495630|NCT00814307|7298711|FG001|Overall Study|Adverse Event|9
4495631|NCT00814307|7298712|FG002|Overall Study|Adverse Event|3
4495632|NCT00814307|7298713|FG003|Overall Study|Adverse Event|2
4495633|NCT00814307|7298710|FG000|Overall Study|Lack of Efficacy|1
4495634|NCT00814307|7298711|FG001|Overall Study|Lack of Efficacy|1
4495635|NCT00814307|7298712|FG002|Overall Study|Lack of Efficacy|3
4495636|NCT00814307|7298713|FG003|Overall Study|Lack of Efficacy|4
4495637|NCT00814307|7298710|FG000|Overall Study|Other|1
4495638|NCT00814307|7298711|FG001|Overall Study|Other|2
4495639|NCT00814307|7298712|FG002|Overall Study|Other|0
4495640|NCT00814307|7298713|FG003|Overall Study|Other|1
4495641|NCT00814307|7298710|FG000|Overall Study|Protocol Violation|2
4495642|NCT00814307|7298711|FG001|Overall Study|Protocol Violation|8
4495643|NCT00814307|7298712|FG002|Overall Study|Protocol Violation|1
4495644|NCT00814307|7298713|FG003|Overall Study|Protocol Violation|1
4495645|NCT00814307|7298710|FG000|Overall Study|Withdrawal by Subject|4
4495646|NCT00814307|7298711|FG001|Overall Study|Withdrawal by Subject|6
4495647|NCT00814307|7298712|FG002|Overall Study|Withdrawal by Subject|0
4495648|NCT00814307|7298713|FG003|Overall Study|Withdrawal by Subject|2
4495649|NCT00814307|7298710|FG000|Overall Study|Death|0
4495650|NCT00814307|7298711|FG001|Overall Study|Death|1
4495651|NCT00814307|7298712|FG002|Overall Study|Death|0
4495652|NCT00814307|7298713|FG003|Overall Study|Death|0
4495653|NCT00814320|7298727|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1
4495654|NCT00814320|7298728|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0
4495655|NCT00814320|7298727|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0
4495656|NCT00814320|7298728|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2
4495657|NCT00814320|7298727|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0
4495658|NCT00814320|7298728|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1
4495659|NCT00814320|7298727|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1
4495660|NCT00814320|7298728|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0
4495661|NCT00814320|7298727|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1
4495662|NCT00814320|7298728|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0
4495663|NCT00814320|7298727|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1
4495664|NCT00814320|7298728|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4
4495665|NCT00814320|7298727|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2
4495666|NCT00814320|7298728|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1
4495667|NCT00814320|7298727|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0
4495668|NCT00814320|7298728|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1
4495669|NCT00814320|7298727|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0
4495670|NCT00814320|7298728|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1
4495671|NCT00814320|7298727|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0
4495672|NCT00814320|7298728|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3
4495673|NCT00814346|7298753|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0
4495674|NCT00814346|7298754|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1
4495675|NCT00814346|7298753|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0
4495676|NCT00814346|7298754|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2
4495677|NCT00814346|7298753|FG000|Open Phase (17 Months)|Adverse Event|5
4495678|NCT00814346|7298754|FG001|Open Phase (17 Months)|Adverse Event|0
4495679|NCT00814346|7298753|FG000|Open Phase (17 Months)|Consent|2
4495680|NCT00814346|7298754|FG001|Open Phase (17 Months)|Consent|0
4495681|NCT00814346|7298753|FG000|Open Phase (17 Months)|Lost to Follow-up|2
4495682|NCT00814346|7298754|FG001|Open Phase (17 Months)|Lost to Follow-up|0
4517738|NCT00969124|7329644|FG000|Overall Study|Inability to reach cecum|9
4495683|NCT00814346|7298753|FG000|Open Phase (17 Months)|Not otherwise specified|1
4495684|NCT00814346|7298754|FG001|Open Phase (17 Months)|Not otherwise specified|0
4495685|NCT00814463|7298773|FG000|Overall Study|Lost to Follow-up|1
4495686|NCT00814489|7298781|FG000|Overall Study|Other|2
4495687|NCT00814489|7298782|FG001|Overall Study|Other|0
4495688|NCT00814489|7298783|FG002|Overall Study|Other|1
4495689|NCT00814502|7298795|FG000|Overall Study|Adverse Event|1
4495690|NCT00814502|7298796|FG001|Overall Study|Adverse Event|0
4495691|NCT00814502|7298795|FG000|Overall Study|Withdrawal by Subject|0
4495692|NCT00814502|7298796|FG001|Overall Study|Withdrawal by Subject|2
4495693|NCT00814580|7298806|FG000|Overall Study|Adverse Event|6
4495694|NCT00814580|7298807|FG001|Overall Study|Adverse Event|15
4495695|NCT00814580|7298806|FG000|Overall Study|Lack of Efficacy|18
4495696|NCT00814580|7298807|FG001|Overall Study|Lack of Efficacy|25
4495697|NCT00814580|7298806|FG000|Overall Study|Protocol Violation|2
4495698|NCT00814580|7298807|FG001|Overall Study|Protocol Violation|0
4495699|NCT00814580|7298806|FG000|Overall Study|Withdrawal by Subject|2
4495700|NCT00814580|7298807|FG001|Overall Study|Withdrawal by Subject|2
4495701|NCT00814580|7298806|FG000|Overall Study|Other|1
4495702|NCT00814580|7298807|FG001|Overall Study|Other|3
4495703|NCT00814580|7298806|FG000|Overall Study|Did Not Take Drug|2
4495704|NCT00814580|7298807|FG001|Overall Study|Did Not Take Drug|2
4495705|NCT00814632|7298825|FG000|Overall Study|Lack of Efficacy|2
4495706|NCT00814658|7298831|FG000|Overall Study|Lost to Follow-up|0
4495707|NCT00814658|7298832|FG001|Overall Study|Lost to Follow-up|1
4495708|NCT00814658|7298831|FG000|Overall Study|Physician Decision|1
4495709|NCT00814658|7298832|FG001|Overall Study|Physician Decision|0
4495710|NCT00814658|7298831|FG000|Overall Study|Adverse Event|3
4495711|NCT00814658|7298832|FG001|Overall Study|Adverse Event|3
4495712|NCT00814710|7298871|FG000|Overall Study|Adverse Event|1
4495713|NCT00814710|7298872|FG001|Overall Study|Adverse Event|0
4495714|NCT00814710|7298871|FG000|Overall Study|Lost to Follow-up|7
4495715|NCT00814710|7298872|FG001|Overall Study|Lost to Follow-up|3
4495716|NCT00814801|7298896|FG000|Overall Study|Adverse Event|15
4495717|NCT00814801|7298897|FG001|Overall Study|Adverse Event|16
4495718|NCT00814801|7298898|FG002|Overall Study|Adverse Event|19
4495719|NCT00814801|7298896|FG000|Overall Study|Withdrawal by Subject|9
4495720|NCT00814801|7298897|FG001|Overall Study|Withdrawal by Subject|11
4495721|NCT00814801|7298898|FG002|Overall Study|Withdrawal by Subject|14
4495722|NCT00814801|7298896|FG000|Overall Study|Inappropriate as a subject|1
4495723|NCT00814801|7298897|FG001|Overall Study|Inappropriate as a subject|1
4495724|NCT00814801|7298898|FG002|Overall Study|Inappropriate as a subject|1
4495725|NCT00814801|7298896|FG000|Overall Study|Change of patients for CIBIC plus-J|1
4495726|NCT00814801|7298897|FG001|Overall Study|Change of patients for CIBIC plus-J|1
4495727|NCT00814801|7298898|FG002|Overall Study|Change of patients for CIBIC plus-J|0
4495728|NCT00814801|7298896|FG000|Overall Study|Missing or change of caregiver|6
4495729|NCT00814801|7298897|FG001|Overall Study|Missing or change of caregiver|2
4495730|NCT00814801|7298898|FG002|Overall Study|Missing or change of caregiver|4
4495731|NCT00814801|7298896|FG000|Overall Study|Non-compliance|0
4495732|NCT00814801|7298897|FG001|Overall Study|Non-compliance|1
4495733|NCT00814801|7298898|FG002|Overall Study|Non-compliance|1
4495734|NCT00814801|7298896|FG000|Overall Study|Other|2
4495735|NCT00814801|7298897|FG001|Overall Study|Other|6
4495736|NCT00814801|7298898|FG002|Overall Study|Other|4
4495737|NCT00814879|7298908|FG000|By Week 24|Cancer Diagnosis|1
4495738|NCT00814879|7298909|FG001|By Week 24|Cancer Diagnosis|0
4495739|NCT00814879|7298908|FG000|By Week 24|Incarceration|0
4495740|NCT00814879|7298909|FG001|By Week 24|Incarceration|1
4495741|NCT00814879|7298908|FG000|By Week 48|Lost to Follow-up|2
4495742|NCT00814879|7298909|FG001|By Week 48|Lost to Follow-up|2
4495743|NCT00814879|7298908|FG000|By Week 48|Death|0
4495744|NCT00814879|7298909|FG001|By Week 48|Death|1
4495745|NCT00815191|7298946|FG000|Overall Study|Protocol Violation|1
4495746|NCT00815191|7298947|FG001|Overall Study|Protocol Violation|1
4495747|NCT00815295|7298956|FG000|Overall Study|Cetuximab hypersensitivity reaction|0
4495748|NCT00815295|7298957|FG001|Overall Study|Cetuximab hypersensitivity reaction|1
4495749|NCT00815295|7298958|FG002|Overall Study|Cetuximab hypersensitivity reaction|3
4495750|NCT00815308|7298966|FG000|Overall Study|Adverse Event|4
4495751|NCT00815308|7298966|FG000|Overall Study|Withdrawal by Subject|0
4495752|NCT00815308|7298966|FG000|Overall Study|Protocol Violation|6
4495753|NCT00815516|7298996|FG000|Overall Study|Death|3
4495754|NCT00815516|7298997|FG001|Overall Study|Death|1
4495755|NCT00815516|7298996|FG000|Overall Study|Physician Decision|1
4495756|NCT00815516|7298997|FG001|Overall Study|Physician Decision|0
4495757|NCT00815659|7299003|FG000|Overall Study|Adverse Event|9
4495758|NCT00815659|7299003|FG000|Overall Study|Withdrawal by Subject|9
4495759|NCT00815659|7299003|FG000|Overall Study|Lost to Follow-up|4
4495760|NCT00815659|7299003|FG000|Overall Study|Protocol Violation|1
4495761|NCT00815919|7299036|FG000|Overall Study|Unrelated Fungal Infection|1
4495762|NCT00815919|7299036|FG000|Overall Study|AML Relapse|1
4495763|NCT00815919|7299036|FG000|Overall Study|Lack of Efficacy|2
4495764|NCT00816023|7299055|FG000|Overall Study|Lost to Follow-up|1
4495765|NCT00816023|7299056|FG001|Overall Study|Lost to Follow-up|1
4495766|NCT00816023|7299057|FG002|Overall Study|Lost to Follow-up|0
4495767|NCT00816023|7299058|FG003|Overall Study|Lost to Follow-up|0
4495768|NCT00816023|7299055|FG000|Overall Study|Withdrawal by Subject|1
4495769|NCT00816023|7299056|FG001|Overall Study|Withdrawal by Subject|0
4495770|NCT00816023|7299057|FG002|Overall Study|Withdrawal by Subject|0
4495771|NCT00816023|7299058|FG003|Overall Study|Withdrawal by Subject|0
4495772|NCT00816023|7299055|FG000|Overall Study|Physician Decision|0
4495773|NCT00816023|7299056|FG001|Overall Study|Physician Decision|0
4495774|NCT00816023|7299057|FG002|Overall Study|Physician Decision|1
4495775|NCT00816023|7299058|FG003|Overall Study|Physician Decision|0
4495776|NCT00816023|7299055|FG000|Overall Study|assessments complete prior to window|1
4495777|NCT00816023|7299056|FG001|Overall Study|assessments complete prior to window|1
4495778|NCT00816023|7299057|FG002|Overall Study|assessments complete prior to window|2
4495779|NCT00816023|7299058|FG003|Overall Study|assessments complete prior to window|1
4495780|NCT00816023|7299055|FG000|Overall Study|Randomized Not Treated|6
4495781|NCT00816023|7299056|FG001|Overall Study|Randomized Not Treated|4
4495782|NCT00816023|7299057|FG002|Overall Study|Randomized Not Treated|6
4495783|NCT00816023|7299058|FG003|Overall Study|Randomized Not Treated|11
4495784|NCT00816036|7299070|FG000|Overall Study|Death|47
4495785|NCT00816036|7299071|FG001|Overall Study|Death|28
4495786|NCT00816036|7299070|FG000|Overall Study|Lost to Follow-up|75
4495787|NCT00816036|7299071|FG001|Overall Study|Lost to Follow-up|57
4495788|NCT00816036|7299070|FG000|Overall Study|Withdrawal by Subject|54
4495789|NCT00816036|7299071|FG001|Overall Study|Withdrawal by Subject|23
4495790|NCT00816166|7299097|FG000|Overall Study|Lost to Follow-up|6
4495791|NCT00816166|7299098|FG001|Overall Study|Lost to Follow-up|10
4495792|NCT00816166|7299097|FG000|Overall Study|Death|4
4495793|NCT00816166|7299098|FG001|Overall Study|Death|2
4495794|NCT00816361|7299115|FG000|Overall Study|Withdrawal by Subject|0
4495795|NCT00816361|7299116|FG001|Overall Study|Withdrawal by Subject|0
4495796|NCT00816361|7299117|FG002|Overall Study|Withdrawal by Subject|0
4495797|NCT00816361|7299118|FG003|Overall Study|Withdrawal by Subject|0
4495798|NCT00816361|7299119|FG004|Overall Study|Withdrawal by Subject|1
4495799|NCT00816361|7299120|FG005|Overall Study|Withdrawal by Subject|2
4495800|NCT00816361|7299121|FG006|Overall Study|Withdrawal by Subject|0
4495801|NCT00816361|7299122|FG007|Overall Study|Withdrawal by Subject|2
4495802|NCT00816361|7299123|FG008|Overall Study|Withdrawal by Subject|1
4495803|NCT00816361|7299115|FG000|Overall Study|Death|4
4495804|NCT00816361|7299116|FG001|Overall Study|Death|3
4495805|NCT00816361|7299117|FG002|Overall Study|Death|3
4495806|NCT00816361|7299118|FG003|Overall Study|Death|3
4495807|NCT00816361|7299119|FG004|Overall Study|Death|1
4495808|NCT00816361|7299120|FG005|Overall Study|Death|1
4495809|NCT00816361|7299121|FG006|Overall Study|Death|3
4495810|NCT00816361|7299122|FG007|Overall Study|Death|7
4495811|NCT00816361|7299123|FG008|Overall Study|Death|8
4495812|NCT00816361|7299115|FG000|Overall Study|Other|0
4495813|NCT00816361|7299116|FG001|Overall Study|Other|0
4495814|NCT00816361|7299117|FG002|Overall Study|Other|0
4495815|NCT00816361|7299118|FG003|Overall Study|Other|0
4495816|NCT00816361|7299119|FG004|Overall Study|Other|0
4495817|NCT00816361|7299120|FG005|Overall Study|Other|0
4626984|NCT01848210|7493311|FG001|Overall Study|Hypesensitivity|0
4626985|NCT01848210|7493310|FG000|Overall Study|Hepatic Function Alteration|4
4626986|NCT01848210|7493311|FG001|Overall Study|Hepatic Function Alteration|0
4626987|NCT01848210|7493310|FG000|Overall Study|Chronic Venous Insufficiency Course|1
4626988|NCT01848210|7493311|FG001|Overall Study|Chronic Venous Insufficiency Course|2
4626989|NCT01848210|7493310|FG000|Overall Study|Administrative|1
4626990|NCT01848210|7493311|FG001|Overall Study|Administrative|0
4626991|NCT01848288|7493317|FG000|Overall Study|Death|1
4495818|NCT00816361|7299121|FG006|Overall Study|Other|0
4495819|NCT00816361|7299122|FG007|Overall Study|Other|0
4495820|NCT00816361|7299123|FG008|Overall Study|Other|1
4495821|NCT00816400|7299153|FG000|Overall Study|Death|2
4495822|NCT00816400|7299154|FG001|Overall Study|Death|3
4495823|NCT00816400|7299155|FG002|Overall Study|Death|3
4495824|NCT00816400|7299156|FG003|Overall Study|Death|3
4495825|NCT00816400|7299157|FG004|Overall Study|Death|2
4495826|NCT00816400|7299158|FG005|Overall Study|Death|3
4495827|NCT00816400|7299159|FG006|Overall Study|Death|2
4495828|NCT00816400|7299160|FG007|Overall Study|Death|5
4495829|NCT00816400|7299161|FG008|Overall Study|Death|6
4495830|NCT00816400|7299153|FG000|Overall Study|In hospice care at the end of the study|0
4495831|NCT00816400|7299154|FG001|Overall Study|In hospice care at the end of the study|0
4495832|NCT00816400|7299155|FG002|Overall Study|In hospice care at the end of the study|2
4495833|NCT00816400|7299156|FG003|Overall Study|In hospice care at the end of the study|0
4495834|NCT00816400|7299157|FG004|Overall Study|In hospice care at the end of the study|0
4495835|NCT00816400|7299158|FG005|Overall Study|In hospice care at the end of the study|0
4495836|NCT00816400|7299159|FG006|Overall Study|In hospice care at the end of the study|0
4495837|NCT00816400|7299160|FG007|Overall Study|In hospice care at the end of the study|0
4495838|NCT00816400|7299161|FG008|Overall Study|In hospice care at the end of the study|0
4626992|NCT01848288|7493317|FG000|Overall Study|Protocol Violation|1
4626993|NCT01848288|7493317|FG000|Overall Study|Withdrawal by Subject|1
4626994|NCT01848353|7493326|FG000|Phase 1|Withdrawal by Subject|3
4495839|NCT00816556|7299185|FG000|Overall Study|Adverse Event|1
4495840|NCT00816556|7299186|FG001|Overall Study|Adverse Event|1
4495841|NCT00816556|7299187|FG002|Overall Study|Adverse Event|1
4626995|NCT01848353|7493327|FG001|Phase 1|Withdrawal by Subject|1
4495842|NCT00816556|7299185|FG000|Overall Study|Withdrawal by Subject|1
4495843|NCT00816556|7299186|FG001|Overall Study|Withdrawal by Subject|1
4495844|NCT00816556|7299187|FG002|Overall Study|Withdrawal by Subject|1
4495845|NCT00816556|7299185|FG000|Overall Study|Lost to Follow-up|0
4495846|NCT00816556|7299186|FG001|Overall Study|Lost to Follow-up|0
4495847|NCT00816556|7299187|FG002|Overall Study|Lost to Follow-up|1
4495848|NCT00816595|7299197|FG000|Overall Study|Withdrawal by Subject|2
4495849|NCT00816595|7299198|FG001|Overall Study|Withdrawal by Subject|0
4495850|NCT00817063|7299237|FG000|Overall Study|Adverse Event|32
4495851|NCT00817063|7299238|FG001|Overall Study|Adverse Event|13
4495852|NCT00817063|7299237|FG000|Overall Study|Death|1
4495853|NCT00817063|7299238|FG001|Overall Study|Death|1
4495854|NCT00817063|7299237|FG000|Overall Study|Lack of Efficacy|33
4495855|NCT00817063|7299238|FG001|Overall Study|Lack of Efficacy|86
4495856|NCT00817063|7299237|FG000|Overall Study|Failure to Return|13
4495857|NCT00817063|7299238|FG001|Overall Study|Failure to Return|12
4495858|NCT00817063|7299237|FG000|Overall Study|Violation of Selection at Entry|7
4495859|NCT00817063|7299238|FG001|Overall Study|Violation of Selection at Entry|4
4495860|NCT00817063|7299237|FG000|Overall Study|Protocol Violation|3
4495861|NCT00817063|7299238|FG001|Overall Study|Protocol Violation|8
4495862|NCT00817063|7299237|FG000|Overall Study|Withdrawal by Subject|17
4495863|NCT00817063|7299238|FG001|Overall Study|Withdrawal by Subject|37
4495864|NCT00817063|7299237|FG000|Overall Study|Early Improvement|19
4495865|NCT00817063|7299238|FG001|Overall Study|Early Improvement|4
4495866|NCT00817063|7299237|FG000|Overall Study|Administrative|10
4495867|NCT00817063|7299238|FG001|Overall Study|Administrative|4
4495868|NCT00817063|7299237|FG000|Overall Study|Abnormality of Laboratory Test|2
4495869|NCT00817063|7299238|FG001|Overall Study|Abnormality of Laboratory Test|1
4495870|NCT00817089|7299248|FG000|First Alcohol Challenge|Lost to Follow-up|0
4495871|NCT00817089|7299249|FG001|First Alcohol Challenge|Lost to Follow-up|0
4495872|NCT00817089|7299250|FG002|First Alcohol Challenge|Lost to Follow-up|0
4495873|NCT00817089|7299251|FG003|First Alcohol Challenge|Lost to Follow-up|1
4495874|NCT00817089|7299248|FG000|Second Alcohol Challenge|Lost to Follow-up|0
4495875|NCT00817089|7299249|FG001|Second Alcohol Challenge|Lost to Follow-up|1
4495876|NCT00817089|7299250|FG002|Second Alcohol Challenge|Lost to Follow-up|0
4495877|NCT00817089|7299251|FG003|Second Alcohol Challenge|Lost to Follow-up|0
4495878|NCT00817206|7299267|FG000|Overall Study|Adverse Event|10
4495879|NCT00817206|7299268|FG001|Overall Study|Adverse Event|3
4495880|NCT00817206|7299267|FG000|Overall Study|Protocol Violation|0
4495881|NCT00817206|7299268|FG001|Overall Study|Protocol Violation|2
4495882|NCT00817206|7299267|FG000|Overall Study|Lost to Follow-up|0
4495883|NCT00817206|7299268|FG001|Overall Study|Lost to Follow-up|1
4495884|NCT00817206|7299267|FG000|Overall Study|Death|2
4495885|NCT00817206|7299268|FG001|Overall Study|Death|0
4495886|NCT00817206|7299267|FG000|Overall Study|Withdrawal by Subject|7
4495887|NCT00817206|7299268|FG001|Overall Study|Withdrawal by Subject|3
4495888|NCT00817206|7299267|FG000|Overall Study|Physician Decision|2
4495889|NCT00817206|7299268|FG001|Overall Study|Physician Decision|0
4495890|NCT00817336|7299280|FG000|Overall Study|Withdrawal by Subject|1
4495891|NCT00817336|7299281|FG001|Overall Study|Withdrawal by Subject|1
4495892|NCT00817414|7299291|FG000|Overall Study|Adverse Event|1
4495893|NCT00817414|7299292|FG001|Overall Study|Adverse Event|1
4495894|NCT00817414|7299293|FG002|Overall Study|Adverse Event|1
4495895|NCT00817414|7299294|FG003|Overall Study|Adverse Event|0
4495896|NCT00817414|7299295|FG004|Overall Study|Adverse Event|0
4495897|NCT00817414|7299291|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0
4495898|NCT00817414|7299292|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1
4495899|NCT00817414|7299293|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2
4495900|NCT00817414|7299294|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4
4495901|NCT00817414|7299295|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0
4495902|NCT00817414|7299291|FG000|Overall Study|Withdrawal by Subject|1
4495903|NCT00817414|7299292|FG001|Overall Study|Withdrawal by Subject|1
4495904|NCT00817414|7299293|FG002|Overall Study|Withdrawal by Subject|0
4495905|NCT00817414|7299294|FG003|Overall Study|Withdrawal by Subject|0
4495906|NCT00817414|7299295|FG004|Overall Study|Withdrawal by Subject|0
4495907|NCT00817414|7299291|FG000|Overall Study|Lost to Follow-up|0
4495908|NCT00817414|7299292|FG001|Overall Study|Lost to Follow-up|0
4495909|NCT00817414|7299293|FG002|Overall Study|Lost to Follow-up|1
4495910|NCT00817414|7299294|FG003|Overall Study|Lost to Follow-up|1
4495911|NCT00817414|7299295|FG004|Overall Study|Lost to Follow-up|1
4495912|NCT00817414|7299291|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0
4495913|NCT00817414|7299292|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0
4495914|NCT00817414|7299293|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0
4495915|NCT00817414|7299294|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7
4495916|NCT00817414|7299295|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0
4495917|NCT00817414|7299291|FG000|Overall Study|Protocol Violation|0
4495918|NCT00817414|7299292|FG001|Overall Study|Protocol Violation|0
4495919|NCT00817414|7299293|FG002|Overall Study|Protocol Violation|0
4495920|NCT00817414|7299294|FG003|Overall Study|Protocol Violation|0
4495921|NCT00817414|7299295|FG004|Overall Study|Protocol Violation|1
4495922|NCT00817479|7299314|FG000|Overall Study|Physician Decision|1
4703476|NCT02732119|7621132|FG001|Phase II|Physician Decision|0
4703477|NCT02732119|7621133|FG002|Phase II|Physician Decision|0
4703478|NCT02732119|7621134|FG003|Phase II|Physician Decision|8
4703479|NCT02732119|7621135|FG004|Phase II|Physician Decision|5
4703480|NCT02732210|7621186|FG000|Overall Study|Site Closed|0
4703481|NCT02732210|7621187|FG001|Overall Study|Site Closed|11
4703482|NCT02732210|7621186|FG000|Overall Study|Study Ended|13
4703483|NCT02732210|7621187|FG001|Overall Study|Study Ended|13
4703484|NCT02732210|7621186|FG000|Overall Study|Withdrawal by Subject|28
4703485|NCT02732210|7621187|FG001|Overall Study|Withdrawal by Subject|87
4703486|NCT02732210|7621186|FG000|Overall Study|Lost to Follow-up|5
4703487|NCT02732210|7621187|FG001|Overall Study|Lost to Follow-up|57
4703488|NCT02732210|7621186|FG000|Overall Study|Death|4
4703489|NCT02732210|7621187|FG001|Overall Study|Death|15
4703490|NCT02732210|7621186|FG000|Overall Study|Other|35
4703491|NCT02732210|7621187|FG001|Overall Study|Other|103
4703492|NCT02732210|7621186|FG000|Overall Study|Missing|0
4703493|NCT02732210|7621187|FG001|Overall Study|Missing|8
4703494|NCT02732561|7621207|FG000|Overall Study|Lost to Follow-up|1
4703495|NCT02732561|7621208|FG001|Overall Study|Lost to Follow-up|1
4703496|NCT02732561|7621207|FG000|Overall Study|Withdrawal by Subject|1
4703497|NCT02732561|7621208|FG001|Overall Study|Withdrawal by Subject|0
4703498|NCT02732639|7621228|FG000|Overall Study|Lost to Follow-up|1
4703499|NCT02732847|7621234|FG000|Overall Study|some filled early|42
4703500|NCT02732847|7621235|FG001|Overall Study|some filled early|42
4703501|NCT02732912|7621252|FG000|Overall Study|Discharged before night|2
4703502|NCT02732912|7621253|FG001|Overall Study|Discharged before night|6
4703503|NCT02732912|7621252|FG000|Overall Study|Incomplete completion of questionnaire|2
4703504|NCT02732912|7621253|FG001|Overall Study|Incomplete completion of questionnaire|3
4703505|NCT02732912|7621252|FG000|Overall Study|No outcome; discharged or refused|6
4703506|NCT02732912|7621253|FG001|Overall Study|No outcome; discharged or refused|9
4703507|NCT02732938|7621261|FG000|Overall Study|Death|0
4703508|NCT02732938|7621262|FG001|Overall Study|Death|11
4703509|NCT02732938|7621263|FG002|Overall Study|Death|0
4703510|NCT02732938|7621261|FG000|Overall Study|Randomized but did not receive treatment|0
4703511|NCT02732938|7621262|FG001|Overall Study|Randomized but did not receive treatment|1
4703512|NCT02732938|7621263|FG002|Overall Study|Randomized but did not receive treatment|0
4703513|NCT02732938|7621261|FG000|Overall Study|Refused further follow-up|1
4703514|NCT02732938|7621262|FG001|Overall Study|Refused further follow-up|0
4703515|NCT02732938|7621263|FG002|Overall Study|Refused further follow-up|0
4703516|NCT02732938|7621261|FG000|Overall Study|Study terminated by sponsor|3
4703517|NCT02732938|7621262|FG001|Overall Study|Study terminated by sponsor|6
4703518|NCT02732938|7621263|FG002|Overall Study|Study terminated by sponsor|0
4703519|NCT02732951|7621273|FG000|Overall Study|Other than listed|1
4703520|NCT02732951|7621274|FG001|Overall Study|Other than listed|0
4703521|NCT02732951|7621273|FG000|Overall Study|Lost to Follow-up|0
4703522|NCT02732951|7621274|FG001|Overall Study|Lost to Follow-up|1
4703523|NCT02732951|7621273|FG000|Overall Study|Adverse Event|4
4703524|NCT02732951|7621274|FG001|Overall Study|Adverse Event|4
4703525|NCT02732951|7621273|FG000|Overall Study|Protocol Violation|0
4703526|NCT02732951|7621274|FG001|Overall Study|Protocol Violation|1
4703527|NCT02733367|7621280|FG000|Overall Study|Withdrawal by Subject|6
4703528|NCT02733627|7621293|FG000|Overall Study|Adverse Event|0
4703529|NCT02733627|7621294|FG001|Overall Study|Adverse Event|1
4703530|NCT02733627|7621295|FG002|Overall Study|Adverse Event|1
4703531|NCT02733627|7621296|FG003|Overall Study|Adverse Event|0
4703532|NCT02733627|7621293|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0
4703533|NCT02733627|7621294|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0
4703534|NCT02733627|7621295|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1
4703535|NCT02733627|7621296|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0
4703536|NCT02733991|7621329|FG000|Overall Study|Adverse Event|1
4703537|NCT02733991|7621330|FG001|Overall Study|Adverse Event|0
4703538|NCT02733991|7621329|FG000|Overall Study|Withdrawal by Subject|0
4703539|NCT02733991|7621330|FG001|Overall Study|Withdrawal by Subject|5
4703540|NCT02734212|7621356|FG000|Overall Study|Lost to Follow-up|5
4703541|NCT02734212|7621357|FG001|Overall Study|Lost to Follow-up|10
4703542|NCT02734693|7621402|FG000|Overall Study|Adverse Event|1
4703543|NCT02734693|7621403|FG001|Overall Study|Adverse Event|3
4703544|NCT02734693|7621404|FG002|Overall Study|Adverse Event|3
4703545|NCT02734693|7621402|FG000|Overall Study|Lack of Efficacy|1
4703546|NCT02734693|7621403|FG001|Overall Study|Lack of Efficacy|0
4703547|NCT02734693|7621404|FG002|Overall Study|Lack of Efficacy|0
4703548|NCT02734693|7621402|FG000|Overall Study|Lost to Follow-up|2
4703549|NCT02734693|7621403|FG001|Overall Study|Lost to Follow-up|0
4703550|NCT02734693|7621404|FG002|Overall Study|Lost to Follow-up|0
4703551|NCT02734693|7621402|FG000|Overall Study|Protocol Violation|1
4703552|NCT02734693|7621403|FG001|Overall Study|Protocol Violation|0
4703553|NCT02734693|7621404|FG002|Overall Study|Protocol Violation|0
4703554|NCT02734693|7621402|FG000|Overall Study|Withdrawal by Subject|1
4703555|NCT02734693|7621403|FG001|Overall Study|Withdrawal by Subject|0
4703556|NCT02734693|7621404|FG002|Overall Study|Withdrawal by Subject|0
4703557|NCT02734810|7621414|FG000|Overall Study|Adverse Event|1
4703558|NCT02734810|7621415|FG001|Overall Study|Adverse Event|0
4703559|NCT02734810|7621414|FG000|Overall Study|Lack of Efficacy|1
4703560|NCT02734810|7621415|FG001|Overall Study|Lack of Efficacy|0
4703561|NCT02734862|7621437|FG000|Part A|Death|3
4703562|NCT02734862|7621438|FG001|Part A|Death|4
4703563|NCT02734862|7621439|FG002|Part A|Death|6
4703564|NCT02734862|7621437|FG000|Part A|Lost to Follow-up|2
4703565|NCT02734862|7621438|FG001|Part A|Lost to Follow-up|1
4703566|NCT02734862|7621439|FG002|Part A|Lost to Follow-up|1
4703567|NCT02734862|7621437|FG000|Part A|Withdrawal by Subject|1
4703568|NCT02734862|7621438|FG001|Part A|Withdrawal by Subject|1
4495923|NCT00817479|7299315|FG001|Overall Study|Physician Decision|1
4495924|NCT00817531|7299321|FG000|Overall Study|Adverse Event|1
4495925|NCT00817531|7299321|FG000|Overall Study|Lack of Efficacy|1
4495926|NCT00817635|7299334|FG000|Overall Study|Adverse Event|1
4495927|NCT00817635|7299335|FG001|Overall Study|Adverse Event|0
4495928|NCT00817635|7299336|FG002|Overall Study|Adverse Event|0
4495929|NCT00817635|7299337|FG003|Overall Study|Adverse Event|1
4495930|NCT00817635|7299338|FG004|Overall Study|Adverse Event|1
4495931|NCT00817635|7299334|FG000|Overall Study|Abnormal Laboratory Value(s)|1
4495932|NCT00817635|7299335|FG001|Overall Study|Abnormal Laboratory Value(s)|1
4495933|NCT00817635|7299336|FG002|Overall Study|Abnormal Laboratory Value(s)|0
4495934|NCT00817635|7299337|FG003|Overall Study|Abnormal Laboratory Value(s)|0
4495935|NCT00817635|7299338|FG004|Overall Study|Abnormal Laboratory Value(s)|1
4495936|NCT00817635|7299334|FG000|Overall Study|Withdrawal by Subject|2
4495937|NCT00817635|7299335|FG001|Overall Study|Withdrawal by Subject|1
4495938|NCT00817635|7299336|FG002|Overall Study|Withdrawal by Subject|0
4495939|NCT00817635|7299337|FG003|Overall Study|Withdrawal by Subject|1
4495940|NCT00817635|7299338|FG004|Overall Study|Withdrawal by Subject|2
4495941|NCT00817635|7299334|FG000|Overall Study|Lost to Follow-up|0
4495942|NCT00817635|7299335|FG001|Overall Study|Lost to Follow-up|1
4495943|NCT00817635|7299336|FG002|Overall Study|Lost to Follow-up|0
4495944|NCT00817635|7299337|FG003|Overall Study|Lost to Follow-up|1
4495945|NCT00817635|7299338|FG004|Overall Study|Lost to Follow-up|0
4495946|NCT00817635|7299334|FG000|Overall Study|Administrative Problems|0
4495947|NCT00817635|7299335|FG001|Overall Study|Administrative Problems|0
4495948|NCT00817635|7299336|FG002|Overall Study|Administrative Problems|0
4495949|NCT00817635|7299337|FG003|Overall Study|Administrative Problems|0
4495950|NCT00817635|7299338|FG004|Overall Study|Administrative Problems|1
4495951|NCT00817635|7299334|FG000|Overall Study|Protocol Violation|5
4495952|NCT00817635|7299335|FG001|Overall Study|Protocol Violation|1
4495953|NCT00817635|7299336|FG002|Overall Study|Protocol Violation|3
4495954|NCT00817635|7299337|FG003|Overall Study|Protocol Violation|2
4495955|NCT00817635|7299338|FG004|Overall Study|Protocol Violation|3
4495956|NCT00817778|7299359|FG000|Overall Study|Adverse Event|1
4495957|NCT00817778|7299360|FG001|Overall Study|Adverse Event|0
4495958|NCT00817778|7299359|FG000|Overall Study|Withdrawal by Subject|1
4495959|NCT00817778|7299360|FG001|Overall Study|Withdrawal by Subject|1
4495960|NCT00817778|7299359|FG000|Overall Study|Protocol Violation|0
4495961|NCT00817778|7299360|FG001|Overall Study|Protocol Violation|1
4495962|NCT00817778|7299359|FG000|Overall Study|Study-specific discontinuation criteria|0
4495963|NCT00817778|7299360|FG001|Overall Study|Study-specific discontinuation criteria|1
4495964|NCT00817778|7299359|FG000|Overall Study|Poor venous access|1
4495965|NCT00817778|7299360|FG001|Overall Study|Poor venous access|0
4626996|NCT01848353|7493328|FG002|Phase 1|Withdrawal by Subject|0
4626997|NCT01848353|7493329|FG003|Phase 1|Withdrawal by Subject|0
4626998|NCT01848353|7493326|FG000|Phase 2|Withdrawal by Subject|3
4626999|NCT01848353|7493327|FG001|Phase 2|Withdrawal by Subject|2
4627000|NCT01848353|7493328|FG002|Phase 2|Withdrawal by Subject|0
4627001|NCT01848353|7493329|FG003|Phase 2|Withdrawal by Subject|0
4627002|NCT01848353|7493326|FG000|Phase 3|Withdrawal by Subject|1
4627003|NCT01848353|7493327|FG001|Phase 3|Withdrawal by Subject|1
4627004|NCT01848353|7493328|FG002|Phase 3|Withdrawal by Subject|0
4627005|NCT01848353|7493329|FG003|Phase 3|Withdrawal by Subject|0
4627006|NCT01848457|7493355|FG000|Overall Study|Death|1
4627007|NCT01848457|7493356|FG001|Overall Study|Death|0
4627008|NCT01848457|7493357|FG002|Overall Study|Death|0
4627009|NCT01848457|7493358|FG003|Overall Study|Death|0
4627010|NCT01848483|7493378|FG000|Overall Study|Death|2
4627011|NCT01848483|7493379|FG001|Overall Study|Death|1
4627012|NCT01848483|7493378|FG000|Overall Study|Lost to Follow-up|6
4627013|NCT01848483|7493379|FG001|Overall Study|Lost to Follow-up|8
4627014|NCT01848483|7493378|FG000|Overall Study|Withdrawal by Subject|1
4703569|NCT02734862|7621439|FG002|Part A|Withdrawal by Subject|2
4703570|NCT02734862|7621437|FG000|Part A|Physician Decision|2
4495966|NCT00818168|7299396|FG000|Overall Study|Lack of Efficacy|18
4495967|NCT00818168|7299396|FG000|Overall Study|Pregnancy|2
4495968|NCT00818168|7299396|FG000|Overall Study|Withdrawal by Subject|16
4495969|NCT00818168|7299396|FG000|Overall Study|Lost to Follow-up|7
4495970|NCT00818168|7299396|FG000|Overall Study|Adverse Event|19
4495971|NCT00818168|7299396|FG000|Overall Study|Reason for Non-completion Not reported|6
4627015|NCT01848483|7493379|FG001|Overall Study|Withdrawal by Subject|0
4627016|NCT01848483|7493378|FG000|Overall Study|Incarceration|2
4627017|NCT01848483|7493379|FG001|Overall Study|Incarceration|2
4627018|NCT01848756|7493386|FG000|Overall Study|Adverse Event|1
4627019|NCT01848756|7493386|FG000|Overall Study|Withdrawal by Subject|1
4703571|NCT02734862|7621438|FG001|Part A|Physician Decision|0
4703572|NCT02734862|7621439|FG002|Part A|Physician Decision|1
4703573|NCT02734862|7621437|FG000|Part A|Adverse Event|2
4703574|NCT02734862|7621438|FG001|Part A|Adverse Event|0
4495972|NCT00818168|7299396|FG000|Overall Study|Participant Moved|2
4495973|NCT00818207|7299402|FG000|Overall Study|Adverse Event|6
4495974|NCT00818207|7299403|FG001|Overall Study|Adverse Event|0
4495975|NCT00818207|7299402|FG000|Overall Study|Lost to Follow-up|160
4495976|NCT00818207|7299403|FG001|Overall Study|Lost to Follow-up|146
4495977|NCT00818207|7299402|FG000|Overall Study|Multiple reasons|11
4495978|NCT00818207|7299403|FG001|Overall Study|Multiple reasons|12
4495979|NCT00818207|7299402|FG000|Overall Study|Withdrawal by Subject|42
4495980|NCT00818207|7299403|FG001|Overall Study|Withdrawal by Subject|104
4495981|NCT00818207|7299402|FG000|Overall Study|Death|3
4495982|NCT00818207|7299403|FG001|Overall Study|Death|5
4495983|NCT00818246|7299409|FG000|Overall Study|Impossible to match pictures|5
4495984|NCT00818259|7299420|FG000|Part I|Withdrawal by Subject|1
4495985|NCT00818259|7299421|FG001|Part I|Withdrawal by Subject|0
4495986|NCT00818259|7299422|FG002|Part I|Withdrawal by Subject|0
4495987|NCT00818259|7299423|FG003|Part I|Withdrawal by Subject|0
4495988|NCT00818259|7299424|FG004|Part I|Withdrawal by Subject|0
4495989|NCT00818259|7299425|FG005|Part I|Withdrawal by Subject|0
4495990|NCT00818259|7299426|FG006|Part I|Withdrawal by Subject|0
4495991|NCT00818259|7299427|FG007|Part I|Withdrawal by Subject|0
4495992|NCT00818259|7299428|FG008|Part I|Withdrawal by Subject|0
4495993|NCT00818259|7299420|FG000|Part II|Physician Decision|0
4495994|NCT00818259|7299421|FG001|Part II|Physician Decision|0
4495995|NCT00818259|7299422|FG002|Part II|Physician Decision|1
4495996|NCT00818259|7299423|FG003|Part II|Physician Decision|0
4495997|NCT00818259|7299424|FG004|Part II|Physician Decision|0
4495998|NCT00818259|7299425|FG005|Part II|Physician Decision|0
4495999|NCT00818259|7299426|FG006|Part II|Physician Decision|0
4496000|NCT00818259|7299427|FG007|Part II|Physician Decision|0
4496001|NCT00818259|7299428|FG008|Part II|Physician Decision|0
4496002|NCT00818259|7299420|FG000|Part II|Lack of Efficacy|0
4496003|NCT00818259|7299421|FG001|Part II|Lack of Efficacy|0
4496004|NCT00818259|7299422|FG002|Part II|Lack of Efficacy|0
4496005|NCT00818259|7299423|FG003|Part II|Lack of Efficacy|1
4496006|NCT00818259|7299424|FG004|Part II|Lack of Efficacy|0
4496007|NCT00818259|7299425|FG005|Part II|Lack of Efficacy|0
4496008|NCT00818259|7299426|FG006|Part II|Lack of Efficacy|0
4496009|NCT00818259|7299427|FG007|Part II|Lack of Efficacy|0
4496010|NCT00818259|7299428|FG008|Part II|Lack of Efficacy|0
4496011|NCT00818259|7299420|FG000|Part II|Not Treated|0
4496012|NCT00818259|7299421|FG001|Part II|Not Treated|0
4496013|NCT00818259|7299422|FG002|Part II|Not Treated|0
4496014|NCT00818259|7299423|FG003|Part II|Not Treated|1
4496015|NCT00818259|7299424|FG004|Part II|Not Treated|0
4496016|NCT00818259|7299425|FG005|Part II|Not Treated|0
4496017|NCT00818259|7299426|FG006|Part II|Not Treated|0
4496018|NCT00818259|7299427|FG007|Part II|Not Treated|0
4496019|NCT00818259|7299428|FG008|Part II|Not Treated|0
4496020|NCT00818259|7299420|FG000|Part IV|Physician Decision|0
4496021|NCT00818259|7299421|FG001|Part IV|Physician Decision|0
4496022|NCT00818259|7299422|FG002|Part IV|Physician Decision|0
4496023|NCT00818259|7299423|FG003|Part IV|Physician Decision|0
4496024|NCT00818259|7299424|FG004|Part IV|Physician Decision|0
4496025|NCT00818259|7299425|FG005|Part IV|Physician Decision|1
4496026|NCT00818259|7299426|FG006|Part IV|Physician Decision|0
4496027|NCT00818259|7299427|FG007|Part IV|Physician Decision|0
4496028|NCT00818259|7299428|FG008|Part IV|Physician Decision|0
4496029|NCT00818259|7299420|FG000|Part V|Adverse Event|0
4496030|NCT00818259|7299421|FG001|Part V|Adverse Event|0
4496031|NCT00818259|7299422|FG002|Part V|Adverse Event|0
4496032|NCT00818259|7299423|FG003|Part V|Adverse Event|0
4496033|NCT00818259|7299424|FG004|Part V|Adverse Event|0
4496034|NCT00818259|7299425|FG005|Part V|Adverse Event|0
4496035|NCT00818259|7299426|FG006|Part V|Adverse Event|0
4496036|NCT00818259|7299427|FG007|Part V|Adverse Event|1
4496037|NCT00818259|7299428|FG008|Part V|Adverse Event|0
4496038|NCT00818389|7299468|FG000|Overall Study|Death|1
4496039|NCT00818389|7299469|FG001|Overall Study|Death|3
4496040|NCT00818389|7299468|FG000|Overall Study|ALS Disease Progression|1
4496041|NCT00818389|7299469|FG001|Overall Study|ALS Disease Progression|0
4496042|NCT00818389|7299468|FG000|Overall Study|Withdrawal by Subject|2
4496043|NCT00818389|7299469|FG001|Overall Study|Withdrawal by Subject|2
4496044|NCT00818389|7299468|FG000|Overall Study|Adverse Event|0
4496045|NCT00818389|7299469|FG001|Overall Study|Adverse Event|1
4496046|NCT00818441|7299477|FG000|Overall Study|Death|69
4496047|NCT00818441|7299478|FG001|Overall Study|Death|26
4496048|NCT00818441|7299477|FG000|Overall Study|Other|5
4496049|NCT00818441|7299478|FG001|Overall Study|Other|0
4496050|NCT00818441|7299477|FG000|Overall Study|Lost to Follow-up|2
4496051|NCT00818441|7299478|FG001|Overall Study|Lost to Follow-up|1
4496052|NCT00818441|7299477|FG000|Overall Study|Withdrawal by Subject|2
4496053|NCT00818441|7299478|FG001|Overall Study|Withdrawal by Subject|0
4496054|NCT00818441|7299477|FG000|Overall Study|Adverse Event|0
4496055|NCT00818441|7299478|FG001|Overall Study|Adverse Event|1
4496056|NCT00818441|7299477|FG000|Overall Study|Study terminated by sponsor|11
4496057|NCT00818441|7299478|FG001|Overall Study|Study terminated by sponsor|2
4496058|NCT00818454|7299485|FG000|Treatment Period 1|Adverse Event|0
4496059|NCT00818454|7299486|FG001|Treatment Period 1|Adverse Event|1
4703575|NCT02734862|7621439|FG002|Part A|Adverse Event|1
4496060|NCT00818454|7299487|FG002|Treatment Period 1|Adverse Event|0
4496061|NCT00818454|7299488|FG003|Treatment Period 1|Adverse Event|0
4496062|NCT00818454|7299485|FG000|Treatment Period 1|Other|3
4496063|NCT00818454|7299486|FG001|Treatment Period 1|Other|0
4496064|NCT00818454|7299487|FG002|Treatment Period 1|Other|0
4496065|NCT00818454|7299488|FG003|Treatment Period 1|Other|0
4496066|NCT00818454|7299485|FG000|Washout Period of 1 Week|Adverse Event|1
4496067|NCT00818454|7299486|FG001|Washout Period of 1 Week|Adverse Event|1
4496068|NCT00818454|7299487|FG002|Washout Period of 1 Week|Adverse Event|0
4496069|NCT00818454|7299488|FG003|Washout Period of 1 Week|Adverse Event|0
4496070|NCT00818454|7299485|FG000|Washout Period of 1 Week|Protocol Violation|2
4496071|NCT00818454|7299486|FG001|Washout Period of 1 Week|Protocol Violation|0
4496072|NCT00818454|7299487|FG002|Washout Period of 1 Week|Protocol Violation|0
4496073|NCT00818454|7299488|FG003|Washout Period of 1 Week|Protocol Violation|0
4496074|NCT00818454|7299485|FG000|Washout Period of 1 Week|Other|1
4496075|NCT00818454|7299486|FG001|Washout Period of 1 Week|Other|2
4496076|NCT00818454|7299487|FG002|Washout Period of 1 Week|Other|0
4496077|NCT00818454|7299488|FG003|Washout Period of 1 Week|Other|0
4496078|NCT00818454|7299485|FG000|Treatment Period 2|Other|2
4496079|NCT00818454|7299486|FG001|Treatment Period 2|Other|1
4496080|NCT00818454|7299487|FG002|Treatment Period 2|Other|0
4496081|NCT00818454|7299488|FG003|Treatment Period 2|Other|0
4496082|NCT00818454|7299485|FG000|Treatment Period 3|Adverse Event|0
4496083|NCT00818454|7299486|FG001|Treatment Period 3|Adverse Event|0
4496084|NCT00818454|7299487|FG002|Treatment Period 3|Adverse Event|0
4496085|NCT00818454|7299488|FG003|Treatment Period 3|Adverse Event|1
4496086|NCT00818519|7299500|FG000|Overall Study|Adverse Event|2
4496087|NCT00818519|7299501|FG001|Overall Study|Adverse Event|2
4496088|NCT00818519|7299500|FG000|Overall Study|Lost to Follow-up|4
4496089|NCT00818519|7299501|FG001|Overall Study|Lost to Follow-up|6
4496090|NCT00818519|7299500|FG000|Overall Study|Protocol Violation|2
4496091|NCT00818519|7299501|FG001|Overall Study|Protocol Violation|1
4496092|NCT00818519|7299500|FG000|Overall Study|Pregnancy|0
4496093|NCT00818519|7299501|FG001|Overall Study|Pregnancy|1
4496094|NCT00818519|7299500|FG000|Overall Study|Withdrawal by Subject|4
4496095|NCT00818519|7299501|FG001|Overall Study|Withdrawal by Subject|9
4496096|NCT00818519|7299500|FG000|Overall Study|participant recovered completely|1
4496097|NCT00818519|7299501|FG001|Overall Study|participant recovered completely|0
4496098|NCT00818519|7299500|FG000|Overall Study|participant will leave for long tme|1
4496099|NCT00818519|7299501|FG001|Overall Study|participant will leave for long tme|0
4496100|NCT00818623|7299515|FG000|Overall Study|Adverse Event|1
4496101|NCT00818623|7299516|FG001|Overall Study|Adverse Event|0
4496102|NCT00818623|7299517|FG002|Overall Study|Adverse Event|1
4496103|NCT00818623|7299518|FG003|Overall Study|Adverse Event|0
4496104|NCT00818623|7299519|FG004|Overall Study|Adverse Event|0
4496105|NCT00818623|7299520|FG005|Overall Study|Adverse Event|1
4496106|NCT00818623|7299521|FG006|Overall Study|Adverse Event|0
4496107|NCT00818623|7299522|FG007|Overall Study|Adverse Event|0
4496108|NCT00818623|7299515|FG000|Overall Study|Bad prostate specific antigen response|0
4496109|NCT00818623|7299516|FG001|Overall Study|Bad prostate specific antigen response|3
4496110|NCT00818623|7299517|FG002|Overall Study|Bad prostate specific antigen response|2
4496111|NCT00818623|7299518|FG003|Overall Study|Bad prostate specific antigen response|5
4496112|NCT00818623|7299519|FG004|Overall Study|Bad prostate specific antigen response|0
4496113|NCT00818623|7299520|FG005|Overall Study|Bad prostate specific antigen response|1
4496114|NCT00818623|7299521|FG006|Overall Study|Bad prostate specific antigen response|0
4496115|NCT00818623|7299522|FG007|Overall Study|Bad prostate specific antigen response|0
4496116|NCT00818623|7299515|FG000|Overall Study|Withdrawal by Subject|0
4496117|NCT00818623|7299516|FG001|Overall Study|Withdrawal by Subject|1
4496118|NCT00818623|7299517|FG002|Overall Study|Withdrawal by Subject|1
4496119|NCT00818623|7299518|FG003|Overall Study|Withdrawal by Subject|0
4496120|NCT00818623|7299519|FG004|Overall Study|Withdrawal by Subject|0
4496121|NCT00818623|7299520|FG005|Overall Study|Withdrawal by Subject|1
4496122|NCT00818623|7299521|FG006|Overall Study|Withdrawal by Subject|1
4496123|NCT00818623|7299522|FG007|Overall Study|Withdrawal by Subject|1
4496124|NCT00818623|7299515|FG000|Overall Study|Protocol Violation|1
4496125|NCT00818623|7299516|FG001|Overall Study|Protocol Violation|0
4496126|NCT00818623|7299517|FG002|Overall Study|Protocol Violation|0
4496127|NCT00818623|7299518|FG003|Overall Study|Protocol Violation|0
4496128|NCT00818623|7299519|FG004|Overall Study|Protocol Violation|1
4496129|NCT00818623|7299520|FG005|Overall Study|Protocol Violation|0
4496130|NCT00818623|7299521|FG006|Overall Study|Protocol Violation|1
4496131|NCT00818623|7299522|FG007|Overall Study|Protocol Violation|0
4496132|NCT00818623|7299515|FG000|Overall Study|Need of additional treatment|0
4496133|NCT00818623|7299516|FG001|Overall Study|Need of additional treatment|0
4496134|NCT00818623|7299517|FG002|Overall Study|Need of additional treatment|0
4496135|NCT00818623|7299518|FG003|Overall Study|Need of additional treatment|0
4496136|NCT00818623|7299519|FG004|Overall Study|Need of additional treatment|1
4496137|NCT00818623|7299520|FG005|Overall Study|Need of additional treatment|0
4496138|NCT00818623|7299521|FG006|Overall Study|Need of additional treatment|0
4496139|NCT00818623|7299522|FG007|Overall Study|Need of additional treatment|0
4496140|NCT00818623|7299515|FG000|Overall Study|Lack of trial drug at site|0
4496141|NCT00818623|7299516|FG001|Overall Study|Lack of trial drug at site|0
4496142|NCT00818623|7299517|FG002|Overall Study|Lack of trial drug at site|0
4496143|NCT00818623|7299518|FG003|Overall Study|Lack of trial drug at site|0
4496144|NCT00818623|7299519|FG004|Overall Study|Lack of trial drug at site|2
4496145|NCT00818623|7299520|FG005|Overall Study|Lack of trial drug at site|0
4496146|NCT00818623|7299521|FG006|Overall Study|Lack of trial drug at site|1
4496147|NCT00818623|7299522|FG007|Overall Study|Lack of trial drug at site|0
4496148|NCT00818623|7299515|FG000|Overall Study|Disease progression|0
4496149|NCT00818623|7299516|FG001|Overall Study|Disease progression|0
4496150|NCT00818623|7299517|FG002|Overall Study|Disease progression|0
4496151|NCT00818623|7299518|FG003|Overall Study|Disease progression|0
4496152|NCT00818623|7299519|FG004|Overall Study|Disease progression|0
4496153|NCT00818623|7299520|FG005|Overall Study|Disease progression|0
4496154|NCT00818623|7299521|FG006|Overall Study|Disease progression|1
4496155|NCT00818623|7299522|FG007|Overall Study|Disease progression|0
4496156|NCT00818649|7299540|FG000|Overall Study|Declining performance status|2
4496157|NCT00818649|7299540|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1
4496158|NCT00818649|7299540|FG000|Overall Study|Adverse Event|1
4496159|NCT00818662|7299549|FG000|Overall Study|Adverse Event|5
4496160|NCT00818662|7299550|FG001|Overall Study|Adverse Event|14
4496161|NCT00818662|7299551|FG002|Overall Study|Adverse Event|4
4496162|NCT00818662|7299552|FG003|Overall Study|Adverse Event|3
4496163|NCT00818662|7299549|FG000|Overall Study|Withdrawal by Subject|5
4496164|NCT00818662|7299550|FG001|Overall Study|Withdrawal by Subject|4
4496165|NCT00818662|7299551|FG002|Overall Study|Withdrawal by Subject|2
4496166|NCT00818662|7299552|FG003|Overall Study|Withdrawal by Subject|2
4496167|NCT00818662|7299549|FG000|Overall Study|Death|1
4496168|NCT00818662|7299550|FG001|Overall Study|Death|3
4496169|NCT00818662|7299551|FG002|Overall Study|Death|0
4496170|NCT00818662|7299552|FG003|Overall Study|Death|0
4496171|NCT00818662|7299549|FG000|Overall Study|Physician Decision|1
4496172|NCT00818662|7299550|FG001|Overall Study|Physician Decision|0
4496173|NCT00818662|7299551|FG002|Overall Study|Physician Decision|0
4496174|NCT00818662|7299552|FG003|Overall Study|Physician Decision|0
4496175|NCT00818662|7299549|FG000|Overall Study|Lost to Follow-up|0
4496176|NCT00818662|7299550|FG001|Overall Study|Lost to Follow-up|0
4496177|NCT00818662|7299551|FG002|Overall Study|Lost to Follow-up|0
4496178|NCT00818662|7299552|FG003|Overall Study|Lost to Follow-up|1
4496179|NCT00818662|7299549|FG000|Overall Study|Unwilling or Unable to Participate|4
4496180|NCT00818662|7299550|FG001|Overall Study|Unwilling or Unable to Participate|6
4496181|NCT00818662|7299551|FG002|Overall Study|Unwilling or Unable to Participate|2
4496182|NCT00818662|7299552|FG003|Overall Study|Unwilling or Unable to Participate|4
4496183|NCT00818662|7299549|FG000|Overall Study|Protocol Violation|1
4496184|NCT00818662|7299550|FG001|Overall Study|Protocol Violation|1
4627020|NCT01848756|7493386|FG000|Overall Study|Enrolled in Error|1
4627021|NCT01848834|7493405|FG000|Overall Study|Adverse Event|3
4496185|NCT00818662|7299551|FG002|Overall Study|Protocol Violation|0
4496186|NCT00818662|7299552|FG003|Overall Study|Protocol Violation|0
4496187|NCT00818662|7299549|FG000|Overall Study|Requires a Prohibited Medication|1
4496188|NCT00818662|7299550|FG001|Overall Study|Requires a Prohibited Medication|0
4496189|NCT00818662|7299551|FG002|Overall Study|Requires a Prohibited Medication|0
4496190|NCT00818662|7299552|FG003|Overall Study|Requires a Prohibited Medication|0
4496191|NCT00818662|7299549|FG000|Overall Study|Safety Risk|1
4496192|NCT00818662|7299550|FG001|Overall Study|Safety Risk|1
4496193|NCT00818662|7299551|FG002|Overall Study|Safety Risk|0
4496194|NCT00818662|7299552|FG003|Overall Study|Safety Risk|1
4496195|NCT00818662|7299549|FG000|Overall Study|Study Partner Unwilling or Unable|3
4496196|NCT00818662|7299550|FG001|Overall Study|Study Partner Unwilling or Unable|2
4496197|NCT00818662|7299551|FG002|Overall Study|Study Partner Unwilling or Unable|1
4496198|NCT00818662|7299552|FG003|Overall Study|Study Partner Unwilling or Unable|1
4496199|NCT00818662|7299549|FG000|Overall Study|Participant's health declined|0
4496200|NCT00818662|7299550|FG001|Overall Study|Participant's health declined|0
4496201|NCT00818662|7299551|FG002|Overall Study|Participant's health declined|0
4496202|NCT00818662|7299552|FG003|Overall Study|Participant's health declined|1
4496203|NCT00818662|7299549|FG000|Overall Study|Caregiver to pursue other treatment|0
4496204|NCT00818662|7299550|FG001|Overall Study|Caregiver to pursue other treatment|1
4496205|NCT00818662|7299551|FG002|Overall Study|Caregiver to pursue other treatment|0
4496206|NCT00818662|7299552|FG003|Overall Study|Caregiver to pursue other treatment|0
4496207|NCT00818662|7299549|FG000|Overall Study|Moving out of state|0
4496208|NCT00818662|7299550|FG001|Overall Study|Moving out of state|0
4496209|NCT00818662|7299551|FG002|Overall Study|Moving out of state|0
4496210|NCT00818662|7299552|FG003|Overall Study|Moving out of state|1
4496211|NCT00818662|7299549|FG000|Overall Study|Declined move to another study site|1
4496212|NCT00818662|7299550|FG001|Overall Study|Declined move to another study site|0
4496213|NCT00818662|7299551|FG002|Overall Study|Declined move to another study site|0
4496214|NCT00818662|7299552|FG003|Overall Study|Declined move to another study site|0
4496215|NCT00818662|7299549|FG000|Overall Study|Change in living situation|0
4627022|NCT01848834|7493406|FG001|Overall Study|Adverse Event|11
4496216|NCT00818662|7299550|FG001|Overall Study|Change in living situation|0
4496217|NCT00818662|7299551|FG002|Overall Study|Change in living situation|0
4496218|NCT00818662|7299552|FG003|Overall Study|Change in living situation|1
4496219|NCT00818662|7299549|FG000|Overall Study|Study partner decision|0
4496220|NCT00818662|7299550|FG001|Overall Study|Study partner decision|0
4496221|NCT00818662|7299551|FG002|Overall Study|Study partner decision|0
4627023|NCT01848834|7493407|FG002|Overall Study|Adverse Event|3
4496222|NCT00818662|7299552|FG003|Overall Study|Study partner decision|1
4496223|NCT00818662|7299549|FG000|Overall Study|Admitted to long term nursing care|0
4496224|NCT00818662|7299550|FG001|Overall Study|Admitted to long term nursing care|1
4496225|NCT00818662|7299551|FG002|Overall Study|Admitted to long term nursing care|0
4496226|NCT00818662|7299552|FG003|Overall Study|Admitted to long term nursing care|0
4496227|NCT00818753|7299566|FG000|Overall Study|Protocol Violation|1
4496228|NCT00818753|7299567|FG001|Overall Study|Protocol Violation|0
4496229|NCT00818753|7299568|FG002|Overall Study|Protocol Violation|0
4496230|NCT00818753|7299566|FG000|Overall Study|Other reason (not specified)|0
4496231|NCT00818753|7299567|FG001|Overall Study|Other reason (not specified)|0
4496232|NCT00818753|7299568|FG002|Overall Study|Other reason (not specified)|1
4496233|NCT00818753|7299566|FG000|Overall Study|Randomised and not treated|2
4496234|NCT00818753|7299567|FG001|Overall Study|Randomised and not treated|0
4496235|NCT00818753|7299568|FG002|Overall Study|Randomised and not treated|0
4496236|NCT00818766|7299578|FG000|Overall Study|Could not be Contacted on Day 28|11
4496237|NCT00818766|7299579|FG001|Overall Study|Could not be Contacted on Day 28|10
4496238|NCT00818766|7299578|FG000|Overall Study|Death|1
4496239|NCT00818766|7299579|FG001|Overall Study|Death|0
4496240|NCT00818766|7299578|FG000|Overall Study|Did not Receive Allocated Intervention|3
4496241|NCT00818766|7299579|FG001|Overall Study|Did not Receive Allocated Intervention|0
4496242|NCT00818779|7299587|FG000|Overall Study|Protocol Violation|1
4496243|NCT00818779|7299588|FG001|Overall Study|Protocol Violation|0
4496244|NCT00818779|7299587|FG000|Overall Study|Lost to Follow-up|1
4496245|NCT00818779|7299588|FG001|Overall Study|Lost to Follow-up|0
4496246|NCT00818779|7299587|FG000|Overall Study|Adverse Event|4
4496247|NCT00818779|7299588|FG001|Overall Study|Adverse Event|1
4496248|NCT00818883|7299607|FG000|Overall Study|Adverse Event|28
4496249|NCT00818883|7299608|FG001|Overall Study|Adverse Event|19
4496250|NCT00818883|7299607|FG000|Overall Study|Protocol Violation|2
4496251|NCT00818883|7299608|FG001|Overall Study|Protocol Violation|2
4496252|NCT00818883|7299607|FG000|Overall Study|Lost to Follow-up|3
4496253|NCT00818883|7299608|FG001|Overall Study|Lost to Follow-up|2
4496254|NCT00818883|7299607|FG000|Overall Study|Withdrawal by Subject|16
4496255|NCT00818883|7299608|FG001|Overall Study|Withdrawal by Subject|14
4496256|NCT00818883|7299607|FG000|Overall Study|Lack of Efficacy|0
4496257|NCT00818883|7299608|FG001|Overall Study|Lack of Efficacy|2
4496258|NCT00818883|7299607|FG000|Overall Study|Other|2
4496259|NCT00818883|7299608|FG001|Overall Study|Other|7
4496260|NCT00819013|7299622|FG000|Overall Study|Not meeting continuing study eligibility|2
4496261|NCT00819013|7299623|FG001|Overall Study|Not meeting continuing study eligibility|1
4496262|NCT00819013|7299624|FG002|Overall Study|Not meeting continuing study eligibility|2
4496263|NCT00819013|7299625|FG003|Overall Study|Not meeting continuing study eligibility|1
4496264|NCT00819013|7299622|FG000|Overall Study|Adverse Event|0
4496265|NCT00819013|7299623|FG001|Overall Study|Adverse Event|0
4496266|NCT00819013|7299624|FG002|Overall Study|Adverse Event|1
4496267|NCT00819013|7299625|FG003|Overall Study|Adverse Event|0
4496268|NCT00819013|7299622|FG000|Overall Study|Withdrawal by Subject|1
4496269|NCT00819013|7299623|FG001|Overall Study|Withdrawal by Subject|0
4496270|NCT00819013|7299624|FG002|Overall Study|Withdrawal by Subject|1
4496271|NCT00819013|7299625|FG003|Overall Study|Withdrawal by Subject|0
4496272|NCT00819013|7299622|FG000|Overall Study|Lost to Follow-up|0
4496273|NCT00819013|7299623|FG001|Overall Study|Lost to Follow-up|0
4496274|NCT00819013|7299624|FG002|Overall Study|Lost to Follow-up|1
4496275|NCT00819013|7299625|FG003|Overall Study|Lost to Follow-up|2
4496276|NCT00819013|7299622|FG000|Overall Study|Death|0
4496277|NCT00819013|7299623|FG001|Overall Study|Death|0
4496278|NCT00819013|7299624|FG002|Overall Study|Death|0
4496279|NCT00819013|7299625|FG003|Overall Study|Death|1
4496280|NCT00819039|7299638|FG000|Overall Study|Physician Decision|1
4496281|NCT00819039|7299639|FG001|Overall Study|Physician Decision|0
4496282|NCT00819039|7299640|FG002|Overall Study|Physician Decision|1
4496283|NCT00819039|7299638|FG000|Overall Study|Protocol Violation|1
4496284|NCT00819039|7299639|FG001|Overall Study|Protocol Violation|0
4496285|NCT00819039|7299640|FG002|Overall Study|Protocol Violation|0
4496286|NCT00819052|7299652|FG000|Overall Study|Adverse Event|0
4496287|NCT00819052|7299653|FG001|Overall Study|Adverse Event|5
4496288|NCT00819052|7299652|FG000|Overall Study|Protocol Violation|1
4496289|NCT00819052|7299653|FG001|Overall Study|Protocol Violation|2
4496290|NCT00819052|7299652|FG000|Overall Study|Lost to Follow-up|1
4496291|NCT00819052|7299653|FG001|Overall Study|Lost to Follow-up|2
4496292|NCT00819052|7299652|FG000|Overall Study|Withdrawal by Subject|1
4496293|NCT00819052|7299653|FG001|Overall Study|Withdrawal by Subject|2
4496294|NCT00819052|7299652|FG000|Overall Study|Lack of Efficacy|1
4496295|NCT00819052|7299653|FG001|Overall Study|Lack of Efficacy|1
4496296|NCT00819052|7299652|FG000|Overall Study|Pregnancy|1
4496297|NCT00819052|7299653|FG001|Overall Study|Pregnancy|2
4496298|NCT00819052|7299652|FG000|Overall Study|Death or events leading to death|1
4496299|NCT00819052|7299653|FG001|Overall Study|Death or events leading to death|0
4496300|NCT00819091|7299664|FG000|Overall Study|Adverse Event|3
4496301|NCT00819091|7299665|FG001|Overall Study|Adverse Event|5
4496302|NCT00819091|7299664|FG000|Overall Study|Protocol Violation|0
4496303|NCT00819091|7299665|FG001|Overall Study|Protocol Violation|1
4496304|NCT00819091|7299664|FG000|Overall Study|Lost to Follow-up|2
4496305|NCT00819091|7299665|FG001|Overall Study|Lost to Follow-up|0
4496306|NCT00819091|7299664|FG000|Overall Study|Withdrawal by Subject|1
4496307|NCT00819091|7299665|FG001|Overall Study|Withdrawal by Subject|2
4496308|NCT00819091|7299664|FG000|Overall Study|Other|1
4496309|NCT00819091|7299665|FG001|Overall Study|Other|2
4496310|NCT00819156|7299677|FG000|Overall Study|Adverse Event|1
4496311|NCT00819156|7299678|FG001|Overall Study|Adverse Event|4
4496312|NCT00819156|7299679|FG002|Overall Study|Adverse Event|2
4496313|NCT00819156|7299680|FG003|Overall Study|Adverse Event|1
4496314|NCT00819156|7299681|FG004|Overall Study|Adverse Event|2
4496315|NCT00819156|7299682|FG005|Overall Study|Adverse Event|3
4496316|NCT00819156|7299677|FG000|Overall Study|Withdrawal by Subject|0
4496317|NCT00819156|7299678|FG001|Overall Study|Withdrawal by Subject|3
4496318|NCT00819156|7299679|FG002|Overall Study|Withdrawal by Subject|2
4496319|NCT00819156|7299680|FG003|Overall Study|Withdrawal by Subject|0
4496320|NCT00819156|7299681|FG004|Overall Study|Withdrawal by Subject|1
4496321|NCT00819156|7299682|FG005|Overall Study|Withdrawal by Subject|0
4496322|NCT00819156|7299677|FG000|Overall Study|Protocol Violation|1
4496323|NCT00819156|7299678|FG001|Overall Study|Protocol Violation|0
4496324|NCT00819156|7299679|FG002|Overall Study|Protocol Violation|1
4496325|NCT00819156|7299680|FG003|Overall Study|Protocol Violation|0
4496326|NCT00819156|7299681|FG004|Overall Study|Protocol Violation|0
4496327|NCT00819156|7299682|FG005|Overall Study|Protocol Violation|1
4496328|NCT00819156|7299677|FG000|Overall Study|Lost to Follow-up|0
4496329|NCT00819156|7299678|FG001|Overall Study|Lost to Follow-up|1
4496330|NCT00819156|7299679|FG002|Overall Study|Lost to Follow-up|0
4496331|NCT00819156|7299680|FG003|Overall Study|Lost to Follow-up|0
4496332|NCT00819156|7299681|FG004|Overall Study|Lost to Follow-up|0
4496333|NCT00819156|7299682|FG005|Overall Study|Lost to Follow-up|2
4496334|NCT00819156|7299677|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5
4496335|NCT00819156|7299678|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2
4496336|NCT00819156|7299679|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1
4496337|NCT00819156|7299680|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1
4496338|NCT00819156|7299681|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1
4496339|NCT00819156|7299682|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2
4496340|NCT00819156|7299677|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3
4496341|NCT00819156|7299678|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0
4496342|NCT00819156|7299679|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0
4496343|NCT00819156|7299680|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0
4496344|NCT00819156|7299681|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1
4627024|NCT01848834|7493408|FG003|Overall Study|Adverse Event|5
4627025|NCT01848834|7493409|FG004|Overall Study|Adverse Event|9
4496345|NCT00819156|7299682|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0
4496346|NCT00819156|7299677|FG000|Overall Study|Prostate-specific antigen progression|0
4496347|NCT00819156|7299678|FG001|Overall Study|Prostate-specific antigen progression|0
4496348|NCT00819156|7299679|FG002|Overall Study|Prostate-specific antigen progression|0
4496349|NCT00819156|7299680|FG003|Overall Study|Prostate-specific antigen progression|0
4496350|NCT00819156|7299681|FG004|Overall Study|Prostate-specific antigen progression|1
4496351|NCT00819156|7299682|FG005|Overall Study|Prostate-specific antigen progression|0
4496352|NCT00819234|7299717|FG000|Overall Study|Withdrawal by Subject|8
4496353|NCT00819234|7299718|FG001|Overall Study|Withdrawal by Subject|13
4496354|NCT00819234|7299719|FG002|Overall Study|Withdrawal by Subject|6
4496355|NCT00819234|7299720|FG003|Overall Study|Withdrawal by Subject|3
4496356|NCT00819234|7299721|FG004|Overall Study|Withdrawal by Subject|0
4496357|NCT00819234|7299722|FG005|Overall Study|Withdrawal by Subject|4
4496358|NCT00819234|7299723|FG006|Overall Study|Withdrawal by Subject|4
4496359|NCT00819234|7299724|FG007|Overall Study|Withdrawal by Subject|8
4496360|NCT00819234|7299725|FG008|Overall Study|Withdrawal by Subject|5
4496361|NCT00819234|7299726|FG009|Overall Study|Withdrawal by Subject|3
4496362|NCT00819234|7299717|FG000|Overall Study|Adverse Event|0
4496363|NCT00819234|7299718|FG001|Overall Study|Adverse Event|0
4496364|NCT00819234|7299719|FG002|Overall Study|Adverse Event|1
4496365|NCT00819234|7299720|FG003|Overall Study|Adverse Event|0
4496366|NCT00819234|7299721|FG004|Overall Study|Adverse Event|0
4496367|NCT00819234|7299722|FG005|Overall Study|Adverse Event|2
4496368|NCT00819234|7299723|FG006|Overall Study|Adverse Event|0
4496369|NCT00819234|7299724|FG007|Overall Study|Adverse Event|0
4496370|NCT00819234|7299725|FG008|Overall Study|Adverse Event|0
4496371|NCT00819234|7299726|FG009|Overall Study|Adverse Event|0
4496372|NCT00819234|7299717|FG000|Overall Study|Physician Decision|0
4496373|NCT00819234|7299718|FG001|Overall Study|Physician Decision|0
4496374|NCT00819234|7299719|FG002|Overall Study|Physician Decision|0
4496375|NCT00819234|7299720|FG003|Overall Study|Physician Decision|1
4496376|NCT00819234|7299721|FG004|Overall Study|Physician Decision|0
4496377|NCT00819234|7299722|FG005|Overall Study|Physician Decision|0
4496378|NCT00819234|7299723|FG006|Overall Study|Physician Decision|0
4496379|NCT00819234|7299724|FG007|Overall Study|Physician Decision|0
4496380|NCT00819234|7299725|FG008|Overall Study|Physician Decision|0
4496381|NCT00819234|7299726|FG009|Overall Study|Physician Decision|2
4496382|NCT00819234|7299717|FG000|Overall Study|Protocol Violation|0
4496383|NCT00819234|7299718|FG001|Overall Study|Protocol Violation|0
4496384|NCT00819234|7299719|FG002|Overall Study|Protocol Violation|1
4496385|NCT00819234|7299720|FG003|Overall Study|Protocol Violation|0
4496386|NCT00819234|7299721|FG004|Overall Study|Protocol Violation|0
4496387|NCT00819234|7299722|FG005|Overall Study|Protocol Violation|0
4496388|NCT00819234|7299723|FG006|Overall Study|Protocol Violation|0
4496389|NCT00819234|7299724|FG007|Overall Study|Protocol Violation|0
4496390|NCT00819234|7299725|FG008|Overall Study|Protocol Violation|0
4496391|NCT00819234|7299726|FG009|Overall Study|Protocol Violation|0
4496392|NCT00819234|7299717|FG000|Overall Study|Lost to Follow-up|2
4496393|NCT00819234|7299718|FG001|Overall Study|Lost to Follow-up|2
4496394|NCT00819234|7299719|FG002|Overall Study|Lost to Follow-up|0
4496395|NCT00819234|7299720|FG003|Overall Study|Lost to Follow-up|2
4496396|NCT00819234|7299721|FG004|Overall Study|Lost to Follow-up|1
4496397|NCT00819234|7299722|FG005|Overall Study|Lost to Follow-up|1
4496398|NCT00819234|7299723|FG006|Overall Study|Lost to Follow-up|1
4496399|NCT00819234|7299724|FG007|Overall Study|Lost to Follow-up|1
4496400|NCT00819234|7299725|FG008|Overall Study|Lost to Follow-up|1
4496401|NCT00819234|7299726|FG009|Overall Study|Lost to Follow-up|2
4496402|NCT00819247|7299784|FG000|Overall Study|Adverse Event|0
4496403|NCT00819247|7299785|FG001|Overall Study|Adverse Event|5
4496404|NCT00819247|7299786|FG002|Overall Study|Adverse Event|3
4496405|NCT00819247|7299784|FG000|Overall Study|Insufficient testosterone response|5
4496406|NCT00819247|7299785|FG001|Overall Study|Insufficient testosterone response|8
4496407|NCT00819247|7299786|FG002|Overall Study|Insufficient testosterone response|10
4496408|NCT00819247|7299784|FG000|Overall Study|Withdrawal by Subject|1
4496409|NCT00819247|7299785|FG001|Overall Study|Withdrawal by Subject|0
4496410|NCT00819247|7299786|FG002|Overall Study|Withdrawal by Subject|0
4496411|NCT00819247|7299784|FG000|Overall Study|Protocol Violation|1
4496412|NCT00819247|7299785|FG001|Overall Study|Protocol Violation|0
4496413|NCT00819247|7299786|FG002|Overall Study|Protocol Violation|1
4496414|NCT00819247|7299784|FG000|Overall Study|Mistakenly withdrawn|0
4496415|NCT00819247|7299785|FG001|Overall Study|Mistakenly withdrawn|1
4496416|NCT00819247|7299786|FG002|Overall Study|Mistakenly withdrawn|0
4496417|NCT00819247|7299784|FG000|Overall Study|Bad prostate-specific antigen response|3
4496418|NCT00819247|7299785|FG001|Overall Study|Bad prostate-specific antigen response|2
4496419|NCT00819247|7299786|FG002|Overall Study|Bad prostate-specific antigen response|0
4496420|NCT00819247|7299784|FG000|Overall Study|Other|1
4496421|NCT00819247|7299785|FG001|Overall Study|Other|0
4496422|NCT00819247|7299786|FG002|Overall Study|Other|0
4496423|NCT00819390|7299813|FG000|Overall Study|Lost to Follow-up|1
4496424|NCT00819390|7299814|FG001|Overall Study|Lost to Follow-up|1
4496425|NCT00819390|7299815|FG002|Overall Study|Lost to Follow-up|0
4496426|NCT00819390|7299816|FG003|Overall Study|Lost to Follow-up|0
4496427|NCT00819390|7299813|FG000|Overall Study|Withdrawal by Subject|2
4496428|NCT00819390|7299814|FG001|Overall Study|Withdrawal by Subject|0
4496429|NCT00819390|7299815|FG002|Overall Study|Withdrawal by Subject|0
4496430|NCT00819390|7299816|FG003|Overall Study|Withdrawal by Subject|0
4496431|NCT00819390|7299813|FG000|Overall Study|Adverse Event|0
4496432|NCT00819390|7299814|FG001|Overall Study|Adverse Event|0
4496433|NCT00819390|7299815|FG002|Overall Study|Adverse Event|1
4496434|NCT00819390|7299816|FG003|Overall Study|Adverse Event|0
4517739|NCT00969124|7329644|FG000|Overall Study|Previously unrecognized disease|3
4517740|NCT00969124|7329644|FG000|Overall Study|Technical error|1
4517741|NCT00969150|7329651|FG000|Overall Study|Adverse Event|4
4517742|NCT00969150|7329652|FG001|Overall Study|Adverse Event|14
4517743|NCT00969150|7329651|FG000|Overall Study|Lack of Efficacy|1
4517744|NCT00969150|7329652|FG001|Overall Study|Lack of Efficacy|1
4703576|NCT02734862|7621437|FG000|Part A|Noncompliance|1
4703577|NCT02734862|7621438|FG001|Part A|Noncompliance|1
4703578|NCT02734862|7621439|FG002|Part A|Noncompliance|0
4703579|NCT02734862|7621437|FG000|Part A|Other|1
4703580|NCT02734862|7621438|FG001|Part A|Other|1
4703581|NCT02734862|7621439|FG002|Part A|Other|3
4703582|NCT02734862|7621437|FG000|Part B|Death|8
4703583|NCT02734862|7621438|FG001|Part B|Death|3
4703584|NCT02734862|7621439|FG002|Part B|Death|5
4703585|NCT02734862|7621437|FG000|Part B|Lost to Follow-up|2
4703586|NCT02734862|7621438|FG001|Part B|Lost to Follow-up|2
4703587|NCT02734862|7621439|FG002|Part B|Lost to Follow-up|0
4703588|NCT02734862|7621437|FG000|Part B|Withdrawal by Subject|3
4703589|NCT02734862|7621438|FG001|Part B|Withdrawal by Subject|1
4703590|NCT02734862|7621439|FG002|Part B|Withdrawal by Subject|0
4517745|NCT00969150|7329651|FG000|Overall Study|Protocol Violation|9
4517746|NCT00969150|7329652|FG001|Overall Study|Protocol Violation|12
4517747|NCT00969150|7329651|FG000|Overall Study|Withdrawal by Subject|13
4517748|NCT00969150|7329652|FG001|Overall Study|Withdrawal by Subject|9
4517749|NCT00969150|7329651|FG000|Overall Study|Lost to Follow-up|5
4517750|NCT00969150|7329652|FG001|Overall Study|Lost to Follow-up|4
4517751|NCT00969150|7329651|FG000|Overall Study|Other reasons|1
4517752|NCT00969150|7329652|FG001|Overall Study|Other reasons|0
4517753|NCT00969228|7329660|FG000|Overall Study|Adverse Event|1
4517754|NCT00969228|7329661|FG001|Overall Study|Adverse Event|0
4703591|NCT02734862|7621437|FG000|Part B|Other|0
4517755|NCT00969228|7329660|FG000|Overall Study|Withdrawal by Subject|4
4517756|NCT00969228|7329661|FG001|Overall Study|Withdrawal by Subject|0
4517757|NCT00969228|7329660|FG000|Overall Study|Porcine circovirus detection in vaccine|38
4517758|NCT00969228|7329661|FG001|Overall Study|Porcine circovirus detection in vaccine|14
4517759|NCT00969280|7329669|FG000|Overall Study|Protocol Violation|2
4703592|NCT02734862|7621438|FG001|Part B|Other|1
4703593|NCT02734862|7621439|FG002|Part B|Other|0
4496435|NCT00819585|7299850|FG000|Core Study|Adverse Event|2
4496436|NCT00819585|7299851|FG001|Core Study|Adverse Event|1
4496437|NCT00819585|7299852|FG002|Core Study|Adverse Event|1
4496438|NCT00819585|7299853|FG003|Core Study|Adverse Event|4
4496439|NCT00819585|7299854|FG004|Core Study|Adverse Event|1
4496440|NCT00819585|7299855|FG005|Core Study|Adverse Event|0
4496441|NCT00819585|7299856|FG006|Core Study|Adverse Event|2
4496442|NCT00819585|7299857|FG007|Core Study|Adverse Event|0
4496443|NCT00819585|7299858|FG008|Core Study|Adverse Event|0
4496444|NCT00819585|7299859|FG009|Core Study|Adverse Event|0
4496445|NCT00819585|7299860|FG010|Core Study|Adverse Event|0
4496446|NCT00819585|7299850|FG000|Core Study|Abnormal Laboratory Value(s)|2
4496447|NCT00819585|7299851|FG001|Core Study|Abnormal Laboratory Value(s)|0
4496448|NCT00819585|7299852|FG002|Core Study|Abnormal Laboratory Value(s)|0
4496449|NCT00819585|7299853|FG003|Core Study|Abnormal Laboratory Value(s)|0
4496450|NCT00819585|7299854|FG004|Core Study|Abnormal Laboratory Value(s)|0
4496451|NCT00819585|7299855|FG005|Core Study|Abnormal Laboratory Value(s)|0
4496452|NCT00819585|7299856|FG006|Core Study|Abnormal Laboratory Value(s)|0
4496453|NCT00819585|7299857|FG007|Core Study|Abnormal Laboratory Value(s)|0
4496454|NCT00819585|7299858|FG008|Core Study|Abnormal Laboratory Value(s)|0
4496455|NCT00819585|7299859|FG009|Core Study|Abnormal Laboratory Value(s)|0
4496456|NCT00819585|7299860|FG010|Core Study|Abnormal Laboratory Value(s)|0
4496457|NCT00819585|7299850|FG000|Core Study|Unsatisfactory Therapeutic Effect|0
4496458|NCT00819585|7299851|FG001|Core Study|Unsatisfactory Therapeutic Effect|1
4496459|NCT00819585|7299852|FG002|Core Study|Unsatisfactory Therapeutic Effect|0
4496460|NCT00819585|7299853|FG003|Core Study|Unsatisfactory Therapeutic Effect|0
4496461|NCT00819585|7299854|FG004|Core Study|Unsatisfactory Therapeutic Effect|0
4496462|NCT00819585|7299855|FG005|Core Study|Unsatisfactory Therapeutic Effect|0
4496463|NCT00819585|7299856|FG006|Core Study|Unsatisfactory Therapeutic Effect|1
4496464|NCT00819585|7299857|FG007|Core Study|Unsatisfactory Therapeutic Effect|0
4496465|NCT00819585|7299858|FG008|Core Study|Unsatisfactory Therapeutic Effect|0
4496466|NCT00819585|7299859|FG009|Core Study|Unsatisfactory Therapeutic Effect|0
4496467|NCT00819585|7299860|FG010|Core Study|Unsatisfactory Therapeutic Effect|0
4496468|NCT00819585|7299850|FG000|Core Study|Subject No Longer Requires Study Drug|0
4496469|NCT00819585|7299851|FG001|Core Study|Subject No Longer Requires Study Drug|0
4496470|NCT00819585|7299852|FG002|Core Study|Subject No Longer Requires Study Drug|0
4496471|NCT00819585|7299853|FG003|Core Study|Subject No Longer Requires Study Drug|0
4496472|NCT00819585|7299854|FG004|Core Study|Subject No Longer Requires Study Drug|1
4496473|NCT00819585|7299855|FG005|Core Study|Subject No Longer Requires Study Drug|0
4496474|NCT00819585|7299856|FG006|Core Study|Subject No Longer Requires Study Drug|0
4496475|NCT00819585|7299857|FG007|Core Study|Subject No Longer Requires Study Drug|0
4496476|NCT00819585|7299858|FG008|Core Study|Subject No Longer Requires Study Drug|0
4496477|NCT00819585|7299859|FG009|Core Study|Subject No Longer Requires Study Drug|0
4496478|NCT00819585|7299860|FG010|Core Study|Subject No Longer Requires Study Drug|0
4496479|NCT00819585|7299850|FG000|Core Study|Subject Withdrew Consent|0
4496480|NCT00819585|7299851|FG001|Core Study|Subject Withdrew Consent|3
4496481|NCT00819585|7299852|FG002|Core Study|Subject Withdrew Consent|2
4496482|NCT00819585|7299853|FG003|Core Study|Subject Withdrew Consent|1
4496483|NCT00819585|7299854|FG004|Core Study|Subject Withdrew Consent|0
4496484|NCT00819585|7299855|FG005|Core Study|Subject Withdrew Consent|0
4496485|NCT00819585|7299856|FG006|Core Study|Subject Withdrew Consent|3
4496486|NCT00819585|7299857|FG007|Core Study|Subject Withdrew Consent|0
4496487|NCT00819585|7299858|FG008|Core Study|Subject Withdrew Consent|0
4496488|NCT00819585|7299859|FG009|Core Study|Subject Withdrew Consent|0
4496489|NCT00819585|7299860|FG010|Core Study|Subject Withdrew Consent|0
4496490|NCT00819585|7299850|FG000|Core Study|Lost to Follow-up|2
4496491|NCT00819585|7299851|FG001|Core Study|Lost to Follow-up|1
4496492|NCT00819585|7299852|FG002|Core Study|Lost to Follow-up|2
4496493|NCT00819585|7299853|FG003|Core Study|Lost to Follow-up|0
4496494|NCT00819585|7299854|FG004|Core Study|Lost to Follow-up|1
4496495|NCT00819585|7299855|FG005|Core Study|Lost to Follow-up|1
4496496|NCT00819585|7299856|FG006|Core Study|Lost to Follow-up|1
4496497|NCT00819585|7299857|FG007|Core Study|Lost to Follow-up|0
4496498|NCT00819585|7299858|FG008|Core Study|Lost to Follow-up|0
4496499|NCT00819585|7299859|FG009|Core Study|Lost to Follow-up|0
4496500|NCT00819585|7299860|FG010|Core Study|Lost to Follow-up|0
4496501|NCT00819585|7299850|FG000|Core Study|Administrative Problems|0
4496502|NCT00819585|7299851|FG001|Core Study|Administrative Problems|0
4496503|NCT00819585|7299852|FG002|Core Study|Administrative Problems|0
4496504|NCT00819585|7299853|FG003|Core Study|Administrative Problems|0
4496505|NCT00819585|7299854|FG004|Core Study|Administrative Problems|0
4496506|NCT00819585|7299855|FG005|Core Study|Administrative Problems|0
4496507|NCT00819585|7299856|FG006|Core Study|Administrative Problems|2
4496508|NCT00819585|7299857|FG007|Core Study|Administrative Problems|0
4496509|NCT00819585|7299858|FG008|Core Study|Administrative Problems|0
4496510|NCT00819585|7299859|FG009|Core Study|Administrative Problems|0
4496511|NCT00819585|7299860|FG010|Core Study|Administrative Problems|0
4496512|NCT00819585|7299850|FG000|Core Study|Death|0
4496513|NCT00819585|7299851|FG001|Core Study|Death|0
4496514|NCT00819585|7299852|FG002|Core Study|Death|0
4496515|NCT00819585|7299853|FG003|Core Study|Death|0
4496516|NCT00819585|7299854|FG004|Core Study|Death|0
4496517|NCT00819585|7299855|FG005|Core Study|Death|0
4496518|NCT00819585|7299856|FG006|Core Study|Death|1
4496519|NCT00819585|7299857|FG007|Core Study|Death|0
4496520|NCT00819585|7299858|FG008|Core Study|Death|0
4496521|NCT00819585|7299859|FG009|Core Study|Death|0
4496522|NCT00819585|7299860|FG010|Core Study|Death|0
4496523|NCT00819585|7299850|FG000|Core Study|Protocol Violation|0
4496524|NCT00819585|7299851|FG001|Core Study|Protocol Violation|0
4496525|NCT00819585|7299852|FG002|Core Study|Protocol Violation|1
4496526|NCT00819585|7299853|FG003|Core Study|Protocol Violation|0
4496527|NCT00819585|7299854|FG004|Core Study|Protocol Violation|0
4496528|NCT00819585|7299855|FG005|Core Study|Protocol Violation|1
4496529|NCT00819585|7299856|FG006|Core Study|Protocol Violation|3
4496530|NCT00819585|7299857|FG007|Core Study|Protocol Violation|0
4496531|NCT00819585|7299858|FG008|Core Study|Protocol Violation|0
4627026|NCT01848834|7493405|FG000|Overall Study|Death|2
4627027|NCT01848834|7493406|FG001|Overall Study|Death|11
4627028|NCT01848834|7493407|FG002|Overall Study|Death|1
4627029|NCT01848834|7493408|FG003|Overall Study|Death|8
4627030|NCT01848834|7493409|FG004|Overall Study|Death|27
4627031|NCT01848834|7493405|FG000|Overall Study|Excluded Medication|5
4627032|NCT01848834|7493406|FG001|Overall Study|Excluded Medication|4
4627033|NCT01848834|7493407|FG002|Overall Study|Excluded Medication|3
4627034|NCT01848834|7493408|FG003|Overall Study|Excluded Medication|6
4627035|NCT01848834|7493409|FG004|Overall Study|Excluded Medication|6
4496532|NCT00819585|7299859|FG009|Core Study|Protocol Violation|0
4496533|NCT00819585|7299860|FG010|Core Study|Protocol Violation|0
4496534|NCT00819585|7299850|FG000|Extension Study|Abnormal Laboratory Value(s)|0
4496535|NCT00819585|7299851|FG001|Extension Study|Abnormal Laboratory Value(s)|0
4496536|NCT00819585|7299852|FG002|Extension Study|Abnormal Laboratory Value(s)|0
4496537|NCT00819585|7299853|FG003|Extension Study|Abnormal Laboratory Value(s)|0
4496538|NCT00819585|7299854|FG004|Extension Study|Abnormal Laboratory Value(s)|0
4496539|NCT00819585|7299855|FG005|Extension Study|Abnormal Laboratory Value(s)|0
4496540|NCT00819585|7299856|FG006|Extension Study|Abnormal Laboratory Value(s)|0
4496541|NCT00819585|7299857|FG007|Extension Study|Abnormal Laboratory Value(s)|0
4496542|NCT00819585|7299858|FG008|Extension Study|Abnormal Laboratory Value(s)|1
4496543|NCT00819585|7299859|FG009|Extension Study|Abnormal Laboratory Value(s)|0
4496544|NCT00819585|7299860|FG010|Extension Study|Abnormal Laboratory Value(s)|0
4496545|NCT00819585|7299850|FG000|Extension Study|Subject Withdrew Consent|0
4496546|NCT00819585|7299851|FG001|Extension Study|Subject Withdrew Consent|0
4496547|NCT00819585|7299852|FG002|Extension Study|Subject Withdrew Consent|0
4496548|NCT00819585|7299853|FG003|Extension Study|Subject Withdrew Consent|0
4496549|NCT00819585|7299854|FG004|Extension Study|Subject Withdrew Consent|0
4496550|NCT00819585|7299855|FG005|Extension Study|Subject Withdrew Consent|0
4496551|NCT00819585|7299856|FG006|Extension Study|Subject Withdrew Consent|0
4496552|NCT00819585|7299857|FG007|Extension Study|Subject Withdrew Consent|0
4496553|NCT00819585|7299858|FG008|Extension Study|Subject Withdrew Consent|3
4496554|NCT00819585|7299859|FG009|Extension Study|Subject Withdrew Consent|0
4496555|NCT00819585|7299860|FG010|Extension Study|Subject Withdrew Consent|1
4496556|NCT00819585|7299850|FG000|Extension Study|Lost to Follow-up|0
4496557|NCT00819585|7299851|FG001|Extension Study|Lost to Follow-up|0
4496558|NCT00819585|7299852|FG002|Extension Study|Lost to Follow-up|0
4496559|NCT00819585|7299853|FG003|Extension Study|Lost to Follow-up|0
4496560|NCT00819585|7299854|FG004|Extension Study|Lost to Follow-up|0
4496561|NCT00819585|7299855|FG005|Extension Study|Lost to Follow-up|0
4496562|NCT00819585|7299856|FG006|Extension Study|Lost to Follow-up|0
4496563|NCT00819585|7299857|FG007|Extension Study|Lost to Follow-up|0
4496564|NCT00819585|7299858|FG008|Extension Study|Lost to Follow-up|2
4496565|NCT00819585|7299859|FG009|Extension Study|Lost to Follow-up|1
4496566|NCT00819585|7299860|FG010|Extension Study|Lost to Follow-up|1
4496567|NCT00819585|7299850|FG000|Extension Study|Death|0
4496568|NCT00819585|7299851|FG001|Extension Study|Death|0
4496569|NCT00819585|7299852|FG002|Extension Study|Death|0
4496570|NCT00819585|7299853|FG003|Extension Study|Death|0
4496571|NCT00819585|7299854|FG004|Extension Study|Death|0
4496572|NCT00819585|7299855|FG005|Extension Study|Death|0
4496573|NCT00819585|7299856|FG006|Extension Study|Death|0
4496574|NCT00819585|7299857|FG007|Extension Study|Death|0
4496575|NCT00819585|7299858|FG008|Extension Study|Death|2
4496576|NCT00819585|7299859|FG009|Extension Study|Death|0
4496577|NCT00819585|7299860|FG010|Extension Study|Death|0
4496578|NCT00819741|7299903|FG000|Overall Study|Adverse Event|5
4496579|NCT00819741|7299904|FG001|Overall Study|Adverse Event|2
4496580|NCT00819741|7299903|FG000|Overall Study|Lack of Efficacy|0
4496581|NCT00819741|7299904|FG001|Overall Study|Lack of Efficacy|2
4496582|NCT00819741|7299903|FG000|Overall Study|Lost to Follow-up|3
4496583|NCT00819741|7299904|FG001|Overall Study|Lost to Follow-up|1
4496584|NCT00819741|7299903|FG000|Overall Study|Protocol Violation|3
4496585|NCT00819741|7299904|FG001|Overall Study|Protocol Violation|4
4496586|NCT00819741|7299903|FG000|Overall Study|Withdrawal by Subject|2
4627036|NCT01848834|7493405|FG000|Overall Study|Lost to Follow-up|5
4496587|NCT00819741|7299904|FG001|Overall Study|Withdrawal by Subject|2
4496588|NCT00819741|7299903|FG000|Overall Study|Unclassified|6
4496589|NCT00819741|7299904|FG001|Overall Study|Unclassified|0
4496590|NCT00819741|7299903|FG000|Overall Study|Reasons unknown|3
4496591|NCT00819741|7299904|FG001|Overall Study|Reasons unknown|3
4496592|NCT00819767|7299912|FG000|Overall Study|Unsatisfactory therapeutic effect|1
4496593|NCT00819767|7299913|FG001|Overall Study|Unsatisfactory therapeutic effect|2
4627037|NCT01848834|7493406|FG001|Overall Study|Lost to Follow-up|5
4496594|NCT00819780|7299921|FG000|Overall Study|Did not receive study drug|3
4496595|NCT00819780|7299922|FG001|Overall Study|Did not receive study drug|4
4496596|NCT00819780|7299921|FG000|Overall Study|Still in treatment|25
4496597|NCT00819780|7299922|FG001|Overall Study|Still in treatment|17
4496598|NCT00819910|7299937|FG000|Overall Study|Adverse Event|0
4496599|NCT00819910|7299938|FG001|Overall Study|Adverse Event|0
4496600|NCT00819910|7299939|FG002|Overall Study|Adverse Event|2
4496601|NCT00819910|7299940|FG003|Overall Study|Adverse Event|1
4496602|NCT00819910|7299937|FG000|Overall Study|Withdrawal by Subject|1
4496603|NCT00819910|7299938|FG001|Overall Study|Withdrawal by Subject|1
4496604|NCT00819910|7299939|FG002|Overall Study|Withdrawal by Subject|1
4496605|NCT00819910|7299940|FG003|Overall Study|Withdrawal by Subject|0
4496606|NCT00819910|7299937|FG000|Overall Study|Lost to Follow-up|1
4496607|NCT00819910|7299938|FG001|Overall Study|Lost to Follow-up|0
4496608|NCT00819910|7299939|FG002|Overall Study|Lost to Follow-up|0
4496609|NCT00819910|7299940|FG003|Overall Study|Lost to Follow-up|0
4496610|NCT00820040|7299952|FG000|Overall Study|Death|1
4496611|NCT00820040|7299952|FG000|Overall Study|Sponsor terminated study|1
4496612|NCT00820040|7299952|FG000|Overall Study|Screen failure|1
4496613|NCT00820170|7299961|FG000|Overall Study|Adverse Event|0
4496614|NCT00820170|7299962|FG001|Overall Study|Adverse Event|0
4496615|NCT00820170|7299963|FG002|Overall Study|Adverse Event|0
4496616|NCT00820170|7299964|FG003|Overall Study|Adverse Event|0
4496617|NCT00820170|7299965|FG004|Overall Study|Adverse Event|2
4496618|NCT00820170|7299961|FG000|Overall Study|Progressive Disease|0
4496619|NCT00820170|7299962|FG001|Overall Study|Progressive Disease|0
4496620|NCT00820170|7299963|FG002|Overall Study|Progressive Disease|0
4496621|NCT00820170|7299964|FG003|Overall Study|Progressive Disease|0
4496622|NCT00820170|7299965|FG004|Overall Study|Progressive Disease|2
4496623|NCT00820222|7299984|FG000|Overall Study|Lost to Follow-up|10
4496624|NCT00820222|7299985|FG001|Overall Study|Lost to Follow-up|9
4496625|NCT00820222|7299984|FG000|Overall Study|Withdrawal by Subject|19
4496626|NCT00820222|7299985|FG001|Overall Study|Withdrawal by Subject|21
4496627|NCT00820222|7299984|FG000|Overall Study|Physician Decision|93
4496628|NCT00820222|7299985|FG001|Overall Study|Physician Decision|88
4496629|NCT00820222|7299984|FG000|Overall Study|Sponsor Terminated Study|43
4496630|NCT00820222|7299985|FG001|Overall Study|Sponsor Terminated Study|65
4496631|NCT00820222|7299984|FG000|Overall Study|Unkown|11
4496632|NCT00820222|7299985|FG001|Overall Study|Unkown|7
4496633|NCT00820248|7300006|FG000|Overall Study|No treated|4
4496634|NCT00820248|7300007|FG001|Overall Study|No treated|1
4496635|NCT00820599|7300053|FG000|Overall Study|Death|129
4496636|NCT00820599|7300053|FG000|Overall Study|Withdrawal by Subject|2
4496637|NCT00820755|7300079|FG000|Period 1: Combination Therapy Phase|Adverse Event|77
4496638|NCT00820755|7300080|FG001|Period 1: Combination Therapy Phase|Adverse Event|0
4496639|NCT00820755|7300081|FG002|Period 1: Combination Therapy Phase|Adverse Event|0
4496640|NCT00820755|7300079|FG000|Period 1: Combination Therapy Phase|Death|28
4496641|NCT00820755|7300080|FG001|Period 1: Combination Therapy Phase|Death|0
4496642|NCT00820755|7300081|FG002|Period 1: Combination Therapy Phase|Death|0
4496643|NCT00820755|7300079|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4
4496644|NCT00820755|7300080|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0
4496645|NCT00820755|7300081|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0
4496646|NCT00820755|7300079|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1
4496647|NCT00820755|7300080|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0
4496648|NCT00820755|7300081|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0
4496649|NCT00820755|7300079|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21
4496650|NCT00820755|7300080|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0
4496651|NCT00820755|7300081|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0
4496652|NCT00820755|7300079|FG000|Period 1: Combination Therapy Phase|Progressive disease|114
4496653|NCT00820755|7300080|FG001|Period 1: Combination Therapy Phase|Progressive disease|0
4496654|NCT00820755|7300081|FG002|Period 1: Combination Therapy Phase|Progressive disease|0
4496655|NCT00820755|7300079|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14
4496656|NCT00820755|7300080|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0
4496657|NCT00820755|7300081|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0
4496658|NCT00820755|7300079|FG000|Period 1: Combination Therapy Phase|Other|11
4496659|NCT00820755|7300080|FG001|Period 1: Combination Therapy Phase|Other|0
4496660|NCT00820755|7300081|FG002|Period 1: Combination Therapy Phase|Other|0
4496661|NCT00820755|7300079|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0
4496662|NCT00820755|7300080|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45
4496663|NCT00820755|7300081|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45
4496664|NCT00820898|7300093|FG000|Overall Study|Inelgible - wrong primary site|1
4496665|NCT00821015|7300103|FG000|Overall Study|Lost to Follow-up|12
4496666|NCT00821093|7300118|FG000|Overall Study|Adverse Event|20
4496667|NCT00821093|7300119|FG001|Overall Study|Adverse Event|12
4496668|NCT00821093|7300118|FG000|Overall Study|Withdrawal by Subject|9
4496669|NCT00821093|7300119|FG001|Overall Study|Withdrawal by Subject|13
4496670|NCT00821093|7300118|FG000|Overall Study|Lost to Follow-up|9
4496671|NCT00821093|7300119|FG001|Overall Study|Lost to Follow-up|3
4496672|NCT00821093|7300118|FG000|Overall Study|Protocol deviation|3
4496673|NCT00821093|7300119|FG001|Overall Study|Protocol deviation|6
4496674|NCT00821093|7300118|FG000|Overall Study|Abnormal laboratory value(s)|2
4496675|NCT00821093|7300119|FG001|Overall Study|Abnormal laboratory value(s)|0
4496676|NCT00821093|7300118|FG000|Overall Study|Lack of Efficacy|2
4496677|NCT00821093|7300119|FG001|Overall Study|Lack of Efficacy|2
4496678|NCT00821093|7300118|FG000|Overall Study|Death|2
4496679|NCT00821093|7300119|FG001|Overall Study|Death|1
4496680|NCT00821093|7300118|FG000|Overall Study|Abnormal test procedure result(s)|1
4496681|NCT00821093|7300119|FG001|Overall Study|Abnormal test procedure result(s)|1
4496682|NCT00821093|7300118|FG000|Overall Study|Administrative problems|1
4496683|NCT00821093|7300119|FG001|Overall Study|Administrative problems|2
4517760|NCT00969280|7329670|FG001|Overall Study|Protocol Violation|1
4517761|NCT00969280|7329669|FG000|Overall Study|Withdrawal by Subject|0
4517762|NCT00969280|7329670|FG001|Overall Study|Withdrawal by Subject|1
4517763|NCT00969280|7329669|FG000|Overall Study|infection of influenza A(H1N1)|0
4517764|NCT00969280|7329670|FG001|Overall Study|infection of influenza A(H1N1)|1
4517765|NCT00969332|7329676|FG000|Overall Study|Physician Decision|8
4517766|NCT00969332|7329676|FG000|Overall Study|Withdrawal by Subject|3
4517767|NCT00969436|7329684|FG000|Overall Study|Protocol Violation|1
4517768|NCT00969436|7329685|FG001|Overall Study|Protocol Violation|3
4517769|NCT00969436|7329686|FG002|Overall Study|Protocol Violation|0
4517770|NCT00969436|7329684|FG000|Overall Study|Migrated/moved from study area|12
4517771|NCT00969436|7329685|FG001|Overall Study|Migrated/moved from study area|10
4517772|NCT00969436|7329686|FG002|Overall Study|Migrated/moved from study area|2
4517773|NCT00969436|7329684|FG000|Overall Study|Father - serious health problem|0
4517774|NCT00969436|7329685|FG001|Overall Study|Father - serious health problem|0
4517775|NCT00969436|7329686|FG002|Overall Study|Father - serious health problem|1
4517776|NCT00969436|7329684|FG000|Overall Study|Parents personal problem|0
4517777|NCT00969436|7329685|FG001|Overall Study|Parents personal problem|0
4517778|NCT00969436|7329686|FG002|Overall Study|Parents personal problem|1
4517779|NCT00969436|7329684|FG000|Overall Study|Subject eliminated (other vaccine)|1
4517780|NCT00969436|7329685|FG001|Overall Study|Subject eliminated (other vaccine)|0
4517781|NCT00969436|7329686|FG002|Overall Study|Subject eliminated (other vaccine)|0
4517782|NCT00969436|7329684|FG000|Overall Study|Withdrawal by Subject|3
4517783|NCT00969436|7329685|FG001|Overall Study|Withdrawal by Subject|0
4517784|NCT00969436|7329686|FG002|Overall Study|Withdrawal by Subject|2
4517785|NCT00969436|7329684|FG000|Overall Study|Lost to Follow-up|8
4517786|NCT00969436|7329685|FG001|Overall Study|Lost to Follow-up|8
4517787|NCT00969436|7329686|FG002|Overall Study|Lost to Follow-up|5
4518680|NCT00975585|7330873|FG001|Overall Study|Adverse Event|4
4518681|NCT00975585|7330872|FG000|Overall Study|Lost to Follow-up|3
4518682|NCT00975585|7330873|FG001|Overall Study|Lost to Follow-up|5
4518683|NCT00975585|7330872|FG000|Overall Study|Withdrawal by Subject|2
4518684|NCT00975585|7330873|FG001|Overall Study|Withdrawal by Subject|1
4518685|NCT00975585|7330872|FG000|Overall Study|Lens issue|2
4518686|NCT00975585|7330873|FG001|Overall Study|Lens issue|2
4518687|NCT00975676|7330917|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6
4518688|NCT00975676|7330918|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8
4518689|NCT00975689|7330931|FG000|Overall Study|Adverse Event|0
4518690|NCT00975689|7330932|FG001|Overall Study|Adverse Event|3
4518691|NCT00975689|7330931|FG000|Overall Study|Withdrawal by Subject|1
4518692|NCT00975689|7330932|FG001|Overall Study|Withdrawal by Subject|0
4518693|NCT00975689|7330931|FG000|Overall Study|Physician Decision|1
4518694|NCT00975689|7330932|FG001|Overall Study|Physician Decision|0
4518695|NCT00975715|7330940|FG000|Titration Period|Adverse Event|6
4518696|NCT00975715|7330941|FG001|Titration Period|Adverse Event|0
4518697|NCT00975715|7330940|FG000|Titration Period|Protocol Violation|1
4518698|NCT00975715|7330941|FG001|Titration Period|Protocol Violation|0
4518699|NCT00975715|7330940|FG000|Maintenance Period|Adverse Event|2
4518700|NCT00975715|7330941|FG001|Maintenance Period|Adverse Event|1
4518701|NCT00975780|7330949|FG000|Follow Up|Death|88
4518702|NCT00975780|7330950|FG001|Follow Up|Death|122
4518703|NCT00975780|7330949|FG000|Follow Up|Facility Withdrawal|7
4518704|NCT00975780|7330950|FG001|Follow Up|Facility Withdrawal|23
4518705|NCT00975780|7330949|FG000|Follow Up|Discharged from Facility|7
4518706|NCT00975780|7330950|FG001|Follow Up|Discharged from Facility|12
4518707|NCT00975806|7330959|FG000|Overall Study|Adverse Event|2
4518708|NCT00975806|7330960|FG001|Overall Study|Adverse Event|1
4518709|NCT00975806|7330961|FG002|Overall Study|Adverse Event|2
4518710|NCT00975806|7330959|FG000|Overall Study|Disease Progression|1
4518711|NCT00975806|7330960|FG001|Overall Study|Disease Progression|5
4518712|NCT00975806|7330961|FG002|Overall Study|Disease Progression|1
4518713|NCT00975806|7330959|FG000|Overall Study|Withdrawal by Subject|1
4518714|NCT00975806|7330960|FG001|Overall Study|Withdrawal by Subject|0
4518715|NCT00975806|7330961|FG002|Overall Study|Withdrawal by Subject|0
4518716|NCT00975806|7330959|FG000|Overall Study|Death|0
4518717|NCT00975806|7330960|FG001|Overall Study|Death|1
4518718|NCT00975806|7330961|FG002|Overall Study|Death|0
4518719|NCT00975806|7330959|FG000|Overall Study|Physician decision and disease related|1
4518720|NCT00975806|7330960|FG001|Overall Study|Physician decision and disease related|0
4518721|NCT00975806|7330961|FG002|Overall Study|Physician decision and disease related|1
4518722|NCT00975884|7330973|FG000|Overall Study|Adverse Event|1
4518723|NCT00975884|7330974|FG001|Overall Study|Adverse Event|0
4496684|NCT04187989|7300149|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6
4496685|NCT04187989|7300150|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8
4496686|NCT04187989|7300149|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8
4496687|NCT04187989|7300150|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8
4496736|NCT02807363|7300302|FG000|Dosing Period|Adverse Event|0
4496737|NCT02807363|7300303|FG001|Dosing Period|Adverse Event|1
4496738|NCT02807363|7300304|FG002|Dosing Period|Adverse Event|0
4496739|NCT02807363|7300305|FG003|Dosing Period|Adverse Event|0
4496740|NCT02756403|7300321|FG000|Overall Study|Unable to swallow medication|0
4496741|NCT02756403|7300322|FG001|Overall Study|Unable to swallow medication|1
4496742|NCT02756403|7300323|FG002|Overall Study|Unable to swallow medication|1
4496743|NCT02756403|7300324|FG003|Overall Study|Unable to swallow medication|1
4496744|NCT02756403|7300321|FG000|Overall Study|Did not complete Procedure|0
4496745|NCT02756403|7300322|FG001|Overall Study|Did not complete Procedure|1
4496746|NCT02756403|7300323|FG002|Overall Study|Did not complete Procedure|0
4496747|NCT02756403|7300324|FG003|Overall Study|Did not complete Procedure|0
4496748|NCT02756403|7300321|FG000|Overall Study|Changed Mind About Procedure|0
4496749|NCT02756403|7300322|FG001|Overall Study|Changed Mind About Procedure|0
4496750|NCT02756403|7300323|FG002|Overall Study|Changed Mind About Procedure|1
4496751|NCT02756403|7300324|FG003|Overall Study|Changed Mind About Procedure|0
4496752|NCT02756403|7300321|FG000|Overall Study|Protocol Violation|0
4496753|NCT02756403|7300322|FG001|Overall Study|Protocol Violation|1
4496754|NCT02756403|7300323|FG002|Overall Study|Protocol Violation|0
4496755|NCT02756403|7300324|FG003|Overall Study|Protocol Violation|1
4496756|NCT02751502|7300334|FG000|Overall Study|Lack of funding|4
4496757|NCT02285062|7300366|FG000|Overall Study|Withdrawal by Subject|12
4496758|NCT02285062|7300367|FG001|Overall Study|Withdrawal by Subject|17
4496759|NCT02285062|7300366|FG000|Overall Study|Death|58
4496760|NCT02285062|7300367|FG001|Overall Study|Death|62
4496761|NCT02285062|7300366|FG000|Overall Study|Lost to Follow-up|8
4496762|NCT02285062|7300367|FG001|Overall Study|Lost to Follow-up|5
4496763|NCT02264977|7300373|FG000|Overall Study|Death|3
4496764|NCT02264977|7300373|FG000|Overall Study|Withdrawal by Subject|1
4496765|NCT02264977|7300373|FG000|Overall Study|Physician Decision|1
4496766|NCT01981096|7300379|FG000|Overall Study|Parent illness|1
4496767|NCT01981096|7300380|FG001|Overall Study|Parent illness|0
4496768|NCT01981096|7300379|FG000|Overall Study|Withdrawal by Subject|0
4496769|NCT01981096|7300380|FG001|Overall Study|Withdrawal by Subject|1
4496770|NCT01981096|7300379|FG000|Overall Study|Lost to Follow-up|2
4496771|NCT01981096|7300380|FG001|Overall Study|Lost to Follow-up|0
4496772|NCT01935336|7300390|FG000|Overall Study|Adverse Event|1
4496773|NCT01935336|7300391|FG001|Overall Study|Adverse Event|0
4496774|NCT01935336|7300392|FG002|Overall Study|Adverse Event|0
4496775|NCT01935336|7300393|FG003|Overall Study|Adverse Event|0
4496776|NCT01935336|7300390|FG000|Overall Study|Progressive disease|5
4496777|NCT01935336|7300391|FG001|Overall Study|Progressive disease|3
4496778|NCT01935336|7300392|FG002|Overall Study|Progressive disease|47
4496779|NCT01935336|7300393|FG003|Overall Study|Progressive disease|66
4496780|NCT01712490|7300411|FG000|Overall Study|Ongoing|601
4496781|NCT01712490|7300412|FG001|Overall Study|Ongoing|586
4496782|NCT01712490|7300411|FG000|Overall Study|Other|11
4496783|NCT01712490|7300412|FG001|Overall Study|Other|11
4496784|NCT01712490|7300411|FG000|Overall Study|Withdrawal by Subject|36
4496785|NCT01712490|7300412|FG001|Overall Study|Withdrawal by Subject|44
4496786|NCT01712490|7300411|FG000|Overall Study|Lost to Follow-up|16
4496787|NCT01712490|7300412|FG001|Overall Study|Lost to Follow-up|29
4496788|NCT01702805|7300420|FG000|Overall Study|Data withdrawn prior to hospital discharge|3
4496789|NCT01702805|7300421|FG001|Overall Study|Data withdrawn prior to hospital discharge|7
4496790|NCT01702805|7300420|FG000|Overall Study|Incomplete Follow-up|18
4496791|NCT01702805|7300421|FG001|Overall Study|Incomplete Follow-up|15
4496792|NCT01702805|7300420|FG000|Overall Study|Vital Status Assessment Only|40
4496793|NCT01702805|7300421|FG001|Overall Study|Vital Status Assessment Only|39
4496794|NCT01702805|7300420|FG000|Overall Study|Lost to Follow-up|5
4496795|NCT01702805|7300421|FG001|Overall Study|Lost to Follow-up|5
4496796|NCT01499160|7300427|FG000|Overall Study|Adverse Event|1
4496797|NCT01499160|7300427|FG000|Overall Study|Withdrawal by Subject|1
4496798|NCT01061151|7300469|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2
4496799|NCT01061151|7300470|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0
4496800|NCT01061151|7300471|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0
4496801|NCT01061151|7300472|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1
4496802|NCT01061151|7300469|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6
4496803|NCT01061151|7300470|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9
4496804|NCT01061151|7300471|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1
4496805|NCT01061151|7300472|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2
4496806|NCT01061151|7300469|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89
4496807|NCT01061151|7300470|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82
4496808|NCT01061151|7300471|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2
4496809|NCT01061151|7300472|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10
4496810|NCT01061151|7300469|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73
4496811|NCT01061151|7300470|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65
4496688|NCT04109118|7300156|FG000|Overall Study|Lost to Follow-up|3
4496689|NCT04045132|7300163|FG000|Overall Study|Lost to Follow-up|3
4496690|NCT04045132|7300164|FG001|Overall Study|Lost to Follow-up|7
4496691|NCT03846219|7300175|FG000|Overall Study|Withdrawal by Subject|3
4496692|NCT03846219|7300176|FG001|Overall Study|Withdrawal by Subject|2
4496693|NCT03846219|7300177|FG002|Overall Study|Withdrawal by Subject|2
4496694|NCT03846219|7300175|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0
4496695|NCT03846219|7300176|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2
4496696|NCT03846219|7300177|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1
4496697|NCT03846219|7300175|FG000|Overall Study|Physician Decision|0
4496698|NCT03846219|7300176|FG001|Overall Study|Physician Decision|0
4496699|NCT03846219|7300177|FG002|Overall Study|Physician Decision|2
4496700|NCT03606668|7300219|FG000|Overall Study|Screen Failure|1
4496701|NCT03606668|7300219|FG000|Overall Study|Lost to Follow-up|1
4496702|NCT03575897|7300225|FG000|Overall Study|Lost to Follow-up|12
4496703|NCT03575897|7300226|FG001|Overall Study|Lost to Follow-up|13
4496704|NCT03343626|7300240|FG000|Overall Study|Lost to Follow-up|4
4496705|NCT03343626|7300241|FG001|Overall Study|Lost to Follow-up|3
4496706|NCT03343626|7300242|FG002|Overall Study|Lost to Follow-up|2
4496707|NCT03343626|7300243|FG003|Overall Study|Lost to Follow-up|5
4496708|NCT03343626|7300244|FG004|Overall Study|Lost to Follow-up|4
4496709|NCT03343626|7300245|FG005|Overall Study|Lost to Follow-up|4
4496710|NCT03343626|7300246|FG006|Overall Study|Lost to Follow-up|4
4496711|NCT03343626|7300247|FG007|Overall Study|Lost to Follow-up|7
4496712|NCT03343626|7300240|FG000|Overall Study|Withdrawal of Consent|2
4496713|NCT03343626|7300241|FG001|Overall Study|Withdrawal of Consent|1
4496714|NCT03343626|7300242|FG002|Overall Study|Withdrawal of Consent|0
4496715|NCT03343626|7300243|FG003|Overall Study|Withdrawal of Consent|3
4496716|NCT03343626|7300244|FG004|Overall Study|Withdrawal of Consent|3
4496717|NCT03343626|7300245|FG005|Overall Study|Withdrawal of Consent|1
4496718|NCT03343626|7300246|FG006|Overall Study|Withdrawal of Consent|1
4496719|NCT03343626|7300247|FG007|Overall Study|Withdrawal of Consent|2
4496720|NCT03343626|7300240|FG000|Overall Study|Reason not Specified|0
4496721|NCT03343626|7300241|FG001|Overall Study|Reason not Specified|1
4496722|NCT03343626|7300242|FG002|Overall Study|Reason not Specified|0
4496723|NCT03343626|7300243|FG003|Overall Study|Reason not Specified|0
4496724|NCT03343626|7300244|FG004|Overall Study|Reason not Specified|0
4496725|NCT03343626|7300245|FG005|Overall Study|Reason not Specified|0
4496726|NCT03343626|7300246|FG006|Overall Study|Reason not Specified|0
4496727|NCT03343626|7300247|FG007|Overall Study|Reason not Specified|1
4496728|NCT03343626|7300240|FG000|Overall Study|Data Entry Error|0
4496729|NCT03343626|7300241|FG001|Overall Study|Data Entry Error|0
4496730|NCT03343626|7300242|FG002|Overall Study|Data Entry Error|0
4496731|NCT03343626|7300243|FG003|Overall Study|Data Entry Error|0
4496732|NCT03343626|7300244|FG004|Overall Study|Data Entry Error|0
4496733|NCT03343626|7300245|FG005|Overall Study|Data Entry Error|0
4496734|NCT03343626|7300246|FG006|Overall Study|Data Entry Error|0
4496735|NCT03343626|7300247|FG007|Overall Study|Data Entry Error|1
4496812|NCT01061151|7300471|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2
4496813|NCT01061151|7300472|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10
4496814|NCT01061151|7300469|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15
4496815|NCT01061151|7300470|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19
4496816|NCT01061151|7300471|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1
4496817|NCT01061151|7300472|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0
4496818|NCT01061151|7300469|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44
4496819|NCT01061151|7300470|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61
4496820|NCT01061151|7300471|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2
4496821|NCT01061151|7300472|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5
4496822|NCT01061151|7300469|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3
4496823|NCT01061151|7300470|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5
4496824|NCT01061151|7300471|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1
4496825|NCT01061151|7300472|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0
4496826|NCT01061151|7300469|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0
4496827|NCT01061151|7300470|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0
4496828|NCT01061151|7300471|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2
4496829|NCT01061151|7300472|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4
4496830|NCT01061151|7300469|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1
4496831|NCT01061151|7300470|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
4496832|NCT01061151|7300471|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
4496833|NCT01061151|7300472|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
4496834|NCT01061151|7300469|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3
4496835|NCT01061151|7300470|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5
4496836|NCT01061151|7300471|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1
4496837|NCT01061151|7300472|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1
4496838|NCT01061151|7300469|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54
4496839|NCT01061151|7300470|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52
4496840|NCT01061151|7300471|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31
4496841|NCT01061151|7300472|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3
4496842|NCT01061151|7300469|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49
4496843|NCT01061151|7300470|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36
4496844|NCT01061151|7300471|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25
4496845|NCT01061151|7300472|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4
4496846|NCT01061151|7300469|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12
4496847|NCT01061151|7300470|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11
4496848|NCT01061151|7300471|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2
4496849|NCT01061151|7300472|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0
4496850|NCT01061151|7300469|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28
4496851|NCT01061151|7300470|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26
4496852|NCT01061151|7300471|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15
4496853|NCT01061151|7300472|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5
4496854|NCT01061151|7300469|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5
4496855|NCT01061151|7300470|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8
4496856|NCT01061151|7300471|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1
4496857|NCT01061151|7300472|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3
4496858|NCT00981058|7300494|FG000|Overall Study|Adverse Event|1
4496859|NCT00981058|7300495|FG001|Overall Study|Adverse Event|1
4496860|NCT00981058|7300494|FG000|Overall Study|Progressive Disease|61
4496861|NCT00981058|7300495|FG001|Overall Study|Progressive Disease|49
4496862|NCT00981058|7300494|FG000|Overall Study|Lost to Follow-up|16
4496863|NCT00981058|7300495|FG001|Overall Study|Lost to Follow-up|15
4496864|NCT00981058|7300494|FG000|Overall Study|New Anticancer Therapy|6
4496865|NCT00981058|7300495|FG001|Overall Study|New Anticancer Therapy|6
4496866|NCT00981058|7300494|FG000|Overall Study|Noncompliance|1
4496867|NCT00981058|7300495|FG001|Overall Study|Noncompliance|0
4496868|NCT00981058|7300494|FG000|Overall Study|Radiologist Error|0
4496869|NCT00981058|7300495|FG001|Overall Study|Radiologist Error|1
4496870|NCT00981058|7300494|FG000|Overall Study|Randomization Error|1
4496871|NCT00981058|7300495|FG001|Overall Study|Randomization Error|2
4496872|NCT00981058|7300494|FG000|Overall Study|Withdrawal by Subject|25
4496873|NCT00981058|7300495|FG001|Overall Study|Withdrawal by Subject|23
4496874|NCT00981058|7300494|FG000|Overall Study|On study treatment at conclusion|9
4496875|NCT00981058|7300495|FG001|Overall Study|On study treatment at conclusion|0
4496876|NCT00885495|7300503|FG000|Overall Study|Adverse Event|1
4496877|NCT00885495|7300504|FG001|Overall Study|Adverse Event|2
4496878|NCT00885495|7300503|FG000|Overall Study|Protocol Violation|0
4496879|NCT00885495|7300504|FG001|Overall Study|Protocol Violation|1
4496880|NCT00885495|7300503|FG000|Overall Study|Withdrawal by Subject|1
4496881|NCT00885495|7300504|FG001|Overall Study|Withdrawal by Subject|0
4496882|NCT00084799|7300517|FG000|Overall Study|Disease Progression|1
4496883|NCT00084799|7300518|FG001|Overall Study|Disease Progression|0
4496884|NCT00821236|7300527|FG000|Overall Study|Lost to Follow-up|3
4496885|NCT00821327|7300535|FG000|Overall Study|Adverse Event|13
4496886|NCT00821327|7300535|FG000|Overall Study|Patient Request|1
4496887|NCT00821327|7300535|FG000|Overall Study|Investigator Request|2
4496888|NCT00821327|7300535|FG000|Overall Study|Sponsor Request|1
4496889|NCT00821327|7300535|FG000|Overall Study|Disease Progression|13
4496890|NCT00821327|7300535|FG000|Overall Study|Other/Unknown|5
4496891|NCT00821431|7300541|FG000|Overall Study|Adverse Event|6
4496892|NCT00821431|7300542|FG001|Overall Study|Adverse Event|3
4496893|NCT00821431|7300541|FG000|Overall Study|Withdrawal by Subject|5
4496894|NCT00821431|7300542|FG001|Overall Study|Withdrawal by Subject|0
4496895|NCT00821431|7300541|FG000|Overall Study|Lost to Follow-up|1
4496896|NCT00821431|7300542|FG001|Overall Study|Lost to Follow-up|0
4496897|NCT00821431|7300541|FG000|Overall Study|Protocol Violation|3
4496898|NCT00821431|7300542|FG001|Overall Study|Protocol Violation|1
4496899|NCT00821431|7300541|FG000|Overall Study|Physician Decision|0
4496900|NCT00821431|7300542|FG001|Overall Study|Physician Decision|1
4496901|NCT00821509|7300551|FG000|Overall Study|Withdrawal by Subject|12
4496902|NCT00821509|7300552|FG001|Overall Study|Withdrawal by Subject|11
4496903|NCT00821509|7300553|FG002|Overall Study|Withdrawal by Subject|34
4496904|NCT00821678|7300574|FG000|Overall Study|Withdrawal by Subject|8
4496905|NCT00821678|7300575|FG001|Overall Study|Withdrawal by Subject|0
4496906|NCT00821678|7300574|FG000|Overall Study|Lost to Follow-up|13
4496907|NCT00821678|7300575|FG001|Overall Study|Lost to Follow-up|12
4496908|NCT00821678|7300574|FG000|Overall Study|Death|0
4496909|NCT00821678|7300575|FG001|Overall Study|Death|2
4496910|NCT00821873|7300607|FG000|Overall Study|Lost to Follow-up|4
4496911|NCT00822172|7300641|FG000|Overall Study|Adverse Event|10
4496912|NCT00822172|7300642|FG001|Overall Study|Adverse Event|12
4496913|NCT00822172|7300641|FG000|Overall Study|Death|1
4496914|NCT00822172|7300642|FG001|Overall Study|Death|0
4496915|NCT00822172|7300641|FG000|Overall Study|Lost to Follow-up|3
4496916|NCT00822172|7300642|FG001|Overall Study|Lost to Follow-up|1
4496917|NCT00822172|7300641|FG000|Overall Study|Withdrawal by Subject|1
4496918|NCT00822172|7300642|FG001|Overall Study|Withdrawal by Subject|4
4496919|NCT00822172|7300641|FG000|Overall Study|site closed|0
4496920|NCT00822172|7300642|FG001|Overall Study|site closed|1
4496921|NCT00822172|7300641|FG000|Overall Study|Other|0
4496922|NCT00822172|7300642|FG001|Overall Study|Other|1
4496923|NCT00822237|7300671|FG000|Dose 1 Vaccination|Not vaccinated|3
4496924|NCT00822237|7300672|FG001|Dose 1 Vaccination|Not vaccinated|0
4496925|NCT00822237|7300671|FG000|Dose 1 Vaccination|Withdrawal by Subject|13
4496926|NCT00822237|7300672|FG001|Dose 1 Vaccination|Withdrawal by Subject|14
4496927|NCT00822237|7300671|FG000|Dose 1 Vaccination|Lost to Follow-up|9
4496928|NCT00822237|7300672|FG001|Dose 1 Vaccination|Lost to Follow-up|12
4496929|NCT00822237|7300671|FG000|Dose 2 Vaccination|Withdrawal by Subject|2
4496930|NCT00822237|7300672|FG001|Dose 2 Vaccination|Withdrawal by Subject|2
4496931|NCT00822237|7300671|FG000|Dose 2 Vaccination|Lost to Follow-up|2
4496932|NCT00822237|7300672|FG001|Dose 2 Vaccination|Lost to Follow-up|9
4496933|NCT00822692|7300740|FG000|Overall Study|Lost to Follow-up|17
4496934|NCT00822692|7300741|FG001|Overall Study|Lost to Follow-up|25
4496935|NCT00822770|7300758|FG000|Overall Study|Not treated|1
4496936|NCT00822770|7300759|FG001|Overall Study|Not treated|0
4496937|NCT00822770|7300758|FG000|Overall Study|Complication/Incomplete treatment|1
4496938|NCT00822770|7300759|FG001|Overall Study|Complication/Incomplete treatment|0
4496939|NCT00822770|7300758|FG000|Overall Study|Death|1
4496940|NCT00822770|7300759|FG001|Overall Study|Death|1
4496941|NCT00822900|7300767|FG000|Overall Study|Withdrawal by Subject|14
4496942|NCT00822900|7300768|FG001|Overall Study|Withdrawal by Subject|14
4496943|NCT00822900|7300767|FG000|Overall Study|Lost to Follow-up|9
4496944|NCT00822900|7300768|FG001|Overall Study|Lost to Follow-up|9
4496945|NCT00822900|7300767|FG000|Overall Study|Death|83
4496946|NCT00822900|7300768|FG001|Overall Study|Death|69
4496947|NCT00822900|7300767|FG000|Overall Study|Became a ward of the state|2
4496948|NCT00822900|7300768|FG001|Overall Study|Became a ward of the state|1
4496949|NCT00822926|7300776|FG000|Second Injection Visit|Lost to Follow-up|1
4496950|NCT00822926|7300777|FG001|Second Injection Visit|Lost to Follow-up|0
4496951|NCT00822926|7300776|FG000|Second Injection Visit|Withdrawal by Subject|0
4496952|NCT00822926|7300777|FG001|Second Injection Visit|Withdrawal by Subject|1
4496953|NCT00823134|7300808|FG000|Overall Study|Invalid measurement|1
4496954|NCT00823199|7300813|FG000|Overall Study|Withdrawal by Subject|2
4496955|NCT00823212|7300820|FG000|Overall Study|Death|8
4496956|NCT00823212|7300821|FG001|Overall Study|Death|10
4496957|NCT00823212|7300820|FG000|Overall Study|Withdrawal by Subject|6
4496958|NCT00823212|7300821|FG001|Overall Study|Withdrawal by Subject|1
4496959|NCT00823212|7300820|FG000|Overall Study|Incarcerated|0
4496960|NCT00823212|7300821|FG001|Overall Study|Incarcerated|1
4496961|NCT00823212|7300820|FG000|Overall Study|Missed 12-month visit|21
4496962|NCT00823212|7300821|FG001|Overall Study|Missed 12-month visit|21
4496963|NCT00823264|7300831|FG000|Overall Study|Protocol Violation|2
4496964|NCT00823264|7300832|FG001|Overall Study|Protocol Violation|0
4496965|NCT00823472|7300854|FG000|Overall Study|Physician Decision|24
4496966|NCT00823472|7300855|FG001|Overall Study|Physician Decision|28
4496967|NCT00823615|7300861|FG000|Period 2|Lost to Follow-up|2
4496968|NCT00823615|7300862|FG001|Period 2|Lost to Follow-up|0
4496969|NCT00823615|7300861|FG000|Period 2|Time/Job Conflict|1
4496970|NCT00823615|7300862|FG001|Period 2|Time/Job Conflict|2
4496971|NCT00823719|7300870|FG000|Overall Study|Adverse Event|1
4496972|NCT00823719|7300871|FG001|Overall Study|Adverse Event|2
4496973|NCT00823719|7300870|FG000|Overall Study|Physician Decision|1
4496974|NCT00823719|7300871|FG001|Overall Study|Physician Decision|4
4496975|NCT00823719|7300870|FG000|Overall Study|Withdrawal by Subject|0
4496976|NCT00823719|7300871|FG001|Overall Study|Withdrawal by Subject|1
4496977|NCT00823719|7300870|FG000|Overall Study|Disease Progression|4
4496978|NCT00823719|7300871|FG001|Overall Study|Disease Progression|4
4496979|NCT00823823|7300889|FG000|Overall Study|Lost to Follow-up|3
4496980|NCT00823823|7300890|FG001|Overall Study|Lost to Follow-up|1
4496981|NCT00823823|7300889|FG000|Overall Study|Protocol Violation|5
4496982|NCT00823823|7300890|FG001|Overall Study|Protocol Violation|5
4496983|NCT00823836|7300898|FG000|NV and PR/XR Switching Phases|Adverse Event|22
4496984|NCT00823836|7300899|FG001|NV and PR/XR Switching Phases|Adverse Event|21
4496985|NCT00823836|7300898|FG000|NV and PR/XR Switching Phases|Protocol Violation|1
4496986|NCT00823836|7300899|FG001|NV and PR/XR Switching Phases|Protocol Violation|1
4496987|NCT00823836|7300898|FG000|NV and PR/XR Switching Phases|Physician Decision|5
4496988|NCT00823836|7300899|FG001|NV and PR/XR Switching Phases|Physician Decision|2
4496989|NCT00823836|7300898|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4
4496990|NCT00823836|7300899|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5
4590294|NCT01519869|7436109|FG000|Overall Study|Lost to Follow-up|1
4590295|NCT01519921|7436124|FG000|Overall Study|Adverse Event|10
4590296|NCT01519921|7436125|FG001|Overall Study|Adverse Event|9
4590297|NCT01519921|7436124|FG000|Overall Study|Lack of Efficacy|4
4590298|NCT01519921|7436125|FG001|Overall Study|Lack of Efficacy|3
4590299|NCT01519921|7436124|FG000|Overall Study|Withdrawal by Subject|3
4590300|NCT01519921|7436125|FG001|Overall Study|Withdrawal by Subject|0
4590301|NCT01519921|7436124|FG000|Overall Study|Lost to Follow-up|2
4590302|NCT01519921|7436125|FG001|Overall Study|Lost to Follow-up|1
4496991|NCT00823836|7300898|FG000|Long-term Phase|Adverse Event|3
4496992|NCT00823836|7300899|FG001|Long-term Phase|Adverse Event|2
4496993|NCT00823836|7300898|FG000|Long-term Phase|Physician Decision|1
4496994|NCT00823836|7300899|FG001|Long-term Phase|Physician Decision|2
4496995|NCT00823836|7300898|FG000|Long-term Phase|Withdrawal by Subject|1
4496996|NCT00823836|7300899|FG001|Long-term Phase|Withdrawal by Subject|1
4590303|NCT01519921|7436124|FG000|Overall Study|Treatment refusal|2
4496997|NCT00823901|7300910|FG000|Overall Study|Adverse Event|1
4496998|NCT00823901|7300911|FG001|Overall Study|Adverse Event|1
4496999|NCT00823901|7300910|FG000|Overall Study|Lack of Efficacy|1
4497000|NCT00823901|7300911|FG001|Overall Study|Lack of Efficacy|0
4497001|NCT00823901|7300910|FG000|Overall Study|Lost to Follow-up|2
4497002|NCT00823901|7300911|FG001|Overall Study|Lost to Follow-up|1
4497003|NCT00823979|7300924|FG000|Overall Study|Lack of Efficacy|13
4497004|NCT00823979|7300925|FG001|Overall Study|Lack of Efficacy|16
4497005|NCT00823979|7300926|FG002|Overall Study|Lack of Efficacy|9
4497006|NCT00823979|7300924|FG000|Overall Study|Lost to Follow-up|2
4497007|NCT00823979|7300925|FG001|Overall Study|Lost to Follow-up|1
4497008|NCT00823979|7300926|FG002|Overall Study|Lost to Follow-up|0
4497009|NCT00823979|7300924|FG000|Overall Study|Withdrawal by Subject|2
4497010|NCT00823979|7300925|FG001|Overall Study|Withdrawal by Subject|3
4497011|NCT00823979|7300926|FG002|Overall Study|Withdrawal by Subject|2
4497012|NCT00823979|7300924|FG000|Overall Study|Protocol Violation|1
4497013|NCT00823979|7300925|FG001|Overall Study|Protocol Violation|1
4497014|NCT00823979|7300926|FG002|Overall Study|Protocol Violation|0
4497015|NCT00823979|7300924|FG000|Overall Study|Pregnancy|0
4497016|NCT00823979|7300925|FG001|Overall Study|Pregnancy|1
4497017|NCT00823979|7300926|FG002|Overall Study|Pregnancy|0
4497018|NCT00823979|7300924|FG000|Overall Study|Adverse Event|0
4497019|NCT00823979|7300925|FG001|Overall Study|Adverse Event|2
4497020|NCT00823979|7300926|FG002|Overall Study|Adverse Event|4
4497021|NCT00823979|7300924|FG000|Overall Study|Other|2
4497022|NCT00823979|7300925|FG001|Overall Study|Other|0
4497023|NCT00823979|7300926|FG002|Overall Study|Other|1
4497024|NCT00823979|7300924|FG000|Overall Study|Randomized but not Treated|4
4497025|NCT00823979|7300925|FG001|Overall Study|Randomized but not Treated|3
4497026|NCT00823979|7300926|FG002|Overall Study|Randomized but not Treated|1
4497027|NCT00823979|7300924|FG000|Overall Study|Study Terminated by Sponsor|5
4497028|NCT00823979|7300925|FG001|Overall Study|Study Terminated by Sponsor|5
4497029|NCT00823979|7300926|FG002|Overall Study|Study Terminated by Sponsor|7
4497030|NCT00824005|7300936|FG000|Overall Study|Death|0
4497031|NCT00824005|7300937|FG001|Overall Study|Death|1
4497032|NCT00824005|7300936|FG000|Overall Study|Lost to Follow-up|0
4497033|NCT00824005|7300937|FG001|Overall Study|Lost to Follow-up|1
4497034|NCT00824161|7300969|FG000|Overall Study|Withdrawal by Subject|1
4497035|NCT00824161|7300969|FG000|Overall Study|Screen Failure|1
4497036|NCT00824265|7300976|FG000|Treatment Phase|Adverse Event,non-fatal|50
4497037|NCT00824265|7300977|FG001|Treatment Phase|Adverse Event,non-fatal|52
4497038|NCT00824265|7300976|FG000|Treatment Phase|Protocol Violation|1
4497039|NCT00824265|7300977|FG001|Treatment Phase|Protocol Violation|0
4497040|NCT00824265|7300976|FG000|Treatment Phase|Lost to Follow-up|1
4497041|NCT00824265|7300977|FG001|Treatment Phase|Lost to Follow-up|1
4497042|NCT00824265|7300976|FG000|Treatment Phase|Physician Decision|6
4497043|NCT00824265|7300977|FG001|Treatment Phase|Physician Decision|12
4497044|NCT00824265|7300976|FG000|Treatment Phase|Withdrawal by Subject|6
4497045|NCT00824265|7300977|FG001|Treatment Phase|Withdrawal by Subject|15
4497046|NCT00824265|7300976|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18
4497047|NCT00824265|7300977|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31
4497048|NCT00824265|7300976|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9
4497049|NCT00824265|7300977|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16
4497050|NCT00824291|7300989|FG000|Overall Study|Adverse Event|15
4497051|NCT00824291|7300990|FG001|Overall Study|Adverse Event|6
4497052|NCT00824291|7300989|FG000|Overall Study|Discontinuation of Study by Sponsor|1
4497053|NCT00824291|7300990|FG001|Overall Study|Discontinuation of Study by Sponsor|2
4497054|NCT00824291|7300989|FG000|Overall Study|Lost to Follow-up|11
4497055|NCT00824291|7300990|FG001|Overall Study|Lost to Follow-up|9
4497056|NCT00824291|7300989|FG000|Overall Study|Non-compliance|1
4497057|NCT00824291|7300990|FG001|Overall Study|Non-compliance|1
4497058|NCT00824291|7300989|FG000|Overall Study|Protocol Violation|4
4497059|NCT00824291|7300990|FG001|Overall Study|Protocol Violation|1
4497060|NCT00824291|7300989|FG000|Overall Study|Withdrawal by Subject|14
4497061|NCT00824291|7300990|FG001|Overall Study|Withdrawal by Subject|8
4497062|NCT00824291|7300989|FG000|Overall Study|Lack of Efficacy|7
4497063|NCT00824291|7300990|FG001|Overall Study|Lack of Efficacy|8
4497064|NCT00824291|7300989|FG000|Overall Study|Participant on prohibited medication|1
4497065|NCT00824291|7300990|FG001|Overall Study|Participant on prohibited medication|0
4497066|NCT00824369|7301002|FG000|Overall Study|Nolonger willing to participate in study|1
4497067|NCT00824369|7301003|FG001|Overall Study|Nolonger willing to participate in study|0
4497068|NCT00824369|7301004|FG002|Overall Study|Nolonger willing to participate in study|1
4497069|NCT00824369|7301005|FG003|Overall Study|Nolonger willing to participate in study|2
4497070|NCT00824369|7301006|FG004|Overall Study|Nolonger willing to participate in study|0
4497071|NCT00824369|7301007|FG005|Overall Study|Nolonger willing to participate in study|1
4497072|NCT00824369|7301002|FG000|Overall Study|Lost to Follow-up|0
4497073|NCT00824369|7301003|FG001|Overall Study|Lost to Follow-up|0
4497074|NCT00824369|7301004|FG002|Overall Study|Lost to Follow-up|0
4497075|NCT00824369|7301005|FG003|Overall Study|Lost to Follow-up|0
4497076|NCT00824369|7301006|FG004|Overall Study|Lost to Follow-up|1
4497077|NCT00824369|7301007|FG005|Overall Study|Lost to Follow-up|0
4497078|NCT00824382|7301025|FG000|Overall Study|Adverse Event|4
4497079|NCT00824382|7301026|FG001|Overall Study|Adverse Event|1
4497080|NCT00824382|7301027|FG002|Overall Study|Adverse Event|1
4497081|NCT00824382|7301028|FG003|Overall Study|Adverse Event|4
4497082|NCT00824382|7301025|FG000|Overall Study|Protocol Violation|1
4497083|NCT00824382|7301026|FG001|Overall Study|Protocol Violation|0
4497084|NCT00824382|7301027|FG002|Overall Study|Protocol Violation|0
4497085|NCT00824382|7301028|FG003|Overall Study|Protocol Violation|1
4497086|NCT00824382|7301025|FG000|Overall Study|Investigator's decision|0
4497087|NCT00824382|7301026|FG001|Overall Study|Investigator's decision|1
4497088|NCT00824382|7301027|FG002|Overall Study|Investigator's decision|2
4497089|NCT00824382|7301028|FG003|Overall Study|Investigator's decision|0
4497090|NCT00824408|7301045|FG000|Run-in Phase|Progressive disease|4
4497091|NCT00824408|7301046|FG001|Run-in Phase|Progressive disease|4
4497092|NCT00824408|7301047|FG002|Run-in Phase|Progressive disease|0
4497093|NCT00824408|7301048|FG003|Run-in Phase|Progressive disease|0
4497094|NCT00824408|7301049|FG004|Run-in Phase|Progressive disease|0
4497095|NCT00824408|7301045|FG000|Run-in Phase|Adverse Event|1
4497096|NCT00824408|7301046|FG001|Run-in Phase|Adverse Event|1
4497097|NCT00824408|7301047|FG002|Run-in Phase|Adverse Event|0
4497098|NCT00824408|7301048|FG003|Run-in Phase|Adverse Event|0
4497099|NCT00824408|7301049|FG004|Run-in Phase|Adverse Event|0
4497100|NCT00824408|7301045|FG000|Run-in Phase|Refused to continue medication|1
4497101|NCT00824408|7301046|FG001|Run-in Phase|Refused to continue medication|0
4497102|NCT00824408|7301047|FG002|Run-in Phase|Refused to continue medication|0
4497103|NCT00824408|7301048|FG003|Run-in Phase|Refused to continue medication|0
4497104|NCT00824408|7301049|FG004|Run-in Phase|Refused to continue medication|0
4497105|NCT00824408|7301045|FG000|Run-in Phase|Other reason not defined above|0
4497106|NCT00824408|7301046|FG001|Run-in Phase|Other reason not defined above|1
4497107|NCT00824408|7301047|FG002|Run-in Phase|Other reason not defined above|0
4497108|NCT00824408|7301048|FG003|Run-in Phase|Other reason not defined above|0
4497109|NCT00824408|7301049|FG004|Run-in Phase|Other reason not defined above|0
4497110|NCT00824408|7301045|FG000|Randomized Phase|Not treated|0
4497111|NCT00824408|7301046|FG001|Randomized Phase|Not treated|0
4497112|NCT00824408|7301047|FG002|Randomized Phase|Not treated|1
4497113|NCT00824408|7301048|FG003|Randomized Phase|Not treated|1
4497114|NCT00824408|7301049|FG004|Randomized Phase|Not treated|1
4497115|NCT00824408|7301045|FG000|Randomized Phase|Progressive disease|0
4497116|NCT00824408|7301046|FG001|Randomized Phase|Progressive disease|0
4497117|NCT00824408|7301047|FG002|Randomized Phase|Progressive disease|25
4497118|NCT00824408|7301048|FG003|Randomized Phase|Progressive disease|36
4497119|NCT00824408|7301049|FG004|Randomized Phase|Progressive disease|34
4497120|NCT00824408|7301045|FG000|Randomized Phase|Adverse Event|0
4497121|NCT00824408|7301046|FG001|Randomized Phase|Adverse Event|0
4497122|NCT00824408|7301047|FG002|Randomized Phase|Adverse Event|4
4497123|NCT00824408|7301048|FG003|Randomized Phase|Adverse Event|5
4497124|NCT00824408|7301049|FG004|Randomized Phase|Adverse Event|5
4497125|NCT00824408|7301045|FG000|Randomized Phase|Refused to continue medication|0
4497126|NCT00824408|7301046|FG001|Randomized Phase|Refused to continue medication|0
4497127|NCT00824408|7301047|FG002|Randomized Phase|Refused to continue medication|2
4497128|NCT00824408|7301048|FG003|Randomized Phase|Refused to continue medication|2
4497129|NCT00824408|7301049|FG004|Randomized Phase|Refused to continue medication|2
4497130|NCT00824408|7301045|FG000|Randomized Phase|Other reason not defined above|0
4497131|NCT00824408|7301046|FG001|Randomized Phase|Other reason not defined above|0
4497132|NCT00824408|7301047|FG002|Randomized Phase|Other reason not defined above|4
4497133|NCT00824408|7301048|FG003|Randomized Phase|Other reason not defined above|2
4497134|NCT00824408|7301049|FG004|Randomized Phase|Other reason not defined above|4
4497135|NCT00824421|7301070|FG000|Overall Study|Adverse Event|6
4497136|NCT00824421|7301071|FG001|Overall Study|Adverse Event|6
4497137|NCT00824421|7301072|FG002|Overall Study|Adverse Event|6
4497138|NCT00824421|7301070|FG000|Overall Study|Death|0
4497139|NCT00824421|7301071|FG001|Overall Study|Death|1
4497140|NCT00824421|7301072|FG002|Overall Study|Death|0
4497141|NCT00824421|7301070|FG000|Overall Study|Lack of Efficacy|5
4497142|NCT00824421|7301071|FG001|Overall Study|Lack of Efficacy|7
4497143|NCT00824421|7301072|FG002|Overall Study|Lack of Efficacy|4
4497144|NCT00824421|7301070|FG000|Overall Study|Lost to Follow-up|2
4497145|NCT00824421|7301071|FG001|Overall Study|Lost to Follow-up|3
4497146|NCT00824421|7301072|FG002|Overall Study|Lost to Follow-up|0
4497147|NCT00824421|7301070|FG000|Overall Study|Pregnancy|1
4497148|NCT00824421|7301071|FG001|Overall Study|Pregnancy|0
4497149|NCT00824421|7301072|FG002|Overall Study|Pregnancy|1
4497150|NCT00824421|7301070|FG000|Overall Study|Withdrawal by Subject|2
4497151|NCT00824421|7301071|FG001|Overall Study|Withdrawal by Subject|3
4497152|NCT00824421|7301072|FG002|Overall Study|Withdrawal by Subject|3
4497153|NCT00824421|7301070|FG000|Overall Study|Randomized but not Treated|1
4497154|NCT00824421|7301071|FG001|Overall Study|Randomized but not Treated|1
4497155|NCT00824421|7301072|FG002|Overall Study|Randomized but not Treated|0
4497156|NCT00824421|7301070|FG000|Overall Study|Other|0
4497157|NCT00824421|7301071|FG001|Overall Study|Other|1
4497158|NCT00824421|7301072|FG002|Overall Study|Other|0
4497159|NCT00824473|7301121|FG000|Overall Study|Adverse Event|4
4497160|NCT00824473|7301122|FG001|Overall Study|Adverse Event|5
4497161|NCT00824473|7301121|FG000|Overall Study|Lack of Efficacy|2
4497162|NCT00824473|7301122|FG001|Overall Study|Lack of Efficacy|2
4497163|NCT00824473|7301121|FG000|Overall Study|Protocol Violation|2
4497164|NCT00824473|7301122|FG001|Overall Study|Protocol Violation|0
4497165|NCT00824473|7301121|FG000|Overall Study|Non-Compliance|4
4497166|NCT00824473|7301122|FG001|Overall Study|Non-Compliance|2
4497167|NCT00824473|7301121|FG000|Overall Study|Withdrawal by Subject|2
4497168|NCT00824473|7301122|FG001|Overall Study|Withdrawal by Subject|3
4497169|NCT00824473|7301121|FG000|Overall Study|Other|1
4497170|NCT00824473|7301122|FG001|Overall Study|Other|1
4497171|NCT00824564|7301144|FG000|Overall Study|Lost to Follow-up|5
4497172|NCT00824564|7301145|FG001|Overall Study|Lost to Follow-up|7
4497173|NCT00824564|7301144|FG000|Overall Study|Withdrawal by Subject|1
4497174|NCT00824564|7301145|FG001|Overall Study|Withdrawal by Subject|1
4497175|NCT00824564|7301144|FG000|Overall Study|Other|1
4497176|NCT00824564|7301145|FG001|Overall Study|Other|2
4497177|NCT00824564|7301144|FG000|Overall Study|Randomized, but not treated|1
4497178|NCT00824564|7301145|FG001|Overall Study|Randomized, but not treated|0
4497179|NCT00824616|7301153|FG000|Overall Study|Adverse Event|2
4497180|NCT00824616|7301154|FG001|Overall Study|Adverse Event|1
4497181|NCT00824616|7301153|FG000|Overall Study|Creatinine/Creatinine Clearance|0
4497182|NCT00824616|7301154|FG001|Overall Study|Creatinine/Creatinine Clearance|2
4497183|NCT00824616|7301153|FG000|Overall Study|Hyperglycemia|1
4497184|NCT00824616|7301154|FG001|Overall Study|Hyperglycemia|1
4497185|NCT00824616|7301153|FG000|Overall Study|Lack of Efficacy|2
4497186|NCT00824616|7301154|FG001|Overall Study|Lack of Efficacy|1
4497187|NCT00824616|7301153|FG000|Overall Study|Lost to Follow-up|0
4497188|NCT00824616|7301154|FG001|Overall Study|Lost to Follow-up|1
4497189|NCT00824616|7301153|FG000|Overall Study|Withdrawal by Subject|1
4497190|NCT00824616|7301154|FG001|Overall Study|Withdrawal by Subject|1
4497191|NCT00824655|7301162|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1
4497192|NCT00824655|7301163|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0
4497193|NCT00824655|7301162|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1
4497194|NCT00824655|7301163|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0
4497195|NCT00824720|7301174|FG000|Overall Study|failed plug insertion|3
4497196|NCT00824720|7301175|FG001|Overall Study|failed plug insertion|1
4497197|NCT00824720|7301176|FG002|Overall Study|failed plug insertion|0
4497198|NCT00824720|7301174|FG000|Overall Study|Protocol Violation|0
4497199|NCT00824720|7301175|FG001|Overall Study|Protocol Violation|0
4497200|NCT00824720|7301176|FG002|Overall Study|Protocol Violation|1
4497201|NCT00824772|7301194|FG000|Overall Study|Withdrawal by Subject|8
4497202|NCT00824850|7301209|FG000|Overall Study|Withdrawal by Subject|0
4497203|NCT00824850|7301210|FG001|Overall Study|Withdrawal by Subject|1
4517788|NCT00969540|7329700|FG000|Overall Study|Lost to Follow-up|1
4517789|NCT00969540|7329701|FG001|Overall Study|Lost to Follow-up|1
4517790|NCT00969553|7329728|FG000|Overall Study|Progressive disease (PD)|2
4517791|NCT00969553|7329729|FG001|Overall Study|Progressive disease (PD)|2
4517792|NCT00969553|7329730|FG002|Overall Study|Progressive disease (PD)|6
4517793|NCT00969553|7329731|FG003|Overall Study|Progressive disease (PD)|9
4517794|NCT00969553|7329732|FG004|Overall Study|Progressive disease (PD)|2
4517795|NCT00969553|7329733|FG005|Overall Study|Progressive disease (PD)|4
4517796|NCT00969553|7329734|FG006|Overall Study|Progressive disease (PD)|2
4517797|NCT00969553|7329735|FG007|Overall Study|Progressive disease (PD)|12
4517798|NCT00969553|7329736|FG008|Overall Study|Progressive disease (PD)|3
4517799|NCT00969553|7329728|FG000|Overall Study|Dose limiting Toxicity (DLT)|0
4517800|NCT00969553|7329729|FG001|Overall Study|Dose limiting Toxicity (DLT)|0
4517801|NCT00969553|7329730|FG002|Overall Study|Dose limiting Toxicity (DLT)|0
4517802|NCT00969553|7329731|FG003|Overall Study|Dose limiting Toxicity (DLT)|0
4517803|NCT00969553|7329732|FG004|Overall Study|Dose limiting Toxicity (DLT)|1
4517804|NCT00969553|7329733|FG005|Overall Study|Dose limiting Toxicity (DLT)|0
4517805|NCT00969553|7329734|FG006|Overall Study|Dose limiting Toxicity (DLT)|0
4517806|NCT00969553|7329735|FG007|Overall Study|Dose limiting Toxicity (DLT)|0
4517807|NCT00969553|7329736|FG008|Overall Study|Dose limiting Toxicity (DLT)|0
4517808|NCT00969553|7329728|FG000|Overall Study|Other Adverse Event|0
4517809|NCT00969553|7329729|FG001|Overall Study|Other Adverse Event|0
4517810|NCT00969553|7329730|FG002|Overall Study|Other Adverse Event|0
4517811|NCT00969553|7329731|FG003|Overall Study|Other Adverse Event|1
4517812|NCT00969553|7329732|FG004|Overall Study|Other Adverse Event|0
4517813|NCT00969553|7329733|FG005|Overall Study|Other Adverse Event|0
4517814|NCT00969553|7329734|FG006|Overall Study|Other Adverse Event|1
4517815|NCT00969553|7329735|FG007|Overall Study|Other Adverse Event|0
4517816|NCT00969553|7329736|FG008|Overall Study|Other Adverse Event|0
4517817|NCT00969553|7329728|FG000|Overall Study|Refused cont. medication|1
4517818|NCT00969553|7329729|FG001|Overall Study|Refused cont. medication|1
4517819|NCT00969553|7329730|FG002|Overall Study|Refused cont. medication|0
4517820|NCT00969553|7329731|FG003|Overall Study|Refused cont. medication|2
4517821|NCT00969553|7329732|FG004|Overall Study|Refused cont. medication|0
4517822|NCT00969553|7329733|FG005|Overall Study|Refused cont. medication|0
4517823|NCT00969553|7329734|FG006|Overall Study|Refused cont. medication|0
4517824|NCT00969553|7329735|FG007|Overall Study|Refused cont. medication|1
4517825|NCT00969553|7329736|FG008|Overall Study|Refused cont. medication|0
4517826|NCT00969553|7329728|FG000|Overall Study|Not specified above|0
4517827|NCT00969553|7329729|FG001|Overall Study|Not specified above|0
4517828|NCT00969553|7329730|FG002|Overall Study|Not specified above|0
4517829|NCT00969553|7329731|FG003|Overall Study|Not specified above|4
4517830|NCT00969553|7329732|FG004|Overall Study|Not specified above|0
4517831|NCT00969553|7329733|FG005|Overall Study|Not specified above|0
4497204|NCT00824993|7301224|FG000|Overall Study|Withdrawal by Subject|1
4497205|NCT00824993|7301225|FG001|Overall Study|Withdrawal by Subject|1
4497206|NCT00824993|7301224|FG000|Overall Study|Malignancy Relapse|9
4497207|NCT00824993|7301225|FG001|Overall Study|Malignancy Relapse|10
4497208|NCT00824993|7301224|FG000|Overall Study|Rapid Bone Loss|0
4497209|NCT00824993|7301225|FG001|Overall Study|Rapid Bone Loss|1
4497210|NCT00824993|7301224|FG000|Overall Study|Non-Compliant|2
4497211|NCT00824993|7301225|FG001|Overall Study|Non-Compliant|1
4497212|NCT00824993|7301224|FG000|Overall Study|Insurance Issue|2
4497213|NCT00824993|7301225|FG001|Overall Study|Insurance Issue|1
4497214|NCT00824993|7301224|FG000|Overall Study|Death|0
4497215|NCT00824993|7301225|FG001|Overall Study|Death|3
4497216|NCT00825162|7301234|FG000|Overall Study|Withdrawal by Subject|11
4497217|NCT00825162|7301235|FG001|Overall Study|Withdrawal by Subject|13
4497218|NCT00825162|7301236|FG002|Overall Study|Withdrawal by Subject|3
4497219|NCT00825162|7301234|FG000|Overall Study|Lost to Follow-up|9
4497220|NCT00825162|7301235|FG001|Overall Study|Lost to Follow-up|6
4497221|NCT00825162|7301236|FG002|Overall Study|Lost to Follow-up|3
4497222|NCT00825162|7301234|FG000|Overall Study|Physician Decision|2
4497223|NCT00825162|7301235|FG001|Overall Study|Physician Decision|0
4497224|NCT00825162|7301236|FG002|Overall Study|Physician Decision|0
4497225|NCT00825162|7301234|FG000|Overall Study|Move away from the study area|1
4497226|NCT00825162|7301235|FG001|Overall Study|Move away from the study area|0
4497227|NCT00825162|7301236|FG002|Overall Study|Move away from the study area|0
4497228|NCT00825162|7301234|FG000|Overall Study|Unable to attend the study visit|5
4497229|NCT00825162|7301235|FG001|Overall Study|Unable to attend the study visit|2
4497230|NCT00825162|7301236|FG002|Overall Study|Unable to attend the study visit|0
4497231|NCT00825175|7301251|FG000|Overall Study|Withdrawal by Subject|0
4497232|NCT00825175|7301252|FG001|Overall Study|Withdrawal by Subject|5
4497233|NCT00825305|7301269|FG000|Overall Study|Adverse Event|1
4497234|NCT00825305|7301270|FG001|Overall Study|Adverse Event|1
4497235|NCT00825305|7301269|FG000|Overall Study|Withdrawal by Subject|6
4497236|NCT00825305|7301270|FG001|Overall Study|Withdrawal by Subject|12
4497237|NCT00825305|7301269|FG000|Overall Study|Inappropriate inclusion|1
4497238|NCT00825305|7301270|FG001|Overall Study|Inappropriate inclusion|0
4497239|NCT00825305|7301269|FG000|Overall Study|Protocol Violation|9
4497240|NCT00825305|7301270|FG001|Overall Study|Protocol Violation|9
4497241|NCT00825305|7301269|FG000|Overall Study|Can not be classified|0
4497242|NCT00825305|7301270|FG001|Overall Study|Can not be classified|1
4497243|NCT00825682|7301344|FG000|Overall Study|personal reasons/ inconvenience|13
4497244|NCT00825682|7301345|FG001|Overall Study|personal reasons/ inconvenience|5
4497245|NCT00825812|7301372|FG000|Overall Study|Never entered follow up|0
4497246|NCT00825812|7301373|FG001|Overall Study|Never entered follow up|0
4497247|NCT00825812|7301374|FG002|Overall Study|Never entered follow up|0
4497248|NCT00825812|7301375|FG003|Overall Study|Never entered follow up|1
4497249|NCT00825812|7301372|FG000|Overall Study|Adverse Event|0
4497250|NCT00825812|7301373|FG001|Overall Study|Adverse Event|0
4497251|NCT00825812|7301374|FG002|Overall Study|Adverse Event|0
4497252|NCT00825812|7301375|FG003|Overall Study|Adverse Event|1
4497253|NCT00825812|7301372|FG000|Overall Study|Subject withdrew consent|0
4497254|NCT00825812|7301373|FG001|Overall Study|Subject withdrew consent|0
4497255|NCT00825812|7301374|FG002|Overall Study|Subject withdrew consent|3
4497256|NCT00825812|7301375|FG003|Overall Study|Subject withdrew consent|2
4497257|NCT00825812|7301372|FG000|Overall Study|Non-compliance with protocol|0
4497258|NCT00825812|7301373|FG001|Overall Study|Non-compliance with protocol|0
4497259|NCT00825812|7301374|FG002|Overall Study|Non-compliance with protocol|0
4497260|NCT00825812|7301375|FG003|Overall Study|Non-compliance with protocol|1
4497261|NCT00825812|7301372|FG000|Overall Study|Administrative|0
4497262|NCT00825812|7301373|FG001|Overall Study|Administrative|1
4497263|NCT00825812|7301374|FG002|Overall Study|Administrative|3
4497264|NCT00825812|7301375|FG003|Overall Study|Administrative|5
4497265|NCT00825825|7301385|FG000|First Medication Period (14 Days)|Adverse Event|1
4497266|NCT00825825|7301386|FG001|First Medication Period (14 Days)|Adverse Event|0
4497267|NCT00825825|7301387|FG002|First Medication Period (14 Days)|Adverse Event|0
4497268|NCT00825825|7301388|FG003|First Medication Period (14 Days)|Adverse Event|0
4497269|NCT00825825|7301389|FG004|First Medication Period (14 Days)|Adverse Event|0
4497270|NCT00825825|7301390|FG005|First Medication Period (14 Days)|Adverse Event|1
4497271|NCT00825825|7301385|FG000|First Medication Period (14 Days)|Physician Decision|2
4497272|NCT00825825|7301386|FG001|First Medication Period (14 Days)|Physician Decision|0
4497273|NCT00825825|7301387|FG002|First Medication Period (14 Days)|Physician Decision|1
4497274|NCT00825825|7301388|FG003|First Medication Period (14 Days)|Physician Decision|0
4497275|NCT00825825|7301389|FG004|First Medication Period (14 Days)|Physician Decision|0
4497276|NCT00825825|7301390|FG005|First Medication Period (14 Days)|Physician Decision|1
4497277|NCT00825825|7301385|FG000|Second Medication Period (14 Days)|Physician Decision|1
4497278|NCT00825825|7301386|FG001|Second Medication Period (14 Days)|Physician Decision|0
4497279|NCT00825825|7301387|FG002|Second Medication Period (14 Days)|Physician Decision|0
4497280|NCT00825825|7301388|FG003|Second Medication Period (14 Days)|Physician Decision|2
4497281|NCT00825825|7301389|FG004|Second Medication Period (14 Days)|Physician Decision|0
4497282|NCT00825825|7301390|FG005|Second Medication Period (14 Days)|Physician Decision|0
4497283|NCT00825825|7301385|FG000|Second Medication Period (14 Days)|Protocol Violation|1
4497284|NCT00825825|7301386|FG001|Second Medication Period (14 Days)|Protocol Violation|0
4497285|NCT00825825|7301387|FG002|Second Medication Period (14 Days)|Protocol Violation|0
4497286|NCT00825825|7301388|FG003|Second Medication Period (14 Days)|Protocol Violation|0
4497287|NCT00825825|7301389|FG004|Second Medication Period (14 Days)|Protocol Violation|1
4497288|NCT00825825|7301390|FG005|Second Medication Period (14 Days)|Protocol Violation|0
4497289|NCT00825825|7301385|FG000|Third Medication Period (14 Days)|Adverse Event|0
4497290|NCT00825825|7301386|FG001|Third Medication Period (14 Days)|Adverse Event|1
4497291|NCT00825825|7301387|FG002|Third Medication Period (14 Days)|Adverse Event|0
4497292|NCT00825825|7301388|FG003|Third Medication Period (14 Days)|Adverse Event|0
4497293|NCT00825825|7301389|FG004|Third Medication Period (14 Days)|Adverse Event|0
4497294|NCT00825825|7301390|FG005|Third Medication Period (14 Days)|Adverse Event|0
4497295|NCT00825825|7301385|FG000|Third Medication Period (14 Days)|Protocol Violation|0
4497296|NCT00825825|7301386|FG001|Third Medication Period (14 Days)|Protocol Violation|0
4497297|NCT00825825|7301387|FG002|Third Medication Period (14 Days)|Protocol Violation|0
4497298|NCT00825825|7301388|FG003|Third Medication Period (14 Days)|Protocol Violation|0
4497299|NCT00825825|7301389|FG004|Third Medication Period (14 Days)|Protocol Violation|0
4497300|NCT00825825|7301390|FG005|Third Medication Period (14 Days)|Protocol Violation|2
4497301|NCT00825825|7301385|FG000|Third Medication Period (14 Days)|poor data quality|0
4497302|NCT00825825|7301386|FG001|Third Medication Period (14 Days)|poor data quality|1
4497303|NCT00825825|7301387|FG002|Third Medication Period (14 Days)|poor data quality|0
4497304|NCT00825825|7301388|FG003|Third Medication Period (14 Days)|poor data quality|0
4497305|NCT00825825|7301389|FG004|Third Medication Period (14 Days)|poor data quality|0
4497306|NCT00825825|7301390|FG005|Third Medication Period (14 Days)|poor data quality|0
4627038|NCT01848834|7493407|FG002|Overall Study|Lost to Follow-up|3
4627039|NCT01848834|7493408|FG003|Overall Study|Lost to Follow-up|0
4627040|NCT01848834|7493409|FG004|Overall Study|Lost to Follow-up|3
4627041|NCT01848834|7493405|FG000|Overall Study|Physician Decision|1
4627042|NCT01848834|7493406|FG001|Overall Study|Physician Decision|3
4627043|NCT01848834|7493407|FG002|Overall Study|Physician Decision|4
4627044|NCT01848834|7493408|FG003|Overall Study|Physician Decision|0
4627045|NCT01848834|7493409|FG004|Overall Study|Physician Decision|11
4627046|NCT01848834|7493405|FG000|Overall Study|Protocol Violation|0
4627047|NCT01848834|7493406|FG001|Overall Study|Protocol Violation|0
4497307|NCT00825916|7301400|FG000|Overall Study|Lost to Follow-up|4
4497308|NCT00825916|7301401|FG001|Overall Study|Lost to Follow-up|2
4497309|NCT00825916|7301402|FG002|Overall Study|Lost to Follow-up|1
4497310|NCT00825994|7301443|FG000|Overall Study|Withdrawal by Subject|2
4627048|NCT01848834|7493407|FG002|Overall Study|Protocol Violation|0
4497311|NCT00825994|7301443|FG000|Overall Study|Lost to Follow-up|1
4497312|NCT00825994|7301443|FG000|Overall Study|Protocol Violation|1
4497313|NCT00825994|7301443|FG000|Overall Study|Placebo Responder at V2|1
4497314|NCT00826111|7301461|FG000|Overall Study|Lost to Follow-up|0
4497315|NCT00826111|7301462|FG001|Overall Study|Lost to Follow-up|1
4497316|NCT00826111|7301461|FG000|Overall Study|Protocol Violation|1
4497317|NCT00826111|7301462|FG001|Overall Study|Protocol Violation|0
4497318|NCT00826111|7301461|FG000|Overall Study|Withdrawal by Subject|5
4497319|NCT00826111|7301462|FG001|Overall Study|Withdrawal by Subject|0
4497320|NCT00826111|7301461|FG000|Overall Study|Physician Decision|1
4497321|NCT00826111|7301462|FG001|Overall Study|Physician Decision|1
4497322|NCT00826176|7301488|FG000|Overall Study|Lost to Follow-up|1
4497323|NCT00826176|7301489|FG001|Overall Study|Lost to Follow-up|0
4497324|NCT00826176|7301488|FG000|Overall Study|Subject Withdrew Consent|3
4497325|NCT00826176|7301489|FG001|Overall Study|Subject Withdrew Consent|0
4497326|NCT00826176|7301488|FG000|Overall Study|Administrative|9
4497327|NCT00826176|7301489|FG001|Overall Study|Administrative|0
4497328|NCT00826228|7301504|FG000|Overall Study|Withdrawal by Subject|1
4497329|NCT00826241|7301509|FG000|Overall Study|Withdrawal from Follow-up|1
4497330|NCT00826241|7301509|FG000|Overall Study|Withdrew consent|2
4497331|NCT00826241|7301509|FG000|Overall Study|Death|4
4497332|NCT00826241|7301509|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1
4497333|NCT00826241|7301509|FG000|Overall Study|Non-compliance|1
4497334|NCT00826241|7301509|FG000|Overall Study|Progression of disease|1
4497335|NCT00826241|7301509|FG000|Overall Study|Patient refused follow-up|3
4497336|NCT00826241|7301509|FG000|Overall Study|Lost to Follow-up|9
4497337|NCT00826241|7301509|FG000|Overall Study|Could not obtain records|1
4497338|NCT00826241|7301509|FG000|Overall Study|Screen failure|2
4497339|NCT00826241|7301509|FG000|Overall Study|Pt unable to proceed to registration|1
4497340|NCT00826241|7301509|FG000|Overall Study|Pt opt not to proceed w/trmt|1
4497341|NCT00826267|7301516|FG000|Overall Study|Other Adverse Event|1
4497342|NCT00826267|7301517|FG001|Overall Study|Other Adverse Event|0
4497343|NCT00826267|7301518|FG002|Overall Study|Other Adverse Event|0
4497344|NCT00826280|7301530|FG000|Overall Study|Randomized but drug not received|1
4497345|NCT00826280|7301531|FG001|Overall Study|Randomized but drug not received|0
4497346|NCT00826280|7301532|FG002|Overall Study|Randomized but drug not received|1
4627049|NCT01848834|7493408|FG003|Overall Study|Protocol Violation|0
4627050|NCT01848834|7493409|FG004|Overall Study|Protocol Violation|1
4497347|NCT00826280|7301530|FG000|Overall Study|Adverse Event|1
4497348|NCT00826280|7301531|FG001|Overall Study|Adverse Event|3
4497349|NCT00826280|7301532|FG002|Overall Study|Adverse Event|0
4627051|NCT01848834|7493405|FG000|Overall Study|Sponsor Decision|1
4497350|NCT00826280|7301530|FG000|Overall Study|Lost to Follow-up|0
4497351|NCT00826280|7301531|FG001|Overall Study|Lost to Follow-up|1
4497352|NCT00826280|7301532|FG002|Overall Study|Lost to Follow-up|0
4497353|NCT00826280|7301530|FG000|Overall Study|Sponsor discontinued subject or study|1
4497354|NCT00826280|7301531|FG001|Overall Study|Sponsor discontinued subject or study|0
4497355|NCT00826280|7301532|FG002|Overall Study|Sponsor discontinued subject or study|0
4497356|NCT00826280|7301530|FG000|Overall Study|Reversible ischemic defect not present|43
4497357|NCT00826280|7301531|FG001|Overall Study|Reversible ischemic defect not present|40
4497358|NCT00826280|7301532|FG002|Overall Study|Reversible ischemic defect not present|44
4497359|NCT00826280|7301530|FG000|Overall Study|Interpretation Failure|1
4497360|NCT00826280|7301531|FG001|Overall Study|Interpretation Failure|0
4497361|NCT00826280|7301532|FG002|Overall Study|Interpretation Failure|0
4497362|NCT00826280|7301530|FG000|Overall Study|Machine Failure|1
4497363|NCT00826280|7301531|FG001|Overall Study|Machine Failure|1
4497364|NCT00826280|7301532|FG002|Overall Study|Machine Failure|0
4497365|NCT00826280|7301530|FG000|Overall Study|One or more non-interpretable scan|0
4497366|NCT00826280|7301531|FG001|Overall Study|One or more non-interpretable scan|1
4497367|NCT00826280|7301532|FG002|Overall Study|One or more non-interpretable scan|1
4497368|NCT00826449|7301542|FG000|Overall Study|Disease Progression|4
4497369|NCT00826449|7301542|FG000|Overall Study|Withdrawal by Subject|1
4497370|NCT00826514|7301549|FG000|Overall Study|Adverse Event|1
4497371|NCT00826514|7301550|FG001|Overall Study|Adverse Event|1
4497372|NCT00826514|7301549|FG000|Overall Study|Lack of Efficacy|0
4497373|NCT00826514|7301550|FG001|Overall Study|Lack of Efficacy|1
4497374|NCT00826514|7301549|FG000|Overall Study|Withdrawal by Subject|2
4497375|NCT00826514|7301550|FG001|Overall Study|Withdrawal by Subject|3
4497376|NCT00826540|7301556|FG000|Overall Study|ineligible|3
4497377|NCT00826540|7301556|FG000|Overall Study|Withdrawal by Subject|1
4497378|NCT00826618|7301560|FG000|Overall Study|Withdrawal by Subject|1
4497379|NCT00826748|7301567|FG000|Overall Study|Withdrawal by Subject|0
4497380|NCT00826748|7301568|FG001|Overall Study|Withdrawal by Subject|0
4497381|NCT00826748|7301569|FG002|Overall Study|Withdrawal by Subject|2
4497382|NCT00826748|7301567|FG000|Overall Study|Physician Decision|0
4497383|NCT00826748|7301568|FG001|Overall Study|Physician Decision|0
4497384|NCT00826748|7301569|FG002|Overall Study|Physician Decision|1
4497385|NCT00826748|7301567|FG000|Overall Study|Samples Did Not pass QC|0
4497386|NCT00826748|7301568|FG001|Overall Study|Samples Did Not pass QC|0
4497387|NCT00826748|7301569|FG002|Overall Study|Samples Did Not pass QC|1
4497388|NCT00826943|7301581|FG000|Overall Study|Withdrawal by Subject|0
4497389|NCT00826943|7301582|FG001|Overall Study|Withdrawal by Subject|0
4497390|NCT00826943|7301583|FG002|Overall Study|Withdrawal by Subject|0
4497391|NCT00826943|7301584|FG003|Overall Study|Withdrawal by Subject|0
4497392|NCT00826943|7301585|FG004|Overall Study|Withdrawal by Subject|1
4497393|NCT00826943|7301586|FG005|Overall Study|Withdrawal by Subject|0
4497394|NCT00827112|7301609|FG000|Overall Study|Adverse Event|2
4497395|NCT00827112|7301610|FG001|Overall Study|Adverse Event|0
4497396|NCT00827112|7301609|FG000|Overall Study|Lack of Efficacy|2
4497397|NCT00827112|7301610|FG001|Overall Study|Lack of Efficacy|0
4497398|NCT00827112|7301609|FG000|Overall Study|Lost to Follow-up|3
4497399|NCT00827112|7301610|FG001|Overall Study|Lost to Follow-up|2
4497400|NCT00827112|7301609|FG000|Overall Study|Pregnancy|0
4497401|NCT00827112|7301610|FG001|Overall Study|Pregnancy|1
4497402|NCT00827112|7301609|FG000|Overall Study|Protocol Violation|0
4497403|NCT00827112|7301610|FG001|Overall Study|Protocol Violation|2
4497404|NCT00827112|7301609|FG000|Overall Study|Withdrawal by Subject|2
4497405|NCT00827112|7301610|FG001|Overall Study|Withdrawal by Subject|1
4497406|NCT00827112|7301609|FG000|Overall Study|Randomized but not treated|5
4497407|NCT00827112|7301610|FG001|Overall Study|Randomized but not treated|3
4497408|NCT00827112|7301609|FG000|Overall Study|Other|1
4497409|NCT00827112|7301610|FG001|Overall Study|Other|3
4497410|NCT00827242|7301618|FG000|Overall Study|Withdrawal by Subject|2
4497411|NCT00827242|7301619|FG001|Overall Study|Withdrawal by Subject|4
4497412|NCT00827242|7301618|FG000|Overall Study|Protocol Violation|1
4497413|NCT00827242|7301619|FG001|Overall Study|Protocol Violation|3
4497414|NCT00827242|7301618|FG000|Overall Study|Lost to Follow-up|0
4497415|NCT00827242|7301619|FG001|Overall Study|Lost to Follow-up|3
4497416|NCT00827242|7301618|FG000|Overall Study|Adverse Event Excluding Death|2
4497417|NCT00827242|7301619|FG001|Overall Study|Adverse Event Excluding Death|1
4497418|NCT00827242|7301618|FG000|Overall Study|Entry Criteria Not Met|4
4497419|NCT00827242|7301619|FG001|Overall Study|Entry Criteria Not Met|1
4497420|NCT00827242|7301618|FG000|Overall Study|Physician Decision|2
4497421|NCT00827242|7301619|FG001|Overall Study|Physician Decision|0
4497422|NCT00827242|7301618|FG000|Overall Study|Death|1
4497423|NCT00827242|7301619|FG001|Overall Study|Death|0
4497424|NCT00827242|7301618|FG000|Overall Study|Lack of Efficacy|1
4497425|NCT00827242|7301619|FG001|Overall Study|Lack of Efficacy|0
4497426|NCT00827359|7301629|FG000|Overall Study|Progressive Diseas|19
4497427|NCT00827359|7301629|FG000|Overall Study|Unacceptable Toxicity|5
4497428|NCT00827359|7301629|FG000|Overall Study|Ineligible|1
4497429|NCT00827372|7301633|FG000|Overall Study|Adverse Event|5
4497430|NCT00827372|7301633|FG000|Overall Study|Lack of Efficacy|3
4497431|NCT00827502|7301638|FG000|Overall Study|randomized but not treated|11
4497432|NCT00827502|7301638|FG000|Overall Study|Adverse Event|1
4497433|NCT00827502|7301638|FG000|Overall Study|Lost to Follow-up|4
4497434|NCT00827502|7301638|FG000|Overall Study|Withdrawal by Subject|5
4497435|NCT00827541|7301644|FG000|Overall Study|Exitus|1
4497436|NCT00827541|7301645|FG001|Overall Study|Exitus|8
4497437|NCT00827541|7301644|FG000|Overall Study|Other|1
4497438|NCT00827541|7301645|FG001|Overall Study|Other|3
4497439|NCT00827541|7301644|FG000|Overall Study|Pathogen not susceptible|1
4497440|NCT00827541|7301645|FG001|Overall Study|Pathogen not susceptible|0
4497441|NCT00827541|7301644|FG000|Overall Study|Lack of effectiveness|1
4497442|NCT00827541|7301645|FG001|Overall Study|Lack of effectiveness|0
4497443|NCT00827606|7301653|FG000|Overall Study|Protocol Violation|4
4497444|NCT00827606|7301654|FG001|Overall Study|Protocol Violation|3
4497445|NCT00827606|7301653|FG000|Overall Study|Lost to Follow-up|3
4497446|NCT00827606|7301654|FG001|Overall Study|Lost to Follow-up|1
4497447|NCT00827606|7301653|FG000|Overall Study|Withdrawal by Subject|7
4497448|NCT00827606|7301654|FG001|Overall Study|Withdrawal by Subject|6
4497449|NCT00827606|7301653|FG000|Overall Study|Pregnancy|0
4497450|NCT00827606|7301654|FG001|Overall Study|Pregnancy|1
4497451|NCT00827606|7301653|FG000|Overall Study|Other|5
4497452|NCT00827606|7301654|FG001|Overall Study|Other|13
4497453|NCT00827606|7301653|FG000|Overall Study|LDL below 2.59 mmol/L|4
4497454|NCT00827606|7301654|FG001|Overall Study|LDL below 2.59 mmol/L|12
4497455|NCT00827606|7301653|FG000|Overall Study|Adverse Event|4
4497456|NCT00827606|7301654|FG001|Overall Study|Adverse Event|2
4497457|NCT00827632|7301668|FG000|Overall Study|Lost to Follow-up|8
4497458|NCT00827632|7301669|FG001|Overall Study|Lost to Follow-up|12
4497459|NCT00827632|7301668|FG000|Overall Study|Early withdrawal|14
4497460|NCT00827632|7301669|FG001|Overall Study|Early withdrawal|11
4497461|NCT00827775|7301677|FG000|Overall Study|Withdrawal by Subject|0
4497462|NCT00827775|7301678|FG001|Overall Study|Withdrawal by Subject|5
4497463|NCT00827827|7301686|FG000|Overall Study|Lost to Follow-up|3
4497464|NCT00827827|7301687|FG001|Overall Study|Lost to Follow-up|0
4497465|NCT00827827|7301686|FG000|Overall Study|Fall at home- hospitalization|1
4497466|NCT00827827|7301687|FG001|Overall Study|Fall at home- hospitalization|0
4497467|NCT00827827|7301686|FG000|Overall Study|Another cerebrovascular accident (CVA)|1
4497468|NCT00827827|7301687|FG001|Overall Study|Another cerebrovascular accident (CVA)|0
4497469|NCT00827827|7301686|FG000|Overall Study|Gout|1
4497470|NCT00827827|7301687|FG001|Overall Study|Gout|0
4497471|NCT00827827|7301686|FG000|Overall Study|Transportation issues|1
4497472|NCT00827827|7301687|FG001|Overall Study|Transportation issues|0
4497473|NCT00827827|7301686|FG000|Overall Study|Burned with water at home|1
4497474|NCT00827827|7301687|FG001|Overall Study|Burned with water at home|0
4497475|NCT00827918|7301697|FG000|Overall Study|Adverse Event|4
4497476|NCT00827918|7301698|FG001|Overall Study|Adverse Event|0
4497477|NCT00827918|7301699|FG002|Overall Study|Adverse Event|0
4497478|NCT00827918|7301697|FG000|Overall Study|Lack of Efficacy|16
4497479|NCT00827918|7301698|FG001|Overall Study|Lack of Efficacy|4
4497480|NCT00827918|7301699|FG002|Overall Study|Lack of Efficacy|15
4497481|NCT00827918|7301697|FG000|Overall Study|Physician Decision|1
4497482|NCT00827918|7301698|FG001|Overall Study|Physician Decision|0
4497483|NCT00827918|7301699|FG002|Overall Study|Physician Decision|0
4497484|NCT00827918|7301697|FG000|Overall Study|Pregnancy|0
4497485|NCT00827918|7301698|FG001|Overall Study|Pregnancy|1
4497486|NCT00827918|7301699|FG002|Overall Study|Pregnancy|0
4497487|NCT00827918|7301697|FG000|Overall Study|Progressive Disease|1
4497488|NCT00827918|7301698|FG001|Overall Study|Progressive Disease|1
4497489|NCT00827918|7301699|FG002|Overall Study|Progressive Disease|0
4497490|NCT00827918|7301697|FG000|Overall Study|Protocol Violation|0
4497491|NCT00827918|7301698|FG001|Overall Study|Protocol Violation|1
4497492|NCT00827918|7301699|FG002|Overall Study|Protocol Violation|0
4497493|NCT00827918|7301697|FG000|Overall Study|Withdrawal by Subject|6
4497494|NCT00827918|7301698|FG001|Overall Study|Withdrawal by Subject|2
4497495|NCT00827918|7301699|FG002|Overall Study|Withdrawal by Subject|6
4497496|NCT00827931|7301709|FG000|Overall Study|Death|3
4497497|NCT00827931|7301710|FG001|Overall Study|Death|5
4497498|NCT00827931|7301709|FG000|Overall Study|Adverse Event|1
4497499|NCT00827931|7301710|FG001|Overall Study|Adverse Event|0
4497500|NCT00827931|7301709|FG000|Overall Study|Lost to Follow-up|1
4497501|NCT00827931|7301710|FG001|Overall Study|Lost to Follow-up|0
4497502|NCT00827931|7301709|FG000|Overall Study|Withdrawal by Subject|0
4497503|NCT00827931|7301710|FG001|Overall Study|Withdrawal by Subject|1
4497504|NCT00827931|7301709|FG000|Overall Study|Other|1
4497505|NCT00827931|7301710|FG001|Overall Study|Other|0
4497506|NCT00828009|7301734|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10
4497507|NCT00828009|7301734|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2
4497508|NCT00828009|7301734|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3
4497509|NCT00828009|7301734|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11
4497510|NCT00828009|7301734|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1
4497511|NCT00828009|7301734|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2
4497512|NCT00828009|7301734|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2
4497513|NCT00828009|7301734|FG000|Step 2 - Maintenance Therapy|Progressive disease|12
4497514|NCT00828009|7301734|FG000|Step 2 - Maintenance Therapy|Adverse Event|13
4497515|NCT00828009|7301734|FG000|Step 2 - Maintenance Therapy|Death|1
4497516|NCT00828009|7301734|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4
4497517|NCT00828009|7301734|FG000|Step 2 - Maintenance Therapy|Complicating disease|2
4497518|NCT00828009|7301734|FG000|Step 2 - Maintenance Therapy|Other|1
4497519|NCT00828113|7301768|FG000|Overall Study|Withdrawal by Subject|27
4497520|NCT00828113|7301769|FG001|Overall Study|Withdrawal by Subject|26
4497521|NCT00828113|7301768|FG000|Overall Study|Lost to Follow-up|3
4497522|NCT00828113|7301769|FG001|Overall Study|Lost to Follow-up|5
4497523|NCT00828139|7301779|FG000|Overall Study|Adverse Event|8
4497524|NCT00828139|7301780|FG001|Overall Study|Adverse Event|1
4497525|NCT00828139|7301781|FG002|Overall Study|Adverse Event|10
4497526|NCT00828139|7301782|FG003|Overall Study|Adverse Event|5
4627052|NCT01848834|7493406|FG001|Overall Study|Sponsor Decision|1
4497527|NCT00828139|7301779|FG000|Overall Study|Death|2
4497528|NCT00828139|7301780|FG001|Overall Study|Death|1
4497529|NCT00828139|7301781|FG002|Overall Study|Death|0
4497530|NCT00828139|7301782|FG003|Overall Study|Death|2
4497531|NCT00828139|7301779|FG000|Overall Study|Refusal unrelated to toxicity|3
4497532|NCT00828139|7301780|FG001|Overall Study|Refusal unrelated to toxicity|4
4497533|NCT00828139|7301781|FG002|Overall Study|Refusal unrelated to toxicity|5
4497534|NCT00828139|7301782|FG003|Overall Study|Refusal unrelated to toxicity|3
4497535|NCT00828139|7301779|FG000|Overall Study|Disease Progression|24
4497536|NCT00828139|7301780|FG001|Overall Study|Disease Progression|33
4497537|NCT00828139|7301781|FG002|Overall Study|Disease Progression|35
4497538|NCT00828139|7301782|FG003|Overall Study|Disease Progression|39
4497539|NCT00828139|7301779|FG000|Overall Study|Other|4
4497540|NCT00828139|7301780|FG001|Overall Study|Other|2
4497541|NCT00828139|7301781|FG002|Overall Study|Other|5
4497542|NCT00828139|7301782|FG003|Overall Study|Other|2
4497543|NCT00828204|7301814|FG000|Main Study: Prior to Study Suspension|Adverse Event|1
4497544|NCT00828204|7301815|FG001|Main Study: Prior to Study Suspension|Adverse Event|0
4497545|NCT00828204|7301814|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2
4497546|NCT00828204|7301815|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0
4497547|NCT00828204|7301814|FG000|Main Study: Prior to Study Suspension|Study Suspension|11
4497548|NCT00828204|7301815|FG001|Main Study: Prior to Study Suspension|Study Suspension|0
4497549|NCT00828204|7301814|FG000|Main Study: After Study Restart|Adverse Event|0
4497550|NCT00828204|7301815|FG001|Main Study: After Study Restart|Adverse Event|2
4497551|NCT00828204|7301814|FG000|Main Study: After Study Restart|Noncompliance|0
4497552|NCT00828204|7301815|FG001|Main Study: After Study Restart|Noncompliance|1
4497553|NCT00828204|7301814|FG000|Extension Study|Lost to Follow-up|0
4497554|NCT00828204|7301815|FG001|Extension Study|Lost to Follow-up|1
4497555|NCT00828204|7301814|FG000|Extension Study|Physician Decision|0
4497556|NCT00828204|7301815|FG001|Extension Study|Physician Decision|2
4497557|NCT00828451|7301849|FG000|Overall Study|Death|2
4497558|NCT00828451|7301849|FG000|Overall Study|Lack of intravenous line|7
4497559|NCT00828451|7301849|FG000|Overall Study|Withdrawal by Subject|1
4497560|NCT00828451|7301849|FG000|Overall Study|Deterioration in clinical status|1
4497561|NCT00828464|7301853|FG000|Overall Study|Withdrawal by Subject|1
4497562|NCT00828516|7301857|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2
4497563|NCT00828568|7301873|FG000|Randomized|Withdrawal by Subject|1
4497564|NCT00828568|7301874|FG001|Randomized|Withdrawal by Subject|0
4627053|NCT01848834|7493407|FG002|Overall Study|Sponsor Decision|0
4627054|NCT01848834|7493408|FG003|Overall Study|Sponsor Decision|1
4627055|NCT01848834|7493409|FG004|Overall Study|Sponsor Decision|1
4497565|NCT00828568|7301875|FG002|Randomized|Withdrawal by Subject|2
4497566|NCT00828568|7301873|FG000|Treated - Received at Least One Dose|Adverse Event|11
4497567|NCT00828568|7301874|FG001|Treated - Received at Least One Dose|Adverse Event|8
4497568|NCT00828568|7301875|FG002|Treated - Received at Least One Dose|Adverse Event|1
4497569|NCT00828568|7301873|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9
4497570|NCT00828568|7301874|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11
4497571|NCT00828568|7301875|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0
4497572|NCT00828568|7301873|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1
4497573|NCT00828568|7301874|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5
4497574|NCT00828568|7301875|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1
4497575|NCT00828568|7301873|FG000|Treated - Received at Least One Dose|Protocol Violation|9
4497576|NCT00828568|7301874|FG001|Treated - Received at Least One Dose|Protocol Violation|5
4497577|NCT00828568|7301875|FG002|Treated - Received at Least One Dose|Protocol Violation|3
4497578|NCT00828672|7301886|FG000|Study Treatment|Lost to Follow-up|1
4497579|NCT00828672|7301887|FG001|Study Treatment|Lost to Follow-up|0
4497580|NCT00828672|7301886|FG000|Study Treatment|Adverse Event|0
4497581|NCT00828672|7301887|FG001|Study Treatment|Adverse Event|1
4497582|NCT00828672|7301886|FG000|Study Treatment|Complete response, no surgery|1
4497583|NCT00828672|7301887|FG001|Study Treatment|Complete response, no surgery|1
4497584|NCT00828672|7301886|FG000|Post-surgery (<30 Days)|No central review materials|0
4497585|NCT00828672|7301887|FG001|Post-surgery (<30 Days)|No central review materials|1
4497586|NCT00828711|7301896|FG000|Overall Study|Lost to Follow-up|1
4497587|NCT00828711|7301897|FG001|Overall Study|Lost to Follow-up|0
4497588|NCT00828711|7301898|FG002|Overall Study|Lost to Follow-up|0
4497589|NCT00828750|7301906|FG000|Overall Study|Lack of Efficacy|3
4497590|NCT00828750|7301906|FG000|Overall Study|Normal PC Remained While No Treatment|1
4497591|NCT00828945|7301926|FG000|Overall Study|Death|4
4627056|NCT01848834|7493405|FG000|Overall Study|Withdrawal by Subject|2
4627057|NCT01848834|7493406|FG001|Overall Study|Withdrawal by Subject|13
4497592|NCT00828945|7301926|FG000|Overall Study|Participant was missing|1
4497593|NCT00828945|7301926|FG000|Overall Study|Other|36
4497594|NCT00828984|7301933|FG000|Overall Study|Adverse Event|2
4497595|NCT00828984|7301934|FG001|Overall Study|Adverse Event|3
4497596|NCT00828984|7301935|FG002|Overall Study|Adverse Event|0
4497597|NCT00828984|7301933|FG000|Overall Study|Lost to Follow-up|5
4497598|NCT00828984|7301934|FG001|Overall Study|Lost to Follow-up|3
4497599|NCT00828984|7301935|FG002|Overall Study|Lost to Follow-up|1
4497600|NCT00828984|7301933|FG000|Overall Study|Withdrawal by Subject|4
4497601|NCT00828984|7301934|FG001|Overall Study|Withdrawal by Subject|4
4497602|NCT00828984|7301935|FG002|Overall Study|Withdrawal by Subject|4
4497603|NCT00828984|7301933|FG000|Overall Study|Ineligable|1
4497604|NCT00828984|7301934|FG001|Overall Study|Ineligable|2
4497605|NCT00828984|7301935|FG002|Overall Study|Ineligable|0
4497606|NCT00828984|7301933|FG000|Overall Study|Medical Contraindication|0
4497607|NCT00828984|7301934|FG001|Overall Study|Medical Contraindication|1
4497608|NCT00828984|7301935|FG002|Overall Study|Medical Contraindication|0
4497609|NCT00828984|7301933|FG000|Overall Study|Noncompliant|1
4497610|NCT00828984|7301934|FG001|Overall Study|Noncompliant|2
4497611|NCT00828984|7301935|FG002|Overall Study|Noncompliant|3
4497612|NCT00828984|7301933|FG000|Overall Study|ConMed|1
4497613|NCT00828984|7301934|FG001|Overall Study|ConMed|1
4497614|NCT00828984|7301935|FG002|Overall Study|ConMed|1
4497615|NCT00829010|7301948|FG000|Overall Study|Adverse Event|1
4497616|NCT00829010|7301949|FG001|Overall Study|Adverse Event|0
4497617|NCT00829010|7301950|FG002|Overall Study|Adverse Event|0
4497618|NCT00829010|7301951|FG003|Overall Study|Adverse Event|0
4497619|NCT00829010|7301952|FG004|Overall Study|Adverse Event|0
4497620|NCT00829010|7301948|FG000|Overall Study|Withdrawal by Subject|0
4497621|NCT00829010|7301949|FG001|Overall Study|Withdrawal by Subject|1
4497622|NCT00829010|7301950|FG002|Overall Study|Withdrawal by Subject|1
4497623|NCT00829010|7301951|FG003|Overall Study|Withdrawal by Subject|0
4497624|NCT00829010|7301952|FG004|Overall Study|Withdrawal by Subject|2
4497625|NCT00829010|7301948|FG000|Overall Study|Lost to Follow-up|1
4497626|NCT00829010|7301949|FG001|Overall Study|Lost to Follow-up|0
4497627|NCT00829010|7301950|FG002|Overall Study|Lost to Follow-up|2
4497628|NCT00829010|7301951|FG003|Overall Study|Lost to Follow-up|0
4497629|NCT00829010|7301952|FG004|Overall Study|Lost to Follow-up|0
4497630|NCT00829010|7301948|FG000|Overall Study|Fatality|5
4497631|NCT00829010|7301949|FG001|Overall Study|Fatality|4
4497632|NCT00829010|7301950|FG002|Overall Study|Fatality|0
4497633|NCT00829010|7301951|FG003|Overall Study|Fatality|3
4497634|NCT00829010|7301952|FG004|Overall Study|Fatality|0
4497635|NCT00829010|7301948|FG000|Overall Study|Migrated/Moved from study area|3
4497636|NCT00829010|7301949|FG001|Overall Study|Migrated/Moved from study area|4
4497637|NCT00829010|7301950|FG002|Overall Study|Migrated/Moved from study area|0
4497638|NCT00829010|7301951|FG003|Overall Study|Migrated/Moved from study area|5
4497639|NCT00829010|7301952|FG004|Overall Study|Migrated/Moved from study area|0
4497640|NCT00829166|7301979|FG000|Overall Study|Death|305
4497641|NCT00829166|7301980|FG001|Overall Study|Death|333
4497642|NCT00829166|7301979|FG000|Overall Study|Lost to Follow-up|5
4497643|NCT00829166|7301980|FG001|Overall Study|Lost to Follow-up|4
4497644|NCT00829166|7301979|FG000|Overall Study|Physician's Decision|4
4497645|NCT00829166|7301980|FG001|Overall Study|Physician's Decision|3
4497646|NCT00829166|7301979|FG000|Overall Study|Subject's Decision|41
4497647|NCT00829166|7301980|FG001|Overall Study|Subject's Decision|55
4497648|NCT00829166|7301979|FG000|Overall Study|Sponsor's Decision|137
4497649|NCT00829166|7301980|FG001|Overall Study|Sponsor's Decision|98
4497650|NCT00829166|7301979|FG000|Overall Study|Reason Not Specified|3
4497651|NCT00829166|7301980|FG001|Overall Study|Reason Not Specified|3
4497652|NCT00829179|7301987|FG000|Overall Study|Withdrawal by Subject|1
4497653|NCT00829244|7301993|FG000|Overall Study|Adverse Event|1
4497654|NCT00829244|7301994|FG001|Overall Study|Adverse Event|3
4497655|NCT00829244|7301993|FG000|Overall Study|Protocol Violation|1
4497656|NCT00829244|7301994|FG001|Overall Study|Protocol Violation|0
4497657|NCT00829244|7301993|FG000|Overall Study|Lack of ovarian response to stimulation|9
4497658|NCT00829244|7301994|FG001|Overall Study|Lack of ovarian response to stimulation|5
4497659|NCT00829244|7301993|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1
4497660|NCT00829244|7301994|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6
4497661|NCT00829244|7301993|FG000|Overall Study|No fertilization|2
4497662|NCT00829244|7301994|FG001|Overall Study|No fertilization|2
4497663|NCT00829244|7301993|FG000|Overall Study|All embryos discarded|0
4497664|NCT00829244|7301994|FG001|Overall Study|All embryos discarded|3
4497665|NCT00829244|7301993|FG000|Overall Study|No embryo cleavage|0
4497666|NCT00829244|7301994|FG001|Overall Study|No embryo cleavage|2
4497667|NCT00829283|7302002|FG000|Overall Study|Lost to Follow-up|7
4497668|NCT00829283|7302003|FG001|Overall Study|Lost to Follow-up|25
4497669|NCT00829296|7302011|FG000|Overall Study|Adverse Event|5
4497670|NCT00829296|7302012|FG001|Overall Study|Adverse Event|4
4497671|NCT00829387|7302020|FG000|Overall Study|Withdrawal by Subject|2
4497672|NCT00829387|7302021|FG001|Overall Study|Withdrawal by Subject|3
4497673|NCT00829387|7302020|FG000|Overall Study|Disqualified by PI|1
4497674|NCT00829387|7302021|FG001|Overall Study|Disqualified by PI|0
4497675|NCT00829413|7302027|FG000|Overall Study|No study drug admimnistered|13
4497676|NCT00829413|7302027|FG000|Overall Study|Training Patients|67
4497677|NCT00829413|7302027|FG000|Overall Study|No truth standard procedure available|9
4497678|NCT00829413|7302027|FG000|Overall Study|Technically inadequate truth standard|2
4497679|NCT00829413|7302027|FG000|Overall Study|Indeterminate diagnosis from truth stand|3
4497680|NCT00829439|7302038|FG000|Overall Study|Adverse Event|0
4497681|NCT00829439|7302039|FG001|Overall Study|Adverse Event|0
4497682|NCT00829439|7302040|FG002|Overall Study|Adverse Event|1
4497683|NCT00829439|7302041|FG003|Overall Study|Adverse Event|0
4497684|NCT00829621|7302047|FG000|Overall Study|Death|1
4497685|NCT00829621|7302048|FG001|Overall Study|Death|0
4497686|NCT00829621|7302047|FG000|Overall Study|Lost to Follow-up|3
4497687|NCT00829621|7302048|FG001|Overall Study|Lost to Follow-up|4
4497688|NCT00829829|7302062|FG000|Overall Study|Protocol Violation|0
4497689|NCT00829829|7302063|FG001|Overall Study|Protocol Violation|3
4497690|NCT00829829|7302064|FG002|Overall Study|Protocol Violation|0
4497691|NCT00829829|7302062|FG000|Overall Study|Adverse Event|4
4497692|NCT00829829|7302063|FG001|Overall Study|Adverse Event|4
4497693|NCT00829829|7302064|FG002|Overall Study|Adverse Event|3
4497694|NCT00829829|7302062|FG000|Overall Study|Withdrawal by Subject|8
4497695|NCT00829829|7302063|FG001|Overall Study|Withdrawal by Subject|4
4497696|NCT00829829|7302064|FG002|Overall Study|Withdrawal by Subject|2
4497697|NCT00829829|7302062|FG000|Overall Study|Decision by the Sponsor|1
4497698|NCT00829829|7302063|FG001|Overall Study|Decision by the Sponsor|0
4497699|NCT00829829|7302064|FG002|Overall Study|Decision by the Sponsor|2
4497700|NCT00829829|7302062|FG000|Overall Study|Lost to Follow-up|7
4497701|NCT00829829|7302063|FG001|Overall Study|Lost to Follow-up|3
4497702|NCT00829829|7302064|FG002|Overall Study|Lost to Follow-up|3
4497703|NCT00829829|7302062|FG000|Overall Study|Other than specified above|2
4497704|NCT00829829|7302063|FG001|Overall Study|Other than specified above|2
4497705|NCT00829829|7302064|FG002|Overall Study|Other than specified above|1
4497706|NCT00829933|7302077|FG000|Overall Study|Adverse Event|2
4497707|NCT00829933|7302078|FG001|Overall Study|Adverse Event|3
4497708|NCT00829933|7302079|FG002|Overall Study|Adverse Event|2
4497709|NCT00829933|7302080|FG003|Overall Study|Adverse Event|1
4497710|NCT00829933|7302077|FG000|Overall Study|Death|0
4497711|NCT00829933|7302078|FG001|Overall Study|Death|0
4497712|NCT00829933|7302079|FG002|Overall Study|Death|1
4497713|NCT00829933|7302080|FG003|Overall Study|Death|1
4497714|NCT00829933|7302077|FG000|Overall Study|Lack of Efficacy|0
4497715|NCT00829933|7302078|FG001|Overall Study|Lack of Efficacy|1
4497716|NCT00829933|7302079|FG002|Overall Study|Lack of Efficacy|0
4497717|NCT00829933|7302080|FG003|Overall Study|Lack of Efficacy|0
4497718|NCT00829933|7302077|FG000|Overall Study|Physician Decision|5
4497719|NCT00829933|7302078|FG001|Overall Study|Physician Decision|7
4497720|NCT00829933|7302079|FG002|Overall Study|Physician Decision|8
4497721|NCT00829933|7302080|FG003|Overall Study|Physician Decision|1
4497722|NCT00829933|7302077|FG000|Overall Study|Pregnancy|0
4497723|NCT00829933|7302078|FG001|Overall Study|Pregnancy|0
4497724|NCT00829933|7302079|FG002|Overall Study|Pregnancy|0
4497725|NCT00829933|7302080|FG003|Overall Study|Pregnancy|2
4497726|NCT00829933|7302077|FG000|Overall Study|Protocol Violation|2
4497727|NCT00829933|7302078|FG001|Overall Study|Protocol Violation|1
4497728|NCT00829933|7302079|FG002|Overall Study|Protocol Violation|0
4497729|NCT00829933|7302080|FG003|Overall Study|Protocol Violation|0
4497730|NCT00829933|7302077|FG000|Overall Study|withdrew before treatment started|5
4497731|NCT00829933|7302078|FG001|Overall Study|withdrew before treatment started|1
4497732|NCT00829933|7302079|FG002|Overall Study|withdrew before treatment started|2
4497733|NCT00829933|7302080|FG003|Overall Study|withdrew before treatment started|9
4497734|NCT00830037|7302101|FG000|Overall Study|Withdrawal by Subject|2
4497735|NCT00830037|7302102|FG001|Overall Study|Withdrawal by Subject|3
4497736|NCT00830037|7302101|FG000|Overall Study|Lost to Follow-up|1
4497737|NCT00830037|7302102|FG001|Overall Study|Lost to Follow-up|2
4497738|NCT00830037|7302101|FG000|Overall Study|Active when terminated by DSMB|15
4497739|NCT00830037|7302102|FG001|Overall Study|Active when terminated by DSMB|14
4497740|NCT00830063|7302112|FG000|Overall Study|Adverse Event|7
4497741|NCT00830063|7302113|FG001|Overall Study|Adverse Event|13
4497742|NCT00830063|7302114|FG002|Overall Study|Adverse Event|16
4497743|NCT00830063|7302115|FG003|Overall Study|Adverse Event|13
4497744|NCT00830063|7302112|FG000|Overall Study|Death|1
4497745|NCT00830063|7302113|FG001|Overall Study|Death|0
4497746|NCT00830063|7302114|FG002|Overall Study|Death|0
4497747|NCT00830063|7302115|FG003|Overall Study|Death|0
4497748|NCT00830063|7302112|FG000|Overall Study|Lost to Follow-up|0
4497749|NCT00830063|7302113|FG001|Overall Study|Lost to Follow-up|0
4497750|NCT00830063|7302114|FG002|Overall Study|Lost to Follow-up|3
4497751|NCT00830063|7302115|FG003|Overall Study|Lost to Follow-up|1
4497752|NCT00830063|7302112|FG000|Overall Study|Preferred Time Entry in Extension Study|119
4497753|NCT00830063|7302113|FG001|Overall Study|Preferred Time Entry in Extension Study|139
4497754|NCT00830063|7302114|FG002|Overall Study|Preferred Time Entry in Extension Study|127
4497755|NCT00830063|7302115|FG003|Overall Study|Preferred Time Entry in Extension Study|126
4497756|NCT00830063|7302112|FG000|Overall Study|Lack of Efficacy|51
4497757|NCT00830063|7302113|FG001|Overall Study|Lack of Efficacy|23
4497758|NCT00830063|7302114|FG002|Overall Study|Lack of Efficacy|25
4497759|NCT00830063|7302115|FG003|Overall Study|Lack of Efficacy|32
4497760|NCT00830063|7302112|FG000|Overall Study|Other|5
4497761|NCT00830063|7302113|FG001|Overall Study|Other|5
4497762|NCT00830063|7302114|FG002|Overall Study|Other|8
4497763|NCT00830063|7302115|FG003|Overall Study|Other|6
4497764|NCT00830063|7302112|FG000|Overall Study|Withdrawal by Subject|16
4497765|NCT00830063|7302113|FG001|Overall Study|Withdrawal by Subject|10
4497766|NCT00830063|7302114|FG002|Overall Study|Withdrawal by Subject|16
4497767|NCT00830063|7302115|FG003|Overall Study|Withdrawal by Subject|13
4497768|NCT00830063|7302112|FG000|Overall Study|Protocol Violation|1
4497769|NCT00830063|7302113|FG001|Overall Study|Protocol Violation|0
4497770|NCT00830063|7302114|FG002|Overall Study|Protocol Violation|3
4497771|NCT00830063|7302115|FG003|Overall Study|Protocol Violation|2
4497772|NCT00830063|7302112|FG000|Overall Study|Randomized But Not Treated|0
4497773|NCT00830063|7302113|FG001|Overall Study|Randomized But Not Treated|2
4497774|NCT00830063|7302114|FG002|Overall Study|Randomized But Not Treated|0
4497775|NCT00830063|7302115|FG003|Overall Study|Randomized But Not Treated|2
4497776|NCT00830115|7302134|FG000|Overall Study|Adverse Event|2
4497777|NCT00830115|7302134|FG000|Overall Study|Improvement/recovery|1
4497778|NCT00830128|7302140|FG000|Overall Study|Adverse Event|5
4497779|NCT00830128|7302140|FG000|Overall Study|Lack of Efficacy|7
4497780|NCT00830128|7302140|FG000|Overall Study|Protocol Violation|1
4497781|NCT00830128|7302140|FG000|Overall Study|Withdrawal by Subject|2
4497782|NCT00830128|7302140|FG000|Overall Study|Family obligation|1
4497783|NCT00830128|7302140|FG000|Overall Study|Relocation|1
4497784|NCT00830128|7302140|FG000|Overall Study|Work obligation|1
4497785|NCT00830128|7302140|FG000|Overall Study|Operating a vehicle|1
4497786|NCT00830167|7302146|FG000|Overall Study|Lack of Efficacy|26
4497787|NCT00830167|7302147|FG001|Overall Study|Lack of Efficacy|10
4497788|NCT00830167|7302146|FG000|Overall Study|Adverse Event|8
4497789|NCT00830167|7302147|FG001|Overall Study|Adverse Event|24
4497790|NCT00830167|7302146|FG000|Overall Study|Not meeting entrance criteria|2
4497791|NCT00830167|7302147|FG001|Overall Study|Not meeting entrance criteria|5
4497792|NCT00830167|7302146|FG000|Overall Study|Withdrawal by Subject|2
4497793|NCT00830167|7302147|FG001|Overall Study|Withdrawal by Subject|0
4497794|NCT00830167|7302146|FG000|Overall Study|Lost to Follow-up|0
4497795|NCT00830167|7302147|FG001|Overall Study|Lost to Follow-up|1
4497796|NCT00830167|7302146|FG000|Overall Study|Protocol Violation|0
4497797|NCT00830167|7302147|FG001|Overall Study|Protocol Violation|1
4497798|NCT00830167|7302146|FG000|Overall Study|Other|2
4497799|NCT00830167|7302147|FG001|Overall Study|Other|2
4497800|NCT00830180|7302153|FG000|Overall Study|Adverse Event|6
4497801|NCT00830180|7302153|FG000|Overall Study|Death|11
4497802|NCT00830180|7302153|FG000|Overall Study|Insufficient clinical response|1
4497803|NCT00830180|7302153|FG000|Overall Study|Withdrawal by Subject|5
4497804|NCT00830180|7302153|FG000|Overall Study|Progressive disease|2
4497805|NCT00830180|7302153|FG000|Overall Study|Other - Unspecified|1
4517832|NCT00969553|7329734|FG006|Overall Study|Not specified above|1
4517833|NCT00969553|7329735|FG007|Overall Study|Not specified above|1
4517834|NCT00969553|7329736|FG008|Overall Study|Not specified above|0
4517835|NCT00969618|7329764|FG000|Overall Study|Adverse Event|29
4517836|NCT00969618|7329764|FG000|Overall Study|Entry Criteria Not Met|3
4517837|NCT00969618|7329764|FG000|Overall Study|Lack of Efficacy|2
4517838|NCT00969618|7329764|FG000|Overall Study|Lost to Follow-up|7
4517839|NCT00969618|7329764|FG000|Overall Study|Physician Decision|1
4517840|NCT00969618|7329764|FG000|Overall Study|Protocol Violation|9
4517841|NCT00969618|7329764|FG000|Overall Study|Withdrawal by Subject|27
4517842|NCT00969709|7329772|FG000|Overall Study|Adverse Event|3
4517843|NCT00969709|7329773|FG001|Overall Study|Adverse Event|13
4517844|NCT00969709|7329774|FG002|Overall Study|Adverse Event|26
4517845|NCT00969709|7329775|FG003|Overall Study|Adverse Event|12
4517846|NCT00969709|7329772|FG000|Overall Study|Lack of Efficacy|7
4517847|NCT00969709|7329773|FG001|Overall Study|Lack of Efficacy|4
4627058|NCT01848834|7493407|FG002|Overall Study|Withdrawal by Subject|10
4627059|NCT01848834|7493408|FG003|Overall Study|Withdrawal by Subject|6
4627060|NCT01848834|7493409|FG004|Overall Study|Withdrawal by Subject|36
4627061|NCT01848938|7493445|FG000|Overall Study|Lost to Follow-up|1
4627062|NCT01848938|7493446|FG001|Overall Study|Lost to Follow-up|1
4627063|NCT01848990|7493464|FG000|Overall Study|Adverse Event|6
4627064|NCT01848990|7493465|FG001|Overall Study|Adverse Event|2
4627065|NCT01848990|7493466|FG002|Overall Study|Adverse Event|0
4627066|NCT01848990|7493464|FG000|Overall Study|Lost to Follow-up|6
4627067|NCT01848990|7493465|FG001|Overall Study|Lost to Follow-up|2
4627068|NCT01848990|7493466|FG002|Overall Study|Lost to Follow-up|2
4627069|NCT01848990|7493464|FG000|Overall Study|Protocol Violation|1
4627070|NCT01848990|7493465|FG001|Overall Study|Protocol Violation|1
4627071|NCT01848990|7493466|FG002|Overall Study|Protocol Violation|0
4627072|NCT01848990|7493464|FG000|Overall Study|Withdrawal by Subject|29
4517848|NCT00969709|7329774|FG002|Overall Study|Lack of Efficacy|1
4517849|NCT00969709|7329775|FG003|Overall Study|Lack of Efficacy|3
4517850|NCT00969709|7329772|FG000|Overall Study|Protocol Violation|9
4627073|NCT01848990|7493465|FG001|Overall Study|Withdrawal by Subject|10
4627074|NCT01848990|7493466|FG002|Overall Study|Withdrawal by Subject|11
4627075|NCT01848990|7493464|FG000|Overall Study|Physician Decision|1
4517851|NCT00969709|7329773|FG001|Overall Study|Protocol Violation|5
4517852|NCT00969709|7329774|FG002|Overall Study|Protocol Violation|9
4517853|NCT00969709|7329775|FG003|Overall Study|Protocol Violation|10
4517854|NCT00969709|7329772|FG000|Overall Study|Withdrawal by Subject|9
4517855|NCT00969709|7329773|FG001|Overall Study|Withdrawal by Subject|12
4627076|NCT01848990|7493465|FG001|Overall Study|Physician Decision|1
4497806|NCT00830375|7302185|FG000|Overall Study|Lost to Follow-up|1
4497807|NCT00830440|7302195|FG000|Overall Study|Protocol Violation|1
4497808|NCT00830440|7302196|FG001|Overall Study|Protocol Violation|0
4497809|NCT00830440|7302195|FG000|Overall Study|Withdrawal by Subject|1
4497810|NCT00830440|7302196|FG001|Overall Study|Withdrawal by Subject|0
4497811|NCT00830440|7302195|FG000|Overall Study|unsuccessful procedure|4
4497812|NCT00830440|7302196|FG001|Overall Study|unsuccessful procedure|0
4497813|NCT00830440|7302195|FG000|Overall Study|Adverse Event|2
4497814|NCT00830440|7302196|FG001|Overall Study|Adverse Event|0
4497815|NCT00830518|7302205|FG000|Overall Study|Progressive Disease|18
4497816|NCT00830518|7302206|FG001|Overall Study|Progressive Disease|8
4497817|NCT00830518|7302205|FG000|Overall Study|Symptomatic Deterioration|4
4497818|NCT00830518|7302206|FG001|Overall Study|Symptomatic Deterioration|1
4497819|NCT00830518|7302205|FG000|Overall Study|Adverse Event|14
4497820|NCT00830518|7302206|FG001|Overall Study|Adverse Event|1
4497821|NCT00830518|7302205|FG000|Overall Study|Withdrawal by Patient|2
4497822|NCT00830518|7302206|FG001|Overall Study|Withdrawal by Patient|0
4497823|NCT00830518|7302205|FG000|Overall Study|Reason not Specified|8
4497824|NCT00830518|7302206|FG001|Overall Study|Reason not Specified|1
4497825|NCT00830765|7302228|FG000|Overall Study|Protocol Violation|3
4497826|NCT00830765|7302229|FG001|Overall Study|Protocol Violation|2
4497827|NCT00830804|7302259|FG000|Overall Study|Lost to Follow-up|4
4497828|NCT00830804|7302259|FG000|Overall Study|Death|1
4497829|NCT00830804|7302259|FG000|Overall Study|Unable to get to clinic|7
4497830|NCT00830804|7302259|FG000|Overall Study|Consent withdrawn|2
4497831|NCT00830804|7302259|FG000|Overall Study|Unwilling to adhere to study requirement|1
4497832|NCT00830869|7302276|FG000|Period 1: Part 1|Symptomatic deterioration|0
4497833|NCT00830869|7302277|FG001|Period 1: Part 1|Symptomatic deterioration|0
4497834|NCT00830869|7302278|FG002|Period 1: Part 1|Symptomatic deterioration|0
4497835|NCT00830869|7302279|FG003|Period 1: Part 1|Symptomatic deterioration|1
4497836|NCT00830869|7302280|FG004|Period 1: Part 1|Symptomatic deterioration|0
4497837|NCT00830869|7302281|FG005|Period 1: Part 1|Symptomatic deterioration|1
4497838|NCT00830869|7302282|FG006|Period 1: Part 1|Symptomatic deterioration|1
4497839|NCT00830869|7302283|FG007|Period 1: Part 1|Symptomatic deterioration|0
4497840|NCT00830869|7302284|FG008|Period 1: Part 1|Symptomatic deterioration|0
4497841|NCT00830869|7302285|FG009|Period 1: Part 1|Symptomatic deterioration|0
4497842|NCT00830869|7302286|FG010|Period 1: Part 1|Symptomatic deterioration|0
4497843|NCT00830869|7302287|FG011|Period 1: Part 1|Symptomatic deterioration|0
4497844|NCT00830869|7302276|FG000|Period 1: Part 1|Withdrawal by Subject|0
4497845|NCT00830869|7302277|FG001|Period 1: Part 1|Withdrawal by Subject|1
4497846|NCT00830869|7302278|FG002|Period 1: Part 1|Withdrawal by Subject|0
4497847|NCT00830869|7302279|FG003|Period 1: Part 1|Withdrawal by Subject|0
4497848|NCT00830869|7302280|FG004|Period 1: Part 1|Withdrawal by Subject|0
4497849|NCT00830869|7302281|FG005|Period 1: Part 1|Withdrawal by Subject|0
4497850|NCT00830869|7302282|FG006|Period 1: Part 1|Withdrawal by Subject|0
4497851|NCT00830869|7302283|FG007|Period 1: Part 1|Withdrawal by Subject|0
4497852|NCT00830869|7302284|FG008|Period 1: Part 1|Withdrawal by Subject|0
4497853|NCT00830869|7302285|FG009|Period 1: Part 1|Withdrawal by Subject|0
4497854|NCT00830869|7302286|FG010|Period 1: Part 1|Withdrawal by Subject|0
4497855|NCT00830869|7302287|FG011|Period 1: Part 1|Withdrawal by Subject|0
4497856|NCT00830869|7302276|FG000|Period 1: Part 1|Adverse Event|0
4497857|NCT00830869|7302277|FG001|Period 1: Part 1|Adverse Event|0
4497858|NCT00830869|7302278|FG002|Period 1: Part 1|Adverse Event|0
4497859|NCT00830869|7302279|FG003|Period 1: Part 1|Adverse Event|0
4497860|NCT00830869|7302280|FG004|Period 1: Part 1|Adverse Event|0
4497861|NCT00830869|7302281|FG005|Period 1: Part 1|Adverse Event|1
4497862|NCT00830869|7302282|FG006|Period 1: Part 1|Adverse Event|1
4497863|NCT00830869|7302283|FG007|Period 1: Part 1|Adverse Event|0
4497864|NCT00830869|7302284|FG008|Period 1: Part 1|Adverse Event|0
4497865|NCT00830869|7302285|FG009|Period 1: Part 1|Adverse Event|0
4497866|NCT00830869|7302286|FG010|Period 1: Part 1|Adverse Event|0
4497867|NCT00830869|7302287|FG011|Period 1: Part 1|Adverse Event|0
4497868|NCT00830869|7302276|FG000|Period 1: Part 1|Progressive disease|1
4497869|NCT00830869|7302277|FG001|Period 1: Part 1|Progressive disease|0
4497870|NCT00830869|7302278|FG002|Period 1: Part 1|Progressive disease|1
4497871|NCT00830869|7302279|FG003|Period 1: Part 1|Progressive disease|6
4497872|NCT00830869|7302280|FG004|Period 1: Part 1|Progressive disease|4
4497873|NCT00830869|7302281|FG005|Period 1: Part 1|Progressive disease|4
4497874|NCT00830869|7302282|FG006|Period 1: Part 1|Progressive disease|1
4497875|NCT00830869|7302283|FG007|Period 1: Part 1|Progressive disease|0
4497876|NCT00830869|7302284|FG008|Period 1: Part 1|Progressive disease|0
4497877|NCT00830869|7302285|FG009|Period 1: Part 1|Progressive disease|0
4497878|NCT00830869|7302286|FG010|Period 1: Part 1|Progressive disease|0
4497879|NCT00830869|7302287|FG011|Period 1: Part 1|Progressive disease|0
4497880|NCT00830869|7302276|FG000|Period 2: Part 2|Protocol Violation|0
4497881|NCT00830869|7302277|FG001|Period 2: Part 2|Protocol Violation|0
4497882|NCT00830869|7302278|FG002|Period 2: Part 2|Protocol Violation|0
4497883|NCT00830869|7302279|FG003|Period 2: Part 2|Protocol Violation|0
4497884|NCT00830869|7302280|FG004|Period 2: Part 2|Protocol Violation|0
4497885|NCT00830869|7302281|FG005|Period 2: Part 2|Protocol Violation|0
4497886|NCT00830869|7302282|FG006|Period 2: Part 2|Protocol Violation|0
4497887|NCT00830869|7302283|FG007|Period 2: Part 2|Protocol Violation|1
4497888|NCT00830869|7302284|FG008|Period 2: Part 2|Protocol Violation|0
4497889|NCT00830869|7302285|FG009|Period 2: Part 2|Protocol Violation|1
4497890|NCT00830869|7302286|FG010|Period 2: Part 2|Protocol Violation|0
4497891|NCT00830869|7302287|FG011|Period 2: Part 2|Protocol Violation|0
4497892|NCT00830869|7302276|FG000|Period 2: Part 2|Withdrawal by Subject|0
4497893|NCT00830869|7302277|FG001|Period 2: Part 2|Withdrawal by Subject|0
4497894|NCT00830869|7302278|FG002|Period 2: Part 2|Withdrawal by Subject|0
4497895|NCT00830869|7302279|FG003|Period 2: Part 2|Withdrawal by Subject|0
4497896|NCT00830869|7302280|FG004|Period 2: Part 2|Withdrawal by Subject|0
4497897|NCT00830869|7302281|FG005|Period 2: Part 2|Withdrawal by Subject|0
4497898|NCT00830869|7302282|FG006|Period 2: Part 2|Withdrawal by Subject|0
4497899|NCT00830869|7302283|FG007|Period 2: Part 2|Withdrawal by Subject|1
4497900|NCT00830869|7302284|FG008|Period 2: Part 2|Withdrawal by Subject|2
4497901|NCT00830869|7302285|FG009|Period 2: Part 2|Withdrawal by Subject|1
4497902|NCT00830869|7302286|FG010|Period 2: Part 2|Withdrawal by Subject|0
4497903|NCT00830869|7302287|FG011|Period 2: Part 2|Withdrawal by Subject|1
4497904|NCT00830869|7302276|FG000|Period 2: Part 2|Adverse Event|0
4497905|NCT00830869|7302277|FG001|Period 2: Part 2|Adverse Event|0
4497906|NCT00830869|7302278|FG002|Period 2: Part 2|Adverse Event|0
4497907|NCT00830869|7302279|FG003|Period 2: Part 2|Adverse Event|0
4497908|NCT00830869|7302280|FG004|Period 2: Part 2|Adverse Event|0
4497909|NCT00830869|7302281|FG005|Period 2: Part 2|Adverse Event|0
4497910|NCT00830869|7302282|FG006|Period 2: Part 2|Adverse Event|0
4497911|NCT00830869|7302283|FG007|Period 2: Part 2|Adverse Event|4
4497912|NCT00830869|7302284|FG008|Period 2: Part 2|Adverse Event|3
4497913|NCT00830869|7302285|FG009|Period 2: Part 2|Adverse Event|2
4497914|NCT00830869|7302286|FG010|Period 2: Part 2|Adverse Event|2
4497915|NCT00830869|7302287|FG011|Period 2: Part 2|Adverse Event|0
4497916|NCT00830869|7302276|FG000|Period 2: Part 2|Symptomatic Deterioration|0
4497917|NCT00830869|7302277|FG001|Period 2: Part 2|Symptomatic Deterioration|0
4497918|NCT00830869|7302278|FG002|Period 2: Part 2|Symptomatic Deterioration|0
4497919|NCT00830869|7302279|FG003|Period 2: Part 2|Symptomatic Deterioration|0
4497920|NCT00830869|7302280|FG004|Period 2: Part 2|Symptomatic Deterioration|0
4497921|NCT00830869|7302281|FG005|Period 2: Part 2|Symptomatic Deterioration|0
4497922|NCT00830869|7302282|FG006|Period 2: Part 2|Symptomatic Deterioration|0
4497923|NCT00830869|7302283|FG007|Period 2: Part 2|Symptomatic Deterioration|0
4497924|NCT00830869|7302284|FG008|Period 2: Part 2|Symptomatic Deterioration|6
4497925|NCT00830869|7302285|FG009|Period 2: Part 2|Symptomatic Deterioration|3
4497926|NCT00830869|7302286|FG010|Period 2: Part 2|Symptomatic Deterioration|1
4497927|NCT00830869|7302287|FG011|Period 2: Part 2|Symptomatic Deterioration|4
4497928|NCT00830869|7302276|FG000|Period 2: Part 2|Progressive disease|0
4497929|NCT00830869|7302277|FG001|Period 2: Part 2|Progressive disease|0
4497930|NCT00830869|7302278|FG002|Period 2: Part 2|Progressive disease|0
4497931|NCT00830869|7302279|FG003|Period 2: Part 2|Progressive disease|0
4497932|NCT00830869|7302280|FG004|Period 2: Part 2|Progressive disease|0
4497933|NCT00830869|7302281|FG005|Period 2: Part 2|Progressive disease|0
4497934|NCT00830869|7302282|FG006|Period 2: Part 2|Progressive disease|0
4497935|NCT00830869|7302283|FG007|Period 2: Part 2|Progressive disease|14
4497936|NCT00830869|7302284|FG008|Period 2: Part 2|Progressive disease|11
4497937|NCT00830869|7302285|FG009|Period 2: Part 2|Progressive disease|12
4497938|NCT00830869|7302286|FG010|Period 2: Part 2|Progressive disease|8
4627077|NCT01848990|7493466|FG002|Overall Study|Physician Decision|0
4627078|NCT01848990|7493464|FG000|Overall Study|Non Compliance|1
4627079|NCT01848990|7493465|FG001|Overall Study|Non Compliance|0
4627080|NCT01848990|7493466|FG002|Overall Study|Non Compliance|0
4627081|NCT01848990|7493464|FG000|Overall Study|Death|1
4627082|NCT01848990|7493465|FG001|Overall Study|Death|0
4627083|NCT01848990|7493466|FG002|Overall Study|Death|1
4627084|NCT01848990|7493464|FG000|Overall Study|Other|1
4627085|NCT01848990|7493465|FG001|Overall Study|Other|4
4627086|NCT01848990|7493466|FG002|Overall Study|Other|2
4627087|NCT01849055|7493484|FG000|Overall Study|Withdrawal by Subject|0
4627088|NCT01849055|7493485|FG001|Overall Study|Withdrawal by Subject|0
4627089|NCT01849055|7493486|FG002|Overall Study|Withdrawal by Subject|1
4627090|NCT01849055|7493487|FG003|Overall Study|Withdrawal by Subject|0
4627091|NCT01849055|7493488|FG004|Overall Study|Withdrawal by Subject|0
4627092|NCT01849055|7493489|FG005|Overall Study|Withdrawal by Subject|0
4627093|NCT01849276|7493525|FG000|Followed for Survival for 5 Years|Death|1
4627094|NCT01849276|7493525|FG000|Followed for Survival for 5 Years|Early termination of the study|1
4627095|NCT01849289|7493531|FG000|Overall Study|Adverse Event|3
4627096|NCT01849289|7493532|FG001|Overall Study|Adverse Event|3
4627097|NCT01849289|7493531|FG000|Overall Study|Protocol Violation|3
4627098|NCT01849289|7493532|FG001|Overall Study|Protocol Violation|3
4627099|NCT01849289|7493531|FG000|Overall Study|Withdrawal criteria|1
4627100|NCT01849289|7493532|FG001|Overall Study|Withdrawal criteria|0
4627101|NCT01849289|7493531|FG000|Overall Study|Unclassified|25
4497939|NCT00830869|7302287|FG011|Period 2: Part 2|Progressive disease|15
4497940|NCT00830869|7302276|FG000|Period 2: Part 2|Other|0
4497941|NCT00830869|7302277|FG001|Period 2: Part 2|Other|0
4497942|NCT00830869|7302278|FG002|Period 2: Part 2|Other|0
4497943|NCT00830869|7302279|FG003|Period 2: Part 2|Other|0
4497944|NCT00830869|7302280|FG004|Period 2: Part 2|Other|0
4627102|NCT01849289|7493532|FG001|Overall Study|Unclassified|18
4627103|NCT01849458|7493543|FG000|Overall Study|Lost to Follow-up|4
4627104|NCT01849497|7493549|FG000|Overall Study|Withdrawal by Subject|1
4627105|NCT01849497|7493550|FG001|Overall Study|Withdrawal by Subject|2
4627106|NCT01849497|7493549|FG000|Overall Study|Sponsor Decision|0
4627107|NCT01849497|7493550|FG001|Overall Study|Sponsor Decision|1
4627108|NCT01849497|7493549|FG000|Overall Study|Lost to Follow-up|0
4627109|NCT01849497|7493550|FG001|Overall Study|Lost to Follow-up|1
4627110|NCT01849562|7493559|FG000|Overall Study|Lost to Follow-up|1
4627111|NCT01849562|7493560|FG001|Overall Study|Lost to Follow-up|0
4627112|NCT01849562|7493561|FG002|Overall Study|Lost to Follow-up|0
4627113|NCT01849562|7493559|FG000|Overall Study|Non-compliance with Study Drug|1
4627114|NCT01849562|7493560|FG001|Overall Study|Non-compliance with Study Drug|0
4627115|NCT01849562|7493561|FG002|Overall Study|Non-compliance with Study Drug|0
4627116|NCT01849588|7493581|FG000|Overall Study|Lack of Efficacy|3
4627117|NCT01849848|7493634|FG000|Overall Study|Physician Decision|1
4627118|NCT01849848|7493634|FG000|Overall Study|Progression of the primary disease|3
4627119|NCT01850030|7493640|FG000|Overall Study|Adverse Event|64
4627120|NCT01850030|7493641|FG001|Overall Study|Adverse Event|82
4627121|NCT01850030|7493640|FG000|Overall Study|Lack of Efficacy|3
4627122|NCT01850030|7493641|FG001|Overall Study|Lack of Efficacy|1
4627123|NCT01850030|7493640|FG000|Overall Study|Lost to Follow-up|5
4627124|NCT01850030|7493641|FG001|Overall Study|Lost to Follow-up|5
4627125|NCT01850030|7493640|FG000|Overall Study|Withdrawal by Subject|3
4627126|NCT01850030|7493641|FG001|Overall Study|Withdrawal by Subject|4
4627127|NCT01850030|7493640|FG000|Overall Study|Protocol Violation|24
4627128|NCT01850030|7493641|FG001|Overall Study|Protocol Violation|28
4627129|NCT01850030|7493640|FG000|Overall Study|pregnancy not confirmed at visit 4|248
4627130|NCT01850030|7493641|FG001|Overall Study|pregnancy not confirmed at visit 4|249
4627131|NCT01850446|7493662|FG000|Overall Study|Lack of Efficacy|1
4627132|NCT01850446|7493663|FG001|Overall Study|Lack of Efficacy|0
4627133|NCT01850446|7493662|FG000|Overall Study|Withdrawal by Subject|4
4627134|NCT01850446|7493663|FG001|Overall Study|Withdrawal by Subject|0
4627135|NCT01850446|7493662|FG000|Overall Study|Protocol Violation|0
4627136|NCT01850446|7493663|FG001|Overall Study|Protocol Violation|2
4497945|NCT00830869|7302281|FG005|Period 2: Part 2|Other|0
4497946|NCT00830869|7302282|FG006|Period 2: Part 2|Other|0
4497947|NCT00830869|7302283|FG007|Period 2: Part 2|Other|0
4497948|NCT00830869|7302284|FG008|Period 2: Part 2|Other|0
4497949|NCT00830869|7302285|FG009|Period 2: Part 2|Other|1
4497950|NCT00830869|7302286|FG010|Period 2: Part 2|Other|0
4497951|NCT00830869|7302287|FG011|Period 2: Part 2|Other|0
4497952|NCT00830947|7302316|FG000|Overall Study|Lost to Follow-up|4
4497953|NCT00830947|7302317|FG001|Overall Study|Lost to Follow-up|4
4497954|NCT00830960|7302329|FG000|Overall Study|Death|5
4497955|NCT00830960|7302330|FG001|Overall Study|Death|4
4497956|NCT00830960|7302331|FG002|Overall Study|Death|3
4497957|NCT00830960|7302332|FG003|Overall Study|Death|2
4497958|NCT00830960|7302333|FG004|Overall Study|Death|6
4497959|NCT00830960|7302334|FG005|Overall Study|Death|1
4497960|NCT00830960|7302329|FG000|Overall Study|Lost to Follow-up|1
4497961|NCT00830960|7302330|FG001|Overall Study|Lost to Follow-up|1
4497962|NCT00830960|7302331|FG002|Overall Study|Lost to Follow-up|1
4497963|NCT00830960|7302332|FG003|Overall Study|Lost to Follow-up|0
4497964|NCT00830960|7302333|FG004|Overall Study|Lost to Follow-up|0
4497965|NCT00830960|7302334|FG005|Overall Study|Lost to Follow-up|1
4497966|NCT00830960|7302329|FG000|Overall Study|Withdrawal by Subject|19
4497967|NCT00830960|7302330|FG001|Overall Study|Withdrawal by Subject|19
4497968|NCT00830960|7302331|FG002|Overall Study|Withdrawal by Subject|18
4497969|NCT00830960|7302332|FG003|Overall Study|Withdrawal by Subject|23
4497970|NCT00830960|7302333|FG004|Overall Study|Withdrawal by Subject|16
4497971|NCT00830960|7302334|FG005|Overall Study|Withdrawal by Subject|21
4497972|NCT00830960|7302329|FG000|Overall Study|Sponsor Decision|1
4497973|NCT00830960|7302330|FG001|Overall Study|Sponsor Decision|2
4497974|NCT00830960|7302331|FG002|Overall Study|Sponsor Decision|3
4497975|NCT00830960|7302332|FG003|Overall Study|Sponsor Decision|4
4497976|NCT00830960|7302333|FG004|Overall Study|Sponsor Decision|5
4497977|NCT00830960|7302334|FG005|Overall Study|Sponsor Decision|7
4497978|NCT00830960|7302329|FG000|Overall Study|No study drug received|7
4497979|NCT00830960|7302330|FG001|Overall Study|No study drug received|2
4497980|NCT00830960|7302331|FG002|Overall Study|No study drug received|4
4497981|NCT00830960|7302332|FG003|Overall Study|No study drug received|3
4497982|NCT00830960|7302333|FG004|Overall Study|No study drug received|5
4633233|NCT01909804|7503304|FG008|Overall Study|Randomized but Never Treated|0
4633234|NCT01909804|7503305|FG009|Overall Study|Randomized but Never Treated|0
4387242|NCT00047385|7165842|FG001|Overall Study|Eligible for screening but had no screen|492
4387243|NCT00047463|7165850|FG000|Overall Study|Withdrawal by Subject|0
4387244|NCT00047463|7165851|FG001|Overall Study|Withdrawal by Subject|3
4497983|NCT00830960|7302334|FG005|Overall Study|No study drug received|7
4497984|NCT00831129|7302373|FG000|Overall Study|Adverse Event|0
4497985|NCT00831129|7302374|FG001|Overall Study|Adverse Event|1
4497986|NCT00831129|7302373|FG000|Overall Study|9 lost to follow-up reasons uknown|0
4497987|NCT00831129|7302374|FG001|Overall Study|9 lost to follow-up reasons uknown|9
4633235|NCT01909804|7503306|FG010|Overall Study|Randomized but Never Treated|0
4633236|NCT01909804|7503307|FG011|Overall Study|Randomized but Never Treated|1
4633237|NCT01909804|7503296|FG000|Overall Study|Death|0
4497988|NCT00831181|7302380|FG000|Overall Study|Adverse Event|12
4497989|NCT00831233|7302387|FG000|Overall Study|Adverse Event|0
4497990|NCT00831233|7302388|FG001|Overall Study|Adverse Event|1
4497991|NCT00831233|7302387|FG000|Overall Study|Protocol Violation|1
4497992|NCT00831233|7302388|FG001|Overall Study|Protocol Violation|0
4497993|NCT00831233|7302387|FG000|Overall Study|Selection Criteria Not Met|2
4497994|NCT00831233|7302388|FG001|Overall Study|Selection Criteria Not Met|0
4497995|NCT00831311|7302413|FG000|Overall Study|Definitive Contraindication|3
4497996|NCT00831311|7302414|FG001|Overall Study|Definitive Contraindication|3
4497997|NCT00831311|7302413|FG000|Overall Study|Lost to Follow-up|3
4497998|NCT00831311|7302414|FG001|Overall Study|Lost to Follow-up|0
4497999|NCT00831311|7302413|FG000|Overall Study|Physician Decision|0
4498000|NCT00831311|7302414|FG001|Overall Study|Physician Decision|1
4498001|NCT00831311|7302413|FG000|Overall Study|Withdrawal by Subject|6
4498002|NCT00831311|7302414|FG001|Overall Study|Withdrawal by Subject|4
4498003|NCT00831389|7302423|FG000|Overall Study|Withdrawal by Subject|0
4498004|NCT00831389|7302424|FG001|Overall Study|Withdrawal by Subject|1
4498005|NCT00831415|7302430|FG000|Overall Study|Adverse Event|14
4498006|NCT00831415|7302430|FG000|Overall Study|Failed to return|3
4498007|NCT00831415|7302430|FG000|Overall Study|Physician Decision|6
4498008|NCT00831415|7302430|FG000|Overall Study|Lost to Follow-up|9
4498009|NCT00831415|7302430|FG000|Overall Study|Protocol Violation|3
4498010|NCT00831415|7302430|FG000|Overall Study|Withdrawal by Subject|35
4498011|NCT00831415|7302430|FG000|Overall Study|Unsatisfactory response - Efficacy|4
4498012|NCT00831415|7302430|FG000|Overall Study|Death|1
4498013|NCT00831441|7302440|FG000|Randomized|Death|82
4498014|NCT00831441|7302441|FG001|Randomized|Death|81
4498015|NCT00831441|7302440|FG000|Randomized|Adverse Event|248
4498016|NCT00831441|7302441|FG001|Randomized|Adverse Event|321
4498017|NCT00831441|7302440|FG000|Randomized|Emergency procedure|2
4498018|NCT00831441|7302441|FG001|Randomized|Emergency procedure|2
4498019|NCT00831441|7302440|FG000|Randomized|Elective procedure|26
4498020|NCT00831441|7302441|FG001|Randomized|Elective procedure|25
4498021|NCT00831441|7302440|FG000|Randomized|Physician Decision|26
4498022|NCT00831441|7302441|FG001|Randomized|Physician Decision|35
4498023|NCT00831441|7302440|FG000|Randomized|No longer met criteria|13
4498024|NCT00831441|7302441|FG001|Randomized|No longer met criteria|19
4498025|NCT00831441|7302440|FG000|Randomized|Withdrawal by Subject|178
4498026|NCT00831441|7302441|FG001|Randomized|Withdrawal by Subject|212
4498027|NCT00831441|7302440|FG000|Randomized|Lost to Follow-up|26
4498028|NCT00831441|7302441|FG001|Randomized|Lost to Follow-up|35
4498029|NCT00831441|7302440|FG000|Randomized|Administrative reason by sponsor|2780
4498030|NCT00831441|7302441|FG001|Randomized|Administrative reason by sponsor|2671
4498031|NCT00831441|7302440|FG000|Randomized|poor/non-compliance|30
4498032|NCT00831441|7302441|FG001|Randomized|poor/non-compliance|38
4498033|NCT00831441|7302440|FG000|Randomized|non-specified|276
4498034|NCT00831441|7302441|FG001|Randomized|non-specified|266
4498035|NCT00831441|7302440|FG000|Follow Up (30 Days)|Withdrawal by Subject|41
4498036|NCT00831441|7302441|FG001|Follow Up (30 Days)|Withdrawal by Subject|34
4498037|NCT00831441|7302440|FG000|Follow Up (30 Days)|Lost to Follow-up|13
4498038|NCT00831441|7302441|FG001|Follow Up (30 Days)|Lost to Follow-up|27
4498039|NCT00831441|7302440|FG000|Follow Up (30 Days)|Death|63
4498040|NCT00831441|7302441|FG001|Follow Up (30 Days)|Death|86
4387245|NCT00047879|7165881|FG000|Overall Study|Progressive disease|4
4498041|NCT00831441|7302440|FG000|Follow Up (30 Days)|non-specified|16
4498042|NCT00831441|7302441|FG001|Follow Up (30 Days)|non-specified|26
4498043|NCT00831441|7302440|FG000|Follow Up (30 Days)|missing end of study status|0
4498044|NCT00831441|7302441|FG001|Follow Up (30 Days)|missing end of study status|1
4498045|NCT00831493|7302452|FG000|Overall Study|Intractable nausea and vomiting|1
4498046|NCT00831701|7302467|FG000|Overall Study|Withdrawal by Subject|2
4498047|NCT00831701|7302468|FG001|Overall Study|Withdrawal by Subject|0
4498048|NCT00831701|7302467|FG000|Overall Study|Stone expulsion before first medication|2
4498049|NCT00831701|7302468|FG001|Overall Study|Stone expulsion before first medication|2
4498050|NCT00831701|7302467|FG000|Overall Study|Lost to Follow-up|1
4498051|NCT00831701|7302468|FG001|Overall Study|Lost to Follow-up|3
4498052|NCT00831779|7302495|FG000|Overall Study|Lost to Follow-up|1
4498053|NCT00831779|7302496|FG001|Overall Study|Lost to Follow-up|0
4498054|NCT00831779|7302495|FG000|Overall Study|No longer met criteria|0
4498055|NCT00831779|7302496|FG001|Overall Study|No longer met criteria|1
4498056|NCT00831792|7302502|FG000|Overall Study|Not Eligible|3
4498057|NCT00831792|7302502|FG000|Overall Study|Adverse Event|1
4498058|NCT00831792|7302502|FG000|Overall Study|Death|1
4498059|NCT00831792|7302502|FG000|Overall Study|Lack of Efficacy|1
4498060|NCT00831844|7302516|FG000|Overall Study|Adverse Event|2
4498061|NCT00831844|7302517|FG001|Overall Study|Adverse Event|0
4498062|NCT00831844|7302518|FG002|Overall Study|Adverse Event|0
4498063|NCT00831844|7302519|FG003|Overall Study|Adverse Event|0
4498064|NCT00831844|7302520|FG004|Overall Study|Adverse Event|1
4498065|NCT00831844|7302521|FG005|Overall Study|Adverse Event|1
4498066|NCT00831844|7302522|FG006|Overall Study|Adverse Event|2
4498067|NCT00831844|7302523|FG007|Overall Study|Adverse Event|0
4387246|NCT00047879|7165882|FG001|Overall Study|Progressive disease|3
4498068|NCT00831844|7302524|FG008|Overall Study|Adverse Event|0
4498069|NCT00831844|7302525|FG009|Overall Study|Adverse Event|0
4498070|NCT00831844|7302516|FG000|Overall Study|Death|0
4498071|NCT00831844|7302517|FG001|Overall Study|Death|0
4498072|NCT00831844|7302518|FG002|Overall Study|Death|0
4498073|NCT00831844|7302519|FG003|Overall Study|Death|1
4498074|NCT00831844|7302520|FG004|Overall Study|Death|0
4498075|NCT00831844|7302521|FG005|Overall Study|Death|0
4498076|NCT00831844|7302522|FG006|Overall Study|Death|0
4498077|NCT00831844|7302523|FG007|Overall Study|Death|0
4498078|NCT00831844|7302524|FG008|Overall Study|Death|0
4498079|NCT00831844|7302525|FG009|Overall Study|Death|0
4498080|NCT00831844|7302516|FG000|Overall Study|Lack of Efficacy|8
4498081|NCT00831844|7302517|FG001|Overall Study|Lack of Efficacy|10
4498082|NCT00831844|7302518|FG002|Overall Study|Lack of Efficacy|15
4498083|NCT00831844|7302519|FG003|Overall Study|Lack of Efficacy|8
4498084|NCT00831844|7302520|FG004|Overall Study|Lack of Efficacy|11
4498085|NCT00831844|7302521|FG005|Overall Study|Lack of Efficacy|17
4498086|NCT00831844|7302522|FG006|Overall Study|Lack of Efficacy|8
4498087|NCT00831844|7302523|FG007|Overall Study|Lack of Efficacy|9
4498088|NCT00831844|7302524|FG008|Overall Study|Lack of Efficacy|7
4498089|NCT00831844|7302525|FG009|Overall Study|Lack of Efficacy|0
4498090|NCT00831844|7302516|FG000|Overall Study|Physician Decision|0
4498091|NCT00831844|7302517|FG001|Overall Study|Physician Decision|1
4498092|NCT00831844|7302518|FG002|Overall Study|Physician Decision|3
4498093|NCT00831844|7302519|FG003|Overall Study|Physician Decision|1
4498094|NCT00831844|7302520|FG004|Overall Study|Physician Decision|1
4498095|NCT00831844|7302521|FG005|Overall Study|Physician Decision|1
4498096|NCT00831844|7302522|FG006|Overall Study|Physician Decision|0
4498097|NCT00831844|7302523|FG007|Overall Study|Physician Decision|0
4498098|NCT00831844|7302524|FG008|Overall Study|Physician Decision|1
4498099|NCT00831844|7302525|FG009|Overall Study|Physician Decision|0
4498100|NCT00831844|7302516|FG000|Overall Study|Withdrawal by Subject|0
4498101|NCT00831844|7302517|FG001|Overall Study|Withdrawal by Subject|0
4498102|NCT00831844|7302518|FG002|Overall Study|Withdrawal by Subject|1
4498103|NCT00831844|7302519|FG003|Overall Study|Withdrawal by Subject|0
4498104|NCT00831844|7302520|FG004|Overall Study|Withdrawal by Subject|0
4498105|NCT00831844|7302521|FG005|Overall Study|Withdrawal by Subject|0
4498106|NCT00831844|7302522|FG006|Overall Study|Withdrawal by Subject|0
4498107|NCT00831844|7302523|FG007|Overall Study|Withdrawal by Subject|1
4498108|NCT00831844|7302524|FG008|Overall Study|Withdrawal by Subject|1
4498109|NCT00831844|7302525|FG009|Overall Study|Withdrawal by Subject|0
4498110|NCT00831844|7302516|FG000|Overall Study|Ineligible|0
4498111|NCT00831844|7302517|FG001|Overall Study|Ineligible|1
4498112|NCT00831844|7302518|FG002|Overall Study|Ineligible|1
4498113|NCT00831844|7302519|FG003|Overall Study|Ineligible|0
4498114|NCT00831844|7302520|FG004|Overall Study|Ineligible|1
4498115|NCT00831844|7302521|FG005|Overall Study|Ineligible|0
4498116|NCT00831844|7302522|FG006|Overall Study|Ineligible|0
4498117|NCT00831844|7302523|FG007|Overall Study|Ineligible|0
4498118|NCT00831844|7302524|FG008|Overall Study|Ineligible|0
4498119|NCT00831844|7302525|FG009|Overall Study|Ineligible|0
4498120|NCT00832000|7302556|FG000|Overall Study|Adverse Event|2
4498121|NCT00832000|7302557|FG001|Overall Study|Adverse Event|0
4498122|NCT00832000|7302556|FG000|Overall Study|Withdrawal by Subject|1
4498123|NCT00832000|7302557|FG001|Overall Study|Withdrawal by Subject|0
4498124|NCT00832000|7302556|FG000|Overall Study|No calls to IVR in either period|1
4498125|NCT00832000|7302557|FG001|Overall Study|No calls to IVR in either period|1
4498126|NCT00832000|7302556|FG000|Overall Study|No calls to IVR in period 2|2
4498127|NCT00832000|7302557|FG001|Overall Study|No calls to IVR in period 2|0
4498128|NCT00832078|7302592|FG000|Test Day 1-2 Period|Lack of Efficacy|0
4498129|NCT00832078|7302593|FG001|Test Day 1-2 Period|Lack of Efficacy|2
4498130|NCT00832078|7302592|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1
4498131|NCT00832078|7302593|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0
4498132|NCT00832091|7302601|FG000|Overall Study|Adverse Event|1
4498133|NCT00832091|7302602|FG001|Overall Study|Adverse Event|1
4498134|NCT00832091|7302601|FG000|Overall Study|Protocol Violation|1
4498135|NCT00832091|7302602|FG001|Overall Study|Protocol Violation|0
4498136|NCT00832091|7302601|FG000|Overall Study|Withdrawal by Subject|2
4498137|NCT00832091|7302602|FG001|Overall Study|Withdrawal by Subject|1
4498138|NCT00832091|7302601|FG000|Overall Study|Prohibited Medication|1
4498139|NCT00832091|7302602|FG001|Overall Study|Prohibited Medication|0
4498140|NCT00832117|7302610|FG000|Overall Study|Death|1
4498141|NCT00832117|7302610|FG000|Overall Study|Disease Progression|11
4498142|NCT00832377|7302634|FG000|Overall Study|Protocol Violation|1
4498143|NCT00832416|7302655|FG000|Overall Study|Lack of Efficacy|17
4498144|NCT00832416|7302656|FG001|Overall Study|Lack of Efficacy|15
4498145|NCT00832416|7302657|FG002|Overall Study|Lack of Efficacy|13
4498146|NCT00832416|7302658|FG003|Overall Study|Lack of Efficacy|52
4498147|NCT00832416|7302655|FG000|Overall Study|Withdrawal by Subject|5
4498148|NCT00832416|7302656|FG001|Overall Study|Withdrawal by Subject|7
4498149|NCT00832416|7302657|FG002|Overall Study|Withdrawal by Subject|2
4498150|NCT00832416|7302658|FG003|Overall Study|Withdrawal by Subject|10
4498151|NCT00832416|7302655|FG000|Overall Study|Physician Decision|2
4498152|NCT00832416|7302656|FG001|Overall Study|Physician Decision|12
4498153|NCT00832416|7302657|FG002|Overall Study|Physician Decision|5
4498154|NCT00832416|7302658|FG003|Overall Study|Physician Decision|10
4498155|NCT00832416|7302655|FG000|Overall Study|Administrative|0
4498156|NCT00832416|7302656|FG001|Overall Study|Administrative|0
4498157|NCT00832416|7302657|FG002|Overall Study|Administrative|0
4498158|NCT00832416|7302658|FG003|Overall Study|Administrative|1
4498159|NCT00832416|7302655|FG000|Overall Study|Adverse Event|21
4498160|NCT00832416|7302656|FG001|Overall Study|Adverse Event|19
4498161|NCT00832416|7302657|FG002|Overall Study|Adverse Event|41
4498162|NCT00832416|7302658|FG003|Overall Study|Adverse Event|10
4498163|NCT00832416|7302655|FG000|Overall Study|Death|1
4498164|NCT00832416|7302656|FG001|Overall Study|Death|0
4498165|NCT00832416|7302657|FG002|Overall Study|Death|0
4498166|NCT00832416|7302658|FG003|Overall Study|Death|0
4498167|NCT00832585|7302668|FG000|Overall Study|Withdrawal by Subject|1
4498168|NCT00832585|7302668|FG000|Overall Study|Lost to Follow-up|1
4498169|NCT00832650|7302679|FG000|Overall Study|Randomized but not treated|0
4498170|NCT00832650|7302680|FG001|Overall Study|Randomized but not treated|0
4498171|NCT00832650|7302681|FG002|Overall Study|Randomized but not treated|1
4498172|NCT00832780|7302700|FG000|Overall Study|Death|16
4498173|NCT00832780|7302700|FG000|Overall Study|Lost to Follow-up|4
4498174|NCT00832780|7302700|FG000|Overall Study|no reason given|2
4498175|NCT00832780|7302700|FG000|Overall Study|other complicating condition|2
4498176|NCT00832780|7302700|FG000|Overall Study|Physician Decision|1
4498177|NCT00832819|7302707|FG000|Overall Study|Adverse Event|0
4498178|NCT00832819|7302708|FG001|Overall Study|Adverse Event|1
4498179|NCT00832819|7302709|FG002|Overall Study|Adverse Event|0
4498180|NCT00832819|7302707|FG000|Overall Study|Protocol Violation|0
4498181|NCT00832819|7302708|FG001|Overall Study|Protocol Violation|0
4498182|NCT00832819|7302709|FG002|Overall Study|Protocol Violation|1
4498183|NCT00832975|7302719|FG000|Overall Study|Lost to Follow-up|7
4498184|NCT00832975|7302719|FG000|Overall Study|Protocol Violation|6
4498185|NCT00832975|7302719|FG000|Overall Study|Death|5
4498186|NCT00832975|7302719|FG000|Overall Study|Physician Decision|4
4498187|NCT00832975|7302719|FG000|Overall Study|Withdrawal by Subject|3
4498188|NCT00832975|7302719|FG000|Overall Study|Other reasons|14
4498189|NCT00833027|7302723|FG000|Overall Study|Adverse Event|33
4498190|NCT00833027|7302723|FG000|Overall Study|Death|1
4498191|NCT00833027|7302723|FG000|Overall Study|Lack of Efficacy|12
4498192|NCT00833027|7302723|FG000|Overall Study|Lost to Follow-up|24
4498193|NCT00833027|7302723|FG000|Overall Study|Protocol Violation|115
4498194|NCT00833027|7302723|FG000|Overall Study|Withdrawal by Subject|16
4498195|NCT00833027|7302723|FG000|Overall Study|Missing|10
4498196|NCT00833040|7302727|FG000|Overall Study|Adverse Event|0
4498197|NCT00833040|7302728|FG001|Overall Study|Adverse Event|0
4498198|NCT00833040|7302729|FG002|Overall Study|Adverse Event|0
4498199|NCT00833040|7302730|FG003|Overall Study|Adverse Event|0
4498200|NCT00833040|7302731|FG004|Overall Study|Adverse Event|0
4498201|NCT00833040|7302732|FG005|Overall Study|Adverse Event|1
4498202|NCT00833053|7302739|FG000|Overall Study|Adverse Event|4
4498203|NCT00833053|7302740|FG001|Overall Study|Adverse Event|0
4498204|NCT00833053|7302739|FG000|Overall Study|Treatment Failure|3
4498205|NCT00833053|7302740|FG001|Overall Study|Treatment Failure|1
4498206|NCT00833053|7302739|FG000|Overall Study|Withdrawal by Subject|0
4498207|NCT00833053|7302740|FG001|Overall Study|Withdrawal by Subject|1
4498208|NCT00833053|7302739|FG000|Overall Study|Protocol Violation|2
4498209|NCT00833053|7302740|FG001|Overall Study|Protocol Violation|1
4498210|NCT00833092|7302748|FG000|Overall Study|Withdrawal by Subject|2
4498211|NCT00833092|7302749|FG001|Overall Study|Withdrawal by Subject|3
4498212|NCT00833092|7302748|FG000|Overall Study|Protocol Violation|2
4498213|NCT00833092|7302749|FG001|Overall Study|Protocol Violation|1
4498214|NCT00833092|7302748|FG000|Overall Study|Diarrhea|0
4498215|NCT00833092|7302749|FG001|Overall Study|Diarrhea|2
4498216|NCT00833092|7302748|FG000|Overall Study|constipation|0
4498217|NCT00833092|7302749|FG001|Overall Study|constipation|1
4498218|NCT00833105|7302755|FG000|Overall Study|Withdrawal by Subject|1
4498219|NCT00833105|7302755|FG000|Overall Study|Adverse Event|2
4498220|NCT00833248|7302763|FG000|Overall Study|Adverse Event|3
4498221|NCT00833248|7302764|FG001|Overall Study|Adverse Event|0
4498222|NCT00833248|7302763|FG000|Overall Study|Protocol Violation|1
4498223|NCT00833248|7302764|FG001|Overall Study|Protocol Violation|2
4498224|NCT00833248|7302763|FG000|Overall Study|Withdrawal by Subject|0
4498225|NCT00833248|7302764|FG001|Overall Study|Withdrawal by Subject|1
4498226|NCT00833261|7302770|FG000|Overall Study|Withdrawal by Subject|4
4498227|NCT00833417|7302785|FG000|Overall Study|Adverse Event|5
4498228|NCT00833417|7302786|FG001|Overall Study|Adverse Event|16
4498229|NCT00833417|7302785|FG000|Overall Study|Death|1
4498230|NCT00833417|7302786|FG001|Overall Study|Death|3
4498231|NCT00833417|7302785|FG000|Overall Study|Lost to Follow-up|1
4498232|NCT00833417|7302786|FG001|Overall Study|Lost to Follow-up|2
4498233|NCT00833417|7302785|FG000|Overall Study|Physician Decision to Withdraw Patient|3
4498234|NCT00833417|7302786|FG001|Overall Study|Physician Decision to Withdraw Patient|7
4498235|NCT00833417|7302785|FG000|Overall Study|Patient Decision to Withdraw|4
4498236|NCT00833417|7302786|FG001|Overall Study|Patient Decision to Withdraw|23
4498237|NCT00833417|7302785|FG000|Overall Study|Sponsor Decision to Terminate Study|1
4498238|NCT00833417|7302786|FG001|Overall Study|Sponsor Decision to Terminate Study|2
4498239|NCT00833417|7302785|FG000|Overall Study|Disease Progression|18
4498240|NCT00833417|7302786|FG001|Overall Study|Disease Progression|17
4498241|NCT00833417|7302785|FG000|Overall Study|Reason Not Specified|0
4498242|NCT00833417|7302786|FG001|Overall Study|Reason Not Specified|1
4498243|NCT00833469|7302804|FG000|Overall Study|Withdrawal by Subject|1
4498244|NCT00833469|7302804|FG000|Overall Study|Lost to Follow-up|1
4498245|NCT00833482|7302810|FG000|Days 11-20|Adverse Event|0
4498246|NCT00833482|7302811|FG001|Days 11-20|Adverse Event|2
4498247|NCT00833482|7302812|FG002|Days 11-20|Adverse Event|0
4498248|NCT00833482|7302813|FG003|Days 11-20|Adverse Event|0
4498249|NCT00833482|7302814|FG004|Days 11-20|Adverse Event|0
4498250|NCT00833482|7302815|FG005|Days 11-20|Adverse Event|0
4498251|NCT00833482|7302810|FG000|Days 11-20|Withdrawal by Subject|0
4498252|NCT00833482|7302811|FG001|Days 11-20|Withdrawal by Subject|1
4498253|NCT00833482|7302812|FG002|Days 11-20|Withdrawal by Subject|0
4498254|NCT00833482|7302813|FG003|Days 11-20|Withdrawal by Subject|0
4498255|NCT00833482|7302814|FG004|Days 11-20|Withdrawal by Subject|0
4498256|NCT00833482|7302815|FG005|Days 11-20|Withdrawal by Subject|0
4498257|NCT00833482|7302810|FG000|Days 21-30|Adverse Event|0
4498258|NCT00833482|7302811|FG001|Days 21-30|Adverse Event|0
4498259|NCT00833482|7302812|FG002|Days 21-30|Adverse Event|1
4498260|NCT00833482|7302813|FG003|Days 21-30|Adverse Event|0
4498261|NCT00833482|7302814|FG004|Days 21-30|Adverse Event|0
4498262|NCT00833482|7302815|FG005|Days 21-30|Adverse Event|0
4498263|NCT00833482|7302810|FG000|Days 21-30|Withdrawal by Subject|0
4498264|NCT00833482|7302811|FG001|Days 21-30|Withdrawal by Subject|0
4498265|NCT00833482|7302812|FG002|Days 21-30|Withdrawal by Subject|0
4498266|NCT00833482|7302813|FG003|Days 21-30|Withdrawal by Subject|0
4498267|NCT00833482|7302814|FG004|Days 21-30|Withdrawal by Subject|1
4498268|NCT00833482|7302815|FG005|Days 21-30|Withdrawal by Subject|0
4498269|NCT00833547|7302839|FG000|Overall Study|Withdrawal by Subject|2
4498270|NCT00833547|7302840|FG001|Overall Study|Withdrawal by Subject|2
4498271|NCT00833560|7302846|FG000|Overall Study|Toxicity|13
4498272|NCT00833560|7302846|FG000|Overall Study|Adverse Event|11
4498273|NCT00833560|7302846|FG000|Overall Study|Protocol Violation|6
4498274|NCT00833560|7302846|FG000|Overall Study|Lack of Efficacy|4
4498275|NCT00833560|7302846|FG000|Overall Study|Death|2
4498276|NCT00833560|7302846|FG000|Overall Study|Pregression of other disease|1
4498277|NCT00833560|7302846|FG000|Overall Study|Other|5
4498278|NCT00833638|7302853|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1
4498279|NCT00833638|7302854|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2
4498280|NCT00833638|7302855|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0
4498281|NCT00833638|7302853|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3
4498282|NCT00833638|7302854|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2
4498283|NCT00833638|7302855|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1
4498284|NCT00833638|7302853|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1
4498285|NCT00833638|7302854|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2
4498286|NCT00833638|7302855|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1
4498287|NCT00833638|7302853|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1
4498288|NCT00833638|7302854|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0
4498289|NCT00833638|7302855|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0
4498290|NCT00833638|7302853|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
4498291|NCT00833638|7302854|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
4498292|NCT00833638|7302855|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
4498293|NCT00833638|7302853|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0
4498294|NCT00833638|7302854|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0
4498295|NCT00833638|7302855|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2
4498296|NCT00833638|7302853|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1
4498297|NCT00833638|7302854|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1
4498298|NCT00833638|7302855|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2
4498299|NCT00833638|7302853|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1
4498300|NCT00833638|7302854|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2
4498301|NCT00833638|7302855|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0
4498302|NCT00833638|7302853|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0
4498303|NCT00833638|7302854|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1
4498304|NCT00833638|7302855|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2
4498305|NCT00833690|7302874|FG000|Overall Study|Withdrawal by Subject|1
4498306|NCT00833690|7302875|FG001|Overall Study|Withdrawal by Subject|0
4498307|NCT00833690|7302876|FG002|Overall Study|Withdrawal by Subject|0
4498308|NCT00833690|7302874|FG000|Overall Study|Discontinued study drug|3
4498309|NCT00833690|7302875|FG001|Overall Study|Discontinued study drug|2
4498310|NCT00833690|7302876|FG002|Overall Study|Discontinued study drug|0
4498311|NCT00833703|7302886|FG000|Overall Study|Parent(s)/guardian(s)'s request|0
4498312|NCT00833703|7302887|FG001|Overall Study|Parent(s)/guardian(s)'s request|1
4498313|NCT00833755|7302897|FG000|Overall Study|Physician Decision|4
4498314|NCT00833755|7302898|FG001|Overall Study|Physician Decision|4
4498315|NCT00833755|7302899|FG002|Overall Study|Physician Decision|2
4498316|NCT00833755|7302900|FG003|Overall Study|Physician Decision|6
4498317|NCT00833755|7302897|FG000|Overall Study|Subject had scheduling issues|0
4498318|NCT00833755|7302898|FG001|Overall Study|Subject had scheduling issues|1
4498319|NCT00833755|7302899|FG002|Overall Study|Subject had scheduling issues|0
4498320|NCT00833755|7302900|FG003|Overall Study|Subject had scheduling issues|0
4498321|NCT00833794|7302921|FG000|Open-label Phase|Adverse Event|225
4498322|NCT00833794|7302922|FG001|Open-label Phase|Adverse Event|0
4498323|NCT00833794|7302921|FG000|Open-label Phase|Lack of Efficacy|28
4498324|NCT00833794|7302922|FG001|Open-label Phase|Lack of Efficacy|0
4498325|NCT00833794|7302921|FG000|Open-label Phase|Withdrawal by Subject|48
4498326|NCT00833794|7302922|FG001|Open-label Phase|Withdrawal by Subject|0
4498327|NCT00833794|7302921|FG000|Open-label Phase|Physician Decision|20
4498328|NCT00833794|7302922|FG001|Open-label Phase|Physician Decision|0
4498329|NCT00833794|7302921|FG000|Open-label Phase|Administrative reason|1
4498330|NCT00833794|7302922|FG001|Open-label Phase|Administrative reason|0
4498331|NCT00833794|7302921|FG000|Open-label Phase|Protocol Violation|47
4498332|NCT00833794|7302922|FG001|Open-label Phase|Protocol Violation|0
4498333|NCT00833794|7302921|FG000|Open-label Phase|Did not complete wash-out period|12
4498334|NCT00833794|7302922|FG001|Open-label Phase|Did not complete wash-out period|0
4498335|NCT00833794|7302921|FG000|Open-label Phase|enrolled in error (immediately D/C)|1
4498336|NCT00833794|7302922|FG001|Open-label Phase|enrolled in error (immediately D/C)|0
4498337|NCT00833794|7302921|FG000|Double-blind Phase|Adverse Event|44
4498338|NCT00833794|7302922|FG001|Double-blind Phase|Adverse Event|11
4498339|NCT00833794|7302921|FG000|Double-blind Phase|Lack of Efficacy|34
4498340|NCT00833794|7302922|FG001|Double-blind Phase|Lack of Efficacy|22
4498341|NCT00833794|7302921|FG000|Double-blind Phase|Withdrawal by Subject|23
4498342|NCT00833794|7302922|FG001|Double-blind Phase|Withdrawal by Subject|6
4498343|NCT00833794|7302921|FG000|Double-blind Phase|Physician Decision|4
4498344|NCT00833794|7302922|FG001|Double-blind Phase|Physician Decision|7
4498345|NCT00833794|7302921|FG000|Double-blind Phase|Administrative reason|1
4498346|NCT00833794|7302922|FG001|Double-blind Phase|Administrative reason|3
4498347|NCT00833833|7302936|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0
4498348|NCT00833833|7302937|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0
4498349|NCT00833833|7302938|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2
4498350|NCT00833833|7302939|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2
4498351|NCT00833833|7302940|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0
4498352|NCT00833833|7302941|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0
4498353|NCT00833833|7302936|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1
4498354|NCT00833833|7302937|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1
4498355|NCT00833833|7302938|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2
4498356|NCT00833833|7302939|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2
4498357|NCT00833833|7302940|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0
4498358|NCT00833833|7302941|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0
4498359|NCT00833833|7302936|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1
4498360|NCT00833833|7302937|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0
4498361|NCT00833833|7302938|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2
4498362|NCT00833833|7302939|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1
4498363|NCT00833833|7302940|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0
4498364|NCT00833833|7302941|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0
4498365|NCT00833833|7302936|FG000|Phase 1 (as of 01 April 2011)|Death|0
4498366|NCT00833833|7302937|FG001|Phase 1 (as of 01 April 2011)|Death|1
4703594|NCT02735096|7621464|FG000|Overall Study|No symptoms in clinic/personal leave|1
4703595|NCT02735200|7621489|FG000|Overall Study|Lost to Follow-up|0
4703596|NCT02735200|7621490|FG001|Overall Study|Lost to Follow-up|5
4703597|NCT02735200|7621489|FG000|Overall Study|Withdrawal by Subject|8
4703598|NCT02735200|7621490|FG001|Overall Study|Withdrawal by Subject|0
4703599|NCT02735421|7621513|FG000|Overall Study|Adverse Event|2
4703600|NCT02735421|7621513|FG000|Overall Study|Withdrawal by Subject|6
4703601|NCT02735421|7621513|FG000|Overall Study|Lost to Follow-up|3
4703602|NCT02735421|7621513|FG000|Overall Study|Inadequate compliance to treatment|1
4703603|NCT02735421|7621513|FG000|Overall Study|Pregnancy|1
4735421|NCT03528551|7683408|FG002|Overall Study|Protocol Violation|0
4735422|NCT03528551|7683406|FG000|Overall Study|Withdrawal by Subject|0
4735423|NCT03528551|7683407|FG001|Overall Study|Withdrawal by Subject|7
4735424|NCT03528551|7683408|FG002|Overall Study|Withdrawal by Subject|0
4735425|NCT03528577|7683417|FG000|Sequence 1|Failed Spirometry|1
4735426|NCT03528577|7683417|FG000|Sequence 1|Restricted medication|1
4735427|NCT03528577|7683417|FG000|Sequence 2|Adverse Event|1
4735428|NCT03528577|7683417|FG000|Sequence 2|Withdrawal by Subject|1
4735429|NCT03528577|7683417|FG000|Sequence 2|Failed Spirometry|1
4735430|NCT03528577|7683417|FG000|Sequence 3|Failed Spirometry|1
4735431|NCT03528577|7683417|FG000|Sequence 4|Failed Spirometry|2
4735432|NCT03528577|7683417|FG000|Sequence 4|Adverse Event|1
4735433|NCT03529162|7683426|FG000|Overall Study|Lost to Follow-up|2
4735434|NCT03529162|7683427|FG001|Overall Study|Lost to Follow-up|2
4735435|NCT03529409|7683438|FG000|Randomized|Lost to Follow-up|0
4735436|NCT03529409|7683439|FG001|Randomized|Lost to Follow-up|0
4735437|NCT03529409|7683440|FG002|Randomized|Lost to Follow-up|4
4735438|NCT03529409|7683438|FG000|Randomized|Excluded|0
4735439|NCT03529409|7683439|FG001|Randomized|Excluded|0
4735440|NCT03529409|7683440|FG002|Randomized|Excluded|1
4735441|NCT03529409|7683438|FG000|Post-treatment Assessment|Death|1
4735442|NCT03529409|7683439|FG001|Post-treatment Assessment|Death|0
4735443|NCT03529409|7683440|FG002|Post-treatment Assessment|Death|0
4735444|NCT03529409|7683438|FG000|Post-treatment Assessment|Lost to Follow-up|1
4735445|NCT03529409|7683439|FG001|Post-treatment Assessment|Lost to Follow-up|1
4735446|NCT03529409|7683440|FG002|Post-treatment Assessment|Lost to Follow-up|0
4735447|NCT03529409|7683438|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2
4771247|NCT02978781|7748153|FG002|Part B|Withdrawal by Subject|0
4498367|NCT00833833|7302938|FG002|Phase 1 (as of 01 April 2011)|Death|2
4498368|NCT00833833|7302939|FG003|Phase 1 (as of 01 April 2011)|Death|0
4498369|NCT00833833|7302940|FG004|Phase 1 (as of 01 April 2011)|Death|0
4498370|NCT00833833|7302941|FG005|Phase 1 (as of 01 April 2011)|Death|0
4498371|NCT00833833|7302936|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1
4498372|NCT00833833|7302937|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
4498373|NCT00833833|7302938|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1
4498374|NCT00833833|7302939|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
4498375|NCT00833833|7302940|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
4498376|NCT00833833|7302941|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
4498377|NCT00833833|7302936|FG000|Phase 1 (as of 01 April 2011)|Other|1
4498378|NCT00833833|7302937|FG001|Phase 1 (as of 01 April 2011)|Other|3
4498379|NCT00833833|7302938|FG002|Phase 1 (as of 01 April 2011)|Other|0
4498380|NCT00833833|7302939|FG003|Phase 1 (as of 01 April 2011)|Other|1
4498381|NCT00833833|7302940|FG004|Phase 1 (as of 01 April 2011)|Other|0
4498382|NCT00833833|7302941|FG005|Phase 1 (as of 01 April 2011)|Other|0
4498383|NCT00833833|7302936|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0
4498384|NCT00833833|7302937|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0
4498385|NCT00833833|7302938|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0
4498386|NCT00833833|7302939|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0
4498387|NCT00833833|7302940|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23
4498388|NCT00833833|7302941|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22
4498389|NCT00833833|7302936|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0
4498390|NCT00833833|7302937|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0
4498391|NCT00833833|7302938|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0
4498392|NCT00833833|7302939|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0
4498393|NCT00833833|7302940|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8
4498394|NCT00833833|7302941|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13
4498395|NCT00833833|7302936|FG000|Phase 2 (as of 01 April 2011)|Death|0
4498396|NCT00833833|7302937|FG001|Phase 2 (as of 01 April 2011)|Death|0
4498397|NCT00833833|7302938|FG002|Phase 2 (as of 01 April 2011)|Death|0
4498398|NCT00833833|7302939|FG003|Phase 2 (as of 01 April 2011)|Death|0
4498399|NCT00833833|7302940|FG004|Phase 2 (as of 01 April 2011)|Death|8
4498400|NCT00833833|7302941|FG005|Phase 2 (as of 01 April 2011)|Death|9
4498401|NCT00833833|7302936|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
4498402|NCT00833833|7302937|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
4498403|NCT00833833|7302938|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
4498404|NCT00833833|7302939|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
4498405|NCT00833833|7302940|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7
4498406|NCT00833833|7302941|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6
4498407|NCT00833833|7302936|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
4498408|NCT00833833|7302937|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
4498409|NCT00833833|7302938|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
4498410|NCT00833833|7302939|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
4498411|NCT00833833|7302940|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5
4498412|NCT00833833|7302941|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7
4498413|NCT00833833|7302936|FG000|Phase 2 (as of 01 April 2011)|Other|0
4498414|NCT00833833|7302937|FG001|Phase 2 (as of 01 April 2011)|Other|0
4498415|NCT00833833|7302938|FG002|Phase 2 (as of 01 April 2011)|Other|0
4498416|NCT00833833|7302939|FG003|Phase 2 (as of 01 April 2011)|Other|0
4498417|NCT00833833|7302940|FG004|Phase 2 (as of 01 April 2011)|Other|4
4498418|NCT00833833|7302941|FG005|Phase 2 (as of 01 April 2011)|Other|3
4498419|NCT00833833|7302936|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
4498420|NCT00833833|7302937|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
4498421|NCT00833833|7302938|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
4498422|NCT00833833|7302939|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
4498423|NCT00833833|7302940|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
4498424|NCT00833833|7302941|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1
4498425|NCT00833898|7302963|FG000|Overall Study|Withdrawal by Subject|33
4498426|NCT00833898|7302964|FG001|Overall Study|Withdrawal by Subject|27
4498427|NCT00833898|7302963|FG000|Overall Study|Lost to Follow-up|7
4498428|NCT00833898|7302964|FG001|Overall Study|Lost to Follow-up|7
4498429|NCT00833898|7302963|FG000|Overall Study|Patient did not receive transplant|0
4498430|NCT00833898|7302964|FG001|Overall Study|Patient did not receive transplant|2
4498431|NCT00833911|7302970|FG000|Titration|Adverse Event|18
4498432|NCT00833911|7302970|FG000|Titration|Withdrawal by Subject|3
4498433|NCT00833911|7302970|FG000|Maintenance Phase I|Adverse Event|73
4498434|NCT00833911|7302970|FG000|Maintenance Phase I|Withdrawal by Subject|11
4498435|NCT00833911|7302970|FG000|Maintenance Phase I|Physician Decision|10
4498436|NCT00833911|7302970|FG000|Maintenance Phase I|Lack of Efficacy|4
4498437|NCT00833911|7302970|FG000|Maintenance Phase II|Adverse Event|6
4498438|NCT00833911|7302970|FG000|Maintenance Phase II|Physician Decision|2
4703604|NCT02735577|7621533|FG000|Disulfiram Treatment|Lost to Follow-up|1
4703605|NCT02735577|7621533|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2
4703606|NCT02735915|7621550|FG000|Overall Study|Not vaccinated but subject ID assigned|8
4498439|NCT00833911|7302970|FG000|Maintenance Phase II|Withdrawal by Subject|1
4498440|NCT00833911|7302970|FG000|Maintenance Phase II|Lack of Efficacy|1
4498441|NCT00833924|7302978|FG000|Overall Study|Death|21
4498442|NCT00833924|7302978|FG000|Overall Study|Conversion|2
4498443|NCT00833924|7302978|FG000|Overall Study|Lost to Follow-up|2
4498444|NCT00833924|7302978|FG000|Overall Study|Withdrawal by Subject|13
4498445|NCT00833924|7302978|FG000|Overall Study|In study follow-up|71
4498446|NCT00833976|7302982|FG000|Overall Study|Withdrawal by Subject|5
4498447|NCT00833976|7302982|FG000|Overall Study|Lost to Follow-up|4
4498448|NCT00833976|7302982|FG000|Overall Study|Did not meet eligibility criteria|41
4498449|NCT00833976|7302982|FG000|Overall Study|Physician Decision|1
4498450|NCT00833989|7302990|FG000|Overall Study|Physician Decision|0
4498451|NCT00833989|7302991|FG001|Overall Study|Physician Decision|0
4498452|NCT00833989|7302992|FG002|Overall Study|Physician Decision|0
4498453|NCT00833989|7302993|FG003|Overall Study|Physician Decision|1
4498454|NCT00833989|7302990|FG000|Overall Study|Withdrawal by Subject|3
4498455|NCT00833989|7302991|FG001|Overall Study|Withdrawal by Subject|0
4498456|NCT00833989|7302992|FG002|Overall Study|Withdrawal by Subject|1
4498457|NCT00833989|7302993|FG003|Overall Study|Withdrawal by Subject|1
4498458|NCT00834041|7303008|FG000|Overall Study|Withdrawal by Subject|1
4498459|NCT00834041|7303009|FG001|Overall Study|Withdrawal by Subject|0
4498460|NCT00834041|7303008|FG000|Overall Study|Lost to Follow-up|0
4498461|NCT00834041|7303009|FG001|Overall Study|Lost to Follow-up|1
4498462|NCT00834080|7303015|FG000|Overall Study|Adverse Event|7
4498463|NCT00834080|7303015|FG000|Overall Study|Lost to Follow-up|7
4498464|NCT00834080|7303015|FG000|Overall Study|Withdrawal by Subject|5
4498465|NCT00834080|7303015|FG000|Overall Study|Other - Pregnancy|1
4498466|NCT00834080|7303015|FG000|Overall Study|Other - False positive tests of the UDS|1
4498467|NCT00834080|7303015|FG000|Overall Study|Physician Decision|1
4498468|NCT00834080|7303015|FG000|Overall Study|Subject Relocated|1
4498469|NCT00834366|7303066|FG000|Treatment Period 1|Adverse Event|1
4498470|NCT00834366|7303067|FG001|Treatment Period 1|Adverse Event|1
4498471|NCT00834834|7303117|FG000|Overall Study|Withdrawal by Subject|4
4498472|NCT00834834|7303118|FG001|Overall Study|Withdrawal by Subject|3
4498473|NCT00834899|7303143|FG000|Overall Study|Withdrawal by Subject|1
4498474|NCT00834899|7303144|FG001|Overall Study|Withdrawal by Subject|1
4498475|NCT00834912|7303156|FG000|Treatment Period 1|Adverse Event|0
4498476|NCT00834912|7303157|FG001|Treatment Period 1|Adverse Event|1
4498477|NCT00834912|7303158|FG002|Treatment Period 1|Adverse Event|0
4498478|NCT00834912|7303159|FG003|Treatment Period 1|Adverse Event|1
4498479|NCT00834912|7303160|FG004|Treatment Period 1|Adverse Event|0
4498480|NCT00834912|7303161|FG005|Treatment Period 1|Adverse Event|0
4498481|NCT00834912|7303156|FG000|Treatment Period 2|Withdrawal by Subject|0
4498482|NCT00834912|7303157|FG001|Treatment Period 2|Withdrawal by Subject|0
4498483|NCT00834912|7303158|FG002|Treatment Period 2|Withdrawal by Subject|1
4498484|NCT00834912|7303159|FG003|Treatment Period 2|Withdrawal by Subject|0
4498485|NCT00834912|7303160|FG004|Treatment Period 2|Withdrawal by Subject|1
4498486|NCT00834912|7303161|FG005|Treatment Period 2|Withdrawal by Subject|0
4498487|NCT00835068|7303180|FG000|Overall Study|Death|1
4498488|NCT00835068|7303181|FG001|Overall Study|Death|0
4498489|NCT00835068|7303180|FG000|Overall Study|Adverse Event|0
4498490|NCT00835068|7303181|FG001|Overall Study|Adverse Event|1
4498491|NCT00835068|7303180|FG000|Overall Study|Other|8
4498492|NCT00835068|7303181|FG001|Overall Study|Other|0
4498493|NCT00835068|7303180|FG000|Overall Study|Withdrawal by Subject|1
4498494|NCT00835068|7303181|FG001|Overall Study|Withdrawal by Subject|0
4498495|NCT00835120|7303187|FG000|Overall Study|Lack of Efficacy|1
4498496|NCT00835120|7303187|FG000|Overall Study|Lost to Follow-up|3
4498497|NCT00835120|7303187|FG000|Overall Study|Adverse Event|2
4498498|NCT00835120|7303187|FG000|Overall Study|Withdrawal by Subject|2
4498499|NCT00835237|7303230|FG000|Overall Study|Lost to Follow-up|4
4590304|NCT01519921|7436125|FG001|Overall Study|Treatment refusal|1
4590305|NCT01519921|7436124|FG000|Overall Study|High alanine aminotransferase (ALT)|0
4590306|NCT01519921|7436125|FG001|Overall Study|High alanine aminotransferase (ALT)|1
4590307|NCT01519934|7436131|FG000|Overall Study|Lost to Follow-up|3
4590308|NCT01519947|7436139|FG000|Overall Study|Death|0
4590309|NCT01519947|7436140|FG001|Overall Study|Death|0
4590310|NCT01519947|7436141|FG002|Overall Study|Death|0
4590311|NCT01519947|7436142|FG003|Overall Study|Death|1
4590312|NCT01519947|7436139|FG000|Overall Study|Protocol Violation|0
4590313|NCT01519947|7436140|FG001|Overall Study|Protocol Violation|0
4590314|NCT01519947|7436141|FG002|Overall Study|Protocol Violation|2
4590315|NCT01519947|7436142|FG003|Overall Study|Protocol Violation|1
4590316|NCT01519947|7436139|FG000|Overall Study|Peritoneal Dialysis Needed|0
4498500|NCT00835237|7303231|FG001|Overall Study|Lost to Follow-up|0
4498501|NCT00835237|7303230|FG000|Overall Study|Withdrawal by Subject|2
4498502|NCT00835237|7303231|FG001|Overall Study|Withdrawal by Subject|0
4517856|NCT00969709|7329774|FG002|Overall Study|Withdrawal by Subject|11
4517857|NCT00969709|7329775|FG003|Overall Study|Withdrawal by Subject|23
4517858|NCT00969709|7329772|FG000|Overall Study|Lost to Follow-up|10
4517859|NCT00969709|7329773|FG001|Overall Study|Lost to Follow-up|14
4517860|NCT00969709|7329774|FG002|Overall Study|Lost to Follow-up|8
4517861|NCT00969709|7329775|FG003|Overall Study|Lost to Follow-up|15
4517862|NCT00969709|7329772|FG000|Overall Study|Other reasons|0
4590317|NCT01519947|7436140|FG001|Overall Study|Peritoneal Dialysis Needed|1
4498503|NCT00835341|7303239|FG000|Overall Study|Lost to Follow-up|3
4498504|NCT00835341|7303240|FG001|Overall Study|Lost to Follow-up|12
4498505|NCT00835380|7303246|FG000|Overall Study|Withdrawal by Subject|2
4498506|NCT00835731|7303265|FG000|Overall Study|Withdrawal by Subject|1
4498507|NCT00835731|7303266|FG001|Overall Study|Withdrawal by Subject|0
4498508|NCT00835731|7303265|FG000|Overall Study|Physician Decision|1
4498509|NCT00835731|7303266|FG001|Overall Study|Physician Decision|1
4498510|NCT00835770|7303274|FG000|Overall Study|MS Relapse|17
4498511|NCT00835770|7303275|FG001|Overall Study|MS Relapse|23
4498512|NCT00835770|7303274|FG000|Overall Study|MS Progression|14
4498513|NCT00835770|7303275|FG001|Overall Study|MS Progression|9
4498514|NCT00835770|7303274|FG000|Overall Study|Adverse Event|113
4498515|NCT00835770|7303275|FG001|Overall Study|Adverse Event|124
4498516|NCT00835770|7303274|FG000|Overall Study|Lost to Follow-up|22
4498517|NCT00835770|7303275|FG001|Overall Study|Lost to Follow-up|19
4498518|NCT00835770|7303274|FG000|Overall Study|Consent Withdrawn|144
4498519|NCT00835770|7303275|FG001|Overall Study|Consent Withdrawn|156
4498520|NCT00835770|7303274|FG000|Overall Study|Investigator Decision|42
4498521|NCT00835770|7303275|FG001|Overall Study|Investigator Decision|42
4498522|NCT00835770|7303274|FG000|Overall Study|Participant Non-Compliance|11
4498523|NCT00835770|7303275|FG001|Overall Study|Participant Non-Compliance|9
4498524|NCT00835770|7303274|FG000|Overall Study|Death|4
4498525|NCT00835770|7303275|FG001|Overall Study|Death|6
4498526|NCT00835770|7303274|FG000|Overall Study|Other|115
4498527|NCT00835770|7303275|FG001|Overall Study|Other|104
4498528|NCT00835770|7303274|FG000|Overall Study|Other|2
4498529|NCT00835770|7303275|FG001|Overall Study|Other|1
4498530|NCT00835978|7303318|FG000|Overall Study|Death|33
4498531|NCT00835978|7303319|FG001|Overall Study|Death|40
4498532|NCT00835978|7303320|FG002|Overall Study|Death|49
4498533|NCT00835978|7303321|FG003|Overall Study|Death|4
4498534|NCT00835978|7303318|FG000|Overall Study|Lost to Follow-up|3
4498535|NCT00835978|7303319|FG001|Overall Study|Lost to Follow-up|4
4498536|NCT00835978|7303320|FG002|Overall Study|Lost to Follow-up|2
4498537|NCT00835978|7303321|FG003|Overall Study|Lost to Follow-up|1
4498538|NCT00835978|7303318|FG000|Overall Study|Other|5
4498539|NCT00835978|7303319|FG001|Overall Study|Other|1
4498540|NCT00835978|7303320|FG002|Overall Study|Other|8
4498541|NCT00835978|7303321|FG003|Overall Study|Other|0
4498542|NCT00835978|7303318|FG000|Overall Study|Objective progression or relapse|2
4498543|NCT00835978|7303319|FG001|Overall Study|Objective progression or relapse|0
4498544|NCT00835978|7303320|FG002|Overall Study|Objective progression or relapse|1
4498545|NCT00835978|7303321|FG003|Overall Study|Objective progression or relapse|0
4498546|NCT00835978|7303318|FG000|Overall Study|Adverse Event|1
4498547|NCT00835978|7303319|FG001|Overall Study|Adverse Event|0
4498548|NCT00835978|7303320|FG002|Overall Study|Adverse Event|1
4498549|NCT00835978|7303321|FG003|Overall Study|Adverse Event|0
4498550|NCT00835978|7303318|FG000|Overall Study|Withdrawal by Subject|0
4498551|NCT00835978|7303319|FG001|Overall Study|Withdrawal by Subject|3
4498552|NCT00835978|7303320|FG002|Overall Study|Withdrawal by Subject|0
4498553|NCT00835978|7303321|FG003|Overall Study|Withdrawal by Subject|5
4498554|NCT00835978|7303318|FG000|Overall Study|Study terminated by sponsor|12
4498555|NCT00835978|7303319|FG001|Overall Study|Study terminated by sponsor|8
4498556|NCT00835978|7303320|FG002|Overall Study|Study terminated by sponsor|30
4498557|NCT00835978|7303321|FG003|Overall Study|Study terminated by sponsor|0
4498558|NCT00836095|7303342|FG000|Overall Study|Physician Decision|0
4498559|NCT00836095|7303343|FG001|Overall Study|Physician Decision|3
4498560|NCT00836186|7303349|FG000|Overall Study|Blood could not be drawn|1
4498561|NCT00836277|7303354|FG000|Overall Study|Not evaluable for response|6
4498562|NCT00836498|7303395|FG000|Overall Study|Adverse Event|1
4498563|NCT00836498|7303396|FG001|Overall Study|Adverse Event|0
4498564|NCT00836498|7303395|FG000|Overall Study|Lost to Follow-up|1
4498565|NCT00836498|7303396|FG001|Overall Study|Lost to Follow-up|0
4498566|NCT00836498|7303395|FG000|Overall Study|Withdrawal by Subject|2
4498567|NCT00836498|7303396|FG001|Overall Study|Withdrawal by Subject|1
4498568|NCT00836589|7303403|FG000|Overall Study|Lost to Follow-up|246
4498569|NCT00836589|7303403|FG000|Overall Study|Death|429
4498570|NCT00836589|7303403|FG000|Overall Study|Withdrawal by Subject or Physician|591
4498571|NCT00836693|7303425|FG000|Overall Study|Adverse Event|4
4498572|NCT00836693|7303426|FG001|Overall Study|Adverse Event|1
4498573|NCT00836693|7303425|FG000|Overall Study|Sponsor Decision|0
4498574|NCT00836693|7303426|FG001|Overall Study|Sponsor Decision|1
4498575|NCT00836693|7303425|FG000|Overall Study|Physician Decision|2
4498576|NCT00836693|7303426|FG001|Overall Study|Physician Decision|0
4498577|NCT00836693|7303425|FG000|Overall Study|Withdrawal by Subject|9
4498578|NCT00836693|7303426|FG001|Overall Study|Withdrawal by Subject|4
4498579|NCT00836693|7303425|FG000|Overall Study|Protocol Violation|1
4498580|NCT00836693|7303426|FG001|Overall Study|Protocol Violation|0
4498581|NCT00836693|7303425|FG000|Overall Study|Lost to Follow-up|1
4498582|NCT00836693|7303426|FG001|Overall Study|Lost to Follow-up|0
4498583|NCT00836745|7303436|FG000|Overall Study|Death|2
4498584|NCT00836745|7303436|FG000|Overall Study|Lost to Follow-up|10
4498585|NCT00836745|7303436|FG000|Overall Study|Adverse Event|3
4498586|NCT00836745|7303436|FG000|Overall Study|Objective progression or relapse|4
4498587|NCT00836745|7303436|FG000|Overall Study|Other|2
4498588|NCT00836810|7303448|FG000|Overall Study|New diagnosis|1
4498589|NCT00836810|7303449|FG001|Overall Study|New diagnosis|0
4498590|NCT00836875|7303457|FG000|Overall Study|Death|3
4498591|NCT00836875|7303458|FG001|Overall Study|Death|2
4498592|NCT00836875|7303457|FG000|Overall Study|Withdrawal by Subject|0
4498593|NCT00836875|7303458|FG001|Overall Study|Withdrawal by Subject|1
4498594|NCT00836927|7303486|FG000|Overall Study|Progressive disease|2
4498595|NCT00836927|7303487|FG001|Overall Study|Progressive disease|0
4498596|NCT00836927|7303488|FG002|Overall Study|Progressive disease|0
4498597|NCT00836927|7303489|FG003|Overall Study|Progressive disease|1
4387247|NCT00048035|7165894|FG000|Core Period|Early Withdrawals|4
4387248|NCT00048035|7165895|FG001|Core Period|Early Withdrawals|2
4387249|NCT00048035|7165896|FG002|Core Period|Early Withdrawals|1
4703607|NCT02735915|7621550|FG000|Overall Study|Withdrawal following SAE|2
4498598|NCT00836927|7303490|FG004|Overall Study|Progressive disease|1
4498599|NCT00836927|7303486|FG000|Overall Study|Withdrawal by Subject|1
4498600|NCT00836927|7303487|FG001|Overall Study|Withdrawal by Subject|0
4498601|NCT00836927|7303488|FG002|Overall Study|Withdrawal by Subject|0
4498602|NCT00836927|7303489|FG003|Overall Study|Withdrawal by Subject|0
4498603|NCT00836927|7303490|FG004|Overall Study|Withdrawal by Subject|0
4498604|NCT00836953|7303504|FG000|Overall Study|Withdrawal by Subject|1
4498605|NCT00836953|7303504|FG000|Overall Study|Lost to Follow-up|1
4498606|NCT00837096|7303514|FG000|Overall Study|Physician Decision|1
4498607|NCT00837096|7303515|FG001|Overall Study|Physician Decision|1
4498608|NCT00837096|7303514|FG000|Overall Study|Not reported|9
4498609|NCT00837096|7303515|FG001|Overall Study|Not reported|8
4498610|NCT00837148|7303521|FG000|Overall Study|Adverse Event|1
4498611|NCT00837148|7303521|FG000|Overall Study|Death|1
4498612|NCT00837161|7303525|FG000|Overall Study|refused hysterectomy|2
4498613|NCT00837213|7303535|FG000|Overall Study|Lost to Follow-up|3
4498614|NCT00837213|7303536|FG001|Overall Study|Lost to Follow-up|2
4498615|NCT00837213|7303535|FG000|Overall Study|Withdrawal by Subject|2
4498616|NCT00837213|7303536|FG001|Overall Study|Withdrawal by Subject|2
4498617|NCT00837213|7303535|FG000|Overall Study|not stated|1
4498618|NCT00837213|7303536|FG001|Overall Study|not stated|1
4498619|NCT00837330|7303548|FG000|Overall Study|Lost to Follow-up|1
4498620|NCT00837330|7303549|FG001|Overall Study|Lost to Follow-up|3
4498621|NCT00837434|7303557|FG000|Overall Study|Physician Decision|3
4498622|NCT00837434|7303558|FG001|Overall Study|Physician Decision|0
4498623|NCT00837434|7303557|FG000|Overall Study|Lost to Follow-up|1
4498624|NCT00837434|7303558|FG001|Overall Study|Lost to Follow-up|1
4498625|NCT00837434|7303557|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1
4498626|NCT00837434|7303558|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0
4498627|NCT00837434|7303557|FG000|Overall Study|Noncompliant|2
4498628|NCT00837434|7303558|FG001|Overall Study|Noncompliant|0
4498629|NCT00837434|7303557|FG000|Overall Study|Baseline assessments not done in time|1
4498630|NCT00837434|7303558|FG001|Overall Study|Baseline assessments not done in time|0
4498631|NCT00837434|7303557|FG000|Overall Study|Unable to obtain study drug|1
4498632|NCT00837434|7303558|FG001|Overall Study|Unable to obtain study drug|0
4498633|NCT00837473|7303569|FG000|Overall Study|Lost to Follow-up|1
4498634|NCT00837473|7303569|FG000|Overall Study|Withdrawal by Subject|2
4498635|NCT00837486|7303575|FG000|Blinded-treatment Phase|Physician Decision|1
4498636|NCT00837486|7303576|FG001|Blinded-treatment Phase|Physician Decision|0
4498637|NCT00837486|7303575|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2
4498638|NCT00837486|7303576|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0
4498639|NCT00837486|7303575|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2
4498640|NCT00837486|7303576|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0
4498641|NCT00837486|7303575|FG000|Long-term Follow-up Phase - Open Label|Death|1
4498642|NCT00837486|7303576|FG001|Long-term Follow-up Phase - Open Label|Death|0
4498643|NCT00837577|7303593|FG000|Double-blind Period|Clinical Adverse Event|1
4498644|NCT00837577|7303594|FG001|Double-blind Period|Clinical Adverse Event|0
4498645|NCT00837577|7303593|FG000|Double-blind Period|Withdrawal by Subject|1
4498646|NCT00837577|7303594|FG001|Double-blind Period|Withdrawal by Subject|0
4498647|NCT00837577|7303593|FG000|Open-label Period|Clinical Adverse Event|2
4498648|NCT00837577|7303594|FG001|Open-label Period|Clinical Adverse Event|2
4498649|NCT00837577|7303593|FG000|Open-label Period|Laboratory Adverse Event|0
4498650|NCT00837577|7303594|FG001|Open-label Period|Laboratory Adverse Event|1
4498651|NCT00837577|7303593|FG000|Open-label Period|Lack of Efficacy|4
4703608|NCT02735915|7621550|FG000|Overall Study|Withdrawal by Subject|1
4703609|NCT02735980|7621559|FG000|Overall Study|Adverse Event|0
4703610|NCT02735980|7621560|FG001|Overall Study|Adverse Event|4
4703611|NCT02735980|7621561|FG002|Overall Study|Adverse Event|1
4703612|NCT02735980|7621559|FG000|Overall Study|Death|5
4703613|NCT02735980|7621560|FG001|Overall Study|Death|4
4703614|NCT02735980|7621561|FG002|Overall Study|Death|0
4703615|NCT02735980|7621559|FG000|Overall Study|Physician Decision|3
4387250|NCT00048035|7165897|FG003|Core Period|Early Withdrawals|1
4498652|NCT00837577|7303594|FG001|Open-label Period|Lack of Efficacy|3
4498653|NCT00837577|7303593|FG000|Open-label Period|Withdrawal by Subject|1
4498654|NCT00837577|7303594|FG001|Open-label Period|Withdrawal by Subject|2
4498655|NCT00837577|7303593|FG000|Open-label Period|Other Reason|1
4498656|NCT00837577|7303594|FG001|Open-label Period|Other Reason|1
4498657|NCT00837616|7303616|FG000|Overall Study|Withdrawal by Subject|0
4498658|NCT00837616|7303617|FG001|Overall Study|Withdrawal by Subject|1
4387251|NCT00048035|7165898|FG004|Core Period|Early Withdrawals|1
4498659|NCT00837694|7303629|FG000|Overall Study|Lost to Follow-up|2
4498660|NCT00837694|7303630|FG001|Overall Study|Lost to Follow-up|0
4498661|NCT00837694|7303631|FG002|Overall Study|Lost to Follow-up|2
4498662|NCT00837694|7303632|FG003|Overall Study|Lost to Follow-up|1
4498663|NCT00837694|7303633|FG004|Overall Study|Lost to Follow-up|1
4498664|NCT00837694|7303634|FG005|Overall Study|Lost to Follow-up|1
4498665|NCT00837759|7303648|FG000|Overall Study|Protocol Violation|3
4498666|NCT00837759|7303648|FG000|Overall Study|Lost to Follow-up|1
4498667|NCT00837811|7303655|FG000|Overall Study|Adverse Event|4
4498668|NCT00837811|7303656|FG001|Overall Study|Adverse Event|6
4498669|NCT00837811|7303657|FG002|Overall Study|Adverse Event|0
4498670|NCT00837811|7303655|FG000|Overall Study|Death|1
4498671|NCT00837811|7303656|FG001|Overall Study|Death|1
4498672|NCT00837811|7303657|FG002|Overall Study|Death|0
4498673|NCT00837811|7303655|FG000|Overall Study|Lack of Efficacy|0
4498674|NCT00837811|7303656|FG001|Overall Study|Lack of Efficacy|11
4498675|NCT00837811|7303657|FG002|Overall Study|Lack of Efficacy|0
4498676|NCT00837811|7303655|FG000|Overall Study|Lost to Follow-up|1
4498677|NCT00837811|7303656|FG001|Overall Study|Lost to Follow-up|3
4498678|NCT00837811|7303657|FG002|Overall Study|Lost to Follow-up|0
4498679|NCT00837811|7303655|FG000|Overall Study|Physician Decision|0
4498680|NCT00837811|7303656|FG001|Overall Study|Physician Decision|2
4498681|NCT00837811|7303657|FG002|Overall Study|Physician Decision|1
4498682|NCT00837811|7303655|FG000|Overall Study|Withdrawal by Subject|1
4498683|NCT00837811|7303656|FG001|Overall Study|Withdrawal by Subject|9
4498684|NCT00837811|7303657|FG002|Overall Study|Withdrawal by Subject|0
4498685|NCT00837811|7303655|FG000|Overall Study|Sponsor Decision|0
4498686|NCT00837811|7303656|FG001|Overall Study|Sponsor Decision|2
4498687|NCT00837811|7303657|FG002|Overall Study|Sponsor Decision|0
4498688|NCT00837876|7303684|FG000|Overall Study|Death|2
4498689|NCT00837876|7303684|FG000|Overall Study|Adverse Event|7
4498690|NCT00837876|7303684|FG000|Overall Study|Physician Decision|1
4498691|NCT00837876|7303684|FG000|Overall Study|Withdrawal by Subject|3
4498692|NCT00837876|7303684|FG000|Overall Study|disease progression|24
4498693|NCT00837967|7303698|FG000|Washout Period of 7 - 14 Days|Adverse Event|2
4498694|NCT00837967|7303699|FG001|Washout Period of 7 - 14 Days|Adverse Event|0
4498695|NCT00838097|7303720|FG000|Overall Study|Ineligibility determined|6
4703616|NCT02735980|7621560|FG001|Overall Study|Physician Decision|1
4498696|NCT00838097|7303720|FG000|Overall Study|Adverse Event|2
4498697|NCT00838097|7303720|FG000|Overall Study|Withdrawal by Subject|3
4498698|NCT00838097|7303720|FG000|Overall Study|Requirement for alternative therapy|2
4498699|NCT00838097|7303720|FG000|Overall Study|Physician Decision|4
4498700|NCT00838097|7303720|FG000|Overall Study|Lost to Follow-up|11
4498701|NCT00838097|7303720|FG000|Overall Study|Death|6
4498702|NCT00838097|7303720|FG000|Overall Study|Protocol-specified criteria|142
4498703|NCT00838110|7303726|FG000|Overall Study|Death|0
4498704|NCT00838110|7303727|FG001|Overall Study|Death|0
4498705|NCT00838110|7303728|FG002|Overall Study|Death|1
4498706|NCT00838110|7303729|FG003|Overall Study|Death|2
4498707|NCT00838110|7303726|FG000|Overall Study|Adverse Event|11
4498708|NCT00838110|7303727|FG001|Overall Study|Adverse Event|10
4498709|NCT00838110|7303728|FG002|Overall Study|Adverse Event|8
4498710|NCT00838110|7303729|FG003|Overall Study|Adverse Event|7
4498711|NCT00838110|7303726|FG000|Overall Study|Withdrawal by Subject|5
4498712|NCT00838110|7303727|FG001|Overall Study|Withdrawal by Subject|6
4498713|NCT00838110|7303728|FG002|Overall Study|Withdrawal by Subject|3
4498714|NCT00838110|7303729|FG003|Overall Study|Withdrawal by Subject|4
4498715|NCT00838110|7303726|FG000|Overall Study|Other|3
4498716|NCT00838110|7303727|FG001|Overall Study|Other|3
4498717|NCT00838110|7303728|FG002|Overall Study|Other|3
4498718|NCT00838110|7303729|FG003|Overall Study|Other|2
4498719|NCT00838110|7303726|FG000|Overall Study|Protocol Violation|0
4498720|NCT00838110|7303727|FG001|Overall Study|Protocol Violation|2
4498721|NCT00838110|7303728|FG002|Overall Study|Protocol Violation|1
4498722|NCT00838110|7303729|FG003|Overall Study|Protocol Violation|1
4498723|NCT00838110|7303726|FG000|Overall Study|Lost to Follow-up|3
4498724|NCT00838110|7303727|FG001|Overall Study|Lost to Follow-up|0
4498725|NCT00838110|7303728|FG002|Overall Study|Lost to Follow-up|0
4498726|NCT00838110|7303729|FG003|Overall Study|Lost to Follow-up|0
4498727|NCT00838110|7303726|FG000|Overall Study|Did not meet eligibility criteria|0
4498728|NCT00838110|7303727|FG001|Overall Study|Did not meet eligibility criteria|0
4498729|NCT00838110|7303728|FG002|Overall Study|Did not meet eligibility criteria|1
4498730|NCT00838110|7303729|FG003|Overall Study|Did not meet eligibility criteria|2
4498731|NCT00838110|7303726|FG000|Overall Study|Randomized but not treated|0
4498732|NCT00838110|7303727|FG001|Overall Study|Randomized but not treated|1
4498733|NCT00838110|7303728|FG002|Overall Study|Randomized but not treated|0
4498734|NCT00838110|7303729|FG003|Overall Study|Randomized but not treated|0
4498735|NCT00838201|7303758|FG000|Overall Study|Investigator decision, or other reasons|2
4498736|NCT00838201|7303759|FG001|Overall Study|Investigator decision, or other reasons|3
4498737|NCT00838201|7303758|FG000|Overall Study|Noncompliance|0
4498738|NCT00838201|7303759|FG001|Overall Study|Noncompliance|1
4498739|NCT00838201|7303758|FG000|Overall Study|Administrative decision|1
4498740|NCT00838201|7303759|FG001|Overall Study|Administrative decision|2
4498741|NCT00838201|7303758|FG000|Overall Study|Disease progression|3
4498742|NCT00838201|7303759|FG001|Overall Study|Disease progression|3
4498743|NCT00838201|7303758|FG000|Overall Study|Consent withdrawn|16
4498744|NCT00838201|7303759|FG001|Overall Study|Consent withdrawn|19
4498745|NCT00838201|7303758|FG000|Overall Study|Lost to Follow-up|4
4498746|NCT00838201|7303759|FG001|Overall Study|Lost to Follow-up|3
4498747|NCT00838201|7303758|FG000|Overall Study|Adverse Event|5
4498748|NCT00838201|7303759|FG001|Overall Study|Adverse Event|9
4498749|NCT00838201|7303758|FG000|Overall Study|Death|11
4498750|NCT00838201|7303759|FG001|Overall Study|Death|13
4498751|NCT00838331|7303765|FG000|Aged Blood Transfusion|Withdrawal by Subject|9
4498752|NCT00838435|7303769|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1
4498753|NCT00838435|7303769|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2
4498754|NCT00838435|7303769|FG000|Part 2 (7 Years)|Adverse Event|2
4498755|NCT00838435|7303769|FG000|Part 2 (7 Years)|Lost to Follow-up|2
4498756|NCT00838435|7303769|FG000|Part 2 (7 Years)|Physician Decision|1
4498757|NCT00838435|7303769|FG000|Part 2 (7 Years)|Sponsor Decision|6
4498758|NCT00838435|7303769|FG000|Part 2 (7 Years)|Withdrawal by Subject|5
4498759|NCT00838513|7303776|FG000|Screening Period|Screen Failure|3
4498760|NCT00838513|7303776|FG000|Extension Treatment Period|Death|1
4498761|NCT00838513|7303776|FG000|Post Treatment Period (Patients Who Disc|Death|1
4498762|NCT00838539|7303792|FG000|Overall Study|Disease Progression|2
4498763|NCT00838539|7303793|FG001|Overall Study|Disease Progression|4
4498764|NCT00838539|7303794|FG002|Overall Study|Disease Progression|3
4498765|NCT00838539|7303795|FG003|Overall Study|Disease Progression|2
4498766|NCT00838539|7303796|FG004|Overall Study|Disease Progression|4
4498767|NCT00838539|7303797|FG005|Overall Study|Disease Progression|2
4498768|NCT00838539|7303798|FG006|Overall Study|Disease Progression|3
4498769|NCT00838539|7303799|FG007|Overall Study|Disease Progression|4
4498770|NCT00838539|7303800|FG008|Overall Study|Disease Progression|4
4498771|NCT00838539|7303801|FG009|Overall Study|Disease Progression|5
4498772|NCT00838539|7303802|FG010|Overall Study|Disease Progression|1
4498773|NCT00838539|7303803|FG011|Overall Study|Disease Progression|4
4498774|NCT00838539|7303792|FG000|Overall Study|Adverse Event|1
4498775|NCT00838539|7303793|FG001|Overall Study|Adverse Event|1
4498776|NCT00838539|7303794|FG002|Overall Study|Adverse Event|1
4498777|NCT00838539|7303795|FG003|Overall Study|Adverse Event|1
4498778|NCT00838539|7303796|FG004|Overall Study|Adverse Event|2
4498779|NCT00838539|7303797|FG005|Overall Study|Adverse Event|1
4498780|NCT00838539|7303798|FG006|Overall Study|Adverse Event|0
4498781|NCT00838539|7303799|FG007|Overall Study|Adverse Event|2
4498782|NCT00838539|7303800|FG008|Overall Study|Adverse Event|0
4498783|NCT00838539|7303801|FG009|Overall Study|Adverse Event|1
4498784|NCT00838539|7303802|FG010|Overall Study|Adverse Event|2
4498785|NCT00838539|7303803|FG011|Overall Study|Adverse Event|0
4498786|NCT00838539|7303792|FG000|Overall Study|Withdrawal by Subject|0
4498787|NCT00838539|7303793|FG001|Overall Study|Withdrawal by Subject|1
4498788|NCT00838539|7303794|FG002|Overall Study|Withdrawal by Subject|0
4498789|NCT00838539|7303795|FG003|Overall Study|Withdrawal by Subject|0
4498790|NCT00838539|7303796|FG004|Overall Study|Withdrawal by Subject|0
4498791|NCT00838539|7303797|FG005|Overall Study|Withdrawal by Subject|0
4498792|NCT00838539|7303798|FG006|Overall Study|Withdrawal by Subject|0
4498793|NCT00838539|7303799|FG007|Overall Study|Withdrawal by Subject|0
4498794|NCT00838539|7303800|FG008|Overall Study|Withdrawal by Subject|0
4498795|NCT00838539|7303801|FG009|Overall Study|Withdrawal by Subject|1
4498796|NCT00838539|7303802|FG010|Overall Study|Withdrawal by Subject|2
4498797|NCT00838539|7303803|FG011|Overall Study|Withdrawal by Subject|0
4498798|NCT00838539|7303792|FG000|Overall Study|Death|0
4498799|NCT00838539|7303793|FG001|Overall Study|Death|0
4498800|NCT00838539|7303794|FG002|Overall Study|Death|0
4498801|NCT00838539|7303795|FG003|Overall Study|Death|0
4498802|NCT00838539|7303796|FG004|Overall Study|Death|0
4498803|NCT00838539|7303797|FG005|Overall Study|Death|0
4498804|NCT00838539|7303798|FG006|Overall Study|Death|1
4498805|NCT00838539|7303799|FG007|Overall Study|Death|0
4498806|NCT00838539|7303800|FG008|Overall Study|Death|0
4498807|NCT00838539|7303801|FG009|Overall Study|Death|0
4498808|NCT00838539|7303802|FG010|Overall Study|Death|0
4498809|NCT00838539|7303803|FG011|Overall Study|Death|0
4498810|NCT00838539|7303792|FG000|Overall Study|Physician Decision|0
4498811|NCT00838539|7303793|FG001|Overall Study|Physician Decision|0
4498812|NCT00838539|7303794|FG002|Overall Study|Physician Decision|0
4498813|NCT00838539|7303795|FG003|Overall Study|Physician Decision|0
4498814|NCT00838539|7303796|FG004|Overall Study|Physician Decision|0
4498815|NCT00838539|7303797|FG005|Overall Study|Physician Decision|0
4498816|NCT00838539|7303798|FG006|Overall Study|Physician Decision|0
4498817|NCT00838539|7303799|FG007|Overall Study|Physician Decision|0
4498818|NCT00838539|7303800|FG008|Overall Study|Physician Decision|1
4498819|NCT00838539|7303801|FG009|Overall Study|Physician Decision|0
4498820|NCT00838539|7303802|FG010|Overall Study|Physician Decision|0
4498821|NCT00838539|7303803|FG011|Overall Study|Physician Decision|0
4498822|NCT00838539|7303792|FG000|Overall Study|Clinical Progression|0
4498823|NCT00838539|7303793|FG001|Overall Study|Clinical Progression|0
4498824|NCT00838539|7303794|FG002|Overall Study|Clinical Progression|0
4498825|NCT00838539|7303795|FG003|Overall Study|Clinical Progression|0
4498826|NCT00838539|7303796|FG004|Overall Study|Clinical Progression|0
4498827|NCT00838539|7303797|FG005|Overall Study|Clinical Progression|0
4498828|NCT00838539|7303798|FG006|Overall Study|Clinical Progression|1
4498829|NCT00838539|7303799|FG007|Overall Study|Clinical Progression|0
4498830|NCT00838539|7303800|FG008|Overall Study|Clinical Progression|0
4498831|NCT00838539|7303801|FG009|Overall Study|Clinical Progression|0
4498832|NCT00838539|7303802|FG010|Overall Study|Clinical Progression|0
4498833|NCT00838539|7303803|FG011|Overall Study|Clinical Progression|0
4498834|NCT00838539|7303792|FG000|Overall Study|Symptomatic Deterioration|0
4498835|NCT00838539|7303793|FG001|Overall Study|Symptomatic Deterioration|0
4498836|NCT00838539|7303794|FG002|Overall Study|Symptomatic Deterioration|1
4498837|NCT00838539|7303795|FG003|Overall Study|Symptomatic Deterioration|1
4498838|NCT00838539|7303796|FG004|Overall Study|Symptomatic Deterioration|0
4498839|NCT00838539|7303797|FG005|Overall Study|Symptomatic Deterioration|1
4498840|NCT00838539|7303798|FG006|Overall Study|Symptomatic Deterioration|0
4498841|NCT00838539|7303799|FG007|Overall Study|Symptomatic Deterioration|0
4498842|NCT00838539|7303800|FG008|Overall Study|Symptomatic Deterioration|0
4498843|NCT00838539|7303801|FG009|Overall Study|Symptomatic Deterioration|1
4498844|NCT00838539|7303802|FG010|Overall Study|Symptomatic Deterioration|0
4498845|NCT00838539|7303803|FG011|Overall Study|Symptomatic Deterioration|0
4498846|NCT00838565|7303849|FG000|Overall Study|Withdrawal by Subject|0
4498847|NCT00838565|7303850|FG001|Overall Study|Withdrawal by Subject|0
4498848|NCT00838565|7303851|FG002|Overall Study|Withdrawal by Subject|1
4498849|NCT00838565|7303852|FG003|Overall Study|Withdrawal by Subject|0
4498850|NCT00838565|7303853|FG004|Overall Study|Withdrawal by Subject|0
4498851|NCT00838565|7303854|FG005|Overall Study|Withdrawal by Subject|2
4498852|NCT00838565|7303849|FG000|Overall Study|Other|0
4498853|NCT00838565|7303850|FG001|Overall Study|Other|2
4498854|NCT00838565|7303851|FG002|Overall Study|Other|0
4498855|NCT00838565|7303852|FG003|Overall Study|Other|0
4498856|NCT00838565|7303853|FG004|Overall Study|Other|0
4498857|NCT00838565|7303854|FG005|Overall Study|Other|0
4498858|NCT00838565|7303849|FG000|Overall Study|Randomized but not Treated|0
4498859|NCT00838565|7303850|FG001|Overall Study|Randomized but not Treated|1
4498860|NCT00838565|7303851|FG002|Overall Study|Randomized but not Treated|0
4498861|NCT00838565|7303852|FG003|Overall Study|Randomized but not Treated|0
4498862|NCT00838565|7303853|FG004|Overall Study|Randomized but not Treated|0
4498863|NCT00838565|7303854|FG005|Overall Study|Randomized but not Treated|0
4498864|NCT00838578|7303873|FG000|Overall Study|Protocol Violation|2
4498865|NCT00838682|7303883|FG000|Overall Study|Lost to Follow-up|21
4498866|NCT00838682|7303884|FG001|Overall Study|Lost to Follow-up|14
4498867|NCT00838682|7303883|FG000|Overall Study|detection of exclusion criteria|4
4498868|NCT00838682|7303884|FG001|Overall Study|detection of exclusion criteria|3
4498869|NCT00838682|7303883|FG000|Overall Study|Protocol Violation|0
4498870|NCT00838682|7303884|FG001|Overall Study|Protocol Violation|1
4498871|NCT00838682|7303883|FG000|Overall Study|Withdrawal by Subject|0
4498872|NCT00838682|7303884|FG001|Overall Study|Withdrawal by Subject|1
4498873|NCT00838903|7303903|FG000|Treatment Period (156 Weeks)|Adverse Event|5
4498874|NCT00838903|7303904|FG001|Treatment Period (156 Weeks)|Adverse Event|13
4498875|NCT00838903|7303905|FG002|Treatment Period (156 Weeks)|Adverse Event|17
4498876|NCT00838903|7303906|FG003|Treatment Period (156 Weeks)|Adverse Event|25
4498877|NCT00838903|7303903|FG000|Treatment Period (156 Weeks)|Protocol Violation|1
4498878|NCT00838903|7303904|FG001|Treatment Period (156 Weeks)|Protocol Violation|6
4498879|NCT00838903|7303905|FG002|Treatment Period (156 Weeks)|Protocol Violation|6
4498880|NCT00838903|7303906|FG003|Treatment Period (156 Weeks)|Protocol Violation|5
4498881|NCT00838903|7303903|FG000|Treatment Period (156 Weeks)|Noncompliance|9
4498882|NCT00838903|7303904|FG001|Treatment Period (156 Weeks)|Noncompliance|13
4498883|NCT00838903|7303905|FG002|Treatment Period (156 Weeks)|Noncompliance|12
4498884|NCT00838903|7303906|FG003|Treatment Period (156 Weeks)|Noncompliance|6
4498885|NCT00838903|7303903|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
4498886|NCT00838903|7303904|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
4703617|NCT02735980|7621561|FG002|Overall Study|Physician Decision|0
4703618|NCT02735980|7621559|FG000|Overall Study|Screen failure|1
4703619|NCT02735980|7621560|FG001|Overall Study|Screen failure|0
4703620|NCT02735980|7621561|FG002|Overall Study|Screen failure|0
4703621|NCT02735980|7621559|FG000|Overall Study|Withdrawal by Subject|1
4703622|NCT02735980|7621560|FG001|Overall Study|Withdrawal by Subject|2
4703623|NCT02735980|7621561|FG002|Overall Study|Withdrawal by Subject|0
4703624|NCT02736188|7621583|FG000|Overall Study|Discontinuation of Study by Sponsor|134
4703625|NCT02736188|7621583|FG000|Overall Study|Adverse Event|1
4703626|NCT02736188|7621583|FG000|Overall Study|Withdrawal by Subject|1
4703627|NCT02736188|7621583|FG000|Overall Study|Other|6
4703628|NCT02736409|7621593|FG000|Overall Study|Withdrawal by Subject|4
4703629|NCT02736409|7621594|FG001|Overall Study|Withdrawal by Subject|2
4703630|NCT02736409|7621595|FG002|Overall Study|Withdrawal by Subject|17
4703631|NCT02736409|7621596|FG003|Overall Study|Withdrawal by Subject|3
4703632|NCT02736409|7621593|FG000|Overall Study|Non-Compliance with Study Drug|0
4703633|NCT02736409|7621594|FG001|Overall Study|Non-Compliance with Study Drug|0
4703634|NCT02736409|7621595|FG002|Overall Study|Non-Compliance with Study Drug|0
4703635|NCT02736409|7621596|FG003|Overall Study|Non-Compliance with Study Drug|1
4703636|NCT02736409|7621593|FG000|Overall Study|Adverse Event|0
4498887|NCT00838903|7303905|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1
4498888|NCT00838903|7303906|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
4703637|NCT02736409|7621594|FG001|Overall Study|Adverse Event|1
4498889|NCT00838903|7303903|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4
4498890|NCT00838903|7303904|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16
4498891|NCT00838903|7303905|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15
4498892|NCT00838903|7303906|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13
4498893|NCT00838903|7303903|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20
4498894|NCT00838903|7303904|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55
4498895|NCT00838903|7303905|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56
4498896|NCT00838903|7303906|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53
4498897|NCT00838903|7303903|FG000|Treatment Period (156 Weeks)|Physician Decision|1
4498898|NCT00838903|7303904|FG001|Treatment Period (156 Weeks)|Physician Decision|2
4498899|NCT00838903|7303905|FG002|Treatment Period (156 Weeks)|Physician Decision|1
4498900|NCT00838903|7303906|FG003|Treatment Period (156 Weeks)|Physician Decision|2
4498901|NCT00838903|7303903|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3
4498902|NCT00838903|7303904|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5
4498903|NCT00838903|7303905|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5
4498904|NCT00838903|7303906|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4
4498905|NCT00838903|7303903|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
4498906|NCT00838903|7303904|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1
4498907|NCT00838903|7303905|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
4498908|NCT00838903|7303906|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
4498909|NCT00838903|7303903|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0
4498910|NCT00838903|7303904|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0
4498911|NCT00838903|7303905|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0
4498912|NCT00838903|7303906|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1
4498913|NCT00838903|7303903|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1
4517863|NCT00969709|7329773|FG001|Overall Study|Other reasons|0
4703638|NCT02736409|7621595|FG002|Overall Study|Adverse Event|5
4703639|NCT02736409|7621596|FG003|Overall Study|Adverse Event|4
4703640|NCT02736409|7621593|FG000|Overall Study|Other|0
4703641|NCT02736409|7621594|FG001|Overall Study|Other|0
4703642|NCT02736409|7621595|FG002|Overall Study|Other|1
4703643|NCT02736409|7621596|FG003|Overall Study|Other|1
4703644|NCT02736409|7621593|FG000|Overall Study|Pregnancy|0
4703645|NCT02736409|7621594|FG001|Overall Study|Pregnancy|0
4703646|NCT02736409|7621595|FG002|Overall Study|Pregnancy|1
4703647|NCT02736409|7621596|FG003|Overall Study|Pregnancy|0
4703648|NCT02736409|7621593|FG000|Overall Study|Lost to Follow-up|0
4703649|NCT02736409|7621594|FG001|Overall Study|Lost to Follow-up|0
4703650|NCT02736409|7621595|FG002|Overall Study|Lost to Follow-up|2
4703651|NCT02736409|7621596|FG003|Overall Study|Lost to Follow-up|1
4703652|NCT02736409|7621593|FG000|Overall Study|Physician Decision|0
4703653|NCT02736409|7621594|FG001|Overall Study|Physician Decision|0
4703654|NCT02736409|7621595|FG002|Overall Study|Physician Decision|0
4703655|NCT02736409|7621596|FG003|Overall Study|Physician Decision|2
4703656|NCT02736474|7621609|FG000|Overall Study|Lost to Follow-up|0
4703657|NCT02736474|7621610|FG001|Overall Study|Lost to Follow-up|1
4703658|NCT02736578|7621618|FG000|Overall Study|Adverse Event|1
4703659|NCT02736578|7621619|FG001|Overall Study|Adverse Event|0
4703660|NCT02736721|7621629|FG000|Overall Study|Adverse Event|8
4703661|NCT02736721|7621629|FG000|Overall Study|Lost to Follow-up|3
4703662|NCT02736721|7621629|FG000|Overall Study|Other|5
4703663|NCT02736825|7621635|FG000|Overall Study|Lost to Follow-up|10
4703664|NCT02736825|7621636|FG001|Overall Study|Lost to Follow-up|11
4703665|NCT02736825|7621635|FG000|Overall Study|Early Termination|0
4703666|NCT02736825|7621636|FG001|Overall Study|Early Termination|1
4703667|NCT02736890|7621645|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1
4703668|NCT02736890|7621646|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2
4703669|NCT02736890|7621645|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1
4703670|NCT02736890|7621646|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0
4703671|NCT02737358|7621700|FG000|Overall Study|Withdrawal by Subject|7
4703672|NCT02737358|7621701|FG001|Overall Study|Withdrawal by Subject|12
4703673|NCT02737358|7621700|FG000|Overall Study|Lost to Follow-up|2
4703674|NCT02737358|7621701|FG001|Overall Study|Lost to Follow-up|3
4703675|NCT02737501|7621719|FG000|Randomized Phase|Died|41
4703676|NCT02737501|7621720|FG001|Randomized Phase|Died|29
4703677|NCT02737501|7621721|FG002|Randomized Phase|Died|0
4703678|NCT02737501|7621719|FG000|Randomized Phase|Withdrawal by Subject|16
4703679|NCT02737501|7621720|FG001|Randomized Phase|Withdrawal by Subject|6
4703680|NCT02737501|7621721|FG002|Randomized Phase|Withdrawal by Subject|0
4703681|NCT02737501|7621719|FG000|Randomized Phase|Lost to Follow-up|0
4703682|NCT02737501|7621720|FG001|Randomized Phase|Lost to Follow-up|1
4703683|NCT02737501|7621721|FG002|Randomized Phase|Lost to Follow-up|0
4703684|NCT02737501|7621719|FG000|Randomized Phase|Site Terminated by Sponsor|58
4703685|NCT02737501|7621720|FG001|Randomized Phase|Site Terminated by Sponsor|16
4703686|NCT02737501|7621721|FG002|Randomized Phase|Site Terminated by Sponsor|0
4703687|NCT02737501|7621719|FG000|Randomized Phase|Reason not Specified|1
4703688|NCT02737501|7621720|FG001|Randomized Phase|Reason not Specified|1
4703689|NCT02737501|7621721|FG002|Randomized Phase|Reason not Specified|0
4703690|NCT02737501|7621719|FG000|Randomized Phase|Never Treated|1
4703691|NCT02737501|7621720|FG001|Randomized Phase|Never Treated|1
4703692|NCT02737501|7621721|FG002|Randomized Phase|Never Treated|0
4498914|NCT00838903|7303904|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
4498915|NCT00838903|7303905|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
4498916|NCT00838903|7303906|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
4498917|NCT00838903|7303903|FG000|Treatment Period (156 Weeks)|Pregnancy|0
4498918|NCT00838903|7303904|FG001|Treatment Period (156 Weeks)|Pregnancy|0
4498919|NCT00838903|7303905|FG002|Treatment Period (156 Weeks)|Pregnancy|1
4498920|NCT00838903|7303906|FG003|Treatment Period (156 Weeks)|Pregnancy|0
4498921|NCT00838903|7303903|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
4498922|NCT00838903|7303904|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
4498923|NCT00838903|7303905|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1
4498924|NCT00838903|7303906|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
4498925|NCT00838903|7303903|FG000|Treatment Period (156 Weeks)|Site closed|0
4498926|NCT00838903|7303904|FG001|Treatment Period (156 Weeks)|Site closed|0
4498927|NCT00838903|7303905|FG002|Treatment Period (156 Weeks)|Site closed|1
4387252|NCT00048035|7165899|FG005|Core Period|Early Withdrawals|1
4387253|NCT00048035|7165900|FG006|Core Period|Early Withdrawals|0
4498928|NCT00838903|7303906|FG003|Treatment Period (156 Weeks)|Site closed|0
4498929|NCT00838903|7303903|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1
4498930|NCT00838903|7303904|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
4498931|NCT00838903|7303905|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
4498932|NCT00838903|7303906|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
4498933|NCT00838903|7303903|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0
4498934|NCT00838903|7303904|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1
4498935|NCT00838903|7303905|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0
4498936|NCT00838903|7303906|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1
4498937|NCT00838903|7303903|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1
4498938|NCT00838903|7303904|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
4498939|NCT00838903|7303905|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
4498940|NCT00838903|7303906|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
4498941|NCT00838903|7303903|FG000|Follow-up Period (8 Weeks)|Adverse Event|0
4498942|NCT00838903|7303904|FG001|Follow-up Period (8 Weeks)|Adverse Event|0
4498943|NCT00838903|7303905|FG002|Follow-up Period (8 Weeks)|Adverse Event|3
4498944|NCT00838903|7303906|FG003|Follow-up Period (8 Weeks)|Adverse Event|1
4498945|NCT00838903|7303903|FG000|Follow-up Period (8 Weeks)|Noncompliance|2
4387254|NCT00048035|7165901|FG007|Core Period|Early Withdrawals|0
4627137|NCT01850589|7493689|FG000|Overall Study|Withdrawal by Subject|8
4627138|NCT01850589|7493690|FG001|Overall Study|Withdrawal by Subject|0
4703693|NCT02737501|7621719|FG000|Crossover Phase|Died|0
4703694|NCT02737501|7621720|FG001|Crossover Phase|Died|0
4703695|NCT02737501|7621721|FG002|Crossover Phase|Died|22
4703696|NCT02737501|7621719|FG000|Crossover Phase|Withdrew Consent|0
4703697|NCT02737501|7621720|FG001|Crossover Phase|Withdrew Consent|0
4703698|NCT02737501|7621721|FG002|Crossover Phase|Withdrew Consent|9
4498946|NCT00838903|7303904|FG001|Follow-up Period (8 Weeks)|Noncompliance|8
4498947|NCT00838903|7303905|FG002|Follow-up Period (8 Weeks)|Noncompliance|5
4498948|NCT00838903|7303906|FG003|Follow-up Period (8 Weeks)|Noncompliance|5
4498949|NCT00838903|7303903|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6
4498950|NCT00838903|7303904|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28
4498951|NCT00838903|7303905|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22
4498952|NCT00838903|7303906|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24
4498953|NCT00838903|7303903|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5
4703699|NCT02737501|7621719|FG000|Crossover Phase|Physician Decision|0
4703700|NCT02737501|7621720|FG001|Crossover Phase|Physician Decision|0
4703701|NCT02737501|7621721|FG002|Crossover Phase|Physician Decision|1
4703702|NCT02737501|7621719|FG000|Crossover Phase|Site Terminated by Sponsor|0
4703703|NCT02737501|7621720|FG001|Crossover Phase|Site Terminated by Sponsor|0
4703704|NCT02737501|7621721|FG002|Crossover Phase|Site Terminated by Sponsor|23
4703705|NCT02737592|7621729|FG000|Overall Study|Withdrawal by Subject|1
4703706|NCT02737618|7621733|FG000|Overall Study|Withdrawal by Subject|9
4703707|NCT02737722|7621745|FG000|Overall Study|Physician Decision|0
4703708|NCT02737722|7621746|FG001|Overall Study|Physician Decision|0
4703709|NCT02737722|7621747|FG002|Overall Study|Physician Decision|1
4703710|NCT02737722|7621748|FG003|Overall Study|Physician Decision|0
4703711|NCT02737826|7621758|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0
4387255|NCT00048035|7165894|FG000|Extension Year 1|Early Withdrawals|0
4498954|NCT00838903|7303904|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7
4627139|NCT01850602|7493698|FG000|Overall Study|Adverse Event|7
4627140|NCT01850602|7493699|FG001|Overall Study|Adverse Event|10
4627141|NCT01850602|7493698|FG000|Overall Study|Physician Decision|2
4627142|NCT01850602|7493699|FG001|Overall Study|Physician Decision|1
4627143|NCT01850602|7493698|FG000|Overall Study|Withdrawal by Subject|2
4627144|NCT01850602|7493699|FG001|Overall Study|Withdrawal by Subject|4
4627145|NCT01850602|7493698|FG000|Overall Study|Decrease in serum calcium|2
4627146|NCT01850602|7493699|FG001|Overall Study|Decrease in serum calcium|3
4627147|NCT01850602|7493698|FG000|Overall Study|Increase in serum ferritin|1
4627148|NCT01850602|7493699|FG001|Overall Study|Increase in serum ferritin|0
4627149|NCT01850615|7493707|FG000|Overall Study|Protocol Violation|4
4498955|NCT00838903|7303905|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12
4498956|NCT00838903|7303906|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7
4498957|NCT00838903|7303903|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8
4498958|NCT00838903|7303904|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13
4498959|NCT00838903|7303905|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14
4498960|NCT00838903|7303906|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14
4498961|NCT00838903|7303903|FG000|Follow-up Period (8 Weeks)|Physician Decision|1
4498962|NCT00838903|7303904|FG001|Follow-up Period (8 Weeks)|Physician Decision|1
4498963|NCT00838903|7303905|FG002|Follow-up Period (8 Weeks)|Physician Decision|1
4498964|NCT00838903|7303906|FG003|Follow-up Period (8 Weeks)|Physician Decision|1
4498965|NCT00838903|7303903|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3
4498966|NCT00838903|7303904|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
4498967|NCT00838903|7303905|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6
4498968|NCT00838903|7303906|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
4498969|NCT00838903|7303903|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0
4498970|NCT00838903|7303904|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1
4498971|NCT00838903|7303905|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0
4498972|NCT00838903|7303906|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0
4498973|NCT00838903|7303903|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
4498974|NCT00838903|7303904|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1
4498975|NCT00838903|7303905|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
4498976|NCT00838903|7303906|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
4498977|NCT00838903|7303903|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
4498978|NCT00838903|7303904|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
4498979|NCT00838903|7303905|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
4498980|NCT00838903|7303906|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1
4498981|NCT00838903|7303903|FG000|Follow-up Period (8 Weeks)|Missing|1
4498982|NCT00838903|7303904|FG001|Follow-up Period (8 Weeks)|Missing|2
4498983|NCT00838903|7303905|FG002|Follow-up Period (8 Weeks)|Missing|1
4498984|NCT00838903|7303906|FG003|Follow-up Period (8 Weeks)|Missing|1
4498985|NCT00838916|7303918|FG000|Treatment Period (156 Weeks)|Adverse Event|50
4498986|NCT00838916|7303919|FG001|Treatment Period (156 Weeks)|Adverse Event|11
4498987|NCT00838916|7303918|FG000|Treatment Period (156 Weeks)|Protocol Violation|12
4498988|NCT00838916|7303919|FG001|Treatment Period (156 Weeks)|Protocol Violation|3
4498989|NCT00838916|7303918|FG000|Treatment Period (156 Weeks)|Noncompliance|21
4498990|NCT00838916|7303919|FG001|Treatment Period (156 Weeks)|Noncompliance|14
4498991|NCT00838916|7303918|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1
4498992|NCT00838916|7303919|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
4498993|NCT00838916|7303918|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19
4498994|NCT00838916|7303919|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18
4498995|NCT00838916|7303918|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81
4498996|NCT00838916|7303919|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29
4498997|NCT00838916|7303918|FG000|Treatment Period (156 Weeks)|Physician Decision|6
4498998|NCT00838916|7303919|FG001|Treatment Period (156 Weeks)|Physician Decision|1
4498999|NCT00838916|7303918|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1
4499000|NCT00838916|7303919|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0
4499001|NCT00838916|7303918|FG000|Treatment Period (156 Weeks)|Missing|3
4499002|NCT00838916|7303919|FG001|Treatment Period (156 Weeks)|Missing|1
4499003|NCT00838916|7303918|FG000|Treatment Period (156 Weeks)|Pregnancy|2
4499004|NCT00838916|7303919|FG001|Treatment Period (156 Weeks)|Pregnancy|0
4499005|NCT00838916|7303918|FG000|Follow-up Period (8 Weeks)|Adverse Event|10
4499006|NCT00838916|7303919|FG001|Follow-up Period (8 Weeks)|Adverse Event|5
4499007|NCT00838916|7303918|FG000|Follow-up Period (8 Weeks)|Noncompliance|6
4499008|NCT00838916|7303919|FG001|Follow-up Period (8 Weeks)|Noncompliance|5
4499009|NCT00838916|7303918|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38
4499010|NCT00838916|7303919|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22
4499011|NCT00838916|7303918|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7
4499012|NCT00838916|7303919|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7
4499013|NCT00838916|7303918|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26
4499014|NCT00838916|7303919|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12
4499015|NCT00838916|7303918|FG000|Follow-up Period (8 Weeks)|Physician Decision|2
4499016|NCT00838916|7303919|FG001|Follow-up Period (8 Weeks)|Physician Decision|0
4499017|NCT00838916|7303918|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2
4499018|NCT00838916|7303919|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0
4499019|NCT00838916|7303918|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2
4499020|NCT00838916|7303919|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0
4499021|NCT00838916|7303918|FG000|Follow-up Period (8 Weeks)|Missing|3
4499022|NCT00838916|7303919|FG001|Follow-up Period (8 Weeks)|Missing|0
4499023|NCT00838929|7303928|FG000|Overall Study|Protocol Violation|0
4499024|NCT00838929|7303929|FG001|Overall Study|Protocol Violation|1
4499025|NCT00838929|7303930|FG002|Overall Study|Protocol Violation|0
4499026|NCT00838929|7303928|FG000|Overall Study|Disease progression|0
4499027|NCT00838929|7303929|FG001|Overall Study|Disease progression|2
4499028|NCT00838929|7303930|FG002|Overall Study|Disease progression|1
4499029|NCT00839072|7303936|FG000|First Intervention Period|Withdrawal by Subject|1
4499030|NCT00839072|7303937|FG001|First Intervention Period|Withdrawal by Subject|0
4499031|NCT00839072|7303936|FG000|First Intervention Period|Adverse Event|1
4499032|NCT00839072|7303937|FG001|First Intervention Period|Adverse Event|1
4499033|NCT00839072|7303936|FG000|Second Intervention Period|Withdrawal by Subject|1
4499034|NCT00839072|7303937|FG001|Second Intervention Period|Withdrawal by Subject|0
4499035|NCT00839098|7303946|FG000|Overall Study|Withdrawal by Subject|2
4703712|NCT02737826|7621759|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12
4499036|NCT00839098|7303947|FG001|Overall Study|Withdrawal by Subject|1
4499037|NCT00839098|7303948|FG002|Overall Study|Withdrawal by Subject|7
4499038|NCT00839254|7303973|FG000|Overall Study|Protocol Violation|0
4499039|NCT00839254|7303974|FG001|Overall Study|Protocol Violation|1
4499040|NCT00839254|7303975|FG002|Overall Study|Protocol Violation|1
4499041|NCT00839254|7303976|FG003|Overall Study|Protocol Violation|1
4499042|NCT00839254|7303977|FG004|Overall Study|Protocol Violation|0
4499043|NCT00839254|7303978|FG005|Overall Study|Protocol Violation|0
4499044|NCT00839254|7303979|FG006|Overall Study|Protocol Violation|1
4499045|NCT00839254|7303980|FG007|Overall Study|Protocol Violation|2
4499046|NCT00839254|7303973|FG000|Overall Study|Physician Decision|0
4499047|NCT00839254|7303974|FG001|Overall Study|Physician Decision|1
4499048|NCT00839254|7303975|FG002|Overall Study|Physician Decision|0
4499049|NCT00839254|7303976|FG003|Overall Study|Physician Decision|0
4499050|NCT00839254|7303977|FG004|Overall Study|Physician Decision|0
4499051|NCT00839254|7303978|FG005|Overall Study|Physician Decision|0
4499052|NCT00839254|7303979|FG006|Overall Study|Physician Decision|0
4499053|NCT00839254|7303980|FG007|Overall Study|Physician Decision|1
4499054|NCT00839254|7303973|FG000|Overall Study|Wrong treatment number allocation|0
4499055|NCT00839254|7303974|FG001|Overall Study|Wrong treatment number allocation|1
4499056|NCT00839254|7303975|FG002|Overall Study|Wrong treatment number allocation|0
4499057|NCT00839254|7303976|FG003|Overall Study|Wrong treatment number allocation|0
4499058|NCT00839254|7303977|FG004|Overall Study|Wrong treatment number allocation|0
4499059|NCT00839254|7303978|FG005|Overall Study|Wrong treatment number allocation|1
4499060|NCT00839254|7303979|FG006|Overall Study|Wrong treatment number allocation|0
4499061|NCT00839254|7303980|FG007|Overall Study|Wrong treatment number allocation|0
4499062|NCT00839254|7303973|FG000|Overall Study|Adverse Event|12
4499063|NCT00839254|7303974|FG001|Overall Study|Adverse Event|6
4499064|NCT00839254|7303975|FG002|Overall Study|Adverse Event|3
4499065|NCT00839254|7303976|FG003|Overall Study|Adverse Event|5
4499066|NCT00839254|7303977|FG004|Overall Study|Adverse Event|2
4499067|NCT00839254|7303978|FG005|Overall Study|Adverse Event|1
4499068|NCT00839254|7303979|FG006|Overall Study|Adverse Event|0
4499069|NCT00839254|7303980|FG007|Overall Study|Adverse Event|1
4499070|NCT00839254|7303973|FG000|Overall Study|Withdrawal by Subject|87
4499071|NCT00839254|7303974|FG001|Overall Study|Withdrawal by Subject|53
4499072|NCT00839254|7303975|FG002|Overall Study|Withdrawal by Subject|54
4499073|NCT00839254|7303976|FG003|Overall Study|Withdrawal by Subject|32
4499074|NCT00839254|7303977|FG004|Overall Study|Withdrawal by Subject|27
4499075|NCT00839254|7303978|FG005|Overall Study|Withdrawal by Subject|15
4499076|NCT00839254|7303979|FG006|Overall Study|Withdrawal by Subject|22
4499077|NCT00839254|7303980|FG007|Overall Study|Withdrawal by Subject|9
4499078|NCT00839254|7303973|FG000|Overall Study|Wrong group allocation|0
4499079|NCT00839254|7303974|FG001|Overall Study|Wrong group allocation|0
4499080|NCT00839254|7303975|FG002|Overall Study|Wrong group allocation|0
4499081|NCT00839254|7303976|FG003|Overall Study|Wrong group allocation|0
4499082|NCT00839254|7303977|FG004|Overall Study|Wrong group allocation|0
4499083|NCT00839254|7303978|FG005|Overall Study|Wrong group allocation|0
4499084|NCT00839254|7303979|FG006|Overall Study|Wrong group allocation|1
4499085|NCT00839254|7303980|FG007|Overall Study|Wrong group allocation|0
4499086|NCT00839254|7303973|FG000|Overall Study|Parents wanted pneumococcal vaccine|1
4499087|NCT00839254|7303974|FG001|Overall Study|Parents wanted pneumococcal vaccine|0
4703713|NCT02737826|7621760|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14
4703714|NCT02737852|7621769|FG000|Overall Study|Withdrawal by Subject|2
4703715|NCT02737930|7621793|FG000|Overall Study|Withdrawal by Subject|0
4703716|NCT02737930|7621794|FG001|Overall Study|Withdrawal by Subject|1
4703717|NCT02738008|7621803|FG000|Overall Study|Study Terminated by Sponsor|1
4703718|NCT02738008|7621804|FG001|Overall Study|Study Terminated by Sponsor|5
4703719|NCT02738008|7621805|FG002|Overall Study|Study Terminated by Sponsor|3
4703720|NCT02738008|7621803|FG000|Overall Study|Adverse Event|0
4499088|NCT00839254|7303975|FG002|Overall Study|Parents wanted pneumococcal vaccine|0
4499089|NCT00839254|7303976|FG003|Overall Study|Parents wanted pneumococcal vaccine|0
4499090|NCT00839254|7303977|FG004|Overall Study|Parents wanted pneumococcal vaccine|0
4499091|NCT00839254|7303978|FG005|Overall Study|Parents wanted pneumococcal vaccine|1
4499092|NCT00839254|7303979|FG006|Overall Study|Parents wanted pneumococcal vaccine|0
4499093|NCT00839254|7303980|FG007|Overall Study|Parents wanted pneumococcal vaccine|0
4499094|NCT00839254|7303973|FG000|Overall Study|Withdrawn due to non-compliance|2
4499095|NCT00839254|7303974|FG001|Overall Study|Withdrawn due to non-compliance|0
4499096|NCT00839254|7303975|FG002|Overall Study|Withdrawn due to non-compliance|0
4499097|NCT00839254|7303976|FG003|Overall Study|Withdrawn due to non-compliance|0
4499098|NCT00839254|7303977|FG004|Overall Study|Withdrawn due to non-compliance|0
4499099|NCT00839254|7303978|FG005|Overall Study|Withdrawn due to non-compliance|0
4499100|NCT00839254|7303979|FG006|Overall Study|Withdrawn due to non-compliance|0
4499101|NCT00839254|7303980|FG007|Overall Study|Withdrawn due to non-compliance|0
4499102|NCT00839254|7303973|FG000|Overall Study|Lost to Follow-up|51
4499103|NCT00839254|7303974|FG001|Overall Study|Lost to Follow-up|30
4499104|NCT00839254|7303975|FG002|Overall Study|Lost to Follow-up|32
4499105|NCT00839254|7303976|FG003|Overall Study|Lost to Follow-up|24
4499106|NCT00839254|7303977|FG004|Overall Study|Lost to Follow-up|8
4499107|NCT00839254|7303978|FG005|Overall Study|Lost to Follow-up|8
4499108|NCT00839254|7303979|FG006|Overall Study|Lost to Follow-up|4
4499109|NCT00839254|7303980|FG007|Overall Study|Lost to Follow-up|2
4499110|NCT00839306|7304031|FG000|Overall Study|Adverse Event|3
4499111|NCT00839306|7304032|FG001|Overall Study|Adverse Event|5
4499112|NCT00839306|7304031|FG000|Overall Study|Lost to Follow-up|6
4499113|NCT00839306|7304032|FG001|Overall Study|Lost to Follow-up|9
4499114|NCT00839306|7304031|FG000|Overall Study|Withdrawal by Subject|5
4499115|NCT00839306|7304032|FG001|Overall Study|Withdrawal by Subject|7
4499116|NCT00839306|7304031|FG000|Overall Study|Lack of Efficacy|5
4499117|NCT00839306|7304032|FG001|Overall Study|Lack of Efficacy|4
4499118|NCT00839306|7304031|FG000|Overall Study|Other|6
4499119|NCT00839306|7304032|FG001|Overall Study|Other|18
4499120|NCT00839332|7304063|FG000|Phase 1|Disease Progression|38
4499121|NCT00839332|7304064|FG001|Phase 1|Disease Progression|0
4499122|NCT00839332|7304065|FG002|Phase 1|Disease Progression|0
4499123|NCT00839332|7304063|FG000|Phase 1|Adverse Event|6
4499124|NCT00839332|7304064|FG001|Phase 1|Adverse Event|0
4499125|NCT00839332|7304065|FG002|Phase 1|Adverse Event|0
4499126|NCT00839332|7304063|FG000|Phase 1|Withdrawal by Subject|4
4499127|NCT00839332|7304064|FG001|Phase 1|Withdrawal by Subject|0
4499128|NCT00839332|7304065|FG002|Phase 1|Withdrawal by Subject|0
4499129|NCT00839332|7304063|FG000|Phase 1|Physician Decision|2
4499130|NCT00839332|7304064|FG001|Phase 1|Physician Decision|0
4499131|NCT00839332|7304065|FG002|Phase 1|Physician Decision|0
4499132|NCT00839332|7304063|FG000|Phase 2|Protocol Violation|0
4499133|NCT00839332|7304064|FG001|Phase 2|Protocol Violation|1
4499134|NCT00839332|7304065|FG002|Phase 2|Protocol Violation|0
4499135|NCT00839332|7304063|FG000|Phase 2|Disease Progression|0
4499136|NCT00839332|7304064|FG001|Phase 2|Disease Progression|46
4499137|NCT00839332|7304065|FG002|Phase 2|Disease Progression|21
4499138|NCT00839332|7304063|FG000|Phase 2|Adverse Event|0
4499139|NCT00839332|7304064|FG001|Phase 2|Adverse Event|8
4499140|NCT00839332|7304065|FG002|Phase 2|Adverse Event|6
4499141|NCT00839332|7304063|FG000|Phase 2|Death|0
4703721|NCT02738008|7621804|FG001|Overall Study|Adverse Event|1
4703722|NCT02738008|7621805|FG002|Overall Study|Adverse Event|2
4703723|NCT02738138|7621827|FG000|Overall Study|Adverse Event|0
4703724|NCT02738138|7621828|FG001|Overall Study|Adverse Event|1
4703725|NCT02738138|7621827|FG000|Overall Study|Lost to Follow-up|2
4703726|NCT02738138|7621828|FG001|Overall Study|Lost to Follow-up|0
4703727|NCT02738138|7621827|FG000|Overall Study|Other - not further specified|1
4703728|NCT02738138|7621828|FG001|Overall Study|Other - not further specified|0
4703729|NCT02738151|7621835|FG000|Overall Study|Randomized but not treated|4
4703730|NCT02738151|7621836|FG001|Overall Study|Randomized but not treated|1
4703731|NCT02738151|7621835|FG000|Overall Study|Adverse Event|4
4703732|NCT02738151|7621836|FG001|Overall Study|Adverse Event|5
4703733|NCT02738151|7621835|FG000|Overall Study|Hypoglycemia|0
4703734|NCT02738151|7621836|FG001|Overall Study|Hypoglycemia|1
4703735|NCT02738151|7621835|FG000|Overall Study|Poor Compliance to Protocol|4
4703736|NCT02738151|7621836|FG001|Overall Study|Poor Compliance to Protocol|3
4703737|NCT02738151|7621835|FG000|Overall Study|Other than specified above|11
4703738|NCT02738151|7621836|FG001|Overall Study|Other than specified above|21
4703739|NCT02738203|7621844|FG000|Overall Study|Failed IUD Insertion|2
4703740|NCT02738203|7621845|FG001|Overall Study|Failed IUD Insertion|2
4703741|NCT02738203|7621844|FG000|Overall Study|Protocol Violation|0
4703742|NCT02738203|7621845|FG001|Overall Study|Protocol Violation|1
4703743|NCT02738333|7621854|FG000|Overall Study|Death|1
4703744|NCT02738333|7621855|FG001|Overall Study|Death|0
4703745|NCT02738333|7621856|FG002|Overall Study|Death|0
4703746|NCT02738333|7621854|FG000|Overall Study|Lost to Follow-up|1
4703747|NCT02738333|7621855|FG001|Overall Study|Lost to Follow-up|0
4703748|NCT02738333|7621856|FG002|Overall Study|Lost to Follow-up|0
4703749|NCT02738450|7621868|FG000|Overall Study|Withdrawal by Subject|0
4703750|NCT02738450|7621869|FG001|Overall Study|Withdrawal by Subject|2
4703751|NCT02738450|7621870|FG002|Overall Study|Withdrawal by Subject|0
4703752|NCT02738580|7621881|FG000|Overall Study|Adverse Event|1
4703753|NCT02738580|7621882|FG001|Overall Study|Adverse Event|0
4703754|NCT02738580|7621881|FG000|Overall Study|Lack of Efficacy|3
4703755|NCT02738580|7621882|FG001|Overall Study|Lack of Efficacy|2
4703756|NCT02738580|7621881|FG000|Overall Study|Withdrawal by Subject|0
4703757|NCT02738580|7621882|FG001|Overall Study|Withdrawal by Subject|1
4499142|NCT00839332|7304064|FG001|Phase 2|Death|4
4499143|NCT00839332|7304065|FG002|Phase 2|Death|2
4499144|NCT00839332|7304063|FG000|Phase 2|Withdrawal by Subject|0
4499145|NCT00839332|7304064|FG001|Phase 2|Withdrawal by Subject|5
4499146|NCT00839332|7304065|FG002|Phase 2|Withdrawal by Subject|8
4499147|NCT00839332|7304063|FG000|Phase 2|Physician Decision|0
4703758|NCT02738580|7621881|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0
4703759|NCT02738580|7621882|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1
4499148|NCT00839332|7304064|FG001|Phase 2|Physician Decision|4
4499149|NCT00839332|7304065|FG002|Phase 2|Physician Decision|1
4499150|NCT00839332|7304063|FG000|Phase 2|Lost to Follow-up|0
4499151|NCT00839332|7304064|FG001|Phase 2|Lost to Follow-up|0
4499152|NCT00839332|7304065|FG002|Phase 2|Lost to Follow-up|1
4499153|NCT00839423|7304078|FG000|Overall Study|Adverse Event|4
4499154|NCT00839423|7304079|FG001|Overall Study|Adverse Event|3
4499155|NCT00839423|7304080|FG002|Overall Study|Adverse Event|7
4499156|NCT00839423|7304081|FG003|Overall Study|Adverse Event|16
4499157|NCT00839423|7304078|FG000|Overall Study|Lack of Efficacy|6
4499158|NCT00839423|7304079|FG001|Overall Study|Lack of Efficacy|6
4499159|NCT00839423|7304080|FG002|Overall Study|Lack of Efficacy|3
4499160|NCT00839423|7304081|FG003|Overall Study|Lack of Efficacy|2
4499161|NCT00839423|7304078|FG000|Overall Study|Non-compliance|0
4499162|NCT00839423|7304079|FG001|Overall Study|Non-compliance|0
4499163|NCT00839423|7304080|FG002|Overall Study|Non-compliance|0
4499164|NCT00839423|7304081|FG003|Overall Study|Non-compliance|1
4499165|NCT00839423|7304078|FG000|Overall Study|Protocol Violation|0
4499166|NCT00839423|7304079|FG001|Overall Study|Protocol Violation|1
4499167|NCT00839423|7304080|FG002|Overall Study|Protocol Violation|2
4499168|NCT00839423|7304081|FG003|Overall Study|Protocol Violation|0
4499169|NCT00839423|7304078|FG000|Overall Study|Withdrawal of consent|4
4499170|NCT00839423|7304079|FG001|Overall Study|Withdrawal of consent|0
4499171|NCT00839423|7304080|FG002|Overall Study|Withdrawal of consent|4
4499172|NCT00839423|7304081|FG003|Overall Study|Withdrawal of consent|1
4499173|NCT00839423|7304078|FG000|Overall Study|Lost to Follow-up|1
4499174|NCT00839423|7304079|FG001|Overall Study|Lost to Follow-up|0
4499175|NCT00839423|7304080|FG002|Overall Study|Lost to Follow-up|1
4499176|NCT00839423|7304081|FG003|Overall Study|Lost to Follow-up|0
4499177|NCT00839423|7304078|FG000|Overall Study|Administrative or other reasons|3
4499178|NCT00839423|7304079|FG001|Overall Study|Administrative or other reasons|0
4499179|NCT00839423|7304080|FG002|Overall Study|Administrative or other reasons|1
4499180|NCT00839423|7304081|FG003|Overall Study|Administrative or other reasons|0
4499181|NCT00839436|7304094|FG000|Overall Study|Developed exclusionary condition|1
4499182|NCT00839436|7304095|FG001|Overall Study|Developed exclusionary condition|0
4499183|NCT00839436|7304096|FG002|Overall Study|Developed exclusionary condition|0
4499184|NCT00839436|7304094|FG000|Overall Study|Withdrawal by Subject|0
4499185|NCT00839436|7304095|FG001|Overall Study|Withdrawal by Subject|1
4499186|NCT00839436|7304096|FG002|Overall Study|Withdrawal by Subject|0
4499187|NCT00839436|7304094|FG000|Overall Study|Study drug no longer available|0
4499188|NCT00839436|7304095|FG001|Overall Study|Study drug no longer available|0
4499189|NCT00839436|7304096|FG002|Overall Study|Study drug no longer available|1
4499190|NCT00839527|7304107|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11
4499191|NCT00839527|7304108|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29
4499192|NCT00839527|7304109|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22
4499193|NCT00839527|7304107|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4
4499194|NCT00839527|7304108|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7
4499195|NCT00839527|7304109|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1
4499196|NCT00839527|7304107|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5
4499197|NCT00839527|7304108|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6
4499198|NCT00839527|7304109|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16
4499199|NCT00839527|7304107|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3
4499200|NCT00839527|7304108|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12
4499201|NCT00839527|7304109|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7
4499202|NCT00839527|7304107|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32
4499203|NCT00839527|7304108|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46
4499204|NCT00839527|7304109|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64
4499205|NCT00839527|7304107|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1
4499206|NCT00839527|7304108|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6
4499207|NCT00839527|7304109|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1
4499208|NCT00839527|7304107|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3
4499209|NCT00839527|7304108|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8
4499210|NCT00839527|7304109|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5
4499211|NCT00839527|7304107|FG000|Treatment Period (TP) (156 Weeks)|Missing|0
4499212|NCT00839527|7304108|FG001|Treatment Period (TP) (156 Weeks)|Missing|1
4499213|NCT00839527|7304109|FG002|Treatment Period (TP) (156 Weeks)|Missing|0
4499214|NCT00839527|7304107|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0
4499215|NCT00839527|7304108|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0
4499216|NCT00839527|7304109|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1
4499217|NCT00839527|7304107|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0
4499218|NCT00839527|7304108|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1
4499219|NCT00839527|7304109|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1
4499220|NCT00839527|7304107|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1
4499221|NCT00839527|7304108|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2
4499222|NCT00839527|7304109|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0
4499223|NCT00839527|7304107|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0
4499224|NCT00839527|7304108|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0
4499225|NCT00839527|7304109|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1
4499226|NCT00839527|7304107|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
4499227|NCT00839527|7304108|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2
4499228|NCT00839527|7304109|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
4499229|NCT00839527|7304107|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1
4499230|NCT00839527|7304108|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0
4499231|NCT00839527|7304109|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5
4499232|NCT00839527|7304107|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8
4499233|NCT00839527|7304108|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20
4499234|NCT00839527|7304109|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29
4499235|NCT00839527|7304107|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12
4499236|NCT00839527|7304108|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21
4499237|NCT00839527|7304109|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19
4703760|NCT02738775|7621894|FG000|Overall Study|Withdrawal by Subject|0
4703761|NCT02738775|7621895|FG001|Overall Study|Withdrawal by Subject|1
4703762|NCT02738775|7621896|FG002|Overall Study|Withdrawal by Subject|0
4703763|NCT02738775|7621897|FG003|Overall Study|Withdrawal by Subject|0
4703764|NCT02738775|7621898|FG004|Overall Study|Withdrawal by Subject|0
4703765|NCT02738775|7621899|FG005|Overall Study|Withdrawal by Subject|0
4703766|NCT02738775|7621894|FG000|Overall Study|Adverse Event|0
4703767|NCT02738775|7621895|FG001|Overall Study|Adverse Event|0
4703768|NCT02738775|7621896|FG002|Overall Study|Adverse Event|0
4703769|NCT02738775|7621897|FG003|Overall Study|Adverse Event|1
4703770|NCT02738775|7621898|FG004|Overall Study|Adverse Event|0
4703771|NCT02738775|7621899|FG005|Overall Study|Adverse Event|0
4703772|NCT02738775|7621894|FG000|Overall Study|Pregnancy|0
4703773|NCT02738775|7621895|FG001|Overall Study|Pregnancy|1
4703774|NCT02738775|7621896|FG002|Overall Study|Pregnancy|0
4703775|NCT02738775|7621897|FG003|Overall Study|Pregnancy|0
4703776|NCT02738775|7621898|FG004|Overall Study|Pregnancy|0
4703777|NCT02738775|7621899|FG005|Overall Study|Pregnancy|0
4703778|NCT02738775|7621894|FG000|Overall Study|Missing|0
4703779|NCT02738775|7621895|FG001|Overall Study|Missing|0
4703780|NCT02738775|7621896|FG002|Overall Study|Missing|0
4703781|NCT02738775|7621897|FG003|Overall Study|Missing|0
4703782|NCT02738775|7621898|FG004|Overall Study|Missing|0
4703783|NCT02738775|7621899|FG005|Overall Study|Missing|1
4703784|NCT02738801|7621919|FG000|Overall Study|Adverse Event|1
4703785|NCT02738801|7621920|FG001|Overall Study|Adverse Event|1
4703786|NCT02738801|7621919|FG000|Overall Study|Withdrawal by Subject|0
4703787|NCT02738801|7621920|FG001|Overall Study|Withdrawal by Subject|1
4703788|NCT02738840|7621927|FG000|Overall Study|MRI Scan not Performed|5
4703789|NCT02738840|7621927|FG000|Overall Study|Lost to Follow-up|1
4703790|NCT02738840|7621927|FG000|Overall Study|Subject Participation Terminated by Investigator|1
4703791|NCT02738840|7621927|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1
4703792|NCT02738879|7621933|FG000|Overall Study|Adverse Event|1
4703793|NCT02738879|7621934|FG001|Overall Study|Adverse Event|1
4703794|NCT02738879|7621933|FG000|Overall Study|Death|0
4703795|NCT02738879|7621934|FG001|Overall Study|Death|2
4703796|NCT02738879|7621933|FG000|Overall Study|Lost to Follow-up|1
4703797|NCT02738879|7621934|FG001|Overall Study|Lost to Follow-up|5
4703798|NCT02738879|7621933|FG000|Overall Study|Protocol Violation|1
4703799|NCT02738879|7621934|FG001|Overall Study|Protocol Violation|3
4703800|NCT02738879|7621933|FG000|Overall Study|Physician Decision|3
4703801|NCT02738879|7621934|FG001|Overall Study|Physician Decision|4
4703802|NCT02738879|7621933|FG000|Overall Study|Pregnancy|0
4703803|NCT02738879|7621934|FG001|Overall Study|Pregnancy|1
4703804|NCT02738879|7621933|FG000|Overall Study|Screen Failure|1
4703805|NCT02738879|7621934|FG001|Overall Study|Screen Failure|2
4703806|NCT02738879|7621933|FG000|Overall Study|Site Discontinued Study Participation|1
4703807|NCT02738879|7621934|FG001|Overall Study|Site Discontinued Study Participation|0
4703808|NCT02738879|7621933|FG000|Overall Study|Withdrawal by Subject|5
4703809|NCT02738879|7621934|FG001|Overall Study|Withdrawal by Subject|7
4703810|NCT02739269|7621950|FG000|Overall Study|Protocol Violation|5
4703811|NCT02739269|7621951|FG001|Overall Study|Protocol Violation|0
4703812|NCT02739269|7621950|FG000|Overall Study|Cycle cancellation|2
4703813|NCT02739269|7621951|FG001|Overall Study|Cycle cancellation|2
4703814|NCT02739269|7621950|FG000|Overall Study|Withdrawal by Subject|0
4703815|NCT02739269|7621951|FG001|Overall Study|Withdrawal by Subject|2
4703816|NCT02739321|7621959|FG000|Overall Study|Lack of Efficacy|1
4703817|NCT02739321|7621960|FG001|Overall Study|Lack of Efficacy|1
4703818|NCT02739321|7621959|FG000|Overall Study|Lost to Follow-up|1
4703819|NCT02739321|7621960|FG001|Overall Study|Lost to Follow-up|1
4703820|NCT02739321|7621959|FG000|Overall Study|Withdrawal by Subject|1
4703821|NCT02739321|7621960|FG001|Overall Study|Withdrawal by Subject|2
4703822|NCT02739360|7621975|FG000|Overall Study|Adverse Event|1
4703823|NCT02739360|7621975|FG000|Overall Study|Study terminated by Sponsor|2
4703824|NCT02739594|7621981|FG000|Overall Study|Undesired Event|3
4499238|NCT00839527|7304107|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0
4703825|NCT02739594|7621982|FG001|Overall Study|Undesired Event|4
4703826|NCT02739594|7621981|FG000|Overall Study|Violation of Eligibility Criteria|1
4703827|NCT02739594|7621982|FG001|Overall Study|Violation of Eligibility Criteria|2
4703828|NCT02739594|7621981|FG000|Overall Study|Protocol Violation|5
4499239|NCT00839527|7304108|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0
4499240|NCT00839527|7304109|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
4499241|NCT00839527|7304107|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3
4499242|NCT00839527|7304108|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10
4499243|NCT00839527|7304109|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5
4499244|NCT00839527|7304107|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1
4499245|NCT00839527|7304108|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0
4499246|NCT00839527|7304109|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0
4499247|NCT00839527|7304107|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1
4499248|NCT00839527|7304108|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0
4499249|NCT00839527|7304109|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0
4499250|NCT00839527|7304107|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0
4499251|NCT00839527|7304108|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1
4499252|NCT00839527|7304109|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0
4499253|NCT00839527|7304107|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1
4499254|NCT00839527|7304108|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0
4499255|NCT00839527|7304109|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1
4499256|NCT00839527|7304107|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0
4499257|NCT00839527|7304108|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1
4499258|NCT00839527|7304109|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0
4499259|NCT00839527|7304107|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0
4499260|NCT00839527|7304108|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1
4499261|NCT00839527|7304109|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1
4499262|NCT00839800|7304134|FG000|Overall Study|Adverse Event|8
4499263|NCT00839800|7304135|FG001|Overall Study|Adverse Event|12
4499264|NCT00839800|7304134|FG000|Overall Study|Lost to Follow-up|31
4499265|NCT00839800|7304135|FG001|Overall Study|Lost to Follow-up|26
4499266|NCT00839800|7304134|FG000|Overall Study|Withdrawal by Subject|28
4499267|NCT00839800|7304135|FG001|Overall Study|Withdrawal by Subject|34
4499268|NCT00839800|7304134|FG000|Overall Study|Incorrect Enrolment|3
4499269|NCT00839800|7304135|FG001|Overall Study|Incorrect Enrolment|3
4499270|NCT00839800|7304134|FG000|Overall Study|Study-Specific Discontinuation Criteria|6
4499271|NCT00839800|7304135|FG001|Overall Study|Study-Specific Discontinuation Criteria|13
4499272|NCT00839800|7304134|FG000|Overall Study|Safety Reasons|2
4499273|NCT00839800|7304135|FG001|Overall Study|Safety Reasons|1
4499274|NCT00839800|7304134|FG000|Overall Study|Other|8
4499275|NCT00839800|7304135|FG001|Overall Study|Other|14
4703829|NCT02739594|7621982|FG001|Overall Study|Protocol Violation|6
4703830|NCT02739594|7621981|FG000|Overall Study|Death|4
4703831|NCT02739594|7621982|FG001|Overall Study|Death|2
4703832|NCT02739594|7621981|FG000|Overall Study|Renal Insufficiency|4
4703833|NCT02739594|7621982|FG001|Overall Study|Renal Insufficiency|6
4703834|NCT02739594|7621981|FG000|Overall Study|Administrative Reasons|1
4703835|NCT02739594|7621982|FG001|Overall Study|Administrative Reasons|3
4703836|NCT02739594|7621981|FG000|Overall Study|Withdrawal by Subject|1
4703837|NCT02739594|7621982|FG001|Overall Study|Withdrawal by Subject|1
4703838|NCT02739594|7621981|FG000|Overall Study|Lost to Follow-up|0
4703839|NCT02739594|7621982|FG001|Overall Study|Lost to Follow-up|1
4703840|NCT02739594|7621981|FG000|Overall Study|Elevated Serum Creatinine|0
4703841|NCT02739594|7621982|FG001|Overall Study|Elevated Serum Creatinine|1
4703842|NCT02739594|7621981|FG000|Overall Study|Other|6
4703843|NCT02739594|7621982|FG001|Overall Study|Other|2
4703844|NCT02739828|7622007|FG000|Overall Study|Adverse Event|1
4703845|NCT02739828|7622007|FG000|Overall Study|Lost to Follow-up|4
4703846|NCT02739984|7622013|FG000|Overall Study|Sponsor Decision|1
4703847|NCT02739984|7622014|FG001|Overall Study|Sponsor Decision|0
4703848|NCT02739984|7622013|FG000|Overall Study|Withdrawal by Subject|1
4703849|NCT02739984|7622014|FG001|Overall Study|Withdrawal by Subject|1
4703850|NCT02739984|7622013|FG000|Overall Study|Death|0
4703851|NCT02739984|7622014|FG001|Overall Study|Death|1
4703852|NCT02739984|7622013|FG000|Overall Study|Lost to Follow-up|3
4703853|NCT02739984|7622014|FG001|Overall Study|Lost to Follow-up|0
4703854|NCT02739997|7622020|FG000|Overall Study|Death|1
4703855|NCT02739997|7622020|FG000|Overall Study|Withdrawal by Subject|1
4703856|NCT02740049|7622024|FG000|Overall Study|Isolated cells did not grow sufficiently|1
4703857|NCT02740478|7622056|FG000|Overall Study|Withdrawal by Subject|1
4703858|NCT02741076|7622112|FG000|Overall Study|Adverse Event|0
4703859|NCT02741076|7622113|FG001|Overall Study|Adverse Event|1
4703860|NCT02741076|7622114|FG002|Overall Study|Adverse Event|1
4703861|NCT02741076|7622115|FG003|Overall Study|Adverse Event|0
4703862|NCT02741076|7622112|FG000|Overall Study|Lack of Efficacy|1
4703863|NCT02741076|7622113|FG001|Overall Study|Lack of Efficacy|0
4703864|NCT02741076|7622114|FG002|Overall Study|Lack of Efficacy|0
4499276|NCT00839800|7304134|FG000|Overall Study|Severe Non-Compliance to Protocol|7
4499277|NCT00839800|7304135|FG001|Overall Study|Severe Non-Compliance to Protocol|7
4499278|NCT00839852|7304141|FG000|Overall Study|Adverse Event|10
4703865|NCT02741076|7622115|FG003|Overall Study|Lack of Efficacy|0
4703866|NCT02741076|7622112|FG000|Overall Study|Withdrawal by Subject|0
4703867|NCT02741076|7622113|FG001|Overall Study|Withdrawal by Subject|1
4499279|NCT00839852|7304141|FG000|Overall Study|Insufficient Therapeutic Response|3
4499280|NCT00839852|7304141|FG000|Overall Study|Protocol Violation|9
4499281|NCT00839852|7304141|FG000|Overall Study|Withdrawal of Consent|16
4499282|NCT00839852|7304141|FG000|Overall Study|Lost to Follow-up|7
4499283|NCT00839852|7304141|FG000|Overall Study|Lack of Compliance While in Jail|1
4499284|NCT00839852|7304141|FG000|Overall Study|Pregnancy|1
4499285|NCT00839917|7304147|FG000|Overall Study|Lost to Follow-up|1
4499286|NCT00839917|7304148|FG001|Overall Study|Lost to Follow-up|0
4499287|NCT00839917|7304147|FG000|Overall Study|Did not receive vaccine|0
4499288|NCT00839917|7304148|FG001|Overall Study|Did not receive vaccine|1
4499289|NCT00839956|7304154|FG000|Overall Study|Adverse Event|2
4499290|NCT00839956|7304154|FG000|Overall Study|Lack of Efficacy|6
4499291|NCT00839956|7304154|FG000|Overall Study|Physician Decision|1
4499292|NCT00839956|7304154|FG000|Overall Study|Withdrawal by Subject|3
4499293|NCT00840034|7304171|FG000|Acute Treatment Phase|Adverse Event|6
4499294|NCT00840034|7304172|FG001|Acute Treatment Phase|Adverse Event|8
4499295|NCT00840034|7304171|FG000|Acute Treatment Phase|Lack of Efficacy|2
4499296|NCT00840034|7304172|FG001|Acute Treatment Phase|Lack of Efficacy|0
4499297|NCT00840034|7304171|FG000|Acute Treatment Phase|Lost to Follow-up|5
4499298|NCT00840034|7304172|FG001|Acute Treatment Phase|Lost to Follow-up|12
4499299|NCT00840034|7304171|FG000|Acute Treatment Phase|Physician Decision|0
4499300|NCT00840034|7304172|FG001|Acute Treatment Phase|Physician Decision|1
4499301|NCT00840034|7304171|FG000|Acute Treatment Phase|Protocol Violation|2
4499302|NCT00840034|7304172|FG001|Acute Treatment Phase|Protocol Violation|4
4499303|NCT00840034|7304171|FG000|Acute Treatment Phase|Withdrawal by Subject|6
4499304|NCT00840034|7304172|FG001|Acute Treatment Phase|Withdrawal by Subject|11
4499305|NCT00840034|7304171|FG000|Taper Phase|Adverse Event|1
4499306|NCT00840034|7304172|FG001|Taper Phase|Adverse Event|0
4499307|NCT00840034|7304171|FG000|Taper Phase|Lost to Follow-up|1
4499308|NCT00840034|7304172|FG001|Taper Phase|Lost to Follow-up|1
4499309|NCT00840034|7304171|FG000|Taper Phase|Withdrawal by Subject|1
4499310|NCT00840034|7304172|FG001|Taper Phase|Withdrawal by Subject|1
4499311|NCT00840060|7304182|FG000|Overall Study|Withdrawal by Subject|1
4499312|NCT00840060|7304183|FG001|Overall Study|Withdrawal by Subject|0
4499313|NCT00840060|7304182|FG000|Overall Study|Change in emotional/behavioral status|0
4499314|NCT00840060|7304183|FG001|Overall Study|Change in emotional/behavioral status|1
4499315|NCT00840086|7304189|FG000|Overall Study|Adverse Event|1
4499316|NCT00840086|7304189|FG000|Overall Study|Protocol Violation|2
4499317|NCT00840086|7304189|FG000|Overall Study|Lost to Follow-up|1
4499318|NCT00840294|7304198|FG000|Overall Study|Withdrawal by Subject|2
4499319|NCT00840294|7304199|FG001|Overall Study|Withdrawal by Subject|1
4499320|NCT00840294|7304198|FG000|Overall Study|Protocol Violation|1
4499321|NCT00840294|7304199|FG001|Overall Study|Protocol Violation|3
4499322|NCT00840294|7304198|FG000|Overall Study|Illness|0
4499323|NCT00840294|7304199|FG001|Overall Study|Illness|1
4499324|NCT00840450|7304209|FG000|Overall Study|Adverse Event|1
4499325|NCT00840450|7304209|FG000|Overall Study|Lack of Efficacy|2
4499326|NCT00840463|7304215|FG000|Overall Study|Adverse Event|1
4499327|NCT00840463|7304216|FG001|Overall Study|Adverse Event|0
4499328|NCT00840658|7304226|FG000|Overall Study|Death|2
4499329|NCT00840658|7304227|FG001|Overall Study|Death|2
4499330|NCT00840658|7304228|FG002|Overall Study|Death|3
4499331|NCT00840658|7304229|FG003|Overall Study|Death|3
4499332|NCT00840658|7304226|FG000|Overall Study|Lost to Follow-up|3
4499333|NCT00840658|7304227|FG001|Overall Study|Lost to Follow-up|1
4499334|NCT00840658|7304228|FG002|Overall Study|Lost to Follow-up|2
4499335|NCT00840658|7304229|FG003|Overall Study|Lost to Follow-up|1
4499336|NCT00840749|7304245|FG000|Overall Study|Death|1
4499337|NCT00840749|7304246|FG001|Overall Study|Death|2
4499338|NCT00840749|7304245|FG000|Overall Study|not treated on study arm|11
4499339|NCT00840749|7304246|FG001|Overall Study|not treated on study arm|11
4499340|NCT00840749|7304245|FG000|Overall Study|study closed|19
4499341|NCT00840749|7304246|FG001|Overall Study|study closed|14
4499342|NCT00840970|7304252|FG000|Overall Study|Adverse Event|0
4499343|NCT00840970|7304253|FG001|Overall Study|Adverse Event|0
4499344|NCT00840970|7304254|FG002|Overall Study|Adverse Event|1
4499345|NCT00840996|7304266|FG000|Overall Study|Withdrawal by Subject|1
4499346|NCT00840996|7304267|FG001|Overall Study|Withdrawal by Subject|0
4499347|NCT00841100|7304282|FG000|Phase 1 (28 Days)|Adverse Event|1
4499348|NCT00841100|7304282|FG000|Phase 1 (28 Days)|Participant non-compliance|2
4499349|NCT00841321|7304307|FG000|Overall Study|Lost to Follow-up|1
4499350|NCT00841321|7304308|FG001|Overall Study|Lost to Follow-up|1
4499351|NCT00841321|7304307|FG000|Overall Study|Adverse Event|0
4499352|NCT00841321|7304308|FG001|Overall Study|Adverse Event|2
4517864|NCT00969709|7329774|FG002|Overall Study|Other reasons|3
4517865|NCT00969709|7329775|FG003|Overall Study|Other reasons|0
4517866|NCT00969761|7329801|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
4517867|NCT00969761|7329802|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
4517868|NCT00969761|7329803|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
4517869|NCT00969761|7329804|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
4517870|NCT00969761|7329805|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
4517871|NCT00969761|7329806|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
4517872|NCT00969761|7329807|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
4499353|NCT00841568|7304332|FG000|Overall Study|Adverse Event|1
4499354|NCT00841568|7304332|FG000|Overall Study|Death|1
4703868|NCT02741076|7622114|FG002|Overall Study|Withdrawal by Subject|0
4703869|NCT02741076|7622115|FG003|Overall Study|Withdrawal by Subject|0
4703870|NCT02741076|7622112|FG000|Overall Study|Sponsor Request|2
4703871|NCT02741076|7622113|FG001|Overall Study|Sponsor Request|3
4499355|NCT00841568|7304332|FG000|Overall Study|Withdrawal by Subject|2
4499356|NCT00841568|7304332|FG000|Overall Study|Creatinine over the withdrawal criteria|1
4499357|NCT00841672|7304342|FG000|Overall Study|Adverse Event|7
4499358|NCT00841672|7304343|FG001|Overall Study|Adverse Event|16
4499359|NCT00841672|7304342|FG000|Overall Study|Abnormal test procedure result(s)|0
4499360|NCT00841672|7304343|FG001|Overall Study|Abnormal test procedure result(s)|1
4499361|NCT00841672|7304342|FG000|Overall Study|Subject withdrew consent|2
4499362|NCT00841672|7304343|FG001|Overall Study|Subject withdrew consent|4
4499363|NCT00841672|7304342|FG000|Overall Study|Lost to Follow-up|1
4499364|NCT00841672|7304343|FG001|Overall Study|Lost to Follow-up|1
4499365|NCT00841672|7304342|FG000|Overall Study|Administrative problems|9
4499366|NCT00841672|7304343|FG001|Overall Study|Administrative problems|9
4499367|NCT00841672|7304342|FG000|Overall Study|Misrandomized|1
4499368|NCT00841672|7304343|FG001|Overall Study|Misrandomized|0
4499369|NCT00841672|7304342|FG000|Overall Study|Protocol Deviation|0
4499370|NCT00841672|7304343|FG001|Overall Study|Protocol Deviation|1
4499371|NCT00841763|7304351|FG000|Overall Study|Withdrawal by Subject|60
4499372|NCT00841763|7304352|FG001|Overall Study|Withdrawal by Subject|17
4499373|NCT00841763|7304353|FG002|Overall Study|Withdrawal by Subject|4
4499374|NCT00841763|7304354|FG003|Overall Study|Withdrawal by Subject|1
4499375|NCT00841763|7304351|FG000|Overall Study|Adverse Event|9
4499376|NCT00841763|7304352|FG001|Overall Study|Adverse Event|10
4499377|NCT00841763|7304353|FG002|Overall Study|Adverse Event|3
4499378|NCT00841763|7304354|FG003|Overall Study|Adverse Event|2
4499379|NCT00841763|7304351|FG000|Overall Study|Lost to Follow-up|63
4499380|NCT00841763|7304352|FG001|Overall Study|Lost to Follow-up|25
4499381|NCT00841763|7304353|FG002|Overall Study|Lost to Follow-up|0
4499382|NCT00841763|7304354|FG003|Overall Study|Lost to Follow-up|0
4499383|NCT00841763|7304351|FG000|Overall Study|Protocol Violation|20
4499384|NCT00841763|7304352|FG001|Overall Study|Protocol Violation|3
4499385|NCT00841763|7304353|FG002|Overall Study|Protocol Violation|1
4499386|NCT00841763|7304354|FG003|Overall Study|Protocol Violation|0
4499387|NCT00841763|7304351|FG000|Overall Study|Administrative Reasons|3
4703872|NCT02741076|7622114|FG002|Overall Study|Sponsor Request|0
4703873|NCT02741076|7622115|FG003|Overall Study|Sponsor Request|1
4703874|NCT02741076|7622112|FG000|Overall Study|No additional information available|0
4703875|NCT02741076|7622113|FG001|Overall Study|No additional information available|0
4703876|NCT02741076|7622114|FG002|Overall Study|No additional information available|1
4703877|NCT02741076|7622115|FG003|Overall Study|No additional information available|1
4703878|NCT02741310|7622143|FG000|Overall Study|Sponsor Decision|2
4703879|NCT02741310|7622144|FG001|Overall Study|Sponsor Decision|2
4703880|NCT02741518|7622160|FG000|Overall Study|Withdrawal by Subject|1
4703881|NCT02741518|7622161|FG001|Overall Study|Withdrawal by Subject|1
4703882|NCT02741596|7622169|FG000|Overall Study|Adverse Event|1
4703883|NCT02741596|7622170|FG001|Overall Study|Adverse Event|5
4703884|NCT02741596|7622169|FG000|Overall Study|Lost to Follow-up|1
4703885|NCT02741596|7622170|FG001|Overall Study|Lost to Follow-up|1
4703886|NCT02741596|7622169|FG000|Overall Study|Physician Decision|2
4703887|NCT02741596|7622170|FG001|Overall Study|Physician Decision|1
4703888|NCT02741596|7622169|FG000|Overall Study|Pregnancy|3
4703889|NCT02741596|7622170|FG001|Overall Study|Pregnancy|1
4703890|NCT02741596|7622169|FG000|Overall Study|Other (Unspecified)|0
4703891|NCT02741596|7622170|FG001|Overall Study|Other (Unspecified)|3
4703892|NCT02741596|7622169|FG000|Overall Study|Subject withdrawn-Other|17
4703893|NCT02741596|7622170|FG001|Overall Study|Subject withdrawn-Other|4
4703894|NCT02741596|7622169|FG000|Overall Study|Subject withdrawn-to commercial product|54
4703895|NCT02741596|7622170|FG001|Overall Study|Subject withdrawn-to commercial product|63
4703896|NCT02741635|7622176|FG000|Overall Study|Withdrawal by Subject|1
4703897|NCT02741713|7622192|FG000|Overall Study|Surgery type changed intra-operatively|2
4703898|NCT02741713|7622193|FG001|Overall Study|Surgery type changed intra-operatively|1
4703899|NCT02742103|7622206|FG000|Overall Study|Protocol Violation|1
4703900|NCT02742103|7622207|FG001|Overall Study|Protocol Violation|0
4703901|NCT02742103|7622206|FG000|Overall Study|Death|2
4703902|NCT02742103|7622207|FG001|Overall Study|Death|2
4703903|NCT02742103|7622206|FG000|Overall Study|Adverse Event|1
4703904|NCT02742103|7622207|FG001|Overall Study|Adverse Event|0
4499388|NCT00841763|7304352|FG001|Overall Study|Administrative Reasons|1
4499389|NCT00841763|7304353|FG002|Overall Study|Administrative Reasons|0
4499390|NCT00841763|7304354|FG003|Overall Study|Administrative Reasons|0
4499391|NCT00841763|7304351|FG000|Overall Study|Unable to Classify|7
4627150|NCT01850615|7493708|FG001|Overall Study|Protocol Violation|1
4627151|NCT01850615|7493707|FG000|Overall Study|Adverse Event|2
4627152|NCT01850615|7493708|FG001|Overall Study|Adverse Event|1
4627153|NCT01850615|7493707|FG000|Overall Study|Withdrawal by Subject|3
4703905|NCT02742103|7622206|FG000|Overall Study|Moved to another town|0
4703906|NCT02742103|7622207|FG001|Overall Study|Moved to another town|1
4703907|NCT02742103|7622206|FG000|Overall Study|Withdrawal by Subject|5
4703908|NCT02742103|7622207|FG001|Overall Study|Withdrawal by Subject|2
4499392|NCT00841763|7304352|FG001|Overall Study|Unable to Classify|1
4499393|NCT00841763|7304353|FG002|Overall Study|Unable to Classify|0
4499394|NCT00841763|7304354|FG003|Overall Study|Unable to Classify|0
4499395|NCT00841776|7304401|FG000|Overall Study|Lack of Efficacy|0
4499396|NCT00841776|7304402|FG001|Overall Study|Lack of Efficacy|1
4499397|NCT00841776|7304401|FG000|Overall Study|Lost to Follow-up|2
4499398|NCT00841776|7304402|FG001|Overall Study|Lost to Follow-up|1
4499399|NCT00841776|7304401|FG000|Overall Study|Withdrawal by Subject|0
4499400|NCT00841776|7304402|FG001|Overall Study|Withdrawal by Subject|1
4499401|NCT00841906|7304421|FG000|Overall Study|Withdrawal by Subject|2
4499402|NCT00841906|7304422|FG001|Overall Study|Withdrawal by Subject|0
4499403|NCT00842153|7304462|FG000|Overall Study|Adverse Event|0
4499404|NCT00842153|7304463|FG001|Overall Study|Adverse Event|1
4499405|NCT00842153|7304462|FG000|Overall Study|Lost to Follow-up|1
4499406|NCT00842153|7304463|FG001|Overall Study|Lost to Follow-up|2
4499407|NCT00842244|7304473|FG000|Overall Study|Death|3
4499408|NCT00842244|7304473|FG000|Overall Study|Withdrawal by Subject|1
4499409|NCT00842244|7304473|FG000|Overall Study|Other|17
4499410|NCT00842257|7304480|FG000|Overall Study|Adverse Event|1
4499411|NCT00842309|7304490|FG000|Overall Study|Withdrawal by Subject|3
4499412|NCT00842309|7304491|FG001|Overall Study|Withdrawal by Subject|1
4499413|NCT00842348|7304505|FG000|Patients Randomised in Study 726|Did not enter Study 729|59
4499414|NCT00842348|7304506|FG001|Patients Randomised in Study 726|Did not enter Study 729|56
4499415|NCT00842348|7304505|FG000|Study 729|Disease progression/death|19
4499416|NCT00842348|7304506|FG001|Study 729|Disease progression/death|30
4499417|NCT00842348|7304505|FG000|Study 729|Adverse Event|1
4499418|NCT00842348|7304506|FG001|Study 729|Adverse Event|1
4499419|NCT00842348|7304505|FG000|Study 729|Protocol Violation|1
4703909|NCT02742441|7622227|FG000|Overall Study|Lost to Follow-up|4
4703910|NCT02742441|7622228|FG001|Overall Study|Lost to Follow-up|4
4703911|NCT02742441|7622227|FG000|Overall Study|Withdrawal by Subject|2
4703912|NCT02742441|7622228|FG001|Overall Study|Withdrawal by Subject|2
4703913|NCT02742441|7622227|FG000|Overall Study|Adverse Event|0
4703914|NCT02742441|7622228|FG001|Overall Study|Adverse Event|2
4703915|NCT02742519|7622236|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1
4703916|NCT02742519|7622237|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1
4703917|NCT02742519|7622238|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0
4703918|NCT02742519|7622236|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0
4703919|NCT02742519|7622237|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0
4703920|NCT02742519|7622238|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9
4703921|NCT02742519|7622236|FG000|Part 2 Open Label Period (32 Weeks)|Other|0
4703922|NCT02742519|7622237|FG001|Part 2 Open Label Period (32 Weeks)|Other|0
4703923|NCT02742519|7622238|FG002|Part 2 Open Label Period (32 Weeks)|Other|1
4703924|NCT02742649|7622258|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5
4703925|NCT02742649|7622259|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0
4703926|NCT02742649|7622260|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0
4703927|NCT02742649|7622261|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0
4703928|NCT02742649|7622262|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0
4703929|NCT02742649|7622258|FG000|Double-Blind Treatment Period|Adverse Event|0
4703930|NCT02742649|7622259|FG001|Double-Blind Treatment Period|Adverse Event|1
4703931|NCT02742649|7622260|FG002|Double-Blind Treatment Period|Adverse Event|0
4703932|NCT02742649|7622261|FG003|Double-Blind Treatment Period|Adverse Event|0
4499420|NCT00842348|7304506|FG001|Study 729|Protocol Violation|1
4499421|NCT00842348|7304505|FG000|Study 729|Withdrawal by Subject|2
4499422|NCT00842348|7304506|FG001|Study 729|Withdrawal by Subject|4
4499423|NCT00842348|7304505|FG000|Study 729|Due to Sponsor stopping the study|1
4499424|NCT00842348|7304506|FG001|Study 729|Due to Sponsor stopping the study|1
4499425|NCT00842348|7304505|FG000|Study 729|Due to non-availability of IP|0
4703933|NCT02742649|7622262|FG004|Double-Blind Treatment Period|Adverse Event|0
4703934|NCT02742649|7622258|FG000|Open-Label Period|Lost to Follow-up|0
4703935|NCT02742649|7622259|FG001|Open-Label Period|Lost to Follow-up|0
4703936|NCT02742649|7622260|FG002|Open-Label Period|Lost to Follow-up|0
4703937|NCT02742649|7622261|FG003|Open-Label Period|Lost to Follow-up|0
4703938|NCT02742649|7622262|FG004|Open-Label Period|Lost to Follow-up|1
4703939|NCT02742766|7622292|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
4703940|NCT02742766|7622293|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
4703941|NCT02742766|7622294|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
4703942|NCT02742766|7622295|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
4703943|NCT02742766|7622296|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
4703944|NCT02742766|7622297|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
4499426|NCT00842348|7304506|FG001|Study 729|Due to non-availability of IP|1
4499427|NCT00842348|7304505|FG000|Study 729|Sponsor's decision|1
4703945|NCT02742766|7622298|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
4703946|NCT02742766|7622299|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
4703947|NCT02742766|7622300|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
4703948|NCT02742766|7622301|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
4771248|NCT02978781|7748154|FG003|Part B|Withdrawal by Subject|1
4499428|NCT00842348|7304506|FG001|Study 729|Sponsor's decision|0
4499429|NCT00842348|7304505|FG000|Study 729|Surgical resection|1
4499430|NCT00842348|7304506|FG001|Study 729|Surgical resection|0
4499431|NCT00842361|7304518|FG000|Overall Study|Protocol Violation|1
4499432|NCT00842361|7304519|FG001|Overall Study|Protocol Violation|0
4499433|NCT00842361|7304518|FG000|Overall Study|Unclassified|0
4499434|NCT00842361|7304519|FG001|Overall Study|Unclassified|2
4499435|NCT00842543|7304529|FG000|Overall Study|Withdrawal by Subject|2
4499436|NCT00842543|7304530|FG001|Overall Study|Withdrawal by Subject|0
4499437|NCT00842543|7304531|FG002|Overall Study|Withdrawal by Subject|3
4499438|NCT00842543|7304532|FG003|Overall Study|Withdrawal by Subject|4
4499439|NCT00842712|7304568|FG000|Safety Run-in Part|Adverse Event|0
4499440|NCT00842712|7304569|FG001|Safety Run-in Part|Adverse Event|1
4499441|NCT00842712|7304570|FG002|Safety Run-in Part|Adverse Event|0
4499442|NCT00842712|7304571|FG003|Safety Run-in Part|Adverse Event|0
4499443|NCT00842712|7304572|FG004|Safety Run-in Part|Adverse Event|0
4499444|NCT00842712|7304573|FG005|Safety Run-in Part|Adverse Event|0
4499445|NCT00842712|7304574|FG006|Safety Run-in Part|Adverse Event|0
4499446|NCT00842712|7304568|FG000|Safety Run-in Part|Progressive disease|3
4499447|NCT00842712|7304569|FG001|Safety Run-in Part|Progressive disease|1
4499448|NCT00842712|7304570|FG002|Safety Run-in Part|Progressive disease|0
4499449|NCT00842712|7304571|FG003|Safety Run-in Part|Progressive disease|1
4499450|NCT00842712|7304572|FG004|Safety Run-in Part|Progressive disease|0
4499451|NCT00842712|7304573|FG005|Safety Run-in Part|Progressive disease|0
4499452|NCT00842712|7304574|FG006|Safety Run-in Part|Progressive disease|0
4499453|NCT00842712|7304568|FG000|Randomized Part|Randomized but not treated|0
4499454|NCT00842712|7304569|FG001|Randomized Part|Randomized but not treated|0
4499455|NCT00842712|7304570|FG002|Randomized Part|Randomized but not treated|0
4499456|NCT00842712|7304571|FG003|Randomized Part|Randomized but not treated|0
4499457|NCT00842712|7304572|FG004|Randomized Part|Randomized but not treated|0
4499458|NCT00842712|7304573|FG005|Randomized Part|Randomized but not treated|1
4499459|NCT00842712|7304574|FG006|Randomized Part|Randomized but not treated|4
4499460|NCT00842712|7304568|FG000|Randomized Part|Ongoing at cut-off date|0
4499461|NCT00842712|7304569|FG001|Randomized Part|Ongoing at cut-off date|0
4499462|NCT00842712|7304570|FG002|Randomized Part|Ongoing at cut-off date|0
4499463|NCT00842712|7304571|FG003|Randomized Part|Ongoing at cut-off date|0
4499464|NCT00842712|7304572|FG004|Randomized Part|Ongoing at cut-off date|0
4499465|NCT00842712|7304573|FG005|Randomized Part|Ongoing at cut-off date|0
4499466|NCT00842712|7304574|FG006|Randomized Part|Ongoing at cut-off date|2
4499467|NCT00842829|7304609|FG000|Dose Titration Period|Adverse Event|11
4499468|NCT00842829|7304610|FG001|Dose Titration Period|Adverse Event|10
4499469|NCT00842829|7304611|FG002|Dose Titration Period|Adverse Event|0
4499470|NCT00842829|7304609|FG000|Dose Titration Period|Lack of Efficacy|4
4499471|NCT00842829|7304610|FG001|Dose Titration Period|Lack of Efficacy|1
4499472|NCT00842829|7304611|FG002|Dose Titration Period|Lack of Efficacy|0
4499473|NCT00842829|7304609|FG000|Dose Titration Period|Unstable persistent cancer pain|1
4499474|NCT00842829|7304610|FG001|Dose Titration Period|Unstable persistent cancer pain|0
4499475|NCT00842829|7304611|FG002|Dose Titration Period|Unstable persistent cancer pain|0
4499476|NCT00842829|7304609|FG000|Dose Titration Period|Withdrawal by Subject|2
4499477|NCT00842829|7304610|FG001|Dose Titration Period|Withdrawal by Subject|6
4499478|NCT00842829|7304611|FG002|Dose Titration Period|Withdrawal by Subject|0
4499479|NCT00842829|7304609|FG000|Dose Titration Period|Other|5
4499480|NCT00842829|7304610|FG001|Dose Titration Period|Other|4
4499481|NCT00842829|7304611|FG002|Dose Titration Period|Other|0
4499482|NCT00842829|7304609|FG000|Dose Titration Period|Non-compliance to study procedures|1
4499483|NCT00842829|7304610|FG001|Dose Titration Period|Non-compliance to study procedures|1
4499484|NCT00842829|7304611|FG002|Dose Titration Period|Non-compliance to study procedures|0
4627154|NCT01850615|7493708|FG001|Overall Study|Withdrawal by Subject|1
4627155|NCT01850615|7493707|FG000|Overall Study|Lost to Follow-up|0
4627156|NCT01850615|7493708|FG001|Overall Study|Lost to Follow-up|1
4627157|NCT01850615|7493707|FG000|Overall Study|Unclassified|0
4627158|NCT01850615|7493708|FG001|Overall Study|Unclassified|1
4627159|NCT01850641|7493714|FG000|Overall Study|Physician Decision|1
4627160|NCT01850641|7493714|FG000|Overall Study|Decrease in serum phosphorus|1
4627161|NCT01850641|7493714|FG000|Overall Study|Decrease in serum calcium|2
4627162|NCT01850641|7493714|FG000|Overall Study|Increase in serum ferritin|1
4627163|NCT01850823|7493734|FG000|Overall Study|Early Visit Window|0
4627164|NCT01850823|7493735|FG001|Overall Study|Early Visit Window|1
4627165|NCT01850823|7493736|FG002|Overall Study|Early Visit Window|4
4627166|NCT01850823|7493734|FG000|Overall Study|Enrolled in Error|0
4627167|NCT01850823|7493735|FG001|Overall Study|Enrolled in Error|1
4627168|NCT01850823|7493736|FG002|Overall Study|Enrolled in Error|2
4499485|NCT00842829|7304609|FG000|Dose Titration Period|Non-compliance to study drug|2
4499486|NCT00842829|7304610|FG001|Dose Titration Period|Non-compliance to study drug|1
4499487|NCT00842829|7304611|FG002|Dose Titration Period|Non-compliance to study drug|0
4499488|NCT00842829|7304609|FG000|Treatment Period|Adverse Event|0
4499489|NCT00842829|7304610|FG001|Treatment Period|Adverse Event|0
4499490|NCT00842829|7304611|FG002|Treatment Period|Adverse Event|15
4499491|NCT00842829|7304609|FG000|Treatment Period|Lack of Efficacy|0
4499492|NCT00842829|7304610|FG001|Treatment Period|Lack of Efficacy|0
4627169|NCT01850823|7493734|FG000|Overall Study|Lack of Efficacy|1
4627170|NCT01850823|7493735|FG001|Overall Study|Lack of Efficacy|0
4627171|NCT01850823|7493736|FG002|Overall Study|Lack of Efficacy|0
4499493|NCT00842829|7304611|FG002|Treatment Period|Lack of Efficacy|6
4499494|NCT00842829|7304609|FG000|Treatment Period|Unstable persistent cancer pain|0
4499495|NCT00842829|7304610|FG001|Treatment Period|Unstable persistent cancer pain|0
4499496|NCT00842829|7304611|FG002|Treatment Period|Unstable persistent cancer pain|5
4499497|NCT00842829|7304609|FG000|Treatment Period|Withdrawal by Subject|0
4499498|NCT00842829|7304610|FG001|Treatment Period|Withdrawal by Subject|0
4499499|NCT00842829|7304611|FG002|Treatment Period|Withdrawal by Subject|11
4499500|NCT00842829|7304609|FG000|Treatment Period|Consistently >4 BTP episodes daily|0
4499501|NCT00842829|7304610|FG001|Treatment Period|Consistently >4 BTP episodes daily|0
4499502|NCT00842829|7304611|FG002|Treatment Period|Consistently >4 BTP episodes daily|1
4499503|NCT00842829|7304609|FG000|Treatment Period|Protocol Violation|0
4499504|NCT00842829|7304610|FG001|Treatment Period|Protocol Violation|0
4499505|NCT00842829|7304611|FG002|Treatment Period|Protocol Violation|2
4499506|NCT00842829|7304609|FG000|Treatment Period|Other|0
4499507|NCT00842829|7304610|FG001|Treatment Period|Other|0
4499508|NCT00842829|7304611|FG002|Treatment Period|Other|18
4499509|NCT00842829|7304609|FG000|Treatment Period|Non-compliance to study procedures|0
4499510|NCT00842829|7304610|FG001|Treatment Period|Non-compliance to study procedures|0
4499511|NCT00842829|7304611|FG002|Treatment Period|Non-compliance to study procedures|4
4499512|NCT00842829|7304609|FG000|Treatment Period|Unclear completion status|0
4499513|NCT00842829|7304610|FG001|Treatment Period|Unclear completion status|0
4499514|NCT00842829|7304611|FG002|Treatment Period|Unclear completion status|1
4499515|NCT00842829|7304609|FG000|Continuation Period|Adverse Event|0
4499516|NCT00842829|7304610|FG001|Continuation Period|Adverse Event|0
4499517|NCT00842829|7304611|FG002|Continuation Period|Adverse Event|32
4499518|NCT00842829|7304609|FG000|Continuation Period|Lack of Efficacy|0
4499519|NCT00842829|7304610|FG001|Continuation Period|Lack of Efficacy|0
4499520|NCT00842829|7304611|FG002|Continuation Period|Lack of Efficacy|6
4499521|NCT00842829|7304609|FG000|Continuation Period|Unstable persistent cancer pain|0
4499522|NCT00842829|7304610|FG001|Continuation Period|Unstable persistent cancer pain|0
4499523|NCT00842829|7304611|FG002|Continuation Period|Unstable persistent cancer pain|3
4499524|NCT00842829|7304609|FG000|Continuation Period|Withdrawal by Subject|0
4499525|NCT00842829|7304610|FG001|Continuation Period|Withdrawal by Subject|0
4499526|NCT00842829|7304611|FG002|Continuation Period|Withdrawal by Subject|10
4499527|NCT00842829|7304609|FG000|Continuation Period|Other|0
4499528|NCT00842829|7304610|FG001|Continuation Period|Other|0
4499529|NCT00842829|7304611|FG002|Continuation Period|Other|7
4499530|NCT00842829|7304609|FG000|Continuation Period|Non-compliance to study procedures|0
4499531|NCT00842829|7304610|FG001|Continuation Period|Non-compliance to study procedures|0
4499532|NCT00842829|7304611|FG002|Continuation Period|Non-compliance to study procedures|2
4499533|NCT00842829|7304609|FG000|Continuation Period|Non-compliance to study drug|0
4499534|NCT00842829|7304610|FG001|Continuation Period|Non-compliance to study drug|0
4499535|NCT00842829|7304611|FG002|Continuation Period|Non-compliance to study drug|1
4499536|NCT00842985|7304632|FG000|Screening|Did not meet entrance requirements|27
4499537|NCT00842985|7304632|FG000|First Intervention|Withdrawal by Subject|3
4499538|NCT00842985|7304632|FG000|First Intervention|Protocol Violation|3
4499539|NCT00842985|7304632|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2
4499540|NCT00842985|7304632|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2
4499541|NCT00843024|7304643|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79
4499542|NCT00843024|7304644|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74
4499543|NCT00843024|7304645|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
4499544|NCT00843024|7304646|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
4499545|NCT00843024|7304647|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
4499546|NCT00843024|7304648|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
4499547|NCT00843024|7304643|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36
4499548|NCT00843024|7304644|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31
4499549|NCT00843024|7304645|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
4499550|NCT00843024|7304646|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
4499551|NCT00843024|7304647|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
4499552|NCT00843024|7304648|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
4499553|NCT00843024|7304643|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19
4499554|NCT00843024|7304644|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18
4499555|NCT00843024|7304645|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
4499556|NCT00843024|7304646|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
4499557|NCT00843024|7304647|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
4499558|NCT00843024|7304648|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
4499559|NCT00843024|7304643|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4
4499560|NCT00843024|7304644|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5
4499561|NCT00843024|7304645|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0
4499562|NCT00843024|7304646|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0
4499563|NCT00843024|7304647|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0
4499564|NCT00843024|7304648|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0
4499565|NCT00843024|7304643|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2
4499566|NCT00843024|7304644|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6
4499567|NCT00843024|7304645|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0
4499568|NCT00843024|7304646|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0
4499569|NCT00843024|7304647|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0
4499570|NCT00843024|7304648|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0
4499571|NCT00843024|7304643|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0
4499572|NCT00843024|7304644|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1
4499573|NCT00843024|7304645|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0
4499574|NCT00843024|7304646|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0
4499575|NCT00843024|7304647|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0
4499576|NCT00843024|7304648|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0
4499577|NCT00843024|7304643|FG000|Single-blind Placebo Run-In Phase|Other|0
4499578|NCT00843024|7304644|FG001|Single-blind Placebo Run-In Phase|Other|1
4499579|NCT00843024|7304645|FG002|Single-blind Placebo Run-In Phase|Other|0
4499580|NCT00843024|7304646|FG003|Single-blind Placebo Run-In Phase|Other|0
4499581|NCT00843024|7304647|FG004|Single-blind Placebo Run-In Phase|Other|0
4499582|NCT00843024|7304648|FG005|Single-blind Placebo Run-In Phase|Other|0
4499583|NCT00843024|7304643|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0
4499584|NCT00843024|7304644|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0
4499585|NCT00843024|7304645|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20
4499586|NCT00843024|7304646|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10
4499587|NCT00843024|7304647|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13
4499588|NCT00843024|7304648|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14
4499589|NCT00843024|7304643|FG000|Double-blind Treatment Phase|Lost to Follow-up|0
4499590|NCT00843024|7304644|FG001|Double-blind Treatment Phase|Lost to Follow-up|0
4499591|NCT00843024|7304645|FG002|Double-blind Treatment Phase|Lost to Follow-up|8
4499592|NCT00843024|7304646|FG003|Double-blind Treatment Phase|Lost to Follow-up|4
4499593|NCT00843024|7304647|FG004|Double-blind Treatment Phase|Lost to Follow-up|4
4499594|NCT00843024|7304648|FG005|Double-blind Treatment Phase|Lost to Follow-up|4
4499595|NCT00843024|7304643|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0
4499596|NCT00843024|7304644|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0
4499597|NCT00843024|7304645|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0
4499598|NCT00843024|7304646|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6
4499599|NCT00843024|7304647|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0
4499600|NCT00843024|7304648|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2
4499601|NCT00843024|7304643|FG000|Double-blind Treatment Phase|Protocol Violation|0
4499602|NCT00843024|7304644|FG001|Double-blind Treatment Phase|Protocol Violation|0
4499603|NCT00843024|7304645|FG002|Double-blind Treatment Phase|Protocol Violation|3
4499604|NCT00843024|7304646|FG003|Double-blind Treatment Phase|Protocol Violation|0
4499605|NCT00843024|7304647|FG004|Double-blind Treatment Phase|Protocol Violation|0
4499606|NCT00843024|7304648|FG005|Double-blind Treatment Phase|Protocol Violation|3
4499607|NCT00843024|7304643|FG000|Double-blind Treatment Phase|Physician Decision|0
4499608|NCT00843024|7304644|FG001|Double-blind Treatment Phase|Physician Decision|0
4499609|NCT00843024|7304645|FG002|Double-blind Treatment Phase|Physician Decision|0
4499610|NCT00843024|7304646|FG003|Double-blind Treatment Phase|Physician Decision|3
4499611|NCT00843024|7304647|FG004|Double-blind Treatment Phase|Physician Decision|1
4499612|NCT00843024|7304648|FG005|Double-blind Treatment Phase|Physician Decision|1
4499613|NCT00843024|7304643|FG000|Double-blind Treatment Phase|Adverse Event|0
4499614|NCT00843024|7304644|FG001|Double-blind Treatment Phase|Adverse Event|0
4499615|NCT00843024|7304645|FG002|Double-blind Treatment Phase|Adverse Event|0
4499616|NCT00843024|7304646|FG003|Double-blind Treatment Phase|Adverse Event|0
4499617|NCT00843024|7304647|FG004|Double-blind Treatment Phase|Adverse Event|1
4499618|NCT00843024|7304648|FG005|Double-blind Treatment Phase|Adverse Event|1
4499619|NCT00843024|7304643|FG000|Double-blind Treatment Phase|Lack of Efficacy|0
4499620|NCT00843024|7304644|FG001|Double-blind Treatment Phase|Lack of Efficacy|0
4499621|NCT00843024|7304645|FG002|Double-blind Treatment Phase|Lack of Efficacy|0
4499622|NCT00843024|7304646|FG003|Double-blind Treatment Phase|Lack of Efficacy|0
4499623|NCT00843024|7304647|FG004|Double-blind Treatment Phase|Lack of Efficacy|1
4499624|NCT00843024|7304648|FG005|Double-blind Treatment Phase|Lack of Efficacy|0
4499625|NCT00843115|7304661|FG000|Overall Study|Death|4
4499626|NCT00843115|7304661|FG000|Overall Study|Adverse Event|30
4627172|NCT01850823|7493734|FG000|Overall Study|Lost to Follow-up|0
4627173|NCT01850823|7493735|FG001|Overall Study|Lost to Follow-up|0
4627174|NCT01850823|7493736|FG002|Overall Study|Lost to Follow-up|1
4627175|NCT01850823|7493734|FG000|Overall Study|Restricted Medication|0
4627176|NCT01850823|7493735|FG001|Overall Study|Restricted Medication|0
4627177|NCT01850823|7493736|FG002|Overall Study|Restricted Medication|2
4627178|NCT01850823|7493734|FG000|Overall Study|Significant worstening of SAR|0
4627179|NCT01850823|7493735|FG001|Overall Study|Significant worstening of SAR|1
4703949|NCT02742766|7622302|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
4703950|NCT02742766|7622303|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
4499627|NCT00843115|7304661|FG000|Overall Study|Lost to Follow-up|4
4499628|NCT00843115|7304661|FG000|Overall Study|Withdrawal by Subject|17
4627180|NCT01850823|7493736|FG002|Overall Study|Significant worstening of SAR|0
4703951|NCT02742766|7622304|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
4703952|NCT02742766|7622305|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1
4499629|NCT00843115|7304661|FG000|Overall Study|Family wanted meds stopped|1
4499630|NCT00843115|7304661|FG000|Overall Study|Family does not want continuation|1
4499631|NCT00843115|7304661|FG000|Overall Study|Patient forgot to take meds|1
4499632|NCT00843115|7304661|FG000|Overall Study|Does not meet entrance criteria|1
4499633|NCT00843115|7304661|FG000|Overall Study|Physician Decision|1
4499634|NCT00843115|7304661|FG000|Overall Study|Family discontinued meds|1
4499635|NCT00843115|7304661|FG000|Overall Study|patient took for 2 days then stopped|1
4499636|NCT00843115|7304661|FG000|Overall Study|patient never took the medication|1
4499637|NCT00843115|7304661|FG000|Overall Study|hospitalized due to deterioration|1
4499638|NCT00843115|7304661|FG000|Overall Study|week 12 not done|1
4499639|NCT00843115|7304661|FG000|Overall Study|Syndrome De Glissement|1
4499640|NCT00843167|7304667|FG000|Treatment Period|Adverse Event|1
4499641|NCT00843167|7304668|FG001|Treatment Period|Adverse Event|5
4499642|NCT00843167|7304667|FG000|Treatment Period|Withdrawal by Subject|2
4499643|NCT00843167|7304668|FG001|Treatment Period|Withdrawal by Subject|3
4499644|NCT00843193|7304689|FG000|Overall Study|Adverse Event|2
4499645|NCT00843193|7304690|FG001|Overall Study|Adverse Event|4
4703953|NCT02742766|7622306|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
4703954|NCT02742766|7622307|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
4703955|NCT02742766|7622308|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
4499646|NCT00843193|7304689|FG000|Overall Study|Lack of Efficacy|1
4627181|NCT01850823|7493734|FG000|Overall Study|Withdrawal by Subject|2
4627182|NCT01850823|7493735|FG001|Overall Study|Withdrawal by Subject|0
4627183|NCT01850823|7493736|FG002|Overall Study|Withdrawal by Subject|1
4627184|NCT01851330|7493749|FG000|Overall Study|Lack of Efficacy|10
4627185|NCT01851330|7493750|FG001|Overall Study|Lack of Efficacy|9
4627186|NCT01851330|7493751|FG002|Overall Study|Lack of Efficacy|2
4627187|NCT01851330|7493749|FG000|Overall Study|Lost to Follow-up|1
4627188|NCT01851330|7493750|FG001|Overall Study|Lost to Follow-up|6
4627189|NCT01851330|7493751|FG002|Overall Study|Lost to Follow-up|9
4703956|NCT02742766|7622309|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
4703957|NCT02742766|7622310|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
4703958|NCT02742766|7622292|FG000|Part 2 (Up to 22 Days)|Physician Decision|0
4703959|NCT02742766|7622293|FG001|Part 2 (Up to 22 Days)|Physician Decision|0
4703960|NCT02742766|7622294|FG002|Part 2 (Up to 22 Days)|Physician Decision|0
4703961|NCT02742766|7622295|FG003|Part 2 (Up to 22 Days)|Physician Decision|0
4703962|NCT02742766|7622296|FG004|Part 2 (Up to 22 Days)|Physician Decision|0
4703963|NCT02742766|7622297|FG005|Part 2 (Up to 22 Days)|Physician Decision|0
4703964|NCT02742766|7622298|FG006|Part 2 (Up to 22 Days)|Physician Decision|0
4703965|NCT02742766|7622299|FG007|Part 2 (Up to 22 Days)|Physician Decision|0
4703966|NCT02742766|7622300|FG008|Part 2 (Up to 22 Days)|Physician Decision|0
4703967|NCT02742766|7622301|FG009|Part 2 (Up to 22 Days)|Physician Decision|0
4703968|NCT02742766|7622302|FG010|Part 2 (Up to 22 Days)|Physician Decision|0
4703969|NCT02742766|7622303|FG011|Part 2 (Up to 22 Days)|Physician Decision|0
4703970|NCT02742766|7622304|FG012|Part 2 (Up to 22 Days)|Physician Decision|2
4703971|NCT02742766|7622305|FG013|Part 2 (Up to 22 Days)|Physician Decision|5
4703972|NCT02742766|7622306|FG014|Part 2 (Up to 22 Days)|Physician Decision|0
4703973|NCT02742766|7622307|FG015|Part 2 (Up to 22 Days)|Physician Decision|1
4703974|NCT02742766|7622308|FG016|Part 2 (Up to 22 Days)|Physician Decision|0
4703975|NCT02742766|7622309|FG017|Part 2 (Up to 22 Days)|Physician Decision|0
4703976|NCT02742766|7622310|FG018|Part 2 (Up to 22 Days)|Physician Decision|0
4703977|NCT02742818|7622372|FG000|Overall Study|Adverse Event|0
4703978|NCT02742818|7622373|FG001|Overall Study|Adverse Event|1
4703979|NCT02742818|7622372|FG000|Overall Study|Protocol Violation|0
4703980|NCT02742818|7622373|FG001|Overall Study|Protocol Violation|1
4703981|NCT02743117|7622396|FG000|Overall Study|Lost to Follow-up|0
4703982|NCT02743117|7622397|FG001|Overall Study|Lost to Follow-up|1
4703983|NCT02743117|7622396|FG000|Overall Study|Other|1
4703984|NCT02743117|7622397|FG001|Overall Study|Other|0
4703985|NCT02743221|7622405|FG000|Overall Study|Progressive disease|29
4703986|NCT02743221|7622406|FG001|Overall Study|Progressive disease|38
4703987|NCT02743221|7622405|FG000|Overall Study|Adverse Event|17
4703988|NCT02743221|7622406|FG001|Overall Study|Adverse Event|14
4703989|NCT02743221|7622405|FG000|Overall Study|non medical reason|8
4703990|NCT02743221|7622406|FG001|Overall Study|non medical reason|2
4703991|NCT02743221|7622405|FG000|Overall Study|Physician Decision|2
4703992|NCT02743221|7622406|FG001|Overall Study|Physician Decision|5
4703993|NCT02743221|7622405|FG000|Overall Study|Patient not eligible, not treated|0
4703994|NCT02743221|7622406|FG001|Overall Study|Patient not eligible, not treated|1
4703995|NCT02743520|7622444|FG000|Overall Study|Withdrawal by Subject|1
4703996|NCT02743780|7622462|FG000|Part 3 (7 Days)|Adverse Event|0
4703997|NCT02743780|7622463|FG001|Part 3 (7 Days)|Adverse Event|0
4703998|NCT02743780|7622464|FG002|Part 3 (7 Days)|Adverse Event|1
4703999|NCT02743780|7622465|FG003|Part 3 (7 Days)|Adverse Event|0
4499647|NCT00843193|7304690|FG001|Overall Study|Lack of Efficacy|1
4499648|NCT00843193|7304689|FG000|Overall Study|Protocol Violation|1
4499649|NCT00843193|7304690|FG001|Overall Study|Protocol Violation|2
4627190|NCT01851330|7493749|FG000|Overall Study|Withdrew Consent|2
4704000|NCT02743780|7622466|FG004|Part 3 (7 Days)|Adverse Event|0
4704001|NCT02743793|7622488|FG000|Overall Study|Death|1
4704002|NCT02743793|7622489|FG001|Overall Study|Death|1
4704003|NCT02743793|7622488|FG000|Overall Study|Withdrawal by Subject|0
4704004|NCT02743793|7622489|FG001|Overall Study|Withdrawal by Subject|1
4704005|NCT02743793|7622488|FG000|Overall Study|Screen Failure|4
4627191|NCT01851330|7493750|FG001|Overall Study|Withdrew Consent|1
4627192|NCT01851330|7493751|FG002|Overall Study|Withdrew Consent|0
4627193|NCT01851330|7493749|FG000|Overall Study|Investigator's Discretion|0
4627194|NCT01851330|7493750|FG001|Overall Study|Investigator's Discretion|0
4627195|NCT01851330|7493751|FG002|Overall Study|Investigator's Discretion|1
4627196|NCT01851590|7493762|FG000|Overall Study|Withdrawal by Subject|0
4499650|NCT00843193|7304689|FG000|Overall Study|Lost to Follow-up|1
4499651|NCT00843193|7304690|FG001|Overall Study|Lost to Follow-up|0
4499652|NCT00843193|7304689|FG000|Overall Study|Physician Decision|0
4499653|NCT00843193|7304690|FG001|Overall Study|Physician Decision|1
4499654|NCT00843193|7304689|FG000|Overall Study|Withdrawal by Subject|3
4499655|NCT00843193|7304690|FG001|Overall Study|Withdrawal by Subject|3
4499656|NCT00843284|7304697|FG000|Overall Study|Adverse Event|39
4499657|NCT00843284|7304697|FG000|Overall Study|Lack of Efficacy|5
4499658|NCT00843284|7304697|FG000|Overall Study|Lost to Follow-up|11
4499659|NCT00843284|7304697|FG000|Overall Study|Other|10
4499660|NCT00843284|7304697|FG000|Overall Study|Withdrawal by Subject|4
4499661|NCT00843284|7304697|FG000|Overall Study|Death|3
4499662|NCT00843492|7304740|FG000|Overall Study|Adverse Event|0
4499663|NCT00843492|7304741|FG001|Overall Study|Adverse Event|3
4499664|NCT00843492|7304740|FG000|Overall Study|Lost to Follow-up|4
4499665|NCT00843492|7304741|FG001|Overall Study|Lost to Follow-up|4
4499666|NCT00843492|7304740|FG000|Overall Study|Withdrawal by Subject|0
4499667|NCT00843492|7304741|FG001|Overall Study|Withdrawal by Subject|4
4499668|NCT00843492|7304740|FG000|Overall Study|Immobilization Stopped|1
4499669|NCT00843492|7304741|FG001|Overall Study|Immobilization Stopped|0
4499670|NCT00843492|7304740|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1
4499671|NCT00843492|7304741|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1
4499672|NCT00843492|7304740|FG000|Overall Study|Orthopedic Surgery|0
4499673|NCT00843492|7304741|FG001|Overall Study|Orthopedic Surgery|2
4499674|NCT00843492|7304740|FG000|Overall Study|Visit Not Performed|1
4499675|NCT00843492|7304741|FG001|Overall Study|Visit Not Performed|0
4499676|NCT00843492|7304740|FG000|Overall Study|Deep-vein Thrombosis|1
4499677|NCT00843492|7304741|FG001|Overall Study|Deep-vein Thrombosis|0
4499678|NCT00843518|7304749|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5
4499679|NCT00843518|7304750|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3
4499680|NCT00843518|7304749|FG000|Period 2 (Double-blind Treatment)|Death|0
4499681|NCT00843518|7304750|FG001|Period 2 (Double-blind Treatment)|Death|1
4499682|NCT00843518|7304749|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2
4499683|NCT00843518|7304750|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3
4499684|NCT00843518|7304749|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2
4499685|NCT00843518|7304750|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1
4499686|NCT00843518|7304749|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2
4499687|NCT00843518|7304750|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5
4499688|NCT00843518|7304749|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2
4499689|NCT00843518|7304750|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0
4499690|NCT00843518|7304749|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7
4499691|NCT00843518|7304750|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7
4627197|NCT01851590|7493763|FG001|Overall Study|Withdrawal by Subject|0
4627198|NCT01851590|7493764|FG002|Overall Study|Withdrawal by Subject|1
4627199|NCT01851590|7493762|FG000|Overall Study|Adverse Event|0
4627200|NCT01851590|7493763|FG001|Overall Study|Adverse Event|0
4627201|NCT01851590|7493764|FG002|Overall Study|Adverse Event|2
4627202|NCT01851590|7493762|FG000|Overall Study|Lack of Efficacy|0
4704006|NCT02743793|7622489|FG001|Overall Study|Screen Failure|0
4704007|NCT02743793|7622488|FG000|Overall Study|No Primary Care Physician|0
4704008|NCT02743793|7622489|FG001|Overall Study|No Primary Care Physician|1
4704009|NCT02743793|7622488|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0
4704010|NCT02743793|7622489|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1
4627203|NCT01851590|7493763|FG001|Overall Study|Lack of Efficacy|1
4704011|NCT02743793|7622488|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0
4704012|NCT02743793|7622489|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32
4704013|NCT02743949|7622506|FG000|Overall Study|Adverse Event|0
4704014|NCT02743949|7622507|FG001|Overall Study|Adverse Event|0
4704015|NCT02743949|7622508|FG002|Overall Study|Adverse Event|2
4704016|NCT02743949|7622506|FG000|Overall Study|Significant Protocol Deviation|2
4704017|NCT02743949|7622507|FG001|Overall Study|Significant Protocol Deviation|0
4704018|NCT02743949|7622508|FG002|Overall Study|Significant Protocol Deviation|1
4704019|NCT02743949|7622506|FG000|Overall Study|Voluntary Withdrawal|2
4704020|NCT02743949|7622507|FG001|Overall Study|Voluntary Withdrawal|1
4704021|NCT02743949|7622508|FG002|Overall Study|Voluntary Withdrawal|0
4704022|NCT02743962|7622518|FG000|Overall Study|Atrophic vaginitis diagnosed|1
4704023|NCT02743962|7622519|FG001|Overall Study|Atrophic vaginitis diagnosed|0
4704024|NCT02744066|7622530|FG000|Overall Study|Withdrawal by parent|0
4704025|NCT02744066|7622531|FG001|Overall Study|Withdrawal by parent|1
4704026|NCT02744066|7622530|FG000|Overall Study|Discharged from NICU prior to completion|0
4704027|NCT02744066|7622531|FG001|Overall Study|Discharged from NICU prior to completion|4
4704028|NCT02744391|7622539|FG000|Overall Study|Lost to Follow-up|9
4704029|NCT02744391|7622539|FG000|Overall Study|Physician Decision|2
4499692|NCT00843635|7304780|FG000|Overall Study|Adverse Event|2
4499693|NCT00843635|7304781|FG001|Overall Study|Adverse Event|2
4499694|NCT00843635|7304782|FG002|Overall Study|Adverse Event|0
4499695|NCT00843726|7304805|FG000|Overall Study|Death|1
4499696|NCT00843726|7304806|FG001|Overall Study|Death|0
4499697|NCT00843726|7304805|FG000|Overall Study|Withdrawal by Subject|0
4499698|NCT00843726|7304806|FG001|Overall Study|Withdrawal by Subject|1
4499699|NCT00843778|7304813|FG000|Overall Study|Adverse Event|15
4499700|NCT00843778|7304813|FG000|Overall Study|Lack of Efficacy|14
4499701|NCT00843778|7304813|FG000|Overall Study|Loss of efficacy|2
4499702|NCT00843778|7304813|FG000|Overall Study|Withdrawal by Subject|4
4499703|NCT00843843|7304819|FG000|Overall Study|Physician Decision|1
4499704|NCT00843843|7304820|FG001|Overall Study|Physician Decision|1
4499705|NCT00843843|7304819|FG000|Overall Study|Protocol Violation|1
4499706|NCT00843843|7304820|FG001|Overall Study|Protocol Violation|1
4499707|NCT00843856|7304828|FG000|Overall Study|Lost to Follow-up|1
4499708|NCT00843856|7304829|FG001|Overall Study|Lost to Follow-up|2
4499709|NCT00844194|7304855|FG000|Overall Study|Adverse Event|17
4499710|NCT00844194|7304856|FG001|Overall Study|Adverse Event|5
4499711|NCT00844194|7304855|FG000|Overall Study|Protocol Violation|1
4499712|NCT00844194|7304856|FG001|Overall Study|Protocol Violation|1
4499713|NCT00844194|7304855|FG000|Overall Study|Lost to Follow-up|1
4499714|NCT00844194|7304856|FG001|Overall Study|Lost to Follow-up|1
4499715|NCT00844194|7304855|FG000|Overall Study|Withdrawal by Subject|2
4499716|NCT00844194|7304856|FG001|Overall Study|Withdrawal by Subject|1
4499717|NCT00844194|7304855|FG000|Overall Study|Lack of Efficacy|3
4499718|NCT00844194|7304856|FG001|Overall Study|Lack of Efficacy|0
4499719|NCT00844194|7304855|FG000|Overall Study|Other reason (not specified)|1
4499720|NCT00844194|7304856|FG001|Overall Study|Other reason (not specified)|0
4499721|NCT00844376|7304870|FG000|Period 1: First Intervention|Withdrawal by Subject|1
4499722|NCT00844376|7304871|FG001|Period 1: First Intervention|Withdrawal by Subject|0
4499723|NCT00844415|7304877|FG000|Overall Study|Withdrawal by Subject|1
4499724|NCT00844428|7304882|FG000|Screening Period|Screen Failure|3
4499725|NCT00844428|7304882|FG000|Extension Treatment Period|Death|1
4499726|NCT00844428|7304882|FG000|Post Treatment Period (Patients Who Disc|Death|1
4499727|NCT00844519|7304888|FG000|Overall Study|Withdrawal by Subject|1
4499728|NCT00844519|7304889|FG001|Overall Study|Withdrawal by Subject|1
4499729|NCT00844519|7304888|FG000|Overall Study|Adverse Event|1
4499730|NCT00844519|7304889|FG001|Overall Study|Adverse Event|0
4499731|NCT00844532|7304895|FG000|Overall Study|Death|16
4499732|NCT00844532|7304895|FG000|Overall Study|Withdrawal by Subject|16
4499733|NCT00844532|7304895|FG000|Overall Study|Lost to Follow-up|7
4499734|NCT00844545|7304899|FG000|Treatment Period (26 Weeks)|Adverse Event|1
4499735|NCT00844545|7304899|FG000|Treatment Period (26 Weeks)|Protocol Violation|1
4499736|NCT00844545|7304899|FG000|Extension Treatment Period|Adverse Event|2
4499737|NCT00844545|7304899|FG000|Post Treatment Period|Withdrawal by Subject|1
4499738|NCT00844558|7304906|FG000|Overall Study|Withdrawal by Subject|9
4499739|NCT00844558|7304907|FG001|Overall Study|Withdrawal by Subject|2
4499740|NCT00844558|7304906|FG000|Overall Study|Death|1
4499741|NCT00844558|7304907|FG001|Overall Study|Death|0
4499742|NCT00844558|7304906|FG000|Overall Study|Protocol Violation|1
4499743|NCT00844558|7304907|FG001|Overall Study|Protocol Violation|1
4499744|NCT00844558|7304906|FG000|Overall Study|Lost to Follow-up|0
4499745|NCT00844558|7304907|FG001|Overall Study|Lost to Follow-up|1
4499746|NCT00844558|7304906|FG000|Overall Study|Physician Decision|1
4499747|NCT00844558|7304907|FG001|Overall Study|Physician Decision|0
4499748|NCT00844597|7304924|FG000|Overall Study|Adverse Event|0
4499749|NCT00844597|7304925|FG001|Overall Study|Adverse Event|0
4499750|NCT00844597|7304926|FG002|Overall Study|Adverse Event|0
4499751|NCT00844597|7304927|FG003|Overall Study|Adverse Event|1
4499752|NCT00844597|7304928|FG004|Overall Study|Adverse Event|0
4499753|NCT00844597|7304929|FG005|Overall Study|Adverse Event|0
4499754|NCT00844649|7304947|FG000|Overall Study|Progressive Disease|196
4499755|NCT00844649|7304948|FG001|Overall Study|Progressive Disease|245
4499756|NCT00844649|7304947|FG000|Overall Study|Adverse Event|128
4499757|NCT00844649|7304948|FG001|Overall Study|Adverse Event|73
4499758|NCT00844649|7304947|FG000|Overall Study|Physician Decision|25
4499759|NCT00844649|7304948|FG001|Overall Study|Physician Decision|18
4499760|NCT00844649|7304947|FG000|Overall Study|Protocol Violation|10
4499761|NCT00844649|7304948|FG001|Overall Study|Protocol Violation|6
4499762|NCT00844649|7304947|FG000|Overall Study|Withdrawal by Subject|28
4499763|NCT00844649|7304948|FG001|Overall Study|Withdrawal by Subject|39
4499764|NCT00844649|7304947|FG000|Overall Study|Other|7
4499765|NCT00844649|7304948|FG001|Overall Study|Other|10
4499766|NCT00844649|7304947|FG000|Overall Study|Withdrew prior to starting treatment|11
4499767|NCT00844649|7304948|FG001|Overall Study|Withdrew prior to starting treatment|27
4499768|NCT00844753|7304964|FG000|Overall Study|Lack of Efficacy|1
4499769|NCT00844753|7304965|FG001|Overall Study|Lack of Efficacy|0
4499770|NCT00844753|7304966|FG002|Overall Study|Lack of Efficacy|2
4499771|NCT00844753|7304967|FG003|Overall Study|Lack of Efficacy|2
4499772|NCT00844753|7304964|FG000|Overall Study|Adverse Event|3
4499773|NCT00844753|7304965|FG001|Overall Study|Adverse Event|2
4499774|NCT00844753|7304966|FG002|Overall Study|Adverse Event|5
4499775|NCT00844753|7304967|FG003|Overall Study|Adverse Event|5
4499776|NCT00844753|7304964|FG000|Overall Study|Lost to Follow-up|1
4499777|NCT00844753|7304965|FG001|Overall Study|Lost to Follow-up|1
4499778|NCT00844753|7304966|FG002|Overall Study|Lost to Follow-up|0
4499779|NCT00844753|7304967|FG003|Overall Study|Lost to Follow-up|1
4499780|NCT00844753|7304964|FG000|Overall Study|could not swallow medication|2
4499781|NCT00844753|7304965|FG001|Overall Study|could not swallow medication|0
4499782|NCT00844753|7304966|FG002|Overall Study|could not swallow medication|0
4499783|NCT00844753|7304967|FG003|Overall Study|could not swallow medication|0
4499784|NCT00844753|7304964|FG000|Overall Study|Withdrawal by Subject|1
4499785|NCT00844753|7304965|FG001|Overall Study|Withdrawal by Subject|0
4499786|NCT00844753|7304966|FG002|Overall Study|Withdrawal by Subject|0
4499787|NCT00844753|7304967|FG003|Overall Study|Withdrawal by Subject|3
4499788|NCT00844805|7304977|FG000|Treatment Phase|Adverse Event|5
4499789|NCT00844805|7304978|FG001|Treatment Phase|Adverse Event|1
4499790|NCT00844805|7304979|FG002|Treatment Phase|Adverse Event|0
4499791|NCT00844805|7304980|FG003|Treatment Phase|Adverse Event|0
4499792|NCT00844805|7304977|FG000|Treatment Phase|Withdrawal by Subject|3
4499793|NCT00844805|7304978|FG001|Treatment Phase|Withdrawal by Subject|4
4499794|NCT00844805|7304979|FG002|Treatment Phase|Withdrawal by Subject|0
4499795|NCT00844805|7304980|FG003|Treatment Phase|Withdrawal by Subject|0
4499796|NCT00844805|7304977|FG000|Treatment Phase|Noncompliance With Protocol|1
4499797|NCT00844805|7304978|FG001|Treatment Phase|Noncompliance With Protocol|0
4499798|NCT00844805|7304979|FG002|Treatment Phase|Noncompliance With Protocol|0
4499799|NCT00844805|7304980|FG003|Treatment Phase|Noncompliance With Protocol|0
4499800|NCT00844805|7304977|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1
4499801|NCT00844805|7304978|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2
4499802|NCT00844805|7304979|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0
4499803|NCT00844805|7304980|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0
4499804|NCT00844805|7304977|FG000|Follow-Up Phase|Adverse Event|0
4499805|NCT00844805|7304978|FG001|Follow-Up Phase|Adverse Event|0
4499806|NCT00844805|7304979|FG002|Follow-Up Phase|Adverse Event|1
4499807|NCT00844805|7304980|FG003|Follow-Up Phase|Adverse Event|0
4499808|NCT00844805|7304977|FG000|Follow-Up Phase|Withdrawal by Subject|0
4499809|NCT00844805|7304978|FG001|Follow-Up Phase|Withdrawal by Subject|0
4499810|NCT00844805|7304979|FG002|Follow-Up Phase|Withdrawal by Subject|6
4499811|NCT00844805|7304980|FG003|Follow-Up Phase|Withdrawal by Subject|3
4499812|NCT00844805|7304977|FG000|Follow-Up Phase|Noncompliance With Protocol|0
4499813|NCT00844805|7304978|FG001|Follow-Up Phase|Noncompliance With Protocol|0
4499814|NCT00844805|7304979|FG002|Follow-Up Phase|Noncompliance With Protocol|0
4499815|NCT00844805|7304980|FG003|Follow-Up Phase|Noncompliance With Protocol|1
4499816|NCT00844805|7304977|FG000|Follow-Up Phase|Relapse/Recurrence|0
4499817|NCT00844805|7304978|FG001|Follow-Up Phase|Relapse/Recurrence|0
4499818|NCT00844805|7304979|FG002|Follow-Up Phase|Relapse/Recurrence|2
4499819|NCT00844805|7304980|FG003|Follow-Up Phase|Relapse/Recurrence|4
4499820|NCT00844805|7304977|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
4499821|NCT00844805|7304978|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
4499822|NCT00844805|7304979|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
4499823|NCT00844805|7304980|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1
4499824|NCT00844831|7304991|FG000|Overall Study|Withdrawal by Subject|4
4499825|NCT00844831|7304991|FG000|Overall Study|Adverse Event|1
4499826|NCT00844831|7304991|FG000|Overall Study|Physician Decision|1
4499827|NCT00844844|7304999|FG000|Treatment Period (26 Weeks)|Adverse Event|1
4499828|NCT00844844|7304999|FG000|Treatment Period (26 Weeks)|Protocol Violation|1
4499829|NCT00844844|7304999|FG000|Extension Treatment Period|Adverse Event|2
4499830|NCT00844844|7304999|FG000|Post Treatment Period|Withdrawal by Subject|1
4499831|NCT00844857|7305005|FG000|Overall Study|Adverse Event|24
4499832|NCT00844857|7305006|FG001|Overall Study|Adverse Event|5
4499833|NCT00844857|7305005|FG000|Overall Study|Sponsor Decision|1
4499834|NCT00844857|7305006|FG001|Overall Study|Sponsor Decision|1
4499835|NCT00844857|7305005|FG000|Overall Study|Physician Decision|2
4499836|NCT00844857|7305006|FG001|Overall Study|Physician Decision|0
4499837|NCT00844857|7305005|FG000|Overall Study|Parent/Caregiver Decision|6
4499838|NCT00844857|7305006|FG001|Overall Study|Parent/Caregiver Decision|2
4499839|NCT00844857|7305005|FG000|Overall Study|Withdrawal by Subject|8
4499840|NCT00844857|7305006|FG001|Overall Study|Withdrawal by Subject|7
4499841|NCT00844857|7305005|FG000|Overall Study|Protocol Violation|6
4499842|NCT00844857|7305006|FG001|Overall Study|Protocol Violation|0
4499843|NCT00844857|7305005|FG000|Overall Study|Lack of Efficacy|5
4499844|NCT00844857|7305006|FG001|Overall Study|Lack of Efficacy|5
4499845|NCT00844857|7305005|FG000|Overall Study|Clinical Relapse|0
4499846|NCT00844857|7305006|FG001|Overall Study|Clinical Relapse|1
4499847|NCT00844857|7305005|FG000|Overall Study|Entry Criteria Not Met|0
4499848|NCT00844857|7305006|FG001|Overall Study|Entry Criteria Not Met|1
4499849|NCT00844857|7305005|FG000|Overall Study|Lost to Follow-up|2
4499850|NCT00844857|7305006|FG001|Overall Study|Lost to Follow-up|3
4499851|NCT00844857|7305005|FG000|Overall Study|Did Not Take Study Drug|3
4499852|NCT00844857|7305006|FG001|Overall Study|Did Not Take Study Drug|1
4499853|NCT00844857|7305005|FG000|Overall Study|Good Clinical Practice Violations|21
4499854|NCT00844857|7305006|FG001|Overall Study|Good Clinical Practice Violations|11
4499855|NCT00844883|7305015|FG000|Overall Study|Bridged to liver transplant|3
4499856|NCT00844883|7305015|FG000|Overall Study|Bridged to resection|1
4499857|NCT00844896|7305021|FG000|Overall Study|Lost to Follow-up|12
4499858|NCT00844896|7305022|FG001|Overall Study|Lost to Follow-up|16
4499859|NCT00844896|7305021|FG000|Overall Study|Parents did not have time to complete|0
4499860|NCT00844896|7305022|FG001|Overall Study|Parents did not have time to complete|1
4499861|NCT00845065|7305061|FG000|Overall Study|Adverse Event|3
4499862|NCT00845065|7305062|FG001|Overall Study|Adverse Event|23
4499863|NCT00845065|7305061|FG000|Overall Study|Lack of Efficacy|43
4499864|NCT00845065|7305062|FG001|Overall Study|Lack of Efficacy|21
4499865|NCT00845065|7305061|FG000|Overall Study|Non-Medical Reasons|1
4499866|NCT00845065|7305062|FG001|Overall Study|Non-Medical Reasons|11
4499867|NCT00845182|7305082|FG000|Overall Study|Lost to Follow-up|3
4499868|NCT00845182|7305083|FG001|Overall Study|Lost to Follow-up|3
4499869|NCT00845182|7305084|FG002|Overall Study|Lost to Follow-up|4
4499870|NCT00845182|7305082|FG000|Overall Study|Adverse Event|0
4499871|NCT00845182|7305083|FG001|Overall Study|Adverse Event|1
4499872|NCT00845182|7305084|FG002|Overall Study|Adverse Event|1
4499873|NCT00845182|7305082|FG000|Overall Study|Physician Decision|0
4499874|NCT00845182|7305083|FG001|Overall Study|Physician Decision|0
4499875|NCT00845182|7305084|FG002|Overall Study|Physician Decision|1
4499876|NCT00845429|7305108|FG000|Overall Study|Protocol Violation|5
4499877|NCT00845429|7305109|FG001|Overall Study|Protocol Violation|4
4499878|NCT00845429|7305110|FG002|Overall Study|Protocol Violation|7
4499879|NCT00845429|7305108|FG000|Overall Study|Lost to Follow-up|7
4499880|NCT00845429|7305109|FG001|Overall Study|Lost to Follow-up|9
4499881|NCT00845429|7305110|FG002|Overall Study|Lost to Follow-up|10
4499882|NCT00845429|7305108|FG000|Overall Study|Withdrawal by Subject|2
4499883|NCT00845429|7305109|FG001|Overall Study|Withdrawal by Subject|2
4704030|NCT02744391|7622539|FG000|Overall Study|Withdrawal by Subject|3
4704031|NCT02744755|7622551|FG000|Study Period 1|Protocol Violation|2
4704032|NCT02744755|7622552|FG001|Study Period 1|Protocol Violation|1
4704033|NCT02744755|7622551|FG000|Study Period 1|not defined|0
4704034|NCT02744755|7622552|FG001|Study Period 1|not defined|1
4704035|NCT02744755|7622551|FG000|Study Period 1|Pregnancy|1
4704036|NCT02744755|7622552|FG001|Study Period 1|Pregnancy|0
4704037|NCT02744755|7622551|FG000|Study Period 1|Adverse Event|1
4704038|NCT02744755|7622552|FG001|Study Period 1|Adverse Event|1
4704039|NCT02744755|7622551|FG000|Study Period 1|Lost to Follow-up|1
4704040|NCT02744755|7622552|FG001|Study Period 1|Lost to Follow-up|1
4704041|NCT02744755|7622551|FG000|Study Period 1|Lack of Efficacy|1
4704042|NCT02744755|7622552|FG001|Study Period 1|Lack of Efficacy|0
4704043|NCT02744755|7622551|FG000|Study Period 1|Withdrawal by Subject|8
4704044|NCT02744755|7622552|FG001|Study Period 1|Withdrawal by Subject|4
4704045|NCT02744755|7622551|FG000|Study Period 2|Adverse Event|5
4704046|NCT02744755|7622552|FG001|Study Period 2|Adverse Event|0
4704047|NCT02744755|7622551|FG000|Study Period 2|Protocol Violation|1
4704048|NCT02744755|7622552|FG001|Study Period 2|Protocol Violation|0
4704049|NCT02744755|7622551|FG000|Study Period 2|not defined|3
4704050|NCT02744755|7622552|FG001|Study Period 2|not defined|2
4704051|NCT02744755|7622551|FG000|Study Period 2|Lost to Follow-up|0
4704052|NCT02744755|7622552|FG001|Study Period 2|Lost to Follow-up|2
4704053|NCT02744755|7622551|FG000|Study Period 2|Withdrawal by Subject|2
4704054|NCT02744755|7622552|FG001|Study Period 2|Withdrawal by Subject|2
4704055|NCT02744755|7622551|FG000|Study Period 2|Lack of Efficacy|3
4704056|NCT02744755|7622552|FG001|Study Period 2|Lack of Efficacy|2
4704057|NCT02744898|7622570|FG000|Overall Study|Progressive Disease|2
4704058|NCT02744898|7622570|FG000|Overall Study|Physician Decision|1
4704059|NCT02744898|7622570|FG000|Overall Study|Toxicity|1
4735448|NCT03529409|7683439|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4
4735449|NCT03529409|7683440|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0
4735450|NCT03529409|7683438|FG000|Follow-up Assessment|Death|1
4735451|NCT03529409|7683439|FG001|Follow-up Assessment|Death|0
4735452|NCT03529409|7683440|FG002|Follow-up Assessment|Death|0
4735453|NCT03529409|7683438|FG000|Follow-up Assessment|Withdrawal by Subject|0
4735454|NCT03529409|7683439|FG001|Follow-up Assessment|Withdrawal by Subject|1
4735455|NCT03529409|7683440|FG002|Follow-up Assessment|Withdrawal by Subject|0
4735456|NCT03530345|7683469|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1
4735457|NCT03530345|7683470|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0
4735458|NCT03530345|7683469|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3
4735459|NCT03530345|7683470|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1
4735460|NCT03530345|7683469|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17
4735461|NCT03530345|7683470|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21
4735462|NCT03530345|7683469|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5
4735463|NCT03530345|7683470|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7
4735464|NCT03531840|7683560|FG000|Overall Study|Death on study|3
4735465|NCT03531840|7683561|FG001|Overall Study|Death on study|2
4735466|NCT03531840|7683562|FG002|Overall Study|Death on study|1
4735467|NCT03531840|7683563|FG003|Overall Study|Death on study|2
4735468|NCT03531840|7683560|FG000|Overall Study|Death during follow up|2
4735469|NCT03531840|7683561|FG001|Overall Study|Death during follow up|3
4735470|NCT03531840|7683562|FG002|Overall Study|Death during follow up|4
4499884|NCT00845429|7305110|FG002|Overall Study|Withdrawal by Subject|2
4499885|NCT00845429|7305108|FG000|Overall Study|Serious adverse event|0
4499886|NCT00845429|7305109|FG001|Overall Study|Serious adverse event|0
4735471|NCT03531840|7683563|FG003|Overall Study|Death during follow up|1
4499887|NCT00845429|7305110|FG002|Overall Study|Serious adverse event|1
4499888|NCT00845520|7305139|FG000|Overall Study|Death|1
4499889|NCT00845520|7305140|FG001|Overall Study|Death|2
4704060|NCT02745080|7622576|FG000|Overall Study|Adverse Event|13
4704061|NCT02745080|7622577|FG001|Overall Study|Adverse Event|21
4704062|NCT02745080|7622576|FG000|Overall Study|Lack of Efficacy|11
4704063|NCT02745080|7622577|FG001|Overall Study|Lack of Efficacy|23
4704064|NCT02745080|7622576|FG000|Overall Study|Lost to Follow-up|3
4704065|NCT02745080|7622577|FG001|Overall Study|Lost to Follow-up|3
4704066|NCT02745080|7622576|FG000|Overall Study|Physician Decision|3
4704067|NCT02745080|7622577|FG001|Overall Study|Physician Decision|0
4704068|NCT02745080|7622576|FG000|Overall Study|Protocol Violation|3
4704069|NCT02745080|7622577|FG001|Overall Study|Protocol Violation|1
4704070|NCT02745080|7622576|FG000|Overall Study|Withdrawal by Subject|22
4704071|NCT02745080|7622577|FG001|Overall Study|Withdrawal by Subject|41
4704072|NCT02745119|7622588|FG000|Overall Study|Adverse Event|1
4704073|NCT02745119|7622589|FG001|Overall Study|Adverse Event|0
4704074|NCT02745119|7622590|FG002|Overall Study|Adverse Event|1
4704075|NCT02745119|7622591|FG003|Overall Study|Adverse Event|3
4704076|NCT02745119|7622588|FG000|Overall Study|Death|3
4704077|NCT02745119|7622589|FG001|Overall Study|Death|3
4704078|NCT02745119|7622590|FG002|Overall Study|Death|0
4704079|NCT02745119|7622591|FG003|Overall Study|Death|4
4704080|NCT02745119|7622588|FG000|Overall Study|Lost to Follow-up|0
4704081|NCT02745119|7622589|FG001|Overall Study|Lost to Follow-up|0
4704082|NCT02745119|7622590|FG002|Overall Study|Lost to Follow-up|0
4704083|NCT02745119|7622591|FG003|Overall Study|Lost to Follow-up|1
4704084|NCT02745119|7622588|FG000|Overall Study|Protocol Deviation|0
4704085|NCT02745119|7622589|FG001|Overall Study|Protocol Deviation|0
4704086|NCT02745119|7622590|FG002|Overall Study|Protocol Deviation|0
4704087|NCT02745119|7622591|FG003|Overall Study|Protocol Deviation|1
4704088|NCT02745119|7622588|FG000|Overall Study|Withdrawal by Subject|7
4704089|NCT02745119|7622589|FG001|Overall Study|Withdrawal by Subject|15
4704090|NCT02745119|7622590|FG002|Overall Study|Withdrawal by Subject|8
4704091|NCT02745119|7622591|FG003|Overall Study|Withdrawal by Subject|14
4704092|NCT02745119|7622588|FG000|Overall Study|Study Terminated by Sponsor|134
4704093|NCT02745119|7622589|FG001|Overall Study|Study Terminated by Sponsor|252
4704094|NCT02745119|7622590|FG002|Overall Study|Study Terminated by Sponsor|135
4704095|NCT02745119|7622591|FG003|Overall Study|Study Terminated by Sponsor|251
4704096|NCT02745119|7622588|FG000|Overall Study|Physician Decision|0
4704097|NCT02745119|7622589|FG001|Overall Study|Physician Decision|2
4704098|NCT02745119|7622590|FG002|Overall Study|Physician Decision|2
4704099|NCT02745119|7622591|FG003|Overall Study|Physician Decision|2
4704100|NCT02745119|7622588|FG000|Overall Study|Reason Not Specified|0
4704101|NCT02745119|7622589|FG001|Overall Study|Reason Not Specified|2
4704102|NCT02745119|7622590|FG002|Overall Study|Reason Not Specified|0
4704103|NCT02745119|7622591|FG003|Overall Study|Reason Not Specified|1
4704104|NCT02745145|7622606|FG000|Overall Study|Adverse Event|1
4704105|NCT02745145|7622607|FG001|Overall Study|Adverse Event|0
4704106|NCT02745145|7622608|FG002|Overall Study|Adverse Event|0
4704107|NCT02745145|7622606|FG000|Overall Study|Death|0
4704108|NCT02745145|7622607|FG001|Overall Study|Death|1
4704109|NCT02745145|7622608|FG002|Overall Study|Death|0
4704110|NCT02745145|7622606|FG000|Overall Study|Progressive disease|0
4704111|NCT02745145|7622607|FG001|Overall Study|Progressive disease|0
4704112|NCT02745145|7622608|FG002|Overall Study|Progressive disease|1
4704113|NCT02745145|7622606|FG000|Overall Study|Withdrew consent|1
4704114|NCT02745145|7622607|FG001|Overall Study|Withdrew consent|1
4704115|NCT02745145|7622608|FG002|Overall Study|Withdrew consent|1
4704116|NCT02745145|7622606|FG000|Overall Study|Study Termination|8
4704117|NCT02745145|7622607|FG001|Overall Study|Study Termination|3
4704118|NCT02745145|7622608|FG002|Overall Study|Study Termination|7
4704119|NCT02745392|7622629|FG000|Overall Study|Lost to Follow-up|0
4704120|NCT02745392|7622630|FG001|Overall Study|Lost to Follow-up|1
4704121|NCT02745392|7622631|FG002|Overall Study|Lost to Follow-up|0
4704122|NCT02745392|7622632|FG003|Overall Study|Lost to Follow-up|0
4704123|NCT02746575|7622674|FG000|Overall Study|Surgery cancelled or time chaned|13
4704124|NCT02746575|7622674|FG000|Overall Study|Received epidural|10
4704125|NCT02746575|7622674|FG000|Overall Study|Withdrawal by Subject|3
4704126|NCT02746575|7622674|FG000|Overall Study|Bradycardia/hypotension|9
4704127|NCT02746575|7622674|FG000|Overall Study|Study paused|8
4704128|NCT02746575|7622674|FG000|Overall Study|put on beta-blocker|3
4704129|NCT02746575|7622674|FG000|Overall Study|type of surgery|1
4704130|NCT02746575|7622674|FG000|Overall Study|typ of surgery|1
4704131|NCT02746575|7622674|FG000|Overall Study|PI unavailable|1
4704132|NCT02746575|7622674|FG000|Overall Study|Unknown history of CVA|1
4704133|NCT02746627|7622681|FG000|Overall Study|Withdrawal by Subject|1
4704134|NCT02746627|7622682|FG001|Overall Study|Withdrawal by Subject|1
4704135|NCT02746627|7622683|FG002|Overall Study|Withdrawal by Subject|1
4499890|NCT00845520|7305141|FG002|Overall Study|Death|0
4704136|NCT02746679|7622693|FG000|Overall Study|Lost to Follow-up|4
4704137|NCT02746679|7622694|FG001|Overall Study|Lost to Follow-up|6
4704138|NCT02746705|7622702|FG000|Overall Study|Physician Decision|1
4704139|NCT02746705|7622703|FG001|Overall Study|Physician Decision|1
4704140|NCT02746705|7622702|FG000|Overall Study|Lost to Follow-up|1
4499891|NCT00845520|7305139|FG000|Overall Study|Lost to Follow-up|1
4704141|NCT02746705|7622703|FG001|Overall Study|Lost to Follow-up|0
4499892|NCT00845520|7305140|FG001|Overall Study|Lost to Follow-up|0
4499893|NCT00845520|7305141|FG002|Overall Study|Lost to Follow-up|0
4499894|NCT00845520|7305139|FG000|Overall Study|Adverse Event|0
4499895|NCT00845520|7305140|FG001|Overall Study|Adverse Event|0
4499896|NCT00845520|7305141|FG002|Overall Study|Adverse Event|1
4499897|NCT00845650|7305161|FG000|Overall Study|Withdrawal by Subject|0
4499898|NCT00845650|7305162|FG001|Overall Study|Withdrawal by Subject|0
4704142|NCT02746705|7622702|FG000|Overall Study|outlier scores deemed not valid|0
4499899|NCT00845650|7305163|FG002|Overall Study|Withdrawal by Subject|0
4499900|NCT00845650|7305164|FG003|Overall Study|Withdrawal by Subject|0
4499901|NCT00845650|7305165|FG004|Overall Study|Withdrawal by Subject|2
4499902|NCT00845650|7305166|FG005|Overall Study|Withdrawal by Subject|0
4499903|NCT00845650|7305161|FG000|Overall Study|Lost to Follow-up|0
4499904|NCT00845650|7305162|FG001|Overall Study|Lost to Follow-up|0
4499905|NCT00845650|7305163|FG002|Overall Study|Lost to Follow-up|3
4499906|NCT00845650|7305164|FG003|Overall Study|Lost to Follow-up|1
4499907|NCT00845650|7305165|FG004|Overall Study|Lost to Follow-up|0
4499908|NCT00845650|7305166|FG005|Overall Study|Lost to Follow-up|1
4499909|NCT00845650|7305161|FG000|Overall Study|Sponsor hold on dosing|0
4499910|NCT00845650|7305162|FG001|Overall Study|Sponsor hold on dosing|0
4499911|NCT00845650|7305163|FG002|Overall Study|Sponsor hold on dosing|0
4499912|NCT00845650|7305164|FG003|Overall Study|Sponsor hold on dosing|0
4499913|NCT00845650|7305165|FG004|Overall Study|Sponsor hold on dosing|1
4499914|NCT00845650|7305166|FG005|Overall Study|Sponsor hold on dosing|1
4499915|NCT00845650|7305161|FG000|Overall Study|Unable to access IV line|1
4499916|NCT00845650|7305162|FG001|Overall Study|Unable to access IV line|0
4499917|NCT00845650|7305163|FG002|Overall Study|Unable to access IV line|0
4499918|NCT00845650|7305164|FG003|Overall Study|Unable to access IV line|0
4499919|NCT00845650|7305165|FG004|Overall Study|Unable to access IV line|0
4499920|NCT00845650|7305166|FG005|Overall Study|Unable to access IV line|0
4499921|NCT00845676|7305191|FG000|Overall Study|Virologic breakthrough at week 20|1
4499922|NCT00845676|7305191|FG000|Overall Study|Adverse Event|1
4499923|NCT00845728|7305198|FG000|Overall Study|Abnormal laboratory value (s)|2
4499924|NCT00845728|7305199|FG001|Overall Study|Abnormal laboratory value (s)|2
4499925|NCT00845728|7305198|FG000|Overall Study|Patient's inability to use the device|4
4499926|NCT00845728|7305199|FG001|Overall Study|Patient's inability to use the device|6
4499927|NCT00845728|7305198|FG000|Overall Study|Abnormal test procedure result (s)|7
4499928|NCT00845728|7305199|FG001|Overall Study|Abnormal test procedure result (s)|2
4499929|NCT00845728|7305198|FG000|Overall Study|Lost to Follow-up|22
4499930|NCT00845728|7305199|FG001|Overall Study|Lost to Follow-up|13
4499931|NCT00845728|7305198|FG000|Overall Study|Death|24
4499932|NCT00845728|7305199|FG001|Overall Study|Death|26
4499933|NCT00845728|7305198|FG000|Overall Study|Administrative Problems|34
4499934|NCT00845728|7305199|FG001|Overall Study|Administrative Problems|26
4499935|NCT00845728|7305198|FG000|Overall Study|Protocol Violation|36
4499936|NCT00845728|7305199|FG001|Overall Study|Protocol Violation|24
4499937|NCT00845728|7305198|FG000|Overall Study|Lack of Efficacy|51
4499938|NCT00845728|7305199|FG001|Overall Study|Lack of Efficacy|39
4499939|NCT00845728|7305198|FG000|Overall Study|Adverse Event|101
4499940|NCT00845728|7305199|FG001|Overall Study|Adverse Event|96
4499941|NCT00845728|7305198|FG000|Overall Study|Withdrawal by Subject|105
4499942|NCT00845728|7305199|FG001|Overall Study|Withdrawal by Subject|108
4499943|NCT00845832|7305208|FG000|Treatment Period|Adverse Event|0
4499944|NCT00845832|7305209|FG001|Treatment Period|Adverse Event|2
4499945|NCT00845832|7305210|FG002|Treatment Period|Adverse Event|0
4499946|NCT00845832|7305208|FG000|Treatment Period|Protocol Violation|1
4499947|NCT00845832|7305209|FG001|Treatment Period|Protocol Violation|1
4499948|NCT00845832|7305210|FG002|Treatment Period|Protocol Violation|0
4499949|NCT00845832|7305208|FG000|Safety Follow-Up|Withdrawal by Subject|1
4499950|NCT00845832|7305209|FG001|Safety Follow-Up|Withdrawal by Subject|0
4499951|NCT00845832|7305210|FG002|Safety Follow-Up|Withdrawal by Subject|0
4499952|NCT00845832|7305208|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0
4499953|NCT00845832|7305209|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0
4499954|NCT00845832|7305210|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7
4499955|NCT00845858|7305221|FG000|Overall Study|Withdrawal by Subject|5
4499956|NCT00845858|7305222|FG001|Overall Study|Withdrawal by Subject|1
4499957|NCT00845858|7305223|FG002|Overall Study|Withdrawal by Subject|1
4499958|NCT00845858|7305221|FG000|Overall Study|Adverse Event|3
4499959|NCT00845858|7305222|FG001|Overall Study|Adverse Event|8
4499960|NCT00845858|7305223|FG002|Overall Study|Adverse Event|4
4499961|NCT00845858|7305221|FG000|Overall Study|Protocol Violation|0
4499962|NCT00845858|7305222|FG001|Overall Study|Protocol Violation|0
4499963|NCT00845858|7305223|FG002|Overall Study|Protocol Violation|1
4499964|NCT00845858|7305221|FG000|Overall Study|not eligible|0
4499965|NCT00845858|7305222|FG001|Overall Study|not eligible|3
4499966|NCT00845858|7305223|FG002|Overall Study|not eligible|2
4499967|NCT00845871|7305234|FG000|Assessment Period|Adverse Event|2
4499968|NCT00845871|7305234|FG000|Assessment Period|Abnormal laboratory values|1
4499969|NCT00845871|7305234|FG000|Assessment Period|Abnormal test procedure results|1
4499970|NCT00845871|7305234|FG000|Assessment Period|Patient withdrew consent|3
4499971|NCT00845897|7305261|FG000|Overall Study|Lost to Follow-up|1
4499972|NCT00845897|7305262|FG001|Overall Study|Lost to Follow-up|1
4499973|NCT00845897|7305263|FG002|Overall Study|Lost to Follow-up|0
4499974|NCT00845897|7305261|FG000|Overall Study|Withdrawal by Subject|0
4499975|NCT00845897|7305262|FG001|Overall Study|Withdrawal by Subject|3
4499976|NCT00845897|7305263|FG002|Overall Study|Withdrawal by Subject|2
4499977|NCT00845897|7305261|FG000|Overall Study|Ulcer did not heal|1
4499978|NCT00845897|7305262|FG001|Overall Study|Ulcer did not heal|0
4499979|NCT00845897|7305263|FG002|Overall Study|Ulcer did not heal|1
4499980|NCT00845897|7305261|FG000|Overall Study|Too ill to participate|0
4499981|NCT00845897|7305262|FG001|Overall Study|Too ill to participate|1
4499982|NCT00845897|7305263|FG002|Overall Study|Too ill to participate|0
4499983|NCT00846027|7305280|FG000|Overall Study|Death|3
4499984|NCT00846027|7305280|FG000|Overall Study|Disease Progression|30
4499985|NCT00846027|7305280|FG000|Overall Study|Toxicity|12
4499986|NCT00846027|7305280|FG000|Overall Study|Patient Decision|7
4499987|NCT00846027|7305280|FG000|Overall Study|Investigator Discretion|29
4499988|NCT00846027|7305280|FG000|Overall Study|Protocol Violation|2
4499989|NCT00846027|7305280|FG000|Overall Study|Subject Not Treated|7
4499990|NCT00846040|7305287|FG000|Baseline: Days 1-5|Withdrawal by Subject|1
4499991|NCT00846040|7305288|FG001|Baseline: Days 1-5|Withdrawal by Subject|0
4499992|NCT00846040|7305289|FG002|Baseline: Days 1-5|Withdrawal by Subject|0
4499993|NCT00846040|7305287|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0
4499994|NCT00846040|7305288|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2
4499995|NCT00846040|7305289|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0
4499996|NCT00846053|7305300|FG000|Overall Study|Physician Decision|3
4499997|NCT00846053|7305301|FG001|Overall Study|Physician Decision|0
4499998|NCT00846365|7305331|FG000|Overall Study|Adverse Event|20
4499999|NCT00846365|7305332|FG001|Overall Study|Adverse Event|30
4500000|NCT00846365|7305333|FG002|Overall Study|Adverse Event|11
4500001|NCT00846365|7305331|FG000|Overall Study|Protocol Violation|5
4500002|NCT00846365|7305332|FG001|Overall Study|Protocol Violation|4
4500003|NCT00846365|7305333|FG002|Overall Study|Protocol Violation|0
4500004|NCT00846365|7305331|FG000|Overall Study|Lost to Follow-up|8
4500005|NCT00846365|7305332|FG001|Overall Study|Lost to Follow-up|2
4704143|NCT02746705|7622703|FG001|Overall Study|outlier scores deemed not valid|1
4704144|NCT02746874|7622711|FG000|Overall Study|Withdrawal by Subject|0
4704145|NCT02746874|7622712|FG001|Overall Study|Withdrawal by Subject|1
4704146|NCT02746874|7622711|FG000|Overall Study|Surgery Date Changed|0
4704147|NCT02746874|7622712|FG001|Overall Study|Surgery Date Changed|2
4704148|NCT02747004|7622732|FG000|Overall Study|Withdrawal by Subject|8
4704149|NCT02747004|7622733|FG001|Overall Study|Withdrawal by Subject|5
4704150|NCT02747004|7622734|FG002|Overall Study|Withdrawal by Subject|4
4704151|NCT02747004|7622732|FG000|Overall Study|Lost to Follow-up|1
4704152|NCT02747004|7622733|FG001|Overall Study|Lost to Follow-up|2
4704153|NCT02747004|7622734|FG002|Overall Study|Lost to Follow-up|2
4704154|NCT02747004|7622732|FG000|Overall Study|on study treatment/follow-up|48
4704155|NCT02747004|7622733|FG001|Overall Study|on study treatment/follow-up|42
4704156|NCT02747004|7622734|FG002|Overall Study|on study treatment/follow-up|41
4704157|NCT02747043|7622744|FG000|Overall Study|Other|1
4704158|NCT02747043|7622745|FG001|Overall Study|Other|1
4704159|NCT02747043|7622744|FG000|Overall Study|Adverse Event|3
4704160|NCT02747043|7622745|FG001|Overall Study|Adverse Event|1
4704161|NCT02747043|7622744|FG000|Overall Study|Withdrawal by Subject|1
4704162|NCT02747043|7622745|FG001|Overall Study|Withdrawal by Subject|1
4704163|NCT02747043|7622744|FG000|Overall Study|Physician Decision|1
4704164|NCT02747043|7622745|FG001|Overall Study|Physician Decision|1
4704165|NCT02747043|7622744|FG000|Overall Study|Protocol Violation|0
4704166|NCT02747043|7622745|FG001|Overall Study|Protocol Violation|1
4704167|NCT02747043|7622744|FG000|Overall Study|Disease progression|4
4704168|NCT02747043|7622745|FG001|Overall Study|Disease progression|0
4704169|NCT02747108|7622753|FG000|Overall Study|Death|2
4704170|NCT02747108|7622754|FG001|Overall Study|Death|2
4704171|NCT02747108|7622753|FG000|Overall Study|Withdrawal by Subject|1
4704172|NCT02747108|7622754|FG001|Overall Study|Withdrawal by Subject|0
4704173|NCT02747108|7622753|FG000|Overall Study|Protocol Violation|2
4704174|NCT02747108|7622754|FG001|Overall Study|Protocol Violation|0
4704175|NCT02747238|7622776|FG000|Overall Study|Lack of Efficacy|0
4704176|NCT02747238|7622777|FG001|Overall Study|Lack of Efficacy|1
4704177|NCT02747238|7622776|FG000|Overall Study|Data lost|3
4704178|NCT02747238|7622777|FG001|Overall Study|Data lost|5
4704179|NCT02747420|7622785|FG000|Overall Study|Lost to Follow-up|4
4704180|NCT02747420|7622786|FG001|Overall Study|Lost to Follow-up|2
4704181|NCT02747420|7622785|FG000|Overall Study|Withdrawal by Subject|3
4704182|NCT02747420|7622786|FG001|Overall Study|Withdrawal by Subject|2
4500006|NCT00846365|7305333|FG002|Overall Study|Lost to Follow-up|5
4500007|NCT00846365|7305331|FG000|Overall Study|Withdrawal by Subject|11
4500008|NCT00846365|7305332|FG001|Overall Study|Withdrawal by Subject|11
4500009|NCT00846365|7305333|FG002|Overall Study|Withdrawal by Subject|9
4500010|NCT00846365|7305331|FG000|Overall Study|Pregnancy|1
4500011|NCT00846365|7305332|FG001|Overall Study|Pregnancy|0
4500012|NCT00846365|7305333|FG002|Overall Study|Pregnancy|0
4500013|NCT00846365|7305331|FG000|Overall Study|Lack of Efficacy|1
4500014|NCT00846365|7305332|FG001|Overall Study|Lack of Efficacy|1
4500015|NCT00846365|7305333|FG002|Overall Study|Lack of Efficacy|2
4500016|NCT00846365|7305331|FG000|Overall Study|Other|9
4704183|NCT02747875|7622828|FG000|Overall Study|Physician Decision|1
4704184|NCT02747875|7622829|FG001|Overall Study|Physician Decision|0
4704185|NCT02747875|7622828|FG000|Overall Study|Adverse Event|0
4500017|NCT00846365|7305332|FG001|Overall Study|Other|1
4500018|NCT00846365|7305333|FG002|Overall Study|Other|6
4704186|NCT02747875|7622829|FG001|Overall Study|Adverse Event|1
4704187|NCT02747927|7622837|FG000|Overall Study|Adverse Event|5
4704188|NCT02747927|7622838|FG001|Overall Study|Adverse Event|14
4704189|NCT02747927|7622837|FG000|Overall Study|Lost to Follow-up|22
4704190|NCT02747927|7622838|FG001|Overall Study|Lost to Follow-up|43
4704191|NCT02747927|7622837|FG000|Overall Study|Pregnancy|34
4704192|NCT02747927|7622838|FG001|Overall Study|Pregnancy|66
4704193|NCT02747927|7622837|FG000|Overall Study|Protocol Violation|2
4704194|NCT02747927|7622838|FG001|Overall Study|Protocol Violation|4
4704195|NCT02747927|7622837|FG000|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|147
4704196|NCT02747927|7622838|FG001|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|304
4704197|NCT02747927|7622837|FG000|Overall Study|Reason not Specified|11
4704198|NCT02747927|7622838|FG001|Overall Study|Reason not Specified|27
4704199|NCT02748213|7622864|FG000|Overall Study|Withdrawal Prior to Treatment|1
4704200|NCT02748213|7622865|FG001|Overall Study|Withdrawal Prior to Treatment|2
4704201|NCT02748213|7622864|FG000|Overall Study|Abnormal Laboratory Test|1
4704202|NCT02748213|7622865|FG001|Overall Study|Abnormal Laboratory Test|0
4704203|NCT02748213|7622864|FG000|Overall Study|Adverse Event or Intercurrent Illness|5
4704204|NCT02748213|7622865|FG001|Overall Study|Adverse Event or Intercurrent Illness|11
4704205|NCT02748213|7622864|FG000|Overall Study|Death|5
4704206|NCT02748213|7622865|FG001|Overall Study|Death|3
4704207|NCT02748213|7622864|FG000|Overall Study|Insufficient Therapeutic Response|56
4704208|NCT02748213|7622865|FG001|Overall Study|Insufficient Therapeutic Response|57
4704209|NCT02748213|7622864|FG000|Overall Study|Violation of Selection Criteria|2
4704210|NCT02748213|7622865|FG001|Overall Study|Violation of Selection Criteria|0
4704211|NCT02748213|7622864|FG000|Overall Study|Protocol Violation|6
4704212|NCT02748213|7622865|FG001|Overall Study|Protocol Violation|4
4704213|NCT02748213|7622864|FG000|Overall Study|Refused Treatment*|6
4704214|NCT02748213|7622865|FG001|Overall Study|Refused Treatment*|6
4704215|NCT02748213|7622864|FG000|Overall Study|Failure to Return|1
4704216|NCT02748213|7622865|FG001|Overall Study|Failure to Return|0
4704217|NCT02748213|7622864|FG000|Overall Study|Other|30
4704218|NCT02748213|7622865|FG001|Overall Study|Other|29
4704219|NCT02748317|7622871|FG000|Overall Study|Withdrawal by Subject|14
4704220|NCT02748317|7622871|FG000|Overall Study|Lost to Follow-up|8
4704221|NCT02748317|7622871|FG000|Overall Study|Death|1
4704222|NCT02748356|7622875|FG000|Overall Study|Withdrawal by Subject|1
4704223|NCT02748512|7622881|FG000|Overall Study|Lost to Follow-up|1
4704224|NCT02748512|7622882|FG001|Overall Study|Lost to Follow-up|1
4704225|NCT02748694|7622907|FG000|Overall Study|Voluntary Withdrawal|0
4704226|NCT02748694|7622908|FG001|Overall Study|Voluntary Withdrawal|0
4704227|NCT02748694|7622909|FG002|Overall Study|Voluntary Withdrawal|0
4704228|NCT02748694|7622910|FG003|Overall Study|Voluntary Withdrawal|0
4704229|NCT02748694|7622911|FG004|Overall Study|Voluntary Withdrawal|0
4704230|NCT02748694|7622912|FG005|Overall Study|Voluntary Withdrawal|0
4704231|NCT02748694|7622913|FG006|Overall Study|Voluntary Withdrawal|0
4704232|NCT02748694|7622914|FG007|Overall Study|Voluntary Withdrawal|0
4704233|NCT02748694|7622915|FG008|Overall Study|Voluntary Withdrawal|0
4704234|NCT02748694|7622916|FG009|Overall Study|Voluntary Withdrawal|0
4704235|NCT02748694|7622917|FG010|Overall Study|Voluntary Withdrawal|0
4704236|NCT02748694|7622918|FG011|Overall Study|Voluntary Withdrawal|0
4704237|NCT02748694|7622919|FG012|Overall Study|Voluntary Withdrawal|0
4704238|NCT02748694|7622920|FG013|Overall Study|Voluntary Withdrawal|0
4704239|NCT02748694|7622921|FG014|Overall Study|Voluntary Withdrawal|2
4704240|NCT02748863|7622997|FG000|Treatment Period 1|Adverse Event|0
4704241|NCT02748863|7622998|FG001|Treatment Period 1|Adverse Event|1
4704242|NCT02748863|7622999|FG002|Treatment Period 1|Adverse Event|0
4704243|NCT02748863|7623000|FG003|Treatment Period 1|Adverse Event|0
4704244|NCT02748863|7623001|FG004|Treatment Period 1|Adverse Event|0
4704245|NCT02748863|7622997|FG000|Treatment Period 1|Lack of Efficacy|0
4704246|NCT02748863|7622998|FG001|Treatment Period 1|Lack of Efficacy|0
4704247|NCT02748863|7622999|FG002|Treatment Period 1|Lack of Efficacy|1
4704248|NCT02748863|7623000|FG003|Treatment Period 1|Lack of Efficacy|0
4704249|NCT02748863|7623001|FG004|Treatment Period 1|Lack of Efficacy|0
4704250|NCT02748863|7622997|FG000|Treatment Period 1|Withdrawal by Subject|0
4704251|NCT02748863|7622998|FG001|Treatment Period 1|Withdrawal by Subject|1
4704252|NCT02748863|7622999|FG002|Treatment Period 1|Withdrawal by Subject|1
4704253|NCT02748863|7623000|FG003|Treatment Period 1|Withdrawal by Subject|0
4704254|NCT02748863|7623001|FG004|Treatment Period 1|Withdrawal by Subject|0
4704255|NCT02748863|7622997|FG000|Treatment Period 2|Lost to Follow-up|2
4704256|NCT02748863|7622998|FG001|Treatment Period 2|Lost to Follow-up|0
4704257|NCT02748863|7622999|FG002|Treatment Period 2|Lost to Follow-up|0
4704258|NCT02748863|7623000|FG003|Treatment Period 2|Lost to Follow-up|0
4704259|NCT02748863|7623001|FG004|Treatment Period 2|Lost to Follow-up|0
4500019|NCT00846391|7305344|FG000|Overall Study|Physician Decision|0
4704260|NCT02748863|7622997|FG000|Treatment Period 2|Adverse Event|3
4704261|NCT02748863|7622998|FG001|Treatment Period 2|Adverse Event|2
4704262|NCT02748863|7622999|FG002|Treatment Period 2|Adverse Event|0
4704263|NCT02748863|7623000|FG003|Treatment Period 2|Adverse Event|2
4704264|NCT02748863|7623001|FG004|Treatment Period 2|Adverse Event|0
4704265|NCT02748863|7622997|FG000|Treatment Period 2|Lack of Efficacy|0
4500020|NCT00846391|7305345|FG001|Overall Study|Physician Decision|0
4500021|NCT00846391|7305346|FG002|Overall Study|Physician Decision|1
4500022|NCT00846391|7305344|FG000|Overall Study|Study Terminated by Sponsor|1
4500023|NCT00846391|7305345|FG001|Overall Study|Study Terminated by Sponsor|2
4500024|NCT00846391|7305346|FG002|Overall Study|Study Terminated by Sponsor|2
4500025|NCT00846495|7305361|FG000|Overall Study|Lost to Follow-up|1
4500026|NCT00846495|7305362|FG001|Overall Study|Lost to Follow-up|0
4500027|NCT00846495|7305361|FG000|Overall Study|Adverse Event|5
4500028|NCT00846495|7305362|FG001|Overall Study|Adverse Event|1
4500029|NCT00846495|7305361|FG000|Overall Study|Lack of Efficacy|1
4500030|NCT00846495|7305362|FG001|Overall Study|Lack of Efficacy|2
4500031|NCT00846495|7305361|FG000|Overall Study|Physician Decision|1
4500032|NCT00846495|7305362|FG001|Overall Study|Physician Decision|0
4500033|NCT00846521|7305368|FG000|Overall Study|Withdrawal by Subject|5
4500034|NCT00846521|7305368|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5
4500035|NCT00846521|7305368|FG000|Overall Study|Protocol Violation|1
4500036|NCT00846586|7305392|FG000|Overall Study|Adverse Event|20
4500037|NCT00846586|7305393|FG001|Overall Study|Adverse Event|10
4500038|NCT00846586|7305392|FG000|Overall Study|Subject withdrew consent|8
4500039|NCT00846586|7305393|FG001|Overall Study|Subject withdrew consent|10
4500040|NCT00846586|7305392|FG000|Overall Study|Administrative problems|5
4500041|NCT00846586|7305393|FG001|Overall Study|Administrative problems|4
4500042|NCT00846586|7305392|FG000|Overall Study|Death|2
4500043|NCT00846586|7305393|FG001|Overall Study|Death|0
4500044|NCT00846586|7305392|FG000|Overall Study|Protocol deviation|2
4704266|NCT02748863|7622998|FG001|Treatment Period 2|Lack of Efficacy|1
4704267|NCT02748863|7622999|FG002|Treatment Period 2|Lack of Efficacy|0
4704268|NCT02748863|7623000|FG003|Treatment Period 2|Lack of Efficacy|0
4704269|NCT02748863|7623001|FG004|Treatment Period 2|Lack of Efficacy|0
4704270|NCT02748863|7622997|FG000|Treatment Period 2|Pregnancy|0
4704271|NCT02748863|7622998|FG001|Treatment Period 2|Pregnancy|0
4704272|NCT02748863|7622999|FG002|Treatment Period 2|Pregnancy|0
4704273|NCT02748863|7623000|FG003|Treatment Period 2|Pregnancy|0
4704274|NCT02748863|7623001|FG004|Treatment Period 2|Pregnancy|1
4704275|NCT02749370|7623032|FG000|Overall Study|Withdrawal by Subject|11
4704276|NCT02749370|7623032|FG000|Overall Study|Lost to Follow-up|3
4704277|NCT02749721|7623036|FG000|Screening|Withdrawal by Subject|1
4704278|NCT02749721|7623036|FG000|Screening|Lost to Follow-up|2
4704279|NCT02749721|7623036|FG000|Screening|Protocol Violation|3
4704280|NCT02749721|7623036|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2
4704281|NCT02749721|7623036|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1
4704282|NCT02749799|7623042|FG000|Overall Study|Adverse Event|2
4704283|NCT02749799|7623042|FG000|Overall Study|Lost to Follow-up|4
4704284|NCT02749799|7623042|FG000|Overall Study|Protocol Violation|1
4704285|NCT02749799|7623042|FG000|Overall Study|Withdrawal by Subject|1
4704286|NCT02750306|7623063|FG000|Overall Study|Withdrawal by Subject|5
4704287|NCT02750306|7623064|FG001|Overall Study|Withdrawal by Subject|2
4704288|NCT02750306|7623063|FG000|Overall Study|Protocol Violation|1
4704289|NCT02750306|7623064|FG001|Overall Study|Protocol Violation|0
4704290|NCT02750332|7623070|FG000|Treatment Period 1|Withdrawal by Subject|0
4704291|NCT02750332|7623071|FG001|Treatment Period 1|Withdrawal by Subject|1
4704292|NCT02750345|7623077|FG000|Intervention 1|Adverse Event|0
4704293|NCT02750345|7623078|FG001|Intervention 1|Adverse Event|0
4704294|NCT02750345|7623079|FG002|Intervention 1|Adverse Event|0
4704295|NCT02750345|7623080|FG003|Intervention 1|Adverse Event|0
4704296|NCT02750345|7623081|FG004|Intervention 1|Adverse Event|1
4704297|NCT02750345|7623082|FG005|Intervention 1|Adverse Event|0
4704298|NCT02750410|7623094|FG000|Double-Blind Treatment Period|Adverse Event|2
4704299|NCT02750410|7623095|FG001|Double-Blind Treatment Period|Adverse Event|2
4704300|NCT02750410|7623094|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0
4704301|NCT02750410|7623095|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1
4704302|NCT02750410|7623094|FG000|Open-Label Extension Period|Adverse Event|5
4704303|NCT02750410|7623095|FG001|Open-Label Extension Period|Adverse Event|3
4704304|NCT02750410|7623094|FG000|Open-Label Extension Period|Protocol Violation|0
4704305|NCT02750410|7623095|FG001|Open-Label Extension Period|Protocol Violation|1
4704306|NCT02750410|7623094|FG000|Open-Label Extension Period|Withdrawal by Subject|1
4704307|NCT02750410|7623095|FG001|Open-Label Extension Period|Withdrawal by Subject|2
4704308|NCT02750501|7623105|FG000|Overall Study|Adverse Event|4
4704309|NCT02750501|7623105|FG000|Overall Study|Physician Decision|1
4704310|NCT02750501|7623105|FG000|Overall Study|Protocol Violation|1
4704311|NCT02750501|7623105|FG000|Overall Study|G-tube came out|1
4704312|NCT02750501|7623105|FG000|Overall Study|Non-compliant use of PERT|1
4704313|NCT02750514|7623118|FG000|Track 1|Disease progression|20
4704314|NCT02750514|7623119|FG001|Track 1|Disease progression|1
4704315|NCT02750514|7623120|FG002|Track 1|Disease progression|0
4704316|NCT02750514|7623121|FG003|Track 1|Disease progression|1
4704317|NCT02750514|7623122|FG004|Track 1|Disease progression|0
4704318|NCT02750514|7623118|FG000|Track 1|Adverse event unrelated to study drug|1
4704319|NCT02750514|7623119|FG001|Track 1|Adverse event unrelated to study drug|0
4704320|NCT02750514|7623120|FG002|Track 1|Adverse event unrelated to study drug|0
4704321|NCT02750514|7623121|FG003|Track 1|Adverse event unrelated to study drug|0
4704322|NCT02750514|7623122|FG004|Track 1|Adverse event unrelated to study drug|0
4500045|NCT00846586|7305393|FG001|Overall Study|Protocol deviation|6
4500046|NCT00846586|7305392|FG000|Overall Study|Abnormal test procedure result(s)|1
4500047|NCT00846586|7305393|FG001|Overall Study|Abnormal test procedure result(s)|0
4500048|NCT00846586|7305392|FG000|Overall Study|Lost to Follow-up|1
4500049|NCT00846586|7305393|FG001|Overall Study|Lost to Follow-up|4
4500050|NCT00846586|7305392|FG000|Overall Study|Unsatisfactory therapeutic effect|0
4500051|NCT00846586|7305393|FG001|Overall Study|Unsatisfactory therapeutic effect|1
4517873|NCT00969761|7329808|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
4517874|NCT00969761|7329809|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
4517875|NCT00969761|7329810|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
4517876|NCT00969761|7329811|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
4517877|NCT00969761|7329812|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
4517878|NCT00969761|7329801|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
4517879|NCT00969761|7329802|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
4517880|NCT00969761|7329803|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1
4517881|NCT00969761|7329804|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
4517882|NCT00969761|7329805|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
4517883|NCT00969761|7329806|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
4517884|NCT00969761|7329807|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
4704323|NCT02750514|7623118|FG000|Track 1|Study drug toxicity|4
4704324|NCT02750514|7623119|FG001|Track 1|Study drug toxicity|1
4704325|NCT02750514|7623120|FG002|Track 1|Study drug toxicity|0
4704326|NCT02750514|7623121|FG003|Track 1|Study drug toxicity|1
4704327|NCT02750514|7623122|FG004|Track 1|Study drug toxicity|0
4704328|NCT02750514|7623118|FG000|Track 1|Participant request to discontinue|1
4704329|NCT02750514|7623119|FG001|Track 1|Participant request to discontinue|0
4704330|NCT02750514|7623120|FG002|Track 1|Participant request to discontinue|0
4704331|NCT02750514|7623121|FG003|Track 1|Participant request to discontinue|0
4704332|NCT02750514|7623122|FG004|Track 1|Participant request to discontinue|0
4704333|NCT02750514|7623118|FG000|Track 1|Other reasons|1
4704334|NCT02750514|7623119|FG001|Track 1|Other reasons|0
4704335|NCT02750514|7623120|FG002|Track 1|Other reasons|0
4704336|NCT02750514|7623121|FG003|Track 1|Other reasons|0
4704337|NCT02750514|7623122|FG004|Track 1|Other reasons|0
4704338|NCT02750514|7623118|FG000|Track 2|Disease progression|4
4704339|NCT02750514|7623119|FG001|Track 2|Disease progression|5
4704340|NCT02750514|7623120|FG002|Track 2|Disease progression|2
4704341|NCT02750514|7623121|FG003|Track 2|Disease progression|5
4704342|NCT02750514|7623122|FG004|Track 2|Disease progression|0
4704343|NCT02750514|7623118|FG000|Track 2|Adverse event unrelated to study drug|1
4704344|NCT02750514|7623119|FG001|Track 2|Adverse event unrelated to study drug|0
4704345|NCT02750514|7623120|FG002|Track 2|Adverse event unrelated to study drug|0
4704346|NCT02750514|7623121|FG003|Track 2|Adverse event unrelated to study drug|0
4704347|NCT02750514|7623122|FG004|Track 2|Adverse event unrelated to study drug|0
4704348|NCT02750514|7623118|FG000|Track 2|Study drug toxicity|1
4704349|NCT02750514|7623119|FG001|Track 2|Study drug toxicity|2
4704350|NCT02750514|7623120|FG002|Track 2|Study drug toxicity|0
4704351|NCT02750514|7623121|FG003|Track 2|Study drug toxicity|2
4704352|NCT02750514|7623122|FG004|Track 2|Study drug toxicity|0
4704353|NCT02750514|7623118|FG000|Track 2|Participant withdrew consent|0
4704354|NCT02750514|7623119|FG001|Track 2|Participant withdrew consent|1
4704355|NCT02750514|7623120|FG002|Track 2|Participant withdrew consent|0
4704356|NCT02750514|7623121|FG003|Track 2|Participant withdrew consent|0
4704357|NCT02750514|7623122|FG004|Track 2|Participant withdrew consent|0
4704358|NCT02750514|7623118|FG000|Track 3|Disease progression|0
4704359|NCT02750514|7623119|FG001|Track 3|Disease progression|24
4704360|NCT02750514|7623120|FG002|Track 3|Disease progression|13
4704361|NCT02750514|7623121|FG003|Track 3|Disease progression|14
4704362|NCT02750514|7623122|FG004|Track 3|Disease progression|0
4704363|NCT02750514|7623118|FG000|Track 3|Adverse event unrelated to study drug|0
4704364|NCT02750514|7623119|FG001|Track 3|Adverse event unrelated to study drug|1
4704365|NCT02750514|7623120|FG002|Track 3|Adverse event unrelated to study drug|1
4704366|NCT02750514|7623121|FG003|Track 3|Adverse event unrelated to study drug|1
4704367|NCT02750514|7623122|FG004|Track 3|Adverse event unrelated to study drug|0
4704368|NCT02750514|7623118|FG000|Track 3|Study drug toxicity|0
4704369|NCT02750514|7623119|FG001|Track 3|Study drug toxicity|3
4704370|NCT02750514|7623120|FG002|Track 3|Study drug toxicity|0
4704371|NCT02750514|7623121|FG003|Track 3|Study drug toxicity|1
4704372|NCT02750514|7623122|FG004|Track 3|Study drug toxicity|0
4704373|NCT02750514|7623118|FG000|Track 3|Participant request to discontinue|0
4704374|NCT02750514|7623119|FG001|Track 3|Participant request to discontinue|2
4704375|NCT02750514|7623120|FG002|Track 3|Participant request to discontinue|0
4704376|NCT02750514|7623121|FG003|Track 3|Participant request to discontinue|0
4704377|NCT02750514|7623122|FG004|Track 3|Participant request to discontinue|0
4704378|NCT02750514|7623118|FG000|Track 3|Participant withdrew consent|0
4704379|NCT02750514|7623119|FG001|Track 3|Participant withdrew consent|3
4704380|NCT02750514|7623120|FG002|Track 3|Participant withdrew consent|1
4704381|NCT02750514|7623121|FG003|Track 3|Participant withdrew consent|0
4704382|NCT02750514|7623122|FG004|Track 3|Participant withdrew consent|0
4704383|NCT02750514|7623118|FG000|Track 3|Other reasons|0
4500052|NCT00846742|7305410|FG000|Overall Study|Withdrawal by Subject|1
4500053|NCT00846768|7305415|FG000|Overall Study|Adverse Event|0
4500054|NCT00846768|7305416|FG001|Overall Study|Adverse Event|1
4500055|NCT00846768|7305417|FG002|Overall Study|Adverse Event|0
4500056|NCT00846768|7305418|FG003|Overall Study|Adverse Event|0
4500057|NCT00846807|7305428|FG000|Overall Study|Adverse Event|270
4627204|NCT01851590|7493764|FG002|Overall Study|Lack of Efficacy|0
4627205|NCT01851720|7493787|FG000|Overall Study|Lost to Follow-up|0
4627206|NCT01851720|7493788|FG001|Overall Study|Lost to Follow-up|1
4704384|NCT02750514|7623119|FG001|Track 3|Other reasons|3
4704385|NCT02750514|7623120|FG002|Track 3|Other reasons|0
4704386|NCT02750514|7623121|FG003|Track 3|Other reasons|0
4704387|NCT02750514|7623122|FG004|Track 3|Other reasons|0
4704388|NCT02750514|7623118|FG000|Track 4|Study drug toxicity|0
4704389|NCT02750514|7623119|FG001|Track 4|Study drug toxicity|6
4704390|NCT02750514|7623120|FG002|Track 4|Study drug toxicity|0
4704391|NCT02750514|7623121|FG003|Track 4|Study drug toxicity|5
4704392|NCT02750514|7623122|FG004|Track 4|Study drug toxicity|0
4704393|NCT02750514|7623118|FG000|Track 4|Participant request to discontinue|0
4704394|NCT02750514|7623119|FG001|Track 4|Participant request to discontinue|1
4704395|NCT02750514|7623120|FG002|Track 4|Participant request to discontinue|0
4704396|NCT02750514|7623121|FG003|Track 4|Participant request to discontinue|1
4704397|NCT02750514|7623122|FG004|Track 4|Participant request to discontinue|0
4704398|NCT02750514|7623118|FG000|Track 4|Participant withdrew consent|0
4704399|NCT02750514|7623119|FG001|Track 4|Participant withdrew consent|1
4704400|NCT02750514|7623120|FG002|Track 4|Participant withdrew consent|0
4704401|NCT02750514|7623121|FG003|Track 4|Participant withdrew consent|0
4704402|NCT02750514|7623122|FG004|Track 4|Participant withdrew consent|0
4704403|NCT02750514|7623118|FG000|Track 4|Other reasons|0
4704404|NCT02750514|7623119|FG001|Track 4|Other reasons|5
4704405|NCT02750514|7623120|FG002|Track 4|Other reasons|0
4704406|NCT02750514|7623121|FG003|Track 4|Other reasons|3
4704407|NCT02750514|7623122|FG004|Track 4|Other reasons|0
4704408|NCT02750514|7623118|FG000|Track 4|Disease progression|0
4704409|NCT02750514|7623119|FG001|Track 4|Disease progression|33
4704410|NCT02750514|7623120|FG002|Track 4|Disease progression|0
4704411|NCT02750514|7623121|FG003|Track 4|Disease progression|32
4704412|NCT02750514|7623122|FG004|Track 4|Disease progression|0
4704413|NCT02750514|7623118|FG000|Track 4|Adverse event unrelated to study drug|0
4704414|NCT02750514|7623119|FG001|Track 4|Adverse event unrelated to study drug|5
4704415|NCT02750514|7623120|FG002|Track 4|Adverse event unrelated to study drug|0
4704416|NCT02750514|7623121|FG003|Track 4|Adverse event unrelated to study drug|0
4704417|NCT02750514|7623122|FG004|Track 4|Adverse event unrelated to study drug|0
4704418|NCT02750514|7623118|FG000|Track 4|Death|0
4704419|NCT02750514|7623119|FG001|Track 4|Death|0
4704420|NCT02750514|7623120|FG002|Track 4|Death|0
4704421|NCT02750514|7623121|FG003|Track 4|Death|1
4704422|NCT02750514|7623122|FG004|Track 4|Death|0
4704423|NCT02750514|7623118|FG000|Track 5|Disease progression|0
4704424|NCT02750514|7623119|FG001|Track 5|Disease progression|0
4704425|NCT02750514|7623120|FG002|Track 5|Disease progression|0
4704426|NCT02750514|7623121|FG003|Track 5|Disease progression|0
4704427|NCT02750514|7623122|FG004|Track 5|Disease progression|34
4704428|NCT02750514|7623118|FG000|Track 5|Adverse event unrelated to study drug|0
4704429|NCT02750514|7623119|FG001|Track 5|Adverse event unrelated to study drug|0
4704430|NCT02750514|7623120|FG002|Track 5|Adverse event unrelated to study drug|0
4704431|NCT02750514|7623121|FG003|Track 5|Adverse event unrelated to study drug|0
4704432|NCT02750514|7623122|FG004|Track 5|Adverse event unrelated to study drug|2
4704433|NCT02750514|7623118|FG000|Track 5|Study drug toxicity|0
4704434|NCT02750514|7623119|FG001|Track 5|Study drug toxicity|0
4704435|NCT02750514|7623120|FG002|Track 5|Study drug toxicity|0
4704436|NCT02750514|7623121|FG003|Track 5|Study drug toxicity|0
4704437|NCT02750514|7623122|FG004|Track 5|Study drug toxicity|2
4704438|NCT02750514|7623118|FG000|Track 5|Participant request to discontinue|0
4704439|NCT02750514|7623119|FG001|Track 5|Participant request to discontinue|0
4704440|NCT02750514|7623120|FG002|Track 5|Participant request to discontinue|0
4704441|NCT02750514|7623121|FG003|Track 5|Participant request to discontinue|0
4704442|NCT02750514|7623122|FG004|Track 5|Participant request to discontinue|3
4704443|NCT02750514|7623118|FG000|Track 5|Other reasons|0
4704444|NCT02750514|7623119|FG001|Track 5|Other reasons|0
4704445|NCT02750514|7623120|FG002|Track 5|Other reasons|0
4704446|NCT02750514|7623121|FG003|Track 5|Other reasons|0
4704447|NCT02750514|7623122|FG004|Track 5|Other reasons|2
4704448|NCT02750592|7623142|FG000|Overall Study|Adverse Event|3
4704449|NCT02750592|7623142|FG000|Overall Study|Lack of Efficacy|2
4704450|NCT02750618|7623146|FG000|Overall Study|Withdrawal by Subject|1
4704451|NCT02750709|7623150|FG000|Treatment Period 1|Adverse Event|0
4704452|NCT02750709|7623151|FG001|Treatment Period 1|Adverse Event|0
4704453|NCT02750709|7623152|FG002|Treatment Period 1|Adverse Event|0
4704454|NCT02750709|7623153|FG003|Treatment Period 1|Adverse Event|0
4704455|NCT02750709|7623154|FG004|Treatment Period 1|Adverse Event|0
4704456|NCT02750709|7623155|FG005|Treatment Period 1|Adverse Event|1
4704457|NCT02750761|7623169|FG000|Overall Study|Lost to Follow-up|0
4704458|NCT02750761|7623170|FG001|Overall Study|Lost to Follow-up|0
4704459|NCT02750761|7623171|FG002|Overall Study|Lost to Follow-up|1
4500058|NCT00846807|7305428|FG000|Overall Study|Lost to Follow-up|94
4500059|NCT00846807|7305428|FG000|Overall Study|Withdrawal by Subject|56
4500060|NCT00846807|7305428|FG000|Overall Study|Non compliant with European label|7
4500061|NCT00846807|7305428|FG000|Overall Study|Switch to other anticoagulants|89
4500062|NCT00846807|7305428|FG000|Overall Study|No prescription after hospital discharge|56
4500063|NCT00846807|7305428|FG000|Overall Study|Other|60
4500064|NCT00846846|7305432|FG000|Overall Study|Death|56
4500065|NCT00846846|7305432|FG000|Overall Study|Withdrawal by Subject|19
4500066|NCT00847015|7305436|FG000|Overall Study|Withdrawal by Subject|1
4500067|NCT00847015|7305436|FG000|Overall Study|declined any surgery|1
4500068|NCT00847015|7305436|FG000|Overall Study|partial cystectomy vs radical cystectomy|1
4500069|NCT00847132|7305442|FG000|Overall Study|Death|1
4500070|NCT00847132|7305443|FG001|Overall Study|Death|1
4500071|NCT00847145|7305457|FG000|Overall Study|AE or Death|0
4500072|NCT00847145|7305458|FG001|Overall Study|AE or Death|1
4500073|NCT00847145|7305459|FG002|Overall Study|AE or Death|1
4500074|NCT00847145|7305460|FG003|Overall Study|AE or Death|0
4500075|NCT00847145|7305461|FG004|Overall Study|AE or Death|0
4500076|NCT00847145|7305462|FG005|Overall Study|AE or Death|0
4500077|NCT00847145|7305463|FG006|Overall Study|AE or Death|0
4500078|NCT00847145|7305464|FG007|Overall Study|AE or Death|0
4500079|NCT00847145|7305457|FG000|Overall Study|Withdrawal by Subject|3
4500080|NCT00847145|7305458|FG001|Overall Study|Withdrawal by Subject|4
4500081|NCT00847145|7305459|FG002|Overall Study|Withdrawal by Subject|6
4500082|NCT00847145|7305460|FG003|Overall Study|Withdrawal by Subject|1
4500083|NCT00847145|7305461|FG004|Overall Study|Withdrawal by Subject|0
4500084|NCT00847145|7305462|FG005|Overall Study|Withdrawal by Subject|0
4500085|NCT00847145|7305463|FG006|Overall Study|Withdrawal by Subject|1
4500086|NCT00847145|7305464|FG007|Overall Study|Withdrawal by Subject|1
4500087|NCT00847145|7305457|FG000|Overall Study|Lost to Follow-up|3
4500088|NCT00847145|7305458|FG001|Overall Study|Lost to Follow-up|1
4500089|NCT00847145|7305459|FG002|Overall Study|Lost to Follow-up|1
4500090|NCT00847145|7305460|FG003|Overall Study|Lost to Follow-up|0
4500091|NCT00847145|7305461|FG004|Overall Study|Lost to Follow-up|4
4500092|NCT00847145|7305462|FG005|Overall Study|Lost to Follow-up|4
4500093|NCT00847145|7305463|FG006|Overall Study|Lost to Follow-up|8
4500094|NCT00847145|7305464|FG007|Overall Study|Lost to Follow-up|2
4500095|NCT00847145|7305457|FG000|Overall Study|Inappropriate enrollment|0
4500096|NCT00847145|7305458|FG001|Overall Study|Inappropriate enrollment|0
4500097|NCT00847145|7305459|FG002|Overall Study|Inappropriate enrollment|0
4500098|NCT00847145|7305460|FG003|Overall Study|Inappropriate enrollment|0
4500099|NCT00847145|7305461|FG004|Overall Study|Inappropriate enrollment|1
4500100|NCT00847145|7305462|FG005|Overall Study|Inappropriate enrollment|0
4500101|NCT00847145|7305463|FG006|Overall Study|Inappropriate enrollment|0
4500102|NCT00847145|7305464|FG007|Overall Study|Inappropriate enrollment|0
4500103|NCT00847145|7305457|FG000|Overall Study|Protocol Violation|0
4500104|NCT00847145|7305458|FG001|Overall Study|Protocol Violation|0
4500105|NCT00847145|7305459|FG002|Overall Study|Protocol Violation|3
4500106|NCT00847145|7305460|FG003|Overall Study|Protocol Violation|0
4500107|NCT00847145|7305461|FG004|Overall Study|Protocol Violation|1
4500108|NCT00847145|7305462|FG005|Overall Study|Protocol Violation|0
4500109|NCT00847145|7305463|FG006|Overall Study|Protocol Violation|0
4500110|NCT00847145|7305464|FG007|Overall Study|Protocol Violation|1
4500111|NCT00847197|7305498|FG000|Overall Study|Adverse Event|21
4500112|NCT00847197|7305499|FG001|Overall Study|Adverse Event|3
4500113|NCT00847197|7305498|FG000|Overall Study|Protocol Violation|0
4500114|NCT00847197|7305499|FG001|Overall Study|Protocol Violation|1
4500115|NCT00847197|7305498|FG000|Overall Study|Withdrawal by Subject|3
4500116|NCT00847197|7305499|FG001|Overall Study|Withdrawal by Subject|1
4500117|NCT00847301|7305523|FG000|Overall Study|Adverse Event|35
4704460|NCT02750761|7623172|FG003|Overall Study|Lost to Follow-up|0
4704461|NCT02750761|7623173|FG004|Overall Study|Lost to Follow-up|0
4704462|NCT02750761|7623174|FG005|Overall Study|Lost to Follow-up|0
4704463|NCT02750800|7623198|FG000|Overall Study|Adverse Event|18
4704464|NCT02750800|7623198|FG000|Overall Study|Lost to Follow-up|12
4704465|NCT02750800|7623198|FG000|Overall Study|Investigator decision|53
4704466|NCT02750800|7623198|FG000|Overall Study|Patient request|12
4704467|NCT02750800|7623198|FG000|Overall Study|Other, not specified|3
4704468|NCT02750813|7623216|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1
4704469|NCT02750813|7623217|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0
4704470|NCT02750813|7623216|FG000|Period 1, First 14 Days of Wear|Reason not given|0
4704471|NCT02750813|7623217|FG001|Period 1, First 14 Days of Wear|Reason not given|1
4704472|NCT02750930|7623224|FG000|Overall Study|Study closed/terminated|8
4704473|NCT02750943|7623230|FG000|Overall Study|Lost to Follow-up|1
4704474|NCT02750943|7623231|FG001|Overall Study|Lost to Follow-up|2
4704475|NCT02750943|7623230|FG000|Overall Study|Withdrawal by Subject|5
4704476|NCT02750943|7623231|FG001|Overall Study|Withdrawal by Subject|7
4500118|NCT00847301|7305523|FG000|Overall Study|Switch to other anticoagulants|16
4500119|NCT00847301|7305523|FG000|Overall Study|Lost to Follow-up|1
4500120|NCT00847301|7305523|FG000|Overall Study|No prescription after hospital discharge|1
4500121|NCT00847301|7305523|FG000|Overall Study|Other reason not defined above|1
4500122|NCT00847379|7305530|FG000|Overall Study|Study terminated by Sponsor|59
4500123|NCT00847379|7305531|FG001|Overall Study|Study terminated by Sponsor|57
4500124|NCT00847379|7305532|FG002|Overall Study|Study terminated by Sponsor|57
4500125|NCT00847535|7305546|FG000|Overall Study|Withdrawal by Subject|2
4500126|NCT00847535|7305547|FG001|Overall Study|Withdrawal by Subject|1
4500127|NCT00847535|7305548|FG002|Overall Study|Withdrawal by Subject|1
4500128|NCT00847535|7305546|FG000|Overall Study|Lost to Follow-up|0
4500129|NCT00847535|7305547|FG001|Overall Study|Lost to Follow-up|1
4500130|NCT00847535|7305548|FG002|Overall Study|Lost to Follow-up|0
4500131|NCT00847561|7305555|FG000|Overall Study|Withdrawal by Subject|4
4500132|NCT00847561|7305556|FG001|Overall Study|Withdrawal by Subject|3
4500133|NCT00847561|7305555|FG000|Overall Study|Unable to schedule|9
4500134|NCT00847561|7305556|FG001|Overall Study|Unable to schedule|1
4500135|NCT00847613|7305575|FG000|Overall Study|Ongoing at cut-off date|250
4500136|NCT00847613|7305576|FG001|Overall Study|Ongoing at cut-off date|265
4500137|NCT00847613|7305577|FG002|Overall Study|Ongoing at cut-off date|64
4500138|NCT00847613|7305578|FG003|Overall Study|Ongoing at cut-off date|64
4500139|NCT00847613|7305575|FG000|Overall Study|Death|1
4500140|NCT00847613|7305576|FG001|Overall Study|Death|1
4500141|NCT00847613|7305577|FG002|Overall Study|Death|0
4500142|NCT00847613|7305578|FG003|Overall Study|Death|0
4500143|NCT00847613|7305575|FG000|Overall Study|Adverse Event|36
4500144|NCT00847613|7305576|FG001|Overall Study|Adverse Event|26
4500145|NCT00847613|7305577|FG002|Overall Study|Adverse Event|5
4500146|NCT00847613|7305578|FG003|Overall Study|Adverse Event|6
4500147|NCT00847613|7305575|FG000|Overall Study|Lack of Efficacy|7
4500148|NCT00847613|7305576|FG001|Overall Study|Lack of Efficacy|3
4500149|NCT00847613|7305577|FG002|Overall Study|Lack of Efficacy|3
4500150|NCT00847613|7305578|FG003|Overall Study|Lack of Efficacy|1
4500151|NCT00847613|7305575|FG000|Overall Study|Study terminated by Sponsor|1
4500152|NCT00847613|7305576|FG001|Overall Study|Study terminated by Sponsor|0
4500153|NCT00847613|7305577|FG002|Overall Study|Study terminated by Sponsor|2
4500154|NCT00847613|7305578|FG003|Overall Study|Study terminated by Sponsor|1
4500155|NCT00847613|7305575|FG000|Overall Study|Lost to Follow-up|5
4500156|NCT00847613|7305576|FG001|Overall Study|Lost to Follow-up|0
4500157|NCT00847613|7305577|FG002|Overall Study|Lost to Follow-up|0
4500158|NCT00847613|7305578|FG003|Overall Study|Lost to Follow-up|3
4500159|NCT00847613|7305575|FG000|Overall Study|Protocol Violation|6
4500160|NCT00847613|7305576|FG001|Overall Study|Protocol Violation|6
4500161|NCT00847613|7305577|FG002|Overall Study|Protocol Violation|3
4500162|NCT00847613|7305578|FG003|Overall Study|Protocol Violation|1
4500163|NCT00847613|7305575|FG000|Overall Study|Pregnancy|1
4500164|NCT00847613|7305576|FG001|Overall Study|Pregnancy|1
4500165|NCT00847613|7305577|FG002|Overall Study|Pregnancy|0
4500166|NCT00847613|7305578|FG003|Overall Study|Pregnancy|0
4500167|NCT00847613|7305575|FG000|Overall Study|Site closure|1
4500168|NCT00847613|7305576|FG001|Overall Study|Site closure|0
4500169|NCT00847613|7305577|FG002|Overall Study|Site closure|0
4500170|NCT00847613|7305578|FG003|Overall Study|Site closure|1
4500171|NCT00847613|7305575|FG000|Overall Study|Withdrawal by Subject|8
4500172|NCT00847613|7305576|FG001|Overall Study|Withdrawal by Subject|11
4500173|NCT00847613|7305577|FG002|Overall Study|Withdrawal by Subject|2
4500174|NCT00847613|7305578|FG003|Overall Study|Withdrawal by Subject|2
4704477|NCT02751320|7623237|FG000|Overall Study|Adverse Event|2
4704478|NCT02751320|7623237|FG000|Overall Study|Withdrawal by Subject|1
4704479|NCT02751359|7623262|FG000|Overall Study|Lost to Follow-up|1
4704480|NCT02751424|7623290|FG000|Part 2|Adverse Event|0
4704481|NCT02751424|7623291|FG001|Part 2|Adverse Event|0
4704482|NCT02751424|7623292|FG002|Part 2|Adverse Event|0
4704483|NCT02751424|7623293|FG003|Part 2|Adverse Event|0
4704484|NCT02751424|7623294|FG004|Part 2|Adverse Event|0
4704485|NCT02751424|7623295|FG005|Part 2|Adverse Event|0
4704486|NCT02751424|7623296|FG006|Part 2|Adverse Event|0
4704487|NCT02751424|7623297|FG007|Part 2|Adverse Event|5
4704488|NCT02751424|7623298|FG008|Part 2|Adverse Event|0
4704489|NCT02751450|7623323|FG000|Overall Study|Adverse Event|1
4704490|NCT02751450|7623324|FG001|Overall Study|Adverse Event|0
4704491|NCT02751580|7623332|FG000|Overall Study|Lost to Follow-up|4
4704492|NCT02751580|7623332|FG000|Overall Study|Death|2
4704493|NCT02751827|7623339|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0
4704494|NCT02751827|7623340|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0
4704495|NCT02751827|7623341|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1
4704496|NCT02751931|7623363|FG000|Overall Study|Adverse Event|3
4704497|NCT02751931|7623364|FG001|Overall Study|Adverse Event|0
4704498|NCT02751931|7623363|FG000|Overall Study|Other: Miscelleneous|10
4704499|NCT02751931|7623364|FG001|Overall Study|Other: Miscelleneous|8
4704500|NCT02751983|7623378|FG000|Treatment|Stopped ACT, but Remained in study|2
4500175|NCT00847613|7305575|FG000|Overall Study|Participant moved|4
4500176|NCT00847613|7305576|FG001|Overall Study|Participant moved|1
4500177|NCT00847613|7305577|FG002|Overall Study|Participant moved|0
4500178|NCT00847613|7305578|FG003|Overall Study|Participant moved|0
4500179|NCT00847613|7305575|FG000|Overall Study|Sponsor request|0
4500180|NCT00847613|7305576|FG001|Overall Study|Sponsor request|1
4500181|NCT00847613|7305577|FG002|Overall Study|Sponsor request|0
4500182|NCT00847613|7305578|FG003|Overall Study|Sponsor request|0
4500183|NCT00847613|7305575|FG000|Overall Study|Randomized, but not treated|0
4500184|NCT00847613|7305576|FG001|Overall Study|Randomized, but not treated|3
4500185|NCT00847613|7305577|FG002|Overall Study|Randomized, but not treated|0
4500186|NCT00847613|7305578|FG003|Overall Study|Randomized, but not treated|0
4500187|NCT00847613|7305575|FG000|Overall Study|Other|1
4500188|NCT00847613|7305576|FG001|Overall Study|Other|1
4500189|NCT00847613|7305577|FG002|Overall Study|Other|2
4500190|NCT00847613|7305578|FG003|Overall Study|Other|0
4500191|NCT00847626|7305606|FG000|Overall Study|Adverse Event|10
4500192|NCT00847626|7305607|FG001|Overall Study|Adverse Event|10
4500193|NCT00847626|7305608|FG002|Overall Study|Adverse Event|6
4500194|NCT00847626|7305609|FG003|Overall Study|Adverse Event|19
4500195|NCT00847626|7305610|FG004|Overall Study|Adverse Event|11
4500196|NCT00847626|7305611|FG005|Overall Study|Adverse Event|22
4500197|NCT00847626|7305612|FG006|Overall Study|Adverse Event|4
4500198|NCT00847626|7305613|FG007|Overall Study|Adverse Event|6
4500199|NCT00847626|7305614|FG008|Overall Study|Adverse Event|3
4500200|NCT00847626|7305615|FG009|Overall Study|Adverse Event|6
4500201|NCT00847626|7305616|FG010|Overall Study|Adverse Event|6
4500202|NCT00847626|7305606|FG000|Overall Study|Protocol Violation|2
4500203|NCT00847626|7305607|FG001|Overall Study|Protocol Violation|1
4500204|NCT00847626|7305608|FG002|Overall Study|Protocol Violation|2
4500205|NCT00847626|7305609|FG003|Overall Study|Protocol Violation|1
4500206|NCT00847626|7305610|FG004|Overall Study|Protocol Violation|1
4500207|NCT00847626|7305611|FG005|Overall Study|Protocol Violation|1
4500208|NCT00847626|7305612|FG006|Overall Study|Protocol Violation|1
4500209|NCT00847626|7305613|FG007|Overall Study|Protocol Violation|1
4500210|NCT00847626|7305614|FG008|Overall Study|Protocol Violation|0
4500211|NCT00847626|7305615|FG009|Overall Study|Protocol Violation|1
4500212|NCT00847626|7305616|FG010|Overall Study|Protocol Violation|1
4500213|NCT00847626|7305606|FG000|Overall Study|Lost to Follow-up|0
4500214|NCT00847626|7305607|FG001|Overall Study|Lost to Follow-up|1
4500215|NCT00847626|7305608|FG002|Overall Study|Lost to Follow-up|1
4500216|NCT00847626|7305609|FG003|Overall Study|Lost to Follow-up|1
4500217|NCT00847626|7305610|FG004|Overall Study|Lost to Follow-up|0
4500218|NCT00847626|7305611|FG005|Overall Study|Lost to Follow-up|3
4500219|NCT00847626|7305612|FG006|Overall Study|Lost to Follow-up|1
4500220|NCT00847626|7305613|FG007|Overall Study|Lost to Follow-up|3
4704501|NCT02751983|7623379|FG001|Treatment|Stopped ACT, but Remained in study|0
4704502|NCT02751983|7623378|FG000|Treatment|Discharged prior to beginning ACT|2
4704503|NCT02751983|7623379|FG001|Treatment|Discharged prior to beginning ACT|0
4704504|NCT02751983|7623378|FG000|Post-Treatment Assessment|Lost to Follow-up|5
4704505|NCT02751983|7623379|FG001|Post-Treatment Assessment|Lost to Follow-up|0
4704506|NCT02751983|7623378|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14
4704507|NCT02751983|7623379|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12
4704508|NCT02751983|7623378|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12
4704509|NCT02751983|7623379|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16
4704510|NCT02752048|7623388|FG000|Overall Study|Withdrawal by Subject|0
4704511|NCT02752048|7623389|FG001|Overall Study|Withdrawal by Subject|0
4704512|NCT02752048|7623390|FG002|Overall Study|Withdrawal by Subject|3
4704513|NCT02752074|7623400|FG000|Overall Study|Lost to Follow-up|1
4704514|NCT02752074|7623401|FG001|Overall Study|Lost to Follow-up|4
4704515|NCT02752074|7623400|FG000|Overall Study|Death|146
4704516|NCT02752074|7623401|FG001|Overall Study|Death|129
4704517|NCT02752074|7623400|FG000|Overall Study|Withdrawal by Subject|9
4704518|NCT02752074|7623401|FG001|Overall Study|Withdrawal by Subject|10
4704519|NCT02752087|7623407|FG000|Washout|Physician Decision|1
4704520|NCT02752087|7623408|FG001|Washout|Physician Decision|0
4704521|NCT02752633|7623432|FG000|Overall Study|Withdrawal by Subject|1
4704522|NCT02752776|7623439|FG000|Overall Study|Adverse Event|15
4704523|NCT02752776|7623440|FG001|Overall Study|Adverse Event|23
4704524|NCT02752776|7623441|FG002|Overall Study|Adverse Event|11
4704525|NCT02752776|7623439|FG000|Overall Study|Lack of Efficacy|2
4704526|NCT02752776|7623440|FG001|Overall Study|Lack of Efficacy|6
4704527|NCT02752776|7623441|FG002|Overall Study|Lack of Efficacy|14
4704528|NCT02752776|7623439|FG000|Overall Study|Lost to Follow-up|11
4704529|NCT02752776|7623440|FG001|Overall Study|Lost to Follow-up|12
4704530|NCT02752776|7623441|FG002|Overall Study|Lost to Follow-up|4
4704531|NCT02752776|7623439|FG000|Overall Study|Non-compliance with study treatment|0
4704532|NCT02752776|7623440|FG001|Overall Study|Non-compliance with study treatment|0
4704533|NCT02752776|7623441|FG002|Overall Study|Non-compliance with study treatment|1
4704534|NCT02752776|7623439|FG000|Overall Study|Physician Decision|2
4704535|NCT02752776|7623440|FG001|Overall Study|Physician Decision|6
4704536|NCT02752776|7623441|FG002|Overall Study|Physician Decision|2
4704537|NCT02752776|7623439|FG000|Overall Study|Pregnancy|1
4704538|NCT02752776|7623440|FG001|Overall Study|Pregnancy|6
4704539|NCT02752776|7623441|FG002|Overall Study|Pregnancy|3
4704540|NCT02752776|7623439|FG000|Overall Study|Protocol Violation|10
4704541|NCT02752776|7623440|FG001|Overall Study|Protocol Violation|13
4704542|NCT02752776|7623441|FG002|Overall Study|Protocol Violation|6
4704543|NCT02752776|7623439|FG000|Overall Study|Subject/guardian decision|8
4500221|NCT00847626|7305614|FG008|Overall Study|Lost to Follow-up|1
4500222|NCT00847626|7305615|FG009|Overall Study|Lost to Follow-up|0
4500223|NCT00847626|7305616|FG010|Overall Study|Lost to Follow-up|1
4500224|NCT00847626|7305606|FG000|Overall Study|Withdrawal by Subject|5
4500225|NCT00847626|7305607|FG001|Overall Study|Withdrawal by Subject|5
4500226|NCT00847626|7305608|FG002|Overall Study|Withdrawal by Subject|3
4500227|NCT00847626|7305609|FG003|Overall Study|Withdrawal by Subject|8
4500228|NCT00847626|7305610|FG004|Overall Study|Withdrawal by Subject|12
4500229|NCT00847626|7305611|FG005|Overall Study|Withdrawal by Subject|9
4500230|NCT00847626|7305612|FG006|Overall Study|Withdrawal by Subject|8
4500231|NCT00847626|7305613|FG007|Overall Study|Withdrawal by Subject|4
4500232|NCT00847626|7305614|FG008|Overall Study|Withdrawal by Subject|4
4500233|NCT00847626|7305615|FG009|Overall Study|Withdrawal by Subject|5
4500234|NCT00847626|7305616|FG010|Overall Study|Withdrawal by Subject|2
4500235|NCT00847626|7305606|FG000|Overall Study|Lack of Efficacy|3
4500236|NCT00847626|7305607|FG001|Overall Study|Lack of Efficacy|1
4500237|NCT00847626|7305608|FG002|Overall Study|Lack of Efficacy|0
4500238|NCT00847626|7305609|FG003|Overall Study|Lack of Efficacy|1
4500239|NCT00847626|7305610|FG004|Overall Study|Lack of Efficacy|2
4500240|NCT00847626|7305611|FG005|Overall Study|Lack of Efficacy|0
4500241|NCT00847626|7305612|FG006|Overall Study|Lack of Efficacy|6
4500242|NCT00847626|7305613|FG007|Overall Study|Lack of Efficacy|2
4500243|NCT00847626|7305614|FG008|Overall Study|Lack of Efficacy|5
4500244|NCT00847626|7305615|FG009|Overall Study|Lack of Efficacy|1
4500245|NCT00847626|7305616|FG010|Overall Study|Lack of Efficacy|7
4500246|NCT00847626|7305606|FG000|Overall Study|Other|1
4500247|NCT00847626|7305607|FG001|Overall Study|Other|5
4500248|NCT00847626|7305608|FG002|Overall Study|Other|4
4500249|NCT00847626|7305609|FG003|Overall Study|Other|1
4500250|NCT00847626|7305610|FG004|Overall Study|Other|2
4500251|NCT00847626|7305611|FG005|Overall Study|Other|2
4500252|NCT00847626|7305612|FG006|Overall Study|Other|2
4500253|NCT00847626|7305613|FG007|Overall Study|Other|3
4500254|NCT00847626|7305614|FG008|Overall Study|Other|1
4500255|NCT00847626|7305615|FG009|Overall Study|Other|1
4500256|NCT00847626|7305616|FG010|Overall Study|Other|3
4500257|NCT00847665|7305645|FG000|Overall Study|Withdrawal by Subject|1
4500258|NCT00847665|7305646|FG001|Overall Study|Withdrawal by Subject|0
4500259|NCT00847704|7305652|FG000|Overall Study|Withdrawal by Subject|1
4500260|NCT00847730|7305656|FG000|Overall Study|Multiple interruptions in therapy|8
4500261|NCT00847808|7305660|FG000|Overall Study|Adverse Event|7
4500262|NCT00847808|7305660|FG000|Overall Study|Protocol Violation|1
4500263|NCT00847808|7305660|FG000|Overall Study|Lost to Follow-up|1
4500264|NCT00847808|7305660|FG000|Overall Study|Withdrawal by Subject|4
4500265|NCT00847808|7305660|FG000|Overall Study|Participant Reported Lack of Efficacy|1
4500266|NCT00847808|7305660|FG000|Overall Study|Participant Took Excluded Medication|1
4500267|NCT00847886|7305666|FG000|Overall Study|Adverse Event|0
4500268|NCT00847886|7305667|FG001|Overall Study|Adverse Event|1
4500269|NCT00847912|7305675|FG000|Overall Study|Protocol Violation|6
4500270|NCT00847912|7305676|FG001|Overall Study|Protocol Violation|7
4500271|NCT00847912|7305675|FG000|Overall Study|Withdrawal by Subject|3
4500272|NCT00847912|7305676|FG001|Overall Study|Withdrawal by Subject|6
4500273|NCT00848042|7305707|FG000|Overall Study|Death|1
4500274|NCT00848042|7305708|FG001|Overall Study|Death|2
4500275|NCT00848042|7305709|FG002|Overall Study|Death|0
4500276|NCT00848042|7305707|FG000|Overall Study|Other Therapy|3
4500277|NCT00848042|7305708|FG001|Overall Study|Other Therapy|0
4704544|NCT02752776|7623440|FG001|Overall Study|Subject/guardian decision|6
4704545|NCT02752776|7623441|FG002|Overall Study|Subject/guardian decision|4
4704546|NCT02752776|7623439|FG000|Overall Study|Death|0
4704547|NCT02752776|7623440|FG001|Overall Study|Death|0
4500278|NCT00848042|7305709|FG002|Overall Study|Other Therapy|0
4500279|NCT00848081|7305719|FG000|Overall Study|Adverse Event|6
4500280|NCT00848081|7305720|FG001|Overall Study|Adverse Event|7
4500281|NCT00848081|7305719|FG000|Overall Study|Protocol Violation|8
4500282|NCT00848081|7305720|FG001|Overall Study|Protocol Violation|5
4704548|NCT02752776|7623441|FG002|Overall Study|Death|1
4704549|NCT02752776|7623439|FG000|Overall Study|Withdrawal by Subject|3
4704550|NCT02752776|7623440|FG001|Overall Study|Withdrawal by Subject|4
4704551|NCT02752776|7623441|FG002|Overall Study|Withdrawal by Subject|2
4704552|NCT02752802|7623453|FG000|Overall Study|Contrast Volume Not Collected|1
4704553|NCT02752802|7623454|FG001|Overall Study|Contrast Volume Not Collected|0
4704554|NCT02752958|7623472|FG000|Overall Study|Adverse Event|3
4704555|NCT02752958|7623472|FG000|Overall Study|Lost to Follow-up|1
4704556|NCT02752958|7623472|FG000|Overall Study|Protocol Violation|1
4704557|NCT02752958|7623472|FG000|Overall Study|Withdrawal by Subject|2
4704558|NCT02752958|7623472|FG000|Overall Study|Other (Reason not specified)|2
4704559|NCT02753075|7623481|FG000|Overall Study|Adverse Event|2
4704560|NCT02753075|7623482|FG001|Overall Study|Adverse Event|1
4500283|NCT00848081|7305719|FG000|Overall Study|Lost to Follow-up|1
4500284|NCT00848081|7305720|FG001|Overall Study|Lost to Follow-up|0
4500285|NCT00848081|7305719|FG000|Overall Study|Physician Decision|0
4704561|NCT02753075|7623483|FG002|Overall Study|Adverse Event|0
4704562|NCT02753075|7623481|FG000|Overall Study|Lost to Follow-up|2
4704563|NCT02753075|7623482|FG001|Overall Study|Lost to Follow-up|0
4704564|NCT02753075|7623483|FG002|Overall Study|Lost to Follow-up|0
4704565|NCT02753075|7623481|FG000|Overall Study|Withdrawal of Consent|1
4500286|NCT00848081|7305720|FG001|Overall Study|Physician Decision|3
4500287|NCT00848081|7305719|FG000|Overall Study|Withdrawal by Subject|5
4500288|NCT00848081|7305720|FG001|Overall Study|Withdrawal by Subject|3
4500289|NCT00848107|7305726|FG000|Overall Study|Lost to Follow-up|2
4500290|NCT00848107|7305726|FG000|Overall Study|Withdrawal by Subject|8
4500291|NCT00848107|7305726|FG000|Overall Study|Adverse Event|9
4704566|NCT02753075|7623482|FG001|Overall Study|Withdrawal of Consent|1
4500292|NCT00848107|7305726|FG000|Overall Study|Death|1
4500293|NCT00848107|7305726|FG000|Overall Study|Pregnancy|1
4500294|NCT00848120|7305730|FG000|Overall Study|Adverse Event|1
4500295|NCT00848198|7305759|FG000|Overall Study|Incomplete Case Report Forms|15
4500296|NCT00848211|7305771|FG000|Overall Study|Protocol Violation|0
4500297|NCT00848211|7305772|FG001|Overall Study|Protocol Violation|1
4500298|NCT00848211|7305773|FG002|Overall Study|Protocol Violation|1
4704567|NCT02753075|7623483|FG002|Overall Study|Withdrawal of Consent|3
4704568|NCT02753075|7623481|FG000|Overall Study|Physician Decision|3
4704569|NCT02753075|7623482|FG001|Overall Study|Physician Decision|1
4704570|NCT02753075|7623483|FG002|Overall Study|Physician Decision|0
4704571|NCT02753400|7623494|FG000|Overall Study|Adverse Event|3
4704572|NCT02753400|7623495|FG001|Overall Study|Adverse Event|0
4704573|NCT02753400|7623494|FG000|Overall Study|Withdrawal by Subject|2
4704574|NCT02753400|7623495|FG001|Overall Study|Withdrawal by Subject|1
4704575|NCT02753595|7623512|FG000|Overall Study|Sponsor termination|2
4704576|NCT02753595|7623513|FG001|Overall Study|Sponsor termination|2
4704577|NCT02753816|7623536|FG000|Overall Study|Protocol Violation|0
4704578|NCT02753816|7623537|FG001|Overall Study|Protocol Violation|1
4704579|NCT02753816|7623538|FG002|Overall Study|Protocol Violation|0
4704580|NCT02753946|7623597|FG000|Overall Study|Adverse Event|7
4704581|NCT02753946|7623598|FG001|Overall Study|Adverse Event|6
4704582|NCT02753946|7623597|FG000|Overall Study|Withdrawal by Subject|6
4704583|NCT02753946|7623598|FG001|Overall Study|Withdrawal by Subject|1
4704584|NCT02753946|7623597|FG000|Overall Study|Lack of Efficacy|1
4704585|NCT02753946|7623598|FG001|Overall Study|Lack of Efficacy|0
4704586|NCT02753946|7623597|FG000|Overall Study|Physician Decision|0
4704587|NCT02753946|7623598|FG001|Overall Study|Physician Decision|2
4704588|NCT02754440|7623626|FG000|Overall Study|Protocol Violation|3
4704589|NCT02754440|7623627|FG001|Overall Study|Protocol Violation|2
4704590|NCT02754440|7623628|FG002|Overall Study|Protocol Violation|2
4704591|NCT02754440|7623629|FG003|Overall Study|Protocol Violation|6
4704592|NCT02754440|7623626|FG000|Overall Study|Adverse Event|3
4704593|NCT02754440|7623627|FG001|Overall Study|Adverse Event|1
4704594|NCT02754440|7623628|FG002|Overall Study|Adverse Event|0
4704595|NCT02754440|7623629|FG003|Overall Study|Adverse Event|9
4704596|NCT02754440|7623626|FG000|Overall Study|Withdrawal by Subject|0
4704597|NCT02754440|7623627|FG001|Overall Study|Withdrawal by Subject|0
4704598|NCT02754440|7623628|FG002|Overall Study|Withdrawal by Subject|0
4704599|NCT02754440|7623629|FG003|Overall Study|Withdrawal by Subject|1
4704600|NCT02754440|7623626|FG000|Overall Study|Equipment failure|0
4704601|NCT02754440|7623627|FG001|Overall Study|Equipment failure|5
4704602|NCT02754440|7623628|FG002|Overall Study|Equipment failure|5
4704603|NCT02754440|7623629|FG003|Overall Study|Equipment failure|7
4704604|NCT02754440|7623626|FG000|Overall Study|Subject issues not resulting in AE|0
4704605|NCT02754440|7623627|FG001|Overall Study|Subject issues not resulting in AE|0
4704606|NCT02754440|7623628|FG002|Overall Study|Subject issues not resulting in AE|0
4704607|NCT02754440|7623629|FG003|Overall Study|Subject issues not resulting in AE|12
4704608|NCT02754492|7623642|FG000|Overall Study|Protocol Violation|2
4704609|NCT02754492|7623643|FG001|Overall Study|Protocol Violation|2
4704610|NCT02754492|7623644|FG002|Overall Study|Protocol Violation|0
4704611|NCT02754492|7623645|FG003|Overall Study|Protocol Violation|1
4704612|NCT02754492|7623642|FG000|Overall Study|Withdrawal by Subject|2
4704613|NCT02754492|7623643|FG001|Overall Study|Withdrawal by Subject|0
4704614|NCT02754492|7623644|FG002|Overall Study|Withdrawal by Subject|0
4704615|NCT02754492|7623645|FG003|Overall Study|Withdrawal by Subject|0
4704616|NCT02754492|7623642|FG000|Overall Study|Equipment malfuntion|0
4704617|NCT02754492|7623643|FG001|Overall Study|Equipment malfuntion|0
4704618|NCT02754492|7623644|FG002|Overall Study|Equipment malfuntion|2
4704619|NCT02754492|7623645|FG003|Overall Study|Equipment malfuntion|5
4704620|NCT02754492|7623642|FG000|Overall Study|Adverse Event|0
4704621|NCT02754492|7623643|FG001|Overall Study|Adverse Event|0
4704622|NCT02754492|7623644|FG002|Overall Study|Adverse Event|0
4704623|NCT02754492|7623645|FG003|Overall Study|Adverse Event|13
4704624|NCT02754492|7623642|FG000|Overall Study|Venous access issues not resulting in AE|0
4704625|NCT02754492|7623643|FG001|Overall Study|Venous access issues not resulting in AE|0
4704626|NCT02754492|7623644|FG002|Overall Study|Venous access issues not resulting in AE|0
4704627|NCT02754492|7623645|FG003|Overall Study|Venous access issues not resulting in AE|4
4704628|NCT02755090|7623686|FG000|Overall Study|equipment malfunction|1
4704629|NCT02755090|7623687|FG001|Overall Study|equipment malfunction|0
4704630|NCT02755116|7623695|FG000|Overall Study|surgery converted to open, pt admitted|3
4704631|NCT02755116|7623696|FG001|Overall Study|surgery converted to open, pt admitted|1
4704632|NCT02755649|7623716|FG000|Overall Study|Transitioned into OLE study|99
4704633|NCT02755649|7623717|FG001|Overall Study|Transitioned into OLE study|98
4704634|NCT02755649|7623718|FG002|Overall Study|Transitioned into OLE study|100
4704635|NCT02755649|7623716|FG000|Overall Study|Did Not Complete Follow-up Visits|1
4704636|NCT02755649|7623717|FG001|Overall Study|Did Not Complete Follow-up Visits|0
4704637|NCT02755649|7623718|FG002|Overall Study|Did Not Complete Follow-up Visits|0
4704638|NCT02755649|7623716|FG000|Overall Study|Physician Decision|0
4704639|NCT02755649|7623717|FG001|Overall Study|Physician Decision|0
4500299|NCT00848211|7305774|FG003|Overall Study|Protocol Violation|0
4500300|NCT00848211|7305771|FG000|Overall Study|Adverse Event|0
4500301|NCT00848211|7305772|FG001|Overall Study|Adverse Event|0
4500302|NCT00848211|7305773|FG002|Overall Study|Adverse Event|0
4500303|NCT00848211|7305774|FG003|Overall Study|Adverse Event|0
4500304|NCT00848250|7305790|FG000|Overall Study|surgery was completed without cardiopulm|0
4500305|NCT00848250|7305791|FG001|Overall Study|surgery was completed without cardiopulm|1
4500306|NCT00848354|7305800|FG000|Phase 1|Adverse Event|5
4500307|NCT00848354|7305801|FG001|Phase 1|Adverse Event|4
4500308|NCT00848354|7305800|FG000|Phase 1|Discontinuation of study by sponsor|2
4500309|NCT00848354|7305801|FG001|Phase 1|Discontinuation of study by sponsor|1
4500310|NCT00848354|7305800|FG000|Phase 1|Failed to return|0
4500311|NCT00848354|7305801|FG001|Phase 1|Failed to return|1
4500312|NCT00848354|7305800|FG000|Phase 1|Lost to Follow-up|1
4500313|NCT00848354|7305801|FG001|Phase 1|Lost to Follow-up|1
4500314|NCT00848354|7305800|FG000|Phase 1|Unspecified Reason|1
4500315|NCT00848354|7305801|FG001|Phase 1|Unspecified Reason|1
4500316|NCT00848354|7305800|FG000|Phase 1|Protocol Violation|1
4500317|NCT00848354|7305801|FG001|Phase 1|Protocol Violation|1
4500318|NCT00848354|7305800|FG000|Phase 1|Withdrawal by Subject|2
4500319|NCT00848354|7305801|FG001|Phase 1|Withdrawal by Subject|4
4500320|NCT00848354|7305800|FG000|Phase 1|Lack of Efficacy|0
4500321|NCT00848354|7305801|FG001|Phase 1|Lack of Efficacy|1
4500322|NCT00848354|7305800|FG000|Phase 2 Year 1|Adverse Event|7
4500323|NCT00848354|7305801|FG001|Phase 2 Year 1|Adverse Event|2
4500324|NCT00848354|7305800|FG000|Phase 2 Year 1|Death|1
4500325|NCT00848354|7305801|FG001|Phase 2 Year 1|Death|0
4500326|NCT00848354|7305800|FG000|Phase 2 Year 1|Failed to Return|1
4500327|NCT00848354|7305801|FG001|Phase 2 Year 1|Failed to Return|1
4500328|NCT00848354|7305800|FG000|Phase 2 Year 1|Lost to Follow-up|1
4500329|NCT00848354|7305801|FG001|Phase 2 Year 1|Lost to Follow-up|0
4500330|NCT00848354|7305800|FG000|Phase 2 Year 1|Unspecified Reason|3
4500331|NCT00848354|7305801|FG001|Phase 2 Year 1|Unspecified Reason|0
4500332|NCT00848354|7305800|FG000|Phase 2 Year 1|Protocol Violation|4
4500333|NCT00848354|7305801|FG001|Phase 2 Year 1|Protocol Violation|1
4500334|NCT00848354|7305800|FG000|Phase 2 Year 1|Subject Request|1
4500335|NCT00848354|7305801|FG001|Phase 2 Year 1|Subject Request|2
4500336|NCT00848354|7305800|FG000|Phase 2 Year 2|Adverse Event|12
4500337|NCT00848354|7305801|FG001|Phase 2 Year 2|Adverse Event|2
4500338|NCT00848354|7305800|FG000|Phase 2 Year 2|Death|2
4500339|NCT00848354|7305801|FG001|Phase 2 Year 2|Death|0
4500340|NCT00848354|7305800|FG000|Phase 2 Year 2|Failed to return|3
4500341|NCT00848354|7305801|FG001|Phase 2 Year 2|Failed to return|0
4500342|NCT00848354|7305800|FG000|Phase 2 Year 2|Lost to Follow-up|1
4500343|NCT00848354|7305801|FG001|Phase 2 Year 2|Lost to Follow-up|3
4500344|NCT00848354|7305800|FG000|Phase 2 Year 2|Unspecified Reason|1
4500345|NCT00848354|7305801|FG001|Phase 2 Year 2|Unspecified Reason|0
4500346|NCT00848354|7305800|FG000|Phase 2 Year 2|Protocol Violation|1
4500347|NCT00848354|7305801|FG001|Phase 2 Year 2|Protocol Violation|1
4500348|NCT00848354|7305800|FG000|Phase 2 Year 2|Subject Request|1
4500349|NCT00848354|7305801|FG001|Phase 2 Year 2|Subject Request|1
4500350|NCT00848354|7305800|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2
4500351|NCT00848354|7305801|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0
4500352|NCT00848393|7305825|FG000|Overall Study|Protocol Violation|0
4500353|NCT00848393|7305826|FG001|Overall Study|Protocol Violation|0
4500354|NCT00848393|7305827|FG002|Overall Study|Protocol Violation|1
4500355|NCT00848393|7305825|FG000|Overall Study|surgical complications unrelated to stud|0
4500356|NCT00848393|7305826|FG001|Overall Study|surgical complications unrelated to stud|0
4500357|NCT00848393|7305827|FG002|Overall Study|surgical complications unrelated to stud|2
4500358|NCT00848484|7305841|FG000|First Intervention (Treatment Period 1)|Adverse Event|2
4500359|NCT00848484|7305842|FG001|First Intervention (Treatment Period 1)|Adverse Event|1
4500360|NCT00848484|7305841|FG000|First Intervention (Treatment Period 1)|Physician Decision|0
4500361|NCT00848484|7305842|FG001|First Intervention (Treatment Period 1)|Physician Decision|1
4500362|NCT00848484|7305841|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0
4500363|NCT00848484|7305842|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1
4500364|NCT00848484|7305841|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0
4500365|NCT00848484|7305842|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3
4500366|NCT00848484|7305841|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0
4500367|NCT00848484|7305842|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1
4500368|NCT00848497|7305850|FG000|Overall Study|Screen failure|2
4500369|NCT00848497|7305851|FG001|Overall Study|Screen failure|0
4500370|NCT00848497|7305850|FG000|Overall Study|Withdrawal by Subject|0
4500371|NCT00848497|7305851|FG001|Overall Study|Withdrawal by Subject|1
4500372|NCT00848536|7305878|FG000|Overall Study|Adverse Event|2
4500373|NCT00848536|7305879|FG001|Overall Study|Adverse Event|2
4500374|NCT00848536|7305878|FG000|Overall Study|Withdrawal by Subject|0
4500375|NCT00848536|7305879|FG001|Overall Study|Withdrawal by Subject|1
4500376|NCT00848536|7305878|FG000|Overall Study|Protocol Violation|0
4500377|NCT00848536|7305879|FG001|Overall Study|Protocol Violation|1
4500378|NCT00848536|7305878|FG000|Overall Study|Noncompliance|1
4500379|NCT00848536|7305879|FG001|Overall Study|Noncompliance|0
4500380|NCT00848536|7305878|FG000|Overall Study|Inadequate Control of IOP|1
4500381|NCT00848536|7305879|FG001|Overall Study|Inadequate Control of IOP|1
4500382|NCT00848536|7305878|FG000|Overall Study|Patient Moved|0
4500383|NCT00848536|7305879|FG001|Overall Study|Patient Moved|2
4500384|NCT00848549|7305887|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31
4518724|NCT00975884|7330973|FG000|Overall Study|Lost to Follow-up|5
4500385|NCT00848549|7305888|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35
4500386|NCT00848549|7305887|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35
4500387|NCT00848549|7305888|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24
4500388|NCT00848549|7305887|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23
4500389|NCT00848549|7305888|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23
4500390|NCT00848549|7305887|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3
4500391|NCT00848549|7305888|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8
4500392|NCT00848549|7305887|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4
4500393|NCT00848549|7305888|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5
4500394|NCT00848549|7305887|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21
4500395|NCT00848549|7305888|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11
4500396|NCT00848549|7305887|FG000|E2090-E044-310 (Base Study) Disposition|Other|4
4500397|NCT00848549|7305888|FG001|E2090-E044-310 (Base Study) Disposition|Other|3
4500398|NCT00848549|7305887|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24
4500399|NCT00848549|7305888|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34
4500400|NCT00848549|7305887|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2
4500401|NCT00848549|7305888|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1
4704640|NCT02755649|7623718|FG002|Overall Study|Physician Decision|2
4704641|NCT02755649|7623716|FG000|Overall Study|Withdrawal by Subject|0
4704642|NCT02755649|7623717|FG001|Overall Study|Withdrawal by Subject|1
4704643|NCT02755649|7623718|FG002|Overall Study|Withdrawal by Subject|0
4704644|NCT02755649|7623716|FG000|Overall Study|Undecided|1
4704645|NCT02755649|7623717|FG001|Overall Study|Undecided|0
4704646|NCT02755649|7623718|FG002|Overall Study|Undecided|0
4735472|NCT03531905|7683581|FG000|Overall Study|Withdrawal by Subject|3
4735473|NCT03531905|7683582|FG001|Overall Study|Withdrawal by Subject|3
4735474|NCT03531905|7683583|FG002|Overall Study|Withdrawal by Subject|2
4735475|NCT03531905|7683581|FG000|Overall Study|Lost to Follow-up|2
4735476|NCT03531905|7683582|FG001|Overall Study|Lost to Follow-up|2
4735477|NCT03531905|7683583|FG002|Overall Study|Lost to Follow-up|1
4735478|NCT03531905|7683581|FG000|Overall Study|Participant was out of town|1
4735479|NCT03531905|7683582|FG001|Overall Study|Participant was out of town|0
4735480|NCT03531905|7683583|FG002|Overall Study|Participant was out of town|0
4735481|NCT03531905|7683581|FG000|Overall Study|Could not speak with the participant|1
4735482|NCT03531905|7683582|FG001|Overall Study|Could not speak with the participant|0
4735483|NCT03531905|7683583|FG002|Overall Study|Could not speak with the participant|0
4735484|NCT03532009|7683595|FG000|Overall Study|Other|1
4735485|NCT03532009|7683596|FG001|Overall Study|Other|1
4735486|NCT03532009|7683595|FG000|Overall Study|Death|1
4735487|NCT03532009|7683596|FG001|Overall Study|Death|1
4735488|NCT03532009|7683595|FG000|Overall Study|Withdrawal by Patient|0
4735489|NCT03532009|7683596|FG001|Overall Study|Withdrawal by Patient|2
4735490|NCT03532048|7683604|FG000|Overall Study|Lost to Follow-up|12
4735491|NCT03532048|7683605|FG001|Overall Study|Lost to Follow-up|17
4735492|NCT03532048|7683604|FG000|Overall Study|Withdrawal by Subject|7
4735493|NCT03532048|7683605|FG001|Overall Study|Withdrawal by Subject|0
4735494|NCT03533114|7683645|FG000|Overall|Adverse Event|16
4735495|NCT03533114|7683646|FG001|Overall|Adverse Event|11
4735496|NCT03533114|7683645|FG000|Overall|Consent Withdrawal by Participant|7
4735497|NCT03533114|7683646|FG001|Overall|Consent Withdrawal by Participant|6
4735498|NCT03533114|7683645|FG000|Overall|Lack of Efficacy|5
4735499|NCT03533114|7683646|FG001|Overall|Lack of Efficacy|3
4735500|NCT03533114|7683645|FG000|Overall|Lost to Follow-up|1
4735501|NCT03533114|7683646|FG001|Overall|Lost to Follow-up|1
4735502|NCT03533114|7683645|FG000|Overall|Physician Decision|0
4735503|NCT03533114|7683646|FG001|Overall|Physician Decision|2
4735504|NCT03533114|7683645|FG000|Overall|Protocol deviation|1
4735505|NCT03533114|7683646|FG001|Overall|Protocol deviation|1
4735506|NCT03533114|7683645|FG000|Overall|Failure to meet randomization criteria|1
4735507|NCT03533114|7683646|FG001|Overall|Failure to meet randomization criteria|2
4735508|NCT03533114|7683645|FG000|Overall|Non-Compliance with study drug|0
4735509|NCT03533114|7683646|FG001|Overall|Non-Compliance with study drug|1
4735510|NCT03533114|7683645|FG000|Overall|Other|0
4735511|NCT03533114|7683646|FG001|Overall|Other|1
4735512|NCT03533114|7683645|FG000|Open Label Titration and Optimization|Adverse Event|11
4735513|NCT03533114|7683646|FG001|Open Label Titration and Optimization|Adverse Event|8
4735514|NCT03533114|7683645|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2
4735515|NCT03533114|7683646|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1
4735516|NCT03533114|7683645|FG000|Open Label Titration and Optimization|Lack of Efficacy|3
4735517|NCT03533114|7683646|FG001|Open Label Titration and Optimization|Lack of Efficacy|1
4735518|NCT03533114|7683645|FG000|Open Label Titration and Optimization|Lost to Follow-up|0
4735519|NCT03533114|7683646|FG001|Open Label Titration and Optimization|Lost to Follow-up|1
4735520|NCT03533114|7683645|FG000|Open Label Titration and Optimization|Protocol Deviation|0
4735521|NCT03533114|7683646|FG001|Open Label Titration and Optimization|Protocol Deviation|1
4735522|NCT03533114|7683645|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0
4735523|NCT03533114|7683646|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1
4735524|NCT03533114|7683645|FG000|Stable Dose|Adverse Event|0
4735525|NCT03533114|7683646|FG001|Stable Dose|Adverse Event|2
4500402|NCT00848549|7305887|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1
4500403|NCT00848549|7305888|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2
4500404|NCT00848549|7305887|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8
4704647|NCT02755805|7623728|FG000|Overall Study|Lost to Follow-up|1
4704648|NCT02755805|7623729|FG001|Overall Study|Lost to Follow-up|2
4704649|NCT02755805|7623728|FG000|Overall Study|Refused assessments|1
4704650|NCT02755805|7623729|FG001|Overall Study|Refused assessments|0
4704651|NCT02755805|7623728|FG000|Overall Study|Withdrawal by Subject|0
4704652|NCT02755805|7623729|FG001|Overall Study|Withdrawal by Subject|2
4704653|NCT02755818|7623739|FG000|Overall Study|Withdrawal by Subject|0
4704654|NCT02755818|7623740|FG001|Overall Study|Withdrawal by Subject|0
4704655|NCT02755818|7623741|FG002|Overall Study|Withdrawal by Subject|0
4704656|NCT02755818|7623742|FG003|Overall Study|Withdrawal by Subject|2
4704657|NCT02755818|7623739|FG000|Overall Study|withdrawal by PI|0
4704658|NCT02755818|7623740|FG001|Overall Study|withdrawal by PI|0
4704659|NCT02755818|7623741|FG002|Overall Study|withdrawal by PI|1
4704660|NCT02755818|7623742|FG003|Overall Study|withdrawal by PI|1
4704661|NCT02755831|7623756|FG000|Overall Study|Lost to Follow-up|3
4704662|NCT02755831|7623757|FG001|Overall Study|Lost to Follow-up|3
4704663|NCT02756013|7623767|FG000|Overall Study|Adverse Event|1
4704664|NCT02756013|7623767|FG000|Overall Study|Hypersensitivity|1
4704665|NCT02756078|7623771|FG000|Period 1|Unsatisfactory Lens Fitting|0
4704666|NCT02756078|7623772|FG001|Period 1|Unsatisfactory Lens Fitting|1
4704667|NCT02756078|7623771|FG000|Period 1|Lost to Follow-up|0
4704668|NCT02756078|7623772|FG001|Period 1|Lost to Follow-up|2
4704669|NCT02756078|7623771|FG000|Period 1|Protocol Violation|0
4704670|NCT02756078|7623772|FG001|Period 1|Protocol Violation|1
4704671|NCT02756078|7623771|FG000|Period 1|Adverse Event|1
4704672|NCT02756078|7623772|FG001|Period 1|Adverse Event|10
4704673|NCT02756078|7623771|FG000|Period 1|Withdrawal by Subject|6
4704674|NCT02756078|7623772|FG001|Period 1|Withdrawal by Subject|6
4704675|NCT02756078|7623771|FG000|Period 1|Lens Discomfort|2
4704676|NCT02756078|7623772|FG001|Period 1|Lens Discomfort|2
4704677|NCT02756078|7623771|FG000|Period 2|Adverse Event|3
4704678|NCT02756078|7623772|FG001|Period 2|Adverse Event|5
4704679|NCT02756078|7623771|FG000|Period 2|Unsatisfactory Lens Fitting|0
4704680|NCT02756078|7623772|FG001|Period 2|Unsatisfactory Lens Fitting|1
4704681|NCT02756078|7623771|FG000|Period 2|Withdrawal by Subject|3
4704682|NCT02756078|7623772|FG001|Period 2|Withdrawal by Subject|1
4704683|NCT02756182|7623778|FG000|Overall Study|StudyTechnical Difficulties|4
4704684|NCT02756338|7623784|FG000|Overall Study|Withdrawn by Investigator|1
4704685|NCT02756338|7623784|FG000|Overall Study|Device Replaced with Pacemaker|4
4704686|NCT02756364|7623800|FG000|Overall Study|Site Terminated by Sponsor|24
4704687|NCT02756364|7623801|FG001|Overall Study|Site Terminated by Sponsor|30
4704688|NCT02756364|7623802|FG002|Overall Study|Site Terminated by Sponsor|21
4704689|NCT02756364|7623800|FG000|Overall Study|Death|20
4704690|NCT02756364|7623801|FG001|Overall Study|Death|15
4704691|NCT02756364|7623802|FG002|Overall Study|Death|18
4704692|NCT02756364|7623800|FG000|Overall Study|Withdrawal by Patient|2
4704693|NCT02756364|7623801|FG001|Overall Study|Withdrawal by Patient|1
4704694|NCT02756364|7623802|FG002|Overall Study|Withdrawal by Patient|8
4704695|NCT02756364|7623800|FG000|Overall Study|Lost to Follow-up|0
4704696|NCT02756364|7623801|FG001|Overall Study|Lost to Follow-up|1
4704697|NCT02756364|7623802|FG002|Overall Study|Lost to Follow-up|1
4704698|NCT02756637|7623830|FG000|Overall Study|Not eligible for initial SWOG study|10
4704699|NCT02756637|7623831|FG001|Overall Study|Not eligible for initial SWOG study|10
4704700|NCT02756637|7623830|FG000|Overall Study|No available NLR value|44
4704701|NCT02756637|7623831|FG001|Overall Study|No available NLR value|44
4704702|NCT02756637|7623830|FG000|Overall Study|Did not complete curative therapy|33
4704703|NCT02756637|7623831|FG001|Overall Study|Did not complete curative therapy|0
4704704|NCT02756650|7623837|FG000|Overall Study|Physician Decision|1
4704705|NCT02756650|7623837|FG000|Overall Study|Adverse Event|1
4704706|NCT02756819|7623884|FG000|Overall Study|Lost for observation|23
4704707|NCT02756819|7623884|FG000|Overall Study|Patient's unwillingness|16
4704708|NCT02756819|7623884|FG000|Overall Study|Insufficient efficacy|2
4704709|NCT02756819|7623884|FG000|Overall Study|Adverse Event|2
4704710|NCT02756819|7623884|FG000|Overall Study|Reason not Specified|9
4704711|NCT02756832|7623888|FG000|Overall Study|Lost for Observation after Baseline|6
4704712|NCT02756832|7623888|FG000|Overall Study|Lost for Observation|13
4704713|NCT02756832|7623888|FG000|Overall Study|Patient's Unwillingness|12
4704714|NCT02756832|7623888|FG000|Overall Study|Insufficient Efficacy|2
4704715|NCT02756832|7623888|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1
4704716|NCT02756832|7623888|FG000|Overall Study|Reason not Specified|9
4704717|NCT02756832|7623888|FG000|Overall Study|Protocol Deviation|10
4704718|NCT02757352|7624002|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2
4704719|NCT02757352|7624003|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
4704720|NCT02757352|7624004|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1
4500405|NCT00848549|7305888|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12
4704721|NCT02757352|7624005|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
4704722|NCT02757352|7624006|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
4704723|NCT02757352|7624007|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
4704724|NCT02757352|7624008|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
4500406|NCT00848549|7305887|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1
4704725|NCT02757352|7624009|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
4704726|NCT02757352|7624010|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
4704727|NCT02757352|7624011|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
4704728|NCT02757352|7624002|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
4704729|NCT02757352|7624003|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
4704730|NCT02757352|7624004|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1
4704731|NCT02757352|7624005|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
4704732|NCT02757352|7624006|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
4704733|NCT02757352|7624007|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
4704734|NCT02757352|7624008|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
4704735|NCT02757352|7624009|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
4704736|NCT02757352|7624010|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
4704737|NCT02757352|7624011|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
4704738|NCT02757352|7624002|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6
4704739|NCT02757352|7624003|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1
4704740|NCT02757352|7624004|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2
4704741|NCT02757352|7624005|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
4704742|NCT02757352|7624006|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
4704743|NCT02757352|7624007|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
4704744|NCT02757352|7624008|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
4704745|NCT02757352|7624009|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
4704746|NCT02757352|7624010|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
4704747|NCT02757352|7624011|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
4704748|NCT02757352|7624002|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
4704749|NCT02757352|7624003|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1
4704750|NCT02757352|7624004|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
4704751|NCT02757352|7624005|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
4704752|NCT02757352|7624006|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
4704753|NCT02757352|7624007|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
4704754|NCT02757352|7624008|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
4704755|NCT02757352|7624009|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
4704756|NCT02757352|7624010|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
4704757|NCT02757352|7624011|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
4704758|NCT02757352|7624002|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
4704759|NCT02757352|7624003|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1
4704760|NCT02757352|7624004|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
4704761|NCT02757352|7624005|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
4704762|NCT02757352|7624006|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
4704763|NCT02757352|7624007|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
4704764|NCT02757352|7624008|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
4704765|NCT02757352|7624009|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
4704766|NCT02757352|7624010|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
4704767|NCT02757352|7624011|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
4704768|NCT02757352|7624002|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1
4704769|NCT02757352|7624003|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1
4704770|NCT02757352|7624004|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4
4704771|NCT02757352|7624005|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
4704772|NCT02757352|7624006|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
4704773|NCT02757352|7624007|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
4704774|NCT02757352|7624008|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
4704775|NCT02757352|7624009|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
4704776|NCT02757352|7624010|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
4704777|NCT02757352|7624011|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
4704778|NCT02757352|7624002|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62
4704779|NCT02757352|7624003|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40
4704780|NCT02757352|7624004|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42
4704781|NCT02757352|7624005|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
4704782|NCT02757352|7624006|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
4704783|NCT02757352|7624007|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
4704784|NCT02757352|7624008|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
4704785|NCT02757352|7624009|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
4704786|NCT02757352|7624010|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
4704787|NCT02757352|7624011|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
4704788|NCT02757352|7624002|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
4704789|NCT02757352|7624003|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
4500407|NCT00848549|7305888|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1
4500408|NCT00848549|7305887|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0
4500409|NCT00848549|7305888|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2
4500410|NCT00848549|7305887|FG000|E2090-E044-314 (Extension Study)|Other|5
4500411|NCT00848549|7305888|FG001|E2090-E044-314 (Extension Study)|Other|6
4500412|NCT00848718|7305909|FG000|Overall Study|Adverse Event|2
4500413|NCT00848718|7305910|FG001|Overall Study|Adverse Event|2
4500414|NCT00848718|7305911|FG002|Overall Study|Adverse Event|1
4500415|NCT00848718|7305912|FG003|Overall Study|Adverse Event|1
4500416|NCT00848718|7305913|FG004|Overall Study|Adverse Event|1
4500417|NCT00848718|7305914|FG005|Overall Study|Adverse Event|0
4500418|NCT00848718|7305915|FG006|Overall Study|Adverse Event|0
4500419|NCT00848718|7305916|FG007|Overall Study|Adverse Event|1
4500420|NCT00848718|7305917|FG008|Overall Study|Adverse Event|1
4500421|NCT00848718|7305918|FG009|Overall Study|Adverse Event|0
4500422|NCT00848718|7305919|FG010|Overall Study|Adverse Event|0
4500423|NCT00848718|7305920|FG011|Overall Study|Adverse Event|0
4500424|NCT00848718|7305921|FG012|Overall Study|Adverse Event|2
4500425|NCT00848718|7305909|FG000|Overall Study|Lack of Efficacy|0
4500426|NCT00848718|7305910|FG001|Overall Study|Lack of Efficacy|0
4500427|NCT00848718|7305911|FG002|Overall Study|Lack of Efficacy|1
4500428|NCT00848718|7305912|FG003|Overall Study|Lack of Efficacy|0
4500429|NCT00848718|7305913|FG004|Overall Study|Lack of Efficacy|0
4500430|NCT00848718|7305914|FG005|Overall Study|Lack of Efficacy|0
4500431|NCT00848718|7305915|FG006|Overall Study|Lack of Efficacy|1
4500432|NCT00848718|7305916|FG007|Overall Study|Lack of Efficacy|0
4500433|NCT00848718|7305917|FG008|Overall Study|Lack of Efficacy|0
4500434|NCT00848718|7305918|FG009|Overall Study|Lack of Efficacy|0
4500435|NCT00848718|7305919|FG010|Overall Study|Lack of Efficacy|0
4500436|NCT00848718|7305920|FG011|Overall Study|Lack of Efficacy|0
4500437|NCT00848718|7305921|FG012|Overall Study|Lack of Efficacy|0
4500438|NCT00848718|7305909|FG000|Overall Study|Physician Decision|0
4500439|NCT00848718|7305910|FG001|Overall Study|Physician Decision|1
4500440|NCT00848718|7305911|FG002|Overall Study|Physician Decision|0
4500441|NCT00848718|7305912|FG003|Overall Study|Physician Decision|0
4500442|NCT00848718|7305913|FG004|Overall Study|Physician Decision|1
4500443|NCT00848718|7305914|FG005|Overall Study|Physician Decision|1
4500444|NCT00848718|7305915|FG006|Overall Study|Physician Decision|0
4500445|NCT00848718|7305916|FG007|Overall Study|Physician Decision|0
4500446|NCT00848718|7305917|FG008|Overall Study|Physician Decision|1
4500447|NCT00848718|7305918|FG009|Overall Study|Physician Decision|2
4500448|NCT00848718|7305919|FG010|Overall Study|Physician Decision|0
4500449|NCT00848718|7305920|FG011|Overall Study|Physician Decision|0
4500450|NCT00848718|7305921|FG012|Overall Study|Physician Decision|1
4500451|NCT00848718|7305909|FG000|Overall Study|Progressive disease before treatment|1
4500452|NCT00848718|7305910|FG001|Overall Study|Progressive disease before treatment|5
4500453|NCT00848718|7305911|FG002|Overall Study|Progressive disease before treatment|1
4500454|NCT00848718|7305912|FG003|Overall Study|Progressive disease before treatment|3
4500455|NCT00848718|7305913|FG004|Overall Study|Progressive disease before treatment|4
4500456|NCT00848718|7305914|FG005|Overall Study|Progressive disease before treatment|4
4500457|NCT00848718|7305915|FG006|Overall Study|Progressive disease before treatment|2
4500458|NCT00848718|7305916|FG007|Overall Study|Progressive disease before treatment|1
4500459|NCT00848718|7305917|FG008|Overall Study|Progressive disease before treatment|2
4500460|NCT00848718|7305918|FG009|Overall Study|Progressive disease before treatment|7
4500461|NCT00848718|7305919|FG010|Overall Study|Progressive disease before treatment|3
4500462|NCT00848718|7305920|FG011|Overall Study|Progressive disease before treatment|6
4500463|NCT00848718|7305921|FG012|Overall Study|Progressive disease before treatment|2
4500464|NCT00848718|7305909|FG000|Overall Study|Protocol Violation|0
4500465|NCT00848718|7305910|FG001|Overall Study|Protocol Violation|1
4500466|NCT00848718|7305911|FG002|Overall Study|Protocol Violation|0
4500467|NCT00848718|7305912|FG003|Overall Study|Protocol Violation|0
4500468|NCT00848718|7305913|FG004|Overall Study|Protocol Violation|0
4500469|NCT00848718|7305914|FG005|Overall Study|Protocol Violation|0
4500470|NCT00848718|7305915|FG006|Overall Study|Protocol Violation|0
4500471|NCT00848718|7305916|FG007|Overall Study|Protocol Violation|1
4500472|NCT00848718|7305917|FG008|Overall Study|Protocol Violation|0
4500473|NCT00848718|7305918|FG009|Overall Study|Protocol Violation|0
4500474|NCT00848718|7305919|FG010|Overall Study|Protocol Violation|0
4500475|NCT00848718|7305920|FG011|Overall Study|Protocol Violation|0
4500476|NCT00848718|7305921|FG012|Overall Study|Protocol Violation|1
4500477|NCT00848718|7305909|FG000|Overall Study|Withdrawal by Subject|1
4500478|NCT00848718|7305910|FG001|Overall Study|Withdrawal by Subject|0
4500479|NCT00848718|7305911|FG002|Overall Study|Withdrawal by Subject|0
4500480|NCT00848718|7305912|FG003|Overall Study|Withdrawal by Subject|1
4500481|NCT00848718|7305913|FG004|Overall Study|Withdrawal by Subject|0
4500482|NCT00848718|7305914|FG005|Overall Study|Withdrawal by Subject|0
4500483|NCT00848718|7305915|FG006|Overall Study|Withdrawal by Subject|0
4500484|NCT00848718|7305916|FG007|Overall Study|Withdrawal by Subject|0
4500485|NCT00848718|7305917|FG008|Overall Study|Withdrawal by Subject|0
4500486|NCT00848718|7305918|FG009|Overall Study|Withdrawal by Subject|0
4500487|NCT00848718|7305919|FG010|Overall Study|Withdrawal by Subject|1
4500488|NCT00848718|7305920|FG011|Overall Study|Withdrawal by Subject|0
4500489|NCT00848718|7305921|FG012|Overall Study|Withdrawal by Subject|0
4500490|NCT00848718|7305909|FG000|Overall Study|Progressive disease during treatment|3
4500491|NCT00848718|7305910|FG001|Overall Study|Progressive disease during treatment|0
4500492|NCT00848718|7305911|FG002|Overall Study|Progressive disease during treatment|3
4500493|NCT00848718|7305912|FG003|Overall Study|Progressive disease during treatment|0
4500494|NCT00848718|7305913|FG004|Overall Study|Progressive disease during treatment|0
4500495|NCT00848718|7305914|FG005|Overall Study|Progressive disease during treatment|0
4500496|NCT00848718|7305915|FG006|Overall Study|Progressive disease during treatment|0
4500497|NCT00848718|7305916|FG007|Overall Study|Progressive disease during treatment|2
4500498|NCT00848718|7305917|FG008|Overall Study|Progressive disease during treatment|0
4500499|NCT00848718|7305918|FG009|Overall Study|Progressive disease during treatment|0
4500500|NCT00848718|7305919|FG010|Overall Study|Progressive disease during treatment|0
4500501|NCT00848718|7305920|FG011|Overall Study|Progressive disease during treatment|0
4500502|NCT00848718|7305921|FG012|Overall Study|Progressive disease during treatment|2
4500503|NCT00848926|7305972|FG000|Treatment Period|Progressive disease|45
4500504|NCT00848926|7305972|FG000|Treatment Period|Adverse Event|20
4500505|NCT00848926|7305972|FG000|Treatment Period|Physician Decision|12
4500506|NCT00848926|7305972|FG000|Treatment Period|Withdrawal by Subject|7
4500507|NCT00848926|7305972|FG000|Follow-up Period|Lost to Follow-up|7
4500508|NCT00848926|7305972|FG000|Follow-up Period|Withdrawal by Subject|3
4500509|NCT00848926|7305972|FG000|Follow-up Period|Other|2
4500510|NCT00848965|7305976|FG000|Overall Study|Adverse Event|1
4500511|NCT00848965|7305976|FG000|Overall Study|Withdrawal by Subject|1
4500512|NCT00849017|7305991|FG000|Treatment Period (156 Weeks)|Adverse Event|5
4500513|NCT00849017|7305992|FG001|Treatment Period (156 Weeks)|Adverse Event|6
4500514|NCT00849017|7305993|FG002|Treatment Period (156 Weeks)|Adverse Event|15
4500515|NCT00849017|7305991|FG000|Treatment Period (156 Weeks)|Noncompliance|3
4500516|NCT00849017|7305992|FG001|Treatment Period (156 Weeks)|Noncompliance|3
4500517|NCT00849017|7305993|FG002|Treatment Period (156 Weeks)|Noncompliance|4
4500518|NCT00849017|7305991|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10
4500519|NCT00849017|7305992|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7
4500520|NCT00849017|7305993|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8
4500521|NCT00849017|7305991|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18
4500522|NCT00849017|7305992|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14
4500523|NCT00849017|7305993|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11
4500524|NCT00849017|7305991|FG000|Treatment Period (156 Weeks)|Physician Decision|0
4500525|NCT00849017|7305992|FG001|Treatment Period (156 Weeks)|Physician Decision|2
4500526|NCT00849017|7305993|FG002|Treatment Period (156 Weeks)|Physician Decision|1
4500527|NCT00849017|7305991|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3
4500528|NCT00849017|7305992|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1
4500529|NCT00849017|7305993|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1
4500530|NCT00849017|7305991|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1
4500531|NCT00849017|7305992|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0
4500532|NCT00849017|7305993|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0
4500533|NCT00849017|7305991|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1
4500534|NCT00849017|7305992|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0
4500535|NCT00849017|7305993|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0
4500536|NCT00849017|7305991|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1
4500537|NCT00849017|7305992|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0
4500538|NCT00849017|7305993|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0
4500539|NCT00849017|7305991|FG000|Treatment Period (156 Weeks)|Pregnancy|1
4500540|NCT00849017|7305992|FG001|Treatment Period (156 Weeks)|Pregnancy|0
4500541|NCT00849017|7305993|FG002|Treatment Period (156 Weeks)|Pregnancy|1
4500542|NCT00849017|7305991|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0
4500543|NCT00849017|7305992|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0
4500544|NCT00849017|7305993|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1
4500545|NCT00849017|7305991|FG000|Follow-up Period (8 Weeks)|Adverse Event|1
4500546|NCT00849017|7305992|FG001|Follow-up Period (8 Weeks)|Adverse Event|0
4500547|NCT00849017|7305993|FG002|Follow-up Period (8 Weeks)|Adverse Event|0
4500548|NCT00849017|7305991|FG000|Follow-up Period (8 Weeks)|Noncompliance|2
4500549|NCT00849017|7305992|FG001|Follow-up Period (8 Weeks)|Noncompliance|1
4500550|NCT00849017|7305993|FG002|Follow-up Period (8 Weeks)|Noncompliance|0
4627207|NCT01851863|7493802|FG000|Overall Study|Did not receive study medication|2
4627208|NCT01851863|7493803|FG001|Overall Study|Did not receive study medication|5
4627209|NCT01851863|7493804|FG002|Overall Study|Did not receive study medication|3
4627210|NCT01851863|7493805|FG003|Overall Study|Did not receive study medication|0
4627211|NCT01851863|7493802|FG000|Overall Study|Lost to Follow-up|3
4627212|NCT01851863|7493803|FG001|Overall Study|Lost to Follow-up|4
4627213|NCT01851863|7493804|FG002|Overall Study|Lost to Follow-up|2
4627214|NCT01851863|7493805|FG003|Overall Study|Lost to Follow-up|3
4500551|NCT00849017|7305991|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13
4500552|NCT00849017|7305992|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12
4500553|NCT00849017|7305993|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16
4500554|NCT00849017|7305991|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1
4627215|NCT01852045|7493853|FG000|Overall Study|Adverse Event|1
4500555|NCT00849017|7305992|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1
4500556|NCT00849017|7305993|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4
4500557|NCT00849017|7305991|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4
4500558|NCT00849017|7305992|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2
4500559|NCT00849017|7305993|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3
4500560|NCT00849017|7305991|FG000|Follow-up Period (8 Weeks)|Physician Decision|0
4500561|NCT00849017|7305992|FG001|Follow-up Period (8 Weeks)|Physician Decision|1
4500562|NCT00849017|7305993|FG002|Follow-up Period (8 Weeks)|Physician Decision|1
4500563|NCT00849017|7305991|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3
4500564|NCT00849017|7305992|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1
4500565|NCT00849017|7305993|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1
4500566|NCT00849017|7305991|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1
4500567|NCT00849017|7305992|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0
4500568|NCT00849017|7305993|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0
4500569|NCT00849056|7306007|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13
4500570|NCT00849056|7306008|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11
4500571|NCT00849056|7306007|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3
4500572|NCT00849056|7306008|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6
4500573|NCT00849056|7306007|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3
4500574|NCT00849056|7306008|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3
4500575|NCT00849056|7306007|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7
4500576|NCT00849056|7306008|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5
4500577|NCT00849056|7306007|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31
4500578|NCT00849056|7306008|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18
4500579|NCT00849056|7306007|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3
4500580|NCT00849056|7306008|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3
4500581|NCT00849056|7306007|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1
4500582|NCT00849056|7306008|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4
4500583|NCT00849056|7306007|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1
4500584|NCT00849056|7306008|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0
4500585|NCT00849056|7306007|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1
4500586|NCT00849056|7306008|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0
4500587|NCT00849056|7306007|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
4500588|NCT00849056|7306008|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3
4500589|NCT00849056|7306007|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0
4500590|NCT00849056|7306008|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1
4500591|NCT00849056|7306007|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14
4500592|NCT00849056|7306008|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9
4500593|NCT00849056|7306007|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9
4500594|NCT00849056|7306008|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7
4500595|NCT00849056|7306007|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
4500596|NCT00849056|7306008|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
4500597|NCT00849056|7306007|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1
4500598|NCT00849056|7306008|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4
4500599|NCT00849056|7306007|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1
4500600|NCT00849056|7306008|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0
4500601|NCT00849108|7306017|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1
4500602|NCT00849108|7306018|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0
4500603|NCT00849108|7306017|FG000|Cohort 2 Efficacy|Adverse Event|0
4500604|NCT00849108|7306018|FG001|Cohort 2 Efficacy|Adverse Event|1
4500605|NCT00849108|7306017|FG000|Cohort 2 Efficacy|Other|0
4500606|NCT00849108|7306018|FG001|Cohort 2 Efficacy|Other|9
4500607|NCT00849147|7306035|FG000|Overall Study|Withdrawal by Subject|1
4500608|NCT00849147|7306035|FG000|Overall Study|Protocol Violation|2
4500609|NCT00849147|7306035|FG000|Overall Study|Disease Relapse/Progression|2
4500610|NCT00849186|7306039|FG000|Overall Study|Adverse Event|2
4500611|NCT00849186|7306039|FG000|Overall Study|Withdrawal by Subject|1
4500612|NCT00849186|7306039|FG000|Overall Study|not treated|6
4500613|NCT00849186|7306039|FG000|Overall Study|Other|1
4500614|NCT00849212|7306044|FG000|Overall Study|Lack of Efficacy|1
4500615|NCT00849212|7306044|FG000|Overall Study|Withdrawal by Subject|3
4500616|NCT00849212|7306044|FG000|Overall Study|Adverse Event|2
4500617|NCT00849212|7306044|FG000|Overall Study|Miscellaneous|1
4500618|NCT00849290|7306055|FG000|Overall Study|Adverse Event|3
4500619|NCT00849290|7306055|FG000|Overall Study|Death|14
4500620|NCT00849290|7306055|FG000|Overall Study|Withdrawal by Subject|11
4500621|NCT00849290|7306055|FG000|Overall Study|Lost to Follow-up|2
4500622|NCT00849290|7306055|FG000|Overall Study|Protocol Violation|5
4500623|NCT00849290|7306055|FG000|Overall Study|Disease Progression|20
4704790|NCT02757352|7624004|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
4500624|NCT00849381|7306059|FG000|Overall Study|Adverse Event|1
4500625|NCT00849381|7306059|FG000|Overall Study|Lost to Follow-up|129
4500626|NCT00849381|7306059|FG000|Overall Study|Protocol Violation|5
4500627|NCT00849381|7306059|FG000|Overall Study|Withdrawal by Subject|6
4500628|NCT00849381|7306059|FG000|Overall Study|Other|4
4500629|NCT00849472|7306063|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2
4500630|NCT00849472|7306063|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1
4500631|NCT00849472|7306063|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1
4500632|NCT00849472|7306063|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1
4500633|NCT00849472|7306063|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1
4500634|NCT00849472|7306063|FG000|Weekly Paclitaxel|Disease Progression|1
4500635|NCT00849472|7306063|FG000|Weekly Paclitaxel|Adverse Event|11
4500636|NCT00849472|7306063|FG000|Weekly Paclitaxel|Withdrawal by Subject|1
4500637|NCT00849472|7306063|FG000|Weekly Paclitaxel|Physician Decision|3
4500638|NCT00849472|7306063|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52
4500639|NCT00849472|7306063|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4
4500640|NCT00849472|7306063|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1
4500641|NCT00849472|7306063|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1
4500642|NCT00849472|7306063|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19
4500643|NCT00849472|7306063|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5
4500644|NCT00849472|7306063|FG000|Pazopanib Postsurgery Treatment|Moved|1
4500645|NCT00849472|7306063|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1
4500646|NCT00849680|7306076|FG000|Overall Study|Adverse Event|0
4500647|NCT00849680|7306077|FG001|Overall Study|Adverse Event|0
4500648|NCT00849680|7306078|FG002|Overall Study|Adverse Event|0
4500649|NCT00849680|7306079|FG003|Overall Study|Adverse Event|0
4500650|NCT00849680|7306080|FG004|Overall Study|Adverse Event|0
4500651|NCT00849680|7306081|FG005|Overall Study|Adverse Event|0
4500652|NCT00849680|7306082|FG006|Overall Study|Adverse Event|2
4500653|NCT00849680|7306083|FG007|Overall Study|Adverse Event|0
4500654|NCT00849680|7306076|FG000|Overall Study|Lost to Follow-up|7
4500655|NCT00849680|7306077|FG001|Overall Study|Lost to Follow-up|3
4500656|NCT00849680|7306078|FG002|Overall Study|Lost to Follow-up|12
4500657|NCT00849680|7306079|FG003|Overall Study|Lost to Follow-up|11
4500658|NCT00849680|7306080|FG004|Overall Study|Lost to Follow-up|8
4500659|NCT00849680|7306081|FG005|Overall Study|Lost to Follow-up|11
4500660|NCT00849680|7306082|FG006|Overall Study|Lost to Follow-up|12
4500661|NCT00849680|7306083|FG007|Overall Study|Lost to Follow-up|5
4500662|NCT00849680|7306076|FG000|Overall Study|Subject moved|1
4500663|NCT00849680|7306077|FG001|Overall Study|Subject moved|0
4500664|NCT00849680|7306078|FG002|Overall Study|Subject moved|3
4500665|NCT00849680|7306079|FG003|Overall Study|Subject moved|1
4500666|NCT00849680|7306080|FG004|Overall Study|Subject moved|0
4500667|NCT00849680|7306081|FG005|Overall Study|Subject moved|2
4500668|NCT00849680|7306082|FG006|Overall Study|Subject moved|2
4500669|NCT00849680|7306083|FG007|Overall Study|Subject moved|2
4500670|NCT00849680|7306076|FG000|Overall Study|Withdrawal by Subject|2
4500671|NCT00849680|7306077|FG001|Overall Study|Withdrawal by Subject|0
4500672|NCT00849680|7306078|FG002|Overall Study|Withdrawal by Subject|0
4500673|NCT00849680|7306079|FG003|Overall Study|Withdrawal by Subject|2
4500674|NCT00849680|7306080|FG004|Overall Study|Withdrawal by Subject|2
4500675|NCT00849680|7306081|FG005|Overall Study|Withdrawal by Subject|2
4500676|NCT00849680|7306082|FG006|Overall Study|Withdrawal by Subject|1
4500677|NCT00849680|7306083|FG007|Overall Study|Withdrawal by Subject|1
4500678|NCT00849680|7306076|FG000|Overall Study|Subject unable to comply with protocol|1
4500679|NCT00849680|7306077|FG001|Overall Study|Subject unable to comply with protocol|0
4500680|NCT00849680|7306078|FG002|Overall Study|Subject unable to comply with protocol|0
4500681|NCT00849680|7306079|FG003|Overall Study|Subject unable to comply with protocol|0
4500682|NCT00849680|7306080|FG004|Overall Study|Subject unable to comply with protocol|0
4500683|NCT00849680|7306081|FG005|Overall Study|Subject unable to comply with protocol|0
4500684|NCT00849680|7306082|FG006|Overall Study|Subject unable to comply with protocol|0
4500685|NCT00849680|7306083|FG007|Overall Study|Subject unable to comply with protocol|0
4500686|NCT00849693|7306105|FG000|Acute Treatment Phase|Adverse Event|12
4500687|NCT00849693|7306106|FG001|Acute Treatment Phase|Adverse Event|7
4500688|NCT00849693|7306107|FG002|Acute Treatment Phase|Adverse Event|6
4500689|NCT00849693|7306108|FG003|Acute Treatment Phase|Adverse Event|4
4500690|NCT00849693|7306105|FG000|Acute Treatment Phase|Lost to Follow-up|5
4500691|NCT00849693|7306106|FG001|Acute Treatment Phase|Lost to Follow-up|8
4500692|NCT00849693|7306107|FG002|Acute Treatment Phase|Lost to Follow-up|11
4500693|NCT00849693|7306108|FG003|Acute Treatment Phase|Lost to Follow-up|9
4500694|NCT00849693|7306105|FG000|Acute Treatment Phase|Protocol Violation|1
4500695|NCT00849693|7306106|FG001|Acute Treatment Phase|Protocol Violation|5
4500696|NCT00849693|7306107|FG002|Acute Treatment Phase|Protocol Violation|2
4500697|NCT00849693|7306108|FG003|Acute Treatment Phase|Protocol Violation|6
4500698|NCT00849693|7306105|FG000|Acute Treatment Phase|Withdrawal by Subject|5
4500699|NCT00849693|7306106|FG001|Acute Treatment Phase|Withdrawal by Subject|5
4500700|NCT00849693|7306107|FG002|Acute Treatment Phase|Withdrawal by Subject|3
4500701|NCT00849693|7306108|FG003|Acute Treatment Phase|Withdrawal by Subject|8
4500702|NCT00849693|7306105|FG000|Acute Treatment Phase|Parent or caregiver decision|7
4500703|NCT00849693|7306106|FG001|Acute Treatment Phase|Parent or caregiver decision|6
4500704|NCT00849693|7306107|FG002|Acute Treatment Phase|Parent or caregiver decision|7
4500705|NCT00849693|7306108|FG003|Acute Treatment Phase|Parent or caregiver decision|7
4500706|NCT00849693|7306105|FG000|Acute Treatment Phase|Physician Decision|2
4500707|NCT00849693|7306106|FG001|Acute Treatment Phase|Physician Decision|1
4500708|NCT00849693|7306107|FG002|Acute Treatment Phase|Physician Decision|2
4627216|NCT01852045|7493854|FG001|Overall Study|Adverse Event|0
4627217|NCT01852045|7493855|FG002|Overall Study|Adverse Event|0
4500709|NCT00849693|7306108|FG003|Acute Treatment Phase|Physician Decision|1
4500710|NCT00849693|7306105|FG000|Acute Treatment Phase|Sponsor decision|0
4500711|NCT00849693|7306106|FG001|Acute Treatment Phase|Sponsor decision|0
4500712|NCT00849693|7306107|FG002|Acute Treatment Phase|Sponsor decision|1
4500713|NCT00849693|7306108|FG003|Acute Treatment Phase|Sponsor decision|0
4387256|NCT00048035|7165895|FG001|Extension Year 1|Early Withdrawals|0
4387257|NCT00048035|7165896|FG002|Extension Year 1|Early Withdrawals|0
4387258|NCT00048035|7165897|FG003|Extension Year 1|Early Withdrawals|0
4387259|NCT00048035|7165898|FG004|Extension Year 1|Early Withdrawals|0
4387260|NCT00048035|7165899|FG005|Extension Year 1|Early Withdrawals|0
4387261|NCT00048035|7165900|FG006|Extension Year 1|Early Withdrawals|11
4387262|NCT00048035|7165901|FG007|Extension Year 1|Early Withdrawals|11
4387263|NCT00048035|7165894|FG000|Extension Year 2|Early Withdrawals|0
4387264|NCT00048035|7165895|FG001|Extension Year 2|Early Withdrawals|0
4387265|NCT00048035|7165896|FG002|Extension Year 2|Early Withdrawals|0
4387266|NCT00048035|7165897|FG003|Extension Year 2|Early Withdrawals|0
4387267|NCT00048035|7165898|FG004|Extension Year 2|Early Withdrawals|0
4387268|NCT00048035|7165899|FG005|Extension Year 2|Early Withdrawals|0
4387269|NCT00048035|7165900|FG006|Extension Year 2|Early Withdrawals|3
4387270|NCT00048035|7165901|FG007|Extension Year 2|Early Withdrawals|3
4387271|NCT00048048|7165925|FG000|Core Treatment|Withdrawal by Subject|0
4500714|NCT00849693|7306105|FG000|Acute Treatment Phase|Lack of Efficacy|1
4500715|NCT00849693|7306106|FG001|Acute Treatment Phase|Lack of Efficacy|3
4500716|NCT00849693|7306107|FG002|Acute Treatment Phase|Lack of Efficacy|1
4500717|NCT00849693|7306108|FG003|Acute Treatment Phase|Lack of Efficacy|2
4500718|NCT00849693|7306105|FG000|Extension Phase|Adverse Event|4
4500719|NCT00849693|7306106|FG001|Extension Phase|Adverse Event|6
4500720|NCT00849693|7306107|FG002|Extension Phase|Adverse Event|3
4500721|NCT00849693|7306108|FG003|Extension Phase|Adverse Event|7
4500722|NCT00849693|7306105|FG000|Extension Phase|Lost to Follow-up|7
4500723|NCT00849693|7306106|FG001|Extension Phase|Lost to Follow-up|5
4500724|NCT00849693|7306107|FG002|Extension Phase|Lost to Follow-up|6
4500725|NCT00849693|7306108|FG003|Extension Phase|Lost to Follow-up|6
4500726|NCT00849693|7306105|FG000|Extension Phase|Protocol Violation|0
4500727|NCT00849693|7306106|FG001|Extension Phase|Protocol Violation|3
4500728|NCT00849693|7306107|FG002|Extension Phase|Protocol Violation|2
4500729|NCT00849693|7306108|FG003|Extension Phase|Protocol Violation|3
4500730|NCT00849693|7306105|FG000|Extension Phase|Withdrawal by Subject|6
4500731|NCT00849693|7306106|FG001|Extension Phase|Withdrawal by Subject|9
4500732|NCT00849693|7306107|FG002|Extension Phase|Withdrawal by Subject|10
4500733|NCT00849693|7306108|FG003|Extension Phase|Withdrawal by Subject|15
4500734|NCT00849693|7306105|FG000|Extension Phase|Parent or caregiver decision|9
4500735|NCT00849693|7306106|FG001|Extension Phase|Parent or caregiver decision|4
4627218|NCT01852045|7493853|FG000|Overall Study|Lack of Efficacy|3
4627219|NCT01852045|7493854|FG001|Overall Study|Lack of Efficacy|0
4627220|NCT01852045|7493855|FG002|Overall Study|Lack of Efficacy|0
4627221|NCT01852045|7493853|FG000|Overall Study|Lost to Follow-up|0
4627222|NCT01852045|7493854|FG001|Overall Study|Lost to Follow-up|1
4627223|NCT01852045|7493855|FG002|Overall Study|Lost to Follow-up|1
4627224|NCT01852045|7493853|FG000|Overall Study|Withdrawal by Subject|1
4627225|NCT01852045|7493854|FG001|Overall Study|Withdrawal by Subject|0
4627226|NCT01852045|7493855|FG002|Overall Study|Withdrawal by Subject|1
4627227|NCT01852045|7493853|FG000|Overall Study|Other Miscellaneous Reasons|1
4627228|NCT01852045|7493854|FG001|Overall Study|Other Miscellaneous Reasons|3
4627229|NCT01852045|7493855|FG002|Overall Study|Other Miscellaneous Reasons|2
4627230|NCT01852058|7493866|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1
4627231|NCT01852058|7493867|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
4627232|NCT01852058|7493868|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
4627233|NCT01852058|7493869|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
4627234|NCT01852058|7493870|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
4627235|NCT01852058|7493871|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
4627236|NCT01852058|7493872|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
4627237|NCT01852058|7493873|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
4627238|NCT01852058|7493874|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
4627239|NCT01852058|7493875|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
4627240|NCT01852058|7493876|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
4627241|NCT01852058|7493877|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
4627242|NCT01852058|7493866|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
4627243|NCT01852058|7493867|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
4627244|NCT01852058|7493868|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
4627245|NCT01852058|7493869|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
4500736|NCT00849693|7306107|FG002|Extension Phase|Parent or caregiver decision|10
4518725|NCT00975884|7330974|FG001|Overall Study|Lost to Follow-up|3
4500737|NCT00849693|7306108|FG003|Extension Phase|Parent or caregiver decision|5
4500738|NCT00849693|7306105|FG000|Extension Phase|Physician Decision|1
4500739|NCT00849693|7306106|FG001|Extension Phase|Physician Decision|1
4500740|NCT00849693|7306107|FG002|Extension Phase|Physician Decision|2
4500741|NCT00849693|7306108|FG003|Extension Phase|Physician Decision|0
4500742|NCT00849693|7306105|FG000|Extension Phase|Sponsor decision|1
4500743|NCT00849693|7306106|FG001|Extension Phase|Sponsor decision|0
4500744|NCT00849693|7306107|FG002|Extension Phase|Sponsor decision|0
4500745|NCT00849693|7306108|FG003|Extension Phase|Sponsor decision|1
4500746|NCT00849693|7306105|FG000|Extension Phase|Lack of Efficacy|2
4500747|NCT00849693|7306106|FG001|Extension Phase|Lack of Efficacy|2
4500748|NCT00849693|7306107|FG002|Extension Phase|Lack of Efficacy|2
4500749|NCT00849693|7306108|FG003|Extension Phase|Lack of Efficacy|1
4500750|NCT00849875|7306137|FG000|Overall Study|Death|28
4500751|NCT00849875|7306137|FG000|Overall Study|Ongoing (unknown completion status)|11
4500752|NCT00849875|7306137|FG000|Overall Study|Others|6
4500753|NCT00849875|7306137|FG000|Overall Study|Lost to Follow-up|2
4500754|NCT00849901|7306151|FG000|Acute Treatment Phase|Adverse Event|9
4500755|NCT00849901|7306152|FG001|Acute Treatment Phase|Adverse Event|1
4500756|NCT00849901|7306153|FG002|Acute Treatment Phase|Adverse Event|3
4500757|NCT00849901|7306151|FG000|Acute Treatment Phase|Lost to Follow-up|2
4500758|NCT00849901|7306152|FG001|Acute Treatment Phase|Lost to Follow-up|4
4500759|NCT00849901|7306153|FG002|Acute Treatment Phase|Lost to Follow-up|1
4500760|NCT00849901|7306151|FG000|Acute Treatment Phase|Protocol Violation|0
4500761|NCT00849901|7306152|FG001|Acute Treatment Phase|Protocol Violation|2
4500762|NCT00849901|7306153|FG002|Acute Treatment Phase|Protocol Violation|1
4500763|NCT00849901|7306151|FG000|Acute Treatment Phase|Withdrawal by Subject|4
4500764|NCT00849901|7306152|FG001|Acute Treatment Phase|Withdrawal by Subject|10
4500765|NCT00849901|7306153|FG002|Acute Treatment Phase|Withdrawal by Subject|4
4500766|NCT00849901|7306151|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11
4500767|NCT00849901|7306152|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5
4500768|NCT00849901|7306153|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4
4500769|NCT00849901|7306151|FG000|Acute Treatment Phase|Physician Decision|1
4500770|NCT00849901|7306152|FG001|Acute Treatment Phase|Physician Decision|1
4500771|NCT00849901|7306153|FG002|Acute Treatment Phase|Physician Decision|1
4500772|NCT00849901|7306151|FG000|Acute Treatment Phase|Sponsor Decision|1
4500773|NCT00849901|7306152|FG001|Acute Treatment Phase|Sponsor Decision|0
4500774|NCT00849901|7306153|FG002|Acute Treatment Phase|Sponsor Decision|0
4500775|NCT00849901|7306151|FG000|Acute Treatment Phase|Lack of Efficacy|2
4500776|NCT00849901|7306152|FG001|Acute Treatment Phase|Lack of Efficacy|3
4500777|NCT00849901|7306153|FG002|Acute Treatment Phase|Lack of Efficacy|2
4500778|NCT00849901|7306151|FG000|Extension Phase|Adverse Event|2
4500779|NCT00849901|7306152|FG001|Extension Phase|Adverse Event|8
4500780|NCT00849901|7306153|FG002|Extension Phase|Adverse Event|4
4500781|NCT00849901|7306151|FG000|Extension Phase|Lost to Follow-up|3
4500782|NCT00849901|7306152|FG001|Extension Phase|Lost to Follow-up|0
4500783|NCT00849901|7306153|FG002|Extension Phase|Lost to Follow-up|1
4500784|NCT00849901|7306151|FG000|Extension Phase|Protocol Violation|2
4500785|NCT00849901|7306152|FG001|Extension Phase|Protocol Violation|2
4500786|NCT00849901|7306153|FG002|Extension Phase|Protocol Violation|4
4500787|NCT00849901|7306151|FG000|Extension Phase|Withdrawal by Subject|7
4500788|NCT00849901|7306152|FG001|Extension Phase|Withdrawal by Subject|6
4500789|NCT00849901|7306153|FG002|Extension Phase|Withdrawal by Subject|3
4500790|NCT00849901|7306151|FG000|Extension Phase|Parent or Caregiver Decision|10
4500791|NCT00849901|7306152|FG001|Extension Phase|Parent or Caregiver Decision|4
4500792|NCT00849901|7306153|FG002|Extension Phase|Parent or Caregiver Decision|4
4500793|NCT00849901|7306151|FG000|Extension Phase|Physician Decision|1
4500794|NCT00849901|7306152|FG001|Extension Phase|Physician Decision|2
4500795|NCT00849901|7306153|FG002|Extension Phase|Physician Decision|0
4500796|NCT00849901|7306151|FG000|Extension Phase|Lack of Efficacy|2
4500797|NCT00849901|7306152|FG001|Extension Phase|Lack of Efficacy|4
4500798|NCT00849901|7306153|FG002|Extension Phase|Lack of Efficacy|1
4500799|NCT00849940|7306167|FG000|Overall Study|Physician Decision|4
4500800|NCT00850070|7306177|FG000|Overall Study|Lack of Efficacy|1
4500801|NCT00850070|7306178|FG001|Overall Study|Lack of Efficacy|1
4500802|NCT00850070|7306177|FG000|Overall Study|Adverse Event|2
4500803|NCT00850070|7306178|FG001|Overall Study|Adverse Event|0
4500804|NCT00850135|7306198|FG000|Overall Study|Physician Decision|1
4500805|NCT00850200|7306204|FG000|Overall Study|Physician Decision|2
4500806|NCT00850200|7306204|FG000|Overall Study|Did not recieve treatment|2
4500807|NCT00850200|7306204|FG000|Overall Study|Withdrawal by Subject|1
4500808|NCT00850343|7306215|FG000|Overall Study|Withdrawal by Subject|11
4500809|NCT00850343|7306216|FG001|Overall Study|Withdrawal by Subject|0
4500810|NCT00850343|7306217|FG002|Overall Study|Withdrawal by Subject|3
4500811|NCT00850343|7306218|FG003|Overall Study|Withdrawal by Subject|2
4500812|NCT00850343|7306215|FG000|Overall Study|Adverse Event|15
4500813|NCT00850343|7306216|FG001|Overall Study|Adverse Event|2
4500814|NCT00850343|7306217|FG002|Overall Study|Adverse Event|6
4500815|NCT00850343|7306218|FG003|Overall Study|Adverse Event|6
4500816|NCT00850343|7306215|FG000|Overall Study|Pregnancy|0
4500817|NCT00850343|7306216|FG001|Overall Study|Pregnancy|0
4500818|NCT00850343|7306217|FG002|Overall Study|Pregnancy|0
4500819|NCT00850343|7306218|FG003|Overall Study|Pregnancy|1
4500820|NCT00850343|7306215|FG000|Overall Study|Lack of Efficacy|17
4500821|NCT00850343|7306216|FG001|Overall Study|Lack of Efficacy|0
4500822|NCT00850343|7306217|FG002|Overall Study|Lack of Efficacy|3
4500823|NCT00850343|7306218|FG003|Overall Study|Lack of Efficacy|2
4500824|NCT00850343|7306215|FG000|Overall Study|Non-compliance with Study Procedures|1
4500825|NCT00850343|7306216|FG001|Overall Study|Non-compliance with Study Procedures|0
4500826|NCT00850343|7306217|FG002|Overall Study|Non-compliance with Study Procedures|1
4500827|NCT00850343|7306218|FG003|Overall Study|Non-compliance with Study Procedures|1
4500828|NCT00850343|7306215|FG000|Overall Study|Physician Decision|2
4500829|NCT00850343|7306216|FG001|Overall Study|Physician Decision|1
4500830|NCT00850343|7306217|FG002|Overall Study|Physician Decision|1
4500831|NCT00850343|7306218|FG003|Overall Study|Physician Decision|1
4500832|NCT00850395|7306228|FG000|Overall Study|Death|1
4500833|NCT00850395|7306228|FG000|Overall Study|Adverse Event|1
4500834|NCT00850395|7306228|FG000|Overall Study|Insufficient clinical response|3
4500835|NCT00850395|7306228|FG000|Overall Study|Other|5
4500836|NCT00850460|7306234|FG000|Overall Study|Lost to Follow-up|4
4500837|NCT00850460|7306235|FG001|Overall Study|Lost to Follow-up|4
4500838|NCT00850499|7306247|FG000|Overall Study|Adverse Event|3
4500839|NCT00850499|7306248|FG001|Overall Study|Adverse Event|1
4500840|NCT00850499|7306247|FG000|Overall Study|Lack of Efficacy|0
4500841|NCT00850499|7306248|FG001|Overall Study|Lack of Efficacy|1
4500842|NCT00850538|7306254|FG000|Overall Study|unable/unwilling to complete MRI|13
4500843|NCT00850538|7306254|FG000|Overall Study|specimen missed due to scheduling error|14
4500844|NCT00850538|7306254|FG000|Overall Study|specimen unusable|7
4500845|NCT00850538|7306254|FG000|Overall Study|Withdrawal by Subject|3
4500846|NCT00850538|7306254|FG000|Overall Study|radiology error|2
4500847|NCT00850538|7306254|FG000|Overall Study|Protocol Violation|2
4500848|NCT00850564|7306258|FG000|Overall Study|Withdrawal by Subject|2
4500849|NCT00850759|7306301|FG000|Overall Study|Lost to Follow-up|7
4500850|NCT00850759|7306302|FG001|Overall Study|Lost to Follow-up|5
4500851|NCT00850759|7306303|FG002|Overall Study|Lost to Follow-up|5
4500852|NCT00850759|7306304|FG003|Overall Study|Lost to Follow-up|3
4500853|NCT00850993|7306325|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1
4500854|NCT00850993|7306326|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0
4500855|NCT00850993|7306327|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0
4500856|NCT00850993|7306328|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1
4500857|NCT00851084|7306348|FG000|Overall Study|Randomized but not treated|1
4500858|NCT00851084|7306349|FG001|Overall Study|Randomized but not treated|0
4500859|NCT00851084|7306348|FG000|Overall Study|Adverse Event|26
4500860|NCT00851084|7306349|FG001|Overall Study|Adverse Event|36
4500861|NCT00851084|7306348|FG000|Overall Study|Disease progression|52
4500862|NCT00851084|7306349|FG001|Overall Study|Disease progression|47
4500863|NCT00851084|7306348|FG000|Overall Study|Poor compliance to protocol|1
4500864|NCT00851084|7306349|FG001|Overall Study|Poor compliance to protocol|1
4500865|NCT00851084|7306348|FG000|Overall Study|Physician Decision|13
4500866|NCT00851084|7306349|FG001|Overall Study|Physician Decision|14
4500867|NCT00851084|7306348|FG000|Overall Study|Consent withdrawn|0
4500868|NCT00851084|7306349|FG001|Overall Study|Consent withdrawn|2
4500869|NCT00851084|7306348|FG000|Overall Study|Withdrawal by Subject|11
4500870|NCT00851084|7306349|FG001|Overall Study|Withdrawal by Subject|12
4500871|NCT00851084|7306348|FG000|Overall Study|Metastatic surgery|6
4500872|NCT00851084|7306349|FG001|Overall Study|Metastatic surgery|6
4500873|NCT00851084|7306348|FG000|Overall Study|Other|7
4500874|NCT00851084|7306349|FG001|Overall Study|Other|1
4500875|NCT00851253|7306359|FG000|Overall Study|Disease Progression|1
4500876|NCT00851253|7306360|FG001|Overall Study|Disease Progression|0
4500877|NCT00851318|7306374|FG000|Overall Study|Withdrawal by Subject|7
4500878|NCT00851318|7306375|FG001|Overall Study|Withdrawal by Subject|1
4627246|NCT01852058|7493870|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1
4627247|NCT01852058|7493871|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
4627248|NCT01852058|7493872|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
4627249|NCT01852058|7493873|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
4627250|NCT01852058|7493874|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
4627251|NCT01852058|7493875|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
4627252|NCT01852058|7493876|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
4627253|NCT01852058|7493877|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
4627254|NCT01852058|7493866|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
4627255|NCT01852058|7493867|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
4627256|NCT01852058|7493868|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
4627257|NCT01852058|7493869|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
4627258|NCT01852058|7493870|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1
4627259|NCT01852058|7493871|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1
4627260|NCT01852058|7493872|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
4633238|NCT01909804|7503297|FG001|Overall Study|Death|0
4500879|NCT00851318|7306376|FG002|Overall Study|Withdrawal by Subject|5
4500880|NCT00851318|7306377|FG003|Overall Study|Withdrawal by Subject|3
4500881|NCT00851318|7306374|FG000|Overall Study|Adverse Event|13
4500882|NCT00851318|7306375|FG001|Overall Study|Adverse Event|2
4500883|NCT00851318|7306376|FG002|Overall Study|Adverse Event|9
4500884|NCT00851318|7306377|FG003|Overall Study|Adverse Event|12
4500885|NCT00851318|7306374|FG000|Overall Study|Pregnancy|0
4500886|NCT00851318|7306375|FG001|Overall Study|Pregnancy|0
4500887|NCT00851318|7306376|FG002|Overall Study|Pregnancy|1
4500888|NCT00851318|7306377|FG003|Overall Study|Pregnancy|1
4500889|NCT00851318|7306374|FG000|Overall Study|Lack of Efficacy|8
4500890|NCT00851318|7306375|FG001|Overall Study|Lack of Efficacy|2
4500891|NCT00851318|7306376|FG002|Overall Study|Lack of Efficacy|4
4500892|NCT00851318|7306377|FG003|Overall Study|Lack of Efficacy|2
4500893|NCT00851318|7306374|FG000|Overall Study|Non-compliance with Study Procedures|2
4500894|NCT00851318|7306375|FG001|Overall Study|Non-compliance with Study Procedures|0
4500895|NCT00851318|7306376|FG002|Overall Study|Non-compliance with Study Procedures|1
4500896|NCT00851318|7306377|FG003|Overall Study|Non-compliance with Study Procedures|0
4500897|NCT00851318|7306374|FG000|Overall Study|Physician Decision|0
4500898|NCT00851318|7306375|FG001|Overall Study|Physician Decision|0
4500899|NCT00851318|7306376|FG002|Overall Study|Physician Decision|1
4500900|NCT00851318|7306377|FG003|Overall Study|Physician Decision|1
4500901|NCT00851630|7306407|FG000|Overall Study|Death|2
4500902|NCT00851630|7306408|FG001|Overall Study|Death|1
4500903|NCT00851630|7306407|FG000|Overall Study|Clinical failure|0
4500904|NCT00851630|7306408|FG001|Overall Study|Clinical failure|1
4500905|NCT00851643|7306420|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1
4500906|NCT00851643|7306421|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0
4500907|NCT00851643|7306422|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0
4500908|NCT00851643|7306423|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0
4500909|NCT00851643|7306424|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0
4500910|NCT00851643|7306425|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0
4500911|NCT00851643|7306420|FG000|Base Study (Up to 12 Months)|Other|0
4500912|NCT00851643|7306421|FG001|Base Study (Up to 12 Months)|Other|0
4500913|NCT00851643|7306422|FG002|Base Study (Up to 12 Months)|Other|0
4500914|NCT00851643|7306423|FG003|Base Study (Up to 12 Months)|Other|0
4500915|NCT00851643|7306424|FG004|Base Study (Up to 12 Months)|Other|0
4500916|NCT00851643|7306425|FG005|Base Study (Up to 12 Months)|Other|1
4500917|NCT00851643|7306420|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4
4500918|NCT00851643|7306421|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2
4500919|NCT00851643|7306422|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4
4500920|NCT00851643|7306423|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1
4500921|NCT00851643|7306424|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2
4500922|NCT00851643|7306425|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0
4500923|NCT00851643|7306420|FG000|Extension Study (Up to 36 Months)|Moved|0
4500924|NCT00851643|7306421|FG001|Extension Study (Up to 36 Months)|Moved|2
4500925|NCT00851643|7306422|FG002|Extension Study (Up to 36 Months)|Moved|1
4500926|NCT00851643|7306423|FG003|Extension Study (Up to 36 Months)|Moved|1
4500927|NCT00851643|7306424|FG004|Extension Study (Up to 36 Months)|Moved|0
4500928|NCT00851643|7306425|FG005|Extension Study (Up to 36 Months)|Moved|1
4500929|NCT00851721|7306440|FG000|Overall Study|planned surgery|1
4500930|NCT00851721|7306441|FG001|Overall Study|planned surgery|0
4500931|NCT00851721|7306440|FG000|Overall Study|Death|1
4500932|NCT00851721|7306441|FG001|Overall Study|Death|0
4627261|NCT01852058|7493873|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
4627262|NCT01852058|7493874|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
4500933|NCT00851721|7306440|FG000|Overall Study|Adverse Event|0
4500934|NCT00851721|7306441|FG001|Overall Study|Adverse Event|1
4500935|NCT00851786|7306455|FG000|Overall Study|Withdrawal by Subject|0
4500936|NCT00851786|7306456|FG001|Overall Study|Withdrawal by Subject|1
4500937|NCT00851786|7306455|FG000|Overall Study|Protocol Violation|0
4500938|NCT00851786|7306456|FG001|Overall Study|Protocol Violation|1
4500939|NCT00851786|7306455|FG000|Overall Study|Lost to Follow-up|1
4500940|NCT00851786|7306456|FG001|Overall Study|Lost to Follow-up|0
4500941|NCT00851786|7306455|FG000|Overall Study|Incarceration|1
4500942|NCT00851786|7306456|FG001|Overall Study|Incarceration|0
4500943|NCT00851786|7306455|FG000|Overall Study|Site Closure|1
4500944|NCT00851786|7306456|FG001|Overall Study|Site Closure|0
4500945|NCT00851786|7306455|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2
4500946|NCT00851786|7306456|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0
4500947|NCT00851799|7306465|FG000|Overall Study|Death|1
4500948|NCT00851799|7306466|FG001|Overall Study|Death|0
4500949|NCT00851799|7306467|FG002|Overall Study|Death|1
4500950|NCT00851799|7306465|FG000|Overall Study|Lost to Follow-up|5
4500951|NCT00851799|7306466|FG001|Overall Study|Lost to Follow-up|3
4500952|NCT00851799|7306467|FG002|Overall Study|Lost to Follow-up|10
4500953|NCT00851799|7306465|FG000|Overall Study|Not able to get to clinic|8
4500954|NCT00851799|7306466|FG001|Overall Study|Not able to get to clinic|5
4500955|NCT00851799|7306467|FG002|Overall Study|Not able to get to clinic|9
4500956|NCT00851799|7306465|FG000|Overall Study|Not willing to adhere to requirements|1
4500957|NCT00851799|7306466|FG001|Overall Study|Not willing to adhere to requirements|2
4500958|NCT00851799|7306467|FG002|Overall Study|Not willing to adhere to requirements|2
4500959|NCT00851799|7306465|FG000|Overall Study|Withdrew consent prior study completion|1
4500960|NCT00851799|7306466|FG001|Overall Study|Withdrew consent prior study completion|2
4500961|NCT00851799|7306467|FG002|Overall Study|Withdrew consent prior study completion|1
4500962|NCT00851799|7306465|FG000|Overall Study|Severe Debilitation|0
4500963|NCT00851799|7306466|FG001|Overall Study|Severe Debilitation|1
4500964|NCT00851799|7306467|FG002|Overall Study|Severe Debilitation|0
4500965|NCT00851799|7306465|FG000|Overall Study|Completed protocol due to pregnancy|0
4500966|NCT00851799|7306466|FG001|Overall Study|Completed protocol due to pregnancy|0
4500967|NCT00851799|7306467|FG002|Overall Study|Completed protocol due to pregnancy|1
4500968|NCT00851877|7306475|FG000|Phase I-1|Death|1
4500969|NCT00851877|7306476|FG001|Phase I-1|Death|0
4500970|NCT00851877|7306477|FG002|Phase I-1|Death|0
4500971|NCT00851877|7306475|FG000|Phase II|Withdrawal by Subject|0
4500972|NCT00851877|7306476|FG001|Phase II|Withdrawal by Subject|0
4500973|NCT00851877|7306477|FG002|Phase II|Withdrawal by Subject|3
4500974|NCT00851890|7306487|FG000|Overall Study|Lost to Follow-up|0
4500975|NCT00851890|7306488|FG001|Overall Study|Lost to Follow-up|1
4500976|NCT00851890|7306489|FG002|Overall Study|Lost to Follow-up|0
4500977|NCT00851890|7306490|FG003|Overall Study|Lost to Follow-up|1
4500978|NCT00851903|7306500|FG000|Overall Study|Withdrawal by Subject|2
4517885|NCT00969761|7329808|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
4517886|NCT00969761|7329809|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
4517887|NCT00969761|7329810|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
4517888|NCT00969761|7329811|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
4517889|NCT00969761|7329812|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
4517890|NCT00969761|7329801|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
4517891|NCT00969761|7329802|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
4517892|NCT00969761|7329803|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1
4517893|NCT00969761|7329804|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
4517894|NCT00969761|7329805|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
4517895|NCT00969761|7329806|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
4517896|NCT00969761|7329807|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
4517897|NCT00969761|7329808|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
4517898|NCT00969761|7329809|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
4517899|NCT00969761|7329810|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
4517900|NCT00969761|7329811|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
4517901|NCT00969761|7329812|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
4517902|NCT00969761|7329801|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
4517903|NCT00969761|7329802|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
4517904|NCT00969761|7329803|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
4517905|NCT00969761|7329804|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
4517906|NCT00969761|7329805|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
4517907|NCT00969761|7329806|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
4517908|NCT00969761|7329807|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
4517909|NCT00969761|7329808|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
4517910|NCT00969761|7329809|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1
4517911|NCT00969761|7329810|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
4517912|NCT00969761|7329811|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
4517913|NCT00969761|7329812|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
4517914|NCT00969761|7329801|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2
4517915|NCT00969761|7329802|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
4517916|NCT00969761|7329803|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10
4517917|NCT00969761|7329804|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
4517918|NCT00969761|7329805|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2
4517919|NCT00969761|7329806|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
4517920|NCT00969761|7329807|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
4517921|NCT00969761|7329808|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6
4517922|NCT00969761|7329809|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9
4517923|NCT00969761|7329810|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2
4517924|NCT00969761|7329811|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
4517925|NCT00969761|7329812|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
4517926|NCT00969761|7329801|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
4517927|NCT00969761|7329802|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
4517928|NCT00969761|7329803|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
4517929|NCT00969761|7329804|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2
4517930|NCT00969761|7329805|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1
4517931|NCT00969761|7329806|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
4517932|NCT00969761|7329807|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
4517933|NCT00969761|7329808|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
4517934|NCT00969761|7329809|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2
4517935|NCT00969761|7329810|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
4517936|NCT00969761|7329811|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
4517937|NCT00969761|7329812|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
4517938|NCT00970268|7329877|FG000|Overall Study|Withdrawal by Subject|12
4517939|NCT00970268|7329878|FG001|Overall Study|Withdrawal by Subject|19
4500979|NCT00852202|7306516|FG000|Overall Study|Adverse Event|2
4500980|NCT00852202|7306517|FG001|Overall Study|Adverse Event|3
4500981|NCT00852202|7306518|FG002|Overall Study|Adverse Event|7
4500982|NCT00852202|7306516|FG000|Overall Study|Lack of Efficacy|4
4500983|NCT00852202|7306517|FG001|Overall Study|Lack of Efficacy|1
4500984|NCT00852202|7306518|FG002|Overall Study|Lack of Efficacy|2
4500985|NCT00852202|7306516|FG000|Overall Study|Protocol Violation|2
4500986|NCT00852202|7306517|FG001|Overall Study|Protocol Violation|2
4500987|NCT00852202|7306518|FG002|Overall Study|Protocol Violation|7
4500988|NCT00852202|7306516|FG000|Overall Study|Withdrawal by Subject|3
4500989|NCT00852202|7306517|FG001|Overall Study|Withdrawal by Subject|1
4500990|NCT00852202|7306518|FG002|Overall Study|Withdrawal by Subject|2
4500991|NCT00852202|7306516|FG000|Overall Study|Lost to Follow-up|5
4500992|NCT00852202|7306517|FG001|Overall Study|Lost to Follow-up|5
4500993|NCT00852202|7306518|FG002|Overall Study|Lost to Follow-up|6
4500994|NCT00852202|7306516|FG000|Overall Study|pregnancy,moving away and surgery|1
4500995|NCT00852202|7306517|FG001|Overall Study|pregnancy,moving away and surgery|0
4500996|NCT00852202|7306518|FG002|Overall Study|pregnancy,moving away and surgery|2
4500997|NCT00852397|7306530|FG000|Overall Study|Adverse Event|4
4500998|NCT00852397|7306531|FG001|Overall Study|Adverse Event|6
4500999|NCT00852397|7306532|FG002|Overall Study|Adverse Event|4
4501000|NCT00852397|7306530|FG000|Overall Study|Death|0
4501001|NCT00852397|7306531|FG001|Overall Study|Death|0
4501002|NCT00852397|7306532|FG002|Overall Study|Death|1
4501003|NCT00852397|7306530|FG000|Overall Study|Withdrawal by Subject|4
4501004|NCT00852397|7306531|FG001|Overall Study|Withdrawal by Subject|1
4501005|NCT00852397|7306532|FG002|Overall Study|Withdrawal by Subject|2
4501006|NCT00852397|7306530|FG000|Overall Study|Study terminated by sponsor|2
4501007|NCT00852397|7306531|FG001|Overall Study|Study terminated by sponsor|1
4501008|NCT00852397|7306532|FG002|Overall Study|Study terminated by sponsor|6
4501009|NCT00852397|7306530|FG000|Overall Study|Difficulty in study site visit|1
4501010|NCT00852397|7306531|FG001|Overall Study|Difficulty in study site visit|0
4501011|NCT00852397|7306532|FG002|Overall Study|Difficulty in study site visit|0
4501012|NCT00852397|7306530|FG000|Overall Study|Protocol Violation|0
4501013|NCT00852397|7306531|FG001|Overall Study|Protocol Violation|0
4501014|NCT00852397|7306532|FG002|Overall Study|Protocol Violation|1
4501015|NCT00852475|7306542|FG000|Overall Study|Lost to Follow-up|3
4501016|NCT00852475|7306543|FG001|Overall Study|Lost to Follow-up|4
4501017|NCT00852540|7306559|FG000|Overall Study|Adverse Event|10
4501018|NCT00852540|7306560|FG001|Overall Study|Adverse Event|3
4501019|NCT00852540|7306559|FG000|Overall Study|Lack of Efficacy|15
4501020|NCT00852540|7306560|FG001|Overall Study|Lack of Efficacy|3
4501021|NCT00852540|7306559|FG000|Overall Study|Protocol Violation|1
4501022|NCT00852540|7306560|FG001|Overall Study|Protocol Violation|2
4501023|NCT00852540|7306559|FG000|Overall Study|Lost to Follow-up|2
4501024|NCT00852540|7306560|FG001|Overall Study|Lost to Follow-up|3
4501025|NCT00852540|7306559|FG000|Overall Study|Investigator Discretion|2
4501026|NCT00852540|7306560|FG001|Overall Study|Investigator Discretion|3
4501027|NCT00852540|7306559|FG000|Overall Study|Withdrawal by Subject|3
4501028|NCT00852540|7306560|FG001|Overall Study|Withdrawal by Subject|1
4501029|NCT00852540|7306559|FG000|Overall Study|Did Not Receive Study Drug|3
4501030|NCT00852540|7306560|FG001|Overall Study|Did Not Receive Study Drug|3
4501031|NCT00852917|7306613|FG000|Overall Study|Adverse Event|13
4501032|NCT00852917|7306614|FG001|Overall Study|Adverse Event|20
4501033|NCT00852917|7306615|FG002|Overall Study|Adverse Event|35
4501034|NCT00852917|7306616|FG003|Overall Study|Adverse Event|17
4501035|NCT00852917|7306613|FG000|Overall Study|Lack of Efficacy|21
4501036|NCT00852917|7306614|FG001|Overall Study|Lack of Efficacy|11
4501037|NCT00852917|7306615|FG002|Overall Study|Lack of Efficacy|11
4501038|NCT00852917|7306616|FG003|Overall Study|Lack of Efficacy|47
4501039|NCT00852917|7306613|FG000|Overall Study|Withdrawal by Subject|4
4501040|NCT00852917|7306614|FG001|Overall Study|Withdrawal by Subject|8
4501041|NCT00852917|7306615|FG002|Overall Study|Withdrawal by Subject|10
4501042|NCT00852917|7306616|FG003|Overall Study|Withdrawal by Subject|9
4501043|NCT00852917|7306613|FG000|Overall Study|Physician Decision|6
4501044|NCT00852917|7306614|FG001|Overall Study|Physician Decision|7
4501045|NCT00852917|7306615|FG002|Overall Study|Physician Decision|2
4501046|NCT00852917|7306616|FG003|Overall Study|Physician Decision|19
4501047|NCT00852917|7306613|FG000|Overall Study|Death|0
4501048|NCT00852917|7306614|FG001|Overall Study|Death|0
4501049|NCT00852917|7306615|FG002|Overall Study|Death|0
4501050|NCT00852917|7306616|FG003|Overall Study|Death|1
4501051|NCT00852930|7306629|FG000|Overall Study|Withdrawal by Subject|1
4501052|NCT00852930|7306630|FG001|Overall Study|Withdrawal by Subject|1
4501053|NCT00852930|7306631|FG002|Overall Study|Withdrawal by Subject|1
4501054|NCT00852930|7306629|FG000|Overall Study|Physician Decision|0
4501055|NCT00852930|7306630|FG001|Overall Study|Physician Decision|0
4501056|NCT00852930|7306631|FG002|Overall Study|Physician Decision|1
4501057|NCT00852969|7306642|FG000|Overall Study|Adverse Event|0
4501058|NCT00852969|7306643|FG001|Overall Study|Adverse Event|1
4501059|NCT00852969|7306642|FG000|Overall Study|Lost to Follow-up|0
4501060|NCT00852969|7306643|FG001|Overall Study|Lost to Follow-up|1
4501061|NCT00852995|7306654|FG000|Overall Study|Adverse Event|1
4501062|NCT00852995|7306655|FG001|Overall Study|Adverse Event|0
4501063|NCT00852995|7306656|FG002|Overall Study|Adverse Event|4
4501064|NCT00852995|7306657|FG003|Overall Study|Adverse Event|0
4501065|NCT00852995|7306658|FG004|Overall Study|Adverse Event|0
4501066|NCT00852995|7306654|FG000|Overall Study|Lost to Follow-up|0
4501067|NCT00852995|7306655|FG001|Overall Study|Lost to Follow-up|1
4501068|NCT00852995|7306656|FG002|Overall Study|Lost to Follow-up|1
4501069|NCT00852995|7306657|FG003|Overall Study|Lost to Follow-up|0
4501070|NCT00852995|7306658|FG004|Overall Study|Lost to Follow-up|0
4501071|NCT00852995|7306654|FG000|Overall Study|Withdrawal by Subject|4
4501072|NCT00852995|7306655|FG001|Overall Study|Withdrawal by Subject|0
4501073|NCT00852995|7306656|FG002|Overall Study|Withdrawal by Subject|0
4501074|NCT00852995|7306657|FG003|Overall Study|Withdrawal by Subject|1
4501075|NCT00852995|7306658|FG004|Overall Study|Withdrawal by Subject|2
4501076|NCT00852995|7306654|FG000|Overall Study|Non-Compliance|0
4501077|NCT00852995|7306655|FG001|Overall Study|Non-Compliance|0
4501078|NCT00852995|7306656|FG002|Overall Study|Non-Compliance|0
4501079|NCT00852995|7306657|FG003|Overall Study|Non-Compliance|2
4501080|NCT00852995|7306658|FG004|Overall Study|Non-Compliance|0
4501081|NCT00852995|7306654|FG000|Overall Study|Progressive Disease|1
4501082|NCT00852995|7306655|FG001|Overall Study|Progressive Disease|0
4501083|NCT00852995|7306656|FG002|Overall Study|Progressive Disease|0
4501084|NCT00852995|7306657|FG003|Overall Study|Progressive Disease|2
4501085|NCT00852995|7306658|FG004|Overall Study|Progressive Disease|1
4501086|NCT00852995|7306654|FG000|Overall Study|Physician Decision|1
4501087|NCT00852995|7306655|FG001|Overall Study|Physician Decision|0
4501088|NCT00852995|7306656|FG002|Overall Study|Physician Decision|0
4501089|NCT00852995|7306657|FG003|Overall Study|Physician Decision|0
4501090|NCT00852995|7306658|FG004|Overall Study|Physician Decision|0
4501091|NCT00852995|7306654|FG000|Overall Study|Protocol Violation|0
4501092|NCT00852995|7306655|FG001|Overall Study|Protocol Violation|0
4501093|NCT00852995|7306656|FG002|Overall Study|Protocol Violation|0
4501094|NCT00852995|7306657|FG003|Overall Study|Protocol Violation|0
4501095|NCT00852995|7306658|FG004|Overall Study|Protocol Violation|1
4501096|NCT00852995|7306654|FG000|Overall Study|Moved Out of Area|1
4501097|NCT00852995|7306655|FG001|Overall Study|Moved Out of Area|0
4501098|NCT00852995|7306656|FG002|Overall Study|Moved Out of Area|0
4501099|NCT00852995|7306657|FG003|Overall Study|Moved Out of Area|0
4501100|NCT00852995|7306658|FG004|Overall Study|Moved Out of Area|0
4501101|NCT00853021|7306675|FG000|Overall Study|Adverse Event|2
4501102|NCT00853021|7306675|FG000|Overall Study|Withdrawal by Subject|2
4501103|NCT00853021|7306675|FG000|Overall Study|Death|1
4501104|NCT00853047|7306684|FG000|Core Phase|Participant Request|0
4501105|NCT00853047|7306685|FG001|Core Phase|Participant Request|0
4501106|NCT00853047|7306686|FG002|Core Phase|Participant Request|0
4501107|NCT00853047|7306687|FG003|Core Phase|Participant Request|1
4501108|NCT00853047|7306688|FG004|Core Phase|Participant Request|0
4501109|NCT00853047|7306689|FG005|Core Phase|Participant Request|0
4501110|NCT00853047|7306684|FG000|Open-Label Extension Phase|Participant Request|0
4501111|NCT00853047|7306685|FG001|Open-Label Extension Phase|Participant Request|0
4501112|NCT00853047|7306686|FG002|Open-Label Extension Phase|Participant Request|0
4501113|NCT00853047|7306687|FG003|Open-Label Extension Phase|Participant Request|0
4501114|NCT00853047|7306688|FG004|Open-Label Extension Phase|Participant Request|0
4501115|NCT00853047|7306689|FG005|Open-Label Extension Phase|Participant Request|7
4501116|NCT00853047|7306684|FG000|Open-Label Extension Phase|Lost to Follow-up|0
4501117|NCT00853047|7306685|FG001|Open-Label Extension Phase|Lost to Follow-up|0
4501118|NCT00853047|7306686|FG002|Open-Label Extension Phase|Lost to Follow-up|0
4501119|NCT00853047|7306687|FG003|Open-Label Extension Phase|Lost to Follow-up|0
4501120|NCT00853047|7306688|FG004|Open-Label Extension Phase|Lost to Follow-up|0
4501121|NCT00853047|7306689|FG005|Open-Label Extension Phase|Lost to Follow-up|1
4501122|NCT00853047|7306684|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0
4501123|NCT00853047|7306685|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0
4501124|NCT00853047|7306686|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0
4501125|NCT00853047|7306687|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0
4501126|NCT00853047|7306688|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0
4501127|NCT00853047|7306689|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2
4501128|NCT00853047|7306684|FG000|Open-Label Extension Phase|Investigator Decision|0
4501129|NCT00853047|7306685|FG001|Open-Label Extension Phase|Investigator Decision|0
4501130|NCT00853047|7306686|FG002|Open-Label Extension Phase|Investigator Decision|0
4501131|NCT00853047|7306687|FG003|Open-Label Extension Phase|Investigator Decision|0
4501132|NCT00853047|7306688|FG004|Open-Label Extension Phase|Investigator Decision|0
4501133|NCT00853047|7306689|FG005|Open-Label Extension Phase|Investigator Decision|1
4501134|NCT00853047|7306684|FG000|Open-Label Extension Phase|Reason Not Specified|0
4501135|NCT00853047|7306685|FG001|Open-Label Extension Phase|Reason Not Specified|0
4501136|NCT00853047|7306686|FG002|Open-Label Extension Phase|Reason Not Specified|0
4501137|NCT00853047|7306687|FG003|Open-Label Extension Phase|Reason Not Specified|0
4501138|NCT00853047|7306688|FG004|Open-Label Extension Phase|Reason Not Specified|0
4501139|NCT00853047|7306689|FG005|Open-Label Extension Phase|Reason Not Specified|6
4501140|NCT00853073|7306706|FG000|Overall Study|Withdrawal by Subject|3
4501141|NCT00853073|7306707|FG001|Overall Study|Withdrawal by Subject|2
4501142|NCT00853099|7306716|FG000|Double-blind Period|Adverse Event|7
4501143|NCT00853099|7306717|FG001|Double-blind Period|Adverse Event|9
4501144|NCT00853099|7306718|FG002|Double-blind Period|Adverse Event|13
4501145|NCT00853099|7306719|FG003|Double-blind Period|Adverse Event|0
4501146|NCT00853099|7306716|FG000|Double-blind Period|Withdrawal by Subject|2
4501147|NCT00853099|7306717|FG001|Double-blind Period|Withdrawal by Subject|3
4501148|NCT00853099|7306718|FG002|Double-blind Period|Withdrawal by Subject|0
4501149|NCT00853099|7306719|FG003|Double-blind Period|Withdrawal by Subject|0
4501150|NCT00853099|7306716|FG000|Double-blind Period|Lack of Efficacy|14
4501151|NCT00853099|7306717|FG001|Double-blind Period|Lack of Efficacy|17
4501152|NCT00853099|7306718|FG002|Double-blind Period|Lack of Efficacy|16
4501153|NCT00853099|7306719|FG003|Double-blind Period|Lack of Efficacy|0
4501154|NCT00853099|7306716|FG000|Double-blind Period|Other|0
4501155|NCT00853099|7306717|FG001|Double-blind Period|Other|0
4501156|NCT00853099|7306718|FG002|Double-blind Period|Other|1
4501157|NCT00853099|7306719|FG003|Double-blind Period|Other|0
4501158|NCT00853099|7306716|FG000|Double-blind Period|Mistreated with rescue study drug|0
4501159|NCT00853099|7306717|FG001|Double-blind Period|Mistreated with rescue study drug|0
4501160|NCT00853099|7306718|FG002|Double-blind Period|Mistreated with rescue study drug|1
4501161|NCT00853099|7306719|FG003|Double-blind Period|Mistreated with rescue study drug|0
4501162|NCT00853099|7306716|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0
4501163|NCT00853099|7306717|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0
4501164|NCT00853099|7306718|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0
4501165|NCT00853099|7306719|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74
4501166|NCT00853099|7306716|FG000|Double-blind + Open-label Periods|Adverse Event|0
4501167|NCT00853099|7306717|FG001|Double-blind + Open-label Periods|Adverse Event|0
4501168|NCT00853099|7306718|FG002|Double-blind + Open-label Periods|Adverse Event|0
4501169|NCT00853099|7306719|FG003|Double-blind + Open-label Periods|Adverse Event|47
4501170|NCT00853099|7306716|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0
4501171|NCT00853099|7306717|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0
4501172|NCT00853099|7306718|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0
4501173|NCT00853099|7306719|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20
4501174|NCT00853099|7306716|FG000|Double-blind + Open-label Periods|Other|0
4501175|NCT00853099|7306717|FG001|Double-blind + Open-label Periods|Other|0
4501176|NCT00853099|7306718|FG002|Double-blind + Open-label Periods|Other|0
4501177|NCT00853099|7306719|FG003|Double-blind + Open-label Periods|Other|6
4501178|NCT00853112|7306736|FG000|Overall Study|Randomized but not treated|0
4501179|NCT00853112|7306737|FG001|Overall Study|Randomized but not treated|1
4501180|NCT00853112|7306738|FG002|Overall Study|Randomized but not treated|0
4501181|NCT00853112|7306739|FG003|Overall Study|Randomized but not treated|2
4501182|NCT00853112|7306740|FG004|Overall Study|Randomized but not treated|0
4501183|NCT00853112|7306741|FG005|Overall Study|Randomized but not treated|0
4501184|NCT00853112|7306742|FG006|Overall Study|Randomized but not treated|1
4501185|NCT00853125|7306758|FG000|Overall Study|Study participant's donor was CMV +|1
4501186|NCT00853151|7306767|FG000|Overall Study|Adverse Event|1
4501187|NCT00853151|7306768|FG001|Overall Study|Adverse Event|4
4501188|NCT00853151|7306769|FG002|Overall Study|Adverse Event|2
4501189|NCT00853151|7306770|FG003|Overall Study|Adverse Event|0
4501190|NCT00853151|7306767|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1
4501191|NCT00853151|7306768|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0
4501192|NCT00853151|7306769|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0
4501193|NCT00853151|7306770|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0
4501194|NCT00853151|7306767|FG000|Overall Study|Lost to Follow-up|2
4501195|NCT00853151|7306768|FG001|Overall Study|Lost to Follow-up|0
4501196|NCT00853151|7306769|FG002|Overall Study|Lost to Follow-up|3
4501197|NCT00853151|7306770|FG003|Overall Study|Lost to Follow-up|0
4501198|NCT00853151|7306767|FG000|Overall Study|Death|1
4501199|NCT00853151|7306768|FG001|Overall Study|Death|0
4501200|NCT00853151|7306769|FG002|Overall Study|Death|0
4501201|NCT00853151|7306770|FG003|Overall Study|Death|1
4501202|NCT00853151|7306767|FG000|Overall Study|Protocol Violation|0
4501203|NCT00853151|7306768|FG001|Overall Study|Protocol Violation|0
4501204|NCT00853151|7306769|FG002|Overall Study|Protocol Violation|0
4501205|NCT00853151|7306770|FG003|Overall Study|Protocol Violation|1
4501206|NCT00853151|7306767|FG000|Overall Study|Withdrawal by Subject|5
4501207|NCT00853151|7306768|FG001|Overall Study|Withdrawal by Subject|4
4501208|NCT00853151|7306769|FG002|Overall Study|Withdrawal by Subject|2
4501209|NCT00853151|7306770|FG003|Overall Study|Withdrawal by Subject|1
4501210|NCT00853151|7306767|FG000|Overall Study|Physician Decision|0
4501211|NCT00853151|7306768|FG001|Overall Study|Physician Decision|2
4501212|NCT00853151|7306769|FG002|Overall Study|Physician Decision|1
4501213|NCT00853151|7306770|FG003|Overall Study|Physician Decision|0
4501214|NCT00853151|7306767|FG000|Overall Study|Sponsor Decision|0
4501215|NCT00853151|7306768|FG001|Overall Study|Sponsor Decision|3
4501216|NCT00853151|7306769|FG002|Overall Study|Sponsor Decision|0
4501217|NCT00853151|7306770|FG003|Overall Study|Sponsor Decision|0
4501218|NCT00853242|7306790|FG000|Overall Study|Adverse Event|0
4501219|NCT00853242|7306791|FG001|Overall Study|Adverse Event|1
4501220|NCT00853242|7306792|FG002|Overall Study|Adverse Event|1
4501221|NCT00853242|7306793|FG003|Overall Study|Adverse Event|0
4501222|NCT00853242|7306794|FG004|Overall Study|Adverse Event|3
4501223|NCT00853242|7306795|FG005|Overall Study|Adverse Event|1
4501224|NCT00853242|7306796|FG006|Overall Study|Adverse Event|1
4501225|NCT00853242|7306790|FG000|Overall Study|Noncompliant|0
4501226|NCT00853242|7306791|FG001|Overall Study|Noncompliant|0
4501227|NCT00853242|7306792|FG002|Overall Study|Noncompliant|0
4501228|NCT00853242|7306793|FG003|Overall Study|Noncompliant|0
4501229|NCT00853242|7306794|FG004|Overall Study|Noncompliant|1
4501230|NCT00853242|7306795|FG005|Overall Study|Noncompliant|0
4501231|NCT00853242|7306796|FG006|Overall Study|Noncompliant|0
4627263|NCT01852058|7493875|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
4627264|NCT01852058|7493876|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
4627265|NCT01852058|7493877|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
4627266|NCT01852058|7493866|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
4501232|NCT00853242|7306790|FG000|Overall Study|Withdrawal by Subject|1
4501233|NCT00853242|7306791|FG001|Overall Study|Withdrawal by Subject|2
4501234|NCT00853242|7306792|FG002|Overall Study|Withdrawal by Subject|0
4387272|NCT00048048|7165926|FG001|Core Treatment|Withdrawal by Subject|0
4501235|NCT00853242|7306793|FG003|Overall Study|Withdrawal by Subject|4
4501236|NCT00853242|7306794|FG004|Overall Study|Withdrawal by Subject|0
4501237|NCT00853242|7306795|FG005|Overall Study|Withdrawal by Subject|0
4501238|NCT00853242|7306796|FG006|Overall Study|Withdrawal by Subject|2
4501239|NCT00853242|7306790|FG000|Overall Study|Other|2
4501240|NCT00853242|7306791|FG001|Overall Study|Other|0
4501241|NCT00853242|7306792|FG002|Overall Study|Other|2
4501242|NCT00853242|7306793|FG003|Overall Study|Other|0
4501243|NCT00853242|7306794|FG004|Overall Study|Other|0
4501244|NCT00853242|7306795|FG005|Overall Study|Other|1
4501245|NCT00853242|7306796|FG006|Overall Study|Other|2
4501246|NCT00853372|7306833|FG000|Overall Study|Death|30
4501247|NCT00853372|7306834|FG001|Overall Study|Death|26
4501248|NCT00853372|7306833|FG000|Overall Study|Lost to Follow-up|1
4501249|NCT00853372|7306834|FG001|Overall Study|Lost to Follow-up|2
4501250|NCT00853372|7306833|FG000|Overall Study|Full Consent Withdrawn|1
4501251|NCT00853372|7306834|FG001|Overall Study|Full Consent Withdrawn|1
4501252|NCT00853385|7306845|FG000|Overall Study|Death|0
4501253|NCT00853385|7306846|FG001|Overall Study|Death|0
4501254|NCT00853385|7306847|FG002|Overall Study|Death|0
4501255|NCT00853385|7306848|FG003|Overall Study|Death|0
4501256|NCT00853385|7306849|FG004|Overall Study|Death|1
4501257|NCT00853385|7306845|FG000|Overall Study|Adverse Event|24
4501258|NCT00853385|7306846|FG001|Overall Study|Adverse Event|24
4501259|NCT00853385|7306847|FG002|Overall Study|Adverse Event|2
4501260|NCT00853385|7306848|FG003|Overall Study|Adverse Event|5
4501261|NCT00853385|7306849|FG004|Overall Study|Adverse Event|22
4501262|NCT00853385|7306845|FG000|Overall Study|Lack of Efficacy|6
4501263|NCT00853385|7306846|FG001|Overall Study|Lack of Efficacy|7
4501264|NCT00853385|7306847|FG002|Overall Study|Lack of Efficacy|3
4501265|NCT00853385|7306848|FG003|Overall Study|Lack of Efficacy|3
4501266|NCT00853385|7306849|FG004|Overall Study|Lack of Efficacy|6
4501267|NCT00853385|7306845|FG000|Overall Study|Lost to Follow-up|2
4501268|NCT00853385|7306846|FG001|Overall Study|Lost to Follow-up|1
4501269|NCT00853385|7306847|FG002|Overall Study|Lost to Follow-up|0
4501270|NCT00853385|7306848|FG003|Overall Study|Lost to Follow-up|0
4501271|NCT00853385|7306849|FG004|Overall Study|Lost to Follow-up|0
4501272|NCT00853385|7306845|FG000|Overall Study|Withdrawal by Subject|4
4501273|NCT00853385|7306846|FG001|Overall Study|Withdrawal by Subject|2
4501274|NCT00853385|7306847|FG002|Overall Study|Withdrawal by Subject|0
4501275|NCT00853385|7306848|FG003|Overall Study|Withdrawal by Subject|1
4501276|NCT00853385|7306849|FG004|Overall Study|Withdrawal by Subject|1
4501277|NCT00853385|7306845|FG000|Overall Study|Other|18
4501278|NCT00853385|7306846|FG001|Overall Study|Other|9
4501279|NCT00853385|7306847|FG002|Overall Study|Other|4
4501280|NCT00853385|7306848|FG003|Overall Study|Other|4
4501281|NCT00853385|7306849|FG004|Overall Study|Other|12
4501282|NCT00853489|7306873|FG000|Overall Study|Lost to Follow-up|5
4501283|NCT00853489|7306874|FG001|Overall Study|Lost to Follow-up|2
4501284|NCT00853580|7306882|FG000|Overall Study|Lost to Follow-up|3
4501285|NCT00853580|7306883|FG001|Overall Study|Lost to Follow-up|5
4501286|NCT00853580|7306882|FG000|Overall Study|Protocol Violation|2
4501287|NCT00853580|7306883|FG001|Overall Study|Protocol Violation|1
4501288|NCT00853580|7306882|FG000|Overall Study|Withdrawal by Subject|2
4501289|NCT00853580|7306883|FG001|Overall Study|Withdrawal by Subject|8
4501290|NCT00853580|7306882|FG000|Overall Study|Commenced contraindicated therapy|0
4501291|NCT00853580|7306883|FG001|Overall Study|Commenced contraindicated therapy|2
4501292|NCT00853593|7306889|FG000|Overall Study|Subjects did not receive a 4396 lead|12
4501293|NCT00853593|7306889|FG000|Overall Study|Model 4396 lead not attempted|29
4501294|NCT00853593|7306889|FG000|Overall Study|Implant not attempted|4
4501295|NCT00853658|7306921|FG000|Overall Study|Death|713
4501296|NCT00853658|7306922|FG001|Overall Study|Death|768
4501297|NCT00853658|7306923|FG002|Overall Study|Death|753
4501298|NCT00853658|7306921|FG000|Overall Study|Lost to Follow-up|11
4501299|NCT00853658|7306922|FG001|Overall Study|Lost to Follow-up|6
4501300|NCT00853658|7306923|FG002|Overall Study|Lost to Follow-up|11
4501301|NCT00853658|7306921|FG000|Overall Study|H.A. Request|26
4501302|NCT00853658|7306922|FG001|Overall Study|H.A. Request|23
4501303|NCT00853658|7306923|FG002|Overall Study|H.A. Request|19
4501304|NCT00853658|7306921|FG000|Overall Study|IRB request|0
4501305|NCT00853658|7306922|FG001|Overall Study|IRB request|0
4501306|NCT00853658|7306923|FG002|Overall Study|IRB request|2
4501307|NCT00853658|7306921|FG000|Overall Study|Vital Status known (alive) at study end|2
4501308|NCT00853658|7306922|FG001|Overall Study|Vital Status known (alive) at study end|3
4501309|NCT00853658|7306923|FG002|Overall Study|Vital Status known (alive) at study end|3
4501310|NCT00853658|7306921|FG000|Overall Study|Vital Status unknown at study end|1
4501311|NCT00853658|7306922|FG001|Overall Study|Vital Status unknown at study end|1
4501312|NCT00853658|7306923|FG002|Overall Study|Vital Status unknown at study end|0
4501313|NCT00853658|7306921|FG000|Overall Study|Vital Status at study end N/A|8
4501314|NCT00853658|7306922|FG001|Overall Study|Vital Status at study end N/A|10
4501315|NCT00853658|7306923|FG002|Overall Study|Vital Status at study end N/A|10
4501316|NCT00853658|7306921|FG000|Overall Study|Patient's request|21
4501317|NCT00853658|7306922|FG001|Overall Study|Patient's request|17
4501318|NCT00853658|7306923|FG002|Overall Study|Patient's request|11
4501319|NCT00853658|7306921|FG000|Overall Study|Missing study completion information|5
4501320|NCT00853658|7306922|FG001|Overall Study|Missing study completion information|4
4501321|NCT00853658|7306923|FG002|Overall Study|Missing study completion information|6
4501322|NCT00853723|7306938|FG000|Overall Study|Adverse Event|3
4501323|NCT00853723|7306939|FG001|Overall Study|Adverse Event|4
4501324|NCT00853723|7306940|FG002|Overall Study|Adverse Event|1
4501325|NCT00853723|7306938|FG000|Overall Study|Withdrawal by Subject|2
4501326|NCT00853723|7306939|FG001|Overall Study|Withdrawal by Subject|1
4501327|NCT00853723|7306940|FG002|Overall Study|Withdrawal by Subject|0
4501328|NCT00853723|7306938|FG000|Overall Study|Protocol Violation|1
4501329|NCT00853723|7306939|FG001|Overall Study|Protocol Violation|2
4501330|NCT00853723|7306940|FG002|Overall Study|Protocol Violation|1
4501331|NCT00853749|7306953|FG000|Overall Study|Lost to Follow-up|0
4501332|NCT00853749|7306954|FG001|Overall Study|Lost to Follow-up|1
4501333|NCT00853762|7306964|FG000|Overall Study|Premature Termination|16
4501334|NCT00853762|7306965|FG001|Overall Study|Premature Termination|15
4501335|NCT00853762|7306966|FG002|Overall Study|Premature Termination|14
4501336|NCT00853762|7306967|FG003|Overall Study|Premature Termination|21
4501337|NCT00853762|7306964|FG000|Overall Study|Protocol Violation|0
4501338|NCT00853762|7306965|FG001|Overall Study|Protocol Violation|0
4501339|NCT00853762|7306966|FG002|Overall Study|Protocol Violation|0
4501340|NCT00853762|7306967|FG003|Overall Study|Protocol Violation|1
4501341|NCT00853762|7306964|FG000|Overall Study|Withdrawal by Subject|0
4501342|NCT00853762|7306965|FG001|Overall Study|Withdrawal by Subject|0
4501343|NCT00853762|7306966|FG002|Overall Study|Withdrawal by Subject|1
4501344|NCT00853762|7306967|FG003|Overall Study|Withdrawal by Subject|0
4501345|NCT00853762|7306964|FG000|Overall Study|Other|0
4501346|NCT00853762|7306965|FG001|Overall Study|Other|2
4501347|NCT00853762|7306966|FG002|Overall Study|Other|0
4501348|NCT00853762|7306967|FG003|Overall Study|Other|0
4501349|NCT00853762|7306964|FG000|Overall Study|Randomised but not Treated|0
4501350|NCT00853762|7306965|FG001|Overall Study|Randomised but not Treated|2
4501351|NCT00853762|7306966|FG002|Overall Study|Randomised but not Treated|2
4501352|NCT00853762|7306967|FG003|Overall Study|Randomised but not Treated|0
4501353|NCT00853827|7306979|FG000|Single Blind Period (1 Week)|Other|4
4501354|NCT00853827|7306980|FG001|Single Blind Period (1 Week)|Other|0
4501355|NCT00853827|7306979|FG000|Single Blind Period (1 Week)|Adverse Event|9
4501356|NCT00853827|7306980|FG001|Single Blind Period (1 Week)|Adverse Event|0
4501357|NCT00853827|7306979|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3
4501358|NCT00853827|7306980|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0
4501359|NCT00853827|7306979|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1
4501360|NCT00853827|7306980|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0
4501361|NCT00853827|7306979|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9
4501362|NCT00853827|7306980|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0
4501363|NCT00853827|7306979|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1
4501364|NCT00853827|7306980|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0
4501365|NCT00853827|7306979|FG000|Single Blind Period (1 Week)|Protocol Violation|12
4501366|NCT00853827|7306980|FG001|Single Blind Period (1 Week)|Protocol Violation|0
4501367|NCT00853827|7306979|FG000|Double Blind Period (103 Weeks)|Adverse Event|25
4501368|NCT00853827|7306980|FG001|Double Blind Period (103 Weeks)|Adverse Event|14
4501369|NCT00853827|7306979|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0
4501370|NCT00853827|7306980|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3
4501371|NCT00853827|7306979|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1
4501372|NCT00853827|7306980|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0
4501373|NCT00853827|7306979|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3
4501374|NCT00853827|7306980|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1
4501375|NCT00853827|7306979|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2
4501376|NCT00853827|7306980|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1
4501377|NCT00853827|7306979|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19
4501378|NCT00853827|7306980|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18
4501379|NCT00853827|7306979|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8
4501380|NCT00853827|7306980|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10
4501381|NCT00853827|7306979|FG000|Double Blind Period (103 Weeks)|Administrative problems|45
4501382|NCT00853827|7306980|FG001|Double Blind Period (103 Weeks)|Administrative problems|56
4501383|NCT00853827|7306979|FG000|Double Blind Period (103 Weeks)|Death|1
4501384|NCT00853827|7306980|FG001|Double Blind Period (103 Weeks)|Death|6
4501385|NCT00853905|7306996|FG000|Overall Study|Lost to Follow-up|1
4501386|NCT00853905|7306997|FG001|Overall Study|Lost to Follow-up|3
4501387|NCT00853905|7306996|FG000|Overall Study|Withdrawal by Subject|0
4501388|NCT00853905|7306997|FG001|Overall Study|Withdrawal by Subject|1
4501389|NCT00853905|7306996|FG000|Overall Study|never had surgery|1
4501390|NCT00853905|7306997|FG001|Overall Study|never had surgery|0
4501391|NCT00853957|7307008|FG000|Overall Study|Adverse Event|9
4501392|NCT00853957|7307009|FG001|Overall Study|Adverse Event|3
4501393|NCT00853957|7307008|FG000|Overall Study|Unsatisfactory therapeutic effect|0
4501394|NCT00853957|7307009|FG001|Overall Study|Unsatisfactory therapeutic effect|2
4501395|NCT00853957|7307008|FG000|Overall Study|Subject withdrew consent|4
4501396|NCT00853957|7307009|FG001|Overall Study|Subject withdrew consent|5
4501397|NCT00853957|7307008|FG000|Overall Study|Lost to Follow-up|1
4501398|NCT00853957|7307009|FG001|Overall Study|Lost to Follow-up|6
4501399|NCT00853957|7307008|FG000|Overall Study|Protocol deviation|0
4501400|NCT00853957|7307009|FG001|Overall Study|Protocol deviation|3
4501401|NCT00853970|7307017|FG000|Overall Study|Withdrawal by Subject|2
4501402|NCT00853970|7307018|FG001|Overall Study|Withdrawal by Subject|1
4501403|NCT00853970|7307017|FG000|Overall Study|Cancelled surgery|4
4627267|NCT01852058|7493867|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
4627268|NCT01852058|7493868|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
4627269|NCT01852058|7493869|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
4627270|NCT01852058|7493870|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1
4627271|NCT01852058|7493871|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
4627272|NCT01852058|7493872|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
4627273|NCT01852058|7493873|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
4627274|NCT01852058|7493874|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
4627275|NCT01852058|7493875|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
4627276|NCT01852058|7493876|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
4627277|NCT01852058|7493877|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
4627278|NCT01852058|7493866|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
4627279|NCT01852058|7493867|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
4627280|NCT01852058|7493868|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
4627281|NCT01852058|7493869|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
4627282|NCT01852058|7493870|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3
4627283|NCT01852058|7493871|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1
4627284|NCT01852058|7493872|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
4627285|NCT01852058|7493873|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
4627286|NCT01852058|7493874|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
4627287|NCT01852058|7493875|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
4627288|NCT01852058|7493876|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
4627289|NCT01852058|7493877|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
4627290|NCT01852058|7493866|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
4627291|NCT01852058|7493867|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
4627292|NCT01852058|7493868|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
4627293|NCT01852058|7493869|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1
4627294|NCT01852058|7493870|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
4627295|NCT01852058|7493871|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
4627296|NCT01852058|7493872|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
4627297|NCT01852058|7493873|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
4627298|NCT01852058|7493874|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
4627299|NCT01852058|7493875|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
4627300|NCT01852058|7493876|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
4627301|NCT01852058|7493877|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
4627302|NCT01852058|7493866|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
4627303|NCT01852058|7493867|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
4627304|NCT01852058|7493868|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
4627305|NCT01852058|7493869|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
4627306|NCT01852058|7493870|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1
4627307|NCT01852058|7493871|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7
4627308|NCT01852058|7493872|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
4627309|NCT01852058|7493873|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
4627310|NCT01852058|7493874|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
4627311|NCT01852058|7493875|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
4627312|NCT01852058|7493876|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
4627313|NCT01852058|7493877|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
4627314|NCT01852058|7493866|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
4627315|NCT01852058|7493867|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
4627316|NCT01852058|7493868|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
4501404|NCT00853970|7307018|FG001|Overall Study|Cancelled surgery|2
4501405|NCT00854100|7307046|FG000|Overall Study|Inability to complete the study visits|0
4501406|NCT00854100|7307047|FG001|Overall Study|Inability to complete the study visits|0
4627317|NCT01852058|7493869|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
4627318|NCT01852058|7493870|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
4627319|NCT01852058|7493871|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
4627320|NCT01852058|7493872|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
4627321|NCT01852058|7493873|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1
4627322|NCT01852058|7493874|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
4627323|NCT01852058|7493875|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
4627324|NCT01852058|7493876|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
4627325|NCT01852058|7493877|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
4627326|NCT01852058|7493866|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
4627327|NCT01852058|7493867|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
4627328|NCT01852058|7493868|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
4627329|NCT01852058|7493869|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
4627330|NCT01852058|7493870|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
4627331|NCT01852058|7493871|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
4627332|NCT01852058|7493872|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
4627333|NCT01852058|7493873|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
4627334|NCT01852058|7493874|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1
4627335|NCT01852058|7493875|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
4627336|NCT01852058|7493876|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
4627337|NCT01852058|7493877|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
4627338|NCT01852110|7493946|FG000|Overall Study|Adverse Event|12
4627339|NCT01852110|7493947|FG001|Overall Study|Adverse Event|5
4627340|NCT01852110|7493948|FG002|Overall Study|Adverse Event|0
4627341|NCT01852110|7493949|FG003|Overall Study|Adverse Event|0
4627342|NCT01852110|7493950|FG004|Overall Study|Adverse Event|0
4627343|NCT01852110|7493951|FG005|Overall Study|Adverse Event|0
4627344|NCT01852110|7493946|FG000|Overall Study|Lost to Follow-up|1
4627345|NCT01852110|7493947|FG001|Overall Study|Lost to Follow-up|3
4627346|NCT01852110|7493948|FG002|Overall Study|Lost to Follow-up|0
4627347|NCT01852110|7493949|FG003|Overall Study|Lost to Follow-up|0
4627348|NCT01852110|7493950|FG004|Overall Study|Lost to Follow-up|0
4627349|NCT01852110|7493951|FG005|Overall Study|Lost to Follow-up|0
4387273|NCT00048048|7165927|FG002|Core Treatment|Withdrawal by Subject|1
4387274|NCT00048048|7165928|FG003|Core Treatment|Withdrawal by Subject|0
4387275|NCT00048048|7165929|FG004|Core Treatment|Withdrawal by Subject|0
4387276|NCT00048048|7165930|FG005|Core Treatment|Withdrawal by Subject|0
4387277|NCT00048048|7165931|FG006|Core Treatment|Withdrawal by Subject|0
4387278|NCT00048048|7165932|FG007|Core Treatment|Withdrawal by Subject|0
4387279|NCT00048048|7165933|FG008|Core Treatment|Withdrawal by Subject|0
4387280|NCT00048048|7165934|FG009|Core Treatment|Withdrawal by Subject|0
4387281|NCT00048048|7165935|FG010|Core Treatment|Withdrawal by Subject|0
4387282|NCT00048048|7165936|FG011|Core Treatment|Withdrawal by Subject|0
4387283|NCT00048048|7165925|FG000|Core Treatment|Adverse Event|0
4501407|NCT00854100|7307048|FG002|Overall Study|Inability to complete the study visits|1
4501408|NCT00854100|7307046|FG000|Overall Study|Lost to Follow-up|2
4501409|NCT00854100|7307047|FG001|Overall Study|Lost to Follow-up|0
4501410|NCT00854100|7307048|FG002|Overall Study|Lost to Follow-up|3
4501411|NCT00854100|7307046|FG000|Overall Study|Withdrawal by Subject|3
4501412|NCT00854100|7307047|FG001|Overall Study|Withdrawal by Subject|1
4501413|NCT00854100|7307048|FG002|Overall Study|Withdrawal by Subject|2
4501414|NCT00854100|7307046|FG000|Overall Study|Protocol Violation|2
4501415|NCT00854100|7307047|FG001|Overall Study|Protocol Violation|4
4501416|NCT00854100|7307048|FG002|Overall Study|Protocol Violation|3
4501417|NCT00854100|7307046|FG000|Overall Study|Adverse Event|2
4501418|NCT00854100|7307047|FG001|Overall Study|Adverse Event|1
4501419|NCT00854100|7307048|FG002|Overall Study|Adverse Event|2
4501420|NCT00854113|7307068|FG000|Overall Study|Adverse Event|0
4501421|NCT00854113|7307069|FG001|Overall Study|Adverse Event|0
4501422|NCT00854113|7307070|FG002|Overall Study|Adverse Event|0
4501423|NCT00854113|7307071|FG003|Overall Study|Adverse Event|0
4501424|NCT00854113|7307072|FG004|Overall Study|Adverse Event|0
4501425|NCT00854113|7307073|FG005|Overall Study|Adverse Event|0
4501426|NCT00854113|7307074|FG006|Overall Study|Adverse Event|0
4501427|NCT00854113|7307075|FG007|Overall Study|Adverse Event|2
4501428|NCT00854113|7307076|FG008|Overall Study|Adverse Event|0
4501429|NCT00854113|7307077|FG009|Overall Study|Adverse Event|0
4501430|NCT00854113|7307078|FG010|Overall Study|Adverse Event|0
4501431|NCT00854113|7307068|FG000|Overall Study|Withdrawal by Subject|0
4501432|NCT00854113|7307069|FG001|Overall Study|Withdrawal by Subject|0
4501433|NCT00854113|7307070|FG002|Overall Study|Withdrawal by Subject|0
4501434|NCT00854113|7307071|FG003|Overall Study|Withdrawal by Subject|0
4501435|NCT00854113|7307072|FG004|Overall Study|Withdrawal by Subject|0
4501436|NCT00854113|7307073|FG005|Overall Study|Withdrawal by Subject|0
4501437|NCT00854113|7307074|FG006|Overall Study|Withdrawal by Subject|0
4501438|NCT00854113|7307075|FG007|Overall Study|Withdrawal by Subject|1
4501439|NCT00854113|7307076|FG008|Overall Study|Withdrawal by Subject|1
4501440|NCT00854113|7307077|FG009|Overall Study|Withdrawal by Subject|0
4501441|NCT00854113|7307078|FG010|Overall Study|Withdrawal by Subject|0
4501442|NCT00854308|7307104|FG000|Overall Study|Disease progression|42
4501443|NCT00854308|7307105|FG001|Overall Study|Disease progression|50
4501444|NCT00854308|7307104|FG000|Overall Study|Adverse Event|8
4501445|NCT00854308|7307105|FG001|Overall Study|Adverse Event|3
4501446|NCT00854308|7307104|FG000|Overall Study|Death|2
4501447|NCT00854308|7307105|FG001|Overall Study|Death|5
4501448|NCT00854308|7307104|FG000|Overall Study|Physician Decision|6
4501449|NCT00854308|7307105|FG001|Overall Study|Physician Decision|6
4501450|NCT00854308|7307104|FG000|Overall Study|Withdrawal by Subject|4
4501451|NCT00854308|7307105|FG001|Overall Study|Withdrawal by Subject|2
4501452|NCT00854308|7307104|FG000|Overall Study|Sponsor's decision to terminate study|0
4501453|NCT00854308|7307105|FG001|Overall Study|Sponsor's decision to terminate study|1
4501454|NCT00854360|7307115|FG000|Overall Study|Adverse Event|0
4501455|NCT00854360|7307116|FG001|Overall Study|Adverse Event|1
4501456|NCT00854360|7307117|FG002|Overall Study|Adverse Event|2
4501457|NCT00854360|7307118|FG003|Overall Study|Adverse Event|6
4501458|NCT00854360|7307115|FG000|Overall Study|Withdrawal by Subject|0
4501459|NCT00854360|7307116|FG001|Overall Study|Withdrawal by Subject|0
4501460|NCT00854360|7307117|FG002|Overall Study|Withdrawal by Subject|0
4501461|NCT00854360|7307118|FG003|Overall Study|Withdrawal by Subject|1
4501462|NCT00854360|7307115|FG000|Overall Study|Pregnancy|0
4501463|NCT00854360|7307116|FG001|Overall Study|Pregnancy|1
4501464|NCT00854360|7307117|FG002|Overall Study|Pregnancy|0
4501465|NCT00854360|7307118|FG003|Overall Study|Pregnancy|0
4501466|NCT00854360|7307115|FG000|Overall Study|Lack of Efficacy|2
4501467|NCT00854360|7307116|FG001|Overall Study|Lack of Efficacy|1
4501468|NCT00854360|7307117|FG002|Overall Study|Lack of Efficacy|0
4501469|NCT00854360|7307118|FG003|Overall Study|Lack of Efficacy|0
4501470|NCT00854360|7307115|FG000|Overall Study|Other|0
4501471|NCT00854360|7307116|FG001|Overall Study|Other|0
4501472|NCT00854360|7307117|FG002|Overall Study|Other|0
4501473|NCT00854360|7307118|FG003|Overall Study|Other|3
4501474|NCT00854373|7307130|FG000|Overall Study|Withdrawal by Subject|1
4501475|NCT00854373|7307131|FG001|Overall Study|Withdrawal by Subject|3
4501476|NCT00854373|7307130|FG000|Overall Study|Forgot to take study drug|1
4501477|NCT00854373|7307131|FG001|Overall Study|Forgot to take study drug|1
4501478|NCT00854581|7307137|FG000|Induction (Up to Day 21)|Lack of Efficacy|4
4501479|NCT00854581|7307137|FG000|Induction (Up to Day 21)|Death|1
4501480|NCT00854581|7307137|FG000|Induction (Up to Day 21)|Physician Decision|1
4501481|NCT00854581|7307137|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3
4501482|NCT00854607|7307155|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65
4501483|NCT00854620|7307166|FG000|Overall Study|Adverse Event|1
4501484|NCT00854724|7307172|FG000|First Intervention|Withdrawal by Subject|1
4501485|NCT00854724|7307173|FG001|First Intervention|Withdrawal by Subject|1
4501486|NCT00854724|7307172|FG000|Washout|Protocol Violation|1
4501487|NCT00854724|7307173|FG001|Washout|Protocol Violation|0
4501488|NCT00854724|7307172|FG000|Washout|Withdrawal by Subject|0
4501489|NCT00854724|7307173|FG001|Washout|Withdrawal by Subject|1
4501490|NCT00854724|7307172|FG000|Second Intervention|Protocol Violation|1
4501491|NCT00854724|7307173|FG001|Second Intervention|Protocol Violation|0
4501492|NCT00854724|7307172|FG000|Second Intervention|Physician Decision|0
4501493|NCT00854724|7307173|FG001|Second Intervention|Physician Decision|1
4501494|NCT00854828|7307183|FG000|Overall Study|Death|1
4501495|NCT00854828|7307184|FG001|Overall Study|Death|0
4501496|NCT00854828|7307185|FG002|Overall Study|Death|0
4501497|NCT00854828|7307186|FG003|Overall Study|Death|0
4501498|NCT00854828|7307183|FG000|Overall Study|Withdrawal by Subject|1
4501499|NCT00854828|7307184|FG001|Overall Study|Withdrawal by Subject|1
4501500|NCT00854828|7307185|FG002|Overall Study|Withdrawal by Subject|0
4501501|NCT00854828|7307186|FG003|Overall Study|Withdrawal by Subject|9
4501502|NCT00854828|7307183|FG000|Overall Study|Missed 24mo visit|1
4501503|NCT00854828|7307184|FG001|Overall Study|Missed 24mo visit|1
4501504|NCT00854828|7307185|FG002|Overall Study|Missed 24mo visit|8
4501505|NCT00854828|7307186|FG003|Overall Study|Missed 24mo visit|8
4501506|NCT00854906|7307196|FG000|Overall Study|One person had no ocular history|1
4501507|NCT00855062|7307218|FG000|Step1|Early Study Closure|5
4501508|NCT00855062|7307219|FG001|Step1|Early Study Closure|7
4501509|NCT00855062|7307218|FG000|Step1|Adverse Event|1
4501510|NCT00855062|7307219|FG001|Step1|Adverse Event|1
4501511|NCT00855062|7307218|FG000|Step1|Protocol Violation|1
4501512|NCT00855062|7307219|FG001|Step1|Protocol Violation|0
4501513|NCT00855062|7307218|FG000|Step1|Pregnancy|1
4501514|NCT00855062|7307219|FG001|Step1|Pregnancy|0
4501515|NCT00855062|7307218|FG000|Step1|Withdrawal by Subject|2
4501516|NCT00855062|7307219|FG001|Step1|Withdrawal by Subject|3
4501517|NCT00855062|7307218|FG000|Step2|Early Study Closure|6
4501518|NCT00855062|7307219|FG001|Step2|Early Study Closure|2
4501519|NCT00855062|7307218|FG000|Step2|Adverse Event|0
4501520|NCT00855062|7307219|FG001|Step2|Adverse Event|3
4501521|NCT00855062|7307218|FG000|Step2|Initiation of antiretroviral therapy/ART|0
4501522|NCT00855062|7307219|FG001|Step2|Initiation of antiretroviral therapy/ART|1
4501523|NCT00855166|7307227|FG000|Overall Study|Adverse Event|0
4501524|NCT00855166|7307228|FG001|Overall Study|Adverse Event|2
4501525|NCT00855166|7307227|FG000|Overall Study|Death|0
4501526|NCT00855166|7307228|FG001|Overall Study|Death|1
4501527|NCT00855166|7307227|FG000|Overall Study|Withdrawal by Subject|1
4501528|NCT00855166|7307228|FG001|Overall Study|Withdrawal by Subject|4
4501529|NCT00855166|7307227|FG000|Overall Study|Poor/non-compliance|2
4501530|NCT00855166|7307228|FG001|Overall Study|Poor/non-compliance|0
4501531|NCT00855166|7307227|FG000|Overall Study|Administrative reasons by sponsor|1
4501532|NCT00855166|7307228|FG001|Overall Study|Administrative reasons by sponsor|0
4501533|NCT00855166|7307227|FG000|Overall Study|Subject no longer meets study criteria|1
4501534|NCT00855166|7307228|FG001|Overall Study|Subject no longer meets study criteria|1
4501535|NCT00855218|7307238|FG000|Overall Study|Adverse Event|43
4501536|NCT00855218|7307239|FG001|Overall Study|Adverse Event|27
4501537|NCT00855218|7307238|FG000|Overall Study|Withdrawal by Subject|10
4501538|NCT00855218|7307239|FG001|Overall Study|Withdrawal by Subject|6
4501539|NCT00855218|7307238|FG000|Overall Study|Physician Decision|18
4501540|NCT00855218|7307239|FG001|Overall Study|Physician Decision|11
4501541|NCT00855218|7307238|FG000|Overall Study|Lost to Follow-up|0
4501542|NCT00855218|7307239|FG001|Overall Study|Lost to Follow-up|1
4501543|NCT00855218|7307238|FG000|Overall Study|Protocol Violation|5
4501544|NCT00855218|7307239|FG001|Overall Study|Protocol Violation|9
4501545|NCT00855218|7307238|FG000|Overall Study|non-compliant with study drug|3
4501546|NCT00855218|7307239|FG001|Overall Study|non-compliant with study drug|1
4501547|NCT00855218|7307238|FG000|Overall Study|patient convenience|2
4501548|NCT00855218|7307239|FG001|Overall Study|patient convenience|0
4501549|NCT00855218|7307238|FG000|Overall Study|technical problems|2
4501550|NCT00855218|7307239|FG001|Overall Study|technical problems|1
4501551|NCT00855218|7307238|FG000|Overall Study|Still treated with study medication|0
4501552|NCT00855218|7307239|FG001|Overall Study|Still treated with study medication|1
4501553|NCT00855218|7307238|FG000|Overall Study|Untreatable disease progression|54
4501554|NCT00855218|7307239|FG001|Overall Study|Untreatable disease progression|67
4501555|NCT00855218|7307238|FG000|Overall Study|Second malignancy|0
4501556|NCT00855218|7307239|FG001|Overall Study|Second malignancy|1
4501557|NCT00855218|7307238|FG000|Overall Study|Progression measurement proven|7
4501558|NCT00855218|7307239|FG001|Overall Study|Progression measurement proven|15
4501559|NCT00855218|7307238|FG000|Overall Study|Clinical endpoint reached|10
4501560|NCT00855218|7307239|FG001|Overall Study|Clinical endpoint reached|13
4501561|NCT00855309|7307247|FG000|Overall Study|patient never recieved drug|1
4501562|NCT00855309|7307248|FG001|Overall Study|patient never recieved drug|0
4501563|NCT00855335|7307259|FG000|Overall Study|Lost to Follow-up|0
4501564|NCT00855335|7307260|FG001|Overall Study|Lost to Follow-up|0
4501565|NCT00855335|7307261|FG002|Overall Study|Lost to Follow-up|3
4501566|NCT00855335|7307262|FG003|Overall Study|Lost to Follow-up|1
4501567|NCT00855335|7307263|FG004|Overall Study|Lost to Follow-up|0
4501568|NCT00855335|7307259|FG000|Overall Study|Withdrawal by Subject|0
4501569|NCT00855335|7307260|FG001|Overall Study|Withdrawal by Subject|0
4501570|NCT00855335|7307261|FG002|Overall Study|Withdrawal by Subject|0
4501571|NCT00855335|7307262|FG003|Overall Study|Withdrawal by Subject|1
4501572|NCT00855335|7307263|FG004|Overall Study|Withdrawal by Subject|0
4501573|NCT00855335|7307259|FG000|Overall Study|Adverse Event|2
4501574|NCT00855335|7307260|FG001|Overall Study|Adverse Event|0
4501575|NCT00855335|7307261|FG002|Overall Study|Adverse Event|0
4501576|NCT00855335|7307262|FG003|Overall Study|Adverse Event|0
4501577|NCT00855335|7307263|FG004|Overall Study|Adverse Event|0
4501578|NCT00855335|7307259|FG000|Overall Study|Physician Decision|1
4501579|NCT00855335|7307260|FG001|Overall Study|Physician Decision|1
4501580|NCT00855335|7307261|FG002|Overall Study|Physician Decision|0
4501581|NCT00855335|7307262|FG003|Overall Study|Physician Decision|0
4501582|NCT00855335|7307263|FG004|Overall Study|Physician Decision|0
4501583|NCT00855335|7307259|FG000|Overall Study|Other|2
4501584|NCT00855335|7307260|FG001|Overall Study|Other|1
4501585|NCT00855335|7307261|FG002|Overall Study|Other|2
4501586|NCT00855335|7307262|FG003|Overall Study|Other|5
4501587|NCT00855335|7307263|FG004|Overall Study|Other|1
4501588|NCT00855439|7307294|FG000|Overall Study|Withdrawal by Subject|2
4501589|NCT00855439|7307295|FG001|Overall Study|Withdrawal by Subject|0
4501590|NCT00855439|7307294|FG000|Overall Study|Pregnancy|1
4501591|NCT00855439|7307295|FG001|Overall Study|Pregnancy|0
4501592|NCT00855465|7307303|FG000|Treatment Period|Adverse Event|4
4501593|NCT00855465|7307304|FG001|Treatment Period|Adverse Event|2
4501594|NCT00855465|7307303|FG000|Treatment Period|Death|2
4501595|NCT00855465|7307304|FG001|Treatment Period|Death|2
4501596|NCT00855465|7307303|FG000|Treatment Period|Lack of Efficacy|2
4501597|NCT00855465|7307304|FG001|Treatment Period|Lack of Efficacy|1
4501598|NCT00855465|7307303|FG000|Treatment Period|Non-compliance|1
4501599|NCT00855465|7307304|FG001|Treatment Period|Non-compliance|0
4501600|NCT00855465|7307303|FG000|Treatment Period|Protocol Violation|2
4501601|NCT00855465|7307304|FG001|Treatment Period|Protocol Violation|0
4501602|NCT00855465|7307303|FG000|Treatment Period|Withdrawal by Subject|2
4501603|NCT00855465|7307304|FG001|Treatment Period|Withdrawal by Subject|0
4501604|NCT00855465|7307303|FG000|Treatment Period|Not treated|1
4501605|NCT00855465|7307304|FG001|Treatment Period|Not treated|0
4501606|NCT00855465|7307303|FG000|Follow-up Period (FUP)|Adverse Event|0
4501607|NCT00855465|7307304|FG001|Follow-up Period (FUP)|Adverse Event|1
4501608|NCT00855465|7307303|FG000|Follow-up Period (FUP)|Death|0
4501609|NCT00855465|7307304|FG001|Follow-up Period (FUP)|Death|1
4501610|NCT00855465|7307303|FG000|Follow-up Period (FUP)|Lost to Follow-up|3
4501611|NCT00855465|7307304|FG001|Follow-up Period (FUP)|Lost to Follow-up|0
4501612|NCT00855465|7307303|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4
4501613|NCT00855465|7307304|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0
4501614|NCT00855465|7307303|FG000|Follow-up Period (FUP)|Missing|1
4501615|NCT00855465|7307304|FG001|Follow-up Period (FUP)|Missing|0
4501616|NCT00855582|7307313|FG000|Overall Study|Adverse Event|2
4501617|NCT00855582|7307314|FG001|Overall Study|Adverse Event|6
4501618|NCT00855582|7307315|FG002|Overall Study|Adverse Event|3
4501619|NCT00855582|7307313|FG000|Overall Study|Death|1
4501620|NCT00855582|7307314|FG001|Overall Study|Death|0
4501621|NCT00855582|7307315|FG002|Overall Study|Death|0
4501622|NCT00855582|7307313|FG000|Overall Study|Lack of Efficacy|1
4501623|NCT00855582|7307314|FG001|Overall Study|Lack of Efficacy|3
4501624|NCT00855582|7307315|FG002|Overall Study|Lack of Efficacy|8
4501625|NCT00855582|7307313|FG000|Overall Study|Lost to Follow-up|1
4501626|NCT00855582|7307314|FG001|Overall Study|Lost to Follow-up|3
4501627|NCT00855582|7307315|FG002|Overall Study|Lost to Follow-up|1
4501628|NCT00855582|7307313|FG000|Overall Study|Physician Decision|0
4501629|NCT00855582|7307314|FG001|Overall Study|Physician Decision|0
4501630|NCT00855582|7307315|FG002|Overall Study|Physician Decision|1
4501631|NCT00855582|7307313|FG000|Overall Study|Protocol Violation|6
4501632|NCT00855582|7307314|FG001|Overall Study|Protocol Violation|2
4501633|NCT00855582|7307315|FG002|Overall Study|Protocol Violation|6
4501634|NCT00855582|7307313|FG000|Overall Study|Entry Criteria Not Met|8
4501635|NCT00855582|7307314|FG001|Overall Study|Entry Criteria Not Met|6
4501636|NCT00855582|7307315|FG002|Overall Study|Entry Criteria Not Met|3
4501637|NCT00855582|7307313|FG000|Overall Study|Withdrawal by Subject|7
4501638|NCT00855582|7307314|FG001|Overall Study|Withdrawal by Subject|4
4501639|NCT00855582|7307315|FG002|Overall Study|Withdrawal by Subject|8
4501640|NCT00855595|7307328|FG000|Overall Study|Withdrawal by Subject|1
4501641|NCT00855595|7307329|FG001|Overall Study|Withdrawal by Subject|2
4501642|NCT00855595|7307328|FG000|Overall Study|Lost to Follow-up|3
4501643|NCT00855595|7307329|FG001|Overall Study|Lost to Follow-up|3
4501644|NCT00855595|7307328|FG000|Overall Study|Adverse Event|1
4501645|NCT00855595|7307329|FG001|Overall Study|Adverse Event|1
4501646|NCT00855595|7307328|FG000|Overall Study|patient moved out of state|1
4501647|NCT00855595|7307329|FG001|Overall Study|patient moved out of state|0
4501648|NCT00855595|7307328|FG000|Overall Study|patient left country|0
4501649|NCT00855595|7307329|FG001|Overall Study|patient left country|1
4501650|NCT00855738|7307335|FG000|Overall Study|Lost to Follow-up|2
4501651|NCT00855738|7307335|FG000|Overall Study|Adverse Event|1
4501652|NCT00855738|7307335|FG000|Overall Study|Subject Defaulted|1
4501653|NCT00855738|7307335|FG000|Overall Study|Death|1
4501654|NCT00855816|7307343|FG000|Overall Study|Withdrawal by Subject|22
4501655|NCT00855816|7307344|FG001|Overall Study|Withdrawal by Subject|15
4501656|NCT00855816|7307343|FG000|Overall Study|Lost to Follow-up|3
4501657|NCT00855816|7307344|FG001|Overall Study|Lost to Follow-up|5
4501658|NCT00855816|7307343|FG000|Overall Study|Death|1
4501659|NCT00855816|7307344|FG001|Overall Study|Death|0
4501660|NCT00855816|7307343|FG000|Overall Study|Became ineligible|0
4501661|NCT00855816|7307344|FG001|Overall Study|Became ineligible|1
4501662|NCT00855894|7307363|FG000|Overall Study|Death|31
4501663|NCT00855894|7307363|FG000|Overall Study|Patient's decision|1
4501664|NCT00855894|7307363|FG000|Overall Study|Disease progression|1
4501665|NCT00855920|7307370|FG000|Overall Study|Protocol Violation|0
4501666|NCT00855920|7307371|FG001|Overall Study|Protocol Violation|0
4501667|NCT00855920|7307372|FG002|Overall Study|Protocol Violation|2
4501668|NCT00855920|7307370|FG000|Overall Study|Adverse Event|2
4501669|NCT00855920|7307371|FG001|Overall Study|Adverse Event|1
4501670|NCT00855920|7307372|FG002|Overall Study|Adverse Event|1
4501671|NCT00855920|7307370|FG000|Overall Study|Lack of Efficacy|2
4501672|NCT00855920|7307371|FG001|Overall Study|Lack of Efficacy|2
4501673|NCT00855920|7307372|FG002|Overall Study|Lack of Efficacy|2
4501674|NCT00855920|7307370|FG000|Overall Study|Withdrawal by Subject|2
4501675|NCT00855920|7307371|FG001|Overall Study|Withdrawal by Subject|3
4501676|NCT00855920|7307372|FG002|Overall Study|Withdrawal by Subject|2
4501677|NCT00855920|7307370|FG000|Overall Study|Lost to Follow-up|1
4501678|NCT00855920|7307371|FG001|Overall Study|Lost to Follow-up|0
4501679|NCT00855920|7307372|FG002|Overall Study|Lost to Follow-up|2
4501680|NCT00855920|7307370|FG000|Overall Study|Death|0
4501681|NCT00855920|7307371|FG001|Overall Study|Death|1
4501682|NCT00855920|7307372|FG002|Overall Study|Death|0
4501683|NCT00855920|7307370|FG000|Overall Study|Decision by the sponsor|0
4501684|NCT00855920|7307371|FG001|Overall Study|Decision by the sponsor|1
4501685|NCT00855920|7307372|FG002|Overall Study|Decision by the sponsor|1
4501686|NCT00855920|7307370|FG000|Overall Study|Other than specified above|1
4501687|NCT00855920|7307371|FG001|Overall Study|Other than specified above|1
4501688|NCT00855920|7307372|FG002|Overall Study|Other than specified above|1
4501689|NCT00855933|7307382|FG000|Overall Study|Withdrawal by Subject|0
4501690|NCT00855933|7307383|FG001|Overall Study|Withdrawal by Subject|1
4501691|NCT00855959|7307389|FG000|Overall Study|Adverse Event|2
4501692|NCT00855959|7307389|FG000|Overall Study|Lost to Follow-up|2
4501693|NCT00855959|7307389|FG000|Overall Study|Withdrawal by Subject|3
4501694|NCT00855959|7307389|FG000|Overall Study|Pregnancy|1
4501695|NCT00855959|7307389|FG000|Overall Study|Incorrect enrolment|1
4501696|NCT00856180|7307403|FG000|Overall Study|Adverse Event|4
4501697|NCT00856180|7307403|FG000|Overall Study|Progressive Disease|16
4501698|NCT00856193|7307409|FG000|Period 2|Abnormal test procedure results|0
4501699|NCT00856193|7307410|FG001|Period 2|Abnormal test procedure results|1
4501700|NCT00856193|7307409|FG000|Period 2|Lost to Follow-up|0
4501701|NCT00856193|7307410|FG001|Period 2|Lost to Follow-up|1
4501702|NCT00856206|7307418|FG000|Overall Study|Protocol Violation|6
4501703|NCT00856206|7307419|FG001|Overall Study|Protocol Violation|18
4501704|NCT00856206|7307418|FG000|Overall Study|Adverse Event|10
4501705|NCT00856206|7307419|FG001|Overall Study|Adverse Event|46
4501706|NCT00856206|7307418|FG000|Overall Study|Lack of Efficacy|1
4501707|NCT00856206|7307419|FG001|Overall Study|Lack of Efficacy|2
4501708|NCT00856206|7307418|FG000|Overall Study|Withdrawal by Subject|15
4501709|NCT00856206|7307419|FG001|Overall Study|Withdrawal by Subject|36
4501710|NCT00856206|7307418|FG000|Overall Study|Lost to Follow-up|13
4501711|NCT00856206|7307419|FG001|Overall Study|Lost to Follow-up|39
4501712|NCT00856206|7307418|FG000|Overall Study|Death|2
4501713|NCT00856206|7307419|FG001|Overall Study|Death|2
4501714|NCT00856206|7307418|FG000|Overall Study|Decision by the Sponsor|4
4501715|NCT00856206|7307419|FG001|Overall Study|Decision by the Sponsor|8
4501716|NCT00856206|7307418|FG000|Overall Study|Other than specified above|3
4501717|NCT00856206|7307419|FG001|Overall Study|Other than specified above|10
4501718|NCT00856245|7307440|FG000|Overall Study|Was not transplanted|5
4501719|NCT00856284|7307447|FG000|Overall Study|Hyperglycemic rescue|231
4501720|NCT00856284|7307448|FG001|Overall Study|Hyperglycemic rescue|201
4501721|NCT00856284|7307449|FG002|Overall Study|Hyperglycemic rescue|235
4501722|NCT00856284|7307447|FG000|Overall Study|Adverse Event|60
4501723|NCT00856284|7307448|FG001|Overall Study|Adverse Event|74
4501724|NCT00856284|7307449|FG002|Overall Study|Adverse Event|82
4501725|NCT00856284|7307447|FG000|Overall Study|Major protocol deviation|24
4501726|NCT00856284|7307448|FG001|Overall Study|Major protocol deviation|16
4501727|NCT00856284|7307449|FG002|Overall Study|Major protocol deviation|15
4501728|NCT00856284|7307447|FG000|Overall Study|Lost to Follow-up|20
4501729|NCT00856284|7307448|FG001|Overall Study|Lost to Follow-up|22
4501730|NCT00856284|7307449|FG002|Overall Study|Lost to Follow-up|28
4501731|NCT00856284|7307447|FG000|Overall Study|Voluntary withdrawal|48
4501732|NCT00856284|7307448|FG001|Overall Study|Voluntary withdrawal|52
4501733|NCT00856284|7307449|FG002|Overall Study|Voluntary withdrawal|62
4501734|NCT00856284|7307447|FG000|Overall Study|Pregnancy|1
4501735|NCT00856284|7307448|FG001|Overall Study|Pregnancy|2
4501736|NCT00856284|7307449|FG002|Overall Study|Pregnancy|0
4501737|NCT00856284|7307447|FG000|Overall Study|Investigator discretion|9
4501738|NCT00856284|7307448|FG001|Overall Study|Investigator discretion|8
4501739|NCT00856284|7307449|FG002|Overall Study|Investigator discretion|10
4501740|NCT00856284|7307447|FG000|Overall Study|Other|15
4501741|NCT00856284|7307448|FG001|Overall Study|Other|17
4501742|NCT00856284|7307449|FG002|Overall Study|Other|14
4501743|NCT00856284|7307447|FG000|Overall Study|Randomized in error|0
4501744|NCT00856284|7307448|FG001|Overall Study|Randomized in error|0
4501745|NCT00856284|7307449|FG002|Overall Study|Randomized in error|1
4501746|NCT00856297|7307462|FG000|Overall Study|Unable to classify|2
4501747|NCT00856297|7307463|FG001|Overall Study|Unable to classify|0
4501748|NCT00856297|7307464|FG002|Overall Study|Unable to classify|0
4501749|NCT00856297|7307465|FG003|Overall Study|Unable to classify|0
4501750|NCT00856297|7307466|FG004|Overall Study|Unable to classify|0
4501751|NCT00856323|7307483|FG000|Overall Study|Withdrawal by Subject|2
4501752|NCT00856349|7307487|FG000|Overall Study|Death|418
4501753|NCT00856349|7307487|FG000|Overall Study|Withdrawal by Subject|116
4501754|NCT00856349|7307487|FG000|Overall Study|Lost to Follow-up|91
4501755|NCT00856349|7307487|FG000|Overall Study|Protocol Violation|38
4501756|NCT00856349|7307487|FG000|Overall Study|Physician Decision|13
4501757|NCT00856349|7307487|FG000|Overall Study|Subject relocation|104
4501758|NCT00856349|7307487|FG000|Overall Study|Device explant|33
4501759|NCT00856349|7307487|FG000|Overall Study|Site closure|78
4501760|NCT00856349|7307487|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130
4501761|NCT00856375|7307495|FG000|Overall Study|Other|0
4501762|NCT00856375|7307496|FG001|Overall Study|Other|1
4501763|NCT00856375|7307495|FG000|Overall Study|Death|32
4501764|NCT00856375|7307496|FG001|Overall Study|Death|30
4501765|NCT00856375|7307495|FG000|Overall Study|Sponsor Terminated Study|7
4501766|NCT00856375|7307496|FG001|Overall Study|Sponsor Terminated Study|7
4501767|NCT00856375|7307495|FG000|Overall Study|Withdrawal by Subject|2
4501768|NCT00856375|7307496|FG001|Overall Study|Withdrawal by Subject|1
4501769|NCT00856375|7307495|FG000|Overall Study|Lost to Follow-up|1
4501770|NCT00856375|7307496|FG001|Overall Study|Lost to Follow-up|2
4501771|NCT00856388|7307502|FG000|Overall Study|Other|1
4501772|NCT00856492|7307514|FG000|Overall Study|Ineligible or withdrew consent|1
4501773|NCT00856492|7307515|FG001|Overall Study|Ineligible or withdrew consent|1
4501774|NCT00856492|7307516|FG002|Overall Study|Ineligible or withdrew consent|2
4501775|NCT00856518|7307529|FG000|Overall Study|Lost to Follow-up|4
4501776|NCT00856518|7307530|FG001|Overall Study|Lost to Follow-up|2
4501777|NCT00856544|7307542|FG000|Overall Study|Randomized but not treated|3
4501778|NCT00856544|7307543|FG001|Overall Study|Randomized but not treated|0
4501779|NCT00856544|7307544|FG002|Overall Study|Randomized but not treated|0
4501780|NCT00856544|7307545|FG003|Overall Study|Randomized but not treated|0
4501781|NCT00856544|7307542|FG000|Overall Study|Death|0
4501782|NCT00856544|7307543|FG001|Overall Study|Death|2
4501783|NCT00856544|7307544|FG002|Overall Study|Death|0
4501784|NCT00856544|7307545|FG003|Overall Study|Death|0
4501785|NCT00856544|7307542|FG000|Overall Study|Adverse Event|20
4501786|NCT00856544|7307543|FG001|Overall Study|Adverse Event|29
4501787|NCT00856544|7307544|FG002|Overall Study|Adverse Event|2
4501788|NCT00856544|7307545|FG003|Overall Study|Adverse Event|3
4501789|NCT00856544|7307542|FG000|Overall Study|Lack of Efficacy|16
4501790|NCT00856544|7307543|FG001|Overall Study|Lack of Efficacy|12
4501791|NCT00856544|7307544|FG002|Overall Study|Lack of Efficacy|3
4501792|NCT00856544|7307545|FG003|Overall Study|Lack of Efficacy|3
4501793|NCT00856544|7307542|FG000|Overall Study|Other|9
4501794|NCT00856544|7307543|FG001|Overall Study|Other|16
4501795|NCT00856544|7307544|FG002|Overall Study|Other|1
4501796|NCT00856544|7307545|FG003|Overall Study|Other|6
4501797|NCT00856544|7307542|FG000|Overall Study|Lost to Follow-up|1
4627350|NCT01852110|7493946|FG000|Overall Study|Non-compliance with Study Drug|2
4627351|NCT01852110|7493947|FG001|Overall Study|Non-compliance with Study Drug|1
4627352|NCT01852110|7493948|FG002|Overall Study|Non-compliance with Study Drug|0
4627353|NCT01852110|7493949|FG003|Overall Study|Non-compliance with Study Drug|0
4501798|NCT00856544|7307543|FG001|Overall Study|Lost to Follow-up|2
4501799|NCT00856544|7307544|FG002|Overall Study|Lost to Follow-up|2
4501800|NCT00856544|7307545|FG003|Overall Study|Lost to Follow-up|0
4501801|NCT00856544|7307542|FG000|Overall Study|Withdrawal by Subject|8
4501802|NCT00856544|7307543|FG001|Overall Study|Withdrawal by Subject|5
4501803|NCT00856544|7307544|FG002|Overall Study|Withdrawal by Subject|0
4501804|NCT00856544|7307545|FG003|Overall Study|Withdrawal by Subject|1
4501805|NCT00856557|7307569|FG000|Overall Study|No patients with contextual flags|12
4501806|NCT00856557|7307570|FG001|Overall Study|No patients with contextual flags|16
4501807|NCT00856583|7307578|FG000|Overall Study|Lack of Efficacy|389
4501808|NCT00856583|7307579|FG001|Overall Study|Lack of Efficacy|377
4501809|NCT00856583|7307578|FG000|Overall Study|Serious Adverse Event (SAE)|99
4501810|NCT00856583|7307579|FG001|Overall Study|Serious Adverse Event (SAE)|65
4501811|NCT00856583|7307578|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393
4501812|NCT00856583|7307579|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179
4501813|NCT00856583|7307578|FG000|Overall Study|Non-compliance|305
4501814|NCT00856583|7307579|FG001|Overall Study|Non-compliance|262
4501815|NCT00856583|7307578|FG000|Overall Study|Withdrawal by Subject|1092
4501816|NCT00856583|7307579|FG001|Overall Study|Withdrawal by Subject|919
4501817|NCT00856583|7307578|FG000|Overall Study|Physician Decision|59
4501818|NCT00856583|7307579|FG001|Overall Study|Physician Decision|82
4501819|NCT00856583|7307578|FG000|Overall Study|Pregnancy|14
4501820|NCT00856583|7307579|FG001|Overall Study|Pregnancy|5
4501821|NCT00856583|7307578|FG000|Overall Study|Other|92
4501822|NCT00856583|7307579|FG001|Overall Study|Other|104
4501823|NCT00856583|7307578|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694
4501824|NCT00856583|7307579|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604
4501825|NCT00856609|7307587|FG000|Overall Study|Adverse Event|1
4501826|NCT00856609|7307588|FG001|Overall Study|Adverse Event|0
4501827|NCT00856635|7307596|FG000|Overall Study|Lost to Follow-up|2
4501828|NCT00856635|7307597|FG001|Overall Study|Lost to Follow-up|5
4501829|NCT00856635|7307596|FG000|Overall Study|Pregnancy|1
4501830|NCT00856635|7307597|FG001|Overall Study|Pregnancy|0
4501831|NCT00856635|7307596|FG000|Overall Study|Withdrawal by Subject|3
4501832|NCT00856635|7307597|FG001|Overall Study|Withdrawal by Subject|1
4501833|NCT00856635|7307596|FG000|Overall Study|Serious Adverse Event|1
4501834|NCT00856635|7307597|FG001|Overall Study|Serious Adverse Event|0
4501835|NCT00856635|7307596|FG000|Overall Study|Other|1
4501836|NCT00856635|7307597|FG001|Overall Study|Other|0
4501837|NCT00856635|7307596|FG000|Overall Study|Discontinued at Randomization|2
4501838|NCT00856635|7307597|FG001|Overall Study|Discontinued at Randomization|2
4501839|NCT00856661|7307607|FG000|Overall Study|Death|15
4501840|NCT00856661|7307608|FG001|Overall Study|Death|18
4501841|NCT00856661|7307607|FG000|Overall Study|Protocol Violation|2
4501842|NCT00856661|7307608|FG001|Overall Study|Protocol Violation|1
4501843|NCT00856661|7307607|FG000|Overall Study|Withdrawal by Subject|1
4501844|NCT00856661|7307608|FG001|Overall Study|Withdrawal by Subject|2
4501845|NCT00856661|7307607|FG000|Overall Study|Lost to Follow-up|1
4501846|NCT00856661|7307608|FG001|Overall Study|Lost to Follow-up|3
4501847|NCT00856661|7307607|FG000|Overall Study|Physician Judgement|8
4501848|NCT00856661|7307608|FG001|Overall Study|Physician Judgement|5
4501849|NCT00856778|7307634|FG000|Overall Study|Adverse Event|7
4501850|NCT00856778|7307634|FG000|Overall Study|Withdrawal by Subject|10
4501851|NCT00856778|7307634|FG000|Overall Study|Study deviation|2
4501852|NCT00856778|7307634|FG000|Overall Study|Lost to Follow-up|5
4501853|NCT00856830|7307646|FG000|Irinotecan & Bendamustine|Death|0
4501854|NCT00856830|7307647|FG001|Irinotecan & Bendamustine|Death|0
4501855|NCT00856830|7307648|FG002|Irinotecan & Bendamustine|Death|0
4501856|NCT00856830|7307649|FG003|Irinotecan & Bendamustine|Death|2
4501857|NCT00856830|7307646|FG000|Irinotecan & Bendamustine|Physician Decision|0
4501858|NCT00856830|7307647|FG001|Irinotecan & Bendamustine|Physician Decision|0
4501859|NCT00856830|7307648|FG002|Irinotecan & Bendamustine|Physician Decision|0
4501860|NCT00856830|7307649|FG003|Irinotecan & Bendamustine|Physician Decision|1
4517940|NCT00970268|7329877|FG000|Overall Study|Adverse Event|15
4517941|NCT00970268|7329878|FG001|Overall Study|Adverse Event|12
4517942|NCT00970268|7329877|FG000|Overall Study|Lack of Efficacy|3
4517943|NCT00970268|7329878|FG001|Overall Study|Lack of Efficacy|6
4517944|NCT00970268|7329877|FG000|Overall Study|Protocol Violation|4
4517945|NCT00970268|7329878|FG001|Overall Study|Protocol Violation|7
4517946|NCT00970268|7329877|FG000|Overall Study|Other Reason|3
4501861|NCT00856843|7307656|FG000|Overall Study|Withdrawal by Subject|1
4501862|NCT00856843|7307657|FG001|Overall Study|Withdrawal by Subject|5
4501863|NCT00856843|7307656|FG000|Overall Study|Lack of Efficacy|1
4501864|NCT00856843|7307657|FG001|Overall Study|Lack of Efficacy|0
4501865|NCT00856856|7307663|FG000|2-year Clinical Follow-up|Lost to Follow-up|1
4501866|NCT00856856|7307663|FG000|4-year Clinical Follow-up|Missed visit|1
4501867|NCT00856908|7307674|FG000|Overall Study|Lost to Follow-up|1
4501868|NCT00856908|7307675|FG001|Overall Study|Lost to Follow-up|0
4501869|NCT00856973|7307684|FG000|Overall Study|Adverse Event|5
4501870|NCT00856973|7307685|FG001|Overall Study|Adverse Event|5
4501871|NCT00856973|7307686|FG002|Overall Study|Adverse Event|3
4627354|NCT01852110|7493950|FG004|Overall Study|Non-compliance with Study Drug|0
4627355|NCT01852110|7493951|FG005|Overall Study|Non-compliance with Study Drug|0
4627356|NCT01852110|7493946|FG000|Overall Study|Physician Decision|1
4627357|NCT01852110|7493947|FG001|Overall Study|Physician Decision|0
4627358|NCT01852110|7493948|FG002|Overall Study|Physician Decision|0
4627359|NCT01852110|7493949|FG003|Overall Study|Physician Decision|0
4627360|NCT01852110|7493950|FG004|Overall Study|Physician Decision|0
4627361|NCT01852110|7493951|FG005|Overall Study|Physician Decision|0
4627362|NCT01852110|7493946|FG000|Overall Study|Protocol Violation|0
4627363|NCT01852110|7493947|FG001|Overall Study|Protocol Violation|1
4627364|NCT01852110|7493948|FG002|Overall Study|Protocol Violation|0
4627365|NCT01852110|7493949|FG003|Overall Study|Protocol Violation|0
4627366|NCT01852110|7493950|FG004|Overall Study|Protocol Violation|0
4627367|NCT01852110|7493951|FG005|Overall Study|Protocol Violation|0
4627368|NCT01852110|7493946|FG000|Overall Study|Study Terminated by Sponsor|30
4627369|NCT01852110|7493947|FG001|Overall Study|Study Terminated by Sponsor|32
4627370|NCT01852110|7493948|FG002|Overall Study|Study Terminated by Sponsor|0
4627371|NCT01852110|7493949|FG003|Overall Study|Study Terminated by Sponsor|0
4627372|NCT01852110|7493950|FG004|Overall Study|Study Terminated by Sponsor|0
4627373|NCT01852110|7493951|FG005|Overall Study|Study Terminated by Sponsor|0
4627374|NCT01852110|7493946|FG000|Overall Study|Withdrawal by Subject|4
4627375|NCT01852110|7493947|FG001|Overall Study|Withdrawal by Subject|4
4627376|NCT01852110|7493948|FG002|Overall Study|Withdrawal by Subject|0
4501872|NCT00856973|7307684|FG000|Overall Study|Lost to Follow-up|6
4501873|NCT00856973|7307685|FG001|Overall Study|Lost to Follow-up|3
4501874|NCT00856973|7307686|FG002|Overall Study|Lost to Follow-up|5
4501875|NCT00856973|7307684|FG000|Overall Study|Physician Decision|0
4501876|NCT00856973|7307685|FG001|Overall Study|Physician Decision|3
4501877|NCT00856973|7307686|FG002|Overall Study|Physician Decision|1
4501878|NCT00856973|7307684|FG000|Overall Study|Protocol Violation|1
4501879|NCT00856973|7307685|FG001|Overall Study|Protocol Violation|2
4501880|NCT00856973|7307686|FG002|Overall Study|Protocol Violation|1
4501881|NCT00856973|7307684|FG000|Overall Study|Withdrawal by Subject|13
4501882|NCT00856973|7307685|FG001|Overall Study|Withdrawal by Subject|16
4501883|NCT00856973|7307686|FG002|Overall Study|Withdrawal by Subject|15
4501884|NCT00856973|7307684|FG000|Overall Study|Other|11
4501885|NCT00856973|7307685|FG001|Overall Study|Other|12
4501886|NCT00856973|7307686|FG002|Overall Study|Other|13
4501887|NCT00856986|7307703|FG000|Run-in Period, Weeks -12-0|Adverse Event|0
4501888|NCT00856986|7307704|FG001|Run-in Period, Weeks -12-0|Adverse Event|0
4501889|NCT00856986|7307705|FG002|Run-in Period, Weeks -12-0|Adverse Event|0
4501890|NCT00856986|7307706|FG003|Run-in Period, Weeks -12-0|Adverse Event|92
4501891|NCT00856986|7307707|FG004|Run-in Period, Weeks -12-0|Adverse Event|0
4501892|NCT00856986|7307703|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0
4501893|NCT00856986|7307704|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0
4501894|NCT00856986|7307705|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0
4501895|NCT00856986|7307706|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24
4501896|NCT00856986|7307707|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0
4501897|NCT00856986|7307703|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
4501898|NCT00856986|7307704|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
4501899|NCT00856986|7307705|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
4501900|NCT00856986|7307706|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10
4501901|NCT00856986|7307707|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
4501902|NCT00856986|7307703|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0
4501903|NCT00856986|7307704|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0
4501904|NCT00856986|7307705|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0
4501905|NCT00856986|7307706|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11
4501906|NCT00856986|7307707|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0
4501907|NCT00856986|7307703|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0
4627377|NCT01852110|7493949|FG003|Overall Study|Withdrawal by Subject|0
4627378|NCT01852110|7493950|FG004|Overall Study|Withdrawal by Subject|0
4627379|NCT01852110|7493951|FG005|Overall Study|Withdrawal by Subject|0
4627380|NCT01852162|7493967|FG000|Overall Study|Adverse Event|1
4627381|NCT01852162|7493968|FG001|Overall Study|Adverse Event|0
4627382|NCT01852162|7493967|FG000|Overall Study|Withdrawal by Subject|3
4501908|NCT00856986|7307704|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0
4501909|NCT00856986|7307705|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0
4501910|NCT00856986|7307706|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6
4501911|NCT00856986|7307707|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0
4501912|NCT00856986|7307703|FG000|Run-in Period, Weeks -12-0|Unclassified|0
4501913|NCT00856986|7307704|FG001|Run-in Period, Weeks -12-0|Unclassified|0
4501914|NCT00856986|7307705|FG002|Run-in Period, Weeks -12-0|Unclassified|0
4501915|NCT00856986|7307706|FG003|Run-in Period, Weeks -12-0|Unclassified|24
4501916|NCT00856986|7307707|FG004|Run-in Period, Weeks -12-0|Unclassified|0
4501917|NCT00856986|7307703|FG000|Main Period, Weeks 0-26|Adverse Event|6
4501918|NCT00856986|7307704|FG001|Main Period, Weeks 0-26|Adverse Event|4
4501919|NCT00856986|7307705|FG002|Main Period, Weeks 0-26|Adverse Event|9
4501920|NCT00856986|7307706|FG003|Main Period, Weeks 0-26|Adverse Event|0
4501921|NCT00856986|7307707|FG004|Main Period, Weeks 0-26|Adverse Event|0
4501922|NCT00856986|7307703|FG000|Main Period, Weeks 0-26|Protocol Violation|4
4501923|NCT00856986|7307704|FG001|Main Period, Weeks 0-26|Protocol Violation|5
4501924|NCT00856986|7307705|FG002|Main Period, Weeks 0-26|Protocol Violation|7
4501925|NCT00856986|7307706|FG003|Main Period, Weeks 0-26|Protocol Violation|0
4501926|NCT00856986|7307707|FG004|Main Period, Weeks 0-26|Protocol Violation|0
4501927|NCT00856986|7307703|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11
4501928|NCT00856986|7307704|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0
4501929|NCT00856986|7307705|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3
4501930|NCT00856986|7307706|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0
4501931|NCT00856986|7307707|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0
4501932|NCT00856986|7307703|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1
4501933|NCT00856986|7307704|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1
4501934|NCT00856986|7307705|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2
4501935|NCT00856986|7307706|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0
4501936|NCT00856986|7307707|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0
4501937|NCT00856986|7307703|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5
4501938|NCT00856986|7307704|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2
4501939|NCT00856986|7307705|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0
4501940|NCT00856986|7307706|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0
4501941|NCT00856986|7307707|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0
4501942|NCT00856986|7307703|FG000|Main Period, Weeks 0-26|Unclassified|7
4501943|NCT00856986|7307704|FG001|Main Period, Weeks 0-26|Unclassified|6
4501944|NCT00856986|7307705|FG002|Main Period, Weeks 0-26|Unclassified|7
4501945|NCT00856986|7307706|FG003|Main Period, Weeks 0-26|Unclassified|0
4501946|NCT00856986|7307707|FG004|Main Period, Weeks 0-26|Unclassified|0
4501947|NCT00856986|7307703|FG000|Extension Period, Weeks 26-52|Adverse Event|3
4501948|NCT00856986|7307704|FG001|Extension Period, Weeks 26-52|Adverse Event|3
4501949|NCT00856986|7307705|FG002|Extension Period, Weeks 26-52|Adverse Event|10
4501950|NCT00856986|7307706|FG003|Extension Period, Weeks 26-52|Adverse Event|0
4501951|NCT00856986|7307707|FG004|Extension Period, Weeks 26-52|Adverse Event|0
4501952|NCT00856986|7307703|FG000|Extension Period, Weeks 26-52|Protocol Violation|6
4501953|NCT00856986|7307704|FG001|Extension Period, Weeks 26-52|Protocol Violation|2
4501954|NCT00856986|7307705|FG002|Extension Period, Weeks 26-52|Protocol Violation|5
4501955|NCT00856986|7307706|FG003|Extension Period, Weeks 26-52|Protocol Violation|0
4501956|NCT00856986|7307707|FG004|Extension Period, Weeks 26-52|Protocol Violation|0
4501957|NCT00856986|7307703|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2
4501958|NCT00856986|7307704|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0
4501959|NCT00856986|7307705|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8
4501960|NCT00856986|7307706|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0
4501961|NCT00856986|7307707|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0
4501962|NCT00856986|7307703|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0
4501963|NCT00856986|7307704|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5
4501964|NCT00856986|7307705|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2
4501965|NCT00856986|7307706|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0
4501966|NCT00856986|7307707|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0
4501967|NCT00856986|7307703|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4
4501968|NCT00856986|7307704|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2
4501969|NCT00856986|7307705|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2
4501970|NCT00856986|7307706|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0
4501971|NCT00856986|7307707|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0
4501972|NCT00856986|7307703|FG000|Extension Period, Weeks 26-52|Unclassified|4
4501973|NCT00856986|7307704|FG001|Extension Period, Weeks 26-52|Unclassified|2
4501974|NCT00856986|7307705|FG002|Extension Period, Weeks 26-52|Unclassified|11
4501975|NCT00856986|7307706|FG003|Extension Period, Weeks 26-52|Unclassified|0
4501976|NCT00856986|7307707|FG004|Extension Period, Weeks 26-52|Unclassified|0
4501977|NCT00856999|7307719|FG000|Overall Study|Withdrawal by Subject|5
4501978|NCT00857207|7307726|FG000|Overall Study|Withdrawal by Subject|13
4501979|NCT00857207|7307727|FG001|Overall Study|Withdrawal by Subject|0
4501980|NCT00857207|7307726|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18
4501981|NCT00857207|7307727|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0
4501982|NCT00857207|7307726|FG000|Overall Study|Subject chose not to participate after signing consent|3
4501983|NCT00857207|7307727|FG001|Overall Study|Subject chose not to participate after signing consent|0
4501984|NCT00857220|7307734|FG000|Overall Study|Adverse Event|35
4501985|NCT00857220|7307734|FG000|Overall Study|Death|1
4590318|NCT01519947|7436141|FG002|Overall Study|Peritoneal Dialysis Needed|0
4501986|NCT00857220|7307734|FG000|Overall Study|Lack of Efficacy|11
4501987|NCT00857220|7307734|FG000|Overall Study|Lost to Follow-up|30
4501988|NCT00857220|7307734|FG000|Overall Study|Physician Decision|4
4501989|NCT00857220|7307734|FG000|Overall Study|Protocol Violation|16
4501990|NCT00857220|7307734|FG000|Overall Study|Withdrawal by Subject|67
4501991|NCT00857220|7307734|FG000|Overall Study|Clinical Hold|6
4501992|NCT00857220|7307734|FG000|Overall Study|Site Closed|5
4501993|NCT00857220|7307734|FG000|Overall Study|Miscellaneous|8
4501994|NCT00857233|7307738|FG000|Overall Study|Adverse Event|24
4501995|NCT00857233|7307738|FG000|Overall Study|Lack of Efficacy|1
4501996|NCT00857233|7307738|FG000|Overall Study|Non-compliance|1
4501997|NCT00857233|7307738|FG000|Overall Study|Withdrawal of Consent|9
4501998|NCT00857233|7307738|FG000|Overall Study|Lost to Follow-up|4
4501999|NCT00857233|7307738|FG000|Overall Study|Nursing Home Placement|14
4502000|NCT00857233|7307738|FG000|Overall Study|Other Reasons|2
4502001|NCT00857246|7307742|FG000|Induction Regimen|Adverse Event|1
4502002|NCT00857246|7307742|FG000|Induction Regimen|disease-related complications|1
4502003|NCT00857246|7307742|FG000|Induction Regimen|Withdrawal by Subject|1
4502004|NCT00857246|7307742|FG000|Surgery (Curative)|disease progression|6
4502005|NCT00857246|7307742|FG000|ChemoRT|Withdrawal by Subject|1
4502006|NCT00857246|7307742|FG000|ChemoRT|Adverse Event|2
4502007|NCT00857259|7307752|FG000|Overall Study|Protocol Violation|1
4502008|NCT00857259|7307753|FG001|Overall Study|Protocol Violation|0
4502009|NCT00857259|7307754|FG002|Overall Study|Protocol Violation|1
4502010|NCT00857311|7307777|FG000|Overall Study|Lost to Follow-up|1
4502011|NCT00857311|7307778|FG001|Overall Study|Lost to Follow-up|0
4502012|NCT00857311|7307779|FG002|Overall Study|Lost to Follow-up|0
4502013|NCT00857311|7307780|FG003|Overall Study|Lost to Follow-up|0
4502014|NCT00857389|7307786|FG000|Overall Study|Did not proceed to transplant|2
4502015|NCT00857415|7307792|FG000|Overall Study|Image acquisition failure|2
4502016|NCT00857415|7307793|FG001|Overall Study|Image acquisition failure|0
4502017|NCT00857415|7307792|FG000|Overall Study|Invalid image or not imaged|3
4502018|NCT00857415|7307793|FG001|Overall Study|Invalid image or not imaged|0
4502019|NCT00857415|7307792|FG000|Overall Study|Subject still living at end of study|110
4502020|NCT00857415|7307793|FG001|Overall Study|Subject still living at end of study|0
4502021|NCT00857415|7307792|FG000|Overall Study|Deceased with no autopsy|2
4502022|NCT00857415|7307793|FG001|Overall Study|Deceased with no autopsy|0
4502023|NCT00857454|7307799|FG000|Overall Study|Withdrawal by Subject|2
4502024|NCT00857454|7307799|FG000|Overall Study|Lost to Follow-up|1
4502025|NCT00857454|7307799|FG000|Overall Study|Adverse Event|2
4502026|NCT00857454|7307799|FG000|Overall Study|Total Testosterone >1050 ng/dL|1
4502027|NCT00857454|7307799|FG000|Overall Study|Total Testosterone <300 ng/dL|8
4502028|NCT00857454|7307799|FG000|Overall Study|MTE09 enrollment criteria not met|6
4502029|NCT00857584|7307855|FG000|Overall Study|Lack of Efficacy|1
4502030|NCT00857584|7307856|FG001|Overall Study|Lack of Efficacy|2
4502031|NCT00857584|7307855|FG000|Overall Study|Adverse Event|2
4502032|NCT00857584|7307856|FG001|Overall Study|Adverse Event|2
4502033|NCT00857584|7307855|FG000|Overall Study|Physician Decision|1
4502034|NCT00857584|7307856|FG001|Overall Study|Physician Decision|1
4502035|NCT00857623|7307864|FG000|Overall Study|Adverse Event|5
4502036|NCT00857623|7307865|FG001|Overall Study|Adverse Event|2
4502037|NCT00857623|7307864|FG000|Overall Study|Study-specific discontinuation criteria|5
4502038|NCT00857623|7307865|FG001|Overall Study|Study-specific discontinuation criteria|3
4502039|NCT00857623|7307864|FG000|Overall Study|Withdrawal by Subject|2
4502040|NCT00857623|7307865|FG001|Overall Study|Withdrawal by Subject|1
4502041|NCT00857623|7307864|FG000|Overall Study|Lack of Efficacy|1
4502042|NCT00857623|7307865|FG001|Overall Study|Lack of Efficacy|1
4502043|NCT00857623|7307864|FG000|Overall Study|Severe non-compliance to protocol|1
4502044|NCT00857623|7307865|FG001|Overall Study|Severe non-compliance to protocol|1
4502045|NCT00857623|7307864|FG000|Overall Study|Intake of prohibited medication|0
4502046|NCT00857623|7307865|FG001|Overall Study|Intake of prohibited medication|1
4502047|NCT00857623|7307864|FG000|Overall Study|Positive for HEP C|0
4502048|NCT00857623|7307865|FG001|Overall Study|Positive for HEP C|1
4502049|NCT00857649|7307873|FG000|Overall Study|Adverse Event|15
4502050|NCT00857649|7307874|FG001|Overall Study|Adverse Event|10
4502051|NCT00857649|7307873|FG000|Overall Study|Non-compliance|1
4502052|NCT00857649|7307874|FG001|Overall Study|Non-compliance|1
4502053|NCT00857649|7307873|FG000|Overall Study|Protocol Violation|2
4502054|NCT00857649|7307874|FG001|Overall Study|Protocol Violation|2
4502055|NCT00857649|7307873|FG000|Overall Study|Withdrawal of Consent|10
4502056|NCT00857649|7307874|FG001|Overall Study|Withdrawal of Consent|7
4502057|NCT00857649|7307873|FG000|Overall Study|Nursing Home Placement|2
4502058|NCT00857649|7307874|FG001|Overall Study|Nursing Home Placement|9
4502059|NCT00857649|7307873|FG000|Overall Study|Other Reasons|1
4502060|NCT00857649|7307874|FG001|Overall Study|Other Reasons|3
4502061|NCT00857766|7307895|FG000|Overall Study|Adverse Event|13
4502062|NCT00857766|7307896|FG001|Overall Study|Adverse Event|12
4502063|NCT00857766|7307895|FG000|Overall Study|Protocol Violation|11
4502064|NCT00857766|7307896|FG001|Overall Study|Protocol Violation|11
4502065|NCT00857766|7307895|FG000|Overall Study|Lost to Follow-up|1
4502066|NCT00857766|7307896|FG001|Overall Study|Lost to Follow-up|0
4502067|NCT00857766|7307895|FG000|Overall Study|Investigator Discretion|2
4502068|NCT00857766|7307896|FG001|Overall Study|Investigator Discretion|3
4502069|NCT00857766|7307895|FG000|Overall Study|Participant Withdrew Consent|4
4502070|NCT00857766|7307896|FG001|Overall Study|Participant Withdrew Consent|4
4502071|NCT00857792|7307902|FG000|Overall Study|inadequate image quality for analysis|12
4502072|NCT00857818|7307908|FG000|Overall Study|Lack of Efficacy|1
4502073|NCT00857818|7307909|FG001|Overall Study|Lack of Efficacy|0
4502074|NCT00857818|7307908|FG000|Overall Study|Adverse Event|3
4502075|NCT00857818|7307909|FG001|Overall Study|Adverse Event|0
4502076|NCT00857818|7307908|FG000|Overall Study|Withdrawal by Subject|0
4502077|NCT00857818|7307909|FG001|Overall Study|Withdrawal by Subject|4
4502078|NCT00857818|7307908|FG000|Overall Study|Sponsor terminated study|6
4502079|NCT00857818|7307909|FG001|Overall Study|Sponsor terminated study|4
4502080|NCT00857818|7307908|FG000|Overall Study|Investigator decision|1
4502081|NCT00857818|7307909|FG001|Overall Study|Investigator decision|0
4502082|NCT00857896|7307927|FG000|Baseline to Week 4|Withdrawal by Subject|1
4502083|NCT00857948|7307936|FG000|Overall Study|Withdrawal by Subject|2
4502084|NCT00857948|7307937|FG001|Overall Study|Withdrawal by Subject|0
4502085|NCT00857948|7307938|FG002|Overall Study|Withdrawal by Subject|0
4502086|NCT00857948|7307939|FG003|Overall Study|Withdrawal by Subject|0
4502087|NCT00857948|7307936|FG000|Overall Study|Protocol Violation|1
4502088|NCT00857948|7307937|FG001|Overall Study|Protocol Violation|0
4502089|NCT00857948|7307938|FG002|Overall Study|Protocol Violation|1
4502090|NCT00857948|7307939|FG003|Overall Study|Protocol Violation|0
4502091|NCT00858117|7307968|FG000|Treatment on Study|Adverse Event|2
4502092|NCT00858117|7307968|FG000|Follow up for 5 Years|Death|4
4502093|NCT00858117|7307968|FG000|Follow up for 5 Years|No further data collected for study|9
4502094|NCT00858143|7307977|FG000|Overall Study|Adverse Event|16
4502095|NCT00858143|7307977|FG000|Overall Study|Lack of Efficacy|4
4502096|NCT00858143|7307977|FG000|Overall Study|Death|7
4502097|NCT00858143|7307977|FG000|Overall Study|Other|23
4502098|NCT00858208|7307981|FG000|Overall Study|Adverse Event|3
4502099|NCT00858208|7307981|FG000|Overall Study|Lost to Follow-up|26
4502100|NCT00858208|7307981|FG000|Overall Study|Participant refused|40
4502101|NCT00858208|7307981|FG000|Overall Study|Other|10
4502102|NCT00858234|7307985|FG000|Overall Study|Adverse Event|6
4502103|NCT00858234|7307985|FG000|Overall Study|Progressive disease|2
4502104|NCT00858234|7307985|FG000|Overall Study|Status unknown|1
4502105|NCT00858247|7307991|FG000|Baseline Assessment|Withdrawal by Subject|1
4502106|NCT00858247|7307992|FG001|Baseline Assessment|Withdrawal by Subject|1
4502107|NCT00858247|7307991|FG000|Baseline Assessment|Poor IV access|1
4502108|NCT00858247|7307992|FG001|Baseline Assessment|Poor IV access|0
4502109|NCT00858247|7307991|FG000|Baseline Assessment|Protocol Violation|0
4502110|NCT00858247|7307992|FG001|Baseline Assessment|Protocol Violation|1
4502111|NCT00858247|7307991|FG000|Week 12 Follow-up|Withdrawal by Subject|0
4502112|NCT00858247|7307992|FG001|Week 12 Follow-up|Withdrawal by Subject|1
4502113|NCT00858364|7308000|FG000|Overall Study|Administrative Decision|3
4502114|NCT00858364|7308001|FG001|Overall Study|Administrative Decision|2
4502115|NCT00858364|7308000|FG000|Overall Study|Adverse Event|5
4502116|NCT00858364|7308001|FG001|Overall Study|Adverse Event|2
4502117|NCT00858364|7308000|FG000|Overall Study|Withdrawal by Subject|44
4502118|NCT00858364|7308001|FG001|Overall Study|Withdrawal by Subject|118
4502119|NCT00858364|7308000|FG000|Overall Study|Ineligibility Determined|1
4502120|NCT00858364|7308001|FG001|Overall Study|Ineligibility Determined|10
4502121|NCT00858364|7308000|FG000|Overall Study|Lost to Follow-up|24
4502122|NCT00858364|7308001|FG001|Overall Study|Lost to Follow-up|54
4502123|NCT00858364|7308000|FG000|Overall Study|Noncompliance|3
4502124|NCT00858364|7308001|FG001|Overall Study|Noncompliance|4
4502125|NCT00858364|7308000|FG000|Overall Study|Protocol Deviation|0
4502126|NCT00858364|7308001|FG001|Overall Study|Protocol Deviation|2
4502127|NCT00858364|7308000|FG000|Overall Study|Other|9
4502128|NCT00858364|7308001|FG001|Overall Study|Other|17
4502129|NCT00858364|7308000|FG000|Overall Study|Missing|1
4502130|NCT00858364|7308001|FG001|Overall Study|Missing|1
4502131|NCT00858364|7308000|FG000|Overall Study|Still on-study|114
4502132|NCT00858364|7308001|FG001|Overall Study|Still on-study|247
4502133|NCT00858403|7308016|FG000|Overall Study|Withdrawal by Subject|1
4502134|NCT00858403|7308016|FG000|Overall Study|Death|3
4502135|NCT00858403|7308016|FG000|Overall Study|Disease Progression|1
4502136|NCT00858442|7308022|FG000|Compression:Start to Finish|Lost to Follow-up|1
4502137|NCT00858442|7308023|FG001|Compression:Start to Finish|Lost to Follow-up|3
4502138|NCT00858637|7308054|FG000|Active Comparison Phase|Adverse Event|14
4502139|NCT00858637|7308055|FG001|Active Comparison Phase|Adverse Event|0
4502140|NCT00858637|7308056|FG002|Active Comparison Phase|Adverse Event|0
4502141|NCT00858637|7308057|FG003|Active Comparison Phase|Adverse Event|9
4502142|NCT00858637|7308058|FG004|Active Comparison Phase|Adverse Event|0
4502143|NCT00858637|7308059|FG005|Active Comparison Phase|Adverse Event|0
4502144|NCT00858637|7308054|FG000|Active Comparison Phase|Death|1
4502145|NCT00858637|7308055|FG001|Active Comparison Phase|Death|0
4502146|NCT00858637|7308056|FG002|Active Comparison Phase|Death|0
4502147|NCT00858637|7308057|FG003|Active Comparison Phase|Death|1
4502148|NCT00858637|7308058|FG004|Active Comparison Phase|Death|0
4502149|NCT00858637|7308059|FG005|Active Comparison Phase|Death|0
4502150|NCT00858637|7308054|FG000|Active Comparison Phase|Physician Decision|1
4502151|NCT00858637|7308055|FG001|Active Comparison Phase|Physician Decision|0
4502152|NCT00858637|7308056|FG002|Active Comparison Phase|Physician Decision|0
4502153|NCT00858637|7308057|FG003|Active Comparison Phase|Physician Decision|1
4502154|NCT00858637|7308058|FG004|Active Comparison Phase|Physician Decision|0
4502155|NCT00858637|7308059|FG005|Active Comparison Phase|Physician Decision|0
4502156|NCT00858637|7308054|FG000|Active Comparison Phase|Withdrawal by Subject|7
4502157|NCT00858637|7308055|FG001|Active Comparison Phase|Withdrawal by Subject|0
4502158|NCT00858637|7308056|FG002|Active Comparison Phase|Withdrawal by Subject|0
4502159|NCT00858637|7308057|FG003|Active Comparison Phase|Withdrawal by Subject|6
4502160|NCT00858637|7308058|FG004|Active Comparison Phase|Withdrawal by Subject|0
4502161|NCT00858637|7308059|FG005|Active Comparison Phase|Withdrawal by Subject|0
4502162|NCT00858637|7308054|FG000|Active Comparison Phase|Other Reasons|1
4502163|NCT00858637|7308055|FG001|Active Comparison Phase|Other Reasons|0
4502164|NCT00858637|7308056|FG002|Active Comparison Phase|Other Reasons|0
4502165|NCT00858637|7308057|FG003|Active Comparison Phase|Other Reasons|1
4502166|NCT00858637|7308058|FG004|Active Comparison Phase|Other Reasons|0
4502167|NCT00858637|7308059|FG005|Active Comparison Phase|Other Reasons|0
4502168|NCT00858637|7308054|FG000|Placebo-controlled Withdrawal Phase|Death|0
4502169|NCT00858637|7308055|FG001|Placebo-controlled Withdrawal Phase|Death|0
4502170|NCT00858637|7308056|FG002|Placebo-controlled Withdrawal Phase|Death|1
4502171|NCT00858637|7308057|FG003|Placebo-controlled Withdrawal Phase|Death|0
4502172|NCT00858637|7308058|FG004|Placebo-controlled Withdrawal Phase|Death|1
4502173|NCT00858637|7308059|FG005|Placebo-controlled Withdrawal Phase|Death|0
4502174|NCT00858637|7308054|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
4502175|NCT00858637|7308055|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
4502176|NCT00858637|7308056|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
4502177|NCT00858637|7308057|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
4502178|NCT00858637|7308058|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
4502179|NCT00858637|7308059|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1
4502180|NCT00858780|7308073|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18
4502181|NCT00858780|7308074|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
4502182|NCT00858780|7308075|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
4502183|NCT00858780|7308076|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
4502184|NCT00858780|7308077|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
4502185|NCT00858780|7308073|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
4502186|NCT00858780|7308074|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
4502187|NCT00858780|7308075|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1
4502188|NCT00858780|7308076|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
4502189|NCT00858780|7308077|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
4502190|NCT00858780|7308073|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0
4502191|NCT00858780|7308074|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
4502192|NCT00858780|7308075|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
4502193|NCT00858780|7308076|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
4502194|NCT00858780|7308077|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0
4502195|NCT00858780|7308073|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0
4502196|NCT00858780|7308074|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1
4502197|NCT00858780|7308075|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0
4502198|NCT00858780|7308076|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0
4502199|NCT00858780|7308077|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0
4502200|NCT00858780|7308073|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
4502201|NCT00858780|7308074|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
4502202|NCT00858780|7308075|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
4502203|NCT00858780|7308076|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
4502204|NCT00858780|7308077|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1
4502205|NCT00858780|7308073|FG000|OL Re-Treatment (Failure to Week 48)|Other|0
4502206|NCT00858780|7308074|FG001|OL Re-Treatment (Failure to Week 48)|Other|0
4502207|NCT00858780|7308075|FG002|OL Re-Treatment (Failure to Week 48)|Other|0
4502208|NCT00858780|7308076|FG003|OL Re-Treatment (Failure to Week 48)|Other|0
4502209|NCT00858780|7308077|FG004|OL Re-Treatment (Failure to Week 48)|Other|1
4502210|NCT00858832|7308089|FG000|Overall Study|became ineligible: delivered vaginally|1
4502211|NCT00858832|7308090|FG001|Overall Study|became ineligible: delivered vaginally|0
4502212|NCT00858832|7308089|FG000|Overall Study|Adverse Event|0
4502213|NCT00858832|7308090|FG001|Overall Study|Adverse Event|1
4502214|NCT00858845|7308098|FG000|Overall Study|Patient underwent heart transplant.|0
4502215|NCT00858845|7308099|FG001|Overall Study|Patient underwent heart transplant.|1
4502216|NCT00858988|7308115|FG000|Analysis|Lactulose unable to be detected in urine|2
4502217|NCT00858988|7308116|FG001|Analysis|Lactulose unable to be detected in urine|1
4502218|NCT00859014|7308122|FG000|Overall Study|Death|4
4502219|NCT00859014|7308122|FG000|Overall Study|Lost to Follow-up|1
4502220|NCT00859222|7308173|FG000|Overall Study|Adverse Event|2
4502221|NCT00859222|7308174|FG001|Overall Study|Adverse Event|3
4502222|NCT00859222|7308175|FG002|Overall Study|Adverse Event|6
4502223|NCT00859222|7308176|FG003|Overall Study|Adverse Event|24
4502224|NCT00859222|7308177|FG004|Overall Study|Adverse Event|15
4502225|NCT00859222|7308173|FG000|Overall Study|DLT|1
4502226|NCT00859222|7308174|FG001|Overall Study|DLT|0
4502227|NCT00859222|7308175|FG002|Overall Study|DLT|0
4502228|NCT00859222|7308176|FG003|Overall Study|DLT|0
4502229|NCT00859222|7308177|FG004|Overall Study|DLT|0
4704791|NCT02757352|7624005|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3
4502230|NCT00859313|7308192|FG000|Overall Study|Lack of Efficacy|2
4502231|NCT00859313|7308192|FG000|Overall Study|Adverse Event|1
4502232|NCT00859313|7308192|FG000|Overall Study|staff error|1
4502233|NCT00859456|7308200|FG000|Overall Study|Adverse Event|3
4502234|NCT00859456|7308200|FG000|Overall Study|Progressive disease|2
4502235|NCT00859456|7308200|FG000|Overall Study|Non-compliance|3
4502236|NCT00859469|7308204|FG000|Overall Study|Adverse Event|2
4502237|NCT00859469|7308204|FG000|Overall Study|Lack of Efficacy|9
4502238|NCT00859469|7308204|FG000|Overall Study|Withdrawal by Subject|1
4502239|NCT00859469|7308204|FG000|Overall Study|Death|16
4502240|NCT00859547|7308221|FG000|Overall Study|Lost to Follow-up|1
4502241|NCT00859547|7308221|FG000|Overall Study|Parent withdrew consent|1
4502242|NCT00859573|7308227|FG000|Overall Study|Withdrawal by Subject|4
4502243|NCT00859573|7308228|FG001|Overall Study|Withdrawal by Subject|1
4502244|NCT00859573|7308227|FG000|Overall Study|Physician Decision|1
4502245|NCT00859573|7308228|FG001|Overall Study|Physician Decision|1
4502246|NCT00859586|7308234|FG000|Overall Study|Donors|4
4502247|NCT00859638|7308240|FG000|Overall Study|Lost to Follow-up|6
4502248|NCT00859638|7308241|FG001|Overall Study|Lost to Follow-up|1
4502249|NCT00859638|7308240|FG000|Overall Study|Withdrawal by Subject|3
4502250|NCT00859638|7308241|FG001|Overall Study|Withdrawal by Subject|2
4502251|NCT00859638|7308240|FG000|Overall Study|Ill health|1
4502252|NCT00859638|7308241|FG001|Overall Study|Ill health|1
4502253|NCT00859898|7308264|FG000|Overall Study|Lack of Efficacy|0
4502254|NCT00859898|7308265|FG001|Overall Study|Lack of Efficacy|1
4502255|NCT00859898|7308266|FG002|Overall Study|Lack of Efficacy|1
4502256|NCT00859898|7308264|FG000|Overall Study|Adverse Event|4
4502257|NCT00859898|7308265|FG001|Overall Study|Adverse Event|9
4502258|NCT00859898|7308266|FG002|Overall Study|Adverse Event|8
4502259|NCT00859898|7308264|FG000|Overall Study|Withdrawal by Subject|11
4502260|NCT00859898|7308265|FG001|Overall Study|Withdrawal by Subject|8
4502261|NCT00859898|7308266|FG002|Overall Study|Withdrawal by Subject|11
4502262|NCT00859898|7308264|FG000|Overall Study|Death|0
4502263|NCT00859898|7308265|FG001|Overall Study|Death|0
4502264|NCT00859898|7308266|FG002|Overall Study|Death|1
4502265|NCT00859898|7308264|FG000|Overall Study|Lost to Follow-up|10
4502266|NCT00859898|7308265|FG001|Overall Study|Lost to Follow-up|11
4502267|NCT00859898|7308266|FG002|Overall Study|Lost to Follow-up|5
4502268|NCT00859898|7308264|FG000|Overall Study|poor/non-compliance|2
4502269|NCT00859898|7308265|FG001|Overall Study|poor/non-compliance|0
4502270|NCT00859898|7308266|FG002|Overall Study|poor/non-compliance|0
4502271|NCT00859898|7308264|FG000|Overall Study|No longer meets criteria|0
4502272|NCT00859898|7308265|FG001|Overall Study|No longer meets criteria|1
4502273|NCT00859898|7308266|FG002|Overall Study|No longer meets criteria|0
4502274|NCT00859898|7308264|FG000|Overall Study|non-specified|1
4502275|NCT00859898|7308265|FG001|Overall Study|non-specified|1
4502276|NCT00859898|7308266|FG002|Overall Study|non-specified|1
4502277|NCT00859937|7308277|FG000|Overall Study|Protocol Violation|1
4502278|NCT00859937|7308278|FG001|Overall Study|Protocol Violation|0
4502279|NCT00860028|7308308|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2
4502280|NCT00860028|7308309|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1
4502281|NCT00860067|7308320|FG000|Overall Study|Lost to Follow-up|46
4502282|NCT00860067|7308321|FG001|Overall Study|Lost to Follow-up|9
4502283|NCT00860067|7308322|FG002|Overall Study|Lost to Follow-up|9
4502284|NCT00860067|7308320|FG000|Overall Study|Withdrawal by Subject|4
4502285|NCT00860067|7308321|FG001|Overall Study|Withdrawal by Subject|0
4502286|NCT00860067|7308322|FG002|Overall Study|Withdrawal by Subject|0
4502287|NCT00860067|7308320|FG000|Overall Study|Pregnancy|1
4502288|NCT00860067|7308321|FG001|Overall Study|Pregnancy|0
4502289|NCT00860067|7308322|FG002|Overall Study|Pregnancy|0
4502290|NCT00860262|7308340|FG000|Overall Study|Adverse Event|9
4502291|NCT00860262|7308341|FG001|Overall Study|Adverse Event|6
4502292|NCT00860262|7308342|FG002|Overall Study|Adverse Event|7
4502293|NCT00860262|7308340|FG000|Overall Study|Protocol Violation|0
4502294|NCT00860262|7308341|FG001|Overall Study|Protocol Violation|1
4502295|NCT00860262|7308342|FG002|Overall Study|Protocol Violation|0
4502296|NCT00860262|7308340|FG000|Overall Study|Lost to Follow-up|2
4502297|NCT00860262|7308341|FG001|Overall Study|Lost to Follow-up|0
4502298|NCT00860262|7308342|FG002|Overall Study|Lost to Follow-up|1
4502299|NCT00860262|7308340|FG000|Overall Study|Withdrawal by Subject|4
4502300|NCT00860262|7308341|FG001|Overall Study|Withdrawal by Subject|8
4502301|NCT00860262|7308342|FG002|Overall Study|Withdrawal by Subject|6
4502302|NCT00860262|7308340|FG000|Overall Study|Lack of Efficacy|0
4502303|NCT00860262|7308341|FG001|Overall Study|Lack of Efficacy|4
4502304|NCT00860262|7308342|FG002|Overall Study|Lack of Efficacy|3
4502305|NCT00860262|7308340|FG000|Overall Study|Other|5
4502306|NCT00860262|7308341|FG001|Overall Study|Other|3
4502307|NCT00860262|7308342|FG002|Overall Study|Other|1
4502308|NCT00860405|7308376|FG000|Overall Study|Main reason: Follow-up data not complete|5
4502309|NCT00860405|7308377|FG001|Overall Study|Main reason: Follow-up data not complete|4
4502310|NCT00860470|7308389|FG000|Overall Study|Death|6
4502311|NCT00860470|7308390|FG001|Overall Study|Death|10
4502312|NCT00860470|7308389|FG000|Overall Study|Moved away|8
4502313|NCT00860470|7308390|FG001|Overall Study|Moved away|10
4502314|NCT00860470|7308389|FG000|Overall Study|Lost to Follow-up|34
4502315|NCT00860470|7308390|FG001|Overall Study|Lost to Follow-up|39
4502316|NCT00860574|7308400|FG000|Overall Study|Death|2
4502317|NCT00860574|7308400|FG000|Overall Study|Relapse|1
4502318|NCT00860743|7308410|FG000|Overall Study|Withdrawal by Subject|3
4502319|NCT00860743|7308411|FG001|Overall Study|Withdrawal by Subject|0
4502320|NCT00860951|7308444|FG000|Overall Study|Withdrawal by Subject|2
4502321|NCT00860951|7308444|FG000|Overall Study|Lost to Follow-up|5
4502322|NCT00861198|7308459|FG000|Overall Study|SpyGlass Failed|5
4502323|NCT00861341|7308467|FG000|Overall Study|Withdrawal by Subject|2
4502324|NCT00861380|7308478|FG000|Overall Study|Withdrawal Information not recorded|8427
4502325|NCT00861380|7308479|FG001|Overall Study|Withdrawal Information not recorded|9112
4502326|NCT00861380|7308480|FG002|Overall Study|Withdrawal Information not recorded|8872
4502327|NCT00861380|7308481|FG003|Overall Study|Withdrawal Information not recorded|3689
4502328|NCT00861380|7308482|FG004|Overall Study|Withdrawal Information not recorded|1812
4502329|NCT00861380|7308483|FG005|Overall Study|Withdrawal Information not recorded|6249
4502330|NCT00861380|7308484|FG006|Overall Study|Withdrawal Information not recorded|3020
4502331|NCT00861471|7308517|FG000|Overall Study|Withdrawal by Subject|1
4502332|NCT00861471|7308517|FG000|Overall Study|Adverse Event|2
4502333|NCT00861471|7308517|FG000|Overall Study|Lack of Efficacy|3
4502334|NCT00861471|7308517|FG000|Overall Study|treatment for lumbar laminectomy|1
4502335|NCT00861471|7308517|FG000|Overall Study|Physician Decision|2
4517947|NCT00970268|7329878|FG001|Overall Study|Other Reason|1
4517948|NCT00970268|7329877|FG000|Overall Study|COPD Exacerbation|4
4517949|NCT00970268|7329878|FG001|Overall Study|COPD Exacerbation|2
4517950|NCT00970268|7329877|FG000|Overall Study|Lost to Follow-up|1
4517951|NCT00970268|7329878|FG001|Overall Study|Lost to Follow-up|2
4517952|NCT00970268|7329877|FG000|Overall Study|Inclusion/Exclusion Criteria|1
4517953|NCT00970268|7329878|FG001|Overall Study|Inclusion/Exclusion Criteria|0
4517954|NCT00970281|7329892|FG000|Overall Study|Lack of Efficacy|1
4517955|NCT00970281|7329893|FG001|Overall Study|Lack of Efficacy|14
4517956|NCT00970281|7329892|FG000|Overall Study|Withdrawal by Subject|0
4517957|NCT00970281|7329893|FG001|Overall Study|Withdrawal by Subject|1
4517958|NCT00970281|7329892|FG000|Overall Study|Physician Decision|1
4517959|NCT00970281|7329893|FG001|Overall Study|Physician Decision|1
4517960|NCT00970294|7329899|FG000|Overall Study|Physician Decision|4
4517961|NCT00970294|7329899|FG000|Overall Study|Withdrawal by Subject|1
4517962|NCT00970307|7329906|FG000|Overall Study|Serious Adverse Event|1
4517963|NCT00970307|7329907|FG001|Overall Study|Serious Adverse Event|0
4517964|NCT00970307|7329908|FG002|Overall Study|Serious Adverse Event|0
4517965|NCT00970307|7329906|FG000|Overall Study|Withdrawal by Subject|2
4517966|NCT00970307|7329907|FG001|Overall Study|Withdrawal by Subject|3
4517967|NCT00970307|7329908|FG002|Overall Study|Withdrawal by Subject|2
4517968|NCT00970359|7329937|FG000|Overall Study|Not Treated|4
4517969|NCT00970489|7329943|FG000|Overall Study|Death/Withdrew/Criteria Violation|54
4517970|NCT00970489|7329944|FG001|Overall Study|Death/Withdrew/Criteria Violation|41
4517971|NCT00970502|7329950|FG000|Overall Study|Withdrawal by Subject|1
4517972|NCT00970593|7329965|FG000|Overall Study|Adverse Event|1
4517973|NCT00970593|7329966|FG001|Overall Study|Adverse Event|1
4517974|NCT00970593|7329967|FG002|Overall Study|Adverse Event|0
4517975|NCT00970593|7329968|FG003|Overall Study|Adverse Event|0
4517976|NCT00970593|7329969|FG004|Overall Study|Adverse Event|0
4517977|NCT00970593|7329970|FG005|Overall Study|Adverse Event|0
4517978|NCT00970593|7329971|FG006|Overall Study|Adverse Event|0
4517979|NCT00970593|7329965|FG000|Overall Study|Discontinuation of study by sponsor|0
4517980|NCT00970593|7329966|FG001|Overall Study|Discontinuation of study by sponsor|0
4517981|NCT00970593|7329967|FG002|Overall Study|Discontinuation of study by sponsor|5
4704792|NCT02757352|7624006|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
4704793|NCT02757352|7624007|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1
4704794|NCT02757352|7624008|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
4704795|NCT02757352|7624009|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
4704796|NCT02757352|7624010|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
4704797|NCT02757352|7624011|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
4704798|NCT02757352|7624002|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
4704799|NCT02757352|7624003|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
4704800|NCT02757352|7624004|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
4704801|NCT02757352|7624005|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2
4704802|NCT02757352|7624006|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1
4704803|NCT02757352|7624007|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4
4704804|NCT02757352|7624008|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
4517982|NCT00970593|7329968|FG003|Overall Study|Discontinuation of study by sponsor|0
4517983|NCT00970593|7329969|FG004|Overall Study|Discontinuation of study by sponsor|0
4517984|NCT00970593|7329970|FG005|Overall Study|Discontinuation of study by sponsor|0
4517985|NCT00970593|7329971|FG006|Overall Study|Discontinuation of study by sponsor|2
4517986|NCT00970593|7329965|FG000|Overall Study|Withdrawal by Subject|0
4517987|NCT00970593|7329966|FG001|Overall Study|Withdrawal by Subject|0
4517988|NCT00970593|7329967|FG002|Overall Study|Withdrawal by Subject|1
4517989|NCT00970593|7329968|FG003|Overall Study|Withdrawal by Subject|0
4517990|NCT00970593|7329969|FG004|Overall Study|Withdrawal by Subject|0
4517991|NCT00970593|7329970|FG005|Overall Study|Withdrawal by Subject|0
4517992|NCT00970593|7329971|FG006|Overall Study|Withdrawal by Subject|0
4517993|NCT00970632|7329994|FG000|Overall Study|Adverse Event|2
4502336|NCT00861614|7308539|FG000|Overall Study|Disease Progression|182
4502337|NCT00861614|7308540|FG001|Overall Study|Disease Progression|263
4502338|NCT00861614|7308539|FG000|Overall Study|Study Drug Toxicity|79
4502339|NCT00861614|7308540|FG001|Overall Study|Study Drug Toxicity|6
4502340|NCT00861614|7308539|FG000|Overall Study|Death|32
4502341|NCT00861614|7308540|FG001|Overall Study|Death|19
4502342|NCT00861614|7308539|FG000|Overall Study|Adverse Event|27
4502343|NCT00861614|7308540|FG001|Overall Study|Adverse Event|23
4502344|NCT00861614|7308539|FG000|Overall Study|Withdrawal by Subject|34
4502345|NCT00861614|7308540|FG001|Overall Study|Withdrawal by Subject|35
4502346|NCT00861614|7308539|FG000|Overall Study|Other|17
4502347|NCT00861614|7308540|FG001|Overall Study|Other|22
4502348|NCT00861692|7308546|FG000|Overall Study|Death|6
4502349|NCT00861744|7308554|FG000|Overall Study|Adverse Event|0
4502350|NCT00861744|7308555|FG001|Overall Study|Adverse Event|0
4502351|NCT00861744|7308556|FG002|Overall Study|Adverse Event|0
4502352|NCT00861744|7308557|FG003|Overall Study|Adverse Event|1
4502353|NCT00861744|7308554|FG000|Overall Study|Lost to Follow-up|7
4502354|NCT00861744|7308555|FG001|Overall Study|Lost to Follow-up|19
4502355|NCT00861744|7308556|FG002|Overall Study|Lost to Follow-up|17
4502356|NCT00861744|7308557|FG003|Overall Study|Lost to Follow-up|12
4502357|NCT00861744|7308554|FG000|Overall Study|Withdrawal by Subject|10
4502358|NCT00861744|7308555|FG001|Overall Study|Withdrawal by Subject|6
4502359|NCT00861744|7308556|FG002|Overall Study|Withdrawal by Subject|6
4502360|NCT00861744|7308557|FG003|Overall Study|Withdrawal by Subject|19
4502361|NCT00861744|7308554|FG000|Overall Study|Protocol Violation|0
4502362|NCT00861744|7308555|FG001|Overall Study|Protocol Violation|1
4502363|NCT00861744|7308556|FG002|Overall Study|Protocol Violation|0
4502364|NCT00861744|7308557|FG003|Overall Study|Protocol Violation|0
4502365|NCT00861744|7308554|FG000|Overall Study|Migration from study area|0
4502366|NCT00861744|7308555|FG001|Overall Study|Migration from study area|3
4502367|NCT00861744|7308556|FG002|Overall Study|Migration from study area|1
4502368|NCT00861744|7308557|FG003|Overall Study|Migration from study area|0
4502369|NCT00861744|7308554|FG000|Overall Study|Blood draws|0
4502370|NCT00861744|7308555|FG001|Overall Study|Blood draws|0
4502371|NCT00861744|7308556|FG002|Overall Study|Blood draws|0
4502372|NCT00861744|7308557|FG003|Overall Study|Blood draws|1
4502373|NCT00861757|7308571|FG000|Overall Study|Adverse Event|1
4502374|NCT00861757|7308572|FG001|Overall Study|Adverse Event|5
4502375|NCT00861757|7308573|FG002|Overall Study|Adverse Event|7
4502376|NCT00861757|7308574|FG003|Overall Study|Adverse Event|2
4502377|NCT00861757|7308571|FG000|Overall Study|Entry Criteria Not Met|1
4502378|NCT00861757|7308572|FG001|Overall Study|Entry Criteria Not Met|2
4502379|NCT00861757|7308573|FG002|Overall Study|Entry Criteria Not Met|1
4502380|NCT00861757|7308574|FG003|Overall Study|Entry Criteria Not Met|1
4502381|NCT00861757|7308571|FG000|Overall Study|Lack of Efficacy|3
4502382|NCT00861757|7308572|FG001|Overall Study|Lack of Efficacy|1
4502383|NCT00861757|7308573|FG002|Overall Study|Lack of Efficacy|0
4502384|NCT00861757|7308574|FG003|Overall Study|Lack of Efficacy|1
4502385|NCT00861757|7308571|FG000|Overall Study|Lost to Follow-up|1
4502386|NCT00861757|7308572|FG001|Overall Study|Lost to Follow-up|0
4502387|NCT00861757|7308573|FG002|Overall Study|Lost to Follow-up|1
4502388|NCT00861757|7308574|FG003|Overall Study|Lost to Follow-up|1
4502389|NCT00861757|7308571|FG000|Overall Study|Physician Decision|0
4502390|NCT00861757|7308572|FG001|Overall Study|Physician Decision|0
4502391|NCT00861757|7308573|FG002|Overall Study|Physician Decision|0
4502392|NCT00861757|7308574|FG003|Overall Study|Physician Decision|1
4502393|NCT00861757|7308571|FG000|Overall Study|Protocol Violation|2
4502394|NCT00861757|7308572|FG001|Overall Study|Protocol Violation|2
4502395|NCT00861757|7308573|FG002|Overall Study|Protocol Violation|4
4502396|NCT00861757|7308574|FG003|Overall Study|Protocol Violation|1
4502397|NCT00861757|7308571|FG000|Overall Study|Withdrawal by Subject|1
4502398|NCT00861757|7308572|FG001|Overall Study|Withdrawal by Subject|5
4502399|NCT00861757|7308573|FG002|Overall Study|Withdrawal by Subject|5
4502400|NCT00861757|7308574|FG003|Overall Study|Withdrawal by Subject|2
4502401|NCT00862082|7308594|FG000|Overall Study|Sponsor decision to terminate the study|5
4502402|NCT00862082|7308595|FG001|Overall Study|Sponsor decision to terminate the study|0
4502403|NCT00862082|7308594|FG000|Overall Study|Withdrawal by Subject|0
4502404|NCT00862082|7308595|FG001|Overall Study|Withdrawal by Subject|1
4502405|NCT00862121|7308610|FG000|Overall Study|Adverse Event|1
4502406|NCT00862121|7308611|FG001|Overall Study|Adverse Event|2
4502407|NCT00862121|7308610|FG000|Overall Study|Lack of Efficacy|0
4502408|NCT00862121|7308611|FG001|Overall Study|Lack of Efficacy|3
4502409|NCT00862121|7308610|FG000|Overall Study|Protocol Violation|0
4502410|NCT00862121|7308611|FG001|Overall Study|Protocol Violation|1
4502411|NCT00862121|7308610|FG000|Overall Study|Exclusion criterion violation|0
4502412|NCT00862121|7308611|FG001|Overall Study|Exclusion criterion violation|1
4502413|NCT00862121|7308610|FG000|Overall Study|Incorrect randomisation|0
4502414|NCT00862121|7308611|FG001|Overall Study|Incorrect randomisation|1
4502415|NCT00862134|7308619|FG000|Overall Study|Death|1
4502416|NCT00862134|7308620|FG001|Overall Study|Death|0
4502417|NCT00862134|7308619|FG000|Overall Study|Physician Decision|0
4502418|NCT00862134|7308620|FG001|Overall Study|Physician Decision|1
4502419|NCT00862134|7308619|FG000|Overall Study|Withdrawal by Subject|1
4502420|NCT00862134|7308620|FG001|Overall Study|Withdrawal by Subject|2
4502421|NCT00862134|7308619|FG000|Overall Study|Sponsor terminated study|5
4502422|NCT00862134|7308620|FG001|Overall Study|Sponsor terminated study|7
4502423|NCT00862134|7308619|FG000|Overall Study|Adverse Event|2
4502424|NCT00862134|7308620|FG001|Overall Study|Adverse Event|2
4502425|NCT00862134|7308619|FG000|Overall Study|Withdrew prior to dosing|2
4502426|NCT00862134|7308620|FG001|Overall Study|Withdrew prior to dosing|0
4502427|NCT00862277|7308634|FG000|Overall Study|Protocol Violation|1
4502428|NCT00862277|7308635|FG001|Overall Study|Protocol Violation|2
4502429|NCT00862277|7308636|FG002|Overall Study|Protocol Violation|5
4502430|NCT00862459|7308651|FG000|Overall Study|Lost to Follow-up|1
4502431|NCT00862459|7308652|FG001|Overall Study|Lost to Follow-up|2
4502432|NCT00862459|7308653|FG002|Overall Study|Lost to Follow-up|2
4502433|NCT00862459|7308651|FG000|Overall Study|Protocol Violation|1
4502434|NCT00862459|7308652|FG001|Overall Study|Protocol Violation|0
4502435|NCT00862459|7308653|FG002|Overall Study|Protocol Violation|0
4502436|NCT00862459|7308651|FG000|Overall Study|Withdrawal by Subject|1
4502437|NCT00862459|7308652|FG001|Overall Study|Withdrawal by Subject|1
4502438|NCT00862459|7308653|FG002|Overall Study|Withdrawal by Subject|3
4502439|NCT00862459|7308651|FG000|Overall Study|Adverse Event|0
4502440|NCT00862459|7308652|FG001|Overall Study|Adverse Event|1
4502441|NCT00862459|7308653|FG002|Overall Study|Adverse Event|0
4502442|NCT00862459|7308651|FG000|Overall Study|Personal reasons|1
4502443|NCT00862459|7308652|FG001|Overall Study|Personal reasons|0
4502444|NCT00862459|7308653|FG002|Overall Study|Personal reasons|0
4502445|NCT00862459|7308651|FG000|Overall Study|Operation|1
4502446|NCT00862459|7308652|FG001|Overall Study|Operation|1
4502447|NCT00862459|7308653|FG002|Overall Study|Operation|0
4502448|NCT00862459|7308651|FG000|Overall Study|Intravenous (IV) site problems|1
4502449|NCT00862459|7308652|FG001|Overall Study|Intravenous (IV) site problems|0
4502450|NCT00862459|7308653|FG002|Overall Study|Intravenous (IV) site problems|1
4502451|NCT00862459|7308651|FG000|Overall Study|Unable to hold still for imaging|0
4502452|NCT00862459|7308652|FG001|Overall Study|Unable to hold still for imaging|1
4502453|NCT00862459|7308653|FG002|Overall Study|Unable to hold still for imaging|0
4627383|NCT01852162|7493968|FG001|Overall Study|Withdrawal by Subject|1
4627384|NCT01852214|7493993|FG000|Period 1|Adverse Event|1
4502454|NCT00862459|7308651|FG000|Overall Study|Inclusion/exclusion criteria not met|0
4502455|NCT00862459|7308652|FG001|Overall Study|Inclusion/exclusion criteria not met|1
4502456|NCT00862459|7308653|FG002|Overall Study|Inclusion/exclusion criteria not met|0
4502457|NCT00862459|7308651|FG000|Overall Study|Administrative problems|0
4502458|NCT00862459|7308652|FG001|Overall Study|Administrative problems|1
4502459|NCT00862459|7308653|FG002|Overall Study|Administrative problems|0
4502460|NCT00862641|7308696|FG000|Overall Study|Randomized, but drug not received|1
4502461|NCT00862641|7308697|FG001|Overall Study|Randomized, but drug not received|4
4502462|NCT00862641|7308698|FG002|Overall Study|Randomized, but drug not received|1
4502463|NCT00862641|7308699|FG003|Overall Study|Randomized, but drug not received|4
4502464|NCT00862654|7308713|FG000|Overall Study|Lack of Efficacy|1
4502465|NCT00862654|7308714|FG001|Overall Study|Lack of Efficacy|0
4502466|NCT00862654|7308715|FG002|Overall Study|Lack of Efficacy|1
4502467|NCT00862654|7308716|FG003|Overall Study|Lack of Efficacy|0
4502468|NCT00862654|7308713|FG000|Overall Study|Lost to Follow-up|1
4502469|NCT00862654|7308714|FG001|Overall Study|Lost to Follow-up|2
4502470|NCT00862654|7308715|FG002|Overall Study|Lost to Follow-up|1
4502471|NCT00862654|7308716|FG003|Overall Study|Lost to Follow-up|3
4502472|NCT00862654|7308713|FG000|Overall Study|Adverse Event|0
4502473|NCT00862654|7308714|FG001|Overall Study|Adverse Event|1
4502474|NCT00862654|7308715|FG002|Overall Study|Adverse Event|1
4502475|NCT00862654|7308716|FG003|Overall Study|Adverse Event|0
4502476|NCT00862654|7308713|FG000|Overall Study|Pregnancy|1
4502477|NCT00862654|7308714|FG001|Overall Study|Pregnancy|1
4502478|NCT00862654|7308715|FG002|Overall Study|Pregnancy|0
4502479|NCT00862654|7308716|FG003|Overall Study|Pregnancy|0
4502480|NCT00862654|7308713|FG000|Overall Study|Withdrawal by Subject|2
4502481|NCT00862654|7308714|FG001|Overall Study|Withdrawal by Subject|2
4502482|NCT00862654|7308715|FG002|Overall Study|Withdrawal by Subject|2
4502483|NCT00862654|7308716|FG003|Overall Study|Withdrawal by Subject|3
4502484|NCT00862654|7308713|FG000|Overall Study|Subject mistake|0
4502485|NCT00862654|7308714|FG001|Overall Study|Subject mistake|1
4502486|NCT00862654|7308715|FG002|Overall Study|Subject mistake|0
4502487|NCT00862654|7308716|FG003|Overall Study|Subject mistake|0
4502488|NCT00862654|7308713|FG000|Overall Study|Familly constraint|0
4502489|NCT00862654|7308714|FG001|Overall Study|Familly constraint|1
4502490|NCT00862654|7308715|FG002|Overall Study|Familly constraint|0
4502491|NCT00862654|7308716|FG003|Overall Study|Familly constraint|0
4502492|NCT00862654|7308713|FG000|Overall Study|Never used study drugs|1
4502493|NCT00862654|7308714|FG001|Overall Study|Never used study drugs|0
4502494|NCT00862654|7308715|FG002|Overall Study|Never used study drugs|0
4502495|NCT00862654|7308716|FG003|Overall Study|Never used study drugs|0
4502496|NCT00862654|7308713|FG000|Overall Study|Included after end of inclusions|0
4502497|NCT00862654|7308714|FG001|Overall Study|Included after end of inclusions|0
4502498|NCT00862654|7308715|FG002|Overall Study|Included after end of inclusions|1
4502499|NCT00862654|7308716|FG003|Overall Study|Included after end of inclusions|0
4502500|NCT00862719|7308730|FG000|Overall Study|Disease Progression|5
4502501|NCT00862719|7308731|FG001|Overall Study|Disease Progression|0
4502502|NCT00862719|7308732|FG002|Overall Study|Disease Progression|1
4502503|NCT00862719|7308733|FG003|Overall Study|Disease Progression|0
4502504|NCT00862719|7308730|FG000|Overall Study|Death|5
4502505|NCT00862719|7308731|FG001|Overall Study|Death|6
4502506|NCT00862719|7308732|FG002|Overall Study|Death|1
4502507|NCT00862719|7308733|FG003|Overall Study|Death|1
4502508|NCT00862719|7308730|FG000|Overall Study|Engraftment failure|0
4502509|NCT00862719|7308731|FG001|Overall Study|Engraftment failure|0
4502510|NCT00862719|7308732|FG002|Overall Study|Engraftment failure|1
4502511|NCT00862719|7308733|FG003|Overall Study|Engraftment failure|0
4502512|NCT00862719|7308730|FG000|Overall Study|Veno-Occlusive Disease|0
4502513|NCT00862719|7308731|FG001|Overall Study|Veno-Occlusive Disease|0
4502514|NCT00862719|7308732|FG002|Overall Study|Veno-Occlusive Disease|1
4502515|NCT00862719|7308733|FG003|Overall Study|Veno-Occlusive Disease|0
4502516|NCT00862823|7308765|FG000|First Intervention|Withdrawal by Subject|1
4502517|NCT00862823|7308766|FG001|First Intervention|Withdrawal by Subject|1
4502518|NCT00862836|7308771|FG000|Overall Study|Withdrawal by Subject|1
4502519|NCT00862849|7308775|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
4502520|NCT00862849|7308776|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1
4502521|NCT00862849|7308777|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
4502522|NCT00862849|7308778|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
4502523|NCT00862849|7308779|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
4502524|NCT00862849|7308780|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
4502525|NCT00862849|7308775|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0
4502526|NCT00862849|7308776|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1
4502527|NCT00862849|7308777|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0
4502528|NCT00862849|7308778|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0
4627385|NCT01852214|7493994|FG001|Period 1|Adverse Event|2
4627386|NCT01852214|7493993|FG000|Period 1|Withdrawal by Subject|0
4627387|NCT01852214|7493994|FG001|Period 1|Withdrawal by Subject|1
4627388|NCT01852214|7493993|FG000|Washout Period|Withdrawal by Subject|0
4627389|NCT01852214|7493994|FG001|Washout Period|Withdrawal by Subject|1
4627390|NCT01852292|7494003|FG000|Overall Study|Untreated - did not receive study drug|3
4502529|NCT00862849|7308779|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0
4502530|NCT00862849|7308780|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0
4502531|NCT00862940|7308790|FG000|Overall Study|Adverse Event|15
4502532|NCT00862940|7308791|FG001|Overall Study|Adverse Event|12
4502533|NCT00862940|7308790|FG000|Overall Study|Lack of Efficacy|1
4502534|NCT00862940|7308791|FG001|Overall Study|Lack of Efficacy|3
4502535|NCT00862940|7308790|FG000|Overall Study|Protocol Violation|2
4502536|NCT00862940|7308791|FG001|Overall Study|Protocol Violation|5
4502537|NCT00862940|7308790|FG000|Overall Study|Withdrawal by Subject|4
4502538|NCT00862940|7308791|FG001|Overall Study|Withdrawal by Subject|6
4502539|NCT00862940|7308790|FG000|Overall Study|Non-compliance|4
4502540|NCT00862940|7308791|FG001|Overall Study|Non-compliance|0
4502541|NCT00862940|7308790|FG000|Overall Study|Lost to Follow-up|0
4502542|NCT00862940|7308791|FG001|Overall Study|Lost to Follow-up|1
4502543|NCT00862940|7308790|FG000|Overall Study|Administrative or other reason(s)|4
4502544|NCT00862940|7308791|FG001|Overall Study|Administrative or other reason(s)|3
4502545|NCT00862979|7308799|FG000|Overall Study|Adverse Event|6
4502546|NCT00862979|7308800|FG001|Overall Study|Adverse Event|3
4502547|NCT00862979|7308799|FG000|Overall Study|Protocol Violation|0
4502548|NCT00862979|7308800|FG001|Overall Study|Protocol Violation|1
4502549|NCT00862979|7308799|FG000|Overall Study|Patient withdrew consent|2
4502550|NCT00862979|7308800|FG001|Overall Study|Patient withdrew consent|1
4502551|NCT00862979|7308799|FG000|Overall Study|Administrative problems|0
4502552|NCT00862979|7308800|FG001|Overall Study|Administrative problems|1
4502553|NCT00862979|7308799|FG000|Overall Study|Death|0
4502554|NCT00862979|7308800|FG001|Overall Study|Death|1
4502555|NCT00862992|7308809|FG000|Overall Study|Adverse Event|2
4502556|NCT00862992|7308810|FG001|Overall Study|Adverse Event|1
4502557|NCT00862992|7308811|FG002|Overall Study|Adverse Event|1
4502558|NCT00862992|7308809|FG000|Overall Study|Physician Decision|1
4502559|NCT00862992|7308810|FG001|Overall Study|Physician Decision|0
4502560|NCT00862992|7308811|FG002|Overall Study|Physician Decision|0
4502561|NCT00862992|7308809|FG000|Overall Study|Withdrawal by Subject|0
4502562|NCT00862992|7308810|FG001|Overall Study|Withdrawal by Subject|0
4502563|NCT00862992|7308811|FG002|Overall Study|Withdrawal by Subject|2
4502564|NCT00863057|7308823|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
4502565|NCT00863057|7308824|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
4502566|NCT00863057|7308825|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0
4502567|NCT00863057|7308826|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
4627391|NCT01852292|7494004|FG001|Overall Study|Untreated - did not receive study drug|1
4627392|NCT01852292|7494003|FG000|Overall Study|Death|9
4502568|NCT00863057|7308823|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
4502569|NCT00863057|7308824|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1
4502570|NCT00863057|7308825|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
4502571|NCT00863057|7308826|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
4502572|NCT00863057|7308823|FG000|Period 2 (Weeks 6-10)|Adverse Event|0
4502573|NCT00863057|7308824|FG001|Period 2 (Weeks 6-10)|Adverse Event|1
4502574|NCT00863057|7308825|FG002|Period 2 (Weeks 6-10)|Adverse Event|1
4502575|NCT00863057|7308826|FG003|Period 2 (Weeks 6-10)|Adverse Event|0
4502576|NCT00863057|7308823|FG000|Period 2 (Weeks 6-10)|Physician Decision|0
4627393|NCT01852292|7494004|FG001|Overall Study|Death|8
4502577|NCT00863057|7308824|FG001|Period 2 (Weeks 6-10)|Physician Decision|0
4502578|NCT00863057|7308825|FG002|Period 2 (Weeks 6-10)|Physician Decision|0
4502579|NCT00863057|7308826|FG003|Period 2 (Weeks 6-10)|Physician Decision|1
4502580|NCT00863304|7308884|FG000|Overall Study|Adverse Event|10
4502581|NCT00863304|7308885|FG001|Overall Study|Adverse Event|4
4502582|NCT00863304|7308886|FG002|Overall Study|Adverse Event|14
4502583|NCT00863304|7308887|FG003|Overall Study|Adverse Event|16
4502584|NCT00863304|7308884|FG000|Overall Study|Lost to Follow-up|1
4502585|NCT00863304|7308885|FG001|Overall Study|Lost to Follow-up|5
4502586|NCT00863304|7308886|FG002|Overall Study|Lost to Follow-up|4
4502587|NCT00863304|7308887|FG003|Overall Study|Lost to Follow-up|2
4502588|NCT00863304|7308884|FG000|Overall Study|Lack of Efficacy|57
4502589|NCT00863304|7308885|FG001|Overall Study|Lack of Efficacy|26
4502590|NCT00863304|7308886|FG002|Overall Study|Lack of Efficacy|30
4502591|NCT00863304|7308887|FG003|Overall Study|Lack of Efficacy|28
4502592|NCT00863304|7308884|FG000|Overall Study|Withdrawal by Subject|19
4502593|NCT00863304|7308885|FG001|Overall Study|Withdrawal by Subject|14
4502594|NCT00863304|7308886|FG002|Overall Study|Withdrawal by Subject|20
4502595|NCT00863304|7308887|FG003|Overall Study|Withdrawal by Subject|18
4502596|NCT00863304|7308884|FG000|Overall Study|Other|1
4502597|NCT00863304|7308885|FG001|Overall Study|Other|0
4502598|NCT00863304|7308886|FG002|Overall Study|Other|0
4502599|NCT00863304|7308887|FG003|Overall Study|Other|1
4502600|NCT00863304|7308884|FG000|Overall Study|Protocol Violation|2
4502601|NCT00863304|7308885|FG001|Overall Study|Protocol Violation|6
4502602|NCT00863304|7308886|FG002|Overall Study|Protocol Violation|2
4502603|NCT00863304|7308887|FG003|Overall Study|Protocol Violation|0
4502604|NCT00863304|7308884|FG000|Overall Study|Randomized, but not Treated|3
4502605|NCT00863304|7308885|FG001|Overall Study|Randomized, but not Treated|1
4502606|NCT00863304|7308886|FG002|Overall Study|Randomized, but not Treated|4
4502607|NCT00863304|7308887|FG003|Overall Study|Randomized, but not Treated|1
4502608|NCT00863304|7308884|FG000|Overall Study|Entered extension study|101
4502609|NCT00863304|7308885|FG001|Overall Study|Entered extension study|129
4502610|NCT00863304|7308886|FG002|Overall Study|Entered extension study|113
4502611|NCT00863304|7308887|FG003|Overall Study|Entered extension study|125
4502612|NCT00863317|7308901|FG000|Overall Study|Lost to Follow-up|8
4502613|NCT00863317|7308902|FG001|Overall Study|Lost to Follow-up|9
4502614|NCT00863655|7308933|FG000|Overall Study|Protocol Violation|4
4502615|NCT00863655|7308934|FG001|Overall Study|Protocol Violation|0
4502616|NCT00863655|7308933|FG000|Overall Study|Adverse Event|52
4502617|NCT00863655|7308934|FG001|Overall Study|Adverse Event|8
4502618|NCT00863655|7308933|FG000|Overall Study|Withdrawal by Subject|47
4502619|NCT00863655|7308934|FG001|Overall Study|Withdrawal by Subject|7
4502620|NCT00863655|7308933|FG000|Overall Study|Administrative problems|1
4502621|NCT00863655|7308934|FG001|Overall Study|Administrative problems|0
4502622|NCT00863655|7308933|FG000|Overall Study|Death|7
4502623|NCT00863655|7308934|FG001|Overall Study|Death|1
4502624|NCT00863655|7308933|FG000|Overall Study|New cancer therapy|5
4502625|NCT00863655|7308934|FG001|Overall Study|New cancer therapy|1
4502626|NCT00863655|7308933|FG000|Overall Study|Disease progression|364
4502627|NCT00863655|7308934|FG001|Overall Study|Disease progression|221
4502628|NCT00863655|7308933|FG000|Overall Study|Treatment completed as per protocol|5
4502629|NCT00863655|7308934|FG001|Overall Study|Treatment completed as per protocol|1
4502630|NCT00863681|7308943|FG000|Overall Study|Other|2
4502631|NCT00863681|7308944|FG001|Overall Study|Other|0
4502632|NCT00863681|7308945|FG002|Overall Study|Other|0
4502633|NCT00863681|7308943|FG000|Overall Study|Missing|1
4502634|NCT00863681|7308944|FG001|Overall Study|Missing|0
4502635|NCT00863681|7308945|FG002|Overall Study|Missing|0
4502636|NCT00863681|7308943|FG000|Overall Study|Death|40
4502637|NCT00863681|7308944|FG001|Overall Study|Death|23
4502638|NCT00863681|7308945|FG002|Overall Study|Death|6
4502639|NCT00863681|7308943|FG000|Overall Study|Withdrawal by Subject|12
4502640|NCT00863681|7308944|FG001|Overall Study|Withdrawal by Subject|5
4502641|NCT00863681|7308945|FG002|Overall Study|Withdrawal by Subject|2
4502642|NCT00863681|7308943|FG000|Overall Study|Protocol Violation|2
4502643|NCT00863681|7308944|FG001|Overall Study|Protocol Violation|0
4502644|NCT00863681|7308945|FG002|Overall Study|Protocol Violation|0
4502645|NCT00863681|7308943|FG000|Overall Study|Lost to Follow-up|3
4502646|NCT00863681|7308944|FG001|Overall Study|Lost to Follow-up|0
4502647|NCT00863681|7308945|FG002|Overall Study|Lost to Follow-up|3
4502648|NCT00863681|7308943|FG000|Overall Study|Adverse Event|28
4502649|NCT00863681|7308944|FG001|Overall Study|Adverse Event|10
4502650|NCT00863681|7308945|FG002|Overall Study|Adverse Event|6
4502651|NCT00863681|7308943|FG000|Overall Study|Lack of Efficacy|2
4502652|NCT00863681|7308944|FG001|Overall Study|Lack of Efficacy|2
4502653|NCT00863681|7308945|FG002|Overall Study|Lack of Efficacy|1
4502654|NCT00863681|7308943|FG000|Overall Study|Non-compliance with study drug|1
4502655|NCT00863681|7308944|FG001|Overall Study|Non-compliance with study drug|3
4502656|NCT00863681|7308945|FG002|Overall Study|Non-compliance with study drug|0
4502657|NCT00863707|7308955|FG000|Overall Study|Randomized, but drug not received|4
4502658|NCT00863707|7308956|FG001|Overall Study|Randomized, but drug not received|3
4502659|NCT00863746|7308964|FG000|Treatment|Not treated|4
4502660|NCT00863746|7308965|FG001|Treatment|Not treated|2
4502661|NCT00863746|7308964|FG000|Treatment|Adverse Event|41
4502662|NCT00863746|7308965|FG001|Treatment|Adverse Event|16
4502663|NCT00863746|7308964|FG000|Treatment|non-compliant with study medication|4
4502664|NCT00863746|7308965|FG001|Treatment|non-compliant with study medication|0
4502665|NCT00863746|7308964|FG000|Treatment|Consent withdrawn|15
4502666|NCT00863746|7308965|FG001|Treatment|Consent withdrawn|14
4502667|NCT00863746|7308964|FG000|Treatment|Lost to Follow-up|1
4502668|NCT00863746|7308965|FG001|Treatment|Lost to Follow-up|0
4502669|NCT00863746|7308964|FG000|Treatment|Protocol Violation|5
4502670|NCT00863746|7308965|FG001|Treatment|Protocol Violation|3
4502671|NCT00863746|7308964|FG000|Treatment|Other|1
4502672|NCT00863746|7308965|FG001|Treatment|Other|0
4502673|NCT00863746|7308964|FG000|Survival Follow up|Death|244
4502674|NCT00863746|7308965|FG001|Survival Follow up|Death|271
4502675|NCT00863746|7308964|FG000|Survival Follow up|Lost to Follow-up|2
4502676|NCT00863746|7308965|FG001|Survival Follow up|Lost to Follow-up|1
4502677|NCT00863746|7308964|FG000|Survival Follow up|Consent Withdrawn|7
4502678|NCT00863746|7308965|FG001|Survival Follow up|Consent Withdrawn|8
4502679|NCT00863772|7308974|FG000|Overall Study|Adverse Event|1
4502680|NCT00863772|7308975|FG001|Overall Study|Adverse Event|4
4502681|NCT00863772|7308976|FG002|Overall Study|Adverse Event|0
4502682|NCT00863772|7308974|FG000|Overall Study|Lack of Efficacy|4
4502683|NCT00863772|7308975|FG001|Overall Study|Lack of Efficacy|2
4502684|NCT00863772|7308976|FG002|Overall Study|Lack of Efficacy|4
4502685|NCT00863772|7308974|FG000|Overall Study|Lost to Follow-up|5
4502686|NCT00863772|7308975|FG001|Overall Study|Lost to Follow-up|1
4502687|NCT00863772|7308976|FG002|Overall Study|Lost to Follow-up|1
4502688|NCT00863772|7308974|FG000|Overall Study|Protocol Violation|2
4502689|NCT00863772|7308975|FG001|Overall Study|Protocol Violation|0
4502690|NCT00863772|7308976|FG002|Overall Study|Protocol Violation|2
4502691|NCT00863772|7308974|FG000|Overall Study|Withdrawal by Subject|4
4502692|NCT00863772|7308975|FG001|Overall Study|Withdrawal by Subject|7
4502693|NCT00863772|7308976|FG002|Overall Study|Withdrawal by Subject|5
4502694|NCT00863772|7308974|FG000|Overall Study|Study terminated by sponsor|44
4502695|NCT00863772|7308975|FG001|Overall Study|Study terminated by sponsor|45
4502696|NCT00863772|7308976|FG002|Overall Study|Study terminated by sponsor|36
4502697|NCT00863772|7308974|FG000|Overall Study|Entered extension study|6
4502698|NCT00863772|7308975|FG001|Overall Study|Entered extension study|4
4502699|NCT00863772|7308976|FG002|Overall Study|Entered extension study|9
4502700|NCT00863772|7308974|FG000|Overall Study|Other|1
4502701|NCT00863772|7308975|FG001|Overall Study|Other|2
4502702|NCT00863772|7308976|FG002|Overall Study|Other|4
4502703|NCT00863772|7308974|FG000|Overall Study|Randomized but not Treated|1
4502704|NCT00863772|7308975|FG001|Overall Study|Randomized but not Treated|0
4502705|NCT00863772|7308976|FG002|Overall Study|Randomized but not Treated|0
4502706|NCT00863798|7308987|FG000|Overall Study|Adverse Event|5
4502707|NCT00863798|7308988|FG001|Overall Study|Adverse Event|2
4502708|NCT00863798|7308989|FG002|Overall Study|Adverse Event|4
4502709|NCT00863798|7308987|FG000|Overall Study|Participant failed to return|2
4502710|NCT00863798|7308988|FG001|Overall Study|Participant failed to return|1
4502711|NCT00863798|7308989|FG002|Overall Study|Participant failed to return|0
4502712|NCT00863798|7308987|FG000|Overall Study|Investigator request|1
4502713|NCT00863798|7308988|FG001|Overall Study|Investigator request|2
4502714|NCT00863798|7308989|FG002|Overall Study|Investigator request|1
4502715|NCT00863798|7308987|FG000|Overall Study|Lack of Efficacy|4
4502716|NCT00863798|7308988|FG001|Overall Study|Lack of Efficacy|3
4502717|NCT00863798|7308989|FG002|Overall Study|Lack of Efficacy|6
4502718|NCT00863798|7308987|FG000|Overall Study|Lost to Follow-up|6
4502719|NCT00863798|7308988|FG001|Overall Study|Lost to Follow-up|9
4502720|NCT00863798|7308989|FG002|Overall Study|Lost to Follow-up|5
4502721|NCT00863798|7308987|FG000|Overall Study|Other|2
4502722|NCT00863798|7308988|FG001|Overall Study|Other|3
4502723|NCT00863798|7308989|FG002|Overall Study|Other|1
4502724|NCT00863798|7308987|FG000|Overall Study|Protocol Violation|0
4502725|NCT00863798|7308988|FG001|Overall Study|Protocol Violation|1
4502726|NCT00863798|7308989|FG002|Overall Study|Protocol Violation|1
4502727|NCT00863798|7308987|FG000|Overall Study|Withdrawal by Subject|8
4502728|NCT00863798|7308988|FG001|Overall Study|Withdrawal by Subject|7
4502729|NCT00863798|7308989|FG002|Overall Study|Withdrawal by Subject|4
4502730|NCT00863798|7308987|FG000|Overall Study|Randomized not treated|4
4502731|NCT00863798|7308988|FG001|Overall Study|Randomized not treated|2
4502732|NCT00863798|7308989|FG002|Overall Study|Randomized not treated|3
4502733|NCT00863928|7308999|FG000|Overall Study|Protocol Violation|26
4502734|NCT00863928|7309000|FG001|Overall Study|Protocol Violation|0
4502735|NCT00863928|7308999|FG000|Overall Study|Withdrawal by Subject|3
4502736|NCT00863928|7309000|FG001|Overall Study|Withdrawal by Subject|0
4502737|NCT00863928|7308999|FG000|Overall Study|surgery cancellation|4
4502738|NCT00863928|7309000|FG001|Overall Study|surgery cancellation|0
4502739|NCT00863928|7308999|FG000|Overall Study|medication allergy|3
4502740|NCT00863928|7309000|FG001|Overall Study|medication allergy|0
4502741|NCT00864097|7309027|FG000|Overall Study|Death|0
4502742|NCT00864097|7309028|FG001|Overall Study|Death|1
4502743|NCT00864097|7309029|FG002|Overall Study|Death|0
4502744|NCT00864097|7309030|FG003|Overall Study|Death|0
4502745|NCT00864097|7309027|FG000|Overall Study|Adverse Event|6
4502746|NCT00864097|7309028|FG001|Overall Study|Adverse Event|8
4502747|NCT00864097|7309029|FG002|Overall Study|Adverse Event|11
4502748|NCT00864097|7309030|FG003|Overall Study|Adverse Event|9
4502749|NCT00864097|7309027|FG000|Overall Study|Lack of Efficacy|9
4502750|NCT00864097|7309028|FG001|Overall Study|Lack of Efficacy|3
4502751|NCT00864097|7309029|FG002|Overall Study|Lack of Efficacy|7
4502752|NCT00864097|7309030|FG003|Overall Study|Lack of Efficacy|2
4502753|NCT00864097|7309027|FG000|Overall Study|Lost to Follow-up|0
4502754|NCT00864097|7309028|FG001|Overall Study|Lost to Follow-up|1
4502755|NCT00864097|7309029|FG002|Overall Study|Lost to Follow-up|0
4502756|NCT00864097|7309030|FG003|Overall Study|Lost to Follow-up|1
4502757|NCT00864097|7309027|FG000|Overall Study|Withdrawal by Subject|15
4502758|NCT00864097|7309028|FG001|Overall Study|Withdrawal by Subject|11
4502759|NCT00864097|7309029|FG002|Overall Study|Withdrawal by Subject|11
4502760|NCT00864097|7309030|FG003|Overall Study|Withdrawal by Subject|12
4502761|NCT00864097|7309027|FG000|Overall Study|Protocol Violation|2
4502762|NCT00864097|7309028|FG001|Overall Study|Protocol Violation|1
4502763|NCT00864097|7309029|FG002|Overall Study|Protocol Violation|0
4502764|NCT00864097|7309030|FG003|Overall Study|Protocol Violation|1
4502765|NCT00864097|7309027|FG000|Overall Study|Terminated by sponsor|105
4502766|NCT00864097|7309028|FG001|Overall Study|Terminated by sponsor|112
4502767|NCT00864097|7309029|FG002|Overall Study|Terminated by sponsor|102
4502768|NCT00864097|7309030|FG003|Overall Study|Terminated by sponsor|99
4502769|NCT00864097|7309027|FG000|Overall Study|Randomized but not treated|2
4502770|NCT00864097|7309028|FG001|Overall Study|Randomized but not treated|0
4502771|NCT00864097|7309029|FG002|Overall Study|Randomized but not treated|1
4502772|NCT00864097|7309030|FG003|Overall Study|Randomized but not treated|0
4502773|NCT00864097|7309027|FG000|Overall Study|Other|0
4502774|NCT00864097|7309028|FG001|Overall Study|Other|0
4502775|NCT00864097|7309029|FG002|Overall Study|Other|0
4502776|NCT00864097|7309030|FG003|Overall Study|Other|1
4502777|NCT00864253|7309051|FG000|Overall Study|Adverse Event|56
4502778|NCT00864253|7309052|FG001|Overall Study|Adverse Event|11
4627394|NCT01852292|7494003|FG000|Overall Study|Patient/guardian decision|8
4627395|NCT01852292|7494004|FG001|Overall Study|Patient/guardian decision|4
4627396|NCT01852292|7494003|FG000|Overall Study|Adverse Event|8
4627397|NCT01852292|7494004|FG001|Overall Study|Adverse Event|11
4627398|NCT01852292|7494003|FG000|Overall Study|Physician Decision|6
4627399|NCT01852292|7494004|FG001|Overall Study|Physician Decision|2
4627400|NCT01852292|7494003|FG000|Overall Study|Protocol Violation|2
4627401|NCT01852292|7494004|FG001|Overall Study|Protocol Violation|0
4502779|NCT00864253|7309051|FG000|Overall Study|Unrelated Adverse Event|3
4502780|NCT00864253|7309052|FG001|Overall Study|Unrelated Adverse Event|1
4502781|NCT00864253|7309051|FG000|Overall Study|Physician Decision|11
4502782|NCT00864253|7309052|FG001|Overall Study|Physician Decision|15
4502783|NCT00864253|7309051|FG000|Overall Study|Protocol Violation|0
4502784|NCT00864253|7309052|FG001|Overall Study|Protocol Violation|2
4502785|NCT00864253|7309051|FG000|Overall Study|Lost to Follow-up|1
4502786|NCT00864253|7309052|FG001|Overall Study|Lost to Follow-up|1
4502787|NCT00864253|7309051|FG000|Overall Study|Withdrawal by Subject|18
4502788|NCT00864253|7309052|FG001|Overall Study|Withdrawal by Subject|18
4502789|NCT00864253|7309051|FG000|Overall Study|Death|1
4502790|NCT00864253|7309052|FG001|Overall Study|Death|0
4502791|NCT00864253|7309051|FG000|Overall Study|Ongoing|2
4502792|NCT00864253|7309052|FG001|Overall Study|Ongoing|3
4502793|NCT00864253|7309051|FG000|Overall Study|Untreated|7
4502794|NCT00864253|7309052|FG001|Overall Study|Untreated|7
4502795|NCT00864513|7309073|FG000|Overall Study|Withdrawal by Subject|3
4502796|NCT00864682|7309105|FG000|Overall Study|Protocol Violation|2
4502797|NCT00864682|7309106|FG001|Overall Study|Protocol Violation|1
4502798|NCT00864682|7309107|FG002|Overall Study|Protocol Violation|2
4502799|NCT00864721|7309121|FG000|Overall Study|Patient request|11
4502800|NCT00864721|7309121|FG000|Overall Study|Hospitalized|1
4502801|NCT00864721|7309121|FG000|Overall Study|Drug hold/delay more than 4 weeks|1
4502802|NCT00864721|7309121|FG000|Overall Study|Adverse Event|21
4502803|NCT00864851|7309128|FG000|Overall Study|Withdrawal by Subject|0
4502804|NCT00864851|7309129|FG001|Overall Study|Withdrawal by Subject|1
4502805|NCT00864851|7309130|FG002|Overall Study|Withdrawal by Subject|0
4502806|NCT00864851|7309128|FG000|Overall Study|Physician Decision|1
4502807|NCT00864851|7309129|FG001|Overall Study|Physician Decision|0
4502808|NCT00864851|7309130|FG002|Overall Study|Physician Decision|0
4502809|NCT00864851|7309128|FG000|Overall Study|Death|1
4502810|NCT00864851|7309129|FG001|Overall Study|Death|0
4502811|NCT00864851|7309130|FG002|Overall Study|Death|0
4502812|NCT00864851|7309128|FG000|Overall Study|Patient uncooperative|1
4502813|NCT00864851|7309129|FG001|Overall Study|Patient uncooperative|0
4502814|NCT00864851|7309130|FG002|Overall Study|Patient uncooperative|0
4502815|NCT00864916|7309142|FG000|Overall Study|Lost to Follow-up|4
4502816|NCT00864916|7309143|FG001|Overall Study|Lost to Follow-up|4
4502817|NCT00864916|7309142|FG000|Overall Study|Protocol Violation|1
4502818|NCT00864916|7309143|FG001|Overall Study|Protocol Violation|0
4502819|NCT00864916|7309142|FG000|Overall Study|Withdrawal by Subject|1
4502820|NCT00864916|7309143|FG001|Overall Study|Withdrawal by Subject|0
4627402|NCT01852292|7494003|FG000|Overall Study|Non-compliance with study treatment|1
4502821|NCT00865020|7309151|FG000|Overall Study|Withdrawal by Subject|22
4502822|NCT00865020|7309152|FG001|Overall Study|Withdrawal by Subject|16
4502823|NCT00865020|7309151|FG000|Overall Study|Adverse Event|9
4502824|NCT00865020|7309152|FG001|Overall Study|Adverse Event|14
4502825|NCT00865020|7309151|FG000|Overall Study|Abnormal test procedure result(s)|6
4627403|NCT01852292|7494004|FG001|Overall Study|Non-compliance with study treatment|0
4627404|NCT01852292|7494003|FG000|Overall Study|Study terminated by Sponsor|0
4627405|NCT01852292|7494004|FG001|Overall Study|Study terminated by Sponsor|1
4627406|NCT01852292|7494003|FG000|Overall Study|Progressive disease|42
4627407|NCT01852292|7494004|FG001|Overall Study|Progressive disease|52
4627408|NCT01852591|7494042|FG000|Overall Study|Withdrawal by Subject|2
4627409|NCT01852591|7494042|FG000|Overall Study|Not Evaluable at Time of Analysis|1
4627410|NCT01852825|7494062|FG000|Overall Study|Withdrawal by Subject|2
4627411|NCT01852825|7494063|FG001|Overall Study|Withdrawal by Subject|0
4627412|NCT01852825|7494064|FG002|Overall Study|Withdrawal by Subject|0
4627413|NCT01852942|7494074|FG000|Overall Study|Physician Decision|1
4627414|NCT01852942|7494075|FG001|Overall Study|Physician Decision|0
4627415|NCT01852942|7494074|FG000|Overall Study|Death|1
4627416|NCT01852942|7494075|FG001|Overall Study|Death|1
4627417|NCT01852942|7494074|FG000|Overall Study|Withdrawal by Subject|2
4627418|NCT01852942|7494075|FG001|Overall Study|Withdrawal by Subject|3
4627419|NCT01852942|7494074|FG000|Overall Study|Lost to Follow-up|1
4627420|NCT01852942|7494075|FG001|Overall Study|Lost to Follow-up|2
4627421|NCT01853046|7494093|FG000|Overall Study|Withdrawal by Subject|1
4627422|NCT01853046|7494094|FG001|Overall Study|Withdrawal by Subject|1
4627423|NCT01853046|7494093|FG000|Overall Study|Adverse Event|4
4627424|NCT01853046|7494094|FG001|Overall Study|Adverse Event|2
4627425|NCT01853046|7494093|FG000|Overall Study|Disease progression|13
4627426|NCT01853046|7494094|FG001|Overall Study|Disease progression|3
4627427|NCT01853072|7494103|FG000|Overall Study|Adverse event prior to treatment|0
4627428|NCT01853072|7494104|FG001|Overall Study|Adverse event prior to treatment|1
4627429|NCT01853072|7494103|FG000|Overall Study|Adverse Event|0
4627430|NCT01853072|7494104|FG001|Overall Study|Adverse Event|3
4627431|NCT01853072|7494103|FG000|Overall Study|Death|1
4627432|NCT01853072|7494104|FG001|Overall Study|Death|4
4627433|NCT01853072|7494103|FG000|Overall Study|Lost to Follow-up|0
4502826|NCT00865020|7309152|FG001|Overall Study|Abnormal test procedure result(s)|8
4502827|NCT00865020|7309151|FG000|Overall Study|Lost to Follow-up|6
4502828|NCT00865020|7309152|FG001|Overall Study|Lost to Follow-up|4
4502829|NCT00865020|7309151|FG000|Overall Study|Protocol deviation|4
4502830|NCT00865020|7309152|FG001|Overall Study|Protocol deviation|1
4502831|NCT00865020|7309151|FG000|Overall Study|Administrative problems|0
4502832|NCT00865020|7309152|FG001|Overall Study|Administrative problems|2
4502833|NCT00865020|7309151|FG000|Overall Study|Abnormal laboratory value(s)|0
4502834|NCT00865020|7309152|FG001|Overall Study|Abnormal laboratory value(s)|1
4502835|NCT00865020|7309151|FG000|Overall Study|Death|0
4502836|NCT00865020|7309152|FG001|Overall Study|Death|1
4502837|NCT00865020|7309151|FG000|Overall Study|Randomized but discontinued|2
4502838|NCT00865020|7309152|FG001|Overall Study|Randomized but discontinued|4
4502839|NCT00865046|7309161|FG000|Overall Study|Lost to Follow-up|1
4502840|NCT00865046|7309162|FG001|Overall Study|Lost to Follow-up|4
4502841|NCT00865046|7309163|FG002|Overall Study|Lost to Follow-up|0
4502842|NCT00865046|7309161|FG000|Overall Study|Death|0
4502843|NCT00865046|7309162|FG001|Overall Study|Death|1
4502844|NCT00865046|7309163|FG002|Overall Study|Death|1
4502845|NCT00865046|7309161|FG000|Overall Study|Withdrawal by Subject|5
4502846|NCT00865046|7309162|FG001|Overall Study|Withdrawal by Subject|0
4502847|NCT00865046|7309163|FG002|Overall Study|Withdrawal by Subject|0
4502848|NCT00865098|7309171|FG000|Overall Study|Progressive disease|1
4502849|NCT00865124|7309178|FG000|Overall Study|Physician Decision|2
4627434|NCT01853072|7494104|FG001|Overall Study|Lost to Follow-up|3
4627435|NCT01853072|7494103|FG000|Overall Study|Non-compliance with study drug|0
4627436|NCT01853072|7494104|FG001|Overall Study|Non-compliance with study drug|1
4627437|NCT01853072|7494103|FG000|Overall Study|Physician Decision|1
4627438|NCT01853072|7494104|FG001|Overall Study|Physician Decision|1
4627439|NCT01853072|7494103|FG000|Overall Study|Withdrawal by Subject|1
4627440|NCT01853072|7494104|FG001|Overall Study|Withdrawal by Subject|2
4627441|NCT01853072|7494103|FG000|Overall Study|Reason not specified|9
4627442|NCT01853072|7494104|FG001|Overall Study|Reason not specified|6
4627443|NCT01853137|7494118|FG000|Overall Study|Lost to Follow-up|4
4502850|NCT00865124|7309179|FG001|Overall Study|Physician Decision|1
4502851|NCT00865124|7309180|FG002|Overall Study|Physician Decision|0
4502852|NCT00865124|7309178|FG000|Overall Study|Withdrawn consent|2
4502853|NCT00865124|7309179|FG001|Overall Study|Withdrawn consent|0
4502854|NCT00865124|7309180|FG002|Overall Study|Withdrawn consent|0
4502855|NCT00865189|7309190|FG000|Overall Study|Other|1
4502856|NCT00865189|7309191|FG001|Overall Study|Other|2
4502857|NCT00865189|7309190|FG000|Overall Study|Death|4
4502858|NCT00865189|7309191|FG001|Overall Study|Death|11
4502859|NCT00865189|7309190|FG000|Overall Study|Lost to Follow-up|6
4502860|NCT00865189|7309191|FG001|Overall Study|Lost to Follow-up|6
4627444|NCT01853137|7494119|FG001|Overall Study|Lost to Follow-up|1
4627445|NCT01853228|7494131|FG000|Phase 1|Lack of Efficacy|8
4627446|NCT01853228|7494132|FG001|Phase 1|Lack of Efficacy|0
4627447|NCT01853228|7494131|FG000|Phase 1|Other|1
4502861|NCT00865189|7309190|FG000|Overall Study|Withdrawal by Subject|1
4502862|NCT00865189|7309191|FG001|Overall Study|Withdrawal by Subject|0
4627448|NCT01853228|7494132|FG001|Phase 1|Other|0
4627449|NCT01853228|7494131|FG000|Phase 2|Physician Decision|0
4502863|NCT00865280|7309209|FG000|Overall Study|Withdrawal by Subject|4
4502864|NCT00865280|7309210|FG001|Overall Study|Withdrawal by Subject|1
4502865|NCT00865280|7309209|FG000|Overall Study|End of Treatment/Lost to Follow-up|0
4502866|NCT00865280|7309210|FG001|Overall Study|End of Treatment/Lost to Follow-up|1
4502867|NCT00865280|7309209|FG000|Overall Study|Adverse Event/Lost to Follow-up|1
4502868|NCT00865280|7309210|FG001|Overall Study|Adverse Event/Lost to Follow-up|0
4502869|NCT00865280|7309209|FG000|Overall Study|Exclusion Condition|1
4502870|NCT00865280|7309210|FG001|Overall Study|Exclusion Condition|0
4502871|NCT00865280|7309209|FG000|Overall Study|Adverse Event|0
4502872|NCT00865280|7309210|FG001|Overall Study|Adverse Event|1
4502873|NCT00865306|7309218|FG000|Controlled Trial|Lost to Follow-up|1
4502874|NCT00865306|7309219|FG001|Controlled Trial|Lost to Follow-up|1
4502875|NCT00865306|7309218|FG000|Controlled Trial|Difficulty commuting|2
4502876|NCT00865306|7309219|FG001|Controlled Trial|Difficulty commuting|0
4502877|NCT00865306|7309218|FG000|Controlled Trial|Improved btw baseline and first session|1
4502878|NCT00865306|7309219|FG001|Controlled Trial|Improved btw baseline and first session|0
4502879|NCT00865306|7309218|FG000|Controlled Trial|Sought treatment for conduct disorder|1
4502880|NCT00865306|7309219|FG001|Controlled Trial|Sought treatment for conduct disorder|0
4502881|NCT00865306|7309218|FG000|Controlled Trial|Withdrawal by Subject|0
4502882|NCT00865306|7309219|FG001|Controlled Trial|Withdrawal by Subject|1
4502883|NCT00865345|7309225|FG000|Overall Study|Withdrawal by Subject|2
4502884|NCT00865566|7309231|FG000|Overall Study|Death|1
4502885|NCT00865566|7309232|FG001|Overall Study|Death|11
4502886|NCT00865566|7309231|FG000|Overall Study|Lost to Follow-up|314
4502887|NCT00865566|7309232|FG001|Overall Study|Lost to Follow-up|315
4502888|NCT00865566|7309231|FG000|Overall Study|Withdrawal by Subject|45
4502889|NCT00865566|7309232|FG001|Overall Study|Withdrawal by Subject|65
4502890|NCT00865566|7309231|FG000|Overall Study|Physician Decision|0
4502891|NCT00865566|7309232|FG001|Overall Study|Physician Decision|1
4502892|NCT00865566|7309231|FG000|Overall Study|Participant relocated|78
4502893|NCT00865566|7309232|FG001|Overall Study|Participant relocated|107
4502894|NCT00865566|7309231|FG000|Overall Study|Participant unable to adhere|27
4502895|NCT00865566|7309232|FG001|Overall Study|Participant unable to adhere|42
4502896|NCT00865566|7309231|FG000|Overall Study|Other; N=245 due to early study closure|154
4502897|NCT00865566|7309232|FG001|Overall Study|Other; N=245 due to early study closure|139
4502898|NCT00865566|7309231|FG000|Overall Study|HIV infection|5
4502899|NCT00865566|7309232|FG001|Overall Study|HIV infection|7
4502900|NCT00865709|7309240|FG000|Treatment|Adverse Event|9
4502901|NCT00865709|7309241|FG001|Treatment|Adverse Event|6
4502902|NCT00865709|7309240|FG000|Treatment|Withdrawal by Subject|10
4502903|NCT00865709|7309241|FG001|Treatment|Withdrawal by Subject|7
4502904|NCT00865709|7309240|FG000|Treatment|Physician Decision|3
4502905|NCT00865709|7309241|FG001|Treatment|Physician Decision|2
4502906|NCT00865709|7309240|FG000|Treatment|Surgery|8
4502907|NCT00865709|7309241|FG001|Treatment|Surgery|3
4502908|NCT00865904|7309254|FG000|Overall Study|Randomized but not Treated|2
4502909|NCT00865904|7309255|FG001|Overall Study|Randomized but not Treated|0
4502910|NCT00865904|7309256|FG002|Overall Study|Randomized but not Treated|0
4502911|NCT00865904|7309257|FG003|Overall Study|Randomized but not Treated|1
4502912|NCT00865904|7309258|FG004|Overall Study|Randomized but not Treated|1
4502913|NCT00866047|7309287|FG000|Treatment Period|Progressive disease|13
4502914|NCT00866047|7309287|FG000|Treatment Period|Adverse Event|16
4502915|NCT00866047|7309287|FG000|Treatment Period|Physician Decision|14
4502916|NCT00866047|7309287|FG000|Treatment Period|Withdrawal by Subject|5
4502917|NCT00866047|7309287|FG000|Follow-up Period|Lost to Follow-up|5
4502918|NCT00866177|7309291|FG000|Overall Study|Withdrawal by Subject|1
4502919|NCT00866177|7309291|FG000|Overall Study|Not Treated|151
4502920|NCT00866281|7309297|FG000|Overall Study|Adverse Event|1
4502921|NCT00866281|7309298|FG001|Overall Study|Adverse Event|0
4502922|NCT00866281|7309297|FG000|Overall Study|Withdrawal by participants|3
4502923|NCT00866281|7309298|FG001|Overall Study|Withdrawal by participants|0
4502924|NCT00866281|7309297|FG000|Overall Study|Disease progression|3
4502925|NCT00866281|7309298|FG001|Overall Study|Disease progression|11
4502926|NCT00866281|7309297|FG000|Overall Study|New cancer therapy|0
4502927|NCT00866281|7309298|FG001|Overall Study|New cancer therapy|4
4502928|NCT00866294|7309310|FG000|Overall Study|Adverse Event|12
4502929|NCT00866294|7309311|FG001|Overall Study|Adverse Event|13
4502930|NCT00866294|7309312|FG002|Overall Study|Adverse Event|9
4502931|NCT00866294|7309310|FG000|Overall Study|Lack of Efficacy|7
4502932|NCT00866294|7309311|FG001|Overall Study|Lack of Efficacy|1
4502933|NCT00866294|7309312|FG002|Overall Study|Lack of Efficacy|0
4502934|NCT00866294|7309310|FG000|Overall Study|Protocol Violation|2
4502935|NCT00866294|7309311|FG001|Overall Study|Protocol Violation|0
4502936|NCT00866294|7309312|FG002|Overall Study|Protocol Violation|0
4502937|NCT00866294|7309310|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5
4502938|NCT00866294|7309311|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1
4502939|NCT00866294|7309312|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1
4502940|NCT00866294|7309310|FG000|Overall Study|Lost to Follow-up|1
4502941|NCT00866294|7309311|FG001|Overall Study|Lost to Follow-up|3
4502942|NCT00866294|7309312|FG002|Overall Study|Lost to Follow-up|0
4502943|NCT00866294|7309310|FG000|Overall Study|Physician Decision|6
4502944|NCT00866294|7309311|FG001|Overall Study|Physician Decision|2
4502945|NCT00866294|7309312|FG002|Overall Study|Physician Decision|1
4502946|NCT00866307|7309328|FG000|Induction|Adverse Event|5
4502947|NCT00866307|7309329|FG001|Induction|Adverse Event|0
4502948|NCT00866307|7309330|FG002|Induction|Adverse Event|0
4502949|NCT00866307|7309328|FG000|Induction|Death|2
4502950|NCT00866307|7309329|FG001|Induction|Death|0
4502951|NCT00866307|7309330|FG002|Induction|Death|0
4502952|NCT00866307|7309328|FG000|Induction|Physician Decision|5
4502953|NCT00866307|7309329|FG001|Induction|Physician Decision|0
4502954|NCT00866307|7309330|FG002|Induction|Physician Decision|0
4502955|NCT00866307|7309328|FG000|Induction|Progressive Disease|1
4502956|NCT00866307|7309329|FG001|Induction|Progressive Disease|0
4502957|NCT00866307|7309330|FG002|Induction|Progressive Disease|0
4502958|NCT00866307|7309328|FG000|Induction|Identification of Patients with Day 29 M|3
4502959|NCT00866307|7309329|FG001|Induction|Identification of Patients with Day 29 M|0
4502960|NCT00866307|7309330|FG002|Induction|Identification of Patients with Day 29 M|0
4502961|NCT00866307|7309328|FG000|Induction|Inadequate cytognetic samples th|1
4502962|NCT00866307|7309329|FG001|Induction|Inadequate cytognetic samples th|0
4502963|NCT00866307|7309330|FG002|Induction|Inadequate cytognetic samples th|0
4502964|NCT00866307|7309328|FG000|Induction|Improper post-induction consent|2
4502965|NCT00866307|7309329|FG001|Induction|Improper post-induction consent|0
4502966|NCT00866307|7309330|FG002|Induction|Improper post-induction consent|0
4502967|NCT00866307|7309328|FG000|Induction|Study was closed at the time|1
4502968|NCT00866307|7309329|FG001|Induction|Study was closed at the time|0
4502969|NCT00866307|7309330|FG002|Induction|Study was closed at the time|0
4502970|NCT00866307|7309328|FG000|Consolidation/Maintenance|Adverse Event|0
4502971|NCT00866307|7309329|FG001|Consolidation/Maintenance|Adverse Event|0
4502972|NCT00866307|7309330|FG002|Consolidation/Maintenance|Adverse Event|8
4502973|NCT00866307|7309328|FG000|Consolidation/Maintenance|Death|0
4502974|NCT00866307|7309329|FG001|Consolidation/Maintenance|Death|0
4502975|NCT00866307|7309330|FG002|Consolidation/Maintenance|Death|1
4502976|NCT00866307|7309328|FG000|Consolidation/Maintenance|Physician Decision|0
4502977|NCT00866307|7309329|FG001|Consolidation/Maintenance|Physician Decision|3
4502978|NCT00866307|7309330|FG002|Consolidation/Maintenance|Physician Decision|2
4502979|NCT00866307|7309328|FG000|Consolidation/Maintenance|Withdrawal by Subject|0
4502980|NCT00866307|7309329|FG001|Consolidation/Maintenance|Withdrawal by Subject|1
4502981|NCT00866307|7309330|FG002|Consolidation/Maintenance|Withdrawal by Subject|1
4502982|NCT00866307|7309328|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0
4502983|NCT00866307|7309329|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0
4502984|NCT00866307|7309330|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2
4502985|NCT00866307|7309328|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0
4502986|NCT00866307|7309329|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3
4502987|NCT00866307|7309330|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1
4502988|NCT00866307|7309328|FG000|Consolidation/Maintenance|Therapy error|0
4502989|NCT00866307|7309329|FG001|Consolidation/Maintenance|Therapy error|1
4502990|NCT00866307|7309330|FG002|Consolidation/Maintenance|Therapy error|0
4502991|NCT00866307|7309328|FG000|Consolidation/Maintenance|Non-compliance|0
4502992|NCT00866307|7309329|FG001|Consolidation/Maintenance|Non-compliance|0
4502993|NCT00866307|7309330|FG002|Consolidation/Maintenance|Non-compliance|1
4502994|NCT00866307|7309328|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0
4502995|NCT00866307|7309329|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1
4502996|NCT00866307|7309330|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0
4502997|NCT00866320|7309336|FG000|Overall Study|Withdrawal by Subject|4
4502998|NCT00866320|7309336|FG000|Overall Study|Death|2
4502999|NCT00866333|7309345|FG000|Overall Study|Withdrawal of consent|0
4503000|NCT00866333|7309346|FG001|Overall Study|Withdrawal of consent|1
4503001|NCT00866333|7309347|FG002|Overall Study|Withdrawal of consent|2
4503002|NCT00866333|7309345|FG000|Overall Study|Reason not Specified|3
4503003|NCT00866333|7309346|FG001|Overall Study|Reason not Specified|1
4503004|NCT00866333|7309347|FG002|Overall Study|Reason not Specified|1
4503005|NCT00866333|7309345|FG000|Overall Study|Study Terminated by Sponsor|2
4503006|NCT00866333|7309346|FG001|Overall Study|Study Terminated by Sponsor|5
4503007|NCT00866333|7309347|FG002|Overall Study|Study Terminated by Sponsor|9
4503008|NCT00866359|7309357|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5
4503009|NCT00866359|7309358|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4
4503010|NCT00866359|7309359|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0
4503011|NCT00866359|7309360|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0
4503012|NCT00866359|7309357|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3
4503013|NCT00866359|7309358|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
4503014|NCT00866359|7309359|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
4503015|NCT00866359|7309360|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
4503016|NCT00866359|7309357|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1
4503017|NCT00866359|7309358|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
4503018|NCT00866359|7309359|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
4503019|NCT00866359|7309360|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
4503020|NCT00866359|7309357|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1
4503021|NCT00866359|7309358|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1
4503022|NCT00866359|7309359|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0
4503023|NCT00866359|7309360|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0
4503024|NCT00866359|7309357|FG000|Treatment Phase (Days 1 to 85)|Other|1
4503025|NCT00866359|7309358|FG001|Treatment Phase (Days 1 to 85)|Other|0
4503026|NCT00866359|7309359|FG002|Treatment Phase (Days 1 to 85)|Other|0
4503027|NCT00866359|7309360|FG003|Treatment Phase (Days 1 to 85)|Other|0
4503028|NCT00866359|7309357|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0
4503029|NCT00866359|7309358|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0
4503030|NCT00866359|7309359|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1
4503031|NCT00866359|7309360|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3
4503032|NCT00866606|7309387|FG000|Overall Study|Lost to Follow-up|3
4503033|NCT00866606|7309387|FG000|Overall Study|Adverse Event|1
4503034|NCT00866619|7309395|FG000|Overall Study|Adverse Event|112
4503035|NCT00866619|7309396|FG001|Overall Study|Adverse Event|106
4503036|NCT00866619|7309397|FG002|Overall Study|Adverse Event|47
4503037|NCT00866619|7309398|FG003|Overall Study|Adverse Event|44
4503038|NCT00866619|7309395|FG000|Overall Study|Protocol Violation|2
4503039|NCT00866619|7309396|FG001|Overall Study|Protocol Violation|39
4503040|NCT00866619|7309397|FG002|Overall Study|Protocol Violation|2
4503041|NCT00866619|7309398|FG003|Overall Study|Protocol Violation|17
4503042|NCT00866619|7309395|FG000|Overall Study|Withdrawal by Subject|587
4503043|NCT00866619|7309396|FG001|Overall Study|Withdrawal by Subject|295
4503044|NCT00866619|7309397|FG002|Overall Study|Withdrawal by Subject|272
4503045|NCT00866619|7309398|FG003|Overall Study|Withdrawal by Subject|144
4503046|NCT00866619|7309395|FG000|Overall Study|Lost to Follow-up|1145
4503047|NCT00866619|7309396|FG001|Overall Study|Lost to Follow-up|830
4503048|NCT00866619|7309397|FG002|Overall Study|Lost to Follow-up|568
4503049|NCT00866619|7309398|FG003|Overall Study|Lost to Follow-up|425
4503050|NCT00866658|7309435|FG000|Overall Study|Adverse Event|5
4503051|NCT00866658|7309436|FG001|Overall Study|Adverse Event|14
4503052|NCT00866658|7309435|FG000|Overall Study|Lack of Efficacy|2
4503053|NCT00866658|7309436|FG001|Overall Study|Lack of Efficacy|1
4503054|NCT00866658|7309435|FG000|Overall Study|Withdrawal by Subject|1
4503055|NCT00866658|7309436|FG001|Overall Study|Withdrawal by Subject|0
4503056|NCT00866658|7309435|FG000|Overall Study|Protocol Violation|1
4503057|NCT00866658|7309436|FG001|Overall Study|Protocol Violation|1
4503058|NCT00866658|7309435|FG000|Overall Study|Familial and Personal Reasons|4
4503059|NCT00866658|7309436|FG001|Overall Study|Familial and Personal Reasons|5
4503060|NCT00866697|7309444|FG000|Overall Study|Study closed/terminated|156
4503061|NCT00866697|7309445|FG001|Overall Study|Study closed/terminated|138
4503062|NCT00866697|7309444|FG000|Overall Study|Lost to Follow-up|22
4503063|NCT00866697|7309445|FG001|Overall Study|Lost to Follow-up|28
4503064|NCT00866697|7309444|FG000|Overall Study|Physician Decision|3
4503065|NCT00866697|7309445|FG001|Overall Study|Physician Decision|5
4503066|NCT00866697|7309444|FG000|Overall Study|Withdrawal by Subject|33
4503067|NCT00866697|7309445|FG001|Overall Study|Withdrawal by Subject|57
4503068|NCT00866723|7309451|FG000|Overall Study|Withdrawal by Subject|1
4503069|NCT00866723|7309451|FG000|Overall Study|Disease Progression|4
4503070|NCT00866775|7309461|FG000|Overall Study|Adverse Event|5
4503071|NCT00866775|7309462|FG001|Overall Study|Adverse Event|19
4503072|NCT00866775|7309461|FG000|Overall Study|Death|1
4503073|NCT00866775|7309462|FG001|Overall Study|Death|0
4503074|NCT00866775|7309461|FG000|Overall Study|Lost to Follow-up|0
4503075|NCT00866775|7309462|FG001|Overall Study|Lost to Follow-up|4
4503076|NCT00866775|7309461|FG000|Overall Study|Physician Decision|0
4503077|NCT00866775|7309462|FG001|Overall Study|Physician Decision|3
4503078|NCT00866775|7309461|FG000|Overall Study|Protocol Violation|3
4503079|NCT00866775|7309462|FG001|Overall Study|Protocol Violation|4
4503080|NCT00866775|7309461|FG000|Overall Study|Withdrawal by Subject|4
4503081|NCT00866775|7309462|FG001|Overall Study|Withdrawal by Subject|4
4503082|NCT00866775|7309461|FG000|Overall Study|met exit criteria|23
4503083|NCT00866775|7309462|FG001|Overall Study|met exit criteria|17
4503084|NCT00866775|7309461|FG000|Overall Study|discontinued due to communication error|0
4503085|NCT00866775|7309462|FG001|Overall Study|discontinued due to communication error|1
4503086|NCT00866788|7309474|FG000|Overall Study|Adverse Event|0
4503087|NCT00866788|7309475|FG001|Overall Study|Adverse Event|2
4503088|NCT00866788|7309476|FG002|Overall Study|Adverse Event|0
4503089|NCT00866788|7309477|FG003|Overall Study|Adverse Event|1
4503090|NCT00866788|7309474|FG000|Overall Study|Lost to Follow-up|1
4503091|NCT00866788|7309475|FG001|Overall Study|Lost to Follow-up|1
4503092|NCT00866788|7309476|FG002|Overall Study|Lost to Follow-up|0
4503093|NCT00866788|7309477|FG003|Overall Study|Lost to Follow-up|2
4503094|NCT00866788|7309474|FG000|Overall Study|Withdrawal by Subject|2
4503095|NCT00866788|7309475|FG001|Overall Study|Withdrawal by Subject|1
4503096|NCT00866788|7309476|FG002|Overall Study|Withdrawal by Subject|0
4503097|NCT00866788|7309477|FG003|Overall Study|Withdrawal by Subject|1
4503098|NCT00866788|7309474|FG000|Overall Study|Pregnancy|0
4503099|NCT00866788|7309475|FG001|Overall Study|Pregnancy|1
4503100|NCT00866788|7309476|FG002|Overall Study|Pregnancy|0
4503101|NCT00866788|7309477|FG003|Overall Study|Pregnancy|0
4503102|NCT00866788|7309474|FG000|Overall Study|Disease progression|3
4503103|NCT00866788|7309475|FG001|Overall Study|Disease progression|1
4503104|NCT00866788|7309476|FG002|Overall Study|Disease progression|1
4503105|NCT00866788|7309477|FG003|Overall Study|Disease progression|0
4503106|NCT00866788|7309474|FG000|Overall Study|Physician Decision|0
4503107|NCT00866788|7309475|FG001|Overall Study|Physician Decision|0
4503108|NCT00866788|7309476|FG002|Overall Study|Physician Decision|1
4503109|NCT00866788|7309477|FG003|Overall Study|Physician Decision|1
4503110|NCT00866814|7309490|FG000|Overall Study|Lost to Follow-up|12
4503111|NCT00866814|7309490|FG000|Overall Study|Adverse Event|2
4503112|NCT00866814|7309490|FG000|Overall Study|Physician Decision|1
4503113|NCT00866814|7309490|FG000|Overall Study|Death|1
4503114|NCT00866814|7309490|FG000|Overall Study|No longer wished to participate|1
4503115|NCT00866814|7309490|FG000|Overall Study|Unable to meet follow-up requirements|2
4503116|NCT00866814|7309490|FG000|Overall Study|Moved to area without study site|1
4503117|NCT00867009|7309509|FG000|Induction Period|Nonserious Adverse Event|5
4503118|NCT00867009|7309509|FG000|Induction Period|Serious Adverse Event|10
4503119|NCT00867009|7309509|FG000|Induction Period|Death due to serious adverse event|6
4503120|NCT00867009|7309509|FG000|Induction Period|Death due to Study Disease|4
4503121|NCT00867009|7309509|FG000|Induction Period|Protocol Violation|1
4503122|NCT00867009|7309509|FG000|Induction Period|Withdrawal by Subject|8
4503123|NCT00867009|7309509|FG000|Induction Period|Physician Decision|3
4503124|NCT00867009|7309509|FG000|Induction Period|Progressive Disease (PD)|25
4503125|NCT00867009|7309509|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4
4503126|NCT00867035|7309515|FG000|Baseline to 1 Hour|Withdrawal by Subject|1
4503127|NCT00867035|7309516|FG001|Baseline to 1 Hour|Withdrawal by Subject|1
4503128|NCT00867035|7309515|FG000|Baseline to 1 Week|Withdrawal by Subject|1
4503129|NCT00867035|7309516|FG001|Baseline to 1 Week|Withdrawal by Subject|0
4503130|NCT00867087|7309522|FG000|Overall Study|Other|1
4503131|NCT00867087|7309522|FG000|Overall Study|Withdrawal by Subject|4
4503132|NCT00867087|7309522|FG000|Overall Study|Death|37
4503133|NCT00867113|7309583|FG000|Treatment Period|Adverse Event|15
4503134|NCT00867113|7309583|FG000|Treatment Period|Death|2
4503135|NCT00867113|7309583|FG000|Treatment Period|Withdrawal by Subject|19
4503136|NCT00867113|7309583|FG000|Treatment Period|Lost to Follow-up|3
4503137|NCT00867113|7309583|FG000|Treatment Period|Administrative problems|1
4503138|NCT00867113|7309583|FG000|Treatment Period|Disease progression/relapse|1
4503139|NCT00867113|7309583|FG000|Treatment Period|Protocol Violation|4
4503140|NCT00867113|7309583|FG000|Post Treatment After Survival Follow-up|Death|1
4503141|NCT00867113|7309583|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1
4503142|NCT00867113|7309583|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5
4503143|NCT00867113|7309583|FG000|Post Treatment After Survival Follow-up|Administrative problems|4
4503144|NCT00867308|7309619|FG000|Overall Study|Death|1
4503145|NCT00867308|7309620|FG001|Overall Study|Death|0
4503146|NCT00867308|7309619|FG000|Overall Study|Adverse Event|1
4503147|NCT00867308|7309620|FG001|Overall Study|Adverse Event|4
4503148|NCT00867308|7309619|FG000|Overall Study|Lack of Efficacy|6
4503149|NCT00867308|7309620|FG001|Overall Study|Lack of Efficacy|12
4503150|NCT00867308|7309619|FG000|Overall Study|Withdrawal by Subject|1
4503151|NCT00867308|7309620|FG001|Overall Study|Withdrawal by Subject|2
4627450|NCT01853228|7494132|FG001|Phase 2|Physician Decision|1
4627451|NCT01853228|7494131|FG000|Phase 2|Proceed To Transplant|0
4627452|NCT01853228|7494132|FG001|Phase 2|Proceed To Transplant|3
4627453|NCT01853228|7494131|FG000|Phase 2|Lack of Efficacy|0
4503152|NCT00867334|7309628|FG000|Overall Study|Withdrawal by Subject|0
4503153|NCT00867334|7309629|FG001|Overall Study|Withdrawal by Subject|1
4503154|NCT00867334|7309628|FG000|Overall Study|Withdrawal by Subject|1
4503155|NCT00867334|7309629|FG001|Overall Study|Withdrawal by Subject|0
4503156|NCT00867334|7309628|FG000|Overall Study|Withdrawal by Subject|1
4503157|NCT00867334|7309629|FG001|Overall Study|Withdrawal by Subject|0
4503158|NCT00867360|7309637|FG000|Overall Study|Withdrawal by Subject|1
4503159|NCT00867360|7309638|FG001|Overall Study|Withdrawal by Subject|0
4503160|NCT00867360|7309637|FG000|Overall Study|Physician Decision|0
4503161|NCT00867360|7309638|FG001|Overall Study|Physician Decision|1
4517994|NCT00970632|7329995|FG001|Overall Study|Adverse Event|2
4517995|NCT00970632|7329996|FG002|Overall Study|Adverse Event|1
4517996|NCT00970632|7329994|FG000|Overall Study|Lack of Efficacy|3
4517997|NCT00970632|7329995|FG001|Overall Study|Lack of Efficacy|0
4517998|NCT00970632|7329996|FG002|Overall Study|Lack of Efficacy|0
4517999|NCT00970632|7329994|FG000|Overall Study|Lost to Follow-up|3
4518000|NCT00970632|7329995|FG001|Overall Study|Lost to Follow-up|0
4518001|NCT00970632|7329996|FG002|Overall Study|Lost to Follow-up|2
4518002|NCT00970632|7329994|FG000|Overall Study|Protocol Violation|8
4518003|NCT00970632|7329995|FG001|Overall Study|Protocol Violation|5
4518004|NCT00970632|7329996|FG002|Overall Study|Protocol Violation|8
4518005|NCT00970632|7329994|FG000|Overall Study|Withdrawal by Subject|7
4518006|NCT00970632|7329995|FG001|Overall Study|Withdrawal by Subject|6
4518007|NCT00970632|7329996|FG002|Overall Study|Withdrawal by Subject|4
4518008|NCT00970632|7329994|FG000|Overall Study|Entry criteria not met|0
4518009|NCT00970632|7329995|FG001|Overall Study|Entry criteria not met|2
4518010|NCT00970632|7329996|FG002|Overall Study|Entry criteria not met|2
4518011|NCT00970632|7329994|FG000|Overall Study|Sponsor decision|1
4518012|NCT00970632|7329995|FG001|Overall Study|Sponsor decision|0
4518013|NCT00970632|7329996|FG002|Overall Study|Sponsor decision|1
4518014|NCT00970684|7330004|FG000|Overall Study|Lack of Efficacy|5
4518015|NCT00970684|7330004|FG000|Overall Study|Adverse Event|4
4518016|NCT00970684|7330004|FG000|Overall Study|Withdrawal by Subject|1
4518017|NCT00970944|7330028|FG000|Overall Study|Death|1
4518018|NCT00970944|7330029|FG001|Overall Study|Death|0
4518019|NCT00970944|7330028|FG000|Overall Study|Physician Decision|0
4518020|NCT00970944|7330029|FG001|Overall Study|Physician Decision|2
4627454|NCT01853228|7494132|FG001|Phase 2|Lack of Efficacy|4
4627455|NCT01853254|7494137|FG000|Overall Study|Abnormal Laboratory Test|1
4503162|NCT00867490|7309658|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5
4503163|NCT00867490|7309658|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4
4503164|NCT00867490|7309658|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1
4503165|NCT00867490|7309658|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2
4503166|NCT00867490|7309658|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1
4503167|NCT00867503|7309665|FG000|Overall Study|Withdrawal by Subject|1
4503168|NCT00867815|7309689|FG000|Overall Study|Lost to Follow-up|1
4503169|NCT00868166|7309721|FG000|Overall Study|Death|58
4503170|NCT00868166|7309722|FG001|Overall Study|Death|65
4503171|NCT00868166|7309721|FG000|Overall Study|Withdrawal by Subject|33
4503172|NCT00868166|7309722|FG001|Overall Study|Withdrawal by Subject|25
4503173|NCT00868166|7309721|FG000|Overall Study|Protocol Violation|1
4503174|NCT00868166|7309722|FG001|Overall Study|Protocol Violation|0
4503175|NCT00868166|7309721|FG000|Overall Study|Lost to Follow-up|1
4503176|NCT00868166|7309722|FG001|Overall Study|Lost to Follow-up|3
4503177|NCT00868166|7309721|FG000|Overall Study|Adverse Event|9
4503178|NCT00868166|7309722|FG001|Overall Study|Adverse Event|10
4503179|NCT00868166|7309721|FG000|Overall Study|Lack of efficacy, logistics, unwell|9
4503180|NCT00868166|7309722|FG001|Overall Study|Lack of efficacy, logistics, unwell|10
4503181|NCT00868166|7309721|FG000|Overall Study|Non-compliance with IMP|1
4503182|NCT00868166|7309722|FG001|Overall Study|Non-compliance with IMP|1
4503183|NCT00868192|7309728|FG000|Overall Study|Ineligible|4
4503184|NCT00868231|7309753|FG000|Treatment Period 1|Adverse Event|0
4503185|NCT00868231|7309754|FG001|Treatment Period 1|Adverse Event|0
4503186|NCT00868231|7309755|FG002|Treatment Period 1|Adverse Event|0
4503187|NCT00868231|7309756|FG003|Treatment Period 1|Adverse Event|0
4503188|NCT00868231|7309757|FG004|Treatment Period 1|Adverse Event|1
4503189|NCT00868231|7309758|FG005|Treatment Period 1|Adverse Event|0
4503190|NCT00868231|7309753|FG000|Treatment Period 2|Adverse Event|1
4503191|NCT00868231|7309754|FG001|Treatment Period 2|Adverse Event|0
4503192|NCT00868231|7309755|FG002|Treatment Period 2|Adverse Event|0
4503193|NCT00868231|7309756|FG003|Treatment Period 2|Adverse Event|0
4503194|NCT00868231|7309757|FG004|Treatment Period 2|Adverse Event|0
4503195|NCT00868231|7309758|FG005|Treatment Period 2|Adverse Event|0
4503196|NCT00868231|7309753|FG000|Treatment Period 3|Adverse Event|0
4503197|NCT00868231|7309754|FG001|Treatment Period 3|Adverse Event|0
4503198|NCT00868231|7309755|FG002|Treatment Period 3|Adverse Event|1
4503199|NCT00868231|7309756|FG003|Treatment Period 3|Adverse Event|0
4503200|NCT00868231|7309757|FG004|Treatment Period 3|Adverse Event|0
4503201|NCT00868231|7309758|FG005|Treatment Period 3|Adverse Event|0
4503202|NCT00868296|7309768|FG000|Overall Study|Adverse Event|0
4503203|NCT00868296|7309769|FG001|Overall Study|Adverse Event|2
4503204|NCT00868296|7309768|FG000|Overall Study|Withdrawal by Subject|0
4503205|NCT00868296|7309769|FG001|Overall Study|Withdrawal by Subject|1
4503206|NCT00868439|7309804|FG000|Overall Study|Adverse Event|4
4503207|NCT00868439|7309805|FG001|Overall Study|Adverse Event|3
4503208|NCT00868439|7309804|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2
4503209|NCT00868439|7309805|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3
4503210|NCT00868439|7309804|FG000|Overall Study|Death|0
4503211|NCT00868439|7309805|FG001|Overall Study|Death|1
4503212|NCT00868439|7309804|FG000|Overall Study|Protocol Violation|1
4627456|NCT01853254|7494137|FG000|Overall Study|Adverse Event/Intercurrent Illness|3
4503213|NCT00868439|7309805|FG001|Overall Study|Protocol Violation|1
4503214|NCT00868439|7309804|FG000|Overall Study|Physician Decision|1
4503215|NCT00868439|7309805|FG001|Overall Study|Physician Decision|0
4503216|NCT00868439|7309804|FG000|Overall Study|Withdrawal by Subject|0
4503217|NCT00868439|7309805|FG001|Overall Study|Withdrawal by Subject|1
4503218|NCT00868517|7309824|FG000|Overall Study|Withdrawal by Subject|3
4503219|NCT00868517|7309825|FG001|Overall Study|Withdrawal by Subject|3
4503220|NCT00868517|7309826|FG002|Overall Study|Withdrawal by Subject|2
4503221|NCT00868517|7309824|FG000|Overall Study|Protocol Violation|1
4503222|NCT00868517|7309825|FG001|Overall Study|Protocol Violation|1
4503223|NCT00868517|7309826|FG002|Overall Study|Protocol Violation|0
4503224|NCT00868530|7309834|FG000|Overall Study|Adverse Event|3
4503225|NCT00868530|7309834|FG000|Overall Study|Lost to Follow-up|1
4503226|NCT00868608|7309841|FG000|Overall Study|Withdrawal by Subject|3
4503227|NCT00868608|7309842|FG001|Overall Study|Withdrawal by Subject|1
4503228|NCT00868608|7309843|FG002|Overall Study|Withdrawal by Subject|0
4503229|NCT00868608|7309841|FG000|Overall Study|Lost to Follow-up|3
4503230|NCT00868608|7309842|FG001|Overall Study|Lost to Follow-up|0
4503231|NCT00868608|7309843|FG002|Overall Study|Lost to Follow-up|1
4503232|NCT00868608|7309841|FG000|Overall Study|Death|16
4627457|NCT01853254|7494137|FG000|Overall Study|Death|1
4503233|NCT00868608|7309842|FG001|Overall Study|Death|2
4503234|NCT00868608|7309843|FG002|Overall Study|Death|4
4503235|NCT00868608|7309841|FG000|Overall Study|Other - Unspecified|1
4503236|NCT00868608|7309842|FG001|Overall Study|Other - Unspecified|0
4503237|NCT00868608|7309843|FG002|Overall Study|Other - Unspecified|0
4503238|NCT00868790|7309881|FG000|Period 1|Adverse Event|1
4503239|NCT00868790|7309882|FG001|Period 1|Adverse Event|0
4503240|NCT00868790|7309883|FG002|Period 1|Adverse Event|0
4503241|NCT00868790|7309884|FG003|Period 1|Adverse Event|0
4503242|NCT00868790|7309885|FG004|Period 1|Adverse Event|0
4503243|NCT00868790|7309886|FG005|Period 1|Adverse Event|0
4503244|NCT00868790|7309887|FG006|Period 1|Adverse Event|0
4503245|NCT00868790|7309888|FG007|Period 1|Adverse Event|3
4503246|NCT00868790|7309889|FG008|Period 1|Adverse Event|1
4503247|NCT00868790|7309890|FG009|Period 1|Adverse Event|0
4503248|NCT00868790|7309891|FG010|Period 1|Adverse Event|0
4503249|NCT00868790|7309892|FG011|Period 1|Adverse Event|0
4503250|NCT00868790|7309893|FG012|Period 1|Adverse Event|0
4503251|NCT00868790|7309894|FG013|Period 1|Adverse Event|1
4503252|NCT00868790|7309881|FG000|Period 1|Protocol Violation|1
4503253|NCT00868790|7309882|FG001|Period 1|Protocol Violation|0
4503254|NCT00868790|7309883|FG002|Period 1|Protocol Violation|0
4503255|NCT00868790|7309884|FG003|Period 1|Protocol Violation|0
4503256|NCT00868790|7309885|FG004|Period 1|Protocol Violation|0
4503257|NCT00868790|7309886|FG005|Period 1|Protocol Violation|0
4503258|NCT00868790|7309887|FG006|Period 1|Protocol Violation|0
4503259|NCT00868790|7309888|FG007|Period 1|Protocol Violation|0
4503260|NCT00868790|7309889|FG008|Period 1|Protocol Violation|0
4503261|NCT00868790|7309890|FG009|Period 1|Protocol Violation|0
4503262|NCT00868790|7309891|FG010|Period 1|Protocol Violation|0
4503263|NCT00868790|7309892|FG011|Period 1|Protocol Violation|0
4503264|NCT00868790|7309893|FG012|Period 1|Protocol Violation|0
4503265|NCT00868790|7309894|FG013|Period 1|Protocol Violation|0
4503266|NCT00868790|7309881|FG000|Period 1|Withdrawal by Subject|0
4503267|NCT00868790|7309882|FG001|Period 1|Withdrawal by Subject|1
4503268|NCT00868790|7309883|FG002|Period 1|Withdrawal by Subject|0
4503269|NCT00868790|7309884|FG003|Period 1|Withdrawal by Subject|0
4503270|NCT00868790|7309885|FG004|Period 1|Withdrawal by Subject|0
4503271|NCT00868790|7309886|FG005|Period 1|Withdrawal by Subject|0
4503272|NCT00868790|7309887|FG006|Period 1|Withdrawal by Subject|0
4503273|NCT00868790|7309888|FG007|Period 1|Withdrawal by Subject|0
4503274|NCT00868790|7309889|FG008|Period 1|Withdrawal by Subject|0
4503275|NCT00868790|7309890|FG009|Period 1|Withdrawal by Subject|0
4503276|NCT00868790|7309891|FG010|Period 1|Withdrawal by Subject|0
4503277|NCT00868790|7309892|FG011|Period 1|Withdrawal by Subject|0
4503278|NCT00868790|7309893|FG012|Period 1|Withdrawal by Subject|0
4503279|NCT00868790|7309894|FG013|Period 1|Withdrawal by Subject|1
4503280|NCT00868790|7309881|FG000|Period 1|Abnormal Triglycerides|0
4503281|NCT00868790|7309882|FG001|Period 1|Abnormal Triglycerides|0
4503282|NCT00868790|7309883|FG002|Period 1|Abnormal Triglycerides|0
4503283|NCT00868790|7309884|FG003|Period 1|Abnormal Triglycerides|0
4503284|NCT00868790|7309885|FG004|Period 1|Abnormal Triglycerides|1
4503285|NCT00868790|7309886|FG005|Period 1|Abnormal Triglycerides|0
4503286|NCT00868790|7309887|FG006|Period 1|Abnormal Triglycerides|0
4503287|NCT00868790|7309888|FG007|Period 1|Abnormal Triglycerides|0
4503288|NCT00868790|7309889|FG008|Period 1|Abnormal Triglycerides|0
4503289|NCT00868790|7309890|FG009|Period 1|Abnormal Triglycerides|0
4503290|NCT00868790|7309891|FG010|Period 1|Abnormal Triglycerides|0
4503291|NCT00868790|7309892|FG011|Period 1|Abnormal Triglycerides|0
4503292|NCT00868790|7309893|FG012|Period 1|Abnormal Triglycerides|0
4503293|NCT00868790|7309894|FG013|Period 1|Abnormal Triglycerides|0
4503294|NCT00868790|7309881|FG000|Period 1|Lost to Follow-up|0
4503295|NCT00868790|7309882|FG001|Period 1|Lost to Follow-up|0
4503296|NCT00868790|7309883|FG002|Period 1|Lost to Follow-up|0
4503297|NCT00868790|7309884|FG003|Period 1|Lost to Follow-up|0
4503298|NCT00868790|7309885|FG004|Period 1|Lost to Follow-up|0
4503299|NCT00868790|7309886|FG005|Period 1|Lost to Follow-up|1
4503300|NCT00868790|7309887|FG006|Period 1|Lost to Follow-up|0
4503301|NCT00868790|7309888|FG007|Period 1|Lost to Follow-up|0
4503302|NCT00868790|7309889|FG008|Period 1|Lost to Follow-up|0
4503303|NCT00868790|7309890|FG009|Period 1|Lost to Follow-up|0
4503304|NCT00868790|7309891|FG010|Period 1|Lost to Follow-up|0
4503305|NCT00868790|7309892|FG011|Period 1|Lost to Follow-up|0
4503306|NCT00868790|7309893|FG012|Period 1|Lost to Follow-up|0
4503307|NCT00868790|7309894|FG013|Period 1|Lost to Follow-up|0
4627458|NCT01853254|7494137|FG000|Overall Study|Failure to Return|43
4627459|NCT01853254|7494137|FG000|Overall Study|Insufficient Therapeutic Response|22
4627460|NCT01853254|7494137|FG000|Overall Study|Refusal of Treatment|1
4627461|NCT01853254|7494137|FG000|Overall Study|Other Protocol Violation|1
4627462|NCT01853254|7494137|FG000|Overall Study|Withdrawal of Consent|16
4627463|NCT01853254|7494137|FG000|Overall Study|Administrative/Other|16
4627464|NCT01853280|7494143|FG000|Overall Study|Lack of Efficacy|2
4627465|NCT01853280|7494144|FG001|Overall Study|Lack of Efficacy|2
4503308|NCT00868790|7309881|FG000|Period 2|Adverse Event|0
4503309|NCT00868790|7309882|FG001|Period 2|Adverse Event|0
4503310|NCT00868790|7309883|FG002|Period 2|Adverse Event|0
4503311|NCT00868790|7309884|FG003|Period 2|Adverse Event|0
4503312|NCT00868790|7309885|FG004|Period 2|Adverse Event|0
4503313|NCT00868790|7309886|FG005|Period 2|Adverse Event|0
4503314|NCT00868790|7309887|FG006|Period 2|Adverse Event|0
4503315|NCT00868790|7309888|FG007|Period 2|Adverse Event|0
4503316|NCT00868790|7309889|FG008|Period 2|Adverse Event|1
4503317|NCT00868790|7309890|FG009|Period 2|Adverse Event|0
4503318|NCT00868790|7309891|FG010|Period 2|Adverse Event|0
4503319|NCT00868790|7309892|FG011|Period 2|Adverse Event|0
4627466|NCT01853280|7494143|FG000|Overall Study|Lost to Follow-up|0
4503320|NCT00868790|7309893|FG012|Period 2|Adverse Event|0
4503321|NCT00868790|7309894|FG013|Period 2|Adverse Event|0
4503322|NCT00868790|7309881|FG000|Period 2|Lost to Follow-up|0
4503323|NCT00868790|7309882|FG001|Period 2|Lost to Follow-up|1
4503324|NCT00868790|7309883|FG002|Period 2|Lost to Follow-up|0
4503325|NCT00868790|7309884|FG003|Period 2|Lost to Follow-up|0
4503326|NCT00868790|7309885|FG004|Period 2|Lost to Follow-up|0
4503327|NCT00868790|7309886|FG005|Period 2|Lost to Follow-up|1
4503328|NCT00868790|7309887|FG006|Period 2|Lost to Follow-up|0
4503329|NCT00868790|7309888|FG007|Period 2|Lost to Follow-up|0
4503330|NCT00868790|7309889|FG008|Period 2|Lost to Follow-up|0
4503331|NCT00868790|7309890|FG009|Period 2|Lost to Follow-up|0
4503332|NCT00868790|7309891|FG010|Period 2|Lost to Follow-up|0
4503333|NCT00868790|7309892|FG011|Period 2|Lost to Follow-up|0
4503334|NCT00868790|7309893|FG012|Period 2|Lost to Follow-up|0
4503335|NCT00868790|7309894|FG013|Period 2|Lost to Follow-up|0
4503336|NCT00868790|7309881|FG000|Period 2|Withdrawal by Subject|0
4503337|NCT00868790|7309882|FG001|Period 2|Withdrawal by Subject|0
4503338|NCT00868790|7309883|FG002|Period 2|Withdrawal by Subject|0
4503339|NCT00868790|7309884|FG003|Period 2|Withdrawal by Subject|0
4503340|NCT00868790|7309885|FG004|Period 2|Withdrawal by Subject|0
4503341|NCT00868790|7309886|FG005|Period 2|Withdrawal by Subject|0
4503342|NCT00868790|7309887|FG006|Period 2|Withdrawal by Subject|0
4503343|NCT00868790|7309888|FG007|Period 2|Withdrawal by Subject|0
4503344|NCT00868790|7309889|FG008|Period 2|Withdrawal by Subject|1
4503345|NCT00868790|7309890|FG009|Period 2|Withdrawal by Subject|0
4503346|NCT00868790|7309891|FG010|Period 2|Withdrawal by Subject|0
4503347|NCT00868790|7309892|FG011|Period 2|Withdrawal by Subject|0
4503348|NCT00868790|7309893|FG012|Period 2|Withdrawal by Subject|0
4503349|NCT00868790|7309894|FG013|Period 2|Withdrawal by Subject|1
4503350|NCT00868790|7309881|FG000|Period 3|Adverse Event|0
4503351|NCT00868790|7309882|FG001|Period 3|Adverse Event|0
4503352|NCT00868790|7309883|FG002|Period 3|Adverse Event|0
4503353|NCT00868790|7309884|FG003|Period 3|Adverse Event|0
4503354|NCT00868790|7309885|FG004|Period 3|Adverse Event|0
4503355|NCT00868790|7309886|FG005|Period 3|Adverse Event|0
4503356|NCT00868790|7309887|FG006|Period 3|Adverse Event|0
4503357|NCT00868790|7309888|FG007|Period 3|Adverse Event|0
4503358|NCT00868790|7309889|FG008|Period 3|Adverse Event|0
4503359|NCT00868790|7309890|FG009|Period 3|Adverse Event|1
4503360|NCT00868790|7309891|FG010|Period 3|Adverse Event|0
4503361|NCT00868790|7309892|FG011|Period 3|Adverse Event|0
4503362|NCT00868790|7309893|FG012|Period 3|Adverse Event|0
4503363|NCT00868790|7309894|FG013|Period 3|Adverse Event|0
4503364|NCT00868790|7309881|FG000|Period 3|Protocol Violation|0
4503365|NCT00868790|7309882|FG001|Period 3|Protocol Violation|0
4503366|NCT00868790|7309883|FG002|Period 3|Protocol Violation|0
4503367|NCT00868790|7309884|FG003|Period 3|Protocol Violation|0
4503368|NCT00868790|7309885|FG004|Period 3|Protocol Violation|0
4503369|NCT00868790|7309886|FG005|Period 3|Protocol Violation|0
4503370|NCT00868790|7309887|FG006|Period 3|Protocol Violation|0
4503371|NCT00868790|7309888|FG007|Period 3|Protocol Violation|0
4503372|NCT00868790|7309889|FG008|Period 3|Protocol Violation|0
4503373|NCT00868790|7309890|FG009|Period 3|Protocol Violation|0
4503374|NCT00868790|7309891|FG010|Period 3|Protocol Violation|1
4503375|NCT00868790|7309892|FG011|Period 3|Protocol Violation|0
4503376|NCT00868790|7309893|FG012|Period 3|Protocol Violation|0
4503377|NCT00868790|7309894|FG013|Period 3|Protocol Violation|0
4503378|NCT00868790|7309881|FG000|Period 3|Study Terminated by Sponsor|0
4503379|NCT00868790|7309882|FG001|Period 3|Study Terminated by Sponsor|0
4503380|NCT00868790|7309883|FG002|Period 3|Study Terminated by Sponsor|0
4503381|NCT00868790|7309884|FG003|Period 3|Study Terminated by Sponsor|1
4503382|NCT00868790|7309885|FG004|Period 3|Study Terminated by Sponsor|0
4503383|NCT00868790|7309886|FG005|Period 3|Study Terminated by Sponsor|0
4503384|NCT00868790|7309887|FG006|Period 3|Study Terminated by Sponsor|0
4503385|NCT00868790|7309888|FG007|Period 3|Study Terminated by Sponsor|0
4503386|NCT00868790|7309889|FG008|Period 3|Study Terminated by Sponsor|0
4503387|NCT00868790|7309890|FG009|Period 3|Study Terminated by Sponsor|0
4503388|NCT00868790|7309891|FG010|Period 3|Study Terminated by Sponsor|0
4503389|NCT00868790|7309892|FG011|Period 3|Study Terminated by Sponsor|0
4503390|NCT00868790|7309893|FG012|Period 3|Study Terminated by Sponsor|0
4503391|NCT00868790|7309894|FG013|Period 3|Study Terminated by Sponsor|0
4503392|NCT00868790|7309881|FG000|Period 4|Adverse Event|0
4503393|NCT00868790|7309882|FG001|Period 4|Adverse Event|0
4503394|NCT00868790|7309883|FG002|Period 4|Adverse Event|0
4503395|NCT00868790|7309884|FG003|Period 4|Adverse Event|0
4503396|NCT00868790|7309885|FG004|Period 4|Adverse Event|0
4503397|NCT00868790|7309886|FG005|Period 4|Adverse Event|0
4503398|NCT00868790|7309887|FG006|Period 4|Adverse Event|0
4503399|NCT00868790|7309888|FG007|Period 4|Adverse Event|1
4503400|NCT00868790|7309889|FG008|Period 4|Adverse Event|0
4503401|NCT00868790|7309890|FG009|Period 4|Adverse Event|0
4503402|NCT00868790|7309891|FG010|Period 4|Adverse Event|1
4503403|NCT00868790|7309892|FG011|Period 4|Adverse Event|0
4503404|NCT00868790|7309893|FG012|Period 4|Adverse Event|1
4503405|NCT00868790|7309894|FG013|Period 4|Adverse Event|0
4503406|NCT00868790|7309881|FG000|Period 4|Lost to Follow-up|0
4503407|NCT00868790|7309882|FG001|Period 4|Lost to Follow-up|0
4503408|NCT00868790|7309883|FG002|Period 4|Lost to Follow-up|0
4503409|NCT00868790|7309884|FG003|Period 4|Lost to Follow-up|0
4503410|NCT00868790|7309885|FG004|Period 4|Lost to Follow-up|0
4503411|NCT00868790|7309886|FG005|Period 4|Lost to Follow-up|0
4503412|NCT00868790|7309887|FG006|Period 4|Lost to Follow-up|0
4503413|NCT00868790|7309888|FG007|Period 4|Lost to Follow-up|1
4503414|NCT00868790|7309889|FG008|Period 4|Lost to Follow-up|0
4503415|NCT00868790|7309890|FG009|Period 4|Lost to Follow-up|0
4503416|NCT00868790|7309891|FG010|Period 4|Lost to Follow-up|0
4503417|NCT00868790|7309892|FG011|Period 4|Lost to Follow-up|0
4503418|NCT00868790|7309893|FG012|Period 4|Lost to Follow-up|0
4503419|NCT00868790|7309894|FG013|Period 4|Lost to Follow-up|0
4503420|NCT00868790|7309881|FG000|Period 4|Study Terminated by Sponsor|2
4503421|NCT00868790|7309882|FG001|Period 4|Study Terminated by Sponsor|0
4503422|NCT00868790|7309883|FG002|Period 4|Study Terminated by Sponsor|0
4503423|NCT00868790|7309884|FG003|Period 4|Study Terminated by Sponsor|0
4503424|NCT00868790|7309885|FG004|Period 4|Study Terminated by Sponsor|0
4503425|NCT00868790|7309886|FG005|Period 4|Study Terminated by Sponsor|0
4503426|NCT00868790|7309887|FG006|Period 4|Study Terminated by Sponsor|0
4503427|NCT00868790|7309888|FG007|Period 4|Study Terminated by Sponsor|1
4503428|NCT00868790|7309889|FG008|Period 4|Study Terminated by Sponsor|2
4503429|NCT00868790|7309890|FG009|Period 4|Study Terminated by Sponsor|0
4503430|NCT00868790|7309891|FG010|Period 4|Study Terminated by Sponsor|2
4503431|NCT00868790|7309892|FG011|Period 4|Study Terminated by Sponsor|1
4503432|NCT00868790|7309893|FG012|Period 4|Study Terminated by Sponsor|0
4503433|NCT00868790|7309894|FG013|Period 4|Study Terminated by Sponsor|1
4503434|NCT00868790|7309881|FG000|Period 4|Abnormal ALT/AST|0
4503435|NCT00868790|7309882|FG001|Period 4|Abnormal ALT/AST|0
4503436|NCT00868790|7309883|FG002|Period 4|Abnormal ALT/AST|1
4503437|NCT00868790|7309884|FG003|Period 4|Abnormal ALT/AST|0
4503438|NCT00868790|7309885|FG004|Period 4|Abnormal ALT/AST|0
4503439|NCT00868790|7309886|FG005|Period 4|Abnormal ALT/AST|0
4503440|NCT00868790|7309887|FG006|Period 4|Abnormal ALT/AST|0
4503441|NCT00868790|7309888|FG007|Period 4|Abnormal ALT/AST|0
4503442|NCT00868790|7309889|FG008|Period 4|Abnormal ALT/AST|0
4503443|NCT00868790|7309890|FG009|Period 4|Abnormal ALT/AST|0
4503444|NCT00868790|7309891|FG010|Period 4|Abnormal ALT/AST|0
4503445|NCT00868790|7309892|FG011|Period 4|Abnormal ALT/AST|0
4503446|NCT00868790|7309893|FG012|Period 4|Abnormal ALT/AST|0
4503447|NCT00868790|7309894|FG013|Period 4|Abnormal ALT/AST|0
4503448|NCT00868790|7309881|FG000|Post-study|Withdrawal by Subject|0
4503449|NCT00868790|7309882|FG001|Post-study|Withdrawal by Subject|0
4503450|NCT00868790|7309883|FG002|Post-study|Withdrawal by Subject|0
4503451|NCT00868790|7309884|FG003|Post-study|Withdrawal by Subject|0
4503452|NCT00868790|7309885|FG004|Post-study|Withdrawal by Subject|1
4503453|NCT00868790|7309886|FG005|Post-study|Withdrawal by Subject|0
4503454|NCT00868790|7309887|FG006|Post-study|Withdrawal by Subject|0
4503455|NCT00868790|7309888|FG007|Post-study|Withdrawal by Subject|0
4503456|NCT00868790|7309889|FG008|Post-study|Withdrawal by Subject|0
4503457|NCT00868790|7309890|FG009|Post-study|Withdrawal by Subject|0
4503458|NCT00868790|7309891|FG010|Post-study|Withdrawal by Subject|0
4503459|NCT00868790|7309892|FG011|Post-study|Withdrawal by Subject|0
4503460|NCT00868790|7309893|FG012|Post-study|Withdrawal by Subject|0
4503461|NCT00868790|7309894|FG013|Post-study|Withdrawal by Subject|0
4503462|NCT00868790|7309881|FG000|Post-study|Excluded Medication|0
4503463|NCT00868790|7309882|FG001|Post-study|Excluded Medication|0
4503464|NCT00868790|7309883|FG002|Post-study|Excluded Medication|0
4503465|NCT00868790|7309884|FG003|Post-study|Excluded Medication|0
4503466|NCT00868790|7309885|FG004|Post-study|Excluded Medication|0
4503467|NCT00868790|7309886|FG005|Post-study|Excluded Medication|0
4503468|NCT00868790|7309887|FG006|Post-study|Excluded Medication|0
4503469|NCT00868790|7309888|FG007|Post-study|Excluded Medication|2
4503470|NCT00868790|7309889|FG008|Post-study|Excluded Medication|0
4503471|NCT00868790|7309890|FG009|Post-study|Excluded Medication|1
4503472|NCT00868790|7309891|FG010|Post-study|Excluded Medication|0
4503473|NCT00868790|7309892|FG011|Post-study|Excluded Medication|0
4503474|NCT00868790|7309893|FG012|Post-study|Excluded Medication|0
4503475|NCT00868790|7309894|FG013|Post-study|Excluded Medication|0
4503476|NCT00869024|7309916|FG000|Overall Study|Death|2
4503477|NCT00869024|7309917|FG001|Overall Study|Death|3
4503478|NCT00869024|7309916|FG000|Overall Study|Lost to Follow-up|0
4503479|NCT00869024|7309917|FG001|Overall Study|Lost to Follow-up|1
4503480|NCT00869024|7309916|FG000|Overall Study|Protocol Violation|0
4503481|NCT00869024|7309917|FG001|Overall Study|Protocol Violation|1
4503482|NCT00869050|7309923|FG000|Overall Study|Screen Failure|3
4503483|NCT00869089|7309927|FG000|Overall Study|Lost to Follow-up|1
4503484|NCT00869089|7309927|FG000|Overall Study|Withdrawal by Subject|1
4503485|NCT00869089|7309927|FG000|Overall Study|Screen Fail|1
4503486|NCT00869323|7309968|FG000|Maintenance Therapy|concurrent illness|1
4503487|NCT00869362|7309983|FG000|Overall Study|Death|0
4503488|NCT00869362|7309984|FG001|Overall Study|Death|2
4503489|NCT00869362|7309983|FG000|Overall Study|Lost to Follow-up|1
4503490|NCT00869362|7309984|FG001|Overall Study|Lost to Follow-up|3
4503491|NCT00869401|7310005|FG000|Overall Study|Withdrawal by Subject|0
4503492|NCT00869401|7310006|FG001|Overall Study|Withdrawal by Subject|0
4503493|NCT00869401|7310007|FG002|Overall Study|Withdrawal by Subject|0
4503494|NCT00869401|7310008|FG003|Overall Study|Withdrawal by Subject|5
4503495|NCT00869401|7310009|FG004|Overall Study|Withdrawal by Subject|3
4503496|NCT00869440|7310025|FG000|Overall Study|Withdrawal by Subject|1
4503497|NCT00869440|7310026|FG001|Overall Study|Withdrawal by Subject|0
4503498|NCT00869440|7310027|FG002|Overall Study|Withdrawal by Subject|0
4503499|NCT00869440|7310028|FG003|Overall Study|Withdrawal by Subject|0
4503500|NCT00869440|7310025|FG000|Overall Study|Physician Decision|1
4503501|NCT00869440|7310026|FG001|Overall Study|Physician Decision|1
4503502|NCT00869440|7310027|FG002|Overall Study|Physician Decision|0
4503503|NCT00869440|7310028|FG003|Overall Study|Physician Decision|0
4503504|NCT00869518|7310040|FG000|Overall Study|Lost to Follow-up|1
4503505|NCT00869518|7310041|FG001|Overall Study|Lost to Follow-up|1
4503506|NCT00869557|7310049|FG000|Randomized Phase|Lost to Follow-up|2
4503507|NCT00869557|7310050|FG001|Randomized Phase|Lost to Follow-up|1
4503508|NCT00869557|7310049|FG000|Randomized Phase|Investigator's Discretion|1
4503509|NCT00869557|7310050|FG001|Randomized Phase|Investigator's Discretion|0
4503510|NCT00869557|7310049|FG000|Randomized Phase|Withdrew Consent|0
4503511|NCT00869557|7310050|FG001|Randomized Phase|Withdrew Consent|1
4503512|NCT00869557|7310049|FG000|Extension Phase|Adverse Event|2
4503513|NCT00869557|7310050|FG001|Extension Phase|Adverse Event|2
4503514|NCT00869557|7310049|FG000|Extension Phase|Lack of Efficacy|1
4503515|NCT00869557|7310050|FG001|Extension Phase|Lack of Efficacy|0
4503516|NCT00869557|7310049|FG000|Extension Phase|Lost to Follow-up|3
4627467|NCT01853280|7494144|FG001|Overall Study|Lost to Follow-up|1
4627468|NCT01853280|7494143|FG000|Overall Study|Physician Decision|0
4627469|NCT01853280|7494144|FG001|Overall Study|Physician Decision|1
4503517|NCT00869557|7310050|FG001|Extension Phase|Lost to Follow-up|1
4503518|NCT00869557|7310049|FG000|Extension Phase|Investigator's Discretion|2
4503519|NCT00869557|7310050|FG001|Extension Phase|Investigator's Discretion|0
4503520|NCT00869557|7310049|FG000|Extension Phase|Withdrew Consent|2
4503521|NCT00869557|7310050|FG001|Extension Phase|Withdrew Consent|0
4503522|NCT00869778|7310079|FG000|Overall Study|Adverse Event|2
4503523|NCT00869778|7310080|FG001|Overall Study|Adverse Event|0
4503524|NCT00869778|7310081|FG002|Overall Study|Adverse Event|0
4503525|NCT00869778|7310079|FG000|Overall Study|Withdrawal by Subject|3
4503526|NCT00869778|7310080|FG001|Overall Study|Withdrawal by Subject|4
4503527|NCT00869778|7310081|FG002|Overall Study|Withdrawal by Subject|5
4503528|NCT00869778|7310079|FG000|Overall Study|Pregnancy|1
4503529|NCT00869778|7310080|FG001|Overall Study|Pregnancy|0
4503530|NCT00869778|7310081|FG002|Overall Study|Pregnancy|0
4503531|NCT00869778|7310079|FG000|Overall Study|Protocol Violation|5
4503532|NCT00869778|7310080|FG001|Overall Study|Protocol Violation|3
4503533|NCT00869778|7310081|FG002|Overall Study|Protocol Violation|5
4503534|NCT00869778|7310079|FG000|Overall Study|Unblinding|1
4503535|NCT00869778|7310080|FG001|Overall Study|Unblinding|0
4503536|NCT00869778|7310081|FG002|Overall Study|Unblinding|0
4503537|NCT00869960|7310110|FG000|Overall Study|Lost to Follow-up|2
4503538|NCT00869999|7310114|FG000|Overall Study|Withdrawal by Subject|1
4503539|NCT00869999|7310114|FG000|Overall Study|removed prior to starting therapy|1
4503540|NCT00870103|7310118|FG000|Overall Study|Physician Decision|2
4503541|NCT00870103|7310118|FG000|Overall Study|Lost to Follow-up|2
4503542|NCT00870194|7310124|FG000|Overall Study|Adverse Event|10
4503543|NCT00870194|7310125|FG001|Overall Study|Adverse Event|5
4503544|NCT00870194|7310124|FG000|Overall Study|Lack of Efficacy|0
4503545|NCT00870194|7310125|FG001|Overall Study|Lack of Efficacy|1
4503546|NCT00870194|7310124|FG000|Overall Study|Lost to Follow-up|2
4503547|NCT00870194|7310125|FG001|Overall Study|Lost to Follow-up|0
4503548|NCT00870194|7310124|FG000|Overall Study|Physician Decision|3
4503549|NCT00870194|7310125|FG001|Overall Study|Physician Decision|1
4503550|NCT00870194|7310124|FG000|Overall Study|Protocol Violation|3
4503551|NCT00870194|7310125|FG001|Overall Study|Protocol Violation|3
4503552|NCT00870194|7310124|FG000|Overall Study|Entry Criteria Not Met|1
4503553|NCT00870194|7310125|FG001|Overall Study|Entry Criteria Not Met|2
4503554|NCT00870194|7310124|FG000|Overall Study|Subject Decision|7
4503555|NCT00870194|7310125|FG001|Overall Study|Subject Decision|2
4503556|NCT00870233|7310131|FG000|Overall Study|Withdrawal by Subject|18
4503557|NCT00870233|7310131|FG000|Overall Study|Did not undergo laparotomy|3
4503558|NCT00870233|7310131|FG000|Overall Study|Incompatible internet browser|2
4503559|NCT00870233|7310131|FG000|Overall Study|Death|1
4503560|NCT00870584|7310178|FG000|Overall Study|Adverse Event|3
4503561|NCT00870584|7310179|FG001|Overall Study|Adverse Event|3
4503562|NCT00870584|7310178|FG000|Overall Study|Withdrawal by Subject|6
4503563|NCT00870584|7310179|FG001|Overall Study|Withdrawal by Subject|7
4503564|NCT00870584|7310178|FG000|Overall Study|Lost to Follow-up|5
4503565|NCT00870584|7310179|FG001|Overall Study|Lost to Follow-up|1
4503566|NCT00870584|7310178|FG000|Overall Study|Protocol Deviation|2
4503567|NCT00870584|7310179|FG001|Overall Study|Protocol Deviation|2
4503568|NCT00870727|7310187|FG000|Overall Study|Lost to Follow-up|0
4503569|NCT00870727|7310188|FG001|Overall Study|Lost to Follow-up|1
4503570|NCT00870727|7310187|FG000|Overall Study|Lack of Efficacy|1
4503571|NCT00870727|7310188|FG001|Overall Study|Lack of Efficacy|3
4503572|NCT00870727|7310187|FG000|Overall Study|Adverse Event|0
4503573|NCT00870727|7310188|FG001|Overall Study|Adverse Event|1
4503574|NCT00870740|7310200|FG000|Overall Study|Adverse Event|2
4503575|NCT00870740|7310201|FG001|Overall Study|Adverse Event|1
4503576|NCT00870740|7310202|FG002|Overall Study|Adverse Event|3
4503577|NCT00870740|7310203|FG003|Overall Study|Adverse Event|2
4503578|NCT00870740|7310204|FG004|Overall Study|Adverse Event|1
4503579|NCT00870740|7310205|FG005|Overall Study|Adverse Event|6
4503580|NCT00870740|7310200|FG000|Overall Study|Consent Withdrawn|6
4503581|NCT00870740|7310201|FG001|Overall Study|Consent Withdrawn|3
4503582|NCT00870740|7310202|FG002|Overall Study|Consent Withdrawn|4
4503583|NCT00870740|7310203|FG003|Overall Study|Consent Withdrawn|6
4503584|NCT00870740|7310204|FG004|Overall Study|Consent Withdrawn|6
4503585|NCT00870740|7310205|FG005|Overall Study|Consent Withdrawn|5
4503586|NCT00870740|7310200|FG000|Overall Study|Investigator Decision|2
4627470|NCT01853280|7494143|FG000|Overall Study|Withdrawal by Subject|0
4503587|NCT00870740|7310201|FG001|Overall Study|Investigator Decision|0
4503588|NCT00870740|7310202|FG002|Overall Study|Investigator Decision|1
4503589|NCT00870740|7310203|FG003|Overall Study|Investigator Decision|0
4503590|NCT00870740|7310204|FG004|Overall Study|Investigator Decision|0
4503591|NCT00870740|7310205|FG005|Overall Study|Investigator Decision|0
4503592|NCT00870740|7310200|FG000|Overall Study|Subject Non-compliance|0
4503593|NCT00870740|7310201|FG001|Overall Study|Subject Non-compliance|0
4627471|NCT01853280|7494144|FG001|Overall Study|Withdrawal by Subject|1
4627472|NCT01853280|7494143|FG000|Overall Study|Ineligible|0
4627473|NCT01853280|7494144|FG001|Overall Study|Ineligible|1
4627474|NCT01853384|7494166|FG000|Randomized|Adverse Event|5
4627475|NCT01853384|7494167|FG001|Randomized|Adverse Event|3
4627476|NCT01853384|7494166|FG000|Randomized|Death|1
4627477|NCT01853384|7494167|FG001|Randomized|Death|2
4627478|NCT01853384|7494166|FG000|Randomized|Lost to Follow-up|1
4627479|NCT01853384|7494167|FG001|Randomized|Lost to Follow-up|1
4627480|NCT01853384|7494166|FG000|Randomized|Withdrawal by Subject|5
4503594|NCT00870740|7310202|FG002|Overall Study|Subject Non-compliance|0
4503595|NCT00870740|7310203|FG003|Overall Study|Subject Non-compliance|0
4503596|NCT00870740|7310204|FG004|Overall Study|Subject Non-compliance|0
4503597|NCT00870740|7310205|FG005|Overall Study|Subject Non-compliance|1
4503598|NCT00870740|7310200|FG000|Overall Study|Death|0
4503599|NCT00870740|7310201|FG001|Overall Study|Death|0
4503600|NCT00870740|7310202|FG002|Overall Study|Death|0
4503601|NCT00870740|7310203|FG003|Overall Study|Death|0
4503602|NCT00870740|7310204|FG004|Overall Study|Death|1
4503603|NCT00870740|7310205|FG005|Overall Study|Death|0
4503604|NCT00870740|7310200|FG000|Overall Study|Other|2
4503605|NCT00870740|7310201|FG001|Overall Study|Other|5
4503606|NCT00870740|7310202|FG002|Overall Study|Other|2
4503607|NCT00870740|7310203|FG003|Overall Study|Other|4
4503608|NCT00870740|7310204|FG004|Overall Study|Other|3
4503609|NCT00870740|7310205|FG005|Overall Study|Other|5
4503610|NCT00870870|7310234|FG000|Overall Study|Withdrawal by Subject|0
4503611|NCT00870870|7310235|FG001|Overall Study|Withdrawal by Subject|1
4503612|NCT00870870|7310236|FG002|Overall Study|Withdrawal by Subject|1
4503613|NCT00870870|7310237|FG003|Overall Study|Withdrawal by Subject|3
4503614|NCT00870870|7310234|FG000|Overall Study|Adverse Event|0
4503615|NCT00870870|7310235|FG001|Overall Study|Adverse Event|0
4503616|NCT00870870|7310236|FG002|Overall Study|Adverse Event|2
4503617|NCT00870870|7310237|FG003|Overall Study|Adverse Event|2
4503618|NCT00871000|7310260|FG000|Overall Study|Withdrawal by Subject|1
4503619|NCT00871000|7310261|FG001|Overall Study|Withdrawal by Subject|0
4503620|NCT00871117|7310269|FG000|Overall Study|Lost to Follow-up|5
4503621|NCT00871117|7310270|FG001|Overall Study|Lost to Follow-up|6
4503622|NCT00871117|7310269|FG000|Overall Study|Other|0
4503623|NCT00871117|7310270|FG001|Overall Study|Other|4
4503624|NCT00871169|7310286|FG000|Overall Study|Protocol Violation|1
4503625|NCT00871169|7310286|FG000|Overall Study|Patient did not receive study treatment|2
4503626|NCT00871234|7310290|FG000|Overall Study|Adverse Event|2
4503627|NCT00871234|7310290|FG000|Overall Study|Lost to Follow-up|3
4503628|NCT00871338|7310309|FG000|Prior to Booster|Withdrawal by Subject|1
4503629|NCT00871338|7310310|FG001|Prior to Booster|Withdrawal by Subject|3
4503630|NCT00871338|7310309|FG000|Prior to Booster|Lost to Follow-up|1
4503631|NCT00871338|7310310|FG001|Prior to Booster|Lost to Follow-up|0
4503632|NCT00871377|7310316|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0
4503633|NCT00871377|7310317|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0
4503634|NCT00871377|7310318|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1
4503635|NCT00871377|7310319|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0
4503636|NCT00871377|7310320|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0
4503637|NCT00871377|7310321|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0
4503638|NCT00871377|7310316|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0
4503639|NCT00871377|7310317|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0
4503640|NCT00871377|7310318|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0
4503641|NCT00871377|7310319|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0
4503642|NCT00871377|7310320|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0
4503643|NCT00871377|7310321|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1
4503644|NCT00871377|7310316|FG000|Washout (6 Weeks)|Withdrawal by Subject|1
4503645|NCT00871377|7310317|FG001|Washout (6 Weeks)|Withdrawal by Subject|0
4503646|NCT00871377|7310318|FG002|Washout (6 Weeks)|Withdrawal by Subject|0
4503647|NCT00871377|7310319|FG003|Washout (6 Weeks)|Withdrawal by Subject|0
4503648|NCT00871377|7310320|FG004|Washout (6 Weeks)|Withdrawal by Subject|0
4503649|NCT00871377|7310321|FG005|Washout (6 Weeks)|Withdrawal by Subject|0
4503650|NCT00871377|7310316|FG000|Washout (6 Weeks)|Withdrawal by Subject|0
4503651|NCT00871377|7310317|FG001|Washout (6 Weeks)|Withdrawal by Subject|0
4503652|NCT00871377|7310318|FG002|Washout (6 Weeks)|Withdrawal by Subject|0
4503653|NCT00871377|7310319|FG003|Washout (6 Weeks)|Withdrawal by Subject|0
4503654|NCT00871377|7310320|FG004|Washout (6 Weeks)|Withdrawal by Subject|0
4503655|NCT00871377|7310321|FG005|Washout (6 Weeks)|Withdrawal by Subject|1
4503656|NCT00871377|7310316|FG000|Third Intervention (10 Weeks)|Death|0
4627481|NCT01853384|7494167|FG001|Randomized|Withdrawal by Subject|3
4627482|NCT01853384|7494166|FG000|Randomized|Sponsor Decision|47
4627483|NCT01853384|7494167|FG001|Randomized|Sponsor Decision|34
4627484|NCT01853384|7494166|FG000|Randomized|Other|3
4627485|NCT01853384|7494167|FG001|Randomized|Other|3
4503657|NCT00871377|7310317|FG001|Third Intervention (10 Weeks)|Death|0
4503658|NCT00871377|7310318|FG002|Third Intervention (10 Weeks)|Death|0
4503659|NCT00871377|7310319|FG003|Third Intervention (10 Weeks)|Death|1
4503660|NCT00871377|7310320|FG004|Third Intervention (10 Weeks)|Death|0
4503661|NCT00871377|7310321|FG005|Third Intervention (10 Weeks)|Death|0
4503662|NCT00871403|7310332|FG000|Combination Treatment Phase|Randomized but Not Treated|1
4503663|NCT00871403|7310333|FG001|Combination Treatment Phase|Randomized but Not Treated|1
4503664|NCT00871403|7310334|FG002|Combination Treatment Phase|Randomized but Not Treated|1
4503665|NCT00871403|7310332|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8
4503666|NCT00871403|7310333|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19
4503667|NCT00871403|7310334|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0
4503668|NCT00871403|7310332|FG000|Combination Treatment Phase|Adverse Event|0
4503669|NCT00871403|7310333|FG001|Combination Treatment Phase|Adverse Event|17
4503670|NCT00871403|7310334|FG002|Combination Treatment Phase|Adverse Event|2
4503671|NCT00871403|7310332|FG000|Combination Treatment Phase|Disease Progression|0
4503672|NCT00871403|7310333|FG001|Combination Treatment Phase|Disease Progression|8
4503673|NCT00871403|7310334|FG002|Combination Treatment Phase|Disease Progression|5
4503674|NCT00871403|7310332|FG000|Combination Treatment Phase|Withdrawal by Subject|0
4503675|NCT00871403|7310333|FG001|Combination Treatment Phase|Withdrawal by Subject|3
4503676|NCT00871403|7310334|FG002|Combination Treatment Phase|Withdrawal by Subject|1
4503677|NCT00871403|7310332|FG000|Combination Treatment Phase|Physician Decision|0
4503678|NCT00871403|7310333|FG001|Combination Treatment Phase|Physician Decision|1
4503679|NCT00871403|7310334|FG002|Combination Treatment Phase|Physician Decision|3
4503680|NCT00871403|7310332|FG000|Monotherapy Treatment Phase|Disease Progression|0
4503681|NCT00871403|7310333|FG001|Monotherapy Treatment Phase|Disease Progression|9
4503682|NCT00871403|7310334|FG002|Monotherapy Treatment Phase|Disease Progression|1
4503683|NCT00871403|7310332|FG000|Monotherapy Treatment Phase|Adverse Event|0
4503684|NCT00871403|7310333|FG001|Monotherapy Treatment Phase|Adverse Event|4
4503685|NCT00871403|7310334|FG002|Monotherapy Treatment Phase|Adverse Event|0
4503686|NCT00871429|7310341|FG000|Overall Study|Lost to Follow-up|6
4503687|NCT00871429|7310341|FG000|Overall Study|Withdrawal by Subject|17
4503688|NCT00871429|7310341|FG000|Overall Study|Questionnaire not completed|1
4503689|NCT00871494|7310349|FG000|Overall Study|Protocol Violation|5
4503690|NCT00871494|7310349|FG000|Overall Study|Lack of Efficacy|4
4503691|NCT00871494|7310349|FG000|Overall Study|Adverse Event|4
4503692|NCT00871494|7310349|FG000|Overall Study|Lost to Follow-up|1
4503693|NCT00871572|7310357|FG000|Overall Study|Adverse Event|0
4503694|NCT00871572|7310358|FG001|Overall Study|Adverse Event|2
4503695|NCT00871572|7310359|FG002|Overall Study|Adverse Event|0
4503696|NCT00871572|7310360|FG003|Overall Study|Adverse Event|3
4503697|NCT00871572|7310357|FG000|Overall Study|Investigator Decision|0
4503698|NCT00871572|7310358|FG001|Overall Study|Investigator Decision|1
4503699|NCT00871572|7310359|FG002|Overall Study|Investigator Decision|0
4503700|NCT00871572|7310360|FG003|Overall Study|Investigator Decision|1
4503701|NCT00871572|7310357|FG000|Overall Study|Lost to Follow-up|0
4503702|NCT00871572|7310358|FG001|Overall Study|Lost to Follow-up|1
4503703|NCT00871572|7310359|FG002|Overall Study|Lost to Follow-up|0
4503704|NCT00871572|7310360|FG003|Overall Study|Lost to Follow-up|1
4503705|NCT00871572|7310357|FG000|Overall Study|Protocol Violation|0
4503706|NCT00871572|7310358|FG001|Overall Study|Protocol Violation|0
4503707|NCT00871572|7310359|FG002|Overall Study|Protocol Violation|1
4503708|NCT00871572|7310360|FG003|Overall Study|Protocol Violation|1
4503709|NCT00871572|7310357|FG000|Overall Study|Sponsor Decision|1
4503710|NCT00871572|7310358|FG001|Overall Study|Sponsor Decision|0
4503711|NCT00871572|7310359|FG002|Overall Study|Sponsor Decision|0
4503712|NCT00871572|7310360|FG003|Overall Study|Sponsor Decision|0
4503713|NCT00871572|7310357|FG000|Overall Study|Withdrawal by Subject|1
4503714|NCT00871572|7310358|FG001|Overall Study|Withdrawal by Subject|2
4503715|NCT00871572|7310359|FG002|Overall Study|Withdrawal by Subject|3
4503716|NCT00871572|7310360|FG003|Overall Study|Withdrawal by Subject|1
4503717|NCT00871715|7310388|FG000|Overall Study|Withdrawal by Subject|6
4503718|NCT00871715|7310389|FG001|Overall Study|Withdrawal by Subject|10
4503719|NCT00871715|7310390|FG002|Overall Study|Withdrawal by Subject|15
4503720|NCT00871715|7310388|FG000|Overall Study|Physician Decision|6
4503721|NCT00871715|7310389|FG001|Overall Study|Physician Decision|0
4503722|NCT00871715|7310390|FG002|Overall Study|Physician Decision|2
4503723|NCT00871715|7310388|FG000|Overall Study|Lost to Follow-up|3
4503724|NCT00871715|7310389|FG001|Overall Study|Lost to Follow-up|6
4503725|NCT00871715|7310390|FG002|Overall Study|Lost to Follow-up|9
4503726|NCT00871728|7310399|FG000|Overall Study|Adverse Event|1
4503727|NCT00871728|7310399|FG000|Overall Study|Protocol Violation|7
4503728|NCT00871728|7310399|FG000|Overall Study|Lost to Follow-up|2
4503729|NCT00871728|7310399|FG000|Overall Study|Failed to Visit Hospital|4
4503730|NCT00871728|7310399|FG000|Overall Study|Participant Non-compliance|1
4503731|NCT00871728|7310399|FG000|Overall Study|Withdrawal of Informed Consent|5
4503732|NCT00871741|7310405|FG000|Overall Study|Premature study termination|9
4503733|NCT00871741|7310406|FG001|Overall Study|Premature study termination|7
4503734|NCT00871780|7310412|FG000|Overall Study|Enrolled But Not Treated|6
4503735|NCT00871780|7310412|FG000|Overall Study|Withdrawal by Subject|9
4503736|NCT00871780|7310412|FG000|Overall Study|Adverse Event|6
4503737|NCT00871780|7310412|FG000|Overall Study|Voluntary Discontinuation|4
4503738|NCT00871780|7310412|FG000|Overall Study|Death|1
4503739|NCT00871780|7310412|FG000|Overall Study|Physician Decision|1
4503740|NCT00871858|7310438|FG000|Overall Study|Protocol Violation|3
4503741|NCT00871858|7310439|FG001|Overall Study|Protocol Violation|4
4503742|NCT00871858|7310438|FG000|Overall Study|Adverse Event|1
4503743|NCT00871858|7310439|FG001|Overall Study|Adverse Event|1
4503744|NCT00871858|7310438|FG000|Overall Study|Withdrawal by Subject|1
4503745|NCT00871858|7310439|FG001|Overall Study|Withdrawal by Subject|1
4503746|NCT00871858|7310438|FG000|Overall Study|Lost to Follow-up|0
4503747|NCT00871858|7310439|FG001|Overall Study|Lost to Follow-up|1
4503748|NCT00871871|7310447|FG000|Part I|Adverse Event|0
4503749|NCT00871871|7310448|FG001|Part I|Adverse Event|2
4503750|NCT00871871|7310449|FG002|Part I|Adverse Event|0
4503751|NCT00871871|7310450|FG003|Part I|Adverse Event|0
4503752|NCT00871871|7310447|FG000|Part I|Withdrawal by Subject|3
4503753|NCT00871871|7310448|FG001|Part I|Withdrawal by Subject|0
4503754|NCT00871871|7310449|FG002|Part I|Withdrawal by Subject|0
4503755|NCT00871871|7310450|FG003|Part I|Withdrawal by Subject|0
4503756|NCT00871871|7310447|FG000|Part I|Laboratory abnormality|0
4503757|NCT00871871|7310448|FG001|Part I|Laboratory abnormality|1
4503758|NCT00871871|7310449|FG002|Part I|Laboratory abnormality|0
4503759|NCT00871871|7310450|FG003|Part I|Laboratory abnormality|0
4503760|NCT00871871|7310447|FG000|Part II|Lack of Efficacy|0
4503761|NCT00871871|7310448|FG001|Part II|Lack of Efficacy|0
4503762|NCT00871871|7310449|FG002|Part II|Lack of Efficacy|1
4503763|NCT00871871|7310450|FG003|Part II|Lack of Efficacy|0
4503764|NCT00871871|7310447|FG000|Part II|Withdrawal by Subject|0
4503765|NCT00871871|7310448|FG001|Part II|Withdrawal by Subject|0
4503766|NCT00871871|7310449|FG002|Part II|Withdrawal by Subject|2
4503767|NCT00871871|7310450|FG003|Part II|Withdrawal by Subject|1
4503768|NCT00871871|7310447|FG000|Part II|Adverse Event|0
4503769|NCT00871871|7310448|FG001|Part II|Adverse Event|0
4503770|NCT00871871|7310449|FG002|Part II|Adverse Event|1
4503771|NCT00871871|7310450|FG003|Part II|Adverse Event|2
4503772|NCT00871871|7310447|FG000|Part II|Protocol Violation|0
4503773|NCT00871871|7310448|FG001|Part II|Protocol Violation|0
4503774|NCT00871871|7310449|FG002|Part II|Protocol Violation|0
4503775|NCT00871871|7310450|FG003|Part II|Protocol Violation|1
4503776|NCT00871923|7310460|FG000|Overall Study|Death|1
4503777|NCT00871923|7310460|FG000|Overall Study|Withdrawal by Subject|1
4503778|NCT00871975|7310464|FG000|Overall Study|Technical difficulty w155-1ith equipment|3
4503779|NCT00871975|7310464|FG000|Overall Study|Catheters could not be inserted|1
4503780|NCT00871975|7310464|FG000|Overall Study|Patient unable to void/insufficient vol|13
4503781|NCT00871975|7310464|FG000|Overall Study|Motion artifact, tracing uninterpretable|5
4503782|NCT00872001|7310470|FG000|Overall Study|Adverse Event|34
4503783|NCT00872001|7310471|FG001|Overall Study|Adverse Event|23
4503784|NCT00872001|7310470|FG000|Overall Study|Protocol Defined Clinical Event|5
4503785|NCT00872001|7310471|FG001|Overall Study|Protocol Defined Clinical Event|7
4503786|NCT00872001|7310470|FG000|Overall Study|Lost to Follow-up|13
4503787|NCT00872001|7310471|FG001|Overall Study|Lost to Follow-up|12
4503788|NCT00872001|7310470|FG000|Overall Study|Withdrawal by Subject|18
4503789|NCT00872001|7310471|FG001|Overall Study|Withdrawal by Subject|30
4503790|NCT00872001|7310470|FG000|Overall Study|Protocol Violation|5
4503791|NCT00872001|7310471|FG001|Overall Study|Protocol Violation|8
4503792|NCT00872001|7310470|FG000|Overall Study|Did Not Meet Protocol Eligibility|38
4503793|NCT00872001|7310471|FG001|Overall Study|Did Not Meet Protocol Eligibility|36
4503794|NCT00872001|7310470|FG000|Overall Study|Administrative|23
4503795|NCT00872001|7310471|FG001|Overall Study|Administrative|15
4503796|NCT00872170|7310494|FG000|Overall Study|Adverse Event|1
4503797|NCT00872170|7310495|FG001|Overall Study|Adverse Event|0
4503798|NCT00872521|7310516|FG000|Completed PAD Induction|Patient choice|0
4503799|NCT00872521|7310517|FG001|Completed PAD Induction|Patient choice|1
4503800|NCT00872521|7310518|FG002|Completed PAD Induction|Patient choice|0
4503801|NCT00872521|7310516|FG000|Completed PAD Induction|Disease progression|0
4503802|NCT00872521|7310517|FG001|Completed PAD Induction|Disease progression|2
4503803|NCT00872521|7310518|FG002|Completed PAD Induction|Disease progression|0
4503804|NCT00872521|7310516|FG000|Completed PAD Induction|Adverse Event|4
4503805|NCT00872521|7310517|FG001|Completed PAD Induction|Adverse Event|0
4503806|NCT00872521|7310518|FG002|Completed PAD Induction|Adverse Event|0
4503807|NCT00872521|7310516|FG000|Completed PAD Induction|Death|1
4503808|NCT00872521|7310517|FG001|Completed PAD Induction|Death|1
4503809|NCT00872521|7310518|FG002|Completed PAD Induction|Death|0
4503810|NCT00872521|7310516|FG000|Primary Endpoint Analysis|Other|1
4503811|NCT00872521|7310517|FG001|Primary Endpoint Analysis|Other|2
4503812|NCT00872521|7310518|FG002|Primary Endpoint Analysis|Other|0
4503813|NCT00872521|7310516|FG000|Primary Endpoint Analysis|Patient choice|0
4503814|NCT00872521|7310517|FG001|Primary Endpoint Analysis|Patient choice|1
4503815|NCT00872521|7310518|FG002|Primary Endpoint Analysis|Patient choice|0
4503816|NCT00872521|7310516|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0
4503817|NCT00872521|7310517|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2
4503818|NCT00872521|7310518|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0
4503819|NCT00872521|7310516|FG000|Primary Endpoint Analysis|Patient response missing|0
4503820|NCT00872521|7310517|FG001|Primary Endpoint Analysis|Patient response missing|0
4503821|NCT00872521|7310518|FG002|Primary Endpoint Analysis|Patient response missing|1
4503822|NCT00872521|7310516|FG000|Completed 3-month Follow up|Other|0
4503823|NCT00872521|7310517|FG001|Completed 3-month Follow up|Other|2
4503824|NCT00872521|7310518|FG002|Completed 3-month Follow up|Other|0
4503825|NCT00872521|7310516|FG000|Completed 3-month Follow up|Physician Decision|0
4503826|NCT00872521|7310517|FG001|Completed 3-month Follow up|Physician Decision|1
4503827|NCT00872521|7310518|FG002|Completed 3-month Follow up|Physician Decision|0
4503828|NCT00872521|7310516|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0
4503829|NCT00872521|7310517|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2
4503830|NCT00872521|7310518|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1
4503831|NCT00872599|7310546|FG000|Second Washout Period|Adverse Event|1
4503832|NCT00872599|7310547|FG001|Second Washout Period|Adverse Event|1
4503833|NCT00872898|7310592|FG000|Part Two - Double Blind|Adverse Event|4
4503834|NCT00872898|7310593|FG001|Part Two - Double Blind|Adverse Event|3
4503835|NCT00872898|7310592|FG000|Part Two - Double Blind|Lack of Efficacy|1
4503836|NCT00872898|7310593|FG001|Part Two - Double Blind|Lack of Efficacy|0
4503837|NCT00872898|7310592|FG000|Part Two - Double Blind|Protocol Violation|1
4503838|NCT00872898|7310593|FG001|Part Two - Double Blind|Protocol Violation|0
4503839|NCT00872898|7310592|FG000|Part Two - Double Blind|Withdrawal by Subject|3
4503840|NCT00872898|7310593|FG001|Part Two - Double Blind|Withdrawal by Subject|1
4503841|NCT00872898|7310592|FG000|Part Two - Double Blind|Lost to Follow-up|0
4503842|NCT00872898|7310593|FG001|Part Two - Double Blind|Lost to Follow-up|2
4503843|NCT00872898|7310592|FG000|Part Two - Double Blind|Other reasons|2
4503844|NCT00872898|7310593|FG001|Part Two - Double Blind|Other reasons|0
4503845|NCT00872989|7310604|FG000|Overall Study|Adverse Event|7
4503846|NCT00872989|7310605|FG001|Overall Study|Adverse Event|15
4503847|NCT00872989|7310604|FG000|Overall Study|Withdrawal by Subject|8
4503848|NCT00872989|7310605|FG001|Overall Study|Withdrawal by Subject|5
4503849|NCT00872989|7310604|FG000|Overall Study|Progression/relapse|47
4503850|NCT00872989|7310605|FG001|Overall Study|Progression/relapse|35
4503851|NCT00872989|7310604|FG000|Overall Study|Not protocol specified|3
4503852|NCT00872989|7310605|FG001|Overall Study|Not protocol specified|8
4503853|NCT00873015|7310621|FG000|Overall Study|Withdrawal by Subject|0
4503854|NCT00873015|7310622|FG001|Overall Study|Withdrawal by Subject|1
4503855|NCT00873015|7310623|FG002|Overall Study|Withdrawal by Subject|0
4503856|NCT00873015|7310624|FG003|Overall Study|Withdrawal by Subject|0
4503857|NCT00873041|7310636|FG000|Core Study|Adverse Event|2
4503858|NCT00873041|7310637|FG001|Core Study|Adverse Event|3
4627486|NCT01853384|7494166|FG000|Completed Follow up Visit 1|Early Termination|13
4627487|NCT01853384|7494167|FG001|Completed Follow up Visit 1|Early Termination|9
4627488|NCT01853384|7494166|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1
4627489|NCT01853384|7494167|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0
4627490|NCT01853384|7494166|FG000|Completed Follow up Visit 2|Adverse Event|1
4503859|NCT00873041|7310638|FG002|Core Study|Adverse Event|1
4503860|NCT00873041|7310636|FG000|Core Study|Withdrawal by Subject|1
4503861|NCT00873041|7310637|FG001|Core Study|Withdrawal by Subject|2
4503862|NCT00873041|7310638|FG002|Core Study|Withdrawal by Subject|2
4503863|NCT00873041|7310636|FG000|Core Study|Lost to Follow-up|3
4503864|NCT00873041|7310637|FG001|Core Study|Lost to Follow-up|1
4503865|NCT00873041|7310638|FG002|Core Study|Lost to Follow-up|0
4503866|NCT00873041|7310636|FG000|Core Study|Abnormal laboratory value|0
4503867|NCT00873041|7310637|FG001|Core Study|Abnormal laboratory value|0
4503868|NCT00873041|7310638|FG002|Core Study|Abnormal laboratory value|1
4503869|NCT00873041|7310636|FG000|Core Study|Protocol deviation|1
4503870|NCT00873041|7310637|FG001|Core Study|Protocol deviation|0
4503871|NCT00873041|7310638|FG002|Core Study|Protocol deviation|1
4503872|NCT00873041|7310636|FG000|Extension Study|Adverse Event|1
4503873|NCT00873041|7310637|FG001|Extension Study|Adverse Event|0
4503874|NCT00873041|7310638|FG002|Extension Study|Adverse Event|1
4503875|NCT00873041|7310636|FG000|Extension Study|Administrative reasons|0
4503876|NCT00873041|7310637|FG001|Extension Study|Administrative reasons|0
4503877|NCT00873041|7310638|FG002|Extension Study|Administrative reasons|1
4503878|NCT00873093|7310658|FG000|Overall Study|Adverse Event|0
4503879|NCT00873093|7310659|FG001|Overall Study|Adverse Event|2
4503880|NCT00873093|7310660|FG002|Overall Study|Adverse Event|0
4503881|NCT00873093|7310661|FG003|Overall Study|Adverse Event|0
4503882|NCT00873093|7310662|FG004|Overall Study|Adverse Event|0
4503883|NCT00873093|7310658|FG000|Overall Study|Death|0
4503884|NCT00873093|7310659|FG001|Overall Study|Death|3
4503885|NCT00873093|7310660|FG002|Overall Study|Death|2
4503886|NCT00873093|7310661|FG003|Overall Study|Death|0
4627491|NCT01853384|7494167|FG001|Completed Follow up Visit 2|Adverse Event|0
4503887|NCT00873093|7310662|FG004|Overall Study|Death|0
4503888|NCT00873093|7310658|FG000|Overall Study|Physician Decision|0
4503889|NCT00873093|7310659|FG001|Overall Study|Physician Decision|17
4503890|NCT00873093|7310660|FG002|Overall Study|Physician Decision|10
4503891|NCT00873093|7310661|FG003|Overall Study|Physician Decision|10
4503892|NCT00873093|7310662|FG004|Overall Study|Physician Decision|2
4503893|NCT00873093|7310658|FG000|Overall Study|Withdrawal by Subject|1
4503894|NCT00873093|7310659|FG001|Overall Study|Withdrawal by Subject|4
4503895|NCT00873093|7310660|FG002|Overall Study|Withdrawal by Subject|4
4503896|NCT00873093|7310661|FG003|Overall Study|Withdrawal by Subject|0
4503897|NCT00873093|7310662|FG004|Overall Study|Withdrawal by Subject|0
4503898|NCT00873093|7310658|FG000|Overall Study|Ineligible|0
4503899|NCT00873093|7310659|FG001|Overall Study|Ineligible|1
4503900|NCT00873093|7310660|FG002|Overall Study|Ineligible|0
4503901|NCT00873093|7310661|FG003|Overall Study|Ineligible|1
4503902|NCT00873093|7310662|FG004|Overall Study|Ineligible|0
4503903|NCT00873119|7310686|FG000|Overall Study|Patient request|4
4503904|NCT00873119|7310687|FG001|Overall Study|Patient request|2
4503905|NCT00873119|7310686|FG000|Overall Study|Adverse Event|8
4503906|NCT00873119|7310687|FG001|Overall Study|Adverse Event|0
4503907|NCT00873119|7310686|FG000|Overall Study|Progressive disease|26
4503908|NCT00873119|7310687|FG001|Overall Study|Progressive disease|18
4503909|NCT00873119|7310686|FG000|Overall Study|Death|2
4503910|NCT00873119|7310687|FG001|Overall Study|Death|1
4503911|NCT00873119|7310686|FG000|Overall Study|Other|2
4503912|NCT00873119|7310687|FG001|Overall Study|Other|5
4503913|NCT00873119|7310686|FG000|Overall Study|Not treated|2
4503914|NCT00873119|7310687|FG001|Overall Study|Not treated|0
4518021|NCT00971048|7330040|FG000|Overall Study|Protocol Violation|1
4518022|NCT00971048|7330041|FG001|Overall Study|Protocol Violation|2
4518023|NCT00971048|7330042|FG002|Overall Study|Protocol Violation|0
4518024|NCT00971048|7330043|FG003|Overall Study|Protocol Violation|1
4518025|NCT00971048|7330040|FG000|Overall Study|Adverse Event|0
4518026|NCT00971048|7330041|FG001|Overall Study|Adverse Event|0
4518027|NCT00971048|7330042|FG002|Overall Study|Adverse Event|1
4518028|NCT00971048|7330043|FG003|Overall Study|Adverse Event|0
4518029|NCT00971048|7330040|FG000|Overall Study|Physician Decision|0
4627492|NCT01853384|7494166|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1
4627493|NCT01853384|7494167|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2
4627494|NCT01853384|7494166|FG000|Completed Follow up Visit 2|Death|1
4627495|NCT01853384|7494167|FG001|Completed Follow up Visit 2|Death|0
4518030|NCT00971048|7330041|FG001|Overall Study|Physician Decision|0
4518031|NCT00971048|7330042|FG002|Overall Study|Physician Decision|0
4518032|NCT00971048|7330043|FG003|Overall Study|Physician Decision|1
4518033|NCT00971178|7330058|FG000|Overall Study|Lost to Follow-up|2
4518034|NCT00971178|7330059|FG001|Overall Study|Lost to Follow-up|2
4518035|NCT00971178|7330060|FG002|Overall Study|Lost to Follow-up|2
4518036|NCT00971204|7330068|FG000|Overall Study|Did not meet all criteria-not treated|14
4518037|NCT00971204|7330068|FG000|Overall Study|Lost to Follow-up|10
4518038|NCT00971243|7330077|FG000|Double Blind Period|Adverse Event|2
4518039|NCT00971243|7330078|FG001|Double Blind Period|Adverse Event|3
4518040|NCT00971243|7330079|FG002|Double Blind Period|Adverse Event|2
4518041|NCT00971243|7330080|FG003|Double Blind Period|Adverse Event|2
4518042|NCT00971243|7330081|FG004|Double Blind Period|Adverse Event|3
4518043|NCT00971243|7330077|FG000|Double Blind Period|Lost to Follow-up|0
4518044|NCT00971243|7330078|FG001|Double Blind Period|Lost to Follow-up|1
4518045|NCT00971243|7330079|FG002|Double Blind Period|Lost to Follow-up|1
4518046|NCT00971243|7330080|FG003|Double Blind Period|Lost to Follow-up|0
4518047|NCT00971243|7330081|FG004|Double Blind Period|Lost to Follow-up|1
4518048|NCT00971243|7330077|FG000|Double Blind Period|Physician Decision|10
4518049|NCT00971243|7330078|FG001|Double Blind Period|Physician Decision|6
4518050|NCT00971243|7330079|FG002|Double Blind Period|Physician Decision|7
4518051|NCT00971243|7330080|FG003|Double Blind Period|Physician Decision|6
4518052|NCT00971243|7330081|FG004|Double Blind Period|Physician Decision|7
4518053|NCT00971243|7330077|FG000|Double Blind Period|Protocol Violation|2
4518054|NCT00971243|7330078|FG001|Double Blind Period|Protocol Violation|0
4518055|NCT00971243|7330079|FG002|Double Blind Period|Protocol Violation|3
4518056|NCT00971243|7330080|FG003|Double Blind Period|Protocol Violation|2
4518057|NCT00971243|7330081|FG004|Double Blind Period|Protocol Violation|2
4518058|NCT00971243|7330077|FG000|Double Blind Period|Withdrawal by Subject|4
4518059|NCT00971243|7330078|FG001|Double Blind Period|Withdrawal by Subject|1
4518060|NCT00971243|7330079|FG002|Double Blind Period|Withdrawal by Subject|4
4518061|NCT00971243|7330080|FG003|Double Blind Period|Withdrawal by Subject|4
4518062|NCT00971243|7330081|FG004|Double Blind Period|Withdrawal by Subject|4
4518063|NCT00971243|7330077|FG000|Double Blind Period|Other reasons|1
4518064|NCT00971243|7330078|FG001|Double Blind Period|Other reasons|0
4518065|NCT00971243|7330079|FG002|Double Blind Period|Other reasons|2
4518066|NCT00971243|7330080|FG003|Double Blind Period|Other reasons|0
4627496|NCT01853384|7494166|FG000|Completed Follow up Visit 2|Lost to Follow-up|0
4627497|NCT01853384|7494167|FG001|Completed Follow up Visit 2|Lost to Follow-up|1
4627498|NCT01853397|7494177|FG000|Overall Study|Withdrawal by Subject|0
4627499|NCT01853397|7494178|FG001|Overall Study|Withdrawal by Subject|0
4627500|NCT01853397|7494179|FG002|Overall Study|Withdrawal by Subject|0
4518067|NCT00971243|7330081|FG004|Double Blind Period|Other reasons|1
4518068|NCT00971243|7330077|FG000|Open-label Period|Adverse Event|1
4518069|NCT00971243|7330078|FG001|Open-label Period|Adverse Event|0
4518070|NCT00971243|7330079|FG002|Open-label Period|Adverse Event|1
4518071|NCT00971243|7330080|FG003|Open-label Period|Adverse Event|1
4518072|NCT00971243|7330081|FG004|Open-label Period|Adverse Event|0
4518073|NCT00971243|7330077|FG000|Open-label Period|Physician Decision|5
4518074|NCT00971243|7330078|FG001|Open-label Period|Physician Decision|9
4518075|NCT00971243|7330079|FG002|Open-label Period|Physician Decision|3
4518076|NCT00971243|7330080|FG003|Open-label Period|Physician Decision|7
4518077|NCT00971243|7330081|FG004|Open-label Period|Physician Decision|2
4518078|NCT00971243|7330077|FG000|Open-label Period|Protocol Violation|1
4518079|NCT00971243|7330078|FG001|Open-label Period|Protocol Violation|1
4518080|NCT00971243|7330079|FG002|Open-label Period|Protocol Violation|1
4627501|NCT01853397|7494180|FG003|Overall Study|Withdrawal by Subject|1
4503915|NCT00873730|7310703|FG000|Overall Study|Protocol Deviation|5
4503916|NCT00873730|7310704|FG001|Overall Study|Protocol Deviation|2
4503917|NCT00873730|7310703|FG000|Overall Study|Adverse Event|0
4503918|NCT00873730|7310704|FG001|Overall Study|Adverse Event|2
4503919|NCT00873730|7310703|FG000|Overall Study|Withdrawal by Subject|0
4503920|NCT00873730|7310704|FG001|Overall Study|Withdrawal by Subject|1
4503921|NCT00873730|7310703|FG000|Overall Study|Sponsor decision|1
4503922|NCT00873730|7310704|FG001|Overall Study|Sponsor decision|0
4503923|NCT00873860|7310727|FG000|Overall Study|Lost to Follow-up|1
4503924|NCT00873860|7310728|FG001|Overall Study|Lost to Follow-up|0
4503925|NCT00873860|7310729|FG002|Overall Study|Lost to Follow-up|0
4503926|NCT00873860|7310730|FG003|Overall Study|Lost to Follow-up|1
4503927|NCT00873860|7310727|FG000|Overall Study|Withdrawal by Subject|1
4503928|NCT00873860|7310728|FG001|Overall Study|Withdrawal by Subject|0
4503929|NCT00873860|7310729|FG002|Overall Study|Withdrawal by Subject|2
4503930|NCT00873860|7310730|FG003|Overall Study|Withdrawal by Subject|0
4503931|NCT00873860|7310727|FG000|Overall Study|Death|1
4503932|NCT00873860|7310728|FG001|Overall Study|Death|0
4503933|NCT00873860|7310729|FG002|Overall Study|Death|0
4503934|NCT00873860|7310730|FG003|Overall Study|Death|0
4503935|NCT00873860|7310727|FG000|Overall Study|Other|1
4503936|NCT00873860|7310728|FG001|Overall Study|Other|0
4503937|NCT00873860|7310729|FG002|Overall Study|Other|1
4503938|NCT00873860|7310730|FG003|Overall Study|Other|0
4503939|NCT00873912|7310762|FG000|Overall Study|Withdrawal by Subject|1
4503940|NCT00873912|7310763|FG001|Overall Study|Withdrawal by Subject|0
4503941|NCT00873912|7310762|FG000|Overall Study|Lost to Follow-up|2
4503942|NCT00873912|7310763|FG001|Overall Study|Lost to Follow-up|0
4503943|NCT00874029|7310769|FG000|Overall Study|Withdrawal by Subject|10
4503944|NCT00874029|7310769|FG000|Overall Study|Pregnancy|4
4503945|NCT00874029|7310769|FG000|Overall Study|Physician Decision|1
4503946|NCT00874029|7310769|FG000|Overall Study|Adverse Event|1
4503947|NCT00874029|7310769|FG000|Overall Study|Lost to Follow-up|5
4503948|NCT00874120|7310789|FG000|First Intervention|Adverse Event|0
4503949|NCT00874120|7310790|FG001|First Intervention|Adverse Event|1
4503950|NCT00874120|7310789|FG000|First Intervention|Withdrawal by Subject|2
4503951|NCT00874120|7310790|FG001|First Intervention|Withdrawal by Subject|0
4627502|NCT01853397|7494177|FG000|Overall Study|Subject Noncompliance|0
4627503|NCT01853397|7494178|FG001|Overall Study|Subject Noncompliance|0
4627504|NCT01853397|7494179|FG002|Overall Study|Subject Noncompliance|0
4627505|NCT01853397|7494180|FG003|Overall Study|Subject Noncompliance|1
4627506|NCT01853462|7494192|FG000|Overall Study|Withdrawal by Subject|1
4627507|NCT01853462|7494193|FG001|Overall Study|Withdrawal by Subject|1
4627508|NCT01853475|7494204|FG000|Overall Study|Withdrawal by Subject|0
4627509|NCT01853475|7494205|FG001|Overall Study|Withdrawal by Subject|1
4627510|NCT01853475|7494206|FG002|Overall Study|Withdrawal by Subject|0
4627511|NCT01853618|7494245|FG000|Overall Study|Bile duct stent blockage/progressive dis|1
4627512|NCT01853618|7494246|FG001|Overall Study|Bile duct stent blockage/progressive dis|0
4627513|NCT01853618|7494247|FG002|Overall Study|Bile duct stent blockage/progressive dis|0
4627514|NCT01853618|7494248|FG003|Overall Study|Bile duct stent blockage/progressive dis|0
4627515|NCT01853618|7494249|FG004|Overall Study|Bile duct stent blockage/progressive dis|0
4627516|NCT01853618|7494245|FG000|Overall Study|Progressive disease|1
4627517|NCT01853618|7494246|FG001|Overall Study|Progressive disease|1
4627518|NCT01853618|7494247|FG002|Overall Study|Progressive disease|1
4627519|NCT01853618|7494248|FG003|Overall Study|Progressive disease|1
4627520|NCT01853618|7494249|FG004|Overall Study|Progressive disease|2
4627521|NCT01853618|7494245|FG000|Overall Study|Physician Decision|0
4627522|NCT01853618|7494246|FG001|Overall Study|Physician Decision|1
4627523|NCT01853618|7494247|FG002|Overall Study|Physician Decision|1
4627524|NCT01853618|7494248|FG003|Overall Study|Physician Decision|0
4627525|NCT01853618|7494249|FG004|Overall Study|Physician Decision|0
4627526|NCT01853618|7494245|FG000|Overall Study|Refused further treatment|0
4627527|NCT01853618|7494246|FG001|Overall Study|Refused further treatment|0
4627528|NCT01853618|7494247|FG002|Overall Study|Refused further treatment|0
4627529|NCT01853618|7494248|FG003|Overall Study|Refused further treatment|0
4627530|NCT01853618|7494249|FG004|Overall Study|Refused further treatment|1
4627531|NCT01853644|7494262|FG000|Registration and Treatment Start|Did not start treatment|1
4627532|NCT01853644|7494262|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2
4627533|NCT01853644|7494262|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1
4627534|NCT01853644|7494262|FG000|Reached First Response/Complete 2 Cycles|Other|1
4627535|NCT01853644|7494262|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2
4627536|NCT01853644|7494262|FG000|Continued Treatment After First Response|Adverse Event|2
4627537|NCT01853644|7494262|FG000|Continued Treatment After First Response|Progressive Diseaes|10
4627538|NCT01853696|7494268|FG000|Overall Study|Withdrawal by Subject|1
4627539|NCT01853696|7494269|FG001|Overall Study|Withdrawal by Subject|1
4627540|NCT01853696|7494268|FG000|Overall Study|Lost to Follow-up|5
4627541|NCT01853696|7494269|FG001|Overall Study|Lost to Follow-up|4
4503952|NCT00874120|7310789|FG000|First Intervention|Lost to Follow-up|0
4503953|NCT00874120|7310790|FG001|First Intervention|Lost to Follow-up|1
4503954|NCT00874120|7310789|FG000|First Intervention|Protocol Violation|3
4503955|NCT00874120|7310790|FG001|First Intervention|Protocol Violation|0
4503956|NCT00874120|7310789|FG000|First Intervention|positive drug test|1
4627542|NCT01853839|7494286|FG000|Overall Study|Violated inclusion criteria|2
4627543|NCT01853839|7494286|FG000|Overall Study|Not meet ITT population definition|58
4627544|NCT01853839|7494286|FG000|Overall Study|End of treatment visit too early|33
4503957|NCT00874120|7310790|FG001|First Intervention|positive drug test|0
4503958|NCT00874120|7310789|FG000|Second Intervention|Withdrawal by Subject|1
4503959|NCT00874120|7310790|FG001|Second Intervention|Withdrawal by Subject|0
4503960|NCT00874120|7310789|FG000|Second Intervention|Protocol Violation|1
4503961|NCT00874120|7310790|FG001|Second Intervention|Protocol Violation|0
4503962|NCT00874237|7310796|FG000|Overall Study|Physician Decision|0
4503963|NCT00874237|7310797|FG001|Overall Study|Physician Decision|1
4503964|NCT00874237|7310798|FG002|Overall Study|Physician Decision|0
4503965|NCT00874237|7310799|FG003|Overall Study|Physician Decision|0
4503966|NCT00874237|7310800|FG004|Overall Study|Physician Decision|0
4503967|NCT00874237|7310801|FG005|Overall Study|Physician Decision|0
4503968|NCT00874237|7310796|FG000|Overall Study|Withdrawal by Subject|0
4503969|NCT00874237|7310797|FG001|Overall Study|Withdrawal by Subject|0
4503970|NCT00874237|7310798|FG002|Overall Study|Withdrawal by Subject|1
4503971|NCT00874237|7310799|FG003|Overall Study|Withdrawal by Subject|0
4503972|NCT00874237|7310800|FG004|Overall Study|Withdrawal by Subject|0
4503973|NCT00874237|7310801|FG005|Overall Study|Withdrawal by Subject|0
4503974|NCT00874276|7310818|FG000|Overall Study|Withdrawal by Subject|1
4503975|NCT00874276|7310819|FG001|Overall Study|Withdrawal by Subject|1
4503976|NCT00874432|7310831|FG000|Overall Study|Withdrawal by Subject|1
4503977|NCT00874432|7310832|FG001|Overall Study|Withdrawal by Subject|0
4503978|NCT00874432|7310833|FG002|Overall Study|Withdrawal by Subject|0
4503979|NCT00874432|7310834|FG003|Overall Study|Withdrawal by Subject|0
4503980|NCT00874432|7310831|FG000|Overall Study|Physician Decision|1
4503981|NCT00874432|7310832|FG001|Overall Study|Physician Decision|0
4503982|NCT00874432|7310833|FG002|Overall Study|Physician Decision|0
4503983|NCT00874432|7310834|FG003|Overall Study|Physician Decision|0
4503984|NCT00874432|7310831|FG000|Overall Study|Other|1
4503985|NCT00874432|7310832|FG001|Overall Study|Other|2
4503986|NCT00874432|7310833|FG002|Overall Study|Other|8
4503987|NCT00874432|7310834|FG003|Overall Study|Other|3
4503988|NCT00874497|7310848|FG000|Overall Study|Lost to Follow-up|2
4503989|NCT00874497|7310849|FG001|Overall Study|Lost to Follow-up|4
4503990|NCT00874497|7310848|FG000|Overall Study|Adverse Event|9
4503991|NCT00874497|7310849|FG001|Overall Study|Adverse Event|4
4503992|NCT00874497|7310848|FG000|Overall Study|Sponsor Discontinued Trial|7
4503993|NCT00874497|7310849|FG001|Overall Study|Sponsor Discontinued Trial|3
4503994|NCT00874497|7310848|FG000|Overall Study|Met Withdrawal Criteria|4
4503995|NCT00874497|7310849|FG001|Overall Study|Met Withdrawal Criteria|2
4503996|NCT00874497|7310848|FG000|Overall Study|Physician Decision|1
4503997|NCT00874497|7310849|FG001|Overall Study|Physician Decision|1
4503998|NCT00874497|7310848|FG000|Overall Study|Withdrawal by Subject|5
4503999|NCT00874497|7310849|FG001|Overall Study|Withdrawal by Subject|4
4504000|NCT00874549|7310868|FG000|Overall Study|Adverse Event|0
4504001|NCT00874549|7310869|FG001|Overall Study|Adverse Event|0
4504002|NCT00874549|7310870|FG002|Overall Study|Adverse Event|1
4504003|NCT00874549|7310871|FG003|Overall Study|Adverse Event|0
4504004|NCT00874549|7310868|FG000|Overall Study|Protocol Violation|1
4504005|NCT00874549|7310869|FG001|Overall Study|Protocol Violation|0
4504006|NCT00874549|7310870|FG002|Overall Study|Protocol Violation|2
4504007|NCT00874549|7310871|FG003|Overall Study|Protocol Violation|1
4504008|NCT00874549|7310868|FG000|Overall Study|Lost to Follow-up|0
4504009|NCT00874549|7310869|FG001|Overall Study|Lost to Follow-up|0
4504010|NCT00874549|7310870|FG002|Overall Study|Lost to Follow-up|1
4504011|NCT00874549|7310871|FG003|Overall Study|Lost to Follow-up|0
4504012|NCT00874549|7310868|FG000|Overall Study|Withdrawal by Subject|0
4504013|NCT00874549|7310869|FG001|Overall Study|Withdrawal by Subject|1
4504014|NCT00874549|7310870|FG002|Overall Study|Withdrawal by Subject|0
4504015|NCT00874549|7310871|FG003|Overall Study|Withdrawal by Subject|1
4504016|NCT00874731|7310887|FG000|Part 1, Day 1: Placebo|Disease Progression|1
4504017|NCT00874731|7310888|FG001|Part 1, Day 1: Placebo|Disease Progression|0
4504018|NCT00874731|7310889|FG002|Part 1, Day 1: Placebo|Disease Progression|0
4504019|NCT00874731|7310887|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0
4504020|NCT00874731|7310888|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0
4504021|NCT00874731|7310889|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3
4504022|NCT00874731|7310887|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0
4504023|NCT00874731|7310888|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0
4504024|NCT00874731|7310889|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19
4504025|NCT00874770|7310901|FG000|Overall Study|Lack of Efficacy|2
4627545|NCT01853839|7494286|FG000|Overall Study|Lost to follow-up or no valid BP measure|336
4504026|NCT00874770|7310902|FG001|Overall Study|Lack of Efficacy|0
4504027|NCT00874770|7310903|FG002|Overall Study|Lack of Efficacy|0
4504028|NCT00874770|7310904|FG003|Overall Study|Lack of Efficacy|2
4504029|NCT00874770|7310901|FG000|Overall Study|Adverse Event|1
4504030|NCT00874770|7310902|FG001|Overall Study|Adverse Event|1
4504031|NCT00874770|7310903|FG002|Overall Study|Adverse Event|4
4504032|NCT00874770|7310904|FG003|Overall Study|Adverse Event|2
4504033|NCT00874770|7310901|FG000|Overall Study|Lost to Follow-up|1
4504034|NCT00874770|7310902|FG001|Overall Study|Lost to Follow-up|0
4504035|NCT00874770|7310903|FG002|Overall Study|Lost to Follow-up|0
4504036|NCT00874770|7310904|FG003|Overall Study|Lost to Follow-up|1
4504037|NCT00874770|7310901|FG000|Overall Study|Subject no Longer Meets Study Criteria|1
4504038|NCT00874770|7310902|FG001|Overall Study|Subject no Longer Meets Study Criteria|0
4504039|NCT00874770|7310903|FG002|Overall Study|Subject no Longer Meets Study Criteria|0
4504040|NCT00874770|7310904|FG003|Overall Study|Subject no Longer Meets Study Criteria|0
4504041|NCT00874822|7310924|FG000|Overall Study|excluded by criteria|8
4504042|NCT00874848|7310930|FG000|Overall Study|Adverse Event|13
4504043|NCT00874848|7310931|FG001|Overall Study|Adverse Event|2
4504044|NCT00874848|7310930|FG000|Overall Study|Progressive neoplastic disease|38
4504045|NCT00874848|7310931|FG001|Overall Study|Progressive neoplastic disease|18
4504046|NCT00874848|7310930|FG000|Overall Study|Withdrawal by Subject|7
4504047|NCT00874848|7310931|FG001|Overall Study|Withdrawal by Subject|4
4504048|NCT00874848|7310930|FG000|Overall Study|Noncompliance|1
4504049|NCT00874848|7310931|FG001|Overall Study|Noncompliance|1
4504050|NCT00874848|7310930|FG000|Overall Study|Failure to comply with protocol|0
4504051|NCT00874848|7310931|FG001|Overall Study|Failure to comply with protocol|1
4504052|NCT00874848|7310930|FG000|Overall Study|Physician Decision|0
4504053|NCT00874848|7310931|FG001|Overall Study|Physician Decision|2
4504054|NCT00875017|7310952|FG000|First Intervention|Withdrawal by Subject|1
4504055|NCT00875017|7310953|FG001|First Intervention|Withdrawal by Subject|0
4504056|NCT00875017|7310954|FG002|First Intervention|Withdrawal by Subject|1
4504057|NCT00875017|7310955|FG003|First Intervention|Withdrawal by Subject|0
4504058|NCT00875017|7310956|FG004|First Intervention|Withdrawal by Subject|0
4504059|NCT00875017|7310957|FG005|First Intervention|Withdrawal by Subject|0
4504060|NCT00875017|7310952|FG000|First Intervention|Adverse Event|0
4504061|NCT00875017|7310953|FG001|First Intervention|Adverse Event|0
4627546|NCT01853878|7494296|FG000|Overall Study|Recurrence|2
4627547|NCT01853878|7494297|FG001|Overall Study|Recurrence|0
4627548|NCT01853878|7494296|FG000|Overall Study|Adverse Event|2
4627549|NCT01853878|7494297|FG001|Overall Study|Adverse Event|0
4627550|NCT01853878|7494296|FG000|Overall Study|Withdrawal by Subject|3
4627551|NCT01853878|7494297|FG001|Overall Study|Withdrawal by Subject|1
4627552|NCT01853878|7494296|FG000|Overall Study|Migrated/moved from the study area|1
4627553|NCT01853878|7494297|FG001|Overall Study|Migrated/moved from the study area|0
4627554|NCT01853878|7494296|FG000|Overall Study|Other|55
4627555|NCT01853878|7494297|FG001|Overall Study|Other|43
4504062|NCT00875017|7310954|FG002|First Intervention|Adverse Event|0
4504063|NCT00875017|7310955|FG003|First Intervention|Adverse Event|1
4504064|NCT00875017|7310956|FG004|First Intervention|Adverse Event|0
4504065|NCT00875017|7310957|FG005|First Intervention|Adverse Event|0
4504066|NCT00875017|7310952|FG000|First Intervention|Problems collecting rectal effluent|1
4504067|NCT00875017|7310953|FG001|First Intervention|Problems collecting rectal effluent|0
4504068|NCT00875017|7310954|FG002|First Intervention|Problems collecting rectal effluent|0
4504069|NCT00875017|7310955|FG003|First Intervention|Problems collecting rectal effluent|0
4504070|NCT00875017|7310956|FG004|First Intervention|Problems collecting rectal effluent|0
4504071|NCT00875017|7310957|FG005|First Intervention|Problems collecting rectal effluent|0
4504072|NCT00875017|7310952|FG000|First Intervention|Intolerance to nasogastric tube|0
4504073|NCT00875017|7310953|FG001|First Intervention|Intolerance to nasogastric tube|0
4504074|NCT00875017|7310954|FG002|First Intervention|Intolerance to nasogastric tube|0
4504075|NCT00875017|7310955|FG003|First Intervention|Intolerance to nasogastric tube|0
4504076|NCT00875017|7310956|FG004|First Intervention|Intolerance to nasogastric tube|1
4504077|NCT00875017|7310957|FG005|First Intervention|Intolerance to nasogastric tube|0
4504078|NCT00875017|7310952|FG000|Washout|Problem collecting rectal effluent|0
4504079|NCT00875017|7310953|FG001|Washout|Problem collecting rectal effluent|0
4504080|NCT00875017|7310954|FG002|Washout|Problem collecting rectal effluent|1
4504081|NCT00875017|7310955|FG003|Washout|Problem collecting rectal effluent|0
4504082|NCT00875017|7310956|FG004|Washout|Problem collecting rectal effluent|0
4504083|NCT00875017|7310957|FG005|Washout|Problem collecting rectal effluent|0
4504084|NCT00875017|7310952|FG000|Second Intervention|Adverse Event|0
4504085|NCT00875017|7310953|FG001|Second Intervention|Adverse Event|0
4504086|NCT00875017|7310954|FG002|Second Intervention|Adverse Event|0
4504087|NCT00875017|7310955|FG003|Second Intervention|Adverse Event|1
4504088|NCT00875017|7310956|FG004|Second Intervention|Adverse Event|0
4504089|NCT00875017|7310957|FG005|Second Intervention|Adverse Event|0
4504090|NCT00875017|7310952|FG000|Washout|Problems collecting rectal effluent|0
4504091|NCT00875017|7310953|FG001|Washout|Problems collecting rectal effluent|1
4504092|NCT00875017|7310954|FG002|Washout|Problems collecting rectal effluent|0
4504093|NCT00875017|7310955|FG003|Washout|Problems collecting rectal effluent|0
4504094|NCT00875017|7310956|FG004|Washout|Problems collecting rectal effluent|0
4504095|NCT00875017|7310957|FG005|Washout|Problems collecting rectal effluent|0
4504096|NCT00875017|7310952|FG000|Third Intervention|Adverse Event|0
4504097|NCT00875017|7310953|FG001|Third Intervention|Adverse Event|1
4504098|NCT00875017|7310954|FG002|Third Intervention|Adverse Event|1
4504099|NCT00875017|7310955|FG003|Third Intervention|Adverse Event|0
4504100|NCT00875017|7310956|FG004|Third Intervention|Adverse Event|0
4504101|NCT00875017|7310957|FG005|Third Intervention|Adverse Event|0
4504102|NCT00875017|7310952|FG000|Washout|Withdrawal by Subject|0
4504103|NCT00875017|7310953|FG001|Washout|Withdrawal by Subject|0
4504104|NCT00875017|7310954|FG002|Washout|Withdrawal by Subject|0
4504105|NCT00875017|7310955|FG003|Washout|Withdrawal by Subject|0
4627556|NCT01854047|7494321|FG000|Overall Study|Lack of Efficacy|1
4627557|NCT01854047|7494322|FG001|Overall Study|Lack of Efficacy|0
4504106|NCT00875017|7310956|FG004|Washout|Withdrawal by Subject|1
4504107|NCT00875017|7310957|FG005|Washout|Withdrawal by Subject|0
4504108|NCT00875017|7310952|FG000|Fourth Intervention|Inability to comply with fasting|0
4504109|NCT00875017|7310953|FG001|Fourth Intervention|Inability to comply with fasting|0
4504110|NCT00875017|7310954|FG002|Fourth Intervention|Inability to comply with fasting|0
4504111|NCT00875017|7310955|FG003|Fourth Intervention|Inability to comply with fasting|0
4504112|NCT00875017|7310956|FG004|Fourth Intervention|Inability to comply with fasting|0
4504113|NCT00875017|7310957|FG005|Fourth Intervention|Inability to comply with fasting|1
4504114|NCT00875056|7310973|FG000|Overall Study|Adverse Event|6
4504115|NCT00875056|7310974|FG001|Overall Study|Adverse Event|1
4504116|NCT00875056|7310975|FG002|Overall Study|Adverse Event|2
4504117|NCT00875056|7310973|FG000|Overall Study|Progressive Disease|14
4504118|NCT00875056|7310974|FG001|Overall Study|Progressive Disease|8
4504119|NCT00875056|7310975|FG002|Overall Study|Progressive Disease|3
4504120|NCT00875056|7310973|FG000|Overall Study|Withdrawal by Subject|3
4504121|NCT00875056|7310974|FG001|Overall Study|Withdrawal by Subject|0
4504122|NCT00875056|7310975|FG002|Overall Study|Withdrawal by Subject|1
4504123|NCT00875420|7311023|FG000|Overall Study|Adverse Event|0
4504124|NCT00875420|7311024|FG001|Overall Study|Adverse Event|1
4504125|NCT00875420|7311025|FG002|Overall Study|Adverse Event|1
4504126|NCT00875420|7311026|FG003|Overall Study|Adverse Event|0
4504127|NCT00875420|7311027|FG004|Overall Study|Adverse Event|0
4504128|NCT00875420|7311023|FG000|Overall Study|Inability to complete study procedures|1
4504129|NCT00875420|7311024|FG001|Overall Study|Inability to complete study procedures|0
4504130|NCT00875420|7311025|FG002|Overall Study|Inability to complete study procedures|1
4504131|NCT00875420|7311026|FG003|Overall Study|Inability to complete study procedures|1
4504132|NCT00875420|7311027|FG004|Overall Study|Inability to complete study procedures|1
4504133|NCT00875420|7311023|FG000|Overall Study|Lost to Follow-up|1
4504134|NCT00875420|7311024|FG001|Overall Study|Lost to Follow-up|0
4504135|NCT00875420|7311025|FG002|Overall Study|Lost to Follow-up|0
4504136|NCT00875420|7311026|FG003|Overall Study|Lost to Follow-up|0
4504137|NCT00875420|7311027|FG004|Overall Study|Lost to Follow-up|0
4504138|NCT00875420|7311023|FG000|Overall Study|Personal reason|0
4504139|NCT00875420|7311024|FG001|Overall Study|Personal reason|0
4504140|NCT00875420|7311025|FG002|Overall Study|Personal reason|0
4504141|NCT00875420|7311026|FG003|Overall Study|Personal reason|0
4504142|NCT00875420|7311027|FG004|Overall Study|Personal reason|1
4504143|NCT00875420|7311023|FG000|Overall Study|Prohibited medication|0
4504144|NCT00875420|7311024|FG001|Overall Study|Prohibited medication|0
4504145|NCT00875420|7311025|FG002|Overall Study|Prohibited medication|0
4504146|NCT00875420|7311026|FG003|Overall Study|Prohibited medication|1
4504147|NCT00875420|7311027|FG004|Overall Study|Prohibited medication|0
4504148|NCT00875420|7311023|FG000|Overall Study|Sponsor decision|0
4504149|NCT00875420|7311024|FG001|Overall Study|Sponsor decision|1
4504150|NCT00875420|7311025|FG002|Overall Study|Sponsor decision|0
4504151|NCT00875420|7311026|FG003|Overall Study|Sponsor decision|0
4504152|NCT00875420|7311027|FG004|Overall Study|Sponsor decision|0
4504153|NCT00875420|7311023|FG000|Overall Study|Withdrawal by Subject|0
4504154|NCT00875420|7311024|FG001|Overall Study|Withdrawal by Subject|0
4504155|NCT00875420|7311025|FG002|Overall Study|Withdrawal by Subject|1
4504156|NCT00875420|7311026|FG003|Overall Study|Withdrawal by Subject|0
4504157|NCT00875420|7311027|FG004|Overall Study|Withdrawal by Subject|0
4504158|NCT00875433|7311039|FG000|Overall Study|Progressive disease|41
4504159|NCT00875433|7311039|FG000|Overall Study|Other Adverse Event|14
4504160|NCT00875433|7311039|FG000|Overall Study|Withdrawal by Subject|2
4504161|NCT00875433|7311039|FG000|Overall Study|Other|3
4504162|NCT00875485|7311045|FG000|Challenge Dose Epoch|Pregnancy|1
4504163|NCT00875485|7311046|FG001|Challenge Dose Epoch|Pregnancy|0
4504164|NCT00875563|7311063|FG000|Overall Study|Death|4
4504165|NCT00875563|7311063|FG000|Overall Study|Withdrawal by Subject|7
4504166|NCT00875563|7311063|FG000|Overall Study|No long-term (3-5 year) consent|6
4504167|NCT00875563|7311063|FG000|Overall Study|Still be eligible for follow-up|7
4504168|NCT00875615|7311076|FG000|Overall Study|Withdrawal by Subject|1
4504169|NCT00875667|7311095|FG000|Overall Study|Adverse Event|29
4504170|NCT00875667|7311096|FG001|Overall Study|Adverse Event|10
4504171|NCT00875667|7311095|FG000|Overall Study|Withdrawal by Subject|17
4504172|NCT00875667|7311096|FG001|Overall Study|Withdrawal by Subject|5
4504173|NCT00875667|7311095|FG000|Overall Study|Death|7
4504174|NCT00875667|7311096|FG001|Overall Study|Death|2
4504175|NCT00875667|7311095|FG000|Overall Study|Protocol Violation|2
4504176|NCT00875667|7311096|FG001|Overall Study|Protocol Violation|0
4504177|NCT00875667|7311095|FG000|Overall Study|Disease Progression|100
4504178|NCT00875667|7311096|FG001|Overall Study|Disease Progression|49
4504179|NCT00875667|7311095|FG000|Overall Study|Miscellaneous|12
4504180|NCT00875667|7311096|FG001|Overall Study|Miscellaneous|6
4504181|NCT00875667|7311095|FG000|Overall Study|Randomized but no Study Drug Given|3
4504182|NCT00875667|7311096|FG001|Overall Study|Randomized but no Study Drug Given|1
4504183|NCT00875706|7311105|FG000|Overall Study|Withdrawal by Subject|1
4504184|NCT00875706|7311106|FG001|Overall Study|Withdrawal by Subject|0
4504185|NCT00875706|7311107|FG002|Overall Study|Withdrawal by Subject|0
4504186|NCT00875797|7311117|FG000|Overall Study|Protocol Violation|6
4504187|NCT00875797|7311118|FG001|Overall Study|Protocol Violation|3
4504188|NCT00875810|7311127|FG000|Overall Study|Withdrawal by Subject|1
4504189|NCT00875810|7311127|FG000|Overall Study|Physician Decision|3
4504190|NCT00875810|7311127|FG000|Overall Study|Lost to Follow-up|39
4504191|NCT00875810|7311127|FG000|Overall Study|Patient enroled but not implanted|2
4504192|NCT00875810|7311127|FG000|Overall Study|Device explanted|1
4504193|NCT00875979|7311142|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1
4504194|NCT00875979|7311143|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0
4504195|NCT00875979|7311142|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1
4504196|NCT00875979|7311143|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0
4504197|NCT00875979|7311142|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1
4504198|NCT00875979|7311143|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0
4504199|NCT00875979|7311142|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0
4504200|NCT00875979|7311143|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6
4504201|NCT00875979|7311142|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0
4504202|NCT00875979|7311143|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37
4504203|NCT00875979|7311142|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0
4504204|NCT00875979|7311143|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3
4504205|NCT00875979|7311142|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0
4504206|NCT00875979|7311143|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3
4504207|NCT00875979|7311142|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0
4504208|NCT00875979|7311143|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3
4504209|NCT00875979|7311142|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0
4504210|NCT00875979|7311143|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1
4504211|NCT00876018|7311152|FG000|Overall Study|Lost to Follow-up|0
4627558|NCT01854047|7494323|FG002|Overall Study|Lack of Efficacy|0
4627559|NCT01854047|7494324|FG003|Overall Study|Lack of Efficacy|0
4627560|NCT01854047|7494325|FG004|Overall Study|Lack of Efficacy|0
4627561|NCT01854047|7494321|FG000|Overall Study|Poor compliance to protocol|3
4627562|NCT01854047|7494322|FG001|Overall Study|Poor compliance to protocol|0
4627563|NCT01854047|7494323|FG002|Overall Study|Poor compliance to protocol|2
4627564|NCT01854047|7494324|FG003|Overall Study|Poor compliance to protocol|0
4627565|NCT01854047|7494325|FG004|Overall Study|Poor compliance to protocol|0
4627566|NCT01854047|7494321|FG000|Overall Study|Adverse Event|5
4627567|NCT01854047|7494322|FG001|Overall Study|Adverse Event|4
4627568|NCT01854047|7494323|FG002|Overall Study|Adverse Event|6
4627569|NCT01854047|7494324|FG003|Overall Study|Adverse Event|10
4627570|NCT01854047|7494325|FG004|Overall Study|Adverse Event|7
4627571|NCT01854047|7494321|FG000|Overall Study|Randomized but not treated|0
4627572|NCT01854047|7494322|FG001|Overall Study|Randomized but not treated|1
4627573|NCT01854047|7494323|FG002|Overall Study|Randomized but not treated|2
4627574|NCT01854047|7494324|FG003|Overall Study|Randomized but not treated|0
4627575|NCT01854047|7494325|FG004|Overall Study|Randomized but not treated|4
4627576|NCT01854047|7494321|FG000|Overall Study|Other than specified above|3
4627577|NCT01854047|7494322|FG001|Overall Study|Other than specified above|3
4627578|NCT01854047|7494323|FG002|Overall Study|Other than specified above|3
4627579|NCT01854047|7494324|FG003|Overall Study|Other than specified above|5
4627580|NCT01854047|7494325|FG004|Overall Study|Other than specified above|8
4627581|NCT01854528|7494393|FG000|Overall Study|Adverse Event|0
4627582|NCT01854528|7494394|FG001|Overall Study|Adverse Event|4
4627583|NCT01854528|7494393|FG000|Overall Study|Withdrawal by Subject|0
4627584|NCT01854528|7494394|FG001|Overall Study|Withdrawal by Subject|2
4627585|NCT01854528|7494393|FG000|Overall Study|Virologic Failure|0
4627586|NCT01854528|7494394|FG001|Overall Study|Virologic Failure|9
4627587|NCT01854645|7494424|FG000|Overall Study|Protocol-Specified Criteria|13
4627588|NCT01854645|7494425|FG001|Overall Study|Protocol-Specified Criteria|10
4627589|NCT01854645|7494426|FG002|Overall Study|Protocol-Specified Criteria|8
4627590|NCT01854645|7494427|FG003|Overall Study|Protocol-Specified Criteria|5
4627591|NCT01854645|7494428|FG004|Overall Study|Protocol-Specified Criteria|7
4627592|NCT01854645|7494424|FG000|Overall Study|Administrative Reasons / Missing|0
4627593|NCT01854645|7494425|FG001|Overall Study|Administrative Reasons / Missing|0
4627594|NCT01854645|7494426|FG002|Overall Study|Administrative Reasons / Missing|0
4627595|NCT01854645|7494427|FG003|Overall Study|Administrative Reasons / Missing|1
4627596|NCT01854645|7494428|FG004|Overall Study|Administrative Reasons / Missing|1
4627597|NCT01854645|7494424|FG000|Overall Study|Protocol Violation|3
4627598|NCT01854645|7494425|FG001|Overall Study|Protocol Violation|0
4627599|NCT01854645|7494426|FG002|Overall Study|Protocol Violation|5
4627600|NCT01854645|7494427|FG003|Overall Study|Protocol Violation|4
4627601|NCT01854645|7494428|FG004|Overall Study|Protocol Violation|1
4627602|NCT01854645|7494424|FG000|Overall Study|Lost to Follow-up|10
4627603|NCT01854645|7494425|FG001|Overall Study|Lost to Follow-up|7
4627604|NCT01854645|7494426|FG002|Overall Study|Lost to Follow-up|8
4627605|NCT01854645|7494427|FG003|Overall Study|Lost to Follow-up|5
4627606|NCT01854645|7494428|FG004|Overall Study|Lost to Follow-up|0
4627607|NCT01854645|7494424|FG000|Overall Study|Physician Decision|1
4627608|NCT01854645|7494425|FG001|Overall Study|Physician Decision|5
4627609|NCT01854645|7494426|FG002|Overall Study|Physician Decision|3
4627610|NCT01854645|7494427|FG003|Overall Study|Physician Decision|3
4627611|NCT01854645|7494428|FG004|Overall Study|Physician Decision|7
4627612|NCT01854645|7494424|FG000|Overall Study|Withdrawal by Subject|31
4627613|NCT01854645|7494425|FG001|Overall Study|Withdrawal by Subject|41
4627614|NCT01854645|7494426|FG002|Overall Study|Withdrawal by Subject|30
4504212|NCT00876018|7311153|FG001|Overall Study|Lost to Follow-up|1
4504213|NCT00876018|7311154|FG002|Overall Study|Lost to Follow-up|1
4504214|NCT00876018|7311152|FG000|Overall Study|Withdrew Consent due to Adverse Event|5
4504215|NCT00876018|7311153|FG001|Overall Study|Withdrew Consent due to Adverse Event|4
4504216|NCT00876018|7311154|FG002|Overall Study|Withdrew Consent due to Adverse Event|2
4504217|NCT00876187|7311169|FG000|Overall Study|Adverse Event|14
4504218|NCT00876187|7311170|FG001|Overall Study|Adverse Event|12
4504219|NCT00876187|7311171|FG002|Overall Study|Adverse Event|19
4504220|NCT00876187|7311172|FG003|Overall Study|Adverse Event|29
4504221|NCT00876187|7311173|FG004|Overall Study|Adverse Event|10
4504222|NCT00876187|7311169|FG000|Overall Study|Lack of Efficacy|59
4504223|NCT00876187|7311170|FG001|Overall Study|Lack of Efficacy|34
4504224|NCT00876187|7311171|FG002|Overall Study|Lack of Efficacy|45
4504225|NCT00876187|7311172|FG003|Overall Study|Lack of Efficacy|34
4504226|NCT00876187|7311173|FG004|Overall Study|Lack of Efficacy|59
4504227|NCT00876187|7311169|FG000|Overall Study|Lost to Follow-up|9
4504228|NCT00876187|7311170|FG001|Overall Study|Lost to Follow-up|10
4504229|NCT00876187|7311171|FG002|Overall Study|Lost to Follow-up|8
4504230|NCT00876187|7311172|FG003|Overall Study|Lost to Follow-up|8
4504231|NCT00876187|7311173|FG004|Overall Study|Lost to Follow-up|11
4504232|NCT00876187|7311169|FG000|Overall Study|Protocol Violation|6
4504233|NCT00876187|7311170|FG001|Overall Study|Protocol Violation|7
4504234|NCT00876187|7311171|FG002|Overall Study|Protocol Violation|7
4504235|NCT00876187|7311172|FG003|Overall Study|Protocol Violation|6
4504236|NCT00876187|7311173|FG004|Overall Study|Protocol Violation|3
4504237|NCT00876187|7311169|FG000|Overall Study|Withdrawal by Subject|16
4504238|NCT00876187|7311170|FG001|Overall Study|Withdrawal by Subject|26
4504239|NCT00876187|7311171|FG002|Overall Study|Withdrawal by Subject|32
4504240|NCT00876187|7311172|FG003|Overall Study|Withdrawal by Subject|38
4504241|NCT00876187|7311173|FG004|Overall Study|Withdrawal by Subject|37
4504242|NCT00876187|7311169|FG000|Overall Study|Entered extension study|101
4504243|NCT00876187|7311170|FG001|Overall Study|Entered extension study|120
4504244|NCT00876187|7311171|FG002|Overall Study|Entered extension study|156
4504245|NCT00876187|7311172|FG003|Overall Study|Entered extension study|151
4504246|NCT00876187|7311173|FG004|Overall Study|Entered extension study|144
4504247|NCT00876187|7311169|FG000|Overall Study|Randomized but not treated|3
4504248|NCT00876187|7311170|FG001|Overall Study|Randomized but not treated|1
4504249|NCT00876187|7311171|FG002|Overall Study|Randomized but not treated|3
4504250|NCT00876187|7311172|FG003|Overall Study|Randomized but not treated|2
4504251|NCT00876187|7311173|FG004|Overall Study|Randomized but not treated|3
4504252|NCT00876187|7311169|FG000|Overall Study|Other|2
4504253|NCT00876187|7311170|FG001|Overall Study|Other|5
4504254|NCT00876187|7311171|FG002|Overall Study|Other|9
4504255|NCT00876187|7311172|FG003|Overall Study|Other|7
4504256|NCT00876187|7311173|FG004|Overall Study|Other|4
4504257|NCT00876265|7311197|FG000|Overall Study|Miscellaneous reasons|4
4504258|NCT00876265|7311197|FG000|Overall Study|Lost to Follow-up|6
4504259|NCT00876265|7311197|FG000|Overall Study|Withdrawal by Subject|2
4504260|NCT00876343|7311206|FG000|Overall Study|Adverse Event|7
4504261|NCT00876343|7311207|FG001|Overall Study|Adverse Event|8
4504262|NCT00876343|7311208|FG002|Overall Study|Adverse Event|2
4504263|NCT00876343|7311206|FG000|Overall Study|Withdrawal by Subject|4
4504264|NCT00876343|7311207|FG001|Overall Study|Withdrawal by Subject|4
4504265|NCT00876343|7311208|FG002|Overall Study|Withdrawal by Subject|3
4504266|NCT00876343|7311206|FG000|Overall Study|Lack of Efficacy|0
4504267|NCT00876343|7311207|FG001|Overall Study|Lack of Efficacy|0
4504268|NCT00876343|7311208|FG002|Overall Study|Lack of Efficacy|1
4504269|NCT00876343|7311206|FG000|Overall Study|Protocol Violation|4
4504270|NCT00876343|7311207|FG001|Overall Study|Protocol Violation|1
4504271|NCT00876343|7311208|FG002|Overall Study|Protocol Violation|1
4504272|NCT00876343|7311206|FG000|Overall Study|Physician Decision|0
4504273|NCT00876343|7311207|FG001|Overall Study|Physician Decision|1
4504274|NCT00876343|7311208|FG002|Overall Study|Physician Decision|1
4504275|NCT00876343|7311206|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0
4504276|NCT00876343|7311207|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1
4504277|NCT00876343|7311208|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1
4504278|NCT00876343|7311206|FG000|Overall Study|Change of residence or other commitments|2
4504279|NCT00876343|7311207|FG001|Overall Study|Change of residence or other commitments|2
4504280|NCT00876343|7311208|FG002|Overall Study|Change of residence or other commitments|3
4504281|NCT00876395|7311218|FG000|Overall Study|Untreated|8
4504282|NCT00876395|7311219|FG001|Overall Study|Untreated|1
4504283|NCT00876395|7311218|FG000|Overall Study|Adverse Event|63
4504284|NCT00876395|7311219|FG001|Overall Study|Adverse Event|11
4504285|NCT00876395|7311218|FG000|Overall Study|Abnormal test procedure result(s)|1
4504286|NCT00876395|7311219|FG001|Overall Study|Abnormal test procedure result(s)|0
4504287|NCT00876395|7311218|FG000|Overall Study|Disease progression|259
4504288|NCT00876395|7311219|FG001|Overall Study|Disease progression|162
4504289|NCT00876395|7311218|FG000|Overall Study|New cancer therapy|25
4504290|NCT00876395|7311219|FG001|Overall Study|New cancer therapy|7
4504291|NCT00876395|7311218|FG000|Overall Study|Protocol Violation|5
4504292|NCT00876395|7311219|FG001|Overall Study|Protocol Violation|2
4504293|NCT00876395|7311218|FG000|Overall Study|Withdrawal by Subject|66
4504294|NCT00876395|7311219|FG001|Overall Study|Withdrawal by Subject|33
4504295|NCT00876395|7311218|FG000|Overall Study|Lost to Follow-up|2
4504296|NCT00876395|7311219|FG001|Overall Study|Lost to Follow-up|0
4504297|NCT00876395|7311218|FG000|Overall Study|Administrative problems|39
4504298|NCT00876395|7311219|FG001|Overall Study|Administrative problems|23
4504299|NCT00876395|7311218|FG000|Overall Study|Death|12
4504300|NCT00876395|7311219|FG001|Overall Study|Death|0
4627615|NCT01854645|7494427|FG003|Overall Study|Withdrawal by Subject|21
4627616|NCT01854645|7494428|FG004|Overall Study|Withdrawal by Subject|24
4627617|NCT01854645|7494424|FG000|Overall Study|Lack of Efficacy|7
4627618|NCT01854645|7494425|FG001|Overall Study|Lack of Efficacy|12
4627619|NCT01854645|7494426|FG002|Overall Study|Lack of Efficacy|9
4627620|NCT01854645|7494427|FG003|Overall Study|Lack of Efficacy|3
4627621|NCT01854645|7494428|FG004|Overall Study|Lack of Efficacy|9
4627622|NCT01854645|7494424|FG000|Overall Study|Adverse Event|33
4627623|NCT01854645|7494425|FG001|Overall Study|Adverse Event|31
4627624|NCT01854645|7494426|FG002|Overall Study|Adverse Event|19
4627625|NCT01854645|7494427|FG003|Overall Study|Adverse Event|20
4627626|NCT01854645|7494428|FG004|Overall Study|Adverse Event|11
4627627|NCT01854658|7494444|FG000|Overall Study|Protocol Violation|6
4627628|NCT01854658|7494445|FG001|Overall Study|Protocol Violation|2
4627629|NCT01854658|7494446|FG002|Overall Study|Protocol Violation|2
4627630|NCT01854658|7494447|FG003|Overall Study|Protocol Violation|1
4504301|NCT00876447|7311232|FG000|Overall Study|Other miscellaneous reasons|3
4504302|NCT00876447|7311233|FG001|Overall Study|Other miscellaneous reasons|8
4504303|NCT00876447|7311232|FG000|Overall Study|Site closure|19
4504304|NCT00876447|7311233|FG001|Overall Study|Site closure|14
4504305|NCT00876447|7311232|FG000|Overall Study|Protocol Violation|9
4504306|NCT00876447|7311233|FG001|Overall Study|Protocol Violation|3
4504307|NCT00876447|7311232|FG000|Overall Study|Personal reasons|30
4504308|NCT00876447|7311233|FG001|Overall Study|Personal reasons|28
4504309|NCT00876447|7311232|FG000|Overall Study|Lost to Follow-up|6
4504310|NCT00876447|7311233|FG001|Overall Study|Lost to Follow-up|15
4504311|NCT00876447|7311232|FG000|Overall Study|Pregnancy|4
4504312|NCT00876447|7311233|FG001|Overall Study|Pregnancy|2
4504313|NCT00876447|7311232|FG000|Overall Study|Lack of Efficacy|5
4504314|NCT00876447|7311233|FG001|Overall Study|Lack of Efficacy|3
4504315|NCT00876447|7311232|FG000|Overall Study|Adverse Event|4
4504316|NCT00876447|7311233|FG001|Overall Study|Adverse Event|8
4504317|NCT00876460|7311271|FG000|Combination Therapy Phase|Progressive disease|2
4504318|NCT00876460|7311272|FG001|Combination Therapy Phase|Progressive disease|3
4504319|NCT00876460|7311273|FG002|Combination Therapy Phase|Progressive disease|3
4504320|NCT00876460|7311274|FG003|Combination Therapy Phase|Progressive disease|3
4504321|NCT00876460|7311275|FG004|Combination Therapy Phase|Progressive disease|3
4504322|NCT00876460|7311276|FG005|Combination Therapy Phase|Progressive disease|1
4504323|NCT00876460|7311277|FG006|Combination Therapy Phase|Progressive disease|1
4504324|NCT00876460|7311278|FG007|Combination Therapy Phase|Progressive disease|1
4504325|NCT00876460|7311271|FG000|Combination Therapy Phase|Dose limiting toxicity|0
4504326|NCT00876460|7311272|FG001|Combination Therapy Phase|Dose limiting toxicity|1
4504327|NCT00876460|7311273|FG002|Combination Therapy Phase|Dose limiting toxicity|0
4504328|NCT00876460|7311274|FG003|Combination Therapy Phase|Dose limiting toxicity|1
4504329|NCT00876460|7311275|FG004|Combination Therapy Phase|Dose limiting toxicity|1
4504330|NCT00876460|7311276|FG005|Combination Therapy Phase|Dose limiting toxicity|2
4504331|NCT00876460|7311277|FG006|Combination Therapy Phase|Dose limiting toxicity|2
4504332|NCT00876460|7311278|FG007|Combination Therapy Phase|Dose limiting toxicity|1
4504333|NCT00876460|7311271|FG000|Combination Therapy Phase|Adverse Event|0
4504334|NCT00876460|7311272|FG001|Combination Therapy Phase|Adverse Event|2
4504335|NCT00876460|7311273|FG002|Combination Therapy Phase|Adverse Event|0
4504336|NCT00876460|7311274|FG003|Combination Therapy Phase|Adverse Event|2
4504337|NCT00876460|7311275|FG004|Combination Therapy Phase|Adverse Event|2
4504338|NCT00876460|7311276|FG005|Combination Therapy Phase|Adverse Event|0
4504339|NCT00876460|7311277|FG006|Combination Therapy Phase|Adverse Event|3
4504340|NCT00876460|7311278|FG007|Combination Therapy Phase|Adverse Event|2
4504341|NCT00876460|7311271|FG000|Combination Therapy Phase|Withdrawal by Subject|1
4504342|NCT00876460|7311272|FG001|Combination Therapy Phase|Withdrawal by Subject|1
4504343|NCT00876460|7311273|FG002|Combination Therapy Phase|Withdrawal by Subject|0
4504344|NCT00876460|7311274|FG003|Combination Therapy Phase|Withdrawal by Subject|0
4504345|NCT00876460|7311275|FG004|Combination Therapy Phase|Withdrawal by Subject|1
4504346|NCT00876460|7311276|FG005|Combination Therapy Phase|Withdrawal by Subject|0
4504347|NCT00876460|7311277|FG006|Combination Therapy Phase|Withdrawal by Subject|0
4504348|NCT00876460|7311278|FG007|Combination Therapy Phase|Withdrawal by Subject|0
4504349|NCT00876460|7311271|FG000|Combination Therapy Phase|Other reason not defined above|0
4504350|NCT00876460|7311272|FG001|Combination Therapy Phase|Other reason not defined above|0
4504351|NCT00876460|7311273|FG002|Combination Therapy Phase|Other reason not defined above|0
4504352|NCT00876460|7311274|FG003|Combination Therapy Phase|Other reason not defined above|0
4504353|NCT00876460|7311275|FG004|Combination Therapy Phase|Other reason not defined above|0
4504354|NCT00876460|7311276|FG005|Combination Therapy Phase|Other reason not defined above|0
4504355|NCT00876460|7311277|FG006|Combination Therapy Phase|Other reason not defined above|1
4504356|NCT00876460|7311278|FG007|Combination Therapy Phase|Other reason not defined above|2
4504357|NCT00876460|7311271|FG000|Combination Therapy Phase|Not treated|0
4504358|NCT00876460|7311272|FG001|Combination Therapy Phase|Not treated|0
4627631|NCT01854658|7494444|FG000|Overall Study|Physician Decision|7
4627632|NCT01854658|7494445|FG001|Overall Study|Physician Decision|5
4504359|NCT00876460|7311273|FG002|Combination Therapy Phase|Not treated|0
4504360|NCT00876460|7311274|FG003|Combination Therapy Phase|Not treated|0
4504361|NCT00876460|7311275|FG004|Combination Therapy Phase|Not treated|0
4504362|NCT00876460|7311276|FG005|Combination Therapy Phase|Not treated|0
4504363|NCT00876460|7311277|FG006|Combination Therapy Phase|Not treated|1
4504364|NCT00876460|7311278|FG007|Combination Therapy Phase|Not treated|0
4504365|NCT00876460|7311271|FG000|Mono Therapy Phase|Progressive disease|0
4504366|NCT00876460|7311272|FG001|Mono Therapy Phase|Progressive disease|0
4504367|NCT00876460|7311273|FG002|Mono Therapy Phase|Progressive disease|0
4504368|NCT00876460|7311274|FG003|Mono Therapy Phase|Progressive disease|0
4504369|NCT00876460|7311275|FG004|Mono Therapy Phase|Progressive disease|2
4504370|NCT00876460|7311276|FG005|Mono Therapy Phase|Progressive disease|0
4504371|NCT00876460|7311277|FG006|Mono Therapy Phase|Progressive disease|1
4504372|NCT00876460|7311278|FG007|Mono Therapy Phase|Progressive disease|3
4504373|NCT00876460|7311271|FG000|Mono Therapy Phase|Withdrawal by Subject|0
4504374|NCT00876460|7311272|FG001|Mono Therapy Phase|Withdrawal by Subject|1
4504375|NCT00876460|7311273|FG002|Mono Therapy Phase|Withdrawal by Subject|0
4504376|NCT00876460|7311274|FG003|Mono Therapy Phase|Withdrawal by Subject|0
4504377|NCT00876460|7311275|FG004|Mono Therapy Phase|Withdrawal by Subject|0
4504378|NCT00876460|7311276|FG005|Mono Therapy Phase|Withdrawal by Subject|0
4504379|NCT00876460|7311277|FG006|Mono Therapy Phase|Withdrawal by Subject|0
4504380|NCT00876460|7311278|FG007|Mono Therapy Phase|Withdrawal by Subject|0
4504381|NCT00876460|7311271|FG000|Mono Therapy Phase|Adverse Event|0
4504382|NCT00876460|7311272|FG001|Mono Therapy Phase|Adverse Event|0
4504383|NCT00876460|7311273|FG002|Mono Therapy Phase|Adverse Event|0
4504384|NCT00876460|7311274|FG003|Mono Therapy Phase|Adverse Event|1
4504385|NCT00876460|7311275|FG004|Mono Therapy Phase|Adverse Event|0
4504386|NCT00876460|7311276|FG005|Mono Therapy Phase|Adverse Event|0
4504387|NCT00876460|7311277|FG006|Mono Therapy Phase|Adverse Event|0
4504388|NCT00876460|7311278|FG007|Mono Therapy Phase|Adverse Event|0
4504389|NCT00876694|7311310|FG000|Overall Study|Adverse Event|10
4504390|NCT00876694|7311311|FG001|Overall Study|Adverse Event|7
4504391|NCT00876694|7311310|FG000|Overall Study|Subject withdrew consent|6
4504392|NCT00876694|7311311|FG001|Overall Study|Subject withdrew consent|4
4504393|NCT00876694|7311310|FG000|Overall Study|Unsatisfactory therapeutic effect|2
4504394|NCT00876694|7311311|FG001|Overall Study|Unsatisfactory therapeutic effect|0
4504395|NCT00876694|7311310|FG000|Overall Study|Abnormal test procedure result(s)|1
4504396|NCT00876694|7311311|FG001|Overall Study|Abnormal test procedure result(s)|0
4504397|NCT00876694|7311310|FG000|Overall Study|Administrative problems|1
4504398|NCT00876694|7311311|FG001|Overall Study|Administrative problems|1
4504399|NCT00876694|7311310|FG000|Overall Study|Death|1
4504400|NCT00876694|7311311|FG001|Overall Study|Death|0
4504401|NCT00876733|7311321|FG000|Overall Study|Adverse Event|34
4504402|NCT00876733|7311322|FG001|Overall Study|Adverse Event|20
4504403|NCT00876733|7311323|FG002|Overall Study|Adverse Event|10
4504404|NCT00876733|7311324|FG003|Overall Study|Adverse Event|3
4504405|NCT00876733|7311321|FG000|Overall Study|Lack of Efficacy|17
4504406|NCT00876733|7311322|FG001|Overall Study|Lack of Efficacy|9
4504407|NCT00876733|7311323|FG002|Overall Study|Lack of Efficacy|10
4504408|NCT00876733|7311324|FG003|Overall Study|Lack of Efficacy|1
4504409|NCT00876733|7311321|FG000|Overall Study|Lost to Follow-up|26
4504410|NCT00876733|7311322|FG001|Overall Study|Lost to Follow-up|10
4504411|NCT00876733|7311323|FG002|Overall Study|Lost to Follow-up|3
4504412|NCT00876733|7311324|FG003|Overall Study|Lost to Follow-up|2
4504413|NCT00876733|7311321|FG000|Overall Study|Data not available|14
4504414|NCT00876733|7311322|FG001|Overall Study|Data not available|3
4504415|NCT00876733|7311323|FG002|Overall Study|Data not available|7
4504416|NCT00876733|7311324|FG003|Overall Study|Data not available|1
4504417|NCT00876928|7311349|FG000|Overall Study|Lost to Follow-up|2
4504418|NCT00876928|7311350|FG001|Overall Study|Lost to Follow-up|5
4504419|NCT00876928|7311349|FG000|Overall Study|Hypokalemia-affects insulin secretion|1
4504420|NCT00876928|7311350|FG001|Overall Study|Hypokalemia-affects insulin secretion|0
4504421|NCT00877006|7311381|FG000|Treatment Period|Death|2
4504422|NCT00877006|7311382|FG001|Treatment Period|Death|1
4504423|NCT00877006|7311381|FG000|Treatment Period|Adverse Event|10
4504424|NCT00877006|7311382|FG001|Treatment Period|Adverse Event|3
4504425|NCT00877006|7311381|FG000|Treatment Period|Withdrawal by Subject|2
4504426|NCT00877006|7311382|FG001|Treatment Period|Withdrawal by Subject|3
4504427|NCT00877006|7311381|FG000|Treatment Period|Protocol Violation|1
4504428|NCT00877006|7311382|FG001|Treatment Period|Protocol Violation|0
4504429|NCT00877006|7311381|FG000|Treatment Period|Lost to Follow-up|0
4504430|NCT00877006|7311382|FG001|Treatment Period|Lost to Follow-up|1
4504431|NCT00877006|7311381|FG000|Treatment Period|Disease Progression|1
4504432|NCT00877006|7311382|FG001|Treatment Period|Disease Progression|2
4504433|NCT00877006|7311381|FG000|Treatment Period|Started New Treatment Regimen|2
4627633|NCT01854658|7494446|FG002|Overall Study|Physician Decision|2
4771249|NCT02978781|7748155|FG004|Part B|Withdrawal by Subject|0
4504434|NCT00877006|7311382|FG001|Treatment Period|Started New Treatment Regimen|5
4504435|NCT00877006|7311381|FG000|Treatment Period|Other|4
4504436|NCT00877006|7311382|FG001|Treatment Period|Other|4
4504437|NCT00877006|7311381|FG000|Treatment Period|Randomized but Not Treated|3
4504438|NCT00877006|7311382|FG001|Treatment Period|Randomized but Not Treated|8
4504439|NCT00877006|7311381|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12
4627634|NCT01854658|7494447|FG003|Overall Study|Physician Decision|4
4504440|NCT00877006|7311382|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19
4504441|NCT00877006|7311381|FG000|Long-Term Follow-up Period|Lost to Follow-up|8
4504442|NCT00877006|7311382|FG001|Long-Term Follow-up Period|Lost to Follow-up|9
4504443|NCT00877006|7311381|FG000|Long-Term Follow-up Period|Death|26
4504444|NCT00877006|7311382|FG001|Long-Term Follow-up Period|Death|18
4504445|NCT00877006|7311381|FG000|Long-Term Follow-up Period|Other|7
4504446|NCT00877006|7311382|FG001|Long-Term Follow-up Period|Other|9
4504447|NCT00877032|7311397|FG000|Overall Study|Did not meet entrance criteria|0
4504448|NCT00877032|7311398|FG001|Overall Study|Did not meet entrance criteria|0
4504449|NCT00877032|7311399|FG002|Overall Study|Did not meet entrance criteria|0
4504450|NCT00877032|7311400|FG003|Overall Study|Did not meet entrance criteria|1
4504451|NCT00877032|7311401|FG004|Overall Study|Did not meet entrance criteria|0
4504452|NCT00877032|7311402|FG005|Overall Study|Did not meet entrance criteria|0
4504453|NCT00877032|7311403|FG006|Overall Study|Did not meet entrance criteria|2
4504454|NCT00877383|7311438|FG000|Overall Study|Adverse Event|13
4504455|NCT00877383|7311439|FG001|Overall Study|Adverse Event|14
4504456|NCT00877383|7311438|FG000|Overall Study|Lost to Follow-up|5
4504457|NCT00877383|7311439|FG001|Overall Study|Lost to Follow-up|3
4504458|NCT00877383|7311438|FG000|Overall Study|Subject withdrew consent|3
4504459|NCT00877383|7311439|FG001|Overall Study|Subject withdrew consent|12
4504460|NCT00877383|7311438|FG000|Overall Study|Subject no longer requires study drug|2
4504461|NCT00877383|7311439|FG001|Overall Study|Subject no longer requires study drug|0
4504462|NCT00877383|7311438|FG000|Overall Study|Administrative problems|2
4504463|NCT00877383|7311439|FG001|Overall Study|Administrative problems|0
4504464|NCT00877383|7311438|FG000|Overall Study|Protocol deviation|2
4504465|NCT00877383|7311439|FG001|Overall Study|Protocol deviation|6
4504466|NCT00877383|7311438|FG000|Overall Study|Unsatisfactory therapeutic effect|1
4504467|NCT00877383|7311439|FG001|Overall Study|Unsatisfactory therapeutic effect|0
4504468|NCT00877383|7311438|FG000|Overall Study|Death|1
4504469|NCT00877383|7311439|FG001|Overall Study|Death|2
4504470|NCT00877487|7311474|FG000|Open-label Treatment Phase|Adverse Event|1
4504471|NCT00877487|7311475|FG001|Open-label Treatment Phase|Adverse Event|0
4504472|NCT00877487|7311474|FG000|Open-label Treatment Phase|Protocol Violation|3
4504473|NCT00877487|7311475|FG001|Open-label Treatment Phase|Protocol Violation|0
4504474|NCT00877487|7311474|FG000|Open-label Treatment Phase|Withdrawal by Subject|1
4504475|NCT00877487|7311475|FG001|Open-label Treatment Phase|Withdrawal by Subject|0
4504476|NCT00877487|7311474|FG000|Open-label Treatment Phase|Lost to Follow-up|1
4504477|NCT00877487|7311475|FG001|Open-label Treatment Phase|Lost to Follow-up|0
4504478|NCT00877487|7311474|FG000|Open-label Treatment Phase|Out of country for business|1
4504479|NCT00877487|7311475|FG001|Open-label Treatment Phase|Out of country for business|0
4504480|NCT00877487|7311474|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5
4504481|NCT00877487|7311475|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45
4504482|NCT00877487|7311474|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0
4504483|NCT00877487|7311475|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1
4504484|NCT00877487|7311474|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0
4504485|NCT00877487|7311475|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1
4504486|NCT00877487|7311474|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1
4504487|NCT00877487|7311475|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0
4504488|NCT00877773|7311490|FG000|Overall Study|Disease Progression|44
4504489|NCT00877799|7311499|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2
4504490|NCT00877799|7311500|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1
4504491|NCT00877799|7311501|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1
4504492|NCT00877799|7311502|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0
4504493|NCT00877799|7311503|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0
4504494|NCT00877799|7311499|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1
4504495|NCT00877799|7311500|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1
4504496|NCT00877799|7311501|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2
4504497|NCT00877799|7311502|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0
4504498|NCT00877799|7311503|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0
4504499|NCT00877799|7311499|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
4504500|NCT00877799|7311500|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3
4504501|NCT00877799|7311501|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
4504502|NCT00877799|7311502|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
4504503|NCT00877799|7311503|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
4504504|NCT00877799|7311499|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
4504505|NCT00877799|7311500|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
4504506|NCT00877799|7311501|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
4504507|NCT00877799|7311502|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1
4504508|NCT00877799|7311503|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
4504509|NCT00877799|7311499|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
4504510|NCT00877799|7311500|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
4504511|NCT00877799|7311501|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
4504512|NCT00877799|7311502|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1
4504513|NCT00877799|7311503|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1
4504514|NCT00877890|7311525|FG000|Overall Study|Adverse Event|6
4504515|NCT00877890|7311526|FG001|Overall Study|Adverse Event|6
4504516|NCT00877890|7311525|FG000|Overall Study|Lost to Follow-up|5
4504517|NCT00877890|7311526|FG001|Overall Study|Lost to Follow-up|5
4504518|NCT00877890|7311525|FG000|Overall Study|Protocol Violation|0
4504519|NCT00877890|7311526|FG001|Overall Study|Protocol Violation|1
4504520|NCT00877890|7311525|FG000|Overall Study|Withdrawal of Consent|6
4504521|NCT00877890|7311526|FG001|Overall Study|Withdrawal of Consent|12
4504522|NCT00877890|7311525|FG000|Overall Study|Investigator Decision|0
4504523|NCT00877890|7311526|FG001|Overall Study|Investigator Decision|2
4504524|NCT00877890|7311525|FG000|Overall Study|Loss of Glucose Control|3
4504525|NCT00877890|7311526|FG001|Overall Study|Loss of Glucose Control|4
4504526|NCT00877929|7311538|FG000|Overall Study|Adverse Event|11
4504527|NCT00877929|7311539|FG001|Overall Study|Adverse Event|20
4504528|NCT00877929|7311538|FG000|Overall Study|Protocol Violation|3
4504529|NCT00877929|7311539|FG001|Overall Study|Protocol Violation|3
4504530|NCT00877929|7311538|FG000|Overall Study|Lost to Follow-up|0
4504531|NCT00877929|7311539|FG001|Overall Study|Lost to Follow-up|1
4504532|NCT00877929|7311538|FG000|Overall Study|Withdrawal by Subject|4
4504533|NCT00877929|7311539|FG001|Overall Study|Withdrawal by Subject|4
4504534|NCT00877929|7311538|FG000|Overall Study|Lack of Efficacy|0
4504535|NCT00877929|7311539|FG001|Overall Study|Lack of Efficacy|1
4504536|NCT00877929|7311538|FG000|Overall Study|Other reason (not specified)|2
4504537|NCT00877929|7311539|FG001|Overall Study|Other reason (not specified)|6
4504538|NCT00878072|7311549|FG000|Overall Study|Withdrew consent|2
4704805|NCT02757352|7624009|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
4704806|NCT02757352|7624010|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
4704807|NCT02757352|7624011|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
4704808|NCT02757352|7624002|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
4704809|NCT02757352|7624003|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
4704810|NCT02757352|7624004|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
4504539|NCT00878189|7311560|FG000|Overall Study|Death|0
4504540|NCT00878189|7311561|FG001|Overall Study|Death|1
4504541|NCT00878189|7311562|FG002|Overall Study|Death|0
4504542|NCT00878189|7311563|FG003|Overall Study|Death|1
4504543|NCT00878189|7311564|FG004|Overall Study|Death|0
4504544|NCT00878189|7311565|FG005|Overall Study|Death|0
4504545|NCT00878189|7311566|FG006|Overall Study|Death|0
4504546|NCT00878189|7311567|FG007|Overall Study|Death|0
4504547|NCT00878189|7311568|FG008|Overall Study|Death|1
4504548|NCT00878189|7311560|FG000|Overall Study|Participant Refused to Follow-up|0
4504549|NCT00878189|7311561|FG001|Overall Study|Participant Refused to Follow-up|0
4504550|NCT00878189|7311562|FG002|Overall Study|Participant Refused to Follow-up|0
4504551|NCT00878189|7311563|FG003|Overall Study|Participant Refused to Follow-up|0
4504552|NCT00878189|7311564|FG004|Overall Study|Participant Refused to Follow-up|0
4504553|NCT00878189|7311565|FG005|Overall Study|Participant Refused to Follow-up|4
4504554|NCT00878189|7311566|FG006|Overall Study|Participant Refused to Follow-up|0
4504555|NCT00878189|7311567|FG007|Overall Study|Participant Refused to Follow-up|0
4504556|NCT00878189|7311568|FG008|Overall Study|Participant Refused to Follow-up|0
4504557|NCT00878189|7311560|FG000|Overall Study|Other|3
4504558|NCT00878189|7311561|FG001|Overall Study|Other|2
4504559|NCT00878189|7311562|FG002|Overall Study|Other|4
4504560|NCT00878189|7311563|FG003|Overall Study|Other|7
4504561|NCT00878189|7311564|FG004|Overall Study|Other|4
4504562|NCT00878189|7311565|FG005|Overall Study|Other|18
4504563|NCT00878189|7311566|FG006|Overall Study|Other|15
4504564|NCT00878189|7311567|FG007|Overall Study|Other|3
4504565|NCT00878189|7311568|FG008|Overall Study|Other|4
4504566|NCT00878189|7311560|FG000|Overall Study|Lost to Follow-up|0
4504567|NCT00878189|7311561|FG001|Overall Study|Lost to Follow-up|0
4504568|NCT00878189|7311562|FG002|Overall Study|Lost to Follow-up|0
4504569|NCT00878189|7311563|FG003|Overall Study|Lost to Follow-up|0
4504570|NCT00878189|7311564|FG004|Overall Study|Lost to Follow-up|0
4504571|NCT00878189|7311565|FG005|Overall Study|Lost to Follow-up|1
4504572|NCT00878189|7311566|FG006|Overall Study|Lost to Follow-up|1
4504573|NCT00878189|7311567|FG007|Overall Study|Lost to Follow-up|0
4504574|NCT00878189|7311568|FG008|Overall Study|Lost to Follow-up|0
4504575|NCT00878189|7311560|FG000|Overall Study|Objection Progression or Relapse|0
4504576|NCT00878189|7311561|FG001|Overall Study|Objection Progression or Relapse|0
4504577|NCT00878189|7311562|FG002|Overall Study|Objection Progression or Relapse|0
4504578|NCT00878189|7311563|FG003|Overall Study|Objection Progression or Relapse|0
4504579|NCT00878189|7311564|FG004|Overall Study|Objection Progression or Relapse|0
4504580|NCT00878189|7311565|FG005|Overall Study|Objection Progression or Relapse|0
4504581|NCT00878189|7311566|FG006|Overall Study|Objection Progression or Relapse|0
4504582|NCT00878189|7311567|FG007|Overall Study|Objection Progression or Relapse|0
4504583|NCT00878189|7311568|FG008|Overall Study|Objection Progression or Relapse|3
4504584|NCT00878215|7311606|FG000|Overall Study|Determined to be ineligible|0
4504585|NCT00878215|7311607|FG001|Overall Study|Determined to be ineligible|10
4504586|NCT00878215|7311608|FG002|Overall Study|Determined to be ineligible|0
4504587|NCT00878215|7311609|FG003|Overall Study|Determined to be ineligible|0
4504588|NCT00878501|7311640|FG000|Overall Study|Adverse Event|11
4504589|NCT00878501|7311641|FG001|Overall Study|Adverse Event|3
4504590|NCT00878501|7311642|FG002|Overall Study|Adverse Event|3
4504591|NCT00878501|7311640|FG000|Overall Study|Lack of Efficacy|2
4504592|NCT00878501|7311641|FG001|Overall Study|Lack of Efficacy|1
4504593|NCT00878501|7311642|FG002|Overall Study|Lack of Efficacy|0
4504594|NCT00878501|7311640|FG000|Overall Study|Withdrawal by Subject|2
4504595|NCT00878501|7311641|FG001|Overall Study|Withdrawal by Subject|1
4504596|NCT00878501|7311642|FG002|Overall Study|Withdrawal by Subject|2
4504597|NCT00878501|7311640|FG000|Overall Study|Protocol Violation|0
4504598|NCT00878501|7311641|FG001|Overall Study|Protocol Violation|0
4504599|NCT00878501|7311642|FG002|Overall Study|Protocol Violation|1
4504600|NCT00878501|7311640|FG000|Overall Study|Incorrect enrolment|1
4504601|NCT00878501|7311641|FG001|Overall Study|Incorrect enrolment|2
4504602|NCT00878501|7311642|FG002|Overall Study|Incorrect enrolment|0
4504603|NCT00878501|7311640|FG000|Overall Study|Intake of prohibited concom. medication|0
4504604|NCT00878501|7311641|FG001|Overall Study|Intake of prohibited concom. medication|0
4504605|NCT00878501|7311642|FG002|Overall Study|Intake of prohibited concom. medication|1
4504606|NCT00878501|7311640|FG000|Overall Study|Mis-randomisation of patient|1
4504607|NCT00878501|7311641|FG001|Overall Study|Mis-randomisation of patient|0
4504608|NCT00878501|7311642|FG002|Overall Study|Mis-randomisation of patient|0
4504609|NCT00878501|7311640|FG000|Overall Study|Administrative|0
4504610|NCT00878501|7311641|FG001|Overall Study|Administrative|0
4504611|NCT00878501|7311642|FG002|Overall Study|Administrative|1
4504612|NCT00878553|7311654|FG000|Sleep Study|Withdrawal by Subject|2
4504613|NCT00878553|7311655|FG001|Sleep Study|Withdrawal by Subject|0
4504614|NCT00878553|7311656|FG002|Sleep Study|Withdrawal by Subject|0
4504615|NCT00878553|7311657|FG003|Sleep Study|Withdrawal by Subject|0
4504616|NCT00878553|7311658|FG004|Sleep Study|Withdrawal by Subject|0
4504617|NCT00878553|7311654|FG000|Sleep Study|Lost to Follow-up|1
4504618|NCT00878553|7311655|FG001|Sleep Study|Lost to Follow-up|0
4504619|NCT00878553|7311656|FG002|Sleep Study|Lost to Follow-up|0
4504620|NCT00878553|7311657|FG003|Sleep Study|Lost to Follow-up|0
4504621|NCT00878553|7311658|FG004|Sleep Study|Lost to Follow-up|0
4504622|NCT00878553|7311654|FG000|Sleep Study|car accident|1
4504623|NCT00878553|7311655|FG001|Sleep Study|car accident|0
4504624|NCT00878553|7311656|FG002|Sleep Study|car accident|0
4504625|NCT00878553|7311657|FG003|Sleep Study|car accident|0
4504626|NCT00878553|7311658|FG004|Sleep Study|car accident|0
4504627|NCT00878553|7311654|FG000|Sleep Study|family emergency|1
4504628|NCT00878553|7311655|FG001|Sleep Study|family emergency|0
4504629|NCT00878553|7311656|FG002|Sleep Study|family emergency|0
4504630|NCT00878553|7311657|FG003|Sleep Study|family emergency|0
4504631|NCT00878553|7311658|FG004|Sleep Study|family emergency|0
4504632|NCT00878553|7311654|FG000|PK Study|Withdrawal by Subject|0
4504633|NCT00878553|7311655|FG001|PK Study|Withdrawal by Subject|0
4504634|NCT00878553|7311656|FG002|PK Study|Withdrawal by Subject|0
4504635|NCT00878553|7311657|FG003|PK Study|Withdrawal by Subject|1
4504636|NCT00878553|7311658|FG004|PK Study|Withdrawal by Subject|0
4504637|NCT00878709|7311686|FG000|Overall Study|Withdrawal by Subject|197
4504638|NCT00878709|7311687|FG001|Overall Study|Withdrawal by Subject|120
4504639|NCT00878709|7311686|FG000|Overall Study|Lost to Follow-up|35
4504640|NCT00878709|7311687|FG001|Overall Study|Lost to Follow-up|33
4504641|NCT00878709|7311686|FG000|Overall Study|Other Reasons|93
4504642|NCT00878709|7311687|FG001|Overall Study|Other Reasons|84
4504643|NCT00878722|7311702|FG000|Overall Study|Progressive disease|3
4504644|NCT00878722|7311703|FG001|Overall Study|Progressive disease|3
4504645|NCT00878722|7311704|FG002|Overall Study|Progressive disease|3
4504646|NCT00878722|7311705|FG003|Overall Study|Progressive disease|7
4504647|NCT00878722|7311706|FG004|Overall Study|Progressive disease|7
4504648|NCT00878722|7311707|FG005|Overall Study|Progressive disease|1
4504649|NCT00878722|7311708|FG006|Overall Study|Progressive disease|4
4504650|NCT00878722|7311709|FG007|Overall Study|Progressive disease|3
4504651|NCT00878722|7311702|FG000|Overall Study|Death|0
4504652|NCT00878722|7311703|FG001|Overall Study|Death|0
4504653|NCT00878722|7311704|FG002|Overall Study|Death|0
4504654|NCT00878722|7311705|FG003|Overall Study|Death|1
4504655|NCT00878722|7311706|FG004|Overall Study|Death|0
4504656|NCT00878722|7311707|FG005|Overall Study|Death|1
4504657|NCT00878722|7311708|FG006|Overall Study|Death|0
4504658|NCT00878722|7311709|FG007|Overall Study|Death|2
4504659|NCT00878722|7311702|FG000|Overall Study|Adverse Event|0
4504660|NCT00878722|7311703|FG001|Overall Study|Adverse Event|0
4504661|NCT00878722|7311704|FG002|Overall Study|Adverse Event|0
4504662|NCT00878722|7311705|FG003|Overall Study|Adverse Event|0
4504663|NCT00878722|7311706|FG004|Overall Study|Adverse Event|0
4504664|NCT00878722|7311707|FG005|Overall Study|Adverse Event|0
4504665|NCT00878722|7311708|FG006|Overall Study|Adverse Event|2
4504666|NCT00878722|7311709|FG007|Overall Study|Adverse Event|0
4504667|NCT00878722|7311702|FG000|Overall Study|Withdrawal by Subject|0
4504668|NCT00878722|7311703|FG001|Overall Study|Withdrawal by Subject|0
4504669|NCT00878722|7311704|FG002|Overall Study|Withdrawal by Subject|0
4504670|NCT00878722|7311705|FG003|Overall Study|Withdrawal by Subject|0
4504671|NCT00878722|7311706|FG004|Overall Study|Withdrawal by Subject|0
4504672|NCT00878722|7311707|FG005|Overall Study|Withdrawal by Subject|0
4504673|NCT00878722|7311708|FG006|Overall Study|Withdrawal by Subject|0
4504674|NCT00878722|7311709|FG007|Overall Study|Withdrawal by Subject|2
4504675|NCT00878722|7311702|FG000|Overall Study|Relapse|0
4504676|NCT00878722|7311703|FG001|Overall Study|Relapse|0
4504677|NCT00878722|7311704|FG002|Overall Study|Relapse|0
4504678|NCT00878722|7311705|FG003|Overall Study|Relapse|1
4504679|NCT00878722|7311706|FG004|Overall Study|Relapse|0
4504680|NCT00878722|7311707|FG005|Overall Study|Relapse|0
4504681|NCT00878722|7311708|FG006|Overall Study|Relapse|0
4504682|NCT00878722|7311709|FG007|Overall Study|Relapse|0
4504683|NCT00878800|7311735|FG000|Overall Study|Adverse Event|0
4504684|NCT00878800|7311736|FG001|Overall Study|Adverse Event|0
4504685|NCT00878800|7311737|FG002|Overall Study|Adverse Event|2
4504686|NCT00878800|7311738|FG003|Overall Study|Adverse Event|0
4504687|NCT00878800|7311739|FG004|Overall Study|Adverse Event|1
4504688|NCT00878800|7311735|FG000|Overall Study|Progressive disease|1
4504689|NCT00878800|7311736|FG001|Overall Study|Progressive disease|5
4504690|NCT00878800|7311737|FG002|Overall Study|Progressive disease|6
4504691|NCT00878800|7311738|FG003|Overall Study|Progressive disease|5
4504692|NCT00878800|7311739|FG004|Overall Study|Progressive disease|13
4504693|NCT00878800|7311735|FG000|Overall Study|Withdrew consent|1
4504694|NCT00878800|7311736|FG001|Overall Study|Withdrew consent|1
4504695|NCT00878800|7311737|FG002|Overall Study|Withdrew consent|0
4504696|NCT00878800|7311738|FG003|Overall Study|Withdrew consent|1
4504697|NCT00878800|7311739|FG004|Overall Study|Withdrew consent|1
4504698|NCT00878800|7311735|FG000|Overall Study|Death|0
4504699|NCT00878800|7311736|FG001|Overall Study|Death|0
4504700|NCT00878800|7311737|FG002|Overall Study|Death|1
4504701|NCT00878800|7311738|FG003|Overall Study|Death|0
4504702|NCT00878800|7311739|FG004|Overall Study|Death|0
4504703|NCT00878800|7311735|FG000|Overall Study|Other|1
4504704|NCT00878800|7311736|FG001|Overall Study|Other|1
4504705|NCT00878800|7311737|FG002|Overall Study|Other|0
4504706|NCT00878800|7311738|FG003|Overall Study|Other|0
4504707|NCT00878800|7311739|FG004|Overall Study|Other|1
4504708|NCT00878995|7311776|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0
4504709|NCT00878995|7311777|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2
4504710|NCT00879229|7311810|FG000|Overall Study|Study terminated by Sponsor|13
4504711|NCT00879229|7311811|FG001|Overall Study|Study terminated by Sponsor|12
4504712|NCT00879229|7311810|FG000|Overall Study|Death|4
4504713|NCT00879229|7311811|FG001|Overall Study|Death|2
4504714|NCT00879229|7311810|FG000|Overall Study|Adverse Event|2
4504715|NCT00879229|7311811|FG001|Overall Study|Adverse Event|0
4504716|NCT00879229|7311810|FG000|Overall Study|Withdrawal by Subject|1
4504717|NCT00879229|7311811|FG001|Overall Study|Withdrawal by Subject|0
4504718|NCT00879229|7311810|FG000|Overall Study|Clinical status did not improve|1
4504719|NCT00879229|7311811|FG001|Overall Study|Clinical status did not improve|0
4504720|NCT00879229|7311810|FG000|Overall Study|Other|1
4504721|NCT00879229|7311811|FG001|Overall Study|Other|0
4504722|NCT00879333|7311828|FG000|Overall Study|Adverse Event|94
4504723|NCT00879333|7311829|FG001|Overall Study|Adverse Event|34
4504724|NCT00879333|7311828|FG000|Overall Study|Abnormal Laboratory Value|1
4504725|NCT00879333|7311829|FG001|Overall Study|Abnormal Laboratory Value|0
4504726|NCT00879333|7311828|FG000|Overall Study|Withdrawal by Subject|20
4504727|NCT00879333|7311829|FG001|Overall Study|Withdrawal by Subject|7
4504728|NCT00879333|7311828|FG000|Overall Study|Lost to Follow-up|2
4504729|NCT00879333|7311829|FG001|Overall Study|Lost to Follow-up|1
4504730|NCT00879333|7311828|FG000|Overall Study|Administrative Problems|2
4504731|NCT00879333|7311829|FG001|Overall Study|Administrative Problems|0
4504732|NCT00879333|7311828|FG000|Overall Study|Death|16
4504733|NCT00879333|7311829|FG001|Overall Study|Death|5
4504734|NCT00879333|7311828|FG000|Overall Study|Disease Progression|292
4504735|NCT00879333|7311829|FG001|Overall Study|Disease Progression|169
4504736|NCT00879333|7311828|FG000|Overall Study|Protocol Violation|1
4504737|NCT00879333|7311829|FG001|Overall Study|Protocol Violation|1
4504738|NCT00879398|7311842|FG000|Overall Study|Visit Stop|399
4504739|NCT00879398|7311842|FG000|Overall Study|Lack of Efficacy|64
4504740|NCT00879398|7311842|FG000|Overall Study|Adverse Event|41
4504741|NCT00879398|7311842|FG000|Overall Study|Other Reasons|171
4504742|NCT00879411|7311846|FG000|Overall Study|lost to follow-up (non-AE)|162
4504743|NCT00879437|7311850|FG000|Overall Study|Protocol Violation|0
4504744|NCT00879437|7311851|FG001|Overall Study|Protocol Violation|1
4504745|NCT00879437|7311850|FG000|Overall Study|Death|1
4504746|NCT00879437|7311851|FG001|Overall Study|Death|0
4504747|NCT00879645|7311863|FG000|Overall Study|Adverse Event|1
4504748|NCT00879645|7311864|FG001|Overall Study|Adverse Event|0
4504749|NCT00879645|7311865|FG002|Overall Study|Adverse Event|0
4504750|NCT00879645|7311866|FG003|Overall Study|Adverse Event|0
4504751|NCT00879658|7311883|FG000|Overall Study|Abnormal laboratory value(s)|3
4504752|NCT00879658|7311884|FG001|Overall Study|Abnormal laboratory value(s)|0
4504753|NCT00879658|7311885|FG002|Overall Study|Abnormal laboratory value(s)|0
4504754|NCT00879658|7311886|FG003|Overall Study|Abnormal laboratory value(s)|1
4504755|NCT00879658|7311887|FG004|Overall Study|Abnormal laboratory value(s)|0
4504756|NCT00879658|7311888|FG005|Overall Study|Abnormal laboratory value(s)|0
4504757|NCT00879658|7311889|FG006|Overall Study|Abnormal laboratory value(s)|0
4504758|NCT00879658|7311883|FG000|Overall Study|Administrative problems|2
4504759|NCT00879658|7311884|FG001|Overall Study|Administrative problems|1
4504760|NCT00879658|7311885|FG002|Overall Study|Administrative problems|0
4504761|NCT00879658|7311886|FG003|Overall Study|Administrative problems|1
4504762|NCT00879658|7311887|FG004|Overall Study|Administrative problems|0
4504763|NCT00879658|7311888|FG005|Overall Study|Administrative problems|0
4704811|NCT02757352|7624005|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
4704812|NCT02757352|7624006|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1
4704813|NCT02757352|7624007|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
4704814|NCT02757352|7624008|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
4704815|NCT02757352|7624009|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
4704816|NCT02757352|7624010|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
4704817|NCT02757352|7624011|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
4704818|NCT02757352|7624002|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
4704819|NCT02757352|7624003|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
4704820|NCT02757352|7624004|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
4704821|NCT02757352|7624005|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
4704822|NCT02757352|7624006|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
4704823|NCT02757352|7624007|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1
4704824|NCT02757352|7624008|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
4704825|NCT02757352|7624009|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
4704826|NCT02757352|7624010|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
4704827|NCT02757352|7624011|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
4704828|NCT02757352|7624002|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
4704829|NCT02757352|7624003|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
4704830|NCT02757352|7624004|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
4704831|NCT02757352|7624005|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2
4704832|NCT02757352|7624006|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1
4704833|NCT02757352|7624007|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1
4704834|NCT02757352|7624008|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
4704835|NCT02757352|7624009|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
4704836|NCT02757352|7624010|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
4704837|NCT02757352|7624011|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
4504764|NCT00879658|7311889|FG006|Overall Study|Administrative problems|0
4504765|NCT00879658|7311883|FG000|Overall Study|Adverse Event|6
4504766|NCT00879658|7311884|FG001|Overall Study|Adverse Event|4
4504767|NCT00879658|7311885|FG002|Overall Study|Adverse Event|3
4504768|NCT00879658|7311886|FG003|Overall Study|Adverse Event|1
4504769|NCT00879658|7311887|FG004|Overall Study|Adverse Event|2
4504770|NCT00879658|7311888|FG005|Overall Study|Adverse Event|0
4627635|NCT01854658|7494444|FG000|Overall Study|Lost to Follow-up|8
4627636|NCT01854658|7494445|FG001|Overall Study|Lost to Follow-up|9
4504771|NCT00879658|7311889|FG006|Overall Study|Adverse Event|0
4504772|NCT00879658|7311883|FG000|Overall Study|Protocol Violation|1
4504773|NCT00879658|7311884|FG001|Overall Study|Protocol Violation|0
4504774|NCT00879658|7311885|FG002|Overall Study|Protocol Violation|0
4504775|NCT00879658|7311886|FG003|Overall Study|Protocol Violation|0
4504776|NCT00879658|7311887|FG004|Overall Study|Protocol Violation|0
4504777|NCT00879658|7311888|FG005|Overall Study|Protocol Violation|0
4504778|NCT00879658|7311889|FG006|Overall Study|Protocol Violation|0
4504779|NCT00879658|7311883|FG000|Overall Study|Withdrawal by Subject|3
4504780|NCT00879658|7311884|FG001|Overall Study|Withdrawal by Subject|0
4504781|NCT00879658|7311885|FG002|Overall Study|Withdrawal by Subject|2
4504782|NCT00879658|7311886|FG003|Overall Study|Withdrawal by Subject|0
4504783|NCT00879658|7311887|FG004|Overall Study|Withdrawal by Subject|0
4504784|NCT00879658|7311888|FG005|Overall Study|Withdrawal by Subject|1
4504785|NCT00879658|7311889|FG006|Overall Study|Withdrawal by Subject|0
4504786|NCT00879658|7311883|FG000|Overall Study|Lack of Efficacy|0
4504787|NCT00879658|7311884|FG001|Overall Study|Lack of Efficacy|0
4504788|NCT00879658|7311885|FG002|Overall Study|Lack of Efficacy|2
4627637|NCT01854658|7494446|FG002|Overall Study|Lost to Follow-up|8
4504789|NCT00879658|7311886|FG003|Overall Study|Lack of Efficacy|0
4504790|NCT00879658|7311887|FG004|Overall Study|Lack of Efficacy|0
4504791|NCT00879658|7311888|FG005|Overall Study|Lack of Efficacy|0
4504792|NCT00879658|7311889|FG006|Overall Study|Lack of Efficacy|0
4504793|NCT00879658|7311883|FG000|Overall Study|misrandomized (never received study med)|0
4504794|NCT00879658|7311884|FG001|Overall Study|misrandomized (never received study med)|0
4504795|NCT00879658|7311885|FG002|Overall Study|misrandomized (never received study med)|0
4504796|NCT00879658|7311886|FG003|Overall Study|misrandomized (never received study med)|1
4504797|NCT00879658|7311887|FG004|Overall Study|misrandomized (never received study med)|0
4504798|NCT00879658|7311888|FG005|Overall Study|misrandomized (never received study med)|0
4504799|NCT00879658|7311889|FG006|Overall Study|misrandomized (never received study med)|0
4504800|NCT00879684|7311911|FG000|Stage 1: Dose Escalation|Adverse Event|1
4504801|NCT00879684|7311912|FG001|Stage 1: Dose Escalation|Adverse Event|0
4504802|NCT00879684|7311913|FG002|Stage 1: Dose Escalation|Adverse Event|0
4504803|NCT00879684|7311914|FG003|Stage 1: Dose Escalation|Adverse Event|0
4504804|NCT00879684|7311915|FG004|Stage 1: Dose Escalation|Adverse Event|0
4627638|NCT01854658|7494447|FG003|Overall Study|Lost to Follow-up|4
4627639|NCT01854658|7494444|FG000|Overall Study|Withdrawal by Subject|28
4627640|NCT01854658|7494445|FG001|Overall Study|Withdrawal by Subject|21
4627641|NCT01854658|7494446|FG002|Overall Study|Withdrawal by Subject|29
4627642|NCT01854658|7494447|FG003|Overall Study|Withdrawal by Subject|15
4504805|NCT00879684|7311916|FG005|Stage 1: Dose Escalation|Adverse Event|0
4504806|NCT00879684|7311917|FG006|Stage 1: Dose Escalation|Adverse Event|0
4504807|NCT00879684|7311911|FG000|Stage 1: Dose Escalation|Progressive Disease|2
4504808|NCT00879684|7311912|FG001|Stage 1: Dose Escalation|Progressive Disease|3
4504809|NCT00879684|7311913|FG002|Stage 1: Dose Escalation|Progressive Disease|0
4504810|NCT00879684|7311914|FG003|Stage 1: Dose Escalation|Progressive Disease|4
4504811|NCT00879684|7311915|FG004|Stage 1: Dose Escalation|Progressive Disease|3
4504812|NCT00879684|7311916|FG005|Stage 1: Dose Escalation|Progressive Disease|3
4504813|NCT00879684|7311917|FG006|Stage 1: Dose Escalation|Progressive Disease|0
4504814|NCT00879684|7311911|FG000|Stage 1: Dose Escalation|Investigator declined participation|0
4504815|NCT00879684|7311912|FG001|Stage 1: Dose Escalation|Investigator declined participation|0
4504816|NCT00879684|7311913|FG002|Stage 1: Dose Escalation|Investigator declined participation|2
4504817|NCT00879684|7311914|FG003|Stage 1: Dose Escalation|Investigator declined participation|2
4504818|NCT00879684|7311915|FG004|Stage 1: Dose Escalation|Investigator declined participation|0
4504819|NCT00879684|7311916|FG005|Stage 1: Dose Escalation|Investigator declined participation|0
4504820|NCT00879684|7311917|FG006|Stage 1: Dose Escalation|Investigator declined participation|0
4504821|NCT00879684|7311911|FG000|Stage 1: Dose Escalation|Death|0
4504822|NCT00879684|7311912|FG001|Stage 1: Dose Escalation|Death|0
4504823|NCT00879684|7311913|FG002|Stage 1: Dose Escalation|Death|1
4504824|NCT00879684|7311914|FG003|Stage 1: Dose Escalation|Death|0
4504825|NCT00879684|7311915|FG004|Stage 1: Dose Escalation|Death|0
4504826|NCT00879684|7311916|FG005|Stage 1: Dose Escalation|Death|0
4504827|NCT00879684|7311917|FG006|Stage 1: Dose Escalation|Death|0
4504828|NCT00879684|7311911|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0
4504829|NCT00879684|7311912|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0
4504830|NCT00879684|7311913|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0
4504831|NCT00879684|7311914|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0
4504832|NCT00879684|7311915|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0
4504833|NCT00879684|7311916|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0
4504834|NCT00879684|7311917|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1
4504835|NCT00879684|7311911|FG000|Stage 2: Expanded Cohort|Progressive Disease|0
4504836|NCT00879684|7311912|FG001|Stage 2: Expanded Cohort|Progressive Disease|0
4504837|NCT00879684|7311913|FG002|Stage 2: Expanded Cohort|Progressive Disease|0
4504838|NCT00879684|7311914|FG003|Stage 2: Expanded Cohort|Progressive Disease|0
4504839|NCT00879684|7311915|FG004|Stage 2: Expanded Cohort|Progressive Disease|0
4504840|NCT00879684|7311916|FG005|Stage 2: Expanded Cohort|Progressive Disease|0
4504841|NCT00879684|7311917|FG006|Stage 2: Expanded Cohort|Progressive Disease|11
4504842|NCT00879684|7311911|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0
4504843|NCT00879684|7311912|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0
4504844|NCT00879684|7311913|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0
4504845|NCT00879684|7311914|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0
4504846|NCT00879684|7311915|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0
4504847|NCT00879684|7311916|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0
4504848|NCT00879684|7311917|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1
4504849|NCT00879697|7311938|FG000|Overall Study|Physician Decision|2
4504850|NCT00879697|7311939|FG001|Overall Study|Physician Decision|2
4504851|NCT00879710|7311947|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2
4504852|NCT00879710|7311948|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3
4504853|NCT00879710|7311949|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1
4504854|NCT00879710|7311950|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4
4504855|NCT00879710|7311947|FG000|Phase 1 - 6 Weeks|Adverse Event|0
4504856|NCT00879710|7311948|FG001|Phase 1 - 6 Weeks|Adverse Event|0
4504857|NCT00879710|7311949|FG002|Phase 1 - 6 Weeks|Adverse Event|1
4504858|NCT00879710|7311950|FG003|Phase 1 - 6 Weeks|Adverse Event|0
4504859|NCT00879775|7311960|FG000|Overall Study|Lost to Follow-up|2
4504860|NCT00879775|7311961|FG001|Overall Study|Lost to Follow-up|1
4518081|NCT00971243|7330080|FG003|Open-label Period|Protocol Violation|0
4518082|NCT00971243|7330081|FG004|Open-label Period|Protocol Violation|1
4518083|NCT00971243|7330077|FG000|Open-label Period|Withdrawal by Subject|1
4518084|NCT00971243|7330078|FG001|Open-label Period|Withdrawal by Subject|0
4518085|NCT00971243|7330079|FG002|Open-label Period|Withdrawal by Subject|0
4518086|NCT00971243|7330080|FG003|Open-label Period|Withdrawal by Subject|2
4518087|NCT00971243|7330081|FG004|Open-label Period|Withdrawal by Subject|1
4518088|NCT00971243|7330077|FG000|Open-label Period|Other reason|0
4518089|NCT00971243|7330078|FG001|Open-label Period|Other reason|0
4518090|NCT00971243|7330079|FG002|Open-label Period|Other reason|0
4518091|NCT00971243|7330080|FG003|Open-label Period|Other reason|0
4518092|NCT00971243|7330081|FG004|Open-label Period|Other reason|2
4518093|NCT00971321|7330108|FG000|Up to Month 7|Withdrawal by Subject|1
4518094|NCT00971321|7330109|FG001|Up to Month 7|Withdrawal by Subject|0
4518095|NCT00971321|7330108|FG000|Up to Month 7|Migrated/moved from study area|3
4518096|NCT00971321|7330109|FG001|Up to Month 7|Migrated/moved from study area|2
4518097|NCT00971321|7330108|FG000|Up to Month 11-12|Withdrawal by Subject|2
4518098|NCT00971321|7330109|FG001|Up to Month 11-12|Withdrawal by Subject|1
4518099|NCT00971321|7330108|FG000|Up to Month 11-12|Migrated/moved from study area|2
4518100|NCT00971321|7330109|FG001|Up to Month 11-12|Migrated/moved from study area|2
4518101|NCT00971321|7330108|FG000|Up to Month 11-12|Lost to Follow-up|1
4504861|NCT00879814|7311971|FG000|Overall Study|Adverse Event|0
4504862|NCT00879814|7311972|FG001|Overall Study|Adverse Event|1
4504863|NCT00879814|7311973|FG002|Overall Study|Adverse Event|0
4504864|NCT00879814|7311974|FG003|Overall Study|Adverse Event|0
4504865|NCT00879814|7311971|FG000|Overall Study|Lost to Follow-up|1
4504866|NCT00879814|7311972|FG001|Overall Study|Lost to Follow-up|0
4504867|NCT00879814|7311973|FG002|Overall Study|Lost to Follow-up|0
4504868|NCT00879814|7311974|FG003|Overall Study|Lost to Follow-up|2
4504869|NCT00879814|7311971|FG000|Overall Study|Participant Failed to Return|0
4504870|NCT00879814|7311972|FG001|Overall Study|Participant Failed to Return|0
4504871|NCT00879814|7311973|FG002|Overall Study|Participant Failed to Return|0
4504872|NCT00879814|7311974|FG003|Overall Study|Participant Failed to Return|1
4504873|NCT00879814|7311971|FG000|Overall Study|Withdrawal by Subject|3
4504874|NCT00879814|7311972|FG001|Overall Study|Withdrawal by Subject|1
4504875|NCT00879814|7311973|FG002|Overall Study|Withdrawal by Subject|1
4504876|NCT00879814|7311974|FG003|Overall Study|Withdrawal by Subject|2
4504877|NCT00879814|7311971|FG000|Overall Study|Physician Decision|0
4504878|NCT00879814|7311972|FG001|Overall Study|Physician Decision|0
4504879|NCT00879814|7311973|FG002|Overall Study|Physician Decision|1
4504880|NCT00879814|7311974|FG003|Overall Study|Physician Decision|0
4504881|NCT00879814|7311971|FG000|Overall Study|Other|0
4504882|NCT00879814|7311972|FG001|Overall Study|Other|0
4504883|NCT00879814|7311973|FG002|Overall Study|Other|1
4504884|NCT00879814|7311974|FG003|Overall Study|Other|0
4504885|NCT00879879|7311984|FG000|Overall Study|Death|1
4504886|NCT00879879|7311984|FG000|Overall Study|Withdrawal by Subject|1
4504887|NCT00879879|7311984|FG000|Overall Study|Physician Decision|1
4504888|NCT00879970|7311993|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3
4504889|NCT00879970|7311994|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3
4504890|NCT00879970|7311995|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4
4504891|NCT00879970|7311996|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0
4504892|NCT00879970|7311997|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0
4504893|NCT00879970|7311993|FG000|Period 1 TZD Randomization|Lost to Follow-up|1
4504894|NCT00879970|7311994|FG001|Period 1 TZD Randomization|Lost to Follow-up|0
4504895|NCT00879970|7311995|FG002|Period 1 TZD Randomization|Lost to Follow-up|1
4504896|NCT00879970|7311996|FG003|Period 1 TZD Randomization|Lost to Follow-up|0
4504897|NCT00879970|7311997|FG004|Period 1 TZD Randomization|Lost to Follow-up|0
4504898|NCT00879970|7311993|FG000|Period 1 TZD Randomization|Death|2
4504899|NCT00879970|7311994|FG001|Period 1 TZD Randomization|Death|1
4504900|NCT00879970|7311995|FG002|Period 1 TZD Randomization|Death|0
4504901|NCT00879970|7311996|FG003|Period 1 TZD Randomization|Death|0
4504902|NCT00879970|7311997|FG004|Period 1 TZD Randomization|Death|0
4504903|NCT00879970|7311993|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2
4504904|NCT00879970|7311994|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
4504905|NCT00879970|7311995|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1
4504906|NCT00879970|7311996|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
4504907|NCT00879970|7311997|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
4504908|NCT00879970|7311993|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
4504909|NCT00879970|7311994|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
4504910|NCT00879970|7311995|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
4504911|NCT00879970|7311996|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2
4504912|NCT00879970|7311997|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6
4504913|NCT00879970|7311993|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0
4504914|NCT00879970|7311994|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0
4504915|NCT00879970|7311995|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0
4504916|NCT00879970|7311996|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0
4504917|NCT00879970|7311997|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1
4504918|NCT00879970|7311993|FG000|Period 2 Vitamin D Randomization|Death|0
4504919|NCT00879970|7311994|FG001|Period 2 Vitamin D Randomization|Death|0
4504920|NCT00879970|7311995|FG002|Period 2 Vitamin D Randomization|Death|0
4504921|NCT00879970|7311996|FG003|Period 2 Vitamin D Randomization|Death|2
4504922|NCT00879970|7311997|FG004|Period 2 Vitamin D Randomization|Death|0
4504923|NCT00879996|7312017|FG000|Overall Study|Lost to Follow-up|7
4504924|NCT00879996|7312018|FG001|Overall Study|Lost to Follow-up|6
4504925|NCT00879996|7312017|FG000|Overall Study|non-compliance|6
4504926|NCT00879996|7312018|FG001|Overall Study|non-compliance|4
4504927|NCT00879996|7312017|FG000|Overall Study|Physician Decision|1
4504928|NCT00879996|7312018|FG001|Overall Study|Physician Decision|2
4504929|NCT00879996|7312017|FG000|Overall Study|psychiatric problem|0
4504930|NCT00879996|7312018|FG001|Overall Study|psychiatric problem|1
4504931|NCT00879996|7312017|FG000|Overall Study|put on parole|1
4504932|NCT00879996|7312018|FG001|Overall Study|put on parole|0
4504933|NCT00880009|7312026|FG000|Overall Study|Study terminated by sponsor|14
4504934|NCT00880009|7312026|FG000|Overall Study|Withdrawal by Subject|1
4504935|NCT00880009|7312026|FG000|Overall Study|Protocol Violation|1
4504936|NCT00880048|7312047|FG000|Overall Study|Adverse Event|2
4504937|NCT00880048|7312048|FG001|Overall Study|Adverse Event|3
4504938|NCT00880048|7312049|FG002|Overall Study|Adverse Event|5
4504939|NCT00880048|7312047|FG000|Overall Study|Lack of Efficacy|1
4504940|NCT00880048|7312048|FG001|Overall Study|Lack of Efficacy|2
4504941|NCT00880048|7312049|FG002|Overall Study|Lack of Efficacy|2
4504942|NCT00880048|7312047|FG000|Overall Study|Protocol Violation|4
4504943|NCT00880048|7312048|FG001|Overall Study|Protocol Violation|6
4504944|NCT00880048|7312049|FG002|Overall Study|Protocol Violation|5
4504945|NCT00880048|7312047|FG000|Overall Study|Lost to Follow-up|6
4504946|NCT00880048|7312048|FG001|Overall Study|Lost to Follow-up|6
4504947|NCT00880048|7312049|FG002|Overall Study|Lost to Follow-up|5
4504948|NCT00880048|7312047|FG000|Overall Study|Physician Decision|1
4504949|NCT00880048|7312048|FG001|Overall Study|Physician Decision|1
4504950|NCT00880048|7312049|FG002|Overall Study|Physician Decision|7
4504951|NCT00880048|7312047|FG000|Overall Study|Withdrawal by Subject|5
4504952|NCT00880048|7312048|FG001|Overall Study|Withdrawal by Subject|8
4504953|NCT00880048|7312049|FG002|Overall Study|Withdrawal by Subject|5
4504954|NCT00880048|7312047|FG000|Overall Study|Study closed/terminated|9
4504955|NCT00880048|7312048|FG001|Overall Study|Study closed/terminated|7
4504956|NCT00880048|7312049|FG002|Overall Study|Study closed/terminated|6
4504957|NCT00880087|7312059|FG000|Overall Study|Lost to Follow-up|0
4504958|NCT00880087|7312060|FG001|Overall Study|Lost to Follow-up|2
4504959|NCT00880100|7312066|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1
4504960|NCT00880100|7312066|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1
4504961|NCT00880100|7312066|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2
4504962|NCT00880165|7312072|FG000|Overall Study|Withdrawal by Subject|27
4504963|NCT00880165|7312073|FG001|Overall Study|Withdrawal by Subject|23
4504964|NCT00880165|7312072|FG000|Overall Study|Not diagnosed with OSA|14
4504965|NCT00880165|7312073|FG001|Overall Study|Not diagnosed with OSA|8
4504966|NCT00880165|7312072|FG000|Overall Study|Required BIPAP or oxygen treatment|12
4504967|NCT00880165|7312073|FG001|Overall Study|Required BIPAP or oxygen treatment|4
4504968|NCT00880165|7312072|FG000|Overall Study|Lost to follow|9
4504969|NCT00880165|7312073|FG001|Overall Study|Lost to follow|15
4504970|NCT00880191|7312081|FG000|Overall Study|Refused further treatment|4
4504971|NCT00880191|7312082|FG001|Overall Study|Refused further treatment|1
4504972|NCT00880191|7312081|FG000|Overall Study|Adverse Event|8
4504973|NCT00880191|7312082|FG001|Overall Study|Adverse Event|6
4504974|NCT00880191|7312081|FG000|Overall Study|Hospitalization/efficacy|1
4504975|NCT00880191|7312082|FG001|Overall Study|Hospitalization/efficacy|1
4504976|NCT00880256|7312092|FG000|Overall Study|Lost to Follow-up|28
4504977|NCT00880269|7312098|FG000|Overall Study|Protocol Violation|1
4504978|NCT00880269|7312099|FG001|Overall Study|Protocol Violation|0
4504979|NCT00880269|7312098|FG000|Overall Study|Disease Progression|13
4504980|NCT00880269|7312099|FG001|Overall Study|Disease Progression|11
4504981|NCT00880269|7312098|FG000|Overall Study|New Cancer Therapy|1
4504982|NCT00880269|7312099|FG001|Overall Study|New Cancer Therapy|0
4504983|NCT00880269|7312098|FG000|Overall Study|Death|4
4504984|NCT00880269|7312099|FG001|Overall Study|Death|2
4504985|NCT00880269|7312098|FG000|Overall Study|Lost to Follow-up|0
4504986|NCT00880269|7312099|FG001|Overall Study|Lost to Follow-up|1
4504987|NCT00880269|7312098|FG000|Overall Study|Withdrawal by Subject|3
4504988|NCT00880269|7312099|FG001|Overall Study|Withdrawal by Subject|4
4504989|NCT00880269|7312098|FG000|Overall Study|Adverse Event|10
4504990|NCT00880269|7312099|FG001|Overall Study|Adverse Event|9
4504991|NCT00880334|7312107|FG000|Randomized Phase|Physician Decision|1
4504992|NCT00880334|7312108|FG001|Randomized Phase|Physician Decision|0
4627643|NCT01854658|7494444|FG000|Overall Study|Protocol-specified criteria|15
4627644|NCT01854658|7494445|FG001|Overall Study|Protocol-specified criteria|15
4627645|NCT01854658|7494446|FG002|Overall Study|Protocol-specified criteria|10
4504993|NCT00880334|7312107|FG000|Randomized Phase|Withdrawal by Subject|2
4504994|NCT00880334|7312108|FG001|Randomized Phase|Withdrawal by Subject|1
4504995|NCT00880334|7312107|FG000|Randomized Phase|Inadequate Labs|1
4504996|NCT00880334|7312108|FG001|Randomized Phase|Inadequate Labs|1
4504997|NCT00880334|7312107|FG000|Randomized Phase|Brain Metastasis|0
4504998|NCT00880334|7312108|FG001|Randomized Phase|Brain Metastasis|1
4504999|NCT00880334|7312107|FG000|Randomized Phase|Crossover Participants|0
4505000|NCT00880334|7312108|FG001|Randomized Phase|Crossover Participants|37
4505001|NCT00880399|7312126|FG000|Overall Study|Adverse Event|4
4505002|NCT00880399|7312127|FG001|Overall Study|Adverse Event|6
4505003|NCT00880399|7312128|FG002|Overall Study|Adverse Event|5
4505004|NCT00880399|7312126|FG000|Overall Study|Lack of Efficacy|1
4505005|NCT00880399|7312127|FG001|Overall Study|Lack of Efficacy|4
4505006|NCT00880399|7312128|FG002|Overall Study|Lack of Efficacy|2
4505007|NCT00880399|7312126|FG000|Overall Study|Protocol Violation|4
4505008|NCT00880399|7312127|FG001|Overall Study|Protocol Violation|4
4505009|NCT00880399|7312128|FG002|Overall Study|Protocol Violation|6
4505010|NCT00880399|7312126|FG000|Overall Study|Study closed/terminated|3
4505011|NCT00880399|7312127|FG001|Overall Study|Study closed/terminated|7
4505012|NCT00880399|7312128|FG002|Overall Study|Study closed/terminated|4
4505013|NCT00880399|7312126|FG000|Overall Study|Lost to Follow-up|8
4505014|NCT00880399|7312127|FG001|Overall Study|Lost to Follow-up|5
4505015|NCT00880399|7312128|FG002|Overall Study|Lost to Follow-up|3
4505016|NCT00880399|7312126|FG000|Overall Study|Physician Decision|5
4505017|NCT00880399|7312127|FG001|Overall Study|Physician Decision|0
4505018|NCT00880399|7312128|FG002|Overall Study|Physician Decision|3
4505019|NCT00880399|7312126|FG000|Overall Study|Withdrawal by Subject|6
4505020|NCT00880399|7312127|FG001|Overall Study|Withdrawal by Subject|3
4505021|NCT00880399|7312128|FG002|Overall Study|Withdrawal by Subject|3
4505022|NCT00880555|7312150|FG000|Overall Study|Physician Decision|0
4505023|NCT00880555|7312151|FG001|Overall Study|Physician Decision|8
4505024|NCT00880555|7312152|FG002|Overall Study|Physician Decision|0
4505025|NCT00880555|7312153|FG003|Overall Study|Physician Decision|2
4505026|NCT00880555|7312154|FG004|Overall Study|Physician Decision|1
4505027|NCT00880555|7312155|FG005|Overall Study|Physician Decision|0
4505028|NCT00880555|7312150|FG000|Overall Study|Withdrawal by Subject|1
4505029|NCT00880555|7312151|FG001|Overall Study|Withdrawal by Subject|1
4505030|NCT00880555|7312152|FG002|Overall Study|Withdrawal by Subject|0
4505031|NCT00880555|7312153|FG003|Overall Study|Withdrawal by Subject|0
4505032|NCT00880555|7312154|FG004|Overall Study|Withdrawal by Subject|0
4505033|NCT00880555|7312155|FG005|Overall Study|Withdrawal by Subject|0
4505034|NCT00880555|7312150|FG000|Overall Study|Lack of resources (hired rater)|9
4505035|NCT00880555|7312151|FG001|Overall Study|Lack of resources (hired rater)|7
4505036|NCT00880555|7312152|FG002|Overall Study|Lack of resources (hired rater)|5
4505037|NCT00880555|7312153|FG003|Overall Study|Lack of resources (hired rater)|0
4505038|NCT00880555|7312154|FG004|Overall Study|Lack of resources (hired rater)|0
4505039|NCT00880555|7312155|FG005|Overall Study|Lack of resources (hired rater)|0
4505040|NCT00880555|7312150|FG000|Overall Study|Death|0
4505041|NCT00880555|7312151|FG001|Overall Study|Death|0
4505042|NCT00880555|7312152|FG002|Overall Study|Death|0
4505043|NCT00880555|7312153|FG003|Overall Study|Death|0
4505044|NCT00880555|7312154|FG004|Overall Study|Death|0
4505045|NCT00880555|7312155|FG005|Overall Study|Death|1
4505046|NCT00880555|7312150|FG000|Overall Study|Lost to Follow-up|0
4505047|NCT00880555|7312151|FG001|Overall Study|Lost to Follow-up|1
4505048|NCT00880555|7312152|FG002|Overall Study|Lost to Follow-up|0
4505049|NCT00880555|7312153|FG003|Overall Study|Lost to Follow-up|0
4505050|NCT00880555|7312154|FG004|Overall Study|Lost to Follow-up|0
4505051|NCT00880555|7312155|FG005|Overall Study|Lost to Follow-up|0
4505052|NCT00880568|7312175|FG000|Overall Study|Disease progression|3
4505053|NCT00880568|7312176|FG001|Overall Study|Disease progression|3
4505054|NCT00880568|7312177|FG002|Overall Study|Disease progression|3
4505055|NCT00880568|7312178|FG003|Overall Study|Disease progression|1
4505056|NCT00880568|7312179|FG004|Overall Study|Disease progression|3
4505057|NCT00880568|7312180|FG005|Overall Study|Disease progression|3
4505058|NCT00880568|7312181|FG006|Overall Study|Disease progression|5
4505059|NCT00880568|7312182|FG007|Overall Study|Disease progression|0
4505060|NCT00880568|7312183|FG008|Overall Study|Disease progression|3
4505061|NCT00880568|7312175|FG000|Overall Study|Adverse Event|0
4505062|NCT00880568|7312176|FG001|Overall Study|Adverse Event|0
4505063|NCT00880568|7312177|FG002|Overall Study|Adverse Event|0
4505064|NCT00880568|7312178|FG003|Overall Study|Adverse Event|0
4505065|NCT00880568|7312179|FG004|Overall Study|Adverse Event|0
4505066|NCT00880568|7312180|FG005|Overall Study|Adverse Event|0
4505067|NCT00880568|7312181|FG006|Overall Study|Adverse Event|1
4505068|NCT00880568|7312182|FG007|Overall Study|Adverse Event|1
4505069|NCT00880568|7312183|FG008|Overall Study|Adverse Event|0
4505070|NCT00880568|7312175|FG000|Overall Study|Withdrawal by Subject|0
4505071|NCT00880568|7312176|FG001|Overall Study|Withdrawal by Subject|0
4505072|NCT00880568|7312177|FG002|Overall Study|Withdrawal by Subject|0
4505073|NCT00880568|7312178|FG003|Overall Study|Withdrawal by Subject|0
4505074|NCT00880568|7312179|FG004|Overall Study|Withdrawal by Subject|0
4505075|NCT00880568|7312180|FG005|Overall Study|Withdrawal by Subject|0
4505076|NCT00880568|7312181|FG006|Overall Study|Withdrawal by Subject|0
4505077|NCT00880568|7312182|FG007|Overall Study|Withdrawal by Subject|1
4505078|NCT00880568|7312183|FG008|Overall Study|Withdrawal by Subject|0
4505079|NCT00880607|7312214|FG000|Overall Study|Physician Decision|2
4505080|NCT00880607|7312215|FG001|Overall Study|Physician Decision|2
4505081|NCT00880607|7312214|FG000|Overall Study|Protocol Violation|2
4505082|NCT00880607|7312215|FG001|Overall Study|Protocol Violation|1
4505083|NCT00880607|7312214|FG000|Overall Study|surgery did not extend past L1 level|3
4505084|NCT00880607|7312215|FG001|Overall Study|surgery did not extend past L1 level|0
4505085|NCT00880620|7312227|FG000|Overall Study|Adverse Event|4
4505086|NCT00880620|7312228|FG001|Overall Study|Adverse Event|5
4505087|NCT00880620|7312229|FG002|Overall Study|Adverse Event|15
4505088|NCT00880620|7312230|FG003|Overall Study|Adverse Event|15
4505089|NCT00880620|7312227|FG000|Overall Study|Death|0
4505090|NCT00880620|7312228|FG001|Overall Study|Death|0
4505091|NCT00880620|7312229|FG002|Overall Study|Death|1
4505092|NCT00880620|7312230|FG003|Overall Study|Death|0
4505093|NCT00880620|7312227|FG000|Overall Study|Lack of Efficacy|12
4505094|NCT00880620|7312228|FG001|Overall Study|Lack of Efficacy|4
4505095|NCT00880620|7312229|FG002|Overall Study|Lack of Efficacy|0
4505096|NCT00880620|7312230|FG003|Overall Study|Lack of Efficacy|1
4505097|NCT00880620|7312227|FG000|Overall Study|Lost to Follow-up|0
4505098|NCT00880620|7312228|FG001|Overall Study|Lost to Follow-up|1
4505099|NCT00880620|7312229|FG002|Overall Study|Lost to Follow-up|1
4505100|NCT00880620|7312230|FG003|Overall Study|Lost to Follow-up|0
4505101|NCT00880620|7312227|FG000|Overall Study|Protocol Violation|0
4505102|NCT00880620|7312228|FG001|Overall Study|Protocol Violation|1
4505103|NCT00880620|7312229|FG002|Overall Study|Protocol Violation|0
4505104|NCT00880620|7312230|FG003|Overall Study|Protocol Violation|2
4505105|NCT00880620|7312227|FG000|Overall Study|Withdrawal by Subject|4
4505106|NCT00880620|7312228|FG001|Overall Study|Withdrawal by Subject|3
4505107|NCT00880620|7312229|FG002|Overall Study|Withdrawal by Subject|1
4505108|NCT00880620|7312230|FG003|Overall Study|Withdrawal by Subject|3
4505109|NCT00880620|7312227|FG000|Overall Study|Noncompliance|0
4505110|NCT00880620|7312228|FG001|Overall Study|Noncompliance|0
4505111|NCT00880620|7312229|FG002|Overall Study|Noncompliance|1
4505112|NCT00880620|7312230|FG003|Overall Study|Noncompliance|1
4505113|NCT00880620|7312227|FG000|Overall Study|Other|1
4505114|NCT00880620|7312228|FG001|Overall Study|Other|1
4505115|NCT00880620|7312229|FG002|Overall Study|Other|2
4505116|NCT00880620|7312230|FG003|Overall Study|Other|2
4505117|NCT00880685|7312244|FG000|Memantine 10mg|Lost to Follow-up|2
4505118|NCT00880685|7312244|FG000|Memantine 20mg|Withdrawal by Subject|1
4505119|NCT00880698|7312255|FG000|Overall Study|Death|0
4505120|NCT00880698|7312256|FG001|Overall Study|Death|0
4505121|NCT00880698|7312257|FG002|Overall Study|Death|1
4505122|NCT00880698|7312258|FG003|Overall Study|Death|2
4505123|NCT00880698|7312255|FG000|Overall Study|Lost to Follow-up|1
4505124|NCT00880698|7312256|FG001|Overall Study|Lost to Follow-up|3
4505125|NCT00880698|7312257|FG002|Overall Study|Lost to Follow-up|0
4505126|NCT00880698|7312258|FG003|Overall Study|Lost to Follow-up|1
4505127|NCT00880750|7312272|FG000|First Intervention|Adverse Event|1
4505128|NCT00880750|7312273|FG001|First Intervention|Adverse Event|0
4505129|NCT00880750|7312272|FG000|First Intervention|Unable to collect urine|4
4505130|NCT00880750|7312273|FG001|First Intervention|Unable to collect urine|0
4505131|NCT00880750|7312272|FG000|First Intervention|Non-compliance with meals|0
4505132|NCT00880750|7312273|FG001|First Intervention|Non-compliance with meals|1
4505133|NCT00880750|7312272|FG000|First Intervention|Withdrawal by Subject|2
4505134|NCT00880750|7312273|FG001|First Intervention|Withdrawal by Subject|0
4505135|NCT00880750|7312272|FG000|First Intervention|Lost to Follow-up|2
4505136|NCT00880750|7312273|FG001|First Intervention|Lost to Follow-up|0
4505137|NCT00880750|7312272|FG000|Second Intervention|Withdrawal by Subject|2
4505138|NCT00880750|7312273|FG001|Second Intervention|Withdrawal by Subject|2
4505139|NCT00880750|7312272|FG000|Second Intervention|Protocol Violation|1
4505140|NCT00880750|7312273|FG001|Second Intervention|Protocol Violation|0
4505141|NCT00880750|7312272|FG000|Second Intervention|Unable to collect urine|1
4505142|NCT00880750|7312273|FG001|Second Intervention|Unable to collect urine|0
4505143|NCT00880763|7312283|FG000|Extension Period (Part 2)|Adverse Event|0
4505144|NCT00880763|7312284|FG001|Extension Period (Part 2)|Adverse Event|0
4505145|NCT00880763|7312285|FG002|Extension Period (Part 2)|Adverse Event|1
4505146|NCT00880763|7312286|FG003|Extension Period (Part 2)|Adverse Event|1
4505147|NCT00880763|7312283|FG000|Extension Period (Part 2)|Withdrawal by Subject|0
4505148|NCT00880763|7312284|FG001|Extension Period (Part 2)|Withdrawal by Subject|2
4505149|NCT00880763|7312285|FG002|Extension Period (Part 2)|Withdrawal by Subject|1
4505150|NCT00880763|7312286|FG003|Extension Period (Part 2)|Withdrawal by Subject|1
4505151|NCT00880763|7312283|FG000|Extension Period (Part 2)|Physician Decision|0
4505152|NCT00880763|7312284|FG001|Extension Period (Part 2)|Physician Decision|1
4505153|NCT00880763|7312285|FG002|Extension Period (Part 2)|Physician Decision|1
4505154|NCT00880763|7312286|FG003|Extension Period (Part 2)|Physician Decision|0
4505155|NCT00880763|7312283|FG000|Extension Period (Part 2)|Lack of Efficacy|0
4505156|NCT00880763|7312284|FG001|Extension Period (Part 2)|Lack of Efficacy|0
4505157|NCT00880763|7312285|FG002|Extension Period (Part 2)|Lack of Efficacy|0
4505158|NCT00880763|7312286|FG003|Extension Period (Part 2)|Lack of Efficacy|1
4505159|NCT00880906|7312298|FG000|Overall Study|Lost to Follow-up|0
4505160|NCT00880906|7312299|FG001|Overall Study|Lost to Follow-up|1
4505161|NCT00880906|7312298|FG000|Overall Study|Did not meet criteria following patholog|12
4505162|NCT00880906|7312299|FG001|Overall Study|Did not meet criteria following patholog|6
4505163|NCT00881335|7312336|FG000|Overall Study|Lost to Follow-up|3
4627646|NCT01854658|7494447|FG003|Overall Study|Protocol-specified criteria|7
4627647|NCT01854658|7494444|FG000|Overall Study|Lack of Efficacy|3
4627648|NCT01854658|7494445|FG001|Overall Study|Lack of Efficacy|8
4627649|NCT01854658|7494446|FG002|Overall Study|Lack of Efficacy|4
4627650|NCT01854658|7494447|FG003|Overall Study|Lack of Efficacy|7
4627651|NCT01854658|7494444|FG000|Overall Study|Adverse Event|21
4627652|NCT01854658|7494445|FG001|Overall Study|Adverse Event|14
4627653|NCT01854658|7494446|FG002|Overall Study|Adverse Event|23
4627654|NCT01854658|7494447|FG003|Overall Study|Adverse Event|19
4627655|NCT01854658|7494444|FG000|Overall Study|Administrative reasons|5
4627656|NCT01854658|7494445|FG001|Overall Study|Administrative reasons|1
4627657|NCT01854658|7494446|FG002|Overall Study|Administrative reasons|2
4627658|NCT01854658|7494447|FG003|Overall Study|Administrative reasons|2
4627659|NCT01854697|7494462|FG000|Overall Study|Adverse Event|1
4627660|NCT01854697|7494463|FG001|Overall Study|Adverse Event|0
4505164|NCT00881335|7312337|FG001|Overall Study|Lost to Follow-up|2
4505165|NCT00881361|7312345|FG000|Overall Study|Terminated prior to surgery|27
4505166|NCT00881361|7312346|FG001|Overall Study|Terminated prior to surgery|7
4505167|NCT00881361|7312347|FG002|Overall Study|Terminated prior to surgery|0
4505168|NCT00881361|7312345|FG000|Overall Study|Ineligible|17
4505169|NCT00881361|7312346|FG001|Overall Study|Ineligible|2
4505170|NCT00881361|7312347|FG002|Overall Study|Ineligible|2
4505171|NCT00881504|7312365|FG000|Overall Study|Withdrawal by Subject|1
4627661|NCT01854697|7494464|FG002|Overall Study|Adverse Event|0
4627662|NCT01854697|7494465|FG003|Overall Study|Adverse Event|0
4627663|NCT01854697|7494466|FG004|Overall Study|Adverse Event|1
4505172|NCT00881530|7312375|FG000|Overall Study|Adverse Event|5
4505173|NCT00881530|7312376|FG001|Overall Study|Adverse Event|1
4505174|NCT00881530|7312377|FG002|Overall Study|Adverse Event|1
4505175|NCT00881530|7312378|FG003|Overall Study|Adverse Event|4
4505176|NCT00881530|7312379|FG004|Overall Study|Adverse Event|10
4505177|NCT00881530|7312380|FG005|Overall Study|Adverse Event|2
4505178|NCT00881530|7312375|FG000|Overall Study|Lack of Efficacy|1
4505179|NCT00881530|7312376|FG001|Overall Study|Lack of Efficacy|0
4505180|NCT00881530|7312377|FG002|Overall Study|Lack of Efficacy|0
4505181|NCT00881530|7312378|FG003|Overall Study|Lack of Efficacy|0
4505182|NCT00881530|7312379|FG004|Overall Study|Lack of Efficacy|1
4505183|NCT00881530|7312380|FG005|Overall Study|Lack of Efficacy|1
4505184|NCT00881530|7312375|FG000|Overall Study|Not compliant with the protocol|0
4505185|NCT00881530|7312376|FG001|Overall Study|Not compliant with the protocol|0
4505186|NCT00881530|7312377|FG002|Overall Study|Not compliant with the protocol|0
4505187|NCT00881530|7312378|FG003|Overall Study|Not compliant with the protocol|0
4505188|NCT00881530|7312379|FG004|Overall Study|Not compliant with the protocol|2
4505189|NCT00881530|7312380|FG005|Overall Study|Not compliant with the protocol|0
4505190|NCT00881530|7312375|FG000|Overall Study|Lost to Follow-up|0
4505191|NCT00881530|7312376|FG001|Overall Study|Lost to Follow-up|1
4505192|NCT00881530|7312377|FG002|Overall Study|Lost to Follow-up|1
4505193|NCT00881530|7312378|FG003|Overall Study|Lost to Follow-up|3
4627664|NCT01854697|7494462|FG000|Overall Study|Lost to Follow-up|4
4627665|NCT01854697|7494463|FG001|Overall Study|Lost to Follow-up|1
4627666|NCT01854697|7494464|FG002|Overall Study|Lost to Follow-up|1
4505194|NCT00881530|7312379|FG004|Overall Study|Lost to Follow-up|1
4505195|NCT00881530|7312380|FG005|Overall Study|Lost to Follow-up|0
4505196|NCT00881530|7312375|FG000|Overall Study|Refused to continue medication|7
4505197|NCT00881530|7312376|FG001|Overall Study|Refused to continue medication|2
4505198|NCT00881530|7312377|FG002|Overall Study|Refused to continue medication|1
4505199|NCT00881530|7312378|FG003|Overall Study|Refused to continue medication|2
4505200|NCT00881530|7312379|FG004|Overall Study|Refused to continue medication|0
4505201|NCT00881530|7312380|FG005|Overall Study|Refused to continue medication|0
4505202|NCT00881530|7312375|FG000|Overall Study|Other reason not defined above|1
4505203|NCT00881530|7312376|FG001|Overall Study|Other reason not defined above|1
4505204|NCT00881530|7312377|FG002|Overall Study|Other reason not defined above|2
4505205|NCT00881530|7312378|FG003|Overall Study|Other reason not defined above|0
4505206|NCT00881530|7312379|FG004|Overall Study|Other reason not defined above|0
4505207|NCT00881530|7312380|FG005|Overall Study|Other reason not defined above|2
4505208|NCT00881569|7312396|FG000|Overall Study|Disease progression|1
4505209|NCT00881569|7312397|FG001|Overall Study|Disease progression|1
4505210|NCT00881621|7312403|FG000|Overall Study|Physician Decision|34
4505211|NCT00881712|7312419|FG000|Overall Study|Death|1
4505212|NCT00881712|7312420|FG001|Overall Study|Death|0
4505213|NCT00881712|7312421|FG002|Overall Study|Death|0
4505214|NCT00881712|7312419|FG000|Overall Study|Withdrawal by Subject|1
4505215|NCT00881712|7312420|FG001|Overall Study|Withdrawal by Subject|0
4505216|NCT00881712|7312421|FG002|Overall Study|Withdrawal by Subject|0
4505217|NCT00881751|7312431|FG000|Overall Study|Physician Decision|0
4505218|NCT00881751|7312432|FG001|Overall Study|Physician Decision|1
4505219|NCT00881751|7312431|FG000|Overall Study|Adverse Event|0
4505220|NCT00881751|7312432|FG001|Overall Study|Adverse Event|2
4505221|NCT00881751|7312431|FG000|Overall Study|Withdrawal by Subject|0
4505222|NCT00881751|7312432|FG001|Overall Study|Withdrawal by Subject|2
4505223|NCT00881868|7312440|FG000|Overall Study|Adverse Event|0
4505224|NCT00881868|7312441|FG001|Overall Study|Adverse Event|1
4505225|NCT00881868|7312440|FG000|Overall Study|Lost to Follow-up|2
4505226|NCT00881868|7312441|FG001|Overall Study|Lost to Follow-up|1
4505227|NCT00881868|7312440|FG000|Overall Study|Physician Decision|4
4627667|NCT01854697|7494465|FG003|Overall Study|Lost to Follow-up|2
4627668|NCT01854697|7494466|FG004|Overall Study|Lost to Follow-up|0
4627669|NCT01854697|7494462|FG000|Overall Study|To enter another AbbVie study|1
4627670|NCT01854697|7494463|FG001|Overall Study|To enter another AbbVie study|0
4627671|NCT01854697|7494464|FG002|Overall Study|To enter another AbbVie study|0
4627672|NCT01854697|7494465|FG003|Overall Study|To enter another AbbVie study|0
4505228|NCT00881868|7312441|FG001|Overall Study|Physician Decision|0
4505229|NCT00881868|7312440|FG000|Overall Study|Protocol Violation|2
4505230|NCT00881868|7312441|FG001|Overall Study|Protocol Violation|0
4505231|NCT00881894|7312449|FG000|Overall Study|Consent withdrawn|0
4505232|NCT00881894|7312450|FG001|Overall Study|Consent withdrawn|1
4505233|NCT00881894|7312449|FG000|Overall Study|Other reasons for premature termination|1
4505234|NCT00881894|7312450|FG001|Overall Study|Other reasons for premature termination|2
4505235|NCT00881959|7312458|FG000|Overall Study|Lost to Follow-up|2
4505236|NCT00881959|7312459|FG001|Overall Study|Lost to Follow-up|4
4505237|NCT00882115|7312469|FG000|Overall Study|Withdrawal by Subject|3
4505238|NCT00882115|7312469|FG000|Overall Study|did not respond to DEP challe|6
4505239|NCT00882362|7312480|FG000|Overall Study|Adverse Event|13
4627673|NCT01854697|7494466|FG004|Overall Study|To enter another AbbVie study|1
4505240|NCT00882362|7312481|FG001|Overall Study|Adverse Event|10
4505241|NCT00882362|7312480|FG000|Overall Study|Withdrawal by Subject|13
4505242|NCT00882362|7312481|FG001|Overall Study|Withdrawal by Subject|10
4505243|NCT00882362|7312480|FG000|Overall Study|Lack of Efficacy|3
4627674|NCT01854697|7494462|FG000|Overall Study|Withdrew Consent|0
4505244|NCT00882362|7312481|FG001|Overall Study|Lack of Efficacy|0
4505245|NCT00882362|7312480|FG000|Overall Study|Protocol Violation|7
4505246|NCT00882362|7312481|FG001|Overall Study|Protocol Violation|2
4505247|NCT00882362|7312480|FG000|Overall Study|Pregnancy|1
4505248|NCT00882362|7312481|FG001|Overall Study|Pregnancy|0
4505249|NCT00882362|7312480|FG000|Overall Study|Physician Decision|5
4505250|NCT00882362|7312481|FG001|Overall Study|Physician Decision|1
4505251|NCT00882362|7312480|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2
4505252|NCT00882362|7312481|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0
4505253|NCT00882362|7312480|FG000|Overall Study|change of residence or other commitments|5
4505254|NCT00882362|7312481|FG001|Overall Study|change of residence or other commitments|0
4505255|NCT00882518|7312489|FG000|Overall Study|Adverse Event|9
4505256|NCT00882518|7312490|FG001|Overall Study|Adverse Event|18
4505257|NCT00882518|7312489|FG000|Overall Study|Withdrawal by Subject|9
4505258|NCT00882518|7312490|FG001|Overall Study|Withdrawal by Subject|13
4505259|NCT00882518|7312489|FG000|Overall Study|Lack of Efficacy|12
4505260|NCT00882518|7312490|FG001|Overall Study|Lack of Efficacy|9
4505261|NCT00882518|7312489|FG000|Overall Study|Severe non-compliance to protocol|3
4505262|NCT00882518|7312490|FG001|Overall Study|Severe non-compliance to protocol|1
4505263|NCT00882518|7312489|FG000|Overall Study|Incorrect enrolment|4
4505264|NCT00882518|7312490|FG001|Overall Study|Incorrect enrolment|2
4505265|NCT00882518|7312489|FG000|Overall Study|Central lab closure for National day|1
4505266|NCT00882518|7312490|FG001|Overall Study|Central lab closure for National day|0
4505267|NCT00882518|7312489|FG000|Overall Study|Allocating random number by mistake|0
4505268|NCT00882518|7312490|FG001|Overall Study|Allocating random number by mistake|1
4505269|NCT00882557|7312498|FG000|Overall Study|Withdrawal by Subject|1
4505270|NCT00882557|7312499|FG001|Overall Study|Withdrawal by Subject|0
4505271|NCT00882557|7312498|FG000|Overall Study|Trouble with Vein Access|1
4505272|NCT00882557|7312499|FG001|Overall Study|Trouble with Vein Access|0
4505273|NCT00882557|7312498|FG000|Overall Study|Randomized Not Treated|0
4505274|NCT00882557|7312499|FG001|Overall Study|Randomized Not Treated|1
4505275|NCT00882583|7312507|FG000|Overall Study|Physician Decision|1
4505276|NCT00882583|7312508|FG001|Overall Study|Physician Decision|0
4505277|NCT00882583|7312507|FG000|Overall Study|Adverse Event|0
4505278|NCT00882583|7312508|FG001|Overall Study|Adverse Event|1
4505279|NCT00882713|7312543|FG000|Overall Study|Adverse Event|2
4505280|NCT00882713|7312543|FG000|Overall Study|Death|3
4505281|NCT00882713|7312543|FG000|Overall Study|Administrative reasons|4
4505282|NCT00882713|7312543|FG000|Overall Study|refused treatment/withdrew consent|4
4505283|NCT00882713|7312543|FG000|Overall Study|Blood transfusion|2
4505284|NCT00882713|7312543|FG000|Overall Study|Insufficient therapeutic response|3
4505285|NCT00882713|7312543|FG000|Overall Study|Failure to return|2
4505286|NCT00882713|7312543|FG000|Overall Study|Other - Reasons|2
4505287|NCT00882908|7312557|FG000|Overall Study|Adverse Event|0
4505288|NCT00882908|7312558|FG001|Overall Study|Adverse Event|0
4505289|NCT00882908|7312559|FG002|Overall Study|Adverse Event|1
4505290|NCT00882908|7312560|FG003|Overall Study|Adverse Event|0
4505291|NCT00882908|7312561|FG004|Overall Study|Adverse Event|1
4505292|NCT00882908|7312557|FG000|Overall Study|Lost to Follow-up|3
4505293|NCT00882908|7312558|FG001|Overall Study|Lost to Follow-up|5
4505294|NCT00882908|7312559|FG002|Overall Study|Lost to Follow-up|3
4505295|NCT00882908|7312560|FG003|Overall Study|Lost to Follow-up|1
4505296|NCT00882908|7312561|FG004|Overall Study|Lost to Follow-up|2
4505297|NCT00882908|7312557|FG000|Overall Study|Protocol Violation|0
4505298|NCT00882908|7312558|FG001|Overall Study|Protocol Violation|1
4505299|NCT00882908|7312559|FG002|Overall Study|Protocol Violation|0
4505300|NCT00882908|7312560|FG003|Overall Study|Protocol Violation|0
4505301|NCT00882908|7312561|FG004|Overall Study|Protocol Violation|0
4505302|NCT00882908|7312557|FG000|Overall Study|Withdrawal by Subject|0
4505303|NCT00882908|7312558|FG001|Overall Study|Withdrawal by Subject|0
4505304|NCT00882908|7312559|FG002|Overall Study|Withdrawal by Subject|3
4505305|NCT00882908|7312560|FG003|Overall Study|Withdrawal by Subject|5
4505306|NCT00882908|7312561|FG004|Overall Study|Withdrawal by Subject|2
4505307|NCT00882908|7312557|FG000|Overall Study|Subject reached a virologic endpoint|0
4505308|NCT00882908|7312558|FG001|Overall Study|Subject reached a virologic endpoint|0
4505309|NCT00882908|7312559|FG002|Overall Study|Subject reached a virologic endpoint|0
4505310|NCT00882908|7312560|FG003|Overall Study|Subject reached a virologic endpoint|0
4505311|NCT00882908|7312561|FG004|Overall Study|Subject reached a virologic endpoint|1
4505312|NCT00882908|7312557|FG000|Overall Study|Study terminated in error|0
4505313|NCT00882908|7312558|FG001|Overall Study|Study terminated in error|0
4505314|NCT00882908|7312559|FG002|Overall Study|Study terminated in error|0
4505315|NCT00882908|7312560|FG003|Overall Study|Study terminated in error|1
4505316|NCT00882908|7312561|FG004|Overall Study|Study terminated in error|0
4505317|NCT00882921|7312574|FG000|Overall Study|Death|2
4505318|NCT00882921|7312574|FG000|Overall Study|Other|3
4505319|NCT00882921|7312574|FG000|Overall Study|Lost to Follow-up|2
4505320|NCT00882921|7312574|FG000|Overall Study|Termination By Investigator|3
4505321|NCT00882921|7312574|FG000|Overall Study|Withdrawal Of Consent|1
4505322|NCT00882999|7312586|FG000|Overall Study|Adverse Event|0
4505323|NCT00882999|7312587|FG001|Overall Study|Adverse Event|0
4505324|NCT00882999|7312588|FG002|Overall Study|Adverse Event|0
4505325|NCT00882999|7312589|FG003|Overall Study|Adverse Event|0
4505326|NCT00882999|7312590|FG004|Overall Study|Adverse Event|1
4505327|NCT00882999|7312591|FG005|Overall Study|Adverse Event|0
4505328|NCT00882999|7312592|FG006|Overall Study|Adverse Event|0
4505329|NCT00882999|7312586|FG000|Overall Study|Death|0
4505330|NCT00882999|7312587|FG001|Overall Study|Death|1
4505331|NCT00882999|7312588|FG002|Overall Study|Death|0
4505332|NCT00882999|7312589|FG003|Overall Study|Death|0
4505333|NCT00882999|7312590|FG004|Overall Study|Death|0
4505334|NCT00882999|7312591|FG005|Overall Study|Death|0
4505335|NCT00882999|7312592|FG006|Overall Study|Death|0
4505336|NCT00882999|7312586|FG000|Overall Study|Withdrawal by Subject|7
4505337|NCT00882999|7312587|FG001|Overall Study|Withdrawal by Subject|6
4505338|NCT00882999|7312588|FG002|Overall Study|Withdrawal by Subject|3
4505339|NCT00882999|7312589|FG003|Overall Study|Withdrawal by Subject|3
4505340|NCT00882999|7312590|FG004|Overall Study|Withdrawal by Subject|6
4505341|NCT00882999|7312591|FG005|Overall Study|Withdrawal by Subject|5
4505342|NCT00882999|7312592|FG006|Overall Study|Withdrawal by Subject|5
4505343|NCT00882999|7312586|FG000|Overall Study|Lost to Follow-up|0
4505344|NCT00882999|7312587|FG001|Overall Study|Lost to Follow-up|1
4505345|NCT00882999|7312588|FG002|Overall Study|Lost to Follow-up|1
4505346|NCT00882999|7312589|FG003|Overall Study|Lost to Follow-up|2
4505347|NCT00882999|7312590|FG004|Overall Study|Lost to Follow-up|1
4505348|NCT00882999|7312591|FG005|Overall Study|Lost to Follow-up|1
4505349|NCT00882999|7312592|FG006|Overall Study|Lost to Follow-up|2
4505350|NCT00882999|7312586|FG000|Overall Study|Physician Decision|1
4505351|NCT00882999|7312587|FG001|Overall Study|Physician Decision|0
4505352|NCT00882999|7312588|FG002|Overall Study|Physician Decision|0
4505353|NCT00882999|7312589|FG003|Overall Study|Physician Decision|0
4505354|NCT00882999|7312590|FG004|Overall Study|Physician Decision|0
4505355|NCT00882999|7312591|FG005|Overall Study|Physician Decision|1
4505356|NCT00882999|7312592|FG006|Overall Study|Physician Decision|1
4505357|NCT00883051|7312620|FG000|Overall Study|Lost to Follow-up|0
4505358|NCT00883051|7312621|FG001|Overall Study|Lost to Follow-up|0
4505359|NCT00883051|7312622|FG002|Overall Study|Lost to Follow-up|0
4505360|NCT00883051|7312623|FG003|Overall Study|Lost to Follow-up|0
4505361|NCT00883051|7312624|FG004|Overall Study|Lost to Follow-up|1
4505362|NCT00883051|7312620|FG000|Overall Study|Did not use study medication|24
4505363|NCT00883051|7312621|FG001|Overall Study|Did not use study medication|22
4505364|NCT00883051|7312622|FG002|Overall Study|Did not use study medication|29
4505365|NCT00883051|7312623|FG003|Overall Study|Did not use study medication|29
4505366|NCT00883051|7312624|FG004|Overall Study|Did not use study medication|17
4505367|NCT00883090|7312636|FG000|Overall Study|Sponsor's decision|1
4505368|NCT00883090|7312636|FG000|Overall Study|Withdrawal by Subject|1
4505369|NCT00883116|7312651|FG000|Overall Study|Adverse event unrelated to study drug|5
4505370|NCT00883116|7312652|FG001|Overall Study|Adverse event unrelated to study drug|10
4505371|NCT00883116|7312651|FG000|Overall Study|Death|6
4505372|NCT00883116|7312652|FG001|Overall Study|Death|2
4505373|NCT00883116|7312651|FG000|Overall Study|Disease progression|130
4505374|NCT00883116|7312652|FG001|Overall Study|Disease progression|128
4505375|NCT00883116|7312651|FG000|Overall Study|Lost to Follow-up|0
4505376|NCT00883116|7312652|FG001|Overall Study|Lost to Follow-up|1
4505377|NCT00883116|7312651|FG000|Overall Study|Maximum clinical benefit|13
4505378|NCT00883116|7312652|FG001|Overall Study|Maximum clinical benefit|46
4505379|NCT00883116|7312651|FG000|Overall Study|Not identified|3
4505380|NCT00883116|7312652|FG001|Overall Study|Not identified|6
4505381|NCT00883116|7312651|FG000|Overall Study|Study drug toxicity|36
4505382|NCT00883116|7312652|FG001|Overall Study|Study drug toxicity|16
4505383|NCT00883116|7312651|FG000|Overall Study|Withdrawal by Subject|14
4505384|NCT00883116|7312652|FG001|Overall Study|Withdrawal by Subject|8
4505385|NCT00883116|7312651|FG000|Overall Study|No longer meets study criteria|2
4505386|NCT00883116|7312652|FG001|Overall Study|No longer meets study criteria|2
4505387|NCT00883129|7312662|FG000|Overall Study|Adverse Event|7
4505388|NCT00883129|7312663|FG001|Overall Study|Adverse Event|15
4505389|NCT00883129|7312662|FG000|Overall Study|Withdrawal by Subject|8
4505390|NCT00883129|7312663|FG001|Overall Study|Withdrawal by Subject|9
4505391|NCT00883129|7312662|FG000|Overall Study|Non-compliance|3
4505392|NCT00883129|7312663|FG001|Overall Study|Non-compliance|6
4505393|NCT00883129|7312662|FG000|Overall Study|Lost to Follow-up|1
4505394|NCT00883129|7312663|FG001|Overall Study|Lost to Follow-up|2
4505395|NCT00883129|7312662|FG000|Overall Study|Death|1
4505396|NCT00883129|7312663|FG001|Overall Study|Death|2
4505397|NCT00883129|7312662|FG000|Overall Study|Defined Treatment Failure|0
4505398|NCT00883129|7312663|FG001|Overall Study|Defined Treatment Failure|2
4505399|NCT00883181|7312686|FG000|Overall Study|Hematological Adverse Event|26
4505400|NCT00883181|7312686|FG000|Overall Study|Non-hematological Adverse Event|55
4505401|NCT00883181|7312686|FG000|Overall Study|Disease Progression|94
4505402|NCT00883181|7312686|FG000|Overall Study|Administrative Reason|24
4505403|NCT00883181|7312686|FG000|Overall Study|Withdrawal by Subject|4
4505404|NCT00883181|7312686|FG000|Overall Study|Death|31
4505405|NCT00883181|7312686|FG000|Overall Study|Other|38
4505406|NCT00883181|7312686|FG000|Overall Study|Protocol Deviation|3
4505407|NCT00883181|7312686|FG000|Overall Study|Noncompliance|3
4505408|NCT00883337|7312733|FG000|Core Treatment Period|Adverse Event|9
4505409|NCT00883337|7312734|FG001|Core Treatment Period|Adverse Event|12
4505410|NCT00883337|7312735|FG002|Core Treatment Period|Adverse Event|22
4505411|NCT00883337|7312733|FG000|Core Treatment Period|Lack of Efficacy|7
4505412|NCT00883337|7312734|FG001|Core Treatment Period|Lack of Efficacy|4
4505413|NCT00883337|7312735|FG002|Core Treatment Period|Lack of Efficacy|2
4505414|NCT00883337|7312733|FG000|Core Treatment Period|Lost to Follow-up|1
4505415|NCT00883337|7312734|FG001|Core Treatment Period|Lost to Follow-up|1
4505416|NCT00883337|7312735|FG002|Core Treatment Period|Lost to Follow-up|0
4505417|NCT00883337|7312733|FG000|Core Treatment Period|Withdrawal by Subject|2
4505418|NCT00883337|7312734|FG001|Core Treatment Period|Withdrawal by Subject|2
4505419|NCT00883337|7312735|FG002|Core Treatment Period|Withdrawal by Subject|6
4505420|NCT00883337|7312733|FG000|Core Treatment Period|Wish to be pregnant|1
4505421|NCT00883337|7312734|FG001|Core Treatment Period|Wish to be pregnant|2
4505422|NCT00883337|7312735|FG002|Core Treatment Period|Wish to be pregnant|1
4505423|NCT00883337|7312733|FG000|Core Treatment Period|Poor compliance to protocol|0
4505424|NCT00883337|7312734|FG001|Core Treatment Period|Poor compliance to protocol|0
4505425|NCT00883337|7312735|FG002|Core Treatment Period|Poor compliance to protocol|1
4505426|NCT00883337|7312733|FG000|Core Treatment Period|Other than above|0
4505427|NCT00883337|7312734|FG001|Core Treatment Period|Other than above|1
4505428|NCT00883337|7312735|FG002|Core Treatment Period|Other than above|1
4505429|NCT00883337|7312733|FG000|Extension Treatment Period|Adverse Event|8
4505430|NCT00883337|7312734|FG001|Extension Treatment Period|Adverse Event|5
4505431|NCT00883337|7312735|FG002|Extension Treatment Period|Adverse Event|5
4505432|NCT00883337|7312733|FG000|Extension Treatment Period|Lack of Efficacy|8
4505433|NCT00883337|7312734|FG001|Extension Treatment Period|Lack of Efficacy|8
4505434|NCT00883337|7312735|FG002|Extension Treatment Period|Lack of Efficacy|8
4505435|NCT00883337|7312733|FG000|Extension Treatment Period|Poor compliance to protocol|1
4505436|NCT00883337|7312734|FG001|Extension Treatment Period|Poor compliance to protocol|1
4505437|NCT00883337|7312735|FG002|Extension Treatment Period|Poor compliance to protocol|1
4505438|NCT00883337|7312733|FG000|Extension Treatment Period|Lost to Follow-up|1
4505439|NCT00883337|7312734|FG001|Extension Treatment Period|Lost to Follow-up|0
4505440|NCT00883337|7312735|FG002|Extension Treatment Period|Lost to Follow-up|0
4505441|NCT00883337|7312733|FG000|Extension Treatment Period|Other than above|10
4505442|NCT00883337|7312734|FG001|Extension Treatment Period|Other than above|9
4505443|NCT00883337|7312735|FG002|Extension Treatment Period|Other than above|5
4505444|NCT00883493|7312759|FG000|Overall Study|Adverse Event|11
4505445|NCT00883493|7312760|FG001|Overall Study|Adverse Event|12
4505446|NCT00883493|7312759|FG000|Overall Study|Lack of Efficacy|4
4505447|NCT00883493|7312760|FG001|Overall Study|Lack of Efficacy|3
4505448|NCT00883493|7312759|FG000|Overall Study|Lost to Follow-up|7
4505449|NCT00883493|7312760|FG001|Overall Study|Lost to Follow-up|6
4505450|NCT00883493|7312759|FG000|Overall Study|Withdrawal by Subject|11
4505451|NCT00883493|7312760|FG001|Overall Study|Withdrawal by Subject|20
4505452|NCT00883493|7312759|FG000|Overall Study|Eligibility Criteria not fullfilled|6
4505453|NCT00883493|7312760|FG001|Overall Study|Eligibility Criteria not fullfilled|6
4505454|NCT00883493|7312759|FG000|Overall Study|Study specific disc. criteria|2
4505455|NCT00883493|7312760|FG001|Overall Study|Study specific disc. criteria|0
4505456|NCT00883493|7312759|FG000|Overall Study|Other|5
4505457|NCT00883493|7312760|FG001|Overall Study|Other|3
4505458|NCT00883558|7312766|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2
4505459|NCT00883558|7312767|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0
4505460|NCT00883558|7312768|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0
4505461|NCT00883558|7312766|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0
4505462|NCT00883558|7312767|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1
4505463|NCT00883558|7312768|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0
4505464|NCT00883558|7312766|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0
4505465|NCT00883558|7312767|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1
4505466|NCT00883558|7312768|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1
4505467|NCT00883558|7312766|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0
4505468|NCT00883558|7312767|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1
4505469|NCT00883558|7312768|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0
4505470|NCT00883558|7312766|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0
4505471|NCT00883558|7312767|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0
4505472|NCT00883558|7312768|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1
4627675|NCT01854697|7494463|FG001|Overall Study|Withdrew Consent|1
4505473|NCT00883688|7312778|FG000|Overall Study|Ineligible|2
4505474|NCT00883740|7312782|FG000|First Intervention|Lost to Follow-up|1
4505475|NCT00883740|7312783|FG001|First Intervention|Lost to Follow-up|0
4505476|NCT00883740|7312782|FG000|First Intervention|No longer willing to participate|2
4505477|NCT00883740|7312783|FG001|First Intervention|No longer willing to participate|0
4505478|NCT00883740|7312782|FG000|First Intervention|Protocol Violation|3
4505479|NCT00883740|7312783|FG001|First Intervention|Protocol Violation|6
4505480|NCT00883740|7312782|FG000|First Intervention|Adverse Event|1
4505481|NCT00883740|7312783|FG001|First Intervention|Adverse Event|2
4505482|NCT00883740|7312782|FG000|Second Intervention|Protocol Violation|1
4505483|NCT00883740|7312783|FG001|Second Intervention|Protocol Violation|0
4505484|NCT00883740|7312782|FG000|Second Intervention|No longer willing to participate|0
4505485|NCT00883740|7312783|FG001|Second Intervention|No longer willing to participate|1
4505486|NCT00883753|7312789|FG000|Overall Study|Adverse Event|37
4505487|NCT00883753|7312789|FG000|Overall Study|Death|2
4505488|NCT00883753|7312789|FG000|Overall Study|Insufficient therapeutic response|16
4505489|NCT00883753|7312789|FG000|Overall Study|Lost to Follow-up|4
4505490|NCT00883753|7312789|FG000|Overall Study|Violation of selection criteria at entry|7
4505491|NCT00883753|7312789|FG000|Overall Study|Protocol Violation|2
4505492|NCT00883753|7312789|FG000|Overall Study|Refused treatment|4
4505493|NCT00883753|7312789|FG000|Overall Study|Withdrew consent|10
4505494|NCT00883753|7312789|FG000|Overall Study|Investigator's decision|17
4505495|NCT00883753|7312789|FG000|Overall Study|Administrative/Other|8
4505496|NCT00883779|7312798|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4
4505497|NCT00883779|7312799|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4
4505498|NCT00883779|7312798|FG000|Primary Study Treatment Phase|Disease progression|75
4505499|NCT00883779|7312799|FG001|Primary Study Treatment Phase|Disease progression|59
4505500|NCT00883779|7312798|FG000|Primary Study Treatment Phase|Adverse Event|16
4505501|NCT00883779|7312799|FG001|Primary Study Treatment Phase|Adverse Event|16
4505502|NCT00883779|7312798|FG000|Primary Study Treatment Phase|Death|2
4505503|NCT00883779|7312799|FG001|Primary Study Treatment Phase|Death|3
4505504|NCT00883779|7312798|FG000|Primary Study Treatment Phase|Refused Treatment|5
4505505|NCT00883779|7312799|FG001|Primary Study Treatment Phase|Refused Treatment|4
4505506|NCT00883779|7312798|FG000|Primary Study Treatment Phase|Other|3
4505507|NCT00883779|7312799|FG001|Primary Study Treatment Phase|Other|0
4505508|NCT00883779|7312798|FG000|Post-Study Treatment Phase|Adverse Event|2
4505509|NCT00883779|7312799|FG001|Post-Study Treatment Phase|Adverse Event|3
4505510|NCT00883779|7312798|FG000|Post-Study Treatment Phase|Death|1
4505511|NCT00883779|7312799|FG001|Post-Study Treatment Phase|Death|3
4505512|NCT00883779|7312798|FG000|Post-Study Treatment Phase|Protocol Violation|0
4505513|NCT00883779|7312799|FG001|Post-Study Treatment Phase|Protocol Violation|1
4505514|NCT00883779|7312798|FG000|Post-Study Treatment Phase|Refused Treatment|3
4505515|NCT00883779|7312799|FG001|Post-Study Treatment Phase|Refused Treatment|0
4505516|NCT00883779|7312798|FG000|Post-Study Treatment Phase|Disease progression|103
4505517|NCT00883779|7312799|FG001|Post-Study Treatment Phase|Disease progression|122
4505518|NCT00883779|7312798|FG000|Post-Study Treatment Phase|Other|3
4505519|NCT00883779|7312799|FG001|Post-Study Treatment Phase|Other|0
4505520|NCT00883779|7312798|FG000|Post-Study Treatment Phase|Ongoing in the study|0
4505521|NCT00883779|7312799|FG001|Post-Study Treatment Phase|Ongoing in the study|6
4505522|NCT00883779|7312798|FG000|Off-study Phase|Death|185
4505523|NCT00883779|7312799|FG001|Off-study Phase|Death|174
4505524|NCT00883779|7312798|FG000|Off-study Phase|Refused treatment|1
4627676|NCT01854697|7494464|FG002|Overall Study|Withdrew Consent|0
4627677|NCT01854697|7494465|FG003|Overall Study|Withdrew Consent|1
4627678|NCT01854697|7494466|FG004|Overall Study|Withdrew Consent|0
4627679|NCT01854697|7494462|FG000|Overall Study|Other|0
4627680|NCT01854697|7494463|FG001|Overall Study|Other|1
4627681|NCT01854697|7494464|FG002|Overall Study|Other|1
4627682|NCT01854697|7494465|FG003|Overall Study|Other|0
4627683|NCT01854697|7494466|FG004|Overall Study|Other|0
4505525|NCT00883779|7312799|FG001|Off-study Phase|Refused treatment|1
4505526|NCT00883779|7312798|FG000|Off-study Phase|Failure to return|5
4505527|NCT00883779|7312799|FG001|Off-study Phase|Failure to return|6
4505528|NCT00883779|7312798|FG000|Off-study Phase|Other|18
4505529|NCT00883779|7312799|FG001|Off-study Phase|Other|21
4505530|NCT00884039|7312807|FG000|Overall Study|Withdrawal by Subject|0
4505531|NCT00884039|7312808|FG001|Overall Study|Withdrawal by Subject|1
4505532|NCT00884039|7312807|FG000|Overall Study|Lack of Efficacy|2
4505533|NCT00884039|7312808|FG001|Overall Study|Lack of Efficacy|0
4505534|NCT00884117|7312830|FG000|Overall Study|Adverse Event|2
4505535|NCT00884117|7312830|FG000|Overall Study|Withdrawal by Subject|89
4505536|NCT00884117|7312830|FG000|Overall Study|Death|3
4505537|NCT00884117|7312830|FG000|Overall Study|Lost to Follow-up|143
4505538|NCT00884117|7312830|FG000|Overall Study|Other|12
4505539|NCT00884221|7312849|FG000|Overall Study|Withdrawal by Subject|0
4505540|NCT00884221|7312850|FG001|Overall Study|Withdrawal by Subject|3
4505541|NCT00884221|7312849|FG000|Overall Study|Adverse Event|6
4505542|NCT00884221|7312850|FG001|Overall Study|Adverse Event|3
4505543|NCT00884221|7312849|FG000|Overall Study|Protocol Violation|16
4505544|NCT00884221|7312850|FG001|Overall Study|Protocol Violation|13
4505545|NCT00884221|7312849|FG000|Overall Study|Cancellation of Cycle and Other Reason|12
4505546|NCT00884221|7312850|FG001|Overall Study|Cancellation of Cycle and Other Reason|13
4505547|NCT00884273|7312860|FG000|Overall Study|Adverse Event|0
4505548|NCT00884273|7312861|FG001|Overall Study|Adverse Event|2
4505549|NCT00884273|7312860|FG000|Overall Study|Protocol Violation|1
4505550|NCT00884273|7312861|FG001|Overall Study|Protocol Violation|3
4505551|NCT00884273|7312860|FG000|Overall Study|Practical reasons|1
4505552|NCT00884273|7312861|FG001|Overall Study|Practical reasons|0
4505553|NCT00884286|7312869|FG000|Overall Study|Progressive disease|21
4505554|NCT00884286|7312870|FG001|Overall Study|Progressive disease|28
4505555|NCT00884286|7312869|FG000|Overall Study|Toxicity|4
4505556|NCT00884286|7312870|FG001|Overall Study|Toxicity|1
4505557|NCT00884286|7312869|FG000|Overall Study|Death|2
4505558|NCT00884286|7312870|FG001|Overall Study|Death|2
4505559|NCT00884286|7312869|FG000|Overall Study|Physician Decision|1
4505560|NCT00884286|7312870|FG001|Overall Study|Physician Decision|0
4505561|NCT00884286|7312869|FG000|Overall Study|Septic shock|1
4505562|NCT00884286|7312870|FG001|Overall Study|Septic shock|0
4627684|NCT01854710|7494476|FG000|Overall Study|Withdrawal by Subject|2
4505563|NCT00884286|7312869|FG000|Overall Study|Thrombus in right auricle|1
4505564|NCT00884286|7312870|FG001|Overall Study|Thrombus in right auricle|0
4505565|NCT00884286|7312869|FG000|Overall Study|Not treated|2
4505566|NCT00884286|7312870|FG001|Overall Study|Not treated|1
4505567|NCT00884286|7312869|FG000|Overall Study|Comprised lung carcinoma|0
4505568|NCT00884286|7312870|FG001|Overall Study|Comprised lung carcinoma|1
4505569|NCT00884312|7312879|FG000|Overall Study|Non-fatal Progressive Disease|0
4505570|NCT00884312|7312880|FG001|Overall Study|Non-fatal Progressive Disease|8
4505571|NCT00884312|7312879|FG000|Overall Study|Fatal Progressive Disease|0
4505572|NCT00884312|7312880|FG001|Overall Study|Fatal Progressive Disease|1
4505573|NCT00884312|7312879|FG000|Overall Study|Non-fatal Adverse Event|1
4505574|NCT00884312|7312880|FG001|Overall Study|Non-fatal Adverse Event|0
4505575|NCT00884312|7312879|FG000|Overall Study|Fatal Adverse Event|1
4505576|NCT00884312|7312880|FG001|Overall Study|Fatal Adverse Event|4
4505577|NCT00884312|7312879|FG000|Overall Study|Withdrawal by Subject|0
4505578|NCT00884312|7312880|FG001|Overall Study|Withdrawal by Subject|6
4505579|NCT00884312|7312879|FG000|Overall Study|Physician Decision|0
4505580|NCT00884312|7312880|FG001|Overall Study|Physician Decision|1
4505581|NCT00884312|7312879|FG000|Overall Study|Other|0
4505582|NCT00884312|7312880|FG001|Overall Study|Other|4
4505583|NCT00884312|7312879|FG000|Overall Study|Did Not Receive Study Drug|0
4505584|NCT00884312|7312880|FG001|Overall Study|Did Not Receive Study Drug|1
4505585|NCT00884325|7312888|FG000|Overall Study|Lost to Follow-up|1
4505586|NCT00884325|7312889|FG001|Overall Study|Lost to Follow-up|2
4505587|NCT00884325|7312888|FG000|Overall Study|Lack of Efficacy|0
4505588|NCT00884325|7312889|FG001|Overall Study|Lack of Efficacy|1
4505589|NCT00884325|7312888|FG000|Overall Study|Withdrawal by Subject|1
4505590|NCT00884325|7312889|FG001|Overall Study|Withdrawal by Subject|1
4505591|NCT00884325|7312888|FG000|Overall Study|Not provided|1
4505592|NCT00884325|7312889|FG001|Overall Study|Not provided|0
4505593|NCT00884377|7312897|FG000|Overall Study|Withdrawal by Subject|1
4505594|NCT00884377|7312898|FG001|Overall Study|Withdrawal by Subject|0
4505595|NCT00884377|7312897|FG000|Overall Study|Could not confirm diagnosis|1
4505596|NCT00884377|7312898|FG001|Overall Study|Could not confirm diagnosis|0
4505597|NCT00884377|7312897|FG000|Overall Study|Physician Decision|0
4505598|NCT00884377|7312898|FG001|Overall Study|Physician Decision|1
4505599|NCT00884390|7312912|FG000|Overall Study|Adverse Event|0
4505600|NCT00884390|7312913|FG001|Overall Study|Adverse Event|1
4505601|NCT00884390|7312912|FG000|Overall Study|Lost to Follow-up|0
4505602|NCT00884390|7312913|FG001|Overall Study|Lost to Follow-up|1
4505603|NCT00884390|7312912|FG000|Overall Study|Physician Decision|2
4505604|NCT00884390|7312913|FG001|Overall Study|Physician Decision|1
4505605|NCT00884390|7312912|FG000|Overall Study|Protocol Violation|4
4505606|NCT00884390|7312913|FG001|Overall Study|Protocol Violation|1
4505607|NCT00884390|7312912|FG000|Overall Study|Withdrawal by Subject|4
4505608|NCT00884390|7312913|FG001|Overall Study|Withdrawal by Subject|1
4505609|NCT00884390|7312912|FG000|Overall Study|Discontinuation of Study by Sponsor|2
4505610|NCT00884390|7312913|FG001|Overall Study|Discontinuation of Study by Sponsor|2
4505611|NCT00884390|7312912|FG000|Overall Study|Other|11
4505612|NCT00884390|7312913|FG001|Overall Study|Other|1
4505613|NCT00884650|7312948|FG000|Overall Study|Did not return complete pain diaries|7
4505614|NCT00884650|7312949|FG001|Overall Study|Did not return complete pain diaries|7
4505615|NCT00884650|7312948|FG000|Overall Study|Admitted Post-Op|1
4505616|NCT00884650|7312949|FG001|Overall Study|Admitted Post-Op|0
4505617|NCT00884650|7312948|FG000|Overall Study|Femoral Stress Fracture|1
4505618|NCT00884650|7312949|FG001|Overall Study|Femoral Stress Fracture|0
4505619|NCT00884650|7312948|FG000|Overall Study|Pain Pump Complication|0
4505620|NCT00884650|7312949|FG001|Overall Study|Pain Pump Complication|1
4505621|NCT00884741|7312959|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157
4505622|NCT00884741|7312960|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0
4505623|NCT00884741|7312961|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0
4505624|NCT00884741|7312962|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0
4505625|NCT00884741|7312959|FG000|Step 1 Registration: Tissue Screening|Death|3
4505626|NCT00884741|7312960|FG001|Step 1 Registration: Tissue Screening|Death|0
4505627|NCT00884741|7312961|FG002|Step 1 Registration: Tissue Screening|Death|0
4505628|NCT00884741|7312962|FG003|Step 1 Registration: Tissue Screening|Death|0
4505629|NCT00884741|7312959|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3
4505630|NCT00884741|7312960|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0
4505631|NCT00884741|7312961|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0
4505632|NCT00884741|7312962|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0
4505633|NCT00884741|7312959|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105
4505634|NCT00884741|7312960|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0
4505635|NCT00884741|7312961|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0
4505636|NCT00884741|7312962|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0
4505637|NCT00884741|7312959|FG000|Step 1 Registration: Tissue Screening|Disease progression|12
4505638|NCT00884741|7312960|FG001|Step 1 Registration: Tissue Screening|Disease progression|0
4505639|NCT00884741|7312961|FG002|Step 1 Registration: Tissue Screening|Disease progression|0
4505640|NCT00884741|7312962|FG003|Step 1 Registration: Tissue Screening|Disease progression|0
4505641|NCT00884741|7312959|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32
4505642|NCT00884741|7312960|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0
4505643|NCT00884741|7312961|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0
4505644|NCT00884741|7312962|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0
4505645|NCT00884741|7312959|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0
4505646|NCT00884741|7312960|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15
4505647|NCT00884741|7312961|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0
4505648|NCT00884741|7312962|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0
4505649|NCT00884741|7312959|FG000|Step 2 Registration: Tissue Analysis|Death|0
4505650|NCT00884741|7312960|FG001|Step 2 Registration: Tissue Analysis|Death|1
4505651|NCT00884741|7312961|FG002|Step 2 Registration: Tissue Analysis|Death|0
4505652|NCT00884741|7312962|FG003|Step 2 Registration: Tissue Analysis|Death|0
4505653|NCT00884741|7312959|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0
4505654|NCT00884741|7312960|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2
4505655|NCT00884741|7312961|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0
4505656|NCT00884741|7312962|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0
4505657|NCT00884741|7312959|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0
4505658|NCT00884741|7312960|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7
4505659|NCT00884741|7312961|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0
4505660|NCT00884741|7312962|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0
4505661|NCT00884741|7312959|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0
4505662|NCT00884741|7312960|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4
4505663|NCT00884741|7312961|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0
4505664|NCT00884741|7312962|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0
4505665|NCT00884741|7312959|FG000|Randomization|Protocol Violation|0
4505666|NCT00884741|7312960|FG001|Randomization|Protocol Violation|0
4505667|NCT00884741|7312961|FG002|Randomization|Protocol Violation|8
4505668|NCT00884741|7312962|FG003|Randomization|Protocol Violation|8
4505669|NCT00884793|7312978|FG000|Overall Study|Withdrawal by Subject|1
4505670|NCT00884832|7312988|FG000|Overall Study|Withdrawal by Subject|0
4505671|NCT00884832|7312989|FG001|Overall Study|Withdrawal by Subject|1
4505672|NCT00884949|7313008|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1
4505673|NCT00884949|7313008|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1
4518102|NCT00971321|7330109|FG001|Up to Month 11-12|Lost to Follow-up|0
4518103|NCT00971425|7330117|FG000|Overall Study|Adverse Event|1
4518104|NCT00971425|7330118|FG001|Overall Study|Adverse Event|1
4518105|NCT00971425|7330117|FG000|Overall Study|Withdrawal by Subject|0
4518106|NCT00971425|7330118|FG001|Overall Study|Withdrawal by Subject|1
4518107|NCT00971932|7330169|FG000|Overall Study|Withdrawal by Subject|1
4518108|NCT00971932|7330169|FG000|Overall Study|Investigator's decision|2
4518109|NCT00971932|7330169|FG000|Overall Study|Ongoing|4
4518110|NCT00971945|7330173|FG000|Overall Study|Progressive Disease|3
4518111|NCT00971945|7330173|FG000|Overall Study|Change in treatment policy|1
4518112|NCT00971945|7330173|FG000|Overall Study|Other reasons|2
4518113|NCT00971997|7330177|FG000|Overall Study|Adverse Event|2
4518114|NCT00971997|7330177|FG000|Overall Study|Death|1
4518115|NCT00971997|7330177|FG000|Overall Study|Protocol Violation|4
4518116|NCT00971997|7330177|FG000|Overall Study|Withdrawal by Subject|5
4518117|NCT00971997|7330177|FG000|Overall Study|Physician Decision|7
4518118|NCT00972153|7330191|FG000|Overall Study|Equipment malfunction during case|0
4518119|NCT00972153|7330192|FG001|Overall Study|Equipment malfunction during case|1
4518120|NCT00972153|7330193|FG002|Overall Study|Equipment malfunction during case|0
4518121|NCT00972244|7330210|FG000|Overall Study|Incorrect Enrolment|1
4518122|NCT00972244|7330211|FG001|Overall Study|Incorrect Enrolment|0
4518123|NCT00972244|7330212|FG002|Overall Study|Incorrect Enrolment|0
4518124|NCT00972244|7330213|FG003|Overall Study|Incorrect Enrolment|0
4518125|NCT00972244|7330214|FG004|Overall Study|Incorrect Enrolment|0
4518126|NCT00972244|7330210|FG000|Overall Study|Adverse Event|0
4518127|NCT00972244|7330211|FG001|Overall Study|Adverse Event|1
4518128|NCT00972244|7330212|FG002|Overall Study|Adverse Event|1
4518129|NCT00972244|7330213|FG003|Overall Study|Adverse Event|0
4518130|NCT00972244|7330214|FG004|Overall Study|Adverse Event|0
4518131|NCT00972244|7330210|FG000|Overall Study|Subject No Longer Meets Study Criteria|2
4518132|NCT00972244|7330211|FG001|Overall Study|Subject No Longer Meets Study Criteria|2
4518133|NCT00972244|7330212|FG002|Overall Study|Subject No Longer Meets Study Criteria|0
4518134|NCT00972244|7330213|FG003|Overall Study|Subject No Longer Meets Study Criteria|0
4518135|NCT00972244|7330214|FG004|Overall Study|Subject No Longer Meets Study Criteria|5
4518136|NCT00972244|7330210|FG000|Overall Study|Withdrawal by Subject|1
4518137|NCT00972244|7330211|FG001|Overall Study|Withdrawal by Subject|2
4518138|NCT00972244|7330212|FG002|Overall Study|Withdrawal by Subject|1
4518139|NCT00972244|7330213|FG003|Overall Study|Withdrawal by Subject|0
4518140|NCT00972244|7330214|FG004|Overall Study|Withdrawal by Subject|1
4518141|NCT00972244|7330210|FG000|Overall Study|Safety|0
4518142|NCT00972244|7330211|FG001|Overall Study|Safety|0
4518143|NCT00972244|7330212|FG002|Overall Study|Safety|0
4518144|NCT00972244|7330213|FG003|Overall Study|Safety|0
4518145|NCT00972244|7330214|FG004|Overall Study|Safety|1
4518146|NCT00972244|7330210|FG000|Overall Study|Death|1
4518147|NCT00972244|7330211|FG001|Overall Study|Death|0
4518148|NCT00972244|7330212|FG002|Overall Study|Death|0
4518149|NCT00972244|7330213|FG003|Overall Study|Death|0
4518150|NCT00972244|7330214|FG004|Overall Study|Death|0
4505674|NCT00885105|7313041|FG000|Overall Study|Withdrawal by Subject|0
4505675|NCT00885105|7313042|FG001|Overall Study|Withdrawal by Subject|8
4505676|NCT00885105|7313041|FG000|Overall Study|Adverse Event|1
4505677|NCT00885105|7313042|FG001|Overall Study|Adverse Event|0
4505678|NCT00885105|7313041|FG000|Overall Study|Protocol Violation|0
4505679|NCT00885105|7313042|FG001|Overall Study|Protocol Violation|2
4505680|NCT00885118|7313053|FG000|Overall Study|Adverse Event|1
4505681|NCT00885118|7313054|FG001|Overall Study|Adverse Event|0
4505682|NCT00885118|7313055|FG002|Overall Study|Adverse Event|0
4505683|NCT00885118|7313056|FG003|Overall Study|Adverse Event|0
4505684|NCT00885118|7313057|FG004|Overall Study|Adverse Event|0
4505685|NCT00885118|7313053|FG000|Overall Study|Withdrawal by Subject|0
4505686|NCT00885118|7313054|FG001|Overall Study|Withdrawal by Subject|0
4505687|NCT00885118|7313055|FG002|Overall Study|Withdrawal by Subject|0
4505688|NCT00885118|7313056|FG003|Overall Study|Withdrawal by Subject|0
4505689|NCT00885118|7313057|FG004|Overall Study|Withdrawal by Subject|1
4505690|NCT00885118|7313053|FG000|Overall Study|Other reason not defined above|0
4505691|NCT00885118|7313054|FG001|Overall Study|Other reason not defined above|0
4505692|NCT00885118|7313055|FG002|Overall Study|Other reason not defined above|1
4505693|NCT00885118|7313056|FG003|Overall Study|Other reason not defined above|0
4505694|NCT00885118|7313057|FG004|Overall Study|Other reason not defined above|0
4505695|NCT00885170|7313075|FG000|Overall Study|Adverse Event|12
4505696|NCT00885170|7313076|FG001|Overall Study|Adverse Event|4
4505697|NCT00885170|7313075|FG000|Overall Study|Excessive bone loss|6
4505698|NCT00885170|7313076|FG001|Overall Study|Excessive bone loss|3
4505699|NCT00885170|7313075|FG000|Overall Study|Lost to Follow-up|2
4505700|NCT00885170|7313076|FG001|Overall Study|Lost to Follow-up|1
4505701|NCT00885170|7313075|FG000|Overall Study|Physician Decision|2
4505702|NCT00885170|7313076|FG001|Overall Study|Physician Decision|1
4505703|NCT00885170|7313075|FG000|Overall Study|Protocol Violation|3
4505704|NCT00885170|7313076|FG001|Overall Study|Protocol Violation|1
4505705|NCT00885170|7313075|FG000|Overall Study|Withdrawal by Subject|13
4505706|NCT00885170|7313076|FG001|Overall Study|Withdrawal by Subject|13
4505707|NCT00885352|7313084|FG000|Overall Study|Adverse Event|2
4505708|NCT00885352|7313085|FG001|Overall Study|Adverse Event|3
4505709|NCT00885352|7313084|FG000|Overall Study|Lost to Follow-up|2
4505710|NCT00885352|7313085|FG001|Overall Study|Lost to Follow-up|2
4505711|NCT00885352|7313084|FG000|Overall Study|Physician Decision|0
4505712|NCT00885352|7313085|FG001|Overall Study|Physician Decision|3
4505713|NCT00885352|7313084|FG000|Overall Study|Protocol Violation|0
4505714|NCT00885352|7313085|FG001|Overall Study|Protocol Violation|2
4505715|NCT00885352|7313084|FG000|Overall Study|Withdrawal by Subject|1
4505716|NCT00885352|7313085|FG001|Overall Study|Withdrawal by Subject|5
4505717|NCT00885352|7313084|FG000|Overall Study|Contradiction to study medication|0
4505718|NCT00885352|7313085|FG001|Overall Study|Contradiction to study medication|2
4505719|NCT00885352|7313084|FG000|Overall Study|Excluded medication|2
4505720|NCT00885352|7313085|FG001|Overall Study|Excluded medication|2
4505721|NCT00885352|7313084|FG000|Overall Study|Lab abnormalities|1
4505722|NCT00885352|7313085|FG001|Overall Study|Lab abnormalities|1
4505723|NCT00885365|7313093|FG000|4 Weeks ON Treatment|Adverse Event|2
4505724|NCT00885365|7313094|FG001|4 Weeks ON Treatment|Adverse Event|4
4505725|NCT00885365|7313093|FG000|4 Weeks ON Treatment|Protocol Violation|1
4505726|NCT00885365|7313094|FG001|4 Weeks ON Treatment|Protocol Violation|2
4505727|NCT00885365|7313093|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1
4505728|NCT00885365|7313094|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0
4505729|NCT00885378|7313102|FG000|Overall Study|Lack of Efficacy|2
4505730|NCT00885378|7313103|FG001|Overall Study|Lack of Efficacy|2
4505731|NCT00885378|7313102|FG000|Overall Study|Withdrawal by Subject|1
4505732|NCT00885378|7313103|FG001|Overall Study|Withdrawal by Subject|2
4505733|NCT00885378|7313102|FG000|Overall Study|Lost to Follow-up|1
4505734|NCT00885378|7313103|FG001|Overall Study|Lost to Follow-up|2
4505735|NCT00885378|7313102|FG000|Overall Study|Poor/Noncompliance|2
4505736|NCT00885378|7313103|FG001|Overall Study|Poor/Noncompliance|2
4505737|NCT00885378|7313102|FG000|Overall Study|Protocol Violation|2
4505738|NCT00885378|7313103|FG001|Overall Study|Protocol Violation|0
4505739|NCT00885482|7313109|FG000|Overall Study|Pregnancy|1
4505740|NCT00885482|7313109|FG000|Overall Study|Lack of Efficacy|1
4505741|NCT00885482|7313109|FG000|Overall Study|Death|1
4505742|NCT00885482|7313109|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1
4505743|NCT00885534|7313113|FG000|Overall Study|Patient deemed ineligible|1
4505744|NCT00885677|7313127|FG000|Overall Study|Death|40
4505745|NCT00885677|7313128|FG001|Overall Study|Death|34
4505746|NCT00885677|7313127|FG000|Overall Study|Lost to Follow-up|15
4505747|NCT00885677|7313128|FG001|Overall Study|Lost to Follow-up|13
4505748|NCT00885677|7313127|FG000|Overall Study|Protocol Violation|54
4505749|NCT00885677|7313128|FG001|Overall Study|Protocol Violation|54
4505750|NCT00885677|7313127|FG000|Overall Study|premature study closure|41
4505751|NCT00885677|7313128|FG001|Overall Study|premature study closure|44
4505752|NCT00885677|7313127|FG000|Overall Study|device/lead revision or replacement|7
4505753|NCT00885677|7313128|FG001|Overall Study|device/lead revision or replacement|6
4505754|NCT00885677|7313127|FG000|Overall Study|Heart transplantation|1
4505755|NCT00885677|7313128|FG001|Overall Study|Heart transplantation|0
4505756|NCT00885677|7313127|FG000|Overall Study|Inclusion/exclusion not met|25
4505757|NCT00885677|7313128|FG001|Overall Study|Inclusion/exclusion not met|27
4505758|NCT00885703|7313141|FG000|Overall Study|Death|9
4505759|NCT00885703|7313142|FG001|Overall Study|Death|7
4505760|NCT00885703|7313143|FG002|Overall Study|Death|8
4505761|NCT00885703|7313144|FG003|Overall Study|Death|7
4505762|NCT00885703|7313145|FG004|Overall Study|Death|7
4505763|NCT00885703|7313146|FG005|Overall Study|Death|8
4505764|NCT00885703|7313147|FG006|Overall Study|Death|4
4505765|NCT00885703|7313141|FG000|Overall Study|Lost to Follow-up|0
4505766|NCT00885703|7313142|FG001|Overall Study|Lost to Follow-up|0
4505767|NCT00885703|7313143|FG002|Overall Study|Lost to Follow-up|1
4505768|NCT00885703|7313144|FG003|Overall Study|Lost to Follow-up|0
4505769|NCT00885703|7313145|FG004|Overall Study|Lost to Follow-up|0
4505770|NCT00885703|7313146|FG005|Overall Study|Lost to Follow-up|1
4505771|NCT00885703|7313147|FG006|Overall Study|Lost to Follow-up|0
4505772|NCT00885703|7313141|FG000|Overall Study|Withdrawal by Subject|0
4505773|NCT00885703|7313142|FG001|Overall Study|Withdrawal by Subject|0
4505774|NCT00885703|7313143|FG002|Overall Study|Withdrawal by Subject|0
4505775|NCT00885703|7313144|FG003|Overall Study|Withdrawal by Subject|1
4627685|NCT01854710|7494477|FG001|Overall Study|Withdrawal by Subject|1
4627686|NCT01854710|7494478|FG002|Overall Study|Withdrawal by Subject|0
4505776|NCT00885703|7313145|FG004|Overall Study|Withdrawal by Subject|3
4505777|NCT00885703|7313146|FG005|Overall Study|Withdrawal by Subject|1
4505778|NCT00885703|7313147|FG006|Overall Study|Withdrawal by Subject|1
4505779|NCT00885703|7313141|FG000|Overall Study|Ineligible (no CM)|1
4505780|NCT00885703|7313142|FG001|Overall Study|Ineligible (no CM)|3
4505781|NCT00885703|7313143|FG002|Overall Study|Ineligible (no CM)|2
4505782|NCT00885703|7313144|FG003|Overall Study|Ineligible (no CM)|1
4505783|NCT00885703|7313145|FG004|Overall Study|Ineligible (no CM)|2
4505784|NCT00885703|7313146|FG005|Overall Study|Ineligible (no CM)|3
4505785|NCT00885703|7313147|FG006|Overall Study|Ineligible (no CM)|1
4505786|NCT00885755|7313174|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1
4505787|NCT00885755|7313175|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0
4505788|NCT00885755|7313176|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0
4505789|NCT00885755|7313174|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16
4505790|NCT00885755|7313175|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0
4505791|NCT00885755|7313176|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0
4505792|NCT00885755|7313174|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1
4505793|NCT00885755|7313175|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0
4505794|NCT00885755|7313176|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0
4505795|NCT00885755|7313174|FG000|Part I: Trastuzumab+Taxane|Death|0
4505796|NCT00885755|7313175|FG001|Part I: Trastuzumab+Taxane|Death|0
4505797|NCT00885755|7313176|FG002|Part I: Trastuzumab+Taxane|Death|1
4704838|NCT02757352|7624002|FG000|Follow-Up Period|Adverse Event|0
4704839|NCT02757352|7624003|FG001|Follow-Up Period|Adverse Event|0
4505798|NCT00885755|7313174|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5
4505799|NCT00885755|7313175|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0
4505800|NCT00885755|7313176|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0
4505801|NCT00885846|7313191|FG000|Overall Study|Withdrawal by Subject|2
4505802|NCT00885846|7313192|FG001|Overall Study|Withdrawal by Subject|5
4505803|NCT00885846|7313193|FG002|Overall Study|Withdrawal by Subject|2
4505804|NCT00886015|7313203|FG000|Overall Study|Death|0
4505805|NCT00886015|7313204|FG001|Overall Study|Death|2
4505806|NCT00886119|7313210|FG000|Period 1|Did not meet inclusion criteria|1
4505807|NCT00886119|7313211|FG001|Period 1|Did not meet inclusion criteria|0
4505808|NCT00886288|7313247|FG000|Overall Study|no respect of the 12 weeks period|657
4505809|NCT00886288|7313248|FG001|Overall Study|no respect of the 12 weeks period|227
4505810|NCT00886288|7313247|FG000|Overall Study|Lost to Follow-up|86
4505811|NCT00886288|7313248|FG001|Overall Study|Lost to Follow-up|0
4505812|NCT00886340|7313258|FG000|Overall Study|Withdrawal by Subject|0
4505813|NCT00886340|7313259|FG001|Overall Study|Withdrawal by Subject|7
4505814|NCT00886379|7313270|FG000|Overall Study|Transferred Schools|0
4627687|NCT01854710|7494479|FG003|Overall Study|Withdrawal by Subject|0
4505815|NCT00886379|7313271|FG001|Overall Study|Transferred Schools|0
4505816|NCT00886379|7313272|FG002|Overall Study|Transferred Schools|2
4505817|NCT00886379|7313273|FG003|Overall Study|Transferred Schools|1
4505818|NCT00886379|7313274|FG004|Overall Study|Transferred Schools|1
4505819|NCT00886379|7313270|FG000|Overall Study|Final blood draw not obtained|3
4505820|NCT00886379|7313271|FG001|Overall Study|Final blood draw not obtained|3
4505821|NCT00886379|7313272|FG002|Overall Study|Final blood draw not obtained|4
4627688|NCT01854710|7494480|FG004|Overall Study|Withdrawal by Subject|0
4627689|NCT01854710|7494481|FG005|Overall Study|Withdrawal by Subject|0
4627690|NCT01854710|7494476|FG000|Overall Study|CRI procedural error|2
4627691|NCT01854710|7494477|FG001|Overall Study|CRI procedural error|2
4627692|NCT01854710|7494478|FG002|Overall Study|CRI procedural error|2
4627693|NCT01854710|7494479|FG003|Overall Study|CRI procedural error|2
4627694|NCT01854710|7494480|FG004|Overall Study|CRI procedural error|2
4627695|NCT01854710|7494481|FG005|Overall Study|CRI procedural error|2
4627696|NCT01854775|7494494|FG000|Treatment Phase (48 Weeks)|Withdrawal by Subject|1
4627697|NCT01854775|7494495|FG001|Treatment Phase (48 Weeks)|Withdrawal by Subject|1
4627698|NCT01854775|7494496|FG002|Treatment Phase (48 Weeks)|Withdrawal by Subject|0
4627699|NCT01854775|7494494|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1
4627700|NCT01854775|7494495|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0
4505822|NCT00886379|7313273|FG003|Overall Study|Final blood draw not obtained|2
4505823|NCT00886379|7313274|FG004|Overall Study|Final blood draw not obtained|2
4505824|NCT00886483|7313288|FG000|Overall Study|Lost to Follow-up|0
4505825|NCT00886483|7313289|FG001|Overall Study|Lost to Follow-up|1
4505826|NCT00886483|7313288|FG000|Overall Study|Pursue medications|1
4505827|NCT00886483|7313289|FG001|Overall Study|Pursue medications|2
4505828|NCT00886483|7313288|FG000|Overall Study|Distance to center, poor grades|1
4505829|NCT00886483|7313289|FG001|Overall Study|Distance to center, poor grades|0
4505830|NCT00886587|7313305|FG000|Overall Study|Adverse Event|2
4505831|NCT00886587|7313306|FG001|Overall Study|Adverse Event|1
4505832|NCT00886587|7313305|FG000|Overall Study|Protocol Violation|2
4505833|NCT00886587|7313306|FG001|Overall Study|Protocol Violation|0
4505834|NCT00886587|7313305|FG000|Overall Study|Withdrawal by Subject|0
4505835|NCT00886587|7313306|FG001|Overall Study|Withdrawal by Subject|1
4505836|NCT00886613|7313315|FG000|Overall Study|Protocol deviation (Part B)|1
4505837|NCT00886613|7313316|FG001|Overall Study|Protocol deviation (Part B)|0
4505838|NCT00886613|7313317|FG002|Overall Study|Protocol deviation (Part B)|0
4505839|NCT00886613|7313315|FG000|Overall Study|Lost to follow-up (Part B)|1
4505840|NCT00886613|7313316|FG001|Overall Study|Lost to follow-up (Part B)|0
4505841|NCT00886613|7313317|FG002|Overall Study|Lost to follow-up (Part B)|1
4505842|NCT00886613|7313315|FG000|Overall Study|Subject withdrew consent (Part A)|0
4505843|NCT00886613|7313316|FG001|Overall Study|Subject withdrew consent (Part A)|0
4505844|NCT00886613|7313317|FG002|Overall Study|Subject withdrew consent (Part A)|2
4505845|NCT00886639|7313335|FG000|Overall Study|acute exacerbation|14
4505846|NCT00886639|7313335|FG000|Overall Study|non-compliance|2
4505847|NCT00886743|7313350|FG000|Overall Study|Adverse Event|3
4505848|NCT00886743|7313350|FG000|Overall Study|Other|1
4505849|NCT00886769|7313356|FG000|Overall Study|Unsatisfactory therapeutic effect|6
4505850|NCT00886769|7313357|FG001|Overall Study|Unsatisfactory therapeutic effect|37
4505851|NCT00886795|7313363|FG000|Overall Study|Lack of Efficacy|1
4505852|NCT00886821|7313382|FG000|Stage 2|Adverse Event|0
4505853|NCT00886821|7313383|FG001|Stage 2|Adverse Event|0
4505854|NCT00886821|7313384|FG002|Stage 2|Adverse Event|0
4505855|NCT00886821|7313385|FG003|Stage 2|Adverse Event|0
4505856|NCT00886821|7313386|FG004|Stage 2|Adverse Event|0
4505857|NCT00886821|7313387|FG005|Stage 2|Adverse Event|0
4505858|NCT00886821|7313388|FG006|Stage 2|Adverse Event|0
4505859|NCT00886821|7313389|FG007|Stage 2|Adverse Event|0
4505860|NCT00886821|7313390|FG008|Stage 2|Adverse Event|0
4505861|NCT00886821|7313391|FG009|Stage 2|Adverse Event|0
4505862|NCT00886821|7313392|FG010|Stage 2|Adverse Event|0
4505863|NCT00886821|7313393|FG011|Stage 2|Adverse Event|1
4505864|NCT00886821|7313394|FG012|Stage 2|Adverse Event|3
4505865|NCT00886821|7313395|FG013|Stage 2|Adverse Event|0
4505866|NCT00886821|7313382|FG000|Stage 2|Lost to Follow-up|0
4505867|NCT00886821|7313383|FG001|Stage 2|Lost to Follow-up|0
4505868|NCT00886821|7313384|FG002|Stage 2|Lost to Follow-up|0
4505869|NCT00886821|7313385|FG003|Stage 2|Lost to Follow-up|0
4505870|NCT00886821|7313386|FG004|Stage 2|Lost to Follow-up|0
4505871|NCT00886821|7313387|FG005|Stage 2|Lost to Follow-up|0
4505872|NCT00886821|7313388|FG006|Stage 2|Lost to Follow-up|0
4627701|NCT01854775|7494496|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0
4627702|NCT01854775|7494494|FG000|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0
4627703|NCT01854775|7494495|FG001|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0
4505873|NCT00886821|7313389|FG007|Stage 2|Lost to Follow-up|0
4505874|NCT00886821|7313390|FG008|Stage 2|Lost to Follow-up|0
4505875|NCT00886821|7313391|FG009|Stage 2|Lost to Follow-up|0
4505876|NCT00886821|7313392|FG010|Stage 2|Lost to Follow-up|0
4505877|NCT00886821|7313393|FG011|Stage 2|Lost to Follow-up|0
4505878|NCT00886821|7313394|FG012|Stage 2|Lost to Follow-up|2
4505879|NCT00886821|7313395|FG013|Stage 2|Lost to Follow-up|1
4505880|NCT00886834|7313441|FG000|Overall Study|Protocol Violation|0
4505881|NCT00886834|7313442|FG001|Overall Study|Protocol Violation|3
4505882|NCT00886938|7313452|FG000|Overall Study|Adverse Event|1
4505883|NCT00886938|7313452|FG000|Overall Study|Withdrawal by Subject|1
4505884|NCT00887068|7313458|FG000|Overall Study|Withdrawal by Subject|2
4505885|NCT00887068|7313459|FG001|Overall Study|Withdrawal by Subject|0
4505886|NCT00887068|7313458|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4
4505887|NCT00887068|7313459|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0
4505888|NCT00887159|7313468|FG000|Overall Study|Disease progression|6
4505889|NCT00887159|7313469|FG001|Overall Study|Disease progression|39
4505890|NCT00887159|7313470|FG002|Overall Study|Disease progression|33
4505891|NCT00887159|7313468|FG000|Overall Study|Adverse Event|3
4505892|NCT00887159|7313469|FG001|Overall Study|Adverse Event|4
4505893|NCT00887159|7313470|FG002|Overall Study|Adverse Event|17
4505894|NCT00887159|7313468|FG000|Overall Study|Death|2
4505895|NCT00887159|7313469|FG001|Overall Study|Death|2
4505896|NCT00887159|7313470|FG002|Overall Study|Death|0
4505897|NCT00887159|7313468|FG000|Overall Study|Withdrawal by Subject|4
4505898|NCT00887159|7313469|FG001|Overall Study|Withdrawal by Subject|4
4627704|NCT01854775|7494496|FG002|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|9
4505899|NCT00887159|7313470|FG002|Overall Study|Withdrawal by Subject|2
4505900|NCT00887159|7313468|FG000|Overall Study|Alternative therapy|2
4505901|NCT00887159|7313469|FG001|Overall Study|Alternative therapy|0
4505902|NCT00887159|7313470|FG002|Overall Study|Alternative therapy|0
4505903|NCT00887159|7313468|FG000|Overall Study|Physician Decision|1
4505904|NCT00887159|7313469|FG001|Overall Study|Physician Decision|1
4505905|NCT00887159|7313470|FG002|Overall Study|Physician Decision|0
4505906|NCT00887159|7313468|FG000|Overall Study|Sympomatic deterioration|1
4505907|NCT00887159|7313469|FG001|Overall Study|Sympomatic deterioration|0
4505908|NCT00887159|7313470|FG002|Overall Study|Sympomatic deterioration|0
4505909|NCT00887159|7313468|FG000|Overall Study|Treatment delayed|1
4505910|NCT00887159|7313469|FG001|Overall Study|Treatment delayed|1
4505911|NCT00887159|7313470|FG002|Overall Study|Treatment delayed|0
4505912|NCT00887159|7313468|FG000|Overall Study|Pt had PD but was SD when re-measured|0
4505913|NCT00887159|7313469|FG001|Overall Study|Pt had PD but was SD when re-measured|1
4505914|NCT00887159|7313470|FG002|Overall Study|Pt had PD but was SD when re-measured|0
4505915|NCT00887159|7313468|FG000|Overall Study|Received more tx instead of observation|1
4505916|NCT00887159|7313469|FG001|Overall Study|Received more tx instead of observation|0
4505917|NCT00887159|7313470|FG002|Overall Study|Received more tx instead of observation|0
4505918|NCT00887159|7313468|FG000|Overall Study|Ineligible|5
4505919|NCT00887159|7313469|FG001|Overall Study|Ineligible|1
4505920|NCT00887159|7313470|FG002|Overall Study|Ineligible|0
4505921|NCT00887159|7313468|FG000|Overall Study|Never started assigned therapy|3
4505922|NCT00887159|7313469|FG001|Overall Study|Never started assigned therapy|3
4505923|NCT00887159|7313470|FG002|Overall Study|Never started assigned therapy|4
4505924|NCT00887198|7313482|FG000|Randomized Period|Ongoing|42
4505925|NCT00887198|7313483|FG001|Randomized Period|Ongoing|0
4505926|NCT00887198|7313484|FG002|Randomized Period|Ongoing|0
4505927|NCT00887198|7313482|FG000|Randomized Period|Adverse Event|50
4505928|NCT00887198|7313483|FG001|Randomized Period|Adverse Event|33
4505929|NCT00887198|7313484|FG002|Randomized Period|Adverse Event|0
4505930|NCT00887198|7313482|FG000|Randomized Period|Lost to Follow-up|1
4505931|NCT00887198|7313483|FG001|Randomized Period|Lost to Follow-up|0
4505932|NCT00887198|7313484|FG002|Randomized Period|Lost to Follow-up|0
4505933|NCT00887198|7313482|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0
4505934|NCT00887198|7313483|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51
4505935|NCT00887198|7313484|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0
4505936|NCT00887198|7313482|FG000|Randomized Period|Withdrawal by Subject|41
4505937|NCT00887198|7313483|FG001|Randomized Period|Withdrawal by Subject|56
4505938|NCT00887198|7313484|FG002|Randomized Period|Withdrawal by Subject|0
4505939|NCT00887198|7313482|FG000|Randomized Period|Progressive disease|366
4505940|NCT00887198|7313483|FG001|Randomized Period|Progressive disease|370
4704840|NCT02757352|7624004|FG002|Follow-Up Period|Adverse Event|0
4704841|NCT02757352|7624005|FG003|Follow-Up Period|Adverse Event|0
4704842|NCT02757352|7624006|FG004|Follow-Up Period|Adverse Event|0
4704843|NCT02757352|7624007|FG005|Follow-Up Period|Adverse Event|0
4704844|NCT02757352|7624008|FG006|Follow-Up Period|Adverse Event|1
4704845|NCT02757352|7624009|FG007|Follow-Up Period|Adverse Event|0
4505941|NCT00887198|7313484|FG002|Randomized Period|Progressive disease|0
4505942|NCT00887198|7313482|FG000|Randomized Period|Other|42
4505943|NCT00887198|7313483|FG001|Randomized Period|Other|30
4505944|NCT00887198|7313484|FG002|Randomized Period|Other|0
4505945|NCT00887198|7313482|FG000|Randomized Period|Randomized, Not treated|4
4505946|NCT00887198|7313483|FG001|Randomized Period|Randomized, Not treated|2
4505947|NCT00887198|7313484|FG002|Randomized Period|Randomized, Not treated|0
4505948|NCT00887198|7313482|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0
4505949|NCT00887198|7313483|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0
4505950|NCT00887198|7313484|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8
4505951|NCT00887198|7313482|FG000|Cross Over (Placebo to AA)|Ongoing|0
4505952|NCT00887198|7313483|FG001|Cross Over (Placebo to AA)|Ongoing|0
4505953|NCT00887198|7313484|FG002|Cross Over (Placebo to AA)|Ongoing|35
4505954|NCT00887198|7313482|FG000|Cross Over (Placebo to AA)|Adverse Event|0
4505955|NCT00887198|7313483|FG001|Cross Over (Placebo to AA)|Adverse Event|0
4505956|NCT00887198|7313484|FG002|Cross Over (Placebo to AA)|Adverse Event|9
4505957|NCT00887198|7313482|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0
4505958|NCT00887198|7313483|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0
4505959|NCT00887198|7313484|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2
4505960|NCT00887198|7313482|FG000|Cross Over (Placebo to AA)|Progressive disease|0
4505961|NCT00887198|7313483|FG001|Cross Over (Placebo to AA)|Progressive disease|0
4505962|NCT00887198|7313484|FG002|Cross Over (Placebo to AA)|Progressive disease|20
4505963|NCT00887198|7313482|FG000|Cross Over (Placebo to AA)|Other|0
4505964|NCT00887198|7313483|FG001|Cross Over (Placebo to AA)|Other|0
4505965|NCT00887198|7313484|FG002|Cross Over (Placebo to AA)|Other|19
4505966|NCT00887224|7313495|FG000|Open-label Response (OLR) Phase|Adverse Event|46
4505967|NCT00887224|7313496|FG001|Open-label Response (OLR) Phase|Adverse Event|0
4505968|NCT00887224|7313497|FG002|Open-label Response (OLR) Phase|Adverse Event|0
4505969|NCT00887224|7313495|FG000|Open-label Response (OLR) Phase|Failed to return|6
4505970|NCT00887224|7313496|FG001|Open-label Response (OLR) Phase|Failed to return|0
4505971|NCT00887224|7313497|FG002|Open-label Response (OLR) Phase|Failed to return|0
4505972|NCT00887224|7313495|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26
4505973|NCT00887224|7313496|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0
4505974|NCT00887224|7313497|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0
4704846|NCT02757352|7624010|FG008|Follow-Up Period|Adverse Event|2
4704847|NCT02757352|7624011|FG009|Follow-Up Period|Adverse Event|0
4704848|NCT02757352|7624002|FG000|Follow-Up Period|Lost to Follow-up|0
4505975|NCT00887224|7313495|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16
4704849|NCT02757352|7624003|FG001|Follow-Up Period|Lost to Follow-up|0
4704850|NCT02757352|7624004|FG002|Follow-Up Period|Lost to Follow-up|0
4704851|NCT02757352|7624005|FG003|Follow-Up Period|Lost to Follow-up|0
4704852|NCT02757352|7624006|FG004|Follow-Up Period|Lost to Follow-up|0
4704853|NCT02757352|7624007|FG005|Follow-Up Period|Lost to Follow-up|0
4704854|NCT02757352|7624008|FG006|Follow-Up Period|Lost to Follow-up|0
4704855|NCT02757352|7624009|FG007|Follow-Up Period|Lost to Follow-up|0
4704856|NCT02757352|7624010|FG008|Follow-Up Period|Lost to Follow-up|1
4704857|NCT02757352|7624011|FG009|Follow-Up Period|Lost to Follow-up|0
4704858|NCT02757352|7624002|FG000|Follow-Up Period|Lack of Efficacy|0
4704859|NCT02757352|7624003|FG001|Follow-Up Period|Lack of Efficacy|0
4704860|NCT02757352|7624004|FG002|Follow-Up Period|Lack of Efficacy|0
4704861|NCT02757352|7624005|FG003|Follow-Up Period|Lack of Efficacy|0
4704862|NCT02757352|7624006|FG004|Follow-Up Period|Lack of Efficacy|0
4704863|NCT02757352|7624007|FG005|Follow-Up Period|Lack of Efficacy|0
4704864|NCT02757352|7624008|FG006|Follow-Up Period|Lack of Efficacy|0
4704865|NCT02757352|7624009|FG007|Follow-Up Period|Lack of Efficacy|0
4704866|NCT02757352|7624010|FG008|Follow-Up Period|Lack of Efficacy|1
4704867|NCT02757352|7624011|FG009|Follow-Up Period|Lack of Efficacy|1
4704868|NCT02757352|7624002|FG000|Follow-Up Period|Withdrawal by Subject|0
4704869|NCT02757352|7624003|FG001|Follow-Up Period|Withdrawal by Subject|0
4704870|NCT02757352|7624004|FG002|Follow-Up Period|Withdrawal by Subject|0
4505976|NCT00887224|7313496|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0
4505977|NCT00887224|7313497|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0
4505978|NCT00887224|7313495|FG000|Open-label Response (OLR) Phase|Other|1
4505979|NCT00887224|7313496|FG001|Open-label Response (OLR) Phase|Other|0
4505980|NCT00887224|7313497|FG002|Open-label Response (OLR) Phase|Other|0
4505981|NCT00887224|7313495|FG000|Open-label Response (OLR) Phase|Protocol Violation|12
4505982|NCT00887224|7313496|FG001|Open-label Response (OLR) Phase|Protocol Violation|0
4505983|NCT00887224|7313497|FG002|Open-label Response (OLR) Phase|Protocol Violation|0
4505984|NCT00887224|7313495|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15
4505985|NCT00887224|7313496|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0
4505986|NCT00887224|7313497|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0
4505987|NCT00887224|7313495|FG000|Open-label Stability (OLS) Phase|Adverse Event|22
4505988|NCT00887224|7313496|FG001|Open-label Stability (OLS) Phase|Adverse Event|0
4505989|NCT00887224|7313497|FG002|Open-label Stability (OLS) Phase|Adverse Event|0
4505990|NCT00887224|7313495|FG000|Open-label Stability (OLS) Phase|Failed to return|3
4505991|NCT00887224|7313496|FG001|Open-label Stability (OLS) Phase|Failed to return|0
4505992|NCT00887224|7313497|FG002|Open-label Stability (OLS) Phase|Failed to return|0
4505993|NCT00887224|7313495|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16
4505994|NCT00887224|7313496|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0
4505995|NCT00887224|7313497|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0
4505996|NCT00887224|7313495|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9
4505997|NCT00887224|7313496|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0
4505998|NCT00887224|7313497|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0
4505999|NCT00887224|7313495|FG000|Open-label Stability (OLS) Phase|Other|1
4506000|NCT00887224|7313496|FG001|Open-label Stability (OLS) Phase|Other|0
4506001|NCT00887224|7313497|FG002|Open-label Stability (OLS) Phase|Other|0
4506002|NCT00887224|7313495|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13
4506003|NCT00887224|7313496|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0
4506004|NCT00887224|7313497|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0
4506005|NCT00887224|7313495|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19
4506006|NCT00887224|7313496|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0
4506007|NCT00887224|7313497|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0
4506008|NCT00887224|7313495|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28
4506009|NCT00887224|7313496|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0
4506010|NCT00887224|7313497|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0
4506011|NCT00887224|7313495|FG000|OL Taper Phase / OL Follow Up|Failed to return|17
4506012|NCT00887224|7313496|FG001|OL Taper Phase / OL Follow Up|Failed to return|0
4506013|NCT00887224|7313497|FG002|OL Taper Phase / OL Follow Up|Failed to return|0
4506014|NCT00887224|7313495|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10
4506015|NCT00887224|7313496|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0
4506016|NCT00887224|7313497|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0
4506017|NCT00887224|7313495|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8
4506018|NCT00887224|7313496|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0
4506019|NCT00887224|7313497|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0
4506020|NCT00887224|7313495|FG000|OL Taper Phase / OL Follow Up|Other|30
4506021|NCT00887224|7313496|FG001|OL Taper Phase / OL Follow Up|Other|0
4506022|NCT00887224|7313497|FG002|OL Taper Phase / OL Follow Up|Other|0
4506023|NCT00887224|7313495|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3
4506024|NCT00887224|7313496|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0
4506025|NCT00887224|7313497|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0
4506026|NCT00887224|7313495|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48
4506027|NCT00887224|7313496|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0
4506028|NCT00887224|7313497|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0
4506029|NCT00887224|7313495|FG000|Double-blind (DB) Phase|Adverse Event|0
4506030|NCT00887224|7313496|FG001|Double-blind (DB) Phase|Adverse Event|7
4506031|NCT00887224|7313497|FG002|Double-blind (DB) Phase|Adverse Event|2
4506032|NCT00887224|7313495|FG000|Double-blind (DB) Phase|Failed to return|0
4506033|NCT00887224|7313496|FG001|Double-blind (DB) Phase|Failed to return|2
4506034|NCT00887224|7313497|FG002|Double-blind (DB) Phase|Failed to return|2
4506035|NCT00887224|7313495|FG000|Double-blind (DB) Phase|Lack of Efficacy|0
4506036|NCT00887224|7313496|FG001|Double-blind (DB) Phase|Lack of Efficacy|67
4506037|NCT00887224|7313497|FG002|Double-blind (DB) Phase|Lack of Efficacy|33
4506038|NCT00887224|7313495|FG000|Double-blind (DB) Phase|Lost to Follow-up|0
4506039|NCT00887224|7313496|FG001|Double-blind (DB) Phase|Lost to Follow-up|8
4506040|NCT00887224|7313497|FG002|Double-blind (DB) Phase|Lost to Follow-up|8
4506041|NCT00887224|7313495|FG000|Double-blind (DB) Phase|Other|0
4506042|NCT00887224|7313496|FG001|Double-blind (DB) Phase|Other|2
4506043|NCT00887224|7313497|FG002|Double-blind (DB) Phase|Other|0
4506044|NCT00887224|7313495|FG000|Double-blind (DB) Phase|Protocol Violation|0
4506045|NCT00887224|7313496|FG001|Double-blind (DB) Phase|Protocol Violation|8
4506046|NCT00887224|7313497|FG002|Double-blind (DB) Phase|Protocol Violation|5
4506047|NCT00887224|7313495|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0
4506048|NCT00887224|7313496|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6
4506049|NCT00887224|7313497|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12
4506050|NCT00887224|7313495|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0
4506051|NCT00887224|7313496|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5
4506052|NCT00887224|7313497|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0
4506053|NCT00887224|7313495|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0
4506054|NCT00887224|7313496|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5
4506055|NCT00887224|7313497|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4
4506056|NCT00887224|7313495|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0
4506057|NCT00887224|7313496|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6
4506058|NCT00887224|7313497|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0
4506059|NCT00887224|7313495|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0
4506060|NCT00887224|7313496|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2
4506061|NCT00887224|7313497|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2
4506062|NCT00887224|7313495|FG000|DB Taper Phase / Post Study Follow Up|Other|0
4506063|NCT00887224|7313496|FG001|DB Taper Phase / Post Study Follow Up|Other|11
4506064|NCT00887224|7313497|FG002|DB Taper Phase / Post Study Follow Up|Other|12
4506065|NCT00887224|7313495|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0
4506066|NCT00887224|7313496|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4
4506067|NCT00887224|7313497|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1
4506068|NCT00887224|7313495|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0
4506069|NCT00887224|7313496|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8
4506070|NCT00887224|7313497|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11
4506071|NCT00887289|7313509|FG000|Overall Study|Lack of Efficacy|14
4506072|NCT00887289|7313509|FG000|Overall Study|Adverse Event|27
4506073|NCT00887289|7313509|FG000|Overall Study|Withdrawal by Subject|26
4506074|NCT00887289|7313509|FG000|Overall Study|Lost to Follow-up|8
4506075|NCT00887289|7313509|FG000|Overall Study|Other|20
4506076|NCT00887341|7313515|FG000|Overall Study|Refused treatment|1
4506077|NCT00887341|7313516|FG001|Overall Study|Refused treatment|0
4506078|NCT00887341|7313515|FG000|Overall Study|Withdrawal by Subject|1
4704871|NCT02757352|7624005|FG003|Follow-Up Period|Withdrawal by Subject|0
4704872|NCT02757352|7624006|FG004|Follow-Up Period|Withdrawal by Subject|0
4704873|NCT02757352|7624007|FG005|Follow-Up Period|Withdrawal by Subject|0
4704874|NCT02757352|7624008|FG006|Follow-Up Period|Withdrawal by Subject|0
4704875|NCT02757352|7624009|FG007|Follow-Up Period|Withdrawal by Subject|1
4704876|NCT02757352|7624010|FG008|Follow-Up Period|Withdrawal by Subject|6
4704877|NCT02757352|7624011|FG009|Follow-Up Period|Withdrawal by Subject|2
4704878|NCT02757430|7624042|FG000|Overall Study|Physician Decision|6
4704879|NCT02757430|7624042|FG000|Overall Study|Inclusion/Exclusion criteria not met|3
4704880|NCT02757430|7624042|FG000|Overall Study|No informed consent|1
4704881|NCT02757430|7624042|FG000|Overall Study|No procedure performed|2
4704882|NCT02757625|7624059|FG000|Overall Study|Investigator's discretion|0
4704883|NCT02757625|7624060|FG001|Overall Study|Investigator's discretion|0
4704884|NCT02757625|7624061|FG002|Overall Study|Investigator's discretion|1
4704885|NCT02757625|7624062|FG003|Overall Study|Investigator's discretion|0
4387284|NCT00048048|7165926|FG001|Core Treatment|Adverse Event|0
4387285|NCT00048048|7165927|FG002|Core Treatment|Adverse Event|0
4387286|NCT00048048|7165928|FG003|Core Treatment|Adverse Event|0
4387287|NCT00048048|7165929|FG004|Core Treatment|Adverse Event|0
4387288|NCT00048048|7165930|FG005|Core Treatment|Adverse Event|0
4387289|NCT00048048|7165931|FG006|Core Treatment|Adverse Event|0
4387290|NCT00048048|7165932|FG007|Core Treatment|Adverse Event|1
4387291|NCT00048048|7165933|FG008|Core Treatment|Adverse Event|0
4387292|NCT00048048|7165934|FG009|Core Treatment|Adverse Event|0
4387293|NCT00048048|7165935|FG010|Core Treatment|Adverse Event|0
4387294|NCT00048048|7165936|FG011|Core Treatment|Adverse Event|0
4387295|NCT00048048|7165925|FG000|Extension Year 1|Early withdrawals|0
4387296|NCT00048048|7165926|FG001|Extension Year 1|Early withdrawals|0
4387297|NCT00048048|7165927|FG002|Extension Year 1|Early withdrawals|0
4506079|NCT00887341|7313516|FG001|Overall Study|Withdrawal by Subject|1
4506080|NCT00887341|7313515|FG000|Overall Study|Adverse Event|0
4506081|NCT00887341|7313516|FG001|Overall Study|Adverse Event|1
4506082|NCT00887341|7313515|FG000|Overall Study|Lost to Follow-up|0
4506083|NCT00887341|7313516|FG001|Overall Study|Lost to Follow-up|1
4506084|NCT00887354|7313524|FG000|Treatment Phase (Week 0 to Week 26)|Death|0
4506085|NCT00887354|7313525|FG001|Treatment Phase (Week 0 to Week 26)|Death|1
4506086|NCT00887354|7313524|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1
4506087|NCT00887354|7313525|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1
4506088|NCT00887354|7313524|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2
4506089|NCT00887354|7313525|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1
4506090|NCT00887354|7313524|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14
4506091|NCT00887354|7313525|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8
4506092|NCT00887354|7313524|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3
4506093|NCT00887354|7313525|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3
4506094|NCT00887354|7313524|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2
4506095|NCT00887354|7313525|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1
4506096|NCT00887354|7313524|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3
4627705|NCT01854775|7494494|FG000|Extension Phase|Pregnancy|3
4627706|NCT01854775|7494495|FG001|Extension Phase|Pregnancy|0
4627707|NCT01854775|7494496|FG002|Extension Phase|Pregnancy|0
4506097|NCT00887354|7313525|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3
4506098|NCT00887354|7313524|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1
4506099|NCT00887354|7313525|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2
4506100|NCT00887354|7313524|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20
4506101|NCT00887354|7313525|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25
4506102|NCT00887354|7313524|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5
4506103|NCT00887354|7313525|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3
4506104|NCT00887354|7313524|FG000|Open Label Phase (Week 26 to Week 78)|Death|0
4506105|NCT00887354|7313525|FG001|Open Label Phase (Week 26 to Week 78)|Death|2
4506106|NCT00887354|7313524|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0
4506107|NCT00887354|7313525|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1
4506108|NCT00887354|7313524|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1
4506109|NCT00887354|7313525|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2
4506110|NCT00887354|7313524|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1
4506111|NCT00887354|7313525|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0
4506112|NCT00887354|7313524|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1
4506113|NCT00887354|7313525|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1
4506114|NCT00887432|7313534|FG000|Overall Study|Start Excluded Therapy|3
4506115|NCT00887432|7313535|FG001|Overall Study|Start Excluded Therapy|0
4506116|NCT00887432|7313534|FG000|Overall Study|Did not complete treatment|6
4506117|NCT00887432|7313535|FG001|Overall Study|Did not complete treatment|8
4506118|NCT00887432|7313534|FG000|Overall Study|Protocol Violation|2
4506119|NCT00887432|7313535|FG001|Overall Study|Protocol Violation|3
4506120|NCT00887432|7313534|FG000|Overall Study|Withdrawal by Subject|3
4506121|NCT00887432|7313535|FG001|Overall Study|Withdrawal by Subject|2
4506122|NCT00887432|7313534|FG000|Overall Study|Lost to Follow-up|1
4506123|NCT00887432|7313535|FG001|Overall Study|Lost to Follow-up|0
4506124|NCT00887432|7313534|FG000|Overall Study|No reason provided|0
4506125|NCT00887432|7313535|FG001|Overall Study|No reason provided|1
4506126|NCT00887484|7313561|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1
4506127|NCT00887484|7313561|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1
4506128|NCT00887484|7313561|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1
4506129|NCT00887549|7313579|FG000|Induction Therapy|Adverse Event|8
4506130|NCT00887549|7313579|FG000|Induction Therapy|Physician Decision|1
4506131|NCT00887549|7313579|FG000|Induction Therapy|Progressive Disease|13
4506132|NCT00887549|7313579|FG000|Induction Therapy|Death due to Study Disease|4
4506133|NCT00887549|7313579|FG000|Induction Therapy|Death due to Study Drug Toxicity|1
4506134|NCT00887549|7313579|FG000|Maintenance Therapy|Adverse Event|16
4506135|NCT00887549|7313579|FG000|Maintenance Therapy|Physician Decision|1
4506136|NCT00887549|7313579|FG000|Maintenance Therapy|Progressive Disease|25
4506137|NCT00887549|7313579|FG000|Maintenance Therapy|Death due to adverse event|1
4506138|NCT00887588|7313607|FG000|Core Period|Death|1
4506139|NCT00887588|7313608|FG001|Core Period|Death|1
4506140|NCT00887588|7313607|FG000|Core Period|Lost to Follow-up|3
4506141|NCT00887588|7313608|FG001|Core Period|Lost to Follow-up|1
4506142|NCT00887588|7313607|FG000|Core Period|Withdrawal by Subject|6
4506143|NCT00887588|7313608|FG001|Core Period|Withdrawal by Subject|8
4506144|NCT00887588|7313607|FG000|Core Period|Adverse Event|9
4506145|NCT00887588|7313608|FG001|Core Period|Adverse Event|11
4506146|NCT00887588|7313607|FG000|Extension Period|Adverse Event|4
4506147|NCT00887588|7313608|FG001|Extension Period|Adverse Event|4
4506148|NCT00887588|7313607|FG000|Extension Period|Death|0
4506149|NCT00887588|7313608|FG001|Extension Period|Death|1
4506150|NCT00887588|7313607|FG000|Extension Period|Protocol deviation|1
4506151|NCT00887588|7313608|FG001|Extension Period|Protocol deviation|0
4506152|NCT00887588|7313607|FG000|Extension Period|Lost to Follow-up|1
4506153|NCT00887588|7313608|FG001|Extension Period|Lost to Follow-up|0
4627708|NCT01854775|7494494|FG000|Extension Phase|Investigator's Discretion|1
4506154|NCT00887679|7313622|FG000|Overall Study|Withdrawal by Subject|1
4506155|NCT00887679|7313622|FG000|Overall Study|Lost to Follow-up|4
4506156|NCT00887679|7313622|FG000|Overall Study|Physician Decision|5
4506157|NCT00887744|7313627|FG000|Overall Study|Adverse Event|3
4506158|NCT00887744|7313627|FG000|Overall Study|Death|1
4506159|NCT00887744|7313627|FG000|Overall Study|Lost to Follow-up|3
4506160|NCT00887744|7313627|FG000|Overall Study|Withdrawal by Subject|18
4506161|NCT00887744|7313627|FG000|Overall Study|Various reasons|9
4506162|NCT00887809|7313642|FG000|Overall Study|Patient Not Treated|3
4506163|NCT00887809|7313643|FG001|Overall Study|Patient Not Treated|0
4506164|NCT00887809|7313642|FG000|Overall Study|Death|1
4506165|NCT00887809|7313643|FG001|Overall Study|Death|0
4506166|NCT00887822|7313651|FG000|Overall Study|Insufficient therapeutic response|53
4506167|NCT00887822|7313652|FG001|Overall Study|Insufficient therapeutic response|55
4506168|NCT00887822|7313651|FG000|Overall Study|Adverse Event|14
4506169|NCT00887822|7313652|FG001|Overall Study|Adverse Event|17
4704886|NCT02757625|7624059|FG000|Overall Study|Adverse Event|0
4704887|NCT02757625|7624060|FG001|Overall Study|Adverse Event|0
4704888|NCT02757625|7624061|FG002|Overall Study|Adverse Event|1
4704889|NCT02757625|7624062|FG003|Overall Study|Adverse Event|0
4704890|NCT02757768|7624076|FG000|Overall Study|Randomized Never Received Study Drug|3
4704891|NCT02757768|7624077|FG001|Overall Study|Randomized Never Received Study Drug|4
4704892|NCT02757768|7624076|FG000|Overall Study|Adverse Event|5
4704893|NCT02757768|7624077|FG001|Overall Study|Adverse Event|3
4704894|NCT02757768|7624076|FG000|Overall Study|Lack of Efficacy|2
4704895|NCT02757768|7624077|FG001|Overall Study|Lack of Efficacy|1
4704896|NCT02757768|7624076|FG000|Overall Study|Lost to Follow-up|1
4704897|NCT02757768|7624077|FG001|Overall Study|Lost to Follow-up|0
4704898|NCT02757768|7624076|FG000|Overall Study|Protocol Deviation|2
4704899|NCT02757768|7624077|FG001|Overall Study|Protocol Deviation|9
4704900|NCT02757768|7624076|FG000|Overall Study|Withdrawal by Subject|16
4704901|NCT02757768|7624077|FG001|Overall Study|Withdrawal by Subject|9
4387298|NCT00048048|7165928|FG003|Extension Year 1|Early withdrawals|0
4506170|NCT00887822|7313651|FG000|Overall Study|Failure to return|11
4506171|NCT00887822|7313652|FG001|Overall Study|Failure to return|11
4506172|NCT00887822|7313651|FG000|Overall Study|Refused treatment/Did not cooperate|12
4506173|NCT00887822|7313652|FG001|Overall Study|Refused treatment/Did not cooperate|10
4506174|NCT00887822|7313651|FG000|Overall Study|Administrative/Other than specified|5
4506175|NCT00887822|7313652|FG001|Overall Study|Administrative/Other than specified|4
4506176|NCT00887822|7313651|FG000|Overall Study|Death|2
4506177|NCT00887822|7313652|FG001|Overall Study|Death|3
4506178|NCT00887822|7313651|FG000|Overall Study|Protocol Violation|0
4506179|NCT00887822|7313652|FG001|Overall Study|Protocol Violation|1
4506180|NCT00887822|7313651|FG000|Overall Study|Randomized but not treated|0
4506181|NCT00887822|7313652|FG001|Overall Study|Randomized but not treated|1
4506182|NCT00887913|7313658|FG000|Overall Study|Withdrawal by Subject|6
4506183|NCT00887926|7313666|FG000|Overall Study|Withdrawal by Subject|0
4506184|NCT00887926|7313667|FG001|Overall Study|Withdrawal by Subject|1
4506185|NCT00887926|7313668|FG002|Overall Study|Withdrawal by Subject|0
4506186|NCT00887926|7313669|FG003|Overall Study|Withdrawal by Subject|0
4506187|NCT00887978|7313687|FG000|Overall Study|Adverse Event|18
4506188|NCT00887978|7313688|FG001|Overall Study|Adverse Event|5
4506189|NCT00887978|7313687|FG000|Overall Study|Clinical Worsening|4
4506190|NCT00887978|7313688|FG001|Overall Study|Clinical Worsening|4
4506191|NCT00887978|7313687|FG000|Overall Study|Death|2
4506192|NCT00887978|7313688|FG001|Overall Study|Death|3
4506193|NCT00887978|7313687|FG000|Overall Study|Withdrawal by Subject|1
4506194|NCT00887978|7313688|FG001|Overall Study|Withdrawal by Subject|2
4506195|NCT00887978|7313687|FG000|Overall Study|Lost to Follow-up|0
4506196|NCT00887978|7313688|FG001|Overall Study|Lost to Follow-up|1
4506197|NCT00888134|7313694|FG000|Treatment With Study Drug|Withdrawal by Subject|1
4506198|NCT00888134|7313694|FG000|Follow-up|being followed for long-term survival|1
4506199|NCT00888173|7313699|FG000|Overall Study|Wrong Primary|1
4506200|NCT00888173|7313699|FG000|Overall Study|Ineligible: required test not done|1
4506201|NCT00888238|7313703|FG000|Washout Period After Period 2|Adverse Event|0
4506202|NCT00888238|7313704|FG001|Washout Period After Period 2|Adverse Event|0
4506203|NCT00888238|7313705|FG002|Washout Period After Period 2|Adverse Event|1
4506204|NCT00888329|7313713|FG000|Overall Study|Physician Decision|6
4506205|NCT00888329|7313714|FG001|Overall Study|Physician Decision|9
4506206|NCT00888381|7313722|FG000|Overall Study|Lost to Follow-up|0
4506207|NCT00888381|7313723|FG001|Overall Study|Lost to Follow-up|1
4506208|NCT00888433|7313731|FG000|Overall Study|Withdrawal by Subject|1
4506209|NCT00888433|7313732|FG001|Overall Study|Withdrawal by Subject|2
4506210|NCT00888433|7313731|FG000|Overall Study|Missed Visit|2
4506211|NCT00888433|7313732|FG001|Overall Study|Missed Visit|1
4704902|NCT02757768|7624076|FG000|Overall Study|Miscellaneous|4
4704903|NCT02757768|7624077|FG001|Overall Study|Miscellaneous|2
4704904|NCT02757963|7624095|FG000|Overall Study|Adverse Event|3
4704905|NCT02757963|7624095|FG000|Overall Study|Reached Stopping Criteria|1054
4704906|NCT02757963|7624095|FG000|Overall Study|Lost to Follow-up|5
4704907|NCT02757963|7624095|FG000|Overall Study|Physician Decision|1
4506212|NCT00888615|7313751|FG000|Overall Study|No treatment|2
4506213|NCT00888654|7313759|FG000|Overall Study|Problems swallowing oral meds.|1
4506214|NCT00888654|7313759|FG000|Overall Study|Not enough oral meds before surgery|3
4506215|NCT00888654|7313759|FG000|Overall Study|Surgery aborted|2
4506216|NCT00888654|7313759|FG000|Overall Study|Withdrawal by Subject|1
4506217|NCT00888654|7313759|FG000|Overall Study|Inelig. due to contraindication of med|1
4506218|NCT00888654|7313759|FG000|Overall Study|Change in surg date|1
4506219|NCT00888654|7313759|FG000|Overall Study|Stopped meds due to headaches|1
4506220|NCT00888849|7313765|FG000|Overall Study|Death|4
4506221|NCT00888849|7313766|FG001|Overall Study|Death|7
4506222|NCT00888849|7313765|FG000|Overall Study|Lost to Follow-up|1
4506223|NCT00888849|7313766|FG001|Overall Study|Lost to Follow-up|2
4506224|NCT00888927|7313776|FG000|Overall Study|Adverse Event|0
4506225|NCT00888927|7313777|FG001|Overall Study|Adverse Event|0
4506226|NCT00888927|7313778|FG002|Overall Study|Adverse Event|0
4506227|NCT00888927|7313779|FG003|Overall Study|Adverse Event|1
4506228|NCT00888927|7313776|FG000|Overall Study|Withdrawal of consent|0
4506229|NCT00888927|7313777|FG001|Overall Study|Withdrawal of consent|0
4506230|NCT00888927|7313778|FG002|Overall Study|Withdrawal of consent|0
4506231|NCT00888927|7313779|FG003|Overall Study|Withdrawal of consent|1
4506232|NCT00888940|7313791|FG000|Overall Study|Adverse Event|12
4506233|NCT00888940|7313792|FG001|Overall Study|Adverse Event|3
4506234|NCT00888940|7313791|FG000|Overall Study|Lost to Follow-up|5
4506235|NCT00888940|7313792|FG001|Overall Study|Lost to Follow-up|5
4506236|NCT00888940|7313791|FG000|Overall Study|Randomized Not Treated|11
4506237|NCT00888940|7313792|FG001|Overall Study|Randomized Not Treated|13
4506238|NCT00889005|7313804|FG000|Overall Study|Lost to Follow-up|4
4506239|NCT00889005|7313805|FG001|Overall Study|Lost to Follow-up|2
4506240|NCT00889005|7313804|FG000|Overall Study|Withdrawal by Subject|4
4506241|NCT00889005|7313805|FG001|Overall Study|Withdrawal by Subject|0
4506242|NCT00889252|7313839|FG000|Overall Study|Adverse Event|2
4506243|NCT00889252|7313840|FG001|Overall Study|Adverse Event|4
4506244|NCT00889252|7313839|FG000|Overall Study|Withdrawal by Subject|3
4506245|NCT00889252|7313840|FG001|Overall Study|Withdrawal by Subject|0
4506246|NCT00889252|7313839|FG000|Overall Study|Protocol Violation|2
4506247|NCT00889252|7313840|FG001|Overall Study|Protocol Violation|0
4506248|NCT00889265|7313846|FG000|Overall Study|Adverse Event|1
4506249|NCT00889265|7313846|FG000|Overall Study|Lost to Follow-up|5
4506250|NCT00889265|7313846|FG000|Overall Study|Protocol Violation|1
4506251|NCT00889603|7313868|FG000|Overall Study|Adverse Event|7
4506252|NCT00889603|7313868|FG000|Overall Study|Death|3
4506253|NCT00889603|7313868|FG000|Overall Study|Lost to Follow-up|19
4506254|NCT00889603|7313868|FG000|Overall Study|No longer willing to participant in stud|4
4506255|NCT00889603|7313868|FG000|Overall Study|Other|4
4506256|NCT00889681|7313872|FG000|Overall Study|Not meeting qualification Criteria|2
4506257|NCT00889681|7313872|FG000|Overall Study|Insurance disapproval|1
4506258|NCT00889707|7313878|FG000|Overall Study|Adverse Event|1
4506259|NCT00889707|7313879|FG001|Overall Study|Adverse Event|0
4506260|NCT00889707|7313878|FG000|Overall Study|Withdrawal by Subject|4
4506261|NCT00889707|7313879|FG001|Overall Study|Withdrawal by Subject|3
4506262|NCT00889707|7313878|FG000|Overall Study|Lost to Follow-up|0
4506263|NCT00889707|7313879|FG001|Overall Study|Lost to Follow-up|2
4506264|NCT00889707|7313878|FG000|Overall Study|Lack of Efficacy|2
4506265|NCT00889707|7313879|FG001|Overall Study|Lack of Efficacy|5
4506266|NCT00889720|7313885|FG000|Overall Study|Withdrawal by Subject|4
4506267|NCT00889720|7313885|FG000|Overall Study|Other|4
4506268|NCT00889863|7313893|FG000|Part I: Open Label|Death|1
4506269|NCT00889863|7313894|FG001|Part I: Open Label|Death|0
4506270|NCT00889863|7313893|FG000|Part I: Open Label|Adverse Event|4
4506271|NCT00889863|7313894|FG001|Part I: Open Label|Adverse Event|0
4506272|NCT00889863|7313893|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72
4506273|NCT00889863|7313894|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0
4506274|NCT00889863|7313893|FG000|Part II: Randomized Double Blind|Adverse Event|0
4506275|NCT00889863|7313894|FG001|Part II: Randomized Double Blind|Adverse Event|4
4506276|NCT00889863|7313893|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11
4506277|NCT00889863|7313894|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20
4506278|NCT00889863|7313893|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0
4506279|NCT00889863|7313894|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1
4506280|NCT00889863|7313893|FG000|Part II: Randomized Double Blind|Protocol deviation|0
4506281|NCT00889863|7313894|FG001|Part II: Randomized Double Blind|Protocol deviation|1
4506282|NCT00890045|7313925|FG000|Overall Study|Death|0
4506283|NCT00890045|7313926|FG001|Overall Study|Death|1
4506284|NCT00890045|7313925|FG000|Overall Study|Did not receive HeRO Graft|0
4506285|NCT00890045|7313926|FG001|Overall Study|Did not receive HeRO Graft|2
4506286|NCT00890045|7313925|FG000|Overall Study|Lost to Follow-up|5
4506287|NCT00890045|7313926|FG001|Overall Study|Lost to Follow-up|7
4506288|NCT00890084|7313932|FG000|Overall Study|Adverse Event|16
4506289|NCT00890084|7313932|FG000|Overall Study|Lost to Follow-up|126
4506290|NCT00890097|7313939|FG000|Overall Study|Adverse Event|21
4506291|NCT00890097|7313940|FG001|Overall Study|Adverse Event|32
4506292|NCT00890097|7313941|FG002|Overall Study|Adverse Event|28
4506293|NCT00890097|7313939|FG000|Overall Study|Decision Unrelated to an Adverse Event|15
4506294|NCT00890097|7313940|FG001|Overall Study|Decision Unrelated to an Adverse Event|12
4506295|NCT00890097|7313941|FG002|Overall Study|Decision Unrelated to an Adverse Event|17
4506296|NCT00890097|7313939|FG000|Overall Study|Withdrew Consent|9
4506297|NCT00890097|7313940|FG001|Overall Study|Withdrew Consent|6
4506298|NCT00890097|7313941|FG002|Overall Study|Withdrew Consent|9
4506299|NCT00890097|7313939|FG000|Overall Study|Lost to Follow-up|5
4506300|NCT00890097|7313940|FG001|Overall Study|Lost to Follow-up|5
4506301|NCT00890097|7313941|FG002|Overall Study|Lost to Follow-up|5
4506302|NCT00890097|7313939|FG000|Overall Study|Noncompliance|0
4506303|NCT00890097|7313940|FG001|Overall Study|Noncompliance|4
4506304|NCT00890097|7313941|FG002|Overall Study|Noncompliance|4
4506305|NCT00890097|7313939|FG000|Overall Study|Sponsor Decision|7
4506306|NCT00890097|7313940|FG001|Overall Study|Sponsor Decision|11
4506307|NCT00890097|7313941|FG002|Overall Study|Sponsor Decision|7
4506308|NCT00890097|7313939|FG000|Overall Study|Did not attend final visit|2
4506309|NCT00890097|7313940|FG001|Overall Study|Did not attend final visit|3
4506310|NCT00890097|7313941|FG002|Overall Study|Did not attend final visit|0
4506311|NCT00890097|7313939|FG000|Overall Study|Subject Decision|3
4506312|NCT00890097|7313940|FG001|Overall Study|Subject Decision|2
4506313|NCT00890097|7313941|FG002|Overall Study|Subject Decision|6
4506314|NCT00890097|7313939|FG000|Overall Study|Randomization Error|2
4506315|NCT00890097|7313940|FG001|Overall Study|Randomization Error|0
4506316|NCT00890097|7313941|FG002|Overall Study|Randomization Error|0
4506317|NCT00890097|7313939|FG000|Overall Study|Failed inclusion criteria|3
4506318|NCT00890097|7313940|FG001|Overall Study|Failed inclusion criteria|4
4506319|NCT00890097|7313941|FG002|Overall Study|Failed inclusion criteria|0
4506320|NCT00890097|7313939|FG000|Overall Study|Transportation|0
4506321|NCT00890097|7313940|FG001|Overall Study|Transportation|2
4506322|NCT00890097|7313941|FG002|Overall Study|Transportation|0
4506323|NCT00890097|7313939|FG000|Overall Study|Subject Moved|0
4506324|NCT00890097|7313940|FG001|Overall Study|Subject Moved|4
4506325|NCT00890097|7313941|FG002|Overall Study|Subject Moved|0
4506326|NCT00890097|7313939|FG000|Overall Study|Protocol Deviation|1
4506327|NCT00890097|7313940|FG001|Overall Study|Protocol Deviation|1
4506328|NCT00890097|7313941|FG002|Overall Study|Protocol Deviation|1
4506329|NCT00890201|7313960|FG000|Overall Study|Protocol Violation|5
4506330|NCT00890201|7313961|FG001|Overall Study|Protocol Violation|56
4518151|NCT00972244|7330210|FG000|Overall Study|Various|0
4518152|NCT00972244|7330211|FG001|Overall Study|Various|0
4518153|NCT00972244|7330212|FG002|Overall Study|Various|0
4518154|NCT00972244|7330213|FG003|Overall Study|Various|0
4518155|NCT00972244|7330214|FG004|Overall Study|Various|2
4518156|NCT00972283|7330228|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31
4518157|NCT00972283|7330229|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9
4518158|NCT00972283|7330228|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3
4518159|NCT00972283|7330229|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0
4518160|NCT00972283|7330228|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23
4518161|NCT00972283|7330229|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12
4518162|NCT00972283|7330228|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8
4518163|NCT00972283|7330229|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2
4518164|NCT00972283|7330228|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72
4518165|NCT00972283|7330229|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17
4518166|NCT00972283|7330228|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4
4518167|NCT00972283|7330229|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0
4518168|NCT00972283|7330228|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1
4518169|NCT00972283|7330229|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1
4518170|NCT00972283|7330228|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5
4518171|NCT00972283|7330229|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0
4518172|NCT00972283|7330228|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6
4518173|NCT00972283|7330229|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2
4518174|NCT00972283|7330228|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11
4518175|NCT00972283|7330229|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5
4518176|NCT00972322|7330237|FG000|Overall Study|Adverse Event|2
4518177|NCT00972322|7330238|FG001|Overall Study|Adverse Event|1
4518178|NCT00972322|7330237|FG000|Overall Study|Positive drug screen|0
4518179|NCT00972322|7330238|FG001|Overall Study|Positive drug screen|1
4518180|NCT00972322|7330237|FG000|Overall Study|Lost to Follow-up|0
4518181|NCT00972322|7330238|FG001|Overall Study|Lost to Follow-up|1
4518182|NCT00972322|7330237|FG000|Overall Study|Consistently high glucose values|1
4518183|NCT00972322|7330238|FG001|Overall Study|Consistently high glucose values|0
4518184|NCT00972478|7330272|FG000|Overall Study|Adverse Event|3
4518185|NCT00972478|7330273|FG001|Overall Study|Adverse Event|16
4518186|NCT00972478|7330272|FG000|Overall Study|Withdrawal by Subject|1
4518187|NCT00972478|7330273|FG001|Overall Study|Withdrawal by Subject|8
4518188|NCT00972478|7330272|FG000|Overall Study|Progression/Relapse|0
4518189|NCT00972478|7330273|FG001|Overall Study|Progression/Relapse|2
4518190|NCT00972478|7330272|FG000|Overall Study|Death|0
4518191|NCT00972478|7330273|FG001|Overall Study|Death|2
4518192|NCT00972478|7330272|FG000|Overall Study|Not protocol specified|1
4518193|NCT00972478|7330273|FG001|Overall Study|Not protocol specified|1
4518194|NCT00972478|7330272|FG000|Overall Study|Ineligible|1
4518195|NCT00972478|7330273|FG001|Overall Study|Ineligible|7
4387299|NCT00048048|7165929|FG004|Extension Year 1|Early withdrawals|0
4387300|NCT00048048|7165930|FG005|Extension Year 1|Early withdrawals|0
4387301|NCT00048048|7165931|FG006|Extension Year 1|Early withdrawals|0
4387302|NCT00048048|7165932|FG007|Extension Year 1|Early withdrawals|0
4387303|NCT00048048|7165933|FG008|Extension Year 1|Early withdrawals|0
4387304|NCT00048048|7165934|FG009|Extension Year 1|Early withdrawals|2
4506331|NCT00890552|7313979|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1
4506332|NCT00890552|7313979|FG000|On-treatment|Early prog disease/ death|10
4506333|NCT00890695|7314002|FG000|Overall Study|Protocol Violation|1
4506334|NCT00890695|7314003|FG001|Overall Study|Protocol Violation|0
4506335|NCT00890825|7314020|FG000|Overall Study|Withdrawal by Subject|1
4506336|NCT00890825|7314021|FG001|Overall Study|Withdrawal by Subject|0
4506337|NCT00890825|7314020|FG000|Overall Study|Alive at data cut off (DCO)|13
4506338|NCT00890825|7314021|FG001|Overall Study|Alive at data cut off (DCO)|14
4506339|NCT00890929|7314031|FG000|Overall Study|Death before treatment|2
4506340|NCT00890929|7314031|FG000|Overall Study|Withdrawal by Subject|3
4506341|NCT00890929|7314031|FG000|Overall Study|Physician Decision|1
4506342|NCT00891020|7314047|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11
4506343|NCT00891020|7314048|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32
4506344|NCT00891020|7314049|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17
4506345|NCT00891020|7314047|FG000|24 Week Treatment Period|Death|0
4506346|NCT00891020|7314048|FG001|24 Week Treatment Period|Death|2
4506347|NCT00891020|7314049|FG002|24 Week Treatment Period|Death|0
4506348|NCT00891020|7314047|FG000|24 Week Treatment Period|Insufficient therapeutic response|6
4506349|NCT00891020|7314048|FG001|24 Week Treatment Period|Insufficient therapeutic response|9
4506350|NCT00891020|7314049|FG002|24 Week Treatment Period|Insufficient therapeutic response|15
4506351|NCT00891020|7314047|FG000|24 Week Treatment Period|Failure to return|4
4506352|NCT00891020|7314048|FG001|24 Week Treatment Period|Failure to return|5
4506353|NCT00891020|7314049|FG002|24 Week Treatment Period|Failure to return|5
4506354|NCT00891020|7314047|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1
4506355|NCT00891020|7314048|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0
4506356|NCT00891020|7314049|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2
4506357|NCT00891020|7314047|FG000|24 Week Treatment Period|Other protocol violation|1
4506358|NCT00891020|7314048|FG001|24 Week Treatment Period|Other protocol violation|1
4506359|NCT00891020|7314049|FG002|24 Week Treatment Period|Other protocol violation|2
4506360|NCT00891020|7314047|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3
4506361|NCT00891020|7314048|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2
4506362|NCT00891020|7314049|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1
4506363|NCT00891020|7314047|FG000|24 Week Treatment Period|Withdrew consent|6
4506364|NCT00891020|7314048|FG001|24 Week Treatment Period|Withdrew consent|3
4506365|NCT00891020|7314049|FG002|24 Week Treatment Period|Withdrew consent|15
4506366|NCT00891020|7314047|FG000|24 Week Treatment Period|Administrative/Other|5
4506367|NCT00891020|7314048|FG001|24 Week Treatment Period|Administrative/Other|6
4506368|NCT00891020|7314049|FG002|24 Week Treatment Period|Administrative/Other|1
4506369|NCT00891020|7314047|FG000|Long-term Extension Period|Adverse Event|1
4506370|NCT00891020|7314048|FG001|Long-term Extension Period|Adverse Event|11
4506371|NCT00891020|7314049|FG002|Long-term Extension Period|Adverse Event|10
4506372|NCT00891020|7314047|FG000|Long-term Extension Period|Death|0
4506373|NCT00891020|7314048|FG001|Long-term Extension Period|Death|0
4506374|NCT00891020|7314049|FG002|Long-term Extension Period|Death|1
4506375|NCT00891020|7314047|FG000|Long-term Extension Period|Insufficient therapeutic response|3
4506376|NCT00891020|7314048|FG001|Long-term Extension Period|Insufficient therapeutic response|2
4506377|NCT00891020|7314049|FG002|Long-term Extension Period|Insufficient therapeutic response|2
4506378|NCT00891020|7314047|FG000|Long-term Extension Period|Protocol Violation|0
4506379|NCT00891020|7314048|FG001|Long-term Extension Period|Protocol Violation|1
4506380|NCT00891020|7314049|FG002|Long-term Extension Period|Protocol Violation|1
4506381|NCT00891020|7314047|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1
4506382|NCT00891020|7314048|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6
4506383|NCT00891020|7314049|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4
4506384|NCT00891020|7314047|FG000|Long-term Extension Period|Failure to return|0
4506385|NCT00891020|7314048|FG001|Long-term Extension Period|Failure to return|2
4506386|NCT00891020|7314049|FG002|Long-term Extension Period|Failure to return|3
4506387|NCT00891020|7314047|FG000|Long-term Extension Period|Administrative|1
4506388|NCT00891020|7314048|FG001|Long-term Extension Period|Administrative|2
4506389|NCT00891020|7314049|FG002|Long-term Extension Period|Administrative|2
4506390|NCT00891046|7314064|FG000|Overall Study|Protocol Violation|1
4506391|NCT00891046|7314065|FG001|Overall Study|Protocol Violation|1
4506392|NCT00891046|7314066|FG002|Overall Study|Protocol Violation|0
4506393|NCT00891046|7314067|FG003|Overall Study|Protocol Violation|0
4506394|NCT00891046|7314068|FG004|Overall Study|Protocol Violation|1
4506395|NCT00891046|7314064|FG000|Overall Study|Unsatisfactory therapeutic effect|5
4506396|NCT00891046|7314065|FG001|Overall Study|Unsatisfactory therapeutic effect|2
4506397|NCT00891046|7314066|FG002|Overall Study|Unsatisfactory therapeutic effect|19
4506398|NCT00891046|7314067|FG003|Overall Study|Unsatisfactory therapeutic effect|2
4506399|NCT00891046|7314068|FG004|Overall Study|Unsatisfactory therapeutic effect|20
4506400|NCT00891046|7314064|FG000|Overall Study|Administrative problems|0
4506401|NCT00891046|7314065|FG001|Overall Study|Administrative problems|0
4506402|NCT00891046|7314066|FG002|Overall Study|Administrative problems|0
4506403|NCT00891046|7314067|FG003|Overall Study|Administrative problems|0
4506404|NCT00891046|7314068|FG004|Overall Study|Administrative problems|1
4506405|NCT00891046|7314064|FG000|Overall Study|Participant no longer required drug|0
4506406|NCT00891046|7314065|FG001|Overall Study|Participant no longer required drug|2
4506407|NCT00891046|7314066|FG002|Overall Study|Participant no longer required drug|0
4506408|NCT00891046|7314067|FG003|Overall Study|Participant no longer required drug|0
4506409|NCT00891046|7314068|FG004|Overall Study|Participant no longer required drug|1
4506410|NCT00891046|7314064|FG000|Overall Study|Adverse Event|4
4506411|NCT00891046|7314065|FG001|Overall Study|Adverse Event|3
4506412|NCT00891046|7314066|FG002|Overall Study|Adverse Event|2
4506413|NCT00891046|7314067|FG003|Overall Study|Adverse Event|0
4506414|NCT00891046|7314068|FG004|Overall Study|Adverse Event|14
4506415|NCT00891046|7314064|FG000|Overall Study|Withdrawal by Subject|2
4506416|NCT00891046|7314065|FG001|Overall Study|Withdrawal by Subject|1
4506417|NCT00891046|7314066|FG002|Overall Study|Withdrawal by Subject|2
4506418|NCT00891046|7314067|FG003|Overall Study|Withdrawal by Subject|1
4506419|NCT00891046|7314068|FG004|Overall Study|Withdrawal by Subject|1
4506420|NCT00891046|7314064|FG000|Overall Study|Lost to Follow-up|0
4506421|NCT00891046|7314065|FG001|Overall Study|Lost to Follow-up|0
4506422|NCT00891046|7314066|FG002|Overall Study|Lost to Follow-up|0
4506423|NCT00891046|7314067|FG003|Overall Study|Lost to Follow-up|0
4506424|NCT00891046|7314068|FG004|Overall Study|Lost to Follow-up|1
4506425|NCT00891202|7314120|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1
4506426|NCT00891202|7314121|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0
4506427|NCT00891202|7314122|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0
4506428|NCT00891202|7314123|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0
4506429|NCT00891202|7314120|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
4506430|NCT00891202|7314121|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
4506431|NCT00891202|7314122|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4
4506432|NCT00891202|7314123|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
4506433|NCT00891202|7314120|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
4506434|NCT00891202|7314121|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
4506435|NCT00891202|7314122|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1
4506436|NCT00891202|7314123|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
4506437|NCT00891202|7314120|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0
4506438|NCT00891202|7314121|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0
4506439|NCT00891202|7314122|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2
4704908|NCT02757963|7624095|FG000|Overall Study|Withdrawal by Subject|34
4704909|NCT02758171|7624123|FG000|Wash-out|Withdrawal by Subject|1
4704910|NCT02758171|7624124|FG001|Wash-out|Withdrawal by Subject|0
4704911|NCT02758171|7624123|FG000|Wash-out|Other reason|1
4704912|NCT02758171|7624124|FG001|Wash-out|Other reason|0
4704913|NCT02758301|7624136|FG000|Overall Study|Death|12
4506440|NCT00891202|7314123|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5
4506441|NCT00891228|7314134|FG000|Overall Study|Adverse Event|0
4506442|NCT00891228|7314135|FG001|Overall Study|Adverse Event|2
4506443|NCT00891228|7314136|FG002|Overall Study|Adverse Event|3
4506444|NCT00891228|7314134|FG000|Overall Study|Withdrawal by Subject|2
4506445|NCT00891228|7314135|FG001|Overall Study|Withdrawal by Subject|4
4506446|NCT00891228|7314136|FG002|Overall Study|Withdrawal by Subject|5
4506447|NCT00891228|7314134|FG000|Overall Study|Protocol Violation|3
4506448|NCT00891228|7314135|FG001|Overall Study|Protocol Violation|1
4506449|NCT00891228|7314136|FG002|Overall Study|Protocol Violation|2
4506450|NCT00891228|7314134|FG000|Overall Study|Physician Decision|2
4506451|NCT00891228|7314135|FG001|Overall Study|Physician Decision|1
4506452|NCT00891228|7314136|FG002|Overall Study|Physician Decision|0
4506453|NCT00891228|7314134|FG000|Overall Study|Lost to Follow-up|4
4506454|NCT00891228|7314135|FG001|Overall Study|Lost to Follow-up|4
4506455|NCT00891228|7314136|FG002|Overall Study|Lost to Follow-up|5
4506456|NCT00891228|7314134|FG000|Overall Study|Pregnancy|0
4506457|NCT00891228|7314135|FG001|Overall Study|Pregnancy|1
4506458|NCT00891228|7314136|FG002|Overall Study|Pregnancy|0
4506459|NCT00891293|7314144|FG000|Overall Study|Adverse Event|2
4506460|NCT00891293|7314144|FG000|Overall Study|Protocol Violation|2
4506461|NCT00891293|7314144|FG000|Overall Study|Laboratory abnormality|4
4506462|NCT00891293|7314144|FG000|Overall Study|Lost to Follow-up|7
4506463|NCT00891293|7314144|FG000|Overall Study|Subject withdrew consent|7
4506464|NCT00891293|7314144|FG000|Overall Study|Sponsor termination|62
4506465|NCT00891371|7314157|FG000|Pre-assignment|Inclusion/exclusion|5
4506466|NCT00891371|7314157|FG000|Pre-assignment|Consent withdrawal|1
4506467|NCT00891371|7314157|FG000|Treatment|Lack of Efficacy|5
4506468|NCT00891371|7314157|FG000|Treatment|Adverse Event|2
4506469|NCT00891371|7314157|FG000|Treatment|Death|1
4506470|NCT00891371|7314157|FG000|Treatment|Lost to Follow-up|1
4506471|NCT00891462|7314173|FG000|Overall Study|Withdrawal by Subject|9
4506472|NCT00891462|7314174|FG001|Overall Study|Withdrawal by Subject|6
4506473|NCT00891462|7314175|FG002|Overall Study|Withdrawal by Subject|7
4506474|NCT00891462|7314173|FG000|Overall Study|Adverse Event|7
4506475|NCT00891462|7314174|FG001|Overall Study|Adverse Event|8
4506476|NCT00891462|7314175|FG002|Overall Study|Adverse Event|7
4506477|NCT00891462|7314173|FG000|Overall Study|Lack of Efficacy|10
4506478|NCT00891462|7314174|FG001|Overall Study|Lack of Efficacy|5
4506479|NCT00891462|7314175|FG002|Overall Study|Lack of Efficacy|1
4506480|NCT00891462|7314173|FG000|Overall Study|COPD exacerbation|7
4704914|NCT02758301|7624137|FG001|Overall Study|Death|0
4506481|NCT00891462|7314174|FG001|Overall Study|COPD exacerbation|4
4506482|NCT00891462|7314175|FG002|Overall Study|COPD exacerbation|1
4506483|NCT00891462|7314173|FG000|Overall Study|Other Reason|2
4506484|NCT00891462|7314174|FG001|Overall Study|Other Reason|5
4506485|NCT00891462|7314175|FG002|Overall Study|Other Reason|3
4506486|NCT00891462|7314173|FG000|Overall Study|Protocol Violation|2
4506487|NCT00891462|7314174|FG001|Overall Study|Protocol Violation|1
4506488|NCT00891462|7314175|FG002|Overall Study|Protocol Violation|3
4506489|NCT00891462|7314173|FG000|Overall Study|Inclusion/exclusion criteria|0
4506490|NCT00891462|7314174|FG001|Overall Study|Inclusion/exclusion criteria|2
4506491|NCT00891462|7314175|FG002|Overall Study|Inclusion/exclusion criteria|2
4506492|NCT00891462|7314173|FG000|Overall Study|Lost to Follow-up|0
4506493|NCT00891462|7314174|FG001|Overall Study|Lost to Follow-up|2
4506494|NCT00891462|7314175|FG002|Overall Study|Lost to Follow-up|0
4506495|NCT00891527|7314185|FG000|Overall Study|Withdrawal by Subject|2
4506496|NCT00891618|7314190|FG000|Overall Study|Withdrawal by Subject|1
4506497|NCT00891657|7314196|FG000|Overall Study|Withdrawal by Subject|1
4506498|NCT00891657|7314197|FG001|Overall Study|Withdrawal by Subject|1
4506499|NCT00891735|7314207|FG000|Overall Study|Adverse Event|2
4506500|NCT00891735|7314208|FG001|Overall Study|Adverse Event|0
4506501|NCT00891735|7314209|FG002|Overall Study|Adverse Event|2
4506502|NCT00891735|7314210|FG003|Overall Study|Adverse Event|0
4506503|NCT00891735|7314207|FG000|Overall Study|Death|8
4506504|NCT00891735|7314208|FG001|Overall Study|Death|5
4506505|NCT00891735|7314209|FG002|Overall Study|Death|4
4506506|NCT00891735|7314210|FG003|Overall Study|Death|5
4506507|NCT00891735|7314207|FG000|Overall Study|Lost to Follow-up|2
4506508|NCT00891735|7314208|FG001|Overall Study|Lost to Follow-up|2
4506509|NCT00891735|7314209|FG002|Overall Study|Lost to Follow-up|2
4506510|NCT00891735|7314210|FG003|Overall Study|Lost to Follow-up|2
4506511|NCT00891735|7314207|FG000|Overall Study|Physician's decision to withdraw patient|1
4506512|NCT00891735|7314208|FG001|Overall Study|Physician's decision to withdraw patient|0
4506513|NCT00891735|7314209|FG002|Overall Study|Physician's decision to withdraw patient|0
4506514|NCT00891735|7314210|FG003|Overall Study|Physician's decision to withdraw patient|0
4506515|NCT00891735|7314207|FG000|Overall Study|Patient's decision to withdraw|4
4506516|NCT00891735|7314208|FG001|Overall Study|Patient's decision to withdraw|9
4506517|NCT00891735|7314209|FG002|Overall Study|Patient's decision to withdraw|4
4506518|NCT00891735|7314210|FG003|Overall Study|Patient's decision to withdraw|8
4506519|NCT00891774|7314220|FG000|Overall Study|Lost to Follow-up|5
4506520|NCT00891774|7314220|FG000|Overall Study|Illness (Self/Mother)|3
4506521|NCT00891774|7314220|FG000|Overall Study|Withdrawal by Subject|2
4506522|NCT00891774|7314220|FG000|Overall Study|Protocol Violation|4
4506523|NCT00891813|7314224|FG000|Overall Study|Adverse Event|3
4506524|NCT00891813|7314224|FG000|Overall Study|Withdrawal by Subject|1
4506525|NCT00891813|7314224|FG000|Overall Study|Patient Noncompliance|6
4506526|NCT00891813|7314224|FG000|Overall Study|Protocol Violation|2
4506527|NCT00891839|7314228|FG000|Overall Study|Adverse Event|2
4506528|NCT00891839|7314228|FG000|Overall Study|Withdrawal by Subject|2
4506529|NCT00891839|7314228|FG000|Overall Study|Disease progression|3
4506530|NCT00891930|7314241|FG000|Part 1: Panitumumab +Irinotecan|Death|38
4506531|NCT00891930|7314241|FG000|Part 1: Panitumumab +Irinotecan|Withdrawal by Subject|1
4506532|NCT00891930|7314241|FG000|Part 1: Panitumumab +Irinotecan|Lost to Follow-up|1
4506533|NCT00891930|7314241|FG000|Part 2: Panitumumab + Ganitumab|Death|30
4506534|NCT00891930|7314241|FG000|Part 2: Panitumumab + Ganitumab|Withdrawal by Subject|1
4506535|NCT00892008|7314267|FG000|Overall Study|Death|5
4506536|NCT00892008|7314267|FG000|Overall Study|Lack of Efficacy|3
4506537|NCT00892008|7314267|FG000|Overall Study|Lost to Follow-up|142
4506538|NCT00892008|7314267|FG000|Overall Study|Other|378
4506539|NCT00892008|7314267|FG000|Overall Study|Adverse Event|37
4506540|NCT00892047|7314273|FG000|Overall Study|Adverse Event|2
4506541|NCT00892047|7314274|FG001|Overall Study|Adverse Event|2
4506542|NCT00892047|7314273|FG000|Overall Study|subject burden|2
4506543|NCT00892047|7314274|FG001|Overall Study|subject burden|3
4506544|NCT00892047|7314273|FG000|Overall Study|Lack of Efficacy|0
4506545|NCT00892047|7314274|FG001|Overall Study|Lack of Efficacy|2
4506546|NCT00892099|7314285|FG000|Overall Study|Death|1
4506547|NCT00892099|7314286|FG001|Overall Study|Death|0
4506548|NCT00892099|7314287|FG002|Overall Study|Death|1
4506549|NCT00892099|7314285|FG000|Overall Study|Adverse Event|1
4506550|NCT00892099|7314286|FG001|Overall Study|Adverse Event|0
4506551|NCT00892099|7314287|FG002|Overall Study|Adverse Event|0
4506552|NCT00892099|7314285|FG000|Overall Study|replocated|1
4506553|NCT00892099|7314286|FG001|Overall Study|replocated|0
4506554|NCT00892099|7314287|FG002|Overall Study|replocated|2
4506555|NCT00892099|7314285|FG000|Overall Study|Prolonged hospitalization|1
4506556|NCT00892099|7314286|FG001|Overall Study|Prolonged hospitalization|0
4506557|NCT00892099|7314287|FG002|Overall Study|Prolonged hospitalization|1
4506558|NCT00892099|7314285|FG000|Overall Study|no further details|1
4506559|NCT00892099|7314286|FG001|Overall Study|no further details|0
4506560|NCT00892099|7314287|FG002|Overall Study|no further details|1
4506561|NCT00892099|7314285|FG000|Overall Study|kidney function recovered|0
4506562|NCT00892099|7314286|FG001|Overall Study|kidney function recovered|1
4506563|NCT00892099|7314287|FG002|Overall Study|kidney function recovered|0
4506564|NCT00892099|7314285|FG000|Overall Study|investigator decision|0
4506565|NCT00892099|7314286|FG001|Overall Study|investigator decision|0
4506566|NCT00892099|7314287|FG002|Overall Study|investigator decision|1
4506567|NCT00892099|7314285|FG000|Overall Study|Lost to Follow-up|0
4506568|NCT00892099|7314286|FG001|Overall Study|Lost to Follow-up|0
4506569|NCT00892099|7314287|FG002|Overall Study|Lost to Follow-up|1
4506570|NCT00892151|7314295|FG000|Overall Study|Protocol Violation|1
4506571|NCT00892177|7314302|FG000|Phase II|Ineligible|0
4506572|NCT00892177|7314303|FG001|Phase II|Ineligible|0
4506573|NCT00892177|7314304|FG002|Phase II|Ineligible|0
4506574|NCT00892177|7314305|FG003|Phase II|Ineligible|0
4506575|NCT00892177|7314306|FG004|Phase II|Ineligible|1
4506576|NCT00892177|7314307|FG005|Phase II|Ineligible|1
4506577|NCT00892177|7314302|FG000|Phase II|Withdrawal by Subject|0
4506578|NCT00892177|7314303|FG001|Phase II|Withdrawal by Subject|0
4506579|NCT00892177|7314304|FG002|Phase II|Withdrawal by Subject|0
4506580|NCT00892177|7314305|FG003|Phase II|Withdrawal by Subject|0
4506581|NCT00892177|7314306|FG004|Phase II|Withdrawal by Subject|4
4506582|NCT00892177|7314307|FG005|Phase II|Withdrawal by Subject|1
4506583|NCT00892281|7314324|FG000|Overall Study|Adverse Event|65
4506584|NCT00892281|7314325|FG001|Overall Study|Adverse Event|8
4506585|NCT00892281|7314324|FG000|Overall Study|Lost to Follow-up|81
4506586|NCT00892281|7314325|FG001|Overall Study|Lost to Follow-up|8
4506587|NCT00892281|7314324|FG000|Overall Study|Pregnancy|1
4506588|NCT00892281|7314325|FG001|Overall Study|Pregnancy|0
4506589|NCT00892281|7314324|FG000|Overall Study|Protocol Violation|7
4506590|NCT00892281|7314325|FG001|Overall Study|Protocol Violation|2
4506591|NCT00892281|7314324|FG000|Overall Study|Withdrawal by Subject|86
4506592|NCT00892281|7314325|FG001|Overall Study|Withdrawal by Subject|14
4506593|NCT00892281|7314324|FG000|Overall Study|Subject failed to return for final visit|2
4506594|NCT00892281|7314325|FG001|Overall Study|Subject failed to return for final visit|0
4506595|NCT00892281|7314324|FG000|Overall Study|Subject unable to keep follow-up visits|1
4506596|NCT00892281|7314325|FG001|Overall Study|Subject unable to keep follow-up visits|0
4506597|NCT00892281|7314324|FG000|Overall Study|Final visit completed 4 weeks late|0
4506598|NCT00892281|7314325|FG001|Overall Study|Final visit completed 4 weeks late|1
4506599|NCT00892281|7314324|FG000|Overall Study|Subject completed day after study closed|1
4506600|NCT00892281|7314325|FG001|Overall Study|Subject completed day after study closed|0
4506601|NCT00892281|7314324|FG000|Overall Study|Family emergency|1
4506602|NCT00892281|7314325|FG001|Overall Study|Family emergency|0
4506603|NCT00892281|7314324|FG000|Overall Study|Last visit not done - death in family|1
4506604|NCT00892281|7314325|FG001|Overall Study|Last visit not done - death in family|0
4506605|NCT00892281|7314324|FG000|Overall Study|Did not meet incl/excl criteria|1
4506606|NCT00892281|7314325|FG001|Overall Study|Did not meet incl/excl criteria|0
4506607|NCT00892281|7314324|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1
4506608|NCT00892281|7314325|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0
4506609|NCT00892281|7314324|FG000|Overall Study|Unable to redeem the drug voucher|1
4506610|NCT00892281|7314325|FG001|Overall Study|Unable to redeem the drug voucher|0
4506611|NCT00892281|7314324|FG000|Overall Study|Subject not good candidate for study|1
4506612|NCT00892281|7314325|FG001|Overall Study|Subject not good candidate for study|0
4506613|NCT00892281|7314324|FG000|Overall Study|Subject did not return for any visits|1
4506614|NCT00892281|7314325|FG001|Overall Study|Subject did not return for any visits|0
4506615|NCT00892281|7314324|FG000|Overall Study|Subject missed several visits/lost meds|1
4506616|NCT00892281|7314325|FG001|Overall Study|Subject missed several visits/lost meds|0
4506617|NCT00892281|7314324|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1
4506618|NCT00892281|7314325|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1
4506619|NCT00892281|7314324|FG000|Overall Study|Scheduled for knee replacement|0
4506620|NCT00892281|7314325|FG001|Overall Study|Scheduled for knee replacement|1
4506621|NCT00892281|7314324|FG000|Overall Study|PI complained of inadequate compensation|3
4506622|NCT00892281|7314325|FG001|Overall Study|PI complained of inadequate compensation|0
4506623|NCT00892281|7314324|FG000|Overall Study|Subject lost interest in program|0
4506624|NCT00892281|7314325|FG001|Overall Study|Subject lost interest in program|1
4506625|NCT00892281|7314324|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0
4506626|NCT00892281|7314325|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1
4506627|NCT00892281|7314324|FG000|Overall Study|Death in family|1
4506628|NCT00892281|7314325|FG001|Overall Study|Death in family|0
4506629|NCT00892281|7314324|FG000|Overall Study|Lack of efficacy of study product|2
4506630|NCT00892281|7314325|FG001|Overall Study|Lack of efficacy of study product|0
4506631|NCT00892281|7314324|FG000|Overall Study|Subject not seen by PI at final visit|1
4506632|NCT00892281|7314325|FG001|Overall Study|Subject not seen by PI at final visit|0
4506633|NCT00892281|7314324|FG000|Overall Study|No show Visit 2; prescription not filled|1
4506634|NCT00892281|7314325|FG001|Overall Study|No show Visit 2; prescription not filled|0
4506635|NCT00892281|7314324|FG000|Overall Study|Missed multiple visits|1
4506636|NCT00892281|7314325|FG001|Overall Study|Missed multiple visits|0
4506637|NCT00892281|7314324|FG000|Overall Study|Missed visits rescheduled out of window|1
4506638|NCT00892281|7314325|FG001|Overall Study|Missed visits rescheduled out of window|0
4506639|NCT00892281|7314324|FG000|Overall Study|Non-compliant with visits as scheduled|1
4506640|NCT00892281|7314325|FG001|Overall Study|Non-compliant with visits as scheduled|0
4506641|NCT00892281|7314324|FG000|Overall Study|Subject had history of drug abuse|1
4506642|NCT00892281|7314325|FG001|Overall Study|Subject had history of drug abuse|0
4506643|NCT00892281|7314324|FG000|Overall Study|Rash on hand|1
4506644|NCT00892281|7314325|FG001|Overall Study|Rash on hand|0
4506645|NCT00892281|7314324|FG000|Overall Study|Visit 4 date out of window|1
4506646|NCT00892281|7314325|FG001|Overall Study|Visit 4 date out of window|0
4506647|NCT00892437|7314333|FG000|Randomized Phase|Randomized but not treated|6
4506648|NCT00892437|7314334|FG001|Randomized Phase|Randomized but not treated|0
4506649|NCT00892437|7314333|FG000|Randomized Phase|Adverse Event|2
4506650|NCT00892437|7314334|FG001|Randomized Phase|Adverse Event|2
4506651|NCT00892437|7314333|FG000|Randomized Phase|Lost to Follow-up|1
4506652|NCT00892437|7314334|FG001|Randomized Phase|Lost to Follow-up|3
4506653|NCT00892437|7314333|FG000|Randomized Phase|Investigator's Discretion|1
4506654|NCT00892437|7314334|FG001|Randomized Phase|Investigator's Discretion|0
4506655|NCT00892437|7314333|FG000|Randomized Phase|Withdrew Consent|1
4506656|NCT00892437|7314334|FG001|Randomized Phase|Withdrew Consent|0
4506657|NCT00892437|7314333|FG000|Open-Label Extension Phase|Adverse Event|4
4506658|NCT00892437|7314334|FG001|Open-Label Extension Phase|Adverse Event|2
4506659|NCT00892437|7314333|FG000|Open-Label Extension Phase|Lack of Efficacy|1
4506660|NCT00892437|7314334|FG001|Open-Label Extension Phase|Lack of Efficacy|0
4506661|NCT00892437|7314333|FG000|Open-Label Extension Phase|Lost to Follow-up|3
4506662|NCT00892437|7314334|FG001|Open-Label Extension Phase|Lost to Follow-up|1
4506663|NCT00892437|7314333|FG000|Open-Label Extension Phase|Investigator's Discretion|1
4506664|NCT00892437|7314334|FG001|Open-Label Extension Phase|Investigator's Discretion|0
4506665|NCT00892437|7314333|FG000|Open-Label Extension Phase|Withdrew Consent|3
4506666|NCT00892437|7314334|FG001|Open-Label Extension Phase|Withdrew Consent|1
4506667|NCT00892723|7314371|FG000|Overall Study|Lost to Follow-up|1
4506668|NCT00892723|7314372|FG001|Overall Study|Lost to Follow-up|3
4506669|NCT00892723|7314373|FG002|Overall Study|Lost to Follow-up|1
4506670|NCT00892723|7314371|FG000|Overall Study|Withdrawal by Subject|1
4506671|NCT00892723|7314372|FG001|Overall Study|Withdrawal by Subject|1
4506672|NCT00892723|7314373|FG002|Overall Study|Withdrawal by Subject|1
4506673|NCT00892775|7314416|FG000|Overall Study|Protocol Violation|1
4506674|NCT00892775|7314417|FG001|Overall Study|Protocol Violation|0
4506675|NCT00892775|7314416|FG000|Overall Study|Subject difficulties with blood drawing|1
4506676|NCT00892775|7314417|FG001|Overall Study|Subject difficulties with blood drawing|0
4506677|NCT00892775|7314416|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1
4506678|NCT00892775|7314417|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0
4506679|NCT00892775|7314416|FG000|Overall Study|Migrated/ moved from study area|1
4506680|NCT00892775|7314417|FG001|Overall Study|Migrated/ moved from study area|0
4506681|NCT00892775|7314416|FG000|Overall Study|Withdrawal by Subject|0
4506682|NCT00892775|7314417|FG001|Overall Study|Withdrawal by Subject|1
4506683|NCT00892775|7314416|FG000|Overall Study|Lost to Follow-up|1
4506684|NCT00892775|7314417|FG001|Overall Study|Lost to Follow-up|0
4506685|NCT00892957|7314425|FG000|Between Postoperative Day 1 and Day 14|Death|0
4506686|NCT00892957|7314426|FG001|Between Postoperative Day 1 and Day 14|Death|2
4506687|NCT00892957|7314425|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0
4506688|NCT00892957|7314426|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2
4506689|NCT00893113|7314463|FG000|Overall Study|Lost to Follow-up|4
4506690|NCT00893113|7314464|FG001|Overall Study|Lost to Follow-up|8
4506691|NCT00893113|7314463|FG000|Overall Study|Early Termination|1
4506692|NCT00893113|7314464|FG001|Overall Study|Early Termination|1
4506693|NCT00893113|7314463|FG000|Overall Study|Withdrew Consent|8
4506694|NCT00893113|7314464|FG001|Overall Study|Withdrew Consent|7
4506695|NCT00893464|7314487|FG000|Overall Study|Did not complete therapy/experience PD|0
4627709|NCT01854775|7494495|FG001|Extension Phase|Investigator's Discretion|0
4627710|NCT01854775|7494496|FG002|Extension Phase|Investigator's Discretion|0
4506696|NCT00893464|7314488|FG001|Overall Study|Did not complete therapy/experience PD|0
4506697|NCT00893464|7314489|FG002|Overall Study|Did not complete therapy/experience PD|0
4506698|NCT00893464|7314490|FG003|Overall Study|Did not complete therapy/experience PD|0
4506699|NCT00893464|7314491|FG004|Overall Study|Did not complete therapy/experience PD|0
4506700|NCT00893464|7314492|FG005|Overall Study|Did not complete therapy/experience PD|0
4506701|NCT00893464|7314493|FG006|Overall Study|Did not complete therapy/experience PD|2
4506702|NCT00893464|7314494|FG007|Overall Study|Did not complete therapy/experience PD|2
4506703|NCT00893737|7314517|FG000|Overall Study|Adverse Event|4
4506704|NCT00893737|7314517|FG000|Overall Study|Withdrawal by Subject|2
4506705|NCT00893737|7314517|FG000|Overall Study|Lost to Follow-up|6
4506706|NCT00893763|7314523|FG000|Overall Study|extubated|110
4506707|NCT00893763|7314524|FG001|Overall Study|extubated|110
4506708|NCT00893971|7314532|FG000|Overall Study|Physician Decision|3
4506709|NCT00894166|7314565|FG000|Overall Study|Withdrew or Lost to Follow-Up|61
4506710|NCT00894166|7314566|FG001|Overall Study|Withdrew or Lost to Follow-Up|63
4506711|NCT00894166|7314567|FG002|Overall Study|Withdrew or Lost to Follow-Up|62
4506712|NCT00894166|7314568|FG003|Overall Study|Withdrew or Lost to Follow-Up|68
4506713|NCT00894166|7314569|FG004|Overall Study|Withdrew or Lost to Follow-Up|24
4506714|NCT00894166|7314570|FG005|Overall Study|Withdrew or Lost to Follow-Up|16
4506715|NCT00894166|7314571|FG006|Overall Study|Withdrew or Lost to Follow-Up|16
4506716|NCT00894166|7314572|FG007|Overall Study|Withdrew or Lost to Follow-Up|34
4506717|NCT00894166|7314565|FG000|Overall Study|Death|0
4506718|NCT00894166|7314566|FG001|Overall Study|Death|0
4506719|NCT00894166|7314567|FG002|Overall Study|Death|0
4506720|NCT00894166|7314568|FG003|Overall Study|Death|1
4506721|NCT00894166|7314569|FG004|Overall Study|Death|0
4627711|NCT01854775|7494494|FG000|Extension Phase|Non-Compliance with Study Drug|1
4627712|NCT01854775|7494495|FG001|Extension Phase|Non-Compliance with Study Drug|0
4627713|NCT01854775|7494496|FG002|Extension Phase|Non-Compliance with Study Drug|0
4627714|NCT01854775|7494494|FG000|Extension Phase|Lost to Follow-up|2
4627715|NCT01854775|7494495|FG001|Extension Phase|Lost to Follow-up|0
4627716|NCT01854775|7494496|FG002|Extension Phase|Lost to Follow-up|0
4506722|NCT00894166|7314570|FG005|Overall Study|Death|0
4506723|NCT00894166|7314571|FG006|Overall Study|Death|0
4506724|NCT00894166|7314572|FG007|Overall Study|Death|0
4506725|NCT00894322|7314598|FG000|Overall Study|Withdrawal by Subject|1
4506726|NCT00894322|7314599|FG001|Overall Study|Withdrawal by Subject|0
4506727|NCT00894322|7314600|FG002|Overall Study|Withdrawal by Subject|0
4506728|NCT00894361|7314612|FG000|Overall Study|deaths and less than 2 years followup|24
4506729|NCT00894361|7314613|FG001|Overall Study|deaths and less than 2 years followup|64
4506730|NCT00894387|7314623|FG000|Overall Study|Adverse Event|44
4506731|NCT00894387|7314624|FG001|Overall Study|Adverse Event|45
4506732|NCT00894387|7314623|FG000|Overall Study|Abnormal Laboratory values|2
4506733|NCT00894387|7314624|FG001|Overall Study|Abnormal Laboratory values|2
4506734|NCT00894387|7314623|FG000|Overall Study|Unsatisfactory therapeutic effect|0
4506735|NCT00894387|7314624|FG001|Overall Study|Unsatisfactory therapeutic effect|1
4506736|NCT00894387|7314623|FG000|Overall Study|Lost to Follow-up|3
4506737|NCT00894387|7314624|FG001|Overall Study|Lost to Follow-up|5
4506738|NCT00894387|7314623|FG000|Overall Study|Administrative problems|2
4506739|NCT00894387|7314624|FG001|Overall Study|Administrative problems|2
4506740|NCT00894387|7314623|FG000|Overall Study|Death|77
4506741|NCT00894387|7314624|FG001|Overall Study|Death|76
4506742|NCT00894387|7314623|FG000|Overall Study|Protocol Deviation|4
4506743|NCT00894387|7314624|FG001|Overall Study|Protocol Deviation|0
4506744|NCT00894387|7314623|FG000|Overall Study|Patient's request|25
4506745|NCT00894387|7314624|FG001|Overall Study|Patient's request|30
4506746|NCT00894387|7314623|FG000|Overall Study|Other (Missing)|5
4506747|NCT00894387|7314624|FG001|Overall Study|Other (Missing)|3
4506748|NCT00894387|7314623|FG000|Overall Study|Mis-randomized|13
4506749|NCT00894387|7314624|FG001|Overall Study|Mis-randomized|9
4506750|NCT00894387|7314623|FG000|Overall Study|GCP non-compliance|0
4506751|NCT00894387|7314624|FG001|Overall Study|GCP non-compliance|2
4506752|NCT00894413|7314632|FG000|Overall Study|Physician Decision|0
4506753|NCT00894413|7314633|FG001|Overall Study|Physician Decision|2
4506754|NCT00894413|7314632|FG000|Overall Study|Adverse Event|0
4506755|NCT00894413|7314633|FG001|Overall Study|Adverse Event|2
4506756|NCT00894413|7314632|FG000|Overall Study|Withdrawal by Subject|0
4506757|NCT00894413|7314633|FG001|Overall Study|Withdrawal by Subject|4
4506758|NCT00894543|7314675|FG000|Baseline to Week 4|No diary or lost or withdrew|3
4506759|NCT00894543|7314676|FG001|Baseline to Week 4|No diary or lost or withdrew|2
4506760|NCT00894543|7314675|FG000|Week 4 to Week 8|No diary or lost or withdrew|4
4506761|NCT00894543|7314676|FG001|Week 4 to Week 8|No diary or lost or withdrew|2
4506762|NCT00894647|7314684|FG000|Overall Study|Adverse Event|5
4506763|NCT00894647|7314685|FG001|Overall Study|Adverse Event|4
4506764|NCT00894647|7314684|FG000|Overall Study|Withdrawal by Subject|4
4627717|NCT01854775|7494494|FG000|Extension Phase|Still on Study|32
4627718|NCT01854775|7494495|FG001|Extension Phase|Still on Study|47
4627719|NCT01854775|7494496|FG002|Extension Phase|Still on Study|18
4627720|NCT01854827|7494504|FG000|Overall Study|Death|1
4627721|NCT01854879|7494508|FG000|Overall Study|Could not complete testing within the scheduled time.|1
4627722|NCT01854879|7494508|FG000|Overall Study|screen fail|3
4627723|NCT01854879|7494508|FG000|Overall Study|incomplete data set|1
4627724|NCT01854918|7494518|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20
4627725|NCT01854918|7494519|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49
4627726|NCT01854918|7494518|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2
4627727|NCT01854918|7494519|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1
4627728|NCT01854918|7494518|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3
4627729|NCT01854918|7494519|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8
4627730|NCT01854918|7494518|FG000|SOC-controlled Period (Year 1)|Death|5
4627731|NCT01854918|7494519|FG001|SOC-controlled Period (Year 1)|Death|5
4627732|NCT01854918|7494518|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78
4627733|NCT01854918|7494519|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117
4627734|NCT01854918|7494518|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8
4627735|NCT01854918|7494519|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11
4627736|NCT01854918|7494518|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27
4627737|NCT01854918|7494519|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51
4627738|NCT01854918|7494518|FG000|All-IP Period (Years 2 and 3)|Death|5
4627739|NCT01854918|7494519|FG001|All-IP Period (Years 2 and 3)|Death|16
4627740|NCT01854944|7494535|FG000|Overall Study|Withdrawal by Subject|0
4506765|NCT00894647|7314685|FG001|Overall Study|Withdrawal by Subject|4
4627741|NCT01854944|7494536|FG001|Overall Study|Withdrawal by Subject|0
4627742|NCT01854944|7494537|FG002|Overall Study|Withdrawal by Subject|1
4627743|NCT01855048|7494565|FG000|Overall Study|Withdrawal by Subject|0
4627744|NCT01855048|7494566|FG001|Overall Study|Withdrawal by Subject|1
4506766|NCT00894647|7314684|FG000|Overall Study|Lost to Follow-up|0
4506767|NCT00894647|7314685|FG001|Overall Study|Lost to Follow-up|2
4627745|NCT01855048|7494567|FG002|Overall Study|Withdrawal by Subject|0
4627746|NCT01855048|7494568|FG003|Overall Study|Withdrawal by Subject|0
4627747|NCT01855048|7494569|FG004|Overall Study|Withdrawal by Subject|1
4704915|NCT02758301|7624136|FG000|Overall Study|Physician Decision|10
4704916|NCT02758301|7624137|FG001|Overall Study|Physician Decision|1
4704917|NCT02758301|7624136|FG000|Overall Study|Withdrawal by Subject|5
4704918|NCT02758301|7624137|FG001|Overall Study|Withdrawal by Subject|6
4704919|NCT02758301|7624136|FG000|Overall Study|Lost to Follow-up|7
4627748|NCT01855048|7494570|FG005|Overall Study|Withdrawal by Subject|0
4627749|NCT01855074|7494594|FG000|Overall Study|Adverse Event|1
4627750|NCT01855074|7494594|FG000|Overall Study|Lost to Follow-up|4
4627751|NCT01855074|7494594|FG000|Overall Study|Withdrawal by Subject|8
4627752|NCT01855074|7494594|FG000|Overall Study|Started but not treated|1
4627753|NCT01855126|7494600|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4
4627754|NCT01855126|7494601|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6
4627755|NCT01855126|7494600|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2
4627756|NCT01855126|7494601|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2
4627757|NCT01855243|7494614|FG000|Overall Study|develpoed diabetic ketoacidosis|1
4627758|NCT01855243|7494615|FG001|Overall Study|develpoed diabetic ketoacidosis|0
4627759|NCT01855243|7494616|FG002|Overall Study|develpoed diabetic ketoacidosis|0
4627760|NCT01855399|7494630|FG000|6 Month|Lost to Follow-up|12
4627761|NCT01855399|7494631|FG001|6 Month|Lost to Follow-up|9
4627762|NCT01855399|7494630|FG000|6 Month|Withdrawal by Subject|8
4506768|NCT00894647|7314684|FG000|Overall Study|Non-compliance with study procedures|0
4506769|NCT00894647|7314685|FG001|Overall Study|Non-compliance with study procedures|2
4506770|NCT00894647|7314684|FG000|Overall Study|Other, not due to AE|1
4506771|NCT00894647|7314685|FG001|Overall Study|Other, not due to AE|2
4506772|NCT00894686|7314691|FG000|Overall Study|Withdrawal by Subject|50
4506773|NCT00894686|7314691|FG000|Overall Study|Physician Decision|1
4506774|NCT00894686|7314691|FG000|Overall Study|Other|5
4506775|NCT00894803|7314715|FG000|Overall Study|Death|20
4506776|NCT00894803|7314716|FG001|Overall Study|Death|4
4506777|NCT00894803|7314715|FG000|Overall Study|Lost to Follow-up|0
4506778|NCT00894803|7314716|FG001|Overall Study|Lost to Follow-up|1
4506779|NCT00894933|7314722|FG000|Overall Study|Lost to Follow-up|2
4506780|NCT00894933|7314722|FG000|Overall Study|Cancelled Procedure|1
4506781|NCT00894933|7314722|FG000|Overall Study|Did not meeting incl/excl criteria|1
4506782|NCT00895011|7314729|FG000|Overall Study|Withdrawal by Subject|14
4506783|NCT00895011|7314730|FG001|Overall Study|Withdrawal by Subject|7
4506784|NCT00895011|7314731|FG002|Overall Study|Withdrawal by Subject|2
4506785|NCT00895011|7314729|FG000|Overall Study|Lost to Follow-up|5
4506786|NCT00895011|7314730|FG001|Overall Study|Lost to Follow-up|4
4506787|NCT00895011|7314731|FG002|Overall Study|Lost to Follow-up|1
4506788|NCT00895011|7314729|FG000|Overall Study|Protocol Violation|3
4506789|NCT00895011|7314730|FG001|Overall Study|Protocol Violation|1
4506790|NCT00895011|7314731|FG002|Overall Study|Protocol Violation|3
4506791|NCT00895011|7314729|FG000|Overall Study|Adverse Event|1
4506792|NCT00895011|7314730|FG001|Overall Study|Adverse Event|2
4506793|NCT00895011|7314731|FG002|Overall Study|Adverse Event|2
4506794|NCT00895011|7314729|FG000|Overall Study|schedule conflict|1
4506795|NCT00895011|7314730|FG001|Overall Study|schedule conflict|0
4506796|NCT00895011|7314731|FG002|Overall Study|schedule conflict|0
4506797|NCT00895037|7314743|FG000|Overall Study|Death|0
4506798|NCT00895037|7314744|FG001|Overall Study|Death|2
4506799|NCT00895037|7314745|FG002|Overall Study|Death|1
4506800|NCT00895154|7314755|FG000|Overall Study|Lost to Follow-up|1
4506801|NCT00895154|7314756|FG001|Overall Study|Lost to Follow-up|1
4506802|NCT00895154|7314755|FG000|Overall Study|Withdrawal by Subject|0
4506803|NCT00895154|7314756|FG001|Overall Study|Withdrawal by Subject|1
4506804|NCT00895245|7314803|FG000|Overall Study|Lack of Efficacy|6
4506805|NCT00895310|7314807|FG000|Overall Study|Withdrawal by Subject|1
4506806|NCT00895414|7314811|FG000|First Intervention (14 Days)|Withdrawal by Subject|1
4506807|NCT00895414|7314812|FG001|First Intervention (14 Days)|Withdrawal by Subject|0
4506808|NCT00895414|7314811|FG000|First Intervention (14 Days)|Physician Decision|0
4506809|NCT00895414|7314812|FG001|First Intervention (14 Days)|Physician Decision|1
4506810|NCT00895453|7314821|FG000|Overall Study|Lost to Follow-up|25
4506811|NCT00895453|7314822|FG001|Overall Study|Lost to Follow-up|25
4506812|NCT00895453|7314823|FG002|Overall Study|Lost to Follow-up|23
4506813|NCT00895583|7314842|FG000|Overall Study|Adverse Event|28
4506814|NCT00895583|7314843|FG001|Overall Study|Adverse Event|4
4506815|NCT00895583|7314842|FG000|Overall Study|Death|2
4506816|NCT00895583|7314843|FG001|Overall Study|Death|1
4506817|NCT00895583|7314842|FG000|Overall Study|Physician Decision|3
4506818|NCT00895583|7314843|FG001|Overall Study|Physician Decision|1
4506819|NCT00895583|7314842|FG000|Overall Study|Lost to Follow-up|1
4506820|NCT00895583|7314843|FG001|Overall Study|Lost to Follow-up|3
4506821|NCT00895583|7314842|FG000|Overall Study|Protocol Violation|1
4506822|NCT00895583|7314843|FG001|Overall Study|Protocol Violation|0
4506823|NCT00895583|7314842|FG000|Overall Study|Withdrawal by Subject|4
4506824|NCT00895583|7314843|FG001|Overall Study|Withdrawal by Subject|2
4506825|NCT00895583|7314842|FG000|Overall Study|Lack of Efficacy|5
4506826|NCT00895583|7314843|FG001|Overall Study|Lack of Efficacy|0
4506827|NCT00895583|7314842|FG000|Overall Study|Other|0
4506828|NCT00895583|7314843|FG001|Overall Study|Other|1
4506829|NCT00895622|7314852|FG000|Overall Study|Protocol Violation|5
4506830|NCT00895622|7314853|FG001|Overall Study|Protocol Violation|4
4506831|NCT00895622|7314854|FG002|Overall Study|Protocol Violation|4
4506832|NCT00895661|7314870|FG000|Overall Study|Death|1
4506833|NCT00895661|7314870|FG000|Overall Study|reason unknown|2
4506834|NCT00895843|7314912|FG000|Overall Study|Protocol Violation|12
4506835|NCT00895843|7314913|FG001|Overall Study|Protocol Violation|12
4506836|NCT00895895|7314924|FG000|Period 1|Adverse Event|7
4506837|NCT00895895|7314925|FG001|Period 1|Adverse Event|6
4506838|NCT00895895|7314926|FG002|Period 1|Adverse Event|4
4506839|NCT00895895|7314927|FG003|Period 1|Adverse Event|6
4506840|NCT00895895|7314928|FG004|Period 1|Adverse Event|7
4506841|NCT00895895|7314924|FG000|Period 1|Death|0
4506842|NCT00895895|7314925|FG001|Period 1|Death|0
4506843|NCT00895895|7314926|FG002|Period 1|Death|0
4506844|NCT00895895|7314927|FG003|Period 1|Death|0
4506845|NCT00895895|7314928|FG004|Period 1|Death|1
4506846|NCT00895895|7314924|FG000|Period 1|discontinued by sponsor|2
4506847|NCT00895895|7314925|FG001|Period 1|discontinued by sponsor|1
4506848|NCT00895895|7314926|FG002|Period 1|discontinued by sponsor|2
4506849|NCT00895895|7314927|FG003|Period 1|discontinued by sponsor|1
4506850|NCT00895895|7314928|FG004|Period 1|discontinued by sponsor|1
4506851|NCT00895895|7314924|FG000|Period 1|failed to return|0
4506852|NCT00895895|7314925|FG001|Period 1|failed to return|0
4506853|NCT00895895|7314926|FG002|Period 1|failed to return|1
4506854|NCT00895895|7314927|FG003|Period 1|failed to return|0
4506855|NCT00895895|7314928|FG004|Period 1|failed to return|1
4506856|NCT00895895|7314924|FG000|Period 1|investigator request|0
4506857|NCT00895895|7314925|FG001|Period 1|investigator request|1
4506858|NCT00895895|7314926|FG002|Period 1|investigator request|0
4506859|NCT00895895|7314927|FG003|Period 1|investigator request|0
4506860|NCT00895895|7314928|FG004|Period 1|investigator request|0
4506861|NCT00895895|7314924|FG000|Period 1|Lost to Follow-up|2
4506862|NCT00895895|7314925|FG001|Period 1|Lost to Follow-up|1
4506863|NCT00895895|7314926|FG002|Period 1|Lost to Follow-up|3
4704920|NCT02758301|7624137|FG001|Overall Study|Lost to Follow-up|0
4704921|NCT02758301|7624136|FG000|Overall Study|Protocol Violation|0
4704922|NCT02758301|7624137|FG001|Overall Study|Protocol Violation|1
4704923|NCT02758613|7624147|FG000|Treatment|Physician and Sponsor Decision|1
4704924|NCT02758613|7624148|FG001|Treatment|Physician and Sponsor Decision|0
4704925|NCT02758613|7624149|FG002|Treatment|Physician and Sponsor Decision|0
4704926|NCT02758613|7624150|FG003|Treatment|Physician and Sponsor Decision|0
4704927|NCT02758613|7624147|FG000|Treatment|Withdrawal by Subject|1
4506864|NCT00895895|7314927|FG003|Period 1|Lost to Follow-up|2
4506865|NCT00895895|7314928|FG004|Period 1|Lost to Follow-up|3
4506866|NCT00895895|7314924|FG000|Period 1|Other|1
4506867|NCT00895895|7314925|FG001|Period 1|Other|2
4506868|NCT00895895|7314926|FG002|Period 1|Other|1
4506869|NCT00895895|7314927|FG003|Period 1|Other|1
4506870|NCT00895895|7314928|FG004|Period 1|Other|1
4506871|NCT00895895|7314924|FG000|Period 1|Protocol Violation|0
4506872|NCT00895895|7314925|FG001|Period 1|Protocol Violation|1
4506873|NCT00895895|7314926|FG002|Period 1|Protocol Violation|0
4506874|NCT00895895|7314927|FG003|Period 1|Protocol Violation|0
4506875|NCT00895895|7314928|FG004|Period 1|Protocol Violation|0
4506876|NCT00895895|7314924|FG000|Period 1|Withdrawal by Subject|6
4506877|NCT00895895|7314925|FG001|Period 1|Withdrawal by Subject|6
4506878|NCT00895895|7314926|FG002|Period 1|Withdrawal by Subject|8
4506879|NCT00895895|7314927|FG003|Period 1|Withdrawal by Subject|2
4506880|NCT00895895|7314928|FG004|Period 1|Withdrawal by Subject|4
4506881|NCT00895895|7314924|FG000|Period 1|unsatisfactory response-efficacy|2
4506882|NCT00895895|7314925|FG001|Period 1|unsatisfactory response-efficacy|0
4506883|NCT00895895|7314926|FG002|Period 1|unsatisfactory response-efficacy|0
4506884|NCT00895895|7314927|FG003|Period 1|unsatisfactory response-efficacy|0
4506885|NCT00895895|7314928|FG004|Period 1|unsatisfactory response-efficacy|0
4506886|NCT00895895|7314924|FG000|Period 1|randomized and not treated|1
4506887|NCT00895895|7314925|FG001|Period 1|randomized and not treated|3
4506888|NCT00895895|7314926|FG002|Period 1|randomized and not treated|1
4506889|NCT00895895|7314927|FG003|Period 1|randomized and not treated|1
4506890|NCT00895895|7314928|FG004|Period 1|randomized and not treated|2
4506891|NCT00895895|7314924|FG000|After Period 1, Prior to Period 2|Adverse Event|0
4506892|NCT00895895|7314925|FG001|After Period 1, Prior to Period 2|Adverse Event|0
4506893|NCT00895895|7314926|FG002|After Period 1, Prior to Period 2|Adverse Event|1
4506894|NCT00895895|7314927|FG003|After Period 1, Prior to Period 2|Adverse Event|0
4506895|NCT00895895|7314928|FG004|After Period 1, Prior to Period 2|Adverse Event|0
4506896|NCT00895895|7314924|FG000|After Period 1, Prior to Period 2|Other|0
4506897|NCT00895895|7314925|FG001|After Period 1, Prior to Period 2|Other|0
4506898|NCT00895895|7314926|FG002|After Period 1, Prior to Period 2|Other|1
4506899|NCT00895895|7314927|FG003|After Period 1, Prior to Period 2|Other|0
4506900|NCT00895895|7314928|FG004|After Period 1, Prior to Period 2|Other|0
4506901|NCT00895895|7314924|FG000|After Period 1, Prior to Period 2|Protocol Violation|0
4506902|NCT00895895|7314925|FG001|After Period 1, Prior to Period 2|Protocol Violation|0
4704928|NCT02758613|7624148|FG001|Treatment|Withdrawal by Subject|0
4704929|NCT02758613|7624149|FG002|Treatment|Withdrawal by Subject|1
4506903|NCT00895895|7314926|FG002|After Period 1, Prior to Period 2|Protocol Violation|0
4506904|NCT00895895|7314927|FG003|After Period 1, Prior to Period 2|Protocol Violation|0
4506905|NCT00895895|7314928|FG004|After Period 1, Prior to Period 2|Protocol Violation|1
4704930|NCT02758613|7624150|FG003|Treatment|Withdrawal by Subject|0
4506906|NCT00895895|7314924|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0
4506907|NCT00895895|7314925|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0
4506908|NCT00895895|7314926|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0
4506909|NCT00895895|7314927|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0
4506910|NCT00895895|7314928|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1
4506911|NCT00895895|7314924|FG000|Period 2|Adverse Event|3
4506912|NCT00895895|7314925|FG001|Period 2|Adverse Event|3
4506913|NCT00895895|7314926|FG002|Period 2|Adverse Event|5
4506914|NCT00895895|7314927|FG003|Period 2|Adverse Event|2
4506915|NCT00895895|7314928|FG004|Period 2|Adverse Event|5
4506916|NCT00895895|7314924|FG000|Period 2|Death|0
4506917|NCT00895895|7314925|FG001|Period 2|Death|0
4506918|NCT00895895|7314926|FG002|Period 2|Death|1
4506919|NCT00895895|7314927|FG003|Period 2|Death|0
4506920|NCT00895895|7314928|FG004|Period 2|Death|0
4506921|NCT00895895|7314924|FG000|Period 2|discontinued by sponsor|44
4506922|NCT00895895|7314925|FG001|Period 2|discontinued by sponsor|44
4506923|NCT00895895|7314926|FG002|Period 2|discontinued by sponsor|38
4506924|NCT00895895|7314927|FG003|Period 2|discontinued by sponsor|46
4506925|NCT00895895|7314928|FG004|Period 2|discontinued by sponsor|37
4506926|NCT00895895|7314924|FG000|Period 2|failed to return|2
4506927|NCT00895895|7314925|FG001|Period 2|failed to return|0
4506928|NCT00895895|7314926|FG002|Period 2|failed to return|0
4506929|NCT00895895|7314927|FG003|Period 2|failed to return|0
4506930|NCT00895895|7314928|FG004|Period 2|failed to return|0
4506931|NCT00895895|7314924|FG000|Period 2|investigator request|2
4627763|NCT01855399|7494631|FG001|6 Month|Withdrawal by Subject|6
4627764|NCT01855399|7494630|FG000|12 Month|Lost to Follow-up|7
4627765|NCT01855399|7494631|FG001|12 Month|Lost to Follow-up|11
4627766|NCT01855412|7494640|FG000|Overall Study|Death|77
4627767|NCT01855412|7494641|FG001|Overall Study|Death|123
4627768|NCT01855412|7494642|FG002|Overall Study|Death|30
4627769|NCT01855412|7494640|FG000|Overall Study|Lost to Follow-up|28
4627770|NCT01855412|7494641|FG001|Overall Study|Lost to Follow-up|46
4506932|NCT00895895|7314925|FG001|Period 2|investigator request|0
4506933|NCT00895895|7314926|FG002|Period 2|investigator request|0
4627771|NCT01855412|7494642|FG002|Overall Study|Lost to Follow-up|15
4627772|NCT01855412|7494640|FG000|Overall Study|Withdrawal by Subject|77
4627773|NCT01855412|7494641|FG001|Overall Study|Withdrawal by Subject|123
4627774|NCT01855412|7494642|FG002|Overall Study|Withdrawal by Subject|24
4627775|NCT01855412|7494640|FG000|Overall Study|Physician Decision|25
4627776|NCT01855412|7494641|FG001|Overall Study|Physician Decision|31
4627777|NCT01855412|7494642|FG002|Overall Study|Physician Decision|3
4627778|NCT01855412|7494640|FG000|Overall Study|Site Closure|4
4627779|NCT01855412|7494641|FG001|Overall Study|Site Closure|18
4704931|NCT02759016|7624174|FG000|Overall Study|Not treated with BI 836826|1
4506934|NCT00895895|7314927|FG003|Period 2|investigator request|0
4506935|NCT00895895|7314928|FG004|Period 2|investigator request|0
4506936|NCT00895895|7314924|FG000|Period 2|Lost to Follow-up|1
4506937|NCT00895895|7314925|FG001|Period 2|Lost to Follow-up|2
4506938|NCT00895895|7314926|FG002|Period 2|Lost to Follow-up|1
4506939|NCT00895895|7314927|FG003|Period 2|Lost to Follow-up|1
4506940|NCT00895895|7314928|FG004|Period 2|Lost to Follow-up|0
4506941|NCT00895895|7314924|FG000|Period 2|Other|1
4506942|NCT00895895|7314925|FG001|Period 2|Other|1
4506943|NCT00895895|7314926|FG002|Period 2|Other|3
4506944|NCT00895895|7314927|FG003|Period 2|Other|1
4506945|NCT00895895|7314928|FG004|Period 2|Other|1
4506946|NCT00895895|7314924|FG000|Period 2|Protocol Violation|1
4506947|NCT00895895|7314925|FG001|Period 2|Protocol Violation|0
4506948|NCT00895895|7314926|FG002|Period 2|Protocol Violation|1
4506949|NCT00895895|7314927|FG003|Period 2|Protocol Violation|1
4506950|NCT00895895|7314928|FG004|Period 2|Protocol Violation|1
4506951|NCT00895895|7314924|FG000|Period 2|Withdrawal by Subject|0
4506952|NCT00895895|7314925|FG001|Period 2|Withdrawal by Subject|2
4506953|NCT00895895|7314926|FG002|Period 2|Withdrawal by Subject|0
4506954|NCT00895895|7314927|FG003|Period 2|Withdrawal by Subject|3
4506955|NCT00895895|7314928|FG004|Period 2|Withdrawal by Subject|5
4506956|NCT00895895|7314924|FG000|Period 2|unsatisfactory response-efficacy|2
4506957|NCT00895895|7314925|FG001|Period 2|unsatisfactory response-efficacy|1
4506958|NCT00895895|7314926|FG002|Period 2|unsatisfactory response-efficacy|0
4506959|NCT00895895|7314927|FG003|Period 2|unsatisfactory response-efficacy|0
4627780|NCT01855412|7494642|FG002|Overall Study|Site Closure|1
4704932|NCT02759016|7624175|FG001|Overall Study|Not treated with BI 836826|0
4704933|NCT02759016|7624174|FG000|Overall Study|Progressive disease|1
4704934|NCT02759016|7624175|FG001|Overall Study|Progressive disease|0
4704935|NCT02759016|7624174|FG000|Overall Study|SD, PR-MRDpos or PR-L|0
4704936|NCT02759016|7624175|FG001|Overall Study|SD, PR-MRDpos or PR-L|2
4704937|NCT02759016|7624174|FG000|Overall Study|Other not defined above|2
4387305|NCT00048048|7165935|FG010|Extension Year 1|Early withdrawals|2
4506960|NCT00895895|7314928|FG004|Period 2|unsatisfactory response-efficacy|0
4506961|NCT00895947|7314973|FG000|Overall Study|Adverse Event|3
4506962|NCT00895947|7314974|FG001|Overall Study|Adverse Event|4
4506963|NCT00895947|7314973|FG000|Overall Study|Lost to Follow-up|3
4506964|NCT00895947|7314974|FG001|Overall Study|Lost to Follow-up|4
4506965|NCT00895947|7314973|FG000|Overall Study|Protocol Violation|4
4506966|NCT00895947|7314974|FG001|Overall Study|Protocol Violation|2
4627781|NCT01855412|7494640|FG000|Overall Study|Reason not Specified|1
4506967|NCT00895947|7314973|FG000|Overall Study|Withdrawal by Subject|2
4506968|NCT00895947|7314974|FG001|Overall Study|Withdrawal by Subject|0
4506969|NCT00896051|7315000|FG000|Overall Study|Adverse Event|2
4506970|NCT00896051|7315001|FG001|Overall Study|Adverse Event|1
4506971|NCT00896051|7315000|FG000|Overall Study|Lost to Follow-up|3
4506972|NCT00896051|7315001|FG001|Overall Study|Lost to Follow-up|2
4506973|NCT00896051|7315000|FG000|Overall Study|Withdrawal by Subject|3
4506974|NCT00896051|7315001|FG001|Overall Study|Withdrawal by Subject|2
4506975|NCT00896051|7315000|FG000|Overall Study|Subject noncompliant|1
4506976|NCT00896051|7315001|FG001|Overall Study|Subject noncompliant|3
4506977|NCT00896051|7315000|FG000|Overall Study|Other|1
4506978|NCT00896051|7315001|FG001|Overall Study|Other|1
4506979|NCT00896168|7315027|FG000|Overall Study|Adverse Event|4
4506980|NCT00896168|7315028|FG001|Overall Study|Adverse Event|7
4506981|NCT00896168|7315027|FG000|Overall Study|Treatment failure|8
4506982|NCT00896168|7315028|FG001|Overall Study|Treatment failure|10
4506983|NCT00896168|7315027|FG000|Overall Study|Lost to Follow-up|1
4506984|NCT00896168|7315028|FG001|Overall Study|Lost to Follow-up|1
4506985|NCT00896168|7315027|FG000|Overall Study|Other|1
4506986|NCT00896168|7315028|FG001|Overall Study|Other|1
4506987|NCT00896233|7315038|FG000|Overall Study|Claustrophobia during MRI|1
4518196|NCT00972478|7330272|FG000|Overall Study|Not start protocol treatment|1
4518197|NCT00972478|7330273|FG001|Overall Study|Not start protocol treatment|2
4518198|NCT00972504|7330280|FG000|Overall Study|Adverse Event|2
4518199|NCT00972504|7330280|FG000|Overall Study|Investigator discretion|1
4518200|NCT00972517|7330290|FG000|Overall Study|Adverse Event|0
4518201|NCT00972517|7330291|FG001|Overall Study|Adverse Event|0
4518202|NCT00972517|7330292|FG002|Overall Study|Adverse Event|0
4518203|NCT00972517|7330293|FG003|Overall Study|Adverse Event|1
4518204|NCT00972517|7330294|FG004|Overall Study|Adverse Event|0
4518205|NCT00972517|7330295|FG005|Overall Study|Adverse Event|0
4518206|NCT00972517|7330290|FG000|Overall Study|Withdrawal by Subject|0
4518207|NCT00972517|7330291|FG001|Overall Study|Withdrawal by Subject|1
4518208|NCT00972517|7330292|FG002|Overall Study|Withdrawal by Subject|0
4518209|NCT00972517|7330293|FG003|Overall Study|Withdrawal by Subject|2
4518210|NCT00972517|7330294|FG004|Overall Study|Withdrawal by Subject|1
4518211|NCT00972517|7330295|FG005|Overall Study|Withdrawal by Subject|0
4518212|NCT00972543|7330326|FG000|Overall Study|Adverse Event|1
4518213|NCT00972543|7330327|FG001|Overall Study|Adverse Event|0
4518214|NCT00972543|7330326|FG000|Overall Study|Early study termination by sponsor|4
4704938|NCT02759016|7624175|FG001|Overall Study|Other not defined above|1
4518215|NCT00972543|7330327|FG001|Overall Study|Early study termination by sponsor|1
4518216|NCT00972595|7330333|FG000|Period 1|Adverse Event|1
4518217|NCT00972595|7330334|FG001|Period 1|Adverse Event|0
4518218|NCT00972777|7330360|FG000|Overall Study|Adverse Event|3
4518219|NCT00972777|7330361|FG001|Overall Study|Adverse Event|2
4518220|NCT00972777|7330360|FG000|Overall Study|Lost to Follow-up|0
4518221|NCT00972777|7330361|FG001|Overall Study|Lost to Follow-up|4
4518222|NCT00972777|7330360|FG000|Overall Study|Withdrawal by Subject|4
4518223|NCT00972777|7330361|FG001|Overall Study|Withdrawal by Subject|5
4518224|NCT00972777|7330360|FG000|Overall Study|Physician Decision|4
4518225|NCT00972777|7330361|FG001|Overall Study|Physician Decision|0
4518226|NCT00972777|7330360|FG000|Overall Study|Protocol Violation|0
4518227|NCT00972777|7330361|FG001|Overall Study|Protocol Violation|2
4518228|NCT00972777|7330360|FG000|Overall Study|Screening Failure|2
4518229|NCT00972777|7330361|FG001|Overall Study|Screening Failure|1
4518230|NCT00972777|7330360|FG000|Overall Study|Missed visit|1
4518231|NCT00972777|7330361|FG001|Overall Study|Missed visit|0
4518232|NCT00972816|7330375|FG000|Overall Study|Adverse Event|0
4518233|NCT00972816|7330376|FG001|Overall Study|Adverse Event|0
4518234|NCT00972816|7330377|FG002|Overall Study|Adverse Event|1
4518235|NCT00972816|7330378|FG003|Overall Study|Adverse Event|0
4518236|NCT00972816|7330379|FG004|Overall Study|Adverse Event|0
4518237|NCT00972816|7330380|FG005|Overall Study|Adverse Event|0
4387306|NCT00048048|7165936|FG011|Extension Year 1|Early withdrawals|4
4387307|NCT00048048|7165925|FG000|Extension Year 2|Early withdrawals|0
4387308|NCT00048048|7165926|FG001|Extension Year 2|Early withdrawals|0
4387309|NCT00048048|7165927|FG002|Extension Year 2|Early withdrawals|0
4387310|NCT00048048|7165928|FG003|Extension Year 2|Early withdrawals|0
4387311|NCT00048048|7165929|FG004|Extension Year 2|Early withdrawals|0
4704939|NCT02759055|7624184|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927
4387312|NCT00048048|7165930|FG005|Extension Year 2|Early withdrawals|0
4387313|NCT00048048|7165931|FG006|Extension Year 2|Early withdrawals|0
4387314|NCT00048048|7165932|FG007|Extension Year 2|Early withdrawals|0
4387315|NCT00048048|7165933|FG008|Extension Year 2|Early withdrawals|0
4387316|NCT00048048|7165934|FG009|Extension Year 2|Early withdrawals|0
4387317|NCT00048048|7165935|FG010|Extension Year 2|Early withdrawals|4
4387318|NCT00048048|7165936|FG011|Extension Year 2|Early withdrawals|2
4387319|NCT00048061|7165967|FG000|Overall Study|Adverse Event|41
4518238|NCT00972816|7330381|FG006|Overall Study|Adverse Event|0
4518239|NCT00972816|7330382|FG007|Overall Study|Adverse Event|0
4518240|NCT00972816|7330375|FG000|Overall Study|Withdrawal by Subject|4
4518241|NCT00972816|7330376|FG001|Overall Study|Withdrawal by Subject|2
4518242|NCT00972816|7330377|FG002|Overall Study|Withdrawal by Subject|1
4506988|NCT00896337|7315052|FG000|Overall Study|Death|7
4506989|NCT00896337|7315052|FG000|Overall Study|Withdrawal by Subject|7
4506990|NCT00896337|7315052|FG000|Overall Study|Lost to Follow-up|11
4506991|NCT00896363|7315064|FG000|Overall Study|Adverse Event|3
4506992|NCT00896363|7315065|FG001|Overall Study|Adverse Event|4
4506993|NCT00896363|7315066|FG002|Overall Study|Adverse Event|2
4506994|NCT00896363|7315064|FG000|Overall Study|Lack of Efficacy|0
4506995|NCT00896363|7315065|FG001|Overall Study|Lack of Efficacy|2
4627782|NCT01855412|7494641|FG001|Overall Study|Reason not Specified|2
4627783|NCT01855412|7494642|FG002|Overall Study|Reason not Specified|3
4627784|NCT01855425|7494656|FG000|Overall Study|Physician Decision|20
4627785|NCT01855750|7494662|FG000|Overall Study|Death|78
4627786|NCT01855750|7494663|FG001|Overall Study|Death|78
4627787|NCT01855750|7494662|FG000|Overall Study|Lost to Follow-up|9
4627788|NCT01855750|7494663|FG001|Overall Study|Lost to Follow-up|23
4627789|NCT01855750|7494662|FG000|Overall Study|Withdrawal by Subject|35
4506996|NCT00896363|7315066|FG002|Overall Study|Lack of Efficacy|1
4506997|NCT00896363|7315064|FG000|Overall Study|Withdrawal by Subject|3
4506998|NCT00896363|7315065|FG001|Overall Study|Withdrawal by Subject|5
4506999|NCT00896363|7315066|FG002|Overall Study|Withdrawal by Subject|5
4507000|NCT00896454|7315085|FG000|Overall Study|Death|10
4507001|NCT00896454|7315085|FG000|Overall Study|Adverse Event|8
4507002|NCT00896454|7315085|FG000|Overall Study|Disease Progression|5
4507003|NCT00896454|7315085|FG000|Overall Study|Other|4
4507004|NCT00896454|7315085|FG000|Overall Study|Requirement for alternative therapy|3
4507005|NCT00896454|7315085|FG000|Overall Study|Ongoing in study|2
4507006|NCT00896454|7315085|FG000|Overall Study|Withdrawal by Subject|1
4507007|NCT00896480|7315089|FG000|Overall Study|Disease progression/recurrence|21
4507008|NCT00896532|7315104|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
4507009|NCT00896532|7315105|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
4507010|NCT00896532|7315106|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
4507011|NCT00896532|7315107|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1
4507012|NCT00896532|7315108|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
4507013|NCT00896532|7315109|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1
4507014|NCT00896532|7315110|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
4507015|NCT00896532|7315111|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
4507016|NCT00896532|7315112|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
4507017|NCT00896532|7315113|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
4507018|NCT00896532|7315114|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
4507019|NCT00896532|7315115|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
4507020|NCT00896532|7315116|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
4507021|NCT00896532|7315117|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
4507022|NCT00896532|7315118|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
4507023|NCT00896532|7315119|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
4507024|NCT00896532|7315120|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
4507025|NCT00896532|7315121|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
4507026|NCT00896532|7315122|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
4507027|NCT00896532|7315123|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
4507028|NCT00896532|7315124|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
4507029|NCT00896532|7315125|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
4507030|NCT00896532|7315126|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
4507031|NCT00896532|7315104|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
4507032|NCT00896532|7315105|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2
4507033|NCT00896532|7315106|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
4507034|NCT00896532|7315107|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2
4507035|NCT00896532|7315108|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
4507036|NCT00896532|7315109|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
4507037|NCT00896532|7315110|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
4507038|NCT00896532|7315111|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
4507039|NCT00896532|7315112|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
4507040|NCT00896532|7315113|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
4507041|NCT00896532|7315114|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
4507042|NCT00896532|7315115|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
4507043|NCT00896532|7315116|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
4507044|NCT00896532|7315117|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
4507045|NCT00896532|7315118|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
4507046|NCT00896532|7315119|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
4507047|NCT00896532|7315120|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
4507048|NCT00896532|7315121|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
4507049|NCT00896532|7315122|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
4507050|NCT00896532|7315123|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
4507051|NCT00896532|7315124|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
4518243|NCT00972816|7330378|FG003|Overall Study|Withdrawal by Subject|3
4507052|NCT00896532|7315125|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
4507053|NCT00896532|7315126|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
4507054|NCT00896532|7315104|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
4507055|NCT00896532|7315105|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3
4507056|NCT00896532|7315106|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
4507057|NCT00896532|7315107|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6
4507058|NCT00896532|7315108|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5
4507059|NCT00896532|7315109|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6
4507060|NCT00896532|7315110|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
4507061|NCT00896532|7315111|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
4507062|NCT00896532|7315112|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
4507063|NCT00896532|7315113|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
4507064|NCT00896532|7315114|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
4507065|NCT00896532|7315115|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
4507066|NCT00896532|7315116|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
4507067|NCT00896532|7315117|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
4507068|NCT00896532|7315118|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
4507069|NCT00896532|7315119|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
4507070|NCT00896532|7315120|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
4507071|NCT00896532|7315121|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
4507072|NCT00896532|7315122|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
4507073|NCT00896532|7315123|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
4507074|NCT00896532|7315124|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
4507075|NCT00896532|7315125|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
4507076|NCT00896532|7315126|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
4507077|NCT00896532|7315104|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
4507078|NCT00896532|7315105|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
4507079|NCT00896532|7315106|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2
4507080|NCT00896532|7315107|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
4507081|NCT00896532|7315108|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1
4507082|NCT00896532|7315109|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
4507083|NCT00896532|7315110|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
4507084|NCT00896532|7315111|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
4507085|NCT00896532|7315112|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
4507086|NCT00896532|7315113|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
4507087|NCT00896532|7315114|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
4507088|NCT00896532|7315115|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
4507089|NCT00896532|7315116|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
4507090|NCT00896532|7315117|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
4507091|NCT00896532|7315118|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
4507092|NCT00896532|7315119|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
4507093|NCT00896532|7315120|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
4507094|NCT00896532|7315121|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
4507095|NCT00896532|7315122|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
4507096|NCT00896532|7315123|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
4507097|NCT00896532|7315124|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
4507098|NCT00896532|7315125|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
4507099|NCT00896532|7315126|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
4507100|NCT00896532|7315104|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1
4507101|NCT00896532|7315105|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0
4507102|NCT00896532|7315106|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0
4507103|NCT00896532|7315107|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1
4507104|NCT00896532|7315108|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0
4507105|NCT00896532|7315109|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0
4507106|NCT00896532|7315110|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0
4507107|NCT00896532|7315111|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0
4507108|NCT00896532|7315112|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0
4507109|NCT00896532|7315113|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0
4507110|NCT00896532|7315114|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0
4507111|NCT00896532|7315115|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0
4507112|NCT00896532|7315116|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0
4507113|NCT00896532|7315117|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0
4507114|NCT00896532|7315118|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0
4507115|NCT00896532|7315119|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0
4507116|NCT00896532|7315120|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0
4507117|NCT00896532|7315121|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0
4507118|NCT00896532|7315122|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0
4507119|NCT00896532|7315123|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0
4507120|NCT00896532|7315124|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0
4507121|NCT00896532|7315125|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0
4507122|NCT00896532|7315126|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0
4507123|NCT00896532|7315104|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
4507124|NCT00896532|7315105|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
4507125|NCT00896532|7315106|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1
4507126|NCT00896532|7315107|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
4507127|NCT00896532|7315108|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
4507128|NCT00896532|7315109|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
4507129|NCT00896532|7315110|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
4507130|NCT00896532|7315111|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
4507131|NCT00896532|7315112|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
4507132|NCT00896532|7315113|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
4507133|NCT00896532|7315114|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
4507134|NCT00896532|7315115|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
4507135|NCT00896532|7315116|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
4507136|NCT00896532|7315117|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
4507137|NCT00896532|7315118|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
4507138|NCT00896532|7315119|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
4507139|NCT00896532|7315120|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
4507140|NCT00896532|7315121|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
4507141|NCT00896532|7315122|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
4507142|NCT00896532|7315123|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
4507143|NCT00896532|7315124|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
4507144|NCT00896532|7315125|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
4507145|NCT00896532|7315126|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
4507146|NCT00896532|7315104|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
4507147|NCT00896532|7315105|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
4507148|NCT00896532|7315106|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1
4507149|NCT00896532|7315107|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
4507150|NCT00896532|7315108|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
4507151|NCT00896532|7315109|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
4507152|NCT00896532|7315110|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
4507153|NCT00896532|7315111|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
4507154|NCT00896532|7315112|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
4507155|NCT00896532|7315113|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
4507156|NCT00896532|7315114|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
4507157|NCT00896532|7315115|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
4507158|NCT00896532|7315116|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
4507159|NCT00896532|7315117|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
4507160|NCT00896532|7315118|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
4507161|NCT00896532|7315119|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
4507162|NCT00896532|7315120|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
4507163|NCT00896532|7315121|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
4507164|NCT00896532|7315122|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
4507165|NCT00896532|7315123|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
4507166|NCT00896532|7315124|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
4507167|NCT00896532|7315125|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
4507168|NCT00896532|7315126|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
4507169|NCT00896532|7315104|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
4507170|NCT00896532|7315105|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
4507171|NCT00896532|7315106|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
4507172|NCT00896532|7315107|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1
4507173|NCT00896532|7315108|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
4507174|NCT00896532|7315109|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
4507175|NCT00896532|7315110|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
4507176|NCT00896532|7315111|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
4507177|NCT00896532|7315112|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
4507178|NCT00896532|7315113|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
4507179|NCT00896532|7315114|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
4507180|NCT00896532|7315115|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
4507181|NCT00896532|7315116|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
4507182|NCT00896532|7315117|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
4507183|NCT00896532|7315118|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
4507184|NCT00896532|7315119|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
4518244|NCT00972816|7330379|FG004|Overall Study|Withdrawal by Subject|0
4507185|NCT00896532|7315120|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
4507186|NCT00896532|7315121|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
4507187|NCT00896532|7315122|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
4507188|NCT00896532|7315123|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
4507189|NCT00896532|7315124|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
4507190|NCT00896532|7315125|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
4507191|NCT00896532|7315126|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
4507192|NCT00896532|7315104|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0
4507193|NCT00896532|7315105|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1
4507194|NCT00896532|7315106|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0
4507195|NCT00896532|7315107|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1
4507196|NCT00896532|7315108|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1
4507197|NCT00896532|7315109|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0
4507198|NCT00896532|7315110|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0
4507199|NCT00896532|7315111|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0
4507200|NCT00896532|7315112|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0
4507201|NCT00896532|7315113|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0
4507202|NCT00896532|7315114|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0
4507203|NCT00896532|7315115|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0
4507204|NCT00896532|7315116|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0
4507205|NCT00896532|7315117|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0
4507206|NCT00896532|7315118|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0
4507207|NCT00896532|7315119|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0
4507208|NCT00896532|7315120|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0
4507209|NCT00896532|7315121|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0
4507210|NCT00896532|7315122|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0
4507211|NCT00896532|7315123|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0
4507212|NCT00896532|7315124|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0
4507213|NCT00896532|7315125|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0
4507214|NCT00896532|7315126|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0
4507215|NCT00896532|7315104|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
4507216|NCT00896532|7315105|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
4507217|NCT00896532|7315106|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
4507218|NCT00896532|7315107|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
4507219|NCT00896532|7315108|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
4507220|NCT00896532|7315109|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
4507221|NCT00896532|7315110|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
4507222|NCT00896532|7315111|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
4507223|NCT00896532|7315112|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1
4507224|NCT00896532|7315113|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
4507225|NCT00896532|7315114|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
4507226|NCT00896532|7315115|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
4507227|NCT00896532|7315116|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
4507228|NCT00896532|7315117|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
4507229|NCT00896532|7315118|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
4507230|NCT00896532|7315119|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
4507231|NCT00896532|7315120|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
4507232|NCT00896532|7315121|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
4507233|NCT00896532|7315122|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
4507234|NCT00896532|7315123|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
4507235|NCT00896532|7315124|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
4507236|NCT00896532|7315125|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
4507237|NCT00896532|7315126|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
4507238|NCT00896532|7315104|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0
4507239|NCT00896532|7315105|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0
4507240|NCT00896532|7315106|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0
4507241|NCT00896532|7315107|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0
4507242|NCT00896532|7315108|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0
4507243|NCT00896532|7315109|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0
4507244|NCT00896532|7315110|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0
4507245|NCT00896532|7315111|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0
4507246|NCT00896532|7315112|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0
4507247|NCT00896532|7315113|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0
4507248|NCT00896532|7315114|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0
4507249|NCT00896532|7315115|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0
4507250|NCT00896532|7315116|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1
4507251|NCT00896532|7315117|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0
4507252|NCT00896532|7315118|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0
4507253|NCT00896532|7315119|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0
4507254|NCT00896532|7315120|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0
4507255|NCT00896532|7315121|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0
4507256|NCT00896532|7315122|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0
4507257|NCT00896532|7315123|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0
4507258|NCT00896532|7315124|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0
4507259|NCT00896532|7315125|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0
4507260|NCT00896532|7315126|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0
4507261|NCT00896532|7315104|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0
4507262|NCT00896532|7315105|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0
4507263|NCT00896532|7315106|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0
4507264|NCT00896532|7315107|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0
4507265|NCT00896532|7315108|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0
4507266|NCT00896532|7315109|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0
4507267|NCT00896532|7315110|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0
4507268|NCT00896532|7315111|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0
4507269|NCT00896532|7315112|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0
4507270|NCT00896532|7315113|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0
4507271|NCT00896532|7315114|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1
4507272|NCT00896532|7315115|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0
4507273|NCT00896532|7315116|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1
4507274|NCT00896532|7315117|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0
4507275|NCT00896532|7315118|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0
4507276|NCT00896532|7315119|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0
4507277|NCT00896532|7315120|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0
4507278|NCT00896532|7315121|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0
4507279|NCT00896532|7315122|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0
4507280|NCT00896532|7315123|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0
4507281|NCT00896532|7315124|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0
4507282|NCT00896532|7315125|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0
4507283|NCT00896532|7315126|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0
4507284|NCT00896532|7315104|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
4507285|NCT00896532|7315105|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
4507286|NCT00896532|7315106|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
4507287|NCT00896532|7315107|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
4507288|NCT00896532|7315108|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
4507289|NCT00896532|7315109|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
4507290|NCT00896532|7315110|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
4507291|NCT00896532|7315111|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
4507292|NCT00896532|7315112|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
4507293|NCT00896532|7315113|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
4507294|NCT00896532|7315114|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
4507295|NCT00896532|7315115|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
4507296|NCT00896532|7315116|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1
4507297|NCT00896532|7315117|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1
4507298|NCT00896532|7315118|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
4507299|NCT00896532|7315119|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
4507300|NCT00896532|7315120|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
4507301|NCT00896532|7315121|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
4507302|NCT00896532|7315122|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
4507303|NCT00896532|7315123|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
4507304|NCT00896532|7315124|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
4507305|NCT00896532|7315125|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
4507306|NCT00896532|7315126|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
4507307|NCT00896532|7315104|FG000|Months 24-36: Denosumab Extension Phase|Other|0
4507308|NCT00896532|7315105|FG001|Months 24-36: Denosumab Extension Phase|Other|0
4507309|NCT00896532|7315106|FG002|Months 24-36: Denosumab Extension Phase|Other|0
4507310|NCT00896532|7315107|FG003|Months 24-36: Denosumab Extension Phase|Other|0
4507311|NCT00896532|7315108|FG004|Months 24-36: Denosumab Extension Phase|Other|0
4507312|NCT00896532|7315109|FG005|Months 24-36: Denosumab Extension Phase|Other|0
4507313|NCT00896532|7315110|FG006|Months 24-36: Denosumab Extension Phase|Other|0
4507314|NCT00896532|7315111|FG007|Months 24-36: Denosumab Extension Phase|Other|0
4507315|NCT00896532|7315112|FG008|Months 24-36: Denosumab Extension Phase|Other|0
4507316|NCT00896532|7315113|FG009|Months 24-36: Denosumab Extension Phase|Other|0
4507317|NCT00896532|7315114|FG010|Months 24-36: Denosumab Extension Phase|Other|1
4507318|NCT00896532|7315115|FG011|Months 24-36: Denosumab Extension Phase|Other|2
4507319|NCT00896532|7315116|FG012|Months 24-36: Denosumab Extension Phase|Other|2
4507320|NCT00896532|7315117|FG013|Months 24-36: Denosumab Extension Phase|Other|1
4507321|NCT00896532|7315118|FG014|Months 24-36: Denosumab Extension Phase|Other|0
4507322|NCT00896532|7315119|FG015|Months 24-36: Denosumab Extension Phase|Other|0
4507323|NCT00896532|7315120|FG016|Months 24-36: Denosumab Extension Phase|Other|0
4507324|NCT00896532|7315121|FG017|Months 24-36: Denosumab Extension Phase|Other|0
4507325|NCT00896532|7315122|FG018|Months 24-36: Denosumab Extension Phase|Other|0
4507326|NCT00896532|7315123|FG019|Months 24-36: Denosumab Extension Phase|Other|0
4507327|NCT00896532|7315124|FG020|Months 24-36: Denosumab Extension Phase|Other|0
4507328|NCT00896532|7315125|FG021|Months 24-36: Denosumab Extension Phase|Other|0
4507329|NCT00896532|7315126|FG022|Months 24-36: Denosumab Extension Phase|Other|0
4507330|NCT00896532|7315104|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0
4507331|NCT00896532|7315105|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0
4507332|NCT00896532|7315106|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0
4507333|NCT00896532|7315107|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0
4507334|NCT00896532|7315108|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0
4507335|NCT00896532|7315109|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0
4507336|NCT00896532|7315110|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0
4507337|NCT00896532|7315111|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0
4507338|NCT00896532|7315112|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0
4507339|NCT00896532|7315113|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0
4507340|NCT00896532|7315114|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0
4507341|NCT00896532|7315115|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0
4507342|NCT00896532|7315116|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0
4507343|NCT00896532|7315117|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0
4507344|NCT00896532|7315118|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0
4507345|NCT00896532|7315119|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1
4507346|NCT00896532|7315120|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3
4507347|NCT00896532|7315121|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0
4507348|NCT00896532|7315122|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0
4507349|NCT00896532|7315123|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0
4507350|NCT00896532|7315124|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0
4507351|NCT00896532|7315125|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0
4507352|NCT00896532|7315126|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0
4507353|NCT00896532|7315104|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
4507354|NCT00896532|7315105|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
4507355|NCT00896532|7315106|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
4507356|NCT00896532|7315107|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
4507357|NCT00896532|7315108|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
4507358|NCT00896532|7315109|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
4507359|NCT00896532|7315110|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
4507360|NCT00896532|7315111|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
4507361|NCT00896532|7315112|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
4507362|NCT00896532|7315113|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
4507363|NCT00896532|7315114|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
4507364|NCT00896532|7315115|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
4507365|NCT00896532|7315116|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
4507366|NCT00896532|7315117|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
4507367|NCT00896532|7315118|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
4507368|NCT00896532|7315119|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1
4507369|NCT00896532|7315120|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2
4507370|NCT00896532|7315121|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2
4507371|NCT00896532|7315122|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
4507372|NCT00896532|7315123|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
4507373|NCT00896532|7315124|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
4507374|NCT00896532|7315125|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
4507375|NCT00896532|7315126|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
4507376|NCT00896532|7315104|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
4507377|NCT00896532|7315105|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
4507378|NCT00896532|7315106|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
4507379|NCT00896532|7315107|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
4507380|NCT00896532|7315108|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
4507381|NCT00896532|7315109|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
4590319|NCT01519947|7436142|FG003|Overall Study|Peritoneal Dialysis Needed|0
4704940|NCT02759055|7624185|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508
4704941|NCT02759120|7624193|FG000|Overall Study|Death|34
4704942|NCT02759120|7624194|FG001|Overall Study|Death|36
4704943|NCT02759120|7624193|FG000|Overall Study|Lost to Follow-up|4
4704944|NCT02759120|7624194|FG001|Overall Study|Lost to Follow-up|7
4704945|NCT02759120|7624193|FG000|Overall Study|Physician Decision|3
4704946|NCT02759120|7624194|FG001|Overall Study|Physician Decision|0
4704947|NCT02759120|7624193|FG000|Overall Study|Withdrawal by Subject|28
4387320|NCT00048061|7165968|FG001|Overall Study|Adverse Event|32
4507382|NCT00896532|7315110|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
4507383|NCT00896532|7315111|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
4507384|NCT00896532|7315112|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
4507385|NCT00896532|7315113|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
4507386|NCT00896532|7315114|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
4507387|NCT00896532|7315115|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
4507388|NCT00896532|7315116|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
4507389|NCT00896532|7315117|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
4507390|NCT00896532|7315118|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
4507391|NCT00896532|7315119|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
4507392|NCT00896532|7315120|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1
4507393|NCT00896532|7315121|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
4507394|NCT00896532|7315122|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
4507395|NCT00896532|7315123|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
4507396|NCT00896532|7315124|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
4507397|NCT00896532|7315125|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
4507398|NCT00896532|7315126|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
4507399|NCT00896532|7315104|FG000|Months 36-48: Romosozumab Retreatment|Other|0
4507400|NCT00896532|7315105|FG001|Months 36-48: Romosozumab Retreatment|Other|0
4507401|NCT00896532|7315106|FG002|Months 36-48: Romosozumab Retreatment|Other|0
4507402|NCT00896532|7315107|FG003|Months 36-48: Romosozumab Retreatment|Other|0
4507403|NCT00896532|7315108|FG004|Months 36-48: Romosozumab Retreatment|Other|0
4507404|NCT00896532|7315109|FG005|Months 36-48: Romosozumab Retreatment|Other|0
4507405|NCT00896532|7315110|FG006|Months 36-48: Romosozumab Retreatment|Other|0
4507406|NCT00896532|7315111|FG007|Months 36-48: Romosozumab Retreatment|Other|0
4507407|NCT00896532|7315112|FG008|Months 36-48: Romosozumab Retreatment|Other|0
4507408|NCT00896532|7315113|FG009|Months 36-48: Romosozumab Retreatment|Other|0
4507409|NCT00896532|7315114|FG010|Months 36-48: Romosozumab Retreatment|Other|0
4507410|NCT00896532|7315115|FG011|Months 36-48: Romosozumab Retreatment|Other|0
4507411|NCT00896532|7315116|FG012|Months 36-48: Romosozumab Retreatment|Other|0
4507412|NCT00896532|7315117|FG013|Months 36-48: Romosozumab Retreatment|Other|0
4507413|NCT00896532|7315118|FG014|Months 36-48: Romosozumab Retreatment|Other|0
4507414|NCT00896532|7315119|FG015|Months 36-48: Romosozumab Retreatment|Other|0
4507415|NCT00896532|7315120|FG016|Months 36-48: Romosozumab Retreatment|Other|0
4507416|NCT00896532|7315121|FG017|Months 36-48: Romosozumab Retreatment|Other|1
4507417|NCT00896532|7315122|FG018|Months 36-48: Romosozumab Retreatment|Other|0
4507418|NCT00896532|7315123|FG019|Months 36-48: Romosozumab Retreatment|Other|0
4507419|NCT00896532|7315124|FG020|Months 36-48: Romosozumab Retreatment|Other|0
4507420|NCT00896532|7315125|FG021|Months 36-48: Romosozumab Retreatment|Other|0
4507421|NCT00896532|7315126|FG022|Months 36-48: Romosozumab Retreatment|Other|0
4507422|NCT00896532|7315104|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
4507423|NCT00896532|7315105|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
4507424|NCT00896532|7315106|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
4507425|NCT00896532|7315107|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
4518245|NCT00972816|7330380|FG005|Overall Study|Withdrawal by Subject|1
4704948|NCT02759120|7624194|FG001|Overall Study|Withdrawal by Subject|15
4704949|NCT02759120|7624193|FG000|Overall Study|Moved out of area|3
4704950|NCT02759120|7624194|FG001|Overall Study|Moved out of area|4
4704951|NCT02759120|7624193|FG000|Overall Study|Lung transplant|3
4704952|NCT02759120|7624194|FG001|Overall Study|Lung transplant|5
4704953|NCT02759120|7624193|FG000|Overall Study|Other reason not completed|10
4704954|NCT02759120|7624194|FG001|Overall Study|Other reason not completed|12
4704955|NCT02759315|7624233|FG000|Overall Study|Adverse Event|0
4387321|NCT00048061|7165969|FG002|Overall Study|Adverse Event|44
4387322|NCT00048061|7165970|FG003|Overall Study|Adverse Event|37
4387323|NCT00048061|7165967|FG000|Overall Study|Lost to Follow-up|3
4387324|NCT00048061|7165968|FG001|Overall Study|Lost to Follow-up|2
4387325|NCT00048061|7165969|FG002|Overall Study|Lost to Follow-up|4
4387326|NCT00048061|7165970|FG003|Overall Study|Lost to Follow-up|5
4387327|NCT00048061|7165967|FG000|Overall Study|Withdrawal by Subject|20
4387328|NCT00048061|7165968|FG001|Overall Study|Withdrawal by Subject|29
4387329|NCT00048061|7165969|FG002|Overall Study|Withdrawal by Subject|29
4387330|NCT00048061|7165970|FG003|Overall Study|Withdrawal by Subject|32
4387331|NCT00048061|7165967|FG000|Overall Study|Did not follow-up|5
4387332|NCT00048061|7165968|FG001|Overall Study|Did not follow-up|5
4387333|NCT00048061|7165969|FG002|Overall Study|Did not follow-up|4
4387334|NCT00048061|7165970|FG003|Overall Study|Did not follow-up|5
4387335|NCT00048061|7165967|FG000|Overall Study|Early improvement|6
4387336|NCT00048061|7165968|FG001|Overall Study|Early improvement|5
4387337|NCT00048061|7165969|FG002|Overall Study|Early improvement|3
4387338|NCT00048061|7165970|FG003|Overall Study|Early improvement|0
4387339|NCT00048074|7165983|FG000|Overall Study|Adverse Event|46
4387340|NCT00048074|7165984|FG001|Overall Study|Adverse Event|41
4387341|NCT00048074|7165985|FG002|Overall Study|Adverse Event|53
4387342|NCT00048074|7165983|FG000|Overall Study|Death|3
4387343|NCT00048074|7165984|FG001|Overall Study|Death|3
4387344|NCT00048074|7165985|FG002|Overall Study|Death|2
4507426|NCT00896532|7315108|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
4507427|NCT00896532|7315109|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
4507428|NCT00896532|7315110|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
4507429|NCT00896532|7315111|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
4507430|NCT00896532|7315112|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
4507431|NCT00896532|7315113|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
4507432|NCT00896532|7315114|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
4507433|NCT00896532|7315115|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
4507434|NCT00896532|7315116|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
4507435|NCT00896532|7315117|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
4507436|NCT00896532|7315118|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
4507437|NCT00896532|7315119|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
4507438|NCT00896532|7315120|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1
4507439|NCT00896532|7315121|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
4507440|NCT00896532|7315122|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
4507441|NCT00896532|7315123|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
4507442|NCT00896532|7315124|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
4507443|NCT00896532|7315125|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
4507444|NCT00896532|7315126|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
4507445|NCT00896532|7315104|FG000|Months 48-72: Follow-on Phase|Death|0
4507446|NCT00896532|7315105|FG001|Months 48-72: Follow-on Phase|Death|0
4507447|NCT00896532|7315106|FG002|Months 48-72: Follow-on Phase|Death|0
4507448|NCT00896532|7315107|FG003|Months 48-72: Follow-on Phase|Death|0
4507449|NCT00896532|7315108|FG004|Months 48-72: Follow-on Phase|Death|0
4507450|NCT00896532|7315109|FG005|Months 48-72: Follow-on Phase|Death|0
4507451|NCT00896532|7315110|FG006|Months 48-72: Follow-on Phase|Death|0
4507452|NCT00896532|7315111|FG007|Months 48-72: Follow-on Phase|Death|0
4507453|NCT00896532|7315112|FG008|Months 48-72: Follow-on Phase|Death|0
4507454|NCT00896532|7315113|FG009|Months 48-72: Follow-on Phase|Death|0
4507455|NCT00896532|7315114|FG010|Months 48-72: Follow-on Phase|Death|0
4507456|NCT00896532|7315115|FG011|Months 48-72: Follow-on Phase|Death|0
4507457|NCT00896532|7315116|FG012|Months 48-72: Follow-on Phase|Death|0
4507458|NCT00896532|7315117|FG013|Months 48-72: Follow-on Phase|Death|0
4507459|NCT00896532|7315118|FG014|Months 48-72: Follow-on Phase|Death|0
4507460|NCT00896532|7315119|FG015|Months 48-72: Follow-on Phase|Death|0
4507461|NCT00896532|7315120|FG016|Months 48-72: Follow-on Phase|Death|0
4507462|NCT00896532|7315121|FG017|Months 48-72: Follow-on Phase|Death|0
4704956|NCT02759315|7624234|FG001|Overall Study|Adverse Event|0
4704957|NCT02759315|7624235|FG002|Overall Study|Adverse Event|0
4507463|NCT00896532|7315122|FG018|Months 48-72: Follow-on Phase|Death|1
4507464|NCT00896532|7315123|FG019|Months 48-72: Follow-on Phase|Death|0
4507465|NCT00896532|7315124|FG020|Months 48-72: Follow-on Phase|Death|0
4507466|NCT00896532|7315125|FG021|Months 48-72: Follow-on Phase|Death|0
4507467|NCT00896532|7315126|FG022|Months 48-72: Follow-on Phase|Death|0
4507468|NCT00896532|7315104|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0
4507469|NCT00896532|7315105|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0
4507470|NCT00896532|7315106|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0
4507471|NCT00896532|7315107|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0
4507472|NCT00896532|7315108|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0
4507473|NCT00896532|7315109|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0
4507474|NCT00896532|7315110|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0
4507475|NCT00896532|7315111|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0
4507476|NCT00896532|7315112|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0
4507477|NCT00896532|7315113|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0
4507478|NCT00896532|7315114|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0
4507479|NCT00896532|7315115|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0
4507480|NCT00896532|7315116|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0
4507481|NCT00896532|7315117|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0
4507482|NCT00896532|7315118|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0
4507483|NCT00896532|7315119|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0
4507484|NCT00896532|7315120|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0
4507485|NCT00896532|7315121|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0
4590320|NCT01519947|7436139|FG000|Overall Study|Development of Anemia|0
4590321|NCT01519947|7436140|FG001|Overall Study|Development of Anemia|1
4590322|NCT01519947|7436141|FG002|Overall Study|Development of Anemia|0
4704958|NCT02759315|7624236|FG003|Overall Study|Adverse Event|1
4704959|NCT02759315|7624237|FG004|Overall Study|Adverse Event|0
4704960|NCT02759315|7624233|FG000|Overall Study|Death|0
4704961|NCT02759315|7624234|FG001|Overall Study|Death|0
4704962|NCT02759315|7624235|FG002|Overall Study|Death|1
4704963|NCT02759315|7624236|FG003|Overall Study|Death|0
4704964|NCT02759315|7624237|FG004|Overall Study|Death|0
4704965|NCT02759315|7624233|FG000|Overall Study|Lost to Follow-up|2
4507486|NCT00896532|7315122|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0
4507487|NCT00896532|7315123|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0
4507488|NCT00896532|7315124|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0
4507489|NCT00896532|7315125|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1
4507490|NCT00896532|7315126|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0
4507491|NCT00896532|7315104|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
4507492|NCT00896532|7315105|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
4507493|NCT00896532|7315106|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
4507494|NCT00896532|7315107|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
4507495|NCT00896532|7315108|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
4507496|NCT00896532|7315109|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
4507497|NCT00896532|7315110|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
4507498|NCT00896532|7315111|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
4507499|NCT00896532|7315112|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
4507500|NCT00896532|7315113|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
4507501|NCT00896532|7315114|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
4507502|NCT00896532|7315115|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
4507503|NCT00896532|7315116|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
4507504|NCT00896532|7315117|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
4507505|NCT00896532|7315118|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
4507506|NCT00896532|7315119|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
4507507|NCT00896532|7315120|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
4507508|NCT00896532|7315121|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
4507509|NCT00896532|7315122|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
4507510|NCT00896532|7315123|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
4507511|NCT00896532|7315124|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
4507512|NCT00896532|7315125|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1
4507513|NCT00896532|7315126|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
4507514|NCT00896649|7315173|FG000|Overall Study|Physician Decision|1
4507515|NCT00896649|7315173|FG000|Overall Study|Pregnancy|1
4507516|NCT00896649|7315173|FG000|Overall Study|missing documentation|1
4507517|NCT00896649|7315173|FG000|Overall Study|technical difficulties|2
4507518|NCT00897390|7315187|FG000|Overall Study|Adverse Event|2
4507519|NCT00897390|7315187|FG000|Overall Study|No Longer Met Study Criteria|1
4507520|NCT00897390|7315187|FG000|Overall Study|Personal Reasons|1
4507521|NCT00897390|7315187|FG000|Overall Study|Did not Return for the Clinic Visit|2
4507522|NCT00897715|7315214|FG000|Overall Study|Lost to Follow-up|0
4507523|NCT00897715|7315215|FG001|Overall Study|Lost to Follow-up|1
4507524|NCT00897715|7315214|FG000|Overall Study|Physician Decision|1
4507525|NCT00897715|7315215|FG001|Overall Study|Physician Decision|0
4507526|NCT00897715|7315214|FG000|Overall Study|increased risk of infection|1
4507527|NCT00897715|7315215|FG001|Overall Study|increased risk of infection|0
4507528|NCT00898443|7315231|FG000|Overall Study|Withdrawal by Subject|1
4507529|NCT00898443|7315232|FG001|Overall Study|Withdrawal by Subject|0
4507530|NCT00898807|7315246|FG000|Overall Study|Withdrawal by Subject|5
4507531|NCT00898807|7315247|FG001|Overall Study|Withdrawal by Subject|3
4507532|NCT00898807|7315246|FG000|Overall Study|Family pressure to discontinue|2
4507533|NCT00898807|7315247|FG001|Overall Study|Family pressure to discontinue|2
4507534|NCT00898807|7315246|FG000|Overall Study|Lost to Follow-up|1
4507535|NCT00898807|7315247|FG001|Overall Study|Lost to Follow-up|3
4507536|NCT00898807|7315246|FG000|Overall Study|Death|0
4507537|NCT00898807|7315247|FG001|Overall Study|Death|1
4507538|NCT00899353|7315266|FG000|Overall Study|Adverse Event|2
4507539|NCT00899353|7315266|FG000|Overall Study|Lost to Follow-up|1
4507540|NCT00899353|7315266|FG000|Overall Study|Withdrawal by Subject|2
4507541|NCT00899392|7315289|FG000|Overall Study|Subject didn't finish/partial pilot data|21
4507542|NCT00899392|7315290|FG001|Overall Study|Subject didn't finish/partial pilot data|24
4507543|NCT00899431|7315299|FG000|Overall Study|Physician Decision|1
4507544|NCT00899431|7315300|FG001|Overall Study|Physician Decision|0
4507545|NCT00899431|7315301|FG002|Overall Study|Physician Decision|0
4507546|NCT00899548|7315330|FG000|Overall Study|Physician Decision|3
4507547|NCT00899678|7315354|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6
4507548|NCT00899678|7315355|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0
4507549|NCT00899678|7315356|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0
4507550|NCT00899678|7315354|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17
4507551|NCT00899678|7315355|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0
4507552|NCT00899678|7315356|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0
4507553|NCT00899678|7315354|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1
4507554|NCT00899678|7315355|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0
4507555|NCT00899678|7315356|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0
4507556|NCT00899678|7315354|FG000|Induction Period (Weeks 0 to 6)|Other reason|1
4507557|NCT00899678|7315355|FG001|Induction Period (Weeks 0 to 6)|Other reason|0
4507558|NCT00899678|7315356|FG002|Induction Period (Weeks 0 to 6)|Other reason|0
4507559|NCT00899678|7315354|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0
4507560|NCT00899678|7315355|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10
4507561|NCT00899678|7315356|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5
4507562|NCT00899678|7315354|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0
4507563|NCT00899678|7315355|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11
4507564|NCT00899678|7315356|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18
4507565|NCT00899678|7315354|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0
4507566|NCT00899678|7315355|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1
4507567|NCT00899678|7315356|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1
4507568|NCT00899678|7315354|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0
4507569|NCT00899678|7315355|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1
4507570|NCT00899678|7315356|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2
4507571|NCT00899678|7315354|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0
4507572|NCT00899678|7315355|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2
4507573|NCT00899678|7315356|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2
4507574|NCT00899847|7315379|FG000|Overall Study|Lack of suitable allogeneic donor|2
4507575|NCT00900029|7315390|FG000|Overall Study|Lost to Follow-up|0
4507576|NCT00900029|7315391|FG001|Overall Study|Lost to Follow-up|2
4507577|NCT00900029|7315392|FG002|Overall Study|Lost to Follow-up|1
4507578|NCT00900029|7315393|FG003|Overall Study|Lost to Follow-up|4
4507579|NCT00900029|7315394|FG004|Overall Study|Lost to Follow-up|4
4627790|NCT01855750|7494663|FG001|Overall Study|Withdrawal by Subject|28
4627791|NCT01855750|7494662|FG000|Overall Study|Sponsor ends the study|297
4627792|NCT01855750|7494663|FG001|Overall Study|Sponsor ends the study|290
4627793|NCT01855789|7494669|FG000|1) Baseline up to Week 24|Adverse Event|37
4507580|NCT00900029|7315390|FG000|Overall Study|Withdrawal by Subject|2
4507581|NCT00900029|7315391|FG001|Overall Study|Withdrawal by Subject|2
4507582|NCT00900029|7315392|FG002|Overall Study|Withdrawal by Subject|1
4507583|NCT00900029|7315393|FG003|Overall Study|Withdrawal by Subject|1
4507584|NCT00900029|7315394|FG004|Overall Study|Withdrawal by Subject|1
4507585|NCT00900029|7315390|FG000|Overall Study|Adverse Event|0
4507586|NCT00900029|7315391|FG001|Overall Study|Adverse Event|0
4507587|NCT00900029|7315392|FG002|Overall Study|Adverse Event|1
4507588|NCT00900029|7315393|FG003|Overall Study|Adverse Event|1
4507589|NCT00900029|7315394|FG004|Overall Study|Adverse Event|1
4507590|NCT00900029|7315390|FG000|Overall Study|Death|1
4507591|NCT00900029|7315391|FG001|Overall Study|Death|0
4507592|NCT00900029|7315392|FG002|Overall Study|Death|0
4507593|NCT00900029|7315393|FG003|Overall Study|Death|1
4507594|NCT00900029|7315394|FG004|Overall Study|Death|0
4507595|NCT00900146|7315411|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2
4507596|NCT00900146|7315412|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2
4507597|NCT00900146|7315413|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5
4507598|NCT00900146|7315414|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1
4507599|NCT00900146|7315415|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9
4507600|NCT00900146|7315411|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2
4507601|NCT00900146|7315412|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0
4507602|NCT00900146|7315413|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0
4507603|NCT00900146|7315414|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1
4507604|NCT00900146|7315415|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3
4507605|NCT00900146|7315411|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1
4507606|NCT00900146|7315412|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0
4507607|NCT00900146|7315413|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0
4507608|NCT00900146|7315414|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0
4507609|NCT00900146|7315415|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0
4507610|NCT00900146|7315411|FG000|Intermediate: Period III|Withdrawal by Subject|0
4507611|NCT00900146|7315412|FG001|Intermediate: Period III|Withdrawal by Subject|1
4507612|NCT00900146|7315413|FG002|Intermediate: Period III|Withdrawal by Subject|0
4507613|NCT00900146|7315414|FG003|Intermediate: Period III|Withdrawal by Subject|0
4507614|NCT00900146|7315415|FG004|Intermediate: Period III|Withdrawal by Subject|3
4507615|NCT00900146|7315411|FG000|Intermediate: Period III|Lost to Follow-up|2
4507616|NCT00900146|7315412|FG001|Intermediate: Period III|Lost to Follow-up|0
4507617|NCT00900146|7315413|FG002|Intermediate: Period III|Lost to Follow-up|0
4627794|NCT01855789|7494670|FG001|1) Baseline up to Week 24|Adverse Event|0
4627795|NCT01855789|7494671|FG002|1) Baseline up to Week 24|Adverse Event|0
4627796|NCT01855789|7494672|FG003|1) Baseline up to Week 24|Adverse Event|0
4627797|NCT01855789|7494669|FG000|1) Baseline up to Week 24|Death|2
4627798|NCT01855789|7494670|FG001|1) Baseline up to Week 24|Death|0
4627799|NCT01855789|7494671|FG002|1) Baseline up to Week 24|Death|0
4627800|NCT01855789|7494672|FG003|1) Baseline up to Week 24|Death|0
4627801|NCT01855789|7494669|FG000|1) Baseline up to Week 24|Lack of Efficacy|16
4627802|NCT01855789|7494670|FG001|1) Baseline up to Week 24|Lack of Efficacy|0
4627803|NCT01855789|7494671|FG002|1) Baseline up to Week 24|Lack of Efficacy|0
4627804|NCT01855789|7494672|FG003|1) Baseline up to Week 24|Lack of Efficacy|0
4627805|NCT01855789|7494669|FG000|1) Baseline up to Week 24|Lost to Follow-up|11
4627806|NCT01855789|7494670|FG001|1) Baseline up to Week 24|Lost to Follow-up|0
4627807|NCT01855789|7494671|FG002|1) Baseline up to Week 24|Lost to Follow-up|0
4627808|NCT01855789|7494672|FG003|1) Baseline up to Week 24|Lost to Follow-up|0
4627809|NCT01855789|7494669|FG000|1) Baseline up to Week 24|Protocol Violation|4
4633239|NCT01909804|7503298|FG002|Overall Study|Death|0
4627810|NCT01855789|7494670|FG001|1) Baseline up to Week 24|Protocol Violation|0
4627811|NCT01855789|7494671|FG002|1) Baseline up to Week 24|Protocol Violation|0
4627812|NCT01855789|7494672|FG003|1) Baseline up to Week 24|Protocol Violation|0
4627813|NCT01855789|7494669|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31
4627814|NCT01855789|7494670|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0
4627815|NCT01855789|7494671|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0
4627816|NCT01855789|7494672|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0
4507618|NCT00900146|7315414|FG003|Intermediate: Period III|Lost to Follow-up|0
4507619|NCT00900146|7315415|FG004|Intermediate: Period III|Lost to Follow-up|1
4507620|NCT00900146|7315411|FG000|Intermediate: Period III|Administrative problems|85
4507621|NCT00900146|7315412|FG001|Intermediate: Period III|Administrative problems|92
4507622|NCT00900146|7315413|FG002|Intermediate: Period III|Administrative problems|84
4507623|NCT00900146|7315414|FG003|Intermediate: Period III|Administrative problems|90
4507624|NCT00900146|7315415|FG004|Intermediate: Period III|Administrative problems|163
4507625|NCT00900159|7315429|FG000|Second Intervention|disempanelled for inappropriate behavior|1
4507626|NCT00900159|7315430|FG001|Second Intervention|disempanelled for inappropriate behavior|0
4507627|NCT00900562|7315447|FG000|Overall Study|Progressive disease|9
4507628|NCT00900562|7315448|FG001|Overall Study|Progressive disease|5
4507629|NCT00900562|7315447|FG000|Overall Study|Toxicity|1
4507630|NCT00900562|7315448|FG001|Overall Study|Toxicity|0
4507631|NCT00900562|7315447|FG000|Overall Study|Death|1
4507632|NCT00900562|7315448|FG001|Overall Study|Death|1
4507633|NCT00900562|7315447|FG000|Overall Study|Withdrawal by Subject|0
4507634|NCT00900562|7315448|FG001|Overall Study|Withdrawal by Subject|1
4507635|NCT00900562|7315447|FG000|Overall Study|Unrelated adverse event|1
4507636|NCT00900562|7315448|FG001|Overall Study|Unrelated adverse event|0
4507637|NCT00900601|7315455|FG000|Overall Study|Physician Decision|1
4507638|NCT00900627|7315465|FG000|Overall Study|Condition under investigation worsened|4
4507639|NCT00900627|7315466|FG001|Overall Study|Condition under investigation worsened|0
4507640|NCT00900627|7315467|FG002|Overall Study|Condition under investigation worsened|5
4507641|NCT00900627|7315468|FG003|Overall Study|Condition under investigation worsened|3
4507642|NCT00900627|7315469|FG004|Overall Study|Condition under investigation worsened|0
4507643|NCT00900627|7315470|FG005|Overall Study|Condition under investigation worsened|0
4507644|NCT00900627|7315465|FG000|Overall Study|Withdrawal by Subject|1
4507645|NCT00900627|7315466|FG001|Overall Study|Withdrawal by Subject|0
4507646|NCT00900627|7315467|FG002|Overall Study|Withdrawal by Subject|1
4507647|NCT00900627|7315468|FG003|Overall Study|Withdrawal by Subject|0
4507648|NCT00900627|7315469|FG004|Overall Study|Withdrawal by Subject|1
4507649|NCT00900627|7315470|FG005|Overall Study|Withdrawal by Subject|2
4507650|NCT00900627|7315465|FG000|Overall Study|Adverse Event|1
4507651|NCT00900627|7315466|FG001|Overall Study|Adverse Event|2
4507652|NCT00900627|7315467|FG002|Overall Study|Adverse Event|0
4507653|NCT00900627|7315468|FG003|Overall Study|Adverse Event|3
4507654|NCT00900627|7315469|FG004|Overall Study|Adverse Event|0
4507655|NCT00900627|7315470|FG005|Overall Study|Adverse Event|0
4507656|NCT00900627|7315465|FG000|Overall Study|Death|0
4507657|NCT00900627|7315466|FG001|Overall Study|Death|0
4507658|NCT00900627|7315467|FG002|Overall Study|Death|0
4507659|NCT00900627|7315468|FG003|Overall Study|Death|0
4507660|NCT00900627|7315469|FG004|Overall Study|Death|28
4507661|NCT00900627|7315470|FG005|Overall Study|Death|24
4507662|NCT00900731|7315495|FG000|Overall Study|Adverse Event|31
4507663|NCT00900731|7315496|FG001|Overall Study|Adverse Event|27
4507664|NCT00900731|7315495|FG000|Overall Study|Withdrawal by Subject|8
4507665|NCT00900731|7315496|FG001|Overall Study|Withdrawal by Subject|7
4507666|NCT00900731|7315495|FG000|Overall Study|Protocol Deviation|8
4507667|NCT00900731|7315496|FG001|Overall Study|Protocol Deviation|11
4507668|NCT00900731|7315495|FG000|Overall Study|Administrative Problems|5
4507669|NCT00900731|7315496|FG001|Overall Study|Administrative Problems|4
4507670|NCT00900731|7315495|FG000|Overall Study|Abnormal Test Procedure Result(s)|3
4507671|NCT00900731|7315496|FG001|Overall Study|Abnormal Test Procedure Result(s)|0
4507672|NCT00900731|7315495|FG000|Overall Study|Abnormal Laboratory Value(s)|2
4507673|NCT00900731|7315496|FG001|Overall Study|Abnormal Laboratory Value(s)|4
4507674|NCT00900731|7315495|FG000|Overall Study|Lost to Follow-up|2
4507675|NCT00900731|7315496|FG001|Overall Study|Lost to Follow-up|3
4507676|NCT00900731|7315495|FG000|Overall Study|Lack of Efficacy|1
4507677|NCT00900731|7315496|FG001|Overall Study|Lack of Efficacy|3
4507678|NCT00900731|7315495|FG000|Overall Study|Death|0
4507679|NCT00900731|7315496|FG001|Overall Study|Death|2
4507680|NCT00900757|7315502|FG000|Overall Study|screen failure|19
4507681|NCT00900796|7315506|FG000|Phase 1|Lacked sufficient information|4
4507682|NCT00900796|7315506|FG000|Phase 1|Missing information at Week 16|7
4507683|NCT00900796|7315506|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110
4507684|NCT00900796|7315506|FG000|Phase 2|Lost to Follow-up|5
4507685|NCT00901186|7315527|FG000|Overall Study|Lack of Efficacy|0
4507686|NCT00901186|7315528|FG001|Overall Study|Lack of Efficacy|1
4507687|NCT00901186|7315527|FG000|Overall Study|Abnormal laboratory values|0
4507688|NCT00901186|7315528|FG001|Overall Study|Abnormal laboratory values|1
4507689|NCT00901186|7315527|FG000|Overall Study|Lost to Follow-up|2
4507690|NCT00901186|7315528|FG001|Overall Study|Lost to Follow-up|0
4507691|NCT00901186|7315527|FG000|Overall Study|Adverse Event|2
4507692|NCT00901186|7315528|FG001|Overall Study|Adverse Event|4
4507693|NCT00901186|7315527|FG000|Overall Study|Administration problems|0
4507694|NCT00901186|7315528|FG001|Overall Study|Administration problems|1
4507695|NCT00901186|7315527|FG000|Overall Study|Protocol deviations|5
4507696|NCT00901186|7315528|FG001|Overall Study|Protocol deviations|4
4507697|NCT00901342|7315551|FG000|Overall Study|Adverse Event|1
4507698|NCT00901342|7315551|FG000|Overall Study|Death|4
4507699|NCT00901342|7315551|FG000|Overall Study|Disease progression|1
4507700|NCT00901342|7315551|FG000|Overall Study|Withdrawal by Subject|9
4507701|NCT00901394|7315558|FG000|Overall Study|Physician Decision|1
4507702|NCT00901394|7315559|FG001|Overall Study|Physician Decision|1
4507703|NCT00901394|7315560|FG002|Overall Study|Physician Decision|2
4507704|NCT00901459|7315568|FG000|Overall Study|Withdrawal by Subject|6
4507705|NCT00901485|7315579|FG000|Overall Study|Lack of Efficacy|0
4507706|NCT00901485|7315580|FG001|Overall Study|Lack of Efficacy|2
4507707|NCT00901485|7315579|FG000|Overall Study|Withdrawal by Subject|1
4507708|NCT00901485|7315580|FG001|Overall Study|Withdrawal by Subject|2
4507709|NCT00901576|7315592|FG000|Second Intervention|Withdrawal by Subject|0
4507710|NCT00901576|7315593|FG001|Second Intervention|Withdrawal by Subject|0
4507711|NCT00901576|7315594|FG002|Second Intervention|Withdrawal by Subject|0
4507712|NCT00901576|7315595|FG003|Second Intervention|Withdrawal by Subject|1
4507713|NCT00901576|7315596|FG004|Second Intervention|Withdrawal by Subject|0
4507714|NCT00901576|7315597|FG005|Second Intervention|Withdrawal by Subject|1
4507715|NCT00901576|7315592|FG000|Second Intervention|Physician Decision|1
4507716|NCT00901576|7315593|FG001|Second Intervention|Physician Decision|0
4507717|NCT00901576|7315594|FG002|Second Intervention|Physician Decision|0
4507718|NCT00901576|7315595|FG003|Second Intervention|Physician Decision|0
4507719|NCT00901576|7315596|FG004|Second Intervention|Physician Decision|0
4507720|NCT00901576|7315597|FG005|Second Intervention|Physician Decision|0
4507721|NCT00901628|7315607|FG000|Overall Study|disconnection of catheter|4
4507722|NCT00901628|7315608|FG001|Overall Study|disconnection of catheter|8
4507723|NCT00901628|7315607|FG000|Overall Study|disconnection of drain|0
4507724|NCT00901628|7315608|FG001|Overall Study|disconnection of drain|1
4507725|NCT00901628|7315607|FG000|Overall Study|peroneal nerve palsy|0
4507726|NCT00901628|7315608|FG001|Overall Study|peroneal nerve palsy|1
4507727|NCT00901901|7315616|FG000|Treatment Period|Adverse Event|120
4507728|NCT00901901|7315617|FG001|Treatment Period|Adverse Event|128
4627817|NCT01855789|7494669|FG000|1) Baseline up to Week 24|Physician Decision|4
4507729|NCT00901901|7315616|FG000|Treatment Period|Withdrawal by Subject|26
4507730|NCT00901901|7315617|FG001|Treatment Period|Withdrawal by Subject|24
4507731|NCT00901901|7315616|FG000|Treatment Period|Physician Decision|2
4507732|NCT00901901|7315617|FG001|Treatment Period|Physician Decision|2
4507733|NCT00901901|7315616|FG000|Treatment Period|Lost to Follow-up|3
4507734|NCT00901901|7315617|FG001|Treatment Period|Lost to Follow-up|5
4507735|NCT00901901|7315616|FG000|Treatment Period|Noncompliance with study medication|4
4507736|NCT00901901|7315617|FG001|Treatment Period|Noncompliance with study medication|1
4507737|NCT00901901|7315616|FG000|Treatment Period|Missing|1
4507738|NCT00901901|7315617|FG001|Treatment Period|Missing|0
4507739|NCT00901901|7315616|FG000|Treatment Period|Never treated|0
4507740|NCT00901901|7315617|FG001|Treatment Period|Never treated|3
4507741|NCT00901901|7315616|FG000|Treatment Period|Protocol driven decision point|0
4507742|NCT00901901|7315617|FG001|Treatment Period|Protocol driven decision point|2
4507743|NCT00901901|7315616|FG000|Treatment Period|Study terminated by sponsor|2
4507744|NCT00901901|7315617|FG001|Treatment Period|Study terminated by sponsor|0
4507745|NCT00901901|7315616|FG000|Treatment Period|Protocol Violation|5
4507746|NCT00901901|7315617|FG001|Treatment Period|Protocol Violation|9
4507747|NCT00901901|7315616|FG000|Treatment Period|Switch to commercial drug|1
4507748|NCT00901901|7315617|FG001|Treatment Period|Switch to commercial drug|1
4507749|NCT00901901|7315616|FG000|Treatment Period|Transfer to treatment continuation study|5
4507750|NCT00901901|7315617|FG001|Treatment Period|Transfer to treatment continuation study|2
4507751|NCT00901901|7315616|FG000|Follow-up Period|Death|181
4507752|NCT00901901|7315617|FG001|Follow-up Period|Death|208
4507753|NCT00901901|7315616|FG000|Follow-up Period|Protocol driven decision point|47
4507754|NCT00901901|7315617|FG001|Follow-up Period|Protocol driven decision point|36
4507755|NCT00901901|7315616|FG000|Follow-up Period|Withdrawal by Subject|6
4507756|NCT00901901|7315617|FG001|Follow-up Period|Withdrawal by Subject|9
4507757|NCT00901901|7315616|FG000|Follow-up Period|Lost to Follow-up|12
4507758|NCT00901901|7315617|FG001|Follow-up Period|Lost to Follow-up|8
4507759|NCT00901901|7315616|FG000|Follow-up Period|Missing|94
4507760|NCT00901901|7315617|FG001|Follow-up Period|Missing|80
4704966|NCT02759315|7624234|FG001|Overall Study|Lost to Follow-up|0
4704967|NCT02759315|7624235|FG002|Overall Study|Lost to Follow-up|4
4704968|NCT02759315|7624236|FG003|Overall Study|Lost to Follow-up|0
4704969|NCT02759315|7624237|FG004|Overall Study|Lost to Follow-up|0
4704970|NCT02759315|7624233|FG000|Overall Study|Protocol Violation|0
4704971|NCT02759315|7624234|FG001|Overall Study|Protocol Violation|1
4704972|NCT02759315|7624235|FG002|Overall Study|Protocol Violation|0
4507761|NCT00901927|7315625|FG000|Overall Study|Lack of Efficacy|1
4507762|NCT00901927|7315625|FG000|Overall Study|Protocol Violation|3
4507763|NCT00901927|7315625|FG000|Overall Study|Withdrawal by Subject|2
4507764|NCT00902174|7315664|FG000|Overall Study|Adverse Event|27
4704973|NCT02759315|7624236|FG003|Overall Study|Protocol Violation|0
4507765|NCT00902174|7315665|FG001|Overall Study|Adverse Event|7
4704974|NCT02759315|7624237|FG004|Overall Study|Protocol Violation|0
4507766|NCT00902174|7315664|FG000|Overall Study|Lack of Efficacy|1
4507767|NCT00902174|7315665|FG001|Overall Study|Lack of Efficacy|5
4507768|NCT00902174|7315664|FG000|Overall Study|Death|2
4507769|NCT00902174|7315665|FG001|Overall Study|Death|2
4507770|NCT00902174|7315664|FG000|Overall Study|Withdrawal by Subject|2
4507771|NCT00902174|7315665|FG001|Overall Study|Withdrawal by Subject|1
4507772|NCT00902174|7315664|FG000|Overall Study|Abnormal labs|1
4507773|NCT00902174|7315665|FG001|Overall Study|Abnormal labs|1
4507774|NCT00902174|7315664|FG000|Overall Study|Protocol Violation|1
4507775|NCT00902174|7315665|FG001|Overall Study|Protocol Violation|1
4507776|NCT00902174|7315664|FG000|Overall Study|Administration problem|0
4507777|NCT00902174|7315665|FG001|Overall Study|Administration problem|1
4507778|NCT00902265|7315678|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1
4507779|NCT00902265|7315678|FG000|Overall Study|Adverse Event|2
4507780|NCT00902265|7315678|FG000|Overall Study|Lack of Efficacy|2
4507781|NCT00902265|7315678|FG000|Overall Study|Protocol Violation|1
4507782|NCT00902278|7315687|FG000|Overall Study|Physician Decision|1
4507783|NCT00902278|7315688|FG001|Overall Study|Physician Decision|0
4507784|NCT00902278|7315689|FG002|Overall Study|Physician Decision|2
4507785|NCT00902278|7315690|FG003|Overall Study|Physician Decision|0
4507786|NCT00902278|7315691|FG004|Overall Study|Physician Decision|1
4507787|NCT00902278|7315687|FG000|Overall Study|Lost to Follow-up|3
4507788|NCT00902278|7315688|FG001|Overall Study|Lost to Follow-up|2
4507789|NCT00902278|7315689|FG002|Overall Study|Lost to Follow-up|3
4507790|NCT00902278|7315690|FG003|Overall Study|Lost to Follow-up|0
4507791|NCT00902278|7315691|FG004|Overall Study|Lost to Follow-up|1
4507792|NCT00902304|7315706|FG000|Overall Study|Adverse Event|4
4507793|NCT00902304|7315707|FG001|Overall Study|Adverse Event|10
4507794|NCT00902304|7315708|FG002|Overall Study|Adverse Event|25
4507795|NCT00902304|7315706|FG000|Overall Study|Investigator discretion|3
4507796|NCT00902304|7315707|FG001|Overall Study|Investigator discretion|5
4507797|NCT00902304|7315708|FG002|Overall Study|Investigator discretion|13
4507798|NCT00902304|7315706|FG000|Overall Study|Lost to Follow-up|7
4507799|NCT00902304|7315707|FG001|Overall Study|Lost to Follow-up|7
4507800|NCT00902304|7315708|FG002|Overall Study|Lost to Follow-up|7
4507801|NCT00902304|7315706|FG000|Overall Study|Protocol Violation|9
4507802|NCT00902304|7315707|FG001|Overall Study|Protocol Violation|18
4507803|NCT00902304|7315708|FG002|Overall Study|Protocol Violation|20
4507804|NCT00902304|7315706|FG000|Overall Study|Withdrawal by Subject|32
4507805|NCT00902304|7315707|FG001|Overall Study|Withdrawal by Subject|22
4507806|NCT00902304|7315708|FG002|Overall Study|Withdrawal by Subject|43
4507807|NCT00902304|7315706|FG000|Overall Study|includes pregnancy|3
4507808|NCT00902304|7315707|FG001|Overall Study|includes pregnancy|9
4507809|NCT00902304|7315708|FG002|Overall Study|includes pregnancy|2
4507810|NCT00902330|7315719|FG000|Overall Study|Too overwhelmed by treatment|2
4507811|NCT00902330|7315720|FG001|Overall Study|Too overwhelmed by treatment|5
4507812|NCT00902330|7315719|FG000|Overall Study|Adverse Event|1
4507813|NCT00902330|7315720|FG001|Overall Study|Adverse Event|0
4507814|NCT00902330|7315719|FG000|Overall Study|No post baseline data|1
4507815|NCT00902330|7315720|FG001|Overall Study|No post baseline data|0
4507816|NCT00902486|7315733|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1
4507817|NCT00902486|7315734|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0
4507818|NCT00902486|7315735|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0
4507819|NCT00902486|7315736|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1
4507820|NCT00902486|7315737|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1
4507821|NCT00902486|7315738|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2
4507822|NCT00902486|7315733|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1
4507823|NCT00902486|7315734|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
4507824|NCT00902486|7315735|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
4507825|NCT00902486|7315736|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
4507826|NCT00902486|7315737|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
4507827|NCT00902486|7315738|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2
4507828|NCT00902486|7315733|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
4507829|NCT00902486|7315734|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
4507830|NCT00902486|7315735|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
4507831|NCT00902486|7315736|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
4507832|NCT00902486|7315737|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1
4507833|NCT00902486|7315738|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1
4507834|NCT00902486|7315733|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
4507835|NCT00902486|7315734|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
4507836|NCT00902486|7315735|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
4507837|NCT00902486|7315736|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1
4507838|NCT00902486|7315737|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
4507839|NCT00902486|7315738|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
4507840|NCT00902486|7315733|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
4507841|NCT00902486|7315734|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
4507842|NCT00902486|7315735|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
4507843|NCT00902486|7315736|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1
4507844|NCT00902486|7315737|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
4507845|NCT00902486|7315738|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
4507846|NCT00902486|7315733|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0
4507847|NCT00902486|7315734|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0
4507848|NCT00902486|7315735|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0
4507849|NCT00902486|7315736|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0
4507850|NCT00902486|7315737|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1
4507851|NCT00902486|7315738|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2
4507852|NCT00902486|7315733|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
4507853|NCT00902486|7315734|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
4507854|NCT00902486|7315735|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1
4507855|NCT00902486|7315736|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1
4507856|NCT00902486|7315737|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
4507857|NCT00902486|7315738|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
4507858|NCT00902486|7315733|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
4507859|NCT00902486|7315734|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
4507860|NCT00902486|7315735|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
4507861|NCT00902486|7315736|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
4507862|NCT00902486|7315737|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
4507863|NCT00902486|7315738|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1
4507864|NCT00902486|7315733|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0
4507865|NCT00902486|7315734|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0
4507866|NCT00902486|7315735|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0
4507867|NCT00902486|7315736|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1
4507868|NCT00902486|7315737|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0
4507869|NCT00902486|7315738|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0
4507870|NCT00902486|7315733|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
4507871|NCT00902486|7315734|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
4507872|NCT00902486|7315735|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1
4507873|NCT00902486|7315736|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
4507874|NCT00902486|7315737|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
4507875|NCT00902486|7315738|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
4507876|NCT00902486|7315733|FG000|Follow-up (After Week 24)|Lost to Follow-up|0
4507877|NCT00902486|7315734|FG001|Follow-up (After Week 24)|Lost to Follow-up|0
4507878|NCT00902486|7315735|FG002|Follow-up (After Week 24)|Lost to Follow-up|0
4507879|NCT00902486|7315736|FG003|Follow-up (After Week 24)|Lost to Follow-up|1
4507880|NCT00902486|7315737|FG004|Follow-up (After Week 24)|Lost to Follow-up|0
4507881|NCT00902486|7315738|FG005|Follow-up (After Week 24)|Lost to Follow-up|0
4507882|NCT00902538|7315771|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49
4507883|NCT00902538|7315772|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
4507884|NCT00902538|7315773|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
4507885|NCT00902538|7315774|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
4507886|NCT00902538|7315775|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
4507887|NCT00902538|7315776|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
4507888|NCT00902538|7315771|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30
4507889|NCT00902538|7315772|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
4507890|NCT00902538|7315773|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
4507891|NCT00902538|7315774|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
4507892|NCT00902538|7315775|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
4507893|NCT00902538|7315776|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
4507894|NCT00902538|7315771|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22
4507895|NCT00902538|7315772|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
4507896|NCT00902538|7315773|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
4507897|NCT00902538|7315774|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
4507898|NCT00902538|7315775|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
4507899|NCT00902538|7315776|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
4507900|NCT00902538|7315771|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13
4507901|NCT00902538|7315772|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
4507902|NCT00902538|7315773|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
4507903|NCT00902538|7315774|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
4507904|NCT00902538|7315775|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
4507905|NCT00902538|7315776|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
4507906|NCT00902538|7315771|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4
4507907|NCT00902538|7315772|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
4507908|NCT00902538|7315773|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
4507909|NCT00902538|7315774|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
4507910|NCT00902538|7315775|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
4507911|NCT00902538|7315776|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
4507912|NCT00902538|7315771|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4
4507913|NCT00902538|7315772|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2
4507914|NCT00902538|7315773|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3
4507915|NCT00902538|7315774|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0
4507916|NCT00902538|7315775|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0
4507917|NCT00902538|7315776|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0
4507918|NCT00902538|7315771|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1
4507919|NCT00902538|7315772|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2
4507920|NCT00902538|7315773|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1
4507921|NCT00902538|7315774|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
4507922|NCT00902538|7315775|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
4507923|NCT00902538|7315776|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
4507924|NCT00902538|7315771|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1
4507925|NCT00902538|7315772|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
4507926|NCT00902538|7315773|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2
4507927|NCT00902538|7315774|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
4507928|NCT00902538|7315775|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
4507929|NCT00902538|7315776|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
4507930|NCT00902538|7315771|FG000|2-Randomized Double-blind 3 Treatments|Other|2
4507931|NCT00902538|7315772|FG001|2-Randomized Double-blind 3 Treatments|Other|1
4507932|NCT00902538|7315773|FG002|2-Randomized Double-blind 3 Treatments|Other|0
4507933|NCT00902538|7315774|FG003|2-Randomized Double-blind 3 Treatments|Other|0
4507934|NCT00902538|7315775|FG004|2-Randomized Double-blind 3 Treatments|Other|0
4507935|NCT00902538|7315776|FG005|2-Randomized Double-blind 3 Treatments|Other|0
4507936|NCT00902538|7315771|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1
4507937|NCT00902538|7315772|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1
4507938|NCT00902538|7315773|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2
4507939|NCT00902538|7315774|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
4507940|NCT00902538|7315775|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
4507941|NCT00902538|7315776|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
4507942|NCT00902538|7315771|FG000|3-Single-blind, Single Treatment|Adverse Event|0
4507943|NCT00902538|7315772|FG001|3-Single-blind, Single Treatment|Adverse Event|5
4507944|NCT00902538|7315773|FG002|3-Single-blind, Single Treatment|Adverse Event|0
4507945|NCT00902538|7315774|FG003|3-Single-blind, Single Treatment|Adverse Event|0
4507946|NCT00902538|7315775|FG004|3-Single-blind, Single Treatment|Adverse Event|0
4507947|NCT00902538|7315776|FG005|3-Single-blind, Single Treatment|Adverse Event|0
4507948|NCT00902538|7315771|FG000|3-Single-blind, Single Treatment|Protocol Violation|0
4507949|NCT00902538|7315772|FG001|3-Single-blind, Single Treatment|Protocol Violation|5
4507950|NCT00902538|7315773|FG002|3-Single-blind, Single Treatment|Protocol Violation|0
4507951|NCT00902538|7315774|FG003|3-Single-blind, Single Treatment|Protocol Violation|0
4507952|NCT00902538|7315775|FG004|3-Single-blind, Single Treatment|Protocol Violation|0
4507953|NCT00902538|7315776|FG005|3-Single-blind, Single Treatment|Protocol Violation|0
4507954|NCT00902538|7315771|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0
4507955|NCT00902538|7315772|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4
4507956|NCT00902538|7315773|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0
4507957|NCT00902538|7315774|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0
4507958|NCT00902538|7315775|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0
4507959|NCT00902538|7315776|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0
4507960|NCT00902538|7315771|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0
4507961|NCT00902538|7315772|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1
4507962|NCT00902538|7315773|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0
4507963|NCT00902538|7315774|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0
4507964|NCT00902538|7315775|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0
4507965|NCT00902538|7315776|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0
4507966|NCT00902538|7315771|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0
4507967|NCT00902538|7315772|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0
4507968|NCT00902538|7315773|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0
4507969|NCT00902538|7315774|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3
4507970|NCT00902538|7315775|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1
4507971|NCT00902538|7315776|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1
4507972|NCT00902538|7315771|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
4507973|NCT00902538|7315772|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
4507974|NCT00902538|7315773|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
4507975|NCT00902538|7315774|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3
4507976|NCT00902538|7315775|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1
4507977|NCT00902538|7315776|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
4507978|NCT00902538|7315771|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
4507979|NCT00902538|7315772|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
4507980|NCT00902538|7315773|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
4507981|NCT00902538|7315774|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3
4507982|NCT00902538|7315775|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
4507983|NCT00902538|7315776|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
4507984|NCT00902564|7315788|FG000|Overall Study|Withdrawal by Subject|2
4507985|NCT00902577|7315792|FG000|Overall Study|Withdrawal by Subject|6
4507986|NCT00902577|7315792|FG000|Overall Study|FMISO production failure|2
4507987|NCT00902746|7315815|FG000|Overall Study|Protocol Violation|7
4507988|NCT00902746|7315815|FG000|Overall Study|Withdrawal by Subject|16
4507989|NCT00902746|7315815|FG000|Overall Study|Adverse Event|8
4507990|NCT00902746|7315815|FG000|Overall Study|Lost to Follow-up|3
4507991|NCT00902746|7315815|FG000|Overall Study|Physician Decision|2
4507992|NCT00902850|7315821|FG000|Overall Study|Physician Decision|2
4507993|NCT00902850|7315822|FG001|Overall Study|Physician Decision|2
4507994|NCT00903032|7315830|FG000|Overall Study|Withdrawal by Subject|5
4507995|NCT00903032|7315831|FG001|Overall Study|Withdrawal by Subject|3
4507996|NCT00903032|7315830|FG000|Overall Study|Lost to Follow-up|2
4507997|NCT00903032|7315831|FG001|Overall Study|Lost to Follow-up|2
4507998|NCT00903175|7315843|FG000|Period 1 - First Line|Adverse Event|36
4507999|NCT00903175|7315844|FG001|Period 1 - First Line|Adverse Event|50
4508000|NCT00903175|7315843|FG000|Period 1 - First Line|Abnormal lab value(s)|0
4508001|NCT00903175|7315844|FG001|Period 1 - First Line|Abnormal lab value(s)|1
4508002|NCT00903175|7315843|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1
4508003|NCT00903175|7315844|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0
4508004|NCT00903175|7315843|FG000|Period 1 - First Line|Protocol Violation|3
4508005|NCT00903175|7315844|FG001|Period 1 - First Line|Protocol Violation|3
4508006|NCT00903175|7315843|FG000|Period 1 - First Line|Withdrawal by Subject|8
4508007|NCT00903175|7315844|FG001|Period 1 - First Line|Withdrawal by Subject|12
4508008|NCT00903175|7315843|FG000|Period 1 - First Line|Administrative problems|12
4508009|NCT00903175|7315844|FG001|Period 1 - First Line|Administrative problems|13
4508010|NCT00903175|7315843|FG000|Period 1 - First Line|Death|17
4508011|NCT00903175|7315844|FG001|Period 1 - First Line|Death|10
4508012|NCT00903175|7315843|FG000|Period 2 - Second Line|Missing|1
4508013|NCT00903175|7315844|FG001|Period 2 - Second Line|Missing|0
4508014|NCT00903175|7315843|FG000|Period 2 - Second Line|Adverse Event|16
4508015|NCT00903175|7315844|FG001|Period 2 - Second Line|Adverse Event|20
4508016|NCT00903175|7315843|FG000|Period 2 - Second Line|Withdrawal by Subject|7
4508017|NCT00903175|7315844|FG001|Period 2 - Second Line|Withdrawal by Subject|5
4508018|NCT00903175|7315843|FG000|Period 2 - Second Line|Lost to Follow-up|1
4508019|NCT00903175|7315844|FG001|Period 2 - Second Line|Lost to Follow-up|0
4508020|NCT00903175|7315843|FG000|Period 2 - Second Line|Administrative problems|19
4508021|NCT00903175|7315844|FG001|Period 2 - Second Line|Administrative problems|9
4508022|NCT00903175|7315843|FG000|Period 2 - Second Line|Death|5
4508023|NCT00903175|7315844|FG001|Period 2 - Second Line|Death|2
4508024|NCT00903201|7315853|FG000|Overall Study|Adverse Event|1
4508025|NCT00903201|7315854|FG001|Overall Study|Adverse Event|4
4508026|NCT00903201|7315855|FG002|Overall Study|Adverse Event|0
4508027|NCT00903201|7315853|FG000|Overall Study|Protocol Violation|2
4508028|NCT00903201|7315854|FG001|Overall Study|Protocol Violation|1
4508029|NCT00903201|7315855|FG002|Overall Study|Protocol Violation|0
4508030|NCT00903201|7315853|FG000|Overall Study|Lost to Follow-up|0
4508031|NCT00903201|7315854|FG001|Overall Study|Lost to Follow-up|1
4508032|NCT00903201|7315855|FG002|Overall Study|Lost to Follow-up|0
4508033|NCT00903201|7315853|FG000|Overall Study|Physician Decision|1
4508034|NCT00903201|7315854|FG001|Overall Study|Physician Decision|0
4508035|NCT00903201|7315855|FG002|Overall Study|Physician Decision|1
4508036|NCT00903201|7315853|FG000|Overall Study|Withdrawal by Subject|1
4508037|NCT00903201|7315854|FG001|Overall Study|Withdrawal by Subject|0
4508038|NCT00903201|7315855|FG002|Overall Study|Withdrawal by Subject|1
4508039|NCT00903331|7315867|FG000|Overall Study|Death|4
4508040|NCT00903331|7315868|FG001|Overall Study|Death|8
4508041|NCT00903331|7315867|FG000|Overall Study|Withdrawal of consent|1
4508042|NCT00903331|7315868|FG001|Overall Study|Withdrawal of consent|8
4508043|NCT00903331|7315867|FG000|Overall Study|Lung transplant|0
4508044|NCT00903331|7315868|FG001|Overall Study|Lung transplant|2
4508045|NCT00903344|7315876|FG000|Overall Study|Pregnancy|2
4508046|NCT00903344|7315877|FG001|Overall Study|Pregnancy|3
4508047|NCT00903344|7315876|FG000|Overall Study|Lost to Follow-up|3
4508048|NCT00903344|7315877|FG001|Overall Study|Lost to Follow-up|0
4508049|NCT00903357|7315883|FG000|First Intervention|Withdrawal by Subject|5
4508050|NCT00903357|7315884|FG001|First Intervention|Withdrawal by Subject|3
4508051|NCT00903357|7315883|FG000|First Intervention|Flu|0
4508052|NCT00903357|7315884|FG001|First Intervention|Flu|1
4508053|NCT00903357|7315883|FG000|Wash Out Period of 2 Weeks|Flu|0
4508054|NCT00903357|7315884|FG001|Wash Out Period of 2 Weeks|Flu|1
4508055|NCT00903357|7315883|FG000|Second Intervention|Lost to Follow-up|1
4508056|NCT00903357|7315884|FG001|Second Intervention|Lost to Follow-up|0
4508057|NCT00903370|7315896|FG000|Overall Study|Death|13
4508058|NCT00903370|7315897|FG001|Overall Study|Death|10
4508059|NCT00903370|7315896|FG000|Overall Study|Withdrawal by Subject|9
4508060|NCT00903370|7315897|FG001|Overall Study|Withdrawal by Subject|6
4508061|NCT00903370|7315896|FG000|Overall Study|Lost to Follow-up|6
4508062|NCT00903370|7315897|FG001|Overall Study|Lost to Follow-up|8
4508063|NCT00903383|7315907|FG000|Overall Study|Adverse Event|1
4508064|NCT00903383|7315908|FG001|Overall Study|Adverse Event|2
4508065|NCT00903383|7315909|FG002|Overall Study|Adverse Event|3
4508066|NCT00903383|7315910|FG003|Overall Study|Adverse Event|1
4508067|NCT00903383|7315907|FG000|Overall Study|Physician Decision|1
4508068|NCT00903383|7315908|FG001|Overall Study|Physician Decision|2
4508069|NCT00903383|7315909|FG002|Overall Study|Physician Decision|0
4508070|NCT00903383|7315910|FG003|Overall Study|Physician Decision|0
4508071|NCT00903383|7315907|FG000|Overall Study|Lost to Follow-up|0
4508072|NCT00903383|7315908|FG001|Overall Study|Lost to Follow-up|0
4508073|NCT00903383|7315909|FG002|Overall Study|Lost to Follow-up|0
4508074|NCT00903383|7315910|FG003|Overall Study|Lost to Follow-up|1
4508075|NCT00903383|7315907|FG000|Overall Study|Decision of Sponsor|1
4508076|NCT00903383|7315908|FG001|Overall Study|Decision of Sponsor|0
4508077|NCT00903383|7315909|FG002|Overall Study|Decision of Sponsor|0
4508078|NCT00903383|7315910|FG003|Overall Study|Decision of Sponsor|0
4508079|NCT00903383|7315907|FG000|Overall Study|Withdrawal by Subject|4
4508080|NCT00903383|7315908|FG001|Overall Study|Withdrawal by Subject|1
4508081|NCT00903383|7315909|FG002|Overall Study|Withdrawal by Subject|0
4508082|NCT00903383|7315910|FG003|Overall Study|Withdrawal by Subject|2
4508083|NCT00903383|7315907|FG000|Overall Study|Patient Decision - Lack of Efficacy|0
4508084|NCT00903383|7315908|FG001|Overall Study|Patient Decision - Lack of Efficacy|1
4508085|NCT00903383|7315909|FG002|Overall Study|Patient Decision - Lack of Efficacy|0
4508086|NCT00903383|7315910|FG003|Overall Study|Patient Decision - Lack of Efficacy|0
4508087|NCT00903383|7315907|FG000|Overall Study|Patient Decision|0
4508088|NCT00903383|7315908|FG001|Overall Study|Patient Decision|0
4508089|NCT00903383|7315909|FG002|Overall Study|Patient Decision|0
4508090|NCT00903383|7315910|FG003|Overall Study|Patient Decision|1
4508091|NCT00903409|7315922|FG000|Overall Study|Adverse Event|11
4508092|NCT00903409|7315923|FG001|Overall Study|Adverse Event|9
4508093|NCT00903409|7315922|FG000|Overall Study|Non-compliance with Protocol|1
4508094|NCT00903409|7315923|FG001|Overall Study|Non-compliance with Protocol|1
4508095|NCT00903409|7315922|FG000|Overall Study|Laboratory Abnormality|2
4508096|NCT00903409|7315923|FG001|Overall Study|Laboratory Abnormality|0
4508097|NCT00903409|7315922|FG000|Overall Study|Withdrawal by Subject|8
4508098|NCT00903409|7315923|FG001|Overall Study|Withdrawal by Subject|8
4508099|NCT00903409|7315922|FG000|Overall Study|Other|2
4508100|NCT00903409|7315923|FG001|Overall Study|Other|3
4508101|NCT00903409|7315922|FG000|Overall Study|Lost to Follow-up|2
4508102|NCT00903409|7315923|FG001|Overall Study|Lost to Follow-up|6
4508103|NCT00903617|7315942|FG000|Overall Study|Adverse Event|0
4508104|NCT00903617|7315943|FG001|Overall Study|Adverse Event|1
4508105|NCT00903617|7315944|FG002|Overall Study|Adverse Event|1
4508106|NCT00903617|7315945|FG003|Overall Study|Adverse Event|0
4508107|NCT00903617|7315942|FG000|Overall Study|Protocol-defined stopping criteria|0
4508108|NCT00903617|7315943|FG001|Overall Study|Protocol-defined stopping criteria|2
4508109|NCT00903617|7315944|FG002|Overall Study|Protocol-defined stopping criteria|0
4508110|NCT00903617|7315945|FG003|Overall Study|Protocol-defined stopping criteria|0
4508111|NCT00903617|7315942|FG000|Overall Study|Lost to Follow-up|2
4508112|NCT00903617|7315943|FG001|Overall Study|Lost to Follow-up|0
4508113|NCT00903617|7315944|FG002|Overall Study|Lost to Follow-up|1
4508114|NCT00903617|7315945|FG003|Overall Study|Lost to Follow-up|1
4508115|NCT00903617|7315942|FG000|Overall Study|Withdrawal by Subject|1
4508116|NCT00903617|7315943|FG001|Overall Study|Withdrawal by Subject|2
4508117|NCT00903617|7315944|FG002|Overall Study|Withdrawal by Subject|3
4508118|NCT00903617|7315945|FG003|Overall Study|Withdrawal by Subject|0
4508119|NCT00903630|7315959|FG000|Phase 2|Adverse Event|0
4508120|NCT00903630|7315960|FG001|Phase 2|Adverse Event|0
4508121|NCT00903630|7315961|FG002|Phase 2|Adverse Event|1
4508122|NCT00903682|7315973|FG000|Overall Study|Adverse Event|6
4508123|NCT00903682|7315974|FG001|Overall Study|Adverse Event|13
4508124|NCT00903682|7315973|FG000|Overall Study|Lost to Follow-up|1
4508125|NCT00903682|7315974|FG001|Overall Study|Lost to Follow-up|0
4508126|NCT00903682|7315973|FG000|Overall Study|Withdrawal by Subject|5
4508127|NCT00903682|7315974|FG001|Overall Study|Withdrawal by Subject|0
4508128|NCT00903682|7315973|FG000|Overall Study|Pregnancy|0
4508129|NCT00903682|7315974|FG001|Overall Study|Pregnancy|1
4508130|NCT00903682|7315973|FG000|Overall Study|Subject Reached A Virologic Endpoint|1
4508131|NCT00903682|7315974|FG001|Overall Study|Subject Reached A Virologic Endpoint|1
4508132|NCT00903682|7315973|FG000|Overall Study|Subject Non-Compliant|1
4508133|NCT00903682|7315974|FG001|Overall Study|Subject Non-Compliant|0
4508134|NCT00903682|7315973|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1
4508135|NCT00903682|7315974|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0
4508136|NCT00903682|7315973|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1
4508137|NCT00903682|7315974|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0
4508138|NCT00903695|7315982|FG000|Overall Study|medical exclusion after 1st testing|1
4508139|NCT00903695|7315983|FG001|Overall Study|medical exclusion after 1st testing|0
4508140|NCT00903695|7315982|FG000|Overall Study|lung cancer|1
4508141|NCT00903695|7315983|FG001|Overall Study|lung cancer|0
4508142|NCT00903760|7315993|FG000|Overall Study|Disease Progression/Death|8
4508143|NCT00903760|7315994|FG001|Overall Study|Disease Progression/Death|6
4508144|NCT00903760|7315993|FG000|Overall Study|Stem Cell Transplant|8
4508145|NCT00903760|7315994|FG001|Overall Study|Stem Cell Transplant|4
4508146|NCT00903760|7315993|FG000|Overall Study|Physician Decision|1
4508147|NCT00903760|7315994|FG001|Overall Study|Physician Decision|2
4508148|NCT00903760|7315993|FG000|Overall Study|Death|0
4508149|NCT00903760|7315994|FG001|Overall Study|Death|1
4508150|NCT00903760|7315993|FG000|Overall Study|Lost to Follow-up|1
4508151|NCT00903760|7315994|FG001|Overall Study|Lost to Follow-up|0
4508152|NCT00903760|7315993|FG000|Overall Study|Withdrawal by Subject|1
4508153|NCT00903760|7315994|FG001|Overall Study|Withdrawal by Subject|2
4508154|NCT00903760|7315993|FG000|Overall Study|Off treatment for long period|0
4508155|NCT00903760|7315994|FG001|Overall Study|Off treatment for long period|1
4508156|NCT00903786|7316000|FG000|Overall Study|Physician Decision|6
4508157|NCT00903786|7316000|FG000|Overall Study|Lack of Efficacy|5
4508158|NCT00903786|7316000|FG000|Overall Study|Reason other than lack of efficacy|4
4508159|NCT00903877|7316005|FG000|Overall Study|Did not meet study criteria|33
4508160|NCT00903877|7316005|FG000|Overall Study|Withdrawal by Subject|3
4508161|NCT00903877|7316005|FG000|Overall Study|Adverse Event|2
4508162|NCT00903877|7316005|FG000|Overall Study|Lost to Follow-up|1
4508163|NCT00903877|7316005|FG000|Overall Study|Participation put on hold|4
4508164|NCT00903929|7316009|FG000|Overall Study|Withdrawal by Subject|0
4508165|NCT00903929|7316010|FG001|Overall Study|Withdrawal by Subject|0
4508166|NCT00903929|7316011|FG002|Overall Study|Withdrawal by Subject|1
4508167|NCT00903929|7316012|FG003|Overall Study|Withdrawal by Subject|2
4508168|NCT00903929|7316009|FG000|Overall Study|Adverse Event|0
4508169|NCT00903929|7316010|FG001|Overall Study|Adverse Event|0
4508170|NCT00903929|7316011|FG002|Overall Study|Adverse Event|0
4508171|NCT00903929|7316012|FG003|Overall Study|Adverse Event|1
4508172|NCT00903968|7316019|FG000|Overall Study|Adverse Event|0
4508173|NCT00903968|7316020|FG001|Overall Study|Adverse Event|0
4508174|NCT00903968|7316021|FG002|Overall Study|Adverse Event|0
4508175|NCT00903968|7316022|FG003|Overall Study|Adverse Event|0
4508176|NCT00903968|7316023|FG004|Overall Study|Adverse Event|0
4508177|NCT00903968|7316024|FG005|Overall Study|Adverse Event|0
4508178|NCT00903968|7316025|FG006|Overall Study|Adverse Event|1
4508179|NCT00903968|7316026|FG007|Overall Study|Adverse Event|8
4508180|NCT00903968|7316019|FG000|Overall Study|DLT|0
4508181|NCT00903968|7316020|FG001|Overall Study|DLT|0
4508182|NCT00903968|7316021|FG002|Overall Study|DLT|0
4508183|NCT00903968|7316022|FG003|Overall Study|DLT|0
4508184|NCT00903968|7316023|FG004|Overall Study|DLT|0
4508185|NCT00903968|7316024|FG005|Overall Study|DLT|0
4508186|NCT00903968|7316025|FG006|Overall Study|DLT|2
4508187|NCT00903968|7316026|FG007|Overall Study|DLT|0
4508188|NCT00903968|7316019|FG000|Overall Study|Withdrawal by Subject|1
4508189|NCT00903968|7316020|FG001|Overall Study|Withdrawal by Subject|0
4508190|NCT00903968|7316021|FG002|Overall Study|Withdrawal by Subject|1
4508191|NCT00903968|7316022|FG003|Overall Study|Withdrawal by Subject|0
4508192|NCT00903968|7316023|FG004|Overall Study|Withdrawal by Subject|1
4508193|NCT00903968|7316024|FG005|Overall Study|Withdrawal by Subject|1
4508194|NCT00903968|7316025|FG006|Overall Study|Withdrawal by Subject|0
4508195|NCT00903968|7316026|FG007|Overall Study|Withdrawal by Subject|4
4508196|NCT00903968|7316019|FG000|Overall Study|Non-Compliance|0
4508197|NCT00903968|7316020|FG001|Overall Study|Non-Compliance|0
4508198|NCT00903968|7316021|FG002|Overall Study|Non-Compliance|0
4508199|NCT00903968|7316022|FG003|Overall Study|Non-Compliance|0
4508200|NCT00903968|7316023|FG004|Overall Study|Non-Compliance|0
4508201|NCT00903968|7316024|FG005|Overall Study|Non-Compliance|1
4508202|NCT00903968|7316025|FG006|Overall Study|Non-Compliance|0
4508203|NCT00903968|7316026|FG007|Overall Study|Non-Compliance|0
4508204|NCT00903968|7316019|FG000|Overall Study|Physician Decision|0
4508205|NCT00903968|7316020|FG001|Overall Study|Physician Decision|0
4508206|NCT00903968|7316021|FG002|Overall Study|Physician Decision|0
4508207|NCT00903968|7316022|FG003|Overall Study|Physician Decision|0
4508208|NCT00903968|7316023|FG004|Overall Study|Physician Decision|0
4508209|NCT00903968|7316024|FG005|Overall Study|Physician Decision|1
4508210|NCT00903968|7316025|FG006|Overall Study|Physician Decision|0
4508211|NCT00903968|7316026|FG007|Overall Study|Physician Decision|0
4508212|NCT00903968|7316019|FG000|Overall Study|Progressive Disease|2
4508213|NCT00903968|7316020|FG001|Overall Study|Progressive Disease|3
4508214|NCT00903968|7316021|FG002|Overall Study|Progressive Disease|2
4508215|NCT00903968|7316022|FG003|Overall Study|Progressive Disease|3
4508216|NCT00903968|7316023|FG004|Overall Study|Progressive Disease|3
4508217|NCT00903968|7316024|FG005|Overall Study|Progressive Disease|3
4508218|NCT00903968|7316025|FG006|Overall Study|Progressive Disease|0
4508219|NCT00903968|7316026|FG007|Overall Study|Progressive Disease|18
4508220|NCT00903968|7316019|FG000|Overall Study|Lack of Efficacy|0
4508221|NCT00903968|7316020|FG001|Overall Study|Lack of Efficacy|0
4508222|NCT00903968|7316021|FG002|Overall Study|Lack of Efficacy|0
4508223|NCT00903968|7316022|FG003|Overall Study|Lack of Efficacy|0
4508224|NCT00903968|7316023|FG004|Overall Study|Lack of Efficacy|0
4508225|NCT00903968|7316024|FG005|Overall Study|Lack of Efficacy|0
4508226|NCT00903968|7316025|FG006|Overall Study|Lack of Efficacy|0
4508227|NCT00903968|7316026|FG007|Overall Study|Lack of Efficacy|3
4508228|NCT00904033|7316062|FG000|Overall Study|Withdrawal by Subject|1
4508229|NCT00904033|7316063|FG001|Overall Study|Withdrawal by Subject|1
4508230|NCT00904033|7316064|FG002|Overall Study|Withdrawal by Subject|0
4508231|NCT00904033|7316065|FG003|Overall Study|Withdrawal by Subject|0
4508232|NCT00904033|7316062|FG000|Overall Study|Physician Decision|0
4508233|NCT00904033|7316063|FG001|Overall Study|Physician Decision|0
4508234|NCT00904033|7316064|FG002|Overall Study|Physician Decision|1
4508235|NCT00904033|7316065|FG003|Overall Study|Physician Decision|0
4508236|NCT00904033|7316062|FG000|Overall Study|Unable to obtain final blood draw|0
4508237|NCT00904033|7316063|FG001|Overall Study|Unable to obtain final blood draw|0
4508238|NCT00904033|7316064|FG002|Overall Study|Unable to obtain final blood draw|0
4508239|NCT00904033|7316065|FG003|Overall Study|Unable to obtain final blood draw|2
4508240|NCT00904150|7316078|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3
4508241|NCT00904150|7316079|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0
4508242|NCT00904150|7316078|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0
4508243|NCT00904150|7316079|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145
4508244|NCT00904215|7316085|FG000|Overall Study|Adverse Event|25
4508245|NCT00904215|7316085|FG000|Overall Study|Protocol Violation|10
4508246|NCT00904215|7316085|FG000|Overall Study|Lost to Follow-up|63
4508247|NCT00904215|7316085|FG000|Overall Study|Withdrawal by Subject|9
4508248|NCT00904215|7316085|FG000|Overall Study|Other|28
4508249|NCT00904371|7316093|FG000|Overall Study|Adverse Event|2
4508250|NCT00904371|7316093|FG000|Overall Study|Lost to Follow-up|4
4508251|NCT00904371|7316093|FG000|Overall Study|Discontinued at target blood pressure|2
4508252|NCT00904371|7316093|FG000|Overall Study|Continued with Tritace|1
4508253|NCT00904670|7316113|FG000|Open Label Phase|Withdrawal by Subject|2
4508254|NCT00904670|7316114|FG001|Open Label Phase|Withdrawal by Subject|0
4508255|NCT00904670|7316113|FG000|Open Label Phase|Adverse Event|2
4508256|NCT00904670|7316114|FG001|Open Label Phase|Adverse Event|0
4508257|NCT00904670|7316113|FG000|Open Label Phase|Lack of Efficacy|1
4508258|NCT00904670|7316114|FG001|Open Label Phase|Lack of Efficacy|0
4508259|NCT00904670|7316113|FG000|Open Label Phase|Lost to Follow-up|1
4508260|NCT00904670|7316114|FG001|Open Label Phase|Lost to Follow-up|0
4508261|NCT00904722|7316122|FG000|Overall Study|Physician Decision|1
4508262|NCT00904748|7316126|FG000|Overall Study|Withdrawal by Subject|1
4508263|NCT00904748|7316127|FG001|Overall Study|Withdrawal by Subject|1
4508264|NCT00904748|7316128|FG002|Overall Study|Withdrawal by Subject|1
4508265|NCT00904748|7316129|FG003|Overall Study|Withdrawal by Subject|2
4508266|NCT00904748|7316130|FG004|Overall Study|Withdrawal by Subject|0
4508267|NCT00904748|7316131|FG005|Overall Study|Withdrawal by Subject|0
4508268|NCT00904748|7316126|FG000|Overall Study|Adverse Event|0
4508269|NCT00904748|7316127|FG001|Overall Study|Adverse Event|0
4508270|NCT00904748|7316128|FG002|Overall Study|Adverse Event|0
4508271|NCT00904748|7316129|FG003|Overall Study|Adverse Event|0
4508272|NCT00904748|7316130|FG004|Overall Study|Adverse Event|1
4508273|NCT00904748|7316131|FG005|Overall Study|Adverse Event|0
4508274|NCT00904839|7316178|FG000|Overall Study|Adverse Event|0
4508275|NCT00904839|7316179|FG001|Overall Study|Adverse Event|5
4508276|NCT00904839|7316180|FG002|Overall Study|Adverse Event|4
4508277|NCT00904839|7316178|FG000|Overall Study|Protocol Violation|0
4508278|NCT00904839|7316179|FG001|Overall Study|Protocol Violation|1
4508279|NCT00904839|7316180|FG002|Overall Study|Protocol Violation|1
4508280|NCT00904839|7316178|FG000|Overall Study|Lost to Follow-up|0
4508281|NCT00904839|7316179|FG001|Overall Study|Lost to Follow-up|1
4508282|NCT00904839|7316180|FG002|Overall Study|Lost to Follow-up|2
4508283|NCT00904839|7316178|FG000|Overall Study|Withdrawal by Subject|0
4508284|NCT00904839|7316179|FG001|Overall Study|Withdrawal by Subject|2
4508285|NCT00904839|7316180|FG002|Overall Study|Withdrawal by Subject|0
4508286|NCT00904839|7316178|FG000|Overall Study|Not treated|1
4508287|NCT00904839|7316179|FG001|Overall Study|Not treated|0
4508288|NCT00904839|7316180|FG002|Overall Study|Not treated|1
4508289|NCT00904839|7316178|FG000|Overall Study|Other than above|0
4508290|NCT00904839|7316179|FG001|Overall Study|Other than above|9
4508291|NCT00904839|7316180|FG002|Overall Study|Other than above|7
4518246|NCT00972816|7330381|FG006|Overall Study|Withdrawal by Subject|1
4518247|NCT00972816|7330382|FG007|Overall Study|Withdrawal by Subject|2
4518248|NCT00972816|7330375|FG000|Overall Study|Lost to Follow-up|11
4518249|NCT00972816|7330376|FG001|Overall Study|Lost to Follow-up|9
4518250|NCT00972816|7330377|FG002|Overall Study|Lost to Follow-up|7
4518251|NCT00972816|7330378|FG003|Overall Study|Lost to Follow-up|5
4518252|NCT00972816|7330379|FG004|Overall Study|Lost to Follow-up|11
4518253|NCT00972816|7330380|FG005|Overall Study|Lost to Follow-up|10
4518254|NCT00972816|7330381|FG006|Overall Study|Lost to Follow-up|7
4518255|NCT00972816|7330382|FG007|Overall Study|Lost to Follow-up|7
4518256|NCT00972816|7330375|FG000|Overall Study|Inappropriate enrolment|0
4518257|NCT00972816|7330376|FG001|Overall Study|Inappropriate enrolment|0
4518258|NCT00972816|7330377|FG002|Overall Study|Inappropriate enrolment|0
4518259|NCT00972816|7330378|FG003|Overall Study|Inappropriate enrolment|0
4518260|NCT00972816|7330379|FG004|Overall Study|Inappropriate enrolment|0
4518261|NCT00972816|7330380|FG005|Overall Study|Inappropriate enrolment|0
4590323|NCT01519947|7436142|FG003|Overall Study|Development of Anemia|1
4518262|NCT00972816|7330381|FG006|Overall Study|Inappropriate enrolment|2
4518263|NCT00972816|7330382|FG007|Overall Study|Inappropriate enrolment|0
4518264|NCT00972816|7330375|FG000|Overall Study|Unable to classify|2
4518265|NCT00972816|7330376|FG001|Overall Study|Unable to classify|0
4518266|NCT00972816|7330377|FG002|Overall Study|Unable to classify|0
4518267|NCT00972816|7330378|FG003|Overall Study|Unable to classify|0
4518268|NCT00972816|7330379|FG004|Overall Study|Unable to classify|1
4518269|NCT00972816|7330380|FG005|Overall Study|Unable to classify|0
4518270|NCT00972816|7330381|FG006|Overall Study|Unable to classify|0
4518271|NCT00972816|7330382|FG007|Overall Study|Unable to classify|0
4518272|NCT00973102|7330406|FG000|Overall Study|Protocol Violation|1
4508292|NCT00904917|7316195|FG000|Overall Study|Lost to Follow-up|2
4508293|NCT00904917|7316196|FG001|Overall Study|Lost to Follow-up|2
4508294|NCT00904917|7316197|FG002|Overall Study|Lost to Follow-up|2
4508295|NCT00904917|7316198|FG003|Overall Study|Lost to Follow-up|2
4508296|NCT00904969|7316211|FG000|Overall Study|Lost to Follow-up|4
4508297|NCT00904969|7316211|FG000|Overall Study|Withdrawal by Subject|3
4508298|NCT00904969|7316211|FG000|Overall Study|Additional Treatments|11
4508299|NCT00904969|7316211|FG000|Overall Study|Case Aborted; Subject Exited|1
4508300|NCT00904982|7316234|FG000|Overall Study|Withdrawal by Subject|2
4508301|NCT00904982|7316235|FG001|Overall Study|Withdrawal by Subject|0
4508302|NCT00904982|7316236|FG002|Overall Study|Withdrawal by Subject|0
4508303|NCT00904982|7316237|FG003|Overall Study|Withdrawal by Subject|0
4508304|NCT00905021|7316256|FG000|Overall Study|Adverse Event|2
4508305|NCT00905034|7316261|FG000|Overall Study|Withdrawal by Subject|1
4508306|NCT00905255|7316284|FG000|Overall Study|Adverse Event|7
4508307|NCT00905255|7316285|FG001|Overall Study|Adverse Event|5
4508308|NCT00905255|7316284|FG000|Overall Study|Withdrawal by Subject|5
4508309|NCT00905255|7316285|FG001|Overall Study|Withdrawal by Subject|4
4508310|NCT00905255|7316284|FG000|Overall Study|Familial and Personal Reasons|1
4508311|NCT00905255|7316285|FG001|Overall Study|Familial and Personal Reasons|0
4508312|NCT00905307|7316315|FG000|Overall Study|Switched to Open Label Rescue|7
4508313|NCT00905307|7316316|FG001|Overall Study|Switched to Open Label Rescue|17
4508314|NCT00905307|7316317|FG002|Overall Study|Switched to Open Label Rescue|11
4508315|NCT00905307|7316318|FG003|Overall Study|Switched to Open Label Rescue|11
4508316|NCT00905307|7316319|FG004|Overall Study|Switched to Open Label Rescue|4
4508317|NCT00905307|7316320|FG005|Overall Study|Switched to Open Label Rescue|15
4508318|NCT00905307|7316315|FG000|Overall Study|Lost to Follow-up|0
4508319|NCT00905307|7316316|FG001|Overall Study|Lost to Follow-up|0
4508320|NCT00905307|7316317|FG002|Overall Study|Lost to Follow-up|0
4508321|NCT00905307|7316318|FG003|Overall Study|Lost to Follow-up|0
4508322|NCT00905307|7316319|FG004|Overall Study|Lost to Follow-up|1
4508323|NCT00905307|7316320|FG005|Overall Study|Lost to Follow-up|1
4508324|NCT00905307|7316315|FG000|Overall Study|Adverse Event|3
4508325|NCT00905307|7316316|FG001|Overall Study|Adverse Event|4
4508326|NCT00905307|7316317|FG002|Overall Study|Adverse Event|5
4508327|NCT00905307|7316318|FG003|Overall Study|Adverse Event|11
4508328|NCT00905307|7316319|FG004|Overall Study|Adverse Event|3
4508329|NCT00905307|7316320|FG005|Overall Study|Adverse Event|5
4508330|NCT00905307|7316315|FG000|Overall Study|Withdrawal by Subject|5
4508331|NCT00905307|7316316|FG001|Overall Study|Withdrawal by Subject|13
4508332|NCT00905307|7316317|FG002|Overall Study|Withdrawal by Subject|15
4508333|NCT00905307|7316318|FG003|Overall Study|Withdrawal by Subject|11
4508334|NCT00905307|7316319|FG004|Overall Study|Withdrawal by Subject|4
4508335|NCT00905307|7316320|FG005|Overall Study|Withdrawal by Subject|13
4508336|NCT00905307|7316315|FG000|Overall Study|Protocol Violation|1
4508337|NCT00905307|7316316|FG001|Overall Study|Protocol Violation|0
4508338|NCT00905307|7316317|FG002|Overall Study|Protocol Violation|1
4508339|NCT00905307|7316318|FG003|Overall Study|Protocol Violation|0
4508340|NCT00905307|7316319|FG004|Overall Study|Protocol Violation|0
4508341|NCT00905307|7316320|FG005|Overall Study|Protocol Violation|0
4508342|NCT00905307|7316315|FG000|Overall Study|Lack of Efficacy|6
4508343|NCT00905307|7316316|FG001|Overall Study|Lack of Efficacy|3
4508344|NCT00905307|7316317|FG002|Overall Study|Lack of Efficacy|5
4508345|NCT00905307|7316318|FG003|Overall Study|Lack of Efficacy|4
4508346|NCT00905307|7316319|FG004|Overall Study|Lack of Efficacy|4
4508347|NCT00905307|7316320|FG005|Overall Study|Lack of Efficacy|8
4508348|NCT00905359|7316349|FG000|Overall Study|Lost to Follow-up|17
4508349|NCT00905359|7316350|FG001|Overall Study|Lost to Follow-up|10
4508350|NCT00905359|7316349|FG000|Overall Study|Death|2
4508351|NCT00905359|7316350|FG001|Overall Study|Death|0
4508352|NCT00905359|7316349|FG000|Overall Study|Withdrawal consent|5
4508353|NCT00905359|7316350|FG001|Overall Study|Withdrawal consent|6
4508354|NCT00905424|7316358|FG000|Overall Study|Lost to Follow-up|3
4508355|NCT00905424|7316359|FG001|Overall Study|Lost to Follow-up|3
4508356|NCT00905424|7316358|FG000|Overall Study|Withdrawal by Subject|1
4508357|NCT00905424|7316359|FG001|Overall Study|Withdrawal by Subject|2
4508358|NCT00905424|7316358|FG000|Overall Study|Adverse Event|4
4508359|NCT00905424|7316359|FG001|Overall Study|Adverse Event|2
4508360|NCT00905424|7316358|FG000|Overall Study|Non-compliance with study medication|2
4508361|NCT00905424|7316359|FG001|Overall Study|Non-compliance with study medication|0
4508362|NCT00905424|7316358|FG000|Overall Study|Sponsor decision|1
4508363|NCT00905424|7316359|FG001|Overall Study|Sponsor decision|0
4508364|NCT00905424|7316358|FG000|Overall Study|Positive urine drug screen|0
4508365|NCT00905424|7316359|FG001|Overall Study|Positive urine drug screen|1
4508366|NCT00905424|7316358|FG000|Overall Study|Non-adherence to visit schedule|0
4508367|NCT00905424|7316359|FG001|Overall Study|Non-adherence to visit schedule|1
4508368|NCT00905437|7316369|FG000|Overall Study|Adverse Event|3
4508369|NCT00905437|7316370|FG001|Overall Study|Adverse Event|2
4508370|NCT00905437|7316369|FG000|Overall Study|Lost to Follow-up|0
4508371|NCT00905437|7316370|FG001|Overall Study|Lost to Follow-up|1
4508372|NCT00905437|7316369|FG000|Overall Study|Withdrawal by Subject|0
4508373|NCT00905437|7316370|FG001|Overall Study|Withdrawal by Subject|1
4508374|NCT00905437|7316369|FG000|Overall Study|Other|5
4508375|NCT00905437|7316370|FG001|Overall Study|Other|6
4508376|NCT00905489|7316409|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2
4508377|NCT00905489|7316409|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3
4508378|NCT00905489|7316409|FG000|Optional Extension Phase (OEP)|Adverse Event|1
4508379|NCT00905632|7316456|FG000|Overall Study|Adverse Event|0
4508380|NCT00905632|7316457|FG001|Overall Study|Adverse Event|0
4508381|NCT00905632|7316458|FG002|Overall Study|Adverse Event|0
4508382|NCT00905632|7316459|FG003|Overall Study|Adverse Event|0
4508383|NCT00905632|7316460|FG004|Overall Study|Adverse Event|0
4508384|NCT00905632|7316461|FG005|Overall Study|Adverse Event|1
4508385|NCT00905632|7316462|FG006|Overall Study|Adverse Event|4
4508386|NCT00905840|7316498|FG000|Overall Study|Lost to Follow-up|11
4508387|NCT00905840|7316498|FG000|Overall Study|Death|3
4508388|NCT00905840|7316498|FG000|Overall Study|Withdrawal by Subject|1
4508389|NCT00905840|7316498|FG000|Overall Study|Adverse Event|1
4508390|NCT00906087|7316514|FG000|Initial Washout|Withdrawal by Subject|1
4508391|NCT00906087|7316514|FG000|Initial Washout|Physician Decision|1
4508392|NCT00906204|7316541|FG000|Primary Endpoint (Early Safety)|Physician Decision|1
4508393|NCT00906204|7316542|FG001|Primary Endpoint (Early Safety)|Physician Decision|0
4508394|NCT00906204|7316541|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0
4508395|NCT00906204|7316542|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1
4508396|NCT00906204|7316541|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1
4508397|NCT00906204|7316542|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0
4508398|NCT00906204|7316541|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2
4508399|NCT00906204|7316542|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2
4508400|NCT00906204|7316541|FG000|Secondary Endpoints (Long-term Safety)|Death|0
4508401|NCT00906204|7316542|FG001|Secondary Endpoints (Long-term Safety)|Death|1
4508402|NCT00906282|7316552|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2
4508403|NCT00906282|7316552|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10
4508404|NCT00906282|7316552|FG000|Preoperative Chemotherapy|Progressive disease|6
4508405|NCT00906282|7316552|FG000|Preoperative Chemotherapy|Toxicity|1
4508406|NCT00906347|7316559|FG000|Received Study Drug|8 cm prior to initiation of study drug|18
4508407|NCT00906347|7316560|FG001|Received Study Drug|8 cm prior to initiation of study drug|30
4508408|NCT00906347|7316559|FG000|Received Study Drug|Nonreassuring fetal heart rate|13
4508409|NCT00906347|7316560|FG001|Received Study Drug|Nonreassuring fetal heart rate|1
4508410|NCT00906347|7316559|FG000|Received Study Drug|Refused study drug|1
4508411|NCT00906347|7316560|FG001|Received Study Drug|Refused study drug|0
4508412|NCT00906347|7316559|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8
4508413|NCT00906347|7316560|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0
4508414|NCT00906373|7316568|FG000|Overall Study|Withdrawal by Subject|0
4508415|NCT00906373|7316569|FG001|Overall Study|Withdrawal by Subject|5
4508416|NCT00906373|7316568|FG000|Overall Study|Other|0
4508417|NCT00906373|7316569|FG001|Overall Study|Other|1
4508418|NCT00906373|7316568|FG000|Overall Study|Still on treatment at cutoff date|0
4508419|NCT00906373|7316569|FG001|Overall Study|Still on treatment at cutoff date|2
4508420|NCT00906399|7316579|FG000|Year 1|Randomized But Not Treated|0
4508421|NCT00906399|7316580|FG001|Year 1|Randomized But Not Treated|1
4508422|NCT00906399|7316581|FG002|Year 1|Randomized But Not Treated|3
4508423|NCT00906399|7316582|FG003|Year 1|Randomized But Not Treated|0
4508424|NCT00906399|7316583|FG004|Year 1|Randomized But Not Treated|0
4508425|NCT00906399|7316584|FG005|Year 1|Randomized But Not Treated|0
4508426|NCT00906399|7316585|FG006|Year 1|Randomized But Not Treated|0
4508427|NCT00906399|7316579|FG000|Year 1|Adverse Event|4
4508428|NCT00906399|7316580|FG001|Year 1|Adverse Event|22
4508429|NCT00906399|7316581|FG002|Year 1|Adverse Event|24
4508430|NCT00906399|7316582|FG003|Year 1|Adverse Event|0
4508431|NCT00906399|7316583|FG004|Year 1|Adverse Event|0
4508432|NCT00906399|7316584|FG005|Year 1|Adverse Event|0
4508433|NCT00906399|7316585|FG006|Year 1|Adverse Event|0
4508434|NCT00906399|7316579|FG000|Year 1|Lost to Follow-up|4
4508435|NCT00906399|7316580|FG001|Year 1|Lost to Follow-up|4
4508436|NCT00906399|7316581|FG002|Year 1|Lost to Follow-up|2
4508437|NCT00906399|7316582|FG003|Year 1|Lost to Follow-up|0
4508438|NCT00906399|7316583|FG004|Year 1|Lost to Follow-up|0
4508439|NCT00906399|7316584|FG005|Year 1|Lost to Follow-up|0
4508440|NCT00906399|7316585|FG006|Year 1|Lost to Follow-up|0
4508441|NCT00906399|7316579|FG000|Year 1|Withdrawal by Subject|30
4508442|NCT00906399|7316580|FG001|Year 1|Withdrawal by Subject|32
4508443|NCT00906399|7316581|FG002|Year 1|Withdrawal by Subject|36
4508444|NCT00906399|7316582|FG003|Year 1|Withdrawal by Subject|0
4508445|NCT00906399|7316583|FG004|Year 1|Withdrawal by Subject|0
4508446|NCT00906399|7316584|FG005|Year 1|Withdrawal by Subject|0
4508447|NCT00906399|7316585|FG006|Year 1|Withdrawal by Subject|0
4508448|NCT00906399|7316579|FG000|Year 1|Physician Decision|0
4508449|NCT00906399|7316580|FG001|Year 1|Physician Decision|1
4508450|NCT00906399|7316581|FG002|Year 1|Physician Decision|3
4508451|NCT00906399|7316582|FG003|Year 1|Physician Decision|0
4508452|NCT00906399|7316583|FG004|Year 1|Physician Decision|0
4508453|NCT00906399|7316584|FG005|Year 1|Physician Decision|0
4508454|NCT00906399|7316585|FG006|Year 1|Physician Decision|0
4508455|NCT00906399|7316579|FG000|Year 1|Death|2
4508456|NCT00906399|7316580|FG001|Year 1|Death|1
4508457|NCT00906399|7316581|FG002|Year 1|Death|1
4508458|NCT00906399|7316582|FG003|Year 1|Death|0
4508459|NCT00906399|7316583|FG004|Year 1|Death|0
4508460|NCT00906399|7316584|FG005|Year 1|Death|0
4508461|NCT00906399|7316585|FG006|Year 1|Death|0
4508462|NCT00906399|7316579|FG000|Year 1|Other|4
4508463|NCT00906399|7316580|FG001|Year 1|Other|2
4508464|NCT00906399|7316581|FG002|Year 1|Other|7
4508465|NCT00906399|7316582|FG003|Year 1|Other|0
4508466|NCT00906399|7316583|FG004|Year 1|Other|0
4508467|NCT00906399|7316584|FG005|Year 1|Other|0
4508468|NCT00906399|7316585|FG006|Year 1|Other|0
4508469|NCT00906399|7316579|FG000|Year 2|Adverse Event|0
4508470|NCT00906399|7316580|FG001|Year 2|Adverse Event|0
4508471|NCT00906399|7316581|FG002|Year 2|Adverse Event|0
4508472|NCT00906399|7316582|FG003|Year 2|Adverse Event|9
4508473|NCT00906399|7316583|FG004|Year 2|Adverse Event|8
4508474|NCT00906399|7316584|FG005|Year 2|Adverse Event|11
4508475|NCT00906399|7316585|FG006|Year 2|Adverse Event|6
4508476|NCT00906399|7316579|FG000|Year 2|Lost to Follow-up|0
4508477|NCT00906399|7316580|FG001|Year 2|Lost to Follow-up|0
4508478|NCT00906399|7316581|FG002|Year 2|Lost to Follow-up|0
4508479|NCT00906399|7316582|FG003|Year 2|Lost to Follow-up|1
4627818|NCT01855789|7494670|FG001|1) Baseline up to Week 24|Physician Decision|0
4627819|NCT01855789|7494671|FG002|1) Baseline up to Week 24|Physician Decision|0
4627820|NCT01855789|7494672|FG003|1) Baseline up to Week 24|Physician Decision|0
4627821|NCT01855789|7494669|FG000|1) Baseline up to Week 24|Pregnancy|1
4627822|NCT01855789|7494670|FG001|1) Baseline up to Week 24|Pregnancy|0
4627823|NCT01855789|7494671|FG002|1) Baseline up to Week 24|Pregnancy|0
4627824|NCT01855789|7494672|FG003|1) Baseline up to Week 24|Pregnancy|0
4627825|NCT01855789|7494669|FG000|1) Baseline up to Week 24|Participant Non-compliance|3
4627826|NCT01855789|7494670|FG001|1) Baseline up to Week 24|Participant Non-compliance|0
4627827|NCT01855789|7494671|FG002|1) Baseline up to Week 24|Participant Non-compliance|0
4627828|NCT01855789|7494672|FG003|1) Baseline up to Week 24|Participant Non-compliance|0
4627829|NCT01855789|7494669|FG000|1) Baseline up to Week 24|Sponsor Decision|3
4627830|NCT01855789|7494670|FG001|1) Baseline up to Week 24|Sponsor Decision|0
4627831|NCT01855789|7494671|FG002|1) Baseline up to Week 24|Sponsor Decision|0
4627832|NCT01855789|7494672|FG003|1) Baseline up to Week 24|Sponsor Decision|0
4627833|NCT01855789|7494669|FG000|1) Baseline up to Week 24|Other|4
4627834|NCT01855789|7494670|FG001|1) Baseline up to Week 24|Other|0
4627835|NCT01855789|7494671|FG002|1) Baseline up to Week 24|Other|0
4627836|NCT01855789|7494672|FG003|1) Baseline up to Week 24|Other|0
4627837|NCT01855789|7494669|FG000|2) Week 24 up to End of Study|Adverse Event|0
4627838|NCT01855789|7494670|FG001|2) Week 24 up to End of Study|Adverse Event|4
4627839|NCT01855789|7494671|FG002|2) Week 24 up to End of Study|Adverse Event|5
4508480|NCT00906399|7316583|FG004|Year 2|Lost to Follow-up|4
4508481|NCT00906399|7316584|FG005|Year 2|Lost to Follow-up|2
4508482|NCT00906399|7316585|FG006|Year 2|Lost to Follow-up|4
4508483|NCT00906399|7316579|FG000|Year 2|Withdrawal by Subject|0
4508484|NCT00906399|7316580|FG001|Year 2|Withdrawal by Subject|0
4508485|NCT00906399|7316581|FG002|Year 2|Withdrawal by Subject|0
4508486|NCT00906399|7316582|FG003|Year 2|Withdrawal by Subject|17
4508487|NCT00906399|7316583|FG004|Year 2|Withdrawal by Subject|18
4508488|NCT00906399|7316584|FG005|Year 2|Withdrawal by Subject|27
4508489|NCT00906399|7316585|FG006|Year 2|Withdrawal by Subject|13
4508490|NCT00906399|7316579|FG000|Year 2|Physician Decision|0
4508491|NCT00906399|7316580|FG001|Year 2|Physician Decision|0
4508492|NCT00906399|7316581|FG002|Year 2|Physician Decision|0
4627840|NCT01855789|7494672|FG003|2) Week 24 up to End of Study|Adverse Event|21
4627841|NCT01855789|7494669|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
4627842|NCT01855789|7494670|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
4627843|NCT01855789|7494671|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
4627844|NCT01855789|7494672|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1
4627845|NCT01855789|7494669|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0
4627846|NCT01855789|7494670|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2
4627847|NCT01855789|7494671|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5
4508493|NCT00906399|7316582|FG003|Year 2|Physician Decision|0
4508494|NCT00906399|7316583|FG004|Year 2|Physician Decision|2
4508495|NCT00906399|7316584|FG005|Year 2|Physician Decision|6
4508496|NCT00906399|7316585|FG006|Year 2|Physician Decision|3
4508497|NCT00906399|7316579|FG000|Year 2|Death|0
4508498|NCT00906399|7316580|FG001|Year 2|Death|0
4508499|NCT00906399|7316581|FG002|Year 2|Death|0
4508500|NCT00906399|7316582|FG003|Year 2|Death|1
4508501|NCT00906399|7316583|FG004|Year 2|Death|0
4508502|NCT00906399|7316584|FG005|Year 2|Death|0
4508503|NCT00906399|7316585|FG006|Year 2|Death|3
4508504|NCT00906399|7316579|FG000|Year 2|Other|0
4508505|NCT00906399|7316580|FG001|Year 2|Other|0
4508506|NCT00906399|7316581|FG002|Year 2|Other|0
4508507|NCT00906399|7316582|FG003|Year 2|Other|2
4508508|NCT00906399|7316583|FG004|Year 2|Other|3
4508509|NCT00906399|7316584|FG005|Year 2|Other|1
4508510|NCT00906399|7316585|FG006|Year 2|Other|0
4508511|NCT00906698|7316616|FG000|Overall Study|Dose-limiting toxicity (DLT)|0
4508512|NCT00906698|7316617|FG001|Overall Study|Dose-limiting toxicity (DLT)|6
4508513|NCT00906698|7316618|FG002|Overall Study|Dose-limiting toxicity (DLT)|0
4508514|NCT00906698|7316619|FG003|Overall Study|Dose-limiting toxicity (DLT)|0
4508515|NCT00906698|7316620|FG004|Overall Study|Dose-limiting toxicity (DLT)|1
4508516|NCT00906698|7316621|FG005|Overall Study|Dose-limiting toxicity (DLT)|0
4508517|NCT00906698|7316616|FG000|Overall Study|Adverse Event|0
4508518|NCT00906698|7316617|FG001|Overall Study|Adverse Event|0
4508519|NCT00906698|7316618|FG002|Overall Study|Adverse Event|2
4508520|NCT00906698|7316619|FG003|Overall Study|Adverse Event|0
4508521|NCT00906698|7316620|FG004|Overall Study|Adverse Event|4
4508522|NCT00906698|7316621|FG005|Overall Study|Adverse Event|1
4508523|NCT00906698|7316616|FG000|Overall Study|Disease progression|3
4508524|NCT00906698|7316617|FG001|Overall Study|Disease progression|12
4508525|NCT00906698|7316618|FG002|Overall Study|Disease progression|4
4508526|NCT00906698|7316619|FG003|Overall Study|Disease progression|4
4508527|NCT00906698|7316620|FG004|Overall Study|Disease progression|12
4508528|NCT00906698|7316621|FG005|Overall Study|Disease progression|4
4508529|NCT00906698|7316616|FG000|Overall Study|Withdrawal by Subject|0
4508530|NCT00906698|7316617|FG001|Overall Study|Withdrawal by Subject|0
4508531|NCT00906698|7316618|FG002|Overall Study|Withdrawal by Subject|0
4508532|NCT00906698|7316619|FG003|Overall Study|Withdrawal by Subject|0
4508533|NCT00906698|7316620|FG004|Overall Study|Withdrawal by Subject|1
4508534|NCT00906698|7316621|FG005|Overall Study|Withdrawal by Subject|0
4508535|NCT00906698|7316616|FG000|Overall Study|incl. non compliance, lost to follow-up|0
4508536|NCT00906698|7316617|FG001|Overall Study|incl. non compliance, lost to follow-up|1
4508537|NCT00906698|7316618|FG002|Overall Study|incl. non compliance, lost to follow-up|0
4508538|NCT00906698|7316619|FG003|Overall Study|incl. non compliance, lost to follow-up|0
4508539|NCT00906698|7316620|FG004|Overall Study|incl. non compliance, lost to follow-up|0
4508540|NCT00906698|7316621|FG005|Overall Study|incl. non compliance, lost to follow-up|0
4508541|NCT00906945|7316673|FG000|Overall Study|Found to be not eligible|0
4508542|NCT00906945|7316674|FG001|Overall Study|Found to be not eligible|0
4508543|NCT00906945|7316675|FG002|Overall Study|Found to be not eligible|0
4508544|NCT00906945|7316676|FG003|Overall Study|Found to be not eligible|1
4508545|NCT00906945|7316677|FG004|Overall Study|Found to be not eligible|1
4508546|NCT00906945|7316678|FG005|Overall Study|Found to be not eligible|1
4508547|NCT00906945|7316673|FG000|Overall Study|Physician Decision|0
4508548|NCT00906945|7316674|FG001|Overall Study|Physician Decision|0
4508549|NCT00906945|7316675|FG002|Overall Study|Physician Decision|0
4508550|NCT00906945|7316676|FG003|Overall Study|Physician Decision|0
4508551|NCT00906945|7316677|FG004|Overall Study|Physician Decision|0
4508552|NCT00906945|7316678|FG005|Overall Study|Physician Decision|1
4508553|NCT00906971|7316705|FG000|Overall Study|Withdrawal by Subject|8
4508554|NCT00906971|7316706|FG001|Overall Study|Withdrawal by Subject|2
4627848|NCT01855789|7494672|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16
4627849|NCT01855789|7494669|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0
4627850|NCT01855789|7494670|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1
4627851|NCT01855789|7494671|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1
4627852|NCT01855789|7494672|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4
4704975|NCT02759315|7624233|FG000|Overall Study|Study terminated prior to completion|2
4704976|NCT02759315|7624234|FG001|Overall Study|Study terminated prior to completion|0
4704977|NCT02759315|7624235|FG002|Overall Study|Study terminated prior to completion|5
4704978|NCT02759315|7624236|FG003|Overall Study|Study terminated prior to completion|0
4704979|NCT02759315|7624237|FG004|Overall Study|Study terminated prior to completion|1
4704980|NCT02759471|7624270|FG000|Overall Study|discomfort|2
4704981|NCT02759562|7624278|FG000|Open-Label Treatment Period|Withdrew Consent|1
4704982|NCT02759562|7624279|FG001|Open-Label Treatment Period|Withdrew Consent|0
4704983|NCT02759562|7624278|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1
4704984|NCT02759562|7624279|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2
4627853|NCT01855789|7494669|FG000|2) Week 24 up to End of Study|Protocol Violation|0
4627854|NCT01855789|7494670|FG001|2) Week 24 up to End of Study|Protocol Violation|0
4627855|NCT01855789|7494671|FG002|2) Week 24 up to End of Study|Protocol Violation|0
4704985|NCT02759692|7624290|FG000|Period 1|Test article no longer available|1
4704986|NCT02759692|7624291|FG001|Period 1|Test article no longer available|1
4704987|NCT02759692|7624290|FG000|Period 1|No longer meets eligibility criteria.|1
4704988|NCT02759692|7624291|FG001|Period 1|No longer meets eligibility criteria.|0
4704989|NCT02759692|7624290|FG000|Period 1|Miss-Randomized|1
4704990|NCT02759692|7624291|FG001|Period 1|Miss-Randomized|1
4704991|NCT02759692|7624290|FG000|Period 2|Lost to Follow-up|1
4704992|NCT02759692|7624291|FG001|Period 2|Lost to Follow-up|0
4704993|NCT02759692|7624290|FG000|Period 2|Test article no longer available|0
4704994|NCT02759692|7624291|FG001|Period 2|Test article no longer available|1
4704995|NCT02759939|7624301|FG000|Overall Study|Missing data on first outcome assessed|11
4704996|NCT02759939|7624302|FG001|Overall Study|Missing data on first outcome assessed|2
4704997|NCT02759939|7624303|FG002|Overall Study|Missing data on first outcome assessed|5
4704998|NCT02759939|7624304|FG003|Overall Study|Missing data on first outcome assessed|2
4704999|NCT02759939|7624301|FG000|Overall Study|Ineligible for T2 and T3|310
4705000|NCT02759939|7624302|FG001|Overall Study|Ineligible for T2 and T3|179
4705001|NCT02759939|7624303|FG002|Overall Study|Ineligible for T2 and T3|366
4705002|NCT02759939|7624304|FG003|Overall Study|Ineligible for T2 and T3|391
4705003|NCT02759939|7624301|FG000|Overall Study|Lost to Follow-up|735
4705004|NCT02759939|7624302|FG001|Overall Study|Lost to Follow-up|791
4705005|NCT02759939|7624303|FG002|Overall Study|Lost to Follow-up|783
4705006|NCT02759939|7624304|FG003|Overall Study|Lost to Follow-up|650
4705007|NCT02760069|7624327|FG000|Overall Study|Withdrawal by Subject|0
4705008|NCT02760069|7624328|FG001|Overall Study|Withdrawal by Subject|1
4508555|NCT00906971|7316705|FG000|Overall Study|Lost to Follow-up|0
4508556|NCT00906971|7316706|FG001|Overall Study|Lost to Follow-up|1
4508557|NCT00907153|7316727|FG000|Overall Study|Lost to Follow-up|1
4508558|NCT00907153|7316728|FG001|Overall Study|Lost to Follow-up|1
4508559|NCT00907153|7316727|FG000|Overall Study|Withdrawal by Subject|1
4508560|NCT00907153|7316728|FG001|Overall Study|Withdrawal by Subject|3
4508561|NCT00907257|7316736|FG000|Overall Study|Adverse Event|0
4508562|NCT00907257|7316737|FG001|Overall Study|Adverse Event|4
4508563|NCT00907257|7316736|FG000|Overall Study|Protocol Violation|1
4508564|NCT00907257|7316737|FG001|Overall Study|Protocol Violation|2
4508565|NCT00907257|7316736|FG000|Overall Study|Lost to Follow-up|3
4508566|NCT00907257|7316737|FG001|Overall Study|Lost to Follow-up|3
4508567|NCT00907257|7316736|FG000|Overall Study|Withdrawal by Subject|1
4508568|NCT00907257|7316737|FG001|Overall Study|Withdrawal by Subject|2
4508569|NCT00907257|7316736|FG000|Overall Study|Per IRB-Subject became vulnerable|1
4508570|NCT00907257|7316737|FG001|Overall Study|Per IRB-Subject became vulnerable|0
4508571|NCT00907257|7316736|FG000|Overall Study|Moved|1
4508572|NCT00907257|7316737|FG001|Overall Study|Moved|0
4508573|NCT00907257|7316736|FG000|Overall Study|Personal Reasons|6
4508574|NCT00907257|7316737|FG001|Overall Study|Personal Reasons|1
4508575|NCT00907296|7316753|FG000|Overall Study|Ineligibility Determined|1
4508576|NCT00907296|7316754|FG001|Overall Study|Ineligibility Determined|0
4508577|NCT00907296|7316755|FG002|Overall Study|Ineligibility Determined|0
4508578|NCT00907296|7316756|FG003|Overall Study|Ineligibility Determined|1
4508579|NCT00907296|7316757|FG004|Overall Study|Ineligibility Determined|0
4508580|NCT00907296|7316758|FG005|Overall Study|Ineligibility Determined|0
4508581|NCT00907296|7316759|FG006|Overall Study|Ineligibility Determined|0
4508582|NCT00907296|7316760|FG007|Overall Study|Ineligibility Determined|1
4508583|NCT00907296|7316761|FG008|Overall Study|Ineligibility Determined|0
4508584|NCT00907296|7316762|FG009|Overall Study|Ineligibility Determined|0
4508585|NCT00907296|7316753|FG000|Overall Study|Protocol Deviation|0
4508586|NCT00907296|7316754|FG001|Overall Study|Protocol Deviation|1
4508587|NCT00907296|7316755|FG002|Overall Study|Protocol Deviation|0
4508588|NCT00907296|7316756|FG003|Overall Study|Protocol Deviation|0
4508589|NCT00907296|7316757|FG004|Overall Study|Protocol Deviation|0
4508590|NCT00907296|7316758|FG005|Overall Study|Protocol Deviation|0
4508591|NCT00907296|7316759|FG006|Overall Study|Protocol Deviation|0
4508592|NCT00907296|7316760|FG007|Overall Study|Protocol Deviation|0
4508593|NCT00907296|7316761|FG008|Overall Study|Protocol Deviation|0
4508594|NCT00907296|7316762|FG009|Overall Study|Protocol Deviation|0
4508595|NCT00907296|7316753|FG000|Overall Study|Noncompliance|1
4508596|NCT00907296|7316754|FG001|Overall Study|Noncompliance|1
4508597|NCT00907296|7316755|FG002|Overall Study|Noncompliance|1
4508598|NCT00907296|7316756|FG003|Overall Study|Noncompliance|0
4508599|NCT00907296|7316757|FG004|Overall Study|Noncompliance|0
4508600|NCT00907296|7316758|FG005|Overall Study|Noncompliance|1
4508601|NCT00907296|7316759|FG006|Overall Study|Noncompliance|0
4508602|NCT00907296|7316760|FG007|Overall Study|Noncompliance|2
4508603|NCT00907296|7316761|FG008|Overall Study|Noncompliance|0
4508604|NCT00907296|7316762|FG009|Overall Study|Noncompliance|0
4508605|NCT00907296|7316753|FG000|Overall Study|Adverse Event|2
4508606|NCT00907296|7316754|FG001|Overall Study|Adverse Event|0
4508607|NCT00907296|7316755|FG002|Overall Study|Adverse Event|0
4508608|NCT00907296|7316756|FG003|Overall Study|Adverse Event|0
4508609|NCT00907296|7316757|FG004|Overall Study|Adverse Event|0
4508610|NCT00907296|7316758|FG005|Overall Study|Adverse Event|0
4508611|NCT00907296|7316759|FG006|Overall Study|Adverse Event|1
4508612|NCT00907296|7316760|FG007|Overall Study|Adverse Event|0
4508613|NCT00907296|7316761|FG008|Overall Study|Adverse Event|0
4508614|NCT00907296|7316762|FG009|Overall Study|Adverse Event|1
4508615|NCT00907296|7316753|FG000|Overall Study|Withdrawal by Subject|7
4508616|NCT00907296|7316754|FG001|Overall Study|Withdrawal by Subject|2
4508617|NCT00907296|7316755|FG002|Overall Study|Withdrawal by Subject|1
4508618|NCT00907296|7316756|FG003|Overall Study|Withdrawal by Subject|1
4508619|NCT00907296|7316757|FG004|Overall Study|Withdrawal by Subject|1
4508620|NCT00907296|7316758|FG005|Overall Study|Withdrawal by Subject|5
4508621|NCT00907296|7316759|FG006|Overall Study|Withdrawal by Subject|3
4508622|NCT00907296|7316760|FG007|Overall Study|Withdrawal by Subject|2
4508623|NCT00907296|7316761|FG008|Overall Study|Withdrawal by Subject|4
4508624|NCT00907296|7316762|FG009|Overall Study|Withdrawal by Subject|2
4508625|NCT00907296|7316753|FG000|Overall Study|Lost to Follow-up|9
4508626|NCT00907296|7316754|FG001|Overall Study|Lost to Follow-up|1
4508627|NCT00907296|7316755|FG002|Overall Study|Lost to Follow-up|0
4508628|NCT00907296|7316756|FG003|Overall Study|Lost to Follow-up|2
4508629|NCT00907296|7316757|FG004|Overall Study|Lost to Follow-up|0
4508630|NCT00907296|7316758|FG005|Overall Study|Lost to Follow-up|3
4508631|NCT00907296|7316759|FG006|Overall Study|Lost to Follow-up|2
4508632|NCT00907296|7316760|FG007|Overall Study|Lost to Follow-up|2
4508633|NCT00907296|7316761|FG008|Overall Study|Lost to Follow-up|0
4508634|NCT00907296|7316762|FG009|Overall Study|Lost to Follow-up|4
4508635|NCT00907335|7316786|FG000|Overall Study|Withdrawal by Subject|2
4508636|NCT00907335|7316787|FG001|Overall Study|Withdrawal by Subject|0
4508637|NCT00907335|7316786|FG000|Overall Study|Adverse Event|4
4508638|NCT00907335|7316787|FG001|Overall Study|Adverse Event|1
4508639|NCT00907335|7316786|FG000|Overall Study|Lost to Follow-up|2
4508640|NCT00907335|7316787|FG001|Overall Study|Lost to Follow-up|0
4508641|NCT00907374|7316795|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2
4508642|NCT00907374|7316796|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2
4705009|NCT02760069|7624329|FG002|Overall Study|Withdrawal by Subject|1
4705010|NCT02760368|7624375|FG000|Overall Study|Withdrawal by Subject|12
4705011|NCT02760368|7624376|FG001|Overall Study|Withdrawal by Subject|8
4705012|NCT02760368|7624377|FG002|Overall Study|Withdrawal by Subject|9
4705013|NCT02760368|7624375|FG000|Overall Study|Screen Failure|0
4705014|NCT02760368|7624376|FG001|Overall Study|Screen Failure|0
4508643|NCT00907478|7316817|FG000|Overall Study|Ineligibility determined|0
4508644|NCT00907478|7316818|FG001|Overall Study|Ineligibility determined|0
4508645|NCT00907478|7316819|FG002|Overall Study|Ineligibility determined|1
4508646|NCT00907478|7316817|FG000|Overall Study|Noncompliance|0
4508647|NCT00907478|7316818|FG001|Overall Study|Noncompliance|0
4508648|NCT00907478|7316819|FG002|Overall Study|Noncompliance|1
4508649|NCT00907478|7316817|FG000|Overall Study|Adverse Event|3
4508650|NCT00907478|7316818|FG001|Overall Study|Adverse Event|1
4508651|NCT00907478|7316819|FG002|Overall Study|Adverse Event|2
4508652|NCT00907478|7316817|FG000|Overall Study|Withdrawal by Subject|8
4508653|NCT00907478|7316818|FG001|Overall Study|Withdrawal by Subject|9
4508654|NCT00907478|7316819|FG002|Overall Study|Withdrawal by Subject|6
4508655|NCT00907478|7316817|FG000|Overall Study|Requirement for alternative therapy|1
4508656|NCT00907478|7316818|FG001|Overall Study|Requirement for alternative therapy|2
4508657|NCT00907478|7316819|FG002|Overall Study|Requirement for alternative therapy|3
4508658|NCT00907478|7316817|FG000|Overall Study|Physician Decision|2
4508659|NCT00907478|7316818|FG001|Overall Study|Physician Decision|0
4508660|NCT00907478|7316819|FG002|Overall Study|Physician Decision|3
4508661|NCT00907478|7316817|FG000|Overall Study|Death|4
4508662|NCT00907478|7316818|FG001|Overall Study|Death|2
4508663|NCT00907478|7316819|FG002|Overall Study|Death|1
4508664|NCT00907478|7316817|FG000|Overall Study|Protocol-specified criteria|5
4508665|NCT00907478|7316818|FG001|Overall Study|Protocol-specified criteria|2
4508666|NCT00907478|7316819|FG002|Overall Study|Protocol-specified criteria|3
4508667|NCT00907478|7316817|FG000|Overall Study|Pregnancy|0
4508668|NCT00907478|7316818|FG001|Overall Study|Pregnancy|1
4508669|NCT00907478|7316819|FG002|Overall Study|Pregnancy|1
4508670|NCT00907478|7316817|FG000|Overall Study|Lost to Follow-up|1
4508671|NCT00907478|7316818|FG001|Overall Study|Lost to Follow-up|0
4508672|NCT00907478|7316819|FG002|Overall Study|Lost to Follow-up|0
4508673|NCT00907478|7316817|FG000|Overall Study|Other|3
4508674|NCT00907478|7316818|FG001|Overall Study|Other|0
4508675|NCT00907478|7316819|FG002|Overall Study|Other|1
4508676|NCT00907517|7316834|FG000|Overall Study|Progressive Disease|3
4508677|NCT00907517|7316835|FG001|Overall Study|Progressive Disease|3
4508678|NCT00907517|7316836|FG002|Overall Study|Progressive Disease|4
4508679|NCT00907517|7316837|FG003|Overall Study|Progressive Disease|4
4508680|NCT00907517|7316838|FG004|Overall Study|Progressive Disease|4
4508681|NCT00907517|7316834|FG000|Overall Study|Symptomatic Deterioration|0
4508682|NCT00907517|7316835|FG001|Overall Study|Symptomatic Deterioration|0
4508683|NCT00907517|7316836|FG002|Overall Study|Symptomatic Deterioration|0
4508684|NCT00907517|7316837|FG003|Overall Study|Symptomatic Deterioration|0
4508685|NCT00907517|7316838|FG004|Overall Study|Symptomatic Deterioration|1
4508686|NCT00907621|7316852|FG000|Overall Study|Lost to Follow-up|6
4508687|NCT00907621|7316853|FG001|Overall Study|Lost to Follow-up|3
4705015|NCT02760368|7624377|FG002|Overall Study|Screen Failure|1
4705016|NCT02760368|7624375|FG000|Overall Study|Death|1
4705017|NCT02760368|7624376|FG001|Overall Study|Death|0
4705018|NCT02760368|7624377|FG002|Overall Study|Death|0
4705019|NCT02760368|7624375|FG000|Overall Study|Withdrawal by Sponsor|0
4705020|NCT02760368|7624376|FG001|Overall Study|Withdrawal by Sponsor|0
4705021|NCT02760368|7624377|FG002|Overall Study|Withdrawal by Sponsor|1
4705022|NCT02760407|7624389|FG000|Overall Study|Death|2
4705023|NCT02760407|7624390|FG001|Overall Study|Death|3
4387345|NCT00048074|7165983|FG000|Overall Study|Lost to Follow-up|2
4387346|NCT00048074|7165984|FG001|Overall Study|Lost to Follow-up|6
4387347|NCT00048074|7165985|FG002|Overall Study|Lost to Follow-up|6
4387348|NCT00048074|7165983|FG000|Overall Study|Withdrawal by Subject|28
4387349|NCT00048074|7165984|FG001|Overall Study|Withdrawal by Subject|30
4387350|NCT00048074|7165985|FG002|Overall Study|Withdrawal by Subject|35
4387351|NCT00048074|7165983|FG000|Overall Study|Protocol Violation|1
4387352|NCT00048074|7165984|FG001|Overall Study|Protocol Violation|3
4387353|NCT00048074|7165985|FG002|Overall Study|Protocol Violation|0
4387354|NCT00048074|7165983|FG000|Overall Study|Study participation was terminated|0
4387355|NCT00048074|7165984|FG001|Overall Study|Study participation was terminated|1
4387356|NCT00048074|7165985|FG002|Overall Study|Study participation was terminated|0
4387357|NCT00048074|7165983|FG000|Overall Study|Husband ill|0
4387358|NCT00048074|7165984|FG001|Overall Study|Husband ill|1
4508688|NCT00907621|7316852|FG000|Overall Study|intercurrent febrile illness|1
4508689|NCT00907621|7316853|FG001|Overall Study|intercurrent febrile illness|1
4508690|NCT00907738|7316864|FG000|Overall Study|Adverse Event|2
4508691|NCT00907738|7316865|FG001|Overall Study|Adverse Event|0
4508692|NCT00907738|7316866|FG002|Overall Study|Adverse Event|1
4508693|NCT00907738|7316867|FG003|Overall Study|Adverse Event|0
4508694|NCT00907738|7316868|FG004|Overall Study|Adverse Event|0
4508695|NCT00907738|7316864|FG000|Overall Study|not specified or withdrew consent|3
4508696|NCT00907738|7316865|FG001|Overall Study|not specified or withdrew consent|0
4508697|NCT00907738|7316866|FG002|Overall Study|not specified or withdrew consent|0
4508698|NCT00907738|7316867|FG003|Overall Study|not specified or withdrew consent|0
4508699|NCT00907738|7316868|FG004|Overall Study|not specified or withdrew consent|0
4508700|NCT00907738|7316864|FG000|Overall Study|Disease progression|8
4627856|NCT01855789|7494672|FG003|2) Week 24 up to End of Study|Protocol Violation|1
4508701|NCT00907738|7316865|FG001|Overall Study|Disease progression|1
4508702|NCT00907738|7316866|FG002|Overall Study|Disease progression|6
4508703|NCT00907738|7316867|FG003|Overall Study|Disease progression|4
4508704|NCT00907738|7316868|FG004|Overall Study|Disease progression|2
4508705|NCT00907777|7316886|FG000|Overall Study|Withdrawal by Subject|0
4508706|NCT00907777|7316887|FG001|Overall Study|Withdrawal by Subject|1
4508707|NCT00907803|7316896|FG000|Overall Study|Withdrawal of consent - long commute|1
4508708|NCT00907803|7316897|FG001|Overall Study|Withdrawal of consent - long commute|0
4508709|NCT00907803|7316898|FG002|Overall Study|Withdrawal of consent - long commute|0
4508710|NCT00907803|7316896|FG000|Overall Study|Adverse Event|2
4508711|NCT00907803|7316897|FG001|Overall Study|Adverse Event|0
4508712|NCT00907803|7316898|FG002|Overall Study|Adverse Event|0
4508713|NCT00907803|7316896|FG000|Overall Study|Withdrawal by Subject|0
4508714|NCT00907803|7316897|FG001|Overall Study|Withdrawal by Subject|1
4508715|NCT00907803|7316898|FG002|Overall Study|Withdrawal by Subject|0
4508716|NCT00907803|7316896|FG000|Overall Study|Lost to Follow-up|0
4508717|NCT00907803|7316897|FG001|Overall Study|Lost to Follow-up|1
4508718|NCT00907803|7316898|FG002|Overall Study|Lost to Follow-up|0
4508719|NCT00907803|7316896|FG000|Overall Study|Protocol Violation|0
4508720|NCT00907803|7316897|FG001|Overall Study|Protocol Violation|1
4508721|NCT00907803|7316898|FG002|Overall Study|Protocol Violation|0
4508722|NCT00907881|7316906|FG000|Overall Study|Lost to Follow-up|59
4508723|NCT00907881|7316906|FG000|Overall Study|Noncompliance|5
4508724|NCT00907881|7316906|FG000|Overall Study|Withdrawal by Subject|5
4508725|NCT00907881|7316906|FG000|Overall Study|Protocol Violation|1
4508726|NCT00907881|7316906|FG000|Overall Study|Missing discontinuation information|15
4508727|NCT00908011|7316912|FG000|Overall Study|Withdrawal by Subject|2
4508728|NCT00908011|7316913|FG001|Overall Study|Withdrawal by Subject|2
4508729|NCT00908037|7316926|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0
4508730|NCT00908037|7316927|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0
4508731|NCT00908037|7316928|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0
4508732|NCT00908037|7316929|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0
4508733|NCT00908037|7316930|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1
4508734|NCT00908037|7316931|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0
4508735|NCT00908037|7316932|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3
4508736|NCT00908037|7316933|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0
4508737|NCT00908037|7316934|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1
4508738|NCT00908037|7316935|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0
4508739|NCT00908037|7316936|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0
4508740|NCT00908037|7316937|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0
4508741|NCT00908037|7316926|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
4508742|NCT00908037|7316927|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
4508743|NCT00908037|7316928|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
4508744|NCT00908037|7316929|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
4508745|NCT00908037|7316930|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2
4508746|NCT00908037|7316931|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
4508747|NCT00908037|7316932|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
4508748|NCT00908037|7316933|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
4508749|NCT00908037|7316934|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4
4508750|NCT00908037|7316935|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
4508751|NCT00908037|7316936|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
4508752|NCT00908037|7316937|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
4508753|NCT00908037|7316926|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
4508754|NCT00908037|7316927|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
4508755|NCT00908037|7316928|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
4508756|NCT00908037|7316929|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1
4508757|NCT00908037|7316930|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
4508758|NCT00908037|7316931|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
4508759|NCT00908037|7316932|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1
4508760|NCT00908037|7316933|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
4508761|NCT00908037|7316934|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
4508762|NCT00908037|7316935|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
4508763|NCT00908037|7316936|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
4508764|NCT00908037|7316937|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
4508765|NCT00908037|7316926|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
4508766|NCT00908037|7316927|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
4508767|NCT00908037|7316928|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
4508768|NCT00908037|7316929|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
4633240|NCT01909804|7503299|FG003|Overall Study|Death|0
4508769|NCT00908037|7316930|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
4508770|NCT00908037|7316931|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
4508771|NCT00908037|7316932|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
4508772|NCT00908037|7316933|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
4508773|NCT00908037|7316934|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
4508774|NCT00908037|7316935|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
4508775|NCT00908037|7316936|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
4508776|NCT00908037|7316937|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1
4508777|NCT00908037|7316926|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
4508778|NCT00908037|7316927|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
4508779|NCT00908037|7316928|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
4508780|NCT00908037|7316929|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
4508781|NCT00908037|7316930|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
4508782|NCT00908037|7316931|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
4508783|NCT00908037|7316932|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
4508784|NCT00908037|7316933|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
4508785|NCT00908037|7316934|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
4508786|NCT00908037|7316935|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1
4508787|NCT00908037|7316936|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
4508788|NCT00908037|7316937|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2
4508789|NCT00908037|7316926|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
4508790|NCT00908037|7316927|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
4508791|NCT00908037|7316928|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
4508792|NCT00908037|7316929|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
4508793|NCT00908037|7316930|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
4508794|NCT00908037|7316931|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
4508795|NCT00908037|7316932|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
4508796|NCT00908037|7316933|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
4508797|NCT00908037|7316934|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
4508798|NCT00908037|7316935|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1
4508799|NCT00908037|7316936|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
4508800|NCT00908037|7316937|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
4508801|NCT00908037|7316926|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
4508802|NCT00908037|7316927|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
4508803|NCT00908037|7316928|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
4508804|NCT00908037|7316929|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
4508805|NCT00908037|7316930|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
4508806|NCT00908037|7316931|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
4627857|NCT01855789|7494669|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0
4627858|NCT01855789|7494670|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7
4627859|NCT01855789|7494671|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5
4508807|NCT00908037|7316932|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
4508808|NCT00908037|7316933|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
4508809|NCT00908037|7316934|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
4508810|NCT00908037|7316935|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
4508811|NCT00908037|7316936|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2
4508812|NCT00908037|7316937|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
4508813|NCT00908037|7316926|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
4508814|NCT00908037|7316927|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
4508815|NCT00908037|7316928|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
4508816|NCT00908037|7316929|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
4508817|NCT00908037|7316930|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
4508818|NCT00908037|7316931|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
4508819|NCT00908037|7316932|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
4508820|NCT00908037|7316933|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
4508821|NCT00908037|7316934|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
4508822|NCT00908037|7316935|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1
4508823|NCT00908037|7316936|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
4508824|NCT00908037|7316937|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
4508825|NCT00908037|7316926|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
4508826|NCT00908037|7316927|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
4508827|NCT00908037|7316928|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
4508828|NCT00908037|7316929|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
4508829|NCT00908037|7316930|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
4627860|NCT01855789|7494672|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8
4627861|NCT01855789|7494669|FG000|2) Week 24 up to End of Study|Physician Decision|0
4508830|NCT00908037|7316931|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
4508831|NCT00908037|7316932|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
4508832|NCT00908037|7316933|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
4508833|NCT00908037|7316934|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
4508834|NCT00908037|7316935|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
4508835|NCT00908037|7316936|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2
4508836|NCT00908037|7316937|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
4508837|NCT00908076|7316991|FG000|Overall Study|Lack of Efficacy|1
4508838|NCT00908076|7316992|FG001|Overall Study|Lack of Efficacy|1
4508839|NCT00908115|7316998|FG000|Overall Study|Other|14
4508840|NCT00908141|7317004|FG000|Overall Study|Withdrawal by Subject|0
4508841|NCT00908141|7317005|FG001|Overall Study|Withdrawal by Subject|1
4508842|NCT00908232|7317011|FG000|Cycle 1 to 4|Death|5
4508843|NCT00908232|7317012|FG001|Cycle 1 to 4|Death|0
4508844|NCT00908232|7317013|FG002|Cycle 1 to 4|Death|0
4508845|NCT00908232|7317014|FG003|Cycle 1 to 4|Death|0
4508846|NCT00908232|7317011|FG000|Cycle 1 to 4|Withdrawal by Subject|4
4508847|NCT00908232|7317012|FG001|Cycle 1 to 4|Withdrawal by Subject|0
4508848|NCT00908232|7317013|FG002|Cycle 1 to 4|Withdrawal by Subject|0
4508849|NCT00908232|7317014|FG003|Cycle 1 to 4|Withdrawal by Subject|0
4508850|NCT00908232|7317011|FG000|Cycle 1 to 4|Progressive Disease|6
4508851|NCT00908232|7317012|FG001|Cycle 1 to 4|Progressive Disease|0
4508852|NCT00908232|7317013|FG002|Cycle 1 to 4|Progressive Disease|0
4508853|NCT00908232|7317014|FG003|Cycle 1 to 4|Progressive Disease|0
4508854|NCT00908232|7317011|FG000|Cycle 1 to 4|Adverse Event|12
4508855|NCT00908232|7317012|FG001|Cycle 1 to 4|Adverse Event|0
4508856|NCT00908232|7317013|FG002|Cycle 1 to 4|Adverse Event|0
4508857|NCT00908232|7317014|FG003|Cycle 1 to 4|Adverse Event|0
4508858|NCT00908232|7317011|FG000|Cycle 1 to 4|Other|1
4508859|NCT00908232|7317012|FG001|Cycle 1 to 4|Other|0
4508860|NCT00908232|7317013|FG002|Cycle 1 to 4|Other|0
4508861|NCT00908232|7317014|FG003|Cycle 1 to 4|Other|0
4508862|NCT00908232|7317011|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1
4508863|NCT00908232|7317012|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
4508864|NCT00908232|7317013|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
4508865|NCT00908232|7317014|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
4508866|NCT00908232|7317011|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5
4508867|NCT00908232|7317012|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
4508868|NCT00908232|7317013|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
4508869|NCT00908232|7317014|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
4508870|NCT00908232|7317011|FG000|Randomization (Cycle 5) to Cycle 8|Death|2
4508871|NCT00908232|7317012|FG001|Randomization (Cycle 5) to Cycle 8|Death|0
4508872|NCT00908232|7317013|FG002|Randomization (Cycle 5) to Cycle 8|Death|0
4508873|NCT00908232|7317014|FG003|Randomization (Cycle 5) to Cycle 8|Death|0
4508874|NCT00908232|7317011|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4
4508875|NCT00908232|7317012|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0
4508876|NCT00908232|7317013|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1
4508877|NCT00908232|7317014|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0
4508878|NCT00908232|7317011|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17
4508879|NCT00908232|7317012|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2
4508880|NCT00908232|7317013|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0
4508881|NCT00908232|7317014|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0
4508882|NCT00908232|7317011|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2
4508883|NCT00908232|7317012|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
4508884|NCT00908232|7317013|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
4508885|NCT00908232|7317014|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
4508886|NCT00908232|7317011|FG000|Randomization (Cycle 5) to Cycle 8|Other|3
4508887|NCT00908232|7317012|FG001|Randomization (Cycle 5) to Cycle 8|Other|1
4508888|NCT00908232|7317013|FG002|Randomization (Cycle 5) to Cycle 8|Other|0
4508889|NCT00908232|7317014|FG003|Randomization (Cycle 5) to Cycle 8|Other|0
4508890|NCT00908232|7317011|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1
4508891|NCT00908232|7317012|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
4508892|NCT00908232|7317013|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
4508893|NCT00908232|7317014|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
4508894|NCT00908310|7317020|FG000|Overall Study|Death|37
4508895|NCT00908310|7317020|FG000|Overall Study|Withdrawal by Subject|7
4705024|NCT02760407|7624391|FG002|Overall Study|Death|1
4705025|NCT02760407|7624392|FG003|Overall Study|Death|1
4705026|NCT02760407|7624389|FG000|Overall Study|Lost to Follow-up|1
4705027|NCT02760407|7624390|FG001|Overall Study|Lost to Follow-up|7
4705028|NCT02760407|7624391|FG002|Overall Study|Lost to Follow-up|4
4705029|NCT02760407|7624392|FG003|Overall Study|Lost to Follow-up|6
4508896|NCT00908310|7317020|FG000|Overall Study|Lost to Follow-up|7
4705030|NCT02760407|7624389|FG000|Overall Study|Withdrawal by Subject|25
4705031|NCT02760407|7624390|FG001|Overall Study|Withdrawal by Subject|31
4508897|NCT00908310|7317020|FG000|Overall Study|Screening failure|5
4508898|NCT00908310|7317020|FG000|Overall Study|Other reasons|4
4508899|NCT00908349|7317024|FG000|Overall Study|Adverse Event|10
4508900|NCT00908349|7317024|FG000|Overall Study|Withdrawal by Subject|9
4508901|NCT00908349|7317024|FG000|Overall Study|Physician Decision|5
4508902|NCT00908349|7317024|FG000|Overall Study|Lost to Follow-up|5
4508903|NCT00908349|7317024|FG000|Overall Study|Various|6
4508904|NCT00908375|7317030|FG000|Overall Study|Withdrawal by Subject|2
4508905|NCT00908375|7317031|FG001|Overall Study|Withdrawal by Subject|4
4508906|NCT00908375|7317030|FG000|Overall Study|Lost to Follow-up|8
4508907|NCT00908375|7317031|FG001|Overall Study|Lost to Follow-up|6
4508908|NCT00908544|7317052|FG000|Overall Study|Withdrawal by Subject|2
4508909|NCT00908544|7317053|FG001|Overall Study|Withdrawal by Subject|4
4508910|NCT00908544|7317052|FG000|Overall Study|Lack of Efficacy|0
4508911|NCT00908544|7317053|FG001|Overall Study|Lack of Efficacy|1
4508912|NCT00908544|7317052|FG000|Overall Study|Pregnancy|1
4508913|NCT00908544|7317053|FG001|Overall Study|Pregnancy|0
4508914|NCT00908544|7317052|FG000|Overall Study|Relocation abroad|1
4508915|NCT00908544|7317053|FG001|Overall Study|Relocation abroad|1
4508916|NCT00908544|7317052|FG000|Overall Study|Unable to visit sutdy center|1
4508917|NCT00908544|7317053|FG001|Overall Study|Unable to visit sutdy center|0
4508918|NCT00908583|7317059|FG000|Phase 1|Withdrawal by Subject|1
4508919|NCT00908583|7317059|FG000|Phase 1|Adverse Event|4
4508920|NCT00908583|7317059|FG000|Phase 2|Physician Decision|1
4508921|NCT00908583|7317059|FG000|Phase 2|Adverse Event|1
4508922|NCT00908583|7317059|FG000|Phase 3|Adverse Event|2
4508923|NCT00908583|7317059|FG000|Phase 4|Adverse Event|1
4508924|NCT00908583|7317059|FG000|Phase 4|Physician Decision|1
4508925|NCT00908583|7317059|FG000|Phase 5|Adverse Event|3
4508926|NCT00908596|7317081|FG000|Overall Study|Other reasons|46
4508927|NCT00908596|7317082|FG001|Overall Study|Other reasons|6
4508928|NCT00908596|7317083|FG002|Overall Study|Other reasons|2
4508929|NCT00908596|7317084|FG003|Overall Study|Other reasons|0
4508930|NCT00908596|7317081|FG000|Overall Study|Lost to Follow-up|0
4508931|NCT00908596|7317082|FG001|Overall Study|Lost to Follow-up|1
4508932|NCT00908596|7317083|FG002|Overall Study|Lost to Follow-up|12
4508933|NCT00908596|7317084|FG003|Overall Study|Lost to Follow-up|4
4508934|NCT00908596|7317081|FG000|Overall Study|Death|0
4508935|NCT00908596|7317082|FG001|Overall Study|Death|5
4508936|NCT00908596|7317083|FG002|Overall Study|Death|57
4508937|NCT00908596|7317084|FG003|Overall Study|Death|32
4508938|NCT00908596|7317081|FG000|Overall Study|Protocol Violation|1
4508939|NCT00908596|7317082|FG001|Overall Study|Protocol Violation|0
4508940|NCT00908596|7317083|FG002|Overall Study|Protocol Violation|0
4508941|NCT00908596|7317084|FG003|Overall Study|Protocol Violation|0
4508942|NCT00908596|7317081|FG000|Overall Study|Withdrawal by Subject|0
4508943|NCT00908596|7317082|FG001|Overall Study|Withdrawal by Subject|1
4508944|NCT00908596|7317083|FG002|Overall Study|Withdrawal by Subject|3
4508945|NCT00908596|7317084|FG003|Overall Study|Withdrawal by Subject|1
4508946|NCT00908895|7317127|FG000|Overall Study|Lost to Follow-up|1
4508947|NCT00908895|7317128|FG001|Overall Study|Lost to Follow-up|3
4508948|NCT00908895|7317127|FG000|Overall Study|algodystrophy|2
4508949|NCT00908895|7317128|FG001|Overall Study|algodystrophy|2
4508950|NCT00908895|7317127|FG000|Overall Study|Adverse Event|1
4508951|NCT00908895|7317128|FG001|Overall Study|Adverse Event|1
4508952|NCT00908960|7317146|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1
4508953|NCT00908960|7317147|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1
4508954|NCT00908960|7317148|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2
4508955|NCT00909038|7317156|FG000|Overall Study|Protocol Violation|187
4508956|NCT00909038|7317156|FG000|Overall Study|Non-evaluable Subjects|230
4508957|NCT00909090|7317166|FG000|Overall Study|Lost to Follow-up|17
4508958|NCT00909090|7317167|FG001|Overall Study|Lost to Follow-up|17
4508959|NCT00909181|7317195|FG000|Overall Study|Lost to Follow-up|39
4508960|NCT00909181|7317196|FG001|Overall Study|Lost to Follow-up|18
4508961|NCT00909181|7317197|FG002|Overall Study|Lost to Follow-up|33
4508962|NCT00909363|7317228|FG000|Overall Study|Withdrawal by Subject|1
4508963|NCT00909363|7317229|FG001|Overall Study|Withdrawal by Subject|0
4508964|NCT00909363|7317230|FG002|Overall Study|Withdrawal by Subject|0
4508965|NCT00909363|7317228|FG000|Overall Study|Lack of Efficacy|1
4508966|NCT00909363|7317229|FG001|Overall Study|Lack of Efficacy|0
4508967|NCT00909363|7317230|FG002|Overall Study|Lack of Efficacy|0
4508968|NCT00909428|7317244|FG000|Overall Study|Lost to Follow-up|13
4508969|NCT00909428|7317245|FG001|Overall Study|Lost to Follow-up|10
4508970|NCT00909428|7317246|FG002|Overall Study|Lost to Follow-up|9
4508971|NCT00909480|7317255|FG000|Overall Study|Adverse Event|5
4508972|NCT00909480|7317256|FG001|Overall Study|Adverse Event|3
4508973|NCT00909480|7317255|FG000|Overall Study|Protocol Violation|6
4508974|NCT00909480|7317256|FG001|Overall Study|Protocol Violation|8
4508975|NCT00909480|7317255|FG000|Overall Study|Withdrawal criteria|9
4508976|NCT00909480|7317256|FG001|Overall Study|Withdrawal criteria|11
4508977|NCT00909480|7317255|FG000|Overall Study|Unclassified|18
4508978|NCT00909480|7317256|FG001|Overall Study|Unclassified|19
4508979|NCT00909532|7317264|FG000|Overall Study|Adverse Event|4
4508980|NCT00909532|7317265|FG001|Overall Study|Adverse Event|1
4508981|NCT00909532|7317264|FG000|Overall Study|Pregnancy|0
4508982|NCT00909532|7317265|FG001|Overall Study|Pregnancy|1
4508983|NCT00909532|7317264|FG000|Overall Study|Prohibited Medication|2
4508984|NCT00909532|7317265|FG001|Overall Study|Prohibited Medication|1
4508985|NCT00909532|7317264|FG000|Overall Study|Withdrawal of Consent|1
4508986|NCT00909532|7317265|FG001|Overall Study|Withdrawal of Consent|1
4508987|NCT00909532|7317264|FG000|Overall Study|Noncompliance with Study Requirements|0
4508988|NCT00909532|7317265|FG001|Overall Study|Noncompliance with Study Requirements|2
4508989|NCT00909532|7317264|FG000|Overall Study|Physician Decision|1
4508990|NCT00909532|7317265|FG001|Overall Study|Physician Decision|0
4508991|NCT00909532|7317264|FG000|Overall Study|Wrong Genotype|1
4508992|NCT00909532|7317265|FG001|Overall Study|Wrong Genotype|0
4508993|NCT00909532|7317264|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1
4508994|NCT00909532|7317265|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0
4508995|NCT00909727|7317292|FG000|Overall Study|Adverse Event|1
4508996|NCT00909727|7317293|FG001|Overall Study|Adverse Event|0
4508997|NCT00909727|7317292|FG000|Overall Study|Wrong Genotype|1
4508998|NCT00909727|7317293|FG001|Overall Study|Wrong Genotype|0
4508999|NCT00909727|7317292|FG000|Overall Study|Withdrawal of Consent|1
4509000|NCT00909727|7317293|FG001|Overall Study|Withdrawal of Consent|0
4509001|NCT00909727|7317292|FG000|Overall Study|Prohibited Medication|1
4509002|NCT00909727|7317293|FG001|Overall Study|Prohibited Medication|0
4509003|NCT00909779|7317301|FG000|Overall Study|Adverse Event|53
4509004|NCT00909779|7317302|FG001|Overall Study|Adverse Event|55
4509005|NCT00909779|7317301|FG000|Overall Study|Lack of Efficacy|7
4509006|NCT00909779|7317302|FG001|Overall Study|Lack of Efficacy|4
4509007|NCT00909779|7317301|FG000|Overall Study|Lost to Follow-up|19
4509008|NCT00909779|7317302|FG001|Overall Study|Lost to Follow-up|15
4509009|NCT00909779|7317301|FG000|Overall Study|Physician Decision|8
4509010|NCT00909779|7317302|FG001|Overall Study|Physician Decision|2
4509011|NCT00909779|7317301|FG000|Overall Study|Protocol Violation|2
4509012|NCT00909779|7317302|FG001|Overall Study|Protocol Violation|5
4509013|NCT00909779|7317301|FG000|Overall Study|Withdrawal by Subject|116
4509014|NCT00909779|7317302|FG001|Overall Study|Withdrawal by Subject|80
4509015|NCT00909779|7317301|FG000|Overall Study|Site Ceasing Operation|2
4509016|NCT00909779|7317302|FG001|Overall Study|Site Ceasing Operation|2
4509017|NCT00909779|7317301|FG000|Overall Study|Medical Monitor Decision|1
4509018|NCT00909779|7317302|FG001|Overall Study|Medical Monitor Decision|0
4509019|NCT00909779|7317301|FG000|Overall Study|Noncompliance|1
4509020|NCT00909779|7317302|FG001|Overall Study|Noncompliance|1
4509021|NCT00909779|7317301|FG000|Overall Study|Randomized in error|1
4509022|NCT00909779|7317302|FG001|Overall Study|Randomized in error|1
4509023|NCT00909792|7317310|FG000|Period 1|Did not meet inclusion criteria|0
4509024|NCT00909792|7317311|FG001|Period 1|Did not meet inclusion criteria|1
4509025|NCT00909792|7317310|FG000|Period 2|Biomicroscopy|1
4509026|NCT00909792|7317311|FG001|Period 2|Biomicroscopy|0
4509027|NCT00909792|7317310|FG000|Period 2|Lost to Follow-up|0
4509028|NCT00909792|7317311|FG001|Period 2|Lost to Follow-up|1
4509029|NCT00909844|7317317|FG000|Overall Study|Adverse Event|1
4509030|NCT00909844|7317317|FG000|Overall Study|Withdrawal by Subject|1
4509031|NCT00909844|7317317|FG000|Overall Study|Lost to Follow-up|2
4509032|NCT00909857|7317324|FG000|Overall Study|Withdrawal by Subject|6
4509033|NCT00909857|7317325|FG001|Overall Study|Withdrawal by Subject|10
4509034|NCT00909857|7317324|FG000|Overall Study|Adverse Event|5
4509035|NCT00909857|7317325|FG001|Overall Study|Adverse Event|5
4509036|NCT00909857|7317324|FG000|Overall Study|Lost to Follow-up|2
4509037|NCT00909857|7317325|FG001|Overall Study|Lost to Follow-up|5
4509038|NCT00909857|7317324|FG000|Overall Study|Protocol Violation|2
4509039|NCT00909857|7317325|FG001|Overall Study|Protocol Violation|1
4509040|NCT00909857|7317324|FG000|Overall Study|Pregnancy|1
4509041|NCT00909857|7317325|FG001|Overall Study|Pregnancy|0
4509042|NCT00909857|7317324|FG000|Overall Study|Other|1
4509043|NCT00909857|7317325|FG001|Overall Study|Other|0
4509044|NCT00909857|7317324|FG000|Overall Study|Did not receive study medication|19
4509045|NCT00909857|7317325|FG001|Overall Study|Did not receive study medication|24
4509046|NCT00909870|7317333|FG000|Overall Study|Adverse Event|13
4509047|NCT00909870|7317334|FG001|Overall Study|Adverse Event|7
4509048|NCT00909870|7317333|FG000|Overall Study|Protocol Violation|1
4509049|NCT00909870|7317334|FG001|Overall Study|Protocol Violation|2
4509050|NCT00909870|7317333|FG000|Overall Study|Withdrawal by Subject|5
4509051|NCT00909870|7317334|FG001|Overall Study|Withdrawal by Subject|8
4509052|NCT00909870|7317333|FG000|Overall Study|Lost to Follow-up|3
4509053|NCT00909870|7317334|FG001|Overall Study|Lost to Follow-up|3
4509054|NCT00909870|7317333|FG000|Overall Study|Physician Decision|0
4509055|NCT00909870|7317334|FG001|Overall Study|Physician Decision|2
4509056|NCT00909870|7317333|FG000|Overall Study|Other|1
4509057|NCT00909870|7317334|FG001|Overall Study|Other|5
4509058|NCT00910000|7317347|FG000|Overall Study|Adverse Event|0
4509059|NCT00910000|7317348|FG001|Overall Study|Adverse Event|3
4509060|NCT00910000|7317349|FG002|Overall Study|Adverse Event|2
4509061|NCT00910000|7317350|FG003|Overall Study|Adverse Event|2
4509062|NCT00910000|7317351|FG004|Overall Study|Adverse Event|0
4509063|NCT00910000|7317352|FG005|Overall Study|Adverse Event|1
4509064|NCT00910000|7317347|FG000|Overall Study|Withdrawal by Subject|0
4509065|NCT00910000|7317348|FG001|Overall Study|Withdrawal by Subject|0
4509066|NCT00910000|7317349|FG002|Overall Study|Withdrawal by Subject|1
4509067|NCT00910000|7317350|FG003|Overall Study|Withdrawal by Subject|0
4509068|NCT00910000|7317351|FG004|Overall Study|Withdrawal by Subject|1
4509069|NCT00910000|7317352|FG005|Overall Study|Withdrawal by Subject|0
4509070|NCT00910039|7317362|FG000|Overall Study|Physician Decision|1
4509071|NCT00910091|7317369|FG000|Pre-assignment|Withdrawal by Subject|0
4509072|NCT00910091|7317370|FG001|Pre-assignment|Withdrawal by Subject|2
4509073|NCT00910091|7317369|FG000|Treatment and Survival|Withdrawal by Subject|3
4509074|NCT00910091|7317370|FG001|Treatment and Survival|Withdrawal by Subject|4
4509075|NCT00910091|7317369|FG000|Treatment and Survival|Adverse Event|1
4509076|NCT00910091|7317370|FG001|Treatment and Survival|Adverse Event|0
4509077|NCT00910247|7317390|FG000|Overall Study|Adverse Event|15
4509078|NCT00910247|7317390|FG000|Overall Study|Death|2
4509079|NCT00910247|7317390|FG000|Overall Study|Lost to Follow-up|10
4509080|NCT00910247|7317390|FG000|Overall Study|Physician Decision|3
4509081|NCT00910247|7317390|FG000|Overall Study|Protocol Violation|10
4509082|NCT00910247|7317390|FG000|Overall Study|Withdrawal by Subject|25
4509083|NCT00910247|7317390|FG000|Overall Study|Not collected|4
4518273|NCT00973102|7330407|FG001|Overall Study|Protocol Violation|0
4518274|NCT00973102|7330406|FG000|Overall Study|Prisoner|0
4518275|NCT00973102|7330407|FG001|Overall Study|Prisoner|1
4518276|NCT00973349|7330429|FG000|Overall Study|Adverse Event|0
4518277|NCT00973349|7330430|FG001|Overall Study|Adverse Event|0
4518278|NCT00973349|7330431|FG002|Overall Study|Adverse Event|0
4518279|NCT00973349|7330432|FG003|Overall Study|Adverse Event|0
4518280|NCT00973349|7330433|FG004|Overall Study|Adverse Event|1
4518281|NCT00973349|7330434|FG005|Overall Study|Adverse Event|0
4518282|NCT00973349|7330435|FG006|Overall Study|Adverse Event|0
4518283|NCT00973349|7330436|FG007|Overall Study|Adverse Event|0
4518284|NCT00973349|7330437|FG008|Overall Study|Adverse Event|1
4518285|NCT00973349|7330438|FG009|Overall Study|Adverse Event|0
4518286|NCT00973349|7330439|FG010|Overall Study|Adverse Event|0
4518287|NCT00973349|7330440|FG011|Overall Study|Adverse Event|0
4518288|NCT00973349|7330441|FG012|Overall Study|Adverse Event|0
4518289|NCT00973349|7330442|FG013|Overall Study|Adverse Event|0
4518290|NCT00973349|7330443|FG014|Overall Study|Adverse Event|1
4518291|NCT00973349|7330444|FG015|Overall Study|Adverse Event|0
4518292|NCT00973349|7330429|FG000|Overall Study|Withdrawal by Subject|1
4518293|NCT00973349|7330430|FG001|Overall Study|Withdrawal by Subject|2
4518294|NCT00973349|7330431|FG002|Overall Study|Withdrawal by Subject|2
4705032|NCT02760407|7624391|FG002|Overall Study|Withdrawal by Subject|37
4705033|NCT02760407|7624392|FG003|Overall Study|Withdrawal by Subject|25
4705034|NCT02760407|7624389|FG000|Overall Study|Violation of Eligibility criteria|0
4705035|NCT02760407|7624390|FG001|Overall Study|Violation of Eligibility criteria|0
4705036|NCT02760407|7624391|FG002|Overall Study|Violation of Eligibility criteria|1
4705037|NCT02760407|7624392|FG003|Overall Study|Violation of Eligibility criteria|1
4705038|NCT02760407|7624389|FG000|Overall Study|Personal reasons|0
4705039|NCT02760407|7624390|FG001|Overall Study|Personal reasons|0
4705040|NCT02760407|7624391|FG002|Overall Study|Personal reasons|0
4705041|NCT02760407|7624392|FG003|Overall Study|Personal reasons|1
4705042|NCT02760407|7624389|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1
4705043|NCT02760407|7624390|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0
4705044|NCT02760407|7624391|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0
4705045|NCT02760407|7624392|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0
4705046|NCT02760407|7624389|FG000|Overall Study|Use of prohibited Medication|0
4705047|NCT02760407|7624390|FG001|Overall Study|Use of prohibited Medication|0
4705048|NCT02760407|7624391|FG002|Overall Study|Use of prohibited Medication|1
4705049|NCT02760407|7624392|FG003|Overall Study|Use of prohibited Medication|0
4705050|NCT02760407|7624389|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0
4705051|NCT02760407|7624390|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0
4705052|NCT02760407|7624391|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1
4705053|NCT02760407|7624392|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0
4705054|NCT02760407|7624389|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1
4705055|NCT02760407|7624390|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0
4387359|NCT00048074|7165985|FG002|Overall Study|Husband ill|0
4387360|NCT00048074|7165983|FG000|Overall Study|Poor compliance|0
4387361|NCT00048074|7165984|FG001|Overall Study|Poor compliance|1
4387362|NCT00048074|7165985|FG002|Overall Study|Poor compliance|0
4387363|NCT00048074|7165983|FG000|Overall Study|Out of station|0
4387364|NCT00048074|7165984|FG001|Overall Study|Out of station|1
4387365|NCT00048074|7165985|FG002|Overall Study|Out of station|1
4387366|NCT00048074|7165983|FG000|Overall Study|Social reasons|1
4387367|NCT00048074|7165984|FG001|Overall Study|Social reasons|0
4518295|NCT00973349|7330432|FG003|Overall Study|Withdrawal by Subject|3
4705056|NCT02760407|7624391|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0
4705057|NCT02760407|7624392|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0
4387368|NCT00048074|7165985|FG002|Overall Study|Social reasons|0
4387369|NCT00048165|7165995|FG000|Completed 6 Months Study|Administration/Other|8
4387370|NCT00048165|7165996|FG001|Completed 6 Months Study|Administration/Other|8
4518296|NCT00973349|7330433|FG004|Overall Study|Withdrawal by Subject|2
4518297|NCT00973349|7330434|FG005|Overall Study|Withdrawal by Subject|0
4518298|NCT00973349|7330435|FG006|Overall Study|Withdrawal by Subject|2
4509084|NCT00910273|7317396|FG000|Overall Study|Lack of Efficacy|6
4509085|NCT00910273|7317397|FG001|Overall Study|Lack of Efficacy|9
4509086|NCT00910273|7317396|FG000|Overall Study|Adverse Event|1
4509087|NCT00910273|7317397|FG001|Overall Study|Adverse Event|1
4509088|NCT00910273|7317396|FG000|Overall Study|Withdrawal by Subject|1
4509089|NCT00910273|7317397|FG001|Overall Study|Withdrawal by Subject|0
4509090|NCT00910273|7317396|FG000|Overall Study|Discontinuation of study by sponsor|8
4509091|NCT00910273|7317397|FG001|Overall Study|Discontinuation of study by sponsor|2
4509092|NCT00910273|7317396|FG000|Overall Study|Protocol Violation|1
4509093|NCT00910273|7317397|FG001|Overall Study|Protocol Violation|0
4509094|NCT00910273|7317396|FG000|Overall Study|Lost to Follow-up|1
4509095|NCT00910273|7317397|FG001|Overall Study|Lost to Follow-up|1
4509096|NCT00910299|7317405|FG000|Overall Study|Withdrawal by Subject|16
4509097|NCT00910299|7317406|FG001|Overall Study|Withdrawal by Subject|13
4509098|NCT00910299|7317405|FG000|Overall Study|Sponsor Decision|58
4509099|NCT00910299|7317406|FG001|Overall Study|Sponsor Decision|60
4509100|NCT00910299|7317405|FG000|Overall Study|Didn't receive any study drug|2
4509101|NCT00910299|7317406|FG001|Overall Study|Didn't receive any study drug|1
4509102|NCT00910429|7317414|FG000|Overall Study|Death|18
4509103|NCT00910429|7317415|FG001|Overall Study|Death|12
4509104|NCT00910429|7317414|FG000|Overall Study|Withdrawal by Subject|3
4509105|NCT00910429|7317415|FG001|Overall Study|Withdrawal by Subject|2
4509106|NCT00910429|7317414|FG000|Overall Study|Protocol Violation|1
4509107|NCT00910429|7317415|FG001|Overall Study|Protocol Violation|0
4509108|NCT00910429|7317414|FG000|Overall Study|Lost to Follow-up|2
4509109|NCT00910429|7317415|FG001|Overall Study|Lost to Follow-up|1
4509110|NCT00910429|7317414|FG000|Overall Study|Adverse Event|10
4509111|NCT00910429|7317415|FG001|Overall Study|Adverse Event|5
4509112|NCT00910429|7317414|FG000|Overall Study|Drug non-compliance|1
4509113|NCT00910429|7317415|FG001|Overall Study|Drug non-compliance|0
4509114|NCT00910429|7317414|FG000|Overall Study|Lack of Efficacy|4
4509115|NCT00910429|7317415|FG001|Overall Study|Lack of Efficacy|1
4509116|NCT00910624|7317443|FG000|Treatment Phase|Adverse Event|2
4509117|NCT00910624|7317444|FG001|Treatment Phase|Adverse Event|6
4509118|NCT00910624|7317445|FG002|Treatment Phase|Adverse Event|6
4509119|NCT00910624|7317446|FG003|Treatment Phase|Adverse Event|0
4509120|NCT00910624|7317443|FG000|Treatment Phase|Treatment Failure|23
4509121|NCT00910624|7317444|FG001|Treatment Phase|Treatment Failure|10
4509122|NCT00910624|7317445|FG002|Treatment Phase|Treatment Failure|0
4509123|NCT00910624|7317446|FG003|Treatment Phase|Treatment Failure|0
4509124|NCT00910624|7317443|FG000|Treatment Phase|Lost to Follow-up|0
4509125|NCT00910624|7317444|FG001|Treatment Phase|Lost to Follow-up|0
4509126|NCT00910624|7317445|FG002|Treatment Phase|Lost to Follow-up|1
4509127|NCT00910624|7317446|FG003|Treatment Phase|Lost to Follow-up|0
4509128|NCT00910624|7317443|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3
4509129|NCT00910624|7317444|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3
4509130|NCT00910624|7317445|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1
4509131|NCT00910624|7317446|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0
4509132|NCT00910624|7317443|FG000|Treatment Phase|Withdrawal by Subject|2
4509133|NCT00910624|7317444|FG001|Treatment Phase|Withdrawal by Subject|1
4509134|NCT00910624|7317445|FG002|Treatment Phase|Withdrawal by Subject|0
4509135|NCT00910624|7317446|FG003|Treatment Phase|Withdrawal by Subject|0
4509136|NCT00910624|7317443|FG000|Treatment Phase|Non-Compliance With Protocol|0
4509137|NCT00910624|7317444|FG001|Treatment Phase|Non-Compliance With Protocol|1
4509138|NCT00910624|7317445|FG002|Treatment Phase|Non-Compliance With Protocol|1
4509139|NCT00910624|7317446|FG003|Treatment Phase|Non-Compliance With Protocol|0
4509140|NCT00910624|7317443|FG000|Follow-Up Phase|Adverse Event|0
4509141|NCT00910624|7317444|FG001|Follow-Up Phase|Adverse Event|0
4509142|NCT00910624|7317445|FG002|Follow-Up Phase|Adverse Event|1
4509143|NCT00910624|7317446|FG003|Follow-Up Phase|Adverse Event|0
4509144|NCT00910624|7317443|FG000|Follow-Up Phase|Lost to Follow-up|3
4509145|NCT00910624|7317444|FG001|Follow-Up Phase|Lost to Follow-up|1
4509146|NCT00910624|7317445|FG002|Follow-Up Phase|Lost to Follow-up|2
4509147|NCT00910624|7317446|FG003|Follow-Up Phase|Lost to Follow-up|0
4509148|NCT00910624|7317443|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1
4509149|NCT00910624|7317444|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2
4509150|NCT00910624|7317445|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0
4509151|NCT00910624|7317446|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0
4509152|NCT00910624|7317443|FG000|Follow-Up Phase|Withdrawal by Subject|1
4509153|NCT00910624|7317444|FG001|Follow-Up Phase|Withdrawal by Subject|0
4509154|NCT00910624|7317445|FG002|Follow-Up Phase|Withdrawal by Subject|0
4509155|NCT00910624|7317446|FG003|Follow-Up Phase|Withdrawal by Subject|0
4509156|NCT00910624|7317443|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1
4509157|NCT00910624|7317444|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
4509158|NCT00910624|7317445|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
4509159|NCT00910624|7317446|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
4509160|NCT00910624|7317443|FG000|Follow-Up Phase|Administrative|0
4509161|NCT00910624|7317444|FG001|Follow-Up Phase|Administrative|1
4509162|NCT00910624|7317445|FG002|Follow-Up Phase|Administrative|1
4509163|NCT00910624|7317446|FG003|Follow-Up Phase|Administrative|0
4509164|NCT00910663|7317456|FG000|Period 1|Withdrawal by Subject|0
4509165|NCT00910663|7317457|FG001|Period 1|Withdrawal by Subject|1
4509166|NCT00910689|7317467|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2
4509167|NCT00910689|7317468|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1
4509168|NCT00910689|7317469|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5
4509169|NCT00910689|7317470|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10
4509170|NCT00910689|7317467|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3
4509171|NCT00910689|7317468|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4
4509172|NCT00910689|7317469|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1
4509173|NCT00910689|7317470|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3
4509174|NCT00910689|7317467|FG000|Month 2- 4: Treatment Period|Adverse Event|2
4509175|NCT00910689|7317468|FG001|Month 2- 4: Treatment Period|Adverse Event|3
4509176|NCT00910689|7317469|FG002|Month 2- 4: Treatment Period|Adverse Event|2
4509177|NCT00910689|7317470|FG003|Month 2- 4: Treatment Period|Adverse Event|0
4509178|NCT00910689|7317467|FG000|Month 2- 4: Treatment Period|Time Demands|1
4509179|NCT00910689|7317468|FG001|Month 2- 4: Treatment Period|Time Demands|0
4509180|NCT00910689|7317469|FG002|Month 2- 4: Treatment Period|Time Demands|4
4509181|NCT00910689|7317470|FG003|Month 2- 4: Treatment Period|Time Demands|8
4509182|NCT00910689|7317467|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2
4509183|NCT00910689|7317468|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1
4509184|NCT00910689|7317469|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0
4509185|NCT00910689|7317470|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0
4509186|NCT00910689|7317467|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0
4509187|NCT00910689|7317468|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0
4509188|NCT00910689|7317469|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1
4509189|NCT00910689|7317470|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0
4509190|NCT00910689|7317467|FG000|Month 2- 4: Treatment Period|Pregnancy|0
4509191|NCT00910689|7317468|FG001|Month 2- 4: Treatment Period|Pregnancy|2
4509192|NCT00910689|7317469|FG002|Month 2- 4: Treatment Period|Pregnancy|0
4509193|NCT00910689|7317470|FG003|Month 2- 4: Treatment Period|Pregnancy|0
4509194|NCT00910689|7317467|FG000|Month 2- 4: Treatment Period|Protocol Violation|1
4509195|NCT00910689|7317468|FG001|Month 2- 4: Treatment Period|Protocol Violation|0
4509196|NCT00910689|7317469|FG002|Month 2- 4: Treatment Period|Protocol Violation|0
4509197|NCT00910689|7317470|FG003|Month 2- 4: Treatment Period|Protocol Violation|0
4509198|NCT00910689|7317467|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2
4509199|NCT00910689|7317468|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5
4509200|NCT00910689|7317469|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1
4509201|NCT00910689|7317470|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1
4509202|NCT00910689|7317467|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1
4509203|NCT00910689|7317468|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0
4509204|NCT00910689|7317469|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2
4509205|NCT00910689|7317470|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4
4509206|NCT00910689|7317467|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0
4509207|NCT00910689|7317468|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
4509208|NCT00910689|7317469|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
4509209|NCT00910689|7317470|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
4509210|NCT00910689|7317467|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1
4509211|NCT00910689|7317468|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1
4509212|NCT00910689|7317469|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0
4509213|NCT00910689|7317470|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0
4509214|NCT00910689|7317467|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0
4509215|NCT00910689|7317468|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0
4509216|NCT00910689|7317469|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2
4509217|NCT00910689|7317470|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0
4509218|NCT00910689|7317467|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0
4509219|NCT00910689|7317468|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0
4509220|NCT00910689|7317469|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1
4509221|NCT00910689|7317470|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1
4509222|NCT00910689|7317467|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3
4509223|NCT00910689|7317468|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0
4509224|NCT00910689|7317469|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1
4509225|NCT00910689|7317470|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2
4509226|NCT00910689|7317467|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2
4509227|NCT00910689|7317468|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4
4509228|NCT00910689|7317469|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2
4509229|NCT00910689|7317470|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2
4509230|NCT00910689|7317467|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1
4509231|NCT00910689|7317468|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0
4509232|NCT00910689|7317469|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0
4509233|NCT00910689|7317470|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0
4509234|NCT00910689|7317467|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2
4509235|NCT00910689|7317468|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3
4509236|NCT00910689|7317469|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3
4509237|NCT00910689|7317470|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1
4509238|NCT00910689|7317467|FG000|Months 11- 16: Evaluation Period II|Time Demands|2
4509239|NCT00910689|7317468|FG001|Months 11- 16: Evaluation Period II|Time Demands|1
4509240|NCT00910689|7317469|FG002|Months 11- 16: Evaluation Period II|Time Demands|0
4509241|NCT00910689|7317470|FG003|Months 11- 16: Evaluation Period II|Time Demands|0
4509242|NCT00910689|7317467|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0
4509243|NCT00910689|7317468|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0
4509244|NCT00910689|7317469|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0
4509245|NCT00910689|7317470|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1
4509246|NCT00910689|7317467|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0
4509247|NCT00910689|7317468|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2
4509248|NCT00910689|7317469|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1
4509249|NCT00910689|7317470|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0
4509250|NCT00910715|7317483|FG000|Overall Study|Lost to Follow-up|22
4509251|NCT00910715|7317484|FG001|Overall Study|Lost to Follow-up|26
4509252|NCT00910715|7317485|FG002|Overall Study|Lost to Follow-up|0
4509253|NCT00910728|7317504|FG000|Overall Study|Lack of Efficacy|2
4509254|NCT00910728|7317505|FG001|Overall Study|Lack of Efficacy|3
4509255|NCT00910728|7317506|FG002|Overall Study|Lack of Efficacy|1
4509256|NCT00910728|7317507|FG003|Overall Study|Lack of Efficacy|2
4509257|NCT00910728|7317508|FG004|Overall Study|Lack of Efficacy|1
4509258|NCT00910728|7317509|FG005|Overall Study|Lack of Efficacy|0
4509259|NCT00910728|7317510|FG006|Overall Study|Lack of Efficacy|2
4509260|NCT00910728|7317511|FG007|Overall Study|Lack of Efficacy|2
4509261|NCT00910728|7317512|FG008|Overall Study|Lack of Efficacy|2
4509262|NCT00910728|7317504|FG000|Overall Study|Withdrawal by Subject|0
4509263|NCT00910728|7317505|FG001|Overall Study|Withdrawal by Subject|0
4509264|NCT00910728|7317506|FG002|Overall Study|Withdrawal by Subject|0
4509265|NCT00910728|7317507|FG003|Overall Study|Withdrawal by Subject|0
4509266|NCT00910728|7317508|FG004|Overall Study|Withdrawal by Subject|3
4509267|NCT00910728|7317509|FG005|Overall Study|Withdrawal by Subject|1
4509268|NCT00910728|7317510|FG006|Overall Study|Withdrawal by Subject|2
4509269|NCT00910728|7317511|FG007|Overall Study|Withdrawal by Subject|0
4509270|NCT00910728|7317512|FG008|Overall Study|Withdrawal by Subject|0
4509271|NCT00910728|7317504|FG000|Overall Study|(not specified)|2
4509272|NCT00910728|7317505|FG001|Overall Study|(not specified)|0
4509273|NCT00910728|7317506|FG002|Overall Study|(not specified)|1
4509274|NCT00910728|7317507|FG003|Overall Study|(not specified)|0
4509275|NCT00910728|7317508|FG004|Overall Study|(not specified)|1
4509276|NCT00910728|7317509|FG005|Overall Study|(not specified)|0
4509277|NCT00910728|7317510|FG006|Overall Study|(not specified)|0
4509278|NCT00910728|7317511|FG007|Overall Study|(not specified)|0
4509279|NCT00910728|7317512|FG008|Overall Study|(not specified)|0
4509280|NCT00910728|7317504|FG000|Overall Study|Adverse Event|2
4627862|NCT01855789|7494670|FG001|2) Week 24 up to End of Study|Physician Decision|0
4627863|NCT01855789|7494671|FG002|2) Week 24 up to End of Study|Physician Decision|2
4627864|NCT01855789|7494672|FG003|2) Week 24 up to End of Study|Physician Decision|4
4627865|NCT01855789|7494669|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0
4627866|NCT01855789|7494670|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1
4627867|NCT01855789|7494671|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0
4627868|NCT01855789|7494672|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1
4627869|NCT01855789|7494669|FG000|2) Week 24 up to End of Study|Sponsor Decision|0
4627870|NCT01855789|7494670|FG001|2) Week 24 up to End of Study|Sponsor Decision|0
4627871|NCT01855789|7494671|FG002|2) Week 24 up to End of Study|Sponsor Decision|0
4627872|NCT01855789|7494672|FG003|2) Week 24 up to End of Study|Sponsor Decision|1
4627873|NCT01855789|7494669|FG000|2) Week 24 up to End of Study|Other|0
4627874|NCT01855789|7494670|FG001|2) Week 24 up to End of Study|Other|0
4627875|NCT01855789|7494671|FG002|2) Week 24 up to End of Study|Other|0
4705058|NCT02760407|7624389|FG000|Overall Study|Investigator's Decision (Adverse Event)|0
4705059|NCT02760407|7624390|FG001|Overall Study|Investigator's Decision (Adverse Event)|1
4705060|NCT02760407|7624391|FG002|Overall Study|Investigator's Decision (Adverse Event)|0
4509281|NCT00910728|7317505|FG001|Overall Study|Adverse Event|0
4509282|NCT00910728|7317506|FG002|Overall Study|Adverse Event|1
4509283|NCT00910728|7317507|FG003|Overall Study|Adverse Event|1
4509284|NCT00910728|7317508|FG004|Overall Study|Adverse Event|0
4509285|NCT00910728|7317509|FG005|Overall Study|Adverse Event|0
4509286|NCT00910728|7317510|FG006|Overall Study|Adverse Event|2
4509287|NCT00910728|7317511|FG007|Overall Study|Adverse Event|1
4509288|NCT00910728|7317512|FG008|Overall Study|Adverse Event|1
4509289|NCT00910858|7317544|FG000|Pharmacokinetic Phase|Adverse Event|1
4509290|NCT00910858|7317545|FG001|Pharmacokinetic Phase|Adverse Event|0
4627876|NCT01855789|7494672|FG003|2) Week 24 up to End of Study|Other|1
4705061|NCT02760407|7624392|FG003|Overall Study|Investigator's Decision (Adverse Event)|0
4705062|NCT02760407|7624389|FG000|Overall Study|Inadequately Enrolled|0
4705063|NCT02760407|7624390|FG001|Overall Study|Inadequately Enrolled|0
4705064|NCT02760407|7624391|FG002|Overall Study|Inadequately Enrolled|0
4705065|NCT02760407|7624392|FG003|Overall Study|Inadequately Enrolled|1
4705066|NCT02760407|7624389|FG000|Overall Study|Withdrawal By PI's Decision|0
4705067|NCT02760407|7624390|FG001|Overall Study|Withdrawal By PI's Decision|1
4509291|NCT00910858|7317546|FG002|Pharmacokinetic Phase|Adverse Event|0
4509292|NCT00910858|7317544|FG000|Monotherapy Phase|Adverse Event|3
4509293|NCT00910858|7317545|FG001|Monotherapy Phase|Adverse Event|2
4509294|NCT00910858|7317546|FG002|Monotherapy Phase|Adverse Event|0
4509295|NCT00910858|7317544|FG000|Monotherapy Phase|Lack of therapeutic effect|9
4509296|NCT00910858|7317545|FG001|Monotherapy Phase|Lack of therapeutic effect|6
4509297|NCT00910858|7317546|FG002|Monotherapy Phase|Lack of therapeutic effect|4
4509298|NCT00910858|7317544|FG000|Monotherapy Phase|Withdrawal by Subject|1
4509299|NCT00910858|7317545|FG001|Monotherapy Phase|Withdrawal by Subject|3
4509300|NCT00910858|7317546|FG002|Monotherapy Phase|Withdrawal by Subject|1
4509301|NCT00910858|7317544|FG000|Monotherapy Phase|Protocol Violation|1
4509302|NCT00910858|7317545|FG001|Monotherapy Phase|Protocol Violation|0
4509303|NCT00910858|7317546|FG002|Monotherapy Phase|Protocol Violation|0
4509304|NCT00910858|7317544|FG000|Monotherapy Phase|Other|3
4509305|NCT00910858|7317545|FG001|Monotherapy Phase|Other|4
4509306|NCT00910858|7317546|FG002|Monotherapy Phase|Other|2
4509307|NCT00910858|7317544|FG000|Combined Treatment Phase|Lack of therapeutic effect|8
4509308|NCT00910858|7317545|FG001|Combined Treatment Phase|Lack of therapeutic effect|6
4509309|NCT00910858|7317546|FG002|Combined Treatment Phase|Lack of therapeutic effect|3
4509310|NCT00910858|7317544|FG000|Combined Treatment Phase|Withdrawal by Subject|0
4509311|NCT00910858|7317545|FG001|Combined Treatment Phase|Withdrawal by Subject|2
4509312|NCT00910858|7317546|FG002|Combined Treatment Phase|Withdrawal by Subject|0
4509313|NCT00910858|7317544|FG000|Combined Treatment Phase|Protocol Violation|1
4509314|NCT00910858|7317545|FG001|Combined Treatment Phase|Protocol Violation|0
4509315|NCT00910858|7317546|FG002|Combined Treatment Phase|Protocol Violation|0
4509316|NCT00910858|7317544|FG000|Combined Treatment Phase|Other|0
4509317|NCT00910858|7317545|FG001|Combined Treatment Phase|Other|2
4509318|NCT00910858|7317546|FG002|Combined Treatment Phase|Other|1
4509319|NCT00910871|7317562|FG000|Overall Study|Adverse Event|5
4509320|NCT00910871|7317562|FG000|Overall Study|Death|12
4509321|NCT00910871|7317562|FG000|Overall Study|Lost to Follow-up|8
4509322|NCT00910871|7317562|FG000|Overall Study|Protocol Violation|11
4509323|NCT00910871|7317562|FG000|Overall Study|Withdrawal by Subject|12
4509324|NCT00910871|7317562|FG000|Overall Study|Subject didn't meet eligibility criteria|5
4509325|NCT00910871|7317562|FG000|Overall Study|Undefined|1
4509326|NCT00910910|7317568|FG000|Overall Study|Adverse Event|63
4509327|NCT00910910|7317569|FG001|Overall Study|Adverse Event|35
4509328|NCT00910910|7317568|FG000|Overall Study|PD without histologic change|27
4509329|NCT00910910|7317569|FG001|Overall Study|PD without histologic change|23
4509330|NCT00910910|7317568|FG000|Overall Study|PD with histologic change|0
4509331|NCT00910910|7317569|FG001|Overall Study|PD with histologic change|2
4509332|NCT00910910|7317568|FG000|Overall Study|Withdrawal by Subject|7
4509333|NCT00910910|7317569|FG001|Overall Study|Withdrawal by Subject|5
4509334|NCT00910910|7317568|FG000|Overall Study|Lost to Follow-up|2
4509335|NCT00910910|7317569|FG001|Overall Study|Lost to Follow-up|2
4509336|NCT00910910|7317568|FG000|Overall Study|Death|9
4509337|NCT00910910|7317569|FG001|Overall Study|Death|3
4509338|NCT00910910|7317568|FG000|Overall Study|Protocol Violation|2
4509339|NCT00910910|7317569|FG001|Overall Study|Protocol Violation|2
4509340|NCT00910910|7317568|FG000|Overall Study|Completed 13 cycles of treatment|0
4509341|NCT00910910|7317569|FG001|Overall Study|Completed 13 cycles of treatment|118
4509342|NCT00910910|7317568|FG000|Overall Study|Other|114
4509343|NCT00910910|7317569|FG001|Overall Study|Other|32
4509344|NCT00910910|7317568|FG000|Overall Study|Untreated before cycle 1|1
4509345|NCT00910910|7317569|FG001|Overall Study|Untreated before cycle 1|2
4509346|NCT00910962|7317578|FG000|Overall Study|Adverse Event|5
4509347|NCT00910962|7317579|FG001|Overall Study|Adverse Event|20
4509348|NCT00910962|7317580|FG002|Overall Study|Adverse Event|17
4509349|NCT00910962|7317578|FG000|Overall Study|Protocol Violation|1
4509350|NCT00910962|7317579|FG001|Overall Study|Protocol Violation|3
4509351|NCT00910962|7317580|FG002|Overall Study|Protocol Violation|3
4509352|NCT00910962|7317578|FG000|Overall Study|Lost to Follow-up|0
4509353|NCT00910962|7317579|FG001|Overall Study|Lost to Follow-up|3
4509354|NCT00910962|7317580|FG002|Overall Study|Lost to Follow-up|1
4509355|NCT00910962|7317578|FG000|Overall Study|Physician Decision|0
4509356|NCT00910962|7317579|FG001|Overall Study|Physician Decision|6
4509357|NCT00910962|7317580|FG002|Overall Study|Physician Decision|6
4509358|NCT00910962|7317578|FG000|Overall Study|Withdrawal by Subject|25
4509359|NCT00910962|7317579|FG001|Overall Study|Withdrawal by Subject|32
4509360|NCT00910962|7317580|FG002|Overall Study|Withdrawal by Subject|32
4509361|NCT00910962|7317578|FG000|Overall Study|Reached defined stopping criteria|12
4509362|NCT00910962|7317579|FG001|Overall Study|Reached defined stopping criteria|14
4509363|NCT00910962|7317580|FG002|Overall Study|Reached defined stopping criteria|17
4509364|NCT00910988|7317594|FG000|Overall Study|Lost to Follow-up|2
4509365|NCT00910988|7317595|FG001|Overall Study|Lost to Follow-up|4
4509366|NCT00910988|7317596|FG002|Overall Study|Lost to Follow-up|3
4509367|NCT00910988|7317597|FG003|Overall Study|Lost to Follow-up|0
4509368|NCT00911144|7317625|FG000|Overall Study|Withdrawal by Subject|16
4509369|NCT00911144|7317626|FG001|Overall Study|Withdrawal by Subject|5
4509370|NCT00911157|7317634|FG000|Overall Study|Adverse Event|4
4509371|NCT00911157|7317635|FG001|Overall Study|Adverse Event|1
4509372|NCT00911157|7317634|FG000|Overall Study|Withdrawal by Subject|1
4509373|NCT00911157|7317635|FG001|Overall Study|Withdrawal by Subject|1
4509374|NCT00911157|7317634|FG000|Overall Study|Need for prohibited drug (heparin)|1
4509375|NCT00911157|7317635|FG001|Overall Study|Need for prohibited drug (heparin)|0
4509376|NCT00911157|7317634|FG000|Overall Study|Need to treat for lung cancer|1
4509377|NCT00911157|7317635|FG001|Overall Study|Need to treat for lung cancer|0
4509378|NCT00911170|7317643|FG000|Treatment Period|Randomized in error|1
4509379|NCT00911170|7317644|FG001|Treatment Period|Randomized in error|1
4509380|NCT00911170|7317643|FG000|Treatment Period|Ineligibility determined|1
4509381|NCT00911170|7317644|FG001|Treatment Period|Ineligibility determined|3
4509382|NCT00911170|7317643|FG000|Treatment Period|Protocol deviation|1
4509383|NCT00911170|7317644|FG001|Treatment Period|Protocol deviation|2
4509384|NCT00911170|7317643|FG000|Treatment Period|Adverse Event|9
4509385|NCT00911170|7317644|FG001|Treatment Period|Adverse Event|10
4509386|NCT00911170|7317643|FG000|Treatment Period|Withdrawal by Subject|4
4509387|NCT00911170|7317644|FG001|Treatment Period|Withdrawal by Subject|4
4509388|NCT00911170|7317643|FG000|Treatment Period|Disease progression|0
4509389|NCT00911170|7317644|FG001|Treatment Period|Disease progression|2
4509390|NCT00911170|7317643|FG000|Treatment Period|Physician Decision|5
4509391|NCT00911170|7317644|FG001|Treatment Period|Physician Decision|5
4509392|NCT00911170|7317643|FG000|Treatment Period|Lost to Follow-up|0
4509393|NCT00911170|7317644|FG001|Treatment Period|Lost to Follow-up|1
4509394|NCT00911170|7317643|FG000|Treatment Period|Death|6
4509395|NCT00911170|7317644|FG001|Treatment Period|Death|9
4509396|NCT00911170|7317643|FG000|Long Term Follow-Up|Continuing in study|274
4509397|NCT00911170|7317644|FG001|Long Term Follow-Up|Continuing in study|269
4509398|NCT00911170|7317643|FG000|Long Term Follow-Up|Withdrawal by Subject|20
4509399|NCT00911170|7317644|FG001|Long Term Follow-Up|Withdrawal by Subject|21
4509400|NCT00911170|7317643|FG000|Long Term Follow-Up|Physician Decision|5
4509401|NCT00911170|7317644|FG001|Long Term Follow-Up|Physician Decision|4
4509402|NCT00911170|7317643|FG000|Long Term Follow-Up|Lost to Follow-up|8
4509403|NCT00911170|7317644|FG001|Long Term Follow-Up|Lost to Follow-up|7
4509404|NCT00911170|7317643|FG000|Long Term Follow-Up|Death|116
4509405|NCT00911170|7317644|FG001|Long Term Follow-Up|Death|121
4509406|NCT00911300|7317652|FG000|Overall Study|Primary Endpoint Component Occurred|1
4509407|NCT00911300|7317653|FG001|Overall Study|Primary Endpoint Component Occurred|2
4509408|NCT00911300|7317652|FG000|Overall Study|Death|1
4509409|NCT00911300|7317653|FG001|Overall Study|Death|0
4509410|NCT00911300|7317652|FG000|Overall Study|Thrombus Persistant in Second TEE|3
4509411|NCT00911300|7317653|FG001|Overall Study|Thrombus Persistant in Second TEE|7
4509412|NCT00911300|7317652|FG000|Overall Study|Adverse Event|14
4509413|NCT00911300|7317653|FG001|Overall Study|Adverse Event|6
4509414|NCT00911300|7317652|FG000|Overall Study|Protocol Violation|3
4509415|NCT00911300|7317653|FG001|Overall Study|Protocol Violation|2
4509416|NCT00911300|7317652|FG000|Overall Study|Consent Withdrawn|4
4509417|NCT00911300|7317653|FG001|Overall Study|Consent Withdrawn|12
4509418|NCT00911300|7317652|FG000|Overall Study|Coronary Angiography Performed|1
4509419|NCT00911300|7317653|FG001|Overall Study|Coronary Angiography Performed|0
4509420|NCT00911300|7317652|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3
4509421|NCT00911300|7317653|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3
4509422|NCT00911300|7317652|FG000|Overall Study|Received Commercial Treatment|1
4509423|NCT00911300|7317653|FG001|Overall Study|Received Commercial Treatment|0
4509424|NCT00911300|7317652|FG000|Overall Study|Recurrent Tachyarrhythmia|1
4509425|NCT00911300|7317653|FG001|Overall Study|Recurrent Tachyarrhythmia|1
4509426|NCT00911300|7317652|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1
4509427|NCT00911300|7317653|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1
4509428|NCT00911300|7317652|FG000|Overall Study|Nurse Unavailable in Participant's City|1
4509429|NCT00911300|7317653|FG001|Overall Study|Nurse Unavailable in Participant's City|0
4509430|NCT00911300|7317652|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1
4509431|NCT00911300|7317653|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0
4509432|NCT00911300|7317652|FG000|Overall Study|Participant Could Not Stay in Hospital|0
4509433|NCT00911300|7317653|FG001|Overall Study|Participant Could Not Stay in Hospital|1
4509434|NCT00911300|7317652|FG000|Overall Study|Investigator's Decision; New AF Episode|0
4509435|NCT00911300|7317653|FG001|Overall Study|Investigator's Decision; New AF Episode|1
4509436|NCT00911300|7317652|FG000|Overall Study|International Normalized Ratio Too High|0
4509437|NCT00911300|7317653|FG001|Overall Study|International Normalized Ratio Too High|1
4509438|NCT00911300|7317652|FG000|Overall Study|Participant Refused Hospital Consulation|0
4509439|NCT00911300|7317653|FG001|Overall Study|Participant Refused Hospital Consulation|1
4509440|NCT00911300|7317652|FG000|Overall Study|Underlying Disease (Myocarditis)|0
4509441|NCT00911300|7317653|FG001|Overall Study|Underlying Disease (Myocarditis)|1
4509442|NCT00911300|7317652|FG000|Overall Study|Physician Decision|0
4509443|NCT00911300|7317653|FG001|Overall Study|Physician Decision|1
4509444|NCT00911300|7317652|FG000|Overall Study|Treatment Stopped by Mistake|0
4509445|NCT00911300|7317653|FG001|Overall Study|Treatment Stopped by Mistake|1
4509446|NCT00911300|7317652|FG000|Overall Study|Randomized; No Study Medication Received|0
4509447|NCT00911300|7317653|FG001|Overall Study|Randomized; No Study Medication Received|2
4509448|NCT00911508|7317670|FG000|Overall Study|Lost to Follow-up|27
4509449|NCT00911508|7317671|FG001|Overall Study|Lost to Follow-up|18
4509450|NCT00911508|7317670|FG000|Overall Study|Withdrawal by Subject|79
4509451|NCT00911508|7317671|FG001|Overall Study|Withdrawal by Subject|112
4509452|NCT00911534|7317679|FG000|Overall Study|Adverse Event|4
4509453|NCT00911534|7317680|FG001|Overall Study|Adverse Event|4
4509454|NCT00911534|7317679|FG000|Overall Study|Lost to Follow-up|2
4509455|NCT00911534|7317680|FG001|Overall Study|Lost to Follow-up|4
4509456|NCT00911534|7317679|FG000|Overall Study|Withdrawal by Subject|2
4509457|NCT00911534|7317680|FG001|Overall Study|Withdrawal by Subject|1
4509458|NCT00911534|7317679|FG000|Overall Study|Lack of Efficacy|4
4509459|NCT00911534|7317680|FG001|Overall Study|Lack of Efficacy|1
4509460|NCT00911534|7317679|FG000|Overall Study|Withdrawal of consent|1
4509461|NCT00911534|7317680|FG001|Overall Study|Withdrawal of consent|4
4509462|NCT00911534|7317679|FG000|Overall Study|Other|2
4509463|NCT00911534|7317680|FG001|Overall Study|Other|2
4509464|NCT00911625|7317702|FG000|Overall Study|Lost to Follow-up|7
4509465|NCT00911625|7317703|FG001|Overall Study|Lost to Follow-up|0
4509466|NCT00911768|7317720|FG000|Overall Study|Protocol Violation|5
4509467|NCT00911768|7317721|FG001|Overall Study|Protocol Violation|4
4509468|NCT00911768|7317720|FG000|Overall Study|Withdrawal by Subject|1
4509469|NCT00911768|7317721|FG001|Overall Study|Withdrawal by Subject|0
4509470|NCT00911807|7317730|FG000|Overall Study|Adverse Event|2
4509471|NCT00911807|7317731|FG001|Overall Study|Adverse Event|1
4509472|NCT00911807|7317732|FG002|Overall Study|Adverse Event|5
4509473|NCT00911807|7317730|FG000|Overall Study|Death|0
4509474|NCT00911807|7317731|FG001|Overall Study|Death|0
4509475|NCT00911807|7317732|FG002|Overall Study|Death|1
4509476|NCT00911807|7317730|FG000|Overall Study|Protocol Violation|6
4509477|NCT00911807|7317731|FG001|Overall Study|Protocol Violation|4
4509478|NCT00911807|7317732|FG002|Overall Study|Protocol Violation|9
4509479|NCT00911807|7317730|FG000|Overall Study|Withdrawal by Subject|8
4509480|NCT00911807|7317731|FG001|Overall Study|Withdrawal by Subject|10
4509481|NCT00911807|7317732|FG002|Overall Study|Withdrawal by Subject|7
4509482|NCT00911807|7317730|FG000|Overall Study|Organizational reasons|1
4509483|NCT00911807|7317731|FG001|Overall Study|Organizational reasons|3
4509484|NCT00911807|7317732|FG002|Overall Study|Organizational reasons|1
4509485|NCT00911820|7317742|FG000|Overall Study|RECIST progression|12
4509486|NCT00911820|7317743|FG001|Overall Study|RECIST progression|8
4509487|NCT00911820|7317742|FG000|Overall Study|Adverse Event|8
4509488|NCT00911820|7317743|FG001|Overall Study|Adverse Event|8
4509489|NCT00911820|7317742|FG000|Overall Study|Clinical Progression|7
4509490|NCT00911820|7317743|FG001|Overall Study|Clinical Progression|5
4509491|NCT00911820|7317742|FG000|Overall Study|Physician Decision|5
4509492|NCT00911820|7317743|FG001|Overall Study|Physician Decision|9
4509493|NCT00911820|7317742|FG000|Overall Study|Decline in Performance Status|4
4509494|NCT00911820|7317743|FG001|Overall Study|Decline in Performance Status|2
4509495|NCT00911820|7317742|FG000|Overall Study|Withdrawal by Subject|3
4509496|NCT00911820|7317743|FG001|Overall Study|Withdrawal by Subject|4
4509497|NCT00911820|7317742|FG000|Overall Study|Death|1
4509498|NCT00911820|7317743|FG001|Overall Study|Death|2
4509499|NCT00911820|7317742|FG000|Overall Study|Pursue surgery|1
4509500|NCT00911820|7317743|FG001|Overall Study|Pursue surgery|1
4509501|NCT00911820|7317742|FG000|Overall Study|Pursue Radiation|1
4509502|NCT00911820|7317743|FG001|Overall Study|Pursue Radiation|0
4509503|NCT00911820|7317742|FG000|Overall Study|Still on Therapy|2
4509504|NCT00911820|7317743|FG001|Overall Study|Still on Therapy|2
4509505|NCT00911820|7317742|FG000|Overall Study|Pathology Not Confirmed|1
4509506|NCT00911820|7317743|FG001|Overall Study|Pathology Not Confirmed|0
4509507|NCT00911820|7317742|FG000|Overall Study|Withdraw before Receive Treatment|0
4509508|NCT00911820|7317743|FG001|Overall Study|Withdraw before Receive Treatment|2
4509509|NCT00911859|7317752|FG000|Treatment Period|Adverse Event|3
4509510|NCT00911859|7317753|FG001|Treatment Period|Adverse Event|3
4509511|NCT00911859|7317754|FG002|Treatment Period|Adverse Event|7
4509512|NCT00911859|7317752|FG000|Treatment Period|Death|1
4509513|NCT00911859|7317753|FG001|Treatment Period|Death|3
4509514|NCT00911859|7317754|FG002|Treatment Period|Death|5
4509515|NCT00911859|7317752|FG000|Treatment Period|Lack of Efficacy|1
4509516|NCT00911859|7317753|FG001|Treatment Period|Lack of Efficacy|7
4509517|NCT00911859|7317754|FG002|Treatment Period|Lack of Efficacy|5
4509518|NCT00911859|7317752|FG000|Treatment Period|Physician Decision|3
4509519|NCT00911859|7317753|FG001|Treatment Period|Physician Decision|3
4509520|NCT00911859|7317754|FG002|Treatment Period|Physician Decision|3
4509521|NCT00911859|7317752|FG000|Treatment Period|Withdrawal by Subject|0
4509522|NCT00911859|7317753|FG001|Treatment Period|Withdrawal by Subject|4
4509523|NCT00911859|7317754|FG002|Treatment Period|Withdrawal by Subject|5
4509524|NCT00911859|7317752|FG000|Treatment Period|Did not receive study treatment|0
4509525|NCT00911859|7317753|FG001|Treatment Period|Did not receive study treatment|1
4509526|NCT00911859|7317754|FG002|Treatment Period|Did not receive study treatment|0
4509527|NCT00911859|7317752|FG000|Maintainance Period|Lack of Efficacy|0
4509528|NCT00911859|7317753|FG001|Maintainance Period|Lack of Efficacy|0
4509529|NCT00911859|7317754|FG002|Maintainance Period|Lack of Efficacy|9
4509530|NCT00911859|7317752|FG000|Maintainance Period|Physician Decision|0
4509531|NCT00911859|7317753|FG001|Maintainance Period|Physician Decision|0
4509532|NCT00911859|7317754|FG002|Maintainance Period|Physician Decision|9
4509533|NCT00911859|7317752|FG000|Maintainance Period|Withdrawal by Subject|0
4509534|NCT00911859|7317753|FG001|Maintainance Period|Withdrawal by Subject|0
4509535|NCT00911859|7317754|FG002|Maintainance Period|Withdrawal by Subject|3
4509536|NCT00911859|7317752|FG000|Follow-up Period|Death|5
4509537|NCT00911859|7317753|FG001|Follow-up Period|Death|8
4509538|NCT00911859|7317754|FG002|Follow-up Period|Death|10
4509539|NCT00911859|7317752|FG000|Follow-up Period|Lost to Follow-up|1
4509540|NCT00911859|7317753|FG001|Follow-up Period|Lost to Follow-up|1
4509541|NCT00911859|7317754|FG002|Follow-up Period|Lost to Follow-up|0
4509542|NCT00911859|7317752|FG000|Follow-up Period|Withdrawal by Subject|0
4509543|NCT00911859|7317753|FG001|Follow-up Period|Withdrawal by Subject|4
4509544|NCT00911859|7317754|FG002|Follow-up Period|Withdrawal by Subject|4
4509545|NCT00911859|7317752|FG000|Follow-up Period|Study terminated by sponsor|5
4509546|NCT00911859|7317753|FG001|Follow-up Period|Study terminated by sponsor|33
4509547|NCT00911859|7317754|FG002|Follow-up Period|Study terminated by sponsor|27
4509548|NCT00911937|7317768|FG000|Overall Study|Death|1
4509549|NCT00911937|7317769|FG001|Overall Study|Death|0
4509550|NCT00911937|7317768|FG000|Overall Study|Lost to Follow-up|8
4509551|NCT00911937|7317769|FG001|Overall Study|Lost to Follow-up|5
4509552|NCT00911937|7317768|FG000|Overall Study|Withdrawal by Subject|10
4509553|NCT00911937|7317769|FG001|Overall Study|Withdrawal by Subject|7
4509554|NCT00911937|7317768|FG000|Overall Study|Withdrawn due to pregnancy|1
4509555|NCT00911937|7317769|FG001|Overall Study|Withdrawn due to pregnancy|0
4509556|NCT00911937|7317768|FG000|Overall Study|Adverse Event|11
4509557|NCT00911937|7317769|FG001|Overall Study|Adverse Event|25
4509558|NCT00911937|7317768|FG000|Overall Study|Lack of Efficacy|11
4509559|NCT00911937|7317769|FG001|Overall Study|Lack of Efficacy|6
4509560|NCT00911937|7317768|FG000|Overall Study|Did not meet inclusion criteria|9
4509561|NCT00911937|7317769|FG001|Overall Study|Did not meet inclusion criteria|11
4509562|NCT00911937|7317768|FG000|Overall Study|Protocol Violation|14
4509563|NCT00911937|7317769|FG001|Overall Study|Protocol Violation|23
4509564|NCT00911937|7317768|FG000|Overall Study|Randomized but not treated|13
4509565|NCT00911937|7317769|FG001|Overall Study|Randomized but not treated|13
4509566|NCT00911937|7317768|FG000|Overall Study|Other|9
4509567|NCT00911937|7317769|FG001|Overall Study|Other|5
4509568|NCT00911989|7317775|FG000|Overall Study|Adverse Event|1
4509569|NCT00912015|7317788|FG000|Overall Study|Lack of Efficacy|1
4509570|NCT00912015|7317789|FG001|Overall Study|Lack of Efficacy|0
4509571|NCT00912015|7317790|FG002|Overall Study|Lack of Efficacy|0
4509572|NCT00912015|7317791|FG003|Overall Study|Lack of Efficacy|0
4509573|NCT00912015|7317788|FG000|Overall Study|Withdrawal by Subject|8
4509574|NCT00912015|7317789|FG001|Overall Study|Withdrawal by Subject|8
4509575|NCT00912015|7317790|FG002|Overall Study|Withdrawal by Subject|3
4509576|NCT00912015|7317791|FG003|Overall Study|Withdrawal by Subject|0
4509577|NCT00912015|7317788|FG000|Overall Study|Protocol Violation|1
4509578|NCT00912015|7317789|FG001|Overall Study|Protocol Violation|0
4509579|NCT00912015|7317790|FG002|Overall Study|Protocol Violation|0
4509580|NCT00912015|7317791|FG003|Overall Study|Protocol Violation|1
4509581|NCT00912015|7317788|FG000|Overall Study|Adverse Event|6
4627877|NCT01855828|7494678|FG000|Overall Study|Adverse Event|1
4627878|NCT01855828|7494678|FG000|Overall Study|Withdrawal by Subject|1
4627879|NCT01855919|7494689|FG000|Overall Study|Adverse Event|16
4627880|NCT01855919|7494690|FG001|Overall Study|Adverse Event|8
4627881|NCT01855919|7494689|FG000|Overall Study|Lack of Efficacy|1
4627882|NCT01855919|7494690|FG001|Overall Study|Lack of Efficacy|3
4627883|NCT01855919|7494689|FG000|Overall Study|Withdrawal by Subject|4
4627884|NCT01855919|7494690|FG001|Overall Study|Withdrawal by Subject|10
4627885|NCT01855919|7494689|FG000|Overall Study|Entry Criteria Not Met|1
4627886|NCT01855919|7494690|FG001|Overall Study|Entry Criteria Not Met|1
4627887|NCT01855919|7494689|FG000|Overall Study|Protocol Violation|1
4627888|NCT01855919|7494690|FG001|Overall Study|Protocol Violation|4
4627889|NCT01855945|7494709|FG000|Overall Study|Adverse Event|0
4705068|NCT02760407|7624391|FG002|Overall Study|Withdrawal By PI's Decision|0
4705069|NCT02760407|7624392|FG003|Overall Study|Withdrawal By PI's Decision|0
4705070|NCT02760407|7624389|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1
4705071|NCT02760407|7624390|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0
4705072|NCT02760407|7624391|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1
4705073|NCT02760407|7624392|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0
4705074|NCT02760407|7624389|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0
4705075|NCT02760407|7624390|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0
4705076|NCT02760407|7624391|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1
4705077|NCT02760407|7624392|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0
4705078|NCT02760407|7624389|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1
4705079|NCT02760407|7624390|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0
4509582|NCT00912015|7317789|FG001|Overall Study|Adverse Event|0
4509583|NCT00912015|7317790|FG002|Overall Study|Adverse Event|0
4509584|NCT00912015|7317791|FG003|Overall Study|Adverse Event|1
4509585|NCT00912028|7317804|FG000|Overall Study|Lost to Follow-up|2
4627890|NCT01855945|7494710|FG001|Overall Study|Adverse Event|0
4627891|NCT01855945|7494711|FG002|Overall Study|Adverse Event|0
4509586|NCT00912028|7317805|FG001|Overall Study|Lost to Follow-up|3
4509587|NCT00912028|7317806|FG002|Overall Study|Lost to Follow-up|0
4509588|NCT00912028|7317807|FG003|Overall Study|Lost to Follow-up|1
4509589|NCT00912028|7317808|FG004|Overall Study|Lost to Follow-up|3
4509590|NCT00912028|7317804|FG000|Overall Study|Withdrawal by Subject|3
4627892|NCT01855945|7494712|FG003|Overall Study|Adverse Event|0
4627893|NCT01855945|7494713|FG004|Overall Study|Adverse Event|0
4627894|NCT01855945|7494714|FG005|Overall Study|Adverse Event|0
4627895|NCT01855945|7494715|FG006|Overall Study|Adverse Event|1
4627896|NCT01855945|7494716|FG007|Overall Study|Adverse Event|0
4627897|NCT01855945|7494717|FG008|Overall Study|Adverse Event|0
4509591|NCT00912028|7317805|FG001|Overall Study|Withdrawal by Subject|0
4509592|NCT00912028|7317806|FG002|Overall Study|Withdrawal by Subject|0
4509593|NCT00912028|7317807|FG003|Overall Study|Withdrawal by Subject|0
4509594|NCT00912028|7317808|FG004|Overall Study|Withdrawal by Subject|0
4509595|NCT00912093|7317823|FG000|The Controlled Phase|Death|0
4509596|NCT00912093|7317824|FG001|The Controlled Phase|Death|1
4509597|NCT00912093|7317825|FG002|The Controlled Phase|Death|0
4509598|NCT00912093|7317826|FG003|The Controlled Phase|Death|0
4509599|NCT00912093|7317827|FG004|The Controlled Phase|Death|0
4509600|NCT00912093|7317823|FG000|The Controlled Phase|Medical Condition|0
4509601|NCT00912093|7317824|FG001|The Controlled Phase|Medical Condition|1
4509602|NCT00912093|7317825|FG002|The Controlled Phase|Medical Condition|0
4509603|NCT00912093|7317826|FG003|The Controlled Phase|Medical Condition|0
4509604|NCT00912093|7317827|FG004|The Controlled Phase|Medical Condition|0
4509605|NCT00912093|7317823|FG000|The Controlled Phase|Lost to Follow-up|0
4509606|NCT00912093|7317824|FG001|The Controlled Phase|Lost to Follow-up|0
4509607|NCT00912093|7317825|FG002|The Controlled Phase|Lost to Follow-up|0
4509608|NCT00912093|7317826|FG003|The Controlled Phase|Lost to Follow-up|0
4509609|NCT00912093|7317827|FG004|The Controlled Phase|Lost to Follow-up|1
4509610|NCT00912197|7317837|FG000|Overall Study|Withdrawal by Subject|3
4509611|NCT00912197|7317838|FG001|Overall Study|Withdrawal by Subject|3
4509612|NCT00912288|7317848|FG000|Overall Study|Death|0
4509613|NCT00912288|7317849|FG001|Overall Study|Death|1
4509614|NCT00912288|7317848|FG000|Overall Study|Adverse Event|1
4509615|NCT00912288|7317849|FG001|Overall Study|Adverse Event|1
4509616|NCT00912288|7317848|FG000|Overall Study|Lost to Follow-up|1
4509617|NCT00912288|7317849|FG001|Overall Study|Lost to Follow-up|0
4509618|NCT00912288|7317848|FG000|Overall Study|Protocol Violation|1
4509619|NCT00912288|7317849|FG001|Overall Study|Protocol Violation|0
4509620|NCT00912288|7317848|FG000|Overall Study|Withdrawal by Subject|3
4509621|NCT00912288|7317849|FG001|Overall Study|Withdrawal by Subject|3
4509622|NCT00912288|7317848|FG000|Overall Study|Study terminated by sponsor|34
4509623|NCT00912288|7317849|FG001|Overall Study|Study terminated by sponsor|35
4509624|NCT00912288|7317848|FG000|Overall Study|Other|1
4509625|NCT00912288|7317849|FG001|Overall Study|Other|0
4509626|NCT00912340|7317871|FG000|Overall Study|Adverse Event|2
4509627|NCT00912340|7317872|FG001|Overall Study|Adverse Event|4
4509628|NCT00912340|7317873|FG002|Overall Study|Adverse Event|0
4509629|NCT00912340|7317871|FG000|Overall Study|Protocol revised to remove arm|0
4509630|NCT00912340|7317872|FG001|Overall Study|Protocol revised to remove arm|0
4509631|NCT00912340|7317873|FG002|Overall Study|Protocol revised to remove arm|4
4509632|NCT00912405|7317881|FG000|Overall Study|Lost to Follow-up|5
4509633|NCT00912509|7317887|FG000|Overall Study|Lost to Follow-up|1
4509634|NCT00912509|7317888|FG001|Overall Study|Lost to Follow-up|0
4509635|NCT00912509|7317887|FG000|Overall Study|Lack of Efficacy|4
4509636|NCT00912509|7317888|FG001|Overall Study|Lack of Efficacy|3
4509637|NCT00912743|7317897|FG000|Overall Study|Adverse Event|3
4509638|NCT00912743|7317898|FG001|Overall Study|Adverse Event|1
4509639|NCT00912743|7317897|FG000|Overall Study|Lack of Efficacy|9
4509640|NCT00912743|7317898|FG001|Overall Study|Lack of Efficacy|18
4509641|NCT00912743|7317897|FG000|Overall Study|Toxicity|0
4509642|NCT00912743|7317898|FG001|Overall Study|Toxicity|1
4509643|NCT00912743|7317897|FG000|Overall Study|End of treatment form was not collected|1
4509644|NCT00912743|7317898|FG001|Overall Study|End of treatment form was not collected|0
4509645|NCT00912782|7317906|FG000|Overall Study|Death|2
4509646|NCT00912782|7317907|FG001|Overall Study|Death|1
4509647|NCT00912782|7317906|FG000|Overall Study|Lost to Follow-up|0
4509648|NCT00912782|7317907|FG001|Overall Study|Lost to Follow-up|1
4509649|NCT00912782|7317906|FG000|Overall Study|Did not receive vascular access type|1
4509650|NCT00912782|7317907|FG001|Overall Study|Did not receive vascular access type|2
4509651|NCT00912782|7317906|FG000|Overall Study|Relocated before study completion|0
4509652|NCT00912782|7317907|FG001|Overall Study|Relocated before study completion|1
4509653|NCT00912808|7317924|FG000|First Intervention (6 Weeks)|Adverse Event|2
4509654|NCT00912808|7317925|FG001|First Intervention (6 Weeks)|Adverse Event|1
4509655|NCT00912808|7317924|FG000|Washout|Withdrawal by Subject|0
4509656|NCT00912808|7317925|FG001|Washout|Withdrawal by Subject|1
4509657|NCT00912808|7317924|FG000|Second Intervention (6 Weeks)|Adverse Event|0
4509658|NCT00912808|7317925|FG001|Second Intervention (6 Weeks)|Adverse Event|1
4509659|NCT00912808|7317924|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1
4509660|NCT00912808|7317925|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0
4509661|NCT00912912|7317945|FG000|Overall Study|Withdrawal by Subject|1
4509662|NCT00912912|7317945|FG000|Overall Study|Disease Progression|3
4509663|NCT00912964|7317961|FG000|Overall Study|Eligibility criterion not met|1
4509664|NCT00912964|7317962|FG001|Overall Study|Eligibility criterion not met|1
4509665|NCT00912964|7317963|FG002|Overall Study|Eligibility criterion not met|0
4627898|NCT01855945|7494718|FG009|Overall Study|Adverse Event|0
4627899|NCT01855945|7494719|FG010|Overall Study|Adverse Event|0
4509666|NCT00912964|7317961|FG000|Overall Study|Adverse Event|15
4509667|NCT00912964|7317962|FG001|Overall Study|Adverse Event|18
4509668|NCT00912964|7317963|FG002|Overall Study|Adverse Event|12
4509669|NCT00912964|7317961|FG000|Overall Study|Lack of Efficacy|11
4627900|NCT01855945|7494720|FG011|Overall Study|Adverse Event|0
4627901|NCT01855945|7494709|FG000|Overall Study|Death|0
4627902|NCT01855945|7494710|FG001|Overall Study|Death|0
4627903|NCT01855945|7494711|FG002|Overall Study|Death|0
4627904|NCT01855945|7494712|FG003|Overall Study|Death|0
4627905|NCT01855945|7494713|FG004|Overall Study|Death|0
4627906|NCT01855945|7494714|FG005|Overall Study|Death|0
4627907|NCT01855945|7494715|FG006|Overall Study|Death|2
4627908|NCT01855945|7494716|FG007|Overall Study|Death|0
4509670|NCT00912964|7317962|FG001|Overall Study|Lack of Efficacy|4
4509671|NCT00912964|7317963|FG002|Overall Study|Lack of Efficacy|3
4509672|NCT00912964|7317961|FG000|Overall Study|Withdrawal by Subject|20
4509673|NCT00912964|7317962|FG001|Overall Study|Withdrawal by Subject|12
4509674|NCT00912964|7317963|FG002|Overall Study|Withdrawal by Subject|18
4509675|NCT00912964|7317961|FG000|Overall Study|Lost to Follow-up|4
4509676|NCT00912964|7317962|FG001|Overall Study|Lost to Follow-up|3
4509677|NCT00912964|7317963|FG002|Overall Study|Lost to Follow-up|3
4509678|NCT00912964|7317961|FG000|Overall Study|Protocol Violation|5
4509679|NCT00912964|7317962|FG001|Overall Study|Protocol Violation|3
4509680|NCT00912964|7317963|FG002|Overall Study|Protocol Violation|8
4509681|NCT00912964|7317961|FG000|Overall Study|Taking exclusionary medications|7
4509682|NCT00912964|7317962|FG001|Overall Study|Taking exclusionary medications|4
4509683|NCT00912964|7317963|FG002|Overall Study|Taking exclusionary medications|8
4509684|NCT00912964|7317961|FG000|Overall Study|Medical History|1
4509685|NCT00912964|7317962|FG001|Overall Study|Medical History|0
4509686|NCT00912964|7317963|FG002|Overall Study|Medical History|0
4509687|NCT00912964|7317961|FG000|Overall Study|Non-compliance with study procedures|2
4509688|NCT00912964|7317962|FG001|Overall Study|Non-compliance with study procedures|0
4509689|NCT00912964|7317963|FG002|Overall Study|Non-compliance with study procedures|0
4509690|NCT00912964|7317961|FG000|Overall Study|Violation of exclusion criterion|0
4509691|NCT00912964|7317962|FG001|Overall Study|Violation of exclusion criterion|0
4509692|NCT00912964|7317963|FG002|Overall Study|Violation of exclusion criterion|2
4509693|NCT00912964|7317961|FG000|Overall Study|Randomized but never received study drug|0
4509694|NCT00912964|7317962|FG001|Overall Study|Randomized but never received study drug|1
4509695|NCT00912964|7317963|FG002|Overall Study|Randomized but never received study drug|0
4509696|NCT00913380|7318022|FG000|Clinical Outcomes|Lost to Follow-up|6
4509697|NCT00913380|7318023|FG001|Clinical Outcomes|Lost to Follow-up|6
4509698|NCT00913458|7318029|FG000|Phase 1|Non-Responder|54
4509699|NCT00913458|7318030|FG001|Phase 1|Non-Responder|0
4509700|NCT00913458|7318031|FG002|Phase 1|Non-Responder|0
4509701|NCT00913458|7318032|FG003|Phase 1|Non-Responder|0
4509702|NCT00913458|7318033|FG004|Phase 1|Non-Responder|0
4509703|NCT00913458|7318034|FG005|Phase 1|Non-Responder|0
4509704|NCT00913458|7318035|FG006|Phase 1|Non-Responder|0
4509705|NCT00913458|7318029|FG000|Phase 1|Subject Request|17
4509706|NCT00913458|7318030|FG001|Phase 1|Subject Request|0
4509707|NCT00913458|7318031|FG002|Phase 1|Subject Request|0
4509708|NCT00913458|7318032|FG003|Phase 1|Subject Request|0
4509709|NCT00913458|7318033|FG004|Phase 1|Subject Request|0
4509710|NCT00913458|7318034|FG005|Phase 1|Subject Request|0
4509711|NCT00913458|7318035|FG006|Phase 1|Subject Request|0
4509712|NCT00913458|7318029|FG000|Phase 1|Adverse Event|20
4509713|NCT00913458|7318030|FG001|Phase 1|Adverse Event|0
4509714|NCT00913458|7318031|FG002|Phase 1|Adverse Event|0
4509715|NCT00913458|7318032|FG003|Phase 1|Adverse Event|0
4509716|NCT00913458|7318033|FG004|Phase 1|Adverse Event|0
4509717|NCT00913458|7318034|FG005|Phase 1|Adverse Event|0
4509718|NCT00913458|7318035|FG006|Phase 1|Adverse Event|0
4509719|NCT00913458|7318029|FG000|Phase 1|Lost to Follow-up|2
4509720|NCT00913458|7318030|FG001|Phase 1|Lost to Follow-up|0
4509721|NCT00913458|7318031|FG002|Phase 1|Lost to Follow-up|0
4509722|NCT00913458|7318032|FG003|Phase 1|Lost to Follow-up|0
4509723|NCT00913458|7318033|FG004|Phase 1|Lost to Follow-up|0
4509724|NCT00913458|7318034|FG005|Phase 1|Lost to Follow-up|0
4509725|NCT00913458|7318035|FG006|Phase 1|Lost to Follow-up|0
4509726|NCT00913458|7318029|FG000|Phase 1|Protocol Violation|10
4509727|NCT00913458|7318030|FG001|Phase 1|Protocol Violation|0
4509728|NCT00913458|7318031|FG002|Phase 1|Protocol Violation|0
4509729|NCT00913458|7318032|FG003|Phase 1|Protocol Violation|0
4509730|NCT00913458|7318033|FG004|Phase 1|Protocol Violation|0
4509731|NCT00913458|7318034|FG005|Phase 1|Protocol Violation|0
4509732|NCT00913458|7318035|FG006|Phase 1|Protocol Violation|0
4509733|NCT00913458|7318029|FG000|Phase 1|Sponsor|2
4509734|NCT00913458|7318030|FG001|Phase 1|Sponsor|0
4509735|NCT00913458|7318031|FG002|Phase 1|Sponsor|0
4509736|NCT00913458|7318032|FG003|Phase 1|Sponsor|0
4509737|NCT00913458|7318033|FG004|Phase 1|Sponsor|0
4509738|NCT00913458|7318034|FG005|Phase 1|Sponsor|0
4509739|NCT00913458|7318035|FG006|Phase 1|Sponsor|0
4627909|NCT01855945|7494717|FG008|Overall Study|Death|0
4627910|NCT01855945|7494718|FG009|Overall Study|Death|0
4509740|NCT00913458|7318029|FG000|Phase 1|Unsatisfactory Response per Investigator|7
4509741|NCT00913458|7318030|FG001|Phase 1|Unsatisfactory Response per Investigator|0
4509742|NCT00913458|7318031|FG002|Phase 1|Unsatisfactory Response per Investigator|0
4627911|NCT01855945|7494719|FG010|Overall Study|Death|0
4509743|NCT00913458|7318032|FG003|Phase 1|Unsatisfactory Response per Investigator|0
4509744|NCT00913458|7318033|FG004|Phase 1|Unsatisfactory Response per Investigator|0
4509745|NCT00913458|7318034|FG005|Phase 1|Unsatisfactory Response per Investigator|0
4509746|NCT00913458|7318035|FG006|Phase 1|Unsatisfactory Response per Investigator|0
4509747|NCT00913458|7318029|FG000|Phase 2|Non-Responder|0
4509748|NCT00913458|7318030|FG001|Phase 2|Non-Responder|5
4509749|NCT00913458|7318031|FG002|Phase 2|Non-Responder|7
4509750|NCT00913458|7318032|FG003|Phase 2|Non-Responder|12
4509751|NCT00913458|7318033|FG004|Phase 2|Non-Responder|0
4509752|NCT00913458|7318034|FG005|Phase 2|Non-Responder|0
4509753|NCT00913458|7318035|FG006|Phase 2|Non-Responder|0
4509754|NCT00913458|7318029|FG000|Phase 2|Subject Request|0
4509755|NCT00913458|7318030|FG001|Phase 2|Subject Request|0
4509756|NCT00913458|7318031|FG002|Phase 2|Subject Request|1
4509757|NCT00913458|7318032|FG003|Phase 2|Subject Request|2
4509758|NCT00913458|7318033|FG004|Phase 2|Subject Request|0
4509759|NCT00913458|7318034|FG005|Phase 2|Subject Request|0
4509760|NCT00913458|7318035|FG006|Phase 2|Subject Request|0
4509761|NCT00913458|7318029|FG000|Phase 2|Adverse Event|0
4509762|NCT00913458|7318030|FG001|Phase 2|Adverse Event|3
4509763|NCT00913458|7318031|FG002|Phase 2|Adverse Event|0
4509764|NCT00913458|7318032|FG003|Phase 2|Adverse Event|1
4509765|NCT00913458|7318033|FG004|Phase 2|Adverse Event|0
4509766|NCT00913458|7318034|FG005|Phase 2|Adverse Event|0
4509767|NCT00913458|7318035|FG006|Phase 2|Adverse Event|0
4509768|NCT00913458|7318029|FG000|Phase 2|Lost to Follow-up|0
4509769|NCT00913458|7318030|FG001|Phase 2|Lost to Follow-up|0
4509770|NCT00913458|7318031|FG002|Phase 2|Lost to Follow-up|0
4509771|NCT00913458|7318032|FG003|Phase 2|Lost to Follow-up|1
4509772|NCT00913458|7318033|FG004|Phase 2|Lost to Follow-up|0
4509773|NCT00913458|7318034|FG005|Phase 2|Lost to Follow-up|0
4509774|NCT00913458|7318035|FG006|Phase 2|Lost to Follow-up|0
4509775|NCT00913458|7318029|FG000|Phase 2|Protocol Violation|0
4509776|NCT00913458|7318030|FG001|Phase 2|Protocol Violation|2
4627912|NCT01855945|7494720|FG011|Overall Study|Death|0
4627913|NCT01855945|7494709|FG000|Overall Study|Lost to Follow-up|11
4627914|NCT01855945|7494710|FG001|Overall Study|Lost to Follow-up|10
4627915|NCT01855945|7494711|FG002|Overall Study|Lost to Follow-up|7
4509777|NCT00913458|7318031|FG002|Phase 2|Protocol Violation|0
4509778|NCT00913458|7318032|FG003|Phase 2|Protocol Violation|0
4509779|NCT00913458|7318033|FG004|Phase 2|Protocol Violation|0
4509780|NCT00913458|7318034|FG005|Phase 2|Protocol Violation|0
4509781|NCT00913458|7318035|FG006|Phase 2|Protocol Violation|0
4509782|NCT00913458|7318029|FG000|Phase 2|Unsatisfactory Response per Investigator|0
4509783|NCT00913458|7318030|FG001|Phase 2|Unsatisfactory Response per Investigator|0
4509784|NCT00913458|7318031|FG002|Phase 2|Unsatisfactory Response per Investigator|11
4509785|NCT00913458|7318032|FG003|Phase 2|Unsatisfactory Response per Investigator|17
4509786|NCT00913458|7318033|FG004|Phase 2|Unsatisfactory Response per Investigator|0
4509787|NCT00913458|7318034|FG005|Phase 2|Unsatisfactory Response per Investigator|0
4509788|NCT00913458|7318035|FG006|Phase 2|Unsatisfactory Response per Investigator|0
4509789|NCT00913458|7318029|FG000|Phase 3|Adverse Event|0
4509790|NCT00913458|7318030|FG001|Phase 3|Adverse Event|0
4509791|NCT00913458|7318031|FG002|Phase 3|Adverse Event|0
4509792|NCT00913458|7318032|FG003|Phase 3|Adverse Event|0
4509793|NCT00913458|7318033|FG004|Phase 3|Adverse Event|5
4509794|NCT00913458|7318034|FG005|Phase 3|Adverse Event|4
4509795|NCT00913458|7318035|FG006|Phase 3|Adverse Event|1
4509796|NCT00913458|7318029|FG000|Phase 3|Lost to Follow-up|0
4509797|NCT00913458|7318030|FG001|Phase 3|Lost to Follow-up|0
4509798|NCT00913458|7318031|FG002|Phase 3|Lost to Follow-up|0
4509799|NCT00913458|7318032|FG003|Phase 3|Lost to Follow-up|0
4509800|NCT00913458|7318033|FG004|Phase 3|Lost to Follow-up|2
4705080|NCT02760407|7624391|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0
4705081|NCT02760407|7624392|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0
4705082|NCT02760407|7624389|FG000|Overall Study|Study Treatment Was Terminated At The Site|0
4705083|NCT02760407|7624390|FG001|Overall Study|Study Treatment Was Terminated At The Site|0
4705084|NCT02760407|7624391|FG002|Overall Study|Study Treatment Was Terminated At The Site|1
4705085|NCT02760407|7624392|FG003|Overall Study|Study Treatment Was Terminated At The Site|0
4705086|NCT02760407|7624389|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1
4705087|NCT02760407|7624390|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0
4705088|NCT02760407|7624391|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0
4705089|NCT02760407|7624392|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0
4509801|NCT00913458|7318034|FG005|Phase 3|Lost to Follow-up|0
4509802|NCT00913458|7318035|FG006|Phase 3|Lost to Follow-up|0
4509803|NCT00913458|7318029|FG000|Phase 3|Non-Responder|0
4509804|NCT00913458|7318030|FG001|Phase 3|Non-Responder|0
4509805|NCT00913458|7318031|FG002|Phase 3|Non-Responder|0
4509806|NCT00913458|7318032|FG003|Phase 3|Non-Responder|0
4509807|NCT00913458|7318033|FG004|Phase 3|Non-Responder|0
4509808|NCT00913458|7318034|FG005|Phase 3|Non-Responder|1
4509809|NCT00913458|7318035|FG006|Phase 3|Non-Responder|3
4509810|NCT00913458|7318029|FG000|Phase 3|Withdrawal by Subject|0
4509811|NCT00913458|7318030|FG001|Phase 3|Withdrawal by Subject|0
4509812|NCT00913458|7318031|FG002|Phase 3|Withdrawal by Subject|0
4627916|NCT01855945|7494712|FG003|Overall Study|Lost to Follow-up|3
4509813|NCT00913458|7318032|FG003|Phase 3|Withdrawal by Subject|0
4509814|NCT00913458|7318033|FG004|Phase 3|Withdrawal by Subject|1
4509815|NCT00913458|7318034|FG005|Phase 3|Withdrawal by Subject|2
4509816|NCT00913458|7318035|FG006|Phase 3|Withdrawal by Subject|0
4509817|NCT00913458|7318029|FG000|Phase 3|Unsatisfactory Response per Investigator|0
4509818|NCT00913458|7318030|FG001|Phase 3|Unsatisfactory Response per Investigator|0
4509819|NCT00913458|7318031|FG002|Phase 3|Unsatisfactory Response per Investigator|0
4509820|NCT00913458|7318032|FG003|Phase 3|Unsatisfactory Response per Investigator|0
4509821|NCT00913458|7318033|FG004|Phase 3|Unsatisfactory Response per Investigator|14
4509822|NCT00913458|7318034|FG005|Phase 3|Unsatisfactory Response per Investigator|11
4509823|NCT00913458|7318035|FG006|Phase 3|Unsatisfactory Response per Investigator|4
4509824|NCT00913523|7318064|FG000|Overall Study|Withdrawal by Subject|3
4509825|NCT00913523|7318065|FG001|Overall Study|Withdrawal by Subject|2
4509826|NCT00913523|7318066|FG002|Overall Study|Withdrawal by Subject|2
4509827|NCT00913523|7318064|FG000|Overall Study|Lost to Follow-up|1
4509828|NCT00913523|7318065|FG001|Overall Study|Lost to Follow-up|1
4509829|NCT00913523|7318066|FG002|Overall Study|Lost to Follow-up|1
4509830|NCT00913523|7318064|FG000|Overall Study|Adverse Event|1
4509831|NCT00913523|7318065|FG001|Overall Study|Adverse Event|0
4509832|NCT00913523|7318066|FG002|Overall Study|Adverse Event|0
4509833|NCT00913523|7318064|FG000|Overall Study|Protocol Violation|5
4509834|NCT00913523|7318065|FG001|Overall Study|Protocol Violation|8
4509835|NCT00913523|7318066|FG002|Overall Study|Protocol Violation|8
4509836|NCT00913523|7318064|FG000|Overall Study|Pregnancy|1
4509837|NCT00913523|7318065|FG001|Overall Study|Pregnancy|3
4509838|NCT00913523|7318066|FG002|Overall Study|Pregnancy|0
4509839|NCT00913523|7318064|FG000|Overall Study|Inadequate Number of Tampons Used|7
4509840|NCT00913523|7318065|FG001|Overall Study|Inadequate Number of Tampons Used|2
4509841|NCT00913523|7318066|FG002|Overall Study|Inadequate Number of Tampons Used|3
4509842|NCT00913744|7318093|FG000|Overall Study|Adverse Event|2
4509843|NCT00913744|7318094|FG001|Overall Study|Adverse Event|0
4509844|NCT00913744|7318093|FG000|Overall Study|Withdrawal by Subject|2
4509845|NCT00913744|7318094|FG001|Overall Study|Withdrawal by Subject|1
4509846|NCT00913744|7318093|FG000|Overall Study|Death|1
4509847|NCT00913744|7318094|FG001|Overall Study|Death|0
4509848|NCT00913770|7318103|FG000|Overall Study|Unable to contact|24
4509849|NCT00913770|7318104|FG001|Overall Study|Unable to contact|19
4509850|NCT00913770|7318105|FG002|Overall Study|Unable to contact|13
4509851|NCT00913770|7318103|FG000|Overall Study|Refused|11
4509852|NCT00913770|7318104|FG001|Overall Study|Refused|10
4509853|NCT00913770|7318105|FG002|Overall Study|Refused|8
4509854|NCT00913835|7318115|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2
4509855|NCT00913835|7318116|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3
4509856|NCT00913835|7318115|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1
4509857|NCT00913835|7318116|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0
4509858|NCT00913835|7318115|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4
4509859|NCT00913835|7318116|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3
4509860|NCT00913835|7318115|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1
4509861|NCT00913835|7318116|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1
4509862|NCT00913835|7318115|FG000|Lip Dox: Olaratumab Monotherapy|Other|0
4509863|NCT00913835|7318116|FG001|Lip Dox: Olaratumab Monotherapy|Other|3
4509864|NCT00913978|7318135|FG000|Overall Study|Surgeon choice|1
4705090|NCT02760407|7624389|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1
4705091|NCT02760407|7624390|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0
4705092|NCT02760407|7624391|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0
4705093|NCT02760407|7624392|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0
4705094|NCT02760407|7624389|FG000|Overall Study|Lack Of Efficacy Per PI|0
4705095|NCT02760407|7624390|FG001|Overall Study|Lack Of Efficacy Per PI|0
4705096|NCT02760407|7624391|FG002|Overall Study|Lack Of Efficacy Per PI|0
4705097|NCT02760407|7624392|FG003|Overall Study|Lack Of Efficacy Per PI|1
4705098|NCT02760407|7624389|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1
4705099|NCT02760407|7624390|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0
4705100|NCT02760407|7624391|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0
4705101|NCT02760407|7624392|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0
4705102|NCT02760407|7624389|FG000|Overall Study|Investigator recorded as Adverse Event|1
4705103|NCT02760407|7624390|FG001|Overall Study|Investigator recorded as Adverse Event|0
4705104|NCT02760407|7624391|FG002|Overall Study|Investigator recorded as Adverse Event|2
4705105|NCT02760407|7624392|FG003|Overall Study|Investigator recorded as Adverse Event|0
4705106|NCT02760433|7624408|FG000|Overall Study|Lost to Follow-up|1
4705107|NCT02760433|7624409|FG001|Overall Study|Lost to Follow-up|0
4705108|NCT02760433|7624410|FG002|Overall Study|Lost to Follow-up|1
4705109|NCT02760433|7624411|FG003|Overall Study|Lost to Follow-up|0
4705110|NCT02760433|7624412|FG004|Overall Study|Lost to Follow-up|0
4705111|NCT02760433|7624408|FG000|Overall Study|Withdrawal by Subject|23
4590324|NCT01519947|7436139|FG000|Overall Study|Blood Transfusion|0
4509865|NCT00913978|7318136|FG001|Overall Study|Surgeon choice|3
4509866|NCT00914316|7318173|FG000|Phase 1|Physician Decision|4
4509867|NCT00914316|7318174|FG001|Phase 1|Physician Decision|0
4509868|NCT00914316|7318175|FG002|Phase 1|Physician Decision|1
4509869|NCT00914316|7318176|FG003|Phase 1|Physician Decision|2
4509870|NCT00914316|7318173|FG000|Phase 1|Withdrawal by Subject|0
4509871|NCT00914316|7318174|FG001|Phase 1|Withdrawal by Subject|2
4509872|NCT00914316|7318175|FG002|Phase 1|Withdrawal by Subject|4
4509873|NCT00914316|7318176|FG003|Phase 1|Withdrawal by Subject|0
4509874|NCT00914316|7318173|FG000|Phase 1|Adverse Event|1
4509875|NCT00914316|7318174|FG001|Phase 1|Adverse Event|0
4509876|NCT00914316|7318175|FG002|Phase 1|Adverse Event|0
4509877|NCT00914316|7318176|FG003|Phase 1|Adverse Event|0
4509878|NCT00914316|7318173|FG000|Phase 2|Withdrawal by Subject|1
4509879|NCT00914316|7318174|FG001|Phase 2|Withdrawal by Subject|0
4509880|NCT00914316|7318175|FG002|Phase 2|Withdrawal by Subject|1
4509881|NCT00914316|7318176|FG003|Phase 2|Withdrawal by Subject|0
4509882|NCT00914459|7318188|FG000|Overall Study|Protocol Violation|0
4509883|NCT00914459|7318189|FG001|Overall Study|Protocol Violation|1
4509884|NCT00914459|7318188|FG000|Overall Study|Parent/Legal guardian request|1
4509885|NCT00914459|7318189|FG001|Overall Study|Parent/Legal guardian request|0
4509886|NCT00914589|7318204|FG000|Overall Study|Adverse Event|1
4509887|NCT00914589|7318205|FG001|Overall Study|Adverse Event|0
4509888|NCT00914589|7318206|FG002|Overall Study|Adverse Event|1
4509889|NCT00914589|7318204|FG000|Overall Study|Protocol Violation|8
4509890|NCT00914589|7318205|FG001|Overall Study|Protocol Violation|6
4509891|NCT00914589|7318206|FG002|Overall Study|Protocol Violation|3
4509892|NCT00914589|7318204|FG000|Overall Study|unclassified|16
4509893|NCT00914589|7318205|FG001|Overall Study|unclassified|9
4509894|NCT00914589|7318206|FG002|Overall Study|unclassified|7
4509895|NCT00914589|7318204|FG000|Overall Study|Death|0
4509896|NCT00914589|7318205|FG001|Overall Study|Death|1
4509897|NCT00914589|7318206|FG002|Overall Study|Death|1
4627917|NCT01855945|7494713|FG004|Overall Study|Lost to Follow-up|0
4705112|NCT02760433|7624409|FG001|Overall Study|Withdrawal by Subject|9
4705113|NCT02760433|7624410|FG002|Overall Study|Withdrawal by Subject|0
4705114|NCT02760433|7624411|FG003|Overall Study|Withdrawal by Subject|2
4705115|NCT02760433|7624412|FG004|Overall Study|Withdrawal by Subject|9
4705116|NCT02760433|7624408|FG000|Overall Study|Lack of Response At Week 14|0
4705117|NCT02760433|7624409|FG001|Overall Study|Lack of Response At Week 14|0
4705118|NCT02760433|7624410|FG002|Overall Study|Lack of Response At Week 14|0
4705119|NCT02760433|7624411|FG003|Overall Study|Lack of Response At Week 14|0
4705120|NCT02760433|7624412|FG004|Overall Study|Lack of Response At Week 14|1
4705121|NCT02760433|7624408|FG000|Overall Study|Subject refused to continue the study|1
4705122|NCT02760433|7624409|FG001|Overall Study|Subject refused to continue the study|0
4705123|NCT02760433|7624410|FG002|Overall Study|Subject refused to continue the study|0
4705124|NCT02760433|7624411|FG003|Overall Study|Subject refused to continue the study|0
4705125|NCT02760433|7624412|FG004|Overall Study|Subject refused to continue the study|0
4705126|NCT02760433|7624408|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2
4705127|NCT02760433|7624409|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0
4705128|NCT02760433|7624410|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0
4509898|NCT00914628|7318216|FG000|Overall Study|Death|35
4509899|NCT00914628|7318217|FG001|Overall Study|Death|17
4509900|NCT00914628|7318216|FG000|Overall Study|Medical decision|4
4705129|NCT02760433|7624411|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0
4705130|NCT02760433|7624412|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0
4705131|NCT02760433|7624408|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0
4705132|NCT02760433|7624409|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1
4705133|NCT02760433|7624410|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0
4771250|NCT02978781|7748151|FG000|Part C|Adverse Event|0
4509901|NCT00914628|7318217|FG001|Overall Study|Medical decision|0
4509902|NCT00914628|7318216|FG000|Overall Study|Protocol Violation|1
4509903|NCT00914628|7318217|FG001|Overall Study|Protocol Violation|0
4509904|NCT00914628|7318216|FG000|Overall Study|Lack of Efficacy|1
4509905|NCT00914628|7318217|FG001|Overall Study|Lack of Efficacy|0
4509906|NCT00914628|7318216|FG000|Overall Study|non-randomized|1
4509907|NCT00914628|7318217|FG001|Overall Study|non-randomized|0
4509908|NCT00914628|7318216|FG000|Overall Study|Relapse|1
4509909|NCT00914628|7318217|FG001|Overall Study|Relapse|2
4627918|NCT01855945|7494714|FG005|Overall Study|Lost to Follow-up|3
4627919|NCT01855945|7494715|FG006|Overall Study|Lost to Follow-up|4
4627920|NCT01855945|7494716|FG007|Overall Study|Lost to Follow-up|7
4627921|NCT01855945|7494717|FG008|Overall Study|Lost to Follow-up|2
4627922|NCT01855945|7494718|FG009|Overall Study|Lost to Follow-up|0
4627923|NCT01855945|7494719|FG010|Overall Study|Lost to Follow-up|0
4627924|NCT01855945|7494720|FG011|Overall Study|Lost to Follow-up|2
4627925|NCT01855945|7494709|FG000|Overall Study|Other - Unclassified|1
4627926|NCT01855945|7494710|FG001|Overall Study|Other - Unclassified|1
4627927|NCT01855945|7494711|FG002|Overall Study|Other - Unclassified|1
4627928|NCT01855945|7494712|FG003|Overall Study|Other - Unclassified|0
4627929|NCT01855945|7494713|FG004|Overall Study|Other - Unclassified|0
4627930|NCT01855945|7494714|FG005|Overall Study|Other - Unclassified|0
4627931|NCT01855945|7494715|FG006|Overall Study|Other - Unclassified|2
4509910|NCT00914628|7318216|FG000|Overall Study|Study terminated by Sponsor|14
4509911|NCT00914628|7318217|FG001|Overall Study|Study terminated by Sponsor|8
4509912|NCT00914628|7318216|FG000|Overall Study|Patients who did not receive a single dose|7
4509913|NCT00914628|7318217|FG001|Overall Study|Patients who did not receive a single dose|1
4509914|NCT00914732|7318230|FG000|Overall Study|Lost to Follow-up|6
4509915|NCT00914732|7318231|FG001|Overall Study|Lost to Follow-up|7
4509916|NCT00914732|7318232|FG002|Overall Study|Lost to Follow-up|9
4509917|NCT00914732|7318230|FG000|Overall Study|Withdrawal by Subject|3
4509918|NCT00914732|7318231|FG001|Overall Study|Withdrawal by Subject|0
4509919|NCT00914732|7318232|FG002|Overall Study|Withdrawal by Subject|2
4509920|NCT00914732|7318230|FG000|Overall Study|Adverse Event|1
4509921|NCT00914732|7318231|FG001|Overall Study|Adverse Event|0
4509922|NCT00914732|7318232|FG002|Overall Study|Adverse Event|0
4509923|NCT00914810|7318243|FG000|Overall Study|Withdrawal by Subject|1
4509924|NCT00914810|7318244|FG001|Overall Study|Withdrawal by Subject|0
4509925|NCT00914810|7318243|FG000|Overall Study|Relocated out of state|1
4509926|NCT00914810|7318244|FG001|Overall Study|Relocated out of state|0
4509927|NCT00914810|7318243|FG000|Overall Study|Hospitalized and unable to follow up.|0
4509928|NCT00914810|7318244|FG001|Overall Study|Hospitalized and unable to follow up.|1
4509929|NCT00914849|7318252|FG000|Overall Study|Withdrawal by Subject|1
4509930|NCT00914849|7318253|FG001|Overall Study|Withdrawal by Subject|0
4509931|NCT00914849|7318252|FG000|Overall Study|Not eligible|0
4509932|NCT00914849|7318253|FG001|Overall Study|Not eligible|1
4509933|NCT00914927|7318287|FG000|Overall Study|Adverse Event|0
4509934|NCT00914927|7318288|FG001|Overall Study|Adverse Event|0
4509935|NCT00914927|7318289|FG002|Overall Study|Adverse Event|0
4509936|NCT00914927|7318290|FG003|Overall Study|Adverse Event|0
4509937|NCT00914927|7318291|FG004|Overall Study|Adverse Event|1
4509938|NCT00914927|7318292|FG005|Overall Study|Adverse Event|0
4509939|NCT00914927|7318293|FG006|Overall Study|Adverse Event|0
4509940|NCT00914927|7318287|FG000|Overall Study|Withdrawal by Subject|0
4509941|NCT00914927|7318288|FG001|Overall Study|Withdrawal by Subject|1
4509942|NCT00914927|7318289|FG002|Overall Study|Withdrawal by Subject|0
4509943|NCT00914927|7318290|FG003|Overall Study|Withdrawal by Subject|1
4509944|NCT00914927|7318291|FG004|Overall Study|Withdrawal by Subject|0
4509945|NCT00914927|7318292|FG005|Overall Study|Withdrawal by Subject|0
4509946|NCT00914927|7318293|FG006|Overall Study|Withdrawal by Subject|0
4509947|NCT00914927|7318287|FG000|Overall Study|Lost to Follow-up|0
4509948|NCT00914927|7318288|FG001|Overall Study|Lost to Follow-up|0
4509949|NCT00914927|7318289|FG002|Overall Study|Lost to Follow-up|0
4705134|NCT02760433|7624411|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0
4705135|NCT02760433|7624412|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0
4705136|NCT02760654|7624431|FG000|Overall Study|Lost to Follow-up|3
4705137|NCT02760654|7624432|FG001|Overall Study|Lost to Follow-up|3
4705138|NCT02760654|7624431|FG000|Overall Study|Withdrawal by Subject|4
4705139|NCT02760654|7624432|FG001|Overall Study|Withdrawal by Subject|3
4705140|NCT02760810|7624438|FG000|Overall Study|Protocol Violation|1
4705141|NCT02760927|7624451|FG000|Overall Study|Tube Slippage from Device|1
4705142|NCT02761330|7624470|FG000|Treatment Week 1|Withdrawal by Subject|0
4705143|NCT02761330|7624471|FG001|Treatment Week 1|Withdrawal by Subject|0
4705144|NCT02761330|7624472|FG002|Treatment Week 1|Withdrawal by Subject|0
4705145|NCT02761330|7624473|FG003|Treatment Week 1|Withdrawal by Subject|1
4705146|NCT02761330|7624474|FG004|Treatment Week 1|Withdrawal by Subject|0
4705147|NCT02761330|7624475|FG005|Treatment Week 1|Withdrawal by Subject|1
4705148|NCT02761629|7624491|FG000|Overall Study|Adverse Event/Intercurrent Illness|7
4705149|NCT02761629|7624492|FG001|Overall Study|Adverse Event/Intercurrent Illness|5
4705150|NCT02761629|7624491|FG000|Overall Study|Insufficient Therapeutic Response|2
4705151|NCT02761629|7624492|FG001|Overall Study|Insufficient Therapeutic Response|7
4705152|NCT02761629|7624491|FG000|Overall Study|Failure to Return|2
4705153|NCT02761629|7624492|FG001|Overall Study|Failure to Return|4
4705154|NCT02761629|7624491|FG000|Overall Study|Did not Cooperate/Refused Treatment|2
4705155|NCT02761629|7624492|FG001|Overall Study|Did not Cooperate/Refused Treatment|4
4705156|NCT02761629|7624491|FG000|Overall Study|Protocol Violation|2
4705157|NCT02761629|7624492|FG001|Overall Study|Protocol Violation|2
4705158|NCT02761629|7624491|FG000|Overall Study|Withdrawal by Subject|0
4705159|NCT02761629|7624492|FG001|Overall Study|Withdrawal by Subject|3
4705160|NCT02761629|7624491|FG000|Overall Study|Other|0
4705161|NCT02761629|7624492|FG001|Overall Study|Other|2
4705162|NCT02761629|7624491|FG000|Overall Study|Lost to Follow-up|4
4705163|NCT02761629|7624492|FG001|Overall Study|Lost to Follow-up|1
4705164|NCT02761629|7624491|FG000|Overall Study|Randomized But Not Treated|8
4705165|NCT02761629|7624492|FG001|Overall Study|Randomized But Not Treated|4
4509950|NCT00914927|7318290|FG003|Overall Study|Lost to Follow-up|1
4509951|NCT00914927|7318291|FG004|Overall Study|Lost to Follow-up|0
4509952|NCT00914927|7318292|FG005|Overall Study|Lost to Follow-up|0
4509953|NCT00914927|7318293|FG006|Overall Study|Lost to Follow-up|0
4509954|NCT00914927|7318287|FG000|Overall Study|Administrative/Other|2
4509955|NCT00914927|7318288|FG001|Overall Study|Administrative/Other|1
4705166|NCT02761642|7624498|FG000|Overall Study|Did not Receive Study Treatment|3
4705167|NCT02761642|7624498|FG000|Overall Study|Adverse Event|13
4705168|NCT02761642|7624498|FG000|Overall Study|Withdrawal by Subject|2
4509956|NCT00914927|7318289|FG002|Overall Study|Administrative/Other|0
4509957|NCT00914927|7318290|FG003|Overall Study|Administrative/Other|0
4509958|NCT00914927|7318291|FG004|Overall Study|Administrative/Other|1
4509959|NCT00914927|7318292|FG005|Overall Study|Administrative/Other|0
4705169|NCT02761642|7624498|FG000|Overall Study|Non-compliant|7
4705170|NCT02761642|7624498|FG000|Overall Study|Death|3
4705171|NCT02761642|7624498|FG000|Overall Study|Lack of Efficacy|20
4705172|NCT02761642|7624498|FG000|Overall Study|Physician Decision|1
4705173|NCT02761642|7624498|FG000|Overall Study|Reason Unspecified|21
4705174|NCT02761733|7624506|FG000|Overall Study|Death|3
4705175|NCT02761733|7624507|FG001|Overall Study|Death|5
4705176|NCT02761733|7624508|FG002|Overall Study|Death|1
4705177|NCT02761733|7624509|FG003|Overall Study|Death|1
4705178|NCT02761733|7624506|FG000|Overall Study|Lost to Follow-up|6
4705179|NCT02761733|7624507|FG001|Overall Study|Lost to Follow-up|7
4705180|NCT02761733|7624508|FG002|Overall Study|Lost to Follow-up|0
4705181|NCT02761733|7624509|FG003|Overall Study|Lost to Follow-up|3
4705182|NCT02761733|7624506|FG000|Overall Study|Physician Decision|4
4705183|NCT02761733|7624507|FG001|Overall Study|Physician Decision|0
4705184|NCT02761733|7624508|FG002|Overall Study|Physician Decision|0
4705185|NCT02761733|7624509|FG003|Overall Study|Physician Decision|0
4705186|NCT02761733|7624506|FG000|Overall Study|Withdrawal by Subject|2
4705187|NCT02761733|7624507|FG001|Overall Study|Withdrawal by Subject|0
4705188|NCT02761733|7624508|FG002|Overall Study|Withdrawal by Subject|0
4705189|NCT02761733|7624509|FG003|Overall Study|Withdrawal by Subject|0
4705190|NCT02761733|7624506|FG000|Overall Study|Discharged from Study Site|10
4705191|NCT02761733|7624507|FG001|Overall Study|Discharged from Study Site|9
4705192|NCT02761733|7624508|FG002|Overall Study|Discharged from Study Site|25
4387371|NCT00048165|7165995|FG000|Completed 6 Months Study|Abnormality of laboratory test|1
4387372|NCT00048165|7165996|FG001|Completed 6 Months Study|Abnormality of laboratory test|0
4387373|NCT00048165|7165995|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14
4387374|NCT00048165|7165996|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11
4387375|NCT00048165|7165995|FG000|Completed 6 Months Study|Death|12
4387376|NCT00048165|7165996|FG001|Completed 6 Months Study|Death|6
4387377|NCT00048165|7165995|FG000|Completed 6 Months Study|Insufficient therapy|1
4387378|NCT00048165|7165996|FG001|Completed 6 Months Study|Insufficient therapy|4
4387379|NCT00048165|7165995|FG000|Completed 6 Months Study|Other violation|4
4387380|NCT00048165|7165996|FG001|Completed 6 Months Study|Other violation|6
4387381|NCT00048165|7165995|FG000|Completed 6 Months Study|Refused treatment|5
4705193|NCT02761733|7624509|FG003|Overall Study|Discharged from Study Site|11
4705194|NCT02761733|7624506|FG000|Overall Study|Cognitive Impairment|5
4705195|NCT02761733|7624507|FG001|Overall Study|Cognitive Impairment|0
4705196|NCT02761733|7624508|FG002|Overall Study|Cognitive Impairment|1
4705197|NCT02761733|7624509|FG003|Overall Study|Cognitive Impairment|0
4705198|NCT02761915|7624525|FG000|Overall Study|Death|3
4705199|NCT02761915|7624526|FG001|Overall Study|Death|1
4705200|NCT02761915|7624527|FG002|Overall Study|Death|1
4705201|NCT02761915|7624528|FG003|Overall Study|Death|1
4705202|NCT02761915|7624529|FG004|Overall Study|Death|0
4705203|NCT02761915|7624530|FG005|Overall Study|Death|1
4705204|NCT02761915|7624525|FG000|Overall Study|Withdrawal by Subject|1
4705205|NCT02761915|7624526|FG001|Overall Study|Withdrawal by Subject|0
4705206|NCT02761915|7624527|FG002|Overall Study|Withdrawal by Subject|0
4705207|NCT02761915|7624528|FG003|Overall Study|Withdrawal by Subject|0
4705208|NCT02761915|7624529|FG004|Overall Study|Withdrawal by Subject|1
4705209|NCT02761915|7624530|FG005|Overall Study|Withdrawal by Subject|2
4705210|NCT02761915|7624525|FG000|Overall Study|Disease Progression|0
4705211|NCT02761915|7624526|FG001|Overall Study|Disease Progression|0
4705212|NCT02761915|7624527|FG002|Overall Study|Disease Progression|0
4705213|NCT02761915|7624528|FG003|Overall Study|Disease Progression|2
4705214|NCT02761915|7624529|FG004|Overall Study|Disease Progression|2
4705215|NCT02761915|7624530|FG005|Overall Study|Disease Progression|2
4705216|NCT02761980|7624564|FG000|Overall Study|Adverse Event|4
4705217|NCT02761980|7624565|FG001|Overall Study|Adverse Event|6
4705218|NCT02761980|7624566|FG002|Overall Study|Adverse Event|5
4705219|NCT02761980|7624567|FG003|Overall Study|Adverse Event|6
4705220|NCT02761980|7624564|FG000|Overall Study|Withdrawal by Subject|0
4705221|NCT02761980|7624565|FG001|Overall Study|Withdrawal by Subject|1
4705222|NCT02761980|7624566|FG002|Overall Study|Withdrawal by Subject|0
4705223|NCT02761980|7624567|FG003|Overall Study|Withdrawal by Subject|0
4387382|NCT00048165|7165996|FG001|Completed 6 Months Study|Refused treatment|5
4387383|NCT00048165|7165995|FG000|Completed 6 Months Study|Violation criteria|0
4387384|NCT00048165|7165996|FG001|Completed 6 Months Study|Violation criteria|2
4387385|NCT00048165|7165995|FG000|Completed 6 Months Study|Did not receive study drug|6
4387386|NCT00048165|7165996|FG001|Completed 6 Months Study|Did not receive study drug|6
4387387|NCT00048165|7165995|FG000|Completed 12 Months Study|Administration/Other|0
4387388|NCT00048165|7165996|FG001|Completed 12 Months Study|Administration/Other|2
4705224|NCT02761980|7624564|FG000|Overall Study|Other|0
4705225|NCT02761980|7624565|FG001|Overall Study|Other|0
4705226|NCT02761980|7624566|FG002|Overall Study|Other|1
4705227|NCT02761980|7624567|FG003|Overall Study|Other|0
4705228|NCT02761993|7624580|FG000|Overall Study|Adverse Event|0
4705229|NCT02761993|7624581|FG001|Overall Study|Adverse Event|2
4705230|NCT02761993|7624582|FG002|Overall Study|Adverse Event|0
4509960|NCT00914927|7318293|FG006|Overall Study|Administrative/Other|0
4509961|NCT00914940|7318318|FG000|D0 to D100 Post-transplant|Death|2
4509962|NCT00914940|7318318|FG000|D101 to 2 Years Post-transplant|Death|8
4509963|NCT00914940|7318318|FG000|2 Years to 5 Years Post-transplant|Death|3
4509964|NCT00914966|7318322|FG000|Step 1: 1500 Units|Withdrawal by Subject|1
4509965|NCT00914966|7318322|FG000|Step 1: 1500 Units|Physician Decision|1
4509966|NCT00914966|7318322|FG000|Step 2: 2000 Units|Withdrawal by Subject|1
4509967|NCT00915005|7318333|FG000|Overall Study|Withdrawal by Subject|4
4509968|NCT00915005|7318334|FG001|Overall Study|Withdrawal by Subject|4
4509969|NCT00915005|7318333|FG000|Overall Study|Patient preferred protons therapy|6
4509970|NCT00915005|7318334|FG001|Overall Study|Patient preferred protons therapy|0
4509971|NCT00915005|7318333|FG000|Overall Study|Insurance denial|3
4509972|NCT00915005|7318334|FG001|Overall Study|Insurance denial|15
4509973|NCT00915018|7318342|FG000|Overall Study|Death|75
4509974|NCT00915018|7318343|FG001|Overall Study|Death|70
4509975|NCT00915018|7318342|FG000|Overall Study|Lost to Follow-up|10
4509976|NCT00915018|7318343|FG001|Overall Study|Lost to Follow-up|5
4509977|NCT00915018|7318342|FG000|Overall Study|Withdrawal by Subject|38
4509978|NCT00915018|7318343|FG001|Overall Study|Withdrawal by Subject|27
4509979|NCT00915018|7318342|FG000|Overall Study|By Sponsor due to Protocol Amendment|92
4509980|NCT00915018|7318343|FG001|Overall Study|By Sponsor due to Protocol Amendment|105
4518299|NCT00973349|7330436|FG007|Overall Study|Withdrawal by Subject|2
4518300|NCT00973349|7330437|FG008|Overall Study|Withdrawal by Subject|0
4518301|NCT00973349|7330438|FG009|Overall Study|Withdrawal by Subject|2
4518302|NCT00973349|7330439|FG010|Overall Study|Withdrawal by Subject|0
4518303|NCT00973349|7330440|FG011|Overall Study|Withdrawal by Subject|1
4518304|NCT00973349|7330441|FG012|Overall Study|Withdrawal by Subject|0
4705231|NCT02761993|7624580|FG000|Overall Study|Lost to Follow-up|1
4705232|NCT02761993|7624581|FG001|Overall Study|Lost to Follow-up|3
4705233|NCT02761993|7624582|FG002|Overall Study|Lost to Follow-up|2
4705234|NCT02761993|7624580|FG000|Overall Study|Withdrawal by Subject|1
4705235|NCT02761993|7624581|FG001|Overall Study|Withdrawal by Subject|1
4705236|NCT02761993|7624582|FG002|Overall Study|Withdrawal by Subject|2
4705237|NCT02762084|7624603|FG000|Overall Study|Withdrawal by Subject|1
4705238|NCT02762084|7624604|FG001|Overall Study|Withdrawal by Subject|0
4705239|NCT02762084|7624605|FG002|Overall Study|Withdrawal by Subject|0
4705240|NCT02762084|7624603|FG000|Overall Study|Adverse Event|0
4705241|NCT02762084|7624604|FG001|Overall Study|Adverse Event|0
4705242|NCT02762084|7624605|FG002|Overall Study|Adverse Event|1
4705243|NCT02762370|7624626|FG000|Overall Study|Protocol Violation|1
4705244|NCT02762370|7624627|FG001|Overall Study|Protocol Violation|0
4705245|NCT02762500|7624637|FG000|Overall Study|Lack of Efficacy|1
4705246|NCT02762500|7624638|FG001|Overall Study|Lack of Efficacy|0
4705247|NCT02762500|7624637|FG000|Overall Study|Withdrawal by Subject|1
4705248|NCT02762500|7624638|FG001|Overall Study|Withdrawal by Subject|1
4705249|NCT02762500|7624637|FG000|Overall Study|Adverse Event|0
4705250|NCT02762500|7624638|FG001|Overall Study|Adverse Event|2
4705251|NCT02762565|7624648|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11
4705252|NCT02762578|7624654|FG000|Overall Study|Adverse Event|1
4705253|NCT02762578|7624655|FG001|Overall Study|Adverse Event|6
4705254|NCT02762578|7624654|FG000|Overall Study|Protocol Violation|4
4705255|NCT02762578|7624655|FG001|Overall Study|Protocol Violation|2
4387389|NCT00048165|7165995|FG000|Completed 12 Months Study|Death|2
4387390|NCT00048165|7165996|FG001|Completed 12 Months Study|Death|1
4387391|NCT00048165|7165995|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1
4387392|NCT00048165|7165996|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0
4387393|NCT00048347|7166004|FG000|Overall Study|Screen failure|2
4387394|NCT00048542|7166012|FG000|Double-Blind Phase|Withdrawal by Subject|0
4387395|NCT00048542|7166013|FG001|Double-Blind Phase|Withdrawal by Subject|1
4387396|NCT00048542|7166014|FG002|Double-Blind Phase|Withdrawal by Subject|0
4387397|NCT00048542|7166015|FG003|Double-Blind Phase|Withdrawal by Subject|0
4387398|NCT00048542|7166016|FG004|Double-Blind Phase|Withdrawal by Subject|0
4387399|NCT00048542|7166017|FG005|Double-Blind Phase|Withdrawal by Subject|0
4387400|NCT00048542|7166018|FG006|Double-Blind Phase|Withdrawal by Subject|0
4387401|NCT00048542|7166019|FG007|Double-Blind Phase|Withdrawal by Subject|0
4387402|NCT00048542|7166012|FG000|Double-Blind Phase|Protocol Violation|0
4387403|NCT00048542|7166013|FG001|Double-Blind Phase|Protocol Violation|0
4387404|NCT00048542|7166014|FG002|Double-Blind Phase|Protocol Violation|1
4387405|NCT00048542|7166015|FG003|Double-Blind Phase|Protocol Violation|0
4387406|NCT00048542|7166016|FG004|Double-Blind Phase|Protocol Violation|0
4387407|NCT00048542|7166017|FG005|Double-Blind Phase|Protocol Violation|0
4387408|NCT00048542|7166018|FG006|Double-Blind Phase|Protocol Violation|0
4387409|NCT00048542|7166019|FG007|Double-Blind Phase|Protocol Violation|0
4387410|NCT00048542|7166012|FG000|Double-Blind Phase|Sponsor request or decision|2
4387411|NCT00048542|7166013|FG001|Double-Blind Phase|Sponsor request or decision|0
4387412|NCT00048542|7166014|FG002|Double-Blind Phase|Sponsor request or decision|0
4387413|NCT00048542|7166015|FG003|Double-Blind Phase|Sponsor request or decision|0
4387414|NCT00048542|7166016|FG004|Double-Blind Phase|Sponsor request or decision|0
4387415|NCT00048542|7166017|FG005|Double-Blind Phase|Sponsor request or decision|0
4387416|NCT00048542|7166018|FG006|Double-Blind Phase|Sponsor request or decision|0
4387417|NCT00048542|7166019|FG007|Double-Blind Phase|Sponsor request or decision|0
4509981|NCT00915278|7318368|FG000|Overall Study|Death|1
4509982|NCT00915278|7318369|FG001|Overall Study|Death|0
4509983|NCT00915278|7318370|FG002|Overall Study|Death|0
4509984|NCT00915278|7318371|FG003|Overall Study|Death|0
4509985|NCT00915278|7318372|FG004|Overall Study|Death|0
4627932|NCT01855945|7494716|FG007|Overall Study|Other - Unclassified|1
4627933|NCT01855945|7494717|FG008|Overall Study|Other - Unclassified|0
4627934|NCT01855945|7494718|FG009|Overall Study|Other - Unclassified|0
4627935|NCT01855945|7494719|FG010|Overall Study|Other - Unclassified|1
4627936|NCT01855945|7494720|FG011|Overall Study|Other - Unclassified|0
4705256|NCT02762578|7624654|FG000|Overall Study|Withdrawal by Subject|4
4509986|NCT00915278|7318373|FG005|Overall Study|Death|0
4509987|NCT00915278|7318368|FG000|Overall Study|Lost to Follow-up|0
4509988|NCT00915278|7318369|FG001|Overall Study|Lost to Follow-up|1
4509989|NCT00915278|7318370|FG002|Overall Study|Lost to Follow-up|0
4509990|NCT00915278|7318371|FG003|Overall Study|Lost to Follow-up|0
4509991|NCT00915278|7318372|FG004|Overall Study|Lost to Follow-up|0
4509992|NCT00915278|7318373|FG005|Overall Study|Lost to Follow-up|0
4509993|NCT00915278|7318368|FG000|Overall Study|Withdrawal by Subject|0
4509994|NCT00915278|7318369|FG001|Overall Study|Withdrawal by Subject|1
4509995|NCT00915278|7318370|FG002|Overall Study|Withdrawal by Subject|0
4509996|NCT00915278|7318371|FG003|Overall Study|Withdrawal by Subject|0
4509997|NCT00915278|7318372|FG004|Overall Study|Withdrawal by Subject|1
4509998|NCT00915278|7318373|FG005|Overall Study|Withdrawal by Subject|4
4509999|NCT00915278|7318368|FG000|Overall Study|Adverse Event|4
4510000|NCT00915278|7318369|FG001|Overall Study|Adverse Event|1
4510001|NCT00915278|7318370|FG002|Overall Study|Adverse Event|0
4510002|NCT00915278|7318371|FG003|Overall Study|Adverse Event|0
4510003|NCT00915278|7318372|FG004|Overall Study|Adverse Event|0
4510004|NCT00915278|7318373|FG005|Overall Study|Adverse Event|0
4510005|NCT00915278|7318368|FG000|Overall Study|Progressive disease/clinical progression|0
4510006|NCT00915278|7318369|FG001|Overall Study|Progressive disease/clinical progression|0
4510007|NCT00915278|7318370|FG002|Overall Study|Progressive disease/clinical progression|0
4510008|NCT00915278|7318371|FG003|Overall Study|Progressive disease/clinical progression|3
4510009|NCT00915278|7318372|FG004|Overall Study|Progressive disease/clinical progression|1
4510010|NCT00915278|7318373|FG005|Overall Study|Progressive disease/clinical progression|2
4510011|NCT00915278|7318368|FG000|Overall Study|Infusion related AEs|0
4510012|NCT00915278|7318369|FG001|Overall Study|Infusion related AEs|0
4510013|NCT00915278|7318370|FG002|Overall Study|Infusion related AEs|0
4510014|NCT00915278|7318371|FG003|Overall Study|Infusion related AEs|0
4510015|NCT00915278|7318372|FG004|Overall Study|Infusion related AEs|0
4510016|NCT00915278|7318373|FG005|Overall Study|Infusion related AEs|2
4510017|NCT00915278|7318368|FG000|Overall Study|Admission to hospice|0
4510018|NCT00915278|7318369|FG001|Overall Study|Admission to hospice|0
4510019|NCT00915278|7318370|FG002|Overall Study|Admission to hospice|1
4510020|NCT00915278|7318371|FG003|Overall Study|Admission to hospice|0
4510021|NCT00915278|7318372|FG004|Overall Study|Admission to hospice|0
4510022|NCT00915278|7318373|FG005|Overall Study|Admission to hospice|0
4510023|NCT00915343|7318387|FG000|Part B - Open Label Period|Treatment switch|0
4510024|NCT00915343|7318388|FG001|Part B - Open Label Period|Treatment switch|0
4510025|NCT00915343|7318389|FG002|Part B - Open Label Period|Treatment switch|1
4510026|NCT00915343|7318387|FG000|Part B - Open Label Period|Did not attend the last visit|0
4510027|NCT00915343|7318388|FG001|Part B - Open Label Period|Did not attend the last visit|0
4510028|NCT00915343|7318389|FG002|Part B - Open Label Period|Did not attend the last visit|1
4510029|NCT00915356|7318406|FG000|Overall Study|Withdrawal by Subject|1
4510030|NCT00915356|7318407|FG001|Overall Study|Withdrawal by Subject|0
4510031|NCT00915356|7318408|FG002|Overall Study|Withdrawal by Subject|0
4510032|NCT00915356|7318409|FG003|Overall Study|Withdrawal by Subject|0
4510033|NCT00915356|7318410|FG004|Overall Study|Withdrawal by Subject|0
4510034|NCT00915473|7318424|FG000|Screening|Withdrawal by Subject|1
4510035|NCT00915473|7318425|FG001|Screening|Withdrawal by Subject|0
4510036|NCT00915473|7318424|FG000|4-week Follow Up|Lost to Follow-up|1
4510037|NCT00915473|7318425|FG001|4-week Follow Up|Lost to Follow-up|5
4510038|NCT00915525|7318442|FG000|Overall Study|Protocol Violation|9
4510039|NCT00915525|7318443|FG001|Overall Study|Protocol Violation|4
4510040|NCT00915525|7318442|FG000|Overall Study|Withdrawal by Subject|59
4705257|NCT02762578|7624655|FG001|Overall Study|Withdrawal by Subject|2
4705258|NCT02762578|7624654|FG000|Overall Study|Unclassified|6
4705259|NCT02762578|7624655|FG001|Overall Study|Unclassified|0
4705260|NCT02762994|7624694|FG000|Overall Study|Withdrawal by Subject|0
4705261|NCT02762994|7624695|FG001|Overall Study|Withdrawal by Subject|1
4705262|NCT02762994|7624696|FG002|Overall Study|Withdrawal by Subject|2
4705263|NCT02762994|7624697|FG003|Overall Study|Withdrawal by Subject|0
4510041|NCT00915525|7318443|FG001|Overall Study|Withdrawal by Subject|21
4510042|NCT00915525|7318442|FG000|Overall Study|Lost to Follow-up|27
4510043|NCT00915525|7318443|FG001|Overall Study|Lost to Follow-up|16
4510044|NCT00915525|7318442|FG000|Overall Study|Pregnancy|2
4510045|NCT00915525|7318443|FG001|Overall Study|Pregnancy|0
4510046|NCT00915525|7318442|FG000|Overall Study|Lack of Efficacy|15
4627937|NCT01855945|7494709|FG000|Overall Study|Withdrawal by Subject|4
4627938|NCT01855945|7494710|FG001|Overall Study|Withdrawal by Subject|0
4627939|NCT01855945|7494711|FG002|Overall Study|Withdrawal by Subject|4
4510047|NCT00915525|7318443|FG001|Overall Study|Lack of Efficacy|32
4510048|NCT00915525|7318442|FG000|Overall Study|Adverse Event|29
4510049|NCT00915525|7318443|FG001|Overall Study|Adverse Event|13
4510050|NCT00915525|7318442|FG000|Overall Study|Missing|12
4510051|NCT00915525|7318443|FG001|Overall Study|Missing|1
4510052|NCT00915525|7318442|FG000|Overall Study|Other Reason|35
4510053|NCT00915525|7318443|FG001|Overall Study|Other Reason|12
4510054|NCT00915525|7318442|FG000|Overall Study|Site Closed|27
4510055|NCT00915525|7318443|FG001|Overall Study|Site Closed|9
4510056|NCT00915525|7318442|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4
4510057|NCT00915525|7318443|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5
4510058|NCT00915525|7318442|FG000|Overall Study|Study Burden|28
4510059|NCT00915525|7318443|FG001|Overall Study|Study Burden|12
4510060|NCT00915525|7318442|FG000|Overall Study|Non-Compliance|3
4510061|NCT00915525|7318443|FG001|Overall Study|Non-Compliance|1
4510062|NCT00915525|7318442|FG000|Overall Study|Patient Moved|15
4510063|NCT00915525|7318443|FG001|Overall Study|Patient Moved|9
4510064|NCT00915551|7318482|FG000|Overall Study|Withdrawal by Subject|0
4510065|NCT00915551|7318483|FG001|Overall Study|Withdrawal by Subject|1
4510066|NCT00915772|7318529|FG000|Overall Study|Adverse Event|12
4510067|NCT00915772|7318530|FG001|Overall Study|Adverse Event|13
4510068|NCT00915772|7318531|FG002|Overall Study|Adverse Event|11
4510069|NCT00915772|7318529|FG000|Overall Study|Protocol Violation|4
4510070|NCT00915772|7318530|FG001|Overall Study|Protocol Violation|1
4510071|NCT00915772|7318531|FG002|Overall Study|Protocol Violation|2
4510072|NCT00915772|7318529|FG000|Overall Study|Lost to Follow-up|1
4510073|NCT00915772|7318530|FG001|Overall Study|Lost to Follow-up|2
4510074|NCT00915772|7318531|FG002|Overall Study|Lost to Follow-up|2
4510075|NCT00915772|7318529|FG000|Overall Study|Lack of Efficacy|9
4510076|NCT00915772|7318530|FG001|Overall Study|Lack of Efficacy|15
4510077|NCT00915772|7318531|FG002|Overall Study|Lack of Efficacy|3
4510078|NCT00915772|7318529|FG000|Overall Study|Refused to continue trial medication|6
4510079|NCT00915772|7318530|FG001|Overall Study|Refused to continue trial medication|8
4510080|NCT00915772|7318531|FG002|Overall Study|Refused to continue trial medication|4
4510081|NCT00915772|7318529|FG000|Overall Study|Any other reason|4
4510082|NCT00915772|7318530|FG001|Overall Study|Any other reason|7
4510083|NCT00915772|7318531|FG002|Overall Study|Any other reason|7
4518305|NCT00973349|7330442|FG013|Overall Study|Withdrawal by Subject|0
4518306|NCT00973349|7330443|FG014|Overall Study|Withdrawal by Subject|0
4518307|NCT00973349|7330444|FG015|Overall Study|Withdrawal by Subject|0
4518308|NCT00973349|7330429|FG000|Overall Study|Lost to Follow-up|3
4518309|NCT00973349|7330430|FG001|Overall Study|Lost to Follow-up|1
4518310|NCT00973349|7330431|FG002|Overall Study|Lost to Follow-up|2
4518311|NCT00973349|7330432|FG003|Overall Study|Lost to Follow-up|2
4518312|NCT00973349|7330433|FG004|Overall Study|Lost to Follow-up|1
4518313|NCT00973349|7330434|FG005|Overall Study|Lost to Follow-up|3
4518314|NCT00973349|7330435|FG006|Overall Study|Lost to Follow-up|0
4518315|NCT00973349|7330436|FG007|Overall Study|Lost to Follow-up|1
4518316|NCT00973349|7330437|FG008|Overall Study|Lost to Follow-up|2
4518317|NCT00973349|7330438|FG009|Overall Study|Lost to Follow-up|1
4518318|NCT00973349|7330439|FG010|Overall Study|Lost to Follow-up|0
4518319|NCT00973349|7330440|FG011|Overall Study|Lost to Follow-up|1
4518320|NCT00973349|7330441|FG012|Overall Study|Lost to Follow-up|0
4518321|NCT00973349|7330442|FG013|Overall Study|Lost to Follow-up|0
4518322|NCT00973349|7330443|FG014|Overall Study|Lost to Follow-up|0
4518323|NCT00973349|7330444|FG015|Overall Study|Lost to Follow-up|1
4518324|NCT00973349|7330429|FG000|Overall Study|Inappropriate enrolment|0
4518325|NCT00973349|7330430|FG001|Overall Study|Inappropriate enrolment|0
4518326|NCT00973349|7330431|FG002|Overall Study|Inappropriate enrolment|1
4518327|NCT00973349|7330432|FG003|Overall Study|Inappropriate enrolment|0
4518328|NCT00973349|7330433|FG004|Overall Study|Inappropriate enrolment|0
4518329|NCT00973349|7330434|FG005|Overall Study|Inappropriate enrolment|0
4518330|NCT00973349|7330435|FG006|Overall Study|Inappropriate enrolment|0
4518331|NCT00973349|7330436|FG007|Overall Study|Inappropriate enrolment|0
4518332|NCT00973349|7330437|FG008|Overall Study|Inappropriate enrolment|0
4518333|NCT00973349|7330438|FG009|Overall Study|Inappropriate enrolment|2
4518334|NCT00973349|7330439|FG010|Overall Study|Inappropriate enrolment|0
4518335|NCT00973349|7330440|FG011|Overall Study|Inappropriate enrolment|0
4518336|NCT00973349|7330441|FG012|Overall Study|Inappropriate enrolment|1
4518337|NCT00973349|7330442|FG013|Overall Study|Inappropriate enrolment|0
4518338|NCT00973349|7330443|FG014|Overall Study|Inappropriate enrolment|1
4518339|NCT00973349|7330444|FG015|Overall Study|Inappropriate enrolment|1
4518340|NCT00973349|7330429|FG000|Overall Study|Protocol Violation|0
4518341|NCT00973349|7330430|FG001|Overall Study|Protocol Violation|0
4518342|NCT00973349|7330431|FG002|Overall Study|Protocol Violation|0
4518343|NCT00973349|7330432|FG003|Overall Study|Protocol Violation|0
4518344|NCT00973349|7330433|FG004|Overall Study|Protocol Violation|0
4518345|NCT00973349|7330434|FG005|Overall Study|Protocol Violation|0
4518346|NCT00973349|7330435|FG006|Overall Study|Protocol Violation|0
4518347|NCT00973349|7330436|FG007|Overall Study|Protocol Violation|0
4518348|NCT00973349|7330437|FG008|Overall Study|Protocol Violation|1
4518349|NCT00973349|7330438|FG009|Overall Study|Protocol Violation|0
4518350|NCT00973349|7330439|FG010|Overall Study|Protocol Violation|0
4518351|NCT00973349|7330440|FG011|Overall Study|Protocol Violation|0
4518352|NCT00973349|7330441|FG012|Overall Study|Protocol Violation|0
4510084|NCT00915876|7318569|FG000|Overall Study|Adverse Event|0
4510085|NCT00915876|7318570|FG001|Overall Study|Adverse Event|1
4510086|NCT00916006|7318621|FG000|Overall Study|Adverse Event|1
4510087|NCT00916006|7318622|FG001|Overall Study|Adverse Event|1
4510088|NCT00916006|7318621|FG000|Overall Study|Withdrawal by Subject|2
4510089|NCT00916006|7318622|FG001|Overall Study|Withdrawal by Subject|5
4510090|NCT00916006|7318621|FG000|Overall Study|Protocol Violation|0
4510091|NCT00916006|7318622|FG001|Overall Study|Protocol Violation|1
4510092|NCT00916058|7318642|FG000|Phase 1|Screen Failure|0
4510093|NCT00916058|7318643|FG001|Phase 1|Screen Failure|0
4510094|NCT00916058|7318644|FG002|Phase 1|Screen Failure|0
4510095|NCT00916058|7318645|FG003|Phase 1|Screen Failure|0
4510096|NCT00916058|7318646|FG004|Phase 1|Screen Failure|0
4510097|NCT00916058|7318647|FG005|Phase 1|Screen Failure|1
4510098|NCT00916058|7318648|FG006|Phase 1|Screen Failure|0
4510099|NCT00916058|7318642|FG000|Phase 2|Screen Failure|0
4510100|NCT00916058|7318643|FG001|Phase 2|Screen Failure|0
4510101|NCT00916058|7318644|FG002|Phase 2|Screen Failure|0
4510102|NCT00916058|7318645|FG003|Phase 2|Screen Failure|0
4510103|NCT00916058|7318646|FG004|Phase 2|Screen Failure|0
4510104|NCT00916058|7318647|FG005|Phase 2|Screen Failure|0
4510105|NCT00916058|7318648|FG006|Phase 2|Screen Failure|3
4705264|NCT02762994|7624694|FG000|Overall Study|Protocol Violation|1
4705265|NCT02762994|7624695|FG001|Overall Study|Protocol Violation|0
4705266|NCT02762994|7624696|FG002|Overall Study|Protocol Violation|0
4705267|NCT02762994|7624697|FG003|Overall Study|Protocol Violation|2
4705268|NCT02763046|7624714|FG000|Overall Study|Adverse Event|5
4705269|NCT02763046|7624715|FG001|Overall Study|Adverse Event|4
4705270|NCT02763046|7624716|FG002|Overall Study|Adverse Event|0
4705271|NCT02763046|7624714|FG000|Overall Study|Lack of Efficacy|1
4705272|NCT02763046|7624715|FG001|Overall Study|Lack of Efficacy|1
4705273|NCT02763046|7624716|FG002|Overall Study|Lack of Efficacy|3
4705274|NCT02763046|7624714|FG000|Overall Study|Physician Decision|1
4705275|NCT02763046|7624715|FG001|Overall Study|Physician Decision|0
4705276|NCT02763046|7624716|FG002|Overall Study|Physician Decision|1
4705277|NCT02763046|7624714|FG000|Overall Study|Subject/guardian decision|2
4705278|NCT02763046|7624715|FG001|Overall Study|Subject/guardian decision|0
4705279|NCT02763046|7624716|FG002|Overall Study|Subject/guardian decision|4
4705280|NCT02763215|7624734|FG000|Overall Study|Participants withdrew from study|3
4705281|NCT02763215|7624734|FG000|Overall Study|Missed visit|1
4705282|NCT02763215|7624734|FG000|Overall Study|Visit outside visit-window|1
4705283|NCT02763215|7624734|FG000|Overall Study|Death|1
4705284|NCT02763215|7624734|FG000|Overall Study|Lost to Follow-up|1
4705285|NCT02763254|7624738|FG000|Overall Study|Adverse Event|1
4705286|NCT02763566|7624746|FG000|Overall Study|Lost to Follow-up|1
4705287|NCT02763566|7624747|FG001|Overall Study|Lost to Follow-up|4
4705288|NCT02763566|7624748|FG002|Overall Study|Lost to Follow-up|0
4705289|NCT02763566|7624749|FG003|Overall Study|Lost to Follow-up|1
4387418|NCT00048542|7166012|FG000|Double-Blind Phase|Randomized in error|1
4387419|NCT00048542|7166013|FG001|Double-Blind Phase|Randomized in error|0
4387420|NCT00048542|7166014|FG002|Double-Blind Phase|Randomized in error|0
4387421|NCT00048542|7166015|FG003|Double-Blind Phase|Randomized in error|0
4510106|NCT00916149|7318678|FG000|Overall Study|Lost to Follow-up|3
4387422|NCT00048542|7166016|FG004|Double-Blind Phase|Randomized in error|0
4387423|NCT00048542|7166017|FG005|Double-Blind Phase|Randomized in error|0
4387424|NCT00048542|7166018|FG006|Double-Blind Phase|Randomized in error|0
4387425|NCT00048542|7166019|FG007|Double-Blind Phase|Randomized in error|0
4387426|NCT00048542|7166012|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0
4387427|NCT00048542|7166013|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0
4387428|NCT00048542|7166014|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0
4387429|NCT00048542|7166015|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0
4387430|NCT00048542|7166016|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3
4387431|NCT00048542|7166017|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6
4387432|NCT00048542|7166018|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0
4387433|NCT00048542|7166019|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0
4387434|NCT00048542|7166012|FG000|Open-Label Extension BSA Phase|Protocol Violation|0
4387435|NCT00048542|7166013|FG001|Open-Label Extension BSA Phase|Protocol Violation|0
4387436|NCT00048542|7166014|FG002|Open-Label Extension BSA Phase|Protocol Violation|0
4387437|NCT00048542|7166015|FG003|Open-Label Extension BSA Phase|Protocol Violation|0
4387438|NCT00048542|7166016|FG004|Open-Label Extension BSA Phase|Protocol Violation|0
4387439|NCT00048542|7166017|FG005|Open-Label Extension BSA Phase|Protocol Violation|1
4387440|NCT00048542|7166018|FG006|Open-Label Extension BSA Phase|Protocol Violation|0
4387441|NCT00048542|7166019|FG007|Open-Label Extension BSA Phase|Protocol Violation|0
4510107|NCT00916149|7318679|FG001|Overall Study|Lost to Follow-up|2
4510108|NCT00916149|7318680|FG002|Overall Study|Lost to Follow-up|0
4510109|NCT00916149|7318678|FG000|Overall Study|Unable to place scalp EEG leads|1
4510110|NCT00916149|7318679|FG001|Overall Study|Unable to place scalp EEG leads|0
4510111|NCT00916149|7318680|FG002|Overall Study|Unable to place scalp EEG leads|0
4510112|NCT00916279|7318687|FG000|Overall Study|Death|2
4705290|NCT02763566|7624746|FG000|Overall Study|On study treatment at study conclusion|114
4705291|NCT02763566|7624747|FG001|Overall Study|On study treatment at study conclusion|34
4705292|NCT02763566|7624748|FG002|Overall Study|On study treatment at study conclusion|54
4510113|NCT00916279|7318687|FG000|Overall Study|Lost to Follow-up|2
4510114|NCT00916305|7318696|FG000|Overall Study|Lost to Follow-up|21
4510115|NCT00916305|7318697|FG001|Overall Study|Lost to Follow-up|27
4510116|NCT00916305|7318696|FG000|Overall Study|Withdrawal by Subject|0
4510117|NCT00916305|7318697|FG001|Overall Study|Withdrawal by Subject|1
4510118|NCT00916344|7318703|FG000|Overall Study|Death|2
4510119|NCT00916344|7318703|FG000|Overall Study|ICD upgrade|1
4510120|NCT00916344|7318703|FG000|Overall Study|Drop-out|5
4510121|NCT00916357|7318707|FG000|Period 1|Withdrawal by Subject|1
4510122|NCT00916357|7318708|FG001|Period 1|Withdrawal by Subject|0
4510123|NCT00916357|7318709|FG002|Period 1|Withdrawal by Subject|0
4510124|NCT00916357|7318710|FG003|Period 1|Withdrawal by Subject|0
4510125|NCT00916357|7318711|FG004|Period 1|Withdrawal by Subject|0
4510126|NCT00916357|7318712|FG005|Period 1|Withdrawal by Subject|0
4510127|NCT00916357|7318707|FG000|Period 2|Weight loss > 3 kilograms (kg)|0
4510128|NCT00916357|7318708|FG001|Period 2|Weight loss > 3 kilograms (kg)|0
4510129|NCT00916357|7318709|FG002|Period 2|Weight loss > 3 kilograms (kg)|0
4510130|NCT00916357|7318710|FG003|Period 2|Weight loss > 3 kilograms (kg)|1
4510131|NCT00916357|7318711|FG004|Period 2|Weight loss > 3 kilograms (kg)|0
4510132|NCT00916357|7318712|FG005|Period 2|Weight loss > 3 kilograms (kg)|0
4510133|NCT00916370|7318723|FG000|Overall Study|Death|3
4510134|NCT00916370|7318724|FG001|Overall Study|Death|1
4510135|NCT00916370|7318723|FG000|Overall Study|Withdrawal by Subject|2
4510136|NCT00916370|7318724|FG001|Overall Study|Withdrawal by Subject|0
4510137|NCT00916370|7318723|FG000|Overall Study|Physician Decision|0
4510138|NCT00916370|7318724|FG001|Overall Study|Physician Decision|1
4510139|NCT00916383|7318731|FG000|Overall Study|Adverse Event|1
4510140|NCT00916383|7318731|FG000|Overall Study|Death|1
4510141|NCT00916383|7318731|FG000|Overall Study|Protocol Violation|1
4510142|NCT00916578|7318748|FG000|Overall Study|Physician Decision|2
4510143|NCT00916578|7318748|FG000|Overall Study|Withdrawal by Subject|3
4510144|NCT00916578|7318748|FG000|Overall Study|Insurance Denial|2
4510145|NCT00916617|7318756|FG000|Overall Study|Adverse Event|3
4510146|NCT00916617|7318757|FG001|Overall Study|Adverse Event|2
4510147|NCT00916617|7318758|FG002|Overall Study|Adverse Event|6
4510148|NCT00916617|7318759|FG003|Overall Study|Adverse Event|3
4510149|NCT00916617|7318756|FG000|Overall Study|Withdrawal by Subject|3
4510150|NCT00916617|7318757|FG001|Overall Study|Withdrawal by Subject|2
4510151|NCT00916617|7318758|FG002|Overall Study|Withdrawal by Subject|0
4510152|NCT00916617|7318759|FG003|Overall Study|Withdrawal by Subject|1
4510153|NCT00916617|7318756|FG000|Overall Study|Caregiver Request|3
4510154|NCT00916617|7318757|FG001|Overall Study|Caregiver Request|2
4510155|NCT00916617|7318758|FG002|Overall Study|Caregiver Request|1
4510156|NCT00916617|7318759|FG003|Overall Study|Caregiver Request|0
4510157|NCT00916617|7318756|FG000|Overall Study|Physician Decision|1
4510158|NCT00916617|7318757|FG001|Overall Study|Physician Decision|1
4510159|NCT00916617|7318758|FG002|Overall Study|Physician Decision|0
4510160|NCT00916617|7318759|FG003|Overall Study|Physician Decision|0
4510161|NCT00916617|7318756|FG000|Overall Study|Discontinuation of Study by Sponsor|8
4510162|NCT00916617|7318757|FG001|Overall Study|Discontinuation of Study by Sponsor|13
4510163|NCT00916617|7318758|FG002|Overall Study|Discontinuation of Study by Sponsor|3
4510164|NCT00916617|7318759|FG003|Overall Study|Discontinuation of Study by Sponsor|1
4510165|NCT00916617|7318756|FG000|Overall Study|Lost to Follow-up|2
4510166|NCT00916617|7318757|FG001|Overall Study|Lost to Follow-up|1
4510167|NCT00916617|7318758|FG002|Overall Study|Lost to Follow-up|0
4510168|NCT00916617|7318759|FG003|Overall Study|Lost to Follow-up|0
4510169|NCT00916617|7318756|FG000|Overall Study|Lack of Efficacy|1
4510170|NCT00916617|7318757|FG001|Overall Study|Lack of Efficacy|0
4510171|NCT00916617|7318758|FG002|Overall Study|Lack of Efficacy|0
4510172|NCT00916617|7318759|FG003|Overall Study|Lack of Efficacy|0
4510173|NCT00916617|7318756|FG000|Overall Study|Other|2
4510174|NCT00916617|7318757|FG001|Overall Study|Other|0
4510175|NCT00916617|7318758|FG002|Overall Study|Other|0
4510176|NCT00916617|7318759|FG003|Overall Study|Other|2
4510177|NCT00916721|7318775|FG000|Overall Study|Lost to Follow-up|0
4510178|NCT00916721|7318776|FG001|Overall Study|Lost to Follow-up|1
4510179|NCT00916721|7318775|FG000|Overall Study|Adverse Event|6
4510180|NCT00916721|7318776|FG001|Overall Study|Adverse Event|3
4510181|NCT00916721|7318775|FG000|Overall Study|Withdrawal by Subject|2
4510182|NCT00916721|7318776|FG001|Overall Study|Withdrawal by Subject|2
4510183|NCT00916721|7318775|FG000|Overall Study|Protocol Violation|2
4510184|NCT00916721|7318776|FG001|Overall Study|Protocol Violation|4
4510185|NCT00916929|7318784|FG000|Overall Study|Lost to Follow-up|1
4510186|NCT00916929|7318785|FG001|Overall Study|Lost to Follow-up|3
4510187|NCT00916929|7318784|FG000|Overall Study|Death|5
4510188|NCT00916929|7318785|FG001|Overall Study|Death|10
4510189|NCT00916929|7318784|FG000|Overall Study|Withdrawal by Subject|1
4510190|NCT00916929|7318785|FG001|Overall Study|Withdrawal by Subject|5
4510191|NCT00916929|7318784|FG000|Overall Study|Left ventricular epicardial lead|1
4510192|NCT00916929|7318785|FG001|Overall Study|Left ventricular epicardial lead|2
4510193|NCT00916929|7318784|FG000|Overall Study|Transferred to hospice care|1
4510194|NCT00916929|7318785|FG001|Overall Study|Transferred to hospice care|1
4510195|NCT00916929|7318784|FG000|Overall Study|System explant|1
4510196|NCT00916929|7318785|FG001|Overall Study|System explant|0
4510197|NCT00916929|7318784|FG000|Overall Study|Moved to another state|0
4510198|NCT00916929|7318785|FG001|Overall Study|Moved to another state|1
4510199|NCT00916929|7318784|FG000|Overall Study|Device unable to process impedance data|0
4510200|NCT00916929|7318785|FG001|Overall Study|Device unable to process impedance data|7
4510201|NCT00917124|7318795|FG000|Overall Study|Protocol Violation|4
4510202|NCT00917124|7318796|FG001|Overall Study|Protocol Violation|6
4510203|NCT00917150|7318806|FG000|Overall Study|Adverse Event|12
4510204|NCT00917150|7318807|FG001|Overall Study|Adverse Event|7
4510205|NCT00917150|7318808|FG002|Overall Study|Adverse Event|12
4510206|NCT00917150|7318809|FG003|Overall Study|Adverse Event|11
4510207|NCT00917150|7318806|FG000|Overall Study|Death|1
4510208|NCT00917150|7318807|FG001|Overall Study|Death|4
4510209|NCT00917150|7318808|FG002|Overall Study|Death|3
4510210|NCT00917150|7318809|FG003|Overall Study|Death|2
4510211|NCT00917150|7318806|FG000|Overall Study|Lost to Follow-up|1
4510212|NCT00917150|7318807|FG001|Overall Study|Lost to Follow-up|0
4510213|NCT00917150|7318808|FG002|Overall Study|Lost to Follow-up|4
4510214|NCT00917150|7318809|FG003|Overall Study|Lost to Follow-up|2
4510215|NCT00917150|7318806|FG000|Overall Study|Physician Decision|0
4510216|NCT00917150|7318807|FG001|Overall Study|Physician Decision|2
4510217|NCT00917150|7318808|FG002|Overall Study|Physician Decision|0
4510218|NCT00917150|7318809|FG003|Overall Study|Physician Decision|1
4510219|NCT00917150|7318806|FG000|Overall Study|Protocol Violation|5
4510220|NCT00917150|7318807|FG001|Overall Study|Protocol Violation|5
4510221|NCT00917150|7318808|FG002|Overall Study|Protocol Violation|3
4510222|NCT00917150|7318809|FG003|Overall Study|Protocol Violation|5
4510223|NCT00917150|7318806|FG000|Overall Study|Withdrawal by Subject|15
4510224|NCT00917150|7318807|FG001|Overall Study|Withdrawal by Subject|16
4510225|NCT00917150|7318808|FG002|Overall Study|Withdrawal by Subject|18
4510226|NCT00917150|7318809|FG003|Overall Study|Withdrawal by Subject|11
4510227|NCT00917150|7318806|FG000|Overall Study|Other than specified|3
4510228|NCT00917150|7318807|FG001|Overall Study|Other than specified|3
4510229|NCT00917150|7318808|FG002|Overall Study|Other than specified|2
4510230|NCT00917150|7318809|FG003|Overall Study|Other than specified|2
4510231|NCT00917267|7318821|FG000|Overall Study|Adverse Event|15
4510232|NCT00917267|7318822|FG001|Overall Study|Adverse Event|36
4510233|NCT00917267|7318821|FG000|Overall Study|Physician Decision|2
4510234|NCT00917267|7318822|FG001|Overall Study|Physician Decision|4
4510235|NCT00917267|7318821|FG000|Overall Study|Protocol Violation|9
4510236|NCT00917267|7318822|FG001|Overall Study|Protocol Violation|18
4510237|NCT00917267|7318821|FG000|Overall Study|Withdrawal by Subject|5
4510238|NCT00917267|7318822|FG001|Overall Study|Withdrawal by Subject|12
4510239|NCT00917267|7318821|FG000|Overall Study|Lost to follow up|0
4510240|NCT00917267|7318822|FG001|Overall Study|Lost to follow up|2
4510241|NCT00917267|7318821|FG000|Overall Study|Entry Criteria Not Met|1
4510242|NCT00917267|7318822|FG001|Overall Study|Entry Criteria Not Met|0
4510243|NCT00917267|7318821|FG000|Overall Study|Sponsor Decision|5
4510244|NCT00917267|7318822|FG001|Overall Study|Sponsor Decision|5
4510245|NCT00917267|7318821|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2
4510246|NCT00917267|7318822|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2
4510247|NCT00917384|7318834|FG000|Overall Study|Lost to Follow-up|4
4510248|NCT00917384|7318835|FG001|Overall Study|Lost to Follow-up|2
4510249|NCT00917384|7318834|FG000|Overall Study|Withdrawal by Subject|10
4510250|NCT00917384|7318835|FG001|Overall Study|Withdrawal by Subject|2
4510251|NCT00917462|7318841|FG000|Overall Study|Clinical Deterioration|1
4510252|NCT00917501|7318847|FG000|Overall Study|Lost to Follow-up|4
4510253|NCT00917501|7318848|FG001|Overall Study|Lost to Follow-up|1
4510254|NCT00917501|7318847|FG000|Overall Study|Withdrawal by Subject|3
4510255|NCT00917501|7318848|FG001|Overall Study|Withdrawal by Subject|1
4510256|NCT00917501|7318847|FG000|Overall Study|Lack of Efficacy|1
4510257|NCT00917501|7318848|FG001|Overall Study|Lack of Efficacy|2
4510258|NCT00917501|7318847|FG000|Overall Study|trouble swollowing capsules|0
4510259|NCT00917501|7318848|FG001|Overall Study|trouble swollowing capsules|1
4510260|NCT00917553|7318856|FG000|Overall Study|Lost to Follow-up|2
4510261|NCT00917553|7318857|FG001|Overall Study|Lost to Follow-up|1
4510262|NCT00917579|7318863|FG000|Washout >= 2 Weeks|Adverse Event|1
4510263|NCT00917579|7318864|FG001|Washout >= 2 Weeks|Adverse Event|0
4510264|NCT00917579|7318863|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1
4510265|NCT00917579|7318864|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0
4510266|NCT00917644|7318870|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1
4510267|NCT00917644|7318871|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0
4510268|NCT00917644|7318870|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1
4510269|NCT00917644|7318871|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0
4510270|NCT00917644|7318870|FG000|Period 2: Second Intervention|family emergency|1
4510271|NCT00917644|7318871|FG001|Period 2: Second Intervention|family emergency|0
4510272|NCT00917852|7318886|FG000|Overall Study|Death|6
4510273|NCT00918138|7318916|FG000|Overall Study|Subject withdrew consent|1
4510274|NCT00918138|7318917|FG001|Overall Study|Subject withdrew consent|1
4510275|NCT00918138|7318916|FG000|Overall Study|Death|1
4510276|NCT00918138|7318917|FG001|Overall Study|Death|0
4510277|NCT00918203|7318925|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1
4510278|NCT00918203|7318926|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1
4510279|NCT00918203|7318927|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0
4510280|NCT00918203|7318925|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2
4510281|NCT00918203|7318926|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8
4510282|NCT00918203|7318927|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0
4510283|NCT00918203|7318925|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2
4510284|NCT00918203|7318926|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1
4510285|NCT00918203|7318927|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0
4510286|NCT00918203|7318925|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1
4510287|NCT00918203|7318926|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0
4510288|NCT00918203|7318927|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0
4510289|NCT00918255|7318946|FG000|Overall Study|Adverse Event|1
4510290|NCT00918255|7318947|FG001|Overall Study|Adverse Event|0
4510291|NCT00918255|7318948|FG002|Overall Study|Adverse Event|0
4510292|NCT00918255|7318946|FG000|Overall Study|Withdrawal by Subject|1
4510293|NCT00918255|7318947|FG001|Overall Study|Withdrawal by Subject|0
4510294|NCT00918255|7318948|FG002|Overall Study|Withdrawal by Subject|2
4510295|NCT00918255|7318946|FG000|Overall Study|Lack of Efficacy|1
4510296|NCT00918255|7318947|FG001|Overall Study|Lack of Efficacy|0
4510297|NCT00918255|7318948|FG002|Overall Study|Lack of Efficacy|0
4510298|NCT00918255|7318946|FG000|Overall Study|Lost to Follow-up|1
4510299|NCT00918255|7318947|FG001|Overall Study|Lost to Follow-up|0
4510300|NCT00918255|7318948|FG002|Overall Study|Lost to Follow-up|2
4510301|NCT00918255|7318946|FG000|Overall Study|Exceeded allowed number of interventions|0
4510302|NCT00918255|7318947|FG001|Overall Study|Exceeded allowed number of interventions|0
4510303|NCT00918255|7318948|FG002|Overall Study|Exceeded allowed number of interventions|1
4510304|NCT00918255|7318946|FG000|Overall Study|Non-compliance|1
4510305|NCT00918255|7318947|FG001|Overall Study|Non-compliance|0
4510306|NCT00918255|7318948|FG002|Overall Study|Non-compliance|0
4510307|NCT00918255|7318946|FG000|Overall Study|Investigator discretion|1
4510308|NCT00918255|7318947|FG001|Overall Study|Investigator discretion|0
4510309|NCT00918255|7318948|FG002|Overall Study|Investigator discretion|0
4510310|NCT00918281|7318956|FG000|Overall Study|Physician Decision|29
4510311|NCT00918333|7318965|FG000|Overall Study|Drug not taken per protocol|1
4510312|NCT00918333|7318966|FG001|Overall Study|Drug not taken per protocol|0
4510313|NCT00918333|7318965|FG000|Overall Study|Inadequate amount of drugs provided|1
4510314|NCT00918333|7318966|FG001|Overall Study|Inadequate amount of drugs provided|4
4510315|NCT00918333|7318965|FG000|Overall Study|Ineligible|1
4510316|NCT00918333|7318966|FG001|Overall Study|Ineligible|0
4510317|NCT00918333|7318965|FG000|Overall Study|Withdrawal by Subject|0
4510318|NCT00918333|7318966|FG001|Overall Study|Withdrawal by Subject|1
4510319|NCT00918346|7318975|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0
4510320|NCT00918346|7318976|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1
4510321|NCT00918385|7318987|FG000|Monotherapy|Adverse Event|1
4510322|NCT00918385|7318988|FG001|Monotherapy|Adverse Event|6
4510323|NCT00918385|7318987|FG000|Monotherapy|Complicating illness|1
4510324|NCT00918385|7318988|FG001|Monotherapy|Complicating illness|0
4510325|NCT00918385|7318987|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1
4510326|NCT00918385|7318988|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1
4510327|NCT00918385|7318987|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2
4510328|NCT00918385|7318988|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0
4510329|NCT00918385|7318987|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1
4510330|NCT00918385|7318988|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0
4510331|NCT00918385|7318987|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2
4510332|NCT00918385|7318988|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7
4705293|NCT02763566|7624749|FG003|Overall Study|On study treatment at study conclusion|13
4705294|NCT02763566|7624746|FG000|Overall Study|Withdrawal by Subject|3
4705295|NCT02763566|7624747|FG001|Overall Study|Withdrawal by Subject|1
4705296|NCT02763566|7624748|FG002|Overall Study|Withdrawal by Subject|0
4705297|NCT02763566|7624749|FG003|Overall Study|Withdrawal by Subject|0
4705298|NCT02763579|7624765|FG000|Overall Study|Death|101
4705299|NCT02763579|7624766|FG001|Overall Study|Death|132
4705300|NCT02763579|7624765|FG000|Overall Study|Lost to Follow-up|3
4705301|NCT02763579|7624766|FG001|Overall Study|Lost to Follow-up|1
4705302|NCT02763579|7624765|FG000|Overall Study|Withdrawal by Subject|18
4705303|NCT02763579|7624766|FG001|Overall Study|Withdrawal by Subject|9
4705304|NCT02763579|7624765|FG000|Overall Study|Physician Decision|2
4705305|NCT02763579|7624766|FG001|Overall Study|Physician Decision|0
4705306|NCT02763579|7624765|FG000|Overall Study|On-going in study|77
4705307|NCT02763579|7624766|FG001|Overall Study|On-going in study|60
4705308|NCT02763644|7624774|FG000|Overall Study|Patient/guardian decision|1
4705309|NCT02763644|7624775|FG001|Overall Study|Patient/guardian decision|0
4705310|NCT02763644|7624774|FG000|Overall Study|Death|1
4705311|NCT02763644|7624775|FG001|Overall Study|Death|1
4510333|NCT00918567|7318998|FG000|Overall Study|Lack of Efficacy|3
4510334|NCT00918567|7318999|FG001|Overall Study|Lack of Efficacy|1
4705312|NCT02763644|7624774|FG000|Overall Study|Adverse Event|1
4705313|NCT02763644|7624775|FG001|Overall Study|Adverse Event|1
4510335|NCT00918567|7318998|FG000|Overall Study|Withdrawal by Subject|1
4510336|NCT00918567|7318999|FG001|Overall Study|Withdrawal by Subject|1
4705314|NCT02764151|7624830|FG000|Overall Study|Subject refused further follow-up|0
4705315|NCT02764151|7624831|FG001|Overall Study|Subject refused further follow-up|0
4705316|NCT02764151|7624832|FG002|Overall Study|Subject refused further follow-up|0
4705317|NCT02764151|7624833|FG003|Overall Study|Subject refused further follow-up|1
4510337|NCT00918567|7318998|FG000|Overall Study|Adverse Event|1
4510338|NCT00918567|7318999|FG001|Overall Study|Adverse Event|0
4510339|NCT00918580|7319005|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1
4510340|NCT00918580|7319005|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5
4510341|NCT00918580|7319005|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2
4510342|NCT00918580|7319005|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2
4510343|NCT00918580|7319005|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1
4510344|NCT00918580|7319005|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58
4510345|NCT00918580|7319005|FG000|After 6-month FU to 1-year FU|Failed to Return|2
4510346|NCT00918684|7319016|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16
4510347|NCT00918684|7319016|FG000|Treatment Phase|Lack of Efficacy|6
4627940|NCT01855945|7494712|FG003|Overall Study|Withdrawal by Subject|1
4627941|NCT01855945|7494713|FG004|Overall Study|Withdrawal by Subject|1
4627942|NCT01855945|7494714|FG005|Overall Study|Withdrawal by Subject|0
4705318|NCT02764151|7624830|FG000|Overall Study|Other|0
4705319|NCT02764151|7624831|FG001|Overall Study|Other|0
4705320|NCT02764151|7624832|FG002|Overall Study|Other|0
4705321|NCT02764151|7624833|FG003|Overall Study|Other|2
4705322|NCT02764190|7624849|FG000|Overall Study|Lost to Follow-up|17
4705323|NCT02764190|7624850|FG001|Overall Study|Lost to Follow-up|13
4705324|NCT02764229|7624856|FG000|Overall Study|Withdrawal by Subject|15
4705325|NCT02764229|7624856|FG000|Overall Study|Adverse Event|9
4705326|NCT02764229|7624856|FG000|Overall Study|Physician Decision|5
4705327|NCT02764229|7624856|FG000|Overall Study|Lost to Follow-up|3
4705328|NCT02764229|7624856|FG000|Overall Study|Lack of Efficacy|1
4705329|NCT02764229|7624856|FG000|Overall Study|Study Stopped by Sponsor|69
4705330|NCT02764320|7624862|FG000|Overall Study|Withdrawal by Subject|35
4705331|NCT02764320|7624863|FG001|Overall Study|Withdrawal by Subject|38
4627943|NCT01855945|7494715|FG006|Overall Study|Withdrawal by Subject|1
4627944|NCT01855945|7494716|FG007|Overall Study|Withdrawal by Subject|0
4627945|NCT01855945|7494717|FG008|Overall Study|Withdrawal by Subject|0
4627946|NCT01855945|7494718|FG009|Overall Study|Withdrawal by Subject|2
4627947|NCT01855945|7494719|FG010|Overall Study|Withdrawal by Subject|4
4705332|NCT02764320|7624862|FG000|Overall Study|Protocol Violation|11
4705333|NCT02764320|7624863|FG001|Overall Study|Protocol Violation|6
4705334|NCT02764320|7624862|FG000|Overall Study|Adverse Event|2
4705335|NCT02764320|7624863|FG001|Overall Study|Adverse Event|0
4705336|NCT02764320|7624862|FG000|Overall Study|Health Issues unable to continue|2
4705337|NCT02764320|7624863|FG001|Overall Study|Health Issues unable to continue|0
4705338|NCT02764320|7624862|FG000|Overall Study|Did not meet inclusion criteria|1
4705339|NCT02764320|7624863|FG001|Overall Study|Did not meet inclusion criteria|0
4705340|NCT02764320|7624862|FG000|Overall Study|Subject moved|0
4705341|NCT02764320|7624863|FG001|Overall Study|Subject moved|2
4705342|NCT02764320|7624862|FG000|Overall Study|Overused medication unavailable|0
4705343|NCT02764320|7624863|FG001|Overall Study|Overused medication unavailable|1
4705344|NCT02764320|7624862|FG000|Overall Study|Seeking care outside site|0
4705345|NCT02764320|7624863|FG001|Overall Study|Seeking care outside site|1
4705346|NCT02764320|7624862|FG000|Overall Study|Technology barriers|0
4705347|NCT02764320|7624863|FG001|Overall Study|Technology barriers|1
4705348|NCT02764333|7624869|FG000|Overall Study|Ineligible|1
4705349|NCT02764697|7624882|FG000|Overall Study|Lack of Efficacy|3
4705350|NCT02764762|7624886|FG000|Overall Study|Adverse Event|5
4705351|NCT02764762|7624886|FG000|Overall Study|Voluntary Withdrawal|3
4705352|NCT02764762|7624886|FG000|Overall Study|Significant Deviation|1
4705353|NCT02764775|7624890|FG000|Overall Study|Death|1
4705354|NCT02764775|7624890|FG000|Overall Study|Lost to Follow-up|2
4705355|NCT02764775|7624890|FG000|Overall Study|Withdrawal by Subject|3
4705356|NCT02765035|7624905|FG000|First Intervention (90 Days)|Adverse Event|1
4705357|NCT02765035|7624906|FG001|First Intervention (90 Days)|Adverse Event|1
4705358|NCT02765035|7624905|FG000|Second Intervention (30 Days)|Protocol Violation|2
4705359|NCT02765035|7624906|FG001|Second Intervention (30 Days)|Protocol Violation|2
4705360|NCT02765100|7624915|FG000|Overall Study|subject found ineligible after baseline|1
4705361|NCT02765100|7624916|FG001|Overall Study|subject found ineligible after baseline|1
4705362|NCT02765100|7624915|FG000|Overall Study|Lost to Follow-up|0
4705363|NCT02765100|7624916|FG001|Overall Study|Lost to Follow-up|1
4705364|NCT02765165|7624929|FG000|Treatment Period|Progressive disease|3
4705365|NCT02765165|7624930|FG001|Treatment Period|Progressive disease|2
4705366|NCT02765165|7624931|FG002|Treatment Period|Progressive disease|3
4705367|NCT02765165|7624932|FG003|Treatment Period|Progressive disease|3
4705368|NCT02765165|7624933|FG004|Treatment Period|Progressive disease|4
4705369|NCT02765165|7624934|FG005|Treatment Period|Progressive disease|2
4705370|NCT02765165|7624935|FG006|Treatment Period|Progressive disease|2
4705371|NCT02765165|7624929|FG000|Treatment Period|Physician Decision|0
4705372|NCT02765165|7624930|FG001|Treatment Period|Physician Decision|1
4705373|NCT02765165|7624931|FG002|Treatment Period|Physician Decision|0
4705374|NCT02765165|7624932|FG003|Treatment Period|Physician Decision|0
4705375|NCT02765165|7624933|FG004|Treatment Period|Physician Decision|0
4705376|NCT02765165|7624934|FG005|Treatment Period|Physician Decision|0
4705377|NCT02765165|7624935|FG006|Treatment Period|Physician Decision|0
4705378|NCT02765165|7624929|FG000|Treatment Period|Adverse Event|0
4705379|NCT02765165|7624930|FG001|Treatment Period|Adverse Event|1
4705380|NCT02765165|7624931|FG002|Treatment Period|Adverse Event|0
4510348|NCT00918684|7319016|FG000|Treatment Phase|Lost to Follow-up|2
4510349|NCT00918684|7319016|FG000|Treatment Phase|Physician Decision|8
4510350|NCT00918684|7319016|FG000|Treatment Phase|Protocol Violation|1
4510351|NCT00918684|7319016|FG000|Treatment Phase|Withdrawal by Subject|8
4510352|NCT00918736|7319026|FG000|Overall Study|Withdrawal by Subject|4
4510353|NCT00918749|7319033|FG000|Overall Study|Adverse Event|1
4510354|NCT00918749|7319034|FG001|Overall Study|Adverse Event|0
4510355|NCT00918749|7319035|FG002|Overall Study|Adverse Event|1
4510356|NCT00918749|7319033|FG000|Overall Study|Lost to Follow-up|0
4510357|NCT00918749|7319034|FG001|Overall Study|Lost to Follow-up|0
4510358|NCT00918749|7319035|FG002|Overall Study|Lost to Follow-up|1
4510359|NCT00918749|7319033|FG000|Overall Study|Withdrawal by Subject|5
4510360|NCT00918749|7319034|FG001|Overall Study|Withdrawal by Subject|3
4510361|NCT00918749|7319035|FG002|Overall Study|Withdrawal by Subject|5
4510362|NCT00918749|7319033|FG000|Overall Study|No Study Medication Taken|1
4627948|NCT01855945|7494720|FG011|Overall Study|Withdrawal by Subject|1
4627949|NCT01855958|7494785|FG000|Overall Study|Withdrawal by Subject|1
4627950|NCT01855958|7494786|FG001|Overall Study|Withdrawal by Subject|0
4627951|NCT01856114|7494808|FG000|Overall Study|Withdrawal by Subject|1
4627952|NCT01856114|7494809|FG001|Overall Study|Withdrawal by Subject|0
4510363|NCT00918749|7319034|FG001|Overall Study|No Study Medication Taken|0
4510364|NCT00918749|7319035|FG002|Overall Study|No Study Medication Taken|0
4510365|NCT00918879|7319054|FG000|Overall Study|Withdrawal by Subject|4
4510366|NCT00918879|7319055|FG001|Overall Study|Withdrawal by Subject|4
4510367|NCT00918879|7319054|FG000|Overall Study|Lost to Follow-up|1
4510368|NCT00918879|7319055|FG001|Overall Study|Lost to Follow-up|1
4510369|NCT00918879|7319054|FG000|Overall Study|Severe non-compliance to protocol|1
4510370|NCT00918879|7319055|FG001|Overall Study|Severe non-compliance to protocol|1
4510371|NCT00918957|7319067|FG000|Overall Study|Adverse Event|2
4510372|NCT00918957|7319068|FG001|Overall Study|Adverse Event|0
4510373|NCT00918957|7319067|FG000|Overall Study|Withdrawal by Subject|1
4510374|NCT00918957|7319068|FG001|Overall Study|Withdrawal by Subject|0
4510375|NCT00919061|7319078|FG000|Overall Study|Adverse Event|1
4510376|NCT00919061|7319078|FG000|Overall Study|Withdrawal by Subject|1
4510377|NCT00919633|7319133|FG000|Overall Study|Adverse Event|1
4510378|NCT00919633|7319134|FG001|Overall Study|Adverse Event|9
4510379|NCT00919633|7319135|FG002|Overall Study|Adverse Event|12
4510380|NCT00919633|7319136|FG003|Overall Study|Adverse Event|10
4510381|NCT00919633|7319133|FG000|Overall Study|Death|0
4510382|NCT00919633|7319134|FG001|Overall Study|Death|0
4510383|NCT00919633|7319135|FG002|Overall Study|Death|2
4510384|NCT00919633|7319136|FG003|Overall Study|Death|0
4510385|NCT00919633|7319133|FG000|Overall Study|Lack of Efficacy|17
4510386|NCT00919633|7319134|FG001|Overall Study|Lack of Efficacy|3
4510387|NCT00919633|7319135|FG002|Overall Study|Lack of Efficacy|2
4510388|NCT00919633|7319136|FG003|Overall Study|Lack of Efficacy|3
4510389|NCT00919633|7319133|FG000|Overall Study|Withdrawal by Subject|1
4510390|NCT00919633|7319134|FG001|Overall Study|Withdrawal by Subject|2
4510391|NCT00919633|7319135|FG002|Overall Study|Withdrawal by Subject|4
4510392|NCT00919633|7319136|FG003|Overall Study|Withdrawal by Subject|3
4510393|NCT00919633|7319133|FG000|Overall Study|Lost to Follow-up|3
4510394|NCT00919633|7319134|FG001|Overall Study|Lost to Follow-up|1
4510395|NCT00919633|7319135|FG002|Overall Study|Lost to Follow-up|0
4510396|NCT00919633|7319136|FG003|Overall Study|Lost to Follow-up|2
4510397|NCT00919633|7319133|FG000|Overall Study|Withdraw consent post transition to SOC|0
4510398|NCT00919633|7319134|FG001|Overall Study|Withdraw consent post transition to SOC|0
4510399|NCT00919633|7319135|FG002|Overall Study|Withdraw consent post transition to SOC|1
4510400|NCT00919633|7319136|FG003|Overall Study|Withdraw consent post transition to SOC|1
4510401|NCT00919633|7319133|FG000|Overall Study|Protocol Violation|0
4510402|NCT00919633|7319134|FG001|Overall Study|Protocol Violation|0
4510403|NCT00919633|7319135|FG002|Overall Study|Protocol Violation|0
4510404|NCT00919633|7319136|FG003|Overall Study|Protocol Violation|1
4510405|NCT00919633|7319133|FG000|Overall Study|Physician Decision|0
4510406|NCT00919633|7319134|FG001|Overall Study|Physician Decision|0
4510407|NCT00919633|7319135|FG002|Overall Study|Physician Decision|0
4510408|NCT00919633|7319136|FG003|Overall Study|Physician Decision|1
4510409|NCT00919633|7319133|FG000|Overall Study|Request of withdrawal w/o future contact|0
4510410|NCT00919633|7319134|FG001|Overall Study|Request of withdrawal w/o future contact|0
4510411|NCT00919633|7319135|FG002|Overall Study|Request of withdrawal w/o future contact|1
4510412|NCT00919633|7319136|FG003|Overall Study|Request of withdrawal w/o future contact|0
4510413|NCT00919633|7319133|FG000|Overall Study|Viral rebound outside protocol timepoint|0
4510414|NCT00919633|7319134|FG001|Overall Study|Viral rebound outside protocol timepoint|0
4510415|NCT00919633|7319135|FG002|Overall Study|Viral rebound outside protocol timepoint|1
4510416|NCT00919633|7319136|FG003|Overall Study|Viral rebound outside protocol timepoint|0
4510417|NCT00919711|7319148|FG000|Overall Study|Withdrawal by Subject|15
4510418|NCT00919711|7319149|FG001|Overall Study|Withdrawal by Subject|7
4510419|NCT00919711|7319148|FG000|Overall Study|Adverse Event|13
4510420|NCT00919711|7319149|FG001|Overall Study|Adverse Event|3
4510421|NCT00919711|7319148|FG000|Overall Study|Other|1
4510422|NCT00919711|7319149|FG001|Overall Study|Other|2
4627953|NCT01856114|7494808|FG000|Overall Study|Adverse Event|1
4510423|NCT00919711|7319148|FG000|Overall Study|Administrative Decision|0
4627954|NCT01856114|7494809|FG001|Overall Study|Adverse Event|0
4510424|NCT00919711|7319149|FG001|Overall Study|Administrative Decision|1
4510425|NCT00919711|7319148|FG000|Overall Study|Lost to Follow-up|2
4510426|NCT00919711|7319149|FG001|Overall Study|Lost to Follow-up|0
4510427|NCT00919711|7319148|FG000|Overall Study|Death|1
4510428|NCT00919711|7319149|FG001|Overall Study|Death|0
4510429|NCT00919711|7319148|FG000|Overall Study|Noncompliance|1
4705381|NCT02765165|7624932|FG003|Treatment Period|Adverse Event|0
4705382|NCT02765165|7624933|FG004|Treatment Period|Adverse Event|0
4705383|NCT02765165|7624934|FG005|Treatment Period|Adverse Event|0
4705384|NCT02765165|7624935|FG006|Treatment Period|Adverse Event|0
4705385|NCT02765165|7624929|FG000|Treatment Period|Withdrawal by Subject|0
4705386|NCT02765165|7624930|FG001|Treatment Period|Withdrawal by Subject|0
4705387|NCT02765165|7624931|FG002|Treatment Period|Withdrawal by Subject|0
4705388|NCT02765165|7624932|FG003|Treatment Period|Withdrawal by Subject|0
4705389|NCT02765165|7624933|FG004|Treatment Period|Withdrawal by Subject|2
4705390|NCT02765165|7624934|FG005|Treatment Period|Withdrawal by Subject|0
4705391|NCT02765165|7624935|FG006|Treatment Period|Withdrawal by Subject|0
4705392|NCT02765165|7624929|FG000|Treatment Period|Study terminated|0
4705393|NCT02765165|7624930|FG001|Treatment Period|Study terminated|0
4705394|NCT02765165|7624931|FG002|Treatment Period|Study terminated|0
4705395|NCT02765165|7624932|FG003|Treatment Period|Study terminated|0
4705396|NCT02765165|7624933|FG004|Treatment Period|Study terminated|0
4705397|NCT02765165|7624934|FG005|Treatment Period|Study terminated|1
4705398|NCT02765165|7624935|FG006|Treatment Period|Study terminated|2
4705399|NCT02765165|7624929|FG000|Post-treatment Follow-up|Death|1
4705400|NCT02765165|7624930|FG001|Post-treatment Follow-up|Death|2
4705401|NCT02765165|7624931|FG002|Post-treatment Follow-up|Death|1
4705402|NCT02765165|7624932|FG003|Post-treatment Follow-up|Death|1
4705403|NCT02765165|7624933|FG004|Post-treatment Follow-up|Death|1
4387442|NCT00048542|7166012|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0
4387443|NCT00048542|7166013|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0
4387444|NCT00048542|7166014|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0
4387445|NCT00048542|7166015|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0
4387446|NCT00048542|7166016|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5
4387447|NCT00048542|7166017|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1
4387448|NCT00048542|7166018|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0
4387449|NCT00048542|7166019|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0
4387450|NCT00048542|7166012|FG000|Open-Label Extension BSA Phase|Adverse Event|0
4387451|NCT00048542|7166013|FG001|Open-Label Extension BSA Phase|Adverse Event|0
4387452|NCT00048542|7166014|FG002|Open-Label Extension BSA Phase|Adverse Event|0
4387453|NCT00048542|7166015|FG003|Open-Label Extension BSA Phase|Adverse Event|0
4387454|NCT00048542|7166016|FG004|Open-Label Extension BSA Phase|Adverse Event|1
4387455|NCT00048542|7166017|FG005|Open-Label Extension BSA Phase|Adverse Event|1
4387456|NCT00048542|7166018|FG006|Open-Label Extension BSA Phase|Adverse Event|0
4387457|NCT00048542|7166019|FG007|Open-Label Extension BSA Phase|Adverse Event|0
4387458|NCT00048542|7166012|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0
4387459|NCT00048542|7166013|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0
4387460|NCT00048542|7166014|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0
4387461|NCT00048542|7166015|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0
4387462|NCT00048542|7166016|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3
4387463|NCT00048542|7166017|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1
4387464|NCT00048542|7166018|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0
4387465|NCT00048542|7166019|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0
4387466|NCT00048542|7166012|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
4387467|NCT00048542|7166013|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
4387468|NCT00048542|7166014|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
4387469|NCT00048542|7166015|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
4387470|NCT00048542|7166016|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
4387471|NCT00048542|7166017|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
4387472|NCT00048542|7166018|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6
4387473|NCT00048542|7166019|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3
4387474|NCT00048542|7166012|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
4387475|NCT00048542|7166013|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
4387476|NCT00048542|7166014|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
4387477|NCT00048542|7166015|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
4387478|NCT00048542|7166016|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
4387479|NCT00048542|7166017|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
4387480|NCT00048542|7166018|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1
4510430|NCT00919711|7319149|FG001|Overall Study|Noncompliance|0
4510431|NCT00919854|7319180|FG000|Overall Study|Adverse Event|1
4705404|NCT02765165|7624934|FG005|Post-treatment Follow-up|Death|1
4705405|NCT02765165|7624935|FG006|Post-treatment Follow-up|Death|0
4705406|NCT02765165|7624929|FG000|Post-treatment Follow-up|Lost to Follow-up|0
4705407|NCT02765165|7624930|FG001|Post-treatment Follow-up|Lost to Follow-up|0
4705408|NCT02765165|7624931|FG002|Post-treatment Follow-up|Lost to Follow-up|0
4705409|NCT02765165|7624932|FG003|Post-treatment Follow-up|Lost to Follow-up|1
4510432|NCT00919867|7319190|FG000|First Intervention|Withdrawal by Subject|0
4510433|NCT00919867|7319191|FG001|First Intervention|Withdrawal by Subject|0
4510434|NCT00919867|7319192|FG002|First Intervention|Withdrawal by Subject|1
4510435|NCT00919867|7319193|FG003|First Intervention|Withdrawal by Subject|0
4510436|NCT00919867|7319194|FG004|First Intervention|Withdrawal by Subject|0
4510437|NCT00919867|7319195|FG005|First Intervention|Withdrawal by Subject|0
4510438|NCT00919867|7319190|FG000|First Intervention|Physician Decision|0
4510439|NCT00919867|7319191|FG001|First Intervention|Physician Decision|0
4510440|NCT00919867|7319192|FG002|First Intervention|Physician Decision|0
4510441|NCT00919867|7319193|FG003|First Intervention|Physician Decision|0
4510442|NCT00919867|7319194|FG004|First Intervention|Physician Decision|0
4510443|NCT00919867|7319195|FG005|First Intervention|Physician Decision|1
4510444|NCT00920140|7319225|FG000|Phase 1 (Dose Escalation)|Adverse Event|3
4510445|NCT00920140|7319226|FG001|Phase 1 (Dose Escalation)|Adverse Event|3
4510446|NCT00920140|7319227|FG002|Phase 1 (Dose Escalation)|Adverse Event|0
4510447|NCT00920140|7319228|FG003|Phase 1 (Dose Escalation)|Adverse Event|0
4510448|NCT00920140|7319229|FG004|Phase 1 (Dose Escalation)|Adverse Event|0
4510449|NCT00920140|7319225|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2
4705410|NCT02765165|7624933|FG004|Post-treatment Follow-up|Lost to Follow-up|0
4705411|NCT02765165|7624934|FG005|Post-treatment Follow-up|Lost to Follow-up|0
4705412|NCT02765165|7624935|FG006|Post-treatment Follow-up|Lost to Follow-up|0
4705413|NCT02765165|7624929|FG000|Post-treatment Follow-up|Site terminated by sponsor|0
4705414|NCT02765165|7624930|FG001|Post-treatment Follow-up|Site terminated by sponsor|0
4705415|NCT02765165|7624931|FG002|Post-treatment Follow-up|Site terminated by sponsor|1
4705416|NCT02765165|7624932|FG003|Post-treatment Follow-up|Site terminated by sponsor|0
4705417|NCT02765165|7624933|FG004|Post-treatment Follow-up|Site terminated by sponsor|0
4705418|NCT02765165|7624934|FG005|Post-treatment Follow-up|Site terminated by sponsor|0
4705419|NCT02765165|7624935|FG006|Post-treatment Follow-up|Site terminated by sponsor|0
4705420|NCT02765165|7624929|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0
4705421|NCT02765165|7624930|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0
4705422|NCT02765165|7624931|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1
4705423|NCT02765165|7624932|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1
4705424|NCT02765165|7624933|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0
4705425|NCT02765165|7624934|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0
4705426|NCT02765165|7624935|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0
4705427|NCT02765165|7624929|FG000|Post-treatment Follow-up|Withdrawal by Subject|0
4705428|NCT02765165|7624930|FG001|Post-treatment Follow-up|Withdrawal by Subject|1
4705429|NCT02765165|7624931|FG002|Post-treatment Follow-up|Withdrawal by Subject|0
4705430|NCT02765165|7624932|FG003|Post-treatment Follow-up|Withdrawal by Subject|0
4705431|NCT02765165|7624933|FG004|Post-treatment Follow-up|Withdrawal by Subject|0
4705432|NCT02765165|7624934|FG005|Post-treatment Follow-up|Withdrawal by Subject|0
4705433|NCT02765165|7624935|FG006|Post-treatment Follow-up|Withdrawal by Subject|0
4705434|NCT02765165|7624929|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0
4705435|NCT02765165|7624930|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0
4705436|NCT02765165|7624931|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0
4705437|NCT02765165|7624932|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0
4705438|NCT02765165|7624933|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2
4705439|NCT02765165|7624934|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2
4705440|NCT02765165|7624935|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1
4735526|NCT03533114|7683645|FG000|Stable Dose|Consent Withdrawal by Participant|1
4735527|NCT03533114|7683646|FG001|Stable Dose|Consent Withdrawal by Participant|0
4735528|NCT03533114|7683645|FG000|Stable Dose|Lack of Efficacy|1
4735529|NCT03533114|7683646|FG001|Stable Dose|Lack of Efficacy|0
4735530|NCT03533114|7683645|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1
4735531|NCT03533114|7683646|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1
4387481|NCT00048542|7166019|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1
4387482|NCT00048542|7166012|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
4510450|NCT00920140|7319226|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4
4510451|NCT00920140|7319227|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0
4735532|NCT03533114|7683645|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1
4735533|NCT03533114|7683646|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0
4735534|NCT03533114|7683645|FG000|Open-Label Safety Extension|Adverse Event|3
4735535|NCT03533114|7683646|FG001|Open-Label Safety Extension|Adverse Event|0
4735536|NCT03533114|7683645|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2
4510452|NCT00920140|7319228|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0
4735537|NCT03533114|7683646|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3
4735538|NCT03533114|7683645|FG000|Open-Label Safety Extension|Lack of Efficacy|1
4735539|NCT03533114|7683646|FG001|Open-Label Safety Extension|Lack of Efficacy|0
4735540|NCT03533114|7683645|FG000|Open-Label Safety Extension|Lost to Follow-up|1
4735541|NCT03533114|7683646|FG001|Open-Label Safety Extension|Lost to Follow-up|0
4735542|NCT03533114|7683645|FG000|Open-Label Safety Extension|Protocol Deviation|1
4735543|NCT03533114|7683646|FG001|Open-Label Safety Extension|Protocol Deviation|0
4735544|NCT03533608|7683676|FG000|Overall Study|Withdrawal by Subject|3
4735545|NCT03533608|7683676|FG000|Overall Study|Physician Decision|2
4510453|NCT00920140|7319229|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0
4510454|NCT00920140|7319225|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
4510455|NCT00920140|7319226|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2
4705441|NCT02765490|7624975|FG000|Overall Study|Lost to Follow-up|1
4705442|NCT02765490|7624976|FG001|Overall Study|Lost to Follow-up|1
4705443|NCT02765490|7624975|FG000|Overall Study|Other|0
4705444|NCT02765490|7624976|FG001|Overall Study|Other|1
4705445|NCT02765490|7624975|FG000|Overall Study|Death|0
4705446|NCT02765490|7624976|FG001|Overall Study|Death|1
4705447|NCT02766023|7624984|FG000|Overall Study|Lost to Follow-up|23
4705448|NCT02766023|7624985|FG001|Overall Study|Lost to Follow-up|11
4387483|NCT00048542|7166013|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
4387484|NCT00048542|7166014|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
4387485|NCT00048542|7166015|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
4387486|NCT00048542|7166016|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
4387487|NCT00048542|7166017|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
4387488|NCT00048542|7166018|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6
4387489|NCT00048542|7166019|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7
4387490|NCT00048542|7166012|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0
4387491|NCT00048542|7166013|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0
4387492|NCT00048542|7166014|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0
4387493|NCT00048542|7166015|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0
4387494|NCT00048542|7166016|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0
4387495|NCT00048542|7166017|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0
4387496|NCT00048542|7166018|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2
4387497|NCT00048542|7166019|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2
4627955|NCT01856257|7494822|FG000|Overall Study|Death|2
4627956|NCT01856257|7494823|FG001|Overall Study|Death|0
4627957|NCT01856257|7494824|FG002|Overall Study|Death|0
4387498|NCT00048542|7166012|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
4387499|NCT00048542|7166013|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
4387500|NCT00048542|7166014|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
4387501|NCT00048542|7166015|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
4387502|NCT00048542|7166016|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
4387503|NCT00048542|7166017|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
4387504|NCT00048542|7166018|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2
4387505|NCT00048542|7166019|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1
4387506|NCT00048542|7166012|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
4387507|NCT00048542|7166013|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
4387508|NCT00048542|7166014|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
4387509|NCT00048542|7166015|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
4387510|NCT00048542|7166016|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
4387511|NCT00048542|7166017|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
4387512|NCT00048542|7166018|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5
4387513|NCT00048542|7166019|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8
4387514|NCT00048568|7166050|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11
4387515|NCT00048568|7166051|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3
4387516|NCT00048568|7166052|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0
4387517|NCT00048568|7166050|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11
4387518|NCT00048568|7166051|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33
4387519|NCT00048568|7166052|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0
4387520|NCT00048568|7166050|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1
4387521|NCT00048568|7166051|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1
4387522|NCT00048568|7166052|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0
4387523|NCT00048568|7166050|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7
4387524|NCT00048568|7166051|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4
4387525|NCT00048568|7166052|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0
4387526|NCT00048568|7166050|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2
4387527|NCT00048568|7166051|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4
4387528|NCT00048568|7166052|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0
4387529|NCT00048568|7166050|FG000|Double-Blind Period Days 170 to 365|Death|1
4387530|NCT00048568|7166051|FG001|Double-Blind Period Days 170 to 365|Death|1
4387531|NCT00048568|7166052|FG002|Double-Blind Period Days 170 to 365|Death|0
4387532|NCT00048568|7166050|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7
4387533|NCT00048568|7166051|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1
4387534|NCT00048568|7166052|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0
4387535|NCT00048568|7166050|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2
4387536|NCT00048568|7166051|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7
4387537|NCT00048568|7166052|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0
4627958|NCT01856257|7494825|FG003|Overall Study|Death|0
4627959|NCT01856257|7494822|FG000|Overall Study|Physician Decision|0
4627960|NCT01856257|7494823|FG001|Overall Study|Physician Decision|0
4705449|NCT02766023|7624984|FG000|Overall Study|Pregnancy|1
4705450|NCT02766023|7624985|FG001|Overall Study|Pregnancy|0
4510456|NCT00920140|7319227|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
4510457|NCT00920140|7319228|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
4510458|NCT00920140|7319229|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
4510459|NCT00920140|7319225|FG000|Phase 2|Adverse Event|0
4510460|NCT00920140|7319226|FG001|Phase 2|Adverse Event|0
4627961|NCT01856257|7494824|FG002|Overall Study|Physician Decision|0
4627962|NCT01856257|7494825|FG003|Overall Study|Physician Decision|1
4705451|NCT02766023|7624984|FG000|Overall Study|Adverse Event|1
4705452|NCT02766023|7624985|FG001|Overall Study|Adverse Event|0
4705453|NCT02766023|7624984|FG000|Overall Study|Withdrawal by Subject|4
4705454|NCT02766023|7624985|FG001|Overall Study|Withdrawal by Subject|5
4705455|NCT02766023|7624984|FG000|Overall Study|Physician Decision|1
4705456|NCT02766023|7624985|FG001|Overall Study|Physician Decision|0
4705457|NCT02766023|7624984|FG000|Overall Study|Not Eligible at Enrollment|0
4705458|NCT02766023|7624985|FG001|Overall Study|Not Eligible at Enrollment|1
4705459|NCT02766088|7624991|FG000|Overall Study|Sponsor study termination|498
4705460|NCT02766088|7624991|FG000|Overall Study|Migrated/moved from the study area|1
4705461|NCT02766088|7624991|FG000|Overall Study|Lost to Follow-up|5
4705462|NCT02766088|7624991|FG000|Overall Study|Other|1
4705463|NCT02766088|7624991|FG000|Overall Study|Death|1
4705464|NCT02766283|7625004|FG000|Overall Study|Lost to Follow-up|27
4705465|NCT02766400|7625023|FG000|Overall Study|Death|1
4705466|NCT02766400|7625024|FG001|Overall Study|Death|2
4705467|NCT02766400|7625023|FG000|Overall Study|Withdrawal by Subject|1
4705468|NCT02766400|7625024|FG001|Overall Study|Withdrawal by Subject|0
4705469|NCT02766608|7625048|FG000|Overall Study|Adverse Event|27
4705470|NCT02766608|7625049|FG001|Overall Study|Adverse Event|22
4705471|NCT02766608|7625050|FG002|Overall Study|Adverse Event|17
4705472|NCT02766608|7625051|FG003|Overall Study|Adverse Event|13
4705473|NCT02766608|7625052|FG004|Overall Study|Adverse Event|12
4705474|NCT02766608|7625048|FG000|Overall Study|Withdrawal by Subject|21
4705475|NCT02766608|7625049|FG001|Overall Study|Withdrawal by Subject|20
4705476|NCT02766608|7625050|FG002|Overall Study|Withdrawal by Subject|24
4705477|NCT02766608|7625051|FG003|Overall Study|Withdrawal by Subject|13
4705478|NCT02766608|7625052|FG004|Overall Study|Withdrawal by Subject|10
4705479|NCT02766608|7625048|FG000|Overall Study|Lack of Efficacy|16
4705480|NCT02766608|7625049|FG001|Overall Study|Lack of Efficacy|15
4705481|NCT02766608|7625050|FG002|Overall Study|Lack of Efficacy|32
4705482|NCT02766608|7625051|FG003|Overall Study|Lack of Efficacy|8
4705483|NCT02766608|7625052|FG004|Overall Study|Lack of Efficacy|2
4705484|NCT02766608|7625048|FG000|Overall Study|Lost to Follow-up|6
4705485|NCT02766608|7625049|FG001|Overall Study|Lost to Follow-up|3
4387538|NCT00048568|7166050|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3
4387539|NCT00048568|7166051|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1
4387540|NCT00048568|7166052|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0
4387541|NCT00048568|7166050|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0
4387542|NCT00048568|7166051|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1
4387543|NCT00048568|7166052|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0
4387544|NCT00048568|7166050|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2
4387545|NCT00048568|7166051|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0
4387546|NCT00048568|7166052|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0
4387547|NCT00048568|7166050|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1
4705486|NCT02766608|7625050|FG002|Overall Study|Lost to Follow-up|5
4387548|NCT00048568|7166051|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1
4387549|NCT00048568|7166052|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0
4387550|NCT00048568|7166050|FG000|Open-Label Period|Death|0
4705487|NCT02766608|7625051|FG003|Overall Study|Lost to Follow-up|2
4705488|NCT02766608|7625052|FG004|Overall Study|Lost to Follow-up|2
4705489|NCT02766608|7625048|FG000|Overall Study|Physician Decision|3
4705490|NCT02766608|7625049|FG001|Overall Study|Physician Decision|2
4705491|NCT02766608|7625050|FG002|Overall Study|Physician Decision|3
4705492|NCT02766608|7625051|FG003|Overall Study|Physician Decision|1
4705493|NCT02766608|7625052|FG004|Overall Study|Physician Decision|2
4705494|NCT02766608|7625048|FG000|Overall Study|Protocol disc criteria|3
4705495|NCT02766608|7625049|FG001|Overall Study|Protocol disc criteria|3
4705496|NCT02766608|7625050|FG002|Overall Study|Protocol disc criteria|4
4705497|NCT02766608|7625051|FG003|Overall Study|Protocol disc criteria|0
4705498|NCT02766608|7625052|FG004|Overall Study|Protocol disc criteria|0
4705499|NCT02766608|7625048|FG000|Overall Study|Protocol Violation|0
4705500|NCT02766608|7625049|FG001|Overall Study|Protocol Violation|4
4705501|NCT02766608|7625050|FG002|Overall Study|Protocol Violation|4
4705502|NCT02766608|7625051|FG003|Overall Study|Protocol Violation|0
4705503|NCT02766608|7625052|FG004|Overall Study|Protocol Violation|1
4705504|NCT02766608|7625048|FG000|Overall Study|Administrative Reasons|3
4705505|NCT02766608|7625049|FG001|Overall Study|Administrative Reasons|1
4705506|NCT02766608|7625050|FG002|Overall Study|Administrative Reasons|1
4705507|NCT02766608|7625051|FG003|Overall Study|Administrative Reasons|0
4705508|NCT02766608|7625052|FG004|Overall Study|Administrative Reasons|0
4705509|NCT02766777|7625080|FG000|Overall Study|Adverse Event|12
4705510|NCT02766777|7625080|FG000|Overall Study|Lost to Follow-up|16
4705511|NCT02766777|7625080|FG000|Overall Study|Non-Compliance With Study Drug|1
4705512|NCT02766777|7625080|FG000|Overall Study|Protocol Violation|1
4510461|NCT00920140|7319227|FG002|Phase 2|Adverse Event|14
4510462|NCT00920140|7319228|FG003|Phase 2|Adverse Event|2
4510463|NCT00920140|7319229|FG004|Phase 2|Adverse Event|3
4510464|NCT00920140|7319225|FG000|Phase 2|Lack of Efficacy|0
4510465|NCT00920140|7319226|FG001|Phase 2|Lack of Efficacy|0
4510466|NCT00920140|7319227|FG002|Phase 2|Lack of Efficacy|29
4510467|NCT00920140|7319228|FG003|Phase 2|Lack of Efficacy|14
4510468|NCT00920140|7319229|FG004|Phase 2|Lack of Efficacy|5
4510469|NCT00920140|7319225|FG000|Phase 2|Lost to Follow-up|0
4510470|NCT00920140|7319226|FG001|Phase 2|Lost to Follow-up|0
4510471|NCT00920140|7319227|FG002|Phase 2|Lost to Follow-up|0
4510472|NCT00920140|7319228|FG003|Phase 2|Lost to Follow-up|1
4510473|NCT00920140|7319229|FG004|Phase 2|Lost to Follow-up|0
4510474|NCT00920140|7319225|FG000|Phase 2|Physician Decision|0
4510475|NCT00920140|7319226|FG001|Phase 2|Physician Decision|0
4510476|NCT00920140|7319227|FG002|Phase 2|Physician Decision|3
4510477|NCT00920140|7319228|FG003|Phase 2|Physician Decision|3
4510478|NCT00920140|7319229|FG004|Phase 2|Physician Decision|2
4510479|NCT00920140|7319225|FG000|Phase 2|Withdrawal by Subject|0
4510480|NCT00920140|7319226|FG001|Phase 2|Withdrawal by Subject|0
4510481|NCT00920140|7319227|FG002|Phase 2|Withdrawal by Subject|4
4705513|NCT02766777|7625080|FG000|Overall Study|Withdrawal by Subject|4
4705514|NCT02767323|7625129|FG000|Overall Study|Withdrawal by Subject|17
4705515|NCT02767323|7625130|FG001|Overall Study|Withdrawal by Subject|5
4705516|NCT02767323|7625131|FG002|Overall Study|Withdrawal by Subject|13
4705517|NCT02767323|7625132|FG003|Overall Study|Withdrawal by Subject|0
4705518|NCT02767323|7625129|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17
4705519|NCT02767323|7625130|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20
4705520|NCT02767323|7625131|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17
4705521|NCT02767323|7625132|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0
4705522|NCT02767765|7625180|FG000|Overall Study|Adverse Event|4
4705523|NCT02767765|7625180|FG000|Overall Study|Death|1
4705524|NCT02767765|7625180|FG000|Overall Study|Insufficient response|1
4705525|NCT02767765|7625180|FG000|Overall Study|Lost to Follow-up|2
4705526|NCT02767765|7625180|FG000|Overall Study|Investigator decision|1
4705527|NCT02767765|7625180|FG000|Overall Study|Non-Compliance|1
4705528|NCT02767765|7625180|FG000|Overall Study|Withdrawal by Subject|1
4705529|NCT02768103|7625213|FG000|Overall Study|1 participant did not fit in the fMRI|1
4705530|NCT02768194|7625226|FG000|Period 1|Adverse Event|0
4705531|NCT02768194|7625227|FG001|Period 1|Adverse Event|0
4705532|NCT02768194|7625228|FG002|Period 1|Adverse Event|0
4705533|NCT02768194|7625229|FG003|Period 1|Adverse Event|1
4705534|NCT02768194|7625230|FG004|Period 1|Adverse Event|0
4387551|NCT00048568|7166051|FG001|Open-Label Period|Death|0
4387552|NCT00048568|7166052|FG002|Open-Label Period|Death|13
4387553|NCT00048568|7166050|FG000|Open-Label Period|Adverse Event|0
4387554|NCT00048568|7166051|FG001|Open-Label Period|Adverse Event|0
4387555|NCT00048568|7166052|FG002|Open-Label Period|Adverse Event|49
4387556|NCT00048568|7166050|FG000|Open-Label Period|Lack of Efficacy|0
4387557|NCT00048568|7166051|FG001|Open-Label Period|Lack of Efficacy|0
4387558|NCT00048568|7166052|FG002|Open-Label Period|Lack of Efficacy|32
4387559|NCT00048568|7166050|FG000|Open-Label Period|Withdrawal by Subject|0
4387560|NCT00048568|7166051|FG001|Open-Label Period|Withdrawal by Subject|0
4387561|NCT00048568|7166052|FG002|Open-Label Period|Withdrawal by Subject|26
4387562|NCT00048568|7166050|FG000|Open-Label Period|Pregnancy|0
4387563|NCT00048568|7166051|FG001|Open-Label Period|Pregnancy|0
4387564|NCT00048568|7166052|FG002|Open-Label Period|Pregnancy|5
4387565|NCT00048568|7166050|FG000|Open-Label Period|No Longer Met Study Criteria|0
4387566|NCT00048568|7166051|FG001|Open-Label Period|No Longer Met Study Criteria|0
4387567|NCT00048568|7166052|FG002|Open-Label Period|No Longer Met Study Criteria|2
4387568|NCT00048568|7166050|FG000|Open-Label Period|Administrative Decision By Sponsor|0
4387569|NCT00048568|7166051|FG001|Open-Label Period|Administrative Decision By Sponsor|0
4387570|NCT00048568|7166052|FG002|Open-Label Period|Administrative Decision By Sponsor|1
4387571|NCT00048568|7166050|FG000|Open-Label Period|Unknown Reasons|0
4387572|NCT00048568|7166051|FG001|Open-Label Period|Unknown Reasons|0
4387573|NCT00048568|7166052|FG002|Open-Label Period|Unknown Reasons|25
4387574|NCT00048568|7166050|FG000|Open-Label Period|Lost to Follow-up|0
4387575|NCT00048568|7166051|FG001|Open-Label Period|Lost to Follow-up|0
4387576|NCT00048568|7166052|FG002|Open-Label Period|Lost to Follow-up|7
4387577|NCT00048581|7166075|FG000|Double-Blind Period|Adverse Event|9
4387578|NCT00048581|7166076|FG001|Double-Blind Period|Adverse Event|5
4387579|NCT00048581|7166077|FG002|Double-Blind Period|Adverse Event|0
4387580|NCT00048581|7166075|FG000|Double-Blind Period|Lack of Efficacy|14
4510482|NCT00920140|7319228|FG003|Phase 2|Withdrawal by Subject|2
4510483|NCT00920140|7319229|FG004|Phase 2|Withdrawal by Subject|1
4510484|NCT00920218|7319246|FG000|Overall Study|Serious Adverse Event|2
4705535|NCT02768194|7625231|FG005|Period 1|Adverse Event|0
4387581|NCT00048581|7166076|FG001|Double-Blind Period|Lack of Efficacy|27
4387582|NCT00048581|7166077|FG002|Double-Blind Period|Lack of Efficacy|0
4387583|NCT00048581|7166075|FG000|Double-Blind Period|Lost to Follow-up|5
4387584|NCT00048581|7166076|FG001|Double-Blind Period|Lost to Follow-up|0
4387585|NCT00048581|7166077|FG002|Double-Blind Period|Lost to Follow-up|0
4387586|NCT00048581|7166075|FG000|Double-Blind Period|Withdrawal by Subject|5
4387587|NCT00048581|7166076|FG001|Double-Blind Period|Withdrawal by Subject|2
4510485|NCT00920218|7319247|FG001|Overall Study|Serious Adverse Event|0
4510486|NCT00920218|7319248|FG002|Overall Study|Serious Adverse Event|2
4510487|NCT00920218|7319249|FG003|Overall Study|Serious Adverse Event|1
4510488|NCT00920218|7319246|FG000|Overall Study|Withdrawal by Subject|0
4510489|NCT00920218|7319247|FG001|Overall Study|Withdrawal by Subject|3
4510490|NCT00920218|7319248|FG002|Overall Study|Withdrawal by Subject|2
4510491|NCT00920218|7319249|FG003|Overall Study|Withdrawal by Subject|0
4510492|NCT00920218|7319246|FG000|Overall Study|Migrated/moved from study area|0
4510493|NCT00920218|7319247|FG001|Overall Study|Migrated/moved from study area|0
4510494|NCT00920218|7319248|FG002|Overall Study|Migrated/moved from study area|1
4510495|NCT00920218|7319249|FG003|Overall Study|Migrated/moved from study area|0
4510496|NCT00920218|7319246|FG000|Overall Study|Lost to Follow-up|0
4510497|NCT00920218|7319247|FG001|Overall Study|Lost to Follow-up|1
4510498|NCT00920218|7319248|FG002|Overall Study|Lost to Follow-up|0
4510499|NCT00920218|7319249|FG003|Overall Study|Lost to Follow-up|3
4510500|NCT00920218|7319246|FG000|Overall Study|Transplant failed/malignancy recurrence|0
4510501|NCT00920218|7319247|FG001|Overall Study|Transplant failed/malignancy recurrence|1
4510502|NCT00920218|7319248|FG002|Overall Study|Transplant failed/malignancy recurrence|2
4510503|NCT00920218|7319249|FG003|Overall Study|Transplant failed/malignancy recurrence|3
4510504|NCT00920218|7319246|FG000|Overall Study|Other|0
4510505|NCT00920218|7319247|FG001|Overall Study|Other|0
4510506|NCT00920218|7319248|FG002|Overall Study|Other|1
4510507|NCT00920218|7319249|FG003|Overall Study|Other|0
4510508|NCT00920426|7319286|FG000|ITZ111451|Adverse Event|1
4510509|NCT00920426|7319287|FG001|ITZ111451|Adverse Event|0
4510510|NCT00920426|7319288|FG002|ITZ111451|Adverse Event|0
4510511|NCT00920426|7319289|FG003|ITZ111451|Adverse Event|0
4510512|NCT00920556|7319305|FG000|Overall Study|Adverse Event|16
4510513|NCT00920556|7319305|FG000|Overall Study|Physician Decision|7
4510514|NCT00920556|7319305|FG000|Overall Study|Withdrawal by Subject|1
4510515|NCT00920686|7319343|FG000|Overall Study|Lost to Follow-up|2
4510516|NCT00920686|7319344|FG001|Overall Study|Lost to Follow-up|3
4510517|NCT00920686|7319345|FG002|Overall Study|Lost to Follow-up|1
4510518|NCT00920686|7319343|FG000|Overall Study|Study drug dosing criteria not met|17
4510519|NCT00920686|7319344|FG001|Overall Study|Study drug dosing criteria not met|19
4510520|NCT00920686|7319345|FG002|Overall Study|Study drug dosing criteria not met|12
4510521|NCT00920699|7319360|FG000|Overall Study|Withdrawal by Subject|2
4510522|NCT00920699|7319361|FG001|Overall Study|Withdrawal by Subject|0
4510523|NCT00920699|7319362|FG002|Overall Study|Withdrawal by Subject|2
4510524|NCT00920699|7319360|FG000|Overall Study|no longer met eligibility|0
4510525|NCT00920699|7319361|FG001|Overall Study|no longer met eligibility|1
4510526|NCT00920699|7319362|FG002|Overall Study|no longer met eligibility|0
4510527|NCT00920699|7319360|FG000|Overall Study|Lost to Follow-up|0
4510528|NCT00920699|7319361|FG001|Overall Study|Lost to Follow-up|0
4510529|NCT00920699|7319362|FG002|Overall Study|Lost to Follow-up|2
4510530|NCT00920790|7319370|FG000|Overall Study|aggravation of general condition|14
4510531|NCT00920816|7319378|FG000|Overall Study|Death|77
4510532|NCT00920816|7319379|FG001|Overall Study|Death|36
4510533|NCT00920816|7319380|FG002|Overall Study|Death|58
4510534|NCT00920816|7319381|FG003|Overall Study|Death|28
4510535|NCT00920816|7319378|FG000|Overall Study|Adverse Event|1
4510536|NCT00920816|7319379|FG001|Overall Study|Adverse Event|0
4510537|NCT00920816|7319380|FG002|Overall Study|Adverse Event|1
4510538|NCT00920816|7319381|FG003|Overall Study|Adverse Event|0
4510539|NCT00920816|7319378|FG000|Overall Study|Lost to Follow-up|1
4510540|NCT00920816|7319379|FG001|Overall Study|Lost to Follow-up|2
4510541|NCT00920816|7319380|FG002|Overall Study|Lost to Follow-up|3
4510542|NCT00920816|7319381|FG003|Overall Study|Lost to Follow-up|4
4510543|NCT00920816|7319378|FG000|Overall Study|Objective progression or relapse|0
4510544|NCT00920816|7319379|FG001|Overall Study|Objective progression or relapse|0
4510545|NCT00920816|7319380|FG002|Overall Study|Objective progression or relapse|2
4510546|NCT00920816|7319381|FG003|Overall Study|Objective progression or relapse|0
4510547|NCT00920816|7319378|FG000|Overall Study|Withdrawal by Subject|7
4510548|NCT00920816|7319379|FG001|Overall Study|Withdrawal by Subject|2
4510549|NCT00920816|7319380|FG002|Overall Study|Withdrawal by Subject|1
4510550|NCT00920816|7319381|FG003|Overall Study|Withdrawal by Subject|1
4510551|NCT00920816|7319378|FG000|Overall Study|Ongoing|106
4510552|NCT00920816|7319379|FG001|Overall Study|Ongoing|56
4510553|NCT00920816|7319380|FG002|Overall Study|Ongoing|70
4510554|NCT00920816|7319381|FG003|Overall Study|Ongoing|36
4510555|NCT00920829|7319395|FG000|Allocation|No post randomization data|3
4510556|NCT00920829|7319396|FG001|Allocation|No post randomization data|1
4510557|NCT00920829|7319397|FG002|Allocation|No post randomization data|0
4510558|NCT00920829|7319398|FG003|Allocation|No post randomization data|2
4510559|NCT00920829|7319395|FG000|Available for Analysis|Withdrawal by Subject|6
4510560|NCT00920829|7319396|FG001|Available for Analysis|Withdrawal by Subject|6
4510561|NCT00920829|7319397|FG002|Available for Analysis|Withdrawal by Subject|6
4510562|NCT00920829|7319398|FG003|Available for Analysis|Withdrawal by Subject|10
4510563|NCT00920829|7319395|FG000|Available for Analysis|Required Medical Treatment|0
4510564|NCT00920829|7319396|FG001|Available for Analysis|Required Medical Treatment|1
4510565|NCT00920829|7319397|FG002|Available for Analysis|Required Medical Treatment|2
4510566|NCT00920829|7319398|FG003|Available for Analysis|Required Medical Treatment|0
4510567|NCT00920829|7319395|FG000|Available for Analysis|Adverse Event|1
4510568|NCT00920829|7319396|FG001|Available for Analysis|Adverse Event|2
4510569|NCT00920829|7319397|FG002|Available for Analysis|Adverse Event|1
4510570|NCT00920829|7319398|FG003|Available for Analysis|Adverse Event|0
4510571|NCT00920829|7319395|FG000|Available for Analysis|Death|1
4510572|NCT00920829|7319396|FG001|Available for Analysis|Death|0
4510573|NCT00920829|7319397|FG002|Available for Analysis|Death|0
4510574|NCT00920829|7319398|FG003|Available for Analysis|Death|0
4510575|NCT00920829|7319395|FG000|Available for Analysis|Protocol Violation|0
4510576|NCT00920829|7319396|FG001|Available for Analysis|Protocol Violation|0
4510577|NCT00920829|7319397|FG002|Available for Analysis|Protocol Violation|1
4510578|NCT00920829|7319398|FG003|Available for Analysis|Protocol Violation|0
4510579|NCT00920829|7319395|FG000|Available for Analysis|Required more treatment|0
4510580|NCT00920829|7319396|FG001|Available for Analysis|Required more treatment|2
4510581|NCT00920829|7319397|FG002|Available for Analysis|Required more treatment|0
4510582|NCT00920829|7319398|FG003|Available for Analysis|Required more treatment|1
4510583|NCT00920855|7319411|FG000|Overall Study|Adverse Event|1
4510584|NCT00920855|7319412|FG001|Overall Study|Adverse Event|1
4510585|NCT00920855|7319413|FG002|Overall Study|Adverse Event|4
4510586|NCT00920855|7319411|FG000|Overall Study|Withdrawal by Subject|2
4510587|NCT00920855|7319412|FG001|Overall Study|Withdrawal by Subject|1
4510588|NCT00920855|7319413|FG002|Overall Study|Withdrawal by Subject|6
4510589|NCT00920855|7319411|FG000|Overall Study|Disease progression|2
4510590|NCT00920855|7319412|FG001|Overall Study|Disease progression|1
4510591|NCT00920855|7319413|FG002|Overall Study|Disease progression|10
4510592|NCT00920855|7319411|FG000|Overall Study|Noncompliance to study medication|0
4510593|NCT00920855|7319412|FG001|Overall Study|Noncompliance to study medication|0
4510594|NCT00920855|7319413|FG002|Overall Study|Noncompliance to study medication|1
4510595|NCT00920855|7319411|FG000|Overall Study|Response plateau; started maintenance|0
4510596|NCT00920855|7319412|FG001|Overall Study|Response plateau; started maintenance|0
4510597|NCT00920855|7319413|FG002|Overall Study|Response plateau; started maintenance|1
4510598|NCT00920907|7319424|FG000|Induction Period|Adverse Event|0
4510599|NCT00920907|7319425|FG001|Induction Period|Adverse Event|2
4510600|NCT00920907|7319424|FG000|Induction Period|Death|1
4510601|NCT00920907|7319425|FG001|Induction Period|Death|1
4510602|NCT00920907|7319424|FG000|Induction Period|Disease Progression|12
4510603|NCT00920907|7319425|FG001|Induction Period|Disease Progression|11
4510604|NCT00920907|7319424|FG000|Induction Period|Study Drug Toxicity|8
4510605|NCT00920907|7319425|FG001|Induction Period|Study Drug Toxicity|6
4510606|NCT00920907|7319424|FG000|Induction Period|No longer meets study criteria|0
4510607|NCT00920907|7319425|FG001|Induction Period|No longer meets study criteria|1
4510608|NCT00920907|7319424|FG000|Induction Period|Withdrawal by Subject|1
4510609|NCT00920907|7319425|FG001|Induction Period|Withdrawal by Subject|1
4510610|NCT00920907|7319424|FG000|Maintenance Period|Disease Progression|3
4510611|NCT00920907|7319425|FG001|Maintenance Period|Disease Progression|7
4510612|NCT00920907|7319424|FG000|Maintenance Period|Administrative (study closure)|7
4510613|NCT00920907|7319425|FG001|Maintenance Period|Administrative (study closure)|2
4510614|NCT00920907|7319424|FG000|Maintenance Period|Study Drug Toxicity|0
4510615|NCT00920907|7319425|FG001|Maintenance Period|Study Drug Toxicity|2
4510616|NCT00920907|7319424|FG000|Maintenance Period|Death|1
4510617|NCT00920907|7319425|FG001|Maintenance Period|Death|1
4510618|NCT00920907|7319424|FG000|Maintenance Period|Withdrawal by Subject|1
4510619|NCT00920907|7319425|FG001|Maintenance Period|Withdrawal by Subject|0
4510620|NCT00920907|7319424|FG000|Maintenance Period|Adverse Event|0
4510621|NCT00920907|7319425|FG001|Maintenance Period|Adverse Event|1
4510622|NCT00921024|7319435|FG000|Overall Study|Lost to Follow-up|2
4510623|NCT00921024|7319436|FG001|Overall Study|Lost to Follow-up|0
4510624|NCT00921024|7319435|FG000|Overall Study|Received concomittant therapy|2
4705536|NCT02768194|7625226|FG000|Period 2|Other (Reason not specified)|1
4705537|NCT02768194|7625227|FG001|Period 2|Other (Reason not specified)|0
4705538|NCT02768194|7625228|FG002|Period 2|Other (Reason not specified)|0
4705539|NCT02768194|7625229|FG003|Period 2|Other (Reason not specified)|0
4705540|NCT02768194|7625230|FG004|Period 2|Other (Reason not specified)|0
4705541|NCT02768194|7625231|FG005|Period 2|Other (Reason not specified)|0
4705542|NCT02768194|7625226|FG000|Period 3|Other (Reason not specified)|0
4705543|NCT02768194|7625227|FG001|Period 3|Other (Reason not specified)|1
4705544|NCT02768194|7625228|FG002|Period 3|Other (Reason not specified)|0
4705545|NCT02768194|7625229|FG003|Period 3|Other (Reason not specified)|0
4705546|NCT02768194|7625230|FG004|Period 3|Other (Reason not specified)|0
4705547|NCT02768194|7625231|FG005|Period 3|Other (Reason not specified)|0
4705548|NCT02768298|7625241|FG000|Overall Study|Adverse Event|1
4705549|NCT02768298|7625242|FG001|Overall Study|Adverse Event|4
4705550|NCT02768298|7625241|FG000|Overall Study|Death|2
4705551|NCT02768298|7625242|FG001|Overall Study|Death|1
4705552|NCT02768298|7625241|FG000|Overall Study|Non-compliance with study treatment|0
4510625|NCT00921024|7319436|FG001|Overall Study|Received concomittant therapy|0
4510626|NCT00921024|7319435|FG000|Overall Study|Withdrawal by Subject|0
4510627|NCT00921024|7319436|FG001|Overall Study|Withdrawal by Subject|3
4510628|NCT00921557|7319474|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2
4510629|NCT00921557|7319475|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0
4705553|NCT02768298|7625242|FG001|Overall Study|Non-compliance with study treatment|1
4705554|NCT02768298|7625241|FG000|Overall Study|Subject/guardian decision|1
4705555|NCT02768298|7625242|FG001|Overall Study|Subject/guardian decision|0
4510630|NCT00921557|7319476|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0
4510631|NCT00921557|7319474|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0
4627963|NCT01856257|7494822|FG000|Overall Study|Withdrawal by Subject|1
4627964|NCT01856257|7494823|FG001|Overall Study|Withdrawal by Subject|1
4705556|NCT02768298|7625241|FG000|Overall Study|Withdrawal of informed consent|0
4705557|NCT02768298|7625242|FG001|Overall Study|Withdrawal of informed consent|1
4705558|NCT02768792|7625266|FG000|Overall Study|Adverse Event|1
4705559|NCT02769065|7625300|FG000|Overall Study|Voluntary Withdrawal|1
4705560|NCT02769065|7625301|FG001|Overall Study|Voluntary Withdrawal|0
4705561|NCT02769065|7625302|FG002|Overall Study|Voluntary Withdrawal|0
4705562|NCT02769065|7625303|FG003|Overall Study|Voluntary Withdrawal|0
4705563|NCT02769065|7625304|FG004|Overall Study|Voluntary Withdrawal|0
4705564|NCT02769065|7625305|FG005|Overall Study|Voluntary Withdrawal|0
4705565|NCT02769065|7625306|FG006|Overall Study|Voluntary Withdrawal|0
4705566|NCT02769065|7625307|FG007|Overall Study|Voluntary Withdrawal|0
4705567|NCT02769065|7625308|FG008|Overall Study|Voluntary Withdrawal|0
4705568|NCT02769065|7625309|FG009|Overall Study|Voluntary Withdrawal|0
4705569|NCT02769065|7625310|FG010|Overall Study|Voluntary Withdrawal|0
4705570|NCT02769065|7625311|FG011|Overall Study|Voluntary Withdrawal|0
4705571|NCT02769065|7625312|FG012|Overall Study|Voluntary Withdrawal|0
4705572|NCT02769065|7625313|FG013|Overall Study|Voluntary Withdrawal|0
4705573|NCT02769065|7625314|FG014|Overall Study|Voluntary Withdrawal|0
4705574|NCT02769065|7625315|FG015|Overall Study|Voluntary Withdrawal|0
4705575|NCT02769065|7625316|FG016|Overall Study|Voluntary Withdrawal|0
4705576|NCT02769065|7625317|FG017|Overall Study|Voluntary Withdrawal|0
4705577|NCT02769065|7625318|FG018|Overall Study|Voluntary Withdrawal|0
4705578|NCT02769065|7625319|FG019|Overall Study|Voluntary Withdrawal|0
4705579|NCT02769065|7625320|FG020|Overall Study|Voluntary Withdrawal|0
4705580|NCT02769065|7625321|FG021|Overall Study|Voluntary Withdrawal|0
4705581|NCT02769065|7625322|FG022|Overall Study|Voluntary Withdrawal|0
4705582|NCT02769065|7625323|FG023|Overall Study|Voluntary Withdrawal|0
4705583|NCT02769065|7625324|FG024|Overall Study|Voluntary Withdrawal|0
4387588|NCT00048581|7166077|FG002|Double-Blind Period|Withdrawal by Subject|0
4387589|NCT00048581|7166075|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1
4705584|NCT02769065|7625325|FG025|Overall Study|Voluntary Withdrawal|0
4705585|NCT02769065|7625326|FG026|Overall Study|Voluntary Withdrawal|0
4705586|NCT02769065|7625327|FG027|Overall Study|Voluntary Withdrawal|0
4705587|NCT02769065|7625328|FG028|Overall Study|Voluntary Withdrawal|0
4705588|NCT02769065|7625329|FG029|Overall Study|Voluntary Withdrawal|0
4705589|NCT02769065|7625300|FG000|Overall Study|Reason Not Specified|0
4705590|NCT02769065|7625301|FG001|Overall Study|Reason Not Specified|0
4705591|NCT02769065|7625302|FG002|Overall Study|Reason Not Specified|0
4705592|NCT02769065|7625303|FG003|Overall Study|Reason Not Specified|0
4705593|NCT02769065|7625304|FG004|Overall Study|Reason Not Specified|0
4705594|NCT02769065|7625305|FG005|Overall Study|Reason Not Specified|0
4705595|NCT02769065|7625306|FG006|Overall Study|Reason Not Specified|1
4705596|NCT02769065|7625307|FG007|Overall Study|Reason Not Specified|0
4705597|NCT02769065|7625308|FG008|Overall Study|Reason Not Specified|0
4705598|NCT02769065|7625309|FG009|Overall Study|Reason Not Specified|0
4705599|NCT02769065|7625310|FG010|Overall Study|Reason Not Specified|0
4705600|NCT02769065|7625311|FG011|Overall Study|Reason Not Specified|0
4705601|NCT02769065|7625312|FG012|Overall Study|Reason Not Specified|0
4705602|NCT02769065|7625313|FG013|Overall Study|Reason Not Specified|0
4705603|NCT02769065|7625314|FG014|Overall Study|Reason Not Specified|0
4387590|NCT00048581|7166076|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0
4387591|NCT00048581|7166077|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0
4387592|NCT00048581|7166075|FG000|Double-Blind Period|Investigator Decision|1
4387593|NCT00048581|7166076|FG001|Double-Blind Period|Investigator Decision|0
4627965|NCT01856257|7494824|FG002|Overall Study|Withdrawal by Subject|0
4627966|NCT01856257|7494825|FG003|Overall Study|Withdrawal by Subject|0
4387594|NCT00048581|7166077|FG002|Double-Blind Period|Investigator Decision|0
4387595|NCT00048581|7166075|FG000|Open-Label Period|Death|0
4387596|NCT00048581|7166076|FG001|Open-Label Period|Death|0
4387597|NCT00048581|7166077|FG002|Open-Label Period|Death|4
4387598|NCT00048581|7166075|FG000|Open-Label Period|Adverse Event|0
4387599|NCT00048581|7166076|FG001|Open-Label Period|Adverse Event|0
4387600|NCT00048581|7166077|FG002|Open-Label Period|Adverse Event|37
4387601|NCT00048581|7166075|FG000|Open-Label Period|Lack of Efficacy|0
4387602|NCT00048581|7166076|FG001|Open-Label Period|Lack of Efficacy|0
4387603|NCT00048581|7166077|FG002|Open-Label Period|Lack of Efficacy|69
4387604|NCT00048581|7166075|FG000|Open-Label Period|Lost to Follow-up|0
4387605|NCT00048581|7166076|FG001|Open-Label Period|Lost to Follow-up|0
4387606|NCT00048581|7166077|FG002|Open-Label Period|Lost to Follow-up|14
4387607|NCT00048581|7166075|FG000|Open-Label Period|Withdrawal by Subject|0
4387608|NCT00048581|7166076|FG001|Open-Label Period|Withdrawal by Subject|0
4705604|NCT02769065|7625315|FG015|Overall Study|Reason Not Specified|0
4705605|NCT02769065|7625316|FG016|Overall Study|Reason Not Specified|0
4705606|NCT02769065|7625317|FG017|Overall Study|Reason Not Specified|0
4705607|NCT02769065|7625318|FG018|Overall Study|Reason Not Specified|0
4705608|NCT02769065|7625319|FG019|Overall Study|Reason Not Specified|0
4510632|NCT00921557|7319475|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1
4510633|NCT00921557|7319476|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0
4510634|NCT00921557|7319474|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0
4510635|NCT00921557|7319475|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0
4510636|NCT00921557|7319476|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1
4510637|NCT00921557|7319474|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1
4510638|NCT00921557|7319475|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0
4510639|NCT00921557|7319476|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0
4510640|NCT00921557|7319474|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2
4510641|NCT00921557|7319475|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1
4518353|NCT00973349|7330442|FG013|Overall Study|Protocol Violation|0
4705609|NCT02769065|7625320|FG020|Overall Study|Reason Not Specified|0
4705610|NCT02769065|7625321|FG021|Overall Study|Reason Not Specified|0
4705611|NCT02769065|7625322|FG022|Overall Study|Reason Not Specified|0
4705612|NCT02769065|7625323|FG023|Overall Study|Reason Not Specified|0
4705613|NCT02769065|7625324|FG024|Overall Study|Reason Not Specified|0
4705614|NCT02769065|7625325|FG025|Overall Study|Reason Not Specified|0
4705615|NCT02769065|7625326|FG026|Overall Study|Reason Not Specified|0
4705616|NCT02769065|7625327|FG027|Overall Study|Reason Not Specified|0
4705617|NCT02769065|7625328|FG028|Overall Study|Reason Not Specified|0
4705618|NCT02769065|7625329|FG029|Overall Study|Reason Not Specified|0
4705619|NCT02769065|7625300|FG000|Overall Study|Pre-treatment Event/Adverse Event|0
4705620|NCT02769065|7625301|FG001|Overall Study|Pre-treatment Event/Adverse Event|0
4705621|NCT02769065|7625302|FG002|Overall Study|Pre-treatment Event/Adverse Event|0
4387609|NCT00048581|7166077|FG002|Open-Label Period|Withdrawal by Subject|20
4387610|NCT00048581|7166075|FG000|Open-Label Period|No Longer Meets Study Criteria|0
4387611|NCT00048581|7166076|FG001|Open-Label Period|No Longer Meets Study Criteria|0
4387612|NCT00048581|7166077|FG002|Open-Label Period|No Longer Meets Study Criteria|2
4387613|NCT00048581|7166075|FG000|Open-Label Period|Poor/Non-compliance|0
4387614|NCT00048581|7166076|FG001|Open-Label Period|Poor/Non-compliance|0
4387615|NCT00048581|7166077|FG002|Open-Label Period|Poor/Non-compliance|5
4387616|NCT00048581|7166075|FG000|Open-Label Period|Pregnancy|0
4387617|NCT00048581|7166076|FG001|Open-Label Period|Pregnancy|0
4387618|NCT00048581|7166077|FG002|Open-Label Period|Pregnancy|7
4387619|NCT00048581|7166075|FG000|Open-Label Period|Study Site Closure|0
4387620|NCT00048581|7166076|FG001|Open-Label Period|Study Site Closure|0
4387621|NCT00048581|7166077|FG002|Open-Label Period|Study Site Closure|2
4387622|NCT00048581|7166075|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0
4387623|NCT00048581|7166076|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0
4387624|NCT00048581|7166077|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3
4387625|NCT00048581|7166075|FG000|Open-Label Period|Problem With Transportation To Site|0
4387626|NCT00048581|7166076|FG001|Open-Label Period|Problem With Transportation To Site|0
4387627|NCT00048581|7166077|FG002|Open-Label Period|Problem With Transportation To Site|1
4387628|NCT00048581|7166075|FG000|Open-Label Period|Primary Investigator Retired|0
4387629|NCT00048581|7166076|FG001|Open-Label Period|Primary Investigator Retired|0
4387630|NCT00048581|7166077|FG002|Open-Label Period|Primary Investigator Retired|2
4387631|NCT00048581|7166075|FG000|Open-Label Period|Study Ended By Sponsor|0
4387632|NCT00048581|7166076|FG001|Open-Label Period|Study Ended By Sponsor|0
4387633|NCT00048581|7166077|FG002|Open-Label Period|Study Ended By Sponsor|1
4387634|NCT00048724|7166092|FG000|Overall Study|Adverse Event|53
4387635|NCT00048724|7166093|FG001|Overall Study|Adverse Event|12
4387636|NCT00048724|7166092|FG000|Overall Study|Withdrawal by Subject|34
4387637|NCT00048724|7166093|FG001|Overall Study|Withdrawal by Subject|54
4387638|NCT00048724|7166092|FG000|Overall Study|Lost to Follow-up|5
4387639|NCT00048724|7166093|FG001|Overall Study|Lost to Follow-up|5
4387640|NCT00048724|7166092|FG000|Overall Study|Protocol-defined Clinical Event|17
4387641|NCT00048724|7166093|FG001|Overall Study|Protocol-defined Clinical Event|32
4387642|NCT00048724|7166092|FG000|Overall Study|Noncompliance With Protocol|4
4387643|NCT00048724|7166093|FG001|Overall Study|Noncompliance With Protocol|12
4387644|NCT00048724|7166092|FG000|Overall Study|Did Not Meet Protocol Eligibility|2
4387645|NCT00048724|7166093|FG001|Overall Study|Did Not Meet Protocol Eligibility|2
4387646|NCT00048724|7166092|FG000|Overall Study|Administrative|1
4387647|NCT00048724|7166093|FG001|Overall Study|Administrative|1
4387648|NCT00048932|7166122|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1
4387649|NCT00048932|7166123|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0
4387650|NCT00048932|7166124|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0
4387651|NCT00048932|7166122|FG000|Double Blind Period (DB)|Adverse Event|51
4387652|NCT00048932|7166123|FG001|Double Blind Period (DB)|Adverse Event|19
4387653|NCT00048932|7166124|FG002|Double Blind Period (DB)|Adverse Event|0
4387654|NCT00048932|7166122|FG000|Double Blind Period (DB)|Death|5
4387655|NCT00048932|7166123|FG001|Double Blind Period (DB)|Death|3
4387656|NCT00048932|7166124|FG002|Double Blind Period (DB)|Death|0
4387657|NCT00048932|7166122|FG000|Double Blind Period (DB)|Lack of Efficacy|26
4387658|NCT00048932|7166123|FG001|Double Blind Period (DB)|Lack of Efficacy|44
4387659|NCT00048932|7166124|FG002|Double Blind Period (DB)|Lack of Efficacy|0
4705622|NCT02769065|7625303|FG003|Overall Study|Pre-treatment Event/Adverse Event|0
4705623|NCT02769065|7625304|FG004|Overall Study|Pre-treatment Event/Adverse Event|0
4510642|NCT00921557|7319476|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1
4510643|NCT00922116|7319533|FG000|Overall Study|Adverse Event|4
4510644|NCT00922116|7319533|FG000|Overall Study|Death|1
4510645|NCT00922116|7319533|FG000|Overall Study|Lost to Follow-up|1
4510646|NCT00922116|7319533|FG000|Overall Study|Withdrawal by Subject|4
4705624|NCT02769065|7625305|FG005|Overall Study|Pre-treatment Event/Adverse Event|0
4705625|NCT02769065|7625306|FG006|Overall Study|Pre-treatment Event/Adverse Event|0
4705626|NCT02769065|7625307|FG007|Overall Study|Pre-treatment Event/Adverse Event|0
4705627|NCT02769065|7625308|FG008|Overall Study|Pre-treatment Event/Adverse Event|0
4705628|NCT02769065|7625309|FG009|Overall Study|Pre-treatment Event/Adverse Event|0
4705629|NCT02769065|7625310|FG010|Overall Study|Pre-treatment Event/Adverse Event|1
4705630|NCT02769065|7625311|FG011|Overall Study|Pre-treatment Event/Adverse Event|0
4705631|NCT02769065|7625312|FG012|Overall Study|Pre-treatment Event/Adverse Event|0
4705632|NCT02769065|7625313|FG013|Overall Study|Pre-treatment Event/Adverse Event|0
4705633|NCT02769065|7625314|FG014|Overall Study|Pre-treatment Event/Adverse Event|0
4705634|NCT02769065|7625315|FG015|Overall Study|Pre-treatment Event/Adverse Event|0
4705635|NCT02769065|7625316|FG016|Overall Study|Pre-treatment Event/Adverse Event|0
4705636|NCT02769065|7625317|FG017|Overall Study|Pre-treatment Event/Adverse Event|0
4705637|NCT02769065|7625318|FG018|Overall Study|Pre-treatment Event/Adverse Event|0
4705638|NCT02769065|7625319|FG019|Overall Study|Pre-treatment Event/Adverse Event|0
4705639|NCT02769065|7625320|FG020|Overall Study|Pre-treatment Event/Adverse Event|0
4705640|NCT02769065|7625321|FG021|Overall Study|Pre-treatment Event/Adverse Event|0
4705641|NCT02769065|7625322|FG022|Overall Study|Pre-treatment Event/Adverse Event|0
4705642|NCT02769065|7625323|FG023|Overall Study|Pre-treatment Event/Adverse Event|0
4705643|NCT02769065|7625324|FG024|Overall Study|Pre-treatment Event/Adverse Event|0
4705644|NCT02769065|7625325|FG025|Overall Study|Pre-treatment Event/Adverse Event|0
4705645|NCT02769065|7625326|FG026|Overall Study|Pre-treatment Event/Adverse Event|0
4705646|NCT02769065|7625327|FG027|Overall Study|Pre-treatment Event/Adverse Event|0
4705647|NCT02769065|7625328|FG028|Overall Study|Pre-treatment Event/Adverse Event|0
4705648|NCT02769065|7625329|FG029|Overall Study|Pre-treatment Event/Adverse Event|0
4705649|NCT02769247|7625426|FG000|Overall Study|Withdrawal by Subject|1
4705650|NCT02769247|7625427|FG001|Overall Study|Withdrawal by Subject|0
4705651|NCT02769247|7625428|FG002|Overall Study|Withdrawal by Subject|0
4705652|NCT02769247|7625429|FG003|Overall Study|Withdrawal by Subject|1
4705653|NCT02769247|7625426|FG000|Overall Study|Protocol Violation|0
4705654|NCT02769247|7625427|FG001|Overall Study|Protocol Violation|0
4705655|NCT02769247|7625428|FG002|Overall Study|Protocol Violation|1
4705656|NCT02769247|7625429|FG003|Overall Study|Protocol Violation|0
4705657|NCT02769247|7625426|FG000|Overall Study|Physician Decision|1
4705658|NCT02769247|7625427|FG001|Overall Study|Physician Decision|0
4705659|NCT02769247|7625428|FG002|Overall Study|Physician Decision|0
4705660|NCT02769247|7625429|FG003|Overall Study|Physician Decision|0
4705661|NCT02769312|7625445|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1
4705662|NCT02769312|7625446|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1
4705663|NCT02769312|7625445|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1
4705664|NCT02769312|7625446|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0
4705665|NCT02769312|7625445|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1
4705666|NCT02769312|7625446|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0
4705667|NCT02769312|7625445|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0
4705668|NCT02769312|7625446|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1
4705669|NCT02769312|7625445|FG000|Follow-up|Lost to Follow-up|1
4705670|NCT02769312|7625446|FG001|Follow-up|Lost to Follow-up|1
4705671|NCT02769481|7625469|FG000|Overall Study|Protocol Violation|1
4705672|NCT02769481|7625470|FG001|Overall Study|Protocol Violation|0
4705673|NCT02769481|7625469|FG000|Overall Study|Adverse Event|3
4705674|NCT02769481|7625470|FG001|Overall Study|Adverse Event|6
4705675|NCT02769481|7625469|FG000|Overall Study|Entry Criteria Not Met|1
4705676|NCT02769481|7625470|FG001|Overall Study|Entry Criteria Not Met|2
4705677|NCT02769481|7625469|FG000|Overall Study|Withdrawal by Subject|14
4705678|NCT02769481|7625470|FG001|Overall Study|Withdrawal by Subject|16
4705679|NCT02769481|7625469|FG000|Overall Study|Lost to Follow-up|9
4705680|NCT02769481|7625470|FG001|Overall Study|Lost to Follow-up|9
4705681|NCT02769481|7625469|FG000|Overall Study|Physician Decision|0
4705682|NCT02769481|7625470|FG001|Overall Study|Physician Decision|1
4705683|NCT02769481|7625469|FG000|Overall Study|Terminated by Sponsor|1
4705684|NCT02769481|7625470|FG001|Overall Study|Terminated by Sponsor|0
4705685|NCT02769481|7625469|FG000|Overall Study|Death|0
4705686|NCT02769481|7625470|FG001|Overall Study|Death|1
4705687|NCT02769481|7625469|FG000|Overall Study|Undefined|4
4705688|NCT02769481|7625470|FG001|Overall Study|Undefined|1
4705689|NCT02769624|7625476|FG000|Overall Study|Lost to Follow-up|0
4705690|NCT02769624|7625477|FG001|Overall Study|Lost to Follow-up|1
4705691|NCT02769858|7625487|FG000|Overall Study|Withdrawal by Subject|2
4705692|NCT02770170|7625500|FG000|Overall Study|Withdrawal by Subject|0
4705693|NCT02770170|7625501|FG001|Overall Study|Withdrawal by Subject|0
4510647|NCT00922116|7319533|FG000|Overall Study|Other|5
4510648|NCT00922207|7319544|FG000|Overall Study|Adverse Event/Intercurrent Illness|3
4705694|NCT02770170|7625502|FG002|Overall Study|Withdrawal by Subject|0
4705695|NCT02770170|7625503|FG003|Overall Study|Withdrawal by Subject|2
4705696|NCT02770170|7625500|FG000|Overall Study|due to pregnancy|1
4705697|NCT02770170|7625501|FG001|Overall Study|due to pregnancy|0
4705698|NCT02770170|7625502|FG002|Overall Study|due to pregnancy|0
4705699|NCT02770170|7625503|FG003|Overall Study|due to pregnancy|0
4705700|NCT02770170|7625500|FG000|Overall Study|Lack of Efficacy|2
4705701|NCT02770170|7625501|FG001|Overall Study|Lack of Efficacy|0
4705702|NCT02770170|7625502|FG002|Overall Study|Lack of Efficacy|0
4705703|NCT02770170|7625503|FG003|Overall Study|Lack of Efficacy|1
4705704|NCT02770170|7625500|FG000|Overall Study|Adverse Event|4
4705705|NCT02770170|7625501|FG001|Overall Study|Adverse Event|3
4705706|NCT02770170|7625502|FG002|Overall Study|Adverse Event|5
4705707|NCT02770170|7625503|FG003|Overall Study|Adverse Event|3
4705708|NCT02770170|7625500|FG000|Overall Study|due to disease worsening|0
4705709|NCT02770170|7625501|FG001|Overall Study|due to disease worsening|0
4705710|NCT02770170|7625502|FG002|Overall Study|due to disease worsening|0
4705711|NCT02770170|7625503|FG003|Overall Study|due to disease worsening|1
4705712|NCT02770248|7625515|FG000|Overall Study|Adverse Event|0
4705713|NCT02770248|7625516|FG001|Overall Study|Adverse Event|1
4705714|NCT02770248|7625515|FG000|Overall Study|Randomized in error, prior to treatment|0
4705715|NCT02770248|7625516|FG001|Overall Study|Randomized in error, prior to treatment|1
4705716|NCT02770547|7625569|FG000|Overall Study|Patient non-compliant|1
4705717|NCT02770547|7625570|FG001|Overall Study|Patient non-compliant|0
4705718|NCT02770547|7625569|FG000|Overall Study|Adverse Event|0
4705719|NCT02770547|7625570|FG001|Overall Study|Adverse Event|1
4705720|NCT02770612|7625576|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1
4705721|NCT02770820|7625584|FG000|Overall Study|Death|1
4705722|NCT02770820|7625584|FG000|Overall Study|Physician Decision|2
4705723|NCT02771145|7625608|FG000|Overall Study|Adverse Event|3
4705724|NCT02771145|7625608|FG000|Overall Study|Lost to Follow-up|1
4705725|NCT02771210|7625630|FG000|Period 1|Adverse Event|5
4705726|NCT02771210|7625631|FG001|Period 1|Adverse Event|3
4705727|NCT02771210|7625630|FG000|Period 1|Lack of Efficacy|3
4705728|NCT02771210|7625631|FG001|Period 1|Lack of Efficacy|6
4705729|NCT02771210|7625630|FG000|Period 1|Lost to Follow-up|2
4705730|NCT02771210|7625631|FG001|Period 1|Lost to Follow-up|0
4705731|NCT02771210|7625630|FG000|Period 1|Physician Decision|0
4705732|NCT02771210|7625631|FG001|Period 1|Physician Decision|1
4705733|NCT02771210|7625630|FG000|Period 1|Withdrawal by Subject|0
4705734|NCT02771210|7625631|FG001|Period 1|Withdrawal by Subject|3
4705735|NCT02771210|7625630|FG000|Period 1|Withdrawal of informed consent|1
4705736|NCT02771210|7625631|FG001|Period 1|Withdrawal of informed consent|5
4705737|NCT02771210|7625630|FG000|Period 2|Adverse Event|1
4705738|NCT02771210|7625631|FG001|Period 2|Adverse Event|0
4705739|NCT02771210|7625630|FG000|Period 2|Lack of Efficacy|0
4705740|NCT02771210|7625631|FG001|Period 2|Lack of Efficacy|1
4705741|NCT02771210|7625630|FG000|Period 2|Withdrawal by Subject|1
4705742|NCT02771210|7625631|FG001|Period 2|Withdrawal by Subject|0
4705743|NCT02771210|7625630|FG000|Period 2|Withdrawal of informed consent|0
4705744|NCT02771210|7625631|FG001|Period 2|Withdrawal of informed consent|2
4705745|NCT02771366|7625652|FG000|Period 1|Withdrawal by Subject|0
4705746|NCT02771366|7625653|FG001|Period 1|Withdrawal by Subject|2
4705747|NCT02771366|7625652|FG000|Period 2 (Crossover)|Withdrawal by Subject|2
4705748|NCT02771366|7625653|FG001|Period 2 (Crossover)|Withdrawal by Subject|0
4705749|NCT02771522|7625660|FG000|Overall Study|Lost to Follow-up|3
4705750|NCT02771522|7625660|FG000|Overall Study|Withdrawal by Subject|2
4705751|NCT02771522|7625660|FG000|Overall Study|No white spot lesions|3
4705752|NCT02772757|7625719|FG000|Overall Study|Withdrawal by Subject|1
4705753|NCT02772757|7625720|FG001|Overall Study|Withdrawal by Subject|0
4705754|NCT02772757|7625721|FG002|Overall Study|Withdrawal by Subject|1
4705755|NCT02772757|7625719|FG000|Overall Study|Protocol Violation|0
4705756|NCT02772757|7625720|FG001|Overall Study|Protocol Violation|0
4705757|NCT02772757|7625721|FG002|Overall Study|Protocol Violation|1
4705758|NCT02772757|7625719|FG000|Overall Study|Physician Decision|0
4705759|NCT02772757|7625720|FG001|Overall Study|Physician Decision|3
4705760|NCT02772757|7625721|FG002|Overall Study|Physician Decision|3
4705761|NCT02772809|7625739|FG000|Overall Study|not completed some tasks|6
4705762|NCT02772978|7625748|FG000|Overall Study|Withdrawal by Subject|1
4705763|NCT02772978|7625749|FG001|Overall Study|Withdrawal by Subject|1
4705764|NCT02773368|7625756|FG000|Overall Study|Lost to Follow-up|4
4705765|NCT02773368|7625757|FG001|Overall Study|Lost to Follow-up|1
4705766|NCT02773368|7625756|FG000|Overall Study|Withdrawal by Subject|5
4705767|NCT02773368|7625757|FG001|Overall Study|Withdrawal by Subject|1
4705768|NCT02773368|7625756|FG000|Overall Study|Unclassified|1
4705769|NCT02773368|7625757|FG001|Overall Study|Unclassified|1
4705770|NCT02773368|7625756|FG000|Overall Study|Missing|0
4705771|NCT02773368|7625757|FG001|Overall Study|Missing|1
4705772|NCT02773446|7625769|FG000|First Admission|Withdrawal by Subject|0
4705773|NCT02773446|7625770|FG001|First Admission|Withdrawal by Subject|0
4705774|NCT02773446|7625771|FG002|First Admission|Withdrawal by Subject|0
4705775|NCT02773446|7625772|FG003|First Admission|Withdrawal by Subject|1
4705776|NCT02773446|7625773|FG004|First Admission|Withdrawal by Subject|0
4705777|NCT02773446|7625774|FG005|First Admission|Withdrawal by Subject|0
4705778|NCT02773446|7625769|FG000|First Admission|Lost to Follow-up|1
4705779|NCT02773446|7625770|FG001|First Admission|Lost to Follow-up|0
4705780|NCT02773446|7625771|FG002|First Admission|Lost to Follow-up|0
4705781|NCT02773446|7625772|FG003|First Admission|Lost to Follow-up|0
4705782|NCT02773446|7625773|FG004|First Admission|Lost to Follow-up|0
4705783|NCT02773446|7625774|FG005|First Admission|Lost to Follow-up|0
4705784|NCT02773537|7625794|FG000|Overall Study|Lost to Follow-up|0
4705785|NCT02773537|7625795|FG001|Overall Study|Lost to Follow-up|1
4705786|NCT02773537|7625796|FG002|Overall Study|Lost to Follow-up|4
4705787|NCT02774278|7625857|FG000|Overall Study|Lack of Efficacy|199
4705788|NCT02774278|7625857|FG000|Overall Study|Death|29
4705789|NCT02774278|7625857|FG000|Overall Study|Adverse event/intercurrent illness|16
4705790|NCT02774278|7625857|FG000|Overall Study|Refused treatment/did not cooperate|9
4705791|NCT02774278|7625857|FG000|Overall Study|Administrative reasons|6
4705792|NCT02774278|7625857|FG000|Overall Study|Withdrawal by Subject|3
4705793|NCT02774278|7625857|FG000|Overall Study|Protocol Violation|2
4705794|NCT02774681|7625885|FG000|Treatment on Study|Progressive Disease|7
4705795|NCT02774681|7625885|FG000|Follow-Up for 3 Years|Death|11
4705796|NCT02774681|7625885|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1
4705797|NCT02775344|7625928|FG000|Overall Study|No ovarian cyst identified|3
4705798|NCT02775344|7625929|FG001|Overall Study|No ovarian cyst identified|2
4705799|NCT02775864|7625948|FG000|Overall Study|Data ended end of 2010|1764
4705800|NCT02775864|7625949|FG001|Overall Study|Data ended end of 2010|2880
4705801|NCT02775864|7625950|FG002|Overall Study|Data ended end of 2010|1140
4705802|NCT02775864|7625951|FG003|Overall Study|Data ended end of 2010|1194
4705803|NCT02775864|7625948|FG000|Overall Study|Medicaid eligibility discontinued|1478
4705804|NCT02775864|7625949|FG001|Overall Study|Medicaid eligibility discontinued|2019
4705805|NCT02775864|7625950|FG002|Overall Study|Medicaid eligibility discontinued|720
4705806|NCT02775864|7625951|FG003|Overall Study|Medicaid eligibility discontinued|890
4705807|NCT02775903|7625966|FG000|Overall Study|Ongoing|14
4705808|NCT02775903|7625967|FG001|Overall Study|Ongoing|15
4705809|NCT02775903|7625968|FG002|Overall Study|Ongoing|15
4705810|NCT02775903|7625969|FG003|Overall Study|Ongoing|19
4705811|NCT02775903|7625966|FG000|Overall Study|Death|19
4705812|NCT02775903|7625967|FG001|Overall Study|Death|18
4705813|NCT02775903|7625968|FG002|Overall Study|Death|38
4705814|NCT02775903|7625969|FG003|Overall Study|Death|35
4705815|NCT02775903|7625966|FG000|Overall Study|Withdrawal by Subject|5
4705816|NCT02775903|7625967|FG001|Overall Study|Withdrawal by Subject|5
4705817|NCT02775903|7625968|FG002|Overall Study|Withdrawal by Subject|5
4705818|NCT02775903|7625969|FG003|Overall Study|Withdrawal by Subject|4
4705819|NCT02775903|7625966|FG000|Overall Study|Adverse Event|0
4705820|NCT02775903|7625967|FG001|Overall Study|Adverse Event|0
4705821|NCT02775903|7625968|FG002|Overall Study|Adverse Event|1
4705822|NCT02775903|7625969|FG003|Overall Study|Adverse Event|1
4705823|NCT02775903|7625966|FG000|Overall Study|Lost to Follow-up|0
4705824|NCT02775903|7625967|FG001|Overall Study|Lost to Follow-up|0
4705825|NCT02775903|7625968|FG002|Overall Study|Lost to Follow-up|1
4705826|NCT02775903|7625969|FG003|Overall Study|Lost to Follow-up|1
4705827|NCT02775903|7625966|FG000|Overall Study|Other-Miscellaneous|4
4705828|NCT02775903|7625967|FG001|Overall Study|Other-Miscellaneous|3
4705829|NCT02775903|7625968|FG002|Overall Study|Other-Miscellaneous|4
4705830|NCT02775903|7625969|FG003|Overall Study|Other-Miscellaneous|5
4705831|NCT02775916|7625985|FG000|Overall Study|Adverse Event|1
4705832|NCT02775916|7625986|FG001|Overall Study|Adverse Event|0
4705833|NCT02775916|7625985|FG000|Overall Study|Subject/Guardian Decision|2
4705834|NCT02775916|7625986|FG001|Overall Study|Subject/Guardian Decision|0
4705835|NCT02776033|7625995|FG000|Overall Study|Withdrawal by Subject|0
4705836|NCT02776033|7625996|FG001|Overall Study|Withdrawal by Subject|0
4705837|NCT02776033|7625997|FG002|Overall Study|Withdrawal by Subject|2
4705838|NCT02776033|7625995|FG000|Overall Study|Physician Decision|2
4705839|NCT02776033|7625996|FG001|Overall Study|Physician Decision|0
4705840|NCT02776033|7625997|FG002|Overall Study|Physician Decision|0
4705841|NCT02776033|7625995|FG000|Overall Study|Lost to Follow-up|1
4705842|NCT02776033|7625996|FG001|Overall Study|Lost to Follow-up|0
4705843|NCT02776033|7625997|FG002|Overall Study|Lost to Follow-up|0
4705844|NCT02776033|7625995|FG000|Overall Study|Adverse Event|1
4705845|NCT02776033|7625996|FG001|Overall Study|Adverse Event|2
4705846|NCT02776033|7625997|FG002|Overall Study|Adverse Event|0
4705847|NCT02776553|7626013|FG000|Overall Study|Lost to Follow-up|1
4705848|NCT02776553|7626014|FG001|Overall Study|Lost to Follow-up|0
4705849|NCT02776553|7626013|FG000|Overall Study|got liver transplant|1
4705850|NCT02776553|7626014|FG001|Overall Study|got liver transplant|2
4705851|NCT02776553|7626013|FG000|Overall Study|had other surgery|1
4705852|NCT02776553|7626014|FG001|Overall Study|had other surgery|0
4705853|NCT02776553|7626013|FG000|Overall Study|Protocol Violation|0
4705854|NCT02776553|7626014|FG001|Overall Study|Protocol Violation|1
4705855|NCT02776670|7626031|FG000|Overall Study|Adverse Event|0
4705856|NCT02776670|7626032|FG001|Overall Study|Adverse Event|2
4705857|NCT02776670|7626031|FG000|Overall Study|Protocol Violation|0
4705858|NCT02776670|7626032|FG001|Overall Study|Protocol Violation|2
4705859|NCT02776670|7626031|FG000|Overall Study|Withdrawal by Subject|0
4705860|NCT02776670|7626032|FG001|Overall Study|Withdrawal by Subject|1
4705861|NCT02776670|7626031|FG000|Overall Study|Other - Reason not given|0
4705862|NCT02776670|7626032|FG001|Overall Study|Other - Reason not given|1
4705863|NCT02776683|7626038|FG000|Pre-switch Period|Protocol Violation|1
4705864|NCT02776683|7626039|FG001|Pre-switch Period|Protocol Violation|0
4705865|NCT02776683|7626038|FG000|Pre-switch Period|Adverse Event|21
4705866|NCT02776683|7626039|FG001|Pre-switch Period|Adverse Event|0
4705867|NCT02776683|7626038|FG000|Pre-switch Period|Withdrawal by Subject|9
4705868|NCT02776683|7626039|FG001|Pre-switch Period|Withdrawal by Subject|0
4705869|NCT02776683|7626038|FG000|Pre-switch Period|Physician Decision|7
4705870|NCT02776683|7626039|FG001|Pre-switch Period|Physician Decision|0
4705871|NCT02776683|7626038|FG000|Pre-switch Period|Progressive disease|39
4705872|NCT02776683|7626039|FG001|Pre-switch Period|Progressive disease|0
4705873|NCT02776683|7626038|FG000|Pre-switch Period|Other than listed|3
4705874|NCT02776683|7626039|FG001|Pre-switch Period|Other than listed|0
4705875|NCT02776683|7626038|FG000|Post-switch Period|Adverse Event|0
4705876|NCT02776683|7626039|FG001|Post-switch Period|Adverse Event|3
4705877|NCT02776683|7626038|FG000|Post-switch Period|Withdrawal by Subject|0
4705878|NCT02776683|7626039|FG001|Post-switch Period|Withdrawal by Subject|2
4705879|NCT02776683|7626038|FG000|Post-switch Period|Physician Decision|0
4705880|NCT02776683|7626039|FG001|Post-switch Period|Physician Decision|3
4705881|NCT02776683|7626038|FG000|Post-switch Period|Progressive disease|0
4705882|NCT02776683|7626039|FG001|Post-switch Period|Progressive disease|20
4705883|NCT02776683|7626038|FG000|Post-switch Period|Other than listed|0
4705884|NCT02776683|7626039|FG001|Post-switch Period|Other than listed|15
4705885|NCT02777086|7626074|FG000|Overall Study|Lost to Follow-up|96
4705886|NCT02777086|7626075|FG001|Overall Study|Lost to Follow-up|99
4705887|NCT02777125|7626083|FG000|Overall Study|Consent form violation|14
4705888|NCT02777125|7626084|FG001|Overall Study|Consent form violation|12
4705889|NCT02777125|7626083|FG000|Overall Study|Assent form violation|21
4705890|NCT02777125|7626084|FG001|Overall Study|Assent form violation|23
4705891|NCT02777125|7626083|FG000|Overall Study|Protocol Violation|8
4705892|NCT02777125|7626084|FG001|Overall Study|Protocol Violation|12
4705893|NCT02777242|7626091|FG000|Overall Study|Other|2
4705894|NCT02777242|7626091|FG000|Overall Study|Lost to Follow-up|1
4705895|NCT02777242|7626091|FG000|Overall Study|Multiple|1
4705896|NCT02777242|7626091|FG000|Overall Study|Sponsor's request|1
4705897|NCT02777242|7626091|FG000|Overall Study|Withdrawal by Subject|1
4705898|NCT02777333|7626119|FG000|Overall Study|Withdrawal by Subject|0
4705899|NCT02777333|7626120|FG001|Overall Study|Withdrawal by Subject|1
4705900|NCT02777333|7626119|FG000|Overall Study|Lost to Follow-up|0
4705901|NCT02777333|7626120|FG001|Overall Study|Lost to Follow-up|1
4735546|NCT03535194|7683721|FG000|Induction Period|Adverse Event|2
4735547|NCT03535194|7683722|FG001|Induction Period|Adverse Event|2
4735548|NCT03535194|7683723|FG002|Induction Period|Adverse Event|1
4735549|NCT03535194|7683724|FG003|Induction Period|Adverse Event|3
4735550|NCT03535194|7683725|FG004|Induction Period|Adverse Event|0
4735551|NCT03535194|7683721|FG000|Induction Period|Death|0
4735552|NCT03535194|7683722|FG001|Induction Period|Death|1
4735553|NCT03535194|7683723|FG002|Induction Period|Death|0
4735554|NCT03535194|7683724|FG003|Induction Period|Death|0
4735555|NCT03535194|7683725|FG004|Induction Period|Death|0
4735556|NCT03535194|7683721|FG000|Induction Period|Lack of Efficacy|1
4735557|NCT03535194|7683722|FG001|Induction Period|Lack of Efficacy|3
4735558|NCT03535194|7683723|FG002|Induction Period|Lack of Efficacy|2
4735559|NCT03535194|7683724|FG003|Induction Period|Lack of Efficacy|2
4735560|NCT03535194|7683725|FG004|Induction Period|Lack of Efficacy|0
4735561|NCT03535194|7683721|FG000|Induction Period|Lost to Follow-up|3
4735562|NCT03535194|7683722|FG001|Induction Period|Lost to Follow-up|5
4735563|NCT03535194|7683723|FG002|Induction Period|Lost to Follow-up|2
4735564|NCT03535194|7683724|FG003|Induction Period|Lost to Follow-up|3
4387660|NCT00048932|7166122|FG000|Double Blind Period (DB)|Lost to Follow-up|3
4387661|NCT00048932|7166123|FG001|Double Blind Period (DB)|Lost to Follow-up|4
4387662|NCT00048932|7166124|FG002|Double Blind Period (DB)|Lost to Follow-up|0
4387663|NCT00048932|7166122|FG000|Double Blind Period (DB)|Relocation|1
4387664|NCT00048932|7166123|FG001|Double Blind Period (DB)|Relocation|0
4387665|NCT00048932|7166124|FG002|Double Blind Period (DB)|Relocation|0
4387666|NCT00048932|7166122|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0
4387667|NCT00048932|7166123|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1
4387668|NCT00048932|7166124|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0
4387669|NCT00048932|7166122|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1
4387670|NCT00048932|7166123|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0
4387671|NCT00048932|7166124|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0
4387672|NCT00048932|7166122|FG000|Double Blind Period (DB)|Pregnancy|1
4387673|NCT00048932|7166123|FG001|Double Blind Period (DB)|Pregnancy|0
4387674|NCT00048932|7166124|FG002|Double Blind Period (DB)|Pregnancy|0
4387675|NCT00048932|7166122|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8
4387676|NCT00048932|7166123|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2
4387677|NCT00048932|7166124|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0
4387678|NCT00048932|7166122|FG000|Double Blind Period (DB)|Withdrawal by Subject|24
4387679|NCT00048932|7166123|FG001|Double Blind Period (DB)|Withdrawal by Subject|10
4387680|NCT00048932|7166124|FG002|Double Blind Period (DB)|Withdrawal by Subject|0
4387681|NCT00048932|7166122|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2
4735565|NCT03535194|7683725|FG004|Induction Period|Lost to Follow-up|0
4387682|NCT00048932|7166123|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4
4735566|NCT03535194|7683721|FG000|Induction Period|Physician Decision|1
4735567|NCT03535194|7683722|FG001|Induction Period|Physician Decision|1
4735568|NCT03535194|7683723|FG002|Induction Period|Physician Decision|0
4735569|NCT03535194|7683724|FG003|Induction Period|Physician Decision|0
4705902|NCT04952701|7626126|FG000|Control Lens|Physician Decision|4
4705903|NCT04952701|7626126|FG000|Test Lens|Physician Decision|1
4705904|NCT04074161|7626139|FG000|Overall Study|Withdrawal by Subject|2
4705905|NCT04074161|7626140|FG001|Overall Study|Withdrawal by Subject|4
4705906|NCT04074161|7626141|FG002|Overall Study|Withdrawal by Subject|1
4705907|NCT04074161|7626139|FG000|Overall Study|Lost to Follow-up|4
4705908|NCT04074161|7626140|FG001|Overall Study|Lost to Follow-up|5
4705909|NCT04074161|7626141|FG002|Overall Study|Lost to Follow-up|3
4705910|NCT04033432|7626149|FG000|Overall Study|Progressive Disease|8
4705911|NCT04033432|7626149|FG000|Overall Study|Adverse Event|4
4705912|NCT04033432|7626149|FG000|Overall Study|Death|1
4705913|NCT04030247|7626154|FG000|Overall Study|Withdrawal by Subject|4
4705914|NCT04030247|7626154|FG000|Overall Study|Lost to Follow-up|13
4705915|NCT03893565|7626163|FG000|Double-blind Induction Phase (10 Weeks)|Other|1
4705916|NCT03893565|7626164|FG001|Double-blind Induction Phase (10 Weeks)|Other|3
4705917|NCT03893565|7626165|FG002|Double-blind Induction Phase (10 Weeks)|Other|0
4705918|NCT03893565|7626166|FG003|Double-blind Induction Phase (10 Weeks)|Other|0
4705919|NCT03893565|7626167|FG004|Double-blind Induction Phase (10 Weeks)|Other|1
4705920|NCT03893565|7626168|FG005|Double-blind Induction Phase (10 Weeks)|Other|0
4705921|NCT03893565|7626169|FG006|Double-blind Induction Phase (10 Weeks)|Other|0
4705922|NCT03893565|7626170|FG007|Double-blind Induction Phase (10 Weeks)|Other|0
4705923|NCT03893565|7626171|FG008|Double-blind Induction Phase (10 Weeks)|Other|0
4705924|NCT03893565|7626163|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0
4705925|NCT03893565|7626164|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1
4705926|NCT03893565|7626165|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0
4705927|NCT03893565|7626166|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0
4735570|NCT03535194|7683725|FG004|Induction Period|Physician Decision|0
4387683|NCT00048932|7166124|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0
4387684|NCT00048932|7166122|FG000|Open Label Period (OL)|Death|0
4387685|NCT00048932|7166123|FG001|Open Label Period (OL)|Death|0
4387686|NCT00048932|7166124|FG002|Open Label Period (OL)|Death|25
4387687|NCT00048932|7166122|FG000|Open Label Period (OL)|Adverse Event|0
4387688|NCT00048932|7166123|FG001|Open Label Period (OL)|Adverse Event|0
4387689|NCT00048932|7166124|FG002|Open Label Period (OL)|Adverse Event|103
4387690|NCT00048932|7166122|FG000|Open Label Period (OL)|Lack of Efficacy|0
4387691|NCT00048932|7166123|FG001|Open Label Period (OL)|Lack of Efficacy|0
4387692|NCT00048932|7166124|FG002|Open Label Period (OL)|Lack of Efficacy|81
4387693|NCT00048932|7166122|FG000|Open Label Period (OL)|Lost to Follow-up|0
4387694|NCT00048932|7166123|FG001|Open Label Period (OL)|Lost to Follow-up|0
4387695|NCT00048932|7166124|FG002|Open Label Period (OL)|Lost to Follow-up|27
4387696|NCT00048932|7166122|FG000|Open Label Period (OL)|Withdrawal by Subject|0
4387697|NCT00048932|7166123|FG001|Open Label Period (OL)|Withdrawal by Subject|0
4387698|NCT00048932|7166124|FG002|Open Label Period (OL)|Withdrawal by Subject|117
4387699|NCT00048932|7166122|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0
4387700|NCT00048932|7166123|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0
4387701|NCT00048932|7166124|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5
4387702|NCT00048932|7166122|FG000|Open Label Period (OL)|Poor/Non-Compliance|0
4387703|NCT00048932|7166123|FG001|Open Label Period (OL)|Poor/Non-Compliance|0
4387704|NCT00048932|7166124|FG002|Open Label Period (OL)|Poor/Non-Compliance|13
4387705|NCT00048932|7166122|FG000|Open Label Period (OL)|Pregnancy|0
4387706|NCT00048932|7166123|FG001|Open Label Period (OL)|Pregnancy|0
4387707|NCT00048932|7166124|FG002|Open Label Period (OL)|Pregnancy|6
4387708|NCT00048932|7166122|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0
4387709|NCT00048932|7166123|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0
4387710|NCT00048932|7166124|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20
4387711|NCT00048932|7166122|FG000|Open Label Period (OL)|Investigator Retiring|0
4387712|NCT00048932|7166123|FG001|Open Label Period (OL)|Investigator Retiring|0
4387713|NCT00048932|7166124|FG002|Open Label Period (OL)|Investigator Retiring|2
4387714|NCT00048932|7166122|FG000|Open Label Period (OL)|Participant Transportation Issues|0
4387715|NCT00048932|7166123|FG001|Open Label Period (OL)|Participant Transportation Issues|0
4387716|NCT00048932|7166124|FG002|Open Label Period (OL)|Participant Transportation Issues|1
4387717|NCT00048932|7166122|FG000|Open Label Period (OL)|Participant Relocated|0
4387718|NCT00048932|7166123|FG001|Open Label Period (OL)|Participant Relocated|0
4387719|NCT00048932|7166124|FG002|Open Label Period (OL)|Participant Relocated|6
4387720|NCT00048932|7166122|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0
4387721|NCT00048932|7166123|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0
4387722|NCT00048932|7166124|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1
4387723|NCT00048932|7166122|FG000|Open Label Period (OL)|Site Closure|0
4387724|NCT00048932|7166123|FG001|Open Label Period (OL)|Site Closure|0
4387725|NCT00048932|7166124|FG002|Open Label Period (OL)|Site Closure|3
4387726|NCT00048932|7166122|FG000|Open Label Period (OL)|Trial Terminated|0
4387727|NCT00048932|7166123|FG001|Open Label Period (OL)|Trial Terminated|0
4387728|NCT00048932|7166124|FG002|Open Label Period (OL)|Trial Terminated|1
4387729|NCT00048932|7166122|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0
4387730|NCT00048932|7166123|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0
4387731|NCT00048932|7166124|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1
4387732|NCT00048932|7166122|FG000|Open Label Period (OL)|Patient Decision|0
4705928|NCT03893565|7626167|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0
4705929|NCT03893565|7626168|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0
4705930|NCT03893565|7626169|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0
4705931|NCT03893565|7626170|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0
4705932|NCT03893565|7626171|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0
4705933|NCT03893565|7626163|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0
4705934|NCT03893565|7626164|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2
4705935|NCT03893565|7626165|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0
4705936|NCT03893565|7626166|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1
4705937|NCT03893565|7626167|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0
4705938|NCT03893565|7626168|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0
4705939|NCT03893565|7626169|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0
4705940|NCT03893565|7626170|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0
4705941|NCT03893565|7626171|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0
4705942|NCT03893565|7626163|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0
4705943|NCT03893565|7626164|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1
4705944|NCT03893565|7626165|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0
4705945|NCT03893565|7626166|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6
4705946|NCT03893565|7626167|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0
4705947|NCT03893565|7626168|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0
4705948|NCT03893565|7626169|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0
4705949|NCT03893565|7626170|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0
4705950|NCT03893565|7626171|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0
4705951|NCT03893565|7626163|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5
4705952|NCT03893565|7626164|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5
4705953|NCT03893565|7626165|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9
4705954|NCT03893565|7626166|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0
4705955|NCT03893565|7626167|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6
4705956|NCT03893565|7626168|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0
4705957|NCT03893565|7626169|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0
4705958|NCT03893565|7626170|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0
4705959|NCT03893565|7626171|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0
4705960|NCT03893565|7626163|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0
4705961|NCT03893565|7626164|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2
4705962|NCT03893565|7626165|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0
4705963|NCT03893565|7626166|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0
4387733|NCT00048932|7166123|FG001|Open Label Period (OL)|Patient Decision|0
4387734|NCT00048932|7166124|FG002|Open Label Period (OL)|Patient Decision|4
4387735|NCT00048932|7166122|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0
4387736|NCT00048932|7166123|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0
4387737|NCT00048932|7166124|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1
4387738|NCT00048932|7166122|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0
4387739|NCT00048932|7166123|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0
4387740|NCT00048932|7166124|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2
4387741|NCT00048932|7166122|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0
4387742|NCT00048932|7166123|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0
4387743|NCT00048932|7166124|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5
4387744|NCT00048932|7166122|FG000|Open Label Period (OL)|Medication Lost Efficacy|0
4387745|NCT00048932|7166123|FG001|Open Label Period (OL)|Medication Lost Efficacy|0
4387746|NCT00048932|7166124|FG002|Open Label Period (OL)|Medication Lost Efficacy|1
4387747|NCT00048932|7166122|FG000|Open Label Period (OL)|Investigator Decision|0
4387748|NCT00048932|7166123|FG001|Open Label Period (OL)|Investigator Decision|0
4387749|NCT00048932|7166124|FG002|Open Label Period (OL)|Investigator Decision|4
4387750|NCT00048932|7166122|FG000|Open Label Period (OL)|Site Staff Issues|0
4387751|NCT00048932|7166123|FG001|Open Label Period (OL)|Site Staff Issues|0
4387752|NCT00048932|7166124|FG002|Open Label Period (OL)|Site Staff Issues|2
4387753|NCT00048932|7166122|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0
4387754|NCT00048932|7166123|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0
4387755|NCT00048932|7166124|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9
4387756|NCT00048932|7166122|FG000|Open Label Period (OL)|Participant Surgery|0
4387757|NCT00048932|7166123|FG001|Open Label Period (OL)|Participant Surgery|0
4387758|NCT00048932|7166124|FG002|Open Label Period (OL)|Participant Surgery|1
4387759|NCT00048997|7166135|FG000|Overall Study|Protocol Violation|7
4387760|NCT00048997|7166136|FG001|Overall Study|Protocol Violation|2
4387761|NCT00048997|7166135|FG000|Overall Study|Withdrawal by Subject|6
4387762|NCT00048997|7166136|FG001|Overall Study|Withdrawal by Subject|1
4387763|NCT00049127|7166155|FG000|Overall Study|Withdrawal by Subject|0
4387764|NCT00049127|7166156|FG001|Overall Study|Withdrawal by Subject|0
4705964|NCT03893565|7626167|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0
4705965|NCT03893565|7626168|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0
4705966|NCT03893565|7626169|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0
4705967|NCT03893565|7626170|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0
4705968|NCT03893565|7626171|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0
4705969|NCT03893565|7626163|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0
4705970|NCT03893565|7626164|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0
4705971|NCT03893565|7626165|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0
4705972|NCT03893565|7626166|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1
4705973|NCT03893565|7626167|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0
4705974|NCT03893565|7626168|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0
4705975|NCT03893565|7626169|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0
4705976|NCT03893565|7626170|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0
4705977|NCT03893565|7626171|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0
4705978|NCT03893565|7626163|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0
4705979|NCT03893565|7626164|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2
4705980|NCT03893565|7626165|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1
4705981|NCT03893565|7626166|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1
4705982|NCT03893565|7626167|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0
4705983|NCT03893565|7626168|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0
4705984|NCT03893565|7626169|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0
4705985|NCT03893565|7626170|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0
4705986|NCT03893565|7626171|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0
4705987|NCT03893565|7626163|FG000|Double-blind Extended Treatment(20weeks)|Other|0
4705988|NCT03893565|7626164|FG001|Double-blind Extended Treatment(20weeks)|Other|0
4705989|NCT03893565|7626165|FG002|Double-blind Extended Treatment(20weeks)|Other|0
4705990|NCT03893565|7626166|FG003|Double-blind Extended Treatment(20weeks)|Other|0
4705991|NCT03893565|7626167|FG004|Double-blind Extended Treatment(20weeks)|Other|0
4705992|NCT03893565|7626168|FG005|Double-blind Extended Treatment(20weeks)|Other|1
4705993|NCT03893565|7626169|FG006|Double-blind Extended Treatment(20weeks)|Other|1
4705994|NCT03893565|7626170|FG007|Double-blind Extended Treatment(20weeks)|Other|0
4705995|NCT03893565|7626171|FG008|Double-blind Extended Treatment(20weeks)|Other|0
4705996|NCT03893565|7626163|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0
4705997|NCT03893565|7626164|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0
4705998|NCT03893565|7626165|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0
4705999|NCT03893565|7626166|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0
4706000|NCT03893565|7626167|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0
4706001|NCT03893565|7626168|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0
4706002|NCT03893565|7626169|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1
4706003|NCT03893565|7626170|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0
4706004|NCT03893565|7626171|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0
4706005|NCT03893565|7626163|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0
4706006|NCT03893565|7626164|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0
4706007|NCT03893565|7626165|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0
4706008|NCT03893565|7626166|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0
4706009|NCT03893565|7626167|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0
4706010|NCT03893565|7626168|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2
4706011|NCT03893565|7626169|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2
4706012|NCT03893565|7626170|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0
4706013|NCT03893565|7626171|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0
4706014|NCT03893565|7626163|FG000|Open-label Induction Phase (10 Weeks)|Other|0
4706015|NCT03893565|7626164|FG001|Open-label Induction Phase (10 Weeks)|Other|0
4706016|NCT03893565|7626165|FG002|Open-label Induction Phase (10 Weeks)|Other|0
4706017|NCT03893565|7626166|FG003|Open-label Induction Phase (10 Weeks)|Other|0
4706018|NCT03893565|7626167|FG004|Open-label Induction Phase (10 Weeks)|Other|0
4706019|NCT03893565|7626168|FG005|Open-label Induction Phase (10 Weeks)|Other|0
4706020|NCT03893565|7626169|FG006|Open-label Induction Phase (10 Weeks)|Other|0
4706021|NCT03893565|7626170|FG007|Open-label Induction Phase (10 Weeks)|Other|3
4706022|NCT03893565|7626171|FG008|Open-label Induction Phase (10 Weeks)|Other|0
4706023|NCT03893565|7626163|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0
4706024|NCT03893565|7626164|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0
4706025|NCT03893565|7626165|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0
4706026|NCT03893565|7626166|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0
4706027|NCT03893565|7626167|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0
4706028|NCT03893565|7626168|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0
4706029|NCT03893565|7626169|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0
4706030|NCT03893565|7626170|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5
4706031|NCT03893565|7626171|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0
4706032|NCT03893565|7626163|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0
4706033|NCT03893565|7626164|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0
4706034|NCT03893565|7626165|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0
4706035|NCT03893565|7626166|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0
4706036|NCT03893565|7626167|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0
4706037|NCT03893565|7626168|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0
4706038|NCT03893565|7626169|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0
4706039|NCT03893565|7626170|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15
4706040|NCT03893565|7626171|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0
4706041|NCT03893565|7626163|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0
4706042|NCT03893565|7626164|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0
4706043|NCT03893565|7626165|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0
4706044|NCT03893565|7626166|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0
4706045|NCT03893565|7626167|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0
4706046|NCT03893565|7626168|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0
4706047|NCT03893565|7626169|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0
4706048|NCT03893565|7626170|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7
4706049|NCT03893565|7626171|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0
4706050|NCT03893565|7626163|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0
4706051|NCT03893565|7626164|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0
4735571|NCT03535194|7683721|FG000|Induction Period|Protocol Violation|1
4387765|NCT00049127|7166157|FG002|Overall Study|Withdrawal by Subject|1
4387766|NCT00049127|7166158|FG003|Overall Study|Withdrawal by Subject|0
4387767|NCT00049127|7166159|FG004|Overall Study|Withdrawal by Subject|0
4387768|NCT00049257|7166171|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10
4387769|NCT00049257|7166171|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1
4387770|NCT00049257|7166171|FG000|Carboplatin, Paclitaxel|Death|2
4387771|NCT00049257|7166171|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4
4387772|NCT00049322|7166177|FG000|Overall Study|disease burden|0
4387773|NCT00049322|7166178|FG001|Overall Study|disease burden|3
4387774|NCT00049322|7166177|FG000|Overall Study|Adverse Event|1
4387775|NCT00049322|7166178|FG001|Overall Study|Adverse Event|0
4387776|NCT00049322|7166177|FG000|Overall Study|refused angio|0
4387777|NCT00049322|7166178|FG001|Overall Study|refused angio|3
4387778|NCT00049517|7166192|FG000|Induction|Disease progression|0
4387779|NCT00049517|7166193|FG001|Induction|Disease progression|0
4387780|NCT00049517|7166194|FG002|Induction|Disease progression|0
4387781|NCT00049517|7166195|FG003|Induction|Disease progression|0
4627967|NCT01856257|7494822|FG000|Overall Study|Donor complication|0
4627968|NCT01856257|7494823|FG001|Overall Study|Donor complication|0
4627969|NCT01856257|7494824|FG002|Overall Study|Donor complication|0
4627970|NCT01856257|7494825|FG003|Overall Study|Donor complication|1
4387782|NCT00049517|7166196|FG004|Induction|Disease progression|18
4387783|NCT00049517|7166197|FG005|Induction|Disease progression|11
4387784|NCT00049517|7166192|FG000|Induction|Adverse Event|0
4387785|NCT00049517|7166193|FG001|Induction|Adverse Event|0
4387786|NCT00049517|7166194|FG002|Induction|Adverse Event|0
4387787|NCT00049517|7166195|FG003|Induction|Adverse Event|0
4387788|NCT00049517|7166196|FG004|Induction|Adverse Event|5
4387789|NCT00049517|7166197|FG005|Induction|Adverse Event|7
4387790|NCT00049517|7166192|FG000|Induction|Death|0
4387791|NCT00049517|7166193|FG001|Induction|Death|0
4387792|NCT00049517|7166194|FG002|Induction|Death|0
4387793|NCT00049517|7166195|FG003|Induction|Death|0
4387794|NCT00049517|7166196|FG004|Induction|Death|9
4387795|NCT00049517|7166197|FG005|Induction|Death|6
4387796|NCT00049517|7166192|FG000|Induction|Withdrawal by Subject|0
4387797|NCT00049517|7166193|FG001|Induction|Withdrawal by Subject|0
4387798|NCT00049517|7166194|FG002|Induction|Withdrawal by Subject|0
4387799|NCT00049517|7166195|FG003|Induction|Withdrawal by Subject|0
4387800|NCT00049517|7166196|FG004|Induction|Withdrawal by Subject|1
4387801|NCT00049517|7166197|FG005|Induction|Withdrawal by Subject|3
4387802|NCT00049517|7166192|FG000|Induction|Alternative therapy|0
4387803|NCT00049517|7166193|FG001|Induction|Alternative therapy|0
4387804|NCT00049517|7166194|FG002|Induction|Alternative therapy|0
4387805|NCT00049517|7166195|FG003|Induction|Alternative therapy|0
4387806|NCT00049517|7166196|FG004|Induction|Alternative therapy|2
4387807|NCT00049517|7166197|FG005|Induction|Alternative therapy|2
4387808|NCT00049517|7166192|FG000|Induction|Other complicating disease|0
4387809|NCT00049517|7166193|FG001|Induction|Other complicating disease|0
4387810|NCT00049517|7166194|FG002|Induction|Other complicating disease|0
4387811|NCT00049517|7166195|FG003|Induction|Other complicating disease|0
4387812|NCT00049517|7166196|FG004|Induction|Other complicating disease|3
4387813|NCT00049517|7166197|FG005|Induction|Other complicating disease|0
4387814|NCT00049517|7166192|FG000|Induction|Reasons not reported|0
4387815|NCT00049517|7166193|FG001|Induction|Reasons not reported|0
4387816|NCT00049517|7166194|FG002|Induction|Reasons not reported|0
4387817|NCT00049517|7166195|FG003|Induction|Reasons not reported|0
4387818|NCT00049517|7166196|FG004|Induction|Reasons not reported|22
4387819|NCT00049517|7166197|FG005|Induction|Reasons not reported|25
4627971|NCT01856309|7494838|FG000|Overall Study|Death|4
4706052|NCT03893565|7626165|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0
4706053|NCT03893565|7626166|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0
4706054|NCT03893565|7626167|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0
4706055|NCT03893565|7626168|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0
4706056|NCT03893565|7626169|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0
4706057|NCT03893565|7626170|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0
4706058|NCT03893565|7626171|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4
4706059|NCT03701516|7626190|FG000|Period 1|Lost to Follow-up|0
4706060|NCT03701516|7626191|FG001|Period 1|Lost to Follow-up|1
4706061|NCT03701516|7626190|FG000|Period 1|Adverse Event|0
4706062|NCT03701516|7626191|FG001|Period 1|Adverse Event|2
4706063|NCT03701516|7626190|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2
4706064|NCT03701516|7626191|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0
4706065|NCT03701516|7626190|FG000|Period 1|Non Compliance to Protocol|2
4706066|NCT03701516|7626191|FG001|Period 1|Non Compliance to Protocol|1
4706067|NCT03701516|7626190|FG000|Period 1|Withdrawal by Subject|0
4706068|NCT03701516|7626191|FG001|Period 1|Withdrawal by Subject|1
4706069|NCT03701516|7626190|FG000|Period 2|failed to meet all eligibility creiteria|1
4706070|NCT03701516|7626191|FG001|Period 2|failed to meet all eligibility creiteria|0
4706071|NCT03701516|7626190|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0
4706072|NCT03701516|7626191|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1
4706073|NCT03692052|7626197|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1
4387820|NCT00049517|7166192|FG000|Conditioning/Transplant|Disease progression|14
4387821|NCT00049517|7166193|FG001|Conditioning/Transplant|Disease progression|6
4387822|NCT00049517|7166194|FG002|Conditioning/Transplant|Disease progression|10
4387823|NCT00049517|7166195|FG003|Conditioning/Transplant|Disease progression|6
4387824|NCT00049517|7166196|FG004|Conditioning/Transplant|Disease progression|0
4387825|NCT00049517|7166197|FG005|Conditioning/Transplant|Disease progression|0
4387826|NCT00049517|7166192|FG000|Conditioning/Transplant|Adverse Event|2
4387827|NCT00049517|7166193|FG001|Conditioning/Transplant|Adverse Event|1
4387828|NCT00049517|7166194|FG002|Conditioning/Transplant|Adverse Event|4
4387829|NCT00049517|7166195|FG003|Conditioning/Transplant|Adverse Event|8
4387830|NCT00049517|7166196|FG004|Conditioning/Transplant|Adverse Event|0
4387831|NCT00049517|7166197|FG005|Conditioning/Transplant|Adverse Event|0
4387832|NCT00049517|7166192|FG000|Conditioning/Transplant|Death|1
4387833|NCT00049517|7166193|FG001|Conditioning/Transplant|Death|0
4387834|NCT00049517|7166194|FG002|Conditioning/Transplant|Death|0
4387835|NCT00049517|7166195|FG003|Conditioning/Transplant|Death|2
4387836|NCT00049517|7166196|FG004|Conditioning/Transplant|Death|0
4387837|NCT00049517|7166197|FG005|Conditioning/Transplant|Death|0
4387838|NCT00049517|7166192|FG000|Conditioning/Transplant|Withdrawal by Subject|4
4387839|NCT00049517|7166193|FG001|Conditioning/Transplant|Withdrawal by Subject|8
4387840|NCT00049517|7166194|FG002|Conditioning/Transplant|Withdrawal by Subject|4
4387841|NCT00049517|7166195|FG003|Conditioning/Transplant|Withdrawal by Subject|7
4387842|NCT00049517|7166196|FG004|Conditioning/Transplant|Withdrawal by Subject|0
4387843|NCT00049517|7166197|FG005|Conditioning/Transplant|Withdrawal by Subject|0
4387844|NCT00049517|7166192|FG000|Conditioning/Transplant|Alternative therapy|4
4387845|NCT00049517|7166193|FG001|Conditioning/Transplant|Alternative therapy|4
4387846|NCT00049517|7166194|FG002|Conditioning/Transplant|Alternative therapy|2
4387847|NCT00049517|7166195|FG003|Conditioning/Transplant|Alternative therapy|1
4387848|NCT00049517|7166196|FG004|Conditioning/Transplant|Alternative therapy|1
4387849|NCT00049517|7166197|FG005|Conditioning/Transplant|Alternative therapy|0
4387850|NCT00049517|7166192|FG000|Conditioning/Transplant|Other complicating disease|2
4387851|NCT00049517|7166193|FG001|Conditioning/Transplant|Other complicating disease|0
4706074|NCT03692052|7626197|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1
4706075|NCT03692052|7626197|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1
4706076|NCT03692052|7626197|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17
4706077|NCT03650556|7626201|FG000|Overall Study|Death|2
4706078|NCT03650556|7626201|FG000|Overall Study|Withdrawal by Subject|20
4706079|NCT03650556|7626201|FG000|Overall Study|Physician Decision|2
4706080|NCT03650556|7626201|FG000|Overall Study|Lost to Follow-up|8
4706081|NCT03650556|7626201|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4
4706082|NCT03650556|7626201|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1
4706083|NCT03639311|7626208|FG000|Overall Study|Ongoing at the time of analysis|88
4706084|NCT03639311|7626209|FG001|Overall Study|Ongoing at the time of analysis|0
4706085|NCT03639311|7626208|FG000|Overall Study|Lost to Follow-up|1
4706086|NCT03639311|7626209|FG001|Overall Study|Lost to Follow-up|0
4706087|NCT03639311|7626208|FG000|Overall Study|Adverse Event|1
4706088|NCT03639311|7626209|FG001|Overall Study|Adverse Event|0
4706089|NCT03628716|7626220|FG000|Overall Study|Adverse Event|1
4387852|NCT00049517|7166194|FG002|Conditioning/Transplant|Other complicating disease|0
4387853|NCT00049517|7166195|FG003|Conditioning/Transplant|Other complicating disease|4
4387854|NCT00049517|7166196|FG004|Conditioning/Transplant|Other complicating disease|0
4387855|NCT00049517|7166197|FG005|Conditioning/Transplant|Other complicating disease|1
4387856|NCT00049517|7166192|FG000|Conditioning/Transplant|Reasons not reported|25
4706090|NCT03628716|7626221|FG001|Overall Study|Adverse Event|1
4706091|NCT03628716|7626220|FG000|Overall Study|Death|1
4706092|NCT03628716|7626221|FG001|Overall Study|Death|0
4706093|NCT03628716|7626220|FG000|Overall Study|Lack of Efficacy|15
4706094|NCT03628716|7626221|FG001|Overall Study|Lack of Efficacy|20
4706095|NCT03628716|7626220|FG000|Overall Study|Withdrawal by Subject|1
4706096|NCT03628716|7626221|FG001|Overall Study|Withdrawal by Subject|2
4706097|NCT03628716|7626220|FG000|Overall Study|Study Terminated by Sponsor|1
4706098|NCT03628716|7626221|FG001|Overall Study|Study Terminated by Sponsor|0
4706099|NCT03377699|7626231|FG000|Overall Study|Withdrawal by Subject|2
4706100|NCT03377699|7626232|FG001|Overall Study|Withdrawal by Subject|9
4706101|NCT03377699|7626231|FG000|Overall Study|Lost to Follow-up|1
4706102|NCT03377699|7626232|FG001|Overall Study|Lost to Follow-up|1
4706103|NCT03377699|7626231|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1
4706104|NCT03377699|7626232|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0
4706105|NCT03377699|7626231|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1
4706106|NCT03377699|7626232|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1
4706107|NCT03377699|7626231|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11
4706108|NCT03377699|7626232|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8
4706109|NCT03377699|7626231|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6
4706110|NCT03377699|7626232|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6
4706111|NCT03275350|7626242|FG000|Overall Study|Lost to Follow-up|4
4706112|NCT03275350|7626243|FG001|Overall Study|Lost to Follow-up|6
4706113|NCT03275350|7626242|FG000|Overall Study|Death|2
4706114|NCT03275350|7626243|FG001|Overall Study|Death|1
4706115|NCT03275350|7626242|FG000|Overall Study|Physician Decision|1
4706116|NCT03275350|7626243|FG001|Overall Study|Physician Decision|0
4706117|NCT03275350|7626242|FG000|Overall Study|Incarcerated|1
4706118|NCT03275350|7626243|FG001|Overall Study|Incarcerated|1
4706119|NCT03272347|7626254|FG000|Overall Study|Death|0
4706120|NCT03272347|7626255|FG001|Overall Study|Death|0
4706121|NCT03272347|7626256|FG002|Overall Study|Death|0
4706122|NCT03272347|7626257|FG003|Overall Study|Death|1
4706123|NCT03272347|7626254|FG000|Overall Study|Lost to Follow-up|1
4706124|NCT03272347|7626255|FG001|Overall Study|Lost to Follow-up|0
4706125|NCT03272347|7626256|FG002|Overall Study|Lost to Follow-up|5
4706126|NCT03272347|7626257|FG003|Overall Study|Lost to Follow-up|1
4706127|NCT03272347|7626254|FG000|Overall Study|Physician Decision|4
4706128|NCT03272347|7626255|FG001|Overall Study|Physician Decision|2
4706129|NCT03272347|7626256|FG002|Overall Study|Physician Decision|5
4706130|NCT03272347|7626257|FG003|Overall Study|Physician Decision|4
4706131|NCT03272347|7626254|FG000|Overall Study|Screen Failure|1
4706132|NCT03272347|7626255|FG001|Overall Study|Screen Failure|0
4706133|NCT03272347|7626256|FG002|Overall Study|Screen Failure|0
4706134|NCT03272347|7626257|FG003|Overall Study|Screen Failure|0
4706135|NCT03272347|7626254|FG000|Overall Study|Withdrawal by Subject|3
4706136|NCT03272347|7626255|FG001|Overall Study|Withdrawal by Subject|1
4706137|NCT03272347|7626256|FG002|Overall Study|Withdrawal by Subject|2
4706138|NCT03272347|7626257|FG003|Overall Study|Withdrawal by Subject|1
4706139|NCT03272347|7626254|FG000|Overall Study|Status Not Recorded|22
4706140|NCT03272347|7626255|FG001|Overall Study|Status Not Recorded|26
4706141|NCT03272347|7626256|FG002|Overall Study|Status Not Recorded|19
4706142|NCT03272347|7626257|FG003|Overall Study|Status Not Recorded|22
4706143|NCT02853305|7626280|FG000|Overall Study|Death|244
4706144|NCT02853305|7626281|FG001|Overall Study|Death|207
4706145|NCT02853305|7626282|FG002|Overall Study|Death|263
4706146|NCT02853305|7626280|FG000|Overall Study|Withdrawal by Subject|2
4706147|NCT02853305|7626281|FG001|Overall Study|Withdrawal by Subject|4
4706148|NCT02853305|7626282|FG002|Overall Study|Withdrawal by Subject|2
4706149|NCT02853305|7626280|FG000|Overall Study|Ongoing in Trial|105
4706150|NCT02853305|7626281|FG001|Overall Study|Ongoing in Trial|96
4706151|NCT02853305|7626282|FG002|Overall Study|Ongoing in Trial|87
4706152|NCT02674750|7626311|FG000|Overall Study|Death|4
4706153|NCT02674750|7626312|FG001|Overall Study|Death|5
4706154|NCT02674750|7626313|FG002|Overall Study|Death|8
4706155|NCT02674750|7626311|FG000|Overall Study|Lost to Follow-up|0
4706156|NCT02674750|7626312|FG001|Overall Study|Lost to Follow-up|8
4706157|NCT02674750|7626313|FG002|Overall Study|Lost to Follow-up|0
4706158|NCT02674750|7626311|FG000|Overall Study|Lack of Efficacy|1
4706159|NCT02674750|7626312|FG001|Overall Study|Lack of Efficacy|17
4706160|NCT02674750|7626313|FG002|Overall Study|Lack of Efficacy|3
4706161|NCT02674750|7626311|FG000|Overall Study|Withdrawal by Subject|0
4706162|NCT02674750|7626312|FG001|Overall Study|Withdrawal by Subject|7
4706163|NCT02674750|7626313|FG002|Overall Study|Withdrawal by Subject|1
4706164|NCT02674750|7626311|FG000|Overall Study|Other|0
4706165|NCT02674750|7626312|FG001|Overall Study|Other|8
4706166|NCT02674750|7626313|FG002|Overall Study|Other|0
4706167|NCT02440854|7626320|FG000|Overall Study|Relocation of patient|1
4706168|NCT02440854|7626320|FG000|Overall Study|Death|6
4706169|NCT02440854|7626320|FG000|Overall Study|Lost to Follow-up|10
4706170|NCT02440854|7626320|FG000|Overall Study|Afatinib discontinuation|46
4706171|NCT02440854|7626320|FG000|Overall Study|stopped study at earlier timepoint|14
4706172|NCT02440854|7626320|FG000|Overall Study|Study medication not received|1
4706173|NCT02440854|7626320|FG000|Overall Study|Violation of inclusion criteria|2
4706174|NCT02367040|7626326|FG000|Overall Study|Lost to Follow-up|1
4706175|NCT02367040|7626327|FG001|Overall Study|Lost to Follow-up|1
4706176|NCT02367040|7626326|FG000|Overall Study|Lack of Efficacy|1
4706177|NCT02367040|7626327|FG001|Overall Study|Lack of Efficacy|0
4706178|NCT02367040|7626326|FG000|Overall Study|Additional primary malignancy|0
4706179|NCT02367040|7626327|FG001|Overall Study|Additional primary malignancy|1
4706180|NCT02367040|7626326|FG000|Overall Study|AE not associated with clinical disease progression|104
4706181|NCT02367040|7626327|FG001|Overall Study|AE not associated with clinical disease progression|9
4706182|NCT02367040|7626326|FG000|Overall Study|AE associated with clinical disease progression|1
4706183|NCT02367040|7626327|FG001|Overall Study|AE associated with clinical disease progression|3
4706184|NCT02367040|7626326|FG000|Overall Study|Physician Decision|2
4706185|NCT02367040|7626327|FG001|Overall Study|Physician Decision|8
4706186|NCT02367040|7626326|FG000|Overall Study|Non-compliance with study drug|1
4706187|NCT02367040|7626327|FG001|Overall Study|Non-compliance with study drug|0
4706188|NCT02367040|7626326|FG000|Overall Study|Failure to meet continuation criteria|1
4706189|NCT02367040|7626327|FG001|Overall Study|Failure to meet continuation criteria|0
4706190|NCT02367040|7626326|FG000|Overall Study|Switching to other therapy|2
4706191|NCT02367040|7626327|FG001|Overall Study|Switching to other therapy|0
4706192|NCT02367040|7626326|FG000|Overall Study|Withdrawal by Subject|41
4706193|NCT02367040|7626327|FG001|Overall Study|Withdrawal by Subject|14
4706194|NCT02367040|7626326|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1
4706195|NCT02367040|7626327|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0
4706196|NCT02367040|7626326|FG000|Overall Study|Patient decision|35
4706197|NCT02367040|7626327|FG001|Overall Study|Patient decision|11
4706198|NCT02367040|7626326|FG000|Overall Study|Required procedure failed|1
4706199|NCT02367040|7626327|FG001|Overall Study|Required procedure failed|0
4706200|NCT02367040|7626326|FG000|Overall Study|Randomized by mistake with study treatment|1
4706201|NCT02367040|7626327|FG001|Overall Study|Randomized by mistake with study treatment|0
4706202|NCT02367040|7626326|FG000|Overall Study|Protocol Violation|1
4706203|NCT02367040|7626327|FG001|Overall Study|Protocol Violation|0
4706204|NCT02367040|7626326|FG000|Overall Study|Progressive disease - radiological progression|39
4706205|NCT02367040|7626327|FG001|Overall Study|Progressive disease - radiological progression|67
4706206|NCT02367040|7626326|FG000|Overall Study|Progressive disease - clinical progression|2
4706207|NCT02367040|7626327|FG001|Overall Study|Progressive disease - clinical progression|6
4706208|NCT02367040|7626326|FG000|Overall Study|Drug not administered|3
4706209|NCT02367040|7626327|FG001|Overall Study|Drug not administered|2
4771251|NCT02978781|7748152|FG001|Part C|Adverse Event|0
4771252|NCT02978781|7748153|FG002|Part C|Adverse Event|0
4771253|NCT02978781|7748154|FG003|Part C|Adverse Event|0
4771254|NCT02978781|7748155|FG004|Part C|Adverse Event|2
4627972|NCT01856309|7494839|FG001|Overall Study|Death|6
4627973|NCT01856309|7494840|FG002|Overall Study|Death|11
4627974|NCT01856309|7494841|FG003|Overall Study|Death|6
4771255|NCT02978781|7748151|FG000|Part C|Withdrawal by Subject|0
4771256|NCT02978781|7748152|FG001|Part C|Withdrawal by Subject|0
4771257|NCT02978781|7748153|FG002|Part C|Withdrawal by Subject|0
4771258|NCT02978781|7748154|FG003|Part C|Withdrawal by Subject|0
4771259|NCT02978781|7748155|FG004|Part C|Withdrawal by Subject|1
4771260|NCT02978781|7748151|FG000|Part C|Tremor not improved due to Topamax discontinuation|0
4771261|NCT02978781|7748152|FG001|Part C|Tremor not improved due to Topamax discontinuation|0
4771262|NCT02978781|7748153|FG002|Part C|Tremor not improved due to Topamax discontinuation|0
4771263|NCT02978781|7748154|FG003|Part C|Tremor not improved due to Topamax discontinuation|0
4771264|NCT02978781|7748155|FG004|Part C|Tremor not improved due to Topamax discontinuation|1
4771265|NCT02964507|7748189|FG000|Overall Study|Protocol specified Withdrawal criteria met|0
4771266|NCT02964507|7748190|FG001|Overall Study|Protocol specified Withdrawal criteria met|1
4771267|NCT02964507|7748191|FG002|Overall Study|Protocol specified Withdrawal criteria met|0
4771268|NCT02964507|7748192|FG003|Overall Study|Protocol specified Withdrawal criteria met|0
4771269|NCT02964507|7748193|FG004|Overall Study|Protocol specified Withdrawal criteria met|1
4771270|NCT02964507|7748194|FG005|Overall Study|Protocol specified Withdrawal criteria met|0
4771271|NCT02964507|7748195|FG006|Overall Study|Protocol specified Withdrawal criteria met|0
4771272|NCT02964507|7748196|FG007|Overall Study|Protocol specified Withdrawal criteria met|0
4771273|NCT02964507|7748189|FG000|Overall Study|Ongoing at the time of analysis|1
4771274|NCT02964507|7748190|FG001|Overall Study|Ongoing at the time of analysis|0
4771275|NCT02964507|7748191|FG002|Overall Study|Ongoing at the time of analysis|2
4771276|NCT02964507|7748192|FG003|Overall Study|Ongoing at the time of analysis|0
4771277|NCT02964507|7748193|FG004|Overall Study|Ongoing at the time of analysis|0
4771278|NCT02964507|7748194|FG005|Overall Study|Ongoing at the time of analysis|0
4627975|NCT01856309|7494838|FG000|Overall Study|Lost to Follow-up|6
4771279|NCT02964507|7748195|FG006|Overall Study|Ongoing at the time of analysis|0
4771280|NCT02964507|7748196|FG007|Overall Study|Ongoing at the time of analysis|0
4771281|NCT02964507|7748189|FG000|Overall Study|Study terminated by Sponsor|9
4771282|NCT02964507|7748190|FG001|Overall Study|Study terminated by Sponsor|1
4771283|NCT02964507|7748191|FG002|Overall Study|Study terminated by Sponsor|9
4771284|NCT02964507|7748192|FG003|Overall Study|Study terminated by Sponsor|3
4771285|NCT02964507|7748193|FG004|Overall Study|Study terminated by Sponsor|3
4627976|NCT01856309|7494839|FG001|Overall Study|Lost to Follow-up|2
4627977|NCT01856309|7494840|FG002|Overall Study|Lost to Follow-up|4
4771286|NCT02964507|7748194|FG005|Overall Study|Study terminated by Sponsor|2
4771287|NCT02964507|7748195|FG006|Overall Study|Study terminated by Sponsor|0
4771288|NCT02964507|7748196|FG007|Overall Study|Study terminated by Sponsor|0
4771289|NCT02964507|7748189|FG000|Overall Study|Other|3
4771290|NCT02964507|7748190|FG001|Overall Study|Other|0
4771291|NCT02964507|7748191|FG002|Overall Study|Other|0
4771292|NCT02964507|7748192|FG003|Overall Study|Other|0
4706255|NCT02154529|7626376|FG000|Overall Study|Death|1
4706256|NCT02154529|7626377|FG001|Overall Study|Death|1
4706257|NCT02154529|7626378|FG002|Overall Study|Death|5
4706258|NCT02154529|7626379|FG003|Overall Study|Death|1
4706259|NCT02154529|7626376|FG000|Overall Study|Termination of study by sponsor|2
4706260|NCT02154529|7626377|FG001|Overall Study|Termination of study by sponsor|2
4706261|NCT02154529|7626378|FG002|Overall Study|Termination of study by sponsor|3
4706262|NCT02154529|7626379|FG003|Overall Study|Termination of study by sponsor|1
4706263|NCT02154529|7626376|FG000|Overall Study|Lost to Follow-up|1
4706264|NCT02154529|7626377|FG001|Overall Study|Lost to Follow-up|0
4706265|NCT02154529|7626378|FG002|Overall Study|Lost to Follow-up|0
4706266|NCT02154529|7626379|FG003|Overall Study|Lost to Follow-up|0
4706267|NCT01590628|7626393|FG000|Overall Study|Death|2
4706268|NCT01590628|7626394|FG001|Overall Study|Death|0
4706269|NCT00788125|7626404|FG000|Overall Study|Death|6
4735572|NCT03535194|7683722|FG001|Induction Period|Protocol Violation|0
4735573|NCT03535194|7683723|FG002|Induction Period|Protocol Violation|0
4735574|NCT03535194|7683724|FG003|Induction Period|Protocol Violation|1
4735575|NCT03535194|7683725|FG004|Induction Period|Protocol Violation|0
4735576|NCT03535194|7683721|FG000|Induction Period|Screen Failure|0
4735577|NCT03535194|7683722|FG001|Induction Period|Screen Failure|1
4735578|NCT03535194|7683723|FG002|Induction Period|Screen Failure|0
4735579|NCT03535194|7683724|FG003|Induction Period|Screen Failure|0
4387857|NCT00049517|7166193|FG001|Conditioning/Transplant|Reasons not reported|31
4387858|NCT00049517|7166194|FG002|Conditioning/Transplant|Reasons not reported|18
4387859|NCT00049517|7166195|FG003|Conditioning/Transplant|Reasons not reported|15
4387860|NCT00049517|7166196|FG004|Conditioning/Transplant|Reasons not reported|5
4735580|NCT03535194|7683725|FG004|Induction Period|Screen Failure|0
4735581|NCT03535194|7683721|FG000|Induction Period|Withdrawal by Subject|3
4735582|NCT03535194|7683722|FG001|Induction Period|Withdrawal by Subject|4
4735583|NCT03535194|7683723|FG002|Induction Period|Withdrawal by Subject|3
4735584|NCT03535194|7683724|FG003|Induction Period|Withdrawal by Subject|2
4735585|NCT03535194|7683725|FG004|Induction Period|Withdrawal by Subject|0
4735586|NCT03535194|7683721|FG000|Maintenance Period|Adverse Event|6
4735587|NCT03535194|7683722|FG001|Maintenance Period|Adverse Event|5
4735588|NCT03535194|7683723|FG002|Maintenance Period|Adverse Event|1
4735589|NCT03535194|7683724|FG003|Maintenance Period|Adverse Event|11
4735590|NCT03535194|7683725|FG004|Maintenance Period|Adverse Event|4
4735591|NCT03535194|7683721|FG000|Maintenance Period|Lack of Efficacy|3
4387861|NCT00049517|7166197|FG005|Conditioning/Transplant|Reasons not reported|5
4387862|NCT00049530|7166205|FG000|Overall Study|Lack of Efficacy|25
4387863|NCT00049530|7166205|FG000|Overall Study|Adverse Event|2
4387864|NCT00049530|7166205|FG000|Overall Study|Death|1
4387865|NCT00049530|7166205|FG000|Overall Study|symptomatic deterioration|1
4387866|NCT00049530|7166205|FG000|Overall Study|ineligible|3
4387867|NCT00049543|7166211|FG000|Overall Study|still on treatment|2
4387868|NCT00049543|7166212|FG001|Overall Study|still on treatment|9
4510649|NCT00922207|7319545|FG001|Overall Study|Adverse Event/Intercurrent Illness|0
4510650|NCT00922207|7319546|FG002|Overall Study|Adverse Event/Intercurrent Illness|0
4510651|NCT00922207|7319544|FG000|Overall Study|Insufficient Therapeutic Response|0
4510652|NCT00922207|7319545|FG001|Overall Study|Insufficient Therapeutic Response|0
4510653|NCT00922207|7319546|FG002|Overall Study|Insufficient Therapeutic Response|1
4510654|NCT00922207|7319544|FG000|Overall Study|Violation of Selection Criteria at Entry|0
4510655|NCT00922207|7319545|FG001|Overall Study|Violation of Selection Criteria at Entry|1
4510656|NCT00922207|7319546|FG002|Overall Study|Violation of Selection Criteria at Entry|0
4510657|NCT00922207|7319544|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1
4510658|NCT00922207|7319545|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0
4510659|NCT00922207|7319546|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0
4510660|NCT00922207|7319544|FG000|Overall Study|Withdrew Consent|2
4510661|NCT00922207|7319545|FG001|Overall Study|Withdrew Consent|5
4735592|NCT03535194|7683722|FG001|Maintenance Period|Lack of Efficacy|2
4735593|NCT03535194|7683723|FG002|Maintenance Period|Lack of Efficacy|5
4735594|NCT03535194|7683724|FG003|Maintenance Period|Lack of Efficacy|9
4735595|NCT03535194|7683725|FG004|Maintenance Period|Lack of Efficacy|0
4735596|NCT03535194|7683721|FG000|Maintenance Period|Lost to Follow-up|4
4735597|NCT03535194|7683722|FG001|Maintenance Period|Lost to Follow-up|2
4735598|NCT03535194|7683723|FG002|Maintenance Period|Lost to Follow-up|1
4735599|NCT03535194|7683724|FG003|Maintenance Period|Lost to Follow-up|5
4735600|NCT03535194|7683725|FG004|Maintenance Period|Lost to Follow-up|2
4735601|NCT03535194|7683721|FG000|Maintenance Period|Other|1
4735602|NCT03535194|7683722|FG001|Maintenance Period|Other|2
4735603|NCT03535194|7683723|FG002|Maintenance Period|Other|0
4735604|NCT03535194|7683724|FG003|Maintenance Period|Other|0
4735605|NCT03535194|7683725|FG004|Maintenance Period|Other|0
4735606|NCT03535194|7683721|FG000|Maintenance Period|Physician Decision|1
4735607|NCT03535194|7683722|FG001|Maintenance Period|Physician Decision|2
4735608|NCT03535194|7683723|FG002|Maintenance Period|Physician Decision|0
4706270|NCT02777554|7626410|FG000|Overall Study|Adverse Event|4
4706271|NCT02777554|7626411|FG001|Overall Study|Adverse Event|4
4706272|NCT02777554|7626412|FG002|Overall Study|Adverse Event|0
4706273|NCT02777554|7626413|FG003|Overall Study|Adverse Event|1
4706274|NCT02777554|7626414|FG004|Overall Study|Adverse Event|0
4706275|NCT02777554|7626415|FG005|Overall Study|Adverse Event|0
4706276|NCT02777554|7626410|FG000|Overall Study|Withdrawal by Subject|3
4706277|NCT02777554|7626411|FG001|Overall Study|Withdrawal by Subject|1
4706278|NCT02777554|7626412|FG002|Overall Study|Withdrawal by Subject|1
4706279|NCT02777554|7626413|FG003|Overall Study|Withdrawal by Subject|0
4706280|NCT02777554|7626414|FG004|Overall Study|Withdrawal by Subject|0
4706281|NCT02777554|7626415|FG005|Overall Study|Withdrawal by Subject|0
4706282|NCT02777554|7626410|FG000|Overall Study|Discharged early due to hurricane|22
4706283|NCT02777554|7626411|FG001|Overall Study|Discharged early due to hurricane|20
4706284|NCT02777554|7626412|FG002|Overall Study|Discharged early due to hurricane|0
4706285|NCT02777554|7626413|FG003|Overall Study|Discharged early due to hurricane|0
4706286|NCT02777554|7626414|FG004|Overall Study|Discharged early due to hurricane|0
4706287|NCT02777554|7626415|FG005|Overall Study|Discharged early due to hurricane|0
4706288|NCT02777554|7626410|FG000|Overall Study|Other - Miscellaneous|1
4706289|NCT02777554|7626411|FG001|Overall Study|Other - Miscellaneous|0
4706290|NCT02777554|7626412|FG002|Overall Study|Other - Miscellaneous|0
4706291|NCT02777554|7626413|FG003|Overall Study|Other - Miscellaneous|0
4706292|NCT02777554|7626414|FG004|Overall Study|Other - Miscellaneous|0
4706293|NCT02777554|7626415|FG005|Overall Study|Other - Miscellaneous|0
4706294|NCT02777827|7626452|FG000|Washout Between Periods 3 and 4|Protocol Violation|0
4706295|NCT02777827|7626453|FG001|Washout Between Periods 3 and 4|Protocol Violation|0
4706296|NCT02777827|7626454|FG002|Washout Between Periods 3 and 4|Protocol Violation|1
4706297|NCT02777827|7626455|FG003|Washout Between Periods 3 and 4|Protocol Violation|0
4706298|NCT02777827|7626456|FG004|Washout Between Periods 3 and 4|Protocol Violation|0
4706299|NCT02777827|7626457|FG005|Washout Between Periods 3 and 4|Protocol Violation|0
4706300|NCT02777918|7626473|FG000|Overall Study|Medical reasons|1
4706301|NCT02777918|7626474|FG001|Overall Study|Medical reasons|2
4706302|NCT02777918|7626473|FG000|Overall Study|Too busy / stressed|1
4387869|NCT00049673|7166220|FG000|Overall Study|No receive treatment/lost to follow-up|1
4387870|NCT00049673|7166221|FG001|Overall Study|No receive treatment/lost to follow-up|3
4387871|NCT00049842|7166229|FG000|Treatment Phase|Adverse Event|47
4387872|NCT00049842|7166230|FG001|Treatment Phase|Adverse Event|12
4387873|NCT00049842|7166229|FG000|Treatment Phase|Withdrawal by Subject|35
4387874|NCT00049842|7166230|FG001|Treatment Phase|Withdrawal by Subject|46
4387875|NCT00049842|7166229|FG000|Treatment Phase|Non-compliance with protocol|7
4387876|NCT00049842|7166230|FG001|Treatment Phase|Non-compliance with protocol|8
4387877|NCT00049842|7166229|FG000|Treatment Phase|Lost to Follow-up|4
4387878|NCT00049842|7166230|FG001|Treatment Phase|Lost to Follow-up|8
4387879|NCT00049842|7166229|FG000|Treatment Phase|Administrative|0
4387880|NCT00049842|7166230|FG001|Treatment Phase|Administrative|3
4387881|NCT00049842|7166229|FG000|Treatment Phase|Did not meet protocol eligibility|0
4387882|NCT00049842|7166230|FG001|Treatment Phase|Did not meet protocol eligibility|1
4387883|NCT00049842|7166229|FG000|Follow-up Phase|Adverse Event|6
4387884|NCT00049842|7166230|FG001|Follow-up Phase|Adverse Event|1
4387885|NCT00049842|7166229|FG000|Follow-up Phase|Other|1
4387886|NCT00049842|7166230|FG001|Follow-up Phase|Other|4
4387887|NCT00050011|7166238|FG000|Overall Study|Adverse Event|41
4387888|NCT00050011|7166239|FG001|Overall Study|Adverse Event|46
4706303|NCT02777918|7626474|FG001|Overall Study|Too busy / stressed|1
4706304|NCT02777918|7626473|FG000|Overall Study|Withdrawal by Subject|1
4706305|NCT02777918|7626474|FG001|Overall Study|Withdrawal by Subject|1
4706306|NCT02777970|7626501|FG000|Overall Study|Lost to Follow-up|0
4706307|NCT02777970|7626502|FG001|Overall Study|Lost to Follow-up|1
4706308|NCT02777970|7626503|FG002|Overall Study|Lost to Follow-up|0
4706309|NCT02777970|7626501|FG000|Overall Study|Protocol Violation|1
4706310|NCT02777970|7626502|FG001|Overall Study|Protocol Violation|0
4706311|NCT02777970|7626503|FG002|Overall Study|Protocol Violation|0
4706312|NCT02778074|7626515|FG000|Overall Study|Lost to Follow-up|7
4706313|NCT02778074|7626516|FG001|Overall Study|Lost to Follow-up|10
4706314|NCT02778100|7626524|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1
4706315|NCT02778100|7626525|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0
4706316|NCT02778555|7626555|FG000|Overall Study|Withdrawal by Subject|55
4706317|NCT02778555|7626556|FG001|Overall Study|Withdrawal by Subject|32
4706318|NCT02778555|7626557|FG002|Overall Study|Withdrawal by Subject|107
4706319|NCT02778867|7626567|FG000|Phase 1|Withdrawal by Subject|2
4706320|NCT02778867|7626568|FG001|Phase 1|Withdrawal by Subject|3
4706321|NCT02778867|7626569|FG002|Phase 1|Withdrawal by Subject|0
4706322|NCT02778867|7626570|FG003|Phase 1|Withdrawal by Subject|0
4387889|NCT00050011|7166238|FG000|Overall Study|Abnormal laboratory value(s)|1
4510662|NCT00922207|7319546|FG002|Overall Study|Withdrew Consent|2
4706323|NCT02778867|7626567|FG000|Phase 2|Withdrawal by Subject|0
4706324|NCT02778867|7626568|FG001|Phase 2|Withdrawal by Subject|0
4706325|NCT02778867|7626569|FG002|Phase 2|Withdrawal by Subject|1
4706326|NCT02778867|7626570|FG003|Phase 2|Withdrawal by Subject|0
4706327|NCT02778867|7626567|FG000|Phase 2|Physician Decision|0
4706328|NCT02778867|7626568|FG001|Phase 2|Physician Decision|0
4706329|NCT02778867|7626569|FG002|Phase 2|Physician Decision|0
4706330|NCT02778867|7626570|FG003|Phase 2|Physician Decision|1
4706331|NCT02778867|7626567|FG000|Phase 2|Adverse Event|0
4706332|NCT02778867|7626568|FG001|Phase 2|Adverse Event|0
4706333|NCT02778867|7626569|FG002|Phase 2|Adverse Event|0
4706334|NCT02778867|7626570|FG003|Phase 2|Adverse Event|1
4706335|NCT02779075|7626600|FG000|Overall Study|Withdrawal by Subject|1
4706336|NCT02779075|7626601|FG001|Overall Study|Withdrawal by Subject|3
4706337|NCT02779075|7626600|FG000|Overall Study|IV lost during 2nd study|1
4706338|NCT02779075|7626601|FG001|Overall Study|IV lost during 2nd study|0
4706339|NCT02780115|7626648|FG000|Overall Study|Withdrawal by Subject|0
4706340|NCT02780115|7626649|FG001|Overall Study|Withdrawal by Subject|1
4706341|NCT02780115|7626650|FG002|Overall Study|Withdrawal by Subject|1
4706342|NCT02780115|7626651|FG003|Overall Study|Withdrawal by Subject|0
4706343|NCT02780115|7626652|FG004|Overall Study|Withdrawal by Subject|0
4706344|NCT02780115|7626648|FG000|Overall Study|Adverse Event|0
4706345|NCT02780115|7626649|FG001|Overall Study|Adverse Event|0
4706346|NCT02780115|7626650|FG002|Overall Study|Adverse Event|0
4706347|NCT02780115|7626651|FG003|Overall Study|Adverse Event|1
4387890|NCT00050011|7166239|FG001|Overall Study|Abnormal laboratory value(s)|1
4387891|NCT00050011|7166238|FG000|Overall Study|Abnormal test procedure results|0
4387892|NCT00050011|7166239|FG001|Overall Study|Abnormal test procedure results|1
4387893|NCT00050011|7166238|FG000|Overall Study|Lack of Efficacy|16
4387894|NCT00050011|7166239|FG001|Overall Study|Lack of Efficacy|21
4387895|NCT00050011|7166238|FG000|Overall Study|Participant condition no longer required|1
4387896|NCT00050011|7166239|FG001|Overall Study|Participant condition no longer required|0
4387897|NCT00050011|7166238|FG000|Overall Study|Protocol Violation|4
4387898|NCT00050011|7166239|FG001|Overall Study|Protocol Violation|10
4387899|NCT00050011|7166238|FG000|Overall Study|Withdrawal by Subject|34
4387900|NCT00050011|7166239|FG001|Overall Study|Withdrawal by Subject|26
4387901|NCT00050011|7166238|FG000|Overall Study|Lost to Follow-up|7
4387902|NCT00050011|7166239|FG001|Overall Study|Lost to Follow-up|9
4387903|NCT00050011|7166238|FG000|Overall Study|Administrative problems|10
4387904|NCT00050011|7166239|FG001|Overall Study|Administrative problems|6
4387905|NCT00050011|7166238|FG000|Overall Study|Death|7
4387906|NCT00050011|7166239|FG001|Overall Study|Death|4
4387907|NCT00050011|7166238|FG000|Overall Study|Unknown - Reason is missing|0
4387908|NCT00050011|7166239|FG001|Overall Study|Unknown - Reason is missing|2
4387909|NCT00050167|7166269|FG000|Overall Study|not eligible not invasive|1
4387910|NCT00050167|7166270|FG001|Overall Study|not eligible not invasive|1
4387911|NCT00050622|7166276|FG000|Overall Study|Adverse Event|1
4387912|NCT00050778|7166303|FG000|Overall Study|Adverse Event|13
4387913|NCT00050778|7166304|FG001|Overall Study|Adverse Event|3
4387914|NCT00050778|7166305|FG002|Overall Study|Adverse Event|2
4387915|NCT00050778|7166303|FG000|Overall Study|Death|0
4387916|NCT00050778|7166304|FG001|Overall Study|Death|1
4387917|NCT00050778|7166305|FG002|Overall Study|Death|1
4387918|NCT00050778|7166303|FG000|Overall Study|Lack of Efficacy|16
4387919|NCT00050778|7166304|FG001|Overall Study|Lack of Efficacy|2
4387920|NCT00050778|7166305|FG002|Overall Study|Lack of Efficacy|2
4387921|NCT00050778|7166303|FG000|Overall Study|Lost to Follow-up|0
4387922|NCT00050778|7166304|FG001|Overall Study|Lost to Follow-up|2
4387923|NCT00050778|7166305|FG002|Overall Study|Lost to Follow-up|4
4387924|NCT00050778|7166303|FG000|Overall Study|Physician Decision|3
4387925|NCT00050778|7166304|FG001|Overall Study|Physician Decision|0
4387926|NCT00050778|7166305|FG002|Overall Study|Physician Decision|2
4387927|NCT00050778|7166303|FG000|Overall Study|Protocol Violation|2
4387928|NCT00050778|7166304|FG001|Overall Study|Protocol Violation|0
4387929|NCT00050778|7166305|FG002|Overall Study|Protocol Violation|1
4387930|NCT00050778|7166303|FG000|Overall Study|Withdrawal by Subject|6
4387931|NCT00050778|7166304|FG001|Overall Study|Withdrawal by Subject|8
4387932|NCT00050778|7166305|FG002|Overall Study|Withdrawal by Subject|4
4387933|NCT00050778|7166303|FG000|Overall Study|Randomized but not treated|4
4387934|NCT00050778|7166304|FG001|Overall Study|Randomized but not treated|5
4387935|NCT00050778|7166305|FG002|Overall Study|Randomized but not treated|2
4387936|NCT00050778|7166303|FG000|Overall Study|Familial and personal reasons|1
4387937|NCT00050778|7166304|FG001|Overall Study|Familial and personal reasons|0
4387938|NCT00050778|7166305|FG002|Overall Study|Familial and personal reasons|0
4387939|NCT00050960|7166317|FG000|Overall Study|Progressive Disease|137
4387940|NCT00050960|7166318|FG001|Overall Study|Progressive Disease|93
4387941|NCT00050960|7166317|FG000|Overall Study|Stable Disease|19
4387942|NCT00050960|7166318|FG001|Overall Study|Stable Disease|48
4387943|NCT00050960|7166317|FG000|Overall Study|Partial Response|14
4387944|NCT00050960|7166318|FG001|Overall Study|Partial Response|19
4387945|NCT00050960|7166317|FG000|Overall Study|Complete Response|0
4387946|NCT00050960|7166318|FG001|Overall Study|Complete Response|2
4387947|NCT00050960|7166317|FG000|Overall Study|Adverse Event|62
4387948|NCT00050960|7166318|FG001|Overall Study|Adverse Event|61
4706348|NCT02780115|7626652|FG004|Overall Study|Adverse Event|1
4706349|NCT02780167|7626669|FG000|Overall Study|Adverse Event|9
4706350|NCT02780167|7626670|FG001|Overall Study|Adverse Event|8
4387949|NCT00050960|7166317|FG000|Overall Study|Lost to Follow-up|0
4387950|NCT00050960|7166318|FG001|Overall Study|Lost to Follow-up|1
4387951|NCT00050960|7166317|FG000|Overall Study|Withdrawal by Subject|23
4387952|NCT00050960|7166318|FG001|Overall Study|Withdrawal by Subject|18
4706351|NCT02780167|7626671|FG002|Overall Study|Adverse Event|8
4706352|NCT02780167|7626672|FG003|Overall Study|Adverse Event|12
4706353|NCT02780167|7626673|FG004|Overall Study|Adverse Event|8
4706354|NCT02780167|7626669|FG000|Overall Study|Lack of Efficacy|6
4706355|NCT02780167|7626670|FG001|Overall Study|Lack of Efficacy|5
4706356|NCT02780167|7626671|FG002|Overall Study|Lack of Efficacy|6
4706357|NCT02780167|7626672|FG003|Overall Study|Lack of Efficacy|1
4706358|NCT02780167|7626673|FG004|Overall Study|Lack of Efficacy|0
4706359|NCT02780167|7626669|FG000|Overall Study|Lost to Follow-up|2
4706360|NCT02780167|7626670|FG001|Overall Study|Lost to Follow-up|0
4706361|NCT02780167|7626671|FG002|Overall Study|Lost to Follow-up|1
4706362|NCT02780167|7626672|FG003|Overall Study|Lost to Follow-up|0
4706363|NCT02780167|7626673|FG004|Overall Study|Lost to Follow-up|0
4706364|NCT02780167|7626669|FG000|Overall Study|Does not meet entrance criteria|0
4706365|NCT02780167|7626670|FG001|Overall Study|Does not meet entrance criteria|0
4706366|NCT02780167|7626671|FG002|Overall Study|Does not meet entrance criteria|1
4706367|NCT02780167|7626672|FG003|Overall Study|Does not meet entrance criteria|0
4706368|NCT02780167|7626673|FG004|Overall Study|Does not meet entrance criteria|0
4706369|NCT02780167|7626669|FG000|Overall Study|No longer meets eligibility criteria|0
4706370|NCT02780167|7626670|FG001|Overall Study|No longer meets eligibility criteria|0
4706371|NCT02780167|7626671|FG002|Overall Study|No longer meets eligibility criteria|0
4706372|NCT02780167|7626672|FG003|Overall Study|No longer meets eligibility criteria|1
4706373|NCT02780167|7626673|FG004|Overall Study|No longer meets eligibility criteria|1
4706374|NCT02780167|7626669|FG000|Overall Study|Protocol Violation|5
4706375|NCT02780167|7626670|FG001|Overall Study|Protocol Violation|5
4706376|NCT02780167|7626671|FG002|Overall Study|Protocol Violation|1
4706377|NCT02780167|7626672|FG003|Overall Study|Protocol Violation|1
4706378|NCT02780167|7626673|FG004|Overall Study|Protocol Violation|2
4706379|NCT02780167|7626669|FG000|Overall Study|Withdrawal by Subject|6
4706380|NCT02780167|7626670|FG001|Overall Study|Withdrawal by Subject|4
4387953|NCT00050960|7166317|FG000|Overall Study|Administrative|31
4387954|NCT00050960|7166318|FG001|Overall Study|Administrative|46
4387955|NCT00050960|7166317|FG000|Overall Study|Non-compliance|3
4387956|NCT00050960|7166318|FG001|Overall Study|Non-compliance|1
4387957|NCT00050960|7166317|FG000|Overall Study|Death|13
4387958|NCT00050960|7166318|FG001|Overall Study|Death|15
4387959|NCT00051025|7166330|FG000|Overall Study|Progressive Disease|1
4387960|NCT00051025|7166331|FG001|Overall Study|Progressive Disease|1
4387961|NCT00051025|7166330|FG000|Overall Study|Adverse Event|1
4387962|NCT00051025|7166331|FG001|Overall Study|Adverse Event|1
4387963|NCT00051025|7166330|FG000|Overall Study|Withdrawal by Subject|0
4387964|NCT00051025|7166331|FG001|Overall Study|Withdrawal by Subject|1
4387965|NCT00051025|7166330|FG000|Overall Study|Death|0
4387966|NCT00051025|7166331|FG001|Overall Study|Death|1
4387967|NCT00051311|7166343|FG000|Overall Study|Starting new study|0
4387968|NCT00051311|7166344|FG001|Overall Study|Starting new study|1
4387969|NCT00051311|7166343|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0
4387970|NCT00051311|7166344|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1
4387971|NCT00051311|7166343|FG000|Overall Study|Death of recipient|8
4387972|NCT00051311|7166344|FG001|Overall Study|Death of recipient|8
4387973|NCT00051311|7166343|FG000|Overall Study|Recipient taken off study|4
4387974|NCT00051311|7166344|FG001|Overall Study|Recipient taken off study|4
4387975|NCT00051363|7166350|FG000|Overall Study|Dropped Post-Rand for Any Reason|102
4387976|NCT00051363|7166351|FG001|Overall Study|Dropped Post-Rand for Any Reason|126
4387977|NCT00051363|7166350|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9
4387978|NCT00051363|7166351|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11
4387979|NCT00051363|7166350|FG000|Overall Study|Death|2
4387980|NCT00051363|7166351|FG001|Overall Study|Death|2
4387981|NCT00051363|7166350|FG000|Overall Study|Excluded Pre-Randomization|2
4387982|NCT00051363|7166351|FG001|Overall Study|Excluded Pre-Randomization|5
4387983|NCT00051558|7166359|FG000|Overall Study|Adverse Event|30
4387984|NCT00051558|7166360|FG001|Overall Study|Adverse Event|18
4387985|NCT00051558|7166359|FG000|Overall Study|Withdrawal by Subject|29
4387986|NCT00051558|7166360|FG001|Overall Study|Withdrawal by Subject|42
4387987|NCT00051558|7166359|FG000|Overall Study|Death|9
4387988|NCT00051558|7166360|FG001|Overall Study|Death|15
4387989|NCT00051558|7166359|FG000|Overall Study|Lost to Follow-up|4
4387990|NCT00051558|7166360|FG001|Overall Study|Lost to Follow-up|13
4387991|NCT00051558|7166359|FG000|Overall Study|Protocol Violation|3
4387992|NCT00051558|7166360|FG001|Overall Study|Protocol Violation|4
4387993|NCT00051558|7166359|FG000|Overall Study|Protocol Entry Criteria Unmet|1
4387994|NCT00051558|7166360|FG001|Overall Study|Protocol Entry Criteria Unmet|2
4387995|NCT00051558|7166359|FG000|Overall Study|Sponsor Decision|6
4387996|NCT00051558|7166360|FG001|Overall Study|Sponsor Decision|1
4387997|NCT00051558|7166359|FG000|Overall Study|Other|2
4387998|NCT00051558|7166360|FG001|Overall Study|Other|1
4387999|NCT00051558|7166359|FG000|Overall Study|Significant Lab Value|2
4706381|NCT02780167|7626671|FG002|Overall Study|Withdrawal by Subject|4
4706382|NCT02780167|7626672|FG003|Overall Study|Withdrawal by Subject|3
4706383|NCT02780167|7626673|FG004|Overall Study|Withdrawal by Subject|4
4706384|NCT02780167|7626669|FG000|Overall Study|Other|0
4706385|NCT02780167|7626670|FG001|Overall Study|Other|0
4706386|NCT02780167|7626671|FG002|Overall Study|Other|3
4706387|NCT02780167|7626672|FG003|Overall Study|Other|1
4388000|NCT00051558|7166360|FG001|Overall Study|Significant Lab Value|0
4706388|NCT02780167|7626673|FG004|Overall Study|Other|2
4706389|NCT02780388|7626694|FG000|Overall Study|Lost to Follow-up|0
4706390|NCT02780388|7626695|FG001|Overall Study|Lost to Follow-up|1
4706391|NCT02780388|7626696|FG002|Overall Study|Lost to Follow-up|0
4706392|NCT02780388|7626697|FG003|Overall Study|Lost to Follow-up|0
4706393|NCT02780388|7626698|FG004|Overall Study|Lost to Follow-up|0
4706394|NCT02780388|7626694|FG000|Overall Study|Withdrawal by Subject|1
4706395|NCT02780388|7626695|FG001|Overall Study|Withdrawal by Subject|1
4706396|NCT02780388|7626696|FG002|Overall Study|Withdrawal by Subject|0
4706397|NCT02780388|7626697|FG003|Overall Study|Withdrawal by Subject|0
4706398|NCT02780388|7626698|FG004|Overall Study|Withdrawal by Subject|0
4706399|NCT02780687|7626732|FG000|Overall Study|Adverse Event|1
4706400|NCT02780687|7626733|FG001|Overall Study|Adverse Event|1
4706401|NCT02780687|7626732|FG000|Overall Study|Withdrawal by Subject|2
4706402|NCT02780687|7626733|FG001|Overall Study|Withdrawal by Subject|1
4706403|NCT02780687|7626732|FG000|Overall Study|Switched to commercial program (in CTP)|2
4706404|NCT02780687|7626733|FG001|Overall Study|Switched to commercial program (in CTP)|0
4706405|NCT02780687|7626732|FG000|Overall Study|progressive disease|29
4706406|NCT02780687|7626733|FG001|Overall Study|progressive disease|6
4706407|NCT02780700|7626738|FG000|Overall Study|Progressive disease|1
4388001|NCT00051558|7166359|FG000|Overall Study|Physician Decision|5
4388002|NCT00051558|7166360|FG001|Overall Study|Physician Decision|0
4388003|NCT00051636|7166368|FG000|Period 1 - Core|Adverse Event|2
4388004|NCT00051636|7166369|FG001|Period 1 - Core|Adverse Event|2
4388005|NCT00051636|7166368|FG000|Period 1 - Core|Protocol Violation|1
4388006|NCT00051636|7166369|FG001|Period 1 - Core|Protocol Violation|0
4388007|NCT00051636|7166368|FG000|Period 1 - Core|Withdrawal by Subject|1
4388008|NCT00051636|7166369|FG001|Period 1 - Core|Withdrawal by Subject|2
4388009|NCT00051636|7166368|FG000|Period 1 - Core|Lost to Follow-up|0
4388010|NCT00051636|7166369|FG001|Period 1 - Core|Lost to Follow-up|2
4388011|NCT00051636|7166368|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5
4388012|NCT00051636|7166369|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4
4388013|NCT00051636|7166368|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12
4388014|NCT00051636|7166369|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7
4388015|NCT00051636|7166368|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9
4388016|NCT00051636|7166369|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2
4388017|NCT00051636|7166368|FG000|Period 2- Extended Observation Period|Death|4
4388018|NCT00051636|7166369|FG001|Period 2- Extended Observation Period|Death|5
4388019|NCT00051636|7166368|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40
4388020|NCT00051636|7166369|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12
4706408|NCT02780713|7626742|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0
4706409|NCT02780713|7626743|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0
4706410|NCT02780713|7626744|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2
4706411|NCT02780713|7626745|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0
4706412|NCT02780713|7626746|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0
4706413|NCT02780856|7626774|FG000|Overall Study|Lost to Follow-up|1
4706414|NCT02781311|7626798|FG000|Overall Study|Adverse Event|2
4706415|NCT02781311|7626799|FG001|Overall Study|Adverse Event|6
4706416|NCT02781311|7626800|FG002|Overall Study|Adverse Event|1
4706417|NCT02781311|7626798|FG000|Overall Study|Withdrawal of Consent|11
4706418|NCT02781311|7626799|FG001|Overall Study|Withdrawal of Consent|12
4706419|NCT02781311|7626800|FG002|Overall Study|Withdrawal of Consent|2
4706420|NCT02781311|7626798|FG000|Overall Study|Lost to Follow-up|11
4706421|NCT02781311|7626799|FG001|Overall Study|Lost to Follow-up|8
4706422|NCT02781311|7626800|FG002|Overall Study|Lost to Follow-up|1
4706423|NCT02781311|7626798|FG000|Overall Study|Non-Compliance with Study Drug|2
4706424|NCT02781311|7626799|FG001|Overall Study|Non-Compliance with Study Drug|0
4706425|NCT02781311|7626800|FG002|Overall Study|Non-Compliance with Study Drug|0
4706426|NCT02781324|7626809|FG000|Overall Study|Withdrawal by Subject|1
4706427|NCT02781324|7626810|FG001|Overall Study|Withdrawal by Subject|0
4706428|NCT02781324|7626809|FG000|Overall Study|Physician Decision|1
4706429|NCT02781324|7626810|FG001|Overall Study|Physician Decision|2
4706430|NCT02781558|7626846|FG000|Overall Study|Lost to Follow-up|2
4706431|NCT02781558|7626847|FG001|Overall Study|Lost to Follow-up|2
4706432|NCT02781558|7626846|FG000|Overall Study|Adverse Event|1
4706433|NCT02781558|7626847|FG001|Overall Study|Adverse Event|0
4706434|NCT02781818|7626891|FG000|Overall Study|Lost to Follow-up|4
4706435|NCT02781818|7626892|FG001|Overall Study|Lost to Follow-up|2
4706436|NCT02781818|7626893|FG002|Overall Study|Lost to Follow-up|1
4706437|NCT02781844|7626905|FG000|Treatment Period 1|Adverse Event|0
4706438|NCT02781844|7626906|FG001|Treatment Period 1|Adverse Event|0
4706439|NCT02781844|7626907|FG002|Treatment Period 1|Adverse Event|0
4706440|NCT02781844|7626908|FG003|Treatment Period 1|Adverse Event|0
4706441|NCT02781844|7626909|FG004|Treatment Period 1|Adverse Event|0
4706442|NCT02781844|7626910|FG005|Treatment Period 1|Adverse Event|1
4706443|NCT02781844|7626911|FG006|Treatment Period 1|Adverse Event|0
4706444|NCT02781844|7626912|FG007|Treatment Period 1|Adverse Event|0
4706445|NCT02782169|7626935|FG000|Overall Study|Lost to Follow-up|1
4706446|NCT02782169|7626936|FG001|Overall Study|Lost to Follow-up|2
4706447|NCT02782325|7626944|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4
4706448|NCT02782325|7626945|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2
4706449|NCT02782325|7626946|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0
4706450|NCT02782325|7626944|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0
4706451|NCT02782325|7626945|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0
4706452|NCT02782325|7626946|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4
4706453|NCT02782377|7626962|FG000|Overall Study|Physician Decision|5
4706454|NCT02782676|7626967|FG000|Overall Study|Lost to Follow-up|0
4706455|NCT02782676|7626968|FG001|Overall Study|Lost to Follow-up|1
4706456|NCT02782741|7626976|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0
4706457|NCT02782741|7626977|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4
4706458|NCT02782741|7626976|FG000|Blinded Treatment Period: up to Week 49|Other|0
4706459|NCT02782741|7626977|FG001|Blinded Treatment Period: up to Week 49|Other|1
4706460|NCT02782741|7626976|FG000|Open-label Long-term: Week 50 to 145|Adverse Event|2
4706461|NCT02782741|7626977|FG001|Open-label Long-term: Week 50 to 145|Adverse Event|1
4706462|NCT02782741|7626976|FG000|Open-label Long-term: Week 50 to 145|Other|1
4706463|NCT02782741|7626977|FG001|Open-label Long-term: Week 50 to 145|Other|0
4706464|NCT02782741|7626976|FG000|Open-label Long-term: Week 50 to 145|Ongoing|48
4706465|NCT02782741|7626977|FG001|Open-label Long-term: Week 50 to 145|Ongoing|43
4706466|NCT02782780|7626989|FG000|Overall Study|dropped out after randomization.|7
4706467|NCT02782780|7626990|FG001|Overall Study|dropped out after randomization.|5
4706468|NCT02782780|7626989|FG000|Overall Study|Protocol Violation|0
4706469|NCT02782780|7626990|FG001|Overall Study|Protocol Violation|2
4706470|NCT02782923|7626996|FG000|Overall Study|Lost to Follow-up|15
4706471|NCT02783066|7627009|FG000|Overall Study|Withdrawal by Subject|13
4706472|NCT02783170|7627016|FG000|Overall Study|Randomized but not Vaccinated|1
4706473|NCT02783170|7627017|FG001|Overall Study|Randomized but not Vaccinated|0
4706474|NCT02783573|7627040|FG000|Placebo-Controlled Treatment Period|Adverse Event|13
4706475|NCT02783573|7627041|FG001|Placebo-Controlled Treatment Period|Adverse Event|17
4706476|NCT02783573|7627042|FG002|Placebo-Controlled Treatment Period|Adverse Event|13
4706477|NCT02783573|7627040|FG000|Placebo-Controlled Treatment Period|Death|4
4706478|NCT02783573|7627041|FG001|Placebo-Controlled Treatment Period|Death|2
4706479|NCT02783573|7627042|FG002|Placebo-Controlled Treatment Period|Death|3
4706480|NCT02783573|7627040|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0
4706481|NCT02783573|7627041|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0
4706482|NCT02783573|7627042|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2
4706483|NCT02783573|7627040|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3
4706484|NCT02783573|7627041|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3
4706485|NCT02783573|7627042|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1
4706486|NCT02783573|7627040|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0
4706487|NCT02783573|7627041|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1
4706488|NCT02783573|7627042|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0
4706489|NCT02783573|7627040|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0
4388021|NCT00052715|7166417|FG000|Overall Study|wrong histology|1
4388022|NCT00052962|7166432|FG000|Overall Study|Not evaluable|0
4388023|NCT00052962|7166433|FG001|Overall Study|Not evaluable|2
4388024|NCT00052962|7166432|FG000|Overall Study|Not randomized/not evaluable|1
4388025|NCT00052962|7166433|FG001|Overall Study|Not randomized/not evaluable|0
4388026|NCT00053352|7166445|FG000|Overall Study|Lost to Follow-up|0
4388027|NCT00053352|7166446|FG001|Overall Study|Lost to Follow-up|1
4388028|NCT00053352|7166445|FG000|Overall Study|Physician Decision|11
4388029|NCT00053352|7166446|FG001|Overall Study|Physician Decision|1
4388030|NCT00053352|7166445|FG000|Overall Study|Withdrawal by Subject|1
4706490|NCT02783573|7627041|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1
4706491|NCT02783573|7627042|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2
4706492|NCT02783573|7627040|FG000|Placebo-Controlled Treatment Period|Physician Decision|3
4706493|NCT02783573|7627041|FG001|Placebo-Controlled Treatment Period|Physician Decision|1
4706494|NCT02783573|7627042|FG002|Placebo-Controlled Treatment Period|Physician Decision|3
4706495|NCT02783573|7627040|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1
4706496|NCT02783573|7627041|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2
4706497|NCT02783573|7627042|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0
4388031|NCT00053352|7166446|FG001|Overall Study|Withdrawal by Subject|0
4388032|NCT00053352|7166445|FG000|Overall Study|Ineligible|8
4388033|NCT00053352|7166446|FG001|Overall Study|Ineligible|8
4388034|NCT00053352|7166445|FG000|Overall Study|Disease at new site|1
4388035|NCT00053352|7166446|FG001|Overall Study|Disease at new site|0
4388036|NCT00053365|7166453|FG000|Overall Study|Incorrect cell type|1
4388037|NCT00053365|7166453|FG000|Overall Study|Platinum-sensitive interval >12 months|1
4388038|NCT00053365|7166453|FG000|Overall Study|Never treated|4
4388039|NCT00053417|7166463|FG000|Overall Study|Adverse Event|1
4388040|NCT00053417|7166464|FG001|Overall Study|Adverse Event|0
4706498|NCT02783573|7627040|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15
4706499|NCT02783573|7627041|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20
4706500|NCT02783573|7627042|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23
4706501|NCT02783573|7627040|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3
4388041|NCT00053417|7166465|FG002|Overall Study|Adverse Event|1
4706502|NCT02783573|7627041|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3
4706503|NCT02783573|7627042|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9
4706504|NCT02783573|7627040|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494
4706505|NCT02783573|7627041|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512
4706506|NCT02783573|7627042|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492
4706507|NCT02783573|7627040|FG000|Delayed-Start Period|Sponsor Decision|0
4706508|NCT02783573|7627041|FG001|Delayed-Start Period|Sponsor Decision|17
4706509|NCT02783573|7627042|FG002|Delayed-Start Period|Sponsor Decision|12
4706510|NCT02783599|7627053|FG000|Overall Study|Progressive disease|23
4706511|NCT02783599|7627053|FG000|Overall Study|Surgical Resection|10
4706512|NCT02783599|7627053|FG000|Overall Study|Adverse Event|4
4706513|NCT02783599|7627053|FG000|Overall Study|Physician Decision|2
4706514|NCT02783599|7627053|FG000|Overall Study|Death|1
4706515|NCT02783729|7627068|FG000|Overall Study|Lack of Efficacy|1
4388042|NCT00053417|7166466|FG003|Overall Study|Adverse Event|5
4388043|NCT00053417|7166463|FG000|Overall Study|Non-Compliance|0
4388044|NCT00053417|7166464|FG001|Overall Study|Non-Compliance|0
4388045|NCT00053417|7166465|FG002|Overall Study|Non-Compliance|0
4388046|NCT00053417|7166466|FG003|Overall Study|Non-Compliance|1
4388047|NCT00053417|7166463|FG000|Overall Study|Withdrawal by Subject|0
4388048|NCT00053417|7166464|FG001|Overall Study|Withdrawal by Subject|1
4388049|NCT00053417|7166465|FG002|Overall Study|Withdrawal by Subject|0
4388050|NCT00053417|7166466|FG003|Overall Study|Withdrawal by Subject|0
4388051|NCT00053417|7166463|FG000|Overall Study|Lost to Follow-up|1
4388052|NCT00053417|7166464|FG001|Overall Study|Lost to Follow-up|1
4388053|NCT00053417|7166465|FG002|Overall Study|Lost to Follow-up|0
4388054|NCT00053417|7166466|FG003|Overall Study|Lost to Follow-up|0
4388055|NCT00053846|7166542|FG000|Overall Study|Changed mind|8
4388056|NCT00053846|7166543|FG001|Overall Study|Changed mind|13
4388057|NCT00053846|7166542|FG000|Overall Study|Became too ill|8
4388058|NCT00053846|7166543|FG001|Overall Study|Became too ill|7
4388059|NCT00053846|7166542|FG000|Overall Study|Expired|5
4388060|NCT00053846|7166543|FG001|Overall Study|Expired|0
4388061|NCT00053846|7166542|FG000|Overall Study|Became ineligible|3
4388062|NCT00053846|7166543|FG001|Overall Study|Became ineligible|1
4388063|NCT00053846|7166542|FG000|Overall Study|Did not return data|1
4388064|NCT00053846|7166543|FG001|Overall Study|Did not return data|2
4388065|NCT00053846|7166542|FG000|Overall Study|Quit due to side effects|1
4388066|NCT00053846|7166543|FG001|Overall Study|Quit due to side effects|3
4388067|NCT00053846|7166542|FG000|Overall Study|Pills too large|0
4388068|NCT00053846|7166543|FG001|Overall Study|Pills too large|1
4388069|NCT00053898|7166551|FG000|Overall Study|No follow-up data from any source|9
4388070|NCT00053898|7166552|FG001|Overall Study|No follow-up data from any source|12
4388071|NCT00053898|7166551|FG000|Overall Study|Follow-up from telephone contact only|5
4388072|NCT00053898|7166552|FG001|Overall Study|Follow-up from telephone contact only|1
4388073|NCT00054132|7166569|FG000|Overall Study|Not Treated|1
4388074|NCT00054275|7166574|FG000|Overall Study|Withdrawal by Subject|4
4388075|NCT00054275|7166574|FG000|Overall Study|Adverse Event|5
4388076|NCT00054275|7166574|FG000|Overall Study|Progressive disease in cycle 1|1
4388077|NCT00054275|7166574|FG000|Overall Study|Physician Decision|1
4388078|NCT00054327|7166584|FG000|Overall Study|Engraftment failure|1
4388079|NCT00054327|7166585|FG001|Overall Study|Engraftment failure|0
4388080|NCT00054327|7166586|FG002|Overall Study|Engraftment failure|0
4388081|NCT00054327|7166587|FG003|Overall Study|Engraftment failure|0
4388082|NCT00054327|7166588|FG004|Overall Study|Engraftment failure|0
4388083|NCT00054327|7166589|FG005|Overall Study|Engraftment failure|0
4388084|NCT00054639|7166616|FG000|Overall Study|Lack of Efficacy|1
4388085|NCT00054639|7166616|FG000|Overall Study|Physician Decision|1
4388086|NCT00054691|7166629|FG000|Overall Study|Unmeasurable Disease|2
4388087|NCT00054691|7166629|FG000|Overall Study|Noncompliant|1
4388088|NCT00054704|7166635|FG000|Overall Study|Lack of Efficacy|2
4388089|NCT00054704|7166636|FG001|Overall Study|Lack of Efficacy|3
4388090|NCT00054704|7166635|FG000|Overall Study|Adverse Event|3
4388091|NCT00054704|7166636|FG001|Overall Study|Adverse Event|1
4388092|NCT00054704|7166635|FG000|Overall Study|Lost to Follow-up|0
4388093|NCT00054704|7166636|FG001|Overall Study|Lost to Follow-up|1
4388094|NCT00054717|7166644|FG000|Overall Study|Randomized but not treated|2
4388095|NCT00054717|7166645|FG001|Overall Study|Randomized but not treated|8
4388096|NCT00054717|7166644|FG000|Overall Study|Adverse Event|70
4388097|NCT00054717|7166645|FG001|Overall Study|Adverse Event|22
4388098|NCT00054717|7166644|FG000|Overall Study|Protocol Violation|18
4388099|NCT00054717|7166645|FG001|Overall Study|Protocol Violation|19
4388100|NCT00054717|7166644|FG000|Overall Study|Lost to Follow-up|23
4388101|NCT00054717|7166645|FG001|Overall Study|Lost to Follow-up|13
4388102|NCT00054717|7166644|FG000|Overall Study|Withdrawal by Subject|32
4388103|NCT00054717|7166645|FG001|Overall Study|Withdrawal by Subject|20
4706516|NCT02783729|7627069|FG001|Overall Study|Lack of Efficacy|0
4388104|NCT00054717|7166644|FG000|Overall Study|Other reason not defined above|117
4388105|NCT00054717|7166645|FG001|Overall Study|Other reason not defined above|217
4388106|NCT00055471|7166679|FG000|Period 1: Dose Escalation Period|Adverse Event|0
4388107|NCT00055471|7166680|FG001|Period 1: Dose Escalation Period|Adverse Event|1
4706517|NCT02783729|7627070|FG002|Overall Study|Lack of Efficacy|0
4706518|NCT02783729|7627071|FG003|Overall Study|Lack of Efficacy|0
4706519|NCT02783729|7627068|FG000|Overall Study|Adverse Event|2
4706520|NCT02783729|7627069|FG001|Overall Study|Adverse Event|6
4706521|NCT02783729|7627070|FG002|Overall Study|Adverse Event|2
4706522|NCT02783729|7627071|FG003|Overall Study|Adverse Event|3
4706523|NCT02783729|7627068|FG000|Overall Study|Other|1
4706524|NCT02783729|7627069|FG001|Overall Study|Other|6
4706525|NCT02783729|7627070|FG002|Overall Study|Other|2
4706526|NCT02783729|7627071|FG003|Overall Study|Other|3
4706527|NCT02783729|7627068|FG000|Overall Study|Withdrawal by Subject|2
4706528|NCT02783729|7627069|FG001|Overall Study|Withdrawal by Subject|3
4706529|NCT02783729|7627070|FG002|Overall Study|Withdrawal by Subject|1
4706530|NCT02783729|7627071|FG003|Overall Study|Withdrawal by Subject|2
4706531|NCT02783729|7627068|FG000|Overall Study|Participant's choice|2
4706532|NCT02783729|7627069|FG001|Overall Study|Participant's choice|1
4706533|NCT02783729|7627070|FG002|Overall Study|Participant's choice|2
4706534|NCT02783729|7627071|FG003|Overall Study|Participant's choice|1
4706535|NCT02783729|7627068|FG000|Overall Study|Lost to Follow-up|2
4706536|NCT02783729|7627069|FG001|Overall Study|Lost to Follow-up|1
4706537|NCT02783729|7627070|FG002|Overall Study|Lost to Follow-up|1
4706538|NCT02783729|7627071|FG003|Overall Study|Lost to Follow-up|0
4706539|NCT02783768|7627086|FG000|Overall Study|Lost to Follow-up|1
4706540|NCT02783768|7627087|FG001|Overall Study|Lost to Follow-up|0
4706541|NCT02783911|7627123|FG000|Overall Study|Lost to Follow-up|3
4706542|NCT02783911|7627124|FG001|Overall Study|Lost to Follow-up|32
4706543|NCT02784106|7627141|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3
4706544|NCT02784106|7627142|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5
4706545|NCT02784106|7627143|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0
4706546|NCT02784106|7627144|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0
4706547|NCT02784106|7627141|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2
4706548|NCT02784106|7627142|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1
4706549|NCT02784106|7627143|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
4706550|NCT02784106|7627144|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
4706551|NCT02784106|7627141|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2
4706552|NCT02784106|7627142|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0
4706553|NCT02784106|7627143|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0
4706554|NCT02784106|7627144|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0
4706555|NCT02784106|7627141|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1
4706556|NCT02784106|7627142|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
4706557|NCT02784106|7627143|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
4706558|NCT02784106|7627144|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
4706559|NCT02784106|7627141|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0
4706560|NCT02784106|7627142|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0
4706561|NCT02784106|7627143|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2
4706562|NCT02784106|7627144|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1
4706563|NCT02784106|7627141|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0
4706564|NCT02784106|7627142|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0
4706565|NCT02784106|7627143|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1
4706566|NCT02784106|7627144|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1
4706567|NCT02784431|7627170|FG000|Overall Study|Unsuccessful Implant Attempt|1
4706568|NCT02784431|7627170|FG000|Overall Study|Early Study Termination|19
4706569|NCT02784834|7627204|FG000|Overall Study|Lack of Efficacy|1
4706570|NCT02785458|7627297|FG000|1 Month|Withdrawal by Subject|2
4706571|NCT02785458|7627298|FG001|1 Month|Withdrawal by Subject|1
4706572|NCT02785458|7627297|FG000|1 Month|Lost to Follow-up|38
4706573|NCT02785458|7627298|FG001|1 Month|Lost to Follow-up|31
4706574|NCT02785458|7627297|FG000|1 Month|Deemed Ineligible|1
4706575|NCT02785458|7627298|FG001|1 Month|Deemed Ineligible|0
4706576|NCT02785458|7627297|FG000|1 Month|Completed Evaluation by Baseline|42
4706577|NCT02785458|7627298|FG001|1 Month|Completed Evaluation by Baseline|39
4706578|NCT02785458|7627297|FG000|1 Month|Partial Interview|0
4706579|NCT02785458|7627298|FG001|1 Month|Partial Interview|4
4706580|NCT02785458|7627297|FG000|3 Months|Withdrawal by Subject|3
4706581|NCT02785458|7627298|FG001|3 Months|Withdrawal by Subject|1
4706582|NCT02785458|7627297|FG000|3 Months|Lost to Follow-up|25
4706583|NCT02785458|7627298|FG001|3 Months|Lost to Follow-up|21
4706584|NCT02785458|7627297|FG000|3 Months|Completed Evaluation at 1 Month|100
4706585|NCT02785458|7627298|FG001|3 Months|Completed Evaluation at 1 Month|89
4706586|NCT02785588|7627304|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1
4706587|NCT02785588|7627304|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1
4706588|NCT02785770|7627308|FG000|Intervention Period 2 (1 Day)|Adverse Event|0
4706589|NCT02785770|7627309|FG001|Intervention Period 2 (1 Day)|Adverse Event|1
4706590|NCT02785770|7627310|FG002|Intervention Period 2 (1 Day)|Adverse Event|0
4706591|NCT02785770|7627311|FG003|Intervention Period 2 (1 Day)|Adverse Event|0
4706592|NCT02785770|7627308|FG000|Intervention Period 2 (1 Day)|Family related obligations|0
4706593|NCT02785770|7627309|FG001|Intervention Period 2 (1 Day)|Family related obligations|0
4706594|NCT02785770|7627310|FG002|Intervention Period 2 (1 Day)|Family related obligations|1
4706595|NCT02785770|7627311|FG003|Intervention Period 2 (1 Day)|Family related obligations|0
4706596|NCT02785770|7627308|FG000|Intervention Period 3 (1 Day)|Adverse Event|0
4706597|NCT02785770|7627309|FG001|Intervention Period 3 (1 Day)|Adverse Event|0
4706598|NCT02785770|7627310|FG002|Intervention Period 3 (1 Day)|Adverse Event|0
4706599|NCT02785770|7627311|FG003|Intervention Period 3 (1 Day)|Adverse Event|1
4706600|NCT02785900|7627326|FG000|Overall Study|Study Termination by Sponsor|64
4706601|NCT02785900|7627327|FG001|Overall Study|Study Termination by Sponsor|81
4706602|NCT02785900|7627326|FG000|Overall Study|Death|46
4706603|NCT02785900|7627327|FG001|Overall Study|Death|32
4706604|NCT02785900|7627326|FG000|Overall Study|Withdrawal by Subject|4
4706605|NCT02785900|7627327|FG001|Overall Study|Withdrawal by Subject|8
4706606|NCT02785900|7627326|FG000|Overall Study|Physician Decision|3
4706607|NCT02785900|7627327|FG001|Overall Study|Physician Decision|2
4706608|NCT02785913|7627333|FG000|Overall Study|Adverse Event|5
4706609|NCT02785913|7627333|FG000|Overall Study|Death|2
4706610|NCT02785913|7627333|FG000|Overall Study|Progression|18
4706611|NCT02785913|7627333|FG000|Overall Study|Not protocol specified|1
4706612|NCT02785939|7627340|FG000|Overall Study|Progression|25
4706613|NCT02785939|7627341|FG001|Overall Study|Progression|8
4706614|NCT02785939|7627340|FG000|Overall Study|Adverse Event|3
4706615|NCT02785939|7627341|FG001|Overall Study|Adverse Event|1
4706616|NCT02785939|7627340|FG000|Overall Study|Death|1
4706617|NCT02785939|7627341|FG001|Overall Study|Death|0
4706618|NCT02785939|7627340|FG000|Overall Study|Refusal|1
4706619|NCT02785939|7627341|FG001|Overall Study|Refusal|0
4706620|NCT02785939|7627340|FG000|Overall Study|Deteriorating health|1
4388108|NCT00055471|7166681|FG002|Period 1: Dose Escalation Period|Adverse Event|2
4388109|NCT00055471|7166679|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0
4388110|NCT00055471|7166680|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0
4388111|NCT00055471|7166681|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1
4388112|NCT00055471|7166679|FG000|Period 1: Dose Escalation Period|Disease progression|0
4388113|NCT00055471|7166680|FG001|Period 1: Dose Escalation Period|Disease progression|1
4388114|NCT00055471|7166681|FG002|Period 1: Dose Escalation Period|Disease progression|0
4388115|NCT00055497|7166693|FG000|Overall Study|Adverse Event|1
4388116|NCT00055497|7166694|FG001|Overall Study|Adverse Event|1
4388117|NCT00055497|7166695|FG002|Overall Study|Adverse Event|1
4388118|NCT00055497|7166696|FG003|Overall Study|Adverse Event|28
4388119|NCT00055497|7166693|FG000|Overall Study|Withdrawal by Subject|3
4388120|NCT00055497|7166694|FG001|Overall Study|Withdrawal by Subject|1
4388121|NCT00055497|7166695|FG002|Overall Study|Withdrawal by Subject|1
4388122|NCT00055497|7166696|FG003|Overall Study|Withdrawal by Subject|15
4388123|NCT00055497|7166693|FG000|Overall Study|Lost to Follow-up|0
4388124|NCT00055497|7166694|FG001|Overall Study|Lost to Follow-up|1
4388125|NCT00055497|7166695|FG002|Overall Study|Lost to Follow-up|0
4388126|NCT00055497|7166696|FG003|Overall Study|Lost to Follow-up|5
4388127|NCT00055497|7166693|FG000|Overall Study|Protocol Violation|0
4388128|NCT00055497|7166694|FG001|Overall Study|Protocol Violation|0
4388129|NCT00055497|7166695|FG002|Overall Study|Protocol Violation|0
4388130|NCT00055497|7166696|FG003|Overall Study|Protocol Violation|3
4388131|NCT00055497|7166693|FG000|Overall Study|Lack of Efficacy|1
4388132|NCT00055497|7166694|FG001|Overall Study|Lack of Efficacy|0
4388133|NCT00055497|7166695|FG002|Overall Study|Lack of Efficacy|0
4388134|NCT00055497|7166696|FG003|Overall Study|Lack of Efficacy|27
4388135|NCT00055497|7166693|FG000|Overall Study|Administrative Reasons|0
4388136|NCT00055497|7166694|FG001|Overall Study|Administrative Reasons|0
4388137|NCT00055497|7166695|FG002|Overall Study|Administrative Reasons|0
4388138|NCT00055497|7166696|FG003|Overall Study|Administrative Reasons|1
4388139|NCT00055497|7166693|FG000|Overall Study|Other|0
4388140|NCT00055497|7166694|FG001|Overall Study|Other|0
4388141|NCT00055497|7166695|FG002|Overall Study|Other|0
4388142|NCT00055497|7166696|FG003|Overall Study|Other|11
4388143|NCT00055601|7166713|FG000|Overall Study|Protocol Violation|1
4388144|NCT00055601|7166714|FG001|Overall Study|Protocol Violation|1
4388145|NCT00055601|7166713|FG000|Overall Study|No protocol treatment received|1
4388146|NCT00055601|7166714|FG001|Overall Study|No protocol treatment received|1
4388147|NCT00056160|7166728|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35
4388148|NCT00056160|7166729|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18
4388149|NCT00056160|7166728|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57
4388150|NCT00056160|7166729|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124
4388151|NCT00056160|7166728|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3
4518354|NCT00973349|7330443|FG014|Overall Study|Protocol Violation|0
4388152|NCT00056160|7166729|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5
4388153|NCT00056160|7166728|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8
4388154|NCT00056160|7166729|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8
4388155|NCT00056160|7166728|FG000|Up to Unblinding (07 Jun 2005)|Death|2
4388156|NCT00056160|7166729|FG001|Up to Unblinding (07 Jun 2005)|Death|1
4388157|NCT00056160|7166728|FG000|Up to Unblinding (07 Jun 2005)|Other|8
4388158|NCT00056160|7166729|FG001|Up to Unblinding (07 Jun 2005)|Other|7
4388159|NCT00056160|7166728|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44
4388160|NCT00056160|7166729|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0
4706621|NCT02785939|7627341|FG001|Overall Study|Deteriorating health|0
4706622|NCT02785939|7627340|FG000|Overall Study|Not protocol specified|0
4706623|NCT02785939|7627341|FG001|Overall Study|Not protocol specified|1
4706624|NCT02786004|7627349|FG000|Overall Study|Withdrawal by Subject|0
4706625|NCT02786004|7627350|FG001|Overall Study|Withdrawal by Subject|1
4706626|NCT02786836|7627391|FG000|Overall Study|Death|1
4706627|NCT02786836|7627391|FG000|Overall Study|Lack of Efficacy|2
4706628|NCT02786836|7627391|FG000|Overall Study|Protocol Violation|3
4706629|NCT02786836|7627391|FG000|Overall Study|Withdrawal by Subject|3
4706630|NCT02786836|7627391|FG000|Overall Study|Liver Transplantation|2
4706631|NCT02786836|7627391|FG000|Overall Study|Device or Pharmacy Issues|3
4706632|NCT02786901|7627399|FG000|Overall Study|Adverse Event|1
4706633|NCT02786901|7627400|FG001|Overall Study|Adverse Event|1
4706634|NCT02786901|7627401|FG002|Overall Study|Adverse Event|2
4706635|NCT02786901|7627399|FG000|Overall Study|Physician Decision|1
4706636|NCT02786901|7627400|FG001|Overall Study|Physician Decision|0
4706637|NCT02786901|7627401|FG002|Overall Study|Physician Decision|0
4706638|NCT02786901|7627399|FG000|Overall Study|Rescue Therapy Use|71
4706639|NCT02786901|7627400|FG001|Overall Study|Rescue Therapy Use|49
4706640|NCT02786901|7627401|FG002|Overall Study|Rescue Therapy Use|33
4706641|NCT02786901|7627399|FG000|Overall Study|Subject Request/Lost to Follow up|1
4706642|NCT02786901|7627400|FG001|Overall Study|Subject Request/Lost to Follow up|5
4706643|NCT02786901|7627401|FG002|Overall Study|Subject Request/Lost to Follow up|5
4706644|NCT02786901|7627399|FG000|Overall Study|Disallowed medication|1
4706645|NCT02786901|7627400|FG001|Overall Study|Disallowed medication|1
4706646|NCT02786901|7627401|FG002|Overall Study|Disallowed medication|0
4706647|NCT02786901|7627399|FG000|Overall Study|Randomized in error|2
4706648|NCT02786901|7627400|FG001|Overall Study|Randomized in error|0
4706649|NCT02786901|7627401|FG002|Overall Study|Randomized in error|1
4706650|NCT02786927|7627409|FG000|Overall Study|Adverse Event|1
4706651|NCT02786927|7627409|FG000|Overall Study|Protocol Violation|4
4706652|NCT02786953|7627416|FG000|Overall Study|Withdrawal by Subject|3
4706653|NCT02786953|7627417|FG001|Overall Study|Withdrawal by Subject|0
4706654|NCT02786953|7627416|FG000|Overall Study|Physician Decision|0
4706655|NCT02786953|7627417|FG001|Overall Study|Physician Decision|1
4706656|NCT02787083|7627434|FG000|Overall Study|Adverse Event|1
4706657|NCT02787083|7627435|FG001|Overall Study|Adverse Event|0
4706658|NCT02787083|7627434|FG000|Overall Study|Withdrawal by Subject|2
4706659|NCT02787083|7627435|FG001|Overall Study|Withdrawal by Subject|2
4706660|NCT02787304|7627449|FG000|Overall Study|Adverse Event|9
4706661|NCT02787304|7627450|FG001|Overall Study|Adverse Event|3
4706662|NCT02787304|7627451|FG002|Overall Study|Adverse Event|8
4706663|NCT02787304|7627452|FG003|Overall Study|Adverse Event|1
4706664|NCT02787304|7627449|FG000|Overall Study|Withdrawal by Subject|1
4706665|NCT02787304|7627450|FG001|Overall Study|Withdrawal by Subject|4
4706666|NCT02787304|7627451|FG002|Overall Study|Withdrawal by Subject|0
4706667|NCT02787304|7627452|FG003|Overall Study|Withdrawal by Subject|0
4706668|NCT02787304|7627449|FG000|Overall Study|Lost to Follow-up|1
4706669|NCT02787304|7627450|FG001|Overall Study|Lost to Follow-up|0
4706670|NCT02787304|7627451|FG002|Overall Study|Lost to Follow-up|0
4706671|NCT02787304|7627452|FG003|Overall Study|Lost to Follow-up|1
4706672|NCT02787304|7627449|FG000|Overall Study|Noncompliance with study drug|0
4706673|NCT02787304|7627450|FG001|Overall Study|Noncompliance with study drug|0
4706674|NCT02787304|7627451|FG002|Overall Study|Noncompliance with study drug|1
4706675|NCT02787304|7627452|FG003|Overall Study|Noncompliance with study drug|0
4706676|NCT02787304|7627449|FG000|Overall Study|Physician Decision|0
4706677|NCT02787304|7627450|FG001|Overall Study|Physician Decision|0
4706678|NCT02787304|7627451|FG002|Overall Study|Physician Decision|1
4706679|NCT02787304|7627452|FG003|Overall Study|Physician Decision|0
4706680|NCT02787304|7627449|FG000|Overall Study|Study terminated by sponsor|25
4706681|NCT02787304|7627450|FG001|Overall Study|Study terminated by sponsor|31
4706682|NCT02787304|7627451|FG002|Overall Study|Study terminated by sponsor|31
4706683|NCT02787304|7627452|FG003|Overall Study|Study terminated by sponsor|32
4735609|NCT03535194|7683724|FG003|Maintenance Period|Physician Decision|2
4735610|NCT03535194|7683725|FG004|Maintenance Period|Physician Decision|0
4735611|NCT03535194|7683721|FG000|Maintenance Period|Pregnancy|0
4735612|NCT03535194|7683722|FG001|Maintenance Period|Pregnancy|0
4735613|NCT03535194|7683723|FG002|Maintenance Period|Pregnancy|0
4735614|NCT03535194|7683724|FG003|Maintenance Period|Pregnancy|2
4735615|NCT03535194|7683725|FG004|Maintenance Period|Pregnancy|0
4735616|NCT03535194|7683721|FG000|Maintenance Period|Protocol Violation|0
4735617|NCT03535194|7683722|FG001|Maintenance Period|Protocol Violation|1
4735618|NCT03535194|7683723|FG002|Maintenance Period|Protocol Violation|0
4735619|NCT03535194|7683724|FG003|Maintenance Period|Protocol Violation|0
4735620|NCT03535194|7683725|FG004|Maintenance Period|Protocol Violation|0
4735621|NCT03535194|7683721|FG000|Maintenance Period|Withdrawal by Subject|7
4735622|NCT03535194|7683722|FG001|Maintenance Period|Withdrawal by Subject|2
4735623|NCT03535194|7683723|FG002|Maintenance Period|Withdrawal by Subject|1
4735624|NCT03535194|7683724|FG003|Maintenance Period|Withdrawal by Subject|8
4735625|NCT03535194|7683725|FG004|Maintenance Period|Withdrawal by Subject|0
4735626|NCT03535194|7683721|FG000|Post-Treatment Followup Period|Adverse Event|4
4735627|NCT03535194|7683722|FG001|Post-Treatment Followup Period|Adverse Event|5
4735628|NCT03535194|7683723|FG002|Post-Treatment Followup Period|Adverse Event|1
4735629|NCT03535194|7683724|FG003|Post-Treatment Followup Period|Adverse Event|8
4735630|NCT03535194|7683725|FG004|Post-Treatment Followup Period|Adverse Event|0
4735631|NCT03535194|7683721|FG000|Post-Treatment Followup Period|Lack of Efficacy|3
4735632|NCT03535194|7683722|FG001|Post-Treatment Followup Period|Lack of Efficacy|4
4735633|NCT03535194|7683723|FG002|Post-Treatment Followup Period|Lack of Efficacy|5
4706684|NCT02787863|7627496|FG000|Overall Study|Death|1
4706685|NCT02787863|7627497|FG001|Overall Study|Death|0
4706686|NCT02787863|7627498|FG002|Overall Study|Death|1
4706687|NCT02787863|7627499|FG003|Overall Study|Death|0
4706688|NCT02787863|7627500|FG004|Overall Study|Death|0
4706689|NCT02787863|7627501|FG005|Overall Study|Death|0
4706690|NCT02787863|7627502|FG006|Overall Study|Death|0
4706691|NCT02787863|7627503|FG007|Overall Study|Death|0
4706692|NCT02787863|7627496|FG000|Overall Study|Withdrawal by Subject|0
4706693|NCT02787863|7627497|FG001|Overall Study|Withdrawal by Subject|1
4706694|NCT02787863|7627498|FG002|Overall Study|Withdrawal by Subject|1
4706695|NCT02787863|7627499|FG003|Overall Study|Withdrawal by Subject|0
4706696|NCT02787863|7627500|FG004|Overall Study|Withdrawal by Subject|0
4706697|NCT02787863|7627501|FG005|Overall Study|Withdrawal by Subject|0
4706698|NCT02787863|7627502|FG006|Overall Study|Withdrawal by Subject|0
4706699|NCT02787863|7627503|FG007|Overall Study|Withdrawal by Subject|0
4706700|NCT02788175|7627562|FG000|Overall Study|Protocol Violation|3
4706701|NCT02788175|7627562|FG000|Overall Study|Withdrawal by Subject|4
4706702|NCT02788175|7627562|FG000|Overall Study|Ineligible prior to study agent|6
4706703|NCT02788201|7627601|FG000|Overall Study|Death|1
4706704|NCT02788201|7627602|FG001|Overall Study|Death|1
4706705|NCT02788201|7627603|FG002|Overall Study|Death|1
4706706|NCT02788201|7627604|FG003|Overall Study|Death|1
4706707|NCT02788201|7627605|FG004|Overall Study|Death|0
4706708|NCT02788201|7627606|FG005|Overall Study|Death|1
4706709|NCT02788201|7627601|FG000|Overall Study|Ineligible|0
4706710|NCT02788201|7627602|FG001|Overall Study|Ineligible|0
4706711|NCT02788201|7627603|FG002|Overall Study|Ineligible|0
4706712|NCT02788201|7627604|FG003|Overall Study|Ineligible|0
4706713|NCT02788201|7627605|FG004|Overall Study|Ineligible|0
4706714|NCT02788201|7627606|FG005|Overall Study|Ineligible|1
4706715|NCT02788201|7627601|FG000|Overall Study|Withdrawal by Subject|0
4706716|NCT02788201|7627602|FG001|Overall Study|Withdrawal by Subject|0
4706717|NCT02788201|7627603|FG002|Overall Study|Withdrawal by Subject|0
4706718|NCT02788201|7627604|FG003|Overall Study|Withdrawal by Subject|0
4706719|NCT02788201|7627605|FG004|Overall Study|Withdrawal by Subject|0
4706720|NCT02788201|7627606|FG005|Overall Study|Withdrawal by Subject|1
4706721|NCT02788279|7627625|FG000|Overall Study|Death|62
4706722|NCT02788279|7627626|FG001|Overall Study|Death|136
4706723|NCT02788279|7627627|FG002|Overall Study|Death|72
4706724|NCT02788279|7627625|FG000|Overall Study|Withdrawal by Subject|10
4706725|NCT02788279|7627626|FG001|Overall Study|Withdrawal by Subject|15
4706726|NCT02788279|7627627|FG002|Overall Study|Withdrawal by Subject|5
4706727|NCT02788279|7627625|FG000|Overall Study|Lost to Follow-up|0
4706728|NCT02788279|7627626|FG001|Overall Study|Lost to Follow-up|3
4706729|NCT02788279|7627627|FG002|Overall Study|Lost to Follow-up|2
4706730|NCT02788279|7627625|FG000|Overall Study|Sponsor decision|18
4706731|NCT02788279|7627626|FG001|Overall Study|Sponsor decision|29
4706732|NCT02788279|7627627|FG002|Overall Study|Sponsor decision|11
4706733|NCT02788357|7627640|FG000|Overall Study|Lost to Follow-up|3
4706734|NCT02788357|7627641|FG001|Overall Study|Lost to Follow-up|0
4706735|NCT02788474|7627649|FG000|Double Blind Treatment Period|Not treated|1
4706736|NCT02788474|7627650|FG001|Double Blind Treatment Period|Not treated|0
4706737|NCT02788474|7627649|FG000|Double Blind Treatment Period|Patient's refusal|3
4706738|NCT02788474|7627650|FG001|Double Blind Treatment Period|Patient's refusal|0
4706739|NCT02788474|7627649|FG000|Double Blind Treatment Period|Adverse Event|6
4706740|NCT02788474|7627650|FG001|Double Blind Treatment Period|Adverse Event|4
4706741|NCT02788474|7627649|FG000|Open Label Treatment Period|Adverse Event|29
4706742|NCT02788474|7627650|FG001|Open Label Treatment Period|Adverse Event|9
4706743|NCT02788474|7627649|FG000|Open Label Treatment Period|Other than reason specified|1
4706744|NCT02788474|7627650|FG001|Open Label Treatment Period|Other than reason specified|0
4706745|NCT02788474|7627649|FG000|Open Label Treatment Period|Patient's refusal|1
4706746|NCT02788474|7627650|FG001|Open Label Treatment Period|Patient's refusal|3
4706747|NCT02788474|7627649|FG000|Open Label Treatment Period|Non-compliance|1
4706748|NCT02788474|7627650|FG001|Open Label Treatment Period|Non-compliance|0
4706749|NCT02788513|7627662|FG000|Overall Study|Withdrawal by Subject|3
4706750|NCT02788513|7627663|FG001|Overall Study|Withdrawal by Subject|0
4706751|NCT02788513|7627664|FG002|Overall Study|Withdrawal by Subject|2
4706752|NCT02788513|7627665|FG003|Overall Study|Withdrawal by Subject|3
4706753|NCT02788513|7627666|FG004|Overall Study|Withdrawal by Subject|1
4706754|NCT02788513|7627662|FG000|Overall Study|Lost to Follow-up|1
4706755|NCT02788513|7627663|FG001|Overall Study|Lost to Follow-up|0
4706756|NCT02788513|7627664|FG002|Overall Study|Lost to Follow-up|0
4706757|NCT02788513|7627665|FG003|Overall Study|Lost to Follow-up|0
4706758|NCT02788513|7627666|FG004|Overall Study|Lost to Follow-up|1
4706759|NCT02788513|7627662|FG000|Overall Study|Adverse Event|5
4706760|NCT02788513|7627663|FG001|Overall Study|Adverse Event|8
4706761|NCT02788513|7627664|FG002|Overall Study|Adverse Event|4
4706762|NCT02788513|7627665|FG003|Overall Study|Adverse Event|2
4706763|NCT02788513|7627666|FG004|Overall Study|Adverse Event|2
4706764|NCT02788513|7627662|FG000|Overall Study|Protocol Violation|0
4706765|NCT02788513|7627663|FG001|Overall Study|Protocol Violation|0
4706766|NCT02788513|7627664|FG002|Overall Study|Protocol Violation|1
4706767|NCT02788513|7627665|FG003|Overall Study|Protocol Violation|1
4706768|NCT02788513|7627666|FG004|Overall Study|Protocol Violation|0
4706769|NCT02788513|7627662|FG000|Overall Study|Subject decided to stop taking treatment|0
4706770|NCT02788513|7627663|FG001|Overall Study|Subject decided to stop taking treatment|0
4706771|NCT02788513|7627664|FG002|Overall Study|Subject decided to stop taking treatment|1
4706772|NCT02788513|7627665|FG003|Overall Study|Subject decided to stop taking treatment|0
4706773|NCT02788513|7627666|FG004|Overall Study|Subject decided to stop taking treatment|0
4706774|NCT02788513|7627662|FG000|Overall Study|Decision by the study team|0
4706775|NCT02788513|7627663|FG001|Overall Study|Decision by the study team|0
4706776|NCT02788513|7627664|FG002|Overall Study|Decision by the study team|0
4706777|NCT02788513|7627665|FG003|Overall Study|Decision by the study team|0
4706778|NCT02788513|7627666|FG004|Overall Study|Decision by the study team|1
4706779|NCT02788656|7627680|FG000|Overall Study|Withdrawal by Subject|1
4706780|NCT02788656|7627681|FG001|Overall Study|Withdrawal by Subject|0
4706781|NCT02788747|7627690|FG000|Overall Study|Adverse Event|1
4706782|NCT02788747|7627691|FG001|Overall Study|Adverse Event|0
4706783|NCT02788747|7627692|FG002|Overall Study|Adverse Event|0
4706784|NCT02789111|7627733|FG000|Overall Study|Withdrawal by Subject|1
4706785|NCT02789111|7627734|FG001|Overall Study|Withdrawal by Subject|4
4706786|NCT02789137|7627742|FG000|Overall Study|Dropped out/Died|58
4706787|NCT02789176|7627751|FG000|Overall Study|Death|0
4706788|NCT02789176|7627752|FG001|Overall Study|Death|0
4706789|NCT02789176|7627753|FG002|Overall Study|Death|3
4706790|NCT02789176|7627754|FG003|Overall Study|Death|0
4706791|NCT02789176|7627751|FG000|Overall Study|Withdrawal by Subject|0
4706792|NCT02789176|7627752|FG001|Overall Study|Withdrawal by Subject|0
4706793|NCT02789176|7627753|FG002|Overall Study|Withdrawal by Subject|1
4388161|NCT00056160|7166728|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87
4388162|NCT00056160|7166729|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0
4388163|NCT00056160|7166728|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3
4388164|NCT00056160|7166729|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0
4388165|NCT00056160|7166728|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11
4388166|NCT00056160|7166729|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0
4388167|NCT00056160|7166728|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5
4388168|NCT00056160|7166729|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0
4388169|NCT00056160|7166728|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21
4388170|NCT00056160|7166729|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0
4388171|NCT00056160|7166728|FG000|Final Follow-up|Transferred into expanded access study.|3
4388172|NCT00056160|7166729|FG001|Final Follow-up|Transferred into expanded access study.|0
4388173|NCT00056160|7166728|FG000|Final Follow-up|Transferred into RevAssist Program|2
4706794|NCT02789176|7627754|FG003|Overall Study|Withdrawal by Subject|0
4706795|NCT02789176|7627751|FG000|Overall Study|Lost to Follow-up|8
4706796|NCT02789176|7627752|FG001|Overall Study|Lost to Follow-up|2
4706797|NCT02789176|7627753|FG002|Overall Study|Lost to Follow-up|6
4706798|NCT02789176|7627754|FG003|Overall Study|Lost to Follow-up|1
4706799|NCT02790073|7627773|FG000|Overall Study|Death|1
4706800|NCT02790073|7627773|FG000|Overall Study|Withdrawal from HD|1
4706801|NCT02790073|7627773|FG000|Overall Study|Withdrawal by Subject|1
4706802|NCT02790437|7627783|FG000|Overall Study|Patient graft failure - nephrectomy|1
4706803|NCT02790437|7627784|FG001|Overall Study|Patient graft failure - nephrectomy|0
4706804|NCT02790437|7627783|FG000|Overall Study|Adverse Event|1
4706805|NCT02790437|7627784|FG001|Overall Study|Adverse Event|0
4706806|NCT02790437|7627783|FG000|Overall Study|Withdrawal by Subject|1
4706807|NCT02790437|7627784|FG001|Overall Study|Withdrawal by Subject|0
4706808|NCT02790606|7627806|FG000|Overall Study|Death|27
4706809|NCT02790606|7627806|FG000|Overall Study|Lost to Follow-up|4
4706810|NCT02790606|7627806|FG000|Overall Study|Physician Decision|3
4706811|NCT02790606|7627806|FG000|Overall Study|Withdrawal by Subject|1
4706812|NCT02791191|7627833|FG000|Overall Study|Adverse Event|2
4706813|NCT02791191|7627834|FG001|Overall Study|Adverse Event|4
4706814|NCT02791191|7627835|FG002|Overall Study|Adverse Event|5
4706815|NCT02791191|7627833|FG000|Overall Study|Lack of Efficacy|0
4706816|NCT02791191|7627834|FG001|Overall Study|Lack of Efficacy|1
4706817|NCT02791191|7627835|FG002|Overall Study|Lack of Efficacy|0
4706818|NCT02791191|7627833|FG000|Overall Study|Study Drug Non-Compliance|0
4706819|NCT02791191|7627834|FG001|Overall Study|Study Drug Non-Compliance|2
4706820|NCT02791191|7627835|FG002|Overall Study|Study Drug Non-Compliance|0
4706821|NCT02791191|7627833|FG000|Overall Study|Site Closed by Sponsor|1
4706822|NCT02791191|7627834|FG001|Overall Study|Site Closed by Sponsor|1
4706823|NCT02791191|7627835|FG002|Overall Study|Site Closed by Sponsor|3
4706824|NCT02791191|7627833|FG000|Overall Study|Progressive Disease|1
4706825|NCT02791191|7627834|FG001|Overall Study|Progressive Disease|0
4706826|NCT02791191|7627835|FG002|Overall Study|Progressive Disease|0
4706827|NCT02791191|7627833|FG000|Overall Study|Study Terminated by Sponsor|29
4706828|NCT02791191|7627834|FG001|Overall Study|Study Terminated by Sponsor|101
4706829|NCT02791191|7627835|FG002|Overall Study|Study Terminated by Sponsor|109
4706830|NCT02791191|7627833|FG000|Overall Study|Withdrawal by Subject|3
4706831|NCT02791191|7627834|FG001|Overall Study|Withdrawal by Subject|1
4706832|NCT02791191|7627835|FG002|Overall Study|Withdrawal by Subject|3
4706833|NCT02791191|7627833|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2
4706834|NCT02791191|7627834|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1
4706835|NCT02791191|7627835|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0
4706836|NCT02791269|7627845|FG000|Overall Study|Lost to Follow-up|0
4706837|NCT02791269|7627846|FG001|Overall Study|Lost to Follow-up|1
4706838|NCT02791438|7627878|FG000|Treatment Period|Adverse Event|1
4706839|NCT02791438|7627879|FG001|Treatment Period|Adverse Event|0
4706840|NCT02791438|7627878|FG000|Treatment Period|Withdrawal by Subject|0
4706841|NCT02791438|7627879|FG001|Treatment Period|Withdrawal by Subject|1
4706842|NCT02791438|7627878|FG000|Treatment Period|Withdrawal by Parent/Guardian|2
4706843|NCT02791438|7627879|FG001|Treatment Period|Withdrawal by Parent/Guardian|0
4706844|NCT02791490|7627887|FG000|Overall Study|Lost to Follow-up|1
4706845|NCT02791490|7627888|FG001|Overall Study|Lost to Follow-up|2
4706846|NCT02791490|7627887|FG000|Overall Study|Withdrawal by Subject|2
4706847|NCT02791490|7627888|FG001|Overall Study|Withdrawal by Subject|6
4706848|NCT02791516|7627896|FG000|Overall Study|Withdrawal by Subject|1
4706849|NCT02791516|7627897|FG001|Overall Study|Withdrawal by Subject|1
4706850|NCT02791659|7627905|FG000|Overall Study|Protocol Violation|0
4706851|NCT02791659|7627906|FG001|Overall Study|Protocol Violation|1
4706852|NCT02791763|7627915|FG000|Overall Study|Protocol Violation|0
4706853|NCT02791763|7627916|FG001|Overall Study|Protocol Violation|0
4706854|NCT02791763|7627917|FG002|Overall Study|Protocol Violation|1
4706855|NCT02791763|7627915|FG000|Overall Study|Withdrawal by Subject|5
4706856|NCT02791763|7627916|FG001|Overall Study|Withdrawal by Subject|1
4706857|NCT02791763|7627917|FG002|Overall Study|Withdrawal by Subject|0
4706858|NCT02791763|7627915|FG000|Overall Study|Physician Decision|0
4706859|NCT02791763|7627916|FG001|Overall Study|Physician Decision|1
4706860|NCT02791763|7627917|FG002|Overall Study|Physician Decision|0
4706861|NCT02791763|7627915|FG000|Overall Study|Needs maintenance/changes in dialysis|16
4706862|NCT02791763|7627916|FG001|Overall Study|Needs maintenance/changes in dialysis|19
4706863|NCT02791763|7627917|FG002|Overall Study|Needs maintenance/changes in dialysis|5
4706864|NCT02791763|7627915|FG000|Overall Study|Cancer event|1
4706865|NCT02791763|7627916|FG001|Overall Study|Cancer event|3
4706866|NCT02791763|7627917|FG002|Overall Study|Cancer event|0
4706867|NCT02791763|7627915|FG000|Overall Study|Participant had renal transplant|3
4706868|NCT02791763|7627916|FG001|Overall Study|Participant had renal transplant|0
4706869|NCT02791763|7627917|FG002|Overall Study|Participant had renal transplant|0
4706870|NCT02791763|7627915|FG000|Overall Study|Met hemoglobin stopping criteria|1
4706871|NCT02791763|7627916|FG001|Overall Study|Met hemoglobin stopping criteria|0
4706872|NCT02791763|7627917|FG002|Overall Study|Met hemoglobin stopping criteria|0
4706873|NCT02791763|7627915|FG000|Overall Study|Adverse Event|12
4706874|NCT02791763|7627916|FG001|Overall Study|Adverse Event|13
4706875|NCT02791763|7627917|FG002|Overall Study|Adverse Event|7
4706876|NCT02791893|7627936|FG000|Blinded Phase|Lost to Follow-up|2
4706877|NCT02791893|7627937|FG001|Blinded Phase|Lost to Follow-up|2
4706878|NCT02791893|7627936|FG000|Blinded Phase|Withdrawal by Subject|1
4706879|NCT02791893|7627937|FG001|Blinded Phase|Withdrawal by Subject|2
4706880|NCT02791893|7627936|FG000|Open Label Phase|Lost to Follow-up|3
4706881|NCT02791893|7627937|FG001|Open Label Phase|Lost to Follow-up|0
4706882|NCT02791893|7627936|FG000|Open Label Phase|Withdrawal by Subject|0
4706883|NCT02791893|7627937|FG001|Open Label Phase|Withdrawal by Subject|2
4706884|NCT02792062|7627980|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1
4706885|NCT02792062|7627981|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
4706886|NCT02792062|7627982|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
4706887|NCT02792062|7627983|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
4706888|NCT02792062|7627984|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
4706889|NCT02792062|7627985|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
4706890|NCT02792192|7627997|FG000|Overall Study|Death|1
4706891|NCT02792192|7627998|FG001|Overall Study|Death|0
4706892|NCT02792192|7627999|FG002|Overall Study|Death|0
4706893|NCT02792192|7628000|FG003|Overall Study|Death|0
4706894|NCT02792192|7627997|FG000|Overall Study|Informed Consent Withdrawn|4
4706895|NCT02792192|7627998|FG001|Overall Study|Informed Consent Withdrawn|0
4706896|NCT02792192|7627999|FG002|Overall Study|Informed Consent Withdrawn|0
4706897|NCT02792192|7628000|FG003|Overall Study|Informed Consent Withdrawn|0
4706898|NCT02792192|7627997|FG000|Overall Study|Physician Decision|1
4706899|NCT02792192|7627998|FG001|Overall Study|Physician Decision|0
4706900|NCT02792192|7627999|FG002|Overall Study|Physician Decision|0
4706901|NCT02792192|7628000|FG003|Overall Study|Physician Decision|0
4706902|NCT02792192|7627997|FG000|Overall Study|Progressive Disease|0
4706903|NCT02792192|7627998|FG001|Overall Study|Progressive Disease|1
4706904|NCT02792192|7627999|FG002|Overall Study|Progressive Disease|0
4706905|NCT02792192|7628000|FG003|Overall Study|Progressive Disease|0
4706906|NCT02792192|7627997|FG000|Overall Study|Study Terminated By Sponsor|6
4706907|NCT02792192|7627998|FG001|Overall Study|Study Terminated By Sponsor|10
4706908|NCT02792192|7627999|FG002|Overall Study|Study Terminated By Sponsor|0
4706909|NCT02792192|7628000|FG003|Overall Study|Study Terminated By Sponsor|0
4706910|NCT02792218|7628013|FG000|Overall Study|Patient/guardian decision|15
4706911|NCT02792218|7628014|FG001|Overall Study|Patient/guardian decision|42
4706912|NCT02792218|7628013|FG000|Overall Study|Adverse Event|15
4706913|NCT02792218|7628014|FG001|Overall Study|Adverse Event|14
4706914|NCT02792218|7628013|FG000|Overall Study|Lost to Follow-up|10
4706915|NCT02792218|7628014|FG001|Overall Study|Lost to Follow-up|5
4706916|NCT02792218|7628013|FG000|Overall Study|Lack of Efficacy|1
4706917|NCT02792218|7628014|FG001|Overall Study|Lack of Efficacy|12
4706918|NCT02792218|7628013|FG000|Overall Study|Physician Decision|4
4706919|NCT02792218|7628014|FG001|Overall Study|Physician Decision|4
4706920|NCT02792218|7628013|FG000|Overall Study|Protocol deviation|3
4706921|NCT02792218|7628014|FG001|Overall Study|Protocol deviation|2
4706922|NCT02792218|7628013|FG000|Overall Study|New therapy for study indication|0
4706923|NCT02792218|7628014|FG001|Overall Study|New therapy for study indication|1
4706924|NCT02792218|7628013|FG000|Overall Study|Non-compliance with study treatment|0
4706925|NCT02792218|7628014|FG001|Overall Study|Non-compliance with study treatment|1
4706926|NCT02792218|7628013|FG000|Overall Study|Pregnancy|1
4706927|NCT02792218|7628014|FG001|Overall Study|Pregnancy|0
4706928|NCT02792231|7628022|FG000|Overall Study|Patient/guardian decision|32
4706929|NCT02792231|7628023|FG001|Overall Study|Patient/guardian decision|42
4706930|NCT02792231|7628022|FG000|Overall Study|Adverse Event|15
4706931|NCT02792231|7628023|FG001|Overall Study|Adverse Event|11
4706932|NCT02792231|7628022|FG000|Overall Study|Physician Decision|14
4706933|NCT02792231|7628023|FG001|Overall Study|Physician Decision|12
4706934|NCT02792231|7628022|FG000|Overall Study|Lack of Efficacy|7
4706935|NCT02792231|7628023|FG001|Overall Study|Lack of Efficacy|9
4706936|NCT02792231|7628022|FG000|Overall Study|Lost to Follow-up|9
4706937|NCT02792231|7628023|FG001|Overall Study|Lost to Follow-up|5
4706938|NCT02792231|7628022|FG000|Overall Study|Pregnancy|1
4706939|NCT02792231|7628023|FG001|Overall Study|Pregnancy|3
4706940|NCT02792231|7628022|FG000|Overall Study|Non-compliance with study treatment|2
4706941|NCT02792231|7628023|FG001|Overall Study|Non-compliance with study treatment|1
4706942|NCT02792231|7628022|FG000|Overall Study|Protocol deviation|2
4706943|NCT02792231|7628023|FG001|Overall Study|Protocol deviation|0
4706944|NCT02792231|7628022|FG000|Overall Study|Technical problems|0
4706945|NCT02792231|7628023|FG001|Overall Study|Technical problems|1
4706946|NCT02792504|7628029|FG000|Overall Study|Lost to Follow-up|24
4706947|NCT02792504|7628029|FG000|Overall Study|Violated inclusion/exclusion criteria|6
4706948|NCT02792517|7628033|FG000|Overall Study|Withdrawal by Subject|10
4706949|NCT02792517|7628033|FG000|Overall Study|Decision by Sponsor|7
4706950|NCT02792517|7628033|FG000|Overall Study|Lost to Follow-up|3
4706951|NCT02792699|7628040|FG000|Overall Study|Adverse Event|1
4706952|NCT02792699|7628041|FG001|Overall Study|Adverse Event|2
4706953|NCT02792699|7628042|FG002|Overall Study|Adverse Event|4
4706954|NCT02792699|7628040|FG000|Overall Study|Withdrawal by Subject|4
4706955|NCT02792699|7628041|FG001|Overall Study|Withdrawal by Subject|4
4706956|NCT02792699|7628042|FG002|Overall Study|Withdrawal by Subject|3
4706957|NCT02792699|7628040|FG000|Overall Study|Lost to Follow-up|0
4706958|NCT02792699|7628041|FG001|Overall Study|Lost to Follow-up|1
4706959|NCT02792699|7628042|FG002|Overall Study|Lost to Follow-up|2
4706960|NCT02792699|7628040|FG000|Overall Study|Physician Decision|2
4706961|NCT02792699|7628041|FG001|Overall Study|Physician Decision|0
4706962|NCT02792699|7628042|FG002|Overall Study|Physician Decision|0
4706963|NCT02792699|7628040|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1
4706964|NCT02792699|7628041|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3
4706965|NCT02792699|7628042|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1
4706966|NCT02792699|7628040|FG000|Overall Study|Other|1
4706967|NCT02792699|7628041|FG001|Overall Study|Other|0
4388174|NCT00056160|7166729|FG001|Final Follow-up|Transferred into RevAssist Program|0
4388175|NCT00056160|7166728|FG000|Final Follow-up|Adverse Event|1
4388176|NCT00056160|7166729|FG001|Final Follow-up|Adverse Event|0
4388177|NCT00056316|7166737|FG000|Overall Study|Withdrawal by Subject|2
4388178|NCT00056316|7166738|FG001|Overall Study|Withdrawal by Subject|2
4706968|NCT02792699|7628042|FG002|Overall Study|Other|0
4706969|NCT02792777|7628059|FG000|Overall Study|Withdrawal by Subject|2
4706970|NCT02792777|7628060|FG001|Overall Study|Withdrawal by Subject|0
4706971|NCT02792777|7628059|FG000|Overall Study|Recording malfunction|2
4706972|NCT02792777|7628060|FG001|Overall Study|Recording malfunction|0
4706973|NCT02792777|7628059|FG000|Overall Study|Later determined to be ineligible|2
4706974|NCT02792777|7628060|FG001|Overall Study|Later determined to be ineligible|0
4706975|NCT02792777|7628059|FG000|Overall Study|Participant interviewed twice|1
4706976|NCT02792777|7628060|FG001|Overall Study|Participant interviewed twice|0
4706977|NCT02792829|7628075|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0
4706978|NCT02792829|7628076|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1
4706979|NCT02792829|7628077|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0
4706980|NCT02792829|7628078|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0
4706981|NCT02792829|7628079|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0
4706982|NCT02792829|7628080|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0
4706983|NCT02792829|7628081|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0
4706984|NCT02792829|7628082|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0
4706985|NCT02792829|7628075|FG000|Treatment Period 2|Adverse Event|0
4706986|NCT02792829|7628076|FG001|Treatment Period 2|Adverse Event|0
4706987|NCT02792829|7628077|FG002|Treatment Period 2|Adverse Event|0
4706988|NCT02792829|7628078|FG003|Treatment Period 2|Adverse Event|0
4388179|NCT00056316|7166737|FG000|Overall Study|Death/NH placement of pt|1
4706989|NCT02792829|7628079|FG004|Treatment Period 2|Adverse Event|1
4706990|NCT02792829|7628080|FG005|Treatment Period 2|Adverse Event|0
4706991|NCT02792829|7628081|FG006|Treatment Period 2|Adverse Event|1
4706992|NCT02792829|7628082|FG007|Treatment Period 2|Adverse Event|1
4706993|NCT02792829|7628075|FG000|Treatment Period 2|Use of proscribed medications|0
4706994|NCT02792829|7628076|FG001|Treatment Period 2|Use of proscribed medications|0
4706995|NCT02792829|7628077|FG002|Treatment Period 2|Use of proscribed medications|0
4706996|NCT02792829|7628078|FG003|Treatment Period 2|Use of proscribed medications|0
4706997|NCT02792829|7628079|FG004|Treatment Period 2|Use of proscribed medications|0
4706998|NCT02792829|7628080|FG005|Treatment Period 2|Use of proscribed medications|0
4706999|NCT02792829|7628081|FG006|Treatment Period 2|Use of proscribed medications|0
4707000|NCT02792829|7628082|FG007|Treatment Period 2|Use of proscribed medications|1
4707001|NCT02792959|7628108|FG000|Overall Study|Protocol Violation|1
4707002|NCT02793128|7628112|FG000|Overall Study|Death|4
4707003|NCT02793128|7628112|FG000|Overall Study|Withdrawal by Subject|2
4707004|NCT02793128|7628112|FG000|Overall Study|Physician Decision|1
4707005|NCT02793128|7628112|FG000|Overall Study|Comorbid conditions and noncompliance|1
4707006|NCT02793128|7628112|FG000|Overall Study|Patient elected nephroureterectomy|1
4707007|NCT02793232|7628146|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
4707008|NCT02793232|7628147|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
4388180|NCT00056316|7166738|FG001|Overall Study|Death/NH placement of pt|1
4510663|NCT00922207|7319544|FG000|Overall Study|Abnormality of Laboratory Test|0
4510664|NCT00922207|7319545|FG001|Overall Study|Abnormality of Laboratory Test|1
4510665|NCT00922207|7319546|FG002|Overall Study|Abnormality of Laboratory Test|1
4518355|NCT00973349|7330444|FG015|Overall Study|Protocol Violation|0
4518356|NCT00973349|7330429|FG000|Overall Study|Unable to classify|0
4518357|NCT00973349|7330430|FG001|Overall Study|Unable to classify|0
4518358|NCT00973349|7330431|FG002|Overall Study|Unable to classify|0
4518359|NCT00973349|7330432|FG003|Overall Study|Unable to classify|0
4518360|NCT00973349|7330433|FG004|Overall Study|Unable to classify|1
4518361|NCT00973349|7330434|FG005|Overall Study|Unable to classify|1
4518362|NCT00973349|7330435|FG006|Overall Study|Unable to classify|0
4518363|NCT00973349|7330436|FG007|Overall Study|Unable to classify|0
4518364|NCT00973349|7330437|FG008|Overall Study|Unable to classify|0
4518365|NCT00973349|7330438|FG009|Overall Study|Unable to classify|1
4518366|NCT00973349|7330439|FG010|Overall Study|Unable to classify|0
4518367|NCT00973349|7330440|FG011|Overall Study|Unable to classify|0
4518368|NCT00973349|7330441|FG012|Overall Study|Unable to classify|0
4518369|NCT00973349|7330442|FG013|Overall Study|Unable to classify|0
4518370|NCT00973349|7330443|FG014|Overall Study|Unable to classify|0
4518371|NCT00973349|7330444|FG015|Overall Study|Unable to classify|0
4518372|NCT00973362|7330472|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25
4518373|NCT00973362|7330473|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0
4518374|NCT00973362|7330472|FG000|Baseline Evaluation|No colposcopy visit|62
4518375|NCT00973362|7330473|FG001|Baseline Evaluation|No colposcopy visit|0
4518376|NCT00973362|7330472|FG000|Baseline Evaluation|Inevaluable|686
4518377|NCT00973362|7330473|FG001|Baseline Evaluation|Inevaluable|223
4518378|NCT00973362|7330472|FG000|3-Year Follow-up|Lost to Follow-up|17
4518379|NCT00973362|7330473|FG001|3-Year Follow-up|Lost to Follow-up|0
4518380|NCT00973479|7330484|FG000|Overall Study|Lost to Follow-up|0
4518381|NCT00973479|7330485|FG001|Overall Study|Lost to Follow-up|3
4518382|NCT00973479|7330484|FG000|Overall Study|Death|2
4518383|NCT00973479|7330485|FG001|Overall Study|Death|2
4518384|NCT00973479|7330484|FG000|Overall Study|Withdrawal by Subject|15
4518385|NCT00973479|7330485|FG001|Overall Study|Withdrawal by Subject|16
4518386|NCT00973479|7330484|FG000|Overall Study|Lack of Efficacy|5
4518387|NCT00973479|7330485|FG001|Overall Study|Lack of Efficacy|7
4518388|NCT00973479|7330484|FG000|Overall Study|Adverse Event|12
4518389|NCT00973479|7330485|FG001|Overall Study|Adverse Event|32
4518390|NCT00973479|7330484|FG000|Overall Study|Protocol Violation|2
4518391|NCT00973479|7330485|FG001|Overall Study|Protocol Violation|2
4518392|NCT00973479|7330484|FG000|Overall Study|Other|1
4518393|NCT00973479|7330485|FG001|Overall Study|Other|7
4518394|NCT00973622|7330495|FG000|Overall Study|did not attend MRI|14
4518395|NCT00973622|7330496|FG001|Overall Study|did not attend MRI|3
4518396|NCT00973622|7330495|FG000|Overall Study|did not pass MRI screen|6
4518397|NCT00973622|7330496|FG001|Overall Study|did not pass MRI screen|0
4518398|NCT00973622|7330495|FG000|Overall Study|did not complete rTMS sessions|11
4518399|NCT00973622|7330496|FG001|Overall Study|did not complete rTMS sessions|2
4518400|NCT00973674|7330504|FG000|Overall Study|Protocol Violation|2
4518401|NCT00973674|7330505|FG001|Overall Study|Protocol Violation|0
4518402|NCT00973700|7330517|FG000|Overall Study|Withdrawal by Subject|2
4518403|NCT00973700|7330518|FG001|Overall Study|Withdrawal by Subject|2
4518404|NCT00973700|7330519|FG002|Overall Study|Withdrawal by Subject|8
4518405|NCT00973700|7330520|FG003|Overall Study|Withdrawal by Subject|4
4518406|NCT00973700|7330521|FG004|Overall Study|Withdrawal by Subject|4
4518407|NCT00973700|7330517|FG000|Overall Study|Lost to Follow-up|5
4518408|NCT00973700|7330518|FG001|Overall Study|Lost to Follow-up|0
4518409|NCT00973700|7330519|FG002|Overall Study|Lost to Follow-up|1
4518410|NCT00973700|7330520|FG003|Overall Study|Lost to Follow-up|8
4518411|NCT00973700|7330521|FG004|Overall Study|Lost to Follow-up|5
4518412|NCT00973700|7330517|FG000|Overall Study|Inappropriate enrolment|0
4518413|NCT00973700|7330518|FG001|Overall Study|Inappropriate enrolment|0
4518414|NCT00973700|7330519|FG002|Overall Study|Inappropriate enrolment|0
4518415|NCT00973700|7330520|FG003|Overall Study|Inappropriate enrolment|4
4518416|NCT00973700|7330521|FG004|Overall Study|Inappropriate enrolment|0
4518417|NCT00973700|7330517|FG000|Overall Study|Unable to Classify|0
4707009|NCT02793232|7628148|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
4707010|NCT02793232|7628149|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
4388181|NCT00056407|7166746|FG000|Overall Study|Adverse Event|282
4627978|NCT01856309|7494841|FG003|Overall Study|Lost to Follow-up|8
4627979|NCT01856309|7494838|FG000|Overall Study|Withdrawal by Subject|11
4707011|NCT02793232|7628150|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1
4707012|NCT02793232|7628151|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
4707013|NCT02793232|7628152|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1
4707014|NCT02793232|7628153|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
4707015|NCT02793232|7628154|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
4707016|NCT02793622|7628190|FG000|Overall Study|Lost to Follow-up|31
4707017|NCT02793622|7628191|FG001|Overall Study|Lost to Follow-up|19
4707018|NCT02793622|7628190|FG000|Overall Study|Withdrawal by Subject|21
4707019|NCT02793622|7628191|FG001|Overall Study|Withdrawal by Subject|17
4707020|NCT02793622|7628190|FG000|Overall Study|Adverse Event|0
4707021|NCT02793622|7628191|FG001|Overall Study|Adverse Event|1
4707022|NCT02793622|7628190|FG000|Overall Study|Protocol Violation|1
4707023|NCT02793622|7628191|FG001|Overall Study|Protocol Violation|5
4707024|NCT02793947|7628268|FG000|Overall Study|Death|1
4707025|NCT02793947|7628269|FG001|Overall Study|Death|0
4707026|NCT02793947|7628268|FG000|Overall Study|Physician Decision|1
4707027|NCT02793947|7628269|FG001|Overall Study|Physician Decision|5
4707028|NCT02794103|7628275|FG000|Overall Study|Loss to follow up due to high sedation|3
4707029|NCT02794246|7628287|FG000|Overall Study|Withdrawal by Subject|2
4707030|NCT02794246|7628287|FG000|Overall Study|Physician Decision|4
4707031|NCT02794480|7628302|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
4707032|NCT02794480|7628303|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
4707033|NCT02794480|7628304|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1
4707034|NCT02794480|7628305|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
4707035|NCT02794480|7628302|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
4707036|NCT02794480|7628303|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
4707037|NCT02794480|7628304|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1
4707038|NCT02794480|7628305|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
4707039|NCT02794480|7628302|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
4707040|NCT02794480|7628303|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
4707041|NCT02794480|7628304|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
4707042|NCT02794480|7628305|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2
4707043|NCT02794480|7628302|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4707044|NCT02794480|7628303|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2
4707045|NCT02794480|7628304|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4707046|NCT02794480|7628305|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1
4707047|NCT02794480|7628302|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1
4707048|NCT02794480|7628303|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0
4707049|NCT02794480|7628304|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0
4707050|NCT02794480|7628305|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1
4707051|NCT02794870|7628353|FG000|Overall Study|Withdrawal by Subject|2
4707052|NCT02794870|7628354|FG001|Overall Study|Withdrawal by Subject|0
4707053|NCT02794974|7628362|FG000|Overall Study|Physician Decision|0
4707054|NCT02794974|7628363|FG001|Overall Study|Physician Decision|1
4707055|NCT02795767|7628385|FG000|Overall Study|Received Commercial Emicizumab|1
4707056|NCT02795767|7628386|FG001|Overall Study|Received Commercial Emicizumab|0
4707057|NCT02795767|7628387|FG002|Overall Study|Received Commercial Emicizumab|0
4707058|NCT02795832|7628432|FG000|Overall Study|Adverse Event|0
4707059|NCT02795832|7628433|FG001|Overall Study|Adverse Event|0
4707060|NCT02795832|7628434|FG002|Overall Study|Adverse Event|0
4707061|NCT02795832|7628435|FG003|Overall Study|Adverse Event|0
4707062|NCT02795832|7628436|FG004|Overall Study|Adverse Event|0
4707063|NCT02795832|7628437|FG005|Overall Study|Adverse Event|3
4707064|NCT02796560|7628502|FG000|Overall Study|Adverse Event|2
4627980|NCT01856309|7494839|FG001|Overall Study|Withdrawal by Subject|13
4627981|NCT01856309|7494840|FG002|Overall Study|Withdrawal by Subject|28
4627982|NCT01856309|7494841|FG003|Overall Study|Withdrawal by Subject|26
4627983|NCT01856309|7494838|FG000|Overall Study|Other|227
4627984|NCT01856309|7494839|FG001|Overall Study|Other|225
4627985|NCT01856309|7494840|FG002|Overall Study|Other|447
4627986|NCT01856309|7494841|FG003|Overall Study|Other|469
4627987|NCT01856309|7494838|FG000|Overall Study|Lack of Efficacy|14
4627988|NCT01856309|7494839|FG001|Overall Study|Lack of Efficacy|9
4627989|NCT01856309|7494840|FG002|Overall Study|Lack of Efficacy|40
4627990|NCT01856309|7494841|FG003|Overall Study|Lack of Efficacy|25
4627991|NCT01856309|7494838|FG000|Overall Study|Adverse Event|31
4627992|NCT01856309|7494839|FG001|Overall Study|Adverse Event|31
4627993|NCT01856309|7494840|FG002|Overall Study|Adverse Event|55
4627994|NCT01856309|7494841|FG003|Overall Study|Adverse Event|65
4627995|NCT01856309|7494838|FG000|Overall Study|Pregnancy|0
4627996|NCT01856309|7494839|FG001|Overall Study|Pregnancy|0
4627997|NCT01856309|7494840|FG002|Overall Study|Pregnancy|0
4627998|NCT01856309|7494841|FG003|Overall Study|Pregnancy|1
4627999|NCT01856309|7494838|FG000|Overall Study|Physician Decision|6
4628000|NCT01856309|7494839|FG001|Overall Study|Physician Decision|1
4628001|NCT01856309|7494840|FG002|Overall Study|Physician Decision|6
4707065|NCT02796560|7628503|FG001|Overall Study|Adverse Event|0
4707066|NCT02796560|7628502|FG000|Overall Study|Withdrawal by Subject|2
4707067|NCT02796560|7628503|FG001|Overall Study|Withdrawal by Subject|2
4707068|NCT02796651|7628513|FG000|Overall Study|Adverse Event|6
4707069|NCT02796651|7628513|FG000|Overall Study|Lost to Follow-up|1
4707070|NCT02796651|7628513|FG000|Overall Study|Withdrawal by Subject|4
4707071|NCT02796651|7628513|FG000|Overall Study|Protocol Violation|4
4707072|NCT02796651|7628513|FG000|Overall Study|Lack of Efficacy|1
4707073|NCT02796651|7628513|FG000|Overall Study|Other|10
4707074|NCT02796664|7628530|FG000|Overall Study|Withdrawal by Subject|0
4707075|NCT02796664|7628531|FG001|Overall Study|Withdrawal by Subject|3
4707076|NCT02796664|7628530|FG000|Overall Study|Noncompliance|1
4707077|NCT02796664|7628531|FG001|Overall Study|Noncompliance|1
4707078|NCT02796664|7628530|FG000|Overall Study|Death|0
4707079|NCT02796664|7628531|FG001|Overall Study|Death|1
4707080|NCT02796677|7628543|FG000|Overall Study|Adverse Event|11
4707081|NCT02796677|7628544|FG001|Overall Study|Adverse Event|22
4707082|NCT02796677|7628545|FG002|Overall Study|Adverse Event|14
4707083|NCT02796677|7628546|FG003|Overall Study|Adverse Event|14
4707084|NCT02796677|7628543|FG000|Overall Study|Protocol Violation|7
4707085|NCT02796677|7628544|FG001|Overall Study|Protocol Violation|5
4707086|NCT02796677|7628545|FG002|Overall Study|Protocol Violation|4
4707087|NCT02796677|7628546|FG003|Overall Study|Protocol Violation|8
4707088|NCT02796677|7628543|FG000|Overall Study|Lost to Follow-up|1
4707089|NCT02796677|7628544|FG001|Overall Study|Lost to Follow-up|5
4707090|NCT02796677|7628545|FG002|Overall Study|Lost to Follow-up|2
4707091|NCT02796677|7628546|FG003|Overall Study|Lost to Follow-up|2
4707092|NCT02796677|7628543|FG000|Overall Study|Lack of Efficacy|7
4707093|NCT02796677|7628544|FG001|Overall Study|Lack of Efficacy|9
4707094|NCT02796677|7628545|FG002|Overall Study|Lack of Efficacy|14
4707095|NCT02796677|7628546|FG003|Overall Study|Lack of Efficacy|20
4707096|NCT02796677|7628543|FG000|Overall Study|Withdrawal by Subject|4
4707097|NCT02796677|7628544|FG001|Overall Study|Withdrawal by Subject|14
4707098|NCT02796677|7628545|FG002|Overall Study|Withdrawal by Subject|6
4707099|NCT02796677|7628546|FG003|Overall Study|Withdrawal by Subject|7
4707100|NCT02796677|7628543|FG000|Overall Study|Progressive disease|6
4707101|NCT02796677|7628544|FG001|Overall Study|Progressive disease|15
4707102|NCT02796677|7628545|FG002|Overall Study|Progressive disease|13
4707103|NCT02796677|7628546|FG003|Overall Study|Progressive disease|18
4707104|NCT02796677|7628543|FG000|Overall Study|Reason not mentioned|2
4707105|NCT02796677|7628544|FG001|Overall Study|Reason not mentioned|3
4707106|NCT02796677|7628545|FG002|Overall Study|Reason not mentioned|0
4707107|NCT02796677|7628546|FG003|Overall Study|Reason not mentioned|5
4707108|NCT02796755|7628560|FG000|Overall Study|Adverse Event|2
4707109|NCT02796755|7628561|FG001|Overall Study|Adverse Event|0
4707110|NCT02796963|7628575|FG000|Overall Study|Lost to Follow-up|89
4707111|NCT02796963|7628576|FG001|Overall Study|Lost to Follow-up|76
4707112|NCT02796963|7628577|FG002|Overall Study|Lost to Follow-up|69
4707113|NCT02796963|7628578|FG003|Overall Study|Lost to Follow-up|72
4707114|NCT02797080|7628601|FG000|Overall Study|Lost to Follow-up|1
4707115|NCT02797080|7628601|FG000|Overall Study|Withdrawal by Subject|1
4707116|NCT02797132|7628605|FG000|Part A (15 Days)|Adverse Event|1
4707117|NCT02797132|7628605|FG000|Part B (24 Weeks)|Adverse Event|3
4707118|NCT02797171|7628624|FG000|Overall Study|Lost to Follow-up|2
4707119|NCT02797171|7628625|FG001|Overall Study|Lost to Follow-up|0
4707120|NCT02797171|7628626|FG002|Overall Study|Lost to Follow-up|2
4707121|NCT02797171|7628627|FG003|Overall Study|Lost to Follow-up|1
4707122|NCT02797171|7628628|FG004|Overall Study|Lost to Follow-up|2
4707123|NCT02797171|7628629|FG005|Overall Study|Lost to Follow-up|0
4707124|NCT02797171|7628624|FG000|Overall Study|Withdrawal by Subject|1
4707125|NCT02797171|7628625|FG001|Overall Study|Withdrawal by Subject|1
4707126|NCT02797171|7628626|FG002|Overall Study|Withdrawal by Subject|0
4707127|NCT02797171|7628627|FG003|Overall Study|Withdrawal by Subject|0
4707128|NCT02797171|7628628|FG004|Overall Study|Withdrawal by Subject|0
4707129|NCT02797171|7628629|FG005|Overall Study|Withdrawal by Subject|0
4707130|NCT02797171|7628624|FG000|Overall Study|Protocol Violation|1
4707131|NCT02797171|7628625|FG001|Overall Study|Protocol Violation|0
4707132|NCT02797171|7628626|FG002|Overall Study|Protocol Violation|0
4707133|NCT02797171|7628627|FG003|Overall Study|Protocol Violation|0
4707134|NCT02797171|7628628|FG004|Overall Study|Protocol Violation|0
4707135|NCT02797171|7628629|FG005|Overall Study|Protocol Violation|0
4707136|NCT02797171|7628624|FG000|Overall Study|Participant unable to adhere|0
4707137|NCT02797171|7628625|FG001|Overall Study|Participant unable to adhere|1
4707138|NCT02797171|7628626|FG002|Overall Study|Participant unable to adhere|0
4707139|NCT02797171|7628627|FG003|Overall Study|Participant unable to adhere|0
4707140|NCT02797171|7628628|FG004|Overall Study|Participant unable to adhere|0
4707141|NCT02797171|7628629|FG005|Overall Study|Participant unable to adhere|0
4707142|NCT02797171|7628624|FG000|Overall Study|Not Randomized|0
4707143|NCT02797171|7628625|FG001|Overall Study|Not Randomized|0
4707144|NCT02797171|7628626|FG002|Overall Study|Not Randomized|0
4707145|NCT02797171|7628627|FG003|Overall Study|Not Randomized|0
4707146|NCT02797171|7628628|FG004|Overall Study|Not Randomized|0
4707147|NCT02797171|7628629|FG005|Overall Study|Not Randomized|1
4707148|NCT02797522|7628654|FG000|Overall Study|Study Terminated by Sponsor|0
4707149|NCT02797522|7628655|FG001|Overall Study|Study Terminated by Sponsor|0
4707150|NCT02797522|7628656|FG002|Overall Study|Study Terminated by Sponsor|0
4707151|NCT02797522|7628657|FG003|Overall Study|Study Terminated by Sponsor|0
4707152|NCT02797522|7628658|FG004|Overall Study|Study Terminated by Sponsor|0
4707153|NCT02797522|7628659|FG005|Overall Study|Study Terminated by Sponsor|0
4707154|NCT02797522|7628660|FG006|Overall Study|Study Terminated by Sponsor|0
4707155|NCT02797522|7628661|FG007|Overall Study|Study Terminated by Sponsor|4
4707156|NCT02797522|7628662|FG008|Overall Study|Study Terminated by Sponsor|2
4707157|NCT02797522|7628663|FG009|Overall Study|Study Terminated by Sponsor|4
4707158|NCT02797522|7628664|FG010|Overall Study|Study Terminated by Sponsor|1
4707159|NCT02797678|7628701|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25
4707160|NCT02797678|7628702|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0
4707161|NCT02797678|7628703|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0
4707162|NCT02797678|7628704|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0
4707163|NCT02797678|7628701|FG000|First Intervention (5 Nights)|study/device use non-compliance|0
4707164|NCT02797678|7628702|FG001|First Intervention (5 Nights)|study/device use non-compliance|1
4707165|NCT02797678|7628703|FG002|First Intervention (5 Nights)|study/device use non-compliance|0
4707166|NCT02797678|7628704|FG003|First Intervention (5 Nights)|study/device use non-compliance|0
4707167|NCT02797678|7628701|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0
4707168|NCT02797678|7628702|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0
4707169|NCT02797678|7628703|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1
4707170|NCT02797678|7628704|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0
4707171|NCT02797808|7628719|FG000|Overall Study|Withdrawal by Subject|1
4707172|NCT02797808|7628720|FG001|Overall Study|Withdrawal by Subject|1
4707173|NCT02797808|7628719|FG000|Overall Study|Physician Decision|6
4707174|NCT02797808|7628720|FG001|Overall Study|Physician Decision|2
4707175|NCT02798211|7628742|FG000|Period 1|Adverse Event|1
4707176|NCT02798211|7628743|FG001|Period 1|Adverse Event|1
4707177|NCT02798211|7628744|FG002|Period 1|Adverse Event|0
4707178|NCT02798211|7628745|FG003|Period 1|Adverse Event|0
4707179|NCT02798211|7628746|FG004|Period 1|Adverse Event|0
4707180|NCT02798211|7628747|FG005|Period 1|Adverse Event|0
4707181|NCT02798211|7628742|FG000|Period 1|Lost to Follow-up|2
4707182|NCT02798211|7628743|FG001|Period 1|Lost to Follow-up|1
4628002|NCT01856309|7494841|FG003|Overall Study|Physician Decision|8
4707183|NCT02798211|7628744|FG002|Period 1|Lost to Follow-up|0
4628003|NCT01856309|7494838|FG000|Overall Study|Noncompliance With Study Drug|0
4628004|NCT01856309|7494839|FG001|Overall Study|Noncompliance With Study Drug|1
4628005|NCT01856309|7494840|FG002|Overall Study|Noncompliance With Study Drug|4
4628006|NCT01856309|7494841|FG003|Overall Study|Noncompliance With Study Drug|1
4628007|NCT01856543|7494866|FG000|Overall Study|Treatment discontinued|6
4628008|NCT01856543|7494867|FG001|Overall Study|Treatment discontinued|3
4628009|NCT01856543|7494866|FG000|Overall Study|Withdrawn before start|7
4628010|NCT01856543|7494867|FG001|Overall Study|Withdrawn before start|3
4628011|NCT01856569|7494874|FG000|Overall Study|Other|1
4628012|NCT01856569|7494874|FG000|Overall Study|Changed Site/Structure|1
4628013|NCT01856569|7494874|FG000|Overall Study|Lost to Follow-up|3
4628014|NCT01856569|7494874|FG000|Overall Study|Did not met inclusion criteria|8
4633241|NCT01909804|7503300|FG004|Overall Study|Death|0
4633242|NCT01909804|7503301|FG005|Overall Study|Death|0
4633243|NCT01909804|7503302|FG006|Overall Study|Death|0
4633244|NCT01909804|7503303|FG007|Overall Study|Death|0
4633245|NCT01909804|7503304|FG008|Overall Study|Death|0
4633246|NCT01909804|7503305|FG009|Overall Study|Death|0
4633247|NCT01909804|7503306|FG010|Overall Study|Death|1
4633248|NCT01909804|7503307|FG011|Overall Study|Death|0
4633249|NCT01909804|7503296|FG000|Overall Study|Lack of Efficacy|4
4633250|NCT01909804|7503297|FG001|Overall Study|Lack of Efficacy|1
4633251|NCT01909804|7503298|FG002|Overall Study|Lack of Efficacy|0
4633252|NCT01909804|7503299|FG003|Overall Study|Lack of Efficacy|0
4633253|NCT01909804|7503300|FG004|Overall Study|Lack of Efficacy|7
4633254|NCT01909804|7503301|FG005|Overall Study|Lack of Efficacy|3
4633255|NCT01909804|7503302|FG006|Overall Study|Lack of Efficacy|1
4633256|NCT01909804|7503303|FG007|Overall Study|Lack of Efficacy|1
4633257|NCT01909804|7503304|FG008|Overall Study|Lack of Efficacy|0
4633258|NCT01909804|7503305|FG009|Overall Study|Lack of Efficacy|1
4633259|NCT01909804|7503306|FG010|Overall Study|Lack of Efficacy|0
4633260|NCT01909804|7503307|FG011|Overall Study|Lack of Efficacy|1
4633261|NCT01909804|7503296|FG000|Overall Study|Withdrew Consent|0
4633262|NCT01909804|7503297|FG001|Overall Study|Withdrew Consent|0
4633263|NCT01909804|7503298|FG002|Overall Study|Withdrew Consent|0
4633264|NCT01909804|7503299|FG003|Overall Study|Withdrew Consent|0
4633265|NCT01909804|7503300|FG004|Overall Study|Withdrew Consent|1
4633266|NCT01909804|7503301|FG005|Overall Study|Withdrew Consent|1
4633267|NCT01909804|7503302|FG006|Overall Study|Withdrew Consent|0
4633268|NCT01909804|7503303|FG007|Overall Study|Withdrew Consent|0
4633269|NCT01909804|7503304|FG008|Overall Study|Withdrew Consent|0
4707184|NCT02798211|7628745|FG003|Period 1|Lost to Follow-up|0
4707185|NCT02798211|7628746|FG004|Period 1|Lost to Follow-up|0
4633270|NCT01909804|7503305|FG009|Overall Study|Withdrew Consent|0
4633271|NCT01909804|7503306|FG010|Overall Study|Withdrew Consent|0
4633272|NCT01909804|7503307|FG011|Overall Study|Withdrew Consent|0
4633273|NCT01909804|7503296|FG000|Overall Study|Protocol Violation|0
4633274|NCT01909804|7503297|FG001|Overall Study|Protocol Violation|0
4707186|NCT02798211|7628747|FG005|Period 1|Lost to Follow-up|0
4707187|NCT02798211|7628742|FG000|Period 1|Protocol Violation|0
4707188|NCT02798211|7628743|FG001|Period 1|Protocol Violation|0
4707189|NCT02798211|7628744|FG002|Period 1|Protocol Violation|2
4707190|NCT02798211|7628745|FG003|Period 1|Protocol Violation|0
4707191|NCT02798211|7628746|FG004|Period 1|Protocol Violation|0
4707192|NCT02798211|7628747|FG005|Period 1|Protocol Violation|0
4707193|NCT02798211|7628742|FG000|Period 1|Withdrawal by Subject|1
4707194|NCT02798211|7628743|FG001|Period 1|Withdrawal by Subject|1
4707195|NCT02798211|7628744|FG002|Period 1|Withdrawal by Subject|0
4707196|NCT02798211|7628745|FG003|Period 1|Withdrawal by Subject|0
4707197|NCT02798211|7628746|FG004|Period 1|Withdrawal by Subject|0
4707198|NCT02798211|7628747|FG005|Period 1|Withdrawal by Subject|0
4707199|NCT02798211|7628742|FG000|Period 1|Death|0
4707200|NCT02798211|7628743|FG001|Period 1|Death|0
4707201|NCT02798211|7628744|FG002|Period 1|Death|1
4707202|NCT02798211|7628745|FG003|Period 1|Death|0
4707203|NCT02798211|7628746|FG004|Period 1|Death|0
4388182|NCT00056407|7166747|FG001|Overall Study|Adverse Event|364
4388183|NCT00056407|7166746|FG000|Overall Study|Withdrawal by Subject|377
4388184|NCT00056407|7166747|FG001|Overall Study|Withdrawal by Subject|361
4388185|NCT00056407|7166746|FG000|Overall Study|Lost to Follow-up|123
4388186|NCT00056407|7166747|FG001|Overall Study|Lost to Follow-up|113
4388187|NCT00056407|7166746|FG000|Overall Study|Protocol Violation|104
4388188|NCT00056407|7166747|FG001|Overall Study|Protocol Violation|95
4388189|NCT00056407|7166746|FG000|Overall Study|Diagnosed with Prostate Cancer|202
4388190|NCT00056407|7166747|FG001|Overall Study|Diagnosed with Prostate Cancer|166
4388191|NCT00056407|7166746|FG000|Overall Study|"Listed as Other on Case Report Form"|98
4388192|NCT00056407|7166747|FG001|Overall Study|"Listed as Other on Case Report Form"|60
4388193|NCT00056407|7166746|FG000|Overall Study|Missing|25
4388194|NCT00056407|7166747|FG001|Overall Study|Missing|34
4388195|NCT00056862|7166787|FG000|Overall Study|Protocol Violation|1
4388196|NCT00056862|7166788|FG001|Overall Study|Protocol Violation|0
4388197|NCT00057330|7166796|FG000|Overall Study|Adverse Event|9
4388198|NCT00057330|7166797|FG001|Overall Study|Adverse Event|12
4388199|NCT00057330|7166796|FG000|Overall Study|Death|1
4388200|NCT00057330|7166797|FG001|Overall Study|Death|0
4388201|NCT00057330|7166796|FG000|Overall Study|Protocol Violation|1
4388202|NCT00057330|7166797|FG001|Overall Study|Protocol Violation|1
4388203|NCT00057330|7166796|FG000|Overall Study|Withdrawal by Subject|115
4388204|NCT00057330|7166797|FG001|Overall Study|Withdrawal by Subject|84
4388205|NCT00057330|7166796|FG000|Overall Study|Lost to Follow-up|745
4388206|NCT00057330|7166797|FG001|Overall Study|Lost to Follow-up|617
4388207|NCT00057330|7166796|FG000|Overall Study|Physician Decision|1
4388208|NCT00057330|7166797|FG001|Overall Study|Physician Decision|0
4388209|NCT00057330|7166796|FG000|Overall Study|Other|260
4388210|NCT00057330|7166797|FG001|Overall Study|Other|206
4388211|NCT00057746|7166846|FG000|Overall Study|Withdrawal by Subject|0
4388212|NCT00057746|7166847|FG001|Overall Study|Withdrawal by Subject|0
4388213|NCT00057746|7166848|FG002|Overall Study|Withdrawal by Subject|1
4388214|NCT00057811|7166862|FG000|Overall Study|Lack of Efficacy|1
4707204|NCT02798211|7628747|FG005|Period 1|Death|0
4707205|NCT02798211|7628742|FG000|Period 1|Withdrawal of Informed Consent|2
4707206|NCT02798211|7628743|FG001|Period 1|Withdrawal of Informed Consent|7
4707207|NCT02798211|7628744|FG002|Period 1|Withdrawal of Informed Consent|3
4707208|NCT02798211|7628745|FG003|Period 1|Withdrawal of Informed Consent|0
4707209|NCT02798211|7628746|FG004|Period 1|Withdrawal of Informed Consent|0
4707210|NCT02798211|7628747|FG005|Period 1|Withdrawal of Informed Consent|0
4707211|NCT02798211|7628742|FG000|Period 2|Withdrawal by Subject|2
4707212|NCT02798211|7628743|FG001|Period 2|Withdrawal by Subject|0
4707213|NCT02798211|7628744|FG002|Period 2|Withdrawal by Subject|0
4707214|NCT02798211|7628745|FG003|Period 2|Withdrawal by Subject|0
4707215|NCT02798211|7628746|FG004|Period 2|Withdrawal by Subject|2
4707216|NCT02798211|7628747|FG005|Period 2|Withdrawal by Subject|2
4707217|NCT02798211|7628742|FG000|Period 2|Adverse Event|5
4707218|NCT02798211|7628743|FG001|Period 2|Adverse Event|0
4707219|NCT02798211|7628744|FG002|Period 2|Adverse Event|0
4707220|NCT02798211|7628745|FG003|Period 2|Adverse Event|0
4707221|NCT02798211|7628746|FG004|Period 2|Adverse Event|1
4707222|NCT02798211|7628747|FG005|Period 2|Adverse Event|0
4707223|NCT02798211|7628742|FG000|Period 2|Lack of Efficacy|1
4707224|NCT02798211|7628743|FG001|Period 2|Lack of Efficacy|0
4707225|NCT02798211|7628744|FG002|Period 2|Lack of Efficacy|0
4707226|NCT02798211|7628745|FG003|Period 2|Lack of Efficacy|1
4707227|NCT02798211|7628746|FG004|Period 2|Lack of Efficacy|0
4707228|NCT02798211|7628747|FG005|Period 2|Lack of Efficacy|1
4707229|NCT02798211|7628742|FG000|Period 2|Lost to Follow-up|3
4707230|NCT02798211|7628743|FG001|Period 2|Lost to Follow-up|0
4707231|NCT02798211|7628744|FG002|Period 2|Lost to Follow-up|0
4707232|NCT02798211|7628745|FG003|Period 2|Lost to Follow-up|0
4388215|NCT00057811|7166863|FG001|Overall Study|Lack of Efficacy|4
4388216|NCT00057811|7166862|FG000|Overall Study|Physician Decision|1
4388217|NCT00057811|7166863|FG001|Overall Study|Physician Decision|0
4388218|NCT00057811|7166862|FG000|Overall Study|Withdrawal by Subject|3
4388219|NCT00057811|7166863|FG001|Overall Study|Withdrawal by Subject|4
4707233|NCT02798211|7628746|FG004|Period 2|Lost to Follow-up|2
4707234|NCT02798211|7628747|FG005|Period 2|Lost to Follow-up|0
4707235|NCT02798211|7628742|FG000|Period 2|Physician Decision|1
4707236|NCT02798211|7628743|FG001|Period 2|Physician Decision|0
4707237|NCT02798211|7628744|FG002|Period 2|Physician Decision|0
4707238|NCT02798211|7628745|FG003|Period 2|Physician Decision|1
4707239|NCT02798211|7628746|FG004|Period 2|Physician Decision|1
4707240|NCT02798211|7628747|FG005|Period 2|Physician Decision|0
4707241|NCT02798211|7628742|FG000|Period 2|Pregnancy|0
4707242|NCT02798211|7628743|FG001|Period 2|Pregnancy|0
4707243|NCT02798211|7628744|FG002|Period 2|Pregnancy|0
4707244|NCT02798211|7628745|FG003|Period 2|Pregnancy|2
4707245|NCT02798211|7628746|FG004|Period 2|Pregnancy|0
4707246|NCT02798211|7628747|FG005|Period 2|Pregnancy|0
4707247|NCT02798211|7628742|FG000|Period 2|Technical problems|1
4707248|NCT02798211|7628743|FG001|Period 2|Technical problems|0
4707249|NCT02798211|7628744|FG002|Period 2|Technical problems|0
4707250|NCT02798211|7628745|FG003|Period 2|Technical problems|1
4707251|NCT02798211|7628746|FG004|Period 2|Technical problems|0
4707252|NCT02798211|7628747|FG005|Period 2|Technical problems|0
4707253|NCT02798211|7628742|FG000|Period 2|Withdrawal of Informed Consent|1
4707254|NCT02798211|7628743|FG001|Period 2|Withdrawal of Informed Consent|0
4707255|NCT02798211|7628744|FG002|Period 2|Withdrawal of Informed Consent|0
4707256|NCT02798211|7628745|FG003|Period 2|Withdrawal of Informed Consent|2
4707257|NCT02798211|7628746|FG004|Period 2|Withdrawal of Informed Consent|2
4707258|NCT02798211|7628747|FG005|Period 2|Withdrawal of Informed Consent|3
4707259|NCT02798315|7628763|FG000|Overall Study|Failure to return|1
4735634|NCT03535194|7683724|FG003|Post-Treatment Followup Period|Lack of Efficacy|4
4735635|NCT03535194|7683725|FG004|Post-Treatment Followup Period|Lack of Efficacy|0
4628015|NCT01856582|7494878|FG000|Overall Study|Died prior to Boost infusion|1
4628016|NCT01856595|7494891|FG000|Overall Study|Withdrawal by Subject|0
4628017|NCT01856595|7494892|FG001|Overall Study|Withdrawal by Subject|1
4628018|NCT01856595|7494893|FG002|Overall Study|Withdrawal by Subject|0
4735636|NCT03535194|7683721|FG000|Post-Treatment Followup Period|Lost to Follow-up|1
4735637|NCT03535194|7683722|FG001|Post-Treatment Followup Period|Lost to Follow-up|1
4735638|NCT03535194|7683723|FG002|Post-Treatment Followup Period|Lost to Follow-up|1
4735639|NCT03535194|7683724|FG003|Post-Treatment Followup Period|Lost to Follow-up|0
4735640|NCT03535194|7683725|FG004|Post-Treatment Followup Period|Lost to Follow-up|0
4735641|NCT03535194|7683721|FG000|Post-Treatment Followup Period|Other|1
4735642|NCT03535194|7683722|FG001|Post-Treatment Followup Period|Other|0
4735643|NCT03535194|7683723|FG002|Post-Treatment Followup Period|Other|0
4735644|NCT03535194|7683724|FG003|Post-Treatment Followup Period|Other|5
4735645|NCT03535194|7683725|FG004|Post-Treatment Followup Period|Other|0
4735646|NCT03535194|7683721|FG000|Post-Treatment Followup Period|Physician Decision|0
4735647|NCT03535194|7683722|FG001|Post-Treatment Followup Period|Physician Decision|2
4735648|NCT03535194|7683723|FG002|Post-Treatment Followup Period|Physician Decision|1
4735649|NCT03535194|7683724|FG003|Post-Treatment Followup Period|Physician Decision|1
4735650|NCT03535194|7683725|FG004|Post-Treatment Followup Period|Physician Decision|0
4735651|NCT03535194|7683721|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2
4735652|NCT03535194|7683722|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2
4735653|NCT03535194|7683723|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3
4735654|NCT03535194|7683724|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6
4735655|NCT03535194|7683725|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0
4735656|NCT03535844|7683761|FG000|Overall Study|Withdrawal by Subject|0
4735657|NCT03535844|7683762|FG001|Overall Study|Withdrawal by Subject|1
4735658|NCT03535974|7683771|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0
4735659|NCT03535974|7683772|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1
4735660|NCT03535974|7683773|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0
4735661|NCT03535974|7683771|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2
4735662|NCT03535974|7683772|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1
4735663|NCT03535974|7683773|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0
4735664|NCT03536663|7683781|FG000|Endexo|Protocol Violation|1
4735665|NCT03536949|7683809|FG000|Overall Study|Adverse Event|4
4735666|NCT03536949|7683810|FG001|Overall Study|Adverse Event|0
4735667|NCT03536949|7683809|FG000|Overall Study|Lost to Follow-up|2
4735668|NCT03536949|7683810|FG001|Overall Study|Lost to Follow-up|1
4735669|NCT03536949|7683809|FG000|Overall Study|Withdrawal by Subject|6
4735670|NCT03536949|7683810|FG001|Overall Study|Withdrawal by Subject|0
4735671|NCT03536949|7683809|FG000|Overall Study|Non-compliance|2
4735672|NCT03536949|7683810|FG001|Overall Study|Non-compliance|1
4735673|NCT03537261|7683831|FG000|Overall Study|Lost to Follow-up|4
4735674|NCT03537261|7683832|FG001|Overall Study|Lost to Follow-up|5
4735675|NCT03537261|7683831|FG000|Overall Study|Withdrawal by Subject|4
4735676|NCT03537261|7683832|FG001|Overall Study|Withdrawal by Subject|6
4735677|NCT03537261|7683831|FG000|Overall Study|Did not return study questionnaires|0
4735678|NCT03537261|7683832|FG001|Overall Study|Did not return study questionnaires|1
4735679|NCT03537651|7683883|FG000|Overall Study|Adverse Event|2
4735680|NCT03537651|7683883|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2
4628019|NCT01856595|7494894|FG003|Overall Study|Withdrawal by Subject|0
4628020|NCT01856595|7494895|FG004|Overall Study|Withdrawal by Subject|0
4628021|NCT01856595|7494896|FG005|Overall Study|Withdrawal by Subject|0
4628022|NCT01856595|7494897|FG006|Overall Study|Withdrawal by Subject|1
4628023|NCT01856595|7494898|FG007|Overall Study|Withdrawal by Subject|0
4628024|NCT01856595|7494899|FG008|Overall Study|Withdrawal by Subject|0
4707260|NCT02798835|7628802|FG000|Overall Study|Protocol Violation|0
4707261|NCT02798835|7628803|FG001|Overall Study|Protocol Violation|0
4707262|NCT02798835|7628804|FG002|Overall Study|Protocol Violation|3
4707263|NCT02798861|7628812|FG000|Overall Study|Lost to Follow-up|22
4707264|NCT02798861|7628812|FG000|Overall Study|Withdrawal by Subject|1
4707265|NCT02799069|7628858|FG000|Overall Study|Adverse Event|0
4707266|NCT02799069|7628859|FG001|Overall Study|Adverse Event|2
4707267|NCT02799069|7628860|FG002|Overall Study|Adverse Event|2
4707268|NCT02799069|7628858|FG000|Overall Study|Lack of Efficacy|2
4707269|NCT02799069|7628859|FG001|Overall Study|Lack of Efficacy|0
4707270|NCT02799069|7628860|FG002|Overall Study|Lack of Efficacy|0
4707271|NCT02799069|7628858|FG000|Overall Study|Lost to Follow-up|1
4707272|NCT02799069|7628859|FG001|Overall Study|Lost to Follow-up|1
4707273|NCT02799069|7628860|FG002|Overall Study|Lost to Follow-up|0
4707274|NCT02799069|7628858|FG000|Overall Study|Withdrawal by Subject|4
4707275|NCT02799069|7628859|FG001|Overall Study|Withdrawal by Subject|4
4707276|NCT02799069|7628860|FG002|Overall Study|Withdrawal by Subject|3
4707277|NCT02799069|7628858|FG000|Overall Study|Protocol Violation|1
4707278|NCT02799069|7628859|FG001|Overall Study|Protocol Violation|0
4707279|NCT02799069|7628860|FG002|Overall Study|Protocol Violation|2
4707280|NCT02799082|7628870|FG000|Overall Study|Refused second PDT or withdraw consent|4
4707281|NCT02799082|7628871|FG001|Overall Study|Refused second PDT or withdraw consent|3
4707282|NCT02799082|7628870|FG000|Overall Study|Protocol Violation|0
4707283|NCT02799082|7628871|FG001|Overall Study|Protocol Violation|1
4707284|NCT02799381|7628896|FG000|Overall Study|Withdrew consent|3
4707285|NCT02799381|7628897|FG001|Overall Study|Withdrew consent|2
4707286|NCT02799381|7628896|FG000|Overall Study|Adverse Event|0
4707287|NCT02799381|7628897|FG001|Overall Study|Adverse Event|1
4707288|NCT02799381|7628896|FG000|Overall Study|Participant did not take any study drug|1
4707289|NCT02799381|7628897|FG001|Overall Study|Participant did not take any study drug|0
4707290|NCT02799472|7628905|FG000|Overall Study|Withdrawal by Subject|2
4707291|NCT02799472|7628906|FG001|Overall Study|Withdrawal by Subject|4
4707292|NCT02799472|7628905|FG000|Overall Study|Lack of Efficacy|2
4707293|NCT02799472|7628906|FG001|Overall Study|Lack of Efficacy|0
4707294|NCT02799472|7628905|FG000|Overall Study|Lost to Follow-up|0
4707295|NCT02799472|7628906|FG001|Overall Study|Lost to Follow-up|1
4707296|NCT02799745|7628923|FG000|Overall Study|Participant moved out of state|1
4707297|NCT02799745|7628924|FG001|Overall Study|Participant moved out of state|0
4707298|NCT02799745|7628923|FG000|Overall Study|Discontinued due to planned surgery|1
4707299|NCT02799745|7628924|FG001|Overall Study|Discontinued due to planned surgery|0
4707300|NCT02799745|7628923|FG000|Overall Study|Withdrawal by Subject|16
4707301|NCT02799745|7628924|FG001|Overall Study|Withdrawal by Subject|25
4707302|NCT02799745|7628923|FG000|Overall Study|Protocol Deviation|4
4707303|NCT02799745|7628924|FG001|Overall Study|Protocol Deviation|5
4707304|NCT02799745|7628923|FG000|Overall Study|Progressive Disease|28
4707305|NCT02799745|7628924|FG001|Overall Study|Progressive Disease|38
4707306|NCT02799745|7628923|FG000|Overall Study|Lost to Follow-up|3
4707307|NCT02799745|7628924|FG001|Overall Study|Lost to Follow-up|2
4707308|NCT02799745|7628923|FG000|Overall Study|Death|3
4707309|NCT02799745|7628924|FG001|Overall Study|Death|0
4707310|NCT02799745|7628923|FG000|Overall Study|Adverse Event|0
4707311|NCT02799745|7628924|FG001|Overall Study|Adverse Event|1
4707312|NCT02799784|7628930|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1
4707313|NCT02799784|7628931|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1
4707314|NCT02799784|7628930|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5
4707315|NCT02799784|7628931|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0
4707316|NCT02799784|7628930|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0
4707317|NCT02799784|7628931|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1
4707318|NCT02799784|7628930|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1
4707319|NCT02799784|7628931|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0
4707320|NCT02799784|7628930|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0
4707321|NCT02799784|7628931|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1
4707322|NCT02799784|7628930|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0
4707323|NCT02799784|7628931|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1
4707324|NCT02800642|7628963|FG000|Overall Study|Death|3
4707325|NCT02800642|7628963|FG000|Overall Study|Other|10
4707326|NCT02800642|7628963|FG000|Overall Study|Physician Decision|2
4707327|NCT02800642|7628963|FG000|Overall Study|Adverse Event|6
4707328|NCT02800642|7628963|FG000|Overall Study|Withdrawal by Subject|3
4707329|NCT02800642|7628963|FG000|Overall Study|Lost to Follow-up|1
4707330|NCT02800928|7628967|FG000|Overall Study|Withdrawal by Subject|1
4707331|NCT02800928|7628968|FG001|Overall Study|Withdrawal by Subject|1
4707332|NCT02800928|7628967|FG000|Overall Study|Protocol Violation|1
4707333|NCT02800928|7628968|FG001|Overall Study|Protocol Violation|1
4707334|NCT02801396|7628993|FG000|Period 1|Withdrawal by Subject|0
4707335|NCT02801396|7628994|FG001|Period 1|Withdrawal by Subject|0
4707336|NCT02801396|7628995|FG002|Period 1|Withdrawal by Subject|0
4707337|NCT02801396|7628996|FG003|Period 1|Withdrawal by Subject|0
4707338|NCT02801396|7628997|FG004|Period 1|Withdrawal by Subject|1
4707339|NCT02801396|7628998|FG005|Period 1|Withdrawal by Subject|0
4707340|NCT02801578|7629006|FG000|Overall Study|Adverse Event|2
4707341|NCT02801617|7629012|FG000|Overall Study|Protocol Violation|2
4707342|NCT02801617|7629013|FG001|Overall Study|Protocol Violation|6
4707343|NCT02801669|7629025|FG000|Overall Study|Death|66
4707344|NCT02801669|7629026|FG001|Overall Study|Death|69
4707345|NCT02801669|7629025|FG000|Overall Study|Withdrawal by Subject|81
4707346|NCT02801669|7629026|FG001|Overall Study|Withdrawal by Subject|77
4707347|NCT02801669|7629025|FG000|Overall Study|Other|4
4707348|NCT02801669|7629026|FG001|Overall Study|Other|6
4707349|NCT02801877|7629036|FG000|Overall Study|Lost to Follow-up|1
4707350|NCT02801877|7629037|FG001|Overall Study|Lost to Follow-up|1
4707351|NCT02801877|7629038|FG002|Overall Study|Lost to Follow-up|2
4707352|NCT02801877|7629039|FG003|Overall Study|Lost to Follow-up|0
4707353|NCT02801877|7629036|FG000|Overall Study|Never Started Treatment|2
4707354|NCT02801877|7629037|FG001|Overall Study|Never Started Treatment|0
4707355|NCT02801877|7629038|FG002|Overall Study|Never Started Treatment|4
4707356|NCT02801877|7629039|FG003|Overall Study|Never Started Treatment|0
4707357|NCT02802319|7629086|FG000|Overall Study|Physician Decision|2
4707358|NCT02802319|7629087|FG001|Overall Study|Physician Decision|1
4707359|NCT02802319|7629086|FG000|Overall Study|Lost to Follow-up|0
4707360|NCT02802319|7629087|FG001|Overall Study|Lost to Follow-up|4
4707361|NCT02802345|7629095|FG000|Overall Study|Not Treated|0
4707362|NCT02802345|7629096|FG001|Overall Study|Not Treated|1
4707363|NCT02802345|7629095|FG000|Overall Study|Adverse Event|28
4707364|NCT02802345|7629096|FG001|Overall Study|Adverse Event|20
4707365|NCT02802345|7629095|FG000|Overall Study|Withdrawal by Subject|3
4707366|NCT02802345|7629096|FG001|Overall Study|Withdrawal by Subject|3
4707367|NCT02802345|7629095|FG000|Overall Study|Protocol Violation|0
4707368|NCT02802345|7629096|FG001|Overall Study|Protocol Violation|1
4707369|NCT02802345|7629095|FG000|Overall Study|Other than listed|1
4707370|NCT02802345|7629096|FG001|Overall Study|Other than listed|5
4707371|NCT02802735|7629148|FG000|Overall Study|Withdrawal by Subject|0
4707372|NCT02802735|7629149|FG001|Overall Study|Withdrawal by Subject|1
4707373|NCT02802735|7629150|FG002|Overall Study|Withdrawal by Subject|0
4707374|NCT02802735|7629151|FG003|Overall Study|Withdrawal by Subject|0
4707375|NCT02802735|7629152|FG004|Overall Study|Withdrawal by Subject|0
4707376|NCT02802865|7629169|FG000|Overall Study|Pregnancy|1
4707377|NCT02802865|7629170|FG001|Overall Study|Pregnancy|1
4707378|NCT02802865|7629169|FG000|Overall Study|Ineliegible due to tuberculosis|0
4707379|NCT02802865|7629170|FG001|Overall Study|Ineliegible due to tuberculosis|1
4707380|NCT02802878|7629178|FG000|Overall Study|Withdrawal by Subject|3
4707381|NCT02802878|7629179|FG001|Overall Study|Withdrawal by Subject|3
4707382|NCT02802878|7629178|FG000|Overall Study|Protocol Violation|1
4707383|NCT02802878|7629179|FG001|Overall Study|Protocol Violation|0
4707384|NCT02803138|7629185|FG000|Overall Study|Failure to return|38
4707385|NCT02803138|7629185|FG000|Overall Study|Insufficient virological response|2
4707386|NCT02803138|7629185|FG000|Overall Study|Withdrawn consent|1
4707387|NCT02803138|7629185|FG000|Overall Study|Death|1
4707388|NCT02803138|7629185|FG000|Overall Study|Other, not specified|28
4707389|NCT02803580|7629211|FG000|Overall Study|Death|13
4707390|NCT02803580|7629211|FG000|Overall Study|Lost to Follow-up|19
4707391|NCT02803580|7629211|FG000|Overall Study|Withdrawal by Subject|3
4707392|NCT02803580|7629211|FG000|Overall Study|Inclusion in clinical trial|1
4707393|NCT02804178|7629224|FG000|Overall Study|Adverse Event|1
4707394|NCT02804399|7629228|FG000|Period 2|Adverse Event|0
4707395|NCT02804399|7629229|FG001|Period 2|Adverse Event|1
4707396|NCT02804750|7629249|FG000|Period 1|Adverse Event|0
4707397|NCT02804750|7629250|FG001|Period 1|Adverse Event|2
4707398|NCT02804750|7629249|FG000|Period 1|Withdrawal by Subject|0
4707399|NCT02804750|7629250|FG001|Period 1|Withdrawal by Subject|1
4707400|NCT02804750|7629249|FG000|Period 2|Adverse Event|1
4707401|NCT02804750|7629250|FG001|Period 2|Adverse Event|0
4707402|NCT02804750|7629249|FG000|Period 3|Adverse Event|0
4707403|NCT02804750|7629250|FG001|Period 3|Adverse Event|2
4707404|NCT02804750|7629249|FG000|Period 4|Adverse Event|0
4707405|NCT02804750|7629250|FG001|Period 4|Adverse Event|5
4707406|NCT02804763|7629262|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1
4707407|NCT02804763|7629263|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0
4707408|NCT02804763|7629264|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0
4707409|NCT02804763|7629265|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0
4707410|NCT02804763|7629262|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0
4707411|NCT02804763|7629263|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0
4707412|NCT02804763|7629264|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1
4707413|NCT02804763|7629265|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2
4707414|NCT02804763|7629262|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0
4707415|NCT02804763|7629263|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1
4707416|NCT02804763|7629264|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0
4707417|NCT02804763|7629265|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0
4707418|NCT02804763|7629262|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2
4707419|NCT02804763|7629263|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0
4707420|NCT02804763|7629264|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1
4707421|NCT02804763|7629265|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1
4707422|NCT02804763|7629262|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4
4707423|NCT02804763|7629263|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0
4707424|NCT02804763|7629264|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2
4707425|NCT02804763|7629265|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2
4707426|NCT02804763|7629262|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0
4707427|NCT02804763|7629263|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1
4707428|NCT02804763|7629264|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0
4707429|NCT02804763|7629265|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0
4707430|NCT02805309|7629286|FG000|Overall Study|Lost to Follow-up|2
4707431|NCT02805309|7629287|FG001|Overall Study|Lost to Follow-up|2
4707432|NCT02805309|7629288|FG002|Overall Study|Lost to Follow-up|2
4707433|NCT02805309|7629286|FG000|Overall Study|Post-Randomization Exclusion|0
4707434|NCT02805309|7629287|FG001|Overall Study|Post-Randomization Exclusion|2
4707435|NCT02805309|7629288|FG002|Overall Study|Post-Randomization Exclusion|1
4707436|NCT02805660|7629312|FG000|Overall Study|Death|5
4707437|NCT02805660|7629313|FG001|Overall Study|Death|2
4707438|NCT02805660|7629314|FG002|Overall Study|Death|9
4707439|NCT02805660|7629315|FG003|Overall Study|Death|5
4707440|NCT02805660|7629316|FG004|Overall Study|Death|0
4707441|NCT02805660|7629317|FG005|Overall Study|Death|14
4707442|NCT02805660|7629318|FG006|Overall Study|Death|12
4707443|NCT02805660|7629312|FG000|Overall Study|Lost to Follow-up|0
4707444|NCT02805660|7629313|FG001|Overall Study|Lost to Follow-up|1
4707445|NCT02805660|7629314|FG002|Overall Study|Lost to Follow-up|1
4707446|NCT02805660|7629315|FG003|Overall Study|Lost to Follow-up|2
4707447|NCT02805660|7629316|FG004|Overall Study|Lost to Follow-up|0
4707448|NCT02805660|7629317|FG005|Overall Study|Lost to Follow-up|0
4707449|NCT02805660|7629318|FG006|Overall Study|Lost to Follow-up|0
4707450|NCT02805660|7629312|FG000|Overall Study|Withdrawal by Subject|0
4707451|NCT02805660|7629313|FG001|Overall Study|Withdrawal by Subject|0
4707452|NCT02805660|7629314|FG002|Overall Study|Withdrawal by Subject|0
4707453|NCT02805660|7629315|FG003|Overall Study|Withdrawal by Subject|3
4707454|NCT02805660|7629316|FG004|Overall Study|Withdrawal by Subject|1
4707455|NCT02805660|7629317|FG005|Overall Study|Withdrawal by Subject|0
4707456|NCT02805660|7629318|FG006|Overall Study|Withdrawal by Subject|2
4707457|NCT02805660|7629312|FG000|Overall Study|Study terminated by Sponsor|0
4707458|NCT02805660|7629313|FG001|Overall Study|Study terminated by Sponsor|0
4707459|NCT02805660|7629314|FG002|Overall Study|Study terminated by Sponsor|1
4707460|NCT02805660|7629315|FG003|Overall Study|Study terminated by Sponsor|4
4707461|NCT02805660|7629316|FG004|Overall Study|Study terminated by Sponsor|2
4707462|NCT02805660|7629317|FG005|Overall Study|Study terminated by Sponsor|3
4707463|NCT02805660|7629318|FG006|Overall Study|Study terminated by Sponsor|1
4707464|NCT02805660|7629312|FG000|Overall Study|Miscellaneous|0
4707465|NCT02805660|7629313|FG001|Overall Study|Miscellaneous|1
4707466|NCT02805660|7629314|FG002|Overall Study|Miscellaneous|0
4707467|NCT02805660|7629315|FG003|Overall Study|Miscellaneous|4
4707468|NCT02805660|7629316|FG004|Overall Study|Miscellaneous|0
4707469|NCT02805660|7629317|FG005|Overall Study|Miscellaneous|6
4707470|NCT02805660|7629318|FG006|Overall Study|Miscellaneous|4
4707471|NCT02805790|7629349|FG000|Second Intervention (4 Weeks)|Physician Decision|0
4707472|NCT02805790|7629350|FG001|Second Intervention (4 Weeks)|Physician Decision|1
4707473|NCT02805907|7629358|FG000|Overall Study|Lost to Follow-up|3
4707474|NCT02805907|7629359|FG001|Overall Study|Lost to Follow-up|3
4707475|NCT02805972|7629367|FG000|Washout Period|Lost to Follow-up|3
4707476|NCT02805972|7629368|FG001|Washout Period|Lost to Follow-up|0
4707477|NCT02806024|7629386|FG000|Overall Study|Night Delivery|1
4707478|NCT02806024|7629387|FG001|Overall Study|Night Delivery|1
4707479|NCT02806024|7629386|FG000|Overall Study|DVT during antepartum admission|0
4707480|NCT02806024|7629387|FG001|Overall Study|DVT during antepartum admission|1
4707481|NCT02806232|7629402|FG000|Overall Study|Lost to Follow-up|1
4707482|NCT02806232|7629403|FG001|Overall Study|Lost to Follow-up|2
4707483|NCT02806232|7629404|FG002|Overall Study|Lost to Follow-up|1
4707484|NCT02806232|7629405|FG003|Overall Study|Lost to Follow-up|0
4707485|NCT02806232|7629406|FG004|Overall Study|Lost to Follow-up|0
4707486|NCT02806232|7629407|FG005|Overall Study|Lost to Follow-up|1
4707487|NCT02806232|7629408|FG006|Overall Study|Lost to Follow-up|0
4707488|NCT02806232|7629409|FG007|Overall Study|Lost to Follow-up|0
4707489|NCT02806232|7629410|FG008|Overall Study|Lost to Follow-up|0
4707490|NCT02806232|7629402|FG000|Overall Study|Withdrawal by Subject|0
4707491|NCT02806232|7629403|FG001|Overall Study|Withdrawal by Subject|2
4707492|NCT02806232|7629404|FG002|Overall Study|Withdrawal by Subject|0
4707493|NCT02806232|7629405|FG003|Overall Study|Withdrawal by Subject|0
4707494|NCT02806232|7629406|FG004|Overall Study|Withdrawal by Subject|2
4707495|NCT02806232|7629407|FG005|Overall Study|Withdrawal by Subject|1
4707496|NCT02806232|7629408|FG006|Overall Study|Withdrawal by Subject|0
4707497|NCT02806232|7629409|FG007|Overall Study|Withdrawal by Subject|0
4707498|NCT02806232|7629410|FG008|Overall Study|Withdrawal by Subject|0
4707499|NCT02806414|7629430|FG000|Overall Study|Lost to Follow-up|2
4707500|NCT02806505|7629436|FG000|Overall Study|Adverse event/intercurrent illness|1
4707501|NCT02806505|7629437|FG001|Overall Study|Adverse event/intercurrent illness|3
4707502|NCT02806505|7629436|FG000|Overall Study|Death|4
4707503|NCT02806505|7629437|FG001|Overall Study|Death|0
4707504|NCT02806505|7629436|FG000|Overall Study|Did not cooperate/refused treatment|3
4707505|NCT02806505|7629437|FG001|Overall Study|Did not cooperate/refused treatment|3
4707506|NCT02806505|7629436|FG000|Overall Study|Failure to return|0
4707507|NCT02806505|7629437|FG001|Overall Study|Failure to return|1
4707508|NCT02806505|7629436|FG000|Overall Study|Insufficient therapeutic response|2
4707509|NCT02806505|7629437|FG001|Overall Study|Insufficient therapeutic response|4
4707510|NCT02806713|7629449|FG000|Overall Study|Urethral injury during procedure|1
4707511|NCT02806713|7629450|FG001|Overall Study|Urethral injury during procedure|0
4707512|NCT02806713|7629449|FG000|Overall Study|cancelled surgery|1
4707513|NCT02806713|7629450|FG001|Overall Study|cancelled surgery|2
4707514|NCT02806726|7629456|FG000|Overall Study|Lost to Follow-up|1
4707515|NCT02806947|7629492|FG000|Overall Study|Withdrawal by Subject|5
4707516|NCT02806947|7629493|FG001|Overall Study|Withdrawal by Subject|1
4707517|NCT02806973|7629499|FG000|Period 1|Withdrawal by Subject|0
4707518|NCT02806973|7629500|FG001|Period 1|Withdrawal by Subject|2
4707519|NCT02806973|7629501|FG002|Period 1|Withdrawal by Subject|1
4707520|NCT02806973|7629502|FG003|Period 1|Withdrawal by Subject|1
4707521|NCT02806973|7629499|FG000|Period 1|Adverse Event|0
4707522|NCT02806973|7629500|FG001|Period 1|Adverse Event|0
4707523|NCT02806973|7629501|FG002|Period 1|Adverse Event|0
4707524|NCT02806973|7629502|FG003|Period 1|Adverse Event|1
4707525|NCT02806973|7629499|FG000|Period 3|Withdrawal by Subject|0
4707526|NCT02806973|7629500|FG001|Period 3|Withdrawal by Subject|0
4707527|NCT02806973|7629501|FG002|Period 3|Withdrawal by Subject|0
4707528|NCT02806973|7629502|FG003|Period 3|Withdrawal by Subject|3
4707529|NCT02806973|7629499|FG000|Period 3|Adverse Event|0
4707530|NCT02806973|7629500|FG001|Period 3|Adverse Event|0
4707531|NCT02806973|7629501|FG002|Period 3|Adverse Event|1
4707532|NCT02806973|7629502|FG003|Period 3|Adverse Event|0
4707533|NCT02806986|7629512|FG000|Treatment Stage 1|Adverse Event|1
4707534|NCT02806986|7629512|FG000|Treatment Stage 2|Adverse Event|3
4707535|NCT02806986|7629512|FG000|Treatment Stage 2|Withdrawal by Subject|2
4707536|NCT02807259|7629522|FG000|Baseline (3 Months)|migration, refusal, not available|77
4707537|NCT02807259|7629523|FG001|Baseline (3 Months)|migration, refusal, not available|112
4707538|NCT02807259|7629522|FG000|Midline (3 Months)|migration, refusal, not available|30
4707539|NCT02807259|7629523|FG001|Midline (3 Months)|migration, refusal, not available|34
4707540|NCT02807259|7629522|FG000|Endline (3 Months)|migration, refusal, not available|35
4707541|NCT02807259|7629523|FG001|Endline (3 Months)|migration, refusal, not available|87
4707542|NCT02807376|7629533|FG000|Overall Study|Intra-operative exclusion criteria|3
4707543|NCT02807376|7629534|FG001|Overall Study|Intra-operative exclusion criteria|0
4707544|NCT02807376|7629533|FG000|Overall Study|Lost to Follow-up|0
4707545|NCT02807376|7629534|FG001|Overall Study|Lost to Follow-up|1
4707546|NCT02807402|7629540|FG000|Overall Study|Failure to Return|1
4707547|NCT02807402|7629540|FG000|Overall Study|Death|3
4707548|NCT02807402|7629540|FG000|Overall Study|Other|2
4707549|NCT02807623|7629555|FG000|Overall Study|Lost to Follow-up|23
4707550|NCT02807623|7629556|FG001|Overall Study|Lost to Follow-up|18
4707551|NCT02807623|7629557|FG002|Overall Study|Lost to Follow-up|22
4707552|NCT02807623|7629555|FG000|Overall Study|Drug intolerance|0
4707553|NCT02807623|7629556|FG001|Overall Study|Drug intolerance|1
4707554|NCT02807623|7629557|FG002|Overall Study|Drug intolerance|0
4707555|NCT02807623|7629555|FG000|Overall Study|incomplete blood draw|0
4707556|NCT02807623|7629556|FG001|Overall Study|incomplete blood draw|2
4707557|NCT02807623|7629557|FG002|Overall Study|incomplete blood draw|1
4707558|NCT02807844|7629584|FG000|Overall Study|Physician Decision|0
4707559|NCT02807844|7629585|FG001|Overall Study|Physician Decision|0
4707560|NCT02807844|7629586|FG002|Overall Study|Physician Decision|0
4707561|NCT02807844|7629587|FG003|Overall Study|Physician Decision|0
4707562|NCT02807844|7629588|FG004|Overall Study|Physician Decision|0
4707563|NCT02807844|7629589|FG005|Overall Study|Physician Decision|0
4707564|NCT02807844|7629590|FG006|Overall Study|Physician Decision|3
4707565|NCT02807844|7629591|FG007|Overall Study|Physician Decision|0
4707566|NCT02807844|7629592|FG008|Overall Study|Physician Decision|1
4707567|NCT02807844|7629593|FG009|Overall Study|Physician Decision|2
4707568|NCT02807844|7629584|FG000|Overall Study|Death|0
4707569|NCT02807844|7629585|FG001|Overall Study|Death|0
4707570|NCT02807844|7629586|FG002|Overall Study|Death|2
4707571|NCT02807844|7629587|FG003|Overall Study|Death|4
4707572|NCT02807844|7629588|FG004|Overall Study|Death|1
4707573|NCT02807844|7629589|FG005|Overall Study|Death|2
4707574|NCT02807844|7629590|FG006|Overall Study|Death|1
4707575|NCT02807844|7629591|FG007|Overall Study|Death|2
4707576|NCT02807844|7629592|FG008|Overall Study|Death|0
4707577|NCT02807844|7629593|FG009|Overall Study|Death|1
4707578|NCT02807844|7629584|FG000|Overall Study|Withdrawal by Subject|0
4707579|NCT02807844|7629585|FG001|Overall Study|Withdrawal by Subject|0
4707580|NCT02807844|7629586|FG002|Overall Study|Withdrawal by Subject|2
4707581|NCT02807844|7629587|FG003|Overall Study|Withdrawal by Subject|1
4707582|NCT02807844|7629588|FG004|Overall Study|Withdrawal by Subject|1
4707583|NCT02807844|7629589|FG005|Overall Study|Withdrawal by Subject|0
4707584|NCT02807844|7629590|FG006|Overall Study|Withdrawal by Subject|1
4707585|NCT02807844|7629591|FG007|Overall Study|Withdrawal by Subject|0
4707586|NCT02807844|7629592|FG008|Overall Study|Withdrawal by Subject|0
4707587|NCT02807844|7629593|FG009|Overall Study|Withdrawal by Subject|0
4707588|NCT02807844|7629584|FG000|Overall Study|Progressive disease|5
4707589|NCT02807844|7629585|FG001|Overall Study|Progressive disease|12
4707590|NCT02807844|7629586|FG002|Overall Study|Progressive disease|8
4707591|NCT02807844|7629587|FG003|Overall Study|Progressive disease|8
4707592|NCT02807844|7629588|FG004|Overall Study|Progressive disease|3
4707593|NCT02807844|7629589|FG005|Overall Study|Progressive disease|8
4707594|NCT02807844|7629590|FG006|Overall Study|Progressive disease|14
4707595|NCT02807844|7629591|FG007|Overall Study|Progressive disease|17
4707596|NCT02807844|7629592|FG008|Overall Study|Progressive disease|19
4707597|NCT02807844|7629593|FG009|Overall Study|Progressive disease|15
4707598|NCT02807844|7629584|FG000|Overall Study|Adverse Event|1
4707599|NCT02807844|7629585|FG001|Overall Study|Adverse Event|0
4707600|NCT02807844|7629586|FG002|Overall Study|Adverse Event|0
4707601|NCT02807844|7629587|FG003|Overall Study|Adverse Event|0
4707602|NCT02807844|7629588|FG004|Overall Study|Adverse Event|1
4707603|NCT02807844|7629589|FG005|Overall Study|Adverse Event|1
4707604|NCT02807844|7629590|FG006|Overall Study|Adverse Event|1
4707605|NCT02807844|7629591|FG007|Overall Study|Adverse Event|1
4707606|NCT02807844|7629592|FG008|Overall Study|Adverse Event|1
4707607|NCT02807844|7629593|FG009|Overall Study|Adverse Event|2
4707608|NCT02807857|7629619|FG000|Enrolled Set|Patients not suitable for follow-up.|551
4707609|NCT02807857|7629619|FG000|Follow-Up Set|Study Terminated By Sponsor|131
4707610|NCT02807857|7629619|FG000|Follow-Up Set|Withdrawal by Subject|8
4707611|NCT02807857|7629619|FG000|Follow-Up Set|Lost to Follow-up|7
4707612|NCT02807857|7629619|FG000|Follow-Up Set|Physician Decision|6
4707613|NCT02807857|7629619|FG000|Follow-Up Set|Adverse Event|3
4707614|NCT02807857|7629619|FG000|Follow-Up Set|Death|27
4707615|NCT02807857|7629619|FG000|Follow-Up Set|Relocation|2
4707616|NCT02807948|7629629|FG000|Overall Study|Physician Decision|1
4707617|NCT02807948|7629630|FG001|Overall Study|Physician Decision|0
4707618|NCT02808312|7629681|FG000|Overall Study|Enrolled but Never Treated|0
4707619|NCT02808312|7629682|FG001|Overall Study|Enrolled but Never Treated|0
4707620|NCT02808312|7629683|FG002|Overall Study|Enrolled but Never Treated|1
4707621|NCT02808312|7629684|FG003|Overall Study|Enrolled but Never Treated|0
4707622|NCT02808312|7629685|FG004|Overall Study|Enrolled but Never Treated|0
4707623|NCT02808338|7629702|FG000|Screening|Screen Failure|10
4707624|NCT02808338|7629702|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1
4707625|NCT02808338|7629702|FG000|Overnight In-lab Polysomonography|Reason not given|1
4707626|NCT02808429|7629716|FG000|Overall Study|Lost to Follow-up|1
4707627|NCT02808429|7629717|FG001|Overall Study|Lost to Follow-up|0
4707628|NCT02808429|7629718|FG002|Overall Study|Lost to Follow-up|0
4707629|NCT02808429|7629716|FG000|Overall Study|Protocol Violation|0
4707630|NCT02808429|7629717|FG001|Overall Study|Protocol Violation|1
4707631|NCT02808429|7629718|FG002|Overall Study|Protocol Violation|0
4707632|NCT02808429|7629716|FG000|Overall Study|Premature study termination by sponsor|2
4707633|NCT02808429|7629717|FG001|Overall Study|Premature study termination by sponsor|0
4707634|NCT02808429|7629718|FG002|Overall Study|Premature study termination by sponsor|1
4707635|NCT02808429|7629716|FG000|Overall Study|Relocation|0
4707636|NCT02808429|7629717|FG001|Overall Study|Relocation|0
4707637|NCT02808429|7629718|FG002|Overall Study|Relocation|1
4707638|NCT02808819|7629728|FG000|Overall Study|eg. no treatment efficacy on asthma|5
4707639|NCT02808819|7629729|FG001|Overall Study|eg. no treatment efficacy on asthma|4
4707640|NCT02808819|7629728|FG000|Overall Study|Withdrawal by Subject|10
4707641|NCT02808819|7629729|FG001|Overall Study|Withdrawal by Subject|13
4707642|NCT02808819|7629728|FG000|Overall Study|Site terminated by sponsor|2
4707643|NCT02808819|7629729|FG001|Overall Study|Site terminated by sponsor|0
4707644|NCT02808819|7629728|FG000|Overall Study|Pregnancy|1
4707645|NCT02808819|7629729|FG001|Overall Study|Pregnancy|0
4707646|NCT02808819|7629728|FG000|Overall Study|Lost to Follow-up|1
4707647|NCT02808819|7629729|FG001|Overall Study|Lost to Follow-up|6
4707648|NCT02808819|7629728|FG000|Overall Study|Protocol Violation|0
4707649|NCT02808819|7629729|FG001|Overall Study|Protocol Violation|1
4707650|NCT02808819|7629728|FG000|Overall Study|Development of study-specific withdrawal criteria|8
4707651|NCT02808819|7629729|FG001|Overall Study|Development of study-specific withdrawal criteria|3
4707652|NCT02808819|7629728|FG000|Overall Study|Death|1
4707653|NCT02808819|7629729|FG001|Overall Study|Death|0
4707654|NCT02808819|7629728|FG000|Overall Study|Adverse Event|3
4707655|NCT02808819|7629729|FG001|Overall Study|Adverse Event|4
4707656|NCT02808975|7629738|FG000|Overall Study|Adverse Event|3
4707657|NCT02808975|7629739|FG001|Overall Study|Adverse Event|4
4707658|NCT02808975|7629738|FG000|Overall Study|Withdrew consent|9
4707659|NCT02808975|7629739|FG001|Overall Study|Withdrew consent|8
4707660|NCT02808975|7629738|FG000|Overall Study|Lost to Follow-up|4
4707661|NCT02808975|7629739|FG001|Overall Study|Lost to Follow-up|6
4707662|NCT02808975|7629738|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1
4707663|NCT02808975|7629739|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0
4707664|NCT02808975|7629738|FG000|Overall Study|Other, not specified|5
4707665|NCT02808975|7629739|FG001|Overall Study|Other, not specified|1
4707666|NCT02809053|7629747|FG000|Overall Study|Death|0
4707667|NCT02809053|7629748|FG001|Overall Study|Death|1
4707668|NCT02809053|7629747|FG000|Overall Study|Lost to Follow-up|3
4707669|NCT02809053|7629748|FG001|Overall Study|Lost to Follow-up|1
4707670|NCT02809053|7629747|FG000|Overall Study|Withdrawal by Subject|2
4707671|NCT02809053|7629748|FG001|Overall Study|Withdrawal by Subject|3
4707672|NCT02809053|7629747|FG000|Overall Study|Disease Progression|2
4707673|NCT02809053|7629748|FG001|Overall Study|Disease Progression|1
4707674|NCT02809833|7629788|FG000|Overall Study|Death|3
4707675|NCT02809833|7629788|FG000|Overall Study|Intolerance|54
4707676|NCT02809833|7629788|FG000|Overall Study|Lack of Efficacy|89
4707677|NCT02809833|7629788|FG000|Overall Study|Remission/Treatment No Longer Needed|3
4707678|NCT02809833|7629788|FG000|Overall Study|Noncompliance|1
4707679|NCT02809833|7629788|FG000|Overall Study|Withdrawal by Subject|34
4707680|NCT02809833|7629788|FG000|Overall Study|Lost to Follow-up|35
4707681|NCT02809833|7629788|FG000|Overall Study|Adverse Event (AE)|24
4707682|NCT02809833|7629788|FG000|Overall Study|Other|5
4707683|NCT02809833|7629788|FG000|Overall Study|Missing Information|52
4707684|NCT02809976|7629814|FG000|Overall Study|Lost to Follow-up|1
4707685|NCT02809976|7629814|FG000|Overall Study|Withdrawal by Subject|1
4707686|NCT02810340|7629830|FG000|Overall Study|Withdrawal by Subject|1
4707687|NCT02810340|7629831|FG001|Overall Study|Withdrawal by Subject|0
4707688|NCT02810340|7629832|FG002|Overall Study|Withdrawal by Subject|0
4707689|NCT02810340|7629830|FG000|Overall Study|Incarceration|0
4707690|NCT02810340|7629831|FG001|Overall Study|Incarceration|1
4707691|NCT02810340|7629832|FG002|Overall Study|Incarceration|0
4707692|NCT02810340|7629830|FG000|Overall Study|Lost to Follow-up|0
4707693|NCT02810340|7629831|FG001|Overall Study|Lost to Follow-up|0
4707694|NCT02810340|7629832|FG002|Overall Study|Lost to Follow-up|1
4707695|NCT02810392|7629842|FG000|Overall Study|Subject too ill to continue|1
4707696|NCT02810392|7629843|FG001|Overall Study|Subject too ill to continue|0
4707697|NCT02810392|7629842|FG000|Overall Study|COVID 19 research restrictions|0
4707698|NCT02810392|7629843|FG001|Overall Study|COVID 19 research restrictions|1
4707699|NCT02810951|7629870|FG000|Overall Study|Adverse Event|1
4707700|NCT02810964|7629878|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1
4707701|NCT02810964|7629879|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2
4707702|NCT02810964|7629878|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1
4707703|NCT02810964|7629879|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0
4707704|NCT02810964|7629878|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0
4707705|NCT02810964|7629879|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1
4707706|NCT02810964|7629878|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1
4707707|NCT02810964|7629879|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0
4707708|NCT02811159|7629885|FG000|Treatment Course 1|Lost to Follow-up|1
4735681|NCT03537651|7683883|FG000|Overall Study|Commercial Drug is Available for Participant|56
4735682|NCT03537651|7683883|FG000|Overall Study|Other|1
4735683|NCT03538431|7683902|FG000|Overall Study|Physician Decision|0
4735684|NCT03538431|7683903|FG001|Overall Study|Physician Decision|1
4735685|NCT03538431|7683902|FG000|Overall Study|Withdrawal by Subject|1
4735686|NCT03538431|7683903|FG001|Overall Study|Withdrawal by Subject|0
4735687|NCT03538743|7683929|FG000|Overall Study|Adverse Event|0
4735688|NCT03538743|7683930|FG001|Overall Study|Adverse Event|0
4735689|NCT03538743|7683931|FG002|Overall Study|Adverse Event|1
4735690|NCT03538743|7683932|FG003|Overall Study|Adverse Event|1
4735691|NCT03538743|7683933|FG004|Overall Study|Adverse Event|0
4735692|NCT03538743|7683934|FG005|Overall Study|Adverse Event|0
4735693|NCT03538743|7683935|FG006|Overall Study|Adverse Event|0
4735694|NCT03538743|7683936|FG007|Overall Study|Adverse Event|0
4735695|NCT03538743|7683937|FG008|Overall Study|Adverse Event|0
4735696|NCT03538743|7683929|FG000|Overall Study|Non-Treatment-Related Reasons|0
4735697|NCT03538743|7683930|FG001|Overall Study|Non-Treatment-Related Reasons|0
4735698|NCT03538743|7683931|FG002|Overall Study|Non-Treatment-Related Reasons|0
4735699|NCT03538743|7683932|FG003|Overall Study|Non-Treatment-Related Reasons|0
4735700|NCT03538743|7683933|FG004|Overall Study|Non-Treatment-Related Reasons|0
4735701|NCT03538743|7683934|FG005|Overall Study|Non-Treatment-Related Reasons|0
4735702|NCT03538743|7683935|FG006|Overall Study|Non-Treatment-Related Reasons|0
4735703|NCT03538743|7683936|FG007|Overall Study|Non-Treatment-Related Reasons|0
4735704|NCT03538743|7683937|FG008|Overall Study|Non-Treatment-Related Reasons|3
4735705|NCT03538743|7683929|FG000|Overall Study|Withdrawal by Subject|0
4735706|NCT03538743|7683930|FG001|Overall Study|Withdrawal by Subject|0
4735707|NCT03538743|7683931|FG002|Overall Study|Withdrawal by Subject|0
4735708|NCT03538743|7683932|FG003|Overall Study|Withdrawal by Subject|1
4735709|NCT03538743|7683933|FG004|Overall Study|Withdrawal by Subject|0
4735710|NCT03538743|7683934|FG005|Overall Study|Withdrawal by Subject|0
4735711|NCT03538743|7683935|FG006|Overall Study|Withdrawal by Subject|0
4735712|NCT03538743|7683936|FG007|Overall Study|Withdrawal by Subject|0
4735713|NCT03538743|7683937|FG008|Overall Study|Withdrawal by Subject|0
4735714|NCT03539432|7683997|FG000|Overall Study|Lost to Follow-up|0
4735715|NCT03539432|7683998|FG001|Overall Study|Lost to Follow-up|1
4735716|NCT03539484|7684011|FG000|Overall Study|Death|1
4735717|NCT03539484|7684012|FG001|Overall Study|Death|0
4735718|NCT03539484|7684013|FG002|Overall Study|Death|0
4735719|NCT03539484|7684014|FG003|Overall Study|Death|2
4735720|NCT03539484|7684015|FG004|Overall Study|Death|8
4735721|NCT03539484|7684016|FG005|Overall Study|Death|3
4735722|NCT03539484|7684017|FG006|Overall Study|Death|0
4735723|NCT03539484|7684011|FG000|Overall Study|Lost to Follow-up|0
4735724|NCT03539484|7684012|FG001|Overall Study|Lost to Follow-up|1
4735725|NCT03539484|7684013|FG002|Overall Study|Lost to Follow-up|0
4735726|NCT03539484|7684014|FG003|Overall Study|Lost to Follow-up|0
4735727|NCT03539484|7684015|FG004|Overall Study|Lost to Follow-up|1
4735728|NCT03539484|7684016|FG005|Overall Study|Lost to Follow-up|0
4735729|NCT03539484|7684017|FG006|Overall Study|Lost to Follow-up|0
4735730|NCT03539484|7684011|FG000|Overall Study|Withdrawal by Subject|0
4735731|NCT03539484|7684012|FG001|Overall Study|Withdrawal by Subject|0
4707709|NCT02811640|7629912|FG000|Overall Study|Technology malfunction|2
4707710|NCT02812186|7629952|FG000|Period 1|Post randomization screen failure|5
4707711|NCT02812186|7629953|FG001|Period 1|Post randomization screen failure|9
4707712|NCT02812186|7629952|FG000|Period 1|nonevaluable data sets|6
4707713|NCT02812186|7629953|FG001|Period 1|nonevaluable data sets|6
4707714|NCT02813421|7630000|FG000|Overall Study|Withdrawal by Subject|1
4707715|NCT02813421|7630001|FG001|Overall Study|Withdrawal by Subject|2
4707716|NCT02813421|7630000|FG000|Overall Study|Lost to Follow-up|1
4707717|NCT02813421|7630001|FG001|Overall Study|Lost to Follow-up|1
4707718|NCT02813577|7630020|FG000|Overall Study|Study terminated|4
4707719|NCT02813681|7630027|FG000|Overall Study|Physician Decision|5
4707720|NCT02813681|7630028|FG001|Overall Study|Physician Decision|5
4707721|NCT02813681|7630029|FG002|Overall Study|Physician Decision|0
4707722|NCT02813681|7630027|FG000|Overall Study|Lost to Follow-up|0
4707723|NCT02813681|7630028|FG001|Overall Study|Lost to Follow-up|1
4707724|NCT02813681|7630029|FG002|Overall Study|Lost to Follow-up|0
4707725|NCT02813694|7630041|FG000|Overall Study|Physician Decision|0
4707726|NCT02813694|7630042|FG001|Overall Study|Physician Decision|1
4707727|NCT02813694|7630041|FG000|Overall Study|Withdrawal by Subject|10
4707728|NCT02813694|7630042|FG001|Overall Study|Withdrawal by Subject|9
4707729|NCT02813694|7630041|FG000|Overall Study|Lost to Follow-up|1
4707730|NCT02813694|7630042|FG001|Overall Study|Lost to Follow-up|1
4707731|NCT02813694|7630041|FG000|Overall Study|Death|3
4707732|NCT02813694|7630042|FG001|Overall Study|Death|3
4707733|NCT02813694|7630041|FG000|Overall Study|Randomized- did not receive study drug|2
4707734|NCT02813694|7630042|FG001|Overall Study|Randomized- did not receive study drug|0
4707735|NCT02813694|7630041|FG000|Overall Study|Patient hospitalized|1
4707736|NCT02813694|7630042|FG001|Overall Study|Patient hospitalized|0
4707737|NCT02814175|7630050|FG000|Part 1|Adverse Event|2
4707738|NCT02814175|7630051|FG001|Part 1|Adverse Event|3
4707739|NCT02814175|7630052|FG002|Part 1|Adverse Event|0
4707740|NCT02814175|7630053|FG003|Part 1|Adverse Event|0
4707741|NCT02814175|7630054|FG004|Part 1|Adverse Event|0
4707742|NCT02814175|7630055|FG005|Part 1|Adverse Event|0
4707743|NCT02814175|7630050|FG000|Part 1|Withdrawal Consent|8
4707744|NCT02814175|7630051|FG001|Part 1|Withdrawal Consent|1
4707745|NCT02814175|7630052|FG002|Part 1|Withdrawal Consent|0
4707746|NCT02814175|7630053|FG003|Part 1|Withdrawal Consent|0
4707747|NCT02814175|7630054|FG004|Part 1|Withdrawal Consent|0
4707748|NCT02814175|7630055|FG005|Part 1|Withdrawal Consent|0
4707749|NCT02814175|7630050|FG000|Part 1|Lost to Follow-up|1
4388220|NCT00057811|7166862|FG000|Overall Study|Ineligible|4
4388221|NCT00057811|7166863|FG001|Overall Study|Ineligible|2
4388222|NCT00057811|7166862|FG000|Overall Study|Inevaluable|1
4388223|NCT00057811|7166863|FG001|Overall Study|Inevaluable|2
4388224|NCT00057837|7166871|FG000|Overall Study|Progression/relapse|12
4388225|NCT00057837|7166872|FG001|Overall Study|Progression/relapse|14
4388226|NCT00057837|7166871|FG000|Overall Study|Adverse Event|2
4388227|NCT00057837|7166872|FG001|Overall Study|Adverse Event|12
4388228|NCT00057837|7166871|FG000|Overall Study|Death|5
4388229|NCT00057837|7166872|FG001|Overall Study|Death|4
4388230|NCT00057837|7166871|FG000|Overall Study|Withdrawal by Subject|5
4388231|NCT00057837|7166872|FG001|Overall Study|Withdrawal by Subject|3
4388232|NCT00057837|7166871|FG000|Overall Study|Alternative therapy|0
4388233|NCT00057837|7166872|FG001|Overall Study|Alternative therapy|1
4388234|NCT00057837|7166871|FG000|Overall Study|Other complicating disease|2
4388235|NCT00057837|7166872|FG001|Overall Study|Other complicating disease|1
4388236|NCT00057837|7166871|FG000|Overall Study|Physician Decision|1
4388237|NCT00057837|7166872|FG001|Overall Study|Physician Decision|0
4388238|NCT00057837|7166871|FG000|Overall Study|Ineligible|3
4388239|NCT00057837|7166872|FG001|Overall Study|Ineligible|3
4388240|NCT00057837|7166871|FG000|Overall Study|Never started treatment|1
4388241|NCT00057837|7166872|FG001|Overall Study|Never started treatment|1
4388242|NCT00057863|7166878|FG000|Overall Study|Death|1
4388243|NCT00057863|7166878|FG000|Overall Study|Withdrawal by Subject|2
4388244|NCT00057876|7166884|FG000|Overall Study|Adverse Event|8
4388245|NCT00057876|7166885|FG001|Overall Study|Adverse Event|8
4388246|NCT00057876|7166884|FG000|Overall Study|Death|2
4388247|NCT00057876|7166885|FG001|Overall Study|Death|1
4388248|NCT00057876|7166884|FG000|Overall Study|Withdrawal by Subject|5
4388249|NCT00057876|7166885|FG001|Overall Study|Withdrawal by Subject|6
4388250|NCT00057876|7166884|FG000|Overall Study|Lack of Efficacy|10
4388251|NCT00057876|7166885|FG001|Overall Study|Lack of Efficacy|8
4388252|NCT00057876|7166884|FG000|Overall Study|Ineligible|1
4707750|NCT02814175|7630051|FG001|Part 1|Lost to Follow-up|0
4707751|NCT02814175|7630052|FG002|Part 1|Lost to Follow-up|0
4707752|NCT02814175|7630053|FG003|Part 1|Lost to Follow-up|0
4707753|NCT02814175|7630054|FG004|Part 1|Lost to Follow-up|0
4707754|NCT02814175|7630055|FG005|Part 1|Lost to Follow-up|0
4707755|NCT02814175|7630050|FG000|Part 1|Lack of Efficacy|1
4707756|NCT02814175|7630051|FG001|Part 1|Lack of Efficacy|2
4707757|NCT02814175|7630052|FG002|Part 1|Lack of Efficacy|0
4707758|NCT02814175|7630053|FG003|Part 1|Lack of Efficacy|0
4707759|NCT02814175|7630054|FG004|Part 1|Lack of Efficacy|0
4388253|NCT00057876|7166885|FG001|Overall Study|Ineligible|2
4388254|NCT00057876|7166884|FG000|Overall Study|other reason|2
4388255|NCT00057876|7166885|FG001|Overall Study|other reason|2
4388256|NCT00057876|7166884|FG000|Overall Study|other complicating disease|1
4707760|NCT02814175|7630055|FG005|Part 1|Lack of Efficacy|0
4707761|NCT02814175|7630050|FG000|Part 2|Adverse Event|0
4707762|NCT02814175|7630051|FG001|Part 2|Adverse Event|0
4707763|NCT02814175|7630052|FG002|Part 2|Adverse Event|0
4707764|NCT02814175|7630053|FG003|Part 2|Adverse Event|1
4707765|NCT02814175|7630054|FG004|Part 2|Adverse Event|1
4707766|NCT02814175|7630055|FG005|Part 2|Adverse Event|2
4707767|NCT02814175|7630050|FG000|Part 2|Withdrawal Consent|0
4707768|NCT02814175|7630051|FG001|Part 2|Withdrawal Consent|0
4707769|NCT02814175|7630052|FG002|Part 2|Withdrawal Consent|0
4707770|NCT02814175|7630053|FG003|Part 2|Withdrawal Consent|2
4388257|NCT00057876|7166885|FG001|Overall Study|other complicating disease|0
4388258|NCT00057941|7166893|FG000|Overall Study|Death|1
4388259|NCT00057941|7166894|FG001|Overall Study|Death|2
4388260|NCT00057941|7166893|FG000|Overall Study|Adverse Event|7
4628025|NCT01856673|7494937|FG000|Overall Study|Withdrawal by Subject|44
4628026|NCT01856673|7494938|FG001|Overall Study|Withdrawal by Subject|50
4628027|NCT01856673|7494939|FG002|Overall Study|Withdrawal by Subject|33
4628028|NCT01856673|7494937|FG000|Overall Study|Lost to Follow-up|31
4628029|NCT01856673|7494938|FG001|Overall Study|Lost to Follow-up|34
4628030|NCT01856673|7494939|FG002|Overall Study|Lost to Follow-up|0
4628031|NCT01856673|7494937|FG000|Overall Study|Unknown reasons|9
4628032|NCT01856673|7494938|FG001|Overall Study|Unknown reasons|0
4628033|NCT01856673|7494939|FG002|Overall Study|Unknown reasons|0
4628034|NCT01856673|7494937|FG000|Overall Study|Psychologist decision|1
4628035|NCT01856673|7494938|FG001|Overall Study|Psychologist decision|0
4628036|NCT01856673|7494939|FG002|Overall Study|Psychologist decision|0
4628037|NCT01856673|7494937|FG000|Overall Study|Paperwork errors|8
4628038|NCT01856673|7494938|FG001|Overall Study|Paperwork errors|0
4628039|NCT01856673|7494939|FG002|Overall Study|Paperwork errors|0
4628040|NCT01856673|7494937|FG000|Overall Study|Death|1
4628041|NCT01856673|7494938|FG001|Overall Study|Death|1
4628042|NCT01856673|7494939|FG002|Overall Study|Death|0
4628043|NCT01856673|7494937|FG000|Overall Study|Protocol Violation|1
4628044|NCT01856673|7494938|FG001|Overall Study|Protocol Violation|0
4628045|NCT01856673|7494939|FG002|Overall Study|Protocol Violation|1
4628046|NCT01856686|7494949|FG000|Overall Study|Lost to Follow-up|5
4628047|NCT01856686|7494950|FG001|Overall Study|Lost to Follow-up|11
4628048|NCT01856790|7494978|FG000|Closed Loop Control|Withdrawal by Subject|2
4628049|NCT01856790|7494978|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2
4628050|NCT01856907|7494992|FG000|Overall Study|Pregnancy|0
4628051|NCT01856907|7494993|FG001|Overall Study|Pregnancy|1
4628052|NCT01856907|7494994|FG002|Overall Study|Pregnancy|0
4628053|NCT01856907|7494992|FG000|Overall Study|Pregnancy|0
4628054|NCT01856907|7494993|FG001|Overall Study|Pregnancy|1
4628055|NCT01856907|7494994|FG002|Overall Study|Pregnancy|0
4628056|NCT01856907|7494992|FG000|Overall Study|Withdrawal by Subject|0
4628057|NCT01856907|7494993|FG001|Overall Study|Withdrawal by Subject|1
4628058|NCT01856907|7494994|FG002|Overall Study|Withdrawal by Subject|0
4628059|NCT01857102|7495009|FG000|Period 1|No longer meets Eligibility Criteria|0
4628060|NCT01857102|7495010|FG001|Period 1|No longer meets Eligibility Criteria|2
4628061|NCT01857102|7495009|FG000|Period 1|Lost to Follow-up|0
4628062|NCT01857102|7495010|FG001|Period 1|Lost to Follow-up|3
4628063|NCT01857102|7495009|FG000|Period 1|Unsatisfactory Lens Fit|1
4628064|NCT01857102|7495010|FG001|Period 1|Unsatisfactory Lens Fit|0
4628065|NCT01857102|7495009|FG000|Period 1|Unsatisfactory Visual Response|1
4628066|NCT01857102|7495010|FG001|Period 1|Unsatisfactory Visual Response|0
4628067|NCT01857102|7495009|FG000|Period 1|Physician Decision|1
4707771|NCT02814175|7630054|FG004|Part 2|Withdrawal Consent|1
4707772|NCT02814175|7630055|FG005|Part 2|Withdrawal Consent|1
4628068|NCT01857102|7495010|FG001|Period 1|Physician Decision|0
4707773|NCT02814175|7630050|FG000|Part 2|Lost to Follow-up|0
4707774|NCT02814175|7630051|FG001|Part 2|Lost to Follow-up|0
4707775|NCT02814175|7630052|FG002|Part 2|Lost to Follow-up|0
4707776|NCT02814175|7630053|FG003|Part 2|Lost to Follow-up|1
4707777|NCT02814175|7630054|FG004|Part 2|Lost to Follow-up|0
4707778|NCT02814175|7630055|FG005|Part 2|Lost to Follow-up|0
4707779|NCT02814175|7630050|FG000|Part 2|Lack of Efficacy|0
4707780|NCT02814175|7630051|FG001|Part 2|Lack of Efficacy|0
4707781|NCT02814175|7630052|FG002|Part 2|Lack of Efficacy|0
4707782|NCT02814175|7630053|FG003|Part 2|Lack of Efficacy|0
4707783|NCT02814175|7630054|FG004|Part 2|Lack of Efficacy|0
4707784|NCT02814175|7630055|FG005|Part 2|Lack of Efficacy|3
4707785|NCT02814565|7630105|FG000|Overall Study|Lack of Efficacy|0
4707786|NCT02814565|7630106|FG001|Overall Study|Lack of Efficacy|1
4707787|NCT02814565|7630105|FG000|Overall Study|Subject decision, caused by AE Influenza|1
4707788|NCT02814565|7630106|FG001|Overall Study|Subject decision, caused by AE Influenza|1
4707789|NCT02814643|7630114|FG000|Overall Study|Lost to Follow-up|0
4707790|NCT02814643|7630115|FG001|Overall Study|Lost to Follow-up|1
4707791|NCT02814643|7630114|FG000|Overall Study|Withdrawal by Subject|1
4707792|NCT02814643|7630115|FG001|Overall Study|Withdrawal by Subject|2
4707793|NCT02814838|7630140|FG000|Overall Study|3 agreed dates for the final visit missed|1
4628069|NCT01857102|7495009|FG000|Period 2|Lens Discomfort|1
4707794|NCT02814838|7630141|FG001|Overall Study|3 agreed dates for the final visit missed|0
4388261|NCT00057941|7166894|FG001|Overall Study|Adverse Event|9
4388262|NCT00057941|7166893|FG000|Overall Study|Lack of Efficacy|54
4628070|NCT01857102|7495010|FG001|Period 2|Lens Discomfort|0
4628071|NCT01857102|7495009|FG000|Period 2|Unsatisfactory Lens Fit|1
4707795|NCT02814838|7630140|FG000|Overall Study|Consent withdrawal|1
4628072|NCT01857102|7495010|FG001|Period 2|Unsatisfactory Lens Fit|0
4628073|NCT01857206|7495020|FG000|Overall Study|ADMINISTRATIVE REASON|0
4628074|NCT01857206|7495021|FG001|Overall Study|ADMINISTRATIVE REASON|1
4628075|NCT01857206|7495020|FG000|Overall Study|Lost to Follow-up|9
4628076|NCT01857206|7495021|FG001|Overall Study|Lost to Follow-up|6
4628077|NCT01857206|7495020|FG000|Overall Study|Unclassified|3
4628078|NCT01857206|7495021|FG001|Overall Study|Unclassified|3
4707796|NCT02814838|7630141|FG001|Overall Study|Consent withdrawal|1
4707797|NCT02815293|7630165|FG000|Overall Study|Study termination by sponsor|10
4707798|NCT02815293|7630166|FG001|Overall Study|Study termination by sponsor|7
4707799|NCT02815293|7630167|FG002|Overall Study|Study termination by sponsor|0
4707800|NCT02815293|7630165|FG000|Overall Study|Participants not randomized|0
4707801|NCT02815293|7630166|FG001|Overall Study|Participants not randomized|0
4707802|NCT02815293|7630167|FG002|Overall Study|Participants not randomized|18
4707803|NCT02815293|7630165|FG000|Overall Study|Adverse Event|0
4707804|NCT02815293|7630166|FG001|Overall Study|Adverse Event|1
4707805|NCT02815293|7630167|FG002|Overall Study|Adverse Event|0
4707806|NCT02815670|7630182|FG000|Overall Study|Prematurely discontinued of the trial|1
4707807|NCT02815735|7630208|FG000|First Intervention (4 Weeks)|Discomfort|1
4707808|NCT02815735|7630209|FG001|First Intervention (4 Weeks)|Discomfort|0
4707809|NCT02815735|7630208|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1
4707810|NCT02815735|7630209|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0
4707811|NCT02815735|7630208|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0
4707812|NCT02815735|7630209|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1
4707813|NCT02815735|7630208|FG000|Second Intervention (4 Weeks)|Protocol Violation|1
4707814|NCT02815735|7630209|FG001|Second Intervention (4 Weeks)|Protocol Violation|0
4707815|NCT02816138|7630243|FG000|Overall Study|Adverse Event|1
4707816|NCT02816398|7630268|FG000|Overall Study|Death|5
4707817|NCT02816398|7630268|FG000|Overall Study|Lack of Efficacy|8
4707818|NCT02816398|7630268|FG000|Overall Study|Lost to Follow-up|1
4707819|NCT02817087|7630299|FG000|Overall Study|Withdrawal by Subject|2
4707820|NCT02817087|7630300|FG001|Overall Study|Withdrawal by Subject|0
4707821|NCT02817516|7630310|FG000|Overall Study|Other|0
4707822|NCT02817516|7630311|FG001|Overall Study|Other|0
4707823|NCT02817516|7630312|FG002|Overall Study|Other|1
4707824|NCT02817516|7630313|FG003|Overall Study|Other|0
4707825|NCT02817555|7630328|FG000|Overall Study|Death|1
4707826|NCT02817555|7630329|FG001|Overall Study|Death|3
4707827|NCT02817555|7630328|FG000|Overall Study|moved away|1
4707828|NCT02817555|7630329|FG001|Overall Study|moved away|0
4707829|NCT02817555|7630328|FG000|Overall Study|transplant|1
4707830|NCT02817555|7630329|FG001|Overall Study|transplant|1
4707831|NCT02817555|7630328|FG000|Overall Study|changed to Peritoneal Dialysis|0
4707832|NCT02817555|7630329|FG001|Overall Study|changed to Peritoneal Dialysis|1
4707833|NCT02817594|7630335|FG000|Overall Study|Withdrawal by Subject|1
4707834|NCT02817594|7630335|FG000|Overall Study|Other|1
4707835|NCT02817594|7630335|FG000|Overall Study|Did Not Receive Treatment|1
4707836|NCT02817776|7630352|FG000|Overall Study|Excluded|33
4707837|NCT02817776|7630352|FG000|Overall Study|Lost to Follow-up|20
4707838|NCT02817776|7630352|FG000|Overall Study|Withdrawal by Subject|33
4707839|NCT02817776|7630352|FG000|Overall Study|Death|2
4707840|NCT02817828|7630356|FG000|Overall Study|Lost to Follow-up|41
4707841|NCT02817828|7630356|FG000|Overall Study|Adverse event not related to bleeding|104
4707842|NCT02817828|7630356|FG000|Overall Study|Adverse event related to bleeding|53
4707843|NCT02817828|7630356|FG000|Overall Study|Protocol Violation|11
4707844|NCT02817828|7630356|FG000|Overall Study|Pregnancy|7
4707845|NCT02817828|7630356|FG000|Overall Study|Pregnancy wish|15
4707846|NCT02817828|7630356|FG000|Overall Study|Withdrawal by Subject|78
4707847|NCT02817828|7630356|FG000|Overall Study|Other|26
4707848|NCT02817841|7630365|FG000|Overall Study|Lost to Follow-up|287
4388263|NCT00057941|7166894|FG001|Overall Study|Lack of Efficacy|53
4388264|NCT00057941|7166893|FG000|Overall Study|Withdrawal by Subject|6
4388265|NCT00057941|7166894|FG001|Overall Study|Withdrawal by Subject|1
4388266|NCT00057941|7166893|FG000|Overall Study|still on treatment|3
4628079|NCT01857206|7495020|FG000|Overall Study|Withdrawal by Subject|1
4388267|NCT00057941|7166894|FG001|Overall Study|still on treatment|1
4388268|NCT00057941|7166893|FG000|Overall Study|insurance, symptomatic deterioration|1
4388269|NCT00057941|7166894|FG001|Overall Study|insurance, symptomatic deterioration|3
4388270|NCT00057941|7166893|FG000|Overall Study|Ineligible|2
4388271|NCT00057941|7166894|FG001|Overall Study|Ineligible|5
4388272|NCT00057954|7166900|FG000|Overall Study|Death|1
4388273|NCT00057954|7166900|FG000|Overall Study|Disease progression|1
4388274|NCT00058058|7166912|FG000|Overall Study|Withdrawal by Subject|4
4388275|NCT00058058|7166912|FG000|Overall Study|Ineligible|20
4388276|NCT00058058|7166912|FG000|Overall Study|Claustrophobic|5
4388277|NCT00058058|7166912|FG000|Overall Study|technical issues|6
4388278|NCT00058058|7166912|FG000|Overall Study|Poor positioning, illness,pain|3
4388279|NCT00058123|7166917|FG000|Overall Study|Wrong histology|9
4628080|NCT01857206|7495021|FG001|Overall Study|Withdrawal by Subject|0
4388280|NCT00058123|7166917|FG000|Overall Study|Received >3 prior treatments|1
4388281|NCT00058214|7166922|FG000|Overall Study|Adverse Event|1
4388282|NCT00058422|7166947|FG000|Overall Study|Not treated|2
4628081|NCT01857310|7495075|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315
4707849|NCT02817841|7630365|FG000|Overall Study|Withdrawal by Subject|183
4707850|NCT02817841|7630365|FG000|Overall Study|Adverse event not related to bleeding|131
4707851|NCT02817841|7630365|FG000|Overall Study|Adverse event related to bleeding|51
4707852|NCT02817841|7630365|FG000|Overall Study|Pregnancy|32
4707853|NCT02817841|7630365|FG000|Overall Study|Pregnancy wish|17
4707854|NCT02817841|7630365|FG000|Overall Study|Other reasons|53
4707855|NCT02817841|7630365|FG000|Overall Study|Protocol Violation|94
4707856|NCT02817906|7630375|FG000|Overall Study|Adverse Event|3
4707857|NCT02817906|7630376|FG001|Overall Study|Adverse Event|0
4707858|NCT02817906|7630375|FG000|Overall Study|Lack of Efficacy|1
4707859|NCT02817906|7630376|FG001|Overall Study|Lack of Efficacy|0
4707860|NCT02817906|7630375|FG000|Overall Study|Protocol Violation|1
4707861|NCT02817906|7630376|FG001|Overall Study|Protocol Violation|1
4707862|NCT02817906|7630375|FG000|Overall Study|Study Terminated by Sponsor|2
4707863|NCT02817906|7630376|FG001|Overall Study|Study Terminated by Sponsor|2
4707864|NCT02817906|7630375|FG000|Overall Study|Withdrawal by Subject|7
4707865|NCT02817906|7630376|FG001|Overall Study|Withdrawal by Subject|0
4707866|NCT02817906|7630375|FG000|Overall Study|Other|2
4707867|NCT02817906|7630376|FG001|Overall Study|Other|2
4707868|NCT02818036|7630384|FG000|Overall Study|head did not fit in fMRI scanner headres|1
4707869|NCT02818036|7630385|FG001|Overall Study|head did not fit in fMRI scanner headres|0
4707870|NCT02818036|7630384|FG000|Overall Study|Withdrawal by Subject|1
4707871|NCT02818036|7630385|FG001|Overall Study|Withdrawal by Subject|0
4707872|NCT02818777|7630423|FG000|Overall Study|Adverse Event|3
4707873|NCT02818998|7630436|FG000|Overall Study|Adverse Event|3
4707874|NCT02818998|7630437|FG001|Overall Study|Adverse Event|2
4707875|NCT02818998|7630438|FG002|Overall Study|Adverse Event|1
4707876|NCT02818998|7630436|FG000|Overall Study|Lost to Follow-up|4
4707877|NCT02818998|7630437|FG001|Overall Study|Lost to Follow-up|1
4707878|NCT02818998|7630438|FG002|Overall Study|Lost to Follow-up|2
4707879|NCT02818998|7630436|FG000|Overall Study|Withdrawal by sponsor|0
4707880|NCT02818998|7630437|FG001|Overall Study|Withdrawal by sponsor|1
4707881|NCT02818998|7630438|FG002|Overall Study|Withdrawal by sponsor|1
4707882|NCT02818998|7630436|FG000|Overall Study|Death|3
4707883|NCT02818998|7630437|FG001|Overall Study|Death|6
4707884|NCT02818998|7630438|FG002|Overall Study|Death|8
4707885|NCT02818998|7630436|FG000|Overall Study|Withdrawal by Subject|7
4707886|NCT02818998|7630437|FG001|Overall Study|Withdrawal by Subject|6
4707887|NCT02818998|7630438|FG002|Overall Study|Withdrawal by Subject|6
4707888|NCT02818998|7630436|FG000|Overall Study|Physician Decision|1
4707889|NCT02818998|7630437|FG001|Overall Study|Physician Decision|0
4707890|NCT02818998|7630438|FG002|Overall Study|Physician Decision|0
4707891|NCT02819297|7630467|FG000|Overall Study|Withdrawal by Subject|25
4707892|NCT02819297|7630468|FG001|Overall Study|Withdrawal by Subject|13
4707893|NCT02819297|7630467|FG000|Overall Study|Lost to Follow-up|12
4628082|NCT01857310|7495076|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282
4707894|NCT02819297|7630468|FG001|Overall Study|Lost to Follow-up|14
4707895|NCT02819297|7630467|FG000|Overall Study|Adverse Event|12
4707896|NCT02819297|7630468|FG001|Overall Study|Adverse Event|10
4707897|NCT02819297|7630467|FG000|Overall Study|Physician Decision|5
4388283|NCT00058539|7166951|FG000|Overall Study|Disease progression|24
4388284|NCT00058539|7166951|FG000|Overall Study|Adverse Event|3
4388285|NCT00058539|7166951|FG000|Overall Study|Withdrawal by Subject|5
4388286|NCT00058539|7166951|FG000|Overall Study|Physician Decision|9
4388287|NCT00058539|7166951|FG000|Overall Study|Death|1
4388288|NCT00058552|7166957|FG000|Overall Study|Died prior to receiving treatment|4
4388289|NCT00058552|7166958|FG001|Overall Study|Died prior to receiving treatment|2
4388290|NCT00058552|7166957|FG000|Overall Study|Disease progression|52
4388291|NCT00058552|7166958|FG001|Overall Study|Disease progression|44
4388292|NCT00058552|7166957|FG000|Overall Study|Adverse Event|4
4388293|NCT00058552|7166958|FG001|Overall Study|Adverse Event|2
4388294|NCT00058552|7166957|FG000|Overall Study|Withdrawal by Subject|3
4388295|NCT00058552|7166958|FG001|Overall Study|Withdrawal by Subject|5
4388296|NCT00058552|7166957|FG000|Overall Study|Physician Decision|2
4388297|NCT00058552|7166958|FG001|Overall Study|Physician Decision|5
4388298|NCT00058552|7166957|FG000|Overall Study|Clinical disease progression|0
4628083|NCT01857323|7495082|FG000|Overall Study|Adverse Event|1
4628084|NCT01857323|7495082|FG000|Overall Study|Withdrawal by Subject|3
4388299|NCT00058552|7166958|FG001|Overall Study|Clinical disease progression|4
4388300|NCT00058825|7166966|FG000|Overall Study|Relapse|9
4628085|NCT01857323|7495082|FG000|Overall Study|Non-compliance|1
4628086|NCT01857323|7495082|FG000|Overall Study|Protocol Violation|6
4628087|NCT01857323|7495082|FG000|Overall Study|Lost to Follow-up|1
4628088|NCT01857323|7495082|FG000|Overall Study|Other|4
4628089|NCT01857323|7495082|FG000|Overall Study|Did not complete 180 doses|48
4628090|NCT01857531|7495093|FG000|Overall Study|Withdrawal by Subject|4
4628091|NCT01857583|7495101|FG000|Overall Study|Adverse Event|0
4628092|NCT01857583|7495102|FG001|Overall Study|Adverse Event|0
4628093|NCT01857583|7495103|FG002|Overall Study|Adverse Event|1
4628094|NCT01857583|7495104|FG003|Overall Study|Adverse Event|1
4628095|NCT01857583|7495101|FG000|Overall Study|Death|0
4628096|NCT01857583|7495102|FG001|Overall Study|Death|1
4628097|NCT01857583|7495103|FG002|Overall Study|Death|1
4628098|NCT01857583|7495104|FG003|Overall Study|Death|0
4628099|NCT01857583|7495101|FG000|Overall Study|Physician Decision|0
4628100|NCT01857583|7495102|FG001|Overall Study|Physician Decision|0
4707898|NCT02819297|7630468|FG001|Overall Study|Physician Decision|5
4707899|NCT02819297|7630467|FG000|Overall Study|Lack of Efficacy|5
4707900|NCT02819297|7630468|FG001|Overall Study|Lack of Efficacy|8
4707901|NCT02819297|7630467|FG000|Overall Study|Protocol Violation|1
4707902|NCT02819297|7630468|FG001|Overall Study|Protocol Violation|2
4707903|NCT02819310|7630474|FG000|Overall Study|Withdrawal by Subject|37
4707904|NCT02819310|7630474|FG000|Overall Study|Lost to Follow-up|16
4707905|NCT02819310|7630474|FG000|Overall Study|Adverse Event|13
4707906|NCT02819310|7630474|FG000|Overall Study|Lack of Efficacy|5
4707907|NCT02819310|7630474|FG000|Overall Study|Physician Decision|8
4707908|NCT02819310|7630474|FG000|Overall Study|Protocol Violation|30
4707909|NCT02819479|7630491|FG000|Overall Study|Adverse Event|2
4707910|NCT02819726|7630503|FG000|Part A (All Participants)|Lost to Follow-up|0
4707911|NCT02819726|7630504|FG001|Part A (All Participants)|Lost to Follow-up|1
4707912|NCT02819726|7630505|FG002|Part A (All Participants)|Lost to Follow-up|0
4707913|NCT02819726|7630506|FG003|Part A (All Participants)|Lost to Follow-up|0
4707914|NCT02819726|7630503|FG000|Part A (All Participants)|Withdrawal by Subject|3
4707915|NCT02819726|7630504|FG001|Part A (All Participants)|Withdrawal by Subject|5
4707916|NCT02819726|7630505|FG002|Part A (All Participants)|Withdrawal by Subject|6
4707917|NCT02819726|7630506|FG003|Part A (All Participants)|Withdrawal by Subject|0
4707918|NCT02819726|7630503|FG000|Part A (All Participants)|Protocol non-compliance|3
4707919|NCT02819726|7630504|FG001|Part A (All Participants)|Protocol non-compliance|4
4707920|NCT02819726|7630505|FG002|Part A (All Participants)|Protocol non-compliance|5
4707921|NCT02819726|7630506|FG003|Part A (All Participants)|Protocol non-compliance|0
4707922|NCT02819726|7630503|FG000|Part B (All Participants)|Lost to Follow-up|1
4707923|NCT02819726|7630504|FG001|Part B (All Participants)|Lost to Follow-up|1
4707924|NCT02819726|7630505|FG002|Part B (All Participants)|Lost to Follow-up|2
4707925|NCT02819726|7630506|FG003|Part B (All Participants)|Lost to Follow-up|2
4707926|NCT02819726|7630503|FG000|Part B (All Participants)|Withdrawal by Subject|2
4707927|NCT02819726|7630504|FG001|Part B (All Participants)|Withdrawal by Subject|1
4707928|NCT02819726|7630505|FG002|Part B (All Participants)|Withdrawal by Subject|1
4707929|NCT02819726|7630506|FG003|Part B (All Participants)|Withdrawal by Subject|0
4707930|NCT02819726|7630503|FG000|Part B (All Participants)|Protocol non-compliance|0
4707931|NCT02819726|7630504|FG001|Part B (All Participants)|Protocol non-compliance|0
4707932|NCT02819726|7630505|FG002|Part B (All Participants)|Protocol non-compliance|1
4707933|NCT02819726|7630506|FG003|Part B (All Participants)|Protocol non-compliance|0
4707934|NCT02820038|7630537|FG000|Overall Study|Lost to Follow-up|7
4707935|NCT02820038|7630538|FG001|Overall Study|Lost to Follow-up|11
4707936|NCT02820038|7630539|FG002|Overall Study|Lost to Follow-up|2
4707937|NCT02820038|7630540|FG003|Overall Study|Lost to Follow-up|9
4707938|NCT02820038|7630537|FG000|Overall Study|Withdrawal by Subject|3
4707939|NCT02820038|7630538|FG001|Overall Study|Withdrawal by Subject|14
4707940|NCT02820038|7630539|FG002|Overall Study|Withdrawal by Subject|3
4707941|NCT02820038|7630540|FG003|Overall Study|Withdrawal by Subject|13
4707942|NCT02820298|7630562|FG000|Overall Study|Withdrawal by Subject|0
4707943|NCT02820298|7630563|FG001|Overall Study|Withdrawal by Subject|1
4707944|NCT02820298|7630562|FG000|Overall Study|Physician Decision|1
4707945|NCT02820298|7630563|FG001|Overall Study|Physician Decision|0
4707946|NCT02820298|7630562|FG000|Overall Study|Protocol Violation|0
4707947|NCT02820298|7630563|FG001|Overall Study|Protocol Violation|1
4707948|NCT02820597|7630596|FG000|Overall Study|Lost to Follow-up|12
4707949|NCT02820844|7630602|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1
4707950|NCT02820844|7630603|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3
4707951|NCT02820844|7630604|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
4388301|NCT00058825|7166966|FG000|Overall Study|Progressive Disease|5
4388302|NCT00058825|7166966|FG000|Overall Study|Graft Failure|5
4388303|NCT00058825|7166966|FG000|Overall Study|Death|3
4388304|NCT00059202|7166974|FG000|Overall Study|Withdrawal by Subject|5
4388305|NCT00059202|7166975|FG001|Overall Study|Withdrawal by Subject|9
4388306|NCT00059202|7166974|FG000|Overall Study|Protocol Violation|1
4388307|NCT00059202|7166975|FG001|Overall Study|Protocol Violation|3
4388308|NCT00059202|7166974|FG000|Overall Study|drug toxicity|0
4388309|NCT00059202|7166975|FG001|Overall Study|drug toxicity|3
4388310|NCT00059215|7166988|FG000|Overall Study|Adverse Event|5
4388311|NCT00059215|7166989|FG001|Overall Study|Adverse Event|5
4388312|NCT00059215|7166990|FG002|Overall Study|Adverse Event|9
4388313|NCT00059215|7166991|FG003|Overall Study|Adverse Event|9
4388314|NCT00059215|7166988|FG000|Overall Study|Death|0
4388315|NCT00059215|7166989|FG001|Overall Study|Death|0
4388316|NCT00059215|7166990|FG002|Overall Study|Death|3
4388317|NCT00059215|7166991|FG003|Overall Study|Death|0
4388318|NCT00059215|7166988|FG000|Overall Study|Lost to Follow-up|1
4707952|NCT02820844|7630605|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
4707953|NCT02820844|7630606|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
4388319|NCT00059215|7166989|FG001|Overall Study|Lost to Follow-up|2
4388320|NCT00059215|7166990|FG002|Overall Study|Lost to Follow-up|0
4388321|NCT00059215|7166991|FG003|Overall Study|Lost to Follow-up|0
4388322|NCT00059215|7166988|FG000|Overall Study|Withdrawal by Subject|4
4388323|NCT00059215|7166989|FG001|Overall Study|Withdrawal by Subject|4
4388324|NCT00059215|7166990|FG002|Overall Study|Withdrawal by Subject|1
4707954|NCT02820844|7630607|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
4707955|NCT02820844|7630602|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1
4707956|NCT02820844|7630603|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2
4707957|NCT02820844|7630604|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
4707958|NCT02820844|7630605|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
4707959|NCT02820844|7630606|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
4707960|NCT02820844|7630607|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
4707961|NCT02820844|7630602|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
4707962|NCT02820844|7630603|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3
4707963|NCT02820844|7630604|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
4707964|NCT02820844|7630605|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
4707965|NCT02820844|7630606|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
4707966|NCT02820844|7630607|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
4707967|NCT02820844|7630602|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2
4707968|NCT02820844|7630603|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1
4707969|NCT02820844|7630604|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0
4707970|NCT02820844|7630605|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0
4707971|NCT02820844|7630606|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0
4707972|NCT02820844|7630607|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0
4707973|NCT02820844|7630602|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1
4707974|NCT02820844|7630603|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
4707975|NCT02820844|7630604|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
4707976|NCT02820844|7630605|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
4707977|NCT02820844|7630606|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
4707978|NCT02820844|7630607|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
4707979|NCT02820844|7630602|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
4707980|NCT02820844|7630603|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
4707981|NCT02820844|7630604|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1
4707982|NCT02820844|7630605|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2
4707983|NCT02820844|7630606|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
4707984|NCT02820844|7630607|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
4707985|NCT02820844|7630602|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
4707986|NCT02820844|7630603|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
4707987|NCT02820844|7630604|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1
4707988|NCT02820844|7630605|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
4707989|NCT02820844|7630606|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
4707990|NCT02820844|7630607|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
4707991|NCT02820844|7630602|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
4707992|NCT02820844|7630603|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
4707993|NCT02820844|7630604|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7
4707994|NCT02820844|7630605|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2
4707995|NCT02820844|7630606|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
4707996|NCT02820844|7630607|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
4707997|NCT02820844|7630602|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
4707998|NCT02820844|7630603|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
4707999|NCT02820844|7630604|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
4708000|NCT02820844|7630605|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
4708001|NCT02820844|7630606|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2
4708002|NCT02820844|7630607|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
4735732|NCT03539484|7684013|FG002|Overall Study|Withdrawal by Subject|0
4388325|NCT00059215|7166991|FG003|Overall Study|Withdrawal by Subject|3
4388326|NCT00059215|7166988|FG000|Overall Study|Protocol Violation|1
4388327|NCT00059215|7166989|FG001|Overall Study|Protocol Violation|0
4388328|NCT00059215|7166990|FG002|Overall Study|Protocol Violation|1
4388329|NCT00059215|7166991|FG003|Overall Study|Protocol Violation|0
4388330|NCT00059215|7166988|FG000|Overall Study|Protocol entry criteria not met|1
4388331|NCT00059215|7166989|FG001|Overall Study|Protocol entry criteria not met|1
4388332|NCT00059215|7166990|FG002|Overall Study|Protocol entry criteria not met|0
4388333|NCT00059215|7166991|FG003|Overall Study|Protocol entry criteria not met|2
4388334|NCT00059215|7166988|FG000|Overall Study|Physician Decision|1
4388335|NCT00059215|7166989|FG001|Overall Study|Physician Decision|2
4388336|NCT00059215|7166990|FG002|Overall Study|Physician Decision|1
4388337|NCT00059215|7166991|FG003|Overall Study|Physician Decision|1
4388338|NCT00059332|7167013|FG000|Overall Study|Withdrawal by Subject|2
4388339|NCT00059332|7167014|FG001|Overall Study|Withdrawal by Subject|1
4388340|NCT00059332|7167013|FG000|Overall Study|Lost to Follow-up|1
4388341|NCT00059332|7167014|FG001|Overall Study|Lost to Follow-up|1
4388342|NCT00059787|7167060|FG000|Overall Study|Adverse Event|13
4388343|NCT00059787|7167060|FG000|Overall Study|disease progression|2
4388344|NCT00059787|7167060|FG000|Overall Study|ineligible|1
4388345|NCT00059787|7167060|FG000|Overall Study|Other|4
4388346|NCT00059839|7167067|FG000|Overall Study|Death|1
4388347|NCT00059839|7167068|FG001|Overall Study|Death|1
4388348|NCT00059839|7167067|FG000|Overall Study|Lack of Efficacy|6
4708003|NCT02820844|7630602|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
4708004|NCT02820844|7630603|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
4708005|NCT02820844|7630604|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
4708006|NCT02820844|7630605|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
4708007|NCT02820844|7630606|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
4708008|NCT02820844|7630607|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1
4708009|NCT02821416|7630666|FG000|Overall Study|Adverse Event|0
4708010|NCT02821416|7630667|FG001|Overall Study|Adverse Event|1
4708011|NCT02821416|7630666|FG000|Overall Study|Withdrawal by Subject|2
4708012|NCT02821416|7630667|FG001|Overall Study|Withdrawal by Subject|0
4708013|NCT02821416|7630666|FG000|Overall Study|Lost to Follow-up|1
4708014|NCT02821416|7630667|FG001|Overall Study|Lost to Follow-up|0
4708015|NCT02821715|7630678|FG000|Overall Study|Protocol Violation|1
4708016|NCT02821715|7630679|FG001|Overall Study|Protocol Violation|0
4708017|NCT02821715|7630680|FG002|Overall Study|Protocol Violation|0
4708018|NCT02821715|7630681|FG003|Overall Study|Protocol Violation|0
4708019|NCT02821715|7630682|FG004|Overall Study|Protocol Violation|0
4708020|NCT02821715|7630683|FG005|Overall Study|Protocol Violation|0
4708021|NCT02821819|7630691|FG000|Overall Study|Protocol Violation|1
4708022|NCT02821910|7630701|FG000|Overall Study|Withdrawal by Subject|0
4708023|NCT02821910|7630702|FG001|Overall Study|Withdrawal by Subject|0
4708024|NCT02821910|7630703|FG002|Overall Study|Withdrawal by Subject|1
4708025|NCT02821910|7630704|FG003|Overall Study|Withdrawal by Subject|0
4708026|NCT02821910|7630705|FG004|Overall Study|Withdrawal by Subject|0
4708027|NCT02821910|7630706|FG005|Overall Study|Withdrawal by Subject|1
4708028|NCT02821910|7630701|FG000|Overall Study|Other than specified|1
4708029|NCT02821910|7630702|FG001|Overall Study|Other than specified|0
4708030|NCT02821910|7630703|FG002|Overall Study|Other than specified|1
4708031|NCT02821910|7630704|FG003|Overall Study|Other than specified|0
4708032|NCT02821910|7630705|FG004|Overall Study|Other than specified|0
4708033|NCT02821910|7630706|FG005|Overall Study|Other than specified|0
4708034|NCT02821962|7630722|FG000|Overall Study|Lost to Follow-up|2
4708035|NCT02821962|7630723|FG001|Overall Study|Lost to Follow-up|0
4708036|NCT02822222|7630731|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1
4708037|NCT02822222|7630732|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0
4708038|NCT02822235|7630740|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144
4708039|NCT02822235|7630741|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107
4708040|NCT02822235|7630740|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2
4708041|NCT02822235|7630741|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0
4708042|NCT02822235|7630740|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0
4708043|NCT02822235|7630741|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1
4708044|NCT02822235|7630740|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4
4708045|NCT02822235|7630741|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0
4708046|NCT02822235|7630740|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1
4708047|NCT02822235|7630741|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0
4708048|NCT02822235|7630740|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6
4708049|NCT02822235|7630741|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1
4708050|NCT02822794|7630792|FG000|Overall Study|Withdrew Consent|1
4708051|NCT02822794|7630793|FG001|Overall Study|Withdrew Consent|0
4708052|NCT02823470|7630835|FG000|Overall Study|Adverse Event|1
4708053|NCT02823470|7630836|FG001|Overall Study|Adverse Event|0
4708054|NCT02823470|7630835|FG000|Overall Study|Study terminated by sponsor|8
4708055|NCT02823470|7630836|FG001|Overall Study|Study terminated by sponsor|15
4708056|NCT02823964|7630851|FG000|Overall Study|Adverse Event|2
4708057|NCT02823964|7630851|FG000|Overall Study|Physician Decision|1
4708058|NCT02823964|7630851|FG000|Overall Study|Lack of Efficacy|1
4708059|NCT02823964|7630851|FG000|Overall Study|Withdrawal by Subject|1
4708060|NCT02824224|7630857|FG000|Overall Study|Discontinued, IUS expulsion|0
4708061|NCT02824224|7630858|FG001|Overall Study|Discontinued, IUS expulsion|1
4708062|NCT02824224|7630857|FG000|Overall Study|Did not show up for allocation visit|2
4708063|NCT02824224|7630858|FG001|Overall Study|Did not show up for allocation visit|0
4708064|NCT02824432|7630866|FG000|Overall Study|Major Protocol Deviation|1
4708065|NCT02824432|7630867|FG001|Overall Study|Major Protocol Deviation|0
4388349|NCT00059839|7167068|FG001|Overall Study|Lack of Efficacy|5
4388350|NCT00059839|7167067|FG000|Overall Study|Lost to Follow-up|2
4388351|NCT00059839|7167068|FG001|Overall Study|Lost to Follow-up|0
4388352|NCT00059839|7167067|FG000|Overall Study|Physician Decision|1
4388353|NCT00059839|7167068|FG001|Overall Study|Physician Decision|2
4510666|NCT00922272|7319559|FG000|Open-label Phase|Adverse Event|5
4388354|NCT00059839|7167067|FG000|Overall Study|Withdrawal by Subject|1
4388355|NCT00059839|7167068|FG001|Overall Study|Withdrawal by Subject|6
4388356|NCT00059839|7167067|FG000|Overall Study|Ineligible|1
4388357|NCT00059839|7167068|FG001|Overall Study|Ineligible|3
4388358|NCT00060840|7167121|FG000|Overall Study|Change in surgical plan|2
4388359|NCT00060840|7167122|FG001|Overall Study|Change in surgical plan|6
4510667|NCT00922272|7319560|FG001|Open-label Phase|Adverse Event|0
4388360|NCT00060840|7167121|FG000|Overall Study|Death|0
4388361|NCT00060840|7167122|FG001|Overall Study|Death|1
4388362|NCT00060840|7167121|FG000|Overall Study|Withdrawal by Subject|0
4708066|NCT02824562|7630875|FG000|Overall Study|Lost to Follow-up|3
4708067|NCT02824562|7630876|FG001|Overall Study|Lost to Follow-up|4
4708068|NCT02824562|7630875|FG000|Overall Study|Death|0
4708069|NCT02824562|7630876|FG001|Overall Study|Death|1
4708070|NCT02825251|7630899|FG000|Overall Study|Adverse Event|0
4708071|NCT02825251|7630900|FG001|Overall Study|Adverse Event|1
4708072|NCT02825251|7630899|FG000|Overall Study|Lost to Follow-up|0
4708073|NCT02825251|7630900|FG001|Overall Study|Lost to Follow-up|1
4708074|NCT02825251|7630899|FG000|Overall Study|Withdrawal by Subject|1
4708075|NCT02825251|7630900|FG001|Overall Study|Withdrawal by Subject|4
4708076|NCT02825251|7630899|FG000|Overall Study|Unclassified|2
4708077|NCT02825251|7630900|FG001|Overall Study|Unclassified|0
4708078|NCT02825420|7630908|FG000|Overall Study|Death|30
4708079|NCT02825420|7630909|FG001|Overall Study|Death|12
4708080|NCT02825420|7630908|FG000|Overall Study|Progressive disease|6
4708081|NCT02825420|7630909|FG001|Overall Study|Progressive disease|1
4708082|NCT02825420|7630908|FG000|Overall Study|Lost to Follow-up|2
4708083|NCT02825420|7630909|FG001|Overall Study|Lost to Follow-up|2
4708084|NCT02825420|7630908|FG000|Overall Study|Withdrawal by Subject|1
4708085|NCT02825420|7630909|FG001|Overall Study|Withdrawal by Subject|1
4708086|NCT02825420|7630908|FG000|Overall Study|Protocol amendment not signed|1
4708087|NCT02825420|7630909|FG001|Overall Study|Protocol amendment not signed|1
4708088|NCT02825420|7630908|FG000|Overall Study|Physician Decision|1
4708089|NCT02825420|7630909|FG001|Overall Study|Physician Decision|0
4708090|NCT02825420|7630908|FG000|Overall Study|Did not receive PLD|2
4708091|NCT02825420|7630909|FG001|Overall Study|Did not receive PLD|0
4708092|NCT02825550|7630920|FG000|Overall Study|Physician Decision|1
4735733|NCT03539484|7684014|FG003|Overall Study|Withdrawal by Subject|0
4735734|NCT03539484|7684015|FG004|Overall Study|Withdrawal by Subject|2
4735735|NCT03539484|7684016|FG005|Overall Study|Withdrawal by Subject|0
4735736|NCT03539484|7684017|FG006|Overall Study|Withdrawal by Subject|1
4735737|NCT03539484|7684011|FG000|Overall Study|Study Terminated by Sponsor|0
4735738|NCT03539484|7684012|FG001|Overall Study|Study Terminated by Sponsor|0
4735739|NCT03539484|7684013|FG002|Overall Study|Study Terminated by Sponsor|1
4735740|NCT03539484|7684014|FG003|Overall Study|Study Terminated by Sponsor|1
4735741|NCT03539484|7684015|FG004|Overall Study|Study Terminated by Sponsor|2
4735742|NCT03539484|7684016|FG005|Overall Study|Study Terminated by Sponsor|2
4735743|NCT03539484|7684017|FG006|Overall Study|Study Terminated by Sponsor|1
4735744|NCT03539549|7684038|FG000|Overall Study|Adverse Event|12
4735745|NCT03539549|7684038|FG000|Overall Study|Lost to Follow-up|1
4735746|NCT03539549|7684038|FG000|Overall Study|Death|2
4735747|NCT03539549|7684038|FG000|Overall Study|Progressive Disease|1
4735748|NCT03539549|7684038|FG000|Overall Study|Reason not Specified|1
4735749|NCT03540030|7684044|FG000|Overall Study|Withdrawal by Subject|2
4735750|NCT03540030|7684045|FG001|Overall Study|Withdrawal by Subject|1
4735751|NCT03540030|7684044|FG000|Overall Study|screen fail|7
4735752|NCT03540030|7684045|FG001|Overall Study|screen fail|1
4735753|NCT03540030|7684044|FG000|Overall Study|never had surgery after signing consent|9
4735754|NCT03540030|7684045|FG001|Overall Study|never had surgery after signing consent|1
4735755|NCT03540160|7684067|FG000|Overall Study|Protocol Violation|1
4735756|NCT03540160|7684067|FG000|Overall Study|Physician Decision|8
4735757|NCT03540160|7684067|FG000|Overall Study|Lack of Efficacy|60
4735758|NCT03540160|7684067|FG000|Overall Study|Pregnancy|1
4735759|NCT03540160|7684067|FG000|Overall Study|Adverse Event|20
4735760|NCT03540160|7684067|FG000|Overall Study|Withdrawal by Subject|68
4735761|NCT03540160|7684067|FG000|Overall Study|COVID-19|2
4735762|NCT03540160|7684067|FG000|Overall Study|Study Closure|10
4735763|NCT03540160|7684067|FG000|Overall Study|Lost to Follow-up|18
4735764|NCT03540160|7684067|FG000|Overall Study|Sponsor decision|191
4735765|NCT03541044|7684071|FG000|Study Period 2: Up to Day 8|Protocol Violation|1
4735766|NCT03541044|7684072|FG001|Study Period 2: Up to Day 8|Protocol Violation|0
4735767|NCT03541044|7684071|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1
4735768|NCT03541044|7684072|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0
4735769|NCT03542266|7684147|FG000|Treatment Phase|Withdrawal by Subject|1
4735770|NCT03542266|7684147|FG000|Treatment Phase|Adverse Event|1
4735771|NCT03542266|7684147|FG000|Treatment Phase|PD|1
4735772|NCT03543137|7684176|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1
4735773|NCT03543137|7684177|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0
4735774|NCT03543137|7684176|FG000|Study Period 2: Up to Day 8|Protocol Violation|1
4735775|NCT03543137|7684177|FG001|Study Period 2: Up to Day 8|Protocol Violation|0
4735776|NCT03543137|7684176|FG000|Study Period 2: Up to Day 8|Adverse Event|0
4735777|NCT03543137|7684177|FG001|Study Period 2: Up to Day 8|Adverse Event|1
4737571|NCT03614078|7687790|FG000|Overall Study|Patient Did Not Meet Eligibility|1
4737572|NCT03614078|7687791|FG001|Overall Study|Patient Did Not Meet Eligibility|0
4737573|NCT03614078|7687792|FG002|Overall Study|Patient Did Not Meet Eligibility|0
4737574|NCT03614078|7687790|FG000|Overall Study|Exacerbation of Psoriasis|0
4737575|NCT03614078|7687791|FG001|Overall Study|Exacerbation of Psoriasis|1
4737576|NCT03614078|7687792|FG002|Overall Study|Exacerbation of Psoriasis|0
4737577|NCT03614078|7687790|FG000|Overall Study|Adverse Event|0
4737578|NCT03614078|7687791|FG001|Overall Study|Adverse Event|2
4737579|NCT03614078|7687792|FG002|Overall Study|Adverse Event|0
4737580|NCT03614078|7687790|FG000|Overall Study|Dizziness and Rash|0
4737581|NCT03614078|7687791|FG001|Overall Study|Dizziness and Rash|1
4737582|NCT03614078|7687792|FG002|Overall Study|Dizziness and Rash|0
4388363|NCT00060840|7167122|FG001|Overall Study|Withdrawal by Subject|1
4388364|NCT00060840|7167121|FG000|Overall Study|Subinvestigator unavailable|0
4388365|NCT00060840|7167122|FG001|Overall Study|Subinvestigator unavailable|1
4388366|NCT00060840|7167121|FG000|Overall Study|Physician Decision|1
4388367|NCT00060840|7167122|FG001|Overall Study|Physician Decision|0
4388368|NCT00060840|7167121|FG000|Overall Study|Other|1
4388369|NCT00060840|7167122|FG001|Overall Study|Other|0
4388370|NCT00060944|7167130|FG000|Overall Study|Adverse Event|12
4388371|NCT00060944|7167131|FG001|Overall Study|Adverse Event|10
4388372|NCT00060944|7167130|FG000|Overall Study|Death|2
4388373|NCT00060944|7167131|FG001|Overall Study|Death|3
4388374|NCT00060944|7167130|FG000|Overall Study|Withdrawal by Subject|18
4388375|NCT00060944|7167131|FG001|Overall Study|Withdrawal by Subject|5
4388376|NCT00060944|7167130|FG000|Overall Study|Disease Progression|93
4388377|NCT00060944|7167131|FG001|Overall Study|Disease Progression|94
4388378|NCT00060944|7167130|FG000|Overall Study|Lost to Follow-up|1
4388379|NCT00060944|7167131|FG001|Overall Study|Lost to Follow-up|0
4388380|NCT00060944|7167130|FG000|Overall Study|Subject Ineligible To Continue|2
4388381|NCT00060944|7167131|FG001|Overall Study|Subject Ineligible To Continue|1
4388382|NCT00060944|7167130|FG000|Overall Study|Treatment Switch|0
4388383|NCT00060944|7167131|FG001|Overall Study|Treatment Switch|13
4388384|NCT00060944|7167130|FG000|Overall Study|Other|2
4388385|NCT00060944|7167131|FG001|Overall Study|Other|4
4388386|NCT00060944|7167130|FG000|Overall Study|randomized but not treated|6
4388387|NCT00060944|7167131|FG001|Overall Study|randomized but not treated|4
4388388|NCT00061048|7167137|FG000|Overall Study|Adverse Event|2
4388389|NCT00061048|7167137|FG000|Overall Study|disease progression|20
4388390|NCT00061633|7167152|FG000|Overall Study|Adverse Event|1
4388391|NCT00061633|7167153|FG001|Overall Study|Adverse Event|2
4388392|NCT00061633|7167152|FG000|Overall Study|Withdrawal by Subject|2
4388393|NCT00061633|7167153|FG001|Overall Study|Withdrawal by Subject|2
4388394|NCT00061633|7167152|FG000|Overall Study|Lost to Follow-up|1
4388395|NCT00061633|7167153|FG001|Overall Study|Lost to Follow-up|4
4628101|NCT01857583|7495103|FG002|Overall Study|Physician Decision|0
4628102|NCT01857583|7495104|FG003|Overall Study|Physician Decision|1
4628103|NCT01857583|7495101|FG000|Overall Study|Withdrawal by Subject|1
4708093|NCT02825992|7630951|FG000|Overall Study|Withdrawal by Subject|4
4388396|NCT00061633|7167152|FG000|Overall Study|Other|1
4388397|NCT00061633|7167153|FG001|Overall Study|Other|1
4388398|NCT00061633|7167152|FG000|Overall Study|Never received study treatment|0
4388399|NCT00061633|7167153|FG001|Overall Study|Never received study treatment|2
4388400|NCT00061932|7167165|FG000|Overall Study|Withdrawal by Subject|13
4388401|NCT00061932|7167166|FG001|Overall Study|Withdrawal by Subject|4
4388402|NCT00061945|7167175|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18
4388403|NCT00061945|7167176|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25
4388404|NCT00061945|7167175|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76
4388405|NCT00061945|7167176|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90
4388406|NCT00061945|7167175|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1
4388407|NCT00061945|7167176|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1
4628104|NCT01857583|7495102|FG001|Overall Study|Withdrawal by Subject|0
4708094|NCT02825992|7630951|FG000|Overall Study|Lost to Follow-up|2
4708095|NCT02825992|7630951|FG000|Overall Study|Procedure terminated|2
4708096|NCT02826421|7630965|FG000|Overall Study|Adverse Event|1
4708097|NCT02826421|7630966|FG001|Overall Study|Adverse Event|0
4708098|NCT02826421|7630967|FG002|Overall Study|Adverse Event|0
4708099|NCT02826421|7630968|FG003|Overall Study|Adverse Event|1
4388408|NCT00061945|7167175|FG000|Course IV: Alemtuzumab|Early exits|6
4388409|NCT00061945|7167176|FG001|Course IV: Alemtuzumab|Early exits|15
4510668|NCT00922272|7319559|FG000|Open-label Phase|Protocol Violation|1
4510669|NCT00922272|7319560|FG001|Open-label Phase|Protocol Violation|0
4510670|NCT00922272|7319559|FG000|Open-label Phase|Withdrawal by Subject|11
4628105|NCT01857583|7495103|FG002|Overall Study|Withdrawal by Subject|1
4628106|NCT01857583|7495104|FG003|Overall Study|Withdrawal by Subject|2
4628107|NCT01857622|7495117|FG000|Overall Study|Adverse Event|5
4628108|NCT01857622|7495118|FG001|Overall Study|Adverse Event|0
4628109|NCT01857622|7495119|FG002|Overall Study|Adverse Event|2
4628110|NCT01857622|7495117|FG000|Overall Study|Physician Decision|1
4628111|NCT01857622|7495118|FG001|Overall Study|Physician Decision|0
4628112|NCT01857622|7495119|FG002|Overall Study|Physician Decision|0
4628113|NCT01857622|7495117|FG000|Overall Study|Protocol Violation|4
4628114|NCT01857622|7495118|FG001|Overall Study|Protocol Violation|1
4628115|NCT01857622|7495119|FG002|Overall Study|Protocol Violation|0
4628116|NCT01857622|7495117|FG000|Overall Study|Withdrawal by Subject|1
4628117|NCT01857622|7495118|FG001|Overall Study|Withdrawal by Subject|0
4628118|NCT01857622|7495119|FG002|Overall Study|Withdrawal by Subject|0
4628119|NCT01857869|7495143|FG000|Primary/Challenge Phase|Lost to Follow-up|2
4628120|NCT01857869|7495144|FG001|Primary/Challenge Phase|Lost to Follow-up|0
4628121|NCT01857869|7495145|FG002|Primary/Challenge Phase|Lost to Follow-up|0
4628122|NCT01857869|7495146|FG003|Primary/Challenge Phase|Lost to Follow-up|0
4628123|NCT01857869|7495147|FG004|Primary/Challenge Phase|Lost to Follow-up|0
4628124|NCT01857869|7495148|FG005|Primary/Challenge Phase|Lost to Follow-up|0
4628125|NCT01857869|7495149|FG006|Primary/Challenge Phase|Lost to Follow-up|0
4388410|NCT00062010|7167184|FG000|Overall Study|Ineligible|3
4388411|NCT00062166|7167188|FG000|Overall Study|Withdrawal by Subject|6
4388412|NCT00062374|7167193|FG000|Overall Study|Not treated|12
4388413|NCT00062439|7167197|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1
4388414|NCT00062439|7167197|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1
4388415|NCT00062439|7167197|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3
4388416|NCT00062439|7167197|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3
4388417|NCT00062439|7167197|FG000|Post Chemoradiation Assessment|Death|1
4388418|NCT00062439|7167197|FG000|Post Chemoradiation Assessment|Disease progression|2
4388419|NCT00062439|7167197|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1
4388420|NCT00062439|7167197|FG000|Post Chemoradiation Assessment|Physician Decision|1
4388421|NCT00062439|7167197|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4
4388422|NCT00062439|7167197|FG000|Surgery|Physician Decision|4
4388423|NCT00062439|7167197|FG000|Surgery|Death|1
4388424|NCT00062439|7167197|FG000|Surgery|Adverse Event|2
4388425|NCT00062439|7167197|FG000|Consolidation Chemotherapy|Adverse Event|2
4388426|NCT00062647|7167208|FG000|Overall Study|Death|2
4388427|NCT00062647|7167209|FG001|Overall Study|Death|2
4388428|NCT00062647|7167208|FG000|Overall Study|Adverse Event|1
4388429|NCT00062647|7167209|FG001|Overall Study|Adverse Event|1
4388430|NCT00062647|7167208|FG000|Overall Study|Withdrawal by Subject|2
4388431|NCT00062647|7167209|FG001|Overall Study|Withdrawal by Subject|1
4388432|NCT00062647|7167208|FG000|Overall Study|Protocol Violation|1
4388433|NCT00062647|7167209|FG001|Overall Study|Protocol Violation|0
4388434|NCT00062647|7167208|FG000|Overall Study|Lost to Follow-up|1
4388435|NCT00062647|7167209|FG001|Overall Study|Lost to Follow-up|2
4388436|NCT00062647|7167208|FG000|Overall Study|Failed continuation criteria|4
4388437|NCT00062647|7167209|FG001|Overall Study|Failed continuation criteria|2
4388438|NCT00062647|7167208|FG000|Overall Study|Other|4
4388439|NCT00062647|7167209|FG001|Overall Study|Other|4
4388440|NCT00062647|7167208|FG000|Overall Study|Never received study treatment|1
4388441|NCT00062647|7167209|FG001|Overall Study|Never received study treatment|1
4388442|NCT00062868|7167256|FG000|Dose Level 1|Death|2
4388443|NCT00062868|7167257|FG001|Dose Level 1|Death|0
4388444|NCT00062868|7167258|FG002|Dose Level 1|Death|0
4388445|NCT00062868|7167259|FG003|Dose Level 1|Death|2
4388446|NCT00062868|7167260|FG004|Dose Level 1|Death|0
4388447|NCT00062868|7167261|FG005|Dose Level 1|Death|0
4388448|NCT00062868|7167262|FG006|Dose Level 1|Death|3
4388449|NCT00062868|7167263|FG007|Dose Level 1|Death|0
4388450|NCT00062868|7167264|FG008|Dose Level 1|Death|0
4388451|NCT00062868|7167265|FG009|Dose Level 1|Death|0
4388452|NCT00062868|7167266|FG010|Dose Level 1|Death|0
4388453|NCT00062868|7167267|FG011|Dose Level 1|Death|0
4388454|NCT00062868|7167268|FG012|Dose Level 1|Death|0
4388455|NCT00062868|7167269|FG013|Dose Level 1|Death|0
4388456|NCT00062868|7167270|FG014|Dose Level 1|Death|0
4388457|NCT00062868|7167271|FG015|Dose Level 1|Death|0
4388458|NCT00062868|7167272|FG016|Dose Level 1|Death|0
4708100|NCT02826421|7630965|FG000|Overall Study|Withdrawal by Subject|1
4708101|NCT02826421|7630966|FG001|Overall Study|Withdrawal by Subject|3
4708102|NCT02826421|7630967|FG002|Overall Study|Withdrawal by Subject|1
4708103|NCT02826421|7630968|FG003|Overall Study|Withdrawal by Subject|1
4708104|NCT02826421|7630965|FG000|Overall Study|Reason not given|1
4708105|NCT02826421|7630966|FG001|Overall Study|Reason not given|0
4708106|NCT02826421|7630967|FG002|Overall Study|Reason not given|1
4708107|NCT02826421|7630968|FG003|Overall Study|Reason not given|0
4708108|NCT02826603|7630981|FG000|Overall Study|Adverse Event|17
4708109|NCT02826603|7630982|FG001|Overall Study|Adverse Event|9
4708110|NCT02826603|7630981|FG000|Overall Study|Lack of Efficacy|4
4708111|NCT02826603|7630982|FG001|Overall Study|Lack of Efficacy|9
4708112|NCT02826603|7630981|FG000|Overall Study|Lost to Follow-up|13
4708113|NCT02826603|7630982|FG001|Overall Study|Lost to Follow-up|12
4708114|NCT02826603|7630981|FG000|Overall Study|Noncompliance with treatment|0
4708115|NCT02826603|7630982|FG001|Overall Study|Noncompliance with treatment|2
4708116|NCT02826603|7630981|FG000|Overall Study|Physician Decision|1
4708117|NCT02826603|7630982|FG001|Overall Study|Physician Decision|7
4708118|NCT02826603|7630981|FG000|Overall Study|Pregnancy|1
4708119|NCT02826603|7630982|FG001|Overall Study|Pregnancy|2
4708120|NCT02826603|7630981|FG000|Overall Study|Protocol Violation|3
4708121|NCT02826603|7630982|FG001|Overall Study|Protocol Violation|3
4708122|NCT02826603|7630981|FG000|Overall Study|Withdrawal by Subject|20
4708123|NCT02826603|7630982|FG001|Overall Study|Withdrawal by Subject|19
4708124|NCT02826603|7630981|FG000|Overall Study|Death|2
4708125|NCT02826603|7630982|FG001|Overall Study|Death|0
4708126|NCT02826603|7630981|FG000|Overall Study|New therapy for study indication|0
4388459|NCT00062868|7167273|FG017|Dose Level 1|Death|0
4388460|NCT00062868|7167274|FG018|Dose Level 1|Death|7
4388461|NCT00062868|7167275|FG019|Dose Level 1|Death|0
4388462|NCT00062868|7167276|FG020|Dose Level 1|Death|1
4388463|NCT00062868|7167256|FG000|Dose Level 1|Lost to Follow-up|0
4388464|NCT00062868|7167257|FG001|Dose Level 1|Lost to Follow-up|0
4388465|NCT00062868|7167258|FG002|Dose Level 1|Lost to Follow-up|0
4388466|NCT00062868|7167259|FG003|Dose Level 1|Lost to Follow-up|0
4388467|NCT00062868|7167260|FG004|Dose Level 1|Lost to Follow-up|0
4388468|NCT00062868|7167261|FG005|Dose Level 1|Lost to Follow-up|0
4708127|NCT02826603|7630982|FG001|Overall Study|New therapy for study indication|1
4708128|NCT02826798|7631005|FG000|Overall Study|Withdrawal by Subject|0
4708129|NCT02826798|7631006|FG001|Overall Study|Withdrawal by Subject|1
4708130|NCT02826798|7631007|FG002|Overall Study|Withdrawal by Subject|0
4708131|NCT02826798|7631008|FG003|Overall Study|Withdrawal by Subject|1
4708132|NCT02826798|7631009|FG004|Overall Study|Withdrawal by Subject|0
4708133|NCT02827500|7631023|FG000|Overall Study|Death|7
4708134|NCT02827500|7631024|FG001|Overall Study|Death|3
4708135|NCT02827500|7631023|FG000|Overall Study|Lost to Follow-up|1
4708136|NCT02827500|7631024|FG001|Overall Study|Lost to Follow-up|1
4708137|NCT02827500|7631023|FG000|Overall Study|Withdrawal by Subject|3
4708138|NCT02827500|7631024|FG001|Overall Study|Withdrawal by Subject|1
4708139|NCT02827500|7631023|FG000|Overall Study|Missing primary endpoint data|3
4708140|NCT02827500|7631024|FG001|Overall Study|Missing primary endpoint data|1
4708141|NCT02827500|7631023|FG000|Overall Study|Other|5
4708142|NCT02827500|7631024|FG001|Overall Study|Other|1
4708143|NCT02827708|7631032|FG000|Overall Study|Lost to Follow-up|3
4708144|NCT02827708|7631033|FG001|Overall Study|Lost to Follow-up|1
4708145|NCT02827708|7631032|FG000|Overall Study|Withdrawal by Subject|1
4708146|NCT02827708|7631033|FG001|Overall Study|Withdrawal by Subject|2
4708147|NCT02827708|7631032|FG000|Overall Study|Death|1
4708148|NCT02827708|7631033|FG001|Overall Study|Death|2
4708149|NCT02828020|7631042|FG000|Treatment Period|Adverse Event|3
4708150|NCT02828020|7631043|FG001|Treatment Period|Adverse Event|1
4708151|NCT02828020|7631044|FG002|Treatment Period|Adverse Event|1
4708152|NCT02828020|7631042|FG000|Treatment Period|Withdrawal of Consent|10
4708153|NCT02828020|7631043|FG001|Treatment Period|Withdrawal of Consent|14
4708154|NCT02828020|7631044|FG002|Treatment Period|Withdrawal of Consent|9
4708155|NCT02828020|7631042|FG000|Treatment Period|Lost to Follow-up|21
4708156|NCT02828020|7631043|FG001|Treatment Period|Lost to Follow-up|24
4708157|NCT02828020|7631044|FG002|Treatment Period|Lost to Follow-up|18
4708158|NCT02828020|7631042|FG000|Treatment Period|Lack of Qualifying Event|44
4708159|NCT02828020|7631043|FG001|Treatment Period|Lack of Qualifying Event|53
4708160|NCT02828020|7631044|FG002|Treatment Period|Lack of Qualifying Event|43
4708161|NCT02828020|7631042|FG000|Treatment Period|Pregnancy|0
4708162|NCT02828020|7631043|FG001|Treatment Period|Pregnancy|2
4708163|NCT02828020|7631044|FG002|Treatment Period|Pregnancy|0
4708164|NCT02828020|7631042|FG000|Treatment Period|Protocol Violation|2
4708165|NCT02828020|7631043|FG001|Treatment Period|Protocol Violation|4
4708166|NCT02828020|7631044|FG002|Treatment Period|Protocol Violation|7
4708167|NCT02828020|7631042|FG000|Treatment Period|Other Miscellaneous Reasons|0
4708168|NCT02828020|7631043|FG001|Treatment Period|Other Miscellaneous Reasons|1
4708169|NCT02828020|7631044|FG002|Treatment Period|Other Miscellaneous Reasons|0
4708170|NCT02828020|7631042|FG000|Safety Follow-up Period|Withdrawal of Consent|10
4708171|NCT02828020|7631043|FG001|Safety Follow-up Period|Withdrawal of Consent|8
4708172|NCT02828020|7631044|FG002|Safety Follow-up Period|Withdrawal of Consent|7
4708173|NCT02828020|7631042|FG000|Safety Follow-up Period|Lost to Follow-up|9
4708174|NCT02828020|7631043|FG001|Safety Follow-up Period|Lost to Follow-up|8
4708175|NCT02828020|7631044|FG002|Safety Follow-up Period|Lost to Follow-up|11
4708176|NCT02828020|7631042|FG000|Safety Follow-up Period|Protocol Violation|0
4708177|NCT02828020|7631043|FG001|Safety Follow-up Period|Protocol Violation|2
4708178|NCT02828020|7631044|FG002|Safety Follow-up Period|Protocol Violation|1
4708179|NCT02828020|7631042|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1
4708180|NCT02828020|7631043|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0
4708181|NCT02828020|7631044|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0
4388469|NCT00062868|7167262|FG006|Dose Level 1|Lost to Follow-up|0
4388470|NCT00062868|7167263|FG007|Dose Level 1|Lost to Follow-up|0
4388471|NCT00062868|7167264|FG008|Dose Level 1|Lost to Follow-up|0
4388472|NCT00062868|7167265|FG009|Dose Level 1|Lost to Follow-up|0
4388473|NCT00062868|7167266|FG010|Dose Level 1|Lost to Follow-up|0
4388474|NCT00062868|7167267|FG011|Dose Level 1|Lost to Follow-up|0
4388475|NCT00062868|7167268|FG012|Dose Level 1|Lost to Follow-up|1
4388476|NCT00062868|7167269|FG013|Dose Level 1|Lost to Follow-up|0
4388477|NCT00062868|7167270|FG014|Dose Level 1|Lost to Follow-up|0
4388478|NCT00062868|7167271|FG015|Dose Level 1|Lost to Follow-up|0
4388479|NCT00062868|7167272|FG016|Dose Level 1|Lost to Follow-up|0
4388480|NCT00062868|7167273|FG017|Dose Level 1|Lost to Follow-up|0
4388481|NCT00062868|7167274|FG018|Dose Level 1|Lost to Follow-up|2
4388482|NCT00062868|7167275|FG019|Dose Level 1|Lost to Follow-up|0
4708182|NCT02828111|7631057|FG000|Overall Study|Withdrawal by Subject|0
4708183|NCT02828111|7631058|FG001|Overall Study|Withdrawal by Subject|0
4708184|NCT02828111|7631059|FG002|Overall Study|Withdrawal by Subject|2
4708185|NCT02828111|7631060|FG003|Overall Study|Withdrawal by Subject|0
4708186|NCT02828111|7631061|FG004|Overall Study|Withdrawal by Subject|0
4708187|NCT02828111|7631057|FG000|Overall Study|Lost to Follow-up|0
4388483|NCT00062868|7167276|FG020|Dose Level 1|Lost to Follow-up|1
4388484|NCT00062868|7167256|FG000|Dose Level 2|Death|0
4388485|NCT00062868|7167257|FG001|Dose Level 2|Death|3
4388486|NCT00062868|7167258|FG002|Dose Level 2|Death|0
4388487|NCT00062868|7167259|FG003|Dose Level 2|Death|0
4388488|NCT00062868|7167260|FG004|Dose Level 2|Death|2
4708188|NCT02828111|7631058|FG001|Overall Study|Lost to Follow-up|0
4708189|NCT02828111|7631059|FG002|Overall Study|Lost to Follow-up|0
4708190|NCT02828111|7631060|FG003|Overall Study|Lost to Follow-up|1
4708191|NCT02828111|7631061|FG004|Overall Study|Lost to Follow-up|1
4708192|NCT02828241|7631097|FG000|Overall Study|Adverse Event|7
4708193|NCT02828241|7631098|FG001|Overall Study|Adverse Event|2
4708194|NCT02828241|7631097|FG000|Overall Study|Protocol Violation|1
4708195|NCT02828241|7631098|FG001|Overall Study|Protocol Violation|0
4708196|NCT02828358|7631126|FG000|Overall Study|Physician Decision|7
4708197|NCT02828358|7631127|FG001|Overall Study|Physician Decision|1
4708198|NCT02828358|7631126|FG000|Overall Study|Treatment Failure|6
4708199|NCT02828358|7631127|FG001|Overall Study|Treatment Failure|0
4708200|NCT02828358|7631126|FG000|Overall Study|Patients without KMT2A rearrangement|0
4708201|NCT02828358|7631127|FG001|Overall Study|Patients without KMT2A rearrangement|21
4708202|NCT02828358|7631126|FG000|Overall Study|Refusal of further protocol therapy|2
4708203|NCT02828358|7631127|FG001|Overall Study|Refusal of further protocol therapy|0
4708204|NCT02828358|7631126|FG000|Overall Study|Relapse|25
4708205|NCT02828358|7631127|FG001|Overall Study|Relapse|0
4708206|NCT02828358|7631126|FG000|Overall Study|Still on therapy|5
4708207|NCT02828358|7631127|FG001|Overall Study|Still on therapy|0
4708208|NCT02828436|7631132|FG000|Period 1|Did Not Meet Inclusion Criteria|0
4708209|NCT02828436|7631133|FG001|Period 1|Did Not Meet Inclusion Criteria|3
4708210|NCT02828436|7631132|FG000|Period 1|Lost to Follow-up|0
4708211|NCT02828436|7631133|FG001|Period 1|Lost to Follow-up|1
4388489|NCT00062868|7167261|FG005|Dose Level 2|Death|0
4388490|NCT00062868|7167262|FG006|Dose Level 2|Death|0
4388491|NCT00062868|7167263|FG007|Dose Level 2|Death|0
4388492|NCT00062868|7167264|FG008|Dose Level 2|Death|0
4388493|NCT00062868|7167265|FG009|Dose Level 2|Death|0
4388494|NCT00062868|7167266|FG010|Dose Level 2|Death|1
4388495|NCT00062868|7167267|FG011|Dose Level 2|Death|0
4388496|NCT00062868|7167268|FG012|Dose Level 2|Death|0
4388497|NCT00062868|7167269|FG013|Dose Level 2|Death|0
4388498|NCT00062868|7167270|FG014|Dose Level 2|Death|0
4388499|NCT00062868|7167271|FG015|Dose Level 2|Death|0
4388500|NCT00062868|7167272|FG016|Dose Level 2|Death|2
4388501|NCT00062868|7167273|FG017|Dose Level 2|Death|0
4388502|NCT00062868|7167274|FG018|Dose Level 2|Death|0
4388503|NCT00062868|7167275|FG019|Dose Level 2|Death|0
4388504|NCT00062868|7167276|FG020|Dose Level 2|Death|0
4388505|NCT00062868|7167256|FG000|Dose Level 2|Lost to Follow-up|0
4388506|NCT00062868|7167257|FG001|Dose Level 2|Lost to Follow-up|0
4388507|NCT00062868|7167258|FG002|Dose Level 2|Lost to Follow-up|0
4388508|NCT00062868|7167259|FG003|Dose Level 2|Lost to Follow-up|0
4388509|NCT00062868|7167260|FG004|Dose Level 2|Lost to Follow-up|0
4388510|NCT00062868|7167261|FG005|Dose Level 2|Lost to Follow-up|0
4388511|NCT00062868|7167262|FG006|Dose Level 2|Lost to Follow-up|0
4388512|NCT00062868|7167263|FG007|Dose Level 2|Lost to Follow-up|0
4388513|NCT00062868|7167264|FG008|Dose Level 2|Lost to Follow-up|0
4388514|NCT00062868|7167265|FG009|Dose Level 2|Lost to Follow-up|0
4388515|NCT00062868|7167266|FG010|Dose Level 2|Lost to Follow-up|0
4388516|NCT00062868|7167267|FG011|Dose Level 2|Lost to Follow-up|0
4388517|NCT00062868|7167268|FG012|Dose Level 2|Lost to Follow-up|0
4388518|NCT00062868|7167269|FG013|Dose Level 2|Lost to Follow-up|1
4388519|NCT00062868|7167270|FG014|Dose Level 2|Lost to Follow-up|0
4388520|NCT00062868|7167271|FG015|Dose Level 2|Lost to Follow-up|0
4388521|NCT00062868|7167272|FG016|Dose Level 2|Lost to Follow-up|1
4388522|NCT00062868|7167273|FG017|Dose Level 2|Lost to Follow-up|0
4388523|NCT00062868|7167274|FG018|Dose Level 2|Lost to Follow-up|0
4388524|NCT00062868|7167275|FG019|Dose Level 2|Lost to Follow-up|0
4388525|NCT00062868|7167276|FG020|Dose Level 2|Lost to Follow-up|0
4388526|NCT00062868|7167256|FG000|Dose Level 3|Death|0
4388527|NCT00062868|7167257|FG001|Dose Level 3|Death|0
4388528|NCT00062868|7167258|FG002|Dose Level 3|Death|0
4388529|NCT00062868|7167259|FG003|Dose Level 3|Death|0
4388530|NCT00062868|7167260|FG004|Dose Level 3|Death|0
4388531|NCT00062868|7167261|FG005|Dose Level 3|Death|0
4388532|NCT00062868|7167262|FG006|Dose Level 3|Death|0
4388533|NCT00062868|7167263|FG007|Dose Level 3|Death|0
4388534|NCT00062868|7167264|FG008|Dose Level 3|Death|0
4388535|NCT00062868|7167265|FG009|Dose Level 3|Death|0
4388536|NCT00062868|7167266|FG010|Dose Level 3|Death|0
4388537|NCT00062868|7167267|FG011|Dose Level 3|Death|1
4388538|NCT00062868|7167268|FG012|Dose Level 3|Death|0
4388539|NCT00062868|7167269|FG013|Dose Level 3|Death|0
4388540|NCT00062868|7167270|FG014|Dose Level 3|Death|0
4388541|NCT00062868|7167271|FG015|Dose Level 3|Death|0
4388542|NCT00062868|7167272|FG016|Dose Level 3|Death|0
4388543|NCT00062868|7167273|FG017|Dose Level 3|Death|1
4708212|NCT02828436|7631132|FG000|Period 2|Withdrawal by Subject|4
4708213|NCT02828436|7631133|FG001|Period 2|Withdrawal by Subject|0
4708214|NCT02828436|7631132|FG000|Period 2|Did Not Meet Inclusion Criteria|3
4708215|NCT02828436|7631133|FG001|Period 2|Did Not Meet Inclusion Criteria|0
4388544|NCT00062868|7167274|FG018|Dose Level 3|Death|0
4388545|NCT00062868|7167275|FG019|Dose Level 3|Death|0
4388546|NCT00062868|7167276|FG020|Dose Level 3|Death|0
4388547|NCT00062868|7167256|FG000|Dose Level 3|Lost to Follow-up|0
4388548|NCT00062868|7167257|FG001|Dose Level 3|Lost to Follow-up|0
4388549|NCT00062868|7167258|FG002|Dose Level 3|Lost to Follow-up|0
4388550|NCT00062868|7167259|FG003|Dose Level 3|Lost to Follow-up|0
4388551|NCT00062868|7167260|FG004|Dose Level 3|Lost to Follow-up|0
4388552|NCT00062868|7167261|FG005|Dose Level 3|Lost to Follow-up|0
4388553|NCT00062868|7167262|FG006|Dose Level 3|Lost to Follow-up|0
4708216|NCT02828436|7631132|FG000|Period 2|Lost to Follow-up|1
4708217|NCT02828436|7631133|FG001|Period 2|Lost to Follow-up|0
4708218|NCT02828644|7631141|FG000|Overall Study|Lost to Follow-up|23
4708219|NCT02828644|7631142|FG001|Overall Study|Lost to Follow-up|22
4708220|NCT02829138|7631160|FG000|Overall Study|Withdrawal by Subject|1
4708221|NCT02829138|7631161|FG001|Overall Study|Withdrawal by Subject|0
4708222|NCT02829775|7631197|FG000|Overall Study|Death|1
4708223|NCT02829775|7631197|FG000|Overall Study|Withdrawal by Subject|3
4708224|NCT02829775|7631197|FG000|Overall Study|Disease remission|1
4708225|NCT02829944|7631204|FG000|Overall Study|Physician Decision|0
4708226|NCT02829944|7631205|FG001|Overall Study|Physician Decision|1
4708227|NCT02829944|7631204|FG000|Overall Study|Screen Failure|2
4708228|NCT02829944|7631205|FG001|Overall Study|Screen Failure|2
4708229|NCT02829944|7631204|FG000|Overall Study|Inadequate Neuraxial Block|1
4708230|NCT02829944|7631205|FG001|Overall Study|Inadequate Neuraxial Block|1
4708231|NCT02829944|7631204|FG000|Overall Study|Withdrawal by Subject|2
4708232|NCT02829944|7631205|FG001|Overall Study|Withdrawal by Subject|1
4708233|NCT02829944|7631204|FG000|Overall Study|Catheter Displacement|1
4708234|NCT02829944|7631205|FG001|Overall Study|Catheter Displacement|0
4708235|NCT02829944|7631204|FG000|Overall Study|Catheter broke|0
4708236|NCT02829944|7631205|FG001|Overall Study|Catheter broke|1
4708237|NCT02829944|7631204|FG000|Overall Study|Staff unavailable|0
4708238|NCT02829944|7631205|FG001|Overall Study|Staff unavailable|1
4708239|NCT02829996|7631225|FG000|Overall Study|Withdrawal by Subject|1
4708240|NCT02829996|7631226|FG001|Overall Study|Withdrawal by Subject|0
4708241|NCT02829996|7631227|FG002|Overall Study|Withdrawal by Subject|0
4708242|NCT02829996|7631228|FG003|Overall Study|Withdrawal by Subject|0
4708243|NCT02829996|7631229|FG004|Overall Study|Withdrawal by Subject|0
4708244|NCT02830087|7631257|FG000|Overall Study|No study staff to follow-up patients|4
4708245|NCT02830087|7631258|FG001|Overall Study|No study staff to follow-up patients|4
4708246|NCT02830087|7631259|FG002|Overall Study|No study staff to follow-up patients|4
4708247|NCT02830087|7631260|FG003|Overall Study|No study staff to follow-up patients|3
4708248|NCT02830087|7631261|FG004|Overall Study|No study staff to follow-up patients|3
4708249|NCT02830087|7631262|FG005|Overall Study|No study staff to follow-up patients|3
4708250|NCT02830776|7631280|FG000|Overall Study|Lost to Follow-up|1
4708251|NCT02830880|7631285|FG000|Overall Study|Adverse reaction to chemotherapy|1
4708252|NCT02830880|7631285|FG000|Overall Study|Death|1
4708253|NCT02830880|7631285|FG000|Overall Study|Physician Decision|1
4708254|NCT02830893|7631291|FG000|Overall Study|Relocation to out of the country|1
4708255|NCT02830893|7631292|FG001|Overall Study|Relocation to out of the country|0
4388554|NCT00062868|7167263|FG007|Dose Level 3|Lost to Follow-up|0
4388555|NCT00062868|7167264|FG008|Dose Level 3|Lost to Follow-up|0
4388556|NCT00062868|7167265|FG009|Dose Level 3|Lost to Follow-up|0
4388557|NCT00062868|7167266|FG010|Dose Level 3|Lost to Follow-up|0
4388558|NCT00062868|7167267|FG011|Dose Level 3|Lost to Follow-up|0
4388559|NCT00062868|7167268|FG012|Dose Level 3|Lost to Follow-up|0
4388560|NCT00062868|7167269|FG013|Dose Level 3|Lost to Follow-up|0
4388561|NCT00062868|7167270|FG014|Dose Level 3|Lost to Follow-up|1
4388562|NCT00062868|7167271|FG015|Dose Level 3|Lost to Follow-up|0
4388563|NCT00062868|7167272|FG016|Dose Level 3|Lost to Follow-up|0
4388564|NCT00062868|7167273|FG017|Dose Level 3|Lost to Follow-up|0
4388565|NCT00062868|7167274|FG018|Dose Level 3|Lost to Follow-up|0
4388566|NCT00062868|7167275|FG019|Dose Level 3|Lost to Follow-up|0
4388567|NCT00062868|7167276|FG020|Dose Level 3|Lost to Follow-up|0
4388568|NCT00062868|7167256|FG000|Dose Level 3|Withdrew|0
4388569|NCT00062868|7167257|FG001|Dose Level 3|Withdrew|0
4388570|NCT00062868|7167258|FG002|Dose Level 3|Withdrew|2
4388571|NCT00062868|7167259|FG003|Dose Level 3|Withdrew|0
4388572|NCT00062868|7167260|FG004|Dose Level 3|Withdrew|0
4388573|NCT00062868|7167261|FG005|Dose Level 3|Withdrew|0
4388574|NCT00062868|7167262|FG006|Dose Level 3|Withdrew|0
4388575|NCT00062868|7167263|FG007|Dose Level 3|Withdrew|0
4388576|NCT00062868|7167264|FG008|Dose Level 3|Withdrew|0
4388577|NCT00062868|7167265|FG009|Dose Level 3|Withdrew|0
4388578|NCT00062868|7167266|FG010|Dose Level 3|Withdrew|0
4388579|NCT00062868|7167267|FG011|Dose Level 3|Withdrew|0
4388580|NCT00062868|7167268|FG012|Dose Level 3|Withdrew|0
4388581|NCT00062868|7167269|FG013|Dose Level 3|Withdrew|0
4388582|NCT00062868|7167270|FG014|Dose Level 3|Withdrew|0
4388583|NCT00062868|7167271|FG015|Dose Level 3|Withdrew|0
4388584|NCT00062868|7167272|FG016|Dose Level 3|Withdrew|0
4388585|NCT00062868|7167273|FG017|Dose Level 3|Withdrew|0
4388586|NCT00062868|7167274|FG018|Dose Level 3|Withdrew|0
4388587|NCT00062868|7167275|FG019|Dose Level 3|Withdrew|0
4708256|NCT02830893|7631291|FG000|Overall Study|Lost to Follow-up|0
4388588|NCT00062868|7167276|FG020|Dose Level 3|Withdrew|0
4388589|NCT00063154|7167320|FG000|Overall Study|Disease progression|27
4388590|NCT00063154|7167320|FG000|Overall Study|Adverse Event|2
4388591|NCT00063154|7167320|FG000|Overall Study|Physician Decision|10
4388592|NCT00063154|7167320|FG000|Overall Study|Death|3
4388593|NCT00063154|7167320|FG000|Overall Study|Reason unspecified|1
4388594|NCT00063154|7167320|FG000|Overall Study|Did not receive treatment|8
4388595|NCT00063258|7167330|FG000|Overall Study|Physician Decision|2
4388596|NCT00063258|7167331|FG001|Overall Study|Physician Decision|0
4388597|NCT00063258|7167330|FG000|Overall Study|Lack of Efficacy|2
4388598|NCT00063258|7167331|FG001|Overall Study|Lack of Efficacy|0
4388599|NCT00063882|7167383|FG000|Overall Study|Protocol Violation|3
4708257|NCT02830893|7631292|FG001|Overall Study|Lost to Follow-up|2
4708258|NCT02830893|7631291|FG000|Overall Study|Discharged to SNF, no transportation.|0
4708259|NCT02830893|7631292|FG001|Overall Study|Discharged to SNF, no transportation.|1
4708260|NCT02831257|7631298|FG000|Overall Study|Lack of Efficacy|3
4708261|NCT02831257|7631298|FG000|Overall Study|Adverse Event|2
4708262|NCT02831257|7631298|FG000|Overall Study|Physician Decision|1
4708263|NCT02831257|7631298|FG000|Overall Study|Withdrawal by Subject|6
4708264|NCT02831387|7631304|FG000|Overall Study|Withdrawal by Subject|1
4628126|NCT01857869|7495150|FG007|Primary/Challenge Phase|Lost to Follow-up|0
4628127|NCT01857869|7495151|FG008|Primary/Challenge Phase|Lost to Follow-up|0
4708265|NCT02831387|7631305|FG001|Overall Study|Withdrawal by Subject|1
4708266|NCT02831387|7631304|FG000|Overall Study|Discontinued due to stock recovery|0
4708267|NCT02831387|7631305|FG001|Overall Study|Discontinued due to stock recovery|1
4708268|NCT02831855|7631330|FG000|Open Label Phase (24 Weeks)|Adverse Event|39
4388600|NCT00063882|7167384|FG001|Overall Study|Protocol Violation|3
4388601|NCT00063882|7167383|FG000|Overall Study|Withdrawal by Subject|2
4388602|NCT00063882|7167384|FG001|Overall Study|Withdrawal by Subject|1
4388603|NCT00063934|7167390|FG000|Overall Study|Ineligible|1
4388604|NCT00063986|7167394|FG000|Overall Study|Withdrawal by Subject|1
4388605|NCT00063986|7167394|FG000|Overall Study|Ineligible|1
4388606|NCT00063986|7167394|FG000|Overall Study|Intra-operatively ineligible|4
4388607|NCT00063999|7167400|FG000|Overall Study|Withdrawal by Subject|1
4388608|NCT00063999|7167401|FG001|Overall Study|Withdrawal by Subject|0
4388609|NCT00063999|7167400|FG000|Overall Study|Ineligible|44
4388610|NCT00063999|7167401|FG001|Overall Study|Ineligible|24
4388611|NCT00064025|7167414|FG000|Overall Study|Ineligible|4
4388612|NCT00064025|7167414|FG000|Overall Study|Inevaluable|3
4388613|NCT00064077|7167437|FG000|Overall Study|Improper prior treatment|1
4388614|NCT00064077|7167438|FG001|Overall Study|Improper prior treatment|0
4388615|NCT00064077|7167439|FG002|Overall Study|Improper prior treatment|0
4708269|NCT02831855|7631331|FG001|Open Label Phase (24 Weeks)|Adverse Event|0
4388616|NCT00064077|7167440|FG003|Overall Study|Improper prior treatment|0
4388617|NCT00064077|7167437|FG000|Overall Study|Poor risk|2
4388618|NCT00064077|7167438|FG001|Overall Study|Poor risk|0
4388619|NCT00064077|7167439|FG002|Overall Study|Poor risk|1
4388620|NCT00064077|7167440|FG003|Overall Study|Poor risk|1
4388621|NCT00064077|7167437|FG000|Overall Study|Pathology|10
4388622|NCT00064077|7167438|FG001|Overall Study|Pathology|7
4388623|NCT00064077|7167439|FG002|Overall Study|Pathology|3
4388624|NCT00064077|7167440|FG003|Overall Study|Pathology|4
4388625|NCT00064077|7167437|FG000|Overall Study|No surgery|0
4388626|NCT00064077|7167438|FG001|Overall Study|No surgery|0
4388627|NCT00064077|7167439|FG002|Overall Study|No surgery|1
4388628|NCT00064077|7167440|FG003|Overall Study|No surgery|0
4388629|NCT00064077|7167437|FG000|Overall Study|No tumor|0
4388630|NCT00064077|7167438|FG001|Overall Study|No tumor|0
4388631|NCT00064077|7167439|FG002|Overall Study|No tumor|1
4388632|NCT00064077|7167440|FG003|Overall Study|No tumor|0
4388633|NCT00064077|7167437|FG000|Overall Study|Other reasons|2
4388634|NCT00064077|7167438|FG001|Overall Study|Other reasons|2
4388635|NCT00064077|7167439|FG002|Overall Study|Other reasons|1
4388636|NCT00064077|7167440|FG003|Overall Study|Other reasons|2
4388637|NCT00064259|7167450|FG000|Overall Study|Adverse Event|1
4388638|NCT00064259|7167451|FG001|Overall Study|Adverse Event|0
4388639|NCT00064259|7167452|FG002|Overall Study|Adverse Event|0
4388640|NCT00064259|7167453|FG003|Overall Study|Adverse Event|1
4388641|NCT00064298|7167460|FG000|Overall Study|Withdrawal by Subject|2
4388642|NCT00064298|7167461|FG001|Overall Study|Withdrawal by Subject|1
4388643|NCT00064298|7167460|FG000|Overall Study|Lost to Follow-up|2
4388644|NCT00064298|7167461|FG001|Overall Study|Lost to Follow-up|2
4388645|NCT00064298|7167460|FG000|Overall Study|Death|0
4388646|NCT00064298|7167461|FG001|Overall Study|Death|1
4388647|NCT00064298|7167460|FG000|Overall Study|Disease Progression|2
4388648|NCT00064298|7167461|FG001|Overall Study|Disease Progression|1
4388649|NCT00064337|7167467|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7
4388650|NCT00064337|7167467|FG000|PBSCC or Induction/PBSCC|Adverse Event|6
4510671|NCT00922272|7319560|FG001|Open-label Phase|Withdrawal by Subject|0
4708270|NCT02831855|7631332|FG002|Open Label Phase (24 Weeks)|Adverse Event|0
4708271|NCT02831855|7631330|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8
4388651|NCT00064337|7167467|FG000|PBSCC or Induction/PBSCC|Progression|3
4388652|NCT00064337|7167467|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2
4388653|NCT00064337|7167467|FG000|PBSCC or Induction/PBSCC|Death|2
4388654|NCT00064337|7167467|FG000|Transplant|Adverse Event|9
4388655|NCT00064337|7167467|FG000|Transplant|Not protocol-specified|5
4388656|NCT00064337|7167467|FG000|Transplant|Death|3
4388657|NCT00064337|7167467|FG000|Transplant|Patient Refusal|2
4388658|NCT00064337|7167467|FG000|Transplant|Progression|2
4388659|NCT00064337|7167467|FG000|Maintenance|Adverse Event|3
4388660|NCT00064337|7167467|FG000|Maintenance|Progression|2
4388661|NCT00064337|7167467|FG000|Maintenance|On treatment at time of analysis|2
4388662|NCT00064337|7167467|FG000|Maintenance|Not protocol-specified|2
4388663|NCT00064337|7167467|FG000|Maintenance|Death|1
4388664|NCT00064350|7167477|FG000|Induction Treatment|Disease Progression|5
4388665|NCT00064350|7167478|FG001|Induction Treatment|Disease Progression|1
4388666|NCT00064350|7167479|FG002|Induction Treatment|Disease Progression|110
4708272|NCT02831855|7631331|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0
4708273|NCT02831855|7631332|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0
4708274|NCT02831855|7631330|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7
4708275|NCT02831855|7631331|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0
4708276|NCT02831855|7631332|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0
4708277|NCT02831855|7631330|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2
4708278|NCT02831855|7631331|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0
4708279|NCT02831855|7631332|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0
4708280|NCT02831855|7631330|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5
4708281|NCT02831855|7631331|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0
4708282|NCT02831855|7631332|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0
4708283|NCT02831855|7631330|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6
4708284|NCT02831855|7631331|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0
4708285|NCT02831855|7631332|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0
4708286|NCT02831855|7631330|FG000|Open Label Phase (24 Weeks)|Other|4
4708287|NCT02831855|7631331|FG001|Open Label Phase (24 Weeks)|Other|0
4708288|NCT02831855|7631332|FG002|Open Label Phase (24 Weeks)|Other|0
4708289|NCT02831855|7631330|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0
4708290|NCT02831855|7631331|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6
4708291|NCT02831855|7631332|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6
4708292|NCT02831855|7631330|FG000|Double Blind Phase (24 Weeks)|Death|0
4708293|NCT02831855|7631331|FG001|Double Blind Phase (24 Weeks)|Death|0
4708294|NCT02831855|7631332|FG002|Double Blind Phase (24 Weeks)|Death|2
4708295|NCT02831855|7631330|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0
4708296|NCT02831855|7631331|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1
4708297|NCT02831855|7631332|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1
4708298|NCT02831855|7631330|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0
4708299|NCT02831855|7631331|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1
4708300|NCT02831855|7631332|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0
4708301|NCT02831855|7631330|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0
4708302|NCT02831855|7631331|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5
4708303|NCT02831855|7631332|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2
4708304|NCT02831855|7631330|FG000|Double Blind Phase (24 Weeks)|Other|0
4708305|NCT02831855|7631331|FG001|Double Blind Phase (24 Weeks)|Other|2
4708306|NCT02831855|7631332|FG002|Double Blind Phase (24 Weeks)|Other|5
4708307|NCT02831855|7631330|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0
4388667|NCT00064350|7167477|FG000|Induction Treatment|Adverse Event|0
4388668|NCT00064350|7167478|FG001|Induction Treatment|Adverse Event|2
4388669|NCT00064350|7167479|FG002|Induction Treatment|Adverse Event|49
4388670|NCT00064350|7167477|FG000|Induction Treatment|Death|0
4388671|NCT00064350|7167478|FG001|Induction Treatment|Death|0
4388672|NCT00064350|7167479|FG002|Induction Treatment|Death|9
4388673|NCT00064350|7167477|FG000|Induction Treatment|Withdrawal by Subject|0
4388674|NCT00064350|7167478|FG001|Induction Treatment|Withdrawal by Subject|0
4388675|NCT00064350|7167479|FG002|Induction Treatment|Withdrawal by Subject|21
4388676|NCT00064350|7167477|FG000|Induction Treatment|Ineligible or never started treatment|3
4388677|NCT00064350|7167478|FG001|Induction Treatment|Ineligible or never started treatment|6
4388678|NCT00064350|7167479|FG002|Induction Treatment|Ineligible or never started treatment|34
4388679|NCT00064350|7167477|FG000|Induction Treatment|Other|0
4388680|NCT00064350|7167478|FG001|Induction Treatment|Other|0
4388681|NCT00064350|7167479|FG002|Induction Treatment|Other|13
4388682|NCT00064350|7167477|FG000|Randomization|Adverse Event|8
4388683|NCT00064350|7167478|FG001|Randomization|Adverse Event|3
4388684|NCT00064350|7167479|FG002|Randomization|Adverse Event|0
4388685|NCT00064350|7167477|FG000|Randomization|Death|3
4388686|NCT00064350|7167478|FG001|Randomization|Death|0
4388687|NCT00064350|7167479|FG002|Randomization|Death|0
4388688|NCT00064350|7167477|FG000|Randomization|Withdrawal by Subject|1
4388689|NCT00064350|7167478|FG001|Randomization|Withdrawal by Subject|0
4388690|NCT00064350|7167479|FG002|Randomization|Withdrawal by Subject|0
4388691|NCT00064350|7167477|FG000|Randomization|Ineligible or never started treatment|9
4388692|NCT00064350|7167478|FG001|Randomization|Ineligible or never started treatment|15
4388693|NCT00064350|7167479|FG002|Randomization|Ineligible or never started treatment|0
4388694|NCT00064350|7167477|FG000|Randomization|Other|5
4388695|NCT00064350|7167478|FG001|Randomization|Other|0
4388696|NCT00064350|7167479|FG002|Randomization|Other|0
4388697|NCT00064350|7167477|FG000|Cross-Over|Adverse Event|0
4388698|NCT00064350|7167478|FG001|Cross-Over|Adverse Event|1
4388699|NCT00064350|7167479|FG002|Cross-Over|Adverse Event|0
4388700|NCT00064350|7167477|FG000|Cross-Over|Death|1
4388701|NCT00064350|7167478|FG001|Cross-Over|Death|3
4388702|NCT00064350|7167479|FG002|Cross-Over|Death|0
4388703|NCT00064350|7167477|FG000|Cross-Over|Withdrawal by Subject|2
4388704|NCT00064350|7167478|FG001|Cross-Over|Withdrawal by Subject|2
4388705|NCT00064350|7167479|FG002|Cross-Over|Withdrawal by Subject|0
4388706|NCT00064350|7167477|FG000|Cross-Over|Ineligible or never started treatment|3
4388707|NCT00064350|7167478|FG001|Cross-Over|Ineligible or never started treatment|6
4388708|NCT00064350|7167479|FG002|Cross-Over|Ineligible or never started treatment|0
4388709|NCT00064350|7167477|FG000|Cross-Over|Other|0
4388710|NCT00064350|7167478|FG001|Cross-Over|Other|2
4708308|NCT02831855|7631331|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6
4708309|NCT02831855|7631332|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1
4708310|NCT02831855|7631330|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0
4708311|NCT02831855|7631331|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5
4708312|NCT02831855|7631332|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2
4708313|NCT02831855|7631330|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0
4708314|NCT02831855|7631331|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3
4708315|NCT02831855|7631332|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0
4708316|NCT02832037|7631358|FG000|Overall Study|Administrative reasons|0
4708317|NCT02832037|7631359|FG001|Overall Study|Administrative reasons|0
4708318|NCT02832037|7631360|FG002|Overall Study|Administrative reasons|1
4708319|NCT02832037|7631361|FG003|Overall Study|Administrative reasons|0
4708320|NCT02832037|7631362|FG004|Overall Study|Administrative reasons|0
4708321|NCT02832037|7631358|FG000|Overall Study|Protocol Violation|3
4708322|NCT02832037|7631359|FG001|Overall Study|Protocol Violation|0
4708323|NCT02832037|7631360|FG002|Overall Study|Protocol Violation|4
4708324|NCT02832037|7631361|FG003|Overall Study|Protocol Violation|1
4708325|NCT02832037|7631362|FG004|Overall Study|Protocol Violation|2
4708326|NCT02832037|7631358|FG000|Overall Study|Lost to Follow-up|2
4708327|NCT02832037|7631359|FG001|Overall Study|Lost to Follow-up|0
4708328|NCT02832037|7631360|FG002|Overall Study|Lost to Follow-up|3
4708329|NCT02832037|7631361|FG003|Overall Study|Lost to Follow-up|0
4708330|NCT02832037|7631362|FG004|Overall Study|Lost to Follow-up|5
4708331|NCT02832037|7631358|FG000|Overall Study|Withdrawal by Subject|9
4708332|NCT02832037|7631359|FG001|Overall Study|Withdrawal by Subject|8
4708333|NCT02832037|7631360|FG002|Overall Study|Withdrawal by Subject|0
4708334|NCT02832037|7631361|FG003|Overall Study|Withdrawal by Subject|4
4708335|NCT02832037|7631362|FG004|Overall Study|Withdrawal by Subject|8
4708336|NCT02832037|7631358|FG000|Overall Study|Adverse Event|5
4708337|NCT02832037|7631359|FG001|Overall Study|Adverse Event|4
4708338|NCT02832037|7631360|FG002|Overall Study|Adverse Event|0
4708339|NCT02832037|7631361|FG003|Overall Study|Adverse Event|2
4708340|NCT02832037|7631362|FG004|Overall Study|Adverse Event|4
4708341|NCT02832375|7631393|FG000|Overall Study|Lost to Follow-up|1
4708342|NCT02832375|7631394|FG001|Overall Study|Lost to Follow-up|0
4708343|NCT02832375|7631393|FG000|Overall Study|Withdrawal of Consent|1
4708344|NCT02832375|7631394|FG001|Overall Study|Withdrawal of Consent|0
4708345|NCT02832622|7631401|FG000|Overall Study|MPP not programmed|1259
4708346|NCT02832622|7631401|FG000|Overall Study|Withdrawal by Subject|123
4708347|NCT02832622|7631401|FG000|Overall Study|Death|119
4708348|NCT02832622|7631401|FG000|Overall Study|Unsuccessful CRT implant|93
4708349|NCT02832622|7631401|FG000|Overall Study|Lost to Follow-up|45
4708350|NCT02832622|7631401|FG000|Overall Study|Patient non-compliance|42
4708351|NCT02832622|7631401|FG000|Overall Study|Withdrawal by other reasons|25
4708352|NCT02832622|7631401|FG000|Overall Study|System explant|24
4708353|NCT02832622|7631401|FG000|Overall Study|Physician Decision|6
4708354|NCT02833077|7631412|FG000|Overall Study|Adverse Event|1
4708355|NCT02833077|7631413|FG001|Overall Study|Adverse Event|2
4708356|NCT02833077|7631412|FG000|Overall Study|Lost to Follow-up|10
4708357|NCT02833077|7631413|FG001|Overall Study|Lost to Follow-up|1
4708358|NCT02833077|7631412|FG000|Overall Study|Personal Reasons|6
4708359|NCT02833077|7631413|FG001|Overall Study|Personal Reasons|4
4708360|NCT02833077|7631412|FG000|Overall Study|Protocol Deviation|0
4388711|NCT00064350|7167479|FG002|Cross-Over|Other|0
4388712|NCT00064662|7167490|FG000|Overall Study|Death|1
4388713|NCT00064662|7167491|FG001|Overall Study|Death|1
4388714|NCT00064662|7167490|FG000|Overall Study|Lost to Follow-up|57
4388715|NCT00064662|7167491|FG001|Overall Study|Lost to Follow-up|44
4388716|NCT00064662|7167490|FG000|Overall Study|Withdrawal by Subject|14
4388717|NCT00064662|7167491|FG001|Overall Study|Withdrawal by Subject|14
4388718|NCT00064662|7167490|FG000|Overall Study|Administratively withdrawn|2
4388719|NCT00064662|7167491|FG001|Overall Study|Administratively withdrawn|2
4388720|NCT00064701|7167500|FG000|One Year Post-transplant|Did not receive study drug|7
4388721|NCT00064701|7167501|FG001|One Year Post-transplant|Did not receive study drug|12
4388722|NCT00064701|7167502|FG002|One Year Post-transplant|Did not receive study drug|11
4388723|NCT00064701|7167500|FG000|One Year Post-transplant|Adverse Event|23
4388724|NCT00064701|7167501|FG001|One Year Post-transplant|Adverse Event|19
4388725|NCT00064701|7167502|FG002|One Year Post-transplant|Adverse Event|37
4708361|NCT02833077|7631413|FG001|Overall Study|Protocol Deviation|1
4708362|NCT02833350|7631431|FG000|Overall Study|Adverse Event|0
4708363|NCT02833350|7631432|FG001|Overall Study|Adverse Event|3
4708364|NCT02833350|7631433|FG002|Overall Study|Adverse Event|4
4708365|NCT02833350|7631434|FG003|Overall Study|Adverse Event|4
4708366|NCT02833350|7631435|FG004|Overall Study|Adverse Event|1
4388726|NCT00064701|7167500|FG000|One Year Post-transplant|Rejection|0
4388727|NCT00064701|7167501|FG001|One Year Post-transplant|Rejection|1
4388728|NCT00064701|7167502|FG002|One Year Post-transplant|Rejection|16
4708367|NCT02833350|7631436|FG005|Overall Study|Adverse Event|0
4708368|NCT02833350|7631437|FG006|Overall Study|Adverse Event|1
4708369|NCT02833350|7631431|FG000|Overall Study|Death|0
4708370|NCT02833350|7631432|FG001|Overall Study|Death|0
4708371|NCT02833350|7631433|FG002|Overall Study|Death|1
4708372|NCT02833350|7631434|FG003|Overall Study|Death|0
4708373|NCT02833350|7631435|FG004|Overall Study|Death|0
4708374|NCT02833350|7631436|FG005|Overall Study|Death|0
4708375|NCT02833350|7631437|FG006|Overall Study|Death|0
4708376|NCT02833350|7631431|FG000|Overall Study|Lack of Efficacy|0
4708377|NCT02833350|7631432|FG001|Overall Study|Lack of Efficacy|2
4708378|NCT02833350|7631433|FG002|Overall Study|Lack of Efficacy|1
4708379|NCT02833350|7631434|FG003|Overall Study|Lack of Efficacy|4
4708380|NCT02833350|7631435|FG004|Overall Study|Lack of Efficacy|0
4708381|NCT02833350|7631436|FG005|Overall Study|Lack of Efficacy|1
4708382|NCT02833350|7631437|FG006|Overall Study|Lack of Efficacy|1
4708383|NCT02833350|7631431|FG000|Overall Study|Lost to Follow-up|0
4708384|NCT02833350|7631432|FG001|Overall Study|Lost to Follow-up|1
4708385|NCT02833350|7631433|FG002|Overall Study|Lost to Follow-up|0
4708386|NCT02833350|7631434|FG003|Overall Study|Lost to Follow-up|0
4708387|NCT02833350|7631435|FG004|Overall Study|Lost to Follow-up|0
4708388|NCT02833350|7631436|FG005|Overall Study|Lost to Follow-up|0
4708389|NCT02833350|7631437|FG006|Overall Study|Lost to Follow-up|1
4708390|NCT02833350|7631431|FG000|Overall Study|Withdrawal by Subject|3
4708391|NCT02833350|7631432|FG001|Overall Study|Withdrawal by Subject|3
4708392|NCT02833350|7631433|FG002|Overall Study|Withdrawal by Subject|2
4708393|NCT02833350|7631434|FG003|Overall Study|Withdrawal by Subject|0
4708394|NCT02833350|7631435|FG004|Overall Study|Withdrawal by Subject|2
4708395|NCT02833350|7631436|FG005|Overall Study|Withdrawal by Subject|0
4708396|NCT02833350|7631437|FG006|Overall Study|Withdrawal by Subject|2
4708397|NCT02833844|7631467|FG000|Double-Blind Period|Withdrawal by Subject|2
4708398|NCT02833844|7631468|FG001|Double-Blind Period|Withdrawal by Subject|3
4708399|NCT02833844|7631467|FG000|Double-Blind Period|Protocol Violation|0
4708400|NCT02833844|7631468|FG001|Double-Blind Period|Protocol Violation|4
4708401|NCT02833844|7631467|FG000|Open-Label Period|Death|0
4708402|NCT02833844|7631468|FG001|Open-Label Period|Death|2
4388729|NCT00064701|7167500|FG000|One Year Post-transplant|Non-compliance|4
4388730|NCT00064701|7167501|FG001|One Year Post-transplant|Non-compliance|2
4388731|NCT00064701|7167502|FG002|One Year Post-transplant|Non-compliance|5
4388732|NCT00064701|7167500|FG000|One Year Post-transplant|Graft Failure|3
4388733|NCT00064701|7167501|FG001|One Year Post-transplant|Graft Failure|2
4388734|NCT00064701|7167502|FG002|One Year Post-transplant|Graft Failure|1
4388735|NCT00064701|7167500|FG000|One Year Post-transplant|Withdrawal by Subject|0
4388736|NCT00064701|7167501|FG001|One Year Post-transplant|Withdrawal by Subject|4
4388737|NCT00064701|7167502|FG002|One Year Post-transplant|Withdrawal by Subject|1
4388738|NCT00064701|7167500|FG000|One Year Post-transplant|Lost to Follow-up|1
4388739|NCT00064701|7167501|FG001|One Year Post-transplant|Lost to Follow-up|0
4388740|NCT00064701|7167502|FG002|One Year Post-transplant|Lost to Follow-up|0
4388741|NCT00064701|7167500|FG000|One Year Post-transplant|Converted to rapamycin|1
4388742|NCT00064701|7167501|FG001|One Year Post-transplant|Converted to rapamycin|0
4388743|NCT00064701|7167502|FG002|One Year Post-transplant|Converted to rapamycin|0
4388744|NCT00064701|7167500|FG000|One Year Post-transplant|Acute tubular necrosis|1
4388745|NCT00064701|7167501|FG001|One Year Post-transplant|Acute tubular necrosis|0
4388746|NCT00064701|7167502|FG002|One Year Post-transplant|Acute tubular necrosis|0
4388747|NCT00064701|7167500|FG000|One Year Post-transplant|Incorrect study drug dispensed|0
4388748|NCT00064701|7167501|FG001|One Year Post-transplant|Incorrect study drug dispensed|1
4388749|NCT00064701|7167502|FG002|One Year Post-transplant|Incorrect study drug dispensed|0
4388750|NCT00064701|7167500|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0
4388751|NCT00064701|7167501|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1
4388752|NCT00064701|7167502|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0
4388753|NCT00064701|7167500|FG000|One Year Post-transplant|Poor absorption|0
4388754|NCT00064701|7167501|FG001|One Year Post-transplant|Poor absorption|1
4388755|NCT00064701|7167502|FG002|One Year Post-transplant|Poor absorption|0
4388756|NCT00064701|7167500|FG000|One Year Post-transplant|Pancreas transplant|0
4388757|NCT00064701|7167501|FG001|One Year Post-transplant|Pancreas transplant|0
4388758|NCT00064701|7167502|FG002|One Year Post-transplant|Pancreas transplant|1
4388759|NCT00064701|7167500|FG000|Clinical Continuation Phase|Adverse Event|12
4388760|NCT00064701|7167501|FG001|Clinical Continuation Phase|Adverse Event|21
4388761|NCT00064701|7167502|FG002|Clinical Continuation Phase|Adverse Event|14
4388762|NCT00064701|7167500|FG000|Clinical Continuation Phase|Non-compliance|8
4388763|NCT00064701|7167501|FG001|Clinical Continuation Phase|Non-compliance|6
4388764|NCT00064701|7167502|FG002|Clinical Continuation Phase|Non-compliance|7
4510672|NCT00922272|7319559|FG000|Open-label Phase|Failure to meet randomization criteria|1
4708403|NCT02833844|7631467|FG000|Open-Label Period|Lost to Follow-up|1
4708404|NCT02833844|7631468|FG001|Open-Label Period|Lost to Follow-up|0
4708405|NCT02833844|7631467|FG000|Open-Label Period|Withdrawal by Subject|1
4388765|NCT00064701|7167500|FG000|Clinical Continuation Phase|Withdrawal by Subject|22
4388766|NCT00064701|7167501|FG001|Clinical Continuation Phase|Withdrawal by Subject|3
4388767|NCT00064701|7167502|FG002|Clinical Continuation Phase|Withdrawal by Subject|22
4388768|NCT00064701|7167500|FG000|Clinical Continuation Phase|Lost to Follow-up|6
4708406|NCT02833844|7631468|FG001|Open-Label Period|Withdrawal by Subject|0
4708407|NCT02833948|7631486|FG000|Overall Study|Death|2
4708408|NCT02833948|7631487|FG001|Overall Study|Death|3
4708409|NCT02833948|7631486|FG000|Overall Study|were not scanned|8
4708410|NCT02833948|7631487|FG001|Overall Study|were not scanned|13
4708411|NCT02833948|7631486|FG000|Overall Study|scans could not be evaluated|5
4708412|NCT02833948|7631487|FG001|Overall Study|scans could not be evaluated|2
4708413|NCT02833974|7631499|FG000|Overall Study|Lost to Follow-up|1
4708414|NCT02833974|7631500|FG001|Overall Study|Lost to Follow-up|0
4708415|NCT02833974|7631499|FG000|Overall Study|Adverse Event|0
4708416|NCT02833974|7631500|FG001|Overall Study|Adverse Event|3
4708417|NCT02834247|7631510|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1
4708418|NCT02834247|7631511|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2
4708419|NCT02834247|7631512|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0
4708420|NCT02834247|7631513|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0
4708421|NCT02834247|7631510|FG000|Dose Escalation Phase|Death|5
4708422|NCT02834247|7631511|FG001|Dose Escalation Phase|Death|6
4708423|NCT02834247|7631512|FG002|Dose Escalation Phase|Death|5
4708424|NCT02834247|7631513|FG003|Dose Escalation Phase|Death|0
4708425|NCT02834247|7631510|FG000|Dose Escalation Phase|Lost to Follow-up|0
4708426|NCT02834247|7631511|FG001|Dose Escalation Phase|Lost to Follow-up|1
4708427|NCT02834247|7631512|FG002|Dose Escalation Phase|Lost to Follow-up|0
4708428|NCT02834247|7631513|FG003|Dose Escalation Phase|Lost to Follow-up|0
4708429|NCT02834247|7631510|FG000|Dose Escalation Phase|Withdrawal by Subject|2
4708430|NCT02834247|7631511|FG001|Dose Escalation Phase|Withdrawal by Subject|2
4708431|NCT02834247|7631512|FG002|Dose Escalation Phase|Withdrawal by Subject|0
4708432|NCT02834247|7631513|FG003|Dose Escalation Phase|Withdrawal by Subject|0
4708433|NCT02834247|7631510|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0
4708434|NCT02834247|7631511|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0
4708435|NCT02834247|7631512|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0
4708436|NCT02834247|7631513|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7
4708437|NCT02834247|7631510|FG000|Dose Expansion Phase|Death|0
4708438|NCT02834247|7631511|FG001|Dose Expansion Phase|Death|0
4708439|NCT02834247|7631512|FG002|Dose Expansion Phase|Death|0
4708440|NCT02834247|7631513|FG003|Dose Expansion Phase|Death|8
4708441|NCT02834247|7631510|FG000|Dose Expansion Phase|Lost to Follow-up|0
4708442|NCT02834247|7631511|FG001|Dose Expansion Phase|Lost to Follow-up|0
4708443|NCT02834247|7631512|FG002|Dose Expansion Phase|Lost to Follow-up|0
4708444|NCT02834247|7631513|FG003|Dose Expansion Phase|Lost to Follow-up|1
4708445|NCT02834247|7631510|FG000|Dose Expansion Phase|Withdrawal by Subject|0
4708446|NCT02834247|7631511|FG001|Dose Expansion Phase|Withdrawal by Subject|0
4708447|NCT02834247|7631512|FG002|Dose Expansion Phase|Withdrawal by Subject|0
4708448|NCT02834247|7631513|FG003|Dose Expansion Phase|Withdrawal by Subject|1
4708449|NCT02834390|7631527|FG000|Induction Phase|Progressive disease|0
4708450|NCT02834390|7631528|FG001|Induction Phase|Progressive disease|1
4708451|NCT02834390|7631527|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2
4708452|NCT02834390|7631528|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0
4708453|NCT02834390|7631527|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0
4708454|NCT02834390|7631528|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1
4708455|NCT02834390|7631527|FG000|Consolidation Phase|Physician Decision|1
4708456|NCT02834390|7631528|FG001|Consolidation Phase|Physician Decision|1
4708457|NCT02834819|7631568|FG000|Overall Study|Did not complete 7 day follow up call.|5
4708458|NCT02834819|7631569|FG001|Overall Study|Did not complete 7 day follow up call.|0
4708459|NCT02835092|7631578|FG000|Overall Study|Withdrawal by Subject|3
4708460|NCT02835092|7631579|FG001|Overall Study|Withdrawal by Subject|6
4708461|NCT02835092|7631580|FG002|Overall Study|Withdrawal by Subject|3
4708462|NCT02835092|7631578|FG000|Overall Study|Lost to Follow-up|0
4708463|NCT02835092|7631579|FG001|Overall Study|Lost to Follow-up|2
4708464|NCT02835092|7631580|FG002|Overall Study|Lost to Follow-up|0
4708465|NCT02835339|7631599|FG000|Overall Study|Did not receive allocated intervention|13
4708466|NCT02835339|7631600|FG001|Overall Study|Did not receive allocated intervention|16
4708467|NCT02835495|7631608|FG000|Overall Study|Cancer diagnosis prior intervention|1
4708468|NCT02835495|7631609|FG001|Overall Study|Cancer diagnosis prior intervention|0
4708469|NCT02835495|7631608|FG000|Overall Study|Declined in-person follow-up visit|4
4708470|NCT02835495|7631609|FG001|Overall Study|Declined in-person follow-up visit|2
4708471|NCT02835820|7631633|FG000|Overall Study|Baseline Screen Failure|0
4708472|NCT02835820|7631634|FG001|Overall Study|Baseline Screen Failure|3
4708473|NCT02836496|7631646|FG000|Overall Study|Adverse Event|2
4708474|NCT02836496|7631647|FG001|Overall Study|Adverse Event|1
4708475|NCT02836496|7631646|FG000|Overall Study|Withdrawal by Subject|0
4708476|NCT02836496|7631647|FG001|Overall Study|Withdrawal by Subject|1
4708477|NCT02836613|7631655|FG000|Overall Study|Accidental drowning|1
4708478|NCT02836613|7631656|FG001|Overall Study|Accidental drowning|0
4708479|NCT02836613|7631655|FG000|Overall Study|Lost to Follow-up|0
4708480|NCT02836613|7631656|FG001|Overall Study|Lost to Follow-up|1
4708481|NCT02836613|7631655|FG000|Overall Study|Withdrawal by Subject|0
4708482|NCT02836613|7631656|FG001|Overall Study|Withdrawal by Subject|2
4708483|NCT02836652|7631664|FG000|Overall Study|Death|3
4708484|NCT02836652|7631665|FG001|Overall Study|Death|3
4708485|NCT02836652|7631664|FG000|Overall Study|Transplant/Explant|3
4708486|NCT02836652|7631665|FG001|Overall Study|Transplant/Explant|4
4708487|NCT02836652|7631664|FG000|Overall Study|Withdrawn|9
4708488|NCT02836652|7631665|FG001|Overall Study|Withdrawn|9
4708489|NCT02836652|7631664|FG000|Overall Study|Not on treatment regimen post-op day 15|3
4708490|NCT02836652|7631665|FG001|Overall Study|Not on treatment regimen post-op day 15|3
4708491|NCT02836769|7631671|FG000|Overall Study|Lost to Follow-up|10
4708492|NCT02836769|7631671|FG000|Overall Study|Medical withdrawal|2
4708493|NCT02836769|7631671|FG000|Overall Study|Withdrawal by Subject|3
4708494|NCT02836873|7631677|FG000|Overall Study|Protocol Violation|0
4708495|NCT02836873|7631678|FG001|Overall Study|Protocol Violation|1
4708496|NCT02836873|7631677|FG000|Overall Study|Adverse Event|1
4708497|NCT02836873|7631678|FG001|Overall Study|Adverse Event|4
4708498|NCT02836873|7631677|FG000|Overall Study|Withdrawal by Subject|2
4708499|NCT02836873|7631678|FG001|Overall Study|Withdrawal by Subject|2
4708500|NCT02836873|7631677|FG000|Overall Study|Lost to Follow-up|1
4708501|NCT02836873|7631678|FG001|Overall Study|Lost to Follow-up|3
4708502|NCT02836873|7631677|FG000|Overall Study|Physician Decision|0
4708503|NCT02836873|7631678|FG001|Overall Study|Physician Decision|1
4708504|NCT02836873|7631677|FG000|Overall Study|Other|1
4708505|NCT02836873|7631678|FG001|Overall Study|Other|0
4708506|NCT02837731|7631710|FG000|Allocation|Admitted to General Floor|3
4708507|NCT02837731|7631711|FG001|Allocation|Admitted to General Floor|4
4708508|NCT02837731|7631710|FG000|Allocation|Immediate surgery/withdrew|2
4708509|NCT02837731|7631711|FG001|Allocation|Immediate surgery/withdrew|0
4708510|NCT02837731|7631710|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1
4708511|NCT02837731|7631711|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0
4708512|NCT02837731|7631710|FG000|Allocation|Withdrawal by Subject|2
4708513|NCT02837731|7631711|FG001|Allocation|Withdrawal by Subject|0
4708514|NCT02837731|7631710|FG000|Allocation|Device not available|1
4388769|NCT00064701|7167501|FG001|Clinical Continuation Phase|Lost to Follow-up|3
4388770|NCT00064701|7167502|FG002|Clinical Continuation Phase|Lost to Follow-up|6
4388771|NCT00064701|7167500|FG000|Clinical Continuation Phase|Graft Failure|5
4388772|NCT00064701|7167501|FG001|Clinical Continuation Phase|Graft Failure|5
4388773|NCT00064701|7167502|FG002|Clinical Continuation Phase|Graft Failure|2
4388774|NCT00064701|7167500|FG000|Clinical Continuation Phase|Rejection|1
4388775|NCT00064701|7167501|FG001|Clinical Continuation Phase|Rejection|2
4388776|NCT00064701|7167502|FG002|Clinical Continuation Phase|Rejection|2
4388777|NCT00064701|7167500|FG000|Clinical Continuation Phase|Sponsor discontinued study|113
4388778|NCT00064701|7167501|FG001|Clinical Continuation Phase|Sponsor discontinued study|129
4388779|NCT00064701|7167502|FG002|Clinical Continuation Phase|Sponsor discontinued study|79
4388780|NCT00064701|7167500|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0
4388781|NCT00064701|7167501|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3
4388782|NCT00064701|7167502|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6
4388783|NCT00064701|7167500|FG000|Clinical Continuation Phase|Physician Decision|1
4388784|NCT00064701|7167501|FG001|Clinical Continuation Phase|Physician Decision|3
4388785|NCT00064701|7167502|FG002|Clinical Continuation Phase|Physician Decision|0
4388786|NCT00064701|7167500|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1
4388787|NCT00064701|7167501|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0
4388788|NCT00064701|7167502|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1
4388789|NCT00064701|7167500|FG000|Clinical Continuation Phase|Pancreas transplant|1
4388790|NCT00064701|7167501|FG001|Clinical Continuation Phase|Pancreas transplant|0
4388791|NCT00064701|7167502|FG002|Clinical Continuation Phase|Pancreas transplant|0
4388792|NCT00064701|7167500|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0
4388793|NCT00064701|7167501|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1
4388794|NCT00064701|7167502|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0
4388795|NCT00064701|7167500|FG000|Clinical Continuation Phase|Discharged to nursing home|0
4388796|NCT00064701|7167501|FG001|Clinical Continuation Phase|Discharged to nursing home|1
4388797|NCT00064701|7167502|FG002|Clinical Continuation Phase|Discharged to nursing home|0
4388798|NCT00064701|7167500|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0
4388799|NCT00064701|7167501|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1
4388800|NCT00064701|7167502|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0
4388801|NCT00064701|7167500|FG000|Clinical Continuation Phase|Patient opted out|0
4388802|NCT00064701|7167501|FG001|Clinical Continuation Phase|Patient opted out|0
4388803|NCT00064701|7167502|FG002|Clinical Continuation Phase|Patient opted out|1
4388804|NCT00064753|7167512|FG000|Overall Study|Death|251
4388805|NCT00064753|7167513|FG001|Overall Study|Death|242
4388806|NCT00064753|7167512|FG000|Overall Study|Withdrawal by Subject|198
4388807|NCT00064753|7167513|FG001|Overall Study|Withdrawal by Subject|171
4388808|NCT00064753|7167512|FG000|Overall Study|Lost to Follow-up|225
4388809|NCT00064753|7167513|FG001|Overall Study|Lost to Follow-up|235
4388810|NCT00064792|7167521|FG000|Overall Study|Withdrawal by Subject|2
4388811|NCT00064792|7167522|FG001|Overall Study|Withdrawal by Subject|0
4388812|NCT00064792|7167521|FG000|Overall Study|Adverse Event|3
4388813|NCT00064792|7167522|FG001|Overall Study|Adverse Event|0
4388814|NCT00064987|7167539|FG000|Overall Study|Physician Decision|3
4388815|NCT00064987|7167540|FG001|Overall Study|Physician Decision|0
4388816|NCT00065065|7167548|FG000|Overall Study|Adverse Event|3
4388817|NCT00065065|7167549|FG001|Overall Study|Adverse Event|2
4388818|NCT00065065|7167548|FG000|Overall Study|Withdrawal by Subject|1
4388819|NCT00065065|7167549|FG001|Overall Study|Withdrawal by Subject|5
4388820|NCT00065065|7167548|FG000|Overall Study|Lack of Efficacy|4
4708515|NCT02837731|7631711|FG001|Allocation|Device not available|0
4708516|NCT02837731|7631710|FG000|Allocation|Protocol not implemented|7
4708517|NCT02837731|7631711|FG001|Allocation|Protocol not implemented|0
4708518|NCT02837731|7631710|FG000|Allocation|Moribund/Do not resuscitate|2
4708519|NCT02837731|7631711|FG001|Allocation|Moribund/Do not resuscitate|0
4708520|NCT02837731|7631710|FG000|Allocation|Did not meet sepsis criteria|1
4708521|NCT02837731|7631711|FG001|Allocation|Did not meet sepsis criteria|2
4708522|NCT02837731|7631710|FG000|Allocation|Known aortic abnormalities|0
4708523|NCT02837731|7631711|FG001|Allocation|Known aortic abnormalities|1
4708524|NCT02837952|7631732|FG000|Overall Study|Adverse Event|0
4708525|NCT02837952|7631733|FG001|Overall Study|Adverse Event|1
4708526|NCT02837952|7631732|FG000|Overall Study|Withdrawal by Subject|4
4708527|NCT02837952|7631733|FG001|Overall Study|Withdrawal by Subject|5
4708528|NCT02837952|7631732|FG000|Overall Study|Medication Error|1
4708529|NCT02837952|7631733|FG001|Overall Study|Medication Error|0
4708530|NCT02838017|7631741|FG000|Overall Study|Lost to Follow-up|14
4708531|NCT02838017|7631742|FG001|Overall Study|Lost to Follow-up|11
4708532|NCT02838134|7631750|FG000|Overall Study|Lost to Follow-up|1
4708533|NCT02838134|7631751|FG001|Overall Study|Lost to Follow-up|2
4708534|NCT02838134|7631750|FG000|Overall Study|logistic problems|1
4708535|NCT02838134|7631751|FG001|Overall Study|logistic problems|1
4708536|NCT02838420|7631763|FG000|Overall Study|Ongoing in Study|113
4708537|NCT02838420|7631764|FG001|Overall Study|Ongoing in Study|45
4708538|NCT02838420|7631763|FG000|Overall Study|Lost to Follow-up|1
4708539|NCT02838420|7631764|FG001|Overall Study|Lost to Follow-up|0
4708540|NCT02838420|7631763|FG000|Overall Study|Withdrawal by Subject|3
4708541|NCT02838420|7631764|FG001|Overall Study|Withdrawal by Subject|4
4708542|NCT02838420|7631763|FG000|Overall Study|Death|8
4708543|NCT02838420|7631764|FG001|Overall Study|Death|13
4708544|NCT02838628|7631772|FG000|Recurrence Follow-up Period|AK Recurrence|18
4708545|NCT02838628|7631773|FG001|Recurrence Follow-up Period|AK Recurrence|13
4708546|NCT02838628|7631772|FG000|Recurrence Follow-up Period|Adverse Event|1
4708547|NCT02838628|7631773|FG001|Recurrence Follow-up Period|Adverse Event|0
4708548|NCT02838628|7631772|FG000|Recurrence Follow-up Period|Non-compliance|0
4708549|NCT02838628|7631773|FG001|Recurrence Follow-up Period|Non-compliance|1
4708550|NCT02838628|7631772|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0
4708551|NCT02838628|7631773|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2
4708552|NCT02838628|7631772|FG000|Recurrence Follow-up Period|Other un-specified|1
4708553|NCT02838628|7631773|FG001|Recurrence Follow-up Period|Other un-specified|1
4708554|NCT02838901|7631782|FG000|Overall Study|Withdrawal by Subject|1
4388821|NCT00065065|7167549|FG001|Overall Study|Lack of Efficacy|11
4388822|NCT00065065|7167548|FG000|Overall Study|Other|2
4388823|NCT00065065|7167549|FG001|Overall Study|Other|2
4388824|NCT00065156|7167557|FG000|Overall Study|Adverse Event|37
4388825|NCT00065156|7167557|FG000|Overall Study|Lack of Efficacy|52
4388826|NCT00065156|7167557|FG000|Overall Study|Withdrawal by Subject|8
4388827|NCT00065156|7167557|FG000|Overall Study|Lost to Follow-up|1
4388828|NCT00065156|7167557|FG000|Overall Study|Death|11
4388829|NCT00065156|7167557|FG000|Overall Study|Study Closed by Sponsor|2
4388830|NCT00065156|7167557|FG000|Overall Study|Disease Progression|7
4388831|NCT00065156|7167557|FG000|Overall Study|Investigator Decision|2
4708555|NCT02838901|7631783|FG001|Overall Study|Withdrawal by Subject|1
4708556|NCT02838901|7631782|FG000|Overall Study|Lost to Follow-up|1
4708557|NCT02838901|7631783|FG001|Overall Study|Lost to Follow-up|1
4708558|NCT02839200|7631797|FG000|Overall Study|Withdrawal by Subject|2
4708559|NCT02839200|7631798|FG001|Overall Study|Withdrawal by Subject|0
4708560|NCT02839200|7631799|FG002|Overall Study|Withdrawal by Subject|1
4708561|NCT02839200|7631800|FG003|Overall Study|Withdrawal by Subject|0
4708562|NCT02839200|7631801|FG004|Overall Study|Withdrawal by Subject|0
4708563|NCT02839200|7631802|FG005|Overall Study|Withdrawal by Subject|1
4708564|NCT02839200|7631797|FG000|Overall Study|Lost to Follow-up|2
4708565|NCT02839200|7631798|FG001|Overall Study|Lost to Follow-up|0
4708566|NCT02839200|7631799|FG002|Overall Study|Lost to Follow-up|0
4708567|NCT02839200|7631800|FG003|Overall Study|Lost to Follow-up|0
4708568|NCT02839200|7631801|FG004|Overall Study|Lost to Follow-up|1
4708569|NCT02839200|7631802|FG005|Overall Study|Lost to Follow-up|0
4708570|NCT02839200|7631797|FG000|Overall Study|Adverse Event|0
4708571|NCT02839200|7631798|FG001|Overall Study|Adverse Event|0
4708572|NCT02839200|7631799|FG002|Overall Study|Adverse Event|0
4708573|NCT02839200|7631800|FG003|Overall Study|Adverse Event|0
4708574|NCT02839200|7631801|FG004|Overall Study|Adverse Event|1
4708575|NCT02839200|7631802|FG005|Overall Study|Adverse Event|0
4708576|NCT02839200|7631797|FG000|Overall Study|Randomized in error|0
4708577|NCT02839200|7631798|FG001|Overall Study|Randomized in error|1
4708578|NCT02839200|7631799|FG002|Overall Study|Randomized in error|0
4708579|NCT02839200|7631800|FG003|Overall Study|Randomized in error|0
4708580|NCT02839200|7631801|FG004|Overall Study|Randomized in error|0
4708581|NCT02839200|7631802|FG005|Overall Study|Randomized in error|0
4388832|NCT00065156|7167557|FG000|Overall Study|Non-Compliance|2
4708582|NCT02839330|7631820|FG000|Overall Study|Adverse Event|0
4708583|NCT02839330|7631821|FG001|Overall Study|Adverse Event|1
4708584|NCT02839330|7631822|FG002|Overall Study|Adverse Event|2
4708585|NCT02839330|7631823|FG003|Overall Study|Adverse Event|2
4708586|NCT02839330|7631820|FG000|Overall Study|Death|4
4708587|NCT02839330|7631821|FG001|Overall Study|Death|6
4708588|NCT02839330|7631822|FG002|Overall Study|Death|1
4708589|NCT02839330|7631823|FG003|Overall Study|Death|1
4708590|NCT02839330|7631820|FG000|Overall Study|Withdrawal by Subject|27
4708591|NCT02839330|7631821|FG001|Overall Study|Withdrawal by Subject|19
4708592|NCT02839330|7631822|FG002|Overall Study|Withdrawal by Subject|11
4708593|NCT02839330|7631823|FG003|Overall Study|Withdrawal by Subject|13
4708594|NCT02839330|7631820|FG000|Overall Study|Lost to Follow-up|22
4708595|NCT02839330|7631821|FG001|Overall Study|Lost to Follow-up|27
4708596|NCT02839330|7631822|FG002|Overall Study|Lost to Follow-up|29
4708597|NCT02839330|7631823|FG003|Overall Study|Lost to Follow-up|25
4708598|NCT02839330|7631820|FG000|Overall Study|Administrative Reason|0
4708599|NCT02839330|7631821|FG001|Overall Study|Administrative Reason|0
4708600|NCT02839330|7631822|FG002|Overall Study|Administrative Reason|0
4708601|NCT02839330|7631823|FG003|Overall Study|Administrative Reason|1
4708602|NCT02839330|7631820|FG000|Overall Study|Protocol Violation|1
4708603|NCT02839330|7631821|FG001|Overall Study|Protocol Violation|2
4708604|NCT02839330|7631822|FG002|Overall Study|Protocol Violation|2
4388833|NCT00065156|7167557|FG000|Overall Study|Loss of Response|1
4388834|NCT00065156|7167557|FG000|Overall Study|Secondary Malign Disease|1
4388835|NCT00065182|7167563|FG000|Overall Study|Adverse Event|24
4388836|NCT00065182|7167564|FG001|Overall Study|Adverse Event|17
4388837|NCT00065182|7167563|FG000|Overall Study|Lost to Follow-up|0
4388838|NCT00065182|7167564|FG001|Overall Study|Lost to Follow-up|4
4388839|NCT00065182|7167563|FG000|Overall Study|Protocol Violation|3
4388840|NCT00065182|7167564|FG001|Overall Study|Protocol Violation|4
4388841|NCT00065182|7167563|FG000|Overall Study|Serious adverse events (SAE)|1
4388842|NCT00065182|7167564|FG001|Overall Study|Serious adverse events (SAE)|0
4388843|NCT00065182|7167563|FG000|Overall Study|Sponsor Decision|11
4388844|NCT00065182|7167564|FG001|Overall Study|Sponsor Decision|7
4388845|NCT00065182|7167563|FG000|Overall Study|Withdrawal by Subject|8
4388846|NCT00065182|7167564|FG001|Overall Study|Withdrawal by Subject|3
4388847|NCT00065182|7167563|FG000|Overall Study|No clinical benefit|1
4388848|NCT00065182|7167564|FG001|Overall Study|No clinical benefit|0
4388849|NCT00065182|7167563|FG000|Overall Study|Death|0
4388850|NCT00065182|7167564|FG001|Overall Study|Death|1
4388851|NCT00065182|7167563|FG000|Overall Study|Decline in Status|0
4388852|NCT00065182|7167564|FG001|Overall Study|Decline in Status|1
4388853|NCT00065260|7167572|FG000|Overall Study|Death|0
4388854|NCT00065260|7167573|FG001|Overall Study|Death|1
4388855|NCT00065429|7167586|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
4388856|NCT00065429|7167587|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
4388857|NCT00065429|7167588|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
4388858|NCT00065429|7167589|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
4628128|NCT01857869|7495152|FG009|Primary/Challenge Phase|Lost to Follow-up|0
4628129|NCT01857869|7495143|FG000|Primary/Challenge Phase|Pregnancy|1
4628130|NCT01857869|7495144|FG001|Primary/Challenge Phase|Pregnancy|0
4628131|NCT01857869|7495145|FG002|Primary/Challenge Phase|Pregnancy|0
4708605|NCT02839330|7631823|FG003|Overall Study|Protocol Violation|3
4708606|NCT02839330|7631820|FG000|Overall Study|Other reason, not specified|4
4708607|NCT02839330|7631821|FG001|Overall Study|Other reason, not specified|3
4708608|NCT02839330|7631822|FG002|Overall Study|Other reason, not specified|3
4708609|NCT02839330|7631823|FG003|Overall Study|Other reason, not specified|6
4708610|NCT02839681|7631834|FG000|Overall Study|Death|2
4708611|NCT02839746|7631838|FG000|Overall Study|Not met selection criteria|12
4708612|NCT02839798|7631865|FG000|Overall Study|Withdrawal by Subject|2
4388859|NCT00065429|7167590|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
4388860|NCT00065429|7167591|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1
4388861|NCT00065429|7167592|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
4628132|NCT01857869|7495146|FG003|Primary/Challenge Phase|Pregnancy|0
4628133|NCT01857869|7495147|FG004|Primary/Challenge Phase|Pregnancy|0
4628134|NCT01857869|7495148|FG005|Primary/Challenge Phase|Pregnancy|0
4628135|NCT01857869|7495149|FG006|Primary/Challenge Phase|Pregnancy|0
4628136|NCT01857869|7495150|FG007|Primary/Challenge Phase|Pregnancy|0
4628137|NCT01857869|7495151|FG008|Primary/Challenge Phase|Pregnancy|0
4628138|NCT01857869|7495152|FG009|Primary/Challenge Phase|Pregnancy|0
4628139|NCT01857869|7495143|FG000|Primary/Challenge Phase|Protocol Violation|1
4628140|NCT01857869|7495144|FG001|Primary/Challenge Phase|Protocol Violation|0
4628141|NCT01857869|7495145|FG002|Primary/Challenge Phase|Protocol Violation|0
4628142|NCT01857869|7495146|FG003|Primary/Challenge Phase|Protocol Violation|0
4628143|NCT01857869|7495147|FG004|Primary/Challenge Phase|Protocol Violation|0
4628144|NCT01857869|7495148|FG005|Primary/Challenge Phase|Protocol Violation|0
4628145|NCT01857869|7495149|FG006|Primary/Challenge Phase|Protocol Violation|0
4628146|NCT01857869|7495150|FG007|Primary/Challenge Phase|Protocol Violation|0
4628147|NCT01857869|7495151|FG008|Primary/Challenge Phase|Protocol Violation|0
4628148|NCT01857869|7495152|FG009|Primary/Challenge Phase|Protocol Violation|0
4628149|NCT01857869|7495143|FG000|Primary/Challenge Phase|Other|1
4628150|NCT01857869|7495144|FG001|Primary/Challenge Phase|Other|1
4628151|NCT01857869|7495145|FG002|Primary/Challenge Phase|Other|0
4628152|NCT01857869|7495146|FG003|Primary/Challenge Phase|Other|0
4628153|NCT01857869|7495147|FG004|Primary/Challenge Phase|Other|0
4628154|NCT01857869|7495148|FG005|Primary/Challenge Phase|Other|0
4628155|NCT01857869|7495149|FG006|Primary/Challenge Phase|Other|0
4628156|NCT01857869|7495150|FG007|Primary/Challenge Phase|Other|0
4628157|NCT01857869|7495151|FG008|Primary/Challenge Phase|Other|0
4628158|NCT01857869|7495152|FG009|Primary/Challenge Phase|Other|0
4628159|NCT01857869|7495143|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0
4628160|NCT01857869|7495144|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0
4628161|NCT01857869|7495145|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0
4628162|NCT01857869|7495146|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1
4708613|NCT02839876|7631871|FG000|Overall Study|Protocol Violation|10
4708614|NCT02839876|7631872|FG001|Overall Study|Protocol Violation|11
4771293|NCT02964507|7748193|FG004|Overall Study|Other|1
4771294|NCT02964507|7748194|FG005|Overall Study|Other|0
4771295|NCT02964507|7748195|FG006|Overall Study|Other|0
4771296|NCT02964507|7748196|FG007|Overall Study|Other|0
4771297|NCT02964507|7748189|FG000|Overall Study|Death|11
4771298|NCT02964507|7748190|FG001|Overall Study|Death|9
4771299|NCT02964507|7748191|FG002|Overall Study|Death|12
4771300|NCT02964507|7748192|FG003|Overall Study|Death|2
4771301|NCT02964507|7748193|FG004|Overall Study|Death|10
4771302|NCT02964507|7748194|FG005|Overall Study|Death|5
4708615|NCT02840253|7631912|FG000|Overall Study|Unsuccessful block|4
4708616|NCT02840461|7631919|FG000|Overall Study|Adverse Event|1
4708617|NCT02840461|7631920|FG001|Overall Study|Adverse Event|5
4708618|NCT02840461|7631921|FG002|Overall Study|Adverse Event|3
4708619|NCT02840461|7631919|FG000|Overall Study|Lost to Follow-up|10
4708620|NCT02840461|7631920|FG001|Overall Study|Lost to Follow-up|7
4708621|NCT02840461|7631921|FG002|Overall Study|Lost to Follow-up|6
4708622|NCT02840461|7631919|FG000|Overall Study|Non-Comliance with Dosing Requirements|0
4708623|NCT02840461|7631920|FG001|Overall Study|Non-Comliance with Dosing Requirements|1
4708624|NCT02840461|7631921|FG002|Overall Study|Non-Comliance with Dosing Requirements|0
4708625|NCT02840461|7631919|FG000|Overall Study|Protocol Violation|2
4708626|NCT02840461|7631920|FG001|Overall Study|Protocol Violation|3
4708627|NCT02840461|7631921|FG002|Overall Study|Protocol Violation|1
4771303|NCT02964507|7748195|FG006|Overall Study|Death|0
4771304|NCT02964507|7748196|FG007|Overall Study|Death|0
4771305|NCT02964507|7748189|FG000|Overall Study|Withdrawal by Subject|1
4771306|NCT02964507|7748190|FG001|Overall Study|Withdrawal by Subject|0
4771307|NCT02964507|7748191|FG002|Overall Study|Withdrawal by Subject|1
4771308|NCT02964507|7748192|FG003|Overall Study|Withdrawal by Subject|1
4771309|NCT02964507|7748193|FG004|Overall Study|Withdrawal by Subject|0
4771310|NCT02964507|7748194|FG005|Overall Study|Withdrawal by Subject|1
4771311|NCT02964507|7748195|FG006|Overall Study|Withdrawal by Subject|0
4771312|NCT02964507|7748196|FG007|Overall Study|Withdrawal by Subject|0
4771313|NCT02964507|7748189|FG000|Overall Study|Physician Decision|1
4771314|NCT02964507|7748190|FG001|Overall Study|Physician Decision|0
4771315|NCT02964507|7748191|FG002|Overall Study|Physician Decision|1
4771316|NCT02964507|7748192|FG003|Overall Study|Physician Decision|0
4771317|NCT02964507|7748193|FG004|Overall Study|Physician Decision|1
4771318|NCT02964507|7748194|FG005|Overall Study|Physician Decision|0
4771319|NCT02964507|7748195|FG006|Overall Study|Physician Decision|0
4771320|NCT02964507|7748196|FG007|Overall Study|Physician Decision|0
4771321|NCT02942277|7748230|FG000|Year 1|Withdrawal by Subject|0
4771322|NCT02942277|7748231|FG001|Year 1|Withdrawal by Subject|0
4771323|NCT02942277|7748232|FG002|Year 1|Withdrawal by Subject|0
4771324|NCT02942277|7748233|FG003|Year 1|Withdrawal by Subject|0
4771325|NCT02942277|7748234|FG004|Year 1|Withdrawal by Subject|1
4771326|NCT02942277|7748235|FG005|Year 1|Withdrawal by Subject|3
4771327|NCT02942277|7748236|FG006|Year 1|Withdrawal by Subject|0
4771328|NCT02942277|7748237|FG007|Year 1|Withdrawal by Subject|1
4771329|NCT02942277|7748238|FG008|Year 1|Withdrawal by Subject|0
4771330|NCT02942277|7748239|FG009|Year 1|Withdrawal by Subject|0
4771331|NCT02942277|7748240|FG010|Year 1|Withdrawal by Subject|3
4771332|NCT02942277|7748230|FG000|Year 1|Travel|0
4771333|NCT02942277|7748231|FG001|Year 1|Travel|1
4771334|NCT02942277|7748232|FG002|Year 1|Travel|0
4771335|NCT02942277|7748233|FG003|Year 1|Travel|0
4771336|NCT02942277|7748234|FG004|Year 1|Travel|4
4771337|NCT02942277|7748235|FG005|Year 1|Travel|5
4771338|NCT02942277|7748236|FG006|Year 1|Travel|0
4771339|NCT02942277|7748237|FG007|Year 1|Travel|0
4771340|NCT02942277|7748238|FG008|Year 1|Travel|0
4771341|NCT02942277|7748239|FG009|Year 1|Travel|0
4771342|NCT02942277|7748240|FG010|Year 1|Travel|8
4771343|NCT02942277|7748230|FG000|Year 1|Joined Army|0
4771344|NCT02942277|7748231|FG001|Year 1|Joined Army|1
4771345|NCT02942277|7748232|FG002|Year 1|Joined Army|0
4771346|NCT02942277|7748233|FG003|Year 1|Joined Army|0
4771347|NCT02942277|7748234|FG004|Year 1|Joined Army|0
4771348|NCT02942277|7748235|FG005|Year 1|Joined Army|0
4771349|NCT02942277|7748236|FG006|Year 1|Joined Army|0
4771350|NCT02942277|7748237|FG007|Year 1|Joined Army|0
4771351|NCT02942277|7748238|FG008|Year 1|Joined Army|0
4771352|NCT02942277|7748239|FG009|Year 1|Joined Army|0
4708628|NCT02840461|7631919|FG000|Overall Study|Withdrawal by Subject|10
4708629|NCT02840461|7631920|FG001|Overall Study|Withdrawal by Subject|6
4771353|NCT02942277|7748240|FG010|Year 1|Joined Army|0
4771354|NCT02942277|7748230|FG000|Year 1|Subject met withdrawal criteria|0
4771355|NCT02942277|7748231|FG001|Year 1|Subject met withdrawal criteria|0
4771356|NCT02942277|7748232|FG002|Year 1|Subject met withdrawal criteria|0
4771357|NCT02942277|7748233|FG003|Year 1|Subject met withdrawal criteria|1
4771358|NCT02942277|7748234|FG004|Year 1|Subject met withdrawal criteria|0
4771359|NCT02942277|7748235|FG005|Year 1|Subject met withdrawal criteria|0
4771360|NCT02942277|7748236|FG006|Year 1|Subject met withdrawal criteria|0
4771361|NCT02942277|7748237|FG007|Year 1|Subject met withdrawal criteria|0
4771362|NCT02942277|7748238|FG008|Year 1|Subject met withdrawal criteria|0
4708630|NCT02840461|7631921|FG002|Overall Study|Withdrawal by Subject|2
4708631|NCT02840461|7631919|FG000|Overall Study|Worsening of Symptom & Kit Error|0
4708632|NCT02840461|7631920|FG001|Overall Study|Worsening of Symptom & Kit Error|0
4708633|NCT02840461|7631921|FG002|Overall Study|Worsening of Symptom & Kit Error|2
4708634|NCT02840474|7631932|FG000|Overall Study|Lost to Follow-up|1
4708635|NCT02840474|7631933|FG001|Overall Study|Lost to Follow-up|0
4735778|NCT03544333|7684225|FG000|Overall Study|Withdrawal by Subject|1
4735779|NCT03544333|7684226|FG001|Overall Study|Withdrawal by Subject|0
4735780|NCT03545503|7684253|FG000|Overall Study|Protocol Violation|14
4735781|NCT03545503|7684254|FG001|Overall Study|Protocol Violation|16
4735782|NCT03545984|7684271|FG000|Overall Study|CSF cases not present during rotation|11
4735783|NCT03545984|7684272|FG001|Overall Study|CSF cases not present during rotation|9
4735784|NCT03546621|7684301|FG000|Overall Study|Withdrawal by Subject|0
4735785|NCT03546621|7684302|FG001|Overall Study|Withdrawal by Subject|1
4735786|NCT03546621|7684303|FG002|Overall Study|Withdrawal by Subject|2
4735787|NCT03546621|7684304|FG003|Overall Study|Withdrawal by Subject|1
4735788|NCT03546621|7684301|FG000|Overall Study|Lost to Follow-up|0
4735789|NCT03546621|7684302|FG001|Overall Study|Lost to Follow-up|1
4735790|NCT03546621|7684303|FG002|Overall Study|Lost to Follow-up|0
4735791|NCT03546621|7684304|FG003|Overall Study|Lost to Follow-up|0
4735792|NCT03546621|7684301|FG000|Overall Study|Adverse Event|0
4735793|NCT03546621|7684302|FG001|Overall Study|Adverse Event|1
4735794|NCT03546621|7684303|FG002|Overall Study|Adverse Event|0
4735795|NCT03546621|7684304|FG003|Overall Study|Adverse Event|1
4735796|NCT03546621|7684301|FG000|Overall Study|Progressive disease|0
4735797|NCT03546621|7684302|FG001|Overall Study|Progressive disease|0
4735798|NCT03546621|7684303|FG002|Overall Study|Progressive disease|0
4735799|NCT03546621|7684304|FG003|Overall Study|Progressive disease|1
4735800|NCT03546647|7684314|FG000|Overall Study|Adverse Event|1
4735801|NCT03546647|7684315|FG001|Overall Study|Adverse Event|0
4735802|NCT03546816|7684323|FG000|Overall Study|Adverse Event|5
4735803|NCT03546816|7684324|FG001|Overall Study|Adverse Event|3
4735804|NCT03546816|7684323|FG000|Overall Study|Lack of Efficacy|2
4735805|NCT03546816|7684324|FG001|Overall Study|Lack of Efficacy|4
4735806|NCT03546816|7684323|FG000|Overall Study|Pregnancy|1
4735807|NCT03546816|7684324|FG001|Overall Study|Pregnancy|0
4735808|NCT03546816|7684323|FG000|Overall Study|Physician Decision|2
4735809|NCT03546816|7684324|FG001|Overall Study|Physician Decision|0
4735810|NCT03546816|7684323|FG000|Overall Study|Withdrawal by Subject|8
4735811|NCT03546816|7684324|FG001|Overall Study|Withdrawal by Subject|10
4735812|NCT03546816|7684323|FG000|Overall Study|Lost to Follow-up|3
4735813|NCT03546816|7684324|FG001|Overall Study|Lost to Follow-up|2
4735814|NCT03546842|7684332|FG000|Overall Study|Protocol Violation|1
4735815|NCT03546842|7684332|FG000|Overall Study|Withdrawal by Subject|2
4735816|NCT03547154|7684338|FG000|Overall Study|Disease Progression/Recurrence|6
4735817|NCT03547154|7684339|FG001|Overall Study|Disease Progression/Recurrence|14
4735818|NCT03547154|7684338|FG000|Overall Study|Adverse Event|26
4735819|NCT03547154|7684339|FG001|Overall Study|Adverse Event|31
4735820|NCT03547154|7684338|FG000|Overall Study|Protocol Violation|6
4735821|NCT03547154|7684339|FG001|Overall Study|Protocol Violation|1
4735822|NCT03547154|7684338|FG000|Overall Study|Physician Decision|4
4735823|NCT03547154|7684339|FG001|Overall Study|Physician Decision|3
4735824|NCT03547154|7684338|FG000|Overall Study|Insufficient Therapeutic Response|13
4735825|NCT03547154|7684339|FG001|Overall Study|Insufficient Therapeutic Response|10
4735826|NCT03547154|7684338|FG000|Overall Study|Withdrawal by Subject|10
4735827|NCT03547154|7684339|FG001|Overall Study|Withdrawal by Subject|6
4735828|NCT03547154|7684338|FG000|Overall Study|Not Selected|0
4735829|NCT03547154|7684339|FG001|Overall Study|Not Selected|1
4735830|NCT03547154|7684338|FG000|Overall Study|Continued treatment beyond 12 mo.|58
4735831|NCT03547154|7684339|FG001|Overall Study|Continued treatment beyond 12 mo.|50
4735832|NCT03547167|7684347|FG000|Overall Study|Withdrawal by Subject|34
4735833|NCT03547167|7684348|FG001|Overall Study|Withdrawal by Subject|12
4735834|NCT03547167|7684347|FG000|Overall Study|Screen Failure|0
4735835|NCT03547167|7684348|FG001|Overall Study|Screen Failure|1
4735836|NCT03547167|7684347|FG000|Overall Study|Lost to Follow-up|59
4735837|NCT03547167|7684348|FG001|Overall Study|Lost to Follow-up|15
4735838|NCT03547167|7684347|FG000|Overall Study|Death|4
4735839|NCT03547167|7684348|FG001|Overall Study|Death|2
4735840|NCT03547531|7684360|FG000|Overall Study|not coming in data collection : sick|2
4735841|NCT03547531|7684361|FG001|Overall Study|not coming in data collection : sick|2
4735842|NCT03547531|7684360|FG000|Overall Study|having family occasion|0
4735843|NCT03547531|7684361|FG001|Overall Study|having family occasion|2
4735844|NCT03547583|7684370|FG000|Overall Study|Adverse Event|16
4735845|NCT03547583|7684371|FG001|Overall Study|Adverse Event|11
4735846|NCT03547583|7684372|FG002|Overall Study|Adverse Event|10
4735847|NCT03547583|7684370|FG000|Overall Study|Death|11
4735848|NCT03547583|7684371|FG001|Overall Study|Death|7
4735849|NCT03547583|7684372|FG002|Overall Study|Death|4
4735850|NCT03547583|7684370|FG000|Overall Study|Lost to Follow-up|1
4735851|NCT03547583|7684371|FG001|Overall Study|Lost to Follow-up|0
4735852|NCT03547583|7684372|FG002|Overall Study|Lost to Follow-up|0
4735853|NCT03547583|7684370|FG000|Overall Study|Non-compliance with study drug|0
4735854|NCT03547583|7684371|FG001|Overall Study|Non-compliance with study drug|0
4735855|NCT03547583|7684372|FG002|Overall Study|Non-compliance with study drug|1
4388862|NCT00065429|7167586|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
4388863|NCT00065429|7167587|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
4388864|NCT00065429|7167588|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1
4388865|NCT00065429|7167589|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
4388866|NCT00065429|7167590|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
4388867|NCT00065429|7167591|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
4388868|NCT00065429|7167592|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
4388869|NCT00065429|7167586|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1
4388870|NCT00065429|7167587|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0
4388871|NCT00065429|7167588|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0
4388872|NCT00065429|7167589|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0
4388873|NCT00065429|7167590|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0
4388874|NCT00065429|7167591|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0
4388875|NCT00065429|7167592|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0
4388876|NCT00065429|7167586|FG000|Phase I - May 2001 - Oct 2002|Death|0
4388877|NCT00065429|7167587|FG001|Phase I - May 2001 - Oct 2002|Death|0
4388878|NCT00065429|7167588|FG002|Phase I - May 2001 - Oct 2002|Death|0
4388879|NCT00065429|7167589|FG003|Phase I - May 2001 - Oct 2002|Death|0
4388880|NCT00065429|7167590|FG004|Phase I - May 2001 - Oct 2002|Death|1
4388881|NCT00065429|7167591|FG005|Phase I - May 2001 - Oct 2002|Death|0
4388882|NCT00065429|7167592|FG006|Phase I - May 2001 - Oct 2002|Death|0
4388883|NCT00065429|7167586|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0
4388884|NCT00065429|7167587|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0
4388885|NCT00065429|7167588|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0
4388886|NCT00065429|7167589|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1
4388887|NCT00065429|7167590|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0
4388888|NCT00065429|7167591|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1
4388889|NCT00065429|7167592|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2
4388890|NCT00065429|7167586|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
4388891|NCT00065429|7167587|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
4388892|NCT00065429|7167588|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
4388893|NCT00065429|7167589|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
4388894|NCT00065429|7167590|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4
4388895|NCT00065429|7167591|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
4388896|NCT00065429|7167592|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
4388897|NCT00065429|7167586|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
4388898|NCT00065429|7167587|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
4388899|NCT00065429|7167588|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
4388900|NCT00065429|7167589|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
4388901|NCT00065429|7167590|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2
4388902|NCT00065429|7167591|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
4388903|NCT00065429|7167592|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
4388904|NCT00065442|7167605|FG000|Overall Study|Lost to Follow-up|1
4388905|NCT00065442|7167606|FG001|Overall Study|Lost to Follow-up|1
4388906|NCT00065442|7167605|FG000|Overall Study|Death|121
4388907|NCT00065442|7167606|FG001|Overall Study|Death|210
4388908|NCT00065442|7167605|FG000|Overall Study|Withdrawal by Subject|3
4708636|NCT02840721|7631939|FG000|Treatment Period|Adverse Event|1
4708637|NCT02840721|7631939|FG000|Follow-Up|Lack of Efficacy|1
4708638|NCT02840721|7631939|FG000|Follow-Up|Withdrawal by Subject|4
4708639|NCT02840721|7631939|FG000|Follow-Up|Withdrawal of Consent|2
4708640|NCT02841709|7632007|FG000|5th Intervention|Adverse Event|2
4708641|NCT02841709|7632008|FG001|5th Intervention|Adverse Event|0
4708642|NCT02841709|7632009|FG002|5th Intervention|Adverse Event|0
4708643|NCT02841709|7632010|FG003|5th Intervention|Adverse Event|0
4708644|NCT02841709|7632011|FG004|5th Intervention|Adverse Event|2
4708645|NCT02841787|7632027|FG000|Overall Study|Lost to Follow-up|1
4708646|NCT02841787|7632028|FG001|Overall Study|Lost to Follow-up|0
4708647|NCT02841787|7632029|FG002|Overall Study|Lost to Follow-up|0
4708648|NCT02841787|7632027|FG000|Overall Study|Symptoms dropped below threshold|1
4708649|NCT02841787|7632028|FG001|Overall Study|Symptoms dropped below threshold|0
4708650|NCT02841787|7632029|FG002|Overall Study|Symptoms dropped below threshold|0
4708651|NCT02841787|7632027|FG000|Overall Study|Withdrawal by Subject|1
4708652|NCT02841787|7632028|FG001|Overall Study|Withdrawal by Subject|4
4708653|NCT02841787|7632029|FG002|Overall Study|Withdrawal by Subject|0
4708654|NCT02842073|7632046|FG000|Overall Study|Withdrawal by Subject|1
4708655|NCT02842086|7632052|FG000|Overall Study|Randomized but Never Treated|6
4708656|NCT02842086|7632053|FG001|Overall Study|Randomized but Never Treated|6
4708657|NCT02842086|7632052|FG000|Overall Study|Still in Double-Blind Phase|7
4388909|NCT00065442|7167606|FG001|Overall Study|Withdrawal by Subject|9
4388910|NCT00065468|7167615|FG000|Overall Study|Death|172
4388911|NCT00065468|7167616|FG001|Overall Study|Death|169
4388912|NCT00065468|7167617|FG002|Overall Study|Death|171
4388913|NCT00065468|7167615|FG000|Overall Study|Withdrawal by Subject|3
4388914|NCT00065468|7167616|FG001|Overall Study|Withdrawal by Subject|4
4708658|NCT02842086|7632053|FG001|Overall Study|Still in Double-Blind Phase|3
4708659|NCT02842086|7632052|FG000|Overall Study|Adverse Event|18
4708660|NCT02842086|7632053|FG001|Overall Study|Adverse Event|20
4708661|NCT02842086|7632052|FG000|Overall Study|Death|3
4708662|NCT02842086|7632053|FG001|Overall Study|Death|3
4708663|NCT02842086|7632052|FG000|Overall Study|Investigator's Discretion|9
4708664|NCT02842086|7632053|FG001|Overall Study|Investigator's Discretion|13
4708665|NCT02842086|7632052|FG000|Overall Study|Non-Compliance with Study Drug|9
4708666|NCT02842086|7632053|FG001|Overall Study|Non-Compliance with Study Drug|8
4708667|NCT02842086|7632052|FG000|Overall Study|Protocol Violation|8
4708668|NCT02842086|7632053|FG001|Overall Study|Protocol Violation|4
4708669|NCT02842086|7632052|FG000|Overall Study|Withdrew Consent|205
4708670|NCT02842086|7632053|FG001|Overall Study|Withdrew Consent|194
4708671|NCT02842086|7632052|FG000|Overall Study|Lost to Follow-up|274
4708672|NCT02842086|7632053|FG001|Overall Study|Lost to Follow-up|236
4628163|NCT01857869|7495147|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0
4628164|NCT01857869|7495148|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0
4628165|NCT01857869|7495149|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0
4628166|NCT01857869|7495150|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0
4628167|NCT01857869|7495151|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0
4628168|NCT01857869|7495152|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0
4628169|NCT01857869|7495143|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
4628170|NCT01857869|7495144|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
4628171|NCT01857869|7495145|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
4628172|NCT01857869|7495146|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1
4628173|NCT01857869|7495147|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
4628174|NCT01857869|7495148|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
4628175|NCT01857869|7495149|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
4628176|NCT01857869|7495150|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
4628177|NCT01857869|7495151|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
4628178|NCT01857869|7495152|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
4628179|NCT01857973|7495184|FG000|Overall Study|Subject did not meet required BG range|3
4628180|NCT01857973|7495184|FG000|Overall Study|drop out after 3 failed attempts|1
4628181|NCT01857973|7495184|FG000|Overall Study|Physician Decision|1
4628182|NCT01858194|7495199|FG000|Overall Study|Total Artificial Heart Implant|0
4628183|NCT01858194|7495200|FG001|Overall Study|Total Artificial Heart Implant|1
4628184|NCT01858194|7495199|FG000|Overall Study|Lost to Follow-up|0
4708673|NCT02842086|7632052|FG000|Overall Study|HIV-1 Infection|5
4708674|NCT02842086|7632053|FG001|Overall Study|HIV-1 Infection|6
4708675|NCT02842151|7632059|FG000|Overall Study|Adverse Event|1
4708676|NCT02842151|7632059|FG000|Overall Study|Subject moved too far away|1
4708677|NCT02842736|7632074|FG000|Overall Study|Lost to Follow-up|13
4708678|NCT02842736|7632074|FG000|Overall Study|Intervention for menstrual bleeding|17
4708679|NCT02842736|7632074|FG000|Overall Study|Withdrawal by Subject|4
4708680|NCT02842736|7632074|FG000|Overall Study|Pregnancy|3
4708681|NCT02842736|7632074|FG000|Overall Study|Hysterectomy for fibroids|2
4708682|NCT02842736|7632074|FG000|Overall Study|Hysterectomy for uterine prolapse|1
4708683|NCT02842736|7632074|FG000|Overall Study|IUD: Mirena|1
4708684|NCT02843178|7632082|FG000|Overall Study|Lost to Follow-up|8
4708685|NCT02843178|7632083|FG001|Overall Study|Lost to Follow-up|8
4708686|NCT02843178|7632084|FG002|Overall Study|Lost to Follow-up|6
4708687|NCT02843178|7632085|FG003|Overall Study|Lost to Follow-up|3
4708688|NCT02843178|7632082|FG000|Overall Study|Withdrawal by Subject|0
4708689|NCT02843178|7632083|FG001|Overall Study|Withdrawal by Subject|0
4708690|NCT02843178|7632084|FG002|Overall Study|Withdrawal by Subject|1
4708691|NCT02843178|7632085|FG003|Overall Study|Withdrawal by Subject|1
4708692|NCT02843659|7632107|FG000|Overall Study|Subject Withdrew Consent|0
4708693|NCT02843659|7632108|FG001|Overall Study|Subject Withdrew Consent|0
4708694|NCT02843659|7632109|FG002|Overall Study|Subject Withdrew Consent|1
4708695|NCT02843659|7632107|FG000|Overall Study|Administrative Reason by Sponsor|4
4708696|NCT02843659|7632108|FG001|Overall Study|Administrative Reason by Sponsor|5
4708697|NCT02843659|7632109|FG002|Overall Study|Administrative Reason by Sponsor|4
4708698|NCT02843659|7632107|FG000|Overall Study|Adverse Event|0
4708699|NCT02843659|7632108|FG001|Overall Study|Adverse Event|1
4708700|NCT02843659|7632109|FG002|Overall Study|Adverse Event|0
4388915|NCT00065468|7167617|FG002|Overall Study|Withdrawal by Subject|5
4388916|NCT00065468|7167615|FG000|Overall Study|Lost to Follow-up|5
4388917|NCT00065468|7167616|FG001|Overall Study|Lost to Follow-up|3
4388918|NCT00065468|7167617|FG002|Overall Study|Lost to Follow-up|2
4388919|NCT00065468|7167615|FG000|Overall Study|Discontinuation of study by Sponsor|13
4388920|NCT00065468|7167616|FG001|Overall Study|Discontinuation of study by Sponsor|9
4628185|NCT01858194|7495200|FG001|Overall Study|Lost to Follow-up|1
4628186|NCT01858363|7495210|FG000|Overall Study|Death|35
4628187|NCT01858363|7495211|FG001|Overall Study|Death|9
4708701|NCT02844439|7632117|FG000|Overall Study|Withdrawal by Subject|1
4708702|NCT02844439|7632117|FG000|Overall Study|Lost to Follow-up|2
4708703|NCT02844439|7632117|FG000|Overall Study|Termination by Sponsor|4
4708704|NCT02844439|7632117|FG000|Overall Study|Death|28
4708705|NCT02844439|7632117|FG000|Overall Study|Other|5
4708706|NCT02844543|7632128|FG000|Overall Study|Withdrawal by Subject|4
4708707|NCT02844543|7632128|FG000|Overall Study|Did not meet eligibility criteria|1
4388921|NCT00065468|7167617|FG002|Overall Study|Discontinuation of study by Sponsor|13
4628188|NCT01858363|7495210|FG000|Overall Study|Withdrawal by Subject|28
4708708|NCT02844920|7632145|FG000|Overall Study|Lost to Follow-up|2
4708709|NCT02845336|7632164|FG000|Overall Study|Lost to Follow-up|3
4708710|NCT02845336|7632165|FG001|Overall Study|Lost to Follow-up|1
4708711|NCT02845336|7632164|FG000|Overall Study|Inability to get medication|2
4708712|NCT02845336|7632165|FG001|Overall Study|Inability to get medication|0
4708713|NCT02845375|7632174|FG000|Overall Study|upper airway obstruction|1
4708714|NCT02845375|7632175|FG001|Overall Study|upper airway obstruction|2
4708715|NCT02845375|7632176|FG002|Overall Study|upper airway obstruction|1
4708716|NCT02846324|7632224|FG000|Overall Study|Other|1
4708717|NCT02846324|7632225|FG001|Overall Study|Other|0
4708718|NCT02846324|7632226|FG002|Overall Study|Other|0
4708719|NCT02846324|7632227|FG003|Overall Study|Other|0
4708720|NCT02846324|7632224|FG000|Overall Study|Withdrawal by Subject|1
4708721|NCT02846324|7632225|FG001|Overall Study|Withdrawal by Subject|0
4708722|NCT02846324|7632226|FG002|Overall Study|Withdrawal by Subject|4
4708723|NCT02846324|7632227|FG003|Overall Study|Withdrawal by Subject|0
4708724|NCT02846415|7632248|FG000|Overall Study|Lost to Follow-up|2
4708725|NCT02846415|7632249|FG001|Overall Study|Lost to Follow-up|0
4708726|NCT02846415|7632248|FG000|Overall Study|Withdrawal by Subject|1
4708727|NCT02846415|7632249|FG001|Overall Study|Withdrawal by Subject|1
4708728|NCT02846558|7632259|FG000|Overall Study|Adverse Event|1
4708729|NCT02846558|7632260|FG001|Overall Study|Adverse Event|0
4708730|NCT02846558|7632261|FG002|Overall Study|Adverse Event|0
4708731|NCT02846558|7632262|FG003|Overall Study|Adverse Event|0
4708732|NCT02846558|7632259|FG000|Overall Study|Withdrawal by Subject|5
4708733|NCT02846558|7632260|FG001|Overall Study|Withdrawal by Subject|4
4708734|NCT02846558|7632261|FG002|Overall Study|Withdrawal by Subject|2
4708735|NCT02846558|7632262|FG003|Overall Study|Withdrawal by Subject|2
4708736|NCT02846558|7632259|FG000|Overall Study|Lost to Follow-up|2
4708737|NCT02846558|7632260|FG001|Overall Study|Lost to Follow-up|0
4708738|NCT02846558|7632261|FG002|Overall Study|Lost to Follow-up|0
4708739|NCT02846558|7632262|FG003|Overall Study|Lost to Follow-up|0
4708740|NCT02846779|7632295|FG000|Overall Study|Lost Enrollment|83
4708741|NCT02846779|7632296|FG001|Overall Study|Lost Enrollment|82
4708742|NCT02846779|7632297|FG002|Overall Study|Lost Enrollment|86
4708743|NCT02846779|7632295|FG000|Overall Study|Less than 31 days of follow-up|56
4708744|NCT02846779|7632296|FG001|Overall Study|Less than 31 days of follow-up|45
4708745|NCT02846779|7632297|FG002|Overall Study|Less than 31 days of follow-up|52
4708746|NCT02847182|7632333|FG000|Overall Study|Withdrawal by Subject|0
4708747|NCT02847182|7632334|FG001|Overall Study|Withdrawal by Subject|1
4708748|NCT02847260|7632346|FG000|Overall Study|Adverse Event|3
4708749|NCT02847260|7632346|FG000|Overall Study|Withdrawal by Subject|2
4708750|NCT02847260|7632346|FG000|Overall Study|Clinical Deterioration|1
4708751|NCT02847260|7632346|FG000|Overall Study|Physician Decision|1
4708752|NCT02847494|7632352|FG000|Overall Study|Lost to Follow-up|8
4708753|NCT02847494|7632353|FG001|Overall Study|Lost to Follow-up|5
4708754|NCT02847650|7632361|FG000|Overall Study|Adverse Event|2
4708755|NCT02847650|7632362|FG001|Overall Study|Adverse Event|4
4708756|NCT02847650|7632361|FG000|Overall Study|Lost to Follow-up|1
4708757|NCT02847650|7632362|FG001|Overall Study|Lost to Follow-up|0
4708758|NCT02847650|7632361|FG000|Overall Study|Protocol Violation|0
4708759|NCT02847650|7632362|FG001|Overall Study|Protocol Violation|1
4708760|NCT02847650|7632361|FG000|Overall Study|Withdrawal by Subject|1
4708761|NCT02847650|7632362|FG001|Overall Study|Withdrawal by Subject|1
4708762|NCT02847858|7632370|FG000|Overall Study|Lost to Follow-up|401
4708763|NCT02847858|7632371|FG001|Overall Study|Lost to Follow-up|269
4708764|NCT02848313|7632401|FG000|Overall Study|Adverse Event|1
4708765|NCT02848313|7632402|FG001|Overall Study|Adverse Event|2
4708766|NCT02848313|7632401|FG000|Overall Study|Lack of Efficacy|0
4708767|NCT02848313|7632402|FG001|Overall Study|Lack of Efficacy|1
4708768|NCT02848313|7632401|FG000|Overall Study|Withdrawal by Subject|1
4708769|NCT02848313|7632402|FG001|Overall Study|Withdrawal by Subject|1
4708770|NCT02848313|7632401|FG000|Overall Study|Lost to follow up|1
4708771|NCT02848313|7632402|FG001|Overall Study|Lost to follow up|0
4708772|NCT02848326|7632414|FG000|Treatment Period|Adverse Event|5
4708773|NCT02848326|7632415|FG001|Treatment Period|Adverse Event|4
4708774|NCT02848326|7632416|FG002|Treatment Period|Adverse Event|11
4708775|NCT02848326|7632417|FG003|Treatment Period|Adverse Event|6
4708776|NCT02848326|7632418|FG004|Treatment Period|Adverse Event|5
4708777|NCT02848326|7632419|FG005|Treatment Period|Adverse Event|7
4708778|NCT02848326|7632414|FG000|Treatment Period|Withdrawal of Consent|20
4708779|NCT02848326|7632415|FG001|Treatment Period|Withdrawal of Consent|6
4708780|NCT02848326|7632416|FG002|Treatment Period|Withdrawal of Consent|9
4708781|NCT02848326|7632417|FG003|Treatment Period|Withdrawal of Consent|6
4708782|NCT02848326|7632418|FG004|Treatment Period|Withdrawal of Consent|9
4708783|NCT02848326|7632419|FG005|Treatment Period|Withdrawal of Consent|6
4708784|NCT02848326|7632414|FG000|Treatment Period|Lost to Follow-up|5
4708785|NCT02848326|7632415|FG001|Treatment Period|Lost to Follow-up|1
4708786|NCT02848326|7632416|FG002|Treatment Period|Lost to Follow-up|11
4708787|NCT02848326|7632417|FG003|Treatment Period|Lost to Follow-up|7
4708788|NCT02848326|7632418|FG004|Treatment Period|Lost to Follow-up|2
4708789|NCT02848326|7632419|FG005|Treatment Period|Lost to Follow-up|3
4708790|NCT02848326|7632414|FG000|Treatment Period|Pregnancy|0
4708791|NCT02848326|7632415|FG001|Treatment Period|Pregnancy|0
4708792|NCT02848326|7632416|FG002|Treatment Period|Pregnancy|1
4708793|NCT02848326|7632417|FG003|Treatment Period|Pregnancy|1
4708794|NCT02848326|7632418|FG004|Treatment Period|Pregnancy|0
4708795|NCT02848326|7632419|FG005|Treatment Period|Pregnancy|1
4708796|NCT02848326|7632414|FG000|Treatment Period|Protocol Violation|4
4708797|NCT02848326|7632415|FG001|Treatment Period|Protocol Violation|3
4708798|NCT02848326|7632416|FG002|Treatment Period|Protocol Violation|4
4708799|NCT02848326|7632417|FG003|Treatment Period|Protocol Violation|2
4708800|NCT02848326|7632418|FG004|Treatment Period|Protocol Violation|3
4708801|NCT02848326|7632419|FG005|Treatment Period|Protocol Violation|3
4708802|NCT02848326|7632414|FG000|Treatment Period|Non-compliance with Study Drug|4
4708803|NCT02848326|7632415|FG001|Treatment Period|Non-compliance with Study Drug|0
4708804|NCT02848326|7632416|FG002|Treatment Period|Non-compliance with Study Drug|0
4708805|NCT02848326|7632417|FG003|Treatment Period|Non-compliance with Study Drug|1
4708806|NCT02848326|7632418|FG004|Treatment Period|Non-compliance with Study Drug|0
4708807|NCT02848326|7632419|FG005|Treatment Period|Non-compliance with Study Drug|0
4708808|NCT02848326|7632414|FG000|Safety Follow-up Period|Withdrawal of Consent|0
4708809|NCT02848326|7632415|FG001|Safety Follow-up Period|Withdrawal of Consent|1
4708810|NCT02848326|7632416|FG002|Safety Follow-up Period|Withdrawal of Consent|1
4708811|NCT02848326|7632417|FG003|Safety Follow-up Period|Withdrawal of Consent|0
4708812|NCT02848326|7632418|FG004|Safety Follow-up Period|Withdrawal of Consent|0
4708813|NCT02848326|7632419|FG005|Safety Follow-up Period|Withdrawal of Consent|2
4708814|NCT02848326|7632414|FG000|Safety Follow-up Period|Lost to Follow-up|4
4708815|NCT02848326|7632415|FG001|Safety Follow-up Period|Lost to Follow-up|0
4708816|NCT02848326|7632416|FG002|Safety Follow-up Period|Lost to Follow-up|2
4708817|NCT02848326|7632417|FG003|Safety Follow-up Period|Lost to Follow-up|0
4708818|NCT02848326|7632418|FG004|Safety Follow-up Period|Lost to Follow-up|1
4708819|NCT02848326|7632419|FG005|Safety Follow-up Period|Lost to Follow-up|3
4708820|NCT02848599|7632435|FG000|Overall Study|Protocol Violation|7
4708821|NCT02848599|7632436|FG001|Overall Study|Protocol Violation|9
4708822|NCT02848651|7632444|FG000|Overall Study|Death|85
4708823|NCT02848651|7632444|FG000|Overall Study|Lost to Follow-up|1
4708824|NCT02848651|7632444|FG000|Overall Study|Non-Compliance|1
4708825|NCT02848651|7632444|FG000|Overall Study|Symptomatic Deterioration|1
4708826|NCT02848651|7632444|FG000|Overall Study|Physician Decision|4
4708827|NCT02848651|7632444|FG000|Overall Study|Withdrawal by Subject|14
4708828|NCT02848664|7632464|FG000|Overall Study|Withdrawal by Subject|2
4708829|NCT02848664|7632464|FG000|Overall Study|Adverse Event|1
4708830|NCT02848664|7632464|FG000|Overall Study|no assistance for device training|1
4708831|NCT02848729|7632474|FG000|Overall Study|Withdrawal by Subject|1
4388922|NCT00065468|7167615|FG000|Overall Study|Disease progression|0
4388923|NCT00065468|7167616|FG001|Overall Study|Disease progression|0
4388924|NCT00065468|7167617|FG002|Overall Study|Disease progression|1
4388925|NCT00065468|7167615|FG000|Overall Study|Other|14
4388926|NCT00065468|7167616|FG001|Overall Study|Other|24
4388927|NCT00065468|7167617|FG002|Overall Study|Other|18
4388928|NCT00065507|7167627|FG000|Overall Study|Death|16
4388929|NCT00065507|7167628|FG001|Overall Study|Death|17
4388930|NCT00065507|7167627|FG000|Overall Study|Adverse Event|4
4388931|NCT00065507|7167628|FG001|Overall Study|Adverse Event|3
4388932|NCT00065507|7167627|FG000|Overall Study|Lack of Efficacy|0
4388933|NCT00065507|7167628|FG001|Overall Study|Lack of Efficacy|6
4388934|NCT00065507|7167627|FG000|Overall Study|Poor/Non-compliance|3
4708832|NCT02848729|7632475|FG001|Overall Study|Withdrawal by Subject|0
4708833|NCT02848729|7632474|FG000|Overall Study|Emesis|15
4708834|NCT02848729|7632475|FG001|Overall Study|Emesis|11
4708835|NCT02848833|7632488|FG000|Overall Study|subject who are duplicated|1
4708836|NCT02848833|7632488|FG000|Overall Study|have not taken the study drug|11
4708837|NCT02848833|7632488|FG000|Overall Study|follow-up failure|6
4708838|NCT02848833|7632488|FG000|Overall Study|Protocol Violation|119
4708839|NCT02849080|7632494|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7
4708840|NCT02849080|7632495|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4
4708841|NCT02849080|7632496|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0
4708842|NCT02849080|7632497|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0
4708843|NCT02849080|7632494|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5
4708844|NCT02849080|7632495|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1
4708845|NCT02849080|7632496|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0
4708846|NCT02849080|7632497|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0
4708847|NCT02849080|7632494|FG000|Main Phase: 0 - 52 Weeks|Death|0
4708848|NCT02849080|7632495|FG001|Main Phase: 0 - 52 Weeks|Death|2
4708849|NCT02849080|7632496|FG002|Main Phase: 0 - 52 Weeks|Death|0
4708850|NCT02849080|7632497|FG003|Main Phase: 0 - 52 Weeks|Death|0
4708851|NCT02849080|7632494|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2
4708852|NCT02849080|7632495|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0
4708853|NCT02849080|7632496|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0
4708854|NCT02849080|7632497|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0
4708855|NCT02849080|7632494|FG000|Extension Phase: 53 - 104 Weeks|Other|0
4708856|NCT02849080|7632495|FG001|Extension Phase: 53 - 104 Weeks|Other|0
4708857|NCT02849080|7632496|FG002|Extension Phase: 53 - 104 Weeks|Other|1
4388935|NCT00065507|7167628|FG001|Overall Study|Poor/Non-compliance|2
4388936|NCT00065507|7167627|FG000|Overall Study|Lost to Follow-up|3
4388937|NCT00065507|7167628|FG001|Overall Study|Lost to Follow-up|0
4388938|NCT00065507|7167627|FG000|Overall Study|Subject Withdrew Consent|2
4388939|NCT00065507|7167628|FG001|Overall Study|Subject Withdrew Consent|1
4388940|NCT00065507|7167627|FG000|Overall Study|Subject No Longer Meets Study Criteria|1
4388941|NCT00065507|7167628|FG001|Overall Study|Subject No Longer Meets Study Criteria|0
4388942|NCT00066066|7167659|FG000|Overall Study|Lost to Follow-up|6
4388943|NCT00066066|7167660|FG001|Overall Study|Lost to Follow-up|4
4388944|NCT00066066|7167661|FG002|Overall Study|Lost to Follow-up|7
4388945|NCT00066066|7167662|FG003|Overall Study|Lost to Follow-up|4
4388946|NCT00066066|7167663|FG004|Overall Study|Lost to Follow-up|3
4388947|NCT00066066|7167664|FG005|Overall Study|Lost to Follow-up|5
4388948|NCT00066170|7167682|FG000|Overall Study|Adverse Event|2
4388949|NCT00066170|7167683|FG001|Overall Study|Adverse Event|4
4388950|NCT00066170|7167684|FG002|Overall Study|Adverse Event|1
4388951|NCT00066170|7167685|FG003|Overall Study|Adverse Event|7
4388952|NCT00066170|7167682|FG000|Overall Study|Serious Adverse Event|0
4388953|NCT00066170|7167683|FG001|Overall Study|Serious Adverse Event|0
4388954|NCT00066170|7167684|FG002|Overall Study|Serious Adverse Event|1
4388955|NCT00066170|7167685|FG003|Overall Study|Serious Adverse Event|1
4388956|NCT00066170|7167682|FG000|Overall Study|Lost to Follow-up|0
4388957|NCT00066170|7167683|FG001|Overall Study|Lost to Follow-up|1
4388958|NCT00066170|7167684|FG002|Overall Study|Lost to Follow-up|0
4388959|NCT00066170|7167685|FG003|Overall Study|Lost to Follow-up|0
4388960|NCT00066170|7167682|FG000|Overall Study|Non-Compliance with Trial Medicine|1
4388961|NCT00066170|7167683|FG001|Overall Study|Non-Compliance with Trial Medicine|0
4388962|NCT00066170|7167684|FG002|Overall Study|Non-Compliance with Trial Medicine|0
4388963|NCT00066170|7167685|FG003|Overall Study|Non-Compliance with Trial Medicine|1
4388964|NCT00066170|7167682|FG000|Overall Study|Protocol Violation|3
4388965|NCT00066170|7167683|FG001|Overall Study|Protocol Violation|0
4388966|NCT00066170|7167684|FG002|Overall Study|Protocol Violation|0
4388967|NCT00066170|7167685|FG003|Overall Study|Protocol Violation|0
4388968|NCT00066170|7167682|FG000|Overall Study|Other|1
4388969|NCT00066170|7167683|FG001|Overall Study|Other|5
4388970|NCT00066170|7167684|FG002|Overall Study|Other|2
4388971|NCT00066170|7167685|FG003|Overall Study|Other|0
4388972|NCT00066222|7167695|FG000|Overall Study|No protocol treatment received|1
4388973|NCT00066365|7167701|FG000|Overall Study|Adverse Event|1
4388974|NCT00066365|7167702|FG001|Overall Study|Adverse Event|0
4388975|NCT00066365|7167701|FG000|Overall Study|Lack of Efficacy|15
4388976|NCT00066365|7167702|FG001|Overall Study|Lack of Efficacy|12
4388977|NCT00066365|7167701|FG000|Overall Study|Physician Decision|1
4388978|NCT00066365|7167702|FG001|Overall Study|Physician Decision|0
4388979|NCT00066365|7167701|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2
4388980|NCT00066365|7167702|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0
4388981|NCT00066365|7167701|FG000|Overall Study|Ineligible|4
4388982|NCT00066365|7167702|FG001|Overall Study|Ineligible|2
4388983|NCT00066469|7167710|FG000|Overall Study|Death|3
4388984|NCT00066469|7167710|FG000|Overall Study|Lack of Efficacy|9
4388985|NCT00066469|7167710|FG000|Overall Study|Lost to Follow-up|1
4388986|NCT00066469|7167710|FG000|Overall Study|Physician Decision|1
4388987|NCT00066469|7167710|FG000|Overall Study|Withdrawal by Subject|1
4708858|NCT02849080|7632497|FG003|Extension Phase: 53 - 104 Weeks|Other|0
4708859|NCT02849080|7632494|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1
4708860|NCT02849080|7632495|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0
4708861|NCT02849080|7632496|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0
4708862|NCT02849080|7632497|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0
4708863|NCT02849509|7632544|FG000|Overall Study|Worsening of disease under study|1
4708864|NCT02849509|7632545|FG001|Overall Study|Worsening of disease under study|1
4708865|NCT02849509|7632546|FG002|Overall Study|Worsening of disease under study|1
4708866|NCT02849509|7632544|FG000|Overall Study|Worsening of other pre-existing disease|0
4708867|NCT02849509|7632545|FG001|Overall Study|Worsening of other pre-existing disease|1
4708868|NCT02849509|7632546|FG002|Overall Study|Worsening of other pre-existing disease|2
4708869|NCT02849509|7632544|FG000|Overall Study|Other adverse event|36
4708870|NCT02849509|7632545|FG001|Overall Study|Other adverse event|41
4708871|NCT02849509|7632546|FG002|Overall Study|Other adverse event|8
4708872|NCT02849509|7632544|FG000|Overall Study|Withdrawal by Subject|6
4708873|NCT02849509|7632545|FG001|Overall Study|Withdrawal by Subject|17
4708874|NCT02849509|7632546|FG002|Overall Study|Withdrawal by Subject|12
4708875|NCT02849509|7632544|FG000|Overall Study|Lost to Follow-up|27
4708876|NCT02849509|7632545|FG001|Overall Study|Lost to Follow-up|67
4708877|NCT02849509|7632546|FG002|Overall Study|Lost to Follow-up|36
4708878|NCT02849509|7632544|FG000|Overall Study|Other, reason not specified|14
4388988|NCT00066469|7167710|FG000|Overall Study|ineligible|1
4388989|NCT00066573|7167716|FG000|Overall Study|Did not received protocol treatment|28
4388990|NCT00066573|7167717|FG001|Overall Study|Did not received protocol treatment|28
4388991|NCT00066690|7167735|FG000|Overall Study|Adverse Event|145
4388992|NCT00066690|7167736|FG001|Overall Study|Adverse Event|58
4388993|NCT00066690|7167737|FG002|Overall Study|Adverse Event|126
4388994|NCT00066690|7167735|FG000|Overall Study|Death|3
4388995|NCT00066690|7167736|FG001|Overall Study|Death|0
4388996|NCT00066690|7167737|FG002|Overall Study|Death|2
4388997|NCT00066690|7167735|FG000|Overall Study|Lack of Efficacy|114
4388998|NCT00066690|7167736|FG001|Overall Study|Lack of Efficacy|110
4388999|NCT00066690|7167737|FG002|Overall Study|Lack of Efficacy|76
4389000|NCT00066690|7167735|FG000|Overall Study|Lost to Follow-up|40
4708879|NCT02849509|7632545|FG001|Overall Study|Other, reason not specified|29
4708880|NCT02849509|7632546|FG002|Overall Study|Other, reason not specified|25
4708881|NCT02849509|7632544|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6
4708882|NCT02849509|7632545|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10
4708883|NCT02849509|7632546|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1
4708884|NCT02849678|7632558|FG000|Overall Study|Protocol Violation|3
4708885|NCT02849678|7632559|FG001|Overall Study|Protocol Violation|6
4708886|NCT02849704|7632567|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1
4708887|NCT02849704|7632568|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0
4708888|NCT02849704|7632567|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1
4708889|NCT02849704|7632568|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0
4708890|NCT02849704|7632567|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1
4708891|NCT02849704|7632568|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0
4708892|NCT02850276|7632600|FG000|Overall Study|screen failure|43
4708893|NCT02850276|7632600|FG000|Overall Study|Withdrawal by Subject|14
4708894|NCT02850276|7632600|FG000|Overall Study|Physician Decision|2
4708895|NCT02850276|7632600|FG000|Overall Study|Lost to Follow-up|2
4708896|NCT02850965|7632616|FG000|Overall Study|Other than listed|3
4708897|NCT02850965|7632617|FG001|Overall Study|Other than listed|4
4708898|NCT02850965|7632616|FG000|Overall Study|Protocol Violation|0
4708899|NCT02850965|7632617|FG001|Overall Study|Protocol Violation|2
4708900|NCT02850965|7632616|FG000|Overall Study|Lost to Follow-up|5
4708901|NCT02850965|7632617|FG001|Overall Study|Lost to Follow-up|3
4708902|NCT02850965|7632616|FG000|Overall Study|Lack of Efficacy|4
4708903|NCT02850965|7632617|FG001|Overall Study|Lack of Efficacy|8
4708904|NCT02850965|7632616|FG000|Overall Study|Adverse Event|3
4708905|NCT02850965|7632617|FG001|Overall Study|Adverse Event|2
4708906|NCT02850965|7632616|FG000|Overall Study|Withdrawal by Subject|3
4708907|NCT02850965|7632617|FG001|Overall Study|Withdrawal by Subject|4
4708908|NCT02850965|7632616|FG000|Overall Study|Physician Decision|0
4708909|NCT02850965|7632617|FG001|Overall Study|Physician Decision|1
4708910|NCT02850965|7632616|FG000|Overall Study|Randomized but not treated|0
4389001|NCT00066690|7167736|FG001|Overall Study|Lost to Follow-up|21
4389002|NCT00066690|7167737|FG002|Overall Study|Lost to Follow-up|29
4389003|NCT00066690|7167735|FG000|Overall Study|Withdrawal by Subject|50
4389004|NCT00066690|7167736|FG001|Overall Study|Withdrawal by Subject|55
4389005|NCT00066690|7167737|FG002|Overall Study|Withdrawal by Subject|49
4389006|NCT00066690|7167735|FG000|Overall Study|Treatment Ongoing|246
4389007|NCT00066690|7167736|FG001|Overall Study|Treatment Ongoing|278
4389008|NCT00066690|7167737|FG002|Overall Study|Treatment Ongoing|282
4389009|NCT00066703|7167750|FG000|Overall Study|Adverse Event|80
4389010|NCT00066703|7167751|FG001|Overall Study|Adverse Event|111
4389011|NCT00066703|7167750|FG000|Overall Study|Death|3
4389012|NCT00066703|7167751|FG001|Overall Study|Death|0
4389013|NCT00066703|7167750|FG000|Overall Study|Lack of Efficacy|114
4389014|NCT00066703|7167751|FG001|Overall Study|Lack of Efficacy|69
4389015|NCT00066703|7167750|FG000|Overall Study|Lost to Follow-up|31
4389016|NCT00066703|7167751|FG001|Overall Study|Lost to Follow-up|28
4389017|NCT00066703|7167750|FG000|Overall Study|Withdrawal by Subject|38
4389018|NCT00066703|7167751|FG001|Overall Study|Withdrawal by Subject|63
4389019|NCT00066703|7167750|FG000|Overall Study|Treatment ongoing|346
4389020|NCT00066703|7167751|FG001|Overall Study|Treatment ongoing|311
4389021|NCT00066729|7167757|FG000|Overall Study|Lost to Follow-up|1
4389022|NCT00066729|7167757|FG000|Overall Study|Disease progression|1
4389023|NCT00066742|7167761|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1
4389024|NCT00066742|7167761|FG000|Induction Chemoradiotherapy|Adverse Event|21
4389025|NCT00066742|7167761|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2
4389026|NCT00066742|7167761|FG000|Induction Chemoradiotherapy|not protocol specified|2
4389027|NCT00066742|7167761|FG000|Induction Chemoradiotherapy|Ineligible|3
4389028|NCT00066742|7167761|FG000|Consolidation Chemotherapy|not protocol specified|1
4389029|NCT00066742|7167761|FG000|Consolidation Chemotherapy|Ineligible|2
4708911|NCT02850965|7632617|FG001|Overall Study|Randomized but not treated|1
4708912|NCT02850978|7632623|FG000|Overall Study|Uncollectable CRF|27
4708913|NCT02850978|7632623|FG000|Overall Study|No visit since the first visit|35
4708914|NCT02850978|7632623|FG000|Overall Study|Adverse Event|81
4708915|NCT02850978|7632623|FG000|Overall Study|Lack of Efficacy|40
4708916|NCT02850978|7632623|FG000|Overall Study|Improvement in condition|34
4708917|NCT02850978|7632623|FG000|Overall Study|Lost to Follow-up|121
4708918|NCT02850978|7632623|FG000|Overall Study|Reason not listed|88
4708919|NCT02851069|7632627|FG000|Overall Study|Failure to Return|3
4708920|NCT02851069|7632627|FG000|Overall Study|Other|3
4708921|NCT02851615|7632643|FG000|Overall Study|Cognitive Issue|1
4708922|NCT02851615|7632644|FG001|Overall Study|Cognitive Issue|0
4708923|NCT02851615|7632643|FG000|Overall Study|Lost to Follow-up|0
4708924|NCT02851615|7632644|FG001|Overall Study|Lost to Follow-up|4
4708925|NCT02852005|7632662|FG000|Overall Study|Lost to Follow-up|0
4708926|NCT02852005|7632663|FG001|Overall Study|Lost to Follow-up|0
4708927|NCT02852005|7632664|FG002|Overall Study|Lost to Follow-up|0
4389030|NCT00067002|7167795|FG000|Overall Study|Early Death|1
4389031|NCT00067002|7167796|FG001|Overall Study|Early Death|2
4389032|NCT00067002|7167795|FG000|Overall Study|Delayed|1
4389033|NCT00067002|7167796|FG001|Overall Study|Delayed|1
4708928|NCT02852005|7632665|FG003|Overall Study|Lost to Follow-up|0
4708929|NCT02852005|7632666|FG004|Overall Study|Lost to Follow-up|1
4708930|NCT02852005|7632662|FG000|Overall Study|Withdrawal by Subject|1
4708931|NCT02852005|7632663|FG001|Overall Study|Withdrawal by Subject|0
4708932|NCT02852005|7632664|FG002|Overall Study|Withdrawal by Subject|0
4708933|NCT02852005|7632665|FG003|Overall Study|Withdrawal by Subject|0
4708934|NCT02852005|7632666|FG004|Overall Study|Withdrawal by Subject|0
4708935|NCT02852265|7632682|FG000|3-month Follow-up|Lost to Follow-up|1
4708936|NCT02852265|7632683|FG001|3-month Follow-up|Lost to Follow-up|1
4708937|NCT02852434|7632699|FG000|Overall Study|Withdrawal by Subject|0
4708938|NCT02852434|7632700|FG001|Overall Study|Withdrawal by Subject|1
4708939|NCT02852434|7632699|FG000|Overall Study|Unsuccessful Dilator Procedure|2
4708940|NCT02852434|7632700|FG001|Overall Study|Unsuccessful Dilator Procedure|0
4708941|NCT02853032|7632708|FG000|Overall Study|Adverse Event|4
4708942|NCT02853032|7632709|FG001|Overall Study|Adverse Event|0
4708943|NCT02853032|7632708|FG000|Overall Study|Withdrawal by Subject|3
4708944|NCT02853032|7632709|FG001|Overall Study|Withdrawal by Subject|1
4708945|NCT02853032|7632708|FG000|Overall Study|Requested to withdraw from all treatment|2
4708946|NCT02853032|7632709|FG001|Overall Study|Requested to withdraw from all treatment|2
4708947|NCT02853123|7632717|FG000|Treatment Period 1|Adverse Event|0
4708948|NCT02853123|7632718|FG001|Treatment Period 1|Adverse Event|3
4708949|NCT02853123|7632717|FG000|Washout Period|Worsening of COPD|0
4708950|NCT02853123|7632718|FG001|Washout Period|Worsening of COPD|3
4708951|NCT02853123|7632717|FG000|Washout Period|Adverse Event|1
4708952|NCT02853123|7632718|FG001|Washout Period|Adverse Event|0
4708953|NCT02853318|7632725|FG000|Overall Study|Withdrawal by Subject|1
4708954|NCT02853435|7632732|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
4708955|NCT02853435|7632733|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
4708956|NCT02853435|7632734|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
4708957|NCT02853435|7632735|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
4389034|NCT00067002|7167795|FG000|Overall Study|Graft Failure|5
4389035|NCT00067002|7167796|FG001|Overall Study|Graft Failure|6
4389036|NCT00067470|7167828|FG000|Overall Study|Withdrawal by Subject|0
4389037|NCT00067470|7167829|FG001|Overall Study|Withdrawal by Subject|1
4389038|NCT00067990|7167850|FG000|Overall Study|Death|5
4389039|NCT00067990|7167851|FG001|Overall Study|Death|7
4389040|NCT00067990|7167850|FG000|Overall Study|ESRD, Non IF/TA|1
4389041|NCT00067990|7167851|FG001|Overall Study|ESRD, Non IF/TA|3
4389042|NCT00067990|7167850|FG000|Overall Study|Withdrawal by Subject|4
4389043|NCT00067990|7167851|FG001|Overall Study|Withdrawal by Subject|12
4389044|NCT00068107|7167857|FG000|Overall Study|end-stage renal disease|6
4389045|NCT00068107|7167857|FG000|Overall Study|Death|2
4389046|NCT00068107|7167857|FG000|Overall Study|Withdrawal by Subject|1
4389047|NCT00068237|7167864|FG000|Overall Study|Ineligible|3
4389048|NCT00068237|7167864|FG000|Overall Study|No protocol treatment received|2
4389049|NCT00068250|7167871|FG000|Phase I: Dose Level 2|Protocol Violation|0
4389050|NCT00068250|7167872|FG001|Phase I: Dose Level 2|Protocol Violation|1
4389051|NCT00068250|7167873|FG002|Phase I: Dose Level 2|Protocol Violation|0
4389052|NCT00068250|7167874|FG003|Phase I: Dose Level 2|Protocol Violation|0
4389053|NCT00068380|7167912|FG000|Overall Study|Withdrawal by Subject|3
4389054|NCT00068380|7167912|FG000|Overall Study|Adverse Event|2
4389055|NCT00068393|7167916|FG000|Overall Study|Adverse Event|2
4389056|NCT00068393|7167916|FG000|Overall Study|Death|3
4389057|NCT00068393|7167916|FG000|Overall Study|Withdrawal by Subject|3
4389058|NCT00068393|7167916|FG000|Overall Study|Alternative treatment|1
4389059|NCT00068393|7167916|FG000|Overall Study|Quality of life worsening|1
4389060|NCT00068406|7167920|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1
4389061|NCT00068406|7167920|FG000|Overall Study|Ineligible-Inadequate Pathology|2
4389062|NCT00068419|7167924|FG000|Overall Study|Adverse Event|3
4389063|NCT00068419|7167924|FG000|Overall Study|Lack of Efficacy|24
4708958|NCT02853435|7632736|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1
4708959|NCT02853435|7632737|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
4708960|NCT02853760|7632767|FG000|Washout (1 Week)|acute illness (not connected with the study)|0
4708961|NCT02853760|7632768|FG001|Washout (1 Week)|acute illness (not connected with the study)|0
4708962|NCT02853760|7632769|FG002|Washout (1 Week)|acute illness (not connected with the study)|1
4708963|NCT02853760|7632770|FG003|Washout (1 Week)|acute illness (not connected with the study)|2
4708964|NCT02853760|7632771|FG004|Washout (1 Week)|acute illness (not connected with the study)|0
4708965|NCT02853760|7632772|FG005|Washout (1 Week)|acute illness (not connected with the study)|2
4708966|NCT02853929|7632782|FG000|Overall Study|Lost to Follow-up|3
4708967|NCT02853929|7632783|FG001|Overall Study|Lost to Follow-up|0
4708968|NCT02853929|7632782|FG000|Overall Study|Withdrawal by Subject|1
4708969|NCT02853929|7632783|FG001|Overall Study|Withdrawal by Subject|0
4708970|NCT02853929|7632782|FG000|Overall Study|Subjects enrolled but not vaccinated|7
4708971|NCT02853929|7632783|FG001|Overall Study|Subjects enrolled but not vaccinated|4
4389064|NCT00068419|7167924|FG000|Overall Study|Lost to Follow-up|1
4389065|NCT00068419|7167924|FG000|Overall Study|Physician Decision|7
4389066|NCT00068419|7167924|FG000|Overall Study|Withdrawal by Subject|14
4389067|NCT00068419|7167924|FG000|Overall Study|Ineligible|11
4389068|NCT00068445|7167930|FG000|Randomization|Cancel|1
4389069|NCT00068445|7167931|FG001|Randomization|Cancel|3
4389070|NCT00068445|7167930|FG000|Randomization|Ineligible|1
4389071|NCT00068445|7167931|FG001|Randomization|Ineligible|1
4708972|NCT02854527|7632808|FG000|Overall Study|Adverse Event|0
4708973|NCT02854527|7632809|FG001|Overall Study|Adverse Event|0
4708974|NCT02854527|7632810|FG002|Overall Study|Adverse Event|0
4708975|NCT02854527|7632811|FG003|Overall Study|Adverse Event|0
4708976|NCT02854527|7632812|FG004|Overall Study|Adverse Event|1
4708977|NCT02854527|7632813|FG005|Overall Study|Adverse Event|0
4708978|NCT02854527|7632814|FG006|Overall Study|Adverse Event|0
4708979|NCT02854527|7632815|FG007|Overall Study|Adverse Event|0
4708980|NCT02854527|7632816|FG008|Overall Study|Adverse Event|0
4708981|NCT02854527|7632817|FG009|Overall Study|Adverse Event|0
4708982|NCT02854527|7632808|FG000|Overall Study|Lost to Follow-up|0
4708983|NCT02854527|7632809|FG001|Overall Study|Lost to Follow-up|0
4708984|NCT02854527|7632810|FG002|Overall Study|Lost to Follow-up|0
4708985|NCT02854527|7632811|FG003|Overall Study|Lost to Follow-up|1
4708986|NCT02854527|7632812|FG004|Overall Study|Lost to Follow-up|0
4708987|NCT02854527|7632813|FG005|Overall Study|Lost to Follow-up|0
4708988|NCT02854527|7632814|FG006|Overall Study|Lost to Follow-up|0
4708989|NCT02854527|7632815|FG007|Overall Study|Lost to Follow-up|0
4708990|NCT02854527|7632816|FG008|Overall Study|Lost to Follow-up|0
4708991|NCT02854527|7632817|FG009|Overall Study|Lost to Follow-up|0
4708992|NCT02854605|7632838|FG000|Overall Study|Adverse Event|1
4708993|NCT02854605|7632839|FG001|Overall Study|Adverse Event|5
4708994|NCT02854605|7632840|FG002|Overall Study|Adverse Event|2
4708995|NCT02854605|7632838|FG000|Overall Study|Lost to Follow-up|0
4708996|NCT02854605|7632839|FG001|Overall Study|Lost to Follow-up|2
4708997|NCT02854605|7632840|FG002|Overall Study|Lost to Follow-up|0
4708998|NCT02854605|7632838|FG000|Overall Study|Withdrew Consent|1
4708999|NCT02854605|7632839|FG001|Overall Study|Withdrew Consent|0
4709000|NCT02854605|7632840|FG002|Overall Study|Withdrew Consent|1
4709001|NCT02854605|7632838|FG000|Overall Study|Investigator's Discretion|1
4709002|NCT02854605|7632839|FG001|Overall Study|Investigator's Discretion|0
4709003|NCT02854605|7632840|FG002|Overall Study|Investigator's Discretion|0
4709004|NCT02854605|7632838|FG000|Overall Study|Protocol Violation|0
4709005|NCT02854605|7632839|FG001|Overall Study|Protocol Violation|0
4709006|NCT02854605|7632840|FG002|Overall Study|Protocol Violation|1
4709007|NCT02854631|7632850|FG000|Overall Study|Adverse Event|1
4709008|NCT02854631|7632851|FG001|Overall Study|Adverse Event|2
4709009|NCT02854631|7632850|FG000|Overall Study|Withdrew Consent|3
4709010|NCT02854631|7632851|FG001|Overall Study|Withdrew Consent|2
4709011|NCT02854631|7632850|FG000|Overall Study|Investigator's Discretion|2
4709012|NCT02854631|7632851|FG001|Overall Study|Investigator's Discretion|0
4709013|NCT02854631|7632850|FG000|Overall Study|Death|12
4709014|NCT02854631|7632851|FG001|Overall Study|Death|8
4709015|NCT02854631|7632850|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2
4709016|NCT02854631|7632851|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0
4709017|NCT02854631|7632850|FG000|Overall Study|Protocol Violation|0
4709018|NCT02854631|7632851|FG001|Overall Study|Protocol Violation|1
4709019|NCT02854631|7632850|FG000|Overall Study|Subjects Randomized but Never Treated|2
4709020|NCT02854631|7632851|FG001|Overall Study|Subjects Randomized but Never Treated|0
4709021|NCT02854631|7632850|FG000|Overall Study|Lost to Follow-up|4
4709022|NCT02854631|7632851|FG001|Overall Study|Lost to Follow-up|2
4709023|NCT02854800|7632860|FG000|Overall Study|Protocol Violation|16
4709024|NCT02854800|7632861|FG001|Overall Study|Protocol Violation|11
4709025|NCT02854800|7632862|FG002|Overall Study|Protocol Violation|3
4709026|NCT02854800|7632860|FG000|Overall Study|Withdrawal by Subject|4
4709027|NCT02854800|7632861|FG001|Overall Study|Withdrawal by Subject|2
4709028|NCT02854800|7632862|FG002|Overall Study|Withdrawal by Subject|3
4709029|NCT02855164|7632890|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0
4709030|NCT02855164|7632891|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0
4709031|NCT02855164|7632892|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1
4709032|NCT02855164|7632893|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2
4709033|NCT02855164|7632894|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1
4709034|NCT02855164|7632895|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0
4709035|NCT02855164|7632896|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0
4709036|NCT02855164|7632897|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0
4709037|NCT02855164|7632890|FG000|Parts A + B (Randomized Set)|Physician Decision|0
4709038|NCT02855164|7632891|FG001|Parts A + B (Randomized Set)|Physician Decision|0
4709039|NCT02855164|7632892|FG002|Parts A + B (Randomized Set)|Physician Decision|0
4709040|NCT02855164|7632893|FG003|Parts A + B (Randomized Set)|Physician Decision|2
4709041|NCT02855164|7632894|FG004|Parts A + B (Randomized Set)|Physician Decision|0
4709042|NCT02855164|7632895|FG005|Parts A + B (Randomized Set)|Physician Decision|0
4709043|NCT02855164|7632896|FG006|Parts A + B (Randomized Set)|Physician Decision|0
4709044|NCT02855164|7632897|FG007|Parts A + B (Randomized Set)|Physician Decision|0
4709045|NCT02855164|7632890|FG000|Parts A + B (Randomized Set)|Adverse Event|0
4771363|NCT02942277|7748239|FG009|Year 1|Subject met withdrawal criteria|0
4771364|NCT02942277|7748240|FG010|Year 1|Subject met withdrawal criteria|0
4771365|NCT02942277|7748230|FG000|Year 1|Lost to Follow-up|0
4771366|NCT02942277|7748231|FG001|Year 1|Lost to Follow-up|0
4771367|NCT02942277|7748232|FG002|Year 1|Lost to Follow-up|0
4771368|NCT02942277|7748233|FG003|Year 1|Lost to Follow-up|0
4771369|NCT02942277|7748234|FG004|Year 1|Lost to Follow-up|1
4771370|NCT02942277|7748235|FG005|Year 1|Lost to Follow-up|0
4771371|NCT02942277|7748236|FG006|Year 1|Lost to Follow-up|0
4709046|NCT02855164|7632891|FG001|Parts A + B (Randomized Set)|Adverse Event|0
4709047|NCT02855164|7632892|FG002|Parts A + B (Randomized Set)|Adverse Event|0
4709048|NCT02855164|7632893|FG003|Parts A + B (Randomized Set)|Adverse Event|4
4709049|NCT02855164|7632894|FG004|Parts A + B (Randomized Set)|Adverse Event|0
4709050|NCT02855164|7632895|FG005|Parts A + B (Randomized Set)|Adverse Event|0
4709051|NCT02855164|7632896|FG006|Parts A + B (Randomized Set)|Adverse Event|0
4709052|NCT02855164|7632897|FG007|Parts A + B (Randomized Set)|Adverse Event|0
4709053|NCT02855164|7632890|FG000|Part C (Randomized Set)|Adverse Event|0
4709054|NCT02855164|7632891|FG001|Part C (Randomized Set)|Adverse Event|0
4709055|NCT02855164|7632892|FG002|Part C (Randomized Set)|Adverse Event|0
4709056|NCT02855164|7632893|FG003|Part C (Randomized Set)|Adverse Event|0
4709057|NCT02855164|7632894|FG004|Part C (Randomized Set)|Adverse Event|0
4709058|NCT02855164|7632895|FG005|Part C (Randomized Set)|Adverse Event|5
4709059|NCT02855164|7632896|FG006|Part C (Randomized Set)|Adverse Event|9
4709060|NCT02855164|7632897|FG007|Part C (Randomized Set)|Adverse Event|2
4709061|NCT02855164|7632890|FG000|Part C (Randomized Set)|Lost to Follow-up|0
4709062|NCT02855164|7632891|FG001|Part C (Randomized Set)|Lost to Follow-up|0
4709063|NCT02855164|7632892|FG002|Part C (Randomized Set)|Lost to Follow-up|0
4709064|NCT02855164|7632893|FG003|Part C (Randomized Set)|Lost to Follow-up|0
4709065|NCT02855164|7632894|FG004|Part C (Randomized Set)|Lost to Follow-up|0
4709066|NCT02855164|7632895|FG005|Part C (Randomized Set)|Lost to Follow-up|1
4709067|NCT02855164|7632896|FG006|Part C (Randomized Set)|Lost to Follow-up|1
4709068|NCT02855164|7632897|FG007|Part C (Randomized Set)|Lost to Follow-up|1
4709069|NCT02855164|7632890|FG000|Part C (Randomized Set)|Physician Decision|0
4709070|NCT02855164|7632891|FG001|Part C (Randomized Set)|Physician Decision|0
4709071|NCT02855164|7632892|FG002|Part C (Randomized Set)|Physician Decision|0
4709072|NCT02855164|7632893|FG003|Part C (Randomized Set)|Physician Decision|0
4709073|NCT02855164|7632894|FG004|Part C (Randomized Set)|Physician Decision|0
4709074|NCT02855164|7632895|FG005|Part C (Randomized Set)|Physician Decision|1
4709075|NCT02855164|7632896|FG006|Part C (Randomized Set)|Physician Decision|0
4709076|NCT02855164|7632897|FG007|Part C (Randomized Set)|Physician Decision|1
4709077|NCT02855164|7632890|FG000|Part C (Randomized Set)|Withdrawal by Subject|0
4709078|NCT02855164|7632891|FG001|Part C (Randomized Set)|Withdrawal by Subject|0
4709079|NCT02855164|7632892|FG002|Part C (Randomized Set)|Withdrawal by Subject|0
4709080|NCT02855164|7632893|FG003|Part C (Randomized Set)|Withdrawal by Subject|0
4709081|NCT02855164|7632894|FG004|Part C (Randomized Set)|Withdrawal by Subject|0
4709082|NCT02855164|7632895|FG005|Part C (Randomized Set)|Withdrawal by Subject|5
4709083|NCT02855164|7632896|FG006|Part C (Randomized Set)|Withdrawal by Subject|4
4709084|NCT02855164|7632897|FG007|Part C (Randomized Set)|Withdrawal by Subject|3
4709085|NCT02855359|7632945|FG000|Overall Study|Death|2
4709086|NCT02855359|7632946|FG001|Overall Study|Death|2
4709087|NCT02855359|7632947|FG002|Overall Study|Death|0
4709088|NCT02855359|7632948|FG003|Overall Study|Death|0
4709089|NCT02855359|7632945|FG000|Overall Study|Study Termination by Sponsor|9
4709090|NCT02855359|7632946|FG001|Overall Study|Study Termination by Sponsor|11
4709091|NCT02855359|7632947|FG002|Overall Study|Study Termination by Sponsor|0
4709092|NCT02855359|7632948|FG003|Overall Study|Study Termination by Sponsor|0
4709093|NCT02855450|7632966|FG000|Overall Study|Adverse Event|1
4709094|NCT02855450|7632967|FG001|Overall Study|Adverse Event|0
4709095|NCT02855450|7632966|FG000|Overall Study|Lost to Follow-up|4
4709096|NCT02855450|7632967|FG001|Overall Study|Lost to Follow-up|0
4709097|NCT02855541|7632973|FG000|Overall Study|Change in health status|2
4709098|NCT02855541|7632973|FG000|Overall Study|Withdrawal by Subject|2
4709099|NCT02856282|7632990|FG000|Overall Study|Withdrawal by Subject|1
4709100|NCT02856555|7633010|FG000|Overall Study|Adverse Event|1
4709101|NCT02856555|7633011|FG001|Overall Study|Adverse Event|0
4709102|NCT02856555|7633012|FG002|Overall Study|Adverse Event|0
4709103|NCT02856555|7633010|FG000|Overall Study|Lost to Follow-up|1
4709104|NCT02856555|7633011|FG001|Overall Study|Lost to Follow-up|3
4709105|NCT02856555|7633012|FG002|Overall Study|Lost to Follow-up|0
4709106|NCT02856555|7633010|FG000|Overall Study|Withdrawal by Subject|3
4709107|NCT02856555|7633011|FG001|Overall Study|Withdrawal by Subject|0
4709108|NCT02856555|7633012|FG002|Overall Study|Withdrawal by Subject|0
4709109|NCT02856555|7633010|FG000|Overall Study|Randomized but Never Treated|0
4709110|NCT02856555|7633011|FG001|Overall Study|Randomized but Never Treated|1
4709111|NCT02856555|7633012|FG002|Overall Study|Randomized but Never Treated|0
4709112|NCT02856802|7633022|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0
4709113|NCT02856802|7633023|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2
4709114|NCT02856802|7633022|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1
4709115|NCT02856802|7633023|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0
4709116|NCT02856802|7633022|FG000|Double-Blind Treatment Period 1|Protocol Violation|0
4709117|NCT02856802|7633023|FG001|Double-Blind Treatment Period 1|Protocol Violation|1
4709118|NCT02856802|7633022|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1
4709119|NCT02856802|7633023|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0
4709120|NCT02856802|7633022|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0
4709121|NCT02856802|7633023|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2
4709122|NCT02856802|7633022|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1
4709123|NCT02856802|7633023|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0
4709124|NCT02856880|7633050|FG000|Overall Study|Withdrawal of consent|1
4709125|NCT02857283|7633071|FG000|First Exposure|Withdrawal by Subject|1
4709126|NCT02857283|7633072|FG001|First Exposure|Withdrawal by Subject|0
4709127|NCT02857816|7633079|FG000|Overall Study|Screen Failure|33
4709128|NCT02857816|7633079|FG000|Overall Study|Withdrawal by Subject|4
4709129|NCT02857816|7633079|FG000|Overall Study|Lost to Follow-up|1
4709130|NCT02858076|7633095|FG000|Overall Study|Death|6
4709131|NCT02858076|7633096|FG001|Overall Study|Death|3
4709132|NCT02858076|7633095|FG000|Overall Study|Withdrawal by Subject|1
4709133|NCT02858076|7633096|FG001|Overall Study|Withdrawal by Subject|5
4709134|NCT02858076|7633095|FG000|Overall Study|Lost to Follow-up|2
4709135|NCT02858076|7633096|FG001|Overall Study|Lost to Follow-up|7
4709136|NCT02858076|7633095|FG000|Overall Study|Completed Out of Window|1
4709137|NCT02858076|7633096|FG001|Overall Study|Completed Out of Window|3
4709138|NCT02858180|7633106|FG000|Overall Study|Lost to Follow-up|0
4709139|NCT02858180|7633107|FG001|Overall Study|Lost to Follow-up|2
4709140|NCT02858362|7633120|FG000|Overall Study|Protocol Violation|0
4709141|NCT02858362|7633121|FG001|Overall Study|Protocol Violation|1
4709142|NCT02858362|7633122|FG002|Overall Study|Protocol Violation|0
4709143|NCT02858362|7633120|FG000|Overall Study|Withdrawal by Subject|1
4709144|NCT02858362|7633121|FG001|Overall Study|Withdrawal by Subject|0
4709145|NCT02858362|7633122|FG002|Overall Study|Withdrawal by Subject|0
4709146|NCT02858362|7633120|FG000|Overall Study|Early Study Termination|0
4709147|NCT02858362|7633121|FG001|Overall Study|Early Study Termination|0
4709148|NCT02858362|7633122|FG002|Overall Study|Early Study Termination|3
4709149|NCT02858362|7633120|FG000|Overall Study|Lost to Follow-up|1
4709150|NCT02858362|7633121|FG001|Overall Study|Lost to Follow-up|0
4709151|NCT02858362|7633122|FG002|Overall Study|Lost to Follow-up|0
4709152|NCT02858401|7633142|FG000|Overall Study|Withdrew Consent|0
4709153|NCT02858401|7633143|FG001|Overall Study|Withdrew Consent|0
4709154|NCT02858401|7633144|FG002|Overall Study|Withdrew Consent|0
4709155|NCT02858401|7633145|FG003|Overall Study|Withdrew Consent|0
4709156|NCT02858401|7633146|FG004|Overall Study|Withdrew Consent|0
4709157|NCT02858401|7633147|FG005|Overall Study|Withdrew Consent|1
4709158|NCT02858401|7633148|FG006|Overall Study|Withdrew Consent|0
4709159|NCT02858401|7633142|FG000|Overall Study|Lost to Follow-up|0
4709160|NCT02858401|7633143|FG001|Overall Study|Lost to Follow-up|1
4709161|NCT02858401|7633144|FG002|Overall Study|Lost to Follow-up|0
4709162|NCT02858401|7633145|FG003|Overall Study|Lost to Follow-up|0
4709163|NCT02858401|7633146|FG004|Overall Study|Lost to Follow-up|0
4709164|NCT02858401|7633147|FG005|Overall Study|Lost to Follow-up|0
4709165|NCT02858401|7633148|FG006|Overall Study|Lost to Follow-up|0
4709166|NCT02858440|7633173|FG000|Overall Study|Lost to Follow-up|3
4709167|NCT02858440|7633173|FG000|Overall Study|Protocol Violation|2
4709168|NCT02858440|7633173|FG000|Overall Study|Consent withdrawal|3
4709169|NCT02858440|7633173|FG000|Overall Study|Migrated/moved from study area|4
4709170|NCT02858492|7633181|FG000|Overall Study|Withdrawal by Subject|0
4709171|NCT02858492|7633182|FG001|Overall Study|Withdrawal by Subject|1
4709172|NCT02858492|7633183|FG002|Overall Study|Withdrawal by Subject|0
4709173|NCT02858492|7633184|FG003|Overall Study|Withdrawal by Subject|1
4709174|NCT02858492|7633181|FG000|Overall Study|Adverse Event|0
4709175|NCT02858492|7633182|FG001|Overall Study|Adverse Event|0
4709176|NCT02858492|7633183|FG002|Overall Study|Adverse Event|0
4709177|NCT02858492|7633184|FG003|Overall Study|Adverse Event|3
4709178|NCT02858492|7633181|FG000|Overall Study|Lack of Efficacy|0
4709179|NCT02858492|7633182|FG001|Overall Study|Lack of Efficacy|0
4709180|NCT02858492|7633183|FG002|Overall Study|Lack of Efficacy|0
4709181|NCT02858492|7633184|FG003|Overall Study|Lack of Efficacy|1
4709182|NCT02858492|7633181|FG000|Overall Study|Protocol defined stopping criteria|0
4709183|NCT02858492|7633182|FG001|Overall Study|Protocol defined stopping criteria|0
4709184|NCT02858492|7633183|FG002|Overall Study|Protocol defined stopping criteria|0
4709185|NCT02858492|7633184|FG003|Overall Study|Protocol defined stopping criteria|1
4709186|NCT02858726|7633213|FG000|Overall Study|Adverse Event|4
4709187|NCT02858726|7633214|FG001|Overall Study|Adverse Event|4
4709188|NCT02858726|7633215|FG002|Overall Study|Adverse Event|9
4709189|NCT02858726|7633216|FG003|Overall Study|Adverse Event|1
4709190|NCT02858726|7633213|FG000|Overall Study|Physician Decision|0
4709191|NCT02858726|7633214|FG001|Overall Study|Physician Decision|0
4709192|NCT02858726|7633215|FG002|Overall Study|Physician Decision|1
4709193|NCT02858726|7633216|FG003|Overall Study|Physician Decision|0
4709194|NCT02858726|7633213|FG000|Overall Study|Protocol Violation|0
4709195|NCT02858726|7633214|FG001|Overall Study|Protocol Violation|0
4709196|NCT02858726|7633215|FG002|Overall Study|Protocol Violation|0
4709197|NCT02858726|7633216|FG003|Overall Study|Protocol Violation|1
4709198|NCT02858726|7633213|FG000|Overall Study|Study Terminated by Sponsor|0
4709199|NCT02858726|7633214|FG001|Overall Study|Study Terminated by Sponsor|0
4709200|NCT02858726|7633215|FG002|Overall Study|Study Terminated by Sponsor|0
4709201|NCT02858726|7633216|FG003|Overall Study|Study Terminated by Sponsor|1
4771372|NCT02942277|7748237|FG007|Year 1|Lost to Follow-up|0
4709202|NCT02858726|7633213|FG000|Overall Study|Withdrawal by Subject|1
4709203|NCT02858726|7633214|FG001|Overall Study|Withdrawal by Subject|2
4709204|NCT02858726|7633215|FG002|Overall Study|Withdrawal by Subject|1
4709205|NCT02858726|7633216|FG003|Overall Study|Withdrawal by Subject|0
4709206|NCT02858726|7633213|FG000|Overall Study|Noncompliance|0
4709207|NCT02858726|7633214|FG001|Overall Study|Noncompliance|1
4709208|NCT02858726|7633215|FG002|Overall Study|Noncompliance|0
4709209|NCT02858726|7633216|FG003|Overall Study|Noncompliance|0
4709210|NCT02859142|7633232|FG000|Overall Study|Adverse Event|1
4709211|NCT02859142|7633233|FG001|Overall Study|Adverse Event|2
4709212|NCT02859142|7633232|FG000|Overall Study|Lost to Follow-up|1
4709213|NCT02859142|7633233|FG001|Overall Study|Lost to Follow-up|4
4709214|NCT02859142|7633232|FG000|Overall Study|Withdrawal by Subject|2
4709215|NCT02859142|7633233|FG001|Overall Study|Withdrawal by Subject|0
4709216|NCT02859142|7633232|FG000|Overall Study|Scheduling difficulties|0
4709217|NCT02859142|7633233|FG001|Overall Study|Scheduling difficulties|3
4709218|NCT02859246|7633239|FG000|Overall Study|Screen fails|3
4709219|NCT02859246|7633239|FG000|Overall Study|Adverse Event|1
4709220|NCT02859246|7633239|FG000|Overall Study|Withdrawal by Subject|1
4709221|NCT02859324|7633247|FG000|Overall Study|Death|4
4709222|NCT02859324|7633248|FG001|Overall Study|Death|6
4709223|NCT02859324|7633249|FG002|Overall Study|Death|5
4709224|NCT02859324|7633247|FG000|Overall Study|Other reasons|3
4709225|NCT02859324|7633248|FG001|Overall Study|Other reasons|3
4709226|NCT02859324|7633249|FG002|Overall Study|Other reasons|0
4709227|NCT02859454|7633278|FG000|Overall Study|PI discretion/off study prior to trtmt|1
4709228|NCT02860130|7633298|FG000|Overall Study|Adverse Event|2
4709229|NCT02860130|7633299|FG001|Overall Study|Adverse Event|3
4709230|NCT02860130|7633298|FG000|Overall Study|Protocol Violation|1
4628189|NCT01858363|7495211|FG001|Overall Study|Withdrawal by Subject|14
4709231|NCT02860130|7633299|FG001|Overall Study|Protocol Violation|1
4709232|NCT02860130|7633298|FG000|Overall Study|Withdrawal by Subject|0
4709233|NCT02860130|7633299|FG001|Overall Study|Withdrawal by Subject|2
4709234|NCT02860130|7633298|FG000|Overall Study|Physician Decision|2
4709235|NCT02860130|7633299|FG001|Overall Study|Physician Decision|2
4709236|NCT02860130|7633298|FG000|Overall Study|Other|2
4709237|NCT02860130|7633299|FG001|Overall Study|Other|1
4709238|NCT02860546|7633332|FG000|Overall Study|Clinical Progression|6
4709239|NCT02860546|7633332|FG000|Overall Study|Radiological Progression|12
4709240|NCT02861534|7633380|FG000|Overall Study|Death|541
4709241|NCT02861534|7633381|FG001|Overall Study|Death|552
4709242|NCT02861534|7633380|FG000|Overall Study|Lost to Follow-up|14
4709243|NCT02861534|7633381|FG001|Overall Study|Lost to Follow-up|14
4709244|NCT02861534|7633380|FG000|Overall Study|Site Terminated by Sponsor|4
4709245|NCT02861534|7633381|FG001|Overall Study|Site Terminated by Sponsor|3
4709246|NCT02861534|7633380|FG000|Overall Study|Withdrawal by Subject|15
4709247|NCT02861534|7633381|FG001|Overall Study|Withdrawal by Subject|18
4709248|NCT02861586|7633395|FG000|Overall Study|Withdrawal by Subject|1
4709249|NCT02861586|7633396|FG001|Overall Study|Withdrawal by Subject|2
4709250|NCT02861586|7633397|FG002|Overall Study|Withdrawal by Subject|0
4709251|NCT02861586|7633398|FG003|Overall Study|Withdrawal by Subject|0
4709252|NCT02861586|7633399|FG004|Overall Study|Withdrawal by Subject|0
4709253|NCT02861586|7633400|FG005|Overall Study|Withdrawal by Subject|1
4709254|NCT02861586|7633401|FG006|Overall Study|Withdrawal by Subject|1
4709255|NCT02861586|7633402|FG007|Overall Study|Withdrawal by Subject|0
4709256|NCT02861586|7633395|FG000|Overall Study|Lost to Follow-up|3
4709257|NCT02861586|7633396|FG001|Overall Study|Lost to Follow-up|1
4709258|NCT02861586|7633397|FG002|Overall Study|Lost to Follow-up|1
4709259|NCT02861586|7633398|FG003|Overall Study|Lost to Follow-up|0
4709260|NCT02861586|7633399|FG004|Overall Study|Lost to Follow-up|0
4709261|NCT02861586|7633400|FG005|Overall Study|Lost to Follow-up|3
4709262|NCT02861586|7633401|FG006|Overall Study|Lost to Follow-up|0
4709263|NCT02861586|7633402|FG007|Overall Study|Lost to Follow-up|0
4709264|NCT02861586|7633395|FG000|Overall Study|Adverse Event|0
4709265|NCT02861586|7633396|FG001|Overall Study|Adverse Event|0
4709266|NCT02861586|7633397|FG002|Overall Study|Adverse Event|0
4709267|NCT02861586|7633398|FG003|Overall Study|Adverse Event|0
4709268|NCT02861586|7633399|FG004|Overall Study|Adverse Event|0
4709269|NCT02861586|7633400|FG005|Overall Study|Adverse Event|1
4709270|NCT02861586|7633401|FG006|Overall Study|Adverse Event|0
4709271|NCT02861586|7633402|FG007|Overall Study|Adverse Event|0
4709272|NCT02861664|7633427|FG000|Overall Study|Withdrawal of Consent|0
4709273|NCT02861664|7633428|FG001|Overall Study|Withdrawal of Consent|1
4709274|NCT02861807|7633436|FG000|Overall Study|Lost to Follow-up|7
4709275|NCT02861807|7633437|FG001|Overall Study|Lost to Follow-up|6
4709276|NCT02861807|7633436|FG000|Overall Study|Withdrawal by Subject|5
4709277|NCT02861807|7633437|FG001|Overall Study|Withdrawal by Subject|8
4709278|NCT02862106|7633478|FG000|Overall Study|Adverse Event|4
4709279|NCT02862106|7633479|FG001|Overall Study|Adverse Event|0
4709280|NCT02862106|7633478|FG000|Overall Study|Protocol Violation|16
4628190|NCT01858363|7495210|FG000|Overall Study|Lost to Follow-up|13
4628191|NCT01858363|7495211|FG001|Overall Study|Lost to Follow-up|3
4628192|NCT01858376|7495217|FG000|Overall Study|Dropped d/t lab work not fitting criter|4
4628193|NCT01858389|7495223|FG000|Overall Study|Death|1
4628194|NCT01858389|7495224|FG001|Overall Study|Death|3
4628195|NCT01858389|7495223|FG000|Overall Study|Study terminated by sponsor|0
4628196|NCT01858389|7495224|FG001|Overall Study|Study terminated by sponsor|2
4628197|NCT01858389|7495223|FG000|Overall Study|Withdrawal by Subject|0
4628198|NCT01858389|7495224|FG001|Overall Study|Withdrawal by Subject|1
4628199|NCT01858389|7495223|FG000|Overall Study|Progressive disease|10
4709281|NCT02862106|7633479|FG001|Overall Study|Protocol Violation|1
4709282|NCT02862106|7633478|FG000|Overall Study|Lost to Follow-up|15
4709283|NCT02862106|7633479|FG001|Overall Study|Lost to Follow-up|5
4709284|NCT02862106|7633478|FG000|Overall Study|Withdrawal by Subject|2
4709285|NCT02862106|7633479|FG001|Overall Study|Withdrawal by Subject|0
4709286|NCT02862106|7633478|FG000|Overall Study|Subjects moved to other city|1
4709287|NCT02862106|7633479|FG001|Overall Study|Subjects moved to other city|0
4709288|NCT02862535|7633495|FG000|Overall Study|Death|7
4709289|NCT02862535|7633496|FG001|Overall Study|Death|3
4709290|NCT02862535|7633497|FG002|Overall Study|Death|2
4709291|NCT02862535|7633498|FG003|Overall Study|Death|5
4709292|NCT02862535|7633495|FG000|Overall Study|Study Terminated by Sponsor|1
4709293|NCT02862535|7633496|FG001|Overall Study|Study Terminated by Sponsor|3
4709294|NCT02862535|7633497|FG002|Overall Study|Study Terminated by Sponsor|8
4709295|NCT02862535|7633498|FG003|Overall Study|Study Terminated by Sponsor|5
4709296|NCT02862535|7633495|FG000|Overall Study|Enrolled, not Treated|1
4709297|NCT02862535|7633496|FG001|Overall Study|Enrolled, not Treated|0
4709298|NCT02862535|7633497|FG002|Overall Study|Enrolled, not Treated|0
4709299|NCT02862535|7633498|FG003|Overall Study|Enrolled, not Treated|1
4709300|NCT02862548|7633510|FG000|Open-Label Phase|Death|0
4709301|NCT02862548|7633511|FG001|Open-Label Phase|Death|1
4709302|NCT02862548|7633510|FG000|Open-Label Extension Phase|Still on Study|26
4709303|NCT02862548|7633511|FG001|Open-Label Extension Phase|Still on Study|24
4709304|NCT02862574|7633520|FG000|Double-Blind Treatment Period|Adverse Event|0
4709305|NCT02862574|7633521|FG001|Double-Blind Treatment Period|Adverse Event|1
4709306|NCT02862574|7633522|FG002|Double-Blind Treatment Period|Adverse Event|0
4709307|NCT02862574|7633520|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3
4709308|NCT02862574|7633521|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1
4709309|NCT02862574|7633522|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4
4709310|NCT02862574|7633520|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2
4709311|NCT02862574|7633521|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3
4709312|NCT02862574|7633522|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1
4709313|NCT02862600|7633531|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9
4709314|NCT02862600|7633531|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3
4709315|NCT02862600|7633531|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1
4709316|NCT02862600|7633531|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7
4389072|NCT00068445|7167930|FG000|Treatment|Refused Further Treatment|13
4389073|NCT00068445|7167931|FG001|Treatment|Refused Further Treatment|10
4389074|NCT00068445|7167930|FG000|Treatment|Adverse Event|7
4389075|NCT00068445|7167931|FG001|Treatment|Adverse Event|1
4389076|NCT00068445|7167930|FG000|Treatment|Other (Specifics not available)|9
4389077|NCT00068445|7167931|FG001|Treatment|Other (Specifics not available)|5
4389078|NCT00068588|7167944|FG000|Overall Study|Adverse Event|0
4389079|NCT00068588|7167945|FG001|Overall Study|Adverse Event|0
4389080|NCT00068588|7167946|FG002|Overall Study|Adverse Event|2
4389081|NCT00068588|7167944|FG000|Overall Study|Withdrawal by Subject|0
4389082|NCT00068588|7167945|FG001|Overall Study|Withdrawal by Subject|0
4389083|NCT00068588|7167946|FG002|Overall Study|Withdrawal by Subject|1
4389084|NCT00068588|7167944|FG000|Overall Study|Poor KPS|0
4389085|NCT00068588|7167945|FG001|Overall Study|Poor KPS|0
4389086|NCT00068588|7167946|FG002|Overall Study|Poor KPS|1
4389087|NCT00068601|7167955|FG000|Overall Study|Ineligible|11
4389088|NCT00068601|7167956|FG001|Overall Study|Ineligible|13
4389089|NCT00068601|7167955|FG000|Overall Study|Not evaluable: withdrew consent|5
4389090|NCT00068601|7167956|FG001|Overall Study|Not evaluable: withdrew consent|4
4389091|NCT00068601|7167955|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2
4389092|NCT00068601|7167956|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4
4389093|NCT00068601|7167955|FG000|Overall Study|Death|11
4389094|NCT00068601|7167956|FG001|Overall Study|Death|3
4389095|NCT00068601|7167955|FG000|Overall Study|Lost to Follow-up|3
4389096|NCT00068601|7167956|FG001|Overall Study|Lost to Follow-up|2
4389097|NCT00068601|7167955|FG000|Overall Study|Missing primary outcome data|30
4389098|NCT00068601|7167956|FG001|Overall Study|Missing primary outcome data|34
4389099|NCT00068692|7167965|FG000|Step 1: Registration|Disese progression/relapse|5
4389100|NCT00068692|7167966|FG001|Step 1: Registration|Disese progression/relapse|0
4389101|NCT00068692|7167967|FG002|Step 1: Registration|Disese progression/relapse|0
4389102|NCT00068692|7167968|FG003|Step 1: Registration|Disese progression/relapse|0
4389103|NCT00068692|7167969|FG004|Step 1: Registration|Disese progression/relapse|0
4389104|NCT00068692|7167970|FG005|Step 1: Registration|Disese progression/relapse|0
4389105|NCT00068692|7167971|FG006|Step 1: Registration|Disese progression/relapse|0
4389106|NCT00068692|7167972|FG007|Step 1: Registration|Disese progression/relapse|0
4389107|NCT00068692|7167965|FG000|Step 1: Registration|Adverse Event|7
4735856|NCT03547583|7684370|FG000|Overall Study|Physician Decision|1
4389108|NCT00068692|7167966|FG001|Step 1: Registration|Adverse Event|0
4389109|NCT00068692|7167967|FG002|Step 1: Registration|Adverse Event|0
4389110|NCT00068692|7167968|FG003|Step 1: Registration|Adverse Event|0
4389111|NCT00068692|7167969|FG004|Step 1: Registration|Adverse Event|0
4389112|NCT00068692|7167970|FG005|Step 1: Registration|Adverse Event|0
4389113|NCT00068692|7167971|FG006|Step 1: Registration|Adverse Event|0
4389114|NCT00068692|7167972|FG007|Step 1: Registration|Adverse Event|0
4389115|NCT00068692|7167965|FG000|Step 1: Registration|Death|1
4389116|NCT00068692|7167966|FG001|Step 1: Registration|Death|0
4389117|NCT00068692|7167967|FG002|Step 1: Registration|Death|0
4389118|NCT00068692|7167968|FG003|Step 1: Registration|Death|0
4389119|NCT00068692|7167969|FG004|Step 1: Registration|Death|0
4389120|NCT00068692|7167970|FG005|Step 1: Registration|Death|0
4389121|NCT00068692|7167971|FG006|Step 1: Registration|Death|0
4389122|NCT00068692|7167972|FG007|Step 1: Registration|Death|0
4709317|NCT02862730|7633537|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
4709318|NCT02862730|7633538|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
4709319|NCT02862730|7633539|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1
4709320|NCT02862730|7633540|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
4709321|NCT02862730|7633541|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
4709322|NCT02862730|7633542|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
4709323|NCT02862730|7633543|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
4709324|NCT02862730|7633537|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1
4709325|NCT02862730|7633538|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0
4709326|NCT02862730|7633539|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0
4709327|NCT02862730|7633540|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0
4709328|NCT02862730|7633541|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0
4709329|NCT02862730|7633542|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0
4709330|NCT02862730|7633543|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0
4709331|NCT02862730|7633537|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
4709332|NCT02862730|7633538|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
4709333|NCT02862730|7633539|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1
4709334|NCT02862730|7633540|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
4709335|NCT02862730|7633541|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1
4709336|NCT02862730|7633542|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
4709337|NCT02862730|7633543|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
4709338|NCT02862730|7633537|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
4709339|NCT02862730|7633538|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
4709340|NCT02862730|7633539|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
4709341|NCT02862730|7633540|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1
4709342|NCT02862730|7633541|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
4709343|NCT02862730|7633542|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
4709344|NCT02862730|7633543|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
4709345|NCT02863328|7633594|FG000|Overall Study|Lost to Follow-up|4
4709346|NCT02863328|7633595|FG001|Overall Study|Lost to Follow-up|10
4709347|NCT02863328|7633594|FG000|Overall Study|Withdrawal by Subject|7
4709348|NCT02863328|7633595|FG001|Overall Study|Withdrawal by Subject|12
4709349|NCT02863328|7633594|FG000|Overall Study|Died|0
4709350|NCT02863328|7633595|FG001|Overall Study|Died|1
4709351|NCT02863354|7633603|FG000|Year 1|Lost to Follow-up|1
4709352|NCT02863354|7633604|FG001|Year 1|Lost to Follow-up|1
4709353|NCT02863354|7633603|FG000|Year 1|Withdrawal by Subject|3
4709354|NCT02863354|7633604|FG001|Year 1|Withdrawal by Subject|0
4709355|NCT02863354|7633603|FG000|Year 1|Death|0
4709356|NCT02863354|7633604|FG001|Year 1|Death|1
4709357|NCT02863354|7633603|FG000|Year 2|Lost to Follow-up|2
4709358|NCT02863354|7633604|FG001|Year 2|Lost to Follow-up|2
4709359|NCT02863419|7633613|FG000|Overall Study|Lost to Follow-up|0
4709360|NCT02863419|7633614|FG001|Overall Study|Lost to Follow-up|1
4709361|NCT02863419|7633615|FG002|Overall Study|Lost to Follow-up|4
4709362|NCT02863419|7633613|FG000|Overall Study|Withdrawal by Subject|5
4709363|NCT02863419|7633614|FG001|Overall Study|Withdrawal by Subject|5
4709364|NCT02863419|7633615|FG002|Overall Study|Withdrawal by Subject|3
4709365|NCT02863419|7633613|FG000|Overall Study|Died|3
4709366|NCT02863419|7633614|FG001|Overall Study|Died|4
4709367|NCT02863419|7633615|FG002|Overall Study|Died|1
4709368|NCT02863575|7633626|FG000|Overall Study|Participants Unable To Swallow Capsule|1
4709369|NCT02863575|7633627|FG001|Overall Study|Participants Unable To Swallow Capsule|0
4709370|NCT02863575|7633628|FG002|Overall Study|Participants Unable To Swallow Capsule|0
4709371|NCT02863575|7633626|FG000|Overall Study|Withdrawal by Subject|0
4709372|NCT02863575|7633627|FG001|Overall Study|Withdrawal by Subject|1
4709373|NCT02863575|7633628|FG002|Overall Study|Withdrawal by Subject|1
4709374|NCT02863575|7633626|FG000|Overall Study|Adverse Event|0
4709375|NCT02863575|7633627|FG001|Overall Study|Adverse Event|1
4709376|NCT02863575|7633628|FG002|Overall Study|Adverse Event|0
4709377|NCT02864082|7633651|FG000|Overall Study|Adverse Event|1
4709378|NCT02864082|7633652|FG001|Overall Study|Adverse Event|1
4709379|NCT02864082|7633651|FG000|Overall Study|Lost to Follow-up|0
4389123|NCT00068692|7167965|FG000|Step 1: Registration|Withdrawal by Subject|11
4389124|NCT00068692|7167966|FG001|Step 1: Registration|Withdrawal by Subject|0
4709380|NCT02864082|7633652|FG001|Overall Study|Lost to Follow-up|1
4709381|NCT02864082|7633651|FG000|Overall Study|Withdrawal by Subject|2
4709382|NCT02864082|7633652|FG001|Overall Study|Withdrawal by Subject|2
4709383|NCT02864316|7633674|FG000|Overall Study|Progressive Disease|2
4709384|NCT02864316|7633675|FG001|Overall Study|Progressive Disease|1
4709385|NCT02864316|7633674|FG000|Overall Study|Adverse Event|0
4389125|NCT00068692|7167967|FG002|Step 1: Registration|Withdrawal by Subject|0
4389126|NCT00068692|7167968|FG003|Step 1: Registration|Withdrawal by Subject|0
4389127|NCT00068692|7167969|FG004|Step 1: Registration|Withdrawal by Subject|0
4389128|NCT00068692|7167970|FG005|Step 1: Registration|Withdrawal by Subject|0
4389129|NCT00068692|7167971|FG006|Step 1: Registration|Withdrawal by Subject|0
4389130|NCT00068692|7167972|FG007|Step 1: Registration|Withdrawal by Subject|0
4389131|NCT00068692|7167965|FG000|Step 1: Registration|Alternative therapy|2
4389132|NCT00068692|7167966|FG001|Step 1: Registration|Alternative therapy|0
4389133|NCT00068692|7167967|FG002|Step 1: Registration|Alternative therapy|0
4389134|NCT00068692|7167968|FG003|Step 1: Registration|Alternative therapy|0
4389135|NCT00068692|7167969|FG004|Step 1: Registration|Alternative therapy|0
4389136|NCT00068692|7167970|FG005|Step 1: Registration|Alternative therapy|0
4389137|NCT00068692|7167971|FG006|Step 1: Registration|Alternative therapy|0
4389138|NCT00068692|7167972|FG007|Step 1: Registration|Alternative therapy|0
4389139|NCT00068692|7167965|FG000|Step 1: Registration|Complicating disease|2
4389140|NCT00068692|7167966|FG001|Step 1: Registration|Complicating disease|0
4389141|NCT00068692|7167967|FG002|Step 1: Registration|Complicating disease|0
4389142|NCT00068692|7167968|FG003|Step 1: Registration|Complicating disease|0
4389143|NCT00068692|7167969|FG004|Step 1: Registration|Complicating disease|0
4389144|NCT00068692|7167970|FG005|Step 1: Registration|Complicating disease|0
4389145|NCT00068692|7167971|FG006|Step 1: Registration|Complicating disease|0
4389146|NCT00068692|7167972|FG007|Step 1: Registration|Complicating disease|0
4389147|NCT00068692|7167965|FG000|Step 1: Registration|Protocol Violation|1
4389148|NCT00068692|7167966|FG001|Step 1: Registration|Protocol Violation|0
4389149|NCT00068692|7167967|FG002|Step 1: Registration|Protocol Violation|0
4389150|NCT00068692|7167968|FG003|Step 1: Registration|Protocol Violation|0
4709386|NCT02864316|7633675|FG001|Overall Study|Adverse Event|1
4709387|NCT02864342|7633683|FG000|Overall Study|Eligibility Criteria Deviation|2
4389151|NCT00068692|7167969|FG004|Step 1: Registration|Protocol Violation|0
4389152|NCT00068692|7167970|FG005|Step 1: Registration|Protocol Violation|0
4389153|NCT00068692|7167971|FG006|Step 1: Registration|Protocol Violation|0
4389154|NCT00068692|7167972|FG007|Step 1: Registration|Protocol Violation|0
4389155|NCT00068692|7167965|FG000|Step 1: Registration|Not eligible|6
4389156|NCT00068692|7167966|FG001|Step 1: Registration|Not eligible|0
4389157|NCT00068692|7167967|FG002|Step 1: Registration|Not eligible|0
4389158|NCT00068692|7167968|FG003|Step 1: Registration|Not eligible|0
4389159|NCT00068692|7167969|FG004|Step 1: Registration|Not eligible|0
4389160|NCT00068692|7167970|FG005|Step 1: Registration|Not eligible|0
4389161|NCT00068692|7167971|FG006|Step 1: Registration|Not eligible|0
4389162|NCT00068692|7167972|FG007|Step 1: Registration|Not eligible|0
4389163|NCT00068692|7167965|FG000|Step 1: Registration|Other|2
4389164|NCT00068692|7167966|FG001|Step 1: Registration|Other|0
4389165|NCT00068692|7167967|FG002|Step 1: Registration|Other|0
4389166|NCT00068692|7167968|FG003|Step 1: Registration|Other|0
4389167|NCT00068692|7167969|FG004|Step 1: Registration|Other|0
4389168|NCT00068692|7167970|FG005|Step 1: Registration|Other|0
4389169|NCT00068692|7167971|FG006|Step 1: Registration|Other|0
4389170|NCT00068692|7167972|FG007|Step 1: Registration|Other|0
4389171|NCT00068692|7167965|FG000|Step 1: Registration|Not start protocol therapy|3
4389172|NCT00068692|7167966|FG001|Step 1: Registration|Not start protocol therapy|0
4389173|NCT00068692|7167967|FG002|Step 1: Registration|Not start protocol therapy|0
4389174|NCT00068692|7167968|FG003|Step 1: Registration|Not start protocol therapy|0
4389175|NCT00068692|7167969|FG004|Step 1: Registration|Not start protocol therapy|0
4709388|NCT02864342|7633684|FG001|Overall Study|Eligibility Criteria Deviation|3
4709389|NCT02864342|7633683|FG000|Overall Study|Withdrawal by Subject|4
4709390|NCT02864342|7633684|FG001|Overall Study|Withdrawal by Subject|2
4709391|NCT02864342|7633683|FG000|Overall Study|Device Technology Issue|6
4709392|NCT02864342|7633684|FG001|Overall Study|Device Technology Issue|7
4709393|NCT02864342|7633683|FG000|Overall Study|Death|0
4709394|NCT02864342|7633684|FG001|Overall Study|Death|1
4709395|NCT02864342|7633683|FG000|Overall Study|Did Not Start Treatment with Symbicort|0
4709396|NCT02864342|7633684|FG001|Overall Study|Did Not Start Treatment with Symbicort|1
4709397|NCT02864342|7633683|FG000|Overall Study|Lost to Follow-up|1
4709398|NCT02864342|7633684|FG001|Overall Study|Lost to Follow-up|5
4709399|NCT02864342|7633683|FG000|Overall Study|Lost Device|1
4709400|NCT02864342|7633684|FG001|Overall Study|Lost Device|0
4709401|NCT02864342|7633683|FG000|Overall Study|Adverse Event|1
4389176|NCT00068692|7167970|FG005|Step 1: Registration|Not start protocol therapy|0
4389177|NCT00068692|7167971|FG006|Step 1: Registration|Not start protocol therapy|0
4389178|NCT00068692|7167972|FG007|Step 1: Registration|Not start protocol therapy|0
4389179|NCT00068692|7167965|FG000|Step 1: Registration|Registered but not randomized|0
4389180|NCT00068692|7167966|FG001|Step 1: Registration|Registered but not randomized|1
4389181|NCT00068692|7167967|FG002|Step 1: Registration|Registered but not randomized|0
4389182|NCT00068692|7167968|FG003|Step 1: Registration|Registered but not randomized|0
4389183|NCT00068692|7167969|FG004|Step 1: Registration|Registered but not randomized|0
4389184|NCT00068692|7167970|FG005|Step 1: Registration|Registered but not randomized|0
4389185|NCT00068692|7167971|FG006|Step 1: Registration|Registered but not randomized|0
4709402|NCT02864342|7633684|FG001|Overall Study|Adverse Event|0
4709403|NCT02864381|7633728|FG000|Overall Study|Death|58
4389186|NCT00068692|7167972|FG007|Step 1: Registration|Registered but not randomized|0
4389187|NCT00068692|7167965|FG000|Step 2: Randomization|Disesae progression/replase|0
4389188|NCT00068692|7167966|FG001|Step 2: Randomization|Disesae progression/replase|0
4389189|NCT00068692|7167967|FG002|Step 2: Randomization|Disesae progression/replase|1
4389190|NCT00068692|7167968|FG003|Step 2: Randomization|Disesae progression/replase|1
4389191|NCT00068692|7167969|FG004|Step 2: Randomization|Disesae progression/replase|0
4389192|NCT00068692|7167970|FG005|Step 2: Randomization|Disesae progression/replase|0
4389193|NCT00068692|7167971|FG006|Step 2: Randomization|Disesae progression/replase|0
4389194|NCT00068692|7167972|FG007|Step 2: Randomization|Disesae progression/replase|0
4389195|NCT00068692|7167965|FG000|Step 2: Randomization|Adverse Event|0
4389196|NCT00068692|7167966|FG001|Step 2: Randomization|Adverse Event|0
4389197|NCT00068692|7167967|FG002|Step 2: Randomization|Adverse Event|4
4389198|NCT00068692|7167968|FG003|Step 2: Randomization|Adverse Event|2
4389199|NCT00068692|7167969|FG004|Step 2: Randomization|Adverse Event|2
4628200|NCT01858389|7495224|FG001|Overall Study|Progressive disease|11
4628201|NCT01858389|7495223|FG000|Overall Study|Other|2
4628202|NCT01858389|7495224|FG001|Overall Study|Other|4
4389200|NCT00068692|7167970|FG005|Step 2: Randomization|Adverse Event|3
4389201|NCT00068692|7167971|FG006|Step 2: Randomization|Adverse Event|4
4389202|NCT00068692|7167972|FG007|Step 2: Randomization|Adverse Event|4
4389203|NCT00068692|7167965|FG000|Step 2: Randomization|Death|0
4389204|NCT00068692|7167966|FG001|Step 2: Randomization|Death|0
4389205|NCT00068692|7167967|FG002|Step 2: Randomization|Death|0
4389206|NCT00068692|7167968|FG003|Step 2: Randomization|Death|0
4389207|NCT00068692|7167969|FG004|Step 2: Randomization|Death|1
4389208|NCT00068692|7167970|FG005|Step 2: Randomization|Death|0
4389209|NCT00068692|7167971|FG006|Step 2: Randomization|Death|0
4389210|NCT00068692|7167972|FG007|Step 2: Randomization|Death|1
4389211|NCT00068692|7167965|FG000|Step 2: Randomization|Withdrawal by Subject|0
4389212|NCT00068692|7167966|FG001|Step 2: Randomization|Withdrawal by Subject|0
4628203|NCT01858389|7495223|FG000|Overall Study|Adverse Event|3
4709404|NCT02864381|7633729|FG001|Overall Study|Death|61
4709405|NCT02864381|7633728|FG000|Overall Study|Withdrew Consent|5
4709406|NCT02864381|7633729|FG001|Overall Study|Withdrew Consent|6
4709407|NCT02864381|7633728|FG000|Overall Study|Reason Unknown|7
4709408|NCT02864381|7633729|FG001|Overall Study|Reason Unknown|3
4709409|NCT02864381|7633728|FG000|Overall Study|Lost to Follow-up|1
4709410|NCT02864381|7633729|FG001|Overall Study|Lost to Follow-up|1
4709411|NCT02864381|7633728|FG000|Overall Study|Investigator's Discretion|1
4709412|NCT02864381|7633729|FG001|Overall Study|Investigator's Discretion|0
4709413|NCT02864381|7633728|FG000|Overall Study|Protocol Violation|0
4709414|NCT02864381|7633729|FG001|Overall Study|Protocol Violation|1
4709415|NCT02864394|7633737|FG000|Overall Study|Death|135
4709416|NCT02864394|7633738|FG001|Overall Study|Death|150
4709417|NCT02864394|7633737|FG000|Overall Study|Withdrawal by Subject|1
4709418|NCT02864394|7633738|FG001|Overall Study|Withdrawal by Subject|9
4709419|NCT02864394|7633737|FG000|Overall Study|Ongoing In Study|77
4709420|NCT02864394|7633738|FG001|Overall Study|Ongoing In Study|53
4709421|NCT02865499|7633825|FG000|Baseline|Adverse Event|1
4709422|NCT02865499|7633825|FG000|Baseline|Withdrawal by Subject|1
4709423|NCT02865538|7633834|FG000|Overall Study|Withdrawal by Subject|0
4709424|NCT02865538|7633835|FG001|Overall Study|Withdrawal by Subject|0
4709425|NCT02865538|7633836|FG002|Overall Study|Withdrawal by Subject|1
4709426|NCT02865538|7633837|FG003|Overall Study|Withdrawal by Subject|0
4709427|NCT02865538|7633838|FG004|Overall Study|Withdrawal by Subject|0
4709428|NCT02865538|7633834|FG000|Overall Study|Lost to Follow-up|1
4709429|NCT02865538|7633835|FG001|Overall Study|Lost to Follow-up|0
4709430|NCT02865538|7633836|FG002|Overall Study|Lost to Follow-up|0
4709431|NCT02865538|7633837|FG003|Overall Study|Lost to Follow-up|0
4709432|NCT02865538|7633838|FG004|Overall Study|Lost to Follow-up|0
4709433|NCT02866175|7633874|FG000|Overall Study|Adverse Event|56
4709434|NCT02866175|7633875|FG001|Overall Study|Adverse Event|54
4709435|NCT02866175|7633874|FG000|Overall Study|Withdrawal by Subject|31
4709436|NCT02866175|7633875|FG001|Overall Study|Withdrawal by Subject|52
4709437|NCT02866175|7633874|FG000|Overall Study|Death|30
4709438|NCT02866175|7633875|FG001|Overall Study|Death|23
4709439|NCT02866175|7633874|FG000|Overall Study|Other|7
4709440|NCT02866175|7633875|FG001|Overall Study|Other|14
4389213|NCT00068692|7167967|FG002|Step 2: Randomization|Withdrawal by Subject|4
4389214|NCT00068692|7167968|FG003|Step 2: Randomization|Withdrawal by Subject|6
4389215|NCT00068692|7167969|FG004|Step 2: Randomization|Withdrawal by Subject|3
4389216|NCT00068692|7167970|FG005|Step 2: Randomization|Withdrawal by Subject|2
4628204|NCT01858389|7495224|FG001|Overall Study|Adverse Event|1
4628205|NCT01858389|7495223|FG000|Overall Study|Did not receive treatment|0
4628206|NCT01858389|7495224|FG001|Overall Study|Did not receive treatment|3
4628207|NCT01858532|7495245|FG000|Overall Study|Adverse Event|58
4628208|NCT01858532|7495246|FG001|Overall Study|Adverse Event|50
4628209|NCT01858532|7495247|FG002|Overall Study|Adverse Event|23
4628210|NCT01858532|7495248|FG003|Overall Study|Adverse Event|28
4628211|NCT01858532|7495245|FG000|Overall Study|Withdrew consent|71
4628212|NCT01858532|7495246|FG001|Overall Study|Withdrew consent|93
4628213|NCT01858532|7495247|FG002|Overall Study|Withdrew consent|46
4628214|NCT01858532|7495248|FG003|Overall Study|Withdrew consent|27
4709441|NCT02866175|7633874|FG000|Overall Study|Progressive disease|1
4709442|NCT02866175|7633875|FG001|Overall Study|Progressive disease|1
4709443|NCT02866175|7633874|FG000|Overall Study|Lost to Follow-up|2
4709444|NCT02866175|7633875|FG001|Overall Study|Lost to Follow-up|0
4709445|NCT02866175|7633874|FG000|Overall Study|Lack of Efficacy|0
4709446|NCT02866175|7633875|FG001|Overall Study|Lack of Efficacy|1
4709447|NCT02866175|7633874|FG000|Overall Study|Physician Decision|3
4709448|NCT02866175|7633875|FG001|Overall Study|Physician Decision|15
4709449|NCT02866175|7633874|FG000|Overall Study|Did not receive treatment|5
4709450|NCT02866175|7633875|FG001|Overall Study|Did not receive treatment|15
4709451|NCT02866942|7633891|FG000|Overall Study|Invalid consent|1
4709452|NCT02867709|7633945|FG000|Treatment Period|Adverse Event|1
4709453|NCT02867709|7633946|FG001|Treatment Period|Adverse Event|1
4709454|NCT02867709|7633947|FG002|Treatment Period|Adverse Event|2
4709455|NCT02867709|7633945|FG000|Treatment Period|Withdrawal of Consent|7
4709456|NCT02867709|7633946|FG001|Treatment Period|Withdrawal of Consent|9
4709457|NCT02867709|7633947|FG002|Treatment Period|Withdrawal of Consent|8
4709458|NCT02867709|7633945|FG000|Treatment Period|Lost to Follow-up|17
4709459|NCT02867709|7633946|FG001|Treatment Period|Lost to Follow-up|20
4709460|NCT02867709|7633947|FG002|Treatment Period|Lost to Follow-up|20
4709461|NCT02867709|7633945|FG000|Treatment Period|Lack of Qualifying Event|42
4709462|NCT02867709|7633946|FG001|Treatment Period|Lack of Qualifying Event|55
4709463|NCT02867709|7633947|FG002|Treatment Period|Lack of Qualifying Event|42
4709464|NCT02867709|7633945|FG000|Treatment Period|Protocol Violation|3
4709465|NCT02867709|7633946|FG001|Treatment Period|Protocol Violation|2
4709466|NCT02867709|7633947|FG002|Treatment Period|Protocol Violation|3
4709467|NCT02867709|7633945|FG000|Safety Follow-up Period|Withdrawal of Consent|1
4709468|NCT02867709|7633946|FG001|Safety Follow-up Period|Withdrawal of Consent|8
4709469|NCT02867709|7633947|FG002|Safety Follow-up Period|Withdrawal of Consent|6
4709470|NCT02867709|7633945|FG000|Safety Follow-up Period|Lost to Follow-up|10
4709471|NCT02867709|7633946|FG001|Safety Follow-up Period|Lost to Follow-up|5
4709472|NCT02867709|7633947|FG002|Safety Follow-up Period|Lost to Follow-up|7
4709473|NCT02867709|7633945|FG000|Safety Follow-up Period|Pregnancy|0
4709474|NCT02867709|7633946|FG001|Safety Follow-up Period|Pregnancy|1
4709475|NCT02867709|7633947|FG002|Safety Follow-up Period|Pregnancy|0
4709476|NCT02867709|7633945|FG000|Safety Follow-up Period|Protocol Violation|0
4709477|NCT02867709|7633946|FG001|Safety Follow-up Period|Protocol Violation|1
4709478|NCT02867709|7633947|FG002|Safety Follow-up Period|Protocol Violation|1
4709479|NCT02867995|7633957|FG000|Overall Study|Withdrawal by Subject|0
4709480|NCT02867995|7633958|FG001|Overall Study|Withdrawal by Subject|1
4709481|NCT02867995|7633957|FG000|Overall Study|Lost to Follow-up|0
4709482|NCT02867995|7633958|FG001|Overall Study|Lost to Follow-up|2
4709483|NCT02868216|7633970|FG000|Overall Study|Death|0
4709484|NCT02868216|7633971|FG001|Overall Study|Death|1
4709485|NCT02868216|7633970|FG000|Overall Study|coronary artery bypass|1
4709486|NCT02868216|7633971|FG001|Overall Study|coronary artery bypass|0
4709487|NCT02868216|7633970|FG000|Overall Study|Withdrawal by Subject|7
4709488|NCT02868216|7633971|FG001|Overall Study|Withdrawal by Subject|5
4709489|NCT02868229|7633981|FG000|Overall Study|Adverse Event|1
4709490|NCT02868229|7633982|FG001|Overall Study|Adverse Event|0
4709491|NCT02868229|7633983|FG002|Overall Study|Adverse Event|0
4709492|NCT02868229|7633984|FG003|Overall Study|Adverse Event|1
4709493|NCT02868229|7633981|FG000|Overall Study|Death|0
4709494|NCT02868229|7633982|FG001|Overall Study|Death|0
4709495|NCT02868229|7633983|FG002|Overall Study|Death|1
4709496|NCT02868229|7633984|FG003|Overall Study|Death|1
4709497|NCT02868229|7633981|FG000|Overall Study|Missed dose|0
4709498|NCT02868229|7633982|FG001|Overall Study|Missed dose|0
4709499|NCT02868229|7633983|FG002|Overall Study|Missed dose|0
4709500|NCT02868229|7633984|FG003|Overall Study|Missed dose|3
4709501|NCT02868281|7634007|FG000|Overall Study|Adverse Event|2
4709502|NCT02868281|7634008|FG001|Overall Study|Adverse Event|2
4709503|NCT02868281|7634007|FG000|Overall Study|Protocol Violation|13
4709504|NCT02868281|7634008|FG001|Overall Study|Protocol Violation|10
4709505|NCT02868281|7634007|FG000|Overall Study|Lost to Follow-up|3
4709506|NCT02868281|7634008|FG001|Overall Study|Lost to Follow-up|6
4709507|NCT02868281|7634007|FG000|Overall Study|Withdrawal by Subject|11
4709508|NCT02868281|7634008|FG001|Overall Study|Withdrawal by Subject|15
4709509|NCT02868281|7634007|FG000|Overall Study|Physician Decision|2
4709510|NCT02868281|7634008|FG001|Overall Study|Physician Decision|0
4709511|NCT02868281|7634007|FG000|Overall Study|Had protocol-defined asthma exacerbation|8
4709512|NCT02868281|7634008|FG001|Overall Study|Had protocol-defined asthma exacerbation|8
4709513|NCT02868281|7634007|FG000|Overall Study|Inclusion/exclusion criteria violation|3
4709514|NCT02868281|7634008|FG001|Overall Study|Inclusion/exclusion criteria violation|2
4709515|NCT02868281|7634007|FG000|Overall Study|Long journey/moving away|1
4709516|NCT02868281|7634008|FG001|Overall Study|Long journey/moving away|1
4709517|NCT02868554|7634017|FG000|Overall Study|Lost to Follow-up|3
4709518|NCT02868554|7634018|FG001|Overall Study|Lost to Follow-up|0
4709519|NCT02868554|7634019|FG002|Overall Study|Lost to Follow-up|1
4709520|NCT02869438|7634059|FG000|Overall Study|Lost to Follow-up|1
4709521|NCT02869438|7634060|FG001|Overall Study|Lost to Follow-up|0
4709522|NCT02869438|7634059|FG000|Overall Study|Adverse Event|1
4709523|NCT02869438|7634060|FG001|Overall Study|Adverse Event|0
4709524|NCT02869438|7634059|FG000|Overall Study|Withdrawal by Subject|1
4709525|NCT02869438|7634060|FG001|Overall Study|Withdrawal by Subject|2
4709526|NCT02869893|7634070|FG000|Overall Study|participant aversion to IV|5
4709527|NCT02869893|7634070|FG000|Overall Study|participant fear of MRI scanner|2
4709528|NCT02870933|7634126|FG000|Overall Study|Death|2
4709529|NCT02870933|7634127|FG001|Overall Study|Death|1
4709530|NCT02870933|7634126|FG000|Overall Study|Withdrawal by Subject|0
4709531|NCT02870933|7634127|FG001|Overall Study|Withdrawal by Subject|1
4709532|NCT02870972|7634139|FG000|Overall Study|Adverse Event|1
4709533|NCT02870972|7634140|FG001|Overall Study|Adverse Event|0
4709534|NCT02870972|7634141|FG002|Overall Study|Adverse Event|0
4709535|NCT02870972|7634142|FG003|Overall Study|Adverse Event|0
4709536|NCT02870972|7634143|FG004|Overall Study|Adverse Event|0
4709537|NCT02871375|7634179|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0
4709538|NCT02871375|7634180|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1
4709539|NCT02871492|7634220|FG000|Overall Study|Lost to Follow-up|6
4709540|NCT02871492|7634221|FG001|Overall Study|Lost to Follow-up|3
4709541|NCT02871492|7634222|FG002|Overall Study|Lost to Follow-up|5
4709542|NCT02871492|7634220|FG000|Overall Study|Withdrawal by Subject|0
4709543|NCT02871492|7634221|FG001|Overall Study|Withdrawal by Subject|0
4709544|NCT02871492|7634222|FG002|Overall Study|Withdrawal by Subject|1
4709545|NCT02871635|7634241|FG000|Overall Study|Primary lack of efficacy|4
4709546|NCT02871635|7634242|FG001|Overall Study|Primary lack of efficacy|4
4709547|NCT02871635|7634241|FG000|Overall Study|Protocol Violation|3
4709548|NCT02871635|7634242|FG001|Overall Study|Protocol Violation|1
4709549|NCT02871635|7634241|FG000|Overall Study|Lost to Follow-up|1
4709550|NCT02871635|7634242|FG001|Overall Study|Lost to Follow-up|2
4709551|NCT02871635|7634241|FG000|Overall Study|Pregnancy|0
4709552|NCT02871635|7634242|FG001|Overall Study|Pregnancy|2
4709553|NCT02871635|7634241|FG000|Overall Study|Physician Decision|1
4709554|NCT02871635|7634242|FG001|Overall Study|Physician Decision|1
4709555|NCT02871635|7634241|FG000|Overall Study|Withdrawal by Subject|3
4709556|NCT02871635|7634242|FG001|Overall Study|Withdrawal by Subject|4
4709557|NCT02871635|7634241|FG000|Overall Study|Adverse Event|4
4709558|NCT02871635|7634242|FG001|Overall Study|Adverse Event|4
4709559|NCT02871635|7634241|FG000|Overall Study|Secondary lack of efficacy|2
4709560|NCT02871635|7634242|FG001|Overall Study|Secondary lack of efficacy|1
4735857|NCT03547583|7684371|FG001|Overall Study|Physician Decision|0
4389217|NCT00068692|7167971|FG006|Step 2: Randomization|Withdrawal by Subject|0
4389218|NCT00068692|7167972|FG007|Step 2: Randomization|Withdrawal by Subject|3
4389219|NCT00068692|7167965|FG000|Step 2: Randomization|alternative therapy|0
4389220|NCT00068692|7167966|FG001|Step 2: Randomization|alternative therapy|0
4389221|NCT00068692|7167967|FG002|Step 2: Randomization|alternative therapy|0
4389222|NCT00068692|7167968|FG003|Step 2: Randomization|alternative therapy|1
4389223|NCT00068692|7167969|FG004|Step 2: Randomization|alternative therapy|1
4389224|NCT00068692|7167970|FG005|Step 2: Randomization|alternative therapy|0
4389225|NCT00068692|7167971|FG006|Step 2: Randomization|alternative therapy|0
4389226|NCT00068692|7167972|FG007|Step 2: Randomization|alternative therapy|0
4389227|NCT00068692|7167965|FG000|Step 2: Randomization|Physician Decision|0
4389228|NCT00068692|7167966|FG001|Step 2: Randomization|Physician Decision|0
4389229|NCT00068692|7167967|FG002|Step 2: Randomization|Physician Decision|0
4389230|NCT00068692|7167968|FG003|Step 2: Randomization|Physician Decision|1
4389231|NCT00068692|7167969|FG004|Step 2: Randomization|Physician Decision|1
4389232|NCT00068692|7167970|FG005|Step 2: Randomization|Physician Decision|0
4389233|NCT00068692|7167971|FG006|Step 2: Randomization|Physician Decision|0
4389234|NCT00068692|7167972|FG007|Step 2: Randomization|Physician Decision|0
4389235|NCT00068692|7167965|FG000|Step 2: Randomization|Other|0
4389236|NCT00068692|7167966|FG001|Step 2: Randomization|Other|0
4389237|NCT00068692|7167967|FG002|Step 2: Randomization|Other|0
4389238|NCT00068692|7167968|FG003|Step 2: Randomization|Other|1
4389239|NCT00068692|7167969|FG004|Step 2: Randomization|Other|0
4389240|NCT00068692|7167970|FG005|Step 2: Randomization|Other|1
4389241|NCT00068692|7167971|FG006|Step 2: Randomization|Other|0
4389242|NCT00068692|7167972|FG007|Step 2: Randomization|Other|0
4389243|NCT00068692|7167965|FG000|Step 2: Randomization|never start protocol therapy|0
4735858|NCT03547583|7684372|FG002|Overall Study|Physician Decision|3
4735859|NCT03547583|7684370|FG000|Overall Study|Protocol Violation|2
4735860|NCT03547583|7684371|FG001|Overall Study|Protocol Violation|1
4735861|NCT03547583|7684372|FG002|Overall Study|Protocol Violation|1
4735862|NCT03547583|7684370|FG000|Overall Study|Withdrawal by Subject|12
4735863|NCT03547583|7684371|FG001|Overall Study|Withdrawal by Subject|19
4735864|NCT03547583|7684372|FG002|Overall Study|Withdrawal by Subject|10
4735865|NCT03547583|7684370|FG000|Overall Study|Other|2
4735866|NCT03547583|7684371|FG001|Overall Study|Other|2
4735867|NCT03547583|7684372|FG002|Overall Study|Other|3
4389244|NCT00068692|7167966|FG001|Step 2: Randomization|never start protocol therapy|0
4389245|NCT00068692|7167967|FG002|Step 2: Randomization|never start protocol therapy|1
4389246|NCT00068692|7167968|FG003|Step 2: Randomization|never start protocol therapy|0
4389247|NCT00068692|7167969|FG004|Step 2: Randomization|never start protocol therapy|1
4389248|NCT00068692|7167970|FG005|Step 2: Randomization|never start protocol therapy|0
4735868|NCT03547635|7684386|FG000|Overall Study|Adverse Event|5
4735869|NCT03547635|7684387|FG001|Overall Study|Adverse Event|2
4735870|NCT03547635|7684388|FG002|Overall Study|Adverse Event|3
4709561|NCT02871739|7634254|FG000|Overall Study|Lost to Follow-up|3
4709562|NCT02871739|7634255|FG001|Overall Study|Lost to Follow-up|2
4709563|NCT02871739|7634256|FG002|Overall Study|Lost to Follow-up|0
4709564|NCT02871739|7634257|FG003|Overall Study|Lost to Follow-up|2
4709565|NCT02872012|7634272|FG000|Overall Study|Withdrawal by Subject|1
4709566|NCT02872012|7634273|FG001|Overall Study|Withdrawal by Subject|0
4709567|NCT02872012|7634274|FG002|Overall Study|Withdrawal by Subject|0
4709568|NCT02872012|7634275|FG003|Overall Study|Withdrawal by Subject|0
4709569|NCT02872012|7634276|FG004|Overall Study|Withdrawal by Subject|0
4709570|NCT02872142|7634301|FG000|Overall Study|Adverse Event|2
4709571|NCT02872142|7634301|FG000|Overall Study|Death|1
4709572|NCT02872142|7634301|FG000|Overall Study|Participant Decision|3
4709573|NCT02872285|7634307|FG000|Overall Study|Withdrawal by Subject|2
4709574|NCT02872285|7634308|FG001|Overall Study|Withdrawal by Subject|0
4709575|NCT02872285|7634307|FG000|Overall Study|Lost to Follow-up|2
4709576|NCT02872285|7634308|FG001|Overall Study|Lost to Follow-up|2
4709577|NCT02872285|7634307|FG000|Overall Study|Discontinued due to back surgery|1
4709578|NCT02872285|7634308|FG001|Overall Study|Discontinued due to back surgery|0
4709579|NCT02872311|7634319|FG000|Overall Study|Death|2
4709580|NCT02872311|7634320|FG001|Overall Study|Death|0
4709581|NCT02872311|7634321|FG002|Overall Study|Death|0
4709582|NCT02872311|7634322|FG003|Overall Study|Death|0
4389249|NCT00068692|7167971|FG006|Step 2: Randomization|never start protocol therapy|0
4389250|NCT00068692|7167972|FG007|Step 2: Randomization|never start protocol therapy|0
4389251|NCT00068822|7168002|FG000|First Randomized Intervention|Lost to Follow-up|1
4389252|NCT00068822|7168003|FG001|First Randomized Intervention|Lost to Follow-up|2
4389253|NCT00069095|7168015|FG000|Primary Treatment Phase|Ongoing|0
4389254|NCT00069095|7168016|FG001|Primary Treatment Phase|Ongoing|0
4389255|NCT00069095|7168017|FG002|Primary Treatment Phase|Ongoing|5
4389256|NCT00069095|7168018|FG003|Primary Treatment Phase|Ongoing|7
4389257|NCT00069095|7168019|FG004|Primary Treatment Phase|Ongoing|7
4389258|NCT00069095|7168020|FG005|Primary Treatment Phase|Ongoing|4
4389259|NCT00069095|7168015|FG000|Primary Treatment Phase|Admin/Other|29
4389260|NCT00069095|7168016|FG001|Primary Treatment Phase|Admin/Other|38
4389261|NCT00069095|7168017|FG002|Primary Treatment Phase|Admin/Other|31
4389262|NCT00069095|7168018|FG003|Primary Treatment Phase|Admin/Other|45
4389263|NCT00069095|7168019|FG004|Primary Treatment Phase|Admin/Other|48
4389264|NCT00069095|7168020|FG005|Primary Treatment Phase|Admin/Other|42
4389265|NCT00069095|7168015|FG000|Primary Treatment Phase|Adverse Event|99
4389266|NCT00069095|7168016|FG001|Primary Treatment Phase|Adverse Event|92
4389267|NCT00069095|7168017|FG002|Primary Treatment Phase|Adverse Event|71
4389268|NCT00069095|7168018|FG003|Primary Treatment Phase|Adverse Event|72
4389269|NCT00069095|7168019|FG004|Primary Treatment Phase|Adverse Event|109
4389270|NCT00069095|7168020|FG005|Primary Treatment Phase|Adverse Event|101
4389271|NCT00069095|7168015|FG000|Primary Treatment Phase|Death|14
4389272|NCT00069095|7168016|FG001|Primary Treatment Phase|Death|8
4389273|NCT00069095|7168017|FG002|Primary Treatment Phase|Death|2
4389274|NCT00069095|7168018|FG003|Primary Treatment Phase|Death|5
4389275|NCT00069095|7168019|FG004|Primary Treatment Phase|Death|8
4389276|NCT00069095|7168020|FG005|Primary Treatment Phase|Death|8
4389277|NCT00069095|7168015|FG000|Primary Treatment Phase|Failure to return|5
4389278|NCT00069095|7168016|FG001|Primary Treatment Phase|Failure to return|5
4389279|NCT00069095|7168017|FG002|Primary Treatment Phase|Failure to return|0
4389280|NCT00069095|7168018|FG003|Primary Treatment Phase|Failure to return|0
4389281|NCT00069095|7168019|FG004|Primary Treatment Phase|Failure to return|0
4389282|NCT00069095|7168020|FG005|Primary Treatment Phase|Failure to return|2
4389283|NCT00069095|7168015|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131
4389284|NCT00069095|7168016|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127
4389285|NCT00069095|7168017|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175
4389286|NCT00069095|7168018|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154
4389287|NCT00069095|7168019|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101
4709583|NCT02872311|7634323|FG004|Overall Study|Death|0
4709584|NCT02872311|7634319|FG000|Overall Study|Lost to Follow-up|2
4709585|NCT02872311|7634320|FG001|Overall Study|Lost to Follow-up|0
4709586|NCT02872311|7634321|FG002|Overall Study|Lost to Follow-up|0
4709587|NCT02872311|7634322|FG003|Overall Study|Lost to Follow-up|0
4709588|NCT02872311|7634323|FG004|Overall Study|Lost to Follow-up|0
4709589|NCT02872311|7634319|FG000|Overall Study|Protocol Violation|0
4709590|NCT02872311|7634320|FG001|Overall Study|Protocol Violation|2
4709591|NCT02872311|7634321|FG002|Overall Study|Protocol Violation|1
4709592|NCT02872311|7634322|FG003|Overall Study|Protocol Violation|0
4709593|NCT02872311|7634323|FG004|Overall Study|Protocol Violation|0
4389288|NCT00069095|7168020|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102
4389289|NCT00069095|7168015|FG000|Primary Treatment Phase|Refused treatment|15
4389290|NCT00069095|7168016|FG001|Primary Treatment Phase|Refused treatment|26
4389291|NCT00069095|7168017|FG002|Primary Treatment Phase|Refused treatment|17
4389292|NCT00069095|7168018|FG003|Primary Treatment Phase|Refused treatment|31
4709594|NCT02872935|7634373|FG000|Overall Study|Other|0
4709595|NCT02872935|7634374|FG001|Overall Study|Other|1
4709596|NCT02873208|7634389|FG000|Overall Study|Withdrawal by Subject|36
4709597|NCT02873208|7634389|FG000|Overall Study|Lost to Follow-up|22
4709598|NCT02873208|7634389|FG000|Overall Study|Adverse Event|15
4709599|NCT02873208|7634389|FG000|Overall Study|Non-compliance with study drug|12
4709600|NCT02873208|7634389|FG000|Overall Study|Protocol Violation|8
4709601|NCT02873208|7634389|FG000|Overall Study|Pregnancy|2
4709602|NCT02873208|7634389|FG000|Overall Study|Incarceration|1
4709603|NCT02873208|7634389|FG000|Overall Study|Lack of Efficacy|1
4709604|NCT02873208|7634389|FG000|Overall Study|Physician Decision|1
4709605|NCT02873221|7634396|FG000|Treatment Period|Other Miscellaneous Reasons|0
4709606|NCT02873221|7634397|FG001|Treatment Period|Other Miscellaneous Reasons|2
4709607|NCT02873221|7634398|FG002|Treatment Period|Other Miscellaneous Reasons|1
4709608|NCT02873221|7634396|FG000|Treatment Period|Non-Compliance with Study Drug|0
4709609|NCT02873221|7634397|FG001|Treatment Period|Non-Compliance with Study Drug|3
4709610|NCT02873221|7634398|FG002|Treatment Period|Non-Compliance with Study Drug|2
4709611|NCT02873221|7634396|FG000|Treatment Period|Protocol Violation|2
4709612|NCT02873221|7634397|FG001|Treatment Period|Protocol Violation|5
4709613|NCT02873221|7634398|FG002|Treatment Period|Protocol Violation|8
4709614|NCT02873221|7634396|FG000|Treatment Period|Pregnancy|4
4709615|NCT02873221|7634397|FG001|Treatment Period|Pregnancy|6
4709616|NCT02873221|7634398|FG002|Treatment Period|Pregnancy|3
4709617|NCT02873221|7634396|FG000|Treatment Period|Lack of Qualifying Event|0
4709618|NCT02873221|7634397|FG001|Treatment Period|Lack of Qualifying Event|3
4709619|NCT02873221|7634398|FG002|Treatment Period|Lack of Qualifying Event|1
4709620|NCT02873221|7634396|FG000|Treatment Period|Withdrawal of Consent|52
4709621|NCT02873221|7634397|FG001|Treatment Period|Withdrawal of Consent|51
4709622|NCT02873221|7634398|FG002|Treatment Period|Withdrawal of Consent|41
4709623|NCT02873221|7634396|FG000|Treatment Period|Lack of Efficacy|0
4709624|NCT02873221|7634397|FG001|Treatment Period|Lack of Efficacy|17
4709625|NCT02873221|7634398|FG002|Treatment Period|Lack of Efficacy|12
4709626|NCT02873221|7634396|FG000|Treatment Period|Adverse Event|4
4709627|NCT02873221|7634397|FG001|Treatment Period|Adverse Event|9
4709628|NCT02873221|7634398|FG002|Treatment Period|Adverse Event|11
4709629|NCT02873221|7634396|FG000|Treatment Period|Lost to Follow-up|26
4709630|NCT02873221|7634397|FG001|Treatment Period|Lost to Follow-up|30
4709631|NCT02873221|7634398|FG002|Treatment Period|Lost to Follow-up|26
4709632|NCT02873221|7634396|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0
4709633|NCT02873221|7634397|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2
4709634|NCT02873221|7634398|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0
4709635|NCT02873221|7634396|FG000|Safety Follow-up Period|Protocol Violation|0
4709636|NCT02873221|7634397|FG001|Safety Follow-up Period|Protocol Violation|0
4709637|NCT02873221|7634398|FG002|Safety Follow-up Period|Protocol Violation|1
4709638|NCT02873221|7634396|FG000|Safety Follow-up Period|Lost to Follow-up|3
4709639|NCT02873221|7634397|FG001|Safety Follow-up Period|Lost to Follow-up|5
4709640|NCT02873221|7634398|FG002|Safety Follow-up Period|Lost to Follow-up|5
4709641|NCT02873221|7634396|FG000|Safety Follow-up Period|Withdrawal of Consent|4
4709642|NCT02873221|7634397|FG001|Safety Follow-up Period|Withdrawal of Consent|10
4709643|NCT02873221|7634398|FG002|Safety Follow-up Period|Withdrawal of Consent|8
4709644|NCT02873338|7634430|FG000|Overall Study|Adverse Event|0
4709645|NCT02873338|7634431|FG001|Overall Study|Adverse Event|2
4709646|NCT02873338|7634432|FG002|Overall Study|Adverse Event|1
4709647|NCT02873338|7634430|FG000|Overall Study|Death|2
4709648|NCT02873338|7634431|FG001|Overall Study|Death|1
4709649|NCT02873338|7634432|FG002|Overall Study|Death|1
4709650|NCT02873338|7634430|FG000|Overall Study|Withdrawal by Subject|2
4709651|NCT02873338|7634431|FG001|Overall Study|Withdrawal by Subject|1
4389293|NCT00069095|7168019|FG004|Primary Treatment Phase|Refused treatment|24
4389294|NCT00069095|7168020|FG005|Primary Treatment Phase|Refused treatment|27
4389295|NCT00069095|7168015|FG000|Primary Treatment Phase|Withdrew|2
4389296|NCT00069095|7168016|FG001|Primary Treatment Phase|Withdrew|3
4389297|NCT00069095|7168017|FG002|Primary Treatment Phase|Withdrew|8
4389298|NCT00069095|7168018|FG003|Primary Treatment Phase|Withdrew|2
4389299|NCT00069095|7168019|FG004|Primary Treatment Phase|Withdrew|4
4389300|NCT00069095|7168020|FG005|Primary Treatment Phase|Withdrew|9
4389301|NCT00069095|7168015|FG000|Primary Treatment Phase|Other Violation|0
4389302|NCT00069095|7168016|FG001|Primary Treatment Phase|Other Violation|1
4628215|NCT01858532|7495245|FG000|Overall Study|Lost to Follow-up|17
4389303|NCT00069095|7168017|FG002|Primary Treatment Phase|Other Violation|1
4389304|NCT00069095|7168018|FG003|Primary Treatment Phase|Other Violation|1
4389305|NCT00069095|7168019|FG004|Primary Treatment Phase|Other Violation|0
4389306|NCT00069095|7168020|FG005|Primary Treatment Phase|Other Violation|1
4389307|NCT00069095|7168015|FG000|Primary Treatment Phase|Violation criteria|0
4389308|NCT00069095|7168016|FG001|Primary Treatment Phase|Violation criteria|2
4389309|NCT00069095|7168017|FG002|Primary Treatment Phase|Violation criteria|4
4389310|NCT00069095|7168018|FG003|Primary Treatment Phase|Violation criteria|3
4389311|NCT00069095|7168019|FG004|Primary Treatment Phase|Violation criteria|1
4389312|NCT00069095|7168020|FG005|Primary Treatment Phase|Violation criteria|5
4389313|NCT00069095|7168015|FG000|Post-study Treatment Phase|Missing reason|1
4389314|NCT00069095|7168016|FG001|Post-study Treatment Phase|Missing reason|3
4389315|NCT00069095|7168017|FG002|Post-study Treatment Phase|Missing reason|12
4389316|NCT00069095|7168018|FG003|Post-study Treatment Phase|Missing reason|8
4389317|NCT00069095|7168019|FG004|Post-study Treatment Phase|Missing reason|18
4389318|NCT00069095|7168020|FG005|Post-study Treatment Phase|Missing reason|17
4709652|NCT02873338|7634432|FG002|Overall Study|Withdrawal by Subject|3
4709653|NCT02873338|7634430|FG000|Overall Study|Lack of Efficacy|0
4709654|NCT02873338|7634431|FG001|Overall Study|Lack of Efficacy|2
4389319|NCT00069095|7168015|FG000|Post-study Treatment Phase|Adverse Event|2
4389320|NCT00069095|7168016|FG001|Post-study Treatment Phase|Adverse Event|3
4709655|NCT02873338|7634432|FG002|Overall Study|Lack of Efficacy|0
4709656|NCT02873338|7634430|FG000|Overall Study|Other or Missing|14
4709657|NCT02873338|7634431|FG001|Overall Study|Other or Missing|15
4709658|NCT02873338|7634432|FG002|Overall Study|Other or Missing|13
4709659|NCT02873377|7634442|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22
4709660|NCT02873377|7634443|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22
4709661|NCT02873377|7634442|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15
4709662|NCT02873377|7634443|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23
4709663|NCT02873429|7634452|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10
4709664|NCT02873429|7634453|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1
4709665|NCT02873429|7634452|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2
4709666|NCT02873429|7634453|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2
4709667|NCT02873429|7634452|FG000|16 Weeks|Lost to Follow-up|3
4709668|NCT02873429|7634453|FG001|16 Weeks|Lost to Follow-up|0
4709669|NCT02873689|7634478|FG000|Overall Study|Lack of Efficacy|1
4709670|NCT02873689|7634479|FG001|Overall Study|Lack of Efficacy|0
4709671|NCT02873689|7634478|FG000|Overall Study|Withdrawal by Subject|2
4709672|NCT02873689|7634479|FG001|Overall Study|Withdrawal by Subject|2
4709673|NCT02873689|7634478|FG000|Overall Study|Protocol Violation|1
4709674|NCT02873689|7634479|FG001|Overall Study|Protocol Violation|0
4709675|NCT02873689|7634478|FG000|Overall Study|Adverse Event|2
4709676|NCT02873689|7634479|FG001|Overall Study|Adverse Event|2
4709677|NCT02873689|7634478|FG000|Overall Study|Randomized but not Treated|1
4709678|NCT02873689|7634479|FG001|Overall Study|Randomized but not Treated|1
4709679|NCT02873702|7634487|FG000|Healing Period (up to Week 8)|Adverse Event|1
4709680|NCT02873702|7634488|FG001|Healing Period (up to Week 8)|Adverse Event|0
4709681|NCT02873702|7634489|FG002|Healing Period (up to Week 8)|Adverse Event|0
4709682|NCT02873702|7634490|FG003|Healing Period (up to Week 8)|Adverse Event|0
4709683|NCT02873702|7634487|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0
4709684|NCT02873702|7634488|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1
4709685|NCT02873702|7634489|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0
4709686|NCT02873702|7634490|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0
4709687|NCT02873702|7634487|FG000|Maintenance Period (up to Month 6)|Adverse Event|0
4709688|NCT02873702|7634488|FG001|Maintenance Period (up to Month 6)|Adverse Event|0
4709689|NCT02873702|7634489|FG002|Maintenance Period (up to Month 6)|Adverse Event|1
4709690|NCT02873702|7634490|FG003|Maintenance Period (up to Month 6)|Adverse Event|0
4709691|NCT02873702|7634487|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0
4709692|NCT02873702|7634488|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0
4709693|NCT02873702|7634489|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4
4709694|NCT02873702|7634490|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1
4709695|NCT02873702|7634487|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0
4709696|NCT02873702|7634488|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0
4709697|NCT02873702|7634489|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2
4709698|NCT02873702|7634490|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1
4709699|NCT02873754|7634500|FG000|Overall Study|Lost to Follow-up|5
4709700|NCT02873754|7634500|FG000|Overall Study|Couldn't complete study procedures|1
4709701|NCT02873936|7634511|FG000|Overall Study|Withdrew Consent|4
4709702|NCT02873936|7634512|FG001|Overall Study|Withdrew Consent|11
4709703|NCT02873936|7634513|FG002|Overall Study|Withdrew Consent|20
4709704|NCT02873936|7634511|FG000|Overall Study|Investigator's Discretion|3
4709705|NCT02873936|7634512|FG001|Overall Study|Investigator's Discretion|5
4709706|NCT02873936|7634513|FG002|Overall Study|Investigator's Discretion|4
4709707|NCT02873936|7634511|FG000|Overall Study|Adverse Event|3
4709708|NCT02873936|7634512|FG001|Overall Study|Adverse Event|5
4709709|NCT02873936|7634513|FG002|Overall Study|Adverse Event|3
4709710|NCT02873936|7634511|FG000|Overall Study|Protocol Violation|0
4709711|NCT02873936|7634512|FG001|Overall Study|Protocol Violation|1
4709712|NCT02873936|7634513|FG002|Overall Study|Protocol Violation|3
4709713|NCT02873936|7634511|FG000|Overall Study|Lost to Follow-up|1
4709714|NCT02873936|7634512|FG001|Overall Study|Lost to Follow-up|1
4709715|NCT02873936|7634513|FG002|Overall Study|Lost to Follow-up|1
4709716|NCT02873936|7634511|FG000|Overall Study|Non-compliance With Study Drug|1
4709717|NCT02873936|7634512|FG001|Overall Study|Non-compliance With Study Drug|0
4709718|NCT02873936|7634513|FG002|Overall Study|Non-compliance With Study Drug|1
4709719|NCT02873936|7634511|FG000|Overall Study|Randomized but not Dosed|1
4709720|NCT02873936|7634512|FG001|Overall Study|Randomized but not Dosed|0
4709721|NCT02873936|7634513|FG002|Overall Study|Randomized but not Dosed|0
4709722|NCT02874534|7634540|FG000|Overall Study|Withdrawal by Subject|5
4709723|NCT02874534|7634541|FG001|Overall Study|Withdrawal by Subject|8
4709724|NCT02874534|7634540|FG000|Overall Study|Lost to Follow-up|2
4709725|NCT02874534|7634541|FG001|Overall Study|Lost to Follow-up|2
4709726|NCT02874534|7634540|FG000|Overall Study|Ongoing in study|1
4709727|NCT02874534|7634541|FG001|Overall Study|Ongoing in study|1
4709728|NCT02874794|7634549|FG000|Overall Study|Physician Decision|3
4709729|NCT02874794|7634550|FG001|Overall Study|Physician Decision|2
4709730|NCT02874794|7634549|FG000|Overall Study|Withdrawal by Subject|2
4628216|NCT01858532|7495246|FG001|Overall Study|Lost to Follow-up|26
4628217|NCT01858532|7495247|FG002|Overall Study|Lost to Follow-up|11
4628218|NCT01858532|7495248|FG003|Overall Study|Lost to Follow-up|14
4628219|NCT01858532|7495245|FG000|Overall Study|Deterioration of medical status|3
4628220|NCT01858532|7495246|FG001|Overall Study|Deterioration of medical status|4
4709731|NCT02874794|7634550|FG001|Overall Study|Withdrawal by Subject|8
4709732|NCT02874794|7634549|FG000|Overall Study|Death|2
4709733|NCT02874794|7634550|FG001|Overall Study|Death|1
4709734|NCT02874924|7634572|FG000|Overall Study|Adverse Event|2
4709735|NCT02874924|7634573|FG001|Overall Study|Adverse Event|0
4709736|NCT02874924|7634574|FG002|Overall Study|Adverse Event|0
4709737|NCT02874924|7634572|FG000|Overall Study|Withdrawal by Subject|1
4709738|NCT02874924|7634573|FG001|Overall Study|Withdrawal by Subject|0
4709739|NCT02874924|7634574|FG002|Overall Study|Withdrawal by Subject|0
4709740|NCT02875028|7634584|FG000|Washout Period|Withdrawal by Subject|0
4709741|NCT02875028|7634585|FG001|Washout Period|Withdrawal by Subject|1
4709742|NCT02875080|7634596|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2
4709743|NCT02875080|7634597|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0
4709744|NCT02875080|7634598|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0
4709745|NCT02875340|7634606|FG000|Overall Study|Death|2
4709746|NCT02875340|7634606|FG000|Overall Study|Withdrawal by Subject|2
4709747|NCT02875340|7634606|FG000|Overall Study|Physician Decision|3
4709748|NCT02875340|7634606|FG000|Overall Study|Adverse Event|1
4709749|NCT02875366|7634618|FG000|Overall Study|Adverse Event|0
4709750|NCT02875366|7634619|FG001|Overall Study|Adverse Event|2
4709751|NCT02875366|7634618|FG000|Overall Study|Noncompliance|0
4709752|NCT02875366|7634619|FG001|Overall Study|Noncompliance|1
4709753|NCT02875392|7634627|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7
4709754|NCT02875392|7634628|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8
4709755|NCT02875613|7634634|FG000|Overall Study|Withdrawal by Subject|1
4709756|NCT02875834|7634642|FG000|Open-label Phase|Withdrawal by Subject|3
4709757|NCT02875834|7634643|FG001|Open-label Phase|Withdrawal by Subject|0
4709758|NCT02875834|7634644|FG002|Open-label Phase|Withdrawal by Subject|0
4709759|NCT02875834|7634645|FG003|Open-label Phase|Withdrawal by Subject|0
4709760|NCT02875834|7634642|FG000|Open-label Phase|(Not collected)|4
4709761|NCT02875834|7634643|FG001|Open-label Phase|(Not collected)|0
4709762|NCT02875834|7634644|FG002|Open-label Phase|(Not collected)|0
4709763|NCT02875834|7634645|FG003|Open-label Phase|(Not collected)|0
4709764|NCT02875834|7634642|FG000|Randomized Treatment Phase|Withdrawal by Subject|0
4709765|NCT02875834|7634643|FG001|Randomized Treatment Phase|Withdrawal by Subject|3
4709766|NCT02875834|7634644|FG002|Randomized Treatment Phase|Withdrawal by Subject|1
4709767|NCT02875834|7634645|FG003|Randomized Treatment Phase|Withdrawal by Subject|0
4709768|NCT02875834|7634642|FG000|Randomized Treatment Phase|Protocol Violation|0
4709769|NCT02875834|7634643|FG001|Randomized Treatment Phase|Protocol Violation|2
4709770|NCT02875834|7634644|FG002|Randomized Treatment Phase|Protocol Violation|0
4709771|NCT02875834|7634645|FG003|Randomized Treatment Phase|Protocol Violation|0
4709772|NCT02875834|7634642|FG000|Randomized Treatment Phase|(Not collected)|0
4709773|NCT02875834|7634643|FG001|Randomized Treatment Phase|(Not collected)|9
4709774|NCT02875834|7634644|FG002|Randomized Treatment Phase|(Not collected)|10
4709775|NCT02875834|7634645|FG003|Randomized Treatment Phase|(Not collected)|9
4709776|NCT02875977|7634657|FG000|Overall Study|Lost to Follow-up|42
4709777|NCT02875977|7634658|FG001|Overall Study|Lost to Follow-up|29
4709778|NCT02876601|7634698|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0
4709779|NCT02876601|7634699|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0
4389321|NCT00069095|7168017|FG002|Post-study Treatment Phase|Adverse Event|1
4389322|NCT00069095|7168018|FG003|Post-study Treatment Phase|Adverse Event|0
4389323|NCT00069095|7168019|FG004|Post-study Treatment Phase|Adverse Event|5
4389324|NCT00069095|7168020|FG005|Post-study Treatment Phase|Adverse Event|1
4709780|NCT02876601|7634700|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1
4709781|NCT02876601|7634701|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0
4709782|NCT02877004|7634793|FG000|Overall Study|Pregnancy|0
4709783|NCT02877004|7634794|FG001|Overall Study|Pregnancy|0
4709784|NCT02877004|7634795|FG002|Overall Study|Pregnancy|1
4709785|NCT02877082|7634803|FG000|Overall Study|Trial was closed early|5
4709786|NCT02877680|7634828|FG000|Overall Study|Lost to Follow-up|1
4709787|NCT02877680|7634829|FG001|Overall Study|Lost to Follow-up|1
4709788|NCT02877927|7634841|FG000|Overall Study|Adverse Event|1
4709789|NCT02877927|7634842|FG001|Overall Study|Adverse Event|0
4709790|NCT02877927|7634841|FG000|Overall Study|Lost to Follow-up|37
4709791|NCT02877927|7634842|FG001|Overall Study|Lost to Follow-up|38
4709792|NCT02877927|7634841|FG000|Overall Study|Withdrawal by Subject|11
4709793|NCT02877927|7634842|FG001|Overall Study|Withdrawal by Subject|12
4709794|NCT02877927|7634841|FG000|Overall Study|Physician Decision|0
4709795|NCT02877927|7634842|FG001|Overall Study|Physician Decision|1
4709796|NCT02877927|7634841|FG000|Overall Study|Missed EOT/PTE Visit|5
4628221|NCT01858532|7495247|FG002|Overall Study|Deterioration of medical status|3
4709797|NCT02877927|7634842|FG001|Overall Study|Missed EOT/PTE Visit|6
4709798|NCT02878213|7634852|FG000|Overall Study|Withdrawal by Subject|2
4709799|NCT02878213|7634852|FG000|Overall Study|Adverse Event|1
4628222|NCT01858532|7495248|FG003|Overall Study|Deterioration of medical status|7
4628223|NCT01858532|7495245|FG000|Overall Study|Investigator request|3
4628224|NCT01858532|7495246|FG001|Overall Study|Investigator request|4
4628225|NCT01858532|7495247|FG002|Overall Study|Investigator request|2
4628226|NCT01858532|7495248|FG003|Overall Study|Investigator request|6
4628227|NCT01858532|7495245|FG000|Overall Study|Other, not specified|29
4628228|NCT01858532|7495246|FG001|Overall Study|Other, not specified|15
4628229|NCT01858532|7495247|FG002|Overall Study|Other, not specified|13
4628230|NCT01858532|7495248|FG003|Overall Study|Other, not specified|11
4628231|NCT01858558|7495269|FG000|Overall Study|Death|1
4628232|NCT01858558|7495270|FG001|Overall Study|Death|1
4628233|NCT01858558|7495269|FG000|Overall Study|Lost to Follow-up|1
4628234|NCT01858558|7495270|FG001|Overall Study|Lost to Follow-up|0
4628235|NCT01858558|7495269|FG000|Overall Study|Disease progression|3
4628236|NCT01858558|7495270|FG001|Overall Study|Disease progression|1
4628237|NCT01858558|7495269|FG000|Overall Study|Product contamination|2
4628238|NCT01858558|7495270|FG001|Overall Study|Product contamination|0
4628239|NCT01858558|7495269|FG000|Overall Study|Failed expansion of cell product|2
4628240|NCT01858558|7495270|FG001|Overall Study|Failed expansion of cell product|0
4628241|NCT01858636|7495276|FG000|Overall Study|No Device Deployment Attempted|24
4628242|NCT01858636|7495276|FG000|Overall Study|Physician Decision|1
4628243|NCT01858636|7495276|FG000|Overall Study|Death|1
4628244|NCT01858636|7495276|FG000|Overall Study|Lost to Follow-up|1
4628245|NCT01858636|7495276|FG000|Overall Study|Withdrawal by Subject|1
4628246|NCT01858701|7495281|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0
4709800|NCT02878330|7634859|FG000|Overall Study|Death|3
4709801|NCT02878330|7634860|FG001|Overall Study|Death|2
4709802|NCT02878330|7634859|FG000|Overall Study|Lost to Follow-up|11
4709803|NCT02878330|7634860|FG001|Overall Study|Lost to Follow-up|26
4709804|NCT02878330|7634859|FG000|Overall Study|Withdrawal by Subject|11
4709805|NCT02878330|7634860|FG001|Overall Study|Withdrawal by Subject|21
4709806|NCT02878330|7634859|FG000|Overall Study|Other|4
4709807|NCT02878330|7634860|FG001|Overall Study|Other|7
4709808|NCT02878590|7634885|FG000|Overall Study|Withdrawal by Subject|2
4709809|NCT02879383|7634908|FG000|First 24 Weeks|Physician Decision|0
4709810|NCT02879383|7634909|FG001|First 24 Weeks|Physician Decision|1
4709811|NCT02879383|7634910|FG002|First 24 Weeks|Physician Decision|0
4709812|NCT02879383|7634911|FG003|First 24 Weeks|Physician Decision|0
4709813|NCT02879578|7634926|FG000|Overall Study|Adverse Event|1
4709814|NCT02879578|7634927|FG001|Overall Study|Adverse Event|2
4709815|NCT02879578|7634928|FG002|Overall Study|Adverse Event|14
4709816|NCT02879578|7634926|FG000|Overall Study|Protocol Violation|0
4709817|NCT02879578|7634927|FG001|Overall Study|Protocol Violation|1
4709818|NCT02879578|7634928|FG002|Overall Study|Protocol Violation|1
4709819|NCT02879578|7634926|FG000|Overall Study|Withdrawal by Subject|8
4709820|NCT02879578|7634927|FG001|Overall Study|Withdrawal by Subject|6
4709821|NCT02879578|7634928|FG002|Overall Study|Withdrawal by Subject|9
4709822|NCT02879578|7634926|FG000|Overall Study|Lost to Follow-up|1
4709823|NCT02879578|7634927|FG001|Overall Study|Lost to Follow-up|0
4709824|NCT02879578|7634928|FG002|Overall Study|Lost to Follow-up|4
4709825|NCT02879578|7634926|FG000|Overall Study|Physician Decision|0
4709826|NCT02879578|7634927|FG001|Overall Study|Physician Decision|0
4709827|NCT02879578|7634928|FG002|Overall Study|Physician Decision|4
4709828|NCT02879994|7634967|FG000|Overall Study|off treatment early|7
4709829|NCT02879994|7634967|FG000|Overall Study|Adverse Event|2
4709830|NCT02879994|7634967|FG000|Overall Study|Death|2
4709831|NCT02880761|7635022|FG000|Overall Study|Death|6
4709832|NCT02880761|7635023|FG001|Overall Study|Death|8
4709833|NCT02880761|7635022|FG000|Overall Study|Withdrawal by Subject|3
4709834|NCT02880761|7635023|FG001|Overall Study|Withdrawal by Subject|6
4709835|NCT02880761|7635022|FG000|Overall Study|Protocol Violation|4
4709836|NCT02880761|7635023|FG001|Overall Study|Protocol Violation|3
4709837|NCT02880761|7635022|FG000|Overall Study|Lost to Follow-up|3
4709838|NCT02880761|7635023|FG001|Overall Study|Lost to Follow-up|4
4709839|NCT02880865|7635035|FG000|Overall Study|Adverse Event|1
4709840|NCT02880865|7635036|FG001|Overall Study|Adverse Event|0
4709841|NCT02880865|7635035|FG000|Overall Study|Withdrawal by Subject|0
4709842|NCT02880865|7635036|FG001|Overall Study|Withdrawal by Subject|2
4709843|NCT02880865|7635035|FG000|Overall Study|Physician Decision|0
4709844|NCT02880865|7635036|FG001|Overall Study|Physician Decision|1
4709845|NCT02881047|7635091|FG000|Overall Study|Adverse Event|1
4709846|NCT02881047|7635091|FG000|Overall Study|Withdrawal by Subject|1
4709847|NCT02881567|7635099|FG000|Overall Study|Adverse Event|1
4709848|NCT02881567|7635099|FG000|Overall Study|Lost to Follow-up|3
4709849|NCT02881567|7635099|FG000|Overall Study|Consent withdrawn|1
4709850|NCT02881567|7635099|FG000|Overall Study|Investigator decision|1
4709851|NCT02881567|7635099|FG000|Overall Study|Study terminated by sponsor|9
4628247|NCT01858701|7495282|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1
4628248|NCT01858701|7495281|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1
4628249|NCT01858701|7495282|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0
4709852|NCT02881567|7635099|FG000|Overall Study|Reason not Specified|3
4709853|NCT02881957|7635127|FG000|Overall Study|Comfort care|0
4709854|NCT02881957|7635128|FG001|Overall Study|Comfort care|1
4389325|NCT00069095|7168015|FG000|Post-study Treatment Phase|Eligible for surgery|2
4389326|NCT00069095|7168016|FG001|Post-study Treatment Phase|Eligible for surgery|0
4389327|NCT00069095|7168017|FG002|Post-study Treatment Phase|Eligible for surgery|0
4389328|NCT00069095|7168018|FG003|Post-study Treatment Phase|Eligible for surgery|0
4389329|NCT00069095|7168019|FG004|Post-study Treatment Phase|Eligible for surgery|0
4389330|NCT00069095|7168020|FG005|Post-study Treatment Phase|Eligible for surgery|0
4389331|NCT00069095|7168015|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1
4389332|NCT00069095|7168016|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4
4389333|NCT00069095|7168017|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5
4389334|NCT00069095|7168018|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6
4389335|NCT00069095|7168019|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7
4389336|NCT00069095|7168020|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9
4389337|NCT00069095|7168015|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1
4389338|NCT00069095|7168016|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0
4389339|NCT00069095|7168017|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0
4389340|NCT00069095|7168018|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0
4389341|NCT00069095|7168019|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0
4389342|NCT00069095|7168020|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1
4389343|NCT00069095|7168015|FG000|Post-study Treatment Phase|Participant had complete response|1
4389344|NCT00069095|7168016|FG001|Post-study Treatment Phase|Participant had complete response|1
4389345|NCT00069095|7168017|FG002|Post-study Treatment Phase|Participant had complete response|0
4389346|NCT00069095|7168018|FG003|Post-study Treatment Phase|Participant had complete response|0
4389347|NCT00069095|7168019|FG004|Post-study Treatment Phase|Participant had complete response|0
4389348|NCT00069095|7168020|FG005|Post-study Treatment Phase|Participant had complete response|0
4389349|NCT00069095|7168015|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0
4389350|NCT00069095|7168016|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1
4389351|NCT00069095|7168017|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0
4389352|NCT00069095|7168018|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0
4389353|NCT00069095|7168019|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0
4389354|NCT00069095|7168020|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0
4389355|NCT00069095|7168015|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0
4389356|NCT00069095|7168016|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1
4389357|NCT00069095|7168017|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1
4389358|NCT00069095|7168018|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0
4389359|NCT00069095|7168019|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1
4389360|NCT00069095|7168020|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0
4389361|NCT00069095|7168015|FG000|Post-study Treatment Phase|Participant withdrew consent|0
4389362|NCT00069095|7168016|FG001|Post-study Treatment Phase|Participant withdrew consent|0
4389363|NCT00069095|7168017|FG002|Post-study Treatment Phase|Participant withdrew consent|1
4389364|NCT00069095|7168018|FG003|Post-study Treatment Phase|Participant withdrew consent|0
4389365|NCT00069095|7168019|FG004|Post-study Treatment Phase|Participant withdrew consent|0
4389366|NCT00069095|7168020|FG005|Post-study Treatment Phase|Participant withdrew consent|0
4389367|NCT00069095|7168015|FG000|Post-study Treatment Phase|Participant will start new treatment|0
4389368|NCT00069095|7168016|FG001|Post-study Treatment Phase|Participant will start new treatment|0
4389369|NCT00069095|7168017|FG002|Post-study Treatment Phase|Participant will start new treatment|1
4389370|NCT00069095|7168018|FG003|Post-study Treatment Phase|Participant will start new treatment|0
4389371|NCT00069095|7168019|FG004|Post-study Treatment Phase|Participant will start new treatment|0
4389372|NCT00069095|7168020|FG005|Post-study Treatment Phase|Participant will start new treatment|0
4389373|NCT00069095|7168015|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0
4389374|NCT00069095|7168016|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0
4389375|NCT00069095|7168017|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0
4389376|NCT00069095|7168018|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1
4389377|NCT00069095|7168019|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0
4389378|NCT00069095|7168020|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0
4628250|NCT01858701|7495281|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1
4628251|NCT01858701|7495282|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2
4628252|NCT01858701|7495281|FG000|Period 2, Second 30 Days of Wear|Comfort|0
4628253|NCT01858701|7495282|FG001|Period 2, Second 30 Days of Wear|Comfort|1
4628254|NCT01858766|7495316|FG000|Overall Study|Randomized but Never Treated|0
4628255|NCT01858766|7495317|FG001|Overall Study|Randomized but Never Treated|0
4628256|NCT01858766|7495318|FG002|Overall Study|Randomized but Never Treated|0
4628257|NCT01858766|7495319|FG003|Overall Study|Randomized but Never Treated|0
4628258|NCT01858766|7495320|FG004|Overall Study|Randomized but Never Treated|0
4628259|NCT01858766|7495321|FG005|Overall Study|Randomized but Never Treated|1
4709855|NCT02881957|7635127|FG000|Overall Study|Concurrent trial enrollment|0
4709856|NCT02881957|7635128|FG001|Overall Study|Concurrent trial enrollment|1
4709857|NCT02881957|7635127|FG000|Overall Study|Discharged within 48 hours|0
4628260|NCT01858766|7495322|FG006|Overall Study|Randomized but Never Treated|0
4628261|NCT01858766|7495323|FG007|Overall Study|Randomized but Never Treated|0
4628262|NCT01858766|7495324|FG008|Overall Study|Randomized but Never Treated|0
4628263|NCT01858766|7495325|FG009|Overall Study|Randomized but Never Treated|0
4628264|NCT01858766|7495326|FG010|Overall Study|Randomized but Never Treated|0
4628265|NCT01858766|7495327|FG011|Overall Study|Randomized but Never Treated|0
4628266|NCT01858766|7495328|FG012|Overall Study|Randomized but Never Treated|0
4628267|NCT01858766|7495329|FG013|Overall Study|Randomized but Never Treated|0
4628268|NCT01858766|7495330|FG014|Overall Study|Randomized but Never Treated|0
4628269|NCT01858766|7495331|FG015|Overall Study|Randomized but Never Treated|0
4628270|NCT01858766|7495332|FG016|Overall Study|Randomized but Never Treated|0
4628271|NCT01858766|7495333|FG017|Overall Study|Randomized but Never Treated|1
4628272|NCT01858766|7495334|FG018|Overall Study|Randomized but Never Treated|0
4628273|NCT01858766|7495316|FG000|Overall Study|Death|0
4628274|NCT01858766|7495317|FG001|Overall Study|Death|0
4628275|NCT01858766|7495318|FG002|Overall Study|Death|1
4628276|NCT01858766|7495319|FG003|Overall Study|Death|0
4628277|NCT01858766|7495320|FG004|Overall Study|Death|0
4628278|NCT01858766|7495321|FG005|Overall Study|Death|0
4628279|NCT01858766|7495322|FG006|Overall Study|Death|0
4628280|NCT01858766|7495323|FG007|Overall Study|Death|0
4628281|NCT01858766|7495324|FG008|Overall Study|Death|0
4709858|NCT02881957|7635128|FG001|Overall Study|Discharged within 48 hours|1
4709859|NCT02881957|7635127|FG000|Overall Study|Withdrawal by Subject|2
4709860|NCT02881957|7635128|FG001|Overall Study|Withdrawal by Subject|1
4709861|NCT02881957|7635127|FG000|Overall Study|Protocol Violation|1
4709862|NCT02881957|7635128|FG001|Overall Study|Protocol Violation|0
4709863|NCT02882152|7635145|FG000|Overall Study|Lost to Follow-up|1
4709864|NCT02882152|7635146|FG001|Overall Study|Lost to Follow-up|0
4709865|NCT02882854|7635171|FG000|Overall Study|Lost to Follow-up|1
4709866|NCT02882854|7635172|FG001|Overall Study|Lost to Follow-up|2
4709867|NCT02882854|7635171|FG000|Overall Study|Physician Decision|0
4709868|NCT02882854|7635172|FG001|Overall Study|Physician Decision|1
4709869|NCT02883244|7635180|FG000|Overall Study|Lost to Follow-up|0
4709870|NCT02883244|7635181|FG001|Overall Study|Lost to Follow-up|1
4709871|NCT02883452|7635193|FG000|Overall Study|Withdrawal by Subject|1
4709872|NCT02883452|7635194|FG001|Overall Study|Withdrawal by Subject|1
4709873|NCT02883452|7635195|FG002|Overall Study|Withdrawal by Subject|3
4709874|NCT02883452|7635196|FG003|Overall Study|Withdrawal by Subject|0
4709875|NCT02883452|7635197|FG004|Overall Study|Withdrawal by Subject|2
4709876|NCT02883452|7635198|FG005|Overall Study|Withdrawal by Subject|5
4709877|NCT02883452|7635193|FG000|Overall Study|Disease progression|1
4709878|NCT02883452|7635194|FG001|Overall Study|Disease progression|0
4709879|NCT02883452|7635195|FG002|Overall Study|Disease progression|0
4709880|NCT02883452|7635196|FG003|Overall Study|Disease progression|1
4709881|NCT02883452|7635197|FG004|Overall Study|Disease progression|4
4709882|NCT02883452|7635198|FG005|Overall Study|Disease progression|5
4709883|NCT02883452|7635193|FG000|Overall Study|Adverse Event|2
4709884|NCT02883452|7635194|FG001|Overall Study|Adverse Event|1
4709885|NCT02883452|7635195|FG002|Overall Study|Adverse Event|1
4709886|NCT02883452|7635196|FG003|Overall Study|Adverse Event|1
4709887|NCT02883452|7635197|FG004|Overall Study|Adverse Event|1
4709888|NCT02883452|7635198|FG005|Overall Study|Adverse Event|3
4709889|NCT02883452|7635193|FG000|Overall Study|Physician Decision|0
4709890|NCT02883452|7635194|FG001|Overall Study|Physician Decision|0
4709891|NCT02883452|7635195|FG002|Overall Study|Physician Decision|0
4709892|NCT02883452|7635196|FG003|Overall Study|Physician Decision|0
4709893|NCT02883452|7635197|FG004|Overall Study|Physician Decision|4
4709894|NCT02883452|7635198|FG005|Overall Study|Physician Decision|1
4709895|NCT02883452|7635193|FG000|Overall Study|Death|1
4709896|NCT02883452|7635194|FG001|Overall Study|Death|0
4709897|NCT02883452|7635195|FG002|Overall Study|Death|1
4709898|NCT02883452|7635196|FG003|Overall Study|Death|0
4709899|NCT02883452|7635197|FG004|Overall Study|Death|0
4709900|NCT02883452|7635198|FG005|Overall Study|Death|0
4709901|NCT02883452|7635193|FG000|Overall Study|Other|0
4709902|NCT02883452|7635194|FG001|Overall Study|Other|0
4709903|NCT02883452|7635195|FG002|Overall Study|Other|0
4709904|NCT02883452|7635196|FG003|Overall Study|Other|0
4709905|NCT02883452|7635197|FG004|Overall Study|Other|0
4709906|NCT02883452|7635198|FG005|Overall Study|Other|1
4709907|NCT02884089|7635213|FG000|Period 1|Dosing error|2
4709908|NCT02884089|7635214|FG001|Period 1|Dosing error|2
4709909|NCT02884089|7635215|FG002|Period 1|Dosing error|0
4709910|NCT02884089|7635216|FG003|Period 1|Dosing error|0
4709911|NCT02884089|7635213|FG000|Washout Period 1|Lost to Follow-up|0
4709912|NCT02884089|7635214|FG001|Washout Period 1|Lost to Follow-up|1
4709913|NCT02884089|7635215|FG002|Washout Period 1|Lost to Follow-up|0
4709914|NCT02884089|7635216|FG003|Washout Period 1|Lost to Follow-up|1
4709915|NCT02884089|7635213|FG000|Washout Period 1|Withdrawal by Subject|0
4709916|NCT02884089|7635214|FG001|Washout Period 1|Withdrawal by Subject|1
4709917|NCT02884089|7635215|FG002|Washout Period 1|Withdrawal by Subject|0
4628282|NCT01858766|7495325|FG009|Overall Study|Death|0
4709918|NCT02884089|7635216|FG003|Washout Period 1|Withdrawal by Subject|0
4709919|NCT02884089|7635213|FG000|Period 2|Adverse Event|1
4389379|NCT00069095|7168015|FG000|Post-study Treatment Phase|Participant completed treatment|0
4389380|NCT00069095|7168016|FG001|Post-study Treatment Phase|Participant completed treatment|0
4389381|NCT00069095|7168017|FG002|Post-study Treatment Phase|Participant completed treatment|0
4389382|NCT00069095|7168018|FG003|Post-study Treatment Phase|Participant completed treatment|1
4389383|NCT00069095|7168019|FG004|Post-study Treatment Phase|Participant completed treatment|0
4389384|NCT00069095|7168020|FG005|Post-study Treatment Phase|Participant completed treatment|0
4389385|NCT00069095|7168015|FG000|Post-study Treatment Phase|Surgery|0
4389386|NCT00069095|7168016|FG001|Post-study Treatment Phase|Surgery|0
4389387|NCT00069095|7168017|FG002|Post-study Treatment Phase|Surgery|0
4389388|NCT00069095|7168018|FG003|Post-study Treatment Phase|Surgery|1
4389389|NCT00069095|7168019|FG004|Post-study Treatment Phase|Surgery|1
4389390|NCT00069095|7168020|FG005|Post-study Treatment Phase|Surgery|0
4389391|NCT00069095|7168015|FG000|Post-study Treatment Phase|Death|0
4389392|NCT00069095|7168016|FG001|Post-study Treatment Phase|Death|0
4389393|NCT00069095|7168017|FG002|Post-study Treatment Phase|Death|0
4389394|NCT00069095|7168018|FG003|Post-study Treatment Phase|Death|0
4389395|NCT00069095|7168019|FG004|Post-study Treatment Phase|Death|1
4389396|NCT00069095|7168020|FG005|Post-study Treatment Phase|Death|0
4389397|NCT00069095|7168015|FG000|Post-study Treatment Phase|Participant had progressive disease|0
4389398|NCT00069095|7168016|FG001|Post-study Treatment Phase|Participant had progressive disease|0
4389399|NCT00069095|7168017|FG002|Post-study Treatment Phase|Participant had progressive disease|0
4389400|NCT00069095|7168018|FG003|Post-study Treatment Phase|Participant had progressive disease|0
4389401|NCT00069095|7168019|FG004|Post-study Treatment Phase|Participant had progressive disease|1
4389402|NCT00069095|7168020|FG005|Post-study Treatment Phase|Participant had progressive disease|0
4389403|NCT00069095|7168015|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0
4389404|NCT00069095|7168016|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0
4389405|NCT00069095|7168017|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0
4389406|NCT00069095|7168018|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0
4389407|NCT00069095|7168019|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1
4389408|NCT00069095|7168020|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0
4389409|NCT00069095|7168015|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
4389410|NCT00069095|7168016|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
4389411|NCT00069095|7168017|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
4389412|NCT00069095|7168018|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
4389413|NCT00069095|7168019|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1
4389414|NCT00069095|7168020|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
4389415|NCT00069095|7168015|FG000|Post-study Treatment Phase|Investigator decision|0
4389416|NCT00069095|7168016|FG001|Post-study Treatment Phase|Investigator decision|0
4389417|NCT00069095|7168017|FG002|Post-study Treatment Phase|Investigator decision|0
4709920|NCT02884089|7635214|FG001|Period 2|Adverse Event|0
4709921|NCT02884089|7635215|FG002|Period 2|Adverse Event|0
4709922|NCT02884089|7635216|FG003|Period 2|Adverse Event|0
4709923|NCT02884089|7635213|FG000|Period 3|Withdrawal by Subject|0
4709924|NCT02884089|7635214|FG001|Period 3|Withdrawal by Subject|0
4709925|NCT02884089|7635215|FG002|Period 3|Withdrawal by Subject|1
4709926|NCT02884089|7635216|FG003|Period 3|Withdrawal by Subject|0
4709927|NCT02884089|7635213|FG000|Washout Period 3|Withdrawal by Subject|0
4709928|NCT02884089|7635214|FG001|Washout Period 3|Withdrawal by Subject|0
4709929|NCT02884089|7635215|FG002|Washout Period 3|Withdrawal by Subject|1
4709930|NCT02884089|7635216|FG003|Washout Period 3|Withdrawal by Subject|0
4709931|NCT02884089|7635213|FG000|Washout Period 3|Lost to Follow-up|0
4709932|NCT02884089|7635214|FG001|Washout Period 3|Lost to Follow-up|0
4709933|NCT02884089|7635215|FG002|Washout Period 3|Lost to Follow-up|0
4709934|NCT02884089|7635216|FG003|Washout Period 3|Lost to Follow-up|1
4709935|NCT02884089|7635213|FG000|Period 4|Withdrawal by Subject|0
4709936|NCT02884089|7635214|FG001|Period 4|Withdrawal by Subject|1
4709937|NCT02884089|7635215|FG002|Period 4|Withdrawal by Subject|0
4709938|NCT02884089|7635216|FG003|Period 4|Withdrawal by Subject|0
4709939|NCT02884089|7635213|FG000|Period 4|Lost to Follow-up|1
4709940|NCT02884089|7635214|FG001|Period 4|Lost to Follow-up|0
4709941|NCT02884089|7635215|FG002|Period 4|Lost to Follow-up|0
4709942|NCT02884089|7635216|FG003|Period 4|Lost to Follow-up|0
4709943|NCT02884089|7635213|FG000|Follow-up Visit|Withdrawal by Subject|1
4709944|NCT02884089|7635214|FG001|Follow-up Visit|Withdrawal by Subject|0
4709945|NCT02884089|7635215|FG002|Follow-up Visit|Withdrawal by Subject|0
4709946|NCT02884089|7635216|FG003|Follow-up Visit|Withdrawal by Subject|1
4709947|NCT02885181|7635286|FG000|Overall Study|Investigator's Discretion|0
4709948|NCT02885181|7635287|FG001|Overall Study|Investigator's Discretion|1
4709949|NCT02885181|7635288|FG002|Overall Study|Investigator's Discretion|0
4709950|NCT02885181|7635289|FG003|Overall Study|Investigator's Discretion|1
4709951|NCT02885181|7635286|FG000|Overall Study|Adverse Event|0
4709952|NCT02885181|7635287|FG001|Overall Study|Adverse Event|0
4709953|NCT02885181|7635288|FG002|Overall Study|Adverse Event|0
4709954|NCT02885181|7635289|FG003|Overall Study|Adverse Event|1
4709955|NCT02885181|7635286|FG000|Overall Study|Withdrawal by Subject|0
4709956|NCT02885181|7635287|FG001|Overall Study|Withdrawal by Subject|0
4709957|NCT02885181|7635288|FG002|Overall Study|Withdrawal by Subject|0
4709958|NCT02885181|7635289|FG003|Overall Study|Withdrawal by Subject|1
4735871|NCT03547635|7684386|FG000|Overall Study|Lost to Follow-up|1
4735872|NCT03547635|7684387|FG001|Overall Study|Lost to Follow-up|3
4735873|NCT03547635|7684388|FG002|Overall Study|Lost to Follow-up|4
4735874|NCT03547635|7684386|FG000|Overall Study|Withdrawal by Subject|1
4735875|NCT03547635|7684387|FG001|Overall Study|Withdrawal by Subject|0
4735876|NCT03547635|7684388|FG002|Overall Study|Withdrawal by Subject|0
4735877|NCT03547635|7684386|FG000|Overall Study|Withdrawal By PI|0
4735878|NCT03547635|7684387|FG001|Overall Study|Withdrawal By PI|1
4735879|NCT03547635|7684388|FG002|Overall Study|Withdrawal By PI|0
4735880|NCT03547635|7684386|FG000|Overall Study|Withdrawal by Sponsor|0
4735881|NCT03547635|7684387|FG001|Overall Study|Withdrawal by Sponsor|0
4735882|NCT03547635|7684388|FG002|Overall Study|Withdrawal by Sponsor|1
4735883|NCT03547635|7684386|FG000|Overall Study|Errant Randomization before Treatment|0
4735884|NCT03547635|7684387|FG001|Overall Study|Errant Randomization before Treatment|1
4735885|NCT03547635|7684388|FG002|Overall Study|Errant Randomization before Treatment|0
4735886|NCT03547635|7684386|FG000|Overall Study|Withdrawal by Subject|1
4735887|NCT03547635|7684387|FG001|Overall Study|Withdrawal by Subject|0
4735888|NCT03547635|7684388|FG002|Overall Study|Withdrawal by Subject|0
4735889|NCT03547687|7684396|FG000|Overall Study|Withdrawal by Subject|1
4735890|NCT03547687|7684396|FG000|Overall Study|Death|1
4735891|NCT03548337|7684402|FG000|Infant Series|Withdrawal by Parent/Guardian|8
4735892|NCT03548337|7684403|FG001|Infant Series|Withdrawal by Parent/Guardian|8
4735893|NCT03548337|7684402|FG000|Infant Series|No Longer Met Eligibility Criteria|1
4735894|NCT03548337|7684403|FG001|Infant Series|No Longer Met Eligibility Criteria|0
4735895|NCT03548337|7684402|FG000|Infant Series|Lost to Follow-up|2
4735896|NCT03548337|7684403|FG001|Infant Series|Lost to Follow-up|1
4735897|NCT03548337|7684402|FG000|Infant Series|Adverse Event|0
4735898|NCT03548337|7684403|FG001|Infant Series|Adverse Event|2
4735899|NCT03548337|7684402|FG000|Infant Series|Randomized but Not Vaccinated|1
4735900|NCT03548337|7684403|FG001|Infant Series|Randomized but Not Vaccinated|0
4735901|NCT03548337|7684402|FG000|Toddler Dose|Withdrawal by parent/guardian|1
4735902|NCT03548337|7684403|FG001|Toddler Dose|Withdrawal by parent/guardian|1
4735903|NCT03548935|7684417|FG000|Overall Study|Withdrawal by Subject|26
4735904|NCT03548935|7684418|FG001|Overall Study|Withdrawal by Subject|17
4735905|NCT03548935|7684417|FG000|Overall Study|Lost to Follow-up|39
4735906|NCT03548935|7684418|FG001|Overall Study|Lost to Follow-up|28
4735907|NCT03548935|7684417|FG000|Overall Study|Death|1
4735908|NCT03548935|7684418|FG001|Overall Study|Death|1
4735909|NCT03549117|7684426|FG000|Overall Study|Withdrawal by Subject|1
4735910|NCT03549117|7684427|FG001|Overall Study|Withdrawal by Subject|0
4735911|NCT03549130|7684435|FG000|Overall Study|Adverse Event|0
4735912|NCT03549130|7684436|FG001|Overall Study|Adverse Event|1
4735913|NCT03549130|7684435|FG000|Overall Study|Lost to Follow-up|0
4735914|NCT03549130|7684436|FG001|Overall Study|Lost to Follow-up|1
4735915|NCT03549338|7684456|FG000|Overall Study|Progressive Disease|1
4735916|NCT03549338|7684457|FG001|Overall Study|Progressive Disease|0
4735917|NCT03549338|7684458|FG002|Overall Study|Progressive Disease|0
4735918|NCT03549338|7684456|FG000|Overall Study|Clinical Progression|0
4389418|NCT00069095|7168018|FG003|Post-study Treatment Phase|Investigator decision|0
4510673|NCT00922272|7319560|FG001|Open-label Phase|Failure to meet randomization criteria|0
4510674|NCT00922272|7319559|FG000|Open-label Phase|Withdrawal criteria met|5
4735919|NCT03549338|7684457|FG001|Overall Study|Clinical Progression|1
4735920|NCT03549338|7684458|FG002|Overall Study|Clinical Progression|0
4735921|NCT03549429|7684466|FG000|Overall Study|Protocol Violation|5
4735922|NCT03549429|7684467|FG001|Overall Study|Protocol Violation|3
4735923|NCT03550209|7684494|FG000|Overall Study|Lost to Follow-up|1
4735924|NCT03550209|7684495|FG001|Overall Study|Lost to Follow-up|0
4735925|NCT03550209|7684496|FG002|Overall Study|Lost to Follow-up|1
4735926|NCT03550209|7684497|FG003|Overall Study|Lost to Follow-up|0
4735927|NCT03550209|7684494|FG000|Overall Study|Withdrawal by Subject|0
4735928|NCT03550209|7684495|FG001|Overall Study|Withdrawal by Subject|3
4735929|NCT03550209|7684496|FG002|Overall Study|Withdrawal by Subject|1
4735930|NCT03550209|7684497|FG003|Overall Study|Withdrawal by Subject|2
4735931|NCT03550209|7684494|FG000|Overall Study|Excluded due to ineligibility after randomization|0
4735932|NCT03550209|7684495|FG001|Overall Study|Excluded due to ineligibility after randomization|0
4735933|NCT03550209|7684496|FG002|Overall Study|Excluded due to ineligibility after randomization|0
4735934|NCT03550209|7684497|FG003|Overall Study|Excluded due to ineligibility after randomization|2
4735935|NCT03550313|7684510|FG000|Overall Study|Adverse Event|0
4735936|NCT03550313|7684511|FG001|Overall Study|Adverse Event|1
4735937|NCT03550313|7684512|FG002|Overall Study|Adverse Event|0
4735938|NCT03550313|7684510|FG000|Overall Study|Lost to Follow-up|5
4735939|NCT03550313|7684511|FG001|Overall Study|Lost to Follow-up|7
4735940|NCT03550313|7684512|FG002|Overall Study|Lost to Follow-up|12
4510675|NCT00922272|7319560|FG001|Open-label Phase|Withdrawal criteria met|0
4735941|NCT03550313|7684510|FG000|Overall Study|Study terminated by sponsor|44
4735942|NCT03550313|7684511|FG001|Overall Study|Study terminated by sponsor|37
4735943|NCT03550313|7684512|FG002|Overall Study|Study terminated by sponsor|48
4735944|NCT03550313|7684510|FG000|Overall Study|No longer met eligibility criteria|3
4735945|NCT03550313|7684511|FG001|Overall Study|No longer met eligibility criteria|5
4709959|NCT02886338|7635385|FG000|Overall Study|Withdrawal by Subject|1
4709960|NCT02886494|7635391|FG000|Overall Study|Adverse Event|1
4709961|NCT02886494|7635392|FG001|Overall Study|Adverse Event|0
4709962|NCT02886494|7635391|FG000|Overall Study|Withdrawal by Subject|12
4709963|NCT02886494|7635392|FG001|Overall Study|Withdrawal by Subject|3
4709964|NCT02886494|7635391|FG000|Overall Study|Protocol Violation|4
4709965|NCT02886494|7635392|FG001|Overall Study|Protocol Violation|1
4709966|NCT02886624|7635401|FG000|12-week Post Treatment Follow-up|Death|1
4709967|NCT02886624|7635401|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1
4709968|NCT02886702|7635408|FG000|Overall Study|Other|4
4709969|NCT02886702|7635409|FG001|Overall Study|Other|3
4709970|NCT02886702|7635410|FG002|Overall Study|Other|9
4709971|NCT02886702|7635408|FG000|Overall Study|Withdrawal by Subject|24
4709972|NCT02886702|7635409|FG001|Overall Study|Withdrawal by Subject|18
4709973|NCT02886702|7635410|FG002|Overall Study|Withdrawal by Subject|22
4709974|NCT02886702|7635408|FG000|Overall Study|Significant Worsening of Condition|0
4709975|NCT02886702|7635409|FG001|Overall Study|Significant Worsening of Condition|1
4709976|NCT02886702|7635410|FG002|Overall Study|Significant Worsening of Condition|0
4709977|NCT02886702|7635408|FG000|Overall Study|Protocol Violation|2
4709978|NCT02886702|7635409|FG001|Overall Study|Protocol Violation|2
4709979|NCT02886702|7635410|FG002|Overall Study|Protocol Violation|1
4709980|NCT02886702|7635408|FG000|Overall Study|Non-Compliance With Study Drug|0
4709981|NCT02886702|7635409|FG001|Overall Study|Non-Compliance With Study Drug|1
4709982|NCT02886702|7635410|FG002|Overall Study|Non-Compliance With Study Drug|4
4709983|NCT02886702|7635408|FG000|Overall Study|Lost to Follow-up|11
4709984|NCT02886702|7635409|FG001|Overall Study|Lost to Follow-up|13
4709985|NCT02886702|7635410|FG002|Overall Study|Lost to Follow-up|8
4709986|NCT02886702|7635408|FG000|Overall Study|Lack of Efficacy|3
4709987|NCT02886702|7635409|FG001|Overall Study|Lack of Efficacy|4
4709988|NCT02886702|7635410|FG002|Overall Study|Lack of Efficacy|5
4709989|NCT02886702|7635408|FG000|Overall Study|Adverse Event|4
4709990|NCT02886702|7635409|FG001|Overall Study|Adverse Event|9
4709991|NCT02886702|7635410|FG002|Overall Study|Adverse Event|3
4709992|NCT02886702|7635408|FG000|Overall Study|Administrative Reasons|0
4709993|NCT02886702|7635409|FG001|Overall Study|Administrative Reasons|0
4709994|NCT02886702|7635410|FG002|Overall Study|Administrative Reasons|1
4709995|NCT02886715|7635421|FG000|Overall Study|Non-Compliance With Study Drug|0
4709996|NCT02886715|7635422|FG001|Overall Study|Non-Compliance With Study Drug|2
4709997|NCT02886715|7635423|FG002|Overall Study|Non-Compliance With Study Drug|0
4709998|NCT02886715|7635421|FG000|Overall Study|Adverse Event|4
4709999|NCT02886715|7635422|FG001|Overall Study|Adverse Event|2
4710000|NCT02886715|7635423|FG002|Overall Study|Adverse Event|0
4710001|NCT02886715|7635421|FG000|Overall Study|Lack of Efficacy|0
4710002|NCT02886715|7635422|FG001|Overall Study|Lack of Efficacy|2
4710003|NCT02886715|7635423|FG002|Overall Study|Lack of Efficacy|1
4710004|NCT02886715|7635421|FG000|Overall Study|Lost to Follow-up|29
4710005|NCT02886715|7635422|FG001|Overall Study|Lost to Follow-up|26
4710006|NCT02886715|7635423|FG002|Overall Study|Lost to Follow-up|10
4710007|NCT02886715|7635421|FG000|Overall Study|Pregnancy|1
4710008|NCT02886715|7635422|FG001|Overall Study|Pregnancy|1
4710009|NCT02886715|7635423|FG002|Overall Study|Pregnancy|1
4710010|NCT02886715|7635421|FG000|Overall Study|Protocol Violation|3
4710011|NCT02886715|7635422|FG001|Overall Study|Protocol Violation|2
4710012|NCT02886715|7635423|FG002|Overall Study|Protocol Violation|1
4710013|NCT02886715|7635421|FG000|Overall Study|Withdrawal by Subject|20
4710014|NCT02886715|7635422|FG001|Overall Study|Withdrawal by Subject|18
4710015|NCT02886715|7635423|FG002|Overall Study|Withdrawal by Subject|5
4710016|NCT02886715|7635421|FG000|Overall Study|missing|7
4710017|NCT02886715|7635422|FG001|Overall Study|missing|2
4710018|NCT02886715|7635423|FG002|Overall Study|missing|2
4710019|NCT02886728|7635435|FG000|Overall Study|Withdrew Consent|31
4710020|NCT02886728|7635436|FG001|Overall Study|Withdrew Consent|13
4710021|NCT02886728|7635437|FG002|Overall Study|Withdrew Consent|11
4710022|NCT02886728|7635438|FG003|Overall Study|Withdrew Consent|47
4710023|NCT02886728|7635435|FG000|Overall Study|Lost to Follow-up|12
4710024|NCT02886728|7635436|FG001|Overall Study|Lost to Follow-up|6
4710025|NCT02886728|7635437|FG002|Overall Study|Lost to Follow-up|13
4710026|NCT02886728|7635438|FG003|Overall Study|Lost to Follow-up|12
4710027|NCT02886728|7635435|FG000|Overall Study|Adverse Event|13
4710028|NCT02886728|7635436|FG001|Overall Study|Adverse Event|5
4710029|NCT02886728|7635437|FG002|Overall Study|Adverse Event|5
4710030|NCT02886728|7635438|FG003|Overall Study|Adverse Event|11
4389419|NCT00069095|7168019|FG004|Post-study Treatment Phase|Investigator decision|0
4710031|NCT02886728|7635435|FG000|Overall Study|Investigator's Discretion|11
4710032|NCT02886728|7635436|FG001|Overall Study|Investigator's Discretion|7
4710033|NCT02886728|7635437|FG002|Overall Study|Investigator's Discretion|5
4710034|NCT02886728|7635438|FG003|Overall Study|Investigator's Discretion|11
4710035|NCT02886728|7635435|FG000|Overall Study|Death|3
4710036|NCT02886728|7635436|FG001|Overall Study|Death|1
4710037|NCT02886728|7635437|FG002|Overall Study|Death|0
4710038|NCT02886728|7635438|FG003|Overall Study|Death|0
4710039|NCT02886728|7635435|FG000|Overall Study|Protocol Violation|0
4710040|NCT02886728|7635436|FG001|Overall Study|Protocol Violation|0
4710041|NCT02886728|7635437|FG002|Overall Study|Protocol Violation|0
4710042|NCT02886728|7635438|FG003|Overall Study|Protocol Violation|4
4710043|NCT02886728|7635435|FG000|Overall Study|Non-Compliance with Study Drug|1
4710044|NCT02886728|7635436|FG001|Overall Study|Non-Compliance with Study Drug|0
4710045|NCT02886728|7635437|FG002|Overall Study|Non-Compliance with Study Drug|1
4710046|NCT02886728|7635438|FG003|Overall Study|Non-Compliance with Study Drug|0
4710047|NCT02886728|7635435|FG000|Overall Study|Pregnancy|0
4710048|NCT02886728|7635436|FG001|Overall Study|Pregnancy|0
4710049|NCT02886728|7635437|FG002|Overall Study|Pregnancy|1
4710050|NCT02886728|7635438|FG003|Overall Study|Pregnancy|0
4710051|NCT02886728|7635435|FG000|Overall Study|Randomized but Not Dosed|1
4710052|NCT02886728|7635436|FG001|Overall Study|Randomized but Not Dosed|0
4710053|NCT02886728|7635437|FG002|Overall Study|Randomized but Not Dosed|0
4710054|NCT02886728|7635438|FG003|Overall Study|Randomized but Not Dosed|2
4710055|NCT02887183|7635455|FG000|Overall Study|Adverse Event|44
4710056|NCT02887183|7635455|FG000|Overall Study|Death|30
4389420|NCT00069095|7168020|FG005|Post-study Treatment Phase|Investigator decision|1
4389421|NCT00069095|7168015|FG000|Follow-up Phase|Death|174
4389422|NCT00069095|7168016|FG001|Follow-up Phase|Death|206
4389423|NCT00069095|7168017|FG002|Follow-up Phase|Death|120
4389424|NCT00069095|7168018|FG003|Follow-up Phase|Death|112
4710057|NCT02887183|7635455|FG000|Overall Study|Pregnancy|1
4710058|NCT02887183|7635455|FG000|Overall Study|Protocol Violation|6
4710059|NCT02887183|7635455|FG000|Overall Study|Technical Problems|2
4710060|NCT02887183|7635455|FG000|Overall Study|Lost to Follow-up|13
4710061|NCT02887183|7635455|FG000|Overall Study|Physician Decision|10
4710062|NCT02887183|7635455|FG000|Overall Study|Withdrawal by Subject|35
4710063|NCT02887521|7635471|FG000|Overall Study|Withdrawal by Subject|0
4710064|NCT02887521|7635472|FG001|Overall Study|Withdrawal by Subject|3
4710065|NCT02887989|7635480|FG000|Overall Study|Withdrawal by Subject|8
4710066|NCT02887989|7635481|FG001|Overall Study|Withdrawal by Subject|11
4710067|NCT02887989|7635480|FG000|Overall Study|Death|1
4710068|NCT02887989|7635481|FG001|Overall Study|Death|0
4710069|NCT02888080|7635489|FG000|Overall Study|Subject / Guardian decision|1
4710070|NCT02888080|7635490|FG001|Overall Study|Subject / Guardian decision|3
4710071|NCT02888080|7635489|FG000|Overall Study|New Therapy for study indication|1
4710072|NCT02888080|7635490|FG001|Overall Study|New Therapy for study indication|0
4710073|NCT02888080|7635489|FG000|Overall Study|Lack of Efficacy|0
4710074|NCT02888080|7635490|FG001|Overall Study|Lack of Efficacy|1
4710075|NCT02888080|7635489|FG000|Overall Study|Adverse Event|0
4710076|NCT02888080|7635490|FG001|Overall Study|Adverse Event|1
4710077|NCT02888106|7635513|FG000|Overall Study|Withdrawal by Subject|1
4710078|NCT02888106|7635514|FG001|Overall Study|Withdrawal by Subject|2
4710079|NCT02888106|7635515|FG002|Overall Study|Withdrawal by Subject|0
4710080|NCT02888106|7635516|FG003|Overall Study|Withdrawal by Subject|1
4710081|NCT02888106|7635517|FG004|Overall Study|Withdrawal by Subject|0
4710082|NCT02888106|7635518|FG005|Overall Study|Withdrawal by Subject|0
4710083|NCT02888106|7635513|FG000|Overall Study|Lost to Follow-up|1
4710084|NCT02888106|7635514|FG001|Overall Study|Lost to Follow-up|0
4710085|NCT02888106|7635515|FG002|Overall Study|Lost to Follow-up|0
4710086|NCT02888106|7635516|FG003|Overall Study|Lost to Follow-up|1
4710087|NCT02888106|7635517|FG004|Overall Study|Lost to Follow-up|0
4710088|NCT02888106|7635518|FG005|Overall Study|Lost to Follow-up|1
4710089|NCT02888106|7635513|FG000|Overall Study|Adverse Event|2
4710090|NCT02888106|7635514|FG001|Overall Study|Adverse Event|0
4710091|NCT02888106|7635515|FG002|Overall Study|Adverse Event|0
4710092|NCT02888106|7635516|FG003|Overall Study|Adverse Event|0
4710093|NCT02888106|7635517|FG004|Overall Study|Adverse Event|0
4710094|NCT02888106|7635518|FG005|Overall Study|Adverse Event|0
4710095|NCT02888106|7635513|FG000|Overall Study|Withdrawal of consent|0
4710096|NCT02888106|7635514|FG001|Overall Study|Withdrawal of consent|0
4710097|NCT02888106|7635515|FG002|Overall Study|Withdrawal of consent|0
4710098|NCT02888106|7635516|FG003|Overall Study|Withdrawal of consent|0
4710099|NCT02888106|7635517|FG004|Overall Study|Withdrawal of consent|1
4710100|NCT02888106|7635518|FG005|Overall Study|Withdrawal of consent|0
4710101|NCT02888106|7635513|FG000|Overall Study|Pregnancy|1
4710102|NCT02888106|7635514|FG001|Overall Study|Pregnancy|0
4710103|NCT02888106|7635515|FG002|Overall Study|Pregnancy|0
4771373|NCT02942277|7748238|FG008|Year 1|Lost to Follow-up|0
4771374|NCT02942277|7748239|FG009|Year 1|Lost to Follow-up|0
4389425|NCT00069095|7168019|FG004|Follow-up Phase|Death|92
4710104|NCT02888106|7635516|FG003|Overall Study|Pregnancy|0
4710105|NCT02888106|7635517|FG004|Overall Study|Pregnancy|0
4710106|NCT02888106|7635518|FG005|Overall Study|Pregnancy|0
4710107|NCT02888171|7635540|FG000|Overall Study|Lost to Follow-up|2
4710108|NCT02888171|7635541|FG001|Overall Study|Lost to Follow-up|1
4710109|NCT02888171|7635540|FG000|Overall Study|Withdrawal by Subject|3
4710110|NCT02888171|7635541|FG001|Overall Study|Withdrawal by Subject|2
4710111|NCT02888171|7635540|FG000|Overall Study|Adverse Event|0
4710112|NCT02888171|7635541|FG001|Overall Study|Adverse Event|1
4710113|NCT02888756|7635571|FG000|Analytical Treatment Interruption|Physician Decision|10
4710114|NCT02888756|7635572|FG001|Analytical Treatment Interruption|Physician Decision|6
4771375|NCT02942277|7748240|FG010|Year 1|Lost to Follow-up|2
4771376|NCT02942277|7748230|FG000|Year 1|Protocol Violation|0
4771377|NCT02942277|7748231|FG001|Year 1|Protocol Violation|0
4771378|NCT02942277|7748232|FG002|Year 1|Protocol Violation|0
4389426|NCT00069095|7168020|FG005|Follow-up Phase|Death|101
4771379|NCT02942277|7748233|FG003|Year 1|Protocol Violation|0
4710115|NCT02888756|7635573|FG002|Analytical Treatment Interruption|Physician Decision|5
4710116|NCT02889562|7635604|FG000|Overall Study|Physician Decision|0
4710117|NCT02889562|7635605|FG001|Overall Study|Physician Decision|1
4710118|NCT02889562|7635604|FG000|Overall Study|Withdrawal by Subject|0
4710119|NCT02889562|7635605|FG001|Overall Study|Withdrawal by Subject|1
4710120|NCT02889796|7635615|FG000|Overall Study|Withdrew Consent|18
4710121|NCT02889796|7635616|FG001|Overall Study|Withdrew Consent|29
4710122|NCT02889796|7635617|FG002|Overall Study|Withdrew Consent|20
4710123|NCT02889796|7635618|FG003|Overall Study|Withdrew Consent|1
4710124|NCT02889796|7635619|FG004|Overall Study|Withdrew Consent|2
4710125|NCT02889796|7635620|FG005|Overall Study|Withdrew Consent|35
4710126|NCT02889796|7635615|FG000|Overall Study|Investigator's Discretion|10
4710127|NCT02889796|7635616|FG001|Overall Study|Investigator's Discretion|9
4710128|NCT02889796|7635617|FG002|Overall Study|Investigator's Discretion|10
4710129|NCT02889796|7635618|FG003|Overall Study|Investigator's Discretion|3
4710130|NCT02889796|7635619|FG004|Overall Study|Investigator's Discretion|0
4710131|NCT02889796|7635620|FG005|Overall Study|Investigator's Discretion|15
4710132|NCT02889796|7635615|FG000|Overall Study|Adverse Event|17
4710133|NCT02889796|7635616|FG001|Overall Study|Adverse Event|8
4710134|NCT02889796|7635617|FG002|Overall Study|Adverse Event|8
4710135|NCT02889796|7635618|FG003|Overall Study|Adverse Event|4
4710136|NCT02889796|7635619|FG004|Overall Study|Adverse Event|1
4710137|NCT02889796|7635620|FG005|Overall Study|Adverse Event|7
4710138|NCT02889796|7635615|FG000|Overall Study|Lost to Follow-up|5
4710139|NCT02889796|7635616|FG001|Overall Study|Lost to Follow-up|7
4710140|NCT02889796|7635617|FG002|Overall Study|Lost to Follow-up|2
4710141|NCT02889796|7635618|FG003|Overall Study|Lost to Follow-up|0
4710142|NCT02889796|7635619|FG004|Overall Study|Lost to Follow-up|2
4710143|NCT02889796|7635620|FG005|Overall Study|Lost to Follow-up|6
4710144|NCT02889796|7635615|FG000|Overall Study|Protocol Violation|0
4710145|NCT02889796|7635616|FG001|Overall Study|Protocol Violation|1
4710146|NCT02889796|7635617|FG002|Overall Study|Protocol Violation|3
4710147|NCT02889796|7635618|FG003|Overall Study|Protocol Violation|0
4710148|NCT02889796|7635619|FG004|Overall Study|Protocol Violation|0
4710149|NCT02889796|7635620|FG005|Overall Study|Protocol Violation|4
4710150|NCT02889796|7635615|FG000|Overall Study|Non-compliance With Study Drug|0
4710151|NCT02889796|7635616|FG001|Overall Study|Non-compliance With Study Drug|2
4710152|NCT02889796|7635617|FG002|Overall Study|Non-compliance With Study Drug|0
4710153|NCT02889796|7635618|FG003|Overall Study|Non-compliance With Study Drug|0
4710154|NCT02889796|7635619|FG004|Overall Study|Non-compliance With Study Drug|1
4710155|NCT02889796|7635620|FG005|Overall Study|Non-compliance With Study Drug|2
4710156|NCT02889796|7635615|FG000|Overall Study|Death|1
4710157|NCT02889796|7635616|FG001|Overall Study|Death|1
4710158|NCT02889796|7635617|FG002|Overall Study|Death|0
4710159|NCT02889796|7635618|FG003|Overall Study|Death|1
4710160|NCT02889796|7635619|FG004|Overall Study|Death|0
4710161|NCT02889796|7635620|FG005|Overall Study|Death|1
4710162|NCT02889796|7635615|FG000|Overall Study|Pregnancy|0
4710163|NCT02889796|7635616|FG001|Overall Study|Pregnancy|1
4710164|NCT02889796|7635617|FG002|Overall Study|Pregnancy|1
4710165|NCT02889796|7635618|FG003|Overall Study|Pregnancy|0
4710166|NCT02889796|7635619|FG004|Overall Study|Pregnancy|0
4710167|NCT02889796|7635620|FG005|Overall Study|Pregnancy|0
4710168|NCT02889796|7635615|FG000|Overall Study|Randomized but not Dosed|2
4710169|NCT02889796|7635616|FG001|Overall Study|Randomized but not Dosed|0
4710170|NCT02889796|7635617|FG002|Overall Study|Randomized but not Dosed|0
4710171|NCT02889796|7635618|FG003|Overall Study|Randomized but not Dosed|0
4710172|NCT02889796|7635619|FG004|Overall Study|Randomized but not Dosed|0
4389427|NCT00069108|7168034|FG000|Overall Study|Withdrawal by Subject|5
4389428|NCT00069108|7168035|FG001|Overall Study|Withdrawal by Subject|9
4710173|NCT02889796|7635620|FG005|Overall Study|Randomized but not Dosed|2
4710174|NCT02889861|7635643|FG000|Overall Study|Ongoing in Survival Follow-up|2
4710175|NCT02890992|7635673|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0
4710176|NCT02890992|7635674|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1
4710177|NCT02890992|7635675|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0
4710178|NCT02890992|7635676|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0
4710179|NCT02890992|7635677|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0
4710180|NCT02890992|7635678|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0
4710181|NCT02890992|7635679|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0
4710182|NCT02890992|7635680|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0
4710183|NCT02890992|7635673|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0
4710184|NCT02890992|7635674|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0
4710185|NCT02890992|7635675|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0
4710186|NCT02890992|7635676|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0
4710187|NCT02890992|7635677|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0
4710188|NCT02890992|7635678|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0
4710189|NCT02890992|7635679|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1
4710190|NCT02890992|7635680|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1
4710191|NCT02890992|7635673|FG000|130 Weeks Open-Label Extension Period|Other than specified|0
4710192|NCT02890992|7635674|FG001|130 Weeks Open-Label Extension Period|Other than specified|2
4710193|NCT02890992|7635675|FG002|130 Weeks Open-Label Extension Period|Other than specified|0
4710194|NCT02890992|7635676|FG003|130 Weeks Open-Label Extension Period|Other than specified|0
4710195|NCT02890992|7635677|FG004|130 Weeks Open-Label Extension Period|Other than specified|0
4710196|NCT02890992|7635678|FG005|130 Weeks Open-Label Extension Period|Other than specified|0
4710197|NCT02890992|7635679|FG006|130 Weeks Open-Label Extension Period|Other than specified|0
4710198|NCT02890992|7635680|FG007|130 Weeks Open-Label Extension Period|Other than specified|0
4710199|NCT02891070|7635707|FG000|Overall Study|Adverse Event|1
4710200|NCT02891070|7635708|FG001|Overall Study|Adverse Event|0
4710201|NCT02891070|7635707|FG000|Overall Study|Physician Decision|0
4710202|NCT02891070|7635708|FG001|Overall Study|Physician Decision|1
4710203|NCT02891070|7635707|FG000|Overall Study|Lost to Follow-up|4
4710204|NCT02891070|7635708|FG001|Overall Study|Lost to Follow-up|4
4710205|NCT02891070|7635707|FG000|Overall Study|Other|1
4710206|NCT02891070|7635708|FG001|Overall Study|Other|0
4710207|NCT02891070|7635707|FG000|Overall Study|Protocol Violation|0
4710208|NCT02891070|7635708|FG001|Overall Study|Protocol Violation|1
4710209|NCT02891070|7635707|FG000|Overall Study|Withdrawal by Subject|1
4710210|NCT02891070|7635708|FG001|Overall Study|Withdrawal by Subject|2
4710211|NCT02891070|7635707|FG000|Overall Study|Death|3
4389429|NCT00069108|7168034|FG000|Overall Study|Adverse Event|64
4389430|NCT00069108|7168035|FG001|Overall Study|Adverse Event|42
4389431|NCT00069108|7168034|FG000|Overall Study|Death|6
4389432|NCT00069108|7168035|FG001|Overall Study|Death|6
4389433|NCT00069108|7168034|FG000|Overall Study|Administration|15
4389434|NCT00069108|7168035|FG001|Overall Study|Administration|4
4389435|NCT00069108|7168034|FG000|Overall Study|Insufficient therapy|117
4389436|NCT00069108|7168035|FG001|Overall Study|Insufficient therapy|144
4389437|NCT00069108|7168034|FG000|Overall Study|Violation criteria|1
4389438|NCT00069108|7168035|FG001|Overall Study|Violation criteria|4
4389439|NCT00069108|7168034|FG000|Overall Study|Refused treatment|5
4389440|NCT00069108|7168035|FG001|Overall Study|Refused treatment|10
4389441|NCT00069121|7168044|FG000|Overall Study|Death|286
4389442|NCT00069121|7168045|FG001|Overall Study|Death|242
4389443|NCT00069121|7168044|FG000|Overall Study|Withdrawal by Subject|18
4389444|NCT00069121|7168045|FG001|Overall Study|Withdrawal by Subject|20
4389445|NCT00069121|7168044|FG000|Overall Study|Lost to Follow-up|63
4389446|NCT00069121|7168045|FG001|Overall Study|Lost to Follow-up|63
4389447|NCT00069264|7168067|FG000|Overall Study|Adverse Event|3
4389448|NCT00069264|7168067|FG000|Overall Study|Progressive Disease|23
4389449|NCT00069264|7168067|FG000|Overall Study|Withdrawal by Subject|3
4389450|NCT00069264|7168067|FG000|Overall Study|Discon Therapy|3
4389451|NCT00069277|7168071|FG000|Overall Study|Adverse Event|3
4389452|NCT00069277|7168071|FG000|Overall Study|Withdrawal by Subject|1
4389453|NCT00069277|7168071|FG000|Overall Study|Progressive Disease|15
4389454|NCT00069277|7168071|FG000|Overall Study|Physician Decision|2
4389455|NCT00069576|7168081|FG000|Original Trial|Lost to Follow-up|25
4389456|NCT00069576|7168082|FG001|Original Trial|Lost to Follow-up|33
4389457|NCT00069576|7168081|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196
4389458|NCT00069576|7168082|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204
4389459|NCT00069641|7168091|FG000|Overall Study|Death|1
4389460|NCT00069641|7168092|FG001|Overall Study|Death|0
4389461|NCT00069641|7168093|FG002|Overall Study|Death|1
4389462|NCT00069784|7168104|FG000|Overall Study|Adverse Event|105
4389463|NCT00069784|7168105|FG001|Overall Study|Adverse Event|0
4389464|NCT00069784|7168104|FG000|Overall Study|Withdrawal by Subject|1090
4389465|NCT00069784|7168105|FG001|Overall Study|Withdrawal by Subject|0
4389466|NCT00069784|7168104|FG000|Overall Study|Other|17
4389467|NCT00069784|7168105|FG001|Overall Study|Other|0
4389468|NCT00069823|7168113|FG000|Overall Study|Did not have follow-up diary cards|6
4389469|NCT00069823|7168114|FG001|Overall Study|Did not have follow-up diary cards|3
4389470|NCT00069953|7168120|FG000|Overall Study|Protocol Violation|2
4389471|NCT00070109|7168146|FG000|Overall Study|Death|1
4389472|NCT00070109|7168147|FG001|Overall Study|Death|1
4389473|NCT00070109|7168148|FG002|Overall Study|Death|0
4389474|NCT00070109|7168149|FG003|Overall Study|Death|0
4389475|NCT00070109|7168150|FG004|Overall Study|Death|1
4389476|NCT00070109|7168146|FG000|Overall Study|Lack of Efficacy|6
4389477|NCT00070109|7168147|FG001|Overall Study|Lack of Efficacy|4
4389478|NCT00070109|7168148|FG002|Overall Study|Lack of Efficacy|5
4389479|NCT00070109|7168149|FG003|Overall Study|Lack of Efficacy|15
4389480|NCT00070109|7168150|FG004|Overall Study|Lack of Efficacy|5
4389481|NCT00070109|7168146|FG000|Overall Study|Physician Decision|1
4389482|NCT00070109|7168147|FG001|Overall Study|Physician Decision|0
4389483|NCT00070109|7168148|FG002|Overall Study|Physician Decision|0
4389484|NCT00070109|7168149|FG003|Overall Study|Physician Decision|0
4389485|NCT00070109|7168150|FG004|Overall Study|Physician Decision|0
4389486|NCT00070109|7168146|FG000|Overall Study|Withdrawal by Subject|0
4389487|NCT00070109|7168147|FG001|Overall Study|Withdrawal by Subject|1
4389488|NCT00070109|7168148|FG002|Overall Study|Withdrawal by Subject|1
4710212|NCT02891070|7635708|FG001|Overall Study|Death|0
4710213|NCT02891174|7635716|FG000|First Intervention (24 Hours)|Declined any study medication|1
4389489|NCT00070109|7168149|FG003|Overall Study|Withdrawal by Subject|0
4389490|NCT00070109|7168150|FG004|Overall Study|Withdrawal by Subject|0
4389491|NCT00070109|7168146|FG000|Overall Study|Adverse Event|0
4389492|NCT00070109|7168147|FG001|Overall Study|Adverse Event|0
4710214|NCT02891174|7635717|FG001|First Intervention (24 Hours)|Declined any study medication|5
4710215|NCT02891174|7635716|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0
4710216|NCT02891174|7635717|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2
4710217|NCT02891174|7635716|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2
4710218|NCT02891174|7635717|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6
4710219|NCT02891174|7635716|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1
4710220|NCT02891174|7635717|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0
4710221|NCT02891174|7635716|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3
4710222|NCT02891174|7635717|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5
4710223|NCT02891174|7635716|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2
4710224|NCT02891174|7635717|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1
4710225|NCT02891174|7635716|FG000|Second Intervention (24 Hours)|Protocol Violation|0
4710226|NCT02891174|7635717|FG001|Second Intervention (24 Hours)|Protocol Violation|1
4710227|NCT02891200|7635729|FG000|Overall Study|Lost to Follow-up|31
4710228|NCT02891200|7635730|FG001|Overall Study|Lost to Follow-up|36
4710229|NCT02891200|7635729|FG000|Overall Study|Death|10
4710230|NCT02891200|7635730|FG001|Overall Study|Death|9
4710231|NCT02891200|7635729|FG000|Overall Study|Withdrawal by Subject|1
4710232|NCT02891200|7635730|FG001|Overall Study|Withdrawal by Subject|4
4710233|NCT02891408|7635743|FG000|Overall Study|Lost to Follow-up|0
4710234|NCT02891408|7635744|FG001|Overall Study|Lost to Follow-up|0
4389493|NCT00070109|7168148|FG002|Overall Study|Adverse Event|2
4389494|NCT00070109|7168149|FG003|Overall Study|Adverse Event|4
4389495|NCT00070109|7168150|FG004|Overall Study|Adverse Event|2
4389496|NCT00070109|7168146|FG000|Overall Study|removed from prot thpy prior to chemo|0
4389497|NCT00070109|7168147|FG001|Overall Study|removed from prot thpy prior to chemo|0
4389498|NCT00070109|7168148|FG002|Overall Study|removed from prot thpy prior to chemo|0
4389499|NCT00070109|7168149|FG003|Overall Study|removed from prot thpy prior to chemo|1
4389500|NCT00070109|7168150|FG004|Overall Study|removed from prot thpy prior to chemo|0
4389501|NCT00070291|7168173|FG000|Step 1|Withdrawal by Subject|1
4389502|NCT00070291|7168173|FG000|Step 1|Adverse Event|1
4389503|NCT00070291|7168173|FG000|Step 2|Adverse Event|1
4389504|NCT00070317|7168177|FG000|Overall Study|Inevaluable (Never Treated)|1
4389505|NCT00070317|7168177|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3
4389506|NCT00070317|7168177|FG000|Overall Study|Ineligible required test not done|1
4389507|NCT00070317|7168177|FG000|Overall Study|Ineligible-Improper prior treatment|2
4389508|NCT00070317|7168177|FG000|Overall Study|Ineligible-Inadequate pathology|6
4389509|NCT00070941|7168184|FG000|Overall Study|Adverse Event|10
4389510|NCT00070941|7168185|FG001|Overall Study|Adverse Event|8
4710235|NCT02891408|7635745|FG002|Overall Study|Lost to Follow-up|1
4710236|NCT02891408|7635746|FG003|Overall Study|Lost to Follow-up|0
4710237|NCT02891408|7635747|FG004|Overall Study|Lost to Follow-up|0
4710238|NCT02891408|7635748|FG005|Overall Study|Lost to Follow-up|0
4710239|NCT02891408|7635749|FG006|Overall Study|Lost to Follow-up|0
4710240|NCT02891681|7635787|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0
4710241|NCT02891681|7635788|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0
4710242|NCT02891681|7635789|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1
4710243|NCT02891681|7635787|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2
4710244|NCT02891681|7635788|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0
4710245|NCT02891681|7635789|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0
4710246|NCT02891681|7635787|FG000|Overall Study|Taken off study after first imaging appointment|1
4710247|NCT02891681|7635788|FG001|Overall Study|Taken off study after first imaging appointment|0
4710248|NCT02891681|7635789|FG002|Overall Study|Taken off study after first imaging appointment|0
4710249|NCT02891850|7635799|FG000|Overall Study|Adverse Event|3
4710250|NCT02891850|7635800|FG001|Overall Study|Adverse Event|0
4710251|NCT02891850|7635799|FG000|Overall Study|Death|0
4710252|NCT02891850|7635800|FG001|Overall Study|Death|4
4710253|NCT02891850|7635799|FG000|Overall Study|Physician Decision|1
4710254|NCT02891850|7635800|FG001|Overall Study|Physician Decision|0
4710255|NCT02891850|7635799|FG000|Overall Study|Pregnancy|1
4710256|NCT02891850|7635800|FG001|Overall Study|Pregnancy|0
4710257|NCT02891850|7635799|FG000|Overall Study|Withdrawal by Subject|2
4710258|NCT02891850|7635800|FG001|Overall Study|Withdrawal by Subject|3
4710259|NCT02891915|7635812|FG000|Overall Study|Enrolled but Treatment Not Administered|6
4710260|NCT02891915|7635813|FG001|Overall Study|Enrolled but Treatment Not Administered|4
4710261|NCT02891915|7635812|FG000|Overall Study|Withdrawal by Subject|3
4710262|NCT02891915|7635813|FG001|Overall Study|Withdrawal by Subject|3
4710263|NCT02891915|7635812|FG000|Overall Study|Became Ineligible After Enrollment|2
4710264|NCT02891915|7635813|FG001|Overall Study|Became Ineligible After Enrollment|1
4710265|NCT02891915|7635812|FG000|Overall Study|Lost to Follow-up|1
4710266|NCT02891915|7635813|FG001|Overall Study|Lost to Follow-up|4
4710267|NCT02891915|7635812|FG000|Overall Study|Physician Decision|1
4710268|NCT02891915|7635813|FG001|Overall Study|Physician Decision|0
4710269|NCT02892019|7635821|FG000|Overall Study|randomized but not treated|0
4710270|NCT02892019|7635822|FG001|Overall Study|randomized but not treated|1
4710271|NCT02892019|7635821|FG000|Overall Study|Withdrawal by Subject|0
4710272|NCT02892019|7635822|FG001|Overall Study|Withdrawal by Subject|1
4710273|NCT02892019|7635821|FG000|Overall Study|Adverse Event|1
4710274|NCT02892019|7635822|FG001|Overall Study|Adverse Event|1
4710275|NCT02892344|7635839|FG000|Overall Study|Protocol deviation|3
4710276|NCT02892344|7635840|FG001|Overall Study|Protocol deviation|4
4710277|NCT02892344|7635839|FG000|Overall Study|Adverse Event|1
4710278|NCT02892344|7635840|FG001|Overall Study|Adverse Event|8
4710279|NCT02892344|7635839|FG000|Overall Study|Lost to Follow-up|0
4710280|NCT02892344|7635840|FG001|Overall Study|Lost to Follow-up|1
4710281|NCT02892344|7635839|FG000|Overall Study|Non-compliance with study treatment|0
4710282|NCT02892344|7635840|FG001|Overall Study|Non-compliance with study treatment|1
4710283|NCT02892344|7635839|FG000|Overall Study|Physician Decision|0
4710284|NCT02892344|7635840|FG001|Overall Study|Physician Decision|2
4710285|NCT02892344|7635839|FG000|Overall Study|Subject/guardian decision|0
4710286|NCT02892344|7635840|FG001|Overall Study|Subject/guardian decision|4
4710287|NCT02892344|7635839|FG000|Overall Study|Technical problems|0
4710288|NCT02892344|7635840|FG001|Overall Study|Technical problems|1
4710289|NCT02892409|7635848|FG000|Overall Study|Adverse Event|1
4710290|NCT02892409|7635849|FG001|Overall Study|Adverse Event|0
4710291|NCT02892409|7635848|FG000|Overall Study|Withdrawal by Subject|2
4710292|NCT02892409|7635849|FG001|Overall Study|Withdrawal by Subject|1
4710293|NCT02892422|7635855|FG000|Overall Study|Enrolled not treated|4
4710294|NCT02892422|7635855|FG000|Overall Study|Adverse Event|38
4710295|NCT02892422|7635855|FG000|Overall Study|Lack of Efficacy|32
4710296|NCT02892422|7635855|FG000|Overall Study|Non-compliance with study drug|11
4710297|NCT02892422|7635855|FG000|Overall Study|Protocol Violation|4
4710298|NCT02892422|7635855|FG000|Overall Study|Withdrawal by Subject|56
4710299|NCT02892422|7635855|FG000|Overall Study|Lost to Follow-up|5
4710300|NCT02892422|7635855|FG000|Overall Study|sponsor information 16159A results|21
4710301|NCT02892422|7635855|FG000|Overall Study|withdrawal of consent|13
4710302|NCT02892422|7635855|FG000|Overall Study|exclusion criteria met|3
4710303|NCT02892422|7635855|FG000|Overall Study|moving elsewhere|4
4710304|NCT02892422|7635855|FG000|Overall Study|non-compliance|10
4710305|NCT02892422|7635855|FG000|Overall Study|patient legally incapable|1
4710306|NCT02892422|7635855|FG000|Overall Study|patient decision|7
4710307|NCT02892422|7635855|FG000|Overall Study|Investigator decision|1
4710308|NCT02892448|7635862|FG000|Overall Study|Screening failure|2
4710309|NCT02892448|7635863|FG001|Overall Study|Screening failure|2
4710310|NCT02892448|7635864|FG002|Overall Study|Screening failure|1
4389511|NCT00070941|7168186|FG002|Overall Study|Adverse Event|4
4389512|NCT00071006|7168194|FG000|Overall Study|Lack of Efficacy|7
4389513|NCT00071006|7168194|FG000|Overall Study|Adverse Event|1
4389514|NCT00071006|7168194|FG000|Overall Study|Withdrawal by Subject|1
4389515|NCT00071006|7168194|FG000|Overall Study|Other|3
4389516|NCT00071032|7168200|FG000|Overall Study|Lost to Follow-up|1
4389517|NCT00071032|7168201|FG001|Overall Study|Lost to Follow-up|1
4389518|NCT00071032|7168200|FG000|Overall Study|Withdrawal by Subject|8
4389519|NCT00071032|7168201|FG001|Overall Study|Withdrawal by Subject|6
4389520|NCT00071032|7168200|FG000|Overall Study|Missing Primary Outcome|0
4389521|NCT00071032|7168201|FG001|Overall Study|Missing Primary Outcome|1
4389522|NCT00071058|7168208|FG000|Overall Study|brain tumor-removed from study|1
4389523|NCT00071110|7168215|FG000|Overall Study|Protocol Violation|0
4389524|NCT00071110|7168216|FG001|Overall Study|Protocol Violation|4
4510676|NCT00922272|7319559|FG000|Double-blind Phase|Adverse Event|1
4510677|NCT00922272|7319560|FG001|Double-blind Phase|Adverse Event|1
4510678|NCT00922272|7319559|FG000|Double-blind Phase|Withdrawal by Subject|1
4510679|NCT00922272|7319560|FG001|Double-blind Phase|Withdrawal by Subject|1
4510680|NCT00922272|7319559|FG000|Double-blind Phase|Lost to Follow-up|2
4510681|NCT00922272|7319560|FG001|Double-blind Phase|Lost to Follow-up|1
4510682|NCT00922272|7319559|FG000|Double-blind Phase|Withdrawal criteria met|1
4510683|NCT00922272|7319560|FG001|Double-blind Phase|Withdrawal criteria met|1
4510684|NCT00922272|7319559|FG000|Double-blind Phase|Noncompliance|1
4510685|NCT00922272|7319560|FG001|Double-blind Phase|Noncompliance|1
4510686|NCT00922272|7319559|FG000|Double-blind Phase|Positive urine drug screen|1
4510687|NCT00922272|7319560|FG001|Double-blind Phase|Positive urine drug screen|1
4510688|NCT00922428|7319568|FG000|Overall Study|retrospective/extremely implausible data|2
4510689|NCT00922428|7319568|FG000|Overall Study|no medication use or questionable use|13
4510690|NCT00922441|7319581|FG000|Overall Study|Protocol Violation|0
4510691|NCT00922441|7319582|FG001|Overall Study|Protocol Violation|0
4510692|NCT00922441|7319583|FG002|Overall Study|Protocol Violation|2
4510693|NCT00922441|7319581|FG000|Overall Study|Withdrawal by Subject|0
4510694|NCT00922441|7319582|FG001|Overall Study|Withdrawal by Subject|0
4510695|NCT00922441|7319583|FG002|Overall Study|Withdrawal by Subject|1
4510696|NCT00922480|7319593|FG000|Main Study|Protocol Violation|3
4510697|NCT00922480|7319594|FG001|Main Study|Protocol Violation|6
4510698|NCT00922480|7319593|FG000|Main Study|Adverse Event|6
4510699|NCT00922480|7319594|FG001|Main Study|Adverse Event|7
4710311|NCT02892513|7635874|FG000|Overall Study|Withdrawal by Subject|0
4710312|NCT02892513|7635875|FG001|Overall Study|Withdrawal by Subject|1
4710313|NCT02892734|7635881|FG000|Treatment on Study|Progressive Disease|2
4710314|NCT02892734|7635881|FG000|Follow up for 2 Years|Death|2
4710315|NCT02892734|7635881|FG000|Follow up for 2 Years|Study closed early|1
4710316|NCT02892760|7635885|FG000|Overall Study|Withdrawal by Subject|3
4710317|NCT02894502|7635908|FG000|Baseline|Withdrawal by Subject|24
4710318|NCT02894502|7635909|FG001|Baseline|Withdrawal by Subject|31
4710319|NCT02894502|7635910|FG002|Baseline|Withdrawal by Subject|36
4710320|NCT02894502|7635908|FG000|Baseline|Death|3
4710321|NCT02894502|7635909|FG001|Baseline|Death|1
4710322|NCT02894502|7635910|FG002|Baseline|Death|9
4710323|NCT02894502|7635908|FG000|First Follow up|Withdrawal by Subject|32
4710324|NCT02894502|7635909|FG001|First Follow up|Withdrawal by Subject|29
4710325|NCT02894502|7635910|FG002|First Follow up|Withdrawal by Subject|37
4710326|NCT02894502|7635908|FG000|First Follow up|Death|2
4710327|NCT02894502|7635909|FG001|First Follow up|Death|2
4710328|NCT02894502|7635910|FG002|First Follow up|Death|3
4710329|NCT02894502|7635908|FG000|Second Follow up|Withdrawal by Subject|13
4710330|NCT02894502|7635909|FG001|Second Follow up|Withdrawal by Subject|15
4710331|NCT02894502|7635910|FG002|Second Follow up|Withdrawal by Subject|13
4710332|NCT02894502|7635908|FG000|Second Follow up|Death|2
4710333|NCT02894502|7635909|FG001|Second Follow up|Death|3
4710334|NCT02894502|7635910|FG002|Second Follow up|Death|1
4710335|NCT02894502|7635908|FG000|Third Follow up|Withdrawal by Subject|5
4710336|NCT02894502|7635909|FG001|Third Follow up|Withdrawal by Subject|6
4710337|NCT02894502|7635910|FG002|Third Follow up|Withdrawal by Subject|3
4389525|NCT00071396|7168222|FG000|Overall Study|Withdrawal by Subject|1
4389526|NCT00071396|7168222|FG000|Overall Study|Physician Decision|2
4389527|NCT00071487|7168230|FG000|52-Week Double-Blind Period|Adverse Event|5
4389528|NCT00071487|7168231|FG001|52-Week Double-Blind Period|Adverse Event|8
4389529|NCT00071487|7168232|FG002|52-Week Double-Blind Period|Adverse Event|4
4628283|NCT01858766|7495326|FG010|Overall Study|Death|0
4389530|NCT00071487|7168233|FG003|52-Week Double-Blind Period|Adverse Event|8
4389531|NCT00071487|7168230|FG000|52-Week Double-Blind Period|Lack of Efficacy|1
4389532|NCT00071487|7168231|FG001|52-Week Double-Blind Period|Lack of Efficacy|2
4389533|NCT00071487|7168232|FG002|52-Week Double-Blind Period|Lack of Efficacy|0
4389534|NCT00071487|7168233|FG003|52-Week Double-Blind Period|Lack of Efficacy|1
4389535|NCT00071487|7168230|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7
4389536|NCT00071487|7168231|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11
4389537|NCT00071487|7168232|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7
4389538|NCT00071487|7168233|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7
4389539|NCT00071487|7168230|FG000|52-Week Double-Blind Period|Physician Decision|1
4389540|NCT00071487|7168231|FG001|52-Week Double-Blind Period|Physician Decision|0
4389541|NCT00071487|7168232|FG002|52-Week Double-Blind Period|Physician Decision|0
4389542|NCT00071487|7168233|FG003|52-Week Double-Blind Period|Physician Decision|0
4389543|NCT00071487|7168230|FG000|52-Week Double-Blind Period|Lost to Follow-up|0
4389544|NCT00071487|7168231|FG001|52-Week Double-Blind Period|Lost to Follow-up|0
4389545|NCT00071487|7168232|FG002|52-Week Double-Blind Period|Lost to Follow-up|2
4389546|NCT00071487|7168233|FG003|52-Week Double-Blind Period|Lost to Follow-up|2
4389547|NCT00071487|7168230|FG000|52-Week Double-Blind Period|Pregnancy|0
4389548|NCT00071487|7168231|FG001|52-Week Double-Blind Period|Pregnancy|1
4389549|NCT00071487|7168232|FG002|52-Week Double-Blind Period|Pregnancy|0
4389550|NCT00071487|7168233|FG003|52-Week Double-Blind Period|Pregnancy|0
4389551|NCT00071487|7168230|FG000|52-Week Double-Blind Period|Protocol Violation|0
4389552|NCT00071487|7168231|FG001|52-Week Double-Blind Period|Protocol Violation|1
4389553|NCT00071487|7168232|FG002|52-Week Double-Blind Period|Protocol Violation|1
4389554|NCT00071487|7168233|FG003|52-Week Double-Blind Period|Protocol Violation|0
4389555|NCT00071487|7168230|FG000|52-Week Double-Blind Period|Death|0
4389556|NCT00071487|7168231|FG001|52-Week Double-Blind Period|Death|1
4389557|NCT00071487|7168232|FG002|52-Week Double-Blind Period|Death|0
4389558|NCT00071487|7168233|FG003|52-Week Double-Blind Period|Death|0
4389559|NCT00071487|7168230|FG000|52-Week Double-Blind Period|Lack of Compliance|6
4389560|NCT00071487|7168231|FG001|52-Week Double-Blind Period|Lack of Compliance|3
4389561|NCT00071487|7168232|FG002|52-Week Double-Blind Period|Lack of Compliance|3
4389562|NCT00071487|7168233|FG003|52-Week Double-Blind Period|Lack of Compliance|3
4389563|NCT00071487|7168230|FG000|24-Week Open-Label Extension Period|Adverse Event|0
4389564|NCT00071487|7168231|FG001|24-Week Open-Label Extension Period|Adverse Event|0
4389565|NCT00071487|7168232|FG002|24-Week Open-Label Extension Period|Adverse Event|1
4389566|NCT00071487|7168233|FG003|24-Week Open-Label Extension Period|Adverse Event|6
4628284|NCT01858766|7495327|FG011|Overall Study|Death|0
4710338|NCT02894502|7635908|FG000|Third Follow up|Death|1
4710339|NCT02894502|7635909|FG001|Third Follow up|Death|1
4710340|NCT02894502|7635910|FG002|Third Follow up|Death|0
4710341|NCT02894840|7635925|FG000|Overall Study|Lost to Follow-up|1
4710342|NCT02894840|7635926|FG001|Overall Study|Lost to Follow-up|0
4710343|NCT02894840|7635927|FG002|Overall Study|Lost to Follow-up|3
4710344|NCT02894840|7635928|FG003|Overall Study|Lost to Follow-up|0
4710345|NCT02895295|7635970|FG000|Overall Study|Survey Non-response|71
4710346|NCT02895295|7635971|FG001|Overall Study|Survey Non-response|94
4710347|NCT02895295|7635972|FG002|Overall Study|Survey Non-response|92
4710348|NCT02895347|7635982|FG000|Overall Study|Withdrawal by Subject|3
4710349|NCT02895347|7635983|FG001|Overall Study|Withdrawal by Subject|1
4710350|NCT02895360|7635996|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4
4710351|NCT02895360|7635997|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0
4710352|NCT02895360|7635998|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0
4710353|NCT02895360|7635999|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0
4771380|NCT02942277|7748234|FG004|Year 1|Protocol Violation|1
4710354|NCT02895360|7636000|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0
4710355|NCT02895360|7636001|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0
4710356|NCT02895360|7635996|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0
4710357|NCT02895360|7635997|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3
4710358|NCT02895360|7635998|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0
4710359|NCT02895360|7635999|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0
4710360|NCT02895360|7636000|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0
4710361|NCT02895360|7636001|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0
4710362|NCT02895360|7635996|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0
4710363|NCT02895360|7635997|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0
4710364|NCT02895360|7635998|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2
4710365|NCT02895360|7635999|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0
4710366|NCT02895360|7636000|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0
4710367|NCT02895360|7636001|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0
4710368|NCT02895360|7635996|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0
4710369|NCT02895360|7635997|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0
4710370|NCT02895360|7635998|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7
4710371|NCT02895360|7635999|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0
4710372|NCT02895360|7636000|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0
4710373|NCT02895360|7636001|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0
4710374|NCT02895360|7635996|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0
4710375|NCT02895360|7635997|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0
4710376|NCT02895360|7635998|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0
4710377|NCT02895360|7635999|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4
4710378|NCT02895360|7636000|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0
4710379|NCT02895360|7636001|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0
4710380|NCT02895360|7635996|FG000|Phase 2a|Adverse Event|0
4710381|NCT02895360|7635997|FG001|Phase 2a|Adverse Event|0
4710382|NCT02895360|7635998|FG002|Phase 2a|Adverse Event|0
4710383|NCT02895360|7635999|FG003|Phase 2a|Adverse Event|0
4710384|NCT02895360|7636000|FG004|Phase 2a|Adverse Event|0
4710385|NCT02895360|7636001|FG005|Phase 2a|Adverse Event|1
4710386|NCT02895360|7635996|FG000|Phase 2a|Progressive disease|0
4710387|NCT02895360|7635997|FG001|Phase 2a|Progressive disease|0
4710388|NCT02895360|7635998|FG002|Phase 2a|Progressive disease|0
4710389|NCT02895360|7635999|FG003|Phase 2a|Progressive disease|0
4710390|NCT02895360|7636000|FG004|Phase 2a|Progressive disease|11
4710391|NCT02895360|7636001|FG005|Phase 2a|Progressive disease|11
4710392|NCT02895945|7636035|FG000|Overall Study|Physician Decision|2
4710393|NCT02895945|7636036|FG001|Overall Study|Physician Decision|1
4710394|NCT02896127|7636051|FG000|COMPLETED WEEK 52|Adverse Event|9
4710395|NCT02896127|7636052|FG001|COMPLETED WEEK 52|Adverse Event|2
4710396|NCT02896127|7636051|FG000|COMPLETED WEEK 52|Lack of Efficacy|2
4710397|NCT02896127|7636052|FG001|COMPLETED WEEK 52|Lack of Efficacy|3
4710398|NCT02896127|7636051|FG000|COMPLETED WEEK 52|Lost to Follow-up|0
4710399|NCT02896127|7636052|FG001|COMPLETED WEEK 52|Lost to Follow-up|1
4710400|NCT02896127|7636051|FG000|COMPLETED WEEK 52|Physician Decision|1
4710401|NCT02896127|7636052|FG001|COMPLETED WEEK 52|Physician Decision|1
4710402|NCT02896127|7636051|FG000|COMPLETED WEEK 52|Pregnancy|2
4710403|NCT02896127|7636052|FG001|COMPLETED WEEK 52|Pregnancy|0
4710404|NCT02896127|7636051|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12
4710405|NCT02896127|7636052|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4
4710406|NCT02896127|7636051|FG000|COMPLETED WEEK 52|Technical problems|1
4710407|NCT02896127|7636052|FG001|COMPLETED WEEK 52|Technical problems|0
4710408|NCT02896127|7636051|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2
4710409|NCT02896127|7636052|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3
4710410|NCT02896127|7636051|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0
4710411|NCT02896127|7636052|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1
4710412|NCT02896127|7636051|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1
4710413|NCT02896127|7636052|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0
4710414|NCT02896127|7636051|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1
4710415|NCT02896127|7636052|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0
4710416|NCT02896127|7636051|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0
4710417|NCT02896127|7636052|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1
4710418|NCT02896296|7636058|FG000|Overall Study|Adverse Event|1
4710419|NCT02896296|7636058|FG000|Overall Study|Lost to Follow-up|19
4710420|NCT02896296|7636058|FG000|Overall Study|Pregnancy|1
4710421|NCT02896296|7636058|FG000|Overall Study|Physician Decision|2
4710422|NCT02896296|7636058|FG000|Overall Study|Withdrawal by Subject|10
4710423|NCT02896296|7636058|FG000|Overall Study|Site closing|7
4710424|NCT02896296|7636058|FG000|Overall Study|Incarceration|1
4710425|NCT02896296|7636058|FG000|Overall Study|Relocation|1
4710426|NCT02896361|7636062|FG000|Third Intervention (2 Weeks)|Protocol Violation|1
4710427|NCT02896361|7636063|FG001|Third Intervention (2 Weeks)|Protocol Violation|0
4710428|NCT02896361|7636064|FG002|Third Intervention (2 Weeks)|Protocol Violation|0
4710429|NCT02896361|7636062|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0
4710430|NCT02896361|7636063|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1
4710431|NCT02896361|7636064|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0
4710432|NCT02896400|7636092|FG000|1 Month Follow-up|Lost to Follow-up|7
4389567|NCT00071487|7168230|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0
4389568|NCT00071487|7168231|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0
4389569|NCT00071487|7168232|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0
4389570|NCT00071487|7168233|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3
4389571|NCT00071487|7168230|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0
4389572|NCT00071487|7168231|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0
4389573|NCT00071487|7168232|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0
4389574|NCT00071487|7168233|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9
4389575|NCT00071487|7168230|FG000|24-Week Open-Label Extension Period|Pregnancy|0
4389576|NCT00071487|7168231|FG001|24-Week Open-Label Extension Period|Pregnancy|0
4389577|NCT00071487|7168232|FG002|24-Week Open-Label Extension Period|Pregnancy|0
4389578|NCT00071487|7168233|FG003|24-Week Open-Label Extension Period|Pregnancy|1
4389579|NCT00071487|7168230|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0
4389580|NCT00071487|7168231|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0
4389581|NCT00071487|7168232|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0
4389582|NCT00071487|7168233|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2
4389583|NCT00071487|7168230|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0
4389584|NCT00071487|7168231|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0
4389585|NCT00071487|7168232|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0
4389586|NCT00071487|7168233|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2
4389587|NCT00071513|7168247|FG000|Intervention Component|Withdrawal by Subject|2
4389588|NCT00071513|7168248|FG001|Intervention Component|Withdrawal by Subject|3
4389589|NCT00071513|7168247|FG000|Follow-up Assessment|Withdrawal by Subject|6
4389590|NCT00071513|7168248|FG001|Follow-up Assessment|Withdrawal by Subject|6
4389591|NCT00071760|7168265|FG000|Overall Study|Adverse Event|3
4389592|NCT00071760|7168265|FG000|Overall Study|Lost to Follow-up|4
4389593|NCT00071760|7168265|FG000|Overall Study|Protocol Violation|1
4389594|NCT00071760|7168265|FG000|Overall Study|Withdrawal by Subject|3
4389595|NCT00071760|7168265|FG000|Overall Study|Insufficient Viral Load Response|3
4389596|NCT00071760|7168265|FG000|Overall Study|Pulmonary Tuberculosis|1
4628285|NCT01858766|7495328|FG012|Overall Study|Death|0
4628286|NCT01858766|7495329|FG013|Overall Study|Death|0
4628287|NCT01858766|7495330|FG014|Overall Study|Death|0
4628288|NCT01858766|7495331|FG015|Overall Study|Death|0
4628289|NCT01858766|7495332|FG016|Overall Study|Death|0
4710433|NCT02896400|7636093|FG001|1 Month Follow-up|Lost to Follow-up|7
4389597|NCT00071760|7168265|FG000|Overall Study|Unavailability of RTV|8
4389598|NCT00071760|7168265|FG000|Overall Study|Relocation|1
4389599|NCT00071760|7168265|FG000|Overall Study|Investigator's Recommendation (Rec.)|4
4389600|NCT00071760|7168265|FG000|Overall Study|Study Team Rec./Resistance|1
4389601|NCT00071760|7168265|FG000|Overall Study|Ongoing|25
4389602|NCT00071799|7168277|FG000|Overall Study|Adverse Event|19
4389603|NCT00071799|7168278|FG001|Overall Study|Adverse Event|10
4389604|NCT00071799|7168277|FG000|Overall Study|Protocol Violation|1
4389605|NCT00071799|7168278|FG001|Overall Study|Protocol Violation|7
4389606|NCT00071799|7168277|FG000|Overall Study|Lost to Follow-up|1
4389607|NCT00071799|7168278|FG001|Overall Study|Lost to Follow-up|1
4389608|NCT00071799|7168277|FG000|Overall Study|Withdrawal by Subject|15
4389609|NCT00071799|7168278|FG001|Overall Study|Withdrawal by Subject|37
4389610|NCT00071799|7168277|FG000|Overall Study|Physician Decision|0
4389611|NCT00071799|7168278|FG001|Overall Study|Physician Decision|2
4389612|NCT00071799|7168277|FG000|Overall Study|Lack of Efficacy|11
4389613|NCT00071799|7168278|FG001|Overall Study|Lack of Efficacy|18
4389614|NCT00071799|7168277|FG000|Overall Study|Disease Progression|23
4389615|NCT00071799|7168278|FG001|Overall Study|Disease Progression|20
4389616|NCT00071799|7168277|FG000|Overall Study|Different Central+Local Pathology Review|0
4389617|NCT00071799|7168278|FG001|Overall Study|Different Central+Local Pathology Review|1
4389618|NCT00071799|7168277|FG000|Overall Study|Not Documented|0
4389619|NCT00071799|7168278|FG001|Overall Study|Not Documented|2
4389620|NCT00071812|7168294|FG000|24-Week Double-Blind Period|Adverse Event|2
4389621|NCT00071812|7168295|FG001|24-Week Double-Blind Period|Adverse Event|3
4389622|NCT00071812|7168296|FG002|24-Week Double-Blind Period|Adverse Event|4
4389623|NCT00071812|7168297|FG003|24-Week Double-Blind Period|Adverse Event|4
4389624|NCT00071812|7168294|FG000|24-Week Double-Blind Period|Lack of Efficacy|3
4389625|NCT00071812|7168295|FG001|24-Week Double-Blind Period|Lack of Efficacy|1
4389626|NCT00071812|7168296|FG002|24-Week Double-Blind Period|Lack of Efficacy|2
4389627|NCT00071812|7168297|FG003|24-Week Double-Blind Period|Lack of Efficacy|1
4389628|NCT00071812|7168294|FG000|24-Week Double-Blind Period|Lost to Follow-up|0
4389629|NCT00071812|7168295|FG001|24-Week Double-Blind Period|Lost to Follow-up|1
4389630|NCT00071812|7168296|FG002|24-Week Double-Blind Period|Lost to Follow-up|1
4389631|NCT00071812|7168297|FG003|24-Week Double-Blind Period|Lost to Follow-up|0
4389632|NCT00071812|7168294|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5
4389633|NCT00071812|7168295|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1
4389634|NCT00071812|7168296|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1
4389635|NCT00071812|7168297|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5
4628290|NCT01858766|7495333|FG017|Overall Study|Death|0
4628291|NCT01858766|7495334|FG018|Overall Study|Death|0
4710434|NCT02896400|7636094|FG002|1 Month Follow-up|Lost to Follow-up|5
4710435|NCT02896400|7636095|FG003|1 Month Follow-up|Lost to Follow-up|8
4710436|NCT02896400|7636096|FG004|1 Month Follow-up|Lost to Follow-up|9
4710437|NCT02896400|7636097|FG005|1 Month Follow-up|Lost to Follow-up|6
4710438|NCT02896400|7636098|FG006|1 Month Follow-up|Lost to Follow-up|5
4710439|NCT02896400|7636099|FG007|1 Month Follow-up|Lost to Follow-up|6
4710440|NCT02896400|7636100|FG008|1 Month Follow-up|Lost to Follow-up|4
4710441|NCT02896400|7636101|FG009|1 Month Follow-up|Lost to Follow-up|7
4710442|NCT02896400|7636102|FG010|1 Month Follow-up|Lost to Follow-up|5
4710443|NCT02896400|7636103|FG011|1 Month Follow-up|Lost to Follow-up|5
4710444|NCT02896400|7636104|FG012|1 Month Follow-up|Lost to Follow-up|3
4710445|NCT02896400|7636105|FG013|1 Month Follow-up|Lost to Follow-up|4
4710446|NCT02896400|7636106|FG014|1 Month Follow-up|Lost to Follow-up|1
4710447|NCT02896400|7636107|FG015|1 Month Follow-up|Lost to Follow-up|2
4710448|NCT02896400|7636092|FG000|1 Month Follow-up|Death|0
4710449|NCT02896400|7636093|FG001|1 Month Follow-up|Death|0
4710450|NCT02896400|7636094|FG002|1 Month Follow-up|Death|0
4710451|NCT02896400|7636095|FG003|1 Month Follow-up|Death|0
4710452|NCT02896400|7636096|FG004|1 Month Follow-up|Death|0
4710453|NCT02896400|7636097|FG005|1 Month Follow-up|Death|0
4710454|NCT02896400|7636098|FG006|1 Month Follow-up|Death|0
4710455|NCT02896400|7636099|FG007|1 Month Follow-up|Death|0
4710456|NCT02896400|7636100|FG008|1 Month Follow-up|Death|0
4710457|NCT02896400|7636101|FG009|1 Month Follow-up|Death|0
4710458|NCT02896400|7636102|FG010|1 Month Follow-up|Death|0
4710459|NCT02896400|7636103|FG011|1 Month Follow-up|Death|0
4710460|NCT02896400|7636104|FG012|1 Month Follow-up|Death|0
4710461|NCT02896400|7636105|FG013|1 Month Follow-up|Death|0
4710462|NCT02896400|7636106|FG014|1 Month Follow-up|Death|0
4710463|NCT02896400|7636107|FG015|1 Month Follow-up|Death|1
4710464|NCT02896400|7636092|FG000|3 Month Follow-up|Lost to Follow-up|6
4710465|NCT02896400|7636093|FG001|3 Month Follow-up|Lost to Follow-up|3
4710466|NCT02896400|7636094|FG002|3 Month Follow-up|Lost to Follow-up|6
4710467|NCT02896400|7636095|FG003|3 Month Follow-up|Lost to Follow-up|11
4710468|NCT02896400|7636096|FG004|3 Month Follow-up|Lost to Follow-up|12
4710469|NCT02896400|7636097|FG005|3 Month Follow-up|Lost to Follow-up|6
4710470|NCT02896400|7636098|FG006|3 Month Follow-up|Lost to Follow-up|4
4710471|NCT02896400|7636099|FG007|3 Month Follow-up|Lost to Follow-up|3
4710472|NCT02896400|7636100|FG008|3 Month Follow-up|Lost to Follow-up|6
4710473|NCT02896400|7636101|FG009|3 Month Follow-up|Lost to Follow-up|5
4710474|NCT02896400|7636102|FG010|3 Month Follow-up|Lost to Follow-up|6
4710475|NCT02896400|7636103|FG011|3 Month Follow-up|Lost to Follow-up|6
4710476|NCT02896400|7636104|FG012|3 Month Follow-up|Lost to Follow-up|3
4710477|NCT02896400|7636105|FG013|3 Month Follow-up|Lost to Follow-up|5
4710478|NCT02896400|7636106|FG014|3 Month Follow-up|Lost to Follow-up|3
4710479|NCT02896400|7636107|FG015|3 Month Follow-up|Lost to Follow-up|2
4710480|NCT02896400|7636092|FG000|3 Month Follow-up|Death|0
4710481|NCT02896400|7636093|FG001|3 Month Follow-up|Death|0
4710482|NCT02896400|7636094|FG002|3 Month Follow-up|Death|0
4710483|NCT02896400|7636095|FG003|3 Month Follow-up|Death|0
4710484|NCT02896400|7636096|FG004|3 Month Follow-up|Death|0
4710485|NCT02896400|7636097|FG005|3 Month Follow-up|Death|0
4710486|NCT02896400|7636098|FG006|3 Month Follow-up|Death|0
4710487|NCT02896400|7636099|FG007|3 Month Follow-up|Death|0
4710488|NCT02896400|7636100|FG008|3 Month Follow-up|Death|0
4710489|NCT02896400|7636101|FG009|3 Month Follow-up|Death|0
4710490|NCT02896400|7636102|FG010|3 Month Follow-up|Death|0
4710491|NCT02896400|7636103|FG011|3 Month Follow-up|Death|0
4710492|NCT02896400|7636104|FG012|3 Month Follow-up|Death|0
4710493|NCT02896400|7636105|FG013|3 Month Follow-up|Death|1
4710494|NCT02896400|7636106|FG014|3 Month Follow-up|Death|1
4710495|NCT02896400|7636107|FG015|3 Month Follow-up|Death|0
4710496|NCT02896400|7636092|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1
4710497|NCT02896400|7636093|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0
4710498|NCT02896400|7636094|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1
4710499|NCT02896400|7636095|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1
4710500|NCT02896400|7636096|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0
4710501|NCT02896400|7636097|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1
4710502|NCT02896400|7636098|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3
4710503|NCT02896400|7636099|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2
4710504|NCT02896400|7636100|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1
4710505|NCT02896400|7636101|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1
4710506|NCT02896400|7636102|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0
4710507|NCT02896400|7636103|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0
4710508|NCT02896400|7636104|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1
4710509|NCT02896400|7636105|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0
4710510|NCT02896400|7636106|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3
4710511|NCT02896400|7636107|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1
4710512|NCT02896400|7636092|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45
4710513|NCT02896400|7636093|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48
4710514|NCT02896400|7636094|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46
4710515|NCT02896400|7636095|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40
4710516|NCT02896400|7636096|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45
4710517|NCT02896400|7636097|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48
4710518|NCT02896400|7636098|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48
4710519|NCT02896400|7636099|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47
4710520|NCT02896400|7636100|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44
4710521|NCT02896400|7636101|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52
4710522|NCT02896400|7636102|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55
4710523|NCT02896400|7636103|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41
4710524|NCT02896400|7636104|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52
4710525|NCT02896400|7636105|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48
4710526|NCT02896400|7636106|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52
4710527|NCT02896400|7636107|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56
4710528|NCT02896569|7636135|FG000|Overall Study|Lost to Follow-up|2
4710529|NCT02896569|7636136|FG001|Overall Study|Lost to Follow-up|1
4710530|NCT02896569|7636135|FG000|Overall Study|Physician Decision|1
4710531|NCT02896569|7636136|FG001|Overall Study|Physician Decision|3
4710532|NCT02896569|7636135|FG000|Overall Study|Adverse Event|0
4710533|NCT02896569|7636136|FG001|Overall Study|Adverse Event|1
4710534|NCT02896569|7636135|FG000|Overall Study|Withdrawal by Subject|1
4710535|NCT02896569|7636136|FG001|Overall Study|Withdrawal by Subject|0
4710536|NCT02897115|7636157|FG000|Overall Study|Early termination of study by sponsor|11
4710537|NCT02897115|7636158|FG001|Overall Study|Early termination of study by sponsor|8
4710538|NCT02897349|7636186|FG000|Overall Study|Lost to Follow-up|2
4710539|NCT02897349|7636187|FG001|Overall Study|Lost to Follow-up|2
4389636|NCT00071812|7168294|FG000|24-Week Double-Blind Period|Protocol Violation|0
4389637|NCT00071812|7168295|FG001|24-Week Double-Blind Period|Protocol Violation|0
4389638|NCT00071812|7168296|FG002|24-Week Double-Blind Period|Protocol Violation|0
4389639|NCT00071812|7168297|FG003|24-Week Double-Blind Period|Protocol Violation|1
4389640|NCT00071812|7168294|FG000|24-Week Open-Label Extension Period|Adverse Event|0
4389641|NCT00071812|7168295|FG001|24-Week Open-Label Extension Period|Adverse Event|0
4389642|NCT00071812|7168296|FG002|24-Week Open-Label Extension Period|Adverse Event|0
4389643|NCT00071812|7168297|FG003|24-Week Open-Label Extension Period|Adverse Event|7
4389644|NCT00071812|7168294|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0
4389645|NCT00071812|7168295|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0
4389646|NCT00071812|7168296|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0
4389647|NCT00071812|7168297|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17
4389648|NCT00071812|7168294|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0
4389649|NCT00071812|7168295|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0
4389650|NCT00071812|7168296|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0
4389651|NCT00071812|7168297|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2
4389652|NCT00071812|7168294|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0
4389653|NCT00071812|7168295|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0
4389654|NCT00071812|7168296|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0
4389655|NCT00071812|7168297|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12
4389656|NCT00071812|7168294|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0
4389657|NCT00071812|7168295|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0
4389658|NCT00071812|7168296|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1
4389659|NCT00071812|7168297|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2
4389660|NCT00071981|7168322|FG000|Overall Study|Lack of Efficacy|37
4389661|NCT00071981|7168323|FG001|Overall Study|Lack of Efficacy|29
4389662|NCT00071981|7168324|FG002|Overall Study|Lack of Efficacy|30
4389663|NCT00071981|7168325|FG003|Overall Study|Lack of Efficacy|43
4389664|NCT00071981|7168322|FG000|Overall Study|Adverse Event|4
4389665|NCT00071981|7168323|FG001|Overall Study|Adverse Event|4
4389666|NCT00071981|7168324|FG002|Overall Study|Adverse Event|3
4389667|NCT00071981|7168325|FG003|Overall Study|Adverse Event|1
4389668|NCT00071981|7168322|FG000|Overall Study|Death|0
4389669|NCT00071981|7168323|FG001|Overall Study|Death|0
4389670|NCT00071981|7168324|FG002|Overall Study|Death|1
4389671|NCT00071981|7168325|FG003|Overall Study|Death|1
4389672|NCT00071981|7168322|FG000|Overall Study|Withdrawal by Subject|3
4389673|NCT00071981|7168323|FG001|Overall Study|Withdrawal by Subject|1
4389674|NCT00071981|7168324|FG002|Overall Study|Withdrawal by Subject|0
4389675|NCT00071981|7168325|FG003|Overall Study|Withdrawal by Subject|0
4389676|NCT00071981|7168322|FG000|Overall Study|No protocol therapy|2
4389677|NCT00071981|7168323|FG001|Overall Study|No protocol therapy|5
4389678|NCT00071981|7168324|FG002|Overall Study|No protocol therapy|1
4389679|NCT00071981|7168325|FG003|Overall Study|No protocol therapy|0
4389680|NCT00071981|7168322|FG000|Overall Study|others (not specified in the study)|0
4389681|NCT00071981|7168323|FG001|Overall Study|others (not specified in the study)|2
4389682|NCT00071981|7168324|FG002|Overall Study|others (not specified in the study)|2
4389683|NCT00071981|7168325|FG003|Overall Study|others (not specified in the study)|0
4389684|NCT00072176|7168337|FG000|Overall Study|Withdrawal by Subject|1
4389685|NCT00072176|7168338|FG001|Overall Study|Withdrawal by Subject|0
4710540|NCT02897349|7636186|FG000|Overall Study|Adverse Event|3
4710541|NCT02897349|7636187|FG001|Overall Study|Adverse Event|3
4710542|NCT02897349|7636186|FG000|Overall Study|Other than listed above|0
4710543|NCT02897349|7636187|FG001|Overall Study|Other than listed above|1
4710544|NCT02898077|7636195|FG000|Overall Study|Adverse Event|21
4710545|NCT02898077|7636196|FG001|Overall Study|Adverse Event|7
4710546|NCT02898077|7636195|FG000|Overall Study|Withdrawal by Subject|51
4710547|NCT02898077|7636196|FG001|Overall Study|Withdrawal by Subject|14
4710548|NCT02898077|7636195|FG000|Overall Study|Physician Decision|12
4710549|NCT02898077|7636196|FG001|Overall Study|Physician Decision|4
4710550|NCT02898077|7636195|FG000|Overall Study|Non-compliance With Study Drug|3
4710551|NCT02898077|7636196|FG001|Overall Study|Non-compliance With Study Drug|2
4710552|NCT02898077|7636195|FG000|Overall Study|Protocol Deviation|3
4710553|NCT02898077|7636196|FG001|Overall Study|Protocol Deviation|0
4710554|NCT02898077|7636195|FG000|Overall Study|On Study Treatment|5
4710555|NCT02898077|7636196|FG001|Overall Study|On Study Treatment|3
4710556|NCT02898116|7636215|FG000|Overall Study|Adverse Event|1
4710557|NCT02898116|7636215|FG000|Overall Study|Progressive disease|1
4710558|NCT02898454|7636222|FG000|Overall Study|Adverse Event|4
4710559|NCT02898454|7636223|FG001|Overall Study|Adverse Event|1
4710560|NCT02898454|7636224|FG002|Overall Study|Adverse Event|2
4710561|NCT02898454|7636222|FG000|Overall Study|Protocol Violation|1
4710562|NCT02898454|7636223|FG001|Overall Study|Protocol Violation|0
4710563|NCT02898454|7636224|FG002|Overall Study|Protocol Violation|1
4710564|NCT02898454|7636222|FG000|Overall Study|Lack of Efficacy|4
4710565|NCT02898454|7636223|FG001|Overall Study|Lack of Efficacy|1
4710566|NCT02898454|7636224|FG002|Overall Study|Lack of Efficacy|0
4710567|NCT02898454|7636222|FG000|Overall Study|Withdrawal by Subject|6
4389686|NCT00072176|7168337|FG000|Overall Study|Protocol Violation|0
4389687|NCT00072176|7168338|FG001|Overall Study|Protocol Violation|1
4389688|NCT00072189|7168344|FG000|Overall Study|Withdrawal by Subject|1
4389689|NCT00072280|7168350|FG000|Treatment|Found ineligible|1
4389690|NCT00072280|7168351|FG001|Treatment|Found ineligible|2
4389691|NCT00072280|7168350|FG000|Follow-up|Early termination of study|2
4389692|NCT00072280|7168351|FG001|Follow-up|Early termination of study|2
4389693|NCT00072293|7168358|FG000|Overall Study|Lost to Follow-up|1
4389694|NCT00072293|7168359|FG001|Overall Study|Lost to Follow-up|1
4389695|NCT00072293|7168358|FG000|Overall Study|Withdrawal by Subject|0
4389696|NCT00072293|7168359|FG001|Overall Study|Withdrawal by Subject|1
4389697|NCT00072384|7168365|FG000|Overall Study|Physician Decision|1
4389698|NCT00072384|7168365|FG000|Overall Study|Ineligible|8
4389699|NCT00072475|7168375|FG000|Overall Study|Adverse Event|44
4389700|NCT00072475|7168375|FG000|Overall Study|Death|3
4389701|NCT00072475|7168375|FG000|Overall Study|Withdrawal by Subject|46
4389702|NCT00072475|7168375|FG000|Overall Study|Patient/Investigator Decision|4
4389703|NCT00073008|7168398|FG000|Overall Study|Missing|6
4389704|NCT00073008|7168399|FG001|Overall Study|Missing|6
4389705|NCT00073008|7168398|FG000|Overall Study|Withdrawal by Subject|2
4389706|NCT00073008|7168399|FG001|Overall Study|Withdrawal by Subject|2
4389707|NCT00073008|7168398|FG000|Overall Study|Lost to Follow-up|1
4389708|NCT00073008|7168399|FG001|Overall Study|Lost to Follow-up|3
4389709|NCT00073008|7168398|FG000|Overall Study|Death|46
4389710|NCT00073008|7168399|FG001|Overall Study|Death|47
4389711|NCT00073008|7168398|FG000|Overall Study|"Other selected on Case Report Form"|7
4389712|NCT00073008|7168399|FG001|Overall Study|"Other selected on Case Report Form"|5
4389713|NCT00073021|7168407|FG000|Overall Study|Protocol Violation|2
4389714|NCT00073021|7168408|FG001|Overall Study|Protocol Violation|1
4389715|NCT00073021|7168407|FG000|Overall Study|Adverse Event|4
4389716|NCT00073021|7168408|FG001|Overall Study|Adverse Event|4
4389717|NCT00073021|7168407|FG000|Overall Study|Withdrawal by Subject|6
4389718|NCT00073021|7168408|FG001|Overall Study|Withdrawal by Subject|5
4389719|NCT00073021|7168407|FG000|Overall Study|Physician Decision|3
4389720|NCT00073021|7168408|FG001|Overall Study|Physician Decision|1
4389721|NCT00073021|7168407|FG000|Overall Study|Lack of Efficacy|11
4710568|NCT02898454|7636223|FG001|Overall Study|Withdrawal by Subject|3
4710569|NCT02898454|7636224|FG002|Overall Study|Withdrawal by Subject|3
4710570|NCT02898454|7636222|FG000|Overall Study|Lost to Follow-up|1
4710571|NCT02898454|7636223|FG001|Overall Study|Lost to Follow-up|0
4710572|NCT02898454|7636224|FG002|Overall Study|Lost to Follow-up|0
4710573|NCT02898454|7636222|FG000|Overall Study|Did Not Met Eligibility Criteria|1
4710574|NCT02898454|7636223|FG001|Overall Study|Did Not Met Eligibility Criteria|0
4710575|NCT02898454|7636224|FG002|Overall Study|Did Not Met Eligibility Criteria|0
4389722|NCT00073021|7168408|FG001|Overall Study|Lack of Efficacy|5
4389723|NCT00073307|7168420|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22
4710576|NCT02898597|7636239|FG000|Overall Study|Protocol Violation|4
4389724|NCT00073307|7168421|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17
4389725|NCT00073307|7168422|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0
4389726|NCT00073307|7168420|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1
4389727|NCT00073307|7168421|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6
4710577|NCT02898597|7636240|FG001|Overall Study|Protocol Violation|2
4710578|NCT02898597|7636239|FG000|Overall Study|Lost to Follow-up|0
4710579|NCT02898597|7636240|FG001|Overall Study|Lost to Follow-up|9
4710580|NCT02898597|7636239|FG000|Overall Study|Death|0
4510700|NCT00922480|7319593|FG000|Main Study|Lack of Efficacy|3
4710581|NCT02898597|7636240|FG001|Overall Study|Death|1
4710582|NCT02898662|7636248|FG000|Overall Study|Adverse Event|1
4710583|NCT02898662|7636249|FG001|Overall Study|Adverse Event|0
4710584|NCT02898662|7636248|FG000|Overall Study|Loss of asthma control|23
4710585|NCT02898662|7636249|FG001|Overall Study|Loss of asthma control|24
4710586|NCT02898662|7636248|FG000|Overall Study|Withdrawal by Subject|4
4710587|NCT02898662|7636249|FG001|Overall Study|Withdrawal by Subject|1
4710588|NCT02898662|7636248|FG000|Overall Study|Technical issue|0
4710589|NCT02898662|7636249|FG001|Overall Study|Technical issue|1
4710590|NCT02898662|7636248|FG000|Overall Study|Randomized in error|0
4710591|NCT02898662|7636249|FG001|Overall Study|Randomized in error|1
4710592|NCT02898662|7636248|FG000|Overall Study|Subject decision|1
4710593|NCT02898662|7636249|FG001|Overall Study|Subject decision|0
4710594|NCT02898662|7636248|FG000|Overall Study|Other|0
4710595|NCT02898662|7636249|FG001|Overall Study|Other|1
4710596|NCT02899156|7636275|FG000|Overall Study|Death|1
4710597|NCT02899156|7636276|FG001|Overall Study|Death|0
4710598|NCT02899156|7636275|FG000|Overall Study|Physician Decision|0
4710599|NCT02899156|7636276|FG001|Overall Study|Physician Decision|1
4710600|NCT02899195|7636282|FG000|Concurrent Durvalumab|Adverse Event|4
4710601|NCT02899195|7636282|FG000|Concurrent Durvalumab|Physician Decision|1
4710602|NCT02899195|7636282|FG000|Concurrent Durvalumab|Withdrawal by Subject|1
4710603|NCT02899195|7636282|FG000|Concurrent Durvalumab|Progressive Disease|5
4710604|NCT02899195|7636282|FG000|Maintenance Durvalumab|Adverse Event|1
4710605|NCT02899195|7636282|FG000|Maintenance Durvalumab|Physician Decision|1
4710606|NCT02899195|7636282|FG000|Maintenance Durvalumab|Withdrawal by Subject|1
4710607|NCT02899195|7636282|FG000|Maintenance Durvalumab|Progressive Disease|31
4710608|NCT02899338|7636288|FG000|Overall Study|Adverse Event|1
4710609|NCT02899338|7636289|FG001|Overall Study|Adverse Event|2
4710610|NCT02899338|7636288|FG000|Overall Study|Withdrawal by Subject|2
4710611|NCT02899338|7636289|FG001|Overall Study|Withdrawal by Subject|0
4710612|NCT02899377|7636297|FG000|Overall Study|Adverse Event|1
4710613|NCT02899377|7636298|FG001|Overall Study|Adverse Event|0
4710614|NCT02899962|7636334|FG000|Open-label Phase|Adverse Event|2
4710615|NCT02899962|7636335|FG001|Open-label Phase|Adverse Event|0
4710616|NCT02899962|7636336|FG002|Open-label Phase|Adverse Event|0
4389728|NCT00073307|7168422|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0
4389729|NCT00073307|7168420|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6
4389730|NCT00073307|7168421|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11
4389731|NCT00073307|7168422|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0
4389732|NCT00073307|7168420|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1
4389733|NCT00073307|7168421|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1
4389734|NCT00073307|7168422|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0
4389735|NCT00073307|7168420|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1
4389736|NCT00073307|7168421|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2
4389737|NCT00073307|7168422|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0
4389738|NCT00073307|7168420|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1
4389739|NCT00073307|7168421|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0
4389740|NCT00073307|7168422|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0
4389741|NCT00073307|7168420|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0
4389742|NCT00073307|7168421|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1
4389743|NCT00073307|7168422|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0
4389744|NCT00073307|7168420|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165
4389745|NCT00073307|7168421|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114
4389746|NCT00073307|7168422|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0
4389747|NCT00073307|7168420|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0
4389748|NCT00073307|7168421|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1
4389749|NCT00073307|7168422|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0
4389750|NCT00073307|7168420|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17
4389751|NCT00073307|7168421|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0
4389752|NCT00073307|7168422|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19
4389753|NCT00073307|7168420|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2
4389754|NCT00073307|7168421|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0
4389755|NCT00073307|7168422|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2
4389756|NCT00073307|7168420|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19
4389757|NCT00073307|7168421|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0
4389758|NCT00073307|7168422|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9
4389759|NCT00073307|7168420|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37
4389760|NCT00073307|7168421|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0
4389761|NCT00073307|7168422|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28
4710617|NCT02899962|7636334|FG000|Open-label Phase|Lost to Follow-up|9
4710618|NCT02899962|7636335|FG001|Open-label Phase|Lost to Follow-up|0
4710619|NCT02899962|7636336|FG002|Open-label Phase|Lost to Follow-up|0
4710620|NCT02899962|7636334|FG000|Open-label Phase|Other reasons|9
4710621|NCT02899962|7636335|FG001|Open-label Phase|Other reasons|0
4710622|NCT02899962|7636336|FG002|Open-label Phase|Other reasons|0
4710623|NCT02899962|7636334|FG000|Open-label Phase|Withdrawal by Subject|7
4771381|NCT02942277|7748235|FG005|Year 1|Protocol Violation|1
4771382|NCT02942277|7748236|FG006|Year 1|Protocol Violation|0
4771383|NCT02942277|7748237|FG007|Year 1|Protocol Violation|0
4771384|NCT02942277|7748238|FG008|Year 1|Protocol Violation|0
4771385|NCT02942277|7748239|FG009|Year 1|Protocol Violation|0
4771386|NCT02942277|7748240|FG010|Year 1|Protocol Violation|2
4771387|NCT02942277|7748230|FG000|Year 1|Pregnancy|0
4771388|NCT02942277|7748231|FG001|Year 1|Pregnancy|0
4771389|NCT02942277|7748232|FG002|Year 1|Pregnancy|0
4771390|NCT02942277|7748233|FG003|Year 1|Pregnancy|0
4771391|NCT02942277|7748234|FG004|Year 1|Pregnancy|0
4771392|NCT02942277|7748235|FG005|Year 1|Pregnancy|1
4771393|NCT02942277|7748236|FG006|Year 1|Pregnancy|0
4771394|NCT02942277|7748237|FG007|Year 1|Pregnancy|0
4771395|NCT02942277|7748238|FG008|Year 1|Pregnancy|0
4771396|NCT02942277|7748239|FG009|Year 1|Pregnancy|0
4771397|NCT02942277|7748240|FG010|Year 1|Pregnancy|0
4771398|NCT02942277|7748230|FG000|Year 2|Lost to Follow-up|0
4771399|NCT02942277|7748231|FG001|Year 2|Lost to Follow-up|0
4771400|NCT02942277|7748232|FG002|Year 2|Lost to Follow-up|0
4771401|NCT02942277|7748233|FG003|Year 2|Lost to Follow-up|0
4771402|NCT02942277|7748234|FG004|Year 2|Lost to Follow-up|2
4771403|NCT02942277|7748235|FG005|Year 2|Lost to Follow-up|1
4771404|NCT02942277|7748236|FG006|Year 2|Lost to Follow-up|0
4771405|NCT02942277|7748237|FG007|Year 2|Lost to Follow-up|0
4771406|NCT02942277|7748238|FG008|Year 2|Lost to Follow-up|0
4771407|NCT02942277|7748239|FG009|Year 2|Lost to Follow-up|0
4771408|NCT02942277|7748240|FG010|Year 2|Lost to Follow-up|0
4771409|NCT02942277|7748230|FG000|Year 2|Did not rescreen|0
4771410|NCT02942277|7748231|FG001|Year 2|Did not rescreen|0
4771411|NCT02942277|7748232|FG002|Year 2|Did not rescreen|1
4771412|NCT02942277|7748233|FG003|Year 2|Did not rescreen|1
4771413|NCT02942277|7748234|FG004|Year 2|Did not rescreen|9
4771414|NCT02942277|7748235|FG005|Year 2|Did not rescreen|6
4771415|NCT02942277|7748236|FG006|Year 2|Did not rescreen|0
4771416|NCT02942277|7748237|FG007|Year 2|Did not rescreen|1
4771417|NCT02942277|7748238|FG008|Year 2|Did not rescreen|0
4771418|NCT02942277|7748239|FG009|Year 2|Did not rescreen|0
4771419|NCT02942277|7748240|FG010|Year 2|Did not rescreen|21
4771420|NCT02942277|7748230|FG000|Year 2|Met withdrawal criteria|0
4771421|NCT02942277|7748231|FG001|Year 2|Met withdrawal criteria|0
4389762|NCT00073307|7168420|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1
4389763|NCT00073307|7168421|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0
4389764|NCT00073307|7168422|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1
4389765|NCT00073307|7168420|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1
4389766|NCT00073307|7168421|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0
4389767|NCT00073307|7168422|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1
4389768|NCT00073307|7168420|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0
4389769|NCT00073307|7168421|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0
4389770|NCT00073307|7168422|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3
4389771|NCT00073307|7168420|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3
4389772|NCT00073307|7168421|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0
4389773|NCT00073307|7168422|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1
4389774|NCT00073307|7168420|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19
4389775|NCT00073307|7168421|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0
4389776|NCT00073307|7168422|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9
4389777|NCT00073307|7168420|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35
4389778|NCT00073307|7168421|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0
4389779|NCT00073307|7168422|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83
4389780|NCT00073528|7168446|FG000|Overall Study|Death|488
4389781|NCT00073528|7168447|FG001|Overall Study|Death|473
4389782|NCT00073528|7168446|FG000|Overall Study|Lost to Follow-up|52
4389783|NCT00073528|7168447|FG001|Overall Study|Lost to Follow-up|45
4389784|NCT00073528|7168446|FG000|Overall Study|Withdrawal by Subject|50
4389785|NCT00073528|7168447|FG001|Overall Study|Withdrawal by Subject|45
4389786|NCT00073528|7168446|FG000|Overall Study|Study terminated by Sponsor|10
4389787|NCT00073528|7168447|FG001|Overall Study|Study terminated by Sponsor|29
4389788|NCT00073528|7168446|FG000|Overall Study|Other|18
4389789|NCT00073528|7168447|FG001|Overall Study|Other|19
4389790|NCT00073528|7168446|FG000|Overall Study|Other|9
4389791|NCT00073528|7168447|FG001|Overall Study|Other|12
4389792|NCT00073528|7168446|FG000|Overall Study|Protocol Violation|3
4389793|NCT00073528|7168447|FG001|Overall Study|Protocol Violation|5
4771422|NCT02942277|7748232|FG002|Year 2|Met withdrawal criteria|0
4771423|NCT02942277|7748233|FG003|Year 2|Met withdrawal criteria|0
4771424|NCT02942277|7748234|FG004|Year 2|Met withdrawal criteria|1
4771425|NCT02942277|7748235|FG005|Year 2|Met withdrawal criteria|2
4771426|NCT02942277|7748236|FG006|Year 2|Met withdrawal criteria|0
4771427|NCT02942277|7748237|FG007|Year 2|Met withdrawal criteria|0
4771428|NCT02942277|7748238|FG008|Year 2|Met withdrawal criteria|0
4771429|NCT02942277|7748239|FG009|Year 2|Met withdrawal criteria|0
4771430|NCT02942277|7748240|FG010|Year 2|Met withdrawal criteria|1
4771431|NCT02942277|7748230|FG000|Year 2|Travel|0
4771432|NCT02942277|7748231|FG001|Year 2|Travel|1
4710624|NCT02899962|7636335|FG001|Open-label Phase|Withdrawal by Subject|0
4710625|NCT02899962|7636336|FG002|Open-label Phase|Withdrawal by Subject|0
4710626|NCT02899962|7636334|FG000|Maintenance Phase|Adverse Event|0
4710627|NCT02899962|7636335|FG001|Maintenance Phase|Adverse Event|2
4710628|NCT02899962|7636336|FG002|Maintenance Phase|Adverse Event|1
4710629|NCT02899962|7636334|FG000|Maintenance Phase|Death|0
4710630|NCT02899962|7636335|FG001|Maintenance Phase|Death|0
4710631|NCT02899962|7636336|FG002|Maintenance Phase|Death|1
4710632|NCT02899962|7636334|FG000|Maintenance Phase|Lack of Efficacy|0
4710633|NCT02899962|7636335|FG001|Maintenance Phase|Lack of Efficacy|20
4710634|NCT02899962|7636336|FG002|Maintenance Phase|Lack of Efficacy|16
4710635|NCT02899962|7636334|FG000|Maintenance Phase|Lost to Follow-up|0
4710636|NCT02899962|7636335|FG001|Maintenance Phase|Lost to Follow-up|12
4710637|NCT02899962|7636336|FG002|Maintenance Phase|Lost to Follow-up|14
4710638|NCT02899962|7636334|FG000|Maintenance Phase|Other reasons|0
4710639|NCT02899962|7636335|FG001|Maintenance Phase|Other reasons|9
4710640|NCT02899962|7636336|FG002|Maintenance Phase|Other reasons|13
4710641|NCT02899962|7636334|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0
4710642|NCT02899962|7636335|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3
4710643|NCT02899962|7636336|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2
4710644|NCT02899962|7636334|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0
4710645|NCT02899962|7636335|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65
4389794|NCT00073749|7168460|FG000|Overall Study|Disease Progression|2
4389795|NCT00073749|7168461|FG001|Overall Study|Disease Progression|0
4389796|NCT00073749|7168462|FG002|Overall Study|Disease Progression|3
4389797|NCT00073749|7168463|FG003|Overall Study|Disease Progression|2
4389798|NCT00073749|7168464|FG004|Overall Study|Disease Progression|3
4389799|NCT00073749|7168465|FG005|Overall Study|Disease Progression|1
4389800|NCT00073749|7168466|FG006|Overall Study|Disease Progression|3
4389801|NCT00073749|7168460|FG000|Overall Study|Death|0
4389802|NCT00073749|7168461|FG001|Overall Study|Death|1
4389803|NCT00073749|7168462|FG002|Overall Study|Death|1
4389804|NCT00073749|7168463|FG003|Overall Study|Death|0
4389805|NCT00073749|7168464|FG004|Overall Study|Death|0
4389806|NCT00073749|7168465|FG005|Overall Study|Death|0
4389807|NCT00073749|7168466|FG006|Overall Study|Death|29
4389808|NCT00073749|7168460|FG000|Overall Study|Adverse Event|0
4389809|NCT00073749|7168461|FG001|Overall Study|Adverse Event|3
4389810|NCT00073749|7168462|FG002|Overall Study|Adverse Event|6
4389811|NCT00073749|7168463|FG003|Overall Study|Adverse Event|4
4389812|NCT00073749|7168464|FG004|Overall Study|Adverse Event|2
4389813|NCT00073749|7168465|FG005|Overall Study|Adverse Event|1
4389814|NCT00073749|7168466|FG006|Overall Study|Adverse Event|0
4389815|NCT00073749|7168460|FG000|Overall Study|Physician Decision|0
4389816|NCT00073749|7168461|FG001|Overall Study|Physician Decision|0
4389817|NCT00073749|7168462|FG002|Overall Study|Physician Decision|1
4389818|NCT00073749|7168463|FG003|Overall Study|Physician Decision|0
4389819|NCT00073749|7168464|FG004|Overall Study|Physician Decision|0
4389820|NCT00073749|7168465|FG005|Overall Study|Physician Decision|2
4389821|NCT00073749|7168466|FG006|Overall Study|Physician Decision|0
4389822|NCT00073749|7168460|FG000|Overall Study|Withdrawal by Subject|0
4389823|NCT00073749|7168461|FG001|Overall Study|Withdrawal by Subject|1
4389824|NCT00073749|7168462|FG002|Overall Study|Withdrawal by Subject|0
4389825|NCT00073749|7168463|FG003|Overall Study|Withdrawal by Subject|0
4389826|NCT00073749|7168464|FG004|Overall Study|Withdrawal by Subject|1
4389827|NCT00073749|7168465|FG005|Overall Study|Withdrawal by Subject|0
4389828|NCT00073749|7168466|FG006|Overall Study|Withdrawal by Subject|2
4389829|NCT00073749|7168460|FG000|Overall Study|Discontinuation of Study by Sponsor|0
4389830|NCT00073749|7168461|FG001|Overall Study|Discontinuation of Study by Sponsor|0
4389831|NCT00073749|7168462|FG002|Overall Study|Discontinuation of Study by Sponsor|0
4389832|NCT00073749|7168463|FG003|Overall Study|Discontinuation of Study by Sponsor|0
4389833|NCT00073749|7168464|FG004|Overall Study|Discontinuation of Study by Sponsor|0
4389834|NCT00073749|7168465|FG005|Overall Study|Discontinuation of Study by Sponsor|0
4389835|NCT00073749|7168466|FG006|Overall Study|Discontinuation of Study by Sponsor|4
4389836|NCT00073749|7168460|FG000|Overall Study|Lost to Follow-up|0
4389837|NCT00073749|7168461|FG001|Overall Study|Lost to Follow-up|0
4389838|NCT00073749|7168462|FG002|Overall Study|Lost to Follow-up|0
4389839|NCT00073749|7168463|FG003|Overall Study|Lost to Follow-up|0
4389840|NCT00073749|7168464|FG004|Overall Study|Lost to Follow-up|0
4389841|NCT00073749|7168465|FG005|Overall Study|Lost to Follow-up|0
4389842|NCT00073749|7168466|FG006|Overall Study|Lost to Follow-up|2
4389843|NCT00073749|7168460|FG000|Overall Study|Other|0
4389844|NCT00073749|7168461|FG001|Overall Study|Other|0
4389845|NCT00073749|7168462|FG002|Overall Study|Other|0
4389846|NCT00073749|7168463|FG003|Overall Study|Other|0
4389847|NCT00073749|7168464|FG004|Overall Study|Other|0
4389848|NCT00073749|7168465|FG005|Overall Study|Other|2
4389849|NCT00073749|7168466|FG006|Overall Study|Other|0
4389850|NCT00073918|7168485|FG000|Overall Study|Eligibility requirement not met - HAMA+|1
4389851|NCT00073918|7168485|FG000|Overall Study|Rapid disease progression|2
4389852|NCT00073918|7168485|FG000|Overall Study|Eligibility requirement not met-low CD20|1
4389853|NCT00073983|7168495|FG000|Overall Study|not evaluable|1
4389854|NCT00074152|7168507|FG000|Overall Study|Death|21
4389855|NCT00074152|7168508|FG001|Overall Study|Death|9
4710646|NCT02899962|7636336|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70
4710647|NCT02899962|7636334|FG000|Maintenance Phase|Withdrawal by Subject|0
4710648|NCT02899962|7636335|FG001|Maintenance Phase|Withdrawal by Subject|30
4710649|NCT02899962|7636336|FG002|Maintenance Phase|Withdrawal by Subject|36
4710650|NCT02899988|7636347|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2
4710651|NCT02899988|7636348|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1
4710652|NCT02899988|7636349|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0
4710653|NCT02899988|7636350|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0
4710654|NCT02899988|7636351|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0
4710655|NCT02899988|7636352|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0
4710656|NCT02899988|7636353|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0
4710657|NCT02899988|7636354|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0
4710658|NCT02899988|7636355|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0
4710659|NCT02899988|7636356|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0
4710660|NCT02899988|7636357|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0
4710661|NCT02899988|7636347|FG000|Induction Period (16 Weeks)|Adverse Event|0
4710662|NCT02899988|7636348|FG001|Induction Period (16 Weeks)|Adverse Event|0
4710663|NCT02899988|7636349|FG002|Induction Period (16 Weeks)|Adverse Event|0
4710664|NCT02899988|7636350|FG003|Induction Period (16 Weeks)|Adverse Event|2
4710665|NCT02899988|7636351|FG004|Induction Period (16 Weeks)|Adverse Event|0
4710666|NCT02899988|7636352|FG005|Induction Period (16 Weeks)|Adverse Event|0
4710667|NCT02899988|7636353|FG006|Induction Period (16 Weeks)|Adverse Event|0
4710668|NCT02899988|7636354|FG007|Induction Period (16 Weeks)|Adverse Event|0
4710669|NCT02899988|7636355|FG008|Induction Period (16 Weeks)|Adverse Event|0
4710670|NCT02899988|7636356|FG009|Induction Period (16 Weeks)|Adverse Event|0
4710671|NCT02899988|7636357|FG010|Induction Period (16 Weeks)|Adverse Event|0
4710672|NCT02899988|7636347|FG000|Induction Period (16 Weeks)|Physician Decision|0
4710673|NCT02899988|7636348|FG001|Induction Period (16 Weeks)|Physician Decision|1
4710674|NCT02899988|7636349|FG002|Induction Period (16 Weeks)|Physician Decision|0
4710675|NCT02899988|7636350|FG003|Induction Period (16 Weeks)|Physician Decision|0
4710676|NCT02899988|7636351|FG004|Induction Period (16 Weeks)|Physician Decision|0
4710677|NCT02899988|7636352|FG005|Induction Period (16 Weeks)|Physician Decision|0
4710678|NCT02899988|7636353|FG006|Induction Period (16 Weeks)|Physician Decision|0
4710679|NCT02899988|7636354|FG007|Induction Period (16 Weeks)|Physician Decision|0
4710680|NCT02899988|7636355|FG008|Induction Period (16 Weeks)|Physician Decision|0
4710681|NCT02899988|7636356|FG009|Induction Period (16 Weeks)|Physician Decision|0
4710682|NCT02899988|7636357|FG010|Induction Period (16 Weeks)|Physician Decision|0
4710683|NCT02899988|7636347|FG000|Maintenance Period (88 Weeks)|Adverse Event|0
4710684|NCT02899988|7636348|FG001|Maintenance Period (88 Weeks)|Adverse Event|0
4710685|NCT02899988|7636349|FG002|Maintenance Period (88 Weeks)|Adverse Event|0
4710686|NCT02899988|7636350|FG003|Maintenance Period (88 Weeks)|Adverse Event|0
4710687|NCT02899988|7636351|FG004|Maintenance Period (88 Weeks)|Adverse Event|1
4710688|NCT02899988|7636352|FG005|Maintenance Period (88 Weeks)|Adverse Event|2
4710689|NCT02899988|7636353|FG006|Maintenance Period (88 Weeks)|Adverse Event|1
4710690|NCT02899988|7636354|FG007|Maintenance Period (88 Weeks)|Adverse Event|2
4710691|NCT02899988|7636355|FG008|Maintenance Period (88 Weeks)|Adverse Event|2
4710692|NCT02899988|7636356|FG009|Maintenance Period (88 Weeks)|Adverse Event|2
4710693|NCT02899988|7636357|FG010|Maintenance Period (88 Weeks)|Adverse Event|1
4710694|NCT02899988|7636347|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0
4710695|NCT02899988|7636348|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0
4710696|NCT02899988|7636349|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0
4710697|NCT02899988|7636350|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0
4710698|NCT02899988|7636351|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0
4710699|NCT02899988|7636352|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1
4710700|NCT02899988|7636353|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0
4710701|NCT02899988|7636354|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1
4710702|NCT02899988|7636355|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0
4710703|NCT02899988|7636356|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0
4710704|NCT02899988|7636357|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0
4710705|NCT02899988|7636347|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
4710706|NCT02899988|7636348|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
4710707|NCT02899988|7636349|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
4710708|NCT02899988|7636350|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
4710709|NCT02899988|7636351|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1
4710710|NCT02899988|7636352|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
4710711|NCT02899988|7636353|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3
4710712|NCT02899988|7636354|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2
4710713|NCT02899988|7636355|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2
4710714|NCT02899988|7636356|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
4710715|NCT02899988|7636357|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1
4710716|NCT02900092|7636389|FG000|Overall Study|Adverse Event|1
4389856|NCT00074152|7168507|FG000|Overall Study|Lack of Efficacy|34
4710717|NCT02900170|7636393|FG000|Overall Study|Lost to Follow-up|8
4710718|NCT02900378|7636399|FG000|Randomization (Visit 2)|Adverse Event|14
4710719|NCT02900378|7636400|FG001|Randomization (Visit 2)|Adverse Event|11
4710720|NCT02900378|7636399|FG000|Randomization (Visit 2)|Death|1
4710721|NCT02900378|7636400|FG001|Randomization (Visit 2)|Death|4
4710722|NCT02900378|7636399|FG000|Randomization (Visit 2)|Lost to Follow-up|1
4710723|NCT02900378|7636400|FG001|Randomization (Visit 2)|Lost to Follow-up|0
4710724|NCT02900378|7636399|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1
4710725|NCT02900378|7636400|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1
4710726|NCT02900378|7636399|FG000|Randomization (Visit 2)|Protocol Deviation|1
4710727|NCT02900378|7636400|FG001|Randomization (Visit 2)|Protocol Deviation|7
4710728|NCT02900378|7636399|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5
4710729|NCT02900378|7636400|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3
4710730|NCT02900378|7636399|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0
4710731|NCT02900378|7636400|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2
4710732|NCT02901054|7636406|FG000|Overall Study|Physician Decision|1
4710733|NCT02901054|7636406|FG000|Overall Study|Withdrawal by Subject|3
4710734|NCT02901431|7636440|FG000|PK Part|Adverse Event|0
4710735|NCT02901431|7636441|FG001|PK Part|Adverse Event|1
4710736|NCT02901431|7636442|FG002|PK Part|Adverse Event|0
4710737|NCT02901431|7636443|FG003|PK Part|Adverse Event|0
4710738|NCT02901431|7636444|FG004|PK Part|Adverse Event|0
4710739|NCT02901431|7636445|FG005|PK Part|Adverse Event|0
4710740|NCT02901431|7636446|FG006|PK Part|Adverse Event|0
4710741|NCT02901431|7636447|FG007|PK Part|Adverse Event|0
4710742|NCT02901431|7636448|FG008|PK Part|Adverse Event|0
4710743|NCT02901431|7636449|FG009|PK Part|Adverse Event|0
4710744|NCT02901431|7636450|FG010|PK Part|Adverse Event|0
4710745|NCT02901431|7636451|FG011|PK Part|Adverse Event|0
4710746|NCT02901431|7636452|FG012|PK Part|Adverse Event|0
4710747|NCT02901431|7636440|FG000|PK Part|Lost to Follow-up|0
4710748|NCT02901431|7636441|FG001|PK Part|Lost to Follow-up|0
4710749|NCT02901431|7636442|FG002|PK Part|Lost to Follow-up|1
4710750|NCT02901431|7636443|FG003|PK Part|Lost to Follow-up|0
4710751|NCT02901431|7636444|FG004|PK Part|Lost to Follow-up|0
4710752|NCT02901431|7636445|FG005|PK Part|Lost to Follow-up|0
4710753|NCT02901431|7636446|FG006|PK Part|Lost to Follow-up|0
4710754|NCT02901431|7636447|FG007|PK Part|Lost to Follow-up|0
4710755|NCT02901431|7636448|FG008|PK Part|Lost to Follow-up|0
4710756|NCT02901431|7636449|FG009|PK Part|Lost to Follow-up|0
4710757|NCT02901431|7636450|FG010|PK Part|Lost to Follow-up|0
4710758|NCT02901431|7636451|FG011|PK Part|Lost to Follow-up|0
4710759|NCT02901431|7636452|FG012|PK Part|Lost to Follow-up|0
4710760|NCT02901431|7636440|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2
4628292|NCT01858766|7495316|FG000|Overall Study|Lack of Efficacy|1
4628293|NCT01858766|7495317|FG001|Overall Study|Lack of Efficacy|0
4628294|NCT01858766|7495318|FG002|Overall Study|Lack of Efficacy|0
4710761|NCT02901431|7636441|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0
4710762|NCT02901431|7636442|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0
4710763|NCT02901431|7636443|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0
4710764|NCT02901431|7636444|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0
4710765|NCT02901431|7636445|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0
4710766|NCT02901431|7636446|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0
4389857|NCT00074152|7168508|FG001|Overall Study|Lack of Efficacy|24
4389858|NCT00074282|7168527|FG000|Step 1|Adverse Event|32
4389859|NCT00074282|7168528|FG001|Step 1|Adverse Event|0
4389860|NCT00074282|7168529|FG002|Step 1|Adverse Event|0
4389861|NCT00074282|7168527|FG000|Step 1|Death|6
4389862|NCT00074282|7168528|FG001|Step 1|Death|0
4389863|NCT00074282|7168529|FG002|Step 1|Death|0
4389864|NCT00074282|7168527|FG000|Step 1|Withdrawal by Subject|7
4389865|NCT00074282|7168528|FG001|Step 1|Withdrawal by Subject|0
4389866|NCT00074282|7168529|FG002|Step 1|Withdrawal by Subject|0
4389867|NCT00074282|7168527|FG000|Step 1|Disease progression|2
4389868|NCT00074282|7168528|FG001|Step 1|Disease progression|0
4389869|NCT00074282|7168529|FG002|Step 1|Disease progression|0
4389870|NCT00074282|7168527|FG000|Step 1|Alternative therapy|2
4389871|NCT00074282|7168528|FG001|Step 1|Alternative therapy|0
4389872|NCT00074282|7168529|FG002|Step 1|Alternative therapy|0
4389873|NCT00074282|7168527|FG000|Step 1|Other complicating disease|2
4389874|NCT00074282|7168528|FG001|Step 1|Other complicating disease|0
4389875|NCT00074282|7168529|FG002|Step 1|Other complicating disease|0
4389876|NCT00074282|7168527|FG000|Step 1|Physician Decision|1
4389877|NCT00074282|7168528|FG001|Step 1|Physician Decision|0
4389878|NCT00074282|7168529|FG002|Step 1|Physician Decision|0
4389879|NCT00074282|7168527|FG000|Step 1|Ineligible|4
4389880|NCT00074282|7168528|FG001|Step 1|Ineligible|0
4389881|NCT00074282|7168529|FG002|Step 1|Ineligible|0
4389882|NCT00074282|7168527|FG000|Step 1|Never started treatment|2
4389883|NCT00074282|7168528|FG001|Step 1|Never started treatment|0
4389884|NCT00074282|7168529|FG002|Step 1|Never started treatment|0
4710767|NCT02901431|7636447|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0
4710768|NCT02901431|7636448|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0
4710769|NCT02901431|7636449|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0
4710770|NCT02901431|7636450|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0
4710771|NCT02901431|7636451|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0
4710772|NCT02901431|7636452|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0
4710773|NCT02901431|7636440|FG000|PK Part|Pending dose confirmation|0
4389885|NCT00074282|7168527|FG000|Step 2|Adverse Event|0
4389886|NCT00074282|7168528|FG001|Step 2|Adverse Event|2
4389887|NCT00074282|7168529|FG002|Step 2|Adverse Event|12
4710774|NCT02901431|7636441|FG001|PK Part|Pending dose confirmation|1
4710775|NCT02901431|7636442|FG002|PK Part|Pending dose confirmation|0
4710776|NCT02901431|7636443|FG003|PK Part|Pending dose confirmation|0
4710777|NCT02901431|7636444|FG004|PK Part|Pending dose confirmation|0
4710778|NCT02901431|7636445|FG005|PK Part|Pending dose confirmation|0
4710779|NCT02901431|7636446|FG006|PK Part|Pending dose confirmation|0
4710780|NCT02901431|7636447|FG007|PK Part|Pending dose confirmation|0
4710781|NCT02901431|7636448|FG008|PK Part|Pending dose confirmation|0
4710782|NCT02901431|7636449|FG009|PK Part|Pending dose confirmation|0
4710783|NCT02901431|7636450|FG010|PK Part|Pending dose confirmation|0
4710784|NCT02901431|7636451|FG011|PK Part|Pending dose confirmation|0
4710785|NCT02901431|7636452|FG012|PK Part|Pending dose confirmation|0
4710786|NCT02901431|7636440|FG000|PK Part|8 weeks of treatment ran out|2
4710787|NCT02901431|7636441|FG001|PK Part|8 weeks of treatment ran out|0
4710788|NCT02901431|7636442|FG002|PK Part|8 weeks of treatment ran out|0
4710789|NCT02901431|7636443|FG003|PK Part|8 weeks of treatment ran out|0
4710790|NCT02901431|7636444|FG004|PK Part|8 weeks of treatment ran out|0
4710791|NCT02901431|7636445|FG005|PK Part|8 weeks of treatment ran out|0
4710792|NCT02901431|7636446|FG006|PK Part|8 weeks of treatment ran out|0
4710793|NCT02901431|7636447|FG007|PK Part|8 weeks of treatment ran out|0
4710794|NCT02901431|7636448|FG008|PK Part|8 weeks of treatment ran out|0
4710795|NCT02901431|7636449|FG009|PK Part|8 weeks of treatment ran out|0
4710796|NCT02901431|7636450|FG010|PK Part|8 weeks of treatment ran out|0
4710797|NCT02901431|7636451|FG011|PK Part|8 weeks of treatment ran out|0
4710798|NCT02901431|7636452|FG012|PK Part|8 weeks of treatment ran out|0
4710799|NCT02901431|7636440|FG000|PK Part|Stopped treatment after 8 weeks|1
4710800|NCT02901431|7636441|FG001|PK Part|Stopped treatment after 8 weeks|0
4710801|NCT02901431|7636442|FG002|PK Part|Stopped treatment after 8 weeks|1
4710802|NCT02901431|7636443|FG003|PK Part|Stopped treatment after 8 weeks|0
4710803|NCT02901431|7636444|FG004|PK Part|Stopped treatment after 8 weeks|0
4710804|NCT02901431|7636445|FG005|PK Part|Stopped treatment after 8 weeks|0
4710805|NCT02901431|7636446|FG006|PK Part|Stopped treatment after 8 weeks|0
4710806|NCT02901431|7636447|FG007|PK Part|Stopped treatment after 8 weeks|0
4710807|NCT02901431|7636448|FG008|PK Part|Stopped treatment after 8 weeks|0
4710808|NCT02901431|7636449|FG009|PK Part|Stopped treatment after 8 weeks|0
4710809|NCT02901431|7636450|FG010|PK Part|Stopped treatment after 8 weeks|0
4710810|NCT02901431|7636451|FG011|PK Part|Stopped treatment after 8 weeks|0
4710811|NCT02901431|7636452|FG012|PK Part|Stopped treatment after 8 weeks|0
4710812|NCT02901431|7636440|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1
4710813|NCT02901431|7636441|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
4710814|NCT02901431|7636442|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4
4710815|NCT02901431|7636443|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
4710816|NCT02901431|7636444|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
4710817|NCT02901431|7636445|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
4710818|NCT02901431|7636446|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
4710819|NCT02901431|7636447|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
4710820|NCT02901431|7636448|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
4710821|NCT02901431|7636449|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
4710822|NCT02901431|7636450|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
4710823|NCT02901431|7636451|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
4710824|NCT02901431|7636452|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0
4710825|NCT02901431|7636440|FG000|PK Part|Discontinued per Sponsor|0
4710826|NCT02901431|7636441|FG001|PK Part|Discontinued per Sponsor|3
4710827|NCT02901431|7636442|FG002|PK Part|Discontinued per Sponsor|0
4710828|NCT02901431|7636443|FG003|PK Part|Discontinued per Sponsor|0
4710829|NCT02901431|7636444|FG004|PK Part|Discontinued per Sponsor|0
4710830|NCT02901431|7636445|FG005|PK Part|Discontinued per Sponsor|0
4710831|NCT02901431|7636446|FG006|PK Part|Discontinued per Sponsor|0
4710832|NCT02901431|7636447|FG007|PK Part|Discontinued per Sponsor|0
4710833|NCT02901431|7636448|FG008|PK Part|Discontinued per Sponsor|0
4710834|NCT02901431|7636449|FG009|PK Part|Discontinued per Sponsor|0
4710835|NCT02901431|7636450|FG010|PK Part|Discontinued per Sponsor|0
4710836|NCT02901431|7636451|FG011|PK Part|Discontinued per Sponsor|0
4710837|NCT02901431|7636452|FG012|PK Part|Discontinued per Sponsor|0
4710838|NCT02901431|7636440|FG000|PK Part|Withdrawal by Subject|1
4710839|NCT02901431|7636441|FG001|PK Part|Withdrawal by Subject|1
4710840|NCT02901431|7636442|FG002|PK Part|Withdrawal by Subject|3
4710841|NCT02901431|7636443|FG003|PK Part|Withdrawal by Subject|0
4710842|NCT02901431|7636444|FG004|PK Part|Withdrawal by Subject|0
4710843|NCT02901431|7636445|FG005|PK Part|Withdrawal by Subject|0
4710844|NCT02901431|7636446|FG006|PK Part|Withdrawal by Subject|0
4710845|NCT02901431|7636447|FG007|PK Part|Withdrawal by Subject|0
4710846|NCT02901431|7636448|FG008|PK Part|Withdrawal by Subject|0
4710847|NCT02901431|7636449|FG009|PK Part|Withdrawal by Subject|0
4710848|NCT02901431|7636450|FG010|PK Part|Withdrawal by Subject|0
4710849|NCT02901431|7636451|FG011|PK Part|Withdrawal by Subject|0
4710850|NCT02901431|7636452|FG012|PK Part|Withdrawal by Subject|0
4710851|NCT02901431|7636440|FG000|Main Treatment Part|Adverse Event|0
4710852|NCT02901431|7636441|FG001|Main Treatment Part|Adverse Event|0
4710853|NCT02901431|7636442|FG002|Main Treatment Part|Adverse Event|0
4710854|NCT02901431|7636443|FG003|Main Treatment Part|Adverse Event|3
4710855|NCT02901431|7636444|FG004|Main Treatment Part|Adverse Event|3
4710856|NCT02901431|7636445|FG005|Main Treatment Part|Adverse Event|4
4710857|NCT02901431|7636446|FG006|Main Treatment Part|Adverse Event|1
4710858|NCT02901431|7636447|FG007|Main Treatment Part|Adverse Event|0
4710859|NCT02901431|7636448|FG008|Main Treatment Part|Adverse Event|0
4710860|NCT02901431|7636449|FG009|Main Treatment Part|Adverse Event|0
4710861|NCT02901431|7636450|FG010|Main Treatment Part|Adverse Event|0
4710862|NCT02901431|7636451|FG011|Main Treatment Part|Adverse Event|0
4710863|NCT02901431|7636452|FG012|Main Treatment Part|Adverse Event|0
4710864|NCT02901431|7636440|FG000|Main Treatment Part|Lack of Efficacy|0
4710865|NCT02901431|7636441|FG001|Main Treatment Part|Lack of Efficacy|0
4710866|NCT02901431|7636442|FG002|Main Treatment Part|Lack of Efficacy|0
4710867|NCT02901431|7636443|FG003|Main Treatment Part|Lack of Efficacy|1
4710868|NCT02901431|7636444|FG004|Main Treatment Part|Lack of Efficacy|0
4389888|NCT00074282|7168527|FG000|Step 2|Disease progression|0
4389889|NCT00074282|7168528|FG001|Step 2|Disease progression|0
4389890|NCT00074282|7168529|FG002|Step 2|Disease progression|5
4389891|NCT00074282|7168527|FG000|Step 2|Death|0
4389892|NCT00074282|7168528|FG001|Step 2|Death|0
4389893|NCT00074282|7168529|FG002|Step 2|Death|3
4389894|NCT00074282|7168527|FG000|Step 2|Withdrawal by Subject|0
4389895|NCT00074282|7168528|FG001|Step 2|Withdrawal by Subject|0
4389896|NCT00074282|7168529|FG002|Step 2|Withdrawal by Subject|2
4389897|NCT00074282|7168527|FG000|Step 2|Physician Decision|0
4389898|NCT00074282|7168528|FG001|Step 2|Physician Decision|0
4389899|NCT00074282|7168529|FG002|Step 2|Physician Decision|1
4389900|NCT00074282|7168527|FG000|Step 2|Ineligible|0
4389901|NCT00074282|7168528|FG001|Step 2|Ineligible|0
4389902|NCT00074282|7168529|FG002|Step 2|Ineligible|1
4389903|NCT00074412|7168555|FG000|Overall Study|Death|30
4389904|NCT00074412|7168556|FG001|Overall Study|Death|26
4389905|NCT00074412|7168555|FG000|Overall Study|Lost to Follow-up|52
4389906|NCT00074412|7168556|FG001|Overall Study|Lost to Follow-up|58
4389907|NCT00074490|7168568|FG000|Overall Study|Progressive malignancy|0
4389908|NCT00074490|7168569|FG001|Overall Study|Progressive malignancy|7
4389909|NCT00074490|7168570|FG002|Overall Study|Progressive malignancy|0
4389910|NCT00074490|7168571|FG003|Overall Study|Progressive malignancy|0
4389911|NCT00074490|7168572|FG004|Overall Study|Progressive malignancy|3
4389912|NCT00074490|7168573|FG005|Overall Study|Progressive malignancy|0
4389913|NCT00074581|7168588|FG000|Overall Study|Death|15
4389914|NCT00074581|7168589|FG001|Overall Study|Death|16
4389915|NCT00074581|7168588|FG000|Overall Study|Withdrawal by Subject|50
4389916|NCT00074581|7168589|FG001|Overall Study|Withdrawal by Subject|49
4389917|NCT00074581|7168588|FG000|Overall Study|Unable to adhere to visit schedule|13
4389918|NCT00074581|7168589|FG001|Overall Study|Unable to adhere to visit schedule|14
4389919|NCT00074581|7168588|FG000|Overall Study|Relocated|14
4389920|NCT00074581|7168589|FG001|Overall Study|Relocated|9
4389921|NCT00074581|7168588|FG000|Overall Study|Were withdrawn by investigator|5
4389922|NCT00074581|7168589|FG001|Overall Study|Were withdrawn by investigator|2
4389923|NCT00074581|7168588|FG000|Overall Study|Lost to Follow-up|16
4389924|NCT00074581|7168589|FG001|Overall Study|Lost to Follow-up|11
4389925|NCT00074581|7168588|FG000|Overall Study|Ended relationship w. index participant|117
4389926|NCT00074581|7168589|FG001|Overall Study|Ended relationship w. index participant|106
4389927|NCT00074581|7168588|FG000|Overall Study|Other|14
4389928|NCT00074581|7168589|FG001|Overall Study|Other|19
4389929|NCT00074711|7168597|FG000|Overall Study|Withdrawal by Subject|1
4389930|NCT00074711|7168598|FG001|Overall Study|Withdrawal by Subject|1
4389931|NCT00074711|7168597|FG000|Overall Study|Lost to Follow-up|10
4389932|NCT00074711|7168598|FG001|Overall Study|Lost to Follow-up|8
4389933|NCT00074711|7168597|FG000|Overall Study|Participant stopped study drug|4
4389934|NCT00074711|7168598|FG001|Overall Study|Participant stopped study drug|6
4389935|NCT00074958|7168626|FG000|Overall Study|Adverse Event|1
4389936|NCT00074984|7168632|FG000|Overall Study|Death|1
4389937|NCT00074984|7168633|FG001|Overall Study|Death|2
4389938|NCT00074984|7168632|FG000|Overall Study|Withdrawal by Subject|2
4389939|NCT00074984|7168633|FG001|Overall Study|Withdrawal by Subject|3
4389940|NCT00074984|7168632|FG000|Overall Study|Patient Withdrawn Per Protocol|0
4389941|NCT00074984|7168633|FG001|Overall Study|Patient Withdrawn Per Protocol|3
4389942|NCT00075023|7168642|FG000|Pilot Study|Physician Decision|1
4389943|NCT00075023|7168643|FG001|Pilot Study|Physician Decision|2
4389944|NCT00075023|7168642|FG000|Pilot Study|Withdrawal by Subject|1
4710869|NCT02901431|7636445|FG005|Main Treatment Part|Lack of Efficacy|0
4710870|NCT02901431|7636446|FG006|Main Treatment Part|Lack of Efficacy|0
4710871|NCT02901431|7636447|FG007|Main Treatment Part|Lack of Efficacy|0
4710872|NCT02901431|7636448|FG008|Main Treatment Part|Lack of Efficacy|0
4710873|NCT02901431|7636449|FG009|Main Treatment Part|Lack of Efficacy|0
4710874|NCT02901431|7636450|FG010|Main Treatment Part|Lack of Efficacy|0
4710875|NCT02901431|7636451|FG011|Main Treatment Part|Lack of Efficacy|0
4710876|NCT02901431|7636452|FG012|Main Treatment Part|Lack of Efficacy|0
4710877|NCT02901431|7636440|FG000|Main Treatment Part|Lost to Follow-up|0
4710878|NCT02901431|7636441|FG001|Main Treatment Part|Lost to Follow-up|0
4710879|NCT02901431|7636442|FG002|Main Treatment Part|Lost to Follow-up|0
4710880|NCT02901431|7636443|FG003|Main Treatment Part|Lost to Follow-up|3
4389945|NCT00075023|7168643|FG001|Pilot Study|Withdrawal by Subject|0
4389946|NCT00075218|7168662|FG000|Double-Blind Treatment|Adverse Event|23
4389947|NCT00075218|7168663|FG001|Double-Blind Treatment|Adverse Event|4
4710881|NCT02901431|7636444|FG004|Main Treatment Part|Lost to Follow-up|1
4710882|NCT02901431|7636445|FG005|Main Treatment Part|Lost to Follow-up|2
4710883|NCT02901431|7636446|FG006|Main Treatment Part|Lost to Follow-up|3
4710884|NCT02901431|7636447|FG007|Main Treatment Part|Lost to Follow-up|0
4710885|NCT02901431|7636448|FG008|Main Treatment Part|Lost to Follow-up|0
4710886|NCT02901431|7636449|FG009|Main Treatment Part|Lost to Follow-up|0
4710887|NCT02901431|7636450|FG010|Main Treatment Part|Lost to Follow-up|0
4710888|NCT02901431|7636451|FG011|Main Treatment Part|Lost to Follow-up|0
4710889|NCT02901431|7636452|FG012|Main Treatment Part|Lost to Follow-up|0
4710890|NCT02901431|7636440|FG000|Main Treatment Part|Withdrawal by Caregiver|0
4710891|NCT02901431|7636441|FG001|Main Treatment Part|Withdrawal by Caregiver|0
4710892|NCT02901431|7636442|FG002|Main Treatment Part|Withdrawal by Caregiver|0
4710893|NCT02901431|7636443|FG003|Main Treatment Part|Withdrawal by Caregiver|0
4710894|NCT02901431|7636444|FG004|Main Treatment Part|Withdrawal by Caregiver|0
4710895|NCT02901431|7636445|FG005|Main Treatment Part|Withdrawal by Caregiver|1
4710896|NCT02901431|7636446|FG006|Main Treatment Part|Withdrawal by Caregiver|0
4710897|NCT02901431|7636447|FG007|Main Treatment Part|Withdrawal by Caregiver|0
4710898|NCT02901431|7636448|FG008|Main Treatment Part|Withdrawal by Caregiver|0
4710899|NCT02901431|7636449|FG009|Main Treatment Part|Withdrawal by Caregiver|0
4710900|NCT02901431|7636450|FG010|Main Treatment Part|Withdrawal by Caregiver|0
4710901|NCT02901431|7636451|FG011|Main Treatment Part|Withdrawal by Caregiver|0
4710902|NCT02901431|7636452|FG012|Main Treatment Part|Withdrawal by Caregiver|0
4710903|NCT02901431|7636440|FG000|Main Treatment Part|Physician Decision|0
4710904|NCT02901431|7636441|FG001|Main Treatment Part|Physician Decision|0
4710905|NCT02901431|7636442|FG002|Main Treatment Part|Physician Decision|0
4710906|NCT02901431|7636443|FG003|Main Treatment Part|Physician Decision|1
4710907|NCT02901431|7636444|FG004|Main Treatment Part|Physician Decision|0
4710908|NCT02901431|7636445|FG005|Main Treatment Part|Physician Decision|0
4710909|NCT02901431|7636446|FG006|Main Treatment Part|Physician Decision|1
4710910|NCT02901431|7636447|FG007|Main Treatment Part|Physician Decision|0
4710911|NCT02901431|7636448|FG008|Main Treatment Part|Physician Decision|0
4710912|NCT02901431|7636449|FG009|Main Treatment Part|Physician Decision|0
4710913|NCT02901431|7636450|FG010|Main Treatment Part|Physician Decision|0
4710914|NCT02901431|7636451|FG011|Main Treatment Part|Physician Decision|0
4710915|NCT02901431|7636452|FG012|Main Treatment Part|Physician Decision|0
4710916|NCT02901431|7636440|FG000|Main Treatment Part|Withdrawal by Subject|0
4710917|NCT02901431|7636441|FG001|Main Treatment Part|Withdrawal by Subject|0
4710918|NCT02901431|7636442|FG002|Main Treatment Part|Withdrawal by Subject|0
4710919|NCT02901431|7636443|FG003|Main Treatment Part|Withdrawal by Subject|18
4710920|NCT02901431|7636444|FG004|Main Treatment Part|Withdrawal by Subject|3
4710921|NCT02901431|7636445|FG005|Main Treatment Part|Withdrawal by Subject|5
4710922|NCT02901431|7636446|FG006|Main Treatment Part|Withdrawal by Subject|6
4710923|NCT02901431|7636447|FG007|Main Treatment Part|Withdrawal by Subject|0
4710924|NCT02901431|7636448|FG008|Main Treatment Part|Withdrawal by Subject|0
4710925|NCT02901431|7636449|FG009|Main Treatment Part|Withdrawal by Subject|0
4710926|NCT02901431|7636450|FG010|Main Treatment Part|Withdrawal by Subject|0
4710927|NCT02901431|7636451|FG011|Main Treatment Part|Withdrawal by Subject|0
4710928|NCT02901431|7636452|FG012|Main Treatment Part|Withdrawal by Subject|0
4710929|NCT02901431|7636440|FG000|Open Label Part|Adverse Event|0
4710930|NCT02901431|7636441|FG001|Open Label Part|Adverse Event|0
4710931|NCT02901431|7636442|FG002|Open Label Part|Adverse Event|0
4710932|NCT02901431|7636443|FG003|Open Label Part|Adverse Event|0
4710933|NCT02901431|7636444|FG004|Open Label Part|Adverse Event|0
4710934|NCT02901431|7636445|FG005|Open Label Part|Adverse Event|0
4710935|NCT02901431|7636446|FG006|Open Label Part|Adverse Event|0
4710936|NCT02901431|7636447|FG007|Open Label Part|Adverse Event|0
4710937|NCT02901431|7636448|FG008|Open Label Part|Adverse Event|4
4710938|NCT02901431|7636449|FG009|Open Label Part|Adverse Event|4
4710939|NCT02901431|7636450|FG010|Open Label Part|Adverse Event|0
4710940|NCT02901431|7636451|FG011|Open Label Part|Adverse Event|4
4710941|NCT02901431|7636452|FG012|Open Label Part|Adverse Event|1
4710942|NCT02901431|7636440|FG000|Open Label Part|Lost to Follow-up|0
4710943|NCT02901431|7636441|FG001|Open Label Part|Lost to Follow-up|0
4710944|NCT02901431|7636442|FG002|Open Label Part|Lost to Follow-up|0
4710945|NCT02901431|7636443|FG003|Open Label Part|Lost to Follow-up|0
4710946|NCT02901431|7636444|FG004|Open Label Part|Lost to Follow-up|0
4710947|NCT02901431|7636445|FG005|Open Label Part|Lost to Follow-up|0
4710948|NCT02901431|7636446|FG006|Open Label Part|Lost to Follow-up|0
4710949|NCT02901431|7636447|FG007|Open Label Part|Lost to Follow-up|0
4710950|NCT02901431|7636448|FG008|Open Label Part|Lost to Follow-up|2
4710951|NCT02901431|7636449|FG009|Open Label Part|Lost to Follow-up|2
4710952|NCT02901431|7636450|FG010|Open Label Part|Lost to Follow-up|1
4710953|NCT02901431|7636451|FG011|Open Label Part|Lost to Follow-up|1
4710954|NCT02901431|7636452|FG012|Open Label Part|Lost to Follow-up|1
4710955|NCT02901431|7636440|FG000|Open Label Part|Physician Decision|0
4710956|NCT02901431|7636441|FG001|Open Label Part|Physician Decision|0
4710957|NCT02901431|7636442|FG002|Open Label Part|Physician Decision|0
4710958|NCT02901431|7636443|FG003|Open Label Part|Physician Decision|0
4710959|NCT02901431|7636444|FG004|Open Label Part|Physician Decision|0
4710960|NCT02901431|7636445|FG005|Open Label Part|Physician Decision|0
4710961|NCT02901431|7636446|FG006|Open Label Part|Physician Decision|0
4710962|NCT02901431|7636447|FG007|Open Label Part|Physician Decision|0
4710963|NCT02901431|7636448|FG008|Open Label Part|Physician Decision|1
4710964|NCT02901431|7636449|FG009|Open Label Part|Physician Decision|1
4710965|NCT02901431|7636450|FG010|Open Label Part|Physician Decision|0
4710966|NCT02901431|7636451|FG011|Open Label Part|Physician Decision|0
4710967|NCT02901431|7636452|FG012|Open Label Part|Physician Decision|0
4710968|NCT02901431|7636440|FG000|Open Label Part|Study Terminated By Sponsor|0
4710969|NCT02901431|7636441|FG001|Open Label Part|Study Terminated By Sponsor|0
4710970|NCT02901431|7636442|FG002|Open Label Part|Study Terminated By Sponsor|0
4710971|NCT02901431|7636443|FG003|Open Label Part|Study Terminated By Sponsor|0
4710972|NCT02901431|7636444|FG004|Open Label Part|Study Terminated By Sponsor|0
4710973|NCT02901431|7636445|FG005|Open Label Part|Study Terminated By Sponsor|0
4710974|NCT02901431|7636446|FG006|Open Label Part|Study Terminated By Sponsor|0
4710975|NCT02901431|7636447|FG007|Open Label Part|Study Terminated By Sponsor|0
4389948|NCT00075218|7168664|FG002|Double-Blind Treatment|Adverse Event|0
4389949|NCT00075218|7168662|FG000|Double-Blind Treatment|Withdrawal by Subject|7
4389950|NCT00075218|7168663|FG001|Double-Blind Treatment|Withdrawal by Subject|4
4389951|NCT00075218|7168664|FG002|Double-Blind Treatment|Withdrawal by Subject|0
4389952|NCT00075218|7168662|FG000|Double-Blind Treatment|Lost to Follow-up|1
4389953|NCT00075218|7168663|FG001|Double-Blind Treatment|Lost to Follow-up|0
4389954|NCT00075218|7168664|FG002|Double-Blind Treatment|Lost to Follow-up|0
4389955|NCT00075218|7168662|FG000|Double-Blind Treatment|Lack of Efficacy|58
4389956|NCT00075218|7168663|FG001|Double-Blind Treatment|Lack of Efficacy|6
4389957|NCT00075218|7168664|FG002|Double-Blind Treatment|Lack of Efficacy|0
4389958|NCT00075218|7168662|FG000|Double-Blind Treatment|Decision of Sponsor|0
4389959|NCT00075218|7168663|FG001|Double-Blind Treatment|Decision of Sponsor|1
4389960|NCT00075218|7168664|FG002|Double-Blind Treatment|Decision of Sponsor|0
4389961|NCT00075218|7168662|FG000|Double-Blind Treatment|No study medication taken|2
4389962|NCT00075218|7168663|FG001|Double-Blind Treatment|No study medication taken|0
4389963|NCT00075218|7168664|FG002|Double-Blind Treatment|No study medication taken|0
4389964|NCT00075218|7168662|FG000|Open-Label Treatment|Lack of Efficacy|0
4389965|NCT00075218|7168663|FG001|Open-Label Treatment|Lack of Efficacy|0
4389966|NCT00075218|7168664|FG002|Open-Label Treatment|Lack of Efficacy|174
4389967|NCT00075218|7168662|FG000|Open-Label Treatment|Adverse Event|0
4389968|NCT00075218|7168663|FG001|Open-Label Treatment|Adverse Event|0
4389969|NCT00075218|7168664|FG002|Open-Label Treatment|Adverse Event|51
4389970|NCT00075218|7168662|FG000|Open-Label Treatment|Withdrawal by Subject|0
4389971|NCT00075218|7168663|FG001|Open-Label Treatment|Withdrawal by Subject|0
4389972|NCT00075218|7168664|FG002|Open-Label Treatment|Withdrawal by Subject|12
4389973|NCT00075218|7168662|FG000|Open-Label Treatment|Decision of Sponsor|0
4389974|NCT00075218|7168663|FG001|Open-Label Treatment|Decision of Sponsor|0
4389975|NCT00075218|7168664|FG002|Open-Label Treatment|Decision of Sponsor|8
4389976|NCT00075218|7168662|FG000|Open-Label Treatment|Protocol Violation|0
4389977|NCT00075218|7168663|FG001|Open-Label Treatment|Protocol Violation|0
4389978|NCT00075218|7168664|FG002|Open-Label Treatment|Protocol Violation|1
4389979|NCT00075218|7168662|FG000|Open-Label Treatment|enrolled in a separate continuation|0
4389980|NCT00075218|7168663|FG001|Open-Label Treatment|enrolled in a separate continuation|0
4389981|NCT00075218|7168664|FG002|Open-Label Treatment|enrolled in a separate continuation|9
4389982|NCT00075270|7168673|FG000|Overall Study|Withdrawal by Subject|28
4389983|NCT00075270|7168674|FG001|Overall Study|Withdrawal by Subject|21
4389984|NCT00075270|7168673|FG000|Overall Study|Lost to Follow-up|25
4389985|NCT00075270|7168674|FG001|Overall Study|Lost to Follow-up|28
4389986|NCT00075270|7168673|FG000|Overall Study|Protocol Violation|0
4389987|NCT00075270|7168674|FG001|Overall Study|Protocol Violation|2
4389988|NCT00075270|7168673|FG000|Overall Study|Death|198
4389989|NCT00075270|7168674|FG001|Overall Study|Death|215
4389990|NCT00075270|7168673|FG000|Overall Study|Other/Unknown|9
4389991|NCT00075270|7168674|FG001|Overall Study|Other/Unknown|5
4389992|NCT00075270|7168673|FG000|Overall Study|Missing|26
4389993|NCT00075270|7168674|FG001|Overall Study|Missing|13
4389994|NCT00075400|7168685|FG000|Overall Study|Ineligible: wrong primary|1
4389995|NCT00075400|7168685|FG000|Overall Study|Never treated|2
4389996|NCT00075478|7168696|FG000|Overall Study|not eligible|1
4389997|NCT00075478|7168697|FG001|Overall Study|not eligible|0
4389998|NCT00075478|7168696|FG000|Overall Study|Physician Decision|0
4389999|NCT00075478|7168697|FG001|Overall Study|Physician Decision|1
4390000|NCT00075504|7168705|FG000|Overall Study|Withdrawal by Subject|9
4390001|NCT00075504|7168706|FG001|Overall Study|Withdrawal by Subject|7
4390002|NCT00075582|7168714|FG000|Overall Study|Adverse Event|3
4390003|NCT00075582|7168715|FG001|Overall Study|Adverse Event|1
4390004|NCT00075582|7168714|FG000|Overall Study|Lack of Efficacy|4
4390005|NCT00075582|7168715|FG001|Overall Study|Lack of Efficacy|8
4390006|NCT00075582|7168714|FG000|Overall Study|Physician Decision|5
4390007|NCT00075582|7168715|FG001|Overall Study|Physician Decision|8
4390008|NCT00075582|7168714|FG000|Overall Study|Withdrawal by Subject|2
4390009|NCT00075582|7168715|FG001|Overall Study|Withdrawal by Subject|2
4510701|NCT00922480|7319594|FG001|Main Study|Lack of Efficacy|0
4510702|NCT00922480|7319593|FG000|Main Study|Withdrawal by Subject|20
4710976|NCT02901431|7636448|FG008|Open Label Part|Study Terminated By Sponsor|35
4710977|NCT02901431|7636449|FG009|Open Label Part|Study Terminated By Sponsor|12
4390010|NCT00075582|7168714|FG000|Overall Study|Ineligible for study|36
4510703|NCT00922480|7319594|FG001|Main Study|Withdrawal by Subject|15
4710978|NCT02901431|7636450|FG010|Open Label Part|Study Terminated By Sponsor|21
4710979|NCT02901431|7636451|FG011|Open Label Part|Study Terminated By Sponsor|31
4710980|NCT02901431|7636452|FG012|Open Label Part|Study Terminated By Sponsor|0
4710981|NCT02901431|7636440|FG000|Open Label Part|Withdrawal by Subject|0
4710982|NCT02901431|7636441|FG001|Open Label Part|Withdrawal by Subject|0
4710983|NCT02901431|7636442|FG002|Open Label Part|Withdrawal by Subject|0
4710984|NCT02901431|7636443|FG003|Open Label Part|Withdrawal by Subject|0
4710985|NCT02901431|7636444|FG004|Open Label Part|Withdrawal by Subject|0
4710986|NCT02901431|7636445|FG005|Open Label Part|Withdrawal by Subject|0
4710987|NCT02901431|7636446|FG006|Open Label Part|Withdrawal by Subject|0
4710988|NCT02901431|7636447|FG007|Open Label Part|Withdrawal by Subject|0
4710989|NCT02901431|7636448|FG008|Open Label Part|Withdrawal by Subject|6
4710990|NCT02901431|7636449|FG009|Open Label Part|Withdrawal by Subject|5
4710991|NCT02901431|7636450|FG010|Open Label Part|Withdrawal by Subject|7
4710992|NCT02901431|7636451|FG011|Open Label Part|Withdrawal by Subject|3
4710993|NCT02901431|7636452|FG012|Open Label Part|Withdrawal by Subject|1
4735946|NCT03550313|7684512|FG002|Overall Study|No longer met eligibility criteria|6
4735947|NCT03550313|7684510|FG000|Overall Study|Withdrawal by parent/guardian|20
4735948|NCT03550313|7684511|FG001|Overall Study|Withdrawal by parent/guardian|18
4735949|NCT03550313|7684512|FG002|Overall Study|Withdrawal by parent/guardian|26
4735950|NCT03550313|7684510|FG000|Overall Study|Other|4
4735951|NCT03550313|7684511|FG001|Overall Study|Other|2
4735952|NCT03550313|7684512|FG002|Overall Study|Other|2
4735953|NCT03550313|7684510|FG000|Overall Study|Randomized but not vaccinated|3
4735954|NCT03550313|7684511|FG001|Overall Study|Randomized but not vaccinated|23
4735955|NCT03550313|7684512|FG002|Overall Study|Randomized but not vaccinated|2
4735956|NCT03550313|7684510|FG000|Overall Study|Sites terminated due to quality issues|18
4735957|NCT03550313|7684511|FG001|Overall Study|Sites terminated due to quality issues|17
4735958|NCT03550313|7684512|FG002|Overall Study|Sites terminated due to quality issues|18
4735959|NCT03550378|7684523|FG000|Overall Study|Death|0
4735960|NCT03550378|7684524|FG001|Overall Study|Death|1
4735961|NCT03551730|7684556|FG000|Overall Study|Adverse Event|1
4735962|NCT03551730|7684557|FG001|Overall Study|Adverse Event|0
4735963|NCT03551730|7684558|FG002|Overall Study|Adverse Event|0
4735964|NCT03551730|7684559|FG003|Overall Study|Adverse Event|0
4735965|NCT03551743|7684573|FG000|Overall Study|Adverse Event|1
4735966|NCT03551743|7684574|FG001|Overall Study|Adverse Event|0
4735967|NCT03551743|7684575|FG002|Overall Study|Adverse Event|0
4735968|NCT03551743|7684576|FG003|Overall Study|Adverse Event|0
4735969|NCT03551743|7684573|FG000|Overall Study|Withdrawal by Subject|1
4735970|NCT03551743|7684574|FG001|Overall Study|Withdrawal by Subject|0
4735971|NCT03551743|7684575|FG002|Overall Study|Withdrawal by Subject|0
4735972|NCT03551743|7684576|FG003|Overall Study|Withdrawal by Subject|0
4735973|NCT03552198|7684594|FG000|Overall Study|Lost to Follow-up|42
4735974|NCT03552198|7684595|FG001|Overall Study|Lost to Follow-up|48
4735975|NCT03552198|7684596|FG002|Overall Study|Lost to Follow-up|15
4735976|NCT03552198|7684597|FG003|Overall Study|Lost to Follow-up|19
4735977|NCT03552198|7684594|FG000|Overall Study|Incomplete/unmatched questionnaire|6
4735978|NCT03552198|7684595|FG001|Overall Study|Incomplete/unmatched questionnaire|7
4735979|NCT03552198|7684596|FG002|Overall Study|Incomplete/unmatched questionnaire|2
4735980|NCT03552198|7684597|FG003|Overall Study|Incomplete/unmatched questionnaire|2
4735981|NCT03552198|7684594|FG000|Overall Study|Did not receive air alerts|1
4735982|NCT03552198|7684595|FG001|Overall Study|Did not receive air alerts|0
4735983|NCT03552198|7684596|FG002|Overall Study|Did not receive air alerts|0
4735984|NCT03552198|7684597|FG003|Overall Study|Did not receive air alerts|1
4735985|NCT03552523|7684616|FG000|Overall Study|Withdrawal by Subject|1
4735986|NCT03552523|7684617|FG001|Overall Study|Withdrawal by Subject|1
4735987|NCT03552549|7684636|FG000|Overall Study|Disease progression|25
4735988|NCT03552549|7684637|FG001|Overall Study|Disease progression|17
4735989|NCT03552549|7684636|FG000|Overall Study|Adverse event in first 12 months|12
4735990|NCT03552549|7684637|FG001|Overall Study|Adverse event in first 12 months|8
4735991|NCT03552549|7684636|FG000|Overall Study|Withdrawal by Subject|7
4735992|NCT03552549|7684637|FG001|Overall Study|Withdrawal by Subject|7
4735993|NCT03552549|7684636|FG000|Overall Study|Unknown (no reason provided)|4
4735994|NCT03552549|7684637|FG001|Overall Study|Unknown (no reason provided)|2
4735995|NCT03552549|7684636|FG000|Overall Study|Not in participant's best interest|2
4735996|NCT03552549|7684637|FG001|Overall Study|Not in participant's best interest|1
4735997|NCT03552549|7684636|FG000|Overall Study|Did not complete study treatment|2
4735998|NCT03552549|7684637|FG001|Overall Study|Did not complete study treatment|3
4735999|NCT03552549|7684636|FG000|Overall Study|Did not meet eligibility criteria|1
4736000|NCT03552549|7684637|FG001|Overall Study|Did not meet eligibility criteria|0
4736001|NCT03552549|7684636|FG000|Overall Study|Administrative|0
4736002|NCT03552549|7684637|FG001|Overall Study|Administrative|14
4736003|NCT03552757|7684646|FG000|Overall Study|Withdrawal by Subject|10
4736004|NCT03552757|7684647|FG001|Overall Study|Withdrawal by Subject|5
4736005|NCT03552757|7684648|FG002|Overall Study|Withdrawal by Subject|12
4736006|NCT03552757|7684646|FG000|Overall Study|Lost to Follow-up|2
4736007|NCT03552757|7684647|FG001|Overall Study|Lost to Follow-up|7
4736008|NCT03552757|7684648|FG002|Overall Study|Lost to Follow-up|7
4736009|NCT03552757|7684646|FG000|Overall Study|Death|1
4736010|NCT03552757|7684647|FG001|Overall Study|Death|1
4710994|NCT02902809|7636536|FG000|Overall Study|Discontinuation of asthma program|28
4710995|NCT02902965|7636548|FG000|Overall Study|Withdrawal by Subject|10
4710996|NCT02903030|7636555|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2
4710997|NCT02903030|7636556|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1
4710998|NCT02903238|7636574|FG000|Overall Study|Lost to Follow-up|4
4710999|NCT02903368|7636581|FG000|Overall Study|Not sprcified|4
4711000|NCT02903368|7636582|FG001|Overall Study|Not sprcified|0
4711001|NCT02903420|7636610|FG000|Overall Study|Death|3
4711002|NCT02903511|7636625|FG000|Overall Study|Withdrawal by Subject|1
4711003|NCT02903511|7636626|FG001|Overall Study|Withdrawal by Subject|0
4711004|NCT02903511|7636625|FG000|Overall Study|Lost to Follow-up|3
4711005|NCT02903511|7636626|FG001|Overall Study|Lost to Follow-up|2
4711006|NCT02903966|7636647|FG000|Part A (Day 1 to 43)|Adverse Event|1
4711007|NCT02903966|7636648|FG001|Part A (Day 1 to 43)|Adverse Event|0
4711008|NCT02903966|7636647|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0
4711009|NCT02903966|7636648|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1
4711010|NCT02903966|7636647|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0
4711011|NCT02903966|7636648|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1
4711012|NCT02904096|7636671|FG000|Overall Study|Adverse Event|1
4711013|NCT02904096|7636672|FG001|Overall Study|Adverse Event|0
4711014|NCT02904096|7636671|FG000|Overall Study|Withdrawal by Subject|4
4711015|NCT02904096|7636672|FG001|Overall Study|Withdrawal by Subject|3
4390011|NCT00075582|7168715|FG001|Overall Study|Ineligible for study|16
4390012|NCT00075725|7168737|FG000|Overall Study|Adverse Event|6
4390013|NCT00075725|7168738|FG001|Overall Study|Adverse Event|6
4390014|NCT00075725|7168739|FG002|Overall Study|Adverse Event|20
4390015|NCT00075725|7168740|FG003|Overall Study|Adverse Event|8
4390016|NCT00075725|7168741|FG004|Overall Study|Adverse Event|4
4390017|NCT00075725|7168742|FG005|Overall Study|Adverse Event|38
4390018|NCT00075725|7168743|FG006|Overall Study|Adverse Event|3
4390019|NCT00075725|7168744|FG007|Overall Study|Adverse Event|51
4390020|NCT00075725|7168745|FG008|Overall Study|Adverse Event|15
4390021|NCT00075725|7168746|FG009|Overall Study|Adverse Event|4
4390022|NCT00075725|7168747|FG010|Overall Study|Adverse Event|2
4390023|NCT00075725|7168748|FG011|Overall Study|Adverse Event|2
4390024|NCT00075725|7168737|FG000|Overall Study|Death|3
4390025|NCT00075725|7168738|FG001|Overall Study|Death|5
4390026|NCT00075725|7168739|FG002|Overall Study|Death|10
4390027|NCT00075725|7168740|FG003|Overall Study|Death|2
4390028|NCT00075725|7168741|FG004|Overall Study|Death|3
4390029|NCT00075725|7168742|FG005|Overall Study|Death|25
4390030|NCT00075725|7168743|FG006|Overall Study|Death|4
4390031|NCT00075725|7168744|FG007|Overall Study|Death|22
4390032|NCT00075725|7168745|FG008|Overall Study|Death|14
4390033|NCT00075725|7168746|FG009|Overall Study|Death|4
4390034|NCT00075725|7168747|FG010|Overall Study|Death|3
4390035|NCT00075725|7168748|FG011|Overall Study|Death|0
4390036|NCT00075725|7168737|FG000|Overall Study|Lost to Follow-up|1
4390037|NCT00075725|7168738|FG001|Overall Study|Lost to Follow-up|1
4390038|NCT00075725|7168739|FG002|Overall Study|Lost to Follow-up|4
4390039|NCT00075725|7168740|FG003|Overall Study|Lost to Follow-up|1
4390040|NCT00075725|7168741|FG004|Overall Study|Lost to Follow-up|0
4390041|NCT00075725|7168742|FG005|Overall Study|Lost to Follow-up|13
4390042|NCT00075725|7168743|FG006|Overall Study|Lost to Follow-up|2
4390043|NCT00075725|7168744|FG007|Overall Study|Lost to Follow-up|4
4390044|NCT00075725|7168745|FG008|Overall Study|Lost to Follow-up|1
4390045|NCT00075725|7168746|FG009|Overall Study|Lost to Follow-up|0
4390046|NCT00075725|7168747|FG010|Overall Study|Lost to Follow-up|0
4390047|NCT00075725|7168748|FG011|Overall Study|Lost to Follow-up|0
4390048|NCT00075725|7168737|FG000|Overall Study|Physician Decision|2
4390049|NCT00075725|7168738|FG001|Overall Study|Physician Decision|6
4390050|NCT00075725|7168739|FG002|Overall Study|Physician Decision|5
4390051|NCT00075725|7168740|FG003|Overall Study|Physician Decision|8
4390052|NCT00075725|7168741|FG004|Overall Study|Physician Decision|4
4390053|NCT00075725|7168742|FG005|Overall Study|Physician Decision|19
4390054|NCT00075725|7168743|FG006|Overall Study|Physician Decision|3
4390055|NCT00075725|7168744|FG007|Overall Study|Physician Decision|17
4390056|NCT00075725|7168745|FG008|Overall Study|Physician Decision|5
4390057|NCT00075725|7168746|FG009|Overall Study|Physician Decision|0
4390058|NCT00075725|7168747|FG010|Overall Study|Physician Decision|1
4390059|NCT00075725|7168748|FG011|Overall Study|Physician Decision|0
4390060|NCT00075725|7168737|FG000|Overall Study|Pregnancy|0
4390061|NCT00075725|7168738|FG001|Overall Study|Pregnancy|0
4390062|NCT00075725|7168739|FG002|Overall Study|Pregnancy|0
4390063|NCT00075725|7168740|FG003|Overall Study|Pregnancy|0
4390064|NCT00075725|7168741|FG004|Overall Study|Pregnancy|0
4711016|NCT02904096|7636671|FG000|Overall Study|Lost to Follow-up|10
4711017|NCT02904096|7636672|FG001|Overall Study|Lost to Follow-up|17
4711018|NCT02904096|7636671|FG000|Overall Study|Non-compliant|3
4711019|NCT02904096|7636672|FG001|Overall Study|Non-compliant|1
4390065|NCT00075725|7168742|FG005|Overall Study|Pregnancy|1
4390066|NCT00075725|7168743|FG006|Overall Study|Pregnancy|0
4390067|NCT00075725|7168744|FG007|Overall Study|Pregnancy|1
4390068|NCT00075725|7168745|FG008|Overall Study|Pregnancy|0
4390069|NCT00075725|7168746|FG009|Overall Study|Pregnancy|0
4390070|NCT00075725|7168747|FG010|Overall Study|Pregnancy|0
4390071|NCT00075725|7168748|FG011|Overall Study|Pregnancy|0
4390072|NCT00075725|7168737|FG000|Overall Study|Protocol Violation|1
4711020|NCT02904096|7636671|FG000|Overall Study|Sponsor instructed|1
4711021|NCT02904096|7636672|FG001|Overall Study|Sponsor instructed|0
4711022|NCT02904200|7636678|FG000|Overall Study|Withdrawal by Subject|1
4711023|NCT02904200|7636679|FG001|Overall Study|Withdrawal by Subject|0
4711024|NCT02904265|7636716|FG000|Overall Study|Physician Decision|1
4711025|NCT02904265|7636717|FG001|Overall Study|Physician Decision|2
4711026|NCT02904512|7636725|FG000|Overall Study|Withdrawal by Subject|1
4711027|NCT02904512|7636726|FG001|Overall Study|Withdrawal by Subject|0
4711028|NCT02904512|7636725|FG000|Overall Study|Transferred to ICU|1
4711029|NCT02904512|7636726|FG001|Overall Study|Transferred to ICU|0
4711030|NCT02904512|7636725|FG000|Overall Study|Minor Bleeding at site of device insertion|1
4711031|NCT02904512|7636726|FG001|Overall Study|Minor Bleeding at site of device insertion|0
4711032|NCT02904902|7636732|FG000|Overall Study|Withdrawal by Subject|1
4711033|NCT02904954|7636747|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1
4711034|NCT02904954|7636748|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1
4711035|NCT02904954|7636747|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1
4711036|NCT02904954|7636748|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0
4711037|NCT02904954|7636747|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2
4711038|NCT02904954|7636748|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3
4711039|NCT02904954|7636747|FG000|Adjuvant Durvalumab|Recurrence|2
4711040|NCT02904954|7636748|FG001|Adjuvant Durvalumab|Recurrence|0
4711041|NCT02904954|7636747|FG000|Adjuvant Durvalumab|Adverse Event|2
4711042|NCT02904954|7636748|FG001|Adjuvant Durvalumab|Adverse Event|6
4711043|NCT02904954|7636747|FG000|Adjuvant Durvalumab|Participant wishes|12
4711044|NCT02904954|7636748|FG001|Adjuvant Durvalumab|Participant wishes|5
4711045|NCT02904954|7636747|FG000|Adjuvant Durvalumab|Physician Decision|2
4711046|NCT02904954|7636748|FG001|Adjuvant Durvalumab|Physician Decision|1
4711047|NCT02904954|7636747|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1
4711048|NCT02904954|7636748|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0
4711049|NCT02904954|7636747|FG000|Adjuvant Durvalumab|Death|0
4711050|NCT02904954|7636748|FG001|Adjuvant Durvalumab|Death|1
4711051|NCT02904954|7636747|FG000|Adjuvant Durvalumab|Prostate cancer|1
4711052|NCT02904954|7636748|FG001|Adjuvant Durvalumab|Prostate cancer|0
4711053|NCT02904954|7636747|FG000|Adjuvant Durvalumab|Currently on treatment|1
4711054|NCT02904954|7636748|FG001|Adjuvant Durvalumab|Currently on treatment|3
4711055|NCT02905006|7636762|FG000|Overall Study|Adverse Event|1
4711056|NCT02905006|7636763|FG001|Overall Study|Adverse Event|1
4711057|NCT02905006|7636764|FG002|Overall Study|Adverse Event|1
4711058|NCT02905006|7636765|FG003|Overall Study|Adverse Event|1
4711059|NCT02905006|7636766|FG004|Overall Study|Adverse Event|0
4711060|NCT02905006|7636767|FG005|Overall Study|Adverse Event|1
4711061|NCT02905006|7636762|FG000|Overall Study|Lack of Efficacy|1
4711062|NCT02905006|7636763|FG001|Overall Study|Lack of Efficacy|0
4711063|NCT02905006|7636764|FG002|Overall Study|Lack of Efficacy|0
4711064|NCT02905006|7636765|FG003|Overall Study|Lack of Efficacy|0
4711065|NCT02905006|7636766|FG004|Overall Study|Lack of Efficacy|0
4711066|NCT02905006|7636767|FG005|Overall Study|Lack of Efficacy|0
4711067|NCT02905006|7636762|FG000|Overall Study|Protocol Violation|2
4711068|NCT02905006|7636763|FG001|Overall Study|Protocol Violation|0
4711069|NCT02905006|7636764|FG002|Overall Study|Protocol Violation|0
4711070|NCT02905006|7636765|FG003|Overall Study|Protocol Violation|0
4711071|NCT02905006|7636766|FG004|Overall Study|Protocol Violation|0
4711072|NCT02905006|7636767|FG005|Overall Study|Protocol Violation|0
4711073|NCT02905006|7636762|FG000|Overall Study|Lost to Follow-up|0
4711074|NCT02905006|7636763|FG001|Overall Study|Lost to Follow-up|0
4711075|NCT02905006|7636764|FG002|Overall Study|Lost to Follow-up|0
4711076|NCT02905006|7636765|FG003|Overall Study|Lost to Follow-up|1
4711077|NCT02905006|7636766|FG004|Overall Study|Lost to Follow-up|1
4711078|NCT02905006|7636767|FG005|Overall Study|Lost to Follow-up|0
4711079|NCT02905006|7636762|FG000|Overall Study|Withdrawal by Subject|0
4711080|NCT02905006|7636763|FG001|Overall Study|Withdrawal by Subject|0
4711081|NCT02905006|7636764|FG002|Overall Study|Withdrawal by Subject|1
4711082|NCT02905006|7636765|FG003|Overall Study|Withdrawal by Subject|1
4711083|NCT02905006|7636766|FG004|Overall Study|Withdrawal by Subject|0
4711084|NCT02905006|7636767|FG005|Overall Study|Withdrawal by Subject|1
4711085|NCT02905006|7636762|FG000|Overall Study|Screening exclusion criteria met|1
4711086|NCT02905006|7636763|FG001|Overall Study|Screening exclusion criteria met|0
4711087|NCT02905006|7636764|FG002|Overall Study|Screening exclusion criteria met|0
4711088|NCT02905006|7636765|FG003|Overall Study|Screening exclusion criteria met|0
4711089|NCT02905006|7636766|FG004|Overall Study|Screening exclusion criteria met|0
4711090|NCT02905006|7636767|FG005|Overall Study|Screening exclusion criteria met|0
4711091|NCT02905006|7636762|FG000|Overall Study|Lab withdrawal criterion met|0
4711092|NCT02905006|7636763|FG001|Overall Study|Lab withdrawal criterion met|1
4711093|NCT02905006|7636764|FG002|Overall Study|Lab withdrawal criterion met|2
4711094|NCT02905006|7636765|FG003|Overall Study|Lab withdrawal criterion met|2
4711095|NCT02905006|7636766|FG004|Overall Study|Lab withdrawal criterion met|2
4711096|NCT02905006|7636767|FG005|Overall Study|Lab withdrawal criterion met|1
4711097|NCT02905006|7636762|FG000|Overall Study|Positive for Tuberculosis|0
4711098|NCT02905006|7636763|FG001|Overall Study|Positive for Tuberculosis|1
4711099|NCT02905006|7636764|FG002|Overall Study|Positive for Tuberculosis|0
4711100|NCT02905006|7636765|FG003|Overall Study|Positive for Tuberculosis|0
4711101|NCT02905006|7636766|FG004|Overall Study|Positive for Tuberculosis|0
4711102|NCT02905006|7636767|FG005|Overall Study|Positive for Tuberculosis|0
4711103|NCT02905006|7636762|FG000|Overall Study|Subject positive for Hep B|0
4711104|NCT02905006|7636763|FG001|Overall Study|Subject positive for Hep B|0
4711105|NCT02905006|7636764|FG002|Overall Study|Subject positive for Hep B|1
4711106|NCT02905006|7636765|FG003|Overall Study|Subject positive for Hep B|0
4711107|NCT02905006|7636766|FG004|Overall Study|Subject positive for Hep B|0
4711108|NCT02905006|7636767|FG005|Overall Study|Subject positive for Hep B|0
4711109|NCT02905006|7636762|FG000|Overall Study|Patient moved abroad|0
4711110|NCT02905006|7636763|FG001|Overall Study|Patient moved abroad|0
4711111|NCT02905006|7636764|FG002|Overall Study|Patient moved abroad|0
4711112|NCT02905006|7636765|FG003|Overall Study|Patient moved abroad|1
4711113|NCT02905006|7636766|FG004|Overall Study|Patient moved abroad|0
4711114|NCT02905006|7636767|FG005|Overall Study|Patient moved abroad|0
4711115|NCT02905006|7636762|FG000|Overall Study|Patient randomized by mistake|0
4711116|NCT02905006|7636763|FG001|Overall Study|Patient randomized by mistake|0
4711117|NCT02905006|7636764|FG002|Overall Study|Patient randomized by mistake|0
4711118|NCT02905006|7636765|FG003|Overall Study|Patient randomized by mistake|0
4711119|NCT02905006|7636766|FG004|Overall Study|Patient randomized by mistake|0
4711120|NCT02905006|7636767|FG005|Overall Study|Patient randomized by mistake|1
4711121|NCT02905149|7636807|FG000|Overall Study|Lost to Follow-up|2
4711122|NCT02905149|7636808|FG001|Overall Study|Lost to Follow-up|0
4711123|NCT02905266|7636816|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1
4711124|NCT02905266|7636817|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0
4711125|NCT02905266|7636816|FG000|Treatment Phase Part 1|Disease Progression|6
4711126|NCT02905266|7636817|FG001|Treatment Phase Part 1|Disease Progression|7
4711127|NCT02905266|7636816|FG000|Treatment Phase Part 1|Study Drug Toxicity|22
4711128|NCT02905266|7636817|FG001|Treatment Phase Part 1|Study Drug Toxicity|16
4711129|NCT02905266|7636816|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1
4711130|NCT02905266|7636817|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0
4711131|NCT02905266|7636816|FG000|Transition From Part 1 to Part 2|Disease progression|2
4711132|NCT02905266|7636817|FG001|Transition From Part 1 to Part 2|Disease progression|1
4711133|NCT02905266|7636816|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0
4711134|NCT02905266|7636817|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4
4711135|NCT02905266|7636816|FG000|Transition From Part 1 to Part 2|Death|0
4711136|NCT02905266|7636817|FG001|Transition From Part 1 to Part 2|Death|1
4711137|NCT02905266|7636816|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0
4711138|NCT02905266|7636817|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1
4711139|NCT02905266|7636816|FG000|Transition From Part 1 to Part 2|Adverse Event|1
4711140|NCT02905266|7636817|FG001|Transition From Part 1 to Part 2|Adverse Event|1
4711141|NCT02905266|7636816|FG000|Maintenance Phase Part 2|Disease Progression|9
4711142|NCT02905266|7636817|FG001|Maintenance Phase Part 2|Disease Progression|2
4711143|NCT02905266|7636816|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3
4711144|NCT02905266|7636817|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4
4711145|NCT02905266|7636816|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0
4711146|NCT02905266|7636817|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2
4711147|NCT02905331|7636825|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1
4711148|NCT02905331|7636826|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0
4711149|NCT02905331|7636827|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0
4711150|NCT02905331|7636825|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2
4711151|NCT02905331|7636826|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0
4711152|NCT02905331|7636827|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0
4711153|NCT02905331|7636825|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0
4711154|NCT02905331|7636826|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1
4711155|NCT02905331|7636827|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0
4711156|NCT02905331|7636825|FG000|Active Treatment and Follow up (wk16-40)|Other|0
4711157|NCT02905331|7636826|FG001|Active Treatment and Follow up (wk16-40)|Other|6
4711158|NCT02905331|7636827|FG002|Active Treatment and Follow up (wk16-40)|Other|0
4711159|NCT02905331|7636825|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0
4711160|NCT02905331|7636826|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2
4711161|NCT02905331|7636827|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0
4711162|NCT02905435|7636835|FG000|Overall Study|Death|2
4711163|NCT02905435|7636835|FG000|Overall Study|Physician Decision|1
4711164|NCT02905435|7636835|FG000|Overall Study|Lost to Follow-up|4
4711165|NCT02905825|7636840|FG000|Overall Study|Protocol Violation|11
4711166|NCT02905825|7636840|FG000|Overall Study|Device Malfunction|1
4711167|NCT02906358|7636850|FG000|Overall Study|Withdrawal by Subject|10
4711168|NCT02906358|7636851|FG001|Overall Study|Withdrawal by Subject|7
4711169|NCT02906358|7636850|FG000|Overall Study|Lost to Follow-up|12
4711170|NCT02906358|7636851|FG001|Overall Study|Lost to Follow-up|15
4711171|NCT02906579|7636868|FG000|Overall Study|Adverse Event|1
4711172|NCT02906579|7636868|FG000|Overall Study|Physician Decision|1
4711173|NCT02906644|7636890|FG000|First 2 Weeks|Withdrawal by Subject|0
4711174|NCT02906644|7636891|FG001|First 2 Weeks|Withdrawal by Subject|2
4711175|NCT02906644|7636890|FG000|First 2 Weeks|Physician Decision|1
4711176|NCT02906644|7636891|FG001|First 2 Weeks|Physician Decision|1
4711177|NCT02906644|7636890|FG000|Weeks 3 to 14|Withdrawal by Subject|13
4711178|NCT02906644|7636891|FG001|Weeks 3 to 14|Withdrawal by Subject|7
4711179|NCT02906644|7636890|FG000|Weeks 3 to 14|Lost to Follow-up|3
4711180|NCT02906644|7636891|FG001|Weeks 3 to 14|Lost to Follow-up|4
4711181|NCT02906670|7636908|FG000|Cohort 1, QW|Radiological Progression|1
4711182|NCT02906670|7636909|FG001|Cohort 1, QW|Radiological Progression|0
4711183|NCT02906670|7636910|FG002|Cohort 1, QW|Radiological Progression|0
4711184|NCT02906670|7636911|FG003|Cohort 1, QW|Radiological Progression|0
4711185|NCT02906670|7636912|FG004|Cohort 1, QW|Radiological Progression|0
4711186|NCT02906670|7636913|FG005|Cohort 1, QW|Radiological Progression|0
4711187|NCT02906670|7636914|FG006|Cohort 1, QW|Radiological Progression|0
4711188|NCT02906670|7636915|FG007|Cohort 1, QW|Radiological Progression|0
4711189|NCT02906670|7636916|FG008|Cohort 1, QW|Radiological Progression|0
4711190|NCT02906670|7636917|FG009|Cohort 1, QW|Radiological Progression|0
4711191|NCT02906670|7636908|FG000|Cohort 2, QW|Radiological Progression|0
4711192|NCT02906670|7636909|FG001|Cohort 2, QW|Radiological Progression|1
4711193|NCT02906670|7636910|FG002|Cohort 2, QW|Radiological Progression|0
4711194|NCT02906670|7636911|FG003|Cohort 2, QW|Radiological Progression|0
4711195|NCT02906670|7636912|FG004|Cohort 2, QW|Radiological Progression|0
4711196|NCT02906670|7636913|FG005|Cohort 2, QW|Radiological Progression|0
4711197|NCT02906670|7636914|FG006|Cohort 2, QW|Radiological Progression|0
4711198|NCT02906670|7636915|FG007|Cohort 2, QW|Radiological Progression|0
4711199|NCT02906670|7636916|FG008|Cohort 2, QW|Radiological Progression|0
4711200|NCT02906670|7636917|FG009|Cohort 2, QW|Radiological Progression|0
4711201|NCT02906670|7636908|FG000|Cohort 3, QW|Radiological Progression|0
4711202|NCT02906670|7636909|FG001|Cohort 3, QW|Radiological Progression|0
4711203|NCT02906670|7636910|FG002|Cohort 3, QW|Radiological Progression|2
4711204|NCT02906670|7636911|FG003|Cohort 3, QW|Radiological Progression|0
4711205|NCT02906670|7636912|FG004|Cohort 3, QW|Radiological Progression|0
4711206|NCT02906670|7636913|FG005|Cohort 3, QW|Radiological Progression|0
4711207|NCT02906670|7636914|FG006|Cohort 3, QW|Radiological Progression|0
4711208|NCT02906670|7636915|FG007|Cohort 3, QW|Radiological Progression|0
4711209|NCT02906670|7636916|FG008|Cohort 3, QW|Radiological Progression|0
4711210|NCT02906670|7636917|FG009|Cohort 3, QW|Radiological Progression|0
4711211|NCT02906670|7636908|FG000|Cohort 3, QW|Lack of Clinical Benefit|0
4711212|NCT02906670|7636909|FG001|Cohort 3, QW|Lack of Clinical Benefit|0
4711213|NCT02906670|7636910|FG002|Cohort 3, QW|Lack of Clinical Benefit|2
4711214|NCT02906670|7636911|FG003|Cohort 3, QW|Lack of Clinical Benefit|0
4711215|NCT02906670|7636912|FG004|Cohort 3, QW|Lack of Clinical Benefit|0
4711216|NCT02906670|7636913|FG005|Cohort 3, QW|Lack of Clinical Benefit|0
4711217|NCT02906670|7636914|FG006|Cohort 3, QW|Lack of Clinical Benefit|0
4711218|NCT02906670|7636915|FG007|Cohort 3, QW|Lack of Clinical Benefit|0
4711219|NCT02906670|7636916|FG008|Cohort 3, QW|Lack of Clinical Benefit|0
4711220|NCT02906670|7636917|FG009|Cohort 3, QW|Lack of Clinical Benefit|0
4711221|NCT02906670|7636908|FG000|Cohort 4, Q2W|Radiological Progression|0
4711222|NCT02906670|7636909|FG001|Cohort 4, Q2W|Radiological Progression|0
4711223|NCT02906670|7636910|FG002|Cohort 4, Q2W|Radiological Progression|0
4711224|NCT02906670|7636911|FG003|Cohort 4, Q2W|Radiological Progression|0
4711225|NCT02906670|7636912|FG004|Cohort 4, Q2W|Radiological Progression|0
4711226|NCT02906670|7636913|FG005|Cohort 4, Q2W|Radiological Progression|1
4711227|NCT02906670|7636914|FG006|Cohort 4, Q2W|Radiological Progression|0
4390073|NCT00075725|7168738|FG001|Overall Study|Protocol Violation|1
4390074|NCT00075725|7168739|FG002|Overall Study|Protocol Violation|0
4390075|NCT00075725|7168740|FG003|Overall Study|Protocol Violation|3
4390076|NCT00075725|7168741|FG004|Overall Study|Protocol Violation|3
4390077|NCT00075725|7168742|FG005|Overall Study|Protocol Violation|2
4390078|NCT00075725|7168743|FG006|Overall Study|Protocol Violation|1
4390079|NCT00075725|7168744|FG007|Overall Study|Protocol Violation|2
4711228|NCT02906670|7636915|FG007|Cohort 4, Q2W|Radiological Progression|0
4711229|NCT02906670|7636916|FG008|Cohort 4, Q2W|Radiological Progression|0
4711230|NCT02906670|7636917|FG009|Cohort 4, Q2W|Radiological Progression|0
4711231|NCT02906670|7636908|FG000|Cohort 4, Q2W|Clinical Progression|0
4711232|NCT02906670|7636909|FG001|Cohort 4, Q2W|Clinical Progression|0
4711233|NCT02906670|7636910|FG002|Cohort 4, Q2W|Clinical Progression|0
4711234|NCT02906670|7636911|FG003|Cohort 4, Q2W|Clinical Progression|0
4711235|NCT02906670|7636912|FG004|Cohort 4, Q2W|Clinical Progression|0
4711236|NCT02906670|7636913|FG005|Cohort 4, Q2W|Clinical Progression|2
4711237|NCT02906670|7636914|FG006|Cohort 4, Q2W|Clinical Progression|0
4711238|NCT02906670|7636915|FG007|Cohort 4, Q2W|Clinical Progression|0
4711239|NCT02906670|7636916|FG008|Cohort 4, Q2W|Clinical Progression|0
4711240|NCT02906670|7636917|FG009|Cohort 4, Q2W|Clinical Progression|0
4711241|NCT02906670|7636908|FG000|Cohort 5, Q2W|Radiological Progression|0
4711242|NCT02906670|7636909|FG001|Cohort 5, Q2W|Radiological Progression|0
4711243|NCT02906670|7636910|FG002|Cohort 5, Q2W|Radiological Progression|0
4711244|NCT02906670|7636911|FG003|Cohort 5, Q2W|Radiological Progression|0
4711245|NCT02906670|7636912|FG004|Cohort 5, Q2W|Radiological Progression|0
4711246|NCT02906670|7636913|FG005|Cohort 5, Q2W|Radiological Progression|0
4711247|NCT02906670|7636914|FG006|Cohort 5, Q2W|Radiological Progression|4
4711248|NCT02906670|7636915|FG007|Cohort 5, Q2W|Radiological Progression|0
4711249|NCT02906670|7636916|FG008|Cohort 5, Q2W|Radiological Progression|0
4390080|NCT00075725|7168745|FG008|Overall Study|Protocol Violation|3
4390081|NCT00075725|7168746|FG009|Overall Study|Protocol Violation|0
4711250|NCT02906670|7636917|FG009|Cohort 5, Q2W|Radiological Progression|0
4711251|NCT02906670|7636908|FG000|Cohort 5, Q2W|Clinical Progression|0
4711252|NCT02906670|7636909|FG001|Cohort 5, Q2W|Clinical Progression|0
4711253|NCT02906670|7636910|FG002|Cohort 5, Q2W|Clinical Progression|0
4711254|NCT02906670|7636911|FG003|Cohort 5, Q2W|Clinical Progression|0
4771433|NCT02942277|7748232|FG002|Year 2|Travel|0
4771434|NCT02942277|7748233|FG003|Year 2|Travel|0
4771435|NCT02942277|7748234|FG004|Year 2|Travel|0
4771436|NCT02942277|7748235|FG005|Year 2|Travel|1
4771437|NCT02942277|7748236|FG006|Year 2|Travel|0
4771438|NCT02942277|7748237|FG007|Year 2|Travel|0
4771439|NCT02942277|7748238|FG008|Year 2|Travel|0
4771440|NCT02942277|7748239|FG009|Year 2|Travel|1
4771441|NCT02942277|7748240|FG010|Year 2|Travel|3
4771442|NCT02942277|7748230|FG000|Year 2|Non-compliant|0
4771443|NCT02942277|7748231|FG001|Year 2|Non-compliant|0
4771444|NCT02942277|7748232|FG002|Year 2|Non-compliant|0
4771445|NCT02942277|7748233|FG003|Year 2|Non-compliant|0
4771446|NCT02942277|7748234|FG004|Year 2|Non-compliant|1
4771447|NCT02942277|7748235|FG005|Year 2|Non-compliant|1
4771448|NCT02942277|7748236|FG006|Year 2|Non-compliant|0
4771449|NCT02942277|7748237|FG007|Year 2|Non-compliant|0
4771450|NCT02942277|7748238|FG008|Year 2|Non-compliant|0
4771451|NCT02942277|7748239|FG009|Year 2|Non-compliant|0
4771452|NCT02942277|7748240|FG010|Year 2|Non-compliant|0
4771453|NCT02942277|7748230|FG000|Year 2|Withdrawal by Subject|0
4771454|NCT02942277|7748231|FG001|Year 2|Withdrawal by Subject|0
4771455|NCT02942277|7748232|FG002|Year 2|Withdrawal by Subject|0
4771456|NCT02942277|7748233|FG003|Year 2|Withdrawal by Subject|0
4771457|NCT02942277|7748234|FG004|Year 2|Withdrawal by Subject|0
4771458|NCT02942277|7748235|FG005|Year 2|Withdrawal by Subject|0
4771459|NCT02942277|7748236|FG006|Year 2|Withdrawal by Subject|1
4771460|NCT02942277|7748237|FG007|Year 2|Withdrawal by Subject|0
4771461|NCT02942277|7748238|FG008|Year 2|Withdrawal by Subject|0
4771462|NCT02942277|7748239|FG009|Year 2|Withdrawal by Subject|0
4771463|NCT02942277|7748240|FG010|Year 2|Withdrawal by Subject|0
4771464|NCT02942017|7748269|FG000|Overall Study|Adverse Event|0
4771465|NCT02942017|7748270|FG001|Overall Study|Adverse Event|1
4771466|NCT02942017|7748269|FG000|Overall Study|Withdrawal by Subject|0
4771467|NCT02942017|7748270|FG001|Overall Study|Withdrawal by Subject|1
4771468|NCT02942017|7748269|FG000|Overall Study|Lost to Follow-up|1
4771469|NCT02942017|7748270|FG001|Overall Study|Lost to Follow-up|1
4771470|NCT02942017|7748269|FG000|Overall Study|Randomized but not dosed|1
4771471|NCT02942017|7748270|FG001|Overall Study|Randomized but not dosed|3
4771472|NCT02942004|7748279|FG000|Overall Study|Withdrawal by Subject|0
4771473|NCT02942004|7748280|FG001|Overall Study|Withdrawal by Subject|2
4771474|NCT02942004|7748281|FG002|Overall Study|Withdrawal by Subject|3
4771475|NCT02942004|7748279|FG000|Overall Study|Lost to Follow-up|1
4771476|NCT02942004|7748280|FG001|Overall Study|Lost to Follow-up|1
4771477|NCT02942004|7748281|FG002|Overall Study|Lost to Follow-up|2
4771478|NCT02942004|7748279|FG000|Overall Study|Randomized but not dosed|3
4771479|NCT02942004|7748280|FG001|Overall Study|Randomized but not dosed|9
4771480|NCT02942004|7748281|FG002|Overall Study|Randomized but not dosed|4
4771481|NCT02861014|7748289|FG000|Primary Analysis|Adverse Event|7
4771482|NCT02861014|7748289|FG000|Primary Analysis|Death|1
4771483|NCT02861014|7748289|FG000|Primary Analysis|Lack of Efficacy|3
4771484|NCT02861014|7748289|FG000|Primary Analysis|Physician Decision|2
4771485|NCT02861014|7748289|FG000|Primary Analysis|Pregnancy|4
4771486|NCT02861014|7748289|FG000|Primary Analysis|Protocol Violation|2
4771487|NCT02861014|7748289|FG000|Primary Analysis|Study Terminated By Sponsor|3
4771488|NCT02861014|7748289|FG000|Primary Analysis|Withdrawal by Subject|14
4510704|NCT00922480|7319593|FG000|Main Study|Lost to Follow-up|5
4771489|NCT02861014|7748289|FG000|Primary Analysis|Commercial ocrelizumab|3
4771490|NCT02861014|7748289|FG000|Safety Follow-up|Adverse Event|1
4771491|NCT02861014|7748289|FG000|Safety Follow-up|Pregnancy|1
4771492|NCT02861014|7748289|FG000|Safety Follow-up|Withdrawal by Subject|9
4771493|NCT02861014|7748289|FG000|Safety Follow-up|Study terminated by sponsor|1
4771494|NCT02861014|7748289|FG000|Safety Follow-up|Physician Decision|1
4771495|NCT02861014|7748289|FG000|Safety Follow-up|Roll-over to a long term extension study|1
4771496|NCT02861014|7748289|FG000|Safety Follow-up|Commercial ocrelizumab|36
4771497|NCT02775435|7748297|FG000|Overall Study|Adverse Event|48
4771498|NCT02775435|7748298|FG001|Overall Study|Adverse Event|25
4771499|NCT02775435|7748297|FG000|Overall Study|Lost to Follow-up|0
4771500|NCT02775435|7748298|FG001|Overall Study|Lost to Follow-up|2
4771501|NCT02775435|7748297|FG000|Overall Study|Physician Decision|5
4771502|NCT02775435|7748298|FG001|Overall Study|Physician Decision|6
4771503|NCT02775435|7748297|FG000|Overall Study|Withdrawal by Subject|5
4771504|NCT02775435|7748298|FG001|Overall Study|Withdrawal by Subject|9
4771505|NCT02775435|7748297|FG000|Overall Study|Progressive Disease|86
4771506|NCT02775435|7748298|FG001|Overall Study|Progressive Disease|140
4771507|NCT02775435|7748297|FG000|Overall Study|Clinical Progression|13
4771508|NCT02775435|7748298|FG001|Overall Study|Clinical Progression|26
4771509|NCT02775435|7748297|FG000|Overall Study|Ongoing in Study|121
4771510|NCT02775435|7748298|FG001|Overall Study|Ongoing in Study|72
4771511|NCT02775435|7748297|FG000|Overall Study|Not Treated|0
4771512|NCT02775435|7748298|FG001|Overall Study|Not Treated|1
4771513|NCT02726880|7748313|FG000|Overall Study|Withdrawal by Subject|2
4771514|NCT02726880|7748314|FG001|Overall Study|Withdrawal by Subject|0
4711255|NCT02906670|7636912|FG004|Cohort 5, Q2W|Clinical Progression|0
4711256|NCT02906670|7636913|FG005|Cohort 5, Q2W|Clinical Progression|0
4711257|NCT02906670|7636914|FG006|Cohort 5, Q2W|Clinical Progression|1
4711258|NCT02906670|7636915|FG007|Cohort 5, Q2W|Clinical Progression|0
4711259|NCT02906670|7636916|FG008|Cohort 5, Q2W|Clinical Progression|0
4711260|NCT02906670|7636917|FG009|Cohort 5, Q2W|Clinical Progression|0
4711261|NCT02906670|7636908|FG000|Cohort 5, Q2W|Adverse Event|0
4711262|NCT02906670|7636909|FG001|Cohort 5, Q2W|Adverse Event|0
4711263|NCT02906670|7636910|FG002|Cohort 5, Q2W|Adverse Event|0
4711264|NCT02906670|7636911|FG003|Cohort 5, Q2W|Adverse Event|0
4711265|NCT02906670|7636912|FG004|Cohort 5, Q2W|Adverse Event|0
4711266|NCT02906670|7636913|FG005|Cohort 5, Q2W|Adverse Event|0
4711267|NCT02906670|7636914|FG006|Cohort 5, Q2W|Adverse Event|1
4711268|NCT02906670|7636915|FG007|Cohort 5, Q2W|Adverse Event|0
4711269|NCT02906670|7636916|FG008|Cohort 5, Q2W|Adverse Event|0
4711270|NCT02906670|7636917|FG009|Cohort 5, Q2W|Adverse Event|0
4711271|NCT02906670|7636908|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0
4711272|NCT02906670|7636909|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0
4711273|NCT02906670|7636910|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0
4711274|NCT02906670|7636911|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0
4711275|NCT02906670|7636912|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0
4711276|NCT02906670|7636913|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0
4711277|NCT02906670|7636914|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1
4711278|NCT02906670|7636915|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0
4711279|NCT02906670|7636916|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0
4711280|NCT02906670|7636917|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0
4711281|NCT02906670|7636908|FG000|Cohort 5P, Q2W|Radiological Progression|0
4711282|NCT02906670|7636909|FG001|Cohort 5P, Q2W|Radiological Progression|0
4711283|NCT02906670|7636910|FG002|Cohort 5P, Q2W|Radiological Progression|0
4711284|NCT02906670|7636911|FG003|Cohort 5P, Q2W|Radiological Progression|0
4711285|NCT02906670|7636912|FG004|Cohort 5P, Q2W|Radiological Progression|0
4711286|NCT02906670|7636913|FG005|Cohort 5P, Q2W|Radiological Progression|0
4711287|NCT02906670|7636914|FG006|Cohort 5P, Q2W|Radiological Progression|0
4711288|NCT02906670|7636915|FG007|Cohort 5P, Q2W|Radiological Progression|2
4711289|NCT02906670|7636916|FG008|Cohort 5P, Q2W|Radiological Progression|0
4711290|NCT02906670|7636917|FG009|Cohort 5P, Q2W|Radiological Progression|0
4390082|NCT00075725|7168747|FG010|Overall Study|Protocol Violation|0
4390083|NCT00075725|7168748|FG011|Overall Study|Protocol Violation|1
4390084|NCT00075725|7168737|FG000|Overall Study|Withdrawal by Subject|12
4390085|NCT00075725|7168738|FG001|Overall Study|Withdrawal by Subject|3
4390086|NCT00075725|7168739|FG002|Overall Study|Withdrawal by Subject|6
4390087|NCT00075725|7168740|FG003|Overall Study|Withdrawal by Subject|10
4390088|NCT00075725|7168741|FG004|Overall Study|Withdrawal by Subject|6
4390089|NCT00075725|7168742|FG005|Overall Study|Withdrawal by Subject|27
4390090|NCT00075725|7168743|FG006|Overall Study|Withdrawal by Subject|7
4390091|NCT00075725|7168744|FG007|Overall Study|Withdrawal by Subject|31
4390092|NCT00075725|7168745|FG008|Overall Study|Withdrawal by Subject|10
4390093|NCT00075725|7168746|FG009|Overall Study|Withdrawal by Subject|2
4390094|NCT00075725|7168747|FG010|Overall Study|Withdrawal by Subject|0
4390095|NCT00075725|7168748|FG011|Overall Study|Withdrawal by Subject|0
4390096|NCT00075725|7168737|FG000|Overall Study|Disease Progression, all other reasons|17
4390097|NCT00075725|7168738|FG001|Overall Study|Disease Progression, all other reasons|5
4390098|NCT00075725|7168739|FG002|Overall Study|Disease Progression, all other reasons|33
4390099|NCT00075725|7168740|FG003|Overall Study|Disease Progression, all other reasons|6
4390100|NCT00075725|7168741|FG004|Overall Study|Disease Progression, all other reasons|21
4390101|NCT00075725|7168742|FG005|Overall Study|Disease Progression, all other reasons|59
4390102|NCT00075725|7168743|FG006|Overall Study|Disease Progression, all other reasons|20
4390103|NCT00075725|7168744|FG007|Overall Study|Disease Progression, all other reasons|46
4390104|NCT00075725|7168745|FG008|Overall Study|Disease Progression, all other reasons|21
4390105|NCT00075725|7168746|FG009|Overall Study|Disease Progression, all other reasons|4
4390106|NCT00075725|7168747|FG010|Overall Study|Disease Progression, all other reasons|0
4390107|NCT00075725|7168748|FG011|Overall Study|Disease Progression, all other reasons|5
4390108|NCT00075725|7168737|FG000|Overall Study|Patient off treatment|0
4711291|NCT02906670|7636908|FG000|Cohort 5P, Q2W|Adverse Event|0
4711292|NCT02906670|7636909|FG001|Cohort 5P, Q2W|Adverse Event|0
4711293|NCT02906670|7636910|FG002|Cohort 5P, Q2W|Adverse Event|0
4711294|NCT02906670|7636911|FG003|Cohort 5P, Q2W|Adverse Event|0
4711295|NCT02906670|7636912|FG004|Cohort 5P, Q2W|Adverse Event|0
4711296|NCT02906670|7636913|FG005|Cohort 5P, Q2W|Adverse Event|0
4711297|NCT02906670|7636914|FG006|Cohort 5P, Q2W|Adverse Event|0
4711298|NCT02906670|7636915|FG007|Cohort 5P, Q2W|Adverse Event|1
4711299|NCT02906670|7636916|FG008|Cohort 5P, Q2W|Adverse Event|0
4711300|NCT02906670|7636917|FG009|Cohort 5P, Q2W|Adverse Event|0
4711301|NCT02906670|7636908|FG000|Cohort 6P, Q2W|Radiological Progression|0
4711302|NCT02906670|7636909|FG001|Cohort 6P, Q2W|Radiological Progression|0
4711303|NCT02906670|7636910|FG002|Cohort 6P, Q2W|Radiological Progression|0
4711304|NCT02906670|7636911|FG003|Cohort 6P, Q2W|Radiological Progression|0
4711305|NCT02906670|7636912|FG004|Cohort 6P, Q2W|Radiological Progression|0
4390109|NCT00075725|7168738|FG001|Overall Study|Patient off treatment|0
4711306|NCT02906670|7636913|FG005|Cohort 6P, Q2W|Radiological Progression|0
4711307|NCT02906670|7636914|FG006|Cohort 6P, Q2W|Radiological Progression|0
4711308|NCT02906670|7636915|FG007|Cohort 6P, Q2W|Radiological Progression|0
4711309|NCT02906670|7636916|FG008|Cohort 6P, Q2W|Radiological Progression|1
4711310|NCT02906670|7636917|FG009|Cohort 6P, Q2W|Radiological Progression|0
4711311|NCT02906670|7636908|FG000|Cohort 6P, Q2W|Clinical Progression|0
4711312|NCT02906670|7636909|FG001|Cohort 6P, Q2W|Clinical Progression|0
4711313|NCT02906670|7636910|FG002|Cohort 6P, Q2W|Clinical Progression|0
4711314|NCT02906670|7636911|FG003|Cohort 6P, Q2W|Clinical Progression|0
4711315|NCT02906670|7636912|FG004|Cohort 6P, Q2W|Clinical Progression|0
4711316|NCT02906670|7636913|FG005|Cohort 6P, Q2W|Clinical Progression|0
4711317|NCT02906670|7636914|FG006|Cohort 6P, Q2W|Clinical Progression|0
4711318|NCT02906670|7636915|FG007|Cohort 6P, Q2W|Clinical Progression|0
4711319|NCT02906670|7636916|FG008|Cohort 6P, Q2W|Clinical Progression|3
4711320|NCT02906670|7636917|FG009|Cohort 6P, Q2W|Clinical Progression|0
4711321|NCT02906670|7636908|FG000|Cohort 4P, QW|Radiological Progression|0
4711322|NCT02906670|7636909|FG001|Cohort 4P, QW|Radiological Progression|0
4711323|NCT02906670|7636910|FG002|Cohort 4P, QW|Radiological Progression|0
4711324|NCT02906670|7636911|FG003|Cohort 4P, QW|Radiological Progression|3
4711325|NCT02906670|7636912|FG004|Cohort 4P, QW|Radiological Progression|0
4711326|NCT02906670|7636913|FG005|Cohort 4P, QW|Radiological Progression|0
4711327|NCT02906670|7636914|FG006|Cohort 4P, QW|Radiological Progression|0
4711328|NCT02906670|7636915|FG007|Cohort 4P, QW|Radiological Progression|0
4711329|NCT02906670|7636916|FG008|Cohort 4P, QW|Radiological Progression|0
4711330|NCT02906670|7636917|FG009|Cohort 4P, QW|Radiological Progression|0
4711331|NCT02906670|7636908|FG000|Cohort 7P, Q2W|Adverse Event|0
4711332|NCT02906670|7636909|FG001|Cohort 7P, Q2W|Adverse Event|0
4711333|NCT02906670|7636910|FG002|Cohort 7P, Q2W|Adverse Event|0
4711334|NCT02906670|7636911|FG003|Cohort 7P, Q2W|Adverse Event|0
4711335|NCT02906670|7636912|FG004|Cohort 7P, Q2W|Adverse Event|0
4711336|NCT02906670|7636913|FG005|Cohort 7P, Q2W|Adverse Event|0
4711337|NCT02906670|7636914|FG006|Cohort 7P, Q2W|Adverse Event|0
4711338|NCT02906670|7636915|FG007|Cohort 7P, Q2W|Adverse Event|0
4711339|NCT02906670|7636916|FG008|Cohort 7P, Q2W|Adverse Event|0
4711340|NCT02906670|7636917|FG009|Cohort 7P, Q2W|Adverse Event|1
4711341|NCT02906670|7636908|FG000|Cohort 7P, Q2W|Physician Decision|0
4628295|NCT01858766|7495319|FG003|Overall Study|Lack of Efficacy|0
4628296|NCT01858766|7495320|FG004|Overall Study|Lack of Efficacy|1
4628297|NCT01858766|7495321|FG005|Overall Study|Lack of Efficacy|2
4628298|NCT01858766|7495322|FG006|Overall Study|Lack of Efficacy|0
4711342|NCT02906670|7636909|FG001|Cohort 7P, Q2W|Physician Decision|0
4711343|NCT02906670|7636910|FG002|Cohort 7P, Q2W|Physician Decision|0
4711344|NCT02906670|7636911|FG003|Cohort 7P, Q2W|Physician Decision|0
4711345|NCT02906670|7636912|FG004|Cohort 7P, Q2W|Physician Decision|0
4711346|NCT02906670|7636913|FG005|Cohort 7P, Q2W|Physician Decision|0
4711347|NCT02906670|7636914|FG006|Cohort 7P, Q2W|Physician Decision|0
4711348|NCT02906670|7636915|FG007|Cohort 7P, Q2W|Physician Decision|0
4711349|NCT02906670|7636916|FG008|Cohort 7P, Q2W|Physician Decision|0
4711350|NCT02906670|7636917|FG009|Cohort 7P, Q2W|Physician Decision|1
4711351|NCT02906670|7636908|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
4711352|NCT02906670|7636909|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
4711353|NCT02906670|7636910|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
4711354|NCT02906670|7636911|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
4711355|NCT02906670|7636912|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
4711356|NCT02906670|7636913|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
4711357|NCT02906670|7636914|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
4711358|NCT02906670|7636915|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
4711359|NCT02906670|7636916|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
4711360|NCT02906670|7636917|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1
4711361|NCT02906670|7636908|FG000|Cohort 5P, QW|Radiological Progression|0
4711362|NCT02906670|7636909|FG001|Cohort 5P, QW|Radiological Progression|0
4711363|NCT02906670|7636910|FG002|Cohort 5P, QW|Radiological Progression|0
4711364|NCT02906670|7636911|FG003|Cohort 5P, QW|Radiological Progression|0
4711365|NCT02906670|7636912|FG004|Cohort 5P, QW|Radiological Progression|3
4711366|NCT02906670|7636913|FG005|Cohort 5P, QW|Radiological Progression|0
4711367|NCT02906670|7636914|FG006|Cohort 5P, QW|Radiological Progression|0
4711368|NCT02906670|7636915|FG007|Cohort 5P, QW|Radiological Progression|0
4711369|NCT02906670|7636916|FG008|Cohort 5P, QW|Radiological Progression|0
4711370|NCT02906670|7636917|FG009|Cohort 5P, QW|Radiological Progression|0
4711371|NCT02906709|7636973|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1
4711372|NCT02906709|7636974|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2
4711373|NCT02906709|7636973|FG000|Phase A (Week 0 to Week 16)|Death|0
4711374|NCT02906709|7636974|FG001|Phase A (Week 0 to Week 16)|Death|1
4711375|NCT02906709|7636973|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3
4711376|NCT02906709|7636974|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0
4711377|NCT02906709|7636973|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2
4711378|NCT02906709|7636974|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0
4711379|NCT02906917|7637001|FG000|Initiation Period (Week 0-26)|Unclassified|1
4711380|NCT02906917|7637002|FG001|Initiation Period (Week 0-26)|Unclassified|3
4711381|NCT02906917|7637001|FG000|Initiation Period (Week 0-26)|Adverse Event|1
4711382|NCT02906917|7637002|FG001|Initiation Period (Week 0-26)|Adverse Event|0
4628299|NCT01858766|7495323|FG007|Overall Study|Lack of Efficacy|0
4711383|NCT02906917|7637001|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1
4711384|NCT02906917|7637002|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4
4711385|NCT02906917|7637001|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3
4711386|NCT02906917|7637002|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4
4711387|NCT02906917|7637001|FG000|Intensification Period (Week 26-38)|Unclassified|3
4711388|NCT02906917|7637002|FG001|Intensification Period (Week 26-38)|Unclassified|2
4711389|NCT02906917|7637001|FG000|Intensification Period (Week 26-38)|Adverse Event|0
4390110|NCT00075725|7168739|FG002|Overall Study|Patient off treatment|1
4390111|NCT00075725|7168740|FG003|Overall Study|Patient off treatment|2
4390112|NCT00075725|7168741|FG004|Overall Study|Patient off treatment|1
4390113|NCT00075725|7168742|FG005|Overall Study|Patient off treatment|0
4390114|NCT00075725|7168743|FG006|Overall Study|Patient off treatment|0
4390115|NCT00075725|7168744|FG007|Overall Study|Patient off treatment|2
4390116|NCT00075725|7168745|FG008|Overall Study|Patient off treatment|1
4390117|NCT00075725|7168746|FG009|Overall Study|Patient off treatment|0
4390118|NCT00075725|7168747|FG010|Overall Study|Patient off treatment|0
4390119|NCT00075725|7168748|FG011|Overall Study|Patient off treatment|0
4390120|NCT00075725|7168737|FG000|Overall Study|Ineligible or wrong diagnosis|8
4390121|NCT00075725|7168738|FG001|Overall Study|Ineligible or wrong diagnosis|3
4390122|NCT00075725|7168739|FG002|Overall Study|Ineligible or wrong diagnosis|3
4390123|NCT00075725|7168740|FG003|Overall Study|Ineligible or wrong diagnosis|10
4390124|NCT00075725|7168741|FG004|Overall Study|Ineligible or wrong diagnosis|3
4390125|NCT00075725|7168742|FG005|Overall Study|Ineligible or wrong diagnosis|17
4390126|NCT00075725|7168743|FG006|Overall Study|Ineligible or wrong diagnosis|6
4390127|NCT00075725|7168744|FG007|Overall Study|Ineligible or wrong diagnosis|9
4390128|NCT00075725|7168745|FG008|Overall Study|Ineligible or wrong diagnosis|10
4390129|NCT00075725|7168746|FG009|Overall Study|Ineligible or wrong diagnosis|1
4390130|NCT00075725|7168747|FG010|Overall Study|Ineligible or wrong diagnosis|2
4390131|NCT00075725|7168748|FG011|Overall Study|Ineligible or wrong diagnosis|4
4390132|NCT00075725|7168737|FG000|Overall Study|Pt/Guardian refused RT therapy|1
4390133|NCT00075725|7168738|FG001|Overall Study|Pt/Guardian refused RT therapy|0
4390134|NCT00075725|7168739|FG002|Overall Study|Pt/Guardian refused RT therapy|1
4390135|NCT00075725|7168740|FG003|Overall Study|Pt/Guardian refused RT therapy|2
4390136|NCT00075725|7168741|FG004|Overall Study|Pt/Guardian refused RT therapy|1
4390137|NCT00075725|7168742|FG005|Overall Study|Pt/Guardian refused RT therapy|0
4390138|NCT00075725|7168743|FG006|Overall Study|Pt/Guardian refused RT therapy|0
4390139|NCT00075725|7168744|FG007|Overall Study|Pt/Guardian refused RT therapy|0
4390140|NCT00075725|7168745|FG008|Overall Study|Pt/Guardian refused RT therapy|0
4390141|NCT00075725|7168746|FG009|Overall Study|Pt/Guardian refused RT therapy|0
4390142|NCT00075725|7168747|FG010|Overall Study|Pt/Guardian refused RT therapy|0
4390143|NCT00075725|7168748|FG011|Overall Study|Pt/Guardian refused RT therapy|0
4390144|NCT00075725|7168737|FG000|Overall Study|Pt non compliant with therapy|2
4390145|NCT00075725|7168738|FG001|Overall Study|Pt non compliant with therapy|1
4390146|NCT00075725|7168739|FG002|Overall Study|Pt non compliant with therapy|1
4390147|NCT00075725|7168740|FG003|Overall Study|Pt non compliant with therapy|0
4390148|NCT00075725|7168741|FG004|Overall Study|Pt non compliant with therapy|2
4390149|NCT00075725|7168742|FG005|Overall Study|Pt non compliant with therapy|14
4390150|NCT00075725|7168743|FG006|Overall Study|Pt non compliant with therapy|2
4390151|NCT00075725|7168744|FG007|Overall Study|Pt non compliant with therapy|5
4390152|NCT00075725|7168745|FG008|Overall Study|Pt non compliant with therapy|3
4390153|NCT00075725|7168746|FG009|Overall Study|Pt non compliant with therapy|0
4390154|NCT00075725|7168747|FG010|Overall Study|Pt non compliant with therapy|0
4711390|NCT02906917|7637002|FG001|Intensification Period (Week 26-38)|Adverse Event|2
4711391|NCT02906917|7637001|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3
4711392|NCT02906917|7637002|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1
4711393|NCT02906917|7637001|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3
4711394|NCT02906917|7637002|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2
4711395|NCT02906930|7637012|FG000|Overall Study|Withdrawal by Subject|0
4711396|NCT02906930|7637013|FG001|Overall Study|Withdrawal by Subject|5
4711397|NCT02906930|7637014|FG002|Overall Study|Withdrawal by Subject|5
4711398|NCT02906930|7637015|FG003|Overall Study|Withdrawal by Subject|4
4711399|NCT02906930|7637012|FG000|Overall Study|Lost to Follow-up|5
4711400|NCT02906930|7637013|FG001|Overall Study|Lost to Follow-up|7
4711401|NCT02906930|7637014|FG002|Overall Study|Lost to Follow-up|5
4711402|NCT02906930|7637015|FG003|Overall Study|Lost to Follow-up|2
4711403|NCT02906930|7637012|FG000|Overall Study|Death|0
4711404|NCT02906930|7637013|FG001|Overall Study|Death|0
4711405|NCT02906930|7637014|FG002|Overall Study|Death|1
4711406|NCT02906930|7637015|FG003|Overall Study|Death|0
4711407|NCT02906930|7637012|FG000|Overall Study|Other|1
4711408|NCT02906930|7637013|FG001|Overall Study|Other|2
4711409|NCT02906930|7637014|FG002|Overall Study|Other|1
4711410|NCT02906930|7637015|FG003|Overall Study|Other|2
4711411|NCT02907177|7637040|FG000|Overall Study|Death|0
4711412|NCT02907177|7637041|FG001|Overall Study|Death|1
4711413|NCT02907177|7637040|FG000|Overall Study|Physician Decision|3
4711414|NCT02907177|7637041|FG001|Overall Study|Physician Decision|3
4711415|NCT02907177|7637040|FG000|Overall Study|Withdrawal by Subject|15
4711416|NCT02907177|7637041|FG001|Overall Study|Withdrawal by Subject|7
4711417|NCT02907177|7637040|FG000|Overall Study|Sponsor's Decision|50
4711418|NCT02907177|7637041|FG001|Overall Study|Sponsor's Decision|57
4711419|NCT02907216|7637049|FG000|Overall Study|No benefit to be obtained by continuing|0
4711420|NCT02907216|7637050|FG001|Overall Study|No benefit to be obtained by continuing|1
4711421|NCT02907216|7637049|FG000|Overall Study|Withdrawal by Subject|1
4711422|NCT02907216|7637050|FG001|Overall Study|Withdrawal by Subject|0
4711423|NCT02907463|7637064|FG000|Overall Study|Lost to Follow-up|17
4711424|NCT02907463|7637064|FG000|Overall Study|Death|10
4711425|NCT02907463|7637064|FG000|Overall Study|Withdrawal by Subject|4
4711426|NCT02907463|7637064|FG000|Overall Study|MIS Approach was not used|2
4711427|NCT02907463|7637064|FG000|Overall Study|Not Implanted with Study Device|2
4711428|NCT02907463|7637064|FG000|Overall Study|Device Explanted|1
4711429|NCT02907463|7637064|FG000|Overall Study|Missing Exit Form|1
4711430|NCT02907619|7637088|FG000|Overall Study|Study terminated by sponsor|18
4711431|NCT02907619|7637089|FG001|Overall Study|Study terminated by sponsor|18
4711432|NCT02907619|7637090|FG002|Overall Study|Study terminated by sponsor|19
4711433|NCT02907619|7637088|FG000|Overall Study|Death|0
4711434|NCT02907619|7637089|FG001|Overall Study|Death|0
4711435|NCT02907619|7637090|FG002|Overall Study|Death|1
4711436|NCT02907619|7637088|FG000|Overall Study|Withdrawal by Subject|1
4711437|NCT02907619|7637089|FG001|Overall Study|Withdrawal by Subject|1
4711438|NCT02907619|7637090|FG002|Overall Study|Withdrawal by Subject|0
4711439|NCT02907619|7637088|FG000|Overall Study|Other|0
4711440|NCT02907619|7637089|FG001|Overall Study|Other|1
4711441|NCT02907619|7637090|FG002|Overall Study|Other|0
4711442|NCT02907892|7637111|FG000|Overall Study|Lost to Follow-up|27
4711443|NCT02907892|7637112|FG001|Overall Study|Lost to Follow-up|40
4711444|NCT02908100|7637128|FG000|Overall Study|Adverse Event|7
4711445|NCT02908100|7637129|FG001|Overall Study|Adverse Event|6
4711446|NCT02908100|7637130|FG002|Overall Study|Adverse Event|9
4711447|NCT02908100|7637128|FG000|Overall Study|Death|2
4711448|NCT02908100|7637129|FG001|Overall Study|Death|0
4711449|NCT02908100|7637130|FG002|Overall Study|Death|0
4711450|NCT02908100|7637128|FG000|Overall Study|Lack of Efficacy|2
4711451|NCT02908100|7637129|FG001|Overall Study|Lack of Efficacy|3
4711452|NCT02908100|7637130|FG002|Overall Study|Lack of Efficacy|3
4711453|NCT02908100|7637128|FG000|Overall Study|Lost to Follow-up|0
4711454|NCT02908100|7637129|FG001|Overall Study|Lost to Follow-up|1
4711455|NCT02908100|7637130|FG002|Overall Study|Lost to Follow-up|2
4711456|NCT02908100|7637128|FG000|Overall Study|Non-Compliance With Study Drug|1
4711457|NCT02908100|7637129|FG001|Overall Study|Non-Compliance With Study Drug|1
4711458|NCT02908100|7637130|FG002|Overall Study|Non-Compliance With Study Drug|2
4711459|NCT02908100|7637128|FG000|Overall Study|Non-Compliance With Contraceptive Method|1
4711460|NCT02908100|7637129|FG001|Overall Study|Non-Compliance With Contraceptive Method|0
4711461|NCT02908100|7637130|FG002|Overall Study|Non-Compliance With Contraceptive Method|0
4711462|NCT02908100|7637128|FG000|Overall Study|Physician Decision|0
4711463|NCT02908100|7637129|FG001|Overall Study|Physician Decision|1
4711464|NCT02908100|7637130|FG002|Overall Study|Physician Decision|0
4711465|NCT02908100|7637128|FG000|Overall Study|Pregnancy|1
4711466|NCT02908100|7637129|FG001|Overall Study|Pregnancy|2
4711467|NCT02908100|7637130|FG002|Overall Study|Pregnancy|0
4711468|NCT02908100|7637128|FG000|Overall Study|Withdrawal by Subject|8
4711469|NCT02908100|7637129|FG001|Overall Study|Withdrawal by Subject|7
4711470|NCT02908100|7637130|FG002|Overall Study|Withdrawal by Subject|5
4711471|NCT02908100|7637128|FG000|Overall Study|Randomised in Error|1
4711472|NCT02908100|7637129|FG001|Overall Study|Randomised in Error|0
4711473|NCT02908100|7637130|FG002|Overall Study|Randomised in Error|0
4711474|NCT02908347|7637158|FG000|Overall Study|Adverse Event|0
4711475|NCT02908347|7637159|FG001|Overall Study|Adverse Event|1
4711476|NCT02908347|7637158|FG000|Overall Study|Lost to Follow-up|1
4711477|NCT02908347|7637159|FG001|Overall Study|Lost to Follow-up|0
4711478|NCT02908464|7637181|FG000|Overall Study|Withdrawal by Subject|2
4711479|NCT02908464|7637182|FG001|Overall Study|Withdrawal by Subject|1
4711480|NCT02908464|7637181|FG000|Overall Study|Found ineligible after randomization|0
4628300|NCT01858766|7495324|FG008|Overall Study|Lack of Efficacy|0
4628301|NCT01858766|7495325|FG009|Overall Study|Lack of Efficacy|0
4711481|NCT02908464|7637182|FG001|Overall Study|Found ineligible after randomization|2
4711482|NCT02908529|7637198|FG000|Overall Study|Lost to Follow-up|0
4711483|NCT02908529|7637199|FG001|Overall Study|Lost to Follow-up|2
4711484|NCT02908841|7637230|FG000|Overall Study|Physician Decision|4
4711485|NCT02908841|7637231|FG001|Overall Study|Physician Decision|0
4711486|NCT02908880|7637237|FG000|Overall Study|Lost to Follow-up|4
4711487|NCT02908880|7637237|FG000|Overall Study|Explantation of the device|1
4711488|NCT02908880|7637237|FG000|Overall Study|Withdrawal by Subject|17
4711489|NCT02908880|7637237|FG000|Overall Study|Death|5
4711490|NCT02909101|7637243|FG000|Overall Study|Lost to Follow-up|1
4711491|NCT02909101|7637244|FG001|Overall Study|Lost to Follow-up|1
4711492|NCT02909153|7637268|FG000|Overall Study|Withdrawal by Subject|0
4711493|NCT02909153|7637269|FG001|Overall Study|Withdrawal by Subject|1
4711494|NCT02909153|7637270|FG002|Overall Study|Withdrawal by Subject|0
4628302|NCT01858766|7495326|FG010|Overall Study|Lack of Efficacy|0
4711495|NCT02909153|7637271|FG003|Overall Study|Withdrawal by Subject|0
4711496|NCT02909153|7637272|FG004|Overall Study|Withdrawal by Subject|0
4711497|NCT02909504|7637293|FG000|Overall Study|Adverse Event|2
4711498|NCT02909504|7637293|FG000|Overall Study|Lack of Efficacy|3
4711499|NCT02909504|7637293|FG000|Overall Study|Withdrawal by Subject|4
4711500|NCT02909504|7637293|FG000|Overall Study|Pregnancy|1
4711501|NCT02909504|7637293|FG000|Overall Study|Subject moved|1
4711502|NCT02909504|7637293|FG000|Overall Study|Lost to Follow-up|1
4711503|NCT02909907|7637312|FG000|Overall Study|Withdrawal by Subject|0
4711504|NCT02909907|7637313|FG001|Overall Study|Withdrawal by Subject|1
4711505|NCT02910011|7637328|FG000|Overall Study|Physician Decision|2
4711506|NCT02910037|7637334|FG000|Overall Study|Withdrawal by Subject|4
4711507|NCT02910037|7637334|FG000|Overall Study|Lost to Follow-up|6
4711508|NCT02910063|7637354|FG000|Phase 2|Withdrawal by Subject|3
4711509|NCT02910063|7637355|FG001|Phase 2|Withdrawal by Subject|0
4711510|NCT02910063|7637356|FG002|Phase 2|Withdrawal by Subject|0
4711511|NCT02910063|7637354|FG000|Phase 2|Lost to Follow-up|1
4711512|NCT02910063|7637355|FG001|Phase 2|Lost to Follow-up|0
4711513|NCT02910063|7637356|FG002|Phase 2|Lost to Follow-up|0
4711514|NCT02910063|7637354|FG000|Phase 2|Death|24
4711515|NCT02910063|7637355|FG001|Phase 2|Death|0
4711516|NCT02910063|7637356|FG002|Phase 2|Death|0
4711517|NCT02910089|7637367|FG000|Overall Study|Lost insurance eligibility|22
4711518|NCT02910089|7637368|FG001|Overall Study|Lost insurance eligibility|16
4711519|NCT02910167|7637388|FG000|Overall Study|Adverse Event|1
4711520|NCT02910167|7637388|FG000|Overall Study|Lost to Follow-up|18
4711521|NCT02910466|7637401|FG000|Overall Study|Adverse Event|1
4711522|NCT02910466|7637401|FG000|Overall Study|Withdrawal by Subject|3
4711523|NCT02910466|7637401|FG000|Overall Study|Lost to Follow-up|5
4711524|NCT02910466|7637401|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29
4711525|NCT02910466|7637401|FG000|Overall Study|Participant didn't meet inclusion criteria|1
4711526|NCT02910713|7637410|FG000|Overall Study|Protocol Violation|2
4711527|NCT02910713|7637410|FG000|Overall Study|Subject Choice|4
4711528|NCT02910713|7637410|FG000|Overall Study|Received One Application|10
4711529|NCT02910713|7637410|FG000|Overall Study|Received Neither Application|18
4711530|NCT02910713|7637410|FG000|Overall Study|Enrollment cap|7
4711531|NCT02910713|7637410|FG000|Overall Study|Investigator Discretion|1
4711532|NCT02910739|7637417|FG000|Overall Study|Adverse Event|1
4711533|NCT02910739|7637418|FG001|Overall Study|Adverse Event|0
4711534|NCT02910739|7637419|FG002|Overall Study|Adverse Event|0
4711535|NCT02910739|7637420|FG003|Overall Study|Adverse Event|0
4711536|NCT02911025|7637426|FG000|Overall Study|Lost to Follow-up|3
4711537|NCT02911116|7637432|FG000|Overall Study|Insufficient Therapeutic Response|1
4711538|NCT02911116|7637433|FG001|Overall Study|Insufficient Therapeutic Response|0
4711539|NCT02911116|7637432|FG000|Overall Study|Lost to Follow-up|0
4711540|NCT02911116|7637433|FG001|Overall Study|Lost to Follow-up|1
4711541|NCT02911285|7637441|FG000|Overall Study|Lost to Follow-up|8
4711542|NCT02911285|7637442|FG001|Overall Study|Lost to Follow-up|5
4711543|NCT02911285|7637441|FG000|Overall Study|Participant got a job and no longer had time to participate.|1
4711544|NCT02911285|7637442|FG001|Overall Study|Participant got a job and no longer had time to participate.|0
4711545|NCT02911519|7637464|FG000|Overall Study|Lost to Follow-up|2
4711546|NCT02911519|7637465|FG001|Overall Study|Lost to Follow-up|2
4711547|NCT02911519|7637464|FG000|Overall Study|Death|0
4711548|NCT02911519|7637465|FG001|Overall Study|Death|2
4711549|NCT02911688|7637473|FG000|Washout|Lost to Follow-up|1
4711550|NCT02911688|7637474|FG001|Washout|Lost to Follow-up|1
4711551|NCT02911688|7637473|FG000|Washout|Withdrawal by Subject|0
4711552|NCT02911688|7637474|FG001|Washout|Withdrawal by Subject|1
4711553|NCT02911948|7637573|FG000|Overall Study|Protocol Violation|0
4711554|NCT02911948|7637574|FG001|Overall Study|Protocol Violation|1
4711555|NCT02911948|7637573|FG000|Overall Study|Withdrawal by Subject|0
4711556|NCT02911948|7637574|FG001|Overall Study|Withdrawal by Subject|2
4711557|NCT02911948|7637573|FG000|Overall Study|Lack of Efficacy|0
4711558|NCT02911948|7637574|FG001|Overall Study|Lack of Efficacy|1
4711559|NCT02911948|7637573|FG000|Overall Study|Unclassified|0
4711560|NCT02911948|7637574|FG001|Overall Study|Unclassified|3
4711561|NCT02912455|7637601|FG000|Overall Study|Withdrawal by Subject|0
4711562|NCT02912455|7637602|FG001|Overall Study|Withdrawal by Subject|1
4711563|NCT02912455|7637601|FG000|Overall Study|Lack of Efficacy|0
4711564|NCT02912455|7637602|FG001|Overall Study|Lack of Efficacy|1
4711565|NCT02912455|7637601|FG000|Overall Study|Lost to Follow-up|2
4711566|NCT02912455|7637602|FG001|Overall Study|Lost to Follow-up|1
4711567|NCT02912468|7637610|FG000|Overall Study|Adverse Event|3
4711568|NCT02912468|7637611|FG001|Overall Study|Adverse Event|2
4711569|NCT02912468|7637610|FG000|Overall Study|Withdrawal by Subject|6
4711570|NCT02912468|7637611|FG001|Overall Study|Withdrawal by Subject|2
4711571|NCT02912468|7637610|FG000|Overall Study|Randomized and not treated|0
4711572|NCT02912468|7637611|FG001|Overall Study|Randomized and not treated|1
4711573|NCT02912650|7637622|FG000|Overall Study|Withdrawal by Subject|1
4711574|NCT02912650|7637623|FG001|Overall Study|Withdrawal by Subject|0
4711575|NCT02912650|7637624|FG002|Overall Study|Withdrawal by Subject|1
4711576|NCT02912650|7637625|FG003|Overall Study|Withdrawal by Subject|5
4711577|NCT02912650|7637622|FG000|Overall Study|Adverse Event|0
4711578|NCT02912650|7637623|FG001|Overall Study|Adverse Event|0
4711579|NCT02912650|7637624|FG002|Overall Study|Adverse Event|1
4711580|NCT02912650|7637625|FG003|Overall Study|Adverse Event|0
4711581|NCT02913105|7637638|FG000|Overall Study|Adverse Event|11
4711582|NCT02913105|7637639|FG001|Overall Study|Adverse Event|0
4711583|NCT02913105|7637640|FG002|Overall Study|Adverse Event|4
4711584|NCT02913105|7637638|FG000|Overall Study|Non-Compliance With Study Drug|0
4711585|NCT02913105|7637639|FG001|Overall Study|Non-Compliance With Study Drug|0
4711586|NCT02913105|7637640|FG002|Overall Study|Non-Compliance With Study Drug|1
4711587|NCT02913105|7637638|FG000|Overall Study|Reason Not Specified|3
4711588|NCT02913105|7637639|FG001|Overall Study|Reason Not Specified|1
4711589|NCT02913105|7637640|FG002|Overall Study|Reason Not Specified|1
4711590|NCT02913105|7637638|FG000|Overall Study|Physician Decision|1
4711591|NCT02913105|7637639|FG001|Overall Study|Physician Decision|1
4711592|NCT02913105|7637640|FG002|Overall Study|Physician Decision|0
4711593|NCT02913105|7637638|FG000|Overall Study|Withdrawal by Subject|0
4711594|NCT02913105|7637639|FG001|Overall Study|Withdrawal by Subject|3
4711595|NCT02913105|7637640|FG002|Overall Study|Withdrawal by Subject|1
4711596|NCT02913326|7637651|FG000|Overall Study|Reason not listed|0
4711597|NCT02913326|7637652|FG001|Overall Study|Reason not listed|1
4711598|NCT02913326|7637651|FG000|Overall Study|Lost to Follow-up|0
4390155|NCT00075725|7168748|FG011|Overall Study|Pt non compliant with therapy|0
4390156|NCT00075725|7168737|FG000|Overall Study|Pt age out of range for treatment|0
4390157|NCT00075725|7168738|FG001|Overall Study|Pt age out of range for treatment|1
4390158|NCT00075725|7168739|FG002|Overall Study|Pt age out of range for treatment|0
4390159|NCT00075725|7168740|FG003|Overall Study|Pt age out of range for treatment|0
4390160|NCT00075725|7168741|FG004|Overall Study|Pt age out of range for treatment|0
4390161|NCT00075725|7168742|FG005|Overall Study|Pt age out of range for treatment|1
4390162|NCT00075725|7168743|FG006|Overall Study|Pt age out of range for treatment|0
4390163|NCT00075725|7168744|FG007|Overall Study|Pt age out of range for treatment|1
4390164|NCT00075725|7168745|FG008|Overall Study|Pt age out of range for treatment|0
4390165|NCT00075725|7168746|FG009|Overall Study|Pt age out of range for treatment|0
4390166|NCT00075725|7168747|FG010|Overall Study|Pt age out of range for treatment|0
4390167|NCT00075725|7168748|FG011|Overall Study|Pt age out of range for treatment|0
4390168|NCT00075725|7168737|FG000|Overall Study|Insurance issues|0
4390169|NCT00075725|7168738|FG001|Overall Study|Insurance issues|1
4390170|NCT00075725|7168739|FG002|Overall Study|Insurance issues|0
4390171|NCT00075725|7168740|FG003|Overall Study|Insurance issues|1
4390172|NCT00075725|7168741|FG004|Overall Study|Insurance issues|1
4390173|NCT00075725|7168742|FG005|Overall Study|Insurance issues|1
4390174|NCT00075725|7168743|FG006|Overall Study|Insurance issues|0
4390175|NCT00075725|7168744|FG007|Overall Study|Insurance issues|1
4390176|NCT00075725|7168745|FG008|Overall Study|Insurance issues|0
4390177|NCT00075725|7168746|FG009|Overall Study|Insurance issues|0
4390178|NCT00075725|7168747|FG010|Overall Study|Insurance issues|0
4390179|NCT00075725|7168748|FG011|Overall Study|Insurance issues|0
4390180|NCT00075725|7168737|FG000|Overall Study|MRD positive after extended ind|0
4390181|NCT00075725|7168738|FG001|Overall Study|MRD positive after extended ind|1
4390182|NCT00075725|7168739|FG002|Overall Study|MRD positive after extended ind|1
4390183|NCT00075725|7168740|FG003|Overall Study|MRD positive after extended ind|0
4390184|NCT00075725|7168741|FG004|Overall Study|MRD positive after extended ind|1
4390185|NCT00075725|7168742|FG005|Overall Study|MRD positive after extended ind|2
4390186|NCT00075725|7168743|FG006|Overall Study|MRD positive after extended ind|0
4390187|NCT00075725|7168744|FG007|Overall Study|MRD positive after extended ind|1
4390188|NCT00075725|7168745|FG008|Overall Study|MRD positive after extended ind|0
4390189|NCT00075725|7168746|FG009|Overall Study|MRD positive after extended ind|0
4390190|NCT00075725|7168747|FG010|Overall Study|MRD positive after extended ind|0
4390191|NCT00075725|7168748|FG011|Overall Study|MRD positive after extended ind|0
4711599|NCT02913326|7637652|FG001|Overall Study|Lost to Follow-up|1
4711600|NCT02913326|7637651|FG000|Overall Study|Adverse Event|1
4711601|NCT02913326|7637652|FG001|Overall Study|Adverse Event|0
4736011|NCT03552757|7684648|FG002|Overall Study|Death|1
4736012|NCT03553758|7684659|FG000|Overall Study|Lost to Follow-up|1
4736013|NCT03553823|7684667|FG000|Overall Study|Physician Decision|0
4736014|NCT03553823|7684668|FG001|Overall Study|Physician Decision|1
4736015|NCT03554005|7684689|FG000|Overall Study|Not in participant's best interest|0
4736016|NCT03554005|7684690|FG001|Overall Study|Not in participant's best interest|0
4736017|NCT03554005|7684691|FG002|Overall Study|Not in participant's best interest|0
4736018|NCT03554005|7684692|FG003|Overall Study|Not in participant's best interest|0
4736019|NCT03554005|7684693|FG004|Overall Study|Not in participant's best interest|0
4736020|NCT03554005|7684694|FG005|Overall Study|Not in participant's best interest|1
4736021|NCT03554005|7684689|FG000|Overall Study|Disease Progression|1
4736022|NCT03554005|7684690|FG001|Overall Study|Disease Progression|1
4736023|NCT03554005|7684691|FG002|Overall Study|Disease Progression|1
4736024|NCT03554005|7684692|FG003|Overall Study|Disease Progression|1
4736025|NCT03554005|7684693|FG004|Overall Study|Disease Progression|5
4736026|NCT03554005|7684694|FG005|Overall Study|Disease Progression|6
4736027|NCT03554005|7684689|FG000|Overall Study|Adverse Event|0
4736028|NCT03554005|7684690|FG001|Overall Study|Adverse Event|0
4736029|NCT03554005|7684691|FG002|Overall Study|Adverse Event|0
4736030|NCT03554005|7684692|FG003|Overall Study|Adverse Event|0
4736031|NCT03554005|7684693|FG004|Overall Study|Adverse Event|0
4736032|NCT03554005|7684694|FG005|Overall Study|Adverse Event|3
4736033|NCT03554005|7684689|FG000|Overall Study|Physician Decision|0
4736034|NCT03554005|7684690|FG001|Overall Study|Physician Decision|0
4736035|NCT03554005|7684691|FG002|Overall Study|Physician Decision|0
4711602|NCT02914184|7637692|FG000|Overall Study|Lost to Follow-up|7
4711603|NCT02914184|7637693|FG001|Overall Study|Lost to Follow-up|10
4711604|NCT02914184|7637694|FG002|Overall Study|Lost to Follow-up|8
4711605|NCT02914184|7637695|FG003|Overall Study|Lost to Follow-up|7
4711606|NCT02914184|7637692|FG000|Overall Study|Withdrawal by Subject|4
4711607|NCT02914184|7637693|FG001|Overall Study|Withdrawal by Subject|2
4711608|NCT02914184|7637694|FG002|Overall Study|Withdrawal by Subject|7
4711609|NCT02914184|7637695|FG003|Overall Study|Withdrawal by Subject|3
4711610|NCT02914184|7637692|FG000|Overall Study|Other|1
4711611|NCT02914184|7637693|FG001|Overall Study|Other|0
4711612|NCT02914184|7637694|FG002|Overall Study|Other|0
4711613|NCT02914184|7637695|FG003|Overall Study|Other|0
4711614|NCT02914184|7637692|FG000|Overall Study|Migrated/moved from the study area|2
4711615|NCT02914184|7637693|FG001|Overall Study|Migrated/moved from the study area|1
4711616|NCT02914184|7637694|FG002|Overall Study|Migrated/moved from the study area|2
4711617|NCT02914184|7637695|FG003|Overall Study|Migrated/moved from the study area|1
4711618|NCT02914236|7637716|FG000|Overall Study|Lost to Follow-up|1
4711619|NCT02914275|7637722|FG000|Overall Study|Lost to Follow-up|84
4711620|NCT02914275|7637723|FG001|Overall Study|Lost to Follow-up|29
4711621|NCT02914275|7637722|FG000|Overall Study|Withdrawal by Subject|26
4711622|NCT02914275|7637723|FG001|Overall Study|Withdrawal by Subject|10
4711623|NCT02914275|7637722|FG000|Overall Study|Protocol Violation|1
4711624|NCT02914275|7637723|FG001|Overall Study|Protocol Violation|1
4711625|NCT02914275|7637722|FG000|Overall Study|Physician Decision|3
4711626|NCT02914275|7637723|FG001|Overall Study|Physician Decision|1
4711627|NCT02914275|7637722|FG000|Overall Study|Other|4
4711628|NCT02914275|7637723|FG001|Overall Study|Other|1
4711629|NCT02914275|7637722|FG000|Overall Study|Excluded due to invalid informed consent|3
4711630|NCT02914275|7637723|FG001|Overall Study|Excluded due to invalid informed consent|0
4711631|NCT02914457|7637733|FG000|Overall Study|Withdrawal by Subject|1
4711632|NCT02914457|7637733|FG000|Overall Study|Physician Decision|1
4711633|NCT02914457|7637733|FG000|Overall Study|No veins available for lead placement|1
4711634|NCT02914457|7637733|FG000|Overall Study|Electrical instability of patient|1
4711635|NCT02914457|7637733|FG000|Overall Study|ECG acquisition error due to sweating|1
4711636|NCT02914457|7637733|FG000|Overall Study|Protocol Violation|1
4711637|NCT02914522|7637754|FG000|Induction Study: Up to Week 11|Adverse Event|5
4711638|NCT02914522|7637755|FG001|Induction Study: Up to Week 11|Adverse Event|6
4711639|NCT02914522|7637756|FG002|Induction Study: Up to Week 11|Adverse Event|4
4711640|NCT02914522|7637757|FG003|Induction Study: Up to Week 11|Adverse Event|18
4711641|NCT02914522|7637758|FG004|Induction Study: Up to Week 11|Adverse Event|14
4711642|NCT02914522|7637759|FG005|Induction Study: Up to Week 11|Adverse Event|10
4711643|NCT02914522|7637760|FG006|Induction Study: Up to Week 11|Adverse Event|0
4711644|NCT02914522|7637761|FG007|Induction Study: Up to Week 11|Adverse Event|0
4711645|NCT02914522|7637762|FG008|Induction Study: Up to Week 11|Adverse Event|0
4711646|NCT02914522|7637763|FG009|Induction Study: Up to Week 11|Adverse Event|0
4711647|NCT02914522|7637764|FG010|Induction Study: Up to Week 11|Adverse Event|0
4711648|NCT02914522|7637754|FG000|Induction Study: Up to Week 11|Withdrew Consent|4
4711649|NCT02914522|7637755|FG001|Induction Study: Up to Week 11|Withdrew Consent|11
4711650|NCT02914522|7637756|FG002|Induction Study: Up to Week 11|Withdrew Consent|4
4711651|NCT02914522|7637757|FG003|Induction Study: Up to Week 11|Withdrew Consent|6
4711652|NCT02914522|7637758|FG004|Induction Study: Up to Week 11|Withdrew Consent|3
4711653|NCT02914522|7637759|FG005|Induction Study: Up to Week 11|Withdrew Consent|3
4711654|NCT02914522|7637760|FG006|Induction Study: Up to Week 11|Withdrew Consent|0
4711655|NCT02914522|7637761|FG007|Induction Study: Up to Week 11|Withdrew Consent|0
4711656|NCT02914522|7637762|FG008|Induction Study: Up to Week 11|Withdrew Consent|0
4711657|NCT02914522|7637763|FG009|Induction Study: Up to Week 11|Withdrew Consent|0
4711658|NCT02914522|7637764|FG010|Induction Study: Up to Week 11|Withdrew Consent|0
4711659|NCT02914522|7637754|FG000|Induction Study: Up to Week 11|Protocol Violation|0
4711660|NCT02914522|7637755|FG001|Induction Study: Up to Week 11|Protocol Violation|2
4711661|NCT02914522|7637756|FG002|Induction Study: Up to Week 11|Protocol Violation|1
4711662|NCT02914522|7637757|FG003|Induction Study: Up to Week 11|Protocol Violation|3
4711663|NCT02914522|7637758|FG004|Induction Study: Up to Week 11|Protocol Violation|4
4711664|NCT02914522|7637759|FG005|Induction Study: Up to Week 11|Protocol Violation|2
4711665|NCT02914522|7637760|FG006|Induction Study: Up to Week 11|Protocol Violation|0
4628303|NCT01858766|7495327|FG011|Overall Study|Lack of Efficacy|3
4628304|NCT01858766|7495328|FG012|Overall Study|Lack of Efficacy|5
4628305|NCT01858766|7495329|FG013|Overall Study|Lack of Efficacy|3
4628306|NCT01858766|7495330|FG014|Overall Study|Lack of Efficacy|5
4628307|NCT01858766|7495331|FG015|Overall Study|Lack of Efficacy|5
4628308|NCT01858766|7495332|FG016|Overall Study|Lack of Efficacy|2
4628309|NCT01858766|7495333|FG017|Overall Study|Lack of Efficacy|3
4628310|NCT01858766|7495334|FG018|Overall Study|Lack of Efficacy|3
4711666|NCT02914522|7637761|FG007|Induction Study: Up to Week 11|Protocol Violation|0
4711667|NCT02914522|7637762|FG008|Induction Study: Up to Week 11|Protocol Violation|0
4711668|NCT02914522|7637763|FG009|Induction Study: Up to Week 11|Protocol Violation|0
4711669|NCT02914522|7637764|FG010|Induction Study: Up to Week 11|Protocol Violation|0
4711670|NCT02914522|7637754|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0
4711671|NCT02914522|7637755|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2
4711672|NCT02914522|7637756|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1
4628311|NCT01858766|7495316|FG000|Overall Study|Lost to Follow-up|0
4711673|NCT02914522|7637757|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1
4711674|NCT02914522|7637758|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0
4711675|NCT02914522|7637759|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0
4711676|NCT02914522|7637760|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0
4711677|NCT02914522|7637761|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0
4711678|NCT02914522|7637762|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0
4711679|NCT02914522|7637763|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0
4711680|NCT02914522|7637764|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0
4711681|NCT02914522|7637754|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0
4711682|NCT02914522|7637755|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0
4711683|NCT02914522|7637756|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0
4711684|NCT02914522|7637757|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0
4711685|NCT02914522|7637758|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1
4711686|NCT02914522|7637759|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0
4711687|NCT02914522|7637760|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0
4711688|NCT02914522|7637761|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0
4711689|NCT02914522|7637762|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0
4711690|NCT02914522|7637763|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0
4711691|NCT02914522|7637764|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0
4711692|NCT02914522|7637754|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1
4711693|NCT02914522|7637755|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
4711694|NCT02914522|7637756|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
4711695|NCT02914522|7637757|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
4711696|NCT02914522|7637758|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
4711697|NCT02914522|7637759|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
4711698|NCT02914522|7637760|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
4711699|NCT02914522|7637761|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
4711700|NCT02914522|7637762|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
4711701|NCT02914522|7637763|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
4711702|NCT02914522|7637764|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0
4711703|NCT02914522|7637754|FG000|Induction Study: Up to Week 11|Pregnancy|0
4711704|NCT02914522|7637755|FG001|Induction Study: Up to Week 11|Pregnancy|0
4711705|NCT02914522|7637756|FG002|Induction Study: Up to Week 11|Pregnancy|0
4390192|NCT00075725|7168737|FG000|Overall Study|Pt has very high risk ALL characteristic|15
4510705|NCT00922480|7319594|FG001|Main Study|Lost to Follow-up|0
4711706|NCT02914522|7637757|FG003|Induction Study: Up to Week 11|Pregnancy|0
4711707|NCT02914522|7637758|FG004|Induction Study: Up to Week 11|Pregnancy|1
4711708|NCT02914522|7637759|FG005|Induction Study: Up to Week 11|Pregnancy|0
4711709|NCT02914522|7637760|FG006|Induction Study: Up to Week 11|Pregnancy|0
4711710|NCT02914522|7637761|FG007|Induction Study: Up to Week 11|Pregnancy|0
4711711|NCT02914522|7637762|FG008|Induction Study: Up to Week 11|Pregnancy|0
4711712|NCT02914522|7637763|FG009|Induction Study: Up to Week 11|Pregnancy|0
4711713|NCT02914522|7637764|FG010|Induction Study: Up to Week 11|Pregnancy|0
4711714|NCT02914522|7637754|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0
4711715|NCT02914522|7637755|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1
4711716|NCT02914522|7637756|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0
4711717|NCT02914522|7637757|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0
4711718|NCT02914522|7637758|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1
4711719|NCT02914522|7637759|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1
4711720|NCT02914522|7637760|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0
4711721|NCT02914522|7637761|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0
4711722|NCT02914522|7637762|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0
4711723|NCT02914522|7637763|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0
4711724|NCT02914522|7637764|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0
4711725|NCT02914522|7637754|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0
4711726|NCT02914522|7637755|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0
4711727|NCT02914522|7637756|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0
4711728|NCT02914522|7637757|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0
4711729|NCT02914522|7637758|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0
4711730|NCT02914522|7637759|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0
4711731|NCT02914522|7637760|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34
4771515|NCT02726880|7748313|FG000|Overall Study|Lost to Follow-up|1
4771516|NCT02726880|7748314|FG001|Overall Study|Lost to Follow-up|3
4771517|NCT02592551|7748336|FG000|Overall Study|Not evaluable|1
4771518|NCT02592551|7748337|FG001|Overall Study|Not evaluable|3
4771519|NCT02592551|7748338|FG002|Overall Study|Not evaluable|0
4771520|NCT02583048|7748350|FG000|Overall Study|Withdrawal by Subject|0
4771521|NCT02583048|7748351|FG001|Overall Study|Withdrawal by Subject|1
4771522|NCT02583048|7748352|FG002|Overall Study|Withdrawal by Subject|0
4771523|NCT02583048|7748350|FG000|Overall Study|Failed to meet eligibility criterion|0
4711732|NCT02914522|7637761|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49
4711733|NCT02914522|7637762|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53
4711734|NCT02914522|7637763|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39
4711735|NCT02914522|7637764|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21
4711736|NCT02914522|7637754|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0
4711737|NCT02914522|7637755|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0
4711738|NCT02914522|7637756|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0
4711739|NCT02914522|7637757|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0
4711740|NCT02914522|7637758|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0
4711741|NCT02914522|7637759|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0
4711742|NCT02914522|7637760|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7
4711743|NCT02914522|7637761|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2
4711744|NCT02914522|7637762|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10
4711745|NCT02914522|7637763|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4
4711746|NCT02914522|7637764|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3
4711747|NCT02914522|7637754|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0
4711748|NCT02914522|7637755|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0
4711749|NCT02914522|7637756|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0
4711750|NCT02914522|7637757|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0
4711751|NCT02914522|7637758|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0
4711752|NCT02914522|7637759|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0
4711753|NCT02914522|7637760|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5
4711754|NCT02914522|7637761|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5
4711755|NCT02914522|7637762|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3
4711756|NCT02914522|7637763|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0
4711757|NCT02914522|7637764|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1
4711758|NCT02914522|7637754|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0
4711759|NCT02914522|7637755|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0
4711760|NCT02914522|7637756|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0
4711761|NCT02914522|7637757|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0
4711762|NCT02914522|7637758|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0
4711763|NCT02914522|7637759|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0
4711764|NCT02914522|7637760|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4
4711765|NCT02914522|7637761|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1
4711766|NCT02914522|7637762|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6
4711767|NCT02914522|7637763|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3
4711768|NCT02914522|7637764|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4
4711769|NCT02914522|7637754|FG000|Maintenance Study: Week 11 to Week 58|Death|0
4711770|NCT02914522|7637755|FG001|Maintenance Study: Week 11 to Week 58|Death|0
4711771|NCT02914522|7637756|FG002|Maintenance Study: Week 11 to Week 58|Death|0
4711772|NCT02914522|7637757|FG003|Maintenance Study: Week 11 to Week 58|Death|0
4711773|NCT02914522|7637758|FG004|Maintenance Study: Week 11 to Week 58|Death|0
4711774|NCT02914522|7637759|FG005|Maintenance Study: Week 11 to Week 58|Death|0
4711775|NCT02914522|7637760|FG006|Maintenance Study: Week 11 to Week 58|Death|2
4711776|NCT02914522|7637761|FG007|Maintenance Study: Week 11 to Week 58|Death|0
4711777|NCT02914522|7637762|FG008|Maintenance Study: Week 11 to Week 58|Death|0
4711778|NCT02914522|7637763|FG009|Maintenance Study: Week 11 to Week 58|Death|0
4711779|NCT02914522|7637764|FG010|Maintenance Study: Week 11 to Week 58|Death|0
4711780|NCT02914522|7637754|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
4711781|NCT02914522|7637755|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
4711782|NCT02914522|7637756|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
4711783|NCT02914522|7637757|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
4711784|NCT02914522|7637758|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
4711785|NCT02914522|7637759|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
4711786|NCT02914522|7637760|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
4711787|NCT02914522|7637761|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1
4711788|NCT02914522|7637762|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2
4711789|NCT02914522|7637763|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
4711790|NCT02914522|7637764|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0
4711791|NCT02914522|7637754|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0
4711792|NCT02914522|7637755|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0
4711793|NCT02914522|7637756|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0
4711794|NCT02914522|7637757|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0
4711795|NCT02914522|7637758|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0
4711796|NCT02914522|7637759|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0
4711797|NCT02914522|7637760|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0
4711798|NCT02914522|7637761|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0
4711799|NCT02914522|7637762|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1
4711800|NCT02914522|7637763|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2
4711801|NCT02914522|7637764|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0
4711802|NCT02914522|7637754|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
4711803|NCT02914522|7637755|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
4711804|NCT02914522|7637756|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
4711805|NCT02914522|7637757|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
4711806|NCT02914522|7637758|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
4711807|NCT02914522|7637759|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
4711808|NCT02914522|7637760|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
4711809|NCT02914522|7637761|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
4711810|NCT02914522|7637762|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
4711811|NCT02914522|7637763|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1
4711812|NCT02914522|7637764|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0
4711813|NCT02914548|7637794|FG000|Overall Study|Adverse Event|15
4711814|NCT02914548|7637795|FG001|Overall Study|Adverse Event|7
4711815|NCT02914548|7637796|FG002|Overall Study|Adverse Event|15
4711816|NCT02914548|7637794|FG000|Overall Study|Physician Decision|2
4711817|NCT02914548|7637795|FG001|Overall Study|Physician Decision|2
4711818|NCT02914548|7637796|FG002|Overall Study|Physician Decision|0
4711819|NCT02914548|7637794|FG000|Overall Study|Protocol Violation|1
4711820|NCT02914548|7637795|FG001|Overall Study|Protocol Violation|0
4711821|NCT02914548|7637796|FG002|Overall Study|Protocol Violation|0
4711822|NCT02914548|7637794|FG000|Overall Study|Withdrawal by Subject|3
4711823|NCT02914548|7637795|FG001|Overall Study|Withdrawal by Subject|4
4711824|NCT02914548|7637796|FG002|Overall Study|Withdrawal by Subject|4
4711825|NCT02914548|7637794|FG000|Overall Study|>40% of body surface area|0
4711826|NCT02914548|7637795|FG001|Overall Study|>40% of body surface area|1
4711827|NCT02914548|7637796|FG002|Overall Study|>40% of body surface area|1
4711828|NCT02914834|7637817|FG000|Overall Study|Study halted due to COVID|1
4711829|NCT02914834|7637818|FG001|Overall Study|Study halted due to COVID|1
4711830|NCT02914834|7637817|FG000|Overall Study|1 subject withdrew|0
4711831|NCT02914834|7637818|FG001|Overall Study|1 subject withdrew|1
4771524|NCT02583048|7748351|FG001|Overall Study|Failed to meet eligibility criterion|0
4771525|NCT02583048|7748352|FG002|Overall Study|Failed to meet eligibility criterion|1
4390193|NCT00075725|7168738|FG001|Overall Study|Pt has very high risk ALL characteristic|11
4390194|NCT00075725|7168739|FG002|Overall Study|Pt has very high risk ALL characteristic|26
4390195|NCT00075725|7168740|FG003|Overall Study|Pt has very high risk ALL characteristic|18
4390196|NCT00075725|7168741|FG004|Overall Study|Pt has very high risk ALL characteristic|11
4390197|NCT00075725|7168742|FG005|Overall Study|Pt has very high risk ALL characteristic|75
4390198|NCT00075725|7168743|FG006|Overall Study|Pt has very high risk ALL characteristic|23
4628312|NCT01858766|7495317|FG001|Overall Study|Lost to Follow-up|0
4628313|NCT01858766|7495318|FG002|Overall Study|Lost to Follow-up|0
4628314|NCT01858766|7495319|FG003|Overall Study|Lost to Follow-up|0
4628315|NCT01858766|7495320|FG004|Overall Study|Lost to Follow-up|0
4628316|NCT01858766|7495321|FG005|Overall Study|Lost to Follow-up|1
4628317|NCT01858766|7495322|FG006|Overall Study|Lost to Follow-up|0
4628318|NCT01858766|7495323|FG007|Overall Study|Lost to Follow-up|2
4628319|NCT01858766|7495324|FG008|Overall Study|Lost to Follow-up|0
4628320|NCT01858766|7495325|FG009|Overall Study|Lost to Follow-up|0
4628321|NCT01858766|7495326|FG010|Overall Study|Lost to Follow-up|0
4628322|NCT01858766|7495327|FG011|Overall Study|Lost to Follow-up|1
4628323|NCT01858766|7495328|FG012|Overall Study|Lost to Follow-up|0
4628324|NCT01858766|7495329|FG013|Overall Study|Lost to Follow-up|0
4628325|NCT01858766|7495330|FG014|Overall Study|Lost to Follow-up|3
4628326|NCT01858766|7495331|FG015|Overall Study|Lost to Follow-up|1
4628327|NCT01858766|7495332|FG016|Overall Study|Lost to Follow-up|1
4628328|NCT01858766|7495333|FG017|Overall Study|Lost to Follow-up|0
4628329|NCT01858766|7495334|FG018|Overall Study|Lost to Follow-up|1
4628330|NCT01858766|7495316|FG000|Overall Study|Withdrew Consent|0
4628331|NCT01858766|7495317|FG001|Overall Study|Withdrew Consent|0
4628332|NCT01858766|7495318|FG002|Overall Study|Withdrew Consent|0
4628333|NCT01858766|7495319|FG003|Overall Study|Withdrew Consent|0
4628334|NCT01858766|7495320|FG004|Overall Study|Withdrew Consent|0
4628335|NCT01858766|7495321|FG005|Overall Study|Withdrew Consent|0
4771526|NCT02546986|7748365|FG000|Treatment Period|Progressive Disease|20
4771527|NCT02546986|7748366|FG001|Treatment Period|Progressive Disease|22
4771528|NCT02546986|7748365|FG000|Treatment Period|Adverse Event|14
4771529|NCT02546986|7748366|FG001|Treatment Period|Adverse Event|6
4771530|NCT02546986|7748365|FG000|Treatment Period|Symptomatic Deterioration|4
4771531|NCT02546986|7748366|FG001|Treatment Period|Symptomatic Deterioration|3
4771532|NCT02546986|7748365|FG000|Treatment Period|Death|3
4771533|NCT02546986|7748366|FG001|Treatment Period|Death|4
4771534|NCT02546986|7748365|FG000|Treatment Period|Physician Decision|1
4771535|NCT02546986|7748366|FG001|Treatment Period|Physician Decision|2
4771536|NCT02546986|7748365|FG000|Treatment Period|Protocol Violation|1
4771537|NCT02546986|7748366|FG001|Treatment Period|Protocol Violation|0
4771538|NCT02546986|7748365|FG000|Treatment Period|Withdrawal by Subject|1
4771539|NCT02546986|7748366|FG001|Treatment Period|Withdrawal by Subject|1
4771540|NCT02546986|7748365|FG000|Treatment Period|Non-compliance with Study Drug|0
4771541|NCT02546986|7748366|FG001|Treatment Period|Non-compliance with Study Drug|1
4771542|NCT02546986|7748365|FG000|Treatment Period|Study Terminated by Sponsor|0
4771543|NCT02546986|7748366|FG001|Treatment Period|Study Terminated by Sponsor|1
4771544|NCT02546986|7748365|FG000|Treatment Period|Miscellaneous|7
4771545|NCT02546986|7748366|FG001|Treatment Period|Miscellaneous|9
4771546|NCT02546986|7748365|FG000|Survival Follow-Up Phase|Missing Status|3
4771547|NCT02546986|7748366|FG001|Survival Follow-Up Phase|Missing Status|5
4771548|NCT02546986|7748365|FG000|Survival Follow-Up Phase|Death|18
4771549|NCT02546986|7748366|FG001|Survival Follow-Up Phase|Death|12
4771550|NCT02546986|7748365|FG000|Survival Follow-Up Phase|Alive|13
4771551|NCT02546986|7748366|FG001|Survival Follow-Up Phase|Alive|16
4771552|NCT02546986|7748365|FG000|Survival Follow-Up Phase|Lost to Follow-up|2
4771553|NCT02546986|7748366|FG001|Survival Follow-Up Phase|Lost to Follow-up|2
4771554|NCT02539160|7748374|FG000|Phase 1 Pre-crossover|Adverse Event|3
4711880|NCT02915159|7637868|FG000|Overall Study|Participant no longer meets criteria|2
4711881|NCT02915159|7637869|FG001|Overall Study|Participant no longer meets criteria|0
4711882|NCT02915159|7637868|FG000|Overall Study|poor/non-compliance|1
4711883|NCT02915159|7637869|FG001|Overall Study|poor/non-compliance|0
4711884|NCT02915159|7637868|FG000|Overall Study|Participant withdrew consent|5
4711885|NCT02915159|7637869|FG001|Overall Study|Participant withdrew consent|1
4711886|NCT02915159|7637868|FG000|Overall Study|Request to discontinue treatment|1
4711887|NCT02915159|7637869|FG001|Overall Study|Request to discontinue treatment|2
4711888|NCT02915159|7637868|FG000|Overall Study|Adverse Event|2
4711889|NCT02915159|7637869|FG001|Overall Study|Adverse Event|2
4711890|NCT02915159|7637868|FG000|Overall Study|Lack of Efficacy|0
4711891|NCT02915159|7637869|FG001|Overall Study|Lack of Efficacy|3
4711892|NCT02915835|7637904|FG000|Overall Study|Physician Decision|1
4711893|NCT02915835|7637905|FG001|Overall Study|Physician Decision|0
4711894|NCT02915835|7637904|FG000|Overall Study|Withdrawal by Subject|0
4711895|NCT02915835|7637905|FG001|Overall Study|Withdrawal by Subject|1
4711896|NCT02915874|7637913|FG000|Overall Study|Lost to Follow-up|5
4711897|NCT02915874|7637914|FG001|Overall Study|Lost to Follow-up|4
4711898|NCT02915874|7637913|FG000|Overall Study|Withdrawal by Subject|1
4711899|NCT02915874|7637914|FG001|Overall Study|Withdrawal by Subject|1
4711900|NCT02915874|7637913|FG000|Overall Study|Started New Anxiety Medication|0
4711901|NCT02915874|7637914|FG001|Overall Study|Started New Anxiety Medication|1
4711902|NCT02915978|7637923|FG000|Overall Study|Adverse Event|2
4711903|NCT02915978|7637924|FG001|Overall Study|Adverse Event|1
4711904|NCT02915978|7637925|FG002|Overall Study|Adverse Event|0
4711905|NCT02916056|7637933|FG000|Overall Study|Adverse Event|6
4711906|NCT02916056|7637933|FG000|Overall Study|Lost to Follow-up|1
4711907|NCT02916056|7637933|FG000|Overall Study|Other|12
4711908|NCT02916056|7637933|FG000|Overall Study|Protocol Violation|1
4711909|NCT02916056|7637933|FG000|Overall Study|Withdrawal by Subject|8
4711910|NCT02916056|7637933|FG000|Overall Study|Study Terminated by Sponsor|269
4711911|NCT02916433|7637948|FG000|Overall Study|Withdrawal by Subject|1
4711912|NCT02916433|7637949|FG001|Overall Study|Withdrawal by Subject|0
4628336|NCT01858766|7495322|FG006|Overall Study|Withdrew Consent|0
4628337|NCT01858766|7495323|FG007|Overall Study|Withdrew Consent|0
4711913|NCT02916433|7637948|FG000|Overall Study|Physician Decision|1
4711914|NCT02916433|7637949|FG001|Overall Study|Physician Decision|0
4711915|NCT02916693|7637971|FG000|Overall Study|Lost to Follow-up|7
4711916|NCT02916927|7637985|FG000|Overall Study|Discharged prior to study drug receipt|0
4711917|NCT02916927|7637986|FG001|Overall Study|Discharged prior to study drug receipt|2
4711918|NCT02916927|7637985|FG000|Overall Study|At radiology for 45 & 60 min time points|0
4711919|NCT02916927|7637986|FG001|Overall Study|At radiology for 45 & 60 min time points|1
4711920|NCT02916927|7637985|FG000|Overall Study|Withdrawal before first time point|1
4771555|NCT02539160|7748375|FG001|Phase 1 Pre-crossover|Adverse Event|3
4711921|NCT02916927|7637986|FG001|Overall Study|Withdrawal before first time point|0
4711922|NCT02917031|7637995|FG000|Overall Study|Reason not specified|7
4711923|NCT02917031|7637996|FG001|Overall Study|Reason not specified|5
4711924|NCT02917031|7637997|FG002|Overall Study|Reason not specified|6
4711925|NCT02917031|7637995|FG000|Overall Study|Development of study-specific withdrawal criteria|1
4711926|NCT02917031|7637996|FG001|Overall Study|Development of study-specific withdrawal criteria|1
4711927|NCT02917031|7637997|FG002|Overall Study|Development of study-specific withdrawal criteria|0
4711928|NCT02917031|7637995|FG000|Overall Study|Withdrawal by Subject|3
4711929|NCT02917031|7637996|FG001|Overall Study|Withdrawal by Subject|3
4711930|NCT02917031|7637997|FG002|Overall Study|Withdrawal by Subject|0
4711931|NCT02917031|7637995|FG000|Overall Study|Physician Decision|1
4711932|NCT02917031|7637996|FG001|Overall Study|Physician Decision|0
4711933|NCT02917031|7637997|FG002|Overall Study|Physician Decision|0
4711934|NCT02917031|7637995|FG000|Overall Study|Adverse Event|4
4711935|NCT02917031|7637996|FG001|Overall Study|Adverse Event|1
4711936|NCT02917031|7637997|FG002|Overall Study|Adverse Event|5
4711937|NCT02917031|7637995|FG000|Overall Study|Death|2
4711938|NCT02917031|7637996|FG001|Overall Study|Death|3
4711939|NCT02917031|7637997|FG002|Overall Study|Death|4
4711940|NCT02917265|7638017|FG000|Overall Study|Physician Decision|1
4711941|NCT02917265|7638018|FG001|Overall Study|Physician Decision|0
4711942|NCT02917265|7638017|FG000|Overall Study|Withdrawal by Subject|1
4711943|NCT02917265|7638018|FG001|Overall Study|Withdrawal by Subject|0
4711944|NCT02917941|7638063|FG000|Treatment Period|Adverse Event|11
4711945|NCT02917941|7638063|FG000|Treatment Period|Progressive Disease|11
4711946|NCT02917941|7638063|FG000|Treatment Period|Reason not Specified|2
4711947|NCT02917941|7638063|FG000|Survival Follow-up Period|Lost to Follow-up|1
4711948|NCT02917941|7638063|FG000|Survival Follow-up Period|Withdrawal by Subject|4
4711949|NCT02918071|7638067|FG000|Overall Study|Withdrawal by Subject|2
4711950|NCT02918071|7638067|FG000|Overall Study|Lost to Follow-up|1
4711951|NCT02918266|7638086|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0
4711952|NCT02918266|7638087|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1
4711953|NCT02918266|7638088|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1
4711954|NCT02918266|7638089|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1
4711955|NCT02918266|7638090|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1
4711956|NCT02918266|7638091|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1
4711957|NCT02918266|7638092|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2
4711958|NCT02918266|7638093|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1
4711959|NCT02918266|7638094|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2
4711960|NCT02918266|7638095|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1
4711961|NCT02918266|7638096|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1
4711962|NCT02918279|7638118|FG000|Overall Study|Lost to Follow-up|3
4711963|NCT02918279|7638119|FG001|Overall Study|Lost to Follow-up|6
4711964|NCT02918279|7638118|FG000|Overall Study|Withdrawal by Subject|5
4711965|NCT02918279|7638119|FG001|Overall Study|Withdrawal by Subject|15
4711966|NCT02918279|7638118|FG000|Overall Study|Withdrawal by parent/guardian|2
4711967|NCT02918279|7638119|FG001|Overall Study|Withdrawal by parent/guardian|1
4711968|NCT02918279|7638118|FG000|Overall Study|Other|3
4711969|NCT02918279|7638119|FG001|Overall Study|Other|1
4711970|NCT02918318|7638129|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1
4711971|NCT02918318|7638130|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4
4711972|NCT02918318|7638131|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2
4711973|NCT02918318|7638132|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3
4711974|NCT02918318|7638133|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0
4711975|NCT02918318|7638129|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0
4711976|NCT02918318|7638130|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0
4711977|NCT02918318|7638131|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0
4711978|NCT02918318|7638132|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2
4711979|NCT02918318|7638133|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0
4711980|NCT02918318|7638129|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0
4711981|NCT02918318|7638130|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0
4711982|NCT02918318|7638131|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0
4711983|NCT02918318|7638132|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1
4711984|NCT02918318|7638133|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0
4711985|NCT02918318|7638129|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1
4711986|NCT02918318|7638130|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1
4711987|NCT02918318|7638131|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0
4711988|NCT02918318|7638132|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0
4711989|NCT02918318|7638133|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0
4711990|NCT02918318|7638129|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0
4711991|NCT02918318|7638130|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0
4711992|NCT02918318|7638131|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0
4711993|NCT02918318|7638132|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1
4711994|NCT02918318|7638133|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0
4711995|NCT02918318|7638129|FG000|Double-blind Induction Phase: 4 Weeks|Other|0
4711996|NCT02918318|7638130|FG001|Double-blind Induction Phase: 4 Weeks|Other|2
4390199|NCT00075725|7168744|FG007|Overall Study|Pt has very high risk ALL characteristic|74
4390200|NCT00075725|7168745|FG008|Overall Study|Pt has very high risk ALL characteristic|29
4390201|NCT00075725|7168746|FG009|Overall Study|Pt has very high risk ALL characteristic|1
4390202|NCT00075725|7168747|FG010|Overall Study|Pt has very high risk ALL characteristic|0
4390203|NCT00075725|7168748|FG011|Overall Study|Pt has very high risk ALL characteristic|3
4390204|NCT00075725|7168737|FG000|Overall Study|Inevaluable|1
4390205|NCT00075725|7168738|FG001|Overall Study|Inevaluable|1
4390206|NCT00075725|7168739|FG002|Overall Study|Inevaluable|4
4390207|NCT00075725|7168740|FG003|Overall Study|Inevaluable|2
4390208|NCT00075725|7168741|FG004|Overall Study|Inevaluable|2
4390209|NCT00075725|7168742|FG005|Overall Study|Inevaluable|9
4390210|NCT00075725|7168743|FG006|Overall Study|Inevaluable|1
4390211|NCT00075725|7168744|FG007|Overall Study|Inevaluable|11
4390212|NCT00075725|7168745|FG008|Overall Study|Inevaluable|2
4390213|NCT00075725|7168746|FG009|Overall Study|Inevaluable|0
4390214|NCT00075725|7168747|FG010|Overall Study|Inevaluable|1
4390215|NCT00075725|7168748|FG011|Overall Study|Inevaluable|0
4390216|NCT00075725|7168737|FG000|Overall Study|Other|4
4390217|NCT00075725|7168738|FG001|Overall Study|Other|2
4390218|NCT00075725|7168739|FG002|Overall Study|Other|1
4390219|NCT00075725|7168740|FG003|Overall Study|Other|1
4390220|NCT00075725|7168741|FG004|Overall Study|Other|1
4390221|NCT00075725|7168742|FG005|Overall Study|Other|4
4390222|NCT00075725|7168743|FG006|Overall Study|Other|2
4390223|NCT00075725|7168744|FG007|Overall Study|Other|9
4390224|NCT00075725|7168745|FG008|Overall Study|Other|2
4390225|NCT00075725|7168746|FG009|Overall Study|Other|1
4390226|NCT00075725|7168747|FG010|Overall Study|Other|0
4390227|NCT00075725|7168748|FG011|Overall Study|Other|3
4390228|NCT00075725|7168737|FG000|Overall Study|Pt trying to find a BM donor|0
4390229|NCT00075725|7168738|FG001|Overall Study|Pt trying to find a BM donor|1
4390230|NCT00075725|7168739|FG002|Overall Study|Pt trying to find a BM donor|0
4390231|NCT00075725|7168740|FG003|Overall Study|Pt trying to find a BM donor|0
4390232|NCT00075725|7168741|FG004|Overall Study|Pt trying to find a BM donor|0
4390233|NCT00075725|7168742|FG005|Overall Study|Pt trying to find a BM donor|0
4390234|NCT00075725|7168743|FG006|Overall Study|Pt trying to find a BM donor|0
4390235|NCT00075725|7168744|FG007|Overall Study|Pt trying to find a BM donor|0
4390236|NCT00075725|7168745|FG008|Overall Study|Pt trying to find a BM donor|0
4390237|NCT00075725|7168746|FG009|Overall Study|Pt trying to find a BM donor|0
4390238|NCT00075725|7168747|FG010|Overall Study|Pt trying to find a BM donor|0
4390239|NCT00075725|7168748|FG011|Overall Study|Pt trying to find a BM donor|0
4390240|NCT00075725|7168737|FG000|Overall Study|Clinic chart lost unable to recreate|0
4390241|NCT00075725|7168738|FG001|Overall Study|Clinic chart lost unable to recreate|0
4390242|NCT00075725|7168739|FG002|Overall Study|Clinic chart lost unable to recreate|1
4390243|NCT00075725|7168740|FG003|Overall Study|Clinic chart lost unable to recreate|0
4390244|NCT00075725|7168741|FG004|Overall Study|Clinic chart lost unable to recreate|0
4390245|NCT00075725|7168742|FG005|Overall Study|Clinic chart lost unable to recreate|0
4390246|NCT00075725|7168743|FG006|Overall Study|Clinic chart lost unable to recreate|0
4390247|NCT00075725|7168744|FG007|Overall Study|Clinic chart lost unable to recreate|0
4390248|NCT00075725|7168745|FG008|Overall Study|Clinic chart lost unable to recreate|0
4390249|NCT00075725|7168746|FG009|Overall Study|Clinic chart lost unable to recreate|0
4390250|NCT00075725|7168747|FG010|Overall Study|Clinic chart lost unable to recreate|0
4390251|NCT00075725|7168748|FG011|Overall Study|Clinic chart lost unable to recreate|0
4390252|NCT00075725|7168737|FG000|Overall Study|Unsuccessful institutional transfer|0
4390253|NCT00075725|7168738|FG001|Overall Study|Unsuccessful institutional transfer|0
4390254|NCT00075725|7168739|FG002|Overall Study|Unsuccessful institutional transfer|2
4390255|NCT00075725|7168740|FG003|Overall Study|Unsuccessful institutional transfer|0
4390256|NCT00075725|7168741|FG004|Overall Study|Unsuccessful institutional transfer|0
4390257|NCT00075725|7168742|FG005|Overall Study|Unsuccessful institutional transfer|0
4390258|NCT00075725|7168743|FG006|Overall Study|Unsuccessful institutional transfer|0
4390259|NCT00075725|7168744|FG007|Overall Study|Unsuccessful institutional transfer|0
4390260|NCT00075725|7168745|FG008|Overall Study|Unsuccessful institutional transfer|0
4390261|NCT00075725|7168746|FG009|Overall Study|Unsuccessful institutional transfer|1
4390262|NCT00075725|7168747|FG010|Overall Study|Unsuccessful institutional transfer|0
4390263|NCT00075725|7168748|FG011|Overall Study|Unsuccessful institutional transfer|0
4390264|NCT00075725|7168737|FG000|Overall Study|specimen(s) not submitted|0
4390265|NCT00075725|7168738|FG001|Overall Study|specimen(s) not submitted|0
4390266|NCT00075725|7168739|FG002|Overall Study|specimen(s) not submitted|2
4711997|NCT02918318|7638131|FG002|Double-blind Induction Phase: 4 Weeks|Other|0
4711998|NCT02918318|7638132|FG003|Double-blind Induction Phase: 4 Weeks|Other|1
4711999|NCT02918318|7638133|FG004|Double-blind Induction Phase: 4 Weeks|Other|0
4712000|NCT02918318|7638129|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0
4712001|NCT02918318|7638130|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0
4712002|NCT02918318|7638131|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0
4712003|NCT02918318|7638132|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2
4712004|NCT02918318|7638133|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0
4712005|NCT02918318|7638129|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1
4712006|NCT02918318|7638130|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0
4712007|NCT02918318|7638131|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1
4712008|NCT02918318|7638132|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1
4712009|NCT02918318|7638133|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0
4712010|NCT02918318|7638129|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1
4712011|NCT02918318|7638130|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0
4712012|NCT02918318|7638131|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0
4712013|NCT02918318|7638132|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1
4712014|NCT02918318|7638133|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0
4712015|NCT02918318|7638129|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0
4712016|NCT02918318|7638130|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3
4712017|NCT02918318|7638131|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1
4712018|NCT02918318|7638132|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1
4712019|NCT02918318|7638133|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0
4712020|NCT02918318|7638129|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0
4712021|NCT02918318|7638130|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0
4712022|NCT02918318|7638131|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0
4712023|NCT02918318|7638132|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0
4712024|NCT02918318|7638133|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1
4712025|NCT02918318|7638129|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0
4712026|NCT02918318|7638130|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0
4712027|NCT02918318|7638131|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0
4712028|NCT02918318|7638132|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0
4712029|NCT02918318|7638133|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1
4712030|NCT02918552|7638191|FG000|Overall Study|Failed Pharmacokinetics|1
4712031|NCT02918552|7638192|FG001|Overall Study|Failed Pharmacokinetics|0
4712032|NCT02918552|7638191|FG000|Overall Study|Withdrawal by Subject|0
4712033|NCT02918552|7638192|FG001|Overall Study|Withdrawal by Subject|1
4712034|NCT02918552|7638191|FG000|Overall Study|Lost to Follow-up|0
4712035|NCT02918552|7638192|FG001|Overall Study|Lost to Follow-up|1
4712036|NCT02918877|7638291|FG000|Overall Study|Withdrawal by Subject|2
4712037|NCT02918877|7638292|FG001|Overall Study|Withdrawal by Subject|2
4712038|NCT02918877|7638291|FG000|Overall Study|Surgery cancelled|1
4712039|NCT02918877|7638292|FG001|Overall Study|Surgery cancelled|0
4712040|NCT02918877|7638291|FG000|Overall Study|Physician Decision|1
4712041|NCT02918877|7638292|FG001|Overall Study|Physician Decision|0
4712042|NCT02918877|7638291|FG000|Overall Study|Received intraoperative steroids|1
4712043|NCT02918877|7638292|FG001|Overall Study|Received intraoperative steroids|0
4712044|NCT02918877|7638291|FG000|Overall Study|Unable to obtain lab samples|1
4712045|NCT02918877|7638292|FG001|Overall Study|Unable to obtain lab samples|0
4712046|NCT02918877|7638291|FG000|Overall Study|Unsafe to perform BAL|0
4712047|NCT02918877|7638292|FG001|Overall Study|Unsafe to perform BAL|1
4712048|NCT02918968|7638300|FG000|1st Line AAT|Progressive disease|9
4712049|NCT02918968|7638301|FG001|1st Line AAT|Progressive disease|4
4712050|NCT02918968|7638300|FG000|1st Line AAT|Adverse Event|12
4712051|NCT02918968|7638301|FG001|1st Line AAT|Adverse Event|3
4712052|NCT02918968|7638300|FG000|1st Line AAT|Physician Decision|4
4712053|NCT02918968|7638301|FG001|1st Line AAT|Physician Decision|2
4712054|NCT02918968|7638300|FG000|1st Line AAT|Withdrawal by Subject|2
4712055|NCT02918968|7638301|FG001|1st Line AAT|Withdrawal by Subject|1
4390267|NCT00075725|7168740|FG003|Overall Study|specimen(s) not submitted|0
4390268|NCT00075725|7168741|FG004|Overall Study|specimen(s) not submitted|0
4390269|NCT00075725|7168742|FG005|Overall Study|specimen(s) not submitted|0
4390270|NCT00075725|7168743|FG006|Overall Study|specimen(s) not submitted|0
4390271|NCT00075725|7168744|FG007|Overall Study|specimen(s) not submitted|0
4390272|NCT00075725|7168745|FG008|Overall Study|specimen(s) not submitted|0
4390273|NCT00075725|7168746|FG009|Overall Study|specimen(s) not submitted|0
4390274|NCT00075725|7168747|FG010|Overall Study|specimen(s) not submitted|0
4390275|NCT00075725|7168748|FG011|Overall Study|specimen(s) not submitted|0
4390276|NCT00075725|7168737|FG000|Overall Study|Pt went to transplant|0
4390277|NCT00075725|7168738|FG001|Overall Study|Pt went to transplant|0
4390278|NCT00075725|7168739|FG002|Overall Study|Pt went to transplant|0
4390279|NCT00075725|7168740|FG003|Overall Study|Pt went to transplant|1
4712056|NCT02918968|7638300|FG000|1st Line AAT|Lost to Follow-up|0
4712057|NCT02918968|7638301|FG001|1st Line AAT|Lost to Follow-up|1
4712058|NCT02918968|7638300|FG000|1st Line AAT|Death|1
4712059|NCT02918968|7638301|FG001|1st Line AAT|Death|0
4712060|NCT02918968|7638300|FG000|1st Line AAT|Miscellaneous|1
4712061|NCT02918968|7638301|FG001|1st Line AAT|Miscellaneous|0
4712062|NCT02918968|7638300|FG000|2nd Line AAT|Progressive disease|21
4712063|NCT02918968|7638301|FG001|2nd Line AAT|Progressive disease|3
4712064|NCT02918968|7638300|FG000|2nd Line AAT|Adverse Event|2
4712065|NCT02918968|7638301|FG001|2nd Line AAT|Adverse Event|5
4712066|NCT02918968|7638300|FG000|2nd Line AAT|Physician Decision|0
4712067|NCT02918968|7638301|FG001|2nd Line AAT|Physician Decision|1
4712068|NCT02918968|7638300|FG000|2nd Line AAT|Withdrawal by Subject|2
4712069|NCT02918968|7638301|FG001|2nd Line AAT|Withdrawal by Subject|2
4712070|NCT02918968|7638300|FG000|2nd Line AAT|Death|0
4712071|NCT02918968|7638301|FG001|2nd Line AAT|Death|1
4712072|NCT02919267|7638321|FG000|Overall Study|Protocol Violation|0
4712073|NCT02919267|7638322|FG001|Overall Study|Protocol Violation|3
4390280|NCT00075725|7168741|FG004|Overall Study|Pt went to transplant|0
4390281|NCT00075725|7168742|FG005|Overall Study|Pt went to transplant|1
4390282|NCT00075725|7168743|FG006|Overall Study|Pt went to transplant|0
4390283|NCT00075725|7168744|FG007|Overall Study|Pt went to transplant|0
4390284|NCT00075725|7168745|FG008|Overall Study|Pt went to transplant|0
4390285|NCT00075725|7168746|FG009|Overall Study|Pt went to transplant|0
4390286|NCT00075725|7168747|FG010|Overall Study|Pt went to transplant|0
4390287|NCT00075725|7168748|FG011|Overall Study|Pt went to transplant|0
4390288|NCT00075725|7168737|FG000|Overall Study|Pt received additional steroids|0
4390289|NCT00075725|7168738|FG001|Overall Study|Pt received additional steroids|0
4390290|NCT00075725|7168739|FG002|Overall Study|Pt received additional steroids|0
4390291|NCT00075725|7168740|FG003|Overall Study|Pt received additional steroids|1
4390292|NCT00075725|7168741|FG004|Overall Study|Pt received additional steroids|0
4390293|NCT00075725|7168742|FG005|Overall Study|Pt received additional steroids|0
4390294|NCT00075725|7168743|FG006|Overall Study|Pt received additional steroids|0
4390295|NCT00075725|7168744|FG007|Overall Study|Pt received additional steroids|0
4390296|NCT00075725|7168745|FG008|Overall Study|Pt received additional steroids|0
4390297|NCT00075725|7168746|FG009|Overall Study|Pt received additional steroids|0
4390298|NCT00075725|7168747|FG010|Overall Study|Pt received additional steroids|0
4390299|NCT00075725|7168748|FG011|Overall Study|Pt received additional steroids|0
4390300|NCT00075725|7168737|FG000|Overall Study|Pt relocated|0
4390301|NCT00075725|7168738|FG001|Overall Study|Pt relocated|0
4390302|NCT00075725|7168739|FG002|Overall Study|Pt relocated|0
4390303|NCT00075725|7168740|FG003|Overall Study|Pt relocated|2
4390304|NCT00075725|7168741|FG004|Overall Study|Pt relocated|0
4390305|NCT00075725|7168742|FG005|Overall Study|Pt relocated|1
4390306|NCT00075725|7168743|FG006|Overall Study|Pt relocated|1
4390307|NCT00075725|7168744|FG007|Overall Study|Pt relocated|2
4390308|NCT00075725|7168745|FG008|Overall Study|Pt relocated|1
4390309|NCT00075725|7168746|FG009|Overall Study|Pt relocated|0
4390310|NCT00075725|7168747|FG010|Overall Study|Pt relocated|0
4390311|NCT00075725|7168748|FG011|Overall Study|Pt relocated|0
4390312|NCT00075725|7168737|FG000|Overall Study|Institution Terminated|0
4390313|NCT00075725|7168738|FG001|Overall Study|Institution Terminated|0
4390314|NCT00075725|7168739|FG002|Overall Study|Institution Terminated|0
4390315|NCT00075725|7168740|FG003|Overall Study|Institution Terminated|0
4390316|NCT00075725|7168741|FG004|Overall Study|Institution Terminated|1
4390317|NCT00075725|7168742|FG005|Overall Study|Institution Terminated|0
4390318|NCT00075725|7168743|FG006|Overall Study|Institution Terminated|0
4390319|NCT00075725|7168744|FG007|Overall Study|Institution Terminated|3
4390320|NCT00075725|7168745|FG008|Overall Study|Institution Terminated|0
4390321|NCT00075725|7168746|FG009|Overall Study|Institution Terminated|0
4390322|NCT00075725|7168747|FG010|Overall Study|Institution Terminated|0
4390323|NCT00075725|7168748|FG011|Overall Study|Institution Terminated|0
4390324|NCT00075725|7168737|FG000|Overall Study|Study Closure|1
4390325|NCT00075725|7168738|FG001|Overall Study|Study Closure|0
4390326|NCT00075725|7168739|FG002|Overall Study|Study Closure|0
4390327|NCT00075725|7168740|FG003|Overall Study|Study Closure|0
4390328|NCT00075725|7168741|FG004|Overall Study|Study Closure|1
4390329|NCT00075725|7168742|FG005|Overall Study|Study Closure|3
4390330|NCT00075725|7168743|FG006|Overall Study|Study Closure|0
4390331|NCT00075725|7168744|FG007|Overall Study|Study Closure|1
4390332|NCT00075725|7168745|FG008|Overall Study|Study Closure|0
4390333|NCT00075725|7168746|FG009|Overall Study|Study Closure|0
4390334|NCT00075725|7168747|FG010|Overall Study|Study Closure|0
4390335|NCT00075725|7168748|FG011|Overall Study|Study Closure|0
4390336|NCT00075725|7168737|FG000|Overall Study|Other complications|0
4390337|NCT00075725|7168738|FG001|Overall Study|Other complications|0
4390338|NCT00075725|7168739|FG002|Overall Study|Other complications|0
4390339|NCT00075725|7168740|FG003|Overall Study|Other complications|0
4390340|NCT00075725|7168741|FG004|Overall Study|Other complications|0
4390341|NCT00075725|7168742|FG005|Overall Study|Other complications|1
4390342|NCT00075725|7168743|FG006|Overall Study|Other complications|0
4390343|NCT00075725|7168744|FG007|Overall Study|Other complications|0
4390344|NCT00075725|7168745|FG008|Overall Study|Other complications|0
4390345|NCT00075725|7168746|FG009|Overall Study|Other complications|0
4390346|NCT00075725|7168747|FG010|Overall Study|Other complications|0
4390347|NCT00075725|7168748|FG011|Overall Study|Other complications|0
4390348|NCT00075725|7168737|FG000|Overall Study|Pt care terminated due to pt behavior|0
4390349|NCT00075725|7168738|FG001|Overall Study|Pt care terminated due to pt behavior|0
4390350|NCT00075725|7168739|FG002|Overall Study|Pt care terminated due to pt behavior|0
4390351|NCT00075725|7168740|FG003|Overall Study|Pt care terminated due to pt behavior|0
4390352|NCT00075725|7168741|FG004|Overall Study|Pt care terminated due to pt behavior|0
4390353|NCT00075725|7168742|FG005|Overall Study|Pt care terminated due to pt behavior|0
4390354|NCT00075725|7168743|FG006|Overall Study|Pt care terminated due to pt behavior|0
4390355|NCT00075725|7168744|FG007|Overall Study|Pt care terminated due to pt behavior|1
4390356|NCT00075725|7168745|FG008|Overall Study|Pt care terminated due to pt behavior|0
4390357|NCT00075725|7168746|FG009|Overall Study|Pt care terminated due to pt behavior|0
4390358|NCT00075725|7168747|FG010|Overall Study|Pt care terminated due to pt behavior|0
4390359|NCT00075725|7168748|FG011|Overall Study|Pt care terminated due to pt behavior|0
4390360|NCT00075725|7168737|FG000|Overall Study|Pt incarcerated|0
4390361|NCT00075725|7168738|FG001|Overall Study|Pt incarcerated|0
4390362|NCT00075725|7168739|FG002|Overall Study|Pt incarcerated|0
4390363|NCT00075725|7168740|FG003|Overall Study|Pt incarcerated|0
4390364|NCT00075725|7168741|FG004|Overall Study|Pt incarcerated|0
4390365|NCT00075725|7168742|FG005|Overall Study|Pt incarcerated|0
4390366|NCT00075725|7168743|FG006|Overall Study|Pt incarcerated|0
4390367|NCT00075725|7168744|FG007|Overall Study|Pt incarcerated|1
4390368|NCT00075725|7168745|FG008|Overall Study|Pt incarcerated|0
4390369|NCT00075725|7168746|FG009|Overall Study|Pt incarcerated|0
4390370|NCT00075725|7168747|FG010|Overall Study|Pt incarcerated|0
4390371|NCT00075725|7168748|FG011|Overall Study|Pt incarcerated|0
4390372|NCT00075764|7168781|FG000|Overall Study|Adverse Event|5
4390373|NCT00075764|7168782|FG001|Overall Study|Adverse Event|12
4390374|NCT00075764|7168781|FG000|Overall Study|Death|4
4390375|NCT00075764|7168782|FG001|Overall Study|Death|8
4390376|NCT00075764|7168781|FG000|Overall Study|Withdrawal by Subject|28
4390377|NCT00075764|7168782|FG001|Overall Study|Withdrawal by Subject|18
4390378|NCT00075764|7168781|FG000|Overall Study|Progression|269
4390379|NCT00075764|7168782|FG001|Overall Study|Progression|274
4390380|NCT00075764|7168781|FG000|Overall Study|Still on treatment|8
4390381|NCT00075764|7168782|FG001|Overall Study|Still on treatment|15
4390382|NCT00075764|7168781|FG000|Overall Study|Delinquent|4
4390383|NCT00075764|7168782|FG001|Overall Study|Delinquent|2
4390384|NCT00075764|7168781|FG000|Overall Study|Not protocol specified|27
4390385|NCT00075764|7168782|FG001|Overall Study|Not protocol specified|19
4390386|NCT00075764|7168781|FG000|Overall Study|Under review|0
4390387|NCT00075764|7168782|FG001|Overall Study|Under review|1
4390388|NCT00075816|7168801|FG000|Overall Study|Did not undergo transplantation|14
4390389|NCT00075816|7168802|FG001|Overall Study|Did not undergo transplantation|11
4390390|NCT00075881|7168830|FG000|Overall Study|Lack of Efficacy|18
4390391|NCT00075881|7168830|FG000|Overall Study|Adverse Event|7
4390392|NCT00075881|7168830|FG000|Overall Study|Death|1
4390393|NCT00075881|7168830|FG000|Overall Study|Withdrawal by Subject|2
4390394|NCT00075881|7168830|FG000|Overall Study|Protocol Violation|4
4390395|NCT00075881|7168830|FG000|Overall Study|other complicating disease|3
4390396|NCT00075881|7168830|FG000|Overall Study|other|4
4390397|NCT00075881|7168830|FG000|Overall Study|missing data|2
4390398|NCT00075881|7168830|FG000|Overall Study|Ineligible|1
4390399|NCT00075881|7168830|FG000|Overall Study|never start protocol therapy|1
4390400|NCT00075946|7168840|FG000|Overall Study|Path ineligible: undetermined histology|0
4390401|NCT00075946|7168841|FG001|Overall Study|Path ineligible: undetermined histology|0
4390402|NCT00075946|7168842|FG002|Overall Study|Path ineligible: undetermined histology|0
4390403|NCT00075946|7168843|FG003|Overall Study|Path ineligible: undetermined histology|0
4390404|NCT00075946|7168844|FG004|Overall Study|Path ineligible: undetermined histology|6
4390405|NCT00075946|7168840|FG000|Overall Study|Did not achieve response after induction|0
4390406|NCT00075946|7168841|FG001|Overall Study|Did not achieve response after induction|0
4390407|NCT00075946|7168842|FG002|Overall Study|Did not achieve response after induction|0
4390408|NCT00075946|7168843|FG003|Overall Study|Did not achieve response after induction|0
4390409|NCT00075946|7168844|FG004|Overall Study|Did not achieve response after induction|182
4390410|NCT00075946|7168840|FG000|Overall Study|Incorrectly randomized (no response)|5
4390411|NCT00075946|7168841|FG001|Overall Study|Incorrectly randomized (no response)|5
4390412|NCT00075946|7168842|FG002|Overall Study|Incorrectly randomized (no response)|5
4390413|NCT00075946|7168843|FG003|Overall Study|Incorrectly randomized (no response)|1
4390414|NCT00075946|7168844|FG004|Overall Study|Incorrectly randomized (no response)|0
4390415|NCT00075946|7168840|FG000|Overall Study|Still on treatment at time of analysis|52
4390416|NCT00075946|7168841|FG001|Overall Study|Still on treatment at time of analysis|19
4390417|NCT00075946|7168842|FG002|Overall Study|Still on treatment at time of analysis|3
4390418|NCT00075946|7168843|FG003|Overall Study|Still on treatment at time of analysis|9
4390419|NCT00075946|7168844|FG004|Overall Study|Still on treatment at time of analysis|0
4390420|NCT00075946|7168840|FG000|Overall Study|Adverse Event|2
4390421|NCT00075946|7168841|FG001|Overall Study|Adverse Event|10
4390422|NCT00075946|7168842|FG002|Overall Study|Adverse Event|0
4390423|NCT00075946|7168843|FG003|Overall Study|Adverse Event|2
4390424|NCT00075946|7168844|FG004|Overall Study|Adverse Event|0
4390425|NCT00075946|7168840|FG000|Overall Study|Death|0
4390426|NCT00075946|7168841|FG001|Overall Study|Death|1
4390427|NCT00075946|7168842|FG002|Overall Study|Death|0
4390428|NCT00075946|7168843|FG003|Overall Study|Death|0
4390429|NCT00075946|7168844|FG004|Overall Study|Death|0
4390430|NCT00075946|7168840|FG000|Overall Study|Withdrawal by Subject|23
4390431|NCT00075946|7168841|FG001|Overall Study|Withdrawal by Subject|58
4390432|NCT00075946|7168842|FG002|Overall Study|Withdrawal by Subject|4
4390433|NCT00075946|7168843|FG003|Overall Study|Withdrawal by Subject|9
4390434|NCT00075946|7168844|FG004|Overall Study|Withdrawal by Subject|0
4390435|NCT00075946|7168840|FG000|Overall Study|Alternative therapy|16
4390436|NCT00075946|7168841|FG001|Overall Study|Alternative therapy|2
4390437|NCT00075946|7168842|FG002|Overall Study|Alternative therapy|5
4390438|NCT00075946|7168843|FG003|Overall Study|Alternative therapy|0
4390439|NCT00075946|7168844|FG004|Overall Study|Alternative therapy|0
4390440|NCT00075946|7168840|FG000|Overall Study|Other complicating disease|7
4390441|NCT00075946|7168841|FG001|Overall Study|Other complicating disease|13
4390442|NCT00075946|7168842|FG002|Overall Study|Other complicating disease|1
4390443|NCT00075946|7168843|FG003|Overall Study|Other complicating disease|4
4390444|NCT00075946|7168844|FG004|Overall Study|Other complicating disease|0
4390445|NCT00075946|7168840|FG000|Overall Study|No response to retreatment|23
4390446|NCT00075946|7168841|FG001|Overall Study|No response to retreatment|0
4390447|NCT00075946|7168842|FG002|Overall Study|No response to retreatment|2
4390448|NCT00075946|7168843|FG003|Overall Study|No response to retreatment|0
4390449|NCT00075946|7168844|FG004|Overall Study|No response to retreatment|0
4390450|NCT00075946|7168840|FG000|Overall Study|Time to progression less than 6 months|15
4390451|NCT00075946|7168841|FG001|Overall Study|Time to progression less than 6 months|30
4390452|NCT00075946|7168842|FG002|Overall Study|Time to progression less than 6 months|8
4390453|NCT00075946|7168843|FG003|Overall Study|Time to progression less than 6 months|3
4390454|NCT00075946|7168844|FG004|Overall Study|Time to progression less than 6 months|0
4390455|NCT00075946|7168840|FG000|Overall Study|Other|5
4390456|NCT00075946|7168841|FG001|Overall Study|Other|13
4390457|NCT00075946|7168842|FG002|Overall Study|Other|0
4390458|NCT00075946|7168843|FG003|Overall Study|Other|2
4390459|NCT00075946|7168844|FG004|Overall Study|Other|0
4390460|NCT00076011|7168855|FG000|Overall Study|Death|1
4390461|NCT00076011|7168855|FG000|Overall Study|Adverse Event|10
4390462|NCT00076011|7168855|FG000|Overall Study|Lack of Efficacy|25
4390463|NCT00076011|7168855|FG000|Overall Study|Withdrawal by Subject|1
4390464|NCT00076011|7168855|FG000|Overall Study|Study terminated by sponsor|3
4390465|NCT00076011|7168855|FG000|Overall Study|Other|11
4390466|NCT00076011|7168855|FG000|Overall Study|Ongoing|1
4390467|NCT00076024|7168862|FG000|Phase 1, Lead-in|Lack of Efficacy|4
4390468|NCT00076024|7168863|FG001|Phase 1, Lead-in|Lack of Efficacy|0
4390469|NCT00076024|7168864|FG002|Phase 1, Lead-in|Lack of Efficacy|0
4390470|NCT00076024|7168865|FG003|Phase 1, Lead-in|Lack of Efficacy|0
4390471|NCT00076024|7168862|FG000|Phase 1, Lead-in|Adverse Event|1
4390472|NCT00076024|7168863|FG001|Phase 1, Lead-in|Adverse Event|0
4390473|NCT00076024|7168864|FG002|Phase 1, Lead-in|Adverse Event|0
4390474|NCT00076024|7168865|FG003|Phase 1, Lead-in|Adverse Event|0
4390475|NCT00076024|7168862|FG000|Phase 1, Lead-in|Clinical progression|1
4390476|NCT00076024|7168863|FG001|Phase 1, Lead-in|Clinical progression|0
4390477|NCT00076024|7168864|FG002|Phase 1, Lead-in|Clinical progression|0
4390478|NCT00076024|7168865|FG003|Phase 1, Lead-in|Clinical progression|0
4390479|NCT00076024|7168862|FG000|Phase 2, Double-blind|Lack of Efficacy|0
4390480|NCT00076024|7168863|FG001|Phase 2, Double-blind|Lack of Efficacy|59
4390481|NCT00076024|7168864|FG002|Phase 2, Double-blind|Lack of Efficacy|40
4390482|NCT00076024|7168865|FG003|Phase 2, Double-blind|Lack of Efficacy|0
4390483|NCT00076024|7168862|FG000|Phase 2, Double-blind|Withdrawal by Subject|0
4390484|NCT00076024|7168863|FG001|Phase 2, Double-blind|Withdrawal by Subject|13
4390485|NCT00076024|7168864|FG002|Phase 2, Double-blind|Withdrawal by Subject|4
4390486|NCT00076024|7168865|FG003|Phase 2, Double-blind|Withdrawal by Subject|0
4390487|NCT00076024|7168862|FG000|Phase 2, Double-blind|Adverse Event|0
4390488|NCT00076024|7168863|FG001|Phase 2, Double-blind|Adverse Event|25
4390489|NCT00076024|7168864|FG002|Phase 2, Double-blind|Adverse Event|6
4390490|NCT00076024|7168865|FG003|Phase 2, Double-blind|Adverse Event|0
4390491|NCT00076024|7168862|FG000|Phase 2, Double-blind|Un-specified|0
4390492|NCT00076024|7168863|FG001|Phase 2, Double-blind|Un-specified|14
4390493|NCT00076024|7168864|FG002|Phase 2, Double-blind|Un-specified|6
4390494|NCT00076024|7168865|FG003|Phase 2, Double-blind|Un-specified|0
4390495|NCT00076024|7168862|FG000|Phase 2, Double-blind|Randomized but not treated|0
4390496|NCT00076024|7168863|FG001|Phase 2, Double-blind|Randomized but not treated|1
4390497|NCT00076024|7168864|FG002|Phase 2, Double-blind|Randomized but not treated|0
4390498|NCT00076024|7168865|FG003|Phase 2, Double-blind|Randomized but not treated|0
4390499|NCT00076024|7168862|FG000|Phase 2, Open-label|Adverse Event|0
4390500|NCT00076024|7168863|FG001|Phase 2, Open-label|Adverse Event|0
4390501|NCT00076024|7168864|FG002|Phase 2, Open-label|Adverse Event|0
4390502|NCT00076024|7168865|FG003|Phase 2, Open-label|Adverse Event|2
4390503|NCT00076024|7168862|FG000|Phase 2, Open-label|Lack of Efficacy|0
4390504|NCT00076024|7168863|FG001|Phase 2, Open-label|Lack of Efficacy|0
4390505|NCT00076024|7168864|FG002|Phase 2, Open-label|Lack of Efficacy|0
4390506|NCT00076024|7168865|FG003|Phase 2, Open-label|Lack of Efficacy|11
4390507|NCT00076024|7168862|FG000|Phase 2, Open-label|Withdrawal by Subject|0
4390508|NCT00076024|7168863|FG001|Phase 2, Open-label|Withdrawal by Subject|0
4390509|NCT00076024|7168864|FG002|Phase 2, Open-label|Withdrawal by Subject|0
4390510|NCT00076024|7168865|FG003|Phase 2, Open-label|Withdrawal by Subject|1
4510706|NCT00922480|7319593|FG000|Main Study|Physician Decision|0
4390511|NCT00076024|7168862|FG000|Phase 2, Open-label|Other|0
4390512|NCT00076024|7168863|FG001|Phase 2, Open-label|Other|0
4390513|NCT00076024|7168864|FG002|Phase 2, Open-label|Other|0
4390514|NCT00076024|7168865|FG003|Phase 2, Open-label|Other|2
4390515|NCT00076102|7168883|FG000|Overall Study|Clinical progression|1
4390516|NCT00076102|7168883|FG000|Overall Study|Progression in pre-existing brain tumor|1
4390517|NCT00076102|7168883|FG000|Overall Study|plexiform neurofibroma surgery|1
4390518|NCT00076102|7168883|FG000|Overall Study|refusal of further therapy|2
4390519|NCT00076336|7168926|FG000|Overall Study|Death|13
4390520|NCT00076336|7168927|FG001|Overall Study|Death|17
4390521|NCT00076336|7168926|FG000|Overall Study|Adverse Event|4
4390522|NCT00076336|7168927|FG001|Overall Study|Adverse Event|4
4390523|NCT00076336|7168926|FG000|Overall Study|Lost to Follow-up|4
4390524|NCT00076336|7168927|FG001|Overall Study|Lost to Follow-up|4
4390525|NCT00076336|7168926|FG000|Overall Study|Non-Compliance|2
4390526|NCT00076336|7168927|FG001|Overall Study|Non-Compliance|0
4390527|NCT00076336|7168926|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0
4390528|NCT00076336|7168927|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1
4390529|NCT00076336|7168926|FG000|Overall Study|Patient, Investigator, Sponsor request|8
4390530|NCT00076336|7168927|FG001|Overall Study|Patient, Investigator, Sponsor request|6
4390531|NCT00076336|7168926|FG000|Overall Study|Liver Transplantation|3
4390532|NCT00076336|7168927|FG001|Overall Study|Liver Transplantation|3
4390533|NCT00076336|7168926|FG000|Overall Study|Virologic Breakthrough|14
4390534|NCT00076336|7168927|FG001|Overall Study|Virologic Breakthrough|16
4390535|NCT00076336|7168926|FG000|Overall Study|Treatment failure|4
4390536|NCT00076336|7168927|FG001|Overall Study|Treatment failure|5
4390537|NCT00076570|7168935|FG000|Overall Study|Drug intolerance|8
4390538|NCT00076570|7168936|FG001|Overall Study|Drug intolerance|8
4390539|NCT00076752|7168976|FG000|Overall Study|Death|2
4390540|NCT00076752|7168976|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1
4390541|NCT00076804|7168983|FG000|Overall Study|Death|9
4390542|NCT00076804|7168984|FG001|Overall Study|Death|20
4390543|NCT00076804|7168983|FG000|Overall Study|Lost to Follow-up|9
4390544|NCT00076804|7168984|FG001|Overall Study|Lost to Follow-up|9
4390545|NCT00076804|7168983|FG000|Overall Study|Withdrawal by Subject|10
4390546|NCT00076804|7168984|FG001|Overall Study|Withdrawal by Subject|8
4390547|NCT00076804|7168983|FG000|Overall Study|Early study Closure|32
4390548|NCT00076804|7168984|FG001|Overall Study|Early study Closure|32
4390549|NCT00076999|7168994|FG000|Overall Study|Adverse Event|2
4390550|NCT00076999|7168995|FG001|Overall Study|Adverse Event|8
4390551|NCT00076999|7168996|FG002|Overall Study|Adverse Event|6
4390552|NCT00076999|7168997|FG003|Overall Study|Adverse Event|0
4390553|NCT00076999|7168998|FG004|Overall Study|Adverse Event|2
4390554|NCT00076999|7168994|FG000|Overall Study|Protocol Violation|0
4390555|NCT00076999|7168995|FG001|Overall Study|Protocol Violation|3
4390556|NCT00076999|7168996|FG002|Overall Study|Protocol Violation|4
4390557|NCT00076999|7168997|FG003|Overall Study|Protocol Violation|0
4390558|NCT00076999|7168998|FG004|Overall Study|Protocol Violation|9
4390559|NCT00076999|7168994|FG000|Overall Study|Lost to Follow-up|2
4390560|NCT00076999|7168995|FG001|Overall Study|Lost to Follow-up|1
4390561|NCT00076999|7168996|FG002|Overall Study|Lost to Follow-up|0
4390562|NCT00076999|7168997|FG003|Overall Study|Lost to Follow-up|0
4390563|NCT00076999|7168998|FG004|Overall Study|Lost to Follow-up|0
4390564|NCT00076999|7168994|FG000|Overall Study|Withdrawal by Subject|0
4390565|NCT00076999|7168995|FG001|Overall Study|Withdrawal by Subject|4
4390566|NCT00076999|7168996|FG002|Overall Study|Withdrawal by Subject|3
4390567|NCT00076999|7168997|FG003|Overall Study|Withdrawal by Subject|0
4390568|NCT00076999|7168998|FG004|Overall Study|Withdrawal by Subject|1
4390569|NCT00076999|7168994|FG000|Overall Study|Other reason (not specified)|8
4390570|NCT00076999|7168995|FG001|Overall Study|Other reason (not specified)|8
4390571|NCT00076999|7168996|FG002|Overall Study|Other reason (not specified)|4
4390572|NCT00076999|7168997|FG003|Overall Study|Other reason (not specified)|1
4390573|NCT00076999|7168998|FG004|Overall Study|Other reason (not specified)|13
4390574|NCT00077064|7169013|FG000|Overall Study|Adverse Event|0
4390575|NCT00077064|7169014|FG001|Overall Study|Adverse Event|4
4390576|NCT00077064|7169013|FG000|Overall Study|Patient refusal|0
4390577|NCT00077064|7169014|FG001|Overall Study|Patient refusal|2
4390578|NCT00077207|7169021|FG000|Overall Study|Adverse Event|5
4390579|NCT00077207|7169021|FG000|Overall Study|Lack of Efficacy|12
4390580|NCT00077207|7169021|FG000|Overall Study|Physician Decision|6
4390581|NCT00077207|7169021|FG000|Overall Study|Withdrawal by Subject|6
4390582|NCT00077207|7169021|FG000|Overall Study|Ineligible|1
4390583|NCT00077376|7169026|FG000|Overall Study|Adverse Event|8
4390584|NCT00077376|7169026|FG000|Overall Study|Withdrawal by Subject|2
4390585|NCT00077376|7169026|FG000|Overall Study|Death|1
4390586|NCT00077376|7169026|FG000|Overall Study|Physician Decision|1
4390587|NCT00077376|7169026|FG000|Overall Study|Alternative therapy|5
4390588|NCT00077376|7169026|FG000|Overall Study|Complicating disease|1
4390589|NCT00077376|7169026|FG000|Overall Study|Still on treatment|1
4390590|NCT00077376|7169026|FG000|Overall Study|Symptomatic deterioration|1
4390591|NCT00077376|7169026|FG000|Overall Study|Surgery|1
4390592|NCT00077376|7169026|FG000|Overall Study|Insurance ran out|1
4390593|NCT00077610|7169033|FG000|Overall Study|Adverse Event|9
4390594|NCT00077610|7169034|FG001|Overall Study|Adverse Event|7
4390595|NCT00077610|7169035|FG002|Overall Study|Adverse Event|1
4390596|NCT00077610|7169033|FG000|Overall Study|Lost to Follow-up|0
4390597|NCT00077610|7169034|FG001|Overall Study|Lost to Follow-up|1
4390598|NCT00077610|7169035|FG002|Overall Study|Lost to Follow-up|2
4390599|NCT00077610|7169033|FG000|Overall Study|Withdrawal by Subject|4
4390600|NCT00077610|7169034|FG001|Overall Study|Withdrawal by Subject|10
4390601|NCT00077610|7169035|FG002|Overall Study|Withdrawal by Subject|6
4390602|NCT00077610|7169033|FG000|Overall Study|Death|17
4390603|NCT00077610|7169034|FG001|Overall Study|Death|13
4390604|NCT00077610|7169035|FG002|Overall Study|Death|13
4390605|NCT00077610|7169033|FG000|Overall Study|Renal transplant|12
4390606|NCT00077610|7169034|FG001|Overall Study|Renal transplant|15
4390607|NCT00077610|7169035|FG002|Overall Study|Renal transplant|11
4390608|NCT00077610|7169033|FG000|Overall Study|Withdrew from dialysis care|5
4390609|NCT00077610|7169034|FG001|Overall Study|Withdrew from dialysis care|0
4390610|NCT00077610|7169035|FG002|Overall Study|Withdrew from dialysis care|3
4390611|NCT00077610|7169033|FG000|Overall Study|Insufficient Therapeutic Response|1
4390612|NCT00077610|7169034|FG001|Overall Study|Insufficient Therapeutic Response|0
4390613|NCT00077610|7169035|FG002|Overall Study|Insufficient Therapeutic Response|0
4390614|NCT00077610|7169033|FG000|Overall Study|Multiple blood transfusions|0
4390615|NCT00077610|7169034|FG001|Overall Study|Multiple blood transfusions|0
4390616|NCT00077610|7169035|FG002|Overall Study|Multiple blood transfusions|1
4390617|NCT00077610|7169033|FG000|Overall Study|Principal Investigator's decision|1
4390618|NCT00077610|7169034|FG001|Overall Study|Principal Investigator's decision|0
4390619|NCT00077610|7169035|FG002|Overall Study|Principal Investigator's decision|1
4390620|NCT00077610|7169033|FG000|Overall Study|Worsening of health condition|1
4390621|NCT00077610|7169034|FG001|Overall Study|Worsening of health condition|1
4390622|NCT00077610|7169035|FG002|Overall Study|Worsening of health condition|0
4390623|NCT00077610|7169033|FG000|Overall Study|Given Epogen in hospital|1
4390624|NCT00077610|7169034|FG001|Overall Study|Given Epogen in hospital|0
4390625|NCT00077610|7169035|FG002|Overall Study|Given Epogen in hospital|0
4390626|NCT00077610|7169033|FG000|Overall Study|Transferred to other unit|0
4390627|NCT00077610|7169034|FG001|Overall Study|Transferred to other unit|0
4390628|NCT00077610|7169035|FG002|Overall Study|Transferred to other unit|1
4390629|NCT00077610|7169033|FG000|Overall Study|Transferred to nursing home|0
4390630|NCT00077610|7169034|FG001|Overall Study|Transferred to nursing home|0
4390631|NCT00077610|7169035|FG002|Overall Study|Transferred to nursing home|1
4390632|NCT00077610|7169033|FG000|Overall Study|Transfer to satellite unit|1
4390633|NCT00077610|7169034|FG001|Overall Study|Transfer to satellite unit|0
4390634|NCT00077610|7169035|FG002|Overall Study|Transfer to satellite unit|0
4390635|NCT00077610|7169033|FG000|Overall Study|Transfer to other center for surgery|1
4390636|NCT00077610|7169034|FG001|Overall Study|Transfer to other center for surgery|0
4390637|NCT00077610|7169035|FG002|Overall Study|Transfer to other center for surgery|0
4390638|NCT00077610|7169033|FG000|Overall Study|Change in dialysis modality|1
4390639|NCT00077610|7169034|FG001|Overall Study|Change in dialysis modality|0
4390640|NCT00077610|7169035|FG002|Overall Study|Change in dialysis modality|0
4390641|NCT00077610|7169033|FG000|Overall Study|Relocation|0
4390642|NCT00077610|7169034|FG001|Overall Study|Relocation|8
4390643|NCT00077610|7169035|FG002|Overall Study|Relocation|5
4390644|NCT00077610|7169033|FG000|Overall Study|Financial issues|0
4390645|NCT00077610|7169034|FG001|Overall Study|Financial issues|1
4390646|NCT00077610|7169035|FG002|Overall Study|Financial issues|0
4390647|NCT00077610|7169033|FG000|Overall Study|Sponsors decision to withdraw|0
4390648|NCT00077610|7169034|FG001|Overall Study|Sponsors decision to withdraw|0
4390649|NCT00077610|7169035|FG002|Overall Study|Sponsors decision to withdraw|1
4390650|NCT00077623|7169051|FG000|Overall Study|Adverse Event|1
4390651|NCT00077623|7169052|FG001|Overall Study|Adverse Event|0
4390652|NCT00077623|7169053|FG002|Overall Study|Adverse Event|1
4390653|NCT00077623|7169051|FG000|Overall Study|Withdrawal by Subject|2
4390654|NCT00077623|7169052|FG001|Overall Study|Withdrawal by Subject|10
4390655|NCT00077623|7169053|FG002|Overall Study|Withdrawal by Subject|1
4390656|NCT00077623|7169051|FG000|Overall Study|Other-Non safety reason|18
4390657|NCT00077623|7169052|FG001|Overall Study|Other-Non safety reason|15
4390658|NCT00077623|7169053|FG002|Overall Study|Other-Non safety reason|19
4390659|NCT00077623|7169051|FG000|Overall Study|Insufficient therapeutic response|2
4390660|NCT00077623|7169052|FG001|Overall Study|Insufficient therapeutic response|0
4390661|NCT00077623|7169053|FG002|Overall Study|Insufficient therapeutic response|0
4390662|NCT00077623|7169051|FG000|Overall Study|Death|12
4390663|NCT00077623|7169052|FG001|Overall Study|Death|18
4390664|NCT00077623|7169053|FG002|Overall Study|Death|11
4390665|NCT00077623|7169051|FG000|Overall Study|Failure to return|1
4390666|NCT00077623|7169052|FG001|Overall Study|Failure to return|0
4390667|NCT00077623|7169053|FG002|Overall Study|Failure to return|0
4390668|NCT00077636|7169063|FG000|Overall Study|Refused Treatment|9
4390669|NCT00077636|7169064|FG001|Overall Study|Refused Treatment|31
4390670|NCT00077636|7169063|FG000|Overall Study|Admin|3
4390671|NCT00077636|7169064|FG001|Overall Study|Admin|3
4390672|NCT00077636|7169063|FG000|Overall Study|Withdrawal by Subject|2
4390673|NCT00077636|7169064|FG001|Overall Study|Withdrawal by Subject|2
4390674|NCT00077636|7169063|FG000|Overall Study|Adverse Event|17
4390675|NCT00077636|7169064|FG001|Overall Study|Adverse Event|34
4390676|NCT00077636|7169063|FG000|Overall Study|Protocol Violation|0
4390677|NCT00077636|7169064|FG001|Overall Study|Protocol Violation|2
4390678|NCT00077636|7169063|FG000|Overall Study|Lost to Follow-up|10
4390679|NCT00077636|7169064|FG001|Overall Study|Lost to Follow-up|18
4390680|NCT00077636|7169063|FG000|Overall Study|Abnormality Of Laboratory Test|3
4390681|NCT00077636|7169064|FG001|Overall Study|Abnormality Of Laboratory Test|2
4390682|NCT00077649|7169075|FG000|Overall Study|Adverse Event|5
4390683|NCT00077649|7169076|FG001|Overall Study|Adverse Event|1
4390684|NCT00077649|7169077|FG002|Overall Study|Adverse Event|7
4390685|NCT00077649|7169078|FG003|Overall Study|Adverse Event|9
4390686|NCT00077649|7169075|FG000|Overall Study|Lack of Efficacy|5
4390687|NCT00077649|7169076|FG001|Overall Study|Lack of Efficacy|3
4390688|NCT00077649|7169077|FG002|Overall Study|Lack of Efficacy|3
4390689|NCT00077649|7169078|FG003|Overall Study|Lack of Efficacy|2
4390690|NCT00077649|7169075|FG000|Overall Study|Withdrawal by Subject|0
4390691|NCT00077649|7169076|FG001|Overall Study|Withdrawal by Subject|1
4390692|NCT00077649|7169077|FG002|Overall Study|Withdrawal by Subject|1
4390693|NCT00077649|7169078|FG003|Overall Study|Withdrawal by Subject|2
4390694|NCT00077649|7169075|FG000|Overall Study|Lost to Follow-up|2
4390695|NCT00077649|7169076|FG001|Overall Study|Lost to Follow-up|2
4390696|NCT00077649|7169077|FG002|Overall Study|Lost to Follow-up|3
4390697|NCT00077649|7169078|FG003|Overall Study|Lost to Follow-up|2
4390698|NCT00077649|7169075|FG000|Overall Study|Abnormality of Laboratory Test|1
4390699|NCT00077649|7169076|FG001|Overall Study|Abnormality of Laboratory Test|2
4390700|NCT00077649|7169077|FG002|Overall Study|Abnormality of Laboratory Test|1
4390701|NCT00077649|7169078|FG003|Overall Study|Abnormality of Laboratory Test|2
4390702|NCT00077649|7169075|FG000|Overall Study|Randomized but never dosed|1
4390703|NCT00077649|7169076|FG001|Overall Study|Randomized but never dosed|0
4390704|NCT00077649|7169077|FG002|Overall Study|Randomized but never dosed|0
4390705|NCT00077649|7169078|FG003|Overall Study|Randomized but never dosed|0
4390706|NCT00077675|7169094|FG000|Overall Study|Adverse Event|1
4390707|NCT00077675|7169095|FG001|Overall Study|Adverse Event|2
4390708|NCT00077675|7169094|FG000|Overall Study|Lost to Follow-up|6
4390709|NCT00077675|7169095|FG001|Overall Study|Lost to Follow-up|3
4390710|NCT00077675|7169094|FG000|Overall Study|Withdrawal by Subject|1
4390711|NCT00077675|7169095|FG001|Overall Study|Withdrawal by Subject|0
4390712|NCT00077675|7169094|FG000|Overall Study|Other|0
4390713|NCT00077675|7169095|FG001|Overall Study|Other|1
4390714|NCT00077675|7169094|FG000|Overall Study|Never received study treatment|3
4390715|NCT00077675|7169095|FG001|Overall Study|Never received study treatment|3
4390716|NCT00077766|7169103|FG000|Overall Study|Adverse Event|1
4390717|NCT00077766|7169104|FG001|Overall Study|Adverse Event|1
4390718|NCT00077766|7169103|FG000|Overall Study|Withdrawal by Subject|4
4390719|NCT00077766|7169104|FG001|Overall Study|Withdrawal by Subject|3
4390720|NCT00077766|7169103|FG000|Overall Study|Death|12
4390721|NCT00077766|7169104|FG001|Overall Study|Death|10
4390722|NCT00077766|7169103|FG000|Overall Study|Lost to Follow-up|2
4390723|NCT00077766|7169104|FG001|Overall Study|Lost to Follow-up|0
4390724|NCT00077766|7169103|FG000|Overall Study|Protocol Violation|1
4390725|NCT00077766|7169104|FG001|Overall Study|Protocol Violation|0
4390726|NCT00077766|7169103|FG000|Overall Study|Kidney Transplantation|9
4390727|NCT00077766|7169104|FG001|Overall Study|Kidney Transplantation|5
4390728|NCT00077766|7169103|FG000|Overall Study|Transplantation|5
4390729|NCT00077766|7169104|FG001|Overall Study|Transplantation|1
4390730|NCT00077766|7169103|FG000|Overall Study|Investigators Discretion|1
4390731|NCT00077766|7169104|FG001|Overall Study|Investigators Discretion|0
4390732|NCT00077766|7169103|FG000|Overall Study|Participant's decision|1
4390733|NCT00077766|7169104|FG001|Overall Study|Participant's decision|0
4390734|NCT00077766|7169103|FG000|Overall Study|Dialysis Discontinued|1
4390735|NCT00077766|7169104|FG001|Overall Study|Dialysis Discontinued|0
4390736|NCT00077766|7169103|FG000|Overall Study|Dialysis|0
4390737|NCT00077766|7169104|FG001|Overall Study|Dialysis|1
4390738|NCT00077766|7169103|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0
4390739|NCT00077766|7169104|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1
4390740|NCT00077766|7169103|FG000|Overall Study|Started Nocturnal Dialysis|0
4390741|NCT00077766|7169104|FG001|Overall Study|Started Nocturnal Dialysis|1
4390742|NCT00077766|7169103|FG000|Overall Study|Stop Dialysis|0
4390743|NCT00077766|7169104|FG001|Overall Study|Stop Dialysis|1
4390744|NCT00077766|7169103|FG000|Overall Study|Participants Vacation|2
4390745|NCT00077766|7169104|FG001|Overall Study|Participants Vacation|1
4390746|NCT00077857|7169113|FG000|Overall Study|Adverse Event|30
4390747|NCT00077857|7169114|FG001|Overall Study|Adverse Event|32
4390748|NCT00077857|7169113|FG000|Overall Study|Death|7
4390749|NCT00077857|7169114|FG001|Overall Study|Death|3
4390750|NCT00077857|7169113|FG000|Overall Study|Insufficient therapeutic response|112
4390751|NCT00077857|7169114|FG001|Overall Study|Insufficient therapeutic response|128
4390752|NCT00077857|7169113|FG000|Overall Study|Violation of selection criteria at entry|3
4390753|NCT00077857|7169114|FG001|Overall Study|Violation of selection criteria at entry|1
4390754|NCT00077857|7169113|FG000|Overall Study|Other protocol violation|0
4390755|NCT00077857|7169114|FG001|Overall Study|Other protocol violation|1
4390756|NCT00077857|7169113|FG000|Overall Study|Refused treatment|29
4390757|NCT00077857|7169114|FG001|Overall Study|Refused treatment|21
4390758|NCT00077857|7169113|FG000|Overall Study|Failure to return|5
4390759|NCT00077857|7169114|FG001|Overall Study|Failure to return|5
4390760|NCT00077857|7169113|FG000|Overall Study|Other|15
4390761|NCT00077857|7169114|FG001|Overall Study|Other|13
4390762|NCT00077974|7169124|FG000|Overall Study|Adverse Event|22
4390763|NCT00077974|7169124|FG000|Overall Study|Protocol Violation|1
4390764|NCT00077974|7169124|FG000|Overall Study|Withdrawal by Subject|3
4390765|NCT00077974|7169124|FG000|Overall Study|Lack of Efficacy|76
4390766|NCT00077974|7169124|FG000|Overall Study|Decision of Sponsor|2
4390767|NCT00078312|7169137|FG000|Overall Study|Adverse Event|43
4390768|NCT00078312|7169137|FG000|Overall Study|Lack of Efficacy|15
4390769|NCT00078312|7169137|FG000|Overall Study|Lost to Follow-up|41
4390770|NCT00078312|7169137|FG000|Overall Study|Physician Decision|9
4390771|NCT00078312|7169137|FG000|Overall Study|Protocol Violation|3
4390772|NCT00078312|7169137|FG000|Overall Study|Withdrawal by Subject|33
4390773|NCT00078312|7169137|FG000|Overall Study|Miscellaneous|33
4390774|NCT00078325|7169144|FG000|Overall Study|Adverse Event|15
4390775|NCT00078325|7169145|FG001|Overall Study|Adverse Event|10
4390776|NCT00078325|7169146|FG002|Overall Study|Adverse Event|5
4390777|NCT00078325|7169144|FG000|Overall Study|Protocol Violation|2
4390778|NCT00078325|7169145|FG001|Overall Study|Protocol Violation|2
4390779|NCT00078325|7169146|FG002|Overall Study|Protocol Violation|0
4390780|NCT00078325|7169144|FG000|Overall Study|Withdrawal by Subject|1
4390781|NCT00078325|7169145|FG001|Overall Study|Withdrawal by Subject|5
4390782|NCT00078325|7169146|FG002|Overall Study|Withdrawal by Subject|3
4390783|NCT00078325|7169144|FG000|Overall Study|Lost to Follow-up|0
4390784|NCT00078325|7169145|FG001|Overall Study|Lost to Follow-up|1
4390785|NCT00078325|7169146|FG002|Overall Study|Lost to Follow-up|1
4390786|NCT00078325|7169144|FG000|Overall Study|Physician Decision|2
4390787|NCT00078325|7169145|FG001|Overall Study|Physician Decision|0
4390788|NCT00078325|7169146|FG002|Overall Study|Physician Decision|1
4390789|NCT00078325|7169144|FG000|Overall Study|Miscellaneous|1
4390790|NCT00078325|7169145|FG001|Overall Study|Miscellaneous|1
4390791|NCT00078325|7169146|FG002|Overall Study|Miscellaneous|1
4390792|NCT00078338|7169156|FG000|Overall Study|Adverse Event|31
4390793|NCT00078338|7169157|FG001|Overall Study|Adverse Event|24
4390794|NCT00078338|7169156|FG000|Overall Study|Lost to Follow-up|17
4390795|NCT00078338|7169157|FG001|Overall Study|Lost to Follow-up|2
4390796|NCT00078338|7169156|FG000|Overall Study|Protocol Violation|2
4712074|NCT02919267|7638323|FG002|Overall Study|Protocol Violation|3
4712075|NCT02919267|7638324|FG003|Overall Study|Protocol Violation|4
4390797|NCT00078338|7169157|FG001|Overall Study|Protocol Violation|2
4390798|NCT00078338|7169156|FG000|Overall Study|Disease Progression|4
4390799|NCT00078338|7169157|FG001|Overall Study|Disease Progression|7
4390800|NCT00078338|7169156|FG000|Overall Study|Other|28
4390801|NCT00078338|7169157|FG001|Overall Study|Other|16
4390802|NCT00078338|7169156|FG000|Overall Study|Subjects randomized, but not treated|3
4390803|NCT00078338|7169157|FG001|Overall Study|Subjects randomized, but not treated|3
4390804|NCT00078377|7169166|FG000|Overall Study|Adverse Event|2
4390805|NCT00078377|7169167|FG001|Overall Study|Adverse Event|5
4390806|NCT00078377|7169168|FG002|Overall Study|Adverse Event|1
4390807|NCT00078377|7169166|FG000|Overall Study|Lack of Efficacy|2
4390808|NCT00078377|7169167|FG001|Overall Study|Lack of Efficacy|0
4390809|NCT00078377|7169168|FG002|Overall Study|Lack of Efficacy|2
4390810|NCT00078377|7169166|FG000|Overall Study|Lost to Follow-up|0
4390811|NCT00078377|7169167|FG001|Overall Study|Lost to Follow-up|1
4390812|NCT00078377|7169168|FG002|Overall Study|Lost to Follow-up|1
4390813|NCT00078377|7169166|FG000|Overall Study|Physician Decision|2
4390814|NCT00078377|7169167|FG001|Overall Study|Physician Decision|0
4390815|NCT00078377|7169168|FG002|Overall Study|Physician Decision|0
4390816|NCT00078377|7169166|FG000|Overall Study|Withdrawal by Subject|3
4390817|NCT00078377|7169167|FG001|Overall Study|Withdrawal by Subject|4
4390818|NCT00078377|7169168|FG002|Overall Study|Withdrawal by Subject|4
4390819|NCT00078377|7169166|FG000|Overall Study|Miscellaneous|2
4390820|NCT00078377|7169167|FG001|Overall Study|Miscellaneous|6
4390821|NCT00078377|7169168|FG002|Overall Study|Miscellaneous|1
4390822|NCT00078767|7169233|FG000|Overall Study|Withdrawal by Subject|1
4390823|NCT00078767|7169234|FG001|Overall Study|Withdrawal by Subject|1
4712076|NCT02919475|7638348|FG000|Overall Study|Adverse Event|3
4712077|NCT02919475|7638349|FG001|Overall Study|Adverse Event|3
4712078|NCT02919475|7638350|FG002|Overall Study|Adverse Event|3
4712079|NCT02919475|7638351|FG003|Overall Study|Adverse Event|9
4712080|NCT02919475|7638352|FG004|Overall Study|Adverse Event|2
4712081|NCT02919475|7638348|FG000|Overall Study|Death|0
4712082|NCT02919475|7638349|FG001|Overall Study|Death|1
4712083|NCT02919475|7638350|FG002|Overall Study|Death|0
4390824|NCT00078819|7169242|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0
4390825|NCT00078819|7169243|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1
4390826|NCT00078819|7169244|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0
4390827|NCT00078819|7169245|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0
4390828|NCT00078819|7169242|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1
4390829|NCT00078819|7169243|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0
4390830|NCT00078819|7169244|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0
4390831|NCT00078819|7169245|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0
4390832|NCT00078819|7169242|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1
4390833|NCT00078819|7169243|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1
4390834|NCT00078819|7169244|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0
4390835|NCT00078819|7169245|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0
4390836|NCT00078819|7169242|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3
4390837|NCT00078819|7169243|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2
4390838|NCT00078819|7169244|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0
4390839|NCT00078819|7169245|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0
4390840|NCT00078819|7169242|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2
4390841|NCT00078819|7169243|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2
4390842|NCT00078819|7169244|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0
4390843|NCT00078819|7169245|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0
4390844|NCT00078819|7169242|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34
4712084|NCT02919475|7638351|FG003|Overall Study|Death|0
4712085|NCT02919475|7638352|FG004|Overall Study|Death|0
4390845|NCT00078819|7169243|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25
4390846|NCT00078819|7169244|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0
4390847|NCT00078819|7169245|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0
4390848|NCT00078819|7169242|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0
4390849|NCT00078819|7169243|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0
4390850|NCT00078819|7169244|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29
4390851|NCT00078819|7169245|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13
4390852|NCT00078819|7169242|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0
4390853|NCT00078819|7169243|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0
4390854|NCT00078819|7169244|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0
4390855|NCT00078819|7169245|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1
4390856|NCT00078949|7169275|FG000|Overall Study|No treated|4
4390857|NCT00078949|7169276|FG001|Overall Study|No treated|5
4390858|NCT00078949|7169277|FG002|Overall Study|No treated|3
4390859|NCT00078949|7169278|FG003|Overall Study|No treated|3
4510707|NCT00922480|7319594|FG001|Main Study|Physician Decision|1
4510708|NCT00922480|7319593|FG000|Extension Study|Protocol Violation|3
4510709|NCT00922480|7319594|FG001|Extension Study|Protocol Violation|0
4510710|NCT00922480|7319593|FG000|Extension Study|Adverse Event|1
4510711|NCT00922480|7319594|FG001|Extension Study|Adverse Event|1
4510712|NCT00922480|7319593|FG000|Extension Study|Withdrawal by Subject|1
4510713|NCT00922480|7319594|FG001|Extension Study|Withdrawal by Subject|1
4510714|NCT00922480|7319593|FG000|Extension Study|Others|0
4510715|NCT00922480|7319594|FG001|Extension Study|Others|1
4510716|NCT00922623|7319602|FG000|Overall Study|Other|4
4510717|NCT00922623|7319602|FG000|Overall Study|Lost to Follow-up|1
4510718|NCT00922636|7319613|FG000|Overall Study|Adverse Event|3
4510719|NCT00922636|7319614|FG001|Overall Study|Adverse Event|3
4510720|NCT00922636|7319615|FG002|Overall Study|Adverse Event|2
4510721|NCT00922636|7319616|FG003|Overall Study|Adverse Event|3
4510722|NCT00922636|7319617|FG004|Overall Study|Adverse Event|2
4510723|NCT00922636|7319613|FG000|Overall Study|Lack of Efficacy|1
4510724|NCT00922636|7319614|FG001|Overall Study|Lack of Efficacy|7
4510725|NCT00922636|7319615|FG002|Overall Study|Lack of Efficacy|3
4510726|NCT00922636|7319616|FG003|Overall Study|Lack of Efficacy|2
4510727|NCT00922636|7319617|FG004|Overall Study|Lack of Efficacy|4
4510728|NCT00922636|7319613|FG000|Overall Study|Sponsor Decision|0
4510729|NCT00922636|7319614|FG001|Overall Study|Sponsor Decision|0
4510730|NCT00922636|7319615|FG002|Overall Study|Sponsor Decision|2
4510731|NCT00922636|7319616|FG003|Overall Study|Sponsor Decision|0
4510732|NCT00922636|7319617|FG004|Overall Study|Sponsor Decision|0
4510733|NCT00922636|7319613|FG000|Overall Study|Withdrawal by Subject|0
4510734|NCT00922636|7319614|FG001|Overall Study|Withdrawal by Subject|0
4510735|NCT00922636|7319615|FG002|Overall Study|Withdrawal by Subject|5
4510736|NCT00922636|7319616|FG003|Overall Study|Withdrawal by Subject|2
4510737|NCT00922636|7319617|FG004|Overall Study|Withdrawal by Subject|4
4510738|NCT00922636|7319613|FG000|Overall Study|Protocol Violation|0
4510739|NCT00922636|7319614|FG001|Overall Study|Protocol Violation|0
4510740|NCT00922636|7319615|FG002|Overall Study|Protocol Violation|2
4510741|NCT00922636|7319616|FG003|Overall Study|Protocol Violation|2
4510742|NCT00922636|7319617|FG004|Overall Study|Protocol Violation|0
4510743|NCT00922636|7319613|FG000|Overall Study|Entry Criteria Not Met|0
4510744|NCT00922636|7319614|FG001|Overall Study|Entry Criteria Not Met|0
4510745|NCT00922636|7319615|FG002|Overall Study|Entry Criteria Not Met|1
4510746|NCT00922636|7319616|FG003|Overall Study|Entry Criteria Not Met|1
4510747|NCT00922636|7319617|FG004|Overall Study|Entry Criteria Not Met|0
4510748|NCT00922636|7319613|FG000|Overall Study|Parent/Caregiver Decision|2
4510749|NCT00922636|7319614|FG001|Overall Study|Parent/Caregiver Decision|4
4510750|NCT00922636|7319615|FG002|Overall Study|Parent/Caregiver Decision|3
4510751|NCT00922636|7319616|FG003|Overall Study|Parent/Caregiver Decision|5
4510752|NCT00922636|7319617|FG004|Overall Study|Parent/Caregiver Decision|2
4510753|NCT00922636|7319613|FG000|Overall Study|Lost to Follow-up|1
4510754|NCT00922636|7319614|FG001|Overall Study|Lost to Follow-up|2
4510755|NCT00922636|7319615|FG002|Overall Study|Lost to Follow-up|2
4510756|NCT00922636|7319616|FG003|Overall Study|Lost to Follow-up|2
4510757|NCT00922636|7319617|FG004|Overall Study|Lost to Follow-up|4
4510758|NCT00922766|7319638|FG000|Overall Study|Death|3
4510759|NCT00922766|7319638|FG000|Overall Study|Withdrawal by Subject|2
4510760|NCT00922766|7319638|FG000|Overall Study|Other|1
4510761|NCT00922766|7319638|FG000|Overall Study|Adverse Event|1
4510762|NCT00922779|7319642|FG000|Overall Study|Adverse Event|67
4510763|NCT00922779|7319642|FG000|Overall Study|Pregnancy|7
4510764|NCT00922779|7319642|FG000|Overall Study|Withdrawal by Subject|308
4510765|NCT00922779|7319642|FG000|Overall Study|Lost to Follow-up|44
4510766|NCT00922779|7319642|FG000|Overall Study|Other|27
4510767|NCT00922779|7319642|FG000|Overall Study|Missing|1874
4510768|NCT00922935|7319653|FG000|Overall Study|Protocol Violation|0
4510769|NCT00922935|7319654|FG001|Overall Study|Protocol Violation|3
4510770|NCT00922935|7319655|FG002|Overall Study|Protocol Violation|0
4510771|NCT00922935|7319653|FG000|Overall Study|Physician Decision|1
4510772|NCT00922935|7319654|FG001|Overall Study|Physician Decision|1
4510773|NCT00922935|7319655|FG002|Overall Study|Physician Decision|0
4510774|NCT00922935|7319653|FG000|Overall Study|Lost to Follow-up|0
4510775|NCT00922935|7319654|FG001|Overall Study|Lost to Follow-up|1
4510776|NCT00922935|7319655|FG002|Overall Study|Lost to Follow-up|0
4390860|NCT00079040|7169299|FG000|Overall Study|Withdrew before treatment|1
4390861|NCT00079040|7169299|FG000|Overall Study|Ineligible|1
4390862|NCT00079183|7169303|FG000|Overall Study|Withdrawal by Subject|4
4390863|NCT00079183|7169303|FG000|Overall Study|Study medication non-compliance|2
4390864|NCT00079183|7169303|FG000|Overall Study|Specimen collection non-compliance|1
4390865|NCT00079274|7169315|FG000|Overall Study|Withdrawal by Subject|111
4390866|NCT00079274|7169316|FG001|Overall Study|Withdrawal by Subject|10
4390867|NCT00079274|7169317|FG002|Overall Study|Withdrawal by Subject|12
4390868|NCT00079274|7169318|FG003|Overall Study|Withdrawal by Subject|163
4390869|NCT00079274|7169319|FG004|Overall Study|Withdrawal by Subject|7
4390870|NCT00079274|7169320|FG005|Overall Study|Withdrawal by Subject|8
4390871|NCT00079274|7169321|FG006|Overall Study|Withdrawal by Subject|0
4390872|NCT00079274|7169315|FG000|Overall Study|Adverse Event|130
4390873|NCT00079274|7169316|FG001|Overall Study|Adverse Event|8
4390874|NCT00079274|7169317|FG002|Overall Study|Adverse Event|8
4390875|NCT00079274|7169318|FG003|Overall Study|Adverse Event|184
4390876|NCT00079274|7169319|FG004|Overall Study|Adverse Event|7
4390877|NCT00079274|7169320|FG005|Overall Study|Adverse Event|8
4390878|NCT00079274|7169321|FG006|Overall Study|Adverse Event|0
4390879|NCT00079274|7169315|FG000|Overall Study|Recurrence|21
4390880|NCT00079274|7169316|FG001|Overall Study|Recurrence|0
4390881|NCT00079274|7169317|FG002|Overall Study|Recurrence|1
4390882|NCT00079274|7169318|FG003|Overall Study|Recurrence|15
4390883|NCT00079274|7169319|FG004|Overall Study|Recurrence|0
4390884|NCT00079274|7169320|FG005|Overall Study|Recurrence|2
4390885|NCT00079274|7169321|FG006|Overall Study|Recurrence|0
4390886|NCT00079274|7169315|FG000|Overall Study|Alternate Treatment|6
4390887|NCT00079274|7169316|FG001|Overall Study|Alternate Treatment|1
4390888|NCT00079274|7169317|FG002|Overall Study|Alternate Treatment|0
4390889|NCT00079274|7169318|FG003|Overall Study|Alternate Treatment|3
4390890|NCT00079274|7169319|FG004|Overall Study|Alternate Treatment|0
4390891|NCT00079274|7169320|FG005|Overall Study|Alternate Treatment|0
4390892|NCT00079274|7169321|FG006|Overall Study|Alternate Treatment|0
4390893|NCT00079274|7169315|FG000|Overall Study|Other Medical Problems|6
4390894|NCT00079274|7169316|FG001|Overall Study|Other Medical Problems|1
4390895|NCT00079274|7169317|FG002|Overall Study|Other Medical Problems|0
4390896|NCT00079274|7169318|FG003|Overall Study|Other Medical Problems|7
4390897|NCT00079274|7169319|FG004|Overall Study|Other Medical Problems|0
4390898|NCT00079274|7169320|FG005|Overall Study|Other Medical Problems|0
4390899|NCT00079274|7169321|FG006|Overall Study|Other Medical Problems|0
4390900|NCT00079274|7169315|FG000|Overall Study|Death|4
4390901|NCT00079274|7169316|FG001|Overall Study|Death|0
4390902|NCT00079274|7169317|FG002|Overall Study|Death|1
4390903|NCT00079274|7169318|FG003|Overall Study|Death|15
4390904|NCT00079274|7169319|FG004|Overall Study|Death|0
4390905|NCT00079274|7169320|FG005|Overall Study|Death|0
4390906|NCT00079274|7169321|FG006|Overall Study|Death|0
4390907|NCT00079274|7169315|FG000|Overall Study|Cytogenetic resistance|0
4390908|NCT00079274|7169316|FG001|Overall Study|Cytogenetic resistance|0
4390909|NCT00079274|7169317|FG002|Overall Study|Cytogenetic resistance|0
4390910|NCT00079274|7169318|FG003|Overall Study|Cytogenetic resistance|2
4390911|NCT00079274|7169319|FG004|Overall Study|Cytogenetic resistance|0
4390912|NCT00079274|7169320|FG005|Overall Study|Cytogenetic resistance|0
4390913|NCT00079274|7169321|FG006|Overall Study|Cytogenetic resistance|0
4390914|NCT00079274|7169315|FG000|Overall Study|Other|43
4390915|NCT00079274|7169316|FG001|Overall Study|Other|7
4390916|NCT00079274|7169317|FG002|Overall Study|Other|5
4390917|NCT00079274|7169318|FG003|Overall Study|Other|55
4390918|NCT00079274|7169319|FG004|Overall Study|Other|1
4390919|NCT00079274|7169320|FG005|Overall Study|Other|2
4390920|NCT00079274|7169321|FG006|Overall Study|Other|0
4390921|NCT00079339|7169345|FG000|Overall Study|Adverse Event|1
4390922|NCT00079339|7169346|FG001|Overall Study|Adverse Event|7
4712086|NCT02919475|7638348|FG000|Overall Study|Lost to Follow-up|0
4712087|NCT02919475|7638349|FG001|Overall Study|Lost to Follow-up|0
4712088|NCT02919475|7638350|FG002|Overall Study|Lost to Follow-up|0
4712089|NCT02919475|7638351|FG003|Overall Study|Lost to Follow-up|1
4712090|NCT02919475|7638352|FG004|Overall Study|Lost to Follow-up|0
4712091|NCT02919475|7638348|FG000|Overall Study|Withdrawal by Subject|2
4712092|NCT02919475|7638349|FG001|Overall Study|Withdrawal by Subject|3
4712093|NCT02919475|7638350|FG002|Overall Study|Withdrawal by Subject|1
4390923|NCT00079339|7169347|FG002|Overall Study|Adverse Event|2
4390924|NCT00079339|7169345|FG000|Overall Study|Death|1
4390925|NCT00079339|7169346|FG001|Overall Study|Death|0
4390926|NCT00079339|7169347|FG002|Overall Study|Death|0
4390927|NCT00079339|7169345|FG000|Overall Study|Non-compliance|0
4390928|NCT00079339|7169346|FG001|Overall Study|Non-compliance|0
4390929|NCT00079339|7169347|FG002|Overall Study|Non-compliance|1
4390930|NCT00079339|7169345|FG000|Overall Study|Withdrawal by Subject|0
4390931|NCT00079339|7169346|FG001|Overall Study|Withdrawal by Subject|4
4390932|NCT00079339|7169347|FG002|Overall Study|Withdrawal by Subject|1
4390933|NCT00079339|7169345|FG000|Overall Study|Disease progression|3
4390934|NCT00079339|7169346|FG001|Overall Study|Disease progression|28
4390935|NCT00079339|7169347|FG002|Overall Study|Disease progression|2
4390936|NCT00079391|7169360|FG000|Overall Study|Withdrawal by Subject|1
4390937|NCT00079417|7169366|FG000|Overall Study|Physician Decision|2
4390938|NCT00079417|7169366|FG000|Overall Study|Ineligible|7
4712094|NCT02919475|7638351|FG003|Overall Study|Withdrawal by Subject|2
4390939|NCT00079677|7169372|FG000|Overall Study|Adverse Event|5
4390940|NCT00079677|7169373|FG001|Overall Study|Adverse Event|6
4390941|NCT00079677|7169372|FG000|Overall Study|Lack of Efficacy|1
4390942|NCT00079677|7169373|FG001|Overall Study|Lack of Efficacy|0
4390943|NCT00079677|7169372|FG000|Overall Study|Lost to Follow-up|2
4390944|NCT00079677|7169373|FG001|Overall Study|Lost to Follow-up|2
4390945|NCT00079677|7169372|FG000|Overall Study|Physician Decision|3
4390946|NCT00079677|7169373|FG001|Overall Study|Physician Decision|0
4390947|NCT00079677|7169372|FG000|Overall Study|Protocol Violation|2
4390948|NCT00079677|7169373|FG001|Overall Study|Protocol Violation|3
4390949|NCT00079677|7169372|FG000|Overall Study|Withdrawal by Subject|5
4390950|NCT00079677|7169373|FG001|Overall Study|Withdrawal by Subject|3
4390951|NCT00079677|7169372|FG000|Overall Study|Miscellaneous|2
4390952|NCT00079677|7169373|FG001|Overall Study|Miscellaneous|0
4390953|NCT00079781|7169382|FG000|Pre-implant Period|Withdrawal by Subject|2
4390954|NCT00079781|7169383|FG001|Pre-implant Period|Withdrawal by Subject|0
4390955|NCT00079781|7169384|FG002|Pre-implant Period|Withdrawal by Subject|0
4390956|NCT00079781|7169382|FG000|Pre-implant Period|Did not meet I/E criteria|1
4390957|NCT00079781|7169383|FG001|Pre-implant Period|Did not meet I/E criteria|1
4390958|NCT00079781|7169384|FG002|Pre-implant Period|Did not meet I/E criteria|1
4390959|NCT00079781|7169382|FG000|Follow-up Period|Withdrawal by Subject|3
4390960|NCT00079781|7169383|FG001|Follow-up Period|Withdrawal by Subject|0
4390961|NCT00079781|7169384|FG002|Follow-up Period|Withdrawal by Subject|1
4390962|NCT00079781|7169382|FG000|Follow-up Period|Lost to Follow-up|1
4390963|NCT00079781|7169383|FG001|Follow-up Period|Lost to Follow-up|0
4390964|NCT00079781|7169384|FG002|Follow-up Period|Lost to Follow-up|0
4390965|NCT00079781|7169382|FG000|Follow-up Period|Death|0
4390966|NCT00079781|7169383|FG001|Follow-up Period|Death|0
4390967|NCT00079781|7169384|FG002|Follow-up Period|Death|1
4390968|NCT00079937|7169392|FG000|Overall Study|Adverse Event|2
4390969|NCT00079937|7169393|FG001|Overall Study|Adverse Event|1
4390970|NCT00079937|7169392|FG000|Overall Study|Unsatisfactory therapeutic effect|1
4390971|NCT00079937|7169393|FG001|Overall Study|Unsatisfactory therapeutic effect|2
4390972|NCT00079937|7169392|FG000|Overall Study|Subject no longer requires study drug|3
4390973|NCT00079937|7169393|FG001|Overall Study|Subject no longer requires study drug|0
4390974|NCT00079937|7169392|FG000|Overall Study|Protocol Violation|8
4390975|NCT00079937|7169393|FG001|Overall Study|Protocol Violation|6
4390976|NCT00079937|7169392|FG000|Overall Study|Withdrawal by Subject|21
4390977|NCT00079937|7169393|FG001|Overall Study|Withdrawal by Subject|7
4390978|NCT00079937|7169392|FG000|Overall Study|Lost to Follow-up|12
4390979|NCT00079937|7169393|FG001|Overall Study|Lost to Follow-up|5
4390980|NCT00079937|7169392|FG000|Overall Study|Administrative problems|22
4390981|NCT00079937|7169393|FG001|Overall Study|Administrative problems|11
4390982|NCT00080119|7169403|FG000|Overall Study|Discontinued because of study closure|0
4390983|NCT00080119|7169404|FG001|Overall Study|Discontinued because of study closure|0
4390984|NCT00080119|7169405|FG002|Overall Study|Discontinued because of study closure|130
4390985|NCT00080119|7169406|FG003|Overall Study|Discontinued because of study closure|141
4390986|NCT00080119|7169403|FG000|Overall Study|Unable to get to clinic|24
4390987|NCT00080119|7169404|FG001|Overall Study|Unable to get to clinic|24
4390988|NCT00080119|7169405|FG002|Overall Study|Unable to get to clinic|7
4390989|NCT00080119|7169406|FG003|Overall Study|Unable to get to clinic|1
4390990|NCT00080119|7169403|FG000|Overall Study|Consent withdrawn|13
4390991|NCT00080119|7169404|FG001|Overall Study|Consent withdrawn|17
4390992|NCT00080119|7169405|FG002|Overall Study|Consent withdrawn|4
4390993|NCT00080119|7169406|FG003|Overall Study|Consent withdrawn|6
4390994|NCT00080119|7169403|FG000|Overall Study|Unwilling to adhere to study requirement|3
4390995|NCT00080119|7169404|FG001|Overall Study|Unwilling to adhere to study requirement|2
4390996|NCT00080119|7169405|FG002|Overall Study|Unwilling to adhere to study requirement|5
4390997|NCT00080119|7169406|FG003|Overall Study|Unwilling to adhere to study requirement|1
4390998|NCT00080119|7169403|FG000|Overall Study|Lost to Follow-up|16
4390999|NCT00080119|7169404|FG001|Overall Study|Lost to Follow-up|19
4391000|NCT00080119|7169405|FG002|Overall Study|Lost to Follow-up|19
4391001|NCT00080119|7169406|FG003|Overall Study|Lost to Follow-up|14
4391002|NCT00080223|7169418|FG000|Overall Study|Adverse Event|23
4391003|NCT00080223|7169418|FG000|Overall Study|Death|21
4391004|NCT00080223|7169418|FG000|Overall Study|Withdrawal by Subject|13
4391005|NCT00080223|7169418|FG000|Overall Study|Lung Transplantation|9
4391006|NCT00080223|7169418|FG000|Overall Study|Non-compliance With Study Treatment|7
4391007|NCT00080223|7169418|FG000|Overall Study|Participant unwilling to continue|2
4391008|NCT00080223|7169418|FG000|Overall Study|Physician Decision|1
4391009|NCT00080288|7169424|FG000|Overall Study|Adverse Event|7
4391010|NCT00080288|7169425|FG001|Overall Study|Adverse Event|4
4391011|NCT00080288|7169424|FG000|Overall Study|Lost to Follow-up|3
4391012|NCT00080288|7169425|FG001|Overall Study|Lost to Follow-up|5
4391013|NCT00080288|7169424|FG000|Overall Study|Physician Decision|6
4391014|NCT00080288|7169425|FG001|Overall Study|Physician Decision|2
4391015|NCT00080288|7169424|FG000|Overall Study|Withdrawal by Subject|3
4391016|NCT00080288|7169425|FG001|Overall Study|Withdrawal by Subject|16
4391017|NCT00080288|7169424|FG000|Overall Study|Miscellaneous|11
4391018|NCT00080288|7169425|FG001|Overall Study|Miscellaneous|11
4391019|NCT00080301|7169433|FG000|Overall Study|Randomized but Never Treated|5
4391020|NCT00080301|7169434|FG001|Overall Study|Randomized but Never Treated|10
4391021|NCT00080301|7169433|FG000|Overall Study|Still on Treatment as of CSR date|0
4391022|NCT00080301|7169434|FG001|Overall Study|Still on Treatment as of CSR date|1
4391023|NCT00080483|7169454|FG000|Overall Study|Lost to Follow-up|1
4391024|NCT00080483|7169455|FG001|Overall Study|Lost to Follow-up|1
4391025|NCT00080483|7169454|FG000|Overall Study|Physician Decision|1
4391026|NCT00080483|7169455|FG001|Overall Study|Physician Decision|1
4391027|NCT00080899|7169465|FG000|Overall Study|Adverse Event|1
4391028|NCT00080938|7169478|FG000|Overall Study|Adverse Event|3
4391029|NCT00080938|7169478|FG000|Overall Study|Withdrawal by Subject|6
4391030|NCT00080938|7169478|FG000|Overall Study|Death|2
4391031|NCT00080938|7169478|FG000|Overall Study|Lack of Efficacy|7
4391032|NCT00080938|7169478|FG000|Overall Study|other disease|1
4391033|NCT00080938|7169478|FG000|Overall Study|Not started protocol therapy|1
4391034|NCT00080938|7169478|FG000|Overall Study|Ineligible|4
4391035|NCT00081159|7169484|FG000|Overall Study|Withdrawal by Subject|0
4391036|NCT00081159|7169485|FG001|Overall Study|Withdrawal by Subject|3
4391037|NCT00081159|7169484|FG000|Overall Study|Myelosuppression prior to treatment|0
4391038|NCT00081159|7169485|FG001|Overall Study|Myelosuppression prior to treatment|1
4391039|NCT00081159|7169484|FG000|Overall Study|Lost to Follow-up|2
4391040|NCT00081159|7169485|FG001|Overall Study|Lost to Follow-up|1
4391041|NCT00081263|7169493|FG000|Overall Study|clerical error|1
4391042|NCT00081263|7169494|FG001|Overall Study|clerical error|0
4391043|NCT00081263|7169493|FG000|Overall Study|wrong cell type|7
4391044|NCT00081263|7169494|FG001|Overall Study|wrong cell type|5
4391045|NCT00081263|7169493|FG000|Overall Study|improper pre-protocol therapy|0
4391046|NCT00081263|7169494|FG001|Overall Study|improper pre-protocol therapy|1
4391047|NCT00081263|7169493|FG000|Overall Study|Inadequate pathology|0
4391048|NCT00081263|7169494|FG001|Overall Study|Inadequate pathology|1
4391049|NCT00081263|7169493|FG000|Overall Study|Never treated|4
4391050|NCT00081263|7169494|FG001|Overall Study|Never treated|5
4391051|NCT00081263|7169493|FG000|Overall Study|Inadequate data|5
4391052|NCT00081263|7169494|FG001|Overall Study|Inadequate data|10
4391053|NCT00081289|7169502|FG000|Overall Study|Accrued prior to chemotherapy amendment|18
4391054|NCT00081289|7169503|FG001|Overall Study|Accrued prior to chemotherapy amendment|17
4391055|NCT00081289|7169502|FG000|Overall Study|Ineligible / no protocol treatment|3
4391056|NCT00081289|7169503|FG001|Overall Study|Ineligible / no protocol treatment|4
4391057|NCT00081458|7169527|FG000|Overall Study|Adverse Event|1
4391058|NCT00081458|7169528|FG001|Overall Study|Adverse Event|5
4391059|NCT00081458|7169529|FG002|Overall Study|Adverse Event|2
4391060|NCT00081458|7169527|FG000|Overall Study|Withdrawal by Subject|0
4391061|NCT00081458|7169528|FG001|Overall Study|Withdrawal by Subject|3
4391062|NCT00081458|7169529|FG002|Overall Study|Withdrawal by Subject|1
4391063|NCT00081458|7169527|FG000|Overall Study|Randomized but not dosed|0
4391064|NCT00081458|7169528|FG001|Overall Study|Randomized but not dosed|0
4391065|NCT00081458|7169529|FG002|Overall Study|Randomized but not dosed|1
4391066|NCT00081497|7169540|FG000|Overall Study|Adverse Event|2
4391067|NCT00081497|7169541|FG001|Overall Study|Adverse Event|0
4391068|NCT00081497|7169540|FG000|Overall Study|Death|0
4391069|NCT00081497|7169541|FG001|Overall Study|Death|1
4391070|NCT00081497|7169540|FG000|Overall Study|Withdrawal by Subject|1
4391071|NCT00081497|7169541|FG001|Overall Study|Withdrawal by Subject|0
4391072|NCT00081497|7169540|FG000|Overall Study|Non-compliance|0
4391073|NCT00081497|7169541|FG001|Overall Study|Non-compliance|1
4391074|NCT00081653|7169555|FG000|Overall Study|Adverse Event|23
4391075|NCT00081653|7169556|FG001|Overall Study|Adverse Event|17
4391076|NCT00081653|7169555|FG000|Overall Study|Lost to Follow-up|2
4391077|NCT00081653|7169556|FG001|Overall Study|Lost to Follow-up|4
4391078|NCT00081653|7169555|FG000|Overall Study|Refused Treatment|18
4391079|NCT00081653|7169556|FG001|Overall Study|Refused Treatment|14
4391080|NCT00081653|7169555|FG000|Overall Study|Low bone mineral density|1
4391081|NCT00081653|7169556|FG001|Overall Study|Low bone mineral density|0
4391082|NCT00081653|7169555|FG000|Overall Study|Bone loss|2
4391083|NCT00081653|7169556|FG001|Overall Study|Bone loss|0
4391084|NCT00081653|7169555|FG000|Overall Study|Participant leaving country|1
4391085|NCT00081653|7169556|FG001|Overall Study|Participant leaving country|0
4391086|NCT00081653|7169555|FG000|Overall Study|Loss of bone mass|0
4391087|NCT00081653|7169556|FG001|Overall Study|Loss of bone mass|2
4391088|NCT00081731|7169565|FG000|Overall Study|scientific integrity issue|8
4391089|NCT00081731|7169566|FG001|Overall Study|scientific integrity issue|8
4391090|NCT00081770|7169575|FG000|Overall Study|Adverse Event|130
4391091|NCT00081770|7169576|FG001|Overall Study|Adverse Event|98
4391092|NCT00081770|7169577|FG002|Overall Study|Adverse Event|136
4391093|NCT00081770|7169575|FG000|Overall Study|Lack of Efficacy|262
4391094|NCT00081770|7169576|FG001|Overall Study|Lack of Efficacy|357
4391095|NCT00081770|7169577|FG002|Overall Study|Lack of Efficacy|211
4391096|NCT00081770|7169575|FG000|Overall Study|Lost to Follow-up|45
4391097|NCT00081770|7169576|FG001|Overall Study|Lost to Follow-up|34
4391098|NCT00081770|7169577|FG002|Overall Study|Lost to Follow-up|45
4391099|NCT00081770|7169575|FG000|Overall Study|Protocol Violation|15
4391100|NCT00081770|7169576|FG001|Overall Study|Protocol Violation|10
4391101|NCT00081770|7169577|FG002|Overall Study|Protocol Violation|10
4391102|NCT00081770|7169575|FG000|Overall Study|Withdrawal by Subject|45
4391103|NCT00081770|7169576|FG001|Overall Study|Withdrawal by Subject|40
4391104|NCT00081770|7169577|FG002|Overall Study|Withdrawal by Subject|42
4510777|NCT00922974|7319666|FG000|Phase II Component|Protocol Violation|2
4391105|NCT00081770|7169575|FG000|Overall Study|Did not meet protocol eligibility|2
4391106|NCT00081770|7169576|FG001|Overall Study|Did not meet protocol eligibility|0
4391107|NCT00081770|7169577|FG002|Overall Study|Did not meet protocol eligibility|3
4391108|NCT00081770|7169575|FG000|Overall Study|Administrative|1
4391109|NCT00081770|7169576|FG001|Overall Study|Administrative|0
4391110|NCT00081770|7169577|FG002|Overall Study|Administrative|1
4391111|NCT00081770|7169575|FG000|Overall Study|Other|2
4391112|NCT00081770|7169576|FG001|Overall Study|Other|7
4391113|NCT00081770|7169577|FG002|Overall Study|Other|8
4391114|NCT00082173|7169602|FG000|Overall Study|Withdrawal by Subject|3
4391115|NCT00082173|7169603|FG001|Overall Study|Withdrawal by Subject|5
4391116|NCT00082173|7169602|FG000|Overall Study|Lost to Follow-up|1
4391117|NCT00082173|7169603|FG001|Overall Study|Lost to Follow-up|0
4391118|NCT00082173|7169602|FG000|Overall Study|Adverse Event|1
4391119|NCT00082173|7169603|FG001|Overall Study|Adverse Event|0
4391120|NCT00082173|7169602|FG000|Overall Study|Culture negative or resistant at baselin|5
4391121|NCT00082173|7169603|FG001|Overall Study|Culture negative or resistant at baselin|6
4391122|NCT00082355|7169636|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1
4391123|NCT00082355|7169636|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1
4391124|NCT00082355|7169636|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28
4391125|NCT00082368|7169640|FG000|Overall Study|Not treated-pt had poor IV access|1
4391126|NCT00082381|7169646|FG000|Overall Study|Adverse Event|27
4391127|NCT00082381|7169647|FG001|Overall Study|Adverse Event|2
4391128|NCT00082381|7169646|FG000|Overall Study|Lost to Follow-up|5
4391129|NCT00082381|7169647|FG001|Overall Study|Lost to Follow-up|7
4391130|NCT00082381|7169646|FG000|Overall Study|Patient Decision|8
4391131|NCT00082381|7169647|FG001|Overall Study|Patient Decision|4
4391132|NCT00082381|7169646|FG000|Overall Study|Physician Decision|1
4391133|NCT00082381|7169647|FG001|Overall Study|Physician Decision|2
4391134|NCT00082381|7169646|FG000|Overall Study|Protocol Violation|10
4391135|NCT00082381|7169647|FG001|Overall Study|Protocol Violation|11
4391136|NCT00082381|7169646|FG000|Overall Study|Loss of Glucose Control|4
4391137|NCT00082381|7169647|FG001|Overall Study|Loss of Glucose Control|0
4391138|NCT00082407|7169655|FG000|Overall Study|Adverse Event|20
4391139|NCT00082407|7169656|FG001|Overall Study|Adverse Event|0
4391140|NCT00082407|7169655|FG000|Overall Study|Protocol Violation|14
4391141|NCT00082407|7169656|FG001|Overall Study|Protocol Violation|12
4391142|NCT00082407|7169655|FG000|Overall Study|Patient Decision|13
4391143|NCT00082407|7169656|FG001|Overall Study|Patient Decision|6
4391144|NCT00082407|7169655|FG000|Overall Study|Physician Decision|5
4391145|NCT00082407|7169656|FG001|Overall Study|Physician Decision|3
4391146|NCT00082407|7169655|FG000|Overall Study|Loss of Glucose Control|2
4391147|NCT00082407|7169656|FG001|Overall Study|Loss of Glucose Control|2
4391148|NCT00082407|7169655|FG000|Overall Study|Death|2
4391149|NCT00082407|7169656|FG001|Overall Study|Death|1
4391150|NCT00082407|7169655|FG000|Overall Study|Lost to Follow-up|0
4391151|NCT00082407|7169656|FG001|Overall Study|Lost to Follow-up|3
4391152|NCT00082433|7169664|FG000|Overall Study|Adverse Event|12
4391153|NCT00082433|7169665|FG001|Overall Study|Adverse Event|17
4391154|NCT00082433|7169664|FG000|Overall Study|Death|8
4391155|NCT00082433|7169665|FG001|Overall Study|Death|18
4391156|NCT00082433|7169664|FG000|Overall Study|Disease Progression/Relapse|270
4391157|NCT00082433|7169665|FG001|Overall Study|Disease Progression/Relapse|388
4391158|NCT00082433|7169664|FG000|Overall Study|Physician Decision|50
4391159|NCT00082433|7169665|FG001|Overall Study|Physician Decision|61
4391160|NCT00082433|7169664|FG000|Overall Study|Lost to Follow-up|1
4391161|NCT00082433|7169665|FG001|Overall Study|Lost to Follow-up|2
4391162|NCT00082433|7169664|FG000|Overall Study|Study Drug Toxicity|179
4391163|NCT00082433|7169665|FG001|Overall Study|Study Drug Toxicity|66
4391164|NCT00082433|7169664|FG000|Overall Study|Withdrawal by Subject|55
4391165|NCT00082433|7169665|FG001|Overall Study|Withdrawal by Subject|30
4391166|NCT00082433|7169664|FG000|Overall Study|Still On Treatment|2
4391167|NCT00082433|7169665|FG001|Overall Study|Still On Treatment|1
4391168|NCT00082433|7169664|FG000|Overall Study|Not Treated|12
4391169|NCT00082433|7169665|FG001|Overall Study|Not Treated|11
4391170|NCT00082433|7169664|FG000|Overall Study|Ineligible|2
4391171|NCT00082433|7169665|FG001|Overall Study|Ineligible|1
4391172|NCT00082433|7169664|FG000|Overall Study|Noncompliance|2
4391173|NCT00082433|7169665|FG001|Overall Study|Noncompliance|1
4391174|NCT00082433|7169664|FG000|Overall Study|New primary cancer|1
4391175|NCT00082433|7169665|FG001|Overall Study|New primary cancer|0
4391176|NCT00082433|7169664|FG000|Overall Study|Impending surgery|0
4391177|NCT00082433|7169665|FG001|Overall Study|Impending surgery|1
4391178|NCT00082628|7169673|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
4391179|NCT00082628|7169674|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1
4391180|NCT00082628|7169675|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
4391181|NCT00082628|7169676|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
4391182|NCT00082628|7169677|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
4391183|NCT00082628|7169673|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2
4391184|NCT00082628|7169674|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1
4391185|NCT00082628|7169675|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0
4391186|NCT00082628|7169676|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0
4391187|NCT00082628|7169677|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0
4391188|NCT00082628|7169673|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5
4391189|NCT00082628|7169674|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43
4391190|NCT00082628|7169675|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0
4391191|NCT00082628|7169676|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0
4391192|NCT00082628|7169677|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0
4391193|NCT00082628|7169673|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1
4391194|NCT00082628|7169674|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15
4391195|NCT00082628|7169675|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0
4391196|NCT00082628|7169676|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0
4391197|NCT00082628|7169677|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0
4391198|NCT00082628|7169673|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
4391199|NCT00082628|7169674|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
4391200|NCT00082628|7169675|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
4391201|NCT00082628|7169676|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
4391202|NCT00082628|7169677|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1
4391203|NCT00082628|7169673|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
4391204|NCT00082628|7169674|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
4391205|NCT00082628|7169675|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
4391206|NCT00082628|7169676|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1
4391207|NCT00082628|7169677|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
4391208|NCT00082628|7169673|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0
4391209|NCT00082628|7169674|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0
4391210|NCT00082628|7169675|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15
4391211|NCT00082628|7169676|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15
4391212|NCT00082628|7169677|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17
4391213|NCT00082758|7169702|FG000|Overall Study|Adverse Event|0
4391214|NCT00082758|7169703|FG001|Overall Study|Adverse Event|2
4391215|NCT00082758|7169704|FG002|Overall Study|Adverse Event|0
4391216|NCT00082758|7169702|FG000|Overall Study|Lack of Efficacy|12
4391217|NCT00082758|7169703|FG001|Overall Study|Lack of Efficacy|13
4391218|NCT00082758|7169704|FG002|Overall Study|Lack of Efficacy|0
4391219|NCT00082758|7169702|FG000|Overall Study|Physician Decision|0
4391220|NCT00082758|7169703|FG001|Overall Study|Physician Decision|1
4391221|NCT00082758|7169704|FG002|Overall Study|Physician Decision|0
4391222|NCT00082758|7169702|FG000|Overall Study|Withdrawal by Subject|3
4391223|NCT00082758|7169703|FG001|Overall Study|Withdrawal by Subject|0
4391224|NCT00082758|7169704|FG002|Overall Study|Withdrawal by Subject|0
4391225|NCT00082758|7169702|FG000|Overall Study|Protocol Violation|0
4391226|NCT00082758|7169703|FG001|Overall Study|Protocol Violation|1
4391227|NCT00082758|7169704|FG002|Overall Study|Protocol Violation|0
4391228|NCT00082810|7169712|FG000|Overall Study|Adverse Event|3
4391229|NCT00082810|7169712|FG000|Overall Study|Progressive disease|24
4391230|NCT00082810|7169712|FG000|Overall Study|Withdrawal by Subject|4
4391231|NCT00082888|7169720|FG000|Overall Study|Ineligible|1
4391232|NCT00082888|7169721|FG001|Overall Study|Ineligible|0
4391233|NCT00082888|7169722|FG002|Overall Study|Ineligible|0
4391234|NCT00083226|7169754|FG000|Overall Study|Lack of Efficacy|19
4391235|NCT00083226|7169754|FG000|Overall Study|Adverse Event|9
4391236|NCT00083226|7169754|FG000|Overall Study|Death|4
4391237|NCT00083226|7169754|FG000|Overall Study|Withdrawal by Subject|4
4391238|NCT00083226|7169754|FG000|Overall Study|Other|2
4391239|NCT00083226|7169754|FG000|Overall Study|ineligible or not receiving treatment|4
4391240|NCT00083616|7169771|FG000|Overall Study|Disease Progression|16
4391241|NCT00083616|7169771|FG000|Overall Study|Lost to Follow-up|1
4391242|NCT00083616|7169771|FG000|Overall Study|Physician Decision|2
4391243|NCT00083616|7169771|FG000|Overall Study|Withdrawal by Subject|3
4391244|NCT00083616|7169771|FG000|Overall Study|Ineligibility determined|2
4391245|NCT00083616|7169771|FG000|Overall Study|Non-compliance|1
4391246|NCT00083616|7169771|FG000|Overall Study|Other|6
4391247|NCT00083889|7169781|FG000|Overall Study|Adverse Event|76
4391248|NCT00083889|7169782|FG001|Overall Study|Adverse Event|86
4391249|NCT00083889|7169781|FG000|Overall Study|Protocol Violation|2
4391250|NCT00083889|7169782|FG001|Overall Study|Protocol Violation|2
4391251|NCT00083889|7169781|FG000|Overall Study|Withdrawal by Subject|22
4391252|NCT00083889|7169782|FG001|Overall Study|Withdrawal by Subject|24
4391253|NCT00083889|7169781|FG000|Overall Study|Lack of Efficacy|240
4391254|NCT00083889|7169782|FG001|Overall Study|Lack of Efficacy|219
4391255|NCT00083889|7169781|FG000|Overall Study|Decision of sponsor|32
4391256|NCT00083889|7169782|FG001|Overall Study|Decision of sponsor|4
4391257|NCT00083889|7169781|FG000|Overall Study|Randomized: did not take study drug|0
4391258|NCT00083889|7169782|FG001|Overall Study|Randomized: did not take study drug|15
4391259|NCT00083889|7169781|FG000|Overall Study|Completed on marketed sunitinub|3
4391260|NCT00083889|7169782|FG001|Overall Study|Completed on marketed sunitinub|0
4391261|NCT00083889|7169781|FG000|Overall Study|Crossover to SU011248|0
4391262|NCT00083889|7169782|FG001|Overall Study|Crossover to SU011248|25
4391263|NCT00084084|7169791|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1
4391264|NCT00084084|7169791|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1
4391265|NCT00084136|7169799|FG000|PI Comparison|Death|10
4391266|NCT00084136|7169800|FG001|PI Comparison|Death|9
4391267|NCT00084136|7169801|FG002|PI Comparison|Death|0
4391268|NCT00084136|7169799|FG000|PI Comparison|Lost to Follow-up|11
4391269|NCT00084136|7169800|FG001|PI Comparison|Lost to Follow-up|8
4391270|NCT00084136|7169801|FG002|PI Comparison|Lost to Follow-up|0
4391271|NCT00084136|7169799|FG000|PI Comparison|Withdrawal by Subject|33
4391272|NCT00084136|7169800|FG001|PI Comparison|Withdrawal by Subject|30
4391273|NCT00084136|7169801|FG002|PI Comparison|Withdrawal by Subject|0
4391274|NCT00084136|7169799|FG000|PI Comparison|Clinic site closed|1
4391275|NCT00084136|7169800|FG001|PI Comparison|Clinic site closed|0
4391276|NCT00084136|7169801|FG002|PI Comparison|Clinic site closed|0
4391277|NCT00084136|7169799|FG000|NRTI Comparison|Death|20
4391278|NCT00084136|7169800|FG001|NRTI Comparison|Death|0
4391279|NCT00084136|7169801|FG002|NRTI Comparison|Death|18
4391280|NCT00084136|7169799|FG000|NRTI Comparison|Lost to Follow-up|14
4391281|NCT00084136|7169800|FG001|NRTI Comparison|Lost to Follow-up|0
4391282|NCT00084136|7169801|FG002|NRTI Comparison|Lost to Follow-up|12
4391283|NCT00084136|7169799|FG000|NRTI Comparison|Withdrawal by Subject|54
4391284|NCT00084136|7169800|FG001|NRTI Comparison|Withdrawal by Subject|0
4391285|NCT00084136|7169801|FG002|NRTI Comparison|Withdrawal by Subject|38
4391286|NCT00084136|7169799|FG000|NRTI Comparison|Clinic site closed|12
4391287|NCT00084136|7169800|FG001|NRTI Comparison|Clinic site closed|0
4391288|NCT00084136|7169801|FG002|NRTI Comparison|Clinic site closed|14
4391289|NCT00084136|7169799|FG000|NRTI Comparison|Not reason above|1
4391290|NCT00084136|7169800|FG001|NRTI Comparison|Not reason above|0
4391291|NCT00084136|7169801|FG002|NRTI Comparison|Not reason above|0
4391292|NCT00084266|7169825|FG000|Overall Study|Death|42
4391293|NCT00084266|7169826|FG001|Overall Study|Death|39
4391294|NCT00084266|7169825|FG000|Overall Study|Adverse Event|8
4391295|NCT00084266|7169826|FG001|Overall Study|Adverse Event|5
4391296|NCT00084266|7169825|FG000|Overall Study|Lack of Efficacy|2
4391297|NCT00084266|7169826|FG001|Overall Study|Lack of Efficacy|4
4391298|NCT00084266|7169825|FG000|Overall Study|Lost to Follow-up|5
4391299|NCT00084266|7169826|FG001|Overall Study|Lost to Follow-up|3
4391300|NCT00084266|7169825|FG000|Overall Study|Participant not willing to participate|3
4391301|NCT00084266|7169826|FG001|Overall Study|Participant not willing to participate|8
4391302|NCT00084266|7169825|FG000|Overall Study|Other|360
4391303|NCT00084266|7169826|FG001|Overall Study|Other|344
4391304|NCT00084266|7169825|FG000|Overall Study|Randomized not treated|21
4391305|NCT00084266|7169826|FG001|Overall Study|Randomized not treated|20
4391306|NCT00084318|7169834|FG000|Overall Study|Withdrawal by Subject|5
4391307|NCT00084318|7169835|FG001|Overall Study|Withdrawal by Subject|2
4391308|NCT00084318|7169834|FG000|Overall Study|Protocol Violation|15
4391309|NCT00084318|7169835|FG001|Overall Study|Protocol Violation|11
4391310|NCT00084318|7169834|FG000|Overall Study|No protocol treatment|2
4391311|NCT00084318|7169835|FG001|Overall Study|No protocol treatment|0
4391312|NCT00084487|7169858|FG000|Overall Study|Death|1
4391313|NCT00084617|7169871|FG000|Overall Study|Withdrawal by Subject|7
4391314|NCT00084617|7169871|FG000|Overall Study|Lack of Efficacy|1
4391315|NCT00084617|7169871|FG000|Overall Study|Protocol Violation|1
4391316|NCT00084682|7169875|FG000|Overall Study|Withdrawal by Subject|1
4391317|NCT00084747|7169880|FG000|Overall Study|Relapsed|8
4391318|NCT00084747|7169880|FG000|Overall Study|Death|3
4391319|NCT00084747|7169880|FG000|Overall Study|Withdrawal by Subject|2
4391320|NCT00084838|7169885|FG000|Overall Study|Death|1
4391321|NCT00084838|7169885|FG000|Overall Study|Adverse Event|2
4391322|NCT00084838|7169885|FG000|Overall Study|Withdrawal by Subject|1
4391323|NCT00084838|7169885|FG000|Overall Study|Progressive Disease|4
4391324|NCT00084838|7169885|FG000|Overall Study|Pt Non-Compliance|1
4391325|NCT00084838|7169885|FG000|Overall Study|Ineligible|4
4391326|NCT00084864|7169895|FG000|Overall Study|Adverse Event|1
4391327|NCT00084864|7169896|FG001|Overall Study|Adverse Event|0
4391328|NCT00084864|7169897|FG002|Overall Study|Adverse Event|0
4391329|NCT00084864|7169898|FG003|Overall Study|Adverse Event|0
4391330|NCT00084929|7169908|FG000|Overall Study|ineligible - medical contraindication|1
4391331|NCT00084929|7169908|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1
4391332|NCT00084929|7169908|FG000|Overall Study|Ineligible - Medical history|6
4391333|NCT00084929|7169908|FG000|Overall Study|Withdrawal by Subject|10
4391334|NCT00084929|7169908|FG000|Overall Study|Missing/incomplete CTC exam|9
4391335|NCT00084929|7169908|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42
4391336|NCT00085098|7169918|FG000|Overall Study|Withdrawal by Subject|0
4391337|NCT00085098|7169919|FG001|Overall Study|Withdrawal by Subject|1
4391338|NCT00085098|7169918|FG000|Overall Study|Ineligible|1
4391339|NCT00085098|7169919|FG001|Overall Study|Ineligible|1
4391340|NCT00085423|7169956|FG000|Overall Study|Withdrawal by Subject|1
4391341|NCT00085423|7169956|FG000|Overall Study|screen failure|1
4391342|NCT00085540|7169967|FG000|Overall Study|Withdrawal by Subject|0
4391343|NCT00085540|7169968|FG001|Overall Study|Withdrawal by Subject|1
4391344|NCT00085540|7169967|FG000|Overall Study|Protocol Violation|0
4391345|NCT00085540|7169968|FG001|Overall Study|Protocol Violation|1
4391346|NCT00085566|7169977|FG000|Overall Study|Adverse Event|0
4391347|NCT00085566|7169978|FG001|Overall Study|Adverse Event|0
4391348|NCT00085566|7169979|FG002|Overall Study|Adverse Event|10
4391349|NCT00085566|7169977|FG000|Overall Study|Patient Not treated|0
4391350|NCT00085566|7169978|FG001|Overall Study|Patient Not treated|0
4391351|NCT00085566|7169979|FG002|Overall Study|Patient Not treated|3
4391352|NCT00085566|7169977|FG000|Overall Study|Clinical progression|0
4391353|NCT00085566|7169978|FG001|Overall Study|Clinical progression|0
4391354|NCT00085566|7169979|FG002|Overall Study|Clinical progression|1
4391355|NCT00085644|7169989|FG000|Double-Blind Period|Adverse Event|5
4391356|NCT00085644|7169990|FG001|Double-Blind Period|Adverse Event|2
4391357|NCT00085644|7169991|FG002|Double-Blind Period|Adverse Event|0
4391358|NCT00085644|7169989|FG000|Double-Blind Period|Withdrawal by Subject|3
4391359|NCT00085644|7169990|FG001|Double-Blind Period|Withdrawal by Subject|0
4391360|NCT00085644|7169991|FG002|Double-Blind Period|Withdrawal by Subject|0
4391361|NCT00085644|7169989|FG000|Double-Blind Period|Lost to Follow-up|2
4391362|NCT00085644|7169990|FG001|Double-Blind Period|Lost to Follow-up|1
4391363|NCT00085644|7169991|FG002|Double-Blind Period|Lost to Follow-up|0
4391364|NCT00085644|7169989|FG000|Double-Blind Period|Lack/loss of efficacy|2
4391365|NCT00085644|7169990|FG001|Double-Blind Period|Lack/loss of efficacy|2
4391366|NCT00085644|7169991|FG002|Double-Blind Period|Lack/loss of efficacy|0
4391367|NCT00085644|7169989|FG000|Double-Blind Period|Contemplating pregnancy|1
4391368|NCT00085644|7169990|FG001|Double-Blind Period|Contemplating pregnancy|0
4391369|NCT00085644|7169991|FG002|Double-Blind Period|Contemplating pregnancy|0
4391370|NCT00085644|7169989|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0
4391371|NCT00085644|7169990|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1
4391372|NCT00085644|7169991|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0
4391373|NCT00085644|7169989|FG000|Open-Label Period|Adverse Event|0
4391374|NCT00085644|7169990|FG001|Open-Label Period|Adverse Event|0
4391375|NCT00085644|7169991|FG002|Open-Label Period|Adverse Event|38
4391376|NCT00085644|7169989|FG000|Open-Label Period|Withdrawal by Subject|0
4391377|NCT00085644|7169990|FG001|Open-Label Period|Withdrawal by Subject|0
4391378|NCT00085644|7169991|FG002|Open-Label Period|Withdrawal by Subject|29
4391379|NCT00085644|7169989|FG000|Open-Label Period|Lost to Follow-up|0
4391380|NCT00085644|7169990|FG001|Open-Label Period|Lost to Follow-up|0
4391381|NCT00085644|7169991|FG002|Open-Label Period|Lost to Follow-up|13
4391382|NCT00085644|7169989|FG000|Open-Label Period|Lack of Efficacy|0
4391383|NCT00085644|7169990|FG001|Open-Label Period|Lack of Efficacy|0
4391384|NCT00085644|7169991|FG002|Open-Label Period|Lack of Efficacy|15
4391385|NCT00085644|7169989|FG000|Open-Label Period|Pregnancy|0
4391386|NCT00085644|7169990|FG001|Open-Label Period|Pregnancy|0
4391387|NCT00085644|7169991|FG002|Open-Label Period|Pregnancy|3
4391388|NCT00085644|7169989|FG000|Open-Label Period|Contemplating pregnancy|0
4391389|NCT00085644|7169990|FG001|Open-Label Period|Contemplating pregnancy|0
4391390|NCT00085644|7169991|FG002|Open-Label Period|Contemplating pregnancy|3
4391391|NCT00085644|7169989|FG000|Open-Label Period|Protocol Violation|0
4391392|NCT00085644|7169990|FG001|Open-Label Period|Protocol Violation|0
4391393|NCT00085644|7169991|FG002|Open-Label Period|Protocol Violation|4
4391394|NCT00085644|7169989|FG000|Open-Label Period|Personal reason|0
4391395|NCT00085644|7169990|FG001|Open-Label Period|Personal reason|0
4391396|NCT00085644|7169991|FG002|Open-Label Period|Personal reason|4
4391397|NCT00085709|7170000|FG000|Overall Study|Adverse Event|8
4391398|NCT00085709|7170001|FG001|Overall Study|Adverse Event|0
4391399|NCT00085709|7170000|FG000|Overall Study|Death|8
4391400|NCT00085709|7170001|FG001|Overall Study|Death|2
4391401|NCT00085709|7170000|FG000|Overall Study|Refusal unrelated to adverse events|1
4391402|NCT00085709|7170001|FG001|Overall Study|Refusal unrelated to adverse events|2
4391403|NCT00085709|7170000|FG000|Overall Study|Progression|3
4391404|NCT00085709|7170001|FG001|Overall Study|Progression|4
4391405|NCT00085709|7170000|FG000|Overall Study|Not protocol specified|12
4391406|NCT00085709|7170001|FG001|Overall Study|Not protocol specified|22
4391407|NCT00085709|7170000|FG000|Overall Study|Not eligible|19
4391408|NCT00085709|7170001|FG001|Overall Study|Not eligible|19
4391409|NCT00085709|7170000|FG000|Overall Study|Withdrawal by Subject|2
4391410|NCT00085709|7170001|FG001|Overall Study|Withdrawal by Subject|1
4391411|NCT00085917|7170026|FG000|Overall Study|Adverse Event|4
4391412|NCT00085917|7170027|FG001|Overall Study|Adverse Event|3
4391413|NCT00086047|7170035|FG000|Overall Study|Lost to Follow-up|7
4628338|NCT01858766|7495324|FG008|Overall Study|Withdrew Consent|0
4628339|NCT01858766|7495325|FG009|Overall Study|Withdrew Consent|0
4628340|NCT01858766|7495326|FG010|Overall Study|Withdrew Consent|0
4628341|NCT01858766|7495327|FG011|Overall Study|Withdrew Consent|1
4628342|NCT01858766|7495328|FG012|Overall Study|Withdrew Consent|0
4628343|NCT01858766|7495329|FG013|Overall Study|Withdrew Consent|0
4628344|NCT01858766|7495330|FG014|Overall Study|Withdrew Consent|0
4628345|NCT01858766|7495331|FG015|Overall Study|Withdrew Consent|0
4628346|NCT01858766|7495332|FG016|Overall Study|Withdrew Consent|0
4628347|NCT01858766|7495333|FG017|Overall Study|Withdrew Consent|0
4628348|NCT01858766|7495334|FG018|Overall Study|Withdrew Consent|0
4628349|NCT01859143|7495384|FG000|Overall Study|Lost to Follow-up|2
4628350|NCT01859143|7495385|FG001|Overall Study|Lost to Follow-up|0
4391414|NCT00086047|7170036|FG001|Overall Study|Lost to Follow-up|6
4391415|NCT00086047|7170035|FG000|Overall Study|Physician Decision|0
4391416|NCT00086047|7170036|FG001|Overall Study|Physician Decision|1
4391417|NCT00086190|7170054|FG000|Overall Study|Adverse Event|6
4712095|NCT02919475|7638352|FG004|Overall Study|Withdrawal by Subject|2
4712096|NCT02919475|7638348|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1
4712097|NCT02919475|7638349|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1
4712098|NCT02919475|7638350|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1
4712099|NCT02919475|7638351|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1
4712100|NCT02919475|7638352|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0
4712101|NCT02919696|7638373|FG000|Overall Study|Adverse Event|1
4712102|NCT02919696|7638374|FG001|Overall Study|Adverse Event|2
4391418|NCT00086190|7170055|FG001|Overall Study|Adverse Event|2
4391419|NCT00086190|7170056|FG002|Overall Study|Adverse Event|2
4628351|NCT01859390|7495454|FG000|Overall Study|Insufficient Sputum Collected|1
4391420|NCT00086190|7170054|FG000|Overall Study|Withdrawal by Subject|0
4391421|NCT00086190|7170055|FG001|Overall Study|Withdrawal by Subject|2
4391422|NCT00086190|7170056|FG002|Overall Study|Withdrawal by Subject|2
4391423|NCT00086190|7170054|FG000|Overall Study|Protocol Violation|1
4391424|NCT00086190|7170055|FG001|Overall Study|Protocol Violation|0
4391425|NCT00086190|7170056|FG002|Overall Study|Protocol Violation|0
4391426|NCT00086190|7170054|FG000|Overall Study|Moved|1
4391427|NCT00086190|7170055|FG001|Overall Study|Moved|0
4391428|NCT00086190|7170056|FG002|Overall Study|Moved|0
4391429|NCT00086190|7170054|FG000|Overall Study|Worsening depression|0
4391430|NCT00086190|7170055|FG001|Overall Study|Worsening depression|0
4391431|NCT00086190|7170056|FG002|Overall Study|Worsening depression|2
4391432|NCT00086281|7170079|FG000|Phase 1|Adverse Event|0
4391433|NCT00086281|7170080|FG001|Phase 1|Adverse Event|0
4391434|NCT00086281|7170081|FG002|Phase 1|Adverse Event|0
4391435|NCT00086281|7170082|FG003|Phase 1|Adverse Event|0
4391436|NCT00086281|7170083|FG004|Phase 1|Adverse Event|0
4391437|NCT00086281|7170084|FG005|Phase 1|Adverse Event|0
4391438|NCT00086281|7170085|FG006|Phase 1|Adverse Event|0
4391439|NCT00086281|7170086|FG007|Phase 1|Adverse Event|0
4391440|NCT00086281|7170087|FG008|Phase 1|Adverse Event|0
4391441|NCT00086281|7170088|FG009|Phase 1|Adverse Event|1
4391442|NCT00086281|7170089|FG010|Phase 1|Adverse Event|2
4391443|NCT00086281|7170090|FG011|Phase 1|Adverse Event|1
4391444|NCT00086281|7170091|FG012|Phase 1|Adverse Event|1
4391445|NCT00086281|7170092|FG013|Phase 1|Adverse Event|1
4391446|NCT00086281|7170093|FG014|Phase 1|Adverse Event|2
4391447|NCT00086281|7170079|FG000|Phase 1|Protocol Violation|0
4391448|NCT00086281|7170080|FG001|Phase 1|Protocol Violation|0
4391449|NCT00086281|7170081|FG002|Phase 1|Protocol Violation|0
4391450|NCT00086281|7170082|FG003|Phase 1|Protocol Violation|0
4391451|NCT00086281|7170083|FG004|Phase 1|Protocol Violation|0
4391452|NCT00086281|7170084|FG005|Phase 1|Protocol Violation|0
4391453|NCT00086281|7170085|FG006|Phase 1|Protocol Violation|0
4391454|NCT00086281|7170086|FG007|Phase 1|Protocol Violation|0
4391455|NCT00086281|7170087|FG008|Phase 1|Protocol Violation|0
4391456|NCT00086281|7170088|FG009|Phase 1|Protocol Violation|0
4391457|NCT00086281|7170089|FG010|Phase 1|Protocol Violation|1
4391458|NCT00086281|7170090|FG011|Phase 1|Protocol Violation|0
4391459|NCT00086281|7170091|FG012|Phase 1|Protocol Violation|0
4391460|NCT00086281|7170092|FG013|Phase 1|Protocol Violation|0
4391461|NCT00086281|7170093|FG014|Phase 1|Protocol Violation|0
4391462|NCT00086281|7170079|FG000|Phase 1|Serious Adverse Event|0
4391463|NCT00086281|7170080|FG001|Phase 1|Serious Adverse Event|0
4391464|NCT00086281|7170081|FG002|Phase 1|Serious Adverse Event|0
4391465|NCT00086281|7170082|FG003|Phase 1|Serious Adverse Event|0
4391466|NCT00086281|7170083|FG004|Phase 1|Serious Adverse Event|0
4391467|NCT00086281|7170084|FG005|Phase 1|Serious Adverse Event|0
4391468|NCT00086281|7170085|FG006|Phase 1|Serious Adverse Event|0
4391469|NCT00086281|7170086|FG007|Phase 1|Serious Adverse Event|0
4391470|NCT00086281|7170087|FG008|Phase 1|Serious Adverse Event|0
4391471|NCT00086281|7170088|FG009|Phase 1|Serious Adverse Event|0
4391472|NCT00086281|7170089|FG010|Phase 1|Serious Adverse Event|0
4391473|NCT00086281|7170090|FG011|Phase 1|Serious Adverse Event|0
4391474|NCT00086281|7170091|FG012|Phase 1|Serious Adverse Event|0
4391475|NCT00086281|7170092|FG013|Phase 1|Serious Adverse Event|0
4391476|NCT00086281|7170093|FG014|Phase 1|Serious Adverse Event|1
4391477|NCT00086281|7170079|FG000|Phase 2|Adverse Event|0
4391478|NCT00086281|7170080|FG001|Phase 2|Adverse Event|0
4391479|NCT00086281|7170081|FG002|Phase 2|Adverse Event|0
4391480|NCT00086281|7170082|FG003|Phase 2|Adverse Event|0
4391481|NCT00086281|7170083|FG004|Phase 2|Adverse Event|0
4391482|NCT00086281|7170084|FG005|Phase 2|Adverse Event|0
4391483|NCT00086281|7170085|FG006|Phase 2|Adverse Event|0
4628352|NCT01859390|7495455|FG001|Overall Study|Insufficient Sputum Collected|3
4628353|NCT01859390|7495454|FG000|Overall Study|Sample Missing Collection Date|0
4712103|NCT02919696|7638373|FG000|Overall Study|Withdrawal by Subject|2
4391484|NCT00086281|7170086|FG007|Phase 2|Adverse Event|0
4391485|NCT00086281|7170087|FG008|Phase 2|Adverse Event|0
4391486|NCT00086281|7170088|FG009|Phase 2|Adverse Event|0
4391487|NCT00086281|7170089|FG010|Phase 2|Adverse Event|0
4391488|NCT00086281|7170090|FG011|Phase 2|Adverse Event|0
4391489|NCT00086281|7170091|FG012|Phase 2|Adverse Event|1
4391490|NCT00086281|7170092|FG013|Phase 2|Adverse Event|1
4391491|NCT00086281|7170093|FG014|Phase 2|Adverse Event|0
4391492|NCT00086307|7170106|FG000|Overall Study|Lack of Efficacy|1
4391493|NCT00086307|7170107|FG001|Overall Study|Lack of Efficacy|1
4391494|NCT00086307|7170108|FG002|Overall Study|Lack of Efficacy|2
4391495|NCT00086307|7170106|FG000|Overall Study|Shortness of breath and muscle spasms|1
4391496|NCT00086307|7170107|FG001|Overall Study|Shortness of breath and muscle spasms|0
4391497|NCT00086307|7170108|FG002|Overall Study|Shortness of breath and muscle spasms|0
4391498|NCT00086307|7170106|FG000|Overall Study|Nausea and headaches|0
4391499|NCT00086307|7170107|FG001|Overall Study|Nausea and headaches|0
4391500|NCT00086307|7170108|FG002|Overall Study|Nausea and headaches|1
4391501|NCT00086307|7170106|FG000|Overall Study|Constipation and sleepiness|0
4391502|NCT00086307|7170107|FG001|Overall Study|Constipation and sleepiness|0
4391503|NCT00086307|7170108|FG002|Overall Study|Constipation and sleepiness|1
4391504|NCT00086307|7170106|FG000|Overall Study|Suicidal ideation|0
4391505|NCT00086307|7170107|FG001|Overall Study|Suicidal ideation|0
4391506|NCT00086307|7170108|FG002|Overall Study|Suicidal ideation|1
4391507|NCT00086307|7170106|FG000|Overall Study|Fatigue and difficulty falling asleep|0
4391508|NCT00086307|7170107|FG001|Overall Study|Fatigue and difficulty falling asleep|0
4391509|NCT00086307|7170108|FG002|Overall Study|Fatigue and difficulty falling asleep|1
4391510|NCT00086307|7170106|FG000|Overall Study|Withdrawal by Subject|0
4391511|NCT00086307|7170107|FG001|Overall Study|Withdrawal by Subject|0
4391512|NCT00086307|7170108|FG002|Overall Study|Withdrawal by Subject|2
4391513|NCT00086346|7170118|FG000|Randomization|Did not receive test article|4
4391514|NCT00086346|7170119|FG001|Randomization|Did not receive test article|4
4391515|NCT00086346|7170118|FG000|Patients Dosed With Test Article|Adverse Event|94
4391516|NCT00086346|7170119|FG001|Patients Dosed With Test Article|Adverse Event|11
4391517|NCT00086346|7170118|FG000|Patients Dosed With Test Article|Lost to Follow-up|1
4391518|NCT00086346|7170119|FG001|Patients Dosed With Test Article|Lost to Follow-up|3
4391519|NCT00086346|7170118|FG000|Patients Dosed With Test Article|Nonmedical event|7
4391520|NCT00086346|7170119|FG001|Patients Dosed With Test Article|Nonmedical event|3
4391521|NCT00086346|7170118|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16
4391522|NCT00086346|7170119|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3
4391523|NCT00086346|7170118|FG000|Patients Dosed With Test Article|Protocol Violation|11
4391524|NCT00086346|7170119|FG001|Patients Dosed With Test Article|Protocol Violation|3
4391525|NCT00086346|7170118|FG000|Patients Dosed With Test Article|Lack of Efficacy|11
4391526|NCT00086346|7170119|FG001|Patients Dosed With Test Article|Lack of Efficacy|0
4391527|NCT00086385|7170129|FG000|Overall Study|Death|2
4391528|NCT00086385|7170130|FG001|Overall Study|Death|2
4391529|NCT00086385|7170131|FG002|Overall Study|Death|1
4391530|NCT00086385|7170132|FG003|Overall Study|Death|1
4391531|NCT00086411|7170146|FG000|Overall Study|Lost to Follow-up|11
4391532|NCT00086411|7170147|FG001|Overall Study|Lost to Follow-up|11
4391533|NCT00086411|7170148|FG002|Overall Study|Lost to Follow-up|13
4391534|NCT00086411|7170149|FG003|Overall Study|Lost to Follow-up|12
4391535|NCT00086502|7170171|FG000|Overall Study|Adverse Event|11
4391536|NCT00086502|7170172|FG001|Overall Study|Adverse Event|2
4391537|NCT00086502|7170171|FG000|Overall Study|Lack of Efficacy|0
4391538|NCT00086502|7170172|FG001|Overall Study|Lack of Efficacy|2
4391539|NCT00086502|7170171|FG000|Overall Study|Lost to Follow-up|3
4391540|NCT00086502|7170172|FG001|Overall Study|Lost to Follow-up|1
4391541|NCT00086502|7170171|FG000|Overall Study|Physician Decision|1
4391542|NCT00086502|7170172|FG001|Overall Study|Physician Decision|1
4391543|NCT00086502|7170171|FG000|Overall Study|Pregnancy|0
4391544|NCT00086502|7170172|FG001|Overall Study|Pregnancy|1
4391545|NCT00086502|7170171|FG000|Overall Study|Protocol Violation|3
4391546|NCT00086502|7170172|FG001|Overall Study|Protocol Violation|3
4391547|NCT00086502|7170171|FG000|Overall Study|Withdrawal by Subject|5
4391548|NCT00086502|7170172|FG001|Overall Study|Withdrawal by Subject|6
4391549|NCT00086502|7170171|FG000|Overall Study|Patient Moved|1
4391550|NCT00086502|7170172|FG001|Overall Study|Patient Moved|1
4391551|NCT00086502|7170171|FG000|Overall Study|Protocol Discontinuation Criteria|1
4391552|NCT00086502|7170172|FG001|Overall Study|Protocol Discontinuation Criteria|3
4391553|NCT00086502|7170171|FG000|Overall Study|Patient Accidentally Unblinded|1
4391554|NCT00086502|7170172|FG001|Overall Study|Patient Accidentally Unblinded|0
4391555|NCT00086515|7170180|FG000|Phase A (Weeks 0-24)|Adverse Event|17
4391556|NCT00086515|7170181|FG001|Phase A (Weeks 0-24)|Adverse Event|9
4391557|NCT00086515|7170180|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7
4391558|NCT00086515|7170181|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13
4391559|NCT00086515|7170180|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4
4391560|NCT00086515|7170181|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5
4391561|NCT00086515|7170180|FG000|Phase A (Weeks 0-24)|Protocol Violation|3
4391562|NCT00086515|7170181|FG001|Phase A (Weeks 0-24)|Protocol Violation|1
4391563|NCT00086515|7170180|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10
4391564|NCT00086515|7170181|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10
4391565|NCT00086515|7170180|FG000|Phase A (Weeks 0-24)|Patient Moved|2
4391566|NCT00086515|7170181|FG001|Phase A (Weeks 0-24)|Patient Moved|3
4391567|NCT00086515|7170180|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4
4391568|NCT00086515|7170181|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3
4391569|NCT00086515|7170180|FG000|Phase A (Weeks 0-24)|Poor compliance|1
4391570|NCT00086515|7170181|FG001|Phase A (Weeks 0-24)|Poor compliance|0
4391571|NCT00086515|7170180|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0
4391572|NCT00086515|7170181|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1
4391573|NCT00086515|7170180|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1
4391574|NCT00086515|7170181|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0
4391575|NCT00086515|7170180|FG000|Phase A to Phase B Transition Period|Adverse Event|2
4391576|NCT00086515|7170181|FG001|Phase A to Phase B Transition Period|Adverse Event|1
4391577|NCT00086515|7170180|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2
4391578|NCT00086515|7170181|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2
4391579|NCT00086515|7170180|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1
4391580|NCT00086515|7170181|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0
4391581|NCT00086515|7170180|FG000|Phase A to Phase B Transition Period|Protocol Violation|0
4391582|NCT00086515|7170181|FG001|Phase A to Phase B Transition Period|Protocol Violation|1
4391583|NCT00086515|7170180|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16
4391584|NCT00086515|7170181|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23
4391585|NCT00086515|7170180|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1
4391586|NCT00086515|7170181|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1
4391587|NCT00086515|7170180|FG000|Phase A to Phase B Transition Period|Poor compliance|1
4391588|NCT00086515|7170181|FG001|Phase A to Phase B Transition Period|Poor compliance|0
4391589|NCT00086515|7170180|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1
4391590|NCT00086515|7170181|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0
4391591|NCT00086515|7170180|FG000|Phase B (Weeks 24-104)|Adverse Event|16
4391592|NCT00086515|7170181|FG001|Phase B (Weeks 24-104)|Adverse Event|10
4391593|NCT00086515|7170180|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94
4391594|NCT00086515|7170181|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19
4391595|NCT00086515|7170180|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13
4391596|NCT00086515|7170181|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4
4391597|NCT00086515|7170180|FG000|Phase B (Weeks 24-104)|Physician Decision|3
4391598|NCT00086515|7170181|FG001|Phase B (Weeks 24-104)|Physician Decision|0
4391599|NCT00086515|7170180|FG000|Phase B (Weeks 24-104)|Protocol Violation|1
4391600|NCT00086515|7170181|FG001|Phase B (Weeks 24-104)|Protocol Violation|0
4391601|NCT00086515|7170180|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15
4391602|NCT00086515|7170181|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5
4391603|NCT00086515|7170180|FG000|Phase B (Weeks 24-104)|Patient Moved|2
4391604|NCT00086515|7170181|FG001|Phase B (Weeks 24-104)|Patient Moved|2
4391605|NCT00086515|7170180|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5
4391606|NCT00086515|7170181|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3
4391607|NCT00086515|7170180|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36
4391608|NCT00086515|7170181|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10
4391609|NCT00086515|7170180|FG000|Phase B (Weeks 24-104)|Patient Died|3
4391610|NCT00086515|7170181|FG001|Phase B (Weeks 24-104)|Patient Died|1
4391611|NCT00086515|7170180|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0
4391612|NCT00086515|7170181|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1
4391613|NCT00086515|7170180|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1
4391614|NCT00086515|7170181|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0
4391615|NCT00086515|7170180|FG000|Phase B (Weeks 24-104)|Discontinued in error|1
4391616|NCT00086515|7170181|FG001|Phase B (Weeks 24-104)|Discontinued in error|0
4391617|NCT00086580|7170189|FG000|Treatment Period|Disease progression|9
4391618|NCT00086580|7170190|FG001|Treatment Period|Disease progression|8
4391619|NCT00086580|7170189|FG000|Treatment Period|Unable to comply with protocol|3
4391620|NCT00086580|7170190|FG001|Treatment Period|Unable to comply with protocol|1
4391621|NCT00086580|7170189|FG000|Treatment Period|Withdrawal by Subject|7
4391622|NCT00086580|7170190|FG001|Treatment Period|Withdrawal by Subject|8
4391623|NCT00086580|7170189|FG000|Treatment Period|Physician Decision|13
4391624|NCT00086580|7170190|FG001|Treatment Period|Physician Decision|7
4391625|NCT00086580|7170189|FG000|Treatment Period|AE - not treatment related|7
4391626|NCT00086580|7170190|FG001|Treatment Period|AE - not treatment related|7
4391627|NCT00086580|7170189|FG000|Treatment Period|Toxicity - treatment related|15
4391628|NCT00086580|7170190|FG001|Treatment Period|Toxicity - treatment related|15
4391629|NCT00086580|7170189|FG000|Treatment Period|Anemia or thrombocytopenia|1
4391630|NCT00086580|7170190|FG001|Treatment Period|Anemia or thrombocytopenia|4
4391631|NCT00086580|7170189|FG000|Treatment Period|Death|5
4391632|NCT00086580|7170190|FG001|Treatment Period|Death|7
4391633|NCT00086580|7170189|FG000|Treatment Period|Other|5
4391634|NCT00086580|7170190|FG001|Treatment Period|Other|3
4391635|NCT00086580|7170189|FG000|Follow-up Period|Disease progression|72
4391636|NCT00086580|7170190|FG001|Follow-up Period|Disease progression|99
4391637|NCT00086580|7170189|FG000|Follow-up Period|Unable to comply with protocol|5
4391638|NCT00086580|7170190|FG001|Follow-up Period|Unable to comply with protocol|0
4391639|NCT00086580|7170189|FG000|Follow-up Period|Withdrawal by Subject|6
4391640|NCT00086580|7170190|FG001|Follow-up Period|Withdrawal by Subject|6
4391641|NCT00086580|7170189|FG000|Follow-up Period|Physician Decision|0
4391642|NCT00086580|7170190|FG001|Follow-up Period|Physician Decision|1
4391643|NCT00086580|7170189|FG000|Follow-up Period|AE - not related|1
4391644|NCT00086580|7170190|FG001|Follow-up Period|AE - not related|0
4391645|NCT00086580|7170189|FG000|Follow-up Period|Death|13
4391646|NCT00086580|7170190|FG001|Follow-up Period|Death|7
4391647|NCT00086580|7170189|FG000|Follow-up Period|Other|7
4391648|NCT00086580|7170190|FG001|Follow-up Period|Other|6
4510778|NCT00922974|7319667|FG001|Phase II Component|Protocol Violation|0
4391649|NCT00086580|7170189|FG000|Observation Period|Unable to comply with protocol|1
4391650|NCT00086580|7170190|FG001|Observation Period|Unable to comply with protocol|1
4391651|NCT00086580|7170189|FG000|Observation Period|Withdrawal by Subject|4
4391652|NCT00086580|7170190|FG001|Observation Period|Withdrawal by Subject|2
4391653|NCT00086580|7170189|FG000|Observation Period|Death|33
4391654|NCT00086580|7170190|FG001|Observation Period|Death|55
4391655|NCT00086580|7170189|FG000|Observation Period|Other|8
4391656|NCT00086580|7170190|FG001|Observation Period|Other|7
4391657|NCT00086619|7170198|FG000|Overall Study|Withdrawal by Subject|6
4391658|NCT00086619|7170199|FG001|Overall Study|Withdrawal by Subject|6
4391659|NCT00086619|7170198|FG000|Overall Study|Adverse Event|8
4391660|NCT00086619|7170199|FG001|Overall Study|Adverse Event|10
4391661|NCT00086619|7170198|FG000|Overall Study|Protocol Violation|1
4391662|NCT00086619|7170199|FG001|Overall Study|Protocol Violation|1
4391663|NCT00086684|7170208|FG000|Overall Study|Adverse Event|12
4391664|NCT00086684|7170209|FG001|Overall Study|Adverse Event|17
4391665|NCT00086684|7170210|FG002|Overall Study|Adverse Event|14
4391666|NCT00086684|7170208|FG000|Overall Study|Lack of Efficacy|6
4391667|NCT00086684|7170209|FG001|Overall Study|Lack of Efficacy|6
4391668|NCT00086684|7170210|FG002|Overall Study|Lack of Efficacy|5
4391669|NCT00086684|7170208|FG000|Overall Study|Lost to Follow-up|15
4391670|NCT00086684|7170209|FG001|Overall Study|Lost to Follow-up|8
4391671|NCT00086684|7170210|FG002|Overall Study|Lost to Follow-up|10
4391672|NCT00086684|7170208|FG000|Overall Study|Protocol Violation|8
4391673|NCT00086684|7170209|FG001|Overall Study|Protocol Violation|3
4391674|NCT00086684|7170210|FG002|Overall Study|Protocol Violation|0
4391675|NCT00086684|7170208|FG000|Overall Study|Withdrawal by Subject|0
4391676|NCT00086684|7170209|FG001|Overall Study|Withdrawal by Subject|4
4391677|NCT00086684|7170210|FG002|Overall Study|Withdrawal by Subject|10
4391678|NCT00086684|7170208|FG000|Overall Study|NONCOMPLIANCE|5
4391679|NCT00086684|7170209|FG001|Overall Study|NONCOMPLIANCE|7
4391680|NCT00086684|7170210|FG002|Overall Study|NONCOMPLIANCE|6
4391681|NCT00086684|7170208|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0
4391682|NCT00086684|7170209|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1
4391683|NCT00086684|7170210|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0
4391684|NCT00086684|7170208|FG000|Overall Study|WITHDRAWAL OF CONSENT|5
4391685|NCT00086684|7170209|FG001|Overall Study|WITHDRAWAL OF CONSENT|7
4391686|NCT00086684|7170210|FG002|Overall Study|WITHDRAWAL OF CONSENT|5
4391687|NCT00086684|7170208|FG000|Overall Study|Other|4
4391688|NCT00086684|7170209|FG001|Overall Study|Other|2
4391689|NCT00086684|7170210|FG002|Overall Study|Other|3
4391690|NCT00086996|7170229|FG000|Overall Study|Adverse Event|29
4391691|NCT00086996|7170229|FG000|Overall Study|Death|4
4391692|NCT00086996|7170229|FG000|Overall Study|progression/relapse|7
4391693|NCT00086996|7170229|FG000|Overall Study|Withdrawal by Subject|13
4391694|NCT00086996|7170229|FG000|Overall Study|Other|6
4391695|NCT00086996|7170229|FG000|Overall Study|not eligible|5
4391696|NCT00087126|7170242|FG000|Overall Study|Ineligible - second primary|1
4391697|NCT00087126|7170242|FG000|Overall Study|Never treated|1
4391698|NCT00087139|7170254|FG000|Overall Study|Adverse Event|18
4391699|NCT00087139|7170255|FG001|Overall Study|Adverse Event|17
4391700|NCT00087139|7170256|FG002|Overall Study|Adverse Event|13
4391701|NCT00087139|7170254|FG000|Overall Study|Death|2
4391702|NCT00087139|7170255|FG001|Overall Study|Death|1
4391703|NCT00087139|7170256|FG002|Overall Study|Death|0
4391704|NCT00087139|7170254|FG000|Overall Study|Withdrawal by Subject|3
4391705|NCT00087139|7170255|FG001|Overall Study|Withdrawal by Subject|2
4391706|NCT00087139|7170256|FG002|Overall Study|Withdrawal by Subject|2
4391707|NCT00087139|7170254|FG000|Overall Study|Physician Decision|1
4391708|NCT00087139|7170255|FG001|Overall Study|Physician Decision|1
4391709|NCT00087139|7170256|FG002|Overall Study|Physician Decision|1
4391710|NCT00087139|7170254|FG000|Overall Study|Disease progression|9
4391711|NCT00087139|7170255|FG001|Overall Study|Disease progression|19
4391712|NCT00087139|7170256|FG002|Overall Study|Disease progression|12
4391713|NCT00087139|7170254|FG000|Overall Study|Ineligible|4
4391714|NCT00087139|7170255|FG001|Overall Study|Ineligible|7
4391715|NCT00087139|7170256|FG002|Overall Study|Ineligible|4
4391716|NCT00087139|7170254|FG000|Overall Study|Symptomatic deterioration|1
4391717|NCT00087139|7170255|FG001|Overall Study|Symptomatic deterioration|1
4391718|NCT00087139|7170256|FG002|Overall Study|Symptomatic deterioration|3
4391719|NCT00087139|7170254|FG000|Overall Study|Use of coumadin|1
4391720|NCT00087139|7170255|FG001|Overall Study|Use of coumadin|0
4712104|NCT02919696|7638374|FG001|Overall Study|Withdrawal by Subject|1
4712105|NCT02919696|7638373|FG000|Overall Study|Sponsor Decision|1
4712106|NCT02919696|7638374|FG001|Overall Study|Sponsor Decision|1
4712107|NCT02919696|7638373|FG000|Overall Study|Never Treated|0
4391721|NCT00087139|7170256|FG002|Overall Study|Use of coumadin|0
4391722|NCT00087139|7170254|FG000|Overall Study|Response achieved|0
4391723|NCT00087139|7170255|FG001|Overall Study|Response achieved|1
4391724|NCT00087139|7170256|FG002|Overall Study|Response achieved|0
4391725|NCT00087139|7170254|FG000|Overall Study|Extradural disease|0
4391726|NCT00087139|7170255|FG001|Overall Study|Extradural disease|0
4712108|NCT02919696|7638374|FG001|Overall Study|Never Treated|1
4391727|NCT00087139|7170256|FG002|Overall Study|Extradural disease|1
4391728|NCT00087152|7170262|FG000|Overall Study|Ineligible|6
4510779|NCT00922974|7319666|FG000|Phase II Component|Not evaluable for treatment review|5
4510780|NCT00922974|7319667|FG001|Phase II Component|Not evaluable for treatment review|0
4391729|NCT00087438|7170267|FG000|Overall Study|Ineligible / No protocol treatment|4
4391730|NCT00087490|7170275|FG000|Overall Study|Death|6
4391731|NCT00087490|7170276|FG001|Overall Study|Death|4
4391732|NCT00087490|7170275|FG000|Overall Study|Adverse Event|3
4391733|NCT00087490|7170276|FG001|Overall Study|Adverse Event|8
4391734|NCT00087490|7170275|FG000|Overall Study|Lack of Efficacy|0
4391735|NCT00087490|7170276|FG001|Overall Study|Lack of Efficacy|2
4391736|NCT00087490|7170275|FG000|Overall Study|Protocol Violation or (/) Unspecified|214
4391737|NCT00087490|7170276|FG001|Overall Study|Protocol Violation or (/) Unspecified|201
4391738|NCT00087490|7170275|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28
4391739|NCT00087490|7170276|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36
4391740|NCT00087490|7170275|FG000|Overall Study|Randomized but not treated|7
4391741|NCT00087490|7170276|FG001|Overall Study|Randomized but not treated|18
4391742|NCT00087516|7170285|FG000|Overall Study|Adverse Event|10
4391743|NCT00087516|7170286|FG001|Overall Study|Adverse Event|10
4391744|NCT00087516|7170287|FG002|Overall Study|Adverse Event|3
4391745|NCT00087516|7170288|FG003|Overall Study|Adverse Event|6
4391746|NCT00087516|7170285|FG000|Overall Study|Lack of Efficacy|82
4391747|NCT00087516|7170286|FG001|Overall Study|Lack of Efficacy|80
4391748|NCT00087516|7170287|FG002|Overall Study|Lack of Efficacy|39
4391749|NCT00087516|7170288|FG003|Overall Study|Lack of Efficacy|29
4391750|NCT00087516|7170285|FG000|Overall Study|Lost to Follow-up|8
4391751|NCT00087516|7170286|FG001|Overall Study|Lost to Follow-up|6
4391752|NCT00087516|7170287|FG002|Overall Study|Lost to Follow-up|5
4391753|NCT00087516|7170288|FG003|Overall Study|Lost to Follow-up|5
4391754|NCT00087516|7170285|FG000|Overall Study|Protocol Violation|4
4391755|NCT00087516|7170286|FG001|Overall Study|Protocol Violation|8
4391756|NCT00087516|7170287|FG002|Overall Study|Protocol Violation|3
4391757|NCT00087516|7170288|FG003|Overall Study|Protocol Violation|6
4391758|NCT00087516|7170285|FG000|Overall Study|Withdrawal by Subject|16
4391759|NCT00087516|7170286|FG001|Overall Study|Withdrawal by Subject|27
4391760|NCT00087516|7170287|FG002|Overall Study|Withdrawal by Subject|11
4391761|NCT00087516|7170288|FG003|Overall Study|Withdrawal by Subject|12
4391762|NCT00087516|7170285|FG000|Overall Study|Site terminated|0
4391763|NCT00087516|7170286|FG001|Overall Study|Site terminated|2
4391764|NCT00087516|7170287|FG002|Overall Study|Site terminated|1
4391765|NCT00087516|7170288|FG003|Overall Study|Site terminated|0
4391766|NCT00087516|7170285|FG000|Overall Study|Protocol specified discontinuation|35
4391767|NCT00087516|7170286|FG001|Overall Study|Protocol specified discontinuation|33
4391768|NCT00087516|7170287|FG002|Overall Study|Protocol specified discontinuation|33
4391769|NCT00087516|7170288|FG003|Overall Study|Protocol specified discontinuation|26
4391770|NCT00087516|7170285|FG000|Overall Study|Patient moved|3
4391771|NCT00087516|7170286|FG001|Overall Study|Patient moved|2
4391772|NCT00087516|7170287|FG002|Overall Study|Patient moved|1
4391773|NCT00087516|7170288|FG003|Overall Study|Patient moved|0
4391774|NCT00087516|7170285|FG000|Overall Study|Patient was non-compliant|3
4391775|NCT00087516|7170286|FG001|Overall Study|Patient was non-compliant|1
4391776|NCT00087516|7170287|FG002|Overall Study|Patient was non-compliant|0
4391777|NCT00087516|7170288|FG003|Overall Study|Patient was non-compliant|0
4391778|NCT00087516|7170285|FG000|Overall Study|Recommendation of Primary Care Physician|0
4391779|NCT00087516|7170286|FG001|Overall Study|Recommendation of Primary Care Physician|0
4391780|NCT00087516|7170287|FG002|Overall Study|Recommendation of Primary Care Physician|0
4391781|NCT00087516|7170288|FG003|Overall Study|Recommendation of Primary Care Physician|1
4391782|NCT00087516|7170285|FG000|Overall Study|Other|0
4391783|NCT00087516|7170286|FG001|Overall Study|Other|0
4391784|NCT00087516|7170287|FG002|Overall Study|Other|1
4391785|NCT00087516|7170288|FG003|Overall Study|Other|0
4391786|NCT00087529|7170304|FG000|Overall Study|Death|1
4391787|NCT00087529|7170305|FG001|Overall Study|Death|0
4391788|NCT00087529|7170304|FG000|Overall Study|Adverse Event|0
4391789|NCT00087529|7170305|FG001|Overall Study|Adverse Event|8
4391790|NCT00087529|7170304|FG000|Overall Study|Pregnancy|0
4391791|NCT00087529|7170305|FG001|Overall Study|Pregnancy|1
4391792|NCT00087529|7170304|FG000|Overall Study|Lost to Follow-up|2
4391793|NCT00087529|7170305|FG001|Overall Study|Lost to Follow-up|3
4391794|NCT00087529|7170304|FG000|Overall Study|Participant Decision|14
4391795|NCT00087529|7170305|FG001|Overall Study|Participant Decision|37
4391796|NCT00087529|7170304|FG000|Overall Study|Physician Decision|4
4391797|NCT00087529|7170305|FG001|Overall Study|Physician Decision|8
4391798|NCT00087529|7170304|FG000|Overall Study|Initiation of Excluded Therapy|0
4391799|NCT00087529|7170305|FG001|Overall Study|Initiation of Excluded Therapy|1
4391800|NCT00087529|7170304|FG000|Overall Study|Participant Noncompliance|0
4391801|NCT00087529|7170305|FG001|Overall Study|Participant Noncompliance|1
4391802|NCT00087529|7170304|FG000|Overall Study|Disease Progression|5
4391803|NCT00087529|7170305|FG001|Overall Study|Disease Progression|4
4391804|NCT00087529|7170304|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5
4391805|NCT00087529|7170305|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5
4391806|NCT00087555|7170314|FG000|Overall Study|Adverse Event|3
4391807|NCT00087555|7170315|FG001|Overall Study|Adverse Event|6
4391808|NCT00087555|7170316|FG002|Overall Study|Adverse Event|14
4391809|NCT00087555|7170314|FG000|Overall Study|Lost to Follow-up|0
4391810|NCT00087555|7170315|FG001|Overall Study|Lost to Follow-up|1
4391811|NCT00087555|7170316|FG002|Overall Study|Lost to Follow-up|1
4391812|NCT00087555|7170314|FG000|Overall Study|Non - Compliance|1
4391813|NCT00087555|7170315|FG001|Overall Study|Non - Compliance|0
4391814|NCT00087555|7170316|FG002|Overall Study|Non - Compliance|0
4391815|NCT00087555|7170314|FG000|Overall Study|Protocol Violation|0
4391816|NCT00087555|7170315|FG001|Overall Study|Protocol Violation|0
4391817|NCT00087555|7170316|FG002|Overall Study|Protocol Violation|2
4391818|NCT00087555|7170314|FG000|Overall Study|Screen Failure|1
4391819|NCT00087555|7170315|FG001|Overall Study|Screen Failure|1
4391820|NCT00087555|7170316|FG002|Overall Study|Screen Failure|0
4391821|NCT00087555|7170314|FG000|Overall Study|Pregnancy|0
4391822|NCT00087555|7170315|FG001|Overall Study|Pregnancy|1
4391823|NCT00087555|7170316|FG002|Overall Study|Pregnancy|1
4391824|NCT00087555|7170314|FG000|Overall Study|Withdrawal by Subject|3
4391825|NCT00087555|7170315|FG001|Overall Study|Withdrawal by Subject|2
4391826|NCT00087555|7170316|FG002|Overall Study|Withdrawal by Subject|1
4391827|NCT00087555|7170314|FG000|Overall Study|Lack of Efficacy|2
4391828|NCT00087555|7170315|FG001|Overall Study|Lack of Efficacy|0
4391829|NCT00087555|7170316|FG002|Overall Study|Lack of Efficacy|1
4391830|NCT00087555|7170314|FG000|Overall Study|Non Compliance|0
4391831|NCT00087555|7170315|FG001|Overall Study|Non Compliance|0
4391832|NCT00087555|7170316|FG002|Overall Study|Non Compliance|1
4391833|NCT00087555|7170314|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1
4391834|NCT00087555|7170315|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0
4391835|NCT00087555|7170316|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0
4391836|NCT00087555|7170314|FG000|Overall Study|Patient wanted to go back on Med|1
4391837|NCT00087555|7170315|FG001|Overall Study|Patient wanted to go back on Med|0
4391838|NCT00087555|7170316|FG002|Overall Study|Patient wanted to go back on Med|0
4391839|NCT00087568|7170326|FG000|Overall Study|Adverse Event|4
4391840|NCT00087568|7170327|FG001|Overall Study|Adverse Event|0
4628354|NCT01859390|7495455|FG001|Overall Study|Sample Missing Collection Date|1
4391841|NCT00087568|7170326|FG000|Overall Study|Withdrawal by Subject|1
4391842|NCT00087568|7170327|FG001|Overall Study|Withdrawal by Subject|1
4391843|NCT00087568|7170326|FG000|Overall Study|Lost to Follow-up|1
4391844|NCT00087568|7170327|FG001|Overall Study|Lost to Follow-up|0
4391845|NCT00087568|7170326|FG000|Overall Study|Lack of Efficacy|24
4391846|NCT00087568|7170327|FG001|Overall Study|Lack of Efficacy|1
4391847|NCT00087594|7170335|FG000|Overall Study|Adverse Event|2
4391848|NCT00087594|7170336|FG001|Overall Study|Adverse Event|3
4391849|NCT00087594|7170335|FG000|Overall Study|Lost to Follow-up|0
4391850|NCT00087594|7170336|FG001|Overall Study|Lost to Follow-up|2
4391851|NCT00087594|7170335|FG000|Overall Study|Withdrawal by Subject|4
4391852|NCT00087594|7170336|FG001|Overall Study|Withdrawal by Subject|2
4391853|NCT00087594|7170335|FG000|Overall Study|Lack of Efficacy|2
4391854|NCT00087594|7170336|FG001|Overall Study|Lack of Efficacy|5
4391855|NCT00087607|7170344|FG000|Overall Study|Adverse Event|14
4391856|NCT00087607|7170345|FG001|Overall Study|Adverse Event|24
4391857|NCT00087607|7170344|FG000|Overall Study|Death|0
4391858|NCT00087607|7170345|FG001|Overall Study|Death|1
4391859|NCT00087607|7170344|FG000|Overall Study|Insufficient Therapeutic Response|53
4391860|NCT00087607|7170345|FG001|Overall Study|Insufficient Therapeutic Response|42
4391861|NCT00087607|7170344|FG000|Overall Study|Failure to return|21
4391862|NCT00087607|7170345|FG001|Overall Study|Failure to return|17
4391863|NCT00087607|7170344|FG000|Overall Study|Withdrew Consent|12
4391864|NCT00087607|7170345|FG001|Overall Study|Withdrew Consent|16
4391865|NCT00087607|7170344|FG000|Overall Study|Administrative|12
4391866|NCT00087607|7170345|FG001|Overall Study|Administrative|12
4391867|NCT00087607|7170344|FG000|Overall Study|Refused Treatment|5
4391868|NCT00087607|7170345|FG001|Overall Study|Refused Treatment|7
4391869|NCT00087607|7170344|FG000|Overall Study|Other Protocol Violation|5
4391870|NCT00087607|7170345|FG001|Overall Study|Other Protocol Violation|2
4391871|NCT00087607|7170344|FG000|Overall Study|Violation of Selection Criteria at Entry|0
4391872|NCT00087607|7170345|FG001|Overall Study|Violation of Selection Criteria at Entry|1
4391873|NCT00087646|7170368|FG000|Overall Study|Adverse Event|37
4391874|NCT00087646|7170369|FG001|Overall Study|Adverse Event|6
4628355|NCT01859390|7495454|FG000|Overall Study|Tube Cracked|0
4628356|NCT01859390|7495455|FG001|Overall Study|Tube Cracked|2
4628357|NCT01859390|7495454|FG000|Overall Study|Shipment Error|0
4628358|NCT01859390|7495455|FG001|Overall Study|Shipment Error|1
4628359|NCT01859403|7495463|FG000|Primary Endpoint Measure|Lost to Follow-up|0
4628360|NCT01859403|7495464|FG001|Primary Endpoint Measure|Lost to Follow-up|2
4628361|NCT01859403|7495463|FG000|Primary Endpoint Measure|Withdrawal by Subject|1
4628362|NCT01859403|7495464|FG001|Primary Endpoint Measure|Withdrawal by Subject|1
4628363|NCT01859403|7495463|FG000|Primary Endpoint Measure|Physician Decision|0
4628364|NCT01859403|7495464|FG001|Primary Endpoint Measure|Physician Decision|1
4628365|NCT01859403|7495463|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6
4628366|NCT01859403|7495464|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8
4628367|NCT01859494|7495470|FG000|Overall Study|Adverse Event|1
4628368|NCT01859507|7495474|FG000|Overall Study|left the country|4
4628369|NCT01859598|7495479|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742
4628370|NCT01859702|7495493|FG000|Overall Study|Protocol deviation|3
4628371|NCT01859702|7495493|FG000|Overall Study|Adverse Event|2
4391875|NCT00087646|7170370|FG002|Overall Study|Adverse Event|18
4391876|NCT00087646|7170371|FG003|Overall Study|Adverse Event|20
4391877|NCT00087646|7170368|FG000|Overall Study|Death|0
4391878|NCT00087646|7170369|FG001|Overall Study|Death|1
4628372|NCT01859715|7495500|FG000|Overall Study|No 2nd VAS|16
4628373|NCT01859715|7495501|FG001|Overall Study|No 2nd VAS|8
4628374|NCT01859715|7495502|FG002|Overall Study|No 2nd VAS|23
4628375|NCT01859741|7495520|FG000|Overall Study|Death|3
4628376|NCT01859741|7495521|FG001|Overall Study|Death|2
4628377|NCT01859741|7495522|FG002|Overall Study|Death|4
4628378|NCT01859741|7495523|FG003|Overall Study|Death|3
4628379|NCT01859741|7495524|FG004|Overall Study|Death|5
4628380|NCT01859741|7495525|FG005|Overall Study|Death|4
4628381|NCT01859741|7495526|FG006|Overall Study|Death|51
4628382|NCT01859741|7495527|FG007|Overall Study|Death|51
4628383|NCT01859741|7495520|FG000|Overall Study|Lost to Follow-up|0
4628384|NCT01859741|7495521|FG001|Overall Study|Lost to Follow-up|0
4628385|NCT01859741|7495522|FG002|Overall Study|Lost to Follow-up|0
4628386|NCT01859741|7495523|FG003|Overall Study|Lost to Follow-up|0
4391879|NCT00087646|7170370|FG002|Overall Study|Death|0
4391880|NCT00087646|7170371|FG003|Overall Study|Death|0
4391881|NCT00087646|7170368|FG000|Overall Study|Withdrawal by Subject|6
4391882|NCT00087646|7170369|FG001|Overall Study|Withdrawal by Subject|1
4391883|NCT00087646|7170370|FG002|Overall Study|Withdrawal by Subject|2
4391884|NCT00087646|7170371|FG003|Overall Study|Withdrawal by Subject|2
4391885|NCT00087646|7170368|FG000|Overall Study|Insufficient therapeutic response|64
4391886|NCT00087646|7170369|FG001|Overall Study|Insufficient therapeutic response|24
4391887|NCT00087646|7170370|FG002|Overall Study|Insufficient therapeutic response|38
4391888|NCT00087646|7170371|FG003|Overall Study|Insufficient therapeutic response|51
4391889|NCT00087646|7170368|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13
4391890|NCT00087646|7170369|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6
4391891|NCT00087646|7170370|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4
4391892|NCT00087646|7170371|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5
4391893|NCT00087646|7170368|FG000|Overall Study|Failure to Return|5
4391894|NCT00087646|7170369|FG001|Overall Study|Failure to Return|2
4391895|NCT00087646|7170370|FG002|Overall Study|Failure to Return|2
4391896|NCT00087646|7170371|FG003|Overall Study|Failure to Return|3
4391897|NCT00087646|7170368|FG000|Overall Study|Administrative/Other|6
4391898|NCT00087646|7170369|FG001|Overall Study|Administrative/Other|1
4391899|NCT00087646|7170370|FG002|Overall Study|Administrative/Other|1
4391900|NCT00087646|7170371|FG003|Overall Study|Administrative/Other|2
4391901|NCT00087646|7170368|FG000|Overall Study|Other Protocol Violation|3
4391902|NCT00087646|7170369|FG001|Overall Study|Other Protocol Violation|1
4391903|NCT00087646|7170370|FG002|Overall Study|Other Protocol Violation|0
4391904|NCT00087646|7170371|FG003|Overall Study|Other Protocol Violation|0
4391905|NCT00087646|7170368|FG000|Overall Study|Violation of Selection Criteria at Entry|1
4391906|NCT00087646|7170369|FG001|Overall Study|Violation of Selection Criteria at Entry|0
4391907|NCT00087646|7170370|FG002|Overall Study|Violation of Selection Criteria at Entry|0
4391908|NCT00087646|7170371|FG003|Overall Study|Violation of Selection Criteria at Entry|1
4391909|NCT00087685|7170390|FG000|Overall Study|Adverse Event|5
4391910|NCT00087685|7170390|FG000|Overall Study|Non-Compliance|1
4391911|NCT00087685|7170390|FG000|Overall Study|Progressive Disease|5
4391912|NCT00087685|7170390|FG000|Overall Study|Withdrawal by Subject|3
4391913|NCT00087698|7170394|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14
4391914|NCT00087698|7170394|FG000|Overall Study|Death from Other Causes|3
4391915|NCT00087698|7170394|FG000|Overall Study|Adverse Event|4
4391916|NCT00087698|7170394|FG000|Overall Study|Withdrawal by Subject|4
4391917|NCT00087698|7170394|FG000|Overall Study|Lack of Efficacy, Physician Perception|3
4391918|NCT00087698|7170394|FG000|Overall Study|Protocol Entry Criteria Not Met|2
4391919|NCT00087698|7170394|FG000|Overall Study|Clinical Relapse|1
4391920|NCT00087698|7170394|FG000|Overall Study|Death from Study Disease|2
4391921|NCT00087698|7170394|FG000|Overall Study|Death from Study Drug Toxicity|2
4391922|NCT00087698|7170394|FG000|Overall Study|Protocol Violation|1
4391923|NCT00088153|7170400|FG000|Overall Study|Physician Decision|3
4391924|NCT00088153|7170401|FG001|Overall Study|Physician Decision|3
4391925|NCT00088153|7170400|FG000|Overall Study|Withdrawal by Subject|10
4391926|NCT00088153|7170401|FG001|Overall Study|Withdrawal by Subject|10
4391927|NCT00088153|7170400|FG000|Overall Study|Lost to Follow-up|11
4391928|NCT00088153|7170401|FG001|Overall Study|Lost to Follow-up|12
4391929|NCT00088166|7170409|FG000|Overall Study|Adverse Event|11
4391930|NCT00088166|7170410|FG001|Overall Study|Adverse Event|9
4391931|NCT00088166|7170409|FG000|Overall Study|Death|3
4391932|NCT00088166|7170410|FG001|Overall Study|Death|1
4391933|NCT00088166|7170409|FG000|Overall Study|Lost to Follow-up|0
4391934|NCT00088166|7170410|FG001|Overall Study|Lost to Follow-up|1
4391935|NCT00088166|7170409|FG000|Overall Study|Physician Decision|4
4628387|NCT01859741|7495524|FG004|Overall Study|Lost to Follow-up|0
4628388|NCT01859741|7495525|FG005|Overall Study|Lost to Follow-up|1
4628389|NCT01859741|7495526|FG006|Overall Study|Lost to Follow-up|0
4628390|NCT01859741|7495527|FG007|Overall Study|Lost to Follow-up|4
4391936|NCT00088166|7170410|FG001|Overall Study|Physician Decision|1
4391937|NCT00088166|7170409|FG000|Overall Study|Protocol Violation|1
4391938|NCT00088166|7170410|FG001|Overall Study|Protocol Violation|5
4391939|NCT00088166|7170409|FG000|Overall Study|Patient deterioration|29
4391940|NCT00088166|7170410|FG001|Overall Study|Patient deterioration|39
4391941|NCT00088166|7170409|FG000|Overall Study|Withdrawal by Subject|5
4391942|NCT00088166|7170410|FG001|Overall Study|Withdrawal by Subject|5
4628391|NCT01859741|7495520|FG000|Overall Study|Withdrawal by Subject|0
4391943|NCT00088205|7170416|FG000|Overall Study|Adverse Event|4
4391944|NCT00088205|7170416|FG000|Overall Study|Progressive Disease|51
4391945|NCT00088205|7170416|FG000|Overall Study|Physician Decision|1
4391946|NCT00088205|7170416|FG000|Overall Study|Death Due to Study Disease|4
4391947|NCT00088374|7170429|FG000|Overall Study|patient did not receive any 17AAG|1
4391948|NCT00088374|7170429|FG000|Overall Study|patient received <1 cycle only of 17AAG|1
4391949|NCT00088413|7170437|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0
4391950|NCT00088413|7170438|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0
4391951|NCT00088413|7170439|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1
4391952|NCT00088413|7170440|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0
4391953|NCT00088413|7170437|FG000|Overall Study|Adverse Events/Side Effects|0
4391954|NCT00088413|7170438|FG001|Overall Study|Adverse Events/Side Effects|1
4391955|NCT00088413|7170439|FG002|Overall Study|Adverse Events/Side Effects|1
4391956|NCT00088413|7170440|FG003|Overall Study|Adverse Events/Side Effects|0
4391957|NCT00088413|7170437|FG000|Overall Study|Refused trmt Off-study per pt wishes|0
4391958|NCT00088413|7170438|FG001|Overall Study|Refused trmt Off-study per pt wishes|1
4391959|NCT00088413|7170439|FG002|Overall Study|Refused trmt Off-study per pt wishes|1
4391960|NCT00088413|7170440|FG003|Overall Study|Refused trmt Off-study per pt wishes|0
4391961|NCT00088413|7170437|FG000|Overall Study|Off study due to missing a vaccine dose|1
4391962|NCT00088413|7170438|FG001|Overall Study|Off study due to missing a vaccine dose|0
4391963|NCT00088413|7170439|FG002|Overall Study|Off study due to missing a vaccine dose|0
4391964|NCT00088413|7170440|FG003|Overall Study|Off study due to missing a vaccine dose|0
4391965|NCT00088413|7170437|FG000|Overall Study|Death|0
4391966|NCT00088413|7170438|FG001|Overall Study|Death|1
4391967|NCT00088413|7170439|FG002|Overall Study|Death|0
4391968|NCT00088413|7170440|FG003|Overall Study|Death|0
4391969|NCT00088413|7170437|FG000|Overall Study|Progressive disease|9
4391970|NCT00088413|7170438|FG001|Overall Study|Progressive disease|11
4391971|NCT00088413|7170439|FG002|Overall Study|Progressive disease|8
4391972|NCT00088413|7170440|FG003|Overall Study|Progressive disease|14
4391973|NCT00088413|7170437|FG000|Overall Study|Other|0
4391974|NCT00088413|7170438|FG001|Overall Study|Other|1
4391975|NCT00088413|7170439|FG002|Overall Study|Other|0
4391976|NCT00088413|7170440|FG003|Overall Study|Other|0
4391977|NCT00088413|7170437|FG000|Overall Study|Patient unevaluable due to adverse event|0
4391978|NCT00088413|7170438|FG001|Overall Study|Patient unevaluable due to adverse event|0
4391979|NCT00088413|7170439|FG002|Overall Study|Patient unevaluable due to adverse event|1
4391980|NCT00088413|7170440|FG003|Overall Study|Patient unevaluable due to adverse event|0
4391981|NCT00088452|7170455|FG000|Overall Study|Did not receive intervention|1
4391982|NCT00088452|7170456|FG001|Overall Study|Did not receive intervention|0
4391983|NCT00088452|7170457|FG002|Overall Study|Did not receive intervention|1
4391984|NCT00088465|7170465|FG000|Overall Study|Withdrawal by Subject|290
4391985|NCT00088465|7170465|FG000|Overall Study|Adverse Event|77
4391986|NCT00088465|7170465|FG000|Overall Study|Lost to Follow-up|57
4391987|NCT00088465|7170465|FG000|Overall Study|Physician Decision|45
4391988|NCT00088465|7170465|FG000|Overall Study|Sponsor Decision|37
4391989|NCT00088465|7170465|FG000|Overall Study|Lack of Efficacy|27
4391990|NCT00088465|7170465|FG000|Overall Study|Protocol Violation|17
4391991|NCT00088465|7170465|FG000|Overall Study|Death|11
4391992|NCT00088530|7170471|FG000|Overall Study|Progressive/Relapsed Disease|28
4391993|NCT00088530|7170472|FG001|Overall Study|Progressive/Relapsed Disease|39
4391994|NCT00088530|7170471|FG000|Overall Study|Adverse Event|15
4391995|NCT00088530|7170472|FG001|Overall Study|Adverse Event|9
4391996|NCT00088530|7170471|FG000|Overall Study|Withdrawal by Subject|2
4391997|NCT00088530|7170472|FG001|Overall Study|Withdrawal by Subject|5
4391998|NCT00088530|7170471|FG000|Overall Study|Lost to Follow-up|2
4391999|NCT00088530|7170472|FG001|Overall Study|Lost to Follow-up|0
4392000|NCT00088530|7170471|FG000|Overall Study|Physician Decision|2
4392001|NCT00088530|7170472|FG001|Overall Study|Physician Decision|0
4392002|NCT00088530|7170471|FG000|Overall Study|Sponsor decision|0
4392003|NCT00088530|7170472|FG001|Overall Study|Sponsor decision|1
4392004|NCT00088530|7170471|FG000|Overall Study|Patient never treated|1
4392005|NCT00088530|7170472|FG001|Overall Study|Patient never treated|0
4392006|NCT00088595|7170478|FG000|Overall Study|Adverse Event|11
4392007|NCT00088595|7170478|FG000|Overall Study|Withdrawal by Subject|8
4392008|NCT00088595|7170478|FG000|Overall Study|Ongoing (After Core)|7
4392009|NCT00088595|7170478|FG000|Overall Study|New Cancer Therapy|2
4392010|NCT00088881|7170520|FG000|Step 1 - R-CHOP|Patient ineligible|9
4392011|NCT00088881|7170520|FG000|Step 1 - R-CHOP|Adverse Event|1
4392012|NCT00088881|7170520|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2
4392013|NCT00088881|7170520|FG000|Step 1 - R-CHOP|Physician Decision|1
4392014|NCT00088881|7170520|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1
4392015|NCT00088881|7170520|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8
4392016|NCT00088881|7170520|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3
4392017|NCT00088907|7170528|FG000|Randomized Study (Step 1)|Lack of Efficacy|55
4392018|NCT00088907|7170529|FG001|Randomized Study (Step 1)|Lack of Efficacy|62
4392019|NCT00088907|7170528|FG000|Randomized Study (Step 1)|Adverse Event|14
4392020|NCT00088907|7170529|FG001|Randomized Study (Step 1)|Adverse Event|19
4392021|NCT00088907|7170528|FG000|Randomized Study (Step 1)|Death|11
4392022|NCT00088907|7170529|FG001|Randomized Study (Step 1)|Death|12
4392023|NCT00088907|7170528|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10
4392024|NCT00088907|7170529|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15
4392025|NCT00088907|7170528|FG000|Randomized Study (Step 1)|complicating disease|3
4392026|NCT00088907|7170529|FG001|Randomized Study (Step 1)|complicating disease|1
4392027|NCT00088907|7170528|FG000|Randomized Study (Step 1)|unknown/not specify|24
4392028|NCT00088907|7170529|FG001|Randomized Study (Step 1)|unknown/not specify|13
4392029|NCT00088907|7170528|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19
4392030|NCT00088907|7170529|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12
4392031|NCT00088907|7170528|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16
4392032|NCT00088907|7170529|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0
4392033|NCT00088907|7170528|FG000|Single Gefitinib Treatment (Step 2)|Death|1
4392034|NCT00088907|7170529|FG001|Single Gefitinib Treatment (Step 2)|Death|0
4392035|NCT00088907|7170528|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2
4392036|NCT00088907|7170529|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0
4392037|NCT00088907|7170528|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5
4392038|NCT00088907|7170529|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0
4392039|NCT00089076|7170553|FG000|Overall Study|Alternate Therapy|1
4392040|NCT00089076|7170553|FG000|Overall Study|Withdrawal by Subject|2
4392041|NCT00089076|7170553|FG000|Overall Study|Progression|7
4392042|NCT00089284|7170566|FG000|Overall Study|Adverse event before starting treatment|0
4392043|NCT00089284|7170567|FG001|Overall Study|Adverse event before starting treatment|0
4392044|NCT00089284|7170568|FG002|Overall Study|Adverse event before starting treatment|0
4392045|NCT00089284|7170569|FG003|Overall Study|Adverse event before starting treatment|0
4392046|NCT00089284|7170570|FG004|Overall Study|Adverse event before starting treatment|0
4392047|NCT00089284|7170571|FG005|Overall Study|Adverse event before starting treatment|0
4392048|NCT00089284|7170572|FG006|Overall Study|Adverse event before starting treatment|1
4392049|NCT00089297|7170594|FG000|Overall Study|Adverse Event|9
4392050|NCT00089297|7170594|FG000|Overall Study|Death|1
4392051|NCT00089297|7170594|FG000|Overall Study|Withdrawal by Subject|12
4392052|NCT00089297|7170594|FG000|Overall Study|Disease progression|2
4392053|NCT00089297|7170594|FG000|Overall Study|Ineligible|11
4392054|NCT00089297|7170594|FG000|Overall Study|Secondary malignancy|1
4392055|NCT00089297|7170594|FG000|Overall Study|IRB approval not ready|1
4392056|NCT00089297|7170594|FG000|Overall Study|Non-compliance|1
4392057|NCT00089479|7170600|FG000|Overall Study|Death|108
4392058|NCT00089479|7170601|FG001|Overall Study|Death|75
4392059|NCT00089479|7170600|FG000|Overall Study|Withdrawal by Subject|86
4392060|NCT00089479|7170601|FG001|Overall Study|Withdrawal by Subject|107
4392061|NCT00089479|7170600|FG000|Overall Study|Lost to Follow-up|137
4392062|NCT00089479|7170601|FG001|Overall Study|Lost to Follow-up|107
4392063|NCT00089505|7170611|FG000|Overall Study|Death|4
4392064|NCT00089505|7170612|FG001|Overall Study|Death|1
4392065|NCT00089505|7170613|FG002|Overall Study|Death|5
4392066|NCT00089505|7170614|FG003|Overall Study|Death|8
4392067|NCT00089505|7170611|FG000|Overall Study|Withdrawal by Subject|3
4392068|NCT00089505|7170612|FG001|Overall Study|Withdrawal by Subject|0
4392069|NCT00089505|7170613|FG002|Overall Study|Withdrawal by Subject|6
4392070|NCT00089505|7170614|FG003|Overall Study|Withdrawal by Subject|6
4392071|NCT00089505|7170611|FG000|Overall Study|Lost to Follow-up|1
4392072|NCT00089505|7170612|FG001|Overall Study|Lost to Follow-up|1
4392073|NCT00089505|7170613|FG002|Overall Study|Lost to Follow-up|9
4392074|NCT00089505|7170614|FG003|Overall Study|Lost to Follow-up|7
4392075|NCT00089505|7170611|FG000|Overall Study|Physician Decision|1
4392076|NCT00089505|7170612|FG001|Overall Study|Physician Decision|0
4392077|NCT00089505|7170613|FG002|Overall Study|Physician Decision|0
4392078|NCT00089505|7170614|FG003|Overall Study|Physician Decision|0
4392079|NCT00089505|7170611|FG000|Overall Study|Protocol Violation|0
4392080|NCT00089505|7170612|FG001|Overall Study|Protocol Violation|0
4392081|NCT00089505|7170613|FG002|Overall Study|Protocol Violation|1
4392082|NCT00089505|7170614|FG003|Overall Study|Protocol Violation|0
4392083|NCT00089544|7170626|FG000|Overall Study|Ineligible|1
4392084|NCT00089544|7170627|FG001|Overall Study|Ineligible|0
4392085|NCT00089583|7170635|FG000|Overall Study|Adverse Event|0
4392086|NCT00089583|7170636|FG001|Overall Study|Adverse Event|3
4392087|NCT00089583|7170635|FG000|Overall Study|Insufficient Viral Load Response|5
4392088|NCT00089583|7170636|FG001|Overall Study|Insufficient Viral Load Response|5
4392089|NCT00089583|7170635|FG000|Overall Study|Withdrawal by Subject|0
4392090|NCT00089583|7170636|FG001|Overall Study|Withdrawal by Subject|4
4392091|NCT00089583|7170635|FG000|Overall Study|Participant (Par) Didn't Take Medication|1
4392092|NCT00089583|7170636|FG001|Overall Study|Participant (Par) Didn't Take Medication|0
4392093|NCT00089583|7170635|FG000|Overall Study|Participant Refused Study Medication|0
4392094|NCT00089583|7170636|FG001|Overall Study|Participant Refused Study Medication|2
4392095|NCT00089583|7170635|FG000|Overall Study|Non-Compliance|0
4392096|NCT00089583|7170636|FG001|Overall Study|Non-Compliance|4
4392097|NCT00089583|7170635|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0
4392098|NCT00089583|7170636|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3
4392099|NCT00089583|7170635|FG000|Overall Study|Participant Management Criteria Met|0
4392100|NCT00089583|7170636|FG001|Overall Study|Participant Management Criteria Met|1
4392101|NCT00089583|7170635|FG000|Overall Study|Reason Not Provided|0
4392102|NCT00089583|7170636|FG001|Overall Study|Reason Not Provided|1
4392103|NCT00089583|7170635|FG000|Overall Study|Protocol Violation|0
4712109|NCT02919761|7638386|FG000|Part 1: Open Label|Withdrawal by Subject|12
4392104|NCT00089583|7170636|FG001|Overall Study|Protocol Violation|3
4392105|NCT00089583|7170635|FG000|Overall Study|Principal Investigator Decision|0
4392106|NCT00089583|7170636|FG001|Overall Study|Principal Investigator Decision|10
4392107|NCT00089583|7170635|FG000|Overall Study|Start of Disallowed Medication|0
4392108|NCT00089583|7170636|FG001|Overall Study|Start of Disallowed Medication|1
4392109|NCT00089583|7170635|FG000|Overall Study|Necessity to Use Prohibited Drug|1
4392110|NCT00089583|7170636|FG001|Overall Study|Necessity to Use Prohibited Drug|0
4392111|NCT00089583|7170635|FG000|Overall Study|Participant Incarcerated|0
4392112|NCT00089583|7170636|FG001|Overall Study|Participant Incarcerated|1
4392113|NCT00089609|7170650|FG000|Overall Study|Withdrawal by Subject|3
4392114|NCT00089609|7170651|FG001|Overall Study|Withdrawal by Subject|1
4392115|NCT00089635|7170660|FG000|Overall Study|Adverse Event|2
4392116|NCT00089635|7170660|FG000|Overall Study|Death|17
4392117|NCT00089635|7170660|FG000|Overall Study|Disease Progression|12
4392118|NCT00089635|7170660|FG000|Overall Study|Lost to Follow-up|3
4392119|NCT00089635|7170660|FG000|Overall Study|Withdrawal by Subject|6
4392120|NCT00089635|7170660|FG000|Overall Study|Ineligibility determined|1
4392121|NCT00089635|7170660|FG000|Overall Study|Other|2
4392122|NCT00089648|7170664|FG000|Overall Study|Adverse Event|7
4392123|NCT00089648|7170664|FG000|Overall Study|Withdrawal by Subject|1
4392124|NCT00089648|7170664|FG000|Overall Study|Lack of Efficacy|33
4392125|NCT00089661|7170670|FG000|Overall Study|Adverse Event|0
4392126|NCT00089661|7170671|FG001|Overall Study|Adverse Event|2
4392127|NCT00089661|7170670|FG000|Overall Study|Death|1
4392128|NCT00089661|7170671|FG001|Overall Study|Death|0
4392129|NCT00089661|7170670|FG000|Overall Study|Lost to Follow-up|0
4392130|NCT00089661|7170671|FG001|Overall Study|Lost to Follow-up|3
4392131|NCT00089661|7170670|FG000|Overall Study|Withdrawal by Subject|11
4392132|NCT00089661|7170671|FG001|Overall Study|Withdrawal by Subject|9
4392133|NCT00089661|7170670|FG000|Overall Study|Disease progression|1
4392134|NCT00089661|7170671|FG001|Overall Study|Disease progression|3
4392135|NCT00089661|7170670|FG000|Overall Study|Ineligibility determined|4
4392136|NCT00089661|7170671|FG001|Overall Study|Ineligibility determined|4
4392137|NCT00089661|7170670|FG000|Overall Study|Noncompliance|2
4392138|NCT00089661|7170671|FG001|Overall Study|Noncompliance|4
4392139|NCT00089661|7170670|FG000|Overall Study|Other|2
4392140|NCT00089661|7170671|FG001|Overall Study|Other|1
4392141|NCT00089674|7170679|FG000|Overall Study|Physician Decision|4
4392142|NCT00089674|7170680|FG001|Overall Study|Physician Decision|2
4392143|NCT00089674|7170679|FG000|Overall Study|Adverse Event|23
4392144|NCT00089674|7170680|FG001|Overall Study|Adverse Event|29
4392145|NCT00089674|7170679|FG000|Overall Study|Withdrawal by Subject|143
4392146|NCT00089674|7170680|FG001|Overall Study|Withdrawal by Subject|127
4392147|NCT00089674|7170679|FG000|Overall Study|Death|43
4392148|NCT00089674|7170680|FG001|Overall Study|Death|43
4392149|NCT00089674|7170679|FG000|Overall Study|Disease progression|21
4392150|NCT00089674|7170680|FG001|Overall Study|Disease progression|23
4392151|NCT00089674|7170679|FG000|Overall Study|Ineligibility determined|8
4392152|NCT00089674|7170680|FG001|Overall Study|Ineligibility determined|10
4392153|NCT00089674|7170679|FG000|Overall Study|Lost to Follow-up|21
4392154|NCT00089674|7170680|FG001|Overall Study|Lost to Follow-up|17
4392155|NCT00089674|7170679|FG000|Overall Study|Noncompliance|7
4392156|NCT00089674|7170680|FG001|Overall Study|Noncompliance|3
4392157|NCT00089674|7170679|FG000|Overall Study|Other|5
4392158|NCT00089674|7170680|FG001|Overall Study|Other|9
4392159|NCT00089674|7170679|FG000|Overall Study|Requirement for alternative therapy|14
4392160|NCT00089674|7170680|FG001|Overall Study|Requirement for alternative therapy|4
4392161|NCT00089778|7170700|FG000|Overall Study|Protocol Violation|0
4392162|NCT00089778|7170701|FG001|Overall Study|Protocol Violation|0
4392163|NCT00089778|7170702|FG002|Overall Study|Protocol Violation|1
4392164|NCT00089843|7170716|FG000|Overall Study|Withdrawal by Subject|1
4392165|NCT00089843|7170717|FG001|Overall Study|Withdrawal by Subject|4
4392166|NCT00089843|7170718|FG002|Overall Study|Withdrawal by Subject|5
4392167|NCT00089843|7170719|FG003|Overall Study|Withdrawal by Subject|6
4392168|NCT00089843|7170716|FG000|Overall Study|Physician Decision|1
4392169|NCT00089843|7170717|FG001|Overall Study|Physician Decision|0
4392170|NCT00089843|7170718|FG002|Overall Study|Physician Decision|0
4392171|NCT00089843|7170719|FG003|Overall Study|Physician Decision|1
4392172|NCT00089973|7170729|FG000|Overall Study|Adverse Event|3
4392173|NCT00089973|7170729|FG000|Overall Study|Withdrawal by Subject|1
4392174|NCT00089973|7170729|FG000|Overall Study|Disease progression|45
4392175|NCT00089973|7170729|FG000|Overall Study|Death|1
4392176|NCT00089986|7170736|FG000|Overall Study|Adverse Event|6
4392177|NCT00089986|7170737|FG001|Overall Study|Adverse Event|9
4392178|NCT00089986|7170738|FG002|Overall Study|Adverse Event|6
4392179|NCT00089986|7170736|FG000|Overall Study|Lost to Follow-up|3
4392180|NCT00089986|7170737|FG001|Overall Study|Lost to Follow-up|1
4392181|NCT00089986|7170738|FG002|Overall Study|Lost to Follow-up|1
4392182|NCT00089986|7170736|FG000|Overall Study|Protocol Violation|0
4392183|NCT00089986|7170737|FG001|Overall Study|Protocol Violation|1
4392184|NCT00089986|7170738|FG002|Overall Study|Protocol Violation|0
4392185|NCT00089986|7170736|FG000|Overall Study|Patient transferred to another hospital|2
4392186|NCT00089986|7170737|FG001|Overall Study|Patient transferred to another hospital|1
4392187|NCT00089986|7170738|FG002|Overall Study|Patient transferred to another hospital|0
4392188|NCT00089986|7170736|FG000|Overall Study|Subject withdrew but agreed follow up|1
4392189|NCT00089986|7170737|FG001|Overall Study|Subject withdrew but agreed follow up|2
4392190|NCT00089986|7170738|FG002|Overall Study|Subject withdrew but agreed follow up|0
4392191|NCT00089986|7170736|FG000|Overall Study|Hemohlobin stopping rule|0
4392192|NCT00089986|7170737|FG001|Overall Study|Hemohlobin stopping rule|1
4392193|NCT00089986|7170738|FG002|Overall Study|Hemohlobin stopping rule|0
4392194|NCT00089986|7170736|FG000|Overall Study|Investigator decision to withdrew|0
4392195|NCT00089986|7170737|FG001|Overall Study|Investigator decision to withdrew|1
4392196|NCT00089986|7170738|FG002|Overall Study|Investigator decision to withdrew|0
4392197|NCT00089986|7170736|FG000|Overall Study|Enrollment in another study|0
4392198|NCT00089986|7170737|FG001|Overall Study|Enrollment in another study|1
4392199|NCT00089986|7170738|FG002|Overall Study|Enrollment in another study|0
4392200|NCT00089986|7170736|FG000|Overall Study|Family decision|0
4392201|NCT00089986|7170737|FG001|Overall Study|Family decision|1
4392202|NCT00089986|7170738|FG002|Overall Study|Family decision|0
4392203|NCT00089986|7170736|FG000|Overall Study|Do not resuscitate (DNR)|0
4392204|NCT00089986|7170737|FG001|Overall Study|Do not resuscitate (DNR)|0
4392205|NCT00089986|7170738|FG002|Overall Study|Do not resuscitate (DNR)|1
4392206|NCT00089986|7170736|FG000|Overall Study|Withdrawal by Subject|3
4392207|NCT00089986|7170737|FG001|Overall Study|Withdrawal by Subject|6
4392208|NCT00089986|7170738|FG002|Overall Study|Withdrawal by Subject|2
4392209|NCT00089999|7170748|FG000|Overall Study|Adverse Event|4
4392210|NCT00089999|7170749|FG001|Overall Study|Adverse Event|7
4392211|NCT00089999|7170748|FG000|Overall Study|Withdrawal by Subject|0
4392212|NCT00089999|7170749|FG001|Overall Study|Withdrawal by Subject|4
4392213|NCT00089999|7170748|FG000|Overall Study|Lost to Follow-up|2
4392214|NCT00089999|7170749|FG001|Overall Study|Lost to Follow-up|1
4392215|NCT00089999|7170748|FG000|Overall Study|Radiological Progression of Cancer|52
4392216|NCT00089999|7170749|FG001|Overall Study|Radiological Progression of Cancer|44
4392217|NCT00089999|7170748|FG000|Overall Study|Symptomatic Progression of Cancer|2
4392218|NCT00089999|7170749|FG001|Overall Study|Symptomatic Progression of Cancer|5
4392219|NCT00089999|7170748|FG000|Overall Study|Death|3
4392220|NCT00089999|7170749|FG001|Overall Study|Death|3
4392221|NCT00089999|7170748|FG000|Overall Study|Poor General Condition|1
4392222|NCT00089999|7170749|FG001|Overall Study|Poor General Condition|0
4392223|NCT00089999|7170748|FG000|Overall Study|Clinical Progression|1
4392224|NCT00089999|7170749|FG001|Overall Study|Clinical Progression|2
4392225|NCT00089999|7170748|FG000|Overall Study|Physician Decision|2
4392226|NCT00089999|7170749|FG001|Overall Study|Physician Decision|2
4392227|NCT00089999|7170748|FG000|Overall Study|Patient Underwent Surgery|2
4392228|NCT00089999|7170749|FG001|Overall Study|Patient Underwent Surgery|0
4392229|NCT00089999|7170748|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0
4392230|NCT00089999|7170749|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1
4392231|NCT00090103|7170780|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211
4392232|NCT00090103|7170781|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185
4392233|NCT00090103|7170782|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210
4392234|NCT00090103|7170780|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114
4392235|NCT00090103|7170781|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160
4392236|NCT00090103|7170782|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148
4392237|NCT00090103|7170780|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53
4392238|NCT00090103|7170781|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48
4392239|NCT00090103|7170782|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58
4392240|NCT00090103|7170780|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29
4392241|NCT00090103|7170781|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29
4392242|NCT00090103|7170782|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34
4392243|NCT00090103|7170780|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53
4392244|NCT00090103|7170781|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71
4392245|NCT00090103|7170782|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104
4392246|NCT00090103|7170780|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7
4392247|NCT00090103|7170781|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2
4392248|NCT00090103|7170782|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8
4392249|NCT00090103|7170780|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7
4392250|NCT00090103|7170781|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7
4392251|NCT00090103|7170782|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4
4392252|NCT00090103|7170780|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6
4392253|NCT00090103|7170781|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4
4392254|NCT00090103|7170782|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7
4392255|NCT00090103|7170780|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3
4392256|NCT00090103|7170781|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7
4392257|NCT00090103|7170782|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19
4392258|NCT00090103|7170780|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2
4392259|NCT00090103|7170781|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0
4392260|NCT00090103|7170782|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4
4392261|NCT00090103|7170780|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2
4392262|NCT00090103|7170781|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3
4392263|NCT00090103|7170782|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6
4392264|NCT00090103|7170780|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2
4392265|NCT00090103|7170781|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2
4392266|NCT00090103|7170782|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8
4392267|NCT00090103|7170780|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2
4392268|NCT00090103|7170781|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0
4392269|NCT00090103|7170782|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0
4392270|NCT00090103|7170780|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1
4392271|NCT00090103|7170781|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0
4392272|NCT00090103|7170782|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0
4392273|NCT00090103|7170780|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1
4392274|NCT00090103|7170781|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0
4392275|NCT00090103|7170782|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0
4392276|NCT00090103|7170780|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1
4392277|NCT00090103|7170781|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0
4392278|NCT00090103|7170782|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0
4392279|NCT00090103|7170780|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1
4392280|NCT00090103|7170781|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0
4392281|NCT00090103|7170782|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5
4392282|NCT00090103|7170780|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1
4392283|NCT00090103|7170781|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0
4392284|NCT00090103|7170782|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0
4392285|NCT00090103|7170780|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1
4392286|NCT00090103|7170781|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0
4392287|NCT00090103|7170782|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0
4392288|NCT00090103|7170780|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0
4392289|NCT00090103|7170781|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2
4392290|NCT00090103|7170782|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0
4392291|NCT00090103|7170780|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0
4392292|NCT00090103|7170781|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1
4392293|NCT00090103|7170782|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0
4392294|NCT00090103|7170780|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0
4392295|NCT00090103|7170781|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1
4392296|NCT00090103|7170782|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1
4392297|NCT00090103|7170780|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0
4392298|NCT00090103|7170781|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2
4392299|NCT00090103|7170782|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0
4392300|NCT00090103|7170780|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0
4392301|NCT00090103|7170781|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1
4392302|NCT00090103|7170782|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0
4392303|NCT00090103|7170780|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0
4392304|NCT00090103|7170781|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1
4392305|NCT00090103|7170782|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0
4392306|NCT00090103|7170780|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0
4392307|NCT00090103|7170781|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1
4628392|NCT01859741|7495521|FG001|Overall Study|Withdrawal by Subject|1
4628393|NCT01859741|7495522|FG002|Overall Study|Withdrawal by Subject|2
4628394|NCT01859741|7495523|FG003|Overall Study|Withdrawal by Subject|0
4628395|NCT01859741|7495524|FG004|Overall Study|Withdrawal by Subject|0
4628396|NCT01859741|7495525|FG005|Overall Study|Withdrawal by Subject|1
4628397|NCT01859741|7495526|FG006|Overall Study|Withdrawal by Subject|1
4628398|NCT01859741|7495527|FG007|Overall Study|Withdrawal by Subject|1
4628399|NCT01859741|7495520|FG000|Overall Study|Study Terminated by Sponsor|0
4628400|NCT01859741|7495521|FG001|Overall Study|Study Terminated by Sponsor|0
4628401|NCT01859741|7495522|FG002|Overall Study|Study Terminated by Sponsor|0
4628402|NCT01859741|7495523|FG003|Overall Study|Study Terminated by Sponsor|0
4628403|NCT01859741|7495524|FG004|Overall Study|Study Terminated by Sponsor|1
4628404|NCT01859741|7495525|FG005|Overall Study|Study Terminated by Sponsor|0
4628405|NCT01859741|7495526|FG006|Overall Study|Study Terminated by Sponsor|16
4628406|NCT01859741|7495527|FG007|Overall Study|Study Terminated by Sponsor|14
4628407|NCT01859741|7495520|FG000|Overall Study|Other|0
4628408|NCT01859741|7495521|FG001|Overall Study|Other|0
4628409|NCT01859741|7495522|FG002|Overall Study|Other|0
4628410|NCT01859741|7495523|FG003|Overall Study|Other|0
4628411|NCT01859741|7495524|FG004|Overall Study|Other|0
4628412|NCT01859741|7495525|FG005|Overall Study|Other|0
4628413|NCT01859741|7495526|FG006|Overall Study|Other|2
4628414|NCT01859741|7495527|FG007|Overall Study|Other|0
4628415|NCT01859793|7495547|FG000|First Intervention (8 Weeks)|Protocol Violation|2
4392308|NCT00090103|7170782|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0
4392309|NCT00090103|7170780|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0
4392310|NCT00090103|7170781|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1
4392311|NCT00090103|7170782|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0
4392312|NCT00090103|7170780|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0
4392313|NCT00090103|7170781|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1
4392314|NCT00090103|7170782|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3
4392315|NCT00090103|7170780|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0
4392316|NCT00090103|7170781|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0
4392317|NCT00090103|7170782|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2
4392318|NCT00090103|7170780|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0
4392319|NCT00090103|7170781|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0
4392320|NCT00090103|7170782|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1
4392321|NCT00090103|7170780|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0
4392322|NCT00090103|7170781|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1
4392323|NCT00090103|7170782|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0
4392324|NCT00090103|7170780|FG000|16-Week Safety Follow-up Period|Adverse Event|34
4392325|NCT00090103|7170781|FG001|16-Week Safety Follow-up Period|Adverse Event|39
4392326|NCT00090103|7170782|FG002|16-Week Safety Follow-up Period|Adverse Event|44
4392327|NCT00090103|7170780|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185
4392328|NCT00090103|7170781|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212
4392329|NCT00090103|7170782|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229
4392330|NCT00090103|7170780|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101
4392331|NCT00090103|7170781|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97
4392332|NCT00090103|7170782|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111
4392333|NCT00090103|7170780|FG000|16-Week Safety Follow-up Period|Protocol Violation|18
4392334|NCT00090103|7170781|FG001|16-Week Safety Follow-up Period|Protocol Violation|18
4392335|NCT00090103|7170782|FG002|16-Week Safety Follow-up Period|Protocol Violation|17
4392336|NCT00090103|7170780|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8
4392337|NCT00090103|7170781|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5
4392338|NCT00090103|7170782|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4
4392339|NCT00090103|7170780|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8
4392340|NCT00090103|7170781|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6
4392341|NCT00090103|7170782|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4
4392342|NCT00090103|7170780|FG000|16-Week Safety Follow-up Period|Loss of Contact|4
4392343|NCT00090103|7170781|FG001|16-Week Safety Follow-up Period|Loss of Contact|0
4392344|NCT00090103|7170782|FG002|16-Week Safety Follow-up Period|Loss of Contact|2
4392345|NCT00090103|7170780|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3
4392346|NCT00090103|7170781|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1
4392347|NCT00090103|7170782|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1
4392348|NCT00090103|7170780|FG000|16-Week Safety Follow-up Period|Participant relocated|2
4392349|NCT00090103|7170781|FG001|16-Week Safety Follow-up Period|Participant relocated|3
4392350|NCT00090103|7170782|FG002|16-Week Safety Follow-up Period|Participant relocated|1
4392351|NCT00090103|7170780|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2
4392352|NCT00090103|7170781|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1
4392353|NCT00090103|7170782|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2
4392354|NCT00090103|7170780|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2
4392355|NCT00090103|7170781|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3
4392356|NCT00090103|7170782|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5
4392357|NCT00090103|7170780|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1
4392358|NCT00090103|7170781|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0
4392359|NCT00090103|7170782|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1
4392360|NCT00090103|7170780|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1
4392361|NCT00090103|7170781|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5
4392362|NCT00090103|7170782|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13
4392363|NCT00090103|7170780|FG000|16-Week Safety Follow-up Period|Loss of Libido|1
4392364|NCT00090103|7170781|FG001|16-Week Safety Follow-up Period|Loss of Libido|0
4392365|NCT00090103|7170782|FG002|16-Week Safety Follow-up Period|Loss of Libido|0
4392366|NCT00090103|7170780|FG000|16-Week Safety Follow-up Period|Enrollment Error|1
4392367|NCT00090103|7170781|FG001|16-Week Safety Follow-up Period|Enrollment Error|0
4392368|NCT00090103|7170782|FG002|16-Week Safety Follow-up Period|Enrollment Error|2
4392369|NCT00090103|7170780|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1
4392370|NCT00090103|7170781|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3
4392371|NCT00090103|7170782|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6
4392372|NCT00090103|7170780|FG000|16-Week Safety Follow-up Period|Death|1
4392373|NCT00090103|7170781|FG001|16-Week Safety Follow-up Period|Death|0
4392374|NCT00090103|7170782|FG002|16-Week Safety Follow-up Period|Death|1
4510781|NCT00922974|7319666|FG000|Phase III Component|Protocol Violation|8
4392375|NCT00090103|7170780|FG000|16-Week Safety Follow-up Period|Gyneomastia|1
4392376|NCT00090103|7170781|FG001|16-Week Safety Follow-up Period|Gyneomastia|0
4392377|NCT00090103|7170782|FG002|16-Week Safety Follow-up Period|Gyneomastia|0
4392378|NCT00090103|7170780|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0
4392379|NCT00090103|7170781|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5
4392380|NCT00090103|7170782|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4
4392381|NCT00090103|7170780|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0
4392382|NCT00090103|7170781|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2
4392383|NCT00090103|7170782|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3
4392384|NCT00090103|7170780|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0
4392385|NCT00090103|7170781|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1
4628416|NCT01859793|7495548|FG001|First Intervention (8 Weeks)|Protocol Violation|0
4392386|NCT00090103|7170782|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0
4392387|NCT00090103|7170780|FG000|16-Week Safety Follow-up Period|Back Pain|0
4392388|NCT00090103|7170781|FG001|16-Week Safety Follow-up Period|Back Pain|1
4392389|NCT00090103|7170782|FG002|16-Week Safety Follow-up Period|Back Pain|0
4392390|NCT00090103|7170780|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0
4392391|NCT00090103|7170781|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2
4392392|NCT00090103|7170782|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4
4392393|NCT00090103|7170780|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0
4392394|NCT00090103|7170781|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2
4392395|NCT00090103|7170782|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3
4392396|NCT00090103|7170780|FG000|16-Week Safety Follow-up Period|Depression|0
4392397|NCT00090103|7170781|FG001|16-Week Safety Follow-up Period|Depression|1
4392398|NCT00090103|7170782|FG002|16-Week Safety Follow-up Period|Depression|0
4392399|NCT00090103|7170780|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0
4392400|NCT00090103|7170781|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1
4392401|NCT00090103|7170782|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0
4392402|NCT00090103|7170780|FG000|16-Week Safety Follow-up Period|Jailed|0
4392403|NCT00090103|7170781|FG001|16-Week Safety Follow-up Period|Jailed|1
4392404|NCT00090103|7170782|FG002|16-Week Safety Follow-up Period|Jailed|0
4392405|NCT00090103|7170780|FG000|16-Week Safety Follow-up Period|Other|0
4392406|NCT00090103|7170781|FG001|16-Week Safety Follow-up Period|Other|1
4392407|NCT00090103|7170782|FG002|16-Week Safety Follow-up Period|Other|0
4392408|NCT00090220|7170792|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1
4392409|NCT00090220|7170793|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1
4392410|NCT00090220|7170794|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0
4392411|NCT00090220|7170795|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0
4392412|NCT00090220|7170796|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0
4392413|NCT00090220|7170797|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0
4392414|NCT00090220|7170792|FG000|Base Study Vaccination Period|Adverse Event|6
4392415|NCT00090220|7170793|FG001|Base Study Vaccination Period|Adverse Event|1
4392416|NCT00090220|7170794|FG002|Base Study Vaccination Period|Adverse Event|0
4392417|NCT00090220|7170795|FG003|Base Study Vaccination Period|Adverse Event|0
4392418|NCT00090220|7170796|FG004|Base Study Vaccination Period|Adverse Event|0
4392419|NCT00090220|7170797|FG005|Base Study Vaccination Period|Adverse Event|0
4392420|NCT00090220|7170792|FG000|Base Study Vaccination Period|Lost to Follow-up|24
4392421|NCT00090220|7170793|FG001|Base Study Vaccination Period|Lost to Follow-up|28
4392422|NCT00090220|7170794|FG002|Base Study Vaccination Period|Lost to Follow-up|0
4392423|NCT00090220|7170795|FG003|Base Study Vaccination Period|Lost to Follow-up|0
4392424|NCT00090220|7170796|FG004|Base Study Vaccination Period|Lost to Follow-up|0
4392425|NCT00090220|7170797|FG005|Base Study Vaccination Period|Lost to Follow-up|0
4392426|NCT00090220|7170792|FG000|Base Study Vaccination Period|Withdrawal by Subject|23
4392427|NCT00090220|7170793|FG001|Base Study Vaccination Period|Withdrawal by Subject|27
4392428|NCT00090220|7170794|FG002|Base Study Vaccination Period|Withdrawal by Subject|0
4392429|NCT00090220|7170795|FG003|Base Study Vaccination Period|Withdrawal by Subject|0
4392430|NCT00090220|7170796|FG004|Base Study Vaccination Period|Withdrawal by Subject|0
4392431|NCT00090220|7170797|FG005|Base Study Vaccination Period|Withdrawal by Subject|0
4392432|NCT00090220|7170792|FG000|Base Study Vaccination Period|Patient Moved|6
4392433|NCT00090220|7170793|FG001|Base Study Vaccination Period|Patient Moved|2
4392434|NCT00090220|7170794|FG002|Base Study Vaccination Period|Patient Moved|0
4392435|NCT00090220|7170795|FG003|Base Study Vaccination Period|Patient Moved|0
4392436|NCT00090220|7170796|FG004|Base Study Vaccination Period|Patient Moved|0
4392437|NCT00090220|7170797|FG005|Base Study Vaccination Period|Patient Moved|0
4392438|NCT00090220|7170792|FG000|Base Study Vaccination Period|Other|4
4392439|NCT00090220|7170793|FG001|Base Study Vaccination Period|Other|4
4392440|NCT00090220|7170794|FG002|Base Study Vaccination Period|Other|0
4392441|NCT00090220|7170795|FG003|Base Study Vaccination Period|Other|0
4392442|NCT00090220|7170796|FG004|Base Study Vaccination Period|Other|0
4392443|NCT00090220|7170797|FG005|Base Study Vaccination Period|Other|0
4392444|NCT00090220|7170792|FG000|Base Study Follow-up Period|Adverse Event|6
4392445|NCT00090220|7170793|FG001|Base Study Follow-up Period|Adverse Event|1
4392446|NCT00090220|7170794|FG002|Base Study Follow-up Period|Adverse Event|0
4392447|NCT00090220|7170795|FG003|Base Study Follow-up Period|Adverse Event|0
4392448|NCT00090220|7170796|FG004|Base Study Follow-up Period|Adverse Event|0
4392449|NCT00090220|7170797|FG005|Base Study Follow-up Period|Adverse Event|0
4392450|NCT00090220|7170792|FG000|Base Study Follow-up Period|Lost to Follow-up|88
4392451|NCT00090220|7170793|FG001|Base Study Follow-up Period|Lost to Follow-up|78
4392452|NCT00090220|7170794|FG002|Base Study Follow-up Period|Lost to Follow-up|0
4392453|NCT00090220|7170795|FG003|Base Study Follow-up Period|Lost to Follow-up|0
4392454|NCT00090220|7170796|FG004|Base Study Follow-up Period|Lost to Follow-up|0
4392455|NCT00090220|7170797|FG005|Base Study Follow-up Period|Lost to Follow-up|0
4392456|NCT00090220|7170792|FG000|Base Study Follow-up Period|Withdrawal by Subject|27
4392457|NCT00090220|7170793|FG001|Base Study Follow-up Period|Withdrawal by Subject|36
4392458|NCT00090220|7170794|FG002|Base Study Follow-up Period|Withdrawal by Subject|0
4392459|NCT00090220|7170795|FG003|Base Study Follow-up Period|Withdrawal by Subject|0
4392460|NCT00090220|7170796|FG004|Base Study Follow-up Period|Withdrawal by Subject|0
4392461|NCT00090220|7170797|FG005|Base Study Follow-up Period|Withdrawal by Subject|0
4392462|NCT00090220|7170792|FG000|Base Study Follow-up Period|Patient Moved|20
4392463|NCT00090220|7170793|FG001|Base Study Follow-up Period|Patient Moved|28
4392464|NCT00090220|7170794|FG002|Base Study Follow-up Period|Patient Moved|0
4392465|NCT00090220|7170795|FG003|Base Study Follow-up Period|Patient Moved|0
4392466|NCT00090220|7170796|FG004|Base Study Follow-up Period|Patient Moved|0
4392467|NCT00090220|7170797|FG005|Base Study Follow-up Period|Patient Moved|0
4392468|NCT00090220|7170792|FG000|Base Study Follow-up Period|Other|19
4392469|NCT00090220|7170793|FG001|Base Study Follow-up Period|Other|21
4392470|NCT00090220|7170794|FG002|Base Study Follow-up Period|Other|0
4392471|NCT00090220|7170795|FG003|Base Study Follow-up Period|Other|0
4392472|NCT00090220|7170796|FG004|Base Study Follow-up Period|Other|0
4392473|NCT00090220|7170797|FG005|Base Study Follow-up Period|Other|0
4392474|NCT00090220|7170792|FG000|Extension 1 (EXT1)|Adverse Event|0
4392475|NCT00090220|7170793|FG001|Extension 1 (EXT1)|Adverse Event|0
4392476|NCT00090220|7170794|FG002|Extension 1 (EXT1)|Adverse Event|4
4392477|NCT00090220|7170795|FG003|Extension 1 (EXT1)|Adverse Event|0
4392478|NCT00090220|7170796|FG004|Extension 1 (EXT1)|Adverse Event|0
4392479|NCT00090220|7170797|FG005|Extension 1 (EXT1)|Adverse Event|0
4392480|NCT00090220|7170792|FG000|Extension 1 (EXT1)|Lost to Follow-up|0
4392481|NCT00090220|7170793|FG001|Extension 1 (EXT1)|Lost to Follow-up|0
4392482|NCT00090220|7170794|FG002|Extension 1 (EXT1)|Lost to Follow-up|22
4392483|NCT00090220|7170795|FG003|Extension 1 (EXT1)|Lost to Follow-up|0
4392484|NCT00090220|7170796|FG004|Extension 1 (EXT1)|Lost to Follow-up|0
4392485|NCT00090220|7170797|FG005|Extension 1 (EXT1)|Lost to Follow-up|0
4392486|NCT00090220|7170792|FG000|Extension 1 (EXT1)|Moved|0
4392487|NCT00090220|7170793|FG001|Extension 1 (EXT1)|Moved|0
4392488|NCT00090220|7170794|FG002|Extension 1 (EXT1)|Moved|2
4392489|NCT00090220|7170795|FG003|Extension 1 (EXT1)|Moved|1
4392490|NCT00090220|7170796|FG004|Extension 1 (EXT1)|Moved|0
4392491|NCT00090220|7170797|FG005|Extension 1 (EXT1)|Moved|0
4392492|NCT00090220|7170792|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0
4392493|NCT00090220|7170793|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0
4392494|NCT00090220|7170794|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25
4392495|NCT00090220|7170795|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0
4392496|NCT00090220|7170796|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0
4392497|NCT00090220|7170797|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0
4392498|NCT00090220|7170792|FG000|Extension 1 (EXT1)|Protocol Violation|0
4392499|NCT00090220|7170793|FG001|Extension 1 (EXT1)|Protocol Violation|0
4392500|NCT00090220|7170794|FG002|Extension 1 (EXT1)|Protocol Violation|0
4392501|NCT00090220|7170795|FG003|Extension 1 (EXT1)|Protocol Violation|1
4392502|NCT00090220|7170796|FG004|Extension 1 (EXT1)|Protocol Violation|0
4392503|NCT00090220|7170797|FG005|Extension 1 (EXT1)|Protocol Violation|0
4392504|NCT00090220|7170792|FG000|Extension 1 (EXT1)|Other reason|0
4392505|NCT00090220|7170793|FG001|Extension 1 (EXT1)|Other reason|0
4392506|NCT00090220|7170794|FG002|Extension 1 (EXT1)|Other reason|2
4392507|NCT00090220|7170795|FG003|Extension 1 (EXT1)|Other reason|0
4392508|NCT00090220|7170796|FG004|Extension 1 (EXT1)|Other reason|0
4392509|NCT00090220|7170797|FG005|Extension 1 (EXT1)|Other reason|0
4392510|NCT00090220|7170792|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0
4392511|NCT00090220|7170793|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0
4392512|NCT00090220|7170794|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0
4392513|NCT00090220|7170795|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0
4392514|NCT00090220|7170796|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38
4392515|NCT00090220|7170797|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23
4392516|NCT00090220|7170792|FG000|Long-term Follow-up (EXT2)|Death|0
4392517|NCT00090220|7170793|FG001|Long-term Follow-up (EXT2)|Death|0
4392518|NCT00090220|7170794|FG002|Long-term Follow-up (EXT2)|Death|0
4392519|NCT00090220|7170795|FG003|Long-term Follow-up (EXT2)|Death|0
4392520|NCT00090220|7170796|FG004|Long-term Follow-up (EXT2)|Death|1
4392521|NCT00090220|7170797|FG005|Long-term Follow-up (EXT2)|Death|1
4392522|NCT00090220|7170792|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
4392523|NCT00090220|7170793|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
4392524|NCT00090220|7170794|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
4392525|NCT00090220|7170795|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
4392526|NCT00090220|7170796|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4
4392527|NCT00090220|7170797|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4
4392528|NCT00090220|7170792|FG000|Long-term Follow-up (EXT2)|Other|0
4392529|NCT00090220|7170793|FG001|Long-term Follow-up (EXT2)|Other|0
4392530|NCT00090220|7170794|FG002|Long-term Follow-up (EXT2)|Other|0
4392531|NCT00090220|7170795|FG003|Long-term Follow-up (EXT2)|Other|0
4392532|NCT00090220|7170796|FG004|Long-term Follow-up (EXT2)|Other|1
4392533|NCT00090220|7170797|FG005|Long-term Follow-up (EXT2)|Other|0
4392534|NCT00090233|7170816|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609
4392535|NCT00090233|7170817|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627
4392536|NCT00090233|7170816|FG000|Overall Study|Adverse Event|214
4392537|NCT00090233|7170817|FG001|Overall Study|Adverse Event|198
4392538|NCT00090233|7170816|FG000|Overall Study|Lost to Follow-up|68
4392539|NCT00090233|7170817|FG001|Overall Study|Lost to Follow-up|95
4392540|NCT00090233|7170816|FG000|Overall Study|Protocol Violation|960
4392541|NCT00090233|7170817|FG001|Overall Study|Protocol Violation|1022
4392542|NCT00090233|7170816|FG000|Overall Study|Withdrawal by Subject|182
4392543|NCT00090233|7170817|FG001|Overall Study|Withdrawal by Subject|211
4392544|NCT00090233|7170816|FG000|Overall Study|Moved|203
4392545|NCT00090233|7170817|FG001|Overall Study|Moved|189
4392546|NCT00090233|7170816|FG000|Overall Study|Other|1211
4392547|NCT00090233|7170817|FG001|Overall Study|Other|1160
4392548|NCT00090233|7170816|FG000|Overall Study|Data not available at data cut-off point|1552
4392549|NCT00090233|7170817|FG001|Overall Study|Data not available at data cut-off point|1563
4392550|NCT00090285|7170829|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7
4392551|NCT00090285|7170830|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3
4392552|NCT00090285|7170831|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0
4392553|NCT00090285|7170832|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0
4392554|NCT00090285|7170833|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0
4392555|NCT00090285|7170834|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0
4392556|NCT00090285|7170829|FG000|Base Study Vaccination Period|Adverse Event|2
4392557|NCT00090285|7170830|FG001|Base Study Vaccination Period|Adverse Event|4
4392558|NCT00090285|7170831|FG002|Base Study Vaccination Period|Adverse Event|0
4392559|NCT00090285|7170832|FG003|Base Study Vaccination Period|Adverse Event|0
4392560|NCT00090285|7170833|FG004|Base Study Vaccination Period|Adverse Event|0
4392561|NCT00090285|7170834|FG005|Base Study Vaccination Period|Adverse Event|0
4392562|NCT00090285|7170829|FG000|Base Study Vaccination Period|Lost to Follow-up|111
4392563|NCT00090285|7170830|FG001|Base Study Vaccination Period|Lost to Follow-up|112
4392564|NCT00090285|7170831|FG002|Base Study Vaccination Period|Lost to Follow-up|0
4392565|NCT00090285|7170832|FG003|Base Study Vaccination Period|Lost to Follow-up|0
4392566|NCT00090285|7170833|FG004|Base Study Vaccination Period|Lost to Follow-up|0
4392567|NCT00090285|7170834|FG005|Base Study Vaccination Period|Lost to Follow-up|0
4392568|NCT00090285|7170829|FG000|Base Study Vaccination Period|Protocol Violation|2
4392569|NCT00090285|7170830|FG001|Base Study Vaccination Period|Protocol Violation|3
4392570|NCT00090285|7170831|FG002|Base Study Vaccination Period|Protocol Violation|0
4392571|NCT00090285|7170832|FG003|Base Study Vaccination Period|Protocol Violation|0
4392572|NCT00090285|7170833|FG004|Base Study Vaccination Period|Protocol Violation|0
4392573|NCT00090285|7170834|FG005|Base Study Vaccination Period|Protocol Violation|0
4392574|NCT00090285|7170829|FG000|Base Study Vaccination Period|Withdrawal by Subject|64
4392575|NCT00090285|7170830|FG001|Base Study Vaccination Period|Withdrawal by Subject|69
4392576|NCT00090285|7170831|FG002|Base Study Vaccination Period|Withdrawal by Subject|0
4392577|NCT00090285|7170832|FG003|Base Study Vaccination Period|Withdrawal by Subject|0
4392578|NCT00090285|7170833|FG004|Base Study Vaccination Period|Withdrawal by Subject|0
4392579|NCT00090285|7170834|FG005|Base Study Vaccination Period|Withdrawal by Subject|0
4392580|NCT00090285|7170829|FG000|Base Study Vaccination Period|Uncooperative|2
4392581|NCT00090285|7170830|FG001|Base Study Vaccination Period|Uncooperative|2
4392582|NCT00090285|7170831|FG002|Base Study Vaccination Period|Uncooperative|0
4392583|NCT00090285|7170832|FG003|Base Study Vaccination Period|Uncooperative|0
4392584|NCT00090285|7170833|FG004|Base Study Vaccination Period|Uncooperative|0
4392585|NCT00090285|7170834|FG005|Base Study Vaccination Period|Uncooperative|0
4392586|NCT00090285|7170829|FG000|Base Study Vaccination Period|Moved|20
4392587|NCT00090285|7170830|FG001|Base Study Vaccination Period|Moved|21
4392588|NCT00090285|7170831|FG002|Base Study Vaccination Period|Moved|0
4392589|NCT00090285|7170832|FG003|Base Study Vaccination Period|Moved|0
4392590|NCT00090285|7170833|FG004|Base Study Vaccination Period|Moved|0
4392591|NCT00090285|7170834|FG005|Base Study Vaccination Period|Moved|0
4392592|NCT00090285|7170829|FG000|Base Study Vaccination Period|Site Terminated|1
4392593|NCT00090285|7170830|FG001|Base Study Vaccination Period|Site Terminated|0
4392594|NCT00090285|7170831|FG002|Base Study Vaccination Period|Site Terminated|0
4392595|NCT00090285|7170832|FG003|Base Study Vaccination Period|Site Terminated|0
4392596|NCT00090285|7170833|FG004|Base Study Vaccination Period|Site Terminated|0
4392597|NCT00090285|7170834|FG005|Base Study Vaccination Period|Site Terminated|0
4392598|NCT00090285|7170829|FG000|Base Study Vaccination Period|Other|2
4392599|NCT00090285|7170830|FG001|Base Study Vaccination Period|Other|2
4392600|NCT00090285|7170831|FG002|Base Study Vaccination Period|Other|0
4392601|NCT00090285|7170832|FG003|Base Study Vaccination Period|Other|0
4392602|NCT00090285|7170833|FG004|Base Study Vaccination Period|Other|0
4392603|NCT00090285|7170834|FG005|Base Study Vaccination Period|Other|0
4392604|NCT00090285|7170829|FG000|Base Study Vaccination Period|Subject Incarcerated|2
4392605|NCT00090285|7170830|FG001|Base Study Vaccination Period|Subject Incarcerated|2
4392606|NCT00090285|7170831|FG002|Base Study Vaccination Period|Subject Incarcerated|0
4392607|NCT00090285|7170832|FG003|Base Study Vaccination Period|Subject Incarcerated|0
4392608|NCT00090285|7170833|FG004|Base Study Vaccination Period|Subject Incarcerated|0
4392609|NCT00090285|7170834|FG005|Base Study Vaccination Period|Subject Incarcerated|0
4392610|NCT00090285|7170829|FG000|Base Study Vaccination Period|HIV positive|1
4392611|NCT00090285|7170830|FG001|Base Study Vaccination Period|HIV positive|1
4392612|NCT00090285|7170831|FG002|Base Study Vaccination Period|HIV positive|0
4392613|NCT00090285|7170832|FG003|Base Study Vaccination Period|HIV positive|0
4392614|NCT00090285|7170833|FG004|Base Study Vaccination Period|HIV positive|0
4392615|NCT00090285|7170834|FG005|Base Study Vaccination Period|HIV positive|0
4392616|NCT00090285|7170829|FG000|Base Study Follow-up Period|Adverse Event|3
4392617|NCT00090285|7170830|FG001|Base Study Follow-up Period|Adverse Event|10
4392618|NCT00090285|7170831|FG002|Base Study Follow-up Period|Adverse Event|0
4392619|NCT00090285|7170832|FG003|Base Study Follow-up Period|Adverse Event|0
4392620|NCT00090285|7170833|FG004|Base Study Follow-up Period|Adverse Event|0
4392621|NCT00090285|7170834|FG005|Base Study Follow-up Period|Adverse Event|0
4392622|NCT00090285|7170829|FG000|Base Study Follow-up Period|Lost to Follow-up|232
4392623|NCT00090285|7170830|FG001|Base Study Follow-up Period|Lost to Follow-up|226
4392624|NCT00090285|7170831|FG002|Base Study Follow-up Period|Lost to Follow-up|0
4392625|NCT00090285|7170832|FG003|Base Study Follow-up Period|Lost to Follow-up|0
4392626|NCT00090285|7170833|FG004|Base Study Follow-up Period|Lost to Follow-up|0
4392627|NCT00090285|7170834|FG005|Base Study Follow-up Period|Lost to Follow-up|0
4392628|NCT00090285|7170829|FG000|Base Study Follow-up Period|Withdrawal by Subject|53
4392629|NCT00090285|7170830|FG001|Base Study Follow-up Period|Withdrawal by Subject|64
4392630|NCT00090285|7170831|FG002|Base Study Follow-up Period|Withdrawal by Subject|0
4392631|NCT00090285|7170832|FG003|Base Study Follow-up Period|Withdrawal by Subject|0
4392632|NCT00090285|7170833|FG004|Base Study Follow-up Period|Withdrawal by Subject|0
4392633|NCT00090285|7170834|FG005|Base Study Follow-up Period|Withdrawal by Subject|0
4392634|NCT00090285|7170829|FG000|Base Study Follow-up Period|Moved|41
4392635|NCT00090285|7170830|FG001|Base Study Follow-up Period|Moved|36
4392636|NCT00090285|7170831|FG002|Base Study Follow-up Period|Moved|0
4392637|NCT00090285|7170832|FG003|Base Study Follow-up Period|Moved|0
4392638|NCT00090285|7170833|FG004|Base Study Follow-up Period|Moved|0
4392639|NCT00090285|7170834|FG005|Base Study Follow-up Period|Moved|0
4392640|NCT00090285|7170829|FG000|Base Study Follow-up Period|Other|2
4392641|NCT00090285|7170830|FG001|Base Study Follow-up Period|Other|0
4392642|NCT00090285|7170831|FG002|Base Study Follow-up Period|Other|0
4392643|NCT00090285|7170832|FG003|Base Study Follow-up Period|Other|0
4392644|NCT00090285|7170833|FG004|Base Study Follow-up Period|Other|0
4392645|NCT00090285|7170834|FG005|Base Study Follow-up Period|Other|0
4392646|NCT00090285|7170829|FG000|Base Study Follow-up Period|Protocol Violation|1
4392647|NCT00090285|7170830|FG001|Base Study Follow-up Period|Protocol Violation|0
4392648|NCT00090285|7170831|FG002|Base Study Follow-up Period|Protocol Violation|0
4392649|NCT00090285|7170832|FG003|Base Study Follow-up Period|Protocol Violation|0
4392650|NCT00090285|7170833|FG004|Base Study Follow-up Period|Protocol Violation|0
4392651|NCT00090285|7170834|FG005|Base Study Follow-up Period|Protocol Violation|0
4392652|NCT00090285|7170829|FG000|Base Study Follow-up Period|Uncooperative|3
4392653|NCT00090285|7170830|FG001|Base Study Follow-up Period|Uncooperative|4
4392654|NCT00090285|7170831|FG002|Base Study Follow-up Period|Uncooperative|0
4392655|NCT00090285|7170832|FG003|Base Study Follow-up Period|Uncooperative|0
4392656|NCT00090285|7170833|FG004|Base Study Follow-up Period|Uncooperative|0
4392657|NCT00090285|7170834|FG005|Base Study Follow-up Period|Uncooperative|0
4392658|NCT00090285|7170829|FG000|Base Study Follow-up Period|Subject Incarcerated|0
4392659|NCT00090285|7170830|FG001|Base Study Follow-up Period|Subject Incarcerated|2
4392660|NCT00090285|7170831|FG002|Base Study Follow-up Period|Subject Incarcerated|0
4392661|NCT00090285|7170832|FG003|Base Study Follow-up Period|Subject Incarcerated|0
4392662|NCT00090285|7170833|FG004|Base Study Follow-up Period|Subject Incarcerated|0
4392663|NCT00090285|7170834|FG005|Base Study Follow-up Period|Subject Incarcerated|0
4628417|NCT01859793|7495547|FG000|First Intervention (8 Weeks)|Adverse Event|1
4392664|NCT00090285|7170829|FG000|Extension 1|Adverse Event|0
4392665|NCT00090285|7170830|FG001|Extension 1|Adverse Event|0
4392666|NCT00090285|7170831|FG002|Extension 1|Adverse Event|2
4392667|NCT00090285|7170832|FG003|Extension 1|Adverse Event|0
4392668|NCT00090285|7170833|FG004|Extension 1|Adverse Event|0
4392669|NCT00090285|7170834|FG005|Extension 1|Adverse Event|0
4392670|NCT00090285|7170829|FG000|Extension 1|Lost to Follow-up|0
4392671|NCT00090285|7170830|FG001|Extension 1|Lost to Follow-up|0
4392672|NCT00090285|7170831|FG002|Extension 1|Lost to Follow-up|35
4392673|NCT00090285|7170832|FG003|Extension 1|Lost to Follow-up|0
4392674|NCT00090285|7170833|FG004|Extension 1|Lost to Follow-up|0
4392675|NCT00090285|7170834|FG005|Extension 1|Lost to Follow-up|0
4392676|NCT00090285|7170829|FG000|Extension 1|Withdrawal by Subject|0
4392677|NCT00090285|7170830|FG001|Extension 1|Withdrawal by Subject|0
4392678|NCT00090285|7170831|FG002|Extension 1|Withdrawal by Subject|13
4392679|NCT00090285|7170832|FG003|Extension 1|Withdrawal by Subject|1
4392680|NCT00090285|7170833|FG004|Extension 1|Withdrawal by Subject|0
4392681|NCT00090285|7170834|FG005|Extension 1|Withdrawal by Subject|0
4392682|NCT00090285|7170829|FG000|Extension 1|Other|0
4392683|NCT00090285|7170830|FG001|Extension 1|Other|0
4392684|NCT00090285|7170831|FG002|Extension 1|Other|4
4392685|NCT00090285|7170832|FG003|Extension 1|Other|0
4628418|NCT01859793|7495548|FG001|First Intervention (8 Weeks)|Adverse Event|0
4392686|NCT00090285|7170833|FG004|Extension 1|Other|0
4392687|NCT00090285|7170834|FG005|Extension 1|Other|0
4392688|NCT00090285|7170829|FG000|Extension 1|Moved|0
4392689|NCT00090285|7170830|FG001|Extension 1|Moved|0
4392690|NCT00090285|7170831|FG002|Extension 1|Moved|3
4392691|NCT00090285|7170832|FG003|Extension 1|Moved|0
4392692|NCT00090285|7170833|FG004|Extension 1|Moved|0
4392693|NCT00090285|7170834|FG005|Extension 1|Moved|0
4392694|NCT00090285|7170829|FG000|Long-term Follow-up (EXT2)|Adverse Event|0
4392695|NCT00090285|7170830|FG001|Long-term Follow-up (EXT2)|Adverse Event|0
4392696|NCT00090285|7170831|FG002|Long-term Follow-up (EXT2)|Adverse Event|0
4392697|NCT00090285|7170832|FG003|Long-term Follow-up (EXT2)|Adverse Event|0
4392698|NCT00090285|7170833|FG004|Long-term Follow-up (EXT2)|Adverse Event|5
4392699|NCT00090285|7170834|FG005|Long-term Follow-up (EXT2)|Adverse Event|2
4392700|NCT00090285|7170829|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0
4392701|NCT00090285|7170830|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0
4392702|NCT00090285|7170831|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0
4392703|NCT00090285|7170832|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0
4392704|NCT00090285|7170833|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156
4392705|NCT00090285|7170834|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143
4392706|NCT00090285|7170829|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
4392707|NCT00090285|7170830|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
4392708|NCT00090285|7170831|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
4392709|NCT00090285|7170832|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
4392710|NCT00090285|7170833|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60
4392711|NCT00090285|7170834|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53
4392712|NCT00090285|7170829|FG000|Long-term Follow-up (EXT2)|Physician Decision|0
4392713|NCT00090285|7170830|FG001|Long-term Follow-up (EXT2)|Physician Decision|0
4392714|NCT00090285|7170831|FG002|Long-term Follow-up (EXT2)|Physician Decision|0
4392715|NCT00090285|7170832|FG003|Long-term Follow-up (EXT2)|Physician Decision|0
4392716|NCT00090285|7170833|FG004|Long-term Follow-up (EXT2)|Physician Decision|6
4392717|NCT00090285|7170834|FG005|Long-term Follow-up (EXT2)|Physician Decision|5
4392718|NCT00090363|7170852|FG000|Overall Study|Lost to Follow-up|1
4392719|NCT00090363|7170853|FG001|Overall Study|Lost to Follow-up|2
4392720|NCT00090363|7170854|FG002|Overall Study|Lost to Follow-up|1
4392721|NCT00090363|7170852|FG000|Overall Study|Withdrawal by Subject|7
4392722|NCT00090363|7170853|FG001|Overall Study|Withdrawal by Subject|7
4392723|NCT00090363|7170854|FG002|Overall Study|Withdrawal by Subject|6
4392724|NCT00090363|7170852|FG000|Overall Study|Study-specific discontinuation criteria|75
4392725|NCT00090363|7170853|FG001|Overall Study|Study-specific discontinuation criteria|74
4392726|NCT00090363|7170854|FG002|Overall Study|Study-specific discontinuation criteria|62
4392727|NCT00090363|7170852|FG000|Overall Study|Eligibility criteria not fulfilled|0
4392728|NCT00090363|7170853|FG001|Overall Study|Eligibility criteria not fulfilled|0
4392729|NCT00090363|7170854|FG002|Overall Study|Eligibility criteria not fulfilled|1
4392730|NCT00090363|7170852|FG000|Overall Study|Consent expired|7
4392731|NCT00090363|7170853|FG001|Overall Study|Consent expired|10
4392732|NCT00090363|7170854|FG002|Overall Study|Consent expired|9
4392733|NCT00090363|7170852|FG000|Overall Study|Reasons not specified|2
4392734|NCT00090363|7170853|FG001|Overall Study|Reasons not specified|1
4392735|NCT00090363|7170854|FG002|Overall Study|Reasons not specified|1
4392736|NCT00090363|7170852|FG000|Overall Study|Continuing on study off treatment|14
4392737|NCT00090363|7170853|FG001|Overall Study|Continuing on study off treatment|13
4392738|NCT00090363|7170854|FG002|Overall Study|Continuing on study off treatment|16
4392739|NCT00090402|7170865|FG000|Overall Study|Death|1
4392740|NCT00090402|7170866|FG001|Overall Study|Death|1
4392741|NCT00090402|7170867|FG002|Overall Study|Death|0
4392742|NCT00090402|7170865|FG000|Overall Study|subject moved|0
4392743|NCT00090402|7170866|FG001|Overall Study|subject moved|1
4392744|NCT00090402|7170867|FG002|Overall Study|subject moved|0
4392745|NCT00090402|7170865|FG000|Overall Study|stopped taking study medication|1
4392746|NCT00090402|7170866|FG001|Overall Study|stopped taking study medication|0
4392747|NCT00090402|7170867|FG002|Overall Study|stopped taking study medication|1
4392748|NCT00090493|7170878|FG000|Overall Study|Physician Decision|2
4392749|NCT00090519|7170884|FG000|Overall Study|Adverse Event|5
4392750|NCT00090519|7170885|FG001|Overall Study|Adverse Event|4
4392751|NCT00090519|7170884|FG000|Overall Study|Death|9
4392752|NCT00090519|7170885|FG001|Overall Study|Death|9
4392753|NCT00090519|7170884|FG000|Overall Study|Lost to Follow-up|26
4392754|NCT00090519|7170885|FG001|Overall Study|Lost to Follow-up|29
4392755|NCT00090519|7170884|FG000|Overall Study|Withdrawal by Subject|28
4392756|NCT00090519|7170885|FG001|Overall Study|Withdrawal by Subject|29
4392757|NCT00090519|7170884|FG000|Overall Study|Physician Decision|2
4392758|NCT00090519|7170885|FG001|Overall Study|Physician Decision|3
4392759|NCT00090519|7170884|FG000|Overall Study|Sponsor Decision|3
4392760|NCT00090519|7170885|FG001|Overall Study|Sponsor Decision|1
4392761|NCT00090545|7170893|FG000|Overall Study|Disease progression on study|21
4392762|NCT00090545|7170894|FG001|Overall Study|Disease progression on study|17
4392763|NCT00090545|7170893|FG000|Overall Study|Refused further treatment|1
4392764|NCT00090545|7170894|FG001|Overall Study|Refused further treatment|4
4392765|NCT00090545|7170893|FG000|Overall Study|Death|0
4392766|NCT00090545|7170894|FG001|Overall Study|Death|1
4392767|NCT00090545|7170893|FG000|Overall Study|Adverse Event|0
4392768|NCT00090545|7170894|FG001|Overall Study|Adverse Event|2
4392769|NCT00090584|7170904|FG000|Baseline to 10 Weeks|Lost to Follow-up|15
4392770|NCT00090584|7170905|FG001|Baseline to 10 Weeks|Lost to Follow-up|12
4392771|NCT00090584|7170904|FG000|Baseline to 8 Months|Lost to Follow-up|44
4392772|NCT00090584|7170905|FG001|Baseline to 8 Months|Lost to Follow-up|41
4628419|NCT01859793|7495547|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2
4628420|NCT01859793|7495548|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1
4628421|NCT01859793|7495547|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1
4628422|NCT01859793|7495548|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1
4628423|NCT01859923|7495558|FG000|Overall Study|Adverse Event|0
4628424|NCT01859923|7495559|FG001|Overall Study|Adverse Event|0
4628425|NCT01859923|7495560|FG002|Overall Study|Adverse Event|1
4628426|NCT01859923|7495561|FG003|Overall Study|Adverse Event|1
4628427|NCT01859949|7495576|FG000|Overall Study|Family Matters|0
4628428|NCT01859949|7495577|FG001|Overall Study|Family Matters|1
4628429|NCT01859949|7495576|FG000|Overall Study|Physician Decision|2
4628430|NCT01859949|7495577|FG001|Overall Study|Physician Decision|4
4628431|NCT01859949|7495576|FG000|Overall Study|Withdrawal by Subject|11
4628432|NCT01859949|7495577|FG001|Overall Study|Withdrawal by Subject|10
4628433|NCT01859949|7495576|FG000|Overall Study|Protocol Violation|1
4628434|NCT01859949|7495577|FG001|Overall Study|Protocol Violation|1
4628435|NCT01859949|7495576|FG000|Overall Study|Adverse Event|0
4628436|NCT01859949|7495577|FG001|Overall Study|Adverse Event|1
4628437|NCT01859988|7495589|FG000|Overall Study|Withdrawal by Subject|6
4392773|NCT00090610|7170921|FG000|Overall Study|Withdrawal by Subject|1
4392774|NCT00090610|7170922|FG001|Overall Study|Withdrawal by Subject|1
4392775|NCT00090753|7170930|FG000|First Treatment Period|Adverse Event|20
4392776|NCT00090753|7170931|FG001|First Treatment Period|Adverse Event|8
4392777|NCT00090753|7170930|FG000|First Treatment Period|Death|88
4392778|NCT00090753|7170931|FG001|First Treatment Period|Death|62
4392779|NCT00090753|7170930|FG000|First Treatment Period|Lack of Efficacy|2
4392780|NCT00090753|7170931|FG001|First Treatment Period|Lack of Efficacy|1
4392781|NCT00090753|7170930|FG000|First Treatment Period|Refused Treatment|32
4392782|NCT00090753|7170931|FG001|First Treatment Period|Refused Treatment|25
4392783|NCT00090753|7170930|FG000|First Treatment Period|Lost to Follow-up|4
4392784|NCT00090753|7170931|FG001|First Treatment Period|Lost to Follow-up|4
4392785|NCT00090753|7170930|FG000|First Treatment Period|Renal Transplant|70
4392786|NCT00090753|7170931|FG001|First Treatment Period|Renal Transplant|50
4392787|NCT00090753|7170930|FG000|First Treatment Period|Mircera Commercialization|1
4392788|NCT00090753|7170931|FG001|First Treatment Period|Mircera Commercialization|0
4392789|NCT00090753|7170930|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39
4392790|NCT00090753|7170931|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28
4392791|NCT00090753|7170930|FG000|Extended Treatment Period|Adverse Event|11
4392792|NCT00090753|7170931|FG001|Extended Treatment Period|Adverse Event|0
4392793|NCT00090753|7170930|FG000|Extended Treatment Period|Death|58
4392794|NCT00090753|7170931|FG001|Extended Treatment Period|Death|30
4392795|NCT00090753|7170930|FG000|Extended Treatment Period|Lack of Efficacy|1
4392796|NCT00090753|7170931|FG001|Extended Treatment Period|Lack of Efficacy|0
4392797|NCT00090753|7170930|FG000|Extended Treatment Period|Refused Treatment|18
4392798|NCT00090753|7170931|FG001|Extended Treatment Period|Refused Treatment|12
4392799|NCT00090753|7170930|FG000|Extended Treatment Period|Lost to Follow-up|3
4392800|NCT00090753|7170931|FG001|Extended Treatment Period|Lost to Follow-up|1
4392801|NCT00090753|7170930|FG000|Extended Treatment Period|Renal Transplant|15
4392802|NCT00090753|7170931|FG001|Extended Treatment Period|Renal Transplant|12
4392803|NCT00090753|7170930|FG000|Extended Treatment Period|Mircera Commercialization|188
4392804|NCT00090753|7170931|FG001|Extended Treatment Period|Mircera Commercialization|93
4392805|NCT00090753|7170930|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65
4392806|NCT00090753|7170931|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43
4392807|NCT00090766|7170940|FG000|Overall Study|Nephrectomy Planned|0
4392808|NCT00090766|7170941|FG001|Overall Study|Nephrectomy Planned|0
4392809|NCT00090766|7170942|FG002|Overall Study|Nephrectomy Planned|1
4392810|NCT00090766|7170940|FG000|Overall Study|Death|1
4392811|NCT00090766|7170941|FG001|Overall Study|Death|0
4392812|NCT00090766|7170942|FG002|Overall Study|Death|0
4392813|NCT00090766|7170940|FG000|Overall Study|Admin|0
4392814|NCT00090766|7170941|FG001|Overall Study|Admin|2
4392815|NCT00090766|7170942|FG002|Overall Study|Admin|0
4392816|NCT00090766|7170940|FG000|Overall Study|Lost to Follow-up|2
4392817|NCT00090766|7170941|FG001|Overall Study|Lost to Follow-up|0
4392818|NCT00090766|7170942|FG002|Overall Study|Lost to Follow-up|2
4392819|NCT00090779|7170954|FG000|Step 1|Withdrawal by Subject|4
4628438|NCT01859988|7495590|FG001|Overall Study|Withdrawal by Subject|3
4628439|NCT01859988|7495591|FG002|Overall Study|Withdrawal by Subject|4
4628440|NCT01859988|7495592|FG003|Overall Study|Withdrawal by Subject|3
4392820|NCT00090779|7170955|FG001|Step 1|Withdrawal by Subject|2
4392821|NCT00090779|7170954|FG000|Step 1|Lost to Follow-up|3
4392822|NCT00090779|7170955|FG001|Step 1|Lost to Follow-up|2
4392823|NCT00090779|7170954|FG000|Step 1|Death|0
4392824|NCT00090779|7170955|FG001|Step 1|Death|2
4392825|NCT00090779|7170954|FG000|Step 1|Physician Decision|1
4392826|NCT00090779|7170955|FG001|Step 1|Physician Decision|0
4392827|NCT00090779|7170954|FG000|Step 1|Pregnancy|1
4392828|NCT00090779|7170955|FG001|Step 1|Pregnancy|0
4392829|NCT00090779|7170954|FG000|Step 1|Non-compliance to study requirements|0
4392830|NCT00090779|7170955|FG001|Step 1|Non-compliance to study requirements|1
4392831|NCT00090779|7170954|FG000|Step 1|Subject relocated|2
4392832|NCT00090779|7170955|FG001|Step 1|Subject relocated|8
4392833|NCT00090779|7170954|FG000|Step 2|Off study per study closure|6
4392834|NCT00090779|7170955|FG001|Step 2|Off study per study closure|16
4392835|NCT00090779|7170954|FG000|Step 2|Subject relocated|0
4392836|NCT00090779|7170955|FG001|Step 2|Subject relocated|1
4392837|NCT00090779|7170954|FG000|Step 2|Non-compliance to study requirements|0
4392838|NCT00090779|7170955|FG001|Step 2|Non-compliance to study requirements|1
4392839|NCT00090779|7170954|FG000|Step 3|Initiation of ART and off extended study|3
4392840|NCT00090779|7170955|FG001|Step 3|Initiation of ART and off extended study|2
4392841|NCT00090779|7170954|FG000|Step 3|Off extended study due to study closure|4
4392842|NCT00090779|7170955|FG001|Step 3|Off extended study due to study closure|3
4392843|NCT00090857|7170973|FG000|Overall Study|Lost to Follow-up|0
4392844|NCT00090857|7170974|FG001|Overall Study|Lost to Follow-up|1
4392845|NCT00090857|7170973|FG000|Overall Study|Withdrawal by Subject|2
4392846|NCT00090857|7170974|FG001|Overall Study|Withdrawal by Subject|0
4392847|NCT00090857|7170973|FG000|Overall Study|Adverse Event|2
4392848|NCT00090857|7170974|FG001|Overall Study|Adverse Event|2
4392849|NCT00090987|7170980|FG000|Overall Study|Adverse Event|5
4392850|NCT00090987|7170980|FG000|Overall Study|Lack of Efficacy|7
4392851|NCT00090987|7170980|FG000|Overall Study|Withdrawal by Subject|3
4392852|NCT00090987|7170980|FG000|Overall Study|alternative therapy|1
4392853|NCT00090987|7170980|FG000|Overall Study|Non-compliance|4
4392854|NCT00090987|7170980|FG000|Overall Study|Incarcerated|1
4392855|NCT00091026|7170986|FG000|Overall Study|Patient deemed non eligible-never receiv|1
4392856|NCT00091026|7170987|FG001|Overall Study|Patient deemed non eligible-never receiv|0
4392857|NCT00091026|7170986|FG000|Overall Study|Patient withdrew and never received trea|0
4392858|NCT00091026|7170987|FG001|Overall Study|Patient withdrew and never received trea|2
4392859|NCT00091026|7170986|FG000|Overall Study|Unknown-never received treatment|0
4392860|NCT00091026|7170987|FG001|Overall Study|Unknown-never received treatment|1
4392861|NCT00091169|7170995|FG000|Overall Study|Disease progression|3
4392862|NCT00091169|7170996|FG001|Overall Study|Disease progression|1
4392863|NCT00091169|7170995|FG000|Overall Study|Adverse Event|11
4392864|NCT00091169|7170996|FG001|Overall Study|Adverse Event|17
4392865|NCT00091169|7170995|FG000|Overall Study|Death|4
4392866|NCT00091169|7170996|FG001|Overall Study|Death|1
4392867|NCT00091169|7170995|FG000|Overall Study|Withdrawal by Subject|10
4392868|NCT00091169|7170996|FG001|Overall Study|Withdrawal by Subject|13
4392869|NCT00091169|7170995|FG000|Overall Study|Other|3
4392870|NCT00091169|7170996|FG001|Overall Study|Other|4
4392871|NCT00091169|7170995|FG000|Overall Study|Not start protocol therapy|26
4392872|NCT00091169|7170996|FG001|Overall Study|Not start protocol therapy|17
4392873|NCT00091390|7171013|FG000|Overall Study|Protocol Violation|1
4392874|NCT00091390|7171013|FG000|Overall Study|No protocol treatment|3
4392875|NCT00091442|7171019|FG000|Overall Study|Progressive Disease|220
4392876|NCT00091442|7171020|FG001|Overall Study|Progressive Disease|189
4392877|NCT00091442|7171019|FG000|Overall Study|Physician Decision|61
4392878|NCT00091442|7171020|FG001|Overall Study|Physician Decision|58
4392879|NCT00091442|7171019|FG000|Overall Study|Withdrawal by Subject|38
4392880|NCT00091442|7171020|FG001|Overall Study|Withdrawal by Subject|46
4392881|NCT00091442|7171019|FG000|Overall Study|Adverse Event|29
4392882|NCT00091442|7171020|FG001|Overall Study|Adverse Event|48
4392883|NCT00091442|7171019|FG000|Overall Study|2cycles therapy beyond Complete response|9
4392884|NCT00091442|7171020|FG001|Overall Study|2cycles therapy beyond Complete response|16
4392885|NCT00091442|7171019|FG000|Overall Study|Death|9
4392886|NCT00091442|7171020|FG001|Overall Study|Death|7
4392887|NCT00091442|7171019|FG000|Overall Study|Lost to Follow-up|1
4392888|NCT00091442|7171020|FG001|Overall Study|Lost to Follow-up|3
4392889|NCT00091442|7171019|FG000|Overall Study|Other|2
4392890|NCT00091442|7171020|FG001|Overall Study|Other|6
4392891|NCT00091572|7171037|FG000|Overall Study|Lost to Follow-up|1
4392892|NCT00091572|7171038|FG001|Overall Study|Lost to Follow-up|1
4392893|NCT00091572|7171037|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14
4392894|NCT00091572|7171038|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22
4392895|NCT00091572|7171037|FG000|Overall Study|Death not due to malignancy/toxicity|1
4392896|NCT00091572|7171038|FG001|Overall Study|Death not due to malignancy/toxicity|3
4392897|NCT00091572|7171037|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10
4392898|NCT00091572|7171038|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22
4392899|NCT00091572|7171037|FG000|Overall Study|Other Reason|6
4392900|NCT00091572|7171038|FG001|Overall Study|Other Reason|13
4392901|NCT00091572|7171037|FG000|Overall Study|Ongoing (still on treatment)|8
4392902|NCT00091572|7171038|FG001|Overall Study|Ongoing (still on treatment)|12
4392903|NCT00091572|7171037|FG000|Overall Study|Major Protocol Violation|2
4392904|NCT00091572|7171038|FG001|Overall Study|Major Protocol Violation|0
4392905|NCT00091572|7171037|FG000|Overall Study|Toxicity (Related AE)|53
4392906|NCT00091572|7171038|FG001|Overall Study|Toxicity (Related AE)|9
4392907|NCT00091793|7171046|FG000|Overall Study|Adverse Event|1
4392908|NCT00091793|7171047|FG001|Overall Study|Adverse Event|2
4392909|NCT00091793|7171046|FG000|Overall Study|Withdrawal by Subject|10
4392910|NCT00091793|7171047|FG001|Overall Study|Withdrawal by Subject|15
4392911|NCT00091793|7171046|FG000|Overall Study|Ineligibility determined|2
4392912|NCT00091793|7171047|FG001|Overall Study|Ineligibility determined|0
4392913|NCT00091793|7171046|FG000|Overall Study|Lost to Follow-up|7
4392914|NCT00091793|7171047|FG001|Overall Study|Lost to Follow-up|5
4392915|NCT00091793|7171046|FG000|Overall Study|Noncompliance|2
4392916|NCT00091793|7171047|FG001|Overall Study|Noncompliance|0
4392917|NCT00091793|7171046|FG000|Overall Study|Other|2
4392918|NCT00091793|7171047|FG001|Overall Study|Other|0
4392919|NCT00091819|7171055|FG000|Overall Study|Adverse Event|1
4392920|NCT00091819|7171056|FG001|Overall Study|Adverse Event|1
4392921|NCT00091819|7171055|FG000|Overall Study|Death|4
4392922|NCT00091819|7171056|FG001|Overall Study|Death|5
4392923|NCT00091819|7171055|FG000|Overall Study|Lost to Follow-up|26
4392924|NCT00091819|7171056|FG001|Overall Study|Lost to Follow-up|23
4392925|NCT00091819|7171055|FG000|Overall Study|Withdrawal by Subject|5
4392926|NCT00091819|7171056|FG001|Overall Study|Withdrawal by Subject|8
4392927|NCT00091819|7171055|FG000|Overall Study|Protocol Violation|1
4392928|NCT00091819|7171056|FG001|Overall Study|Protocol Violation|2
4392929|NCT00091819|7171055|FG000|Overall Study|Other|2
4392930|NCT00091819|7171056|FG001|Overall Study|Other|3
4392931|NCT00091819|7171055|FG000|Overall Study|Never received study treatment|3
4392932|NCT00091819|7171056|FG001|Overall Study|Never received study treatment|4
4392933|NCT00091832|7171068|FG000|Overall Study|Physician Decision|1
4392934|NCT00091832|7171069|FG001|Overall Study|Physician Decision|0
4392935|NCT00091832|7171070|FG002|Overall Study|Physician Decision|0
4392936|NCT00091832|7171071|FG003|Overall Study|Physician Decision|0
4392937|NCT00091832|7171072|FG004|Overall Study|Physician Decision|0
4392938|NCT00091832|7171073|FG005|Overall Study|Physician Decision|0
4392939|NCT00091832|7171068|FG000|Overall Study|Adverse Event|0
4392940|NCT00091832|7171069|FG001|Overall Study|Adverse Event|0
4392941|NCT00091832|7171070|FG002|Overall Study|Adverse Event|0
4392942|NCT00091832|7171071|FG003|Overall Study|Adverse Event|1
4392943|NCT00091832|7171072|FG004|Overall Study|Adverse Event|3
4392944|NCT00091832|7171073|FG005|Overall Study|Adverse Event|0
4392945|NCT00091832|7171068|FG000|Overall Study|Withdrawal by Subject|4
4392946|NCT00091832|7171069|FG001|Overall Study|Withdrawal by Subject|5
4392947|NCT00091832|7171070|FG002|Overall Study|Withdrawal by Subject|0
4392948|NCT00091832|7171071|FG003|Overall Study|Withdrawal by Subject|1
4392949|NCT00091832|7171072|FG004|Overall Study|Withdrawal by Subject|3
4392950|NCT00091832|7171073|FG005|Overall Study|Withdrawal by Subject|1
4392951|NCT00091832|7171068|FG000|Overall Study|Death|6
4392952|NCT00091832|7171069|FG001|Overall Study|Death|4
4392953|NCT00091832|7171070|FG002|Overall Study|Death|5
4392954|NCT00091832|7171071|FG003|Overall Study|Death|8
4392955|NCT00091832|7171072|FG004|Overall Study|Death|5
4392956|NCT00091832|7171073|FG005|Overall Study|Death|6
4392957|NCT00091832|7171068|FG000|Overall Study|Disease Progression|2
4392958|NCT00091832|7171069|FG001|Overall Study|Disease Progression|0
4392959|NCT00091832|7171070|FG002|Overall Study|Disease Progression|0
4392960|NCT00091832|7171071|FG003|Overall Study|Disease Progression|1
4392961|NCT00091832|7171072|FG004|Overall Study|Disease Progression|1
4392962|NCT00091832|7171073|FG005|Overall Study|Disease Progression|2
4392963|NCT00091832|7171068|FG000|Overall Study|Ineligibility Determined|0
4392964|NCT00091832|7171069|FG001|Overall Study|Ineligibility Determined|0
4392965|NCT00091832|7171070|FG002|Overall Study|Ineligibility Determined|1
4392966|NCT00091832|7171071|FG003|Overall Study|Ineligibility Determined|0
4392967|NCT00091832|7171072|FG004|Overall Study|Ineligibility Determined|1
4392968|NCT00091832|7171073|FG005|Overall Study|Ineligibility Determined|0
4392969|NCT00091832|7171068|FG000|Overall Study|Lost to Follow-up|1
4392970|NCT00091832|7171069|FG001|Overall Study|Lost to Follow-up|0
4392971|NCT00091832|7171070|FG002|Overall Study|Lost to Follow-up|3
4392972|NCT00091832|7171071|FG003|Overall Study|Lost to Follow-up|3
4392973|NCT00091832|7171072|FG004|Overall Study|Lost to Follow-up|2
4392974|NCT00091832|7171073|FG005|Overall Study|Lost to Follow-up|1
4392975|NCT00091832|7171068|FG000|Overall Study|Noncompliance|0
4392976|NCT00091832|7171069|FG001|Overall Study|Noncompliance|1
4392977|NCT00091832|7171070|FG002|Overall Study|Noncompliance|0
4392978|NCT00091832|7171071|FG003|Overall Study|Noncompliance|0
4392979|NCT00091832|7171072|FG004|Overall Study|Noncompliance|0
4392980|NCT00091832|7171073|FG005|Overall Study|Noncompliance|0
4392981|NCT00091832|7171068|FG000|Overall Study|Other|0
4392982|NCT00091832|7171069|FG001|Overall Study|Other|1
4392983|NCT00091832|7171070|FG002|Overall Study|Other|2
4392984|NCT00091832|7171071|FG003|Overall Study|Other|0
4392985|NCT00091832|7171072|FG004|Overall Study|Other|0
4392986|NCT00091832|7171073|FG005|Overall Study|Other|0
4392987|NCT00091832|7171068|FG000|Overall Study|Protocol Violation|0
4392988|NCT00091832|7171069|FG001|Overall Study|Protocol Violation|0
4392989|NCT00091832|7171070|FG002|Overall Study|Protocol Violation|1
4392990|NCT00091832|7171071|FG003|Overall Study|Protocol Violation|0
4392991|NCT00091832|7171072|FG004|Overall Study|Protocol Violation|0
4392992|NCT00091832|7171073|FG005|Overall Study|Protocol Violation|1
4392993|NCT00091949|7171089|FG000|Overall Study|Withdrawal by Subject|117
4392994|NCT00091949|7171090|FG001|Overall Study|Withdrawal by Subject|110
4392995|NCT00091949|7171089|FG000|Overall Study|Lost to Follow-up|58
4392996|NCT00091949|7171090|FG001|Overall Study|Lost to Follow-up|41
4392997|NCT00092417|7171114|FG000|Overall Study|Lost to Follow-up|2
4392998|NCT00092417|7171115|FG001|Overall Study|Lost to Follow-up|0
4392999|NCT00092417|7171114|FG000|Overall Study|Withdrawal by Subject|2
4393000|NCT00092417|7171115|FG001|Overall Study|Withdrawal by Subject|1
4393001|NCT00092417|7171114|FG000|Overall Study|Other|1
4393002|NCT00092417|7171115|FG001|Overall Study|Other|0
4393003|NCT00092443|7171123|FG000|Overall Study|Adverse Event|9
4393004|NCT00092443|7171124|FG001|Overall Study|Adverse Event|13
4393005|NCT00092443|7171123|FG000|Overall Study|Lost to Follow-up|7
4393006|NCT00092443|7171124|FG001|Overall Study|Lost to Follow-up|3
4393007|NCT00092443|7171123|FG000|Overall Study|Protocol Violation|11
4393008|NCT00092443|7171124|FG001|Overall Study|Protocol Violation|9
4393009|NCT00092443|7171123|FG000|Overall Study|Withdrawal by Subject|9
4393010|NCT00092443|7171124|FG001|Overall Study|Withdrawal by Subject|11
4393011|NCT00092443|7171123|FG000|Overall Study|Moved|5
4393012|NCT00092443|7171124|FG001|Overall Study|Moved|5
4393013|NCT00092443|7171123|FG000|Overall Study|Other|17
4393014|NCT00092443|7171124|FG001|Overall Study|Other|13
4393015|NCT00092456|7171144|FG000|Overall Study|Adverse Event|0
4393016|NCT00092456|7171145|FG001|Overall Study|Adverse Event|0
4393017|NCT00092456|7171146|FG002|Overall Study|Adverse Event|1
4393018|NCT00092456|7171147|FG003|Overall Study|Adverse Event|1
4393019|NCT00092456|7171144|FG000|Overall Study|Lost to Follow-up|2
4393020|NCT00092456|7171145|FG001|Overall Study|Lost to Follow-up|2
4393021|NCT00092456|7171146|FG002|Overall Study|Lost to Follow-up|1
4393022|NCT00092456|7171147|FG003|Overall Study|Lost to Follow-up|2
4393023|NCT00092456|7171144|FG000|Overall Study|Protocol Violation|5
4393024|NCT00092456|7171145|FG001|Overall Study|Protocol Violation|7
4393025|NCT00092456|7171146|FG002|Overall Study|Protocol Violation|8
4393026|NCT00092456|7171147|FG003|Overall Study|Protocol Violation|6
4393027|NCT00092456|7171144|FG000|Overall Study|Withdrawal by Subject|13
4393028|NCT00092456|7171145|FG001|Overall Study|Withdrawal by Subject|5
4393029|NCT00092456|7171146|FG002|Overall Study|Withdrawal by Subject|16
4393030|NCT00092456|7171147|FG003|Overall Study|Withdrawal by Subject|6
4393031|NCT00092456|7171144|FG000|Overall Study|Moved|1
4393032|NCT00092456|7171145|FG001|Overall Study|Moved|1
4393033|NCT00092456|7171146|FG002|Overall Study|Moved|0
4393034|NCT00092456|7171147|FG003|Overall Study|Moved|1
4393035|NCT00092456|7171144|FG000|Overall Study|Other|4
4393036|NCT00092456|7171145|FG001|Overall Study|Other|2
4393037|NCT00092456|7171146|FG002|Overall Study|Other|3
4393038|NCT00092456|7171147|FG003|Overall Study|Other|0
4393039|NCT00092495|7171161|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1
4393040|NCT00092495|7171162|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1
4393041|NCT00092495|7171163|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0
4393042|NCT00092495|7171164|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4
4393043|NCT00092495|7171165|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0
4393044|NCT00092495|7171161|FG000|Base Study Vaccination Period|Extended|0
4393045|NCT00092495|7171162|FG001|Base Study Vaccination Period|Extended|0
4393046|NCT00092495|7171163|FG002|Base Study Vaccination Period|Extended|0
4393047|NCT00092495|7171164|FG003|Base Study Vaccination Period|Extended|1
4393048|NCT00092495|7171165|FG004|Base Study Vaccination Period|Extended|0
4393049|NCT00092495|7171161|FG000|Base Study Vaccination Period|*Clinical AE|1
4712110|NCT02919761|7638387|FG001|Part 1: Open Label|Withdrawal by Subject|0
4712111|NCT02919761|7638388|FG002|Part 1: Open Label|Withdrawal by Subject|0
4712112|NCT02919761|7638386|FG000|Part 1: Open Label|Adverse Event|1
4712113|NCT02919761|7638387|FG001|Part 1: Open Label|Adverse Event|0
4393050|NCT00092495|7171162|FG001|Base Study Vaccination Period|*Clinical AE|0
4393051|NCT00092495|7171163|FG002|Base Study Vaccination Period|*Clinical AE|1
4393052|NCT00092495|7171164|FG003|Base Study Vaccination Period|*Clinical AE|2
4393053|NCT00092495|7171165|FG004|Base Study Vaccination Period|*Clinical AE|0
4393054|NCT00092495|7171161|FG000|Base Study Vaccination Period|*Other reasons|1
4393055|NCT00092495|7171162|FG001|Base Study Vaccination Period|*Other reasons|0
4393056|NCT00092495|7171163|FG002|Base Study Vaccination Period|*Other reasons|0
4393057|NCT00092495|7171164|FG003|Base Study Vaccination Period|*Other reasons|1
4393058|NCT00092495|7171165|FG004|Base Study Vaccination Period|*Other reasons|0
4393059|NCT00092495|7171161|FG000|Base Study Vaccination Period|*Pregnancy|0
4393060|NCT00092495|7171162|FG001|Base Study Vaccination Period|*Pregnancy|2
4393061|NCT00092495|7171163|FG002|Base Study Vaccination Period|*Pregnancy|5
4393062|NCT00092495|7171164|FG003|Base Study Vaccination Period|*Pregnancy|7
4393063|NCT00092495|7171165|FG004|Base Study Vaccination Period|*Pregnancy|0
4393064|NCT00092495|7171161|FG000|Base Study Vaccination Period|Adverse Event|1
4393065|NCT00092495|7171162|FG001|Base Study Vaccination Period|Adverse Event|0
4393066|NCT00092495|7171163|FG002|Base Study Vaccination Period|Adverse Event|0
4393067|NCT00092495|7171164|FG003|Base Study Vaccination Period|Adverse Event|3
4393068|NCT00092495|7171165|FG004|Base Study Vaccination Period|Adverse Event|0
4393069|NCT00092495|7171161|FG000|Base Study Vaccination Period|Lost to Follow-up|16
4393070|NCT00092495|7171162|FG001|Base Study Vaccination Period|Lost to Follow-up|6
4393071|NCT00092495|7171163|FG002|Base Study Vaccination Period|Lost to Follow-up|11
4393072|NCT00092495|7171164|FG003|Base Study Vaccination Period|Lost to Follow-up|36
4393073|NCT00092495|7171165|FG004|Base Study Vaccination Period|Lost to Follow-up|0
4393074|NCT00092495|7171161|FG000|Base Study Vaccination Period|Moved|3
4712114|NCT02919761|7638388|FG002|Part 1: Open Label|Adverse Event|0
4393075|NCT00092495|7171162|FG001|Base Study Vaccination Period|Moved|1
4393076|NCT00092495|7171163|FG002|Base Study Vaccination Period|Moved|2
4393077|NCT00092495|7171164|FG003|Base Study Vaccination Period|Moved|2
4393078|NCT00092495|7171165|FG004|Base Study Vaccination Period|Moved|0
4393079|NCT00092495|7171161|FG000|Base Study Vaccination Period|Other|1
4393080|NCT00092495|7171162|FG001|Base Study Vaccination Period|Other|1
4393081|NCT00092495|7171163|FG002|Base Study Vaccination Period|Other|0
4393082|NCT00092495|7171164|FG003|Base Study Vaccination Period|Other|2
4393083|NCT00092495|7171165|FG004|Base Study Vaccination Period|Other|0
4393084|NCT00092495|7171161|FG000|Base Study Vaccination Period|Pregnancy|2
4393085|NCT00092495|7171162|FG001|Base Study Vaccination Period|Pregnancy|0
4393086|NCT00092495|7171163|FG002|Base Study Vaccination Period|Pregnancy|0
4393087|NCT00092495|7171164|FG003|Base Study Vaccination Period|Pregnancy|0
4393088|NCT00092495|7171165|FG004|Base Study Vaccination Period|Pregnancy|0
4393089|NCT00092495|7171161|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1
4393090|NCT00092495|7171162|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1
4393091|NCT00092495|7171163|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1
4393092|NCT00092495|7171164|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5
4393093|NCT00092495|7171165|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0
4393094|NCT00092495|7171161|FG000|Base Study Vaccination Period|Protocol Violation|1
4393095|NCT00092495|7171162|FG001|Base Study Vaccination Period|Protocol Violation|0
4393096|NCT00092495|7171163|FG002|Base Study Vaccination Period|Protocol Violation|0
4393097|NCT00092495|7171164|FG003|Base Study Vaccination Period|Protocol Violation|0
4393098|NCT00092495|7171165|FG004|Base Study Vaccination Period|Protocol Violation|0
4393099|NCT00092495|7171161|FG000|Base Study Vaccination Period|Withdrawal by Subject|9
4393100|NCT00092495|7171162|FG001|Base Study Vaccination Period|Withdrawal by Subject|10
4393101|NCT00092495|7171163|FG002|Base Study Vaccination Period|Withdrawal by Subject|14
4393102|NCT00092495|7171164|FG003|Base Study Vaccination Period|Withdrawal by Subject|25
4393103|NCT00092495|7171165|FG004|Base Study Vaccination Period|Withdrawal by Subject|0
4393104|NCT00092495|7171161|FG000|Base Study Follow-up Period|Extended|0
4393105|NCT00092495|7171162|FG001|Base Study Follow-up Period|Extended|0
4393106|NCT00092495|7171163|FG002|Base Study Follow-up Period|Extended|1
4393107|NCT00092495|7171164|FG003|Base Study Follow-up Period|Extended|2
4393108|NCT00092495|7171165|FG004|Base Study Follow-up Period|Extended|0
4393109|NCT00092495|7171161|FG000|Base Study Follow-up Period|Lost to Follow-up|1
4393110|NCT00092495|7171162|FG001|Base Study Follow-up Period|Lost to Follow-up|3
4393111|NCT00092495|7171163|FG002|Base Study Follow-up Period|Lost to Follow-up|3
4393112|NCT00092495|7171164|FG003|Base Study Follow-up Period|Lost to Follow-up|12
4393113|NCT00092495|7171165|FG004|Base Study Follow-up Period|Lost to Follow-up|0
4393114|NCT00092495|7171161|FG000|Base Study Follow-up Period|Withdrawal by Subject|2
4393115|NCT00092495|7171162|FG001|Base Study Follow-up Period|Withdrawal by Subject|0
4393116|NCT00092495|7171163|FG002|Base Study Follow-up Period|Withdrawal by Subject|0
4393117|NCT00092495|7171164|FG003|Base Study Follow-up Period|Withdrawal by Subject|0
4393118|NCT00092495|7171165|FG004|Base Study Follow-up Period|Withdrawal by Subject|0
4393119|NCT00092521|7171181|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6
4393120|NCT00092521|7171182|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0
4393121|NCT00092521|7171183|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7
4393122|NCT00092521|7171184|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0
4393123|NCT00092521|7171181|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1
4393124|NCT00092521|7171182|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0
4393125|NCT00092521|7171183|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7
4393126|NCT00092521|7171184|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0
4393127|NCT00092521|7171181|FG000|Vaccination (Day 1 Through Month 7)|Death|0
4393128|NCT00092521|7171182|FG001|Vaccination (Day 1 Through Month 7)|Death|0
4393129|NCT00092521|7171183|FG002|Vaccination (Day 1 Through Month 7)|Death|1
4393130|NCT00092521|7171184|FG003|Vaccination (Day 1 Through Month 7)|Death|0
4393131|NCT00092521|7171181|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51
4393132|NCT00092521|7171182|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6
4393133|NCT00092521|7171183|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44
4393134|NCT00092521|7171184|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0
4393135|NCT00092521|7171181|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5
4393136|NCT00092521|7171182|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0
4393137|NCT00092521|7171183|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7
4393138|NCT00092521|7171184|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0
4393139|NCT00092521|7171181|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59
4393140|NCT00092521|7171182|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7
4393141|NCT00092521|7171183|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62
4393142|NCT00092521|7171184|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0
4393143|NCT00092521|7171181|FG000|Vaccination (Day 1 Through Month 7)|Moved|14
4393144|NCT00092521|7171182|FG001|Vaccination (Day 1 Through Month 7)|Moved|1
4393145|NCT00092521|7171183|FG002|Vaccination (Day 1 Through Month 7)|Moved|18
4393146|NCT00092521|7171184|FG003|Vaccination (Day 1 Through Month 7)|Moved|0
4393147|NCT00092521|7171181|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2
4393148|NCT00092521|7171182|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0
4393149|NCT00092521|7171183|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0
4393150|NCT00092521|7171184|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0
4393151|NCT00092521|7171181|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2
4393152|NCT00092521|7171182|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
4393153|NCT00092521|7171183|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
4393154|NCT00092521|7171184|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
4393155|NCT00092521|7171181|FG000|Follow-Up (After Month 7)|Subjects Continuing|34
4393156|NCT00092521|7171182|FG001|Follow-Up (After Month 7)|Subjects Continuing|4
4393157|NCT00092521|7171183|FG002|Follow-Up (After Month 7)|Subjects Continuing|35
4393158|NCT00092521|7171184|FG003|Follow-Up (After Month 7)|Subjects Continuing|0
4393159|NCT00092521|7171181|FG000|Follow-Up (After Month 7)|Subjects in Extension|13
4393160|NCT00092521|7171182|FG001|Follow-Up (After Month 7)|Subjects in Extension|109
4393161|NCT00092521|7171183|FG002|Follow-Up (After Month 7)|Subjects in Extension|412
4393162|NCT00092521|7171184|FG003|Follow-Up (After Month 7)|Subjects in Extension|0
4393163|NCT00092521|7171181|FG000|Follow-Up (After Month 7)|Adverse Event|1
4393164|NCT00092521|7171182|FG001|Follow-Up (After Month 7)|Adverse Event|0
4393165|NCT00092521|7171183|FG002|Follow-Up (After Month 7)|Adverse Event|0
4393166|NCT00092521|7171184|FG003|Follow-Up (After Month 7)|Adverse Event|0
4393167|NCT00092521|7171181|FG000|Follow-Up (After Month 7)|Death|2
4393168|NCT00092521|7171182|FG001|Follow-Up (After Month 7)|Death|0
4393169|NCT00092521|7171183|FG002|Follow-Up (After Month 7)|Death|1
4393170|NCT00092521|7171184|FG003|Follow-Up (After Month 7)|Death|0
4393171|NCT00092521|7171181|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113
4393172|NCT00092521|7171182|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14
4393173|NCT00092521|7171183|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108
4393174|NCT00092521|7171184|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0
4393175|NCT00092521|7171181|FG000|Follow-Up (After Month 7)|Protocol Violation|1
4393176|NCT00092521|7171182|FG001|Follow-Up (After Month 7)|Protocol Violation|1
4393177|NCT00092521|7171183|FG002|Follow-Up (After Month 7)|Protocol Violation|5
4393178|NCT00092521|7171184|FG003|Follow-Up (After Month 7)|Protocol Violation|0
4393179|NCT00092521|7171181|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40
4393180|NCT00092521|7171182|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6
4393181|NCT00092521|7171183|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51
4393182|NCT00092521|7171184|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0
4393183|NCT00092521|7171181|FG000|Follow-Up (After Month 7)|Moved|32
4393184|NCT00092521|7171182|FG001|Follow-Up (After Month 7)|Moved|2
4393185|NCT00092521|7171183|FG002|Follow-Up (After Month 7)|Moved|28
4393186|NCT00092521|7171184|FG003|Follow-Up (After Month 7)|Moved|0
4393187|NCT00092521|7171181|FG000|Follow-Up (After Month 7)|Site Terminated|3
4393188|NCT00092521|7171182|FG001|Follow-Up (After Month 7)|Site Terminated|0
4393189|NCT00092521|7171183|FG002|Follow-Up (After Month 7)|Site Terminated|3
4393190|NCT00092521|7171184|FG003|Follow-Up (After Month 7)|Site Terminated|0
4393191|NCT00092521|7171181|FG000|Follow-Up (After Month 7)|Travel|2
4393192|NCT00092521|7171182|FG001|Follow-Up (After Month 7)|Travel|0
4393193|NCT00092521|7171183|FG002|Follow-Up (After Month 7)|Travel|0
4393194|NCT00092521|7171184|FG003|Follow-Up (After Month 7)|Travel|0
4393195|NCT00092521|7171181|FG000|Follow-Up (After Month 7)|Visits Compressed|5
4393196|NCT00092521|7171182|FG001|Follow-Up (After Month 7)|Visits Compressed|0
4393197|NCT00092521|7171183|FG002|Follow-Up (After Month 7)|Visits Compressed|5
4393198|NCT00092521|7171184|FG003|Follow-Up (After Month 7)|Visits Compressed|0
4393199|NCT00092521|7171181|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0
4393200|NCT00092521|7171182|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0
4393201|NCT00092521|7171183|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0
4393202|NCT00092521|7171184|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23
4393203|NCT00092521|7171181|FG000|Extension Study (Group 4)|Adverse Event|0
4393204|NCT00092521|7171182|FG001|Extension Study (Group 4)|Adverse Event|0
4393205|NCT00092521|7171183|FG002|Extension Study (Group 4)|Adverse Event|0
4393206|NCT00092521|7171184|FG003|Extension Study (Group 4)|Adverse Event|2
4393207|NCT00092521|7171181|FG000|Extension Study (Group 4)|Lost to Follow-up|0
4393208|NCT00092521|7171182|FG001|Extension Study (Group 4)|Lost to Follow-up|0
4393209|NCT00092521|7171183|FG002|Extension Study (Group 4)|Lost to Follow-up|0
4393210|NCT00092521|7171184|FG003|Extension Study (Group 4)|Lost to Follow-up|87
4393211|NCT00092521|7171181|FG000|Extension Study (Group 4)|Pregnancy|0
4393212|NCT00092521|7171182|FG001|Extension Study (Group 4)|Pregnancy|0
4393213|NCT00092521|7171183|FG002|Extension Study (Group 4)|Pregnancy|0
4393214|NCT00092521|7171184|FG003|Extension Study (Group 4)|Pregnancy|4
4393215|NCT00092521|7171181|FG000|Extension Study (Group 4)|Protocol Violation|0
4393216|NCT00092521|7171182|FG001|Extension Study (Group 4)|Protocol Violation|0
4393217|NCT00092521|7171183|FG002|Extension Study (Group 4)|Protocol Violation|0
4393218|NCT00092521|7171184|FG003|Extension Study (Group 4)|Protocol Violation|2
4510782|NCT00922974|7319667|FG001|Phase III Component|Protocol Violation|6
4393219|NCT00092521|7171181|FG000|Extension Study (Group 4)|Withdrawal by Subject|0
4393220|NCT00092521|7171182|FG001|Extension Study (Group 4)|Withdrawal by Subject|0
4393221|NCT00092521|7171183|FG002|Extension Study (Group 4)|Withdrawal by Subject|0
4393222|NCT00092521|7171184|FG003|Extension Study (Group 4)|Withdrawal by Subject|46
4393223|NCT00092521|7171181|FG000|Extension Study (Group 4)|Moved|0
4393224|NCT00092521|7171182|FG001|Extension Study (Group 4)|Moved|0
4393225|NCT00092521|7171183|FG002|Extension Study (Group 4)|Moved|0
4393226|NCT00092521|7171184|FG003|Extension Study (Group 4)|Moved|16
4393227|NCT00092521|7171181|FG000|Extension Study (Group 4)|Site Terminated|0
4393228|NCT00092521|7171182|FG001|Extension Study (Group 4)|Site Terminated|0
4393229|NCT00092521|7171183|FG002|Extension Study (Group 4)|Site Terminated|0
4393230|NCT00092521|7171184|FG003|Extension Study (Group 4)|Site Terminated|4
4393231|NCT00092521|7171181|FG000|Extension Study (Group 4)|Unable/unwilling to return|0
4393232|NCT00092521|7171182|FG001|Extension Study (Group 4)|Unable/unwilling to return|0
4393233|NCT00092521|7171183|FG002|Extension Study (Group 4)|Unable/unwilling to return|0
4393234|NCT00092521|7171184|FG003|Extension Study (Group 4)|Unable/unwilling to return|25
4393235|NCT00092534|7171194|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5
4393236|NCT00092534|7171195|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5
4393237|NCT00092534|7171196|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0
4393238|NCT00092534|7171197|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0
4393239|NCT00092534|7171198|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0
4393240|NCT00092534|7171194|FG000|Base Study Vaccination Period|Adverse Event|3
4393241|NCT00092534|7171195|FG001|Base Study Vaccination Period|Adverse Event|1
4393242|NCT00092534|7171196|FG002|Base Study Vaccination Period|Adverse Event|0
4393243|NCT00092534|7171197|FG003|Base Study Vaccination Period|Adverse Event|0
4393244|NCT00092534|7171198|FG004|Base Study Vaccination Period|Adverse Event|0
4393245|NCT00092534|7171194|FG000|Base Study Vaccination Period|Death|5
4393246|NCT00092534|7171195|FG001|Base Study Vaccination Period|Death|4
4393247|NCT00092534|7171196|FG002|Base Study Vaccination Period|Death|0
4393248|NCT00092534|7171197|FG003|Base Study Vaccination Period|Death|0
4393249|NCT00092534|7171198|FG004|Base Study Vaccination Period|Death|0
4393250|NCT00092534|7171194|FG000|Base Study Vaccination Period|Lost to Follow-up|41
4393251|NCT00092534|7171195|FG001|Base Study Vaccination Period|Lost to Follow-up|37
4393252|NCT00092534|7171196|FG002|Base Study Vaccination Period|Lost to Follow-up|0
4393253|NCT00092534|7171197|FG003|Base Study Vaccination Period|Lost to Follow-up|0
4393254|NCT00092534|7171198|FG004|Base Study Vaccination Period|Lost to Follow-up|0
4393255|NCT00092534|7171194|FG000|Base Study Vaccination Period|Physician Decision|1
4393256|NCT00092534|7171195|FG001|Base Study Vaccination Period|Physician Decision|0
4393257|NCT00092534|7171196|FG002|Base Study Vaccination Period|Physician Decision|0
4393258|NCT00092534|7171197|FG003|Base Study Vaccination Period|Physician Decision|0
4393259|NCT00092534|7171198|FG004|Base Study Vaccination Period|Physician Decision|0
4393260|NCT00092534|7171194|FG000|Base Study Vaccination Period|Pregnancy|9
4393261|NCT00092534|7171195|FG001|Base Study Vaccination Period|Pregnancy|7
4393262|NCT00092534|7171196|FG002|Base Study Vaccination Period|Pregnancy|0
4393263|NCT00092534|7171197|FG003|Base Study Vaccination Period|Pregnancy|0
4393264|NCT00092534|7171198|FG004|Base Study Vaccination Period|Pregnancy|0
4393265|NCT00092534|7171194|FG000|Base Study Vaccination Period|Protocol Violation|2
4393266|NCT00092534|7171195|FG001|Base Study Vaccination Period|Protocol Violation|1
4393267|NCT00092534|7171196|FG002|Base Study Vaccination Period|Protocol Violation|0
4393268|NCT00092534|7171197|FG003|Base Study Vaccination Period|Protocol Violation|0
4393269|NCT00092534|7171198|FG004|Base Study Vaccination Period|Protocol Violation|0
4393270|NCT00092534|7171194|FG000|Base Study Vaccination Period|Withdrawal by Subject|85
4393271|NCT00092534|7171195|FG001|Base Study Vaccination Period|Withdrawal by Subject|58
4393272|NCT00092534|7171196|FG002|Base Study Vaccination Period|Withdrawal by Subject|0
4393273|NCT00092534|7171197|FG003|Base Study Vaccination Period|Withdrawal by Subject|0
4393274|NCT00092534|7171198|FG004|Base Study Vaccination Period|Withdrawal by Subject|0
4393275|NCT00092534|7171194|FG000|Base Study Vaccination Period|Moved|14
4393276|NCT00092534|7171195|FG001|Base Study Vaccination Period|Moved|12
4393277|NCT00092534|7171196|FG002|Base Study Vaccination Period|Moved|0
4393278|NCT00092534|7171197|FG003|Base Study Vaccination Period|Moved|0
4393279|NCT00092534|7171198|FG004|Base Study Vaccination Period|Moved|0
4393280|NCT00092534|7171194|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5
4393281|NCT00092534|7171195|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0
4393282|NCT00092534|7171196|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0
4393283|NCT00092534|7171197|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0
4393284|NCT00092534|7171198|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0
4393285|NCT00092534|7171194|FG000|Base Study Vaccination Period|Travel|1
4393286|NCT00092534|7171195|FG001|Base Study Vaccination Period|Travel|0
4393287|NCT00092534|7171196|FG002|Base Study Vaccination Period|Travel|0
4393288|NCT00092534|7171197|FG003|Base Study Vaccination Period|Travel|0
4393289|NCT00092534|7171198|FG004|Base Study Vaccination Period|Travel|0
4393290|NCT00092534|7171194|FG000|Base Study Vaccination Period|Site Closed|0
4393291|NCT00092534|7171195|FG001|Base Study Vaccination Period|Site Closed|1
4393292|NCT00092534|7171196|FG002|Base Study Vaccination Period|Site Closed|0
4393293|NCT00092534|7171197|FG003|Base Study Vaccination Period|Site Closed|0
4393294|NCT00092534|7171198|FG004|Base Study Vaccination Period|Site Closed|0
4393295|NCT00092534|7171194|FG000|Base Study Follow-Up Period|Adverse Event|2
4393296|NCT00092534|7171195|FG001|Base Study Follow-Up Period|Adverse Event|4
4393297|NCT00092534|7171196|FG002|Base Study Follow-Up Period|Adverse Event|0
4393298|NCT00092534|7171197|FG003|Base Study Follow-Up Period|Adverse Event|0
4393299|NCT00092534|7171198|FG004|Base Study Follow-Up Period|Adverse Event|0
4393300|NCT00092534|7171194|FG000|Base Study Follow-Up Period|Death|2
4393301|NCT00092534|7171195|FG001|Base Study Follow-Up Period|Death|1
4393302|NCT00092534|7171196|FG002|Base Study Follow-Up Period|Death|0
4393303|NCT00092534|7171197|FG003|Base Study Follow-Up Period|Death|0
4393304|NCT00092534|7171198|FG004|Base Study Follow-Up Period|Death|0
4393305|NCT00092534|7171194|FG000|Base Study Follow-Up Period|Lost to Follow-up|120
4393306|NCT00092534|7171195|FG001|Base Study Follow-Up Period|Lost to Follow-up|146
4393307|NCT00092534|7171196|FG002|Base Study Follow-Up Period|Lost to Follow-up|0
4393308|NCT00092534|7171197|FG003|Base Study Follow-Up Period|Lost to Follow-up|0
4393309|NCT00092534|7171198|FG004|Base Study Follow-Up Period|Lost to Follow-up|0
4393310|NCT00092534|7171194|FG000|Base Study Follow-Up Period|Pregnancy|6
4393311|NCT00092534|7171195|FG001|Base Study Follow-Up Period|Pregnancy|10
4393312|NCT00092534|7171196|FG002|Base Study Follow-Up Period|Pregnancy|0
4393313|NCT00092534|7171197|FG003|Base Study Follow-Up Period|Pregnancy|0
4393314|NCT00092534|7171198|FG004|Base Study Follow-Up Period|Pregnancy|0
4393315|NCT00092534|7171194|FG000|Base Study Follow-Up Period|Protocol Violation|1
4393316|NCT00092534|7171195|FG001|Base Study Follow-Up Period|Protocol Violation|2
4393317|NCT00092534|7171196|FG002|Base Study Follow-Up Period|Protocol Violation|0
4393318|NCT00092534|7171197|FG003|Base Study Follow-Up Period|Protocol Violation|0
4393319|NCT00092534|7171198|FG004|Base Study Follow-Up Period|Protocol Violation|0
4393320|NCT00092534|7171194|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71
4628441|NCT01859988|7495593|FG004|Overall Study|Withdrawal by Subject|2
4628442|NCT01859988|7495594|FG005|Overall Study|Withdrawal by Subject|2
4628443|NCT01859988|7495589|FG000|Overall Study|Lack of Efficacy|1
4628444|NCT01859988|7495590|FG001|Overall Study|Lack of Efficacy|1
4628445|NCT01859988|7495591|FG002|Overall Study|Lack of Efficacy|5
4628446|NCT01859988|7495592|FG003|Overall Study|Lack of Efficacy|0
4628447|NCT01859988|7495593|FG004|Overall Study|Lack of Efficacy|7
4628448|NCT01859988|7495594|FG005|Overall Study|Lack of Efficacy|9
4628449|NCT01859988|7495589|FG000|Overall Study|Physician Decision|1
4628450|NCT01859988|7495590|FG001|Overall Study|Physician Decision|3
4628451|NCT01859988|7495591|FG002|Overall Study|Physician Decision|1
4628452|NCT01859988|7495592|FG003|Overall Study|Physician Decision|3
4628453|NCT01859988|7495593|FG004|Overall Study|Physician Decision|4
4628454|NCT01859988|7495594|FG005|Overall Study|Physician Decision|1
4628455|NCT01859988|7495589|FG000|Overall Study|Adverse Event|2
4628456|NCT01859988|7495590|FG001|Overall Study|Adverse Event|1
4628457|NCT01859988|7495591|FG002|Overall Study|Adverse Event|3
4628458|NCT01859988|7495592|FG003|Overall Study|Adverse Event|1
4628459|NCT01859988|7495593|FG004|Overall Study|Adverse Event|2
4628460|NCT01859988|7495594|FG005|Overall Study|Adverse Event|2
4628461|NCT01859988|7495589|FG000|Overall Study|Lost to Follow-up|1
4628462|NCT01859988|7495590|FG001|Overall Study|Lost to Follow-up|2
4628463|NCT01859988|7495591|FG002|Overall Study|Lost to Follow-up|3
4628464|NCT01859988|7495592|FG003|Overall Study|Lost to Follow-up|0
4628465|NCT01859988|7495593|FG004|Overall Study|Lost to Follow-up|3
4628466|NCT01859988|7495594|FG005|Overall Study|Lost to Follow-up|2
4628467|NCT01859988|7495589|FG000|Overall Study|Protocol Violation|0
4628468|NCT01859988|7495590|FG001|Overall Study|Protocol Violation|0
4628469|NCT01859988|7495591|FG002|Overall Study|Protocol Violation|1
4628470|NCT01859988|7495592|FG003|Overall Study|Protocol Violation|0
4628471|NCT01859988|7495593|FG004|Overall Study|Protocol Violation|0
4628472|NCT01859988|7495594|FG005|Overall Study|Protocol Violation|0
4628473|NCT01859988|7495589|FG000|Overall Study|Other than specified above|0
4628474|NCT01859988|7495590|FG001|Overall Study|Other than specified above|2
4393321|NCT00092534|7171195|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62
4393322|NCT00092534|7171196|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0
4393323|NCT00092534|7171197|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0
4393324|NCT00092534|7171198|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0
4393325|NCT00092534|7171194|FG000|Base Study Follow-Up Period|Moved|62
4393326|NCT00092534|7171195|FG001|Base Study Follow-Up Period|Moved|58
4393327|NCT00092534|7171196|FG002|Base Study Follow-Up Period|Moved|0
4393328|NCT00092534|7171197|FG003|Base Study Follow-Up Period|Moved|0
4393329|NCT00092534|7171198|FG004|Base Study Follow-Up Period|Moved|0
4393330|NCT00092534|7171194|FG000|Base Study Follow-Up Period|Travel|10
4393331|NCT00092534|7171195|FG001|Base Study Follow-Up Period|Travel|7
4393332|NCT00092534|7171196|FG002|Base Study Follow-Up Period|Travel|0
4393333|NCT00092534|7171197|FG003|Base Study Follow-Up Period|Travel|0
4393334|NCT00092534|7171198|FG004|Base Study Follow-Up Period|Travel|0
4393335|NCT00092534|7171194|FG000|Base Study Follow-Up Period|Site Closed|0
4393336|NCT00092534|7171195|FG001|Base Study Follow-Up Period|Site Closed|2
4393337|NCT00092534|7171196|FG002|Base Study Follow-Up Period|Site Closed|0
4393338|NCT00092534|7171197|FG003|Base Study Follow-Up Period|Site Closed|0
4393339|NCT00092534|7171198|FG004|Base Study Follow-Up Period|Site Closed|0
4393340|NCT00092534|7171194|FG000|Base Study Follow-Up Period|Subjects continuing|27
4393341|NCT00092534|7171195|FG001|Base Study Follow-Up Period|Subjects continuing|31
4393342|NCT00092534|7171196|FG002|Base Study Follow-Up Period|Subjects continuing|0
4393343|NCT00092534|7171197|FG003|Base Study Follow-Up Period|Subjects continuing|0
4393344|NCT00092534|7171198|FG004|Base Study Follow-Up Period|Subjects continuing|0
4628475|NCT01859988|7495591|FG002|Overall Study|Other than specified above|11
4628476|NCT01859988|7495592|FG003|Overall Study|Other than specified above|3
4628477|NCT01859988|7495593|FG004|Overall Study|Other than specified above|5
4628478|NCT01859988|7495594|FG005|Overall Study|Other than specified above|3
4628479|NCT01860079|7495610|FG000|Overall Study|Physician Decision|14
4628480|NCT01860079|7495611|FG001|Overall Study|Physician Decision|22
4393345|NCT00092534|7171194|FG000|Base Study Follow-Up Period|Subjects in extension|15
4393346|NCT00092534|7171195|FG001|Base Study Follow-Up Period|Subjects in extension|371
4393347|NCT00092534|7171196|FG002|Base Study Follow-Up Period|Subjects in extension|0
4393348|NCT00092534|7171197|FG003|Base Study Follow-Up Period|Subjects in extension|0
4393349|NCT00092534|7171198|FG004|Base Study Follow-Up Period|Subjects in extension|0
4393350|NCT00092534|7171194|FG000|Base Study EXT|Lost to Follow-up|0
4393351|NCT00092534|7171195|FG001|Base Study EXT|Lost to Follow-up|0
4393352|NCT00092534|7171196|FG002|Base Study EXT|Lost to Follow-up|41
4393353|NCT00092534|7171197|FG003|Base Study EXT|Lost to Follow-up|0
4393354|NCT00092534|7171198|FG004|Base Study EXT|Lost to Follow-up|0
4393355|NCT00092534|7171194|FG000|Base Study EXT|Physician Decision|0
4393356|NCT00092534|7171195|FG001|Base Study EXT|Physician Decision|0
4393357|NCT00092534|7171196|FG002|Base Study EXT|Physician Decision|1
4393358|NCT00092534|7171197|FG003|Base Study EXT|Physician Decision|0
4393359|NCT00092534|7171198|FG004|Base Study EXT|Physician Decision|0
4393360|NCT00092534|7171194|FG000|Base Study EXT|Pregnancy|0
4393361|NCT00092534|7171195|FG001|Base Study EXT|Pregnancy|0
4393362|NCT00092534|7171196|FG002|Base Study EXT|Pregnancy|12
4393363|NCT00092534|7171197|FG003|Base Study EXT|Pregnancy|0
4393364|NCT00092534|7171198|FG004|Base Study EXT|Pregnancy|0
4393365|NCT00092534|7171194|FG000|Base Study EXT|Withdrawal by Subject|0
4393366|NCT00092534|7171195|FG001|Base Study EXT|Withdrawal by Subject|0
4393367|NCT00092534|7171196|FG002|Base Study EXT|Withdrawal by Subject|18
4393368|NCT00092534|7171197|FG003|Base Study EXT|Withdrawal by Subject|0
4393369|NCT00092534|7171198|FG004|Base Study EXT|Withdrawal by Subject|0
4393370|NCT00092534|7171194|FG000|Base Study EXT|Participant moved|0
4393371|NCT00092534|7171195|FG001|Base Study EXT|Participant moved|0
4393372|NCT00092534|7171196|FG002|Base Study EXT|Participant moved|6
4393373|NCT00092534|7171197|FG003|Base Study EXT|Participant moved|0
4393374|NCT00092534|7171198|FG004|Base Study EXT|Participant moved|0
4393375|NCT00092534|7171194|FG000|Base Study EXT|Travel|0
4393376|NCT00092534|7171195|FG001|Base Study EXT|Travel|0
4393377|NCT00092534|7171196|FG002|Base Study EXT|Travel|2
4393378|NCT00092534|7171197|FG003|Base Study EXT|Travel|0
4393379|NCT00092534|7171198|FG004|Base Study EXT|Travel|0
4393380|NCT00092534|7171194|FG000|Base Study EXT|Site closed|0
4393381|NCT00092534|7171195|FG001|Base Study EXT|Site closed|0
4393382|NCT00092534|7171196|FG002|Base Study EXT|Site closed|21
4393383|NCT00092534|7171197|FG003|Base Study EXT|Site closed|0
4393384|NCT00092534|7171198|FG004|Base Study EXT|Site closed|0
4393385|NCT00092534|7171194|FG000|Base Study EXT|Study ended|0
4393386|NCT00092534|7171195|FG001|Base Study EXT|Study ended|0
4393387|NCT00092534|7171196|FG002|Base Study EXT|Study ended|29
4393388|NCT00092534|7171197|FG003|Base Study EXT|Study ended|0
4393389|NCT00092534|7171198|FG004|Base Study EXT|Study ended|0
4393390|NCT00092534|7171194|FG000|Base Study EXT|Protocol Violation|0
4393391|NCT00092534|7171195|FG001|Base Study EXT|Protocol Violation|0
4393392|NCT00092534|7171196|FG002|Base Study EXT|Protocol Violation|15
4393393|NCT00092534|7171197|FG003|Base Study EXT|Protocol Violation|0
4393394|NCT00092534|7171198|FG004|Base Study EXT|Protocol Violation|0
4393395|NCT00092534|7171194|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0
4393396|NCT00092534|7171195|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0
4393397|NCT00092534|7171196|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0
4393398|NCT00092534|7171197|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1
4393399|NCT00092534|7171198|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0
4393400|NCT00092547|7171210|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5
4393401|NCT00092547|7171211|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1
4393402|NCT00092547|7171212|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0
4393403|NCT00092547|7171210|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4
4393404|NCT00092547|7171211|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1
4393405|NCT00092547|7171212|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0
4393406|NCT00092547|7171210|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18
4393407|NCT00092547|7171211|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7
4393408|NCT00092547|7171212|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0
4393409|NCT00092547|7171210|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28
4393410|NCT00092547|7171211|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21
4393411|NCT00092547|7171212|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0
4393412|NCT00092547|7171210|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3
4393413|NCT00092547|7171211|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1
4393414|NCT00092547|7171212|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0
4393415|NCT00092547|7171210|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0
4393416|NCT00092547|7171211|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1
4393417|NCT00092547|7171212|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0
4393418|NCT00092547|7171210|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0
4393419|NCT00092547|7171211|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1
4393420|NCT00092547|7171212|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0
4393421|NCT00092547|7171210|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5
4393422|NCT00092547|7171211|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3
4393423|NCT00092547|7171212|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0
4393424|NCT00092547|7171210|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1
4393425|NCT00092547|7171211|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5
4393426|NCT00092547|7171212|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0
4393427|NCT00092547|7171210|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4
4393428|NCT00092547|7171211|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2
4393429|NCT00092547|7171212|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0
4393430|NCT00092547|7171210|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13
4393431|NCT00092547|7171211|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7
4393432|NCT00092547|7171212|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0
4393433|NCT00092547|7171210|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1
4393434|NCT00092547|7171211|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0
4393435|NCT00092547|7171212|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0
4393436|NCT00092547|7171210|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1
4393437|NCT00092547|7171211|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0
4393438|NCT00092547|7171212|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0
4393439|NCT00092547|7171210|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4
4393440|NCT00092547|7171211|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2
4393441|NCT00092547|7171212|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0
4393442|NCT00092547|7171210|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1
4393443|NCT00092547|7171211|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3
4393444|NCT00092547|7171212|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0
4393445|NCT00092547|7171210|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2
4393446|NCT00092547|7171211|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0
4393447|NCT00092547|7171212|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0
4393448|NCT00092547|7171210|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1
4393449|NCT00092547|7171211|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0
4393450|NCT00092547|7171212|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0
4393451|NCT00092547|7171210|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3
4393452|NCT00092547|7171211|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0
4393453|NCT00092547|7171212|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0
4393454|NCT00092547|7171210|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6
4393455|NCT00092547|7171211|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0
4393456|NCT00092547|7171212|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9
4393457|NCT00092547|7171210|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14
4393458|NCT00092547|7171211|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0
4393459|NCT00092547|7171212|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7
4393460|NCT00092547|7171210|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1
4393461|NCT00092547|7171211|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0
4393462|NCT00092547|7171212|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0
4393463|NCT00093015|7171225|FG000|Overall Study|Withdrawal by Subject|194
4393464|NCT00093015|7171226|FG001|Overall Study|Withdrawal by Subject|171
4393465|NCT00093015|7171225|FG000|Overall Study|Lost to Follow-up|96
4393466|NCT00093015|7171226|FG001|Overall Study|Lost to Follow-up|108
4393467|NCT00093015|7171225|FG000|Overall Study|Death|375
4393468|NCT00093015|7171226|FG001|Overall Study|Death|385
4393469|NCT00093145|7171257|FG000|Overall Study|Unacceptable Toxicity Only|2
4393470|NCT00093145|7171257|FG000|Overall Study|Physician Decision|5
4393471|NCT00093145|7171257|FG000|Overall Study|Withdrawal by Subject|9
4393472|NCT00093145|7171257|FG000|Overall Study|Other|1
4393473|NCT00093470|7171267|FG000|Overall Study|Disease progression|39
4393474|NCT00093470|7171268|FG001|Overall Study|Disease progression|0
4393475|NCT00093470|7171267|FG000|Overall Study|Adverse Event|15
4393476|NCT00093470|7171268|FG001|Overall Study|Adverse Event|0
4393477|NCT00093470|7171267|FG000|Overall Study|Death|2
4393478|NCT00093470|7171268|FG001|Overall Study|Death|0
4393479|NCT00093470|7171267|FG000|Overall Study|Withdrawal by Subject|8
4393480|NCT00093470|7171268|FG001|Overall Study|Withdrawal by Subject|0
4393481|NCT00093470|7171267|FG000|Overall Study|Alternative therapy|2
4393482|NCT00093470|7171268|FG001|Overall Study|Alternative therapy|0
4393483|NCT00093470|7171267|FG000|Overall Study|Other complicating disease|3
4393484|NCT00093470|7171268|FG001|Overall Study|Other complicating disease|0
4393485|NCT00093470|7171267|FG000|Overall Study|Physician Decision|2
4393486|NCT00093470|7171268|FG001|Overall Study|Physician Decision|0
4393487|NCT00093470|7171267|FG000|Overall Study|Never started treatment|1
4393488|NCT00093470|7171268|FG001|Overall Study|Never started treatment|0
4393489|NCT00093470|7171267|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1
4393490|NCT00093470|7171268|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0
4393491|NCT00093496|7171276|FG000|Overall Study|Protocol Violation|1
4393492|NCT00093496|7171277|FG001|Overall Study|Protocol Violation|3
4393493|NCT00093795|7171300|FG000|Overall Study|No follow up data|20
4393494|NCT00093795|7171301|FG001|Overall Study|No follow up data|16
4393495|NCT00093795|7171302|FG002|Overall Study|No follow up data|17
4393496|NCT00093808|7171310|FG000|Overall Study|Cancel participation before receiving tx|1
4393497|NCT00093808|7171310|FG000|Overall Study|Protocol Violation|1
4510783|NCT00922987|7319675|FG000|Overall Study|Insufficient clinical response|1
4510784|NCT00922987|7319675|FG000|Overall Study|Protocol Violation|2
4510785|NCT00922987|7319675|FG000|Overall Study|Adverse Event|1
4518418|NCT00973700|7330518|FG001|Overall Study|Unable to Classify|0
4393498|NCT00094055|7171334|FG000|Overall Study|Adverse Event|11
4393499|NCT00094055|7171334|FG000|Overall Study|Death|4
4393500|NCT00094055|7171334|FG000|Overall Study|Lack of Efficacy|17
4393501|NCT00094055|7171334|FG000|Overall Study|Lost to Follow-up|2
4393502|NCT00094055|7171334|FG000|Overall Study|progressive disease|2
4393503|NCT00094055|7171334|FG000|Overall Study|clinical progression|1
4393504|NCT00094055|7171334|FG000|Overall Study|roll-over to another study|14
4393505|NCT00094055|7171334|FG000|Overall Study|Withdrawal by Subject|9
4393506|NCT00094094|7171338|FG000|Overall Study|Death|2
4393507|NCT00094094|7171338|FG000|Overall Study|Lack of Efficacy|23
4393508|NCT00094094|7171338|FG000|Overall Study|Adverse Event|7
4393509|NCT00094107|7171342|FG000|Overall Study|Lack of Efficacy|23
4393510|NCT00094107|7171342|FG000|Overall Study|Death|5
4393511|NCT00094107|7171342|FG000|Overall Study|Adverse Event|3
4393512|NCT00094107|7171342|FG000|Overall Study|Withdrawal due to Disease Progression|1
4393513|NCT00094172|7171348|FG000|Overall Study|Adverse Event|0
4393514|NCT00094172|7171349|FG001|Overall Study|Adverse Event|1
4393515|NCT00094172|7171348|FG000|Overall Study|Lost to Follow-up|2
4393516|NCT00094172|7171349|FG001|Overall Study|Lost to Follow-up|0
4393517|NCT00094172|7171348|FG000|Overall Study|Protocol Violation|0
4393518|NCT00094172|7171349|FG001|Overall Study|Protocol Violation|1
4393519|NCT00094172|7171348|FG000|Overall Study|Withdrawal by Subject|10
4393520|NCT00094172|7171349|FG001|Overall Study|Withdrawal by Subject|5
4393521|NCT00094172|7171348|FG000|Overall Study|Primary endpoint met.|1
4393522|NCT00094172|7171349|FG001|Overall Study|Primary endpoint met.|0
4393523|NCT00094172|7171348|FG000|Overall Study|Started other MS therapy due to disease|1
4393524|NCT00094172|7171349|FG001|Overall Study|Started other MS therapy due to disease|0
4393525|NCT00094302|7171378|FG000|Overall Study|Lost to Follow-up|43
4393526|NCT00094302|7171379|FG001|Overall Study|Lost to Follow-up|41
4393527|NCT00094302|7171378|FG000|Overall Study|Physician Decision|5
4393528|NCT00094302|7171379|FG001|Overall Study|Physician Decision|8
4393529|NCT00094302|7171378|FG000|Overall Study|Withdrawal by Subject|103
4393530|NCT00094302|7171379|FG001|Overall Study|Withdrawal by Subject|111
4393531|NCT00094302|7171378|FG000|Overall Study|Death|266
4393532|NCT00094302|7171379|FG001|Overall Study|Death|246
4393533|NCT00094328|7171385|FG000|Overall Study|Lost to Follow-up|1
4393534|NCT00094445|7171389|FG000|Overall Study|Withdrawal by Subject|3
4393535|NCT00094445|7171389|FG000|Overall Study|Lost to Follow-up|1
4393536|NCT00094445|7171389|FG000|Overall Study|Progressive Disease|2
4393537|NCT00094458|7171396|FG000|Main Study: Through Week 30|Eligibility criteria not met|3
4393538|NCT00094458|7171397|FG001|Main Study: Through Week 30|Eligibility criteria not met|8
4393539|NCT00094458|7171398|FG002|Main Study: Through Week 30|Eligibility criteria not met|2
4393540|NCT00094458|7171399|FG003|Main Study: Through Week 30|Eligibility criteria not met|0
4393541|NCT00094458|7171400|FG004|Main Study: Through Week 30|Eligibility criteria not met|0
4393542|NCT00094458|7171401|FG005|Main Study: Through Week 30|Eligibility criteria not met|0
4393543|NCT00094458|7171396|FG000|Main Study: Through Week 30|Lost to Follow-up|5
4393544|NCT00094458|7171397|FG001|Main Study: Through Week 30|Lost to Follow-up|5
4393545|NCT00094458|7171398|FG002|Main Study: Through Week 30|Lost to Follow-up|2
4393546|NCT00094458|7171399|FG003|Main Study: Through Week 30|Lost to Follow-up|0
4393547|NCT00094458|7171400|FG004|Main Study: Through Week 30|Lost to Follow-up|0
4393548|NCT00094458|7171401|FG005|Main Study: Through Week 30|Lost to Follow-up|0
4393549|NCT00094458|7171396|FG000|Main Study: Through Week 30|Withdrawal by Subject|18
4393550|NCT00094458|7171397|FG001|Main Study: Through Week 30|Withdrawal by Subject|9
4393551|NCT00094458|7171398|FG002|Main Study: Through Week 30|Withdrawal by Subject|7
4393552|NCT00094458|7171399|FG003|Main Study: Through Week 30|Withdrawal by Subject|0
4393553|NCT00094458|7171400|FG004|Main Study: Through Week 30|Withdrawal by Subject|0
4393554|NCT00094458|7171401|FG005|Main Study: Through Week 30|Withdrawal by Subject|0
4393555|NCT00094458|7171396|FG000|Main Study: Through Week 30|Adverse Event|38
4393556|NCT00094458|7171397|FG001|Main Study: Through Week 30|Adverse Event|20
4393557|NCT00094458|7171398|FG002|Main Study: Through Week 30|Adverse Event|28
4393558|NCT00094458|7171399|FG003|Main Study: Through Week 30|Adverse Event|0
4393559|NCT00094458|7171400|FG004|Main Study: Through Week 30|Adverse Event|0
4393560|NCT00094458|7171401|FG005|Main Study: Through Week 30|Adverse Event|0
4393561|NCT00094458|7171396|FG000|Main Study: Through Week 30|Death|1
4393562|NCT00094458|7171397|FG001|Main Study: Through Week 30|Death|0
4393563|NCT00094458|7171398|FG002|Main Study: Through Week 30|Death|0
4393564|NCT00094458|7171399|FG003|Main Study: Through Week 30|Death|0
4393565|NCT00094458|7171400|FG004|Main Study: Through Week 30|Death|0
4393566|NCT00094458|7171401|FG005|Main Study: Through Week 30|Death|0
4393567|NCT00094458|7171396|FG000|Main Study: Through Week 30|Other|19
4393568|NCT00094458|7171397|FG001|Main Study: Through Week 30|Other|16
4393569|NCT00094458|7171398|FG002|Main Study: Through Week 30|Other|9
4393570|NCT00094458|7171399|FG003|Main Study: Through Week 30|Other|0
4393571|NCT00094458|7171400|FG004|Main Study: Through Week 30|Other|0
4393572|NCT00094458|7171401|FG005|Main Study: Through Week 30|Other|0
4393573|NCT00094458|7171396|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2
4393574|NCT00094458|7171397|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1
4393575|NCT00094458|7171398|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4
4393576|NCT00094458|7171399|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
4393577|NCT00094458|7171400|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
4393578|NCT00094458|7171401|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
4393579|NCT00094458|7171396|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2
4393580|NCT00094458|7171397|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
4393581|NCT00094458|7171398|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4
4628481|NCT01860534|7495654|FG000|ROP #1|Needed treatment for ROP|0
4628482|NCT01860534|7495655|FG001|ROP #1|Needed treatment for ROP|1
4393582|NCT00094458|7171399|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
4393583|NCT00094458|7171400|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
4393584|NCT00094458|7171401|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
4393585|NCT00094458|7171396|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3
4393586|NCT00094458|7171397|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9
4393587|NCT00094458|7171398|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7
4393588|NCT00094458|7171399|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0
4393589|NCT00094458|7171400|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0
4393590|NCT00094458|7171401|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0
4393591|NCT00094458|7171396|FG000|Study Extension: Week 30 Through Week 50|Other|1
4393592|NCT00094458|7171397|FG001|Study Extension: Week 30 Through Week 50|Other|2
4393593|NCT00094458|7171398|FG002|Study Extension: Week 30 Through Week 50|Other|3
4393594|NCT00094458|7171399|FG003|Study Extension: Week 30 Through Week 50|Other|0
4393595|NCT00094458|7171400|FG004|Study Extension: Week 30 Through Week 50|Other|0
4393596|NCT00094458|7171401|FG005|Study Extension: Week 30 Through Week 50|Other|0
4393597|NCT00094458|7171396|FG000|OLE: Open-Label Extension|Adverse Event|0
4393598|NCT00094458|7171397|FG001|OLE: Open-Label Extension|Adverse Event|0
4393599|NCT00094458|7171398|FG002|OLE: Open-Label Extension|Adverse Event|0
4393600|NCT00094458|7171399|FG003|OLE: Open-Label Extension|Adverse Event|0
4393601|NCT00094458|7171400|FG004|OLE: Open-Label Extension|Adverse Event|3
4393602|NCT00094458|7171401|FG005|OLE: Open-Label Extension|Adverse Event|4
4393603|NCT00094458|7171396|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0
4393604|NCT00094458|7171397|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0
4393605|NCT00094458|7171398|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0
4393606|NCT00094458|7171399|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1
4393607|NCT00094458|7171400|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1
4393608|NCT00094458|7171401|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0
4393609|NCT00094458|7171396|FG000|OLE: Open-Label Extension|Patient decision|0
4393610|NCT00094458|7171397|FG001|OLE: Open-Label Extension|Patient decision|0
4393611|NCT00094458|7171398|FG002|OLE: Open-Label Extension|Patient decision|0
4393612|NCT00094458|7171399|FG003|OLE: Open-Label Extension|Patient decision|0
4393613|NCT00094458|7171400|FG004|OLE: Open-Label Extension|Patient decision|1
4393614|NCT00094458|7171401|FG005|OLE: Open-Label Extension|Patient decision|0
4393615|NCT00094536|7171424|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24
4393616|NCT00094536|7171424|FG000|Treatment and Follow-up|Adverse Event|4
4393617|NCT00094536|7171424|FG000|Treatment and Follow-up|Lack of Efficacy|9
4393618|NCT00094536|7171424|FG000|Treatment and Follow-up|Lost to Follow-up|7
4393619|NCT00094536|7171424|FG000|Treatment and Follow-up|Withdrawal by Subject|1
4393620|NCT00094536|7171424|FG000|Treatment and Follow-up|Subject non-compliance|9
4393621|NCT00094536|7171424|FG000|Treatment and Follow-up|Unable to attend visits|1
4393622|NCT00094575|7171430|FG000|Overall Study|Death|146
4393623|NCT00094575|7171431|FG001|Overall Study|Death|146
4393624|NCT00094653|7171442|FG000|Overall Study|Death|306
4393625|NCT00094653|7171443|FG001|Overall Study|Death|100
4393626|NCT00094653|7171444|FG002|Overall Study|Death|119
4393627|NCT00094653|7171442|FG000|Overall Study|Subject Withdrew Consent|10
4393628|NCT00094653|7171443|FG001|Overall Study|Subject Withdrew Consent|2
4393629|NCT00094653|7171444|FG002|Overall Study|Subject Withdrew Consent|3
4393630|NCT00094653|7171442|FG000|Overall Study|Other|2
4393631|NCT00094653|7171443|FG001|Overall Study|Other|2
4393632|NCT00094653|7171444|FG002|Overall Study|Other|2
4393633|NCT00094653|7171442|FG000|Overall Study|Lost to Follow-up|3
4393634|NCT00094653|7171443|FG001|Overall Study|Lost to Follow-up|2
4393635|NCT00094653|7171444|FG002|Overall Study|Lost to Follow-up|1
4393636|NCT00094653|7171442|FG000|Overall Study|Protocol Violation|0
4393637|NCT00094653|7171443|FG001|Overall Study|Protocol Violation|0
4393638|NCT00094653|7171444|FG002|Overall Study|Protocol Violation|1
4393639|NCT00094757|7171456|FG000|Overall Study|Adverse Event|11
4393640|NCT00094757|7171457|FG001|Overall Study|Adverse Event|9
4393641|NCT00094757|7171458|FG002|Overall Study|Adverse Event|6
4393642|NCT00094757|7171456|FG000|Overall Study|Lack of Efficacy|11
4393643|NCT00094757|7171457|FG001|Overall Study|Lack of Efficacy|15
4393644|NCT00094757|7171458|FG002|Overall Study|Lack of Efficacy|8
4393645|NCT00094757|7171456|FG000|Overall Study|Lost to Follow-up|3
4393646|NCT00094757|7171457|FG001|Overall Study|Lost to Follow-up|5
4393647|NCT00094757|7171458|FG002|Overall Study|Lost to Follow-up|6
4393648|NCT00094757|7171456|FG000|Overall Study|Patient Moved|2
4393649|NCT00094757|7171457|FG001|Overall Study|Patient Moved|1
4393650|NCT00094757|7171458|FG002|Overall Study|Patient Moved|1
4393651|NCT00094757|7171456|FG000|Overall Study|Protocol Violation|8
4393652|NCT00094757|7171457|FG001|Overall Study|Protocol Violation|5
4393653|NCT00094757|7171458|FG002|Overall Study|Protocol Violation|3
4393654|NCT00094757|7171456|FG000|Overall Study|Withdrawal by Subject|14
4393655|NCT00094757|7171457|FG001|Overall Study|Withdrawal by Subject|21
4393656|NCT00094757|7171458|FG002|Overall Study|Withdrawal by Subject|5
4393657|NCT00094757|7171456|FG000|Overall Study|Other|3
4393658|NCT00094757|7171457|FG001|Overall Study|Other|3
4393659|NCT00094757|7171458|FG002|Overall Study|Other|1
4393660|NCT00094757|7171456|FG000|Overall Study|Protocol specified discontinuation|1
4393661|NCT00094757|7171457|FG001|Overall Study|Protocol specified discontinuation|3
4393662|NCT00094757|7171458|FG002|Overall Study|Protocol specified discontinuation|0
4393663|NCT00094770|7171468|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25
4393664|NCT00094770|7171469|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26
4393665|NCT00094770|7171468|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86
4393666|NCT00094770|7171469|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58
4393667|NCT00094770|7171468|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19
4393668|NCT00094770|7171469|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10
4393669|NCT00094770|7171468|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10
4393670|NCT00094770|7171469|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10
4393671|NCT00094770|7171468|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19
4393672|NCT00094770|7171469|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25
4393673|NCT00094770|7171468|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6
4393674|NCT00094770|7171469|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2
4393675|NCT00094770|7171468|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25
4393676|NCT00094770|7171469|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28
4393677|NCT00094770|7171468|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2
4393678|NCT00094770|7171469|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2
4393679|NCT00094770|7171468|FG000|Year 1 ( Week 0 to Week 52)|Other|10
4393680|NCT00094770|7171469|FG001|Year 1 ( Week 0 to Week 52)|Other|11
4393681|NCT00094770|7171468|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35
4393682|NCT00094770|7171469|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36
4393683|NCT00094770|7171468|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180
4393684|NCT00094770|7171469|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162
4393685|NCT00094770|7171468|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25
4393686|NCT00094770|7171469|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15
4393687|NCT00094770|7171468|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13
4393688|NCT00094770|7171469|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12
4393689|NCT00094770|7171468|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29
4393690|NCT00094770|7171469|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30
4393691|NCT00094770|7171468|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6
4393692|NCT00094770|7171469|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2
4393693|NCT00094770|7171468|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28
4393694|NCT00094770|7171469|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38
4393695|NCT00094770|7171468|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2
4393696|NCT00094770|7171469|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2
4393697|NCT00094770|7171468|FG000|Year 2 (Week 0 to Week 104)|Other|15
4393698|NCT00094770|7171469|FG001|Year 2 (Week 0 to Week 104)|Other|23
4393699|NCT00094809|7171477|FG000|Overall Study|Protocol deviation|2
4393700|NCT00094809|7171478|FG001|Overall Study|Protocol deviation|2
4393701|NCT00094809|7171477|FG000|Overall Study|Noncompliance|1
4393702|NCT00094809|7171478|FG001|Overall Study|Noncompliance|0
4393703|NCT00094809|7171477|FG000|Overall Study|Adverse Event|3
4393704|NCT00094809|7171478|FG001|Overall Study|Adverse Event|1
4393705|NCT00094809|7171477|FG000|Overall Study|Withdrawal by Subject|8
4393706|NCT00094809|7171478|FG001|Overall Study|Withdrawal by Subject|9
4393707|NCT00094809|7171477|FG000|Overall Study|Disease progression|3
4393708|NCT00094809|7171478|FG001|Overall Study|Disease progression|3
4393709|NCT00094809|7171477|FG000|Overall Study|Physician Decision|3
4393710|NCT00094809|7171478|FG001|Overall Study|Physician Decision|5
4393711|NCT00094809|7171477|FG000|Overall Study|Lost to Follow-up|6
4393712|NCT00094809|7171478|FG001|Overall Study|Lost to Follow-up|6
4393713|NCT00094809|7171477|FG000|Overall Study|Death|19
4393714|NCT00094809|7171478|FG001|Overall Study|Death|25
4393715|NCT00094809|7171477|FG000|Overall Study|Protocol-specified criteria|1
4393716|NCT00094809|7171478|FG001|Overall Study|Protocol-specified criteria|1
4393717|NCT00094809|7171477|FG000|Overall Study|Other|2
4393718|NCT00094809|7171478|FG001|Overall Study|Other|4
4393719|NCT00094809|7171477|FG000|Overall Study|Informed consent signed after treatment|1
4393720|NCT00094809|7171478|FG001|Overall Study|Informed consent signed after treatment|0
4393721|NCT00094809|7171477|FG000|Overall Study|Study drug not received|2
4393722|NCT00094809|7171478|FG001|Overall Study|Study drug not received|8
4393723|NCT00094809|7171477|FG000|Overall Study|Other|1
4393724|NCT00094809|7171478|FG001|Overall Study|Other|1
4393725|NCT00094835|7171491|FG000|Overall Study|Physician Decision|1
4393726|NCT00094835|7171492|FG001|Overall Study|Physician Decision|0
4393727|NCT00094835|7171493|FG002|Overall Study|Physician Decision|0
4393728|NCT00094835|7171494|FG003|Overall Study|Physician Decision|0
4393729|NCT00094835|7171495|FG004|Overall Study|Physician Decision|0
4393730|NCT00094835|7171496|FG005|Overall Study|Physician Decision|1
4393731|NCT00094835|7171497|FG006|Overall Study|Physician Decision|0
4393732|NCT00094835|7171491|FG000|Overall Study|Withdrawal by Subject|0
4393733|NCT00094835|7171492|FG001|Overall Study|Withdrawal by Subject|0
4393734|NCT00094835|7171493|FG002|Overall Study|Withdrawal by Subject|0
4393735|NCT00094835|7171494|FG003|Overall Study|Withdrawal by Subject|0
4393736|NCT00094835|7171495|FG004|Overall Study|Withdrawal by Subject|0
4393737|NCT00094835|7171496|FG005|Overall Study|Withdrawal by Subject|0
4393738|NCT00094835|7171497|FG006|Overall Study|Withdrawal by Subject|1
4393739|NCT00094835|7171491|FG000|Overall Study|Lost to Follow-up|0
4393740|NCT00094835|7171492|FG001|Overall Study|Lost to Follow-up|0
4393741|NCT00094835|7171493|FG002|Overall Study|Lost to Follow-up|0
4393742|NCT00094835|7171494|FG003|Overall Study|Lost to Follow-up|0
4393743|NCT00094835|7171495|FG004|Overall Study|Lost to Follow-up|1
4393744|NCT00094835|7171496|FG005|Overall Study|Lost to Follow-up|0
4393745|NCT00094835|7171497|FG006|Overall Study|Lost to Follow-up|0
4393746|NCT00094835|7171491|FG000|Overall Study|Death|1
4393747|NCT00094835|7171492|FG001|Overall Study|Death|0
4393748|NCT00094835|7171493|FG002|Overall Study|Death|0
4393749|NCT00094835|7171494|FG003|Overall Study|Death|0
4393750|NCT00094835|7171495|FG004|Overall Study|Death|1
4393751|NCT00094835|7171496|FG005|Overall Study|Death|0
4393752|NCT00094835|7171497|FG006|Overall Study|Death|0
4393753|NCT00094835|7171491|FG000|Overall Study|Non-compliance|1
4393754|NCT00094835|7171492|FG001|Overall Study|Non-compliance|2
4393755|NCT00094835|7171493|FG002|Overall Study|Non-compliance|2
4393756|NCT00094835|7171494|FG003|Overall Study|Non-compliance|0
4393757|NCT00094835|7171495|FG004|Overall Study|Non-compliance|2
4393758|NCT00094835|7171496|FG005|Overall Study|Non-compliance|2
4393759|NCT00094835|7171497|FG006|Overall Study|Non-compliance|1
4393760|NCT00094835|7171491|FG000|Overall Study|Other|1
4393761|NCT00094835|7171492|FG001|Overall Study|Other|1
4393762|NCT00094835|7171493|FG002|Overall Study|Other|1
4393763|NCT00094835|7171494|FG003|Overall Study|Other|1
4393764|NCT00094835|7171495|FG004|Overall Study|Other|0
4393765|NCT00094835|7171496|FG005|Overall Study|Other|0
4393766|NCT00094835|7171497|FG006|Overall Study|Other|0
4393767|NCT00094861|7171520|FG000|Overall Study|Adverse Event|5
4393768|NCT00094861|7171521|FG001|Overall Study|Adverse Event|2
4393769|NCT00094861|7171520|FG000|Overall Study|Withdrawal by Subject|5
4393770|NCT00094861|7171521|FG001|Overall Study|Withdrawal by Subject|3
4393771|NCT00094861|7171520|FG000|Overall Study|Physician Decision|1
4393772|NCT00094861|7171521|FG001|Overall Study|Physician Decision|1
4393773|NCT00094861|7171520|FG000|Overall Study|Lost to Follow-up|0
4393774|NCT00094861|7171521|FG001|Overall Study|Lost to Follow-up|1
4393775|NCT00094861|7171520|FG000|Overall Study|Death|4
4393776|NCT00094861|7171521|FG001|Overall Study|Death|2
4393777|NCT00094861|7171520|FG000|Overall Study|Other|3
4393778|NCT00094861|7171521|FG001|Overall Study|Other|0
4393779|NCT00095056|7171542|FG000|Phase A (Weeks 0-12)|Adverse Event|1
4393780|NCT00095056|7171543|FG001|Phase A (Weeks 0-12)|Adverse Event|1
4393781|NCT00095056|7171542|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3
4393782|NCT00095056|7171543|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0
4393783|NCT00095056|7171542|FG000|Phase A (Weeks 0-12)|Death|1
4393784|NCT00095056|7171543|FG001|Phase A (Weeks 0-12)|Death|0
4393785|NCT00095056|7171542|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2
4393786|NCT00095056|7171543|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0
4393787|NCT00095056|7171542|FG000|Phase B (Weeks 12-54)|Adverse Event|2
4393788|NCT00095056|7171543|FG001|Phase B (Weeks 12-54)|Adverse Event|2
4393789|NCT00095056|7171542|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1
4393790|NCT00095056|7171543|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0
4393791|NCT00095056|7171542|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2
4393792|NCT00095056|7171543|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1
4393793|NCT00095056|7171542|FG000|Phase B (Weeks 12-54)|Patient Moved|1
4393794|NCT00095056|7171543|FG001|Phase B (Weeks 12-54)|Patient Moved|0
4393795|NCT00095056|7171542|FG000|Phase B (Weeks 12-54)|Death|3
4393796|NCT00095056|7171543|FG001|Phase B (Weeks 12-54)|Death|1
4393797|NCT00095056|7171542|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1
4393798|NCT00095056|7171543|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0
4393799|NCT00095056|7171542|FG000|Phase B (Weeks 12-54)|Protocol Violation|0
4393800|NCT00095056|7171543|FG001|Phase B (Weeks 12-54)|Protocol Violation|1
4393801|NCT00095121|7171551|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1
4393802|NCT00095121|7171552|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0
4393803|NCT00095121|7171551|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2
4393804|NCT00095121|7171552|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0
4393805|NCT00095147|7171571|FG000|Double-blind Period 1 (Days 1-197)|Death|1
4393806|NCT00095147|7171572|FG001|Double-blind Period 1 (Days 1-197)|Death|0
4393807|NCT00095147|7171573|FG002|Double-blind Period 1 (Days 1-197)|Death|0
4393808|NCT00095147|7171574|FG003|Double-blind Period 1 (Days 1-197)|Death|0
4393809|NCT00095147|7171575|FG004|Double-blind Period 1 (Days 1-197)|Death|0
4393810|NCT00095147|7171571|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2
4393811|NCT00095147|7171572|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8
4393812|NCT00095147|7171573|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1
4393813|NCT00095147|7171574|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0
4393814|NCT00095147|7171575|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0
4393815|NCT00095147|7171571|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2
4393816|NCT00095147|7171572|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2
4393817|NCT00095147|7171573|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1
4393818|NCT00095147|7171574|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0
4393819|NCT00095147|7171575|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0
4393820|NCT00095147|7171571|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2
4393821|NCT00095147|7171572|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2
4393822|NCT00095147|7171573|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
4393823|NCT00095147|7171574|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
4393824|NCT00095147|7171575|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
4393825|NCT00095147|7171571|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1
4393826|NCT00095147|7171572|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
4393827|NCT00095147|7171573|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1
4393828|NCT00095147|7171574|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
4393829|NCT00095147|7171575|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
4393830|NCT00095147|7171571|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1
4393831|NCT00095147|7171572|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1
4393832|NCT00095147|7171573|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0
4393833|NCT00095147|7171574|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0
4393834|NCT00095147|7171575|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0
4393835|NCT00095147|7171571|FG000|Double-blind Period 2 (Days 198-365)|Death|0
4393836|NCT00095147|7171572|FG001|Double-blind Period 2 (Days 198-365)|Death|1
4393837|NCT00095147|7171573|FG002|Double-blind Period 2 (Days 198-365)|Death|0
4393838|NCT00095147|7171574|FG003|Double-blind Period 2 (Days 198-365)|Death|1
4393839|NCT00095147|7171575|FG004|Double-blind Period 2 (Days 198-365)|Death|0
4393840|NCT00095147|7171571|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2
4393841|NCT00095147|7171572|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4
4393842|NCT00095147|7171573|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0
4393843|NCT00095147|7171574|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0
4393844|NCT00095147|7171575|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0
4393845|NCT00095147|7171571|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2
4393846|NCT00095147|7171572|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4
4393847|NCT00095147|7171573|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0
4393848|NCT00095147|7171574|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1
4393849|NCT00095147|7171575|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0
4393850|NCT00095147|7171571|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3
4393851|NCT00095147|7171572|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2
4393852|NCT00095147|7171573|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
4393853|NCT00095147|7171574|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
4393854|NCT00095147|7171575|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
4393855|NCT00095147|7171571|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1
4393856|NCT00095147|7171572|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0
4393857|NCT00095147|7171573|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0
4393858|NCT00095147|7171574|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1
4393859|NCT00095147|7171575|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0
4393860|NCT00095147|7171571|FG000|Long-term Extension Period|Death|0
4393861|NCT00095147|7171572|FG001|Long-term Extension Period|Death|0
4393862|NCT00095147|7171573|FG002|Long-term Extension Period|Death|0
4393863|NCT00095147|7171574|FG003|Long-term Extension Period|Death|0
4393864|NCT00095147|7171575|FG004|Long-term Extension Period|Death|3
4393865|NCT00095147|7171571|FG000|Long-term Extension Period|Adverse Event|0
4393866|NCT00095147|7171572|FG001|Long-term Extension Period|Adverse Event|0
4628483|NCT01860534|7495654|FG000|ROP #2|discharged prior to ROP #2|1
4628484|NCT01860534|7495655|FG001|ROP #2|discharged prior to ROP #2|0
4393867|NCT00095147|7171573|FG002|Long-term Extension Period|Adverse Event|0
4393868|NCT00095147|7171574|FG003|Long-term Extension Period|Adverse Event|0
4393869|NCT00095147|7171575|FG004|Long-term Extension Period|Adverse Event|11
4393870|NCT00095147|7171571|FG000|Long-term Extension Period|Lack of Efficacy|0
4393871|NCT00095147|7171572|FG001|Long-term Extension Period|Lack of Efficacy|0
4393872|NCT00095147|7171573|FG002|Long-term Extension Period|Lack of Efficacy|0
4393873|NCT00095147|7171574|FG003|Long-term Extension Period|Lack of Efficacy|0
4393874|NCT00095147|7171575|FG004|Long-term Extension Period|Lack of Efficacy|9
4393875|NCT00095147|7171571|FG000|Long-term Extension Period|Lost to Follow-up|0
4393876|NCT00095147|7171572|FG001|Long-term Extension Period|Lost to Follow-up|0
4393877|NCT00095147|7171573|FG002|Long-term Extension Period|Lost to Follow-up|0
4393878|NCT00095147|7171574|FG003|Long-term Extension Period|Lost to Follow-up|0
4393879|NCT00095147|7171575|FG004|Long-term Extension Period|Lost to Follow-up|6
4393880|NCT00095147|7171571|FG000|Long-term Extension Period|Withdrawal of consent|0
4393881|NCT00095147|7171572|FG001|Long-term Extension Period|Withdrawal of consent|0
4393882|NCT00095147|7171573|FG002|Long-term Extension Period|Withdrawal of consent|0
4393883|NCT00095147|7171574|FG003|Long-term Extension Period|Withdrawal of consent|0
4393884|NCT00095147|7171575|FG004|Long-term Extension Period|Withdrawal of consent|12
4393885|NCT00095147|7171571|FG000|Long-term Extension Period|Pregnancy|0
4393886|NCT00095147|7171572|FG001|Long-term Extension Period|Pregnancy|0
4393887|NCT00095147|7171573|FG002|Long-term Extension Period|Pregnancy|0
4393888|NCT00095147|7171574|FG003|Long-term Extension Period|Pregnancy|0
4393889|NCT00095147|7171575|FG004|Long-term Extension Period|Pregnancy|1
4628485|NCT01860677|7495692|FG000|Second Intervention (1 Day)|Lost to Follow-up|7
4393890|NCT00095147|7171571|FG000|Long-term Extension Period|No longer meets study criteria|0
4393891|NCT00095147|7171572|FG001|Long-term Extension Period|No longer meets study criteria|0
4393892|NCT00095147|7171573|FG002|Long-term Extension Period|No longer meets study criteria|0
4393893|NCT00095147|7171574|FG003|Long-term Extension Period|No longer meets study criteria|0
4393894|NCT00095147|7171575|FG004|Long-term Extension Period|No longer meets study criteria|1
4393895|NCT00095147|7171571|FG000|Long-term Extension Period|Participant chose to use Revellex|0
4393896|NCT00095147|7171572|FG001|Long-term Extension Period|Participant chose to use Revellex|0
4393897|NCT00095147|7171573|FG002|Long-term Extension Period|Participant chose to use Revellex|0
4393898|NCT00095147|7171574|FG003|Long-term Extension Period|Participant chose to use Revellex|0
4393899|NCT00095147|7171575|FG004|Long-term Extension Period|Participant chose to use Revellex|1
4393900|NCT00095147|7171571|FG000|Long-term Extension Period|Leaving country|0
4393901|NCT00095147|7171572|FG001|Long-term Extension Period|Leaving country|0
4393902|NCT00095147|7171573|FG002|Long-term Extension Period|Leaving country|0
4393903|NCT00095147|7171574|FG003|Long-term Extension Period|Leaving country|0
4393904|NCT00095147|7171575|FG004|Long-term Extension Period|Leaving country|1
4393905|NCT00095173|7171593|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1
4393906|NCT00095173|7171594|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0
4393907|NCT00095173|7171595|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0
4393908|NCT00095173|7171596|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0
4393909|NCT00095173|7171597|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0
4393910|NCT00095173|7171598|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0
4393911|NCT00095173|7171593|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17
4393912|NCT00095173|7171594|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
4393913|NCT00095173|7171595|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
4393914|NCT00095173|7171596|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
4393915|NCT00095173|7171597|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
4393916|NCT00095173|7171598|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
4393917|NCT00095173|7171593|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1
4393918|NCT00095173|7171594|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
4393919|NCT00095173|7171595|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
4393920|NCT00095173|7171596|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
4393921|NCT00095173|7171597|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
4393922|NCT00095173|7171598|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
4393923|NCT00095173|7171593|FG000|Open-Label Lead-In Phase (Period A)|Other|1
4393924|NCT00095173|7171594|FG001|Open-Label Lead-In Phase (Period A)|Other|0
4393925|NCT00095173|7171595|FG002|Open-Label Lead-In Phase (Period A)|Other|0
4393926|NCT00095173|7171596|FG003|Open-Label Lead-In Phase (Period A)|Other|0
4393927|NCT00095173|7171597|FG004|Open-Label Lead-In Phase (Period A)|Other|0
4393928|NCT00095173|7171598|FG005|Open-Label Lead-In Phase (Period A)|Other|0
4393929|NCT00095173|7171593|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0
4393930|NCT00095173|7171594|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10
4393931|NCT00095173|7171595|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31
4393932|NCT00095173|7171596|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0
4393933|NCT00095173|7171597|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0
4393934|NCT00095173|7171598|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0
4393935|NCT00095173|7171593|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0
4393936|NCT00095173|7171594|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1
4393937|NCT00095173|7171595|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0
4393938|NCT00095173|7171596|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0
4393939|NCT00095173|7171597|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0
4393940|NCT00095173|7171598|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0
4393941|NCT00095173|7171593|FG000|Open-Label Extension Phase (Period C)|Death|0
4393942|NCT00095173|7171594|FG001|Open-Label Extension Phase (Period C)|Death|0
4393943|NCT00095173|7171595|FG002|Open-Label Extension Phase (Period C)|Death|0
4393944|NCT00095173|7171596|FG003|Open-Label Extension Phase (Period C)|Death|0
4393945|NCT00095173|7171597|FG004|Open-Label Extension Phase (Period C)|Death|0
4393946|NCT00095173|7171598|FG005|Open-Label Extension Phase (Period C)|Death|1
4393947|NCT00095173|7171593|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0
4393948|NCT00095173|7171594|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0
4393949|NCT00095173|7171595|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0
4393950|NCT00095173|7171596|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1
4393951|NCT00095173|7171597|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2
4393952|NCT00095173|7171598|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3
4393953|NCT00095173|7171593|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
4393954|NCT00095173|7171594|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
4393955|NCT00095173|7171595|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
4393956|NCT00095173|7171596|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11
4393957|NCT00095173|7171597|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5
4393958|NCT00095173|7171598|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8
4393959|NCT00095173|7171593|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
4393960|NCT00095173|7171594|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
4518419|NCT00973700|7330519|FG002|Overall Study|Unable to Classify|1
4393961|NCT00095173|7171595|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
4393962|NCT00095173|7171596|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2
4393963|NCT00095173|7171597|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5
4393964|NCT00095173|7171598|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6
4393965|NCT00095173|7171593|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
4393966|NCT00095173|7171594|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
4393967|NCT00095173|7171595|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
4712115|NCT02919761|7638386|FG000|Part 1: Open Label|Lost to Follow-up|1
4712116|NCT02919761|7638387|FG001|Part 1: Open Label|Lost to Follow-up|0
4712117|NCT02919761|7638388|FG002|Part 1: Open Label|Lost to Follow-up|0
4712118|NCT02919761|7638386|FG000|Part 1: Open Label|Met withdrawal criteria|5
4712119|NCT02919761|7638387|FG001|Part 1: Open Label|Met withdrawal criteria|0
4712120|NCT02919761|7638388|FG002|Part 1: Open Label|Met withdrawal criteria|0
4712121|NCT02919761|7638386|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2
4712122|NCT02919761|7638387|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0
4712123|NCT02919761|7638388|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0
4393968|NCT00095173|7171596|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4
4393969|NCT00095173|7171597|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6
4393970|NCT00095173|7171598|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
4393971|NCT00095173|7171593|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
4393972|NCT00095173|7171594|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
4393973|NCT00095173|7171595|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
4393974|NCT00095173|7171596|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
4393975|NCT00095173|7171597|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1
4393976|NCT00095173|7171598|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1
4393977|NCT00095173|7171593|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
4393978|NCT00095173|7171594|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
4393979|NCT00095173|7171595|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
4393980|NCT00095173|7171596|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
4393981|NCT00095173|7171597|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2
4393982|NCT00095173|7171598|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2
4393983|NCT00095173|7171593|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0
4393984|NCT00095173|7171594|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0
4393985|NCT00095173|7171595|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0
4393986|NCT00095173|7171596|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1
4393987|NCT00095173|7171597|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2
4393988|NCT00095173|7171598|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3
4393989|NCT00095173|7171593|FG000|Open-Label Extension Phase (Period C)|Other|0
4393990|NCT00095173|7171594|FG001|Open-Label Extension Phase (Period C)|Other|0
4393991|NCT00095173|7171595|FG002|Open-Label Extension Phase (Period C)|Other|0
4393992|NCT00095173|7171596|FG003|Open-Label Extension Phase (Period C)|Other|4
4393993|NCT00095173|7171597|FG004|Open-Label Extension Phase (Period C)|Other|6
4393994|NCT00095173|7171598|FG005|Open-Label Extension Phase (Period C)|Other|8
4393995|NCT00095199|7171616|FG000|Overall Study|Adverse Event|40
4393996|NCT00095199|7171617|FG001|Overall Study|Adverse Event|22
4393997|NCT00095199|7171618|FG002|Overall Study|Adverse Event|26
4393998|NCT00095199|7171619|FG003|Overall Study|Adverse Event|11
4393999|NCT00095199|7171616|FG000|Overall Study|Progressive disease|213
4394000|NCT00095199|7171617|FG001|Overall Study|Progressive disease|179
4394001|NCT00095199|7171618|FG002|Overall Study|Progressive disease|105
4394002|NCT00095199|7171619|FG003|Overall Study|Progressive disease|98
4394003|NCT00095199|7171616|FG000|Overall Study|Death|10
4394004|NCT00095199|7171617|FG001|Overall Study|Death|6
4394005|NCT00095199|7171618|FG002|Overall Study|Death|11
4394006|NCT00095199|7171619|FG003|Overall Study|Death|9
4394007|NCT00095199|7171616|FG000|Overall Study|Withdrawal by Subject|21
4394008|NCT00095199|7171617|FG001|Overall Study|Withdrawal by Subject|16
4394009|NCT00095199|7171618|FG002|Overall Study|Withdrawal by Subject|13
4394010|NCT00095199|7171619|FG003|Overall Study|Withdrawal by Subject|22
4394011|NCT00095199|7171616|FG000|Overall Study|Protocol Violation|4
4394012|NCT00095199|7171617|FG001|Overall Study|Protocol Violation|4
4394013|NCT00095199|7171618|FG002|Overall Study|Protocol Violation|2
4394014|NCT00095199|7171619|FG003|Overall Study|Protocol Violation|0
4394015|NCT00095199|7171616|FG000|Overall Study|Liver function test results elevated|0
4394016|NCT00095199|7171617|FG001|Overall Study|Liver function test results elevated|0
4394017|NCT00095199|7171618|FG002|Overall Study|Liver function test results elevated|1
4394018|NCT00095199|7171619|FG003|Overall Study|Liver function test results elevated|1
4394019|NCT00095199|7171616|FG000|Overall Study|Surgery needed could not start in 7 days|0
4394020|NCT00095199|7171617|FG001|Overall Study|Surgery needed could not start in 7 days|0
4394021|NCT00095199|7171618|FG002|Overall Study|Surgery needed could not start in 7 days|1
4394022|NCT00095199|7171619|FG003|Overall Study|Surgery needed could not start in 7 days|0
4394023|NCT00095199|7171616|FG000|Overall Study|Physician Decision|5
4394024|NCT00095199|7171617|FG001|Overall Study|Physician Decision|6
4394025|NCT00095199|7171618|FG002|Overall Study|Physician Decision|1
4712124|NCT02919761|7638386|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1
4394026|NCT00095199|7171619|FG003|Overall Study|Physician Decision|1
4394027|NCT00095199|7171616|FG000|Overall Study|Not eligible|1
4394028|NCT00095199|7171617|FG001|Overall Study|Not eligible|7
4394029|NCT00095199|7171618|FG002|Overall Study|Not eligible|0
4394030|NCT00095199|7171619|FG003|Overall Study|Not eligible|1
4394031|NCT00095199|7171616|FG000|Overall Study|Started Palliative Radiotherapy|1
4394032|NCT00095199|7171617|FG001|Overall Study|Started Palliative Radiotherapy|0
4394033|NCT00095199|7171618|FG002|Overall Study|Started Palliative Radiotherapy|0
4394034|NCT00095199|7171619|FG003|Overall Study|Started Palliative Radiotherapy|0
4394035|NCT00095199|7171616|FG000|Overall Study|Started radiotherapy regimen|0
4394036|NCT00095199|7171617|FG001|Overall Study|Started radiotherapy regimen|1
4394037|NCT00095199|7171618|FG002|Overall Study|Started radiotherapy regimen|0
4394038|NCT00095199|7171619|FG003|Overall Study|Started radiotherapy regimen|0
4394039|NCT00095199|7171616|FG000|Overall Study|Primary tumor removed in other surgery|0
4394040|NCT00095199|7171617|FG001|Overall Study|Primary tumor removed in other surgery|1
4394041|NCT00095199|7171618|FG002|Overall Study|Primary tumor removed in other surgery|0
4394042|NCT00095199|7171619|FG003|Overall Study|Primary tumor removed in other surgery|0
4394043|NCT00095199|7171616|FG000|Overall Study|Data inadvertently lost by site|1
4394044|NCT00095199|7171617|FG001|Overall Study|Data inadvertently lost by site|0
4394045|NCT00095199|7171618|FG002|Overall Study|Data inadvertently lost by site|0
4394046|NCT00095199|7171619|FG003|Overall Study|Data inadvertently lost by site|0
4394047|NCT00095212|7171636|FG000|Overall Study|Withdrawal by Subject|1
4394048|NCT00095212|7171637|FG001|Overall Study|Withdrawal by Subject|3
4394049|NCT00095238|7171645|FG000|Overall Study|Lack of Efficacy|9
4394050|NCT00095238|7171646|FG001|Overall Study|Lack of Efficacy|9
4394051|NCT00095238|7171645|FG000|Overall Study|Adverse Event|331
4394052|NCT00095238|7171646|FG001|Overall Study|Adverse Event|287
4394053|NCT00095238|7171645|FG000|Overall Study|Subject Withdrew Consent|208
4394054|NCT00095238|7171646|FG001|Overall Study|Subject Withdrew Consent|223
4394055|NCT00095238|7171645|FG000|Overall Study|Death|154
4394056|NCT00095238|7171646|FG001|Overall Study|Death|170
4394057|NCT00095238|7171645|FG000|Overall Study|Lost to Follow-up|19
4394058|NCT00095238|7171646|FG001|Overall Study|Lost to Follow-up|24
4394059|NCT00095238|7171645|FG000|Overall Study|Noncompliance|44
4394060|NCT00095238|7171646|FG001|Overall Study|Noncompliance|45
4394061|NCT00095238|7171645|FG000|Overall Study|No longer met study criteria|4
4394062|NCT00095238|7171646|FG001|Overall Study|No longer met study criteria|5
4394063|NCT00095238|7171645|FG000|Overall Study|Study terminated by sponsor|0
4394064|NCT00095238|7171646|FG001|Overall Study|Study terminated by sponsor|1
4394065|NCT00095238|7171645|FG000|Overall Study|Missing|1
4394066|NCT00095238|7171646|FG001|Overall Study|Missing|0
4394067|NCT00095238|7171645|FG000|Overall Study|Other Reasons|87
4394068|NCT00095238|7171646|FG001|Overall Study|Other Reasons|88
4394069|NCT00095303|7171686|FG000|Main Study|Lost to Follow-up|91
4394070|NCT00095303|7171687|FG001|Main Study|Lost to Follow-up|87
4394071|NCT00095303|7171686|FG000|Follow Up Study|Lost to Follow-up|59
4394072|NCT00095303|7171687|FG001|Follow Up Study|Lost to Follow-up|58
4394073|NCT00095498|7171696|FG000|Overall Study|Physician Decision|9
4394074|NCT00095498|7171697|FG001|Overall Study|Physician Decision|10
4394075|NCT00095498|7171698|FG002|Overall Study|Physician Decision|8
4394076|NCT00095498|7171696|FG000|Overall Study|Adverse Event|1
4394077|NCT00095498|7171697|FG001|Overall Study|Adverse Event|0
4394078|NCT00095498|7171698|FG002|Overall Study|Adverse Event|1
4394079|NCT00095498|7171696|FG000|Overall Study|Withdrawal by Subject|15
4394080|NCT00095498|7171697|FG001|Overall Study|Withdrawal by Subject|16
4394081|NCT00095498|7171698|FG002|Overall Study|Withdrawal by Subject|15
4394082|NCT00095498|7171696|FG000|Overall Study|Disease progression|0
4394083|NCT00095498|7171697|FG001|Overall Study|Disease progression|1
4394084|NCT00095498|7171698|FG002|Overall Study|Disease progression|1
4394085|NCT00095498|7171696|FG000|Overall Study|Ineligibility determined|3
4394086|NCT00095498|7171697|FG001|Overall Study|Ineligibility determined|0
4394087|NCT00095498|7171698|FG002|Overall Study|Ineligibility determined|2
4394088|NCT00095498|7171696|FG000|Overall Study|Lost to Follow-up|1
4394089|NCT00095498|7171697|FG001|Overall Study|Lost to Follow-up|1
4394090|NCT00095498|7171698|FG002|Overall Study|Lost to Follow-up|2
4394091|NCT00095498|7171696|FG000|Overall Study|Noncompliance|1
4394092|NCT00095498|7171697|FG001|Overall Study|Noncompliance|0
4394093|NCT00095498|7171698|FG002|Overall Study|Noncompliance|1
4394094|NCT00095498|7171696|FG000|Overall Study|Other|6
4394095|NCT00095498|7171697|FG001|Overall Study|Other|7
4394096|NCT00095498|7171698|FG002|Overall Study|Other|6
4394097|NCT00095498|7171696|FG000|Overall Study|Protocol Violation|0
4394098|NCT00095498|7171697|FG001|Overall Study|Protocol Violation|0
4394099|NCT00095498|7171698|FG002|Overall Study|Protocol Violation|1
4394100|NCT00095498|7171696|FG000|Overall Study|Requirement for alternative therapy|1
4394101|NCT00095498|7171697|FG001|Overall Study|Requirement for alternative therapy|0
4394102|NCT00095498|7171698|FG002|Overall Study|Requirement for alternative therapy|2
4394103|NCT00095576|7171712|FG000|Overall Study|Adverse Event|5
4394104|NCT00095576|7171713|FG001|Overall Study|Adverse Event|3
4394105|NCT00095576|7171712|FG000|Overall Study|Lost to Follow-up|233
4394106|NCT00095576|7171713|FG001|Overall Study|Lost to Follow-up|229
4394107|NCT00095576|7171712|FG000|Overall Study|Protocol Violation|1
4394108|NCT00095576|7171713|FG001|Overall Study|Protocol Violation|0
4394109|NCT00095576|7171712|FG000|Overall Study|Withdrawal by Subject|34
4394110|NCT00095576|7171713|FG001|Overall Study|Withdrawal by Subject|47
4394111|NCT00095576|7171712|FG000|Overall Study|Option to switch to a rollover study|1097
4394112|NCT00095576|7171713|FG001|Overall Study|Option to switch to a rollover study|1099
4394113|NCT00095576|7171712|FG000|Overall Study|Site terminated|75
4394114|NCT00095576|7171713|FG001|Overall Study|Site terminated|67
4394115|NCT00095576|7171712|FG000|Overall Study|Subject moved|30
4394116|NCT00095576|7171713|FG001|Overall Study|Subject moved|36
4394117|NCT00095628|7171719|FG000|Overall Study|Disease progression prior to treatment|1
4394118|NCT00095836|7171723|FG000|Overall Study|Lost to Follow-up|1
4394119|NCT00095836|7171723|FG000|Overall Study|Adverse Event|1
4394120|NCT00095836|7171723|FG000|Overall Study|Death|2
4394121|NCT00095940|7171743|FG000|Lapatinib Continuation/Phase II|Disease Progression|1
4394122|NCT00095940|7171744|FG001|Lapatinib Continuation/Phase II|Disease Progression|1
4394123|NCT00095940|7171745|FG002|Lapatinib Continuation/Phase II|Disease Progression|15
4394124|NCT00095940|7171746|FG003|Lapatinib Continuation/Phase II|Disease Progression|0
4394125|NCT00095940|7171747|FG004|Lapatinib Continuation/Phase II|Disease Progression|0
4394126|NCT00095940|7171748|FG005|Lapatinib Continuation/Phase II|Disease Progression|13
4394127|NCT00095940|7171749|FG006|Lapatinib Continuation/Phase II|Disease Progression|2
4394128|NCT00095940|7171750|FG007|Lapatinib Continuation/Phase II|Disease Progression|1
4394129|NCT00095940|7171751|FG008|Lapatinib Continuation/Phase II|Disease Progression|12
4394130|NCT00095940|7171743|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
4394131|NCT00095940|7171744|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
4394132|NCT00095940|7171745|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
4394133|NCT00095940|7171746|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
4394134|NCT00095940|7171747|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
4394135|NCT00095940|7171748|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
4394136|NCT00095940|7171749|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
4394137|NCT00095940|7171750|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
4394138|NCT00095940|7171751|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
4394139|NCT00095940|7171743|FG000|Lapatinib Continuation/Phase II|Adverse Event|0
4394140|NCT00095940|7171744|FG001|Lapatinib Continuation/Phase II|Adverse Event|0
4394141|NCT00095940|7171745|FG002|Lapatinib Continuation/Phase II|Adverse Event|0
4394142|NCT00095940|7171746|FG003|Lapatinib Continuation/Phase II|Adverse Event|0
4394143|NCT00095940|7171747|FG004|Lapatinib Continuation/Phase II|Adverse Event|0
4394144|NCT00095940|7171748|FG005|Lapatinib Continuation/Phase II|Adverse Event|0
4394145|NCT00095940|7171749|FG006|Lapatinib Continuation/Phase II|Adverse Event|0
4394146|NCT00095940|7171750|FG007|Lapatinib Continuation/Phase II|Adverse Event|1
4394147|NCT00095940|7171751|FG008|Lapatinib Continuation/Phase II|Adverse Event|0
4394148|NCT00095979|7171769|FG000|Overall Study|Ineligible: Second primary cancer site|2
4394149|NCT00096018|7171780|FG000|Overall Study|Became Ineligible (not treated)|0
4394150|NCT00096018|7171781|FG001|Overall Study|Became Ineligible (not treated)|3
4394151|NCT00096018|7171780|FG000|Overall Study|Miscellaneous (not treated)|0
4394152|NCT00096018|7171781|FG001|Overall Study|Miscellaneous (not treated)|2
4394153|NCT00096018|7171780|FG000|Overall Study|Adverse Event|0
4394154|NCT00096018|7171781|FG001|Overall Study|Adverse Event|5
4394155|NCT00096018|7171780|FG000|Overall Study|Death|0
4394156|NCT00096018|7171781|FG001|Overall Study|Death|1
4394157|NCT00096018|7171780|FG000|Overall Study|Withdrawal by Subject|0
4394158|NCT00096018|7171781|FG001|Overall Study|Withdrawal by Subject|2
4394159|NCT00096018|7171780|FG000|Overall Study|Miscellaneous|2
4394160|NCT00096018|7171781|FG001|Overall Study|Miscellaneous|1
4394161|NCT00096031|7171787|FG000|Overall Study|Adverse Event|3
4394162|NCT00096031|7171787|FG000|Overall Study|Lack of Efficacy|42
4394163|NCT00096031|7171787|FG000|Overall Study|Death|4
4394164|NCT00096031|7171787|FG000|Overall Study|Withdrawal by Subject|1
4394165|NCT00096031|7171787|FG000|Overall Study|Ineligible|8
4394166|NCT00096031|7171787|FG000|Overall Study|Not protocol specified|5
4394167|NCT00096044|7171791|FG000|Overall Study|Withdrawal by Subject|9
4394168|NCT00096044|7171791|FG000|Overall Study|Adverse Event|21
4394169|NCT00096044|7171791|FG000|Overall Study|Disease Progression|4
4394170|NCT00096135|7171805|FG000|Overall Study|Physician Decision|20
4394171|NCT00096135|7171806|FG001|Overall Study|Physician Decision|4
4394172|NCT00096135|7171805|FG000|Overall Study|Refusal of further protocol therapy|4
4394173|NCT00096135|7171806|FG001|Overall Study|Refusal of further protocol therapy|1
4394174|NCT00096135|7171805|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22
4394175|NCT00096135|7171806|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7
4394176|NCT00096135|7171805|FG000|Overall Study|Other, specify|15
4394177|NCT00096135|7171806|FG001|Overall Study|Other, specify|3
4394178|NCT00096135|7171805|FG000|Overall Study|Ineligible|2
4633275|NCT01909804|7503298|FG002|Overall Study|Protocol Violation|0
4394179|NCT00096135|7171806|FG001|Overall Study|Ineligible|0
4394180|NCT00096174|7171829|FG000|Overall Study|Lack of Efficacy|9
4510786|NCT00923078|7319682|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1
4394181|NCT00096174|7171829|FG000|Overall Study|Adverse Event|15
4394182|NCT00096174|7171829|FG000|Overall Study|Death|6
4394183|NCT00096174|7171829|FG000|Overall Study|Withdrawal by Subject|15
4394184|NCT00096174|7171829|FG000|Overall Study|Not started protocol therapy|3
4394185|NCT00096174|7171829|FG000|Overall Study|Ineligible|6
4394186|NCT00096174|7171829|FG000|Overall Study|other reason|8
4394187|NCT00096226|7171833|FG000|Overall Study|Ineligible|2
4394188|NCT00096226|7171833|FG000|Overall Study|Protocol treatment not started|1
4394189|NCT00096265|7171840|FG000|Overall Study|Ineligible|1
4394190|NCT00096265|7171841|FG001|Overall Study|Ineligible|0
4394191|NCT00096265|7171842|FG002|Overall Study|Ineligible|0
4394192|NCT00096278|7171853|FG000|Overall Study|No follow-up data|15
4394193|NCT00096278|7171854|FG001|Overall Study|No follow-up data|18
4394194|NCT00096278|7171853|FG000|Overall Study|Patient not at risk for primary endpoint|3
4394195|NCT00096278|7171854|FG001|Overall Study|Patient not at risk for primary endpoint|2
4394196|NCT00096356|7171864|FG000|Overall Study|Adverse Event|11
4394197|NCT00096356|7171865|FG001|Overall Study|Adverse Event|9
4394198|NCT00096356|7171864|FG000|Overall Study|Physician Decision|5
4394199|NCT00096356|7171865|FG001|Overall Study|Physician Decision|3
4394200|NCT00096356|7171864|FG000|Overall Study|Withdrawal by Subject|17
4394201|NCT00096356|7171865|FG001|Overall Study|Withdrawal by Subject|23
4394202|NCT00096356|7171864|FG000|Overall Study|Lack of Efficacy|1
4394203|NCT00096356|7171865|FG001|Overall Study|Lack of Efficacy|0
4394204|NCT00096356|7171864|FG000|Overall Study|multiple reasons|10
4394205|NCT00096356|7171865|FG001|Overall Study|multiple reasons|18
4394206|NCT00096382|7171874|FG000|Overall Study|Not treated|1
4394207|NCT00096382|7171875|FG001|Overall Study|Not treated|0
4394208|NCT00096382|7171874|FG000|Overall Study|Death during treatment|1
4394209|NCT00096382|7171875|FG001|Overall Study|Death during treatment|0
4394210|NCT00096447|7171881|FG000|Overall Study|Never treated|1
4394211|NCT00096486|7171903|FG000|Overall Study|Withdrawal by Subject|0
4394212|NCT00096486|7171904|FG001|Overall Study|Withdrawal by Subject|0
4394213|NCT00096486|7171905|FG002|Overall Study|Withdrawal by Subject|1
4394214|NCT00096486|7171906|FG003|Overall Study|Withdrawal by Subject|1
4394215|NCT00096486|7171903|FG000|Overall Study|Not Treated|0
4394216|NCT00096486|7171904|FG001|Overall Study|Not Treated|0
4394217|NCT00096486|7171905|FG002|Overall Study|Not Treated|1
4394218|NCT00096486|7171906|FG003|Overall Study|Not Treated|1
4394219|NCT00096538|7171916|FG000|Overall Study|Withdrawal by Subject|1
4394220|NCT00096785|7171926|FG000|Overall Study|Lost to Follow-up|1
4394221|NCT00096785|7171927|FG001|Overall Study|Lost to Follow-up|0
4394222|NCT00096785|7171926|FG000|Overall Study|Withdrawal by Subject|0
4394223|NCT00096785|7171927|FG001|Overall Study|Withdrawal by Subject|1
4394224|NCT00096785|7171926|FG000|Overall Study|Relocated|1
4394225|NCT00096785|7171927|FG001|Overall Study|Relocated|0
4394226|NCT00096941|7171933|FG000|Overall Study|disease progression|3
4394227|NCT00096954|7171939|FG000|Overall Study|Adverse Event|3
4394228|NCT00096954|7171940|FG001|Overall Study|Adverse Event|1
4394229|NCT00096954|7171939|FG000|Overall Study|Withdrawal by Subject|9
4394230|NCT00096954|7171940|FG001|Overall Study|Withdrawal by Subject|8
4394231|NCT00096954|7171939|FG000|Overall Study|Physician Decision|1
4394232|NCT00096954|7171940|FG001|Overall Study|Physician Decision|1
4394233|NCT00096954|7171939|FG000|Overall Study|Sponsors Decision|1
4394234|NCT00096954|7171940|FG001|Overall Study|Sponsors Decision|1
4394235|NCT00096954|7171939|FG000|Overall Study|Pregnancy|1
4394236|NCT00096954|7171940|FG001|Overall Study|Pregnancy|1
4394237|NCT00096954|7171939|FG000|Overall Study|Initiation of immunotherapy|1
4394238|NCT00096954|7171940|FG001|Overall Study|Initiation of immunotherapy|0
4394239|NCT00096954|7171939|FG000|Overall Study|Non-compliance|0
4394240|NCT00096954|7171940|FG001|Overall Study|Non-compliance|3
4394241|NCT00096954|7171939|FG000|Overall Study|Lost to Follow-up|8
4394242|NCT00096954|7171940|FG001|Overall Study|Lost to Follow-up|5
4394243|NCT00096993|7171948|FG000|Overall Study|Death|1
4394244|NCT00096993|7171949|FG001|Overall Study|Death|0
4394245|NCT00096993|7171948|FG000|Overall Study|Disease progression|56
4394246|NCT00096993|7171949|FG001|Overall Study|Disease progression|53
4394247|NCT00096993|7171948|FG000|Overall Study|Adverse Event|2
4394248|NCT00096993|7171949|FG001|Overall Study|Adverse Event|8
4394249|NCT00096993|7171948|FG000|Overall Study|Subject's decision|3
4394250|NCT00096993|7171949|FG001|Overall Study|Subject's decision|1
4394251|NCT00096993|7171948|FG000|Overall Study|Physician Decision|2
4394252|NCT00096993|7171949|FG001|Overall Study|Physician Decision|1
4394253|NCT00096993|7171948|FG000|Overall Study|Non-compliance|0
4394254|NCT00096993|7171949|FG001|Overall Study|Non-compliance|1
4394255|NCT00096993|7171948|FG000|Overall Study|Other unspecified|1
4394256|NCT00096993|7171949|FG001|Overall Study|Other unspecified|1
4394257|NCT00097370|7171963|FG000|Stage 1|Adverse Event|3
4394258|NCT00097370|7171963|FG000|Stage 1|Withdrawal by Subject|1
4394259|NCT00097370|7171963|FG000|Stage 1|Lack of Efficacy|2
4394260|NCT00097370|7171963|FG000|Stage 2|Adverse Event|5
4394261|NCT00097370|7171963|FG000|Stage 2|Withdrawal by Subject|1
4394262|NCT00097370|7171963|FG000|Stage 2|Lack of Efficacy|3
4394263|NCT00097370|7171963|FG000|Stage 2|Pregnancy|1
4394264|NCT00097370|7171963|FG000|Stage 2|Sponsor Terminated Study|2
4394265|NCT00097370|7171963|FG000|Stage 2|Lost to Follow-up|1
4394266|NCT00097370|7171963|FG000|Stage 3|Adverse Event|2
4394267|NCT00097370|7171963|FG000|Stage 3|Withdrawal by Subject|3
4394268|NCT00097370|7171963|FG000|Stage 3|Lack of Efficacy|1
4394269|NCT00097370|7171963|FG000|Stage 3|Sponsor Terminated Study|52
4394270|NCT00097370|7171963|FG000|Stage 3|Lost to Follow-up|1
4394271|NCT00097500|7171978|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1
4394272|NCT00097500|7171979|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1
4394273|NCT00097500|7171978|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5
4394274|NCT00097500|7171979|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0
4394275|NCT00097500|7171978|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0
4394276|NCT00097500|7171979|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1
4394277|NCT00097500|7171978|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0
4394278|NCT00097500|7171979|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1
4394279|NCT00097500|7171978|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2
4394280|NCT00097500|7171979|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1
4394281|NCT00097500|7171978|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0
4394282|NCT00097500|7171979|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1
4394283|NCT00097500|7171978|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3
4394284|NCT00097500|7171979|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2
4394285|NCT00097539|7171992|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959
4394286|NCT00097539|7171993|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948
4394287|NCT00097539|7171994|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646
4394288|NCT00097539|7171995|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170
4394289|NCT00097539|7171996|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106
4394290|NCT00097539|7171997|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546
4394291|NCT00097539|7171998|FG006|Overall Study|Status Unknown (Or no final evaluation)|108
4394292|NCT00097539|7171992|FG000|Overall Study|Withdrawal by Subject|925
4394293|NCT00097539|7171993|FG001|Overall Study|Withdrawal by Subject|323
4394294|NCT00097539|7171994|FG002|Overall Study|Withdrawal by Subject|346
4394295|NCT00097539|7171995|FG003|Overall Study|Withdrawal by Subject|217
4394296|NCT00097539|7171996|FG004|Overall Study|Withdrawal by Subject|68
4394297|NCT00097539|7171997|FG005|Overall Study|Withdrawal by Subject|229
4394298|NCT00097539|7171998|FG006|Overall Study|Withdrawal by Subject|3
4394299|NCT00097539|7171992|FG000|Overall Study|Participant Non-compliant|2140
4394300|NCT00097539|7171993|FG001|Overall Study|Participant Non-compliant|567
4394301|NCT00097539|7171994|FG002|Overall Study|Participant Non-compliant|1067
4394302|NCT00097539|7171995|FG003|Overall Study|Participant Non-compliant|353
4394303|NCT00097539|7171996|FG004|Overall Study|Participant Non-compliant|136
4394304|NCT00097539|7171997|FG005|Overall Study|Participant Non-compliant|543
4394305|NCT00097539|7171998|FG006|Overall Study|Participant Non-compliant|18
4394306|NCT00097539|7171992|FG000|Overall Study|Lack of Efficacy|249
4394307|NCT00097539|7171993|FG001|Overall Study|Lack of Efficacy|122
4394308|NCT00097539|7171994|FG002|Overall Study|Lack of Efficacy|202
4394309|NCT00097539|7171995|FG003|Overall Study|Lack of Efficacy|105
4394310|NCT00097539|7171996|FG004|Overall Study|Lack of Efficacy|45
4394311|NCT00097539|7171997|FG005|Overall Study|Lack of Efficacy|228
4394312|NCT00097539|7171998|FG006|Overall Study|Lack of Efficacy|5
4394313|NCT00097539|7171992|FG000|Overall Study|Adverse Event|78
4394314|NCT00097539|7171993|FG001|Overall Study|Adverse Event|133
4394315|NCT00097539|7171994|FG002|Overall Study|Adverse Event|37
4394316|NCT00097539|7171995|FG003|Overall Study|Adverse Event|27
4394317|NCT00097539|7171996|FG004|Overall Study|Adverse Event|30
4394318|NCT00097539|7171997|FG005|Overall Study|Adverse Event|59
4394319|NCT00097539|7171998|FG006|Overall Study|Adverse Event|1
4394320|NCT00097539|7171992|FG000|Overall Study|Death|2
4394321|NCT00097539|7171993|FG001|Overall Study|Death|7
4394322|NCT00097539|7171994|FG002|Overall Study|Death|0
4394323|NCT00097539|7171995|FG003|Overall Study|Death|0
4394324|NCT00097539|7171996|FG004|Overall Study|Death|1
4394325|NCT00097539|7171997|FG005|Overall Study|Death|3
4394326|NCT00097539|7171998|FG006|Overall Study|Death|0
4394327|NCT00097539|7171992|FG000|Overall Study|Reasons Other Than Above|3602
4394328|NCT00097539|7171993|FG001|Overall Study|Reasons Other Than Above|1382
4394329|NCT00097539|7171994|FG002|Overall Study|Reasons Other Than Above|1757
4394330|NCT00097539|7171995|FG003|Overall Study|Reasons Other Than Above|692
4394331|NCT00097539|7171996|FG004|Overall Study|Reasons Other Than Above|361
4394332|NCT00097539|7171997|FG005|Overall Study|Reasons Other Than Above|1244
4394333|NCT00097539|7171998|FG006|Overall Study|Reasons Other Than Above|34
4394334|NCT00097539|7171992|FG000|Overall Study|Reason not Specified|111
4394335|NCT00097539|7171993|FG001|Overall Study|Reason not Specified|49
4394336|NCT00097539|7171994|FG002|Overall Study|Reason not Specified|53
4394337|NCT00097539|7171995|FG003|Overall Study|Reason not Specified|21
4394338|NCT00097539|7171996|FG004|Overall Study|Reason not Specified|11
4394339|NCT00097539|7171997|FG005|Overall Study|Reason not Specified|40
4394340|NCT00097539|7171998|FG006|Overall Study|Reason not Specified|2
4394341|NCT00097591|7172016|FG000|Overall Study|Withdrawal of consent|342
4394342|NCT00097591|7172017|FG001|Overall Study|Withdrawal of consent|323
4394343|NCT00097591|7172016|FG000|Overall Study|Less than 6 months on study drug|9
4394344|NCT00097591|7172017|FG001|Overall Study|Less than 6 months on study drug|7
4394345|NCT00097591|7172016|FG000|Overall Study|Unable to attend termination visit|53
4394346|NCT00097591|7172017|FG001|Overall Study|Unable to attend termination visit|51
4394347|NCT00097591|7172016|FG000|Overall Study|Lost to follow up|6
4394348|NCT00097591|7172017|FG001|Overall Study|Lost to follow up|10
4394349|NCT00097591|7172016|FG000|Overall Study|Other|0
4394350|NCT00097591|7172017|FG001|Overall Study|Other|3
4394351|NCT00097721|7172066|FG000|Overall Study|Adverse Event|8
4394352|NCT00097721|7172067|FG001|Overall Study|Adverse Event|1
4394353|NCT00097721|7172066|FG000|Overall Study|Withdrawal by Subject|6
4394354|NCT00097721|7172067|FG001|Overall Study|Withdrawal by Subject|1
4394355|NCT00097721|7172066|FG000|Overall Study|Progressive Disease|55
4394356|NCT00097721|7172067|FG001|Overall Study|Progressive Disease|27
4394357|NCT00097721|7172066|FG000|Overall Study|Physician Decision|1
4394358|NCT00097721|7172067|FG001|Overall Study|Physician Decision|3
4394359|NCT00097721|7172066|FG000|Overall Study|Reason not given|1
4394360|NCT00097721|7172067|FG001|Overall Study|Reason not given|1
4394361|NCT00097773|7172077|FG000|Overall Study|Lost to Follow-up|2
4394362|NCT00097773|7172078|FG001|Overall Study|Lost to Follow-up|2
4394363|NCT00097773|7172079|FG002|Overall Study|Lost to Follow-up|0
4394364|NCT00097773|7172080|FG003|Overall Study|Lost to Follow-up|1
4394365|NCT00097773|7172077|FG000|Overall Study|Physician Decision|2
4394366|NCT00097773|7172078|FG001|Overall Study|Physician Decision|2
4394367|NCT00097773|7172079|FG002|Overall Study|Physician Decision|3
4394368|NCT00097773|7172080|FG003|Overall Study|Physician Decision|1
4394369|NCT00097773|7172077|FG000|Overall Study|Withdrawal by Subject|3
4394370|NCT00097773|7172078|FG001|Overall Study|Withdrawal by Subject|3
4394371|NCT00097773|7172079|FG002|Overall Study|Withdrawal by Subject|3
4394372|NCT00097773|7172080|FG003|Overall Study|Withdrawal by Subject|1
4394373|NCT00097773|7172077|FG000|Overall Study|Adverse Event|0
4394374|NCT00097773|7172078|FG001|Overall Study|Adverse Event|1
4394375|NCT00097773|7172079|FG002|Overall Study|Adverse Event|0
4394376|NCT00097773|7172080|FG003|Overall Study|Adverse Event|0
4394377|NCT00097773|7172077|FG000|Overall Study|Other|1
4394378|NCT00097773|7172078|FG001|Overall Study|Other|0
4394379|NCT00097773|7172079|FG002|Overall Study|Other|2
4394380|NCT00097773|7172080|FG003|Overall Study|Other|0
4394381|NCT00097786|7172099|FG000|Overall Study|lost to follow-up for all-cause death|296
4394382|NCT00097786|7172100|FG001|Overall Study|lost to follow-up for all-cause death|292
4394383|NCT00097786|7172101|FG002|Overall Study|lost to follow-up for all-cause death|313
4394384|NCT00097786|7172102|FG003|Overall Study|lost to follow-up for all-cause death|310
4394385|NCT00097981|7172114|FG000|Overall Study|Adverse Event|31
4394386|NCT00097981|7172115|FG001|Overall Study|Adverse Event|44
4394387|NCT00097981|7172114|FG000|Overall Study|Withdrawal by Subject|10
4394388|NCT00097981|7172115|FG001|Overall Study|Withdrawal by Subject|8
4394389|NCT00097981|7172114|FG000|Overall Study|Protocol Violation|1
4394390|NCT00097981|7172115|FG001|Overall Study|Protocol Violation|1
4394391|NCT00097981|7172114|FG000|Overall Study|Death|2
4394392|NCT00097981|7172115|FG001|Overall Study|Death|4
4394393|NCT00097981|7172114|FG000|Overall Study|Physician Decision|7
4394394|NCT00097981|7172115|FG001|Overall Study|Physician Decision|1
4394395|NCT00097981|7172114|FG000|Overall Study|Disease Progression|8
4394396|NCT00097981|7172115|FG001|Overall Study|Disease Progression|2
4394397|NCT00097981|7172114|FG000|Overall Study|Transplant planned|28
4394398|NCT00097981|7172115|FG001|Overall Study|Transplant planned|27
4394399|NCT00097981|7172114|FG000|Overall Study|Other|19
4394400|NCT00097981|7172115|FG001|Overall Study|Other|13
4394401|NCT00098020|7172121|FG000|Overall Study|Adverse Event|2
4394402|NCT00098020|7172121|FG000|Overall Study|Lost to Follow-up|1
4394403|NCT00098020|7172121|FG000|Overall Study|elevated liver enzymes|1
4394404|NCT00098020|7172121|FG000|Overall Study|Low urine PCR|1
4394405|NCT00098020|7172121|FG000|Overall Study|Low epidermal growth factor receptor|1
4394406|NCT00098254|7172139|FG000|Overall Study|Adverse Event|2
4394407|NCT00098254|7172139|FG000|Overall Study|Death|1
4394408|NCT00098293|7172146|FG000|Double-blind (DB) Phase|Adverse Event|14
4394409|NCT00098293|7172147|FG001|Double-blind (DB) Phase|Adverse Event|27
4394410|NCT00098293|7172148|FG002|Double-blind (DB) Phase|Adverse Event|60
4394411|NCT00098293|7172149|FG003|Double-blind (DB) Phase|Adverse Event|0
4394412|NCT00098293|7172150|FG004|Double-blind (DB) Phase|Adverse Event|0
4394413|NCT00098293|7172146|FG000|Double-blind (DB) Phase|Pregnancy|0
4394414|NCT00098293|7172147|FG001|Double-blind (DB) Phase|Pregnancy|7
4394415|NCT00098293|7172148|FG002|Double-blind (DB) Phase|Pregnancy|9
4394416|NCT00098293|7172149|FG003|Double-blind (DB) Phase|Pregnancy|0
4394417|NCT00098293|7172150|FG004|Double-blind (DB) Phase|Pregnancy|0
4394418|NCT00098293|7172146|FG000|Double-blind (DB) Phase|Participant Defaulted|11
4394419|NCT00098293|7172147|FG001|Double-blind (DB) Phase|Participant Defaulted|40
4394420|NCT00098293|7172148|FG002|Double-blind (DB) Phase|Participant Defaulted|36
4394421|NCT00098293|7172149|FG003|Double-blind (DB) Phase|Participant Defaulted|0
4394422|NCT00098293|7172150|FG004|Double-blind (DB) Phase|Participant Defaulted|0
4394423|NCT00098293|7172146|FG000|Double-blind (DB) Phase|Lack of Efficacy|11
4394424|NCT00098293|7172147|FG001|Double-blind (DB) Phase|Lack of Efficacy|64
4394425|NCT00098293|7172148|FG002|Double-blind (DB) Phase|Lack of Efficacy|30
4394426|NCT00098293|7172149|FG003|Double-blind (DB) Phase|Lack of Efficacy|0
4394427|NCT00098293|7172150|FG004|Double-blind (DB) Phase|Lack of Efficacy|0
4394428|NCT00098293|7172146|FG000|Double-blind (DB) Phase|Death|1
4394429|NCT00098293|7172147|FG001|Double-blind (DB) Phase|Death|2
4394430|NCT00098293|7172148|FG002|Double-blind (DB) Phase|Death|2
4394431|NCT00098293|7172149|FG003|Double-blind (DB) Phase|Death|0
4394432|NCT00098293|7172150|FG004|Double-blind (DB) Phase|Death|0
4394433|NCT00098293|7172146|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3
4394434|NCT00098293|7172147|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8
4394435|NCT00098293|7172148|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11
4394436|NCT00098293|7172149|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0
4394437|NCT00098293|7172150|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0
4394438|NCT00098293|7172146|FG000|Double-blind (DB) Phase|Protocol Violation|2
4394439|NCT00098293|7172147|FG001|Double-blind (DB) Phase|Protocol Violation|18
4394440|NCT00098293|7172148|FG002|Double-blind (DB) Phase|Protocol Violation|22
4394441|NCT00098293|7172149|FG003|Double-blind (DB) Phase|Protocol Violation|0
4394442|NCT00098293|7172150|FG004|Double-blind (DB) Phase|Protocol Violation|0
4394443|NCT00098293|7172146|FG000|Double-blind (DB) Phase|Terminated by sponsor|135
4394444|NCT00098293|7172147|FG001|Double-blind (DB) Phase|Terminated by sponsor|0
4394445|NCT00098293|7172148|FG002|Double-blind (DB) Phase|Terminated by sponsor|0
4394446|NCT00098293|7172149|FG003|Double-blind (DB) Phase|Terminated by sponsor|0
4394447|NCT00098293|7172150|FG004|Double-blind (DB) Phase|Terminated by sponsor|0
4394448|NCT00098293|7172146|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0
4394449|NCT00098293|7172147|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0
4394450|NCT00098293|7172148|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3
4394451|NCT00098293|7172149|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0
4394452|NCT00098293|7172150|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0
4394453|NCT00098293|7172146|FG000|Open-label (OL) Phase|Adverse Event|0
4394454|NCT00098293|7172147|FG001|Open-label (OL) Phase|Adverse Event|3
4394455|NCT00098293|7172148|FG002|Open-label (OL) Phase|Adverse Event|7
4394456|NCT00098293|7172149|FG003|Open-label (OL) Phase|Adverse Event|6
4394457|NCT00098293|7172150|FG004|Open-label (OL) Phase|Adverse Event|0
4394458|NCT00098293|7172146|FG000|Open-label (OL) Phase|Lack of Efficacy|0
4394459|NCT00098293|7172147|FG001|Open-label (OL) Phase|Lack of Efficacy|7
4394460|NCT00098293|7172148|FG002|Open-label (OL) Phase|Lack of Efficacy|2
4394461|NCT00098293|7172149|FG003|Open-label (OL) Phase|Lack of Efficacy|20
4394462|NCT00098293|7172150|FG004|Open-label (OL) Phase|Lack of Efficacy|0
4394463|NCT00098293|7172146|FG000|Open-label (OL) Phase|Pregnancy|0
4394464|NCT00098293|7172147|FG001|Open-label (OL) Phase|Pregnancy|1
4394465|NCT00098293|7172148|FG002|Open-label (OL) Phase|Pregnancy|0
4394466|NCT00098293|7172149|FG003|Open-label (OL) Phase|Pregnancy|3
4394467|NCT00098293|7172150|FG004|Open-label (OL) Phase|Pregnancy|0
4394468|NCT00098293|7172146|FG000|Open-label (OL) Phase|Protocol Violation|0
4394469|NCT00098293|7172147|FG001|Open-label (OL) Phase|Protocol Violation|6
4394470|NCT00098293|7172148|FG002|Open-label (OL) Phase|Protocol Violation|13
4394471|NCT00098293|7172149|FG003|Open-label (OL) Phase|Protocol Violation|16
4394472|NCT00098293|7172150|FG004|Open-label (OL) Phase|Protocol Violation|0
4394473|NCT00098293|7172146|FG000|Open-label (OL) Phase|Participant Defaulted|0
4394474|NCT00098293|7172147|FG001|Open-label (OL) Phase|Participant Defaulted|6
4394475|NCT00098293|7172148|FG002|Open-label (OL) Phase|Participant Defaulted|16
4394476|NCT00098293|7172149|FG003|Open-label (OL) Phase|Participant Defaulted|20
4394477|NCT00098293|7172150|FG004|Open-label (OL) Phase|Participant Defaulted|0
4394478|NCT00098293|7172146|FG000|Open-label (OL) Phase|Death|0
4394479|NCT00098293|7172147|FG001|Open-label (OL) Phase|Death|2
4394480|NCT00098293|7172148|FG002|Open-label (OL) Phase|Death|3
4394481|NCT00098293|7172149|FG003|Open-label (OL) Phase|Death|0
4394482|NCT00098293|7172150|FG004|Open-label (OL) Phase|Death|0
4394483|NCT00098293|7172146|FG000|Supplemental Phase (SP)|Death|0
4394484|NCT00098293|7172147|FG001|Supplemental Phase (SP)|Death|0
4394485|NCT00098293|7172148|FG002|Supplemental Phase (SP)|Death|0
4394486|NCT00098293|7172149|FG003|Supplemental Phase (SP)|Death|0
4394487|NCT00098293|7172150|FG004|Supplemental Phase (SP)|Death|1
4394488|NCT00098293|7172146|FG000|Supplemental Phase (SP)|Lost to Follow-up|0
4394489|NCT00098293|7172147|FG001|Supplemental Phase (SP)|Lost to Follow-up|0
4394490|NCT00098293|7172148|FG002|Supplemental Phase (SP)|Lost to Follow-up|0
4394491|NCT00098293|7172149|FG003|Supplemental Phase (SP)|Lost to Follow-up|0
4394492|NCT00098293|7172150|FG004|Supplemental Phase (SP)|Lost to Follow-up|2
4394493|NCT00098293|7172146|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0
4394494|NCT00098293|7172147|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0
4394495|NCT00098293|7172148|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0
4394496|NCT00098293|7172149|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0
4394497|NCT00098293|7172150|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8
4394498|NCT00098293|7172146|FG000|Supplemental Phase (SP)|Other|0
4394499|NCT00098293|7172147|FG001|Supplemental Phase (SP)|Other|0
4394500|NCT00098293|7172148|FG002|Supplemental Phase (SP)|Other|0
4394501|NCT00098293|7172149|FG003|Supplemental Phase (SP)|Other|0
4394502|NCT00098293|7172150|FG004|Supplemental Phase (SP)|Other|22
4394503|NCT00098306|7172164|FG000|Double Blind|Randomized, not treated|9
4394504|NCT00098306|7172165|FG001|Double Blind|Randomized, not treated|5
4394505|NCT00098306|7172166|FG002|Double Blind|Randomized, not treated|2
4394506|NCT00098306|7172167|FG003|Double Blind|Randomized, not treated|0
4394507|NCT00098306|7172168|FG004|Double Blind|Randomized, not treated|0
4394508|NCT00098306|7172169|FG005|Double Blind|Randomized, not treated|0
4394509|NCT00098306|7172170|FG006|Double Blind|Randomized, not treated|0
4394510|NCT00098306|7172164|FG000|Double Blind|Ongoing at cut-off date|151
4394511|NCT00098306|7172165|FG001|Double Blind|Ongoing at cut-off date|166
4394512|NCT00098306|7172166|FG002|Double Blind|Ongoing at cut-off date|72
4394513|NCT00098306|7172167|FG003|Double Blind|Ongoing at cut-off date|0
4394514|NCT00098306|7172168|FG004|Double Blind|Ongoing at cut-off date|0
4394515|NCT00098306|7172169|FG005|Double Blind|Ongoing at cut-off date|0
4394516|NCT00098306|7172170|FG006|Double Blind|Ongoing at cut-off date|0
4394517|NCT00098306|7172164|FG000|Double Blind|Adverse Event|11
4394518|NCT00098306|7172165|FG001|Double Blind|Adverse Event|10
4394519|NCT00098306|7172166|FG002|Double Blind|Adverse Event|6
4394520|NCT00098306|7172167|FG003|Double Blind|Adverse Event|0
4394521|NCT00098306|7172168|FG004|Double Blind|Adverse Event|0
4394522|NCT00098306|7172169|FG005|Double Blind|Adverse Event|0
4394523|NCT00098306|7172170|FG006|Double Blind|Adverse Event|0
4394524|NCT00098306|7172164|FG000|Double Blind|Lack of Efficacy|43
4394525|NCT00098306|7172165|FG001|Double Blind|Lack of Efficacy|34
4394526|NCT00098306|7172166|FG002|Double Blind|Lack of Efficacy|17
4394527|NCT00098306|7172167|FG003|Double Blind|Lack of Efficacy|0
4394528|NCT00098306|7172168|FG004|Double Blind|Lack of Efficacy|0
4394529|NCT00098306|7172169|FG005|Double Blind|Lack of Efficacy|0
4394530|NCT00098306|7172170|FG006|Double Blind|Lack of Efficacy|0
4394531|NCT00098306|7172164|FG000|Double Blind|Death|1
4394532|NCT00098306|7172165|FG001|Double Blind|Death|4
4394533|NCT00098306|7172166|FG002|Double Blind|Death|1
4394534|NCT00098306|7172167|FG003|Double Blind|Death|0
4394535|NCT00098306|7172168|FG004|Double Blind|Death|0
4394536|NCT00098306|7172169|FG005|Double Blind|Death|0
4394537|NCT00098306|7172170|FG006|Double Blind|Death|0
4394538|NCT00098306|7172164|FG000|Double Blind|Participant defaulted|19
4394539|NCT00098306|7172165|FG001|Double Blind|Participant defaulted|18
4394540|NCT00098306|7172166|FG002|Double Blind|Participant defaulted|11
4394541|NCT00098306|7172167|FG003|Double Blind|Participant defaulted|0
4394542|NCT00098306|7172168|FG004|Double Blind|Participant defaulted|0
4394543|NCT00098306|7172169|FG005|Double Blind|Participant defaulted|0
4394544|NCT00098306|7172170|FG006|Double Blind|Participant defaulted|0
4394545|NCT00098306|7172164|FG000|Double Blind|Un-specified|7
4394546|NCT00098306|7172165|FG001|Double Blind|Un-specified|3
4394547|NCT00098306|7172166|FG002|Double Blind|Un-specified|11
4394548|NCT00098306|7172167|FG003|Double Blind|Un-specified|0
4394549|NCT00098306|7172168|FG004|Double Blind|Un-specified|0
4394550|NCT00098306|7172169|FG005|Double Blind|Un-specified|0
4394551|NCT00098306|7172170|FG006|Double Blind|Un-specified|0
4394552|NCT00098306|7172164|FG000|Open Label|Lack of Efficacy|0
4394553|NCT00098306|7172165|FG001|Open Label|Lack of Efficacy|0
4394554|NCT00098306|7172166|FG002|Open Label|Lack of Efficacy|0
4394555|NCT00098306|7172167|FG003|Open Label|Lack of Efficacy|13
4394556|NCT00098306|7172168|FG004|Open Label|Lack of Efficacy|0
4394557|NCT00098306|7172169|FG005|Open Label|Lack of Efficacy|0
4394558|NCT00098306|7172170|FG006|Open Label|Lack of Efficacy|0
4394559|NCT00098306|7172164|FG000|Open Label|Adverse Event|0
4394560|NCT00098306|7172165|FG001|Open Label|Adverse Event|0
4394561|NCT00098306|7172166|FG002|Open Label|Adverse Event|0
4394562|NCT00098306|7172167|FG003|Open Label|Adverse Event|2
4394563|NCT00098306|7172168|FG004|Open Label|Adverse Event|0
4394564|NCT00098306|7172169|FG005|Open Label|Adverse Event|0
4394565|NCT00098306|7172170|FG006|Open Label|Adverse Event|0
4394566|NCT00098306|7172164|FG000|Open Label|Death|0
4394567|NCT00098306|7172165|FG001|Open Label|Death|0
4394568|NCT00098306|7172166|FG002|Open Label|Death|0
4394569|NCT00098306|7172167|FG003|Open Label|Death|4
4394570|NCT00098306|7172168|FG004|Open Label|Death|0
4394571|NCT00098306|7172169|FG005|Open Label|Death|0
4394572|NCT00098306|7172170|FG006|Open Label|Death|0
4394573|NCT00098306|7172164|FG000|Open Label|Participant defaulted|0
4394574|NCT00098306|7172165|FG001|Open Label|Participant defaulted|0
4394575|NCT00098306|7172166|FG002|Open Label|Participant defaulted|0
4394576|NCT00098306|7172167|FG003|Open Label|Participant defaulted|24
4394577|NCT00098306|7172168|FG004|Open Label|Participant defaulted|0
4394578|NCT00098306|7172169|FG005|Open Label|Participant defaulted|0
4394579|NCT00098306|7172170|FG006|Open Label|Participant defaulted|0
4394580|NCT00098306|7172164|FG000|Open Label|Un-specified|0
4394581|NCT00098306|7172165|FG001|Open Label|Un-specified|0
4394582|NCT00098306|7172166|FG002|Open Label|Un-specified|0
4394583|NCT00098306|7172167|FG003|Open Label|Un-specified|15
4394584|NCT00098306|7172168|FG004|Open Label|Un-specified|0
4394585|NCT00098306|7172169|FG005|Open Label|Un-specified|0
4394586|NCT00098306|7172170|FG006|Open Label|Un-specified|0
4394587|NCT00098306|7172164|FG000|Open Label|Ongoing at cut-off date|0
4394588|NCT00098306|7172165|FG001|Open Label|Ongoing at cut-off date|0
4394589|NCT00098306|7172166|FG002|Open Label|Ongoing at cut-off date|0
4394590|NCT00098306|7172167|FG003|Open Label|Ongoing at cut-off date|269
4394591|NCT00098306|7172168|FG004|Open Label|Ongoing at cut-off date|62
4394592|NCT00098306|7172169|FG005|Open Label|Ongoing at cut-off date|0
4394593|NCT00098306|7172170|FG006|Open Label|Ongoing at cut-off date|0
4394594|NCT00098306|7172164|FG000|Observational Phase|Death|0
4394595|NCT00098306|7172165|FG001|Observational Phase|Death|0
4394596|NCT00098306|7172166|FG002|Observational Phase|Death|0
4394597|NCT00098306|7172167|FG003|Observational Phase|Death|0
4394598|NCT00098306|7172168|FG004|Observational Phase|Death|0
4394599|NCT00098306|7172169|FG005|Observational Phase|Death|5
4394600|NCT00098306|7172170|FG006|Observational Phase|Death|4
4394601|NCT00098306|7172164|FG000|Observational Phase|Participant defaulted|0
4394602|NCT00098306|7172165|FG001|Observational Phase|Participant defaulted|0
4394603|NCT00098306|7172166|FG002|Observational Phase|Participant defaulted|0
4394604|NCT00098306|7172167|FG003|Observational Phase|Participant defaulted|0
4394605|NCT00098306|7172168|FG004|Observational Phase|Participant defaulted|0
4394606|NCT00098306|7172169|FG005|Observational Phase|Participant defaulted|34
4394607|NCT00098306|7172170|FG006|Observational Phase|Participant defaulted|18
4394608|NCT00098306|7172164|FG000|Observational Phase|Un-specified|0
4394609|NCT00098306|7172165|FG001|Observational Phase|Un-specified|0
4394610|NCT00098306|7172166|FG002|Observational Phase|Un-specified|0
4394611|NCT00098306|7172167|FG003|Observational Phase|Un-specified|0
4394612|NCT00098306|7172168|FG004|Observational Phase|Un-specified|0
4394613|NCT00098306|7172169|FG005|Observational Phase|Un-specified|7
4394614|NCT00098306|7172170|FG006|Observational Phase|Un-specified|4
4394615|NCT00098345|7172183|FG000|Overall Study|Adverse Event|7
4394616|NCT00098345|7172183|FG000|Overall Study|Withdrawal by Subject|2
4394617|NCT00098345|7172183|FG000|Overall Study|progression|4
4771556|NCT02539160|7748376|FG002|Phase 1 Pre-crossover|Adverse Event|2
4771557|NCT02539160|7748377|FG003|Phase 1 Pre-crossover|Adverse Event|1
4510787|NCT00923078|7319683|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1
4510788|NCT00923078|7319684|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0
4510789|NCT00923078|7319682|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0
4510790|NCT00923078|7319683|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0
4510791|NCT00923078|7319684|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20
4510792|NCT00923091|7319699|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11
4510793|NCT00923091|7319700|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3
4510794|NCT00923091|7319701|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7
4518420|NCT00973700|7330520|FG003|Overall Study|Unable to Classify|2
4771558|NCT02539160|7748374|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2
4771559|NCT02539160|7748375|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1
4771560|NCT02539160|7748376|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1
4771561|NCT02539160|7748377|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0
4771562|NCT02539160|7748374|FG000|Phase 1 Pre-crossover|Protocol Violation|0
4771563|NCT02539160|7748375|FG001|Phase 1 Pre-crossover|Protocol Violation|0
4771564|NCT02539160|7748376|FG002|Phase 1 Pre-crossover|Protocol Violation|0
4771565|NCT02539160|7748377|FG003|Phase 1 Pre-crossover|Protocol Violation|2
4771566|NCT02507973|7748387|FG000|Overall Study|Adverse Event|1
4771567|NCT02477696|7748395|FG000|Overall Study|Adverse Event|40
4771568|NCT02477696|7748396|FG001|Overall Study|Adverse Event|59
4771569|NCT02477696|7748395|FG000|Overall Study|CLL Disease Progression|82
4771570|NCT02477696|7748396|FG001|Overall Study|CLL Disease Progression|68
4771571|NCT02477696|7748395|FG000|Overall Study|Includes Non-compliance, Relocation, Subject's Decision and Medical Monitor's Decision.|2
4771572|NCT02477696|7748396|FG001|Overall Study|Includes Non-compliance, Relocation, Subject's Decision and Medical Monitor's Decision.|10
4771573|NCT02477696|7748395|FG000|Overall Study|Death|5
4771574|NCT02477696|7748396|FG001|Overall Study|Death|6
4771575|NCT02477696|7748395|FG000|Overall Study|Withdrawal by Subject|7
4771576|NCT02477696|7748396|FG001|Overall Study|Withdrawal by Subject|7
4771577|NCT02477696|7748395|FG000|Overall Study|Physician Decision|5
4771578|NCT02477696|7748396|FG001|Overall Study|Physician Decision|5
4771579|NCT02477618|7748404|FG000|Overall Study|Completed Visits but Discontinued Drug|2
4771580|NCT02477618|7748405|FG001|Overall Study|Completed Visits but Discontinued Drug|1
4771581|NCT02477618|7748404|FG000|Overall Study|Died in Double-Blind Treatment Period|11
4771582|NCT02477618|7748405|FG001|Overall Study|Died in Double-Blind Treatment Period|11
4771583|NCT02477618|7748404|FG000|Overall Study|Adverse Event|1
4771584|NCT02477618|7748405|FG001|Overall Study|Adverse Event|1
4771585|NCT02477618|7748404|FG000|Overall Study|Transferred Away from Study Site|1
4771586|NCT02477618|7748405|FG001|Overall Study|Transferred Away from Study Site|0
4771587|NCT02477618|7748404|FG000|Overall Study|Left Study Site for Rehabilitation|0
4771588|NCT02477618|7748405|FG001|Overall Study|Left Study Site for Rehabilitation|1
4771589|NCT02257528|7748424|FG000|Overall Study|Never received study treatment|1
4771590|NCT02003924|7748441|FG000|Double-blind Phase|Lost to Follow-up|2
4771591|NCT02003924|7748442|FG001|Double-blind Phase|Lost to Follow-up|1
4771592|NCT02003924|7748443|FG002|Double-blind Phase|Lost to Follow-up|0
4771593|NCT02003924|7748441|FG000|Double-blind Phase|Protocol Violation|1
4771594|NCT02003924|7748442|FG001|Double-blind Phase|Protocol Violation|2
4771595|NCT02003924|7748443|FG002|Double-blind Phase|Protocol Violation|0
4771596|NCT02003924|7748441|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71
4771597|NCT02003924|7748442|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47
4771598|NCT02003924|7748443|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0
4771599|NCT02003924|7748441|FG000|Double-blind Phase|Disease Progression|229
4771600|NCT02003924|7748442|FG001|Double-blind Phase|Disease Progression|247
4771601|NCT02003924|7748443|FG002|Double-blind Phase|Disease Progression|0
4771602|NCT02003924|7748441|FG000|Double-blind Phase|Adverse Event|120
4771603|NCT02003924|7748442|FG001|Double-blind Phase|Adverse Event|31
4771604|NCT02003924|7748443|FG002|Double-blind Phase|Adverse Event|0
4771605|NCT02003924|7748441|FG000|Double-blind Phase|Randomized But not Treated|3
4771606|NCT02003924|7748442|FG001|Double-blind Phase|Randomized But not Treated|3
4771607|NCT02003924|7748443|FG002|Double-blind Phase|Randomized But not Treated|0
4771608|NCT02003924|7748441|FG000|Double-blind Phase|Other|29
4771609|NCT02003924|7748442|FG001|Double-blind Phase|Other|50
4771610|NCT02003924|7748443|FG002|Double-blind Phase|Other|0
4771611|NCT02003924|7748441|FG000|Open-label Phase|Lost to Follow-up|0
4771612|NCT02003924|7748442|FG001|Open-label Phase|Lost to Follow-up|0
4771613|NCT02003924|7748443|FG002|Open-label Phase|Lost to Follow-up|1
4771614|NCT02003924|7748441|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9
4771615|NCT02003924|7748442|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0
4771616|NCT02003924|7748443|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1
4771617|NCT02003924|7748441|FG000|Open-label Phase|Disease Progression|59
4771618|NCT02003924|7748442|FG001|Open-label Phase|Disease Progression|0
4771619|NCT02003924|7748443|FG002|Open-label Phase|Disease Progression|5
4771620|NCT02003924|7748441|FG000|Open-label Phase|Adverse Event|25
4771621|NCT02003924|7748442|FG001|Open-label Phase|Adverse Event|0
4771622|NCT02003924|7748443|FG002|Open-label Phase|Adverse Event|10
4771623|NCT02003924|7748441|FG000|Open-label Phase|Other|7
4771624|NCT02003924|7748442|FG001|Open-label Phase|Other|0
4771625|NCT02003924|7748443|FG002|Open-label Phase|Other|0
4771626|NCT02003924|7748441|FG000|Long-term Follow-up Phase|Death|288
4771627|NCT02003924|7748442|FG001|Long-term Follow-up Phase|Death|174
4771628|NCT02003924|7748443|FG002|Long-term Follow-up Phase|Death|4
4771629|NCT02003924|7748441|FG000|Long-term Follow-up Phase|Lost to Follow-up|8
4771630|NCT02003924|7748442|FG001|Long-term Follow-up Phase|Lost to Follow-up|6
4771631|NCT02003924|7748443|FG002|Long-term Follow-up Phase|Lost to Follow-up|1
4771632|NCT02003924|7748441|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66
4771633|NCT02003924|7748442|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55
4771634|NCT02003924|7748443|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1
4771635|NCT02003924|7748441|FG000|Long-term Follow-up Phase|Other|5
4771636|NCT02003924|7748442|FG001|Long-term Follow-up Phase|Other|2
4771637|NCT02003924|7748443|FG002|Long-term Follow-up Phase|Other|1
4771638|NCT01971970|7748452|FG000|Baseline Until Week 6|Stopped anti-TNF use|1
4771639|NCT01971970|7748453|FG001|Baseline Until Week 6|Stopped anti-TNF use|0
4771640|NCT01971970|7748452|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0
4771641|NCT01971970|7748453|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1
4771642|NCT01971970|7748452|FG000|Week 14 Until Week 22|Lost to Follow-up|0
4771643|NCT01971970|7748453|FG001|Week 14 Until Week 22|Lost to Follow-up|1
4771644|NCT01971970|7748452|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7
4771645|NCT01971970|7748453|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3
4771646|NCT01971970|7748452|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1
4771647|NCT01971970|7748453|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0
4771648|NCT01971970|7748452|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0
4771649|NCT01971970|7748453|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1
4771650|NCT01971970|7748452|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1
4771651|NCT01971970|7748453|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3
4771652|NCT01969409|7748466|FG000|Overall Study|Death|2
4771653|NCT01969409|7748467|FG001|Overall Study|Death|2
4771654|NCT01969409|7748466|FG000|Overall Study|Transplant|1
4771655|NCT01969409|7748467|FG001|Overall Study|Transplant|1
4771656|NCT01969409|7748466|FG000|Overall Study|Withdrawal by Subject|0
4771657|NCT01969409|7748467|FG001|Overall Study|Withdrawal by Subject|1
4394734|NCT00098722|7172225|FG000|Double Blind Phase|Adverse Event|7
4394735|NCT00098722|7172226|FG001|Double Blind Phase|Adverse Event|7
4394736|NCT00098722|7172227|FG002|Double Blind Phase|Adverse Event|3
4394737|NCT00098722|7172228|FG003|Double Blind Phase|Adverse Event|0
4394738|NCT00098722|7172229|FG004|Double Blind Phase|Adverse Event|0
4394739|NCT00098722|7172230|FG005|Double Blind Phase|Adverse Event|0
4394740|NCT00098722|7172231|FG006|Double Blind Phase|Adverse Event|0
4394741|NCT00098722|7172225|FG000|Double Blind Phase|Death|2
4394742|NCT00098722|7172226|FG001|Double Blind Phase|Death|5
4394743|NCT00098722|7172227|FG002|Double Blind Phase|Death|0
4394744|NCT00098722|7172228|FG003|Double Blind Phase|Death|0
4394745|NCT00098722|7172229|FG004|Double Blind Phase|Death|0
4394746|NCT00098722|7172230|FG005|Double Blind Phase|Death|0
4394747|NCT00098722|7172231|FG006|Double Blind Phase|Death|0
4394748|NCT00098722|7172225|FG000|Double Blind Phase|Lack of Efficacy|21
4394749|NCT00098722|7172226|FG001|Double Blind Phase|Lack of Efficacy|23
4394750|NCT00098722|7172227|FG002|Double Blind Phase|Lack of Efficacy|15
4394751|NCT00098722|7172228|FG003|Double Blind Phase|Lack of Efficacy|0
4394752|NCT00098722|7172229|FG004|Double Blind Phase|Lack of Efficacy|0
4394753|NCT00098722|7172230|FG005|Double Blind Phase|Lack of Efficacy|0
4394754|NCT00098722|7172231|FG006|Double Blind Phase|Lack of Efficacy|0
4394755|NCT00098722|7172225|FG000|Double Blind Phase|Participant defaulted|16
4394756|NCT00098722|7172226|FG001|Double Blind Phase|Participant defaulted|11
4394757|NCT00098722|7172227|FG002|Double Blind Phase|Participant defaulted|9
4394758|NCT00098722|7172228|FG003|Double Blind Phase|Participant defaulted|0
4394759|NCT00098722|7172229|FG004|Double Blind Phase|Participant defaulted|0
4394760|NCT00098722|7172230|FG005|Double Blind Phase|Participant defaulted|0
4394761|NCT00098722|7172231|FG006|Double Blind Phase|Participant defaulted|0
4394762|NCT00098722|7172225|FG000|Double Blind Phase|Pregnancy|1
4394763|NCT00098722|7172226|FG001|Double Blind Phase|Pregnancy|0
4394764|NCT00098722|7172227|FG002|Double Blind Phase|Pregnancy|0
4394765|NCT00098722|7172228|FG003|Double Blind Phase|Pregnancy|0
4394766|NCT00098722|7172229|FG004|Double Blind Phase|Pregnancy|0
4394767|NCT00098722|7172230|FG005|Double Blind Phase|Pregnancy|0
4394768|NCT00098722|7172231|FG006|Double Blind Phase|Pregnancy|0
4394769|NCT00098722|7172225|FG000|Double Blind Phase|Randomized, not treated|4
4394770|NCT00098722|7172226|FG001|Double Blind Phase|Randomized, not treated|3
4394771|NCT00098722|7172227|FG002|Double Blind Phase|Randomized, not treated|3
4394772|NCT00098722|7172228|FG003|Double Blind Phase|Randomized, not treated|0
4394773|NCT00098722|7172229|FG004|Double Blind Phase|Randomized, not treated|0
4394774|NCT00098722|7172230|FG005|Double Blind Phase|Randomized, not treated|0
4394775|NCT00098722|7172231|FG006|Double Blind Phase|Randomized, not treated|0
4394776|NCT00098722|7172225|FG000|Double Blind Phase|Ongoing at cut-off date|128
4394777|NCT00098722|7172226|FG001|Double Blind Phase|Ongoing at cut-off date|137
4394778|NCT00098722|7172227|FG002|Double Blind Phase|Ongoing at cut-off date|57
4394779|NCT00098722|7172228|FG003|Double Blind Phase|Ongoing at cut-off date|0
4394780|NCT00098722|7172229|FG004|Double Blind Phase|Ongoing at cut-off date|0
4394781|NCT00098722|7172230|FG005|Double Blind Phase|Ongoing at cut-off date|0
4394782|NCT00098722|7172231|FG006|Double Blind Phase|Ongoing at cut-off date|0
4394783|NCT00098722|7172225|FG000|Double Blind Phase|Other|7
4394784|NCT00098722|7172226|FG001|Double Blind Phase|Other|8
4394785|NCT00098722|7172227|FG002|Double Blind Phase|Other|7
4394786|NCT00098722|7172228|FG003|Double Blind Phase|Other|0
4394787|NCT00098722|7172229|FG004|Double Blind Phase|Other|0
4394788|NCT00098722|7172230|FG005|Double Blind Phase|Other|0
4394789|NCT00098722|7172231|FG006|Double Blind Phase|Other|0
4394790|NCT00098722|7172225|FG000|Open Label Phase|Adverse Event|0
4394791|NCT00098722|7172226|FG001|Open Label Phase|Adverse Event|0
4394792|NCT00098722|7172227|FG002|Open Label Phase|Adverse Event|0
4394793|NCT00098722|7172228|FG003|Open Label Phase|Adverse Event|5
4394794|NCT00098722|7172229|FG004|Open Label Phase|Adverse Event|0
4394795|NCT00098722|7172230|FG005|Open Label Phase|Adverse Event|0
4394796|NCT00098722|7172231|FG006|Open Label Phase|Adverse Event|0
4394797|NCT00098722|7172225|FG000|Open Label Phase|Death|0
4394798|NCT00098722|7172226|FG001|Open Label Phase|Death|0
4394799|NCT00098722|7172227|FG002|Open Label Phase|Death|0
4394800|NCT00098722|7172228|FG003|Open Label Phase|Death|2
4394801|NCT00098722|7172229|FG004|Open Label Phase|Death|0
4394802|NCT00098722|7172230|FG005|Open Label Phase|Death|0
4394803|NCT00098722|7172231|FG006|Open Label Phase|Death|0
4394804|NCT00098722|7172225|FG000|Open Label Phase|Lack of Efficacy|0
4394805|NCT00098722|7172226|FG001|Open Label Phase|Lack of Efficacy|0
4394806|NCT00098722|7172227|FG002|Open Label Phase|Lack of Efficacy|0
4394807|NCT00098722|7172228|FG003|Open Label Phase|Lack of Efficacy|8
4394808|NCT00098722|7172229|FG004|Open Label Phase|Lack of Efficacy|0
4394809|NCT00098722|7172230|FG005|Open Label Phase|Lack of Efficacy|0
4394810|NCT00098722|7172231|FG006|Open Label Phase|Lack of Efficacy|0
4394811|NCT00098722|7172225|FG000|Open Label Phase|Pregnancy|0
4394812|NCT00098722|7172226|FG001|Open Label Phase|Pregnancy|0
4394813|NCT00098722|7172227|FG002|Open Label Phase|Pregnancy|0
4394814|NCT00098722|7172228|FG003|Open Label Phase|Pregnancy|1
4394815|NCT00098722|7172229|FG004|Open Label Phase|Pregnancy|0
4394816|NCT00098722|7172230|FG005|Open Label Phase|Pregnancy|0
4394817|NCT00098722|7172231|FG006|Open Label Phase|Pregnancy|0
4394818|NCT00098722|7172225|FG000|Open Label Phase|Participant defaulted|0
4394819|NCT00098722|7172226|FG001|Open Label Phase|Participant defaulted|0
4394820|NCT00098722|7172227|FG002|Open Label Phase|Participant defaulted|0
4394821|NCT00098722|7172228|FG003|Open Label Phase|Participant defaulted|18
4394822|NCT00098722|7172229|FG004|Open Label Phase|Participant defaulted|0
4394823|NCT00098722|7172230|FG005|Open Label Phase|Participant defaulted|0
4394824|NCT00098722|7172231|FG006|Open Label Phase|Participant defaulted|0
4394825|NCT00098722|7172225|FG000|Open Label Phase|Ongoing at cut-off date|0
4394826|NCT00098722|7172226|FG001|Open Label Phase|Ongoing at cut-off date|0
4394827|NCT00098722|7172227|FG002|Open Label Phase|Ongoing at cut-off date|0
4394828|NCT00098722|7172228|FG003|Open Label Phase|Ongoing at cut-off date|220
4394829|NCT00098722|7172229|FG004|Open Label Phase|Ongoing at cut-off date|50
4394830|NCT00098722|7172230|FG005|Open Label Phase|Ongoing at cut-off date|0
4394831|NCT00098722|7172231|FG006|Open Label Phase|Ongoing at cut-off date|0
4394832|NCT00098722|7172225|FG000|Open Label Phase|Other|0
4394833|NCT00098722|7172226|FG001|Open Label Phase|Other|0
4394834|NCT00098722|7172227|FG002|Open Label Phase|Other|0
4394835|NCT00098722|7172228|FG003|Open Label Phase|Other|18
4394836|NCT00098722|7172229|FG004|Open Label Phase|Other|0
4394837|NCT00098722|7172230|FG005|Open Label Phase|Other|0
4394838|NCT00098722|7172231|FG006|Open Label Phase|Other|0
4394839|NCT00098722|7172225|FG000|Observation Phase|Death|0
4394840|NCT00098722|7172226|FG001|Observation Phase|Death|0
4394841|NCT00098722|7172227|FG002|Observation Phase|Death|0
4394842|NCT00098722|7172228|FG003|Observation Phase|Death|0
4394843|NCT00098722|7172229|FG004|Observation Phase|Death|0
4394844|NCT00098722|7172230|FG005|Observation Phase|Death|5
4394845|NCT00098722|7172231|FG006|Observation Phase|Death|3
4394846|NCT00098722|7172225|FG000|Observation Phase|Lack of Efficacy|0
4394847|NCT00098722|7172226|FG001|Observation Phase|Lack of Efficacy|0
4394848|NCT00098722|7172227|FG002|Observation Phase|Lack of Efficacy|0
4394849|NCT00098722|7172228|FG003|Observation Phase|Lack of Efficacy|0
4394850|NCT00098722|7172229|FG004|Observation Phase|Lack of Efficacy|0
4394851|NCT00098722|7172230|FG005|Observation Phase|Lack of Efficacy|2
4394852|NCT00098722|7172231|FG006|Observation Phase|Lack of Efficacy|0
4394853|NCT00098722|7172225|FG000|Observation Phase|Participant defaulted|0
4394854|NCT00098722|7172226|FG001|Observation Phase|Participant defaulted|0
4394855|NCT00098722|7172227|FG002|Observation Phase|Participant defaulted|0
4394856|NCT00098722|7172228|FG003|Observation Phase|Participant defaulted|0
4394857|NCT00098722|7172229|FG004|Observation Phase|Participant defaulted|0
4394858|NCT00098722|7172230|FG005|Observation Phase|Participant defaulted|17
4394859|NCT00098722|7172231|FG006|Observation Phase|Participant defaulted|4
4394860|NCT00098722|7172225|FG000|Observation Phase|Other|0
4394861|NCT00098722|7172226|FG001|Observation Phase|Other|0
4394862|NCT00098722|7172227|FG002|Observation Phase|Other|0
4394863|NCT00098722|7172228|FG003|Observation Phase|Other|0
4394864|NCT00098722|7172229|FG004|Observation Phase|Other|0
4394865|NCT00098722|7172230|FG005|Observation Phase|Other|21
4394866|NCT00098722|7172231|FG006|Observation Phase|Other|10
4394867|NCT00098748|7172246|FG000|Assigned to Study Treatment|Randomized, but not treated|0
4394868|NCT00098748|7172247|FG001|Assigned to Study Treatment|Randomized, but not treated|2
4394869|NCT00098748|7172248|FG002|Assigned to Study Treatment|Randomized, but not treated|2
4394870|NCT00098748|7172246|FG000|Received Study Treatment|Death|2
4394871|NCT00098748|7172247|FG001|Received Study Treatment|Death|1
4394872|NCT00098748|7172248|FG002|Received Study Treatment|Death|2
4394873|NCT00098748|7172246|FG000|Received Study Treatment|Adverse Event|1
4394874|NCT00098748|7172247|FG001|Received Study Treatment|Adverse Event|2
4394875|NCT00098748|7172248|FG002|Received Study Treatment|Adverse Event|5
4394876|NCT00098748|7172246|FG000|Received Study Treatment|Lack of Efficacy|40
4394877|NCT00098748|7172247|FG001|Received Study Treatment|Lack of Efficacy|27
4394878|NCT00098748|7172248|FG002|Received Study Treatment|Lack of Efficacy|27
4394879|NCT00098748|7172246|FG000|Received Study Treatment|Other|2
4394880|NCT00098748|7172247|FG001|Received Study Treatment|Other|2
4394881|NCT00098748|7172248|FG002|Received Study Treatment|Other|6
4394882|NCT00098748|7172246|FG000|Received Study Treatment|Subject defaulted|3
4394883|NCT00098748|7172247|FG001|Received Study Treatment|Subject defaulted|4
4394884|NCT00098748|7172248|FG002|Received Study Treatment|Subject defaulted|4
4394885|NCT00098748|7172246|FG000|Continued on Open-Label Treatment|Adverse Event|0
4394886|NCT00098748|7172247|FG001|Continued on Open-Label Treatment|Adverse Event|1
4394887|NCT00098748|7172248|FG002|Continued on Open-Label Treatment|Adverse Event|0
4394888|NCT00098748|7172246|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1
4394889|NCT00098748|7172247|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2
4394890|NCT00098748|7172248|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0
4394891|NCT00098748|7172246|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6
4394892|NCT00098748|7172247|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7
4394893|NCT00098748|7172248|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0
4394894|NCT00098748|7172246|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1
4394895|NCT00098748|7172247|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1
4394896|NCT00098748|7172248|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0
4394897|NCT00098748|7172246|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0
4394898|NCT00098748|7172247|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4
4394899|NCT00098748|7172248|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0
4394900|NCT00098774|7172256|FG000|Overall Study|Adverse Event|2
4394901|NCT00098774|7172256|FG000|Overall Study|Disease Progression|9
4394902|NCT00098774|7172256|FG000|Overall Study|Withdrawal by Subject|1
4394903|NCT00098774|7172256|FG000|Overall Study|Failed (to respond) during induction|4
4394904|NCT00098774|7172256|FG000|Overall Study|Physician Decision|2
4394905|NCT00098787|7172263|FG000|Overall Study|Never started treatment|3
4394906|NCT00098787|7172264|FG001|Overall Study|Never started treatment|2
4394907|NCT00098787|7172265|FG002|Overall Study|Never started treatment|1
4394908|NCT00098787|7172263|FG000|Overall Study|Ineligible|9
4394909|NCT00098787|7172264|FG001|Overall Study|Ineligible|7
4394910|NCT00098787|7172265|FG002|Overall Study|Ineligible|3
4394911|NCT00098787|7172263|FG000|Overall Study|Disease progression|28
4394912|NCT00098787|7172264|FG001|Overall Study|Disease progression|17
4394913|NCT00098787|7172265|FG002|Overall Study|Disease progression|23
4394914|NCT00098787|7172263|FG000|Overall Study|Adverse Event|8
4394915|NCT00098787|7172264|FG001|Overall Study|Adverse Event|17
4394916|NCT00098787|7172265|FG002|Overall Study|Adverse Event|8
4394917|NCT00098787|7172263|FG000|Overall Study|Death|6
4394918|NCT00098787|7172264|FG001|Overall Study|Death|1
4394919|NCT00098787|7172265|FG002|Overall Study|Death|0
4394920|NCT00098787|7172263|FG000|Overall Study|Withdrawal by Subject|4
4394921|NCT00098787|7172264|FG001|Overall Study|Withdrawal by Subject|12
4394922|NCT00098787|7172265|FG002|Overall Study|Withdrawal by Subject|6
4394923|NCT00098787|7172263|FG000|Overall Study|Alternative therapy|8
4394924|NCT00098787|7172264|FG001|Overall Study|Alternative therapy|13
4394925|NCT00098787|7172265|FG002|Overall Study|Alternative therapy|13
4394926|NCT00098787|7172263|FG000|Overall Study|Other|7
4394927|NCT00098787|7172264|FG001|Overall Study|Other|6
4394928|NCT00098787|7172265|FG002|Overall Study|Other|9
4394929|NCT00098813|7172273|FG000|Overall Study|Death|8
4394930|NCT00098813|7172273|FG000|Overall Study|Protocol Violation|1
4394931|NCT00098813|7172273|FG000|Overall Study|Withdrawal by Subject|7
4394932|NCT00098813|7172273|FG000|Overall Study|Progression of Disease|1
4394933|NCT00098813|7172273|FG000|Overall Study|Other complicating disease|1
4394934|NCT00098813|7172273|FG000|Overall Study|Reversal of RAI resistance|1
4394935|NCT00098839|7172279|FG000|Overall Study|Adverse Event|5
4394936|NCT00098839|7172280|FG001|Overall Study|Adverse Event|2
4394937|NCT00098839|7172279|FG000|Overall Study|Death|1
4394938|NCT00098839|7172280|FG001|Overall Study|Death|2
4394939|NCT00098839|7172279|FG000|Overall Study|Physician Decision|4
4394940|NCT00098839|7172280|FG001|Overall Study|Physician Decision|14
4394941|NCT00098839|7172279|FG000|Overall Study|Withdrawal by Subject|1
4394942|NCT00098839|7172280|FG001|Overall Study|Withdrawal by Subject|0
4394943|NCT00098839|7172279|FG000|Overall Study|Refusal of further protocol therapy|3
4394944|NCT00098839|7172280|FG001|Overall Study|Refusal of further protocol therapy|1
4394945|NCT00098839|7172279|FG000|Overall Study|Relapse|6
4394946|NCT00098839|7172280|FG001|Overall Study|Relapse|3
4394947|NCT00098839|7172279|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10
4394948|NCT00098839|7172280|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11
4394949|NCT00098839|7172279|FG000|Overall Study|Ineligible|2
4394950|NCT00098839|7172280|FG001|Overall Study|Ineligible|0
4394951|NCT00098865|7172287|FG000|Overall Study|Progressive Disease|6
4394952|NCT00098865|7172287|FG000|Overall Study|Adverse Event|2
4394953|NCT00098865|7172287|FG000|Overall Study|Alternative Therapy|1
4394954|NCT00099268|7172310|FG000|Overall Study|Withdrawal by Subject|46
4394955|NCT00099268|7172311|FG001|Overall Study|Withdrawal by Subject|28
4394956|NCT00099268|7172310|FG000|Overall Study|Adverse Event|19
4394957|NCT00099268|7172311|FG001|Overall Study|Adverse Event|19
4394958|NCT00099268|7172310|FG000|Overall Study|Protocol Violation|9
4394959|NCT00099268|7172311|FG001|Overall Study|Protocol Violation|8
4394960|NCT00099268|7172310|FG000|Overall Study|Lost to Follow-up|6
4394961|NCT00099268|7172311|FG001|Overall Study|Lost to Follow-up|4
4394962|NCT00099268|7172310|FG000|Overall Study|Lack of Efficacy|5
4394963|NCT00099268|7172311|FG001|Overall Study|Lack of Efficacy|18
4394964|NCT00099268|7172310|FG000|Overall Study|Administrative problems|4
4394965|NCT00099268|7172311|FG001|Overall Study|Administrative problems|4
4394966|NCT00099268|7172310|FG000|Overall Study|Death|3
4394967|NCT00099268|7172311|FG001|Overall Study|Death|1
4394968|NCT00099359|7172320|FG000|Overall Study|Death|11
4394969|NCT00099359|7172321|FG001|Overall Study|Death|15
4394970|NCT00099359|7172322|FG002|Overall Study|Death|17
4394971|NCT00099359|7172320|FG000|Overall Study|Withdrawal by Subject|19
4394972|NCT00099359|7172321|FG001|Overall Study|Withdrawal by Subject|19
4394973|NCT00099359|7172322|FG002|Overall Study|Withdrawal by Subject|23
4394974|NCT00099359|7172320|FG000|Overall Study|Lost to Follow-up|15
4394975|NCT00099359|7172321|FG001|Overall Study|Lost to Follow-up|24
4394976|NCT00099359|7172322|FG002|Overall Study|Lost to Follow-up|24
4394977|NCT00099359|7172320|FG000|Overall Study|moved out of area|9
4394978|NCT00099359|7172321|FG001|Overall Study|moved out of area|7
4628486|NCT01860677|7495693|FG001|Second Intervention (1 Day)|Lost to Follow-up|0
4628487|NCT01860703|7495700|FG000|Overall Study|Adverse Event|1
4712125|NCT02919761|7638387|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0
4394979|NCT00099359|7172322|FG002|Overall Study|moved out of area|4
4394980|NCT00099632|7172357|FG000|Overall Study|Lost to Follow-up|1
4394981|NCT00099632|7172358|FG001|Overall Study|Lost to Follow-up|0
4394982|NCT00099632|7172359|FG002|Overall Study|Lost to Follow-up|3
4394983|NCT00099632|7172360|FG003|Overall Study|Lost to Follow-up|1
4394984|NCT00099632|7172361|FG004|Overall Study|Lost to Follow-up|1
4394985|NCT00099632|7172362|FG005|Overall Study|Lost to Follow-up|0
4394986|NCT00099632|7172357|FG000|Overall Study|Withdrawal by Subject|0
4394987|NCT00099632|7172358|FG001|Overall Study|Withdrawal by Subject|1
4394988|NCT00099632|7172359|FG002|Overall Study|Withdrawal by Subject|0
4394989|NCT00099632|7172360|FG003|Overall Study|Withdrawal by Subject|0
4394990|NCT00099632|7172361|FG004|Overall Study|Withdrawal by Subject|0
4394991|NCT00099632|7172362|FG005|Overall Study|Withdrawal by Subject|1
4394992|NCT00099632|7172357|FG000|Overall Study|Protocol Violation|0
4394993|NCT00099632|7172358|FG001|Overall Study|Protocol Violation|0
4394994|NCT00099632|7172359|FG002|Overall Study|Protocol Violation|0
4394995|NCT00099632|7172360|FG003|Overall Study|Protocol Violation|0
4394996|NCT00099632|7172361|FG004|Overall Study|Protocol Violation|0
4394997|NCT00099632|7172362|FG005|Overall Study|Protocol Violation|1
4394998|NCT00099983|7172378|FG000|Overall Study|Lost to Follow-up|2
4394999|NCT00099983|7172379|FG001|Overall Study|Lost to Follow-up|3
4712126|NCT02919761|7638388|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0
4712127|NCT02919761|7638386|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1
4712128|NCT02919761|7638387|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0
4712129|NCT02919761|7638388|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0
4712130|NCT02919761|7638386|FG000|Part 1: Open Label|Termination by Sponsor|1
4712131|NCT02919761|7638387|FG001|Part 1: Open Label|Termination by Sponsor|0
4712132|NCT02919761|7638388|FG002|Part 1: Open Label|Termination by Sponsor|0
4712133|NCT02919761|7638386|FG000|Part 2: Double-blind|Withdrawal by Subject|0
4712134|NCT02919761|7638387|FG001|Part 2: Double-blind|Withdrawal by Subject|0
4395000|NCT00099983|7172378|FG000|Overall Study|Missing Source Documents|14
4395001|NCT00099983|7172379|FG001|Overall Study|Missing Source Documents|15
4395002|NCT00099983|7172378|FG000|Overall Study|Withdrawal by Subject|3
4395003|NCT00099983|7172379|FG001|Overall Study|Withdrawal by Subject|2
4395004|NCT00099983|7172378|FG000|Overall Study|Adverse Event|1
4395005|NCT00099983|7172379|FG001|Overall Study|Adverse Event|1
4395006|NCT00099983|7172378|FG000|Overall Study|Lack of Efficacy|0
4395007|NCT00099983|7172379|FG001|Overall Study|Lack of Efficacy|1
4395008|NCT00099983|7172378|FG000|Overall Study|Unable to return for appointments|1
4395009|NCT00099983|7172379|FG001|Overall Study|Unable to return for appointments|1
4395010|NCT00099983|7172378|FG000|Overall Study|Moved|1
4628488|NCT01860703|7495701|FG001|Overall Study|Adverse Event|4
4712135|NCT02919761|7638388|FG002|Part 2: Double-blind|Withdrawal by Subject|2
4395011|NCT00099983|7172379|FG001|Overall Study|Moved|0
4395012|NCT00099983|7172378|FG000|Overall Study|Other psychiatric problem|1
4395013|NCT00099983|7172379|FG001|Overall Study|Other psychiatric problem|0
4395014|NCT00099983|7172378|FG000|Overall Study|Incarcerated|0
4395015|NCT00099983|7172379|FG001|Overall Study|Incarcerated|1
4395016|NCT00099983|7172378|FG000|Overall Study|Intolerant of burden of visits|0
4395017|NCT00099983|7172379|FG001|Overall Study|Intolerant of burden of visits|1
4395018|NCT00099983|7172378|FG000|Overall Study|Other issue|1
4395019|NCT00099983|7172379|FG001|Overall Study|Other issue|0
4395020|NCT00100048|7172390|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2
4395021|NCT00100048|7172391|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0
4395022|NCT00100048|7172392|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0
4628489|NCT01860703|7495702|FG002|Overall Study|Adverse Event|0
4628490|NCT01860703|7495703|FG003|Overall Study|Adverse Event|2
4628491|NCT01860703|7495700|FG000|Overall Study|Withdrawal by Subject|0
4628492|NCT01860703|7495701|FG001|Overall Study|Withdrawal by Subject|1
4712136|NCT02919761|7638386|FG000|Part 2: Double-blind|Adverse Event|0
4395023|NCT00100048|7172393|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0
4395024|NCT00100048|7172394|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0
4395025|NCT00100048|7172395|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1
4395026|NCT00100048|7172390|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0
4395027|NCT00100048|7172391|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1
4395028|NCT00100048|7172392|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2
4395029|NCT00100048|7172393|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0
4395030|NCT00100048|7172394|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0
4395031|NCT00100048|7172395|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1
4395032|NCT00100048|7172390|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1
4395033|NCT00100048|7172391|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3
4395034|NCT00100048|7172392|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
4395035|NCT00100048|7172393|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
4395036|NCT00100048|7172394|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
4395037|NCT00100048|7172395|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2
4395038|NCT00100048|7172390|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2
4395039|NCT00100048|7172391|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1
4395040|NCT00100048|7172392|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3
4395041|NCT00100048|7172393|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2
4395042|NCT00100048|7172394|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0
4395043|NCT00100048|7172395|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3
4395044|NCT00100048|7172390|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1
4395045|NCT00100048|7172391|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2
4395046|NCT00100048|7172392|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2
4395047|NCT00100048|7172393|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5
4395048|NCT00100048|7172394|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0
4395049|NCT00100048|7172395|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4
4395050|NCT00100048|7172390|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7
4395051|NCT00100048|7172391|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1
4395052|NCT00100048|7172392|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4
4395053|NCT00100048|7172393|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2
4395054|NCT00100048|7172394|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0
4395055|NCT00100048|7172395|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0
4395056|NCT00100048|7172390|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1
4395057|NCT00100048|7172391|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1
4395058|NCT00100048|7172392|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2
4395059|NCT00100048|7172393|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0
4395060|NCT00100048|7172394|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0
4395061|NCT00100048|7172395|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2
4395062|NCT00100048|7172390|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
4395063|NCT00100048|7172391|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
4395064|NCT00100048|7172392|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
4395065|NCT00100048|7172393|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1
4395066|NCT00100048|7172394|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
4395067|NCT00100048|7172395|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
4395068|NCT00100178|7172439|FG000|Overall Study|Lost to Follow-up|0
4395069|NCT00100178|7172440|FG001|Overall Study|Lost to Follow-up|6
4395070|NCT00100178|7172441|FG002|Overall Study|Lost to Follow-up|5
4395071|NCT00100178|7172439|FG000|Overall Study|Adverse Event|2
4395072|NCT00100178|7172440|FG001|Overall Study|Adverse Event|2
4395073|NCT00100178|7172441|FG002|Overall Study|Adverse Event|1
4395074|NCT00100178|7172439|FG000|Overall Study|Withdrawal by Subject|1
4395075|NCT00100178|7172440|FG001|Overall Study|Withdrawal by Subject|1
4395076|NCT00100178|7172441|FG002|Overall Study|Withdrawal by Subject|1
4395077|NCT00100178|7172439|FG000|Overall Study|Physician Decision|6
4395078|NCT00100178|7172440|FG001|Overall Study|Physician Decision|1
4628493|NCT01860703|7495702|FG002|Overall Study|Withdrawal by Subject|0
4712137|NCT02919761|7638387|FG001|Part 2: Double-blind|Adverse Event|1
4712138|NCT02919761|7638388|FG002|Part 2: Double-blind|Adverse Event|0
4712139|NCT02919761|7638386|FG000|Part 2: Double-blind|Lost to Follow-up|0
4395079|NCT00100178|7172441|FG002|Overall Study|Physician Decision|3
4510795|NCT00923091|7319702|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13
4510796|NCT00923091|7319703|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10
4510797|NCT00923091|7319704|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5
4510798|NCT00923091|7319705|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9
4510799|NCT00923091|7319706|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17
4510800|NCT00923091|7319707|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
4628494|NCT01860703|7495703|FG003|Overall Study|Withdrawal by Subject|0
4628495|NCT01860703|7495700|FG000|Overall Study|Personal reason|1
4628496|NCT01860703|7495701|FG001|Overall Study|Personal reason|0
4628497|NCT01860703|7495702|FG002|Overall Study|Personal reason|1
4628498|NCT01860703|7495703|FG003|Overall Study|Personal reason|0
4628499|NCT01860846|7495728|FG000|Overall Study|Lost to Follow-up|33
4510801|NCT00923091|7319708|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
4510802|NCT00923091|7319709|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
4510803|NCT00923091|7319710|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
4510804|NCT00923091|7319711|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
4510805|NCT00923091|7319699|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4
4510806|NCT00923091|7319700|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6
4510807|NCT00923091|7319701|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
4510808|NCT00923091|7319702|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8
4510809|NCT00923091|7319703|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7
4510810|NCT00923091|7319704|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6
4510811|NCT00923091|7319705|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
4510812|NCT00923091|7319706|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
4510813|NCT00923091|7319707|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
4510814|NCT00923091|7319708|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
4510815|NCT00923091|7319709|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
4510816|NCT00923091|7319710|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
4510817|NCT00923091|7319711|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
4510818|NCT00923091|7319699|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
4510819|NCT00923091|7319700|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
4510820|NCT00923091|7319701|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
4510821|NCT00923091|7319702|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5
4510822|NCT00923091|7319703|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4
4510823|NCT00923091|7319704|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2
4510824|NCT00923091|7319705|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4
4510825|NCT00923091|7319706|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3
4510826|NCT00923091|7319707|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
4510827|NCT00923091|7319708|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
4510828|NCT00923091|7319709|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
4510829|NCT00923091|7319710|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
4510830|NCT00923091|7319711|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
4510831|NCT00923091|7319699|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
4510832|NCT00923091|7319700|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
4510833|NCT00923091|7319701|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
4510834|NCT00923091|7319702|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
4510835|NCT00923091|7319703|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
4510836|NCT00923091|7319704|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1
4510837|NCT00923091|7319705|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
4510838|NCT00923091|7319706|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
4510839|NCT00923091|7319707|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
4510840|NCT00923091|7319708|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
4510841|NCT00923091|7319709|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
4510842|NCT00923091|7319710|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
4510843|NCT00923091|7319711|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
4510844|NCT00923091|7319699|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
4510845|NCT00923091|7319700|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
4510846|NCT00923091|7319701|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
4510847|NCT00923091|7319702|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
4510848|NCT00923091|7319703|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
4510849|NCT00923091|7319704|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
4510850|NCT00923091|7319705|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
4510851|NCT00923091|7319706|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
4510852|NCT00923091|7319707|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
4510853|NCT00923091|7319708|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
4510854|NCT00923091|7319709|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
4628500|NCT01860989|7495758|FG000|Overall Study|Unsatisfactory therapeutic|5
4395080|NCT00100789|7172480|FG000|Overall Study|Adverse Event|10
4395081|NCT00100789|7172480|FG000|Overall Study|Withdrawal by Subject|1
4395082|NCT00100789|7172480|FG000|Overall Study|Progression/relapse|42
4395083|NCT00100789|7172480|FG000|Overall Study|Death|2
4395084|NCT00100789|7172480|FG000|Overall Study|Not protocol specified|5
4395085|NCT00100789|7172480|FG000|Overall Study|Ineligible|3
4395086|NCT00100789|7172480|FG000|Overall Study|Never received treatment|1
4395087|NCT00100802|7172485|FG000|Overall Study|Adverse Event|9
4395088|NCT00100802|7172485|FG000|Overall Study|Death|1
4395089|NCT00100802|7172485|FG000|Overall Study|Lack of Efficacy|47
4395090|NCT00100802|7172485|FG000|Overall Study|Physician Decision|5
4395091|NCT00100802|7172485|FG000|Overall Study|Protocol Violation|1
4395092|NCT00100802|7172485|FG000|Overall Study|Withdrawal by Subject|5
4395093|NCT00100802|7172485|FG000|Overall Study|Ineligible|12
4395094|NCT00100815|7172489|FG000|Overall Study|Progression|24
4395095|NCT00100815|7172489|FG000|Overall Study|Adverse Event|18
4395096|NCT00100815|7172489|FG000|Overall Study|Death|4
4395097|NCT00100815|7172489|FG000|Overall Study|Other|3
4395098|NCT00100932|7172499|FG000|Overall Study|Adverse Event|11
4395099|NCT00100932|7172500|FG001|Overall Study|Adverse Event|2
4395100|NCT00100932|7172499|FG000|Overall Study|Withdrawal by Subject|6
4395101|NCT00100932|7172500|FG001|Overall Study|Withdrawal by Subject|0
4395102|NCT00100932|7172499|FG000|Overall Study|Progressive Disease|44
4395103|NCT00100932|7172500|FG001|Overall Study|Progressive Disease|18
4395104|NCT00100932|7172499|FG000|Overall Study|Physician Decision|7
4395105|NCT00100932|7172500|FG001|Overall Study|Physician Decision|5
4395106|NCT00100932|7172499|FG000|Overall Study|Other|5
4395107|NCT00100932|7172500|FG001|Overall Study|Other|2
4395108|NCT00101010|7172506|FG000|Overall Study|Physician Decision|1
4395109|NCT00101101|7172519|FG000|Overall Study|never received vaccine|20
4395110|NCT00101166|7172523|FG000|Overall Study|progressive disease|10
4395111|NCT00101192|7172527|FG000|Overall Study|Ineligible|6
4395112|NCT00101192|7172527|FG000|Overall Study|Inevaluable|1
4395113|NCT00101283|7172533|FG000|Overall Study|Withdrawal by Subject|0
4395114|NCT00101283|7172534|FG001|Overall Study|Withdrawal by Subject|1
4395115|NCT00101283|7172533|FG000|Overall Study|Insurance Refusal|0
4395116|NCT00101283|7172534|FG001|Overall Study|Insurance Refusal|1
4395117|NCT00101283|7172533|FG000|Overall Study|Prostate Cancer Recurrence|0
4395118|NCT00101283|7172534|FG001|Overall Study|Prostate Cancer Recurrence|1
4395119|NCT00101400|7172549|FG000|Survival Follow-Up|Alive|7
4395120|NCT00101452|7172560|FG000|Overall Study|Adverse Event|2
4395121|NCT00101452|7172561|FG001|Overall Study|Adverse Event|0
4395122|NCT00101452|7172562|FG002|Overall Study|Adverse Event|1
4395123|NCT00101452|7172560|FG000|Overall Study|Lost to Follow-up|13
4395124|NCT00101452|7172561|FG001|Overall Study|Lost to Follow-up|8
4395125|NCT00101452|7172562|FG002|Overall Study|Lost to Follow-up|14
4395126|NCT00101452|7172560|FG000|Overall Study|Withdrawal by Subject|10
4395127|NCT00101452|7172561|FG001|Overall Study|Withdrawal by Subject|14
4395128|NCT00101452|7172562|FG002|Overall Study|Withdrawal by Subject|9
4395129|NCT00101452|7172560|FG000|Overall Study|Baseline Fail|2
4395130|NCT00101452|7172561|FG001|Overall Study|Baseline Fail|1
4395131|NCT00101452|7172562|FG002|Overall Study|Baseline Fail|2
4395132|NCT00101452|7172560|FG000|Overall Study|Physician Decision|0
4395133|NCT00101452|7172561|FG001|Overall Study|Physician Decision|3
4395134|NCT00101452|7172562|FG002|Overall Study|Physician Decision|2
4395135|NCT00101452|7172560|FG000|Overall Study|Protocol Violation|2
4395136|NCT00101452|7172561|FG001|Overall Study|Protocol Violation|1
4395137|NCT00101452|7172562|FG002|Overall Study|Protocol Violation|3
4395138|NCT00101452|7172560|FG000|Overall Study|Other|15
4395139|NCT00101452|7172561|FG001|Overall Study|Other|16
4395140|NCT00101452|7172562|FG002|Overall Study|Other|12
4395141|NCT00101582|7172576|FG000|Overall Study|Ineligibility determined|0
4395142|NCT00101582|7172577|FG001|Overall Study|Ineligibility determined|1
4395143|NCT00101582|7172576|FG000|Overall Study|Adverse Event|1
4395144|NCT00101582|7172577|FG001|Overall Study|Adverse Event|4
4395145|NCT00101582|7172576|FG000|Overall Study|Withdrawal by Subject|6
4395146|NCT00101582|7172577|FG001|Overall Study|Withdrawal by Subject|4
4395147|NCT00101582|7172576|FG000|Overall Study|Physician Decision|1
4395148|NCT00101582|7172577|FG001|Overall Study|Physician Decision|0
4395149|NCT00101582|7172576|FG000|Overall Study|Death|3
4395150|NCT00101582|7172577|FG001|Overall Study|Death|5
4395151|NCT00101582|7172576|FG000|Overall Study|Other|0
4395152|NCT00101582|7172577|FG001|Overall Study|Other|1
4395153|NCT00101686|7172627|FG000|Overall Study|Progressive Disease|37
4395154|NCT00101686|7172628|FG001|Overall Study|Progressive Disease|28
4395155|NCT00101686|7172629|FG002|Overall Study|Progressive Disease|37
4395156|NCT00101686|7172630|FG003|Overall Study|Progressive Disease|38
4395157|NCT00101686|7172631|FG004|Overall Study|Progressive Disease|28
4395158|NCT00101686|7172632|FG005|Overall Study|Progressive Disease|25
4395159|NCT00101686|7172633|FG006|Overall Study|Progressive Disease|5
4395160|NCT00101686|7172634|FG007|Overall Study|Progressive Disease|7
4395161|NCT00101686|7172635|FG008|Overall Study|Progressive Disease|10
4395162|NCT00101686|7172636|FG009|Overall Study|Progressive Disease|8
4395163|NCT00101686|7172627|FG000|Overall Study|initiation other anti-cancer treatment|4
4395164|NCT00101686|7172628|FG001|Overall Study|initiation other anti-cancer treatment|3
4395165|NCT00101686|7172629|FG002|Overall Study|initiation other anti-cancer treatment|4
4395166|NCT00101686|7172630|FG003|Overall Study|initiation other anti-cancer treatment|3
4395167|NCT00101686|7172631|FG004|Overall Study|initiation other anti-cancer treatment|1
4395168|NCT00101686|7172632|FG005|Overall Study|initiation other anti-cancer treatment|1
4395169|NCT00101686|7172633|FG006|Overall Study|initiation other anti-cancer treatment|2
4395170|NCT00101686|7172634|FG007|Overall Study|initiation other anti-cancer treatment|2
4395171|NCT00101686|7172635|FG008|Overall Study|initiation other anti-cancer treatment|3
4395172|NCT00101686|7172636|FG009|Overall Study|initiation other anti-cancer treatment|3
4395173|NCT00101686|7172627|FG000|Overall Study|>3 week delay treatment due toxicity|6
4395174|NCT00101686|7172628|FG001|Overall Study|>3 week delay treatment due toxicity|2
4395175|NCT00101686|7172629|FG002|Overall Study|>3 week delay treatment due toxicity|1
4395176|NCT00101686|7172630|FG003|Overall Study|>3 week delay treatment due toxicity|2
4395177|NCT00101686|7172631|FG004|Overall Study|>3 week delay treatment due toxicity|7
4395178|NCT00101686|7172632|FG005|Overall Study|>3 week delay treatment due toxicity|3
4395179|NCT00101686|7172633|FG006|Overall Study|>3 week delay treatment due toxicity|2
4395180|NCT00101686|7172634|FG007|Overall Study|>3 week delay treatment due toxicity|1
4395181|NCT00101686|7172635|FG008|Overall Study|>3 week delay treatment due toxicity|3
4395182|NCT00101686|7172636|FG009|Overall Study|>3 week delay treatment due toxicity|0
4395183|NCT00101686|7172627|FG000|Overall Study|unacceptable toxicity|3
4395184|NCT00101686|7172628|FG001|Overall Study|unacceptable toxicity|9
4395185|NCT00101686|7172629|FG002|Overall Study|unacceptable toxicity|10
4395186|NCT00101686|7172630|FG003|Overall Study|unacceptable toxicity|6
4395187|NCT00101686|7172631|FG004|Overall Study|unacceptable toxicity|16
4395188|NCT00101686|7172632|FG005|Overall Study|unacceptable toxicity|10
4395189|NCT00101686|7172633|FG006|Overall Study|unacceptable toxicity|4
4395190|NCT00101686|7172634|FG007|Overall Study|unacceptable toxicity|2
4395191|NCT00101686|7172635|FG008|Overall Study|unacceptable toxicity|1
4395192|NCT00101686|7172636|FG009|Overall Study|unacceptable toxicity|4
4395193|NCT00101686|7172627|FG000|Overall Study|Randomized but did not receive treament|1
4395194|NCT00101686|7172628|FG001|Overall Study|Randomized but did not receive treament|6
4395195|NCT00101686|7172629|FG002|Overall Study|Randomized but did not receive treament|2
4395196|NCT00101686|7172630|FG003|Overall Study|Randomized but did not receive treament|2
4395197|NCT00101686|7172631|FG004|Overall Study|Randomized but did not receive treament|2
4395198|NCT00101686|7172632|FG005|Overall Study|Randomized but did not receive treament|2
4395199|NCT00101686|7172633|FG006|Overall Study|Randomized but did not receive treament|0
4395200|NCT00101686|7172634|FG007|Overall Study|Randomized but did not receive treament|1
4395201|NCT00101686|7172635|FG008|Overall Study|Randomized but did not receive treament|0
4395202|NCT00101686|7172636|FG009|Overall Study|Randomized but did not receive treament|1
4395203|NCT00101686|7172627|FG000|Overall Study|intercurrent non-cancer related illness|0
4395204|NCT00101686|7172628|FG001|Overall Study|intercurrent non-cancer related illness|0
4395205|NCT00101686|7172629|FG002|Overall Study|intercurrent non-cancer related illness|2
4395206|NCT00101686|7172630|FG003|Overall Study|intercurrent non-cancer related illness|0
4395207|NCT00101686|7172631|FG004|Overall Study|intercurrent non-cancer related illness|1
4395208|NCT00101686|7172632|FG005|Overall Study|intercurrent non-cancer related illness|3
4395209|NCT00101686|7172633|FG006|Overall Study|intercurrent non-cancer related illness|1
4395210|NCT00101686|7172634|FG007|Overall Study|intercurrent non-cancer related illness|0
4395211|NCT00101686|7172635|FG008|Overall Study|intercurrent non-cancer related illness|1
4395212|NCT00101686|7172636|FG009|Overall Study|intercurrent non-cancer related illness|1
4395213|NCT00101686|7172627|FG000|Overall Study|Physician Decision|10
4395214|NCT00101686|7172628|FG001|Overall Study|Physician Decision|13
4395215|NCT00101686|7172629|FG002|Overall Study|Physician Decision|6
4395216|NCT00101686|7172630|FG003|Overall Study|Physician Decision|7
4395217|NCT00101686|7172631|FG004|Overall Study|Physician Decision|8
4395218|NCT00101686|7172632|FG005|Overall Study|Physician Decision|9
4395219|NCT00101686|7172633|FG006|Overall Study|Physician Decision|5
4395220|NCT00101686|7172634|FG007|Overall Study|Physician Decision|5
4395221|NCT00101686|7172635|FG008|Overall Study|Physician Decision|1
4395222|NCT00101686|7172636|FG009|Overall Study|Physician Decision|1
4395223|NCT00101686|7172627|FG000|Overall Study|Other|1
4395224|NCT00101686|7172628|FG001|Overall Study|Other|4
4395225|NCT00101686|7172629|FG002|Overall Study|Other|1
4395226|NCT00101686|7172630|FG003|Overall Study|Other|6
4395227|NCT00101686|7172631|FG004|Overall Study|Other|2
4395228|NCT00101686|7172632|FG005|Overall Study|Other|12
4395229|NCT00101686|7172633|FG006|Overall Study|Other|1
4395230|NCT00101686|7172634|FG007|Overall Study|Other|5
4395231|NCT00101686|7172635|FG008|Overall Study|Other|3
4395232|NCT00101686|7172636|FG009|Overall Study|Other|3
4395233|NCT00101686|7172627|FG000|Overall Study|Withdrawal by Subject|9
4395234|NCT00101686|7172628|FG001|Overall Study|Withdrawal by Subject|8
4395235|NCT00101686|7172629|FG002|Overall Study|Withdrawal by Subject|6
4395236|NCT00101686|7172630|FG003|Overall Study|Withdrawal by Subject|8
4395237|NCT00101686|7172631|FG004|Overall Study|Withdrawal by Subject|8
4395238|NCT00101686|7172632|FG005|Overall Study|Withdrawal by Subject|7
4395239|NCT00101686|7172633|FG006|Overall Study|Withdrawal by Subject|7
4395240|NCT00101686|7172634|FG007|Overall Study|Withdrawal by Subject|7
4395241|NCT00101686|7172635|FG008|Overall Study|Withdrawal by Subject|8
4395242|NCT00101686|7172636|FG009|Overall Study|Withdrawal by Subject|9
4395243|NCT00101868|7172672|FG000|Overall Study|Death|10
4395244|NCT00101868|7172673|FG001|Overall Study|Death|10
4395245|NCT00101868|7172672|FG000|Overall Study|Withdrawal by Subject|8
4395246|NCT00101868|7172673|FG001|Overall Study|Withdrawal by Subject|9
4395247|NCT00101868|7172672|FG000|Overall Study|Protocol Violation|3
4395248|NCT00101868|7172673|FG001|Overall Study|Protocol Violation|0
4395249|NCT00101868|7172672|FG000|Overall Study|Lost to Follow-up|8
4395250|NCT00101868|7172673|FG001|Overall Study|Lost to Follow-up|13
4395251|NCT00101907|7172687|FG000|Overall Study|Adverse Event|1
4395252|NCT00101907|7172688|FG001|Overall Study|Adverse Event|0
4395253|NCT00101907|7172689|FG002|Overall Study|Adverse Event|0
4395254|NCT00101907|7172690|FG003|Overall Study|Adverse Event|0
4395255|NCT00101907|7172691|FG004|Overall Study|Adverse Event|0
4395256|NCT00101907|7172692|FG005|Overall Study|Adverse Event|0
4395257|NCT00101907|7172687|FG000|Overall Study|Death|0
4395258|NCT00101907|7172688|FG001|Overall Study|Death|1
4395259|NCT00101907|7172689|FG002|Overall Study|Death|0
4395260|NCT00101907|7172690|FG003|Overall Study|Death|0
4395261|NCT00101907|7172691|FG004|Overall Study|Death|3
4395262|NCT00101907|7172692|FG005|Overall Study|Death|0
4395263|NCT00101907|7172687|FG000|Overall Study|Physician Decision|0
4395264|NCT00101907|7172688|FG001|Overall Study|Physician Decision|0
4395265|NCT00101907|7172689|FG002|Overall Study|Physician Decision|0
4395266|NCT00101907|7172690|FG003|Overall Study|Physician Decision|1
4395267|NCT00101907|7172691|FG004|Overall Study|Physician Decision|1
4395268|NCT00101907|7172692|FG005|Overall Study|Physician Decision|0
4395269|NCT00101907|7172687|FG000|Overall Study|Withdrawal by Subject|1
4395270|NCT00101907|7172688|FG001|Overall Study|Withdrawal by Subject|0
4395271|NCT00101907|7172689|FG002|Overall Study|Withdrawal by Subject|1
4395272|NCT00101907|7172690|FG003|Overall Study|Withdrawal by Subject|0
4395273|NCT00101907|7172691|FG004|Overall Study|Withdrawal by Subject|1
4395274|NCT00101907|7172692|FG005|Overall Study|Withdrawal by Subject|0
4395275|NCT00102063|7172726|FG000|Overall Study|Lack of Efficacy|5
4395276|NCT00102063|7172727|FG001|Overall Study|Lack of Efficacy|1
4395277|NCT00102063|7172728|FG002|Overall Study|Lack of Efficacy|1
4395278|NCT00102063|7172726|FG000|Overall Study|Adverse Event|7
4395279|NCT00102063|7172727|FG001|Overall Study|Adverse Event|4
4395280|NCT00102063|7172728|FG002|Overall Study|Adverse Event|2
4395281|NCT00102063|7172726|FG000|Overall Study|Withdrawal by Subject|4
4395282|NCT00102063|7172727|FG001|Overall Study|Withdrawal by Subject|12
4395283|NCT00102063|7172728|FG002|Overall Study|Withdrawal by Subject|5
4395284|NCT00102063|7172726|FG000|Overall Study|Lost to Follow-up|0
4395285|NCT00102063|7172727|FG001|Overall Study|Lost to Follow-up|0
4395286|NCT00102063|7172728|FG002|Overall Study|Lost to Follow-up|1
4395287|NCT00102063|7172726|FG000|Overall Study|Protocol Violation|0
4395288|NCT00102063|7172727|FG001|Overall Study|Protocol Violation|1
4395289|NCT00102063|7172728|FG002|Overall Study|Protocol Violation|1
4395290|NCT00102440|7172739|FG000|Overall Study|Lost to Follow-up|25
4395291|NCT00102440|7172740|FG001|Overall Study|Lost to Follow-up|18
4395292|NCT00102440|7172741|FG002|Overall Study|Lost to Follow-up|21
4395293|NCT00102440|7172739|FG000|Overall Study|Adverse Event|16
4395294|NCT00102440|7172740|FG001|Overall Study|Adverse Event|23
4395295|NCT00102440|7172741|FG002|Overall Study|Adverse Event|8
4395296|NCT00102440|7172739|FG000|Overall Study|Gout Flare|10
4395297|NCT00102440|7172740|FG001|Overall Study|Gout Flare|28
4395298|NCT00102440|7172741|FG002|Overall Study|Gout Flare|9
4395299|NCT00102440|7172739|FG000|Overall Study|Personal Reason(s)|19
4395300|NCT00102440|7172740|FG001|Overall Study|Personal Reason(s)|13
4395301|NCT00102440|7172741|FG002|Overall Study|Personal Reason(s)|13
4395302|NCT00102440|7172739|FG000|Overall Study|Other|11
4395303|NCT00102440|7172740|FG001|Overall Study|Other|14
4395304|NCT00102440|7172741|FG002|Overall Study|Other|14
4395305|NCT00102440|7172739|FG000|Overall Study|Protocol Violation|7
4395306|NCT00102440|7172740|FG001|Overall Study|Protocol Violation|2
4395307|NCT00102440|7172741|FG002|Overall Study|Protocol Violation|1
4395308|NCT00102531|7172755|FG000|Overall Study|Adverse Event|0
4395309|NCT00102531|7172756|FG001|Overall Study|Adverse Event|1
4395310|NCT00102531|7172755|FG000|Overall Study|Disease Progression|5
4395311|NCT00102531|7172756|FG001|Overall Study|Disease Progression|9
4395312|NCT00102531|7172755|FG000|Overall Study|Physician Decision|0
4395313|NCT00102531|7172756|FG001|Overall Study|Physician Decision|1
4395314|NCT00102596|7172762|FG000|Part A|Screen failures|6
4395315|NCT00102596|7172763|FG001|Part A|Screen failures|0
4395316|NCT00102596|7172762|FG000|Part A|Adverse Event|1
4395317|NCT00102596|7172763|FG001|Part A|Adverse Event|0
4395318|NCT00102687|7172773|FG000|Initial Period|Withdrawal by Subject|6
4395319|NCT00102687|7172774|FG001|Initial Period|Withdrawal by Subject|3
4395320|NCT00102687|7172775|FG002|Initial Period|Withdrawal by Subject|5
4395321|NCT00102687|7172776|FG003|Initial Period|Withdrawal by Subject|0
4395322|NCT00102687|7172777|FG004|Initial Period|Withdrawal by Subject|0
4395323|NCT00102687|7172773|FG000|Initial Period|Adverse Event|4
4395324|NCT00102687|7172774|FG001|Initial Period|Adverse Event|7
4395325|NCT00102687|7172775|FG002|Initial Period|Adverse Event|9
4395326|NCT00102687|7172776|FG003|Initial Period|Adverse Event|0
4395327|NCT00102687|7172777|FG004|Initial Period|Adverse Event|0
4395328|NCT00102687|7172773|FG000|Initial Period|Transformation to AML (blast > 30%)|1
4395329|NCT00102687|7172774|FG001|Initial Period|Transformation to AML (blast > 30%)|3
4395330|NCT00102687|7172775|FG002|Initial Period|Transformation to AML (blast > 30%)|0
4395331|NCT00102687|7172776|FG003|Initial Period|Transformation to AML (blast > 30%)|0
4395332|NCT00102687|7172777|FG004|Initial Period|Transformation to AML (blast > 30%)|0
4395333|NCT00102687|7172773|FG000|Initial Period|Protocol Violation|0
4395334|NCT00102687|7172774|FG001|Initial Period|Protocol Violation|0
4395335|NCT00102687|7172775|FG002|Initial Period|Protocol Violation|2
4395336|NCT00102687|7172776|FG003|Initial Period|Protocol Violation|0
4395337|NCT00102687|7172777|FG004|Initial Period|Protocol Violation|0
4395338|NCT00102687|7172773|FG000|Initial Period|Physician Decision|2
4395339|NCT00102687|7172774|FG001|Initial Period|Physician Decision|9
4395340|NCT00102687|7172775|FG002|Initial Period|Physician Decision|6
4395341|NCT00102687|7172776|FG003|Initial Period|Physician Decision|0
4395342|NCT00102687|7172777|FG004|Initial Period|Physician Decision|0
4395343|NCT00102687|7172773|FG000|Initial Period|Sponsor's decision|0
4395344|NCT00102687|7172774|FG001|Initial Period|Sponsor's decision|1
4395345|NCT00102687|7172775|FG002|Initial Period|Sponsor's decision|1
4395346|NCT00102687|7172776|FG003|Initial Period|Sponsor's decision|0
4395347|NCT00102687|7172777|FG004|Initial Period|Sponsor's decision|0
4395348|NCT00102687|7172773|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4
4395349|NCT00102687|7172774|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4
4395350|NCT00102687|7172775|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2
4395351|NCT00102687|7172776|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0
4395352|NCT00102687|7172777|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0
4395353|NCT00102687|7172773|FG000|Initial Period|Death|1
4395354|NCT00102687|7172774|FG001|Initial Period|Death|1
4395355|NCT00102687|7172775|FG002|Initial Period|Death|1
4395356|NCT00102687|7172776|FG003|Initial Period|Death|0
4395357|NCT00102687|7172777|FG004|Initial Period|Death|0
4395358|NCT00102687|7172773|FG000|Maintenance Period|Withdrawal by Subject|4
4395359|NCT00102687|7172774|FG001|Maintenance Period|Withdrawal by Subject|0
4395360|NCT00102687|7172775|FG002|Maintenance Period|Withdrawal by Subject|2
4395361|NCT00102687|7172776|FG003|Maintenance Period|Withdrawal by Subject|3
4395362|NCT00102687|7172777|FG004|Maintenance Period|Withdrawal by Subject|1
4395363|NCT00102687|7172773|FG000|Maintenance Period|Adverse Event|1
4395364|NCT00102687|7172774|FG001|Maintenance Period|Adverse Event|0
4395365|NCT00102687|7172775|FG002|Maintenance Period|Adverse Event|0
4395366|NCT00102687|7172776|FG003|Maintenance Period|Adverse Event|1
4395367|NCT00102687|7172777|FG004|Maintenance Period|Adverse Event|3
4395368|NCT00102687|7172773|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0
4395369|NCT00102687|7172774|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1
4395370|NCT00102687|7172775|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0
4395371|NCT00102687|7172776|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2
4395372|NCT00102687|7172777|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0
4395373|NCT00102687|7172773|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1
4395374|NCT00102687|7172774|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1
4395375|NCT00102687|7172775|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1
4395376|NCT00102687|7172776|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3
4395377|NCT00102687|7172777|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4
4395378|NCT00102687|7172773|FG000|Maintenance Period|Death|0
4395379|NCT00102687|7172774|FG001|Maintenance Period|Death|0
4395380|NCT00102687|7172775|FG002|Maintenance Period|Death|0
4395381|NCT00102687|7172776|FG003|Maintenance Period|Death|1
4395382|NCT00102687|7172777|FG004|Maintenance Period|Death|1
4395383|NCT00102687|7172773|FG000|Maintenance Period|Physician Decision|1
4395384|NCT00102687|7172774|FG001|Maintenance Period|Physician Decision|2
4395385|NCT00102687|7172775|FG002|Maintenance Period|Physician Decision|3
4395386|NCT00102687|7172776|FG003|Maintenance Period|Physician Decision|0
4395387|NCT00102687|7172777|FG004|Maintenance Period|Physician Decision|4
4395388|NCT00102804|7172795|FG000|Overall Study|Progressive Disease (PD)|307
4395389|NCT00102804|7172796|FG001|Overall Study|Progressive Disease (PD)|196
4395390|NCT00102804|7172795|FG000|Overall Study|Withdrawal by Subject|46
4395391|NCT00102804|7172796|FG001|Overall Study|Withdrawal by Subject|7
4395392|NCT00102804|7172795|FG000|Overall Study|Adverse Event|37
4395393|NCT00102804|7172796|FG001|Overall Study|Adverse Event|3
4395394|NCT00102804|7172795|FG000|Overall Study|Physician Decision|24
4395395|NCT00102804|7172796|FG001|Overall Study|Physician Decision|6
4395396|NCT00102804|7172795|FG000|Overall Study|Death|5
4395397|NCT00102804|7172796|FG001|Overall Study|Death|6
4395398|NCT00102804|7172795|FG000|Overall Study|Enrollment Criteria Not Met|6
4395399|NCT00102804|7172796|FG001|Overall Study|Enrollment Criteria Not Met|0
4395400|NCT00102804|7172795|FG000|Overall Study|Lost to Follow-up|4
4395401|NCT00102804|7172796|FG001|Overall Study|Lost to Follow-up|1
4395402|NCT00102804|7172795|FG000|Overall Study|Protocol Violation|2
4395403|NCT00102804|7172796|FG001|Overall Study|Protocol Violation|1
4395404|NCT00102804|7172795|FG000|Overall Study|Satisfactory Response|2
4395405|NCT00102804|7172796|FG001|Overall Study|Satisfactory Response|0
4395406|NCT00102804|7172795|FG000|Overall Study|Sponsor Decision|1
4395407|NCT00102804|7172796|FG001|Overall Study|Sponsor Decision|0
4395408|NCT00102804|7172795|FG000|Overall Study|Alive, Receiving Treatment|7
4395409|NCT00102804|7172796|FG001|Overall Study|Alive, Receiving Treatment|2
4395410|NCT00102960|7172805|FG000|Overall Study|Death|23
4395411|NCT00102960|7172806|FG001|Overall Study|Death|11
4395412|NCT00102960|7172807|FG002|Overall Study|Death|11
4395413|NCT00102960|7172805|FG000|Overall Study|Lost to Follow-up|6
4395414|NCT00102960|7172806|FG001|Overall Study|Lost to Follow-up|12
4395415|NCT00102960|7172807|FG002|Overall Study|Lost to Follow-up|16
4395416|NCT00102960|7172805|FG000|Overall Study|Withdrawal by Subject|1
4395417|NCT00102960|7172806|FG001|Overall Study|Withdrawal by Subject|0
4395418|NCT00102960|7172807|FG002|Overall Study|Withdrawal by Subject|1
4395419|NCT00103012|7172822|FG000|Overall Study|Withdrawal by Subject|2
4395420|NCT00103012|7172823|FG001|Overall Study|Withdrawal by Subject|1
4395421|NCT00103012|7172824|FG002|Overall Study|Withdrawal by Subject|2
4395422|NCT00103012|7172822|FG000|Overall Study|Pregnancy|1
4395423|NCT00103012|7172823|FG001|Overall Study|Pregnancy|0
4395424|NCT00103012|7172824|FG002|Overall Study|Pregnancy|0
4395425|NCT00103012|7172822|FG000|Overall Study|Adverse Event|0
4395426|NCT00103012|7172823|FG001|Overall Study|Adverse Event|0
4395427|NCT00103012|7172824|FG002|Overall Study|Adverse Event|1
4395428|NCT00103012|7172822|FG000|Overall Study|Subject non-compliant with medications|0
4395429|NCT00103012|7172823|FG001|Overall Study|Subject non-compliant with medications|0
4395430|NCT00103012|7172824|FG002|Overall Study|Subject non-compliant with medications|1
4395431|NCT00103142|7172838|FG000|Overall Study|Adverse Event|1
4395432|NCT00103142|7172839|FG001|Overall Study|Adverse Event|0
4395433|NCT00103142|7172838|FG000|Overall Study|Progression of disease|2
4395434|NCT00103142|7172839|FG001|Overall Study|Progression of disease|1
4395435|NCT00103207|7172851|FG000|Overall Study|Adverse Event|3
4395436|NCT00103207|7172851|FG000|Overall Study|Death|1
4395437|NCT00103207|7172851|FG000|Overall Study|Withdrawal by Subject|2
4395438|NCT00103207|7172851|FG000|Overall Study|Other complicating disease|1
4395439|NCT00103207|7172851|FG000|Overall Study|Ineligible|4
4395440|NCT00103207|7172851|FG000|Overall Study|Diagnosis of BAC not confirmed|27
4395441|NCT00103259|7172859|FG000|Overall Study|Death|3
4395442|NCT00103259|7172860|FG001|Overall Study|Death|2
4395443|NCT00103259|7172859|FG000|Overall Study|Withdrawal by Subject|2
4395444|NCT00103259|7172860|FG001|Overall Study|Withdrawal by Subject|3
4395445|NCT00103259|7172859|FG000|Overall Study|alternative therapy|1
4395446|NCT00103259|7172860|FG001|Overall Study|alternative therapy|0
4395447|NCT00103259|7172859|FG000|Overall Study|other (reasons were not specified)|2
4395448|NCT00103259|7172860|FG001|Overall Study|other (reasons were not specified)|1
4395449|NCT00103259|7172859|FG000|Overall Study|ineligible/no protocol therapy|4
4395450|NCT00103259|7172860|FG001|Overall Study|ineligible/no protocol therapy|6
4395451|NCT00103285|7172868|FG000|Induction|Adverse Event|14
4395452|NCT00103285|7172869|FG001|Induction|Adverse Event|0
4395453|NCT00103285|7172870|FG002|Induction|Adverse Event|0
4395454|NCT00103285|7172871|FG003|Induction|Adverse Event|0
4395455|NCT00103285|7172872|FG004|Induction|Adverse Event|0
4395456|NCT00103285|7172873|FG005|Induction|Adverse Event|0
4395457|NCT00103285|7172874|FG006|Induction|Adverse Event|0
4395458|NCT00103285|7172875|FG007|Induction|Adverse Event|0
4395459|NCT00103285|7172868|FG000|Induction|Death|24
4395460|NCT00103285|7172869|FG001|Induction|Death|0
4395461|NCT00103285|7172870|FG002|Induction|Death|0
4395462|NCT00103285|7172871|FG003|Induction|Death|0
4395463|NCT00103285|7172872|FG004|Induction|Death|0
4395464|NCT00103285|7172873|FG005|Induction|Death|0
4395465|NCT00103285|7172874|FG006|Induction|Death|0
4395466|NCT00103285|7172875|FG007|Induction|Death|0
4395467|NCT00103285|7172868|FG000|Induction|Physician Decision|103
4395468|NCT00103285|7172869|FG001|Induction|Physician Decision|0
4395469|NCT00103285|7172870|FG002|Induction|Physician Decision|0
4395470|NCT00103285|7172871|FG003|Induction|Physician Decision|0
4395471|NCT00103285|7172872|FG004|Induction|Physician Decision|0
4395472|NCT00103285|7172873|FG005|Induction|Physician Decision|0
4395473|NCT00103285|7172874|FG006|Induction|Physician Decision|0
4395474|NCT00103285|7172875|FG007|Induction|Physician Decision|0
4395475|NCT00103285|7172868|FG000|Induction|Withdrawal by Subject|1
4395476|NCT00103285|7172869|FG001|Induction|Withdrawal by Subject|0
4395477|NCT00103285|7172870|FG002|Induction|Withdrawal by Subject|0
4395478|NCT00103285|7172871|FG003|Induction|Withdrawal by Subject|0
4395479|NCT00103285|7172872|FG004|Induction|Withdrawal by Subject|0
4395480|NCT00103285|7172873|FG005|Induction|Withdrawal by Subject|0
4395481|NCT00103285|7172874|FG006|Induction|Withdrawal by Subject|0
4395482|NCT00103285|7172875|FG007|Induction|Withdrawal by Subject|0
4395483|NCT00103285|7172868|FG000|Induction|Ineligible|43
4395484|NCT00103285|7172869|FG001|Induction|Ineligible|0
4395485|NCT00103285|7172870|FG002|Induction|Ineligible|0
4395486|NCT00103285|7172871|FG003|Induction|Ineligible|0
4395487|NCT00103285|7172872|FG004|Induction|Ineligible|0
4395488|NCT00103285|7172873|FG005|Induction|Ineligible|0
4395489|NCT00103285|7172874|FG006|Induction|Ineligible|0
4395490|NCT00103285|7172875|FG007|Induction|Ineligible|0
4395491|NCT00103285|7172868|FG000|Induction|Refusal|906
4395492|NCT00103285|7172869|FG001|Induction|Refusal|0
4395493|NCT00103285|7172870|FG002|Induction|Refusal|0
4395494|NCT00103285|7172871|FG003|Induction|Refusal|0
4395495|NCT00103285|7172872|FG004|Induction|Refusal|0
4395496|NCT00103285|7172873|FG005|Induction|Refusal|0
4395497|NCT00103285|7172874|FG006|Induction|Refusal|0
4395498|NCT00103285|7172875|FG007|Induction|Refusal|0
4395499|NCT00103285|7172868|FG000|Induction|Other|258
4395500|NCT00103285|7172869|FG001|Induction|Other|0
4395501|NCT00103285|7172870|FG002|Induction|Other|0
4395502|NCT00103285|7172871|FG003|Induction|Other|0
4395503|NCT00103285|7172872|FG004|Induction|Other|0
4395504|NCT00103285|7172873|FG005|Induction|Other|0
4395505|NCT00103285|7172874|FG006|Induction|Other|0
4395506|NCT00103285|7172875|FG007|Induction|Other|0
4395507|NCT00103285|7172868|FG000|Response Assignment|Adverse Event|0
4395508|NCT00103285|7172869|FG001|Response Assignment|Adverse Event|8
4395509|NCT00103285|7172870|FG002|Response Assignment|Adverse Event|3
4395510|NCT00103285|7172871|FG003|Response Assignment|Adverse Event|2
4395511|NCT00103285|7172872|FG004|Response Assignment|Adverse Event|3
4395512|NCT00103285|7172873|FG005|Response Assignment|Adverse Event|1
4395513|NCT00103285|7172874|FG006|Response Assignment|Adverse Event|1
4395514|NCT00103285|7172875|FG007|Response Assignment|Adverse Event|2
4395515|NCT00103285|7172868|FG000|Response Assignment|Death|0
4395516|NCT00103285|7172869|FG001|Response Assignment|Death|5
4395517|NCT00103285|7172870|FG002|Response Assignment|Death|2
4395518|NCT00103285|7172871|FG003|Response Assignment|Death|2
4395519|NCT00103285|7172872|FG004|Response Assignment|Death|3
4395520|NCT00103285|7172873|FG005|Response Assignment|Death|1
4395521|NCT00103285|7172874|FG006|Response Assignment|Death|0
4395522|NCT00103285|7172875|FG007|Response Assignment|Death|8
4395523|NCT00103285|7172868|FG000|Response Assignment|Lost to Follow-up|0
4395524|NCT00103285|7172869|FG001|Response Assignment|Lost to Follow-up|9
4395525|NCT00103285|7172870|FG002|Response Assignment|Lost to Follow-up|5
4395526|NCT00103285|7172871|FG003|Response Assignment|Lost to Follow-up|5
4395527|NCT00103285|7172872|FG004|Response Assignment|Lost to Follow-up|1
4395528|NCT00103285|7172873|FG005|Response Assignment|Lost to Follow-up|2
4395529|NCT00103285|7172874|FG006|Response Assignment|Lost to Follow-up|2
4395530|NCT00103285|7172875|FG007|Response Assignment|Lost to Follow-up|5
4395531|NCT00103285|7172868|FG000|Response Assignment|Physician Decision|0
4395532|NCT00103285|7172869|FG001|Response Assignment|Physician Decision|13
4395533|NCT00103285|7172870|FG002|Response Assignment|Physician Decision|14
4395534|NCT00103285|7172871|FG003|Response Assignment|Physician Decision|9
4395535|NCT00103285|7172872|FG004|Response Assignment|Physician Decision|13
4395536|NCT00103285|7172873|FG005|Response Assignment|Physician Decision|7
4395537|NCT00103285|7172874|FG006|Response Assignment|Physician Decision|4
4395538|NCT00103285|7172875|FG007|Response Assignment|Physician Decision|35
4395539|NCT00103285|7172868|FG000|Response Assignment|Protocol Violation|0
4395540|NCT00103285|7172869|FG001|Response Assignment|Protocol Violation|2
4395541|NCT00103285|7172870|FG002|Response Assignment|Protocol Violation|0
4395542|NCT00103285|7172871|FG003|Response Assignment|Protocol Violation|0
4395543|NCT00103285|7172872|FG004|Response Assignment|Protocol Violation|0
4712140|NCT02919761|7638387|FG001|Part 2: Double-blind|Lost to Follow-up|0
4712141|NCT02919761|7638388|FG002|Part 2: Double-blind|Lost to Follow-up|3
4712142|NCT02919761|7638386|FG000|Part 2: Double-blind|Met withdrawal criteria|0
4712143|NCT02919761|7638387|FG001|Part 2: Double-blind|Met withdrawal criteria|1
4712144|NCT02919761|7638388|FG002|Part 2: Double-blind|Met withdrawal criteria|2
4712145|NCT02919761|7638386|FG000|Part 2: Double-blind|Worsening of disease activity|0
4395544|NCT00103285|7172873|FG005|Response Assignment|Protocol Violation|0
4395545|NCT00103285|7172874|FG006|Response Assignment|Protocol Violation|0
4395546|NCT00103285|7172875|FG007|Response Assignment|Protocol Violation|0
4395547|NCT00103285|7172868|FG000|Response Assignment|Withdrawal by Subject|0
4395548|NCT00103285|7172869|FG001|Response Assignment|Withdrawal by Subject|4
4395549|NCT00103285|7172870|FG002|Response Assignment|Withdrawal by Subject|1
4395550|NCT00103285|7172871|FG003|Response Assignment|Withdrawal by Subject|1
4395551|NCT00103285|7172872|FG004|Response Assignment|Withdrawal by Subject|2
4395552|NCT00103285|7172873|FG005|Response Assignment|Withdrawal by Subject|2
4395553|NCT00103285|7172874|FG006|Response Assignment|Withdrawal by Subject|0
4395554|NCT00103285|7172875|FG007|Response Assignment|Withdrawal by Subject|2
4395555|NCT00103285|7172868|FG000|Response Assignment|Ineligible|0
4395556|NCT00103285|7172869|FG001|Response Assignment|Ineligible|8
4395557|NCT00103285|7172870|FG002|Response Assignment|Ineligible|6
4395558|NCT00103285|7172871|FG003|Response Assignment|Ineligible|2
4395559|NCT00103285|7172872|FG004|Response Assignment|Ineligible|0
4395560|NCT00103285|7172873|FG005|Response Assignment|Ineligible|3
4395561|NCT00103285|7172874|FG006|Response Assignment|Ineligible|1
4395562|NCT00103285|7172875|FG007|Response Assignment|Ineligible|5
4395563|NCT00103285|7172868|FG000|Response Assignment|Refusal|0
4395564|NCT00103285|7172869|FG001|Response Assignment|Refusal|53
4395565|NCT00103285|7172870|FG002|Response Assignment|Refusal|5
4395566|NCT00103285|7172871|FG003|Response Assignment|Refusal|3
4395567|NCT00103285|7172872|FG004|Response Assignment|Refusal|25
4395568|NCT00103285|7172873|FG005|Response Assignment|Refusal|15
4395569|NCT00103285|7172874|FG006|Response Assignment|Refusal|30
4395570|NCT00103285|7172875|FG007|Response Assignment|Refusal|10
4395571|NCT00103285|7172868|FG000|Response Assignment|Other|0
4395572|NCT00103285|7172869|FG001|Response Assignment|Other|30
4395573|NCT00103285|7172870|FG002|Response Assignment|Other|48
4712146|NCT02919761|7638387|FG001|Part 2: Double-blind|Worsening of disease activity|4
4395574|NCT00103285|7172871|FG003|Response Assignment|Other|38
4395575|NCT00103285|7172872|FG004|Response Assignment|Other|37
4395576|NCT00103285|7172873|FG005|Response Assignment|Other|17
4395577|NCT00103285|7172874|FG006|Response Assignment|Other|11
4395578|NCT00103285|7172875|FG007|Response Assignment|Other|53
4395579|NCT00103311|7172902|FG000|Overall Study|Lost to Follow-up|1
4395580|NCT00103311|7172903|FG001|Overall Study|Lost to Follow-up|0
4395581|NCT00103311|7172902|FG000|Overall Study|Withdrawal by Subject|2
4395582|NCT00103311|7172903|FG001|Overall Study|Withdrawal by Subject|1
4395583|NCT00103311|7172902|FG000|Overall Study|Adverse Event|1
4395584|NCT00103311|7172903|FG001|Overall Study|Adverse Event|0
4395585|NCT00103402|7172930|FG000|Overall Study|Adverse Event|3
4395586|NCT00103402|7172931|FG001|Overall Study|Adverse Event|4
4395587|NCT00103402|7172930|FG000|Overall Study|Lost to Follow-up|8
4395588|NCT00103402|7172931|FG001|Overall Study|Lost to Follow-up|7
4395589|NCT00103402|7172930|FG000|Overall Study|Dissatisfied/No longer interested|6
4395590|NCT00103402|7172931|FG001|Overall Study|Dissatisfied/No longer interested|6
4395591|NCT00103402|7172930|FG000|Overall Study|Personal constraints/Other|5
4395592|NCT00103402|7172931|FG001|Overall Study|Personal constraints/Other|0
4395593|NCT00103506|7172939|FG000|Overall Study|Study closed by sponsor|34
4395594|NCT00103506|7172940|FG001|Overall Study|Study closed by sponsor|37
4395595|NCT00103506|7172939|FG000|Overall Study|Death|257
4395596|NCT00103506|7172940|FG001|Overall Study|Death|253
4395597|NCT00103506|7172939|FG000|Overall Study|Lost to Follow-up|13
4395598|NCT00103506|7172940|FG001|Overall Study|Lost to Follow-up|13
4395599|NCT00103506|7172939|FG000|Overall Study|Withdrawal by Subject|18
4395600|NCT00103506|7172940|FG001|Overall Study|Withdrawal by Subject|21
4395601|NCT00103610|7172948|FG000|Overall Study|Entered Rescue Procedure|10
4395602|NCT00103610|7172949|FG001|Overall Study|Entered Rescue Procedure|52
4395603|NCT00103610|7172948|FG000|Overall Study|Death|16
4395604|NCT00103610|7172949|FG001|Overall Study|Death|12
4395605|NCT00103610|7172948|FG000|Overall Study|Elective Withdrawal|4
4395606|NCT00103610|7172949|FG001|Overall Study|Elective Withdrawal|0
4395607|NCT00103610|7172948|FG000|Overall Study|Lost to Follow-up|3
4395608|NCT00103610|7172949|FG001|Overall Study|Lost to Follow-up|1
4395609|NCT00103610|7172948|FG000|Overall Study|Adverse Event|2
4395610|NCT00103610|7172949|FG001|Overall Study|Adverse Event|2
4395611|NCT00103610|7172948|FG000|Overall Study|Other|2
4395612|NCT00103610|7172949|FG001|Overall Study|Other|7
4395613|NCT00103610|7172948|FG000|Overall Study|Failed mobilization|1
4395614|NCT00103610|7172949|FG001|Overall Study|Failed mobilization|5
4395615|NCT00103610|7172948|FG000|Overall Study|Noncompliance|0
4395616|NCT00103610|7172949|FG001|Overall Study|Noncompliance|1
4395617|NCT00103662|7172958|FG000|Overall Study|Entered Rescue Procedure|0
4395618|NCT00103662|7172959|FG001|Overall Study|Entered Rescue Procedure|7
4395619|NCT00103662|7172958|FG000|Overall Study|Death|7
4395620|NCT00103662|7172959|FG001|Overall Study|Death|7
4395621|NCT00103662|7172958|FG000|Overall Study|Elective Withdrawal|5
4395622|NCT00103662|7172959|FG001|Overall Study|Elective Withdrawal|5
4395623|NCT00103662|7172958|FG000|Overall Study|Lost to Follow-up|0
4395624|NCT00103662|7172959|FG001|Overall Study|Lost to Follow-up|1
4395625|NCT00103662|7172958|FG000|Overall Study|Other|6
4395626|NCT00103662|7172959|FG001|Overall Study|Other|9
4395627|NCT00103662|7172958|FG000|Overall Study|Failed mobilization|0
4395628|NCT00103662|7172959|FG001|Overall Study|Failed mobilization|4
4395629|NCT00103662|7172958|FG000|Overall Study|Intercurrent illness|1
4395630|NCT00103662|7172959|FG001|Overall Study|Intercurrent illness|0
4395631|NCT00103740|7172967|FG000|Period 1 - Core|Adverse Event|1
4395632|NCT00103740|7172968|FG001|Period 1 - Core|Adverse Event|0
4395633|NCT00103740|7172967|FG000|Period 1 - Core|Protocol Violation|3
4395634|NCT00103740|7172968|FG001|Period 1 - Core|Protocol Violation|2
4395635|NCT00103740|7172967|FG000|Period 1 - Core|Patient withdrew consent|3
4395636|NCT00103740|7172968|FG001|Period 1 - Core|Patient withdrew consent|2
4395637|NCT00103740|7172967|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7
4395638|NCT00103740|7172968|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6
4395639|NCT00103740|7172967|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21
4395640|NCT00103740|7172968|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13
4395641|NCT00103740|7172967|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5
4395642|NCT00103740|7172968|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6
4395643|NCT00103740|7172967|FG000|Period 2 - Extended Observation Period|Death|6
4395644|NCT00103740|7172968|FG001|Period 2 - Extended Observation Period|Death|2
4395645|NCT00103740|7172967|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30
4395646|NCT00103740|7172968|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9
4395647|NCT00103857|7172990|FG000|54-Week Base Study|Adverse Event|12
4395648|NCT00103857|7172991|FG001|54-Week Base Study|Adverse Event|9
4395649|NCT00103857|7172992|FG002|54-Week Base Study|Adverse Event|11
4395650|NCT00103857|7172993|FG003|54-Week Base Study|Adverse Event|6
4395651|NCT00103857|7172994|FG004|54-Week Base Study|Adverse Event|5
4395652|NCT00103857|7172995|FG005|54-Week Base Study|Adverse Event|11
4395653|NCT00103857|7172996|FG006|54-Week Base Study|Adverse Event|3
4395654|NCT00103857|7172990|FG000|54-Week Base Study|Death|0
4395655|NCT00103857|7172991|FG001|54-Week Base Study|Death|0
4395656|NCT00103857|7172992|FG002|54-Week Base Study|Death|0
4395657|NCT00103857|7172993|FG003|54-Week Base Study|Death|0
4395658|NCT00103857|7172994|FG004|54-Week Base Study|Death|1
4395659|NCT00103857|7172995|FG005|54-Week Base Study|Death|1
4395660|NCT00103857|7172996|FG006|54-Week Base Study|Death|0
4395661|NCT00103857|7172990|FG000|54-Week Base Study|Lack of Efficacy|11
4395662|NCT00103857|7172991|FG001|54-Week Base Study|Lack of Efficacy|14
4395663|NCT00103857|7172992|FG002|54-Week Base Study|Lack of Efficacy|8
4395664|NCT00103857|7172993|FG003|54-Week Base Study|Lack of Efficacy|4
4395665|NCT00103857|7172994|FG004|54-Week Base Study|Lack of Efficacy|3
4395666|NCT00103857|7172995|FG005|54-Week Base Study|Lack of Efficacy|14
4395667|NCT00103857|7172996|FG006|54-Week Base Study|Lack of Efficacy|19
4395668|NCT00103857|7172990|FG000|54-Week Base Study|Lost to Follow-up|5
4395669|NCT00103857|7172991|FG001|54-Week Base Study|Lost to Follow-up|4
4395670|NCT00103857|7172992|FG002|54-Week Base Study|Lost to Follow-up|7
4395671|NCT00103857|7172993|FG003|54-Week Base Study|Lost to Follow-up|5
4395672|NCT00103857|7172994|FG004|54-Week Base Study|Lost to Follow-up|10
4395673|NCT00103857|7172995|FG005|54-Week Base Study|Lost to Follow-up|9
4395674|NCT00103857|7172996|FG006|54-Week Base Study|Lost to Follow-up|3
4395675|NCT00103857|7172990|FG000|54-Week Base Study|Physician Decision|1
4395676|NCT00103857|7172991|FG001|54-Week Base Study|Physician Decision|1
4395677|NCT00103857|7172992|FG002|54-Week Base Study|Physician Decision|0
4395678|NCT00103857|7172993|FG003|54-Week Base Study|Physician Decision|0
4395679|NCT00103857|7172994|FG004|54-Week Base Study|Physician Decision|1
4395680|NCT00103857|7172995|FG005|54-Week Base Study|Physician Decision|0
4395681|NCT00103857|7172996|FG006|54-Week Base Study|Physician Decision|0
4395682|NCT00103857|7172990|FG000|54-Week Base Study|Pregnancy|1
4395683|NCT00103857|7172991|FG001|54-Week Base Study|Pregnancy|0
4395684|NCT00103857|7172992|FG002|54-Week Base Study|Pregnancy|0
4395685|NCT00103857|7172993|FG003|54-Week Base Study|Pregnancy|0
4395686|NCT00103857|7172994|FG004|54-Week Base Study|Pregnancy|1
4395687|NCT00103857|7172995|FG005|54-Week Base Study|Pregnancy|0
4395688|NCT00103857|7172996|FG006|54-Week Base Study|Pregnancy|1
4395689|NCT00103857|7172990|FG000|54-Week Base Study|Protocol Violation|6
4395690|NCT00103857|7172991|FG001|54-Week Base Study|Protocol Violation|4
4395691|NCT00103857|7172992|FG002|54-Week Base Study|Protocol Violation|2
4395692|NCT00103857|7172993|FG003|54-Week Base Study|Protocol Violation|4
4395693|NCT00103857|7172994|FG004|54-Week Base Study|Protocol Violation|0
4395694|NCT00103857|7172995|FG005|54-Week Base Study|Protocol Violation|3
4395695|NCT00103857|7172996|FG006|54-Week Base Study|Protocol Violation|3
4395696|NCT00103857|7172990|FG000|54-Week Base Study|Withdrawal by Subject|17
4395697|NCT00103857|7172991|FG001|54-Week Base Study|Withdrawal by Subject|16
4395698|NCT00103857|7172992|FG002|54-Week Base Study|Withdrawal by Subject|16
4395699|NCT00103857|7172993|FG003|54-Week Base Study|Withdrawal by Subject|15
4395700|NCT00103857|7172994|FG004|54-Week Base Study|Withdrawal by Subject|10
4395701|NCT00103857|7172995|FG005|54-Week Base Study|Withdrawal by Subject|15
4395702|NCT00103857|7172996|FG006|54-Week Base Study|Withdrawal by Subject|4
4395703|NCT00103857|7172990|FG000|54-Week Base Study|protocol discontinuation criteria|2
4395704|NCT00103857|7172991|FG001|54-Week Base Study|protocol discontinuation criteria|5
4395705|NCT00103857|7172992|FG002|54-Week Base Study|protocol discontinuation criteria|2
4395706|NCT00103857|7172993|FG003|54-Week Base Study|protocol discontinuation criteria|6
4395707|NCT00103857|7172994|FG004|54-Week Base Study|protocol discontinuation criteria|5
4395708|NCT00103857|7172995|FG005|54-Week Base Study|protocol discontinuation criteria|3
4395709|NCT00103857|7172996|FG006|54-Week Base Study|protocol discontinuation criteria|5
4395710|NCT00103857|7172990|FG000|54-Week Base Study|patient moved|0
4395711|NCT00103857|7172991|FG001|54-Week Base Study|patient moved|1
4395712|NCT00103857|7172992|FG002|54-Week Base Study|patient moved|1
4395713|NCT00103857|7172993|FG003|54-Week Base Study|patient moved|2
4395714|NCT00103857|7172994|FG004|54-Week Base Study|patient moved|3
4395715|NCT00103857|7172995|FG005|54-Week Base Study|patient moved|1
4395716|NCT00103857|7172996|FG006|54-Week Base Study|patient moved|0
4395717|NCT00103857|7172990|FG000|54-Week Base Study|non-compliance with study procedures|1
4395718|NCT00103857|7172991|FG001|54-Week Base Study|non-compliance with study procedures|2
4395719|NCT00103857|7172992|FG002|54-Week Base Study|non-compliance with study procedures|0
4395720|NCT00103857|7172993|FG003|54-Week Base Study|non-compliance with study procedures|0
4395721|NCT00103857|7172994|FG004|54-Week Base Study|non-compliance with study procedures|0
4395722|NCT00103857|7172995|FG005|54-Week Base Study|non-compliance with study procedures|2
4395723|NCT00103857|7172996|FG006|54-Week Base Study|non-compliance with study procedures|0
4395724|NCT00103857|7172990|FG000|54-Week Base Study|patient incarcerated|0
4395725|NCT00103857|7172991|FG001|54-Week Base Study|patient incarcerated|0
4395726|NCT00103857|7172992|FG002|54-Week Base Study|patient incarcerated|0
4395727|NCT00103857|7172993|FG003|54-Week Base Study|patient incarcerated|0
4395728|NCT00103857|7172994|FG004|54-Week Base Study|patient incarcerated|1
4395729|NCT00103857|7172995|FG005|54-Week Base Study|patient incarcerated|1
4395730|NCT00103857|7172996|FG006|54-Week Base Study|patient incarcerated|0
4395731|NCT00103857|7172990|FG000|54-Week Base Study|laboratory reporting error|0
4395732|NCT00103857|7172991|FG001|54-Week Base Study|laboratory reporting error|0
4395733|NCT00103857|7172992|FG002|54-Week Base Study|laboratory reporting error|0
4395734|NCT00103857|7172993|FG003|54-Week Base Study|laboratory reporting error|0
4395735|NCT00103857|7172994|FG004|54-Week Base Study|laboratory reporting error|1
4395736|NCT00103857|7172995|FG005|54-Week Base Study|laboratory reporting error|0
4395737|NCT00103857|7172996|FG006|54-Week Base Study|laboratory reporting error|0
4395738|NCT00103857|7172990|FG000|54-Week Base Study|site error|0
4395739|NCT00103857|7172991|FG001|54-Week Base Study|site error|0
4395740|NCT00103857|7172992|FG002|54-Week Base Study|site error|0
4395741|NCT00103857|7172993|FG003|54-Week Base Study|site error|0
4395742|NCT00103857|7172994|FG004|54-Week Base Study|site error|0
4395743|NCT00103857|7172995|FG005|54-Week Base Study|site error|1
4395744|NCT00103857|7172996|FG006|54-Week Base Study|site error|0
4395745|NCT00103857|7172990|FG000|54-Week Base Study|patient intolerance to rescue therapy|1
4395746|NCT00103857|7172991|FG001|54-Week Base Study|patient intolerance to rescue therapy|0
4395747|NCT00103857|7172992|FG002|54-Week Base Study|patient intolerance to rescue therapy|0
4395748|NCT00103857|7172993|FG003|54-Week Base Study|patient intolerance to rescue therapy|0
4395749|NCT00103857|7172994|FG004|54-Week Base Study|patient intolerance to rescue therapy|0
4395750|NCT00103857|7172995|FG005|54-Week Base Study|patient intolerance to rescue therapy|0
4395751|NCT00103857|7172996|FG006|54-Week Base Study|patient intolerance to rescue therapy|0
4712147|NCT02919761|7638388|FG002|Part 2: Double-blind|Worsening of disease activity|10
4712148|NCT02919761|7638386|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0
4712149|NCT02919761|7638387|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0
4712150|NCT02919761|7638388|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1
4712151|NCT02919761|7638386|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0
4712152|NCT02919761|7638387|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0
4712153|NCT02919761|7638388|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1
4712154|NCT02919761|7638386|FG000|Part 2: Double-blind|Discontinued exclusion 16|0
4712155|NCT02919761|7638387|FG001|Part 2: Double-blind|Discontinued exclusion 16|0
4712156|NCT02919761|7638388|FG002|Part 2: Double-blind|Discontinued exclusion 16|2
4712157|NCT02919995|7638425|FG000|Overall Study|Adverse Event|0
4712158|NCT02919995|7638426|FG001|Overall Study|Adverse Event|0
4712159|NCT02919995|7638427|FG002|Overall Study|Adverse Event|0
4712160|NCT02919995|7638428|FG003|Overall Study|Adverse Event|0
4712161|NCT02919995|7638429|FG004|Overall Study|Adverse Event|0
4712162|NCT02919995|7638430|FG005|Overall Study|Adverse Event|1
4712163|NCT02920528|7638445|FG000|Overall Study|Incomplete Data|1
4712164|NCT02920528|7638446|FG001|Overall Study|Incomplete Data|1
4712165|NCT02920528|7638447|FG002|Overall Study|Incomplete Data|1
4712166|NCT02920528|7638445|FG000|Overall Study|Adverse Event|0
4712167|NCT02920528|7638446|FG001|Overall Study|Adverse Event|0
4712168|NCT02920528|7638447|FG002|Overall Study|Adverse Event|3
4395752|NCT00103857|7172990|FG000|50-Week Extension Study|Adverse Event|2
4395753|NCT00103857|7172991|FG001|50-Week Extension Study|Adverse Event|3
4395754|NCT00103857|7172992|FG002|50-Week Extension Study|Adverse Event|2
4395755|NCT00103857|7172993|FG003|50-Week Extension Study|Adverse Event|0
4395756|NCT00103857|7172994|FG004|50-Week Extension Study|Adverse Event|1
4395757|NCT00103857|7172995|FG005|50-Week Extension Study|Adverse Event|1
4395758|NCT00103857|7172996|FG006|50-Week Extension Study|Adverse Event|0
4395759|NCT00103857|7172990|FG000|50-Week Extension Study|Death|0
4395760|NCT00103857|7172991|FG001|50-Week Extension Study|Death|0
4395761|NCT00103857|7172992|FG002|50-Week Extension Study|Death|0
4395762|NCT00103857|7172993|FG003|50-Week Extension Study|Death|1
4395763|NCT00103857|7172994|FG004|50-Week Extension Study|Death|0
4395764|NCT00103857|7172995|FG005|50-Week Extension Study|Death|1
4395765|NCT00103857|7172996|FG006|50-Week Extension Study|Death|0
4395766|NCT00103857|7172990|FG000|50-Week Extension Study|Lack of Efficacy|26
4395767|NCT00103857|7172991|FG001|50-Week Extension Study|Lack of Efficacy|15
4395768|NCT00103857|7172992|FG002|50-Week Extension Study|Lack of Efficacy|13
4395769|NCT00103857|7172993|FG003|50-Week Extension Study|Lack of Efficacy|16
4395770|NCT00103857|7172994|FG004|50-Week Extension Study|Lack of Efficacy|8
4395771|NCT00103857|7172995|FG005|50-Week Extension Study|Lack of Efficacy|8
4395772|NCT00103857|7172996|FG006|50-Week Extension Study|Lack of Efficacy|0
4395773|NCT00103857|7172990|FG000|50-Week Extension Study|Lost to Follow-up|4
4395774|NCT00103857|7172991|FG001|50-Week Extension Study|Lost to Follow-up|0
4395775|NCT00103857|7172992|FG002|50-Week Extension Study|Lost to Follow-up|1
4395776|NCT00103857|7172993|FG003|50-Week Extension Study|Lost to Follow-up|4
4395777|NCT00103857|7172994|FG004|50-Week Extension Study|Lost to Follow-up|3
4395778|NCT00103857|7172995|FG005|50-Week Extension Study|Lost to Follow-up|3
4395779|NCT00103857|7172996|FG006|50-Week Extension Study|Lost to Follow-up|0
4395780|NCT00103857|7172990|FG000|50-Week Extension Study|Physician Decision|0
4395781|NCT00103857|7172991|FG001|50-Week Extension Study|Physician Decision|1
4395782|NCT00103857|7172992|FG002|50-Week Extension Study|Physician Decision|1
4395783|NCT00103857|7172993|FG003|50-Week Extension Study|Physician Decision|0
4395784|NCT00103857|7172994|FG004|50-Week Extension Study|Physician Decision|0
4395785|NCT00103857|7172995|FG005|50-Week Extension Study|Physician Decision|0
4395786|NCT00103857|7172996|FG006|50-Week Extension Study|Physician Decision|0
4395787|NCT00103857|7172990|FG000|50-Week Extension Study|Pregnancy|0
4395788|NCT00103857|7172991|FG001|50-Week Extension Study|Pregnancy|0
4395789|NCT00103857|7172992|FG002|50-Week Extension Study|Pregnancy|1
4395790|NCT00103857|7172993|FG003|50-Week Extension Study|Pregnancy|0
4395791|NCT00103857|7172994|FG004|50-Week Extension Study|Pregnancy|1
4712169|NCT02920528|7638445|FG000|Overall Study|Did not meet inclusion criteria|2
4712170|NCT02920528|7638446|FG001|Overall Study|Did not meet inclusion criteria|0
4712171|NCT02920528|7638447|FG002|Overall Study|Did not meet inclusion criteria|1
4712172|NCT02920957|7638485|FG000|First Intervention : 1 Month|Withdrawal by Subject|2
4712173|NCT02920957|7638486|FG001|First Intervention : 1 Month|Withdrawal by Subject|0
4712174|NCT02920957|7638485|FG000|First Intervention : 1 Month|Lost to Follow-up|1
4395792|NCT00103857|7172995|FG005|50-Week Extension Study|Pregnancy|0
4395793|NCT00103857|7172996|FG006|50-Week Extension Study|Pregnancy|0
4395794|NCT00103857|7172990|FG000|50-Week Extension Study|Protocol Violation|1
4395795|NCT00103857|7172991|FG001|50-Week Extension Study|Protocol Violation|1
4395796|NCT00103857|7172992|FG002|50-Week Extension Study|Protocol Violation|1
4395797|NCT00103857|7172993|FG003|50-Week Extension Study|Protocol Violation|2
4395798|NCT00103857|7172994|FG004|50-Week Extension Study|Protocol Violation|0
4395799|NCT00103857|7172995|FG005|50-Week Extension Study|Protocol Violation|1
4395800|NCT00103857|7172996|FG006|50-Week Extension Study|Protocol Violation|0
4395801|NCT00103857|7172990|FG000|50-Week Extension Study|Withdrawal by Subject|2
4395802|NCT00103857|7172991|FG001|50-Week Extension Study|Withdrawal by Subject|5
4395803|NCT00103857|7172992|FG002|50-Week Extension Study|Withdrawal by Subject|2
4395804|NCT00103857|7172993|FG003|50-Week Extension Study|Withdrawal by Subject|8
4395805|NCT00103857|7172994|FG004|50-Week Extension Study|Withdrawal by Subject|3
4395806|NCT00103857|7172995|FG005|50-Week Extension Study|Withdrawal by Subject|3
4395807|NCT00103857|7172996|FG006|50-Week Extension Study|Withdrawal by Subject|0
4395808|NCT00103857|7172990|FG000|50-Week Extension Study|protocol discontinuation criteria|2
4395809|NCT00103857|7172991|FG001|50-Week Extension Study|protocol discontinuation criteria|2
4395810|NCT00103857|7172992|FG002|50-Week Extension Study|protocol discontinuation criteria|3
4395811|NCT00103857|7172993|FG003|50-Week Extension Study|protocol discontinuation criteria|2
4395812|NCT00103857|7172994|FG004|50-Week Extension Study|protocol discontinuation criteria|3
4395813|NCT00103857|7172995|FG005|50-Week Extension Study|protocol discontinuation criteria|3
4395814|NCT00103857|7172996|FG006|50-Week Extension Study|protocol discontinuation criteria|0
4395815|NCT00103857|7172990|FG000|50-Week Extension Study|non-compliance with study procedures|1
4395816|NCT00103857|7172991|FG001|50-Week Extension Study|non-compliance with study procedures|0
4395817|NCT00103857|7172992|FG002|50-Week Extension Study|non-compliance with study procedures|0
4395818|NCT00103857|7172993|FG003|50-Week Extension Study|non-compliance with study procedures|1
4395819|NCT00103857|7172994|FG004|50-Week Extension Study|non-compliance with study procedures|1
4395820|NCT00103857|7172995|FG005|50-Week Extension Study|non-compliance with study procedures|0
4395821|NCT00103857|7172996|FG006|50-Week Extension Study|non-compliance with study procedures|0
4395822|NCT00103857|7172990|FG000|50-Week Extension Study|patient moved|0
4395823|NCT00103857|7172991|FG001|50-Week Extension Study|patient moved|0
4395824|NCT00103857|7172992|FG002|50-Week Extension Study|patient moved|1
4395825|NCT00103857|7172993|FG003|50-Week Extension Study|patient moved|2
4395826|NCT00103857|7172994|FG004|50-Week Extension Study|patient moved|0
4395827|NCT00103857|7172995|FG005|50-Week Extension Study|patient moved|0
4395828|NCT00103857|7172996|FG006|50-Week Extension Study|patient moved|0
4395829|NCT00103857|7172990|FG000|50-Week Extension Study|patient scheduled for elective surgery|0
4395830|NCT00103857|7172991|FG001|50-Week Extension Study|patient scheduled for elective surgery|0
4395831|NCT00103857|7172992|FG002|50-Week Extension Study|patient scheduled for elective surgery|1
4395832|NCT00103857|7172993|FG003|50-Week Extension Study|patient scheduled for elective surgery|0
4395833|NCT00103857|7172994|FG004|50-Week Extension Study|patient scheduled for elective surgery|0
4395834|NCT00103857|7172995|FG005|50-Week Extension Study|patient scheduled for elective surgery|0
4395835|NCT00103857|7172996|FG006|50-Week Extension Study|patient scheduled for elective surgery|0
4395836|NCT00103857|7172990|FG000|50-Week Extension Study|reason unspecified|0
4395837|NCT00103857|7172991|FG001|50-Week Extension Study|reason unspecified|0
4395838|NCT00103857|7172992|FG002|50-Week Extension Study|reason unspecified|0
4395839|NCT00103857|7172993|FG003|50-Week Extension Study|reason unspecified|0
4395840|NCT00103857|7172994|FG004|50-Week Extension Study|reason unspecified|1
4395841|NCT00103857|7172995|FG005|50-Week Extension Study|reason unspecified|0
4395842|NCT00103857|7172996|FG006|50-Week Extension Study|reason unspecified|0
4395843|NCT00104052|7173011|FG000|Overall Study|Adverse Event|1
4395844|NCT00104052|7173011|FG000|Overall Study|Lack of Efficacy|26
4395845|NCT00104052|7173011|FG000|Overall Study|Discontinuation unrelated to treatment|2
4395846|NCT00104104|7173017|FG000|Overall Study|Adverse Event|8
4395847|NCT00104104|7173018|FG001|Overall Study|Adverse Event|8
4395848|NCT00104104|7173017|FG000|Overall Study|Abnormal laboratory value(s)|20
4395849|NCT00104104|7173018|FG001|Overall Study|Abnormal laboratory value(s)|14
4395850|NCT00104104|7173017|FG000|Overall Study|Lack of Efficacy|0
4395851|NCT00104104|7173018|FG001|Overall Study|Lack of Efficacy|3
4395852|NCT00104104|7173017|FG000|Overall Study|Condition no longer requires study drug|7
4395853|NCT00104104|7173018|FG001|Overall Study|Condition no longer requires study drug|4
4395854|NCT00104104|7173017|FG000|Overall Study|Protocol Violation|5
4395855|NCT00104104|7173018|FG001|Overall Study|Protocol Violation|2
4395856|NCT00104104|7173017|FG000|Overall Study|Withdrawal by Subject|11
4395857|NCT00104104|7173018|FG001|Overall Study|Withdrawal by Subject|15
4395858|NCT00104104|7173017|FG000|Overall Study|Lost to Follow-up|3
4395859|NCT00104104|7173018|FG001|Overall Study|Lost to Follow-up|7
4395860|NCT00104104|7173017|FG000|Overall Study|Administrative problems|12
4395861|NCT00104104|7173018|FG001|Overall Study|Administrative problems|13
4395862|NCT00104104|7173017|FG000|Overall Study|Death|9
4395863|NCT00104104|7173018|FG001|Overall Study|Death|6
4395864|NCT00104247|7173035|FG000|Overall Study|Withdrawal by Subject|1
4395865|NCT00104247|7173036|FG001|Overall Study|Withdrawal by Subject|0
4395866|NCT00104247|7173035|FG000|Overall Study|Noncompliant with dosing|0
4395867|NCT00104247|7173036|FG001|Overall Study|Noncompliant with dosing|1
4712175|NCT02920957|7638486|FG001|First Intervention : 1 Month|Lost to Follow-up|0
4712176|NCT02920957|7638485|FG000|First Intervention : 1 Month|Adverse Event|1
4712177|NCT02920957|7638486|FG001|First Intervention : 1 Month|Adverse Event|0
4712178|NCT02920957|7638485|FG000|Second Intervention: 1 Month|Lost to Follow-up|0
4712179|NCT02920957|7638486|FG001|Second Intervention: 1 Month|Lost to Follow-up|1
4712180|NCT02920970|7638503|FG000|First Intervention|Protocol Violation|0
4712181|NCT02920970|7638504|FG001|First Intervention|Protocol Violation|1
4395868|NCT00104299|7173044|FG000|Overall Study|Adverse Event|3
4395869|NCT00104299|7173045|FG001|Overall Study|Adverse Event|1
4395870|NCT00104299|7173044|FG000|Overall Study|Death|2
4395871|NCT00104299|7173045|FG001|Overall Study|Death|2
4395872|NCT00104299|7173044|FG000|Overall Study|Withdrawal by Subject|2
4395873|NCT00104299|7173045|FG001|Overall Study|Withdrawal by Subject|6
4395874|NCT00104299|7173044|FG000|Overall Study|Physician Decision|1
4395875|NCT00104299|7173045|FG001|Overall Study|Physician Decision|1
4395876|NCT00104299|7173044|FG000|Overall Study|To have renal transplant|1
4395877|NCT00104299|7173045|FG001|Overall Study|To have renal transplant|0
4395878|NCT00104416|7173053|FG000|Double-Blind Phase|Adverse Event|2
4395879|NCT00104416|7173054|FG001|Double-Blind Phase|Adverse Event|1
4395880|NCT00104416|7173055|FG002|Double-Blind Phase|Adverse Event|0
4395881|NCT00104416|7173056|FG003|Double-Blind Phase|Adverse Event|0
4395882|NCT00104416|7173057|FG004|Double-Blind Phase|Adverse Event|0
4395883|NCT00104416|7173053|FG000|Double-Blind Phase|Lost to Follow-up|0
4395884|NCT00104416|7173054|FG001|Double-Blind Phase|Lost to Follow-up|1
4395885|NCT00104416|7173055|FG002|Double-Blind Phase|Lost to Follow-up|0
4395886|NCT00104416|7173056|FG003|Double-Blind Phase|Lost to Follow-up|0
4395887|NCT00104416|7173057|FG004|Double-Blind Phase|Lost to Follow-up|0
4395888|NCT00104416|7173053|FG000|Double-Blind Phase|Protocol Violation|0
4395889|NCT00104416|7173054|FG001|Double-Blind Phase|Protocol Violation|1
4395890|NCT00104416|7173055|FG002|Double-Blind Phase|Protocol Violation|0
4395891|NCT00104416|7173056|FG003|Double-Blind Phase|Protocol Violation|0
4395892|NCT00104416|7173057|FG004|Double-Blind Phase|Protocol Violation|0
4395893|NCT00104416|7173053|FG000|Double-Blind Phase|Withdrawal by Subject|2
4395894|NCT00104416|7173054|FG001|Double-Blind Phase|Withdrawal by Subject|3
4395895|NCT00104416|7173055|FG002|Double-Blind Phase|Withdrawal by Subject|0
4395896|NCT00104416|7173056|FG003|Double-Blind Phase|Withdrawal by Subject|0
4395897|NCT00104416|7173057|FG004|Double-Blind Phase|Withdrawal by Subject|0
4395898|NCT00104416|7173053|FG000|Double-Blind Phase|Pregnancy|1
4395899|NCT00104416|7173054|FG001|Double-Blind Phase|Pregnancy|0
4395900|NCT00104416|7173055|FG002|Double-Blind Phase|Pregnancy|0
4395901|NCT00104416|7173056|FG003|Double-Blind Phase|Pregnancy|0
4395902|NCT00104416|7173057|FG004|Double-Blind Phase|Pregnancy|0
4395903|NCT00104416|7173053|FG000|Double-Blind Phase|Participant Did Not Take Drug|3
4395904|NCT00104416|7173054|FG001|Double-Blind Phase|Participant Did Not Take Drug|4
4395905|NCT00104416|7173055|FG002|Double-Blind Phase|Participant Did Not Take Drug|0
4395906|NCT00104416|7173056|FG003|Double-Blind Phase|Participant Did Not Take Drug|0
4395907|NCT00104416|7173057|FG004|Double-Blind Phase|Participant Did Not Take Drug|0
4395908|NCT00104416|7173053|FG000|Continuation Phase|Adverse Event|0
4395909|NCT00104416|7173054|FG001|Continuation Phase|Adverse Event|0
4395910|NCT00104416|7173055|FG002|Continuation Phase|Adverse Event|2
4395911|NCT00104416|7173056|FG003|Continuation Phase|Adverse Event|0
4395912|NCT00104416|7173057|FG004|Continuation Phase|Adverse Event|2
4395913|NCT00104416|7173053|FG000|Continuation Phase|Lost to Follow-up|0
4395914|NCT00104416|7173054|FG001|Continuation Phase|Lost to Follow-up|0
4395915|NCT00104416|7173055|FG002|Continuation Phase|Lost to Follow-up|1
4395916|NCT00104416|7173056|FG003|Continuation Phase|Lost to Follow-up|0
4395917|NCT00104416|7173057|FG004|Continuation Phase|Lost to Follow-up|1
4395918|NCT00104416|7173053|FG000|Continuation Phase|Withdrawal by Subject|0
4395919|NCT00104416|7173054|FG001|Continuation Phase|Withdrawal by Subject|0
4395920|NCT00104416|7173055|FG002|Continuation Phase|Withdrawal by Subject|2
4395921|NCT00104416|7173056|FG003|Continuation Phase|Withdrawal by Subject|1
4395922|NCT00104416|7173057|FG004|Continuation Phase|Withdrawal by Subject|1
4395923|NCT00104416|7173053|FG000|Continuation Phase|Pregnancy|0
4395924|NCT00104416|7173054|FG001|Continuation Phase|Pregnancy|0
4395925|NCT00104416|7173055|FG002|Continuation Phase|Pregnancy|1
4395926|NCT00104416|7173056|FG003|Continuation Phase|Pregnancy|1
4395927|NCT00104416|7173057|FG004|Continuation Phase|Pregnancy|0
4395928|NCT00104416|7173053|FG000|Continuation Phase|Non-compliance|0
4395929|NCT00104416|7173054|FG001|Continuation Phase|Non-compliance|0
4395930|NCT00104416|7173055|FG002|Continuation Phase|Non-compliance|0
4395931|NCT00104416|7173056|FG003|Continuation Phase|Non-compliance|0
4395932|NCT00104416|7173057|FG004|Continuation Phase|Non-compliance|1
4395933|NCT00104520|7173071|FG000|Overall Study|Unrelated adverse event|34
4395934|NCT00104520|7173072|FG001|Overall Study|Unrelated adverse event|47
4395935|NCT00104520|7173071|FG000|Overall Study|Study drug intolerance|0
4395936|NCT00104520|7173072|FG001|Overall Study|Study drug intolerance|1
4395937|NCT00104520|7173071|FG000|Overall Study|Related adverse event|13
4395938|NCT00104520|7173072|FG001|Overall Study|Related adverse event|15
4395939|NCT00104520|7173071|FG000|Overall Study|Lost to Follow-up|1
4395940|NCT00104520|7173072|FG001|Overall Study|Lost to Follow-up|0
4395941|NCT00104520|7173071|FG000|Overall Study|Noncompliance|0
4395942|NCT00104520|7173072|FG001|Overall Study|Noncompliance|2
4395943|NCT00104520|7173071|FG000|Overall Study|Personal/administrative|1
4395944|NCT00104520|7173072|FG001|Overall Study|Personal/administrative|1
4395945|NCT00104520|7173071|FG000|Overall Study|Other|1
4395946|NCT00104520|7173072|FG001|Overall Study|Other|5
4395947|NCT00104572|7173081|FG000|Overall Study|Withdrawal by Subject|3
4395948|NCT00104572|7173082|FG001|Overall Study|Withdrawal by Subject|3
4395949|NCT00104572|7173083|FG002|Overall Study|Withdrawal by Subject|0
4395950|NCT00104637|7173091|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1
4395951|NCT00104637|7173092|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0
4395952|NCT00104650|7173104|FG000|Treatment Period (25 Weeks)|Physician Decision|0
4395953|NCT00104650|7173105|FG001|Treatment Period (25 Weeks)|Physician Decision|0
4395954|NCT00104650|7173106|FG002|Treatment Period (25 Weeks)|Physician Decision|1
4395955|NCT00104650|7173104|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2
4395956|NCT00104650|7173105|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1
4395957|NCT00104650|7173106|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1
4395958|NCT00104650|7173104|FG000|Treatment Period (25 Weeks)|Death|7
4395959|NCT00104650|7173105|FG001|Treatment Period (25 Weeks)|Death|5
4395960|NCT00104650|7173106|FG002|Treatment Period (25 Weeks)|Death|6
4395961|NCT00104650|7173104|FG000|Treatment Period (25 Weeks)|Disease progression|2
4395962|NCT00104650|7173105|FG001|Treatment Period (25 Weeks)|Disease progression|3
4395963|NCT00104650|7173106|FG002|Treatment Period (25 Weeks)|Disease progression|2
4395964|NCT00104650|7173104|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0
4395965|NCT00104650|7173105|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1
4395966|NCT00104650|7173106|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0
4395967|NCT00104650|7173104|FG000|Treatment Period (25 Weeks)|Other|1
4395968|NCT00104650|7173105|FG001|Treatment Period (25 Weeks)|Other|0
4395969|NCT00104650|7173106|FG002|Treatment Period (25 Weeks)|Other|0
4395970|NCT00104650|7173104|FG000|Treatment Period (25 Weeks)|Protocol deviation|0
4395971|NCT00104650|7173105|FG001|Treatment Period (25 Weeks)|Protocol deviation|1
4395972|NCT00104650|7173106|FG002|Treatment Period (25 Weeks)|Protocol deviation|0
4395973|NCT00104650|7173104|FG000|Follow-up Period|Physician Decision|1
4395974|NCT00104650|7173105|FG001|Follow-up Period|Physician Decision|1
4395975|NCT00104650|7173106|FG002|Follow-up Period|Physician Decision|0
4395976|NCT00104650|7173104|FG000|Follow-up Period|Adverse Event|1
4395977|NCT00104650|7173105|FG001|Follow-up Period|Adverse Event|0
4395978|NCT00104650|7173106|FG002|Follow-up Period|Adverse Event|1
4395979|NCT00104650|7173104|FG000|Follow-up Period|Withdrawal by Subject|0
4395980|NCT00104650|7173105|FG001|Follow-up Period|Withdrawal by Subject|3
4395981|NCT00104650|7173106|FG002|Follow-up Period|Withdrawal by Subject|3
4395982|NCT00104650|7173104|FG000|Follow-up Period|Death|6
4395983|NCT00104650|7173105|FG001|Follow-up Period|Death|6
4395984|NCT00104650|7173106|FG002|Follow-up Period|Death|4
4395985|NCT00104650|7173104|FG000|Follow-up Period|Disease progression|3
4395986|NCT00104650|7173105|FG001|Follow-up Period|Disease progression|1
4395987|NCT00104650|7173106|FG002|Follow-up Period|Disease progression|0
4395988|NCT00104650|7173104|FG000|Follow-up Period|Lost to Follow-up|0
4395989|NCT00104650|7173105|FG001|Follow-up Period|Lost to Follow-up|1
4395990|NCT00104650|7173106|FG002|Follow-up Period|Lost to Follow-up|2
4395991|NCT00104650|7173104|FG000|Follow-up Period|Other|0
4395992|NCT00104650|7173105|FG001|Follow-up Period|Other|1
4395993|NCT00104650|7173106|FG002|Follow-up Period|Other|0
4395994|NCT00104676|7173116|FG000|Overall Study|Death|3
4395995|NCT00104676|7173117|FG001|Overall Study|Death|2
4395996|NCT00104676|7173116|FG000|Overall Study|Withdrawal by Subject|0
4395997|NCT00104676|7173117|FG001|Overall Study|Withdrawal by Subject|2
4395998|NCT00104676|7173116|FG000|Overall Study|treatment interruption|4
4395999|NCT00104676|7173117|FG001|Overall Study|treatment interruption|10
4396000|NCT00104871|7173129|FG000|Overall Study|Not evaluable|1
4396001|NCT00104884|7173133|FG000|Overall Study|Disease progression|4
4396002|NCT00105066|7173177|FG000|Overall Study|Adverse Event|2
4396003|NCT00105066|7173178|FG001|Overall Study|Adverse Event|5
4396004|NCT00105079|7173186|FG000|Overall Study|Adverse Event|5
4396005|NCT00105079|7173187|FG001|Overall Study|Adverse Event|12
4396006|NCT00105079|7173186|FG000|Overall Study|Death|3
4396007|NCT00105079|7173187|FG001|Overall Study|Death|1
4396008|NCT00105079|7173186|FG000|Overall Study|Lost to Follow-up|12
4396009|NCT00105079|7173187|FG001|Overall Study|Lost to Follow-up|12
4396010|NCT00105079|7173186|FG000|Overall Study|Lack of Efficacy|9
4396011|NCT00105079|7173187|FG001|Overall Study|Lack of Efficacy|3
4396012|NCT00105079|7173186|FG000|Overall Study|Refused treatment|6
4396013|NCT00105079|7173187|FG001|Overall Study|Refused treatment|4
4396014|NCT00105079|7173186|FG000|Overall Study|Violation of selection criteria at entry|0
4396015|NCT00105079|7173187|FG001|Overall Study|Violation of selection criteria at entry|2
4396016|NCT00105079|7173186|FG000|Overall Study|Protocol Violation|1
4396017|NCT00105079|7173187|FG001|Overall Study|Protocol Violation|0
4396018|NCT00105079|7173186|FG000|Overall Study|Other|3
4396019|NCT00105079|7173187|FG001|Overall Study|Other|1
4396020|NCT00105157|7173197|FG000|Double-Blind (DB)|Never Treated|1
4396021|NCT00105157|7173198|FG001|Double-Blind (DB)|Never Treated|0
4396022|NCT00105157|7173199|FG002|Double-Blind (DB)|Never Treated|0
4396023|NCT00105157|7173200|FG003|Double-Blind (DB)|Never Treated|0
4396024|NCT00105157|7173197|FG000|Double-Blind (DB)|Adverse Event|2
4396025|NCT00105157|7173198|FG001|Double-Blind (DB)|Adverse Event|0
4396026|NCT00105157|7173199|FG002|Double-Blind (DB)|Adverse Event|1
4396027|NCT00105157|7173200|FG003|Double-Blind (DB)|Adverse Event|1
4396028|NCT00105157|7173197|FG000|Double-Blind (DB)|Lack of Efficacy|11
4396029|NCT00105157|7173198|FG001|Double-Blind (DB)|Lack of Efficacy|14
4396030|NCT00105157|7173199|FG002|Double-Blind (DB)|Lack of Efficacy|11
4396031|NCT00105157|7173200|FG003|Double-Blind (DB)|Lack of Efficacy|38
4396032|NCT00105157|7173197|FG000|Open-Label Continuation of DB|Adverse Event|3
4396033|NCT00105157|7173198|FG001|Open-Label Continuation of DB|Adverse Event|1
4396034|NCT00105157|7173199|FG002|Open-Label Continuation of DB|Adverse Event|0
4396035|NCT00105157|7173200|FG003|Open-Label Continuation of DB|Adverse Event|0
4396036|NCT00105157|7173197|FG000|Open-Label Continuation of DB|Lack of Efficacy|1
4396037|NCT00105157|7173198|FG001|Open-Label Continuation of DB|Lack of Efficacy|4
4396038|NCT00105157|7173199|FG002|Open-Label Continuation of DB|Lack of Efficacy|3
4396039|NCT00105157|7173200|FG003|Open-Label Continuation of DB|Lack of Efficacy|1
4396040|NCT00105157|7173197|FG000|Open-Label Continuation of DB|Lost to Follow-up|1
4396041|NCT00105157|7173198|FG001|Open-Label Continuation of DB|Lost to Follow-up|1
4396042|NCT00105157|7173199|FG002|Open-Label Continuation of DB|Lost to Follow-up|1
4396043|NCT00105157|7173200|FG003|Open-Label Continuation of DB|Lost to Follow-up|0
4396044|NCT00105157|7173197|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0
4396045|NCT00105157|7173198|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1
4396046|NCT00105157|7173199|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3
4396047|NCT00105157|7173200|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0
4396048|NCT00105157|7173197|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1
4396049|NCT00105157|7173198|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0
4396050|NCT00105157|7173199|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0
4396051|NCT00105157|7173200|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0
4396052|NCT00105157|7173197|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1
4396053|NCT00105157|7173198|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3
4396054|NCT00105157|7173199|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2
4396055|NCT00105157|7173200|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0
4396056|NCT00105157|7173197|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
4396057|NCT00105157|7173198|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
4396058|NCT00105157|7173199|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
4396059|NCT00105157|7173200|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1
4396060|NCT00105157|7173197|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7
4396061|NCT00105157|7173198|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6
4396062|NCT00105157|7173199|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5
4396063|NCT00105157|7173200|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10
4396064|NCT00105157|7173197|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1
4396065|NCT00105157|7173198|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0
4396066|NCT00105157|7173199|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0
4396067|NCT00105157|7173200|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1
4396068|NCT00105157|7173197|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
4396069|NCT00105157|7173198|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
4396070|NCT00105157|7173199|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
4396071|NCT00105157|7173200|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5
4396072|NCT00105157|7173197|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
4396073|NCT00105157|7173198|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0
4396074|NCT00105157|7173199|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
4396075|NCT00105157|7173200|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
4396076|NCT00105183|7173211|FG000|Overall Study|Death|19
4396077|NCT00105183|7173212|FG001|Overall Study|Death|13
4396078|NCT00105183|7173213|FG002|Overall Study|Death|15
4396079|NCT00105183|7173211|FG000|Overall Study|Withdrawal by Subject|1
4396080|NCT00105183|7173212|FG001|Overall Study|Withdrawal by Subject|1
4396081|NCT00105183|7173213|FG002|Overall Study|Withdrawal by Subject|4
4396082|NCT00105183|7173211|FG000|Overall Study|Physician Decision|1
4396083|NCT00105183|7173212|FG001|Overall Study|Physician Decision|2
4396084|NCT00105183|7173213|FG002|Overall Study|Physician Decision|3
4396085|NCT00105183|7173211|FG000|Overall Study|Lost to Follow-up|0
4396086|NCT00105183|7173212|FG001|Overall Study|Lost to Follow-up|1
4396087|NCT00105183|7173213|FG002|Overall Study|Lost to Follow-up|1
4396088|NCT00105183|7173211|FG000|Overall Study|Other reason|1
4396089|NCT00105183|7173212|FG001|Overall Study|Other reason|2
4396090|NCT00105183|7173213|FG002|Overall Study|Other reason|0
4396091|NCT00105196|7173223|FG000|Overall Study|Lack of Efficacy|2
4396092|NCT00105196|7173224|FG001|Overall Study|Lack of Efficacy|3
4396093|NCT00105196|7173223|FG000|Overall Study|Adverse Event|11
4396094|NCT00105196|7173224|FG001|Overall Study|Adverse Event|3
4396095|NCT00105196|7173223|FG000|Overall Study|Withdrawal by Subject|6
4396096|NCT00105196|7173224|FG001|Overall Study|Withdrawal by Subject|6
4396097|NCT00105196|7173223|FG000|Overall Study|Lost to Follow-up|3
4396098|NCT00105196|7173224|FG001|Overall Study|Lost to Follow-up|2
4396099|NCT00105196|7173223|FG000|Overall Study|Poor/noncompliance|3
4396100|NCT00105196|7173224|FG001|Overall Study|Poor/noncompliance|4
4396101|NCT00105196|7173223|FG000|Overall Study|Protocol Violation|5
4396102|NCT00105196|7173224|FG001|Overall Study|Protocol Violation|2
4396103|NCT00105196|7173223|FG000|Overall Study|pending surgery|0
4396104|NCT00105196|7173224|FG001|Overall Study|pending surgery|1
4396105|NCT00105196|7173223|FG000|Overall Study|marijuana use|0
4396106|NCT00105196|7173224|FG001|Overall Study|marijuana use|1
4396107|NCT00105196|7173223|FG000|Overall Study|Subject became unblinded|0
4396108|NCT00105196|7173224|FG001|Overall Study|Subject became unblinded|1
4396109|NCT00105235|7173230|FG000|Overall Study|Death|4
4396110|NCT00105235|7173230|FG000|Overall Study|Physician Decision|1
4396111|NCT00105235|7173230|FG000|Overall Study|Withdrawal by Subject|2
4396112|NCT00105443|7173240|FG000|Double-Blind Treatment|Adverse Event|1
4396113|NCT00105443|7173241|FG001|Double-Blind Treatment|Adverse Event|0
4396114|NCT00105443|7173242|FG002|Double-Blind Treatment|Adverse Event|0
4396115|NCT00105443|7173243|FG003|Double-Blind Treatment|Adverse Event|0
4396116|NCT00105443|7173240|FG000|Double-Blind Treatment|Lost to Follow-up|0
4396117|NCT00105443|7173241|FG001|Double-Blind Treatment|Lost to Follow-up|0
4396118|NCT00105443|7173242|FG002|Double-Blind Treatment|Lost to Follow-up|1
4396119|NCT00105443|7173243|FG003|Double-Blind Treatment|Lost to Follow-up|0
4396120|NCT00105443|7173240|FG000|Double-Blind Treatment|Withdrawal by Subject|8
4396121|NCT00105443|7173241|FG001|Double-Blind Treatment|Withdrawal by Subject|0
4396122|NCT00105443|7173242|FG002|Double-Blind Treatment|Withdrawal by Subject|7
4396123|NCT00105443|7173243|FG003|Double-Blind Treatment|Withdrawal by Subject|0
4396124|NCT00105443|7173240|FG000|Double-Blind Treatment|Physician Decision|1
4396125|NCT00105443|7173241|FG001|Double-Blind Treatment|Physician Decision|0
4396126|NCT00105443|7173242|FG002|Double-Blind Treatment|Physician Decision|2
4396127|NCT00105443|7173243|FG003|Double-Blind Treatment|Physician Decision|0
4396128|NCT00105443|7173240|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4
4396129|NCT00105443|7173241|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0
4396130|NCT00105443|7173242|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1
4396131|NCT00105443|7173243|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0
4396132|NCT00105443|7173240|FG000|Follow-up and/or Open Label Nexavar|Death|180
4396133|NCT00105443|7173241|FG001|Follow-up and/or Open Label Nexavar|Death|7
4396134|NCT00105443|7173242|FG002|Follow-up and/or Open Label Nexavar|Death|219
4396135|NCT00105443|7173243|FG003|Follow-up and/or Open Label Nexavar|Death|4
4396136|NCT00105443|7173240|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14
4396137|NCT00105443|7173241|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0
4396138|NCT00105443|7173242|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10
4396139|NCT00105443|7173243|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0
4396140|NCT00105443|7173240|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24
4396141|NCT00105443|7173241|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3
4396142|NCT00105443|7173242|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13
4396143|NCT00105443|7173243|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4
4396144|NCT00105443|7173240|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0
4396145|NCT00105443|7173241|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14
4396146|NCT00105443|7173242|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0
4396147|NCT00105443|7173243|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16
4396148|NCT00105443|7173240|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1
4396149|NCT00105443|7173241|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0
4396150|NCT00105443|7173242|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1
4396151|NCT00105443|7173243|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0
4396152|NCT00105443|7173240|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0
4396153|NCT00105443|7173241|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2
4396154|NCT00105443|7173242|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0
4396155|NCT00105443|7173243|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0
4396156|NCT00105443|7173240|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0
4396157|NCT00105443|7173241|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2
4396158|NCT00105443|7173242|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0
4396159|NCT00105443|7173243|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5
4396160|NCT00105443|7173240|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0
4396161|NCT00105443|7173241|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3
4396162|NCT00105443|7173242|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0
4396163|NCT00105443|7173243|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3
4396164|NCT00105443|7173240|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6
4396165|NCT00105443|7173241|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0
4396166|NCT00105443|7173242|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1
4396167|NCT00105443|7173243|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0
4396168|NCT00105443|7173240|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
4396169|NCT00105443|7173241|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
4396170|NCT00105443|7173242|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1
4396171|NCT00105443|7173243|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
4396172|NCT00105443|7173240|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1
4396173|NCT00105443|7173241|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
4396174|NCT00105443|7173242|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
4396175|NCT00105443|7173243|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
4396176|NCT00105443|7173240|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
4396177|NCT00105443|7173241|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
4396178|NCT00105443|7173242|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
4396179|NCT00105443|7173243|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1
4396180|NCT00105443|7173240|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0
4396181|NCT00105443|7173241|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1
4396182|NCT00105443|7173242|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0
4396183|NCT00105443|7173243|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1
4396184|NCT00105443|7173240|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0
4396185|NCT00105443|7173241|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23
4396186|NCT00105443|7173242|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0
4396187|NCT00105443|7173243|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11
4396188|NCT00105469|7173254|FG000|Overall Study|Adverse Event|9
4396189|NCT00105469|7173255|FG001|Overall Study|Adverse Event|8
4396190|NCT00105469|7173254|FG000|Overall Study|Protocol Violation|4
4396191|NCT00105469|7173255|FG001|Overall Study|Protocol Violation|0
4396192|NCT00105469|7173254|FG000|Overall Study|Withdrawal by Subject|2
4396193|NCT00105469|7173255|FG001|Overall Study|Withdrawal by Subject|3
4396194|NCT00105469|7173254|FG000|Overall Study|Lost to Follow-up|1
4396195|NCT00105469|7173255|FG001|Overall Study|Lost to Follow-up|0
4628501|NCT01861522|7495803|FG000|Overall Study|Adverse Event|1
4628502|NCT01861522|7495804|FG001|Overall Study|Adverse Event|0
4396196|NCT00105469|7173254|FG000|Overall Study|Lack of Efficacy|2
4396197|NCT00105469|7173255|FG001|Overall Study|Lack of Efficacy|0
4396198|NCT00105469|7173254|FG000|Overall Study|Other Reason|4
4396199|NCT00105469|7173255|FG001|Overall Study|Other Reason|0
4396200|NCT00105482|7173263|FG000|Overall Study|Adverse Event|1
4396201|NCT00105482|7173264|FG001|Overall Study|Adverse Event|1
4396202|NCT00105482|7173263|FG000|Overall Study|Lost to Follow-up|26
4396203|NCT00105482|7173264|FG001|Overall Study|Lost to Follow-up|17
4396204|NCT00105482|7173263|FG000|Overall Study|Withdrawal by Subject|0
4396205|NCT00105482|7173264|FG001|Overall Study|Withdrawal by Subject|1
4396206|NCT00105482|7173263|FG000|Overall Study|Lost Interest|29
4396207|NCT00105482|7173264|FG001|Overall Study|Lost Interest|32
4396208|NCT00105482|7173263|FG000|Overall Study|Scheduling Conflict|2
4396209|NCT00105482|7173264|FG001|Overall Study|Scheduling Conflict|3
4396210|NCT00105482|7173263|FG000|Overall Study|Withdrawn by PI|1
4396211|NCT00105482|7173264|FG001|Overall Study|Withdrawn by PI|1
4396212|NCT00105508|7173272|FG000|Overall Study|Prephase Dropout|1
4396213|NCT00105508|7173273|FG001|Overall Study|Prephase Dropout|0
4396214|NCT00105508|7173272|FG000|Overall Study|Adverse Event|16
4396215|NCT00105508|7173273|FG001|Overall Study|Adverse Event|19
4396216|NCT00105508|7173272|FG000|Overall Study|Insufficient Efficacy|1
4396217|NCT00105508|7173273|FG001|Overall Study|Insufficient Efficacy|0
4396218|NCT00105508|7173272|FG000|Overall Study|Withdrawal by Subject|10
4396219|NCT00105508|7173273|FG001|Overall Study|Withdrawal by Subject|6
4396220|NCT00105508|7173272|FG000|Overall Study|Lost to Follow-up|3
4396221|NCT00105508|7173273|FG001|Overall Study|Lost to Follow-up|0
4396222|NCT00105508|7173272|FG000|Overall Study|Protocol Violation|1
4396223|NCT00105508|7173273|FG001|Overall Study|Protocol Violation|2
4396224|NCT00105508|7173272|FG000|Overall Study|Other|8
4396225|NCT00105508|7173273|FG001|Overall Study|Other|9
4396226|NCT00105521|7173283|FG000|Overall Study|Other|1
4396227|NCT00105521|7173284|FG001|Overall Study|Other|1
4396228|NCT00105521|7173285|FG002|Overall Study|Other|2
4628503|NCT01861522|7495803|FG000|Overall Study|Withdrawal by Subject|2
4628504|NCT01861522|7495804|FG001|Overall Study|Withdrawal by Subject|0
4712182|NCT02920970|7638503|FG000|First Intervention|Adverse Event|0
4712183|NCT02920970|7638504|FG001|First Intervention|Adverse Event|1
4712184|NCT02920970|7638503|FG000|Second Intervention|Poor Lens Fit|1
4712185|NCT02920970|7638504|FG001|Second Intervention|Poor Lens Fit|0
4712186|NCT02920983|7638512|FG000|Dispense 1|Unacceptable Lens Fit|0
4712187|NCT02920983|7638513|FG001|Dispense 1|Unacceptable Lens Fit|0
4712188|NCT02920983|7638514|FG002|Dispense 1|Unacceptable Lens Fit|0
4712189|NCT02920983|7638515|FG003|Dispense 1|Unacceptable Lens Fit|0
4712190|NCT02920983|7638516|FG004|Dispense 1|Unacceptable Lens Fit|1
4712191|NCT02920983|7638517|FG005|Dispense 1|Unacceptable Lens Fit|0
4712192|NCT02920983|7638512|FG000|Dispense 2|Unscceptable lens fit|1
4712193|NCT02920983|7638513|FG001|Dispense 2|Unscceptable lens fit|0
4712194|NCT02920983|7638514|FG002|Dispense 2|Unscceptable lens fit|0
4712195|NCT02920983|7638515|FG003|Dispense 2|Unscceptable lens fit|0
4712196|NCT02920983|7638516|FG004|Dispense 2|Unscceptable lens fit|1
4712197|NCT02920983|7638517|FG005|Dispense 2|Unscceptable lens fit|0
4396229|NCT00105521|7173286|FG003|Overall Study|Other|0
4396230|NCT00105521|7173283|FG000|Overall Study|Adverse Event|10
4396231|NCT00105521|7173284|FG001|Overall Study|Adverse Event|4
4396232|NCT00105521|7173285|FG002|Overall Study|Adverse Event|10
4396233|NCT00105521|7173286|FG003|Overall Study|Adverse Event|8
4396234|NCT00105521|7173283|FG000|Overall Study|Withdrawal by Subject|1
4396235|NCT00105521|7173284|FG001|Overall Study|Withdrawal by Subject|0
4712198|NCT02920983|7638512|FG000|Dispense 3|Unacceptable Lens Fit|1
4712199|NCT02920983|7638513|FG001|Dispense 3|Unacceptable Lens Fit|1
4712200|NCT02920983|7638514|FG002|Dispense 3|Unacceptable Lens Fit|0
4712201|NCT02920983|7638515|FG003|Dispense 3|Unacceptable Lens Fit|0
4712202|NCT02920983|7638516|FG004|Dispense 3|Unacceptable Lens Fit|1
4712203|NCT02920983|7638517|FG005|Dispense 3|Unacceptable Lens Fit|0
4396236|NCT00105521|7173285|FG002|Overall Study|Withdrawal by Subject|1
4712204|NCT02921087|7638531|FG000|Overall Study|Withdrawal by Subject|0
4396237|NCT00105521|7173286|FG003|Overall Study|Withdrawal by Subject|4
4396238|NCT00105521|7173283|FG000|Overall Study|Lack of Efficacy|0
4396239|NCT00105521|7173284|FG001|Overall Study|Lack of Efficacy|0
4396240|NCT00105521|7173285|FG002|Overall Study|Lack of Efficacy|0
4396241|NCT00105521|7173286|FG003|Overall Study|Lack of Efficacy|1
4396242|NCT00105521|7173283|FG000|Overall Study|Protocol Violation|3
4396243|NCT00105521|7173284|FG001|Overall Study|Protocol Violation|5
4396244|NCT00105521|7173285|FG002|Overall Study|Protocol Violation|4
4396245|NCT00105521|7173286|FG003|Overall Study|Protocol Violation|4
4396246|NCT00105521|7173283|FG000|Overall Study|Lost to Follow-up|0
4396247|NCT00105521|7173284|FG001|Overall Study|Lost to Follow-up|1
4396248|NCT00105521|7173285|FG002|Overall Study|Lost to Follow-up|0
4396249|NCT00105521|7173286|FG003|Overall Study|Lost to Follow-up|0
4396250|NCT00105534|7173298|FG000|Overall Study|Adverse Event|2
4396251|NCT00105534|7173299|FG001|Overall Study|Adverse Event|5
4396252|NCT00105534|7173298|FG000|Overall Study|Protocol Violation|1
4396253|NCT00105534|7173299|FG001|Overall Study|Protocol Violation|4
4396254|NCT00105534|7173298|FG000|Overall Study|Withdrawal by Subject|6
4396255|NCT00105534|7173299|FG001|Overall Study|Withdrawal by Subject|6
4396256|NCT00105534|7173298|FG000|Overall Study|Lost to Follow-up|5
4396257|NCT00105534|7173299|FG001|Overall Study|Lost to Follow-up|1
4396258|NCT00105534|7173298|FG000|Overall Study|Lack of Efficacy|7
4396259|NCT00105534|7173299|FG001|Overall Study|Lack of Efficacy|15
4396260|NCT00105534|7173298|FG000|Overall Study|Treatment unmasked|1
4396261|NCT00105534|7173299|FG001|Overall Study|Treatment unmasked|0
4396262|NCT00105534|7173298|FG000|Overall Study|Other Reason|0
4396263|NCT00105534|7173299|FG001|Overall Study|Other Reason|2
4396264|NCT00105586|7173307|FG000|Overall Study|Adverse Event|4
4396265|NCT00105586|7173308|FG001|Overall Study|Adverse Event|3
4396266|NCT00105586|7173307|FG000|Overall Study|Physician Decision|13
4396267|NCT00105586|7173308|FG001|Overall Study|Physician Decision|13
4396268|NCT00105989|7173316|FG000|Acute - Open Label: Week 0-10|Adverse Event|33
4396269|NCT00105989|7173317|FG001|Acute - Open Label: Week 0-10|Adverse Event|0
4396270|NCT00105989|7173316|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24
4396271|NCT00105989|7173317|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0
4396272|NCT00105989|7173316|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17
4396273|NCT00105989|7173317|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0
4396274|NCT00105989|7173316|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14
4396275|NCT00105989|7173317|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0
4396276|NCT00105989|7173316|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8
4396277|NCT00105989|7173317|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0
4396278|NCT00105989|7173316|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4
4396279|NCT00105989|7173317|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0
4396280|NCT00105989|7173316|FG000|Acute - Open Label: Week 0-10|Physician Decision|0
4396281|NCT00105989|7173317|FG001|Acute - Open Label: Week 0-10|Physician Decision|0
4396282|NCT00105989|7173316|FG000|Acute - Open Label: Week 0-10|Death|1
4396283|NCT00105989|7173317|FG001|Acute - Open Label: Week 0-10|Death|0
4396284|NCT00105989|7173316|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0
4396285|NCT00105989|7173317|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0
4396286|NCT00105989|7173316|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0
4396287|NCT00105989|7173317|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0
4396288|NCT00105989|7173316|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25
4396289|NCT00105989|7173317|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0
4396290|NCT00105989|7173316|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50
4396291|NCT00105989|7173317|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0
4396292|NCT00105989|7173316|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15
4396293|NCT00105989|7173317|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0
4396294|NCT00105989|7173316|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16
4396295|NCT00105989|7173317|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0
4396296|NCT00105989|7173316|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5
4396297|NCT00105989|7173317|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0
4396298|NCT00105989|7173316|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9
4396299|NCT00105989|7173317|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0
4396300|NCT00105989|7173316|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3
4396301|NCT00105989|7173317|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0
4396302|NCT00105989|7173316|FG000|Continuation - Open Label:Week 10-34|Death|0
4396303|NCT00105989|7173317|FG001|Continuation - Open Label:Week 10-34|Death|0
4396304|NCT00105989|7173316|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2
4396305|NCT00105989|7173317|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0
4396306|NCT00105989|7173316|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0
4396307|NCT00105989|7173317|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0
4396308|NCT00105989|7173316|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6
4396309|NCT00105989|7173317|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3
4396310|NCT00105989|7173316|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17
4396311|NCT00105989|7173317|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18
4396312|NCT00105989|7173316|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0
4396313|NCT00105989|7173317|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0
4396314|NCT00105989|7173316|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0
4396315|NCT00105989|7173317|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0
4396316|NCT00105989|7173316|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5
4396317|NCT00105989|7173317|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4
4396318|NCT00105989|7173316|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4
4396319|NCT00105989|7173317|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0
4396320|NCT00105989|7173316|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4
4396321|NCT00105989|7173317|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1
4396322|NCT00105989|7173316|FG000|Maintenance - Double-Blind:Week 34-86|Death|0
4396323|NCT00105989|7173317|FG001|Maintenance - Double-Blind:Week 34-86|Death|0
4396324|NCT00105989|7173316|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14
4396325|NCT00105989|7173317|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43
4396326|NCT00105989|7173316|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0
4396327|NCT00105989|7173317|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0
4396328|NCT00106002|7173333|FG000|Overall Study|Did not take any study drug|1
4396329|NCT00106002|7173333|FG000|Overall Study|Ineligible after Registration|1
4396330|NCT00106028|7173339|FG000|Overall Study|Adverse Event|3
4396331|NCT00106028|7173340|FG001|Overall Study|Adverse Event|2
4396332|NCT00106028|7173339|FG000|Overall Study|Protocol Violation|1
4396333|NCT00106028|7173340|FG001|Overall Study|Protocol Violation|1
4396334|NCT00106028|7173339|FG000|Overall Study|Withdrawal by Subject|2
4396335|NCT00106028|7173340|FG001|Overall Study|Withdrawal by Subject|8
4396336|NCT00106028|7173339|FG000|Overall Study|Lost to Follow-up|0
4396337|NCT00106028|7173340|FG001|Overall Study|Lost to Follow-up|1
4396338|NCT00106080|7173350|FG000|Overall Study|Withdrew/Loss to follow-up|43
4396339|NCT00106080|7173351|FG001|Overall Study|Withdrew/Loss to follow-up|27
4396340|NCT00106184|7173375|FG000|Overall Study|Withdrawal by Subject|3
4396341|NCT00106184|7173376|FG001|Overall Study|Withdrawal by Subject|2
4396342|NCT00106249|7173386|FG000|Overall Study|Lost to Follow-up|3
4396343|NCT00106249|7173387|FG001|Overall Study|Lost to Follow-up|2
4396344|NCT00106353|7173395|FG000|Part 1|Disease progression|3
4396345|NCT00106353|7173396|FG001|Part 1|Disease progression|4
4396346|NCT00106353|7173397|FG002|Part 1|Disease progression|1
4396347|NCT00106353|7173398|FG003|Part 1|Disease progression|3
4396348|NCT00106353|7173399|FG004|Part 1|Disease progression|0
4628505|NCT01862029|7495884|FG000|Overall Study|Physician Decision|1
4628506|NCT01862250|7495900|FG000|Overall Study|Adverse Event|4
4712205|NCT02921087|7638532|FG001|Overall Study|Withdrawal by Subject|1
4712206|NCT02921425|7638576|FG000|Overall Study|Protocol Violation|9
4396349|NCT00106353|7173400|FG005|Part 1|Disease progression|0
4396350|NCT00106353|7173401|FG006|Part 1|Disease progression|0
4396351|NCT00106353|7173395|FG000|Part 1|Withdrawal by Subject|0
4396352|NCT00106353|7173396|FG001|Part 1|Withdrawal by Subject|0
4396353|NCT00106353|7173397|FG002|Part 1|Withdrawal by Subject|1
4396354|NCT00106353|7173398|FG003|Part 1|Withdrawal by Subject|2
4396355|NCT00106353|7173399|FG004|Part 1|Withdrawal by Subject|0
4396356|NCT00106353|7173400|FG005|Part 1|Withdrawal by Subject|0
4396357|NCT00106353|7173401|FG006|Part 1|Withdrawal by Subject|0
4396358|NCT00106353|7173395|FG000|Part 1|Symptomatic deterioration|0
4712207|NCT02921750|7638590|FG000|Overall Study|Adverse Event|1
4712208|NCT02921750|7638591|FG001|Overall Study|Adverse Event|2
4712209|NCT02921750|7638590|FG000|Overall Study|Withdrawal by Subject|1
4712210|NCT02921750|7638591|FG001|Overall Study|Withdrawal by Subject|1
4712211|NCT02921750|7638590|FG000|Overall Study|Lost to Follow-up|3
4712212|NCT02921750|7638591|FG001|Overall Study|Lost to Follow-up|3
4712213|NCT02921750|7638590|FG000|Overall Study|Wound healed|3
4712214|NCT02921750|7638591|FG001|Overall Study|Wound healed|3
4712215|NCT02921750|7638590|FG000|Overall Study|Serious Adverse Event|1
4712216|NCT02921750|7638591|FG001|Overall Study|Serious Adverse Event|2
4396359|NCT00106353|7173396|FG001|Part 1|Symptomatic deterioration|0
4628507|NCT01862328|7495911|FG000|Overall Study|Progressive Disease|3
4396360|NCT00106353|7173397|FG002|Part 1|Symptomatic deterioration|1
4396361|NCT00106353|7173398|FG003|Part 1|Symptomatic deterioration|0
4396362|NCT00106353|7173399|FG004|Part 1|Symptomatic deterioration|0
4396363|NCT00106353|7173400|FG005|Part 1|Symptomatic deterioration|0
4396364|NCT00106353|7173401|FG006|Part 1|Symptomatic deterioration|0
4396365|NCT00106353|7173395|FG000|Part 1|Entered follow-up phase|1
4396366|NCT00106353|7173396|FG001|Part 1|Entered follow-up phase|1
4396367|NCT00106353|7173397|FG002|Part 1|Entered follow-up phase|0
4628508|NCT01862328|7495912|FG001|Overall Study|Progressive Disease|11
4628509|NCT01862328|7495913|FG002|Overall Study|Progressive Disease|5
4628510|NCT01862328|7495914|FG003|Overall Study|Progressive Disease|6
4628511|NCT01862328|7495915|FG004|Overall Study|Progressive Disease|7
4628512|NCT01862328|7495916|FG005|Overall Study|Progressive Disease|4
4628513|NCT01862328|7495917|FG006|Overall Study|Progressive Disease|3
4628514|NCT01862328|7495911|FG000|Overall Study|Adverse Event|0
4628515|NCT01862328|7495912|FG001|Overall Study|Adverse Event|4
4628516|NCT01862328|7495913|FG002|Overall Study|Adverse Event|0
4628517|NCT01862328|7495914|FG003|Overall Study|Adverse Event|1
4628518|NCT01862328|7495915|FG004|Overall Study|Adverse Event|0
4628519|NCT01862328|7495916|FG005|Overall Study|Adverse Event|2
4396368|NCT00106353|7173398|FG003|Part 1|Entered follow-up phase|1
4396369|NCT00106353|7173399|FG004|Part 1|Entered follow-up phase|0
4396370|NCT00106353|7173400|FG005|Part 1|Entered follow-up phase|0
4396371|NCT00106353|7173401|FG006|Part 1|Entered follow-up phase|0
4396372|NCT00106353|7173395|FG000|Part 1|Adverse Event|0
4396373|NCT00106353|7173396|FG001|Part 1|Adverse Event|0
4396374|NCT00106353|7173397|FG002|Part 1|Adverse Event|0
4396375|NCT00106353|7173398|FG003|Part 1|Adverse Event|1
4396376|NCT00106353|7173399|FG004|Part 1|Adverse Event|0
4396377|NCT00106353|7173400|FG005|Part 1|Adverse Event|0
4396378|NCT00106353|7173401|FG006|Part 1|Adverse Event|0
4396379|NCT00106353|7173395|FG000|Part 2|Disease progression|0
4396380|NCT00106353|7173396|FG001|Part 2|Disease progression|0
4396381|NCT00106353|7173397|FG002|Part 2|Disease progression|0
4396382|NCT00106353|7173398|FG003|Part 2|Disease progression|0
4396383|NCT00106353|7173399|FG004|Part 2|Disease progression|8
4396384|NCT00106353|7173400|FG005|Part 2|Disease progression|14
4396385|NCT00106353|7173401|FG006|Part 2|Disease progression|13
4396386|NCT00106353|7173395|FG000|Part 2|Death|0
4396387|NCT00106353|7173396|FG001|Part 2|Death|0
4396388|NCT00106353|7173397|FG002|Part 2|Death|0
4396389|NCT00106353|7173398|FG003|Part 2|Death|0
4396390|NCT00106353|7173399|FG004|Part 2|Death|3
4396391|NCT00106353|7173400|FG005|Part 2|Death|0
4396392|NCT00106353|7173401|FG006|Part 2|Death|1
4396393|NCT00106353|7173395|FG000|Part 2|Symptomatic deterioration|0
4396394|NCT00106353|7173396|FG001|Part 2|Symptomatic deterioration|0
4396395|NCT00106353|7173397|FG002|Part 2|Symptomatic deterioration|0
4396396|NCT00106353|7173398|FG003|Part 2|Symptomatic deterioration|0
4396397|NCT00106353|7173399|FG004|Part 2|Symptomatic deterioration|3
4396398|NCT00106353|7173400|FG005|Part 2|Symptomatic deterioration|0
4396399|NCT00106353|7173401|FG006|Part 2|Symptomatic deterioration|0
4396400|NCT00106353|7173395|FG000|Part 2|Adverse Event|0
4396401|NCT00106353|7173396|FG001|Part 2|Adverse Event|0
4396402|NCT00106353|7173397|FG002|Part 2|Adverse Event|0
4396403|NCT00106353|7173398|FG003|Part 2|Adverse Event|0
4396404|NCT00106353|7173399|FG004|Part 2|Adverse Event|0
4396405|NCT00106353|7173400|FG005|Part 2|Adverse Event|2
4396406|NCT00106353|7173401|FG006|Part 2|Adverse Event|1
4396407|NCT00106353|7173395|FG000|Part 2|Other|0
4396408|NCT00106353|7173396|FG001|Part 2|Other|0
4396409|NCT00106353|7173397|FG002|Part 2|Other|0
4396410|NCT00106353|7173398|FG003|Part 2|Other|0
4712217|NCT02922153|7638611|FG000|Overall Study|Death|8
4712218|NCT02922153|7638612|FG001|Overall Study|Death|1
4712219|NCT02922153|7638611|FG000|Overall Study|Lost to Follow-up|1
4712220|NCT02922153|7638612|FG001|Overall Study|Lost to Follow-up|0
4712221|NCT02922153|7638611|FG000|Overall Study|Physician Decision|1
4712222|NCT02922153|7638612|FG001|Overall Study|Physician Decision|1
4712223|NCT02922634|7638635|FG000|Overall Study|Withdrawal by Subject|5
4712224|NCT02922634|7638635|FG000|Overall Study|Did not have their surgery|5
4736036|NCT03554005|7684692|FG003|Overall Study|Physician Decision|0
4736037|NCT03554005|7684693|FG004|Overall Study|Physician Decision|1
4736038|NCT03554005|7684694|FG005|Overall Study|Physician Decision|0
4736039|NCT03554005|7684689|FG000|Overall Study|Other|0
4736040|NCT03554005|7684690|FG001|Overall Study|Other|0
4736041|NCT03554005|7684691|FG002|Overall Study|Other|0
4736042|NCT03554005|7684692|FG003|Overall Study|Other|0
4736043|NCT03554005|7684693|FG004|Overall Study|Other|0
4736044|NCT03554005|7684694|FG005|Overall Study|Other|1
4736045|NCT03554018|7684710|FG000|Overall Study|Lost to Follow-up|3
4736046|NCT03554018|7684711|FG001|Overall Study|Lost to Follow-up|7
4736047|NCT03554486|7684719|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1
4736048|NCT03554486|7684720|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0
4736049|NCT03554486|7684721|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0
4736050|NCT03554486|7684719|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2
4736051|NCT03554486|7684720|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0
4736052|NCT03554486|7684721|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0
4736053|NCT03554486|7684719|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0
4736054|NCT03554486|7684720|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1
4396411|NCT00106353|7173399|FG004|Part 2|Other|1
4396412|NCT00106353|7173400|FG005|Part 2|Other|1
4396413|NCT00106353|7173401|FG006|Part 2|Other|1
4396414|NCT00106353|7173395|FG000|Part 2|Withdrawal by Subject|0
4396415|NCT00106353|7173396|FG001|Part 2|Withdrawal by Subject|0
4736055|NCT03554486|7684721|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1
4736056|NCT03554629|7684728|FG000|Overall Study|Inadequate data|6
4736057|NCT03554772|7684769|FG000|Overall Study|Lost to Follow-up|0
4736058|NCT03554772|7684770|FG001|Overall Study|Lost to Follow-up|0
4736059|NCT03554772|7684771|FG002|Overall Study|Lost to Follow-up|0
4736060|NCT03554772|7684772|FG003|Overall Study|Lost to Follow-up|2
4396416|NCT00106353|7173397|FG002|Part 2|Withdrawal by Subject|0
4396417|NCT00106353|7173398|FG003|Part 2|Withdrawal by Subject|0
4396418|NCT00106353|7173399|FG004|Part 2|Withdrawal by Subject|1
4396419|NCT00106353|7173400|FG005|Part 2|Withdrawal by Subject|0
4396420|NCT00106353|7173401|FG006|Part 2|Withdrawal by Subject|0
4396421|NCT00106353|7173395|FG000|Part 2|Physician Decision|0
4396422|NCT00106353|7173396|FG001|Part 2|Physician Decision|0
4396423|NCT00106353|7173397|FG002|Part 2|Physician Decision|0
4396424|NCT00106353|7173398|FG003|Part 2|Physician Decision|0
4396425|NCT00106353|7173399|FG004|Part 2|Physician Decision|0
4396426|NCT00106353|7173400|FG005|Part 2|Physician Decision|1
4396427|NCT00106353|7173401|FG006|Part 2|Physician Decision|0
4396428|NCT00106639|7173456|FG000|Overall Study|Adverse Event|3
4396429|NCT00106639|7173457|FG001|Overall Study|Adverse Event|4
4396430|NCT00106639|7173458|FG002|Overall Study|Adverse Event|1
4396431|NCT00106639|7173456|FG000|Overall Study|Protocol Violation|0
4396432|NCT00106639|7173457|FG001|Overall Study|Protocol Violation|1
4396433|NCT00106639|7173458|FG002|Overall Study|Protocol Violation|0
4396434|NCT00106639|7173456|FG000|Overall Study|Withdrawal by Subject|0
4396435|NCT00106639|7173457|FG001|Overall Study|Withdrawal by Subject|1
4396436|NCT00106639|7173458|FG002|Overall Study|Withdrawal by Subject|0
4396437|NCT00106639|7173456|FG000|Overall Study|Participant defaulted|0
4396438|NCT00106639|7173457|FG001|Overall Study|Participant defaulted|1
4396439|NCT00106639|7173458|FG002|Overall Study|Participant defaulted|1
4396440|NCT00106704|7173469|FG000|Overall Study|Adverse Event|10
4396441|NCT00106704|7173470|FG001|Overall Study|Adverse Event|7
4396442|NCT00106704|7173469|FG000|Overall Study|Death|2
4396443|NCT00106704|7173470|FG001|Overall Study|Death|1
4396444|NCT00106704|7173469|FG000|Overall Study|Lack of Efficacy|67
4396445|NCT00106704|7173470|FG001|Overall Study|Lack of Efficacy|69
4396446|NCT00106704|7173469|FG000|Overall Study|Lost to Follow-up|7
4396447|NCT00106704|7173470|FG001|Overall Study|Lost to Follow-up|3
4396448|NCT00106704|7173469|FG000|Overall Study|Pregnancy|1
4396449|NCT00106704|7173470|FG001|Overall Study|Pregnancy|0
4396450|NCT00106704|7173469|FG000|Overall Study|Protocol Violation|4
4396451|NCT00106704|7173470|FG001|Overall Study|Protocol Violation|7
4396452|NCT00106704|7173469|FG000|Overall Study|Withdrawal by Subject|14
4396453|NCT00106704|7173470|FG001|Overall Study|Withdrawal by Subject|21
4396454|NCT00106704|7173469|FG000|Overall Study|Patient moved|1
4396455|NCT00106704|7173470|FG001|Overall Study|Patient moved|0
4396456|NCT00106704|7173469|FG000|Overall Study|Site terminated|0
4396457|NCT00106704|7173470|FG001|Overall Study|Site terminated|1
4396458|NCT00106704|7173469|FG000|Overall Study|Planned major surgery|1
4396459|NCT00106704|7173470|FG001|Overall Study|Planned major surgery|0
4396460|NCT00106704|7173469|FG000|Overall Study|Patient Received Glycemic Medication|22
4396461|NCT00106704|7173470|FG001|Overall Study|Patient Received Glycemic Medication|41
4396462|NCT00106704|7173469|FG000|Overall Study|Unable to re-enter US|1
4396463|NCT00106704|7173470|FG001|Overall Study|Unable to re-enter US|0
4396464|NCT00106704|7173469|FG000|Overall Study|Laboratory test|1
4396465|NCT00106704|7173470|FG001|Overall Study|Laboratory test|1
4396466|NCT00106964|7173488|FG000|Overall Study|Lost to Follow-up|8
4396467|NCT00106964|7173489|FG001|Overall Study|Lost to Follow-up|6
4396468|NCT00106964|7173490|FG002|Overall Study|Lost to Follow-up|2
4396469|NCT00106964|7173488|FG000|Overall Study|Pregnancy|2
4396470|NCT00106964|7173489|FG001|Overall Study|Pregnancy|3
4396471|NCT00106964|7173490|FG002|Overall Study|Pregnancy|2
4396472|NCT00106964|7173488|FG000|Overall Study|Death|1
4396473|NCT00106964|7173489|FG001|Overall Study|Death|1
4396474|NCT00106964|7173490|FG002|Overall Study|Death|0
4396475|NCT00106964|7173488|FG000|Overall Study|Incarceration|0
4396476|NCT00106964|7173489|FG001|Overall Study|Incarceration|1
4396477|NCT00106964|7173490|FG002|Overall Study|Incarceration|0
4396478|NCT00106964|7173488|FG000|Overall Study|Site Funding Terminated|0
4396479|NCT00106964|7173489|FG001|Overall Study|Site Funding Terminated|1
4396480|NCT00106964|7173490|FG002|Overall Study|Site Funding Terminated|1
4396481|NCT00106964|7173488|FG000|Overall Study|Failure to adhere|2
4396482|NCT00106964|7173489|FG001|Overall Study|Failure to adhere|0
4628520|NCT01862328|7495917|FG006|Overall Study|Adverse Event|4
4628521|NCT01862328|7495911|FG000|Overall Study|Other|0
4628522|NCT01862328|7495912|FG001|Overall Study|Other|2
4712225|NCT02923115|7638681|FG000|Overall Study|Lost to Follow-up|0
4712226|NCT02923115|7638682|FG001|Overall Study|Lost to Follow-up|0
4712227|NCT02923115|7638683|FG002|Overall Study|Lost to Follow-up|0
4712228|NCT02923115|7638684|FG003|Overall Study|Lost to Follow-up|1
4712229|NCT02923115|7638685|FG004|Overall Study|Lost to Follow-up|0
4712230|NCT02923115|7638686|FG005|Overall Study|Lost to Follow-up|0
4712231|NCT02923115|7638681|FG000|Overall Study|Withdrawal by Subject|0
4712232|NCT02923115|7638682|FG001|Overall Study|Withdrawal by Subject|1
4712233|NCT02923115|7638683|FG002|Overall Study|Withdrawal by Subject|0
4712234|NCT02923115|7638684|FG003|Overall Study|Withdrawal by Subject|0
4396483|NCT00106964|7173490|FG002|Overall Study|Failure to adhere|0
4396484|NCT00106964|7173488|FG000|Overall Study|Did not meet eligibility criteria|0
4396485|NCT00106964|7173489|FG001|Overall Study|Did not meet eligibility criteria|2
4396486|NCT00106964|7173490|FG002|Overall Study|Did not meet eligibility criteria|2
4628523|NCT01862328|7495913|FG002|Overall Study|Other|1
4628524|NCT01862328|7495914|FG003|Overall Study|Other|0
4396487|NCT00106964|7173488|FG000|Overall Study|Required disallowed medication|0
4396488|NCT00106964|7173489|FG001|Overall Study|Required disallowed medication|1
4396489|NCT00106964|7173490|FG002|Overall Study|Required disallowed medication|0
4396490|NCT00107042|7173509|FG000|Overall Study|Lost to Follow-up|9
4396491|NCT00107042|7173510|FG001|Overall Study|Lost to Follow-up|7
4396492|NCT00107042|7173509|FG000|Overall Study|Withdrawal by Subject|6
4628525|NCT01862328|7495915|FG004|Overall Study|Other|4
4628526|NCT01862328|7495916|FG005|Overall Study|Other|0
4628527|NCT01862328|7495917|FG006|Overall Study|Other|1
4628528|NCT01862328|7495911|FG000|Overall Study|Withdrawal by Subject|1
4396493|NCT00107042|7173510|FG001|Overall Study|Withdrawal by Subject|1
4396494|NCT00107042|7173509|FG000|Overall Study|Moved out of area|5
4396495|NCT00107042|7173510|FG001|Overall Study|Moved out of area|3
4396496|NCT00107042|7173509|FG000|Overall Study|Pregnancy|1
4396497|NCT00107042|7173510|FG001|Overall Study|Pregnancy|1
4396498|NCT00107042|7173509|FG000|Overall Study|Inadvertent enrollment|0
4396499|NCT00107042|7173510|FG001|Overall Study|Inadvertent enrollment|1
4396500|NCT00107042|7173509|FG000|Overall Study|vaccinated outside window|1
4396501|NCT00107042|7173510|FG001|Overall Study|vaccinated outside window|1
4396502|NCT00107042|7173509|FG000|Overall Study|Disallowed medications|0
4396503|NCT00107042|7173510|FG001|Overall Study|Disallowed medications|2
4396504|NCT00107120|7173560|FG000|Overall Study|Adverse Event|4
4396505|NCT00107120|7173561|FG001|Overall Study|Adverse Event|1
4396506|NCT00107120|7173560|FG000|Overall Study|Lack of Efficacy|5
4396507|NCT00107120|7173561|FG001|Overall Study|Lack of Efficacy|5
4396508|NCT00107120|7173560|FG000|Overall Study|Protocol Violation|3
4396509|NCT00107120|7173561|FG001|Overall Study|Protocol Violation|0
4396510|NCT00107120|7173560|FG000|Overall Study|Withdrawal by Subject|8
4396511|NCT00107120|7173561|FG001|Overall Study|Withdrawal by Subject|9
4396512|NCT00107120|7173560|FG000|Overall Study|Lost to Follow-up|8
4396513|NCT00107120|7173561|FG001|Overall Study|Lost to Follow-up|6
4396514|NCT00107120|7173560|FG000|Overall Study|Pregnancy|0
4396515|NCT00107120|7173561|FG001|Overall Study|Pregnancy|1
4396516|NCT00107120|7173560|FG000|Overall Study|moving away from site|1
4396517|NCT00107120|7173561|FG001|Overall Study|moving away from site|1
4396518|NCT00107120|7173560|FG000|Overall Study|death of parent|0
4396519|NCT00107120|7173561|FG001|Overall Study|death of parent|1
4396520|NCT00107172|7173569|FG000|Overall Study|Withdrawal by Subject|1
4396521|NCT00107172|7173570|FG001|Overall Study|Withdrawal by Subject|0
4396522|NCT00107172|7173569|FG000|Overall Study|Death|0
4396523|NCT00107172|7173570|FG001|Overall Study|Death|2
4396524|NCT00107172|7173569|FG000|Overall Study|Other Reason|4
4396525|NCT00107172|7173570|FG001|Overall Study|Other Reason|3
4396526|NCT00107198|7173576|FG000|Overall Study|Lack of Efficacy|28
4396527|NCT00107198|7173576|FG000|Overall Study|Lost to Follow-up|12
4396528|NCT00107198|7173576|FG000|Overall Study|Protocol Violation|1
4396529|NCT00107198|7173576|FG000|Overall Study|Withdrawal by Subject|6
4396530|NCT00107198|7173576|FG000|Overall Study|Ineligible|5
4396531|NCT00107276|7173580|FG000|Overall Study|Progression|46
4396532|NCT00107276|7173580|FG000|Overall Study|Adverse Event|6
4396533|NCT00107276|7173580|FG000|Overall Study|M.D. decision|2
4396534|NCT00107276|7173580|FG000|Overall Study|Patient refusal|1
4396535|NCT00107276|7173580|FG000|Overall Study|Death|1
4396536|NCT00107276|7173580|FG000|Overall Study|Ineligible|16
4396537|NCT00107380|7173585|FG000|Overall Study|Adverse Event|7
4396538|NCT00107380|7173585|FG000|Overall Study|Refusal Unrelated to Adverse Event|7
4396539|NCT00107380|7173585|FG000|Overall Study|Progression/relapse|4
4396540|NCT00107380|7173585|FG000|Overall Study|Death|3
4396541|NCT00107380|7173585|FG000|Overall Study|Other - not protocol specified|7
4396542|NCT00107380|7173585|FG000|Overall Study|Ineligible|2
4510855|NCT00923091|7319710|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
4510856|NCT00923091|7319711|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
4510857|NCT00923091|7319699|FG000|Period III (Single-Blind)|Adverse Event|5
4510858|NCT00923091|7319700|FG001|Period III (Single-Blind)|Adverse Event|0
4510859|NCT00923091|7319701|FG002|Period III (Single-Blind)|Adverse Event|0
4510860|NCT00923091|7319702|FG003|Period III (Single-Blind)|Adverse Event|0
4510861|NCT00923091|7319703|FG004|Period III (Single-Blind)|Adverse Event|0
4510862|NCT00923091|7319704|FG005|Period III (Single-Blind)|Adverse Event|0
4510863|NCT00923091|7319705|FG006|Period III (Single-Blind)|Adverse Event|0
4510864|NCT00923091|7319706|FG007|Period III (Single-Blind)|Adverse Event|0
4510865|NCT00923091|7319707|FG008|Period III (Single-Blind)|Adverse Event|0
4510866|NCT00923091|7319708|FG009|Period III (Single-Blind)|Adverse Event|0
4510867|NCT00923091|7319709|FG010|Period III (Single-Blind)|Adverse Event|0
4510868|NCT00923091|7319710|FG011|Period III (Single-Blind)|Adverse Event|0
4510869|NCT00923091|7319711|FG012|Period III (Single-Blind)|Adverse Event|0
4510870|NCT00923091|7319699|FG000|Period III (Single-Blind)|Withdrawal by Subject|10
4510871|NCT00923091|7319700|FG001|Period III (Single-Blind)|Withdrawal by Subject|0
4510872|NCT00923091|7319701|FG002|Period III (Single-Blind)|Withdrawal by Subject|0
4510873|NCT00923091|7319702|FG003|Period III (Single-Blind)|Withdrawal by Subject|0
4510874|NCT00923091|7319703|FG004|Period III (Single-Blind)|Withdrawal by Subject|0
4510875|NCT00923091|7319704|FG005|Period III (Single-Blind)|Withdrawal by Subject|0
4510876|NCT00923091|7319705|FG006|Period III (Single-Blind)|Withdrawal by Subject|0
4510877|NCT00923091|7319706|FG007|Period III (Single-Blind)|Withdrawal by Subject|0
4510878|NCT00923091|7319707|FG008|Period III (Single-Blind)|Withdrawal by Subject|0
4510879|NCT00923091|7319708|FG009|Period III (Single-Blind)|Withdrawal by Subject|0
4628529|NCT01862328|7495912|FG001|Overall Study|Withdrawal by Subject|1
4628530|NCT01862328|7495913|FG002|Overall Study|Withdrawal by Subject|0
4510880|NCT00923091|7319709|FG010|Period III (Single-Blind)|Withdrawal by Subject|0
4510881|NCT00923091|7319710|FG011|Period III (Single-Blind)|Withdrawal by Subject|0
4510882|NCT00923091|7319711|FG012|Period III (Single-Blind)|Withdrawal by Subject|0
4510883|NCT00923091|7319699|FG000|Period III (Single-Blind)|Protocol Violation|3
4510884|NCT00923091|7319700|FG001|Period III (Single-Blind)|Protocol Violation|0
4510885|NCT00923091|7319701|FG002|Period III (Single-Blind)|Protocol Violation|0
4396543|NCT00107653|7173605|FG000|Overall Study|Adverse Event|24
4396544|NCT00107653|7173606|FG001|Overall Study|Adverse Event|43
4396545|NCT00107653|7173605|FG000|Overall Study|Insufficient Therapeutic Response|25
4396546|NCT00107653|7173606|FG001|Overall Study|Insufficient Therapeutic Response|11
4396547|NCT00107653|7173605|FG000|Overall Study|Violation of Selection Criteria at Entry|1
4396548|NCT00107653|7173606|FG001|Overall Study|Violation of Selection Criteria at Entry|1
4396549|NCT00107653|7173605|FG000|Overall Study|Protocol Violation|1
4396550|NCT00107653|7173606|FG001|Overall Study|Protocol Violation|0
4396551|NCT00107653|7173605|FG000|Overall Study|Withdrawal by Subject|12
4396552|NCT00107653|7173606|FG001|Overall Study|Withdrawal by Subject|13
4396553|NCT00107653|7173605|FG000|Overall Study|Lost to Follow-up|13
4396554|NCT00107653|7173606|FG001|Overall Study|Lost to Follow-up|5
4396555|NCT00107653|7173605|FG000|Overall Study|Administrative Reasons|3
4396556|NCT00107653|7173606|FG001|Overall Study|Administrative Reasons|3
4396557|NCT00107783|7173627|FG000|Overall Study|Adverse Event|0
4396558|NCT00107783|7173628|FG001|Overall Study|Adverse Event|2
4396559|NCT00107783|7173627|FG000|Overall Study|Death|0
4396560|NCT00107783|7173628|FG001|Overall Study|Death|1
4396561|NCT00107783|7173627|FG000|Overall Study|Withdrawal by Subject|2
4396562|NCT00107783|7173628|FG001|Overall Study|Withdrawal by Subject|0
4396563|NCT00107783|7173627|FG000|Overall Study|Second hip replacement|1
4396564|NCT00107783|7173628|FG001|Overall Study|Second hip replacement|1
4396565|NCT00107900|7173640|FG000|Overall Study|Adverse Event|3
4396566|NCT00107900|7173641|FG001|Overall Study|Adverse Event|2
4396567|NCT00107900|7173642|FG002|Overall Study|Adverse Event|10
4396568|NCT00107900|7173643|FG003|Overall Study|Adverse Event|3
4396569|NCT00107900|7173644|FG004|Overall Study|Adverse Event|5
4396570|NCT00107900|7173645|FG005|Overall Study|Adverse Event|3
4396571|NCT00107900|7173640|FG000|Overall Study|Death|0
4396572|NCT00107900|7173641|FG001|Overall Study|Death|0
4396573|NCT00107900|7173642|FG002|Overall Study|Death|0
4396574|NCT00107900|7173643|FG003|Overall Study|Death|0
4396575|NCT00107900|7173644|FG004|Overall Study|Death|1
4396576|NCT00107900|7173645|FG005|Overall Study|Death|0
4396577|NCT00107900|7173640|FG000|Overall Study|Lost to Follow-up|4
4396578|NCT00107900|7173641|FG001|Overall Study|Lost to Follow-up|1
4396579|NCT00107900|7173642|FG002|Overall Study|Lost to Follow-up|3
4396580|NCT00107900|7173643|FG003|Overall Study|Lost to Follow-up|2
4396581|NCT00107900|7173644|FG004|Overall Study|Lost to Follow-up|5
4396582|NCT00107900|7173645|FG005|Overall Study|Lost to Follow-up|5
4396583|NCT00107900|7173640|FG000|Overall Study|Protocol Violation|1
4396584|NCT00107900|7173641|FG001|Overall Study|Protocol Violation|0
4396585|NCT00107900|7173642|FG002|Overall Study|Protocol Violation|5
4396586|NCT00107900|7173643|FG003|Overall Study|Protocol Violation|5
4396587|NCT00107900|7173644|FG004|Overall Study|Protocol Violation|7
4396588|NCT00107900|7173645|FG005|Overall Study|Protocol Violation|0
4396589|NCT00107900|7173640|FG000|Overall Study|Withdrawal by Subject|1
4396590|NCT00107900|7173641|FG001|Overall Study|Withdrawal by Subject|0
4396591|NCT00107900|7173642|FG002|Overall Study|Withdrawal by Subject|5
4396592|NCT00107900|7173643|FG003|Overall Study|Withdrawal by Subject|0
4396593|NCT00107900|7173644|FG004|Overall Study|Withdrawal by Subject|1
4396594|NCT00107900|7173645|FG005|Overall Study|Withdrawal by Subject|1
4396595|NCT00107900|7173640|FG000|Overall Study|Administrative Reasons|1
4396596|NCT00107900|7173641|FG001|Overall Study|Administrative Reasons|0
4396597|NCT00107900|7173642|FG002|Overall Study|Administrative Reasons|2
4396598|NCT00107900|7173643|FG003|Overall Study|Administrative Reasons|2
4396599|NCT00107900|7173644|FG004|Overall Study|Administrative Reasons|2
4396600|NCT00107900|7173645|FG005|Overall Study|Administrative Reasons|0
4396601|NCT00107952|7173661|FG000|Overall Study|Death|75
4396602|NCT00107952|7173662|FG001|Overall Study|Death|61
4396603|NCT00107952|7173661|FG000|Overall Study|Lost to Follow-up|0
4396604|NCT00107952|7173662|FG001|Overall Study|Lost to Follow-up|3
4396605|NCT00107952|7173661|FG000|Overall Study|Withdrawal by Subject|9
4396606|NCT00107952|7173662|FG001|Overall Study|Withdrawal by Subject|6
4396607|NCT00107952|7173661|FG000|Overall Study|Other|2
4396608|NCT00107952|7173662|FG001|Overall Study|Other|5
4396609|NCT00107952|7173661|FG000|Overall Study|Never received study treatment|9
4396610|NCT00107952|7173662|FG001|Overall Study|Never received study treatment|6
4396611|NCT00107978|7173670|FG000|Overall Study|Adverse Event|1
4396612|NCT00107978|7173671|FG001|Overall Study|Adverse Event|5
4396613|NCT00107978|7173670|FG000|Overall Study|Death|3
4396614|NCT00107978|7173671|FG001|Overall Study|Death|3
4396615|NCT00107978|7173670|FG000|Overall Study|Lost to Follow-up|20
4396616|NCT00107978|7173671|FG001|Overall Study|Lost to Follow-up|28
4396617|NCT00107978|7173670|FG000|Overall Study|Withdrawal by Subject|4
4396618|NCT00107978|7173671|FG001|Overall Study|Withdrawal by Subject|9
4396619|NCT00107978|7173670|FG000|Overall Study|Protocol Violation|0
4396620|NCT00107978|7173671|FG001|Overall Study|Protocol Violation|1
4396621|NCT00107978|7173670|FG000|Overall Study|Other|5
4396622|NCT00107978|7173671|FG001|Overall Study|Other|4
4396623|NCT00107991|7173677|FG000|Eligibility Assessment|Disease not severe enough|7
4396624|NCT00107991|7173677|FG000|Eligibility Assessment|Unwilling to participate|7
4396625|NCT00107991|7173677|FG000|Eligibility Assessment|Positive purified protein derivative|4
4396626|NCT00107991|7173677|FG000|Eligibility Assessment|Abnormal labs|2
4396627|NCT00107991|7173677|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1
4396628|NCT00107991|7173677|FG000|Eligibility Assessment|chronic uncontrolled asthma|1
4396629|NCT00107991|7173677|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1
4396630|NCT00107991|7173677|FG000|12 Week Treatment Period|Lack of Efficacy|2
4396631|NCT00107991|7173677|FG000|12 Week Treatment Period|Adverse Event|1
4396632|NCT00107991|7173677|FG000|12 Week Treatment Period|Protocol Violation|1
4396633|NCT00107991|7173677|FG000|12 Week Treatment Period|Incarcerated|1
4396634|NCT00107991|7173677|FG000|18-Week Post Treatment Assessment|Adverse Event|2
4396635|NCT00108069|7173683|FG000|Overall Study|Never rec'd study drug|0
4396636|NCT00108069|7173684|FG001|Overall Study|Never rec'd study drug|1
4396637|NCT00108069|7173683|FG000|Overall Study|Adverse Event|1
4396638|NCT00108069|7173684|FG001|Overall Study|Adverse Event|1
4396639|NCT00108069|7173683|FG000|Overall Study|Withdrawal by Subject|1
4396640|NCT00108069|7173684|FG001|Overall Study|Withdrawal by Subject|0
4396641|NCT00108069|7173683|FG000|Overall Study|Death|1
4396642|NCT00108069|7173684|FG001|Overall Study|Death|0
4396643|NCT00108069|7173683|FG000|Overall Study|Progessive disease|27
4396644|NCT00108069|7173684|FG001|Overall Study|Progessive disease|11
4396645|NCT00108082|7173699|FG000|Overall Study|Adverse Event|14
4396646|NCT00108082|7173700|FG001|Overall Study|Adverse Event|12
4396647|NCT00108082|7173701|FG002|Overall Study|Adverse Event|17
4396648|NCT00108082|7173699|FG000|Overall Study|Lost to Follow-up|6
4396649|NCT00108082|7173700|FG001|Overall Study|Lost to Follow-up|3
4396650|NCT00108082|7173701|FG002|Overall Study|Lost to Follow-up|7
4396651|NCT00108082|7173699|FG000|Overall Study|Consent Withdrawn|3
4396652|NCT00108082|7173700|FG001|Overall Study|Consent Withdrawn|3
4396653|NCT00108082|7173701|FG002|Overall Study|Consent Withdrawn|5
4396654|NCT00108082|7173699|FG000|Overall Study|Protocol Violation|1
4396655|NCT00108082|7173700|FG001|Overall Study|Protocol Violation|2
4396656|NCT00108082|7173701|FG002|Overall Study|Protocol Violation|0
4396657|NCT00108082|7173699|FG000|Overall Study|Lack of Efficacy|3
4396658|NCT00108082|7173700|FG001|Overall Study|Lack of Efficacy|1
4396659|NCT00108082|7173701|FG002|Overall Study|Lack of Efficacy|2
4396660|NCT00108082|7173699|FG000|Overall Study|Amendment 4: > Month 12|5
4396661|NCT00108082|7173700|FG001|Overall Study|Amendment 4: > Month 12|7
4396662|NCT00108082|7173701|FG002|Overall Study|Amendment 4: > Month 12|5
4396663|NCT00108082|7173699|FG000|Overall Study|Woman of Child-bearing Potential|2
4396664|NCT00108082|7173700|FG001|Overall Study|Woman of Child-bearing Potential|0
4396665|NCT00108082|7173701|FG002|Overall Study|Woman of Child-bearing Potential|2
4396666|NCT00108082|7173699|FG000|Overall Study|Incorrectly Randomized|0
4396667|NCT00108082|7173700|FG001|Overall Study|Incorrectly Randomized|0
4396668|NCT00108082|7173701|FG002|Overall Study|Incorrectly Randomized|2
4396669|NCT00108082|7173699|FG000|Overall Study|Non-compliance|1
4396670|NCT00108082|7173700|FG001|Overall Study|Non-compliance|0
4396671|NCT00108082|7173701|FG002|Overall Study|Non-compliance|2
4396672|NCT00108082|7173699|FG000|Overall Study|Stopped Study Medication|0
4396673|NCT00108082|7173700|FG001|Overall Study|Stopped Study Medication|0
4396674|NCT00108082|7173701|FG002|Overall Study|Stopped Study Medication|1
4396675|NCT00108082|7173699|FG000|Overall Study|Site Closed Study|0
4396676|NCT00108082|7173700|FG001|Overall Study|Site Closed Study|2
4396677|NCT00108082|7173701|FG002|Overall Study|Site Closed Study|0
4396678|NCT00108082|7173699|FG000|Overall Study|Protocol Amendment|0
4396679|NCT00108082|7173700|FG001|Overall Study|Protocol Amendment|1
4396680|NCT00108082|7173701|FG002|Overall Study|Protocol Amendment|0
4396681|NCT00108082|7173699|FG000|Overall Study|Study Medication Not Tapered|0
4396682|NCT00108082|7173700|FG001|Overall Study|Study Medication Not Tapered|1
4396683|NCT00108082|7173701|FG002|Overall Study|Study Medication Not Tapered|0
4396684|NCT00108082|7173699|FG000|Overall Study|Subject Left Site Location|1
4396685|NCT00108082|7173700|FG001|Overall Study|Subject Left Site Location|0
4396686|NCT00108082|7173701|FG002|Overall Study|Subject Left Site Location|0
4396687|NCT00108082|7173699|FG000|Overall Study|Investigator Not at Site|1
4396688|NCT00108082|7173700|FG001|Overall Study|Investigator Not at Site|0
4396689|NCT00108082|7173701|FG002|Overall Study|Investigator Not at Site|0
4396690|NCT00108082|7173699|FG000|Overall Study|Blood Pressure Not Controlled|1
4396691|NCT00108082|7173700|FG001|Overall Study|Blood Pressure Not Controlled|0
4396692|NCT00108082|7173701|FG002|Overall Study|Blood Pressure Not Controlled|0
4396693|NCT00108160|7173711|FG000|Overall Study|Lost to Follow-up|25
4396694|NCT00108160|7173712|FG001|Overall Study|Lost to Follow-up|12
4396695|NCT00108160|7173711|FG000|Overall Study|Death|1
4396696|NCT00108160|7173712|FG001|Overall Study|Death|2
4396697|NCT00108160|7173711|FG000|Overall Study|Withdrawal by Subject|4
4396698|NCT00108160|7173712|FG001|Overall Study|Withdrawal by Subject|2
4396699|NCT00108160|7173711|FG000|Overall Study|Protocol Violation|9
4396700|NCT00108160|7173712|FG001|Overall Study|Protocol Violation|5
4396701|NCT00108355|7173752|FG000|Overall Study|Peritonitis at index paracentesis|1
4396702|NCT00108355|7173753|FG001|Overall Study|Peritonitis at index paracentesis|1
4712235|NCT02923115|7638685|FG004|Overall Study|Withdrawal by Subject|0
4712236|NCT02923115|7638686|FG005|Overall Study|Withdrawal by Subject|0
4396703|NCT00108355|7173752|FG000|Overall Study|Loculated ascites, limiting paracentesis|1
4396704|NCT00108355|7173753|FG001|Overall Study|Loculated ascites, limiting paracentesis|1
4396705|NCT00108485|7173761|FG000|Overall Study|Withdrawal by Subject|3
4712237|NCT02923115|7638681|FG000|Overall Study|Randomized, but not dosed|0
4396706|NCT00108485|7173762|FG001|Overall Study|Withdrawal by Subject|0
4396707|NCT00108485|7173761|FG000|Overall Study|Lost to Follow-up|0
4396708|NCT00108485|7173762|FG001|Overall Study|Lost to Follow-up|2
4396709|NCT00108628|7173788|FG000|Overall Study|Withdrawal by Subject|17
4396710|NCT00108628|7173789|FG001|Overall Study|Withdrawal by Subject|9
4396711|NCT00108628|7173788|FG000|Overall Study|Lack of Efficacy|2
4396712|NCT00108628|7173789|FG001|Overall Study|Lack of Efficacy|1
4396713|NCT00108628|7173788|FG000|Overall Study|Death|1
4396714|NCT00108628|7173789|FG001|Overall Study|Death|0
4396715|NCT00108732|7173795|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1
4396716|NCT00108732|7173795|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2
4396717|NCT00108732|7173795|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10
4396718|NCT00108732|7173795|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1
4396719|NCT00108732|7173795|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3
4396720|NCT00108732|7173795|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1
4396721|NCT00108732|7173795|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1
4396722|NCT00108745|7173802|FG000|Overall Study|Withdrawal by Subject|19
4396723|NCT00108745|7173803|FG001|Overall Study|Withdrawal by Subject|12
4396724|NCT00108745|7173804|FG002|Overall Study|Withdrawal by Subject|12
4396725|NCT00108745|7173802|FG000|Overall Study|Never Treated|8
4396726|NCT00108745|7173803|FG001|Overall Study|Never Treated|10
4396727|NCT00108745|7173804|FG002|Overall Study|Never Treated|12
4396728|NCT00108745|7173802|FG000|Overall Study|Ineligible|7
4396729|NCT00108745|7173803|FG001|Overall Study|Ineligible|13
4396730|NCT00108745|7173804|FG002|Overall Study|Ineligible|13
4396731|NCT00108862|7173814|FG000|Overall Study|Death|31
4396732|NCT00108862|7173815|FG001|Overall Study|Death|37
4396733|NCT00108862|7173814|FG000|Overall Study|Withdrawal by Subject|10
4396734|NCT00108862|7173815|FG001|Overall Study|Withdrawal by Subject|6
4396735|NCT00108862|7173814|FG000|Overall Study|Lost to Follow-up|27
4396736|NCT00108862|7173815|FG001|Overall Study|Lost to Follow-up|19
4396737|NCT00108953|7173823|FG000|Follow-up|Death|18
4396738|NCT00108953|7173824|FG001|Follow-up|Death|26
4396739|NCT00108953|7173823|FG000|Follow-up|Lost to Follow-up|1
4396740|NCT00108953|7173824|FG001|Follow-up|Lost to Follow-up|1
4396741|NCT00108953|7173823|FG000|Follow-up|Study terminated by sponsor|10
4396742|NCT00108953|7173824|FG001|Follow-up|Study terminated by sponsor|6
4396743|NCT00109031|7173846|FG000|Overall Study|Adverse Event|0
4396744|NCT00109031|7173847|FG001|Overall Study|Adverse Event|0
4396745|NCT00109031|7173848|FG002|Overall Study|Adverse Event|1
4396746|NCT00109031|7173849|FG003|Overall Study|Adverse Event|0
4396747|NCT00109031|7173846|FG000|Overall Study|Withdrawal by Subject|0
4396748|NCT00109031|7173847|FG001|Overall Study|Withdrawal by Subject|1
4396749|NCT00109031|7173848|FG002|Overall Study|Withdrawal by Subject|0
4396750|NCT00109031|7173849|FG003|Overall Study|Withdrawal by Subject|0
4396751|NCT00109031|7173846|FG000|Overall Study|Physician Decision|0
4396752|NCT00109031|7173847|FG001|Overall Study|Physician Decision|1
4396753|NCT00109031|7173848|FG002|Overall Study|Physician Decision|0
4396754|NCT00109031|7173849|FG003|Overall Study|Physician Decision|0
4396755|NCT00109031|7173846|FG000|Overall Study|Protocol Violation|0
4396756|NCT00109031|7173847|FG001|Overall Study|Protocol Violation|0
4396757|NCT00109031|7173848|FG002|Overall Study|Protocol Violation|1
4396758|NCT00109031|7173849|FG003|Overall Study|Protocol Violation|0
4396759|NCT00109343|7173862|FG000|Overall Study|Adverse Event|1
4396760|NCT00109343|7173863|FG001|Overall Study|Adverse Event|0
4396761|NCT00109343|7173864|FG002|Overall Study|Adverse Event|2
4396762|NCT00109343|7173862|FG000|Overall Study|Lack of Efficacy|1
4396763|NCT00109343|7173863|FG001|Overall Study|Lack of Efficacy|0
4396764|NCT00109343|7173864|FG002|Overall Study|Lack of Efficacy|0
4396765|NCT00109343|7173862|FG000|Overall Study|Lost to Follow-up|35
4396766|NCT00109343|7173863|FG001|Overall Study|Lost to Follow-up|20
4396767|NCT00109343|7173864|FG002|Overall Study|Lost to Follow-up|14
4396768|NCT00109343|7173862|FG000|Overall Study|Protocol Violation|1
4396769|NCT00109343|7173863|FG001|Overall Study|Protocol Violation|2
4396770|NCT00109343|7173864|FG002|Overall Study|Protocol Violation|2
4396771|NCT00109343|7173862|FG000|Overall Study|Withdrawal by Subject|15
4396772|NCT00109343|7173863|FG001|Overall Study|Withdrawal by Subject|11
4396773|NCT00109343|7173864|FG002|Overall Study|Withdrawal by Subject|10
4396774|NCT00109343|7173862|FG000|Overall Study|Subject Moved|6
4396775|NCT00109343|7173863|FG001|Overall Study|Subject Moved|2
4396776|NCT00109343|7173864|FG002|Overall Study|Subject Moved|1
4396777|NCT00109343|7173862|FG000|Overall Study|Other|5
4396778|NCT00109343|7173863|FG001|Overall Study|Other|2
4396779|NCT00109343|7173864|FG002|Overall Study|Other|1
4396780|NCT00109577|7173886|FG000|Overall Study|Withdrawal by Subject|3
4396781|NCT00109577|7173887|FG001|Overall Study|Withdrawal by Subject|3
4396782|NCT00109590|7173896|FG000|Overall Study|Lost to Follow-up|1
4396783|NCT00109590|7173897|FG001|Overall Study|Lost to Follow-up|0
4396784|NCT00109590|7173898|FG002|Overall Study|Lost to Follow-up|1
4396785|NCT00109590|7173896|FG000|Overall Study|Never Started Treatment|1
4396786|NCT00109590|7173897|FG001|Overall Study|Never Started Treatment|2
4396787|NCT00109590|7173898|FG002|Overall Study|Never Started Treatment|3
4396788|NCT00109707|7173923|FG000|Overall Study|Discontinued in core study without entering the extension study|215
4396789|NCT00109707|7173924|FG001|Overall Study|Discontinued in core study without entering the extension study|122
4396790|NCT00109707|7173925|FG002|Overall Study|Discontinued in core study without entering the extension study|34
4396791|NCT00109707|7173923|FG000|Overall Study|Abnormal laboratory values|1
4396792|NCT00109707|7173924|FG001|Overall Study|Abnormal laboratory values|0
4396793|NCT00109707|7173925|FG002|Overall Study|Abnormal laboratory values|0
4396794|NCT00109707|7173923|FG000|Overall Study|Administrative problems|2
4396795|NCT00109707|7173924|FG001|Overall Study|Administrative problems|0
4396796|NCT00109707|7173925|FG002|Overall Study|Administrative problems|1
4396797|NCT00109707|7173923|FG000|Overall Study|Adverse Event|10
4396798|NCT00109707|7173924|FG001|Overall Study|Adverse Event|2
4396799|NCT00109707|7173925|FG002|Overall Study|Adverse Event|3
4396800|NCT00109707|7173923|FG000|Overall Study|Death|4
4396801|NCT00109707|7173924|FG001|Overall Study|Death|0
4396802|NCT00109707|7173925|FG002|Overall Study|Death|0
4396803|NCT00109707|7173923|FG000|Overall Study|Disease progression|12
4396804|NCT00109707|7173924|FG001|Overall Study|Disease progression|4
4396805|NCT00109707|7173925|FG002|Overall Study|Disease progression|3
4396806|NCT00109707|7173923|FG000|Overall Study|Lost to Follow-up|3
4396807|NCT00109707|7173924|FG001|Overall Study|Lost to Follow-up|0
4396808|NCT00109707|7173925|FG002|Overall Study|Lost to Follow-up|0
4396809|NCT00109707|7173923|FG000|Overall Study|Protocol Violation|1
4396810|NCT00109707|7173924|FG001|Overall Study|Protocol Violation|0
4396811|NCT00109707|7173925|FG002|Overall Study|Protocol Violation|0
4396812|NCT00109707|7173923|FG000|Overall Study|Patient withdrew consent|6
4396813|NCT00109707|7173924|FG001|Overall Study|Patient withdrew consent|1
4396814|NCT00109707|7173925|FG002|Overall Study|Patient withdrew consent|0
4396815|NCT00109733|7173939|FG000|Overall Study|Protocol Violation|0
4396816|NCT00109733|7173940|FG001|Overall Study|Protocol Violation|1
4396817|NCT00109733|7173939|FG000|Overall Study|Stopped taking study drug|1
4396818|NCT00109733|7173940|FG001|Overall Study|Stopped taking study drug|1
4396819|NCT00109733|7173939|FG000|Overall Study|Non-compliant|0
4396820|NCT00109733|7173940|FG001|Overall Study|Non-compliant|1
4396821|NCT00109733|7173939|FG000|Overall Study|Could not commit time for study|1
4396822|NCT00109733|7173940|FG001|Overall Study|Could not commit time for study|1
4396823|NCT00109772|7173948|FG000|Double-blind Treatment|Adverse Event|14
4396824|NCT00109772|7173949|FG001|Double-blind Treatment|Adverse Event|5
4712238|NCT02923115|7638682|FG001|Overall Study|Randomized, but not dosed|0
4712239|NCT02923115|7638683|FG002|Overall Study|Randomized, but not dosed|3
4712240|NCT02923115|7638684|FG003|Overall Study|Randomized, but not dosed|1
4712241|NCT02923115|7638685|FG004|Overall Study|Randomized, but not dosed|5
4712242|NCT02923115|7638686|FG005|Overall Study|Randomized, but not dosed|0
4712243|NCT02923180|7638705|FG000|Overall Study|Off Study Due to Detectable PSA|13
4712244|NCT02923180|7638705|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13
4712245|NCT02923245|7638711|FG000|Overall Study|ultrasound order was cancelled|2
4712246|NCT02923245|7638712|FG001|Overall Study|ultrasound order was cancelled|1
4712247|NCT02923349|7638735|FG000|Overall Study|Other|1
4712248|NCT02923349|7638736|FG001|Overall Study|Other|2
4712249|NCT02923349|7638737|FG002|Overall Study|Other|4
4712250|NCT02923349|7638738|FG003|Overall Study|Other|1
4712251|NCT02923349|7638739|FG004|Overall Study|Other|3
4712252|NCT02923349|7638740|FG005|Overall Study|Other|0
4712253|NCT02923349|7638741|FG006|Overall Study|Other|1
4712254|NCT02923349|7638735|FG000|Overall Study|Withdrawal by Subject|2
4712255|NCT02923349|7638736|FG001|Overall Study|Withdrawal by Subject|2
4712256|NCT02923349|7638737|FG002|Overall Study|Withdrawal by Subject|8
4712257|NCT02923349|7638738|FG003|Overall Study|Withdrawal by Subject|10
4712258|NCT02923349|7638739|FG004|Overall Study|Withdrawal by Subject|12
4712259|NCT02923349|7638740|FG005|Overall Study|Withdrawal by Subject|3
4712260|NCT02923349|7638741|FG006|Overall Study|Withdrawal by Subject|0
4712261|NCT02923349|7638735|FG000|Overall Study|Physician Decision|0
4712262|NCT02923349|7638736|FG001|Overall Study|Physician Decision|0
4712263|NCT02923349|7638737|FG002|Overall Study|Physician Decision|0
4712264|NCT02923349|7638738|FG003|Overall Study|Physician Decision|1
4712265|NCT02923349|7638739|FG004|Overall Study|Physician Decision|1
4712266|NCT02923349|7638740|FG005|Overall Study|Physician Decision|0
4712267|NCT02923349|7638741|FG006|Overall Study|Physician Decision|2
4712268|NCT02923349|7638735|FG000|Overall Study|Lost to Follow-up|0
4712269|NCT02923349|7638736|FG001|Overall Study|Lost to Follow-up|0
4712270|NCT02923349|7638737|FG002|Overall Study|Lost to Follow-up|3
4396825|NCT00109772|7173948|FG000|Double-blind Treatment|Lack of Efficacy|1
4396826|NCT00109772|7173949|FG001|Double-blind Treatment|Lack of Efficacy|0
4396827|NCT00109772|7173948|FG000|Double-blind Treatment|Withdrawal by Subject|2
4396828|NCT00109772|7173949|FG001|Double-blind Treatment|Withdrawal by Subject|1
4396829|NCT00109772|7173948|FG000|Double-blind Treatment|Lost to Follow-up|2
4396830|NCT00109772|7173949|FG001|Double-blind Treatment|Lost to Follow-up|3
4396831|NCT00109772|7173948|FG000|Double-blind Treatment|Protocol Violation|0
4712271|NCT02923349|7638738|FG003|Overall Study|Lost to Follow-up|0
4712272|NCT02923349|7638739|FG004|Overall Study|Lost to Follow-up|1
4712273|NCT02923349|7638740|FG005|Overall Study|Lost to Follow-up|1
4712274|NCT02923349|7638741|FG006|Overall Study|Lost to Follow-up|0
4712275|NCT02923349|7638735|FG000|Overall Study|Death|1
4396832|NCT00109772|7173949|FG001|Double-blind Treatment|Protocol Violation|1
4396833|NCT00109772|7173948|FG000|Double-blind Treatment|Other|0
4396834|NCT00109772|7173949|FG001|Double-blind Treatment|Other|4
4396835|NCT00109772|7173948|FG000|Double-blind Treatment|Withdrew prior to treatment|3
4712276|NCT02923349|7638736|FG001|Overall Study|Death|0
4712277|NCT02923349|7638737|FG002|Overall Study|Death|2
4396836|NCT00109772|7173949|FG001|Double-blind Treatment|Withdrew prior to treatment|1
4396837|NCT00109772|7173948|FG000|Open-label Extension|Adverse Event|10
4396838|NCT00109772|7173949|FG001|Open-label Extension|Adverse Event|19
4396839|NCT00109772|7173948|FG000|Open-label Extension|Lack of Efficacy|19
4396840|NCT00109772|7173949|FG001|Open-label Extension|Lack of Efficacy|11
4396841|NCT00109772|7173948|FG000|Open-label Extension|Withdrawal by Subject|9
4396842|NCT00109772|7173949|FG001|Open-label Extension|Withdrawal by Subject|6
4396843|NCT00109772|7173948|FG000|Open-label Extension|Lost to Follow-up|1
4396844|NCT00109772|7173949|FG001|Open-label Extension|Lost to Follow-up|0
4396845|NCT00109772|7173948|FG000|Open-label Extension|Death|0
4396846|NCT00109772|7173949|FG001|Open-label Extension|Death|1
4396847|NCT00109772|7173948|FG000|Open-label Extension|Protocol Violation|2
4396848|NCT00109772|7173949|FG001|Open-label Extension|Protocol Violation|2
4396849|NCT00109772|7173948|FG000|Open-label Extension|Other|4
4396850|NCT00109772|7173949|FG001|Open-label Extension|Other|10
4396851|NCT00109837|7173955|FG000|Overall Study|Adverse Event|2
4396852|NCT00109837|7173955|FG000|Overall Study|Refusal unrelated to adverse effects|1
4396853|NCT00109837|7173955|FG000|Overall Study|Death|1
4396854|NCT00109837|7173955|FG000|Overall Study|BCR/ABL+ or Ph+|17
4396855|NCT00109837|7173955|FG000|Overall Study|Not treated|1
4396856|NCT00109837|7173955|FG000|Overall Study|Ineligible|1
4396857|NCT00109850|7173963|FG000|Overall Study|Adverse Event|1
4396858|NCT00109850|7173963|FG000|Overall Study|Death|2
4396859|NCT00109850|7173963|FG000|Overall Study|Ineligible|1
4396860|NCT00109928|7173971|FG000|Overall Study|Adverse Event|2
4396861|NCT00109928|7173971|FG000|Overall Study|Progression|6
4396862|NCT00109928|7173971|FG000|Overall Study|Death|2
4396863|NCT00109928|7173971|FG000|Overall Study|not protocol specified|2
4396864|NCT00109928|7173971|FG000|Overall Study|not eligible|1
4396865|NCT00109967|7173978|FG000|Overall Study|Cancel Prior to Treatment|2
4628531|NCT01862328|7495914|FG003|Overall Study|Withdrawal by Subject|0
4628532|NCT01862328|7495915|FG004|Overall Study|Withdrawal by Subject|1
4628533|NCT01862328|7495916|FG005|Overall Study|Withdrawal by Subject|1
4628534|NCT01862328|7495917|FG006|Overall Study|Withdrawal by Subject|1
4628535|NCT01862328|7495911|FG000|Overall Study|Symptomatic Deterioration|0
4628536|NCT01862328|7495912|FG001|Overall Study|Symptomatic Deterioration|0
4396866|NCT00109967|7173979|FG001|Overall Study|Cancel Prior to Treatment|0
4396867|NCT00109967|7173978|FG000|Overall Study|Adverse Event|12
4396868|NCT00109967|7173979|FG001|Overall Study|Adverse Event|1
4396869|NCT00109967|7173978|FG000|Overall Study|Withdrawal by Subject|5
4396870|NCT00109967|7173979|FG001|Overall Study|Withdrawal by Subject|0
4396871|NCT00109967|7173978|FG000|Overall Study|Physician Decision|1
4396872|NCT00109967|7173979|FG001|Overall Study|Physician Decision|3
4396873|NCT00109967|7173978|FG000|Overall Study|Death|0
4396874|NCT00109967|7173979|FG001|Overall Study|Death|2
4396875|NCT00110019|7173987|FG000|Overall Study|Lack of Efficacy|253
4396876|NCT00110019|7173988|FG001|Overall Study|Lack of Efficacy|285
4396877|NCT00110019|7173987|FG000|Overall Study|Adverse Event|61
4396878|NCT00110019|7173988|FG001|Overall Study|Adverse Event|40
4396879|NCT00110019|7173987|FG000|Overall Study|Death|13
4396880|NCT00110019|7173988|FG001|Overall Study|Death|15
4396881|NCT00110019|7173987|FG000|Overall Study|Withdrawal by Subject|21
4396882|NCT00110019|7173988|FG001|Overall Study|Withdrawal by Subject|9
4396883|NCT00110019|7173987|FG000|Overall Study|alternative therapy|5
4396884|NCT00110019|7173988|FG001|Overall Study|alternative therapy|1
4396885|NCT00110019|7173987|FG000|Overall Study|complicating disease|1
4396886|NCT00110019|7173988|FG001|Overall Study|complicating disease|1
4396887|NCT00110019|7173987|FG000|Overall Study|symptom deterioration|13
4396888|NCT00110019|7173988|FG001|Overall Study|symptom deterioration|16
4396889|NCT00110019|7173987|FG000|Overall Study|Not start protocol therapy|17
4396890|NCT00110019|7173988|FG001|Overall Study|Not start protocol therapy|16
4396891|NCT00110019|7173987|FG000|Overall Study|other reasons|22
4396892|NCT00110019|7173988|FG001|Overall Study|other reasons|30
4396893|NCT00110084|7173994|FG000|Overall Study|Adverse Event|9
4396894|NCT00110084|7173994|FG000|Overall Study|Death|1
4396895|NCT00110084|7173994|FG000|Overall Study|Patient Refusal|10
4396896|NCT00110084|7173994|FG000|Overall Study|Alternate Therapy|5
4396897|NCT00110084|7173994|FG000|Overall Study|Intercurrent Illness|1
4396898|NCT00110084|7173994|FG000|Overall Study|Other|2
4396899|NCT00110149|7174003|FG000|Overall Study|Physician Decision|3
4396900|NCT00110214|7174010|FG000|Overall Study|Never started treatment|21
4396901|NCT00110214|7174011|FG001|Overall Study|Never started treatment|20
4396902|NCT00110214|7174010|FG000|Overall Study|Disease progression or death|260
4396903|NCT00110214|7174011|FG001|Overall Study|Disease progression or death|151
4396904|NCT00110214|7174010|FG000|Overall Study|Adverse Event|115
4396905|NCT00110214|7174011|FG001|Overall Study|Adverse Event|192
4396906|NCT00110214|7174010|FG000|Overall Study|Refused further treatment|52
4628537|NCT01862328|7495913|FG002|Overall Study|Symptomatic Deterioration|0
4396907|NCT00110214|7174011|FG001|Overall Study|Refused further treatment|65
4396908|NCT00110214|7174010|FG000|Overall Study|Other (not specified)|61
4396909|NCT00110214|7174011|FG001|Overall Study|Other (not specified)|75
4396910|NCT00110266|7174017|FG000|Overall Study|Adverse Event|27
4396911|NCT00110266|7174017|FG000|Overall Study|Abnormal laboratory value|15
4396912|NCT00110266|7174017|FG000|Overall Study|Withdrawal by Subject|16
4396913|NCT00110266|7174017|FG000|Overall Study|Death|17
4396914|NCT00110266|7174017|FG000|Overall Study|Unsatisfactory therapeutic effect|2
4396915|NCT00110266|7174017|FG000|Overall Study|Participant condition no longer requires study drug|1
4396916|NCT00110305|7174026|FG000|Overall Study|Adverse Event|46
4396917|NCT00110305|7174027|FG001|Overall Study|Adverse Event|13
4712278|NCT02923349|7638738|FG003|Overall Study|Death|4
4712279|NCT02923349|7638739|FG004|Overall Study|Death|2
4712280|NCT02923349|7638740|FG005|Overall Study|Death|3
4712281|NCT02923349|7638741|FG006|Overall Study|Death|0
4712282|NCT02923427|7638759|FG000|Overall Study|convert to laparatomy|2
4712283|NCT02923427|7638760|FG001|Overall Study|convert to laparatomy|2
4712284|NCT02923427|7638759|FG000|Overall Study|destaturation|1
4712285|NCT02923427|7638760|FG001|Overall Study|destaturation|0
4712286|NCT02923427|7638759|FG000|Overall Study|can not replace LMA|1
4396918|NCT00110305|7174026|FG000|Overall Study|Sponsors Decision|1
4396919|NCT00110305|7174027|FG001|Overall Study|Sponsors Decision|0
4396920|NCT00110305|7174026|FG000|Overall Study|Subject Non-Compliant|9
4396921|NCT00110305|7174027|FG001|Overall Study|Subject Non-Compliant|2
4396922|NCT00110305|7174026|FG000|Overall Study|Subject Ineligible To Continue The Trial|2
4396923|NCT00110305|7174027|FG001|Overall Study|Subject Ineligible To Continue The Trial|1
4396924|NCT00110305|7174026|FG000|Overall Study|Subject Reached A Virologic Endpoint|21
4396925|NCT00110305|7174027|FG001|Overall Study|Subject Reached A Virologic Endpoint|3
4396926|NCT00110305|7174026|FG000|Overall Study|Protocol Violation|0
4396927|NCT00110305|7174027|FG001|Overall Study|Protocol Violation|1
4396928|NCT00110305|7174026|FG000|Overall Study|Withdrawal by Subject|7
4396929|NCT00110305|7174027|FG001|Overall Study|Withdrawal by Subject|7
4396930|NCT00110305|7174026|FG000|Overall Study|Lost to Follow-up|20
4396931|NCT00110305|7174027|FG001|Overall Study|Lost to Follow-up|3
4396932|NCT00110305|7174026|FG000|Overall Study|Other|8
4396933|NCT00110305|7174027|FG001|Overall Study|Other|2
4396934|NCT00110357|7174046|FG000|Overall Study|Deterioration without progression|2
4396935|NCT00110357|7174047|FG001|Overall Study|Deterioration without progression|0
4396936|NCT00110357|7174046|FG000|Overall Study|Disease progression/relapse|20
4396937|NCT00110357|7174047|FG001|Overall Study|Disease progression/relapse|15
4396938|NCT00110357|7174046|FG000|Overall Study|Study Closure|1
4396939|NCT00110357|7174047|FG001|Overall Study|Study Closure|0
4396940|NCT00110357|7174046|FG000|Overall Study|Study Drug Toxicity|1
4396941|NCT00110357|7174047|FG001|Overall Study|Study Drug Toxicity|3
4396942|NCT00110357|7174046|FG000|Overall Study|Withdrawal by Subject|3
4396943|NCT00110357|7174047|FG001|Overall Study|Withdrawal by Subject|1
4396944|NCT00110396|7174080|FG000|Overall Study|Adverse Event|15
4396945|NCT00110396|7174080|FG000|Overall Study|Lost to Follow-up|1
4396946|NCT00110396|7174080|FG000|Overall Study|Administration of plasmapheresis|1
4396947|NCT00110396|7174080|FG000|Overall Study|Initiated mitoxantrone therapy|1
4396948|NCT00110396|7174080|FG000|Overall Study|Lack of Efficacy|1
4396949|NCT00110396|7174080|FG000|Overall Study|Decided not to continue treatment|1
4396950|NCT00110396|7174080|FG000|Overall Study|Patient non-compliance|1
4396951|NCT00110396|7174080|FG000|Overall Study|Patient refused to continue|1
4396952|NCT00110396|7174080|FG000|Overall Study|Patient refused to participate|1
4396953|NCT00110396|7174080|FG000|Overall Study|Patient will|1
4396954|NCT00110396|7174080|FG000|Overall Study|Patient's decision|1
4396955|NCT00110396|7174080|FG000|Overall Study|Participation in MS vaccine study|1
4396956|NCT00110396|7174080|FG000|Overall Study|Pregnancy|1
4396957|NCT00110396|7174080|FG000|Overall Study|Pregnancy (Protocol violation)|2
4396958|NCT00110396|7174080|FG000|Overall Study|Protocol Violation|2
4396959|NCT00110396|7174080|FG000|Overall Study|Patient refused to come back|1
4396960|NCT00110396|7174080|FG000|Overall Study|The patient has refused|2
4396961|NCT00110396|7174080|FG000|Overall Study|The patient has refused to visit site|1
4396962|NCT00110396|7174080|FG000|Overall Study|Patient is to be administered copaxone|1
4396963|NCT00110617|7174103|FG000|Overall Study|Adverse Event|2
4396964|NCT00110617|7174104|FG001|Overall Study|Adverse Event|4
4396965|NCT00110617|7174103|FG000|Overall Study|Abnormal Laboratory Value|4
4396966|NCT00110617|7174104|FG001|Overall Study|Abnormal Laboratory Value|2
4396967|NCT00110617|7174103|FG000|Overall Study|Lack of Efficacy|1
4396968|NCT00110617|7174104|FG001|Overall Study|Lack of Efficacy|0
4396969|NCT00110617|7174103|FG000|Overall Study|Patient no longer requires study drug|1
4396970|NCT00110617|7174104|FG001|Overall Study|Patient no longer requires study drug|0
4396971|NCT00110617|7174103|FG000|Overall Study|Protocol Violation|5
4396972|NCT00110617|7174104|FG001|Overall Study|Protocol Violation|0
4396973|NCT00110617|7174103|FG000|Overall Study|Withdrawal by Subject|10
4396974|NCT00110617|7174104|FG001|Overall Study|Withdrawal by Subject|4
4396975|NCT00110617|7174103|FG000|Overall Study|Lost to Follow-up|9
4396976|NCT00110617|7174104|FG001|Overall Study|Lost to Follow-up|1
4396977|NCT00110617|7174103|FG000|Overall Study|Administrative problems|6
4396978|NCT00110617|7174104|FG001|Overall Study|Administrative problems|5
4396979|NCT00110617|7174103|FG000|Overall Study|Death|1
4396980|NCT00110617|7174104|FG001|Overall Study|Death|1
4396981|NCT00110617|7174103|FG000|Overall Study|Did not receive study drug|0
4396982|NCT00110617|7174104|FG001|Overall Study|Did not receive study drug|12
4396983|NCT00110812|7174115|FG000|Main Study|Death|0
4396984|NCT00110812|7174116|FG001|Main Study|Death|0
4396985|NCT00110812|7174117|FG002|Main Study|Death|2
4396986|NCT00110812|7174115|FG000|Main Study|Withdrawal by Subject|0
4712287|NCT02923427|7638760|FG001|Overall Study|can not replace LMA|0
4712288|NCT02923921|7638777|FG000|Overall Study|Sponsor Decision|39
4396987|NCT00110812|7174116|FG001|Main Study|Withdrawal by Subject|0
4396988|NCT00110812|7174117|FG002|Main Study|Withdrawal by Subject|1
4396989|NCT00110812|7174115|FG000|Main Study|Lost to Follow-up|8
4396990|NCT00110812|7174116|FG001|Main Study|Lost to Follow-up|11
4628538|NCT01862328|7495914|FG003|Overall Study|Symptomatic Deterioration|0
4628539|NCT01862328|7495915|FG004|Overall Study|Symptomatic Deterioration|0
4712289|NCT02923921|7638778|FG001|Overall Study|Sponsor Decision|38
4712290|NCT02923921|7638777|FG000|Overall Study|Lost to Follow-up|1
4712291|NCT02923921|7638778|FG001|Overall Study|Lost to Follow-up|0
4712292|NCT02923921|7638777|FG000|Overall Study|Withdrawal by Subject|6
4712293|NCT02923921|7638778|FG001|Overall Study|Withdrawal by Subject|13
4712294|NCT02923921|7638777|FG000|Overall Study|Unknown, Not Collected|7
4712295|NCT02923921|7638778|FG001|Overall Study|Unknown, Not Collected|6
4712296|NCT02924051|7638786|FG000|Overall Study|Withdrawal by Subject|1
4712297|NCT02924051|7638787|FG001|Overall Study|Withdrawal by Subject|9
4712298|NCT02924428|7638806|FG000|Overall Study|Adverse Event|1
4712299|NCT02924428|7638807|FG001|Overall Study|Adverse Event|0
4712300|NCT02924428|7638806|FG000|Overall Study|Physician Decision|1
4712301|NCT02924428|7638807|FG001|Overall Study|Physician Decision|0
4712302|NCT02924428|7638806|FG000|Overall Study|Lost to Follow-up|2
4712303|NCT02924428|7638807|FG001|Overall Study|Lost to Follow-up|4
4396991|NCT00110812|7174117|FG002|Main Study|Lost to Follow-up|10
4396992|NCT00110812|7174115|FG000|Extended Follow-up|Death|1
4396993|NCT00110812|7174116|FG001|Extended Follow-up|Death|0
4396994|NCT00110812|7174117|FG002|Extended Follow-up|Death|3
4396995|NCT00110812|7174115|FG000|Extended Follow-up|Withdrawal by Subject|0
4396996|NCT00110812|7174116|FG001|Extended Follow-up|Withdrawal by Subject|1
4396997|NCT00110812|7174117|FG002|Extended Follow-up|Withdrawal by Subject|0
4396998|NCT00110812|7174115|FG000|Extended Follow-up|Lost to Follow-up|1
4396999|NCT00110812|7174116|FG001|Extended Follow-up|Lost to Follow-up|3
4628540|NCT01862328|7495916|FG005|Overall Study|Symptomatic Deterioration|0
4628541|NCT01862328|7495917|FG006|Overall Study|Symptomatic Deterioration|1
4712304|NCT02924428|7638806|FG000|Overall Study|Pregnancy|0
4712305|NCT02924428|7638807|FG001|Overall Study|Pregnancy|1
4712306|NCT02924688|7638819|FG000|Overall Study|Adverse Event|9
4712307|NCT02924688|7638820|FG001|Overall Study|Adverse Event|3
4712308|NCT02924688|7638821|FG002|Overall Study|Adverse Event|2
4712309|NCT02924688|7638822|FG003|Overall Study|Adverse Event|2
4712310|NCT02924688|7638823|FG004|Overall Study|Adverse Event|3
4712311|NCT02924688|7638824|FG005|Overall Study|Adverse Event|2
4712312|NCT02924688|7638819|FG000|Overall Study|Lack of Efficacy|2
4712313|NCT02924688|7638820|FG001|Overall Study|Lack of Efficacy|3
4712314|NCT02924688|7638821|FG002|Overall Study|Lack of Efficacy|4
4712315|NCT02924688|7638822|FG003|Overall Study|Lack of Efficacy|2
4712316|NCT02924688|7638823|FG004|Overall Study|Lack of Efficacy|1
4712317|NCT02924688|7638824|FG005|Overall Study|Lack of Efficacy|1
4712318|NCT02924688|7638819|FG000|Overall Study|Protocol Violation|3
4712319|NCT02924688|7638820|FG001|Overall Study|Protocol Violation|7
4712320|NCT02924688|7638821|FG002|Overall Study|Protocol Violation|5
4712321|NCT02924688|7638822|FG003|Overall Study|Protocol Violation|6
4712322|NCT02924688|7638823|FG004|Overall Study|Protocol Violation|2
4712323|NCT02924688|7638824|FG005|Overall Study|Protocol Violation|2
4712324|NCT02924688|7638819|FG000|Overall Study|Protocol defined withdrawal criteria met|1
4712325|NCT02924688|7638820|FG001|Overall Study|Protocol defined withdrawal criteria met|0
4712326|NCT02924688|7638821|FG002|Overall Study|Protocol defined withdrawal criteria met|1
4712327|NCT02924688|7638822|FG003|Overall Study|Protocol defined withdrawal criteria met|1
4712328|NCT02924688|7638823|FG004|Overall Study|Protocol defined withdrawal criteria met|1
4712329|NCT02924688|7638824|FG005|Overall Study|Protocol defined withdrawal criteria met|0
4712330|NCT02924688|7638819|FG000|Overall Study|Lost to Follow-up|2
4712331|NCT02924688|7638820|FG001|Overall Study|Lost to Follow-up|4
4712332|NCT02924688|7638821|FG002|Overall Study|Lost to Follow-up|2
4712333|NCT02924688|7638822|FG003|Overall Study|Lost to Follow-up|4
4712334|NCT02924688|7638823|FG004|Overall Study|Lost to Follow-up|2
4712335|NCT02924688|7638824|FG005|Overall Study|Lost to Follow-up|4
4712336|NCT02924688|7638819|FG000|Overall Study|Physician Decision|2
4712337|NCT02924688|7638820|FG001|Overall Study|Physician Decision|1
4712338|NCT02924688|7638821|FG002|Overall Study|Physician Decision|0
4712339|NCT02924688|7638822|FG003|Overall Study|Physician Decision|1
4712340|NCT02924688|7638823|FG004|Overall Study|Physician Decision|1
4712341|NCT02924688|7638824|FG005|Overall Study|Physician Decision|1
4712342|NCT02924688|7638819|FG000|Overall Study|Withdrawal by Subject|14
4712343|NCT02924688|7638820|FG001|Overall Study|Withdrawal by Subject|13
4712344|NCT02924688|7638821|FG002|Overall Study|Withdrawal by Subject|9
4712345|NCT02924688|7638822|FG003|Overall Study|Withdrawal by Subject|12
4712346|NCT02924688|7638823|FG004|Overall Study|Withdrawal by Subject|13
4712347|NCT02924688|7638824|FG005|Overall Study|Withdrawal by Subject|14
4736061|NCT03555266|7684792|FG000|Overall Study|Protocol Violation|6
4736062|NCT03555266|7684793|FG001|Overall Study|Protocol Violation|4
4736063|NCT03555305|7684799|FG000|Period 1|Physician Decision|0
4397000|NCT00110812|7174117|FG002|Extended Follow-up|Lost to Follow-up|1
4397001|NCT00110890|7174132|FG000|Overall Study|Adverse Event|30
4397002|NCT00110890|7174133|FG001|Overall Study|Adverse Event|7
4397003|NCT00110890|7174132|FG000|Overall Study|Death|16
4736064|NCT03555305|7684800|FG001|Period 1|Physician Decision|1
4736065|NCT03555305|7684799|FG000|Period 1|Adverse Event|0
4397004|NCT00110890|7174133|FG001|Overall Study|Death|9
4397005|NCT00110890|7174132|FG000|Overall Study|Lost to Follow-up|3
4397006|NCT00110890|7174133|FG001|Overall Study|Lost to Follow-up|1
4397007|NCT00110890|7174132|FG000|Overall Study|Physician Decision|4
4397008|NCT00110890|7174133|FG001|Overall Study|Physician Decision|5
4397009|NCT00110890|7174132|FG000|Overall Study|Withdrawal by Subject|17
4397010|NCT00110890|7174133|FG001|Overall Study|Withdrawal by Subject|5
4397011|NCT00110890|7174132|FG000|Overall Study|Protocol Deviation|1
4397012|NCT00110890|7174133|FG001|Overall Study|Protocol Deviation|0
4397013|NCT00110890|7174132|FG000|Overall Study|Noncompliance|10
4397014|NCT00110890|7174133|FG001|Overall Study|Noncompliance|0
4397015|NCT00110890|7174132|FG000|Overall Study|Kidney Transplant|16
4397016|NCT00110890|7174133|FG001|Overall Study|Kidney Transplant|12
4397017|NCT00110890|7174132|FG000|Overall Study|Invest. Product Commercially Available|217
4397018|NCT00110890|7174133|FG001|Overall Study|Invest. Product Commercially Available|110
4397019|NCT00110890|7174132|FG000|Overall Study|Other|34
4397020|NCT00110890|7174133|FG001|Overall Study|Other|23
4397021|NCT00110890|7174132|FG000|Overall Study|Ineligibility determined|3
4397022|NCT00110890|7174133|FG001|Overall Study|Ineligibility determined|0
4628542|NCT01862484|7495950|FG000|Overall Study|Lack of Efficacy|1
4712348|NCT02924883|7638843|FG000|Overall Study|Death|39
4397023|NCT00110890|7174132|FG000|Overall Study|Requirement for alternative therapy|0
4397024|NCT00110890|7174133|FG001|Overall Study|Requirement for alternative therapy|1
4397025|NCT00110890|7174132|FG000|Overall Study|Disease progression|0
4397026|NCT00110890|7174133|FG001|Overall Study|Disease progression|1
4397027|NCT00110890|7174132|FG000|Overall Study|Parathyroidectomy|0
4397028|NCT00110890|7174133|FG001|Overall Study|Parathyroidectomy|1
4397029|NCT00110890|7174132|FG000|Overall Study|Did not enter follow-up phase|10
4397030|NCT00110890|7174133|FG001|Overall Study|Did not enter follow-up phase|4
4397031|NCT00110994|7174141|FG000|Double-blind (DB) Treatment|Adverse Event|3
4397032|NCT00110994|7174142|FG001|Double-blind (DB) Treatment|Adverse Event|0
4397033|NCT00110994|7174141|FG000|Double-blind (DB) Treatment|Death|1
4397034|NCT00110994|7174142|FG001|Double-blind (DB) Treatment|Death|0
4397035|NCT00110994|7174141|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0
4397036|NCT00110994|7174142|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2
4397037|NCT00110994|7174141|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2
4397038|NCT00110994|7174142|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1
4397039|NCT00110994|7174141|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34
4397040|NCT00110994|7174142|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41
4397041|NCT00110994|7174141|FG000|Double-blind (DB) Treatment|other reasons|2
4397042|NCT00110994|7174142|FG001|Double-blind (DB) Treatment|other reasons|3
4397043|NCT00110994|7174141|FG000|Active Follow-up|Disease progression/recurrence/replace|1
4397044|NCT00110994|7174142|FG001|Active Follow-up|Disease progression/recurrence/replace|0
4397045|NCT00110994|7174141|FG000|Active Follow-up|Other reasons|0
4397046|NCT00110994|7174142|FG001|Active Follow-up|Other reasons|2
4397047|NCT00110994|7174141|FG000|Long Term Follow-up|Death|19
4397048|NCT00110994|7174142|FG001|Long Term Follow-up|Death|17
4397049|NCT00111007|7174150|FG000|Double-blind (DB) Treatment|Adverse Event|12
4397050|NCT00111007|7174151|FG001|Double-blind (DB) Treatment|Adverse Event|4
4397051|NCT00111007|7174150|FG000|Double-blind (DB) Treatment|Death|5
4397052|NCT00111007|7174151|FG001|Double-blind (DB) Treatment|Death|2
4397053|NCT00111007|7174150|FG000|Double-blind (DB) Treatment|Protocol Violation|0
4397054|NCT00111007|7174151|FG001|Double-blind (DB) Treatment|Protocol Violation|1
4712349|NCT02924883|7638844|FG001|Overall Study|Death|20
4712350|NCT02924883|7638843|FG000|Overall Study|Lost to Follow-up|1
4712351|NCT02924883|7638844|FG001|Overall Study|Lost to Follow-up|0
4712352|NCT02924883|7638843|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0
4712353|NCT02924883|7638844|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1
4712354|NCT02924883|7638843|FG000|Overall Study|Protocol Violation|1
4712355|NCT02924883|7638844|FG001|Overall Study|Protocol Violation|0
4712356|NCT02924883|7638843|FG000|Overall Study|Withdrawal by Subject|22
4712357|NCT02924883|7638844|FG001|Overall Study|Withdrawal by Subject|16
4397055|NCT00111007|7174150|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6
4397056|NCT00111007|7174151|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8
4397057|NCT00111007|7174150|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1
4397058|NCT00111007|7174151|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0
4397059|NCT00111007|7174150|FG000|Double-blind (DB) Treatment|Relapse|1
4397060|NCT00111007|7174151|FG001|Double-blind (DB) Treatment|Relapse|0
4397061|NCT00111007|7174150|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0
4397062|NCT00111007|7174151|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2
4397063|NCT00111007|7174150|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83
4397064|NCT00111007|7174151|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93
4397065|NCT00111007|7174150|FG000|Double-blind (DB) Treatment|Primary reason with other category|0
4397066|NCT00111007|7174151|FG001|Double-blind (DB) Treatment|Primary reason with other category|1
4397067|NCT00111007|7174150|FG000|Active Follow-up|Adverse Event|1
4397068|NCT00111007|7174151|FG001|Active Follow-up|Adverse Event|0
4397069|NCT00111007|7174150|FG000|Active Follow-up|Death|2
4397070|NCT00111007|7174151|FG001|Active Follow-up|Death|0
4397071|NCT00111007|7174150|FG000|Active Follow-up|Disease progression/recurrence/relapse|3
4397072|NCT00111007|7174151|FG001|Active Follow-up|Disease progression/recurrence/relapse|2
4397073|NCT00111007|7174150|FG000|Long Term Follow-up|Death|34
4397074|NCT00111007|7174151|FG001|Long Term Follow-up|Death|39
4397075|NCT00111007|7174150|FG000|Long Term Follow-up|Lost to Follow-up|1
4397076|NCT00111007|7174151|FG001|Long Term Follow-up|Lost to Follow-up|1
4397077|NCT00111007|7174150|FG000|Long Term Follow-up|Withdrawal by Subject|0
4397078|NCT00111007|7174151|FG001|Long Term Follow-up|Withdrawal by Subject|1
4397079|NCT00111007|7174150|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2
4397080|NCT00111007|7174151|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1
4397081|NCT00111007|7174150|FG000|Long Term Follow-up|Missing|10
4397082|NCT00111007|7174151|FG001|Long Term Follow-up|Missing|3
4397083|NCT00111228|7174160|FG000|Overall Study|Withdrawal by Subject|5
4397084|NCT00111228|7174161|FG001|Overall Study|Withdrawal by Subject|1
4397085|NCT00111228|7174162|FG002|Overall Study|Withdrawal by Subject|0
4397086|NCT00111241|7174172|FG000|Overall Study|Lost to Follow-up|1
4397087|NCT00111241|7174173|FG001|Overall Study|Lost to Follow-up|0
4397088|NCT00111241|7174172|FG000|Overall Study|Withdrawal by Subject|4
4397089|NCT00111241|7174173|FG001|Overall Study|Withdrawal by Subject|0
4397090|NCT00111241|7174172|FG000|Overall Study|Protocol Violation|9
4397091|NCT00111241|7174173|FG001|Overall Study|Protocol Violation|8
4397092|NCT00111241|7174172|FG000|Overall Study|Adverse Event|1
4397093|NCT00111241|7174173|FG001|Overall Study|Adverse Event|0
4397094|NCT00111475|7174191|FG000|Overall Study|Lost to Follow-up|0
4397095|NCT00111475|7174192|FG001|Overall Study|Lost to Follow-up|0
4518421|NCT00973700|7330521|FG004|Overall Study|Unable to Classify|1
4590325|NCT01519947|7436140|FG001|Overall Study|Blood Transfusion|1
4590326|NCT01519947|7436141|FG002|Overall Study|Blood Transfusion|1
4590327|NCT01519947|7436142|FG003|Overall Study|Blood Transfusion|0
4712358|NCT02924883|7638843|FG000|Overall Study|Progressive Disease|1
4712359|NCT02924883|7638844|FG001|Overall Study|Progressive Disease|0
4712360|NCT02924883|7638843|FG000|Overall Study|Study Terminated by Sponsor|69
4712361|NCT02924883|7638844|FG001|Overall Study|Study Terminated by Sponsor|32
4712362|NCT02925117|7638865|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1
4712363|NCT02925117|7638866|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3
4712364|NCT02925117|7638867|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1
4712365|NCT02925117|7638868|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2
4712366|NCT02925117|7638869|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0
4712367|NCT02925117|7638870|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0
4712368|NCT02925117|7638871|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0
4712369|NCT02925117|7638872|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0
4712370|NCT02925117|7638873|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0
4712371|NCT02925117|7638874|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0
4712372|NCT02925117|7638875|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0
4712373|NCT02925117|7638876|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0
4712374|NCT02925117|7638865|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10
4712375|NCT02925117|7638866|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3
4712376|NCT02925117|7638867|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3
4712377|NCT02925117|7638868|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
4712378|NCT02925117|7638869|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
4712379|NCT02925117|7638870|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
4712380|NCT02925117|7638871|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
4712381|NCT02925117|7638872|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
4712382|NCT02925117|7638873|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
4712383|NCT02925117|7638874|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
4712384|NCT02925117|7638875|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
4712385|NCT02925117|7638876|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
4712386|NCT02925117|7638865|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2
4712387|NCT02925117|7638866|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1
4712388|NCT02925117|7638867|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
4712389|NCT02925117|7638868|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
4712390|NCT02925117|7638869|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
4712391|NCT02925117|7638870|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
4712392|NCT02925117|7638871|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
4712393|NCT02925117|7638872|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
4712394|NCT02925117|7638873|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
4712395|NCT02925117|7638874|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
4712396|NCT02925117|7638875|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
4712397|NCT02925117|7638876|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
4712398|NCT02925117|7638865|FG000|Period 1 (Weeks 0 - 16)|Other|5
4712399|NCT02925117|7638866|FG001|Period 1 (Weeks 0 - 16)|Other|4
4712400|NCT02925117|7638867|FG002|Period 1 (Weeks 0 - 16)|Other|1
4712401|NCT02925117|7638868|FG003|Period 1 (Weeks 0 - 16)|Other|1
4712402|NCT02925117|7638869|FG004|Period 1 (Weeks 0 - 16)|Other|0
4712403|NCT02925117|7638870|FG005|Period 1 (Weeks 0 - 16)|Other|0
4397096|NCT00111475|7174193|FG002|Overall Study|Lost to Follow-up|0
4397097|NCT00111475|7174194|FG003|Overall Study|Lost to Follow-up|0
4397098|NCT00111475|7174195|FG004|Overall Study|Lost to Follow-up|0
4397099|NCT00111475|7174196|FG005|Overall Study|Lost to Follow-up|1
4397100|NCT00111475|7174197|FG006|Overall Study|Lost to Follow-up|0
4397101|NCT00111475|7174198|FG007|Overall Study|Lost to Follow-up|0
4397102|NCT00111475|7174199|FG008|Overall Study|Lost to Follow-up|0
4518422|NCT00973765|7330558|FG000|Overall Study|Lost to Follow-up|8
4397103|NCT00111475|7174200|FG009|Overall Study|Lost to Follow-up|0
4397104|NCT00111761|7174235|FG000|Part 1|Physician Decision|0
4397105|NCT00111761|7174236|FG001|Part 1|Physician Decision|1
4397106|NCT00111761|7174235|FG000|Part 1|Death|0
4397107|NCT00111761|7174236|FG001|Part 1|Death|2
4397108|NCT00111761|7174235|FG000|Part 1|Other|0
4397109|NCT00111761|7174236|FG001|Part 1|Other|1
4397110|NCT00111761|7174235|FG000|Part 1|Withdrawal by Subject|0
4397111|NCT00111761|7174236|FG001|Part 1|Withdrawal by Subject|1
4397112|NCT00111761|7174235|FG000|Part 2|Adverse Event|1
4397113|NCT00111761|7174236|FG001|Part 2|Adverse Event|0
4397114|NCT00111761|7174235|FG000|Part 2|Physician Decision|1
4397115|NCT00111761|7174236|FG001|Part 2|Physician Decision|0
4397116|NCT00111761|7174235|FG000|Part 2|Death|1
4397117|NCT00111761|7174236|FG001|Part 2|Death|0
4397118|NCT00111761|7174235|FG000|Part 2|Disease progression|3
4397119|NCT00111761|7174236|FG001|Part 2|Disease progression|0
4397120|NCT00111761|7174235|FG000|Part 2|Protocol-specified criteria|1
4397121|NCT00111761|7174236|FG001|Part 2|Protocol-specified criteria|0
4397122|NCT00111761|7174235|FG000|Part 2|Other|1
4397123|NCT00111761|7174236|FG001|Part 2|Other|0
4397124|NCT00111800|7174248|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5
4397125|NCT00111800|7174249|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4
4397126|NCT00111800|7174250|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0
4397127|NCT00111800|7174251|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0
4397128|NCT00111800|7174252|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1
4397129|NCT00111800|7174253|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0
4397130|NCT00111800|7174248|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1
4397131|NCT00111800|7174249|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
4397132|NCT00111800|7174250|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2
4397133|NCT00111800|7174251|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
4397134|NCT00111800|7174252|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
4397135|NCT00111800|7174253|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2
4397136|NCT00111800|7174248|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0
4397137|NCT00111800|7174249|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2
4397138|NCT00111800|7174250|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4
4397139|NCT00111800|7174251|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2
4397140|NCT00111800|7174252|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1
4397141|NCT00111800|7174253|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1
4397142|NCT00111800|7174248|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2
4397143|NCT00111800|7174249|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2
4397144|NCT00111800|7174250|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3
4397145|NCT00111800|7174251|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0
4397146|NCT00111800|7174252|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0
4397147|NCT00111800|7174253|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1
4397148|NCT00111800|7174248|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3
4397149|NCT00111800|7174249|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
4397150|NCT00111800|7174250|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
4397151|NCT00111800|7174251|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1
4397152|NCT00111800|7174252|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
4397153|NCT00111800|7174253|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
4397154|NCT00111800|7174248|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1
4397155|NCT00111800|7174249|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
4397156|NCT00111800|7174250|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
4397157|NCT00111800|7174251|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
4397158|NCT00111800|7174252|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1
4397159|NCT00111800|7174253|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
4397160|NCT00111800|7174248|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
4397161|NCT00111800|7174249|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
4397162|NCT00111800|7174250|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
4397163|NCT00111800|7174251|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
4397164|NCT00111800|7174252|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
4397165|NCT00111800|7174253|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
4397166|NCT00111800|7174248|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1
4397167|NCT00111800|7174249|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1
4397168|NCT00111800|7174250|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
4397169|NCT00111800|7174251|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
4397170|NCT00111800|7174252|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
4397171|NCT00111800|7174253|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
4397172|NCT00111800|7174248|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1
4397173|NCT00111800|7174249|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
4397174|NCT00111800|7174250|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
4397175|NCT00111800|7174251|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
4397176|NCT00111800|7174252|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
4518423|NCT00973765|7330559|FG001|Overall Study|Lost to Follow-up|14
4397177|NCT00111800|7174253|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
4397178|NCT00111800|7174248|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
4397179|NCT00111800|7174249|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1
4397180|NCT00111800|7174250|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
4397181|NCT00111800|7174251|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
4397182|NCT00111800|7174252|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
4397183|NCT00111800|7174253|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
4397184|NCT00111800|7174248|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
4397185|NCT00111800|7174249|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1
4397186|NCT00111800|7174250|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
4397187|NCT00111800|7174251|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
4397188|NCT00111800|7174252|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
4397189|NCT00111800|7174253|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
4397190|NCT00111800|7174248|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
4397191|NCT00111800|7174249|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1
4397192|NCT00111800|7174250|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
4397193|NCT00111800|7174251|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
4397194|NCT00111800|7174252|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
4397195|NCT00111800|7174253|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
4397196|NCT00111800|7174248|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
4397197|NCT00111800|7174249|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1
4397198|NCT00111800|7174250|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
4397199|NCT00111800|7174251|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
4397200|NCT00111800|7174252|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
4397201|NCT00111800|7174253|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
4397202|NCT00111800|7174248|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
4397203|NCT00111800|7174249|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
4397204|NCT00111800|7174250|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
4397205|NCT00111800|7174251|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1
4397206|NCT00111800|7174252|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
4397207|NCT00111800|7174253|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
4397208|NCT00111800|7174248|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
4397209|NCT00111800|7174249|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
4397210|NCT00111800|7174250|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
4397211|NCT00111800|7174251|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1
4397212|NCT00111800|7174252|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
4397213|NCT00111800|7174253|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
4397214|NCT00111800|7174248|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
4397215|NCT00111800|7174249|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
4397216|NCT00111800|7174250|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
4397217|NCT00111800|7174251|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
4397218|NCT00111800|7174252|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1
4397219|NCT00111800|7174253|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
4397220|NCT00111800|7174248|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
4397221|NCT00111800|7174249|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
4397222|NCT00111800|7174250|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
4397223|NCT00111800|7174251|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
4397224|NCT00111800|7174252|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1
4397225|NCT00111800|7174253|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
4397226|NCT00111800|7174248|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
4397227|NCT00111800|7174249|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
4397228|NCT00111800|7174250|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
4397229|NCT00111800|7174251|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
4397230|NCT00111800|7174252|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
4397231|NCT00111800|7174253|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1
4397232|NCT00111800|7174248|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
4397233|NCT00111800|7174249|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2
4397234|NCT00111800|7174250|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1
4397235|NCT00111800|7174251|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3
4397236|NCT00111800|7174252|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
4397237|NCT00111800|7174253|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
4397238|NCT00111800|7174248|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
4397239|NCT00111800|7174249|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1
4397240|NCT00111800|7174250|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1
4397241|NCT00111800|7174251|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
4397242|NCT00111800|7174252|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
4397243|NCT00111800|7174253|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
4397244|NCT00111800|7174248|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
4397245|NCT00111800|7174249|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2
4397246|NCT00111800|7174250|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2
4397247|NCT00111800|7174251|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
4397248|NCT00111800|7174252|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3
4397249|NCT00111800|7174253|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
4397250|NCT00111800|7174248|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
4397251|NCT00111800|7174249|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0
4397252|NCT00111800|7174250|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
4397253|NCT00111800|7174251|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
4397254|NCT00111800|7174252|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0
4397255|NCT00111800|7174253|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
4397256|NCT00111800|7174248|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
4397257|NCT00111800|7174249|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
4397258|NCT00111800|7174250|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0
4397259|NCT00111800|7174251|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
4397260|NCT00111800|7174252|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
4397261|NCT00111800|7174253|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
4397262|NCT00111800|7174248|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
4397263|NCT00111800|7174249|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1
4397264|NCT00111800|7174250|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
4397265|NCT00111800|7174251|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
4397266|NCT00111800|7174252|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
4397267|NCT00111800|7174253|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
4397268|NCT00111800|7174248|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
4397269|NCT00111800|7174249|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
4397270|NCT00111800|7174250|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1
4397271|NCT00111800|7174251|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
4397272|NCT00111800|7174252|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
4397273|NCT00111800|7174253|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
4397274|NCT00111800|7174248|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
4397275|NCT00111800|7174249|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
4397276|NCT00111800|7174250|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1
4397277|NCT00111800|7174251|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
4397278|NCT00111800|7174252|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
4397279|NCT00111800|7174253|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
4397280|NCT00111813|7174276|FG000|Overall Study|Adverse Event|1
4397281|NCT00111813|7174277|FG001|Overall Study|Adverse Event|2
4397282|NCT00111813|7174278|FG002|Overall Study|Adverse Event|4
4397283|NCT00111813|7174279|FG003|Overall Study|Adverse Event|2
4397284|NCT00111813|7174280|FG004|Overall Study|Adverse Event|2
4397285|NCT00111813|7174281|FG005|Overall Study|Adverse Event|2
4397286|NCT00111813|7174276|FG000|Overall Study|Progressive disease|2
4397287|NCT00111813|7174277|FG001|Overall Study|Progressive disease|1
4397288|NCT00111813|7174278|FG002|Overall Study|Progressive disease|5
4397289|NCT00111813|7174279|FG003|Overall Study|Progressive disease|3
4712404|NCT02925117|7638871|FG006|Period 1 (Weeks 0 - 16)|Other|0
4712405|NCT02925117|7638872|FG007|Period 1 (Weeks 0 - 16)|Other|0
4712406|NCT02925117|7638873|FG008|Period 1 (Weeks 0 - 16)|Other|0
4712407|NCT02925117|7638874|FG009|Period 1 (Weeks 0 - 16)|Other|0
4397290|NCT00111813|7174280|FG004|Overall Study|Progressive disease|4
4397291|NCT00111813|7174281|FG005|Overall Study|Progressive disease|3
4397292|NCT00111813|7174276|FG000|Overall Study|Lack of Efficacy|0
4397293|NCT00111813|7174277|FG001|Overall Study|Lack of Efficacy|0
4397294|NCT00111813|7174278|FG002|Overall Study|Lack of Efficacy|0
4397295|NCT00111813|7174279|FG003|Overall Study|Lack of Efficacy|0
4397296|NCT00111813|7174280|FG004|Overall Study|Lack of Efficacy|0
4397297|NCT00111813|7174281|FG005|Overall Study|Lack of Efficacy|1
4397298|NCT00111813|7174276|FG000|Overall Study|Other|0
4397299|NCT00111813|7174277|FG001|Overall Study|Other|0
4397300|NCT00111813|7174278|FG002|Overall Study|Other|1
4397301|NCT00111813|7174279|FG003|Overall Study|Other|0
4397302|NCT00111813|7174280|FG004|Overall Study|Other|0
4397303|NCT00111813|7174281|FG005|Overall Study|Other|0
4397304|NCT00111839|7174299|FG000|Overall Study|Disease Progression|30
4397305|NCT00111839|7174300|FG001|Overall Study|Disease Progression|33
4510886|NCT00923091|7319702|FG003|Period III (Single-Blind)|Protocol Violation|0
4397306|NCT00111839|7174301|FG002|Overall Study|Disease Progression|33
4397307|NCT00111839|7174299|FG000|Overall Study|Adverse Event|5
4397308|NCT00111839|7174300|FG001|Overall Study|Adverse Event|3
4712408|NCT02925117|7638875|FG010|Period 1 (Weeks 0 - 16)|Other|0
4712409|NCT02925117|7638876|FG011|Period 1 (Weeks 0 - 16)|Other|0
4397309|NCT00111839|7174301|FG002|Overall Study|Adverse Event|1
4397310|NCT00111839|7174299|FG000|Overall Study|Protocol Violation|2
4397311|NCT00111839|7174300|FG001|Overall Study|Protocol Violation|4
4397312|NCT00111839|7174301|FG002|Overall Study|Protocol Violation|2
4397313|NCT00111839|7174299|FG000|Overall Study|Death|1
4397314|NCT00111839|7174300|FG001|Overall Study|Death|1
4397315|NCT00111839|7174301|FG002|Overall Study|Death|6
4397316|NCT00111839|7174299|FG000|Overall Study|Withdrawal by Subject|2
4397317|NCT00111839|7174300|FG001|Overall Study|Withdrawal by Subject|2
4397318|NCT00111839|7174301|FG002|Overall Study|Withdrawal by Subject|2
4397319|NCT00111839|7174299|FG000|Overall Study|Lost to Follow-up|1
4397320|NCT00111839|7174300|FG001|Overall Study|Lost to Follow-up|0
4397321|NCT00111839|7174301|FG002|Overall Study|Lost to Follow-up|0
4397322|NCT00111839|7174299|FG000|Overall Study|Logistical Constraint|1
4397323|NCT00111839|7174300|FG001|Overall Study|Logistical Constraint|0
4397324|NCT00111839|7174301|FG002|Overall Study|Logistical Constraint|0
4397325|NCT00111839|7174299|FG000|Overall Study|Other|6
4397326|NCT00111839|7174300|FG001|Overall Study|Other|3
4397327|NCT00111839|7174301|FG002|Overall Study|Other|3
4397328|NCT00111839|7174299|FG000|Overall Study|Randomized but Not Treated|0
4397329|NCT00111839|7174300|FG001|Overall Study|Randomized but Not Treated|0
4397330|NCT00111839|7174301|FG002|Overall Study|Randomized but Not Treated|2
4397331|NCT00111917|7174311|FG000|Overall Study|Withdrawal by Subject|1
4397332|NCT00111917|7174312|FG001|Overall Study|Withdrawal by Subject|1
4397333|NCT00112047|7174324|FG000|Randomized Phase|Lost to Follow-up|26
4397334|NCT00112047|7174325|FG001|Randomized Phase|Lost to Follow-up|33
4397335|NCT00112047|7174324|FG000|Randomized Phase|Adverse Event|10
4397336|NCT00112047|7174325|FG001|Randomized Phase|Adverse Event|10
4397337|NCT00112047|7174324|FG000|Randomized Phase|Withrawal of consent|10
4397338|NCT00112047|7174325|FG001|Randomized Phase|Withrawal of consent|18
4397339|NCT00112047|7174324|FG000|Randomized Phase|Sub-optimal virological response|3
4397340|NCT00112047|7174325|FG001|Randomized Phase|Sub-optimal virological response|13
4397341|NCT00112047|7174324|FG000|Randomized Phase|Noncompliance|8
4397342|NCT00112047|7174325|FG001|Randomized Phase|Noncompliance|4
4712410|NCT02925117|7638865|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0
4712411|NCT02925117|7638866|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0
4712412|NCT02925117|7638867|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0
4712413|NCT02925117|7638868|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0
4712414|NCT02925117|7638869|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0
4712415|NCT02925117|7638870|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1
4712416|NCT02925117|7638871|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0
4712417|NCT02925117|7638872|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0
4712418|NCT02925117|7638873|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0
4712419|NCT02925117|7638874|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0
4712420|NCT02925117|7638875|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3
4712421|NCT02925117|7638876|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2
4712422|NCT02925117|7638865|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0
4712423|NCT02925117|7638866|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0
4712424|NCT02925117|7638867|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0
4712425|NCT02925117|7638868|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0
4712426|NCT02925117|7638869|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0
4712427|NCT02925117|7638870|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1
4712428|NCT02925117|7638871|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4
4712429|NCT02925117|7638872|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3
4712430|NCT02925117|7638873|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2
4712431|NCT02925117|7638874|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2
4712432|NCT02925117|7638875|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2
4712433|NCT02925117|7638876|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2
4712434|NCT02925117|7638865|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
4712435|NCT02925117|7638866|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
4712436|NCT02925117|7638867|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
4712437|NCT02925117|7638868|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
4712438|NCT02925117|7638869|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1
4712439|NCT02925117|7638870|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2
4712440|NCT02925117|7638871|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1
4712441|NCT02925117|7638872|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1
4712442|NCT02925117|7638873|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1
4712443|NCT02925117|7638874|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
4712444|NCT02925117|7638875|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
4712445|NCT02925117|7638876|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1
4397343|NCT00112047|7174324|FG000|Randomized Phase|Protocol Violation|2
4397344|NCT00112047|7174325|FG001|Randomized Phase|Protocol Violation|0
4397345|NCT00112047|7174324|FG000|Randomized Phase|Pregnancy|3
4397346|NCT00112047|7174325|FG001|Randomized Phase|Pregnancy|1
4397347|NCT00112047|7174324|FG000|Randomized Phase|Death|1
4397348|NCT00112047|7174325|FG001|Randomized Phase|Death|3
4397349|NCT00112047|7174324|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0
4397350|NCT00112047|7174325|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1
4397351|NCT00112047|7174324|FG000|Randomized Phase|Inability to swallow pills|0
4397352|NCT00112047|7174325|FG001|Randomized Phase|Inability to swallow pills|1
4397353|NCT00112047|7174324|FG000|Randomized Phase|Incarceration|3
4397354|NCT00112047|7174325|FG001|Randomized Phase|Incarceration|2
4397355|NCT00112047|7174324|FG000|Randomized Phase|Moved out of State|0
4397356|NCT00112047|7174325|FG001|Randomized Phase|Moved out of State|1
4397357|NCT00112047|7174324|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4
4397358|NCT00112047|7174325|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0
4397359|NCT00112047|7174324|FG000|Randomized Phase|High Hepatitis B DNA|0
4397360|NCT00112047|7174325|FG001|Randomized Phase|High Hepatitis B DNA|1
4397361|NCT00112047|7174324|FG000|Atripla Phase|Adverse Event|2
4397362|NCT00112047|7174325|FG001|Atripla Phase|Adverse Event|1
4397363|NCT00112047|7174324|FG000|Atripla Phase|Lost to Follow-up|5
4397364|NCT00112047|7174325|FG001|Atripla Phase|Lost to Follow-up|7
4397365|NCT00112047|7174324|FG000|Atripla Phase|Pregnancy|0
4397366|NCT00112047|7174325|FG001|Atripla Phase|Pregnancy|1
4397367|NCT00112047|7174324|FG000|Atripla Phase|Death|0
4397368|NCT00112047|7174325|FG001|Atripla Phase|Death|2
4397369|NCT00112047|7174324|FG000|Atripla Phase|Withdrew consent|7
4397370|NCT00112047|7174325|FG001|Atripla Phase|Withdrew consent|7
4397371|NCT00112047|7174324|FG000|Atripla Phase|Sub-optimal virological response|0
4712446|NCT02925117|7638865|FG000|Period 2 (Weeks 16 - 88)|Other|0
4712447|NCT02925117|7638866|FG001|Period 2 (Weeks 16 - 88)|Other|0
4712448|NCT02925117|7638867|FG002|Period 2 (Weeks 16 - 88)|Other|0
4712449|NCT02925117|7638868|FG003|Period 2 (Weeks 16 - 88)|Other|0
4712450|NCT02925117|7638869|FG004|Period 2 (Weeks 16 - 88)|Other|1
4712451|NCT02925117|7638870|FG005|Period 2 (Weeks 16 - 88)|Other|1
4712452|NCT02925117|7638871|FG006|Period 2 (Weeks 16 - 88)|Other|1
4712453|NCT02925117|7638872|FG007|Period 2 (Weeks 16 - 88)|Other|1
4712454|NCT02925117|7638873|FG008|Period 2 (Weeks 16 - 88)|Other|3
4712455|NCT02925117|7638874|FG009|Period 2 (Weeks 16 - 88)|Other|4
4712456|NCT02925117|7638875|FG010|Period 2 (Weeks 16 - 88)|Other|3
4712457|NCT02925117|7638876|FG011|Period 2 (Weeks 16 - 88)|Other|0
4712458|NCT02925312|7638904|FG000|Overall Study|Lost to Follow-up|25
4712459|NCT02925312|7638905|FG001|Overall Study|Lost to Follow-up|0
4712460|NCT02925312|7638904|FG000|Overall Study|Adverse Event|2
4712461|NCT02925312|7638905|FG001|Overall Study|Adverse Event|0
4712462|NCT02925403|7638913|FG000|Overall Study|Lost to Follow-up|0
4712463|NCT02925403|7638914|FG001|Overall Study|Lost to Follow-up|1
4712464|NCT02925455|7638922|FG000|Overall Study|Withdrawal by Subject|2
4712465|NCT02925455|7638923|FG001|Overall Study|Withdrawal by Subject|0
4712466|NCT02925494|7638933|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8
4712467|NCT02925494|7638934|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2
4712468|NCT02925494|7638935|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8
4712469|NCT02925494|7638936|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23
4712470|NCT02925494|7638933|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3
4712471|NCT02925494|7638934|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2
4712472|NCT02925494|7638935|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9
4712473|NCT02925494|7638936|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10
4712474|NCT02925494|7638933|FG000|Post-Treatment Follow-Up Period|Other|1
4712475|NCT02925494|7638934|FG001|Post-Treatment Follow-Up Period|Other|4
4712476|NCT02925494|7638935|FG002|Post-Treatment Follow-Up Period|Other|3
4712477|NCT02925494|7638936|FG003|Post-Treatment Follow-Up Period|Other|6
4712478|NCT02925494|7638933|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1
4712479|NCT02925494|7638934|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2
4712480|NCT02925494|7638935|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2
4712481|NCT02925494|7638936|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6
4712482|NCT02925494|7638933|FG000|Post-Treatment Follow-Up Period|Pregnancy|1
4712483|NCT02925494|7638934|FG001|Post-Treatment Follow-Up Period|Pregnancy|0
4712484|NCT02925494|7638935|FG002|Post-Treatment Follow-Up Period|Pregnancy|1
4712485|NCT02925494|7638936|FG003|Post-Treatment Follow-Up Period|Pregnancy|2
4712486|NCT02925494|7638933|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0
4712487|NCT02925494|7638934|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0
4712488|NCT02925494|7638935|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1
4712489|NCT02925494|7638936|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2
4712490|NCT02925494|7638933|FG000|Post-Treatment Follow-Up Period|Adverse Event|0
4712491|NCT02925494|7638934|FG001|Post-Treatment Follow-Up Period|Adverse Event|0
4712492|NCT02925494|7638935|FG002|Post-Treatment Follow-Up Period|Adverse Event|0
4712493|NCT02925494|7638936|FG003|Post-Treatment Follow-Up Period|Adverse Event|1
4712494|NCT02925741|7638958|FG000|Overall Study|Withdrawal by Subject|11
4712495|NCT02925741|7638959|FG001|Overall Study|Withdrawal by Subject|0
4397372|NCT00112047|7174325|FG001|Atripla Phase|Sub-optimal virological response|1
4397373|NCT00112047|7174324|FG000|Atripla Phase|Non-compliance|1
4397374|NCT00112047|7174325|FG001|Atripla Phase|Non-compliance|0
4397375|NCT00112047|7174324|FG000|Atripla Phase|Other|3
4712496|NCT02925923|7638979|FG000|Overall Study|blood samples hemolyzed|0
4712497|NCT02925923|7638980|FG001|Overall Study|blood samples hemolyzed|2
4712498|NCT02926209|7638995|FG000|Study Cohort|Poor Bowel Preparation|1
4712499|NCT02926209|7638996|FG001|Study Cohort|Poor Bowel Preparation|0
4712500|NCT02926573|7639005|FG000|Overall Study|Nausea|1
4397376|NCT00112047|7174325|FG001|Atripla Phase|Other|1
4397377|NCT00112294|7174407|FG000|Overall Study|Still on study|5
4397378|NCT00112294|7174408|FG001|Overall Study|Still on study|0
4397379|NCT00112359|7174416|FG000|Overall Study|Unrelated adverse event|16
4397380|NCT00112359|7174417|FG001|Overall Study|Unrelated adverse event|8
4397381|NCT00112359|7174416|FG000|Overall Study|Trial drug intolerance (adverse event)|2
4397382|NCT00112359|7174417|FG001|Overall Study|Trial drug intolerance (adverse event)|0
4397383|NCT00112359|7174416|FG000|Overall Study|Related adverse event|5
4397384|NCT00112359|7174417|FG001|Overall Study|Related adverse event|3
4397385|NCT00112359|7174416|FG000|Overall Study|Lost to Follow-up|0
4397386|NCT00112359|7174417|FG001|Overall Study|Lost to Follow-up|1
4397387|NCT00112359|7174416|FG000|Overall Study|Personal/administrative|1
4397388|NCT00112359|7174417|FG001|Overall Study|Personal/administrative|1
4397389|NCT00112359|7174416|FG000|Overall Study|Other|3
4397390|NCT00112359|7174417|FG001|Overall Study|Other|0
4397391|NCT00112385|7174425|FG000|Overall Study|Lost to Follow-up|1
4397392|NCT00112385|7174426|FG001|Overall Study|Lost to Follow-up|0
4397393|NCT00112385|7174425|FG000|Overall Study|Withdrawal by Subject|0
4397394|NCT00112385|7174426|FG001|Overall Study|Withdrawal by Subject|1
4397395|NCT00112437|7174437|FG000|Year 1 (12-Month Base Study)|Adverse Event|9
4397396|NCT00112437|7174438|FG001|Year 1 (12-Month Base Study)|Adverse Event|10
4397397|NCT00112437|7174439|FG002|Year 1 (12-Month Base Study)|Adverse Event|6
4397398|NCT00112437|7174440|FG003|Year 1 (12-Month Base Study)|Adverse Event|4
4397399|NCT00112437|7174441|FG004|Year 1 (12-Month Base Study)|Adverse Event|3
4397400|NCT00112437|7174442|FG005|Year 1 (12-Month Base Study)|Adverse Event|0
4397401|NCT00112437|7174443|FG006|Year 1 (12-Month Base Study)|Adverse Event|0
4397402|NCT00112437|7174444|FG007|Year 1 (12-Month Base Study)|Adverse Event|0
4397403|NCT00112437|7174445|FG008|Year 1 (12-Month Base Study)|Adverse Event|0
4397404|NCT00112437|7174446|FG009|Year 1 (12-Month Base Study)|Adverse Event|0
4397405|NCT00112437|7174447|FG010|Year 1 (12-Month Base Study)|Adverse Event|0
4397406|NCT00112437|7174448|FG011|Year 1 (12-Month Base Study)|Adverse Event|0
4397407|NCT00112437|7174449|FG012|Year 1 (12-Month Base Study)|Adverse Event|0
4397408|NCT00112437|7174450|FG013|Year 1 (12-Month Base Study)|Adverse Event|0
4397409|NCT00112437|7174451|FG014|Year 1 (12-Month Base Study)|Adverse Event|0
4712501|NCT02926573|7639006|FG001|Overall Study|Nausea|0
4712502|NCT02926573|7639005|FG000|Overall Study|Remain intubated|2
4712503|NCT02926573|7639006|FG001|Overall Study|Remain intubated|2
4712504|NCT02926573|7639005|FG000|Overall Study|Change in surgery plan|3
4712505|NCT02926573|7639006|FG001|Overall Study|Change in surgery plan|1
4712506|NCT02926573|7639005|FG000|Overall Study|Change to outpatient status|5
4712507|NCT02926573|7639006|FG001|Overall Study|Change to outpatient status|1
4712508|NCT02926573|7639005|FG000|Overall Study|Withdrawal by Subject|0
4712509|NCT02926573|7639006|FG001|Overall Study|Withdrawal by Subject|2
4712510|NCT02926573|7639005|FG000|Overall Study|Return to operating room|0
4712511|NCT02926573|7639006|FG001|Overall Study|Return to operating room|2
4712512|NCT02926573|7639005|FG000|Overall Study|Delirium|0
4712513|NCT02926573|7639006|FG001|Overall Study|Delirium|1
4712514|NCT02926937|7639029|FG000|Overall Study|Adverse Event|0
4712515|NCT02926937|7639030|FG001|Overall Study|Adverse Event|1
4712516|NCT02926937|7639031|FG002|Overall Study|Adverse Event|1
4712517|NCT02926937|7639029|FG000|Overall Study|Poor Compliance to Protocol|1
4712518|NCT02926937|7639030|FG001|Overall Study|Poor Compliance to Protocol|0
4712519|NCT02926937|7639031|FG002|Overall Study|Poor Compliance to Protocol|0
4712520|NCT02926937|7639029|FG000|Overall Study|Lost to Follow-up|4
4712521|NCT02926937|7639030|FG001|Overall Study|Lost to Follow-up|5
4712522|NCT02926937|7639031|FG002|Overall Study|Lost to Follow-up|0
4712523|NCT02926937|7639029|FG000|Overall Study|At the Participant's own Request|11
4712524|NCT02926937|7639030|FG001|Overall Study|At the Participant's own Request|5
4712525|NCT02926937|7639031|FG002|Overall Study|At the Participant's own Request|8
4712526|NCT02926937|7639029|FG000|Overall Study|Reason not Specified|3
4712527|NCT02926937|7639030|FG001|Overall Study|Reason not Specified|4
4712528|NCT02926937|7639031|FG002|Overall Study|Reason not Specified|2
4712529|NCT02926950|7639042|FG000|Overall Study|Adverse Event|4
4712530|NCT02926950|7639043|FG001|Overall Study|Adverse Event|6
4712531|NCT02926950|7639042|FG000|Overall Study|At the participant's own request|21
4712532|NCT02926950|7639043|FG001|Overall Study|At the participant's own request|25
4712533|NCT02926950|7639042|FG000|Overall Study|Reason not Specified|17
4712534|NCT02926950|7639043|FG001|Overall Study|Reason not Specified|9
4712535|NCT02926950|7639042|FG000|Overall Study|Lost to Follow-up|7
4712536|NCT02926950|7639043|FG001|Overall Study|Lost to Follow-up|8
4712537|NCT02927080|7639060|FG000|Overall Study|Withdrawal by Subject|0
4712538|NCT02927080|7639061|FG001|Overall Study|Withdrawal by Subject|0
4712539|NCT02927080|7639062|FG002|Overall Study|Withdrawal by Subject|0
4712540|NCT02927080|7639063|FG003|Overall Study|Withdrawal by Subject|0
4397410|NCT00112437|7174452|FG015|Year 1 (12-Month Base Study)|Adverse Event|0
4397411|NCT00112437|7174453|FG016|Year 1 (12-Month Base Study)|Adverse Event|0
4397412|NCT00112437|7174454|FG017|Year 1 (12-Month Base Study)|Adverse Event|0
4397413|NCT00112437|7174455|FG018|Year 1 (12-Month Base Study)|Adverse Event|0
4712541|NCT02927080|7639064|FG004|Overall Study|Withdrawal by Subject|1
4712542|NCT02927080|7639065|FG005|Overall Study|Withdrawal by Subject|0
4712543|NCT02927080|7639066|FG006|Overall Study|Withdrawal by Subject|1
4712544|NCT02927080|7639067|FG007|Overall Study|Withdrawal by Subject|1
4712545|NCT02927080|7639068|FG008|Overall Study|Withdrawal by Subject|0
4712546|NCT02927080|7639069|FG009|Overall Study|Withdrawal by Subject|2
4397414|NCT00112437|7174456|FG019|Year 1 (12-Month Base Study)|Adverse Event|0
4397415|NCT00112437|7174457|FG020|Year 1 (12-Month Base Study)|Adverse Event|0
4397416|NCT00112437|7174458|FG021|Year 1 (12-Month Base Study)|Adverse Event|0
4397417|NCT00112437|7174459|FG022|Year 1 (12-Month Base Study)|Adverse Event|0
4397418|NCT00112437|7174460|FG023|Year 1 (12-Month Base Study)|Adverse Event|0
4397419|NCT00112437|7174461|FG024|Year 1 (12-Month Base Study)|Adverse Event|0
4397420|NCT00112437|7174462|FG025|Year 1 (12-Month Base Study)|Adverse Event|0
4397421|NCT00112437|7174437|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0
4397422|NCT00112437|7174438|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1
4397423|NCT00112437|7174439|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0
4397424|NCT00112437|7174440|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0
4397425|NCT00112437|7174441|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0
4397426|NCT00112437|7174442|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0
4397427|NCT00112437|7174443|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0
4397428|NCT00112437|7174444|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0
4397429|NCT00112437|7174445|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0
4397430|NCT00112437|7174446|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0
4397431|NCT00112437|7174447|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0
4397432|NCT00112437|7174448|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0
4397433|NCT00112437|7174449|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0
4397434|NCT00112437|7174450|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0
4397435|NCT00112437|7174451|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0
4397436|NCT00112437|7174452|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0
4397437|NCT00112437|7174453|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0
4397438|NCT00112437|7174454|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0
4397439|NCT00112437|7174455|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0
4397440|NCT00112437|7174456|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0
4397441|NCT00112437|7174457|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0
4397442|NCT00112437|7174458|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0
4397443|NCT00112437|7174459|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0
4397444|NCT00112437|7174460|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0
4397445|NCT00112437|7174461|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0
4397446|NCT00112437|7174462|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0
4397447|NCT00112437|7174437|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0
4397448|NCT00112437|7174438|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1
4397449|NCT00112437|7174439|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0
4397450|NCT00112437|7174440|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0
4397451|NCT00112437|7174441|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0
4397452|NCT00112437|7174442|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0
4397453|NCT00112437|7174443|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0
4397454|NCT00112437|7174444|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0
4397455|NCT00112437|7174445|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0
4397456|NCT00112437|7174446|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0
4397457|NCT00112437|7174447|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0
4397458|NCT00112437|7174448|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0
4397459|NCT00112437|7174449|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0
4397460|NCT00112437|7174450|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0
4397461|NCT00112437|7174451|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0
4397462|NCT00112437|7174452|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0
4397463|NCT00112437|7174453|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0
4397464|NCT00112437|7174454|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0
4397465|NCT00112437|7174455|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0
4510887|NCT00923091|7319703|FG004|Period III (Single-Blind)|Protocol Violation|0
4628543|NCT01862484|7495951|FG001|Overall Study|Lack of Efficacy|1
4628544|NCT01862484|7495950|FG000|Overall Study|Lost to Follow-up|1
4628545|NCT01862484|7495951|FG001|Overall Study|Lost to Follow-up|2
4628546|NCT01862484|7495950|FG000|Overall Study|Protocol Violation|0
4628547|NCT01862484|7495951|FG001|Overall Study|Protocol Violation|2
4628548|NCT01862484|7495950|FG000|Overall Study|Withdrawal by Subject|0
4628549|NCT01862484|7495951|FG001|Overall Study|Withdrawal by Subject|3
4628550|NCT01862640|7495979|FG000|Overall Study|Adverse Event|4
4628551|NCT01862640|7495980|FG001|Overall Study|Adverse Event|10
4628552|NCT01862640|7495981|FG002|Overall Study|Adverse Event|6
4628553|NCT01862640|7495982|FG003|Overall Study|Adverse Event|8
4712547|NCT02927080|7639060|FG000|Overall Study|Willingness to comply with protocol|0
4712548|NCT02927080|7639061|FG001|Overall Study|Willingness to comply with protocol|0
4712549|NCT02927080|7639062|FG002|Overall Study|Willingness to comply with protocol|0
4510888|NCT00923091|7319704|FG005|Period III (Single-Blind)|Protocol Violation|0
4712550|NCT02927080|7639063|FG003|Overall Study|Willingness to comply with protocol|0
4712551|NCT02927080|7639064|FG004|Overall Study|Willingness to comply with protocol|0
4397466|NCT00112437|7174456|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0
4397467|NCT00112437|7174457|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0
4397468|NCT00112437|7174458|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0
4397469|NCT00112437|7174459|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0
4628554|NCT01862640|7495979|FG000|Overall Study|Participant Met Withdrawal Criteria|1
4628555|NCT01862640|7495980|FG001|Overall Study|Participant Met Withdrawal Criteria|1
4397470|NCT00112437|7174460|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0
4397471|NCT00112437|7174461|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0
4397472|NCT00112437|7174462|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0
4397473|NCT00112437|7174437|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1
4397474|NCT00112437|7174438|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0
4397475|NCT00112437|7174439|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3
4397476|NCT00112437|7174440|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1
4397477|NCT00112437|7174441|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1
4397478|NCT00112437|7174442|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0
4397479|NCT00112437|7174443|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0
4397480|NCT00112437|7174444|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0
4397481|NCT00112437|7174445|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0
4397482|NCT00112437|7174446|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0
4397483|NCT00112437|7174447|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0
4397484|NCT00112437|7174448|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0
4397485|NCT00112437|7174449|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0
4397486|NCT00112437|7174450|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0
4397487|NCT00112437|7174451|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0
4397488|NCT00112437|7174452|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0
4397489|NCT00112437|7174453|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0
4397490|NCT00112437|7174454|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0
4397491|NCT00112437|7174455|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0
4397492|NCT00112437|7174456|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0
4397493|NCT00112437|7174457|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0
4397494|NCT00112437|7174458|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0
4397495|NCT00112437|7174459|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0
4397496|NCT00112437|7174460|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0
4397497|NCT00112437|7174461|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0
4397498|NCT00112437|7174462|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0
4397499|NCT00112437|7174437|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5
4397500|NCT00112437|7174438|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5
4397501|NCT00112437|7174439|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2
4397502|NCT00112437|7174440|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1
4397503|NCT00112437|7174441|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7
4397504|NCT00112437|7174442|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
4397505|NCT00112437|7174443|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
4397506|NCT00112437|7174444|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
4397507|NCT00112437|7174445|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
4397508|NCT00112437|7174446|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
4397509|NCT00112437|7174447|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
4397510|NCT00112437|7174448|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
4397511|NCT00112437|7174449|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
4397512|NCT00112437|7174450|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
4397513|NCT00112437|7174451|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
4397514|NCT00112437|7174452|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
4397515|NCT00112437|7174453|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
4397516|NCT00112437|7174454|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
4397517|NCT00112437|7174455|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
4397518|NCT00112437|7174456|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
4397519|NCT00112437|7174457|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
4712552|NCT02927080|7639065|FG005|Overall Study|Willingness to comply with protocol|0
4712553|NCT02927080|7639066|FG006|Overall Study|Willingness to comply with protocol|0
4712554|NCT02927080|7639067|FG007|Overall Study|Willingness to comply with protocol|0
4712555|NCT02927080|7639068|FG008|Overall Study|Willingness to comply with protocol|0
4712556|NCT02927080|7639069|FG009|Overall Study|Willingness to comply with protocol|1
4712557|NCT02927080|7639060|FG000|Overall Study|Study terminated by Sponsor|0
4712558|NCT02927080|7639061|FG001|Overall Study|Study terminated by Sponsor|0
4712559|NCT02927080|7639062|FG002|Overall Study|Study terminated by Sponsor|0
4712560|NCT02927080|7639063|FG003|Overall Study|Study terminated by Sponsor|0
4712561|NCT02927080|7639064|FG004|Overall Study|Study terminated by Sponsor|0
4712562|NCT02927080|7639065|FG005|Overall Study|Study terminated by Sponsor|0
4712563|NCT02927080|7639066|FG006|Overall Study|Study terminated by Sponsor|6
4712564|NCT02927080|7639067|FG007|Overall Study|Study terminated by Sponsor|7
4712565|NCT02927080|7639068|FG008|Overall Study|Study terminated by Sponsor|2
4712566|NCT02927080|7639069|FG009|Overall Study|Study terminated by Sponsor|3
4712567|NCT02927080|7639060|FG000|Overall Study|Adverse Event|0
4712568|NCT02927080|7639061|FG001|Overall Study|Adverse Event|1
4397520|NCT00112437|7174458|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
4397521|NCT00112437|7174459|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
4397522|NCT00112437|7174460|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
4397523|NCT00112437|7174461|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
4397524|NCT00112437|7174462|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
4397525|NCT00112437|7174437|FG000|Year 1 (12-Month Base Study)|moved|0
4397526|NCT00112437|7174438|FG001|Year 1 (12-Month Base Study)|moved|1
4397527|NCT00112437|7174439|FG002|Year 1 (12-Month Base Study)|moved|1
4397528|NCT00112437|7174440|FG003|Year 1 (12-Month Base Study)|moved|0
4397529|NCT00112437|7174441|FG004|Year 1 (12-Month Base Study)|moved|0
4397530|NCT00112437|7174442|FG005|Year 1 (12-Month Base Study)|moved|0
4397531|NCT00112437|7174443|FG006|Year 1 (12-Month Base Study)|moved|0
4397532|NCT00112437|7174444|FG007|Year 1 (12-Month Base Study)|moved|0
4397533|NCT00112437|7174445|FG008|Year 1 (12-Month Base Study)|moved|0
4397534|NCT00112437|7174446|FG009|Year 1 (12-Month Base Study)|moved|0
4397535|NCT00112437|7174447|FG010|Year 1 (12-Month Base Study)|moved|0
4397536|NCT00112437|7174448|FG011|Year 1 (12-Month Base Study)|moved|0
4397537|NCT00112437|7174449|FG012|Year 1 (12-Month Base Study)|moved|0
4397538|NCT00112437|7174450|FG013|Year 1 (12-Month Base Study)|moved|0
4397539|NCT00112437|7174451|FG014|Year 1 (12-Month Base Study)|moved|0
4397540|NCT00112437|7174452|FG015|Year 1 (12-Month Base Study)|moved|0
4397541|NCT00112437|7174453|FG016|Year 1 (12-Month Base Study)|moved|0
4397542|NCT00112437|7174454|FG017|Year 1 (12-Month Base Study)|moved|0
4397543|NCT00112437|7174455|FG018|Year 1 (12-Month Base Study)|moved|0
4712569|NCT02927080|7639062|FG002|Overall Study|Adverse Event|0
4712570|NCT02927080|7639063|FG003|Overall Study|Adverse Event|0
4712571|NCT02927080|7639064|FG004|Overall Study|Adverse Event|0
4712572|NCT02927080|7639065|FG005|Overall Study|Adverse Event|0
4712573|NCT02927080|7639066|FG006|Overall Study|Adverse Event|0
4712574|NCT02927080|7639067|FG007|Overall Study|Adverse Event|1
4712575|NCT02927080|7639068|FG008|Overall Study|Adverse Event|0
4712576|NCT02927080|7639069|FG009|Overall Study|Adverse Event|1
4712577|NCT02927080|7639060|FG000|Overall Study|Other|0
4712578|NCT02927080|7639061|FG001|Overall Study|Other|0
4712579|NCT02927080|7639062|FG002|Overall Study|Other|0
4712580|NCT02927080|7639063|FG003|Overall Study|Other|0
4712581|NCT02927080|7639064|FG004|Overall Study|Other|0
4712582|NCT02927080|7639065|FG005|Overall Study|Other|0
4712583|NCT02927080|7639066|FG006|Overall Study|Other|1
4712584|NCT02927080|7639067|FG007|Overall Study|Other|0
4712585|NCT02927080|7639068|FG008|Overall Study|Other|1
4712586|NCT02927080|7639069|FG009|Overall Study|Other|0
4712587|NCT02927171|7639116|FG000|Overall Study|Lost to Follow-up|0
4712588|NCT02927171|7639117|FG001|Overall Study|Lost to Follow-up|1
4712589|NCT02927301|7639129|FG000|Overall Study|Adverse Event|7
4712590|NCT02927301|7639129|FG000|Overall Study|Withdrawal by Subject|1
4712591|NCT02927301|7639129|FG000|Overall Study|Physician Decision|2
4712592|NCT02927366|7639144|FG000|Overall Study|Adverse Event|1
4712593|NCT02927366|7639145|FG001|Overall Study|Adverse Event|0
4712594|NCT02927366|7639144|FG000|Overall Study|Patient schedule|1
4712595|NCT02927366|7639145|FG001|Overall Study|Patient schedule|0
4712596|NCT02927431|7639154|FG000|Overall Study|Withdrawal by Subject|0
4712597|NCT02927431|7639155|FG001|Overall Study|Withdrawal by Subject|0
4712598|NCT02927431|7639156|FG002|Overall Study|Withdrawal by Subject|1
4712599|NCT02927795|7639188|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19
4712600|NCT02927795|7639188|FG000|Overall Study|Not Treated|4
4712601|NCT02927834|7639195|FG000|Overall Study|Lost to Follow-up|1
4712602|NCT02927834|7639196|FG001|Overall Study|Lost to Follow-up|2
4712603|NCT02927834|7639197|FG002|Overall Study|Lost to Follow-up|2
4712604|NCT02927873|7639211|FG000|Overall Study|Lost to Follow-up|0
4712605|NCT02927873|7639212|FG001|Overall Study|Lost to Follow-up|1
4712606|NCT02927873|7639213|FG002|Overall Study|Lost to Follow-up|0
4712607|NCT02927873|7639214|FG003|Overall Study|Lost to Follow-up|0
4712608|NCT02927873|7639215|FG004|Overall Study|Lost to Follow-up|0
4712609|NCT02927873|7639216|FG005|Overall Study|Lost to Follow-up|0
4712610|NCT02927873|7639211|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
4712611|NCT02927873|7639212|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1
4712612|NCT02927873|7639213|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
4712613|NCT02927873|7639214|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
4712614|NCT02927873|7639215|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
4712615|NCT02927873|7639216|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
4712616|NCT02927873|7639211|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
4712617|NCT02927873|7639212|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
4712618|NCT02927873|7639213|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
4712619|NCT02927873|7639214|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
4712620|NCT02927873|7639215|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
4712621|NCT02927873|7639216|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1
4712622|NCT02927873|7639211|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0
4712623|NCT02927873|7639212|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1
4712624|NCT02927873|7639213|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0
4712625|NCT02927873|7639214|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0
4712626|NCT02927873|7639215|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0
4712627|NCT02927873|7639216|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0
4397544|NCT00112437|7174456|FG019|Year 1 (12-Month Base Study)|moved|0
4397545|NCT00112437|7174457|FG020|Year 1 (12-Month Base Study)|moved|0
4397546|NCT00112437|7174458|FG021|Year 1 (12-Month Base Study)|moved|0
4397547|NCT00112437|7174459|FG022|Year 1 (12-Month Base Study)|moved|0
4712628|NCT02927873|7639211|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1
4397548|NCT00112437|7174460|FG023|Year 1 (12-Month Base Study)|moved|0
4397549|NCT00112437|7174461|FG024|Year 1 (12-Month Base Study)|moved|0
4397550|NCT00112437|7174462|FG025|Year 1 (12-Month Base Study)|moved|0
4397551|NCT00112437|7174437|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
4397552|NCT00112437|7174438|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
4397553|NCT00112437|7174439|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
4397554|NCT00112437|7174440|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2
4397555|NCT00112437|7174441|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
4397556|NCT00112437|7174442|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
4397557|NCT00112437|7174443|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
4397558|NCT00112437|7174444|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
4397559|NCT00112437|7174445|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
4397560|NCT00112437|7174446|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
4397561|NCT00112437|7174447|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
4397562|NCT00112437|7174448|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
4397563|NCT00112437|7174449|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
4397564|NCT00112437|7174450|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
4397565|NCT00112437|7174451|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
4397566|NCT00112437|7174452|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
4397567|NCT00112437|7174453|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
4397568|NCT00112437|7174454|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
4397569|NCT00112437|7174455|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
4397570|NCT00112437|7174456|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
4397571|NCT00112437|7174457|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
4397572|NCT00112437|7174458|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
4397573|NCT00112437|7174459|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
4397574|NCT00112437|7174460|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
4397575|NCT00112437|7174461|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
4397576|NCT00112437|7174462|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
4397577|NCT00112437|7174437|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
4397578|NCT00112437|7174438|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
4397579|NCT00112437|7174439|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
4397580|NCT00112437|7174440|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
4397581|NCT00112437|7174441|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1
4397582|NCT00112437|7174442|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
4397583|NCT00112437|7174443|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
4397584|NCT00112437|7174444|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
4397585|NCT00112437|7174445|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
4397586|NCT00112437|7174446|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
4712629|NCT02927873|7639212|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0
4712630|NCT02927873|7639213|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0
4712631|NCT02927873|7639214|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0
4712632|NCT02927873|7639215|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0
4712633|NCT02927873|7639216|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0
4712634|NCT02927873|7639211|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1
4712635|NCT02927873|7639212|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0
4712636|NCT02927873|7639213|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0
4712637|NCT02927873|7639214|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0
4712638|NCT02927873|7639215|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0
4712639|NCT02927873|7639216|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0
4712640|NCT02927925|7639230|FG000|Overall Study|Death|16
4712641|NCT02927925|7639230|FG000|Overall Study|Physician Decision|1
4712642|NCT02927925|7639230|FG000|Overall Study|Withdrawal by Subject|11
4712643|NCT02927925|7639230|FG000|Overall Study|Other|3
4712644|NCT02927925|7639230|FG000|Overall Study|Disease progression at clinical cutoff|1
4712645|NCT02928029|7639236|FG000|Overall Study|Withdrawal by Subject|0
4712646|NCT02928029|7639237|FG001|Overall Study|Withdrawal by Subject|1
4712647|NCT02928029|7639236|FG000|Overall Study|Radiological progression|1
4712648|NCT02928029|7639237|FG001|Overall Study|Radiological progression|0
4397587|NCT00112437|7174447|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
4397588|NCT00112437|7174448|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
4397589|NCT00112437|7174449|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
4397590|NCT00112437|7174450|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
4712649|NCT02928029|7639236|FG000|Overall Study|Clinical progression|1
4712650|NCT02928029|7639237|FG001|Overall Study|Clinical progression|2
4397591|NCT00112437|7174451|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
4397592|NCT00112437|7174452|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
4397593|NCT00112437|7174453|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
4397594|NCT00112437|7174454|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
4397595|NCT00112437|7174455|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
4397596|NCT00112437|7174456|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
4397597|NCT00112437|7174457|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
4397598|NCT00112437|7174458|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
4397599|NCT00112437|7174459|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
4397600|NCT00112437|7174460|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
4397601|NCT00112437|7174461|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
4397602|NCT00112437|7174462|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
4397603|NCT00112437|7174437|FG000|Year 2 (12-Month Extension)|Adverse Event|0
4397604|NCT00112437|7174438|FG001|Year 2 (12-Month Extension)|Adverse Event|0
4397605|NCT00112437|7174439|FG002|Year 2 (12-Month Extension)|Adverse Event|0
4397606|NCT00112437|7174440|FG003|Year 2 (12-Month Extension)|Adverse Event|0
4397607|NCT00112437|7174441|FG004|Year 2 (12-Month Extension)|Adverse Event|0
4397608|NCT00112437|7174442|FG005|Year 2 (12-Month Extension)|Adverse Event|1
4397609|NCT00112437|7174443|FG006|Year 2 (12-Month Extension)|Adverse Event|2
4712651|NCT02928029|7639236|FG000|Overall Study|AE not related to clinical progression|1
4712652|NCT02928029|7639237|FG001|Overall Study|AE not related to clinical progression|1
4712653|NCT02928770|7639276|FG000|Overall Study|Withdrawal by Subject|2
4712654|NCT02928848|7639282|FG000|Arm 2|Withdrawal by Subject|1
4712655|NCT02928848|7639283|FG001|Arm 2|Withdrawal by Subject|0
4712656|NCT02928952|7639293|FG000|Overall Study|Lost to Follow-up|5
4712657|NCT02928952|7639294|FG001|Overall Study|Lost to Follow-up|5
4712658|NCT02928952|7639293|FG000|Overall Study|Withdrawal by Subject|5
4712659|NCT02928952|7639294|FG001|Overall Study|Withdrawal by Subject|1
4712660|NCT02928952|7639293|FG000|Overall Study|Physician Decision|0
4712661|NCT02928952|7639294|FG001|Overall Study|Physician Decision|1
4712662|NCT02929329|7639302|FG000|Overall Study|Withdrawal by Subject|24
4712663|NCT02929329|7639303|FG001|Overall Study|Withdrawal by Subject|21
4712664|NCT02929329|7639302|FG000|Overall Study|Lost to Follow-up|26
4712665|NCT02929329|7639303|FG001|Overall Study|Lost to Follow-up|20
4712666|NCT02929329|7639302|FG000|Overall Study|Death|1054
4712667|NCT02929329|7639303|FG001|Overall Study|Death|1051
4712668|NCT02929407|7639313|FG000|Overall Study|Adverse Event|1
4712669|NCT02929498|7639320|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3
4712670|NCT02929498|7639321|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0
4712671|NCT02929498|7639322|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0
4712672|NCT02929498|7639320|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2
4712673|NCT02929498|7639321|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0
4712674|NCT02929498|7639322|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0
4590328|NCT01519947|7436139|FG000|Overall Study|Withdrawal by Subject|0
4590329|NCT01519947|7436140|FG001|Overall Study|Withdrawal by Subject|1
4590330|NCT01519947|7436141|FG002|Overall Study|Withdrawal by Subject|0
4590331|NCT01519947|7436142|FG003|Overall Study|Withdrawal by Subject|1
4590332|NCT01519947|7436139|FG000|Overall Study|Lost to Follow-up|0
4590333|NCT01519947|7436140|FG001|Overall Study|Lost to Follow-up|0
4590334|NCT01519947|7436141|FG002|Overall Study|Lost to Follow-up|3
4712675|NCT02930005|7639364|FG000|Overall Study|Lost to Follow-up|1
4712676|NCT02930005|7639365|FG001|Overall Study|Lost to Follow-up|5
4712677|NCT02930018|7639373|FG000|Overall Study|Lost to Follow-up|1
4712678|NCT02930018|7639374|FG001|Overall Study|Lost to Follow-up|1
4712679|NCT02930018|7639373|FG000|Overall Study|Withdrawal by Subject|5
4712680|NCT02930018|7639374|FG001|Overall Study|Withdrawal by Subject|2
4712681|NCT02930226|7639397|FG000|Overall Study|Technical Problems: Leak in plasma bag|0
4712682|NCT02930226|7639398|FG001|Overall Study|Technical Problems: Leak in plasma bag|0
4712683|NCT02930226|7639399|FG002|Overall Study|Technical Problems: Leak in plasma bag|0
4712684|NCT02930226|7639400|FG003|Overall Study|Technical Problems: Leak in plasma bag|0
4712685|NCT02930226|7639401|FG004|Overall Study|Technical Problems: Leak in plasma bag|1
4712686|NCT02930226|7639402|FG005|Overall Study|Technical Problems: Leak in plasma bag|0
4712687|NCT02930343|7639420|FG000|Overall Study|Lost to Follow-up|9
4712688|NCT02930343|7639421|FG001|Overall Study|Lost to Follow-up|7
4712689|NCT02930837|7639465|FG000|Overall Study|Adverse Event|6
4712690|NCT02930837|7639465|FG000|Overall Study|Lost to Follow-up|5
4712691|NCT02930837|7639465|FG000|Overall Study|Withdrawal by Subject|1
4712692|NCT02930941|7639471|FG000|Overall Study|Lost to Follow-up|1
4712693|NCT02930941|7639472|FG001|Overall Study|Lost to Follow-up|2
4397610|NCT00112437|7174444|FG007|Year 2 (12-Month Extension)|Adverse Event|6
4397611|NCT00112437|7174445|FG008|Year 2 (12-Month Extension)|Adverse Event|1
4712694|NCT02931396|7639506|FG000|Overall Study|Lost to Follow-up|3
4712695|NCT02931396|7639507|FG001|Overall Study|Lost to Follow-up|0
4712696|NCT02931396|7639506|FG000|Overall Study|Withdrawal by Subject|2
4712697|NCT02931396|7639507|FG001|Overall Study|Withdrawal by Subject|0
4712698|NCT02931539|7639515|FG000|Period 1: Treatment Phase|Investigator discretion|1
4712699|NCT02931539|7639516|FG001|Period 1: Treatment Phase|Investigator discretion|1
4736066|NCT03555305|7684800|FG001|Period 1|Adverse Event|1
4397612|NCT00112437|7174446|FG009|Year 2 (12-Month Extension)|Adverse Event|7
4397613|NCT00112437|7174447|FG010|Year 2 (12-Month Extension)|Adverse Event|0
4397614|NCT00112437|7174448|FG011|Year 2 (12-Month Extension)|Adverse Event|0
4397615|NCT00112437|7174449|FG012|Year 2 (12-Month Extension)|Adverse Event|0
4397616|NCT00112437|7174450|FG013|Year 2 (12-Month Extension)|Adverse Event|0
4397617|NCT00112437|7174451|FG014|Year 2 (12-Month Extension)|Adverse Event|0
4397618|NCT00112437|7174452|FG015|Year 2 (12-Month Extension)|Adverse Event|0
4397619|NCT00112437|7174453|FG016|Year 2 (12-Month Extension)|Adverse Event|0
4397620|NCT00112437|7174454|FG017|Year 2 (12-Month Extension)|Adverse Event|0
4397621|NCT00112437|7174455|FG018|Year 2 (12-Month Extension)|Adverse Event|0
4397622|NCT00112437|7174456|FG019|Year 2 (12-Month Extension)|Adverse Event|0
4397623|NCT00112437|7174457|FG020|Year 2 (12-Month Extension)|Adverse Event|0
4397624|NCT00112437|7174458|FG021|Year 2 (12-Month Extension)|Adverse Event|0
4397625|NCT00112437|7174459|FG022|Year 2 (12-Month Extension)|Adverse Event|0
4397626|NCT00112437|7174460|FG023|Year 2 (12-Month Extension)|Adverse Event|0
4397627|NCT00112437|7174461|FG024|Year 2 (12-Month Extension)|Adverse Event|0
4397628|NCT00112437|7174462|FG025|Year 2 (12-Month Extension)|Adverse Event|0
4397629|NCT00112437|7174437|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0
4397630|NCT00112437|7174438|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0
4397631|NCT00112437|7174439|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0
4397632|NCT00112437|7174440|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0
4397633|NCT00112437|7174441|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0
4712700|NCT02931539|7639517|FG002|Period 1: Treatment Phase|Investigator discretion|0
4712701|NCT02931539|7639515|FG000|Period 1: Treatment Phase|Adverse Event|5
4712702|NCT02931539|7639516|FG001|Period 1: Treatment Phase|Adverse Event|1
4712703|NCT02931539|7639517|FG002|Period 1: Treatment Phase|Adverse Event|0
4712704|NCT02931539|7639515|FG000|Period 1: Treatment Phase|Lost to Follow-up|1
4712705|NCT02931539|7639516|FG001|Period 1: Treatment Phase|Lost to Follow-up|2
4712706|NCT02931539|7639517|FG002|Period 1: Treatment Phase|Lost to Follow-up|0
4712707|NCT02931539|7639515|FG000|Period 1: Treatment Phase|Death|8
4712708|NCT02931539|7639516|FG001|Period 1: Treatment Phase|Death|24
4712709|NCT02931539|7639517|FG002|Period 1: Treatment Phase|Death|0
4712710|NCT02931539|7639515|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16
4712711|NCT02931539|7639516|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8
4712712|NCT02931539|7639517|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0
4712713|NCT02931539|7639515|FG000|Period 1: Treatment Phase|Protocol Violation|6
4712714|NCT02931539|7639516|FG001|Period 1: Treatment Phase|Protocol Violation|0
4712715|NCT02931539|7639517|FG002|Period 1: Treatment Phase|Protocol Violation|0
4712716|NCT02931539|7639515|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22
4712717|NCT02931539|7639516|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0
4712718|NCT02931539|7639517|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0
4712719|NCT02931539|7639515|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0
4712720|NCT02931539|7639516|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0
4712721|NCT02931539|7639517|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2
4712722|NCT02931838|7639546|FG000|Overall Study|Reason not provided by investigator|1
4712723|NCT02931838|7639547|FG001|Overall Study|Reason not provided by investigator|0
4712724|NCT02931838|7639548|FG002|Overall Study|Reason not provided by investigator|1
4712725|NCT02931838|7639549|FG003|Overall Study|Reason not provided by investigator|0
4712726|NCT02931838|7639550|FG004|Overall Study|Reason not provided by investigator|0
4712727|NCT02931838|7639551|FG005|Overall Study|Reason not provided by investigator|0
4712728|NCT02931838|7639546|FG000|Overall Study|Poor/non-compliance|0
4712729|NCT02931838|7639547|FG001|Overall Study|Poor/non-compliance|0
4712730|NCT02931838|7639548|FG002|Overall Study|Poor/non-compliance|1
4712731|NCT02931838|7639549|FG003|Overall Study|Poor/non-compliance|0
4712732|NCT02931838|7639550|FG004|Overall Study|Poor/non-compliance|0
4712733|NCT02931838|7639551|FG005|Overall Study|Poor/non-compliance|0
4712734|NCT02931838|7639546|FG000|Overall Study|Lack of Efficacy|5
4712735|NCT02931838|7639547|FG001|Overall Study|Lack of Efficacy|4
4712736|NCT02931838|7639548|FG002|Overall Study|Lack of Efficacy|0
4712737|NCT02931838|7639549|FG003|Overall Study|Lack of Efficacy|0
4712738|NCT02931838|7639550|FG004|Overall Study|Lack of Efficacy|0
4712739|NCT02931838|7639551|FG005|Overall Study|Lack of Efficacy|1
4712740|NCT02931838|7639546|FG000|Overall Study|Lost to Follow-up|1
4712741|NCT02931838|7639547|FG001|Overall Study|Lost to Follow-up|0
4712742|NCT02931838|7639548|FG002|Overall Study|Lost to Follow-up|1
4712743|NCT02931838|7639549|FG003|Overall Study|Lost to Follow-up|1
4712744|NCT02931838|7639550|FG004|Overall Study|Lost to Follow-up|2
4712745|NCT02931838|7639551|FG005|Overall Study|Lost to Follow-up|0
4712746|NCT02931838|7639546|FG000|Overall Study|Subject request to discontinue treatment|4
4712747|NCT02931838|7639547|FG001|Overall Study|Subject request to discontinue treatment|3
4397634|NCT00112437|7174442|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1
4397635|NCT00112437|7174443|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6
4397636|NCT00112437|7174444|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0
4397637|NCT00112437|7174445|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0
4397638|NCT00112437|7174446|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2
4397639|NCT00112437|7174447|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0
4712748|NCT02931838|7639548|FG002|Overall Study|Subject request to discontinue treatment|3
4712749|NCT02931838|7639549|FG003|Overall Study|Subject request to discontinue treatment|0
4397640|NCT00112437|7174448|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0
4397641|NCT00112437|7174449|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0
4397642|NCT00112437|7174450|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0
4397643|NCT00112437|7174451|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0
4397644|NCT00112437|7174452|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0
4397645|NCT00112437|7174453|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0
4397646|NCT00112437|7174454|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0
4397647|NCT00112437|7174455|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0
4397648|NCT00112437|7174456|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0
4397649|NCT00112437|7174457|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0
4397650|NCT00112437|7174458|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0
4397651|NCT00112437|7174459|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0
4397652|NCT00112437|7174460|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0
4397653|NCT00112437|7174461|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0
4397654|NCT00112437|7174462|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0
4397655|NCT00112437|7174437|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0
4397656|NCT00112437|7174438|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0
4397657|NCT00112437|7174439|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0
4397658|NCT00112437|7174440|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0
4397659|NCT00112437|7174441|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0
4397660|NCT00112437|7174442|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0
4397661|NCT00112437|7174443|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0
4397662|NCT00112437|7174444|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0
4397663|NCT00112437|7174445|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1
4397664|NCT00112437|7174446|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0
4397665|NCT00112437|7174447|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0
4397666|NCT00112437|7174448|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0
4397667|NCT00112437|7174449|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0
4397668|NCT00112437|7174450|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0
4397669|NCT00112437|7174451|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0
4397670|NCT00112437|7174452|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0
4397671|NCT00112437|7174453|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0
4397672|NCT00112437|7174454|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0
4397673|NCT00112437|7174455|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0
4397674|NCT00112437|7174456|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0
4397675|NCT00112437|7174457|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0
4397676|NCT00112437|7174458|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0
4397677|NCT00112437|7174459|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0
4397678|NCT00112437|7174460|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0
4397679|NCT00112437|7174461|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0
4397680|NCT00112437|7174462|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0
4397681|NCT00112437|7174437|FG000|Year 2 (12-Month Extension)|Protocol Violation|0
4397682|NCT00112437|7174438|FG001|Year 2 (12-Month Extension)|Protocol Violation|0
4397683|NCT00112437|7174439|FG002|Year 2 (12-Month Extension)|Protocol Violation|0
4397684|NCT00112437|7174440|FG003|Year 2 (12-Month Extension)|Protocol Violation|0
4397685|NCT00112437|7174441|FG004|Year 2 (12-Month Extension)|Protocol Violation|0
4397686|NCT00112437|7174442|FG005|Year 2 (12-Month Extension)|Protocol Violation|0
4397687|NCT00112437|7174443|FG006|Year 2 (12-Month Extension)|Protocol Violation|0
4397688|NCT00112437|7174444|FG007|Year 2 (12-Month Extension)|Protocol Violation|0
4397689|NCT00112437|7174445|FG008|Year 2 (12-Month Extension)|Protocol Violation|1
4397690|NCT00112437|7174446|FG009|Year 2 (12-Month Extension)|Protocol Violation|0
4397691|NCT00112437|7174447|FG010|Year 2 (12-Month Extension)|Protocol Violation|0
4397692|NCT00112437|7174448|FG011|Year 2 (12-Month Extension)|Protocol Violation|0
4397693|NCT00112437|7174449|FG012|Year 2 (12-Month Extension)|Protocol Violation|0
4397694|NCT00112437|7174450|FG013|Year 2 (12-Month Extension)|Protocol Violation|0
4397695|NCT00112437|7174451|FG014|Year 2 (12-Month Extension)|Protocol Violation|0
4397696|NCT00112437|7174452|FG015|Year 2 (12-Month Extension)|Protocol Violation|0
4397697|NCT00112437|7174453|FG016|Year 2 (12-Month Extension)|Protocol Violation|0
4397698|NCT00112437|7174454|FG017|Year 2 (12-Month Extension)|Protocol Violation|0
4397699|NCT00112437|7174455|FG018|Year 2 (12-Month Extension)|Protocol Violation|0
4397700|NCT00112437|7174456|FG019|Year 2 (12-Month Extension)|Protocol Violation|0
4397701|NCT00112437|7174457|FG020|Year 2 (12-Month Extension)|Protocol Violation|0
4397702|NCT00112437|7174458|FG021|Year 2 (12-Month Extension)|Protocol Violation|0
4397703|NCT00112437|7174459|FG022|Year 2 (12-Month Extension)|Protocol Violation|0
4397704|NCT00112437|7174460|FG023|Year 2 (12-Month Extension)|Protocol Violation|0
4397705|NCT00112437|7174461|FG024|Year 2 (12-Month Extension)|Protocol Violation|0
4397706|NCT00112437|7174462|FG025|Year 2 (12-Month Extension)|Protocol Violation|0
4397707|NCT00112437|7174437|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0
4397708|NCT00112437|7174438|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0
4397709|NCT00112437|7174439|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0
4397710|NCT00112437|7174440|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0
4397711|NCT00112437|7174441|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0
4397712|NCT00112437|7174442|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1
4397713|NCT00112437|7174443|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1
4397714|NCT00112437|7174444|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2
4397715|NCT00112437|7174445|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4
4397716|NCT00112437|7174446|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1
4397717|NCT00112437|7174447|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0
4397718|NCT00112437|7174448|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0
4397719|NCT00112437|7174449|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0
4397720|NCT00112437|7174450|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0
4397721|NCT00112437|7174451|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0
4397722|NCT00112437|7174452|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0
4397723|NCT00112437|7174453|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0
4397724|NCT00112437|7174454|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0
4397725|NCT00112437|7174455|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0
4397726|NCT00112437|7174456|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0
4397727|NCT00112437|7174457|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0
4397728|NCT00112437|7174458|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0
4397729|NCT00112437|7174459|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0
4397730|NCT00112437|7174460|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0
4397731|NCT00112437|7174461|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0
4397732|NCT00112437|7174462|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0
4397733|NCT00112437|7174437|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0
4397734|NCT00112437|7174438|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0
4397735|NCT00112437|7174439|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0
4397736|NCT00112437|7174440|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0
4397737|NCT00112437|7174441|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0
4397738|NCT00112437|7174442|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0
4397739|NCT00112437|7174443|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0
4397740|NCT00112437|7174444|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0
4397741|NCT00112437|7174445|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0
4397742|NCT00112437|7174446|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1
4397743|NCT00112437|7174447|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0
4397744|NCT00112437|7174448|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0
4397745|NCT00112437|7174449|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0
4397746|NCT00112437|7174450|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0
4397747|NCT00112437|7174451|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0
4397748|NCT00112437|7174452|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0
4397749|NCT00112437|7174453|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0
4397750|NCT00112437|7174454|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0
4397751|NCT00112437|7174455|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0
4397752|NCT00112437|7174456|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0
4397753|NCT00112437|7174457|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0
4397754|NCT00112437|7174458|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0
4397755|NCT00112437|7174459|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0
4397756|NCT00112437|7174460|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0
4397757|NCT00112437|7174461|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0
4397758|NCT00112437|7174462|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0
4397759|NCT00112437|7174437|FG000|Year 2 (12-Month Extension)|patient was out of windows|0
4397760|NCT00112437|7174438|FG001|Year 2 (12-Month Extension)|patient was out of windows|0
4397761|NCT00112437|7174439|FG002|Year 2 (12-Month Extension)|patient was out of windows|0
4397762|NCT00112437|7174440|FG003|Year 2 (12-Month Extension)|patient was out of windows|0
4397763|NCT00112437|7174441|FG004|Year 2 (12-Month Extension)|patient was out of windows|0
4397764|NCT00112437|7174442|FG005|Year 2 (12-Month Extension)|patient was out of windows|0
4397765|NCT00112437|7174443|FG006|Year 2 (12-Month Extension)|patient was out of windows|0
4397766|NCT00112437|7174444|FG007|Year 2 (12-Month Extension)|patient was out of windows|0
4397767|NCT00112437|7174445|FG008|Year 2 (12-Month Extension)|patient was out of windows|0
4397768|NCT00112437|7174446|FG009|Year 2 (12-Month Extension)|patient was out of windows|1
4397769|NCT00112437|7174447|FG010|Year 2 (12-Month Extension)|patient was out of windows|0
4397770|NCT00112437|7174448|FG011|Year 2 (12-Month Extension)|patient was out of windows|0
4397771|NCT00112437|7174449|FG012|Year 2 (12-Month Extension)|patient was out of windows|0
4397772|NCT00112437|7174450|FG013|Year 2 (12-Month Extension)|patient was out of windows|0
4397773|NCT00112437|7174451|FG014|Year 2 (12-Month Extension)|patient was out of windows|0
4397774|NCT00112437|7174452|FG015|Year 2 (12-Month Extension)|patient was out of windows|0
4397775|NCT00112437|7174453|FG016|Year 2 (12-Month Extension)|patient was out of windows|0
4397776|NCT00112437|7174454|FG017|Year 2 (12-Month Extension)|patient was out of windows|0
4397777|NCT00112437|7174455|FG018|Year 2 (12-Month Extension)|patient was out of windows|0
4397778|NCT00112437|7174456|FG019|Year 2 (12-Month Extension)|patient was out of windows|0
4397779|NCT00112437|7174457|FG020|Year 2 (12-Month Extension)|patient was out of windows|0
4397780|NCT00112437|7174458|FG021|Year 2 (12-Month Extension)|patient was out of windows|0
4397781|NCT00112437|7174459|FG022|Year 2 (12-Month Extension)|patient was out of windows|0
4397782|NCT00112437|7174460|FG023|Year 2 (12-Month Extension)|patient was out of windows|0
4397783|NCT00112437|7174461|FG024|Year 2 (12-Month Extension)|patient was out of windows|0
4397784|NCT00112437|7174462|FG025|Year 2 (12-Month Extension)|patient was out of windows|0
4397785|NCT00112437|7174437|FG000|Year 2 (12-Month Extension)|Moved|0
4397786|NCT00112437|7174438|FG001|Year 2 (12-Month Extension)|Moved|0
4397787|NCT00112437|7174439|FG002|Year 2 (12-Month Extension)|Moved|0
4397788|NCT00112437|7174440|FG003|Year 2 (12-Month Extension)|Moved|0
4397789|NCT00112437|7174441|FG004|Year 2 (12-Month Extension)|Moved|0
4397790|NCT00112437|7174442|FG005|Year 2 (12-Month Extension)|Moved|0
4397791|NCT00112437|7174443|FG006|Year 2 (12-Month Extension)|Moved|0
4397792|NCT00112437|7174444|FG007|Year 2 (12-Month Extension)|Moved|0
4397793|NCT00112437|7174445|FG008|Year 2 (12-Month Extension)|Moved|0
4397794|NCT00112437|7174446|FG009|Year 2 (12-Month Extension)|Moved|1
4397795|NCT00112437|7174447|FG010|Year 2 (12-Month Extension)|Moved|0
4397796|NCT00112437|7174448|FG011|Year 2 (12-Month Extension)|Moved|0
4397797|NCT00112437|7174449|FG012|Year 2 (12-Month Extension)|Moved|0
4397798|NCT00112437|7174450|FG013|Year 2 (12-Month Extension)|Moved|0
4397799|NCT00112437|7174451|FG014|Year 2 (12-Month Extension)|Moved|0
4397800|NCT00112437|7174452|FG015|Year 2 (12-Month Extension)|Moved|0
4397801|NCT00112437|7174453|FG016|Year 2 (12-Month Extension)|Moved|0
4397802|NCT00112437|7174454|FG017|Year 2 (12-Month Extension)|Moved|0
4397803|NCT00112437|7174455|FG018|Year 2 (12-Month Extension)|Moved|0
4397804|NCT00112437|7174456|FG019|Year 2 (12-Month Extension)|Moved|0
4397805|NCT00112437|7174457|FG020|Year 2 (12-Month Extension)|Moved|0
4397806|NCT00112437|7174458|FG021|Year 2 (12-Month Extension)|Moved|0
4397807|NCT00112437|7174459|FG022|Year 2 (12-Month Extension)|Moved|0
4397808|NCT00112437|7174460|FG023|Year 2 (12-Month Extension)|Moved|0
4397809|NCT00112437|7174461|FG024|Year 2 (12-Month Extension)|Moved|0
4397810|NCT00112437|7174462|FG025|Year 2 (12-Month Extension)|Moved|0
4397811|NCT00112437|7174437|FG000|Year 3 (12-Month Extension)|Adverse Event|0
4397812|NCT00112437|7174438|FG001|Year 3 (12-Month Extension)|Adverse Event|0
4397813|NCT00112437|7174439|FG002|Year 3 (12-Month Extension)|Adverse Event|0
4397814|NCT00112437|7174440|FG003|Year 3 (12-Month Extension)|Adverse Event|0
4397815|NCT00112437|7174441|FG004|Year 3 (12-Month Extension)|Adverse Event|0
4397816|NCT00112437|7174442|FG005|Year 3 (12-Month Extension)|Adverse Event|0
4397817|NCT00112437|7174443|FG006|Year 3 (12-Month Extension)|Adverse Event|0
4397818|NCT00112437|7174444|FG007|Year 3 (12-Month Extension)|Adverse Event|0
4397819|NCT00112437|7174445|FG008|Year 3 (12-Month Extension)|Adverse Event|0
4397820|NCT00112437|7174446|FG009|Year 3 (12-Month Extension)|Adverse Event|0
4397821|NCT00112437|7174447|FG010|Year 3 (12-Month Extension)|Adverse Event|1
4397822|NCT00112437|7174448|FG011|Year 3 (12-Month Extension)|Adverse Event|0
4397823|NCT00112437|7174449|FG012|Year 3 (12-Month Extension)|Adverse Event|0
4397824|NCT00112437|7174450|FG013|Year 3 (12-Month Extension)|Adverse Event|0
4397825|NCT00112437|7174451|FG014|Year 3 (12-Month Extension)|Adverse Event|0
4397826|NCT00112437|7174452|FG015|Year 3 (12-Month Extension)|Adverse Event|1
4397827|NCT00112437|7174453|FG016|Year 3 (12-Month Extension)|Adverse Event|3
4397828|NCT00112437|7174454|FG017|Year 3 (12-Month Extension)|Adverse Event|1
4397829|NCT00112437|7174455|FG018|Year 3 (12-Month Extension)|Adverse Event|0
4397830|NCT00112437|7174456|FG019|Year 3 (12-Month Extension)|Adverse Event|1
4397831|NCT00112437|7174457|FG020|Year 3 (12-Month Extension)|Adverse Event|0
4397832|NCT00112437|7174458|FG021|Year 3 (12-Month Extension)|Adverse Event|0
4397833|NCT00112437|7174459|FG022|Year 3 (12-Month Extension)|Adverse Event|0
4397834|NCT00112437|7174460|FG023|Year 3 (12-Month Extension)|Adverse Event|0
4397835|NCT00112437|7174461|FG024|Year 3 (12-Month Extension)|Adverse Event|0
4397836|NCT00112437|7174462|FG025|Year 3 (12-Month Extension)|Adverse Event|0
4397837|NCT00112437|7174437|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0
4397838|NCT00112437|7174438|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0
4397839|NCT00112437|7174439|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0
4397840|NCT00112437|7174440|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0
4397841|NCT00112437|7174441|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0
4397842|NCT00112437|7174442|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0
4397843|NCT00112437|7174443|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0
4397844|NCT00112437|7174444|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0
4397845|NCT00112437|7174445|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0
4397846|NCT00112437|7174446|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0
4397847|NCT00112437|7174447|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0
4397848|NCT00112437|7174448|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1
4397849|NCT00112437|7174449|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0
4397850|NCT00112437|7174450|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1
4397851|NCT00112437|7174451|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0
4397852|NCT00112437|7174452|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1
4397853|NCT00112437|7174453|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0
4397854|NCT00112437|7174454|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0
4397855|NCT00112437|7174455|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2
4397856|NCT00112437|7174456|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0
4397857|NCT00112437|7174457|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0
4397858|NCT00112437|7174458|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0
4397859|NCT00112437|7174459|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0
4397860|NCT00112437|7174460|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0
4397861|NCT00112437|7174461|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0
4397862|NCT00112437|7174462|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0
4397863|NCT00112437|7174437|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0
4397864|NCT00112437|7174438|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0
4397865|NCT00112437|7174439|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0
4397866|NCT00112437|7174440|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0
4397867|NCT00112437|7174441|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0
4397868|NCT00112437|7174442|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0
4397869|NCT00112437|7174443|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0
4397870|NCT00112437|7174444|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0
4397871|NCT00112437|7174445|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0
4397872|NCT00112437|7174446|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0
4397873|NCT00112437|7174447|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0
4397874|NCT00112437|7174448|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0
4397875|NCT00112437|7174449|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0
4397876|NCT00112437|7174450|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0
4397877|NCT00112437|7174451|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0
4397878|NCT00112437|7174452|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1
4397879|NCT00112437|7174453|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0
4397880|NCT00112437|7174454|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0
4397881|NCT00112437|7174455|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0
4397882|NCT00112437|7174456|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0
4397883|NCT00112437|7174457|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0
4397884|NCT00112437|7174458|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0
4397885|NCT00112437|7174459|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0
4397886|NCT00112437|7174460|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0
4397887|NCT00112437|7174461|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0
4397888|NCT00112437|7174462|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0
4397889|NCT00112437|7174437|FG000|Year 3 (12-Month Extension)|Protocol Violation|0
4397890|NCT00112437|7174438|FG001|Year 3 (12-Month Extension)|Protocol Violation|0
4397891|NCT00112437|7174439|FG002|Year 3 (12-Month Extension)|Protocol Violation|0
4397892|NCT00112437|7174440|FG003|Year 3 (12-Month Extension)|Protocol Violation|0
4397893|NCT00112437|7174441|FG004|Year 3 (12-Month Extension)|Protocol Violation|0
4397894|NCT00112437|7174442|FG005|Year 3 (12-Month Extension)|Protocol Violation|0
4397895|NCT00112437|7174443|FG006|Year 3 (12-Month Extension)|Protocol Violation|0
4397896|NCT00112437|7174444|FG007|Year 3 (12-Month Extension)|Protocol Violation|0
4397897|NCT00112437|7174445|FG008|Year 3 (12-Month Extension)|Protocol Violation|0
4397898|NCT00112437|7174446|FG009|Year 3 (12-Month Extension)|Protocol Violation|0
4397899|NCT00112437|7174447|FG010|Year 3 (12-Month Extension)|Protocol Violation|0
4397900|NCT00112437|7174448|FG011|Year 3 (12-Month Extension)|Protocol Violation|0
4397901|NCT00112437|7174449|FG012|Year 3 (12-Month Extension)|Protocol Violation|0
4397902|NCT00112437|7174450|FG013|Year 3 (12-Month Extension)|Protocol Violation|0
4397903|NCT00112437|7174451|FG014|Year 3 (12-Month Extension)|Protocol Violation|0
4712750|NCT02931838|7639550|FG004|Overall Study|Subject request to discontinue treatment|1
4712751|NCT02931838|7639551|FG005|Overall Study|Subject request to discontinue treatment|0
4712752|NCT02931838|7639546|FG000|Overall Study|Withdrawal by Subject|1
4712753|NCT02931838|7639547|FG001|Overall Study|Withdrawal by Subject|2
4712754|NCT02931838|7639548|FG002|Overall Study|Withdrawal by Subject|0
4712755|NCT02931838|7639549|FG003|Overall Study|Withdrawal by Subject|1
4712756|NCT02931838|7639550|FG004|Overall Study|Withdrawal by Subject|0
4712757|NCT02931838|7639551|FG005|Overall Study|Withdrawal by Subject|0
4712758|NCT02931838|7639546|FG000|Overall Study|Adverse Event|2
4712759|NCT02931838|7639547|FG001|Overall Study|Adverse Event|1
4712760|NCT02931838|7639548|FG002|Overall Study|Adverse Event|2
4712761|NCT02931838|7639549|FG003|Overall Study|Adverse Event|1
4712762|NCT02931838|7639550|FG004|Overall Study|Adverse Event|3
4712763|NCT02931838|7639551|FG005|Overall Study|Adverse Event|1
4712764|NCT02932228|7639572|FG000|Overall Study|Death|8
4712765|NCT02932228|7639573|FG001|Overall Study|Death|23
4712766|NCT02932228|7639572|FG000|Overall Study|not eligible upon chart review|2
4712767|NCT02932228|7639573|FG001|Overall Study|not eligible upon chart review|5
4712768|NCT02932267|7639581|FG000|Overall Study|Withdrawal by Subject|3
4712769|NCT02932267|7639581|FG000|Overall Study|Lost to Follow-up|4
4712770|NCT02932267|7639581|FG000|Overall Study|Pregnancy|1
4712771|NCT02932306|7639587|FG000|Overall Study|Withdrawal by Subject|16
4712772|NCT02932306|7639588|FG001|Overall Study|Withdrawal by Subject|25
4712773|NCT02932306|7639587|FG000|Overall Study|Adverse Event|3
4712774|NCT02932306|7639588|FG001|Overall Study|Adverse Event|0
4712775|NCT02932306|7639587|FG000|Overall Study|Pregnancy|2
4712776|NCT02932306|7639588|FG001|Overall Study|Pregnancy|0
4712777|NCT02932306|7639587|FG000|Overall Study|Protocol Violation|1
4712778|NCT02932306|7639588|FG001|Overall Study|Protocol Violation|1
4712779|NCT02932306|7639587|FG000|Overall Study|Noncompliance with Study Drug|1
4712780|NCT02932306|7639588|FG001|Overall Study|Noncompliance with Study Drug|1
4712781|NCT02932306|7639587|FG000|Overall Study|Lost to Follow-up|36
4397904|NCT00112437|7174452|FG015|Year 3 (12-Month Extension)|Protocol Violation|1
4397905|NCT00112437|7174453|FG016|Year 3 (12-Month Extension)|Protocol Violation|0
4397906|NCT00112437|7174454|FG017|Year 3 (12-Month Extension)|Protocol Violation|0
4397907|NCT00112437|7174455|FG018|Year 3 (12-Month Extension)|Protocol Violation|0
4397908|NCT00112437|7174456|FG019|Year 3 (12-Month Extension)|Protocol Violation|0
4397909|NCT00112437|7174457|FG020|Year 3 (12-Month Extension)|Protocol Violation|0
4397910|NCT00112437|7174458|FG021|Year 3 (12-Month Extension)|Protocol Violation|0
4397911|NCT00112437|7174459|FG022|Year 3 (12-Month Extension)|Protocol Violation|0
4397912|NCT00112437|7174460|FG023|Year 3 (12-Month Extension)|Protocol Violation|0
4397913|NCT00112437|7174461|FG024|Year 3 (12-Month Extension)|Protocol Violation|0
4397914|NCT00112437|7174462|FG025|Year 3 (12-Month Extension)|Protocol Violation|0
4397915|NCT00112437|7174437|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0
4397916|NCT00112437|7174438|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0
4397917|NCT00112437|7174439|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0
4397918|NCT00112437|7174440|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0
4397919|NCT00112437|7174441|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0
4397920|NCT00112437|7174442|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0
4397921|NCT00112437|7174443|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0
4397922|NCT00112437|7174444|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0
4397923|NCT00112437|7174445|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0
4397924|NCT00112437|7174446|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0
4397925|NCT00112437|7174447|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0
4397926|NCT00112437|7174448|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3
4397927|NCT00112437|7174449|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0
4397928|NCT00112437|7174450|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0
4397929|NCT00112437|7174451|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1
4397930|NCT00112437|7174452|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0
4397931|NCT00112437|7174453|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0
4397932|NCT00112437|7174454|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0
4397933|NCT00112437|7174455|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0
4397934|NCT00112437|7174456|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0
4397935|NCT00112437|7174457|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0
4397936|NCT00112437|7174458|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0
4397937|NCT00112437|7174459|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0
4397938|NCT00112437|7174460|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0
4397939|NCT00112437|7174461|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0
4397940|NCT00112437|7174462|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0
4397941|NCT00112437|7174437|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
4397942|NCT00112437|7174438|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
4628556|NCT01862640|7495981|FG002|Overall Study|Participant Met Withdrawal Criteria|2
4628557|NCT01862640|7495982|FG003|Overall Study|Participant Met Withdrawal Criteria|1
4628558|NCT01862640|7495979|FG000|Overall Study|Participant Withdrawn by Investigator|0
4628559|NCT01862640|7495980|FG001|Overall Study|Participant Withdrawn by Investigator|1
4628560|NCT01862640|7495981|FG002|Overall Study|Participant Withdrawn by Investigator|1
4628561|NCT01862640|7495982|FG003|Overall Study|Participant Withdrawn by Investigator|1
4628562|NCT01862640|7495979|FG000|Overall Study|Withdrawal by Subject|2
4628563|NCT01862640|7495980|FG001|Overall Study|Withdrawal by Subject|4
4712782|NCT02932306|7639588|FG001|Overall Study|Lost to Follow-up|40
4712783|NCT02932306|7639587|FG000|Overall Study|Withdrawal by Parent or Guardian|6
4712784|NCT02932306|7639588|FG001|Overall Study|Withdrawal by Parent or Guardian|8
4712785|NCT02932306|7639587|FG000|Overall Study|Lack of Efficacy|0
4712786|NCT02932306|7639588|FG001|Overall Study|Lack of Efficacy|2
4712787|NCT02932306|7639587|FG000|Overall Study|Worsening condition|2
4712788|NCT02932306|7639588|FG001|Overall Study|Worsening condition|0
4712789|NCT02932306|7639587|FG000|Overall Study|Withdrew due to burning,itching,stinging|1
4712790|NCT02932306|7639588|FG001|Overall Study|Withdrew due to burning,itching,stinging|0
4712791|NCT02932462|7639596|FG000|Overall Study|Adverse Event|1
4712792|NCT02932462|7639597|FG001|Overall Study|Adverse Event|2
4712793|NCT02932462|7639596|FG000|Overall Study|Lost to Follow-up|4
4712794|NCT02932462|7639597|FG001|Overall Study|Lost to Follow-up|1
4712795|NCT02932462|7639596|FG000|Overall Study|Protocol Violation|0
4712796|NCT02932462|7639597|FG001|Overall Study|Protocol Violation|5
4712797|NCT02932462|7639596|FG000|Overall Study|Withdrawal by Subject|1
4712798|NCT02932462|7639597|FG001|Overall Study|Withdrawal by Subject|4
4712799|NCT02932462|7639596|FG000|Overall Study|Non-Compliance With Study Drug|0
4712800|NCT02932462|7639597|FG001|Overall Study|Non-Compliance With Study Drug|1
4712801|NCT02932462|7639596|FG000|Overall Study|Progressive Disease|1
4712802|NCT02932462|7639597|FG001|Overall Study|Progressive Disease|0
4712803|NCT02932878|7639617|FG000|Overall Study|Due to Lab Results|2
4628564|NCT01862640|7495981|FG002|Overall Study|Withdrawal by Subject|8
4628565|NCT01862640|7495982|FG003|Overall Study|Withdrawal by Subject|5
4712804|NCT02932878|7639618|FG001|Overall Study|Due to Lab Results|1
4712805|NCT02932891|7639624|FG000|Overall Study|Lost to Follow-up|2
4712806|NCT02932891|7639624|FG000|Overall Study|HPA Suppress|2
4712807|NCT02932904|7639632|FG000|Overall Study|Reason not Specified|1
4712808|NCT02932904|7639633|FG001|Overall Study|Reason not Specified|0
4397943|NCT00112437|7174439|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
4397944|NCT00112437|7174440|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
4397945|NCT00112437|7174441|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
4397946|NCT00112437|7174442|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
4712809|NCT02932904|7639634|FG002|Overall Study|Reason not Specified|2
4712810|NCT02932904|7639635|FG003|Overall Study|Reason not Specified|2
4712811|NCT02932904|7639632|FG000|Overall Study|Noncompliance with Study Drug|2
4712812|NCT02932904|7639633|FG001|Overall Study|Noncompliance with Study Drug|3
4712813|NCT02932904|7639634|FG002|Overall Study|Noncompliance with Study Drug|3
4397947|NCT00112437|7174443|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
4397948|NCT00112437|7174444|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
4397949|NCT00112437|7174445|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
4397950|NCT00112437|7174446|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
4397951|NCT00112437|7174447|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1
4397952|NCT00112437|7174448|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1
4397953|NCT00112437|7174449|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
4397954|NCT00112437|7174450|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
4397955|NCT00112437|7174451|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
4397956|NCT00112437|7174452|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
4397957|NCT00112437|7174453|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
4397958|NCT00112437|7174454|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
4397959|NCT00112437|7174455|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
4397960|NCT00112437|7174456|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
4397961|NCT00112437|7174457|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
4397962|NCT00112437|7174458|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
4397963|NCT00112437|7174459|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
4397964|NCT00112437|7174460|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
4518726|NCT00975884|7330973|FG000|Overall Study|Withdrawal by Subject|9
4712814|NCT02932904|7639635|FG003|Overall Study|Noncompliance with Study Drug|4
4712815|NCT02932904|7639632|FG000|Overall Study|Pregnancy|0
4712816|NCT02932904|7639633|FG001|Overall Study|Pregnancy|1
4712817|NCT02932904|7639634|FG002|Overall Study|Pregnancy|1
4712818|NCT02932904|7639635|FG003|Overall Study|Pregnancy|0
4712819|NCT02932904|7639632|FG000|Overall Study|Study Termination|0
4712820|NCT02932904|7639633|FG001|Overall Study|Study Termination|1
4712821|NCT02932904|7639634|FG002|Overall Study|Study Termination|0
4712822|NCT02932904|7639635|FG003|Overall Study|Study Termination|0
4712823|NCT02932904|7639632|FG000|Overall Study|Voluntary Withdrawal|2
4712824|NCT02932904|7639633|FG001|Overall Study|Voluntary Withdrawal|1
4712825|NCT02932904|7639634|FG002|Overall Study|Voluntary Withdrawal|4
4712826|NCT02932904|7639635|FG003|Overall Study|Voluntary Withdrawal|2
4712827|NCT02932904|7639632|FG000|Overall Study|Lost to Follow-up|5
4712828|NCT02932904|7639633|FG001|Overall Study|Lost to Follow-up|3
4712829|NCT02932904|7639634|FG002|Overall Study|Lost to Follow-up|6
4712830|NCT02932904|7639635|FG003|Overall Study|Lost to Follow-up|0
4712831|NCT02932904|7639632|FG000|Overall Study|Significant Protocol Deviation|2
4712832|NCT02932904|7639633|FG001|Overall Study|Significant Protocol Deviation|3
4712833|NCT02932904|7639634|FG002|Overall Study|Significant Protocol Deviation|6
4712834|NCT02932904|7639635|FG003|Overall Study|Significant Protocol Deviation|1
4712835|NCT02932904|7639632|FG000|Overall Study|Pretreatment Event/Adverse Event|3
4712836|NCT02932904|7639633|FG001|Overall Study|Pretreatment Event/Adverse Event|5
4712837|NCT02932904|7639634|FG002|Overall Study|Pretreatment Event/Adverse Event|1
4712838|NCT02932904|7639635|FG003|Overall Study|Pretreatment Event/Adverse Event|3
4712839|NCT02932904|7639632|FG000|Overall Study|Randomized But Not Treated|1
4712840|NCT02932904|7639633|FG001|Overall Study|Randomized But Not Treated|1
4712841|NCT02932904|7639634|FG002|Overall Study|Randomized But Not Treated|0
4712842|NCT02932904|7639635|FG003|Overall Study|Randomized But Not Treated|2
4712843|NCT02932943|7639650|FG000|Overall Study|Lost to Follow-up|0
4712844|NCT02932943|7639651|FG001|Overall Study|Lost to Follow-up|2
4712845|NCT02932943|7639650|FG000|Overall Study|Adverse Event|2
4712846|NCT02932943|7639651|FG001|Overall Study|Adverse Event|2
4712847|NCT02932943|7639650|FG000|Overall Study|Withdrawal by Subject|3
4712848|NCT02932943|7639651|FG001|Overall Study|Withdrawal by Subject|3
4712849|NCT02933060|7639663|FG000|Overall Study|Withdrawal by Subject|0
4712850|NCT02933060|7639664|FG001|Overall Study|Withdrawal by Subject|1
4712851|NCT02933489|7639711|FG000|Overall Study|Ineligible|3
4712852|NCT02933489|7639712|FG001|Overall Study|Ineligible|3
4712853|NCT02933489|7639711|FG000|Overall Study|Withdrawal by Subject|27
4712854|NCT02933489|7639712|FG001|Overall Study|Withdrawal by Subject|18
4712855|NCT02933489|7639711|FG000|Overall Study|Unable to complete exams (other)|14
4712856|NCT02933489|7639712|FG001|Overall Study|Unable to complete exams (other)|7
4712857|NCT02933528|7639727|FG000|Overall Study|Lost to Follow-up|2
4712858|NCT02934178|7639757|FG000|Received Vaccination 2|Death|0
4712859|NCT02934178|7639758|FG001|Received Vaccination 2|Death|1
4712860|NCT02934178|7639757|FG000|Received Vaccination 3|Withdrawal by Subject|1
4712861|NCT02934178|7639758|FG001|Received Vaccination 3|Withdrawal by Subject|0
4712862|NCT02935192|7639840|FG000|Overall Study|Withdrawal by Subject|8
4712863|NCT02935192|7639841|FG001|Overall Study|Withdrawal by Subject|4
4712864|NCT02935452|7639849|FG000|Overall Study|work and life commintment|3
4712865|NCT02935452|7639850|FG001|Overall Study|work and life commintment|1
4712866|NCT02935673|7639863|FG000|Overall Study|Adverse Event|0
4712867|NCT02935673|7639864|FG001|Overall Study|Adverse Event|1
4712868|NCT02935673|7639865|FG002|Overall Study|Adverse Event|0
4712869|NCT02935673|7639863|FG000|Overall Study|Withdrawal by Subject|1
4712870|NCT02935673|7639864|FG001|Overall Study|Withdrawal by Subject|2
4712871|NCT02935673|7639865|FG002|Overall Study|Withdrawal by Subject|0
4397965|NCT00112437|7174461|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
4397966|NCT00112437|7174462|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
4397967|NCT00112437|7174437|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
4397968|NCT00112437|7174438|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
4397969|NCT00112437|7174439|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
4397970|NCT00112437|7174440|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
4397971|NCT00112437|7174441|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
4397972|NCT00112437|7174442|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
4397973|NCT00112437|7174443|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
4397974|NCT00112437|7174444|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
4397975|NCT00112437|7174445|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
4397976|NCT00112437|7174446|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
4397977|NCT00112437|7174447|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
4397978|NCT00112437|7174448|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
4397979|NCT00112437|7174449|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
4397980|NCT00112437|7174450|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
4397981|NCT00112437|7174451|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
4397982|NCT00112437|7174452|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
4397983|NCT00112437|7174453|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
4397984|NCT00112437|7174454|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
4397985|NCT00112437|7174455|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
4397986|NCT00112437|7174456|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
4397987|NCT00112437|7174457|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2
4397988|NCT00112437|7174458|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1
4397989|NCT00112437|7174459|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
4397990|NCT00112437|7174460|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
4712872|NCT02935842|7639905|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2
4712873|NCT02935842|7639906|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0
4712874|NCT02935842|7639907|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0
4712875|NCT02935842|7639908|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0
4712876|NCT02935842|7639905|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1
4712877|NCT02935842|7639906|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2
4712878|NCT02935842|7639907|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2
4712879|NCT02935842|7639908|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0
4712880|NCT02935842|7639905|FG000|Testing and Therapy Period 3|Accident prior to treatment|2
4712881|NCT02935842|7639906|FG001|Testing and Therapy Period 3|Accident prior to treatment|2
4712882|NCT02935842|7639907|FG002|Testing and Therapy Period 3|Accident prior to treatment|0
4712883|NCT02935842|7639908|FG003|Testing and Therapy Period 3|Accident prior to treatment|0
4712884|NCT02935842|7639905|FG000|Testing and Therapy Period 3|Lost to Follow-up|0
4712885|NCT02935842|7639906|FG001|Testing and Therapy Period 3|Lost to Follow-up|0
4712886|NCT02935842|7639907|FG002|Testing and Therapy Period 3|Lost to Follow-up|0
4712887|NCT02935842|7639908|FG003|Testing and Therapy Period 3|Lost to Follow-up|1
4712888|NCT02935842|7639905|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0
4712889|NCT02935842|7639906|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0
4712890|NCT02935842|7639907|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3
4712891|NCT02935842|7639908|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0
4712892|NCT02935894|7639925|FG000|Overall Study|Subject dismissed|1
4712893|NCT02936037|7639931|FG000|Double-Blind Treatment Period|Protocol Violation|1
4712894|NCT02936037|7639932|FG001|Double-Blind Treatment Period|Protocol Violation|4
4712895|NCT02936037|7639931|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2
4712896|NCT02936037|7639932|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8
4712897|NCT02936037|7639931|FG000|Double-Blind Treatment Period|Lack of Efficacy|4
4712898|NCT02936037|7639932|FG001|Double-Blind Treatment Period|Lack of Efficacy|12
4712899|NCT02936037|7639931|FG000|Double-Blind Treatment Period|Death|0
4712900|NCT02936037|7639932|FG001|Double-Blind Treatment Period|Death|1
4712901|NCT02936037|7639931|FG000|Double-Blind Treatment Period|Adverse Event|11
4712902|NCT02936037|7639932|FG001|Double-Blind Treatment Period|Adverse Event|11
4712903|NCT02936037|7639931|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31
4712904|NCT02936037|7639932|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28
4712905|NCT02936037|7639931|FG000|Double-Blind Treatment Period|Lost to Follow-up|0
4712906|NCT02936037|7639932|FG001|Double-Blind Treatment Period|Lost to Follow-up|1
4712907|NCT02936037|7639931|FG000|Open Label Extension|Adverse Event|0
4712908|NCT02936037|7639932|FG001|Open Label Extension|Adverse Event|3
4712909|NCT02936037|7639931|FG000|Open Label Extension|Other|0
4712910|NCT02936037|7639932|FG001|Open Label Extension|Other|3
4712911|NCT02936037|7639931|FG000|Open Label Extension|Withdrawal by Subject|0
4712912|NCT02936037|7639932|FG001|Open Label Extension|Withdrawal by Subject|4
4736067|NCT03555435|7684809|FG000|Overall Study|Lost to Follow-up|17
4736068|NCT03555435|7684810|FG001|Overall Study|Lost to Follow-up|19
4736069|NCT03555435|7684811|FG002|Overall Study|Lost to Follow-up|8
4736070|NCT03555565|7684819|FG000|Overall Study|Case Report Forms Uncollected|2
4736071|NCT03555565|7684819|FG000|Overall Study|Protocol Deviation|13
4736072|NCT03555890|7684827|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0
4736073|NCT03555890|7684828|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0
4397991|NCT00112437|7174461|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
4397992|NCT00112437|7174462|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
4397993|NCT00112437|7174437|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
4397994|NCT00112437|7174438|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
4397995|NCT00112437|7174439|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
4397996|NCT00112437|7174440|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
4397997|NCT00112437|7174441|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
4397998|NCT00112437|7174442|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
4397999|NCT00112437|7174443|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
4398000|NCT00112437|7174444|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
4398001|NCT00112437|7174445|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
4398002|NCT00112437|7174446|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
4398003|NCT00112437|7174447|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
4398004|NCT00112437|7174448|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
4398005|NCT00112437|7174449|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
4398006|NCT00112437|7174450|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
4398007|NCT00112437|7174451|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
4398008|NCT00112437|7174452|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
4398009|NCT00112437|7174453|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
4398010|NCT00112437|7174454|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
4398011|NCT00112437|7174455|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
4398012|NCT00112437|7174456|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
4398013|NCT00112437|7174457|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1
4398014|NCT00112437|7174458|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
4398015|NCT00112437|7174459|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
4398016|NCT00112437|7174460|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
4398017|NCT00112437|7174461|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
4398018|NCT00112437|7174462|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
4712913|NCT02936635|7639953|FG000|Overall Study|Adverse Event|43
4712914|NCT02936635|7639954|FG001|Overall Study|Adverse Event|25
4712915|NCT02936635|7639953|FG000|Overall Study|Progressive Disease|10
4712916|NCT02936635|7639954|FG001|Overall Study|Progressive Disease|18
4712917|NCT02936635|7639953|FG000|Overall Study|Sponsor Discretion|10
4712918|NCT02936635|7639954|FG001|Overall Study|Sponsor Discretion|16
4712919|NCT02936635|7639953|FG000|Overall Study|Death|9
4712920|NCT02936635|7639954|FG001|Overall Study|Death|15
4712921|NCT02936635|7639953|FG000|Overall Study|Withdrawal by Subject|8
4712922|NCT02936635|7639954|FG001|Overall Study|Withdrawal by Subject|15
4712923|NCT02936635|7639953|FG000|Overall Study|Physician Decision|2
4712924|NCT02936635|7639954|FG001|Overall Study|Physician Decision|9
4712925|NCT02936635|7639953|FG000|Overall Study|Lost to Follow-up|1
4712926|NCT02936635|7639954|FG001|Overall Study|Lost to Follow-up|2
4712927|NCT02936635|7639953|FG000|Overall Study|Protocol Violation|1
4712928|NCT02936635|7639954|FG001|Overall Study|Protocol Violation|0
4712929|NCT02936635|7639953|FG000|Overall Study|Lack of effect/Entry into other study|31
4712930|NCT02936635|7639954|FG001|Overall Study|Lack of effect/Entry into other study|65
4712931|NCT02936869|7639966|FG000|Overall Study|Lost to Follow-up|1
4712932|NCT02936869|7639967|FG001|Overall Study|Lost to Follow-up|3
4712933|NCT02936869|7639966|FG000|Overall Study|Death|0
4712934|NCT02936869|7639967|FG001|Overall Study|Death|1
4712935|NCT02936869|7639966|FG000|Overall Study|Legal Case|0
4712936|NCT02936869|7639967|FG001|Overall Study|Legal Case|1
4712937|NCT02936869|7639966|FG000|Overall Study|Protocol Violation|1
4712938|NCT02936869|7639967|FG001|Overall Study|Protocol Violation|0
4712939|NCT02937350|7640043|FG000|Overall Study|Withdrawal by Subject|0
4712940|NCT02937350|7640044|FG001|Overall Study|Withdrawal by Subject|1
4712941|NCT02937350|7640045|FG002|Overall Study|Withdrawal by Subject|0
4712942|NCT02937454|7640053|FG000|Overall Study|Adverse Event|0
4712943|NCT02937454|7640054|FG001|Overall Study|Adverse Event|1
4712944|NCT02937454|7640053|FG000|Overall Study|Death|98
4712945|NCT02937454|7640054|FG001|Overall Study|Death|95
4712946|NCT02937454|7640053|FG000|Overall Study|Lost to Follow-up|1
4712947|NCT02937454|7640054|FG001|Overall Study|Lost to Follow-up|1
4712948|NCT02937454|7640053|FG000|Overall Study|Physician Decision|0
4712949|NCT02937454|7640054|FG001|Overall Study|Physician Decision|1
4712950|NCT02937454|7640053|FG000|Overall Study|Protocol Violation|6
4712951|NCT02937454|7640054|FG001|Overall Study|Protocol Violation|10
4712952|NCT02937454|7640053|FG000|Overall Study|Withdrawal by Subject|27
4712953|NCT02937454|7640054|FG001|Overall Study|Withdrawal by Subject|15
4712954|NCT02937454|7640053|FG000|Overall Study|Other|8
4712955|NCT02937454|7640054|FG001|Overall Study|Other|5
4712956|NCT02937545|7640072|FG000|Overall Study|Withdrawal by Subject|1
4712957|NCT02937545|7640073|FG001|Overall Study|Withdrawal by Subject|2
4712958|NCT02937545|7640074|FG002|Overall Study|Withdrawal by Subject|6
4712959|NCT02937545|7640075|FG003|Overall Study|Withdrawal by Subject|7
4712960|NCT02937545|7640072|FG000|Overall Study|Lost to Follow-up|1
4712961|NCT02937545|7640073|FG001|Overall Study|Lost to Follow-up|0
4712962|NCT02937545|7640074|FG002|Overall Study|Lost to Follow-up|0
4398019|NCT00112437|7174437|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0
4398020|NCT00112437|7174438|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0
4398021|NCT00112437|7174439|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0
4398022|NCT00112437|7174440|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0
4398023|NCT00112437|7174441|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0
4398024|NCT00112437|7174442|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0
4398025|NCT00112437|7174443|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0
4712963|NCT02937545|7640075|FG003|Overall Study|Lost to Follow-up|0
4712964|NCT02937584|7640096|FG000|Period 1|Adverse Event|1
4712965|NCT02937584|7640097|FG001|Period 1|Adverse Event|2
4712966|NCT02937584|7640096|FG000|Washout|Adverse Event|0
4712967|NCT02937584|7640097|FG001|Washout|Adverse Event|1
4712968|NCT02937636|7640114|FG000|Overall Study|Other (Not specified)|3
4712969|NCT02937636|7640115|FG001|Overall Study|Other (Not specified)|2
4712970|NCT02937701|7640124|FG000|Day 1 to Week 22|Adverse Event|11
4712971|NCT02937701|7640125|FG001|Day 1 to Week 22|Adverse Event|14
4712972|NCT02937701|7640126|FG002|Day 1 to Week 22|Adverse Event|0
4712973|NCT02937701|7640127|FG003|Day 1 to Week 22|Adverse Event|0
4712974|NCT02937701|7640128|FG004|Day 1 to Week 22|Adverse Event|0
4712975|NCT02937701|7640124|FG000|Day 1 to Week 22|Protocol Specified Criteria|7
4712976|NCT02937701|7640125|FG001|Day 1 to Week 22|Protocol Specified Criteria|7
4712977|NCT02937701|7640126|FG002|Day 1 to Week 22|Protocol Specified Criteria|0
4712978|NCT02937701|7640127|FG003|Day 1 to Week 22|Protocol Specified Criteria|0
4712979|NCT02937701|7640128|FG004|Day 1 to Week 22|Protocol Specified Criteria|0
4712980|NCT02937701|7640124|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5
4712981|NCT02937701|7640125|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9
4712982|NCT02937701|7640126|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0
4712983|NCT02937701|7640127|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0
4712984|NCT02937701|7640128|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0
4712985|NCT02937701|7640124|FG000|Day 1 to Week 22|Withdrawal by Subject|6
4712986|NCT02937701|7640125|FG001|Day 1 to Week 22|Withdrawal by Subject|6
4712987|NCT02937701|7640126|FG002|Day 1 to Week 22|Withdrawal by Subject|0
4712988|NCT02937701|7640127|FG003|Day 1 to Week 22|Withdrawal by Subject|0
4712989|NCT02937701|7640128|FG004|Day 1 to Week 22|Withdrawal by Subject|0
4712990|NCT02937701|7640124|FG000|Day 1 to Week 22|Death|1
4712991|NCT02937701|7640125|FG001|Day 1 to Week 22|Death|1
4712992|NCT02937701|7640126|FG002|Day 1 to Week 22|Death|0
4712993|NCT02937701|7640127|FG003|Day 1 to Week 22|Death|0
4712994|NCT02937701|7640128|FG004|Day 1 to Week 22|Death|0
4712995|NCT02937701|7640124|FG000|Day 1 to Week 22|Protocol Violation|1
4712996|NCT02937701|7640125|FG001|Day 1 to Week 22|Protocol Violation|1
4712997|NCT02937701|7640126|FG002|Day 1 to Week 22|Protocol Violation|0
4712998|NCT02937701|7640127|FG003|Day 1 to Week 22|Protocol Violation|0
4712999|NCT02937701|7640128|FG004|Day 1 to Week 22|Protocol Violation|0
4713000|NCT02937701|7640124|FG000|Day 1 to Week 22|Lost to Follow-up|1
4713001|NCT02937701|7640125|FG001|Day 1 to Week 22|Lost to Follow-up|1
4713002|NCT02937701|7640126|FG002|Day 1 to Week 22|Lost to Follow-up|0
4713003|NCT02937701|7640127|FG003|Day 1 to Week 22|Lost to Follow-up|0
4713004|NCT02937701|7640128|FG004|Day 1 to Week 22|Lost to Follow-up|0
4713005|NCT02937701|7640124|FG000|Day 1 to Week 22|Physician Decision|2
4713006|NCT02937701|7640125|FG001|Day 1 to Week 22|Physician Decision|0
4713007|NCT02937701|7640126|FG002|Day 1 to Week 22|Physician Decision|0
4713008|NCT02937701|7640127|FG003|Day 1 to Week 22|Physician Decision|0
4713009|NCT02937701|7640128|FG004|Day 1 to Week 22|Physician Decision|0
4713010|NCT02937701|7640124|FG000|Day 1 to Week 22|Other|1
4713011|NCT02937701|7640125|FG001|Day 1 to Week 22|Other|0
4713012|NCT02937701|7640126|FG002|Day 1 to Week 22|Other|0
4713013|NCT02937701|7640127|FG003|Day 1 to Week 22|Other|0
4713014|NCT02937701|7640128|FG004|Day 1 to Week 22|Other|0
4713015|NCT02937701|7640124|FG000|Week 22 to Week 50|Adverse Event|0
4713016|NCT02937701|7640125|FG001|Week 22 to Week 50|Adverse Event|0
4713017|NCT02937701|7640126|FG002|Week 22 to Week 50|Adverse Event|10
4713018|NCT02937701|7640127|FG003|Week 22 to Week 50|Adverse Event|3
4713019|NCT02937701|7640128|FG004|Week 22 to Week 50|Adverse Event|3
4713020|NCT02937701|7640124|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0
4713021|NCT02937701|7640125|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0
4713022|NCT02937701|7640126|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10
4713023|NCT02937701|7640127|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3
4713024|NCT02937701|7640128|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2
4713025|NCT02937701|7640124|FG000|Week 22 to Week 50|Withdrawal by Subject|0
4713026|NCT02937701|7640125|FG001|Week 22 to Week 50|Withdrawal by Subject|0
4713027|NCT02937701|7640126|FG002|Week 22 to Week 50|Withdrawal by Subject|8
4713028|NCT02937701|7640127|FG003|Week 22 to Week 50|Withdrawal by Subject|2
4713029|NCT02937701|7640128|FG004|Week 22 to Week 50|Withdrawal by Subject|1
4713030|NCT02937701|7640124|FG000|Week 22 to Week 50|Lost to Follow-up|0
4713031|NCT02937701|7640125|FG001|Week 22 to Week 50|Lost to Follow-up|0
4713032|NCT02937701|7640126|FG002|Week 22 to Week 50|Lost to Follow-up|2
4713033|NCT02937701|7640127|FG003|Week 22 to Week 50|Lost to Follow-up|0
4713034|NCT02937701|7640128|FG004|Week 22 to Week 50|Lost to Follow-up|1
4713035|NCT02937701|7640124|FG000|Week 22 to Week 50|Physician Decision|0
4713036|NCT02937701|7640125|FG001|Week 22 to Week 50|Physician Decision|0
4713037|NCT02937701|7640126|FG002|Week 22 to Week 50|Physician Decision|2
4398026|NCT00112437|7174444|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0
4398027|NCT00112437|7174445|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0
4398028|NCT00112437|7174446|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0
4398029|NCT00112437|7174447|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0
4398030|NCT00112437|7174448|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0
4398031|NCT00112437|7174449|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0
4398032|NCT00112437|7174450|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0
4398033|NCT00112437|7174451|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0
4398034|NCT00112437|7174452|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0
4398035|NCT00112437|7174453|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0
4398036|NCT00112437|7174454|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0
4398037|NCT00112437|7174455|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0
4398038|NCT00112437|7174456|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0
4398039|NCT00112437|7174457|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0
4398040|NCT00112437|7174458|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4
4398041|NCT00112437|7174459|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0
4398042|NCT00112437|7174460|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0
4398043|NCT00112437|7174461|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0
4398044|NCT00112437|7174462|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0
4628566|NCT01862640|7495979|FG000|Overall Study|Protocol Deviation|0
4713038|NCT02937701|7640127|FG003|Week 22 to Week 50|Physician Decision|0
4713039|NCT02937701|7640128|FG004|Week 22 to Week 50|Physician Decision|1
4713040|NCT02937701|7640124|FG000|Week 22 to Week 50|Other|0
4713041|NCT02937701|7640125|FG001|Week 22 to Week 50|Other|0
4713042|NCT02937701|7640126|FG002|Week 22 to Week 50|Other|0
4713043|NCT02937701|7640127|FG003|Week 22 to Week 50|Other|0
4713044|NCT02937701|7640128|FG004|Week 22 to Week 50|Other|1
4713045|NCT02937740|7640142|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3
4713046|NCT02937740|7640143|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14
4713047|NCT02937740|7640142|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0
4713048|NCT02937740|7640143|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10
4713049|NCT02937740|7640142|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2
4713050|NCT02937740|7640143|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7
4713051|NCT02937740|7640142|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1
4713052|NCT02937740|7640143|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0
4713053|NCT02937740|7640142|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0
4713054|NCT02937740|7640143|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1
4713055|NCT02937740|7640142|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0
4713056|NCT02937740|7640143|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1
4713057|NCT02937870|7640155|FG000|Overall Study|Adverse Event|1
4713058|NCT02937870|7640155|FG000|Overall Study|Protocol Deviation|2
4713059|NCT02938520|7640216|FG000|Overall Study|On-going at the time of analysis|258
4713060|NCT02938520|7640217|FG001|Overall Study|On-going at the time of analysis|261
4713061|NCT02938520|7640216|FG000|Overall Study|Physician Decision|2
4713062|NCT02938520|7640217|FG001|Overall Study|Physician Decision|5
4713063|NCT02938520|7640216|FG000|Overall Study|Lost to Follow-up|2
4713064|NCT02938520|7640217|FG001|Overall Study|Lost to Follow-up|2
4713065|NCT02938520|7640216|FG000|Overall Study|Withdrawal by Subject|7
4398045|NCT00112437|7174437|FG000|Years 4-5 (24-Month Extension)|Participant moved|0
4398046|NCT00112437|7174438|FG001|Years 4-5 (24-Month Extension)|Participant moved|0
4628567|NCT01862640|7495980|FG001|Overall Study|Protocol Deviation|0
4628568|NCT01862640|7495981|FG002|Overall Study|Protocol Deviation|1
4628569|NCT01862640|7495982|FG003|Overall Study|Protocol Deviation|0
4628570|NCT01862796|7495994|FG000|Overall Study|Prohibited medications|0
4628571|NCT01862796|7495995|FG001|Overall Study|Prohibited medications|0
4628572|NCT01862796|7495996|FG002|Overall Study|Prohibited medications|1
4628573|NCT01862874|7496006|FG000|Overall Study|Randomized not treated|1
4628574|NCT01862874|7496007|FG001|Overall Study|Randomized not treated|0
4628575|NCT01862874|7496006|FG000|Overall Study|Adverse Event|0
4628576|NCT01862874|7496007|FG001|Overall Study|Adverse Event|3
4628577|NCT01862874|7496006|FG000|Overall Study|Lost to Follow-up|26
4628578|NCT01862874|7496007|FG001|Overall Study|Lost to Follow-up|29
4628579|NCT01862874|7496006|FG000|Overall Study|Physician Decision|5
4628580|NCT01862874|7496007|FG001|Overall Study|Physician Decision|3
4628581|NCT01862874|7496006|FG000|Overall Study|Withdrawn by parent/guardian|1
4628582|NCT01862874|7496007|FG001|Overall Study|Withdrawn by parent/guardian|1
4628583|NCT01862874|7496006|FG000|Overall Study|Withdrawal by Subject|46
4628584|NCT01862874|7496007|FG001|Overall Study|Withdrawal by Subject|40
4628585|NCT01862874|7496006|FG000|Overall Study|Death|0
4628586|NCT01862874|7496007|FG001|Overall Study|Death|1
4628587|NCT01862991|7496016|FG000|Overall Study|Lost to Follow-up|2
4628588|NCT01862991|7496017|FG001|Overall Study|Lost to Follow-up|1
4628589|NCT01862991|7496018|FG002|Overall Study|Lost to Follow-up|1
4628590|NCT01862991|7496016|FG000|Overall Study|Protocol Violation|1
4628591|NCT01862991|7496017|FG001|Overall Study|Protocol Violation|0
4628592|NCT01862991|7496018|FG002|Overall Study|Protocol Violation|0
4633276|NCT01909804|7503299|FG003|Overall Study|Protocol Violation|0
4633277|NCT01909804|7503300|FG004|Overall Study|Protocol Violation|0
4633278|NCT01909804|7503301|FG005|Overall Study|Protocol Violation|0
4633279|NCT01909804|7503302|FG006|Overall Study|Protocol Violation|0
4398047|NCT00112437|7174439|FG002|Years 4-5 (24-Month Extension)|Participant moved|0
4398048|NCT00112437|7174440|FG003|Years 4-5 (24-Month Extension)|Participant moved|0
4398049|NCT00112437|7174441|FG004|Years 4-5 (24-Month Extension)|Participant moved|0
4398050|NCT00112437|7174442|FG005|Years 4-5 (24-Month Extension)|Participant moved|0
4398051|NCT00112437|7174443|FG006|Years 4-5 (24-Month Extension)|Participant moved|0
4398052|NCT00112437|7174444|FG007|Years 4-5 (24-Month Extension)|Participant moved|0
4398053|NCT00112437|7174445|FG008|Years 4-5 (24-Month Extension)|Participant moved|0
4398054|NCT00112437|7174446|FG009|Years 4-5 (24-Month Extension)|Participant moved|0
4398055|NCT00112437|7174447|FG010|Years 4-5 (24-Month Extension)|Participant moved|0
4398056|NCT00112437|7174448|FG011|Years 4-5 (24-Month Extension)|Participant moved|0
4398057|NCT00112437|7174449|FG012|Years 4-5 (24-Month Extension)|Participant moved|0
4398058|NCT00112437|7174450|FG013|Years 4-5 (24-Month Extension)|Participant moved|0
4398059|NCT00112437|7174451|FG014|Years 4-5 (24-Month Extension)|Participant moved|0
4398060|NCT00112437|7174452|FG015|Years 4-5 (24-Month Extension)|Participant moved|0
4398061|NCT00112437|7174453|FG016|Years 4-5 (24-Month Extension)|Participant moved|0
4398062|NCT00112437|7174454|FG017|Years 4-5 (24-Month Extension)|Participant moved|0
4398063|NCT00112437|7174455|FG018|Years 4-5 (24-Month Extension)|Participant moved|0
4398064|NCT00112437|7174456|FG019|Years 4-5 (24-Month Extension)|Participant moved|0
4398065|NCT00112437|7174457|FG020|Years 4-5 (24-Month Extension)|Participant moved|0
4398066|NCT00112437|7174458|FG021|Years 4-5 (24-Month Extension)|Participant moved|1
4518727|NCT00975884|7330974|FG001|Overall Study|Withdrawal by Subject|9
4713066|NCT02938520|7640217|FG001|Overall Study|Withdrawal by Subject|7
4713067|NCT02938520|7640216|FG000|Overall Study|Protocol Violation|0
4713068|NCT02938520|7640217|FG001|Overall Study|Protocol Violation|1
4713069|NCT02938520|7640216|FG000|Overall Study|Lack of Efficacy|5
4713070|NCT02938520|7640217|FG001|Overall Study|Lack of Efficacy|3
4713071|NCT02938520|7640216|FG000|Overall Study|Adverse Event|9
4713072|NCT02938520|7640217|FG001|Overall Study|Adverse Event|4
4713073|NCT02938585|7640230|FG000|Overall Study|Withdrawal by parent or guardian|0
4713074|NCT02938585|7640231|FG001|Overall Study|Withdrawal by parent or guardian|1
4713075|NCT02938585|7640232|FG002|Overall Study|Withdrawal by parent or guardian|0
4713076|NCT02938585|7640233|FG003|Overall Study|Withdrawal by parent or guardian|0
4713077|NCT02938585|7640230|FG000|Overall Study|Withdrawal by Subject|0
4713078|NCT02938585|7640231|FG001|Overall Study|Withdrawal by Subject|0
4713079|NCT02938585|7640232|FG002|Overall Study|Withdrawal by Subject|0
4713080|NCT02938585|7640233|FG003|Overall Study|Withdrawal by Subject|5
4713081|NCT02939014|7640268|FG000|Overall Study|Lost to Follow-up|1
4713082|NCT02939014|7640269|FG001|Overall Study|Lost to Follow-up|0
4713083|NCT02939014|7640268|FG000|Overall Study|Death|4
4713084|NCT02939014|7640269|FG001|Overall Study|Death|3
4713085|NCT02939079|7640278|FG000|Overall Study|Adverse Event|2
4713086|NCT02939079|7640279|FG001|Overall Study|Adverse Event|1
4713087|NCT02939079|7640278|FG000|Overall Study|Lost to Follow-up|0
4713088|NCT02939079|7640279|FG001|Overall Study|Lost to Follow-up|2
4713089|NCT02939079|7640278|FG000|Overall Study|Protocol Violation|1
4713090|NCT02939079|7640279|FG001|Overall Study|Protocol Violation|0
4713091|NCT02939079|7640278|FG000|Overall Study|Withdrawal by Subject|0
4713092|NCT02939079|7640279|FG001|Overall Study|Withdrawal by Subject|1
4713093|NCT02939079|7640278|FG000|Overall Study|relapse during the study|1
4713094|NCT02939079|7640279|FG001|Overall Study|relapse during the study|1
4713095|NCT02939131|7640292|FG000|Overall Study|Unable to get to clinic|6
4713096|NCT02939131|7640293|FG001|Overall Study|Unable to get to clinic|4
4713097|NCT02939131|7640292|FG000|Overall Study|Lost to Follow-up|2
4713098|NCT02939131|7640293|FG001|Overall Study|Lost to Follow-up|4
4713099|NCT02939131|7640292|FG000|Overall Study|severe debilitation|1
4713100|NCT02939131|7640293|FG001|Overall Study|severe debilitation|0
4713101|NCT02939131|7640292|FG000|Overall Study|Other|0
4713102|NCT02939131|7640293|FG001|Overall Study|Other|1
4713103|NCT02939131|7640292|FG000|Overall Study|not willing to adhere to protocol|2
4713104|NCT02939131|7640293|FG001|Overall Study|not willing to adhere to protocol|0
4713105|NCT02939560|7640343|FG000|Overall Study|Withdrawal by Subject|2
4713106|NCT02939560|7640343|FG000|Overall Study|Protocol Violation|1
4713107|NCT02939599|7640349|FG000|Overall Study|Adverse Event|1
4713108|NCT02939599|7640350|FG001|Overall Study|Adverse Event|0
4713109|NCT02939599|7640349|FG000|Overall Study|Study Terminated By Sponsor|2
4713110|NCT02939599|7640350|FG001|Overall Study|Study Terminated By Sponsor|2
4713111|NCT02939716|7640361|FG000|Overall Study|scanner failure|0
4713112|NCT02939716|7640362|FG001|Overall Study|scanner failure|0
4713113|NCT02939716|7640363|FG002|Overall Study|scanner failure|0
4713114|NCT02939716|7640364|FG003|Overall Study|scanner failure|1
4713115|NCT02939716|7640365|FG004|Overall Study|scanner failure|1
4713116|NCT02939716|7640366|FG005|Overall Study|scanner failure|1
4713117|NCT02939781|7640383|FG000|Overall Study|Protocol Violation|8
4713118|NCT02939781|7640383|FG000|Overall Study|Withdrawal by Subject|1
4713119|NCT02939937|7640390|FG000|Overall Study|Adverse Event|5
4713120|NCT02939937|7640391|FG001|Overall Study|Adverse Event|0
4713121|NCT02939937|7640390|FG000|Overall Study|Lost to Follow-up|1
4713122|NCT02939937|7640391|FG001|Overall Study|Lost to Follow-up|3
4713123|NCT02939950|7640399|FG000|Overall Study|Lost to Follow-up|13
4713124|NCT02939950|7640400|FG001|Overall Study|Lost to Follow-up|16
4713125|NCT02939950|7640399|FG000|Overall Study|Positive slit lamp findings|0
4713126|NCT02939950|7640400|FG001|Overall Study|Positive slit lamp findings|1
4398067|NCT00112437|7174459|FG022|Years 4-5 (24-Month Extension)|Participant moved|0
4398068|NCT00112437|7174460|FG023|Years 4-5 (24-Month Extension)|Participant moved|0
4398069|NCT00112437|7174461|FG024|Years 4-5 (24-Month Extension)|Participant moved|0
4398070|NCT00112437|7174462|FG025|Years 4-5 (24-Month Extension)|Participant moved|0
4398071|NCT00112437|7174437|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
4398072|NCT00112437|7174438|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
4398073|NCT00112437|7174439|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
4398074|NCT00112437|7174440|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
4398075|NCT00112437|7174441|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
4398076|NCT00112437|7174442|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
4398077|NCT00112437|7174443|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
4398078|NCT00112437|7174444|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
4398079|NCT00112437|7174445|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
4398080|NCT00112437|7174446|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
4398081|NCT00112437|7174447|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
4398082|NCT00112437|7174448|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
4398083|NCT00112437|7174449|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
4398084|NCT00112437|7174450|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
4398085|NCT00112437|7174451|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
4398086|NCT00112437|7174452|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
4398087|NCT00112437|7174453|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
4398088|NCT00112437|7174454|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
4398089|NCT00112437|7174455|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
4398090|NCT00112437|7174456|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
4398091|NCT00112437|7174457|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1
4398092|NCT00112437|7174458|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2
4398093|NCT00112437|7174459|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
4398094|NCT00112437|7174460|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
4398095|NCT00112437|7174461|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
4398096|NCT00112437|7174462|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
4398097|NCT00112437|7174437|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0
4398098|NCT00112437|7174438|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0
4398099|NCT00112437|7174439|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0
4398100|NCT00112437|7174440|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0
4398101|NCT00112437|7174441|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0
4398102|NCT00112437|7174442|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0
4398103|NCT00112437|7174443|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0
4398104|NCT00112437|7174444|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0
4398105|NCT00112437|7174445|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0
4398106|NCT00112437|7174446|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0
4398107|NCT00112437|7174447|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0
4398108|NCT00112437|7174448|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0
4398109|NCT00112437|7174449|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0
4398110|NCT00112437|7174450|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0
4398111|NCT00112437|7174451|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0
4398112|NCT00112437|7174452|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0
4398113|NCT00112437|7174453|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0
4398114|NCT00112437|7174454|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0
4398115|NCT00112437|7174455|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0
4398116|NCT00112437|7174456|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0
4398117|NCT00112437|7174457|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0
4398118|NCT00112437|7174458|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0
4398119|NCT00112437|7174459|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1
4398120|NCT00112437|7174460|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2
4398121|NCT00112437|7174461|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0
4398122|NCT00112437|7174462|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1
4398123|NCT00112437|7174437|FG000|Years 6-10 (60-Month Extension)|Death|0
4398124|NCT00112437|7174438|FG001|Years 6-10 (60-Month Extension)|Death|0
4398125|NCT00112437|7174439|FG002|Years 6-10 (60-Month Extension)|Death|0
4398126|NCT00112437|7174440|FG003|Years 6-10 (60-Month Extension)|Death|0
4398127|NCT00112437|7174441|FG004|Years 6-10 (60-Month Extension)|Death|0
4398128|NCT00112437|7174442|FG005|Years 6-10 (60-Month Extension)|Death|0
4398129|NCT00112437|7174443|FG006|Years 6-10 (60-Month Extension)|Death|0
4398130|NCT00112437|7174444|FG007|Years 6-10 (60-Month Extension)|Death|0
4398131|NCT00112437|7174445|FG008|Years 6-10 (60-Month Extension)|Death|0
4398132|NCT00112437|7174446|FG009|Years 6-10 (60-Month Extension)|Death|0
4398133|NCT00112437|7174447|FG010|Years 6-10 (60-Month Extension)|Death|0
4398134|NCT00112437|7174448|FG011|Years 6-10 (60-Month Extension)|Death|0
4398135|NCT00112437|7174449|FG012|Years 6-10 (60-Month Extension)|Death|0
4398136|NCT00112437|7174450|FG013|Years 6-10 (60-Month Extension)|Death|0
4398137|NCT00112437|7174451|FG014|Years 6-10 (60-Month Extension)|Death|0
4398138|NCT00112437|7174452|FG015|Years 6-10 (60-Month Extension)|Death|0
4398139|NCT00112437|7174453|FG016|Years 6-10 (60-Month Extension)|Death|0
4398140|NCT00112437|7174454|FG017|Years 6-10 (60-Month Extension)|Death|0
4398141|NCT00112437|7174455|FG018|Years 6-10 (60-Month Extension)|Death|0
4398142|NCT00112437|7174456|FG019|Years 6-10 (60-Month Extension)|Death|0
4398143|NCT00112437|7174457|FG020|Years 6-10 (60-Month Extension)|Death|0
4398144|NCT00112437|7174458|FG021|Years 6-10 (60-Month Extension)|Death|0
4713127|NCT02939950|7640399|FG000|Overall Study|Chalazion upper lid|0
4713128|NCT02939950|7640400|FG001|Overall Study|Chalazion upper lid|1
4713129|NCT02939950|7640399|FG000|Overall Study|Lack of motivation|0
4713130|NCT02939950|7640400|FG001|Overall Study|Lack of motivation|2
4713131|NCT02939950|7640399|FG000|Overall Study|Unacceptable distance lens visual acuity|1
4713132|NCT02939950|7640400|FG001|Overall Study|Unacceptable distance lens visual acuity|1
4713133|NCT02939950|7640399|FG000|Overall Study|Military orders|1
4713134|NCT02939950|7640400|FG001|Overall Study|Military orders|0
4713135|NCT02939950|7640399|FG000|Overall Study|Participant Relocated|5
4713136|NCT02939950|7640400|FG001|Overall Study|Participant Relocated|3
4713137|NCT02939950|7640399|FG000|Overall Study|Study related symptoms|8
4713138|NCT02939950|7640400|FG001|Overall Study|Study related symptoms|8
4713139|NCT02939950|7640399|FG000|Overall Study|Unacceptable lens movement|2
4713140|NCT02939950|7640400|FG001|Overall Study|Unacceptable lens movement|0
4713141|NCT02939950|7640399|FG000|Overall Study|Protocol Violation|6
4713142|NCT02939950|7640400|FG001|Overall Study|Protocol Violation|3
4713143|NCT02939950|7640399|FG000|Overall Study|Physician Decision|2
4713144|NCT02939950|7640400|FG001|Overall Study|Physician Decision|0
4713145|NCT02939950|7640399|FG000|Overall Study|Pregnancy|6
4713146|NCT02939950|7640400|FG001|Overall Study|Pregnancy|7
4713147|NCT02939950|7640399|FG000|Overall Study|Withdrawal by Subject|12
4713148|NCT02939950|7640400|FG001|Overall Study|Withdrawal by Subject|28
4713149|NCT02939950|7640399|FG000|Overall Study|Adverse Event|7
4713150|NCT02939950|7640400|FG001|Overall Study|Adverse Event|3
4713151|NCT02939950|7640399|FG000|Overall Study|Randomized, not dispensed|1
4713152|NCT02939950|7640400|FG001|Overall Study|Randomized, not dispensed|0
4713153|NCT02939950|7640399|FG000|Overall Study|Ineligible at Baseline|2
4713154|NCT02939950|7640400|FG001|Overall Study|Ineligible at Baseline|8
4713155|NCT02940392|7640421|FG000|Overall Study|Lost to Follow-up|3
4713156|NCT02940392|7640421|FG000|Overall Study|Retreatment|3
4713157|NCT02940392|7640421|FG000|Overall Study|Death|2
4771658|NCT01665144|7748475|FG000|Overall Study|New therapy for study indication|2
4771659|NCT01665144|7748476|FG001|Overall Study|New therapy for study indication|1
4771660|NCT01665144|7748475|FG000|Overall Study|Technical problems|2
4713162|NCT02940574|7640436|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1
4713163|NCT02940574|7640437|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0
4713164|NCT02940574|7640436|FG000|1-year Follow-up|Lost to Follow-up|3
4713165|NCT02940574|7640437|FG001|1-year Follow-up|Lost to Follow-up|4
4713166|NCT02940626|7640449|FG000|Overall Study|Death|40
4713167|NCT02940626|7640450|FG001|Overall Study|Death|32
4713168|NCT02940626|7640449|FG000|Overall Study|Lost to Follow-up|5
4713169|NCT02940626|7640450|FG001|Overall Study|Lost to Follow-up|2
4713170|NCT02940626|7640449|FG000|Overall Study|Withdrawal by Subject|1
4713171|NCT02940626|7640450|FG001|Overall Study|Withdrawal by Subject|0
4713172|NCT02940626|7640449|FG000|Overall Study|Transfer to Hospice Care|1
4713173|NCT02940626|7640450|FG001|Overall Study|Transfer to Hospice Care|0
4713174|NCT02940626|7640449|FG000|Overall Study|Prohibited Concomitant Medication|0
4713175|NCT02940626|7640450|FG001|Overall Study|Prohibited Concomitant Medication|1
4713176|NCT02940691|7640458|FG000|Overall Study|Lost to Follow-up|5
4713177|NCT02940691|7640458|FG000|Overall Study|Incarceration|1
4713178|NCT02940730|7640465|FG000|Intervention 2|Physician Decision|7
4713179|NCT02940730|7640466|FG001|Intervention 2|Physician Decision|0
4713180|NCT02940860|7640474|FG000|Overall Study|Non-serious AE|1
4713181|NCT02940860|7640475|FG001|Overall Study|Non-serious AE|2
4713182|NCT02940860|7640474|FG000|Overall Study|Serious AE|7
4713183|NCT02940860|7640475|FG001|Overall Study|Serious AE|3
4713184|NCT02940860|7640474|FG000|Overall Study|Withdrawal by Subject|19
4713185|NCT02940860|7640475|FG001|Overall Study|Withdrawal by Subject|9
4713186|NCT02940860|7640474|FG000|Overall Study|Lost to Follow-up|13
4713187|NCT02940860|7640475|FG001|Overall Study|Lost to Follow-up|7
4713188|NCT02940860|7640474|FG000|Overall Study|Physician Decision|5
4713189|NCT02940860|7640475|FG001|Overall Study|Physician Decision|3
4713190|NCT02940860|7640474|FG000|Overall Study|Sponsor Decision|0
4713191|NCT02940860|7640475|FG001|Overall Study|Sponsor Decision|1
4713192|NCT02940860|7640474|FG000|Overall Study|Protocol Violation|0
4713193|NCT02940860|7640475|FG001|Overall Study|Protocol Violation|2
4713194|NCT02940860|7640474|FG000|Overall Study|Death|3
4713195|NCT02940860|7640475|FG001|Overall Study|Death|2
4713196|NCT02940860|7640474|FG000|Overall Study|Moved, poor venous access, transport|6
4713197|NCT02940860|7640475|FG001|Overall Study|Moved, poor venous access, transport|4
4398145|NCT00112437|7174459|FG022|Years 6-10 (60-Month Extension)|Death|0
4398146|NCT00112437|7174460|FG023|Years 6-10 (60-Month Extension)|Death|2
4713198|NCT02940860|7640474|FG000|Overall Study|Not treated|2
4713199|NCT02940860|7640475|FG001|Overall Study|Not treated|2
4713200|NCT02940886|7640485|FG000|Overall Study|Adverse Event|7
4713201|NCT02940886|7640486|FG001|Overall Study|Adverse Event|3
4713202|NCT02940886|7640485|FG000|Overall Study|Protocol Violation|0
4713203|NCT02940886|7640486|FG001|Overall Study|Protocol Violation|2
4713204|NCT02940886|7640485|FG000|Overall Study|Withdrawal by Subject|28
4713205|NCT02940886|7640486|FG001|Overall Study|Withdrawal by Subject|20
4398147|NCT00112437|7174461|FG024|Years 6-10 (60-Month Extension)|Death|0
4398148|NCT00112437|7174462|FG025|Years 6-10 (60-Month Extension)|Death|0
4398149|NCT00112437|7174437|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
4398150|NCT00112437|7174438|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
4398151|NCT00112437|7174439|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
4398152|NCT00112437|7174440|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
4398153|NCT00112437|7174441|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
4398154|NCT00112437|7174442|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
4713206|NCT02940886|7640485|FG000|Overall Study|Death|1
4713207|NCT02940886|7640486|FG001|Overall Study|Death|0
4713208|NCT02940886|7640485|FG000|Overall Study|Lack of Efficacy|1
4713209|NCT02940886|7640486|FG001|Overall Study|Lack of Efficacy|0
4713210|NCT02940886|7640485|FG000|Overall Study|Lost to Follow-up|49
4713211|NCT02940886|7640486|FG001|Overall Study|Lost to Follow-up|21
4713212|NCT02940886|7640485|FG000|Overall Study|Physician Decision|9
4713213|NCT02940886|7640486|FG001|Overall Study|Physician Decision|4
4713214|NCT02940886|7640485|FG000|Overall Study|Sponsor decision|0
4713215|NCT02940886|7640486|FG001|Overall Study|Sponsor decision|1
4713216|NCT02940886|7640485|FG000|Overall Study|No treatment|7
4713217|NCT02940886|7640486|FG001|Overall Study|No treatment|2
4713218|NCT02940886|7640485|FG000|Overall Study|Enrolment error|0
4713219|NCT02940886|7640486|FG001|Overall Study|Enrolment error|1
4713220|NCT02941523|7640496|FG000|Monotherapy|Withdrawal by Subject|0
4713221|NCT02941523|7640497|FG001|Monotherapy|Withdrawal by Subject|1
4713222|NCT02941523|7640496|FG000|Carboplatin Combination Therapy|Adverse Event|0
4713223|NCT02941523|7640497|FG001|Carboplatin Combination Therapy|Adverse Event|1
4713224|NCT02941523|7640496|FG000|Carboplatin Combination Therapy|Death|1
4713225|NCT02941523|7640497|FG001|Carboplatin Combination Therapy|Death|2
4713226|NCT02941523|7640496|FG000|Carboplatin Combination Therapy|Disease progression|2
4713227|NCT02941523|7640497|FG001|Carboplatin Combination Therapy|Disease progression|0
4713228|NCT02941523|7640496|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2
4713229|NCT02941523|7640497|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1
4713230|NCT02941627|7640522|FG000|Overall Study|Death|1
4713231|NCT02941627|7640522|FG000|Overall Study|Surgical failure|1
4713232|NCT02941627|7640522|FG000|Overall Study|cholesteatoma prevented implantation|1
4713233|NCT02942264|7640575|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0
4713234|NCT02942264|7640576|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1
4713235|NCT02942264|7640577|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0
4713236|NCT02942264|7640578|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0
4713237|NCT02942264|7640579|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0
4713238|NCT02942264|7640580|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0
4713239|NCT02942264|7640581|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1
4713240|NCT02942264|7640582|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0
4713241|NCT02942264|7640583|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0
4713242|NCT02942264|7640575|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0
4713243|NCT02942264|7640576|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0
4713244|NCT02942264|7640577|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0
4713245|NCT02942264|7640578|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0
4713246|NCT02942264|7640579|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0
4713247|NCT02942264|7640580|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0
4713248|NCT02942264|7640581|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0
4713249|NCT02942264|7640582|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0
4713250|NCT02942264|7640583|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1
4713251|NCT02942407|7640610|FG000|Overall Study|Lost to Follow-up|3
4713252|NCT02942407|7640611|FG001|Overall Study|Lost to Follow-up|2
4713253|NCT02942407|7640610|FG000|Overall Study|Withdrawal by Subject|7
4713254|NCT02942407|7640611|FG001|Overall Study|Withdrawal by Subject|9
4713255|NCT02942407|7640610|FG000|Overall Study|Death|16
4713256|NCT02942407|7640611|FG001|Overall Study|Death|13
4713257|NCT02942485|7640627|FG000|Overall Study|Lost to Follow-up|1
4713258|NCT02942485|7640628|FG001|Overall Study|Lost to Follow-up|0
4713259|NCT02942576|7640636|FG000|Overall Study|Adverse Event|28
4713260|NCT02942576|7640637|FG001|Overall Study|Adverse Event|6
4713261|NCT02942576|7640636|FG000|Overall Study|Withdrawal by Subject|7
4713262|NCT02942576|7640637|FG001|Overall Study|Withdrawal by Subject|5
4713263|NCT02942576|7640636|FG000|Overall Study|Physician Decision|1
4713264|NCT02942576|7640637|FG001|Overall Study|Physician Decision|4
4713265|NCT02942576|7640636|FG000|Overall Study|Other|10
4713266|NCT02942576|7640637|FG001|Overall Study|Other|8
4713267|NCT02942771|7640655|FG000|Overall Study|Adverse Event|1
4713268|NCT02942771|7640656|FG001|Overall Study|Adverse Event|0
4713269|NCT02942771|7640657|FG002|Overall Study|Adverse Event|0
4713270|NCT02942771|7640658|FG003|Overall Study|Adverse Event|0
4713271|NCT02942771|7640659|FG004|Overall Study|Adverse Event|2
4713272|NCT02942771|7640655|FG000|Overall Study|Lost to Follow-up|1
4398155|NCT00112437|7174443|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
4713273|NCT02942771|7640656|FG001|Overall Study|Lost to Follow-up|0
4713274|NCT02942771|7640657|FG002|Overall Study|Lost to Follow-up|0
4713275|NCT02942771|7640658|FG003|Overall Study|Lost to Follow-up|0
4713276|NCT02942771|7640659|FG004|Overall Study|Lost to Follow-up|0
4713277|NCT02942771|7640655|FG000|Overall Study|Withdrawal by Subject|1
4398156|NCT00112437|7174444|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
4398157|NCT00112437|7174445|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
4398158|NCT00112437|7174446|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
4398159|NCT00112437|7174447|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
4398160|NCT00112437|7174448|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
4398161|NCT00112437|7174449|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
4398162|NCT00112437|7174450|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
4398163|NCT00112437|7174451|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
4398164|NCT00112437|7174452|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
4398165|NCT00112437|7174453|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
4398166|NCT00112437|7174454|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
4398167|NCT00112437|7174455|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
4398168|NCT00112437|7174456|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
4398169|NCT00112437|7174457|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
4398170|NCT00112437|7174458|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
4398171|NCT00112437|7174459|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
4398172|NCT00112437|7174460|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
4398173|NCT00112437|7174461|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
4398174|NCT00112437|7174462|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1
4398175|NCT00112437|7174437|FG000|Years 6-10 (60-Month Extension)|Other|0
4398176|NCT00112437|7174438|FG001|Years 6-10 (60-Month Extension)|Other|0
4398177|NCT00112437|7174439|FG002|Years 6-10 (60-Month Extension)|Other|0
4398178|NCT00112437|7174440|FG003|Years 6-10 (60-Month Extension)|Other|0
4398179|NCT00112437|7174441|FG004|Years 6-10 (60-Month Extension)|Other|0
4398180|NCT00112437|7174442|FG005|Years 6-10 (60-Month Extension)|Other|0
4398181|NCT00112437|7174443|FG006|Years 6-10 (60-Month Extension)|Other|0
4398182|NCT00112437|7174444|FG007|Years 6-10 (60-Month Extension)|Other|0
4398183|NCT00112437|7174445|FG008|Years 6-10 (60-Month Extension)|Other|0
4398184|NCT00112437|7174446|FG009|Years 6-10 (60-Month Extension)|Other|0
4398185|NCT00112437|7174447|FG010|Years 6-10 (60-Month Extension)|Other|0
4398186|NCT00112437|7174448|FG011|Years 6-10 (60-Month Extension)|Other|0
4398187|NCT00112437|7174449|FG012|Years 6-10 (60-Month Extension)|Other|0
4398188|NCT00112437|7174450|FG013|Years 6-10 (60-Month Extension)|Other|0
4398189|NCT00112437|7174451|FG014|Years 6-10 (60-Month Extension)|Other|0
4398190|NCT00112437|7174452|FG015|Years 6-10 (60-Month Extension)|Other|0
4398191|NCT00112437|7174453|FG016|Years 6-10 (60-Month Extension)|Other|0
4398192|NCT00112437|7174454|FG017|Years 6-10 (60-Month Extension)|Other|0
4398193|NCT00112437|7174455|FG018|Years 6-10 (60-Month Extension)|Other|0
4398194|NCT00112437|7174456|FG019|Years 6-10 (60-Month Extension)|Other|0
4398195|NCT00112437|7174457|FG020|Years 6-10 (60-Month Extension)|Other|0
4398196|NCT00112437|7174458|FG021|Years 6-10 (60-Month Extension)|Other|0
4398197|NCT00112437|7174459|FG022|Years 6-10 (60-Month Extension)|Other|0
4398198|NCT00112437|7174460|FG023|Years 6-10 (60-Month Extension)|Other|0
4398199|NCT00112437|7174461|FG024|Years 6-10 (60-Month Extension)|Other|1
4398200|NCT00112437|7174462|FG025|Years 6-10 (60-Month Extension)|Other|0
4398201|NCT00112437|7174437|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0
4398202|NCT00112437|7174438|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0
4398203|NCT00112437|7174439|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0
4398204|NCT00112437|7174440|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0
4398205|NCT00112437|7174441|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0
4398206|NCT00112437|7174442|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0
4398207|NCT00112437|7174443|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0
4398208|NCT00112437|7174444|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0
4398209|NCT00112437|7174445|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0
4398210|NCT00112437|7174446|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0
4398211|NCT00112437|7174447|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0
4398212|NCT00112437|7174448|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0
4398213|NCT00112437|7174449|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0
4398214|NCT00112437|7174450|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0
4398215|NCT00112437|7174451|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0
4398216|NCT00112437|7174452|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0
4398217|NCT00112437|7174453|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0
4398218|NCT00112437|7174454|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0
4398219|NCT00112437|7174455|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0
4398220|NCT00112437|7174456|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0
4398221|NCT00112437|7174457|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0
4398222|NCT00112437|7174458|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0
4398223|NCT00112437|7174459|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0
4398224|NCT00112437|7174460|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2
4398225|NCT00112437|7174461|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0
4398226|NCT00112437|7174462|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0
4398227|NCT00112437|7174437|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
4398228|NCT00112437|7174438|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
4398229|NCT00112437|7174439|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
4398230|NCT00112437|7174440|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
4398231|NCT00112437|7174441|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
4398232|NCT00112437|7174442|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
4398233|NCT00112437|7174443|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
4398234|NCT00112437|7174444|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
4398235|NCT00112437|7174445|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
4398236|NCT00112437|7174446|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
4398237|NCT00112437|7174447|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
4398238|NCT00112437|7174448|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
4398239|NCT00112437|7174449|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
4398240|NCT00112437|7174450|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
4398241|NCT00112437|7174451|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
4398242|NCT00112437|7174452|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
4398243|NCT00112437|7174453|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
4398244|NCT00112437|7174454|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
4398245|NCT00112437|7174455|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
4398246|NCT00112437|7174456|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
4398247|NCT00112437|7174457|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
4398248|NCT00112437|7174458|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
4398249|NCT00112437|7174459|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4
4398250|NCT00112437|7174460|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6
4398251|NCT00112437|7174461|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
4398252|NCT00112437|7174462|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3
4398253|NCT00112463|7174516|FG000|Overall Study|Physician Decision|1
4398254|NCT00112463|7174516|FG000|Overall Study|Progression|30
4398255|NCT00112463|7174516|FG000|Overall Study|Second Primary|1
4398256|NCT00112463|7174516|FG000|Overall Study|Toxicity|3
4398257|NCT00112463|7174516|FG000|Overall Study|Withdrawal by Subject|2
4398258|NCT00112463|7174516|FG000|Overall Study|Never started treatment|2
4398259|NCT00112489|7174521|FG000|Overall Study|Refused further treatment|8
4398260|NCT00112489|7174521|FG000|Overall Study|Adverse Event|12
4398261|NCT00112489|7174521|FG000|Overall Study|Death|2
4398262|NCT00112489|7174521|FG000|Overall Study|Other, Not Specified|9
4398263|NCT00112489|7174521|FG000|Overall Study|Patient never treated|2
4398264|NCT00112489|7174521|FG000|Overall Study|Ineligible|7
4398265|NCT00112502|7174539|FG000|Overall Study|Withdrawal by Subject|0
4398266|NCT00112502|7174540|FG001|Overall Study|Withdrawal by Subject|1
4398267|NCT00112502|7174541|FG002|Overall Study|Withdrawal by Subject|1
4398268|NCT00112502|7174542|FG003|Overall Study|Withdrawal by Subject|4
4398269|NCT00112502|7174543|FG004|Overall Study|Withdrawal by Subject|2
4398270|NCT00112502|7174544|FG005|Overall Study|Withdrawal by Subject|5
4398271|NCT00112502|7174545|FG006|Overall Study|Withdrawal by Subject|3
4398272|NCT00112502|7174546|FG007|Overall Study|Withdrawal by Subject|7
4398273|NCT00112580|7174576|FG000|Overall Study|Adverse Event|1
4398274|NCT00112580|7174577|FG001|Overall Study|Adverse Event|2
4398275|NCT00112580|7174576|FG000|Overall Study|Disease progression|5
4398276|NCT00112580|7174577|FG001|Overall Study|Disease progression|16
4398277|NCT00112580|7174576|FG000|Overall Study|Participant withdrew consent|2
4398278|NCT00112580|7174577|FG001|Overall Study|Participant withdrew consent|1
4398279|NCT00112736|7174616|FG000|Overall Study|1 pt never had had RX due rapid decline|1
4398280|NCT00112736|7174617|FG001|Overall Study|1 pt never had had RX due rapid decline|0
4398281|NCT00112866|7174653|FG000|Overall Study|Protocol Violation|1
4398282|NCT00112866|7174654|FG001|Overall Study|Protocol Violation|0
4398283|NCT00112866|7174653|FG000|Overall Study|did not start treatment post-op|1
4398284|NCT00112866|7174654|FG001|Overall Study|did not start treatment post-op|2
4398285|NCT00112905|7174668|FG000|Overall Study|Adverse Event|4
4398286|NCT00112905|7174668|FG000|Overall Study|Death|1
4398287|NCT00112905|7174668|FG000|Overall Study|Ineligibility|5
4398288|NCT00112905|7174668|FG000|Overall Study|Alternative treatment|1
4398289|NCT00112905|7174668|FG000|Overall Study|performance status was deteiorating|1
4398290|NCT00112957|7174685|FG000|Overall Study|Progressive disease|18
4398291|NCT00112957|7174685|FG000|Overall Study|Physician Decision|1
4398292|NCT00113087|7174700|FG000|Overall Study|Death or Transplant|14
4398293|NCT00113087|7174701|FG001|Overall Study|Death or Transplant|16
4398294|NCT00113087|7174700|FG000|Overall Study|Family or MD withdrew subject|10
4628593|NCT01863368|7496051|FG000|Phase I, Day 0 to Day 35|Adverse Event|2
4628594|NCT01863368|7496052|FG001|Phase I, Day 0 to Day 35|Adverse Event|4
4628595|NCT01863368|7496051|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1
4628596|NCT01863368|7496052|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0
4628597|NCT01863368|7496051|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0
4628598|NCT01863368|7496052|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1
4628599|NCT01863368|7496051|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0
4628600|NCT01863368|7496052|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2
4628601|NCT01863368|7496051|FG000|Phase II, Day 35 to Day 90|Adverse Event|1
4628602|NCT01863368|7496052|FG001|Phase II, Day 35 to Day 90|Adverse Event|0
4628603|NCT01863368|7496051|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1
4628604|NCT01863368|7496052|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0
4628605|NCT01863433|7496059|FG000|Overall Study|Protocol Violation|1
4628606|NCT01863667|7496078|FG000|Overall Study|Adverse Event|1
4628607|NCT01863667|7496079|FG001|Overall Study|Adverse Event|0
4628608|NCT01863667|7496078|FG000|Overall Study|Study terminated by Sponsor|30
4628609|NCT01863667|7496079|FG001|Overall Study|Study terminated by Sponsor|30
4628610|NCT01863667|7496078|FG000|Overall Study|Withdrawal by Subject|2
4628611|NCT01863667|7496079|FG001|Overall Study|Withdrawal by Subject|2
4628612|NCT01863680|7496085|FG000|Overall Study|Adverse Event|17
4628613|NCT01863680|7496085|FG000|Overall Study|Risk of OHSS|17
4628614|NCT01863680|7496085|FG000|Overall Study|Spontaneous pregnancy|2
4628615|NCT01863680|7496085|FG000|Overall Study|Withdrawal by Subject|1
4628616|NCT01863680|7496085|FG000|Overall Study|Did not undergo IVF/ET|14
4628617|NCT01863680|7496085|FG000|Overall Study|Other|6
4628618|NCT01863732|7496093|FG000|Overall Study|Adverse Event|2
4628619|NCT01863732|7496094|FG001|Overall Study|Adverse Event|0
4628620|NCT01863732|7496095|FG002|Overall Study|Adverse Event|3
4628621|NCT01863732|7496096|FG003|Overall Study|Adverse Event|3
4628622|NCT01863732|7496093|FG000|Overall Study|Lack of Efficacy|1
4628623|NCT01863732|7496094|FG001|Overall Study|Lack of Efficacy|0
4628624|NCT01863732|7496095|FG002|Overall Study|Lack of Efficacy|2
4628625|NCT01863732|7496096|FG003|Overall Study|Lack of Efficacy|1
4628626|NCT01863732|7496093|FG000|Overall Study|Lost to Follow-up|2
4628627|NCT01863732|7496094|FG001|Overall Study|Lost to Follow-up|2
4628628|NCT01863732|7496095|FG002|Overall Study|Lost to Follow-up|1
4628629|NCT01863732|7496096|FG003|Overall Study|Lost to Follow-up|1
4628630|NCT01863732|7496093|FG000|Overall Study|Physician Decision|1
4628631|NCT01863732|7496094|FG001|Overall Study|Physician Decision|0
4628632|NCT01863732|7496095|FG002|Overall Study|Physician Decision|1
4628633|NCT01863732|7496096|FG003|Overall Study|Physician Decision|0
4628634|NCT01863732|7496093|FG000|Overall Study|Pregnancy|0
4628635|NCT01863732|7496094|FG001|Overall Study|Pregnancy|0
4628636|NCT01863732|7496095|FG002|Overall Study|Pregnancy|0
4628637|NCT01863732|7496096|FG003|Overall Study|Pregnancy|1
4628638|NCT01863732|7496093|FG000|Overall Study|Technical problems|0
4628639|NCT01863732|7496094|FG001|Overall Study|Technical problems|1
4628640|NCT01863732|7496095|FG002|Overall Study|Technical problems|1
4628641|NCT01863732|7496096|FG003|Overall Study|Technical problems|0
4628642|NCT01863732|7496093|FG000|Overall Study|Subject/guardian decision|6
4628643|NCT01863732|7496094|FG001|Overall Study|Subject/guardian decision|9
4628644|NCT01863732|7496095|FG002|Overall Study|Subject/guardian decision|3
4398295|NCT00113087|7174701|FG001|Overall Study|Family or MD withdrew subject|5
4398296|NCT00113269|7174719|FG000|Overall Study|Not transplanted, donor issues|4
4398297|NCT00113269|7174720|FG001|Overall Study|Not transplanted, donor issues|0
4398298|NCT00113269|7174721|FG002|Overall Study|Not transplanted, donor issues|2
4398299|NCT00113269|7174722|FG003|Overall Study|Not transplanted, donor issues|2
4398300|NCT00113269|7174719|FG000|Overall Study|Not transplanted, recipient issues|2
4398301|NCT00113269|7174720|FG001|Overall Study|Not transplanted, recipient issues|1
4398302|NCT00113269|7174721|FG002|Overall Study|Not transplanted, recipient issues|7
4398303|NCT00113269|7174722|FG003|Overall Study|Not transplanted, recipient issues|4
4398304|NCT00113269|7174719|FG000|Overall Study|Early graft loss, technical|0
4398305|NCT00113269|7174720|FG001|Overall Study|Early graft loss, technical|0
4398306|NCT00113269|7174721|FG002|Overall Study|Early graft loss, technical|2
4398307|NCT00113269|7174722|FG003|Overall Study|Early graft loss, technical|0
4398308|NCT00113269|7174719|FG000|Overall Study|Death in operating room|0
4398309|NCT00113269|7174720|FG001|Overall Study|Death in operating room|0
4398310|NCT00113269|7174721|FG002|Overall Study|Death in operating room|0
4398311|NCT00113269|7174722|FG003|Overall Study|Death in operating room|1
4398312|NCT00113269|7174719|FG000|Overall Study|Did not meet eligibility - pre-treatment|0
4398313|NCT00113269|7174720|FG001|Overall Study|Did not meet eligibility - pre-treatment|0
4398314|NCT00113269|7174721|FG002|Overall Study|Did not meet eligibility - pre-treatment|0
4398315|NCT00113269|7174722|FG003|Overall Study|Did not meet eligibility - pre-treatment|2
4398316|NCT00113269|7174719|FG000|Overall Study|Adverse Event|2
4398317|NCT00113269|7174720|FG001|Overall Study|Adverse Event|7
4398318|NCT00113269|7174721|FG002|Overall Study|Adverse Event|11
4398319|NCT00113269|7174722|FG003|Overall Study|Adverse Event|7
4398320|NCT00113269|7174719|FG000|Overall Study|Withdrawal by Subject|4
4398321|NCT00113269|7174720|FG001|Overall Study|Withdrawal by Subject|3
4398322|NCT00113269|7174721|FG002|Overall Study|Withdrawal by Subject|4
4398323|NCT00113269|7174722|FG003|Overall Study|Withdrawal by Subject|2
4398324|NCT00113269|7174719|FG000|Overall Study|Graft loss|6
4628645|NCT01863732|7496096|FG003|Overall Study|Subject/guardian decision|1
4628646|NCT01863732|7496093|FG000|Overall Study|Death|1
4628647|NCT01863732|7496094|FG001|Overall Study|Death|0
4628648|NCT01863732|7496095|FG002|Overall Study|Death|0
4628649|NCT01863732|7496096|FG003|Overall Study|Death|1
4628650|NCT01863758|7496105|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1
4628651|NCT01863758|7496105|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1
4628652|NCT01863771|7496109|FG000|Induction Phase|Adverse Event|9
4628653|NCT01863771|7496110|FG001|Induction Phase|Adverse Event|0
4398325|NCT00113269|7174720|FG001|Overall Study|Graft loss|6
4628654|NCT01863771|7496111|FG002|Induction Phase|Adverse Event|0
4398326|NCT00113269|7174721|FG002|Overall Study|Graft loss|4
4398327|NCT00113269|7174722|FG003|Overall Study|Graft loss|9
4628655|NCT01863771|7496112|FG003|Induction Phase|Adverse Event|0
4398328|NCT00113269|7174719|FG000|Overall Study|Protocol Violation|1
4398329|NCT00113269|7174720|FG001|Overall Study|Protocol Violation|0
4398330|NCT00113269|7174721|FG002|Overall Study|Protocol Violation|4
4398331|NCT00113269|7174722|FG003|Overall Study|Protocol Violation|2
4398332|NCT00113269|7174719|FG000|Overall Study|Lost to Follow-up|2
4398333|NCT00113269|7174720|FG001|Overall Study|Lost to Follow-up|3
4398334|NCT00113269|7174721|FG002|Overall Study|Lost to Follow-up|6
4398335|NCT00113269|7174722|FG003|Overall Study|Lost to Follow-up|3
4398336|NCT00113269|7174719|FG000|Overall Study|Sponsor elected to discontinue patient|1
4398337|NCT00113269|7174720|FG001|Overall Study|Sponsor elected to discontinue patient|0
4398338|NCT00113269|7174721|FG002|Overall Study|Sponsor elected to discontinue patient|0
4398339|NCT00113269|7174722|FG003|Overall Study|Sponsor elected to discontinue patient|1
4398340|NCT00113269|7174719|FG000|Overall Study|Discontinued due to rejection|0
4398341|NCT00113269|7174720|FG001|Overall Study|Discontinued due to rejection|0
4398342|NCT00113269|7174721|FG002|Overall Study|Discontinued due to rejection|1
4398343|NCT00113269|7174722|FG003|Overall Study|Discontinued due to rejection|0
4398344|NCT00113269|7174719|FG000|Overall Study|Moved|0
4398345|NCT00113269|7174720|FG001|Overall Study|Moved|1
4398346|NCT00113269|7174721|FG002|Overall Study|Moved|0
4398347|NCT00113269|7174722|FG003|Overall Study|Moved|3
4398348|NCT00113269|7174719|FG000|Overall Study|Received pancreas transplant|0
4398349|NCT00113269|7174720|FG001|Overall Study|Received pancreas transplant|0
4398350|NCT00113269|7174721|FG002|Overall Study|Received pancreas transplant|0
4398351|NCT00113269|7174722|FG003|Overall Study|Received pancreas transplant|2
4398352|NCT00113269|7174719|FG000|Overall Study|Withdrew consent, Prednisone initiated|0
4398353|NCT00113269|7174720|FG001|Overall Study|Withdrew consent, Prednisone initiated|0
4398354|NCT00113269|7174721|FG002|Overall Study|Withdrew consent, Prednisone initiated|0
4398355|NCT00113269|7174722|FG003|Overall Study|Withdrew consent, Prednisone initiated|1
4398356|NCT00113269|7174719|FG000|Overall Study|Did not meet eligibility criteria|1
4398357|NCT00113269|7174720|FG001|Overall Study|Did not meet eligibility criteria|0
4398358|NCT00113269|7174721|FG002|Overall Study|Did not meet eligibility criteria|0
4398359|NCT00113269|7174722|FG003|Overall Study|Did not meet eligibility criteria|1
4398360|NCT00113269|7174719|FG000|Overall Study|Unable to return for follow up|2
4398361|NCT00113269|7174720|FG001|Overall Study|Unable to return for follow up|1
4398362|NCT00113269|7174721|FG002|Overall Study|Unable to return for follow up|0
4398363|NCT00113269|7174722|FG003|Overall Study|Unable to return for follow up|0
4398364|NCT00113295|7174734|FG000|Overall Study|Adverse Event|4
4398365|NCT00113295|7174735|FG001|Overall Study|Adverse Event|1
4398366|NCT00113295|7174734|FG000|Overall Study|Unrelated Medical Illness|1
4398367|NCT00113295|7174735|FG001|Overall Study|Unrelated Medical Illness|0
4398368|NCT00113360|7174751|FG000|Overall Study|Adverse Event|3
4398369|NCT00113360|7174751|FG000|Overall Study|Subject required surgery|1
4398370|NCT00113360|7174751|FG000|Overall Study|Did not meet eligibility criteria|3
4398371|NCT00113373|7174755|FG000|Overall Study|Ineligible: wrong primary|1
4398372|NCT00113373|7174755|FG000|Overall Study|Ineligible: second primary|1
4398373|NCT00113373|7174755|FG000|Overall Study|Never Treated|1
4398374|NCT00113490|7174771|FG000|Overall Study|Withdrawal by Subject|1
4398375|NCT00113490|7174772|FG001|Overall Study|Withdrawal by Subject|3
4398376|NCT00113490|7174771|FG000|Overall Study|Lost to Follow-up|1
4398377|NCT00113490|7174772|FG001|Overall Study|Lost to Follow-up|0
4398378|NCT00113516|7174778|FG000|Part 1|Adverse Event|6
4398379|NCT00113516|7174779|FG001|Part 1|Adverse Event|0
4398380|NCT00113516|7174778|FG000|Part 1|Death|3
4398381|NCT00113516|7174779|FG001|Part 1|Death|0
4398382|NCT00113516|7174778|FG000|Part 1|Other|3
4398383|NCT00113516|7174779|FG001|Part 1|Other|0
4398384|NCT00113516|7174778|FG000|Part 1|Withdrawal by Subject|2
4398385|NCT00113516|7174779|FG001|Part 1|Withdrawal by Subject|0
4398386|NCT00113516|7174778|FG000|Part 1|Lack of Efficacy|2
4398387|NCT00113516|7174779|FG001|Part 1|Lack of Efficacy|0
4398388|NCT00113516|7174778|FG000|Part 1|Did Not Meet Entrance Criteria|1
4398389|NCT00113516|7174779|FG001|Part 1|Did Not Meet Entrance Criteria|0
4398390|NCT00113516|7174778|FG000|Part 1|Laboratory Abnormality|1
4398391|NCT00113516|7174779|FG001|Part 1|Laboratory Abnormality|0
4398392|NCT00113516|7174778|FG000|Part 1|Ongoing|1
4398393|NCT00113516|7174779|FG001|Part 1|Ongoing|0
4398394|NCT00113516|7174778|FG000|Part 1|Missing|65
4398395|NCT00113516|7174779|FG001|Part 1|Missing|0
4398396|NCT00113516|7174778|FG000|Part 2|Adverse Event|0
4398397|NCT00113516|7174779|FG001|Part 2|Adverse Event|16
4398398|NCT00113516|7174778|FG000|Part 2|Death|0
4398399|NCT00113516|7174779|FG001|Part 2|Death|5
4398400|NCT00113516|7174778|FG000|Part 2|Lack of Efficacy|0
4398401|NCT00113516|7174779|FG001|Part 2|Lack of Efficacy|37
4398402|NCT00113516|7174778|FG000|Part 2|Withdrawal by Subject|0
4398403|NCT00113516|7174779|FG001|Part 2|Withdrawal by Subject|3
4398404|NCT00113516|7174778|FG000|Part 2|Other|0
4398405|NCT00113516|7174779|FG001|Part 2|Other|3
4398406|NCT00113516|7174778|FG000|Part 2|Laboratory Abnormality|0
4398407|NCT00113516|7174779|FG001|Part 2|Laboratory Abnormality|1
4398408|NCT00113516|7174778|FG000|Part 2|Ongoing|0
4398409|NCT00113516|7174779|FG001|Part 2|Ongoing|1
4398410|NCT00113529|7174785|FG000|Overall Study|Adverse Event|4
4398411|NCT00113529|7174785|FG000|Overall Study|Lack of Efficacy|20
4398412|NCT00113529|7174785|FG000|Overall Study|Decision of sponsor|6
4398413|NCT00113529|7174785|FG000|Overall Study|Withdrawal by Subject|4
4398414|NCT00113555|7174789|FG000|Overall Study|Baseline Failure|59
4398415|NCT00113555|7174789|FG000|Overall Study|Permanently Explanted|7
4713278|NCT02942771|7640656|FG001|Overall Study|Withdrawal by Subject|0
4713279|NCT02942771|7640657|FG002|Overall Study|Withdrawal by Subject|0
4398416|NCT00113555|7174789|FG000|Overall Study|Death|1
4398417|NCT00113555|7174789|FG000|Overall Study|Missed Followup|4
4398418|NCT00113555|7174789|FG000|Overall Study|Lost to Follow-up|8
4398419|NCT00113568|7174794|FG000|Overall Study|Adverse Event|97
4398420|NCT00113568|7174794|FG000|Overall Study|Death|1
4398421|NCT00113568|7174794|FG000|Overall Study|Lack of Efficacy|30
4398422|NCT00113568|7174794|FG000|Overall Study|Lost to Follow-up|156
4398423|NCT00113568|7174794|FG000|Overall Study|Protocol Violation|32
4398424|NCT00113568|7174794|FG000|Overall Study|Withdrawal by Subject|117
4398425|NCT00113568|7174794|FG000|Overall Study|Other|112
4510889|NCT00923091|7319705|FG006|Period III (Single-Blind)|Protocol Violation|0
4510890|NCT00923091|7319706|FG007|Period III (Single-Blind)|Protocol Violation|0
4510891|NCT00923091|7319707|FG008|Period III (Single-Blind)|Protocol Violation|0
4510892|NCT00923091|7319708|FG009|Period III (Single-Blind)|Protocol Violation|0
4510893|NCT00923091|7319709|FG010|Period III (Single-Blind)|Protocol Violation|0
4510894|NCT00923091|7319710|FG011|Period III (Single-Blind)|Protocol Violation|0
4510895|NCT00923091|7319711|FG012|Period III (Single-Blind)|Protocol Violation|0
4510896|NCT00923091|7319699|FG000|Period III (Single-Blind)|Lost to Follow-up|2
4510897|NCT00923091|7319700|FG001|Period III (Single-Blind)|Lost to Follow-up|0
4510898|NCT00923091|7319701|FG002|Period III (Single-Blind)|Lost to Follow-up|0
4510899|NCT00923091|7319702|FG003|Period III (Single-Blind)|Lost to Follow-up|0
4510900|NCT00923091|7319703|FG004|Period III (Single-Blind)|Lost to Follow-up|0
4510901|NCT00923091|7319704|FG005|Period III (Single-Blind)|Lost to Follow-up|0
4510902|NCT00923091|7319705|FG006|Period III (Single-Blind)|Lost to Follow-up|0
4510903|NCT00923091|7319706|FG007|Period III (Single-Blind)|Lost to Follow-up|0
4510904|NCT00923091|7319707|FG008|Period III (Single-Blind)|Lost to Follow-up|0
4510905|NCT00923091|7319708|FG009|Period III (Single-Blind)|Lost to Follow-up|0
4510906|NCT00923091|7319709|FG010|Period III (Single-Blind)|Lost to Follow-up|0
4510907|NCT00923091|7319710|FG011|Period III (Single-Blind)|Lost to Follow-up|0
4510908|NCT00923091|7319711|FG012|Period III (Single-Blind)|Lost to Follow-up|0
4510909|NCT00923091|7319699|FG000|Period IV (Double-Blind)|Adverse Event|2
4510910|NCT00923091|7319700|FG001|Period IV (Double-Blind)|Adverse Event|0
4510911|NCT00923091|7319701|FG002|Period IV (Double-Blind)|Adverse Event|0
4510912|NCT00923091|7319702|FG003|Period IV (Double-Blind)|Adverse Event|0
4510913|NCT00923091|7319703|FG004|Period IV (Double-Blind)|Adverse Event|0
4510914|NCT00923091|7319704|FG005|Period IV (Double-Blind)|Adverse Event|0
4510915|NCT00923091|7319705|FG006|Period IV (Double-Blind)|Adverse Event|0
4510916|NCT00923091|7319706|FG007|Period IV (Double-Blind)|Adverse Event|0
4510917|NCT00923091|7319707|FG008|Period IV (Double-Blind)|Adverse Event|0
4510918|NCT00923091|7319708|FG009|Period IV (Double-Blind)|Adverse Event|0
4510919|NCT00923091|7319709|FG010|Period IV (Double-Blind)|Adverse Event|0
4510920|NCT00923091|7319710|FG011|Period IV (Double-Blind)|Adverse Event|0
4510921|NCT00923091|7319711|FG012|Period IV (Double-Blind)|Adverse Event|0
4510922|NCT00923091|7319699|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0
4510923|NCT00923091|7319700|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1
4510924|NCT00923091|7319701|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0
4510925|NCT00923091|7319702|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0
4510926|NCT00923091|7319703|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0
4510927|NCT00923091|7319704|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0
4510928|NCT00923091|7319705|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0
4510929|NCT00923091|7319706|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0
4510930|NCT00923091|7319707|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0
4510931|NCT00923091|7319708|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0
4510932|NCT00923091|7319709|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0
4510933|NCT00923091|7319710|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0
4510934|NCT00923091|7319711|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0
4510935|NCT00923091|7319699|FG000|Period IV (Double-Blind)|Protocol Violation|0
4510936|NCT00923091|7319700|FG001|Period IV (Double-Blind)|Protocol Violation|1
4510937|NCT00923091|7319701|FG002|Period IV (Double-Blind)|Protocol Violation|0
4510938|NCT00923091|7319702|FG003|Period IV (Double-Blind)|Protocol Violation|0
4510939|NCT00923091|7319703|FG004|Period IV (Double-Blind)|Protocol Violation|0
4510940|NCT00923091|7319704|FG005|Period IV (Double-Blind)|Protocol Violation|0
4510941|NCT00923091|7319705|FG006|Period IV (Double-Blind)|Protocol Violation|0
4510942|NCT00923091|7319706|FG007|Period IV (Double-Blind)|Protocol Violation|0
4510943|NCT00923091|7319707|FG008|Period IV (Double-Blind)|Protocol Violation|0
4510944|NCT00923091|7319708|FG009|Period IV (Double-Blind)|Protocol Violation|0
4510945|NCT00923091|7319709|FG010|Period IV (Double-Blind)|Protocol Violation|0
4713280|NCT02942771|7640658|FG003|Overall Study|Withdrawal by Subject|0
4510946|NCT00923091|7319710|FG011|Period IV (Double-Blind)|Protocol Violation|0
4510947|NCT00923091|7319711|FG012|Period IV (Double-Blind)|Protocol Violation|0
4510948|NCT00923091|7319699|FG000|Period V (Double -Blind)|Withdrawal by Subject|0
4510949|NCT00923091|7319700|FG001|Period V (Double -Blind)|Withdrawal by Subject|0
4510950|NCT00923091|7319701|FG002|Period V (Double -Blind)|Withdrawal by Subject|0
4713281|NCT02942771|7640659|FG004|Overall Study|Withdrawal by Subject|2
4398426|NCT00113607|7174800|FG000|Overall Study|Adverse Event|40
4398427|NCT00113607|7174801|FG001|Overall Study|Adverse Event|71
4398428|NCT00113607|7174800|FG000|Overall Study|Death|8
4398429|NCT00113607|7174801|FG001|Overall Study|Death|8
4398430|NCT00113607|7174800|FG000|Overall Study|Withdrawal by Subject|50
4398431|NCT00113607|7174801|FG001|Overall Study|Withdrawal by Subject|58
4398432|NCT00113607|7174800|FG000|Overall Study|Lost to Follow-up|0
4398433|NCT00113607|7174801|FG001|Overall Study|Lost to Follow-up|2
4398434|NCT00113607|7174800|FG000|Overall Study|Disease Progression|180
4398435|NCT00113607|7174801|FG001|Overall Study|Disease Progression|142
4398436|NCT00113607|7174800|FG000|Overall Study|Complete Response (Confirmed)|14
4398437|NCT00113607|7174801|FG001|Overall Study|Complete Response (Confirmed)|24
4398438|NCT00113607|7174800|FG000|Overall Study|Other|43
4398439|NCT00113607|7174801|FG001|Overall Study|Other|32
4398440|NCT00113763|7174810|FG000|Overall Study|Adverse Event|5
4398441|NCT00113763|7174811|FG001|Overall Study|Adverse Event|2
4398442|NCT00113763|7174810|FG000|Overall Study|Disease Progression|28
4398443|NCT00113763|7174811|FG001|Overall Study|Disease Progression|14
4398444|NCT00113763|7174810|FG000|Overall Study|Lost to Follow-up|10
4398445|NCT00113763|7174811|FG001|Overall Study|Lost to Follow-up|0
4398446|NCT00113763|7174810|FG000|Overall Study|Withdrawal by Subject|1
4398447|NCT00113763|7174811|FG001|Overall Study|Withdrawal by Subject|4
4398448|NCT00113763|7174810|FG000|Overall Study|Other|27
4398449|NCT00113763|7174811|FG001|Overall Study|Other|6
4398450|NCT00113763|7174810|FG000|Overall Study|Non-compliance|1
4398451|NCT00113763|7174811|FG001|Overall Study|Non-compliance|0
4398452|NCT00113763|7174810|FG000|Overall Study|Ongoing|1
4398453|NCT00113763|7174811|FG001|Overall Study|Ongoing|0
4398454|NCT00113841|7174820|FG000|Overall Study|Disease progression|0
4398455|NCT00113841|7174821|FG001|Overall Study|Disease progression|2
4398456|NCT00113841|7174820|FG000|Overall Study|Non-compliant|1
4398457|NCT00113841|7174821|FG001|Overall Study|Non-compliant|0
4398458|NCT00114127|7174876|FG000|Overall Study|Adverse Event|2
4398459|NCT00114127|7174877|FG001|Overall Study|Adverse Event|1
4398460|NCT00114127|7174876|FG000|Overall Study|Lost to Follow-up|1
4398461|NCT00114127|7174877|FG001|Overall Study|Lost to Follow-up|0
4398462|NCT00114127|7174876|FG000|Overall Study|Withdrawal by Subject|1
4398463|NCT00114127|7174877|FG001|Overall Study|Withdrawal by Subject|3
4398464|NCT00114140|7174883|FG000|Overall Study|Protocol Violation|7
4398465|NCT00114166|7174896|FG000|Overall Study|Wrong primary|0
4398466|NCT00114166|7174897|FG001|Overall Study|Wrong primary|1
4398467|NCT00114218|7174905|FG000|Overall Study|Wrong Cell Type|2
4398468|NCT00114218|7174905|FG000|Overall Study|Wrong Primary|1
4398469|NCT00114218|7174905|FG000|Overall Study|Never Treated|1
4398470|NCT00114231|7174911|FG000|Overall Study|No consent|2
4398471|NCT00114231|7174912|FG001|Overall Study|No consent|0
4398472|NCT00114231|7174911|FG000|Overall Study|QARC requirement not met|1
4398473|NCT00114231|7174912|FG001|Overall Study|QARC requirement not met|0
4398474|NCT00114231|7174911|FG000|Overall Study|Suspected metastatic disease|1
4398475|NCT00114231|7174912|FG001|Overall Study|Suspected metastatic disease|0
4398476|NCT00114231|7174911|FG000|Overall Study|No adenocarcinoma|1
4398477|NCT00114231|7174912|FG001|Overall Study|No adenocarcinoma|0
4398478|NCT00114231|7174911|FG000|Overall Study|Low creatinine clearance|0
4398479|NCT00114231|7174912|FG001|Overall Study|Low creatinine clearance|1
4398480|NCT00114231|7174911|FG000|Overall Study|Tumor size > 4cm|1
4398481|NCT00114231|7174912|FG001|Overall Study|Tumor size > 4cm|0
4398482|NCT00114231|7174911|FG000|Overall Study|Tumor fixed on digital exam|0
4398483|NCT00114231|7174912|FG001|Overall Study|Tumor fixed on digital exam|1
4398484|NCT00114231|7174911|FG000|Overall Study|No Absolute Neutrophil Count|2
4398485|NCT00114231|7174912|FG001|Overall Study|No Absolute Neutrophil Count|0
4398486|NCT00114231|7174911|FG000|Overall Study|Biopsy done after registration|1
4398487|NCT00114231|7174912|FG001|Overall Study|Biopsy done after registration|0
4398488|NCT00114244|7174919|FG000|Overall Study|Adverse Event|2
4398489|NCT00114244|7174920|FG001|Overall Study|Adverse Event|5
4398490|NCT00114244|7174919|FG000|Overall Study|Withdrawal by Subject|0
4398491|NCT00114244|7174920|FG001|Overall Study|Withdrawal by Subject|2
4398492|NCT00114530|7174954|FG000|Overall Study|Death|3
4628656|NCT01863771|7496109|FG000|Induction Phase|Lack of Efficacy|10
4398493|NCT00114530|7174955|FG001|Overall Study|Death|11
4398494|NCT00114530|7174954|FG000|Overall Study|Lost to Follow-up|1
4398495|NCT00114530|7174955|FG001|Overall Study|Lost to Follow-up|1
4398496|NCT00114530|7174954|FG000|Overall Study|Physician Decision|1
4398497|NCT00114530|7174955|FG001|Overall Study|Physician Decision|1
4398498|NCT00114530|7174954|FG000|Overall Study|Withdrawal by Subject|2
4398499|NCT00114530|7174955|FG001|Overall Study|Withdrawal by Subject|6
4398500|NCT00114530|7174954|FG000|Overall Study|Breast Cancer|1
4398501|NCT00114530|7174955|FG001|Overall Study|Breast Cancer|0
4398502|NCT00114530|7174954|FG000|Overall Study|Subject decision after endpoint failure|0
4398503|NCT00114530|7174955|FG001|Overall Study|Subject decision after endpoint failure|1
4398504|NCT00114530|7174954|FG000|Overall Study|Ineligible|1
4398505|NCT00114530|7174955|FG001|Overall Study|Ineligible|0
4398506|NCT00114634|7174965|FG000|Overall Study|failure to return forms|3
4398507|NCT00114738|7174971|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1
4398508|NCT00114738|7174972|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0
4398509|NCT00114738|7174973|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0
4628657|NCT01863771|7496110|FG001|Induction Phase|Lack of Efficacy|0
4628658|NCT01863771|7496111|FG002|Induction Phase|Lack of Efficacy|0
4628659|NCT01863771|7496112|FG003|Induction Phase|Lack of Efficacy|0
4628660|NCT01863771|7496109|FG000|Induction Phase|Withdrawal by Subject|2
4628661|NCT01863771|7496110|FG001|Induction Phase|Withdrawal by Subject|0
4398510|NCT00114738|7174971|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1
4398511|NCT00114738|7174972|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0
4398512|NCT00114738|7174973|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0
4398513|NCT00114738|7174971|FG000|Screening for Randomization|Neuropathy|17
4398514|NCT00114738|7174972|FG001|Screening for Randomization|Neuropathy|0
4398515|NCT00114738|7174973|FG002|Screening for Randomization|Neuropathy|0
4398516|NCT00114738|7174971|FG000|Screening for Randomization|Progressive disease|2
4398517|NCT00114738|7174972|FG001|Screening for Randomization|Progressive disease|0
4398518|NCT00114738|7174973|FG002|Screening for Randomization|Progressive disease|0
4398519|NCT00114738|7174971|FG000|Screening for Randomization|CNS Hemorrhage|1
4398520|NCT00114738|7174972|FG001|Screening for Randomization|CNS Hemorrhage|0
4398521|NCT00114738|7174973|FG002|Screening for Randomization|CNS Hemorrhage|0
4398522|NCT00114738|7174971|FG000|Screening for Randomization|Other|1
4398523|NCT00114738|7174972|FG001|Screening for Randomization|Other|0
4398524|NCT00114738|7174973|FG002|Screening for Randomization|Other|0
4398525|NCT00114777|7174983|FG000|Randomization to Month 36|Death|10
4398526|NCT00114777|7174984|FG001|Randomization to Month 36|Death|4
4398527|NCT00114777|7174985|FG002|Randomization to Month 36|Death|3
4398528|NCT00114777|7174983|FG000|Randomization to Month 36|No Longer Met Study Criteria|0
4398529|NCT00114777|7174984|FG001|Randomization to Month 36|No Longer Met Study Criteria|0
4398530|NCT00114777|7174985|FG002|Randomization to Month 36|No Longer Met Study Criteria|2
4398531|NCT00114777|7174983|FG000|Randomization to Month 36|Lack of Efficacy|19
4398532|NCT00114777|7174984|FG001|Randomization to Month 36|Lack of Efficacy|15
4398533|NCT00114777|7174985|FG002|Randomization to Month 36|Lack of Efficacy|17
4398534|NCT00114777|7174983|FG000|Randomization to Month 36|Poor or Non-Compliance|0
4398535|NCT00114777|7174984|FG001|Randomization to Month 36|Poor or Non-Compliance|0
4398536|NCT00114777|7174985|FG002|Randomization to Month 36|Poor or Non-Compliance|1
4398537|NCT00114777|7174983|FG000|Randomization to Month 36|Adverse Event|34
4398538|NCT00114777|7174984|FG001|Randomization to Month 36|Adverse Event|35
4398539|NCT00114777|7174985|FG002|Randomization to Month 36|Adverse Event|44
4398540|NCT00114777|7174983|FG000|Randomization to Month 36|Withdrawal by Subject|3
4398541|NCT00114777|7174984|FG001|Randomization to Month 36|Withdrawal by Subject|4
4398542|NCT00114777|7174985|FG002|Randomization to Month 36|Withdrawal by Subject|5
4398543|NCT00114777|7174983|FG000|Randomization to Month 36|Other|9
4398544|NCT00114777|7174984|FG001|Randomization to Month 36|Other|3
4398545|NCT00114777|7174985|FG002|Randomization to Month 36|Other|12
4398546|NCT00114777|7174983|FG000|Long-Term Extension to Month 84|Death|8
4398547|NCT00114777|7174984|FG001|Long-Term Extension to Month 84|Death|13
4398548|NCT00114777|7174985|FG002|Long-Term Extension to Month 84|Death|7
4398549|NCT00114777|7174983|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1
4398550|NCT00114777|7174984|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0
4398551|NCT00114777|7174985|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1
4398552|NCT00114777|7174983|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1
4398553|NCT00114777|7174984|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0
4398554|NCT00114777|7174985|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1
4398555|NCT00114777|7174983|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1
4398556|NCT00114777|7174984|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1
4398557|NCT00114777|7174985|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3
4398558|NCT00114777|7174983|FG000|Long-Term Extension to Month 84|Adverse Event|15
4398559|NCT00114777|7174984|FG001|Long-Term Extension to Month 84|Adverse Event|14
4398560|NCT00114777|7174985|FG002|Long-Term Extension to Month 84|Adverse Event|7
4398561|NCT00114777|7174983|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2
4398562|NCT00114777|7174984|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1
4398563|NCT00114777|7174985|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6
4398564|NCT00114777|7174983|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0
4398565|NCT00114777|7174984|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0
4398566|NCT00114777|7174985|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2
4398567|NCT00114777|7174983|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0
4398568|NCT00114777|7174984|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0
4398569|NCT00114777|7174985|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1
4398570|NCT00114777|7174983|FG000|Long-Term Extension to Month 84|Other|2
4398571|NCT00114777|7174984|FG001|Long-Term Extension to Month 84|Other|0
4628662|NCT01863771|7496111|FG002|Induction Phase|Withdrawal by Subject|0
4628663|NCT01863771|7496112|FG003|Induction Phase|Withdrawal by Subject|0
4398572|NCT00114777|7174985|FG002|Long-Term Extension to Month 84|Other|2
4398573|NCT00114959|7174994|FG000|Overall Study|Lack of Efficacy|6
4398574|NCT00114959|7174994|FG000|Overall Study|Physician Decision|1
4398575|NCT00114959|7174994|FG000|Overall Study|Death|1
4398576|NCT00114972|7175000|FG000|Overall Study|Withdrawal by Subject|40
4398577|NCT00114972|7175001|FG001|Overall Study|Withdrawal by Subject|7
4398578|NCT00114972|7175000|FG000|Overall Study|Lost to Follow-up|8
4628664|NCT01863771|7496109|FG000|Maintenance Phase|Adverse Event|0
4398579|NCT00114972|7175001|FG001|Overall Study|Lost to Follow-up|5
4398580|NCT00115037|7175009|FG000|Phase1|Lost to Follow-up|16
4398581|NCT00115037|7175010|FG001|Phase1|Lost to Follow-up|23
4398582|NCT00115037|7175011|FG002|Phase1|Lost to Follow-up|0
4398583|NCT00115037|7175012|FG003|Phase1|Lost to Follow-up|0
4398584|NCT00115037|7175013|FG004|Phase1|Lost to Follow-up|0
4398585|NCT00115037|7175014|FG005|Phase1|Lost to Follow-up|0
4398586|NCT00115037|7175009|FG000|Phase1|Withdrawal by Subject|9
4398587|NCT00115037|7175010|FG001|Phase1|Withdrawal by Subject|4
4398588|NCT00115037|7175011|FG002|Phase1|Withdrawal by Subject|0
4398589|NCT00115037|7175012|FG003|Phase1|Withdrawal by Subject|0
4398590|NCT00115037|7175013|FG004|Phase1|Withdrawal by Subject|0
4398591|NCT00115037|7175014|FG005|Phase1|Withdrawal by Subject|0
4398592|NCT00115037|7175009|FG000|Phase2|Death|0
4398593|NCT00115037|7175010|FG001|Phase2|Death|0
4398594|NCT00115037|7175011|FG002|Phase2|Death|1
4398595|NCT00115037|7175012|FG003|Phase2|Death|0
4398596|NCT00115037|7175013|FG004|Phase2|Death|0
4398597|NCT00115037|7175014|FG005|Phase2|Death|1
4398598|NCT00115037|7175009|FG000|Phase2|Withdrawal by Subject|0
4398599|NCT00115037|7175010|FG001|Phase2|Withdrawal by Subject|0
4398600|NCT00115037|7175011|FG002|Phase2|Withdrawal by Subject|2
4398601|NCT00115037|7175012|FG003|Phase2|Withdrawal by Subject|1
4398602|NCT00115037|7175013|FG004|Phase2|Withdrawal by Subject|2
4398603|NCT00115037|7175014|FG005|Phase2|Withdrawal by Subject|1
4398604|NCT00115037|7175009|FG000|Phase2|Lost to Follow-up|0
4398605|NCT00115037|7175010|FG001|Phase2|Lost to Follow-up|0
4398606|NCT00115037|7175011|FG002|Phase2|Lost to Follow-up|12
4398607|NCT00115037|7175012|FG003|Phase2|Lost to Follow-up|14
4398608|NCT00115037|7175013|FG004|Phase2|Lost to Follow-up|4
4398609|NCT00115037|7175014|FG005|Phase2|Lost to Follow-up|10
4398610|NCT00115063|7175030|FG000|Overall Study|Lost to Follow-up|98
4398611|NCT00115063|7175031|FG001|Overall Study|Lost to Follow-up|104
4398612|NCT00115063|7175030|FG000|Overall Study|Death|1
4398613|NCT00115063|7175031|FG001|Overall Study|Death|0
4398614|NCT00115336|7175055|FG000|Overall Study|Hospital discharge before study drug|0
4398615|NCT00115336|7175056|FG001|Overall Study|Hospital discharge before study drug|1
4398616|NCT00115349|7175066|FG000|Overall Study|Study closed due to low enrollment.|11
4398617|NCT00115349|7175067|FG001|Overall Study|Study closed due to low enrollment.|9
4398618|NCT00115739|7175073|FG000|Overall Study|Lost to Follow-up|3
4398619|NCT00115765|7175083|FG000|Overall Study|Withdrawal by Subject|22
4398620|NCT00115765|7175084|FG001|Overall Study|Withdrawal by Subject|53
4398621|NCT00115765|7175085|FG002|Overall Study|Withdrawal by Subject|76
4398622|NCT00115765|7175086|FG003|Overall Study|Withdrawal by Subject|15
4398623|NCT00115765|7175083|FG000|Overall Study|Physician Decision|4
4398624|NCT00115765|7175084|FG001|Overall Study|Physician Decision|15
4713282|NCT02943070|7640680|FG000|Overall Study|Physician Decision|1
4713283|NCT02943070|7640680|FG000|Overall Study|Adverse Event|2
4713284|NCT02943070|7640680|FG000|Overall Study|Death|2
4713285|NCT02943070|7640680|FG000|Overall Study|Withdrawal by Subject|3
4713286|NCT02943070|7640680|FG000|Overall Study|Lost to Follow-up|4
4713287|NCT02943070|7640680|FG000|Overall Study|Retreatment or TURP|13
4713288|NCT02943070|7640680|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18
4398625|NCT00115765|7175085|FG002|Overall Study|Physician Decision|18
4398626|NCT00115765|7175086|FG003|Overall Study|Physician Decision|13
4398627|NCT00115765|7175083|FG000|Overall Study|Lost to Follow-up|3
4398628|NCT00115765|7175084|FG001|Overall Study|Lost to Follow-up|20
4398629|NCT00115765|7175085|FG002|Overall Study|Lost to Follow-up|18
4398630|NCT00115765|7175086|FG003|Overall Study|Lost to Follow-up|1
4398631|NCT00115765|7175083|FG000|Overall Study|Other|6
4398632|NCT00115765|7175084|FG001|Overall Study|Other|12
4398633|NCT00115765|7175085|FG002|Overall Study|Other|9
4398634|NCT00115765|7175086|FG003|Overall Study|Other|2
4398635|NCT00115778|7175094|FG000|Overall Study|Withdrawal by Subject|0
4398636|NCT00115778|7175095|FG001|Overall Study|Withdrawal by Subject|1
4398637|NCT00115804|7175101|FG000|Overall Study|Adverse Event|2
4398638|NCT00115934|7175120|FG000|Overall Study|Lost to Follow-up|1
4398639|NCT00115934|7175121|FG001|Overall Study|Lost to Follow-up|0
4398640|NCT00115934|7175120|FG000|Overall Study|Did not receive intervention|3
4398641|NCT00115934|7175121|FG001|Overall Study|Did not receive intervention|2
4398642|NCT00116168|7175131|FG000|Overall Study|Lost to Follow-up|6
4398643|NCT00116168|7175132|FG001|Overall Study|Lost to Follow-up|5
4398644|NCT00116168|7175133|FG002|Overall Study|Lost to Follow-up|0
4398645|NCT00116168|7175134|FG003|Overall Study|Lost to Follow-up|0
4398646|NCT00116272|7175155|FG000|Overall Study|Lost to Follow-up|11
4398647|NCT00116272|7175156|FG001|Overall Study|Lost to Follow-up|6
4398648|NCT00116428|7175177|FG000|Overall Study|Withdrawal by Subject|2
4398649|NCT00116428|7175178|FG001|Overall Study|Withdrawal by Subject|5
4398650|NCT00116428|7175177|FG000|Overall Study|Did not meet inclusion criteria|1
4398651|NCT00116428|7175178|FG001|Overall Study|Did not meet inclusion criteria|0
4713289|NCT02943096|7640693|FG000|Overall Study|Lack of Efficacy|0
4398652|NCT00116558|7175190|FG000|Overall Study|Death|11
4398653|NCT00116558|7175191|FG001|Overall Study|Death|5
4398654|NCT00116558|7175192|FG002|Overall Study|Death|3
4398655|NCT00116558|7175190|FG000|Overall Study|Withdrawal by Subject|17
4398656|NCT00116558|7175191|FG001|Overall Study|Withdrawal by Subject|3
4398657|NCT00116558|7175192|FG002|Overall Study|Withdrawal by Subject|12
4398658|NCT00116558|7175190|FG000|Overall Study|disease progression|3
4398659|NCT00116558|7175191|FG001|Overall Study|disease progression|7
4398660|NCT00116558|7175192|FG002|Overall Study|disease progression|18
4398661|NCT00116584|7175201|FG000|Overall Study|Withdrawal by Subject|1
4398662|NCT00116584|7175202|FG001|Overall Study|Withdrawal by Subject|0
4398663|NCT00116584|7175201|FG000|Overall Study|Protocol Violation|1
4398664|NCT00116584|7175202|FG001|Overall Study|Protocol Violation|1
4398665|NCT00116649|7175208|FG000|Overall Study|Adverse Event|20
4398666|NCT00116649|7175208|FG000|Overall Study|Lack of Efficacy|1
4398667|NCT00116649|7175208|FG000|Overall Study|Lost to Follow-up|32
4398668|NCT00116649|7175208|FG000|Overall Study|Withdrawal by Subject|68
4398669|NCT00116649|7175208|FG000|Overall Study|Local Skin Reaction|9
4398670|NCT00116649|7175208|FG000|Overall Study|Various Reasons|18
4398671|NCT00116649|7175208|FG000|Overall Study|Protocol Specified|7
4398672|NCT00116688|7175214|FG000|Overall Study|Protocol deviation|1
4398673|NCT00116688|7175215|FG001|Overall Study|Protocol deviation|0
4398674|NCT00116688|7175214|FG000|Overall Study|Noncompliance|3
4398675|NCT00116688|7175215|FG001|Overall Study|Noncompliance|1
4398676|NCT00116688|7175214|FG000|Overall Study|Adverse Event|11
4398677|NCT00116688|7175215|FG001|Overall Study|Adverse Event|0
4398678|NCT00116688|7175214|FG000|Overall Study|Withdrawal by Subject|26
4398679|NCT00116688|7175215|FG001|Overall Study|Withdrawal by Subject|2
4398680|NCT00116688|7175214|FG000|Overall Study|Requirement for alternative therapy|11
4398681|NCT00116688|7175215|FG001|Overall Study|Requirement for alternative therapy|1
4398682|NCT00116688|7175214|FG000|Overall Study|Physician Decision|7
4398683|NCT00116688|7175215|FG001|Overall Study|Physician Decision|0
4398684|NCT00116688|7175214|FG000|Overall Study|Lost to Follow-up|3
4398685|NCT00116688|7175215|FG001|Overall Study|Lost to Follow-up|0
4398686|NCT00116688|7175214|FG000|Overall Study|Death|15
4398687|NCT00116688|7175215|FG001|Overall Study|Death|0
4398688|NCT00116688|7175214|FG000|Overall Study|Protocol-specified criteria|3
4398689|NCT00116688|7175215|FG001|Overall Study|Protocol-specified criteria|0
4398690|NCT00116688|7175214|FG000|Overall Study|Pregnancy|1
4398691|NCT00116688|7175215|FG001|Overall Study|Pregnancy|0
4398692|NCT00116688|7175214|FG000|Overall Study|Other|11
4398693|NCT00116688|7175215|FG001|Overall Study|Other|0
4398694|NCT00116753|7175224|FG000|Overall Study|Adverse Event|16
4398695|NCT00116753|7175225|FG001|Overall Study|Adverse Event|10
4398696|NCT00116753|7175226|FG002|Overall Study|Adverse Event|7
4398697|NCT00116753|7175224|FG000|Overall Study|Withdrawal by Subject|11
4398698|NCT00116753|7175225|FG001|Overall Study|Withdrawal by Subject|12
4398699|NCT00116753|7175226|FG002|Overall Study|Withdrawal by Subject|8
4398700|NCT00116753|7175224|FG000|Overall Study|Lost to Follow-up|0
4398701|NCT00116753|7175225|FG001|Overall Study|Lost to Follow-up|2
4398702|NCT00116753|7175226|FG002|Overall Study|Lost to Follow-up|1
4398703|NCT00116753|7175224|FG000|Overall Study|Protocol Violation|0
4398704|NCT00116753|7175225|FG001|Overall Study|Protocol Violation|0
4398705|NCT00116753|7175226|FG002|Overall Study|Protocol Violation|1
4398706|NCT00116753|7175224|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1
4398707|NCT00116753|7175225|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1
4398708|NCT00116753|7175226|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3
4398709|NCT00116753|7175224|FG000|Overall Study|Disease Progression|3
4398710|NCT00116753|7175225|FG001|Overall Study|Disease Progression|4
4398711|NCT00116753|7175226|FG002|Overall Study|Disease Progression|3
4398712|NCT00116753|7175224|FG000|Overall Study|Abnormal Echocardiogram|0
4398713|NCT00116753|7175225|FG001|Overall Study|Abnormal Echocardiogram|0
4398714|NCT00116753|7175226|FG002|Overall Study|Abnormal Echocardiogram|1
4398715|NCT00116753|7175224|FG000|Overall Study|Progressive Parkinson's Disease|1
4398716|NCT00116753|7175225|FG001|Overall Study|Progressive Parkinson's Disease|0
4398717|NCT00116753|7175226|FG002|Overall Study|Progressive Parkinson's Disease|0
4398718|NCT00116753|7175224|FG000|Overall Study|Dosing Error|0
4398719|NCT00116753|7175225|FG001|Overall Study|Dosing Error|1
4398720|NCT00116753|7175226|FG002|Overall Study|Dosing Error|0
4398721|NCT00116779|7175236|FG000|Overall Study|Adverse Event|4
4398722|NCT00116779|7175237|FG001|Overall Study|Adverse Event|2
4398723|NCT00116779|7175236|FG000|Overall Study|Protocol Violation|1
4398724|NCT00116779|7175237|FG001|Overall Study|Protocol Violation|4
4398725|NCT00116779|7175236|FG000|Overall Study|Withdrawal by Subject|4
4398726|NCT00116779|7175237|FG001|Overall Study|Withdrawal by Subject|1
4398727|NCT00116779|7175236|FG000|Overall Study|Inadequate testosterone suppression|7
4398728|NCT00116779|7175237|FG001|Overall Study|Inadequate testosterone suppression|9
4398729|NCT00116779|7175236|FG000|Overall Study|Physician Decision|3
4398730|NCT00116779|7175237|FG001|Overall Study|Physician Decision|1
4398731|NCT00116779|7175236|FG000|Overall Study|Elevated PSA levels|2
4398732|NCT00116779|7175237|FG001|Overall Study|Elevated PSA levels|2
4510951|NCT00923091|7319702|FG003|Period V (Double -Blind)|Withdrawal by Subject|0
4398733|NCT00116805|7175245|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6
4398734|NCT00116805|7175246|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2
4398735|NCT00116805|7175245|FG000|Double-blind Period Through Week 48|Protocol Violation|1
4398736|NCT00116805|7175246|FG001|Double-blind Period Through Week 48|Protocol Violation|1
4398737|NCT00116805|7175245|FG000|Double-blind Period Through Week 48|Withdrew Consent|4
4398738|NCT00116805|7175246|FG001|Double-blind Period Through Week 48|Withdrew Consent|2
4398739|NCT00116805|7175245|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1
4398740|NCT00116805|7175246|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0
4398741|NCT00116805|7175245|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2
4398742|NCT00116805|7175246|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0
4398743|NCT00116805|7175245|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2
4398744|NCT00116805|7175246|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0
4398745|NCT00116805|7175245|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1
4398746|NCT00116805|7175246|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0
4628665|NCT01863771|7496110|FG001|Maintenance Phase|Adverse Event|0
4628666|NCT01863771|7496111|FG002|Maintenance Phase|Adverse Event|1
4398747|NCT00116805|7175245|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2
4398748|NCT00116805|7175246|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0
4398749|NCT00116805|7175245|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2
4398750|NCT00116805|7175246|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1
4398751|NCT00116805|7175245|FG000|Open-label Period Weeks 97 - 144|Completed Study|1
4398752|NCT00116805|7175246|FG001|Open-label Period Weeks 97 - 144|Completed Study|0
4398753|NCT00116805|7175245|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2
4398754|NCT00116805|7175246|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0
4398755|NCT00116805|7175245|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5
4398756|NCT00116805|7175246|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2
4398757|NCT00116805|7175245|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0
4398758|NCT00116805|7175246|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1
4398759|NCT00116805|7175245|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2
4398760|NCT00116805|7175246|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3
4398761|NCT00116805|7175245|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1
4398762|NCT00116805|7175246|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3
4398763|NCT00116805|7175245|FG000|Open-label Period Weeks 145 - 192|Completed Study|1
4398764|NCT00116805|7175246|FG001|Open-label Period Weeks 145 - 192|Completed Study|1
4398765|NCT00116805|7175245|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2
4398766|NCT00116805|7175246|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0
4398767|NCT00116805|7175245|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3
4398768|NCT00116805|7175246|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1
4398769|NCT00116805|7175245|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1
4398770|NCT00116805|7175246|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0
4398771|NCT00116805|7175245|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0
4398772|NCT00116805|7175246|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1
4398773|NCT00116805|7175245|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0
4398774|NCT00116805|7175246|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1
4398775|NCT00116805|7175245|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3
4398776|NCT00116805|7175246|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2
4398777|NCT00116805|7175245|FG000|Open-label Period Weeks 193 - 240|Completed Study|0
4398778|NCT00116805|7175246|FG001|Open-label Period Weeks 193 - 240|Completed Study|1
4398779|NCT00116805|7175245|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1
4398780|NCT00116805|7175246|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0
4398781|NCT00116805|7175245|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3
4398782|NCT00116805|7175246|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0
4398783|NCT00116805|7175245|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
4398784|NCT00116805|7175246|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
4398785|NCT00116805|7175245|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7
4398786|NCT00116805|7175246|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1
4398787|NCT00116805|7175245|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2
4398788|NCT00116805|7175246|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0
4398789|NCT00116805|7175245|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4
4398790|NCT00116805|7175246|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0
4398791|NCT00116805|7175245|FG000|Open-label Period Weeks 289 - 336|Completed Study|0
4398792|NCT00116805|7175246|FG001|Open-label Period Weeks 289 - 336|Completed Study|1
4398793|NCT00116805|7175245|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3
4398794|NCT00116805|7175246|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2
4398795|NCT00116805|7175245|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1
4398796|NCT00116805|7175246|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1
4398797|NCT00116805|7175245|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0
4398798|NCT00116805|7175246|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1
4398799|NCT00116805|7175245|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0
4398800|NCT00116805|7175246|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1
4398801|NCT00116805|7175245|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0
4398802|NCT00116805|7175246|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1
4398803|NCT00116805|7175245|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2
4398804|NCT00116805|7175246|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0
4398805|NCT00116805|7175245|FG000|Open-label Period Weeks 337 - 384|Completed Study|1
4398806|NCT00116805|7175246|FG001|Open-label Period Weeks 337 - 384|Completed Study|0
4518728|NCT00975884|7330973|FG000|Overall Study|Other|1
4398807|NCT00116805|7175245|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1
4398808|NCT00116805|7175246|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0
4398809|NCT00116805|7175245|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2
4398810|NCT00116805|7175246|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0
4398811|NCT00116805|7175245|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1
4398812|NCT00116805|7175246|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0
4398813|NCT00116805|7175245|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3
4398814|NCT00116805|7175246|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1
4398815|NCT00116805|7175245|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1
4398816|NCT00116805|7175246|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0
4398817|NCT00116805|7175245|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1
4398818|NCT00116805|7175246|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0
4398819|NCT00116805|7175245|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1
4398820|NCT00116805|7175246|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0
4398821|NCT00116805|7175245|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3
4398822|NCT00116805|7175246|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0
4398823|NCT00116831|7175263|FG000|Overall Study|Adverse Event|14
4398824|NCT00116831|7175264|FG001|Overall Study|Adverse Event|16
4398825|NCT00116831|7175263|FG000|Overall Study|Baseline IVUS determined unevaluable|12
4398826|NCT00116831|7175264|FG001|Overall Study|Baseline IVUS determined unevaluable|11
4398827|NCT00116831|7175263|FG000|Overall Study|Lost to Follow-up|8
4398828|NCT00116831|7175264|FG001|Overall Study|Lost to Follow-up|6
4398829|NCT00116831|7175263|FG000|Overall Study|Protocol Violation|3
4398830|NCT00116831|7175264|FG001|Overall Study|Protocol Violation|6
4398831|NCT00116831|7175263|FG000|Overall Study|Hypoglycaemic events|1
4398832|NCT00116831|7175264|FG001|Overall Study|Hypoglycaemic events|0
4398833|NCT00116831|7175263|FG000|Overall Study|Low haemoglobin on screening|1
4398834|NCT00116831|7175264|FG001|Overall Study|Low haemoglobin on screening|0
4398835|NCT00116831|7175263|FG000|Overall Study|Withdrawn investigational product|1
4398836|NCT00116831|7175264|FG001|Overall Study|Withdrawn investigational product|0
4398837|NCT00116831|7175263|FG000|Overall Study|Withdrawal by Subject|32
4398838|NCT00116831|7175264|FG001|Overall Study|Withdrawal by Subject|32
4398839|NCT00116831|7175263|FG000|Overall Study|Insufficient therapeutic effect|0
4398840|NCT00116831|7175264|FG001|Overall Study|Insufficient therapeutic effect|1
4398841|NCT00116831|7175263|FG000|Overall Study|Missing data for participant|1
4398842|NCT00116831|7175264|FG001|Overall Study|Missing data for participant|0
4398843|NCT00116844|7175272|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1
4398844|NCT00116844|7175273|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1
4398845|NCT00116844|7175272|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0
4398846|NCT00116844|7175273|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1
4398847|NCT00116844|7175272|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5
4398848|NCT00116844|7175273|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0
4398849|NCT00116844|7175272|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1
4398850|NCT00116844|7175273|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1
4398851|NCT00116844|7175272|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1
4398852|NCT00116844|7175273|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0
4398853|NCT00116844|7175272|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2
4398854|NCT00116844|7175273|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1
4398855|NCT00116844|7175272|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0
4398856|NCT00116844|7175273|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2
4398857|NCT00116844|7175272|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0
4398858|NCT00116844|7175273|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1
4398859|NCT00116844|7175272|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1
4398860|NCT00116844|7175273|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1
4398861|NCT00117156|7175305|FG000|Overall Study|Adverse Event|9
4398862|NCT00117156|7175305|FG000|Overall Study|Physician Decision|1
4398863|NCT00117156|7175305|FG000|Overall Study|Trt for Pre-Exist Second Primary|1
4398864|NCT00117286|7175311|FG000|Overall Study|Adverse Event|12
4398865|NCT00117286|7175312|FG001|Overall Study|Adverse Event|6
4398866|NCT00117286|7175311|FG000|Overall Study|Lost to Follow-up|2
4398867|NCT00117286|7175312|FG001|Overall Study|Lost to Follow-up|0
4398868|NCT00117286|7175311|FG000|Overall Study|Protocol Violation|3
4398869|NCT00117286|7175312|FG001|Overall Study|Protocol Violation|3
4398870|NCT00117286|7175311|FG000|Overall Study|Withdrawal by Subject|6
4398871|NCT00117286|7175312|FG001|Overall Study|Withdrawal by Subject|2
4398872|NCT00117286|7175311|FG000|Overall Study|Physician Decision|3
4398873|NCT00117286|7175312|FG001|Overall Study|Physician Decision|7
4398874|NCT00117286|7175311|FG000|Overall Study|Lack of Efficacy|2
4398875|NCT00117286|7175312|FG001|Overall Study|Lack of Efficacy|1
4398876|NCT00117286|7175311|FG000|Overall Study|Research site closing|0
4398877|NCT00117286|7175312|FG001|Overall Study|Research site closing|2
4398878|NCT00117312|7175322|FG000|Overall Study|Testosterone >1.0 ng/mL|9
4398879|NCT00117312|7175323|FG001|Overall Study|Testosterone >1.0 ng/mL|9
4398880|NCT00117312|7175324|FG002|Overall Study|Testosterone >1.0 ng/mL|5
4398881|NCT00117312|7175325|FG003|Overall Study|Testosterone >1.0 ng/mL|9
4398882|NCT00117312|7175322|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1
4398883|NCT00117312|7175323|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0
4398884|NCT00117312|7175324|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3
4398885|NCT00117312|7175325|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2
4398886|NCT00117312|7175322|FG000|Overall Study|Prostate-specific antigen increase >=25%|0
4398887|NCT00117312|7175323|FG001|Overall Study|Prostate-specific antigen increase >=25%|1
4398888|NCT00117312|7175324|FG002|Overall Study|Prostate-specific antigen increase >=25%|5
4398889|NCT00117312|7175325|FG003|Overall Study|Prostate-specific antigen increase >=25%|3
4398890|NCT00117312|7175322|FG000|Overall Study|Other|0
4398891|NCT00117312|7175323|FG001|Overall Study|Other|1
4398892|NCT00117312|7175324|FG002|Overall Study|Other|3
4398893|NCT00117312|7175325|FG003|Overall Study|Other|1
4398894|NCT00117312|7175322|FG000|Overall Study|Patient choice|0
4398895|NCT00117312|7175323|FG001|Overall Study|Patient choice|0
4398896|NCT00117312|7175324|FG002|Overall Study|Patient choice|2
4398897|NCT00117312|7175325|FG003|Overall Study|Patient choice|1
4398898|NCT00117312|7175322|FG000|Overall Study|Adverse Event|0
4398899|NCT00117312|7175323|FG001|Overall Study|Adverse Event|2
4398900|NCT00117312|7175324|FG002|Overall Study|Adverse Event|0
4398901|NCT00117312|7175325|FG003|Overall Study|Adverse Event|0
4398902|NCT00117312|7175322|FG000|Overall Study|Protocol Violation|0
4398903|NCT00117312|7175323|FG001|Overall Study|Protocol Violation|1
4398904|NCT00117312|7175324|FG002|Overall Study|Protocol Violation|3
4398905|NCT00117312|7175325|FG003|Overall Study|Protocol Violation|0
4398906|NCT00117312|7175322|FG000|Overall Study|PSA decrease <=50%|0
4398907|NCT00117312|7175323|FG001|Overall Study|PSA decrease <=50%|2
4398908|NCT00117312|7175324|FG002|Overall Study|PSA decrease <=50%|2
4398909|NCT00117312|7175325|FG003|Overall Study|PSA decrease <=50%|4
4398910|NCT00117312|7175322|FG000|Overall Study|PSA increase >= 10ng/mL|0
4398911|NCT00117312|7175323|FG001|Overall Study|PSA increase >= 10ng/mL|1
4398912|NCT00117312|7175324|FG002|Overall Study|PSA increase >= 10ng/mL|1
4398913|NCT00117312|7175325|FG003|Overall Study|PSA increase >= 10ng/mL|0
4398914|NCT00117312|7175322|FG000|Overall Study|Hepatic abnormality|0
4398915|NCT00117312|7175323|FG001|Overall Study|Hepatic abnormality|1
4398916|NCT00117312|7175324|FG002|Overall Study|Hepatic abnormality|0
4398917|NCT00117312|7175325|FG003|Overall Study|Hepatic abnormality|1
4398918|NCT00117312|7175322|FG000|Overall Study|Withdrawal by Subject|0
4398919|NCT00117312|7175323|FG001|Overall Study|Withdrawal by Subject|2
4398920|NCT00117312|7175324|FG002|Overall Study|Withdrawal by Subject|0
4398921|NCT00117312|7175325|FG003|Overall Study|Withdrawal by Subject|0
4398922|NCT00117325|7175337|FG000|Overall Study|Adverse Event|3
4398923|NCT00117325|7175338|FG001|Overall Study|Adverse Event|3
4398924|NCT00117325|7175337|FG000|Overall Study|Lost to Follow-up|1
4398925|NCT00117325|7175338|FG001|Overall Study|Lost to Follow-up|1
4398926|NCT00117325|7175337|FG000|Overall Study|Protocol Violation|2
4398927|NCT00117325|7175338|FG001|Overall Study|Protocol Violation|3
4398928|NCT00117325|7175337|FG000|Overall Study|Withdrawal by Subject|3
4398929|NCT00117325|7175338|FG001|Overall Study|Withdrawal by Subject|2
4398930|NCT00117325|7175337|FG000|Overall Study|Lack of Efficacy|1
4398931|NCT00117325|7175338|FG001|Overall Study|Lack of Efficacy|0
4398932|NCT00117325|7175337|FG000|Overall Study|Use of prohibited medicine|1
4398933|NCT00117325|7175338|FG001|Overall Study|Use of prohibited medicine|2
4398934|NCT00117325|7175337|FG000|Overall Study|Early termination|1
4398935|NCT00117325|7175338|FG001|Overall Study|Early termination|1
4398936|NCT00117325|7175337|FG000|Overall Study|Admisnitrative|1
4398937|NCT00117325|7175338|FG001|Overall Study|Admisnitrative|0
4398938|NCT00117507|7175345|FG000|Overall Study|Adverse Event|4
4398939|NCT00117507|7175345|FG000|Overall Study|Abnormal laboratory values|3
4398940|NCT00117507|7175345|FG000|Overall Study|Unsatisfactory therapeutic effect|1
4398941|NCT00117507|7175345|FG000|Overall Study|Patient withdrew consent|4
4398942|NCT00117507|7175345|FG000|Overall Study|Death|3
4398943|NCT00117572|7175361|FG000|Overall Study|Site withdrew before starting treatment|2
4398944|NCT00117572|7175362|FG001|Overall Study|Site withdrew before starting treatment|3
4398945|NCT00117572|7175361|FG000|Overall Study|Withdrawal by Subject|3
4398946|NCT00117572|7175362|FG001|Overall Study|Withdrawal by Subject|3
4398947|NCT00117572|7175361|FG000|Overall Study|Protocol Violation|1
4398948|NCT00117572|7175362|FG001|Overall Study|Protocol Violation|0
4398949|NCT00117598|7175375|FG000|Prior to Treatment Cross Over|Death|40
4398950|NCT00117598|7175376|FG001|Prior to Treatment Cross Over|Death|41
4398951|NCT00117598|7175377|FG002|Prior to Treatment Cross Over|Death|37
4398952|NCT00117598|7175378|FG003|Prior to Treatment Cross Over|Death|0
4398953|NCT00117598|7175379|FG004|Prior to Treatment Cross Over|Death|0
4398954|NCT00117598|7175375|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0
4398955|NCT00117598|7175376|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2
4398956|NCT00117598|7175377|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2
4398957|NCT00117598|7175378|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0
4398958|NCT00117598|7175379|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0
4398959|NCT00117598|7175375|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2
4398960|NCT00117598|7175376|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1
4398961|NCT00117598|7175377|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4
4398962|NCT00117598|7175378|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0
4510952|NCT00923091|7319703|FG004|Period V (Double -Blind)|Withdrawal by Subject|0
4398963|NCT00117598|7175379|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0
4398964|NCT00117598|7175375|FG000|Prior to Treatment Cross Over|Other|15
4398965|NCT00117598|7175376|FG001|Prior to Treatment Cross Over|Other|9
4398966|NCT00117598|7175377|FG002|Prior to Treatment Cross Over|Other|9
4398967|NCT00117598|7175378|FG003|Prior to Treatment Cross Over|Other|0
4398968|NCT00117598|7175379|FG004|Prior to Treatment Cross Over|Other|0
4398969|NCT00117598|7175375|FG000|After Treament Cross Over|Death|0
4628667|NCT01863771|7496112|FG003|Maintenance Phase|Adverse Event|1
4628668|NCT01863771|7496109|FG000|Maintenance Phase|Lack of Efficacy|0
4628669|NCT01863771|7496110|FG001|Maintenance Phase|Lack of Efficacy|3
4628670|NCT01863771|7496111|FG002|Maintenance Phase|Lack of Efficacy|7
4628671|NCT01863771|7496112|FG003|Maintenance Phase|Lack of Efficacy|38
4628672|NCT01863771|7496109|FG000|Maintenance Phase|Physician Decision|0
4628673|NCT01863771|7496110|FG001|Maintenance Phase|Physician Decision|0
4628674|NCT01863771|7496111|FG002|Maintenance Phase|Physician Decision|2
4628675|NCT01863771|7496112|FG003|Maintenance Phase|Physician Decision|1
4628676|NCT01863771|7496109|FG000|Maintenance Phase|Pregnancy|0
4628677|NCT01863771|7496110|FG001|Maintenance Phase|Pregnancy|1
4628678|NCT01863771|7496111|FG002|Maintenance Phase|Pregnancy|0
4628679|NCT01863771|7496112|FG003|Maintenance Phase|Pregnancy|0
4628680|NCT01863771|7496109|FG000|Maintenance Phase|Withdrawal by Subject|0
4628681|NCT01863771|7496110|FG001|Maintenance Phase|Withdrawal by Subject|1
4628682|NCT01863771|7496111|FG002|Maintenance Phase|Withdrawal by Subject|2
4628683|NCT01863771|7496112|FG003|Maintenance Phase|Withdrawal by Subject|3
4713290|NCT02943096|7640694|FG001|Overall Study|Lack of Efficacy|1
4713291|NCT02943447|7640718|FG000|Blinded Study Phase|Withdrew Consent|1
4713292|NCT02943447|7640719|FG001|Blinded Study Phase|Withdrew Consent|2
4713293|NCT02943447|7640720|FG002|Blinded Study Phase|Withdrew Consent|1
4713294|NCT02943447|7640718|FG000|Blinded Study Phase|Adverse Event|3
4713295|NCT02943447|7640719|FG001|Blinded Study Phase|Adverse Event|0
4713296|NCT02943447|7640720|FG002|Blinded Study Phase|Adverse Event|0
4713297|NCT02943447|7640718|FG000|Blinded Study Phase|Investigator's discretion|1
4713298|NCT02943447|7640719|FG001|Blinded Study Phase|Investigator's discretion|0
4398970|NCT00117598|7175376|FG001|After Treament Cross Over|Death|0
4398971|NCT00117598|7175377|FG002|After Treament Cross Over|Death|0
4398972|NCT00117598|7175378|FG003|After Treament Cross Over|Death|1
4398973|NCT00117598|7175379|FG004|After Treament Cross Over|Death|2
4398974|NCT00117598|7175375|FG000|After Treament Cross Over|Withdrawal by Subject|0
4398975|NCT00117598|7175376|FG001|After Treament Cross Over|Withdrawal by Subject|0
4398976|NCT00117598|7175377|FG002|After Treament Cross Over|Withdrawal by Subject|0
4398977|NCT00117598|7175378|FG003|After Treament Cross Over|Withdrawal by Subject|1
4398978|NCT00117598|7175379|FG004|After Treament Cross Over|Withdrawal by Subject|0
4398979|NCT00117598|7175375|FG000|After Treament Cross Over|Other|0
4398980|NCT00117598|7175376|FG001|After Treament Cross Over|Other|0
4398981|NCT00117598|7175377|FG002|After Treament Cross Over|Other|0
4398982|NCT00117598|7175378|FG003|After Treament Cross Over|Other|1
4398983|NCT00117598|7175379|FG004|After Treament Cross Over|Other|2
4398984|NCT00117637|7175391|FG000|First Intervention (Period 1)|Adverse Event|11
4398985|NCT00117637|7175392|FG001|First Intervention (Period 1)|Adverse Event|16
4398986|NCT00117637|7175391|FG000|First Intervention (Period 1)|Lost to Follow-up|0
4398987|NCT00117637|7175392|FG001|First Intervention (Period 1)|Lost to Follow-up|2
4398988|NCT00117637|7175391|FG000|First Intervention (Period 1)|Protocol Violation|1
4398989|NCT00117637|7175392|FG001|First Intervention (Period 1)|Protocol Violation|0
4398990|NCT00117637|7175391|FG000|First Intervention (Period 1)|Withdrawal by Subject|2
4398991|NCT00117637|7175392|FG001|First Intervention (Period 1)|Withdrawal by Subject|4
4398992|NCT00117637|7175391|FG000|First Intervention (Period 1)|study terminated by the sponsor|3
4398993|NCT00117637|7175392|FG001|First Intervention (Period 1)|study terminated by the sponsor|1
4398994|NCT00117637|7175391|FG000|First Intervention (Period 1)|protocol driven decision point|1
4398995|NCT00117637|7175392|FG001|First Intervention (Period 1)|protocol driven decision point|0
4398996|NCT00117637|7175391|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0
4398997|NCT00117637|7175392|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1
4398998|NCT00117637|7175391|FG000|First Intervention (Period 1)|reason not reported|0
4398999|NCT00117637|7175392|FG001|First Intervention (Period 1)|reason not reported|1
4399000|NCT00117637|7175391|FG000|Second Intervention (Period 2)|Adverse Event|0
4399001|NCT00117637|7175392|FG001|Second Intervention (Period 2)|Adverse Event|9
4399002|NCT00117637|7175391|FG000|Second Intervention (Period 2)|Lost to Follow-up|1
4399003|NCT00117637|7175392|FG001|Second Intervention (Period 2)|Lost to Follow-up|0
4713299|NCT02943447|7640720|FG002|Blinded Study Phase|Investigator's discretion|0
4713300|NCT02943447|7640718|FG000|Open-Label Extension Phase|Study terminated by sponsor|10
4713301|NCT02943447|7640719|FG001|Open-Label Extension Phase|Study terminated by sponsor|12
4713302|NCT02943447|7640720|FG002|Open-Label Extension Phase|Study terminated by sponsor|6
4399004|NCT00117637|7175391|FG000|Second Intervention (Period 2)|Protocol Violation|1
4399005|NCT00117637|7175392|FG001|Second Intervention (Period 2)|Protocol Violation|0
4399006|NCT00117637|7175391|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4
4399007|NCT00117637|7175392|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3
4399008|NCT00117637|7175391|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2
4399009|NCT00117637|7175392|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9
4399010|NCT00117637|7175391|FG000|Second Intervention (Period 2)|non compliant with study medication|1
4399011|NCT00117637|7175392|FG001|Second Intervention (Period 2)|non compliant with study medication|1
4399012|NCT00117637|7175391|FG000|Second Intervention (Period 2)|reason not reported|1
4399013|NCT00117637|7175392|FG001|Second Intervention (Period 2)|reason not reported|0
4399014|NCT00117676|7175407|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4
4399015|NCT00117676|7175408|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3
4399016|NCT00117676|7175407|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1
4399017|NCT00117676|7175408|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0
4399018|NCT00117676|7175407|FG000|Double-blind Period Through Week 48|Protocol Violation|0
4399019|NCT00117676|7175408|FG001|Double-blind Period Through Week 48|Protocol Violation|1
4399020|NCT00117676|7175407|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5
4399021|NCT00117676|7175408|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2
4399022|NCT00117676|7175407|FG000|Double-blind Period Through Week 48|Withdrew Consent|0
4399023|NCT00117676|7175408|FG001|Double-blind Period Through Week 48|Withdrew Consent|1
4399024|NCT00117676|7175407|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2
4399025|NCT00117676|7175408|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0
4399026|NCT00117676|7175407|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3
4399027|NCT00117676|7175408|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1
4399028|NCT00117676|7175407|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5
4399029|NCT00117676|7175408|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1
4399030|NCT00117676|7175407|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4
4399031|NCT00117676|7175408|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1
4399032|NCT00117676|7175407|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1
4399033|NCT00117676|7175408|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0
4399034|NCT00117676|7175407|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1
4399035|NCT00117676|7175408|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0
4399036|NCT00117676|7175407|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2
4399037|NCT00117676|7175408|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0
4399038|NCT00117676|7175407|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3
4399039|NCT00117676|7175408|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1
4399040|NCT00117676|7175407|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5
4399041|NCT00117676|7175408|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2
4399042|NCT00117676|7175407|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1
4399043|NCT00117676|7175408|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1
4399044|NCT00117676|7175407|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0
4399045|NCT00117676|7175408|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1
4399046|NCT00117676|7175407|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
4399047|NCT00117676|7175408|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0
4399048|NCT00117676|7175407|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4
4399049|NCT00117676|7175408|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1
4399050|NCT00117676|7175407|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0
4399051|NCT00117676|7175408|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1
4399052|NCT00117676|7175407|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2
4399053|NCT00117676|7175408|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1
4399054|NCT00117676|7175407|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2
4399055|NCT00117676|7175408|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0
4399056|NCT00117676|7175407|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1
4399057|NCT00117676|7175408|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0
4399058|NCT00117676|7175407|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5
4399059|NCT00117676|7175408|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1
4399060|NCT00117676|7175407|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7
4399061|NCT00117676|7175408|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4
4399062|NCT00117676|7175407|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2
4399063|NCT00117676|7175408|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2
4399064|NCT00117676|7175407|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0
4399065|NCT00117676|7175408|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1
4399066|NCT00117676|7175407|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1
4399067|NCT00117676|7175408|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1
4399068|NCT00117676|7175407|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3
4399069|NCT00117676|7175408|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1
4399070|NCT00117676|7175407|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1
4399071|NCT00117676|7175408|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0
4399072|NCT00117676|7175407|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2
4399073|NCT00117676|7175408|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1
4399074|NCT00117676|7175407|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0
4399075|NCT00117676|7175408|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1
4399076|NCT00117676|7175407|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0
4399077|NCT00117676|7175408|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1
4399078|NCT00117676|7175407|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1
4399079|NCT00117676|7175408|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0
4399080|NCT00117676|7175407|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1
4399081|NCT00117676|7175408|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1
4399082|NCT00117676|7175407|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0
4399083|NCT00117676|7175408|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1
4399084|NCT00117793|7175423|FG000|Overall Study|Withdrawal by Subject|12
4399085|NCT00117845|7175440|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1
4399086|NCT00117949|7175448|FG000|Overall Study|Testosterone >1.0 ng/mL|10
4399087|NCT00117949|7175449|FG001|Overall Study|Testosterone >1.0 ng/mL|18
4399088|NCT00117949|7175450|FG002|Overall Study|Testosterone >1.0 ng/mL|17
4399089|NCT00117949|7175451|FG003|Overall Study|Testosterone >1.0 ng/mL|15
4399090|NCT00117949|7175448|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0
4399091|NCT00117949|7175449|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1
4399092|NCT00117949|7175450|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3
4399093|NCT00117949|7175451|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2
4399094|NCT00117949|7175448|FG000|Overall Study|Prostate-specific antigen increase >=25%|0
4399095|NCT00117949|7175449|FG001|Overall Study|Prostate-specific antigen increase >=25%|1
4399096|NCT00117949|7175450|FG002|Overall Study|Prostate-specific antigen increase >=25%|1
4399097|NCT00117949|7175451|FG003|Overall Study|Prostate-specific antigen increase >=25%|2
4399098|NCT00117949|7175448|FG000|Overall Study|PSA increase >=10ng/mL|0
4399099|NCT00117949|7175449|FG001|Overall Study|PSA increase >=10ng/mL|1
4399100|NCT00117949|7175450|FG002|Overall Study|PSA increase >=10ng/mL|1
4399101|NCT00117949|7175451|FG003|Overall Study|PSA increase >=10ng/mL|0
4399102|NCT00117949|7175448|FG000|Overall Study|PSA reduction <=50%|0
4399103|NCT00117949|7175449|FG001|Overall Study|PSA reduction <=50%|2
4399104|NCT00117949|7175450|FG002|Overall Study|PSA reduction <=50%|2
4399105|NCT00117949|7175451|FG003|Overall Study|PSA reduction <=50%|4
4399106|NCT00117949|7175448|FG000|Overall Study|Hepatic abnormalities|0
4399107|NCT00117949|7175449|FG001|Overall Study|Hepatic abnormalities|1
4399108|NCT00117949|7175450|FG002|Overall Study|Hepatic abnormalities|0
4399109|NCT00117949|7175451|FG003|Overall Study|Hepatic abnormalities|1
4399110|NCT00117988|7175470|FG000|Overall Study|Death|3
4399111|NCT00117988|7175470|FG000|Overall Study|Adverse Event|1
4399112|NCT00118040|7175477|FG000|Overall Study|Adverse Event|0
4399113|NCT00118040|7175478|FG001|Overall Study|Adverse Event|1
4399114|NCT00118040|7175479|FG002|Overall Study|Adverse Event|0
4399115|NCT00118040|7175477|FG000|Overall Study|Withdrawal by Subject|0
4399116|NCT00118040|7175478|FG001|Overall Study|Withdrawal by Subject|0
4399117|NCT00118040|7175479|FG002|Overall Study|Withdrawal by Subject|2
4399118|NCT00118040|7175477|FG000|Overall Study|Medical Contraindication|0
4399119|NCT00118040|7175478|FG001|Overall Study|Medical Contraindication|0
4399120|NCT00118040|7175479|FG002|Overall Study|Medical Contraindication|1
4399121|NCT00118040|7175477|FG000|Overall Study|Non-Compliant Participant|1
4399122|NCT00118040|7175478|FG001|Overall Study|Non-Compliant Participant|1
4399123|NCT00118040|7175479|FG002|Overall Study|Non-Compliant Participant|2
4399124|NCT00118040|7175477|FG000|Overall Study|Other|0
4399125|NCT00118040|7175478|FG001|Overall Study|Other|0
4399126|NCT00118040|7175479|FG002|Overall Study|Other|1
4399127|NCT00118092|7175492|FG000|Overall Study|Withdrawal by Subject|1
4399128|NCT00118092|7175492|FG000|Overall Study|Protocol Violation|1
4399129|NCT00118157|7175506|FG000|Overall Study|Adverse Event|2
4399130|NCT00118157|7175506|FG000|Overall Study|Death|8
4399131|NCT00118157|7175506|FG000|Overall Study|Withdrawal by Subject|2
4399132|NCT00118287|7175545|FG000|Overall Study|Intracranial haemorrhage|1
4399133|NCT00118287|7175545|FG000|Overall Study|Muscle pain|1
4399134|NCT00118417|7175625|FG000|Phase I (Weeks 0 to 6)|Remission|8
4399135|NCT00118417|7175626|FG001|Phase I (Weeks 0 to 6)|Remission|0
4399136|NCT00118417|7175625|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6
4399137|NCT00118417|7175626|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0
4399138|NCT00118417|7175625|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4
4399139|NCT00118417|7175626|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0
4399140|NCT00118417|7175625|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1
4399141|NCT00118417|7175626|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1
4399142|NCT00118417|7175625|FG000|Phase II (Weeks 6 to 12)|Remission|1
4399143|NCT00118417|7175626|FG001|Phase II (Weeks 6 to 12)|Remission|2
4399144|NCT00118430|7175639|FG000|Overall Study|Withdrawal by Subject|6
4399145|NCT00118430|7175640|FG001|Overall Study|Withdrawal by Subject|2
4399146|NCT00118430|7175641|FG002|Overall Study|Withdrawal by Subject|0
4399147|NCT00118430|7175639|FG000|Overall Study|Lost to Follow-up|15
4399148|NCT00118430|7175640|FG001|Overall Study|Lost to Follow-up|22
4399149|NCT00118430|7175641|FG002|Overall Study|Lost to Follow-up|28
4399150|NCT00118482|7175650|FG000|Overall Study|Lost to Follow-up|7
4399151|NCT00118482|7175651|FG001|Overall Study|Lost to Follow-up|7
4399152|NCT00118482|7175650|FG000|Overall Study|Withdrawal by Subject|23
4399153|NCT00118482|7175651|FG001|Overall Study|Withdrawal by Subject|22
4399154|NCT00118703|7175669|FG000|Overall Study|Protocol Violation|1
4399155|NCT00118703|7175670|FG001|Overall Study|Protocol Violation|0
4399156|NCT00118703|7175669|FG000|Overall Study|Adverse Event|1
4399157|NCT00118703|7175670|FG001|Overall Study|Adverse Event|1
4399158|NCT00118703|7175669|FG000|Overall Study|Participant took two different treatment|0
4399159|NCT00118703|7175670|FG001|Overall Study|Participant took two different treatment|1
4399160|NCT00118703|7175669|FG000|Overall Study|Withdrawal by Subject|2
4399161|NCT00118703|7175670|FG001|Overall Study|Withdrawal by Subject|5
4399162|NCT00118703|7175669|FG000|Overall Study|Lost to Follow-up|1
4399163|NCT00118703|7175670|FG001|Overall Study|Lost to Follow-up|2
4399164|NCT00118716|7175678|FG000|Overall Study|Adverse Event|2
4399165|NCT00118716|7175679|FG001|Overall Study|Adverse Event|7
4399166|NCT00118716|7175678|FG000|Overall Study|Protocol Violation|5
4399167|NCT00118716|7175679|FG001|Overall Study|Protocol Violation|4
4399168|NCT00118716|7175678|FG000|Overall Study|Withdrawal by Subject|0
4399169|NCT00118716|7175679|FG001|Overall Study|Withdrawal by Subject|1
4399170|NCT00118716|7175678|FG000|Overall Study|Exacerbation|2
4399171|NCT00118716|7175679|FG001|Overall Study|Exacerbation|2
4399172|NCT00118716|7175678|FG000|Overall Study|Discontinued by sponsor|1
4399173|NCT00118716|7175679|FG001|Overall Study|Discontinued by sponsor|1
4399174|NCT00118716|7175678|FG000|Overall Study|Non-compliance|1
4399175|NCT00118716|7175679|FG001|Overall Study|Non-compliance|3
4399176|NCT00118716|7175678|FG000|Overall Study|misrandomized|1
4399177|NCT00118716|7175679|FG001|Overall Study|misrandomized|1
4399178|NCT00118716|7175678|FG000|Overall Study|Expired drug use|1
4399179|NCT00118716|7175679|FG001|Overall Study|Expired drug use|2
4399180|NCT00118716|7175678|FG000|Overall Study|Investigator discretion|0
4399181|NCT00118716|7175679|FG001|Overall Study|Investigator discretion|1
4399182|NCT00118898|7175707|FG000|Overall Study|Death|6
4399183|NCT00118898|7175708|FG001|Overall Study|Death|11
4399184|NCT00118898|7175709|FG002|Overall Study|Death|6
4399185|NCT00118898|7175710|FG003|Overall Study|Death|8
4399186|NCT00118898|7175707|FG000|Overall Study|Lost to Follow-up|26
4399187|NCT00118898|7175708|FG001|Overall Study|Lost to Follow-up|34
4399188|NCT00118898|7175709|FG002|Overall Study|Lost to Follow-up|33
4399189|NCT00118898|7175710|FG003|Overall Study|Lost to Follow-up|33
4399190|NCT00118898|7175707|FG000|Overall Study|Withdrawal by Subject|10
4399191|NCT00118898|7175708|FG001|Overall Study|Withdrawal by Subject|5
4399192|NCT00118898|7175709|FG002|Overall Study|Withdrawal by Subject|8
4399193|NCT00118898|7175710|FG003|Overall Study|Withdrawal by Subject|8
4399194|NCT00118898|7175707|FG000|Overall Study|Site Closure|33
4399195|NCT00118898|7175708|FG001|Overall Study|Site Closure|31
4399196|NCT00118898|7175709|FG002|Overall Study|Site Closure|28
4399197|NCT00118898|7175710|FG003|Overall Study|Site Closure|37
4399198|NCT00118898|7175707|FG000|Overall Study|Severe debilitation|1
4399199|NCT00118898|7175708|FG001|Overall Study|Severe debilitation|4
4399200|NCT00118898|7175709|FG002|Overall Study|Severe debilitation|6
4399201|NCT00118898|7175710|FG003|Overall Study|Severe debilitation|4
4399202|NCT00118898|7175707|FG000|Overall Study|Not compliant with requirements|11
4399203|NCT00118898|7175708|FG001|Overall Study|Not compliant with requirements|13
4399204|NCT00118898|7175709|FG002|Overall Study|Not compliant with requirements|11
4399205|NCT00118898|7175710|FG003|Overall Study|Not compliant with requirements|11
4399206|NCT00118898|7175707|FG000|Overall Study|Not able to get to clinic|34
4399207|NCT00118898|7175708|FG001|Overall Study|Not able to get to clinic|43
4399208|NCT00118898|7175709|FG002|Overall Study|Not able to get to clinic|31
4399209|NCT00118898|7175710|FG003|Overall Study|Not able to get to clinic|40
4399210|NCT00118911|7175722|FG000|Overall Study|Withdrawal by Subject|2
4399211|NCT00118911|7175723|FG001|Overall Study|Withdrawal by Subject|5
4399212|NCT00119015|7175731|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48
4399213|NCT00119015|7175732|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0
4399214|NCT00119015|7175733|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0
4399215|NCT00119106|7175755|FG000|Overall Study|HIV infected at baseline|179
4399216|NCT00119106|7175756|FG001|Overall Study|HIV infected at baseline|178
4399217|NCT00119262|7175781|FG000|Overall Study|Lack of Efficacy|0
4399218|NCT00119262|7175782|FG001|Overall Study|Lack of Efficacy|3
4399219|NCT00119262|7175781|FG000|Overall Study|Withdrawal by Subject|12
4399220|NCT00119262|7175782|FG001|Overall Study|Withdrawal by Subject|11
4399221|NCT00119262|7175781|FG000|Overall Study|Adverse Event|33
4399222|NCT00119262|7175782|FG001|Overall Study|Adverse Event|35
4399223|NCT00119262|7175781|FG000|Overall Study|other disease|0
4399224|NCT00119262|7175782|FG001|Overall Study|other disease|2
4399225|NCT00119262|7175781|FG000|Overall Study|ineligble|1
4399226|NCT00119262|7175782|FG001|Overall Study|ineligble|2
4399227|NCT00119262|7175781|FG000|Overall Study|others|0
4399228|NCT00119262|7175782|FG001|Overall Study|others|5
4510953|NCT00923091|7319704|FG005|Period V (Double -Blind)|Withdrawal by Subject|0
4399229|NCT00119379|7175790|FG000|Overall Study|Adverse Event|4
4399230|NCT00119379|7175791|FG001|Overall Study|Adverse Event|1
4399231|NCT00119405|7175801|FG000|Overall Study|Withdrawal by Subject|1
4399232|NCT00119678|7175807|FG000|Double-blind Treatment Period|Death|1
4399233|NCT00119678|7175808|FG001|Double-blind Treatment Period|Death|0
4399234|NCT00119678|7175807|FG000|Double-blind Treatment Period|Adverse Event|7
4399235|NCT00119678|7175808|FG001|Double-blind Treatment Period|Adverse Event|1
4399236|NCT00119678|7175807|FG000|Double-blind Treatment Period|Lack of Efficacy|21
4399237|NCT00119678|7175808|FG001|Double-blind Treatment Period|Lack of Efficacy|12
4399238|NCT00119678|7175807|FG000|Double-blind Treatment Period|Lost to Follow-up|1
4399239|NCT00119678|7175808|FG001|Double-blind Treatment Period|Lost to Follow-up|2
4399240|NCT00119678|7175807|FG000|Double-blind Treatment Period|Participant withdrew consent|4
4399241|NCT00119678|7175808|FG001|Double-blind Treatment Period|Participant withdrew consent|4
4399242|NCT00119678|7175807|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0
4399243|NCT00119678|7175808|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1
4399244|NCT00119678|7175807|FG000|Double-blind Treatment Period|Poor/Non-compliance|3
4399245|NCT00119678|7175808|FG001|Double-blind Treatment Period|Poor/Non-compliance|0
4399246|NCT00119678|7175807|FG000|Double-blind Treatment Period|Pregnancy|0
4399247|NCT00119678|7175808|FG001|Double-blind Treatment Period|Pregnancy|2
4399248|NCT00119678|7175807|FG000|Double-blind Treatment Period|Not treated|1
4399249|NCT00119678|7175808|FG001|Double-blind Treatment Period|Not treated|2
4399250|NCT00119678|7175807|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3
4399251|NCT00119678|7175808|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2
4399252|NCT00119678|7175807|FG000|Open-label Treatment Period|Death|1
4399253|NCT00119678|7175808|FG001|Open-label Treatment Period|Death|0
4399254|NCT00119678|7175807|FG000|Open-label Treatment Period|Adverse Event|3
4399255|NCT00119678|7175808|FG001|Open-label Treatment Period|Adverse Event|0
4399256|NCT00119678|7175807|FG000|Open-label Treatment Period|Lack of Efficacy|9
4399257|NCT00119678|7175808|FG001|Open-label Treatment Period|Lack of Efficacy|0
4399258|NCT00119678|7175807|FG000|Open-label Treatment Period|Lost to Follow-up|3
4399259|NCT00119678|7175808|FG001|Open-label Treatment Period|Lost to Follow-up|0
4399260|NCT00119678|7175807|FG000|Open-label Treatment Period|Participant withdrew consent|4
4399261|NCT00119678|7175808|FG001|Open-label Treatment Period|Participant withdrew consent|0
4399262|NCT00119678|7175807|FG000|Open-label Treatment Period|Participants not meeting study criteria|2
4399263|NCT00119678|7175808|FG001|Open-label Treatment Period|Participants not meeting study criteria|0
4399264|NCT00119678|7175807|FG000|Open-label Treatment Period|Pregnancy|1
4399265|NCT00119678|7175808|FG001|Open-label Treatment Period|Pregnancy|0
4399266|NCT00119678|7175807|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87
4399267|NCT00119678|7175808|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0
4399268|NCT00120250|7175825|FG000|Overall Study|Lost to Follow-up|1
4399269|NCT00120250|7175826|FG001|Overall Study|Lost to Follow-up|1
4399270|NCT00120250|7175825|FG000|Overall Study|Protocol Violation|0
4399271|NCT00120250|7175826|FG001|Overall Study|Protocol Violation|1
4399272|NCT00120289|7175835|FG000|Overall Study|Death|96
4399273|NCT00120289|7175836|FG001|Overall Study|Death|82
4399274|NCT00120289|7175835|FG000|Overall Study|Lost to Follow-up|11
4399275|NCT00120289|7175836|FG001|Overall Study|Lost to Follow-up|14
4399276|NCT00120289|7175835|FG000|Overall Study|Withdrawal by Subject|14
4399277|NCT00120289|7175836|FG001|Overall Study|Withdrawal by Subject|13
4510954|NCT00923091|7319705|FG006|Period V (Double -Blind)|Withdrawal by Subject|0
4510955|NCT00923091|7319706|FG007|Period V (Double -Blind)|Withdrawal by Subject|0
4510956|NCT00923091|7319707|FG008|Period V (Double -Blind)|Withdrawal by Subject|1
4510957|NCT00923091|7319708|FG009|Period V (Double -Blind)|Withdrawal by Subject|0
4510958|NCT00923091|7319709|FG010|Period V (Double -Blind)|Withdrawal by Subject|0
4510959|NCT00923091|7319710|FG011|Period V (Double -Blind)|Withdrawal by Subject|0
4510960|NCT00923091|7319711|FG012|Period V (Double -Blind)|Withdrawal by Subject|1
4510961|NCT00923091|7319699|FG000|Period V (Double -Blind)|Protocol Violation|0
4510962|NCT00923091|7319700|FG001|Period V (Double -Blind)|Protocol Violation|0
4510963|NCT00923091|7319701|FG002|Period V (Double -Blind)|Protocol Violation|0
4510964|NCT00923091|7319702|FG003|Period V (Double -Blind)|Protocol Violation|0
4510965|NCT00923091|7319703|FG004|Period V (Double -Blind)|Protocol Violation|0
4510966|NCT00923091|7319704|FG005|Period V (Double -Blind)|Protocol Violation|0
4510967|NCT00923091|7319705|FG006|Period V (Double -Blind)|Protocol Violation|0
4510968|NCT00923091|7319706|FG007|Period V (Double -Blind)|Protocol Violation|0
4510969|NCT00923091|7319707|FG008|Period V (Double -Blind)|Protocol Violation|0
4510970|NCT00923091|7319708|FG009|Period V (Double -Blind)|Protocol Violation|0
4510971|NCT00923091|7319709|FG010|Period V (Double -Blind)|Protocol Violation|0
4510972|NCT00923091|7319710|FG011|Period V (Double -Blind)|Protocol Violation|0
4510973|NCT00923091|7319711|FG012|Period V (Double -Blind)|Protocol Violation|1
4510974|NCT00923091|7319699|FG000|Period V (Double -Blind)|Lost to Follow-up|0
4510975|NCT00923091|7319700|FG001|Period V (Double -Blind)|Lost to Follow-up|0
4510976|NCT00923091|7319701|FG002|Period V (Double -Blind)|Lost to Follow-up|0
4510977|NCT00923091|7319702|FG003|Period V (Double -Blind)|Lost to Follow-up|0
4510978|NCT00923091|7319703|FG004|Period V (Double -Blind)|Lost to Follow-up|0
4510979|NCT00923091|7319704|FG005|Period V (Double -Blind)|Lost to Follow-up|0
4510980|NCT00923091|7319705|FG006|Period V (Double -Blind)|Lost to Follow-up|0
4510981|NCT00923091|7319706|FG007|Period V (Double -Blind)|Lost to Follow-up|0
4510982|NCT00923091|7319707|FG008|Period V (Double -Blind)|Lost to Follow-up|0
4510983|NCT00923091|7319708|FG009|Period V (Double -Blind)|Lost to Follow-up|0
4510984|NCT00923091|7319709|FG010|Period V (Double -Blind)|Lost to Follow-up|1
4510985|NCT00923091|7319710|FG011|Period V (Double -Blind)|Lost to Follow-up|0
4510986|NCT00923091|7319711|FG012|Period V (Double -Blind)|Lost to Follow-up|0
4510987|NCT00923091|7319699|FG000|Period VI (Open-Label)|Adverse Event|17
4510988|NCT00923091|7319700|FG001|Period VI (Open-Label)|Adverse Event|0
4399278|NCT00120406|7175844|FG000|Overall Study|Death|9
4399279|NCT00120406|7175845|FG001|Overall Study|Death|4
4399280|NCT00120406|7175844|FG000|Overall Study|Withdrawal by Subject|5
4399281|NCT00120406|7175845|FG001|Overall Study|Withdrawal by Subject|7
4399282|NCT00120406|7175844|FG000|Overall Study|Lost to Follow-up|5
4399283|NCT00120406|7175845|FG001|Overall Study|Lost to Follow-up|2
4399284|NCT00120406|7175844|FG000|Overall Study|received non-study stent|0
4399285|NCT00120406|7175845|FG001|Overall Study|received non-study stent|2
4399286|NCT00120406|7175844|FG000|Overall Study|patient moved but has not withdrawn|0
4399287|NCT00120406|7175845|FG001|Overall Study|patient moved but has not withdrawn|1
4399288|NCT00120627|7175863|FG000|Overall Study|Withdrawal by Subject|5
4399289|NCT00120627|7175864|FG001|Overall Study|Withdrawal by Subject|5
4399290|NCT00120874|7175881|FG000|Overall Study|Death|0
4399291|NCT00120874|7175882|FG001|Overall Study|Death|1
4399292|NCT00121134|7175892|FG000|Overall Study|Progression of Disease|5
4399293|NCT00121134|7175893|FG001|Overall Study|Progression of Disease|3
4399294|NCT00121134|7175894|FG002|Overall Study|Progression of Disease|4
4399295|NCT00121134|7175895|FG003|Overall Study|Progression of Disease|2
4399296|NCT00121134|7175892|FG000|Overall Study|Toxicity|4
4399297|NCT00121134|7175893|FG001|Overall Study|Toxicity|7
4399298|NCT00121134|7175894|FG002|Overall Study|Toxicity|13
4399299|NCT00121134|7175895|FG003|Overall Study|Toxicity|5
4399300|NCT00121134|7175892|FG000|Overall Study|Physician Decision|6
4399301|NCT00121134|7175893|FG001|Overall Study|Physician Decision|4
4399302|NCT00121134|7175894|FG002|Overall Study|Physician Decision|4
4399303|NCT00121134|7175895|FG003|Overall Study|Physician Decision|1
4399304|NCT00121134|7175892|FG000|Overall Study|Treatment Delay|1
4399305|NCT00121134|7175893|FG001|Overall Study|Treatment Delay|0
4399306|NCT00121134|7175894|FG002|Overall Study|Treatment Delay|0
4399307|NCT00121134|7175895|FG003|Overall Study|Treatment Delay|0
4399308|NCT00121134|7175892|FG000|Overall Study|Intercurrent Illness|0
4399309|NCT00121134|7175893|FG001|Overall Study|Intercurrent Illness|0
4399310|NCT00121134|7175894|FG002|Overall Study|Intercurrent Illness|0
4399311|NCT00121134|7175895|FG003|Overall Study|Intercurrent Illness|1
4399312|NCT00121134|7175892|FG000|Overall Study|Patient Personal Reasons|0
4399313|NCT00121134|7175893|FG001|Overall Study|Patient Personal Reasons|1
4399314|NCT00121134|7175894|FG002|Overall Study|Patient Personal Reasons|0
4399315|NCT00121134|7175895|FG003|Overall Study|Patient Personal Reasons|0
4399316|NCT00121199|7175925|FG000|Overall Study|Adverse Event|11
4399317|NCT00121199|7175925|FG000|Overall Study|Refusal Unrelated to Adverse Event|1
4399318|NCT00121199|7175925|FG000|Overall Study|Progression/Relapse|1
4399319|NCT00121199|7175925|FG000|Overall Study|Death|3
4399320|NCT00121199|7175925|FG000|Overall Study|Other - Not Protocol Specified|3
4399321|NCT00121199|7175925|FG000|Overall Study|Ineligible|9
4399322|NCT00121238|7175934|FG000|Overall Study|disease progression before intervention|1
4399323|NCT00121238|7175934|FG000|Overall Study|Protocol Violation|2
4399324|NCT00121485|7175952|FG000|Overall Study|Not implanted|1
4399325|NCT00121485|7175953|FG001|Overall Study|Not implanted|5
4399326|NCT00121485|7175952|FG000|Overall Study|Crossover|0
4399327|NCT00121485|7175953|FG001|Overall Study|Crossover|2
4399328|NCT00121641|7175964|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15
4399329|NCT00121641|7175965|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21
4399330|NCT00121641|7175966|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14
4399331|NCT00121641|7175967|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25
4399332|NCT00121641|7175968|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30
4399333|NCT00121641|7175964|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9
4399334|NCT00121641|7175965|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11
4399335|NCT00121641|7175966|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5
4399336|NCT00121641|7175967|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10
4399337|NCT00121641|7175968|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3
4399338|NCT00121641|7175964|FG000|24-week Short-term Treatment Period|Adverse Event|3
4399339|NCT00121641|7175965|FG001|24-week Short-term Treatment Period|Adverse Event|3
4399340|NCT00121641|7175966|FG002|24-week Short-term Treatment Period|Adverse Event|4
4399341|NCT00121641|7175967|FG003|24-week Short-term Treatment Period|Adverse Event|0
4399342|NCT00121641|7175968|FG004|24-week Short-term Treatment Period|Adverse Event|2
4399343|NCT00121641|7175964|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0
4399344|NCT00121641|7175965|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2
4399345|NCT00121641|7175966|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3
4399346|NCT00121641|7175967|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4
4399347|NCT00121641|7175968|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4
4399348|NCT00121641|7175964|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0
4399349|NCT00121641|7175965|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0
4399350|NCT00121641|7175966|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3
4399351|NCT00121641|7175967|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1
4399352|NCT00121641|7175968|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1
4399353|NCT00121641|7175964|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
4399354|NCT00121641|7175965|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
4399355|NCT00121641|7175966|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0
4399356|NCT00121641|7175967|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0
4399357|NCT00121641|7175968|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
4399358|NCT00121641|7175964|FG000|24-week Short-term Treatment Period|Other Reason|1
4399359|NCT00121641|7175965|FG001|24-week Short-term Treatment Period|Other Reason|0
4399360|NCT00121641|7175966|FG002|24-week Short-term Treatment Period|Other Reason|0
4399361|NCT00121641|7175967|FG003|24-week Short-term Treatment Period|Other Reason|0
4399362|NCT00121641|7175968|FG004|24-week Short-term Treatment Period|Other Reason|0
4399363|NCT00121641|7175964|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26
4399364|NCT00121641|7175965|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27
4399365|NCT00121641|7175966|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21
4399366|NCT00121641|7175967|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26
4399367|NCT00121641|7175968|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25
4399368|NCT00121641|7175964|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25
4399369|NCT00121641|7175965|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28
4399370|NCT00121641|7175966|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17
4399371|NCT00121641|7175967|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24
4399372|NCT00121641|7175968|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10
4399373|NCT00121641|7175964|FG000|48-month Short Term + Long Term Period|Adverse Event|9
4399374|NCT00121641|7175965|FG001|48-month Short Term + Long Term Period|Adverse Event|10
4399375|NCT00121641|7175966|FG002|48-month Short Term + Long Term Period|Adverse Event|10
4399376|NCT00121641|7175967|FG003|48-month Short Term + Long Term Period|Adverse Event|5
4399377|NCT00121641|7175968|FG004|48-month Short Term + Long Term Period|Adverse Event|5
4399378|NCT00121641|7175964|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9
4399379|NCT00121641|7175965|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7
4399380|NCT00121641|7175966|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12
4399381|NCT00121641|7175967|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11
4399382|NCT00121641|7175968|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12
4399383|NCT00121641|7175964|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4
4399384|NCT00121641|7175965|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1
4399385|NCT00121641|7175966|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4
4399386|NCT00121641|7175967|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2
4399387|NCT00121641|7175968|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2
4399388|NCT00121641|7175964|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1
4399389|NCT00121641|7175965|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3
4399390|NCT00121641|7175966|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2
4399391|NCT00121641|7175967|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1
4399392|NCT00121641|7175968|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2
4399393|NCT00121641|7175964|FG000|48-month Short Term + Long Term Period|Pregnancy|0
4399394|NCT00121641|7175965|FG001|48-month Short Term + Long Term Period|Pregnancy|1
4399395|NCT00121641|7175966|FG002|48-month Short Term + Long Term Period|Pregnancy|0
4399396|NCT00121641|7175967|FG003|48-month Short Term + Long Term Period|Pregnancy|1
4399397|NCT00121641|7175968|FG004|48-month Short Term + Long Term Period|Pregnancy|0
4399398|NCT00121641|7175964|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0
4399399|NCT00121641|7175965|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2
4399400|NCT00121641|7175966|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1
4399401|NCT00121641|7175967|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0
4399402|NCT00121641|7175968|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1
4399403|NCT00121641|7175964|FG000|48-month Short Term + Long Term Period|Death|0
4399404|NCT00121641|7175965|FG001|48-month Short Term + Long Term Period|Death|0
4399405|NCT00121641|7175966|FG002|48-month Short Term + Long Term Period|Death|0
4399406|NCT00121641|7175967|FG003|48-month Short Term + Long Term Period|Death|1
4399407|NCT00121641|7175968|FG004|48-month Short Term + Long Term Period|Death|0
4399408|NCT00121641|7175964|FG000|48-month Short Term + Long Term Period|Missing|0
4399409|NCT00121641|7175965|FG001|48-month Short Term + Long Term Period|Missing|0
4399410|NCT00121641|7175966|FG002|48-month Short Term + Long Term Period|Missing|1
4399411|NCT00121641|7175967|FG003|48-month Short Term + Long Term Period|Missing|0
4399412|NCT00121641|7175968|FG004|48-month Short Term + Long Term Period|Missing|0
4399413|NCT00121641|7175964|FG000|48-month Short Term + Long Term Period|Other Reason|5
4399414|NCT00121641|7175965|FG001|48-month Short Term + Long Term Period|Other Reason|3
4399415|NCT00121641|7175966|FG002|48-month Short Term + Long Term Period|Other Reason|2
4399416|NCT00121641|7175967|FG003|48-month Short Term + Long Term Period|Other Reason|0
4399417|NCT00121641|7175968|FG004|48-month Short Term + Long Term Period|Other Reason|1
4399418|NCT00121667|7175986|FG000|Short Term (ST) Period|Lack of Efficacy|25
4399419|NCT00121667|7175987|FG001|Short Term (ST) Period|Lack of Efficacy|22
4399420|NCT00121667|7175988|FG002|Short Term (ST) Period|Lack of Efficacy|27
4399421|NCT00121667|7175989|FG003|Short Term (ST) Period|Lack of Efficacy|44
4399422|NCT00121667|7175986|FG000|Short Term (ST) Period|Subject Withdrew Consent|8
4399423|NCT00121667|7175987|FG001|Short Term (ST) Period|Subject Withdrew Consent|13
4399424|NCT00121667|7175988|FG002|Short Term (ST) Period|Subject Withdrew Consent|4
4399425|NCT00121667|7175989|FG003|Short Term (ST) Period|Subject Withdrew Consent|11
4399426|NCT00121667|7175986|FG000|Short Term (ST) Period|Adverse Event|5
4399427|NCT00121667|7175987|FG001|Short Term (ST) Period|Adverse Event|6
4399428|NCT00121667|7175988|FG002|Short Term (ST) Period|Adverse Event|5
4399429|NCT00121667|7175989|FG003|Short Term (ST) Period|Adverse Event|3
4399430|NCT00121667|7175986|FG000|Short Term (ST) Period|Lost to Follow-up|3
4399431|NCT00121667|7175987|FG001|Short Term (ST) Period|Lost to Follow-up|4
4399432|NCT00121667|7175988|FG002|Short Term (ST) Period|Lost to Follow-up|4
4399433|NCT00121667|7175989|FG003|Short Term (ST) Period|Lost to Follow-up|3
4399434|NCT00121667|7175986|FG000|Short Term (ST) Period|Poor / Non-compliance|0
4399435|NCT00121667|7175987|FG001|Short Term (ST) Period|Poor / Non-compliance|1
4399436|NCT00121667|7175988|FG002|Short Term (ST) Period|Poor / Non-compliance|1
4399437|NCT00121667|7175989|FG003|Short Term (ST) Period|Poor / Non-compliance|2
4399438|NCT00121667|7175986|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0
4399439|NCT00121667|7175987|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2
4399440|NCT00121667|7175988|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0
4399441|NCT00121667|7175989|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2
4399442|NCT00121667|7175986|FG000|Short Term (ST) Period|Other Reason|3
4713303|NCT02943447|7640718|FG000|Open-Label Extension Phase|Adverse Event|4
4399443|NCT00121667|7175987|FG001|Short Term (ST) Period|Other Reason|0
4399444|NCT00121667|7175988|FG002|Short Term (ST) Period|Other Reason|0
4399445|NCT00121667|7175989|FG003|Short Term (ST) Period|Other Reason|0
4399446|NCT00121667|7175986|FG000|Short Term (ST) Period|Death|0
4399447|NCT00121667|7175987|FG001|Short Term (ST) Period|Death|0
4399448|NCT00121667|7175988|FG002|Short Term (ST) Period|Death|0
4399449|NCT00121667|7175989|FG003|Short Term (ST) Period|Death|1
4399450|NCT00121667|7175986|FG000|Short Term (ST) Period|Pregnancy|0
4399451|NCT00121667|7175987|FG001|Short Term (ST) Period|Pregnancy|0
4399452|NCT00121667|7175988|FG002|Short Term (ST) Period|Pregnancy|0
4399453|NCT00121667|7175989|FG003|Short Term (ST) Period|Pregnancy|1
4399454|NCT00121667|7175986|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54
4399455|NCT00121667|7175987|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51
4399456|NCT00121667|7175988|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42
4399457|NCT00121667|7175989|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65
4399458|NCT00121667|7175986|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38
4399459|NCT00121667|7175987|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34
4399460|NCT00121667|7175988|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26
4399461|NCT00121667|7175989|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30
4399462|NCT00121667|7175986|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12
4399463|NCT00121667|7175987|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18
4399464|NCT00121667|7175988|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13
4399465|NCT00121667|7175989|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10
4399466|NCT00121667|7175986|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11
4399467|NCT00121667|7175987|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11
4399468|NCT00121667|7175988|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13
4399469|NCT00121667|7175989|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16
4399470|NCT00121667|7175986|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5
4399471|NCT00121667|7175987|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7
4399472|NCT00121667|7175988|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6
4399473|NCT00121667|7175989|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3
4399474|NCT00121667|7175986|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3
4399475|NCT00121667|7175987|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6
4399476|NCT00121667|7175988|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5
4399477|NCT00121667|7175989|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9
4399478|NCT00121667|7175986|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3
4399479|NCT00121667|7175987|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5
4399480|NCT00121667|7175988|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8
4399481|NCT00121667|7175989|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4
4399482|NCT00121667|7175986|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
4399483|NCT00121667|7175987|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
4399484|NCT00121667|7175988|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0
4399485|NCT00121667|7175989|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
4399486|NCT00121667|7175986|FG000|Short Term (ST) + Long Term (LT) Period|Death|1
4399487|NCT00121667|7175987|FG001|Short Term (ST) + Long Term (LT) Period|Death|0
4399488|NCT00121667|7175988|FG002|Short Term (ST) + Long Term (LT) Period|Death|0
4399489|NCT00121667|7175989|FG003|Short Term (ST) + Long Term (LT) Period|Death|2
4399490|NCT00121992|7176082|FG000|Overall Study|Treatment not received|2
4399491|NCT00121992|7176083|FG001|Overall Study|Treatment not received|11
4399492|NCT00122109|7176091|FG000|Overall Study|Did not meet criteria|6
4399493|NCT00122109|7176092|FG001|Overall Study|Did not meet criteria|7
4399494|NCT00122135|7176103|FG000|Overall Study|Withdrawal by Subject|3
4399495|NCT00122135|7176104|FG001|Overall Study|Withdrawal by Subject|0
4399496|NCT00122187|7176112|FG000|Overall Study|Withdrew because of resource limitations|2
4713304|NCT02943447|7640719|FG001|Open-Label Extension Phase|Adverse Event|7
4713305|NCT02943447|7640720|FG002|Open-Label Extension Phase|Adverse Event|3
4713306|NCT02943447|7640718|FG000|Open-Label Extension Phase|Lack of Efficacy|3
4399497|NCT00122187|7176113|FG001|Overall Study|Withdrew because of resource limitations|2
4399498|NCT00122278|7176123|FG000|Overall Study|Lost to Follow-up|2
4399499|NCT00122278|7176124|FG001|Overall Study|Lost to Follow-up|0
4399500|NCT00122317|7176130|FG000|Overall Study|Death|3
4399501|NCT00122317|7176130|FG000|Overall Study|Adverse Event|4
4399502|NCT00122317|7176130|FG000|Overall Study|Physician Decision|2
4399503|NCT00122317|7176130|FG000|Overall Study|patient non-compliance|1
4399504|NCT00122317|7176130|FG000|Overall Study|Withdrawal by Subject|1
4399505|NCT00122382|7176152|FG000|Double-Blind Study|Adverse Event|9
4399506|NCT00122382|7176153|FG001|Double-Blind Study|Adverse Event|11
4399507|NCT00122382|7176154|FG002|Double-Blind Study|Adverse Event|0
4399508|NCT00122382|7176152|FG000|Double-Blind Study|Death|2
4399509|NCT00122382|7176153|FG001|Double-Blind Study|Death|2
4399510|NCT00122382|7176154|FG002|Double-Blind Study|Death|0
4399511|NCT00122382|7176152|FG000|Double-Blind Study|Lack of Efficacy|0
4399512|NCT00122382|7176153|FG001|Double-Blind Study|Lack of Efficacy|8
4399513|NCT00122382|7176154|FG002|Double-Blind Study|Lack of Efficacy|0
4399514|NCT00122382|7176152|FG000|Double-Blind Study|Lost to Follow-up|2
4399515|NCT00122382|7176153|FG001|Double-Blind Study|Lost to Follow-up|1
4399516|NCT00122382|7176154|FG002|Double-Blind Study|Lost to Follow-up|0
4399517|NCT00122382|7176152|FG000|Double-Blind Study|Pregnancy|2
4399518|NCT00122382|7176153|FG001|Double-Blind Study|Pregnancy|0
4399519|NCT00122382|7176154|FG002|Double-Blind Study|Pregnancy|0
4399520|NCT00122382|7176152|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1
4399521|NCT00122382|7176153|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0
4399522|NCT00122382|7176154|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0
4399523|NCT00122382|7176152|FG000|Double-Blind Study|Withdrawal of Consent|7
4399524|NCT00122382|7176153|FG001|Double-Blind Study|Withdrawal of Consent|3
4399525|NCT00122382|7176154|FG002|Double-Blind Study|Withdrawal of Consent|0
4399526|NCT00122382|7176152|FG000|Double-Blind Study|Protocol Violation|1
4399527|NCT00122382|7176153|FG001|Double-Blind Study|Protocol Violation|0
4399528|NCT00122382|7176154|FG002|Double-Blind Study|Protocol Violation|0
4399529|NCT00122382|7176152|FG000|Double-Blind Study|Methotrexate Discontinued|0
4399530|NCT00122382|7176153|FG001|Double-Blind Study|Methotrexate Discontinued|1
4399531|NCT00122382|7176154|FG002|Double-Blind Study|Methotrexate Discontinued|0
4399532|NCT00122382|7176152|FG000|Double-Blind Study|Randomized but not treated|0
4399533|NCT00122382|7176153|FG001|Double-Blind Study|Randomized but not treated|2
4399534|NCT00122382|7176154|FG002|Double-Blind Study|Randomized but not treated|0
4399535|NCT00122382|7176152|FG000|Open-Label Study|Adverse Event|0
4399536|NCT00122382|7176153|FG001|Open-Label Study|Adverse Event|0
4399537|NCT00122382|7176154|FG002|Open-Label Study|Adverse Event|11
4399538|NCT00122382|7176152|FG000|Open-Label Study|Death|0
4399539|NCT00122382|7176153|FG001|Open-Label Study|Death|0
4399540|NCT00122382|7176154|FG002|Open-Label Study|Death|2
4399541|NCT00122382|7176152|FG000|Open-Label Study|Lack of Efficacy|0
4399542|NCT00122382|7176153|FG001|Open-Label Study|Lack of Efficacy|0
4399543|NCT00122382|7176154|FG002|Open-Label Study|Lack of Efficacy|3
4399544|NCT00122382|7176152|FG000|Open-Label Study|Lost to Follow-up|0
4399545|NCT00122382|7176153|FG001|Open-Label Study|Lost to Follow-up|0
4399546|NCT00122382|7176154|FG002|Open-Label Study|Lost to Follow-up|3
4399547|NCT00122382|7176152|FG000|Open-Label Study|Pregnancy|0
4399548|NCT00122382|7176153|FG001|Open-Label Study|Pregnancy|0
4399549|NCT00122382|7176154|FG002|Open-Label Study|Pregnancy|2
4399550|NCT00122382|7176152|FG000|Open-Label Study|Poor/Non-Compliance|0
4399551|NCT00122382|7176153|FG001|Open-Label Study|Poor/Non-Compliance|0
4399552|NCT00122382|7176154|FG002|Open-Label Study|Poor/Non-Compliance|1
4399553|NCT00122382|7176152|FG000|Open-Label Study|Withdrawal of Consent|0
4399554|NCT00122382|7176153|FG001|Open-Label Study|Withdrawal of Consent|0
4399555|NCT00122382|7176154|FG002|Open-Label Study|Withdrawal of Consent|4
4399556|NCT00122460|7176195|FG000|Overall Study|investigational study phase ongoing|7
4399557|NCT00122460|7176196|FG001|Overall Study|investigational study phase ongoing|1
4399558|NCT00122681|7176204|FG000|Overall Study|Adverse Event|20
4399559|NCT00122681|7176205|FG001|Overall Study|Adverse Event|16
4399560|NCT00122681|7176204|FG000|Overall Study|Lost to Follow-up|1080
4399561|NCT00122681|7176205|FG001|Overall Study|Lost to Follow-up|1097
4399562|NCT00122681|7176204|FG000|Overall Study|Protocol Violation|7
4399563|NCT00122681|7176205|FG001|Overall Study|Protocol Violation|10
4399564|NCT00122681|7176204|FG000|Overall Study|Withdrawal by Subject|257
4399565|NCT00122681|7176205|FG001|Overall Study|Withdrawal by Subject|251
4399566|NCT00122681|7176204|FG000|Overall Study|Personal reasons|150
4399567|NCT00122681|7176205|FG001|Overall Study|Personal reasons|147
4399568|NCT00122954|7176221|FG000|Overall Study|Withdrawal by Subject|2
4399569|NCT00122954|7176222|FG001|Overall Study|Withdrawal by Subject|2
4771661|NCT01665144|7748476|FG001|Overall Study|Technical problems|0
4399570|NCT00122954|7176221|FG000|Overall Study|Protocol Violation|0
4399571|NCT00122954|7176222|FG001|Overall Study|Protocol Violation|1
4399572|NCT00122980|7176230|FG000|Overall Study|Death|0
4399573|NCT00122980|7176231|FG001|Overall Study|Death|1
4399574|NCT00122980|7176230|FG000|Overall Study|Physician Decision|2
4399575|NCT00122980|7176231|FG001|Overall Study|Physician Decision|0
4399576|NCT00122980|7176230|FG000|Overall Study|Protocol Violation|5
4399577|NCT00122980|7176231|FG001|Overall Study|Protocol Violation|1
4399578|NCT00122980|7176230|FG000|Overall Study|Withdrawal by Subject|2
4399579|NCT00122980|7176231|FG001|Overall Study|Withdrawal by Subject|3
4399580|NCT00122980|7176230|FG000|Overall Study|Adjudicated stroke (study endpoint)|7
4399581|NCT00122980|7176231|FG001|Overall Study|Adjudicated stroke (study endpoint)|0
4399582|NCT00122980|7176230|FG000|Overall Study|Study termination|27
4399583|NCT00122980|7176231|FG001|Overall Study|Study termination|35
4399584|NCT00123422|7176286|FG000|Overall Study|Physician Decision|2
4399585|NCT00123422|7176287|FG001|Overall Study|Physician Decision|2
4399586|NCT00123422|7176288|FG002|Overall Study|Physician Decision|6
4399587|NCT00123422|7176286|FG000|Overall Study|Withdrawal by Subject|1
4399588|NCT00123422|7176287|FG001|Overall Study|Withdrawal by Subject|2
4399589|NCT00123422|7176288|FG002|Overall Study|Withdrawal by Subject|2
4399590|NCT00123422|7176286|FG000|Overall Study|Lost to Follow-up|1
4399591|NCT00123422|7176287|FG001|Overall Study|Lost to Follow-up|2
4399592|NCT00123422|7176288|FG002|Overall Study|Lost to Follow-up|2
4399593|NCT00123474|7176300|FG000|Randomized to Treatment|Randomized, never treated|1
4399594|NCT00123474|7176301|FG001|Randomized to Treatment|Randomized, never treated|4
4399595|NCT00123474|7176302|FG002|Randomized to Treatment|Randomized, never treated|2
4399596|NCT00123474|7176303|FG003|Randomized to Treatment|Randomized, never treated|1
4399597|NCT00123474|7176300|FG000|As Treated at Study Closure|not reported when site closed|1
4399598|NCT00123474|7176301|FG001|As Treated at Study Closure|not reported when site closed|0
4399599|NCT00123474|7176302|FG002|As Treated at Study Closure|not reported when site closed|1
4399600|NCT00123474|7176303|FG003|As Treated at Study Closure|not reported when site closed|0
4399601|NCT00123474|7176300|FG000|As Treated at Study Closure|Adverse Event|10
4399602|NCT00123474|7176301|FG001|As Treated at Study Closure|Adverse Event|4
4399603|NCT00123474|7176302|FG002|As Treated at Study Closure|Adverse Event|10
4399604|NCT00123474|7176303|FG003|As Treated at Study Closure|Adverse Event|8
4399605|NCT00123474|7176300|FG000|As Treated at Study Closure|Disease Progression|35
4399606|NCT00123474|7176301|FG001|As Treated at Study Closure|Disease Progression|42
4399607|NCT00123474|7176302|FG002|As Treated at Study Closure|Disease Progression|29
4399608|NCT00123474|7176303|FG003|As Treated at Study Closure|Disease Progression|27
4399609|NCT00123474|7176300|FG000|As Treated at Study Closure|Investigator Request|12
4399610|NCT00123474|7176301|FG001|As Treated at Study Closure|Investigator Request|6
4399611|NCT00123474|7176302|FG002|As Treated at Study Closure|Investigator Request|7
4399612|NCT00123474|7176303|FG003|As Treated at Study Closure|Investigator Request|5
4399613|NCT00123474|7176300|FG000|As Treated at Study Closure|non-specified|54
4399614|NCT00123474|7176301|FG001|As Treated at Study Closure|non-specified|47
4399615|NCT00123474|7176302|FG002|As Treated at Study Closure|non-specified|57
4399616|NCT00123474|7176303|FG003|As Treated at Study Closure|non-specified|60
4399617|NCT00123474|7176300|FG000|As Treated at Study Closure|Study Drug Toxicity|39
4399618|NCT00123474|7176301|FG001|As Treated at Study Closure|Study Drug Toxicity|45
4399619|NCT00123474|7176302|FG002|As Treated at Study Closure|Study Drug Toxicity|45
4399620|NCT00123474|7176303|FG003|As Treated at Study Closure|Study Drug Toxicity|51
4399621|NCT00123474|7176300|FG000|As Treated at Study Closure|Withdrawal by Subject|14
4399622|NCT00123474|7176301|FG001|As Treated at Study Closure|Withdrawal by Subject|19
4399623|NCT00123474|7176302|FG002|As Treated at Study Closure|Withdrawal by Subject|18
4399624|NCT00123474|7176303|FG003|As Treated at Study Closure|Withdrawal by Subject|16
4399625|NCT00123487|7176336|FG000|Randomized|Death prior to starting treatment|0
4399626|NCT00123487|7176337|FG001|Randomized|Death prior to starting treatment|1
4399627|NCT00123487|7176336|FG000|Randomized|SAE prior to starting treatment|1
4399628|NCT00123487|7176337|FG001|Randomized|SAE prior to starting treatment|0
4399629|NCT00123487|7176336|FG000|Treated With Study Drug|Adverse Event|23
4399630|NCT00123487|7176337|FG001|Treated With Study Drug|Adverse Event|22
4399631|NCT00123487|7176336|FG000|Treated With Study Drug|Disease Progression|141
4399632|NCT00123487|7176337|FG001|Treated With Study Drug|Disease Progression|122
4399633|NCT00123487|7176336|FG000|Treated With Study Drug|Physician Decision|8
4399634|NCT00123487|7176337|FG001|Treated With Study Drug|Physician Decision|9
4399635|NCT00123487|7176336|FG000|Treated With Study Drug|Other|59
4399636|NCT00123487|7176337|FG001|Treated With Study Drug|Other|58
4399637|NCT00123487|7176336|FG000|Treated With Study Drug|Study Drug Toxicity|62
4399638|NCT00123487|7176337|FG001|Treated With Study Drug|Study Drug Toxicity|80
4399639|NCT00123487|7176336|FG000|Treated With Study Drug|Withdrawal by Subject|11
4399640|NCT00123487|7176337|FG001|Treated With Study Drug|Withdrawal by Subject|13
4399641|NCT00123487|7176336|FG000|Treated With Study Drug|Unknown (case report form lost)|0
4399642|NCT00123487|7176337|FG001|Treated With Study Drug|Unknown (case report form lost)|1
4399643|NCT00123734|7176392|FG000|Overall Study|Death|3
4399644|NCT00123734|7176392|FG000|Overall Study|Lost to Follow-up|3
4399645|NCT00123734|7176392|FG000|Overall Study|Dropout|1
4399646|NCT00123734|7176392|FG000|Overall Study|Withdrawal by Subject|1
4399647|NCT00123955|7176401|FG000|Overall Study|Adverse Event|1
4399648|NCT00123955|7176402|FG001|Overall Study|Adverse Event|0
4399649|NCT00123955|7176401|FG000|Overall Study|Withdrawal by Subject|4
4399650|NCT00123955|7176402|FG001|Overall Study|Withdrawal by Subject|3
4399651|NCT00123955|7176401|FG000|Overall Study|Death|0
4399652|NCT00123955|7176402|FG001|Overall Study|Death|1
4399653|NCT00124020|7176410|FG000|Overall Study|Death|67
4399654|NCT00124020|7176411|FG001|Overall Study|Death|71
4399655|NCT00124020|7176410|FG000|Overall Study|Withdrawal by Subject|13
4399656|NCT00124020|7176411|FG001|Overall Study|Withdrawal by Subject|11
4399657|NCT00124020|7176410|FG000|Overall Study|Lost to Follow-up|5
4399658|NCT00124020|7176411|FG001|Overall Study|Lost to Follow-up|8
4399659|NCT00124020|7176410|FG000|Overall Study|Other|1
4399660|NCT00124020|7176411|FG001|Overall Study|Other|1
4399661|NCT00124020|7176410|FG000|Overall Study|Transfer to another hospital|2
4399662|NCT00124020|7176411|FG001|Overall Study|Transfer to another hospital|0
4399663|NCT00124072|7176421|FG000|Overall Study|Lost to Follow-up for Mortality|0
4399664|NCT00124072|7176422|FG001|Overall Study|Lost to Follow-up for Mortality|3
4399665|NCT00124072|7176423|FG002|Overall Study|Lost to Follow-up for Mortality|2
4399666|NCT00124072|7176424|FG003|Overall Study|Lost to Follow-up for Mortality|2
4399667|NCT00124072|7176421|FG000|Overall Study|Lost to Follow-up for Morbidity|15
4399668|NCT00124072|7176422|FG001|Overall Study|Lost to Follow-up for Morbidity|25
4399669|NCT00124072|7176423|FG002|Overall Study|Lost to Follow-up for Morbidity|19
4399670|NCT00124072|7176424|FG003|Overall Study|Lost to Follow-up for Morbidity|18
4399671|NCT00124072|7176421|FG000|Overall Study|Death|499
4399672|NCT00124072|7176422|FG001|Overall Study|Death|484
4399673|NCT00124072|7176423|FG002|Overall Study|Death|471
4399674|NCT00124072|7176424|FG003|Overall Study|Death|480
4399675|NCT00124449|7176445|FG000|6-month Double-Blind Treatment Period|Adverse Event|1
4399676|NCT00124449|7176446|FG001|6-month Double-Blind Treatment Period|Adverse Event|0
4399677|NCT00124449|7176445|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3
4399678|NCT00124449|7176446|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8
4399679|NCT00124449|7176445|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1
4399680|NCT00124449|7176446|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1
4399681|NCT00124449|7176445|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1
4399682|NCT00124449|7176446|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0
4399683|NCT00124449|7176445|FG000|6-month Double-Blind Treatment Period|Sponsor request|0
4399684|NCT00124449|7176446|FG001|6-month Double-Blind Treatment Period|Sponsor request|1
4399685|NCT00124449|7176445|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0
4399686|NCT00124449|7176446|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1
4399687|NCT00124449|7176445|FG000|18-Month Untreated Observation Period|Adverse Event|0
4399688|NCT00124449|7176446|FG001|18-Month Untreated Observation Period|Adverse Event|1
4399689|NCT00124449|7176445|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11
4399690|NCT00124449|7176446|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12
4399691|NCT00124449|7176445|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1
4399692|NCT00124449|7176446|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0
4399693|NCT00124449|7176445|FG000|18-Month Untreated Observation Period|Pregnancy|1
4399694|NCT00124449|7176446|FG001|18-Month Untreated Observation Period|Pregnancy|0
4399695|NCT00124449|7176445|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1
4399696|NCT00124449|7176446|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0
4399697|NCT00124449|7176445|FG000|18-Month Untreated Observation Period|Relocated|1
4399698|NCT00124449|7176446|FG001|18-Month Untreated Observation Period|Relocated|0
4399699|NCT00124462|7176455|FG000|Overall Study|Lost to Follow-up|3
4399700|NCT00124462|7176456|FG001|Overall Study|Lost to Follow-up|3
4399701|NCT00124462|7176455|FG000|Overall Study|Physician Decision|3
4399702|NCT00124462|7176456|FG001|Overall Study|Physician Decision|4
4399703|NCT00124462|7176455|FG000|Overall Study|Withdrawal by Subject|4
4399704|NCT00124462|7176456|FG001|Overall Study|Withdrawal by Subject|5
4399705|NCT00124462|7176455|FG000|Overall Study|Device fitting, n=2, other hlth issues|1
4399706|NCT00124462|7176456|FG001|Overall Study|Device fitting, n=2, other hlth issues|1
4399707|NCT00124618|7176483|FG000|Overall Study|Ineligible|1
4399708|NCT00124657|7176490|FG000|Overall Study|Toxicity|0
4399709|NCT00124657|7176491|FG001|Overall Study|Toxicity|0
4399710|NCT00124657|7176492|FG002|Overall Study|Toxicity|1
4399711|NCT00124657|7176490|FG000|Overall Study|Non-compliance|1
4399712|NCT00124657|7176491|FG001|Overall Study|Non-compliance|0
4399713|NCT00124657|7176492|FG002|Overall Study|Non-compliance|4
4399714|NCT00124657|7176490|FG000|Overall Study|Progressive disease|14
4399715|NCT00124657|7176491|FG001|Overall Study|Progressive disease|5
4399716|NCT00124657|7176492|FG002|Overall Study|Progressive disease|27
4399717|NCT00124657|7176490|FG000|Overall Study|Intercurrent illness|1
4399718|NCT00124657|7176491|FG001|Overall Study|Intercurrent illness|0
4399719|NCT00124657|7176492|FG002|Overall Study|Intercurrent illness|0
4399720|NCT00124709|7176515|FG000|Overall Study|Randomized but did not take medication|3
4399721|NCT00124709|7176516|FG001|Overall Study|Randomized but did not take medication|1
4399722|NCT00124709|7176515|FG000|Overall Study|Adverse Event|3
4399723|NCT00124709|7176516|FG001|Overall Study|Adverse Event|0
4399724|NCT00124709|7176515|FG000|Overall Study|Lack of Efficacy|5
4399725|NCT00124709|7176516|FG001|Overall Study|Lack of Efficacy|10
4399726|NCT00124709|7176515|FG000|Overall Study|Protocol Violation|3
4399727|NCT00124709|7176516|FG001|Overall Study|Protocol Violation|5
4399728|NCT00124709|7176515|FG000|Overall Study|Withdrawal by Subject|127
4399729|NCT00124709|7176516|FG001|Overall Study|Withdrawal by Subject|136
4399730|NCT00124709|7176515|FG000|Overall Study|Lost to Follow-up|114
4399731|NCT00124709|7176516|FG001|Overall Study|Lost to Follow-up|120
4399732|NCT00124748|7176557|FG000|Overall Study|Adverse Event|8
4399733|NCT00124748|7176558|FG001|Overall Study|Adverse Event|39
4399734|NCT00124748|7176557|FG000|Overall Study|Abnormal laboratory Value|2
4399735|NCT00124748|7176558|FG001|Overall Study|Abnormal laboratory Value|2
4399736|NCT00124748|7176557|FG000|Overall Study|Abnormal Procedure|0
4399737|NCT00124748|7176558|FG001|Overall Study|Abnormal Procedure|1
4399738|NCT00124748|7176557|FG000|Overall Study|Lack of Efficacy|20
4399739|NCT00124748|7176558|FG001|Overall Study|Lack of Efficacy|41
4399740|NCT00124748|7176557|FG000|Overall Study|No longer requires study drug|1
4399741|NCT00124748|7176558|FG001|Overall Study|No longer requires study drug|1
4399742|NCT00124748|7176557|FG000|Overall Study|Protocol Violation|3
4399743|NCT00124748|7176558|FG001|Overall Study|Protocol Violation|1
4399744|NCT00124748|7176557|FG000|Overall Study|Withdrawal by Subject|5
4399745|NCT00124748|7176558|FG001|Overall Study|Withdrawal by Subject|15
4399746|NCT00124748|7176557|FG000|Overall Study|Lost to Follow-up|2
4399747|NCT00124748|7176558|FG001|Overall Study|Lost to Follow-up|7
4399748|NCT00124748|7176557|FG000|Overall Study|Administrative Problem(Study Terminated)|101
4399749|NCT00124748|7176558|FG001|Overall Study|Administrative Problem(Study Terminated)|174
4399750|NCT00124748|7176557|FG000|Overall Study|Death|1
4399751|NCT00124748|7176558|FG001|Overall Study|Death|3
4399752|NCT00124917|7176564|FG000|Overall Study|Physician Decision|3
4399753|NCT00124943|7176573|FG000|Phase II|Adverse Event|0
4399754|NCT00124943|7176574|FG001|Phase II|Adverse Event|2
4399755|NCT00124943|7176575|FG002|Phase II|Adverse Event|0
4399756|NCT00124943|7176576|FG003|Phase II|Adverse Event|1
4399757|NCT00124943|7176573|FG000|Phase II|Protocol Violation|0
4399758|NCT00124943|7176574|FG001|Phase II|Protocol Violation|0
4399759|NCT00124943|7176575|FG002|Phase II|Protocol Violation|0
4399760|NCT00124943|7176576|FG003|Phase II|Protocol Violation|1
4399761|NCT00124943|7176573|FG000|Phase II|Lost to Follow-up|0
4399762|NCT00124943|7176574|FG001|Phase II|Lost to Follow-up|0
4399763|NCT00124943|7176575|FG002|Phase II|Lost to Follow-up|0
4399764|NCT00124943|7176576|FG003|Phase II|Lost to Follow-up|1
4399765|NCT00124943|7176573|FG000|Phase II|Withdrawal by Subject|0
4399766|NCT00124943|7176574|FG001|Phase II|Withdrawal by Subject|0
4399767|NCT00124943|7176575|FG002|Phase II|Withdrawal by Subject|0
4399768|NCT00124943|7176576|FG003|Phase II|Withdrawal by Subject|2
4399769|NCT00124982|7176588|FG000|Short-term Period|Death|1
4399770|NCT00124982|7176589|FG001|Short-term Period|Death|1
4399771|NCT00124982|7176590|FG002|Short-term Period|Death|0
4399772|NCT00124982|7176588|FG000|Short-term Period|Adverse Event|17
4399773|NCT00124982|7176589|FG001|Short-term Period|Adverse Event|22
4399774|NCT00124982|7176590|FG002|Short-term Period|Adverse Event|0
4399775|NCT00124982|7176588|FG000|Short-term Period|Lack of Efficacy|32
4399776|NCT00124982|7176589|FG001|Short-term Period|Lack of Efficacy|73
4399777|NCT00124982|7176590|FG002|Short-term Period|Lack of Efficacy|0
4399778|NCT00124982|7176588|FG000|Short-term Period|Lost to Follow-up|8
4399779|NCT00124982|7176589|FG001|Short-term Period|Lost to Follow-up|5
4399780|NCT00124982|7176590|FG002|Short-term Period|Lost to Follow-up|0
4399781|NCT00124982|7176588|FG000|Short-term Period|Withdrawal of Consent|7
4399782|NCT00124982|7176589|FG001|Short-term Period|Withdrawal of Consent|9
4399783|NCT00124982|7176590|FG002|Short-term Period|Withdrawal of Consent|0
4399784|NCT00124982|7176588|FG000|Short-term Period|Poor/Non-compliance|3
4399785|NCT00124982|7176589|FG001|Short-term Period|Poor/Non-compliance|1
4399786|NCT00124982|7176590|FG002|Short-term Period|Poor/Non-compliance|0
4399787|NCT00124982|7176588|FG000|Short-term Period|No Longer Meets Study Criteria|1
4399788|NCT00124982|7176589|FG001|Short-term Period|No Longer Meets Study Criteria|2
4399789|NCT00124982|7176590|FG002|Short-term Period|No Longer Meets Study Criteria|0
4399790|NCT00124982|7176588|FG000|Short-term Period|Participant Decision|1
4399791|NCT00124982|7176589|FG001|Short-term Period|Participant Decision|0
4399792|NCT00124982|7176590|FG002|Short-term Period|Participant Decision|0
4399793|NCT00124982|7176588|FG000|Short-term Period|Participant Chose Own Doctor|0
4399794|NCT00124982|7176589|FG001|Short-term Period|Participant Chose Own Doctor|1
4399795|NCT00124982|7176590|FG002|Short-term Period|Participant Chose Own Doctor|0
4399796|NCT00124982|7176588|FG000|Short-term Period|Investigator Decision-No Specific AE|1
4399797|NCT00124982|7176589|FG001|Short-term Period|Investigator Decision-No Specific AE|0
4399798|NCT00124982|7176590|FG002|Short-term Period|Investigator Decision-No Specific AE|0
4399799|NCT00124982|7176588|FG000|Short-term Period|Participant Had Lymphopenia|1
4399800|NCT00124982|7176589|FG001|Short-term Period|Participant Had Lymphopenia|0
4399801|NCT00124982|7176590|FG002|Short-term Period|Participant Had Lymphopenia|0
4399802|NCT00124982|7176588|FG000|Long-term Period|Death|0
4399803|NCT00124982|7176589|FG001|Long-term Period|Death|0
4399804|NCT00124982|7176590|FG002|Long-term Period|Death|1
4399805|NCT00124982|7176588|FG000|Long-term Period|Adverse Event|0
4399806|NCT00124982|7176589|FG001|Long-term Period|Adverse Event|0
4399807|NCT00124982|7176590|FG002|Long-term Period|Adverse Event|17
4399808|NCT00124982|7176588|FG000|Long-term Period|Lack of Efficacy|0
4399809|NCT00124982|7176589|FG001|Long-term Period|Lack of Efficacy|0
4399810|NCT00124982|7176590|FG002|Long-term Period|Lack of Efficacy|46
4399811|NCT00124982|7176588|FG000|Long-term Period|Lost to Follow-up|0
4399812|NCT00124982|7176589|FG001|Long-term Period|Lost to Follow-up|0
4399813|NCT00124982|7176590|FG002|Long-term Period|Lost to Follow-up|4
4399814|NCT00124982|7176588|FG000|Long-term Period|Withdrawal by Subject|0
4399815|NCT00124982|7176589|FG001|Long-term Period|Withdrawal by Subject|0
4399816|NCT00124982|7176590|FG002|Long-term Period|Withdrawal by Subject|16
4399817|NCT00124982|7176588|FG000|Long-term Period|Pregnancy|0
4399818|NCT00124982|7176589|FG001|Long-term Period|Pregnancy|0
4399819|NCT00124982|7176590|FG002|Long-term Period|Pregnancy|1
4399820|NCT00124982|7176588|FG000|Long-term Period|Poor/Non-compliance|0
4399821|NCT00124982|7176589|FG001|Long-term Period|Poor/Non-compliance|0
4399822|NCT00124982|7176590|FG002|Long-term Period|Poor/Non-compliance|2
4399823|NCT00124982|7176588|FG000|Long-term Period|Administrative Reason by Sponsor|0
4399824|NCT00124982|7176589|FG001|Long-term Period|Administrative Reason by Sponsor|0
4399825|NCT00124982|7176590|FG002|Long-term Period|Administrative Reason by Sponsor|1
4713307|NCT02943447|7640719|FG001|Open-Label Extension Phase|Lack of Efficacy|4
4713308|NCT02943447|7640720|FG002|Open-Label Extension Phase|Lack of Efficacy|0
4713309|NCT02943447|7640718|FG000|Open-Label Extension Phase|Withdrew consent|1
4399826|NCT00124982|7176588|FG000|Long-term Period|Neurologist Recommendation|0
4399827|NCT00124982|7176589|FG001|Long-term Period|Neurologist Recommendation|0
4399828|NCT00124982|7176590|FG002|Long-term Period|Neurologist Recommendation|1
4399829|NCT00125138|7176612|FG000|Overall Study|Adverse Event|1
4399830|NCT00125138|7176613|FG001|Overall Study|Adverse Event|0
4399831|NCT00125138|7176614|FG002|Overall Study|Adverse Event|3
4399832|NCT00125138|7176615|FG003|Overall Study|Adverse Event|2
4399833|NCT00125138|7176612|FG000|Overall Study|Withdrawal by Subject|2
4399834|NCT00125138|7176613|FG001|Overall Study|Withdrawal by Subject|3
4399835|NCT00125138|7176614|FG002|Overall Study|Withdrawal by Subject|1
4399836|NCT00125138|7176615|FG003|Overall Study|Withdrawal by Subject|1
4399837|NCT00125138|7176612|FG000|Overall Study|Lack of Efficacy|0
4399838|NCT00125138|7176613|FG001|Overall Study|Lack of Efficacy|0
4399839|NCT00125138|7176614|FG002|Overall Study|Lack of Efficacy|0
4399840|NCT00125138|7176615|FG003|Overall Study|Lack of Efficacy|1
4399841|NCT00125138|7176612|FG000|Overall Study|Sponsor decision-pt moved to assist care|0
4399842|NCT00125138|7176613|FG001|Overall Study|Sponsor decision-pt moved to assist care|0
4399843|NCT00125138|7176614|FG002|Overall Study|Sponsor decision-pt moved to assist care|0
4399844|NCT00125138|7176615|FG003|Overall Study|Sponsor decision-pt moved to assist care|1
4399845|NCT00125164|7176629|FG000|Overall Study|Adverse Event|0
4399846|NCT00125164|7176630|FG001|Overall Study|Adverse Event|0
4399847|NCT00125164|7176631|FG002|Overall Study|Adverse Event|2
4399848|NCT00125164|7176632|FG003|Overall Study|Adverse Event|4
4399849|NCT00125164|7176629|FG000|Overall Study|Lost to Follow-up|0
4399850|NCT00125164|7176630|FG001|Overall Study|Lost to Follow-up|0
4399851|NCT00125164|7176631|FG002|Overall Study|Lost to Follow-up|1
4399852|NCT00125164|7176632|FG003|Overall Study|Lost to Follow-up|1
4399853|NCT00125164|7176629|FG000|Overall Study|Withdrawal by Subject|2
4399854|NCT00125164|7176630|FG001|Overall Study|Withdrawal by Subject|0
4399855|NCT00125164|7176631|FG002|Overall Study|Withdrawal by Subject|1
4399856|NCT00125164|7176632|FG003|Overall Study|Withdrawal by Subject|1
4399857|NCT00125190|7176642|FG000|Overall Study|Subject/Parent Decision|7
4399858|NCT00125190|7176642|FG000|Overall Study|Non-compliance|2
4399859|NCT00125190|7176642|FG000|Overall Study|Adverse Event|1
4399860|NCT00125190|7176642|FG000|Overall Study|Other|1
4399861|NCT00125190|7176642|FG000|Overall Study|Lost to Follow-up|4
4399862|NCT00125242|7176649|FG000|Overall Study|did not qualify|7
4399863|NCT00125242|7176650|FG001|Overall Study|did not qualify|2
4399864|NCT00125359|7176655|FG000|Overall Study|Death|4
4399865|NCT00125359|7176655|FG000|Overall Study|Adverse Event|5
4399866|NCT00125359|7176655|FG000|Overall Study|Physician Decision|14
4399867|NCT00125853|7176728|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3
4399868|NCT00125853|7176729|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7
4399869|NCT00126126|7176759|FG000|Overall Study|Lost to Follow-up|0
4399870|NCT00126126|7176760|FG001|Overall Study|Lost to Follow-up|2
4399871|NCT00126191|7176768|FG000|Overall Study|Physician Decision|0
4399872|NCT00126191|7176769|FG001|Overall Study|Physician Decision|1
4399873|NCT00126191|7176768|FG000|Overall Study|Death|0
4399874|NCT00126191|7176769|FG001|Overall Study|Death|1
4399875|NCT00126425|7176777|FG000|Overall Study|Withdrawal by Subject|17
4399876|NCT00126425|7176778|FG001|Overall Study|Withdrawal by Subject|1
4399877|NCT00126425|7176777|FG000|Overall Study|Lost to Follow-up|8
4399878|NCT00126425|7176778|FG001|Overall Study|Lost to Follow-up|4
4399879|NCT00126425|7176777|FG000|Overall Study|Protocol Violation|9
4399880|NCT00126425|7176778|FG001|Overall Study|Protocol Violation|6
4399881|NCT00126425|7176777|FG000|Overall Study|Adverse Event|1
4399882|NCT00126425|7176778|FG001|Overall Study|Adverse Event|0
4399883|NCT00126425|7176777|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1
4399884|NCT00126425|7176778|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0
4399885|NCT00126425|7176777|FG000|Overall Study|Other|5
4399886|NCT00126425|7176778|FG001|Overall Study|Other|0
4399887|NCT00126438|7176786|FG000|Overall Study|Withdrawal due to adverse event|1
4399888|NCT00126438|7176787|FG001|Overall Study|Withdrawal due to adverse event|0
4399889|NCT00126438|7176786|FG000|Overall Study|Lost to Follow-up|22
4399890|NCT00126438|7176787|FG001|Overall Study|Lost to Follow-up|0
4399891|NCT00126438|7176786|FG000|Overall Study|Protocol Violation|8
4399892|NCT00126438|7176787|FG001|Overall Study|Protocol Violation|8
4399893|NCT00126438|7176786|FG000|Overall Study|Withdrawal by Subject|3
4399894|NCT00126438|7176787|FG001|Overall Study|Withdrawal by Subject|2
4713310|NCT02943447|7640719|FG001|Open-Label Extension Phase|Withdrew consent|1
4713311|NCT02943447|7640720|FG002|Open-Label Extension Phase|Withdrew consent|1
4399895|NCT00126490|7176793|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1
4399896|NCT00126503|7176799|FG000|Overall Study|disease progression|23
4399897|NCT00126503|7176800|FG001|Overall Study|disease progression|14
4399898|NCT00126503|7176799|FG000|Overall Study|Withdrawal by Subject|0
4399899|NCT00126503|7176800|FG001|Overall Study|Withdrawal by Subject|1
4399900|NCT00126503|7176799|FG000|Overall Study|alternative therapy|1
4399901|NCT00126503|7176800|FG001|Overall Study|alternative therapy|1
4399902|NCT00126503|7176799|FG000|Overall Study|other complicating disease|4
4399903|NCT00126503|7176800|FG001|Overall Study|other complicating disease|1
4399904|NCT00126503|7176799|FG000|Overall Study|Death|3
4399905|NCT00126503|7176800|FG001|Overall Study|Death|0
4399906|NCT00126503|7176799|FG000|Overall Study|Adverse Event|13
4399907|NCT00126503|7176800|FG001|Overall Study|Adverse Event|3
4399908|NCT00126503|7176799|FG000|Overall Study|non-compliant|1
4399909|NCT00126503|7176800|FG001|Overall Study|non-compliant|0
4399910|NCT00126503|7176799|FG000|Overall Study|Physician Decision|2
4399911|NCT00126503|7176800|FG001|Overall Study|Physician Decision|1
4399912|NCT00126555|7176810|FG000|Overall Study|Withdrawal by Subject|1
4399913|NCT00126555|7176810|FG000|Overall Study|Adverse Event|2
4399914|NCT00126555|7176810|FG000|Overall Study|Progressive Disease|3
4399915|NCT00126568|7176826|FG000|Overall Study|Death|2
4399916|NCT00126581|7176833|FG000|Overall Study|Adverse Event|3
4399917|NCT00126581|7176834|FG001|Overall Study|Adverse Event|7
4399918|NCT00126581|7176833|FG000|Overall Study|Death|3
4399919|NCT00126581|7176834|FG001|Overall Study|Death|2
4399920|NCT00126581|7176833|FG000|Overall Study|Withdrawal by Subject|1
4399921|NCT00126581|7176834|FG001|Overall Study|Withdrawal by Subject|4
4399922|NCT00126581|7176833|FG000|Overall Study|Alternative therapy|3
4399923|NCT00126581|7176834|FG001|Overall Study|Alternative therapy|3
4399924|NCT00126581|7176833|FG000|Overall Study|Other illness/MD discretion|3
4399925|NCT00126581|7176834|FG001|Overall Study|Other illness/MD discretion|4
4399926|NCT00126594|7176844|FG000|Overall Study|Ineligible|2
4399927|NCT00126594|7176845|FG001|Overall Study|Ineligible|0
4399928|NCT00126594|7176844|FG000|Overall Study|Withdrawal by Subject|0
4399929|NCT00126594|7176845|FG001|Overall Study|Withdrawal by Subject|4
4399930|NCT00126594|7176844|FG000|Overall Study|Physician Decision|1
4399931|NCT00126594|7176845|FG001|Overall Study|Physician Decision|3
4399932|NCT00126594|7176844|FG000|Overall Study|Adverse Event|7
4399933|NCT00126594|7176845|FG001|Overall Study|Adverse Event|5
4399934|NCT00126594|7176844|FG000|Overall Study|Non-compliance|0
4399935|NCT00126594|7176845|FG001|Overall Study|Non-compliance|1
4399936|NCT00126594|7176844|FG000|Overall Study|Disease Progression|29
4399937|NCT00126594|7176845|FG001|Overall Study|Disease Progression|24
4399938|NCT00127036|7176883|FG000|Overall Study|Insufficient Data for Analysis|6
4399939|NCT00127036|7176884|FG001|Overall Study|Insufficient Data for Analysis|11
4399940|NCT00127036|7176883|FG000|Overall Study|Screen Failure|2
4399941|NCT00127036|7176884|FG001|Overall Study|Screen Failure|0
4399942|NCT00127101|7176909|FG000|Base Protocol|Adverse Event|0
4399943|NCT00127101|7176910|FG001|Base Protocol|Adverse Event|2
4399944|NCT00127101|7176911|FG002|Base Protocol|Adverse Event|1
4399945|NCT00127101|7176912|FG003|Base Protocol|Adverse Event|0
4399946|NCT00127101|7176913|FG004|Base Protocol|Adverse Event|0
4399947|NCT00127101|7176914|FG005|Base Protocol|Adverse Event|0
4399948|NCT00127101|7176909|FG000|Base Protocol|Lack of Efficacy|1
4399949|NCT00127101|7176910|FG001|Base Protocol|Lack of Efficacy|0
4399950|NCT00127101|7176911|FG002|Base Protocol|Lack of Efficacy|0
4399951|NCT00127101|7176912|FG003|Base Protocol|Lack of Efficacy|0
4399952|NCT00127101|7176913|FG004|Base Protocol|Lack of Efficacy|2
4399953|NCT00127101|7176914|FG005|Base Protocol|Lack of Efficacy|0
4399954|NCT00127101|7176909|FG000|Base Protocol|Withdrawal by Subject|1
4399955|NCT00127101|7176910|FG001|Base Protocol|Withdrawal by Subject|2
4399956|NCT00127101|7176911|FG002|Base Protocol|Withdrawal by Subject|1
4399957|NCT00127101|7176912|FG003|Base Protocol|Withdrawal by Subject|0
4399958|NCT00127101|7176913|FG004|Base Protocol|Withdrawal by Subject|0
4399959|NCT00127101|7176914|FG005|Base Protocol|Withdrawal by Subject|1
4399960|NCT00127101|7176909|FG000|Continuation Phase|Adverse Event|0
4399961|NCT00127101|7176910|FG001|Continuation Phase|Adverse Event|0
4399962|NCT00127101|7176911|FG002|Continuation Phase|Adverse Event|0
4399963|NCT00127101|7176912|FG003|Continuation Phase|Adverse Event|0
4399964|NCT00127101|7176913|FG004|Continuation Phase|Adverse Event|1
4399965|NCT00127101|7176914|FG005|Continuation Phase|Adverse Event|1
4399966|NCT00127101|7176909|FG000|Continuation Phase|Lack of Efficacy|0
4399967|NCT00127101|7176910|FG001|Continuation Phase|Lack of Efficacy|0
4399968|NCT00127101|7176911|FG002|Continuation Phase|Lack of Efficacy|0
4399969|NCT00127101|7176912|FG003|Continuation Phase|Lack of Efficacy|0
4399970|NCT00127101|7176913|FG004|Continuation Phase|Lack of Efficacy|0
4399971|NCT00127101|7176914|FG005|Continuation Phase|Lack of Efficacy|1
4399972|NCT00127101|7176909|FG000|Continuation Phase|Withdrawal by Subject|0
4399973|NCT00127101|7176910|FG001|Continuation Phase|Withdrawal by Subject|0
4399974|NCT00127101|7176911|FG002|Continuation Phase|Withdrawal by Subject|1
4399975|NCT00127101|7176912|FG003|Continuation Phase|Withdrawal by Subject|0
4399976|NCT00127101|7176913|FG004|Continuation Phase|Withdrawal by Subject|2
4399977|NCT00127101|7176914|FG005|Continuation Phase|Withdrawal by Subject|1
4399978|NCT00127166|7176930|FG000|Period I|Protocol Violation|0
4399979|NCT00127166|7176931|FG001|Period I|Protocol Violation|2
4399980|NCT00127166|7176930|FG000|Period I|Withdrawal by Subject|2
4399981|NCT00127166|7176931|FG001|Period I|Withdrawal by Subject|0
4510989|NCT00923091|7319701|FG002|Period VI (Open-Label)|Adverse Event|4
4399982|NCT00127166|7176930|FG000|Period I|Patient did not meet inclusion criteria|1
4399983|NCT00127166|7176931|FG001|Period I|Patient did not meet inclusion criteria|0
4399984|NCT00127166|7176930|FG000|Washout Period|Patient did not meet inclusion criteria|0
4399985|NCT00127166|7176931|FG001|Washout Period|Patient did not meet inclusion criteria|1
4399986|NCT00127166|7176930|FG000|Period II|Withdrawal by Subject|2
4399987|NCT00127166|7176931|FG001|Period II|Withdrawal by Subject|0
4399988|NCT00127166|7176930|FG000|Period II|Patient did not perform Visit 6 exercise|1
4399989|NCT00127166|7176931|FG001|Period II|Patient did not perform Visit 6 exercise|0
4399990|NCT00127192|7176942|FG000|Overall Study|Adverse Event|0
4399991|NCT00127192|7176943|FG001|Overall Study|Adverse Event|1
4399992|NCT00127192|7176944|FG002|Overall Study|Adverse Event|1
4399993|NCT00127192|7176945|FG003|Overall Study|Adverse Event|1
4399994|NCT00127192|7176946|FG004|Overall Study|Adverse Event|0
4399995|NCT00127192|7176942|FG000|Overall Study|Lack of Efficacy|2
4399996|NCT00127192|7176943|FG001|Overall Study|Lack of Efficacy|0
4399997|NCT00127192|7176944|FG002|Overall Study|Lack of Efficacy|0
4399998|NCT00127192|7176945|FG003|Overall Study|Lack of Efficacy|0
4399999|NCT00127192|7176946|FG004|Overall Study|Lack of Efficacy|2
4400000|NCT00127192|7176942|FG000|Overall Study|Withdrawal by Subject|0
4400001|NCT00127192|7176943|FG001|Overall Study|Withdrawal by Subject|0
4400002|NCT00127192|7176944|FG002|Overall Study|Withdrawal by Subject|1
4400003|NCT00127192|7176945|FG003|Overall Study|Withdrawal by Subject|0
4400004|NCT00127192|7176946|FG004|Overall Study|Withdrawal by Subject|3
4400005|NCT00127192|7176942|FG000|Overall Study|Adverse event in pre-treatment period|1
4400006|NCT00127192|7176943|FG001|Overall Study|Adverse event in pre-treatment period|0
4400007|NCT00127192|7176944|FG002|Overall Study|Adverse event in pre-treatment period|0
4400008|NCT00127192|7176945|FG003|Overall Study|Adverse event in pre-treatment period|0
4400009|NCT00127192|7176946|FG004|Overall Study|Adverse event in pre-treatment period|0
4400010|NCT00127205|7176961|FG000|Overall Study|Adverse Event|228
4400011|NCT00127205|7176962|FG001|Overall Study|Adverse Event|387
4400012|NCT00127205|7176963|FG002|Overall Study|Adverse Event|273
4400013|NCT00127205|7176961|FG000|Overall Study|Death|8
4400014|NCT00127205|7176962|FG001|Overall Study|Death|6
4400015|NCT00127205|7176963|FG002|Overall Study|Death|5
4400016|NCT00127205|7176961|FG000|Overall Study|Withdrawal by Subject|318
4400017|NCT00127205|7176962|FG001|Overall Study|Withdrawal by Subject|310
4400018|NCT00127205|7176963|FG002|Overall Study|Withdrawal by Subject|172
4400019|NCT00127205|7176961|FG000|Overall Study|Other-non protocol specified|142
4400020|NCT00127205|7176962|FG001|Overall Study|Other-non protocol specified|129
4400021|NCT00127205|7176963|FG002|Overall Study|Other-non protocol specified|77
4400022|NCT00127205|7176961|FG000|Overall Study|Data not reported|6
4400023|NCT00127205|7176962|FG001|Overall Study|Data not reported|10
4400024|NCT00127205|7176963|FG002|Overall Study|Data not reported|1
4400025|NCT00127205|7176961|FG000|Overall Study|Progression|127
4400026|NCT00127205|7176962|FG001|Overall Study|Progression|131
4400027|NCT00127205|7176963|FG002|Overall Study|Progression|84
4400028|NCT00127413|7176997|FG000|Overall Study|Lost to Follow-up|6
4400029|NCT00127413|7176998|FG001|Overall Study|Lost to Follow-up|4
4400030|NCT00127413|7176999|FG002|Overall Study|Lost to Follow-up|8
4400031|NCT00127413|7177000|FG003|Overall Study|Lost to Follow-up|2
4510990|NCT00923091|7319702|FG003|Period VI (Open-Label)|Adverse Event|1
4510991|NCT00923091|7319703|FG004|Period VI (Open-Label)|Adverse Event|1
4510992|NCT00923091|7319704|FG005|Period VI (Open-Label)|Adverse Event|0
4510993|NCT00923091|7319705|FG006|Period VI (Open-Label)|Adverse Event|0
4510994|NCT00923091|7319706|FG007|Period VI (Open-Label)|Adverse Event|0
4510995|NCT00923091|7319707|FG008|Period VI (Open-Label)|Adverse Event|0
4510996|NCT00923091|7319708|FG009|Period VI (Open-Label)|Adverse Event|0
4510997|NCT00923091|7319709|FG010|Period VI (Open-Label)|Adverse Event|0
4510998|NCT00923091|7319710|FG011|Period VI (Open-Label)|Adverse Event|0
4510999|NCT00923091|7319711|FG012|Period VI (Open-Label)|Adverse Event|0
4511000|NCT00923091|7319699|FG000|Period VI (Open-Label)|Withdrawal by Subject|15
4511001|NCT00923091|7319700|FG001|Period VI (Open-Label)|Withdrawal by Subject|7
4511002|NCT00923091|7319701|FG002|Period VI (Open-Label)|Withdrawal by Subject|5
4511003|NCT00923091|7319702|FG003|Period VI (Open-Label)|Withdrawal by Subject|0
4511004|NCT00923091|7319703|FG004|Period VI (Open-Label)|Withdrawal by Subject|1
4511005|NCT00923091|7319704|FG005|Period VI (Open-Label)|Withdrawal by Subject|0
4511006|NCT00923091|7319705|FG006|Period VI (Open-Label)|Withdrawal by Subject|0
4511007|NCT00923091|7319706|FG007|Period VI (Open-Label)|Withdrawal by Subject|0
4511008|NCT00923091|7319707|FG008|Period VI (Open-Label)|Withdrawal by Subject|0
4511009|NCT00923091|7319708|FG009|Period VI (Open-Label)|Withdrawal by Subject|0
4511010|NCT00923091|7319709|FG010|Period VI (Open-Label)|Withdrawal by Subject|0
4511011|NCT00923091|7319710|FG011|Period VI (Open-Label)|Withdrawal by Subject|0
4511012|NCT00923091|7319711|FG012|Period VI (Open-Label)|Withdrawal by Subject|0
4511013|NCT00923091|7319699|FG000|Period VI (Open-Label)|Protocol Violation|6
4511014|NCT00923091|7319700|FG001|Period VI (Open-Label)|Protocol Violation|1
4511015|NCT00923091|7319701|FG002|Period VI (Open-Label)|Protocol Violation|3
4511016|NCT00923091|7319702|FG003|Period VI (Open-Label)|Protocol Violation|1
4511017|NCT00923091|7319703|FG004|Period VI (Open-Label)|Protocol Violation|4
4511018|NCT00923091|7319704|FG005|Period VI (Open-Label)|Protocol Violation|0
4511019|NCT00923091|7319705|FG006|Period VI (Open-Label)|Protocol Violation|0
4511020|NCT00923091|7319706|FG007|Period VI (Open-Label)|Protocol Violation|0
4400032|NCT00127608|7177031|FG000|Overall Study|VZV DNA negative|1
4400033|NCT00127660|7177039|FG000|Overall Study|Protocol Violation|3
4400034|NCT00127660|7177040|FG001|Overall Study|Protocol Violation|3
4713312|NCT02943447|7640718|FG000|Open-Label Extension Phase|Lost to Follow-up|0
4713313|NCT02943447|7640719|FG001|Open-Label Extension Phase|Lost to Follow-up|1
4400035|NCT00127660|7177041|FG002|Overall Study|Protocol Violation|5
4400036|NCT00127660|7177042|FG003|Overall Study|Protocol Violation|0
4400037|NCT00127712|7177054|FG000|Overall Study|Adverse Event|3
4400038|NCT00127712|7177055|FG001|Overall Study|Adverse Event|0
4400039|NCT00127712|7177054|FG000|Overall Study|Lack of GI access to continue|2
4400040|NCT00127712|7177055|FG001|Overall Study|Lack of GI access to continue|0
4400041|NCT00127803|7177082|FG000|Overall Study|Adverse Event|2
4400042|NCT00127803|7177083|FG001|Overall Study|Adverse Event|0
4400043|NCT00127803|7177084|FG002|Overall Study|Adverse Event|0
4400044|NCT00127803|7177085|FG003|Overall Study|Adverse Event|0
4400045|NCT00127803|7177082|FG000|Overall Study|Withdrawal by Subject|1
4400046|NCT00127803|7177083|FG001|Overall Study|Withdrawal by Subject|0
4400047|NCT00127803|7177084|FG002|Overall Study|Withdrawal by Subject|0
4400048|NCT00127803|7177085|FG003|Overall Study|Withdrawal by Subject|0
4400049|NCT00127803|7177082|FG000|Overall Study|Lost to Follow-up|0
4400050|NCT00127803|7177083|FG001|Overall Study|Lost to Follow-up|0
4400051|NCT00127803|7177084|FG002|Overall Study|Lost to Follow-up|0
4400052|NCT00127803|7177085|FG003|Overall Study|Lost to Follow-up|1
4400053|NCT00127842|7177095|FG000|Overall Study|Adverse Event|15
4400054|NCT00127842|7177095|FG000|Overall Study|Withdrawal by Subject|3
4400055|NCT00127842|7177095|FG000|Overall Study|Lost to Follow-up|1
4400056|NCT00127842|7177095|FG000|Overall Study|Lack of Efficacy|12
4400057|NCT00127842|7177095|FG000|Overall Study|Noncompliance|2
4400058|NCT00127842|7177095|FG000|Overall Study|Protocol Violation|1
4400059|NCT00127842|7177095|FG000|Overall Study|Other|5
4400060|NCT00127855|7177104|FG000|Primary Vaccination Course|Adverse Event|0
4400061|NCT00127855|7177105|FG001|Primary Vaccination Course|Adverse Event|0
4400062|NCT00127855|7177106|FG002|Primary Vaccination Course|Adverse Event|1
4400063|NCT00127855|7177107|FG003|Primary Vaccination Course|Adverse Event|0
4400064|NCT00127855|7177108|FG004|Primary Vaccination Course|Adverse Event|0
4400065|NCT00127855|7177104|FG000|Primary Vaccination Course|Withdrawal by Subject|1
4400066|NCT00127855|7177105|FG001|Primary Vaccination Course|Withdrawal by Subject|0
4400067|NCT00127855|7177106|FG002|Primary Vaccination Course|Withdrawal by Subject|0
4400068|NCT00127855|7177107|FG003|Primary Vaccination Course|Withdrawal by Subject|0
4400069|NCT00127855|7177108|FG004|Primary Vaccination Course|Withdrawal by Subject|1
4400070|NCT00127855|7177104|FG000|Primary Vaccination Course|Lost to Follow-up|1
4400071|NCT00127855|7177105|FG001|Primary Vaccination Course|Lost to Follow-up|1
4400072|NCT00127855|7177106|FG002|Primary Vaccination Course|Lost to Follow-up|1
4400073|NCT00127855|7177107|FG003|Primary Vaccination Course|Lost to Follow-up|0
4400074|NCT00127855|7177108|FG004|Primary Vaccination Course|Lost to Follow-up|2
4400075|NCT00127855|7177104|FG000|Primary Vaccination Course|Other|0
4400076|NCT00127855|7177105|FG001|Primary Vaccination Course|Other|0
4400077|NCT00127855|7177106|FG002|Primary Vaccination Course|Other|0
4400078|NCT00127855|7177107|FG003|Primary Vaccination Course|Other|0
4400079|NCT00127855|7177108|FG004|Primary Vaccination Course|Other|1
4400080|NCT00127933|7177122|FG000|Overall Study|Randomized but not dosed|1
4400081|NCT00127933|7177123|FG001|Overall Study|Randomized but not dosed|0
4400082|NCT00128102|7177131|FG000|Overall Study|Site Discontinued|3
4400083|NCT00128102|7177132|FG001|Overall Study|Site Discontinued|6
4400084|NCT00128102|7177131|FG000|Overall Study|Other|0
4400085|NCT00128102|7177132|FG001|Overall Study|Other|1
4400086|NCT00128102|7177131|FG000|Overall Study|Progressive Disease|255
4400087|NCT00128102|7177132|FG001|Overall Study|Progressive Disease|285
4400088|NCT00128102|7177131|FG000|Overall Study|Adverse Event|34
4400089|NCT00128102|7177132|FG001|Overall Study|Adverse Event|11
4400090|NCT00128102|7177131|FG000|Overall Study|Death|12
4400091|NCT00128102|7177132|FG001|Overall Study|Death|13
4400092|NCT00128102|7177131|FG000|Overall Study|Physician Decision|3
4400093|NCT00128102|7177132|FG001|Overall Study|Physician Decision|3
4400094|NCT00128102|7177131|FG000|Overall Study|Withdrawal by Subject|19
4400095|NCT00128102|7177132|FG001|Overall Study|Withdrawal by Subject|11
4400096|NCT00128102|7177131|FG000|Overall Study|Protocol Violation|2
4400097|NCT00128102|7177132|FG001|Overall Study|Protocol Violation|2
4400098|NCT00128206|7177252|FG000|Overall Study|Lost to Follow-up|137
4400099|NCT00128206|7177253|FG001|Overall Study|Lost to Follow-up|118
4400100|NCT00128206|7177252|FG000|Overall Study|Adverse Event|0
4400101|NCT00128206|7177253|FG001|Overall Study|Adverse Event|2
4400102|NCT00128492|7177280|FG000|Overall Study|AE unrelated to study|2
4400103|NCT00128492|7177281|FG001|Overall Study|AE unrelated to study|9
4400104|NCT00128492|7177280|FG000|Overall Study|Study drug intolerance (AE)|2
4400105|NCT00128492|7177281|FG001|Overall Study|Study drug intolerance (AE)|8
4400106|NCT00128492|7177280|FG000|Overall Study|AE related to study|1
4400107|NCT00128492|7177281|FG001|Overall Study|AE related to study|4
4400108|NCT00128492|7177280|FG000|Overall Study|Death|1
4400109|NCT00128492|7177281|FG001|Overall Study|Death|0
4713314|NCT02943447|7640720|FG002|Open-Label Extension Phase|Lost to Follow-up|0
4713315|NCT02943460|7640740|FG000|Blinded Study Phase|Adverse Event|3
4713316|NCT02943460|7640741|FG001|Blinded Study Phase|Adverse Event|0
4400110|NCT00128492|7177280|FG000|Overall Study|Lost to Follow-up|1
4713317|NCT02943460|7640742|FG002|Blinded Study Phase|Adverse Event|0
4400111|NCT00128492|7177281|FG001|Overall Study|Lost to Follow-up|5
4400112|NCT00128492|7177280|FG000|Overall Study|Noncompliance|0
4400113|NCT00128492|7177281|FG001|Overall Study|Noncompliance|5
4400114|NCT00128492|7177280|FG000|Overall Study|Personal or administrative|10
4400115|NCT00128492|7177281|FG001|Overall Study|Personal or administrative|22
4400116|NCT00128492|7177280|FG000|Overall Study|Withdrawal by Subject|3
4400117|NCT00128492|7177281|FG001|Overall Study|Withdrawal by Subject|5
4400118|NCT00128492|7177280|FG000|Overall Study|Pregnancy|0
4400119|NCT00128492|7177281|FG001|Overall Study|Pregnancy|1
4400120|NCT00128661|7177289|FG000|Overall Study|Adverse Event|14
4400121|NCT00128661|7177290|FG001|Overall Study|Adverse Event|11
4400122|NCT00128661|7177289|FG000|Overall Study|Lost to Follow-up|10
4400123|NCT00128661|7177290|FG001|Overall Study|Lost to Follow-up|7
4400124|NCT00128661|7177289|FG000|Overall Study|Withdrawal by Subject|243
4400125|NCT00128661|7177290|FG001|Overall Study|Withdrawal by Subject|232
4400126|NCT00128661|7177289|FG000|Overall Study|Other|7
4400127|NCT00128661|7177290|FG001|Overall Study|Other|8
4400128|NCT00128830|7177309|FG000|Overall Study|Adverse Event|10
4400129|NCT00128830|7177309|FG000|Overall Study|Withdrawal by Subject|14
4400130|NCT00128830|7177309|FG000|Overall Study|Lost to Follow-up|4
4400131|NCT00128830|7177309|FG000|Overall Study|Reached a virologic endpoint|29
4400132|NCT00128830|7177309|FG000|Overall Study|Non-compliant|4
4400133|NCT00128830|7177309|FG000|Overall Study|Discontinued or ineligible for study|2
4400134|NCT00128830|7177309|FG000|Overall Study|Other|9
4400135|NCT00129116|7177335|FG000|Primary Phase|Lost to Follow-up|1
4400136|NCT00129116|7177336|FG001|Primary Phase|Lost to Follow-up|1
4400137|NCT00129116|7177337|FG002|Primary Phase|Lost to Follow-up|0
4400138|NCT00129116|7177338|FG003|Primary Phase|Lost to Follow-up|1
4400139|NCT00129116|7177339|FG004|Primary Phase|Lost to Follow-up|1
4400140|NCT00129116|7177335|FG000|Primary Phase|Protocol Violation|0
4400141|NCT00129116|7177336|FG001|Primary Phase|Protocol Violation|1
4400142|NCT00129116|7177337|FG002|Primary Phase|Protocol Violation|0
4400143|NCT00129116|7177338|FG003|Primary Phase|Protocol Violation|0
4400144|NCT00129116|7177339|FG004|Primary Phase|Protocol Violation|0
4400145|NCT00129116|7177335|FG000|Primary Phase|Adverse Event|1
4400146|NCT00129116|7177336|FG001|Primary Phase|Adverse Event|1
4400147|NCT00129116|7177337|FG002|Primary Phase|Adverse Event|0
4400148|NCT00129116|7177338|FG003|Primary Phase|Adverse Event|0
4400149|NCT00129116|7177339|FG004|Primary Phase|Adverse Event|0
4400150|NCT00129116|7177335|FG000|Primary Phase|Withdrawal by Subject|0
4400151|NCT00129116|7177336|FG001|Primary Phase|Withdrawal by Subject|1
4400152|NCT00129116|7177337|FG002|Primary Phase|Withdrawal by Subject|0
4400153|NCT00129116|7177338|FG003|Primary Phase|Withdrawal by Subject|0
4400154|NCT00129116|7177339|FG004|Primary Phase|Withdrawal by Subject|0
4400155|NCT00129116|7177335|FG000|Primary Phase|Other|0
4400156|NCT00129116|7177336|FG001|Primary Phase|Other|0
4400157|NCT00129116|7177337|FG002|Primary Phase|Other|1
4400158|NCT00129116|7177338|FG003|Primary Phase|Other|0
4400159|NCT00129116|7177339|FG004|Primary Phase|Other|0
4400160|NCT00129116|7177335|FG000|Booster Phase|Lost to Follow-up|2
4400161|NCT00129116|7177336|FG001|Booster Phase|Lost to Follow-up|0
4400162|NCT00129116|7177337|FG002|Booster Phase|Lost to Follow-up|0
4400163|NCT00129116|7177338|FG003|Booster Phase|Lost to Follow-up|0
4400164|NCT00129116|7177339|FG004|Booster Phase|Lost to Follow-up|1
4400165|NCT00129129|7177354|FG000|Primary Phase|Adverse Event|2
4400166|NCT00129129|7177355|FG001|Primary Phase|Adverse Event|1
4400167|NCT00129129|7177356|FG002|Primary Phase|Adverse Event|0
4400168|NCT00129129|7177357|FG003|Primary Phase|Adverse Event|0
4400169|NCT00129129|7177358|FG004|Primary Phase|Adverse Event|0
4400170|NCT00129129|7177354|FG000|Primary Phase|Withdrawal by Subject|12
4400171|NCT00129129|7177355|FG001|Primary Phase|Withdrawal by Subject|10
4400172|NCT00129129|7177356|FG002|Primary Phase|Withdrawal by Subject|0
4400173|NCT00129129|7177357|FG003|Primary Phase|Withdrawal by Subject|0
4400174|NCT00129129|7177358|FG004|Primary Phase|Withdrawal by Subject|0
4400175|NCT00129129|7177354|FG000|Primary Phase|Migration from study area|1
4400176|NCT00129129|7177355|FG001|Primary Phase|Migration from study area|3
4400177|NCT00129129|7177356|FG002|Primary Phase|Migration from study area|0
4400178|NCT00129129|7177357|FG003|Primary Phase|Migration from study area|0
4400179|NCT00129129|7177358|FG004|Primary Phase|Migration from study area|0
4400180|NCT00129129|7177354|FG000|Primary Phase|Lost to Follow-up|8
4400181|NCT00129129|7177355|FG001|Primary Phase|Lost to Follow-up|6
4400182|NCT00129129|7177356|FG002|Primary Phase|Lost to Follow-up|0
4400183|NCT00129129|7177357|FG003|Primary Phase|Lost to Follow-up|0
4400184|NCT00129129|7177358|FG004|Primary Phase|Lost to Follow-up|0
4400185|NCT00129129|7177354|FG000|Primary Phase|Other|2
4400186|NCT00129129|7177355|FG001|Primary Phase|Other|5
4400187|NCT00129129|7177356|FG002|Primary Phase|Other|0
4400188|NCT00129129|7177357|FG003|Primary Phase|Other|0
4400189|NCT00129129|7177358|FG004|Primary Phase|Other|0
4400190|NCT00129129|7177354|FG000|Fourth Dose Phase|Lost to Follow-up|4
4400191|NCT00129129|7177355|FG001|Fourth Dose Phase|Lost to Follow-up|0
4400192|NCT00129129|7177356|FG002|Fourth Dose Phase|Lost to Follow-up|0
4400193|NCT00129129|7177357|FG003|Fourth Dose Phase|Lost to Follow-up|2
4400194|NCT00129129|7177358|FG004|Fourth Dose Phase|Lost to Follow-up|2
4400195|NCT00129129|7177354|FG000|Fourth Dose Phase|Withdrawal by Subject|0
4400196|NCT00129129|7177355|FG001|Fourth Dose Phase|Withdrawal by Subject|0
4400197|NCT00129129|7177356|FG002|Fourth Dose Phase|Withdrawal by Subject|0
4400198|NCT00129129|7177357|FG003|Fourth Dose Phase|Withdrawal by Subject|0
4400199|NCT00129129|7177358|FG004|Fourth Dose Phase|Withdrawal by Subject|1
4400200|NCT00129129|7177354|FG000|Fourth Dose Phase|Migration from study area|0
4400201|NCT00129129|7177355|FG001|Fourth Dose Phase|Migration from study area|0
4400202|NCT00129129|7177356|FG002|Fourth Dose Phase|Migration from study area|0
4400203|NCT00129129|7177357|FG003|Fourth Dose Phase|Migration from study area|0
4400204|NCT00129129|7177358|FG004|Fourth Dose Phase|Migration from study area|2
4400205|NCT00129129|7177354|FG000|Fourth Dose Phase|Other|0
4400206|NCT00129129|7177355|FG001|Fourth Dose Phase|Other|0
4400207|NCT00129129|7177356|FG002|Fourth Dose Phase|Other|0
4400208|NCT00129129|7177357|FG003|Fourth Dose Phase|Other|1
4400209|NCT00129129|7177358|FG004|Fourth Dose Phase|Other|1
4400210|NCT00129129|7177354|FG000|Fourth Dose Phase|Protocol Violation|0
4400211|NCT00129129|7177355|FG001|Fourth Dose Phase|Protocol Violation|0
4400212|NCT00129129|7177356|FG002|Fourth Dose Phase|Protocol Violation|0
4400213|NCT00129129|7177357|FG003|Fourth Dose Phase|Protocol Violation|1
4400214|NCT00129129|7177358|FG004|Fourth Dose Phase|Protocol Violation|0
4400215|NCT00129220|7177381|FG000|Study Period II|Adverse Event|9
4400216|NCT00129220|7177382|FG001|Study Period II|Adverse Event|5
4400217|NCT00129220|7177383|FG002|Study Period II|Adverse Event|7
4400218|NCT00129220|7177381|FG000|Study Period II|Lack of Efficacy|15
4400219|NCT00129220|7177382|FG001|Study Period II|Lack of Efficacy|1
4400220|NCT00129220|7177383|FG002|Study Period II|Lack of Efficacy|28
4400221|NCT00129220|7177381|FG000|Study Period II|Entry Criteria Not Met|2
4400222|NCT00129220|7177382|FG001|Study Period II|Entry Criteria Not Met|0
4400223|NCT00129220|7177383|FG002|Study Period II|Entry Criteria Not Met|2
4400224|NCT00129220|7177381|FG000|Study Period II|Protocol Violation|4
4400225|NCT00129220|7177382|FG001|Study Period II|Protocol Violation|2
4400226|NCT00129220|7177383|FG002|Study Period II|Protocol Violation|1
4400227|NCT00129220|7177381|FG000|Study Period II|Physician Decision|0
4400228|NCT00129220|7177382|FG001|Study Period II|Physician Decision|1
4400229|NCT00129220|7177383|FG002|Study Period II|Physician Decision|0
4400230|NCT00129220|7177381|FG000|Study Period II|Withdrawal by Subject|1
4400231|NCT00129220|7177382|FG001|Study Period II|Withdrawal by Subject|3
4400232|NCT00129220|7177383|FG002|Study Period II|Withdrawal by Subject|4
4400233|NCT00129220|7177381|FG000|Study Period II|Reason Not Specified|2
4400234|NCT00129220|7177382|FG001|Study Period II|Reason Not Specified|0
4400235|NCT00129220|7177383|FG002|Study Period II|Reason Not Specified|5
4400236|NCT00129220|7177381|FG000|Study Period III|Adverse Event|1
4400237|NCT00129220|7177382|FG001|Study Period III|Adverse Event|0
4400238|NCT00129220|7177383|FG002|Study Period III|Adverse Event|3
4400239|NCT00129220|7177381|FG000|Study Period III|Protocol Violation|1
4400240|NCT00129220|7177382|FG001|Study Period III|Protocol Violation|1
4400241|NCT00129220|7177383|FG002|Study Period III|Protocol Violation|2
4400242|NCT00129220|7177381|FG000|Study Period III|Withdrawal by Subject|1
4400243|NCT00129220|7177382|FG001|Study Period III|Withdrawal by Subject|0
4400244|NCT00129220|7177383|FG002|Study Period III|Withdrawal by Subject|3
4400245|NCT00129220|7177381|FG000|Study Period III|Sponsor Decision|1
4400246|NCT00129220|7177382|FG001|Study Period III|Sponsor Decision|0
4400247|NCT00129220|7177383|FG002|Study Period III|Sponsor Decision|0
4400248|NCT00129220|7177381|FG000|Study Period III|Reason Not Specified|9
4400249|NCT00129220|7177382|FG001|Study Period III|Reason Not Specified|0
4400250|NCT00129220|7177383|FG002|Study Period III|Reason Not Specified|2
4400251|NCT00129259|7177404|FG000|Overall Study|Lost to Follow-up|1
4400252|NCT00129259|7177405|FG001|Overall Study|Lost to Follow-up|1
4400253|NCT00129259|7177404|FG000|Overall Study|Withdrawal by Subject|2
4400254|NCT00129259|7177405|FG001|Overall Study|Withdrawal by Subject|1
4400255|NCT00129259|7177404|FG000|Overall Study|Only available minimal phone assessments|0
4400256|NCT00129259|7177405|FG001|Overall Study|Only available minimal phone assessments|1
4400257|NCT00129272|7177413|FG000|Overall Study|Lost to Follow-up|12
4400258|NCT00129272|7177414|FG001|Overall Study|Lost to Follow-up|11
4400259|NCT00129272|7177413|FG000|Overall Study|Withdrawal by Subject|5
4400260|NCT00129272|7177414|FG001|Overall Study|Withdrawal by Subject|11
4400261|NCT00129311|7177439|FG000|Overall Study|Withdrawal by Subject|12
4400262|NCT00129311|7177440|FG001|Overall Study|Withdrawal by Subject|19
4400263|NCT00129376|7177446|FG000|Overall Study|Adverse Event|1
4400264|NCT00129376|7177446|FG000|Overall Study|Lack of Efficacy|1
4400265|NCT00129389|7177452|FG000|Overall Study|Adverse Event|19
4400266|NCT00129389|7177453|FG001|Overall Study|Adverse Event|87
4400267|NCT00129389|7177452|FG000|Overall Study|Death|0
4713318|NCT02943460|7640740|FG000|Blinded Study Phase|Withdrew Consent|0
4713319|NCT02943460|7640741|FG001|Blinded Study Phase|Withdrew Consent|1
4713320|NCT02943460|7640742|FG002|Blinded Study Phase|Withdrew Consent|0
4713321|NCT02943460|7640740|FG000|Open Label Extension (OLE) Phase|Adverse Event|2
4400268|NCT00129389|7177453|FG001|Overall Study|Death|1
4400269|NCT00129389|7177452|FG000|Overall Study|Lost to Follow-up|2
4400270|NCT00129389|7177453|FG001|Overall Study|Lost to Follow-up|1
4400271|NCT00129389|7177452|FG000|Overall Study|Physician Decision|0
4400272|NCT00129389|7177453|FG001|Overall Study|Physician Decision|4
4400273|NCT00129389|7177452|FG000|Overall Study|Protocol Violation|0
4400274|NCT00129389|7177453|FG001|Overall Study|Protocol Violation|6
4400275|NCT00129389|7177452|FG000|Overall Study|Withdrawal by Subject|9
4400276|NCT00129389|7177453|FG001|Overall Study|Withdrawal by Subject|23
4400277|NCT00129389|7177452|FG000|Overall Study|Relapse|1
4400278|NCT00129389|7177453|FG001|Overall Study|Relapse|0
4400279|NCT00129389|7177452|FG000|Overall Study|Not eligible|1
4400280|NCT00129389|7177453|FG001|Overall Study|Not eligible|2
4400281|NCT00129389|7177452|FG000|Overall Study|Crossed to the other arm|1
4400282|NCT00129389|7177453|FG001|Overall Study|Crossed to the other arm|16
4400283|NCT00129467|7177470|FG000|Received Intervention|Death|1
4400284|NCT00129467|7177471|FG001|Received Intervention|Death|1
4400285|NCT00129467|7177470|FG000|Received Intervention|Cardiac SAE (hypertension)|1
4400286|NCT00129467|7177471|FG001|Received Intervention|Cardiac SAE (hypertension)|1
4400287|NCT00129467|7177470|FG000|Received Intervention|Delirium|2
4400288|NCT00129467|7177471|FG001|Received Intervention|Delirium|0
4400289|NCT00129467|7177470|FG000|Received Intervention|Withdrawal by Subject|1
4400290|NCT00129467|7177471|FG001|Received Intervention|Withdrawal by Subject|0
4400291|NCT00129467|7177470|FG000|Received Intervention|Nausea|1
4400292|NCT00129467|7177471|FG001|Received Intervention|Nausea|0
4400293|NCT00129467|7177470|FG000|Received Intervention|Intolerance to citalopram|0
4400294|NCT00129467|7177471|FG001|Received Intervention|Intolerance to citalopram|1
4400295|NCT00129467|7177470|FG000|Received Intervention|Dizzyness, fatigue|0
4400296|NCT00129467|7177471|FG001|Received Intervention|Dizzyness, fatigue|1
4400297|NCT00129467|7177470|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1
4400298|NCT00129467|7177471|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0
4400299|NCT00129467|7177470|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1
4400300|NCT00129467|7177471|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0
4400301|NCT00129545|7177489|FG000|Overall Study|Death|5
4400302|NCT00129545|7177490|FG001|Overall Study|Death|60
4400303|NCT00129545|7177491|FG002|Overall Study|Death|44
4400304|NCT00129545|7177489|FG000|Overall Study|Withdrawal by Subject|3
4400305|NCT00129545|7177490|FG001|Overall Study|Withdrawal by Subject|18
4400306|NCT00129545|7177491|FG002|Overall Study|Withdrawal by Subject|44
4400307|NCT00129545|7177489|FG000|Overall Study|Lost to Follow-up|2
4400308|NCT00129545|7177490|FG001|Overall Study|Lost to Follow-up|22
4400309|NCT00129545|7177491|FG002|Overall Study|Lost to Follow-up|13
4400310|NCT00129545|7177489|FG000|Overall Study|Physician Decision|0
4400311|NCT00129545|7177490|FG001|Overall Study|Physician Decision|3
4400312|NCT00129545|7177491|FG002|Overall Study|Physician Decision|10
4400313|NCT00129545|7177489|FG000|Overall Study|Device not implanted|16
4400314|NCT00129545|7177490|FG001|Overall Study|Device not implanted|61
4400315|NCT00129545|7177491|FG002|Overall Study|Device not implanted|0
4400316|NCT00129623|7177501|FG000|Overall Study|Adverse Event|3
4400317|NCT00129623|7177502|FG001|Overall Study|Adverse Event|7
4400318|NCT00129623|7177501|FG000|Overall Study|Refused Treatment|5
4400319|NCT00129623|7177502|FG001|Overall Study|Refused Treatment|3
4400320|NCT00129623|7177501|FG000|Overall Study|Failure to Return|1
4400321|NCT00129623|7177502|FG001|Overall Study|Failure to Return|1
4400322|NCT00129623|7177501|FG000|Overall Study|Relocated job out of state|1
4400323|NCT00129623|7177502|FG001|Overall Study|Relocated job out of state|0
4400324|NCT00129623|7177501|FG000|Overall Study|Uncertainty to return|0
4400325|NCT00129623|7177502|FG001|Overall Study|Uncertainty to return|1
4400326|NCT00129649|7177512|FG000|Overall Study|Withdrawal by Subject|76
4400327|NCT00129649|7177513|FG001|Overall Study|Withdrawal by Subject|65
4400328|NCT00129701|7177519|FG000|Overall Study|Withdrawal by Subject|33
4400329|NCT00129766|7177536|FG000|Overall Study|Death|3
4400330|NCT00129766|7177537|FG001|Overall Study|Death|8
4400331|NCT00129766|7177536|FG000|Overall Study|Withdrawal of consent|31
4400332|NCT00129766|7177537|FG001|Overall Study|Withdrawal of consent|30
4400333|NCT00129766|7177536|FG000|Overall Study|Lost to Follow-up|26
4400334|NCT00129766|7177537|FG001|Overall Study|Lost to Follow-up|21
4400335|NCT00129935|7177546|FG000|Overall Study|Adverse Event|18
4400336|NCT00129935|7177547|FG001|Overall Study|Adverse Event|56
4400337|NCT00129935|7177546|FG000|Overall Study|Death|1
4400338|NCT00129935|7177547|FG001|Overall Study|Death|1
4400339|NCT00129935|7177546|FG000|Overall Study|Withdrawal by Subject|7
4400340|NCT00129935|7177547|FG001|Overall Study|Withdrawal by Subject|20
4400341|NCT00129935|7177546|FG000|Overall Study|Protocol Violation|0
4400342|NCT00129935|7177547|FG001|Overall Study|Protocol Violation|4
4400343|NCT00129935|7177546|FG000|Overall Study|Physician Decision|3
4400344|NCT00129935|7177547|FG001|Overall Study|Physician Decision|4
4400345|NCT00129935|7177546|FG000|Overall Study|Recurrence|1
4400346|NCT00129935|7177547|FG001|Overall Study|Recurrence|3
4400347|NCT00129935|7177546|FG000|Overall Study|Second primary|0
4400348|NCT00129935|7177547|FG001|Overall Study|Second primary|1
4400349|NCT00129935|7177546|FG000|Overall Study|Other|3
4400350|NCT00129935|7177547|FG001|Overall Study|Other|2
4400351|NCT00129935|7177546|FG000|Overall Study|Crossed to the other arm|2
4400352|NCT00129935|7177547|FG001|Overall Study|Crossed to the other arm|1
4400353|NCT00129935|7177546|FG000|Overall Study|Incorrect study treatment|1
4400354|NCT00129935|7177547|FG001|Overall Study|Incorrect study treatment|0
4400355|NCT00129961|7177555|FG000|Overall Study|Adverse Event|1
4400356|NCT00129961|7177556|FG001|Overall Study|Adverse Event|0
4400357|NCT00129961|7177555|FG000|Overall Study|Death|1
4400358|NCT00129961|7177556|FG001|Overall Study|Death|1
4400359|NCT00129961|7177555|FG000|Overall Study|Withdrawal by Sponsor|14
4400360|NCT00129961|7177556|FG001|Overall Study|Withdrawal by Sponsor|20
4400361|NCT00129961|7177555|FG000|Overall Study|Physician Decision|1
4400362|NCT00129961|7177556|FG001|Overall Study|Physician Decision|0
4400363|NCT00129961|7177555|FG000|Overall Study|Withdrawal by Subject|2
4400364|NCT00129961|7177556|FG001|Overall Study|Withdrawal by Subject|1
4400365|NCT00129961|7177555|FG000|Overall Study|Missing Record|0
4400366|NCT00129961|7177556|FG001|Overall Study|Missing Record|1
4400367|NCT00129987|7177564|FG000|1st Educational Session|Withdrawal by Subject|141
4400368|NCT00129987|7177565|FG001|1st Educational Session|Withdrawal by Subject|109
4400369|NCT00129987|7177564|FG000|1 Year|Withdrawal by Subject|32
4400370|NCT00129987|7177565|FG001|1 Year|Withdrawal by Subject|21
4400371|NCT00130039|7177573|FG000|Overall Study|Withdrawal by Subject|15
4400372|NCT00130039|7177574|FG001|Overall Study|Withdrawal by Subject|11
4400373|NCT00130039|7177573|FG000|Overall Study|Lost to Follow-up|3
4400374|NCT00130039|7177574|FG001|Overall Study|Lost to Follow-up|1
4400375|NCT00130039|7177573|FG000|Overall Study|Adverse Event|4
4400376|NCT00130039|7177574|FG001|Overall Study|Adverse Event|2
4400377|NCT00130039|7177573|FG000|Overall Study|Physician Decision|3
4400378|NCT00130039|7177574|FG001|Overall Study|Physician Decision|0
4400379|NCT00130039|7177573|FG000|Overall Study|clinical events without follow up MRI|5
4400380|NCT00130039|7177574|FG001|Overall Study|clinical events without follow up MRI|4
4400381|NCT00130208|7177592|FG000|Maintenance Period (26 Weeks)|Adverse Event|10
4400382|NCT00130208|7177593|FG001|Maintenance Period (26 Weeks)|Adverse Event|12
4400383|NCT00130208|7177592|FG000|Maintenance Period (26 Weeks)|Physician Decision|0
4400384|NCT00130208|7177593|FG001|Maintenance Period (26 Weeks)|Physician Decision|2
4400385|NCT00130208|7177592|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8
4400386|NCT00130208|7177593|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11
4400387|NCT00130208|7177592|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5
4400388|NCT00130208|7177593|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4
4400389|NCT00130208|7177592|FG000|Maintenance Period (26 Weeks)|Other|1
4400390|NCT00130208|7177593|FG001|Maintenance Period (26 Weeks)|Other|1
4400391|NCT00130208|7177592|FG000|Washout Period (8 Weeks)|Adverse Event|3
4400392|NCT00130208|7177593|FG001|Washout Period (8 Weeks)|Adverse Event|6
4400393|NCT00130208|7177592|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2
4400394|NCT00130208|7177593|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4
4400395|NCT00130208|7177592|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0
4400396|NCT00130208|7177593|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1
4400397|NCT00130208|7177592|FG000|Washout Period (8 Weeks)|Other|1
4400398|NCT00130208|7177593|FG001|Washout Period (8 Weeks)|Other|1
4400399|NCT00130247|7177601|FG000|Overall Study|Pregnancy|1
4400400|NCT00130247|7177602|FG001|Overall Study|Pregnancy|0
4400401|NCT00130247|7177601|FG000|Overall Study|Post-randomization exclusion|1
4400402|NCT00130247|7177602|FG001|Overall Study|Post-randomization exclusion|2
4400403|NCT00130247|7177601|FG000|Overall Study|Not compliant with DOT|0
4400404|NCT00130247|7177602|FG001|Overall Study|Not compliant with DOT|2
4400405|NCT00130286|7177612|FG000|Overall Study|Withdrawal by Subject|0
4400406|NCT00130286|7177613|FG001|Overall Study|Withdrawal by Subject|1
4400407|NCT00130286|7177614|FG002|Overall Study|Withdrawal by Subject|2
4400408|NCT00130286|7177615|FG003|Overall Study|Withdrawal by Subject|2
4400409|NCT00130286|7177612|FG000|Overall Study|Adverse Event|0
4400410|NCT00130286|7177613|FG001|Overall Study|Adverse Event|0
4400411|NCT00130286|7177614|FG002|Overall Study|Adverse Event|2
4400412|NCT00130286|7177615|FG003|Overall Study|Adverse Event|0
4400413|NCT00130286|7177612|FG000|Overall Study|Missing lab specimens|0
4400414|NCT00130286|7177613|FG001|Overall Study|Missing lab specimens|2
4400415|NCT00130286|7177614|FG002|Overall Study|Missing lab specimens|0
4400416|NCT00130286|7177615|FG003|Overall Study|Missing lab specimens|0
4400417|NCT00130442|7177627|FG000|Overall Study|Withdrawal by Subject|0
4400418|NCT00130442|7177628|FG001|Overall Study|Withdrawal by Subject|1
4400419|NCT00130442|7177627|FG000|Overall Study|did not meet criteria|1
4400420|NCT00130442|7177628|FG001|Overall Study|did not meet criteria|1
4400421|NCT00130520|7177636|FG000|Overall Study|Adverse Event|11
4400422|NCT00130520|7177636|FG000|Overall Study|Death|1
4400423|NCT00130520|7177636|FG000|Overall Study|Physician Decision|1
4400424|NCT00130520|7177636|FG000|Overall Study|Withdrawal by Subject|1
4400425|NCT00130520|7177636|FG000|Overall Study|Disease Progression|23
4400426|NCT00130520|7177636|FG000|Overall Study|Protocol non-compliance|1
4400427|NCT00130520|7177636|FG000|Overall Study|Did not meet re-treatment criteria|1
4400428|NCT00130533|7177642|FG000|Overall Study|Withdrawal by Subject|33
4400429|NCT00130533|7177643|FG001|Overall Study|Withdrawal by Subject|6
4400430|NCT00130533|7177642|FG000|Overall Study|Adverse Event|34
4400431|NCT00130533|7177643|FG001|Overall Study|Adverse Event|1
4400432|NCT00130533|7177642|FG000|Overall Study|Disease relapse|9
4400433|NCT00130533|7177643|FG001|Overall Study|Disease relapse|13
4400434|NCT00130533|7177642|FG000|Overall Study|Interruption of treatment > 3 weeks|11
4400435|NCT00130533|7177643|FG001|Overall Study|Interruption of treatment > 3 weeks|0
4400436|NCT00130533|7177642|FG000|Overall Study|Death|4
4400437|NCT00130533|7177643|FG001|Overall Study|Death|2
4400438|NCT00130533|7177642|FG000|Overall Study|Protocol Violation|5
4400439|NCT00130533|7177643|FG001|Overall Study|Protocol Violation|1
4400440|NCT00130533|7177642|FG000|Overall Study|Lost to Follow-up|1
4400441|NCT00130533|7177643|FG001|Overall Study|Lost to Follow-up|1
4400442|NCT00130533|7177642|FG000|Overall Study|Sponsor´s decision|2
4400443|NCT00130533|7177643|FG001|Overall Study|Sponsor´s decision|0
4400444|NCT00130533|7177642|FG000|Overall Study|Second Primary Malignancy|0
4400445|NCT00130533|7177643|FG001|Overall Study|Second Primary Malignancy|1
4400446|NCT00130533|7177642|FG000|Overall Study|Other|12
4400447|NCT00130533|7177643|FG001|Overall Study|Other|5
4400448|NCT00130637|7177649|FG000|Overall Study|Adverse Event|2
4400449|NCT00130637|7177649|FG000|Overall Study|Withdrawal by Subject|1
4400450|NCT00130689|7177653|FG000|Overall Study|Progressive Disease|29
4400451|NCT00130689|7177653|FG000|Overall Study|Death|1
4400452|NCT00130689|7177653|FG000|Overall Study|Clinical Deterioration|4
4400453|NCT00130689|7177653|FG000|Overall Study|Withdrawal by Subject|3
4400454|NCT00130689|7177653|FG000|Overall Study|Ineligible|6
4400455|NCT00130728|7177659|FG000|Overall Study|Death|258
4400456|NCT00130728|7177660|FG001|Overall Study|Death|258
4400457|NCT00130728|7177659|FG000|Overall Study|Lost to Follow-up|4
4400458|NCT00130728|7177660|FG001|Overall Study|Lost to Follow-up|0
4400459|NCT00130728|7177659|FG000|Overall Study|Withdrawal by Subject|0
4400460|NCT00130728|7177660|FG001|Overall Study|Withdrawal by Subject|2
4400461|NCT00130793|7177677|FG000|Overall Study|Lost to Follow-up|1
4400462|NCT00130793|7177678|FG001|Overall Study|Lost to Follow-up|4
4400463|NCT00130793|7177677|FG000|Overall Study|Withdrew consent|2
4400464|NCT00130793|7177678|FG001|Overall Study|Withdrew consent|0
4400465|NCT00130832|7177687|FG000|Overall Study|Adverse Event|1
4400466|NCT00130832|7177688|FG001|Overall Study|Adverse Event|1
4400467|NCT00130832|7177687|FG000|Overall Study|Lost to Follow-up|1
4400468|NCT00130832|7177688|FG001|Overall Study|Lost to Follow-up|2
4400469|NCT00130832|7177687|FG000|Overall Study|Protocol Violation|6
4400470|NCT00130832|7177688|FG001|Overall Study|Protocol Violation|8
4400471|NCT00130832|7177687|FG000|Overall Study|Withdrawal by Subject|6
4400472|NCT00130832|7177688|FG001|Overall Study|Withdrawal by Subject|1
4400473|NCT00130832|7177687|FG000|Overall Study|Moved|2
4400474|NCT00130832|7177688|FG001|Overall Study|Moved|2
4400475|NCT00130832|7177687|FG000|Overall Study|Other|0
4400476|NCT00130832|7177688|FG001|Overall Study|Other|3
4400477|NCT00131248|7177704|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1
4400478|NCT00131248|7177705|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0
4400479|NCT00131352|7177713|FG000|Initial Treatment Period|Adverse Event|1
4400480|NCT00131352|7177714|FG001|Initial Treatment Period|Adverse Event|3
4400481|NCT00131352|7177713|FG000|Initial Treatment Period|Non-compliant|1
4400482|NCT00131352|7177714|FG001|Initial Treatment Period|Non-compliant|2
4400483|NCT00131352|7177713|FG000|Initial Treatment Period|Withdrawal by Subject|1
4400484|NCT00131352|7177714|FG001|Initial Treatment Period|Withdrawal by Subject|1
4400485|NCT00131352|7177713|FG000|Initial Treatment Period|Lack of Efficacy|6
4400486|NCT00131352|7177714|FG001|Initial Treatment Period|Lack of Efficacy|4
4400487|NCT00131352|7177713|FG000|Initial Treatment Period|Other|0
4400488|NCT00131352|7177714|FG001|Initial Treatment Period|Other|2
4400489|NCT00131352|7177713|FG000|Repeat Treatment Period|Adverse Event|1
4400490|NCT00131352|7177714|FG001|Repeat Treatment Period|Adverse Event|0
4400491|NCT00131352|7177713|FG000|Repeat Treatment Period|Other|1
4400492|NCT00131352|7177714|FG001|Repeat Treatment Period|Other|0
4400493|NCT00131365|7177722|FG000|Overall Study|Withdrawal by Subject|1
4400494|NCT00131365|7177722|FG000|Overall Study|Alternative treatment|3
4400495|NCT00131469|7177757|FG000|Overall Study|Withdrawal by Subject|3
4400496|NCT00131469|7177758|FG001|Overall Study|Withdrawal by Subject|4
4400497|NCT00131469|7177757|FG000|Overall Study|Protocol Violation|3
4400498|NCT00131469|7177758|FG001|Overall Study|Protocol Violation|1
4400499|NCT00131469|7177757|FG000|Overall Study|Death|0
4400500|NCT00131469|7177758|FG001|Overall Study|Death|1
4400501|NCT00131469|7177757|FG000|Overall Study|Lost to Follow-up|0
4400502|NCT00131469|7177758|FG001|Overall Study|Lost to Follow-up|1
4400503|NCT00131469|7177757|FG000|Overall Study|scan not analyzable|3
4400504|NCT00131469|7177758|FG001|Overall Study|scan not analyzable|6
4400505|NCT00131508|7177766|FG000|Overall Study|Disease progression|0
4400506|NCT00131508|7177767|FG001|Overall Study|Disease progression|2
4400507|NCT00131508|7177766|FG000|Overall Study|Non-Compliance|2
4400508|NCT00131508|7177767|FG001|Overall Study|Non-Compliance|4
4400509|NCT00131508|7177766|FG000|Overall Study|Withdrawal by Subject|1
4400510|NCT00131508|7177767|FG001|Overall Study|Withdrawal by Subject|2
4400511|NCT00131664|7177786|FG000|First Period (First 6 Months)|Lost to Follow-up|7
4400512|NCT00131664|7177787|FG001|First Period (First 6 Months)|Lost to Follow-up|3
4400513|NCT00131664|7177788|FG002|First Period (First 6 Months)|Lost to Follow-up|3
4400514|NCT00131664|7177789|FG003|First Period (First 6 Months)|Lost to Follow-up|0
4400515|NCT00131664|7177790|FG004|First Period (First 6 Months)|Lost to Follow-up|0
4400516|NCT00131664|7177791|FG005|First Period (First 6 Months)|Lost to Follow-up|0
4400517|NCT00131664|7177786|FG000|First Period (First 6 Months)|Death|0
4400518|NCT00131664|7177787|FG001|First Period (First 6 Months)|Death|1
4400519|NCT00131664|7177788|FG002|First Period (First 6 Months)|Death|0
4400520|NCT00131664|7177789|FG003|First Period (First 6 Months)|Death|0
4400521|NCT00131664|7177790|FG004|First Period (First 6 Months)|Death|0
4400522|NCT00131664|7177791|FG005|First Period (First 6 Months)|Death|0
4400523|NCT00131664|7177786|FG000|First Period (First 6 Months)|Protocol Violation|2
4400524|NCT00131664|7177787|FG001|First Period (First 6 Months)|Protocol Violation|2
4400525|NCT00131664|7177788|FG002|First Period (First 6 Months)|Protocol Violation|1
4400526|NCT00131664|7177789|FG003|First Period (First 6 Months)|Protocol Violation|0
4400527|NCT00131664|7177790|FG004|First Period (First 6 Months)|Protocol Violation|0
4400528|NCT00131664|7177791|FG005|First Period (First 6 Months)|Protocol Violation|0
4400529|NCT00131664|7177786|FG000|First Period (First 6 Months)|Withdrawal by Subject|4
4400530|NCT00131664|7177787|FG001|First Period (First 6 Months)|Withdrawal by Subject|6
4400531|NCT00131664|7177788|FG002|First Period (First 6 Months)|Withdrawal by Subject|2
4400532|NCT00131664|7177789|FG003|First Period (First 6 Months)|Withdrawal by Subject|0
4400533|NCT00131664|7177790|FG004|First Period (First 6 Months)|Withdrawal by Subject|0
4400534|NCT00131664|7177791|FG005|First Period (First 6 Months)|Withdrawal by Subject|0
4400535|NCT00131664|7177786|FG000|First Period (First 6 Months)|Adverse Event|9
4400536|NCT00131664|7177787|FG001|First Period (First 6 Months)|Adverse Event|4
4400537|NCT00131664|7177788|FG002|First Period (First 6 Months)|Adverse Event|5
4400538|NCT00131664|7177789|FG003|First Period (First 6 Months)|Adverse Event|0
4400539|NCT00131664|7177790|FG004|First Period (First 6 Months)|Adverse Event|0
4400540|NCT00131664|7177791|FG005|First Period (First 6 Months)|Adverse Event|0
4400541|NCT00131664|7177786|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1
4400542|NCT00131664|7177787|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2
4400543|NCT00131664|7177788|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0
4400544|NCT00131664|7177789|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0
4400545|NCT00131664|7177790|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0
4400546|NCT00131664|7177791|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0
4400547|NCT00131664|7177786|FG000|First Period (First 6 Months)|Administrative reasons|2
4400548|NCT00131664|7177787|FG001|First Period (First 6 Months)|Administrative reasons|0
4400549|NCT00131664|7177788|FG002|First Period (First 6 Months)|Administrative reasons|5
4400550|NCT00131664|7177789|FG003|First Period (First 6 Months)|Administrative reasons|0
4400551|NCT00131664|7177790|FG004|First Period (First 6 Months)|Administrative reasons|0
4400552|NCT00131664|7177791|FG005|First Period (First 6 Months)|Administrative reasons|0
4400553|NCT00131664|7177786|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3
4400554|NCT00131664|7177787|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0
4400555|NCT00131664|7177788|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2
4400556|NCT00131664|7177789|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1
4400557|NCT00131664|7177790|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0
4400558|NCT00131664|7177791|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2
4400559|NCT00131664|7177786|FG000|Second Period (Additional Drug Added)|Protocol Violation|0
4400560|NCT00131664|7177787|FG001|Second Period (Additional Drug Added)|Protocol Violation|1
4400561|NCT00131664|7177788|FG002|Second Period (Additional Drug Added)|Protocol Violation|1
4400562|NCT00131664|7177789|FG003|Second Period (Additional Drug Added)|Protocol Violation|0
4400563|NCT00131664|7177790|FG004|Second Period (Additional Drug Added)|Protocol Violation|0
4400564|NCT00131664|7177791|FG005|Second Period (Additional Drug Added)|Protocol Violation|0
4400565|NCT00131664|7177786|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2
4400566|NCT00131664|7177787|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0
4400567|NCT00131664|7177788|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0
4400568|NCT00131664|7177789|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0
4400569|NCT00131664|7177790|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0
4400570|NCT00131664|7177791|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0
4400571|NCT00131664|7177786|FG000|Second Period (Additional Drug Added)|Adverse Event|0
4400572|NCT00131664|7177787|FG001|Second Period (Additional Drug Added)|Adverse Event|1
4400573|NCT00131664|7177788|FG002|Second Period (Additional Drug Added)|Adverse Event|0
4400574|NCT00131664|7177789|FG003|Second Period (Additional Drug Added)|Adverse Event|0
4400575|NCT00131664|7177790|FG004|Second Period (Additional Drug Added)|Adverse Event|0
4400576|NCT00131664|7177791|FG005|Second Period (Additional Drug Added)|Adverse Event|1
4400577|NCT00131664|7177786|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
4400578|NCT00131664|7177787|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
4400579|NCT00131664|7177788|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
4400580|NCT00131664|7177789|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1
4400581|NCT00131664|7177790|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
4400582|NCT00131664|7177791|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
4400583|NCT00131664|7177786|FG000|Second Period (Additional Drug Added)|Administrative reasons|4
4400584|NCT00131664|7177787|FG001|Second Period (Additional Drug Added)|Administrative reasons|2
4400585|NCT00131664|7177788|FG002|Second Period (Additional Drug Added)|Administrative reasons|0
4400586|NCT00131664|7177789|FG003|Second Period (Additional Drug Added)|Administrative reasons|0
4400587|NCT00131664|7177790|FG004|Second Period (Additional Drug Added)|Administrative reasons|1
4400588|NCT00131664|7177791|FG005|Second Period (Additional Drug Added)|Administrative reasons|0
4400589|NCT00131911|7177835|FG000|Overall Study|Withdrawal by Subject|1
4400590|NCT00131911|7177836|FG001|Overall Study|Withdrawal by Subject|0
4400591|NCT00131937|7177841|FG000|Overall Study|Adverse Event|3
4400592|NCT00131937|7177841|FG000|Overall Study|Withdrawal by Subject|2
4400593|NCT00131937|7177841|FG000|Overall Study|Physician Decision|1
4400594|NCT00131937|7177841|FG000|Overall Study|Disease Progression|7
4400595|NCT00131937|7177841|FG000|Overall Study|Alternative therapy|1
4400596|NCT00132028|7177849|FG000|Overall Study|Adverse Event|7
4400597|NCT00132028|7177849|FG000|Overall Study|Death|2
4400598|NCT00132028|7177849|FG000|Overall Study|Lack of Efficacy|11
4400599|NCT00132028|7177849|FG000|Overall Study|Withdrawal by Subject|2
4400600|NCT00132028|7177849|FG000|Overall Study|not eligible|2
4713322|NCT02943460|7640741|FG001|Open Label Extension (OLE) Phase|Adverse Event|5
4713323|NCT02943460|7640742|FG002|Open Label Extension (OLE) Phase|Adverse Event|2
4713324|NCT02943460|7640740|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2
4713325|NCT02943460|7640741|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1
4713326|NCT02943460|7640742|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0
4400601|NCT00132028|7177849|FG000|Overall Study|Physician Decision|3
4400602|NCT00132041|7177853|FG000|Baseline|Ineligible|6
4400603|NCT00132041|7177853|FG000|3 Months Post Ablation|Transplant|1
4400604|NCT00132041|7177853|FG000|3 Months Post Ablation|Non-Protocol Treatment|2
4400605|NCT00132041|7177853|FG000|6 Months Post Ablation|Withdrawal by Subject|2
4400606|NCT00132041|7177853|FG000|6 Months Post Ablation|Death|2
4400607|NCT00132041|7177853|FG000|6 Months Post Ablation|Transplant|6
4400608|NCT00132041|7177853|FG000|9 Months Post Ablation|Death|1
4400609|NCT00132041|7177853|FG000|9 Months Post Ablation|Transplant|1
4400610|NCT00132041|7177853|FG000|12 Months Post Ablation|Withdrawal by Subject|1
4400611|NCT00132041|7177853|FG000|12 Months Post Ablation|Death|1
4400612|NCT00132041|7177853|FG000|12 Months Post Ablation|Transplant|1
4400613|NCT00132041|7177853|FG000|12 Months Post Ablation|non-protocol Treatment|1
4400614|NCT00132041|7177853|FG000|15 Months Post Ablation|Withdrawal by Subject|1
4400615|NCT00132041|7177853|FG000|15 Months Post Ablation|Death|1
4400616|NCT00132041|7177853|FG000|15 Months Post Ablation|Transplant|5
4400617|NCT00132041|7177853|FG000|15 Months Post Ablation|Non-Protocol Treatment|1
4400618|NCT00132041|7177853|FG000|18 Months Post Ablation|Withdrawal by Subject|1
4400619|NCT00132041|7177853|FG000|18 Months Post Ablation|Transplant|1
4400620|NCT00132041|7177853|FG000|18 Months Post Ablation|Non-Protocol Treatment|3
4400621|NCT00132041|7177853|FG000|18 Months Post Ablation|ExtraHepatic tumor|1
4400622|NCT00132132|7177865|FG000|Overall Study|Lost to Follow-up|7
4400623|NCT00132132|7177866|FG001|Overall Study|Lost to Follow-up|2
4400624|NCT00132301|7177874|FG000|Overall Study|Death|7
4400625|NCT00132301|7177875|FG001|Overall Study|Death|6
4400626|NCT00132301|7177874|FG000|Overall Study|Withdrawal by Subject|5
4400627|NCT00132301|7177875|FG001|Overall Study|Withdrawal by Subject|2
4400628|NCT00132301|7177874|FG000|Overall Study|Physician Decision|1
4400629|NCT00132301|7177875|FG001|Overall Study|Physician Decision|1
4400630|NCT00132301|7177874|FG000|Overall Study|Lost to Follow-up|5
4400631|NCT00132301|7177875|FG001|Overall Study|Lost to Follow-up|3
4400632|NCT00132301|7177874|FG000|Overall Study|Other|1
4400633|NCT00132301|7177875|FG001|Overall Study|Other|1
4400634|NCT00132301|7177874|FG000|Overall Study|Excluded by Data Monitoring Committee|1
4400635|NCT00132301|7177875|FG001|Overall Study|Excluded by Data Monitoring Committee|0
4400636|NCT00132314|7177883|FG000|Overall Study|Lost to Follow-up|70
4400637|NCT00132314|7177884|FG001|Overall Study|Lost to Follow-up|62
4400638|NCT00132314|7177883|FG000|Overall Study|Lacked SSN|1
4400639|NCT00132314|7177884|FG001|Overall Study|Lacked SSN|3
4400640|NCT00132314|7177883|FG000|Overall Study|Refused intervention at baseline|2
4400641|NCT00132314|7177884|FG001|Overall Study|Refused intervention at baseline|7
4400642|NCT00132496|7177892|FG000|Overall Study|Withdrawal by Subject|1
4400643|NCT00132496|7177893|FG001|Overall Study|Withdrawal by Subject|2
4400644|NCT00132496|7177892|FG000|Overall Study|Physician Decision|1
4400645|NCT00132496|7177893|FG001|Overall Study|Physician Decision|0
4400646|NCT00132678|7177901|FG000|Period II (Open-Label Oral Risperidone)|Death|0
4400647|NCT00132678|7177902|FG001|Period II (Open-Label Oral Risperidone)|Death|0
4400648|NCT00132678|7177903|FG002|Period II (Open-Label Oral Risperidone)|Death|1
4400649|NCT00132678|7177901|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0
4400650|NCT00132678|7177902|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0
4400651|NCT00132678|7177903|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13
4400652|NCT00132678|7177901|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0
4400653|NCT00132678|7177902|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0
4400654|NCT00132678|7177903|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6
4400655|NCT00132678|7177901|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0
4400656|NCT00132678|7177902|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0
4400657|NCT00132678|7177903|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7
4400658|NCT00132678|7177901|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0
4400659|NCT00132678|7177902|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0
4400660|NCT00132678|7177903|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14
4400661|NCT00132678|7177901|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0
4400662|NCT00132678|7177902|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0
4400663|NCT00132678|7177903|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16
4400664|NCT00132678|7177901|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0
4400665|NCT00132678|7177902|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0
4400666|NCT00132678|7177903|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1
4400667|NCT00132678|7177901|FG000|Period III (Open-Label Stabilization)|Death|2
4400668|NCT00132678|7177902|FG001|Period III (Open-Label Stabilization)|Death|0
4713327|NCT02943460|7640740|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1
4400669|NCT00132678|7177903|FG002|Period III (Open-Label Stabilization)|Death|0
4400670|NCT00132678|7177901|FG000|Period III (Open-Label Stabilization)|Adverse Event|12
4400671|NCT00132678|7177902|FG001|Period III (Open-Label Stabilization)|Adverse Event|0
4400672|NCT00132678|7177903|FG002|Period III (Open-Label Stabilization)|Adverse Event|0
4400673|NCT00132678|7177901|FG000|Period III (Open-Label Stabilization)|Non responder|107
4400674|NCT00132678|7177902|FG001|Period III (Open-Label Stabilization)|Non responder|0
4400675|NCT00132678|7177903|FG002|Period III (Open-Label Stabilization)|Non responder|0
4400676|NCT00132678|7177901|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5
4400677|NCT00132678|7177902|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0
4400678|NCT00132678|7177903|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0
4400679|NCT00132678|7177901|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19
4400680|NCT00132678|7177902|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0
4400681|NCT00132678|7177903|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0
4400682|NCT00132678|7177901|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49
4400683|NCT00132678|7177902|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0
4400684|NCT00132678|7177903|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0
4400685|NCT00132678|7177901|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1
4400686|NCT00132678|7177902|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0
4400687|NCT00132678|7177903|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0
4400688|NCT00132678|7177901|FG000|Period III (Open-Label Stabilization)|Physician Decision|1
4400689|NCT00132678|7177902|FG001|Period III (Open-Label Stabilization)|Physician Decision|0
4400690|NCT00132678|7177903|FG002|Period III (Open-Label Stabilization)|Physician Decision|0
4400691|NCT00132678|7177901|FG000|Period III (Open-Label Stabilization)|Pregnancy|2
4400692|NCT00132678|7177902|FG001|Period III (Open-Label Stabilization)|Pregnancy|0
4400693|NCT00132678|7177903|FG002|Period III (Open-Label Stabilization)|Pregnancy|0
4400694|NCT00132678|7177901|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1
4400695|NCT00132678|7177902|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1
4400696|NCT00132678|7177903|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0
4400697|NCT00132678|7177901|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4
4400698|NCT00132678|7177902|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4
4400699|NCT00132678|7177903|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0
4400700|NCT00132678|7177901|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6
4400701|NCT00132678|7177902|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3
4400702|NCT00132678|7177903|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0
4400703|NCT00132678|7177901|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14
4628684|NCT01863849|7496122|FG000|Overall Study|Lost to Follow-up|1
4628685|NCT01863849|7496123|FG001|Overall Study|Lost to Follow-up|0
4628686|NCT01863953|7496133|FG000|Overall Study|Adverse Event|0
4713328|NCT02943460|7640741|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1
4713329|NCT02943460|7640742|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0
4713330|NCT02943473|7640751|FG000|Overall Study|enrolled but not dosed|1
4713331|NCT02943473|7640751|FG000|Overall Study|screen failure|1
4713332|NCT02943473|7640751|FG000|Overall Study|Physician Decision|4
4713333|NCT02943564|7640767|FG000|Overall Study|Miscellaneous Reasons|0
4713334|NCT02943564|7640768|FG001|Overall Study|Miscellaneous Reasons|0
4713335|NCT02943564|7640769|FG002|Overall Study|Miscellaneous Reasons|3
4713336|NCT02943564|7640767|FG000|Overall Study|Site terminated by sponsor|0
4713337|NCT02943564|7640768|FG001|Overall Study|Site terminated by sponsor|1
4713338|NCT02943564|7640769|FG002|Overall Study|Site terminated by sponsor|0
4713339|NCT02943564|7640767|FG000|Overall Study|Non-compliance with study drug|0
4713340|NCT02943564|7640768|FG001|Overall Study|Non-compliance with study drug|1
4628687|NCT01863953|7496134|FG001|Overall Study|Adverse Event|0
4628688|NCT01863953|7496135|FG002|Overall Study|Adverse Event|1
4628689|NCT01864005|7496145|FG000|Overall Study|Protocol Violation|0
4628690|NCT01864005|7496146|FG001|Overall Study|Protocol Violation|1
4628691|NCT01864005|7496145|FG000|Overall Study|Withdrawal by Subject|0
4628692|NCT01864005|7496146|FG001|Overall Study|Withdrawal by Subject|1
4628693|NCT01864005|7496145|FG000|Overall Study|Incorrect enrolment|1
4628694|NCT01864005|7496146|FG001|Overall Study|Incorrect enrolment|0
4628695|NCT01864005|7496145|FG000|Overall Study|Disease need|1
4628696|NCT01864005|7496146|FG001|Overall Study|Disease need|1
4628697|NCT01864005|7496145|FG000|Overall Study|Need GP IIb/IIIa|1
4628698|NCT01864005|7496146|FG001|Overall Study|Need GP IIb/IIIa|3
4628699|NCT01864148|7496157|FG000|Overall Study|Other|2
4628700|NCT01864148|7496158|FG001|Overall Study|Other|1
4628701|NCT01864148|7496159|FG002|Overall Study|Other|1
4628702|NCT01864148|7496160|FG003|Overall Study|Other|3
4628703|NCT01864148|7496161|FG004|Overall Study|Other|1
4628704|NCT01864148|7496157|FG000|Overall Study|Death|0
4628705|NCT01864148|7496158|FG001|Overall Study|Death|0
4628706|NCT01864148|7496159|FG002|Overall Study|Death|0
4628707|NCT01864148|7496160|FG003|Overall Study|Death|1
4628708|NCT01864148|7496161|FG004|Overall Study|Death|0
4628709|NCT01864148|7496157|FG000|Overall Study|Investigator Decision|5
4628710|NCT01864148|7496158|FG001|Overall Study|Investigator Decision|0
4628711|NCT01864148|7496159|FG002|Overall Study|Investigator Decision|0
4628712|NCT01864148|7496160|FG003|Overall Study|Investigator Decision|4
4628713|NCT01864148|7496161|FG004|Overall Study|Investigator Decision|6
4628714|NCT01864148|7496157|FG000|Overall Study|Withdrawal by Subject|9
4628715|NCT01864148|7496158|FG001|Overall Study|Withdrawal by Subject|2
4628716|NCT01864148|7496159|FG002|Overall Study|Withdrawal by Subject|6
4628717|NCT01864148|7496160|FG003|Overall Study|Withdrawal by Subject|8
4628718|NCT01864148|7496161|FG004|Overall Study|Withdrawal by Subject|8
4628719|NCT01864148|7496157|FG000|Overall Study|Lost to Follow-up|0
4628720|NCT01864148|7496158|FG001|Overall Study|Lost to Follow-up|0
4628721|NCT01864148|7496159|FG002|Overall Study|Lost to Follow-up|0
4628722|NCT01864148|7496160|FG003|Overall Study|Lost to Follow-up|2
4628723|NCT01864148|7496161|FG004|Overall Study|Lost to Follow-up|1
4628724|NCT01864148|7496157|FG000|Overall Study|Adverse Event|4
4628725|NCT01864148|7496158|FG001|Overall Study|Adverse Event|2
4628726|NCT01864148|7496159|FG002|Overall Study|Adverse Event|4
4628727|NCT01864148|7496160|FG003|Overall Study|Adverse Event|7
4628728|NCT01864148|7496161|FG004|Overall Study|Adverse Event|7
4628729|NCT01864148|7496157|FG000|Overall Study|Not Dosed|0
4628730|NCT01864148|7496158|FG001|Overall Study|Not Dosed|0
4628731|NCT01864148|7496159|FG002|Overall Study|Not Dosed|0
4628732|NCT01864148|7496160|FG003|Overall Study|Not Dosed|1
4628733|NCT01864148|7496161|FG004|Overall Study|Not Dosed|0
4628734|NCT01864174|7496180|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15
4628735|NCT01864174|7496181|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14
4628736|NCT01864174|7496180|FG000|Double Blind - Compliant Randomized|Adverse Event|6
4628737|NCT01864174|7496181|FG001|Double Blind - Compliant Randomized|Adverse Event|1
4628738|NCT01864174|7496180|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2
4628739|NCT01864174|7496181|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0
4628740|NCT01864174|7496180|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4
4628741|NCT01864174|7496181|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5
4628742|NCT01864174|7496180|FG000|Double Blind - Compliant Randomized|Death|1
4628743|NCT01864174|7496181|FG001|Double Blind - Compliant Randomized|Death|0
4628744|NCT01864174|7496180|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3
4628745|NCT01864174|7496181|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10
4628746|NCT01864174|7496180|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1
4628747|NCT01864174|7496181|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0
4628748|NCT01864174|7496180|FG000|Double Blind - Compliant Randomized|Other|6
4628749|NCT01864174|7496181|FG001|Double Blind - Compliant Randomized|Other|10
4628750|NCT01864174|7496180|FG000|Off Treatment Follow-Up|Other|2
4628751|NCT01864174|7496181|FG001|Off Treatment Follow-Up|Other|0
4628752|NCT01864174|7496180|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1
4628753|NCT01864174|7496181|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0
4628754|NCT01864200|7496189|FG000|Overall Study|Lost to Follow-up|1
4590335|NCT01519947|7436142|FG003|Overall Study|Lost to Follow-up|2
4590336|NCT01519947|7436139|FG000|Overall Study|Poor Response|1
4590337|NCT01519947|7436140|FG001|Overall Study|Poor Response|0
4590338|NCT01519947|7436141|FG002|Overall Study|Poor Response|0
4590339|NCT01519947|7436142|FG003|Overall Study|Poor Response|1
4628755|NCT01864200|7496190|FG001|Overall Study|Lost to Follow-up|3
4628756|NCT01864200|7496189|FG000|Overall Study|Protocol Violation|1
4628757|NCT01864200|7496190|FG001|Overall Study|Protocol Violation|0
4628758|NCT01864291|7496196|FG000|Overall Study|need for revision surgery|2
4628759|NCT01864525|7496211|FG000|Overall Study|Adverse Event|1
4628760|NCT01864525|7496212|FG001|Overall Study|Adverse Event|0
4590340|NCT01519947|7436139|FG000|Overall Study|Adverse Event|1
4590341|NCT01519947|7436140|FG001|Overall Study|Adverse Event|0
4590342|NCT01519947|7436141|FG002|Overall Study|Adverse Event|1
4590343|NCT01519947|7436142|FG003|Overall Study|Adverse Event|1
4590344|NCT01520324|7436165|FG000|Overall Study|Subject discontinued (moderate illness)|1
4590345|NCT01520363|7436171|FG000|Overall Study|Withdrawal by Subject|2
4628761|NCT01864564|7496224|FG000|Overall Study|Lost to Follow-up|17
4628762|NCT01864564|7496225|FG001|Overall Study|Lost to Follow-up|23
4628763|NCT01864564|7496224|FG000|Overall Study|Withdrawal by Subject|20
4628764|NCT01864564|7496225|FG001|Overall Study|Withdrawal by Subject|11
4628765|NCT01864564|7496224|FG000|Overall Study|Protocol Violation|0
4628766|NCT01864564|7496225|FG001|Overall Study|Protocol Violation|27
4628767|NCT01864564|7496224|FG000|Overall Study|not reported|0
4628768|NCT01864564|7496225|FG001|Overall Study|not reported|34
4628769|NCT01865084|7496234|FG000|Double Blind Period (DB)|Adverse Event|2
4628770|NCT01865084|7496235|FG001|Double Blind Period (DB)|Adverse Event|2
4628771|NCT01865084|7496236|FG002|Double Blind Period (DB)|Adverse Event|1
4628772|NCT01865084|7496234|FG000|Double Blind Period (DB)|Protocol Violation|0
4628773|NCT01865084|7496235|FG001|Double Blind Period (DB)|Protocol Violation|0
4628774|NCT01865084|7496236|FG002|Double Blind Period (DB)|Protocol Violation|1
4628775|NCT01865084|7496234|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2
4628776|NCT01865084|7496235|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2
4628777|NCT01865084|7496236|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4
4628778|NCT01865084|7496234|FG000|Double Blind Period (DB)|Withdrawal by Subject|1
4628779|NCT01865084|7496235|FG001|Double Blind Period (DB)|Withdrawal by Subject|0
4590346|NCT01520363|7436172|FG001|Overall Study|Withdrawal by Subject|0
4628780|NCT01865084|7496236|FG002|Double Blind Period (DB)|Withdrawal by Subject|0
4628781|NCT01865084|7496234|FG000|Open Label Extension (OLE) Period|Adverse Event|0
4628782|NCT01865084|7496235|FG001|Open Label Extension (OLE) Period|Adverse Event|0
4628783|NCT01865084|7496236|FG002|Open Label Extension (OLE) Period|Adverse Event|1
4628784|NCT01865084|7496234|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0
4628785|NCT01865084|7496235|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0
4628786|NCT01865084|7496236|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2
4628787|NCT01865084|7496234|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0
4628788|NCT01865084|7496235|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1
4628789|NCT01865084|7496236|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0
4628790|NCT01865084|7496234|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0
4628791|NCT01865084|7496235|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8
4628792|NCT01865084|7496236|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2
4628793|NCT01865084|7496234|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0
4628794|NCT01865084|7496235|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2
4628795|NCT01865084|7496236|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2
4628796|NCT01865448|7496250|FG000|Overall Study|Adverse Event|1
4628797|NCT01865448|7496251|FG001|Overall Study|Adverse Event|1
4628798|NCT01865448|7496250|FG000|Overall Study|Pregnancy|0
4628799|NCT01865448|7496251|FG001|Overall Study|Pregnancy|1
4628800|NCT01865448|7496250|FG000|Overall Study|dropout unrelated to study|1
4628801|NCT01865448|7496251|FG001|Overall Study|dropout unrelated to study|1
4628802|NCT01865487|7496264|FG000|Overall Study|Lost to Follow-up|0
4628803|NCT01865487|7496265|FG001|Overall Study|Lost to Follow-up|0
4628804|NCT01865487|7496266|FG002|Overall Study|Lost to Follow-up|0
4628805|NCT01865487|7496267|FG003|Overall Study|Lost to Follow-up|1
4628806|NCT01865487|7496268|FG004|Overall Study|Lost to Follow-up|0
4628807|NCT01865487|7496269|FG005|Overall Study|Lost to Follow-up|0
4628808|NCT01865487|7496270|FG006|Overall Study|Lost to Follow-up|1
4628809|NCT01865487|7496271|FG007|Overall Study|Lost to Follow-up|0
4628810|NCT01865487|7496272|FG008|Overall Study|Lost to Follow-up|0
4628811|NCT01865487|7496273|FG009|Overall Study|Lost to Follow-up|0
4628812|NCT01865487|7496264|FG000|Overall Study|Withdrawal by Subject|0
4628813|NCT01865487|7496265|FG001|Overall Study|Withdrawal by Subject|0
4628814|NCT01865487|7496266|FG002|Overall Study|Withdrawal by Subject|0
4628815|NCT01865487|7496267|FG003|Overall Study|Withdrawal by Subject|0
4628816|NCT01865487|7496268|FG004|Overall Study|Withdrawal by Subject|1
4628817|NCT01865487|7496269|FG005|Overall Study|Withdrawal by Subject|0
4628818|NCT01865487|7496270|FG006|Overall Study|Withdrawal by Subject|0
4628819|NCT01865487|7496271|FG007|Overall Study|Withdrawal by Subject|0
4628820|NCT01865487|7496272|FG008|Overall Study|Withdrawal by Subject|0
4628821|NCT01865487|7496273|FG009|Overall Study|Withdrawal by Subject|0
4628822|NCT01865552|7496307|FG000|Period 1|Adverse Event|1
4628823|NCT01865552|7496308|FG001|Period 1|Adverse Event|0
4628824|NCT01865552|7496309|FG002|Period 1|Adverse Event|0
4628825|NCT01865552|7496310|FG003|Period 1|Adverse Event|1
4628826|NCT01865552|7496311|FG004|Period 1|Adverse Event|1
4628827|NCT01865552|7496312|FG005|Period 1|Adverse Event|1
4628828|NCT01865552|7496307|FG000|Period 1|Pathological lab|0
4628829|NCT01865552|7496308|FG001|Period 1|Pathological lab|0
4628830|NCT01865552|7496309|FG002|Period 1|Pathological lab|0
4628831|NCT01865552|7496310|FG003|Period 1|Pathological lab|0
4628832|NCT01865552|7496311|FG004|Period 1|Pathological lab|1
4628833|NCT01865552|7496312|FG005|Period 1|Pathological lab|0
4628834|NCT01865552|7496307|FG000|Period 1|Other|0
4628835|NCT01865552|7496308|FG001|Period 1|Other|0
4628836|NCT01865552|7496309|FG002|Period 1|Other|0
4628837|NCT01865552|7496310|FG003|Period 1|Other|0
4628838|NCT01865552|7496311|FG004|Period 1|Other|1
4713341|NCT02943564|7640769|FG002|Overall Study|Non-compliance with study drug|0
4628839|NCT01865552|7496312|FG005|Period 1|Other|0
4628840|NCT01865747|7496332|FG000|Overall Study (ITT)|Adverse Event|32
4628841|NCT01865747|7496333|FG001|Overall Study (ITT)|Adverse Event|31
4628842|NCT01865747|7496332|FG000|Overall Study (ITT)|Clinical Deterioration|29
4628843|NCT01865747|7496333|FG001|Overall Study (ITT)|Clinical Deterioration|50
4628844|NCT01865747|7496332|FG000|Overall Study (ITT)|Lack of Efficacy|3
4628845|NCT01865747|7496333|FG001|Overall Study (ITT)|Lack of Efficacy|0
4628846|NCT01865747|7496332|FG000|Overall Study (ITT)|Protocol Violation|1
4628847|NCT01865747|7496333|FG001|Overall Study (ITT)|Protocol Violation|1
4628848|NCT01865747|7496332|FG000|Overall Study (ITT)|Physician Decision|5
4628849|NCT01865747|7496333|FG001|Overall Study (ITT)|Physician Decision|2
4628850|NCT01865747|7496332|FG000|Overall Study (ITT)|Withdrawal by Subject|6
4628851|NCT01865747|7496333|FG001|Overall Study (ITT)|Withdrawal by Subject|11
4628852|NCT01865747|7496332|FG000|Overall Study (ITT)|Sponsor Decision|0
4628853|NCT01865747|7496333|FG001|Overall Study (ITT)|Sponsor Decision|1
4628854|NCT01865747|7496332|FG000|Overall Study (ITT)|Progressive Disease|122
4628855|NCT01865747|7496333|FG001|Overall Study (ITT)|Progressive Disease|158
4628856|NCT01865747|7496332|FG000|Overall Study (ITT)|Reason Not Provided|0
4628857|NCT01865747|7496333|FG001|Overall Study (ITT)|Reason Not Provided|1
4628858|NCT01865747|7496332|FG000|Primary Intent to Treat (PITT)|Adverse Event|21
4628859|NCT01865747|7496333|FG001|Primary Intent to Treat (PITT)|Adverse Event|20
4713342|NCT02943564|7640767|FG000|Overall Study|Pregnancy|0
4633280|NCT01909804|7503303|FG007|Overall Study|Protocol Violation|0
4628860|NCT01865747|7496332|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18
4628861|NCT01865747|7496333|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29
4628862|NCT01865747|7496332|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2
4628863|NCT01865747|7496333|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0
4628864|NCT01865747|7496332|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1
4628865|NCT01865747|7496333|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1
4628866|NCT01865747|7496332|FG000|Primary Intent to Treat (PITT)|Physician Decision|4
4400704|NCT00132678|7177902|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15
4400705|NCT00132678|7177903|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0
4400706|NCT00132678|7177901|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10
4400707|NCT00132678|7177902|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14
4400708|NCT00132678|7177903|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0
4400709|NCT00132678|7177901|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2
4400710|NCT00132678|7177902|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1
4400711|NCT00132678|7177903|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0
4400712|NCT00132678|7177901|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0
4400713|NCT00132678|7177902|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2
4400714|NCT00132678|7177903|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0
4400715|NCT00132691|7177913|FG000|Overall Study|Lost to Follow-up|5
4400716|NCT00132691|7177914|FG001|Overall Study|Lost to Follow-up|8
4400717|NCT00132691|7177913|FG000|Overall Study|Missed 2-year visit|4
4400718|NCT00132691|7177914|FG001|Overall Study|Missed 2-year visit|4
4400719|NCT00132691|7177913|FG000|Overall Study|Death|2
4400720|NCT00132691|7177914|FG001|Overall Study|Death|0
4400721|NCT00132730|7177929|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11
4400722|NCT00132730|7177930|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4
4400723|NCT00132730|7177931|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9
4400724|NCT00132730|7177932|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9
4400725|NCT00132730|7177933|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0
4400726|NCT00132730|7177934|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0
4400727|NCT00132730|7177929|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1
4400728|NCT00132730|7177930|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1
4400729|NCT00132730|7177931|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
4400730|NCT00132730|7177932|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
4400731|NCT00132730|7177933|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
4400732|NCT00132730|7177934|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
4400733|NCT00132730|7177929|FG000|Period II - 12-week Treatment (Base)|Other reasons|11
4400734|NCT00132730|7177930|FG001|Period II - 12-week Treatment (Base)|Other reasons|10
4400735|NCT00132730|7177931|FG002|Period II - 12-week Treatment (Base)|Other reasons|9
4400736|NCT00132730|7177932|FG003|Period II - 12-week Treatment (Base)|Other reasons|13
4400737|NCT00132730|7177933|FG004|Period II - 12-week Treatment (Base)|Other reasons|0
4400738|NCT00132730|7177934|FG005|Period II - 12-week Treatment (Base)|Other reasons|0
4400739|NCT00132730|7177929|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0
4400740|NCT00132730|7177930|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0
4400741|NCT00132730|7177931|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57
4400742|NCT00132730|7177932|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20
4400743|NCT00132730|7177933|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0
4400744|NCT00132730|7177934|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0
4400745|NCT00132730|7177929|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
4400746|NCT00132730|7177930|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
4400747|NCT00132730|7177931|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11
4400748|NCT00132730|7177932|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1
4400749|NCT00132730|7177933|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
4400750|NCT00132730|7177934|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
4400751|NCT00132730|7177929|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
4400752|NCT00132730|7177930|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
4400753|NCT00132730|7177931|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
4400754|NCT00132730|7177932|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1
4400755|NCT00132730|7177933|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
4400756|NCT00132730|7177934|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
4400757|NCT00132730|7177929|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0
4400758|NCT00132730|7177930|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0
4400759|NCT00132730|7177931|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14
4400760|NCT00132730|7177932|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3
4400761|NCT00132730|7177933|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0
4400762|NCT00132730|7177934|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0
4400763|NCT00132730|7177929|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0
4628867|NCT01865747|7496333|FG001|Primary Intent to Treat (PITT)|Physician Decision|2
4628868|NCT01865747|7496332|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3
4400764|NCT00132730|7177930|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0
4400765|NCT00132730|7177931|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0
4400766|NCT00132730|7177932|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0
4400767|NCT00132730|7177933|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169
4400768|NCT00132730|7177934|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68
4400769|NCT00132730|7177929|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
4400770|NCT00132730|7177930|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
4400771|NCT00132730|7177931|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
4400772|NCT00132730|7177932|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
4400773|NCT00132730|7177933|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3
4400774|NCT00132730|7177934|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
4400775|NCT00132730|7177929|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
4400776|NCT00132730|7177930|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
4400777|NCT00132730|7177931|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
4400778|NCT00132730|7177932|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
4400779|NCT00132730|7177933|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1
4400780|NCT00132730|7177934|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
4400781|NCT00132730|7177929|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0
4400782|NCT00132730|7177930|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0
4400783|NCT00132730|7177931|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0
4400784|NCT00132730|7177932|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0
4400785|NCT00132730|7177933|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6
4400786|NCT00132730|7177934|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0
4400787|NCT00132730|7177929|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0
4400788|NCT00132730|7177930|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0
4400789|NCT00132730|7177931|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0
4400790|NCT00132730|7177932|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0
4400791|NCT00132730|7177933|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7
4400792|NCT00132730|7177934|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2
4400793|NCT00132769|7177950|FG000|Overall Study|Withdrawal by Subject|1
4400794|NCT00132769|7177951|FG001|Overall Study|Withdrawal by Subject|3
4400795|NCT00132769|7177950|FG000|Overall Study|Lack of Efficacy|7
4400796|NCT00132769|7177951|FG001|Overall Study|Lack of Efficacy|6
4400797|NCT00132769|7177950|FG000|Overall Study|Adverse Event|2
4400798|NCT00132769|7177951|FG001|Overall Study|Adverse Event|1
4400799|NCT00132769|7177950|FG000|Overall Study|Protocol Violation|1
4400800|NCT00132769|7177951|FG001|Overall Study|Protocol Violation|1
4400801|NCT00132808|7177960|FG000|Stratum I|Adverse Event|2
4400802|NCT00132808|7177961|FG001|Stratum I|Adverse Event|1
4400803|NCT00132808|7177962|FG002|Stratum I|Adverse Event|0
4400804|NCT00132808|7177960|FG000|Stratum I|Lost to Follow-up|3
4400805|NCT00132808|7177961|FG001|Stratum I|Lost to Follow-up|4
4400806|NCT00132808|7177962|FG002|Stratum I|Lost to Follow-up|1
4400807|NCT00132808|7177960|FG000|Stratum I|Withdrawal by Subject|4
4400808|NCT00132808|7177961|FG001|Stratum I|Withdrawal by Subject|7
4400809|NCT00132808|7177962|FG002|Stratum I|Withdrawal by Subject|3
4400810|NCT00132808|7177960|FG000|Stratum I|Abnormal test procedure result (s)|0
4400811|NCT00132808|7177961|FG001|Stratum I|Abnormal test procedure result (s)|0
4400812|NCT00132808|7177962|FG002|Stratum I|Abnormal test procedure result (s)|1
4400813|NCT00132808|7177960|FG000|Stratum II|Adverse Event|1
4400814|NCT00132808|7177961|FG001|Stratum II|Adverse Event|2
4400815|NCT00132808|7177962|FG002|Stratum II|Adverse Event|1
4400816|NCT00132808|7177960|FG000|Stratum II|Death|1
4400817|NCT00132808|7177961|FG001|Stratum II|Death|0
4400818|NCT00132808|7177962|FG002|Stratum II|Death|0
4400819|NCT00132808|7177960|FG000|Stratum II|Lost to Follow-up|2
4400820|NCT00132808|7177961|FG001|Stratum II|Lost to Follow-up|2
4400821|NCT00132808|7177962|FG002|Stratum II|Lost to Follow-up|1
4400822|NCT00132808|7177960|FG000|Stratum II|Protocol Violation|0
4400823|NCT00132808|7177961|FG001|Stratum II|Protocol Violation|2
4400824|NCT00132808|7177962|FG002|Stratum II|Protocol Violation|1
4400825|NCT00132808|7177960|FG000|Stratum II|Withdrawal by Subject|4
4400826|NCT00132808|7177961|FG001|Stratum II|Withdrawal by Subject|9
4400827|NCT00132808|7177962|FG002|Stratum II|Withdrawal by Subject|6
4400828|NCT00132873|7177970|FG000|Overall Study|Adverse Event|3
4400829|NCT00132873|7177970|FG000|Overall Study|Lost to Follow-up|1
4400830|NCT00132873|7177970|FG000|Overall Study|Lack of Efficacy|1
4400831|NCT00132873|7177970|FG000|Overall Study|Withdrawal by Subject|3
4713343|NCT02943564|7640768|FG001|Overall Study|Pregnancy|1
4400832|NCT00132873|7177970|FG000|Overall Study|Planned Pregnancy|1
4400833|NCT00133705|7178014|FG000|Overall Study|Withdrawal by Subject|2
4400834|NCT00133705|7178015|FG001|Overall Study|Withdrawal by Subject|3
4400835|NCT00133952|7178027|FG000|Overall Study|Adverse Event|1
4400836|NCT00133952|7178028|FG001|Overall Study|Adverse Event|2
4400837|NCT00133952|7178027|FG000|Overall Study|Death|3
4400838|NCT00133952|7178028|FG001|Overall Study|Death|2
4400839|NCT00133952|7178027|FG000|Overall Study|Lost to Follow-up|9
4400840|NCT00133952|7178028|FG001|Overall Study|Lost to Follow-up|14
4713344|NCT02943564|7640769|FG002|Overall Study|Pregnancy|1
4400841|NCT00133952|7178027|FG000|Overall Study|Protocol Entry Criteria Exclusion|4
4400842|NCT00133952|7178028|FG001|Overall Study|Protocol Entry Criteria Exclusion|1
4400843|NCT00133952|7178027|FG000|Overall Study|Protocol Violation|1
4400844|NCT00133952|7178028|FG001|Overall Study|Protocol Violation|1
4400845|NCT00133952|7178027|FG000|Overall Study|Withdrawal by Subject|20
4400846|NCT00133952|7178028|FG001|Overall Study|Withdrawal by Subject|4
4400847|NCT00133952|7178027|FG000|Overall Study|Physician Decision|4
4400848|NCT00133952|7178028|FG001|Overall Study|Physician Decision|3
4400849|NCT00133952|7178027|FG000|Overall Study|Sponsor Decision|0
4400850|NCT00133952|7178028|FG001|Overall Study|Sponsor Decision|1
4400851|NCT00133991|7178055|FG000|Overall Study|Death|4
4400852|NCT00134056|7178077|FG000|Randomization|Not eligible for assigned treatment|22
4400853|NCT00134056|7178078|FG001|Randomization|Not eligible for assigned treatment|20
4400854|NCT00134056|7178077|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171
4400855|NCT00134056|7178078|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171
4400856|NCT00134056|7178077|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81
4400857|NCT00134056|7178078|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67
4400858|NCT00134056|7178077|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20
4400859|NCT00134056|7178078|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21
4400860|NCT00134056|7178077|FG000|Eligible for Protocol Assigned Treatment|Other|55
4400861|NCT00134056|7178078|FG001|Eligible for Protocol Assigned Treatment|Other|56
4400862|NCT00134082|7178087|FG000|Overall Study|Adverse Event|2
4400863|NCT00134082|7178087|FG000|Overall Study|Death|1
4400864|NCT00134563|7178116|FG000|Overall Study|Not treated due to protocol violation|0
4400865|NCT00134563|7178117|FG001|Overall Study|Not treated due to protocol violation|1
4400866|NCT00134563|7178118|FG002|Overall Study|Not treated due to protocol violation|1
4400867|NCT00134563|7178116|FG000|Overall Study|Adverse Event|29
4400868|NCT00134563|7178117|FG001|Overall Study|Adverse Event|37
4400869|NCT00134563|7178118|FG002|Overall Study|Adverse Event|38
4400870|NCT00134563|7178116|FG000|Overall Study|Lack of Efficacy|24
4400871|NCT00134563|7178117|FG001|Overall Study|Lack of Efficacy|14
4400872|NCT00134563|7178118|FG002|Overall Study|Lack of Efficacy|17
4400873|NCT00134563|7178116|FG000|Overall Study|Protocol Violation|3
4400874|NCT00134563|7178117|FG001|Overall Study|Protocol Violation|2
4400875|NCT00134563|7178118|FG002|Overall Study|Protocol Violation|5
4400876|NCT00134563|7178116|FG000|Overall Study|Lost to Follow-up|4
4400877|NCT00134563|7178117|FG001|Overall Study|Lost to Follow-up|0
4400878|NCT00134563|7178118|FG002|Overall Study|Lost to Follow-up|2
4400879|NCT00134563|7178116|FG000|Overall Study|progressive disease|11
4400880|NCT00134563|7178117|FG001|Overall Study|progressive disease|4
4400881|NCT00134563|7178118|FG002|Overall Study|progressive disease|2
4400882|NCT00134563|7178116|FG000|Overall Study|did not wish to continue|33
4400883|NCT00134563|7178117|FG001|Overall Study|did not wish to continue|32
4400884|NCT00134563|7178118|FG002|Overall Study|did not wish to continue|26
4400885|NCT00134563|7178116|FG000|Overall Study|Reason other than above|0
4400886|NCT00134563|7178117|FG001|Overall Study|Reason other than above|2
4400887|NCT00134563|7178118|FG002|Overall Study|Reason other than above|5
4400888|NCT00134719|7178129|FG000|Primary Vaccination Phase|Adverse Event|4
4400889|NCT00134719|7178130|FG001|Primary Vaccination Phase|Adverse Event|0
4400890|NCT00134719|7178131|FG002|Primary Vaccination Phase|Adverse Event|0
4400891|NCT00134719|7178129|FG000|Primary Vaccination Phase|Protocol Violation|1
4400892|NCT00134719|7178130|FG001|Primary Vaccination Phase|Protocol Violation|0
4400893|NCT00134719|7178131|FG002|Primary Vaccination Phase|Protocol Violation|0
4400894|NCT00134719|7178129|FG000|Primary Vaccination Phase|Withdrawal by Subject|2
4400895|NCT00134719|7178130|FG001|Primary Vaccination Phase|Withdrawal by Subject|3
4400896|NCT00134719|7178131|FG002|Primary Vaccination Phase|Withdrawal by Subject|2
4400897|NCT00134719|7178129|FG000|Primary Vaccination Phase|Lost to Follow-up|7
4400898|NCT00134719|7178130|FG001|Primary Vaccination Phase|Lost to Follow-up|3
4400899|NCT00134719|7178131|FG002|Primary Vaccination Phase|Lost to Follow-up|3
4400900|NCT00134719|7178129|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1
4400901|NCT00134719|7178130|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3
4400902|NCT00134719|7178131|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1
4400903|NCT00134719|7178129|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1
4400904|NCT00134719|7178130|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0
4400905|NCT00134719|7178131|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0
4400906|NCT00134784|7178143|FG000|Overall Study|Withdrawal by Subject|2
4400907|NCT00134784|7178144|FG001|Overall Study|Withdrawal by Subject|2
4400908|NCT00134784|7178145|FG002|Overall Study|Withdrawal by Subject|2
4400909|NCT00134784|7178146|FG003|Overall Study|Withdrawal by Subject|1
4400910|NCT00134901|7178155|FG000|Overall Study|Lost to Follow-up|5
4400911|NCT00134901|7178156|FG001|Overall Study|Lost to Follow-up|5
4400912|NCT00134901|7178155|FG000|Overall Study|discontinued intervention|12
4400913|NCT00134901|7178156|FG001|Overall Study|discontinued intervention|10
4511021|NCT00923091|7319707|FG008|Period VI (Open-Label)|Protocol Violation|0
4511022|NCT00923091|7319708|FG009|Period VI (Open-Label)|Protocol Violation|0
4511023|NCT00923091|7319709|FG010|Period VI (Open-Label)|Protocol Violation|0
4511024|NCT00923091|7319710|FG011|Period VI (Open-Label)|Protocol Violation|0
4511025|NCT00923091|7319711|FG012|Period VI (Open-Label)|Protocol Violation|0
4511026|NCT00923091|7319699|FG000|Period VI (Open-Label)|Lost to Follow-up|1
4400914|NCT00135330|7178186|FG000|Overall Study|Adverse Event|2
4400915|NCT00135330|7178187|FG001|Overall Study|Adverse Event|5
4400916|NCT00135330|7178188|FG002|Overall Study|Adverse Event|1
4400917|NCT00135330|7178186|FG000|Overall Study|Lost to Follow-up|0
4400918|NCT00135330|7178187|FG001|Overall Study|Lost to Follow-up|2
4400919|NCT00135330|7178188|FG002|Overall Study|Lost to Follow-up|3
4400920|NCT00135330|7178186|FG000|Overall Study|Physician Decision|1
4400921|NCT00135330|7178187|FG001|Overall Study|Physician Decision|1
4400922|NCT00135330|7178188|FG002|Overall Study|Physician Decision|0
4400923|NCT00135330|7178186|FG000|Overall Study|Protocol Violation|4
4400924|NCT00135330|7178187|FG001|Overall Study|Protocol Violation|3
4400925|NCT00135330|7178188|FG002|Overall Study|Protocol Violation|3
4400926|NCT00135330|7178186|FG000|Overall Study|Patient Decision|5
4400927|NCT00135330|7178187|FG001|Overall Study|Patient Decision|1
4400928|NCT00135330|7178188|FG002|Overall Study|Patient Decision|4
4400929|NCT00135330|7178186|FG000|Overall Study|Sponsor Decision|0
4400930|NCT00135330|7178187|FG001|Overall Study|Sponsor Decision|1
4400931|NCT00135330|7178188|FG002|Overall Study|Sponsor Decision|0
4400932|NCT00135356|7178198|FG000|Overall Study|Adverse Event|6
4400933|NCT00135356|7178199|FG001|Overall Study|Adverse Event|2
4400934|NCT00135356|7178198|FG000|Overall Study|Lack of Efficacy|2
4400935|NCT00135356|7178199|FG001|Overall Study|Lack of Efficacy|0
4400936|NCT00135356|7178198|FG000|Overall Study|Lost to Follow-up|3
4400937|NCT00135356|7178199|FG001|Overall Study|Lost to Follow-up|1
4400938|NCT00135356|7178198|FG000|Overall Study|Surgery for abdominal fat|1
4400939|NCT00135356|7178199|FG001|Overall Study|Surgery for abdominal fat|0
4400940|NCT00135356|7178198|FG000|Overall Study|Change in antiviral regimen|0
4400941|NCT00135356|7178199|FG001|Overall Study|Change in antiviral regimen|1
4400942|NCT00135356|7178198|FG000|Overall Study|Poor/noncompliance|1
4400943|NCT00135356|7178199|FG001|Overall Study|Poor/noncompliance|1
4400944|NCT00135356|7178198|FG000|Overall Study|No longer meets study criteria|2
4400945|NCT00135356|7178199|FG001|Overall Study|No longer meets study criteria|0
4400946|NCT00135356|7178198|FG000|Overall Study|Withdrawal by Subject|2
4400947|NCT00135356|7178199|FG001|Overall Study|Withdrawal by Subject|4
4400948|NCT00135512|7178205|FG000|Overall Study|Adverse Event|56
4400949|NCT00135512|7178205|FG000|Overall Study|Lack of Efficacy|25
4400950|NCT00135512|7178205|FG000|Overall Study|Other|42
4400951|NCT00135694|7178212|FG000|Overall Study|Adverse Event|17
4400952|NCT00135694|7178213|FG001|Overall Study|Adverse Event|4
4400953|NCT00135694|7178214|FG002|Overall Study|Adverse Event|0
4400954|NCT00135694|7178212|FG000|Overall Study|Death|14
4400955|NCT00135694|7178213|FG001|Overall Study|Death|1
4400956|NCT00135694|7178214|FG002|Overall Study|Death|2
4400957|NCT00135694|7178212|FG000|Overall Study|Lost to Follow-up|8
4400958|NCT00135694|7178213|FG001|Overall Study|Lost to Follow-up|7
4400959|NCT00135694|7178214|FG002|Overall Study|Lost to Follow-up|1
4400960|NCT00135694|7178212|FG000|Overall Study|Withdrawal by Subject|41
4400961|NCT00135694|7178213|FG001|Overall Study|Withdrawal by Subject|7
4400962|NCT00135694|7178214|FG002|Overall Study|Withdrawal by Subject|4
4400963|NCT00135694|7178212|FG000|Overall Study|Protocol Violation|19
4400964|NCT00135694|7178213|FG001|Overall Study|Protocol Violation|1
4400965|NCT00135694|7178214|FG002|Overall Study|Protocol Violation|0
4400966|NCT00135694|7178212|FG000|Overall Study|Hepatitis C related reasons|39
4400967|NCT00135694|7178213|FG001|Overall Study|Hepatitis C related reasons|1
4400968|NCT00135694|7178214|FG002|Overall Study|Hepatitis C related reasons|0
4400969|NCT00135694|7178212|FG000|Overall Study|Ineligible for Random assignment|42
4400970|NCT00135694|7178213|FG001|Overall Study|Ineligible for Random assignment|0
4400971|NCT00135694|7178214|FG002|Overall Study|Ineligible for Random assignment|0
4400972|NCT00135707|7178224|FG000|Overall Study|Lost to Follow-up|94
4400973|NCT00135707|7178225|FG001|Overall Study|Lost to Follow-up|89
4400974|NCT00135707|7178224|FG000|Overall Study|Withdrawal by Subject|0
4400975|NCT00135707|7178225|FG001|Overall Study|Withdrawal by Subject|1
4400976|NCT00135707|7178224|FG000|Overall Study|Institutional review board request|1
4400977|NCT00135707|7178225|FG001|Overall Study|Institutional review board request|0
4400978|NCT00136084|7178249|FG000|Overall Study|Death|12
4400979|NCT00136084|7178250|FG001|Overall Study|Death|5
4400980|NCT00136084|7178249|FG000|Overall Study|Unacceptable toxicity|8
4400981|NCT00136084|7178250|FG001|Overall Study|Unacceptable toxicity|11
4400982|NCT00136084|7178249|FG000|Overall Study|Relapse|20
4400983|NCT00136084|7178250|FG001|Overall Study|Relapse|23
4400984|NCT00136084|7178249|FG000|Overall Study|Lost to Follow-up|2
4400985|NCT00136084|7178250|FG001|Overall Study|Lost to Follow-up|0
4400986|NCT00136084|7178249|FG000|Overall Study|No Response|1
4400987|NCT00136084|7178250|FG001|Overall Study|No Response|2
4400988|NCT00136084|7178249|FG000|Overall Study|Withdrawal by Subject|5
4400989|NCT00136084|7178250|FG001|Overall Study|Withdrawal by Subject|1
4400990|NCT00136318|7178275|FG000|Overall Study|Adverse Event|5
4400991|NCT00136318|7178276|FG001|Overall Study|Adverse Event|5
4400992|NCT00136318|7178275|FG000|Overall Study|Withdrawal by Subject|2
4400993|NCT00136318|7178276|FG001|Overall Study|Withdrawal by Subject|2
4400994|NCT00136357|7178285|FG000|Overall Study|Withdrawal by Subject|3
4400995|NCT00136357|7178286|FG001|Overall Study|Withdrawal by Subject|2
4400996|NCT00136604|7178297|FG000|Overall Study|Lost to Follow-up|1
4400997|NCT00136604|7178298|FG001|Overall Study|Lost to Follow-up|0
4400998|NCT00136604|7178299|FG002|Overall Study|Lost to Follow-up|0
4400999|NCT00136604|7178300|FG003|Overall Study|Lost to Follow-up|0
4401000|NCT00136604|7178301|FG004|Overall Study|Lost to Follow-up|1
4401001|NCT00136604|7178297|FG000|Overall Study|Migrated/moved from study area|0
4401002|NCT00136604|7178298|FG001|Overall Study|Migrated/moved from study area|1
4401003|NCT00136604|7178299|FG002|Overall Study|Migrated/moved from study area|0
4401004|NCT00136604|7178300|FG003|Overall Study|Migrated/moved from study area|0
4401005|NCT00136604|7178301|FG004|Overall Study|Migrated/moved from study area|0
4401006|NCT00136916|7178363|FG000|Overall Study|Never received study treatment|3
4401007|NCT00136916|7178364|FG001|Overall Study|Never received study treatment|5
4401008|NCT00136916|7178363|FG000|Overall Study|Death|1
4401009|NCT00136916|7178364|FG001|Overall Study|Death|3
4401010|NCT00136916|7178363|FG000|Overall Study|Adverse Event|27
4401011|NCT00136916|7178364|FG001|Overall Study|Adverse Event|8
4401012|NCT00136916|7178363|FG000|Overall Study|Laboratory abnormality|0
4401013|NCT00136916|7178364|FG001|Overall Study|Laboratory abnormality|1
4401014|NCT00136916|7178363|FG000|Overall Study|Lack of Efficacy|13
4401015|NCT00136916|7178364|FG001|Overall Study|Lack of Efficacy|3
4401016|NCT00136916|7178363|FG000|Overall Study|Lost to Follow-up|12
4401017|NCT00136916|7178364|FG001|Overall Study|Lost to Follow-up|14
4401018|NCT00136916|7178363|FG000|Overall Study|Withdrawal by Subject|44
4401019|NCT00136916|7178364|FG001|Overall Study|Withdrawal by Subject|46
4401020|NCT00136916|7178363|FG000|Overall Study|Other|22
4401021|NCT00136916|7178364|FG001|Overall Study|Other|24
4401022|NCT00136916|7178363|FG000|Overall Study|Discontinued in follow up period|3
4401023|NCT00136916|7178364|FG001|Overall Study|Discontinued in follow up period|0
4401024|NCT00136955|7178372|FG000|Overall Study|Adverse Event|8
4401025|NCT00136955|7178372|FG000|Overall Study|Lost to Follow-up|1
4401026|NCT00136955|7178372|FG000|Overall Study|Withdrawal by Subject|2
4401027|NCT00136955|7178372|FG000|Overall Study|Incl. prog. disease, protocol violation|12
4401028|NCT00137046|7178378|FG000|Overall Study|Death|2
4401029|NCT00137046|7178379|FG001|Overall Study|Death|1
4401030|NCT00137046|7178378|FG000|Overall Study|Adverse Event|16
4401031|NCT00137046|7178379|FG001|Overall Study|Adverse Event|5
4401032|NCT00137046|7178378|FG000|Overall Study|Laboratory Abnormality|2
4401033|NCT00137046|7178379|FG001|Overall Study|Laboratory Abnormality|0
4401034|NCT00137046|7178378|FG000|Overall Study|Lack of Efficacy|13
4401035|NCT00137046|7178379|FG001|Overall Study|Lack of Efficacy|1
4401036|NCT00137046|7178378|FG000|Overall Study|Lost to Follow-up|8
4401037|NCT00137046|7178379|FG001|Overall Study|Lost to Follow-up|24
4401038|NCT00137046|7178378|FG000|Overall Study|Other|23
4401039|NCT00137046|7178379|FG001|Overall Study|Other|19
4401040|NCT00137046|7178378|FG000|Overall Study|Withdrawal by Subject|33
4401041|NCT00137046|7178379|FG001|Overall Study|Withdrawal by Subject|42
4401042|NCT00137046|7178378|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1
4401043|NCT00137046|7178379|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0
4401044|NCT00137046|7178378|FG000|Overall Study|Withdrew prior to study treatment|1
4401045|NCT00137046|7178379|FG001|Overall Study|Withdrew prior to study treatment|1
4401046|NCT00137111|7178393|FG000|Total Therapy|Death|35
4401047|NCT00137111|7178394|FG001|Total Therapy|Death|0
4401048|NCT00137111|7178395|FG002|Total Therapy|Death|0
4401049|NCT00137111|7178396|FG003|Total Therapy|Death|0
4401050|NCT00137111|7178393|FG000|Total Therapy|Non Compliance|5
4401051|NCT00137111|7178394|FG001|Total Therapy|Non Compliance|0
4401052|NCT00137111|7178395|FG002|Total Therapy|Non Compliance|0
4401053|NCT00137111|7178396|FG003|Total Therapy|Non Compliance|0
4401054|NCT00137267|7178405|FG000|Overall Study|Lost to Follow-up|15
4401055|NCT00137267|7178406|FG001|Overall Study|Lost to Follow-up|21
4401056|NCT00137423|7178423|FG000|Overall Study|Adverse Event|7
4401057|NCT00137423|7178424|FG001|Overall Study|Adverse Event|9
4401058|NCT00137423|7178423|FG000|Overall Study|consent withdrawn|1
4401059|NCT00137423|7178424|FG001|Overall Study|consent withdrawn|1
4401060|NCT00137423|7178423|FG000|Overall Study|Lack of Efficacy|31
4401061|NCT00137423|7178424|FG001|Overall Study|Lack of Efficacy|33
4401062|NCT00137423|7178423|FG000|Overall Study|Death|0
4401063|NCT00137423|7178424|FG001|Overall Study|Death|1
4401064|NCT00137436|7178434|FG000|Overall Study|Adverse Event|13
4401065|NCT00137436|7178434|FG000|Overall Study|Death|2
4401066|NCT00137436|7178434|FG000|Overall Study|Lack of Efficacy|17
4401067|NCT00137436|7178434|FG000|Overall Study|Withdrawal by Subject|6
4401068|NCT00137436|7178434|FG000|Overall Study|Other|5
4401069|NCT00137449|7178440|FG000|Overall Study|Disease Progression|8
4401070|NCT00137449|7178441|FG001|Overall Study|Disease Progression|13
4401071|NCT00137449|7178440|FG000|Overall Study|Death|4
4401072|NCT00137449|7178441|FG001|Overall Study|Death|3
4401073|NCT00137449|7178440|FG000|Overall Study|Adverse Event|3
4401074|NCT00137449|7178441|FG001|Overall Study|Adverse Event|1
4401075|NCT00137449|7178440|FG000|Overall Study|Withdrawal by Subject|1
4401076|NCT00137449|7178441|FG001|Overall Study|Withdrawal by Subject|1
4401077|NCT00137631|7178450|FG000|Overall Study|Lost to Follow-up|37
4401078|NCT00137631|7178451|FG001|Overall Study|Lost to Follow-up|41
4401079|NCT00137839|7178457|FG000|Overall Study|Adverse Event|7
4401080|NCT00137839|7178457|FG000|Overall Study|Physician Decision|7
4401081|NCT00137839|7178457|FG000|Overall Study|Death|8
4401082|NCT00137839|7178457|FG000|Overall Study|Disease Progression|60
4401083|NCT00137839|7178457|FG000|Overall Study|Not Start Treatment|1
4401084|NCT00137839|7178457|FG000|Overall Study|Prolonged Treatment Delay|1
4401085|NCT00138424|7178502|FG000|Overall Study|Physician Decision|0
4401086|NCT00138424|7178503|FG001|Overall Study|Physician Decision|1
4401087|NCT00138424|7178504|FG002|Overall Study|Physician Decision|0
4401088|NCT00138424|7178505|FG003|Overall Study|Physician Decision|0
4401089|NCT00138658|7178526|FG000|Overall Study|Adverse Event|23
4401090|NCT00138658|7178526|FG000|Overall Study|Death|1
4401091|NCT00138658|7178526|FG000|Overall Study|Disease Progression|21
4401092|NCT00138658|7178526|FG000|Overall Study|Physician Decision|11
4401093|NCT00138658|7178526|FG000|Overall Study|Withdrawal by Subject|5
4401094|NCT00138671|7178534|FG000|Overall Study|Death|0
4401095|NCT00138671|7178535|FG001|Overall Study|Death|3
4401096|NCT00138671|7178534|FG000|Overall Study|Adverse Event|6
4401097|NCT00138671|7178535|FG001|Overall Study|Adverse Event|3
4401098|NCT00138671|7178534|FG000|Overall Study|Lost to Follow-up|1
4401099|NCT00138671|7178535|FG001|Overall Study|Lost to Follow-up|2
4401100|NCT00138671|7178534|FG000|Overall Study|Withdrawal by Subject|3
4401101|NCT00138671|7178535|FG001|Overall Study|Withdrawal by Subject|5
4401102|NCT00138671|7178534|FG000|Overall Study|Other|3
4401103|NCT00138671|7178535|FG001|Overall Study|Other|3
4401104|NCT00139477|7178554|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6
4401105|NCT00139477|7178555|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7
4401106|NCT00139477|7178554|FG000|First Intervention -Baseline to 6Months|Relocation|1
4401107|NCT00139477|7178555|FG001|First Intervention -Baseline to 6Months|Relocation|2
4401108|NCT00139477|7178554|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3
4401109|NCT00139477|7178555|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3
4401110|NCT00139477|7178554|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2
4401111|NCT00139477|7178555|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0
4401112|NCT00139477|7178554|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0
4401113|NCT00139477|7178555|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2
4401114|NCT00139477|7178554|FG000|Second Intervention -6Months to 12Months|Relocation|1
4401115|NCT00139477|7178555|FG001|Second Intervention -6Months to 12Months|Relocation|0
4401116|NCT00139477|7178554|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4
4401117|NCT00139477|7178555|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3
4401118|NCT00139659|7178565|FG000|Overall Study|Adverse Event|12
4401119|NCT00139659|7178566|FG001|Overall Study|Adverse Event|1
4401120|NCT00139659|7178565|FG000|Overall Study|Lack of Efficacy|1
4401121|NCT00139659|7178566|FG001|Overall Study|Lack of Efficacy|1
4401122|NCT00139659|7178565|FG000|Overall Study|Lost to Follow-up|7
4401123|NCT00139659|7178566|FG001|Overall Study|Lost to Follow-up|3
4401124|NCT00139659|7178565|FG000|Overall Study|Reason not Specified|6
4401125|NCT00139659|7178566|FG001|Overall Study|Reason not Specified|3
4401126|NCT00139659|7178565|FG000|Overall Study|Withdrawal by Subject|14
4401127|NCT00139659|7178566|FG001|Overall Study|Withdrawal by Subject|10
4401128|NCT00139737|7178576|FG000|Overall Study|Withdrawal by Subject|190
4401129|NCT00139737|7178576|FG000|Overall Study|Adverse Event|58
4401130|NCT00139737|7178576|FG000|Overall Study|Lack of Efficacy|40
4401131|NCT00139737|7178576|FG000|Overall Study|Lost to Follow-up|8
4401132|NCT00139737|7178576|FG000|Overall Study|Death|3
4401133|NCT00139737|7178576|FG000|Overall Study|Laboratory Abnormality|2
4401134|NCT00139737|7178576|FG000|Overall Study|Protocol Violation|18
4401135|NCT00139737|7178576|FG000|Overall Study|Withdrew During Screening Phase|8
4401136|NCT00139737|7178576|FG000|Overall Study|Did Not Meet Entrance Criteria|1
4401137|NCT00139737|7178576|FG000|Overall Study|Screened, Not Treated|13
4401138|NCT00139776|7178582|FG000|Period I|Did not enter Period II|575
4401139|NCT00139776|7178583|FG001|Period I|Did not enter Period II|0
4401140|NCT00139776|7178584|FG002|Period I|Did not enter Period II|0
4401141|NCT00139776|7178585|FG003|Period I|Did not enter Period II|0
4401142|NCT00139776|7178582|FG000|Period II|Not Randomized into Period III|0
4401143|NCT00139776|7178583|FG001|Period II|Not Randomized into Period III|322
4401144|NCT00139776|7178584|FG002|Period II|Not Randomized into Period III|0
4401145|NCT00139776|7178585|FG003|Period II|Not Randomized into Period III|0
4401146|NCT00139776|7178582|FG000|Period III|Adverse Event|0
4401147|NCT00139776|7178583|FG001|Period III|Adverse Event|0
4401148|NCT00139776|7178584|FG002|Period III|Adverse Event|22
4401149|NCT00139776|7178585|FG003|Period III|Adverse Event|23
4401150|NCT00139776|7178582|FG000|Period III|Other|0
4401151|NCT00139776|7178583|FG001|Period III|Other|0
4401152|NCT00139776|7178584|FG002|Period III|Other|23
4401153|NCT00139776|7178585|FG003|Period III|Other|34
4401154|NCT00139776|7178582|FG000|Period III|Lack of Efficacy|0
4401155|NCT00139776|7178583|FG001|Period III|Lack of Efficacy|0
4401156|NCT00139776|7178584|FG002|Period III|Lack of Efficacy|10
4401157|NCT00139776|7178585|FG003|Period III|Lack of Efficacy|24
4401158|NCT00139776|7178582|FG000|Period III|Lost to Follow-up|0
4401159|NCT00139776|7178583|FG001|Period III|Lost to Follow-up|0
4401160|NCT00139776|7178584|FG002|Period III|Lost to Follow-up|5
4401161|NCT00139776|7178585|FG003|Period III|Lost to Follow-up|4
4401162|NCT00139776|7178582|FG000|Period III|Withdrawal by Subject|0
4401163|NCT00139776|7178583|FG001|Period III|Withdrawal by Subject|0
4401164|NCT00139776|7178584|FG002|Period III|Withdrawal by Subject|16
4401165|NCT00139776|7178585|FG003|Period III|Withdrawal by Subject|21
4401166|NCT00140140|7178604|FG000|Overall Study|Unacceptable toxicity|1
4401167|NCT00140140|7178605|FG001|Overall Study|Unacceptable toxicity|1
4401168|NCT00140140|7178606|FG002|Overall Study|Unacceptable toxicity|2
4401169|NCT00140140|7178604|FG000|Overall Study|Physician Decision|1
4401170|NCT00140140|7178605|FG001|Overall Study|Physician Decision|1
4401171|NCT00140140|7178606|FG002|Overall Study|Physician Decision|0
4401172|NCT00140413|7178667|FG000|Overall Study|Lost to Follow-up|1
4401173|NCT00140413|7178668|FG001|Overall Study|Lost to Follow-up|0
4401174|NCT00140413|7178667|FG000|Overall Study|Withdrawal by Subject|2
4401175|NCT00140413|7178668|FG001|Overall Study|Withdrawal by Subject|0
4401176|NCT00140426|7178677|FG000|Overall Study|Withdrawal by Subject|0
4401177|NCT00140426|7178678|FG001|Overall Study|Withdrawal by Subject|3
4401178|NCT00140855|7178706|FG000|Overall Study|Progressive disease|2
4401179|NCT00141037|7178712|FG000|Overall Study|Physician Decision|1
4401180|NCT00141037|7178713|FG001|Overall Study|Physician Decision|2
4401181|NCT00141037|7178712|FG000|Overall Study|Lost to Follow-up|3
4401182|NCT00141037|7178713|FG001|Overall Study|Lost to Follow-up|1
4401183|NCT00141037|7178712|FG000|Overall Study|Protocol Violation|0
4401184|NCT00141037|7178713|FG001|Overall Study|Protocol Violation|2
4401185|NCT00141037|7178712|FG000|Overall Study|Withdrawal by Subject|2
4401186|NCT00141037|7178713|FG001|Overall Study|Withdrawal by Subject|1
4401187|NCT00141037|7178712|FG000|Overall Study|Other|0
4401188|NCT00141037|7178713|FG001|Overall Study|Other|1
4401189|NCT00141037|7178712|FG000|Overall Study|Moved from area|1
4401190|NCT00141037|7178713|FG001|Overall Study|Moved from area|7
4401191|NCT00141037|7178712|FG000|Overall Study|Graft Failure|3
4401192|NCT00141037|7178713|FG001|Overall Study|Graft Failure|4
4401193|NCT00141102|7178721|FG000|Overall Study|Adverse Event|233
4401194|NCT00141102|7178722|FG001|Overall Study|Adverse Event|305
4401195|NCT00141102|7178721|FG000|Overall Study|Laboratory Abnormality|9
4401196|NCT00141102|7178722|FG001|Overall Study|Laboratory Abnormality|33
4401197|NCT00141102|7178721|FG000|Overall Study|Lack of Efficacy|21
4401198|NCT00141102|7178722|FG001|Overall Study|Lack of Efficacy|26
4401199|NCT00141102|7178721|FG000|Overall Study|Lost to Follow-up|29
4401200|NCT00141102|7178722|FG001|Overall Study|Lost to Follow-up|32
4401201|NCT00141102|7178721|FG000|Overall Study|Other|87
4401202|NCT00141102|7178722|FG001|Overall Study|Other|76
4401203|NCT00141102|7178721|FG000|Overall Study|Withdrawal by Subject|112
4401204|NCT00141102|7178722|FG001|Overall Study|Withdrawal by Subject|142
4401205|NCT00141102|7178721|FG000|Overall Study|Randomized But Did Not Receive Treatment|15
4401206|NCT00141102|7178722|FG001|Overall Study|Randomized But Did Not Receive Treatment|9
4401207|NCT00141102|7178721|FG000|Overall Study|Death|2
4401208|NCT00141102|7178722|FG001|Overall Study|Death|2
4401209|NCT00141219|7178736|FG000|Overall Study|Protocol violations|5
4401210|NCT00141219|7178737|FG001|Overall Study|Protocol violations|4
4401211|NCT00141219|7178736|FG000|Overall Study|Adverse Event|8
4401212|NCT00141219|7178737|FG001|Overall Study|Adverse Event|6
4401213|NCT00141219|7178736|FG000|Overall Study|Lack of Efficacy|5
4401214|NCT00141219|7178737|FG001|Overall Study|Lack of Efficacy|4
4401215|NCT00141219|7178736|FG000|Overall Study|Withdrawal by Subject|6
4401216|NCT00141219|7178737|FG001|Overall Study|Withdrawal by Subject|2
4401217|NCT00141271|7178746|FG000|Overall Study|Adverse Event|31
4401218|NCT00141271|7178747|FG001|Overall Study|Adverse Event|19
4401219|NCT00141271|7178748|FG002|Overall Study|Adverse Event|17
4401220|NCT00141271|7178746|FG000|Overall Study|Laboratory Abnormality|2
4401221|NCT00141271|7178747|FG001|Overall Study|Laboratory Abnormality|1
4401222|NCT00141271|7178748|FG002|Overall Study|Laboratory Abnormality|1
4401223|NCT00141271|7178746|FG000|Overall Study|Lack of Efficacy|7
4401224|NCT00141271|7178747|FG001|Overall Study|Lack of Efficacy|7
4401225|NCT00141271|7178748|FG002|Overall Study|Lack of Efficacy|3
4401226|NCT00141271|7178746|FG000|Overall Study|Lost to Follow-up|15
4401227|NCT00141271|7178747|FG001|Overall Study|Lost to Follow-up|15
4401228|NCT00141271|7178748|FG002|Overall Study|Lost to Follow-up|21
4401229|NCT00141271|7178746|FG000|Overall Study|Withdrawal by Subject|14
4401230|NCT00141271|7178747|FG001|Overall Study|Withdrawal by Subject|9
4401231|NCT00141271|7178748|FG002|Overall Study|Withdrawal by Subject|10
4401232|NCT00141271|7178746|FG000|Overall Study|Other|11
4401233|NCT00141271|7178747|FG001|Overall Study|Other|12
4401234|NCT00141271|7178748|FG002|Overall Study|Other|5
4401235|NCT00141297|7178758|FG000|Overall Study|Adverse Event|0
4401236|NCT00141297|7178759|FG001|Overall Study|Adverse Event|0
4401237|NCT00141297|7178760|FG002|Overall Study|Adverse Event|1
4401238|NCT00141297|7178761|FG003|Overall Study|Adverse Event|0
4401239|NCT00141297|7178762|FG004|Overall Study|Adverse Event|1
4401240|NCT00141297|7178763|FG005|Overall Study|Adverse Event|1
4401241|NCT00141297|7178764|FG006|Overall Study|Adverse Event|0
4401242|NCT00141297|7178765|FG007|Overall Study|Adverse Event|1
4401243|NCT00141297|7178766|FG008|Overall Study|Adverse Event|1
4401244|NCT00141297|7178767|FG009|Overall Study|Adverse Event|0
4401245|NCT00141297|7178758|FG000|Overall Study|Death|1
4401246|NCT00141297|7178759|FG001|Overall Study|Death|0
4401247|NCT00141297|7178760|FG002|Overall Study|Death|0
4401248|NCT00141297|7178761|FG003|Overall Study|Death|0
4401249|NCT00141297|7178762|FG004|Overall Study|Death|0
4401250|NCT00141297|7178763|FG005|Overall Study|Death|0
4401251|NCT00141297|7178764|FG006|Overall Study|Death|0
4401252|NCT00141297|7178765|FG007|Overall Study|Death|0
4401253|NCT00141297|7178766|FG008|Overall Study|Death|1
4401254|NCT00141297|7178767|FG009|Overall Study|Death|0
4401255|NCT00141297|7178758|FG000|Overall Study|Withdrawal by Subject|0
4401256|NCT00141297|7178759|FG001|Overall Study|Withdrawal by Subject|0
4401257|NCT00141297|7178760|FG002|Overall Study|Withdrawal by Subject|0
4401258|NCT00141297|7178761|FG003|Overall Study|Withdrawal by Subject|0
4401259|NCT00141297|7178762|FG004|Overall Study|Withdrawal by Subject|0
4401260|NCT00141297|7178763|FG005|Overall Study|Withdrawal by Subject|0
4401261|NCT00141297|7178764|FG006|Overall Study|Withdrawal by Subject|0
4401262|NCT00141297|7178765|FG007|Overall Study|Withdrawal by Subject|0
4401263|NCT00141297|7178766|FG008|Overall Study|Withdrawal by Subject|1
4401264|NCT00141297|7178767|FG009|Overall Study|Withdrawal by Subject|0
4401265|NCT00141297|7178758|FG000|Overall Study|Other|0
4401266|NCT00141297|7178759|FG001|Overall Study|Other|0
4401267|NCT00141297|7178760|FG002|Overall Study|Other|0
4401268|NCT00141297|7178761|FG003|Overall Study|Other|1
4401269|NCT00141297|7178762|FG004|Overall Study|Other|5
4401270|NCT00141297|7178763|FG005|Overall Study|Other|0
4401271|NCT00141297|7178764|FG006|Overall Study|Other|0
4401272|NCT00141297|7178765|FG007|Overall Study|Other|0
4401273|NCT00141297|7178766|FG008|Overall Study|Other|2
4401274|NCT00141297|7178767|FG009|Overall Study|Other|0
4401275|NCT00141297|7178758|FG000|Overall Study|Progressive Disease|2
4401276|NCT00141297|7178759|FG001|Overall Study|Progressive Disease|3
4401277|NCT00141297|7178760|FG002|Overall Study|Progressive Disease|6
4401278|NCT00141297|7178761|FG003|Overall Study|Progressive Disease|2
4401279|NCT00141297|7178762|FG004|Overall Study|Progressive Disease|15
4401280|NCT00141297|7178763|FG005|Overall Study|Progressive Disease|2
4401281|NCT00141297|7178764|FG006|Overall Study|Progressive Disease|3
4401282|NCT00141297|7178765|FG007|Overall Study|Progressive Disease|3
4401283|NCT00141297|7178766|FG008|Overall Study|Progressive Disease|15
4401284|NCT00141297|7178767|FG009|Overall Study|Progressive Disease|6
4401285|NCT00141297|7178758|FG000|Overall Study|Transitioned|0
4401286|NCT00141297|7178759|FG001|Overall Study|Transitioned|0
4401287|NCT00141297|7178760|FG002|Overall Study|Transitioned|0
4401288|NCT00141297|7178761|FG003|Overall Study|Transitioned|0
4401289|NCT00141297|7178762|FG004|Overall Study|Transitioned|1
4401290|NCT00141297|7178763|FG005|Overall Study|Transitioned|0
4401291|NCT00141297|7178764|FG006|Overall Study|Transitioned|0
4401292|NCT00141297|7178765|FG007|Overall Study|Transitioned|0
4401293|NCT00141297|7178766|FG008|Overall Study|Transitioned|0
4401294|NCT00141297|7178767|FG009|Overall Study|Transitioned|0
4401295|NCT00141453|7178802|FG000|Overall Study|Protocol Violation|6
4401296|NCT00141453|7178803|FG001|Overall Study|Protocol Violation|5
4401297|NCT00141518|7178812|FG000|Overall Study|Withdrew Consent Prior to Treatment|1
4401298|NCT00141518|7178813|FG001|Overall Study|Withdrew Consent Prior to Treatment|0
4401299|NCT00141518|7178814|FG002|Overall Study|Withdrew Consent Prior to Treatment|0
4401300|NCT00141518|7178812|FG000|Overall Study|Adverse Event|7
4401301|NCT00141518|7178813|FG001|Overall Study|Adverse Event|5
4401302|NCT00141518|7178814|FG002|Overall Study|Adverse Event|2
4401303|NCT00141518|7178812|FG000|Overall Study|Withdrawal by Subject|2
4401304|NCT00141518|7178813|FG001|Overall Study|Withdrawal by Subject|0
4401305|NCT00141518|7178814|FG002|Overall Study|Withdrawal by Subject|2
4401306|NCT00141518|7178812|FG000|Overall Study|Protocol Violation|1
4401307|NCT00141518|7178813|FG001|Overall Study|Protocol Violation|1
4401308|NCT00141518|7178814|FG002|Overall Study|Protocol Violation|2
4401309|NCT00141518|7178812|FG000|Overall Study|Lack of Efficacy|5
4401310|NCT00141518|7178813|FG001|Overall Study|Lack of Efficacy|0
4401311|NCT00141518|7178814|FG002|Overall Study|Lack of Efficacy|0
4401312|NCT00141726|7178824|FG000|Overall Study|Completed <50% Scheduled Dosing|3
4401313|NCT00141778|7178841|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5
4401314|NCT00141778|7178842|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2
4401315|NCT00141778|7178843|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6
4401316|NCT00141778|7178841|FG000|Started Study Medication|Met safety criteria for discontinuation|2
4401317|NCT00141778|7178842|FG001|Started Study Medication|Met safety criteria for discontinuation|4
4401318|NCT00141778|7178843|FG002|Started Study Medication|Met safety criteria for discontinuation|3
4401319|NCT00141778|7178841|FG000|Started Study Medication|Withdrawal by Subject|0
4401320|NCT00141778|7178842|FG001|Started Study Medication|Withdrawal by Subject|2
4401321|NCT00141778|7178843|FG002|Started Study Medication|Withdrawal by Subject|0
4401322|NCT00141778|7178841|FG000|Started Study Medication|Difficulty Swallowing|0
4401323|NCT00141778|7178842|FG001|Started Study Medication|Difficulty Swallowing|1
4401324|NCT00141778|7178843|FG002|Started Study Medication|Difficulty Swallowing|0
4401325|NCT00141778|7178841|FG000|Started Study Medication|Chest Discomfort|0
4401326|NCT00141778|7178842|FG001|Started Study Medication|Chest Discomfort|0
4401327|NCT00141778|7178843|FG002|Started Study Medication|Chest Discomfort|1
4401328|NCT00141817|7178855|FG000|Overall Study|Protocol Violation|0
4401329|NCT00141817|7178856|FG001|Overall Study|Protocol Violation|0
4401330|NCT00141817|7178857|FG002|Overall Study|Protocol Violation|1
4401331|NCT00141817|7178858|FG003|Overall Study|Protocol Violation|0
4401332|NCT00141817|7178855|FG000|Overall Study|Parent request|1
4401333|NCT00141817|7178856|FG001|Overall Study|Parent request|0
4401334|NCT00141817|7178857|FG002|Overall Study|Parent request|0
4401335|NCT00141817|7178858|FG003|Overall Study|Parent request|0
4401336|NCT00141921|7178868|FG000|Overall Study|Remain on Study|28
4401337|NCT00141921|7178868|FG000|Overall Study|Withdrawal by Subject|42
4401338|NCT00141921|7178868|FG000|Overall Study|Lost to Follow-up|19
4401339|NCT00141921|7178868|FG000|Overall Study|Noncompliance|17
4401340|NCT00141921|7178868|FG000|Overall Study|Disease Progression|7
4401341|NCT00141921|7178868|FG000|Overall Study|Protocol Deviation|7
4401342|NCT00141921|7178868|FG000|Overall Study|Adverse Event|5
4401343|NCT00141921|7178868|FG000|Overall Study|Administrative Decision|2
4401344|NCT00141921|7178868|FG000|Overall Study|Pregnancy|4
4401345|NCT00141921|7178868|FG000|Overall Study|Ineligibility Determined|2
4401346|NCT00141921|7178868|FG000|Overall Study|Other|8
4401347|NCT00142298|7178891|FG000|Overall Study|Adverse Event|10
4401348|NCT00142298|7178892|FG001|Overall Study|Adverse Event|10
4401349|NCT00142298|7178893|FG002|Overall Study|Adverse Event|1
4401350|NCT00142298|7178894|FG003|Overall Study|Adverse Event|5
4401351|NCT00142298|7178895|FG004|Overall Study|Adverse Event|2
4401352|NCT00142298|7178896|FG005|Overall Study|Adverse Event|2
4401353|NCT00142298|7178897|FG006|Overall Study|Adverse Event|0
4401354|NCT00142298|7178898|FG007|Overall Study|Adverse Event|0
4401355|NCT00142298|7178899|FG008|Overall Study|Adverse Event|0
4401356|NCT00142298|7178900|FG009|Overall Study|Adverse Event|0
4401357|NCT00142298|7178891|FG000|Overall Study|Clinical disease progression|1
4401358|NCT00142298|7178892|FG001|Overall Study|Clinical disease progression|0
4401359|NCT00142298|7178893|FG002|Overall Study|Clinical disease progression|0
4401360|NCT00142298|7178894|FG003|Overall Study|Clinical disease progression|0
4401361|NCT00142298|7178895|FG004|Overall Study|Clinical disease progression|0
4401362|NCT00142298|7178896|FG005|Overall Study|Clinical disease progression|0
4401363|NCT00142298|7178897|FG006|Overall Study|Clinical disease progression|0
4401364|NCT00142298|7178898|FG007|Overall Study|Clinical disease progression|0
4401365|NCT00142298|7178899|FG008|Overall Study|Clinical disease progression|0
4401366|NCT00142298|7178900|FG009|Overall Study|Clinical disease progression|0
4401367|NCT00142298|7178891|FG000|Overall Study|Death|1
4401368|NCT00142298|7178892|FG001|Overall Study|Death|1
4401369|NCT00142298|7178893|FG002|Overall Study|Death|1
4401370|NCT00142298|7178894|FG003|Overall Study|Death|0
4401371|NCT00142298|7178895|FG004|Overall Study|Death|0
4401372|NCT00142298|7178896|FG005|Overall Study|Death|6
4401373|NCT00142298|7178897|FG006|Overall Study|Death|0
4401374|NCT00142298|7178898|FG007|Overall Study|Death|0
4401375|NCT00142298|7178899|FG008|Overall Study|Death|0
4401376|NCT00142298|7178900|FG009|Overall Study|Death|0
4401377|NCT00142298|7178891|FG000|Overall Study|Lack of Efficacy|44
4401378|NCT00142298|7178892|FG001|Overall Study|Lack of Efficacy|62
4401379|NCT00142298|7178893|FG002|Overall Study|Lack of Efficacy|9
4401380|NCT00142298|7178894|FG003|Overall Study|Lack of Efficacy|12
4401381|NCT00142298|7178895|FG004|Overall Study|Lack of Efficacy|1
4401382|NCT00142298|7178896|FG005|Overall Study|Lack of Efficacy|0
4401383|NCT00142298|7178897|FG006|Overall Study|Lack of Efficacy|0
4401384|NCT00142298|7178898|FG007|Overall Study|Lack of Efficacy|1
4401385|NCT00142298|7178899|FG008|Overall Study|Lack of Efficacy|0
4401386|NCT00142298|7178900|FG009|Overall Study|Lack of Efficacy|0
4401387|NCT00142298|7178891|FG000|Overall Study|Non-compliance|15
4401388|NCT00142298|7178892|FG001|Overall Study|Non-compliance|13
4401389|NCT00142298|7178893|FG002|Overall Study|Non-compliance|0
4401390|NCT00142298|7178894|FG003|Overall Study|Non-compliance|6
4401391|NCT00142298|7178895|FG004|Overall Study|Non-compliance|1
4401392|NCT00142298|7178896|FG005|Overall Study|Non-compliance|0
4401393|NCT00142298|7178897|FG006|Overall Study|Non-compliance|0
4401394|NCT00142298|7178898|FG007|Overall Study|Non-compliance|3
4401395|NCT00142298|7178899|FG008|Overall Study|Non-compliance|3
4401396|NCT00142298|7178900|FG009|Overall Study|Non-compliance|0
4401397|NCT00142298|7178891|FG000|Overall Study|Patient, Investigator,or Sponsor request|66
4401398|NCT00142298|7178892|FG001|Overall Study|Patient, Investigator,or Sponsor request|60
4401399|NCT00142298|7178893|FG002|Overall Study|Patient, Investigator,or Sponsor request|11
4401400|NCT00142298|7178894|FG003|Overall Study|Patient, Investigator,or Sponsor request|51
4401401|NCT00142298|7178895|FG004|Overall Study|Patient, Investigator,or Sponsor request|4
4401402|NCT00142298|7178896|FG005|Overall Study|Patient, Investigator,or Sponsor request|3
4401403|NCT00142298|7178897|FG006|Overall Study|Patient, Investigator,or Sponsor request|1
4401404|NCT00142298|7178898|FG007|Overall Study|Patient, Investigator,or Sponsor request|4
4401405|NCT00142298|7178899|FG008|Overall Study|Patient, Investigator,or Sponsor request|1
4401406|NCT00142298|7178900|FG009|Overall Study|Patient, Investigator,or Sponsor request|0
4401407|NCT00142298|7178891|FG000|Overall Study|Pregnancy|4
4401408|NCT00142298|7178892|FG001|Overall Study|Pregnancy|4
4401409|NCT00142298|7178893|FG002|Overall Study|Pregnancy|2
4401410|NCT00142298|7178894|FG003|Overall Study|Pregnancy|3
4401411|NCT00142298|7178895|FG004|Overall Study|Pregnancy|0
4401412|NCT00142298|7178896|FG005|Overall Study|Pregnancy|0
4401413|NCT00142298|7178897|FG006|Overall Study|Pregnancy|0
4401414|NCT00142298|7178898|FG007|Overall Study|Pregnancy|0
4401415|NCT00142298|7178899|FG008|Overall Study|Pregnancy|1
4401416|NCT00142298|7178900|FG009|Overall Study|Pregnancy|0
4401417|NCT00142298|7178891|FG000|Overall Study|Virologic breakthrough|19
4401418|NCT00142298|7178892|FG001|Overall Study|Virologic breakthrough|23
4401419|NCT00142298|7178893|FG002|Overall Study|Virologic breakthrough|9
4401420|NCT00142298|7178894|FG003|Overall Study|Virologic breakthrough|7
4401421|NCT00142298|7178895|FG004|Overall Study|Virologic breakthrough|2
4401422|NCT00142298|7178896|FG005|Overall Study|Virologic breakthrough|3
4401423|NCT00142298|7178897|FG006|Overall Study|Virologic breakthrough|3
4401424|NCT00142298|7178898|FG007|Overall Study|Virologic breakthrough|0
4401425|NCT00142298|7178899|FG008|Overall Study|Virologic breakthrough|0
4401426|NCT00142298|7178900|FG009|Overall Study|Virologic breakthrough|0
4401427|NCT00142298|7178891|FG000|Overall Study|Other- not specified|0
4401428|NCT00142298|7178892|FG001|Overall Study|Other- not specified|3
4401429|NCT00142298|7178893|FG002|Overall Study|Other- not specified|0
4401430|NCT00142298|7178894|FG003|Overall Study|Other- not specified|1
4401431|NCT00142298|7178895|FG004|Overall Study|Other- not specified|0
4401432|NCT00142298|7178896|FG005|Overall Study|Other- not specified|0
4401433|NCT00142298|7178897|FG006|Overall Study|Other- not specified|0
4401434|NCT00142298|7178898|FG007|Overall Study|Other- not specified|0
4401435|NCT00142298|7178899|FG008|Overall Study|Other- not specified|0
4401436|NCT00142298|7178900|FG009|Overall Study|Other- not specified|0
4401437|NCT00142298|7178891|FG000|Overall Study|Lost to Follow-up|0
4401438|NCT00142298|7178892|FG001|Overall Study|Lost to Follow-up|0
4401439|NCT00142298|7178893|FG002|Overall Study|Lost to Follow-up|0
4401440|NCT00142298|7178894|FG003|Overall Study|Lost to Follow-up|0
4401441|NCT00142298|7178895|FG004|Overall Study|Lost to Follow-up|0
4401442|NCT00142298|7178896|FG005|Overall Study|Lost to Follow-up|0
4401443|NCT00142298|7178897|FG006|Overall Study|Lost to Follow-up|2
4401444|NCT00142298|7178898|FG007|Overall Study|Lost to Follow-up|0
4401445|NCT00142298|7178899|FG008|Overall Study|Lost to Follow-up|0
4401446|NCT00142298|7178900|FG009|Overall Study|Lost to Follow-up|0
4401447|NCT00142298|7178891|FG000|Overall Study|Treatment Failure|0
4401448|NCT00142298|7178892|FG001|Overall Study|Treatment Failure|0
4401449|NCT00142298|7178893|FG002|Overall Study|Treatment Failure|0
4401450|NCT00142298|7178894|FG003|Overall Study|Treatment Failure|0
4401451|NCT00142298|7178895|FG004|Overall Study|Treatment Failure|0
4401452|NCT00142298|7178896|FG005|Overall Study|Treatment Failure|2
4401453|NCT00142298|7178897|FG006|Overall Study|Treatment Failure|2
4401454|NCT00142298|7178898|FG007|Overall Study|Treatment Failure|0
4401455|NCT00142298|7178899|FG008|Overall Study|Treatment Failure|0
4401456|NCT00142298|7178900|FG009|Overall Study|Treatment Failure|0
4401457|NCT00142415|7178928|FG000|Overall Study|Physician Decision|0
4401458|NCT00142415|7178929|FG001|Overall Study|Physician Decision|0
4401459|NCT00142415|7178930|FG002|Overall Study|Physician Decision|0
4401460|NCT00142415|7178931|FG003|Overall Study|Physician Decision|0
4401461|NCT00142415|7178932|FG004|Overall Study|Physician Decision|1
4401462|NCT00142415|7178933|FG005|Overall Study|Physician Decision|2
4401463|NCT00142792|7178974|FG000|Overall Study|Death|0
4401464|NCT00142792|7178975|FG001|Overall Study|Death|0
4401465|NCT00142792|7178976|FG002|Overall Study|Death|1
4401466|NCT00142792|7178974|FG000|Overall Study|Withdrawal by Subject|3
4401467|NCT00142792|7178975|FG001|Overall Study|Withdrawal by Subject|2
4401468|NCT00142792|7178976|FG002|Overall Study|Withdrawal by Subject|3
4401469|NCT00142792|7178974|FG000|Overall Study|Lost to Follow-up|8
4401470|NCT00142792|7178975|FG001|Overall Study|Lost to Follow-up|11
4401471|NCT00142792|7178976|FG002|Overall Study|Lost to Follow-up|7
4401472|NCT00142792|7178974|FG000|Overall Study|No category|1
4401473|NCT00142792|7178975|FG001|Overall Study|No category|2
4401474|NCT00142792|7178976|FG002|Overall Study|No category|1
4401475|NCT00142909|7179007|FG000|Randomization|Various Reasons|7
4401476|NCT00142909|7179008|FG001|Randomization|Various Reasons|10
4401477|NCT00142909|7179007|FG000|Medications Begin|Protocol Violation|2
4401478|NCT00142909|7179008|FG001|Medications Begin|Protocol Violation|0
4401479|NCT00142909|7179007|FG000|Medications Begin|Withdrawal by Subject|5
4401480|NCT00142909|7179008|FG001|Medications Begin|Withdrawal by Subject|3
4401481|NCT00142909|7179007|FG000|Medications Begin|Withdrawal by Subject|2
4401482|NCT00142909|7179008|FG001|Medications Begin|Withdrawal by Subject|0
4401483|NCT00142935|7179017|FG000|Overall Study|Other reason|1
4401484|NCT00142935|7179018|FG001|Overall Study|Other reason|1
4401485|NCT00142935|7179019|FG002|Overall Study|Other reason|1
4401486|NCT00142935|7179017|FG000|Overall Study|Lost to Follow-up|2
4401487|NCT00142935|7179018|FG001|Overall Study|Lost to Follow-up|5
4401488|NCT00142935|7179019|FG002|Overall Study|Lost to Follow-up|5
4401489|NCT00142935|7179017|FG000|Overall Study|Death|0
4401490|NCT00142935|7179018|FG001|Overall Study|Death|2
4401491|NCT00142935|7179019|FG002|Overall Study|Death|1
4401492|NCT00143247|7179031|FG000|Overall Study|Death|8
4401493|NCT00143247|7179031|FG000|Overall Study|Adverse Event|19
4401494|NCT00143247|7179031|FG000|Overall Study|Lack of Efficacy|3
4401495|NCT00143247|7179031|FG000|Overall Study|Withdrawal by Subject|55
4401496|NCT00143247|7179031|FG000|Overall Study|Study terminated by sponsor|31
4401497|NCT00143247|7179031|FG000|Overall Study|Protocol Violation|15
4401498|NCT00143247|7179031|FG000|Overall Study|Lost to Follow-up|12
4401499|NCT00143247|7179031|FG000|Overall Study|following inaccurate lab adverse event|1
4401500|NCT00143247|7179031|FG000|Overall Study|Other|12
4401501|NCT00143312|7179035|FG000|Overall Study|Death|11
4401502|NCT00143312|7179035|FG000|Overall Study|Adverse Event|2
4401503|NCT00143312|7179035|FG000|Overall Study|Lost to Follow-up|1
4401504|NCT00143312|7179035|FG000|Overall Study|Other|1
4401505|NCT00143312|7179035|FG000|Overall Study|Withdrawal by Subject|1
4401506|NCT00143390|7179041|FG000|Overall Study|Death|2
4401507|NCT00143390|7179042|FG001|Overall Study|Death|0
4401508|NCT00143390|7179041|FG000|Overall Study|Not meeting entry criteria|2
4401509|NCT00143390|7179042|FG001|Overall Study|Not meeting entry criteria|5
4401510|NCT00143390|7179041|FG000|Overall Study|Withdrawal by Subject|4
4401511|NCT00143390|7179042|FG001|Overall Study|Withdrawal by Subject|4
4401512|NCT00143390|7179041|FG000|Overall Study|Progressive disease|119
4401513|NCT00143390|7179042|FG001|Overall Study|Progressive disease|115
4401514|NCT00143390|7179041|FG000|Overall Study|Protocol Violation|2
4401515|NCT00143390|7179042|FG001|Overall Study|Protocol Violation|0
4401516|NCT00143390|7179041|FG000|Overall Study|Study termination|10
4401517|NCT00143390|7179042|FG001|Overall Study|Study termination|15
4401518|NCT00143390|7179041|FG000|Overall Study|Adverse Event|9
4401519|NCT00143390|7179042|FG001|Overall Study|Adverse Event|8
4401520|NCT00143390|7179041|FG000|Overall Study|Other|1
4401521|NCT00143390|7179042|FG001|Overall Study|Other|2
4401522|NCT00143403|7179050|FG000|Overall Study|Adverse Event|3
4401523|NCT00143403|7179051|FG001|Overall Study|Adverse Event|8
4401524|NCT00143403|7179050|FG000|Overall Study|Death|1
4401525|NCT00143403|7179051|FG001|Overall Study|Death|0
4401526|NCT00143403|7179050|FG000|Overall Study|Withdrawal by Subject|3
4401527|NCT00143403|7179051|FG001|Overall Study|Withdrawal by Subject|12
4401528|NCT00143403|7179050|FG000|Overall Study|Relapse|15
4401529|NCT00143403|7179051|FG001|Overall Study|Relapse|7
4401530|NCT00143403|7179050|FG000|Overall Study|Protocol Violation|2
4401531|NCT00143403|7179051|FG001|Overall Study|Protocol Violation|2
4401532|NCT00143403|7179050|FG000|Overall Study|specified by site|4
4401533|NCT00143403|7179051|FG001|Overall Study|specified by site|9
4401534|NCT00143403|7179050|FG000|Overall Study|Randomized Not Treated|7
4401535|NCT00143403|7179051|FG001|Overall Study|Randomized Not Treated|8
4401536|NCT00143455|7179061|FG000|Cohort 1|Adverse Event|8
4401537|NCT00143455|7179062|FG001|Cohort 1|Adverse Event|4
4401538|NCT00143455|7179063|FG002|Cohort 1|Adverse Event|0
4401539|NCT00143455|7179064|FG003|Cohort 1|Adverse Event|0
4401540|NCT00143455|7179061|FG000|Cohort 1|Death|5
4401541|NCT00143455|7179062|FG001|Cohort 1|Death|2
4401542|NCT00143455|7179063|FG002|Cohort 1|Death|0
4401543|NCT00143455|7179064|FG003|Cohort 1|Death|0
4401544|NCT00143455|7179061|FG000|Cohort 1|Progressive Disease|0
4401545|NCT00143455|7179062|FG001|Cohort 1|Progressive Disease|6
4401546|NCT00143455|7179063|FG002|Cohort 1|Progressive Disease|0
4401547|NCT00143455|7179064|FG003|Cohort 1|Progressive Disease|0
4401548|NCT00143455|7179061|FG000|Cohort 1|Withdrawal by Subject|1
4401549|NCT00143455|7179062|FG001|Cohort 1|Withdrawal by Subject|4
4401550|NCT00143455|7179063|FG002|Cohort 1|Withdrawal by Subject|0
4401551|NCT00143455|7179064|FG003|Cohort 1|Withdrawal by Subject|0
4401552|NCT00143455|7179061|FG000|Cohort 1|Randomized But Not Treated|0
4401553|NCT00143455|7179062|FG001|Cohort 1|Randomized But Not Treated|1
4401554|NCT00143455|7179063|FG002|Cohort 1|Randomized But Not Treated|0
4401555|NCT00143455|7179064|FG003|Cohort 1|Randomized But Not Treated|0
4401556|NCT00143455|7179061|FG000|Cohort 2|Adverse Event|0
4401557|NCT00143455|7179062|FG001|Cohort 2|Adverse Event|0
4401558|NCT00143455|7179063|FG002|Cohort 2|Adverse Event|42
4401559|NCT00143455|7179064|FG003|Cohort 2|Adverse Event|30
4401560|NCT00143455|7179061|FG000|Cohort 2|No Longer Required Study Treatment|0
4401561|NCT00143455|7179062|FG001|Cohort 2|No Longer Required Study Treatment|0
4401562|NCT00143455|7179063|FG002|Cohort 2|No Longer Required Study Treatment|1
4401563|NCT00143455|7179064|FG003|Cohort 2|No Longer Required Study Treatment|0
4401564|NCT00143455|7179061|FG000|Cohort 2|Protocol Violation|0
4401565|NCT00143455|7179062|FG001|Cohort 2|Protocol Violation|0
4401566|NCT00143455|7179063|FG002|Cohort 2|Protocol Violation|1
4401567|NCT00143455|7179064|FG003|Cohort 2|Protocol Violation|1
4401568|NCT00143455|7179061|FG000|Cohort 2|Lost to Follow-up|0
4401569|NCT00143455|7179062|FG001|Cohort 2|Lost to Follow-up|0
4401570|NCT00143455|7179063|FG002|Cohort 2|Lost to Follow-up|1
4401571|NCT00143455|7179064|FG003|Cohort 2|Lost to Follow-up|4
4401572|NCT00143455|7179061|FG000|Cohort 2|Death|0
4401573|NCT00143455|7179062|FG001|Cohort 2|Death|0
4401574|NCT00143455|7179063|FG002|Cohort 2|Death|20
4401575|NCT00143455|7179064|FG003|Cohort 2|Death|12
4401576|NCT00143455|7179061|FG000|Cohort 2|Progressive Disease|0
4401577|NCT00143455|7179062|FG001|Cohort 2|Progressive Disease|0
4401578|NCT00143455|7179063|FG002|Cohort 2|Progressive Disease|20
4401579|NCT00143455|7179064|FG003|Cohort 2|Progressive Disease|27
4401580|NCT00143455|7179061|FG000|Cohort 2|Withdrawal by Subject|0
4401581|NCT00143455|7179062|FG001|Cohort 2|Withdrawal by Subject|0
4401582|NCT00143455|7179063|FG002|Cohort 2|Withdrawal by Subject|13
4401583|NCT00143455|7179064|FG003|Cohort 2|Withdrawal by Subject|12
4401584|NCT00143455|7179061|FG000|Cohort 2|Other|0
4401585|NCT00143455|7179062|FG001|Cohort 2|Other|0
4401586|NCT00143455|7179063|FG002|Cohort 2|Other|7
4401587|NCT00143455|7179064|FG003|Cohort 2|Other|6
4401588|NCT00143455|7179061|FG000|Cohort 2|Randomized But Not Treated|0
4401589|NCT00143455|7179062|FG001|Cohort 2|Randomized But Not Treated|0
4401590|NCT00143455|7179063|FG002|Cohort 2|Randomized But Not Treated|1
4401591|NCT00143455|7179064|FG003|Cohort 2|Randomized But Not Treated|1
4401592|NCT00143507|7179078|FG000|Overall Study|Death|572
4401593|NCT00143507|7179079|FG001|Overall Study|Death|547
4401594|NCT00143507|7179078|FG000|Overall Study|Withdrawal by Subject|114
4401595|NCT00143507|7179079|FG001|Overall Study|Withdrawal by Subject|102
4401596|NCT00143507|7179078|FG000|Overall Study|Lost to Follow-up|1
4401597|NCT00143507|7179079|FG001|Overall Study|Lost to Follow-up|0
4401598|NCT00143507|7179078|FG000|Overall Study|Withdrawn by sponsor's decision|0
4401599|NCT00143507|7179079|FG001|Overall Study|Withdrawn by sponsor's decision|3
4401600|NCT00143598|7179087|FG000|Overall Study|Lost to Follow-up|23
4401601|NCT00143598|7179088|FG001|Overall Study|Lost to Follow-up|21
4401602|NCT00143598|7179087|FG000|Overall Study|Withdrawal by Subject|33
4401603|NCT00143598|7179088|FG001|Overall Study|Withdrawal by Subject|37
4401604|NCT00143598|7179087|FG000|Overall Study|Death|36
4401605|NCT00143598|7179088|FG001|Overall Study|Death|36
4401606|NCT00144027|7179113|FG000|Overall Study|Lost to Follow-up|1
4401607|NCT00144027|7179114|FG001|Overall Study|Lost to Follow-up|3
4401608|NCT00144027|7179113|FG000|Overall Study|Withdrawal by Subject|2
4401609|NCT00144027|7179114|FG001|Overall Study|Withdrawal by Subject|2
4401610|NCT00144027|7179113|FG000|Overall Study|did not complete baseline assessment|0
4401611|NCT00144027|7179114|FG001|Overall Study|did not complete baseline assessment|6
4401612|NCT00144170|7179122|FG000|Overall Study|Adverse Event|84
4401613|NCT00144170|7179123|FG001|Overall Study|Adverse Event|41
4401614|NCT00144170|7179122|FG000|Overall Study|Protocol Violation|23
4401615|NCT00144170|7179123|FG001|Overall Study|Protocol Violation|16
4401616|NCT00144170|7179122|FG000|Overall Study|Lost to Follow-up|5
4401617|NCT00144170|7179123|FG001|Overall Study|Lost to Follow-up|10
4401618|NCT00144170|7179122|FG000|Overall Study|Withdrawal by Subject|29
4401619|NCT00144170|7179123|FG001|Overall Study|Withdrawal by Subject|13
4401620|NCT00144170|7179122|FG000|Overall Study|Other reason not defined above|211
4401621|NCT00144170|7179123|FG001|Overall Study|Other reason not defined above|316
4401622|NCT00144300|7179131|FG000|Overall Study|Adverse Event|18
4401623|NCT00144300|7179132|FG001|Overall Study|Adverse Event|16
4401624|NCT00144300|7179131|FG000|Overall Study|Protocol Violation|1
4401625|NCT00144300|7179132|FG001|Overall Study|Protocol Violation|3
4401626|NCT00144300|7179131|FG000|Overall Study|Lost to Follow-up|3
4401627|NCT00144300|7179132|FG001|Overall Study|Lost to Follow-up|0
4401628|NCT00144300|7179131|FG000|Overall Study|Withdrawal by Subject|6
4401629|NCT00144300|7179132|FG001|Overall Study|Withdrawal by Subject|6
4401630|NCT00144300|7179131|FG000|Overall Study|Other reason (not specified)|1
4401631|NCT00144300|7179132|FG001|Overall Study|Other reason (not specified)|3
4401632|NCT00144339|7179140|FG000|Overall Study|Adverse Event|746
4401633|NCT00144339|7179141|FG001|Overall Study|Adverse Event|627
4401634|NCT00144339|7179140|FG000|Overall Study|Protocol Violation|75
4401635|NCT00144339|7179141|FG001|Overall Study|Protocol Violation|48
4401636|NCT00144339|7179140|FG000|Overall Study|Withdrawal by Subject|403
4401637|NCT00144339|7179141|FG001|Overall Study|Withdrawal by Subject|300
4401638|NCT00144339|7179140|FG000|Overall Study|Lost to Follow-up|76
4401639|NCT00144339|7179141|FG001|Overall Study|Lost to Follow-up|64
4401640|NCT00144339|7179140|FG000|Overall Study|Other|58
4401641|NCT00144339|7179141|FG001|Overall Study|Other|60
4401642|NCT00144781|7179160|FG000|Overall Study|Adverse Event|0
4401643|NCT00144781|7179161|FG001|Overall Study|Adverse Event|1
4401644|NCT00144781|7179162|FG002|Overall Study|Adverse Event|0
4401645|NCT00144781|7179163|FG003|Overall Study|Adverse Event|0
4401646|NCT00144781|7179160|FG000|Overall Study|Non-compliant|0
4401647|NCT00144781|7179161|FG001|Overall Study|Non-compliant|1
4401648|NCT00144781|7179162|FG002|Overall Study|Non-compliant|0
4401649|NCT00144781|7179163|FG003|Overall Study|Non-compliant|0
4401650|NCT00145119|7179181|FG000|Overall Study|Death|45
4401651|NCT00145327|7179205|FG000|Overall Study|Withdrawal by Subject|77
4401652|NCT00145327|7179206|FG001|Overall Study|Withdrawal by Subject|72
4401653|NCT00145327|7179207|FG002|Overall Study|Withdrawal by Subject|164
4401654|NCT00145327|7179205|FG000|Overall Study|Death|26
4401655|NCT00145327|7179206|FG001|Overall Study|Death|18
4401656|NCT00145327|7179207|FG002|Overall Study|Death|30
4401657|NCT00145327|7179205|FG000|Overall Study|Adverse Event|14
4401658|NCT00145327|7179206|FG001|Overall Study|Adverse Event|11
4401659|NCT00145327|7179207|FG002|Overall Study|Adverse Event|22
4401660|NCT00145327|7179205|FG000|Overall Study|Lost to Follow-up|9
4713345|NCT02943564|7640767|FG000|Overall Study|Protocol Violation|2
4401661|NCT00145327|7179206|FG001|Overall Study|Lost to Follow-up|14
4401662|NCT00145327|7179207|FG002|Overall Study|Lost to Follow-up|14
4401663|NCT00145327|7179205|FG000|Overall Study|Administrative problems|12
4401664|NCT00145327|7179206|FG001|Overall Study|Administrative problems|9
4401665|NCT00145327|7179207|FG002|Overall Study|Administrative problems|13
4401666|NCT00145327|7179205|FG000|Overall Study|Protocol Violation|2
4401667|NCT00145327|7179206|FG001|Overall Study|Protocol Violation|0
4401668|NCT00145327|7179207|FG002|Overall Study|Protocol Violation|2
4401669|NCT00145327|7179205|FG000|Overall Study|Abnormal laboratory value(s)|1
4401670|NCT00145327|7179206|FG001|Overall Study|Abnormal laboratory value(s)|0
4401671|NCT00145327|7179207|FG002|Overall Study|Abnormal laboratory value(s)|2
4401672|NCT00145327|7179205|FG000|Overall Study|Missing - not stated|1
4401673|NCT00145327|7179206|FG001|Overall Study|Missing - not stated|0
4401674|NCT00145327|7179207|FG002|Overall Study|Missing - not stated|1
4401675|NCT00145574|7179222|FG000|Double Blind|Adverse Event|0
4401676|NCT00145574|7179223|FG001|Double Blind|Adverse Event|3
4401677|NCT00145574|7179224|FG002|Double Blind|Adverse Event|1
4401678|NCT00145574|7179222|FG000|Double Blind|Withdrawal by Subject|1
4401679|NCT00145574|7179223|FG001|Double Blind|Withdrawal by Subject|1
4401680|NCT00145574|7179224|FG002|Double Blind|Withdrawal by Subject|1
4401681|NCT00145574|7179222|FG000|Double Blind|required restricted medicine|0
4401682|NCT00145574|7179223|FG001|Double Blind|required restricted medicine|1
4401683|NCT00145574|7179224|FG002|Double Blind|required restricted medicine|0
4401684|NCT00145574|7179222|FG000|Open Label Long-term Extension|Adverse Event|0
4511027|NCT00923091|7319700|FG001|Period VI (Open-Label)|Lost to Follow-up|0
4401685|NCT00145574|7179223|FG001|Open Label Long-term Extension|Adverse Event|0
4401686|NCT00145574|7179224|FG002|Open Label Long-term Extension|Adverse Event|5
4401687|NCT00145574|7179222|FG000|Open Label Long-term Extension|Lost to Follow-up|0
4401688|NCT00145574|7179223|FG001|Open Label Long-term Extension|Lost to Follow-up|0
4401689|NCT00145574|7179224|FG002|Open Label Long-term Extension|Lost to Follow-up|1
4401690|NCT00145574|7179222|FG000|Open Label Long-term Extension|Withdrawal by Subject|0
4401691|NCT00145574|7179223|FG001|Open Label Long-term Extension|Withdrawal by Subject|0
4401692|NCT00145574|7179224|FG002|Open Label Long-term Extension|Withdrawal by Subject|4
4401693|NCT00145574|7179222|FG000|Open Label Long-term Extension|required restricted medicine|0
4401694|NCT00145574|7179223|FG001|Open Label Long-term Extension|required restricted medicine|0
4401695|NCT00145574|7179224|FG002|Open Label Long-term Extension|required restricted medicine|1
4511028|NCT00923091|7319701|FG002|Period VI (Open-Label)|Lost to Follow-up|1
4511029|NCT00923091|7319702|FG003|Period VI (Open-Label)|Lost to Follow-up|0
4511030|NCT00923091|7319703|FG004|Period VI (Open-Label)|Lost to Follow-up|0
4511031|NCT00923091|7319704|FG005|Period VI (Open-Label)|Lost to Follow-up|0
4511032|NCT00923091|7319705|FG006|Period VI (Open-Label)|Lost to Follow-up|0
4511033|NCT00923091|7319706|FG007|Period VI (Open-Label)|Lost to Follow-up|0
4511034|NCT00923091|7319707|FG008|Period VI (Open-Label)|Lost to Follow-up|0
4511035|NCT00923091|7319708|FG009|Period VI (Open-Label)|Lost to Follow-up|0
4511036|NCT00923091|7319709|FG010|Period VI (Open-Label)|Lost to Follow-up|0
4511037|NCT00923091|7319710|FG011|Period VI (Open-Label)|Lost to Follow-up|0
4511038|NCT00923091|7319711|FG012|Period VI (Open-Label)|Lost to Follow-up|0
4511039|NCT00923091|7319699|FG000|Period VI (Open-Label)|Other Reason|0
4511040|NCT00923091|7319700|FG001|Period VI (Open-Label)|Other Reason|0
4511041|NCT00923091|7319701|FG002|Period VI (Open-Label)|Other Reason|0
4511042|NCT00923091|7319702|FG003|Period VI (Open-Label)|Other Reason|1
4511043|NCT00923091|7319703|FG004|Period VI (Open-Label)|Other Reason|1
4511044|NCT00923091|7319704|FG005|Period VI (Open-Label)|Other Reason|0
4511045|NCT00923091|7319705|FG006|Period VI (Open-Label)|Other Reason|0
4511046|NCT00923091|7319706|FG007|Period VI (Open-Label)|Other Reason|0
4511047|NCT00923091|7319707|FG008|Period VI (Open-Label)|Other Reason|0
4511048|NCT00923091|7319708|FG009|Period VI (Open-Label)|Other Reason|0
4511049|NCT00923091|7319709|FG010|Period VI (Open-Label)|Other Reason|0
4511050|NCT00923091|7319710|FG011|Period VI (Open-Label)|Other Reason|0
4511051|NCT00923091|7319711|FG012|Period VI (Open-Label)|Other Reason|0
4511052|NCT00923130|7319745|FG000|Overall Study|Stopped treatment due to progression|17
4511053|NCT00923130|7319745|FG000|Overall Study|Death|1
4511054|NCT00923130|7319745|FG000|Overall Study|Discontinued treatment due to toxicities|3
4511055|NCT00923130|7319745|FG000|Overall Study|Switched to alternative treatment|2
4511056|NCT00923130|7319745|FG000|Overall Study|Refused further treatment|2
4511057|NCT00923156|7319752|FG000|Overall Study|Adverse Event|0
4511058|NCT00923156|7319753|FG001|Overall Study|Adverse Event|2
4511059|NCT00923156|7319754|FG002|Overall Study|Adverse Event|1
4511060|NCT00923156|7319752|FG000|Overall Study|Abnormal laboratory values|0
4511061|NCT00923156|7319753|FG001|Overall Study|Abnormal laboratory values|0
4511062|NCT00923156|7319754|FG002|Overall Study|Abnormal laboratory values|1
4511063|NCT00923156|7319752|FG000|Overall Study|Withdrawal by Subject|0
4511064|NCT00923156|7319753|FG001|Overall Study|Withdrawal by Subject|1
4511065|NCT00923156|7319754|FG002|Overall Study|Withdrawal by Subject|0
4511066|NCT00923156|7319752|FG000|Overall Study|Death|0
4511067|NCT00923156|7319753|FG001|Overall Study|Death|1
4511068|NCT00923156|7319754|FG002|Overall Study|Death|0
4511069|NCT00923156|7319752|FG000|Overall Study|Lack of Efficacy|0
4511070|NCT00923156|7319753|FG001|Overall Study|Lack of Efficacy|0
4511071|NCT00923156|7319754|FG002|Overall Study|Lack of Efficacy|1
4511072|NCT00923195|7319764|FG000|Overall Study|Death|0
4511073|NCT00923195|7319765|FG001|Overall Study|Death|1
4511074|NCT00923260|7319773|FG000|Overall Study|Lost to Follow-up|1
4511075|NCT00923260|7319774|FG001|Overall Study|Lost to Follow-up|1
4511076|NCT00923273|7319785|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
4511077|NCT00923273|7319786|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
4511078|NCT00923273|7319787|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
4511079|NCT00923273|7319788|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1
4511080|NCT00923273|7319789|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
4511081|NCT00923273|7319785|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
4511082|NCT00923273|7319786|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
4511083|NCT00923273|7319787|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
4511084|NCT00923273|7319788|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6
4511085|NCT00923273|7319789|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
4511086|NCT00923351|7319809|FG000|Overall Study|no apheresis/adequate tumor sample|0
4511087|NCT00923351|7319810|FG001|Overall Study|no apheresis/adequate tumor sample|0
4511088|NCT00923351|7319811|FG002|Overall Study|no apheresis/adequate tumor sample|12
4511089|NCT00923364|7319817|FG000|Overall Study|Death|3
4511090|NCT00923364|7319818|FG001|Overall Study|Death|0
4511091|NCT00923364|7319817|FG000|Overall Study|Did not go to transplant|1
4511092|NCT00923364|7319818|FG001|Overall Study|Did not go to transplant|0
4511093|NCT00923559|7319829|FG000|Overall Study|Lost to Follow-up|2
4401696|NCT00145600|7179250|FG000|Overall Study|Death|1
4401697|NCT00145600|7179251|FG001|Overall Study|Death|2
4401698|NCT00145600|7179252|FG002|Overall Study|Death|2
4401699|NCT00145600|7179253|FG003|Overall Study|Death|6
4401700|NCT00145600|7179250|FG000|Overall Study|Ineligible|3
4401701|NCT00145600|7179251|FG001|Overall Study|Ineligible|0
4401702|NCT00145600|7179252|FG002|Overall Study|Ineligible|1
4401703|NCT00145600|7179253|FG003|Overall Study|Ineligible|5
4401704|NCT00145600|7179250|FG000|Overall Study|Lost to Follow-up|2
4401705|NCT00145600|7179251|FG001|Overall Study|Lost to Follow-up|6
4401706|NCT00145600|7179252|FG002|Overall Study|Lost to Follow-up|2
4401707|NCT00145600|7179253|FG003|Overall Study|Lost to Follow-up|4
4401708|NCT00145600|7179250|FG000|Overall Study|Noncompliance|1
4401709|NCT00145600|7179251|FG001|Overall Study|Noncompliance|0
4401710|NCT00145600|7179252|FG002|Overall Study|Noncompliance|0
4401711|NCT00145600|7179253|FG003|Overall Study|Noncompliance|0
4401712|NCT00145600|7179250|FG000|Overall Study|Withdrawal by Subject|1
4401713|NCT00145600|7179251|FG001|Overall Study|Withdrawal by Subject|2
4401714|NCT00145600|7179252|FG002|Overall Study|Withdrawal by Subject|0
4401715|NCT00145600|7179253|FG003|Overall Study|Withdrawal by Subject|1
4401716|NCT00145626|7179279|FG000|Overall Study|Did not have NK infusions|2
4401717|NCT00145626|7179279|FG000|Overall Study|Turned 2 years old before treatment|1
4401718|NCT00145626|7179279|FG000|Overall Study|Death|1
4401719|NCT00145626|7179279|FG000|Overall Study|Withdrawal by Subject|1
4401720|NCT00145795|7179301|FG000|Overall Study|Adverse Event|1
4401721|NCT00145795|7179302|FG001|Overall Study|Adverse Event|0
4401722|NCT00145977|7179310|FG000|Overall Study|Lack of Efficacy|0
4401723|NCT00145977|7179311|FG001|Overall Study|Lack of Efficacy|4
4401724|NCT00145977|7179310|FG000|Overall Study|Lost to Follow-up|1
4401725|NCT00145977|7179311|FG001|Overall Study|Lost to Follow-up|0
4401726|NCT00145977|7179310|FG000|Overall Study|Withdrawal by Subject|1
4401727|NCT00145977|7179311|FG001|Overall Study|Withdrawal by Subject|0
4401728|NCT00146172|7179325|FG000|Overall Study|Adverse Event|0
4401729|NCT00146172|7179326|FG001|Overall Study|Adverse Event|0
4401730|NCT00146172|7179327|FG002|Overall Study|Adverse Event|1
4401731|NCT00146172|7179328|FG003|Overall Study|Adverse Event|1
4401732|NCT00146172|7179329|FG004|Overall Study|Adverse Event|0
4401733|NCT00146172|7179330|FG005|Overall Study|Adverse Event|2
4401734|NCT00146172|7179331|FG006|Overall Study|Adverse Event|3
4401735|NCT00146172|7179332|FG007|Overall Study|Adverse Event|10
4401736|NCT00146172|7179325|FG000|Overall Study|Lost to Follow-up|0
4401737|NCT00146172|7179326|FG001|Overall Study|Lost to Follow-up|0
4401738|NCT00146172|7179327|FG002|Overall Study|Lost to Follow-up|0
4401739|NCT00146172|7179328|FG003|Overall Study|Lost to Follow-up|0
4401740|NCT00146172|7179329|FG004|Overall Study|Lost to Follow-up|0
4401741|NCT00146172|7179330|FG005|Overall Study|Lost to Follow-up|0
4401742|NCT00146172|7179331|FG006|Overall Study|Lost to Follow-up|0
4401743|NCT00146172|7179332|FG007|Overall Study|Lost to Follow-up|1
4401744|NCT00146172|7179325|FG000|Overall Study|Disease Progression|2
4401745|NCT00146172|7179326|FG001|Overall Study|Disease Progression|4
4401746|NCT00146172|7179327|FG002|Overall Study|Disease Progression|2
4401747|NCT00146172|7179328|FG003|Overall Study|Disease Progression|5
4401748|NCT00146172|7179329|FG004|Overall Study|Disease Progression|2
4401749|NCT00146172|7179330|FG005|Overall Study|Disease Progression|2
4401750|NCT00146172|7179331|FG006|Overall Study|Disease Progression|1
4401751|NCT00146172|7179332|FG007|Overall Study|Disease Progression|22
4401752|NCT00146172|7179325|FG000|Overall Study|Death|0
4401753|NCT00146172|7179326|FG001|Overall Study|Death|0
4401754|NCT00146172|7179327|FG002|Overall Study|Death|0
4401755|NCT00146172|7179328|FG003|Overall Study|Death|0
4401756|NCT00146172|7179329|FG004|Overall Study|Death|0
4401757|NCT00146172|7179330|FG005|Overall Study|Death|0
4401758|NCT00146172|7179331|FG006|Overall Study|Death|1
4401759|NCT00146172|7179332|FG007|Overall Study|Death|0
4401760|NCT00146172|7179325|FG000|Overall Study|Physician Decision|0
4401761|NCT00146172|7179326|FG001|Overall Study|Physician Decision|0
4401762|NCT00146172|7179327|FG002|Overall Study|Physician Decision|0
4401763|NCT00146172|7179328|FG003|Overall Study|Physician Decision|0
4401764|NCT00146172|7179329|FG004|Overall Study|Physician Decision|0
4401765|NCT00146172|7179330|FG005|Overall Study|Physician Decision|0
4401766|NCT00146172|7179331|FG006|Overall Study|Physician Decision|0
4401767|NCT00146172|7179332|FG007|Overall Study|Physician Decision|1
4401768|NCT00146172|7179325|FG000|Overall Study|Withdrawal by Subject|0
4401769|NCT00146172|7179326|FG001|Overall Study|Withdrawal by Subject|0
4401770|NCT00146172|7179327|FG002|Overall Study|Withdrawal by Subject|0
4401771|NCT00146172|7179328|FG003|Overall Study|Withdrawal by Subject|0
4401772|NCT00146172|7179329|FG004|Overall Study|Withdrawal by Subject|0
4401773|NCT00146172|7179330|FG005|Overall Study|Withdrawal by Subject|1
4401774|NCT00146172|7179331|FG006|Overall Study|Withdrawal by Subject|1
4401775|NCT00146172|7179332|FG007|Overall Study|Withdrawal by Subject|4
4401776|NCT00146172|7179325|FG000|Overall Study|Symptomatic Deterioration|1
4401777|NCT00146172|7179326|FG001|Overall Study|Symptomatic Deterioration|0
4401778|NCT00146172|7179327|FG002|Overall Study|Symptomatic Deterioration|1
4401779|NCT00146172|7179328|FG003|Overall Study|Symptomatic Deterioration|0
4401780|NCT00146172|7179329|FG004|Overall Study|Symptomatic Deterioration|1
4401781|NCT00146172|7179330|FG005|Overall Study|Symptomatic Deterioration|2
4401782|NCT00146172|7179331|FG006|Overall Study|Symptomatic Deterioration|0
4401783|NCT00146172|7179332|FG007|Overall Study|Symptomatic Deterioration|2
4401784|NCT00146328|7179361|FG000|Overall Study|Adverse Event|39
4401785|NCT00146328|7179362|FG001|Overall Study|Adverse Event|48
4401786|NCT00146328|7179363|FG002|Overall Study|Adverse Event|79
4401787|NCT00146328|7179361|FG000|Overall Study|Protocol Violation|11
4401788|NCT00146328|7179362|FG001|Overall Study|Protocol Violation|6
4401789|NCT00146328|7179363|FG002|Overall Study|Protocol Violation|12
4401790|NCT00146328|7179361|FG000|Overall Study|Lost to Follow-up|7
4401791|NCT00146328|7179362|FG001|Overall Study|Lost to Follow-up|4
4401792|NCT00146328|7179363|FG002|Overall Study|Lost to Follow-up|7
4401793|NCT00146328|7179361|FG000|Overall Study|Withdrawal by Subject|16
4401794|NCT00146328|7179362|FG001|Overall Study|Withdrawal by Subject|16
4401795|NCT00146328|7179363|FG002|Overall Study|Withdrawal by Subject|22
4401796|NCT00146328|7179361|FG000|Overall Study|Virologic Failure/lack of efficacy|54
4401797|NCT00146328|7179362|FG001|Overall Study|Virologic Failure/lack of efficacy|72
4401798|NCT00146328|7179363|FG002|Overall Study|Virologic Failure/lack of efficacy|142
4401799|NCT00146328|7179361|FG000|Overall Study|Trial ended/site closed|8
4401800|NCT00146328|7179362|FG001|Overall Study|Trial ended/site closed|2
4401801|NCT00146328|7179363|FG002|Overall Study|Trial ended/site closed|19
4401802|NCT00146328|7179361|FG000|Overall Study|Patient decision to end|0
4401803|NCT00146328|7179362|FG001|Overall Study|Patient decision to end|1
4401804|NCT00146328|7179363|FG002|Overall Study|Patient decision to end|6
4401805|NCT00146328|7179361|FG000|Overall Study|Enroll into other trial|2
4401806|NCT00146328|7179362|FG001|Overall Study|Enroll into other trial|4
4401807|NCT00146328|7179363|FG002|Overall Study|Enroll into other trial|2
4401808|NCT00146328|7179361|FG000|Overall Study|Death|0
4401809|NCT00146328|7179362|FG001|Overall Study|Death|1
4401810|NCT00146328|7179363|FG002|Overall Study|Death|1
4401811|NCT00146328|7179361|FG000|Overall Study|Moved|2
4401812|NCT00146328|7179362|FG001|Overall Study|Moved|0
4401813|NCT00146328|7179363|FG002|Overall Study|Moved|0
4401814|NCT00146328|7179361|FG000|Overall Study|Interaction with other medication|2
4401815|NCT00146328|7179362|FG001|Overall Study|Interaction with other medication|0
4401816|NCT00146328|7179363|FG002|Overall Study|Interaction with other medication|1
4401817|NCT00146640|7179373|FG000|Overall Study|Adverse Event|12
4401818|NCT00146640|7179374|FG001|Overall Study|Adverse Event|10
4401819|NCT00146640|7179373|FG000|Overall Study|Medical Reasons|3
4401820|NCT00146640|7179374|FG001|Overall Study|Medical Reasons|0
4401821|NCT00146640|7179373|FG000|Overall Study|Non-Medical Reasons|8
4401822|NCT00146640|7179374|FG001|Overall Study|Non-Medical Reasons|4
4401823|NCT00146757|7179380|FG000|Overall Study|Death|1
4401824|NCT00146757|7179381|FG001|Overall Study|Death|0
4401825|NCT00146757|7179380|FG000|Overall Study|Adverse Event|1
4401826|NCT00146757|7179381|FG001|Overall Study|Adverse Event|0
4401827|NCT00146770|7179389|FG000|Overall Study|Adverse Event|2
4401828|NCT00146770|7179390|FG001|Overall Study|Adverse Event|0
4401829|NCT00146770|7179389|FG000|Overall Study|Pregnancy|1
4401830|NCT00146770|7179390|FG001|Overall Study|Pregnancy|0
4401831|NCT00146770|7179389|FG000|Overall Study|Withdrawal by Subject|2
4401832|NCT00146770|7179390|FG001|Overall Study|Withdrawal by Subject|0
4401833|NCT00146848|7179399|FG000|Pre-randomization|Death|19
4401834|NCT00146848|7179400|FG001|Pre-randomization|Death|0
4401835|NCT00146848|7179401|FG002|Pre-randomization|Death|0
4401836|NCT00146848|7179399|FG000|Pre-randomization|Lost to Follow-up|70
4401837|NCT00146848|7179400|FG001|Pre-randomization|Lost to Follow-up|0
4401838|NCT00146848|7179401|FG002|Pre-randomization|Lost to Follow-up|0
4401839|NCT00146848|7179399|FG000|Pre-randomization|Physician Decision|8
4401840|NCT00146848|7179400|FG001|Pre-randomization|Physician Decision|0
4401841|NCT00146848|7179401|FG002|Pre-randomization|Physician Decision|0
4401842|NCT00146848|7179399|FG000|Pre-randomization|Protocol Violation|172
4401843|NCT00146848|7179400|FG001|Pre-randomization|Protocol Violation|0
4401844|NCT00146848|7179401|FG002|Pre-randomization|Protocol Violation|0
4401845|NCT00146848|7179399|FG000|Pre-randomization|Withdrawal by Subject|40
4401846|NCT00146848|7179400|FG001|Pre-randomization|Withdrawal by Subject|0
4401847|NCT00146848|7179401|FG002|Pre-randomization|Withdrawal by Subject|0
4401848|NCT00146848|7179399|FG000|Post-randomization|Lost to Follow-up|12
4401849|NCT00146848|7179400|FG001|Post-randomization|Lost to Follow-up|15
4401850|NCT00146848|7179401|FG002|Post-randomization|Lost to Follow-up|12
4401851|NCT00146848|7179399|FG000|Post-randomization|Withdrawn|26
4401852|NCT00146848|7179400|FG001|Post-randomization|Withdrawn|32
4401853|NCT00146848|7179401|FG002|Post-randomization|Withdrawn|27
4401854|NCT00147225|7179487|FG000|Overall Study|Withdrawal by Subject|1
4401855|NCT00147225|7179488|FG001|Overall Study|Withdrawal by Subject|0
4401856|NCT00147225|7179489|FG002|Overall Study|Withdrawal by Subject|1
4401857|NCT00147225|7179490|FG003|Overall Study|Withdrawal by Subject|0
4401858|NCT00147225|7179491|FG004|Overall Study|Withdrawal by Subject|0
4401859|NCT00147225|7179492|FG005|Overall Study|Withdrawal by Subject|1
4401860|NCT00147225|7179487|FG000|Overall Study|Adverse Event|0
4401861|NCT00147225|7179488|FG001|Overall Study|Adverse Event|0
4401862|NCT00147225|7179489|FG002|Overall Study|Adverse Event|1
4401863|NCT00147225|7179490|FG003|Overall Study|Adverse Event|1
4401864|NCT00147225|7179491|FG004|Overall Study|Adverse Event|0
4401865|NCT00147225|7179492|FG005|Overall Study|Adverse Event|0
4401866|NCT00147225|7179487|FG000|Overall Study|Screen Failure|0
4401867|NCT00147225|7179488|FG001|Overall Study|Screen Failure|0
4401868|NCT00147225|7179489|FG002|Overall Study|Screen Failure|0
4401869|NCT00147225|7179490|FG003|Overall Study|Screen Failure|0
4401870|NCT00147225|7179491|FG004|Overall Study|Screen Failure|1
4401871|NCT00147225|7179492|FG005|Overall Study|Screen Failure|0
4401872|NCT00147225|7179487|FG000|Overall Study|Chemotherapy Changed|0
4401873|NCT00147225|7179488|FG001|Overall Study|Chemotherapy Changed|0
4401874|NCT00147225|7179489|FG002|Overall Study|Chemotherapy Changed|0
4401875|NCT00147225|7179490|FG003|Overall Study|Chemotherapy Changed|0
4401876|NCT00147225|7179491|FG004|Overall Study|Chemotherapy Changed|0
4401877|NCT00147225|7179492|FG005|Overall Study|Chemotherapy Changed|1
4401878|NCT00147251|7179508|FG000|Recruitment and Enrollment|change in treatment guidelines|24
4401879|NCT00147251|7179509|FG001|Recruitment and Enrollment|change in treatment guidelines|25
4401880|NCT00147498|7179536|FG000|Overall Study|Adverse Event|1
4401881|NCT00147498|7179537|FG001|Overall Study|Adverse Event|6
4401882|NCT00147498|7179538|FG002|Overall Study|Adverse Event|7
4401883|NCT00147498|7179539|FG003|Overall Study|Adverse Event|3
4401884|NCT00147498|7179536|FG000|Overall Study|Lack of Efficacy|1
4401885|NCT00147498|7179537|FG001|Overall Study|Lack of Efficacy|1
4401886|NCT00147498|7179538|FG002|Overall Study|Lack of Efficacy|1
4401887|NCT00147498|7179539|FG003|Overall Study|Lack of Efficacy|8
4401888|NCT00147498|7179536|FG000|Overall Study|Laboratory abnormality|0
4401889|NCT00147498|7179537|FG001|Overall Study|Laboratory abnormality|0
4401890|NCT00147498|7179538|FG002|Overall Study|Laboratory abnormality|2
4401891|NCT00147498|7179539|FG003|Overall Study|Laboratory abnormality|0
4401892|NCT00147498|7179536|FG000|Overall Study|Participant defaulted|0
4401893|NCT00147498|7179537|FG001|Overall Study|Participant defaulted|1
4401894|NCT00147498|7179538|FG002|Overall Study|Participant defaulted|4
4401895|NCT00147498|7179539|FG003|Overall Study|Participant defaulted|3
4401896|NCT00147498|7179536|FG000|Overall Study|Other|1
4401897|NCT00147498|7179537|FG001|Overall Study|Other|1
4401898|NCT00147498|7179538|FG002|Overall Study|Other|3
4401899|NCT00147498|7179539|FG003|Overall Study|Other|3
4401900|NCT00147537|7179553|FG000|Phase 1b|Death|0
4401901|NCT00147537|7179554|FG001|Phase 1b|Death|1
4401902|NCT00147537|7179555|FG002|Phase 1b|Death|2
4401903|NCT00147537|7179556|FG003|Phase 1b|Death|1
4401904|NCT00147537|7179557|FG004|Phase 1b|Death|2
4401905|NCT00147537|7179558|FG005|Phase 1b|Death|2
4401906|NCT00147537|7179559|FG006|Phase 1b|Death|1
4401907|NCT00147537|7179560|FG007|Phase 1b|Death|3
4401908|NCT00147537|7179561|FG008|Phase 1b|Death|9
4401909|NCT00147537|7179562|FG009|Phase 1b|Death|0
4401910|NCT00147537|7179563|FG010|Phase 1b|Death|0
4401911|NCT00147537|7179553|FG000|Phase 1b|Lost to Follow-up|2
4401912|NCT00147537|7179554|FG001|Phase 1b|Lost to Follow-up|1
4401913|NCT00147537|7179555|FG002|Phase 1b|Lost to Follow-up|0
4401914|NCT00147537|7179556|FG003|Phase 1b|Lost to Follow-up|0
4401915|NCT00147537|7179557|FG004|Phase 1b|Lost to Follow-up|0
4401916|NCT00147537|7179558|FG005|Phase 1b|Lost to Follow-up|0
4401917|NCT00147537|7179559|FG006|Phase 1b|Lost to Follow-up|2
4401918|NCT00147537|7179560|FG007|Phase 1b|Lost to Follow-up|0
4401919|NCT00147537|7179561|FG008|Phase 1b|Lost to Follow-up|1
4401920|NCT00147537|7179562|FG009|Phase 1b|Lost to Follow-up|0
4401921|NCT00147537|7179563|FG010|Phase 1b|Lost to Follow-up|0
4401922|NCT00147537|7179553|FG000|Phase 1b|Other|0
4401923|NCT00147537|7179554|FG001|Phase 1b|Other|0
4401924|NCT00147537|7179555|FG002|Phase 1b|Other|2
4401925|NCT00147537|7179556|FG003|Phase 1b|Other|1
4401926|NCT00147537|7179557|FG004|Phase 1b|Other|1
4401927|NCT00147537|7179558|FG005|Phase 1b|Other|1
4401928|NCT00147537|7179559|FG006|Phase 1b|Other|14
4401929|NCT00147537|7179560|FG007|Phase 1b|Other|4
4401930|NCT00147537|7179561|FG008|Phase 1b|Other|4
4401931|NCT00147537|7179562|FG009|Phase 1b|Other|0
4401932|NCT00147537|7179563|FG010|Phase 1b|Other|0
4401933|NCT00147537|7179553|FG000|Phase 1b|Withdrawal by Subject|0
4401934|NCT00147537|7179554|FG001|Phase 1b|Withdrawal by Subject|0
4401935|NCT00147537|7179555|FG002|Phase 1b|Withdrawal by Subject|0
4401936|NCT00147537|7179556|FG003|Phase 1b|Withdrawal by Subject|0
4401937|NCT00147537|7179557|FG004|Phase 1b|Withdrawal by Subject|0
4401938|NCT00147537|7179558|FG005|Phase 1b|Withdrawal by Subject|0
4401939|NCT00147537|7179559|FG006|Phase 1b|Withdrawal by Subject|0
4401940|NCT00147537|7179560|FG007|Phase 1b|Withdrawal by Subject|0
4401941|NCT00147537|7179561|FG008|Phase 1b|Withdrawal by Subject|2
4401942|NCT00147537|7179562|FG009|Phase 1b|Withdrawal by Subject|0
4401943|NCT00147537|7179563|FG010|Phase 1b|Withdrawal by Subject|0
4401944|NCT00147537|7179553|FG000|Phase 1b|Randomized but not treated|0
4401945|NCT00147537|7179554|FG001|Phase 1b|Randomized but not treated|0
4401946|NCT00147537|7179555|FG002|Phase 1b|Randomized but not treated|0
4401947|NCT00147537|7179556|FG003|Phase 1b|Randomized but not treated|0
4401948|NCT00147537|7179557|FG004|Phase 1b|Randomized but not treated|0
4401949|NCT00147537|7179558|FG005|Phase 1b|Randomized but not treated|0
4401950|NCT00147537|7179559|FG006|Phase 1b|Randomized but not treated|1
4401951|NCT00147537|7179560|FG007|Phase 1b|Randomized but not treated|0
4401952|NCT00147537|7179561|FG008|Phase 1b|Randomized but not treated|1
4401953|NCT00147537|7179562|FG009|Phase 1b|Randomized but not treated|0
4401954|NCT00147537|7179563|FG010|Phase 1b|Randomized but not treated|0
4401955|NCT00147537|7179553|FG000|Phase 2|Death|0
4401956|NCT00147537|7179554|FG001|Phase 2|Death|0
4401957|NCT00147537|7179555|FG002|Phase 2|Death|0
4401958|NCT00147537|7179556|FG003|Phase 2|Death|0
4401959|NCT00147537|7179557|FG004|Phase 2|Death|0
4401960|NCT00147537|7179558|FG005|Phase 2|Death|0
4401961|NCT00147537|7179559|FG006|Phase 2|Death|0
4401962|NCT00147537|7179560|FG007|Phase 2|Death|0
4401963|NCT00147537|7179561|FG008|Phase 2|Death|0
4401964|NCT00147537|7179562|FG009|Phase 2|Death|85
4401965|NCT00147537|7179563|FG010|Phase 2|Death|31
4401966|NCT00147537|7179553|FG000|Phase 2|Lost to Follow-up|0
4401967|NCT00147537|7179554|FG001|Phase 2|Lost to Follow-up|0
4401968|NCT00147537|7179555|FG002|Phase 2|Lost to Follow-up|0
4401969|NCT00147537|7179556|FG003|Phase 2|Lost to Follow-up|0
4401970|NCT00147537|7179557|FG004|Phase 2|Lost to Follow-up|0
4401971|NCT00147537|7179558|FG005|Phase 2|Lost to Follow-up|0
4401972|NCT00147537|7179559|FG006|Phase 2|Lost to Follow-up|0
4401973|NCT00147537|7179560|FG007|Phase 2|Lost to Follow-up|0
4401974|NCT00147537|7179561|FG008|Phase 2|Lost to Follow-up|0
4401975|NCT00147537|7179562|FG009|Phase 2|Lost to Follow-up|12
4401976|NCT00147537|7179563|FG010|Phase 2|Lost to Follow-up|4
4401977|NCT00147537|7179553|FG000|Phase 2|Other|0
4401978|NCT00147537|7179554|FG001|Phase 2|Other|0
4401979|NCT00147537|7179555|FG002|Phase 2|Other|0
4401980|NCT00147537|7179556|FG003|Phase 2|Other|0
4401981|NCT00147537|7179557|FG004|Phase 2|Other|0
4401982|NCT00147537|7179558|FG005|Phase 2|Other|0
4401983|NCT00147537|7179559|FG006|Phase 2|Other|0
4401984|NCT00147537|7179560|FG007|Phase 2|Other|0
4401985|NCT00147537|7179561|FG008|Phase 2|Other|0
4401986|NCT00147537|7179562|FG009|Phase 2|Other|47
4401987|NCT00147537|7179563|FG010|Phase 2|Other|12
4401988|NCT00147537|7179553|FG000|Phase 2|Withdrawal by Subject|0
4401989|NCT00147537|7179554|FG001|Phase 2|Withdrawal by Subject|0
4401990|NCT00147537|7179555|FG002|Phase 2|Withdrawal by Subject|0
4401991|NCT00147537|7179556|FG003|Phase 2|Withdrawal by Subject|0
4401992|NCT00147537|7179557|FG004|Phase 2|Withdrawal by Subject|0
4401993|NCT00147537|7179558|FG005|Phase 2|Withdrawal by Subject|0
4401994|NCT00147537|7179559|FG006|Phase 2|Withdrawal by Subject|0
4401995|NCT00147537|7179560|FG007|Phase 2|Withdrawal by Subject|0
4401996|NCT00147537|7179561|FG008|Phase 2|Withdrawal by Subject|0
4401997|NCT00147537|7179562|FG009|Phase 2|Withdrawal by Subject|16
4401998|NCT00147537|7179563|FG010|Phase 2|Withdrawal by Subject|4
4401999|NCT00147537|7179553|FG000|Phase 2|Randomized but not treated|0
4402000|NCT00147537|7179554|FG001|Phase 2|Randomized but not treated|0
4402001|NCT00147537|7179555|FG002|Phase 2|Randomized but not treated|0
4402002|NCT00147537|7179556|FG003|Phase 2|Randomized but not treated|0
4402003|NCT00147537|7179557|FG004|Phase 2|Randomized but not treated|0
4402004|NCT00147537|7179558|FG005|Phase 2|Randomized but not treated|0
4402005|NCT00147537|7179559|FG006|Phase 2|Randomized but not treated|0
4402006|NCT00147537|7179560|FG007|Phase 2|Randomized but not treated|0
4402007|NCT00147537|7179561|FG008|Phase 2|Randomized but not treated|0
4402008|NCT00147537|7179562|FG009|Phase 2|Randomized but not treated|1
4402009|NCT00147537|7179563|FG010|Phase 2|Randomized but not treated|1
4402010|NCT00147745|7179611|FG000|Overall Study|Withdrawal by Subject|1
4402011|NCT00147745|7179612|FG001|Overall Study|Withdrawal by Subject|0
4402012|NCT00147745|7179613|FG002|Overall Study|Withdrawal by Subject|0
4402013|NCT00147823|7179623|FG000|Overall Study|Lost to Follow-up|6
4402014|NCT00147823|7179624|FG001|Overall Study|Lost to Follow-up|12
4402015|NCT00147823|7179623|FG000|Overall Study|Physician Decision|1
4402016|NCT00147823|7179624|FG001|Overall Study|Physician Decision|0
4402017|NCT00147823|7179623|FG000|Overall Study|Withdrawal by Subject|0
4402018|NCT00147823|7179624|FG001|Overall Study|Withdrawal by Subject|1
4402019|NCT00147823|7179623|FG000|Overall Study|Did not receive vitoss due to infection|6
4402020|NCT00147823|7179624|FG001|Overall Study|Did not receive vitoss due to infection|2
4402021|NCT00148109|7179636|FG000|Overall Study|Lack of Efficacy|10
4402022|NCT00148109|7179637|FG001|Overall Study|Lack of Efficacy|18
4402023|NCT00148109|7179636|FG000|Overall Study|Adverse Event|0
4402024|NCT00148109|7179637|FG001|Overall Study|Adverse Event|2
4402025|NCT00148109|7179636|FG000|Overall Study|Withdrawal by Subject|2
4402026|NCT00148109|7179637|FG001|Overall Study|Withdrawal by Subject|0
4402027|NCT00148122|7179643|FG000|Overall Study|Withdrawal by Subject|2
4402028|NCT00148317|7179647|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8
4402029|NCT00148317|7179647|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2
4402030|NCT00148317|7179647|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1
4402031|NCT00148343|7179656|FG000|Overall Study|Withdrawal by Subject|12
4402032|NCT00148343|7179657|FG001|Overall Study|Withdrawal by Subject|7
4402033|NCT00148343|7179656|FG000|Overall Study|Physician Decision|3
4402034|NCT00148343|7179657|FG001|Overall Study|Physician Decision|4
4402035|NCT00148759|7179674|FG000|Overall Study|Withdrawal by Subject|1
4402036|NCT00148759|7179675|FG001|Overall Study|Withdrawal by Subject|1
4402037|NCT00148759|7179674|FG000|Overall Study|Lost to Follow-up|1
4402038|NCT00148759|7179675|FG001|Overall Study|Lost to Follow-up|0
4402039|NCT00148941|7179696|FG000|Overall Study|Lost to Follow-up|17
4402040|NCT00148941|7179697|FG001|Overall Study|Lost to Follow-up|24
4628869|NCT01865747|7496333|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7
4628870|NCT01865747|7496332|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82
4402041|NCT00148941|7179698|FG002|Overall Study|Lost to Follow-up|18
4402042|NCT00148941|7179699|FG003|Overall Study|Lost to Follow-up|22
4402043|NCT00148941|7179696|FG000|Overall Study|Withdrawal by Subject|1
4402044|NCT00148941|7179697|FG001|Overall Study|Withdrawal by Subject|0
4628871|NCT01865747|7496333|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92
4628872|NCT01865747|7496332|FG000|Primary Intent to Treat (PITT)|Other|0
4628873|NCT01865747|7496333|FG001|Primary Intent to Treat (PITT)|Other|1
4628874|NCT01865812|7496339|FG000|Overall Study|Adverse Event|2
4628875|NCT01866098|7496346|FG000|Overall Study|Lost to Follow-up|11
4628876|NCT01866098|7496347|FG001|Overall Study|Lost to Follow-up|18
4628877|NCT01866098|7496348|FG002|Overall Study|Lost to Follow-up|13
4628878|NCT01866098|7496346|FG000|Overall Study|Physician Decision|0
4628879|NCT01866098|7496347|FG001|Overall Study|Physician Decision|1
4628880|NCT01866098|7496348|FG002|Overall Study|Physician Decision|2
4628881|NCT01866098|7496346|FG000|Overall Study|Adverse Event|1
4628882|NCT01866098|7496347|FG001|Overall Study|Adverse Event|5
4628883|NCT01866098|7496348|FG002|Overall Study|Adverse Event|4
4628884|NCT01866098|7496346|FG000|Overall Study|Protocol Violation|1
4628885|NCT01866098|7496347|FG001|Overall Study|Protocol Violation|0
4628886|NCT01866098|7496348|FG002|Overall Study|Protocol Violation|0
4628887|NCT01866098|7496346|FG000|Overall Study|Withdrawal by Subject|1
4628888|NCT01866098|7496347|FG001|Overall Study|Withdrawal by Subject|2
4628889|NCT01866098|7496348|FG002|Overall Study|Withdrawal by Subject|0
4628890|NCT01866098|7496346|FG000|Overall Study|Unrelated Hospitalization|2
4628891|NCT01866098|7496347|FG001|Overall Study|Unrelated Hospitalization|0
4628892|NCT01866098|7496348|FG002|Overall Study|Unrelated Hospitalization|1
4402045|NCT00148941|7179698|FG002|Overall Study|Withdrawal by Subject|1
4402046|NCT00148941|7179699|FG003|Overall Study|Withdrawal by Subject|0
4402047|NCT00148941|7179696|FG000|Overall Study|Other|0
4402048|NCT00148941|7179697|FG001|Overall Study|Other|0
4402049|NCT00148941|7179698|FG002|Overall Study|Other|1
4402050|NCT00148941|7179699|FG003|Overall Study|Other|2
4402051|NCT00149214|7179720|FG000|Overall Study|Adverse Event|12
4402052|NCT00149214|7179721|FG001|Overall Study|Adverse Event|9
4402053|NCT00149214|7179720|FG000|Overall Study|Withdrawal by Subject|4
4402054|NCT00149214|7179721|FG001|Overall Study|Withdrawal by Subject|1
4402055|NCT00149214|7179720|FG000|Overall Study|Physician Decision|3
4402056|NCT00149214|7179721|FG001|Overall Study|Physician Decision|3
4402057|NCT00149214|7179720|FG000|Overall Study|Sponsor Decision|0
4402058|NCT00149214|7179721|FG001|Overall Study|Sponsor Decision|1
4402059|NCT00149214|7179720|FG000|Overall Study|Progressive Disease|7
4402060|NCT00149214|7179721|FG001|Overall Study|Progressive Disease|3
4402061|NCT00149396|7179736|FG000|Overall Study|Death|15
4402062|NCT00149396|7179736|FG000|Overall Study|Withdrawal by Subject|1
4511094|NCT00923559|7319830|FG001|Overall Study|Lost to Follow-up|3
4511095|NCT00923845|7319849|FG000|Induction Therapy|Poor performance status|0
4511096|NCT00923845|7319850|FG001|Induction Therapy|Poor performance status|2
4511097|NCT00923936|7319867|FG000|Overall Study|progressive disease on study|2
4511098|NCT00923936|7319868|FG001|Overall Study|progressive disease on study|1
4511099|NCT00923936|7319867|FG000|Overall Study|Adverse Event|2
4511100|NCT00923936|7319868|FG001|Overall Study|Adverse Event|1
4511101|NCT00923936|7319867|FG000|Overall Study|Lost to follow up|2
4511102|NCT00923936|7319868|FG001|Overall Study|Lost to follow up|0
4511103|NCT00923936|7319867|FG000|Overall Study|Continuing in follow up period|2
4511104|NCT00923936|7319868|FG001|Overall Study|Continuing in follow up period|1
4511105|NCT00923975|7319880|FG000|Overall Study|Did not meet inclusion criteria|1
4511106|NCT00924287|7319927|FG000|Overall Study|Death|1
4511107|NCT00924313|7319931|FG000|Overall Study|not imaged due to failed tracer imaging|1
4511108|NCT00924404|7319945|FG000|Overall Study|Lost to Follow-up|6
4511109|NCT00924404|7319946|FG001|Overall Study|Lost to Follow-up|4
4511110|NCT00924443|7319952|FG000|Overall Study|Physician Decision|2
4511111|NCT00924443|7319952|FG000|Overall Study|Protocol Violation|1
4511112|NCT00924469|7319958|FG000|Overall Study|Adverse Event|2
4511113|NCT00924469|7319959|FG001|Overall Study|Adverse Event|0
4511114|NCT00924469|7319958|FG000|Overall Study|Withdrawal by Subject|0
4511115|NCT00924469|7319959|FG001|Overall Study|Withdrawal by Subject|1
4628893|NCT01866098|7496346|FG000|Overall Study|Non-compliance|1
4628894|NCT01866098|7496347|FG001|Overall Study|Non-compliance|0
4628895|NCT01866098|7496348|FG002|Overall Study|Non-compliance|1
4628896|NCT01866098|7496346|FG000|Overall Study|Pregnancy|2
4628897|NCT01866098|7496347|FG001|Overall Study|Pregnancy|0
4628898|NCT01866098|7496348|FG002|Overall Study|Pregnancy|0
4628899|NCT01866098|7496346|FG000|Overall Study|Death|0
4628900|NCT01866098|7496347|FG001|Overall Study|Death|1
4628901|NCT01866098|7496348|FG002|Overall Study|Death|0
4628902|NCT01866293|7496372|FG000|Overall Study|Adverse Event|2
4628903|NCT01866319|7496408|FG000|Overall Study|Adverse Event|12
4628904|NCT01866319|7496409|FG001|Overall Study|Adverse Event|5
4628905|NCT01866319|7496410|FG002|Overall Study|Adverse Event|9
4628906|NCT01866319|7496408|FG000|Overall Study|Clinical progression|3
4511116|NCT00924469|7319958|FG000|Overall Study|Lost to Follow-up|0
4511117|NCT00924469|7319959|FG001|Overall Study|Lost to Follow-up|1
4628907|NCT01866319|7496409|FG001|Overall Study|Clinical progression|2
4628908|NCT01866319|7496410|FG002|Overall Study|Clinical progression|2
4628909|NCT01866319|7496408|FG000|Overall Study|Death|153
4628910|NCT01866319|7496409|FG001|Overall Study|Death|154
4628911|NCT01866319|7496410|FG002|Overall Study|Death|147
4628912|NCT01866319|7496408|FG000|Overall Study|Lost to Follow-up|6
4628913|NCT01866319|7496409|FG001|Overall Study|Lost to Follow-up|3
4628914|NCT01866319|7496410|FG002|Overall Study|Lost to Follow-up|8
4402063|NCT00149396|7179736|FG000|Overall Study|Subject noncompliance|2
4402064|NCT00149396|7179736|FG000|Overall Study|other treatment|5
4402065|NCT00149630|7179749|FG000|Overall Study|Incarceration|2
4402066|NCT00149630|7179750|FG001|Overall Study|Incarceration|0
4402067|NCT00149630|7179749|FG000|Overall Study|Treatment Programs|4
4402068|NCT00149630|7179750|FG001|Overall Study|Treatment Programs|5
4402069|NCT00149630|7179749|FG000|Overall Study|Adverse Event|2
4402070|NCT00149630|7179750|FG001|Overall Study|Adverse Event|0
4402071|NCT00149747|7179789|FG000|Overall Study|Death|1
4402072|NCT00149747|7179790|FG001|Overall Study|Death|0
4402073|NCT00149747|7179789|FG000|Overall Study|Withdrawal by Subject|3
4402074|NCT00149747|7179790|FG001|Overall Study|Withdrawal by Subject|3
4402075|NCT00149825|7179810|FG000|Overall Study|Intolerance to medication side effects|1
4402076|NCT00149825|7179811|FG001|Overall Study|Intolerance to medication side effects|2
4402077|NCT00149825|7179810|FG000|Overall Study|Time commitments|2
4402078|NCT00149825|7179811|FG001|Overall Study|Time commitments|1
4402079|NCT00149825|7179810|FG000|Overall Study|Not liking insomnia therapy|1
4402080|NCT00149825|7179811|FG001|Overall Study|Not liking insomnia therapy|0
4402081|NCT00149825|7179810|FG000|Overall Study|Other|1
4402082|NCT00149825|7179811|FG001|Overall Study|Other|0
4402083|NCT00149890|7179834|FG000|Overall Study|Adverse Event|1
4402084|NCT00149890|7179835|FG001|Overall Study|Adverse Event|8
4402085|NCT00149890|7179834|FG000|Overall Study|Lack of Efficacy|8
4402086|NCT00149890|7179835|FG001|Overall Study|Lack of Efficacy|9
4402087|NCT00149890|7179834|FG000|Overall Study|Protocol Violation|1
4402088|NCT00149890|7179835|FG001|Overall Study|Protocol Violation|0
4402089|NCT00149890|7179834|FG000|Overall Study|Lost to Follow-up|1
4402090|NCT00149890|7179835|FG001|Overall Study|Lost to Follow-up|0
4402091|NCT00149890|7179834|FG000|Overall Study|Graft Loss|2
4402092|NCT00149890|7179835|FG001|Overall Study|Graft Loss|1
4402093|NCT00149994|7179843|FG000|Overall Study|Administrative problems:|1
4402094|NCT00149994|7179844|FG001|Overall Study|Administrative problems:|0
4402095|NCT00149994|7179843|FG000|Overall Study|Protocol Violation|0
4402096|NCT00149994|7179844|FG001|Overall Study|Protocol Violation|1
4402097|NCT00150345|7179852|FG000|Overall Study|Death|5
4402098|NCT00150345|7179853|FG001|Overall Study|Death|2
4402099|NCT00150345|7179852|FG000|Overall Study|Adverse Event|8
4402100|NCT00150345|7179853|FG001|Overall Study|Adverse Event|6
4402101|NCT00150345|7179852|FG000|Overall Study|Lack of Efficacy|5
4402102|NCT00150345|7179853|FG001|Overall Study|Lack of Efficacy|4
4402103|NCT00150345|7179852|FG000|Overall Study|Withdrawal by Subject|3
4402104|NCT00150345|7179853|FG001|Overall Study|Withdrawal by Subject|4
4402105|NCT00150345|7179852|FG000|Overall Study|Laboratory abnormality|1
4402106|NCT00150345|7179853|FG001|Overall Study|Laboratory abnormality|2
4402107|NCT00150345|7179852|FG000|Overall Study|Other|12
4402108|NCT00150345|7179853|FG001|Overall Study|Other|14
4402109|NCT00150462|7179871|FG000|Overall Study|Disease Progression or Relapse|3
4402110|NCT00150462|7179872|FG001|Overall Study|Disease Progression or Relapse|1
4402111|NCT00150462|7179873|FG002|Overall Study|Disease Progression or Relapse|2
4402112|NCT00150462|7179874|FG003|Overall Study|Disease Progression or Relapse|1
4402113|NCT00150462|7179875|FG004|Overall Study|Disease Progression or Relapse|2
4402114|NCT00150462|7179876|FG005|Overall Study|Disease Progression or Relapse|2
4402115|NCT00150462|7179877|FG006|Overall Study|Disease Progression or Relapse|3
4402116|NCT00150462|7179878|FG007|Overall Study|Disease Progression or Relapse|5
4402117|NCT00150462|7179879|FG008|Overall Study|Disease Progression or Relapse|5
4402118|NCT00150462|7179880|FG009|Overall Study|Disease Progression or Relapse|3
4402119|NCT00150462|7179881|FG010|Overall Study|Disease Progression or Relapse|2
4402120|NCT00150462|7179871|FG000|Overall Study|Withdrawal by Subject|0
4402121|NCT00150462|7179872|FG001|Overall Study|Withdrawal by Subject|1
4402122|NCT00150462|7179873|FG002|Overall Study|Withdrawal by Subject|1
4402123|NCT00150462|7179874|FG003|Overall Study|Withdrawal by Subject|0
4402124|NCT00150462|7179875|FG004|Overall Study|Withdrawal by Subject|1
4402125|NCT00150462|7179876|FG005|Overall Study|Withdrawal by Subject|2
4402126|NCT00150462|7179877|FG006|Overall Study|Withdrawal by Subject|0
4402127|NCT00150462|7179878|FG007|Overall Study|Withdrawal by Subject|1
4402128|NCT00150462|7179879|FG008|Overall Study|Withdrawal by Subject|0
4402129|NCT00150462|7179880|FG009|Overall Study|Withdrawal by Subject|1
4402130|NCT00150462|7179881|FG010|Overall Study|Withdrawal by Subject|0
4402131|NCT00150462|7179871|FG000|Overall Study|Death|0
4402132|NCT00150462|7179872|FG001|Overall Study|Death|1
4402133|NCT00150462|7179873|FG002|Overall Study|Death|0
4402134|NCT00150462|7179874|FG003|Overall Study|Death|0
4402135|NCT00150462|7179875|FG004|Overall Study|Death|0
4402136|NCT00150462|7179876|FG005|Overall Study|Death|0
4402137|NCT00150462|7179877|FG006|Overall Study|Death|0
4402138|NCT00150462|7179878|FG007|Overall Study|Death|0
4402139|NCT00150462|7179879|FG008|Overall Study|Death|1
4402140|NCT00150462|7179880|FG009|Overall Study|Death|0
4402141|NCT00150462|7179881|FG010|Overall Study|Death|0
4402142|NCT00150462|7179871|FG000|Overall Study|Adverse Event|0
4402143|NCT00150462|7179872|FG001|Overall Study|Adverse Event|0
4402144|NCT00150462|7179873|FG002|Overall Study|Adverse Event|0
4402145|NCT00150462|7179874|FG003|Overall Study|Adverse Event|1
4402146|NCT00150462|7179875|FG004|Overall Study|Adverse Event|0
4402147|NCT00150462|7179876|FG005|Overall Study|Adverse Event|0
4402148|NCT00150462|7179877|FG006|Overall Study|Adverse Event|0
4402149|NCT00150462|7179878|FG007|Overall Study|Adverse Event|2
4402150|NCT00150462|7179879|FG008|Overall Study|Adverse Event|0
4402151|NCT00150462|7179880|FG009|Overall Study|Adverse Event|1
4402152|NCT00150462|7179881|FG010|Overall Study|Adverse Event|0
4402153|NCT00150462|7179871|FG000|Overall Study|Physician Decision|0
4402154|NCT00150462|7179872|FG001|Overall Study|Physician Decision|0
4402155|NCT00150462|7179873|FG002|Overall Study|Physician Decision|1
4402156|NCT00150462|7179874|FG003|Overall Study|Physician Decision|1
4402157|NCT00150462|7179875|FG004|Overall Study|Physician Decision|0
4402158|NCT00150462|7179876|FG005|Overall Study|Physician Decision|0
4402159|NCT00150462|7179877|FG006|Overall Study|Physician Decision|0
4402160|NCT00150462|7179878|FG007|Overall Study|Physician Decision|0
4402161|NCT00150462|7179879|FG008|Overall Study|Physician Decision|0
4402162|NCT00150462|7179880|FG009|Overall Study|Physician Decision|0
4402163|NCT00150462|7179881|FG010|Overall Study|Physician Decision|0
4402164|NCT00150462|7179871|FG000|Overall Study|Other|0
4402165|NCT00150462|7179872|FG001|Overall Study|Other|0
4402166|NCT00150462|7179873|FG002|Overall Study|Other|0
4402167|NCT00150462|7179874|FG003|Overall Study|Other|0
4402168|NCT00150462|7179875|FG004|Overall Study|Other|0
4402169|NCT00150462|7179876|FG005|Overall Study|Other|0
4402170|NCT00150462|7179877|FG006|Overall Study|Other|0
4402171|NCT00150462|7179878|FG007|Overall Study|Other|0
4402172|NCT00150462|7179879|FG008|Overall Study|Other|0
4402173|NCT00150462|7179880|FG009|Overall Study|Other|1
4402174|NCT00150462|7179881|FG010|Overall Study|Other|1
4402175|NCT00150592|7179910|FG000|Overall Study|Adverse Event|4
4402176|NCT00150592|7179911|FG001|Overall Study|Adverse Event|1
4402177|NCT00150592|7179910|FG000|Overall Study|Protocol Violation|1
4402178|NCT00150592|7179911|FG001|Overall Study|Protocol Violation|0
4402179|NCT00150592|7179910|FG000|Overall Study|Withdrawal by Subject|1
4402180|NCT00150592|7179911|FG001|Overall Study|Withdrawal by Subject|2
4402181|NCT00150592|7179910|FG000|Overall Study|Non-compliance|1
4402182|NCT00150592|7179911|FG001|Overall Study|Non-compliance|0
4402183|NCT00150618|7179922|FG000|Overall Study|Adverse Event|2
4402184|NCT00150618|7179923|FG001|Overall Study|Adverse Event|2
4402185|NCT00150618|7179924|FG002|Overall Study|Adverse Event|6
4402186|NCT00150618|7179925|FG003|Overall Study|Adverse Event|9
4402187|NCT00150618|7179926|FG004|Overall Study|Adverse Event|5
4402188|NCT00150618|7179922|FG000|Overall Study|Withdrawal by Subject|6
4402189|NCT00150618|7179923|FG001|Overall Study|Withdrawal by Subject|8
4402190|NCT00150618|7179924|FG002|Overall Study|Withdrawal by Subject|8
4402191|NCT00150618|7179925|FG003|Overall Study|Withdrawal by Subject|4
4402192|NCT00150618|7179926|FG004|Overall Study|Withdrawal by Subject|5
4402193|NCT00150618|7179922|FG000|Overall Study|Lost to Follow-up|4
4402194|NCT00150618|7179923|FG001|Overall Study|Lost to Follow-up|1
4402195|NCT00150618|7179924|FG002|Overall Study|Lost to Follow-up|5
4402196|NCT00150618|7179925|FG003|Overall Study|Lost to Follow-up|8
4402197|NCT00150618|7179926|FG004|Overall Study|Lost to Follow-up|4
4402198|NCT00150618|7179922|FG000|Overall Study|Protocol Violation|1
4402199|NCT00150618|7179923|FG001|Overall Study|Protocol Violation|0
4402200|NCT00150618|7179924|FG002|Overall Study|Protocol Violation|0
4402201|NCT00150618|7179925|FG003|Overall Study|Protocol Violation|0
4402202|NCT00150618|7179926|FG004|Overall Study|Protocol Violation|1
4402203|NCT00150618|7179922|FG000|Overall Study|Lack of Efficacy|1
4402204|NCT00150618|7179923|FG001|Overall Study|Lack of Efficacy|4
4402205|NCT00150618|7179924|FG002|Overall Study|Lack of Efficacy|7
4402206|NCT00150618|7179925|FG003|Overall Study|Lack of Efficacy|4
4402207|NCT00150618|7179926|FG004|Overall Study|Lack of Efficacy|6
4402208|NCT00150618|7179922|FG000|Overall Study|No study meds|0
4402209|NCT00150618|7179923|FG001|Overall Study|No study meds|0
4402210|NCT00150618|7179924|FG002|Overall Study|No study meds|0
4402211|NCT00150618|7179925|FG003|Overall Study|No study meds|0
4402212|NCT00150618|7179926|FG004|Overall Study|No study meds|2
4402213|NCT00150618|7179922|FG000|Overall Study|Physician Decision|0
4402214|NCT00150618|7179923|FG001|Overall Study|Physician Decision|2
4402215|NCT00150618|7179924|FG002|Overall Study|Physician Decision|0
4402216|NCT00150618|7179925|FG003|Overall Study|Physician Decision|0
4402217|NCT00150618|7179926|FG004|Overall Study|Physician Decision|1
4402218|NCT00150618|7179922|FG000|Overall Study|Lack of compliance|2
4402219|NCT00150618|7179923|FG001|Overall Study|Lack of compliance|1
4402220|NCT00150618|7179924|FG002|Overall Study|Lack of compliance|1
4402221|NCT00150618|7179925|FG003|Overall Study|Lack of compliance|0
4628915|NCT01866319|7496408|FG000|Overall Study|Physician Decision|1
4402222|NCT00150618|7179926|FG004|Overall Study|Lack of compliance|1
4402223|NCT00150618|7179922|FG000|Overall Study|Abnormal ECG|1
4402224|NCT00150618|7179923|FG001|Overall Study|Abnormal ECG|0
4402225|NCT00150618|7179924|FG002|Overall Study|Abnormal ECG|0
4402226|NCT00150618|7179925|FG003|Overall Study|Abnormal ECG|0
4402227|NCT00150618|7179926|FG004|Overall Study|Abnormal ECG|0
4402228|NCT00150618|7179922|FG000|Overall Study|Sponsor's decision|0
4402229|NCT00150618|7179923|FG001|Overall Study|Sponsor's decision|0
4402230|NCT00150618|7179924|FG002|Overall Study|Sponsor's decision|0
4402231|NCT00150618|7179925|FG003|Overall Study|Sponsor's decision|1
4628916|NCT01866319|7496409|FG001|Overall Study|Physician Decision|0
4402232|NCT00150618|7179926|FG004|Overall Study|Sponsor's decision|0
4402233|NCT00150800|7179938|FG000|Overall Study|Adverse Event|89
4402234|NCT00150800|7179938|FG000|Overall Study|Death|18
4402235|NCT00150800|7179938|FG000|Overall Study|Lack of Efficacy|166
4402236|NCT00150800|7179938|FG000|Overall Study|Lost to Follow-up|58
4402237|NCT00150800|7179938|FG000|Overall Study|Subject's choice|90
4402238|NCT00150800|7179938|FG000|Overall Study|No compliance|18
4402239|NCT00150800|7179938|FG000|Overall Study|IP misshandling|1
4511118|NCT00924508|7319970|FG000|Overall Study|Withdrawal by Subject|3
4511119|NCT00924560|7319980|FG000|Overall Study|Did Not Meet Protocol Requirements|4
4511120|NCT00924560|7319981|FG001|Overall Study|Did Not Meet Protocol Requirements|2
4511121|NCT00924560|7319982|FG002|Overall Study|Did Not Meet Protocol Requirements|1
4511122|NCT00924560|7319980|FG000|Overall Study|Non Compliance with the Protocol|20
4511123|NCT00924560|7319981|FG001|Overall Study|Non Compliance with the Protocol|15
4511124|NCT00924560|7319982|FG002|Overall Study|Non Compliance with the Protocol|4
4511125|NCT00924560|7319980|FG000|Overall Study|Physician Decision|2
4511126|NCT00924560|7319981|FG001|Overall Study|Physician Decision|3
4511127|NCT00924560|7319982|FG002|Overall Study|Physician Decision|4
4511128|NCT00924560|7319980|FG000|Overall Study|Withdrawal by Subject|50
4511129|NCT00924560|7319981|FG001|Overall Study|Withdrawal by Subject|44
4511130|NCT00924560|7319982|FG002|Overall Study|Withdrawal by Subject|18
4511131|NCT00924560|7319980|FG000|Overall Study|Adverse Event|39
4511132|NCT00924560|7319981|FG001|Overall Study|Adverse Event|33
4511133|NCT00924560|7319982|FG002|Overall Study|Adverse Event|0
4511134|NCT00924560|7319980|FG000|Overall Study|Pregnancy|5
4511135|NCT00924560|7319981|FG001|Overall Study|Pregnancy|7
4402240|NCT00150800|7179938|FG000|Overall Study|Site closure|24
4402241|NCT00150800|7179938|FG000|Overall Study|Protocol non-adherence|2
4402242|NCT00150800|7179938|FG000|Overall Study|Nobody to accompany patient|1
4402243|NCT00150800|7179938|FG000|Overall Study|Distance too long for patient|1
4402244|NCT00150800|7179938|FG000|Overall Study|Neurosurgery|2
4511136|NCT00924560|7319982|FG002|Overall Study|Pregnancy|1
4511137|NCT00924560|7319980|FG000|Overall Study|Lost to Follow-up|78
4511138|NCT00924560|7319981|FG001|Overall Study|Lost to Follow-up|94
4511139|NCT00924560|7319982|FG002|Overall Study|Lost to Follow-up|45
4402245|NCT00150800|7179938|FG000|Overall Study|BRV monotherapy|1
4402246|NCT00150800|7179938|FG000|Overall Study|Visit refusal|3
4402247|NCT00150800|7179938|FG000|Overall Study|Sponsor's request|2
4402248|NCT00150800|7179938|FG000|Overall Study|Generalized Epilepsy|1
4402249|NCT00150800|7179938|FG000|Overall Study|Moved from area/country|8
4402250|NCT00150800|7179938|FG000|Overall Study|PI retiring|2
4402251|NCT00150800|7179938|FG000|Overall Study|PI leaving site|2
4402252|NCT00150800|7179938|FG000|Overall Study|Patient insurance|1
4402253|NCT00150800|7179938|FG000|Overall Study|Surgical intervention|4
4402254|NCT00150800|7179938|FG000|Overall Study|Pregnancy planned|1
4402255|NCT00150800|7179938|FG000|Overall Study|PI discontinuation request|1
4402256|NCT00150813|7179943|FG000|Overall Study|Adverse Event|1
4402257|NCT00150813|7179943|FG000|Overall Study|Lack of Efficacy|1
4402258|NCT00150813|7179943|FG000|Overall Study|Lost to Follow-up|5
4402259|NCT00150813|7179943|FG000|Overall Study|Withdrawal by Subject|5
4402260|NCT00150813|7179943|FG000|Overall Study|Remission|3
4402261|NCT00150813|7179943|FG000|Overall Study|Planned pregancy|1
4402262|NCT00150813|7179943|FG000|Overall Study|Switch to commercially available LEV|2
4402263|NCT00150969|7179949|FG000|24 Month Main Study|Adverse Event|3
4402264|NCT00150969|7179950|FG001|24 Month Main Study|Adverse Event|4
4402265|NCT00150969|7179949|FG000|24 Month Main Study|Death|1
4402266|NCT00150969|7179950|FG001|24 Month Main Study|Death|1
4402267|NCT00150969|7179949|FG000|24 Month Main Study|Lack of Efficacy|1
4402268|NCT00150969|7179950|FG001|24 Month Main Study|Lack of Efficacy|8
4402269|NCT00150969|7179949|FG000|24 Month Main Study|Lost to Follow-up|3
4402270|NCT00150969|7179950|FG001|24 Month Main Study|Lost to Follow-up|2
4402271|NCT00150969|7179949|FG000|24 Month Main Study|Protocol Violation|4
4402272|NCT00150969|7179950|FG001|24 Month Main Study|Protocol Violation|2
4402273|NCT00150969|7179949|FG000|24 Month Main Study|Withdrawal by Subject|7
4402274|NCT00150969|7179950|FG001|24 Month Main Study|Withdrawal by Subject|4
4402275|NCT00150969|7179949|FG000|24-48 Month Extension|Withdrawal by Subject|6
4402276|NCT00150969|7179950|FG001|24-48 Month Extension|Withdrawal by Subject|5
4402277|NCT00150969|7179949|FG000|24-48 Month Extension|Lack of Efficacy|0
4402278|NCT00150969|7179950|FG001|24-48 Month Extension|Lack of Efficacy|1
4402279|NCT00150969|7179949|FG000|24-48 Month Extension|Adverse Event|1
4402280|NCT00150969|7179950|FG001|24-48 Month Extension|Adverse Event|3
4402281|NCT00150969|7179949|FG000|24-48 Month Extension|Other Reason|81
4402282|NCT00150969|7179950|FG001|24-48 Month Extension|Other Reason|91
4402283|NCT00151281|7179957|FG000|Overall Study|Not evaluable|3
4402284|NCT00151372|7179971|FG000|Overall Study|Death|12
4402285|NCT00151372|7179972|FG001|Overall Study|Death|11
4402286|NCT00151372|7179971|FG000|Overall Study|Lost to Follow-up|5
4402287|NCT00151372|7179972|FG001|Overall Study|Lost to Follow-up|5
4402288|NCT00151372|7179971|FG000|Overall Study|Too sick medically to continue|5
4402289|NCT00151372|7179972|FG001|Overall Study|Too sick medically to continue|6
4402290|NCT00151372|7179971|FG000|Overall Study|Withdrawal by Subject|7
4402291|NCT00151372|7179972|FG001|Overall Study|Withdrawal by Subject|7
4402292|NCT00151411|7179980|FG000|Overall Study|Lost to Follow-up|15
4402293|NCT00151411|7179981|FG001|Overall Study|Lost to Follow-up|19
4402294|NCT00151411|7179980|FG000|Overall Study|Withdrawal by Subject|12
4402295|NCT00151411|7179981|FG001|Overall Study|Withdrawal by Subject|20
4402296|NCT00151411|7179980|FG000|Overall Study|Adverse Event|6
4511140|NCT00924560|7319980|FG000|Overall Study|Miscellaneous Reasons|13
4402297|NCT00151411|7179981|FG001|Overall Study|Adverse Event|0
4402298|NCT00151411|7179980|FG000|Overall Study|Pregnancy|0
4402299|NCT00151411|7179981|FG001|Overall Study|Pregnancy|4
4402300|NCT00151476|7179990|FG000|FAP Identified Subjects|Protocol Violation|0
4402301|NCT00151476|7179991|FG001|FAP Identified Subjects|Protocol Violation|1
4402302|NCT00151476|7179990|FG000|FAP Analyzed Subjects|Lost to Follow-up|0
4402303|NCT00151476|7179991|FG001|FAP Analyzed Subjects|Lost to Follow-up|2
4402304|NCT00151476|7179990|FG000|FAP Analyzed Subjects|Other study participation|0
4402305|NCT00151476|7179991|FG001|FAP Analyzed Subjects|Other study participation|1
4402306|NCT00151775|7180003|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1
4402307|NCT00151775|7180004|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2
4402308|NCT00151775|7180005|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0
4402309|NCT00151775|7180006|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0
4402310|NCT00151775|7180007|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0
4402311|NCT00151775|7180008|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0
4402312|NCT00151775|7180009|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0
4402313|NCT00151775|7180010|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0
4402314|NCT00151775|7180011|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0
4402315|NCT00151775|7180012|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0
4402316|NCT00151775|7180013|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0
4402317|NCT00151775|7180014|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0
4402318|NCT00151775|7180003|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
4402319|NCT00151775|7180004|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
4402320|NCT00151775|7180005|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
4402321|NCT00151775|7180006|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
4402322|NCT00151775|7180007|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
4402323|NCT00151775|7180008|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
4402324|NCT00151775|7180009|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
4402325|NCT00151775|7180010|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
4402326|NCT00151775|7180011|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
4402327|NCT00151775|7180012|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
4402328|NCT00151775|7180013|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
4402329|NCT00151775|7180014|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
4402330|NCT00151775|7180003|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0
4402331|NCT00151775|7180004|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4
4402332|NCT00151775|7180005|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0
4402333|NCT00151775|7180006|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0
4402334|NCT00151775|7180007|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0
4402335|NCT00151775|7180008|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0
4402336|NCT00151775|7180009|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0
4402337|NCT00151775|7180010|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0
4402338|NCT00151775|7180011|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0
4402339|NCT00151775|7180012|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0
4402340|NCT00151775|7180013|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0
4402341|NCT00151775|7180014|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0
4402342|NCT00151775|7180003|FG000|Period 2 - Double-Blind Dose Response|Other|0
4402343|NCT00151775|7180004|FG001|Period 2 - Double-Blind Dose Response|Other|0
4402344|NCT00151775|7180005|FG002|Period 2 - Double-Blind Dose Response|Other|0
4402345|NCT00151775|7180006|FG003|Period 2 - Double-Blind Dose Response|Other|0
4402346|NCT00151775|7180007|FG004|Period 2 - Double-Blind Dose Response|Other|0
4402347|NCT00151775|7180008|FG005|Period 2 - Double-Blind Dose Response|Other|0
4402348|NCT00151775|7180009|FG006|Period 2 - Double-Blind Dose Response|Other|1
4402349|NCT00151775|7180010|FG007|Period 2 - Double-Blind Dose Response|Other|0
4402350|NCT00151775|7180011|FG008|Period 2 - Double-Blind Dose Response|Other|0
4402351|NCT00151775|7180012|FG009|Period 2 - Double-Blind Dose Response|Other|0
4402352|NCT00151775|7180013|FG010|Period 2 - Double-Blind Dose Response|Other|0
4402353|NCT00151775|7180014|FG011|Period 2 - Double-Blind Dose Response|Other|0
4402354|NCT00151775|7180003|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0
4402355|NCT00151775|7180004|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0
4402356|NCT00151775|7180005|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0
4402357|NCT00151775|7180006|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0
4402358|NCT00151775|7180007|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0
4402359|NCT00151775|7180008|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1
4402360|NCT00151775|7180009|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0
4402361|NCT00151775|7180010|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0
4402362|NCT00151775|7180011|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0
4402363|NCT00151775|7180012|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0
4402364|NCT00151775|7180013|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0
4402365|NCT00151775|7180014|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0
4402366|NCT00151775|7180003|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0
4402367|NCT00151775|7180004|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0
4402368|NCT00151775|7180005|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0
4402369|NCT00151775|7180006|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0
4402370|NCT00151775|7180007|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0
4402371|NCT00151775|7180008|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1
4402372|NCT00151775|7180009|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0
4402373|NCT00151775|7180010|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0
4402374|NCT00151775|7180011|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0
4402375|NCT00151775|7180012|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0
4402376|NCT00151775|7180013|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0
4402377|NCT00151775|7180014|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0
4402378|NCT00151775|7180003|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
4402379|NCT00151775|7180004|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
4402380|NCT00151775|7180005|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
4402381|NCT00151775|7180006|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
4402382|NCT00151775|7180007|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
4402383|NCT00151775|7180008|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
4402384|NCT00151775|7180009|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1
4402385|NCT00151775|7180010|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
4402386|NCT00151775|7180011|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
4402387|NCT00151775|7180012|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
4402388|NCT00151775|7180013|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
4402389|NCT00151775|7180014|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
4402390|NCT00151775|7180003|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
4402391|NCT00151775|7180004|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
4402392|NCT00151775|7180005|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
4402393|NCT00151775|7180006|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
4402394|NCT00151775|7180007|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
4402395|NCT00151775|7180008|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1
4402396|NCT00151775|7180009|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
4402397|NCT00151775|7180010|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
4402398|NCT00151775|7180011|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
4402399|NCT00151775|7180012|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
4402400|NCT00151775|7180013|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
4402401|NCT00151775|7180014|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
4402402|NCT00151775|7180003|FG000|Period 3: Double-blind, Withdrawal|Other|0
4402403|NCT00151775|7180004|FG001|Period 3: Double-blind, Withdrawal|Other|0
4402404|NCT00151775|7180005|FG002|Period 3: Double-blind, Withdrawal|Other|1
4402405|NCT00151775|7180006|FG003|Period 3: Double-blind, Withdrawal|Other|0
4402406|NCT00151775|7180007|FG004|Period 3: Double-blind, Withdrawal|Other|0
4402407|NCT00151775|7180008|FG005|Period 3: Double-blind, Withdrawal|Other|0
4402408|NCT00151775|7180009|FG006|Period 3: Double-blind, Withdrawal|Other|0
4402409|NCT00151775|7180010|FG007|Period 3: Double-blind, Withdrawal|Other|1
4402410|NCT00151775|7180011|FG008|Period 3: Double-blind, Withdrawal|Other|0
4402411|NCT00151775|7180012|FG009|Period 3: Double-blind, Withdrawal|Other|0
4402412|NCT00151775|7180013|FG010|Period 3: Double-blind, Withdrawal|Other|0
4402413|NCT00151775|7180014|FG011|Period 3: Double-blind, Withdrawal|Other|0
4402414|NCT00151775|7180003|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
4402415|NCT00151775|7180004|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
4402416|NCT00151775|7180005|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
4402417|NCT00151775|7180006|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
4402418|NCT00151775|7180007|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
4402419|NCT00151775|7180008|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
4402420|NCT00151775|7180009|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1
4402421|NCT00151775|7180010|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
4402422|NCT00151775|7180011|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
4402423|NCT00151775|7180012|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
4402424|NCT00151775|7180013|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
4402425|NCT00151775|7180014|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
4402426|NCT00151775|7180003|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0
4402427|NCT00151775|7180004|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0
4402428|NCT00151775|7180005|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1
4402429|NCT00151775|7180006|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0
4402430|NCT00151775|7180007|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0
4402431|NCT00151775|7180008|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0
4402432|NCT00151775|7180009|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0
4402433|NCT00151775|7180010|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0
4402434|NCT00151775|7180011|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0
4402435|NCT00151775|7180012|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0
4402436|NCT00151775|7180013|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0
4402437|NCT00151775|7180014|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0
4402438|NCT00151775|7180003|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0
4402439|NCT00151775|7180004|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0
4402440|NCT00151775|7180005|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1
4402441|NCT00151775|7180006|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0
4402442|NCT00151775|7180007|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0
4402443|NCT00151775|7180008|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0
4402444|NCT00151775|7180009|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0
4402445|NCT00151775|7180010|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0
4402446|NCT00151775|7180011|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0
4402447|NCT00151775|7180012|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0
4402448|NCT00151775|7180013|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0
4402449|NCT00151775|7180014|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0
4402450|NCT00151775|7180003|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
4402451|NCT00151775|7180004|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
4402452|NCT00151775|7180005|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
4402453|NCT00151775|7180006|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
4402454|NCT00151775|7180007|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
4402455|NCT00151775|7180008|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
4402456|NCT00151775|7180009|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
4402457|NCT00151775|7180010|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
4402458|NCT00151775|7180011|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
4402459|NCT00151775|7180012|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
4402460|NCT00151775|7180013|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
4402461|NCT00151775|7180014|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1
4402462|NCT00151775|7180003|FG000|Period 4: Open Label|Increased blood pressure|0
4402463|NCT00151775|7180004|FG001|Period 4: Open Label|Increased blood pressure|0
4402464|NCT00151775|7180005|FG002|Period 4: Open Label|Increased blood pressure|0
4402465|NCT00151775|7180006|FG003|Period 4: Open Label|Increased blood pressure|0
4402466|NCT00151775|7180007|FG004|Period 4: Open Label|Increased blood pressure|1
4402467|NCT00151775|7180008|FG005|Period 4: Open Label|Increased blood pressure|0
4402468|NCT00151775|7180009|FG006|Period 4: Open Label|Increased blood pressure|0
4402469|NCT00151775|7180010|FG007|Period 4: Open Label|Increased blood pressure|0
4402470|NCT00151775|7180011|FG008|Period 4: Open Label|Increased blood pressure|0
4402471|NCT00151775|7180012|FG009|Period 4: Open Label|Increased blood pressure|1
4402472|NCT00151775|7180013|FG010|Period 4: Open Label|Increased blood pressure|0
4402473|NCT00151775|7180014|FG011|Period 4: Open Label|Increased blood pressure|0
4402474|NCT00151775|7180003|FG000|Period 4: Open Label|Withdrawal by Subject|0
4402475|NCT00151775|7180004|FG001|Period 4: Open Label|Withdrawal by Subject|0
4402476|NCT00151775|7180005|FG002|Period 4: Open Label|Withdrawal by Subject|0
4402477|NCT00151775|7180006|FG003|Period 4: Open Label|Withdrawal by Subject|0
4402478|NCT00151775|7180007|FG004|Period 4: Open Label|Withdrawal by Subject|5
4402479|NCT00151775|7180008|FG005|Period 4: Open Label|Withdrawal by Subject|0
4402480|NCT00151775|7180009|FG006|Period 4: Open Label|Withdrawal by Subject|0
4402481|NCT00151775|7180010|FG007|Period 4: Open Label|Withdrawal by Subject|0
4402482|NCT00151775|7180011|FG008|Period 4: Open Label|Withdrawal by Subject|0
4402483|NCT00151775|7180012|FG009|Period 4: Open Label|Withdrawal by Subject|2
4402484|NCT00151775|7180013|FG010|Period 4: Open Label|Withdrawal by Subject|0
4402485|NCT00151775|7180014|FG011|Period 4: Open Label|Withdrawal by Subject|0
4402486|NCT00151775|7180003|FG000|Period 4: Open Label|Adverse Event|0
4402487|NCT00151775|7180004|FG001|Period 4: Open Label|Adverse Event|0
4402488|NCT00151775|7180005|FG002|Period 4: Open Label|Adverse Event|0
4402489|NCT00151775|7180006|FG003|Period 4: Open Label|Adverse Event|0
4402490|NCT00151775|7180007|FG004|Period 4: Open Label|Adverse Event|1
4402491|NCT00151775|7180008|FG005|Period 4: Open Label|Adverse Event|0
4402492|NCT00151775|7180009|FG006|Period 4: Open Label|Adverse Event|0
4402493|NCT00151775|7180010|FG007|Period 4: Open Label|Adverse Event|0
4402494|NCT00151775|7180011|FG008|Period 4: Open Label|Adverse Event|0
4402495|NCT00151775|7180012|FG009|Period 4: Open Label|Adverse Event|2
4402496|NCT00151775|7180013|FG010|Period 4: Open Label|Adverse Event|0
4402497|NCT00151775|7180014|FG011|Period 4: Open Label|Adverse Event|0
4402498|NCT00151775|7180003|FG000|Period 4: Open Label|Lost to Follow-up|0
4402499|NCT00151775|7180004|FG001|Period 4: Open Label|Lost to Follow-up|0
4402500|NCT00151775|7180005|FG002|Period 4: Open Label|Lost to Follow-up|0
4402501|NCT00151775|7180006|FG003|Period 4: Open Label|Lost to Follow-up|0
4402502|NCT00151775|7180007|FG004|Period 4: Open Label|Lost to Follow-up|17
4402503|NCT00151775|7180008|FG005|Period 4: Open Label|Lost to Follow-up|0
4402504|NCT00151775|7180009|FG006|Period 4: Open Label|Lost to Follow-up|0
4402505|NCT00151775|7180010|FG007|Period 4: Open Label|Lost to Follow-up|0
4402506|NCT00151775|7180011|FG008|Period 4: Open Label|Lost to Follow-up|0
4402507|NCT00151775|7180012|FG009|Period 4: Open Label|Lost to Follow-up|7
4402508|NCT00151775|7180013|FG010|Period 4: Open Label|Lost to Follow-up|0
4402509|NCT00151775|7180014|FG011|Period 4: Open Label|Lost to Follow-up|0
4402510|NCT00151775|7180003|FG000|Period 4: Open Label|Non-compliance with protocol|0
4402511|NCT00151775|7180004|FG001|Period 4: Open Label|Non-compliance with protocol|0
4511141|NCT00924560|7319981|FG001|Overall Study|Miscellaneous Reasons|10
4402512|NCT00151775|7180005|FG002|Period 4: Open Label|Non-compliance with protocol|0
4402513|NCT00151775|7180006|FG003|Period 4: Open Label|Non-compliance with protocol|0
4402514|NCT00151775|7180007|FG004|Period 4: Open Label|Non-compliance with protocol|4
4402515|NCT00151775|7180008|FG005|Period 4: Open Label|Non-compliance with protocol|0
4402516|NCT00151775|7180009|FG006|Period 4: Open Label|Non-compliance with protocol|0
4402517|NCT00151775|7180010|FG007|Period 4: Open Label|Non-compliance with protocol|0
4402518|NCT00151775|7180011|FG008|Period 4: Open Label|Non-compliance with protocol|0
4402519|NCT00151775|7180012|FG009|Period 4: Open Label|Non-compliance with protocol|4
4402520|NCT00151775|7180013|FG010|Period 4: Open Label|Non-compliance with protocol|0
4402521|NCT00151775|7180014|FG011|Period 4: Open Label|Non-compliance with protocol|0
4402522|NCT00151775|7180003|FG000|Period 4: Open Label|Other|0
4402523|NCT00151775|7180004|FG001|Period 4: Open Label|Other|0
4402524|NCT00151775|7180005|FG002|Period 4: Open Label|Other|0
4402525|NCT00151775|7180006|FG003|Period 4: Open Label|Other|0
4590347|NCT01520402|7436202|FG000|Overall Study|Withdrawal by Subject|2
4590348|NCT01520402|7436202|FG000|Overall Study|Physician Decision|3
4402526|NCT00151775|7180007|FG004|Period 4: Open Label|Other|1
4402527|NCT00151775|7180008|FG005|Period 4: Open Label|Other|0
4402528|NCT00151775|7180009|FG006|Period 4: Open Label|Other|0
4402529|NCT00151775|7180010|FG007|Period 4: Open Label|Other|0
4402530|NCT00151775|7180011|FG008|Period 4: Open Label|Other|0
4402531|NCT00151775|7180012|FG009|Period 4: Open Label|Other|3
4402532|NCT00151775|7180013|FG010|Period 4: Open Label|Other|0
4402533|NCT00151775|7180014|FG011|Period 4: Open Label|Other|0
4402534|NCT00151775|7180003|FG000|Period 4: Open Label|Physician Decision|0
4402535|NCT00151775|7180004|FG001|Period 4: Open Label|Physician Decision|0
4402536|NCT00151775|7180005|FG002|Period 4: Open Label|Physician Decision|0
4402537|NCT00151775|7180006|FG003|Period 4: Open Label|Physician Decision|0
4402538|NCT00151775|7180007|FG004|Period 4: Open Label|Physician Decision|0
4402539|NCT00151775|7180008|FG005|Period 4: Open Label|Physician Decision|0
4402540|NCT00151775|7180009|FG006|Period 4: Open Label|Physician Decision|0
4402541|NCT00151775|7180010|FG007|Period 4: Open Label|Physician Decision|0
4402542|NCT00151775|7180011|FG008|Period 4: Open Label|Physician Decision|0
4402543|NCT00151775|7180012|FG009|Period 4: Open Label|Physician Decision|2
4402544|NCT00151775|7180013|FG010|Period 4: Open Label|Physician Decision|0
4402545|NCT00151775|7180014|FG011|Period 4: Open Label|Physician Decision|0
4402546|NCT00151775|7180003|FG000|Period 4: Open Label|Protocol Violation|0
4402547|NCT00151775|7180004|FG001|Period 4: Open Label|Protocol Violation|0
4402548|NCT00151775|7180005|FG002|Period 4: Open Label|Protocol Violation|0
4402549|NCT00151775|7180006|FG003|Period 4: Open Label|Protocol Violation|0
4402550|NCT00151775|7180007|FG004|Period 4: Open Label|Protocol Violation|1
4402551|NCT00151775|7180008|FG005|Period 4: Open Label|Protocol Violation|0
4402552|NCT00151775|7180009|FG006|Period 4: Open Label|Protocol Violation|0
4402553|NCT00151775|7180010|FG007|Period 4: Open Label|Protocol Violation|0
4402554|NCT00151775|7180011|FG008|Period 4: Open Label|Protocol Violation|0
4402555|NCT00151775|7180012|FG009|Period 4: Open Label|Protocol Violation|0
4402556|NCT00151775|7180013|FG010|Period 4: Open Label|Protocol Violation|0
4402557|NCT00151775|7180014|FG011|Period 4: Open Label|Protocol Violation|0
4402558|NCT00151892|7180069|FG000|Overall Study|Lack of Efficacy|50
4402559|NCT00151892|7180070|FG001|Overall Study|Lack of Efficacy|57
4402560|NCT00151892|7180069|FG000|Overall Study|Patient request|10
4402561|NCT00151892|7180070|FG001|Overall Study|Patient request|7
4402562|NCT00151892|7180069|FG000|Overall Study|Lost to Follow-up|5
4402563|NCT00151892|7180070|FG001|Overall Study|Lost to Follow-up|10
4402564|NCT00151892|7180069|FG000|Overall Study|Adverse Event|6
4402565|NCT00151892|7180070|FG001|Overall Study|Adverse Event|3
4402566|NCT00151892|7180069|FG000|Overall Study|Protocol Violation|3
4402567|NCT00151892|7180070|FG001|Overall Study|Protocol Violation|3
4402568|NCT00151892|7180069|FG000|Overall Study|Non-compliance|0
4402569|NCT00151892|7180070|FG001|Overall Study|Non-compliance|1
4402570|NCT00151892|7180069|FG000|Overall Study|Pregnancy|0
4402571|NCT00151892|7180070|FG001|Overall Study|Pregnancy|1
4402572|NCT00151892|7180069|FG000|Overall Study|Did not return for a visit|1
4402573|NCT00151892|7180070|FG001|Overall Study|Did not return for a visit|0
4402574|NCT00151892|7180069|FG000|Overall Study|Used prohibited corticosteroids|1
4402575|NCT00151892|7180070|FG001|Overall Study|Used prohibited corticosteroids|0
4402576|NCT00151892|7180069|FG000|Overall Study|Lack of study medication at center|0
4402577|NCT00151892|7180070|FG001|Overall Study|Lack of study medication at center|1
4402578|NCT00151996|7180078|FG000|Overall Study|Adverse Event|3
4402579|NCT00151996|7180079|FG001|Overall Study|Adverse Event|2
4402580|NCT00151996|7180078|FG000|Overall Study|Withdrawal by Subject|1
4402581|NCT00151996|7180079|FG001|Overall Study|Withdrawal by Subject|1
4402582|NCT00151996|7180078|FG000|Overall Study|Protocol Violation|1
4402583|NCT00151996|7180079|FG001|Overall Study|Protocol Violation|2
4402584|NCT00151996|7180078|FG000|Overall Study|Sponsor's decision|0
4402585|NCT00151996|7180079|FG001|Overall Study|Sponsor's decision|2
4402586|NCT00152009|7180089|FG000|Overall Study|Adverse Event|9
4402587|NCT00152009|7180090|FG001|Overall Study|Adverse Event|13
4402588|NCT00152009|7180091|FG002|Overall Study|Adverse Event|20
4402589|NCT00152009|7180092|FG003|Overall Study|Adverse Event|1
4402590|NCT00152009|7180089|FG000|Overall Study|Protocol Violation|3
4402591|NCT00152009|7180090|FG001|Overall Study|Protocol Violation|0
4402592|NCT00152009|7180091|FG002|Overall Study|Protocol Violation|0
4402593|NCT00152009|7180092|FG003|Overall Study|Protocol Violation|1
4402594|NCT00152009|7180089|FG000|Overall Study|Withdrawal by Subject|2
4402595|NCT00152009|7180090|FG001|Overall Study|Withdrawal by Subject|3
4402596|NCT00152009|7180091|FG002|Overall Study|Withdrawal by Subject|4
4402597|NCT00152009|7180092|FG003|Overall Study|Withdrawal by Subject|9
4402598|NCT00152009|7180089|FG000|Overall Study|Lost to Follow-up|2
4402599|NCT00152009|7180090|FG001|Overall Study|Lost to Follow-up|4
4402600|NCT00152009|7180091|FG002|Overall Study|Lost to Follow-up|3
4402601|NCT00152009|7180092|FG003|Overall Study|Lost to Follow-up|3
4402602|NCT00152009|7180089|FG000|Overall Study|Lack of Efficacy|8
4402603|NCT00152009|7180090|FG001|Overall Study|Lack of Efficacy|6
4402604|NCT00152009|7180091|FG002|Overall Study|Lack of Efficacy|7
4402605|NCT00152009|7180092|FG003|Overall Study|Lack of Efficacy|15
4402606|NCT00152009|7180089|FG000|Overall Study|ECG abnormalities|2
4402607|NCT00152009|7180090|FG001|Overall Study|ECG abnormalities|2
4402608|NCT00152009|7180091|FG002|Overall Study|ECG abnormalities|2
4402609|NCT00152009|7180092|FG003|Overall Study|ECG abnormalities|1
4402610|NCT00152009|7180089|FG000|Overall Study|Sponsor's decision|3
4402611|NCT00152009|7180090|FG001|Overall Study|Sponsor's decision|3
4402612|NCT00152009|7180091|FG002|Overall Study|Sponsor's decision|1
4402613|NCT00152009|7180092|FG003|Overall Study|Sponsor's decision|3
4402614|NCT00152464|7180104|FG000|Overall Study|Adverse Event|3
4402615|NCT00152464|7180105|FG001|Overall Study|Adverse Event|6
4402616|NCT00152464|7180104|FG000|Overall Study|Lost to Follow-up|8
4402617|NCT00152464|7180105|FG001|Overall Study|Lost to Follow-up|4
4402618|NCT00152464|7180104|FG000|Overall Study|Protocol Violation|3
4402619|NCT00152464|7180105|FG001|Overall Study|Protocol Violation|1
4402620|NCT00152464|7180104|FG000|Overall Study|Withdrawal by Subject|21
4402621|NCT00152464|7180105|FG001|Overall Study|Withdrawal by Subject|22
4402622|NCT00152464|7180104|FG000|Overall Study|Atopic dermatitis poorly controlled|0
4402623|NCT00152464|7180105|FG001|Overall Study|Atopic dermatitis poorly controlled|1
4402624|NCT00152464|7180104|FG000|Overall Study|Eczema deterioration|0
4402625|NCT00152464|7180105|FG001|Overall Study|Eczema deterioration|1
4402626|NCT00152464|7180104|FG000|Overall Study|Parent decision|1
4402627|NCT00152464|7180105|FG001|Overall Study|Parent decision|1
4402628|NCT00152464|7180104|FG000|Overall Study|Investigator decision|1
4402629|NCT00152464|7180105|FG001|Overall Study|Investigator decision|0
4402630|NCT00152464|7180104|FG000|Overall Study|Lack of Efficacy|1
4402631|NCT00152464|7180105|FG001|Overall Study|Lack of Efficacy|0
4402632|NCT00152464|7180104|FG000|Overall Study|Eczema poorly controlled|1
4402633|NCT00152464|7180105|FG001|Overall Study|Eczema poorly controlled|0
4402634|NCT00152464|7180104|FG000|Overall Study|Patient relocated|1
4402635|NCT00152464|7180105|FG001|Overall Study|Patient relocated|0
4402636|NCT00152516|7180111|FG000|Overall Study|Adverse Event|18
4402637|NCT00152516|7180111|FG000|Overall Study|Lack and Loss of Efficacy|30
4402638|NCT00152516|7180111|FG000|Overall Study|Lost to Follow-up|5
4402639|NCT00152516|7180111|FG000|Overall Study|Withdrawal by Subject|8
4402640|NCT00152516|7180111|FG000|Overall Study|Protocol Violation|3
4402641|NCT00152516|7180111|FG000|Overall Study|Other: Mother Refused To Cooperate|1
4402642|NCT00152516|7180111|FG000|Overall Study|Other: Given Commercial Drug in Error|2
4402643|NCT00152516|7180111|FG000|Overall Study|Other: Parents Withdrew Consent|2
4402644|NCT00152516|7180111|FG000|Overall Study|Other: Non-Compliance|2
4402645|NCT00152516|7180111|FG000|Overall Study|Other: Primary Care Physician's Decision|1
4402646|NCT00152516|7180111|FG000|Overall Study|Other: Moved Out Of State|1
4402647|NCT00152516|7180111|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1
4402648|NCT00152516|7180111|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1
4402649|NCT00152763|7180119|FG000|Overall Study|Death|4
4402650|NCT00152763|7180120|FG001|Overall Study|Death|1
4402651|NCT00152763|7180121|FG002|Overall Study|Death|2
4402652|NCT00152763|7180122|FG003|Overall Study|Death|1
4402653|NCT00152763|7180119|FG000|Overall Study|Lost to Follow-up|6
4402654|NCT00152763|7180120|FG001|Overall Study|Lost to Follow-up|4
4402655|NCT00152763|7180121|FG002|Overall Study|Lost to Follow-up|2
4402656|NCT00152763|7180122|FG003|Overall Study|Lost to Follow-up|13
4402657|NCT00152971|7180137|FG000|Overall Study|Adverse Event|12
4402658|NCT00152971|7180138|FG001|Overall Study|Adverse Event|10
4402659|NCT00152971|7180139|FG002|Overall Study|Adverse Event|9
4402660|NCT00152971|7180137|FG000|Overall Study|Protocol Violation|10
4402661|NCT00152971|7180138|FG001|Overall Study|Protocol Violation|11
4402662|NCT00152971|7180139|FG002|Overall Study|Protocol Violation|8
4402663|NCT00152971|7180137|FG000|Overall Study|Lost to Follow-up|17
4402664|NCT00152971|7180138|FG001|Overall Study|Lost to Follow-up|14
4402665|NCT00152971|7180139|FG002|Overall Study|Lost to Follow-up|13
4402666|NCT00152971|7180137|FG000|Overall Study|Withdrawal by Subject|9
4402667|NCT00152971|7180138|FG001|Overall Study|Withdrawal by Subject|8
4402668|NCT00152971|7180139|FG002|Overall Study|Withdrawal by Subject|14
4402669|NCT00152971|7180137|FG000|Overall Study|Other|3
4402670|NCT00152971|7180138|FG001|Overall Study|Other|5
4402671|NCT00152971|7180139|FG002|Overall Study|Other|5
4402672|NCT00152971|7180137|FG000|Treatment|Adverse Event|49
4402673|NCT00152971|7180138|FG001|Treatment|Adverse Event|40
4402674|NCT00152971|7180139|FG002|Treatment|Adverse Event|54
4402675|NCT00152971|7180137|FG000|Treatment|Protocol Violation|8
4402676|NCT00152971|7180138|FG001|Treatment|Protocol Violation|6
4402677|NCT00152971|7180139|FG002|Treatment|Protocol Violation|10
4402678|NCT00152971|7180137|FG000|Treatment|Lost to Follow-up|1
4402679|NCT00152971|7180138|FG001|Treatment|Lost to Follow-up|2
4402680|NCT00152971|7180139|FG002|Treatment|Lost to Follow-up|1
4402681|NCT00152971|7180137|FG000|Treatment|Withdrawal by Subject|4
4402682|NCT00152971|7180138|FG001|Treatment|Withdrawal by Subject|4
4402683|NCT00152971|7180139|FG002|Treatment|Withdrawal by Subject|5
4402684|NCT00152971|7180137|FG000|Treatment|Other|9
4402685|NCT00152971|7180138|FG001|Treatment|Other|11
4402686|NCT00152971|7180139|FG002|Treatment|Other|10
4402687|NCT00153062|7180151|FG000|Overall Study|Death|360
4402688|NCT00153062|7180152|FG001|Overall Study|Death|352
4402689|NCT00153062|7180153|FG002|Overall Study|Death|369
4402690|NCT00153062|7180154|FG003|Overall Study|Death|365
4402691|NCT00153062|7180151|FG000|Overall Study|Withdrawal by Subject|14
4402692|NCT00153062|7180152|FG001|Overall Study|Withdrawal by Subject|30
4402693|NCT00153062|7180153|FG002|Overall Study|Withdrawal by Subject|27
4402694|NCT00153062|7180154|FG003|Overall Study|Withdrawal by Subject|28
4402695|NCT00153062|7180151|FG000|Overall Study|Lost to Follow-up|12
4402696|NCT00153062|7180152|FG001|Overall Study|Lost to Follow-up|20
4402697|NCT00153062|7180153|FG002|Overall Study|Lost to Follow-up|15
4402698|NCT00153062|7180154|FG003|Overall Study|Lost to Follow-up|16
4402699|NCT00153062|7180151|FG000|Overall Study|Adverse Event|0
4402700|NCT00153062|7180152|FG001|Overall Study|Adverse Event|1
4402701|NCT00153062|7180153|FG002|Overall Study|Adverse Event|1
4402702|NCT00153062|7180154|FG003|Overall Study|Adverse Event|0
4402703|NCT00153062|7180151|FG000|Overall Study|Protocol Violation|0
4402704|NCT00153062|7180152|FG001|Overall Study|Protocol Violation|2
4402705|NCT00153062|7180153|FG002|Overall Study|Protocol Violation|1
4402706|NCT00153062|7180154|FG003|Overall Study|Protocol Violation|1
4402707|NCT00153062|7180151|FG000|Overall Study|No disposition data available|1
4402708|NCT00153062|7180152|FG001|Overall Study|No disposition data available|1
4402709|NCT00153062|7180153|FG002|Overall Study|No disposition data available|1
4402710|NCT00153062|7180154|FG003|Overall Study|No disposition data available|1
4402711|NCT00153062|7180151|FG000|Overall Study|Other|0
4402712|NCT00153062|7180152|FG001|Overall Study|Other|0
4402713|NCT00153062|7180153|FG002|Overall Study|Other|1
4402714|NCT00153062|7180154|FG003|Overall Study|Other|0
4402715|NCT00153101|7180169|FG000|Overall Study|Lost to Follow-up|14
4402716|NCT00153101|7180170|FG001|Overall Study|Lost to Follow-up|14
4402717|NCT00153101|7180171|FG002|Overall Study|Lost to Follow-up|12
4402718|NCT00153101|7180172|FG003|Overall Study|Lost to Follow-up|5
4402719|NCT00153101|7180173|FG004|Overall Study|Lost to Follow-up|5
4402720|NCT00153101|7180169|FG000|Overall Study|Withdrawal by Subject|3
4402721|NCT00153101|7180170|FG001|Overall Study|Withdrawal by Subject|4
4402722|NCT00153101|7180171|FG002|Overall Study|Withdrawal by Subject|3
4402723|NCT00153101|7180172|FG003|Overall Study|Withdrawal by Subject|3
4402724|NCT00153101|7180173|FG004|Overall Study|Withdrawal by Subject|5
4402725|NCT00153179|7180203|FG000|Study Visit Day 2|Withdrawal by Subject|1
4402726|NCT00153179|7180204|FG001|Study Visit Day 2|Withdrawal by Subject|0
4402727|NCT00153179|7180205|FG002|Study Visit Day 2|Withdrawal by Subject|2
4402728|NCT00153179|7180206|FG003|Study Visit Day 2|Withdrawal by Subject|2
4402729|NCT00153816|7180232|FG000|Overall Study|Death|6
4402730|NCT00153816|7180233|FG001|Overall Study|Death|5
4402731|NCT00153816|7180234|FG002|Overall Study|Death|4
4402732|NCT00153816|7180235|FG003|Overall Study|Death|6
4402733|NCT00153816|7180236|FG004|Overall Study|Death|0
4402734|NCT00153816|7180237|FG005|Overall Study|Death|2
4402735|NCT00153816|7180232|FG000|Overall Study|Lost to Follow-up|7
4402736|NCT00153816|7180233|FG001|Overall Study|Lost to Follow-up|8
4402737|NCT00153816|7180234|FG002|Overall Study|Lost to Follow-up|5
4402738|NCT00153816|7180235|FG003|Overall Study|Lost to Follow-up|8
4402739|NCT00153816|7180236|FG004|Overall Study|Lost to Follow-up|7
4402740|NCT00153816|7180237|FG005|Overall Study|Lost to Follow-up|9
4402741|NCT00153816|7180232|FG000|Overall Study|Withdrawal by Subject|9
4402742|NCT00153816|7180233|FG001|Overall Study|Withdrawal by Subject|9
4402743|NCT00153816|7180234|FG002|Overall Study|Withdrawal by Subject|9
4402744|NCT00153816|7180235|FG003|Overall Study|Withdrawal by Subject|4
4402745|NCT00153816|7180236|FG004|Overall Study|Withdrawal by Subject|1
4402746|NCT00153816|7180237|FG005|Overall Study|Withdrawal by Subject|5
4402747|NCT00153816|7180232|FG000|Overall Study|Follow-up exam not done|8
4402748|NCT00153816|7180233|FG001|Overall Study|Follow-up exam not done|7
4402749|NCT00153816|7180234|FG002|Overall Study|Follow-up exam not done|11
4402750|NCT00153816|7180235|FG003|Overall Study|Follow-up exam not done|10
4402751|NCT00153816|7180236|FG004|Overall Study|Follow-up exam not done|8
4402752|NCT00153816|7180237|FG005|Overall Study|Follow-up exam not done|9
4402753|NCT00153816|7180232|FG000|Overall Study|Follow-up exam done, histology missing|2
4402754|NCT00153816|7180233|FG001|Overall Study|Follow-up exam done, histology missing|3
4402755|NCT00153816|7180234|FG002|Overall Study|Follow-up exam done, histology missing|3
4402756|NCT00153816|7180235|FG003|Overall Study|Follow-up exam done, histology missing|3
4402757|NCT00153816|7180236|FG004|Overall Study|Follow-up exam done, histology missing|1
4402758|NCT00153816|7180237|FG005|Overall Study|Follow-up exam done, histology missing|2
4402759|NCT00153920|7180262|FG000|Overall Study|Adverse Event|9
4402760|NCT00153920|7180262|FG000|Overall Study|Progressive Disease|9
4402761|NCT00153920|7180262|FG000|Overall Study|Physician Decision|3
4402762|NCT00153920|7180262|FG000|Overall Study|Lack of Response|3
4402763|NCT00153920|7180262|FG000|Overall Study|Death|2
4402764|NCT00153920|7180262|FG000|Overall Study|Withdrawal by Subject|1
4402765|NCT00153920|7180262|FG000|Overall Study|Non-Protocol Therapy|1
4402766|NCT00153920|7180262|FG000|Overall Study|Withdrawal of Consent before Trt|1
4402767|NCT00153920|7180262|FG000|Overall Study|Progressive Disease before Trt|1
4402768|NCT00154063|7180272|FG000|Overall Study|Adverse Event|4
4402769|NCT00154063|7180273|FG001|Overall Study|Adverse Event|8
4402770|NCT00154063|7180272|FG000|Overall Study|Protocol Violation|1
4402771|NCT00154063|7180273|FG001|Overall Study|Protocol Violation|1
4402772|NCT00154063|7180272|FG000|Overall Study|Investigator or Sponsor Request|0
4402773|NCT00154063|7180273|FG001|Overall Study|Investigator or Sponsor Request|1
4402774|NCT00154063|7180272|FG000|Overall Study|Withdrawal by Subject|4
4402775|NCT00154063|7180273|FG001|Overall Study|Withdrawal by Subject|9
4402776|NCT00154063|7180272|FG000|Overall Study|Other|3
4402777|NCT00154063|7180273|FG001|Overall Study|Other|3
4402778|NCT00154102|7180285|FG000|Overall Study|investigational study phase ongoing|7
4402779|NCT00154102|7180286|FG001|Overall Study|investigational study phase ongoing|2
4402780|NCT00154284|7180294|FG000|Overall Study|Adverse Event|6
4402781|NCT00154284|7180295|FG001|Overall Study|Adverse Event|9
4402782|NCT00154284|7180294|FG000|Overall Study|Abnormal laboratory value(s)|0
4402783|NCT00154284|7180295|FG001|Overall Study|Abnormal laboratory value(s)|1
4402784|NCT00154284|7180294|FG000|Overall Study|Lack of Efficacy|1
4402785|NCT00154284|7180295|FG001|Overall Study|Lack of Efficacy|2
4402786|NCT00154284|7180294|FG000|Overall Study|Protocol Violation|0
4402787|NCT00154284|7180295|FG001|Overall Study|Protocol Violation|1
4402788|NCT00154297|7180305|FG000|Overall Study|Death|5
4402789|NCT00154297|7180306|FG001|Overall Study|Death|2
4402790|NCT00154297|7180305|FG000|Overall Study|Withdrawal by Subject|0
4402791|NCT00154297|7180306|FG001|Overall Study|Withdrawal by Subject|5
4402792|NCT00154297|7180305|FG000|Overall Study|Lost to Follow-up|3
4402793|NCT00154297|7180306|FG001|Overall Study|Lost to Follow-up|0
4402794|NCT00154310|7180314|FG000|Overall Study|Adverse Event|19
4402795|NCT00154310|7180315|FG001|Overall Study|Adverse Event|9
4402796|NCT00154310|7180314|FG000|Overall Study|Lack of Efficacy|5
4402797|NCT00154310|7180315|FG001|Overall Study|Lack of Efficacy|4
4402798|NCT00154310|7180314|FG000|Overall Study|Protocol Violation|4
4402799|NCT00154310|7180315|FG001|Overall Study|Protocol Violation|2
4402800|NCT00154310|7180314|FG000|Overall Study|Withdrawal by Subject|9
4402801|NCT00154310|7180315|FG001|Overall Study|Withdrawal by Subject|3
4402802|NCT00154310|7180314|FG000|Overall Study|Lost to Follow-up|0
4402803|NCT00154310|7180315|FG001|Overall Study|Lost to Follow-up|8
4402804|NCT00154310|7180314|FG000|Overall Study|Administrative problems|0
4402805|NCT00154310|7180315|FG001|Overall Study|Administrative problems|1
4402806|NCT00154310|7180314|FG000|Overall Study|Death|0
4402807|NCT00154310|7180315|FG001|Overall Study|Death|1
4402808|NCT00154375|7180323|FG000|Overall Study|Unsatisfactory therapeutic effect|25
4402809|NCT00154375|7180324|FG001|Overall Study|Unsatisfactory therapeutic effect|26
4402810|NCT00154375|7180323|FG000|Overall Study|Adverse Event|18
4402811|NCT00154375|7180324|FG001|Overall Study|Adverse Event|20
4402812|NCT00154375|7180323|FG000|Overall Study|Withdrawal by Subject|14
4402813|NCT00154375|7180324|FG001|Overall Study|Withdrawal by Subject|10
4402814|NCT00154375|7180323|FG000|Overall Study|Death|5
4402815|NCT00154375|7180324|FG001|Overall Study|Death|13
4402816|NCT00154375|7180323|FG000|Overall Study|Study drug no longer required|5
4402817|NCT00154375|7180324|FG001|Overall Study|Study drug no longer required|3
4402818|NCT00154375|7180323|FG000|Overall Study|Lost to Follow-up|2
4402819|NCT00154375|7180324|FG001|Overall Study|Lost to Follow-up|1
4402820|NCT00154375|7180323|FG000|Overall Study|Abnormal laboratory value(s)|0
4402821|NCT00154375|7180324|FG001|Overall Study|Abnormal laboratory value(s)|2
4402822|NCT00154375|7180323|FG000|Overall Study|Protocol Violation|0
4402823|NCT00154375|7180324|FG001|Overall Study|Protocol Violation|1
4402824|NCT00154375|7180323|FG000|Overall Study|Suspected progression of disease|44
4402825|NCT00154375|7180324|FG001|Overall Study|Suspected progression of disease|30
4402826|NCT00156533|7180370|FG000|Overall Study|Withdrawn - Medication Expiration|0
4402827|NCT00156533|7180371|FG001|Overall Study|Withdrawn - Medication Expiration|2
4402828|NCT00156533|7180372|FG002|Overall Study|Withdrawn - Medication Expiration|1
4402829|NCT00156533|7180373|FG003|Overall Study|Withdrawn - Medication Expiration|0
4402830|NCT00156533|7180370|FG000|Overall Study|Withdrawal by Subject|1
4402831|NCT00156533|7180371|FG001|Overall Study|Withdrawal by Subject|0
4402832|NCT00156533|7180372|FG002|Overall Study|Withdrawal by Subject|0
4402833|NCT00156533|7180373|FG003|Overall Study|Withdrawal by Subject|1
4402834|NCT00156533|7180370|FG000|Overall Study|Failed Screening|1
4402835|NCT00156533|7180371|FG001|Overall Study|Failed Screening|0
4402836|NCT00156533|7180372|FG002|Overall Study|Failed Screening|1
4402837|NCT00156533|7180373|FG003|Overall Study|Failed Screening|1
4402838|NCT00156819|7180392|FG000|Overall Study|Lost to Follow-up|1
4402839|NCT00156819|7180393|FG001|Overall Study|Lost to Follow-up|1
4402840|NCT00156819|7180394|FG002|Overall Study|Lost to Follow-up|3
4402841|NCT00157014|7180433|FG000|Overall Study|Death|4
4402842|NCT00157014|7180434|FG001|Overall Study|Death|2
4402843|NCT00157014|7180435|FG002|Overall Study|Death|1
4402844|NCT00157014|7180436|FG003|Overall Study|Death|1
4402845|NCT00157014|7180433|FG000|Overall Study|Physician Decision|0
4402846|NCT00157014|7180434|FG001|Overall Study|Physician Decision|1
4402847|NCT00157014|7180435|FG002|Overall Study|Physician Decision|0
4402848|NCT00157014|7180436|FG003|Overall Study|Physician Decision|0
4402849|NCT00157014|7180433|FG000|Overall Study|Medications withdrawn on family request|0
4402850|NCT00157014|7180434|FG001|Overall Study|Medications withdrawn on family request|1
4402851|NCT00157014|7180435|FG002|Overall Study|Medications withdrawn on family request|0
4402852|NCT00157014|7180436|FG003|Overall Study|Medications withdrawn on family request|0
4402853|NCT00157014|7180433|FG000|Overall Study|Patient withdrawn by investigator|1
4402854|NCT00157014|7180434|FG001|Overall Study|Patient withdrawn by investigator|0
4402855|NCT00157014|7180435|FG002|Overall Study|Patient withdrawn by investigator|0
4402856|NCT00157014|7180436|FG003|Overall Study|Patient withdrawn by investigator|0
4402857|NCT00157014|7180433|FG000|Overall Study|Patient unable to return in nursing home|1
4402858|NCT00157014|7180434|FG001|Overall Study|Patient unable to return in nursing home|0
4402859|NCT00157014|7180435|FG002|Overall Study|Patient unable to return in nursing home|0
4402860|NCT00157014|7180436|FG003|Overall Study|Patient unable to return in nursing home|0
4402861|NCT00157014|7180433|FG000|Overall Study|Patient would not receive transplant|0
4402862|NCT00157014|7180434|FG001|Overall Study|Patient would not receive transplant|1
4402863|NCT00157014|7180435|FG002|Overall Study|Patient would not receive transplant|0
4402864|NCT00157014|7180436|FG003|Overall Study|Patient would not receive transplant|0
4402865|NCT00157014|7180433|FG000|Overall Study|Withdrawal by Subject|1
4402866|NCT00157014|7180434|FG001|Overall Study|Withdrawal by Subject|0
4402867|NCT00157014|7180435|FG002|Overall Study|Withdrawal by Subject|0
4402868|NCT00157014|7180436|FG003|Overall Study|Withdrawal by Subject|0
4402869|NCT00157157|7180446|FG000|Overall Study|Withdrawal by Subject|6
4402870|NCT00157157|7180446|FG000|Overall Study|Physician Decision|1
4402871|NCT00157157|7180446|FG000|Overall Study|Lost to Follow-up|1
4402872|NCT00157157|7180446|FG000|Overall Study|Enrolled in another study|1
4402873|NCT00157157|7180446|FG000|Overall Study|Met exclusion criteria|1
4402874|NCT00157157|7180446|FG000|Overall Study|Inclusion not met- baseline FVIII value|1
4402875|NCT00157196|7180457|FG000|Overall Study|Ongoing at data cut-off|9
4402876|NCT00157209|7180463|FG000|Overall Study|Ongoing at data cut-off|10
4402877|NCT00157209|7180464|FG001|Overall Study|Ongoing at data cut-off|0
4402878|NCT00157248|7180474|FG000|Overall Study|Adverse Event|36
4402879|NCT00157248|7180475|FG001|Overall Study|Adverse Event|25
4402880|NCT00157248|7180476|FG002|Overall Study|Adverse Event|13
4402881|NCT00157248|7180477|FG003|Overall Study|Adverse Event|33
4402882|NCT00157248|7180474|FG000|Overall Study|Protocol Violation|4
4402883|NCT00157248|7180475|FG001|Overall Study|Protocol Violation|0
4402884|NCT00157248|7180476|FG002|Overall Study|Protocol Violation|2
4402885|NCT00157248|7180477|FG003|Overall Study|Protocol Violation|2
4402886|NCT00157248|7180474|FG000|Overall Study|Lost to Follow-up|0
4402887|NCT00157248|7180475|FG001|Overall Study|Lost to Follow-up|1
4402888|NCT00157248|7180476|FG002|Overall Study|Lost to Follow-up|0
4402889|NCT00157248|7180477|FG003|Overall Study|Lost to Follow-up|0
4402890|NCT00157248|7180474|FG000|Overall Study|Withdrawal by Subject|1
4402891|NCT00157248|7180475|FG001|Overall Study|Withdrawal by Subject|4
4402892|NCT00157248|7180476|FG002|Overall Study|Withdrawal by Subject|3
4402893|NCT00157248|7180477|FG003|Overall Study|Withdrawal by Subject|3
4402894|NCT00157248|7180474|FG000|Overall Study|site closures, subject moving|7
4402895|NCT00157248|7180475|FG001|Overall Study|site closures, subject moving|7
4402896|NCT00157248|7180476|FG002|Overall Study|site closures, subject moving|3
4402897|NCT00157248|7180477|FG003|Overall Study|site closures, subject moving|9
4511142|NCT00924560|7319982|FG002|Overall Study|Miscellaneous Reasons|10
4511143|NCT00924638|7320009|FG000|Overall Study|Death|3
4511144|NCT00924638|7320010|FG001|Overall Study|Death|2
4511145|NCT00924638|7320009|FG000|Overall Study|Lost to Follow-up|1
4511146|NCT00924638|7320010|FG001|Overall Study|Lost to Follow-up|1
4511147|NCT00924638|7320009|FG000|Overall Study|Withdrawal by Subject|5
4511148|NCT00924638|7320010|FG001|Overall Study|Withdrawal by Subject|7
4511149|NCT00924638|7320009|FG000|Overall Study|Physician Decision|3
4511150|NCT00924638|7320010|FG001|Overall Study|Physician Decision|3
4511151|NCT00924651|7320018|FG000|Overall Study|Chemo started too soon|2
4511152|NCT00924651|7320019|FG001|Overall Study|Chemo started too soon|3
4511153|NCT00924651|7320018|FG000|Overall Study|No Reason|3
4511154|NCT00924651|7320019|FG001|Overall Study|No Reason|7
4511155|NCT00924651|7320018|FG000|Overall Study|Overwhelmed|6
4511156|NCT00924651|7320019|FG001|Overall Study|Overwhelmed|6
4511157|NCT00924651|7320018|FG000|Overall Study|Noncompliant|1
4511158|NCT00924651|7320019|FG001|Overall Study|Noncompliant|4
4511159|NCT00924651|7320018|FG000|Overall Study|Medical|1
4511160|NCT00924651|7320019|FG001|Overall Study|Medical|3
4511161|NCT00924651|7320018|FG000|Overall Study|Changed Mind|10
4511162|NCT00924651|7320019|FG001|Overall Study|Changed Mind|1
4511163|NCT00924651|7320018|FG000|Overall Study|Incomplete Form|2
4511164|NCT00924651|7320019|FG001|Overall Study|Incomplete Form|1
4511165|NCT00924664|7320027|FG000|Overall Study|Adverse Event|23
4511166|NCT00924664|7320028|FG001|Overall Study|Adverse Event|39
4511167|NCT00924664|7320027|FG000|Overall Study|Lack of Efficacy|10
4511168|NCT00924664|7320028|FG001|Overall Study|Lack of Efficacy|15
4628917|NCT01866319|7496410|FG002|Overall Study|Physician Decision|1
4628918|NCT01866319|7496408|FG000|Overall Study|Protocol Violation|0
4511169|NCT00924664|7320027|FG000|Overall Study|Lost to Follow-up|10
4628919|NCT01866319|7496409|FG001|Overall Study|Protocol Violation|0
4511170|NCT00924664|7320028|FG001|Overall Study|Lost to Follow-up|12
4628920|NCT01866319|7496410|FG002|Overall Study|Protocol Violation|1
4628921|NCT01866319|7496408|FG000|Overall Study|Withdrawal by Subject|32
4628922|NCT01866319|7496409|FG001|Overall Study|Withdrawal by Subject|14
4628923|NCT01866319|7496410|FG002|Overall Study|Withdrawal by Subject|12
4628924|NCT01866423|7496425|FG000|Overall Study|Lack of Efficacy|3
4402898|NCT00157755|7180499|FG000|Overall Study|Death|2
4402899|NCT00157755|7180500|FG001|Overall Study|Death|3
4402900|NCT00157755|7180501|FG002|Overall Study|Death|3
4402901|NCT00157755|7180502|FG003|Overall Study|Death|2
4402902|NCT00157755|7180503|FG004|Overall Study|Death|0
4402903|NCT00157755|7180504|FG005|Overall Study|Death|0
4402904|NCT00157755|7180499|FG000|Overall Study|Lost to Follow-up|0
4402905|NCT00157755|7180500|FG001|Overall Study|Lost to Follow-up|0
4402906|NCT00157755|7180501|FG002|Overall Study|Lost to Follow-up|1
4402907|NCT00157755|7180502|FG003|Overall Study|Lost to Follow-up|0
4402908|NCT00157755|7180503|FG004|Overall Study|Lost to Follow-up|0
4402909|NCT00157755|7180504|FG005|Overall Study|Lost to Follow-up|0
4402910|NCT00157755|7180499|FG000|Overall Study|Withdrawal by Subject|0
4402911|NCT00157755|7180500|FG001|Overall Study|Withdrawal by Subject|0
4402912|NCT00157755|7180501|FG002|Overall Study|Withdrawal by Subject|1
4402913|NCT00157755|7180502|FG003|Overall Study|Withdrawal by Subject|1
4402914|NCT00157755|7180503|FG004|Overall Study|Withdrawal by Subject|1
4402915|NCT00157755|7180504|FG005|Overall Study|Withdrawal by Subject|2
4402916|NCT00157755|7180499|FG000|Overall Study|Explant due to infection|0
4402917|NCT00157755|7180500|FG001|Overall Study|Explant due to infection|0
4402918|NCT00157755|7180501|FG002|Overall Study|Explant due to infection|1
4402919|NCT00157755|7180502|FG003|Overall Study|Explant due to infection|0
4402920|NCT00157755|7180503|FG004|Overall Study|Explant due to infection|0
4402921|NCT00157755|7180504|FG005|Overall Study|Explant due to infection|0
4402922|NCT00157755|7180499|FG000|Overall Study|Medical reason|0
4402923|NCT00157755|7180500|FG001|Overall Study|Medical reason|0
4402924|NCT00157755|7180501|FG002|Overall Study|Medical reason|1
4402925|NCT00157755|7180502|FG003|Overall Study|Medical reason|1
4402926|NCT00157755|7180503|FG004|Overall Study|Medical reason|0
4402927|NCT00157755|7180504|FG005|Overall Study|Medical reason|0
4402928|NCT00157755|7180499|FG000|Overall Study|Study site closure|0
4402929|NCT00157755|7180500|FG001|Overall Study|Study site closure|1
4402930|NCT00157755|7180501|FG002|Overall Study|Study site closure|0
4402931|NCT00157755|7180502|FG003|Overall Study|Study site closure|0
4402932|NCT00157755|7180503|FG004|Overall Study|Study site closure|0
4402933|NCT00157755|7180504|FG005|Overall Study|Study site closure|0
4402934|NCT00157755|7180499|FG000|Overall Study|Subject non-compliance|0
4402935|NCT00157755|7180500|FG001|Overall Study|Subject non-compliance|0
4402936|NCT00157755|7180501|FG002|Overall Study|Subject non-compliance|0
4402937|NCT00157755|7180502|FG003|Overall Study|Subject non-compliance|0
4402938|NCT00157755|7180503|FG004|Overall Study|Subject non-compliance|0
4402939|NCT00157755|7180504|FG005|Overall Study|Subject non-compliance|1
4402940|NCT00157755|7180499|FG000|Overall Study|Study completion|0
4402941|NCT00157755|7180500|FG001|Overall Study|Study completion|0
4402942|NCT00157755|7180501|FG002|Overall Study|Study completion|0
4402943|NCT00157755|7180502|FG003|Overall Study|Study completion|0
4402944|NCT00157755|7180503|FG004|Overall Study|Study completion|1
4402945|NCT00157755|7180504|FG005|Overall Study|Study completion|2
4402946|NCT00157820|7180513|FG000|Randomized|Physician Decision|4
4402947|NCT00157820|7180514|FG001|Randomized|Physician Decision|2
4402948|NCT00157820|7180515|FG002|Randomized|Physician Decision|3
4402949|NCT00157820|7180513|FG000|Randomized|Withdrawal by Subject|1
4402950|NCT00157820|7180514|FG001|Randomized|Withdrawal by Subject|2
4402951|NCT00157820|7180515|FG002|Randomized|Withdrawal by Subject|3
4402952|NCT00157820|7180513|FG000|Randomized|Protocol Violation|2
4402953|NCT00157820|7180514|FG001|Randomized|Protocol Violation|1
4402954|NCT00157820|7180515|FG002|Randomized|Protocol Violation|2
4402955|NCT00157820|7180513|FG000|1st 8 Month|Death|7
4402956|NCT00157820|7180514|FG001|1st 8 Month|Death|8
4402957|NCT00157820|7180515|FG002|1st 8 Month|Death|3
4402958|NCT00157820|7180513|FG000|1st 8 Month|Lost to Follow-up|1
4402959|NCT00157820|7180514|FG001|1st 8 Month|Lost to Follow-up|2
4402960|NCT00157820|7180515|FG002|1st 8 Month|Lost to Follow-up|1
4402961|NCT00157820|7180513|FG000|1st 8 Month|Premature cross-over|0
4402962|NCT00157820|7180514|FG001|1st 8 Month|Premature cross-over|2
4402963|NCT00157820|7180515|FG002|1st 8 Month|Premature cross-over|2
4402964|NCT00157820|7180513|FG000|2nd 8 Months|Death|3
4402965|NCT00157820|7180514|FG001|2nd 8 Months|Death|1
4402966|NCT00157820|7180515|FG002|2nd 8 Months|Death|3
4402967|NCT00157820|7180513|FG000|2nd 8 Months|Lost to Follow-up|1
4402968|NCT00157820|7180514|FG001|2nd 8 Months|Lost to Follow-up|5
4628925|NCT01866423|7496425|FG000|Overall Study|Sponsor Decision|1
4628926|NCT01866826|7496433|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1
4628927|NCT01866826|7496434|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0
4402969|NCT00157820|7180515|FG002|2nd 8 Months|Lost to Follow-up|2
4402970|NCT00157820|7180513|FG000|2nd 8 Months|Premature cross-over|1
4402971|NCT00157820|7180514|FG001|2nd 8 Months|Premature cross-over|7
4402972|NCT00157820|7180515|FG002|2nd 8 Months|Premature cross-over|9
4402973|NCT00157950|7180526|FG000|Overall Study|Death|1
4402974|NCT00157950|7180527|FG001|Overall Study|Death|0
4402975|NCT00158054|7180535|FG000|Overall Study|Refused to continue|3
4402976|NCT00158054|7180536|FG001|Overall Study|Refused to continue|0
4402977|NCT00158054|7180535|FG000|Overall Study|Unavailable for follow up|7
4402978|NCT00158054|7180536|FG001|Overall Study|Unavailable for follow up|3
4402979|NCT00158184|7180544|FG000|Overall Study|personal issues|3
4402980|NCT00158184|7180545|FG001|Overall Study|personal issues|1
4402981|NCT00158184|7180544|FG000|Overall Study|failed for follow unit/study rules|2
4402982|NCT00158184|7180545|FG001|Overall Study|failed for follow unit/study rules|0
4402983|NCT00158184|7180544|FG000|Overall Study|Adverse Event|1
4402984|NCT00158184|7180545|FG001|Overall Study|Adverse Event|1
4402985|NCT00158262|7180590|FG000|Overall Study|Lost to Follow-up|1
4402986|NCT00158262|7180591|FG001|Overall Study|Lost to Follow-up|1
4402987|NCT00158600|7180603|FG000|Overall Study|unable to commit time to study|0
4402988|NCT00158600|7180604|FG001|Overall Study|unable to commit time to study|1
4402989|NCT00158600|7180603|FG000|Overall Study|Adverse Event|2
4402990|NCT00158600|7180604|FG001|Overall Study|Adverse Event|1
4402991|NCT00158600|7180603|FG000|Overall Study|Death|1
4402992|NCT00158600|7180604|FG001|Overall Study|Death|0
4402993|NCT00158600|7180603|FG000|Overall Study|Withdrawal by Subject|2
4402994|NCT00158600|7180604|FG001|Overall Study|Withdrawal by Subject|2
4402995|NCT00158756|7180625|FG000|Overall Study|Withdrawal by Subject|5
4402996|NCT00158756|7180626|FG001|Overall Study|Withdrawal by Subject|0
4402997|NCT00158756|7180627|FG002|Overall Study|Withdrawal by Subject|6
4402998|NCT00158756|7180628|FG003|Overall Study|Withdrawal by Subject|1
4402999|NCT00158756|7180629|FG004|Overall Study|Withdrawal by Subject|3
4403000|NCT00158756|7180625|FG000|Overall Study|Adverse Event|0
4403001|NCT00158756|7180626|FG001|Overall Study|Adverse Event|0
4403002|NCT00158756|7180627|FG002|Overall Study|Adverse Event|1
4403003|NCT00158756|7180628|FG003|Overall Study|Adverse Event|0
4403004|NCT00158756|7180629|FG004|Overall Study|Adverse Event|0
4403005|NCT00158756|7180625|FG000|Overall Study|Serious adverse event|0
4403006|NCT00158756|7180626|FG001|Overall Study|Serious adverse event|0
4403007|NCT00158756|7180627|FG002|Overall Study|Serious adverse event|1
4403008|NCT00158756|7180628|FG003|Overall Study|Serious adverse event|0
4403009|NCT00158756|7180629|FG004|Overall Study|Serious adverse event|0
4403010|NCT00158860|7180643|FG000|Overall Study|Adverse Event|3
4403011|NCT00158860|7180644|FG001|Overall Study|Adverse Event|6
4403012|NCT00158860|7180643|FG000|Overall Study|Lost to Follow-up|11
4403013|NCT00158860|7180644|FG001|Overall Study|Lost to Follow-up|17
4403014|NCT00158860|7180643|FG000|Overall Study|Protocol Violation|8
4403015|NCT00158860|7180644|FG001|Overall Study|Protocol Violation|23
4403016|NCT00158860|7180643|FG000|Overall Study|Withdrawal by Subject|7
4403017|NCT00158860|7180644|FG001|Overall Study|Withdrawal by Subject|17
4403018|NCT00158860|7180643|FG000|Overall Study|MOVING OUT OF STATE|1
4403019|NCT00158860|7180644|FG001|Overall Study|MOVING OUT OF STATE|0
4403020|NCT00158860|7180643|FG000|Overall Study|Pregnancy|3
4403021|NCT00158860|7180644|FG001|Overall Study|Pregnancy|3
4403022|NCT00158860|7180643|FG000|Overall Study|SPONSOR STOPPED STUDY|2
4403023|NCT00158860|7180644|FG001|Overall Study|SPONSOR STOPPED STUDY|2
4403024|NCT00158860|7180643|FG000|Overall Study|SPONSOR REQUEST|0
4403025|NCT00158860|7180644|FG001|Overall Study|SPONSOR REQUEST|1
4403026|NCT00158860|7180643|FG000|Overall Study|Lost to Follow up but returned per GSK|0
4403027|NCT00158860|7180644|FG001|Overall Study|Lost to Follow up but returned per GSK|1
4403028|NCT00158860|7180643|FG000|Overall Study|Closed per sponsor|0
4403029|NCT00158860|7180644|FG001|Overall Study|Closed per sponsor|1
4403030|NCT00159432|7180692|FG000|Overall Study|Adverse Event|1
4403031|NCT00159432|7180692|FG000|Overall Study|Death|1
4403032|NCT00159432|7180692|FG000|Overall Study|Lack of Efficacy|8
4403033|NCT00159822|7180696|FG000|Voriconazole Treatment Period|Lack of Efficacy|3
4403034|NCT00159822|7180696|FG000|Voriconazole Treatment Period|Adverse Event|9
4403035|NCT00159822|7180696|FG000|Voriconazole Treatment Period|Death|4
4403036|NCT00159822|7180696|FG000|Voriconazole Treatment Period|Protocol Violation|2
4403037|NCT00159822|7180696|FG000|Voriconazole Treatment Period|Lost to Follow-up|2
4403038|NCT00159822|7180696|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2
4403039|NCT00159822|7180696|FG000|Post-treatment Follow-up Period|Death|1
4403040|NCT00159822|7180696|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1
4403041|NCT00159822|7180696|FG000|Post-treatment Follow-up Period|Reason unspecified|1
4403042|NCT00159861|7180702|FG000|Core Study - 16 Weeks|Death|3
4403043|NCT00159861|7180703|FG001|Core Study - 16 Weeks|Death|0
4403044|NCT00159861|7180702|FG000|Core Study - 16 Weeks|Adverse Event|12
4403045|NCT00159861|7180703|FG001|Core Study - 16 Weeks|Adverse Event|6
4403046|NCT00159861|7180702|FG000|Core Study - 16 Weeks|Lack of Efficacy|2
4403047|NCT00159861|7180703|FG001|Core Study - 16 Weeks|Lack of Efficacy|3
4403048|NCT00159861|7180702|FG000|Core Study - 16 Weeks|Reason Unspecified|5
4403049|NCT00159861|7180703|FG001|Core Study - 16 Weeks|Reason Unspecified|3
4403050|NCT00159861|7180702|FG000|Core Study - 16 Weeks|Subject Defaulted|1
4403051|NCT00159861|7180703|FG001|Core Study - 16 Weeks|Subject Defaulted|0
4403052|NCT00159861|7180702|FG000|Core Study - 16 Weeks|Randomized but not Treated|2
4403053|NCT00159861|7180703|FG001|Core Study - 16 Weeks|Randomized but not Treated|0
4403054|NCT00159861|7180702|FG000|Extension Study - up to 3 Years|Death|24
4403055|NCT00159861|7180703|FG001|Extension Study - up to 3 Years|Death|28
4403056|NCT00159861|7180702|FG000|Extension Study - up to 3 Years|Adverse Event|14
4403057|NCT00159861|7180703|FG001|Extension Study - up to 3 Years|Adverse Event|14
4403058|NCT00159861|7180702|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5
4403059|NCT00159861|7180703|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1
4403060|NCT00159861|7180702|FG000|Extension Study - up to 3 Years|Reason Unspecified|12
4403061|NCT00159861|7180703|FG001|Extension Study - up to 3 Years|Reason Unspecified|19
4403062|NCT00159861|7180702|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7
4403063|NCT00159861|7180703|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9
4403064|NCT00159874|7180721|FG000|Overall Study|Adverse Event|2
4403065|NCT00159874|7180722|FG001|Overall Study|Adverse Event|2
4403066|NCT00159874|7180723|FG002|Overall Study|Adverse Event|5
4403067|NCT00159874|7180724|FG003|Overall Study|Adverse Event|1
4403068|NCT00159874|7180725|FG004|Overall Study|Adverse Event|1
4403069|NCT00159874|7180726|FG005|Overall Study|Adverse Event|2
4403070|NCT00159874|7180727|FG006|Overall Study|Adverse Event|0
4403071|NCT00159874|7180721|FG000|Overall Study|Does Not Meet Entrance Criteria|1
4403072|NCT00159874|7180722|FG001|Overall Study|Does Not Meet Entrance Criteria|0
4403073|NCT00159874|7180723|FG002|Overall Study|Does Not Meet Entrance Criteria|1
4403074|NCT00159874|7180724|FG003|Overall Study|Does Not Meet Entrance Criteria|0
4403075|NCT00159874|7180725|FG004|Overall Study|Does Not Meet Entrance Criteria|0
4403076|NCT00159874|7180726|FG005|Overall Study|Does Not Meet Entrance Criteria|0
4403077|NCT00159874|7180727|FG006|Overall Study|Does Not Meet Entrance Criteria|0
4403078|NCT00159874|7180721|FG000|Overall Study|Lack of Efficacy|2
4403079|NCT00159874|7180722|FG001|Overall Study|Lack of Efficacy|0
4403080|NCT00159874|7180723|FG002|Overall Study|Lack of Efficacy|1
4403081|NCT00159874|7180724|FG003|Overall Study|Lack of Efficacy|1
4403082|NCT00159874|7180725|FG004|Overall Study|Lack of Efficacy|0
4403083|NCT00159874|7180726|FG005|Overall Study|Lack of Efficacy|3
4403084|NCT00159874|7180727|FG006|Overall Study|Lack of Efficacy|0
4403085|NCT00159874|7180721|FG000|Overall Study|Lost to Follow-up|1
4403086|NCT00159874|7180722|FG001|Overall Study|Lost to Follow-up|0
4403087|NCT00159874|7180723|FG002|Overall Study|Lost to Follow-up|3
4403088|NCT00159874|7180724|FG003|Overall Study|Lost to Follow-up|0
4403089|NCT00159874|7180725|FG004|Overall Study|Lost to Follow-up|1
4403090|NCT00159874|7180726|FG005|Overall Study|Lost to Follow-up|2
4403091|NCT00159874|7180727|FG006|Overall Study|Lost to Follow-up|1
4403092|NCT00159874|7180721|FG000|Overall Study|Other|8
4403093|NCT00159874|7180722|FG001|Overall Study|Other|8
4403094|NCT00159874|7180723|FG002|Overall Study|Other|8
4403095|NCT00159874|7180724|FG003|Overall Study|Other|0
4403096|NCT00159874|7180725|FG004|Overall Study|Other|2
4403097|NCT00159874|7180726|FG005|Overall Study|Other|1
4403098|NCT00159874|7180727|FG006|Overall Study|Other|3
4403099|NCT00159874|7180721|FG000|Overall Study|Protocol Violation|0
4403100|NCT00159874|7180722|FG001|Overall Study|Protocol Violation|5
4403101|NCT00159874|7180723|FG002|Overall Study|Protocol Violation|2
4403102|NCT00159874|7180724|FG003|Overall Study|Protocol Violation|0
4403103|NCT00159874|7180725|FG004|Overall Study|Protocol Violation|0
4403104|NCT00159874|7180726|FG005|Overall Study|Protocol Violation|0
4403105|NCT00159874|7180727|FG006|Overall Study|Protocol Violation|0
4403106|NCT00159874|7180721|FG000|Overall Study|Death|3
4403107|NCT00159874|7180722|FG001|Overall Study|Death|8
4403108|NCT00159874|7180723|FG002|Overall Study|Death|15
4403109|NCT00159874|7180724|FG003|Overall Study|Death|0
4403110|NCT00159874|7180725|FG004|Overall Study|Death|1
4403111|NCT00159874|7180726|FG005|Overall Study|Death|2
4403112|NCT00159874|7180727|FG006|Overall Study|Death|0
4403113|NCT00159874|7180721|FG000|Overall Study|Withdrawal by Subject|2
4403114|NCT00159874|7180722|FG001|Overall Study|Withdrawal by Subject|6
4403115|NCT00159874|7180723|FG002|Overall Study|Withdrawal by Subject|8
4403116|NCT00159874|7180724|FG003|Overall Study|Withdrawal by Subject|4
4403117|NCT00159874|7180725|FG004|Overall Study|Withdrawal by Subject|3
4403118|NCT00159874|7180726|FG005|Overall Study|Withdrawal by Subject|2
4403119|NCT00159874|7180727|FG006|Overall Study|Withdrawal by Subject|1
4403120|NCT00159874|7180721|FG000|Overall Study|Pregnancy|1
4403121|NCT00159874|7180722|FG001|Overall Study|Pregnancy|1
4403122|NCT00159874|7180723|FG002|Overall Study|Pregnancy|0
4403123|NCT00159874|7180724|FG003|Overall Study|Pregnancy|0
4403124|NCT00159874|7180725|FG004|Overall Study|Pregnancy|0
4403125|NCT00159874|7180726|FG005|Overall Study|Pregnancy|0
4403126|NCT00159874|7180727|FG006|Overall Study|Pregnancy|0
4403127|NCT00159913|7180747|FG000|Overall Study|Adverse Event|1
4403128|NCT00159913|7180748|FG001|Overall Study|Adverse Event|0
4403129|NCT00159913|7180749|FG002|Overall Study|Adverse Event|1
4403130|NCT00159913|7180750|FG003|Overall Study|Adverse Event|0
4403131|NCT00159913|7180747|FG000|Overall Study|Withdrawal by Subject|0
4403132|NCT00159913|7180748|FG001|Overall Study|Withdrawal by Subject|0
4403133|NCT00159913|7180749|FG002|Overall Study|Withdrawal by Subject|0
4403134|NCT00159913|7180750|FG003|Overall Study|Withdrawal by Subject|1
4403135|NCT00159913|7180747|FG000|Overall Study|Lost to Follow-up|0
4403136|NCT00159913|7180748|FG001|Overall Study|Lost to Follow-up|0
4403137|NCT00159913|7180749|FG002|Overall Study|Lost to Follow-up|0
4403138|NCT00159913|7180750|FG003|Overall Study|Lost to Follow-up|1
4403139|NCT00159913|7180747|FG000|Overall Study|Protocol Violation|1
4403140|NCT00159913|7180748|FG001|Overall Study|Protocol Violation|0
4403141|NCT00159913|7180749|FG002|Overall Study|Protocol Violation|1
4403142|NCT00159913|7180750|FG003|Overall Study|Protocol Violation|0
4403143|NCT00160199|7180773|FG000|Overall Study|Adverse Event|5
4403144|NCT00160199|7180774|FG001|Overall Study|Adverse Event|14
4403145|NCT00160199|7180773|FG000|Overall Study|Lack of Efficacy|0
4403146|NCT00160199|7180774|FG001|Overall Study|Lack of Efficacy|1
4403147|NCT00160199|7180773|FG000|Overall Study|Lost to Follow-up|7
4403148|NCT00160199|7180774|FG001|Overall Study|Lost to Follow-up|7
4403149|NCT00160199|7180773|FG000|Overall Study|Withdrawal by Subject|4
4403150|NCT00160199|7180774|FG001|Overall Study|Withdrawal by Subject|6
4403151|NCT00160199|7180773|FG000|Overall Study|Administrative|0
4403152|NCT00160199|7180774|FG001|Overall Study|Administrative|1
4403153|NCT00160199|7180773|FG000|Overall Study|Protocol Violation|8
4403154|NCT00160199|7180774|FG001|Overall Study|Protocol Violation|8
4403155|NCT00160251|7180786|FG000|Prior to Amendment 2|Adverse Event|2
4403156|NCT00160251|7180787|FG001|Prior to Amendment 2|Adverse Event|1
4403157|NCT00160251|7180788|FG002|Prior to Amendment 2|Adverse Event|3
4403158|NCT00160251|7180789|FG003|Prior to Amendment 2|Adverse Event|1
4403159|NCT00160251|7180790|FG004|Prior to Amendment 2|Adverse Event|1
4403160|NCT00160251|7180791|FG005|Prior to Amendment 2|Adverse Event|1
4403161|NCT00160251|7180792|FG006|Prior to Amendment 2|Adverse Event|1
4403162|NCT00160251|7180793|FG007|Prior to Amendment 2|Adverse Event|0
4403163|NCT00160251|7180786|FG000|Prior to Amendment 2|Lack of Efficacy|0
4403164|NCT00160251|7180787|FG001|Prior to Amendment 2|Lack of Efficacy|4
4403165|NCT00160251|7180788|FG002|Prior to Amendment 2|Lack of Efficacy|37
4403166|NCT00160251|7180789|FG003|Prior to Amendment 2|Lack of Efficacy|35
4403167|NCT00160251|7180790|FG004|Prior to Amendment 2|Lack of Efficacy|24
4403168|NCT00160251|7180791|FG005|Prior to Amendment 2|Lack of Efficacy|55
4403169|NCT00160251|7180792|FG006|Prior to Amendment 2|Lack of Efficacy|0
4403170|NCT00160251|7180793|FG007|Prior to Amendment 2|Lack of Efficacy|0
4403171|NCT00160251|7180786|FG000|Prior to Amendment 2|Lost to Follow-up|0
4403172|NCT00160251|7180787|FG001|Prior to Amendment 2|Lost to Follow-up|0
4403173|NCT00160251|7180788|FG002|Prior to Amendment 2|Lost to Follow-up|1
4403174|NCT00160251|7180789|FG003|Prior to Amendment 2|Lost to Follow-up|0
4403175|NCT00160251|7180790|FG004|Prior to Amendment 2|Lost to Follow-up|1
4403176|NCT00160251|7180791|FG005|Prior to Amendment 2|Lost to Follow-up|1
4403177|NCT00160251|7180792|FG006|Prior to Amendment 2|Lost to Follow-up|0
4403178|NCT00160251|7180793|FG007|Prior to Amendment 2|Lost to Follow-up|0
4403179|NCT00160251|7180786|FG000|Prior to Amendment 2|Withdrawal by Subject|3
4403180|NCT00160251|7180787|FG001|Prior to Amendment 2|Withdrawal by Subject|1
4403181|NCT00160251|7180788|FG002|Prior to Amendment 2|Withdrawal by Subject|3
4403182|NCT00160251|7180789|FG003|Prior to Amendment 2|Withdrawal by Subject|4
4403183|NCT00160251|7180790|FG004|Prior to Amendment 2|Withdrawal by Subject|2
4403184|NCT00160251|7180791|FG005|Prior to Amendment 2|Withdrawal by Subject|3
4403185|NCT00160251|7180792|FG006|Prior to Amendment 2|Withdrawal by Subject|3
4403186|NCT00160251|7180793|FG007|Prior to Amendment 2|Withdrawal by Subject|0
4403187|NCT00160251|7180786|FG000|Prior to Amendment 2|Noncompliance with protocol|1
4403188|NCT00160251|7180787|FG001|Prior to Amendment 2|Noncompliance with protocol|0
4403189|NCT00160251|7180788|FG002|Prior to Amendment 2|Noncompliance with protocol|0
4403190|NCT00160251|7180789|FG003|Prior to Amendment 2|Noncompliance with protocol|0
4403191|NCT00160251|7180790|FG004|Prior to Amendment 2|Noncompliance with protocol|0
4403192|NCT00160251|7180791|FG005|Prior to Amendment 2|Noncompliance with protocol|0
4403193|NCT00160251|7180792|FG006|Prior to Amendment 2|Noncompliance with protocol|0
4403194|NCT00160251|7180793|FG007|Prior to Amendment 2|Noncompliance with protocol|0
4403195|NCT00160251|7180786|FG000|Prior to Amendment 2|Completed Treatment Phase|3
4403196|NCT00160251|7180787|FG001|Prior to Amendment 2|Completed Treatment Phase|0
4403197|NCT00160251|7180788|FG002|Prior to Amendment 2|Completed Treatment Phase|0
4403198|NCT00160251|7180789|FG003|Prior to Amendment 2|Completed Treatment Phase|0
4403199|NCT00160251|7180790|FG004|Prior to Amendment 2|Completed Treatment Phase|0
4403200|NCT00160251|7180791|FG005|Prior to Amendment 2|Completed Treatment Phase|23
4403201|NCT00160251|7180792|FG006|Prior to Amendment 2|Completed Treatment Phase|0
4403202|NCT00160251|7180793|FG007|Prior to Amendment 2|Completed Treatment Phase|0
4403203|NCT00160251|7180786|FG000|Post-amendment 2|Adverse Event|0
4403204|NCT00160251|7180787|FG001|Post-amendment 2|Adverse Event|0
4403205|NCT00160251|7180788|FG002|Post-amendment 2|Adverse Event|0
4403206|NCT00160251|7180789|FG003|Post-amendment 2|Adverse Event|0
4403207|NCT00160251|7180790|FG004|Post-amendment 2|Adverse Event|0
4403208|NCT00160251|7180791|FG005|Post-amendment 2|Adverse Event|0
4403209|NCT00160251|7180792|FG006|Post-amendment 2|Adverse Event|0
4403210|NCT00160251|7180793|FG007|Post-amendment 2|Adverse Event|20
4403211|NCT00160251|7180786|FG000|Post-amendment 2|Lack of Efficacy|0
4403212|NCT00160251|7180787|FG001|Post-amendment 2|Lack of Efficacy|0
4403213|NCT00160251|7180788|FG002|Post-amendment 2|Lack of Efficacy|0
4403214|NCT00160251|7180789|FG003|Post-amendment 2|Lack of Efficacy|0
4403215|NCT00160251|7180790|FG004|Post-amendment 2|Lack of Efficacy|0
4403216|NCT00160251|7180791|FG005|Post-amendment 2|Lack of Efficacy|0
4403217|NCT00160251|7180792|FG006|Post-amendment 2|Lack of Efficacy|0
4403218|NCT00160251|7180793|FG007|Post-amendment 2|Lack of Efficacy|24
4403219|NCT00160251|7180786|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
4403220|NCT00160251|7180787|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
4403221|NCT00160251|7180788|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
4403222|NCT00160251|7180789|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
4403223|NCT00160251|7180790|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
4403224|NCT00160251|7180791|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
4403225|NCT00160251|7180792|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
4403226|NCT00160251|7180793|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11
4403227|NCT00160524|7180850|FG000|Overall Study|Adverse Event|119
4403228|NCT00160524|7180850|FG000|Overall Study|Adverse Event and Other|94
4403229|NCT00160524|7180850|FG000|Overall Study|Protocol Violation|16
4403230|NCT00160524|7180850|FG000|Overall Study|Protocol Violation and Other|2
4403231|NCT00160524|7180850|FG000|Overall Study|Withdrawal by Subject|141
4403232|NCT00160524|7180850|FG000|Overall Study|Withdrawal by Subject and Other|17
4403233|NCT00160524|7180850|FG000|Overall Study|Physician Decision|27
4403234|NCT00160524|7180850|FG000|Overall Study|Physician Decision and Other|6
4403235|NCT00160524|7180850|FG000|Overall Study|Lost to Follow-up|13
4403236|NCT00160524|7180850|FG000|Overall Study|Lost to Follow-up and Other|1
4403237|NCT00160524|7180850|FG000|Overall Study|Lack of Efficacy|21
4403238|NCT00160524|7180850|FG000|Overall Study|Lack of Efficacy and Other|1
4403239|NCT00160524|7180850|FG000|Overall Study|Other|20
4403240|NCT00160615|7180856|FG000|Overall Study|Adverse Event|5
4403241|NCT00160615|7180857|FG001|Overall Study|Adverse Event|12
4403242|NCT00160615|7180856|FG000|Overall Study|Withdrawal by Subject|0
4403243|NCT00160615|7180857|FG001|Overall Study|Withdrawal by Subject|2
4403244|NCT00160615|7180856|FG000|Overall Study|Lack of Efficacy|11
4403245|NCT00160615|7180857|FG001|Overall Study|Lack of Efficacy|23
4403246|NCT00160615|7180856|FG000|Overall Study|Patient decision|1
4403247|NCT00160615|7180857|FG001|Overall Study|Patient decision|2
4403248|NCT00160615|7180856|FG000|Overall Study|Investigator decision|1
4403249|NCT00160615|7180857|FG001|Overall Study|Investigator decision|1
4403250|NCT00160615|7180856|FG000|Overall Study|AE agents had to be discontinued (exam.)|0
4403251|NCT00160615|7180857|FG001|Overall Study|AE agents had to be discontinued (exam.)|1
4403252|NCT00160615|7180856|FG000|Overall Study|Switch to surgical treatment|0
4403253|NCT00160615|7180857|FG001|Overall Study|Switch to surgical treatment|2
4403254|NCT00160615|7180856|FG000|Overall Study|Non-compliance was suspected|0
4403255|NCT00160615|7180857|FG001|Overall Study|Non-compliance was suspected|1
4403256|NCT00160615|7180856|FG000|Overall Study|Poor compliance|0
4403257|NCT00160615|7180857|FG001|Overall Study|Poor compliance|1
4403258|NCT00160641|7180865|FG000|Overall Study|Adverse Event|102
4403259|NCT00160641|7180865|FG000|Overall Study|Withdrawal by Subject|87
4403260|NCT00160641|7180865|FG000|Overall Study|Lost to Follow-up|8
4403261|NCT00160641|7180865|FG000|Overall Study|Lack of Efficacy|12
4403262|NCT00160641|7180865|FG000|Overall Study|Protocol Violation|3
4403263|NCT00160641|7180865|FG000|Overall Study|Other|9
4403264|NCT00160654|7180869|FG000|Overall Study|Adverse Event|14
4403265|NCT00160654|7180869|FG000|Overall Study|Lack of Efficacy|4
4403266|NCT00160654|7180869|FG000|Overall Study|Lost to Follow-up|2
4403267|NCT00160654|7180869|FG000|Overall Study|Intake of expired drug|7
4403268|NCT00160654|7180869|FG000|Overall Study|Psychological trauma|1
4403269|NCT00160654|7180869|FG000|Overall Study|Sponsor decision|1
4403270|NCT00160654|7180869|FG000|Overall Study|Patient met exclusion criteria|1
4403271|NCT00160654|7180869|FG000|Overall Study|Patient decision|1
4403272|NCT00160654|7180869|FG000|Overall Study|Poor compliance, dilantin toxicity|1
4403273|NCT00160654|7180869|FG000|Overall Study|Met exclusion criteria|1
4403274|NCT00160667|7180876|FG000|Overall Study|Adverse Event|3
4403275|NCT00160667|7180877|FG001|Overall Study|Adverse Event|1
4403276|NCT00160667|7180878|FG002|Overall Study|Adverse Event|4
4403277|NCT00160667|7180876|FG000|Overall Study|Withdrawal by Subject|2
4403278|NCT00160667|7180877|FG001|Overall Study|Withdrawal by Subject|0
4403279|NCT00160667|7180878|FG002|Overall Study|Withdrawal by Subject|1
4403280|NCT00160667|7180876|FG000|Overall Study|Lack of Efficacy|0
4403281|NCT00160667|7180877|FG001|Overall Study|Lack of Efficacy|1
4403282|NCT00160667|7180878|FG002|Overall Study|Lack of Efficacy|0
4403283|NCT00160667|7180876|FG000|Overall Study|Protocol Violation|0
4403284|NCT00160667|7180877|FG001|Overall Study|Protocol Violation|1
4403285|NCT00160667|7180878|FG002|Overall Study|Protocol Violation|0
4403286|NCT00160667|7180876|FG000|Overall Study|Patient decision|0
4403287|NCT00160667|7180877|FG001|Overall Study|Patient decision|0
4628928|NCT01866826|7496433|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0
4628929|NCT01866826|7496434|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2
4403288|NCT00160667|7180878|FG002|Overall Study|Patient decision|1
4403289|NCT00160680|7180889|FG000|Overall Study|Adverse Event|0
4403290|NCT00160680|7180890|FG001|Overall Study|Adverse Event|1
4403291|NCT00160680|7180889|FG000|Overall Study|Lack of Efficacy|2
4403292|NCT00160680|7180890|FG001|Overall Study|Lack of Efficacy|1
4403293|NCT00160680|7180889|FG000|Overall Study|Lost to Follow-up|3
4403294|NCT00160680|7180890|FG001|Overall Study|Lost to Follow-up|2
4403295|NCT00160680|7180889|FG000|Overall Study|Withdrawal by Subject|4
4403296|NCT00160680|7180890|FG001|Overall Study|Withdrawal by Subject|9
4403297|NCT00160693|7180896|FG000|Overall Study|Adverse Event|97
4403298|NCT00160693|7180896|FG000|Overall Study|Lack of Efficacy|30
4403299|NCT00160693|7180896|FG000|Overall Study|Protocol Violation|24
4403300|NCT00160693|7180896|FG000|Overall Study|Lost to Follow-up|15
4403301|NCT00160693|7180896|FG000|Overall Study|Withdrawal by Subject|54
4403302|NCT00160693|7180896|FG000|Overall Study|Study terminated by sponsor|15
4403303|NCT00160706|7180900|FG000|Overall Study|Adverse Event|53
4403304|NCT00160706|7180900|FG000|Overall Study|Adverse Event and Other Reason|105
4403305|NCT00160706|7180900|FG000|Overall Study|Protocol Violation|3
4403306|NCT00160706|7180900|FG000|Overall Study|Withdrawal by Subject|41
4403307|NCT00160706|7180900|FG000|Overall Study|Withdrawal by Subject and Other|12
4403308|NCT00160706|7180900|FG000|Overall Study|Physician Decision|10
4403309|NCT00160706|7180900|FG000|Overall Study|Physician Decision and Other|3
4403310|NCT00160706|7180900|FG000|Overall Study|Lost to Follow-up|4
4403311|NCT00160706|7180900|FG000|Overall Study|Lost to Follow-up and Other|1
4403312|NCT00160706|7180900|FG000|Overall Study|Lack of Efficacy|42
4403313|NCT00160706|7180900|FG000|Overall Study|Lack of Efficacy and Other|1
4403314|NCT00160706|7180900|FG000|Overall Study|Other Reason|11
4403315|NCT00161213|7180904|FG000|Overall Study|Withdrawal by Subject|1
4403316|NCT00161213|7180904|FG000|Overall Study|Evaluable for toxicity but not response|1
4403317|NCT00161616|7180928|FG000|Overall Study|Withdrawal by Subject|6
4403318|NCT00161616|7180929|FG001|Overall Study|Withdrawal by Subject|5
4403319|NCT00161616|7180928|FG000|Overall Study|Physician Decision|1
4403320|NCT00161616|7180929|FG001|Overall Study|Physician Decision|0
4403321|NCT00161616|7180928|FG000|Overall Study|Death|1
4403322|NCT00161616|7180929|FG001|Overall Study|Death|1
4403323|NCT00161616|7180928|FG000|Overall Study|Lost to Follow-up|17
4403324|NCT00161616|7180929|FG001|Overall Study|Lost to Follow-up|13
4403325|NCT00161616|7180928|FG000|Overall Study|Protocol deviation|1
4403326|NCT00161616|7180929|FG001|Overall Study|Protocol deviation|0
4403327|NCT00162032|7180937|FG000|Overall Study|Lost to Follow-up|4
4403328|NCT00162032|7180938|FG001|Overall Study|Lost to Follow-up|2
4403329|NCT00162032|7180937|FG000|Overall Study|Reason not specified|1
4403330|NCT00162032|7180938|FG001|Overall Study|Reason not specified|0
4403331|NCT00162097|7180953|FG000|Overall Study|Participant no longer met study criteria|0
4403332|NCT00162097|7180954|FG001|Overall Study|Participant no longer met study criteria|0
4403333|NCT00162097|7180955|FG002|Overall Study|Participant no longer met study criteria|0
4403334|NCT00162097|7180956|FG003|Overall Study|Participant no longer met study criteria|1
4403335|NCT00162123|7180980|FG000|Overall Study|Disease progression|27
4403336|NCT00162123|7180981|FG001|Overall Study|Disease progression|19
4403337|NCT00162123|7180982|FG002|Overall Study|Disease progression|10
4403338|NCT00162123|7180983|FG003|Overall Study|Disease progression|4
4403339|NCT00162123|7180984|FG004|Overall Study|Disease progression|8
4403340|NCT00162123|7180985|FG005|Overall Study|Disease progression|3
4403341|NCT00162123|7180986|FG006|Overall Study|Disease progression|1
4403342|NCT00162123|7180987|FG007|Overall Study|Disease progression|0
4403343|NCT00162123|7180980|FG000|Overall Study|Study drug toxicity|6
4403344|NCT00162123|7180981|FG001|Overall Study|Study drug toxicity|1
4403345|NCT00162123|7180982|FG002|Overall Study|Study drug toxicity|5
4403346|NCT00162123|7180983|FG003|Overall Study|Study drug toxicity|0
4403347|NCT00162123|7180984|FG004|Overall Study|Study drug toxicity|4
4403348|NCT00162123|7180985|FG005|Overall Study|Study drug toxicity|1
4403349|NCT00162123|7180986|FG006|Overall Study|Study drug toxicity|1
4403350|NCT00162123|7180987|FG007|Overall Study|Study drug toxicity|0
4403351|NCT00162123|7180980|FG000|Overall Study|Death|3
4403352|NCT00162123|7180981|FG001|Overall Study|Death|3
4403353|NCT00162123|7180982|FG002|Overall Study|Death|1
4403354|NCT00162123|7180983|FG003|Overall Study|Death|1
4403355|NCT00162123|7180984|FG004|Overall Study|Death|1
4403356|NCT00162123|7180985|FG005|Overall Study|Death|1
4403357|NCT00162123|7180986|FG006|Overall Study|Death|0
4403358|NCT00162123|7180987|FG007|Overall Study|Death|0
4403359|NCT00162123|7180980|FG000|Overall Study|Withdrawal by Subject|2
4403360|NCT00162123|7180981|FG001|Overall Study|Withdrawal by Subject|0
4403361|NCT00162123|7180982|FG002|Overall Study|Withdrawal by Subject|2
4403362|NCT00162123|7180983|FG003|Overall Study|Withdrawal by Subject|1
4403363|NCT00162123|7180984|FG004|Overall Study|Withdrawal by Subject|1
4403364|NCT00162123|7180985|FG005|Overall Study|Withdrawal by Subject|2
4403365|NCT00162123|7180986|FG006|Overall Study|Withdrawal by Subject|1
4403366|NCT00162123|7180987|FG007|Overall Study|Withdrawal by Subject|0
4403367|NCT00162123|7180980|FG000|Overall Study|Deterioration without progression|2
4403368|NCT00162123|7180981|FG001|Overall Study|Deterioration without progression|2
4403369|NCT00162123|7180982|FG002|Overall Study|Deterioration without progression|3
4403370|NCT00162123|7180983|FG003|Overall Study|Deterioration without progression|0
4403371|NCT00162123|7180984|FG004|Overall Study|Deterioration without progression|1
4403372|NCT00162123|7180985|FG005|Overall Study|Deterioration without progression|0
4403373|NCT00162123|7180986|FG006|Overall Study|Deterioration without progression|0
4403374|NCT00162123|7180987|FG007|Overall Study|Deterioration without progression|0
4403375|NCT00162123|7180980|FG000|Overall Study|Adverse Event|1
4403376|NCT00162123|7180981|FG001|Overall Study|Adverse Event|2
4403377|NCT00162123|7180982|FG002|Overall Study|Adverse Event|0
4403378|NCT00162123|7180983|FG003|Overall Study|Adverse Event|2
4403379|NCT00162123|7180984|FG004|Overall Study|Adverse Event|1
4403380|NCT00162123|7180985|FG005|Overall Study|Adverse Event|0
4403381|NCT00162123|7180986|FG006|Overall Study|Adverse Event|0
4403382|NCT00162123|7180987|FG007|Overall Study|Adverse Event|0
4403383|NCT00162123|7180980|FG000|Overall Study|Not specified (before treatment)|2
4403384|NCT00162123|7180981|FG001|Overall Study|Not specified (before treatment)|0
4403385|NCT00162123|7180982|FG002|Overall Study|Not specified (before treatment)|0
4403386|NCT00162123|7180983|FG003|Overall Study|Not specified (before treatment)|0
4403387|NCT00162123|7180984|FG004|Overall Study|Not specified (before treatment)|12
4403388|NCT00162123|7180985|FG005|Overall Study|Not specified (before treatment)|1
4403389|NCT00162123|7180986|FG006|Overall Study|Not specified (before treatment)|0
4403390|NCT00162123|7180987|FG007|Overall Study|Not specified (before treatment)|0
4403391|NCT00162123|7180980|FG000|Overall Study|Not specified (after start of treatment)|0
4403392|NCT00162123|7180981|FG001|Overall Study|Not specified (after start of treatment)|0
4403393|NCT00162123|7180982|FG002|Overall Study|Not specified (after start of treatment)|0
4403394|NCT00162123|7180983|FG003|Overall Study|Not specified (after start of treatment)|0
4403395|NCT00162123|7180984|FG004|Overall Study|Not specified (after start of treatment)|3
4403396|NCT00162123|7180985|FG005|Overall Study|Not specified (after start of treatment)|0
4403397|NCT00162123|7180986|FG006|Overall Study|Not specified (after start of treatment)|0
4403398|NCT00162123|7180987|FG007|Overall Study|Not specified (after start of treatment)|0
4403399|NCT00162123|7180980|FG000|Overall Study|Physician Decision|1
4403400|NCT00162123|7180981|FG001|Overall Study|Physician Decision|2
4403401|NCT00162123|7180982|FG002|Overall Study|Physician Decision|0
4403402|NCT00162123|7180983|FG003|Overall Study|Physician Decision|0
4403403|NCT00162123|7180984|FG004|Overall Study|Physician Decision|0
4403404|NCT00162123|7180985|FG005|Overall Study|Physician Decision|1
4403405|NCT00162123|7180986|FG006|Overall Study|Physician Decision|1
4403406|NCT00162123|7180987|FG007|Overall Study|Physician Decision|0
4403407|NCT00162123|7180980|FG000|Overall Study|Tumor assessment only (not treated)|0
4403408|NCT00162123|7180981|FG001|Overall Study|Tumor assessment only (not treated)|0
4403409|NCT00162123|7180982|FG002|Overall Study|Tumor assessment only (not treated)|0
4403410|NCT00162123|7180983|FG003|Overall Study|Tumor assessment only (not treated)|0
4403411|NCT00162123|7180984|FG004|Overall Study|Tumor assessment only (not treated)|0
4403412|NCT00162123|7180985|FG005|Overall Study|Tumor assessment only (not treated)|0
4403413|NCT00162123|7180986|FG006|Overall Study|Tumor assessment only (not treated)|0
4403414|NCT00162123|7180987|FG007|Overall Study|Tumor assessment only (not treated)|1
4403415|NCT00162123|7180980|FG000|Overall Study|Follow-up only (not treated or assessed)|0
4403416|NCT00162123|7180981|FG001|Overall Study|Follow-up only (not treated or assessed)|0
4403417|NCT00162123|7180982|FG002|Overall Study|Follow-up only (not treated or assessed)|0
4403418|NCT00162123|7180983|FG003|Overall Study|Follow-up only (not treated or assessed)|0
4403419|NCT00162123|7180984|FG004|Overall Study|Follow-up only (not treated or assessed)|0
4403420|NCT00162123|7180985|FG005|Overall Study|Follow-up only (not treated or assessed)|0
4403421|NCT00162123|7180986|FG006|Overall Study|Follow-up only (not treated or assessed)|0
4403422|NCT00162123|7180987|FG007|Overall Study|Follow-up only (not treated or assessed)|57
4403423|NCT00162136|7181012|FG000|Overall Study|Adverse Event|1
4403424|NCT00162136|7181012|FG000|Overall Study|Death|1
4403425|NCT00162136|7181012|FG000|Overall Study|Disease Progression/Relapse|23
4403426|NCT00162136|7181012|FG000|Overall Study|Investigator Request|5
4403427|NCT00162136|7181012|FG000|Overall Study|Study Drug Toxicity|4
4403428|NCT00162136|7181012|FG000|Overall Study|Withdrawal by Subject|1
4403429|NCT00162266|7181039|FG000|Double-Blind Period|Adverse Event|5
4403430|NCT00162266|7181040|FG001|Double-Blind Period|Adverse Event|9
4403431|NCT00162266|7181041|FG002|Double-Blind Period|Adverse Event|11
4403432|NCT00162266|7181042|FG003|Double-Blind Period|Adverse Event|0
4403433|NCT00162266|7181039|FG000|Double-Blind Period|Death|0
4403434|NCT00162266|7181040|FG001|Double-Blind Period|Death|1
4403435|NCT00162266|7181041|FG002|Double-Blind Period|Death|0
4403436|NCT00162266|7181042|FG003|Double-Blind Period|Death|0
4403437|NCT00162266|7181039|FG000|Double-Blind Period|Lost to Follow-up|1
4403438|NCT00162266|7181040|FG001|Double-Blind Period|Lost to Follow-up|2
4403439|NCT00162266|7181041|FG002|Double-Blind Period|Lost to Follow-up|0
4403440|NCT00162266|7181042|FG003|Double-Blind Period|Lost to Follow-up|0
4403441|NCT00162266|7181039|FG000|Double-Blind Period|Other Reason|1
4403442|NCT00162266|7181040|FG001|Double-Blind Period|Other Reason|0
4403443|NCT00162266|7181041|FG002|Double-Blind Period|Other Reason|1
4403444|NCT00162266|7181042|FG003|Double-Blind Period|Other Reason|0
4403445|NCT00162266|7181039|FG000|Double-Blind Period|Lack of Efficacy|13
4403446|NCT00162266|7181040|FG001|Double-Blind Period|Lack of Efficacy|17
4403447|NCT00162266|7181041|FG002|Double-Blind Period|Lack of Efficacy|30
4403448|NCT00162266|7181042|FG003|Double-Blind Period|Lack of Efficacy|0
4403449|NCT00162266|7181039|FG000|Double-Blind Period|Withdrawal by Subject|5
4403450|NCT00162266|7181040|FG001|Double-Blind Period|Withdrawal by Subject|2
4403451|NCT00162266|7181041|FG002|Double-Blind Period|Withdrawal by Subject|6
4403452|NCT00162266|7181042|FG003|Double-Blind Period|Withdrawal by Subject|0
4403453|NCT00162266|7181039|FG000|Open-Label Period|Death|0
4403454|NCT00162266|7181040|FG001|Open-Label Period|Death|0
4633281|NCT01909804|7503304|FG008|Overall Study|Protocol Violation|0
4403455|NCT00162266|7181041|FG002|Open-Label Period|Death|0
4403456|NCT00162266|7181042|FG003|Open-Label Period|Death|7
4403457|NCT00162266|7181039|FG000|Open-Label Period|Adverse Event|0
4403458|NCT00162266|7181040|FG001|Open-Label Period|Adverse Event|0
4403459|NCT00162266|7181041|FG002|Open-Label Period|Adverse Event|0
4403460|NCT00162266|7181042|FG003|Open-Label Period|Adverse Event|46
4403461|NCT00162266|7181039|FG000|Open-Label Period|Lack of Efficacy|0
4511171|NCT00924664|7320027|FG000|Overall Study|Withdrawal by Subject|47
4403462|NCT00162266|7181040|FG001|Open-Label Period|Lack of Efficacy|0
4403463|NCT00162266|7181041|FG002|Open-Label Period|Lack of Efficacy|0
4403464|NCT00162266|7181042|FG003|Open-Label Period|Lack of Efficacy|26
4403465|NCT00162266|7181039|FG000|Open-Label Period|Lost to Follow-up|0
4403466|NCT00162266|7181040|FG001|Open-Label Period|Lost to Follow-up|0
4403467|NCT00162266|7181041|FG002|Open-Label Period|Lost to Follow-up|0
4403468|NCT00162266|7181042|FG003|Open-Label Period|Lost to Follow-up|3
4403469|NCT00162266|7181039|FG000|Open-Label Period|Withdrawal by Subject|0
4403470|NCT00162266|7181040|FG001|Open-Label Period|Withdrawal by Subject|0
4403471|NCT00162266|7181041|FG002|Open-Label Period|Withdrawal by Subject|0
4403472|NCT00162266|7181042|FG003|Open-Label Period|Withdrawal by Subject|31
4403473|NCT00162266|7181039|FG000|Open-Label Period|Administrative Reason By Sponsor|0
4403474|NCT00162266|7181040|FG001|Open-Label Period|Administrative Reason By Sponsor|0
4403475|NCT00162266|7181041|FG002|Open-Label Period|Administrative Reason By Sponsor|0
4403476|NCT00162266|7181042|FG003|Open-Label Period|Administrative Reason By Sponsor|9
4403477|NCT00162266|7181039|FG000|Open-Label Period|Other Reasons|0
4403478|NCT00162266|7181040|FG001|Open-Label Period|Other Reasons|0
4403479|NCT00162266|7181041|FG002|Open-Label Period|Other Reasons|0
4403480|NCT00162266|7181042|FG003|Open-Label Period|Other Reasons|15
4403481|NCT00162981|7181096|FG000|Overall Study|Adverse Event|2
4403482|NCT00162981|7181097|FG001|Overall Study|Adverse Event|5
4403483|NCT00162981|7181096|FG000|Overall Study|Withdrawal by Subject|1
4403484|NCT00162981|7181097|FG001|Overall Study|Withdrawal by Subject|1
4403485|NCT00162981|7181096|FG000|Overall Study|Physician Decision|1
4403486|NCT00162981|7181097|FG001|Overall Study|Physician Decision|0
4403487|NCT00163020|7181105|FG000|Overall Study|Lost to Follow-up|0
4403488|NCT00163020|7181106|FG001|Overall Study|Lost to Follow-up|2
4403489|NCT00163189|7181114|FG000|Overall Study|Other|6
4403490|NCT00163189|7181114|FG000|Overall Study|Lost to Follow-up|1
4403491|NCT00163189|7181114|FG000|Overall Study|Protocol Violation|2
4403492|NCT00163189|7181114|FG000|Overall Study|Death|3
4403493|NCT00163189|7181114|FG000|Overall Study|Adverse Event|6
4403494|NCT00163189|7181114|FG000|Overall Study|Lack of Efficacy|7
4403495|NCT00163189|7181114|FG000|Overall Study|Study terminated by sponsor|11
4403496|NCT00163189|7181114|FG000|Overall Study|Withdrawal by Subject|11
4403497|NCT00163189|7181114|FG000|Overall Study|Did not meet continuation criterion|16
4403498|NCT00163215|7181118|FG000|Overall Study|Lack of Efficacy|3
4403499|NCT00163215|7181118|FG000|Overall Study|Withdrawal by Subject|5
4403500|NCT00163215|7181118|FG000|Overall Study|Other|7
4403501|NCT00163657|7181138|FG000|Overall Study|Death|12
4403502|NCT00163657|7181139|FG001|Overall Study|Death|14
4403503|NCT00163657|7181140|FG002|Overall Study|Death|19
4403504|NCT00163657|7181138|FG000|Overall Study|graft loss|4
4403505|NCT00163657|7181139|FG001|Overall Study|graft loss|1
4403506|NCT00163657|7181140|FG002|Overall Study|graft loss|2
4403507|NCT00163657|7181138|FG000|Overall Study|Withdrawal by Subject|2
4403508|NCT00163657|7181139|FG001|Overall Study|Withdrawal by Subject|3
4403509|NCT00163657|7181140|FG002|Overall Study|Withdrawal by Subject|2
4403510|NCT00163657|7181138|FG000|Overall Study|Physician Decision|0
4403511|NCT00163657|7181139|FG001|Overall Study|Physician Decision|1
4403512|NCT00163657|7181140|FG002|Overall Study|Physician Decision|1
4403513|NCT00163657|7181138|FG000|Overall Study|Non Compliance|1
4403514|NCT00163657|7181139|FG001|Overall Study|Non Compliance|0
4403515|NCT00163657|7181140|FG002|Overall Study|Non Compliance|0
4403516|NCT00163657|7181138|FG000|Overall Study|Lost to Follow-up|1
4403517|NCT00163657|7181139|FG001|Overall Study|Lost to Follow-up|3
4403518|NCT00163657|7181140|FG002|Overall Study|Lost to Follow-up|10
4403519|NCT00163657|7181138|FG000|Overall Study|Other reason|0
4403520|NCT00163657|7181139|FG001|Overall Study|Other reason|1
4403521|NCT00163657|7181140|FG002|Overall Study|Other reason|3
4403522|NCT00165646|7181151|FG000|Overall Study|Adverse Event|1
4403523|NCT00165646|7181152|FG001|Overall Study|Adverse Event|1
4403524|NCT00165646|7181153|FG002|Overall Study|Adverse Event|1
4403525|NCT00165646|7181151|FG000|Overall Study|Lack of Efficacy|1
4403526|NCT00165646|7181152|FG001|Overall Study|Lack of Efficacy|2
4403527|NCT00165646|7181153|FG002|Overall Study|Lack of Efficacy|0
4403528|NCT00165646|7181151|FG000|Overall Study|Withdrawal by Subject|0
4403529|NCT00165646|7181152|FG001|Overall Study|Withdrawal by Subject|2
4403530|NCT00165646|7181153|FG002|Overall Study|Withdrawal by Subject|1
4403531|NCT00165646|7181151|FG000|Overall Study|Physician Decision|2
4403532|NCT00165646|7181152|FG001|Overall Study|Physician Decision|0
4403533|NCT00165646|7181153|FG002|Overall Study|Physician Decision|2
4403534|NCT00165646|7181151|FG000|Overall Study|Protocol Violation|1
4403535|NCT00165646|7181152|FG001|Overall Study|Protocol Violation|0
4403536|NCT00165646|7181153|FG002|Overall Study|Protocol Violation|0
4403537|NCT00165672|7181163|FG000|Overall Study|Adverse Event|0
4403538|NCT00165672|7181164|FG001|Overall Study|Adverse Event|1
4403539|NCT00165698|7181172|FG000|Overall Study|Adverse Event|2
4403540|NCT00165698|7181173|FG001|Overall Study|Adverse Event|10
4403541|NCT00165698|7181172|FG000|Overall Study|Lost to Follow-up|2
4403542|NCT00165698|7181173|FG001|Overall Study|Lost to Follow-up|2
4403543|NCT00165698|7181172|FG000|Overall Study|Withdrawal by Subject|2
4403544|NCT00165698|7181173|FG001|Overall Study|Withdrawal by Subject|1
4403545|NCT00165698|7181172|FG000|Overall Study|Protocol Violation|1
4403546|NCT00165698|7181173|FG001|Overall Study|Protocol Violation|0
4403547|NCT00165698|7181172|FG000|Overall Study|Not Taken/Lost the medicine|1
4403548|NCT00165698|7181173|FG001|Overall Study|Not Taken/Lost the medicine|2
4403549|NCT00165776|7181183|FG000|Overall Study|Lack of Efficacy|0
4403550|NCT00165776|7181184|FG001|Overall Study|Lack of Efficacy|0
4403551|NCT00165776|7181185|FG002|Overall Study|Lack of Efficacy|0
4403552|NCT00165776|7181186|FG003|Overall Study|Lack of Efficacy|1
4403553|NCT00165776|7181183|FG000|Overall Study|Withdrawal by Subject|4
4403554|NCT00165776|7181184|FG001|Overall Study|Withdrawal by Subject|1
4403555|NCT00165776|7181185|FG002|Overall Study|Withdrawal by Subject|2
4403556|NCT00165776|7181186|FG003|Overall Study|Withdrawal by Subject|0
4403557|NCT00165776|7181183|FG000|Overall Study|Worsening of Cervical Dystonia|0
4403558|NCT00165776|7181184|FG001|Overall Study|Worsening of Cervical Dystonia|0
4403559|NCT00165776|7181185|FG002|Overall Study|Worsening of Cervical Dystonia|0
4403560|NCT00165776|7181186|FG003|Overall Study|Worsening of Cervical Dystonia|1
4403561|NCT00165789|7181200|FG000|Overall Study|Adverse Event|0
4403562|NCT00165789|7181201|FG001|Overall Study|Adverse Event|3
4403563|NCT00165789|7181202|FG002|Overall Study|Adverse Event|0
4403564|NCT00165789|7181203|FG003|Overall Study|Adverse Event|12
4403565|NCT00165789|7181200|FG000|Overall Study|Withdrawal by Subject|0
4403566|NCT00165789|7181201|FG001|Overall Study|Withdrawal by Subject|1
4403567|NCT00165789|7181202|FG002|Overall Study|Withdrawal by Subject|1
4403568|NCT00165789|7181203|FG003|Overall Study|Withdrawal by Subject|2
4403569|NCT00165841|7181215|FG000|Overall Study|Adverse Event|2
4403570|NCT00165841|7181216|FG001|Overall Study|Adverse Event|3
4403571|NCT00165841|7181215|FG000|Overall Study|Lack of Efficacy|6
4403572|NCT00165841|7181216|FG001|Overall Study|Lack of Efficacy|33
4403573|NCT00165841|7181215|FG000|Overall Study|Lost to Follow-up|4
4403574|NCT00165841|7181216|FG001|Overall Study|Lost to Follow-up|4
4403575|NCT00165841|7181215|FG000|Overall Study|Withdrawal by Subject|7
4403576|NCT00165841|7181216|FG001|Overall Study|Withdrawal by Subject|8
4403577|NCT00165841|7181215|FG000|Overall Study|Physician Decision|1
4403578|NCT00165841|7181216|FG001|Overall Study|Physician Decision|0
4403579|NCT00165841|7181215|FG000|Overall Study|Protocol Violation|6
4403580|NCT00165841|7181216|FG001|Overall Study|Protocol Violation|8
4403581|NCT00165841|7181215|FG000|Overall Study|Other|3
4403582|NCT00165841|7181216|FG001|Overall Study|Other|5
4403583|NCT00165841|7181215|FG000|Overall Study|Medication Noncompliance|1
4403584|NCT00165841|7181216|FG001|Overall Study|Medication Noncompliance|1
4403585|NCT00165984|7181231|FG000|Overall Study|Death|15
4403586|NCT00166114|7181250|FG000|Overall Study|Protocol Violation|2
4403587|NCT00166114|7181251|FG001|Overall Study|Protocol Violation|1
4403588|NCT00166114|7181250|FG000|Overall Study|Withdrawal by Subject|10
4403589|NCT00166114|7181251|FG001|Overall Study|Withdrawal by Subject|4
4403590|NCT00166114|7181250|FG000|Overall Study|Adverse Event|2
4403591|NCT00166114|7181251|FG001|Overall Study|Adverse Event|1
4403592|NCT00166296|7181285|FG000|Overall Study|Withdrawal by Subject|1
4403593|NCT00166296|7181286|FG001|Overall Study|Withdrawal by Subject|3
4403594|NCT00166296|7181285|FG000|Overall Study|Adverse Event|2
4403595|NCT00166296|7181286|FG001|Overall Study|Adverse Event|4
4403596|NCT00166296|7181285|FG000|Overall Study|Lost to Follow-up|4
4403597|NCT00166296|7181286|FG001|Overall Study|Lost to Follow-up|2
4403598|NCT00166439|7181301|FG000|Overall Study|Ineligible|5
4403599|NCT00166517|7181307|FG000|Overall Study|Lost to Follow-up|1
4403600|NCT00166517|7181308|FG001|Overall Study|Lost to Follow-up|0
4403601|NCT00166517|7181307|FG000|Overall Study|Protocol Violation|4
4403602|NCT00166517|7181308|FG001|Overall Study|Protocol Violation|1
4403603|NCT00166517|7181307|FG000|Overall Study|Withdrawal by Subject|0
4403604|NCT00166517|7181308|FG001|Overall Study|Withdrawal by Subject|1
4403605|NCT00166712|7181316|FG000|Overall Study|Death|0
4403606|NCT00166712|7181317|FG001|Overall Study|Death|1
4403607|NCT00166712|7181316|FG000|Overall Study|Adverse Event|1
4403608|NCT00166712|7181317|FG001|Overall Study|Adverse Event|0
4403609|NCT00166712|7181316|FG000|Overall Study|Withdrawal by Subject|1
4403610|NCT00166712|7181317|FG001|Overall Study|Withdrawal by Subject|2
4403611|NCT00166712|7181316|FG000|Overall Study|Physician Decision|0
4403612|NCT00166712|7181317|FG001|Overall Study|Physician Decision|2
4403613|NCT00167245|7181353|FG000|Overall Study|Lost to Follow-up|20
4403614|NCT00167245|7181354|FG001|Overall Study|Lost to Follow-up|31
4403615|NCT00167245|7181353|FG000|Overall Study|Withdrawal by Subject|5
4403616|NCT00167245|7181354|FG001|Overall Study|Withdrawal by Subject|8
4403617|NCT00167245|7181353|FG000|Overall Study|Incarcerated|3
4403618|NCT00167245|7181354|FG001|Overall Study|Incarcerated|2
4403619|NCT00167245|7181353|FG000|Overall Study|Drowsy|1
4403620|NCT00167245|7181354|FG001|Overall Study|Drowsy|0
4403621|NCT00167310|7181365|FG000|Overall Study|Protocol Violation|5
4403622|NCT00167310|7181366|FG001|Overall Study|Protocol Violation|3
4403623|NCT00167310|7181365|FG000|Overall Study|Withdrawal by Subject|3
4403624|NCT00167310|7181366|FG001|Overall Study|Withdrawal by Subject|7
4403625|NCT00167414|7181387|FG000|Overall Study|Death|10
4403626|NCT00167778|7181404|FG000|Overall Study|Withdrawal by Subject|1
4403627|NCT00168038|7181418|FG000|Overall Study|Adverse Event|1
4403628|NCT00168038|7181418|FG000|Overall Study|Therapy failure|1
4403629|NCT00168064|7181424|FG000|Overall Study|Adverse Event|26
4403630|NCT00168064|7181425|FG001|Overall Study|Adverse Event|22
4403631|NCT00168064|7181424|FG000|Overall Study|Withdrawal by Subject|3
4403632|NCT00168064|7181425|FG001|Overall Study|Withdrawal by Subject|4
4403633|NCT00168064|7181424|FG000|Overall Study|Lack of Efficacy|4
4403634|NCT00168064|7181425|FG001|Overall Study|Lack of Efficacy|4
4403635|NCT00168064|7181424|FG000|Overall Study|Lost to Follow-up|4
4403636|NCT00168064|7181425|FG001|Overall Study|Lost to Follow-up|3
4403637|NCT00168064|7181424|FG000|Overall Study|Non-compliance|2
4403638|NCT00168064|7181425|FG001|Overall Study|Non-compliance|3
4403639|NCT00168064|7181424|FG000|Overall Study|Concurrent Illness|4
4403640|NCT00168064|7181425|FG001|Overall Study|Concurrent Illness|3
4403641|NCT00168064|7181424|FG000|Overall Study|Subject's Best interest|2
4403642|NCT00168064|7181425|FG001|Overall Study|Subject's Best interest|2
4403643|NCT00168064|7181424|FG000|Overall Study|Various|4
4403644|NCT00168064|7181425|FG001|Overall Study|Various|3
4403645|NCT00168103|7181436|FG000|Overall Study|Withdrawal by Subject|1
4403646|NCT00168103|7181437|FG001|Overall Study|Withdrawal by Subject|2
4403647|NCT00168103|7181438|FG002|Overall Study|Withdrawal by Subject|1
4403648|NCT00168103|7181439|FG003|Overall Study|Withdrawal by Subject|0
4403649|NCT00168103|7181436|FG000|Overall Study|Lost to Follow-up|1
4403650|NCT00168103|7181437|FG001|Overall Study|Lost to Follow-up|3
4403651|NCT00168103|7181438|FG002|Overall Study|Lost to Follow-up|0
4403652|NCT00168103|7181439|FG003|Overall Study|Lost to Follow-up|0
4403653|NCT00168805|7181545|FG000|Overall Study|Adverse Event|7
4403654|NCT00168805|7181546|FG001|Overall Study|Adverse Event|11
4403655|NCT00168805|7181547|FG002|Overall Study|Adverse Event|16
4403656|NCT00168805|7181545|FG000|Overall Study|Protocol Violation|12
4403657|NCT00168805|7181546|FG001|Overall Study|Protocol Violation|11
4403658|NCT00168805|7181547|FG002|Overall Study|Protocol Violation|8
4403659|NCT00168805|7181545|FG000|Overall Study|Lost to Follow-up|12
4403660|NCT00168805|7181546|FG001|Overall Study|Lost to Follow-up|17
4403661|NCT00168805|7181547|FG002|Overall Study|Lost to Follow-up|11
4403662|NCT00168805|7181545|FG000|Overall Study|Withdrawal by Subject|16
4403663|NCT00168805|7181546|FG001|Overall Study|Withdrawal by Subject|18
4403664|NCT00168805|7181547|FG002|Overall Study|Withdrawal by Subject|21
4403665|NCT00168805|7181545|FG000|Overall Study|Other|24
4403666|NCT00168805|7181546|FG001|Overall Study|Other|21
4403667|NCT00168805|7181547|FG002|Overall Study|Other|22
4403668|NCT00168805|7181545|FG000|Treatment|Adverse Event|25
4403669|NCT00168805|7181546|FG001|Treatment|Adverse Event|26
4403670|NCT00168805|7181547|FG002|Treatment|Adverse Event|32
4403671|NCT00168805|7181545|FG000|Treatment|Protocol Violation|3
4403672|NCT00168805|7181546|FG001|Treatment|Protocol Violation|5
4403673|NCT00168805|7181547|FG002|Treatment|Protocol Violation|5
4403674|NCT00168805|7181545|FG000|Treatment|Withdrawal by Subject|3
4403675|NCT00168805|7181546|FG001|Treatment|Withdrawal by Subject|7
4403676|NCT00168805|7181547|FG002|Treatment|Withdrawal by Subject|8
4403677|NCT00168805|7181545|FG000|Treatment|Other|18
4403678|NCT00168805|7181546|FG001|Treatment|Other|18
4403679|NCT00168805|7181547|FG002|Treatment|Other|17
4403680|NCT00168818|7181558|FG000|Overall Study|Adverse Event|23
4403681|NCT00168818|7181559|FG001|Overall Study|Adverse Event|29
4403682|NCT00168818|7181560|FG002|Overall Study|Adverse Event|31
4403683|NCT00168818|7181558|FG000|Overall Study|Protocol Violation|16
4403684|NCT00168818|7181559|FG001|Overall Study|Protocol Violation|11
4403685|NCT00168818|7181560|FG002|Overall Study|Protocol Violation|11
4403686|NCT00168818|7181558|FG000|Overall Study|Lost to Follow-up|13
4403687|NCT00168818|7181559|FG001|Overall Study|Lost to Follow-up|4
4403688|NCT00168818|7181560|FG002|Overall Study|Lost to Follow-up|15
4403689|NCT00168818|7181558|FG000|Overall Study|Withdrawal by Subject|43
4403690|NCT00168818|7181559|FG001|Overall Study|Withdrawal by Subject|41
4403691|NCT00168818|7181560|FG002|Overall Study|Withdrawal by Subject|37
4403692|NCT00168818|7181558|FG000|Overall Study|Other|22
4403693|NCT00168818|7181559|FG001|Overall Study|Other|24
4403694|NCT00168818|7181560|FG002|Overall Study|Other|30
4403695|NCT00168818|7181558|FG000|Treatment|Adverse Event|77
4403696|NCT00168818|7181559|FG001|Treatment|Adverse Event|89
4403697|NCT00168818|7181560|FG002|Treatment|Adverse Event|68
4403698|NCT00168818|7181558|FG000|Treatment|Protocol Violation|8
4403699|NCT00168818|7181559|FG001|Treatment|Protocol Violation|11
4403700|NCT00168818|7181560|FG002|Treatment|Protocol Violation|11
4403701|NCT00168818|7181558|FG000|Treatment|Lost to Follow-up|0
4403702|NCT00168818|7181559|FG001|Treatment|Lost to Follow-up|2
4403703|NCT00168818|7181560|FG002|Treatment|Lost to Follow-up|1
4403704|NCT00168818|7181558|FG000|Treatment|Withdrawal by Subject|25
4403705|NCT00168818|7181559|FG001|Treatment|Withdrawal by Subject|20
4403706|NCT00168818|7181560|FG002|Treatment|Withdrawal by Subject|22
4403707|NCT00168818|7181558|FG000|Treatment|Other|23
4403708|NCT00168818|7181559|FG001|Treatment|Other|29
4403709|NCT00168818|7181560|FG002|Treatment|Other|31
4403710|NCT00168831|7181571|FG000|Overall Study|Adverse Event|36
4403711|NCT00168831|7181572|FG001|Overall Study|Adverse Event|47
4403712|NCT00168831|7181573|FG002|Overall Study|Adverse Event|74
4403713|NCT00168831|7181571|FG000|Overall Study|Lost to Follow-up|5
4403714|NCT00168831|7181572|FG001|Overall Study|Lost to Follow-up|6
4403715|NCT00168831|7181573|FG002|Overall Study|Lost to Follow-up|4
4403716|NCT00168831|7181571|FG000|Overall Study|Withdrawal by Subject|7
4403717|NCT00168831|7181572|FG001|Overall Study|Withdrawal by Subject|14
4403718|NCT00168831|7181573|FG002|Overall Study|Withdrawal by Subject|19
4403719|NCT00168831|7181571|FG000|Overall Study|Protocol Violation|6
4403720|NCT00168831|7181572|FG001|Overall Study|Protocol Violation|11
4403721|NCT00168831|7181573|FG002|Overall Study|Protocol Violation|11
4403722|NCT00168831|7181571|FG000|Overall Study|Other|6
4403723|NCT00168831|7181572|FG001|Overall Study|Other|3
4403724|NCT00168831|7181573|FG002|Overall Study|Other|6
4403725|NCT00168844|7181584|FG000|Overall Study|Adverse Event|31
4403726|NCT00168844|7181585|FG001|Overall Study|Adverse Event|32
4403727|NCT00168844|7181586|FG002|Overall Study|Adverse Event|48
4403728|NCT00168844|7181584|FG000|Overall Study|Lost to Follow-up|4
4403729|NCT00168844|7181585|FG001|Overall Study|Lost to Follow-up|5
4403730|NCT00168844|7181586|FG002|Overall Study|Lost to Follow-up|11
4403731|NCT00168844|7181584|FG000|Overall Study|Withdrawal by Subject|12
4403732|NCT00168844|7181585|FG001|Overall Study|Withdrawal by Subject|9
4403733|NCT00168844|7181586|FG002|Overall Study|Withdrawal by Subject|19
4403734|NCT00168844|7181584|FG000|Overall Study|Protocol Violation|2
4403735|NCT00168844|7181585|FG001|Overall Study|Protocol Violation|2
4403736|NCT00168844|7181586|FG002|Overall Study|Protocol Violation|4
4403737|NCT00168844|7181584|FG000|Overall Study|Other|6
4403738|NCT00168844|7181585|FG001|Overall Study|Other|7
4403739|NCT00168844|7181586|FG002|Overall Study|Other|9
4403740|NCT00169104|7181596|FG000|Overall Study|Withdrawal by Subject|2
4403741|NCT00169104|7181597|FG001|Overall Study|Withdrawal by Subject|0
4403742|NCT00169104|7181596|FG000|Overall Study|Protocol Violation|0
4403743|NCT00169104|7181597|FG001|Overall Study|Protocol Violation|1
4403744|NCT00169104|7181596|FG000|Overall Study|Physician Decision|0
4628930|NCT01866826|7496433|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0
4628931|NCT01866826|7496434|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1
4628932|NCT01866917|7496446|FG000|Overall Study|Pharmacist stopped dispensing treatment|4
4628933|NCT01866917|7496447|FG001|Overall Study|Pharmacist stopped dispensing treatment|6
4628934|NCT01867008|7496465|FG000|Overall Study|Withdrawal by Subject|1
4628935|NCT01867021|7496471|FG000|Overall Study|Adverse Event|0
4628936|NCT01867021|7496472|FG001|Overall Study|Adverse Event|1
4628937|NCT01867021|7496471|FG000|Overall Study|Not Eligible|0
4628938|NCT01867021|7496472|FG001|Overall Study|Not Eligible|1
4628939|NCT01867021|7496471|FG000|Overall Study|Death|1
4628940|NCT01867021|7496472|FG001|Overall Study|Death|0
4628941|NCT01867021|7496471|FG000|Overall Study|Lost to Follow-up|0
4628942|NCT01867021|7496472|FG001|Overall Study|Lost to Follow-up|2
4628943|NCT01867021|7496471|FG000|Overall Study|Withdrawal by Subject|1
4628944|NCT01867021|7496472|FG001|Overall Study|Withdrawal by Subject|6
4628945|NCT01867047|7496485|FG000|Overall Study|Lost to Follow-up|3
4628946|NCT01867047|7496486|FG001|Overall Study|Lost to Follow-up|3
4628947|NCT01867047|7496485|FG000|Overall Study|Withdrawal by Subject|2
4628948|NCT01867047|7496486|FG001|Overall Study|Withdrawal by Subject|0
4628949|NCT01867047|7496485|FG000|Overall Study|Physician Decision|2
4628950|NCT01867047|7496486|FG001|Overall Study|Physician Decision|0
4628951|NCT01867047|7496485|FG000|Overall Study|surgery not indicated in protocol|1
4628952|NCT01867047|7496486|FG001|Overall Study|surgery not indicated in protocol|2
4628953|NCT01867086|7496496|FG000|Overall Study|Disease Progression|1
4403745|NCT00169104|7181597|FG001|Overall Study|Physician Decision|1
4403746|NCT00169442|7181610|FG000|Overall Study|Withdrawal by Subject|0
4403747|NCT00169442|7181611|FG001|Overall Study|Withdrawal by Subject|0
4403748|NCT00169442|7181612|FG002|Overall Study|Withdrawal by Subject|1
4403749|NCT00169442|7181613|FG003|Overall Study|Withdrawal by Subject|0
4403750|NCT00169442|7181614|FG004|Overall Study|Withdrawal by Subject|0
4403751|NCT00169442|7181615|FG005|Overall Study|Withdrawal by Subject|0
4403752|NCT00169442|7181610|FG000|Overall Study|Migrated/moved from study area|0
4403753|NCT00169442|7181611|FG001|Overall Study|Migrated/moved from study area|0
4403754|NCT00169442|7181612|FG002|Overall Study|Migrated/moved from study area|0
4403755|NCT00169442|7181613|FG003|Overall Study|Migrated/moved from study area|0
4403756|NCT00169442|7181614|FG004|Overall Study|Migrated/moved from study area|0
4403757|NCT00169442|7181615|FG005|Overall Study|Migrated/moved from study area|2
4403758|NCT00169442|7181610|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0
4403759|NCT00169442|7181611|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0
4403760|NCT00169442|7181612|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0
4403761|NCT00169442|7181613|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0
4403762|NCT00169442|7181614|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1
4403763|NCT00169442|7181615|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0
4403764|NCT00169442|7181610|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0
4403765|NCT00169442|7181611|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1
4403766|NCT00169442|7181612|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0
4403767|NCT00169442|7181613|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0
4403768|NCT00169442|7181614|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0
4403769|NCT00169442|7181615|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0
4403770|NCT00170846|7181645|FG000|Overall Study|Subject withdrew Informed Consent|5
4403771|NCT00170846|7181646|FG001|Overall Study|Subject withdrew Informed Consent|12
4403772|NCT00170846|7181647|FG002|Overall Study|Subject withdrew Informed Consent|8
4403773|NCT00170846|7181645|FG000|Overall Study|Lost to Follow-up|6
4403774|NCT00170846|7181646|FG001|Overall Study|Lost to Follow-up|3
4403775|NCT00170846|7181647|FG002|Overall Study|Lost to Follow-up|2
4403776|NCT00170846|7181645|FG000|Overall Study|Death|0
4403777|NCT00170846|7181646|FG001|Overall Study|Death|3
4403778|NCT00170846|7181647|FG002|Overall Study|Death|3
4403779|NCT00170846|7181645|FG000|Overall Study|Reason Missing|0
4403780|NCT00170846|7181646|FG001|Overall Study|Reason Missing|1
4403781|NCT00170846|7181647|FG002|Overall Study|Reason Missing|0
4403782|NCT00170950|7181657|FG000|Overall Study|Death|236
4628954|NCT01867216|7496516|FG000|Overall Study|Withdrawal by Subject|2
4628955|NCT01867216|7496517|FG001|Overall Study|Withdrawal by Subject|0
4628956|NCT01867216|7496518|FG002|Overall Study|Withdrawal by Subject|0
4403783|NCT00170950|7181658|FG001|Overall Study|Death|274
4403784|NCT00170950|7181657|FG000|Overall Study|Withdrawal by Subject|496
4713346|NCT02943564|7640768|FG001|Overall Study|Protocol Violation|2
4713347|NCT02943564|7640769|FG002|Overall Study|Protocol Violation|2
4713348|NCT02943564|7640767|FG000|Overall Study|Lost to Follow-up|1
4713349|NCT02943564|7640768|FG001|Overall Study|Lost to Follow-up|0
4713350|NCT02943564|7640769|FG002|Overall Study|Lost to Follow-up|0
4713351|NCT02943564|7640767|FG000|Overall Study|Withdrawal by Subject|6
4713352|NCT02943564|7640768|FG001|Overall Study|Withdrawal by Subject|5
4713353|NCT02943564|7640769|FG002|Overall Study|Withdrawal by Subject|2
4713354|NCT02943564|7640767|FG000|Overall Study|Adverse Event|1
4713355|NCT02943564|7640768|FG001|Overall Study|Adverse Event|2
4713356|NCT02943564|7640769|FG002|Overall Study|Adverse Event|1
4713357|NCT02943564|7640767|FG000|Overall Study|Lack of Efficacy|0
4713358|NCT02943564|7640768|FG001|Overall Study|Lack of Efficacy|1
4713359|NCT02943564|7640769|FG002|Overall Study|Lack of Efficacy|0
4713360|NCT02943577|7640779|FG000|Overall Study|Protocol Violation|0
4713361|NCT02943577|7640780|FG001|Overall Study|Protocol Violation|1
4713362|NCT02943577|7640779|FG000|Overall Study|Adverse Event|3
4713363|NCT02943577|7640780|FG001|Overall Study|Adverse Event|2
4713364|NCT02943577|7640779|FG000|Overall Study|Lost to Follow-up|0
4713365|NCT02943577|7640780|FG001|Overall Study|Lost to Follow-up|1
4713366|NCT02943577|7640779|FG000|Overall Study|Withdrawal by Subject|1
4713367|NCT02943577|7640780|FG001|Overall Study|Withdrawal by Subject|1
4713368|NCT02943577|7640779|FG000|Overall Study|Pregnancy|1
4713369|NCT02943577|7640780|FG001|Overall Study|Pregnancy|0
4713370|NCT02943668|7640786|FG000|Overall Study|Disease Progression|1
4403785|NCT00170950|7181658|FG001|Overall Study|Withdrawal by Subject|498
4403786|NCT00170950|7181657|FG000|Overall Study|Lost to Follow-up|134
4403787|NCT00170950|7181658|FG001|Overall Study|Lost to Follow-up|115
4403788|NCT00170950|7181657|FG000|Overall Study|Missing|2
4403789|NCT00170950|7181658|FG001|Overall Study|Missing|1
4403790|NCT00170950|7181657|FG000|Overall Study|Termination Data Not Recorded|17
4403791|NCT00170950|7181658|FG001|Overall Study|Termination Data Not Recorded|22
4403792|NCT00171054|7181666|FG000|Overall Study|Protocol Violation|1
4403793|NCT00171054|7181667|FG001|Overall Study|Protocol Violation|2
4403794|NCT00171054|7181666|FG000|Overall Study|Patient withdrew consent|1
4403795|NCT00171054|7181667|FG001|Overall Study|Patient withdrew consent|0
4403796|NCT00171054|7181666|FG000|Overall Study|Lost to Follow-up|0
4403797|NCT00171054|7181667|FG001|Overall Study|Lost to Follow-up|1
4403798|NCT00171054|7181666|FG000|Overall Study|Adverse Event|8
4403799|NCT00171054|7181667|FG001|Overall Study|Adverse Event|8
4403800|NCT00171054|7181666|FG000|Overall Study|Condition no longer required study drug|0
4403801|NCT00171054|7181667|FG001|Overall Study|Condition no longer required study drug|1
4403802|NCT00171158|7181673|FG000|Core Study|Death|27
4403803|NCT00171158|7181673|FG000|Core Study|Unsatisfactory therapeutic effect|163
4403804|NCT00171158|7181673|FG000|Core Study|Protocol Violation|4
4403805|NCT00171158|7181673|FG000|Core Study|Administrative problems|1
4403806|NCT00171158|7181673|FG000|Core Study|Adverse event, non-fatal|21
4403807|NCT00171158|7181673|FG000|Core Study|Consent withdrawn by subject|6
4403808|NCT00171158|7181673|FG000|Core Study|No longer required drug (BMT)|14
4403809|NCT00171158|7181673|FG000|Core Study|Abnormal Laboratory Values|2
4403810|NCT00171158|7181673|FG000|Core Study|Lost to Follow-up|1
4403811|NCT00171158|7181673|FG000|E2 Extension|Other|7
4511172|NCT00924664|7320028|FG001|Overall Study|Withdrawal by Subject|71
4511173|NCT00924664|7320027|FG000|Overall Study|Protocol Violation|2
4511174|NCT00924664|7320028|FG001|Overall Study|Protocol Violation|5
4511175|NCT00924664|7320027|FG000|Overall Study|Pregnancy|1
4511176|NCT00924664|7320028|FG001|Overall Study|Pregnancy|1
4511177|NCT00924664|7320027|FG000|Overall Study|Death|0
4511178|NCT00924664|7320028|FG001|Overall Study|Death|2
4511179|NCT00924664|7320027|FG000|Overall Study|Study terminated by sponsor|199
4511180|NCT00924664|7320028|FG001|Overall Study|Study terminated by sponsor|330
4511181|NCT00924664|7320027|FG000|Overall Study|Other|29
4511182|NCT00924664|7320028|FG001|Overall Study|Other|52
4511183|NCT00924664|7320027|FG000|Overall Study|Randomized but not Treated|1
4511184|NCT00924664|7320028|FG001|Overall Study|Randomized but not Treated|0
4511185|NCT00924703|7320034|FG000|Overall Study|Withdrawal by Subject|11
4511186|NCT00924703|7320034|FG000|Overall Study|Physician Decision|5
4511187|NCT00924703|7320034|FG000|Overall Study|Lost to Follow-up|3
4511188|NCT00924703|7320034|FG000|Overall Study|Adverse Event|2
4511189|NCT00924703|7320034|FG000|Overall Study|Withdrawal by Sponsor|1
4511190|NCT00924729|7320040|FG000|Overall Study|insufficient volume for analysis|1
4511191|NCT00924729|7320041|FG001|Overall Study|insufficient volume for analysis|0
4511192|NCT00924729|7320040|FG000|Overall Study|Protocol Violation|1
4511193|NCT00924729|7320041|FG001|Overall Study|Protocol Violation|0
4511194|NCT00924781|7320053|FG000|Overall Study|Study terminated by sponsor|12
4511195|NCT00924781|7320054|FG001|Overall Study|Study terminated by sponsor|10
4511196|NCT00924820|7320070|FG000|Overall Study|Death|2
4511197|NCT00924820|7320070|FG000|Overall Study|Ineligible, Screen Failure|5
4511198|NCT00924898|7320085|FG000|Overall Study|Withdrawal by Subject|2
4511199|NCT00924950|7320094|FG000|Overall Study|Lost to Follow-up|2
4511200|NCT00925002|7320104|FG000|Overall Study|Other|1
4511201|NCT00925002|7320105|FG001|Overall Study|Other|4
4713371|NCT02944383|7640801|FG000|Overall Study|Lost to Follow-up|0
4713372|NCT02944383|7640802|FG001|Overall Study|Lost to Follow-up|0
4713373|NCT02944383|7640803|FG002|Overall Study|Lost to Follow-up|1
4713374|NCT02944383|7640801|FG000|Overall Study|Withdrawal by Subject|1
4403812|NCT00171210|7181679|FG000|Overall Study|Adverse Event|16
4403813|NCT00171210|7181680|FG001|Overall Study|Adverse Event|27
4403814|NCT00171210|7181679|FG000|Overall Study|Abnormal laboratory value(s)|6
4403815|NCT00171210|7181680|FG001|Overall Study|Abnormal laboratory value(s)|3
4403816|NCT00171210|7181679|FG000|Overall Study|Abnormal test procedure result(s)|0
4403817|NCT00171210|7181680|FG001|Overall Study|Abnormal test procedure result(s)|1
4403818|NCT00171210|7181679|FG000|Overall Study|Unsatisfactory therapeutic effect|11
4403819|NCT00171210|7181680|FG001|Overall Study|Unsatisfactory therapeutic effect|15
4403820|NCT00171210|7181679|FG000|Overall Study|Protocol Violation|0
4403821|NCT00171210|7181680|FG001|Overall Study|Protocol Violation|2
4403822|NCT00171210|7181679|FG000|Overall Study|Withdrawal by Subject|32
4403823|NCT00171210|7181680|FG001|Overall Study|Withdrawal by Subject|30
4403824|NCT00171210|7181679|FG000|Overall Study|Lost to Follow-up|1
4403825|NCT00171210|7181680|FG001|Overall Study|Lost to Follow-up|0
4403826|NCT00171210|7181679|FG000|Overall Study|Administrative problems|1
4403827|NCT00171210|7181680|FG001|Overall Study|Administrative problems|1
4403828|NCT00171210|7181679|FG000|Overall Study|Death|2
4403829|NCT00171210|7181680|FG001|Overall Study|Death|3
4403830|NCT00171210|7181679|FG000|Overall Study|Stopped at end of core|0
4403831|NCT00171210|7181680|FG001|Overall Study|Stopped at end of core|32
4403832|NCT00171210|7181679|FG000|Overall Study|Stopped at end of extension 1|0
4403833|NCT00171210|7181680|FG001|Overall Study|Stopped at end of extension 1|1
4403834|NCT00171223|7181689|FG000|Overall Study|Adverse Event (Non-fatal)|6
4403835|NCT00171223|7181690|FG001|Overall Study|Adverse Event (Non-fatal)|5
4403836|NCT00171223|7181691|FG002|Overall Study|Adverse Event (Non-fatal)|19
4403837|NCT00171223|7181689|FG000|Overall Study|Abnormal Laboratory Value (s)|4
4403838|NCT00171223|7181690|FG001|Overall Study|Abnormal Laboratory Value (s)|2
4403839|NCT00171223|7181691|FG002|Overall Study|Abnormal Laboratory Value (s)|3
4403840|NCT00171223|7181689|FG000|Overall Study|Abnormal Procedure|1
4403841|NCT00171223|7181690|FG001|Overall Study|Abnormal Procedure|0
4403842|NCT00171223|7181691|FG002|Overall Study|Abnormal Procedure|0
4403843|NCT00171223|7181689|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57
4403844|NCT00171223|7181690|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43
4403845|NCT00171223|7181691|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52
4403846|NCT00171223|7181689|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2
4403847|NCT00171223|7181690|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4
4403848|NCT00171223|7181691|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2
4403849|NCT00171223|7181689|FG000|Overall Study|Protocol Violation|2
4403850|NCT00171223|7181690|FG001|Overall Study|Protocol Violation|2
4403851|NCT00171223|7181691|FG002|Overall Study|Protocol Violation|3
4403852|NCT00171223|7181689|FG000|Overall Study|Participant Withdrew Consent|12
4403853|NCT00171223|7181690|FG001|Overall Study|Participant Withdrew Consent|21
4403854|NCT00171223|7181691|FG002|Overall Study|Participant Withdrew Consent|15
4403855|NCT00171223|7181689|FG000|Overall Study|Lost to Follow-up|5
4403856|NCT00171223|7181690|FG001|Overall Study|Lost to Follow-up|2
4403857|NCT00171223|7181691|FG002|Overall Study|Lost to Follow-up|3
4403858|NCT00171223|7181689|FG000|Overall Study|Administrative Problems|4
4403859|NCT00171223|7181690|FG001|Overall Study|Administrative Problems|7
4403860|NCT00171223|7181691|FG002|Overall Study|Administrative Problems|6
4403861|NCT00171223|7181689|FG000|Overall Study|Adverse Event (Serious Fatal)|6
4403862|NCT00171223|7181690|FG001|Overall Study|Adverse Event (Serious Fatal)|8
4403863|NCT00171223|7181691|FG002|Overall Study|Adverse Event (Serious Fatal)|9
4403864|NCT00171223|7181689|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41
4403865|NCT00171223|7181690|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47
4403866|NCT00171223|7181691|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58
4403867|NCT00171249|7181697|FG000|Overall Study|Withdrawal by Subject|2
4403868|NCT00171249|7181698|FG001|Overall Study|Withdrawal by Subject|0
4403869|NCT00171249|7181699|FG002|Overall Study|Withdrawal by Subject|0
4403870|NCT00171249|7181700|FG003|Overall Study|Withdrawal by Subject|6
4403871|NCT00171249|7181701|FG004|Overall Study|Withdrawal by Subject|0
4403872|NCT00171249|7181702|FG005|Overall Study|Withdrawal by Subject|0
4403873|NCT00171249|7181703|FG006|Overall Study|Withdrawal by Subject|0
4403874|NCT00171249|7181697|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44
4403875|NCT00171249|7181698|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3
4403876|NCT00171249|7181699|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5
4403877|NCT00171249|7181700|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70
4403878|NCT00171249|7181701|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3
4403879|NCT00171249|7181702|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31
4403880|NCT00171249|7181703|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1
4403881|NCT00171249|7181697|FG000|Overall Study|Death|7
4403882|NCT00171249|7181698|FG001|Overall Study|Death|1
4403883|NCT00171249|7181699|FG002|Overall Study|Death|0
4403884|NCT00171249|7181700|FG003|Overall Study|Death|4
4403885|NCT00171249|7181701|FG004|Overall Study|Death|0
4403886|NCT00171249|7181702|FG005|Overall Study|Death|3
4403887|NCT00171249|7181703|FG006|Overall Study|Death|1
4403888|NCT00171249|7181697|FG000|Overall Study|Other|10
4403889|NCT00171249|7181698|FG001|Overall Study|Other|0
4403890|NCT00171249|7181699|FG002|Overall Study|Other|0
4403891|NCT00171249|7181700|FG003|Overall Study|Other|43
4403892|NCT00171249|7181701|FG004|Overall Study|Other|0
4403893|NCT00171249|7181702|FG005|Overall Study|Other|2
4403894|NCT00171249|7181703|FG006|Overall Study|Other|0
4403895|NCT00171249|7181697|FG000|Overall Study|No Longer Requires Study Drug|4
4403896|NCT00171249|7181698|FG001|Overall Study|No Longer Requires Study Drug|0
4403897|NCT00171249|7181699|FG002|Overall Study|No Longer Requires Study Drug|0
4403898|NCT00171249|7181700|FG003|Overall Study|No Longer Requires Study Drug|3
4403899|NCT00171249|7181701|FG004|Overall Study|No Longer Requires Study Drug|0
4403900|NCT00171249|7181702|FG005|Overall Study|No Longer Requires Study Drug|5
4403901|NCT00171249|7181703|FG006|Overall Study|No Longer Requires Study Drug|0
4403902|NCT00171249|7181697|FG000|Overall Study|Administrative Problems|1
4403903|NCT00171249|7181698|FG001|Overall Study|Administrative Problems|0
4403904|NCT00171249|7181699|FG002|Overall Study|Administrative Problems|0
4403905|NCT00171249|7181700|FG003|Overall Study|Administrative Problems|2
4403906|NCT00171249|7181701|FG004|Overall Study|Administrative Problems|0
4403907|NCT00171249|7181702|FG005|Overall Study|Administrative Problems|0
4403908|NCT00171249|7181703|FG006|Overall Study|Administrative Problems|0
4403909|NCT00171249|7181697|FG000|Overall Study|Adverse Event|3
4403910|NCT00171249|7181698|FG001|Overall Study|Adverse Event|1
4403911|NCT00171249|7181699|FG002|Overall Study|Adverse Event|0
4403912|NCT00171249|7181700|FG003|Overall Study|Adverse Event|15
4403913|NCT00171249|7181701|FG004|Overall Study|Adverse Event|0
4403914|NCT00171249|7181702|FG005|Overall Study|Adverse Event|2
4403915|NCT00171249|7181703|FG006|Overall Study|Adverse Event|0
4403916|NCT00171249|7181697|FG000|Overall Study|Lost to Follow-up|5
4403917|NCT00171249|7181698|FG001|Overall Study|Lost to Follow-up|0
4403918|NCT00171249|7181699|FG002|Overall Study|Lost to Follow-up|0
4403919|NCT00171249|7181700|FG003|Overall Study|Lost to Follow-up|9
4403920|NCT00171249|7181701|FG004|Overall Study|Lost to Follow-up|0
4403921|NCT00171249|7181702|FG005|Overall Study|Lost to Follow-up|0
4403922|NCT00171249|7181703|FG006|Overall Study|Lost to Follow-up|0
4403923|NCT00171301|7181714|FG000|Overall Study|Death|1
4403924|NCT00171301|7181715|FG001|Overall Study|Death|2
4403925|NCT00171301|7181714|FG000|Overall Study|Adverse Event|1
4403926|NCT00171301|7181715|FG001|Overall Study|Adverse Event|2
4403927|NCT00171301|7181714|FG000|Overall Study|Lost to Follow-up|6
4403928|NCT00171301|7181715|FG001|Overall Study|Lost to Follow-up|2
4403929|NCT00171301|7181714|FG000|Overall Study|Protocol Violation|0
4403930|NCT00171301|7181715|FG001|Overall Study|Protocol Violation|2
4403931|NCT00171301|7181714|FG000|Overall Study|Withdrawal by Subject|0
4403932|NCT00171301|7181715|FG001|Overall Study|Withdrawal by Subject|1
4403933|NCT00171314|7181724|FG000|Overall Study|Adverse Event|44
4403934|NCT00171314|7181725|FG001|Overall Study|Adverse Event|41
4403935|NCT00171314|7181724|FG000|Overall Study|Lack of Efficacy|19
4403936|NCT00171314|7181725|FG001|Overall Study|Lack of Efficacy|14
4403937|NCT00171314|7181724|FG000|Overall Study|Withdrawal by Subject|9
4403938|NCT00171314|7181725|FG001|Overall Study|Withdrawal by Subject|6
4403939|NCT00171314|7181724|FG000|Overall Study|Abnormal Test Procedure Results|9
4403940|NCT00171314|7181725|FG001|Overall Study|Abnormal Test Procedure Results|3
4403941|NCT00171314|7181724|FG000|Overall Study|Protocol Violation|3
4403942|NCT00171314|7181725|FG001|Overall Study|Protocol Violation|7
4403943|NCT00171314|7181724|FG000|Overall Study|Administrative Problems|4
4403944|NCT00171314|7181725|FG001|Overall Study|Administrative Problems|3
4403945|NCT00171314|7181724|FG000|Overall Study|Lost to Follow-up|1
4403946|NCT00171314|7181725|FG001|Overall Study|Lost to Follow-up|3
4403947|NCT00171314|7181724|FG000|Overall Study|Death|2
4403948|NCT00171314|7181725|FG001|Overall Study|Death|1
4403949|NCT00171340|7181733|FG000|Overall Study|Adverse Event|46
4403950|NCT00171340|7181734|FG001|Overall Study|Adverse Event|42
4403951|NCT00171340|7181733|FG000|Overall Study|Lack of Efficacy|29
4403952|NCT00171340|7181734|FG001|Overall Study|Lack of Efficacy|41
4403953|NCT00171340|7181733|FG000|Overall Study|Protocol Violation|7
4403954|NCT00171340|7181734|FG001|Overall Study|Protocol Violation|8
4403955|NCT00171340|7181733|FG000|Overall Study|Withdrawal by Subject|22
4403956|NCT00171340|7181734|FG001|Overall Study|Withdrawal by Subject|19
4403957|NCT00171340|7181733|FG000|Overall Study|Lost to Follow-up|0
4403958|NCT00171340|7181734|FG001|Overall Study|Lost to Follow-up|5
4403959|NCT00171340|7181733|FG000|Overall Study|Abnormal Laboratory Results|2
4403960|NCT00171340|7181734|FG001|Overall Study|Abnormal Laboratory Results|0
4403961|NCT00171340|7181733|FG000|Overall Study|Abnormal Test Procedure Results|6
4403962|NCT00171340|7181734|FG001|Overall Study|Abnormal Test Procedure Results|11
4403963|NCT00171340|7181733|FG000|Overall Study|No Longer Required Study Drug|1
4403964|NCT00171340|7181734|FG001|Overall Study|No Longer Required Study Drug|1
4403965|NCT00171340|7181733|FG000|Overall Study|Administrative Problems|5
4403966|NCT00171340|7181734|FG001|Overall Study|Administrative Problems|2
4403967|NCT00171340|7181733|FG000|Overall Study|Death|6
4403968|NCT00171340|7181734|FG001|Overall Study|Death|6
4403969|NCT00171704|7181744|FG000|Overall Study|Adverse Event|24
4403970|NCT00171704|7181745|FG001|Overall Study|Adverse Event|33
4403971|NCT00171704|7181744|FG000|Overall Study|Disease Progression|14
4403972|NCT00171704|7181745|FG001|Overall Study|Disease Progression|9
4403973|NCT00171704|7181744|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1
4403974|NCT00171704|7181745|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0
4403975|NCT00171704|7181744|FG000|Overall Study|Administrative Problems|2
4403976|NCT00171704|7181745|FG001|Overall Study|Administrative Problems|1
4403977|NCT00171704|7181744|FG000|Overall Study|Death|2
4403978|NCT00171704|7181745|FG001|Overall Study|Death|2
4403979|NCT00171704|7181744|FG000|Overall Study|Withdrawal by Subject|1
4403980|NCT00171704|7181745|FG001|Overall Study|Withdrawal by Subject|3
4403981|NCT00171704|7181744|FG000|Overall Study|Protocol Violation|0
4403982|NCT00171704|7181745|FG001|Overall Study|Protocol Violation|1
4403983|NCT00171730|7181751|FG000|Overall Study|Adverse Event|3
4403984|NCT00171730|7181751|FG000|Overall Study|Abnormal Laboratory Value(s)|1
4403985|NCT00171730|7181751|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8
4403986|NCT00171730|7181751|FG000|Overall Study|Withdrawal by Subject|3
4403987|NCT00171834|7181768|FG000|Overall Study|Adverse Event|2
4403988|NCT00171834|7181769|FG001|Overall Study|Adverse Event|1
4403989|NCT00171834|7181770|FG002|Overall Study|Adverse Event|3
4403990|NCT00171834|7181771|FG003|Overall Study|Adverse Event|2
4403991|NCT00171834|7181772|FG004|Overall Study|Adverse Event|2
4403992|NCT00171834|7181773|FG005|Overall Study|Adverse Event|15
4403993|NCT00171834|7181774|FG006|Overall Study|Adverse Event|1
4403994|NCT00171834|7181768|FG000|Overall Study|Withdrawal by Subject|0
4403995|NCT00171834|7181769|FG001|Overall Study|Withdrawal by Subject|2
4403996|NCT00171834|7181770|FG002|Overall Study|Withdrawal by Subject|0
4403997|NCT00171834|7181771|FG003|Overall Study|Withdrawal by Subject|1
4403998|NCT00171834|7181772|FG004|Overall Study|Withdrawal by Subject|1
4403999|NCT00171834|7181773|FG005|Overall Study|Withdrawal by Subject|1
4404000|NCT00171834|7181774|FG006|Overall Study|Withdrawal by Subject|0
4404001|NCT00171834|7181768|FG000|Overall Study|Death from study indication|0
4404002|NCT00171834|7181769|FG001|Overall Study|Death from study indication|1
4404003|NCT00171834|7181770|FG002|Overall Study|Death from study indication|0
4404004|NCT00171834|7181771|FG003|Overall Study|Death from study indication|0
4404005|NCT00171834|7181772|FG004|Overall Study|Death from study indication|1
4404006|NCT00171834|7181773|FG005|Overall Study|Death from study indication|0
4404007|NCT00171834|7181774|FG006|Overall Study|Death from study indication|0
4404008|NCT00171834|7181768|FG000|Overall Study|Disease Progression|4
4404009|NCT00171834|7181769|FG001|Overall Study|Disease Progression|8
4404010|NCT00171834|7181770|FG002|Overall Study|Disease Progression|8
4404011|NCT00171834|7181771|FG003|Overall Study|Disease Progression|9
4404012|NCT00171834|7181772|FG004|Overall Study|Disease Progression|2
4404013|NCT00171834|7181773|FG005|Overall Study|Disease Progression|18
4404014|NCT00171834|7181774|FG006|Overall Study|Disease Progression|3
4404015|NCT00171834|7181768|FG000|Overall Study|Treatment Duration Completed|0
4404016|NCT00171834|7181769|FG001|Overall Study|Treatment Duration Completed|0
4404017|NCT00171834|7181770|FG002|Overall Study|Treatment Duration Completed|1
4404018|NCT00171834|7181771|FG003|Overall Study|Treatment Duration Completed|0
4404019|NCT00171834|7181772|FG004|Overall Study|Treatment Duration Completed|2
4404020|NCT00171834|7181773|FG005|Overall Study|Treatment Duration Completed|1
4404021|NCT00171834|7181774|FG006|Overall Study|Treatment Duration Completed|0
4404022|NCT00171873|7181806|FG000|Overall Study|Withdrawal by Subject|4
4404023|NCT00171873|7181807|FG001|Overall Study|Withdrawal by Subject|2
4404024|NCT00171873|7181806|FG000|Overall Study|Adverse Event|5
4404025|NCT00171873|7181807|FG001|Overall Study|Adverse Event|0
4404026|NCT00171873|7181806|FG000|Overall Study|Switched to Octreotide|0
4404027|NCT00171873|7181807|FG001|Overall Study|Switched to Octreotide|1
4404028|NCT00171925|7181815|FG000|Overall Study|Adverse Event|10
4404029|NCT00171925|7181816|FG001|Overall Study|Adverse Event|6
4404030|NCT00171925|7181815|FG000|Overall Study|Protocol Violation|1
4404031|NCT00171925|7181816|FG001|Overall Study|Protocol Violation|1
4404032|NCT00171925|7181815|FG000|Overall Study|Withdrawal by Subject|6
4404033|NCT00171925|7181816|FG001|Overall Study|Withdrawal by Subject|9
4404034|NCT00171925|7181815|FG000|Overall Study|Lost to Follow-up|2
4404035|NCT00171925|7181816|FG001|Overall Study|Lost to Follow-up|2
4404036|NCT00171925|7181815|FG000|Overall Study|Administrative problems|10
4404037|NCT00171925|7181816|FG001|Overall Study|Administrative problems|11
4404038|NCT00171925|7181815|FG000|Overall Study|Death|1
4404039|NCT00171925|7181816|FG001|Overall Study|Death|2
4404040|NCT00171951|7181822|FG000|Overall Study|Adverse Event|1
4404041|NCT00171951|7181822|FG000|Overall Study|Abnormal Laboratory Values|2
4404042|NCT00171951|7181822|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3
4404043|NCT00171951|7181822|FG000|Overall Study|Participants Withdrew Consent|3
4404044|NCT00171951|7181822|FG000|Overall Study|New Cancer Therapy|5
4404045|NCT00171951|7181822|FG000|Overall Study|Reason not Specified|2
4404046|NCT00172042|7181831|FG000|Overall Study|Adverse Event|27
4404047|NCT00172042|7181832|FG001|Overall Study|Adverse Event|13
4404048|NCT00172042|7181831|FG000|Overall Study|Abnormal laboratory value(s)|5
4404049|NCT00172042|7181832|FG001|Overall Study|Abnormal laboratory value(s)|1
4404050|NCT00172042|7181831|FG000|Overall Study|Abnormal test procedure(s)|0
4404051|NCT00172042|7181832|FG001|Overall Study|Abnormal test procedure(s)|3
4404052|NCT00172042|7181831|FG000|Overall Study|Unsatisfactory therapeutic effect|13
4404053|NCT00172042|7181832|FG001|Overall Study|Unsatisfactory therapeutic effect|11
4404054|NCT00172042|7181831|FG000|Overall Study|Patient no longer requires study drug|10
4404055|NCT00172042|7181832|FG001|Overall Study|Patient no longer requires study drug|8
4404056|NCT00172042|7181831|FG000|Overall Study|Protocol Violation|8
4404057|NCT00172042|7181832|FG001|Overall Study|Protocol Violation|7
4404058|NCT00172042|7181831|FG000|Overall Study|Withdrawal by Subject|37
4404059|NCT00172042|7181832|FG001|Overall Study|Withdrawal by Subject|25
4404060|NCT00172042|7181831|FG000|Overall Study|Lost to Follow-up|3
4404061|NCT00172042|7181832|FG001|Overall Study|Lost to Follow-up|5
4404062|NCT00172042|7181831|FG000|Overall Study|Administrative problems|13
4404063|NCT00172042|7181832|FG001|Overall Study|Administrative problems|10
4404064|NCT00172042|7181831|FG000|Overall Study|Death|42
4404065|NCT00172042|7181832|FG001|Overall Study|Death|42
4404066|NCT00172185|7181842|FG000|Overall Study|Adverse Event|0
4404067|NCT00172185|7181843|FG001|Overall Study|Adverse Event|1
4404068|NCT00172185|7181844|FG002|Overall Study|Adverse Event|3
4404069|NCT00172185|7181845|FG003|Overall Study|Adverse Event|4
4404070|NCT00172185|7181842|FG000|Overall Study|Physician Decision|0
4404071|NCT00172185|7181843|FG001|Overall Study|Physician Decision|0
4404072|NCT00172185|7181844|FG002|Overall Study|Physician Decision|1
4404073|NCT00172185|7181845|FG003|Overall Study|Physician Decision|0
4404074|NCT00172185|7181842|FG000|Overall Study|SPONSOR Decision|0
4404075|NCT00172185|7181843|FG001|Overall Study|SPONSOR Decision|1
4404076|NCT00172185|7181844|FG002|Overall Study|SPONSOR Decision|0
4404077|NCT00172185|7181845|FG003|Overall Study|SPONSOR Decision|0
4404078|NCT00172185|7181842|FG000|Overall Study|Withdrawal by Subject|0
4404079|NCT00172185|7181843|FG001|Overall Study|Withdrawal by Subject|0
4404080|NCT00172185|7181844|FG002|Overall Study|Withdrawal by Subject|1
4404081|NCT00172185|7181845|FG003|Overall Study|Withdrawal by Subject|0
4404082|NCT00174187|7181861|FG000|Period 1 (up to 3 Years)|Serious adverse event|0
4404083|NCT00174187|7181862|FG001|Period 1 (up to 3 Years)|Serious adverse event|1
4404084|NCT00174187|7181863|FG002|Period 1 (up to 3 Years)|Serious adverse event|0
4404085|NCT00174187|7181861|FG000|Period 1 (up to 3 Years)|Non compliance|0
4404086|NCT00174187|7181862|FG001|Period 1 (up to 3 Years)|Non compliance|1
4404087|NCT00174187|7181863|FG002|Period 1 (up to 3 Years)|Non compliance|0
4404088|NCT00174187|7181861|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0
4404089|NCT00174187|7181862|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1
4404090|NCT00174187|7181863|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0
4404091|NCT00174187|7181861|FG000|Period 1 (up to 3 Years)|Other|0
4404092|NCT00174187|7181862|FG001|Period 1 (up to 3 Years)|Other|1
4404093|NCT00174187|7181863|FG002|Period 1 (up to 3 Years)|Other|0
4404094|NCT00174187|7181861|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0
4404095|NCT00174187|7181862|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0
4404096|NCT00174187|7181863|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2
4404097|NCT00174187|7181861|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0
4404098|NCT00174187|7181862|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0
4404099|NCT00174187|7181863|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3
4404100|NCT00174187|7181861|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0
4404101|NCT00174187|7181862|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0
4404102|NCT00174187|7181863|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2
4404103|NCT00174187|7181861|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0
4404104|NCT00174187|7181862|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0
4404105|NCT00174187|7181863|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1
4404106|NCT00174187|7181861|FG000|Period 2 (After 3 Years)|Other|0
4404107|NCT00174187|7181862|FG001|Period 2 (After 3 Years)|Other|0
4404108|NCT00174187|7181863|FG002|Period 2 (After 3 Years)|Other|5
4404109|NCT00174252|7181871|FG000|Overall Study|Protocol Violation|2
4628957|NCT01867216|7496519|FG003|Overall Study|Withdrawal by Subject|0
4628958|NCT01867216|7496520|FG004|Overall Study|Withdrawal by Subject|1
4628959|NCT01867216|7496521|FG005|Overall Study|Withdrawal by Subject|0
4628960|NCT01867216|7496522|FG006|Overall Study|Withdrawal by Subject|1
4628961|NCT01867216|7496516|FG000|Overall Study|Physician Decision|1
4628962|NCT01867216|7496517|FG001|Overall Study|Physician Decision|0
4628963|NCT01867216|7496518|FG002|Overall Study|Physician Decision|0
4628964|NCT01867216|7496519|FG003|Overall Study|Physician Decision|0
4628965|NCT01867216|7496520|FG004|Overall Study|Physician Decision|0
4628966|NCT01867216|7496521|FG005|Overall Study|Physician Decision|0
4628967|NCT01867216|7496522|FG006|Overall Study|Physician Decision|0
4628968|NCT01867216|7496516|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1
4628969|NCT01867216|7496517|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0
4628970|NCT01867216|7496518|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0
4628971|NCT01867216|7496519|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0
4628972|NCT01867216|7496520|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0
4628973|NCT01867216|7496521|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0
4404110|NCT00174291|7181879|FG000|Overall Study|Lost to Follow-up|1
4404111|NCT00174291|7181880|FG001|Overall Study|Lost to Follow-up|1
4404112|NCT00174291|7181879|FG000|Overall Study|Protocol Violation|0
4404113|NCT00174291|7181880|FG001|Overall Study|Protocol Violation|2
4404114|NCT00174291|7181879|FG000|Overall Study|Study terminated by sponsor|1
4404115|NCT00174291|7181880|FG001|Overall Study|Study terminated by sponsor|0
4404116|NCT00174291|7181879|FG000|Overall Study|Withdrawal by Subject|3
4404117|NCT00174291|7181880|FG001|Overall Study|Withdrawal by Subject|3
4404118|NCT00174382|7181886|FG000|Overall Study|Death|2
4404119|NCT00174382|7181886|FG000|Overall Study|Adverse Event|19
4404120|NCT00174382|7181886|FG000|Overall Study|Withdrawal by Subject|6
4404121|NCT00174382|7181886|FG000|Overall Study|Protocol Violation|3
4404122|NCT00174382|7181886|FG000|Overall Study|Arrived early for last visit in error|1
4404123|NCT00174382|7181886|FG000|Overall Study|Subject felt pill not effective enough|1
4404124|NCT00174382|7181886|FG000|Overall Study|Lost to Follow-up|1
4404125|NCT00174447|7181890|FG000|Overall Study|Adverse Event|19
4404126|NCT00174447|7181890|FG000|Overall Study|Withdrawal by Subject|15
4404127|NCT00174447|7181890|FG000|Overall Study|Protocol Violation|1
4404128|NCT00174447|7181890|FG000|Overall Study|Lack of Efficacy|1
4404129|NCT00174447|7181890|FG000|Overall Study|Administrative reason/Other|2
4404130|NCT00174460|7181896|FG000|Overall Study|Withdrawal by Subject|0
4404131|NCT00174460|7181897|FG001|Overall Study|Withdrawal by Subject|1
4404132|NCT00174785|7181906|FG000|Overall Study|Adverse Event|293
4404133|NCT00174785|7181907|FG001|Overall Study|Adverse Event|191
4404134|NCT00174785|7181906|FG000|Overall Study|Protocol Violation|14
4404135|NCT00174785|7181907|FG001|Overall Study|Protocol Violation|14
4404136|NCT00174785|7181906|FG000|Overall Study|Withdrawal by Subject|173
4404137|NCT00174785|7181907|FG001|Overall Study|Withdrawal by Subject|175
4404138|NCT00174785|7181906|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110
4404139|NCT00174785|7181907|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167
4404140|NCT00174785|7181906|FG000|Overall Study|Prohibited antiarrhythmic medication|39
4404141|NCT00174785|7181907|FG001|Overall Study|Prohibited antiarrhythmic medication|88
4404142|NCT00174785|7181906|FG000|Overall Study|Other prohibited medication|5
4404143|NCT00174785|7181907|FG001|Overall Study|Other prohibited medication|3
4404144|NCT00174785|7181906|FG000|Overall Study|Family request|6
4404145|NCT00174785|7181907|FG001|Overall Study|Family request|8
4404146|NCT00174785|7181906|FG000|Overall Study|Not pre-specified/Not coded|56
4404147|NCT00174785|7181907|FG001|Overall Study|Not pre-specified/Not coded|70
4404148|NCT00174915|7181918|FG000|Overall Study|Lost to Follow-up|19
4404149|NCT00174915|7181919|FG001|Overall Study|Lost to Follow-up|17
4404150|NCT00174915|7181920|FG002|Overall Study|Lost to Follow-up|9
4404151|NCT00174915|7181921|FG003|Overall Study|Lost to Follow-up|17
4404152|NCT00174915|7181922|FG004|Overall Study|Lost to Follow-up|10
4404153|NCT00174915|7181918|FG000|Overall Study|Adverse Event|18
4404154|NCT00174915|7181919|FG001|Overall Study|Adverse Event|16
4404155|NCT00174915|7181920|FG002|Overall Study|Adverse Event|11
4404156|NCT00174915|7181921|FG003|Overall Study|Adverse Event|18
4404157|NCT00174915|7181922|FG004|Overall Study|Adverse Event|5
4404158|NCT00174915|7181918|FG000|Overall Study|Personal Reason(s)|16
4404159|NCT00174915|7181919|FG001|Overall Study|Personal Reason(s)|16
4404160|NCT00174915|7181920|FG002|Overall Study|Personal Reason(s)|9
4404161|NCT00174915|7181921|FG003|Overall Study|Personal Reason(s)|9
4404162|NCT00174915|7181922|FG004|Overall Study|Personal Reason(s)|9
4404163|NCT00174915|7181918|FG000|Overall Study|Other|15
4404164|NCT00174915|7181919|FG001|Overall Study|Other|8
4404165|NCT00174915|7181920|FG002|Overall Study|Other|6
4404166|NCT00174915|7181921|FG003|Overall Study|Other|5
4404167|NCT00174915|7181922|FG004|Overall Study|Other|3
4404168|NCT00174915|7181918|FG000|Overall Study|Gout Flare|13
4404169|NCT00174915|7181919|FG001|Overall Study|Gout Flare|6
4404170|NCT00174915|7181920|FG002|Overall Study|Gout Flare|8
4404171|NCT00174915|7181921|FG003|Overall Study|Gout Flare|1
4404172|NCT00174915|7181922|FG004|Overall Study|Gout Flare|0
4404173|NCT00174915|7181918|FG000|Overall Study|Protocol Violation|6
4404174|NCT00174915|7181919|FG001|Overall Study|Protocol Violation|3
4404175|NCT00174915|7181920|FG002|Overall Study|Protocol Violation|3
4404176|NCT00174915|7181921|FG003|Overall Study|Protocol Violation|6
4404177|NCT00174915|7181922|FG004|Overall Study|Protocol Violation|3
4404178|NCT00174915|7181918|FG000|Overall Study|Therapeutic Failure|6
4404179|NCT00174915|7181919|FG001|Overall Study|Therapeutic Failure|3
4404180|NCT00174915|7181920|FG002|Overall Study|Therapeutic Failure|2
4404181|NCT00174915|7181921|FG003|Overall Study|Therapeutic Failure|1
4404182|NCT00174915|7181922|FG004|Overall Study|Therapeutic Failure|3
4404183|NCT00174941|7181937|FG000|Overall Study|Adverse Event|1
4404184|NCT00174941|7181938|FG001|Overall Study|Adverse Event|10
4404185|NCT00174941|7181939|FG002|Overall Study|Adverse Event|2
4404186|NCT00174941|7181940|FG003|Overall Study|Adverse Event|13
4404187|NCT00174941|7181937|FG000|Overall Study|Protocol Violation|0
4404188|NCT00174941|7181938|FG001|Overall Study|Protocol Violation|1
4404189|NCT00174941|7181939|FG002|Overall Study|Protocol Violation|0
4404190|NCT00174941|7181940|FG003|Overall Study|Protocol Violation|1
4404191|NCT00174941|7181937|FG000|Overall Study|Lost to Follow-up|0
4404192|NCT00174941|7181938|FG001|Overall Study|Lost to Follow-up|3
4404193|NCT00174941|7181939|FG002|Overall Study|Lost to Follow-up|2
4404194|NCT00174941|7181940|FG003|Overall Study|Lost to Follow-up|5
4404195|NCT00174941|7181937|FG000|Overall Study|Personal Reason(s)|0
4404196|NCT00174941|7181938|FG001|Overall Study|Personal Reason(s)|14
4404197|NCT00174941|7181939|FG002|Overall Study|Personal Reason(s)|8
4404198|NCT00174941|7181940|FG003|Overall Study|Personal Reason(s)|22
4404199|NCT00174941|7181937|FG000|Overall Study|Gout Flare|0
4404200|NCT00174941|7181938|FG001|Overall Study|Gout Flare|4
4404201|NCT00174941|7181939|FG002|Overall Study|Gout Flare|4
4404202|NCT00174941|7181940|FG003|Overall Study|Gout Flare|8
4404203|NCT00174941|7181937|FG000|Overall Study|Reason Not Specified|1
4404204|NCT00174941|7181938|FG001|Overall Study|Reason Not Specified|6
4404205|NCT00174941|7181939|FG002|Overall Study|Reason Not Specified|2
4404206|NCT00174941|7181940|FG003|Overall Study|Reason Not Specified|9
4404207|NCT00174954|7181950|FG000|Overall Study|Adverse Event|2
4404208|NCT00174954|7181950|FG000|Overall Study|No tophi found in MRI|1
4404209|NCT00174954|7181950|FG000|Overall Study|Physician Decision|1
4404210|NCT00174967|7181958|FG000|Overall Study|Adverse Event|1
4404211|NCT00174967|7181959|FG001|Overall Study|Adverse Event|2
4404212|NCT00174967|7181960|FG002|Overall Study|Adverse Event|2
4404213|NCT00174967|7181961|FG003|Overall Study|Adverse Event|1
4404214|NCT00174967|7181958|FG000|Overall Study|Gout Flare|0
4404215|NCT00174967|7181959|FG001|Overall Study|Gout Flare|0
4404216|NCT00174967|7181960|FG002|Overall Study|Gout Flare|0
4404217|NCT00174967|7181961|FG003|Overall Study|Gout Flare|1
4404218|NCT00174967|7181958|FG000|Overall Study|Other|0
4404219|NCT00174967|7181959|FG001|Overall Study|Other|1
4404220|NCT00174967|7181960|FG002|Overall Study|Other|0
4404221|NCT00174967|7181961|FG003|Overall Study|Other|0
4404222|NCT00175019|7181978|FG000|Overall Study|Adverse Event|54
4404223|NCT00175019|7181979|FG001|Overall Study|Adverse Event|22
4404224|NCT00175019|7181980|FG002|Overall Study|Adverse Event|2
4404225|NCT00175019|7181978|FG000|Overall Study|Protocol Violation|6
4404226|NCT00175019|7181979|FG001|Overall Study|Protocol Violation|3
4404227|NCT00175019|7181980|FG002|Overall Study|Protocol Violation|3
4404228|NCT00175019|7181978|FG000|Overall Study|Lost to Follow-up|42
4404229|NCT00175019|7181979|FG001|Overall Study|Lost to Follow-up|39
4404230|NCT00175019|7181980|FG002|Overall Study|Lost to Follow-up|9
4404231|NCT00175019|7181978|FG000|Overall Study|Did not continue under Amendment 4|1
4404232|NCT00175019|7181979|FG001|Overall Study|Did not continue under Amendment 4|1
4404233|NCT00175019|7181980|FG002|Overall Study|Did not continue under Amendment 4|2
4404234|NCT00175019|7181978|FG000|Overall Study|Personal Reason(s)|39
4404235|NCT00175019|7181979|FG001|Overall Study|Personal Reason(s)|31
4404236|NCT00175019|7181980|FG002|Overall Study|Personal Reason(s)|8
4404237|NCT00175019|7181978|FG000|Overall Study|Therapeutic Failure|10
4404238|NCT00175019|7181979|FG001|Overall Study|Therapeutic Failure|38
4404239|NCT00175019|7181980|FG002|Overall Study|Therapeutic Failure|22
4404240|NCT00175019|7181978|FG000|Overall Study|Gout Flare|2
4404241|NCT00175019|7181979|FG001|Overall Study|Gout Flare|3
4404242|NCT00175019|7181980|FG002|Overall Study|Gout Flare|0
4404243|NCT00175019|7181978|FG000|Overall Study|Reason Not Specified|40
4404244|NCT00175019|7181979|FG001|Overall Study|Reason Not Specified|34
4404245|NCT00175019|7181980|FG002|Overall Study|Reason Not Specified|11
4404246|NCT00175825|7181992|FG000|Overall Study|Adverse Event|3
4404247|NCT00175825|7181993|FG001|Overall Study|Adverse Event|2
4404248|NCT00175825|7181994|FG002|Overall Study|Adverse Event|1
4404249|NCT00175825|7181995|FG003|Overall Study|Adverse Event|1
4404250|NCT00175825|7181992|FG000|Overall Study|Lost to Follow-up|1
4404251|NCT00175825|7181993|FG001|Overall Study|Lost to Follow-up|2
4404252|NCT00175825|7181994|FG002|Overall Study|Lost to Follow-up|0
4404253|NCT00175825|7181995|FG003|Overall Study|Lost to Follow-up|0
4404254|NCT00175825|7181992|FG000|Overall Study|Withdrawal by Subject|1
4404255|NCT00175825|7181993|FG001|Overall Study|Withdrawal by Subject|0
4404256|NCT00175825|7181994|FG002|Overall Study|Withdrawal by Subject|0
4404257|NCT00175825|7181995|FG003|Overall Study|Withdrawal by Subject|0
4404258|NCT00175877|7182005|FG000|Overall Study|Adverse Event|136
4404259|NCT00175877|7182005|FG000|Overall Study|Withdrawal by Subject|141
4404260|NCT00175877|7182005|FG000|Overall Study|Lost to Follow-up|9
4404261|NCT00175877|7182005|FG000|Overall Study|Lack of Efficacy|26
4404262|NCT00175877|7182005|FG000|Overall Study|Protocol Violation|15
4404263|NCT00175877|7182005|FG000|Overall Study|Other Reason|20
4404264|NCT00175877|7182005|FG000|Overall Study|AE & Other|1
4404265|NCT00175877|7182005|FG000|Overall Study|Withdrawal by subject & Other|1
4404266|NCT00175916|7182009|FG000|Overall Study|Death|19
4404267|NCT00175916|7182009|FG000|Overall Study|Adverse Event|81
4404268|NCT00175916|7182009|FG000|Overall Study|Lack of Efficacy|354
4404269|NCT00175916|7182009|FG000|Overall Study|Lost to Follow-up|17
4404270|NCT00175916|7182009|FG000|Overall Study|Subject Choice|98
4404271|NCT00175916|7182009|FG000|Overall Study|Lack of compliance|8
4404272|NCT00175916|7182009|FG000|Overall Study|Patient cannot record seizures|1
4404273|NCT00175916|7182009|FG000|Overall Study|Sponsor decision|17
4404274|NCT00175916|7182009|FG000|Overall Study|Vigabatrin intake|1
4404275|NCT00175916|7182009|FG000|Overall Study|Suicidal behaviour|1
4404276|NCT00175916|7182009|FG000|Overall Study|Withdrawal by Subject|1
4404277|NCT00175916|7182009|FG000|Overall Study|Seizure - free|4
4404278|NCT00175916|7182009|FG000|Overall Study|Administrative reason|1
4404279|NCT00175916|7182009|FG000|Overall Study|Pregnancy|1
4404280|NCT00175916|7182009|FG000|Overall Study|Patient's request|2
4404281|NCT00175916|7182009|FG000|Overall Study|Treating physiciant's choice|1
4404282|NCT00175916|7182009|FG000|Overall Study|Moved overseas|1
4404283|NCT00175916|7182009|FG000|Overall Study|Loss of job and economic burden|1
4404284|NCT00175916|7182009|FG000|Overall Study|Site was closed|9
4404285|NCT00175916|7182009|FG000|Overall Study|Patient went to prison|1
4404286|NCT00176254|7182030|FG000|Overall Study|Lost to Follow-up|1
4404287|NCT00176462|7182049|FG000|Induction (4 Weeks)|Withdrawal by Subject|0
4404288|NCT00176462|7182050|FG001|Induction (4 Weeks)|Withdrawal by Subject|2
4404289|NCT00176462|7182049|FG000|Induction (4 Weeks)|Death|1
4404290|NCT00176462|7182050|FG001|Induction (4 Weeks)|Death|2
4404291|NCT00176462|7182049|FG000|Induction (4 Weeks)|Lack of Efficacy|0
4404292|NCT00176462|7182050|FG001|Induction (4 Weeks)|Lack of Efficacy|1
4404293|NCT00176462|7182049|FG000|Consolidation (12 Weeks)|Patient moved to another state|0
4404294|NCT00176462|7182050|FG001|Consolidation (12 Weeks)|Patient moved to another state|1
4404295|NCT00176462|7182049|FG000|Consolidation (12 Weeks)|Adverse Event|0
4404296|NCT00176462|7182050|FG001|Consolidation (12 Weeks)|Adverse Event|1
4404297|NCT00176462|7182049|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0
4404298|NCT00176462|7182050|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2
4404299|NCT00176462|7182049|FG000|Consolidation (12 Weeks)|Not documented|0
4404300|NCT00176462|7182050|FG001|Consolidation (12 Weeks)|Not documented|1
4404301|NCT00176462|7182049|FG000|Intensive Continuation (8X8-week Cycles)|Death|1
4404302|NCT00176462|7182050|FG001|Intensive Continuation (8X8-week Cycles)|Death|0
4404303|NCT00176462|7182049|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0
4404304|NCT00176462|7182050|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3
4404305|NCT00176605|7182066|FG000|Overall Study|Withdrawal by Subject|2
4404306|NCT00176644|7182070|FG000|Overall Study|Withdrawal by Subject|1
4404307|NCT00177164|7182167|FG000|Overall Study|Protocol Violation|0
4404308|NCT00177164|7182168|FG001|Overall Study|Protocol Violation|7
4404309|NCT00177164|7182167|FG000|Overall Study|Lost to Follow-up|4
4404310|NCT00177164|7182168|FG001|Overall Study|Lost to Follow-up|5
4404311|NCT00177164|7182167|FG000|Overall Study|increase in alcohol and drug use|1
4404312|NCT00177164|7182168|FG001|Overall Study|increase in alcohol and drug use|2
4404313|NCT00177164|7182167|FG000|Overall Study|Adverse Event|1
4404314|NCT00177164|7182168|FG001|Overall Study|Adverse Event|0
4404315|NCT00177164|7182167|FG000|Overall Study|discharge from hospital|1
4404316|NCT00177164|7182168|FG001|Overall Study|discharge from hospital|0
4404317|NCT00177164|7182167|FG000|Overall Study|Lack of Efficacy|2
4404318|NCT00177164|7182168|FG001|Overall Study|Lack of Efficacy|1
4404319|NCT00177164|7182167|FG000|Overall Study|Pregnancy|0
4404320|NCT00177164|7182168|FG001|Overall Study|Pregnancy|1
4404321|NCT00177216|7182177|FG000|Overall Study|Withdrawal by Subject|6
4404322|NCT00177216|7182178|FG001|Overall Study|Withdrawal by Subject|3
4404323|NCT00177216|7182179|FG002|Overall Study|Withdrawal by Subject|1
4404324|NCT00177294|7182197|FG000|Overall Study|Withdrawal by Subject|7
4404325|NCT00177294|7182198|FG001|Overall Study|Withdrawal by Subject|5
4404326|NCT00177307|7182204|FG000|Overall Study|Withdrawal by Subject|1
4404327|NCT00177671|7182210|FG000|Overall Study|Withdrawal by Subject|5
4404328|NCT00177671|7182211|FG001|Overall Study|Withdrawal by Subject|6
4404329|NCT00177671|7182210|FG000|Overall Study|medical complications|2
4404330|NCT00177671|7182211|FG001|Overall Study|medical complications|0
4404331|NCT00177671|7182210|FG000|Overall Study|Adverse Event|6
4404332|NCT00177671|7182211|FG001|Overall Study|Adverse Event|0
4404333|NCT00177671|7182210|FG000|Overall Study|Physician Decision|12
4404334|NCT00177671|7182211|FG001|Overall Study|Physician Decision|8
4404335|NCT00178126|7182219|FG000|Overall Study|Lost to Follow-up|21
4404336|NCT00178126|7182220|FG001|Overall Study|Lost to Follow-up|21
4404337|NCT00178126|7182219|FG000|Overall Study|did not receive intervention|4
4404338|NCT00178126|7182220|FG001|Overall Study|did not receive intervention|6
4404339|NCT00178256|7182256|FG000|Overall Study|Adverse Event|2
4404340|NCT00178256|7182257|FG001|Overall Study|Adverse Event|0
4404341|NCT00178256|7182258|FG002|Overall Study|Adverse Event|0
4404342|NCT00178256|7182259|FG003|Overall Study|Adverse Event|0
4404343|NCT00178256|7182256|FG000|Overall Study|Death|0
4404344|NCT00178256|7182257|FG001|Overall Study|Death|1
4404345|NCT00178256|7182258|FG002|Overall Study|Death|0
4404346|NCT00178256|7182259|FG003|Overall Study|Death|1
4404347|NCT00178256|7182256|FG000|Overall Study|Cancer progression|2
4404348|NCT00178256|7182257|FG001|Overall Study|Cancer progression|0
4404349|NCT00178256|7182258|FG002|Overall Study|Cancer progression|0
4404350|NCT00178256|7182259|FG003|Overall Study|Cancer progression|1
4404351|NCT00178399|7182266|FG000|Overall Study|Physician Decision|4
4404352|NCT00178399|7182266|FG000|Overall Study|Withdrawal by Subject|8
4404353|NCT00178399|7182266|FG000|Overall Study|Lost to Follow-up|1
4404354|NCT00178464|7182271|FG000|Overall Study|Withdrawal by Subject|1
4404355|NCT00178464|7182271|FG000|Overall Study|Physician Decision|1
4404356|NCT00178633|7182290|FG000|Overall Study|Lost to Follow-up|6
4404357|NCT00178685|7182314|FG000|Overall Study|Death|3
4404358|NCT00178685|7182315|FG001|Overall Study|Death|3
4404359|NCT00178685|7182316|FG002|Overall Study|Death|6
4404360|NCT00178685|7182314|FG000|Overall Study|Lost to Follow-up|100
4404361|NCT00178685|7182315|FG001|Overall Study|Lost to Follow-up|187
4404362|NCT00178685|7182316|FG002|Overall Study|Lost to Follow-up|183
4404363|NCT00178685|7182314|FG000|Overall Study|Withdrawal by Subject|8
4404364|NCT00178685|7182315|FG001|Overall Study|Withdrawal by Subject|14
4404365|NCT00178685|7182316|FG002|Overall Study|Withdrawal by Subject|7
4404366|NCT00179010|7182351|FG000|Overall Study|Muscle probe defective|1
4404367|NCT00179010|7182352|FG001|Overall Study|Muscle probe defective|1
4404368|NCT00179010|7182351|FG000|Overall Study|Failure to place arterial line|0
4404369|NCT00179010|7182352|FG001|Overall Study|Failure to place arterial line|1
4404370|NCT00179309|7182361|FG000|Treatment|Toxicity|2
4404371|NCT00179309|7182362|FG001|Treatment|Toxicity|3
4404372|NCT00179309|7182361|FG000|Treatment|Withdrawal by Subject|1
4404373|NCT00179309|7182362|FG001|Treatment|Withdrawal by Subject|2
4404374|NCT00179309|7182361|FG000|Treatment|Allergy|1
4404375|NCT00179309|7182362|FG001|Treatment|Allergy|0
4404376|NCT00179413|7182370|FG000|Overall Study|Adverse Event|38
4404377|NCT00179413|7182371|FG001|Overall Study|Adverse Event|20
4404378|NCT00179413|7182370|FG000|Overall Study|Withdrawal by Subject|87
4404379|NCT00179413|7182371|FG001|Overall Study|Withdrawal by Subject|95
4404380|NCT00179517|7182387|FG000|Overall Study|Withdrawal by Subject|2
4404381|NCT00179517|7182388|FG001|Overall Study|Withdrawal by Subject|1
4404382|NCT00179621|7182397|FG000|Double-Blind Period|Lack of Therapeutic Effect|59
4404383|NCT00179621|7182398|FG001|Double-Blind Period|Lack of Therapeutic Effect|35
4404384|NCT00179621|7182399|FG002|Double-Blind Period|Lack of Therapeutic Effect|19
4404385|NCT00179621|7182400|FG003|Double-Blind Period|Lack of Therapeutic Effect|0
4404386|NCT00179621|7182397|FG000|Double-Blind Period|Adverse Event|2
4404387|NCT00179621|7182398|FG001|Double-Blind Period|Adverse Event|7
4404388|NCT00179621|7182399|FG002|Double-Blind Period|Adverse Event|4
4404389|NCT00179621|7182400|FG003|Double-Blind Period|Adverse Event|0
4404390|NCT00179621|7182397|FG000|Double-Blind Period|Withdrawal by Subject|2
4404391|NCT00179621|7182398|FG001|Double-Blind Period|Withdrawal by Subject|1
4404392|NCT00179621|7182399|FG002|Double-Blind Period|Withdrawal by Subject|3
4404393|NCT00179621|7182400|FG003|Double-Blind Period|Withdrawal by Subject|0
4404394|NCT00179621|7182397|FG000|Double-Blind Period|Death|0
4404395|NCT00179621|7182398|FG001|Double-Blind Period|Death|1
4404396|NCT00179621|7182399|FG002|Double-Blind Period|Death|2
4404397|NCT00179621|7182400|FG003|Double-Blind Period|Death|0
4404398|NCT00179621|7182397|FG000|Double-Blind Period|Protocol Violation|1
4404399|NCT00179621|7182398|FG001|Double-Blind Period|Protocol Violation|0
4404400|NCT00179621|7182399|FG002|Double-Blind Period|Protocol Violation|0
4404401|NCT00179621|7182400|FG003|Double-Blind Period|Protocol Violation|0
4404402|NCT00179621|7182397|FG000|Double-Blind Period|Other|0
4404403|NCT00179621|7182398|FG001|Double-Blind Period|Other|2
4511202|NCT00925002|7320106|FG002|Overall Study|Other|0
4511203|NCT00925002|7320104|FG000|Overall Study|Death|1
4511204|NCT00925002|7320105|FG001|Overall Study|Death|1
4511205|NCT00925002|7320106|FG002|Overall Study|Death|5
4511206|NCT00925002|7320104|FG000|Overall Study|Adverse Event|3
4511207|NCT00925002|7320105|FG001|Overall Study|Adverse Event|1
4511208|NCT00925002|7320106|FG002|Overall Study|Adverse Event|2
4511209|NCT00925002|7320104|FG000|Overall Study|Participant withdrew consent|1
4511210|NCT00925002|7320105|FG001|Overall Study|Participant withdrew consent|3
4511211|NCT00925002|7320106|FG002|Overall Study|Participant withdrew consent|3
4511212|NCT00925015|7320118|FG000|Overall Study|Adverse Event|1
4511213|NCT00925015|7320119|FG001|Overall Study|Adverse Event|2
4511214|NCT00925015|7320120|FG002|Overall Study|Adverse Event|1
4511215|NCT00925015|7320118|FG000|Overall Study|Physician Decision|0
4511216|NCT00925015|7320119|FG001|Overall Study|Physician Decision|1
4511217|NCT00925015|7320120|FG002|Overall Study|Physician Decision|0
4511218|NCT00925015|7320118|FG000|Overall Study|Progressive Disease|7
4511219|NCT00925015|7320119|FG001|Overall Study|Progressive Disease|3
4511220|NCT00925015|7320120|FG002|Overall Study|Progressive Disease|4
4404404|NCT00179621|7182399|FG002|Double-Blind Period|Other|2
4404405|NCT00179621|7182400|FG003|Double-Blind Period|Other|0
4404406|NCT00179621|7182397|FG000|Open-Label Period|Lack of Therapeutic Effect|0
4404407|NCT00179621|7182398|FG001|Open-Label Period|Lack of Therapeutic Effect|19
4404408|NCT00179621|7182399|FG002|Open-Label Period|Lack of Therapeutic Effect|19
4404409|NCT00179621|7182400|FG003|Open-Label Period|Lack of Therapeutic Effect|31
4404410|NCT00179621|7182397|FG000|Open-Label Period|Adverse Event|0
4404411|NCT00179621|7182398|FG001|Open-Label Period|Adverse Event|6
4404412|NCT00179621|7182399|FG002|Open-Label Period|Adverse Event|5
4404413|NCT00179621|7182400|FG003|Open-Label Period|Adverse Event|6
4404414|NCT00179621|7182397|FG000|Open-Label Period|Withdrawal by Subject|0
4404415|NCT00179621|7182398|FG001|Open-Label Period|Withdrawal by Subject|2
4404416|NCT00179621|7182399|FG002|Open-Label Period|Withdrawal by Subject|2
4404417|NCT00179621|7182400|FG003|Open-Label Period|Withdrawal by Subject|2
4404418|NCT00179621|7182397|FG000|Open-Label Period|Death|0
4404419|NCT00179621|7182398|FG001|Open-Label Period|Death|0
4404420|NCT00179621|7182399|FG002|Open-Label Period|Death|1
4404421|NCT00179621|7182400|FG003|Open-Label Period|Death|2
4404422|NCT00179621|7182397|FG000|Open-Label Period|Other|0
4404423|NCT00179621|7182398|FG001|Open-Label Period|Other|1
4404424|NCT00179621|7182399|FG002|Open-Label Period|Other|1
4404425|NCT00179621|7182400|FG003|Open-Label Period|Other|2
4404426|NCT00179647|7182409|FG000|Overall Study|Adverse Event|294
4404427|NCT00179647|7182409|FG000|Overall Study|Lack of Efficacy|478
4404428|NCT00179647|7182409|FG000|Overall Study|Withdrawal by Subject|83
4404429|NCT00179647|7182409|FG000|Overall Study|Lost to Follow-up|4
4404430|NCT00179647|7182409|FG000|Overall Study|Death|94
4404431|NCT00179647|7182409|FG000|Overall Study|Other|960
4404432|NCT00179660|7182413|FG000|Overall Study|Adverse Event|7
4404433|NCT00179660|7182413|FG000|Overall Study|Lack of therapeutic effect|28
4404434|NCT00179660|7182413|FG000|Overall Study|Withdrawal by Subject|2
4404435|NCT00179660|7182413|FG000|Overall Study|Lost to Follow-up|1
4404436|NCT00179660|7182413|FG000|Overall Study|Death|3
4404437|NCT00179660|7182413|FG000|Overall Study|Other - Unspecified|9
4404438|NCT00179673|7182417|FG000|Overall Study|Adverse Event|7
4404439|NCT00179673|7182417|FG000|Overall Study|Lack of Efficacy|15
4404440|NCT00179673|7182417|FG000|Overall Study|Withdrawal by Subject|3
4404441|NCT00179673|7182417|FG000|Overall Study|Death|4
4404442|NCT00179673|7182417|FG000|Overall Study|Other Observations and options|14
4404443|NCT00179959|7182434|FG000|Overall Study|Lost to Follow-up|3
4404444|NCT00179959|7182435|FG001|Overall Study|Lost to Follow-up|1
4511221|NCT00925015|7320118|FG000|Overall Study|Withdrawal by Subject|0
4511222|NCT00925015|7320119|FG001|Overall Study|Withdrawal by Subject|0
4404445|NCT00179959|7182434|FG000|Overall Study|Withdrawal by Subject|3
4404446|NCT00179959|7182435|FG001|Overall Study|Withdrawal by Subject|2
4404447|NCT00180479|7182482|FG000|Overall Study|Death|4
4404448|NCT00180479|7182483|FG001|Overall Study|Death|2
4404449|NCT00180479|7182482|FG000|Overall Study|Lost to Follow-up|9
4404450|NCT00180479|7182483|FG001|Overall Study|Lost to Follow-up|7
4404451|NCT00180479|7182482|FG000|Overall Study|Withdrawal by Subject|3
4404452|NCT00180479|7182483|FG001|Overall Study|Withdrawal by Subject|3
4404453|NCT00180479|7182482|FG000|Overall Study|Informed consent not signed|0
4404454|NCT00180479|7182483|FG001|Overall Study|Informed consent not signed|1
4404455|NCT00180674|7182498|FG000|Phase 1, Observation Period|Withdrawal by Subject|4
4404456|NCT00180674|7182498|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1
4404457|NCT00180713|7182525|FG000|Overall Study|Withdrawal by Subject|2
4404458|NCT00180713|7182526|FG001|Overall Study|Withdrawal by Subject|0
4404459|NCT00180713|7182525|FG000|Overall Study|Adverse Event|3
4404460|NCT00180713|7182526|FG001|Overall Study|Adverse Event|3
4404461|NCT00181155|7182532|FG000|Overall Study|Physician Decision|1
4404462|NCT00181155|7182533|FG001|Overall Study|Physician Decision|0
4404463|NCT00181155|7182532|FG000|Overall Study|Withdrawal by Subject|1
4404464|NCT00181155|7182533|FG001|Overall Study|Withdrawal by Subject|0
4404465|NCT00181766|7182597|FG000|Overall Study|Lost to Follow-up|6
4404466|NCT00181766|7182597|FG000|Overall Study|Adverse Event|4
4404467|NCT00181766|7182597|FG000|Overall Study|non-compliance|2
4404468|NCT00181844|7182601|FG000|Signed Consent|Withdrawal by Subject|5
4404469|NCT00181844|7182601|FG000|Signed Consent|Did not meet entrance criteria|7
4404470|NCT00181844|7182601|FG000|Exposed to Study Medication|Adverse Event|10
4404471|NCT00181844|7182601|FG000|Exposed to Study Medication|Lack of Efficacy|2
4404472|NCT00181844|7182601|FG000|Exposed to Study Medication|Non-compliance|2
4404473|NCT00181844|7182601|FG000|Exposed to Study Medication|Withdrawal by Subject|1
4404474|NCT00181844|7182601|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2
4404475|NCT00181883|7182605|FG000|Overall Study|Lack of Efficacy|2
4404476|NCT00181883|7182605|FG000|Overall Study|Treatment Limiting AEs|3
4404477|NCT00181883|7182605|FG000|Overall Study|Withdrawal by Subject|4
4404478|NCT00181883|7182605|FG000|Overall Study|Lost to Follow-up|1
4511223|NCT00925015|7320120|FG002|Overall Study|Withdrawal by Subject|1
4511224|NCT00925132|7320158|FG000|Overall Study|Withdrawal by Subject|2
4511225|NCT00925132|7320159|FG001|Overall Study|Withdrawal by Subject|0
4511226|NCT00925132|7320160|FG002|Overall Study|Withdrawal by Subject|0
4511227|NCT00925132|7320161|FG003|Overall Study|Withdrawal by Subject|0
4511228|NCT00925132|7320162|FG004|Overall Study|Withdrawal by Subject|1
4511229|NCT00925132|7320158|FG000|Overall Study|Removed due to disease progression|0
4511230|NCT00925132|7320159|FG001|Overall Study|Removed due to disease progression|0
4511231|NCT00925132|7320160|FG002|Overall Study|Removed due to disease progression|0
4511232|NCT00925132|7320161|FG003|Overall Study|Removed due to disease progression|0
4511233|NCT00925132|7320162|FG004|Overall Study|Removed due to disease progression|4
4511234|NCT00925288|7320170|FG000|Overall Study|Lost to Follow-up|9
4511235|NCT00925288|7320171|FG001|Overall Study|Lost to Follow-up|7
4511236|NCT00925301|7320181|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0
4511237|NCT00925301|7320182|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2
4511238|NCT00925301|7320183|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0
4511239|NCT00925301|7320184|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0
4511240|NCT00925301|7320181|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0
4511241|NCT00925301|7320182|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1
4511242|NCT00925301|7320183|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0
4511243|NCT00925301|7320184|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0
4511244|NCT00925301|7320181|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0
4511245|NCT00925301|7320182|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0
4511246|NCT00925301|7320183|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1
4511247|NCT00925301|7320184|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0
4511248|NCT00925301|7320181|FG000|6-Month Open-label (Stage 2)|Adverse Event|0
4511249|NCT00925301|7320182|FG001|6-Month Open-label (Stage 2)|Adverse Event|0
4511250|NCT00925301|7320183|FG002|6-Month Open-label (Stage 2)|Adverse Event|2
4511251|NCT00925301|7320184|FG003|6-Month Open-label (Stage 2)|Adverse Event|0
4511252|NCT00925301|7320181|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0
4511253|NCT00925301|7320182|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0
4511254|NCT00925301|7320183|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0
4511255|NCT00925301|7320184|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1
4511256|NCT00925301|7320181|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0
4511257|NCT00925301|7320182|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0
4511258|NCT00925301|7320183|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0
4511259|NCT00925301|7320184|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1
4511260|NCT00925301|7320181|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0
4511261|NCT00925301|7320182|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0
4713375|NCT02944383|7640802|FG001|Overall Study|Withdrawal by Subject|0
4511262|NCT00925301|7320183|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0
4511263|NCT00925301|7320184|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1
4511264|NCT00925353|7320195|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3
4713376|NCT02944383|7640803|FG002|Overall Study|Withdrawal by Subject|0
4404479|NCT00182078|7182629|FG000|Overall Study|Withdrawal by Subject|1
4404480|NCT00182078|7182630|FG001|Overall Study|Withdrawal by Subject|0
4404481|NCT00182091|7182640|FG000|Overall Study|Withdrawal by Subject|1
4404482|NCT00182091|7182641|FG001|Overall Study|Withdrawal by Subject|0
4404483|NCT00182091|7182642|FG002|Overall Study|Withdrawal by Subject|0
4404484|NCT00182091|7182643|FG003|Overall Study|Withdrawal by Subject|0
4404485|NCT00182325|7182653|FG000|Overall Study|Lost to Follow-up|7
4404486|NCT00182325|7182654|FG001|Overall Study|Lost to Follow-up|7
4404487|NCT00182325|7182653|FG000|Overall Study|Miscarriage|5
4404488|NCT00182325|7182654|FG001|Overall Study|Miscarriage|3
4404489|NCT00182325|7182653|FG000|Overall Study|Did not complete survey|22
4404490|NCT00182325|7182654|FG001|Overall Study|Did not complete survey|43
4404491|NCT00182689|7182662|FG000|Overall Study|Adverse Event|8
4404492|NCT00182689|7182663|FG001|Overall Study|Adverse Event|11
4404493|NCT00182689|7182662|FG000|Overall Study|Withdrawal by Subject|2
4404494|NCT00182689|7182663|FG001|Overall Study|Withdrawal by Subject|2
4404495|NCT00182689|7182662|FG000|Overall Study|Progression|27
4404496|NCT00182689|7182663|FG001|Overall Study|Progression|29
4404497|NCT00182689|7182662|FG000|Overall Study|Death|1
4404498|NCT00182689|7182663|FG001|Overall Study|Death|0
4404499|NCT00182689|7182662|FG000|Overall Study|not protocol specified|0
4404500|NCT00182689|7182663|FG001|Overall Study|not protocol specified|3
4404501|NCT00182689|7182662|FG000|Overall Study|Ineligible|1
4404502|NCT00182689|7182663|FG001|Overall Study|Ineligible|4
4404503|NCT00182689|7182662|FG000|Overall Study|Never received treatment|1
4404504|NCT00182689|7182663|FG001|Overall Study|Never received treatment|0
4404505|NCT00183170|7182718|FG000|First Intervention|Did not complete study|1
4404506|NCT00183170|7182719|FG001|First Intervention|Did not complete study|0
4404507|NCT00183170|7182718|FG000|First Intervention|Did not meet targeted BrAC|1
4404508|NCT00183170|7182719|FG001|First Intervention|Did not meet targeted BrAC|0
4404509|NCT00183170|7182718|FG000|Washout 1 Week|Did not complete study|6
4404510|NCT00183170|7182719|FG001|Washout 1 Week|Did not complete study|8
4404511|NCT00183170|7182718|FG000|Second Intervention|Did not complete study|1
4404512|NCT00183170|7182719|FG001|Second Intervention|Did not complete study|0
4404513|NCT00183170|7182718|FG000|Second Intervention|Did not meet targeted BrAC|0
4404514|NCT00183170|7182719|FG001|Second Intervention|Did not meet targeted BrAC|2
4404515|NCT00183196|7182728|FG000|Overall Study|Withdrawal by Subject|18
4404516|NCT00183196|7182729|FG001|Overall Study|Withdrawal by Subject|11
4404517|NCT00183196|7182730|FG002|Overall Study|Withdrawal by Subject|13
4404518|NCT00183196|7182728|FG000|Overall Study|Adverse Event|1
4404519|NCT00183196|7182729|FG001|Overall Study|Adverse Event|2
4404520|NCT00183196|7182730|FG002|Overall Study|Adverse Event|2
4404521|NCT00183196|7182728|FG000|Overall Study|Legal event|1
4404522|NCT00183196|7182729|FG001|Overall Study|Legal event|1
4404523|NCT00183196|7182730|FG002|Overall Study|Legal event|1
4404524|NCT00183196|7182728|FG000|Overall Study|Required more intensive care|0
4404525|NCT00183196|7182729|FG001|Overall Study|Required more intensive care|1
4404526|NCT00183196|7182730|FG002|Overall Study|Required more intensive care|2
4404527|NCT00183248|7182740|FG000|Overall Study|Lost to Follow-up|0
4404528|NCT00183248|7182741|FG001|Overall Study|Lost to Follow-up|1
4404529|NCT00183248|7182740|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1
4404530|NCT00183248|7182741|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0
4404531|NCT00183274|7182747|FG000|Phase 1: Open-Label|Adverse Event|31
4404532|NCT00183274|7182748|FG001|Phase 1: Open-Label|Adverse Event|0
4404533|NCT00183274|7182749|FG002|Phase 1: Open-Label|Adverse Event|0
4404534|NCT00183274|7182750|FG003|Phase 1: Open-Label|Adverse Event|0
4404535|NCT00183274|7182751|FG004|Phase 1: Open-Label|Adverse Event|0
4404536|NCT00183274|7182752|FG005|Phase 1: Open-Label|Adverse Event|0
4404537|NCT00183274|7182747|FG000|Phase 1: Open-Label|Lack of Efficacy|13
4404538|NCT00183274|7182748|FG001|Phase 1: Open-Label|Lack of Efficacy|0
4404539|NCT00183274|7182749|FG002|Phase 1: Open-Label|Lack of Efficacy|0
4404540|NCT00183274|7182750|FG003|Phase 1: Open-Label|Lack of Efficacy|0
4404541|NCT00183274|7182751|FG004|Phase 1: Open-Label|Lack of Efficacy|0
4404542|NCT00183274|7182752|FG005|Phase 1: Open-Label|Lack of Efficacy|0
4404543|NCT00183274|7182747|FG000|Phase 1: Open-Label|Protocol Violation|11
4404544|NCT00183274|7182748|FG001|Phase 1: Open-Label|Protocol Violation|0
4404545|NCT00183274|7182749|FG002|Phase 1: Open-Label|Protocol Violation|0
4404546|NCT00183274|7182750|FG003|Phase 1: Open-Label|Protocol Violation|0
4404547|NCT00183274|7182751|FG004|Phase 1: Open-Label|Protocol Violation|0
4404548|NCT00183274|7182752|FG005|Phase 1: Open-Label|Protocol Violation|0
4404549|NCT00183274|7182747|FG000|Phase 1: Open-Label|Withdrawal by Subject|13
4404550|NCT00183274|7182748|FG001|Phase 1: Open-Label|Withdrawal by Subject|0
4404551|NCT00183274|7182749|FG002|Phase 1: Open-Label|Withdrawal by Subject|0
4404552|NCT00183274|7182750|FG003|Phase 1: Open-Label|Withdrawal by Subject|0
4404553|NCT00183274|7182751|FG004|Phase 1: Open-Label|Withdrawal by Subject|0
4404554|NCT00183274|7182752|FG005|Phase 1: Open-Label|Withdrawal by Subject|0
4404555|NCT00183274|7182747|FG000|Phase 1: Open-Label|Lost to Follow-up|33
4404556|NCT00183274|7182748|FG001|Phase 1: Open-Label|Lost to Follow-up|0
4404557|NCT00183274|7182749|FG002|Phase 1: Open-Label|Lost to Follow-up|0
4404558|NCT00183274|7182750|FG003|Phase 1: Open-Label|Lost to Follow-up|0
4404559|NCT00183274|7182751|FG004|Phase 1: Open-Label|Lost to Follow-up|0
4404560|NCT00183274|7182752|FG005|Phase 1: Open-Label|Lost to Follow-up|0
4404561|NCT00183274|7182747|FG000|Phase 1: Open-Label|Other|9
4404562|NCT00183274|7182748|FG001|Phase 1: Open-Label|Other|0
4404563|NCT00183274|7182749|FG002|Phase 1: Open-Label|Other|0
4404564|NCT00183274|7182750|FG003|Phase 1: Open-Label|Other|0
4404565|NCT00183274|7182751|FG004|Phase 1: Open-Label|Other|0
4404566|NCT00183274|7182752|FG005|Phase 1: Open-Label|Other|0
4404567|NCT00183274|7182747|FG000|Phase 2: Double-Blind|Relapsed|0
4404568|NCT00183274|7182748|FG001|Phase 2: Double-Blind|Relapsed|8
4404569|NCT00183274|7182749|FG002|Phase 2: Double-Blind|Relapsed|29
4404570|NCT00183274|7182750|FG003|Phase 2: Double-Blind|Relapsed|0
4404571|NCT00183274|7182751|FG004|Phase 2: Double-Blind|Relapsed|0
4404572|NCT00183274|7182752|FG005|Phase 2: Double-Blind|Relapsed|0
4404573|NCT00183274|7182747|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0
4404574|NCT00183274|7182748|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18
4404575|NCT00183274|7182749|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14
4404576|NCT00183274|7182750|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0
4404577|NCT00183274|7182751|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0
4404578|NCT00183274|7182752|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0
4404579|NCT00183274|7182747|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0
4404580|NCT00183274|7182748|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0
4404581|NCT00183274|7182749|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0
4404582|NCT00183274|7182750|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1
4404583|NCT00183274|7182751|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9
4404584|NCT00183274|7182752|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2
4404585|NCT00183274|7182747|FG000|Phase 3: Double-Blind|Relapsed|0
4404586|NCT00183274|7182748|FG001|Phase 3: Double-Blind|Relapsed|0
4404587|NCT00183274|7182749|FG002|Phase 3: Double-Blind|Relapsed|0
4404588|NCT00183274|7182750|FG003|Phase 3: Double-Blind|Relapsed|1
4404589|NCT00183274|7182751|FG004|Phase 3: Double-Blind|Relapsed|11
4404590|NCT00183274|7182752|FG005|Phase 3: Double-Blind|Relapsed|2
4404591|NCT00183391|7182781|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13
4404592|NCT00183391|7182782|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14
4404593|NCT00183391|7182781|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4
4404594|NCT00183391|7182782|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2
4404595|NCT00183430|7182792|FG000|Overall Study|Adverse Event|1
4404596|NCT00183430|7182793|FG001|Overall Study|Adverse Event|0
4404597|NCT00183430|7182792|FG000|Overall Study|Lost to Follow-up|3
4404598|NCT00183430|7182793|FG001|Overall Study|Lost to Follow-up|0
4404599|NCT00183430|7182792|FG000|Overall Study|did not meet inclusion criteria|1
4404600|NCT00183430|7182793|FG001|Overall Study|did not meet inclusion criteria|0
4404601|NCT00183430|7182792|FG000|Overall Study|Withdrawal by Subject|1
4404602|NCT00183430|7182793|FG001|Overall Study|Withdrawal by Subject|0
4404603|NCT00183625|7182840|FG000|Overall Study|Withdrawal by Subject|18
4404604|NCT00183625|7182841|FG001|Overall Study|Withdrawal by Subject|18
4404605|NCT00183625|7182842|FG002|Overall Study|Withdrawal by Subject|19
4404606|NCT00183625|7182843|FG003|Overall Study|Withdrawal by Subject|14
4404607|NCT00183872|7182868|FG000|Overall Study|Death|3
4404608|NCT00183872|7182868|FG000|Overall Study|Adverse Event|9
4404609|NCT00183872|7182868|FG000|Overall Study|Withdrawal by Subject|2
4404610|NCT00183872|7182868|FG000|Overall Study|Drug delayed more than 28 days|2
4404611|NCT00184002|7182872|FG000|Overall Study|Adverse Event|9
4404612|NCT00184002|7182872|FG000|Overall Study|Death|3
4404613|NCT00184002|7182872|FG000|Overall Study|Physician Decision|1
4404614|NCT00184002|7182872|FG000|Overall Study|Withdrawal by Subject|4
4404615|NCT00184028|7182876|FG000|Overall Study|Death|1
4404616|NCT00184028|7182876|FG000|Overall Study|Lack of Efficacy|4
4404617|NCT00184028|7182876|FG000|Overall Study|Adverse Event|2
4404618|NCT00184028|7182876|FG000|Overall Study|Withdrawal by Subject|1
4404619|NCT00184028|7182876|FG000|Overall Study|Non-compliance|2
4404620|NCT00184054|7182881|FG000|Overall Study|Adverse Event|1
4404621|NCT00184093|7182885|FG000|Overall Study|Adverse Event|3
4404622|NCT00184093|7182885|FG000|Overall Study|Lost to Follow-up|3
4404623|NCT00184093|7182885|FG000|Overall Study|Physician Decision|1
4404624|NCT00184093|7182885|FG000|Overall Study|Withdrawal by Subject|2
4404625|NCT00184600|7182909|FG000|Overall Study|Adverse Event|9
4404626|NCT00184600|7182910|FG001|Overall Study|Adverse Event|0
4404627|NCT00184600|7182911|FG002|Overall Study|Adverse Event|5
4404628|NCT00184600|7182909|FG000|Overall Study|Death|3
4404629|NCT00184600|7182910|FG001|Overall Study|Death|9
4404630|NCT00184600|7182911|FG002|Overall Study|Death|7
4404631|NCT00184600|7182909|FG000|Overall Study|Lack of Efficacy|3
4404632|NCT00184600|7182910|FG001|Overall Study|Lack of Efficacy|1
4404633|NCT00184600|7182911|FG002|Overall Study|Lack of Efficacy|3
4404634|NCT00184600|7182909|FG000|Overall Study|Lost to Follow-up|4
4404635|NCT00184600|7182910|FG001|Overall Study|Lost to Follow-up|6
4404636|NCT00184600|7182911|FG002|Overall Study|Lost to Follow-up|1
4404637|NCT00184600|7182909|FG000|Overall Study|Protocol Violation|2
4404638|NCT00184600|7182910|FG001|Overall Study|Protocol Violation|2
4404639|NCT00184600|7182911|FG002|Overall Study|Protocol Violation|3
4404640|NCT00184600|7182909|FG000|Overall Study|Withdrawal by Subject|20
4404641|NCT00184600|7182910|FG001|Overall Study|Withdrawal by Subject|28
4404642|NCT00184600|7182911|FG002|Overall Study|Withdrawal by Subject|12
4404643|NCT00184600|7182909|FG000|Overall Study|Unclassified|4
4404644|NCT00184600|7182910|FG001|Overall Study|Unclassified|5
4404645|NCT00184600|7182911|FG002|Overall Study|Unclassified|3
4404646|NCT00185211|7182938|FG000|Placebo-controlled Study (92012)|Adverse Event|8
4404647|NCT00185211|7182939|FG001|Placebo-controlled Study (92012)|Adverse Event|0
4404648|NCT00185211|7182938|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3
4404649|NCT00185211|7182939|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2
4404650|NCT00185211|7182938|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9
4404651|NCT00185211|7182939|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7
4404652|NCT00185211|7182938|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0
4404653|NCT00185211|7182939|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1
4404654|NCT00185211|7182938|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1
4404655|NCT00185211|7182939|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0
4404656|NCT00185211|7182938|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5
4404657|NCT00185211|7182939|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6
4404658|NCT00185211|7182938|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1
4404659|NCT00185211|7182939|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0
4404660|NCT00185211|7182938|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6
4404661|NCT00185211|7182939|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4
4404662|NCT00185211|7182938|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1
4404663|NCT00185211|7182939|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0
4404664|NCT00185211|7182938|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0
4404665|NCT00185211|7182939|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1
4404666|NCT00185211|7182938|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13
4404667|NCT00185211|7182939|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21
4404668|NCT00185211|7182938|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0
4404669|NCT00185211|7182939|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2
4404670|NCT00185380|7182949|FG000|Overall Study|Adverse Event|41
4404671|NCT00185380|7182950|FG001|Overall Study|Adverse Event|43
4404672|NCT00185380|7182951|FG002|Overall Study|Adverse Event|48
4404673|NCT00185380|7182949|FG000|Overall Study|Lost to Follow-up|0
4404674|NCT00185380|7182950|FG001|Overall Study|Lost to Follow-up|4
4404675|NCT00185380|7182951|FG002|Overall Study|Lost to Follow-up|3
4404676|NCT00185380|7182949|FG000|Overall Study|Pregnancy|1
4404677|NCT00185380|7182950|FG001|Overall Study|Pregnancy|4
4404678|NCT00185380|7182951|FG002|Overall Study|Pregnancy|0
4404679|NCT00185380|7182949|FG000|Overall Study|Protocol Violation|2
4404680|NCT00185380|7182950|FG001|Overall Study|Protocol Violation|2
4404681|NCT00185380|7182951|FG002|Overall Study|Protocol Violation|1
4404682|NCT00185380|7182949|FG000|Overall Study|Withdrawal by Subject|1
4404683|NCT00185380|7182950|FG001|Overall Study|Withdrawal by Subject|2
4404684|NCT00185380|7182951|FG002|Overall Study|Withdrawal by Subject|0
4404685|NCT00185380|7182949|FG000|Overall Study|Failed insertion|1
4404686|NCT00185380|7182950|FG001|Overall Study|Failed insertion|1
4404687|NCT00185380|7182951|FG002|Overall Study|Failed insertion|2
4404688|NCT00185380|7182949|FG000|Overall Study|Planned pregnancy|9
4404689|NCT00185380|7182950|FG001|Overall Study|Planned pregnancy|12
4404690|NCT00185380|7182951|FG002|Overall Study|Planned pregnancy|12
4404691|NCT00185380|7182949|FG000|Overall Study|No need for contraception|3
4404692|NCT00185380|7182950|FG001|Overall Study|No need for contraception|3
4404693|NCT00185380|7182951|FG002|Overall Study|No need for contraception|3
4404694|NCT00185380|7182949|FG000|Overall Study|Could not attend visits|2
4404695|NCT00185380|7182950|FG001|Overall Study|Could not attend visits|0
4404696|NCT00185380|7182951|FG002|Overall Study|Could not attend visits|4
4404697|NCT00185380|7182949|FG000|Overall Study|personal reason|6
4404698|NCT00185380|7182950|FG001|Overall Study|personal reason|1
4404699|NCT00185380|7182951|FG002|Overall Study|personal reason|1
4404700|NCT00185458|7182959|FG000|Contraception Phase|Adverse Event|37
4404701|NCT00185458|7182959|FG000|Contraception Phase|Lost to Follow-up|10
4404702|NCT00185458|7182959|FG000|Contraception Phase|Protocol Violation|2
4404703|NCT00185458|7182959|FG000|Contraception Phase|Physician Decision|2
4404704|NCT00185458|7182959|FG000|Contraception Phase|Withdrawal by Subject|7
4404705|NCT00185458|7182959|FG000|HRT Phase|Adverse Event|18
4404706|NCT00185458|7182959|FG000|HRT Phase|Lost to Follow-up|4
4404707|NCT00185458|7182959|FG000|HRT Phase|Protocol Violation|2
4404708|NCT00185458|7182959|FG000|HRT Phase|Withdrawal by Subject|3
4404709|NCT00185588|7182975|FG000|Overall Study|Adverse Event|3
4404710|NCT00185588|7182976|FG001|Overall Study|Adverse Event|1
4404711|NCT00185588|7182977|FG002|Overall Study|Adverse Event|4
4404712|NCT00185588|7182978|FG003|Overall Study|Adverse Event|2
4404713|NCT00185588|7182975|FG000|Overall Study|Lost to Follow-up|0
4404714|NCT00185588|7182976|FG001|Overall Study|Lost to Follow-up|0
4404715|NCT00185588|7182977|FG002|Overall Study|Lost to Follow-up|1
4404716|NCT00185588|7182978|FG003|Overall Study|Lost to Follow-up|2
4404717|NCT00185588|7182975|FG000|Overall Study|Withdrawal by Subject|0
4404718|NCT00185588|7182976|FG001|Overall Study|Withdrawal by Subject|1
4404719|NCT00185588|7182977|FG002|Overall Study|Withdrawal by Subject|0
4404720|NCT00185588|7182978|FG003|Overall Study|Withdrawal by Subject|0
4404721|NCT00185588|7182975|FG000|Overall Study|Physician Decision|0
4404722|NCT00185588|7182976|FG001|Overall Study|Physician Decision|0
4404723|NCT00185588|7182977|FG002|Overall Study|Physician Decision|1
4404724|NCT00185588|7182978|FG003|Overall Study|Physician Decision|0
4404725|NCT00185614|7182988|FG000|Inter-treatment Period|Physician Decision|1
4404726|NCT00185614|7182988|FG000|Inter-treatment Period|Relapse|2
4404727|NCT00185614|7182988|FG000|Inter-treatment Period|Lack of allogenic donor|1
4404728|NCT00185640|7182992|FG000|Overall Study|Not Eligible|4
4404729|NCT00185640|7182992|FG000|Overall Study|Withdrawal by Subject|3
4404730|NCT00185640|7182992|FG000|Overall Study|Death|138
4404731|NCT00185731|7183004|FG000|Overall Study|Withdrawal by Subject|1
4404732|NCT00185731|7183004|FG000|Overall Study|Not Eligible|1
4404733|NCT00185965|7183021|FG000|Overall Study|Adverse Event|0
4628974|NCT01867216|7496522|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0
4628975|NCT01867294|7496548|FG000|Overall Study|Withdrawal by Subject|1
4628976|NCT01867294|7496549|FG001|Overall Study|Withdrawal by Subject|1
4628977|NCT01867294|7496550|FG002|Overall Study|Withdrawal by Subject|0
4628978|NCT01867294|7496551|FG003|Overall Study|Withdrawal by Subject|0
4628979|NCT01867307|7496561|FG000|Overall Study|Protocol Violation|2
4628980|NCT01867307|7496562|FG001|Overall Study|Protocol Violation|0
4628981|NCT01867307|7496561|FG000|Overall Study|Other Adverse Event|1
4628982|NCT01867307|7496562|FG001|Overall Study|Other Adverse Event|3
4628983|NCT01867424|7496570|FG000|Overall Study|Patient noncompliance|2
4404734|NCT00185965|7183022|FG001|Overall Study|Adverse Event|1
4404735|NCT00186043|7183040|FG000|Overall Study|Lack of Efficacy|1
4404736|NCT00186043|7183041|FG001|Overall Study|Lack of Efficacy|3
4404737|NCT00186043|7183040|FG000|Overall Study|Lost to Follow-up|4
4404738|NCT00186043|7183041|FG001|Overall Study|Lost to Follow-up|6
4404739|NCT00186043|7183040|FG000|Overall Study|Withdrawal by Subject|1
4404740|NCT00186043|7183041|FG001|Overall Study|Withdrawal by Subject|0
4404741|NCT00186043|7183040|FG000|Overall Study|Adverse Event|7
4404742|NCT00186043|7183041|FG001|Overall Study|Adverse Event|3
4404743|NCT00186043|7183040|FG000|Overall Study|Protocol Violation|2
4404744|NCT00186043|7183041|FG001|Overall Study|Protocol Violation|1
4404745|NCT00186121|7183065|FG000|Overall Study|Subject withdrawal (no treatment)|1
4404746|NCT00186121|7183065|FG000|Overall Study|Underwent oophorectomy (no treatment)|1
4404747|NCT00186121|7183065|FG000|Overall Study|Not eligible (no treatment)|1
4404748|NCT00186186|7183069|FG000|Overall Study|Lack of Efficacy|3
4404749|NCT00186186|7183069|FG000|Overall Study|Withdrawal by Subject|3
4404750|NCT00186186|7183069|FG000|Overall Study|Not reported as to reason|2
4404751|NCT00186485|7183080|FG000|Overall Study|Lost to Follow-up|3
4404752|NCT00186537|7183096|FG000|Overall Study|Withdrawal by Subject|4
4404753|NCT00186537|7183097|FG001|Overall Study|Withdrawal by Subject|0
4404754|NCT00186537|7183098|FG002|Overall Study|Withdrawal by Subject|3
4404755|NCT00186537|7183096|FG000|Overall Study|ALT > 1.5 x ULN|3
4404756|NCT00186537|7183097|FG001|Overall Study|ALT > 1.5 x ULN|0
4404757|NCT00186537|7183098|FG002|Overall Study|ALT > 1.5 x ULN|0
4511265|NCT00925522|7320199|FG000|Overall Study|study closed -- business decision|20
4511266|NCT00925587|7320205|FG000|Overall Study|Protocol Specified Criteria|6
4511267|NCT00925587|7320206|FG001|Overall Study|Protocol Specified Criteria|6
4404758|NCT00186628|7183106|FG000|Overall Study|Death|2
4404759|NCT00186628|7183106|FG000|Overall Study|Withdrawal by subject (before treatment)|1
4404760|NCT00186901|7183125|FG000|Overall Study|Pregnancy|6
4404761|NCT00186901|7183126|FG001|Overall Study|Pregnancy|3
4404762|NCT00186901|7183127|FG002|Overall Study|Pregnancy|0
4404763|NCT00186901|7183125|FG000|Overall Study|Lost to Follow-up|6
4404764|NCT00186901|7183126|FG001|Overall Study|Lost to Follow-up|3
4404765|NCT00186901|7183127|FG002|Overall Study|Lost to Follow-up|0
4404766|NCT00186901|7183125|FG000|Overall Study|Bone Mineral Density dropped > 5%|9
4404767|NCT00186901|7183126|FG001|Overall Study|Bone Mineral Density dropped > 5%|7
4404768|NCT00186901|7183127|FG002|Overall Study|Bone Mineral Density dropped > 5%|0
4404769|NCT00186901|7183125|FG000|Overall Study|ALL relapse or second malignancy|1
4404770|NCT00186901|7183126|FG001|Overall Study|ALL relapse or second malignancy|2
4404771|NCT00186901|7183127|FG002|Overall Study|ALL relapse or second malignancy|0
4404772|NCT00186901|7183125|FG000|Overall Study|Withdrawal by Subject|4
4404773|NCT00186901|7183126|FG001|Overall Study|Withdrawal by Subject|5
4404774|NCT00186901|7183127|FG002|Overall Study|Withdrawal by Subject|0
4404775|NCT00186901|7183125|FG000|Overall Study|Open label|3
4404776|NCT00186901|7183126|FG001|Overall Study|Open label|2
4404777|NCT00186901|7183127|FG002|Overall Study|Open label|0
4404778|NCT00186901|7183125|FG000|Overall Study|Limited adherence to study requirements|20
4404779|NCT00186901|7183126|FG001|Overall Study|Limited adherence to study requirements|23
4404780|NCT00186901|7183127|FG002|Overall Study|Limited adherence to study requirements|0
4404781|NCT00186901|7183125|FG000|Overall Study|Bone Mineral Density > 0|0
4404782|NCT00186901|7183126|FG001|Overall Study|Bone Mineral Density > 0|0
4404783|NCT00186901|7183127|FG002|Overall Study|Bone Mineral Density > 0|149
4404784|NCT00187096|7183167|FG000|Overall Study|unacceptable toxicity|0
4404785|NCT00187096|7183168|FG001|Overall Study|unacceptable toxicity|0
4404786|NCT00187096|7183169|FG002|Overall Study|unacceptable toxicity|1
4404787|NCT00187135|7183183|FG000|Visit One|Withdrawal by Subject|1
4404788|NCT00187135|7183184|FG001|Visit One|Withdrawal by Subject|0
4404789|NCT00187135|7183185|FG002|Visit One|Withdrawal by Subject|0
4404790|NCT00187135|7183186|FG003|Visit One|Withdrawal by Subject|0
4404791|NCT00187135|7183187|FG004|Visit One|Withdrawal by Subject|0
4404792|NCT00187135|7183188|FG005|Visit One|Withdrawal by Subject|1
4404793|NCT00187135|7183183|FG000|Visit One|Physician Decision|3
4404794|NCT00187135|7183184|FG001|Visit One|Physician Decision|1
4404795|NCT00187135|7183185|FG002|Visit One|Physician Decision|0
4404796|NCT00187135|7183186|FG003|Visit One|Physician Decision|0
4404797|NCT00187135|7183187|FG004|Visit One|Physician Decision|0
4404798|NCT00187135|7183188|FG005|Visit One|Physician Decision|1
4404799|NCT00187135|7183183|FG000|Visit Two|Death|0
4404800|NCT00187135|7183184|FG001|Visit Two|Death|0
4404801|NCT00187135|7183185|FG002|Visit Two|Death|0
4404802|NCT00187135|7183186|FG003|Visit Two|Death|1
4511268|NCT00925587|7320205|FG000|Overall Study|Physician Decision|4
4511269|NCT00925587|7320206|FG001|Overall Study|Physician Decision|1
4511270|NCT00925587|7320205|FG000|Overall Study|Protocol Violation|6
4511271|NCT00925587|7320206|FG001|Overall Study|Protocol Violation|4
4511272|NCT00925587|7320205|FG000|Overall Study|Withdrawal by Subject|9
4511273|NCT00925587|7320206|FG001|Overall Study|Withdrawal by Subject|6
4511274|NCT00925587|7320205|FG000|Overall Study|Death|5
4511275|NCT00925587|7320206|FG001|Overall Study|Death|5
4511276|NCT00925587|7320205|FG000|Overall Study|Adverse Event|6
4511277|NCT00925587|7320206|FG001|Overall Study|Adverse Event|2
4511278|NCT00925587|7320205|FG000|Overall Study|Lost to Follow-up|0
4511279|NCT00925587|7320206|FG001|Overall Study|Lost to Follow-up|1
4511280|NCT00925600|7320214|FG000|Overall Study|Withdrawal by Subject|16
4511281|NCT00925600|7320215|FG001|Overall Study|Withdrawal by Subject|14
4511282|NCT00925600|7320214|FG000|Overall Study|Death|4
4511283|NCT00925600|7320215|FG001|Overall Study|Death|3
4511284|NCT00925600|7320214|FG000|Overall Study|Lost to Follow-up|2
4511285|NCT00925600|7320215|FG001|Overall Study|Lost to Follow-up|2
4511286|NCT00925600|7320214|FG000|Overall Study|Disease Progression|1
4511287|NCT00925600|7320215|FG001|Overall Study|Disease Progression|3
4511288|NCT00925600|7320214|FG000|Overall Study|Administrative Decision|1
4511289|NCT00925600|7320215|FG001|Overall Study|Administrative Decision|1
4511290|NCT00925600|7320214|FG000|Overall Study|Noncompliance|2
4404803|NCT00187135|7183187|FG004|Visit Two|Death|0
4404804|NCT00187135|7183188|FG005|Visit Two|Death|1
4404805|NCT00187135|7183183|FG000|Visit Two|Physician Decision|1
4404806|NCT00187135|7183184|FG001|Visit Two|Physician Decision|0
4404807|NCT00187135|7183185|FG002|Visit Two|Physician Decision|0
4404808|NCT00187135|7183186|FG003|Visit Two|Physician Decision|0
4404809|NCT00187135|7183187|FG004|Visit Two|Physician Decision|0
4404810|NCT00187135|7183188|FG005|Visit Two|Physician Decision|0
4404811|NCT00187135|7183183|FG000|Visit Two|Withdrawal by Subject|1
4404812|NCT00187135|7183184|FG001|Visit Two|Withdrawal by Subject|1
4404813|NCT00187135|7183185|FG002|Visit Two|Withdrawal by Subject|1
4404814|NCT00187135|7183186|FG003|Visit Two|Withdrawal by Subject|0
4404815|NCT00187135|7183187|FG004|Visit Two|Withdrawal by Subject|1
4404816|NCT00187135|7183188|FG005|Visit Two|Withdrawal by Subject|1
4404817|NCT00187135|7183183|FG000|Visit Two|Study Discontinued|3
4404818|NCT00187135|7183184|FG001|Visit Two|Study Discontinued|2
4404819|NCT00187135|7183185|FG002|Visit Two|Study Discontinued|1
4404820|NCT00187135|7183186|FG003|Visit Two|Study Discontinued|7
4404821|NCT00187135|7183187|FG004|Visit Two|Study Discontinued|5
4404822|NCT00187135|7183188|FG005|Visit Two|Study Discontinued|6
4404823|NCT00187135|7183183|FG000|Visit Three|Death|0
4404824|NCT00187135|7183184|FG001|Visit Three|Death|0
4404825|NCT00187135|7183185|FG002|Visit Three|Death|1
4404826|NCT00187135|7183186|FG003|Visit Three|Death|0
4404827|NCT00187135|7183187|FG004|Visit Three|Death|1
4404828|NCT00187135|7183188|FG005|Visit Three|Death|0
4404829|NCT00187135|7183183|FG000|Visit Three|Withdrawal by Subject|0
4404830|NCT00187135|7183184|FG001|Visit Three|Withdrawal by Subject|1
4404831|NCT00187135|7183185|FG002|Visit Three|Withdrawal by Subject|1
4404832|NCT00187135|7183186|FG003|Visit Three|Withdrawal by Subject|2
4404833|NCT00187135|7183187|FG004|Visit Three|Withdrawal by Subject|0
4404834|NCT00187135|7183188|FG005|Visit Three|Withdrawal by Subject|0
4404835|NCT00187135|7183183|FG000|Visit Three|Study Discontinued|7
4404836|NCT00187135|7183184|FG001|Visit Three|Study Discontinued|6
4404837|NCT00187135|7183185|FG002|Visit Three|Study Discontinued|7
4404838|NCT00187135|7183186|FG003|Visit Three|Study Discontinued|7
4404839|NCT00187135|7183187|FG004|Visit Three|Study Discontinued|7
4404840|NCT00187135|7183188|FG005|Visit Three|Study Discontinued|6
4404841|NCT00187278|7183238|FG000|Overall Study|Protocol Violation|10
4404842|NCT00187278|7183239|FG001|Overall Study|Protocol Violation|13
4404843|NCT00187486|7183262|FG000|Overall Study|Protocol Violation|1
4404844|NCT00187889|7183302|FG000|Overall Study|Withdrawal by Subject|6
4404845|NCT00187889|7183303|FG001|Overall Study|Withdrawal by Subject|4
4404846|NCT00189202|7183330|FG000|Overall Study|Physician Decision|5
4404847|NCT00189306|7183338|FG000|Treatment Period|Withdrawal by Subject|2
4404848|NCT00189306|7183338|FG000|Treatment Period|Adverse Event|2
4404849|NCT00189306|7183338|FG000|Treatment Period|Protocol Violation|1
4404850|NCT00189306|7183338|FG000|Posttreatment Period|Death|1
4404851|NCT00189306|7183338|FG000|Posttreatment Period|Withdrawal by Subject|2
4404852|NCT00189306|7183338|FG000|Posttreatment Period|Noncompliance|1
4404853|NCT00189306|7183338|FG000|Posttreatment Period|Target lesion excised|1
4404854|NCT00189306|7183338|FG000|Posttreatment Period|Protocol Violation|1
4511291|NCT00925600|7320215|FG001|Overall Study|Noncompliance|0
4511292|NCT00925600|7320214|FG000|Overall Study|Ineligibility Determined|2
4404855|NCT00189306|7183338|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5
4404856|NCT00189306|7183338|FG000|Posttreatment Period|Local skin reaction/sign|1
4404857|NCT00189306|7183338|FG000|Long-Term Follow-up|Adverse Event|2
4511293|NCT00925600|7320215|FG001|Overall Study|Ineligibility Determined|0
4404858|NCT00189306|7183338|FG000|Long-Term Follow-up|Death|4
4404859|NCT00189306|7183338|FG000|Long-Term Follow-up|Withdrawal by Subject|1
4404860|NCT00189306|7183338|FG000|Long-Term Follow-up|Intercurrent disease|2
4404861|NCT00189306|7183338|FG000|Long-Term Follow-up|Lost to Follow-up|9
4404862|NCT00189306|7183338|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20
4404863|NCT00189423|7183344|FG000|Overall Study|Death|746
4404864|NCT00189423|7183345|FG001|Overall Study|Death|747
4404865|NCT00189423|7183344|FG000|Overall Study|Withdrawal by Subject|9
4404866|NCT00189423|7183345|FG001|Overall Study|Withdrawal by Subject|9
4404867|NCT00189423|7183344|FG000|Overall Study|Lost to Follow-up|10
4404868|NCT00189423|7183345|FG001|Overall Study|Lost to Follow-up|10
4404869|NCT00189462|7183362|FG000|Overall Study|Lack of Efficacy|5
4404870|NCT00189462|7183363|FG001|Overall Study|Lack of Efficacy|1
4404871|NCT00189462|7183362|FG000|Overall Study|Lost to Follow-up|18
4404872|NCT00189462|7183363|FG001|Overall Study|Lost to Follow-up|20
4404873|NCT00189488|7183380|FG000|Overall Study|Ineligibility determined|1
4404874|NCT00189488|7183381|FG001|Overall Study|Ineligibility determined|0
4628984|NCT01867424|7496571|FG001|Overall Study|Patient noncompliance|1
4628985|NCT01867580|7496592|FG000|Overall Study|Withdrawal by Subject|2
4628986|NCT01867580|7496593|FG001|Overall Study|Withdrawal by Subject|3
4628987|NCT01867580|7496592|FG000|Overall Study|Physician Decision|17
4628988|NCT01867580|7496593|FG001|Overall Study|Physician Decision|12
4628989|NCT01867580|7496592|FG000|Overall Study|Lost to Follow-up|3
4628990|NCT01867580|7496593|FG001|Overall Study|Lost to Follow-up|5
4628991|NCT01867580|7496592|FG000|Overall Study|Sponsor terminated study|1
4628992|NCT01867580|7496593|FG001|Overall Study|Sponsor terminated study|0
4628993|NCT01867580|7496592|FG000|Overall Study|Missed follow-up assessment|2
4404875|NCT00189488|7183380|FG000|Overall Study|Protocol deviation|2
4404876|NCT00189488|7183381|FG001|Overall Study|Protocol deviation|1
4404877|NCT00189488|7183380|FG000|Overall Study|Adverse Event|2
4404878|NCT00189488|7183381|FG001|Overall Study|Adverse Event|1
4404879|NCT00189488|7183380|FG000|Overall Study|Withdrawal by Subject|2
4404880|NCT00189488|7183381|FG001|Overall Study|Withdrawal by Subject|6
4404881|NCT00189488|7183380|FG000|Overall Study|Disease progression|2
4404882|NCT00189488|7183381|FG001|Overall Study|Disease progression|4
4404883|NCT00189488|7183380|FG000|Overall Study|Administrative Decision|0
4404884|NCT00189488|7183381|FG001|Overall Study|Administrative Decision|2
4404885|NCT00189488|7183380|FG000|Overall Study|Death|5
4404886|NCT00189488|7183381|FG001|Overall Study|Death|8
4404887|NCT00189488|7183380|FG000|Overall Study|Other|1
4404888|NCT00189488|7183381|FG001|Overall Study|Other|0
4404889|NCT00189540|7183390|FG000|Overall Study|Withdrawal by Subject|3
4404890|NCT00189540|7183391|FG001|Overall Study|Withdrawal by Subject|0
4404891|NCT00189540|7183390|FG000|Overall Study|Death|4
4404892|NCT00189540|7183391|FG001|Overall Study|Death|1
4404893|NCT00190671|7183399|FG000|Overall Study|Satisfactory Response|4
4404894|NCT00190671|7183400|FG001|Overall Study|Satisfactory Response|7
4404895|NCT00190671|7183399|FG000|Overall Study|Lack of Efficacy|19
4404896|NCT00190671|7183400|FG001|Overall Study|Lack of Efficacy|24
4404897|NCT00190671|7183399|FG000|Overall Study|Death from Study Disease|1
4404898|NCT00190671|7183400|FG001|Overall Study|Death from Study Disease|1
4404899|NCT00190671|7183399|FG000|Overall Study|Adverse Event|3
4404900|NCT00190671|7183400|FG001|Overall Study|Adverse Event|2
4404901|NCT00190671|7183399|FG000|Overall Study|Clinical Relapse|0
4404902|NCT00190671|7183400|FG001|Overall Study|Clinical Relapse|1
4404903|NCT00190671|7183399|FG000|Overall Study|Death from Study-Drug Toxicity|0
4404904|NCT00190671|7183400|FG001|Overall Study|Death from Study-Drug Toxicity|2
4404905|NCT00190671|7183399|FG000|Overall Study|Death from Other Causes|0
4404906|NCT00190671|7183400|FG001|Overall Study|Death from Other Causes|2
4404907|NCT00190671|7183399|FG000|Overall Study|Protocol Violation|0
4404908|NCT00190671|7183400|FG001|Overall Study|Protocol Violation|1
4404909|NCT00190671|7183399|FG000|Overall Study|Withdrawal by Subject|0
4404910|NCT00190671|7183400|FG001|Overall Study|Withdrawal by Subject|2
4404911|NCT00190684|7183407|FG000|Overall Study|Adverse Event|86
4404912|NCT00190684|7183407|FG000|Overall Study|Satisfactory response|80
4404913|NCT00190684|7183407|FG000|Overall Study|Lack of efficacy|204
4404914|NCT00190684|7183407|FG000|Overall Study|Lost to Follow-up|232
4404915|NCT00190684|7183407|FG000|Overall Study|Patient moved|60
4404916|NCT00190684|7183407|FG000|Overall Study|Patient Decision|432
4404917|NCT00190684|7183407|FG000|Overall Study|Clinical relapse|67
4404918|NCT00190684|7183407|FG000|Overall Study|Sponsor's decision|17
4404919|NCT00190684|7183407|FG000|Overall Study|Physician Decision|84
4404920|NCT00190684|7183407|FG000|Overall Study|Protocol Violation|123
4404921|NCT00190684|7183407|FG000|Overall Study|Study Period III Completed|103
4511294|NCT00925600|7320214|FG000|Overall Study|Protocol Deviation|0
4511295|NCT00925600|7320215|FG001|Overall Study|Protocol Deviation|1
4511296|NCT00925600|7320214|FG000|Overall Study|Requirement for Alternative Therapy|0
4511297|NCT00925600|7320215|FG001|Overall Study|Requirement for Alternative Therapy|1
4511298|NCT00925600|7320214|FG000|Overall Study|Other|3
4404922|NCT00190684|7183407|FG000|Overall Study|Study Period V Completed|1
4404923|NCT00190749|7183413|FG000|Overall Study|Lost to Follow-up|8
4404924|NCT00190749|7183414|FG001|Overall Study|Lost to Follow-up|11
4404925|NCT00190749|7183413|FG000|Overall Study|Withdrawal by Subject|10
4511299|NCT00925600|7320215|FG001|Overall Study|Other|1
4511300|NCT00925600|7320214|FG000|Overall Study|Adverse Event|1
4511301|NCT00925600|7320215|FG001|Overall Study|Adverse Event|2
4511302|NCT00925704|7320231|FG000|First Intervention|Withdrew consent|0
4511303|NCT00925704|7320232|FG001|First Intervention|Withdrew consent|0
4511304|NCT00925704|7320233|FG002|First Intervention|Withdrew consent|0
4511305|NCT00925704|7320234|FG003|First Intervention|Withdrew consent|1
4511306|NCT00925704|7320235|FG004|First Intervention|Withdrew consent|1
4511307|NCT00925704|7320236|FG005|First Intervention|Withdrew consent|0
4404926|NCT00190749|7183414|FG001|Overall Study|Withdrawal by Subject|6
4404927|NCT00190749|7183413|FG000|Overall Study|Protocol Violation|5
4404928|NCT00190749|7183414|FG001|Overall Study|Protocol Violation|4
4404929|NCT00190749|7183413|FG000|Overall Study|Adverse Event|0
4404930|NCT00190749|7183414|FG001|Overall Study|Adverse Event|5
4404931|NCT00190749|7183413|FG000|Overall Study|Lack of Efficacy|2
4404932|NCT00190749|7183414|FG001|Overall Study|Lack of Efficacy|3
4404933|NCT00190749|7183413|FG000|Overall Study|Reason Not Specified|0
4404934|NCT00190749|7183414|FG001|Overall Study|Reason Not Specified|2
4404935|NCT00190749|7183413|FG000|Overall Study|Sponsor Decision|1
4404936|NCT00190749|7183414|FG001|Overall Study|Sponsor Decision|0
4404937|NCT00190775|7183422|FG000|Overall Study|Adverse Event|57
4404938|NCT00190775|7183423|FG001|Overall Study|Adverse Event|22
4404939|NCT00190775|7183422|FG000|Overall Study|Satisfactory Response|1
4404940|NCT00190775|7183423|FG001|Overall Study|Satisfactory Response|0
4404941|NCT00190775|7183422|FG000|Overall Study|Lack of Efficacy|28
4404942|NCT00190775|7183423|FG001|Overall Study|Lack of Efficacy|32
4404943|NCT00190775|7183422|FG000|Overall Study|Lost to Follow-up|31
4404944|NCT00190775|7183423|FG001|Overall Study|Lost to Follow-up|23
4404945|NCT00190775|7183422|FG000|Overall Study|Participant Moved|0
4404946|NCT00190775|7183423|FG001|Overall Study|Participant Moved|1
4404947|NCT00190775|7183422|FG000|Overall Study|Withdrawal by Subject|24
4404948|NCT00190775|7183423|FG001|Overall Study|Withdrawal by Subject|13
4404949|NCT00190775|7183422|FG000|Overall Study|Sponsor Decision|1
4404950|NCT00190775|7183423|FG001|Overall Study|Sponsor Decision|0
4404951|NCT00190775|7183422|FG000|Overall Study|Physician Decision|3
4404952|NCT00190775|7183423|FG001|Overall Study|Physician Decision|0
4404953|NCT00190775|7183422|FG000|Overall Study|Noncompliance|3
4404954|NCT00190775|7183423|FG001|Overall Study|Noncompliance|5
4404955|NCT00190775|7183422|FG000|Overall Study|Protocol Violation|0
4404956|NCT00190775|7183423|FG001|Overall Study|Protocol Violation|1
4404957|NCT00190775|7183422|FG000|Overall Study|Exclusion Criteria Met|1
4404958|NCT00190775|7183423|FG001|Overall Study|Exclusion Criteria Met|3
4404959|NCT00190983|7183436|FG000|Overall Study|Inevaluable (never treated)|2
4404960|NCT00191100|7183442|FG000|Overall Study|Adverse Event|18
4404961|NCT00191100|7183443|FG001|Overall Study|Adverse Event|1
4404962|NCT00191100|7183442|FG000|Overall Study|Lost to Follow-up|2
4404963|NCT00191100|7183443|FG001|Overall Study|Lost to Follow-up|0
4404964|NCT00191100|7183442|FG000|Overall Study|Patient Moved|0
4404965|NCT00191100|7183443|FG001|Overall Study|Patient Moved|1
4404966|NCT00191100|7183442|FG000|Overall Study|Withdrawal by Subject|9
4404967|NCT00191100|7183443|FG001|Overall Study|Withdrawal by Subject|3
4404968|NCT00191100|7183442|FG000|Overall Study|Protocol Entry Criteria Not Met|2
4404969|NCT00191100|7183443|FG001|Overall Study|Protocol Entry Criteria Not Met|1
4404970|NCT00191100|7183442|FG000|Overall Study|Clinical Relapse|2
4404971|NCT00191100|7183443|FG001|Overall Study|Clinical Relapse|1
4404972|NCT00191100|7183442|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1
4404973|NCT00191100|7183443|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2
4404974|NCT00191100|7183442|FG000|Overall Study|Lack of Efficacy, Stable Disease|1
4404975|NCT00191100|7183443|FG001|Overall Study|Lack of Efficacy, Stable Disease|0
4404976|NCT00191100|7183442|FG000|Overall Study|Physician Decision|3
4404977|NCT00191100|7183443|FG001|Overall Study|Physician Decision|1
4404978|NCT00191100|7183442|FG000|Overall Study|Death from Study Drug Toxicity|2
4404979|NCT00191100|7183443|FG001|Overall Study|Death from Study Drug Toxicity|0
4404980|NCT00191100|7183442|FG000|Overall Study|Protocol Violation|1
4404981|NCT00191100|7183443|FG001|Overall Study|Protocol Violation|1
4404982|NCT00191100|7183442|FG000|Overall Study|Death from Other Cause|1
4404983|NCT00191100|7183443|FG001|Overall Study|Death from Other Cause|0
4404984|NCT00191100|7183442|FG000|Overall Study|Reason Not Specified|0
4404985|NCT00191100|7183443|FG001|Overall Study|Reason Not Specified|1
4404986|NCT00191113|7183451|FG000|Core Study|Withdrawal by Subject|25
4404987|NCT00191113|7183452|FG001|Core Study|Withdrawal by Subject|9
4404988|NCT00191113|7183451|FG000|Core Study|Protocol Violation|6
4404989|NCT00191113|7183452|FG001|Core Study|Protocol Violation|2
4404990|NCT00191113|7183451|FG000|Core Study|Lost to Follow-up|3
4404991|NCT00191113|7183452|FG001|Core Study|Lost to Follow-up|0
4404992|NCT00191113|7183451|FG000|Core Study|Adverse Event|0
4404993|NCT00191113|7183452|FG001|Core Study|Adverse Event|2
4404994|NCT00191113|7183451|FG000|Core Study|Lack of Efficacy|0
4404995|NCT00191113|7183452|FG001|Core Study|Lack of Efficacy|2
4404996|NCT00191113|7183451|FG000|Core Study|Death|1
4404997|NCT00191113|7183452|FG001|Core Study|Death|0
4404998|NCT00191139|7183466|FG000|Overall Study|Adverse Event|2
4404999|NCT00191139|7183467|FG001|Overall Study|Adverse Event|6
4405000|NCT00191139|7183466|FG000|Overall Study|Death|2
4405001|NCT00191139|7183467|FG001|Overall Study|Death|0
4405002|NCT00191139|7183466|FG000|Overall Study|Withdrawal by Subject|0
4405003|NCT00191139|7183467|FG001|Overall Study|Withdrawal by Subject|3
4511308|NCT00925704|7320231|FG000|Second Intervention|Withdrawal by Subject|1
4511309|NCT00925704|7320232|FG001|Second Intervention|Withdrawal by Subject|0
4511310|NCT00925704|7320233|FG002|Second Intervention|Withdrawal by Subject|0
4511311|NCT00925704|7320234|FG003|Second Intervention|Withdrawal by Subject|0
4511312|NCT00925704|7320235|FG004|Second Intervention|Withdrawal by Subject|1
4405004|NCT00191139|7183466|FG000|Overall Study|Disease Progression|0
4511313|NCT00925704|7320236|FG005|Second Intervention|Withdrawal by Subject|0
4511314|NCT00925704|7320231|FG000|Third Intervention|Withdrew consent|0
4511315|NCT00925704|7320232|FG001|Third Intervention|Withdrew consent|0
4511316|NCT00925704|7320233|FG002|Third Intervention|Withdrew consent|0
4511317|NCT00925704|7320234|FG003|Third Intervention|Withdrew consent|0
4511318|NCT00925704|7320235|FG004|Third Intervention|Withdrew consent|0
4511319|NCT00925704|7320236|FG005|Third Intervention|Withdrew consent|1
4511320|NCT00925769|7320251|FG000|Overall Study|Major toxicity|1
4511321|NCT00925769|7320252|FG001|Overall Study|Major toxicity|0
4511322|NCT00925769|7320253|FG002|Overall Study|Major toxicity|1
4511323|NCT00925769|7320254|FG003|Overall Study|Major toxicity|1
4511324|NCT00925769|7320255|FG004|Overall Study|Major toxicity|0
4511325|NCT00925769|7320256|FG005|Overall Study|Major toxicity|0
4511326|NCT00925769|7320251|FG000|Overall Study|Disease progression|4
4511327|NCT00925769|7320252|FG001|Overall Study|Disease progression|5
4511328|NCT00925769|7320253|FG002|Overall Study|Disease progression|3
4511329|NCT00925769|7320254|FG003|Overall Study|Disease progression|4
4511330|NCT00925769|7320255|FG004|Overall Study|Disease progression|2
4511331|NCT00925769|7320256|FG005|Overall Study|Disease progression|3
4511332|NCT00925769|7320251|FG000|Overall Study|Death|0
4511333|NCT00925769|7320252|FG001|Overall Study|Death|0
4511334|NCT00925769|7320253|FG002|Overall Study|Death|1
4511335|NCT00925769|7320254|FG003|Overall Study|Death|0
4511336|NCT00925769|7320255|FG004|Overall Study|Death|0
4511337|NCT00925769|7320256|FG005|Overall Study|Death|0
4511338|NCT00925769|7320251|FG000|Overall Study|Physician Decision|1
4511339|NCT00925769|7320252|FG001|Overall Study|Physician Decision|0
4511340|NCT00925769|7320253|FG002|Overall Study|Physician Decision|0
4511341|NCT00925769|7320254|FG003|Overall Study|Physician Decision|0
4511342|NCT00925769|7320255|FG004|Overall Study|Physician Decision|0
4511343|NCT00925769|7320256|FG005|Overall Study|Physician Decision|0
4511344|NCT00925769|7320251|FG000|Overall Study|Missing documentation|0
4511345|NCT00925769|7320252|FG001|Overall Study|Missing documentation|1
4405005|NCT00191139|7183467|FG001|Overall Study|Disease Progression|1
4405006|NCT00191139|7183466|FG000|Overall Study|Other|1
4405007|NCT00191139|7183467|FG001|Overall Study|Other|2
4405008|NCT00191152|7183475|FG000|Initial Treatment|Adverse Event|43
4405009|NCT00191152|7183476|FG001|Initial Treatment|Adverse Event|67
4405010|NCT00191152|7183475|FG000|Initial Treatment|Physician Decision|40
4405011|NCT00191152|7183476|FG001|Initial Treatment|Physician Decision|31
4405012|NCT00191152|7183475|FG000|Initial Treatment|Withdrawal by Subject|40
4405013|NCT00191152|7183476|FG001|Initial Treatment|Withdrawal by Subject|28
4405014|NCT00191152|7183475|FG000|Initial Treatment|Lost to Follow-up|0
4405015|NCT00191152|7183476|FG001|Initial Treatment|Lost to Follow-up|6
4405016|NCT00191152|7183475|FG000|Initial Treatment|Other|18
4405017|NCT00191152|7183476|FG001|Initial Treatment|Other|21
4405018|NCT00191152|7183475|FG000|Crossover Treatment|Adverse Event|8
4405019|NCT00191152|7183476|FG001|Crossover Treatment|Adverse Event|8
4405020|NCT00191152|7183475|FG000|Crossover Treatment|Physician Decision|7
4405021|NCT00191152|7183476|FG001|Crossover Treatment|Physician Decision|7
4405022|NCT00191152|7183475|FG000|Crossover Treatment|Withdrawal by Subject|6
4405023|NCT00191152|7183476|FG001|Crossover Treatment|Withdrawal by Subject|9
4405024|NCT00191152|7183475|FG000|Crossover Treatment|Lost to Follow-up|2
4405025|NCT00191152|7183476|FG001|Crossover Treatment|Lost to Follow-up|1
4405026|NCT00191152|7183475|FG000|Crossover Treatment|Other|4
4405027|NCT00191152|7183476|FG001|Crossover Treatment|Other|3
4405028|NCT00191165|7183496|FG000|Overall Study|Adverse Event|2
4405029|NCT00191165|7183497|FG001|Overall Study|Adverse Event|0
4405030|NCT00191165|7183496|FG000|Overall Study|Protocol Violation|0
4405031|NCT00191165|7183497|FG001|Overall Study|Protocol Violation|1
4405032|NCT00191165|7183496|FG000|Overall Study|Participant Moved Away|0
4405033|NCT00191165|7183497|FG001|Overall Study|Participant Moved Away|1
4405034|NCT00191191|7183505|FG000|Overall Study|Entry Criteria Exclusion|2
4405035|NCT00191191|7183506|FG001|Overall Study|Entry Criteria Exclusion|0
4405036|NCT00191191|7183505|FG000|Overall Study|Treated with Another Systemic Agent|1
4405037|NCT00191191|7183506|FG001|Overall Study|Treated with Another Systemic Agent|1
4405038|NCT00191191|7183505|FG000|Overall Study|Adverse Event|11
4405039|NCT00191191|7183506|FG001|Overall Study|Adverse Event|21
4405040|NCT00191191|7183505|FG000|Overall Study|Progressive Disease|84
4511346|NCT00925769|7320253|FG002|Overall Study|Missing documentation|0
4511347|NCT00925769|7320254|FG003|Overall Study|Missing documentation|0
4511348|NCT00925769|7320255|FG004|Overall Study|Missing documentation|0
4511349|NCT00925769|7320256|FG005|Overall Study|Missing documentation|0
4511350|NCT00925769|7320251|FG000|Overall Study|End of study visit not done|0
4405041|NCT00191191|7183506|FG001|Overall Study|Progressive Disease|72
4405042|NCT00191191|7183505|FG000|Overall Study|Toxicity After Dose Reduction|7
4405043|NCT00191191|7183506|FG001|Overall Study|Toxicity After Dose Reduction|8
4405044|NCT00191191|7183505|FG000|Overall Study|Family/Caregiver Decision|5
4405045|NCT00191191|7183506|FG001|Overall Study|Family/Caregiver Decision|7
4405046|NCT00191191|7183505|FG000|Overall Study|Lost to Follow-up|1
4405047|NCT00191191|7183506|FG001|Overall Study|Lost to Follow-up|0
4405048|NCT00191191|7183505|FG000|Overall Study|Physician Decision|3
4405049|NCT00191191|7183506|FG001|Overall Study|Physician Decision|2
4405050|NCT00191191|7183505|FG000|Overall Study|Good Clinical Practice Violation|0
4405051|NCT00191191|7183506|FG001|Overall Study|Good Clinical Practice Violation|1
4405052|NCT00191269|7183514|FG000|Overall Study|Protocol Violation|0
4405053|NCT00191269|7183515|FG001|Overall Study|Protocol Violation|2
4405054|NCT00191269|7183514|FG000|Overall Study|Adverse Event|1
4405055|NCT00191269|7183515|FG001|Overall Study|Adverse Event|4
4405056|NCT00191269|7183514|FG000|Overall Study|Progression of Disease|4
4405057|NCT00191269|7183515|FG001|Overall Study|Progression of Disease|42
4405058|NCT00191269|7183514|FG000|Overall Study|Lack of Efficacy|1
4405059|NCT00191269|7183515|FG001|Overall Study|Lack of Efficacy|5
4405060|NCT00191269|7183514|FG000|Overall Study|Withdrawal by Subject|0
4405061|NCT00191269|7183515|FG001|Overall Study|Withdrawal by Subject|1
4405062|NCT00191269|7183514|FG000|Overall Study|Pathologic Aggrevation|0
4405063|NCT00191269|7183515|FG001|Overall Study|Pathologic Aggrevation|1
4405064|NCT00191269|7183514|FG000|Overall Study|Physician Decision|0
4405065|NCT00191269|7183515|FG001|Overall Study|Physician Decision|3
4405066|NCT00191282|7183524|FG000|Overall Study|Adverse Event|5
4405067|NCT00191282|7183525|FG001|Overall Study|Adverse Event|6
4405068|NCT00191282|7183524|FG000|Overall Study|Death|51
4405069|NCT00191282|7183525|FG001|Overall Study|Death|51
4405070|NCT00191282|7183524|FG000|Overall Study|Lack of Efficacy|11
4405071|NCT00191282|7183525|FG001|Overall Study|Lack of Efficacy|6
4405072|NCT00191282|7183524|FG000|Overall Study|Noncompliance|14
4405073|NCT00191282|7183525|FG001|Overall Study|Noncompliance|17
4628994|NCT01867580|7496593|FG001|Overall Study|Missed follow-up assessment|1
4628995|NCT01867580|7496592|FG000|Overall Study|Interruption to therapy|3
4628996|NCT01867580|7496593|FG001|Overall Study|Interruption to therapy|0
4405074|NCT00191282|7183524|FG000|Overall Study|Patient moved|11
4511351|NCT00925769|7320252|FG001|Overall Study|End of study visit not done|0
4511352|NCT00925769|7320253|FG002|Overall Study|End of study visit not done|1
4511353|NCT00925769|7320254|FG003|Overall Study|End of study visit not done|0
4511354|NCT00925769|7320255|FG004|Overall Study|End of study visit not done|0
4511355|NCT00925769|7320256|FG005|Overall Study|End of study visit not done|0
4511356|NCT00925769|7320251|FG000|Overall Study|Participant is unable to swallow drug|0
4511357|NCT00925769|7320252|FG001|Overall Study|Participant is unable to swallow drug|0
4511358|NCT00925769|7320253|FG002|Overall Study|Participant is unable to swallow drug|0
4511359|NCT00925769|7320254|FG003|Overall Study|Participant is unable to swallow drug|1
4511360|NCT00925769|7320255|FG004|Overall Study|Participant is unable to swallow drug|0
4405075|NCT00191282|7183525|FG001|Overall Study|Patient moved|14
4405076|NCT00191282|7183524|FG000|Overall Study|Withdrawal by Subject|59
4405077|NCT00191282|7183525|FG001|Overall Study|Withdrawal by Subject|44
4405078|NCT00191282|7183524|FG000|Overall Study|Physician Decision|18
4405079|NCT00191282|7183525|FG001|Overall Study|Physician Decision|15
4405080|NCT00191282|7183524|FG000|Overall Study|Protocol entry criteria not met|14
4405081|NCT00191282|7183525|FG001|Overall Study|Protocol entry criteria not met|9
4405082|NCT00191282|7183524|FG000|Overall Study|Protocol Violation|9
4405083|NCT00191282|7183525|FG001|Overall Study|Protocol Violation|12
4405084|NCT00191282|7183524|FG000|Overall Study|Severity of outcome|2
4405085|NCT00191282|7183525|FG001|Overall Study|Severity of outcome|5
4405086|NCT00191282|7183524|FG000|Overall Study|Sponsor's decision|2
4405087|NCT00191282|7183525|FG001|Overall Study|Sponsor's decision|2
4405088|NCT00191282|7183524|FG000|Overall Study|Lost to Follow-up|24
4405089|NCT00191282|7183525|FG001|Overall Study|Lost to Follow-up|31
4405090|NCT00191308|7183531|FG000|Overall Study|Adverse Event|1
4405091|NCT00191334|7183535|FG000|Overall Study|Adverse Event|4
4405092|NCT00191334|7183535|FG000|Overall Study|Disease Progression or Relapse|8
4405093|NCT00191334|7183535|FG000|Overall Study|Physician Decision|1
4405094|NCT00191334|7183535|FG000|Overall Study|Withdrawal by Subject|4
4405095|NCT00191386|7183539|FG000|Overall Study|Adverse Event|16
4405096|NCT00191386|7183539|FG000|Overall Study|Lost to Follow-up|1
4405097|NCT00191386|7183539|FG000|Overall Study|Entry Criteria Exclusion|3
4405098|NCT00191386|7183539|FG000|Overall Study|Protocol Violation|18
4405099|NCT00191386|7183539|FG000|Overall Study|Withdrawal by Subject|96
4405100|NCT00191386|7183539|FG000|Overall Study|Physician Decision|11
4405101|NCT00191386|7183539|FG000|Overall Study|Lack of Efficacy|15
4511361|NCT00925769|7320256|FG005|Overall Study|Participant is unable to swallow drug|0
4511362|NCT00925769|7320251|FG000|Overall Study|Adverse Event|0
4511363|NCT00925769|7320252|FG001|Overall Study|Adverse Event|0
4511364|NCT00925769|7320253|FG002|Overall Study|Adverse Event|0
4511365|NCT00925769|7320254|FG003|Overall Study|Adverse Event|0
4511366|NCT00925769|7320255|FG004|Overall Study|Adverse Event|1
4405102|NCT00191451|7183546|FG000|Overall Study|Withdrawal by Subject|2
4405103|NCT00191451|7183547|FG001|Overall Study|Withdrawal by Subject|3
4405104|NCT00191451|7183548|FG002|Overall Study|Withdrawal by Subject|5
4405105|NCT00191451|7183546|FG000|Overall Study|Physician Decision|2
4405106|NCT00191451|7183547|FG001|Overall Study|Physician Decision|9
4405107|NCT00191451|7183548|FG002|Overall Study|Physician Decision|6
4405108|NCT00191451|7183546|FG000|Overall Study|Sponsor Decision|1
4405109|NCT00191451|7183547|FG001|Overall Study|Sponsor Decision|0
4405110|NCT00191451|7183548|FG002|Overall Study|Sponsor Decision|0
4511367|NCT00925769|7320256|FG005|Overall Study|Adverse Event|0
4511368|NCT00925899|7320282|FG000|Part 1|Death|1
4511369|NCT00925899|7320283|FG001|Part 1|Death|2
4511370|NCT00925899|7320282|FG000|Part 1|Withdrawal by Subject|10
4511371|NCT00925899|7320283|FG001|Part 1|Withdrawal by Subject|9
4511372|NCT00925990|7320305|FG000|Overall Study|Adverse Event|1
4628997|NCT01867580|7496592|FG000|Overall Study|Osteomyelitis|0
4405111|NCT00191451|7183546|FG000|Overall Study|Ineligible|0
4405112|NCT00191451|7183547|FG001|Overall Study|Ineligible|1
4405113|NCT00191451|7183548|FG002|Overall Study|Ineligible|0
4405114|NCT00191451|7183546|FG000|Overall Study|Reason Not Specified|2
4405115|NCT00191451|7183547|FG001|Overall Study|Reason Not Specified|1
4405116|NCT00191451|7183548|FG002|Overall Study|Reason Not Specified|3
4405117|NCT00191477|7183558|FG000|Overall Study|Tumor Recurrence|49
4405118|NCT00191477|7183559|FG001|Overall Study|Tumor Recurrence|48
4405119|NCT00191477|7183558|FG000|Overall Study|Death, Study Disease|1
4405120|NCT00191477|7183559|FG001|Overall Study|Death, Study Disease|1
4405121|NCT00191477|7183558|FG000|Overall Study|Death, Other Cause|3
4405122|NCT00191477|7183559|FG001|Overall Study|Death, Other Cause|6
4405123|NCT00191477|7183558|FG000|Overall Study|Lost to Follow-up|23
4405124|NCT00191477|7183559|FG001|Overall Study|Lost to Follow-up|21
4405125|NCT00191477|7183558|FG000|Overall Study|Protocol Violation|1
4405126|NCT00191477|7183559|FG001|Overall Study|Protocol Violation|1
4405127|NCT00191477|7183558|FG000|Overall Study|Treatment Change|2
4405128|NCT00191477|7183559|FG001|Overall Study|Treatment Change|0
4405129|NCT00191477|7183558|FG000|Overall Study|Withdrawal by Subject|2
4405130|NCT00191477|7183559|FG001|Overall Study|Withdrawal by Subject|0
4405131|NCT00191477|7183558|FG000|Overall Study|Other|2
4405132|NCT00191477|7183559|FG001|Overall Study|Other|0
4405133|NCT00191477|7183558|FG000|Overall Study|Not Eligible|41
4405134|NCT00191477|7183559|FG001|Overall Study|Not Eligible|38
4405135|NCT00191477|7183558|FG000|Overall Study|Pathological Specimen Lost|1
4405136|NCT00191477|7183559|FG001|Overall Study|Pathological Specimen Lost|0
4405137|NCT00191477|7183558|FG000|Overall Study|Discontinued Prior to Instillation|13
4405138|NCT00191477|7183559|FG001|Overall Study|Discontinued Prior to Instillation|14
4405139|NCT00191646|7183567|FG000|Overall Study|Toxicity|26
4405140|NCT00191646|7183568|FG001|Overall Study|Toxicity|37
4405141|NCT00191646|7183567|FG000|Overall Study|Disease Progression|5
4405142|NCT00191646|7183568|FG001|Overall Study|Disease Progression|6
4405143|NCT00191646|7183567|FG000|Overall Study|Physician Decision|20
4405144|NCT00191646|7183568|FG001|Overall Study|Physician Decision|11
4405145|NCT00191646|7183567|FG000|Overall Study|Withdrawal by Subject|58
4405146|NCT00191646|7183568|FG001|Overall Study|Withdrawal by Subject|39
4405147|NCT00191646|7183567|FG000|Overall Study|Protocol Violation|5
4405148|NCT00191646|7183568|FG001|Overall Study|Protocol Violation|7
4405149|NCT00191646|7183567|FG000|Overall Study|Death|6
4405150|NCT00191646|7183568|FG001|Overall Study|Death|8
4405151|NCT00191646|7183567|FG000|Overall Study|Other|33
4405152|NCT00191646|7183568|FG001|Overall Study|Other|34
4405153|NCT00191646|7183567|FG000|Overall Study|Missing Data|18
4405154|NCT00191646|7183568|FG001|Overall Study|Missing Data|11
4405155|NCT00191724|7183587|FG000|Overall Study|Adverse Event|0
4405156|NCT00191724|7183588|FG001|Overall Study|Adverse Event|0
4405157|NCT00191724|7183589|FG002|Overall Study|Adverse Event|1
4405158|NCT00191724|7183590|FG003|Overall Study|Adverse Event|0
4405159|NCT00191724|7183591|FG004|Overall Study|Adverse Event|0
4405160|NCT00191724|7183587|FG000|Overall Study|Lost to Follow-up|1
4405161|NCT00191724|7183588|FG001|Overall Study|Lost to Follow-up|1
4405162|NCT00191724|7183589|FG002|Overall Study|Lost to Follow-up|0
4405163|NCT00191724|7183590|FG003|Overall Study|Lost to Follow-up|2
4405164|NCT00191724|7183591|FG004|Overall Study|Lost to Follow-up|3
4405165|NCT00191724|7183587|FG000|Overall Study|Withdrawal by Subject|0
4405166|NCT00191724|7183588|FG001|Overall Study|Withdrawal by Subject|0
4405167|NCT00191724|7183589|FG002|Overall Study|Withdrawal by Subject|0
4405168|NCT00191724|7183590|FG003|Overall Study|Withdrawal by Subject|1
4405169|NCT00191724|7183591|FG004|Overall Study|Withdrawal by Subject|0
4405170|NCT00191789|7183603|FG000|Overall Study|Adverse Event|5
4405171|NCT00191789|7183603|FG000|Overall Study|Patient: Satisfactory Response|5
4405172|NCT00191789|7183603|FG000|Overall Study|Patient/Physician: Satisfactory Response|4
4405173|NCT00191789|7183603|FG000|Overall Study|Withdrawal by Subject|4
4405174|NCT00191789|7183603|FG000|Overall Study|Death - Possibly Study Drug Related|4
4405175|NCT00191789|7183603|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2
4405176|NCT00191789|7183603|FG000|Overall Study|Death - Not Study-Drug Related|1
4511373|NCT00925990|7320306|FG001|Overall Study|Adverse Event|3
4511374|NCT00925990|7320305|FG000|Overall Study|Withdrawal by Subject|2
4511375|NCT00925990|7320306|FG001|Overall Study|Withdrawal by Subject|2
4511376|NCT00925990|7320305|FG000|Overall Study|Lost to Follow-up|1
4511377|NCT00925990|7320306|FG001|Overall Study|Lost to Follow-up|3
4511378|NCT00925990|7320305|FG000|Overall Study|Physician Decision|1
4511379|NCT00925990|7320306|FG001|Overall Study|Physician Decision|1
4511380|NCT00925990|7320305|FG000|Overall Study|moved out of state, missed medication|0
4511381|NCT00925990|7320306|FG001|Overall Study|moved out of state, missed medication|2
4511382|NCT00926003|7320315|FG000|Post-Training Evaluation|Withdrawal by Subject|1
4511383|NCT00926003|7320316|FG001|Post-Training Evaluation|Withdrawal by Subject|0
4511384|NCT00926003|7320317|FG002|Post-Training Evaluation|Withdrawal by Subject|0
4511385|NCT00926003|7320315|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1
4511386|NCT00926003|7320316|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0
4511387|NCT00926003|7320317|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0
4511388|NCT00926029|7320328|FG000|Overall Study|Lost to Follow-up|2
4511389|NCT00926029|7320329|FG001|Overall Study|Lost to Follow-up|1
4511390|NCT00926029|7320330|FG002|Overall Study|Lost to Follow-up|1
4511391|NCT00926211|7320357|FG000|Overall Study|Lost to Follow-up|1
4511392|NCT00926237|7320362|FG000|Overall Study|Withdrawal by Subject|2
4405177|NCT00191815|7183607|FG000|Overall Study|Adverse Event|2
4405178|NCT00191815|7183607|FG000|Overall Study|Disease progression or relapse|24
4405179|NCT00191815|7183607|FG000|Overall Study|Death|2
4405180|NCT00191815|7183607|FG000|Overall Study|Protocol Violation|3
4405181|NCT00191815|7183607|FG000|Overall Study|Physician Decision|2
4405182|NCT00191815|7183607|FG000|Overall Study|Withdrawal by Subject|7
4405183|NCT00191854|7183614|FG000|Overall Study|Death|26
4405184|NCT00191854|7183615|FG001|Overall Study|Death|23
4405185|NCT00191854|7183616|FG002|Overall Study|Death|29
4511393|NCT00926237|7320363|FG001|Overall Study|Withdrawal by Subject|1
4511394|NCT00926289|7320385|FG000|Overall Study|Adverse Event|9
4511395|NCT00926289|7320386|FG001|Overall Study|Adverse Event|11
4511396|NCT00926289|7320385|FG000|Overall Study|Protocol Violation|8
4511397|NCT00926289|7320386|FG001|Overall Study|Protocol Violation|12
4511398|NCT00926289|7320385|FG000|Overall Study|Lost to Follow-up|3
4511399|NCT00926289|7320386|FG001|Overall Study|Lost to Follow-up|6
4511400|NCT00926289|7320385|FG000|Overall Study|Withdrawal by Subject|4
4511401|NCT00926289|7320386|FG001|Overall Study|Withdrawal by Subject|4
4511402|NCT00926289|7320385|FG000|Overall Study|Other|1
4511403|NCT00926289|7320386|FG001|Overall Study|Other|3
4511404|NCT00926328|7320394|FG000|Overall Study|Lost to Follow-up|12
4511405|NCT00926328|7320395|FG001|Overall Study|Lost to Follow-up|14
4511406|NCT00926367|7320403|FG000|Overall Study|Withdrawal by Subject|0
4511407|NCT00926367|7320404|FG001|Overall Study|Withdrawal by Subject|1
4511408|NCT00926367|7320403|FG000|Overall Study|Lost to Follow-up|1
4511409|NCT00926367|7320404|FG001|Overall Study|Lost to Follow-up|0
4511410|NCT00926367|7320403|FG000|Overall Study|Skin Irritation|1
4511411|NCT00926367|7320404|FG001|Overall Study|Skin Irritation|2
4511412|NCT00926393|7320427|FG000|Overall Study|Withdrawal by Subject|1
4511413|NCT00926393|7320428|FG001|Overall Study|Withdrawal by Subject|2
4405186|NCT00191854|7183614|FG000|Overall Study|Lost to Follow-up|7
4405187|NCT00191854|7183615|FG001|Overall Study|Lost to Follow-up|5
4405188|NCT00191854|7183616|FG002|Overall Study|Lost to Follow-up|5
4405189|NCT00191854|7183614|FG000|Overall Study|Withdrawal by Subject|4
4405190|NCT00191854|7183615|FG001|Overall Study|Withdrawal by Subject|2
4405191|NCT00191854|7183616|FG002|Overall Study|Withdrawal by Subject|3
4405192|NCT00191854|7183614|FG000|Overall Study|Sponsor Decision|0
4405193|NCT00191854|7183615|FG001|Overall Study|Sponsor Decision|0
4405194|NCT00191854|7183616|FG002|Overall Study|Sponsor Decision|1
4405195|NCT00191854|7183614|FG000|Overall Study|Screen Failure|0
4405196|NCT00191854|7183615|FG001|Overall Study|Screen Failure|0
4405197|NCT00191854|7183616|FG002|Overall Study|Screen Failure|1
4405198|NCT00191906|7183628|FG000|Study Period II|Adverse Event|0
4405199|NCT00191906|7183629|FG001|Study Period II|Adverse Event|1
4405200|NCT00191906|7183630|FG002|Study Period II|Adverse Event|0
4405201|NCT00191906|7183631|FG003|Study Period II|Adverse Event|0
4405202|NCT00191906|7183628|FG000|Study Period II|Withdrawal by Subject|0
4405203|NCT00191906|7183629|FG001|Study Period II|Withdrawal by Subject|3
4405204|NCT00191906|7183630|FG002|Study Period II|Withdrawal by Subject|0
4405205|NCT00191906|7183631|FG003|Study Period II|Withdrawal by Subject|0
4405206|NCT00191906|7183628|FG000|Study Period II|Parent/Caregiver Decision|0
4405207|NCT00191906|7183629|FG001|Study Period II|Parent/Caregiver Decision|1
4405208|NCT00191906|7183630|FG002|Study Period II|Parent/Caregiver Decision|0
4405209|NCT00191906|7183631|FG003|Study Period II|Parent/Caregiver Decision|0
4405210|NCT00191906|7183628|FG000|Study Period II|Entry Criteria Exclusion|0
4405211|NCT00191906|7183629|FG001|Study Period II|Entry Criteria Exclusion|0
4405212|NCT00191906|7183630|FG002|Study Period II|Entry Criteria Exclusion|1
4405213|NCT00191906|7183631|FG003|Study Period II|Entry Criteria Exclusion|0
4405214|NCT00191906|7183628|FG000|Study Period III|Adverse Event|1
4405215|NCT00191906|7183629|FG001|Study Period III|Adverse Event|0
4405216|NCT00191906|7183630|FG002|Study Period III|Adverse Event|0
4405217|NCT00191906|7183631|FG003|Study Period III|Adverse Event|0
4405218|NCT00191906|7183628|FG000|Study Period III|Lost to Follow-up|0
4405219|NCT00191906|7183629|FG001|Study Period III|Lost to Follow-up|1
4405220|NCT00191906|7183630|FG002|Study Period III|Lost to Follow-up|0
4405221|NCT00191906|7183631|FG003|Study Period III|Lost to Follow-up|0
4405222|NCT00191906|7183628|FG000|Study Period III|Parent/Caregiver Decision|1
4405223|NCT00191906|7183629|FG001|Study Period III|Parent/Caregiver Decision|0
4405224|NCT00191906|7183630|FG002|Study Period III|Parent/Caregiver Decision|0
4405225|NCT00191906|7183631|FG003|Study Period III|Parent/Caregiver Decision|0
4405226|NCT00191906|7183628|FG000|Study Period III|Lack of Efficacy|3
4405227|NCT00191906|7183629|FG001|Study Period III|Lack of Efficacy|3
4405228|NCT00191906|7183630|FG002|Study Period III|Lack of Efficacy|0
4405229|NCT00191906|7183631|FG003|Study Period III|Lack of Efficacy|0
4405230|NCT00191945|7183649|FG000|Double-Blind Acute Treatment|Parent's Decision|3
4405231|NCT00191945|7183650|FG001|Double-Blind Acute Treatment|Parent's Decision|0
4511414|NCT00926393|7320427|FG000|Overall Study|Adverse Event|1
4405232|NCT00191945|7183649|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0
4405233|NCT00191945|7183650|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1
4405234|NCT00191945|7183649|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3
4405235|NCT00191945|7183650|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0
4405236|NCT00191945|7183649|FG000|Double-Blind Acute Treatment|Physician Decision|0
4405237|NCT00191945|7183650|FG001|Double-Blind Acute Treatment|Physician Decision|2
4405238|NCT00191984|7183657|FG000|Overall Study|Disease Progression|21
4405239|NCT00191984|7183657|FG000|Overall Study|Adverse Event|4
4405240|NCT00191984|7183657|FG000|Overall Study|Death|2
4405241|NCT00191984|7183657|FG000|Overall Study|Entry Criteria Exclusion|1
4405242|NCT00191984|7183657|FG000|Overall Study|Withdrawal by Subject|7
4405243|NCT00191984|7183657|FG000|Overall Study|Physician Decision|4
4405244|NCT00192023|7183663|FG000|Period III - Double-Blind|Adverse Event|3
4405245|NCT00192023|7183664|FG001|Period III - Double-Blind|Adverse Event|0
4405246|NCT00192023|7183663|FG000|Period III - Double-Blind|Physician Decision|2
4405247|NCT00192023|7183664|FG001|Period III - Double-Blind|Physician Decision|0
4405248|NCT00192023|7183663|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2
4405249|NCT00192023|7183664|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0
4405250|NCT00192023|7183663|FG000|Period IV - Optional Open-Label|Adverse Event|6
4405251|NCT00192023|7183664|FG001|Period IV - Optional Open-Label|Adverse Event|0
4405252|NCT00192023|7183663|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7
4405253|NCT00192023|7183664|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0
4405254|NCT00192023|7183663|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46
4405255|NCT00192023|7183664|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0
4405256|NCT00192023|7183663|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2
4405257|NCT00192023|7183664|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0
4405258|NCT00192023|7183663|FG000|Period IV - Optional Open-Label|Protocol Violation|1
4405259|NCT00192023|7183664|FG001|Period IV - Optional Open-Label|Protocol Violation|0
4405260|NCT00192023|7183663|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4
4405261|NCT00192023|7183664|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0
4405262|NCT00192023|7183663|FG000|Period IV - Optional Open-Label|Physician Decision|9
4405263|NCT00192023|7183664|FG001|Period IV - Optional Open-Label|Physician Decision|0
4405264|NCT00192036|7183670|FG000|Overall Study|Protocol Violation|3
4405265|NCT00192036|7183670|FG000|Overall Study|Adverse Event|6
4405266|NCT00192036|7183670|FG000|Overall Study|Patient/Physician Perception|1
4405267|NCT00192036|7183670|FG000|Overall Study|Objective Tumor Progression|4
4405268|NCT00192036|7183670|FG000|Overall Study|Clinical Disease Progression|1
4405269|NCT00192036|7183670|FG000|Overall Study|Death|1
4405270|NCT00192036|7183670|FG000|Overall Study|Unknown or Not Specified|5
4405271|NCT00192075|7183676|FG000|Overall Study|Disease Progression|23
4405272|NCT00192075|7183677|FG001|Overall Study|Disease Progression|6
4405273|NCT00192075|7183676|FG000|Overall Study|Adverse Event|1
4405274|NCT00192075|7183677|FG001|Overall Study|Adverse Event|3
4405275|NCT00192075|7183676|FG000|Overall Study|Death|0
4405276|NCT00192075|7183677|FG001|Overall Study|Death|1
4405277|NCT00192075|7183676|FG000|Overall Study|Lack of Efficacy|0
4405278|NCT00192075|7183677|FG001|Overall Study|Lack of Efficacy|0
4405279|NCT00192075|7183676|FG000|Overall Study|Physician Decision|3
4405280|NCT00192075|7183677|FG001|Overall Study|Physician Decision|0
4405281|NCT00192075|7183676|FG000|Overall Study|Withdrawal by Subject|5
4405282|NCT00192075|7183677|FG001|Overall Study|Withdrawal by Subject|5
4405283|NCT00192075|7183676|FG000|Overall Study|Patient Non-Compliance|0
4405284|NCT00192075|7183677|FG001|Overall Study|Patient Non-Compliance|1
4405285|NCT00192075|7183676|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2
4405286|NCT00192075|7183677|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1
4405287|NCT00192075|7183676|FG000|Overall Study|Other|5
4405288|NCT00192075|7183677|FG001|Overall Study|Other|2
4405289|NCT00192114|7183688|FG000|Overall Study|Objective Tumor Progression|19
4405290|NCT00192114|7183688|FG000|Overall Study|Adverse Event|2
4405291|NCT00192114|7183688|FG000|Overall Study|Clinical Progression|2
4405292|NCT00192114|7183688|FG000|Overall Study|Death|1
4405293|NCT00192296|7183696|FG000|Overall Study|Withdrawal by Subject|0
4405294|NCT00192296|7183697|FG001|Overall Study|Withdrawal by Subject|1
4405295|NCT00192296|7183698|FG002|Overall Study|Withdrawal by Subject|0
4405296|NCT00192296|7183699|FG003|Overall Study|Withdrawal by Subject|0
4405297|NCT00192504|7183713|FG000|Overall Study|Lost to Follow-up|1
4405298|NCT00192504|7183714|FG001|Overall Study|Lost to Follow-up|0
4405299|NCT00192504|7183715|FG002|Overall Study|Lost to Follow-up|0
4405300|NCT00192504|7183716|FG003|Overall Study|Lost to Follow-up|0
4405301|NCT00192504|7183713|FG000|Overall Study|Dosing window missed|0
4405302|NCT00192504|7183714|FG001|Overall Study|Dosing window missed|0
4405303|NCT00192504|7183715|FG002|Overall Study|Dosing window missed|1
4405304|NCT00192504|7183716|FG003|Overall Study|Dosing window missed|0
4405305|NCT00192647|7183728|FG000|Overall Study|Death|1
4405306|NCT00192647|7183729|FG001|Overall Study|Death|1
4405307|NCT00192647|7183728|FG000|Overall Study|Adverse Event|35
4405308|NCT00192647|7183729|FG001|Overall Study|Adverse Event|29
4405309|NCT00192647|7183728|FG000|Overall Study|Laboratory Test Abnormality|4
4405310|NCT00192647|7183729|FG001|Overall Study|Laboratory Test Abnormality|2
4405311|NCT00192647|7183728|FG000|Overall Study|Insufficient Therapeutic Response|53
4405312|NCT00192647|7183729|FG001|Overall Study|Insufficient Therapeutic Response|83
4405313|NCT00192647|7183728|FG000|Overall Study|Entry Criteria Violation|6
4405314|NCT00192647|7183729|FG001|Overall Study|Entry Criteria Violation|6
4405315|NCT00192647|7183728|FG000|Overall Study|Protocol Violation|3
4405316|NCT00192647|7183729|FG001|Overall Study|Protocol Violation|1
4405317|NCT00192647|7183728|FG000|Overall Study|Refused Treatment/Did not Cooperate|10
4405318|NCT00192647|7183729|FG001|Overall Study|Refused Treatment/Did not Cooperate|8
4405319|NCT00192647|7183728|FG000|Overall Study|Failure to Return|11
4405320|NCT00192647|7183729|FG001|Overall Study|Failure to Return|13
4405321|NCT00192647|7183728|FG000|Overall Study|Other/Administrative|5
4405322|NCT00192647|7183729|FG001|Overall Study|Other/Administrative|3
4405323|NCT00193050|7183744|FG000|Neoadjuvant Treatment|Lack of Efficacy|2
4405324|NCT00193050|7183744|FG000|Neoadjuvant Treatment|Intercurrent Illness|3
4405325|NCT00193050|7183744|FG000|Neoadjuvant Treatment|Physician Decision|2
4405326|NCT00193050|7183744|FG000|Neoadjuvant Treatment|Adverse Event|2
4405327|NCT00193050|7183744|FG000|Adjuvant|Physician Decision|5
4405328|NCT00193050|7183744|FG000|Adjuvant|Intercurrent Hospitalization|3
4405329|NCT00193050|7183744|FG000|Adjuvant|Lack of Efficacy|2
4405330|NCT00193063|7183749|FG000|Overall Study|Lack of Efficacy|3
4405331|NCT00193063|7183749|FG000|Overall Study|Adverse Event|1
4405332|NCT00193180|7183764|FG000|Overall Study|Lack of Efficacy|1
4405333|NCT00193180|7183764|FG000|Overall Study|Adverse Event|8
4405334|NCT00193180|7183764|FG000|Overall Study|Protocol Violation|1
4405335|NCT00193206|7183769|FG000|Preoperative Therapy|Lack of Efficacy|2
4405336|NCT00193206|7183769|FG000|Preoperative Therapy|Adverse Event|2
4405337|NCT00193206|7183769|FG000|Preoperative Therapy|Withdrawal by Subject|2
4405338|NCT00193206|7183769|FG000|Preoperative Therapy|False Positive Pregnancy Test|1
4405339|NCT00193206|7183769|FG000|Postoperative Therapy|Withdrawal by Subject|7
4405340|NCT00193206|7183769|FG000|Postoperative Therapy|Physician Decision|3
4405341|NCT00193206|7183769|FG000|Postoperative Therapy|Intercurrent Illness|2
4405342|NCT00193206|7183769|FG000|Postoperative Therapy|Lack of Efficacy|1
4405343|NCT00193206|7183769|FG000|Postoperative Therapy|Protocol Violation|1
4405344|NCT00193609|7183803|FG000|Overall Study|Lack of Efficacy|2
4405345|NCT00193609|7183803|FG000|Overall Study|Adverse Event|2
4405346|NCT00194012|7183809|FG000|Randomized Phase|Lack of Efficacy|8
4405347|NCT00194012|7183810|FG001|Randomized Phase|Lack of Efficacy|18
4405348|NCT00194012|7183809|FG000|Randomized Phase|Study nonadherence|2
4405349|NCT00194012|7183810|FG001|Randomized Phase|Study nonadherence|1
4405350|NCT00194012|7183809|FG000|Randomized Phase|Withdrawal by Subject|3
4405351|NCT00194012|7183810|FG001|Randomized Phase|Withdrawal by Subject|3
4405352|NCT00194012|7183809|FG000|Randomized Phase|Adverse Event|2
4405353|NCT00194012|7183810|FG001|Randomized Phase|Adverse Event|1
4405354|NCT00194012|7183809|FG000|Randomized Phase|Participant reported having a rash|1
4405355|NCT00194012|7183810|FG001|Randomized Phase|Participant reported having a rash|0
4405356|NCT00194012|7183809|FG000|Randomized Phase|Emesis and enuresis|0
4405357|NCT00194012|7183810|FG001|Randomized Phase|Emesis and enuresis|1
4405358|NCT00194012|7183809|FG000|Randomized Phase|Oral/nasal twitching|0
4405359|NCT00194012|7183810|FG001|Randomized Phase|Oral/nasal twitching|1
4405360|NCT00194012|7183809|FG000|Open Label Extension (OLE)|Weight Gain|1
4405361|NCT00194012|7183810|FG001|Open Label Extension (OLE)|Weight Gain|0
4405362|NCT00194012|7183809|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0
4405363|NCT00194012|7183810|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1
4405364|NCT00194012|7183809|FG000|Open Label Extension (OLE)|Lost to Follow-up|3
4405365|NCT00194012|7183810|FG001|Open Label Extension (OLE)|Lost to Follow-up|5
4405366|NCT00194012|7183809|FG000|Open Label Extension (OLE)|Lack of Efficacy|1
4405367|NCT00194012|7183810|FG001|Open Label Extension (OLE)|Lack of Efficacy|0
4405368|NCT00194025|7183822|FG000|Overall Study|Adverse Event|1
4405369|NCT00194025|7183822|FG000|Overall Study|non-adherence with study medication|4
4405370|NCT00194077|7183828|FG000|Overall Study|Lack of Efficacy|22
4405371|NCT00194077|7183829|FG001|Overall Study|Lack of Efficacy|29
4405372|NCT00194077|7183828|FG000|Overall Study|Study nonadherence|1
4405373|NCT00194077|7183829|FG001|Overall Study|Study nonadherence|0
4405374|NCT00194077|7183828|FG000|Overall Study|Withdrawal by Subject|1
4405375|NCT00194077|7183829|FG001|Overall Study|Withdrawal by Subject|1
4405376|NCT00194675|7183880|FG000|Overall Study|Lost to Follow-up|1
4405377|NCT00194675|7183881|FG001|Overall Study|Lost to Follow-up|1
4405378|NCT00194675|7183880|FG000|Overall Study|lack of interest|1
4405379|NCT00194675|7183881|FG001|Overall Study|lack of interest|1
4405380|NCT00194675|7183880|FG000|Overall Study|"withdrew due to edgy feeling"|1
4405381|NCT00194675|7183881|FG001|Overall Study|"withdrew due to edgy feeling"|0
4405382|NCT00194675|7183880|FG000|Overall Study|Protocol Violation|1
4405383|NCT00194675|7183881|FG001|Overall Study|Protocol Violation|0
4405384|NCT00194675|7183880|FG000|Overall Study|Death|1
4405385|NCT00194675|7183881|FG001|Overall Study|Death|0
4405386|NCT00194792|7183893|FG000|Overall Study|Withdrawal by Subject|1
4405387|NCT00194987|7183916|FG000|Overall Study|Withdrawal by Subject|0
4405388|NCT00194987|7183917|FG001|Overall Study|Withdrawal by Subject|3
4405389|NCT00195260|7183940|FG000|Part 1: Dose Escalation|Adverse Event|0
4405390|NCT00195260|7183941|FG001|Part 1: Dose Escalation|Adverse Event|1
4405391|NCT00195260|7183942|FG002|Part 1: Dose Escalation|Adverse Event|0
4405392|NCT00195260|7183943|FG003|Part 1: Dose Escalation|Adverse Event|1
4405393|NCT00195260|7183944|FG004|Part 1: Dose Escalation|Adverse Event|1
4405394|NCT00195260|7183945|FG005|Part 1: Dose Escalation|Adverse Event|0
4405395|NCT00195260|7183946|FG006|Part 1: Dose Escalation|Adverse Event|3
4405396|NCT00195260|7183947|FG007|Part 1: Dose Escalation|Adverse Event|0
4405397|NCT00195260|7183948|FG008|Part 1: Dose Escalation|Adverse Event|0
4405398|NCT00195260|7183949|FG009|Part 1: Dose Escalation|Adverse Event|0
4405399|NCT00195260|7183950|FG010|Part 1: Dose Escalation|Adverse Event|0
4405400|NCT00195260|7183940|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0
4405401|NCT00195260|7183941|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0
4405402|NCT00195260|7183942|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0
4405403|NCT00195260|7183943|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0
4405404|NCT00195260|7183944|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2
4405405|NCT00195260|7183945|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0
4405406|NCT00195260|7183946|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0
4405407|NCT00195260|7183947|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1
4405408|NCT00195260|7183948|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0
4405409|NCT00195260|7183949|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0
4405410|NCT00195260|7183950|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0
4405411|NCT00195260|7183940|FG000|Part 1: Dose Escalation|Death|0
4405412|NCT00195260|7183941|FG001|Part 1: Dose Escalation|Death|0
4405413|NCT00195260|7183942|FG002|Part 1: Dose Escalation|Death|0
4405414|NCT00195260|7183943|FG003|Part 1: Dose Escalation|Death|0
4405415|NCT00195260|7183944|FG004|Part 1: Dose Escalation|Death|0
4405416|NCT00195260|7183945|FG005|Part 1: Dose Escalation|Death|0
4405417|NCT00195260|7183946|FG006|Part 1: Dose Escalation|Death|0
4405418|NCT00195260|7183947|FG007|Part 1: Dose Escalation|Death|1
4405419|NCT00195260|7183948|FG008|Part 1: Dose Escalation|Death|0
4405420|NCT00195260|7183949|FG009|Part 1: Dose Escalation|Death|0
4405421|NCT00195260|7183950|FG010|Part 1: Dose Escalation|Death|0
4405422|NCT00195260|7183940|FG000|Part 1: Dose Escalation|Disease Progression|3
4405423|NCT00195260|7183941|FG001|Part 1: Dose Escalation|Disease Progression|2
4405424|NCT00195260|7183942|FG002|Part 1: Dose Escalation|Disease Progression|5
4405425|NCT00195260|7183943|FG003|Part 1: Dose Escalation|Disease Progression|6
4405426|NCT00195260|7183944|FG004|Part 1: Dose Escalation|Disease Progression|4
4405427|NCT00195260|7183945|FG005|Part 1: Dose Escalation|Disease Progression|6
4405428|NCT00195260|7183946|FG006|Part 1: Dose Escalation|Disease Progression|7
4405429|NCT00195260|7183947|FG007|Part 1: Dose Escalation|Disease Progression|4
4405430|NCT00195260|7183948|FG008|Part 1: Dose Escalation|Disease Progression|0
4405431|NCT00195260|7183949|FG009|Part 1: Dose Escalation|Disease Progression|0
4405432|NCT00195260|7183950|FG010|Part 1: Dose Escalation|Disease Progression|0
4405433|NCT00195260|7183940|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1
4405434|NCT00195260|7183941|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1
4405435|NCT00195260|7183942|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1
4405436|NCT00195260|7183943|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0
4405437|NCT00195260|7183944|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0
4405438|NCT00195260|7183945|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1
4405439|NCT00195260|7183946|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0
4405440|NCT00195260|7183947|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0
4405441|NCT00195260|7183948|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0
4405442|NCT00195260|7183949|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0
4713377|NCT02944448|7640815|FG000|Overall Study|Adverse Event|37
4713378|NCT02944448|7640816|FG001|Overall Study|Adverse Event|6
4713379|NCT02944448|7640815|FG000|Overall Study|Lack of Efficacy|8
4713380|NCT02944448|7640816|FG001|Overall Study|Lack of Efficacy|5
4713381|NCT02944448|7640815|FG000|Overall Study|Lost to Follow-up|3
4713382|NCT02944448|7640816|FG001|Overall Study|Lost to Follow-up|1
4713383|NCT02944448|7640815|FG000|Overall Study|Protocol Violation|25
4405443|NCT00195260|7183950|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0
4405444|NCT00195260|7183940|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
4405445|NCT00195260|7183941|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
4405446|NCT00195260|7183942|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
4405447|NCT00195260|7183943|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
4405448|NCT00195260|7183944|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
4405449|NCT00195260|7183945|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
4405450|NCT00195260|7183946|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
4405451|NCT00195260|7183947|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
4405452|NCT00195260|7183948|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21
4405453|NCT00195260|7183949|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29
4405454|NCT00195260|7183950|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15
4405455|NCT00195260|7183940|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
4405456|NCT00195260|7183941|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
4405457|NCT00195260|7183942|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
4405458|NCT00195260|7183943|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
4405459|NCT00195260|7183944|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
4405460|NCT00195260|7183945|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
4405461|NCT00195260|7183946|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
4405462|NCT00195260|7183947|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
4713384|NCT02944448|7640816|FG001|Overall Study|Protocol Violation|7
4405463|NCT00195260|7183948|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5
4405464|NCT00195260|7183949|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3
4405465|NCT00195260|7183950|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2
4405466|NCT00195260|7183940|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
4405467|NCT00195260|7183941|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
4405468|NCT00195260|7183942|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
4405469|NCT00195260|7183943|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
4628998|NCT01867580|7496593|FG001|Overall Study|Osteomyelitis|1
4628999|NCT01867580|7496592|FG000|Overall Study|Continuation of therapy|0
4405470|NCT00195260|7183944|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
4405471|NCT00195260|7183945|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
4405472|NCT00195260|7183946|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
4405473|NCT00195260|7183947|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
4405474|NCT00195260|7183948|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1
4405475|NCT00195260|7183949|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2
4405476|NCT00195260|7183950|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3
4405477|NCT00195260|7183940|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
4405478|NCT00195260|7183941|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
4405479|NCT00195260|7183942|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
4405480|NCT00195260|7183943|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
4405481|NCT00195260|7183944|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
4405482|NCT00195260|7183945|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
4405483|NCT00195260|7183946|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
4405484|NCT00195260|7183947|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
4405485|NCT00195260|7183948|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6
4405486|NCT00195260|7183949|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4
4405487|NCT00195260|7183950|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3
4405488|NCT00195273|7183980|FG000|Overall Study|Adverse Event|9
4629000|NCT01867580|7496593|FG001|Overall Study|Continuation of therapy|1
4629001|NCT01867580|7496592|FG000|Overall Study|Wound recurrence|0
4629002|NCT01867580|7496593|FG001|Overall Study|Wound recurrence|1
4629003|NCT01867658|7496608|FG000|Overall Study|Withdrawal by Subject|6
4629004|NCT01867658|7496608|FG000|Overall Study|Death|2
4629005|NCT01867658|7496608|FG000|Overall Study|Subject could not be contacted|1
4405489|NCT00195273|7183981|FG001|Overall Study|Adverse Event|9
4405490|NCT00195273|7183980|FG000|Overall Study|Protocol deviation|0
4405491|NCT00195273|7183981|FG001|Overall Study|Protocol deviation|1
4405492|NCT00195273|7183980|FG000|Overall Study|Lack of Efficacy|3
4405493|NCT00195273|7183981|FG001|Overall Study|Lack of Efficacy|1
4405494|NCT00195273|7183980|FG000|Overall Study|Procedural complications|9
4405495|NCT00195273|7183981|FG001|Overall Study|Procedural complications|3
4405496|NCT00195338|7183987|FG000|Overall Study|Lost to Follow-up|2
4405497|NCT00195338|7183987|FG000|Overall Study|Adverse Event|5
4405498|NCT00195338|7183987|FG000|Overall Study|Lack of Efficacy|1
4405499|NCT00195338|7183987|FG000|Overall Study|Early closure of the site|4
4405500|NCT00195351|7183993|FG000|Overall Study|Lost to Follow-up|9
4405501|NCT00195351|7183994|FG001|Overall Study|Lost to Follow-up|9
4405502|NCT00195351|7183993|FG000|Overall Study|Withdrawal by Subject|6
4405503|NCT00195351|7183994|FG001|Overall Study|Withdrawal by Subject|3
4405504|NCT00195351|7183993|FG000|Overall Study|Protocol Deviation|3
4405505|NCT00195351|7183994|FG001|Overall Study|Protocol Deviation|2
4405506|NCT00195351|7183993|FG000|Overall Study|Death|3
4405507|NCT00195351|7183994|FG001|Overall Study|Death|1
4405508|NCT00195351|7183993|FG000|Overall Study|Lack of Efficacy|0
4405509|NCT00195351|7183994|FG001|Overall Study|Lack of Efficacy|1
4405510|NCT00195429|7184006|FG000|Overall Study|Adverse Event|2
4405511|NCT00195429|7184007|FG001|Overall Study|Adverse Event|4
4405512|NCT00195429|7184006|FG000|Overall Study|Lack of Efficacy|2
4405513|NCT00195429|7184007|FG001|Overall Study|Lack of Efficacy|1
4405514|NCT00195429|7184006|FG000|Overall Study|Lost to Follow-up|1
4405515|NCT00195429|7184007|FG001|Overall Study|Lost to Follow-up|0
4405516|NCT00195442|7184013|FG000|Overall Study|Less than expected therapeutic effect|38
4405517|NCT00195442|7184013|FG000|Overall Study|Lost to Follow-up|27
4405518|NCT00195442|7184013|FG000|Overall Study|Switch to other Factor VIII preparation|23
4405519|NCT00195442|7184013|FG000|Overall Study|Intermittent product shortage|21
4629006|NCT01867671|7496614|FG000|Overall Study|Adverse Event|5
4629007|NCT01867671|7496615|FG001|Overall Study|Adverse Event|3
4629008|NCT01867671|7496614|FG000|Overall Study|Anaphylaxis|0
4405520|NCT00195442|7184013|FG000|Overall Study|Death|7
4405521|NCT00195442|7184013|FG000|Overall Study|No reason specified|4
4405522|NCT00195442|7184013|FG000|Overall Study|Poor cooperation|2
4405523|NCT00195442|7184013|FG000|Overall Study|Other|14
4405524|NCT00195494|7184019|FG000|Year 1|Adverse Event|0
4405525|NCT00195494|7184020|FG001|Year 1|Adverse Event|0
4405526|NCT00195494|7184021|FG002|Year 1|Adverse Event|0
4405527|NCT00195494|7184022|FG003|Year 1|Adverse Event|0
4405528|NCT00195494|7184023|FG004|Year 1|Adverse Event|34
4405529|NCT00195494|7184024|FG005|Year 1|Adverse Event|27
4405530|NCT00195494|7184019|FG000|Year 1|System Toxicity|0
4405531|NCT00195494|7184020|FG001|Year 1|System Toxicity|0
4405532|NCT00195494|7184021|FG002|Year 1|System Toxicity|0
4405533|NCT00195494|7184022|FG003|Year 1|System Toxicity|0
4405534|NCT00195494|7184023|FG004|Year 1|System Toxicity|0
4405535|NCT00195494|7184024|FG005|Year 1|System Toxicity|1
4405536|NCT00195494|7184019|FG000|Year 1|Lack of Efficacy|0
4405537|NCT00195494|7184020|FG001|Year 1|Lack of Efficacy|0
4405538|NCT00195494|7184021|FG002|Year 1|Lack of Efficacy|0
4405539|NCT00195494|7184022|FG003|Year 1|Lack of Efficacy|0
4405540|NCT00195494|7184023|FG004|Year 1|Lack of Efficacy|24
4405541|NCT00195494|7184024|FG005|Year 1|Lack of Efficacy|9
4405542|NCT00195494|7184019|FG000|Year 1|Compliance|0
4405543|NCT00195494|7184020|FG001|Year 1|Compliance|0
4405544|NCT00195494|7184021|FG002|Year 1|Compliance|0
4405545|NCT00195494|7184022|FG003|Year 1|Compliance|0
4405546|NCT00195494|7184023|FG004|Year 1|Compliance|5
4405547|NCT00195494|7184024|FG005|Year 1|Compliance|1
4405548|NCT00195494|7184019|FG000|Year 1|Lost to Follow-up|0
4405549|NCT00195494|7184020|FG001|Year 1|Lost to Follow-up|0
4405550|NCT00195494|7184021|FG002|Year 1|Lost to Follow-up|0
4405551|NCT00195494|7184022|FG003|Year 1|Lost to Follow-up|0
4405552|NCT00195494|7184023|FG004|Year 1|Lost to Follow-up|1
4405553|NCT00195494|7184024|FG005|Year 1|Lost to Follow-up|0
4405554|NCT00195494|7184019|FG000|Year 1|Missed >4 consecutive doses|0
4405555|NCT00195494|7184020|FG001|Year 1|Missed >4 consecutive doses|0
4405556|NCT00195494|7184021|FG002|Year 1|Missed >4 consecutive doses|0
4405557|NCT00195494|7184022|FG003|Year 1|Missed >4 consecutive doses|0
4405558|NCT00195494|7184023|FG004|Year 1|Missed >4 consecutive doses|3
4405559|NCT00195494|7184024|FG005|Year 1|Missed >4 consecutive doses|2
4405560|NCT00195494|7184019|FG000|Year 1|Protocol deviation|0
4405561|NCT00195494|7184020|FG001|Year 1|Protocol deviation|0
4405562|NCT00195494|7184021|FG002|Year 1|Protocol deviation|0
4405563|NCT00195494|7184022|FG003|Year 1|Protocol deviation|0
4405564|NCT00195494|7184023|FG004|Year 1|Protocol deviation|2
4405565|NCT00195494|7184024|FG005|Year 1|Protocol deviation|3
4405566|NCT00195494|7184019|FG000|Year 1|Physician Decision|0
4405567|NCT00195494|7184020|FG001|Year 1|Physician Decision|0
4405568|NCT00195494|7184021|FG002|Year 1|Physician Decision|0
4405569|NCT00195494|7184022|FG003|Year 1|Physician Decision|0
4405570|NCT00195494|7184023|FG004|Year 1|Physician Decision|1
4405571|NCT00195494|7184024|FG005|Year 1|Physician Decision|0
4405572|NCT00195494|7184019|FG000|Year 1|Withdrawal by Subject|0
4405573|NCT00195494|7184020|FG001|Year 1|Withdrawal by Subject|0
4405574|NCT00195494|7184021|FG002|Year 1|Withdrawal by Subject|0
4405575|NCT00195494|7184022|FG003|Year 1|Withdrawal by Subject|0
4405576|NCT00195494|7184023|FG004|Year 1|Withdrawal by Subject|8
4405577|NCT00195494|7184024|FG005|Year 1|Withdrawal by Subject|9
4405578|NCT00195494|7184019|FG000|Year 1|Protocol Violation|0
4405579|NCT00195494|7184020|FG001|Year 1|Protocol Violation|0
4405580|NCT00195494|7184021|FG002|Year 1|Protocol Violation|0
4405581|NCT00195494|7184022|FG003|Year 1|Protocol Violation|0
4405582|NCT00195494|7184023|FG004|Year 1|Protocol Violation|1
4405583|NCT00195494|7184024|FG005|Year 1|Protocol Violation|1
4405584|NCT00195494|7184019|FG000|Year 2|Adverse Event|3
4405585|NCT00195494|7184020|FG001|Year 2|Adverse Event|7
4405586|NCT00195494|7184021|FG002|Year 2|Adverse Event|5
4405587|NCT00195494|7184022|FG003|Year 2|Adverse Event|9
4405588|NCT00195494|7184023|FG004|Year 2|Adverse Event|0
4405589|NCT00195494|7184024|FG005|Year 2|Adverse Event|0
4405590|NCT00195494|7184019|FG000|Year 2|Lack of Efficacy|0
4405591|NCT00195494|7184020|FG001|Year 2|Lack of Efficacy|1
4405592|NCT00195494|7184021|FG002|Year 2|Lack of Efficacy|7
4405593|NCT00195494|7184022|FG003|Year 2|Lack of Efficacy|7
4405594|NCT00195494|7184023|FG004|Year 2|Lack of Efficacy|0
4405595|NCT00195494|7184024|FG005|Year 2|Lack of Efficacy|0
4405596|NCT00195494|7184019|FG000|Year 2|Compliance|1
4405597|NCT00195494|7184020|FG001|Year 2|Compliance|0
4405598|NCT00195494|7184021|FG002|Year 2|Compliance|0
4405599|NCT00195494|7184022|FG003|Year 2|Compliance|2
4405600|NCT00195494|7184023|FG004|Year 2|Compliance|0
4405601|NCT00195494|7184024|FG005|Year 2|Compliance|0
4405602|NCT00195494|7184019|FG000|Year 2|Lost to Follow-up|0
4405603|NCT00195494|7184020|FG001|Year 2|Lost to Follow-up|0
4405604|NCT00195494|7184021|FG002|Year 2|Lost to Follow-up|1
4405605|NCT00195494|7184022|FG003|Year 2|Lost to Follow-up|1
4405606|NCT00195494|7184023|FG004|Year 2|Lost to Follow-up|0
4405607|NCT00195494|7184024|FG005|Year 2|Lost to Follow-up|0
4405608|NCT00195494|7184019|FG000|Year 2|Missed >4 consecutive doses|1
4405609|NCT00195494|7184020|FG001|Year 2|Missed >4 consecutive doses|1
4405610|NCT00195494|7184021|FG002|Year 2|Missed >4 consecutive doses|1
4405611|NCT00195494|7184022|FG003|Year 2|Missed >4 consecutive doses|0
4405612|NCT00195494|7184023|FG004|Year 2|Missed >4 consecutive doses|0
4405613|NCT00195494|7184024|FG005|Year 2|Missed >4 consecutive doses|0
4405614|NCT00195494|7184019|FG000|Year 2|Protocol deviation|0
4405615|NCT00195494|7184020|FG001|Year 2|Protocol deviation|1
4405616|NCT00195494|7184021|FG002|Year 2|Protocol deviation|0
4405617|NCT00195494|7184022|FG003|Year 2|Protocol deviation|0
4405618|NCT00195494|7184023|FG004|Year 2|Protocol deviation|0
4405619|NCT00195494|7184024|FG005|Year 2|Protocol deviation|0
4405620|NCT00195494|7184019|FG000|Year 2|Physician Decision|1
4405621|NCT00195494|7184020|FG001|Year 2|Physician Decision|1
4405622|NCT00195494|7184021|FG002|Year 2|Physician Decision|0
4405623|NCT00195494|7184022|FG003|Year 2|Physician Decision|0
4405624|NCT00195494|7184023|FG004|Year 2|Physician Decision|0
4405625|NCT00195494|7184024|FG005|Year 2|Physician Decision|0
4405626|NCT00195494|7184019|FG000|Year 2|Withdrawal by Subject|1
4405627|NCT00195494|7184020|FG001|Year 2|Withdrawal by Subject|5
4405628|NCT00195494|7184021|FG002|Year 2|Withdrawal by Subject|4
4405629|NCT00195494|7184022|FG003|Year 2|Withdrawal by Subject|3
4405630|NCT00195494|7184023|FG004|Year 2|Withdrawal by Subject|0
4405631|NCT00195494|7184024|FG005|Year 2|Withdrawal by Subject|0
4405632|NCT00195494|7184019|FG000|Year 2|System toxicity|0
4405633|NCT00195494|7184020|FG001|Year 2|System toxicity|0
4405634|NCT00195494|7184021|FG002|Year 2|System toxicity|0
4405635|NCT00195494|7184022|FG003|Year 2|System toxicity|1
4405636|NCT00195494|7184023|FG004|Year 2|System toxicity|0
4405637|NCT00195494|7184024|FG005|Year 2|System toxicity|0
4405638|NCT00195507|7184042|FG000|Overall Study|Adverse Event|24
4405639|NCT00195507|7184043|FG001|Overall Study|Adverse Event|13
4405640|NCT00195507|7184042|FG000|Overall Study|Death|0
4405641|NCT00195507|7184043|FG001|Overall Study|Death|1
4405642|NCT00195507|7184042|FG000|Overall Study|Failed to Return|4
4405643|NCT00195507|7184043|FG001|Overall Study|Failed to Return|3
4405644|NCT00195507|7184042|FG000|Overall Study|Physician Decision|1
4405645|NCT00195507|7184043|FG001|Overall Study|Physician Decision|2
4405646|NCT00195507|7184042|FG000|Overall Study|Lost to Follow-up|3
4405647|NCT00195507|7184043|FG001|Overall Study|Lost to Follow-up|2
4405648|NCT00195507|7184042|FG000|Overall Study|Protocol Violation|5
4405649|NCT00195507|7184043|FG001|Overall Study|Protocol Violation|4
4405650|NCT00195507|7184042|FG000|Overall Study|Lack of Efficacy|40
4405651|NCT00195507|7184043|FG001|Overall Study|Lack of Efficacy|67
4405652|NCT00195507|7184042|FG000|Overall Study|Withdrawal by Subject|16
4405653|NCT00195507|7184043|FG001|Overall Study|Withdrawal by Subject|23
4405654|NCT00195507|7184042|FG000|Overall Study|Protocol Deviation|6
4405655|NCT00195507|7184043|FG001|Overall Study|Protocol Deviation|3
4405656|NCT00195650|7184058|FG000|Overall Study|Adverse Event|194
4405657|NCT00195650|7184058|FG000|Overall Study|Lack of Efficacy|99
4405658|NCT00195650|7184058|FG000|Overall Study|Withdrawal by Subject|67
4405659|NCT00195650|7184058|FG000|Overall Study|Lost to Follow-up|44
4405660|NCT00195650|7184058|FG000|Overall Study|Death|23
4405661|NCT00195650|7184058|FG000|Overall Study|Protocol Violation|15
4405662|NCT00195650|7184058|FG000|Overall Study|Administrative reasons|83
4405663|NCT00195663|7184065|FG000|2-year Double-blind Treatment Period|Adverse Event|21
4405664|NCT00195663|7184066|FG001|2-year Double-blind Treatment Period|Adverse Event|27
4405665|NCT00195663|7184067|FG002|2-year Double-blind Treatment Period|Adverse Event|32
4405666|NCT00195663|7184065|FG000|2-year Double-blind Treatment Period|Death|0
4405667|NCT00195663|7184066|FG001|2-year Double-blind Treatment Period|Death|2
4405668|NCT00195663|7184067|FG002|2-year Double-blind Treatment Period|Death|0
4405669|NCT00195663|7184065|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0
4405670|NCT00195663|7184066|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0
4405671|NCT00195663|7184067|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1
4405672|NCT00195663|7184065|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15
4405673|NCT00195663|7184066|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18
4405674|NCT00195663|7184067|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12
4405675|NCT00195663|7184065|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47
4405676|NCT00195663|7184066|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52
4405677|NCT00195663|7184067|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13
4405678|NCT00195663|7184065|FG000|2-year Double-blind Treatment Period|Protocol Violation|6
4405679|NCT00195663|7184066|FG001|2-year Double-blind Treatment Period|Protocol Violation|6
4405680|NCT00195663|7184067|FG002|2-year Double-blind Treatment Period|Protocol Violation|4
4405681|NCT00195663|7184065|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0
4405682|NCT00195663|7184066|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1
4405683|NCT00195663|7184067|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0
4405684|NCT00195663|7184065|FG000|2-year Double-blind Treatment Period|Recovery|1
4405685|NCT00195663|7184066|FG001|2-year Double-blind Treatment Period|Recovery|0
4405686|NCT00195663|7184067|FG002|2-year Double-blind Treatment Period|Recovery|1
4405687|NCT00195663|7184065|FG000|2-year Double-blind Treatment Period|Administrative reasons|3
4405688|NCT00195663|7184066|FG001|2-year Double-blind Treatment Period|Administrative reasons|2
4405689|NCT00195663|7184067|FG002|2-year Double-blind Treatment Period|Administrative reasons|9
4405690|NCT00195663|7184065|FG000|Open-Label Extension Period|Adverse Event|21
4405691|NCT00195663|7184066|FG001|Open-Label Extension Period|Adverse Event|32
4405692|NCT00195663|7184067|FG002|Open-Label Extension Period|Adverse Event|36
4405693|NCT00195663|7184065|FG000|Open-Label Extension Period|Lost to Follow-up|9
4405694|NCT00195663|7184066|FG001|Open-Label Extension Period|Lost to Follow-up|2
4405695|NCT00195663|7184067|FG002|Open-Label Extension Period|Lost to Follow-up|6
4405696|NCT00195663|7184065|FG000|Open-Label Extension Period|Recovery|0
4405697|NCT00195663|7184066|FG001|Open-Label Extension Period|Recovery|2
4405698|NCT00195663|7184067|FG002|Open-Label Extension Period|Recovery|2
4405699|NCT00195663|7184065|FG000|Open-Label Extension Period|Protocol Violation|3
4405700|NCT00195663|7184066|FG001|Open-Label Extension Period|Protocol Violation|4
4405701|NCT00195663|7184067|FG002|Open-Label Extension Period|Protocol Violation|4
4405702|NCT00195663|7184065|FG000|Open-Label Extension Period|Death|2
4405703|NCT00195663|7184066|FG001|Open-Label Extension Period|Death|2
4405704|NCT00195663|7184067|FG002|Open-Label Extension Period|Death|2
4405705|NCT00195663|7184065|FG000|Open-Label Extension Period|Withdrawal by Subject|16
4405706|NCT00195663|7184066|FG001|Open-Label Extension Period|Withdrawal by Subject|15
4405707|NCT00195663|7184067|FG002|Open-Label Extension Period|Withdrawal by Subject|22
4405708|NCT00195663|7184065|FG000|Open-Label Extension Period|Lack of Efficacy|14
4405709|NCT00195663|7184066|FG001|Open-Label Extension Period|Lack of Efficacy|6
4405710|NCT00195663|7184067|FG002|Open-Label Extension Period|Lack of Efficacy|12
4405711|NCT00195663|7184065|FG000|Open-Label Extension Period|Administrative reasons|11
4405712|NCT00195663|7184066|FG001|Open-Label Extension Period|Administrative reasons|11
4405713|NCT00195663|7184067|FG002|Open-Label Extension Period|Administrative reasons|13
4405714|NCT00195676|7184085|FG000|Period O - Open-label Treatment|Adverse Event|82
4405715|NCT00195676|7184085|FG000|Period O - Open-label Treatment|Death|6
4405716|NCT00195676|7184085|FG000|Period O - Open-label Treatment|Lack of Efficacy|198
4405717|NCT00195676|7184085|FG000|Period O - Open-label Treatment|Lost to Follow-up|91
4405718|NCT00195676|7184085|FG000|Period O - Open-label Treatment|Protocol Violation|12
4405719|NCT00195676|7184085|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147
4405720|NCT00195676|7184085|FG000|Period O - Open-label Treatment|Administrative reasons|2
4405721|NCT00195676|7184085|FG000|Period O - Open-label Treatment|Other reasons|68
4405722|NCT00195676|7184085|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4
4405723|NCT00195676|7184085|FG000|Period W (Withdrawal) - No Treatment|Death|2
4405724|NCT00195676|7184085|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11
4405725|NCT00195676|7184085|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46
4405726|NCT00195676|7184085|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397
4405727|NCT00195676|7184085|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129
4405728|NCT00195676|7184085|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1
4405729|NCT00195676|7184085|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18
4405730|NCT00195676|7184085|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4
4405731|NCT00195676|7184085|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5
4405732|NCT00195676|7184085|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11
4405733|NCT00195676|7184085|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9
4405734|NCT00195676|7184085|FG000|Period R - Retreatment 16 Weeks|Other reasons|6
4405735|NCT00195715|7184114|FG000|Overall Study|Adverse Event|122
4405736|NCT00195715|7184114|FG000|Overall Study|Withdrawal by Subject|58
4405737|NCT00195715|7184114|FG000|Overall Study|Lost to Follow-up|27
4405738|NCT00195715|7184114|FG000|Overall Study|Protocol Violation|13
4405739|NCT00195715|7184114|FG000|Overall Study|Lack of Efficacy|93
4405740|NCT00195715|7184114|FG000|Overall Study|Pregnancy|14
4405741|NCT00195715|7184114|FG000|Overall Study|Investigative site closure|8
4405742|NCT00195715|7184114|FG000|Overall Study|Subject moved/relocated|7
4405743|NCT00195715|7184114|FG000|Overall Study|Subject non-compliance|6
4405744|NCT00195715|7184114|FG000|Overall Study|Subject started commercial Humira|5
4405745|NCT00195715|7184114|FG000|Overall Study|Subject choice|3
4405746|NCT00195715|7184114|FG000|Overall Study|Loss of response/no improvement|3
4405747|NCT00195715|7184114|FG000|Overall Study|Sponsor stopped study|1
4405748|NCT00195715|7184114|FG000|Overall Study|Administrative reasons|2
4405749|NCT00195715|7184114|FG000|Overall Study|Investigator's decision|2
4405750|NCT00195715|7184114|FG000|Overall Study|Subject wants to get pregnant|4
4405751|NCT00195715|7184114|FG000|Overall Study|Use of prohibited medication|2
4405752|NCT00195715|7184114|FG000|Overall Study|Planned surgery|2
4405753|NCT00195715|7184114|FG000|Overall Study|Increased infection rate|1
4405754|NCT00195715|7184114|FG000|Overall Study|Ineligible|1
4405755|NCT00195715|7184114|FG000|Overall Study|Colonic stricture|1
4405756|NCT00195715|7184114|FG000|Overall Study|Sponsor discontinued trial|1
4405757|NCT00195715|7184114|FG000|Overall Study|Sponsor discretion - trial ended early|1
4405758|NCT00195819|7184118|FG000|Double-Blind|Withdrawal by Subject|1
4405759|NCT00195819|7184119|FG001|Double-Blind|Withdrawal by Subject|0
4405760|NCT00195819|7184118|FG000|Double-Blind|Moved|1
4405761|NCT00195819|7184119|FG001|Double-Blind|Moved|0
4405762|NCT00195819|7184118|FG000|Open-label|Adverse Event|0
4405763|NCT00195819|7184119|FG001|Open-label|Adverse Event|9
4405764|NCT00195819|7184118|FG000|Open-label|Lack of Efficacy|0
4405765|NCT00195819|7184119|FG001|Open-label|Lack of Efficacy|2
4405766|NCT00195819|7184118|FG000|Open-label|Pregnancy|0
4405767|NCT00195819|7184119|FG001|Open-label|Pregnancy|1
4405768|NCT00195819|7184118|FG000|Open-label|Protocol Violation|0
4405769|NCT00195819|7184119|FG001|Open-label|Protocol Violation|2
4713385|NCT02944448|7640815|FG000|Overall Study|Withdrawal by Subject|14
4713386|NCT02944448|7640816|FG001|Overall Study|Withdrawal by Subject|4
4713387|NCT02944448|7640815|FG000|Overall Study|Sponsor did not supply drug in time|0
4713388|NCT02944448|7640816|FG001|Overall Study|Sponsor did not supply drug in time|1
4713389|NCT02944448|7640815|FG000|Overall Study|Noncompliant with dosing|1
4713390|NCT02944448|7640816|FG001|Overall Study|Noncompliant with dosing|0
4713391|NCT02944448|7640815|FG000|Overall Study|Abnormal laboratory values|1
4713392|NCT02944448|7640816|FG001|Overall Study|Abnormal laboratory values|0
4713393|NCT02944656|7640834|FG000|Overall Study|No longer eligible|3
4713394|NCT02944656|7640835|FG001|Overall Study|No longer eligible|0
4713395|NCT02944656|7640834|FG000|Overall Study|Lost to Follow-up|7
4713396|NCT02944656|7640835|FG001|Overall Study|Lost to Follow-up|10
4713397|NCT02944968|7640841|FG000|Overall Study|Subject excluded before study procedure|1
4713398|NCT02944968|7640841|FG000|Overall Study|Subject didn't meet eligibility criteria|2
4713399|NCT02945046|7640848|FG000|Overall Study|Adverse Event|1
4713400|NCT02945046|7640849|FG001|Overall Study|Adverse Event|0
4713401|NCT02945046|7640850|FG002|Overall Study|Adverse Event|2
4405770|NCT00195819|7184118|FG000|Open-label|Moved|0
4405771|NCT00195819|7184119|FG001|Open-label|Moved|1
4405772|NCT00195819|7184118|FG000|Open-label|Withdrawal by Subject|0
4405773|NCT00195819|7184119|FG001|Open-label|Withdrawal by Subject|5
4405774|NCT00196105|7184134|FG000|Overall Study|Lost to Follow-up|4
4405775|NCT00196105|7184135|FG001|Overall Study|Lost to Follow-up|5
4405776|NCT00196105|7184136|FG002|Overall Study|Lost to Follow-up|7
4405777|NCT00196196|7184144|FG000|Overall Study|Withdrawal by Subject|2
4405778|NCT00196196|7184144|FG000|Overall Study|Did not have required condition (hydroce|5
4405779|NCT00196313|7184150|FG000|Overall Study|Protocol Violation|2
4405780|NCT00196313|7184151|FG001|Overall Study|Protocol Violation|3
4405781|NCT00196313|7184150|FG000|Overall Study|Withdrawal by Subject|3
4405782|NCT00196313|7184151|FG001|Overall Study|Withdrawal by Subject|1
4405783|NCT00196313|7184150|FG000|Overall Study|Adverse Event|3
4405784|NCT00196313|7184151|FG001|Overall Study|Adverse Event|1
4405785|NCT00196313|7184150|FG000|Overall Study|Subject Pregnant|1
4405786|NCT00196313|7184151|FG001|Overall Study|Subject Pregnant|1
4405787|NCT00196313|7184150|FG000|Overall Study|Lost to Follow-up|2
4405788|NCT00196313|7184151|FG001|Overall Study|Lost to Follow-up|2
4405789|NCT00196326|7184158|FG000|Overall Study|Did not meet protocol requirements|64
4405790|NCT00196326|7184158|FG000|Overall Study|Non-compliance with the protocol|81
4405791|NCT00196326|7184158|FG000|Overall Study|Physician Decision|3
4405792|NCT00196326|7184158|FG000|Overall Study|Withdrawal by Subject|225
4405793|NCT00196326|7184158|FG000|Overall Study|Adverse Event|253
4405794|NCT00196326|7184158|FG000|Overall Study|Pregnancy|34
4405795|NCT00196326|7184158|FG000|Overall Study|Lost to Follow-up|304
4405796|NCT00196326|7184158|FG000|Overall Study|Other|22
4405797|NCT00196937|7184171|FG000|Overall Study|Serious Adverse Event|1
4405798|NCT00196937|7184172|FG001|Overall Study|Serious Adverse Event|0
4405799|NCT00196937|7184173|FG002|Overall Study|Serious Adverse Event|0
4405800|NCT00196937|7184171|FG000|Overall Study|Non-serious adverse event|1
4405801|NCT00196937|7184172|FG001|Overall Study|Non-serious adverse event|1
4405802|NCT00196937|7184173|FG002|Overall Study|Non-serious adverse event|1
4405803|NCT00196937|7184171|FG000|Overall Study|Withdrawal by Subject|0
4405804|NCT00196937|7184172|FG001|Overall Study|Withdrawal by Subject|0
4405805|NCT00196937|7184173|FG002|Overall Study|Withdrawal by Subject|2
4405806|NCT00196937|7184171|FG000|Overall Study|Lost to Follow-up|4
4405807|NCT00196937|7184172|FG001|Overall Study|Lost to Follow-up|3
4405808|NCT00196937|7184173|FG002|Overall Study|Lost to Follow-up|3
4405809|NCT00196937|7184171|FG000|Overall Study|Other|3
4405810|NCT00196937|7184172|FG001|Overall Study|Other|1
4405811|NCT00196937|7184173|FG002|Overall Study|Other|1
4405812|NCT00196976|7184196|FG000|Primary Study|Migrated from study area|0
4405813|NCT00196976|7184197|FG001|Primary Study|Migrated from study area|0
4405814|NCT00196976|7184198|FG002|Primary Study|Migrated from study area|0
4405815|NCT00196976|7184199|FG003|Primary Study|Migrated from study area|0
4405816|NCT00196976|7184200|FG004|Primary Study|Migrated from study area|0
4405817|NCT00196976|7184201|FG005|Primary Study|Migrated from study area|0
4405818|NCT00196976|7184202|FG006|Primary Study|Migrated from study area|0
4405819|NCT00196976|7184203|FG007|Primary Study|Migrated from study area|1
4405820|NCT00196976|7184204|FG008|Primary Study|Migrated from study area|0
4405821|NCT00196976|7184205|FG009|Primary Study|Migrated from study area|0
4405822|NCT00196976|7184206|FG010|Primary Study|Migrated from study area|0
4405823|NCT00196976|7184207|FG011|Primary Study|Migrated from study area|0
4405824|NCT00196976|7184208|FG012|Primary Study|Migrated from study area|0
4405825|NCT00196976|7184209|FG013|Primary Study|Migrated from study area|0
4405826|NCT00196976|7184196|FG000|Primary Study|Protocol Violation|0
4405827|NCT00196976|7184197|FG001|Primary Study|Protocol Violation|1
4713402|NCT02945046|7640848|FG000|Overall Study|Withdrawal by Subject|3
4405828|NCT00196976|7184198|FG002|Primary Study|Protocol Violation|1
4405829|NCT00196976|7184199|FG003|Primary Study|Protocol Violation|0
4405830|NCT00196976|7184200|FG004|Primary Study|Protocol Violation|0
4405831|NCT00196976|7184201|FG005|Primary Study|Protocol Violation|0
4405832|NCT00196976|7184202|FG006|Primary Study|Protocol Violation|0
4405833|NCT00196976|7184203|FG007|Primary Study|Protocol Violation|0
4405834|NCT00196976|7184204|FG008|Primary Study|Protocol Violation|0
4405835|NCT00196976|7184205|FG009|Primary Study|Protocol Violation|0
4405836|NCT00196976|7184206|FG010|Primary Study|Protocol Violation|0
4405837|NCT00196976|7184207|FG011|Primary Study|Protocol Violation|0
4405838|NCT00196976|7184208|FG012|Primary Study|Protocol Violation|0
4405839|NCT00196976|7184209|FG013|Primary Study|Protocol Violation|0
4405840|NCT00196976|7184196|FG000|Primary Study|Withdrawal by Subject|1
4713403|NCT02945046|7640849|FG001|Overall Study|Withdrawal by Subject|3
4713404|NCT02945046|7640850|FG002|Overall Study|Withdrawal by Subject|3
4713405|NCT02945046|7640848|FG000|Overall Study|Protocol Violation|2
4713406|NCT02945046|7640849|FG001|Overall Study|Protocol Violation|3
4405841|NCT00196976|7184197|FG001|Primary Study|Withdrawal by Subject|0
4405842|NCT00196976|7184198|FG002|Primary Study|Withdrawal by Subject|1
4405843|NCT00196976|7184199|FG003|Primary Study|Withdrawal by Subject|1
4405844|NCT00196976|7184200|FG004|Primary Study|Withdrawal by Subject|2
4405845|NCT00196976|7184201|FG005|Primary Study|Withdrawal by Subject|1
4405846|NCT00196976|7184202|FG006|Primary Study|Withdrawal by Subject|0
4405847|NCT00196976|7184203|FG007|Primary Study|Withdrawal by Subject|0
4405848|NCT00196976|7184204|FG008|Primary Study|Withdrawal by Subject|0
4713407|NCT02945046|7640850|FG002|Overall Study|Protocol Violation|2
4405849|NCT00196976|7184205|FG009|Primary Study|Withdrawal by Subject|1
4405850|NCT00196976|7184206|FG010|Primary Study|Withdrawal by Subject|0
4405851|NCT00196976|7184207|FG011|Primary Study|Withdrawal by Subject|0
4405852|NCT00196976|7184208|FG012|Primary Study|Withdrawal by Subject|0
4405853|NCT00196976|7184209|FG013|Primary Study|Withdrawal by Subject|0
4405854|NCT00196976|7184196|FG000|Primary Study|Lost to Follow-up|0
4405855|NCT00196976|7184197|FG001|Primary Study|Lost to Follow-up|0
4405856|NCT00196976|7184198|FG002|Primary Study|Lost to Follow-up|0
4405857|NCT00196976|7184199|FG003|Primary Study|Lost to Follow-up|0
4405858|NCT00196976|7184200|FG004|Primary Study|Lost to Follow-up|1
4405859|NCT00196976|7184201|FG005|Primary Study|Lost to Follow-up|1
4405860|NCT00196976|7184202|FG006|Primary Study|Lost to Follow-up|0
4405861|NCT00196976|7184203|FG007|Primary Study|Lost to Follow-up|2
4405862|NCT00196976|7184204|FG008|Primary Study|Lost to Follow-up|0
4405863|NCT00196976|7184205|FG009|Primary Study|Lost to Follow-up|0
4405864|NCT00196976|7184206|FG010|Primary Study|Lost to Follow-up|0
4405865|NCT00196976|7184207|FG011|Primary Study|Lost to Follow-up|0
4405866|NCT00196976|7184208|FG012|Primary Study|Lost to Follow-up|0
4405867|NCT00196976|7184209|FG013|Primary Study|Lost to Follow-up|0
4629009|NCT01867671|7496615|FG001|Overall Study|Anaphylaxis|1
4629010|NCT01867671|7496614|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2
4405868|NCT00196976|7184196|FG000|Primary Study|Other|0
4405869|NCT00196976|7184197|FG001|Primary Study|Other|0
4405870|NCT00196976|7184198|FG002|Primary Study|Other|2
4405871|NCT00196976|7184199|FG003|Primary Study|Other|0
4405872|NCT00196976|7184200|FG004|Primary Study|Other|0
4405873|NCT00196976|7184201|FG005|Primary Study|Other|0
4405874|NCT00196976|7184202|FG006|Primary Study|Other|0
4405875|NCT00196976|7184203|FG007|Primary Study|Other|0
4405876|NCT00196976|7184204|FG008|Primary Study|Other|0
4405877|NCT00196976|7184205|FG009|Primary Study|Other|0
4405878|NCT00196976|7184206|FG010|Primary Study|Other|0
4405879|NCT00196976|7184207|FG011|Primary Study|Other|0
4405880|NCT00196976|7184208|FG012|Primary Study|Other|0
4405881|NCT00196976|7184209|FG013|Primary Study|Other|0
4405882|NCT00196976|7184196|FG000|Booster Study|Withdrawal by Subject|0
4405883|NCT00196976|7184197|FG001|Booster Study|Withdrawal by Subject|0
4405884|NCT00196976|7184198|FG002|Booster Study|Withdrawal by Subject|0
4405885|NCT00196976|7184199|FG003|Booster Study|Withdrawal by Subject|0
4405886|NCT00196976|7184200|FG004|Booster Study|Withdrawal by Subject|0
4405887|NCT00196976|7184201|FG005|Booster Study|Withdrawal by Subject|0
4405888|NCT00196976|7184202|FG006|Booster Study|Withdrawal by Subject|0
4405889|NCT00196976|7184203|FG007|Booster Study|Withdrawal by Subject|0
4405890|NCT00196976|7184204|FG008|Booster Study|Withdrawal by Subject|0
4405891|NCT00196976|7184205|FG009|Booster Study|Withdrawal by Subject|0
4405892|NCT00196976|7184206|FG010|Booster Study|Withdrawal by Subject|1
4405893|NCT00196976|7184207|FG011|Booster Study|Withdrawal by Subject|0
4405894|NCT00196976|7184208|FG012|Booster Study|Withdrawal by Subject|0
4405895|NCT00196976|7184209|FG013|Booster Study|Withdrawal by Subject|0
4405896|NCT00196976|7184196|FG000|Booster Study|Lost to Follow-up|0
4405897|NCT00196976|7184197|FG001|Booster Study|Lost to Follow-up|0
4405898|NCT00196976|7184198|FG002|Booster Study|Lost to Follow-up|0
4405899|NCT00196976|7184199|FG003|Booster Study|Lost to Follow-up|0
4405900|NCT00196976|7184200|FG004|Booster Study|Lost to Follow-up|0
4405901|NCT00196976|7184201|FG005|Booster Study|Lost to Follow-up|0
4405902|NCT00196976|7184202|FG006|Booster Study|Lost to Follow-up|0
4405903|NCT00196976|7184203|FG007|Booster Study|Lost to Follow-up|0
4405904|NCT00196976|7184204|FG008|Booster Study|Lost to Follow-up|0
4405905|NCT00196976|7184205|FG009|Booster Study|Lost to Follow-up|0
4405906|NCT00196976|7184206|FG010|Booster Study|Lost to Follow-up|1
4405907|NCT00196976|7184207|FG011|Booster Study|Lost to Follow-up|2
4405908|NCT00196976|7184208|FG012|Booster Study|Lost to Follow-up|0
4405909|NCT00196976|7184209|FG013|Booster Study|Lost to Follow-up|0
4405910|NCT00197002|7184252|FG000|Overall Study|Adverse Event|0
4405911|NCT00197002|7184253|FG001|Overall Study|Adverse Event|1
4405912|NCT00197002|7184254|FG002|Overall Study|Adverse Event|0
4405913|NCT00197002|7184252|FG000|Overall Study|Protocol Violation|1
4405914|NCT00197002|7184253|FG001|Overall Study|Protocol Violation|0
4405915|NCT00197002|7184254|FG002|Overall Study|Protocol Violation|2
4405916|NCT00197002|7184252|FG000|Overall Study|Withdrawal by Subject|9
4405917|NCT00197002|7184253|FG001|Overall Study|Withdrawal by Subject|5
4405918|NCT00197002|7184254|FG002|Overall Study|Withdrawal by Subject|7
4405919|NCT00197002|7184252|FG000|Overall Study|Migrated/moved from study area|3
4405920|NCT00197002|7184253|FG001|Overall Study|Migrated/moved from study area|5
4405921|NCT00197002|7184254|FG002|Overall Study|Migrated/moved from study area|1
4405922|NCT00197002|7184252|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4
4405923|NCT00197002|7184253|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4
4405924|NCT00197002|7184254|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5
4405925|NCT00197002|7184252|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2
4405926|NCT00197002|7184253|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2
4405927|NCT00197002|7184254|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1
4405928|NCT00197002|7184252|FG000|Overall Study|Others|3
4405929|NCT00197002|7184253|FG001|Overall Study|Others|1
4405930|NCT00197002|7184254|FG002|Overall Study|Others|1
4405931|NCT00197015|7184268|FG000|Overall Study|Adverse Event|3
4405932|NCT00197015|7184269|FG001|Overall Study|Adverse Event|0
4405933|NCT00197015|7184270|FG002|Overall Study|Adverse Event|1
4405934|NCT00197015|7184268|FG000|Overall Study|Protocol Violation|0
4405935|NCT00197015|7184269|FG001|Overall Study|Protocol Violation|3
4405936|NCT00197015|7184270|FG002|Overall Study|Protocol Violation|3
4405937|NCT00197015|7184268|FG000|Overall Study|Withdrawal by Subject|17
4405938|NCT00197015|7184269|FG001|Overall Study|Withdrawal by Subject|37
4405939|NCT00197015|7184270|FG002|Overall Study|Withdrawal by Subject|34
4405940|NCT00197015|7184268|FG000|Overall Study|Lost to Follow-up|28
4405941|NCT00197015|7184269|FG001|Overall Study|Lost to Follow-up|46
4405942|NCT00197015|7184270|FG002|Overall Study|Lost to Follow-up|37
4405943|NCT00197015|7184268|FG000|Overall Study|Other|2
4405944|NCT00197015|7184269|FG001|Overall Study|Other|3
4405945|NCT00197015|7184270|FG002|Overall Study|Other|2
4405946|NCT00197028|7184280|FG000|Overall Study|Adverse Event|2
4405947|NCT00197028|7184281|FG001|Overall Study|Adverse Event|2
4405948|NCT00197028|7184280|FG000|Overall Study|Protocol Violation|2
4405949|NCT00197028|7184281|FG001|Overall Study|Protocol Violation|1
4405950|NCT00197028|7184280|FG000|Overall Study|Withdrawal by Subject|8
4405951|NCT00197028|7184281|FG001|Overall Study|Withdrawal by Subject|12
4405952|NCT00197028|7184280|FG000|Overall Study|Lost to Follow-up|1
4405953|NCT00197028|7184281|FG001|Overall Study|Lost to Follow-up|0
4405954|NCT00197028|7184280|FG000|Overall Study|Other|3
4405955|NCT00197028|7184281|FG001|Overall Study|Other|6
4405956|NCT00197054|7184290|FG000|Overall Study|Withdrawal by Subject|9
4405957|NCT00197054|7184291|FG001|Overall Study|Withdrawal by Subject|3
4405958|NCT00197054|7184292|FG002|Overall Study|Withdrawal by Subject|3
4405959|NCT00197054|7184290|FG000|Overall Study|Moved from area|7
4405960|NCT00197054|7184291|FG001|Overall Study|Moved from area|14
4405961|NCT00197054|7184292|FG002|Overall Study|Moved from area|9
4405962|NCT00197054|7184290|FG000|Overall Study|Lost to Follow-up|1
4405963|NCT00197054|7184291|FG001|Overall Study|Lost to Follow-up|4
4405964|NCT00197054|7184292|FG002|Overall Study|Lost to Follow-up|0
4405965|NCT00197106|7184312|FG000|4-Week Run-In Period|Did not meet entry criteria|99
4405966|NCT00197106|7184313|FG001|4-Week Run-In Period|Did not meet entry criteria|0
4405967|NCT00197106|7184314|FG002|4-Week Run-In Period|Did not meet entry criteria|0
4405968|NCT00197106|7184312|FG000|Overall Treatment Period|Lack of Efficacy|0
4405969|NCT00197106|7184313|FG001|Overall Treatment Period|Lack of Efficacy|1
4405970|NCT00197106|7184314|FG002|Overall Treatment Period|Lack of Efficacy|0
4405971|NCT00197106|7184312|FG000|Overall Treatment Period|Lost to Follow-up|0
4405972|NCT00197106|7184313|FG001|Overall Treatment Period|Lost to Follow-up|0
4405973|NCT00197106|7184314|FG002|Overall Treatment Period|Lost to Follow-up|2
4405974|NCT00197106|7184312|FG000|Overall Treatment Period|Protocol Violation|0
4405975|NCT00197106|7184313|FG001|Overall Treatment Period|Protocol Violation|0
4405976|NCT00197106|7184314|FG002|Overall Treatment Period|Protocol Violation|2
4405977|NCT00197106|7184312|FG000|Overall Treatment Period|Withdrawal by Subject|0
4405978|NCT00197106|7184313|FG001|Overall Treatment Period|Withdrawal by Subject|0
4405979|NCT00197106|7184314|FG002|Overall Treatment Period|Withdrawal by Subject|2
4405980|NCT00197145|7184331|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1
4405981|NCT00197145|7184332|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1
4405982|NCT00197145|7184331|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10
4405983|NCT00197145|7184332|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8
4405984|NCT00197145|7184331|FG000|Period 1: Randomized Treatment Phase|Other|2
4405985|NCT00197145|7184332|FG001|Period 1: Randomized Treatment Phase|Other|2
4405986|NCT00197145|7184331|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1
4405987|NCT00197145|7184332|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0
4405988|NCT00197145|7184331|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3
4405989|NCT00197145|7184332|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0
4405990|NCT00197145|7184331|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2
4405991|NCT00197145|7184332|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0
4405992|NCT00197145|7184331|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3
4405993|NCT00197145|7184332|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0
4405994|NCT00197145|7184331|FG000|Period 2 : Open Label Phase|Other|1
4405995|NCT00197145|7184332|FG001|Period 2 : Open Label Phase|Other|0
4405996|NCT00197236|7184351|FG000|Overall Study|Adverse Event|1
4405997|NCT00197236|7184352|FG001|Overall Study|Adverse Event|0
4405998|NCT00197236|7184353|FG002|Overall Study|Adverse Event|1
4405999|NCT00197236|7184351|FG000|Overall Study|Lost to Follow-up|5
4406000|NCT00197236|7184352|FG001|Overall Study|Lost to Follow-up|14
4406001|NCT00197236|7184353|FG002|Overall Study|Lost to Follow-up|6
4406002|NCT00197236|7184351|FG000|Overall Study|Protocol Violation|0
4406003|NCT00197236|7184352|FG001|Overall Study|Protocol Violation|0
4406004|NCT00197236|7184353|FG002|Overall Study|Protocol Violation|1
4406005|NCT00197236|7184351|FG000|Overall Study|Withdrawal by Subject|7
4406006|NCT00197236|7184352|FG001|Overall Study|Withdrawal by Subject|3
4406007|NCT00197236|7184353|FG002|Overall Study|Withdrawal by Subject|11
4406008|NCT00197236|7184351|FG000|Overall Study|Study drug/medication expiration|1
4406009|NCT00197236|7184352|FG001|Overall Study|Study drug/medication expiration|0
4406010|NCT00197236|7184353|FG002|Overall Study|Study drug/medication expiration|3
4406011|NCT00197236|7184351|FG000|Overall Study|Returned out of specified time window|0
4406012|NCT00197236|7184352|FG001|Overall Study|Returned out of specified time window|0
4406013|NCT00197236|7184353|FG002|Overall Study|Returned out of specified time window|1
4406014|NCT00197496|7184391|FG000|Baseline to Discharge|not interested|1
4406015|NCT00197496|7184392|FG001|Baseline to Discharge|not interested|0
4406016|NCT00197496|7184391|FG000|Baseline to Discharge|MRSA|1
4406017|NCT00197496|7184392|FG001|Baseline to Discharge|MRSA|0
4406018|NCT00197496|7184391|FG000|Baseline to Discharge|Physician Decision|0
4406019|NCT00197496|7184392|FG001|Baseline to Discharge|Physician Decision|1
4406020|NCT00197496|7184391|FG000|Baseline to Discharge|Protocol Violation|0
4406021|NCT00197496|7184392|FG001|Baseline to Discharge|Protocol Violation|1
4406022|NCT00197496|7184391|FG000|Follow-up|Lost to Follow-up|2
4406023|NCT00197496|7184392|FG001|Follow-up|Lost to Follow-up|1
4406024|NCT00198029|7184398|FG000|Overall Study|Withdrawal by Subject|4
4406025|NCT00198107|7184422|FG000|Double-Blind Period|Adverse Event|1
4406026|NCT00198107|7184423|FG001|Double-Blind Period|Adverse Event|1
4406027|NCT00198107|7184424|FG002|Double-Blind Period|Adverse Event|0
4406028|NCT00198107|7184422|FG000|Double-Blind Period|Lack of Efficacy|2
4406029|NCT00198107|7184423|FG001|Double-Blind Period|Lack of Efficacy|0
4406030|NCT00198107|7184424|FG002|Double-Blind Period|Lack of Efficacy|0
4406031|NCT00198107|7184422|FG000|Double-Blind Period|Lost to Follow-up|2
4406032|NCT00198107|7184423|FG001|Double-Blind Period|Lost to Follow-up|1
4406033|NCT00198107|7184424|FG002|Double-Blind Period|Lost to Follow-up|0
4406034|NCT00198107|7184422|FG000|Double-Blind Period|Physician Decision|1
4406035|NCT00198107|7184423|FG001|Double-Blind Period|Physician Decision|0
4406036|NCT00198107|7184424|FG002|Double-Blind Period|Physician Decision|0
4406037|NCT00198107|7184422|FG000|Double-Blind Period|Withdrawal by Subject|0
4406038|NCT00198107|7184423|FG001|Double-Blind Period|Withdrawal by Subject|1
4406039|NCT00198107|7184424|FG002|Double-Blind Period|Withdrawal by Subject|0
4406040|NCT00198107|7184422|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0
4406041|NCT00198107|7184423|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0
4406042|NCT00198107|7184424|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2
4406043|NCT00198133|7184434|FG000|Overall Study|Disease progression|2
4406044|NCT00198133|7184435|FG001|Overall Study|Disease progression|5
4406045|NCT00198133|7184434|FG000|Overall Study|Adverse Event|1
4406046|NCT00198133|7184435|FG001|Overall Study|Adverse Event|3
4406047|NCT00198133|7184434|FG000|Overall Study|Withdrawal by Subject|1
4406048|NCT00198133|7184435|FG001|Overall Study|Withdrawal by Subject|0
4406049|NCT00198133|7184434|FG000|Overall Study|Physician Decision|1
4406050|NCT00198133|7184435|FG001|Overall Study|Physician Decision|0
4406051|NCT00198822|7184444|FG000|Overall Study|Lost to Follow-up|14
4406052|NCT00198822|7184445|FG001|Overall Study|Lost to Follow-up|20
4406053|NCT00198822|7184446|FG002|Overall Study|Lost to Follow-up|21
4406054|NCT00199381|7184454|FG000|Overall Study|Withdrawal by Subject|38
4406055|NCT00199381|7184454|FG000|Overall Study|Adverse Event|73
4406056|NCT00199381|7184454|FG000|Overall Study|Protocol Violation|6
4406057|NCT00199381|7184454|FG000|Overall Study|Lack of Efficacy|27
4406058|NCT00199381|7184454|FG000|Overall Study|Not including due to early termination|37
4406059|NCT00199381|7184454|FG000|Overall Study|Study termination by Sponsor|323
4406060|NCT00199797|7184458|FG000|Overall Study|Progressive Disease|1
4406061|NCT00199797|7184458|FG000|Overall Study|Adverse Event|1
4406062|NCT00199797|7184458|FG000|Overall Study|Physician Decision|1
4406063|NCT00199836|7184463|FG000|Overall Study|Progressive Disease|5
4406064|NCT00199836|7184463|FG000|Overall Study|Death|1
4406065|NCT00199849|7184471|FG000|Overall Study|Unrelated illness or complication|0
4406066|NCT00199849|7184472|FG001|Overall Study|Unrelated illness or complication|1
4406067|NCT00199849|7184473|FG002|Overall Study|Unrelated illness or complication|0
4406068|NCT00199849|7184471|FG000|Overall Study|Progressive disease requiring intervention|0
4590349|NCT01520506|7436233|FG000|Overall Study|Missed Visit|4
4590350|NCT01520506|7436233|FG000|Overall Study|Lost to Follow-up|1
4590351|NCT01520506|7436233|FG000|Overall Study|Withdrawal by Subject|1
4406069|NCT00199849|7184472|FG001|Overall Study|Progressive disease requiring intervention|0
4406070|NCT00199849|7184473|FG002|Overall Study|Progressive disease requiring intervention|1
4406071|NCT00199849|7184471|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0
4406072|NCT00199849|7184472|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0
4406073|NCT00199849|7184473|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1
4406074|NCT00199875|7184486|FG000|Overall Study|Withdrawal by Subject|0
4406075|NCT00199875|7184487|FG001|Overall Study|Withdrawal by Subject|0
4406076|NCT00199875|7184488|FG002|Overall Study|Withdrawal by Subject|0
4406077|NCT00199875|7184489|FG003|Overall Study|Withdrawal by Subject|0
4406078|NCT00199875|7184490|FG004|Overall Study|Withdrawal by Subject|1
4406079|NCT00199888|7184502|FG000|Overall Study|Lost to Follow-up|1
4406080|NCT00199901|7184508|FG000|Overall Study|Protocol Violation|2
4406081|NCT00199901|7184509|FG001|Overall Study|Protocol Violation|0
4406082|NCT00199901|7184508|FG000|Overall Study|Withdrawal by Subject|1
4406083|NCT00199901|7184509|FG001|Overall Study|Withdrawal by Subject|0
4406084|NCT00199901|7184508|FG000|Overall Study|Progressive Disease|24
4406085|NCT00199901|7184509|FG001|Overall Study|Progressive Disease|24
4406086|NCT00200057|7184526|FG000|Overall Study|Lack of Efficacy|3
4406087|NCT00200057|7184526|FG000|Overall Study|Exited due to terminal illness of PI|2
4406088|NCT00200057|7184526|FG000|Overall Study|Withdrawal by Subject|1
4406089|NCT00200057|7184526|FG000|Overall Study|Change in medical condition|1
4406090|NCT00200057|7184526|FG000|Overall Study|Infection|1
4406091|NCT00200057|7184526|FG000|Overall Study|Death|1
4406092|NCT00200356|7184554|FG000|Overall Study|Lack of Efficacy|3
4406093|NCT00200356|7184555|FG001|Overall Study|Lack of Efficacy|3
4406094|NCT00200356|7184554|FG000|Overall Study|Protocol Violation|4
4406095|NCT00200356|7184555|FG001|Overall Study|Protocol Violation|4
4406096|NCT00200356|7184554|FG000|Overall Study|Nontreatment|1
4406097|NCT00200356|7184555|FG001|Overall Study|Nontreatment|0
4406098|NCT00200850|7184573|FG000|Overall Study|relocation|1
4406099|NCT00200850|7184574|FG001|Overall Study|relocation|0
4406100|NCT00200850|7184575|FG002|Overall Study|relocation|1
4406101|NCT00200850|7184573|FG000|Overall Study|too busy|1
4406102|NCT00200850|7184574|FG001|Overall Study|too busy|0
4406103|NCT00200850|7184575|FG002|Overall Study|too busy|0
4406104|NCT00200850|7184573|FG000|Overall Study|Pregnancy|0
4406105|NCT00200850|7184574|FG001|Overall Study|Pregnancy|0
4406106|NCT00200850|7184575|FG002|Overall Study|Pregnancy|1
4406107|NCT00200850|7184573|FG000|Overall Study|Poor adherence|0
4406108|NCT00200850|7184574|FG001|Overall Study|Poor adherence|0
4406109|NCT00200850|7184575|FG002|Overall Study|Poor adherence|1
4406110|NCT00200850|7184573|FG000|Overall Study|optic neuritis|0
4406111|NCT00200850|7184574|FG001|Overall Study|optic neuritis|0
4406112|NCT00200850|7184575|FG002|Overall Study|optic neuritis|1
4406113|NCT00200850|7184573|FG000|Overall Study|Adverse Event|1
4406114|NCT00200850|7184574|FG001|Overall Study|Adverse Event|1
4406115|NCT00200850|7184575|FG002|Overall Study|Adverse Event|2
4406116|NCT00200967|7184604|FG000|First Treatment Period|Withdrawal by Subject|5
4406117|NCT00200967|7184605|FG001|First Treatment Period|Withdrawal by Subject|1
4406118|NCT00200967|7184604|FG000|First Treatment Period|Pregnancy|1
4406119|NCT00200967|7184605|FG001|First Treatment Period|Pregnancy|0
4406120|NCT00200967|7184604|FG000|Wash-out Period|Lost to Follow-up|0
4406121|NCT00200967|7184605|FG001|Wash-out Period|Lost to Follow-up|1
4406122|NCT00200967|7184604|FG000|Second Treatment Period|Withdrawal by Subject|1
4406123|NCT00200967|7184605|FG001|Second Treatment Period|Withdrawal by Subject|2
4406124|NCT00200967|7184604|FG000|Run-out Period|Lost to Follow-up|1
4406125|NCT00200967|7184605|FG001|Run-out Period|Lost to Follow-up|0
4406126|NCT00201006|7184614|FG000|Overall Study|Withdrawal by Subject|7
4406127|NCT00201006|7184615|FG001|Overall Study|Withdrawal by Subject|2
4406128|NCT00201006|7184616|FG002|Overall Study|Withdrawal by Subject|3
4406129|NCT00201006|7184614|FG000|Overall Study|Adverse Event|1
4406130|NCT00201006|7184615|FG001|Overall Study|Adverse Event|0
4406131|NCT00201006|7184616|FG002|Overall Study|Adverse Event|1
4406132|NCT00201201|7184643|FG000|Overall Study|Death|0
4406133|NCT00201201|7184644|FG001|Overall Study|Death|2
4406134|NCT00201201|7184643|FG000|Overall Study|Withdrawal by Subject|5
4406135|NCT00201201|7184644|FG001|Overall Study|Withdrawal by Subject|5
4511415|NCT00926393|7320428|FG001|Overall Study|Adverse Event|1
4511416|NCT00926536|7320445|FG000|Overall Study|Physician Decision|1
4511417|NCT00926536|7320446|FG001|Overall Study|Physician Decision|2
4511418|NCT00926783|7320463|FG000|Overall Study|Incomplete CFAE Procedures|3
4511419|NCT00926783|7320464|FG001|Overall Study|Incomplete CFAE Procedures|3
4511420|NCT00926796|7320472|FG000|Overall Study|Did not receive randomized treatment|4
4511421|NCT00926796|7320473|FG001|Overall Study|Did not receive randomized treatment|7
4511422|NCT00926796|7320472|FG000|Overall Study|Ineligible, negative for gonorrhea|57
4511423|NCT00926796|7320473|FG001|Overall Study|Ineligible, negative for gonorrhea|60
4511424|NCT00926796|7320472|FG000|Overall Study|Ineligible, but positive for gonorrhea|1
4511425|NCT00926796|7320473|FG001|Overall Study|Ineligible, but positive for gonorrhea|1
4511426|NCT00926796|7320472|FG000|Overall Study|Adverse Event|7
4511427|NCT00926796|7320473|FG001|Overall Study|Adverse Event|14
4511428|NCT00926796|7320472|FG000|Overall Study|Lost to Follow-up|22
4511429|NCT00926796|7320473|FG001|Overall Study|Lost to Follow-up|13
4511430|NCT00926796|7320472|FG000|Overall Study|Protocol Violation|15
4511431|NCT00926796|7320473|FG001|Overall Study|Protocol Violation|11
4511432|NCT00926796|7320472|FG000|Overall Study|Withdrawal by Subject|1
4511433|NCT00926796|7320473|FG001|Overall Study|Withdrawal by Subject|0
4511434|NCT00927069|7320515|FG000|Week 0 to Week 12|Worsening of psoriasis|1
4511435|NCT00927069|7320516|FG001|Week 0 to Week 12|Worsening of psoriasis|1
4511436|NCT00927069|7320517|FG002|Week 0 to Week 12|Worsening of psoriasis|0
4511437|NCT00927069|7320518|FG003|Week 0 to Week 12|Worsening of psoriasis|0
4511438|NCT00927069|7320515|FG000|Week 12 to Week 24|Lack of Efficacy|0
4511439|NCT00927069|7320516|FG001|Week 12 to Week 24|Lack of Efficacy|0
4511440|NCT00927069|7320517|FG002|Week 12 to Week 24|Lack of Efficacy|2
4511441|NCT00927069|7320518|FG003|Week 12 to Week 24|Lack of Efficacy|3
4511442|NCT00927069|7320515|FG000|Week 12 to Week 24|Lost to Follow-up|0
4511443|NCT00927069|7320516|FG001|Week 12 to Week 24|Lost to Follow-up|0
4511444|NCT00927069|7320517|FG002|Week 12 to Week 24|Lost to Follow-up|1
4511445|NCT00927069|7320518|FG003|Week 12 to Week 24|Lost to Follow-up|0
4511446|NCT00927069|7320515|FG000|Week 12 to Week 24|Withdrawal by Subject|1
4511447|NCT00927069|7320516|FG001|Week 12 to Week 24|Withdrawal by Subject|0
4511448|NCT00927069|7320517|FG002|Week 12 to Week 24|Withdrawal by Subject|0
4511449|NCT00927069|7320518|FG003|Week 12 to Week 24|Withdrawal by Subject|0
4511450|NCT00927069|7320515|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1
4511451|NCT00927069|7320516|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0
4511452|NCT00927069|7320517|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0
4511453|NCT00927069|7320518|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0
4406136|NCT00201643|7184677|FG000|Overall Study|Withdrawal by Subject|5
4406137|NCT00201643|7184678|FG001|Overall Study|Withdrawal by Subject|4
4406138|NCT00201851|7184732|FG000|Overall Study|Lost to Follow-up|2
4406139|NCT00201851|7184733|FG001|Overall Study|Lost to Follow-up|1
4406140|NCT00201851|7184734|FG002|Overall Study|Lost to Follow-up|0
4406141|NCT00201851|7184732|FG000|Overall Study|Ineligible post enrollment|6
4406142|NCT00201851|7184733|FG001|Overall Study|Ineligible post enrollment|1
4406143|NCT00201851|7184734|FG002|Overall Study|Ineligible post enrollment|1
4406144|NCT00202644|7184768|FG000|Overall Study|Adverse Event|12
4406145|NCT00202644|7184769|FG001|Overall Study|Adverse Event|13
4406146|NCT00202644|7184768|FG000|Overall Study|Withdrawal by Subject|8
4406147|NCT00202644|7184769|FG001|Overall Study|Withdrawal by Subject|6
4406148|NCT00202644|7184768|FG000|Overall Study|Lack of Efficacy|6
4406149|NCT00202644|7184769|FG001|Overall Study|Lack of Efficacy|6
4406150|NCT00202644|7184768|FG000|Overall Study|Lost to Follow-up|0
4406151|NCT00202644|7184769|FG001|Overall Study|Lost to Follow-up|1
4406152|NCT00202644|7184768|FG000|Overall Study|Other|9
4406153|NCT00202644|7184769|FG001|Overall Study|Other|1
4406154|NCT00202839|7184782|FG000|Overall Study|Adverse Event|1
4406155|NCT00202839|7184783|FG001|Overall Study|Adverse Event|5
4406156|NCT00202839|7184782|FG000|Overall Study|Physician Decision|12
4406157|NCT00202839|7184783|FG001|Overall Study|Physician Decision|0
4406158|NCT00202839|7184782|FG000|Overall Study|Withdrawal by Subject|6
4406159|NCT00202839|7184783|FG001|Overall Study|Withdrawal by Subject|2
4406160|NCT00202839|7184782|FG000|Overall Study|Protocol Violation|2
4406161|NCT00202839|7184783|FG001|Overall Study|Protocol Violation|1
4406162|NCT00202839|7184782|FG000|Overall Study|Lost to Follow-up|3
4406163|NCT00202839|7184783|FG001|Overall Study|Lost to Follow-up|2
4406164|NCT00203021|7184795|FG000|Overall Study|Death|4
4406165|NCT00203021|7184796|FG001|Overall Study|Death|1
4406166|NCT00203021|7184795|FG000|Overall Study|Adverse Event|10
4406167|NCT00203021|7184796|FG001|Overall Study|Adverse Event|5
4406168|NCT00203021|7184795|FG000|Overall Study|Withdrawal by Subject|45
4406169|NCT00203021|7184796|FG001|Overall Study|Withdrawal by Subject|48
4406170|NCT00203021|7184795|FG000|Overall Study|Lost to Follow-up|9
4406171|NCT00203021|7184796|FG001|Overall Study|Lost to Follow-up|7
4406172|NCT00203021|7184795|FG000|Overall Study|Other than specified|11
4406173|NCT00203021|7184796|FG001|Overall Study|Other than specified|16
4406174|NCT00203047|7184804|FG000|Overall Study|Ongoing: in database - January 29, 2009|131
4406175|NCT00203047|7184805|FG001|Overall Study|Ongoing: in database - January 29, 2009|109
4406176|NCT00203047|7184804|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5
4406177|NCT00203047|7184805|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1
4406178|NCT00203047|7184804|FG000|Overall Study|Withdrawal by Subject|13
4406179|NCT00203047|7184805|FG001|Overall Study|Withdrawal by Subject|47
4406180|NCT00203047|7184804|FG000|Overall Study|Teva requested participant withdrawal|1
4406181|NCT00203047|7184805|FG001|Overall Study|Teva requested participant withdrawal|1
4406182|NCT00203047|7184804|FG000|Overall Study|Physician Decision|8
4406183|NCT00203047|7184805|FG001|Overall Study|Physician Decision|7
4406184|NCT00203047|7184804|FG000|Overall Study|Non-compliance|4
4406185|NCT00203047|7184805|FG001|Overall Study|Non-compliance|8
4406186|NCT00203047|7184804|FG000|Overall Study|Protocol Violation|1
4406187|NCT00203047|7184805|FG001|Overall Study|Protocol Violation|0
4406188|NCT00203047|7184804|FG000|Overall Study|Lost to Follow-up|11
4406189|NCT00203047|7184805|FG001|Overall Study|Lost to Follow-up|5
4406190|NCT00203047|7184804|FG000|Overall Study|Adverse Event|8
4406191|NCT00203047|7184805|FG001|Overall Study|Adverse Event|18
4406192|NCT00203047|7184804|FG000|Overall Study|Death|1
4406193|NCT00203047|7184805|FG001|Overall Study|Death|2
4406194|NCT00203047|7184804|FG000|Overall Study|Pregnancy|3
4406195|NCT00203047|7184805|FG001|Overall Study|Pregnancy|0
4406196|NCT00203047|7184804|FG000|Overall Study|Other|5
4406197|NCT00203047|7184805|FG001|Overall Study|Other|5
4406198|NCT00203242|7184833|FG000|Overall Study|Lost to Follow-up|1
4406199|NCT00203268|7184837|FG000|Early Treatment|only treated one headache|2
4406200|NCT00203268|7184837|FG000|Early Treatment|Lost to Follow-up|1
4406201|NCT00203268|7184837|FG000|Early Treatment|Withdrawal by Subject|1
4406202|NCT00203294|7184845|FG000|Overall Study|Withdrawal by Subject|8
4406203|NCT00203294|7184846|FG001|Overall Study|Withdrawal by Subject|13
4406204|NCT00203307|7184854|FG000|First Intervention|Adverse Event|2
4406205|NCT00203307|7184855|FG001|First Intervention|Adverse Event|0
4406206|NCT00203411|7184861|FG000|Follow-up|Progressive Disease|4
4406207|NCT00203424|7184866|FG000|Treatment Period|Withdrawal by Subject|4
4406208|NCT00203424|7184866|FG000|Treatment Period|Adverse Event|5
4406209|NCT00203424|7184866|FG000|Treatment Period|progressive disease|2
4406210|NCT00203424|7184866|FG000|Follow-up Period|Withdrawal by Subject|1
4629011|NCT01867671|7496615|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0
4629012|NCT01867671|7496614|FG000|Overall Study|Lost to Follow-up|0
4629013|NCT01867671|7496615|FG001|Overall Study|Lost to Follow-up|1
4406211|NCT00203424|7184866|FG000|Follow-up Period|progressive disease|4
4629014|NCT01867671|7496614|FG000|Overall Study|Non-compliance with Study Drug|1
4406212|NCT00203424|7184866|FG000|Follow-up Period|Lost to Follow-up|1
4406213|NCT00203476|7184873|FG000|Overall Study|Lost to Follow-up|1
4406214|NCT00203476|7184874|FG001|Overall Study|Lost to Follow-up|0
4406215|NCT00203476|7184875|FG002|Overall Study|Lost to Follow-up|0
4406216|NCT00203476|7184873|FG000|Overall Study|Withdrawal by Subject|0
4406217|NCT00203476|7184874|FG001|Overall Study|Withdrawal by Subject|1
4406218|NCT00203476|7184875|FG002|Overall Study|Withdrawal by Subject|0
4406219|NCT00203502|7184883|FG000|Overall Study|Death|1
4406220|NCT00203892|7184890|FG000|Overall Study|Physician Decision|1
4406221|NCT00203892|7184891|FG001|Overall Study|Physician Decision|2
4406222|NCT00203892|7184892|FG002|Overall Study|Physician Decision|0
4406223|NCT00203892|7184890|FG000|Overall Study|Death|1
4406224|NCT00203892|7184891|FG001|Overall Study|Death|0
4406225|NCT00203892|7184892|FG002|Overall Study|Death|0
4406226|NCT00203996|7184919|FG000|Overall Study|Lost to Follow-up|0
4406227|NCT00203996|7184920|FG001|Overall Study|Lost to Follow-up|0
4406228|NCT00203996|7184921|FG002|Overall Study|Lost to Follow-up|0
4406229|NCT00203996|7184922|FG003|Overall Study|Lost to Follow-up|1
4406230|NCT00203996|7184923|FG004|Overall Study|Lost to Follow-up|0
4406231|NCT00203996|7184924|FG005|Overall Study|Lost to Follow-up|0
4406232|NCT00203996|7184925|FG006|Overall Study|Lost to Follow-up|0
4406233|NCT00203996|7184926|FG007|Overall Study|Lost to Follow-up|0
4406234|NCT00203996|7184927|FG008|Overall Study|Lost to Follow-up|0
4406235|NCT00203996|7184928|FG009|Overall Study|Lost to Follow-up|0
4406236|NCT00203996|7184919|FG000|Overall Study|Protocol Violation|0
4406237|NCT00203996|7184920|FG001|Overall Study|Protocol Violation|0
4406238|NCT00203996|7184921|FG002|Overall Study|Protocol Violation|0
4406239|NCT00203996|7184922|FG003|Overall Study|Protocol Violation|6
4406240|NCT00203996|7184923|FG004|Overall Study|Protocol Violation|1
4406241|NCT00203996|7184924|FG005|Overall Study|Protocol Violation|0
4406242|NCT00203996|7184925|FG006|Overall Study|Protocol Violation|0
4406243|NCT00203996|7184926|FG007|Overall Study|Protocol Violation|0
4406244|NCT00203996|7184927|FG008|Overall Study|Protocol Violation|0
4406245|NCT00203996|7184928|FG009|Overall Study|Protocol Violation|0
4406246|NCT00203996|7184919|FG000|Overall Study|Physician Decision|0
4406247|NCT00203996|7184920|FG001|Overall Study|Physician Decision|0
4406248|NCT00203996|7184921|FG002|Overall Study|Physician Decision|0
4406249|NCT00203996|7184922|FG003|Overall Study|Physician Decision|2
4406250|NCT00203996|7184923|FG004|Overall Study|Physician Decision|0
4406251|NCT00203996|7184924|FG005|Overall Study|Physician Decision|0
4406252|NCT00203996|7184925|FG006|Overall Study|Physician Decision|0
4406253|NCT00203996|7184926|FG007|Overall Study|Physician Decision|0
4406254|NCT00203996|7184927|FG008|Overall Study|Physician Decision|0
4406255|NCT00203996|7184928|FG009|Overall Study|Physician Decision|1
4406256|NCT00203996|7184919|FG000|Overall Study|CPAP machine malfunction|0
4406257|NCT00203996|7184920|FG001|Overall Study|CPAP machine malfunction|0
4406258|NCT00203996|7184921|FG002|Overall Study|CPAP machine malfunction|0
4406259|NCT00203996|7184922|FG003|Overall Study|CPAP machine malfunction|1
4406260|NCT00203996|7184923|FG004|Overall Study|CPAP machine malfunction|0
4406261|NCT00203996|7184924|FG005|Overall Study|CPAP machine malfunction|0
4406262|NCT00203996|7184925|FG006|Overall Study|CPAP machine malfunction|0
4406263|NCT00203996|7184926|FG007|Overall Study|CPAP machine malfunction|0
4406264|NCT00203996|7184927|FG008|Overall Study|CPAP machine malfunction|0
4406265|NCT00203996|7184928|FG009|Overall Study|CPAP machine malfunction|0
4406266|NCT00203996|7184919|FG000|Overall Study|Scheduling issue|0
4406267|NCT00203996|7184920|FG001|Overall Study|Scheduling issue|0
4406268|NCT00203996|7184921|FG002|Overall Study|Scheduling issue|0
4406269|NCT00203996|7184922|FG003|Overall Study|Scheduling issue|0
4406270|NCT00203996|7184923|FG004|Overall Study|Scheduling issue|0
4406271|NCT00203996|7184924|FG005|Overall Study|Scheduling issue|0
4406272|NCT00203996|7184925|FG006|Overall Study|Scheduling issue|0
4406273|NCT00203996|7184926|FG007|Overall Study|Scheduling issue|2
4406274|NCT00203996|7184927|FG008|Overall Study|Scheduling issue|0
4406275|NCT00203996|7184928|FG009|Overall Study|Scheduling issue|0
4406276|NCT00205179|7184959|FG000|Overall Study|Death|0
4406277|NCT00205179|7184960|FG001|Overall Study|Death|2
4406278|NCT00205179|7184959|FG000|Overall Study|Physician Decision|1
4406279|NCT00205179|7184960|FG001|Overall Study|Physician Decision|1
4406280|NCT00205179|7184959|FG000|Overall Study|Adverse Event|1
4406281|NCT00205179|7184960|FG001|Overall Study|Adverse Event|1
4406282|NCT00205699|7185006|FG000|Overall Study|Lost to Follow-up|1
4406283|NCT00205699|7185007|FG001|Overall Study|Lost to Follow-up|3
4406284|NCT00205699|7185008|FG002|Overall Study|Lost to Follow-up|5
4406285|NCT00205699|7185006|FG000|Overall Study|Adverse Event|1
4406286|NCT00205699|7185007|FG001|Overall Study|Adverse Event|0
4406287|NCT00205699|7185008|FG002|Overall Study|Adverse Event|0
4406288|NCT00205699|7185006|FG000|Overall Study|Withdrawal by Subject|1
4406289|NCT00205699|7185007|FG001|Overall Study|Withdrawal by Subject|2
4406290|NCT00205699|7185008|FG002|Overall Study|Withdrawal by Subject|1
4406291|NCT00205699|7185006|FG000|Overall Study|Lack of Efficacy|0
4406292|NCT00205699|7185007|FG001|Overall Study|Lack of Efficacy|1
4406293|NCT00205699|7185008|FG002|Overall Study|Lack of Efficacy|0
4406294|NCT00205712|7185021|FG000|Overall Study|Lost to Follow-up|0
4406295|NCT00205712|7185022|FG001|Overall Study|Lost to Follow-up|1
4406296|NCT00205777|7185034|FG000|Core Study (Up to 3 Years)|Adverse Event|260
4406297|NCT00205777|7185035|FG001|Core Study (Up to 3 Years)|Adverse Event|267
4406298|NCT00205777|7185036|FG002|Core Study (Up to 3 Years)|Adverse Event|252
4406299|NCT00205777|7185037|FG003|Core Study (Up to 3 Years)|Adverse Event|232
4406300|NCT00205777|7185038|FG004|Core Study (Up to 3 Years)|Adverse Event|0
4406301|NCT00205777|7185039|FG005|Core Study (Up to 3 Years)|Adverse Event|0
4406302|NCT00205777|7185034|FG000|Core Study (Up to 3 Years)|Death|9
4406303|NCT00205777|7185035|FG001|Core Study (Up to 3 Years)|Death|7
4406304|NCT00205777|7185036|FG002|Core Study (Up to 3 Years)|Death|14
4406305|NCT00205777|7185037|FG003|Core Study (Up to 3 Years)|Death|7
4406306|NCT00205777|7185038|FG004|Core Study (Up to 3 Years)|Death|0
4406307|NCT00205777|7185039|FG005|Core Study (Up to 3 Years)|Death|0
4406308|NCT00205777|7185034|FG000|Core Study (Up to 3 Years)|Failed to return|40
4406309|NCT00205777|7185035|FG001|Core Study (Up to 3 Years)|Failed to return|25
4406310|NCT00205777|7185036|FG002|Core Study (Up to 3 Years)|Failed to return|27
4406311|NCT00205777|7185037|FG003|Core Study (Up to 3 Years)|Failed to return|27
4406312|NCT00205777|7185038|FG004|Core Study (Up to 3 Years)|Failed to return|0
4713408|NCT02945046|7640848|FG000|Overall Study|Lost to Follow-up|1
4713409|NCT02945046|7640849|FG001|Overall Study|Lost to Follow-up|1
4713410|NCT02945046|7640850|FG002|Overall Study|Lost to Follow-up|0
4713411|NCT02945046|7640848|FG000|Overall Study|Lack of Efficacy|1
4713412|NCT02945046|7640849|FG001|Overall Study|Lack of Efficacy|2
4713413|NCT02945046|7640850|FG002|Overall Study|Lack of Efficacy|1
4713414|NCT02945046|7640848|FG000|Overall Study|Other than specified|5
4713415|NCT02945046|7640849|FG001|Overall Study|Other than specified|4
4713416|NCT02945046|7640850|FG002|Overall Study|Other than specified|7
4713417|NCT02945254|7640864|FG000|Overall Study|Lost to Follow-up|1
4713418|NCT02945254|7640865|FG001|Overall Study|Lost to Follow-up|0
4713419|NCT02945254|7640864|FG000|Overall Study|Withdrawal by Subject|1
4713420|NCT02945254|7640865|FG001|Overall Study|Withdrawal by Subject|0
4713421|NCT02945410|7640877|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0
4713422|NCT02945410|7640878|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3
4713423|NCT02945410|7640879|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0
4713424|NCT02945410|7640880|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0
4713425|NCT02945410|7640881|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0
4713426|NCT02945410|7640882|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0
4713427|NCT02945410|7640877|FG000|Intervention 1 (5 Days)|Adverse Event|1
4713428|NCT02945410|7640878|FG001|Intervention 1 (5 Days)|Adverse Event|0
4713429|NCT02945410|7640879|FG002|Intervention 1 (5 Days)|Adverse Event|0
4713430|NCT02945410|7640880|FG003|Intervention 1 (5 Days)|Adverse Event|0
4713431|NCT02945410|7640881|FG004|Intervention 1 (5 Days)|Adverse Event|0
4713432|NCT02945410|7640882|FG005|Intervention 1 (5 Days)|Adverse Event|1
4713433|NCT02945410|7640877|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0
4713434|NCT02945410|7640878|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0
4713435|NCT02945410|7640879|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2
4713436|NCT02945410|7640880|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0
4713437|NCT02945410|7640881|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1
4713438|NCT02945410|7640882|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0
4713439|NCT02945657|7640903|FG000|Overall Study|Adverse Event|1
4713440|NCT02945657|7640903|FG000|Overall Study|Withdrawal by Parent/Guardian|3
4713441|NCT02946385|7640959|FG000|Overall Study|Lost to Follow-up|0
4713442|NCT02946385|7640960|FG001|Overall Study|Lost to Follow-up|0
4713443|NCT02946385|7640961|FG002|Overall Study|Lost to Follow-up|3
4713444|NCT02946385|7640962|FG003|Overall Study|Lost to Follow-up|0
4713445|NCT02946385|7640963|FG004|Overall Study|Lost to Follow-up|2
4713446|NCT02946385|7640964|FG005|Overall Study|Lost to Follow-up|1
4713447|NCT02946463|7640986|FG000|Primary Evaluation Period|Physician Decision|0
4713448|NCT02946463|7640987|FG001|Primary Evaluation Period|Physician Decision|1
4713449|NCT02946463|7640986|FG000|Primary Evaluation Period|Withdrawal by Subject|0
4713450|NCT02946463|7640987|FG001|Primary Evaluation Period|Withdrawal by Subject|1
4713451|NCT02946515|7640999|FG000|Overall Study|Lost to Follow-up|2
4713452|NCT02946515|7641000|FG001|Overall Study|Lost to Follow-up|1
4713453|NCT02946580|7641008|FG000|Overall Study|Withdrawal by Subject|1
4713454|NCT02946580|7641009|FG001|Overall Study|Withdrawal by Subject|2
4713455|NCT02946580|7641008|FG000|Overall Study|Adverse Event|0
4713456|NCT02946580|7641009|FG001|Overall Study|Adverse Event|2
4713457|NCT02946580|7641008|FG000|Overall Study|Did not undergo posterior spinal fusion|0
4713458|NCT02946580|7641009|FG001|Overall Study|Did not undergo posterior spinal fusion|1
4713459|NCT02946918|7641024|FG000|Overall Study|Patient unblinded himself|1
4713460|NCT02946918|7641025|FG001|Overall Study|Patient unblinded himself|0
4713461|NCT02946918|7641024|FG000|Overall Study|Physician Decision|0
4713462|NCT02946918|7641025|FG001|Overall Study|Physician Decision|2
4713463|NCT02946918|7641024|FG000|Overall Study|Ran out of study medication|0
4713464|NCT02946918|7641025|FG001|Overall Study|Ran out of study medication|1
4713465|NCT02948582|7641067|FG000|Washout Period 1|Adverse Event|0
4713466|NCT02948582|7641068|FG001|Washout Period 1|Adverse Event|2
4713467|NCT02948582|7641069|FG002|Washout Period 1|Adverse Event|0
4713468|NCT02948582|7641070|FG003|Washout Period 1|Adverse Event|0
4713469|NCT02948582|7641071|FG004|Washout Period 1|Adverse Event|0
4713470|NCT02948582|7641072|FG005|Washout Period 1|Adverse Event|0
4713471|NCT02948582|7641067|FG000|Washout Period 1|Protocol Violation|0
4713472|NCT02948582|7641068|FG001|Washout Period 1|Protocol Violation|0
4713473|NCT02948582|7641069|FG002|Washout Period 1|Protocol Violation|0
4713474|NCT02948582|7641070|FG003|Washout Period 1|Protocol Violation|0
4713475|NCT02948582|7641071|FG004|Washout Period 1|Protocol Violation|0
4713476|NCT02948582|7641072|FG005|Washout Period 1|Protocol Violation|1
4713477|NCT02948582|7641067|FG000|Washout Period 2|Adverse Event|0
4406313|NCT00205777|7185039|FG005|Core Study (Up to 3 Years)|Failed to return|0
4713478|NCT02948582|7641068|FG001|Washout Period 2|Adverse Event|1
4406314|NCT00205777|7185034|FG000|Core Study (Up to 3 Years)|Other Event|49
4406315|NCT00205777|7185035|FG001|Core Study (Up to 3 Years)|Other Event|52
4406316|NCT00205777|7185036|FG002|Core Study (Up to 3 Years)|Other Event|41
4406317|NCT00205777|7185037|FG003|Core Study (Up to 3 Years)|Other Event|58
4406318|NCT00205777|7185038|FG004|Core Study (Up to 3 Years)|Other Event|0
4406319|NCT00205777|7185039|FG005|Core Study (Up to 3 Years)|Other Event|0
4406320|NCT00205777|7185034|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144
4406321|NCT00205777|7185035|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169
4406322|NCT00205777|7185036|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149
4406323|NCT00205777|7185037|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162
4406324|NCT00205777|7185038|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0
4406325|NCT00205777|7185039|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0
4406326|NCT00205777|7185034|FG000|Core Study (Up to 3 Years)|Protocol Violation|53
4406327|NCT00205777|7185035|FG001|Core Study (Up to 3 Years)|Protocol Violation|55
4406328|NCT00205777|7185036|FG002|Core Study (Up to 3 Years)|Protocol Violation|50
4406329|NCT00205777|7185037|FG003|Core Study (Up to 3 Years)|Protocol Violation|42
4406330|NCT00205777|7185038|FG004|Core Study (Up to 3 Years)|Protocol Violation|0
4406331|NCT00205777|7185039|FG005|Core Study (Up to 3 Years)|Protocol Violation|0
4406332|NCT00205777|7185034|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52
4406333|NCT00205777|7185035|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52
4406334|NCT00205777|7185036|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39
4406335|NCT00205777|7185037|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75
4406336|NCT00205777|7185038|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0
4406337|NCT00205777|7185039|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0
4406338|NCT00205777|7185034|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21
4406339|NCT00205777|7185035|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32
4406340|NCT00205777|7185036|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35
4406341|NCT00205777|7185037|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29
4406342|NCT00205777|7185038|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0
4406343|NCT00205777|7185039|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0
4406344|NCT00205777|7185034|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180
4406345|NCT00205777|7185035|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158
4406346|NCT00205777|7185036|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160
4406347|NCT00205777|7185037|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174
4406348|NCT00205777|7185038|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0
4406349|NCT00205777|7185039|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0
4406350|NCT00205777|7185034|FG000|Completed Core Study, Entered SE I|Other Event|52
4406351|NCT00205777|7185035|FG001|Completed Core Study, Entered SE I|Other Event|46
4406352|NCT00205777|7185036|FG002|Completed Core Study, Entered SE I|Other Event|47
4406353|NCT00205777|7185037|FG003|Completed Core Study, Entered SE I|Other Event|50
4406354|NCT00205777|7185038|FG004|Completed Core Study, Entered SE I|Other Event|0
4406355|NCT00205777|7185039|FG005|Completed Core Study, Entered SE I|Other Event|0
4406356|NCT00205777|7185034|FG000|Study Extension I|Adverse Event|57
4406357|NCT00205777|7185035|FG001|Study Extension I|Adverse Event|0
4406358|NCT00205777|7185036|FG002|Study Extension I|Adverse Event|0
4406359|NCT00205777|7185037|FG003|Study Extension I|Adverse Event|61
4406360|NCT00205777|7185038|FG004|Study Extension I|Adverse Event|58
4406361|NCT00205777|7185039|FG005|Study Extension I|Adverse Event|0
4406362|NCT00205777|7185034|FG000|Study Extension I|Death|5
4406363|NCT00205777|7185035|FG001|Study Extension I|Death|0
4406364|NCT00205777|7185036|FG002|Study Extension I|Death|0
4406365|NCT00205777|7185037|FG003|Study Extension I|Death|1
4406366|NCT00205777|7185038|FG004|Study Extension I|Death|2
4406367|NCT00205777|7185039|FG005|Study Extension I|Death|0
4406368|NCT00205777|7185034|FG000|Study Extension I|Withdrawal by Subject|99
4406369|NCT00205777|7185035|FG001|Study Extension I|Withdrawal by Subject|0
4406370|NCT00205777|7185036|FG002|Study Extension I|Withdrawal by Subject|0
4406371|NCT00205777|7185037|FG003|Study Extension I|Withdrawal by Subject|106
4406372|NCT00205777|7185038|FG004|Study Extension I|Withdrawal by Subject|89
4406373|NCT00205777|7185039|FG005|Study Extension I|Withdrawal by Subject|0
4406374|NCT00205777|7185034|FG000|Study Extension I|Protocol Violation|4
4406375|NCT00205777|7185035|FG001|Study Extension I|Protocol Violation|0
4406376|NCT00205777|7185036|FG002|Study Extension I|Protocol Violation|0
4406377|NCT00205777|7185037|FG003|Study Extension I|Protocol Violation|8
4406378|NCT00205777|7185038|FG004|Study Extension I|Protocol Violation|8
4406379|NCT00205777|7185039|FG005|Study Extension I|Protocol Violation|0
4406380|NCT00205777|7185034|FG000|Study Extension I|Lack of Efficacy|0
4406381|NCT00205777|7185035|FG001|Study Extension I|Lack of Efficacy|0
4406382|NCT00205777|7185036|FG002|Study Extension I|Lack of Efficacy|0
4406383|NCT00205777|7185037|FG003|Study Extension I|Lack of Efficacy|1
4406384|NCT00205777|7185038|FG004|Study Extension I|Lack of Efficacy|2
4406385|NCT00205777|7185039|FG005|Study Extension I|Lack of Efficacy|0
4406386|NCT00205777|7185034|FG000|Study Extension I|Failed to return|15
4406387|NCT00205777|7185035|FG001|Study Extension I|Failed to return|0
4406388|NCT00205777|7185036|FG002|Study Extension I|Failed to return|0
4406389|NCT00205777|7185037|FG003|Study Extension I|Failed to return|17
4406390|NCT00205777|7185038|FG004|Study Extension I|Failed to return|13
4406391|NCT00205777|7185039|FG005|Study Extension I|Failed to return|0
4406392|NCT00205777|7185034|FG000|Study Extension I|Other Event|34
4406393|NCT00205777|7185035|FG001|Study Extension I|Other Event|0
4406394|NCT00205777|7185036|FG002|Study Extension I|Other Event|0
4406395|NCT00205777|7185037|FG003|Study Extension I|Other Event|34
4406396|NCT00205777|7185038|FG004|Study Extension I|Other Event|29
4406397|NCT00205777|7185039|FG005|Study Extension I|Other Event|0
4406398|NCT00205777|7185034|FG000|Study Extension I|Withdrawn as per protocol|0
4406399|NCT00205777|7185035|FG001|Study Extension I|Withdrawn as per protocol|0
4406400|NCT00205777|7185036|FG002|Study Extension I|Withdrawn as per protocol|1070
4406401|NCT00205777|7185037|FG003|Study Extension I|Withdrawn as per protocol|0
4406402|NCT00205777|7185038|FG004|Study Extension I|Withdrawn as per protocol|0
4406403|NCT00205777|7185039|FG005|Study Extension I|Withdrawn as per protocol|0
4406404|NCT00205777|7185034|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273
4406405|NCT00205777|7185035|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
4406406|NCT00205777|7185036|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
4713479|NCT02948582|7641069|FG002|Washout Period 2|Adverse Event|0
4406407|NCT00205777|7185037|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240
4406408|NCT00205777|7185038|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258
4406409|NCT00205777|7185039|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
4406410|NCT00205777|7185034|FG000|Study Extension II|Adverse Event|0
4406411|NCT00205777|7185035|FG001|Study Extension II|Adverse Event|0
4406412|NCT00205777|7185036|FG002|Study Extension II|Adverse Event|0
4406413|NCT00205777|7185037|FG003|Study Extension II|Adverse Event|14
4406414|NCT00205777|7185038|FG004|Study Extension II|Adverse Event|0
4406415|NCT00205777|7185039|FG005|Study Extension II|Adverse Event|30
4406416|NCT00205777|7185034|FG000|Study Extension II|Death|0
4406417|NCT00205777|7185035|FG001|Study Extension II|Death|0
4406418|NCT00205777|7185036|FG002|Study Extension II|Death|0
4406419|NCT00205777|7185037|FG003|Study Extension II|Death|2
4406420|NCT00205777|7185038|FG004|Study Extension II|Death|0
4406421|NCT00205777|7185039|FG005|Study Extension II|Death|5
4406422|NCT00205777|7185034|FG000|Study Extension II|Withdrawal by Subject|0
4406423|NCT00205777|7185035|FG001|Study Extension II|Withdrawal by Subject|0
4406424|NCT00205777|7185036|FG002|Study Extension II|Withdrawal by Subject|0
4406425|NCT00205777|7185037|FG003|Study Extension II|Withdrawal by Subject|35
4406426|NCT00205777|7185038|FG004|Study Extension II|Withdrawal by Subject|0
4406427|NCT00205777|7185039|FG005|Study Extension II|Withdrawal by Subject|59
4406428|NCT00205777|7185034|FG000|Study Extension II|Protocol Violation|0
4406429|NCT00205777|7185035|FG001|Study Extension II|Protocol Violation|0
4406430|NCT00205777|7185036|FG002|Study Extension II|Protocol Violation|0
4406431|NCT00205777|7185037|FG003|Study Extension II|Protocol Violation|1
4406432|NCT00205777|7185038|FG004|Study Extension II|Protocol Violation|0
4406433|NCT00205777|7185039|FG005|Study Extension II|Protocol Violation|10
4406434|NCT00205777|7185034|FG000|Study Extension II|Lack of Efficacy|0
4406435|NCT00205777|7185035|FG001|Study Extension II|Lack of Efficacy|0
4406436|NCT00205777|7185036|FG002|Study Extension II|Lack of Efficacy|0
4406437|NCT00205777|7185037|FG003|Study Extension II|Lack of Efficacy|0
4406438|NCT00205777|7185038|FG004|Study Extension II|Lack of Efficacy|0
4406439|NCT00205777|7185039|FG005|Study Extension II|Lack of Efficacy|1
4406440|NCT00205777|7185034|FG000|Study Extension II|Failed to return|0
4406441|NCT00205777|7185035|FG001|Study Extension II|Failed to return|0
4406442|NCT00205777|7185036|FG002|Study Extension II|Failed to return|0
4406443|NCT00205777|7185037|FG003|Study Extension II|Failed to return|14
4406444|NCT00205777|7185038|FG004|Study Extension II|Failed to return|0
4406445|NCT00205777|7185039|FG005|Study Extension II|Failed to return|26
4406446|NCT00205777|7185034|FG000|Study Extension II|Other Event|0
4406447|NCT00205777|7185035|FG001|Study Extension II|Other Event|0
4406448|NCT00205777|7185036|FG002|Study Extension II|Other Event|0
4406449|NCT00205777|7185037|FG003|Study Extension II|Other Event|12
4406450|NCT00205777|7185038|FG004|Study Extension II|Other Event|0
4406451|NCT00205777|7185039|FG005|Study Extension II|Other Event|20
4406452|NCT00205777|7185034|FG000|Study Extension II|Enrolled but not treated|0
4406453|NCT00205777|7185035|FG001|Study Extension II|Enrolled but not treated|0
4406454|NCT00205777|7185036|FG002|Study Extension II|Enrolled but not treated|0
4406455|NCT00205777|7185037|FG003|Study Extension II|Enrolled but not treated|71
4406456|NCT00205777|7185038|FG004|Study Extension II|Enrolled but not treated|0
4406457|NCT00205777|7185039|FG005|Study Extension II|Enrolled but not treated|131
4406458|NCT00205803|7185056|FG000|Infant Series|Lost to Follow-up|10
4406459|NCT00205803|7185057|FG001|Infant Series|Lost to Follow-up|4
4406460|NCT00205803|7185056|FG000|Infant Series|Withdrawal by Subject|2
4406461|NCT00205803|7185057|FG001|Infant Series|Withdrawal by Subject|5
4406462|NCT00205803|7185056|FG000|Infant Series|Physician Decision|3
4406463|NCT00205803|7185057|FG001|Infant Series|Physician Decision|1
4406464|NCT00205803|7185056|FG000|Infant Series|Protocol Violation|1
4406465|NCT00205803|7185057|FG001|Infant Series|Protocol Violation|0
4406466|NCT00205803|7185056|FG000|Infant Series|Lost Kaiser coverage|0
4406467|NCT00205803|7185057|FG001|Infant Series|Lost Kaiser coverage|1
4406468|NCT00205803|7185056|FG000|Infant Series|Non-compliant|1
4406469|NCT00205803|7185057|FG001|Infant Series|Non-compliant|0
4406470|NCT00205803|7185056|FG000|Infant Series|Sponsor request|1
4406471|NCT00205803|7185057|FG001|Infant Series|Sponsor request|0
4406472|NCT00205803|7185056|FG000|After Infant Series|Adverse Event|1
4406473|NCT00205803|7185057|FG001|After Infant Series|Adverse Event|1
4406474|NCT00205803|7185056|FG000|After Infant Series|Protocol Violation|1
4406475|NCT00205803|7185057|FG001|After Infant Series|Protocol Violation|1
4406476|NCT00205803|7185056|FG000|After Infant Series|Lost to Follow-up|2
4406477|NCT00205803|7185057|FG001|After Infant Series|Lost to Follow-up|1
4406478|NCT00205803|7185056|FG000|After Infant Series|Physician Decision|3
4406479|NCT00205803|7185057|FG001|After Infant Series|Physician Decision|2
4406480|NCT00205803|7185056|FG000|After Infant Series|Withdrawal by Subject|1
4406481|NCT00205803|7185057|FG001|After Infant Series|Withdrawal by Subject|4
4406482|NCT00205803|7185056|FG000|After Infant Series|Other|10
4406483|NCT00205803|7185057|FG001|After Infant Series|Other|4
4406484|NCT00205803|7185056|FG000|Toddler Dose|Lost to Follow-up|2
4406485|NCT00205803|7185057|FG001|Toddler Dose|Lost to Follow-up|3
4406486|NCT00205855|7185081|FG000|Overall Study|Only received temporary implants|16
4406487|NCT00205855|7185081|FG000|Overall Study|Withdrawal by Subject|5
4406488|NCT00205881|7185085|FG000|Overall Study|Withdrawal by Subject|16
4406489|NCT00206076|7185092|FG000|Overall Study|Physician Decision|2
4406490|NCT00206076|7185093|FG001|Overall Study|Physician Decision|0
4406491|NCT00206076|7185092|FG000|Overall Study|Withdrawal by Subject|1
4406492|NCT00206076|7185093|FG001|Overall Study|Withdrawal by Subject|1
4406493|NCT00206102|7185103|FG000|Overall Study|Adverse Event|119
4406494|NCT00206102|7185104|FG001|Overall Study|Adverse Event|82
4406495|NCT00206102|7185103|FG000|Overall Study|Protocol Violation|0
4406496|NCT00206102|7185104|FG001|Overall Study|Protocol Violation|2
4406497|NCT00206102|7185103|FG000|Overall Study|Lack of therapeutic response|16
4406498|NCT00206102|7185104|FG001|Overall Study|Lack of therapeutic response|11
4406499|NCT00206102|7185103|FG000|Overall Study|Lost to Follow-up|95
4406500|NCT00206102|7185104|FG001|Overall Study|Lost to Follow-up|66
4406501|NCT00206102|7185103|FG000|Overall Study|Withdrawal by Subject|118
4406502|NCT00206102|7185104|FG001|Overall Study|Withdrawal by Subject|101
4406503|NCT00206102|7185103|FG000|Overall Study|Study-specific discontinuation criteria|18
4406504|NCT00206102|7185104|FG001|Overall Study|Study-specific discontinuation criteria|17
4406505|NCT00206102|7185103|FG000|Overall Study|None of those categories|42
4406506|NCT00206102|7185104|FG001|Overall Study|None of those categories|36
4406507|NCT00206323|7185112|FG000|Overall Study|Lack of Efficacy|4
4406508|NCT00206323|7185113|FG001|Overall Study|Lack of Efficacy|1
4406509|NCT00206323|7185112|FG000|Overall Study|Adverse Event|1
4406510|NCT00206323|7185113|FG001|Overall Study|Adverse Event|1
4406511|NCT00206323|7185112|FG000|Overall Study|Lost to Follow-up|1
4406512|NCT00206323|7185113|FG001|Overall Study|Lost to Follow-up|1
4406513|NCT00206427|7185123|FG000|Overall Study|Adverse Event|2
4406514|NCT00206440|7185129|FG000|Overall Study|Protocol Violation|1
4629015|NCT01867671|7496615|FG001|Overall Study|Non-compliance with Study Drug|2
4406515|NCT00206440|7185130|FG001|Overall Study|Protocol Violation|2
4406516|NCT00206440|7185129|FG000|Overall Study|Adverse Event|4
4406517|NCT00206440|7185130|FG001|Overall Study|Adverse Event|2
4406518|NCT00206518|7185138|FG000|Overall Study|Lack of Efficacy|6
4629016|NCT01867671|7496614|FG000|Overall Study|Withdrawal by Subject|21
4629017|NCT01867671|7496615|FG001|Overall Study|Withdrawal by Subject|21
4629018|NCT01867710|7496625|FG000|Overall Study|Death|25
4629019|NCT01867710|7496626|FG001|Overall Study|Death|15
4629020|NCT01867710|7496627|FG002|Overall Study|Death|27
4629021|NCT01867710|7496628|FG003|Overall Study|Death|20
4406519|NCT00206518|7185139|FG001|Overall Study|Lack of Efficacy|4
4406520|NCT00206518|7185138|FG000|Overall Study|Adverse Event|2
4406521|NCT00206518|7185139|FG001|Overall Study|Adverse Event|1
4406522|NCT00206518|7185138|FG000|Overall Study|Physician Decision|1
4406523|NCT00206518|7185139|FG001|Overall Study|Physician Decision|0
4406524|NCT00206518|7185138|FG000|Overall Study|Protocol Violation|1
4406525|NCT00206518|7185139|FG001|Overall Study|Protocol Violation|1
4406526|NCT00206726|7185145|FG000|Overall Study|Delayed recovery of blood counts|1
4406527|NCT00206726|7185145|FG000|Overall Study|Progressive disease or relapsed disease|18
4406528|NCT00206726|7185145|FG000|Overall Study|Placed on new protocol|1
4406529|NCT00206726|7185145|FG000|Overall Study|Bone marrow transplant|1
4406530|NCT00206726|7185145|FG000|Overall Study|Adverse Event|17
4406531|NCT00206726|7185145|FG000|Overall Study|Death|4
4406532|NCT00206726|7185145|FG000|Overall Study|Protocol Violation|1
4406533|NCT00206726|7185145|FG000|Overall Study|Withdrawal by Subject|8
4406534|NCT00207090|7185149|FG000|Overall Study|Study drug toxicity|3
4406535|NCT00207090|7185149|FG000|Overall Study|Chest wall mass larger|1
4406536|NCT00207090|7185149|FG000|Overall Study|Disease progression/relapse|2
4406537|NCT00207090|7185149|FG000|Overall Study|Physician Decision|1
4406538|NCT00207142|7185161|FG000|Induction Phase|Adverse Event|9
4406539|NCT00207142|7185162|FG001|Induction Phase|Adverse Event|0
4406540|NCT00207142|7185163|FG002|Induction Phase|Adverse Event|0
4406541|NCT00207142|7185164|FG003|Induction Phase|Adverse Event|0
4406542|NCT00207142|7185161|FG000|Induction Phase|Death|1
4406543|NCT00207142|7185162|FG001|Induction Phase|Death|0
4406544|NCT00207142|7185163|FG002|Induction Phase|Death|0
4406545|NCT00207142|7185164|FG003|Induction Phase|Death|0
4406546|NCT00207142|7185161|FG000|Induction Phase|Lack of Efficacy|1
4406547|NCT00207142|7185162|FG001|Induction Phase|Lack of Efficacy|0
4406548|NCT00207142|7185163|FG002|Induction Phase|Lack of Efficacy|0
4406549|NCT00207142|7185164|FG003|Induction Phase|Lack of Efficacy|0
4406550|NCT00207142|7185161|FG000|Induction Phase|Lost to Follow-up|5
4406551|NCT00207142|7185162|FG001|Induction Phase|Lost to Follow-up|0
4406552|NCT00207142|7185163|FG002|Induction Phase|Lost to Follow-up|0
4406553|NCT00207142|7185164|FG003|Induction Phase|Lost to Follow-up|0
4406554|NCT00207142|7185161|FG000|Induction Phase|Physician Decision|2
4406555|NCT00207142|7185162|FG001|Induction Phase|Physician Decision|0
4406556|NCT00207142|7185163|FG002|Induction Phase|Physician Decision|0
4406557|NCT00207142|7185164|FG003|Induction Phase|Physician Decision|0
4406558|NCT00207142|7185161|FG000|Induction Phase|Poor/noncompliance|2
4406559|NCT00207142|7185162|FG001|Induction Phase|Poor/noncompliance|0
4406560|NCT00207142|7185163|FG002|Induction Phase|Poor/noncompliance|0
4406561|NCT00207142|7185164|FG003|Induction Phase|Poor/noncompliance|0
4406562|NCT00207142|7185161|FG000|Induction Phase|Pregnancy|1
4406563|NCT00207142|7185162|FG001|Induction Phase|Pregnancy|0
4406564|NCT00207142|7185163|FG002|Induction Phase|Pregnancy|0
4406565|NCT00207142|7185164|FG003|Induction Phase|Pregnancy|0
4406566|NCT00207142|7185161|FG000|Induction Phase|Subject no longer meets study criteria|3
4406567|NCT00207142|7185162|FG001|Induction Phase|Subject no longer meets study criteria|0
4406568|NCT00207142|7185163|FG002|Induction Phase|Subject no longer meets study criteria|0
4406569|NCT00207142|7185164|FG003|Induction Phase|Subject no longer meets study criteria|0
4406570|NCT00207142|7185161|FG000|Induction Phase|Withdrawal by Subject|4
4406571|NCT00207142|7185162|FG001|Induction Phase|Withdrawal by Subject|0
4406572|NCT00207142|7185163|FG002|Induction Phase|Withdrawal by Subject|0
4406573|NCT00207142|7185164|FG003|Induction Phase|Withdrawal by Subject|0
4406574|NCT00207142|7185161|FG000|Induction Phase|Incarceration|1
4406575|NCT00207142|7185162|FG001|Induction Phase|Incarceration|0
4406576|NCT00207142|7185163|FG002|Induction Phase|Incarceration|0
4406577|NCT00207142|7185164|FG003|Induction Phase|Incarceration|0
4406578|NCT00207142|7185161|FG000|Induction Phase|Missing lab data|1
4406579|NCT00207142|7185162|FG001|Induction Phase|Missing lab data|0
4406580|NCT00207142|7185163|FG002|Induction Phase|Missing lab data|0
4406581|NCT00207142|7185164|FG003|Induction Phase|Missing lab data|0
4406582|NCT00207142|7185161|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0
4406583|NCT00207142|7185162|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1
4406584|NCT00207142|7185163|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4
4406585|NCT00207142|7185164|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1
4406586|NCT00207142|7185161|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0
4406587|NCT00207142|7185162|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1
4406588|NCT00207142|7185163|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1
4406589|NCT00207142|7185164|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2
4406590|NCT00207142|7185161|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0
4406591|NCT00207142|7185162|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0
4406592|NCT00207142|7185163|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1
4406593|NCT00207142|7185164|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0
4406594|NCT00207142|7185161|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0
4406595|NCT00207142|7185162|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3
4406596|NCT00207142|7185163|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2
4406597|NCT00207142|7185164|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3
4406598|NCT00207142|7185161|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0
4406599|NCT00207142|7185162|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2
4406600|NCT00207142|7185163|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2
4406601|NCT00207142|7185164|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0
4406602|NCT00207142|7185161|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
4406603|NCT00207142|7185162|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
4406604|NCT00207142|7185163|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1
4406605|NCT00207142|7185164|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
4406606|NCT00207142|7185161|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0
4406607|NCT00207142|7185162|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2
4406608|NCT00207142|7185163|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2
4406609|NCT00207142|7185164|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1
4406610|NCT00207142|7185161|FG000|Maintenance Phase/Rescue Phase|Death|0
4406611|NCT00207142|7185162|FG001|Maintenance Phase/Rescue Phase|Death|0
4406612|NCT00207142|7185163|FG002|Maintenance Phase/Rescue Phase|Death|0
4629022|NCT01867710|7496625|FG000|Overall Study|Lost to Follow-up|3
4629023|NCT01867710|7496626|FG001|Overall Study|Lost to Follow-up|4
4629024|NCT01867710|7496627|FG002|Overall Study|Lost to Follow-up|3
4713480|NCT02948582|7641070|FG003|Washout Period 2|Adverse Event|0
4713481|NCT02948582|7641071|FG004|Washout Period 2|Adverse Event|0
4713482|NCT02948582|7641072|FG005|Washout Period 2|Adverse Event|0
4713483|NCT02948582|7641067|FG000|Washout Period 2|personal reasons|0
4713484|NCT02948582|7641068|FG001|Washout Period 2|personal reasons|0
4713485|NCT02948582|7641069|FG002|Washout Period 2|personal reasons|0
4713486|NCT02948582|7641070|FG003|Washout Period 2|personal reasons|1
4713487|NCT02948582|7641071|FG004|Washout Period 2|personal reasons|0
4713488|NCT02948582|7641072|FG005|Washout Period 2|personal reasons|0
4713489|NCT02948582|7641067|FG000|Washout Period 4|Adverse Event|1
4406613|NCT00207142|7185164|FG003|Maintenance Phase/Rescue Phase|Death|1
4406614|NCT00207142|7185161|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
4406615|NCT00207142|7185162|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
4406616|NCT00207142|7185163|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
4713490|NCT02948582|7641068|FG001|Washout Period 4|Adverse Event|0
4406617|NCT00207142|7185164|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1
4406618|NCT00207714|7185184|FG000|Overall Study|Adverse Event|6
4406619|NCT00207714|7185185|FG001|Overall Study|Adverse Event|2
4406620|NCT00207714|7185186|FG002|Overall Study|Adverse Event|4
4406621|NCT00207714|7185187|FG003|Overall Study|Adverse Event|3
4406622|NCT00207714|7185188|FG004|Overall Study|Adverse Event|1
4406623|NCT00207714|7185184|FG000|Overall Study|Unsatisfactory therapeutic effect|5
4406624|NCT00207714|7185185|FG001|Overall Study|Unsatisfactory therapeutic effect|3
4406625|NCT00207714|7185186|FG002|Overall Study|Unsatisfactory therapeutic effect|1
4406626|NCT00207714|7185187|FG003|Overall Study|Unsatisfactory therapeutic effect|4
4406627|NCT00207714|7185188|FG004|Overall Study|Unsatisfactory therapeutic effect|4
4406628|NCT00207714|7185184|FG000|Overall Study|Other|3
4406629|NCT00207714|7185185|FG001|Overall Study|Other|2
4406630|NCT00207714|7185186|FG002|Overall Study|Other|5
4406631|NCT00207714|7185187|FG003|Overall Study|Other|1
4406632|NCT00207714|7185188|FG004|Overall Study|Other|0
4406633|NCT00207727|7185212|FG000|Overall Study|Withdrawal by Subject|0
4406634|NCT00207727|7185213|FG001|Overall Study|Withdrawal by Subject|0
4406635|NCT00207727|7185214|FG002|Overall Study|Withdrawal by Subject|0
4406636|NCT00207727|7185215|FG003|Overall Study|Withdrawal by Subject|0
4406637|NCT00207727|7185216|FG004|Overall Study|Withdrawal by Subject|1
4406638|NCT00207727|7185212|FG000|Overall Study|Lost to Follow-up|0
4406639|NCT00207727|7185213|FG001|Overall Study|Lost to Follow-up|1
4406640|NCT00207727|7185214|FG002|Overall Study|Lost to Follow-up|0
4406641|NCT00207727|7185215|FG003|Overall Study|Lost to Follow-up|0
4406642|NCT00207727|7185216|FG004|Overall Study|Lost to Follow-up|0
4406643|NCT00207727|7185212|FG000|Overall Study|Other|38
4406644|NCT00207727|7185213|FG001|Overall Study|Other|41
4406645|NCT00207727|7185214|FG002|Overall Study|Other|41
4406646|NCT00207727|7185215|FG003|Overall Study|Other|37
4406647|NCT00207727|7185216|FG004|Overall Study|Other|33
4406648|NCT00207740|7185232|FG000|Overall Study|Adverse Event|4
4406649|NCT00207740|7185233|FG001|Overall Study|Adverse Event|14
4406650|NCT00207740|7185234|FG002|Overall Study|Adverse Event|14
4406651|NCT00207740|7185235|FG003|Overall Study|Adverse Event|11
4406652|NCT00207740|7185232|FG000|Overall Study|Unsatisfactory therapeutic effect|1
4406653|NCT00207740|7185233|FG001|Overall Study|Unsatisfactory therapeutic effect|0
4406654|NCT00207740|7185234|FG002|Overall Study|Unsatisfactory therapeutic effect|2
4406655|NCT00207740|7185235|FG003|Overall Study|Unsatisfactory therapeutic effect|4
4406656|NCT00207740|7185232|FG000|Overall Study|Lost to Follow-up|0
4406657|NCT00207740|7185233|FG001|Overall Study|Lost to Follow-up|2
4406658|NCT00207740|7185234|FG002|Overall Study|Lost to Follow-up|1
4406659|NCT00207740|7185235|FG003|Overall Study|Lost to Follow-up|1
4406660|NCT00207740|7185232|FG000|Overall Study|Death|0
4406661|NCT00207740|7185233|FG001|Overall Study|Death|0
4406662|NCT00207740|7185234|FG002|Overall Study|Death|0
4406663|NCT00207740|7185235|FG003|Overall Study|Death|1
4406664|NCT00207740|7185232|FG000|Overall Study|Sponsor Directive|22
4406665|NCT00207740|7185233|FG001|Overall Study|Sponsor Directive|15
4406666|NCT00207740|7185234|FG002|Overall Study|Sponsor Directive|16
4406667|NCT00207740|7185235|FG003|Overall Study|Sponsor Directive|21
4406668|NCT00207740|7185232|FG000|Overall Study|Other|2
4406669|NCT00207740|7185233|FG001|Overall Study|Other|10
4406670|NCT00207740|7185234|FG002|Overall Study|Other|7
4406671|NCT00207740|7185235|FG003|Overall Study|Other|5
4406672|NCT00208325|7185276|FG000|Overall Study|Death|18
4406673|NCT00208325|7185277|FG001|Overall Study|Death|19
4406674|NCT00208325|7185278|FG002|Overall Study|Death|7
4406675|NCT00208325|7185279|FG003|Overall Study|Death|5
4406676|NCT00208325|7185276|FG000|Overall Study|Withdrawal by Subject|0
4406677|NCT00208325|7185277|FG001|Overall Study|Withdrawal by Subject|1
4406678|NCT00208325|7185278|FG002|Overall Study|Withdrawal by Subject|0
4406679|NCT00208325|7185279|FG003|Overall Study|Withdrawal by Subject|0
4406680|NCT00208325|7185276|FG000|Overall Study|Revision|4
4406681|NCT00208325|7185277|FG001|Overall Study|Revision|1
4406682|NCT00208325|7185278|FG002|Overall Study|Revision|0
4406683|NCT00208325|7185279|FG003|Overall Study|Revision|4
4406684|NCT00208325|7185276|FG000|Overall Study|Lost to Follow-up|1
4406685|NCT00208325|7185277|FG001|Overall Study|Lost to Follow-up|0
4406686|NCT00208325|7185278|FG002|Overall Study|Lost to Follow-up|2
4406687|NCT00208325|7185279|FG003|Overall Study|Lost to Follow-up|0
4406688|NCT00208325|7185276|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4
4406689|NCT00208325|7185277|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4
4406690|NCT00208325|7185278|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1
4406691|NCT00208325|7185279|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3
4406692|NCT00208325|7185276|FG000|Overall Study|Does not wish to Continue in Study|5
4406693|NCT00208325|7185277|FG001|Overall Study|Does not wish to Continue in Study|8
4406694|NCT00208325|7185278|FG002|Overall Study|Does not wish to Continue in Study|3
4406695|NCT00208325|7185279|FG003|Overall Study|Does not wish to Continue in Study|2
4406696|NCT00208325|7185276|FG000|Overall Study|Other|2
4406697|NCT00208325|7185277|FG001|Overall Study|Other|1
4406698|NCT00208325|7185278|FG002|Overall Study|Other|1
4406699|NCT00208325|7185279|FG003|Overall Study|Other|0
4406700|NCT00208325|7185276|FG000|Overall Study|Mis-Randomized|17
4406701|NCT00208325|7185277|FG001|Overall Study|Mis-Randomized|20
4406702|NCT00208325|7185278|FG002|Overall Study|Mis-Randomized|0
4406703|NCT00208325|7185279|FG003|Overall Study|Mis-Randomized|0
4406704|NCT00208767|7185309|FG000|Overall Study|Adverse Event|9
4406705|NCT00208767|7185310|FG001|Overall Study|Adverse Event|1
4406706|NCT00208767|7185309|FG000|Overall Study|Withdrawal by Subject|14
4406707|NCT00208767|7185310|FG001|Overall Study|Withdrawal by Subject|3
4406708|NCT00208767|7185309|FG000|Overall Study|Death|1
4406709|NCT00208767|7185310|FG001|Overall Study|Death|0
4406710|NCT00208767|7185309|FG000|Overall Study|Lost to Follow-up|3
4406711|NCT00208767|7185310|FG001|Overall Study|Lost to Follow-up|3
4406712|NCT00209092|7185332|FG000|Overall Study|Progression of disease|7
4406713|NCT00209092|7185333|FG001|Overall Study|Progression of disease|1
4406714|NCT00209092|7185332|FG000|Overall Study|Adverse Event|0
4406715|NCT00209092|7185333|FG001|Overall Study|Adverse Event|1
4406716|NCT00209092|7185332|FG000|Overall Study|Withdrawal by Subject|1
4406717|NCT00209092|7185333|FG001|Overall Study|Withdrawal by Subject|0
4406718|NCT00209170|7185341|FG000|Overall Study|Adverse Event|0
4406719|NCT00209170|7185342|FG001|Overall Study|Adverse Event|1
4406720|NCT00209170|7185341|FG000|Overall Study|Withdrawal by Subject|2
4406721|NCT00209170|7185342|FG001|Overall Study|Withdrawal by Subject|1
4406722|NCT00209170|7185341|FG000|Overall Study|Lack of Efficacy|0
4406723|NCT00209170|7185342|FG001|Overall Study|Lack of Efficacy|1
4406724|NCT00209274|7185350|FG000|Overall Study|Missed visit|3
4406725|NCT00209274|7185351|FG001|Overall Study|Missed visit|2
4406726|NCT00209274|7185350|FG000|Overall Study|Death|32
4406727|NCT00209274|7185351|FG001|Overall Study|Death|15
4406728|NCT00209274|7185350|FG000|Overall Study|Withdrawal by Subject|30
4406729|NCT00209274|7185351|FG001|Overall Study|Withdrawal by Subject|15
4406730|NCT00209274|7185350|FG000|Overall Study|Randomized not treated (RNT)|6
4406731|NCT00209274|7185351|FG001|Overall Study|Randomized not treated (RNT)|15
4406732|NCT00209339|7185357|FG000|At 12 Months Follow-up|Withdrawal by Subject|8
4406733|NCT00209339|7185357|FG000|At 12 Months Follow-up|Death|1
4406734|NCT00209339|7185357|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6
4406735|NCT00209339|7185357|FG000|At 24 Months Follow-up|Withdrawal by Subject|4
4406736|NCT00209339|7185357|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6
4406737|NCT00209339|7185357|FG000|At 24 Months Follow-up|Death|1
4406738|NCT00209339|7185357|FG000|At 3 Years Follow-up|Withdrawal by Subject|1
4406739|NCT00209339|7185357|FG000|At 4 Years Follow-up|Withdrawal by Subject|4
4406740|NCT00209339|7185357|FG000|At 4 Years Follow-up|Death|1
4406741|NCT00209339|7185357|FG000|At 5 Years Follow-up|Withdrawal by Subject|2
4406742|NCT00209339|7185357|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5
4406743|NCT00209339|7185357|FG000|At 5 Years Follow-up|Death|1
4406744|NCT00209560|7185372|FG000|Overall Study|Lack of Efficacy|1
4406745|NCT00209560|7185373|FG001|Overall Study|Lack of Efficacy|0
4406746|NCT00210106|7185379|FG000|Overall Study|Death|1
4406747|NCT00210106|7185379|FG000|Overall Study|Protocol Violation|13
4406748|NCT00210119|7185384|FG000|Overall Study|Protocol Violation|1
4406749|NCT00210119|7185384|FG000|Overall Study|Withdrawal by Subject|1
4406750|NCT00210184|7185388|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2
4406751|NCT00210626|7185419|FG000|Overall Study|Adverse Event|1
4406752|NCT00210626|7185420|FG001|Overall Study|Adverse Event|2
4406753|NCT00210626|7185419|FG000|Overall Study|Protocol Violation|1
4406754|NCT00210626|7185420|FG001|Overall Study|Protocol Violation|5
4406755|NCT00210626|7185419|FG000|Overall Study|Lost to Follow-up|11
4406756|NCT00210626|7185420|FG001|Overall Study|Lost to Follow-up|11
4406757|NCT00210626|7185419|FG000|Overall Study|Death|1
4406758|NCT00210626|7185420|FG001|Overall Study|Death|0
4406759|NCT00210626|7185419|FG000|Overall Study|Withdrawal by Subject|29
4406760|NCT00210626|7185420|FG001|Overall Study|Withdrawal by Subject|20
4406761|NCT00210626|7185419|FG000|Overall Study|Physician Decision|0
4406762|NCT00210626|7185420|FG001|Overall Study|Physician Decision|2
4406763|NCT00210626|7185419|FG000|Overall Study|Sponser Request|1
4406764|NCT00210626|7185420|FG001|Overall Study|Sponser Request|0
4406765|NCT00210626|7185419|FG000|Overall Study|Other|4
4406766|NCT00210626|7185420|FG001|Overall Study|Other|5
4406767|NCT00210639|7185428|FG000|Overall Study|Lost to Follow-up|37
4406768|NCT00210639|7185429|FG001|Overall Study|Lost to Follow-up|29
4406769|NCT00210639|7185428|FG000|Overall Study|Withdrawal by Subject|8
4406770|NCT00210639|7185429|FG001|Overall Study|Withdrawal by Subject|1
4406771|NCT00210639|7185428|FG000|Overall Study|Other|18
4406772|NCT00210639|7185429|FG001|Overall Study|Other|12
4406773|NCT00211081|7185435|FG000|Overall Study|Withdrawal by Subject|2
4406774|NCT00211172|7185441|FG000|Overall Study|Died or lost health plan eligibility|39
4406775|NCT00211172|7185442|FG001|Overall Study|Died or lost health plan eligibility|32
4406776|NCT00211185|7185448|FG000|Overall Study|Death|2
4406777|NCT00211185|7185448|FG000|Overall Study|Disease progression|7
4406778|NCT00211185|7185448|FG000|Overall Study|Withdrawal by Subject|6
4406779|NCT00211185|7185448|FG000|Overall Study|Physician Decision|5
4406780|NCT00211237|7185454|FG000|Baseline|Withdrew|1
4406781|NCT00211237|7185455|FG001|Baseline|Withdrew|3
4406782|NCT00211237|7185456|FG002|Baseline|Withdrew|0
4406783|NCT00211237|7185454|FG000|Baseline|Refused random assignment|1
4406784|NCT00211237|7185455|FG001|Baseline|Refused random assignment|0
4406785|NCT00211237|7185456|FG002|Baseline|Refused random assignment|0
4406786|NCT00211237|7185454|FG000|1 Month|Death|2
4406787|NCT00211237|7185455|FG001|1 Month|Death|1
4406788|NCT00211237|7185456|FG002|1 Month|Death|0
4406789|NCT00211237|7185454|FG000|1 Month|Lost to Follow-up|0
4406790|NCT00211237|7185455|FG001|1 Month|Lost to Follow-up|2
4406791|NCT00211237|7185456|FG002|1 Month|Lost to Follow-up|0
4406792|NCT00211237|7185454|FG000|1 Month|Withdrew|0
4406793|NCT00211237|7185455|FG001|1 Month|Withdrew|4
4406794|NCT00211237|7185456|FG002|1 Month|Withdrew|0
4406795|NCT00211237|7185454|FG000|1 Month|Additional surgery needed|1
4406796|NCT00211237|7185455|FG001|1 Month|Additional surgery needed|0
4406797|NCT00211237|7185456|FG002|1 Month|Additional surgery needed|0
4406798|NCT00211237|7185454|FG000|1 Month|Non-medical problem|0
4406799|NCT00211237|7185455|FG001|1 Month|Non-medical problem|2
4406800|NCT00211237|7185456|FG002|1 Month|Non-medical problem|0
4406801|NCT00211237|7185454|FG000|3 Months|Death|7
4406802|NCT00211237|7185455|FG001|3 Months|Death|3
4406803|NCT00211237|7185456|FG002|3 Months|Death|0
4406804|NCT00211237|7185454|FG000|3 Months|Could not comply with protocol|1
4406805|NCT00211237|7185455|FG001|3 Months|Could not comply with protocol|0
4406806|NCT00211237|7185456|FG002|3 Months|Could not comply with protocol|0
4406807|NCT00211237|7185454|FG000|3 Months|Withdrew|0
4406808|NCT00211237|7185455|FG001|3 Months|Withdrew|1
4406809|NCT00211237|7185456|FG002|3 Months|Withdrew|0
4406810|NCT00211237|7185454|FG000|3 Months|Non-medical problem|0
4406811|NCT00211237|7185455|FG001|3 Months|Non-medical problem|0
4406812|NCT00211237|7185456|FG002|3 Months|Non-medical problem|1
4406813|NCT00211237|7185454|FG000|6 Months|Death|6
4406814|NCT00211237|7185455|FG001|6 Months|Death|0
4406815|NCT00211237|7185456|FG002|6 Months|Death|3
4406816|NCT00211237|7185454|FG000|6 Months|Lost to Follow-up|2
4406817|NCT00211237|7185455|FG001|6 Months|Lost to Follow-up|0
4406818|NCT00211237|7185456|FG002|6 Months|Lost to Follow-up|0
4406819|NCT00211237|7185454|FG000|6 Months|Could not comply with protocol|0
4406820|NCT00211237|7185455|FG001|6 Months|Could not comply with protocol|2
4406821|NCT00211237|7185456|FG002|6 Months|Could not comply with protocol|0
4406822|NCT00211237|7185454|FG000|12 Months|Death|8
4406823|NCT00211237|7185455|FG001|12 Months|Death|2
4406824|NCT00211237|7185456|FG002|12 Months|Death|3
4406825|NCT00211237|7185454|FG000|12 Months|Lost to Follow-up|1
4406826|NCT00211237|7185455|FG001|12 Months|Lost to Follow-up|0
4406827|NCT00211237|7185456|FG002|12 Months|Lost to Follow-up|1
4406828|NCT00211237|7185454|FG000|12 Months|Withdrew|0
4406829|NCT00211237|7185455|FG001|12 Months|Withdrew|0
4406830|NCT00211237|7185456|FG002|12 Months|Withdrew|1
4406831|NCT00211237|7185454|FG000|12 Months|unrelated medical problem|0
4406832|NCT00211237|7185455|FG001|12 Months|unrelated medical problem|0
4406833|NCT00211237|7185456|FG002|12 Months|unrelated medical problem|1
4406834|NCT00211510|7185475|FG000|Overall Study|Physician Decision|3
4406835|NCT00211510|7185476|FG001|Overall Study|Physician Decision|1
4406836|NCT00211510|7185475|FG000|Overall Study|Withdrawal by Subject|3
4406837|NCT00211510|7185476|FG001|Overall Study|Withdrawal by Subject|1
4406838|NCT00211536|7185487|FG000|Overall Study|Withdrawal by Subject|2
4406839|NCT00211536|7185488|FG001|Overall Study|Withdrawal by Subject|2
4406840|NCT00211536|7185487|FG000|Overall Study|Physician Decision|0
4406841|NCT00211536|7185488|FG001|Overall Study|Physician Decision|5
4406842|NCT00211536|7185487|FG000|Overall Study|Adverse Event|2
4406843|NCT00211536|7185488|FG001|Overall Study|Adverse Event|0
4406844|NCT00211757|7185505|FG000|Overall Study|Withdrawal by Subject|1
4406845|NCT00211757|7185506|FG001|Overall Study|Withdrawal by Subject|1
4406846|NCT00211757|7185505|FG000|Overall Study|Lack of Efficacy|0
4406847|NCT00211757|7185506|FG001|Overall Study|Lack of Efficacy|1
4406848|NCT00211809|7185514|FG000|Overall Study|Lack of Efficacy|1
4406849|NCT00211809|7185514|FG000|Overall Study|Lost to Follow-up|2
4406850|NCT00211809|7185514|FG000|Overall Study|Pregnancy|1
4406851|NCT00211809|7185514|FG000|Overall Study|side effects|2
4406852|NCT00211887|7185523|FG000|Overall Study|Adverse Event|8
4406853|NCT00211887|7185524|FG001|Overall Study|Adverse Event|4
4406854|NCT00211887|7185525|FG002|Overall Study|Adverse Event|6
4406855|NCT00211887|7185523|FG000|Overall Study|Death|1
4406856|NCT00211887|7185524|FG001|Overall Study|Death|1
4406857|NCT00211887|7185525|FG002|Overall Study|Death|1
4406858|NCT00211887|7185523|FG000|Overall Study|Lost to Follow-up|28
4629025|NCT01867710|7496628|FG003|Overall Study|Lost to Follow-up|2
4629026|NCT01867710|7496625|FG000|Overall Study|Withdrawal of consent|2
4629027|NCT01867710|7496626|FG001|Overall Study|Withdrawal of consent|5
4406859|NCT00211887|7185524|FG001|Overall Study|Lost to Follow-up|13
4406860|NCT00211887|7185525|FG002|Overall Study|Lost to Follow-up|9
4406861|NCT00211887|7185523|FG000|Overall Study|Non-medical reason|31
4406862|NCT00211887|7185524|FG001|Overall Study|Non-medical reason|14
4406863|NCT00211887|7185525|FG002|Overall Study|Non-medical reason|8
4406864|NCT00211887|7185523|FG000|Overall Study|Other medical reason|15
4406865|NCT00211887|7185524|FG001|Overall Study|Other medical reason|11
4406866|NCT00211887|7185525|FG002|Overall Study|Other medical reason|7
4406867|NCT00211887|7185523|FG000|Overall Study|Side effects|19
4406868|NCT00211887|7185524|FG001|Overall Study|Side effects|13
4406869|NCT00211887|7185525|FG002|Overall Study|Side effects|5
4406870|NCT00212355|7185559|FG000|Overall Study|Adverse Event|1
4406871|NCT00212355|7185559|FG000|Overall Study|Withdrawal by Subject|1
4406872|NCT00212355|7185559|FG000|Overall Study|A change of address|1
4406873|NCT00212758|7185567|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1
4406874|NCT00212758|7185568|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0
4406875|NCT00212758|7185567|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1
4406876|NCT00212758|7185568|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1
4406877|NCT00213135|7185592|FG000|Overall Study|Adverse Event|9
4406878|NCT00213135|7185593|FG001|Overall Study|Adverse Event|5
4406879|NCT00213135|7185594|FG002|Overall Study|Adverse Event|5
4406880|NCT00213135|7185592|FG000|Overall Study|Lost to Follow-up|11
4406881|NCT00213135|7185593|FG001|Overall Study|Lost to Follow-up|8
4406882|NCT00213135|7185594|FG002|Overall Study|Lost to Follow-up|4
4406883|NCT00213135|7185592|FG000|Overall Study|Protocol Violation|4
4406884|NCT00213135|7185593|FG001|Overall Study|Protocol Violation|4
4406885|NCT00213135|7185594|FG002|Overall Study|Protocol Violation|10
4406886|NCT00213135|7185592|FG000|Overall Study|Death|1
4406887|NCT00213135|7185593|FG001|Overall Study|Death|1
4406888|NCT00213135|7185594|FG002|Overall Study|Death|2
4406889|NCT00213135|7185592|FG000|Overall Study|Disease progression|4
4406890|NCT00213135|7185593|FG001|Overall Study|Disease progression|5
4406891|NCT00213135|7185594|FG002|Overall Study|Disease progression|21
4406892|NCT00213135|7185592|FG000|Overall Study|Other|21
4406893|NCT00213135|7185593|FG001|Overall Study|Other|12
4406894|NCT00213135|7185594|FG002|Overall Study|Other|15
4406895|NCT00213148|7185606|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1
4406896|NCT00213148|7185607|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0
4406897|NCT00213148|7185608|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2
4406898|NCT00213148|7185609|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2
4406899|NCT00213148|7185610|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1
4406900|NCT00213148|7185606|FG000|Cycle 1 (1 Month)|Adverse Event|0
4406901|NCT00213148|7185607|FG001|Cycle 1 (1 Month)|Adverse Event|0
4406902|NCT00213148|7185608|FG002|Cycle 1 (1 Month)|Adverse Event|1
4406903|NCT00213148|7185609|FG003|Cycle 1 (1 Month)|Adverse Event|0
4406904|NCT00213148|7185610|FG004|Cycle 1 (1 Month)|Adverse Event|0
4406905|NCT00213148|7185606|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4
4406906|NCT00213148|7185607|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0
4406907|NCT00213148|7185608|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8
4406908|NCT00213148|7185609|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5
4406909|NCT00213148|7185610|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8
4406910|NCT00213148|7185606|FG000|Cycle 1 (1 Month)|Protocol Violation|1
4406911|NCT00213148|7185607|FG001|Cycle 1 (1 Month)|Protocol Violation|0
4406912|NCT00213148|7185608|FG002|Cycle 1 (1 Month)|Protocol Violation|1
4406913|NCT00213148|7185609|FG003|Cycle 1 (1 Month)|Protocol Violation|0
4406914|NCT00213148|7185610|FG004|Cycle 1 (1 Month)|Protocol Violation|0
4406915|NCT00213148|7185606|FG000|Cycle 1 (1 Month)|Other|3
4406916|NCT00213148|7185607|FG001|Cycle 1 (1 Month)|Other|0
4406917|NCT00213148|7185608|FG002|Cycle 1 (1 Month)|Other|2
4406918|NCT00213148|7185609|FG003|Cycle 1 (1 Month)|Other|2
4406919|NCT00213148|7185610|FG004|Cycle 1 (1 Month)|Other|7
4406920|NCT00213148|7185606|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
4406921|NCT00213148|7185607|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
4406922|NCT00213148|7185608|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
4406923|NCT00213148|7185609|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1
4406924|NCT00213148|7185610|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
4406925|NCT00213148|7185606|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
4406926|NCT00213148|7185607|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
4406927|NCT00213148|7185608|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
4406928|NCT00213148|7185609|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
4406929|NCT00213148|7185610|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1
4406930|NCT00213148|7185606|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15
4406931|NCT00213148|7185607|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0
4406932|NCT00213148|7185608|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5
4406933|NCT00213148|7185609|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8
4406934|NCT00213148|7185610|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5
4406935|NCT00213148|7185606|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0
4406936|NCT00213148|7185607|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0
4406937|NCT00213148|7185608|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2
4406938|NCT00213148|7185609|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2
4406939|NCT00213148|7185610|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1
4406940|NCT00213148|7185606|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1
4406941|NCT00213148|7185607|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3
4406942|NCT00213148|7185608|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7
4406943|NCT00213148|7185609|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6
4406944|NCT00213148|7185610|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16
4406945|NCT00213148|7185606|FG000|Cycle 2 (1 Month)|Other|2
4406946|NCT00213148|7185607|FG001|Cycle 2 (1 Month)|Other|1
4406947|NCT00213148|7185608|FG002|Cycle 2 (1 Month)|Other|2
4406948|NCT00213148|7185609|FG003|Cycle 2 (1 Month)|Other|8
4406949|NCT00213148|7185610|FG004|Cycle 2 (1 Month)|Other|7
4406950|NCT00213148|7185606|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
4406951|NCT00213148|7185607|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1
4406952|NCT00213148|7185608|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
4406953|NCT00213148|7185609|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
4406954|NCT00213148|7185610|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
4406955|NCT00213148|7185606|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1
4406956|NCT00213148|7185607|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
4406957|NCT00213148|7185608|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
4406958|NCT00213148|7185609|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
4406959|NCT00213148|7185610|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
4406960|NCT00213148|7185606|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10
4406961|NCT00213148|7185607|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1
4406962|NCT00213148|7185608|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3
4406963|NCT00213148|7185609|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3
4406964|NCT00213148|7185610|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6
4406965|NCT00213148|7185606|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0
4406966|NCT00213148|7185607|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2
4406967|NCT00213148|7185608|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0
4406968|NCT00213148|7185609|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0
4406969|NCT00213148|7185610|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1
4406970|NCT00213148|7185606|FG000|Cycle 3 (1 Month)|Other|0
4406971|NCT00213148|7185607|FG001|Cycle 3 (1 Month)|Other|0
4406972|NCT00213148|7185608|FG002|Cycle 3 (1 Month)|Other|1
4406973|NCT00213148|7185609|FG003|Cycle 3 (1 Month)|Other|1
4406974|NCT00213148|7185610|FG004|Cycle 3 (1 Month)|Other|0
4406975|NCT00213980|7185641|FG000|Overall Study|Withdrawal by Subject|3
4406976|NCT00213980|7185642|FG001|Overall Study|Withdrawal by Subject|1
4406977|NCT00213980|7185641|FG000|Overall Study|Adverse Event|1
4406978|NCT00213980|7185642|FG001|Overall Study|Adverse Event|1
4406979|NCT00213980|7185641|FG000|Overall Study|Disease progression|0
4406980|NCT00213980|7185642|FG001|Overall Study|Disease progression|2
4406981|NCT00213980|7185641|FG000|Overall Study|Developed ovarian cancer|1
4406982|NCT00213980|7185642|FG001|Overall Study|Developed ovarian cancer|0
4406983|NCT00213980|7185641|FG000|Overall Study|Failed to obtain all 3 DXAs|1
4406984|NCT00213980|7185642|FG001|Overall Study|Failed to obtain all 3 DXAs|3
4406985|NCT00214019|7185648|FG000|Overall Study|Lost to Follow-up|11
4406986|NCT00214019|7185648|FG000|Overall Study|Withdrawal by Subject|2
4406987|NCT00214019|7185648|FG000|Overall Study|Screen Failed prior to randomization|17
4511454|NCT00927082|7320532|FG000|Overall Study|Lost to Follow-up|9
4511455|NCT00927082|7320533|FG001|Overall Study|Lost to Follow-up|8
4511456|NCT00927082|7320534|FG002|Overall Study|Lost to Follow-up|12
4511457|NCT00927082|7320535|FG003|Overall Study|Lost to Follow-up|16
4511458|NCT00927082|7320532|FG000|Overall Study|Withdrawal by Subject|3
4511459|NCT00927082|7320533|FG001|Overall Study|Withdrawal by Subject|2
4511460|NCT00927082|7320534|FG002|Overall Study|Withdrawal by Subject|7
4511461|NCT00927082|7320535|FG003|Overall Study|Withdrawal by Subject|2
4511462|NCT00927082|7320532|FG000|Overall Study|Death|0
4511463|NCT00927082|7320533|FG001|Overall Study|Death|0
4629028|NCT01867710|7496627|FG002|Overall Study|Withdrawal of consent|1
4629029|NCT01867710|7496628|FG003|Overall Study|Withdrawal of consent|2
4511464|NCT00927082|7320534|FG002|Overall Study|Death|1
4511465|NCT00927082|7320535|FG003|Overall Study|Death|0
4511466|NCT00927082|7320532|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0
4511467|NCT00927082|7320533|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0
4511468|NCT00927082|7320534|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2
4511469|NCT00927082|7320535|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1
4511470|NCT00927095|7320552|FG000|Overall Study|Adverse Event|3
4511471|NCT00927095|7320553|FG001|Overall Study|Adverse Event|1
4511472|NCT00927095|7320554|FG002|Overall Study|Adverse Event|0
4511473|NCT00927095|7320552|FG000|Overall Study|Withdrawal by Subject|2
4511474|NCT00927095|7320553|FG001|Overall Study|Withdrawal by Subject|1
4511475|NCT00927095|7320554|FG002|Overall Study|Withdrawal by Subject|1
4511476|NCT00927095|7320552|FG000|Overall Study|Physician Decision|1
4511477|NCT00927095|7320553|FG001|Overall Study|Physician Decision|2
4511478|NCT00927095|7320554|FG002|Overall Study|Physician Decision|1
4511479|NCT00927186|7320573|FG000|12 Months Primary Study|Adverse Event|5
4511480|NCT00927186|7320574|FG001|12 Months Primary Study|Adverse Event|2
4511481|NCT00927186|7320573|FG000|12 Months Primary Study|Lost to Follow-up|1
4511482|NCT00927186|7320574|FG001|12 Months Primary Study|Lost to Follow-up|0
4511483|NCT00927186|7320573|FG000|12 Months Primary Study|Protocol Violation|0
4511484|NCT00927186|7320574|FG001|12 Months Primary Study|Protocol Violation|1
4511485|NCT00927186|7320573|FG000|12 Months Primary Study|Withdrawal by Subject|1
4511486|NCT00927186|7320574|FG001|12 Months Primary Study|Withdrawal by Subject|1
4518424|NCT00973921|7330565|FG000|Overall Study|IVUS results were not available|9
4518425|NCT00973973|7330571|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1
4629030|NCT01867710|7496625|FG000|Overall Study|Study Terminated by Sponsor|9
4518426|NCT00973973|7330572|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3
4518427|NCT00973973|7330571|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1
4518428|NCT00973973|7330572|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0
4518429|NCT00973973|7330571|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1
4518430|NCT00973973|7330572|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3
4518431|NCT00973973|7330571|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1
4518432|NCT00973973|7330572|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0
4518433|NCT00973973|7330571|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1
4518434|NCT00973973|7330572|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1
4518435|NCT00973973|7330571|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1
4713491|NCT02948582|7641069|FG002|Washout Period 4|Adverse Event|1
4713492|NCT02948582|7641070|FG003|Washout Period 4|Adverse Event|0
4713493|NCT02948582|7641071|FG004|Washout Period 4|Adverse Event|0
4713494|NCT02948582|7641072|FG005|Washout Period 4|Adverse Event|0
4713495|NCT02948634|7641088|FG000|Overall Study|Lack of efficacy and study suspended|10
4713496|NCT02948634|7641089|FG001|Overall Study|Lack of efficacy and study suspended|2
4736074|NCT03555890|7684829|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0
4736075|NCT03555890|7684830|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1
4736076|NCT03556891|7684862|FG000|Overall Study|Adverse Event|4
4736077|NCT03556891|7684862|FG000|Overall Study|MRI Need|3
4736078|NCT03556891|7684862|FG000|Overall Study|Device Failure|1
4736079|NCT03556891|7684862|FG000|Overall Study|Death|1
4736080|NCT03556891|7684862|FG000|Overall Study|Lost to Follow-up|1
4736081|NCT03556891|7684862|FG000|Overall Study|Missing at random|1
4736082|NCT03556891|7684862|FG000|Overall Study|Missing due to COVID|1
4736083|NCT03556891|7684862|FG000|Overall Study|Protocol Violation|1
4736084|NCT03557034|7684868|FG000|Overall Study|Withdrawal by Subject|1
4736085|NCT03557034|7684869|FG001|Overall Study|Withdrawal by Subject|0
4736086|NCT03557775|7684926|FG000|Overall Study|Withdrawal by Subject|1
4736087|NCT03557775|7684927|FG001|Overall Study|Withdrawal by Subject|2
4736088|NCT03557775|7684928|FG002|Overall Study|Withdrawal by Subject|4
4736089|NCT03557775|7684926|FG000|Overall Study|Physician Decision|0
4736090|NCT03557775|7684927|FG001|Overall Study|Physician Decision|1
4736091|NCT03557775|7684928|FG002|Overall Study|Physician Decision|0
4736092|NCT03557801|7684939|FG000|Overall Study|Protocol Violation|1
4736093|NCT03557801|7684940|FG001|Overall Study|Protocol Violation|0
4736094|NCT03557801|7684941|FG002|Overall Study|Protocol Violation|0
4736095|NCT03557801|7684939|FG000|Overall Study|Withdrawal by Subject|1
4736096|NCT03557801|7684940|FG001|Overall Study|Withdrawal by Subject|0
4736097|NCT03557801|7684941|FG002|Overall Study|Withdrawal by Subject|3
4736098|NCT03557801|7684939|FG000|Overall Study|Lost to Follow-up|0
4736099|NCT03557801|7684940|FG001|Overall Study|Lost to Follow-up|1
4736100|NCT03557801|7684941|FG002|Overall Study|Lost to Follow-up|0
4736101|NCT03557931|7684952|FG000|Overall Study|Adverse Event|4
4736102|NCT03557931|7684953|FG001|Overall Study|Adverse Event|6
4736103|NCT03557931|7684954|FG002|Overall Study|Adverse Event|1
4736104|NCT03557931|7684952|FG000|Overall Study|Lost to Follow-up|4
4736105|NCT03557931|7684953|FG001|Overall Study|Lost to Follow-up|4
4736106|NCT03557931|7684954|FG002|Overall Study|Lost to Follow-up|1
4736107|NCT03557931|7684952|FG000|Overall Study|Protocol Violation|1
4736108|NCT03557931|7684953|FG001|Overall Study|Protocol Violation|4
4736109|NCT03557931|7684954|FG002|Overall Study|Protocol Violation|1
4736110|NCT03557931|7684952|FG000|Overall Study|Withdrawal by Subject|14
4736111|NCT03557931|7684953|FG001|Overall Study|Withdrawal by Subject|0
4736112|NCT03557931|7684954|FG002|Overall Study|Withdrawal by Subject|7
4736113|NCT03557931|7684952|FG000|Overall Study|Miscellaneous|8
4736114|NCT03557931|7684953|FG001|Overall Study|Miscellaneous|5
4736115|NCT03557931|7684954|FG002|Overall Study|Miscellaneous|3
4736116|NCT03558516|7684984|FG000|Overall Study|Protocol Violation|2
4736117|NCT03558516|7684985|FG001|Overall Study|Protocol Violation|2
4736118|NCT03558555|7684993|FG000|Overall Study|Lost to Follow-up|2
4736119|NCT03558555|7684994|FG001|Overall Study|Lost to Follow-up|1
4736120|NCT03558672|7685000|FG000|Overall Study|Study Early Termination|10
4736121|NCT03558997|7685008|FG000|Overall Study|Adverse Event|0
4736122|NCT03558997|7685009|FG001|Overall Study|Adverse Event|2
4736123|NCT03558997|7685010|FG002|Overall Study|Adverse Event|5
4736124|NCT03558997|7685011|FG003|Overall Study|Adverse Event|1
4736125|NCT03558997|7685008|FG000|Overall Study|Physician Decision|0
4736126|NCT03558997|7685009|FG001|Overall Study|Physician Decision|0
4736127|NCT03558997|7685010|FG002|Overall Study|Physician Decision|1
4736128|NCT03558997|7685011|FG003|Overall Study|Physician Decision|0
4736129|NCT03558997|7685008|FG000|Overall Study|Withdrawal by Subject|1
4736130|NCT03558997|7685009|FG001|Overall Study|Withdrawal by Subject|0
4736131|NCT03558997|7685010|FG002|Overall Study|Withdrawal by Subject|1
4736132|NCT03558997|7685011|FG003|Overall Study|Withdrawal by Subject|1
4736133|NCT03558997|7685008|FG000|Overall Study|Lost to Follow-up|0
4736134|NCT03558997|7685009|FG001|Overall Study|Lost to Follow-up|0
4736135|NCT03558997|7685010|FG002|Overall Study|Lost to Follow-up|1
4736136|NCT03558997|7685011|FG003|Overall Study|Lost to Follow-up|0
4736137|NCT03559062|7685027|FG000|Overall Study|Other|0
4736138|NCT03559062|7685028|FG001|Overall Study|Other|1
4736139|NCT03559062|7685029|FG002|Overall Study|Other|0
4736140|NCT03559218|7685071|FG000|Overall Study|Withdrawal by Subject|1
4736141|NCT03559218|7685072|FG001|Overall Study|Withdrawal by Subject|0
4736142|NCT03559257|7685080|FG000|Double Blind Treatment Period|Withdrawal by Subject|2
4736143|NCT03559257|7685081|FG001|Double Blind Treatment Period|Withdrawal by Subject|1
4736144|NCT03559257|7685080|FG000|Double Blind Treatment Period|Protocol Violation|1
4736145|NCT03559257|7685081|FG001|Double Blind Treatment Period|Protocol Violation|4
4736146|NCT03559257|7685080|FG000|Double Blind Treatment Period|Lack of Efficacy|1
4736147|NCT03559257|7685081|FG001|Double Blind Treatment Period|Lack of Efficacy|1
4736148|NCT03559257|7685080|FG000|Double Blind Treatment Period|Adverse Event|0
4736149|NCT03559257|7685081|FG001|Double Blind Treatment Period|Adverse Event|1
4736150|NCT03559257|7685080|FG000|Double Blind Treatment Period|Screen Failure|0
4736151|NCT03559257|7685081|FG001|Double Blind Treatment Period|Screen Failure|1
4713497|NCT02948777|7641095|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1
4713498|NCT02948829|7641100|FG000|Overall Study|Withdrawal by Subject|4
4713499|NCT02948829|7641100|FG000|Overall Study|Ongoing (at data cut-off date: 29 May 2018)|195
4713500|NCT02948829|7641100|FG000|Overall Study|Non-Compliance with Study Procedures|1
4713501|NCT02949011|7641122|FG000|Overall Study|Adverse Event|6
4713502|NCT02949011|7641123|FG001|Overall Study|Adverse Event|7
4713503|NCT02949011|7641124|FG002|Overall Study|Adverse Event|3
4713504|NCT02949011|7641122|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0
4713505|NCT02949011|7641123|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0
4713506|NCT02949011|7641124|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3
4713507|NCT02949011|7641122|FG000|Overall Study|Protocol Deviation|5
4713508|NCT02949011|7641123|FG001|Overall Study|Protocol Deviation|3
4713509|NCT02949011|7641124|FG002|Overall Study|Protocol Deviation|3
4713510|NCT02949011|7641122|FG000|Overall Study|Lack of Efficacy|0
4713511|NCT02949011|7641123|FG001|Overall Study|Lack of Efficacy|2
4713512|NCT02949011|7641124|FG002|Overall Study|Lack of Efficacy|0
4713513|NCT02949011|7641122|FG000|Overall Study|Withdrawal by Subject|13
4713514|NCT02949011|7641123|FG001|Overall Study|Withdrawal by Subject|13
4713515|NCT02949011|7641124|FG002|Overall Study|Withdrawal by Subject|21
4713516|NCT02949011|7641122|FG000|Overall Study|Lost to Follow-up|7
4713517|NCT02949011|7641123|FG001|Overall Study|Lost to Follow-up|5
4713518|NCT02949011|7641124|FG002|Overall Study|Lost to Follow-up|5
4713519|NCT02949011|7641122|FG000|Overall Study|Death|0
4713520|NCT02949011|7641123|FG001|Overall Study|Death|0
4713521|NCT02949011|7641124|FG002|Overall Study|Death|1
4713522|NCT02949011|7641122|FG000|Overall Study|Miscellaneous|2
4406988|NCT00214136|7185683|FG000|Overall Study|Death|5
4406989|NCT00214201|7185689|FG000|Overall Study|Withdrawal by Subject|2
4406990|NCT00214201|7185690|FG001|Overall Study|Withdrawal by Subject|0
4406991|NCT00214201|7185689|FG000|Overall Study|Death|0
4406992|NCT00214201|7185690|FG001|Overall Study|Death|2
4406993|NCT00214383|7185699|FG000|Overall Study|Lost to Follow-up|16
4406994|NCT00214383|7185700|FG001|Overall Study|Lost to Follow-up|26
4406995|NCT00214422|7185709|FG000|Overall Study|Physician Decision|2
4406996|NCT00214422|7185710|FG001|Overall Study|Physician Decision|0
4406997|NCT00214422|7185711|FG002|Overall Study|Physician Decision|0
4406998|NCT00214422|7185709|FG000|Overall Study|Developed esophageal ca|1
4406999|NCT00214422|7185710|FG001|Overall Study|Developed esophageal ca|0
4407000|NCT00214422|7185711|FG002|Overall Study|Developed esophageal ca|0
4407001|NCT00214422|7185709|FG000|Overall Study|Pt taken off study|1
4407002|NCT00214422|7185710|FG001|Overall Study|Pt taken off study|1
4407003|NCT00214422|7185711|FG002|Overall Study|Pt taken off study|0
4407004|NCT00214422|7185709|FG000|Overall Study|Disease progression on study|1
4407005|NCT00214422|7185710|FG001|Overall Study|Disease progression on study|0
4407006|NCT00214422|7185711|FG002|Overall Study|Disease progression on study|0
4407007|NCT00214422|7185709|FG000|Overall Study|Unable to make a radiation treatment|0
4407008|NCT00214422|7185710|FG001|Overall Study|Unable to make a radiation treatment|0
4407009|NCT00214422|7185711|FG002|Overall Study|Unable to make a radiation treatment|1
4407010|NCT00214461|7185727|FG000|Overall Study|Adverse Event|0
4407011|NCT00214461|7185728|FG001|Overall Study|Adverse Event|0
4407012|NCT00214461|7185729|FG002|Overall Study|Adverse Event|1
4407013|NCT00214461|7185730|FG003|Overall Study|Adverse Event|1
4407014|NCT00214461|7185727|FG000|Overall Study|Withdrawal by Subject|0
4407015|NCT00214461|7185728|FG001|Overall Study|Withdrawal by Subject|0
4407016|NCT00214461|7185729|FG002|Overall Study|Withdrawal by Subject|1
4407017|NCT00214461|7185730|FG003|Overall Study|Withdrawal by Subject|0
4407018|NCT00215137|7185803|FG000|Open Label Escitalopram|Lack of Efficacy|1
4407019|NCT00215137|7185804|FG001|Open Label Escitalopram|Lack of Efficacy|0
4407020|NCT00215137|7185805|FG002|Open Label Escitalopram|Lack of Efficacy|0
4407021|NCT00215137|7185803|FG000|Randomization Period|Lost to Follow-up|0
4407022|NCT00215137|7185804|FG001|Randomization Period|Lost to Follow-up|1
4407023|NCT00215137|7185805|FG002|Randomization Period|Lost to Follow-up|0
4407024|NCT00215137|7185803|FG000|Randomization Period|Withdrawal by Subject|0
4407025|NCT00215137|7185804|FG001|Randomization Period|Withdrawal by Subject|1
4407026|NCT00215137|7185805|FG002|Randomization Period|Withdrawal by Subject|0
4407027|NCT00215150|7185813|FG000|Open Label Phase|Lost to Follow-up|7
4407028|NCT00215150|7185813|FG000|Open Label Phase|Withdrawal by Subject|1
4407029|NCT00215150|7185813|FG000|Open Label Phase|Did not complete a post base visit|13
4407030|NCT00215150|7185813|FG000|Open Label Phase|Did not meet randomization criteria|9
4407031|NCT00215150|7185813|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2
4407032|NCT00215150|7185813|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1
4407033|NCT00215150|7185813|FG000|Randomization Phase Placebo|Withdrawal by Subject|1
4407034|NCT00215540|7185824|FG000|Overall Study|Withdrew from study medication|1
4407035|NCT00215540|7185825|FG001|Overall Study|Withdrew from study medication|0
4407036|NCT00215540|7185826|FG002|Overall Study|Withdrew from study medication|0
4407037|NCT00215553|7185841|FG000|Overall Study|Adverse Event|0
4407038|NCT00215553|7185842|FG001|Overall Study|Adverse Event|1
4407039|NCT00215553|7185843|FG002|Overall Study|Adverse Event|2
4407040|NCT00215553|7185844|FG003|Overall Study|Adverse Event|1
4407041|NCT00215553|7185845|FG004|Overall Study|Adverse Event|2
4713523|NCT02949011|7641123|FG001|Overall Study|Miscellaneous|4
4713524|NCT02949011|7641124|FG002|Overall Study|Miscellaneous|6
4407042|NCT00215553|7185846|FG005|Overall Study|Adverse Event|6
4407043|NCT00215553|7185847|FG006|Overall Study|Adverse Event|0
4407044|NCT00215644|7185865|FG000|Overall Study|Disease Progression|28
4407045|NCT00215644|7185866|FG001|Overall Study|Disease Progression|10
4407046|NCT00215644|7185865|FG000|Overall Study|Adverse Event|2
4407047|NCT00215644|7185866|FG001|Overall Study|Adverse Event|9
4407048|NCT00215644|7185865|FG000|Overall Study|Death|1
4407049|NCT00215644|7185866|FG001|Overall Study|Death|2
4407050|NCT00215644|7185865|FG000|Overall Study|Withdrawal by Subject|1
4407051|NCT00215644|7185866|FG001|Overall Study|Withdrawal by Subject|0
4407052|NCT00215644|7185865|FG000|Overall Study|Other|3
4407053|NCT00215644|7185866|FG001|Overall Study|Other|15
4407054|NCT00215644|7185865|FG000|Overall Study|Randomized but Not Treated|1
4407055|NCT00215644|7185866|FG001|Overall Study|Randomized but Not Treated|0
4407056|NCT00215657|7185880|FG000|Overall Study|Adverse Event|5
4407057|NCT00215657|7185881|FG001|Overall Study|Adverse Event|1
4407058|NCT00215657|7185882|FG002|Overall Study|Adverse Event|3
4407059|NCT00215657|7185883|FG003|Overall Study|Adverse Event|0
4407060|NCT00215657|7185884|FG004|Overall Study|Adverse Event|3
4407061|NCT00215657|7185885|FG005|Overall Study|Adverse Event|1
4407062|NCT00215657|7185886|FG006|Overall Study|Adverse Event|0
4407063|NCT00215657|7185887|FG007|Overall Study|Adverse Event|3
4407064|NCT00215657|7185880|FG000|Overall Study|Withdrawal by Subject|6
4407065|NCT00215657|7185881|FG001|Overall Study|Withdrawal by Subject|3
4407066|NCT00215657|7185882|FG002|Overall Study|Withdrawal by Subject|3
4407067|NCT00215657|7185883|FG003|Overall Study|Withdrawal by Subject|1
4407068|NCT00215657|7185884|FG004|Overall Study|Withdrawal by Subject|6
4407069|NCT00215657|7185885|FG005|Overall Study|Withdrawal by Subject|1
4407070|NCT00215657|7185886|FG006|Overall Study|Withdrawal by Subject|10
4407071|NCT00215657|7185887|FG007|Overall Study|Withdrawal by Subject|3
4407072|NCT00215657|7185880|FG000|Overall Study|Insuff prostate specific antigen resp|3
4407073|NCT00215657|7185881|FG001|Overall Study|Insuff prostate specific antigen resp|2
4407074|NCT00215657|7185882|FG002|Overall Study|Insuff prostate specific antigen resp|2
4407075|NCT00215657|7185883|FG003|Overall Study|Insuff prostate specific antigen resp|2
4407076|NCT00215657|7185884|FG004|Overall Study|Insuff prostate specific antigen resp|1
4407077|NCT00215657|7185885|FG005|Overall Study|Insuff prostate specific antigen resp|2
4407078|NCT00215657|7185886|FG006|Overall Study|Insuff prostate specific antigen resp|3
4407079|NCT00215657|7185887|FG007|Overall Study|Insuff prostate specific antigen resp|2
4407080|NCT00215657|7185880|FG000|Overall Study|Insufficient testosterone response|5
4407081|NCT00215657|7185881|FG001|Overall Study|Insufficient testosterone response|4
4407082|NCT00215657|7185882|FG002|Overall Study|Insufficient testosterone response|1
4407083|NCT00215657|7185883|FG003|Overall Study|Insufficient testosterone response|12
4407084|NCT00215657|7185884|FG004|Overall Study|Insufficient testosterone response|8
4407085|NCT00215657|7185885|FG005|Overall Study|Insufficient testosterone response|12
4407086|NCT00215657|7185886|FG006|Overall Study|Insufficient testosterone response|4
4407087|NCT00215657|7185887|FG007|Overall Study|Insufficient testosterone response|7
4407088|NCT00215657|7185880|FG000|Overall Study|Other|3
4407089|NCT00215657|7185881|FG001|Overall Study|Other|1
4407090|NCT00215657|7185882|FG002|Overall Study|Other|2
4407091|NCT00215657|7185883|FG003|Overall Study|Other|3
4407092|NCT00215657|7185884|FG004|Overall Study|Other|5
4407093|NCT00215657|7185885|FG005|Overall Study|Other|4
4407094|NCT00215657|7185886|FG006|Overall Study|Other|6
4407095|NCT00215657|7185887|FG007|Overall Study|Other|1
4407096|NCT00215683|7185908|FG000|Overall Study|Adverse Event|15
4407097|NCT00215683|7185909|FG001|Overall Study|Adverse Event|16
4407098|NCT00215683|7185910|FG002|Overall Study|Adverse Event|15
4407099|NCT00215683|7185908|FG000|Overall Study|Lack of Efficacy|5
4407100|NCT00215683|7185909|FG001|Overall Study|Lack of Efficacy|1
4407101|NCT00215683|7185910|FG002|Overall Study|Lack of Efficacy|2
4407102|NCT00215683|7185908|FG000|Overall Study|Lost to Follow-up|0
4407103|NCT00215683|7185909|FG001|Overall Study|Lost to Follow-up|2
4407104|NCT00215683|7185910|FG002|Overall Study|Lost to Follow-up|1
4407105|NCT00215683|7185908|FG000|Overall Study|Withdrawal by Subject|9
4407106|NCT00215683|7185909|FG001|Overall Study|Withdrawal by Subject|4
4407107|NCT00215683|7185910|FG002|Overall Study|Withdrawal by Subject|13
4407108|NCT00215683|7185908|FG000|Overall Study|Physician Decision|0
4407109|NCT00215683|7185909|FG001|Overall Study|Physician Decision|0
4407110|NCT00215683|7185910|FG002|Overall Study|Physician Decision|1
4407111|NCT00215683|7185908|FG000|Overall Study|Difficult to attend visits|0
4407112|NCT00215683|7185909|FG001|Overall Study|Difficult to attend visits|1
4407113|NCT00215683|7185910|FG002|Overall Study|Difficult to attend visits|0
4407114|NCT00215683|7185908|FG000|Overall Study|No study drug available|0
4407115|NCT00215683|7185909|FG001|Overall Study|No study drug available|1
4407116|NCT00215683|7185910|FG002|Overall Study|No study drug available|0
4407117|NCT00215683|7185908|FG000|Overall Study|Intermittent therapy required|0
4407118|NCT00215683|7185909|FG001|Overall Study|Intermittent therapy required|1
4407119|NCT00215683|7185910|FG002|Overall Study|Intermittent therapy required|0
4407120|NCT00215943|7185929|FG000|Overall Study|Disease Progression|3
4407121|NCT00215943|7185930|FG001|Overall Study|Disease Progression|5
4407122|NCT00215943|7185929|FG000|Overall Study|Alternate therapy|0
4407123|NCT00215943|7185930|FG001|Overall Study|Alternate therapy|1
4407124|NCT00215943|7185929|FG000|Overall Study|Adverse Event|3
4407125|NCT00215943|7185930|FG001|Overall Study|Adverse Event|6
4407126|NCT00215943|7185929|FG000|Overall Study|Other disease|0
4407127|NCT00215943|7185930|FG001|Overall Study|Other disease|1
4407128|NCT00215943|7185929|FG000|Overall Study|Other complications|3
4407129|NCT00215943|7185930|FG001|Overall Study|Other complications|1
4407130|NCT00216086|7185947|FG000|Overall Study|Protocol Violation|1
4407131|NCT00216086|7185947|FG000|Overall Study|Diagnosis of Metastatic Disease|1
4713525|NCT02949024|7641134|FG000|Overall Study|Withdrawal by Subject|0
4407132|NCT00216086|7185947|FG000|Overall Study|Social Reasons|2
4407133|NCT00216203|7185964|FG000|Overall Study|Withdrawal by Subject|2
4407134|NCT00216476|7185985|FG000|Overall Study|Withdrawal by Subject|59
4407135|NCT00216476|7185986|FG001|Overall Study|Withdrawal by Subject|72
4407136|NCT00216476|7185987|FG002|Overall Study|Withdrawal by Subject|9
4407137|NCT00216476|7185985|FG000|Overall Study|Lost to Follow-up|10
4407138|NCT00216476|7185986|FG001|Overall Study|Lost to Follow-up|9
4407139|NCT00216476|7185987|FG002|Overall Study|Lost to Follow-up|1
4407140|NCT00216476|7185985|FG000|Overall Study|Adverse Event|6
4407141|NCT00216476|7185986|FG001|Overall Study|Adverse Event|10
4407142|NCT00216476|7185987|FG002|Overall Study|Adverse Event|1
4407143|NCT00216476|7185985|FG000|Overall Study|Lack of Efficacy|4
4407144|NCT00216476|7185986|FG001|Overall Study|Lack of Efficacy|3
4407145|NCT00216476|7185987|FG002|Overall Study|Lack of Efficacy|0
4407146|NCT00216476|7185985|FG000|Overall Study|Death|2
4407147|NCT00216476|7185986|FG001|Overall Study|Death|0
4407148|NCT00216476|7185987|FG002|Overall Study|Death|0
4407149|NCT00216476|7185985|FG000|Overall Study|Pregnancy|0
4407150|NCT00216476|7185986|FG001|Overall Study|Pregnancy|1
4407151|NCT00216476|7185987|FG002|Overall Study|Pregnancy|1
4407152|NCT00216476|7185985|FG000|Overall Study|Other|0
4407153|NCT00216476|7185986|FG001|Overall Study|Other|0
4407154|NCT00216476|7185987|FG002|Overall Study|Other|1
4407155|NCT00216476|7185985|FG000|Overall Study|Refuses Injection|11
4407156|NCT00216476|7185986|FG001|Overall Study|Refuses Injection|0
4407157|NCT00216476|7185987|FG002|Overall Study|Refuses Injection|0
4407158|NCT00216476|7185985|FG000|Overall Study|No Further Need for Treatment|3
4407159|NCT00216476|7185986|FG001|Overall Study|No Further Need for Treatment|4
4407160|NCT00216476|7185987|FG002|Overall Study|No Further Need for Treatment|1
4407161|NCT00216476|7185985|FG000|Overall Study|Non-compliance|0
4407162|NCT00216476|7185986|FG001|Overall Study|Non-compliance|4
4407163|NCT00216476|7185987|FG002|Overall Study|Non-compliance|1
4407164|NCT00216476|7185985|FG000|Overall Study|Higher dose/Extra Medication Required|2
4407165|NCT00216476|7185986|FG001|Overall Study|Higher dose/Extra Medication Required|0
4407166|NCT00216476|7185987|FG002|Overall Study|Higher dose/Extra Medication Required|2
4407167|NCT00216476|7185985|FG000|Overall Study|Administrative Reasons|1
4407168|NCT00216476|7185986|FG001|Overall Study|Administrative Reasons|1
4407169|NCT00216476|7185987|FG002|Overall Study|Administrative Reasons|0
4407170|NCT00216476|7185985|FG000|Overall Study|Protocol Deviation|5
4407171|NCT00216476|7185986|FG001|Overall Study|Protocol Deviation|1
4407172|NCT00216476|7185987|FG002|Overall Study|Protocol Deviation|0
4407173|NCT00216476|7185985|FG000|Overall Study|Patient Moved|2
4407174|NCT00216476|7185986|FG001|Overall Study|Patient Moved|2
4407175|NCT00216476|7185987|FG002|Overall Study|Patient Moved|0
4407176|NCT00216671|7186000|FG000|Overall Study|Adverse Event|4
4407177|NCT00216671|7186001|FG001|Overall Study|Adverse Event|9
4407178|NCT00216671|7186000|FG000|Overall Study|Pregnancy|0
4407179|NCT00216671|7186001|FG001|Overall Study|Pregnancy|1
4407180|NCT00216671|7186000|FG000|Overall Study|Withdrawal by Subject|4
4407181|NCT00216671|7186001|FG001|Overall Study|Withdrawal by Subject|2
4407182|NCT00216671|7186000|FG000|Overall Study|Refused Injections|3
4407183|NCT00216671|7186001|FG001|Overall Study|Refused Injections|13
4407184|NCT00216671|7186000|FG000|Overall Study|No Need to Continue Medication|1
4407185|NCT00216671|7186001|FG001|Overall Study|No Need to Continue Medication|1
4407186|NCT00216671|7186000|FG000|Overall Study|Insufficient Response|9
4407187|NCT00216671|7186001|FG001|Overall Study|Insufficient Response|4
4407188|NCT00216671|7186000|FG000|Overall Study|Lost to Follow-up|3
4407189|NCT00216671|7186001|FG001|Overall Study|Lost to Follow-up|5
4407190|NCT00216671|7186000|FG000|Overall Study|Non compliant|2
4407191|NCT00216671|7186001|FG001|Overall Study|Non compliant|2
4407192|NCT00216671|7186000|FG000|Overall Study|Ineligible|0
4407193|NCT00216671|7186001|FG001|Overall Study|Ineligible|2
4407194|NCT00216671|7186000|FG000|Overall Study|Physician Decision|1
4407195|NCT00216671|7186001|FG001|Overall Study|Physician Decision|1
4407196|NCT00216671|7186000|FG000|Overall Study|Protocol Violation|3
4407197|NCT00216671|7186001|FG001|Overall Study|Protocol Violation|5
4407198|NCT00216671|7186000|FG000|Overall Study|Relapse|1
4407199|NCT00216671|7186001|FG001|Overall Study|Relapse|0
4407200|NCT00216671|7186000|FG000|Overall Study|Investigator Illness|0
4407201|NCT00216671|7186001|FG001|Overall Study|Investigator Illness|1
4407202|NCT00216671|7186000|FG000|Overall Study|Patient Moved|0
4407203|NCT00216671|7186001|FG001|Overall Study|Patient Moved|1
4407204|NCT00216671|7186000|FG000|Overall Study|Ineligible, no efficacy data|2
4407205|NCT00216671|7186001|FG001|Overall Study|Ineligible, no efficacy data|2
4407206|NCT00216671|7186000|FG000|Overall Study|Insufficient Response Adverse Event|2
4407207|NCT00216671|7186001|FG001|Overall Study|Insufficient Response Adverse Event|1
4407208|NCT00216736|7186009|FG000|Overall Study|Lost to Follow-up|1
4407209|NCT00216736|7186010|FG001|Overall Study|Lost to Follow-up|1
4407210|NCT00217022|7186018|FG000|Overall Study|Withdrawal by Subject|1
4407211|NCT00217022|7186019|FG001|Overall Study|Withdrawal by Subject|1
4407212|NCT00217087|7186027|FG000|Overall Study|decided to have esophagectomy|1
4407213|NCT00217087|7186028|FG001|Overall Study|decided to have esophagectomy|2
4407214|NCT00217087|7186027|FG000|Overall Study|completed less than 12 months return|10
4407215|NCT00217087|7186028|FG001|Overall Study|completed less than 12 months return|18
4407216|NCT00217425|7186046|FG000|Overall Study|Never started treatment|2
4407217|NCT00217425|7186046|FG000|Overall Study|Patient ineligible|5
4407218|NCT00217425|7186046|FG000|Overall Study|Lack of Efficacy|13
4407219|NCT00217425|7186046|FG000|Overall Study|Adverse Event|8
4407220|NCT00217425|7186046|FG000|Overall Study|Withdrawal by Subject|4
4407221|NCT00217425|7186046|FG000|Overall Study|Other complicating disease|1
4407222|NCT00217425|7186046|FG000|Overall Study|Other|4
4407223|NCT00217464|7186059|FG000|Overall Study|Progression|15
4407224|NCT00217464|7186059|FG000|Overall Study|Other|2
4407225|NCT00217581|7186084|FG000|Overall Study|Withdrawal by Subject|1
4407226|NCT00217620|7186093|FG000|Overall Study|Adverse Event|2
4407227|NCT00217620|7186093|FG000|Overall Study|Progression|31
4407228|NCT00217620|7186093|FG000|Overall Study|Not Protocol Specified|4
4407229|NCT00217620|7186093|FG000|Overall Study|Ineligible|13
4407230|NCT00217620|7186093|FG000|Overall Study|Never received treatment|1
4407231|NCT00217672|7186101|FG000|Allocation|Ineligible|2
4407232|NCT00217672|7186102|FG001|Allocation|Ineligible|0
4407233|NCT00217672|7186101|FG000|Treatment|disease progression|33
4407234|NCT00217672|7186102|FG001|Treatment|disease progression|4
4407235|NCT00217672|7186101|FG000|Treatment|Adverse Event|18
4407236|NCT00217672|7186102|FG001|Treatment|Adverse Event|2
4407237|NCT00217672|7186101|FG000|Treatment|reqd treatment not permitted by protocol|6
4407238|NCT00217672|7186102|FG001|Treatment|reqd treatment not permitted by protocol|0
4407239|NCT00217672|7186101|FG000|Treatment|Physician Decision|6
4407240|NCT00217672|7186102|FG001|Treatment|Physician Decision|0
4713526|NCT02949024|7641135|FG001|Overall Study|Withdrawal by Subject|1
4713527|NCT02949219|7641150|FG000|Overall Study|Withdrawal by Subject|1
4407241|NCT00217672|7186101|FG000|Treatment|insurance issues|1
4407242|NCT00217672|7186102|FG001|Treatment|insurance issues|1
4407243|NCT00217672|7186101|FG000|Treatment|Death|2
4407244|NCT00217672|7186102|FG001|Treatment|Death|0
4407245|NCT00217672|7186101|FG000|Treatment|secondary malignancy|1
4407246|NCT00217672|7186102|FG001|Treatment|secondary malignancy|0
4407247|NCT00217672|7186101|FG000|Follow-up|Withdrawal by Subject|4
4407248|NCT00217672|7186102|FG001|Follow-up|Withdrawal by Subject|0
4407249|NCT00217672|7186101|FG000|Follow-up|Lost to Follow-up|1
4407250|NCT00217672|7186102|FG001|Follow-up|Lost to Follow-up|0
4407251|NCT00217971|7186115|FG000|Overall Study|Adverse Event|1
4407252|NCT00217971|7186116|FG001|Overall Study|Adverse Event|1
4407253|NCT00217971|7186115|FG000|Overall Study|Lost to Follow-up|15
4407254|NCT00217971|7186116|FG001|Overall Study|Lost to Follow-up|19
4407255|NCT00217971|7186115|FG000|Overall Study|Physician Decision|0
4407256|NCT00217971|7186116|FG001|Overall Study|Physician Decision|1
4407257|NCT00217971|7186115|FG000|Overall Study|Withdrawal by Subject|7
4407258|NCT00217971|7186116|FG001|Overall Study|Withdrawal by Subject|12
4407259|NCT00217971|7186115|FG000|Overall Study|non compliant|1
4407260|NCT00217971|7186116|FG001|Overall Study|non compliant|0
4407261|NCT00218257|7186156|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4
4407262|NCT00218257|7186157|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3
4407263|NCT00218296|7186168|FG000|Overall Study|Lost to Follow-up|9
4407264|NCT00218296|7186169|FG001|Overall Study|Lost to Follow-up|7
4407265|NCT00218296|7186168|FG000|Overall Study|Withdrawal by Subject|36
4407266|NCT00218296|7186169|FG001|Overall Study|Withdrawal by Subject|47
4407267|NCT00218296|7186168|FG000|Overall Study|Randomized but did not enter treatment|66
4407268|NCT00218296|7186169|FG001|Overall Study|Randomized but did not enter treatment|67
4407269|NCT00218543|7186264|FG000|Overall Study|Lost to Follow-up|8
4407270|NCT00218543|7186264|FG000|Overall Study|relocated|1
4407271|NCT00218543|7186264|FG000|Overall Study|Withdrawal by Subject|1
4407272|NCT00218543|7186264|FG000|Overall Study|Physician Decision|3
4407273|NCT00218543|7186264|FG000|Overall Study|Adverse Event|2
4407274|NCT00218634|7186270|FG000|Overall Study|Lost to Follow-up|8
4407275|NCT00218634|7186271|FG001|Overall Study|Lost to Follow-up|15
4407276|NCT00219141|7186283|FG000|Overall Study|Adverse Event|4
4407277|NCT00219141|7186284|FG001|Overall Study|Adverse Event|10
4407278|NCT00219141|7186285|FG002|Overall Study|Adverse Event|5
4407279|NCT00219141|7186283|FG000|Overall Study|Lack of Efficacy|3
4407280|NCT00219141|7186284|FG001|Overall Study|Lack of Efficacy|2
4407281|NCT00219141|7186285|FG002|Overall Study|Lack of Efficacy|0
4407282|NCT00219141|7186283|FG000|Overall Study|Administrative problems|0
4407283|NCT00219141|7186284|FG001|Overall Study|Administrative problems|1
4407284|NCT00219141|7186285|FG002|Overall Study|Administrative problems|0
4407285|NCT00219141|7186283|FG000|Overall Study|Lost to Follow-up|2
4407286|NCT00219141|7186284|FG001|Overall Study|Lost to Follow-up|4
4407287|NCT00219141|7186285|FG002|Overall Study|Lost to Follow-up|1
4407288|NCT00219141|7186283|FG000|Overall Study|Protocol Violation|3
4407289|NCT00219141|7186284|FG001|Overall Study|Protocol Violation|1
4407290|NCT00219141|7186285|FG002|Overall Study|Protocol Violation|1
4407291|NCT00219141|7186283|FG000|Overall Study|Withdrawal by Subject|1
4407292|NCT00219141|7186284|FG001|Overall Study|Withdrawal by Subject|3
4407293|NCT00219141|7186285|FG002|Overall Study|Withdrawal by Subject|5
4407294|NCT00219141|7186283|FG000|Overall Study|Condition no longer requires study drug|1
4407295|NCT00219141|7186284|FG001|Overall Study|Condition no longer requires study drug|0
4407296|NCT00219141|7186285|FG002|Overall Study|Condition no longer requires study drug|0
4407297|NCT00219284|7186295|FG000|Treatment Phase - 16 Weeks|Adverse Event|26
4407298|NCT00219284|7186296|FG001|Treatment Phase - 16 Weeks|Adverse Event|24
4407299|NCT00219284|7186295|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0
4407300|NCT00219284|7186296|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1
4407301|NCT00219284|7186295|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3
4407302|NCT00219284|7186296|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10
4407303|NCT00219284|7186295|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9
4407304|NCT00219284|7186296|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5
4407305|NCT00219284|7186295|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5
4407306|NCT00219284|7186296|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9
4407307|NCT00219284|7186295|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1
4407308|NCT00219284|7186296|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2
4407309|NCT00219284|7186295|FG000|Extension Phase - 8 Weeks|Adverse Event|2
4407310|NCT00219284|7186296|FG001|Extension Phase - 8 Weeks|Adverse Event|3
4407311|NCT00219284|7186295|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0
4407312|NCT00219284|7186296|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2
4407313|NCT00219284|7186295|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0
4407314|NCT00219284|7186296|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2
4407315|NCT00219349|7186302|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6
4407316|NCT00219349|7186302|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2
4407317|NCT00219349|7186302|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2
4407318|NCT00219349|7186302|FG000|Escitalopram Phase|Withdrawal by Subject|3
4407319|NCT00219544|7186306|FG000|Single Blind Treatment Period|Lack of Efficacy|5
4407320|NCT00219544|7186307|FG001|Single Blind Treatment Period|Lack of Efficacy|0
4407321|NCT00219544|7186306|FG000|Single Blind Treatment Period|Adverse Event|9
4407322|NCT00219544|7186307|FG001|Single Blind Treatment Period|Adverse Event|0
4407323|NCT00219544|7186306|FG000|Single Blind Treatment Period|Protocol Violation|4
4407324|NCT00219544|7186307|FG001|Single Blind Treatment Period|Protocol Violation|0
4407325|NCT00219544|7186306|FG000|Single Blind Treatment Period|Lost to Follow-up|2
4407326|NCT00219544|7186307|FG001|Single Blind Treatment Period|Lost to Follow-up|0
4407327|NCT00219544|7186306|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1
4407328|NCT00219544|7186307|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0
4407329|NCT00219544|7186306|FG000|Single Blind Treatment Period|Withdrawal by Subject|1
4407330|NCT00219544|7186307|FG001|Single Blind Treatment Period|Withdrawal by Subject|0
4407331|NCT00219557|7186318|FG000|Phase 1|Lack of Efficacy|3
4407332|NCT00219557|7186319|FG001|Phase 1|Lack of Efficacy|0
4407333|NCT00219557|7186320|FG002|Phase 1|Lack of Efficacy|0
4407334|NCT00219557|7186318|FG000|Phase 1|Adverse Event|2
4407335|NCT00219557|7186319|FG001|Phase 1|Adverse Event|0
4407336|NCT00219557|7186320|FG002|Phase 1|Adverse Event|0
4407337|NCT00219557|7186318|FG000|Phase 1|Withdrawal by Subject|1
4407338|NCT00219557|7186319|FG001|Phase 1|Withdrawal by Subject|0
4407339|NCT00219557|7186320|FG002|Phase 1|Withdrawal by Subject|0
4407340|NCT00219557|7186318|FG000|Phase 1|Started chemotherapy at other institute|1
4407341|NCT00219557|7186319|FG001|Phase 1|Started chemotherapy at other institute|0
4407342|NCT00219557|7186320|FG002|Phase 1|Started chemotherapy at other institute|0
4407343|NCT00219557|7186318|FG000|Phase 2|Lack of Efficacy|0
4407344|NCT00219557|7186319|FG001|Phase 2|Lack of Efficacy|21
4407345|NCT00219557|7186320|FG002|Phase 2|Lack of Efficacy|15
4407346|NCT00219557|7186318|FG000|Phase 2|Adverse Event|0
4407347|NCT00219557|7186319|FG001|Phase 2|Adverse Event|22
4407348|NCT00219557|7186320|FG002|Phase 2|Adverse Event|2
4407349|NCT00219557|7186318|FG000|Phase 2|Death|0
4407350|NCT00219557|7186319|FG001|Phase 2|Death|8
4407351|NCT00219557|7186320|FG002|Phase 2|Death|2
4407352|NCT00219557|7186318|FG000|Phase 2|Other|0
4407353|NCT00219557|7186319|FG001|Phase 2|Other|8
4407354|NCT00219557|7186320|FG002|Phase 2|Other|6
4407355|NCT00219557|7186318|FG000|Phase 2|Withdrawal by Subject|0
4407356|NCT00219557|7186319|FG001|Phase 2|Withdrawal by Subject|9
4407357|NCT00219557|7186320|FG002|Phase 2|Withdrawal by Subject|5
4407358|NCT00219557|7186318|FG000|Phase 2|Treatment not received|0
4407359|NCT00219557|7186319|FG001|Phase 2|Treatment not received|1
4407360|NCT00219557|7186320|FG002|Phase 2|Treatment not received|3
4407361|NCT00220636|7186329|FG000|Overall Study|Withdrawal by Subject|4
4407362|NCT00220701|7186336|FG000|Overall Study|Lost to Follow-up|5
4407363|NCT00220701|7186337|FG001|Overall Study|Lost to Follow-up|4
4407364|NCT00220727|7186345|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1
4407365|NCT00220727|7186346|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0
4407366|NCT00220740|7186356|FG000|Efficacy Period|Entered rescue treatment with placebo|23
4407367|NCT00220740|7186357|FG001|Efficacy Period|Entered rescue treatment with placebo|0
4407368|NCT00220740|7186356|FG000|Efficacy Period|Adverse Event|1
4407369|NCT00220740|7186357|FG001|Efficacy Period|Adverse Event|1
4407370|NCT00220740|7186356|FG000|Efficacy Period|Withdrawal by Subject|1
4407371|NCT00220740|7186357|FG001|Efficacy Period|Withdrawal by Subject|0
4407372|NCT00220740|7186356|FG000|Efficacy Period|Protocol Violation|1
4407373|NCT00220740|7186357|FG001|Efficacy Period|Protocol Violation|0
4407374|NCT00220740|7186356|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0
4407375|NCT00220740|7186357|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45
4407376|NCT00220779|7186368|FG000|Overall Study|Adverse Event|1
4407377|NCT00220779|7186369|FG001|Overall Study|Adverse Event|0
4407378|NCT00220779|7186370|FG002|Overall Study|Adverse Event|0
4407379|NCT00220779|7186368|FG000|Overall Study|Withdrawal by Subject|1
4407380|NCT00220779|7186369|FG001|Overall Study|Withdrawal by Subject|4
4407381|NCT00220779|7186370|FG002|Overall Study|Withdrawal by Subject|1
4407382|NCT00220779|7186368|FG000|Overall Study|Non-compliance|1
4407383|NCT00220779|7186369|FG001|Overall Study|Non-compliance|0
4407384|NCT00220779|7186370|FG002|Overall Study|Non-compliance|0
4407385|NCT00220779|7186368|FG000|Overall Study|Too time consuming|1
4407386|NCT00220779|7186369|FG001|Overall Study|Too time consuming|0
4407387|NCT00220779|7186370|FG002|Overall Study|Too time consuming|0
4407388|NCT00220779|7186368|FG000|Overall Study|Pregnancy|0
4407389|NCT00220779|7186369|FG001|Overall Study|Pregnancy|0
4407390|NCT00220779|7186370|FG002|Overall Study|Pregnancy|2
4407391|NCT00220779|7186368|FG000|Overall Study|Lack of Efficacy|3
4407392|NCT00220779|7186369|FG001|Overall Study|Lack of Efficacy|0
4407393|NCT00220779|7186370|FG002|Overall Study|Lack of Efficacy|1
4407394|NCT00220805|7186380|FG000|Overall Study|Adverse Event|1
4407395|NCT00220805|7186381|FG001|Overall Study|Adverse Event|3
4407396|NCT00220805|7186380|FG000|Overall Study|Withdrawal by Subject|3
4407397|NCT00220805|7186381|FG001|Overall Study|Withdrawal by Subject|0
4407398|NCT00220805|7186380|FG000|Overall Study|Lack of Efficacy|1
4407399|NCT00220805|7186381|FG001|Overall Study|Lack of Efficacy|0
4407400|NCT00220805|7186380|FG000|Overall Study|Develop. of choroidal neovascularization|3
4407401|NCT00220805|7186381|FG001|Overall Study|Develop. of choroidal neovascularization|8
4407402|NCT00221104|7186398|FG000|Overall Study|Adverse Event|1
4407403|NCT00221104|7186399|FG001|Overall Study|Adverse Event|0
4407404|NCT00221104|7186398|FG000|Overall Study|Physician Decision|1
4407405|NCT00221104|7186399|FG001|Overall Study|Physician Decision|0
4407406|NCT00221104|7186398|FG000|Overall Study|Protocol Violation|2
4407407|NCT00221104|7186399|FG001|Overall Study|Protocol Violation|0
4407408|NCT00221104|7186398|FG000|Overall Study|Withdrawal by Subject|42
4407409|NCT00221104|7186399|FG001|Overall Study|Withdrawal by Subject|29
4407410|NCT00221104|7186398|FG000|Overall Study|Others|37
4407411|NCT00221104|7186399|FG001|Overall Study|Others|47
4407412|NCT00221195|7186420|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3
4407413|NCT00221195|7186421|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1
4407414|NCT00221195|7186420|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0
4407415|NCT00221195|7186421|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1
4407416|NCT00221195|7186420|FG000|Washout Period (Months 7-9)|Death|0
4407417|NCT00221195|7186421|FG001|Washout Period (Months 7-9)|Death|1
4407418|NCT00221195|7186420|FG000|Therapy 2 (Months 10-15)|Death|1
4407419|NCT00221195|7186421|FG001|Therapy 2 (Months 10-15)|Death|0
4407420|NCT00221195|7186420|FG000|Therapy 2 (Months 10-15)|Adverse Event|1
4407421|NCT00221195|7186421|FG001|Therapy 2 (Months 10-15)|Adverse Event|0
4407422|NCT00221403|7186454|FG000|Overall Study|Protocol Violation|1
4407423|NCT00221403|7186455|FG001|Overall Study|Protocol Violation|0
4407424|NCT00221403|7186456|FG002|Overall Study|Protocol Violation|0
4407425|NCT00221403|7186454|FG000|Overall Study|Physician Decision|1
4407426|NCT00221403|7186455|FG001|Overall Study|Physician Decision|0
4407427|NCT00221403|7186456|FG002|Overall Study|Physician Decision|0
4407428|NCT00221403|7186454|FG000|Overall Study|Withdrawal by Subject|0
4407429|NCT00221403|7186455|FG001|Overall Study|Withdrawal by Subject|3
4407430|NCT00221403|7186456|FG002|Overall Study|Withdrawal by Subject|0
4407431|NCT00221403|7186454|FG000|Overall Study|Lack of Efficacy|0
4407432|NCT00221403|7186455|FG001|Overall Study|Lack of Efficacy|1
4407433|NCT00221403|7186456|FG002|Overall Study|Lack of Efficacy|0
4407434|NCT00221403|7186454|FG000|Overall Study|Adverse Event|0
4407435|NCT00221403|7186455|FG001|Overall Study|Adverse Event|1
4407436|NCT00221403|7186456|FG002|Overall Study|Adverse Event|0
4407437|NCT00222105|7186464|FG000|Overall Study|Removed due to wrong diagnosis|1
4407438|NCT00222105|7186464|FG000|Overall Study|Withdrawal by Subject|1
4407439|NCT00222105|7186464|FG000|Overall Study|Adverse Event|8
4407440|NCT00222105|7186464|FG000|Overall Study|Treatment delays|2
4407441|NCT00222105|7186464|FG000|Overall Study|Death|2
4407442|NCT00222729|7186477|FG000|Overall Study|Adverse Event|3
4407443|NCT00223080|7186483|FG000|Overall Study|Withdrawal by Subject|253
4407444|NCT00223080|7186484|FG001|Overall Study|Withdrawal by Subject|232
4407445|NCT00223080|7186483|FG000|Overall Study|Required contraindicated med|0
4407446|NCT00223080|7186484|FG001|Overall Study|Required contraindicated med|1
4407447|NCT00223080|7186483|FG000|Overall Study|Non-compliant|7
4407448|NCT00223080|7186484|FG001|Overall Study|Non-compliant|7
4407449|NCT00223080|7186483|FG000|Overall Study|Moved from study area|37
4407450|NCT00223080|7186484|FG001|Overall Study|Moved from study area|47
4407451|NCT00223080|7186483|FG000|Overall Study|Lost to Follow-up|259
4407452|NCT00223080|7186484|FG001|Overall Study|Lost to Follow-up|284
4407453|NCT00223080|7186483|FG000|Overall Study|Death|85
4407454|NCT00223080|7186484|FG001|Overall Study|Death|74
4407455|NCT00223080|7186483|FG000|Overall Study|Other|14
4407456|NCT00223080|7186484|FG001|Overall Study|Other|11
4407457|NCT00223080|7186483|FG000|Overall Study|Reason not provided|141
4407458|NCT00223080|7186484|FG001|Overall Study|Reason not provided|140
4407459|NCT00223080|7186483|FG000|Overall Study|Adverse Event|0
4407460|NCT00223080|7186484|FG001|Overall Study|Adverse Event|1
4407461|NCT00223496|7186508|FG000|Overall Study|screen failure|9
4407462|NCT00223496|7186508|FG000|Overall Study|Lost to Follow-up|4
4407463|NCT00223496|7186508|FG000|Overall Study|Lack of Efficacy|6
4407464|NCT00223496|7186508|FG000|Overall Study|Withdrawal by Subject|1
4407465|NCT00223496|7186508|FG000|Overall Study|Physician Decision|2
4407466|NCT00223795|7186549|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7
4407467|NCT00223795|7186550|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9
4407468|NCT00223795|7186549|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1
4407469|NCT00223795|7186550|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1
4407470|NCT00223808|7186560|FG000|Overall Study|<5 hrs therapy before discharge|3
4407471|NCT00223808|7186561|FG001|Overall Study|<5 hrs therapy before discharge|5
4407472|NCT00223808|7186562|FG002|Overall Study|<5 hrs therapy before discharge|5
4407473|NCT00223977|7186582|FG000|Overall Study|Adverse Event|7
4407474|NCT00223977|7186583|FG001|Overall Study|Adverse Event|10
4407475|NCT00223977|7186584|FG002|Overall Study|Adverse Event|0
4407476|NCT00223977|7186582|FG000|Overall Study|Protocol Violation|0
4407477|NCT00223977|7186583|FG001|Overall Study|Protocol Violation|0
4407478|NCT00223977|7186584|FG002|Overall Study|Protocol Violation|1
4407479|NCT00223977|7186582|FG000|Overall Study|Withdrawal by Subject|1
4407480|NCT00223977|7186583|FG001|Overall Study|Withdrawal by Subject|1
4407481|NCT00223977|7186584|FG002|Overall Study|Withdrawal by Subject|2
4407482|NCT00223977|7186582|FG000|Overall Study|Other|1
4407483|NCT00223977|7186583|FG001|Overall Study|Other|0
4407484|NCT00223977|7186584|FG002|Overall Study|Other|0
4407485|NCT00223990|7186594|FG000|Overall Study|Moved from area|2
4407486|NCT00223990|7186595|FG001|Overall Study|Moved from area|1
4407487|NCT00223990|7186594|FG000|Overall Study|Withdrawal by Subject|4
4407488|NCT00223990|7186595|FG001|Overall Study|Withdrawal by Subject|8
4407489|NCT00223990|7186594|FG000|Overall Study|Lost to Follow-up|1
4407490|NCT00223990|7186595|FG001|Overall Study|Lost to Follow-up|0
4407491|NCT00224016|7186603|FG000|Titration Period|Withdrawal by Subject|0
4407492|NCT00224016|7186604|FG001|Titration Period|Withdrawal by Subject|1
4407493|NCT00224016|7186603|FG000|Titration Period|Lost to Follow-up|1
4407494|NCT00224016|7186604|FG001|Titration Period|Lost to Follow-up|0
4407495|NCT00224016|7186603|FG000|Maintenance Period|Withdrawal by Subject|2
4407496|NCT00224016|7186604|FG001|Maintenance Period|Withdrawal by Subject|0
4407497|NCT00224016|7186603|FG000|Maintenance Period|Lost to Follow-up|0
4407498|NCT00224016|7186604|FG001|Maintenance Period|Lost to Follow-up|1
4407499|NCT00224029|7186610|FG000|Overall Study|Lost to Follow-up|1
4407500|NCT00224029|7186610|FG000|Overall Study|Withdrawal by Subject|4
4407501|NCT00224029|7186610|FG000|Overall Study|Other|1
4407502|NCT00224042|7186616|FG000|Overall Study|Adverse Event|2
4407503|NCT00224042|7186617|FG001|Overall Study|Adverse Event|1
4407504|NCT00224042|7186616|FG000|Overall Study|Protocol Violation|0
4407505|NCT00224042|7186617|FG001|Overall Study|Protocol Violation|1
4407506|NCT00224042|7186616|FG000|Overall Study|Physician Decision|0
4407507|NCT00224042|7186617|FG001|Overall Study|Physician Decision|1
4407508|NCT00224042|7186616|FG000|Overall Study|Did not meet lab incusion criteria|2
4407509|NCT00224042|7186617|FG001|Overall Study|Did not meet lab incusion criteria|3
4407510|NCT00224042|7186616|FG000|Overall Study|Other|2
4407511|NCT00224042|7186617|FG001|Overall Study|Other|0
4407512|NCT00224055|7186625|FG000|Overall Study|Adverse Event|9
4407513|NCT00224055|7186626|FG001|Overall Study|Adverse Event|3
4407514|NCT00224055|7186625|FG000|Overall Study|Lost to Follow-up|1
4407515|NCT00224055|7186626|FG001|Overall Study|Lost to Follow-up|2
4407516|NCT00224055|7186625|FG000|Overall Study|Protocol Violation|1
4407517|NCT00224055|7186626|FG001|Overall Study|Protocol Violation|1
4407518|NCT00224055|7186625|FG000|Overall Study|Inclusion Violation|3
4407519|NCT00224055|7186626|FG001|Overall Study|Inclusion Violation|6
4407520|NCT00224055|7186625|FG000|Overall Study|Withdrawal by Subject|0
4407521|NCT00224055|7186626|FG001|Overall Study|Withdrawal by Subject|2
4407522|NCT00224055|7186625|FG000|Overall Study|Other|1
4407523|NCT00224055|7186626|FG001|Overall Study|Other|0
4407524|NCT00224107|7186634|FG000|Overall Study|Adverse Event|20
4407525|NCT00224107|7186635|FG001|Overall Study|Adverse Event|6
4407526|NCT00224107|7186634|FG000|Overall Study|Protocol Violation|2
4407527|NCT00224107|7186635|FG001|Overall Study|Protocol Violation|3
4407528|NCT00224107|7186634|FG000|Overall Study|Withdrawal by Subject|1
4407529|NCT00224107|7186635|FG001|Overall Study|Withdrawal by Subject|4
4407530|NCT00224107|7186634|FG000|Overall Study|Lack of Efficacy|2
4407531|NCT00224107|7186635|FG001|Overall Study|Lack of Efficacy|0
4407532|NCT00224107|7186634|FG000|Overall Study|Lost to Follow-up|4
4407533|NCT00224107|7186635|FG001|Overall Study|Lost to Follow-up|0
4407534|NCT00224107|7186634|FG000|Overall Study|Physician Decision|1
4407535|NCT00224107|7186635|FG001|Overall Study|Physician Decision|0
4407536|NCT00224107|7186634|FG000|Overall Study|Other|1
4407537|NCT00224107|7186635|FG001|Overall Study|Other|1
4407538|NCT00224120|7186643|FG000|Overall Study|Adverse Event|10
4407539|NCT00224120|7186644|FG001|Overall Study|Adverse Event|4
4407540|NCT00224120|7186643|FG000|Overall Study|Protocol Violation|1
4407541|NCT00224120|7186644|FG001|Overall Study|Protocol Violation|0
4407542|NCT00224120|7186643|FG000|Overall Study|Withdrawal by Subject|5
4407543|NCT00224120|7186644|FG001|Overall Study|Withdrawal by Subject|10
4407544|NCT00224120|7186643|FG000|Overall Study|Lack of Efficacy|0
4407545|NCT00224120|7186644|FG001|Overall Study|Lack of Efficacy|2
4407546|NCT00224120|7186643|FG000|Overall Study|Lost to Follow-up|2
4407547|NCT00224120|7186644|FG001|Overall Study|Lost to Follow-up|3
4407548|NCT00224120|7186643|FG000|Overall Study|Other|4
4407549|NCT00224120|7186644|FG001|Overall Study|Other|5
4407550|NCT00224133|7186650|FG000|Overall Study|Adverse Event|93
4407551|NCT00224133|7186650|FG000|Overall Study|Protocol Violation|6
4407552|NCT00224133|7186650|FG000|Overall Study|Withdrawal by Subject|33
4407553|NCT00224133|7186650|FG000|Overall Study|Lack of Efficacy|58
4407554|NCT00224133|7186650|FG000|Overall Study|Lost to Follow-up|21
4407555|NCT00224133|7186650|FG000|Overall Study|Physician Decision|1
4407556|NCT00224133|7186650|FG000|Overall Study|Other|14
4407557|NCT00224484|7186661|FG000|Overall Study|Serious Adverse Event|1
4407558|NCT00224484|7186662|FG001|Overall Study|Serious Adverse Event|1
4407559|NCT00224484|7186663|FG002|Overall Study|Serious Adverse Event|0
4407560|NCT00224484|7186661|FG000|Overall Study|Non-Serious Adverse Event|5
4407561|NCT00224484|7186662|FG001|Overall Study|Non-Serious Adverse Event|7
4407562|NCT00224484|7186663|FG002|Overall Study|Non-Serious Adverse Event|3
4407563|NCT00224484|7186661|FG000|Overall Study|Protocol Violation|2
4407564|NCT00224484|7186662|FG001|Overall Study|Protocol Violation|2
4407565|NCT00224484|7186663|FG002|Overall Study|Protocol Violation|0
4407566|NCT00224484|7186661|FG000|Overall Study|Withdrawal by Subject|49
4407567|NCT00224484|7186662|FG001|Overall Study|Withdrawal by Subject|18
4407568|NCT00224484|7186663|FG002|Overall Study|Withdrawal by Subject|16
4407569|NCT00224484|7186661|FG000|Overall Study|Migrated/moved from study area|18
4407570|NCT00224484|7186662|FG001|Overall Study|Migrated/moved from study area|5
4407571|NCT00224484|7186663|FG002|Overall Study|Migrated/moved from study area|5
4407572|NCT00224484|7186661|FG000|Overall Study|Lost to Follow-up|66
4407573|NCT00224484|7186662|FG001|Overall Study|Lost to Follow-up|28
4407574|NCT00224484|7186663|FG002|Overall Study|Lost to Follow-up|36
4407575|NCT00224484|7186661|FG000|Overall Study|Reason not specified|5
4407576|NCT00224484|7186662|FG001|Overall Study|Reason not specified|4
4407577|NCT00224484|7186663|FG002|Overall Study|Reason not specified|2
4407578|NCT00224770|7186677|FG000|Overall Study|Lost to Follow-up|4
4407579|NCT00224770|7186678|FG001|Overall Study|Lost to Follow-up|2
4407580|NCT00224770|7186679|FG002|Overall Study|Lost to Follow-up|0
4511487|NCT00927251|7320583|FG000|Overall Study|Patients not implanted with 4296 lead|8
4511488|NCT00927355|7320600|FG000|Overall Study|Adverse Event|1
4511489|NCT00927355|7320601|FG001|Overall Study|Adverse Event|1
4511490|NCT00927368|7320622|FG000|Overall Study|enrollment in another study|1
4511491|NCT00927368|7320623|FG001|Overall Study|enrollment in another study|1
4511492|NCT00927368|7320624|FG002|Overall Study|enrollment in another study|2
4511493|NCT00927368|7320622|FG000|Overall Study|Lost to Follow-up|4
4511494|NCT00927368|7320623|FG001|Overall Study|Lost to Follow-up|0
4511495|NCT00927368|7320624|FG002|Overall Study|Lost to Follow-up|0
4511496|NCT00927368|7320622|FG000|Overall Study|equipment failure|1
4511497|NCT00927368|7320623|FG001|Overall Study|equipment failure|0
4511498|NCT00927368|7320624|FG002|Overall Study|equipment failure|0
4511499|NCT00927368|7320622|FG000|Overall Study|ineligible post randomization|0
4511500|NCT00927368|7320623|FG001|Overall Study|ineligible post randomization|3
4511501|NCT00927368|7320624|FG002|Overall Study|ineligible post randomization|1
4511502|NCT00927368|7320622|FG000|Overall Study|cancellation of surgery|0
4511503|NCT00927368|7320623|FG001|Overall Study|cancellation of surgery|1
4511504|NCT00927368|7320624|FG002|Overall Study|cancellation of surgery|2
4511505|NCT00927394|7320634|FG000|Overall Study|Adverse Event|14
4511506|NCT00927394|7320635|FG001|Overall Study|Adverse Event|9
4511507|NCT00927394|7320634|FG000|Overall Study|Unsatisfactory therapeutic effect|17
4511508|NCT00927394|7320635|FG001|Overall Study|Unsatisfactory therapeutic effect|23
4511509|NCT00927394|7320634|FG000|Overall Study|Withdrawal by Subject|20
4511510|NCT00927394|7320635|FG001|Overall Study|Withdrawal by Subject|24
4713528|NCT02949271|7641156|FG000|Overall Study|Lack of Efficacy|5
4713529|NCT02949271|7641157|FG001|Overall Study|Lack of Efficacy|4
4713530|NCT02949271|7641156|FG000|Overall Study|Lost to Follow-up|3
4713531|NCT02949271|7641157|FG001|Overall Study|Lost to Follow-up|6
4713532|NCT02949271|7641156|FG000|Overall Study|Physician Decision|5
4713533|NCT02949271|7641157|FG001|Overall Study|Physician Decision|5
4713534|NCT02949271|7641156|FG000|Overall Study|Protocol Violation|6
4713535|NCT02949271|7641157|FG001|Overall Study|Protocol Violation|3
4713536|NCT02949271|7641156|FG000|Overall Study|Withdrawal by Subject|1
4713537|NCT02949271|7641157|FG001|Overall Study|Withdrawal by Subject|0
4713538|NCT02949271|7641156|FG000|Overall Study|Delivered prior to intervention|7
4713539|NCT02949271|7641157|FG001|Overall Study|Delivered prior to intervention|9
4713540|NCT02949271|7641156|FG000|Overall Study|Outside the window for cervical dilation|2
4713541|NCT02949271|7641157|FG001|Overall Study|Outside the window for cervical dilation|3
4713542|NCT02949362|7641165|FG000|Retrospective Period|Inform consent not signed by participant|4
4713543|NCT02949362|7641166|FG001|Retrospective Period|Inform consent not signed by participant|1
4713544|NCT02949362|7641167|FG002|Retrospective Period|Inform consent not signed by participant|0
4736152|NCT03559257|7685080|FG000|Open-label Treatment Period|Adverse Event|1
4511511|NCT00927394|7320634|FG000|Overall Study|Lost to Follow-up|8
4511512|NCT00927394|7320635|FG001|Overall Study|Lost to Follow-up|14
4511513|NCT00927394|7320634|FG000|Overall Study|Administrative Problem|1
4511514|NCT00927394|7320635|FG001|Overall Study|Administrative Problem|0
4511515|NCT00927394|7320634|FG000|Overall Study|Death|1
4407581|NCT00224874|7186692|FG000|Overall Study|Withdrawal by Subject|0
4407582|NCT00224874|7186693|FG001|Overall Study|Withdrawal by Subject|0
4407583|NCT00224874|7186694|FG002|Overall Study|Withdrawal by Subject|1
4407584|NCT00224874|7186695|FG003|Overall Study|Withdrawal by Subject|0
4407585|NCT00224887|7186707|FG000|Overall Study|Pregnancy|6
4407586|NCT00224887|7186708|FG001|Overall Study|Pregnancy|6
4407587|NCT00225147|7186741|FG000|Open-label Phase|Lost to Follow-up|0
4407588|NCT00225147|7186742|FG001|Open-label Phase|Lost to Follow-up|0
4407589|NCT00225147|7186743|FG002|Open-label Phase|Lost to Follow-up|0
4407590|NCT00225147|7186744|FG003|Open-label Phase|Lost to Follow-up|4
4407591|NCT00225147|7186741|FG000|Open-label Phase|Withdrawal by Subject|0
4407592|NCT00225147|7186742|FG001|Open-label Phase|Withdrawal by Subject|0
4407593|NCT00225147|7186743|FG002|Open-label Phase|Withdrawal by Subject|0
4407594|NCT00225147|7186744|FG003|Open-label Phase|Withdrawal by Subject|6
4407595|NCT00225212|7186756|FG000|Overall Study|Disease progression|2
4407596|NCT00225212|7186756|FG000|Overall Study|Death|1
4407597|NCT00225212|7186756|FG000|Overall Study|Adverse Event|2
4407598|NCT00225212|7186756|FG000|Overall Study|Intercurrent illness|1
4407599|NCT00225251|7186762|FG000|Overall Study|Withdrawal by Subject|1
4407600|NCT00225251|7186763|FG001|Overall Study|Withdrawal by Subject|1
4407601|NCT00225277|7186771|FG000|Overall Study|Adverse Event|30
4407602|NCT00225277|7186772|FG001|Overall Study|Adverse Event|34
4407603|NCT00225277|7186771|FG000|Overall Study|Lack of Efficacy|4
4407604|NCT00225277|7186772|FG001|Overall Study|Lack of Efficacy|1
4407605|NCT00225277|7186771|FG000|Overall Study|Lost to Follow-up|4
4407606|NCT00225277|7186772|FG001|Overall Study|Lost to Follow-up|6
4407607|NCT00225277|7186771|FG000|Overall Study|Physician Decision|6
4407608|NCT00225277|7186772|FG001|Overall Study|Physician Decision|8
4407609|NCT00225277|7186771|FG000|Overall Study|Protocol Violation|6
4407610|NCT00225277|7186772|FG001|Overall Study|Protocol Violation|3
4407611|NCT00225277|7186771|FG000|Overall Study|Withdrawal by Subject|40
4407612|NCT00225277|7186772|FG001|Overall Study|Withdrawal by Subject|34
4407613|NCT00225277|7186771|FG000|Overall Study|Other|7
4407614|NCT00225277|7186772|FG001|Overall Study|Other|9
4407615|NCT00225758|7186800|FG000|Overall Study|Adverse Event|4
4407616|NCT00226499|7186821|FG000|Overall Study|Adverse Event|10
4407617|NCT00226499|7186822|FG001|Overall Study|Adverse Event|6
4407618|NCT00226499|7186823|FG002|Overall Study|Adverse Event|3
4407619|NCT00226499|7186821|FG000|Overall Study|Others|1064
4407620|NCT00226499|7186822|FG001|Overall Study|Others|1066
4407621|NCT00226499|7186823|FG002|Overall Study|Others|356
4407622|NCT00226655|7186842|FG000|Overall Study|Death|13
4407623|NCT00226655|7186842|FG000|Overall Study|Withdrawal by Subject|15
4407624|NCT00226655|7186842|FG000|Overall Study|Adverse Event|35
4407625|NCT00226655|7186842|FG000|Overall Study|Physician Decision|6
4407626|NCT00226655|7186842|FG000|Overall Study|Clinical deterioration|10
4407627|NCT00226811|7186846|FG000|Overall Study|Death|8
4407628|NCT00226811|7186846|FG000|Overall Study|Adverse Event|11
4407629|NCT00226811|7186846|FG000|Overall Study|Lack of Efficacy|55
4407630|NCT00226811|7186846|FG000|Overall Study|Withdrawal by Subject|2
4407631|NCT00226941|7186854|FG000|Overall Study|Withdrawal by subject - toxicity|0
4407632|NCT00226941|7186855|FG001|Overall Study|Withdrawal by subject - toxicity|0
4407633|NCT00226941|7186856|FG002|Overall Study|Withdrawal by subject - toxicity|0
4407634|NCT00226941|7186857|FG003|Overall Study|Withdrawal by subject - toxicity|1
4407635|NCT00226941|7186854|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0
4407636|NCT00226941|7186855|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0
4407637|NCT00226941|7186856|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0
4407638|NCT00226941|7186857|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1
4407639|NCT00227266|7186881|FG000|Overall Study|Withdrawal by Subject|0
4407640|NCT00227266|7186882|FG001|Overall Study|Withdrawal by Subject|0
4407641|NCT00227266|7186883|FG002|Overall Study|Withdrawal by Subject|1
4407642|NCT00227266|7186881|FG000|Overall Study|Protocol Violation|1
4407643|NCT00227266|7186882|FG001|Overall Study|Protocol Violation|0
4407644|NCT00227266|7186883|FG002|Overall Study|Protocol Violation|1
4407645|NCT00227266|7186881|FG000|Overall Study|Excessive weight gain|0
4407646|NCT00227266|7186882|FG001|Overall Study|Excessive weight gain|0
4407647|NCT00227266|7186883|FG002|Overall Study|Excessive weight gain|2
4407648|NCT00227305|7186894|FG000|Overall Study|Adverse Event|40
4407649|NCT00227305|7186894|FG000|Overall Study|Withdrawal by Subject|42
4407650|NCT00227305|7186894|FG000|Overall Study|Lost to Follow-up|33
4407651|NCT00227305|7186894|FG000|Overall Study|Study specific discontinuation|13
4407652|NCT00227305|7186894|FG000|Overall Study|MOVED OUT OF AREA|3
4407653|NCT00227305|7186894|FG000|Overall Study|Lack of Efficacy|7
4407654|NCT00227305|7186894|FG000|Overall Study|Physician Decision|3
4407655|NCT00227305|7186894|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1
4407656|NCT00227305|7186894|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1
4407657|NCT00227305|7186894|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1
4407658|NCT00227344|7186900|FG000|Overall Study|study terminated early|12
4407659|NCT00227344|7186901|FG001|Overall Study|study terminated early|5
4407660|NCT00227370|7186909|FG000|Overall Study|Withdrawal by Subject|1
4407661|NCT00227370|7186910|FG001|Overall Study|Withdrawal by Subject|2
4407662|NCT00227370|7186909|FG000|Overall Study|Death|3
4407663|NCT00227370|7186910|FG001|Overall Study|Death|4
4407664|NCT00227370|7186909|FG000|Overall Study|Adverse Event|6
4407665|NCT00227370|7186910|FG001|Overall Study|Adverse Event|11
4407666|NCT00227370|7186909|FG000|Overall Study|Physician Decision|9
4407667|NCT00227370|7186910|FG001|Overall Study|Physician Decision|6
4407668|NCT00227370|7186909|FG000|Overall Study|Other reasons|2
4407669|NCT00227370|7186910|FG001|Overall Study|Other reasons|1
4407670|NCT00227539|7186916|FG000|Overall Study|Protocol Violation|1
4407671|NCT00227591|7186920|FG000|Overall Study|Withdrawal by Subject|1
4407672|NCT00227721|7186938|FG000|Overall Study|On study, but never treated.|1
4407673|NCT00227877|7186950|FG000|Pre-visit Assessment|Technical difficulties|7
4407674|NCT00227877|7186951|FG001|Pre-visit Assessment|Technical difficulties|3
4407675|NCT00227877|7186952|FG002|Pre-visit Assessment|Technical difficulties|0
4407676|NCT00227877|7186953|FG003|Pre-visit Assessment|Technical difficulties|0
4407677|NCT00227877|7186950|FG000|Post-visit Checklist|Lost to Follow-up|24
4407678|NCT00227877|7186951|FG001|Post-visit Checklist|Lost to Follow-up|13
4407679|NCT00227877|7186952|FG002|Post-visit Checklist|Lost to Follow-up|1
4407680|NCT00227877|7186953|FG003|Post-visit Checklist|Lost to Follow-up|0
4407681|NCT00227877|7186950|FG000|3-months Follow-up|Completed late|135
4407682|NCT00227877|7186951|FG001|3-months Follow-up|Completed late|128
4407683|NCT00227877|7186952|FG002|3-months Follow-up|Completed late|34
4407684|NCT00227877|7186953|FG003|3-months Follow-up|Completed late|8
4407685|NCT00227877|7186950|FG000|3-months Follow-up|Lost to Follow-up|178
4407686|NCT00227877|7186951|FG001|3-months Follow-up|Lost to Follow-up|139
4407687|NCT00227877|7186952|FG002|3-months Follow-up|Lost to Follow-up|18
4407688|NCT00227877|7186953|FG003|3-months Follow-up|Lost to Follow-up|13
4407689|NCT00227877|7186950|FG000|12-months Follow-up|Completed late|78
4407690|NCT00227877|7186951|FG001|12-months Follow-up|Completed late|74
4407691|NCT00227877|7186952|FG002|12-months Follow-up|Completed late|1
4407692|NCT00227877|7186953|FG003|12-months Follow-up|Completed late|0
4407693|NCT00227877|7186950|FG000|12-months Follow-up|Lost to Follow-up|232
4407694|NCT00227877|7186951|FG001|12-months Follow-up|Lost to Follow-up|189
4407695|NCT00227877|7186952|FG002|12-months Follow-up|Lost to Follow-up|30
4407696|NCT00227877|7186953|FG003|12-months Follow-up|Lost to Follow-up|26
4407697|NCT00227903|7186967|FG000|Overall Study|Withdrawal by Subject|2
4407698|NCT00227903|7186968|FG001|Overall Study|Withdrawal by Subject|5
4407699|NCT00227903|7186967|FG000|Overall Study|Subject moved out of area|1
4407700|NCT00227903|7186968|FG001|Overall Study|Subject moved out of area|2
4407701|NCT00227903|7186967|FG000|Overall Study|Lost to Follow-up|1
4407702|NCT00227903|7186968|FG001|Overall Study|Lost to Follow-up|3
4407703|NCT00227903|7186967|FG000|Overall Study|Miscarriage|1
4407704|NCT00227903|7186968|FG001|Overall Study|Miscarriage|0
4407705|NCT00228384|7186985|FG000|Overall Study|Death|9
4407706|NCT00228384|7186986|FG001|Overall Study|Death|3
4407707|NCT00228384|7186985|FG000|Overall Study|Lost to Follow-up|6
4407708|NCT00228384|7186986|FG001|Overall Study|Lost to Follow-up|10
4407709|NCT00228384|7186985|FG000|Overall Study|Surgical Intervention (bypass)|5
4407710|NCT00228384|7186986|FG001|Overall Study|Surgical Intervention (bypass)|5
4407711|NCT00228384|7186985|FG000|Overall Study|Withdrawal by Subject|9
4407712|NCT00228384|7186986|FG001|Overall Study|Withdrawal by Subject|10
4407713|NCT00228384|7186985|FG000|Overall Study|Physician Decision|0
4407714|NCT00228384|7186986|FG001|Overall Study|Physician Decision|1
4407715|NCT00228423|7186994|FG000|Overall Study|Adverse Event|2
4407716|NCT00228423|7186995|FG001|Overall Study|Adverse Event|5
4407717|NCT00228423|7186994|FG000|Overall Study|Withdrawal by Subject|7
4407718|NCT00228423|7186995|FG001|Overall Study|Withdrawal by Subject|3
4407719|NCT00228423|7186994|FG000|Overall Study|Protocol Violation|1
4407720|NCT00228423|7186995|FG001|Overall Study|Protocol Violation|3
4407721|NCT00228423|7186994|FG000|Overall Study|Physician Decision|0
4407722|NCT00228423|7186995|FG001|Overall Study|Physician Decision|1
4407723|NCT00228553|7187001|FG000|Overall Study|Adverse Event|112
4407724|NCT00228553|7187001|FG000|Overall Study|Lack of Efficacy|34
4407725|NCT00228553|7187001|FG000|Overall Study|Lost to Follow-up|67
4407726|NCT00228553|7187001|FG000|Overall Study|Physician Decision|48
4407727|NCT00228553|7187001|FG000|Overall Study|Protocol Violation|6
4407728|NCT00228553|7187001|FG000|Overall Study|Withdrawal by Subject|115
4407729|NCT00228553|7187001|FG000|Overall Study|Pregnancy|2
4407730|NCT00228553|7187001|FG000|Overall Study|Miscellaneous|46
4407731|NCT00228566|7187005|FG000|Overall Study|Adverse Event|31
4407732|NCT00228566|7187005|FG000|Overall Study|Lack of Efficacy|14
4407733|NCT00228566|7187005|FG000|Overall Study|Lost to Follow-up|16
4407734|NCT00228566|7187005|FG000|Overall Study|Physician Decision|5
4407735|NCT00228566|7187005|FG000|Overall Study|Withdrawal by Subject|4
4407736|NCT00228566|7187005|FG000|Overall Study|Miscellaneous|1
4407737|NCT00228813|7187009|FG000|Overall Study|Death|4
4407738|NCT00228917|7187021|FG000|Overall Study|Migrated/moved from study area|0
4407739|NCT00228917|7187022|FG001|Overall Study|Migrated/moved from study area|0
4407740|NCT00228917|7187023|FG002|Overall Study|Migrated/moved from study area|0
4407741|NCT00228917|7187024|FG003|Overall Study|Migrated/moved from study area|0
4407742|NCT00228917|7187025|FG004|Overall Study|Migrated/moved from study area|0
4407743|NCT00228917|7187026|FG005|Overall Study|Migrated/moved from study area|2
4407744|NCT00228917|7187027|FG006|Overall Study|Migrated/moved from study area|0
4407745|NCT00228917|7187028|FG007|Overall Study|Migrated/moved from study area|0
4407746|NCT00229203|7187050|FG000|Overall Study|Progressive disease|18
4407747|NCT00229203|7187051|FG001|Overall Study|Progressive disease|9
4407748|NCT00229203|7187050|FG000|Overall Study|Toxicity|6
4407749|NCT00229203|7187051|FG001|Overall Study|Toxicity|1
4407750|NCT00229203|7187050|FG000|Overall Study|Death|4
4407751|NCT00229203|7187051|FG001|Overall Study|Death|2
4407752|NCT00229203|7187050|FG000|Overall Study|Other|3
4407753|NCT00229203|7187051|FG001|Overall Study|Other|3
4407754|NCT00229203|7187050|FG000|Overall Study|Withdrawal by Subject|1
4407755|NCT00229203|7187051|FG001|Overall Study|Withdrawal by Subject|4
4407756|NCT00229658|7187065|FG000|Overall Study|Administrative|2
4407757|NCT00229658|7187066|FG001|Overall Study|Administrative|1
4407758|NCT00229658|7187065|FG000|Overall Study|Investigator decision|13
4407759|NCT00229658|7187066|FG001|Overall Study|Investigator decision|10
4407760|NCT00229658|7187065|FG000|Overall Study|Other|80
4407761|NCT00229658|7187066|FG001|Overall Study|Other|60
4407762|NCT00229658|7187065|FG000|Overall Study|Lost to Follow-up|82
4407763|NCT00229658|7187066|FG001|Overall Study|Lost to Follow-up|55
4407764|NCT00229658|7187065|FG000|Overall Study|Serious Adverse Event|2
4407765|NCT00229658|7187066|FG001|Overall Study|Serious Adverse Event|2
4407766|NCT00229658|7187065|FG000|Overall Study|Withdrawal of consent|46
4407767|NCT00229658|7187066|FG001|Overall Study|Withdrawal of consent|39
4407768|NCT00229723|7187079|FG000|Concomitant Phase|Adverse Event|4
4407769|NCT00229723|7187080|FG001|Concomitant Phase|Adverse Event|2
4407770|NCT00229723|7187081|FG002|Concomitant Phase|Adverse Event|5
4407771|NCT00229723|7187082|FG003|Concomitant Phase|Adverse Event|2
4407772|NCT00229723|7187083|FG004|Concomitant Phase|Adverse Event|0
4407773|NCT00229723|7187084|FG005|Concomitant Phase|Adverse Event|1
4407774|NCT00229723|7187085|FG006|Concomitant Phase|Adverse Event|2
4407775|NCT00229723|7187079|FG000|Concomitant Phase|Objective disease progression|0
4407776|NCT00229723|7187080|FG001|Concomitant Phase|Objective disease progression|0
4407777|NCT00229723|7187081|FG002|Concomitant Phase|Objective disease progression|0
4407778|NCT00229723|7187082|FG003|Concomitant Phase|Objective disease progression|0
4407779|NCT00229723|7187083|FG004|Concomitant Phase|Objective disease progression|0
4407780|NCT00229723|7187084|FG005|Concomitant Phase|Objective disease progression|0
4407781|NCT00229723|7187085|FG006|Concomitant Phase|Objective disease progression|0
4407782|NCT00229723|7187079|FG000|Concomitant Phase|Clinical progression|0
4407783|NCT00229723|7187080|FG001|Concomitant Phase|Clinical progression|0
4407784|NCT00229723|7187081|FG002|Concomitant Phase|Clinical progression|0
4407785|NCT00229723|7187082|FG003|Concomitant Phase|Clinical progression|0
4407786|NCT00229723|7187083|FG004|Concomitant Phase|Clinical progression|0
4407787|NCT00229723|7187084|FG005|Concomitant Phase|Clinical progression|0
4407788|NCT00229723|7187085|FG006|Concomitant Phase|Clinical progression|1
4407789|NCT00229723|7187079|FG000|Concomitant Phase|Lost to Follow-up|0
4407790|NCT00229723|7187080|FG001|Concomitant Phase|Lost to Follow-up|0
4407791|NCT00229723|7187081|FG002|Concomitant Phase|Lost to Follow-up|0
4407792|NCT00229723|7187082|FG003|Concomitant Phase|Lost to Follow-up|0
4407793|NCT00229723|7187083|FG004|Concomitant Phase|Lost to Follow-up|1
4407794|NCT00229723|7187084|FG005|Concomitant Phase|Lost to Follow-up|0
4407795|NCT00229723|7187085|FG006|Concomitant Phase|Lost to Follow-up|0
4407796|NCT00229723|7187079|FG000|Concomitant Phase|Informed consent withdrawn|3
4407797|NCT00229723|7187080|FG001|Concomitant Phase|Informed consent withdrawn|2
4407798|NCT00229723|7187081|FG002|Concomitant Phase|Informed consent withdrawn|0
4407799|NCT00229723|7187082|FG003|Concomitant Phase|Informed consent withdrawn|2
4407800|NCT00229723|7187083|FG004|Concomitant Phase|Informed consent withdrawn|0
4407801|NCT00229723|7187084|FG005|Concomitant Phase|Informed consent withdrawn|0
4407802|NCT00229723|7187085|FG006|Concomitant Phase|Informed consent withdrawn|0
4407803|NCT00229723|7187079|FG000|Concomitant Phase|Severe non-compliance|0
4407804|NCT00229723|7187080|FG001|Concomitant Phase|Severe non-compliance|1
4407805|NCT00229723|7187081|FG002|Concomitant Phase|Severe non-compliance|0
4407806|NCT00229723|7187082|FG003|Concomitant Phase|Severe non-compliance|0
4407807|NCT00229723|7187083|FG004|Concomitant Phase|Severe non-compliance|1
4407808|NCT00229723|7187084|FG005|Concomitant Phase|Severe non-compliance|0
4407809|NCT00229723|7187085|FG006|Concomitant Phase|Severe non-compliance|0
4407810|NCT00229723|7187079|FG000|Concomitant Phase|Other|3
4407811|NCT00229723|7187080|FG001|Concomitant Phase|Other|0
4407812|NCT00229723|7187081|FG002|Concomitant Phase|Other|1
4407813|NCT00229723|7187082|FG003|Concomitant Phase|Other|1
4407814|NCT00229723|7187083|FG004|Concomitant Phase|Other|0
4407815|NCT00229723|7187084|FG005|Concomitant Phase|Other|2
4407816|NCT00229723|7187085|FG006|Concomitant Phase|Other|0
4407817|NCT00229723|7187079|FG000|Maintenance Phase|Adverse Event|7
4407818|NCT00229723|7187080|FG001|Maintenance Phase|Adverse Event|2
4407819|NCT00229723|7187081|FG002|Maintenance Phase|Adverse Event|1
4407820|NCT00229723|7187082|FG003|Maintenance Phase|Adverse Event|4
4407821|NCT00229723|7187083|FG004|Maintenance Phase|Adverse Event|7
4407822|NCT00229723|7187084|FG005|Maintenance Phase|Adverse Event|5
4407823|NCT00229723|7187085|FG006|Maintenance Phase|Adverse Event|2
4407824|NCT00229723|7187079|FG000|Maintenance Phase|Objective disease progression|5
4407825|NCT00229723|7187080|FG001|Maintenance Phase|Objective disease progression|5
4407826|NCT00229723|7187081|FG002|Maintenance Phase|Objective disease progression|3
4407827|NCT00229723|7187082|FG003|Maintenance Phase|Objective disease progression|6
4407828|NCT00229723|7187083|FG004|Maintenance Phase|Objective disease progression|2
4407829|NCT00229723|7187084|FG005|Maintenance Phase|Objective disease progression|9
4407830|NCT00229723|7187085|FG006|Maintenance Phase|Objective disease progression|5
4407831|NCT00229723|7187079|FG000|Maintenance Phase|Clinical progression|4
4407832|NCT00229723|7187080|FG001|Maintenance Phase|Clinical progression|1
4407833|NCT00229723|7187081|FG002|Maintenance Phase|Clinical progression|2
4407834|NCT00229723|7187082|FG003|Maintenance Phase|Clinical progression|2
4407835|NCT00229723|7187083|FG004|Maintenance Phase|Clinical progression|1
4407836|NCT00229723|7187084|FG005|Maintenance Phase|Clinical progression|1
4407837|NCT00229723|7187085|FG006|Maintenance Phase|Clinical progression|1
4407838|NCT00229723|7187079|FG000|Maintenance Phase|Lost to Follow-up|0
4407839|NCT00229723|7187080|FG001|Maintenance Phase|Lost to Follow-up|1
4407840|NCT00229723|7187081|FG002|Maintenance Phase|Lost to Follow-up|2
4407841|NCT00229723|7187082|FG003|Maintenance Phase|Lost to Follow-up|2
4407842|NCT00229723|7187083|FG004|Maintenance Phase|Lost to Follow-up|0
4407843|NCT00229723|7187084|FG005|Maintenance Phase|Lost to Follow-up|0
4407844|NCT00229723|7187085|FG006|Maintenance Phase|Lost to Follow-up|1
4407845|NCT00229723|7187079|FG000|Maintenance Phase|Informed consent withdrawn|1
4407846|NCT00229723|7187080|FG001|Maintenance Phase|Informed consent withdrawn|0
4407847|NCT00229723|7187081|FG002|Maintenance Phase|Informed consent withdrawn|0
4407848|NCT00229723|7187082|FG003|Maintenance Phase|Informed consent withdrawn|1
4407849|NCT00229723|7187083|FG004|Maintenance Phase|Informed consent withdrawn|1
4407850|NCT00229723|7187084|FG005|Maintenance Phase|Informed consent withdrawn|1
4407851|NCT00229723|7187085|FG006|Maintenance Phase|Informed consent withdrawn|0
4407852|NCT00229723|7187079|FG000|Maintenance Phase|Severe non-compliance|3
4407853|NCT00229723|7187080|FG001|Maintenance Phase|Severe non-compliance|1
4407854|NCT00229723|7187081|FG002|Maintenance Phase|Severe non-compliance|0
4407855|NCT00229723|7187082|FG003|Maintenance Phase|Severe non-compliance|0
4407856|NCT00229723|7187083|FG004|Maintenance Phase|Severe non-compliance|1
4407857|NCT00229723|7187084|FG005|Maintenance Phase|Severe non-compliance|0
4407858|NCT00229723|7187085|FG006|Maintenance Phase|Severe non-compliance|0
4407859|NCT00229723|7187079|FG000|Maintenance Phase|Other|5
4407860|NCT00229723|7187080|FG001|Maintenance Phase|Other|4
4407861|NCT00229723|7187081|FG002|Maintenance Phase|Other|1
4407862|NCT00229723|7187082|FG003|Maintenance Phase|Other|2
4407863|NCT00229723|7187083|FG004|Maintenance Phase|Other|3
4407864|NCT00229723|7187084|FG005|Maintenance Phase|Other|3
4407865|NCT00229723|7187085|FG006|Maintenance Phase|Other|1
4407866|NCT00230048|7187130|FG000|Overall Study|Lost to Follow-up|13
4407867|NCT00230048|7187131|FG001|Overall Study|Lost to Follow-up|18
4407868|NCT00230178|7187162|FG000|Overall Study|Adverse Event|1
4407869|NCT00230178|7187163|FG001|Overall Study|Adverse Event|5
4407870|NCT00230178|7187164|FG002|Overall Study|Adverse Event|2
4407871|NCT00230178|7187162|FG000|Overall Study|Withdrawal by Subject|0
4407872|NCT00230178|7187163|FG001|Overall Study|Withdrawal by Subject|0
4407873|NCT00230178|7187164|FG002|Overall Study|Withdrawal by Subject|1
4407874|NCT00230178|7187162|FG000|Overall Study|Various other reasons|3
4407875|NCT00230178|7187163|FG001|Overall Study|Various other reasons|2
4407876|NCT00230178|7187164|FG002|Overall Study|Various other reasons|4
4407877|NCT00230282|7187172|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4
4407878|NCT00230282|7187172|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1
4407879|NCT00230282|7187172|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1
4407880|NCT00230282|7187172|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2
4407881|NCT00230971|7187202|FG000|Randomization|No study drug administered|3
4407882|NCT00230971|7187203|FG001|Randomization|No study drug administered|3
4407883|NCT00230971|7187202|FG000|Baseline Participants|Lost to Follow-up|5
4407884|NCT00230971|7187203|FG001|Baseline Participants|Lost to Follow-up|12
4407885|NCT00230971|7187202|FG000|Baseline Participants|Death|6
4407886|NCT00230971|7187203|FG001|Baseline Participants|Death|5
4407887|NCT00230971|7187202|FG000|Baseline Participants|Withdrawal by Subject|7
4407888|NCT00230971|7187203|FG001|Baseline Participants|Withdrawal by Subject|1
4407889|NCT00230971|7187202|FG000|Baseline Participants|Adverse Event|1
4407890|NCT00230971|7187203|FG001|Baseline Participants|Adverse Event|0
4407891|NCT00230971|7187202|FG000|Baseline Participants|No bacteria observed|1
4407892|NCT00230971|7187203|FG001|Baseline Participants|No bacteria observed|0
4407893|NCT00230971|7187202|FG000|Baseline Participants|Failure to return|1
4407894|NCT00230971|7187203|FG001|Baseline Participants|Failure to return|1
4407895|NCT00230971|7187202|FG000|Baseline Participants|Reintervention|1
4407896|NCT00230971|7187203|FG001|Baseline Participants|Reintervention|0
4407897|NCT00231062|7187209|FG000|Overall Study|Physician Decision|6
4407898|NCT00231114|7187215|FG000|Randomized|Withdrawal by Subject|6
4407899|NCT00231114|7187216|FG001|Randomized|Withdrawal by Subject|3
4407900|NCT00231114|7187215|FG000|Treatment Period|Death: Motor Vehicle Accident|1
4407901|NCT00231114|7187216|FG001|Treatment Period|Death: Motor Vehicle Accident|0
4407902|NCT00231114|7187215|FG000|Post-Treatment Period|Lost to Follow-up|6
4713545|NCT02949362|7641168|FG003|Retrospective Period|Inform consent not signed by participant|0
4713546|NCT02949362|7641165|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0
4713547|NCT02949362|7641166|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0
4736153|NCT03559257|7685081|FG001|Open-label Treatment Period|Adverse Event|4
4407903|NCT00231114|7187216|FG001|Post-Treatment Period|Lost to Follow-up|1
4407904|NCT00231114|7187215|FG000|Post-Treatment Period|Physician Decision|1
4407905|NCT00231114|7187216|FG001|Post-Treatment Period|Physician Decision|0
4407906|NCT00231114|7187215|FG000|Post-Treatment Period|Withdrawal by Subject|1
4407907|NCT00231114|7187216|FG001|Post-Treatment Period|Withdrawal by Subject|0
4407908|NCT00231179|7187226|FG000|Overall Study|Lost to Follow-up|21
4407909|NCT00231179|7187227|FG001|Overall Study|Lost to Follow-up|21
4407910|NCT00231179|7187226|FG000|Overall Study|Withdrawal by Subject|3
4407911|NCT00231179|7187227|FG001|Overall Study|Withdrawal by Subject|3
4407912|NCT00231413|7187249|FG000|Overall Study|Non-serious AE|0
4407913|NCT00231413|7187250|FG001|Overall Study|Non-serious AE|0
4407914|NCT00231413|7187251|FG002|Overall Study|Non-serious AE|1
4407915|NCT00231413|7187252|FG003|Overall Study|Non-serious AE|0
4407916|NCT00231413|7187253|FG004|Overall Study|Non-serious AE|0
4407917|NCT00231413|7187254|FG005|Overall Study|Non-serious AE|0
4407918|NCT00231413|7187255|FG006|Overall Study|Non-serious AE|1
4407919|NCT00231413|7187249|FG000|Overall Study|Withdrawal by Subject|3
4407920|NCT00231413|7187250|FG001|Overall Study|Withdrawal by Subject|1
4407921|NCT00231413|7187251|FG002|Overall Study|Withdrawal by Subject|4
4407922|NCT00231413|7187252|FG003|Overall Study|Withdrawal by Subject|2
4407923|NCT00231413|7187253|FG004|Overall Study|Withdrawal by Subject|2
4407924|NCT00231413|7187254|FG005|Overall Study|Withdrawal by Subject|0
4407925|NCT00231413|7187255|FG006|Overall Study|Withdrawal by Subject|3
4407926|NCT00231413|7187249|FG000|Overall Study|Migrated/moved from study area|0
4407927|NCT00231413|7187250|FG001|Overall Study|Migrated/moved from study area|0
4407928|NCT00231413|7187251|FG002|Overall Study|Migrated/moved from study area|1
4407929|NCT00231413|7187252|FG003|Overall Study|Migrated/moved from study area|0
4407930|NCT00231413|7187253|FG004|Overall Study|Migrated/moved from study area|0
4407931|NCT00231413|7187254|FG005|Overall Study|Migrated/moved from study area|1
4407932|NCT00231413|7187255|FG006|Overall Study|Migrated/moved from study area|0
4407933|NCT00231413|7187249|FG000|Overall Study|Lost to Follow-up|4
4407934|NCT00231413|7187250|FG001|Overall Study|Lost to Follow-up|4
4407935|NCT00231413|7187251|FG002|Overall Study|Lost to Follow-up|1
4407936|NCT00231413|7187252|FG003|Overall Study|Lost to Follow-up|1
4407937|NCT00231413|7187253|FG004|Overall Study|Lost to Follow-up|1
4407938|NCT00231413|7187254|FG005|Overall Study|Lost to Follow-up|4
4407939|NCT00231413|7187255|FG006|Overall Study|Lost to Follow-up|0
4407940|NCT00231413|7187249|FG000|Overall Study|Pregnancy|1
4407941|NCT00231413|7187250|FG001|Overall Study|Pregnancy|0
4407942|NCT00231413|7187251|FG002|Overall Study|Pregnancy|0
4407943|NCT00231413|7187252|FG003|Overall Study|Pregnancy|0
4407944|NCT00231413|7187253|FG004|Overall Study|Pregnancy|0
4407945|NCT00231413|7187254|FG005|Overall Study|Pregnancy|0
4407946|NCT00231413|7187255|FG006|Overall Study|Pregnancy|0
4407947|NCT00231465|7187271|FG000|Overall Study|Completed only one cycle|1
4407948|NCT00231465|7187271|FG000|Overall Study|Did not have follow up CT scans|1
4407949|NCT00231478|7187277|FG000|Overall Study|Protocol Violation|3
4407950|NCT00231478|7187278|FG001|Overall Study|Protocol Violation|2
4407951|NCT00231478|7187277|FG000|Overall Study|Refused Treatment|1
4407952|NCT00231478|7187278|FG001|Overall Study|Refused Treatment|1
4407953|NCT00231478|7187277|FG000|Overall Study|Withdrawal by Subject|1
4407954|NCT00231478|7187278|FG001|Overall Study|Withdrawal by Subject|0
4407955|NCT00231478|7187277|FG000|Overall Study|Adverse Event|0
4407956|NCT00231478|7187278|FG001|Overall Study|Adverse Event|1
4407957|NCT00231478|7187277|FG000|Overall Study|Administrative|3
4407958|NCT00231478|7187278|FG001|Overall Study|Administrative|2
4407959|NCT00231777|7187286|FG000|Overall Study|Lost to Follow-up|3
4407960|NCT00231777|7187287|FG001|Overall Study|Lost to Follow-up|0
4407961|NCT00231777|7187286|FG000|Overall Study|Other|3
4407962|NCT00231777|7187287|FG001|Overall Study|Other|2
4407963|NCT00231816|7187295|FG000|Overall Study|Adverse Event|1
4407964|NCT00231816|7187296|FG001|Overall Study|Adverse Event|0
4407965|NCT00231816|7187295|FG000|Overall Study|Lost to Follow-up|8
4407966|NCT00231816|7187296|FG001|Overall Study|Lost to Follow-up|5
4407967|NCT00231816|7187295|FG000|Overall Study|Protocol Violation|2
4407968|NCT00231816|7187296|FG001|Overall Study|Protocol Violation|3
4407969|NCT00231816|7187295|FG000|Overall Study|Withdrawal by Subject|3
4407970|NCT00231816|7187296|FG001|Overall Study|Withdrawal by Subject|3
4407971|NCT00231816|7187295|FG000|Overall Study|Other|2
4407972|NCT00231816|7187296|FG001|Overall Study|Other|1
4407973|NCT00231842|7187303|FG000|Overall Study|Withdrawal by Subject|3
4407974|NCT00231842|7187303|FG000|Overall Study|Did not complete the last 3 cycle|8
4407975|NCT00231894|7187314|FG000|Overall Study|Withdrawal by Subject|1
4407976|NCT00231894|7187315|FG001|Overall Study|Withdrawal by Subject|1
4407977|NCT00232180|7187329|FG000|Double-blind (DB) Phase|Death|186
4407978|NCT00232180|7187330|FG001|Double-blind (DB) Phase|Death|222
4407979|NCT00232180|7187331|FG002|Double-blind (DB) Phase|Death|0
4407980|NCT00232180|7187329|FG000|Double-blind (DB) Phase|Lost to Follow-up|34
4407981|NCT00232180|7187330|FG001|Double-blind (DB) Phase|Lost to Follow-up|28
4407982|NCT00232180|7187331|FG002|Double-blind (DB) Phase|Lost to Follow-up|0
4407983|NCT00232180|7187329|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131
4407984|NCT00232180|7187330|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148
4407985|NCT00232180|7187331|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0
4407986|NCT00232180|7187329|FG000|Double-blind (DB) Phase|Protocol Violation|28
4407987|NCT00232180|7187330|FG001|Double-blind (DB) Phase|Protocol Violation|21
4407988|NCT00232180|7187331|FG002|Double-blind (DB) Phase|Protocol Violation|0
4407989|NCT00232180|7187329|FG000|Double-blind (DB) Phase|Adverse Event|83
4407990|NCT00232180|7187330|FG001|Double-blind (DB) Phase|Adverse Event|100
4407991|NCT00232180|7187331|FG002|Double-blind (DB) Phase|Adverse Event|0
4407992|NCT00232180|7187329|FG000|Double-blind (DB) Phase|Other|70
4407993|NCT00232180|7187330|FG001|Double-blind (DB) Phase|Other|75
4407994|NCT00232180|7187331|FG002|Double-blind (DB) Phase|Other|0
4407995|NCT00232180|7187329|FG000|Double-blind (DB) Phase|Randomized but not treated|3
4407996|NCT00232180|7187330|FG001|Double-blind (DB) Phase|Randomized but not treated|4
4407997|NCT00232180|7187331|FG002|Double-blind (DB) Phase|Randomized but not treated|0
4407998|NCT00232180|7187329|FG000|Double-blind (DB) Phase|Laboratory abnormality|6
4407999|NCT00232180|7187330|FG001|Double-blind (DB) Phase|Laboratory abnormality|7
4408000|NCT00232180|7187331|FG002|Double-blind (DB) Phase|Laboratory abnormality|0
4408001|NCT00232180|7187329|FG000|Open Label Phase|Death|0
4408002|NCT00232180|7187330|FG001|Open Label Phase|Death|0
4408003|NCT00232180|7187331|FG002|Open Label Phase|Death|48
4408004|NCT00232180|7187329|FG000|Open Label Phase|Lost to Follow-up|0
4408005|NCT00232180|7187330|FG001|Open Label Phase|Lost to Follow-up|0
4408006|NCT00232180|7187331|FG002|Open Label Phase|Lost to Follow-up|5
4408007|NCT00232180|7187329|FG000|Open Label Phase|Protocol Violation|0
4408008|NCT00232180|7187330|FG001|Open Label Phase|Protocol Violation|0
4408009|NCT00232180|7187331|FG002|Open Label Phase|Protocol Violation|3
4408010|NCT00232180|7187329|FG000|Open Label Phase|Study terminated by sponsor|0
4408011|NCT00232180|7187330|FG001|Open Label Phase|Study terminated by sponsor|0
4408012|NCT00232180|7187331|FG002|Open Label Phase|Study terminated by sponsor|3
4408013|NCT00232180|7187329|FG000|Open Label Phase|Withdrawal by Subject|0
4408014|NCT00232180|7187330|FG001|Open Label Phase|Withdrawal by Subject|0
4408015|NCT00232180|7187331|FG002|Open Label Phase|Withdrawal by Subject|37
4408016|NCT00232180|7187329|FG000|Open Label Phase|Other|0
4408017|NCT00232180|7187330|FG001|Open Label Phase|Other|0
4408018|NCT00232180|7187331|FG002|Open Label Phase|Other|16
4629031|NCT01867710|7496626|FG001|Overall Study|Study Terminated by Sponsor|13
4629032|NCT01867710|7496627|FG002|Overall Study|Study Terminated by Sponsor|8
4408019|NCT00232180|7187329|FG000|Open Label Phase|Adverse Event|0
4408020|NCT00232180|7187330|FG001|Open Label Phase|Adverse Event|0
4408021|NCT00232180|7187331|FG002|Open Label Phase|Adverse Event|25
4408022|NCT00232180|7187329|FG000|Open Label Phase|Laboratory abnormality|0
4408023|NCT00232180|7187330|FG001|Open Label Phase|Laboratory abnormality|0
4408024|NCT00232180|7187331|FG002|Open Label Phase|Laboratory abnormality|10
4408025|NCT00232180|7187329|FG000|Open Label Phase|Randomized but not treated|0
4408026|NCT00232180|7187330|FG001|Open Label Phase|Randomized but not treated|0
4408027|NCT00232180|7187331|FG002|Open Label Phase|Randomized but not treated|1
4408028|NCT00232544|7187360|FG000|Overall Study|Lost to Follow-up|20
4408029|NCT00232544|7187361|FG001|Overall Study|Lost to Follow-up|15
4408030|NCT00232557|7187369|FG000|Overall Study|Lost to Follow-up|3
4408031|NCT00232557|7187370|FG001|Overall Study|Lost to Follow-up|5
4408032|NCT00232596|7187391|FG000|6-Week Titration Phase|Adverse Event|6
4408033|NCT00232596|7187392|FG001|6-Week Titration Phase|Adverse Event|19
4408034|NCT00232596|7187391|FG000|6-Week Titration Phase|Failed to Return|2
4408035|NCT00232596|7187392|FG001|6-Week Titration Phase|Failed to Return|1
4408036|NCT00232596|7187391|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1
4408037|NCT00232596|7187392|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2
4408038|NCT00232596|7187391|FG000|6-Week Titration Phase|Protocol Violation|1
4408039|NCT00232596|7187392|FG001|6-Week Titration Phase|Protocol Violation|3
4408040|NCT00232596|7187391|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1
4408041|NCT00232596|7187392|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0
4408042|NCT00232596|7187391|FG000|6-Week Titration Phase|Other|3
4408043|NCT00232596|7187392|FG001|6-Week Titration Phase|Other|3
4408044|NCT00232596|7187391|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0
4408045|NCT00232596|7187392|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1
4408046|NCT00232596|7187391|FG000|12-Week Maintenance Phase|Adverse Event|7
4408047|NCT00232596|7187392|FG001|12-Week Maintenance Phase|Adverse Event|22
4408048|NCT00232596|7187391|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1
4408049|NCT00232596|7187392|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2
4408050|NCT00232596|7187391|FG000|12-Week Maintenance Phase|Protocol Violation|3
4408051|NCT00232596|7187392|FG001|12-Week Maintenance Phase|Protocol Violation|1
4408052|NCT00232596|7187391|FG000|12-Week Maintenance Phase|Other|1
4408053|NCT00232596|7187392|FG001|12-Week Maintenance Phase|Other|3
4408054|NCT00233064|7187416|FG000|Overall Study|Lost to Follow-up|7
4408055|NCT00233064|7187417|FG001|Overall Study|Lost to Follow-up|7
4408056|NCT00233064|7187416|FG000|Overall Study|Withdrawal by Subject|5
4408057|NCT00233064|7187417|FG001|Overall Study|Withdrawal by Subject|3
4408058|NCT00233064|7187416|FG000|Overall Study|Death|0
4408059|NCT00233064|7187417|FG001|Overall Study|Death|1
4408060|NCT00233064|7187416|FG000|Overall Study|Relocation|0
4408061|NCT00233064|7187417|FG001|Overall Study|Relocation|1
4408062|NCT00233064|7187416|FG000|Overall Study|Protocol Violation|1
4408063|NCT00233064|7187417|FG001|Overall Study|Protocol Violation|0
4408064|NCT00233064|7187416|FG000|Overall Study|Moved to Dom. Republic|1
4408065|NCT00233064|7187417|FG001|Overall Study|Moved to Dom. Republic|0
4408066|NCT00233324|7187437|FG000|Main Study|Death|68
4408067|NCT00233324|7187438|FG001|Main Study|Death|60
4408068|NCT00233324|7187439|FG002|Main Study|Death|62
4408069|NCT00233324|7187440|FG003|Main Study|Death|47
4408070|NCT00233324|7187437|FG000|Follow up at 18-22 Months Corrected Age|Death|5
4408071|NCT00233324|7187438|FG001|Follow up at 18-22 Months Corrected Age|Death|7
4629033|NCT01867710|7496628|FG003|Overall Study|Study Terminated by Sponsor|16
4408072|NCT00233324|7187439|FG002|Follow up at 18-22 Months Corrected Age|Death|5
4408073|NCT00233324|7187440|FG003|Follow up at 18-22 Months Corrected Age|Death|4
4408074|NCT00233324|7187437|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8
4408075|NCT00233324|7187438|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7
4408076|NCT00233324|7187439|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13
4408077|NCT00233324|7187440|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7
4408078|NCT00233363|7187459|FG000|Overall Study|Adverse Event|1
4408079|NCT00233363|7187460|FG001|Overall Study|Adverse Event|2
4408080|NCT00233363|7187459|FG000|Overall Study|Lack of Efficacy|0
4408081|NCT00233363|7187460|FG001|Overall Study|Lack of Efficacy|2
4408082|NCT00233363|7187459|FG000|Overall Study|Withdrawal by Subject|1
4408083|NCT00233363|7187460|FG001|Overall Study|Withdrawal by Subject|1
4408084|NCT00233363|7187459|FG000|Overall Study|Aggravation of complication|1
4408085|NCT00233363|7187460|FG001|Overall Study|Aggravation of complication|0
4408086|NCT00233389|7187468|FG000|Overall Study|Adverse Event|5
4408087|NCT00233389|7187469|FG001|Overall Study|Adverse Event|5
4408088|NCT00233389|7187468|FG000|Overall Study|Lack of Efficacy|11
4408089|NCT00233389|7187469|FG001|Overall Study|Lack of Efficacy|8
4408090|NCT00233389|7187468|FG000|Overall Study|Lost to Follow-up|1
4408091|NCT00233389|7187469|FG001|Overall Study|Lost to Follow-up|1
4408092|NCT00233389|7187468|FG000|Overall Study|Physician Decision|1
4408093|NCT00233389|7187469|FG001|Overall Study|Physician Decision|0
4408094|NCT00233389|7187468|FG000|Overall Study|Protocol Violation|0
4408095|NCT00233389|7187469|FG001|Overall Study|Protocol Violation|1
4408096|NCT00233389|7187468|FG000|Overall Study|Withdrawal by Subject|0
4408097|NCT00233389|7187469|FG001|Overall Study|Withdrawal by Subject|1
4408098|NCT00233402|7187477|FG000|Overall Study|No pathology data|12
4408099|NCT00233402|7187478|FG001|Overall Study|No pathology data|9
4408100|NCT00233402|7187477|FG000|Overall Study|No Ta/T1|89
4408101|NCT00233402|7187478|FG001|Overall Study|No Ta/T1|94
4408102|NCT00233402|7187477|FG000|Overall Study|Lost to follow up etc|3
4408103|NCT00233402|7187478|FG001|Overall Study|Lost to follow up etc|21
4408104|NCT00233454|7187486|FG000|Overall Study|Death|6
4408105|NCT00233480|7187492|FG000|Overall Study|Underwent status II heart transplant|0
4408106|NCT00233480|7187493|FG001|Overall Study|Underwent status II heart transplant|1
4408107|NCT00233948|7187512|FG000|Overall Study|Adverse Event|1
4408108|NCT00233948|7187513|FG001|Overall Study|Adverse Event|0
4408109|NCT00233948|7187514|FG002|Overall Study|Adverse Event|0
4408110|NCT00233948|7187515|FG003|Overall Study|Adverse Event|0
4408111|NCT00233948|7187516|FG004|Overall Study|Adverse Event|0
4408112|NCT00233948|7187517|FG005|Overall Study|Adverse Event|0
4408113|NCT00233987|7187532|FG000|Overall Study|Withdrawal by Subject|1
4408114|NCT00233987|7187532|FG000|Overall Study|Lack of Efficacy|2
4408115|NCT00233987|7187532|FG000|Overall Study|Reason Under Review|1
4408116|NCT00233987|7187532|FG000|Overall Study|Other - Not Protocol Specified|5
4408117|NCT00233987|7187532|FG000|Overall Study|Eligible but No Treatment Received|2
4408118|NCT00233987|7187532|FG000|Overall Study|Ineligible|4
4408119|NCT00234039|7187536|FG000|Overall Study|Adverse Event|2
4408120|NCT00234039|7187536|FG000|Overall Study|Progression/relapse|34
4408121|NCT00234039|7187536|FG000|Overall Study|Other - Not Protocol Specified|3
4408122|NCT00234039|7187536|FG000|Overall Study|Ineligible|9
4408123|NCT00234039|7187536|FG000|Overall Study|No Protocol Treatment Received|2
4408124|NCT00234052|7187540|FG000|Treatment|Withdrawal by Subject|3
4408125|NCT00234052|7187540|FG000|Treatment|Adverse Event|5
4408126|NCT00234052|7187540|FG000|Treatment|Death|2
4408127|NCT00234052|7187540|FG000|Treatment|Progressive Disease|11
4408128|NCT00234052|7187540|FG000|Follow-up for 5 Years|Death|41
4408129|NCT00234052|7187540|FG000|Follow-up for 5 Years|Lost to Follow-up|1
4408130|NCT00234052|7187540|FG000|Follow-up for 5 Years|Other|7
4408131|NCT00234065|7187546|FG000|Overall Study|Adverse Event|268
4408132|NCT00234065|7187547|FG001|Overall Study|Adverse Event|166
4408133|NCT00234065|7187546|FG000|Overall Study|Withdrawal by Subject|73
4408134|NCT00234065|7187547|FG001|Overall Study|Withdrawal by Subject|56
4408135|NCT00234065|7187546|FG000|Overall Study|Physician Decision|23
4408136|NCT00234065|7187547|FG001|Overall Study|Physician Decision|22
4408137|NCT00234065|7187546|FG000|Overall Study|Not Classified|111
4408138|NCT00234065|7187547|FG001|Overall Study|Not Classified|112
4408139|NCT00234104|7187574|FG000|Overall Study|Adverse Event|4
4408140|NCT00234104|7187575|FG001|Overall Study|Adverse Event|0
4408141|NCT00234104|7187576|FG002|Overall Study|Adverse Event|3
4408142|NCT00234104|7187577|FG003|Overall Study|Adverse Event|5
4408143|NCT00234104|7187574|FG000|Overall Study|Protocol Violation|0
4408144|NCT00234104|7187575|FG001|Overall Study|Protocol Violation|0
4408145|NCT00234104|7187576|FG002|Overall Study|Protocol Violation|0
4408146|NCT00234104|7187577|FG003|Overall Study|Protocol Violation|1
4408147|NCT00234104|7187574|FG000|Overall Study|Physician Decision|0
4408148|NCT00234104|7187575|FG001|Overall Study|Physician Decision|1
4408149|NCT00234104|7187576|FG002|Overall Study|Physician Decision|2
4408150|NCT00234104|7187577|FG003|Overall Study|Physician Decision|2
4408151|NCT00234494|7187620|FG000|Overall Study|Protocol Violation|2
4408152|NCT00234533|7187624|FG000|Overall Study|Withdrawal by Subject|6
4408153|NCT00234533|7187624|FG000|Overall Study|Adverse Event|2
4408154|NCT00234533|7187624|FG000|Overall Study|Enrolled but not treated|3
4408155|NCT00235391|7187655|FG000|Overall Study|Adverse Event|4
4408156|NCT00235391|7187656|FG001|Overall Study|Adverse Event|5
4408157|NCT00235391|7187657|FG002|Overall Study|Adverse Event|10
4408158|NCT00235391|7187658|FG003|Overall Study|Adverse Event|72
4408159|NCT00235391|7187659|FG004|Overall Study|Adverse Event|5
4408160|NCT00235391|7187660|FG005|Overall Study|Adverse Event|2
4408161|NCT00235391|7187655|FG000|Overall Study|Abnormal laboratory value(s)|3
4408162|NCT00235391|7187656|FG001|Overall Study|Abnormal laboratory value(s)|5
4408163|NCT00235391|7187657|FG002|Overall Study|Abnormal laboratory value(s)|4
4408164|NCT00235391|7187658|FG003|Overall Study|Abnormal laboratory value(s)|27
4408165|NCT00235391|7187659|FG004|Overall Study|Abnormal laboratory value(s)|1
4408166|NCT00235391|7187660|FG005|Overall Study|Abnormal laboratory value(s)|2
4408167|NCT00235391|7187655|FG000|Overall Study|Unsatisfactory therapeutic effect|0
4408168|NCT00235391|7187656|FG001|Overall Study|Unsatisfactory therapeutic effect|2
4408169|NCT00235391|7187657|FG002|Overall Study|Unsatisfactory therapeutic effect|2
4408170|NCT00235391|7187658|FG003|Overall Study|Unsatisfactory therapeutic effect|17
4408171|NCT00235391|7187659|FG004|Overall Study|Unsatisfactory therapeutic effect|0
4408172|NCT00235391|7187660|FG005|Overall Study|Unsatisfactory therapeutic effect|0
4408173|NCT00235391|7187655|FG000|Overall Study|Condition no longer requires treatment|3
4408174|NCT00235391|7187656|FG001|Overall Study|Condition no longer requires treatment|0
4408175|NCT00235391|7187657|FG002|Overall Study|Condition no longer requires treatment|0
4408176|NCT00235391|7187658|FG003|Overall Study|Condition no longer requires treatment|11
4408177|NCT00235391|7187659|FG004|Overall Study|Condition no longer requires treatment|1
4408178|NCT00235391|7187660|FG005|Overall Study|Condition no longer requires treatment|0
4408179|NCT00235391|7187655|FG000|Overall Study|Protocol deviation|0
4408180|NCT00235391|7187656|FG001|Overall Study|Protocol deviation|0
4408181|NCT00235391|7187657|FG002|Overall Study|Protocol deviation|1
4408182|NCT00235391|7187658|FG003|Overall Study|Protocol deviation|11
4408183|NCT00235391|7187659|FG004|Overall Study|Protocol deviation|0
4408184|NCT00235391|7187660|FG005|Overall Study|Protocol deviation|0
4408185|NCT00235391|7187655|FG000|Overall Study|Withdrawal by Subject|2
4408186|NCT00235391|7187656|FG001|Overall Study|Withdrawal by Subject|3
4408187|NCT00235391|7187657|FG002|Overall Study|Withdrawal by Subject|3
4408188|NCT00235391|7187658|FG003|Overall Study|Withdrawal by Subject|61
4408189|NCT00235391|7187659|FG004|Overall Study|Withdrawal by Subject|5
4408190|NCT00235391|7187660|FG005|Overall Study|Withdrawal by Subject|0
4408191|NCT00235391|7187655|FG000|Overall Study|Lost to Follow-up|0
4408192|NCT00235391|7187656|FG001|Overall Study|Lost to Follow-up|3
4408193|NCT00235391|7187657|FG002|Overall Study|Lost to Follow-up|3
4408194|NCT00235391|7187658|FG003|Overall Study|Lost to Follow-up|16
4408195|NCT00235391|7187659|FG004|Overall Study|Lost to Follow-up|0
4408196|NCT00235391|7187660|FG005|Overall Study|Lost to Follow-up|0
4408197|NCT00235391|7187655|FG000|Overall Study|Administrative problems|0
4408198|NCT00235391|7187656|FG001|Overall Study|Administrative problems|0
4408199|NCT00235391|7187657|FG002|Overall Study|Administrative problems|0
4408200|NCT00235391|7187658|FG003|Overall Study|Administrative problems|1
4408201|NCT00235391|7187659|FG004|Overall Study|Administrative problems|0
4408202|NCT00235391|7187660|FG005|Overall Study|Administrative problems|0
4408203|NCT00235391|7187655|FG000|Overall Study|Death|0
4408204|NCT00235391|7187656|FG001|Overall Study|Death|0
4408205|NCT00235391|7187657|FG002|Overall Study|Death|1
4408206|NCT00235391|7187658|FG003|Overall Study|Death|4
4408207|NCT00235391|7187659|FG004|Overall Study|Death|0
4408208|NCT00235391|7187660|FG005|Overall Study|Death|0
4408209|NCT00235443|7187675|FG000|Overall Study|Adverse Event|4
4408210|NCT00235443|7187676|FG001|Overall Study|Adverse Event|12
4408211|NCT00235443|7187677|FG002|Overall Study|Adverse Event|17
4408212|NCT00235443|7187678|FG003|Overall Study|Adverse Event|44
4408213|NCT00235443|7187679|FG004|Overall Study|Adverse Event|10
4408214|NCT00235443|7187680|FG005|Overall Study|Adverse Event|15
4408215|NCT00235443|7187675|FG000|Overall Study|Lack of Efficacy|0
4408216|NCT00235443|7187676|FG001|Overall Study|Lack of Efficacy|1
4408217|NCT00235443|7187677|FG002|Overall Study|Lack of Efficacy|5
4408218|NCT00235443|7187678|FG003|Overall Study|Lack of Efficacy|12
4408219|NCT00235443|7187679|FG004|Overall Study|Lack of Efficacy|2
4408220|NCT00235443|7187680|FG005|Overall Study|Lack of Efficacy|9
4408221|NCT00235443|7187675|FG000|Overall Study|Withdrawal by Subject|3
4408222|NCT00235443|7187676|FG001|Overall Study|Withdrawal by Subject|9
4408223|NCT00235443|7187677|FG002|Overall Study|Withdrawal by Subject|25
4408224|NCT00235443|7187678|FG003|Overall Study|Withdrawal by Subject|24
4408225|NCT00235443|7187679|FG004|Overall Study|Withdrawal by Subject|10
4408226|NCT00235443|7187680|FG005|Overall Study|Withdrawal by Subject|12
4408227|NCT00235443|7187675|FG000|Overall Study|Lost to Follow-up|0
4408228|NCT00235443|7187676|FG001|Overall Study|Lost to Follow-up|8
4408229|NCT00235443|7187677|FG002|Overall Study|Lost to Follow-up|6
4408230|NCT00235443|7187678|FG003|Overall Study|Lost to Follow-up|6
4408231|NCT00235443|7187679|FG004|Overall Study|Lost to Follow-up|4
4408232|NCT00235443|7187680|FG005|Overall Study|Lost to Follow-up|3
4408233|NCT00235443|7187675|FG000|Overall Study|Unsatisfactory compliance|0
4408234|NCT00235443|7187676|FG001|Overall Study|Unsatisfactory compliance|2
4408235|NCT00235443|7187677|FG002|Overall Study|Unsatisfactory compliance|3
4408236|NCT00235443|7187678|FG003|Overall Study|Unsatisfactory compliance|4
4408237|NCT00235443|7187679|FG004|Overall Study|Unsatisfactory compliance|1
4408238|NCT00235443|7187680|FG005|Overall Study|Unsatisfactory compliance|0
4408239|NCT00235443|7187675|FG000|Overall Study|Other reasons for premature termination|1
4408240|NCT00235443|7187676|FG001|Overall Study|Other reasons for premature termination|6
4408241|NCT00235443|7187677|FG002|Overall Study|Other reasons for premature termination|6
4408242|NCT00235443|7187678|FG003|Overall Study|Other reasons for premature termination|7
4408243|NCT00235443|7187679|FG004|Overall Study|Other reasons for premature termination|3
4408244|NCT00235443|7187680|FG005|Overall Study|Other reasons for premature termination|6
4511516|NCT00927394|7320635|FG001|Overall Study|Death|1
4511517|NCT00927394|7320634|FG000|Overall Study|Protocol deviation|16
4511518|NCT00927394|7320635|FG001|Overall Study|Protocol deviation|13
4511519|NCT00927394|7320634|FG000|Overall Study|Randomized in error|0
4511520|NCT00927394|7320635|FG001|Overall Study|Randomized in error|1
4511521|NCT00927472|7320644|FG000|Overall Study|Withdrawal by Subject|10
4511522|NCT00927472|7320645|FG001|Overall Study|Withdrawal by Subject|11
4511523|NCT00927472|7320644|FG000|Overall Study|Lost to Follow-up|1
4511524|NCT00927472|7320645|FG001|Overall Study|Lost to Follow-up|6
4511525|NCT00927472|7320644|FG000|Overall Study|Protocol Violation|0
4511526|NCT00927472|7320645|FG001|Overall Study|Protocol Violation|1
4511527|NCT00927472|7320644|FG000|Overall Study|Post treatment Assessment out of window|0
4511528|NCT00927472|7320645|FG001|Overall Study|Post treatment Assessment out of window|4
4511529|NCT00927485|7320653|FG000|Overall Study|Adverse Event|4
4511530|NCT00927485|7320654|FG001|Overall Study|Adverse Event|2
4511531|NCT00927485|7320653|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2
4511532|NCT00927485|7320654|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2
4511533|NCT00927563|7320660|FG000|Overall Study|Lost to Follow-up|1
4511534|NCT00927563|7320660|FG000|Overall Study|Withdrawal by Subject|1
4511535|NCT00927589|7320672|FG000|Overall Study|Death|1
4511536|NCT00927589|7320672|FG000|Overall Study|Physician Decision|1
4511537|NCT00927589|7320672|FG000|Overall Study|Withdrawal by Subject|3
4511538|NCT00927589|7320672|FG000|Overall Study|Adverse Event|2
4511539|NCT00927589|7320672|FG000|Overall Study|Disease Progression|8
4511540|NCT00927589|7320672|FG000|Overall Study|Non-compliance|1
4511541|NCT00927758|7320676|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
4511542|NCT00927758|7320677|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
4511543|NCT00927758|7320678|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
4511544|NCT00927758|7320679|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1
4511545|NCT00927758|7320680|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
4511546|NCT00927758|7320681|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1
4511547|NCT00927758|7320676|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
4511548|NCT00927758|7320677|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
4511549|NCT00927758|7320678|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
4511550|NCT00927758|7320679|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
4511551|NCT00927758|7320680|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
4511552|NCT00927758|7320681|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
4511553|NCT00927784|7320691|FG000|Overall Study|Death|1
4511554|NCT00927784|7320692|FG001|Overall Study|Death|0
4511555|NCT00927784|7320691|FG000|Overall Study|Withdrawal by Subject|1
4511556|NCT00927784|7320692|FG001|Overall Study|Withdrawal by Subject|0
4511557|NCT00927810|7320702|FG000|Overall Study|Withdrawal by Subject|0
4511558|NCT00927810|7320703|FG001|Overall Study|Withdrawal by Subject|3
4511559|NCT00927810|7320704|FG002|Overall Study|Withdrawal by Subject|0
4511560|NCT00927810|7320705|FG003|Overall Study|Withdrawal by Subject|1
4511561|NCT00927810|7320702|FG000|Overall Study|Lost to Follow-up|0
4511562|NCT00927810|7320703|FG001|Overall Study|Lost to Follow-up|2
4511563|NCT00927810|7320704|FG002|Overall Study|Lost to Follow-up|1
4511564|NCT00927810|7320705|FG003|Overall Study|Lost to Follow-up|1
4511565|NCT00927810|7320702|FG000|Overall Study|Death|0
4511566|NCT00927810|7320703|FG001|Overall Study|Death|2
4511567|NCT00927810|7320704|FG002|Overall Study|Death|0
4511568|NCT00927810|7320705|FG003|Overall Study|Death|0
4511569|NCT00927810|7320702|FG000|Overall Study|Abnormal laboratory value(s)|0
4511570|NCT00927810|7320703|FG001|Overall Study|Abnormal laboratory value(s)|1
4511571|NCT00927810|7320704|FG002|Overall Study|Abnormal laboratory value(s)|0
4511572|NCT00927810|7320705|FG003|Overall Study|Abnormal laboratory value(s)|0
4511573|NCT00927823|7320723|FG000|Continuous Dosing Period|Death|0
4511574|NCT00927823|7320724|FG001|Continuous Dosing Period|Death|0
4511575|NCT00927823|7320725|FG002|Continuous Dosing Period|Death|6
4511576|NCT00927823|7320726|FG003|Continuous Dosing Period|Death|0
4511577|NCT00927823|7320723|FG000|Continuous Dosing Period|Lost to Follow-up|1
4511578|NCT00927823|7320724|FG001|Continuous Dosing Period|Lost to Follow-up|1
4511579|NCT00927823|7320725|FG002|Continuous Dosing Period|Lost to Follow-up|9
4511580|NCT00927823|7320726|FG003|Continuous Dosing Period|Lost to Follow-up|0
4511581|NCT00927823|7320723|FG000|Continuous Dosing Period|Withdrawal by Subject|1
4511582|NCT00927823|7320724|FG001|Continuous Dosing Period|Withdrawal by Subject|0
4511583|NCT00927823|7320725|FG002|Continuous Dosing Period|Withdrawal by Subject|2
4511584|NCT00927823|7320726|FG003|Continuous Dosing Period|Withdrawal by Subject|2
4511585|NCT00927823|7320723|FG000|Continuous Dosing Period|Other|1
4511586|NCT00927823|7320724|FG001|Continuous Dosing Period|Other|2
4511587|NCT00927823|7320725|FG002|Continuous Dosing Period|Other|9
4511588|NCT00927823|7320726|FG003|Continuous Dosing Period|Other|3
4408245|NCT00235495|7187707|FG000|Overall Study|Death|52
4408246|NCT00235495|7187708|FG001|Overall Study|Death|42
4408247|NCT00235495|7187707|FG000|Overall Study|Withdrawal by Subject|5
4408248|NCT00235495|7187708|FG001|Overall Study|Withdrawal by Subject|3
4408249|NCT00235495|7187707|FG000|Overall Study|Lost to Follow-up|11
4408250|NCT00235495|7187708|FG001|Overall Study|Lost to Follow-up|13
4408251|NCT00235495|7187707|FG000|Overall Study|Visit/assessmen outside window/missing|0
4408252|NCT00235495|7187708|FG001|Overall Study|Visit/assessmen outside window/missing|10
4408253|NCT00235716|7187731|FG000|Overall Study|Death|26
4408254|NCT00235716|7187732|FG001|Overall Study|Death|39
4408255|NCT00235716|7187733|FG002|Overall Study|Death|32
4408256|NCT00235716|7187734|FG003|Overall Study|Death|31
4408257|NCT00235716|7187731|FG000|Overall Study|Withdrawal by Subject|23
4408258|NCT00235716|7187732|FG001|Overall Study|Withdrawal by Subject|19
4408259|NCT00235716|7187733|FG002|Overall Study|Withdrawal by Subject|17
4408260|NCT00235716|7187734|FG003|Overall Study|Withdrawal by Subject|18
4408261|NCT00235716|7187731|FG000|Overall Study|Lost to Follow-up|12
4408262|NCT00235716|7187732|FG001|Overall Study|Lost to Follow-up|7
4408263|NCT00235716|7187733|FG002|Overall Study|Lost to Follow-up|14
4408264|NCT00235716|7187734|FG003|Overall Study|Lost to Follow-up|10
4408265|NCT00235716|7187731|FG000|Overall Study|Adverse Event|1
4408266|NCT00235716|7187732|FG001|Overall Study|Adverse Event|1
4408267|NCT00235716|7187733|FG002|Overall Study|Adverse Event|1
4408268|NCT00235716|7187734|FG003|Overall Study|Adverse Event|0
4408269|NCT00235716|7187731|FG000|Overall Study|Physician Decision|0
4408270|NCT00235716|7187732|FG001|Overall Study|Physician Decision|1
4408271|NCT00235716|7187733|FG002|Overall Study|Physician Decision|1
4408272|NCT00235716|7187734|FG003|Overall Study|Physician Decision|3
4408273|NCT00235755|7187747|FG000|4-Week Titration Phase|Adverse Event|6
4408274|NCT00235755|7187748|FG001|4-Week Titration Phase|Adverse Event|14
4408275|NCT00235755|7187749|FG002|4-Week Titration Phase|Adverse Event|20
4408276|NCT00235755|7187747|FG000|4-Week Titration Phase|Lost to Follow-up|0
4408277|NCT00235755|7187748|FG001|4-Week Titration Phase|Lost to Follow-up|1
4408278|NCT00235755|7187749|FG002|4-Week Titration Phase|Lost to Follow-up|1
4408279|NCT00235755|7187747|FG000|4-Week Titration Phase|Protocol Violation|2
4408280|NCT00235755|7187748|FG001|4-Week Titration Phase|Protocol Violation|2
4408281|NCT00235755|7187749|FG002|4-Week Titration Phase|Protocol Violation|1
4408282|NCT00235755|7187747|FG000|4-Week Titration Phase|Withdrawal by Subject|1
4408283|NCT00235755|7187748|FG001|4-Week Titration Phase|Withdrawal by Subject|2
4408284|NCT00235755|7187749|FG002|4-Week Titration Phase|Withdrawal by Subject|3
4408285|NCT00235755|7187747|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0
4408286|NCT00235755|7187748|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0
4408287|NCT00235755|7187749|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1
4408288|NCT00235755|7187747|FG000|4-Week Titration Phase|Randomization Occurred in Error|1
4408289|NCT00235755|7187748|FG001|4-Week Titration Phase|Randomization Occurred in Error|0
4408290|NCT00235755|7187749|FG002|4-Week Titration Phase|Randomization Occurred in Error|0
4408291|NCT00235755|7187747|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1
4408292|NCT00235755|7187748|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0
4408293|NCT00235755|7187749|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0
4408294|NCT00235755|7187747|FG000|12-Week Maintenance Phase|Adverse Event|8
4408295|NCT00235755|7187748|FG001|12-Week Maintenance Phase|Adverse Event|12
4408296|NCT00235755|7187749|FG002|12-Week Maintenance Phase|Adverse Event|26
4408297|NCT00235755|7187747|FG000|12-Week Maintenance Phase|Lost to Follow-up|2
4408298|NCT00235755|7187748|FG001|12-Week Maintenance Phase|Lost to Follow-up|3
4408299|NCT00235755|7187749|FG002|12-Week Maintenance Phase|Lost to Follow-up|0
4408300|NCT00235755|7187747|FG000|12-Week Maintenance Phase|Lack of Efficacy|5
4408301|NCT00235755|7187748|FG001|12-Week Maintenance Phase|Lack of Efficacy|0
4408302|NCT00235755|7187749|FG002|12-Week Maintenance Phase|Lack of Efficacy|0
4408303|NCT00235755|7187747|FG000|12-Week Maintenance Phase|Protocol Violation|0
4408304|NCT00235755|7187748|FG001|12-Week Maintenance Phase|Protocol Violation|4
4408305|NCT00235755|7187749|FG002|12-Week Maintenance Phase|Protocol Violation|2
4408306|NCT00235755|7187747|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0
4408307|NCT00235755|7187748|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8
4408308|NCT00235755|7187749|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3
4408309|NCT00235755|7187747|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1
4408310|NCT00235755|7187748|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0
4408311|NCT00235755|7187749|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0
4408312|NCT00235872|7187776|FG000|Overall Study|Adverse Event|34
4408313|NCT00235872|7187776|FG000|Overall Study|Death|1
4408314|NCT00235872|7187776|FG000|Overall Study|Lost to Follow-up|1
4408315|NCT00235872|7187776|FG000|Overall Study|Withdrawal by Subject|50
4408316|NCT00235872|7187776|FG000|Overall Study|Administrative reason|61
4408317|NCT00235989|7187784|FG000|Core Treatment Period (CT)|Lost to Follow-up|0
4408318|NCT00235989|7187785|FG001|Core Treatment Period (CT)|Lost to Follow-up|0
4408319|NCT00235989|7187786|FG002|Core Treatment Period (CT)|Lost to Follow-up|0
4408320|NCT00235989|7187787|FG003|Core Treatment Period (CT)|Lost to Follow-up|0
4408321|NCT00235989|7187788|FG004|Core Treatment Period (CT)|Lost to Follow-up|0
4408322|NCT00235989|7187789|FG005|Core Treatment Period (CT)|Lost to Follow-up|2
4408323|NCT00235989|7187784|FG000|Extension Treatment Period (ET)|Adverse Event|3
4408324|NCT00235989|7187785|FG001|Extension Treatment Period (ET)|Adverse Event|0
4408325|NCT00235989|7187786|FG002|Extension Treatment Period (ET)|Adverse Event|2
4408326|NCT00235989|7187787|FG003|Extension Treatment Period (ET)|Adverse Event|0
4408327|NCT00235989|7187788|FG004|Extension Treatment Period (ET)|Adverse Event|0
4408328|NCT00235989|7187789|FG005|Extension Treatment Period (ET)|Adverse Event|0
4408329|NCT00235989|7187784|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2
4408330|NCT00235989|7187785|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0
4408331|NCT00235989|7187786|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1
4408332|NCT00235989|7187787|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0
4408333|NCT00235989|7187788|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0
4408334|NCT00235989|7187789|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0
4408335|NCT00235989|7187784|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1
4408336|NCT00235989|7187785|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1
4408337|NCT00235989|7187786|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1
4408338|NCT00235989|7187787|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4
4408339|NCT00235989|7187788|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0
4408340|NCT00235989|7187789|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0
4408341|NCT00235989|7187784|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2
4408342|NCT00235989|7187785|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3
4408343|NCT00235989|7187786|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1
4408344|NCT00235989|7187787|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2
4408345|NCT00235989|7187788|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0
4408346|NCT00235989|7187789|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0
4408347|NCT00236080|7187804|FG000|Overall Study|Adverse Event|0
4408348|NCT00236080|7187805|FG001|Overall Study|Adverse Event|0
4408349|NCT00236080|7187806|FG002|Overall Study|Adverse Event|3
4408350|NCT00236080|7187807|FG003|Overall Study|Adverse Event|1
4408351|NCT00236080|7187808|FG004|Overall Study|Adverse Event|0
4408352|NCT00236080|7187804|FG000|Overall Study|Lost to Follow-up|0
4408353|NCT00236080|7187805|FG001|Overall Study|Lost to Follow-up|1
4408354|NCT00236080|7187806|FG002|Overall Study|Lost to Follow-up|0
4408355|NCT00236080|7187807|FG003|Overall Study|Lost to Follow-up|0
4408356|NCT00236080|7187808|FG004|Overall Study|Lost to Follow-up|0
4408357|NCT00236080|7187804|FG000|Overall Study|Physician Decision|1
4408358|NCT00236080|7187805|FG001|Overall Study|Physician Decision|0
4408359|NCT00236080|7187806|FG002|Overall Study|Physician Decision|1
4408360|NCT00236080|7187807|FG003|Overall Study|Physician Decision|1
4408361|NCT00236080|7187808|FG004|Overall Study|Physician Decision|1
4408362|NCT00236080|7187804|FG000|Overall Study|Withdrawal by Subject|1
4408363|NCT00236080|7187805|FG001|Overall Study|Withdrawal by Subject|0
4408364|NCT00236080|7187806|FG002|Overall Study|Withdrawal by Subject|0
4408365|NCT00236080|7187807|FG003|Overall Study|Withdrawal by Subject|0
4408366|NCT00236080|7187808|FG004|Overall Study|Withdrawal by Subject|0
4408367|NCT00236080|7187804|FG000|Overall Study|Miscellaneous|0
4408368|NCT00236080|7187805|FG001|Overall Study|Miscellaneous|0
4408369|NCT00236080|7187806|FG002|Overall Study|Miscellaneous|1
4408370|NCT00236080|7187807|FG003|Overall Study|Miscellaneous|0
4408371|NCT00236080|7187808|FG004|Overall Study|Miscellaneous|0
4408372|NCT00236184|7187822|FG000|Overall Study|Adverse Event|5
4408373|NCT00236184|7187823|FG001|Overall Study|Adverse Event|2
4408374|NCT00236184|7187822|FG000|Overall Study|Lack of Efficacy|0
4408375|NCT00236184|7187823|FG001|Overall Study|Lack of Efficacy|1
4408376|NCT00236184|7187822|FG000|Overall Study|Lost to Follow-up|3
4408377|NCT00236184|7187823|FG001|Overall Study|Lost to Follow-up|4
4408378|NCT00236184|7187822|FG000|Overall Study|Physician Decision|1
4408379|NCT00236184|7187823|FG001|Overall Study|Physician Decision|1
4408380|NCT00236184|7187822|FG000|Overall Study|Withdrawal by Subject|3
4408381|NCT00236184|7187823|FG001|Overall Study|Withdrawal by Subject|0
4408382|NCT00236184|7187822|FG000|Overall Study|Protocol Violation|3
4408383|NCT00236184|7187823|FG001|Overall Study|Protocol Violation|0
4408384|NCT00236184|7187822|FG000|Overall Study|non-compliance with study drug|2
4408385|NCT00236184|7187823|FG001|Overall Study|non-compliance with study drug|1
4408386|NCT00236184|7187822|FG000|Overall Study|other|1
4408387|NCT00236184|7187823|FG001|Overall Study|other|2
4408388|NCT00236197|7187831|FG000|Overall Study|Withdrawal by Subject|3
4408389|NCT00236197|7187832|FG001|Overall Study|Withdrawal by Subject|2
4408390|NCT00236197|7187831|FG000|Overall Study|Lost to Follow-up|1
4408391|NCT00236197|7187832|FG001|Overall Study|Lost to Follow-up|5
4408392|NCT00236197|7187831|FG000|Overall Study|Protocol Violation|0
4408393|NCT00236197|7187832|FG001|Overall Study|Protocol Violation|3
4408394|NCT00236197|7187831|FG000|Overall Study|Medication non-compliance|1
4408395|NCT00236197|7187832|FG001|Overall Study|Medication non-compliance|2
4408396|NCT00236197|7187831|FG000|Overall Study|Other|0
4408397|NCT00236197|7187832|FG001|Overall Study|Other|2
4408398|NCT00236899|7187842|FG000|Overall Study|Adverse Event (Study Related)|1
4408399|NCT00236899|7187843|FG001|Overall Study|Adverse Event (Study Related)|1
4408400|NCT00236899|7187844|FG002|Overall Study|Adverse Event (Study Related)|2
4408401|NCT00236899|7187845|FG003|Overall Study|Adverse Event (Study Related)|1
4408402|NCT00236899|7187842|FG000|Overall Study|Adverse Event (Not Study Related)|3
4408403|NCT00236899|7187843|FG001|Overall Study|Adverse Event (Not Study Related)|3
4408404|NCT00236899|7187844|FG002|Overall Study|Adverse Event (Not Study Related)|4
4408405|NCT00236899|7187845|FG003|Overall Study|Adverse Event (Not Study Related)|7
4408406|NCT00236899|7187842|FG000|Overall Study|Death (Study Disease)|1
4408407|NCT00236899|7187843|FG001|Overall Study|Death (Study Disease)|4
4408408|NCT00236899|7187844|FG002|Overall Study|Death (Study Disease)|0
4408409|NCT00236899|7187845|FG003|Overall Study|Death (Study Disease)|0
4408410|NCT00236899|7187842|FG000|Overall Study|Death (Not Study Related)|2
4408411|NCT00236899|7187843|FG001|Overall Study|Death (Not Study Related)|0
4408412|NCT00236899|7187844|FG002|Overall Study|Death (Not Study Related)|0
4408413|NCT00236899|7187845|FG003|Overall Study|Death (Not Study Related)|0
4408414|NCT00236899|7187842|FG000|Overall Study|Death (Study Drug Toxicity)|1
4408415|NCT00236899|7187843|FG001|Overall Study|Death (Study Drug Toxicity)|0
4408416|NCT00236899|7187844|FG002|Overall Study|Death (Study Drug Toxicity)|0
4408417|NCT00236899|7187845|FG003|Overall Study|Death (Study Drug Toxicity)|0
4408418|NCT00236899|7187842|FG000|Overall Study|Lost to Follow-up|0
4408419|NCT00236899|7187843|FG001|Overall Study|Lost to Follow-up|1
4408420|NCT00236899|7187844|FG002|Overall Study|Lost to Follow-up|0
4408421|NCT00236899|7187845|FG003|Overall Study|Lost to Follow-up|0
4408422|NCT00236899|7187842|FG000|Overall Study|Entry Criteria Exclusion|0
4408423|NCT00236899|7187843|FG001|Overall Study|Entry Criteria Exclusion|1
4408424|NCT00236899|7187844|FG002|Overall Study|Entry Criteria Exclusion|1
4408425|NCT00236899|7187845|FG003|Overall Study|Entry Criteria Exclusion|0
4408426|NCT00236899|7187842|FG000|Overall Study|Protocol Violation|1
4408427|NCT00236899|7187843|FG001|Overall Study|Protocol Violation|0
4408428|NCT00236899|7187844|FG002|Overall Study|Protocol Violation|0
4408429|NCT00236899|7187845|FG003|Overall Study|Protocol Violation|0
4408430|NCT00236899|7187842|FG000|Overall Study|Withdrawal by Subject|6
4408431|NCT00236899|7187843|FG001|Overall Study|Withdrawal by Subject|4
4408432|NCT00236899|7187844|FG002|Overall Study|Withdrawal by Subject|5
4408433|NCT00236899|7187845|FG003|Overall Study|Withdrawal by Subject|2
4408434|NCT00236899|7187842|FG000|Overall Study|Physician Decision|7
4408435|NCT00236899|7187843|FG001|Overall Study|Physician Decision|8
4408436|NCT00236899|7187844|FG002|Overall Study|Physician Decision|7
4408437|NCT00236899|7187845|FG003|Overall Study|Physician Decision|6
4408438|NCT00236899|7187842|FG000|Overall Study|Satisfactory Response|2
4408439|NCT00236899|7187843|FG001|Overall Study|Satisfactory Response|0
4408440|NCT00236899|7187844|FG002|Overall Study|Satisfactory Response|0
4408441|NCT00236899|7187845|FG003|Overall Study|Satisfactory Response|1
4408442|NCT00236899|7187842|FG000|Overall Study|Lack of Efficacy|18
4408443|NCT00236899|7187843|FG001|Overall Study|Lack of Efficacy|18
4408444|NCT00236899|7187844|FG002|Overall Study|Lack of Efficacy|25
4408445|NCT00236899|7187845|FG003|Overall Study|Lack of Efficacy|23
4408446|NCT00237042|7187900|FG000|Treatment|Became ineligible post-randomization|0
4408447|NCT00237042|7187901|FG001|Treatment|Became ineligible post-randomization|1
4408448|NCT00237042|7187902|FG002|Treatment|Became ineligible post-randomization|16
4408449|NCT00237042|7187900|FG000|Treatment|Moved out of state|1
4408450|NCT00237042|7187901|FG001|Treatment|Moved out of state|1
4408451|NCT00237042|7187902|FG002|Treatment|Moved out of state|1
4408452|NCT00237042|7187900|FG000|Treatment|Completed no treatment|5
4408453|NCT00237042|7187901|FG001|Treatment|Completed no treatment|5
4408454|NCT00237042|7187902|FG002|Treatment|Completed no treatment|21
4408455|NCT00237042|7187900|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9
4408456|NCT00237042|7187901|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8
4408457|NCT00237042|7187902|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11
4408458|NCT00237042|7187900|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11
4408459|NCT00237042|7187901|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9
4408460|NCT00237042|7187902|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9
4408461|NCT00237185|7187912|FG000|Core|Adverse Event|3
4408462|NCT00237185|7187913|FG001|Core|Adverse Event|4
4408463|NCT00237185|7187912|FG000|Core|Abnormal laboratory value|0
4408464|NCT00237185|7187913|FG001|Core|Abnormal laboratory value|4
4408465|NCT00237185|7187912|FG000|Core|Abnormal test procedure results|1
4408466|NCT00237185|7187913|FG001|Core|Abnormal test procedure results|0
4408467|NCT00237185|7187912|FG000|Core|Lack of Efficacy|30
4408468|NCT00237185|7187913|FG001|Core|Lack of Efficacy|23
4408469|NCT00237185|7187912|FG000|Core|Protocol Violation|1
4408470|NCT00237185|7187913|FG001|Core|Protocol Violation|1
4408471|NCT00237185|7187912|FG000|Core|Withdrawal by Subject|4
4408472|NCT00237185|7187913|FG001|Core|Withdrawal by Subject|4
4408473|NCT00237185|7187912|FG000|Core|Administrative problems|0
4408474|NCT00237185|7187913|FG001|Core|Administrative problems|1
4408475|NCT00237185|7187912|FG000|Core|Death|4
4408476|NCT00237185|7187913|FG001|Core|Death|0
4408477|NCT00237185|7187912|FG000|Core|Determined ineligible post randomization|1
4408478|NCT00237185|7187913|FG001|Core|Determined ineligible post randomization|0
4408479|NCT00237185|7187912|FG000|Extension|Adverse Event|1
4408480|NCT00237185|7187913|FG001|Extension|Adverse Event|0
4408481|NCT00237185|7187912|FG000|Extension|Abnormal laboratory value|0
4408482|NCT00237185|7187913|FG001|Extension|Abnormal laboratory value|1
4408483|NCT00237185|7187912|FG000|Extension|Lack of Efficacy|9
4408484|NCT00237185|7187913|FG001|Extension|Lack of Efficacy|14
4408485|NCT00237185|7187912|FG000|Extension|Condition no longer required study drug|0
4408486|NCT00237185|7187913|FG001|Extension|Condition no longer required study drug|1
4408487|NCT00237185|7187912|FG000|Extension|Withdrawal by Subject|3
4408488|NCT00237185|7187913|FG001|Extension|Withdrawal by Subject|2
4408489|NCT00237185|7187912|FG000|Extension|Lost to Follow-up|1
4408490|NCT00237185|7187913|FG001|Extension|Lost to Follow-up|0
4408491|NCT00237185|7187912|FG000|Extension|Administrative problems|1
4408492|NCT00237185|7187913|FG001|Extension|Administrative problems|0
4408493|NCT00237185|7187912|FG000|Extension|Death|1
4408494|NCT00237185|7187913|FG001|Extension|Death|1
4408495|NCT00237458|7187919|FG000|Overall Study|Lack of Efficacy|1
4408496|NCT00237458|7187919|FG000|Overall Study|Adverse Event|1
4408497|NCT00237458|7187919|FG000|Overall Study|Withdrawal by Subject|1
4408498|NCT00237692|7187931|FG000|Overall Study|Lost to Follow-up|9
4408499|NCT00237692|7187932|FG001|Overall Study|Lost to Follow-up|3
4408500|NCT00237692|7187933|FG002|Overall Study|Lost to Follow-up|5
4408501|NCT00237692|7187934|FG003|Overall Study|Lost to Follow-up|3
4408502|NCT00237692|7187931|FG000|Overall Study|Death|1
4408503|NCT00237692|7187932|FG001|Overall Study|Death|2
4408504|NCT00237692|7187933|FG002|Overall Study|Death|2
4408505|NCT00237692|7187934|FG003|Overall Study|Death|3
4408506|NCT00237692|7187931|FG000|Overall Study|Excluded - did not meet criteria|4
4408507|NCT00237692|7187932|FG001|Overall Study|Excluded - did not meet criteria|3
4408508|NCT00237692|7187933|FG002|Overall Study|Excluded - did not meet criteria|5
4408509|NCT00237692|7187934|FG003|Overall Study|Excluded - did not meet criteria|9
4408510|NCT00237692|7187931|FG000|Overall Study|Withdrawal by Subject|4
4408511|NCT00237692|7187932|FG001|Overall Study|Withdrawal by Subject|6
4408512|NCT00237692|7187933|FG002|Overall Study|Withdrawal by Subject|10
4408513|NCT00237692|7187934|FG003|Overall Study|Withdrawal by Subject|4
4408514|NCT00237744|7187956|FG000|Overall Study|Withdrawal by Subject|3
4408515|NCT00237744|7187957|FG001|Overall Study|Withdrawal by Subject|1
4408516|NCT00237744|7187958|FG002|Overall Study|Withdrawal by Subject|0
4408517|NCT00237796|7187984|FG000|Overall Study|Baseline and one other ILSS required|10
4408518|NCT00237796|7187985|FG001|Overall Study|Baseline and one other ILSS required|5
4408519|NCT00237809|7187996|FG000|Overall Study|Lost to Follow-up|11
4408520|NCT00237809|7187997|FG001|Overall Study|Lost to Follow-up|10
4408521|NCT00237809|7187998|FG002|Overall Study|Lost to Follow-up|9
4408522|NCT00237809|7187999|FG003|Overall Study|Lost to Follow-up|9
4408523|NCT00238121|7188020|FG000|Overall Study|Withdrawal by Subject|1
4408524|NCT00238121|7188021|FG001|Overall Study|Withdrawal by Subject|1
4408525|NCT00238121|7188020|FG000|Overall Study|Adverse Event|2
4408526|NCT00238121|7188021|FG001|Overall Study|Adverse Event|1
4408527|NCT00238238|7188029|FG000|Overall Study|Withdrawal by Subject|0
4408528|NCT00238238|7188030|FG001|Overall Study|Withdrawal by Subject|3
4408529|NCT00238238|7188031|FG002|Overall Study|Withdrawal by Subject|0
4408530|NCT00238264|7188039|FG000|Overall Study|Death|7
4408531|NCT00238264|7188039|FG000|Overall Study|Lost to Follow-up|18
4408532|NCT00238264|7188039|FG000|Overall Study|Withdrawal by Subject|4
4408533|NCT00238264|7188039|FG000|Overall Study|Ineligible|7
4408534|NCT00238303|7188046|FG000|Overall Study|Withdrawal by Subject|11
4408535|NCT00238303|7188047|FG001|Overall Study|Withdrawal by Subject|1
4408536|NCT00238303|7188048|FG002|Overall Study|Withdrawal by Subject|2
4408537|NCT00238303|7188046|FG000|Overall Study|Death|1
4408538|NCT00238303|7188047|FG001|Overall Study|Death|0
4408539|NCT00238303|7188048|FG002|Overall Study|Death|1
4408540|NCT00238303|7188046|FG000|Overall Study|Other Medical Problems|2
4408541|NCT00238303|7188047|FG001|Overall Study|Other Medical Problems|0
4408542|NCT00238303|7188048|FG002|Overall Study|Other Medical Problems|2
4408543|NCT00238303|7188046|FG000|Overall Study|Poor tolerance of study treatment|1
4408544|NCT00238303|7188047|FG001|Overall Study|Poor tolerance of study treatment|0
4408545|NCT00238303|7188048|FG002|Overall Study|Poor tolerance of study treatment|1
4408546|NCT00238303|7188046|FG000|Overall Study|Adverse Event|0
4408547|NCT00238303|7188047|FG001|Overall Study|Adverse Event|1
4408548|NCT00238303|7188048|FG002|Overall Study|Adverse Event|3
4408549|NCT00238433|7188061|FG000|Overall Study|Screen failure|1
4408550|NCT00238433|7188061|FG000|Overall Study|Lost to Follow-up|1
4408551|NCT00238433|7188061|FG000|Overall Study|Death|1
4408552|NCT00239005|7188074|FG000|Overall Study|Adverse Event|6
4408553|NCT00239005|7188075|FG001|Overall Study|Adverse Event|6
4408554|NCT00239005|7188074|FG000|Overall Study|Withdrawal by Subject|3
4408555|NCT00239005|7188075|FG001|Overall Study|Withdrawal by Subject|4
4408556|NCT00239005|7188074|FG000|Overall Study|Unsatisfactory Therapeutic effect|2
4408557|NCT00239005|7188075|FG001|Overall Study|Unsatisfactory Therapeutic effect|0
4408558|NCT00239005|7188074|FG000|Overall Study|Protocol Violation|1
4408559|NCT00239005|7188075|FG001|Overall Study|Protocol Violation|0
4408560|NCT00239005|7188074|FG000|Overall Study|Subj. cond. no longer needs study drug|0
4408561|NCT00239005|7188075|FG001|Overall Study|Subj. cond. no longer needs study drug|1
4408562|NCT00239005|7188074|FG000|Overall Study|Lost to Follow-up|0
4408563|NCT00239005|7188075|FG001|Overall Study|Lost to Follow-up|1
4408564|NCT00239226|7188085|FG000|Overall Study|permAF during stabilization period|0
4408565|NCT00239226|7188086|FG001|Overall Study|permAF during stabilization period|0
4408566|NCT00239226|7188087|FG002|Overall Study|permAF during stabilization period|0
4408567|NCT00239226|7188088|FG003|Overall Study|permAF during stabilization period|3
4408568|NCT00239226|7188085|FG000|Overall Study|Lost to Follow-up|1
4408569|NCT00239226|7188086|FG001|Overall Study|Lost to Follow-up|0
4408570|NCT00239226|7188087|FG002|Overall Study|Lost to Follow-up|1
4408571|NCT00239226|7188088|FG003|Overall Study|Lost to Follow-up|0
4408572|NCT00239356|7188100|FG000|Overall Study|Lack of Efficacy|1
4408573|NCT00239356|7188101|FG001|Overall Study|Lack of Efficacy|0
4408574|NCT00239356|7188100|FG000|Overall Study|Adverse Event|6
4408575|NCT00239356|7188101|FG001|Overall Study|Adverse Event|0
4408576|NCT00239356|7188100|FG000|Overall Study|Withdrawal by Subject|15
4408577|NCT00239356|7188101|FG001|Overall Study|Withdrawal by Subject|6
4408578|NCT00239356|7188100|FG000|Overall Study|Lost to Follow-up|3
4408579|NCT00239356|7188101|FG001|Overall Study|Lost to Follow-up|0
4408580|NCT00239356|7188100|FG000|Overall Study|poor/non-compliance|2
4408581|NCT00239356|7188101|FG001|Overall Study|poor/non-compliance|0
4408582|NCT00239356|7188100|FG000|Overall Study|Pregnancy|1
4408583|NCT00239356|7188101|FG001|Overall Study|Pregnancy|0
4408584|NCT00239356|7188100|FG000|Overall Study|Administrative reason|0
4408585|NCT00239356|7188101|FG001|Overall Study|Administrative reason|1
4408586|NCT00239356|7188100|FG000|Overall Study|Drug available on market|11
4408587|NCT00239356|7188101|FG001|Overall Study|Drug available on market|2
4408588|NCT00239577|7188111|FG000|Primary Phase|Adverse Event|0
4408589|NCT00239577|7188112|FG001|Primary Phase|Adverse Event|0
4408590|NCT00239577|7188113|FG002|Primary Phase|Adverse Event|1
4408591|NCT00239577|7188114|FG003|Primary Phase|Adverse Event|0
4408592|NCT00239577|7188111|FG000|Primary Phase|Other|5
4408593|NCT00239577|7188112|FG001|Primary Phase|Other|3
4408594|NCT00239577|7188113|FG002|Primary Phase|Other|2
4408595|NCT00239577|7188114|FG003|Primary Phase|Other|0
4511589|NCT00927862|7320758|FG000|Overall Study|Missing data needed for endpt analyses|27
4511590|NCT00927862|7320759|FG001|Overall Study|Missing data needed for endpt analyses|45
4511591|NCT00927901|7320778|FG000|Treatment Period 1|Subject withdrew consent|0
4511592|NCT00927901|7320779|FG001|Treatment Period 1|Subject withdrew consent|0
4511593|NCT00927901|7320780|FG002|Treatment Period 1|Subject withdrew consent|1
4511594|NCT00927901|7320781|FG003|Treatment Period 1|Subject withdrew consent|0
4511595|NCT00927901|7320778|FG000|Treatment Period 4|Adverse Event|0
4511596|NCT00927901|7320779|FG001|Treatment Period 4|Adverse Event|0
4511597|NCT00927901|7320780|FG002|Treatment Period 4|Adverse Event|0
4511598|NCT00927901|7320781|FG003|Treatment Period 4|Adverse Event|1
4511599|NCT00927901|7320778|FG000|Treatment Period 4|Subject withdrew consent|0
4511600|NCT00927901|7320779|FG001|Treatment Period 4|Subject withdrew consent|0
4511601|NCT00927901|7320780|FG002|Treatment Period 4|Subject withdrew consent|1
4511602|NCT00927901|7320781|FG003|Treatment Period 4|Subject withdrew consent|0
4511603|NCT00927927|7320809|FG000|Overall Study|Withdrawal by Subject|0
4511604|NCT00927927|7320810|FG001|Overall Study|Withdrawal by Subject|0
4511605|NCT00927927|7320811|FG002|Overall Study|Withdrawal by Subject|0
4511606|NCT00927927|7320812|FG003|Overall Study|Withdrawal by Subject|0
4511607|NCT00927927|7320813|FG004|Overall Study|Withdrawal by Subject|0
4511608|NCT00927927|7320814|FG005|Overall Study|Withdrawal by Subject|0
4511609|NCT00927927|7320815|FG006|Overall Study|Withdrawal by Subject|0
4511610|NCT00927927|7320816|FG007|Overall Study|Withdrawal by Subject|2
4511611|NCT00927927|7320817|FG008|Overall Study|Withdrawal by Subject|0
4511612|NCT00927927|7320818|FG009|Overall Study|Withdrawal by Subject|0
4511613|NCT00927927|7320819|FG010|Overall Study|Withdrawal by Subject|0
4629034|NCT01867710|7496625|FG000|Overall Study|Biochemical progression|0
4736154|NCT03559257|7685080|FG000|Open-label Treatment Period|Lack of Efficacy|3
4511614|NCT00927927|7320820|FG011|Overall Study|Withdrawal by Subject|2
4511615|NCT00927927|7320821|FG012|Overall Study|Withdrawal by Subject|0
4511616|NCT00927927|7320822|FG013|Overall Study|Withdrawal by Subject|0
4511617|NCT00927927|7320823|FG014|Overall Study|Withdrawal by Subject|0
4511618|NCT00927940|7320855|FG000|Overall Study|Death|1
4511619|NCT00928018|7320866|FG000|Overall Study|Withdrawal by Subject|1
4511620|NCT00928018|7320867|FG001|Overall Study|Withdrawal by Subject|0
4511621|NCT00928057|7320879|FG000|Overall Study|Adverse Event|1
4511622|NCT00928057|7320880|FG001|Overall Study|Adverse Event|2
4511623|NCT00928057|7320879|FG000|Overall Study|Withdrawal by Subject|1
4511624|NCT00928057|7320880|FG001|Overall Study|Withdrawal by Subject|0
4511625|NCT00928057|7320879|FG000|Overall Study|Lost to Follow-up|0
4511626|NCT00928057|7320880|FG001|Overall Study|Lost to Follow-up|1
4511627|NCT00928057|7320879|FG000|Overall Study|Protocol Violation|0
4511628|NCT00928057|7320880|FG001|Overall Study|Protocol Violation|1
4511629|NCT00928070|7320898|FG000|Overall Study|Lost to Follow-up|1
4511630|NCT00928070|7320899|FG001|Overall Study|Lost to Follow-up|2
4511631|NCT00928070|7320898|FG000|Overall Study|Withdrawal by Subject|10
4511632|NCT00928070|7320899|FG001|Overall Study|Withdrawal by Subject|3
4511633|NCT00928070|7320898|FG000|Overall Study|Adverse Event|14
4511634|NCT00928070|7320899|FG001|Overall Study|Adverse Event|26
4511635|NCT00928070|7320898|FG000|Overall Study|Lack of Efficacy|9
4511636|NCT00928070|7320899|FG001|Overall Study|Lack of Efficacy|5
4511637|NCT00928070|7320898|FG000|Overall Study|Did not meet entrance criteria|16
4511638|NCT00928070|7320899|FG001|Overall Study|Did not meet entrance criteria|9
4629035|NCT01867710|7496626|FG001|Overall Study|Biochemical progression|1
4629036|NCT01867710|7496627|FG002|Overall Study|Biochemical progression|0
4629037|NCT01867710|7496628|FG003|Overall Study|Biochemical progression|0
4629038|NCT01867710|7496625|FG000|Overall Study|Clinical progression|0
4629039|NCT01867710|7496626|FG001|Overall Study|Clinical progression|0
4629040|NCT01867710|7496627|FG002|Overall Study|Clinical progression|1
4629041|NCT01867710|7496628|FG003|Overall Study|Clinical progression|0
4408596|NCT00239590|7188126|FG000|Randomized|Lost to Follow-up|0
4408597|NCT00239590|7188127|FG001|Randomized|Lost to Follow-up|1
4408598|NCT00239590|7188126|FG000|Randomized|Withdrawal by Subject|0
4408599|NCT00239590|7188127|FG001|Randomized|Withdrawal by Subject|1
4408600|NCT00239590|7188126|FG000|Completed Study Protocol|Adverse Event|1
4408601|NCT00239590|7188127|FG001|Completed Study Protocol|Adverse Event|1
4408602|NCT00239590|7188126|FG000|Completed Study Protocol|Withdrawal by Subject|0
4408603|NCT00239590|7188127|FG001|Completed Study Protocol|Withdrawal by Subject|1
4408604|NCT00239681|7188150|FG000|Overall Study|Adverse Event|100
4408605|NCT00239681|7188151|FG001|Overall Study|Adverse Event|99
4408606|NCT00239681|7188150|FG000|Overall Study|Withdrawal by Subject|458
4408607|NCT00239681|7188151|FG001|Overall Study|Withdrawal by Subject|489
4408608|NCT00239681|7188150|FG000|Overall Study|Lost to Follow-up|28
4408609|NCT00239681|7188151|FG001|Overall Study|Lost to Follow-up|22
4408610|NCT00239681|7188150|FG000|Overall Study|Protocol Violation|4
4408611|NCT00239681|7188151|FG001|Overall Study|Protocol Violation|4
4408612|NCT00239681|7188150|FG000|Overall Study|Physician Decision|13
4408613|NCT00239681|7188151|FG001|Overall Study|Physician Decision|17
4408614|NCT00239681|7188150|FG000|Overall Study|No information chacked on CaseReportForm|90
4408615|NCT00239681|7188151|FG001|Overall Study|No information chacked on CaseReportForm|84
4408616|NCT00239837|7188163|FG000|Overall Study|Lost to Follow-up|3
4408617|NCT00239837|7188164|FG001|Overall Study|Lost to Follow-up|7
4408618|NCT00239928|7188172|FG000|Overall Study|Lack of Efficacy|1
4408619|NCT00239928|7188172|FG000|Overall Study|Adverse Event|4
4408620|NCT00239928|7188172|FG000|Overall Study|Not need to continue study|3
4408621|NCT00239928|7188172|FG000|Overall Study|Withdrawal by Subject|2
4408622|NCT00240071|7188176|FG000|Overall Study|Withdrawal by Subject|3
4408623|NCT00240097|7188181|FG000|Part I|Adverse Event|1
4408624|NCT00240097|7188181|FG000|Part I|Death|1
4408625|NCT00240097|7188181|FG000|Part I|histology|1
4408626|NCT00240097|7188181|FG000|Part I|unevaluable|1
4408627|NCT00240097|7188181|FG000|Part II|did not continue from Part I|23
4408628|NCT00240110|7188191|FG000|Overall Study|Lost to Follow-up|6
4408629|NCT00240110|7188192|FG001|Overall Study|Lost to Follow-up|7
4408630|NCT00240331|7188206|FG000|Overall Study|Withdrawal by Subject|125
4408631|NCT00240331|7188207|FG001|Overall Study|Withdrawal by Subject|132
4408632|NCT00240331|7188206|FG000|Overall Study|Option selected by investigator|1
4408633|NCT00240331|7188207|FG001|Overall Study|Option selected by investigator|2
4408634|NCT00240994|7188270|FG000|Overall Study|Lost to Follow-up|1
4408635|NCT00240994|7188270|FG000|Overall Study|Protocol Violation|1
4408636|NCT00240994|7188270|FG000|Overall Study|Graft failure|1
4408637|NCT00241280|7188281|FG000|Overall Study|Adverse Event|2
4408638|NCT00241280|7188282|FG001|Overall Study|Adverse Event|6
4408639|NCT00241280|7188281|FG000|Overall Study|Discomfort|11
4408640|NCT00241280|7188282|FG001|Overall Study|Discomfort|16
4408641|NCT00241280|7188281|FG000|Overall Study|Pregnancy|1
4408642|NCT00241280|7188282|FG001|Overall Study|Pregnancy|5
4408643|NCT00241280|7188281|FG000|Overall Study|Lost to Follow-up|5
4408644|NCT00241280|7188282|FG001|Overall Study|Lost to Follow-up|8
4408645|NCT00241280|7188281|FG000|Overall Study|Withdrawal by Subject|7
4408646|NCT00241280|7188282|FG001|Overall Study|Withdrawal by Subject|4
4408647|NCT00241280|7188281|FG000|Overall Study|Protocol Violation|4
4408648|NCT00241280|7188282|FG001|Overall Study|Protocol Violation|10
4408649|NCT00241280|7188281|FG000|Overall Study|Relocation|4
4408650|NCT00241280|7188282|FG001|Overall Study|Relocation|4
4408651|NCT00241280|7188281|FG000|Overall Study|Unsatisfactory Physiological Response|1
4408652|NCT00241280|7188282|FG001|Overall Study|Unsatisfactory Physiological Response|1
4408653|NCT00241280|7188281|FG000|Overall Study|Unsatisfactory Visual Response|1
4408654|NCT00241280|7188282|FG001|Overall Study|Unsatisfactory Visual Response|1
4408655|NCT00241280|7188281|FG000|Overall Study|Diabetic|1
4408656|NCT00241280|7188282|FG001|Overall Study|Diabetic|0
4408657|NCT00241280|7188281|FG000|Overall Study|Subject Ineligible/Dispensed|9
4408658|NCT00241280|7188282|FG001|Overall Study|Subject Ineligible/Dispensed|6
4408659|NCT00241280|7188281|FG000|Overall Study|Dispensed incorrect test article|1
4408660|NCT00241280|7188282|FG001|Overall Study|Dispensed incorrect test article|2
4408661|NCT00241280|7188281|FG000|Overall Study|Unacceptable Fit|0
4408662|NCT00241280|7188282|FG001|Overall Study|Unacceptable Fit|1
4408663|NCT00241280|7188281|FG000|Overall Study|Scheduling Conflict|0
4408664|NCT00241280|7188282|FG001|Overall Study|Scheduling Conflict|2
4408665|NCT00241280|7188281|FG000|Overall Study|History of Ocular Surgery|0
4408666|NCT00241280|7188282|FG001|Overall Study|History of Ocular Surgery|1
4408667|NCT00241280|7188281|FG000|Overall Study|Coating on Lens|1
4408668|NCT00241280|7188282|FG001|Overall Study|Coating on Lens|0
4408669|NCT00241280|7188281|FG000|Overall Study|Excessive Dryness|0
4408670|NCT00241280|7188282|FG001|Overall Study|Excessive Dryness|1
4408671|NCT00241358|7188292|FG000|Overall Study|Determined to be not ineligible|0
4408672|NCT00241358|7188293|FG001|Overall Study|Determined to be not ineligible|1
4408673|NCT00241358|7188294|FG002|Overall Study|Determined to be not ineligible|1
4408674|NCT00241631|7188303|FG000|Run in (2 Weeks)|Physician Decision|3
4408675|NCT00241631|7188304|FG001|Run in (2 Weeks)|Physician Decision|3
4408676|NCT00241631|7188303|FG000|Phase 1 (4 Weeks)|sore throat|1
4408677|NCT00241631|7188304|FG001|Phase 1 (4 Weeks)|sore throat|0
4408678|NCT00241631|7188303|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4
4408679|NCT00241631|7188304|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4
4408680|NCT00241631|7188303|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3
4408681|NCT00241631|7188304|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0
4408682|NCT00241631|7188303|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0
4408683|NCT00241631|7188304|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1
4408684|NCT00241644|7188314|FG000|First Efficacy Period (Year 1)|Adverse Event|46
4408685|NCT00241644|7188315|FG001|First Efficacy Period (Year 1)|Adverse Event|45
4408686|NCT00241644|7188316|FG002|First Efficacy Period (Year 1)|Adverse Event|45
4408687|NCT00241644|7188317|FG003|First Efficacy Period (Year 1)|Adverse Event|91
4408688|NCT00241644|7188314|FG000|First Efficacy Period (Year 1)|Protocol Violation|3
4408689|NCT00241644|7188315|FG001|First Efficacy Period (Year 1)|Protocol Violation|5
4408690|NCT00241644|7188316|FG002|First Efficacy Period (Year 1)|Protocol Violation|4
4408691|NCT00241644|7188317|FG003|First Efficacy Period (Year 1)|Protocol Violation|8
4408692|NCT00241644|7188314|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59
4408693|NCT00241644|7188315|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74
4408694|NCT00241644|7188316|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81
4408695|NCT00241644|7188317|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133
4408696|NCT00241644|7188314|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116
4408697|NCT00241644|7188315|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142
4408698|NCT00241644|7188316|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116
4408699|NCT00241644|7188317|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258
4408700|NCT00241644|7188314|FG000|First Efficacy Period (Year 1)|Non-compliance|2
4408701|NCT00241644|7188315|FG001|First Efficacy Period (Year 1)|Non-compliance|1
4408702|NCT00241644|7188316|FG002|First Efficacy Period (Year 1)|Non-compliance|2
4408703|NCT00241644|7188317|FG003|First Efficacy Period (Year 1)|Non-compliance|3
4408704|NCT00241644|7188314|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1
4408705|NCT00241644|7188315|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0
4408706|NCT00241644|7188316|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0
4408707|NCT00241644|7188317|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1
4408708|NCT00241644|7188314|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
4629042|NCT01867710|7496625|FG000|Overall Study|Disease progression|1
4629043|NCT01867710|7496626|FG001|Overall Study|Disease progression|0
4408709|NCT00241644|7188315|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
4408710|NCT00241644|7188316|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1
4408711|NCT00241644|7188317|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
4408712|NCT00241644|7188314|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0
4408713|NCT00241644|7188315|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1
4408714|NCT00241644|7188316|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0
4408715|NCT00241644|7188317|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1
4408716|NCT00241644|7188314|FG000|Second Efficacy Period (Year 2)|Adverse Event|11
4408717|NCT00241644|7188315|FG001|Second Efficacy Period (Year 2)|Adverse Event|9
4408718|NCT00241644|7188316|FG002|Second Efficacy Period (Year 2)|Adverse Event|12
4408719|NCT00241644|7188317|FG003|Second Efficacy Period (Year 2)|Adverse Event|20
4408720|NCT00241644|7188314|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2
4408721|NCT00241644|7188315|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1
4408722|NCT00241644|7188316|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2
4408723|NCT00241644|7188317|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3
4408724|NCT00241644|7188314|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4
4408725|NCT00241644|7188315|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3
4408726|NCT00241644|7188316|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2
4408727|NCT00241644|7188317|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7
4408728|NCT00241644|7188314|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43
4408729|NCT00241644|7188315|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43
4408730|NCT00241644|7188316|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46
4408731|NCT00241644|7188317|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86
4408732|NCT00241644|7188314|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1
4408733|NCT00241644|7188315|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1
4408734|NCT00241644|7188316|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2
4408735|NCT00241644|7188317|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2
4408736|NCT00241839|7188329|FG000|Overall Study|Withdrawal by Subject|18
4408737|NCT00241839|7188330|FG001|Overall Study|Withdrawal by Subject|17
4408738|NCT00241839|7188329|FG000|Overall Study|Adverse Event|1
4408739|NCT00241839|7188330|FG001|Overall Study|Adverse Event|1
4408740|NCT00242216|7188357|FG000|Overall Study|Lost to Follow-up|12
4408741|NCT00242216|7188358|FG001|Overall Study|Lost to Follow-up|17
4408742|NCT00242216|7188357|FG000|Overall Study|Death|4
4408743|NCT00242216|7188358|FG001|Overall Study|Death|2
4408744|NCT00242216|7188357|FG000|Overall Study|Lack of Efficacy|1
4408745|NCT00242216|7188358|FG001|Overall Study|Lack of Efficacy|2
4408746|NCT00242216|7188357|FG000|Overall Study|no medicaiton dispensed|1
4408747|NCT00242216|7188358|FG001|Overall Study|no medicaiton dispensed|1
4408748|NCT00242567|7188377|FG000|Overall Study|Adverse Event|70
4408749|NCT00242567|7188378|FG001|Overall Study|Adverse Event|43
4629044|NCT01867710|7496627|FG002|Overall Study|Disease progression|0
4629045|NCT01867710|7496628|FG003|Overall Study|Disease progression|0
4771662|NCT01665144|7748475|FG000|Overall Study|Death|3
4408750|NCT00242567|7188377|FG000|Overall Study|Disease Progression|17
4408751|NCT00242567|7188378|FG001|Overall Study|Disease Progression|22
4408752|NCT00242567|7188377|FG000|Overall Study|Symptomatic deterioration|9
4408753|NCT00242567|7188378|FG001|Overall Study|Symptomatic deterioration|3
4408754|NCT00242567|7188377|FG000|Overall Study|Lack of Efficacy|2
4408755|NCT00242567|7188378|FG001|Overall Study|Lack of Efficacy|2
4408756|NCT00242567|7188377|FG000|Overall Study|Lost to Follow-up|9
4408757|NCT00242567|7188378|FG001|Overall Study|Lost to Follow-up|19
4408758|NCT00242567|7188377|FG000|Overall Study|Withdrawal by Subject|33
4408759|NCT00242567|7188378|FG001|Overall Study|Withdrawal by Subject|28
4408760|NCT00242567|7188377|FG000|Overall Study|Protocol Violation|12
4408761|NCT00242567|7188378|FG001|Overall Study|Protocol Violation|12
4408762|NCT00242567|7188377|FG000|Overall Study|Use of an inhibitor of bone resorption|0
4408763|NCT00242567|7188378|FG001|Overall Study|Use of an inhibitor of bone resorption|2
4408764|NCT00242567|7188377|FG000|Overall Study|Other|14
4408765|NCT00242567|7188378|FG001|Overall Study|Other|9
4408766|NCT00242580|7188389|FG000|Overall Study|Adverse Event|3
4408767|NCT00242580|7188390|FG001|Overall Study|Adverse Event|0
4408768|NCT00242580|7188391|FG002|Overall Study|Adverse Event|2
4408769|NCT00242580|7188389|FG000|Overall Study|Unsatisfactory therapeutic effect|4
4408770|NCT00242580|7188390|FG001|Overall Study|Unsatisfactory therapeutic effect|5
4408771|NCT00242580|7188391|FG002|Overall Study|Unsatisfactory therapeutic effect|5
4408772|NCT00242580|7188389|FG000|Overall Study|Protocol Violation|0
4408773|NCT00242580|7188390|FG001|Overall Study|Protocol Violation|0
4408774|NCT00242580|7188391|FG002|Overall Study|Protocol Violation|1
4408775|NCT00242580|7188389|FG000|Overall Study|Subject withdrew consent|2
4408776|NCT00242580|7188390|FG001|Overall Study|Subject withdrew consent|2
4408777|NCT00242580|7188391|FG002|Overall Study|Subject withdrew consent|5
4408778|NCT00242580|7188389|FG000|Overall Study|Lost to Follow-up|0
4408779|NCT00242580|7188390|FG001|Overall Study|Lost to Follow-up|3
4408780|NCT00242580|7188391|FG002|Overall Study|Lost to Follow-up|0
4408781|NCT00242580|7188389|FG000|Overall Study|Death|1
4408782|NCT00242580|7188390|FG001|Overall Study|Death|2
4408783|NCT00242580|7188391|FG002|Overall Study|Death|1
4408784|NCT00242658|7188420|FG000|Overall Study|Lost to Follow-up|22
4408785|NCT00242658|7188421|FG001|Overall Study|Lost to Follow-up|19
4408786|NCT00242710|7188435|FG000|Core Study (up to Year 1)|Adverse Event|30
4408787|NCT00242710|7188436|FG001|Core Study (up to Year 1)|Adverse Event|25
4408788|NCT00242710|7188437|FG002|Core Study (up to Year 1)|Adverse Event|23
4408789|NCT00242710|7188438|FG003|Core Study (up to Year 1)|Adverse Event|14
4408790|NCT00242710|7188435|FG000|Core Study (up to Year 1)|Death|0
4408791|NCT00242710|7188436|FG001|Core Study (up to Year 1)|Death|0
4408792|NCT00242710|7188437|FG002|Core Study (up to Year 1)|Death|1
4408793|NCT00242710|7188438|FG003|Core Study (up to Year 1)|Death|0
4408794|NCT00242710|7188435|FG000|Core Study (up to Year 1)|Physician Decision|0
4408795|NCT00242710|7188436|FG001|Core Study (up to Year 1)|Physician Decision|1
4408796|NCT00242710|7188437|FG002|Core Study (up to Year 1)|Physician Decision|0
4408797|NCT00242710|7188438|FG003|Core Study (up to Year 1)|Physician Decision|1
4408798|NCT00242710|7188435|FG000|Core Study (up to Year 1)|Lost to Follow-up|8
4408799|NCT00242710|7188436|FG001|Core Study (up to Year 1)|Lost to Follow-up|8
4408800|NCT00242710|7188437|FG002|Core Study (up to Year 1)|Lost to Follow-up|7
4408801|NCT00242710|7188438|FG003|Core Study (up to Year 1)|Lost to Follow-up|3
4408802|NCT00242710|7188435|FG000|Core Study (up to Year 1)|Other|6
4408803|NCT00242710|7188436|FG001|Core Study (up to Year 1)|Other|1
4408804|NCT00242710|7188437|FG002|Core Study (up to Year 1)|Other|0
4408805|NCT00242710|7188438|FG003|Core Study (up to Year 1)|Other|2
4408806|NCT00242710|7188435|FG000|Core Study (up to Year 1)|Protocol Violation|2
4408807|NCT00242710|7188436|FG001|Core Study (up to Year 1)|Protocol Violation|9
4408808|NCT00242710|7188437|FG002|Core Study (up to Year 1)|Protocol Violation|1
4408809|NCT00242710|7188438|FG003|Core Study (up to Year 1)|Protocol Violation|3
4408810|NCT00242710|7188435|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27
4408811|NCT00242710|7188436|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16
4408812|NCT00242710|7188437|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15
4408813|NCT00242710|7188438|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6
4408814|NCT00242710|7188435|FG000|Core Study (up to Year 1)|Lack of Efficacy|1
4408815|NCT00242710|7188436|FG001|Core Study (up to Year 1)|Lack of Efficacy|0
4629046|NCT01867710|7496625|FG000|Overall Study|Patient decision|0
4629047|NCT01867710|7496626|FG001|Overall Study|Patient decision|0
4629048|NCT01867710|7496627|FG002|Overall Study|Patient decision|0
4629049|NCT01867710|7496628|FG003|Overall Study|Patient decision|1
4629050|NCT01867710|7496625|FG000|Overall Study|Patient to follow subsequent treatment|0
4408816|NCT00242710|7188437|FG002|Core Study (up to Year 1)|Lack of Efficacy|0
4408817|NCT00242710|7188438|FG003|Core Study (up to Year 1)|Lack of Efficacy|0
4408818|NCT00242710|7188435|FG000|Core Study (up to Year 1)|Randomized but not Treated|12
4408819|NCT00242710|7188436|FG001|Core Study (up to Year 1)|Randomized but not Treated|4
4408820|NCT00242710|7188437|FG002|Core Study (up to Year 1)|Randomized but not Treated|4
4408821|NCT00242710|7188438|FG003|Core Study (up to Year 1)|Randomized but not Treated|2
4408822|NCT00242710|7188435|FG000|Period Between Core Study and Extension|Adverse Event|2
4408823|NCT00242710|7188436|FG001|Period Between Core Study and Extension|Adverse Event|3
4408824|NCT00242710|7188437|FG002|Period Between Core Study and Extension|Adverse Event|5
4633282|NCT01909804|7503305|FG009|Overall Study|Protocol Violation|0
4629051|NCT01867710|7496626|FG001|Overall Study|Patient to follow subsequent treatment|1
4629052|NCT01867710|7496627|FG002|Overall Study|Patient to follow subsequent treatment|0
4408825|NCT00242710|7188438|FG003|Period Between Core Study and Extension|Adverse Event|2
4408826|NCT00242710|7188435|FG000|Period Between Core Study and Extension|Physician Decision|1
4408827|NCT00242710|7188436|FG001|Period Between Core Study and Extension|Physician Decision|1
4408828|NCT00242710|7188437|FG002|Period Between Core Study and Extension|Physician Decision|0
4408829|NCT00242710|7188438|FG003|Period Between Core Study and Extension|Physician Decision|0
4408830|NCT00242710|7188435|FG000|Period Between Core Study and Extension|Other|24
4408831|NCT00242710|7188436|FG001|Period Between Core Study and Extension|Other|24
4408832|NCT00242710|7188437|FG002|Period Between Core Study and Extension|Other|9
4408833|NCT00242710|7188438|FG003|Period Between Core Study and Extension|Other|11
4408834|NCT00242710|7188435|FG000|Period Between Core Study and Extension|Extension not Available|17
4408835|NCT00242710|7188436|FG001|Period Between Core Study and Extension|Extension not Available|21
4408836|NCT00242710|7188437|FG002|Period Between Core Study and Extension|Extension not Available|8
4408837|NCT00242710|7188438|FG003|Period Between Core Study and Extension|Extension not Available|7
4408838|NCT00242710|7188435|FG000|Period Between Core Study and Extension|Protocol Violation|0
4408839|NCT00242710|7188436|FG001|Period Between Core Study and Extension|Protocol Violation|0
4408840|NCT00242710|7188437|FG002|Period Between Core Study and Extension|Protocol Violation|2
4408841|NCT00242710|7188438|FG003|Period Between Core Study and Extension|Protocol Violation|1
4408842|NCT00242710|7188435|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75
4408843|NCT00242710|7188436|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63
4408844|NCT00242710|7188437|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24
4408845|NCT00242710|7188438|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28
4408846|NCT00242710|7188435|FG000|Study Extension (up to Year 2)|Adverse Event|7
4408847|NCT00242710|7188436|FG001|Study Extension (up to Year 2)|Adverse Event|9
4408848|NCT00242710|7188437|FG002|Study Extension (up to Year 2)|Adverse Event|2
4408849|NCT00242710|7188438|FG003|Study Extension (up to Year 2)|Adverse Event|4
4408850|NCT00242710|7188435|FG000|Study Extension (up to Year 2)|Death|0
4408851|NCT00242710|7188436|FG001|Study Extension (up to Year 2)|Death|0
4408852|NCT00242710|7188437|FG002|Study Extension (up to Year 2)|Death|0
4408853|NCT00242710|7188438|FG003|Study Extension (up to Year 2)|Death|1
4408854|NCT00242710|7188435|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7
4408855|NCT00242710|7188436|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7
4408856|NCT00242710|7188437|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5
4408857|NCT00242710|7188438|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0
4408858|NCT00242710|7188435|FG000|Study Extension (up to Year 2)|Other|3
4408859|NCT00242710|7188436|FG001|Study Extension (up to Year 2)|Other|5
4408860|NCT00242710|7188437|FG002|Study Extension (up to Year 2)|Other|4
4408861|NCT00242710|7188438|FG003|Study Extension (up to Year 2)|Other|3
4408862|NCT00242710|7188435|FG000|Study Extension (up to Year 2)|Protocol Violation|0
4408863|NCT00242710|7188436|FG001|Study Extension (up to Year 2)|Protocol Violation|2
4408864|NCT00242710|7188437|FG002|Study Extension (up to Year 2)|Protocol Violation|0
4408865|NCT00242710|7188438|FG003|Study Extension (up to Year 2)|Protocol Violation|1
4408866|NCT00242710|7188435|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10
4408867|NCT00242710|7188436|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6
4408868|NCT00242710|7188437|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4
4408869|NCT00242710|7188438|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1
4408870|NCT00243022|7188450|FG000|Overall Study|Withdrawal by Subject|1
4408871|NCT00243022|7188451|FG001|Overall Study|Withdrawal by Subject|0
4408872|NCT00243022|7188450|FG000|Overall Study|Death|1
4408873|NCT00243022|7188451|FG001|Overall Study|Death|0
4408874|NCT00243022|7188450|FG000|Overall Study|Difficult Travel Distance|0
4408875|NCT00243022|7188451|FG001|Overall Study|Difficult Travel Distance|1
4408876|NCT00243074|7188463|FG000|Overall Study|Ineligible|6
4408877|NCT00243074|7188463|FG000|Overall Study|Adverse Event|6
4408878|NCT00243074|7188463|FG000|Overall Study|Withdrawal by Subject|2
4408879|NCT00243074|7188463|FG000|Overall Study|Lack of Efficacy|36
4408880|NCT00243074|7188463|FG000|Overall Study|Death|2
4408881|NCT00243074|7188463|FG000|Overall Study|not protocol specified|1
4408882|NCT00243074|7188463|FG000|Overall Study|Did not receive any treatment|1
4408883|NCT00243230|7188483|FG000|Double-Blind Period|Adverse Event|0
4408884|NCT00243230|7188484|FG001|Double-Blind Period|Adverse Event|2
4408885|NCT00243230|7188485|FG002|Double-Blind Period|Adverse Event|2
4408886|NCT00243230|7188486|FG003|Double-Blind Period|Adverse Event|0
4408887|NCT00243230|7188483|FG000|Double-Blind Period|Withdrawal by Subject|1
4408888|NCT00243230|7188484|FG001|Double-Blind Period|Withdrawal by Subject|0
4408889|NCT00243230|7188485|FG002|Double-Blind Period|Withdrawal by Subject|0
4408890|NCT00243230|7188486|FG003|Double-Blind Period|Withdrawal by Subject|0
4408891|NCT00243230|7188483|FG000|Double-Blind Period|Protocol Violation|0
4408892|NCT00243230|7188484|FG001|Double-Blind Period|Protocol Violation|0
4408893|NCT00243230|7188485|FG002|Double-Blind Period|Protocol Violation|1
4408894|NCT00243230|7188486|FG003|Double-Blind Period|Protocol Violation|0
4408895|NCT00243230|7188483|FG000|Double-Blind Period|Randomized but Not Treated|0
4408896|NCT00243230|7188484|FG001|Double-Blind Period|Randomized but Not Treated|0
4408897|NCT00243230|7188485|FG002|Double-Blind Period|Randomized but Not Treated|2
4408898|NCT00243230|7188486|FG003|Double-Blind Period|Randomized but Not Treated|0
4408899|NCT00243230|7188483|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5
4408900|NCT00243230|7188484|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3
4408901|NCT00243230|7188485|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14
4408902|NCT00243230|7188486|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0
4408903|NCT00243230|7188483|FG000|Open Label Period|Adverse Event|0
4408904|NCT00243230|7188484|FG001|Open Label Period|Adverse Event|0
4408905|NCT00243230|7188485|FG002|Open Label Period|Adverse Event|0
4408906|NCT00243230|7188486|FG003|Open Label Period|Adverse Event|2
4408907|NCT00243230|7188483|FG000|Open Label Period|Treatment Failure - Virologic Failure|0
4408908|NCT00243230|7188484|FG001|Open Label Period|Treatment Failure - Virologic Failure|0
4408909|NCT00243230|7188485|FG002|Open Label Period|Treatment Failure - Virologic Failure|0
4408910|NCT00243230|7188486|FG003|Open Label Period|Treatment Failure - Virologic Failure|13
4408911|NCT00243230|7188483|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0
4408912|NCT00243230|7188484|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0
4408913|NCT00243230|7188485|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0
4408914|NCT00243230|7188486|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1
4408915|NCT00243230|7188483|FG000|Open Label Period|Lost to Follow-up|0
4408916|NCT00243230|7188484|FG001|Open Label Period|Lost to Follow-up|0
4408917|NCT00243230|7188485|FG002|Open Label Period|Lost to Follow-up|0
4408918|NCT00243230|7188486|FG003|Open Label Period|Lost to Follow-up|2
4408919|NCT00243230|7188483|FG000|Open Label Period|Withdrawal by Subject|0
4408920|NCT00243230|7188484|FG001|Open Label Period|Withdrawal by Subject|0
4408921|NCT00243230|7188485|FG002|Open Label Period|Withdrawal by Subject|0
4408922|NCT00243230|7188486|FG003|Open Label Period|Withdrawal by Subject|2
4408923|NCT00243230|7188483|FG000|Open Label Period|Protocol Violation|0
4408924|NCT00243230|7188484|FG001|Open Label Period|Protocol Violation|0
4408925|NCT00243230|7188485|FG002|Open Label Period|Protocol Violation|0
4408926|NCT00243230|7188486|FG003|Open Label Period|Protocol Violation|2
4408927|NCT00243230|7188483|FG000|Open Label Period|Administrative Reason|0
4408928|NCT00243230|7188484|FG001|Open Label Period|Administrative Reason|0
4408929|NCT00243230|7188485|FG002|Open Label Period|Administrative Reason|0
4408930|NCT00243230|7188486|FG003|Open Label Period|Administrative Reason|63
4408931|NCT00243269|7188509|FG000|Overall Study|Protocol Violation|2
4408932|NCT00243269|7188510|FG001|Overall Study|Protocol Violation|1
4408933|NCT00243269|7188511|FG002|Overall Study|Protocol Violation|0
4408934|NCT00243269|7188512|FG003|Overall Study|Protocol Violation|1
4408935|NCT00243269|7188509|FG000|Overall Study|Lost to Follow-up|1
4408936|NCT00243269|7188510|FG001|Overall Study|Lost to Follow-up|0
4408937|NCT00243269|7188511|FG002|Overall Study|Lost to Follow-up|1
4408938|NCT00243269|7188512|FG003|Overall Study|Lost to Follow-up|3
4408939|NCT00243347|7188522|FG000|Overall Study|Lack of Efficacy|4
4408940|NCT00243347|7188522|FG000|Overall Study|Adverse Event|2
4408941|NCT00243347|7188522|FG000|Overall Study|Death|1
4408942|NCT00243347|7188522|FG000|Overall Study|Withdrawal by Subject|5
4408943|NCT00243347|7188522|FG000|Overall Study|Condition worsened|7
4408944|NCT00243386|7188526|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1
4408945|NCT00243386|7188527|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0
4408946|NCT00243386|7188528|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0
4408947|NCT00243386|7188526|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1
4408948|NCT00243386|7188527|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0
4408949|NCT00243386|7188528|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0
4408950|NCT00243386|7188526|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2
4408951|NCT00243386|7188527|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0
4408952|NCT00243386|7188528|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0
4408953|NCT00243386|7188526|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1
4408954|NCT00243386|7188527|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0
4408955|NCT00243386|7188528|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0
4408956|NCT00243386|7188526|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1
4408957|NCT00243386|7188527|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0
4408958|NCT00243386|7188528|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0
4408959|NCT00243386|7188526|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1
4408960|NCT00243386|7188527|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0
4408961|NCT00243386|7188528|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0
4408962|NCT00243386|7188526|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0
4408963|NCT00243386|7188527|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2
4408964|NCT00243386|7188528|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0
4408965|NCT00243386|7188526|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0
4408966|NCT00243386|7188527|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1
4408967|NCT00243386|7188528|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0
4408968|NCT00243412|7188566|FG000|Overall Study|Death|0
4408969|NCT00243412|7188567|FG001|Overall Study|Death|1
4408970|NCT00243412|7188566|FG000|Overall Study|Adverse Event|4
4408971|NCT00243412|7188567|FG001|Overall Study|Adverse Event|2
4408972|NCT00243412|7188566|FG000|Overall Study|Lost to Follow-up|0
4408973|NCT00243412|7188567|FG001|Overall Study|Lost to Follow-up|1
4408974|NCT00243412|7188566|FG000|Overall Study|Physician Decision|1
4408975|NCT00243412|7188567|FG001|Overall Study|Physician Decision|1
4408976|NCT00243412|7188566|FG000|Overall Study|Withdrawal by Subject|4
4408977|NCT00243412|7188567|FG001|Overall Study|Withdrawal by Subject|5
4408978|NCT00243412|7188566|FG000|Overall Study|Other|1
4408979|NCT00243412|7188567|FG001|Overall Study|Other|1
4408980|NCT00243503|7188573|FG000|Overall Study|Adverse Event|11
4408981|NCT00243503|7188573|FG000|Overall Study|Withdrawal by Subject|1
4408982|NCT00243503|7188573|FG000|Overall Study|Lack of Efficacy|44
4408983|NCT00243503|7188573|FG000|Overall Study|Death|1
4408984|NCT00243503|7188573|FG000|Overall Study|Other|1
4408985|NCT00243659|7188580|FG000|Overall Study|Withdrawal by Subject|1
4408986|NCT00243659|7188581|FG001|Overall Study|Withdrawal by Subject|1
4408987|NCT00243659|7188580|FG000|Overall Study|Protocol Violation|1
4408988|NCT00243659|7188581|FG001|Overall Study|Protocol Violation|2
4408989|NCT00243841|7188590|FG000|Overall Study|Physician Decision|0
4408990|NCT00243841|7188591|FG001|Overall Study|Physician Decision|0
4408991|NCT00243841|7188592|FG002|Overall Study|Physician Decision|1
4408992|NCT00243841|7188593|FG003|Overall Study|Physician Decision|0
4408993|NCT00243841|7188594|FG004|Overall Study|Physician Decision|0
4408994|NCT00243841|7188595|FG005|Overall Study|Physician Decision|2
4408995|NCT00243919|7188614|FG000|Overall Study|Death|3
4408996|NCT00243919|7188615|FG001|Overall Study|Death|4
4408997|NCT00243919|7188616|FG002|Overall Study|Death|6
4408998|NCT00243919|7188614|FG000|Overall Study|Withdrawal by Subject|6
4408999|NCT00243919|7188615|FG001|Overall Study|Withdrawal by Subject|6
4409000|NCT00243919|7188616|FG002|Overall Study|Withdrawal by Subject|2
4409001|NCT00243919|7188614|FG000|Overall Study|Lost to Follow-up|6
4409002|NCT00243919|7188615|FG001|Overall Study|Lost to Follow-up|7
4409003|NCT00243919|7188616|FG002|Overall Study|Lost to Follow-up|3
4409004|NCT00243919|7188614|FG000|Overall Study|Administrative Error|1
4409005|NCT00243919|7188615|FG001|Overall Study|Administrative Error|0
4409006|NCT00243919|7188616|FG002|Overall Study|Administrative Error|0
4409007|NCT00243919|7188614|FG000|Overall Study|Physician Decision|1
4409008|NCT00243919|7188615|FG001|Overall Study|Physician Decision|1
4409009|NCT00243919|7188616|FG002|Overall Study|Physician Decision|0
4409010|NCT00243932|7188627|FG000|Stage 1: Dose Selection|Lost to Follow-up|2
4409011|NCT00243932|7188628|FG001|Stage 1: Dose Selection|Lost to Follow-up|0
4409012|NCT00243932|7188629|FG002|Stage 1: Dose Selection|Lost to Follow-up|0
4409013|NCT00244374|7188659|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105
4409014|NCT00244374|7188660|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
4409015|NCT00244374|7188661|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
4409016|NCT00244374|7188662|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
4409017|NCT00244374|7188663|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
4409018|NCT00244374|7188659|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17
4409019|NCT00244374|7188660|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
4409020|NCT00244374|7188661|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
4409021|NCT00244374|7188662|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
4409022|NCT00244374|7188663|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
4409023|NCT00244374|7188659|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14
4409024|NCT00244374|7188660|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
4409025|NCT00244374|7188661|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
4409026|NCT00244374|7188662|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
4409027|NCT00244374|7188663|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
4409028|NCT00244374|7188659|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1
4409029|NCT00244374|7188660|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
4409030|NCT00244374|7188661|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
4409031|NCT00244374|7188662|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
4409032|NCT00244374|7188663|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
4409033|NCT00244374|7188659|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172
4409034|NCT00244374|7188660|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
4409035|NCT00244374|7188661|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
4409036|NCT00244374|7188662|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
4409037|NCT00244374|7188663|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
4409038|NCT00244374|7188659|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51
4409039|NCT00244374|7188660|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
4409040|NCT00244374|7188661|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
4409041|NCT00244374|7188662|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
4713548|NCT02949362|7641167|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1
4713549|NCT02949362|7641168|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0
4409042|NCT00244374|7188663|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
4409043|NCT00244374|7188659|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34
4409044|NCT00244374|7188660|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
4409045|NCT00244374|7188661|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
4409046|NCT00244374|7188662|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
4409047|NCT00244374|7188663|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
4409048|NCT00244374|7188659|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4
4409049|NCT00244374|7188660|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
4409050|NCT00244374|7188661|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
4409051|NCT00244374|7188662|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
4409052|NCT00244374|7188663|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
4409053|NCT00244374|7188659|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12
4409054|NCT00244374|7188660|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
4409055|NCT00244374|7188661|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
4409056|NCT00244374|7188662|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
4409057|NCT00244374|7188663|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
4409058|NCT00244621|7188682|FG000|Double-blind Treatment Period|Lost to Follow-up|0
4409059|NCT00244621|7188683|FG001|Double-blind Treatment Period|Lost to Follow-up|0
4409060|NCT00244621|7188684|FG002|Double-blind Treatment Period|Lost to Follow-up|1
4409061|NCT00244621|7188682|FG000|Double-blind Treatment Period|Withdrawal by Subject|0
4409062|NCT00244621|7188683|FG001|Double-blind Treatment Period|Withdrawal by Subject|1
4409063|NCT00244621|7188684|FG002|Double-blind Treatment Period|Withdrawal by Subject|0
4409064|NCT00244621|7188682|FG000|Double-blind Treatment Period|Lack of Efficacy|0
4409065|NCT00244621|7188683|FG001|Double-blind Treatment Period|Lack of Efficacy|1
4409066|NCT00244621|7188684|FG002|Double-blind Treatment Period|Lack of Efficacy|0
4409067|NCT00244621|7188682|FG000|Double-blind Treatment Period|Multiple Reasons|2
4409068|NCT00244621|7188683|FG001|Double-blind Treatment Period|Multiple Reasons|1
4409069|NCT00244621|7188684|FG002|Double-blind Treatment Period|Multiple Reasons|1
4409070|NCT00244621|7188682|FG000|Open-label Treatment Period|Lost to Follow-up|0
4409071|NCT00244621|7188683|FG001|Open-label Treatment Period|Lost to Follow-up|1
4409072|NCT00244621|7188684|FG002|Open-label Treatment Period|Lost to Follow-up|0
4409073|NCT00244621|7188682|FG000|Open-label Treatment Period|Withdrawal by Subject|1
4409074|NCT00244621|7188683|FG001|Open-label Treatment Period|Withdrawal by Subject|0
4409075|NCT00244621|7188684|FG002|Open-label Treatment Period|Withdrawal by Subject|0
4409076|NCT00244621|7188682|FG000|Open-label Treatment Period|Adverse Event|0
4409077|NCT00244621|7188683|FG001|Open-label Treatment Period|Adverse Event|0
4409078|NCT00244621|7188684|FG002|Open-label Treatment Period|Adverse Event|1
4409079|NCT00244621|7188682|FG000|Open-label Treatment Period|Moved abroad|0
4409080|NCT00244621|7188683|FG001|Open-label Treatment Period|Moved abroad|0
4409081|NCT00244621|7188684|FG002|Open-label Treatment Period|Moved abroad|1
4409082|NCT00244712|7188694|FG000|Overall Study|Adverse Event|20
4409083|NCT00244712|7188695|FG001|Overall Study|Adverse Event|21
4409084|NCT00244712|7188694|FG000|Overall Study|Protocol-Defined Virologic Failure|8
4409085|NCT00244712|7188695|FG001|Overall Study|Protocol-Defined Virologic Failure|6
4409086|NCT00244712|7188694|FG000|Overall Study|Lack of Compliance|10
4409087|NCT00244712|7188695|FG001|Overall Study|Lack of Compliance|11
4409088|NCT00244712|7188694|FG000|Overall Study|Lost to Follow-up|45
4409089|NCT00244712|7188695|FG001|Overall Study|Lost to Follow-up|52
4409090|NCT00244712|7188694|FG000|Overall Study|Withdrawal by Subject|13
4409091|NCT00244712|7188695|FG001|Overall Study|Withdrawal by Subject|23
4409092|NCT00244712|7188694|FG000|Overall Study|Protocol Violation, disease progression|13
4409093|NCT00244712|7188695|FG001|Overall Study|Protocol Violation, disease progression|11
4409094|NCT00244725|7188705|FG000|Overall Study|Lost to Follow-up|3
4409095|NCT00244725|7188706|FG001|Overall Study|Lost to Follow-up|4
4409096|NCT00244725|7188707|FG002|Overall Study|Lost to Follow-up|9
4409097|NCT00244725|7188708|FG003|Overall Study|Lost to Follow-up|2
4409098|NCT00244725|7188705|FG000|Overall Study|Withdrawal by Subject|9
4409099|NCT00244725|7188706|FG001|Overall Study|Withdrawal by Subject|7
4409100|NCT00244725|7188707|FG002|Overall Study|Withdrawal by Subject|7
4409101|NCT00244725|7188708|FG003|Overall Study|Withdrawal by Subject|8
4409102|NCT00244725|7188705|FG000|Overall Study|Not meet treatment eligibility criteria|1
4409103|NCT00244725|7188706|FG001|Overall Study|Not meet treatment eligibility criteria|2
4409104|NCT00244725|7188707|FG002|Overall Study|Not meet treatment eligibility criteria|0
4409105|NCT00244725|7188708|FG003|Overall Study|Not meet treatment eligibility criteria|0
4409106|NCT00244725|7188705|FG000|Overall Study|Physician Decision|3
4409107|NCT00244725|7188706|FG001|Overall Study|Physician Decision|0
4409108|NCT00244725|7188707|FG002|Overall Study|Physician Decision|1
4409109|NCT00244725|7188708|FG003|Overall Study|Physician Decision|2
4409110|NCT00244725|7188705|FG000|Overall Study|Adverse Events|3
4409111|NCT00244725|7188706|FG001|Overall Study|Adverse Events|1
4409112|NCT00244725|7188707|FG002|Overall Study|Adverse Events|4
4409113|NCT00244725|7188708|FG003|Overall Study|Adverse Events|4
4409114|NCT00244725|7188705|FG000|Overall Study|Withdrwal by participant|1
4409115|NCT00244725|7188706|FG001|Overall Study|Withdrwal by participant|0
4409116|NCT00244725|7188707|FG002|Overall Study|Withdrwal by participant|0
4409117|NCT00244725|7188708|FG003|Overall Study|Withdrwal by participant|1
4409118|NCT00244725|7188705|FG000|Overall Study|Liver function test abnormality|2
4409119|NCT00244725|7188706|FG001|Overall Study|Liver function test abnormality|0
4409120|NCT00244725|7188707|FG002|Overall Study|Liver function test abnormality|0
4409121|NCT00244725|7188708|FG003|Overall Study|Liver function test abnormality|1
4409122|NCT00244725|7188705|FG000|Overall Study|Sponsor withdrew the participant|1
4409123|NCT00244725|7188706|FG001|Overall Study|Sponsor withdrew the participant|0
4409124|NCT00244725|7188707|FG002|Overall Study|Sponsor withdrew the participant|0
4409125|NCT00244725|7188708|FG003|Overall Study|Sponsor withdrew the participant|1
4409126|NCT00244725|7188705|FG000|Overall Study|Mediciation Error|0
4409127|NCT00244725|7188706|FG001|Overall Study|Mediciation Error|1
4409128|NCT00244725|7188707|FG002|Overall Study|Mediciation Error|0
4409129|NCT00244725|7188708|FG003|Overall Study|Mediciation Error|0
4409130|NCT00244725|7188705|FG000|Overall Study|Rehab Refused to allow participantion|0
4409131|NCT00244725|7188706|FG001|Overall Study|Rehab Refused to allow participantion|1
4409132|NCT00244725|7188707|FG002|Overall Study|Rehab Refused to allow participantion|0
4409133|NCT00244725|7188708|FG003|Overall Study|Rehab Refused to allow participantion|0
4409134|NCT00244725|7188705|FG000|Overall Study|Headache|0
4409135|NCT00244725|7188706|FG001|Overall Study|Headache|1
4409136|NCT00244725|7188707|FG002|Overall Study|Headache|0
4409137|NCT00244725|7188708|FG003|Overall Study|Headache|0
4409138|NCT00244725|7188705|FG000|Overall Study|Received prohibited medication|0
4409139|NCT00244725|7188706|FG001|Overall Study|Received prohibited medication|1
4409140|NCT00244725|7188707|FG002|Overall Study|Received prohibited medication|0
4409141|NCT00244725|7188708|FG003|Overall Study|Received prohibited medication|1
4409142|NCT00244725|7188705|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0
4409143|NCT00244725|7188706|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1
4409144|NCT00244725|7188707|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0
4409145|NCT00244725|7188708|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0
4409146|NCT00244725|7188705|FG000|Overall Study|Administrative reason|0
4409147|NCT00244725|7188706|FG001|Overall Study|Administrative reason|0
4409148|NCT00244725|7188707|FG002|Overall Study|Administrative reason|1
4409149|NCT00244725|7188708|FG003|Overall Study|Administrative reason|0
4409150|NCT00244725|7188705|FG000|Overall Study|Vomit|0
4409151|NCT00244725|7188706|FG001|Overall Study|Vomit|0
4409152|NCT00244725|7188707|FG002|Overall Study|Vomit|1
4409153|NCT00244725|7188708|FG003|Overall Study|Vomit|0
4409154|NCT00244725|7188705|FG000|Overall Study|Failed to follow-up|0
4409155|NCT00244725|7188706|FG001|Overall Study|Failed to follow-up|0
4409156|NCT00244725|7188707|FG002|Overall Study|Failed to follow-up|1
4409157|NCT00244725|7188708|FG003|Overall Study|Failed to follow-up|1
4409158|NCT00244751|7188721|FG000|Overall Study|Adverse Event|7
4409159|NCT00244751|7188722|FG001|Overall Study|Adverse Event|7
4409160|NCT00244751|7188723|FG002|Overall Study|Adverse Event|5
4409161|NCT00244751|7188721|FG000|Overall Study|Lost to Follow-up|0
4409162|NCT00244751|7188722|FG001|Overall Study|Lost to Follow-up|1
4409163|NCT00244751|7188723|FG002|Overall Study|Lost to Follow-up|0
4409164|NCT00244751|7188721|FG000|Overall Study|Protocol Violation|1
4409165|NCT00244751|7188722|FG001|Overall Study|Protocol Violation|0
4409166|NCT00244751|7188723|FG002|Overall Study|Protocol Violation|1
4409167|NCT00244751|7188721|FG000|Overall Study|Withdrawal by Subject|7
4409168|NCT00244751|7188722|FG001|Overall Study|Withdrawal by Subject|5
4409169|NCT00244751|7188723|FG002|Overall Study|Withdrawal by Subject|3
4409170|NCT00244751|7188721|FG000|Overall Study|Elevated liver enzymes|1
4409171|NCT00244751|7188722|FG001|Overall Study|Elevated liver enzymes|0
4409172|NCT00244751|7188723|FG002|Overall Study|Elevated liver enzymes|0
4409173|NCT00244751|7188721|FG000|Overall Study|Lack of compliance with protocol|0
4409174|NCT00244751|7188722|FG001|Overall Study|Lack of compliance with protocol|1
4409175|NCT00244751|7188723|FG002|Overall Study|Lack of compliance with protocol|0
4409176|NCT00244751|7188721|FG000|Overall Study|Safety reasons|0
4409177|NCT00244751|7188722|FG001|Overall Study|Safety reasons|1
4409178|NCT00244751|7188723|FG002|Overall Study|Safety reasons|0
4409179|NCT00244751|7188721|FG000|Overall Study|Participant randomized by mistake|0
4409180|NCT00244751|7188722|FG001|Overall Study|Participant randomized by mistake|0
4409181|NCT00244751|7188723|FG002|Overall Study|Participant randomized by mistake|1
4409182|NCT00244764|7188740|FG000|Overall Study|Adverse Event|37
4409183|NCT00244764|7188740|FG000|Overall Study|Lost to Follow-up|23
4409184|NCT00244764|7188740|FG000|Overall Study|Withdrawal by Subject|12
4409185|NCT00244764|7188740|FG000|Overall Study|Disease Progression|13
4409186|NCT00244764|7188740|FG000|Overall Study|Protocol Violation|2
4409187|NCT00244764|7188740|FG000|Overall Study|Death|1
4409188|NCT00244764|7188740|FG000|Overall Study|Off Study Medication for >21 Days|1
4409189|NCT00244764|7188740|FG000|Overall Study|Declining Performance Status|1
4409190|NCT00244764|7188740|FG000|Overall Study|Participant was Hospitalized until Death|1
4409191|NCT00244764|7188740|FG000|Overall Study|Primary Investigator Discretion|2
4409192|NCT00244764|7188740|FG000|Overall Study|Sponsor Terminated Study|2
4409193|NCT00244764|7188740|FG000|Overall Study|Developed Secondary Malignancy|1
4409194|NCT00244855|7188747|FG000|Overall Study|Withdrawal by Subject|0
4409195|NCT00244855|7188748|FG001|Overall Study|Withdrawal by Subject|1
4713550|NCT02949362|7641165|FG000|Prospective Period|Other|0
4713551|NCT02949362|7641166|FG001|Prospective Period|Other|0
4713552|NCT02949362|7641167|FG002|Prospective Period|Other|0
4713553|NCT02949362|7641168|FG003|Prospective Period|Other|4
4713554|NCT02949908|7641204|FG000|Overall Study|Study termination|2
4713555|NCT02949973|7641217|FG000|Overall Study|Physician Decision|1
4713556|NCT02950545|7641240|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0
4713557|NCT02950545|7641241|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0
4713558|NCT02950545|7641242|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0
4713559|NCT02950545|7641243|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0
4713560|NCT02950545|7641244|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0
4713561|NCT02950545|7641245|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1
4713562|NCT02950545|7641240|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1
4713563|NCT02950545|7641241|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0
4713564|NCT02950545|7641242|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0
4713565|NCT02950545|7641243|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1
4713566|NCT02950545|7641244|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0
4713567|NCT02950545|7641245|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1
4713568|NCT02950545|7641240|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0
4713569|NCT02950545|7641241|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0
4713570|NCT02950545|7641242|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0
4713571|NCT02950545|7641243|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0
4713572|NCT02950545|7641244|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1
4713573|NCT02950545|7641245|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0
4713574|NCT02950545|7641240|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1
4713575|NCT02950545|7641241|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0
4713576|NCT02950545|7641242|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0
4713577|NCT02950545|7641243|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0
4713578|NCT02950545|7641244|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0
4713579|NCT02950545|7641245|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0
4713580|NCT02950545|7641240|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0
4713581|NCT02950545|7641241|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0
4713582|NCT02950545|7641242|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0
4713583|NCT02950545|7641243|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0
4713584|NCT02950545|7641244|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0
4713585|NCT02950545|7641245|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1
4713586|NCT02950558|7641253|FG000|Overall Study|Lost to Follow-up|2
4713587|NCT02950558|7641254|FG001|Overall Study|Lost to Follow-up|0
4713588|NCT02950831|7641270|FG000|Overall Study|Lost to Follow-up|1
4713589|NCT02950831|7641270|FG000|Overall Study|Withdrawal by Subject|3
4713590|NCT02950831|7641270|FG000|Overall Study|stimulation trail failure|5
4713591|NCT02951156|7641302|FG000|Overall Study|Death|3
4409196|NCT00244881|7188756|FG000|Overall Study|Withdrawal by Subject|3
4409197|NCT00244933|7188760|FG000|Overall Study|Not response evaluable|2
4409198|NCT00245011|7188768|FG000|Overall Study|Lack of Efficacy|1
4511639|NCT00928070|7320898|FG000|Overall Study|Protocol Violation|6
4511640|NCT00928070|7320899|FG001|Overall Study|Protocol Violation|5
4511641|NCT00928070|7320898|FG000|Overall Study|Randomized but not treated|2
4511642|NCT00928070|7320899|FG001|Overall Study|Randomized but not treated|2
4511643|NCT00928070|7320898|FG000|Overall Study|Other|5
4511644|NCT00928070|7320899|FG001|Overall Study|Other|5
4511645|NCT00928135|7320967|FG000|Overall Study|Withdrawal by Subject|1
4511646|NCT00928135|7320968|FG001|Overall Study|Withdrawal by Subject|0
4511647|NCT00928187|7320981|FG000|Overall Study|Death|1
4511648|NCT00928187|7320982|FG001|Overall Study|Death|2
4511649|NCT00928187|7320983|FG002|Overall Study|Death|3
4511650|NCT00928187|7320981|FG000|Overall Study|Lost to Follow-up|1
4511651|NCT00928187|7320982|FG001|Overall Study|Lost to Follow-up|2
4511652|NCT00928187|7320983|FG002|Overall Study|Lost to Follow-up|1
4511653|NCT00928187|7320981|FG000|Overall Study|Withdrawal by Subject|0
4511654|NCT00928187|7320982|FG001|Overall Study|Withdrawal by Subject|1
4511655|NCT00928187|7320983|FG002|Overall Study|Withdrawal by Subject|1
4511656|NCT00928187|7320981|FG000|Overall Study|Protocol Violation|0
4511657|NCT00928187|7320982|FG001|Overall Study|Protocol Violation|1
4511658|NCT00928187|7320983|FG002|Overall Study|Protocol Violation|0
4511659|NCT00928252|7320995|FG000|Overall Study|Physician Decision|3
4511660|NCT00928408|7321018|FG000|Overall Study|Other|2
4511661|NCT00928408|7321018|FG000|Overall Study|Withdrawal by Subject|4
4511662|NCT00928408|7321018|FG000|Overall Study|Death|5
4511663|NCT00928408|7321018|FG000|Overall Study|Lost to Follow-up|12
4511664|NCT00928434|7321029|FG000|Overall Study|Adverse Event|14
4511665|NCT00928434|7321030|FG001|Overall Study|Adverse Event|5
4511666|NCT00928434|7321031|FG002|Overall Study|Adverse Event|18
4511667|NCT00928434|7321029|FG000|Overall Study|Protocol Violation|5
4511668|NCT00928434|7321030|FG001|Overall Study|Protocol Violation|0
4511669|NCT00928434|7321031|FG002|Overall Study|Protocol Violation|8
4511670|NCT00928434|7321029|FG000|Overall Study|Physician Decision|2
4511671|NCT00928434|7321030|FG001|Overall Study|Physician Decision|0
4713592|NCT02951156|7641303|FG001|Overall Study|Death|8
4713593|NCT02951156|7641304|FG002|Overall Study|Death|5
4713594|NCT02951156|7641302|FG000|Overall Study|Progressive disease|1
4511672|NCT00928434|7321031|FG002|Overall Study|Physician Decision|3
4511673|NCT00928434|7321029|FG000|Overall Study|Lost to Follow-up|1
4713595|NCT02951156|7641303|FG001|Overall Study|Progressive disease|0
4713596|NCT02951156|7641304|FG002|Overall Study|Progressive disease|1
4409199|NCT00245037|7188772|FG000|Overall Study|Death|17
4409200|NCT00245050|7188778|FG000|Overall Study|Adverse Event|3
4409201|NCT00245050|7188779|FG001|Overall Study|Adverse Event|2
4409202|NCT00245063|7188787|FG000|Overall Study|Adverse Event|6
4409203|NCT00245063|7188788|FG001|Overall Study|Adverse Event|5
4409204|NCT00245063|7188787|FG000|Overall Study|Death|1
4409205|NCT00245063|7188788|FG001|Overall Study|Death|0
4409206|NCT00245102|7188800|FG000|Overall Study|Not Treated|1
4409207|NCT00245102|7188801|FG001|Overall Study|Not Treated|0
4409208|NCT00245102|7188802|FG002|Overall Study|Not Treated|1
4409209|NCT00245102|7188803|FG003|Overall Study|Not Treated|0
4409210|NCT00245102|7188804|FG004|Overall Study|Not Treated|0
4409211|NCT00245102|7188805|FG005|Overall Study|Not Treated|0
4409212|NCT00245102|7188800|FG000|Overall Study|Protocol Violation|1
4409213|NCT00245102|7188801|FG001|Overall Study|Protocol Violation|0
4409214|NCT00245102|7188802|FG002|Overall Study|Protocol Violation|0
4409215|NCT00245102|7188803|FG003|Overall Study|Protocol Violation|0
4409216|NCT00245102|7188804|FG004|Overall Study|Protocol Violation|0
4409217|NCT00245102|7188805|FG005|Overall Study|Protocol Violation|0
4409218|NCT00245102|7188800|FG000|Overall Study|Death|0
4409219|NCT00245102|7188801|FG001|Overall Study|Death|0
4409220|NCT00245102|7188802|FG002|Overall Study|Death|0
4409221|NCT00245102|7188803|FG003|Overall Study|Death|1
4409222|NCT00245102|7188804|FG004|Overall Study|Death|0
4409223|NCT00245102|7188805|FG005|Overall Study|Death|0
4409224|NCT00245102|7188800|FG000|Overall Study|Adverse Event|4
4409225|NCT00245102|7188801|FG001|Overall Study|Adverse Event|2
4409226|NCT00245102|7188802|FG002|Overall Study|Adverse Event|5
4409227|NCT00245102|7188803|FG003|Overall Study|Adverse Event|1
4409228|NCT00245102|7188804|FG004|Overall Study|Adverse Event|0
4409229|NCT00245102|7188805|FG005|Overall Study|Adverse Event|2
4409230|NCT00245102|7188800|FG000|Overall Study|Decline in performance|0
4409231|NCT00245102|7188801|FG001|Overall Study|Decline in performance|2
4409232|NCT00245102|7188802|FG002|Overall Study|Decline in performance|0
4409233|NCT00245102|7188803|FG003|Overall Study|Decline in performance|1
4409234|NCT00245102|7188804|FG004|Overall Study|Decline in performance|0
4409235|NCT00245102|7188805|FG005|Overall Study|Decline in performance|2
4409236|NCT00245102|7188800|FG000|Overall Study|Participant needed surgery|0
4409237|NCT00245102|7188801|FG001|Overall Study|Participant needed surgery|0
4409238|NCT00245102|7188802|FG002|Overall Study|Participant needed surgery|1
4409239|NCT00245102|7188803|FG003|Overall Study|Participant needed surgery|0
4409240|NCT00245102|7188804|FG004|Overall Study|Participant needed surgery|0
4409241|NCT00245102|7188805|FG005|Overall Study|Participant needed surgery|0
4409242|NCT00245102|7188800|FG000|Overall Study|Clinical progression|1
4409243|NCT00245102|7188801|FG001|Overall Study|Clinical progression|0
4409244|NCT00245102|7188802|FG002|Overall Study|Clinical progression|0
4409245|NCT00245102|7188803|FG003|Overall Study|Clinical progression|0
4409246|NCT00245102|7188804|FG004|Overall Study|Clinical progression|0
4409247|NCT00245102|7188805|FG005|Overall Study|Clinical progression|0
4409248|NCT00245466|7188835|FG000|Overall Study|Adverse Event|2
4409249|NCT00245466|7188836|FG001|Overall Study|Adverse Event|8
4409250|NCT00245466|7188837|FG002|Overall Study|Adverse Event|4
4409251|NCT00245466|7188835|FG000|Overall Study|Low prostate specific antigen suppr|16
4409252|NCT00245466|7188836|FG001|Overall Study|Low prostate specific antigen suppr|14
4409253|NCT00245466|7188837|FG002|Overall Study|Low prostate specific antigen suppr|5
4409254|NCT00245466|7188835|FG000|Overall Study|Insufficient testosterone suppr|12
4409255|NCT00245466|7188836|FG001|Overall Study|Insufficient testosterone suppr|12
4409256|NCT00245466|7188837|FG002|Overall Study|Insufficient testosterone suppr|21
4409257|NCT00245466|7188835|FG000|Overall Study|Insufficient PSA and testosterone suppr|0
4409258|NCT00245466|7188836|FG001|Overall Study|Insufficient PSA and testosterone suppr|0
4409259|NCT00245466|7188837|FG002|Overall Study|Insufficient PSA and testosterone suppr|3
4409260|NCT00245466|7188835|FG000|Overall Study|Withdrawal by Subject|2
4409261|NCT00245466|7188836|FG001|Overall Study|Withdrawal by Subject|2
4409262|NCT00245466|7188837|FG002|Overall Study|Withdrawal by Subject|1
4409263|NCT00245466|7188835|FG000|Overall Study|Lost to Follow-up|3
4409264|NCT00245466|7188836|FG001|Overall Study|Lost to Follow-up|0
4409265|NCT00245466|7188837|FG002|Overall Study|Lost to Follow-up|0
4409266|NCT00245466|7188835|FG000|Overall Study|Disease progression|0
4409267|NCT00245466|7188836|FG001|Overall Study|Disease progression|3
4713597|NCT02951156|7641302|FG000|Overall Study|Withdrawal by Subject|0
4713598|NCT02951156|7641303|FG001|Overall Study|Withdrawal by Subject|0
4713599|NCT02951156|7641304|FG002|Overall Study|Withdrawal by Subject|1
4713600|NCT02951156|7641302|FG000|Overall Study|Study terminated by sponsor|0
4713601|NCT02951156|7641303|FG001|Overall Study|Study terminated by sponsor|0
4713602|NCT02951156|7641304|FG002|Overall Study|Study terminated by sponsor|1
4713603|NCT02951156|7641302|FG000|Overall Study|Other|5
4713604|NCT02951156|7641303|FG001|Overall Study|Other|1
4713605|NCT02951156|7641304|FG002|Overall Study|Other|2
4713606|NCT02951429|7641429|FG000|Overall Study|Adverse Event|3
4409268|NCT00245466|7188837|FG002|Overall Study|Disease progression|1
4409269|NCT00245466|7188835|FG000|Overall Study|Protocol Violation|1
4409270|NCT00245466|7188836|FG001|Overall Study|Protocol Violation|2
4713607|NCT02951429|7641430|FG001|Overall Study|Adverse Event|7
4409271|NCT00245466|7188837|FG002|Overall Study|Protocol Violation|2
4409272|NCT00245466|7188835|FG000|Overall Study|Death|0
4409273|NCT00245466|7188836|FG001|Overall Study|Death|2
4409274|NCT00245466|7188837|FG002|Overall Study|Death|0
4409275|NCT00245466|7188835|FG000|Overall Study|Administrative reasons|0
4409276|NCT00245466|7188836|FG001|Overall Study|Administrative reasons|1
4409277|NCT00245466|7188837|FG002|Overall Study|Administrative reasons|0
4409278|NCT00245583|7188866|FG000|Overall Study|Lost to Follow-up|1
4409279|NCT00245583|7188867|FG001|Overall Study|Lost to Follow-up|5
4409280|NCT00245583|7188866|FG000|Overall Study|Adverse Event|2
4409281|NCT00245583|7188867|FG001|Overall Study|Adverse Event|1
4409282|NCT00245583|7188866|FG000|Overall Study|Lack of Efficacy|1
4409283|NCT00245583|7188867|FG001|Overall Study|Lack of Efficacy|0
4409284|NCT00245583|7188866|FG000|Overall Study|Withdrawal by Subject|2
4409285|NCT00245583|7188867|FG001|Overall Study|Withdrawal by Subject|3
4409286|NCT00245765|7188885|FG000|Overall Study|Adverse Event|1
4409287|NCT00245765|7188886|FG001|Overall Study|Adverse Event|1
4409288|NCT00245765|7188887|FG002|Overall Study|Adverse Event|0
4409289|NCT00245765|7188885|FG000|Overall Study|Lack of Efficacy|14
4409290|NCT00245765|7188886|FG001|Overall Study|Lack of Efficacy|7
4409291|NCT00245765|7188887|FG002|Overall Study|Lack of Efficacy|0
4409292|NCT00245765|7188885|FG000|Overall Study|Lost to Follow-up|1
4409293|NCT00245765|7188886|FG001|Overall Study|Lost to Follow-up|2
4409294|NCT00245765|7188887|FG002|Overall Study|Lost to Follow-up|0
4409295|NCT00245765|7188885|FG000|Overall Study|Withdrawal by Subject|1
4409296|NCT00245765|7188886|FG001|Overall Study|Withdrawal by Subject|0
4409297|NCT00245765|7188887|FG002|Overall Study|Withdrawal by Subject|3
4409298|NCT00245765|7188885|FG000|Overall Study|Other reason|2
4409299|NCT00245765|7188886|FG001|Overall Study|Other reason|0
4409300|NCT00245765|7188887|FG002|Overall Study|Other reason|1
4409301|NCT00245765|7188885|FG000|Overall Study|Other|13
4409302|NCT00245765|7188886|FG001|Overall Study|Other|4
4409303|NCT00245765|7188887|FG002|Overall Study|Other|4
4409304|NCT00245856|7188895|FG000|Period Two|Withdrawal by Subject|0
4409305|NCT00245856|7188896|FG001|Period Two|Withdrawal by Subject|1
4409306|NCT00246012|7188912|FG000|Overall Study|Adverse Event|0
4409307|NCT00246012|7188913|FG001|Overall Study|Adverse Event|0
4409308|NCT00246012|7188914|FG002|Overall Study|Adverse Event|0
4409309|NCT00246012|7188915|FG003|Overall Study|Adverse Event|0
4409310|NCT00246012|7188916|FG004|Overall Study|Adverse Event|0
4409311|NCT00246012|7188917|FG005|Overall Study|Adverse Event|1
4409312|NCT00246012|7188918|FG006|Overall Study|Adverse Event|0
4409313|NCT00246012|7188919|FG007|Overall Study|Adverse Event|0
4409314|NCT00246012|7188920|FG008|Overall Study|Adverse Event|2
4409315|NCT00246012|7188912|FG000|Overall Study|Withdrawal by Subject|0
4409316|NCT00246012|7188913|FG001|Overall Study|Withdrawal by Subject|0
4409317|NCT00246012|7188914|FG002|Overall Study|Withdrawal by Subject|0
4409318|NCT00246012|7188915|FG003|Overall Study|Withdrawal by Subject|0
4409319|NCT00246012|7188916|FG004|Overall Study|Withdrawal by Subject|0
4409320|NCT00246012|7188917|FG005|Overall Study|Withdrawal by Subject|1
4409321|NCT00246012|7188918|FG006|Overall Study|Withdrawal by Subject|0
4409322|NCT00246012|7188919|FG007|Overall Study|Withdrawal by Subject|0
4409323|NCT00246012|7188920|FG008|Overall Study|Withdrawal by Subject|0
4409324|NCT00246012|7188912|FG000|Overall Study|Disease progression|3
4629053|NCT01867710|7496628|FG003|Overall Study|Patient to follow subsequent treatment|0
4629054|NCT01867710|7496625|FG000|Overall Study|Progressive disease|1
4409325|NCT00246012|7188913|FG001|Overall Study|Disease progression|1
4409326|NCT00246012|7188914|FG002|Overall Study|Disease progression|2
4409327|NCT00246012|7188915|FG003|Overall Study|Disease progression|3
4409328|NCT00246012|7188916|FG004|Overall Study|Disease progression|3
4409329|NCT00246012|7188917|FG005|Overall Study|Disease progression|25
4409330|NCT00246012|7188918|FG006|Overall Study|Disease progression|30
4409331|NCT00246012|7188919|FG007|Overall Study|Disease progression|27
4409332|NCT00246012|7188920|FG008|Overall Study|Disease progression|26
4409333|NCT00246012|7188912|FG000|Overall Study|Other|0
4409334|NCT00246012|7188913|FG001|Overall Study|Other|0
4409335|NCT00246012|7188914|FG002|Overall Study|Other|0
4409336|NCT00246012|7188915|FG003|Overall Study|Other|0
4409337|NCT00246012|7188916|FG004|Overall Study|Other|0
4409338|NCT00246012|7188917|FG005|Overall Study|Other|0
4409339|NCT00246012|7188918|FG006|Overall Study|Other|0
4409340|NCT00246012|7188919|FG007|Overall Study|Other|1
4409341|NCT00246012|7188920|FG008|Overall Study|Other|0
4409342|NCT00246012|7188912|FG000|Overall Study|Randomly assigned but not treated|0
4409343|NCT00246012|7188913|FG001|Overall Study|Randomly assigned but not treated|0
4409344|NCT00246012|7188914|FG002|Overall Study|Randomly assigned but not treated|0
4409345|NCT00246012|7188915|FG003|Overall Study|Randomly assigned but not treated|0
4409346|NCT00246012|7188916|FG004|Overall Study|Randomly assigned but not treated|0
4409347|NCT00246012|7188917|FG005|Overall Study|Randomly assigned but not treated|1
4409348|NCT00246012|7188918|FG006|Overall Study|Randomly assigned but not treated|1
4409349|NCT00246012|7188919|FG007|Overall Study|Randomly assigned but not treated|0
4409350|NCT00246012|7188920|FG008|Overall Study|Randomly assigned but not treated|0
4409351|NCT00246025|7188946|FG000|Overall Study|Adverse Event|7
4409352|NCT00246025|7188947|FG001|Overall Study|Adverse Event|9
4409353|NCT00246025|7188948|FG002|Overall Study|Adverse Event|9
4409354|NCT00246025|7188949|FG003|Overall Study|Adverse Event|10
4409355|NCT00246025|7188946|FG000|Overall Study|Withdrawal by Subject|3
4409356|NCT00246025|7188947|FG001|Overall Study|Withdrawal by Subject|0
4409357|NCT00246025|7188948|FG002|Overall Study|Withdrawal by Subject|1
4409358|NCT00246025|7188949|FG003|Overall Study|Withdrawal by Subject|2
4409359|NCT00246025|7188946|FG000|Overall Study|unsuitable medical history was found|0
4409360|NCT00246025|7188947|FG001|Overall Study|unsuitable medical history was found|0
4409361|NCT00246025|7188948|FG002|Overall Study|unsuitable medical history was found|0
4409362|NCT00246025|7188949|FG003|Overall Study|unsuitable medical history was found|1
4409363|NCT00246090|7188959|FG000|Overall Study|Adverse Event|25
4409364|NCT00246090|7188959|FG000|Overall Study|Withdrawal by Subject|7
4409365|NCT00246090|7188959|FG000|Overall Study|Progressive Disease|212
4409366|NCT00246090|7188959|FG000|Overall Study|Clinical Progression|30
4409367|NCT00246090|7188959|FG000|Overall Study|Physician Decision|11
4409368|NCT00246090|7188959|FG000|Overall Study|Not Otherwise Specified|10
4409369|NCT00246129|7188965|FG000|Overall Study|Lost to Follow-up|1
4409370|NCT00246129|7188966|FG001|Overall Study|Lost to Follow-up|0
4409371|NCT00246129|7188965|FG000|Overall Study|Death|2
4409372|NCT00246129|7188966|FG001|Overall Study|Death|1
4409373|NCT00246129|7188965|FG000|Overall Study|suffered primary non-function|1
4409374|NCT00246129|7188966|FG001|Overall Study|suffered primary non-function|0
4409375|NCT00246129|7188965|FG000|Overall Study|grafts failed|3
4409376|NCT00246129|7188966|FG001|Overall Study|grafts failed|1
4409377|NCT00246259|7188977|FG000|Overall Study|Other|3
4409378|NCT00246259|7188978|FG001|Overall Study|Other|3
4409379|NCT00246259|7188977|FG000|Overall Study|Not stable by Week 18|2
4409380|NCT00246259|7188978|FG001|Overall Study|Not stable by Week 18|1
4409381|NCT00246259|7188977|FG000|Overall Study|Participant non-compliant|4
4409382|NCT00246259|7188978|FG001|Overall Study|Participant non-compliant|9
4409383|NCT00246259|7188977|FG000|Overall Study|Lack of Efficacy|2
4409384|NCT00246259|7188978|FG001|Overall Study|Lack of Efficacy|2
4409385|NCT00246259|7188977|FG000|Overall Study|Investigator withdrew participant|2
4409386|NCT00246259|7188978|FG001|Overall Study|Investigator withdrew participant|0
4409387|NCT00246259|7188977|FG000|Overall Study|Adverse Event|5
4409388|NCT00246259|7188978|FG001|Overall Study|Adverse Event|0
4409389|NCT00246259|7188977|FG000|Overall Study|Lost to Follow-up|3
4409390|NCT00246259|7188978|FG001|Overall Study|Lost to Follow-up|4
4409391|NCT00246259|7188977|FG000|Overall Study|Withdrawal by Subject|5
4409392|NCT00246259|7188978|FG001|Overall Study|Withdrawal by Subject|1
4409393|NCT00246259|7188977|FG000|Overall Study|randomly assigned, not eligible for ITT|2
4409394|NCT00246259|7188978|FG001|Overall Study|randomly assigned, not eligible for ITT|6
4409395|NCT00246324|7188984|FG000|Overall Study|Withdrawal by Subject|1
4409396|NCT00246337|7188997|FG000|Overall Study|Lost to Follow-up|3
4409397|NCT00246337|7188998|FG001|Overall Study|Lost to Follow-up|0
4409398|NCT00246337|7188999|FG002|Overall Study|Lost to Follow-up|0
4409399|NCT00246337|7189000|FG003|Overall Study|Lost to Follow-up|0
4409400|NCT00246337|7189001|FG004|Overall Study|Lost to Follow-up|2
4409401|NCT00246337|7189002|FG005|Overall Study|Lost to Follow-up|2
4409402|NCT00246337|7189003|FG006|Overall Study|Lost to Follow-up|1
4409403|NCT00246337|7189004|FG007|Overall Study|Lost to Follow-up|2
4409404|NCT00246337|7189005|FG008|Overall Study|Lost to Follow-up|0
4409405|NCT00246337|7188997|FG000|Overall Study|Protocol Violation|1
4409406|NCT00246337|7188998|FG001|Overall Study|Protocol Violation|0
4409407|NCT00246337|7188999|FG002|Overall Study|Protocol Violation|0
4409408|NCT00246337|7189000|FG003|Overall Study|Protocol Violation|0
4409409|NCT00246337|7189001|FG004|Overall Study|Protocol Violation|1
4409410|NCT00246337|7189002|FG005|Overall Study|Protocol Violation|0
4409411|NCT00246337|7189003|FG006|Overall Study|Protocol Violation|1
4409412|NCT00246337|7189004|FG007|Overall Study|Protocol Violation|1
4409413|NCT00246337|7189005|FG008|Overall Study|Protocol Violation|0
4409414|NCT00246337|7188997|FG000|Overall Study|Withdrawal by Subject|2
4409415|NCT00246337|7188998|FG001|Overall Study|Withdrawal by Subject|0
4409416|NCT00246337|7188999|FG002|Overall Study|Withdrawal by Subject|0
4409417|NCT00246337|7189000|FG003|Overall Study|Withdrawal by Subject|0
4409418|NCT00246337|7189001|FG004|Overall Study|Withdrawal by Subject|0
4409419|NCT00246337|7189002|FG005|Overall Study|Withdrawal by Subject|0
4409420|NCT00246337|7189003|FG006|Overall Study|Withdrawal by Subject|1
4409421|NCT00246337|7189004|FG007|Overall Study|Withdrawal by Subject|1
4409422|NCT00246337|7189005|FG008|Overall Study|Withdrawal by Subject|0
4409423|NCT00246337|7188997|FG000|Overall Study|Lack of Qualifying Event|8
4409424|NCT00246337|7188998|FG001|Overall Study|Lack of Qualifying Event|2
4409425|NCT00246337|7188999|FG002|Overall Study|Lack of Qualifying Event|1
4409426|NCT00246337|7189000|FG003|Overall Study|Lack of Qualifying Event|1
4409427|NCT00246337|7189001|FG004|Overall Study|Lack of Qualifying Event|1
4409428|NCT00246337|7189002|FG005|Overall Study|Lack of Qualifying Event|3
4409429|NCT00246337|7189003|FG006|Overall Study|Lack of Qualifying Event|3
4409430|NCT00246337|7189004|FG007|Overall Study|Lack of Qualifying Event|2
4409431|NCT00246337|7189005|FG008|Overall Study|Lack of Qualifying Event|5
4409432|NCT00246337|7188997|FG000|Overall Study|Site Terminated|10
4409433|NCT00246337|7188998|FG001|Overall Study|Site Terminated|0
4409434|NCT00246337|7188999|FG002|Overall Study|Site Terminated|0
4409435|NCT00246337|7189000|FG003|Overall Study|Site Terminated|0
4409436|NCT00246337|7189001|FG004|Overall Study|Site Terminated|0
4409437|NCT00246337|7189002|FG005|Overall Study|Site Terminated|7
4409438|NCT00246337|7189003|FG006|Overall Study|Site Terminated|1
4409439|NCT00246337|7189004|FG007|Overall Study|Site Terminated|6
4409440|NCT00246337|7189005|FG008|Overall Study|Site Terminated|2
4409441|NCT00246337|7188997|FG000|Overall Study|Abnormal baseline lab values|7
4409442|NCT00246337|7188998|FG001|Overall Study|Abnormal baseline lab values|0
4409443|NCT00246337|7188999|FG002|Overall Study|Abnormal baseline lab values|2
4409444|NCT00246337|7189000|FG003|Overall Study|Abnormal baseline lab values|0
4409445|NCT00246337|7189001|FG004|Overall Study|Abnormal baseline lab values|0
4409446|NCT00246337|7189002|FG005|Overall Study|Abnormal baseline lab values|2
4409447|NCT00246337|7189003|FG006|Overall Study|Abnormal baseline lab values|2
4409448|NCT00246337|7189004|FG007|Overall Study|Abnormal baseline lab values|0
4409449|NCT00246337|7189005|FG008|Overall Study|Abnormal baseline lab values|4
4409450|NCT00246337|7188997|FG000|Overall Study|Overwhelmed|0
4409451|NCT00246337|7188998|FG001|Overall Study|Overwhelmed|0
4409452|NCT00246337|7188999|FG002|Overall Study|Overwhelmed|0
4409453|NCT00246337|7189000|FG003|Overall Study|Overwhelmed|0
4409454|NCT00246337|7189001|FG004|Overall Study|Overwhelmed|0
4409455|NCT00246337|7189002|FG005|Overall Study|Overwhelmed|1
4409456|NCT00246337|7189003|FG006|Overall Study|Overwhelmed|0
4409457|NCT00246337|7189004|FG007|Overall Study|Overwhelmed|0
4409458|NCT00246337|7189005|FG008|Overall Study|Overwhelmed|0
4409459|NCT00246337|7188997|FG000|Overall Study|Protocol Violator|1
4409460|NCT00246337|7188998|FG001|Overall Study|Protocol Violator|0
4409461|NCT00246337|7188999|FG002|Overall Study|Protocol Violator|0
4409462|NCT00246337|7189000|FG003|Overall Study|Protocol Violator|0
4409463|NCT00246337|7189001|FG004|Overall Study|Protocol Violator|0
4409464|NCT00246337|7189002|FG005|Overall Study|Protocol Violator|0
4409465|NCT00246337|7189003|FG006|Overall Study|Protocol Violator|0
4409466|NCT00246337|7189004|FG007|Overall Study|Protocol Violator|0
4409467|NCT00246337|7189005|FG008|Overall Study|Protocol Violator|0
4409468|NCT00246337|7188997|FG000|Overall Study|Reported as completing trial in error|0
4409469|NCT00246337|7188998|FG001|Overall Study|Reported as completing trial in error|0
4409470|NCT00246337|7188999|FG002|Overall Study|Reported as completing trial in error|0
4713608|NCT02951429|7641429|FG000|Overall Study|Death|28
4713609|NCT02951429|7641430|FG001|Overall Study|Death|36
4713610|NCT02951429|7641429|FG000|Overall Study|Lack of Efficacy|0
4713611|NCT02951429|7641430|FG001|Overall Study|Lack of Efficacy|1
4713612|NCT02951429|7641429|FG000|Overall Study|Lost to Follow-up|0
4713613|NCT02951429|7641430|FG001|Overall Study|Lost to Follow-up|1
4713614|NCT02951429|7641429|FG000|Overall Study|Lung Transplantation|9
4713615|NCT02951429|7641430|FG001|Overall Study|Lung Transplantation|6
4713616|NCT02951429|7641429|FG000|Overall Study|Other|1
4713617|NCT02951429|7641430|FG001|Overall Study|Other|3
4713618|NCT02951429|7641429|FG000|Overall Study|Progressive Disease|1
4713619|NCT02951429|7641430|FG001|Overall Study|Progressive Disease|1
4713620|NCT02951429|7641429|FG000|Overall Study|Withdrawal by Subject|7
4713621|NCT02951429|7641430|FG001|Overall Study|Withdrawal by Subject|11
4713622|NCT02951429|7641429|FG000|Overall Study|Participant ongoing in the study|23
4713623|NCT02951429|7641430|FG001|Overall Study|Participant ongoing in the study|17
4713624|NCT02951533|7641438|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0
4713625|NCT02951533|7641439|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16
4713626|NCT02951533|7641440|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0
4713627|NCT02951533|7641438|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2
4713628|NCT02951533|7641439|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2
4713629|NCT02951533|7641440|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0
4713630|NCT02951533|7641438|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2
4713631|NCT02951533|7641439|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4
4713632|NCT02951533|7641440|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0
4713633|NCT02951533|7641438|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0
4713634|NCT02951533|7641439|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1
4713635|NCT02951533|7641440|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0
4713636|NCT02951533|7641438|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0
4713637|NCT02951533|7641439|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1
4713638|NCT02951533|7641440|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0
4713639|NCT02951533|7641438|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1
4713640|NCT02951533|7641439|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0
4713641|NCT02951533|7641440|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0
4713642|NCT02951533|7641438|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0
4713643|NCT02951533|7641439|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2
4713644|NCT02951533|7641440|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0
4713645|NCT02951533|7641438|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1
4713646|NCT02951533|7641439|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2
4713647|NCT02951533|7641440|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0
4713648|NCT02951533|7641438|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1
4713649|NCT02951533|7641439|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0
4713650|NCT02951533|7641440|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0
4713651|NCT02951533|7641438|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1
4409471|NCT00246337|7189000|FG003|Overall Study|Reported as completing trial in error|0
4713652|NCT02951533|7641439|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0
4590352|NCT01520870|7436309|FG000|Overall Study|Withdrawal by Subject|2
4590353|NCT01520909|7436315|FG000|Part 1 (Randomized Period)|Adverse Event|1
4590354|NCT01520909|7436316|FG001|Part 1 (Randomized Period)|Adverse Event|2
4590355|NCT01520909|7436317|FG002|Part 1 (Randomized Period)|Adverse Event|0
4590356|NCT01520909|7436315|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0
4590357|NCT01520909|7436316|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0
4590358|NCT01520909|7436317|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4
4590359|NCT01520909|7436315|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0
4590360|NCT01520909|7436316|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0
4590361|NCT01520909|7436317|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2
4590362|NCT01520909|7436315|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0
4590363|NCT01520909|7436316|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0
4590364|NCT01520909|7436317|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1
4409472|NCT00246337|7189001|FG004|Overall Study|Reported as completing trial in error|0
4409473|NCT00246337|7189002|FG005|Overall Study|Reported as completing trial in error|0
4409474|NCT00246337|7189003|FG006|Overall Study|Reported as completing trial in error|0
4409475|NCT00246337|7189004|FG007|Overall Study|Reported as completing trial in error|1
4409476|NCT00246337|7189005|FG008|Overall Study|Reported as completing trial in error|0
4409477|NCT00246376|7189030|FG000|Overall Study|Dropped/withdrew during dietary run-in|11
4409478|NCT00246376|7189031|FG001|Overall Study|Dropped/withdrew during dietary run-in|5
4409479|NCT00246376|7189032|FG002|Overall Study|Dropped/withdrew during dietary run-in|4
4409480|NCT00246376|7189033|FG003|Overall Study|Dropped/withdrew during dietary run-in|7
4409481|NCT00246376|7189034|FG004|Overall Study|Dropped/withdrew during dietary run-in|3
4409482|NCT00246376|7189030|FG000|Overall Study|Adverse Event|2
4409483|NCT00246376|7189031|FG001|Overall Study|Adverse Event|3
4409484|NCT00246376|7189032|FG002|Overall Study|Adverse Event|1
4409485|NCT00246376|7189033|FG003|Overall Study|Adverse Event|3
4409486|NCT00246376|7189034|FG004|Overall Study|Adverse Event|1
4409487|NCT00246376|7189030|FG000|Overall Study|Lost to Follow-up|2
4409488|NCT00246376|7189031|FG001|Overall Study|Lost to Follow-up|11
4409489|NCT00246376|7189032|FG002|Overall Study|Lost to Follow-up|11
4409490|NCT00246376|7189033|FG003|Overall Study|Lost to Follow-up|16
4409491|NCT00246376|7189034|FG004|Overall Study|Lost to Follow-up|13
4409492|NCT00246571|7189072|FG000|Overall Study|Adverse Event|7
4409493|NCT00246571|7189073|FG001|Overall Study|Adverse Event|0
4409494|NCT00246571|7189072|FG000|Overall Study|Protocol Violation|0
4409495|NCT00246571|7189073|FG001|Overall Study|Protocol Violation|1
4409496|NCT00246571|7189072|FG000|Overall Study|Withdrawal by Subject|2
4409497|NCT00246571|7189073|FG001|Overall Study|Withdrawal by Subject|3
4409498|NCT00246571|7189072|FG000|Overall Study|Lack of Efficacy|84
4409499|NCT00246571|7189073|FG001|Overall Study|Lack of Efficacy|21
4409500|NCT00246571|7189072|FG000|Overall Study|Death|17
4409501|NCT00246571|7189073|FG001|Overall Study|Death|3
4409502|NCT00246571|7189072|FG000|Overall Study|Sponsor|0
4409503|NCT00246571|7189073|FG001|Overall Study|Sponsor|1
4409504|NCT00246571|7189072|FG000|Overall Study|Did not meet entrance criteria|2
4409505|NCT00246571|7189073|FG001|Overall Study|Did not meet entrance criteria|1
4409506|NCT00246571|7189072|FG000|Overall Study|Laboratory abnormalities|1
4409507|NCT00246571|7189073|FG001|Overall Study|Laboratory abnormalities|0
4409508|NCT00246571|7189072|FG000|Overall Study|Crossover participants|0
4409509|NCT00246571|7189073|FG001|Overall Study|Crossover participants|74
4409510|NCT00246740|7189081|FG000|Initial Enrollment|Death|1
4409511|NCT00246740|7189082|FG001|Initial Enrollment|Death|0
4409512|NCT00246740|7189081|FG000|Initial Enrollment|Additional surgery scheduled|0
4409513|NCT00246740|7189082|FG001|Initial Enrollment|Additional surgery scheduled|2
4409514|NCT00246740|7189081|FG000|Initial Enrollment|Surgery schedule change|4
4409515|NCT00246740|7189082|FG001|Initial Enrollment|Surgery schedule change|4
4409516|NCT00246740|7189081|FG000|Initial Enrollment|Other|1
4409517|NCT00246740|7189082|FG001|Initial Enrollment|Other|2
4409518|NCT00246753|7189088|FG000|Overall Study|Withdrawal by Subject|2
4409519|NCT00246753|7189088|FG000|Overall Study|Physician Decision|2
4409520|NCT00246753|7189088|FG000|Overall Study|Adverse Event|2
4409521|NCT00246753|7189088|FG000|Overall Study|Unacceptable toxicity|2
4409522|NCT00246805|7189094|FG000|Phase 1|Lost to Follow-up|1
4409523|NCT00246805|7189095|FG001|Phase 1|Lost to Follow-up|0
4409524|NCT00247273|7189103|FG000|Overall Study|Adverse Event|85
4409525|NCT00247273|7189104|FG001|Overall Study|Adverse Event|80
4409526|NCT00247273|7189103|FG000|Overall Study|Physician Decision|6
4409527|NCT00247273|7189104|FG001|Overall Study|Physician Decision|3
4409528|NCT00247273|7189103|FG000|Overall Study|Lost to Follow-up|7
4409529|NCT00247273|7189104|FG001|Overall Study|Lost to Follow-up|7
4409530|NCT00247273|7189103|FG000|Overall Study|Withdrawal by Subject|46
4409531|NCT00247273|7189104|FG001|Overall Study|Withdrawal by Subject|47
4409532|NCT00247273|7189103|FG000|Overall Study|Did not take any study drug|2
4409533|NCT00247273|7189104|FG001|Overall Study|Did not take any study drug|0
4409534|NCT00247416|7189121|FG000|Overall Study|3 patients were found to be ineligible|1
4409535|NCT00247416|7189122|FG001|Overall Study|3 patients were found to be ineligible|2
4409536|NCT00247611|7189132|FG000|Baselined|Completed baseline, never placed on ARVs|8
4409537|NCT00247611|7189133|FG001|Baselined|Completed baseline, never placed on ARVs|5
4590365|NCT01520922|7436339|FG000|Treatment Phase|Physician Decision|2
4409538|NCT00247611|7189132|FG000|Baselined|Completed baseline only|9
4409539|NCT00247611|7189133|FG001|Baselined|Completed baseline only|8
4409540|NCT00247676|7189154|FG000|Overall Study|Death|5
4409541|NCT00247676|7189154|FG000|Overall Study|Adverse Event|11
4409542|NCT00247676|7189154|FG000|Overall Study|Lack of Efficacy|15
4409543|NCT00247676|7189154|FG000|Overall Study|Other|3
4409544|NCT00247676|7189154|FG000|Overall Study|Withdrawal by Subject|2
4409545|NCT00247962|7189175|FG000|Overall Study|Adverse Event|15
4409546|NCT00247962|7189176|FG001|Overall Study|Adverse Event|12
4409547|NCT00247962|7189175|FG000|Overall Study|Lost to Follow-up|3
4409548|NCT00247962|7189176|FG001|Overall Study|Lost to Follow-up|1
4409549|NCT00247962|7189175|FG000|Overall Study|Physician Decision|0
4409550|NCT00247962|7189176|FG001|Overall Study|Physician Decision|1
4409551|NCT00247962|7189175|FG000|Overall Study|Protocol Violation|1
4409552|NCT00247962|7189176|FG001|Overall Study|Protocol Violation|1
4409553|NCT00247962|7189175|FG000|Overall Study|Withdrawal by Subject|3
4409554|NCT00247962|7189176|FG001|Overall Study|Withdrawal by Subject|2
4409555|NCT00247962|7189175|FG000|Overall Study|Lack of Efficacy|4
4409556|NCT00247962|7189176|FG001|Overall Study|Lack of Efficacy|2
4409557|NCT00248040|7189185|FG000|Overall Study|transplantectomy|2
4409558|NCT00248040|7189186|FG001|Overall Study|transplantectomy|1
4409559|NCT00248040|7189187|FG002|Overall Study|transplantectomy|3
4409560|NCT00248040|7189185|FG000|Overall Study|transplant cancelled post treat start|1
4409561|NCT00248040|7189186|FG001|Overall Study|transplant cancelled post treat start|0
4409562|NCT00248040|7189187|FG002|Overall Study|transplant cancelled post treat start|0
4409563|NCT00248040|7189185|FG000|Overall Study|Death|0
4409564|NCT00248040|7189186|FG001|Overall Study|Death|0
4409565|NCT00248040|7189187|FG002|Overall Study|Death|1
4409566|NCT00248170|7189198|FG000|Overall Study|Withdrawal by Subject|71
4409567|NCT00248170|7189199|FG001|Overall Study|Withdrawal by Subject|79
4409568|NCT00248170|7189198|FG000|Overall Study|Protocol Violation|35
4409569|NCT00248170|7189199|FG001|Overall Study|Protocol Violation|30
4409570|NCT00248170|7189198|FG000|Overall Study|Lost to Follow-up|28
4409571|NCT00248170|7189199|FG001|Overall Study|Lost to Follow-up|35
4409572|NCT00248170|7189198|FG000|Overall Study|Disease progression|196
4409573|NCT00248170|7189199|FG001|Overall Study|Disease progression|216
4409574|NCT00248170|7189198|FG000|Overall Study|Death|28
4409575|NCT00248170|7189199|FG001|Overall Study|Death|47
4409576|NCT00248170|7189198|FG000|Overall Study|Adverse Event|311
4409577|NCT00248170|7189199|FG001|Overall Study|Adverse Event|296
4409578|NCT00248170|7189198|FG000|Overall Study|Administrative problems|22
4409579|NCT00248170|7189199|FG001|Overall Study|Administrative problems|25
4409580|NCT00248170|7189198|FG000|Overall Study|Abnormal test procedure(s) result|49
4409581|NCT00248170|7189199|FG001|Overall Study|Abnormal test procedure(s) result|61
4409582|NCT00248170|7189198|FG000|Overall Study|Abnormal laboratory values|4
4409583|NCT00248170|7189199|FG001|Overall Study|Abnormal laboratory values|0
4409584|NCT00248170|7189198|FG000|Overall Study|Protocol deviation|17
4409585|NCT00248170|7189199|FG001|Overall Study|Protocol deviation|19
4409586|NCT00248495|7189205|FG000|Overall Study|Withdrawal by Subject|1
4409587|NCT00248625|7189248|FG000|Overall Study|Withdrawal by Subject|0
4409588|NCT00248625|7189249|FG001|Overall Study|Withdrawal by Subject|2
4409589|NCT00248651|7189269|FG000|Overall Study|Withdrawal by Subject|28
4409590|NCT00248651|7189270|FG001|Overall Study|Withdrawal by Subject|40
4409591|NCT00248651|7189271|FG002|Overall Study|Withdrawal by Subject|32
4409592|NCT00248794|7189291|FG000|Overall Study|Lost to Follow-up|6
4409593|NCT00248794|7189292|FG001|Overall Study|Lost to Follow-up|8
4409594|NCT00248794|7189293|FG002|Overall Study|Lost to Follow-up|3
4409595|NCT00248833|7189325|FG000|Overall Study|Adverse Event|2
4409596|NCT00248833|7189326|FG001|Overall Study|Adverse Event|0
4409597|NCT00248833|7189327|FG002|Overall Study|Adverse Event|0
4409598|NCT00248833|7189325|FG000|Overall Study|Withdrawal by Subject|0
4409599|NCT00248833|7189326|FG001|Overall Study|Withdrawal by Subject|1
4409600|NCT00248833|7189327|FG002|Overall Study|Withdrawal by Subject|1
4409601|NCT00248833|7189325|FG000|Overall Study|Lost to Follow-up|1
4409602|NCT00248833|7189326|FG001|Overall Study|Lost to Follow-up|1
4409603|NCT00248833|7189327|FG002|Overall Study|Lost to Follow-up|1
4713653|NCT02951533|7641440|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0
4713654|NCT02951533|7641438|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2
4713655|NCT02951533|7641439|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0
4713656|NCT02951533|7641440|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2
4713657|NCT02951780|7641475|FG000|Period 1|Adverse Event|0
4713658|NCT02951780|7641476|FG001|Period 1|Adverse Event|0
4713659|NCT02951780|7641477|FG002|Period 1|Adverse Event|0
4713660|NCT02951780|7641478|FG003|Period 1|Adverse Event|1
4713661|NCT02951780|7641479|FG004|Period 1|Adverse Event|0
4713662|NCT02951780|7641480|FG005|Period 1|Adverse Event|0
4713663|NCT02951780|7641481|FG006|Period 1|Adverse Event|0
4713664|NCT02951780|7641482|FG007|Period 1|Adverse Event|0
4409604|NCT00248833|7189325|FG000|Overall Study|Other|0
4409605|NCT00248833|7189326|FG001|Overall Study|Other|1
4713665|NCT02951780|7641483|FG008|Period 1|Adverse Event|0
4409606|NCT00248833|7189327|FG002|Overall Study|Other|0
4409607|NCT00249002|7189337|FG000|Overall Study|Adverse Event|2
4409608|NCT00249002|7189337|FG000|Overall Study|Study cancellation|3
4409609|NCT00249002|7189337|FG000|Overall Study|Other|2
4409610|NCT00249288|7189360|FG000|Overall Study|Lost to Follow-up|3
4409611|NCT00249288|7189361|FG001|Overall Study|Lost to Follow-up|3
4409612|NCT00249288|7189360|FG000|Overall Study|Withdrawal by Subject|2
4409613|NCT00249288|7189361|FG001|Overall Study|Withdrawal by Subject|2
4409614|NCT00249444|7189386|FG000|Overall Study|Lost to Follow-up|2
4409615|NCT00249444|7189387|FG001|Overall Study|Lost to Follow-up|2
4409616|NCT00249444|7189386|FG000|Overall Study|non-compliant|9
4409617|NCT00249444|7189387|FG001|Overall Study|non-compliant|11
4409618|NCT00249444|7189386|FG000|Overall Study|Adverse Event|1
4409619|NCT00249444|7189387|FG001|Overall Study|Adverse Event|1
4409620|NCT00249444|7189386|FG000|Overall Study|life event|0
4409621|NCT00249444|7189387|FG001|Overall Study|life event|1
4409622|NCT00249613|7189415|FG000|12 Month Follow-up|Death|1
4409623|NCT00249613|7189416|FG001|12 Month Follow-up|Death|1
4409624|NCT00249613|7189415|FG000|12 Month Follow-up|Withdrawal by Subject|6
4409625|NCT00249613|7189416|FG001|12 Month Follow-up|Withdrawal by Subject|6
4409626|NCT00249613|7189415|FG000|12 Month Follow-up|Lost to Follow-up|10
4409627|NCT00249613|7189416|FG001|12 Month Follow-up|Lost to Follow-up|8
4409628|NCT00249769|7189428|FG000|Overall Study|Withdrawal by Subject|1
4409629|NCT00249769|7189429|FG001|Overall Study|Withdrawal by Subject|10
4409630|NCT00249769|7189430|FG002|Overall Study|Withdrawal by Subject|6
4409631|NCT00249769|7189428|FG000|Overall Study|Migration from Study Area|1
4409632|NCT00249769|7189429|FG001|Overall Study|Migration from Study Area|3
4409633|NCT00249769|7189430|FG002|Overall Study|Migration from Study Area|14
4409634|NCT00249769|7189428|FG000|Overall Study|Miscellaneous|0
4409635|NCT00249769|7189429|FG001|Overall Study|Miscellaneous|2
4409636|NCT00249769|7189430|FG002|Overall Study|Miscellaneous|2
4409637|NCT00249769|7189428|FG000|Overall Study|Adverse Event|0
4409638|NCT00249769|7189429|FG001|Overall Study|Adverse Event|0
4409639|NCT00249769|7189430|FG002|Overall Study|Adverse Event|1
4409640|NCT00249769|7189428|FG000|Overall Study|Physician Decision|0
4409641|NCT00249769|7189429|FG001|Overall Study|Physician Decision|0
4409642|NCT00249769|7189430|FG002|Overall Study|Physician Decision|2
4409643|NCT00249769|7189428|FG000|Overall Study|Lost to Follow-up|0
4409644|NCT00249769|7189429|FG001|Overall Study|Lost to Follow-up|0
4409645|NCT00249769|7189430|FG002|Overall Study|Lost to Follow-up|3
4409646|NCT00249795|7189440|FG000|Overall Study|Not treated|16
4409647|NCT00249795|7189441|FG001|Overall Study|Not treated|14
4409648|NCT00249795|7189440|FG000|Overall Study|Symptomatic hypotension|127
4409649|NCT00249795|7189441|FG001|Overall Study|Symptomatic hypotension|64
4409650|NCT00249795|7189440|FG000|Overall Study|Other Serious Adverse Event|84
4409651|NCT00249795|7189441|FG001|Overall Study|Other Serious Adverse Event|93
4409652|NCT00249795|7189440|FG000|Overall Study|Qualifying condition not present|26
4409653|NCT00249795|7189441|FG001|Overall Study|Qualifying condition not present|29
4409654|NCT00249795|7189440|FG000|Overall Study|Withdrawal by Subject|678
4409655|NCT00249795|7189441|FG001|Overall Study|Withdrawal by Subject|742
4409656|NCT00249795|7189440|FG000|Overall Study|Thromboembolic / outcome event|39
4409657|NCT00249795|7189441|FG001|Overall Study|Thromboembolic / outcome event|45
4409658|NCT00249795|7189440|FG000|Overall Study|Oral anticoagulant required|2
4409659|NCT00249795|7189441|FG001|Overall Study|Oral anticoagulant required|0
4409660|NCT00249795|7189440|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7
4409661|NCT00249795|7189441|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3
4409662|NCT00249795|7189440|FG000|Overall Study|Non-compliance|71
4409663|NCT00249795|7189441|FG001|Overall Study|Non-compliance|69
4409664|NCT00249795|7189440|FG000|Overall Study|Study drug intolerance|3
4409665|NCT00249795|7189441|FG001|Overall Study|Study drug intolerance|3
4409666|NCT00249795|7189440|FG000|Overall Study|Other adverse events (non-serious)|188
4409667|NCT00249795|7189441|FG001|Overall Study|Other adverse events (non-serious)|159
4409668|NCT00249795|7189440|FG000|Overall Study|Physician withdrew consent|71
4409669|NCT00249795|7189441|FG001|Overall Study|Physician withdrew consent|63
4409670|NCT00249795|7189440|FG000|Overall Study|Surgery / procedure|4
4409671|NCT00249795|7189441|FG001|Overall Study|Surgery / procedure|5
4409672|NCT00249795|7189440|FG000|Overall Study|Angiotensin II receptor blocker required|35
4409673|NCT00249795|7189441|FG001|Overall Study|Angiotensin II receptor blocker required|58
4409674|NCT00249795|7189440|FG000|Overall Study|Lightheadedness / dizziness|15
4409675|NCT00249795|7189441|FG001|Overall Study|Lightheadedness / dizziness|11
4409676|NCT00249795|7189440|FG000|Overall Study|Hypotension (non-symptomatic)|5
4409677|NCT00249795|7189441|FG001|Overall Study|Hypotension (non-symptomatic)|5
4409678|NCT00249795|7189440|FG000|Overall Study|Other contraindicated medication|1
4409679|NCT00249795|7189441|FG001|Overall Study|Other contraindicated medication|1
4409680|NCT00249795|7189440|FG000|Overall Study|Event related to cardiac condition|17
4409681|NCT00249795|7189441|FG001|Overall Study|Event related to cardiac condition|16
4409682|NCT00249795|7189440|FG000|Overall Study|Patient not wish to continue after May08|4
4409683|NCT00249795|7189441|FG001|Overall Study|Patient not wish to continue after May08|6
4409684|NCT00249795|7189440|FG000|Overall Study|Site not agree to continue after May08|1
4409685|NCT00249795|7189441|FG001|Overall Study|Site not agree to continue after May08|1
4409686|NCT00249795|7189440|FG000|Overall Study|Lost to Follow-up|0
4409687|NCT00249795|7189441|FG001|Overall Study|Lost to Follow-up|2
4409688|NCT00249795|7189440|FG000|Overall Study|Missing|0
4409689|NCT00249795|7189441|FG001|Overall Study|Missing|1
4409690|NCT00249808|7189447|FG000|Overall Study|Other|27
4409691|NCT00249808|7189447|FG000|Overall Study|Protocol Violation|3
4409692|NCT00249808|7189447|FG000|Overall Study|Lost to Follow-up|8
4409693|NCT00249808|7189447|FG000|Overall Study|Adverse Event|81
4409694|NCT00249808|7189447|FG000|Overall Study|Lack of Efficacy|52
4409695|NCT00249808|7189447|FG000|Overall Study|Did Not Provide Post-Baseline Data|11
4409696|NCT00249821|7189453|FG000|Overall Study|Technical problem|0
4409697|NCT00249821|7189454|FG001|Overall Study|Technical problem|1
4409698|NCT00249834|7189468|FG000|Overall Study|Ovarian stimulation failed|1
4409699|NCT00249834|7189469|FG001|Overall Study|Ovarian stimulation failed|0
4409700|NCT00249834|7189470|FG002|Overall Study|Ovarian stimulation failed|0
4409701|NCT00249834|7189471|FG003|Overall Study|Ovarian stimulation failed|0
4409702|NCT00249834|7189472|FG004|Overall Study|Ovarian stimulation failed|0
4409703|NCT00249834|7189473|FG005|Overall Study|Ovarian stimulation failed|0
4409704|NCT00249834|7189474|FG006|Overall Study|Ovarian stimulation failed|0
4409705|NCT00249834|7189475|FG007|Overall Study|Ovarian stimulation failed|0
4409706|NCT00249834|7189468|FG000|Overall Study|Failure of down-regulation|0
4409707|NCT00249834|7189469|FG001|Overall Study|Failure of down-regulation|0
4409708|NCT00249834|7189470|FG002|Overall Study|Failure of down-regulation|0
4409709|NCT00249834|7189471|FG003|Overall Study|Failure of down-regulation|0
4409710|NCT00249834|7189472|FG004|Overall Study|Failure of down-regulation|0
4409711|NCT00249834|7189473|FG005|Overall Study|Failure of down-regulation|0
4409712|NCT00249834|7189474|FG006|Overall Study|Failure of down-regulation|1
4409713|NCT00249834|7189475|FG007|Overall Study|Failure of down-regulation|0
4409714|NCT00249834|7189468|FG000|Overall Study|Protocol Violation|0
4409715|NCT00249834|7189469|FG001|Overall Study|Protocol Violation|19
4409716|NCT00249834|7189470|FG002|Overall Study|Protocol Violation|14
4409717|NCT00249834|7189471|FG003|Overall Study|Protocol Violation|8
4409718|NCT00249834|7189472|FG004|Overall Study|Protocol Violation|5
4409719|NCT00249834|7189473|FG005|Overall Study|Protocol Violation|2
4409720|NCT00249834|7189474|FG006|Overall Study|Protocol Violation|0
4409721|NCT00249834|7189475|FG007|Overall Study|Protocol Violation|0
4409722|NCT00249873|7189489|FG000|Overall Study|Not treated|7
4409723|NCT00249873|7189490|FG001|Overall Study|Not treated|8
4409724|NCT00249873|7189489|FG000|Overall Study|Significant thrombocytopenia|9
4409725|NCT00249873|7189490|FG001|Overall Study|Significant thrombocytopenia|8
4409726|NCT00249873|7189489|FG000|Overall Study|Severe allergic reaction|8
4409727|NCT00249873|7189490|FG001|Overall Study|Severe allergic reaction|1
4409728|NCT00249873|7189489|FG000|Overall Study|Serious haemorrhagic Adverse Event|74
4409729|NCT00249873|7189490|FG001|Overall Study|Serious haemorrhagic Adverse Event|30
4409730|NCT00249873|7189489|FG000|Overall Study|Other Serious Adverse Event|86
4409731|NCT00249873|7189490|FG001|Overall Study|Other Serious Adverse Event|97
4409732|NCT00249873|7189489|FG000|Overall Study|Qualifying condition not present|20
4409733|NCT00249873|7189490|FG001|Overall Study|Qualifying condition not present|23
4409734|NCT00249873|7189489|FG000|Overall Study|Contraindication to oral anticoagulant|4
4409735|NCT00249873|7189490|FG001|Overall Study|Contraindication to oral anticoagulant|8
4409736|NCT00249873|7189489|FG000|Overall Study|Withdrawal by Subject|504
4409737|NCT00249873|7189490|FG001|Overall Study|Withdrawal by Subject|466
4409738|NCT00249873|7189489|FG000|Overall Study|Lost to Follow-up|4
4409739|NCT00249873|7189490|FG001|Overall Study|Lost to Follow-up|7
4409740|NCT00249873|7189489|FG000|Overall Study|Minor bleeding|99
4409741|NCT00249873|7189490|FG001|Overall Study|Minor bleeding|37
4409742|NCT00249873|7189489|FG000|Overall Study|Non-compliance|41
4409743|NCT00249873|7189490|FG001|Overall Study|Non-compliance|46
4409744|NCT00249873|7189489|FG000|Overall Study|Other non serious Adverse Event|112
4409745|NCT00249873|7189490|FG001|Overall Study|Other non serious Adverse Event|108
4409746|NCT00249873|7189489|FG000|Overall Study|Other contraindicated medication|1
4409747|NCT00249873|7189490|FG001|Overall Study|Other contraindicated medication|0
4409748|NCT00249873|7189489|FG000|Overall Study|Patient not wish to continue after May08|3
4409749|NCT00249873|7189490|FG001|Overall Study|Patient not wish to continue after May08|4
4409750|NCT00249873|7189489|FG000|Overall Study|Physician withdrew consent|59
4409751|NCT00249873|7189490|FG001|Overall Study|Physician withdrew consent|60
4409752|NCT00249873|7189489|FG000|Overall Study|Open label clopidogrel required|31
4409753|NCT00249873|7189490|FG001|Overall Study|Open label clopidogrel required|42
4409754|NCT00249873|7189489|FG000|Overall Study|Angiotensin II receptor blocker required|1
4409755|NCT00249873|7189490|FG001|Overall Study|Angiotensin II receptor blocker required|0
4409756|NCT00249873|7189489|FG000|Overall Study|Oral anticoagulant required|159
4409757|NCT00249873|7189490|FG001|Overall Study|Oral anticoagulant required|157
4409758|NCT00249873|7189489|FG000|Overall Study|Study drug intolerance|5
4409759|NCT00249873|7189490|FG001|Overall Study|Study drug intolerance|0
4409760|NCT00249873|7189489|FG000|Overall Study|Surgery/ procedure|9
4409761|NCT00249873|7189490|FG001|Overall Study|Surgery/ procedure|9
4409762|NCT00249873|7189489|FG000|Overall Study|Event related to cardiac condition|12
4409763|NCT00249873|7189490|FG001|Overall Study|Event related to cardiac condition|21
4409764|NCT00249873|7189489|FG000|Overall Study|Thromboembolic/outcome event|82
4409765|NCT00249873|7189490|FG001|Overall Study|Thromboembolic/outcome event|122
4409766|NCT00250276|7189500|FG000|Overall Study|Serious Adverse Event|0
4409767|NCT00250276|7189501|FG001|Overall Study|Serious Adverse Event|0
4409768|NCT00250276|7189502|FG002|Overall Study|Serious Adverse Event|1
4409769|NCT00250276|7189503|FG003|Overall Study|Serious Adverse Event|0
4409770|NCT00250276|7189500|FG000|Overall Study|Non-serious Adverse Event|2
4409771|NCT00250276|7189501|FG001|Overall Study|Non-serious Adverse Event|0
4409772|NCT00250276|7189502|FG002|Overall Study|Non-serious Adverse Event|0
4409773|NCT00250276|7189503|FG003|Overall Study|Non-serious Adverse Event|2
4409774|NCT00250276|7189500|FG000|Overall Study|Protocol Violation|0
4409775|NCT00250276|7189501|FG001|Overall Study|Protocol Violation|1
4409776|NCT00250276|7189502|FG002|Overall Study|Protocol Violation|0
4409777|NCT00250276|7189503|FG003|Overall Study|Protocol Violation|0
4409778|NCT00250276|7189500|FG000|Overall Study|Withdrawal by Subject|1
4409779|NCT00250276|7189501|FG001|Overall Study|Withdrawal by Subject|2
4409780|NCT00250276|7189502|FG002|Overall Study|Withdrawal by Subject|3
4409781|NCT00250276|7189503|FG003|Overall Study|Withdrawal by Subject|2
4409782|NCT00250276|7189500|FG000|Overall Study|Migrated/moved from study area|3
4409783|NCT00250276|7189501|FG001|Overall Study|Migrated/moved from study area|0
4409784|NCT00250276|7189502|FG002|Overall Study|Migrated/moved from study area|2
4409785|NCT00250276|7189503|FG003|Overall Study|Migrated/moved from study area|7
4409786|NCT00250276|7189500|FG000|Overall Study|Lost to Follow-up|11
4409787|NCT00250276|7189501|FG001|Overall Study|Lost to Follow-up|18
4409788|NCT00250276|7189502|FG002|Overall Study|Lost to Follow-up|13
4409789|NCT00250276|7189503|FG003|Overall Study|Lost to Follow-up|8
4409790|NCT00250432|7189520|FG000|Overall Study|Adverse Event|25
4409791|NCT00250432|7189521|FG001|Overall Study|Adverse Event|29
4409792|NCT00250432|7189520|FG000|Overall Study|Lack of Efficacy|2
4409793|NCT00250432|7189521|FG001|Overall Study|Lack of Efficacy|1
4409794|NCT00250432|7189520|FG000|Overall Study|Lost to Follow-up|6
4409795|NCT00250432|7189521|FG001|Overall Study|Lost to Follow-up|5
4409796|NCT00250432|7189520|FG000|Overall Study|Patient Moved|0
4409797|NCT00250432|7189521|FG001|Overall Study|Patient Moved|1
4409798|NCT00250432|7189520|FG000|Overall Study|Protocol Violation|0
4409799|NCT00250432|7189521|FG001|Overall Study|Protocol Violation|3
4409800|NCT00250432|7189520|FG000|Overall Study|Withdrawal by Subject|6
4409801|NCT00250432|7189521|FG001|Overall Study|Withdrawal by Subject|2
4409802|NCT00250432|7189520|FG000|Overall Study|Pt died out of posttherapy report period|6
4409803|NCT00250432|7189521|FG001|Overall Study|Pt died out of posttherapy report period|5
4409804|NCT00250432|7189520|FG000|Overall Study|Pt was considered untreatable|0
4409805|NCT00250432|7189521|FG001|Overall Study|Pt was considered untreatable|1
4409806|NCT00250588|7189548|FG000|Overall Study|Withdrawal by Subject|3
4409807|NCT00250588|7189549|FG001|Overall Study|Withdrawal by Subject|6
4409808|NCT00250588|7189550|FG002|Overall Study|Withdrawal by Subject|0
4409809|NCT00250588|7189548|FG000|Overall Study|Lost to Follow-up|6
4409810|NCT00250588|7189549|FG001|Overall Study|Lost to Follow-up|13
4409811|NCT00250588|7189550|FG002|Overall Study|Lost to Follow-up|13
4409812|NCT00250679|7189561|FG000|Overall Study|Adverse Event|12
4409813|NCT00250679|7189562|FG001|Overall Study|Adverse Event|15
4409814|NCT00250679|7189563|FG002|Overall Study|Adverse Event|16
4409815|NCT00250679|7189561|FG000|Overall Study|Protocol Violation|2
4409816|NCT00250679|7189562|FG001|Overall Study|Protocol Violation|4
4409817|NCT00250679|7189563|FG002|Overall Study|Protocol Violation|3
4409818|NCT00250679|7189561|FG000|Overall Study|Withdrawal by Subject|15
4409819|NCT00250679|7189562|FG001|Overall Study|Withdrawal by Subject|18
4409820|NCT00250679|7189563|FG002|Overall Study|Withdrawal by Subject|15
4409821|NCT00250679|7189561|FG000|Overall Study|Lost to Follow-up|3
4409822|NCT00250679|7189562|FG001|Overall Study|Lost to Follow-up|4
4409823|NCT00250679|7189563|FG002|Overall Study|Lost to Follow-up|2
4409824|NCT00250679|7189561|FG000|Overall Study|Does Not Meet Entry Criteria|1
4409825|NCT00250679|7189562|FG001|Overall Study|Does Not Meet Entry Criteria|4
4409826|NCT00250679|7189563|FG002|Overall Study|Does Not Meet Entry Criteria|2
4409827|NCT00250679|7189561|FG000|Overall Study|Lack of Efficacy|0
4409828|NCT00250679|7189562|FG001|Overall Study|Lack of Efficacy|1
4409829|NCT00250679|7189563|FG002|Overall Study|Lack of Efficacy|3
4409830|NCT00250679|7189561|FG000|Overall Study|Technical Holter issues|1
4409831|NCT00250679|7189562|FG001|Overall Study|Technical Holter issues|0
4409832|NCT00250679|7189563|FG002|Overall Study|Technical Holter issues|2
4409833|NCT00250679|7189561|FG000|Overall Study|Moved|1
4409834|NCT00250679|7189562|FG001|Overall Study|Moved|1
4409835|NCT00250679|7189563|FG002|Overall Study|Moved|0
4409836|NCT00250679|7189561|FG000|Overall Study|Non-compliance|1
4409837|NCT00250679|7189562|FG001|Overall Study|Non-compliance|1
4409838|NCT00250679|7189563|FG002|Overall Study|Non-compliance|0
4409839|NCT00250679|7189561|FG000|Overall Study|various single events: hip surgery,diary|3
4409840|NCT00250679|7189562|FG001|Overall Study|various single events: hip surgery,diary|1
4409841|NCT00250679|7189563|FG002|Overall Study|various single events: hip surgery,diary|1
4409842|NCT00250705|7189571|FG000|Overall Study|Lack of Efficacy|2
4409843|NCT00250835|7189577|FG000|Overall Study|Withdrawal by Subject|1
4409844|NCT00251004|7189589|FG000|Overall Study|Withdrawal by Subject|23
4409845|NCT00251004|7189590|FG001|Overall Study|Withdrawal by Subject|16
4409846|NCT00251004|7189591|FG002|Overall Study|Withdrawal by Subject|14
4409847|NCT00251004|7189589|FG000|Overall Study|Death|9
4409848|NCT00251004|7189590|FG001|Overall Study|Death|10
4409849|NCT00251004|7189591|FG002|Overall Study|Death|8
4409850|NCT00251004|7189589|FG000|Overall Study|Lost to Follow-up|1
4409851|NCT00251004|7189590|FG001|Overall Study|Lost to Follow-up|2
4409852|NCT00251004|7189591|FG002|Overall Study|Lost to Follow-up|1
4409853|NCT00251004|7189589|FG000|Overall Study|Graft Loss|12
4409854|NCT00251004|7189590|FG001|Overall Study|Graft Loss|13
4409855|NCT00251004|7189591|FG002|Overall Study|Graft Loss|8
4409856|NCT00251316|7189625|FG000|Overall Study|Physician Decision|2
4409857|NCT00251316|7189626|FG001|Overall Study|Physician Decision|3
4409858|NCT00251589|7189636|FG000|Overall Study|Adverse Event|5
4409859|NCT00251589|7189637|FG001|Overall Study|Adverse Event|1
4409860|NCT00251589|7189638|FG002|Overall Study|Adverse Event|2
4409861|NCT00251589|7189639|FG003|Overall Study|Adverse Event|1
4409862|NCT00251589|7189636|FG000|Overall Study|Withdrawal by Subject|1
4409863|NCT00251589|7189637|FG001|Overall Study|Withdrawal by Subject|1
4409864|NCT00251589|7189638|FG002|Overall Study|Withdrawal by Subject|0
4409865|NCT00251589|7189639|FG003|Overall Study|Withdrawal by Subject|0
4409866|NCT00251589|7189636|FG000|Overall Study|Discontinued due to progressive disease|9
4409867|NCT00251589|7189637|FG001|Overall Study|Discontinued due to progressive disease|1
4409868|NCT00251589|7189638|FG002|Overall Study|Discontinued due to progressive disease|0
4409869|NCT00251589|7189639|FG003|Overall Study|Discontinued due to progressive disease|1
4409870|NCT00251641|7189651|FG000|Overall Study|Adverse Event|80
4409871|NCT00251641|7189652|FG001|Overall Study|Adverse Event|8
4409872|NCT00251641|7189651|FG000|Overall Study|Lack of Efficacy|2
4409873|NCT00251641|7189652|FG001|Overall Study|Lack of Efficacy|1
4409874|NCT00251641|7189651|FG000|Overall Study|Progression of Disease|0
4409875|NCT00251641|7189652|FG001|Overall Study|Progression of Disease|2
4409876|NCT00251641|7189651|FG000|Overall Study|Lost to Follow-up|3
4409877|NCT00251641|7189652|FG001|Overall Study|Lost to Follow-up|3
4409878|NCT00251641|7189651|FG000|Overall Study|Withdrawal by Subject|6
4409879|NCT00251641|7189652|FG001|Overall Study|Withdrawal by Subject|8
4409880|NCT00251641|7189651|FG000|Overall Study|Protocol Violation|10
4409881|NCT00251641|7189652|FG001|Overall Study|Protocol Violation|2
4409882|NCT00251641|7189651|FG000|Overall Study|Did not Meet protocol Eligibility|2
4409883|NCT00251641|7189652|FG001|Overall Study|Did not Meet protocol Eligibility|1
4409884|NCT00251641|7189651|FG000|Overall Study|Switched Treatment|9
4409885|NCT00251641|7189652|FG001|Overall Study|Switched Treatment|63
4409886|NCT00251693|7189663|FG000|Overall Study|Adverse Event|17
4409887|NCT00251693|7189664|FG001|Overall Study|Adverse Event|9
4409888|NCT00251693|7189665|FG002|Overall Study|Adverse Event|9
4409889|NCT00251693|7189663|FG000|Overall Study|Protocol Violation|2
4409890|NCT00251693|7189664|FG001|Overall Study|Protocol Violation|0
4409891|NCT00251693|7189665|FG002|Overall Study|Protocol Violation|2
4409892|NCT00251693|7189663|FG000|Overall Study|Lost to Follow-up|12
4409893|NCT00251693|7189664|FG001|Overall Study|Lost to Follow-up|7
4409894|NCT00251693|7189665|FG002|Overall Study|Lost to Follow-up|8
4409895|NCT00251693|7189663|FG000|Overall Study|Withdrawal by Subject|11
4409896|NCT00251693|7189664|FG001|Overall Study|Withdrawal by Subject|17
4409897|NCT00251693|7189665|FG002|Overall Study|Withdrawal by Subject|14
4409898|NCT00251693|7189663|FG000|Overall Study|Lack of Efficacy|0
4409899|NCT00251693|7189664|FG001|Overall Study|Lack of Efficacy|1
4409900|NCT00251693|7189665|FG002|Overall Study|Lack of Efficacy|0
4409901|NCT00251693|7189663|FG000|Overall Study|Inclusion/exclusion criteria not met|5
4409902|NCT00251693|7189664|FG001|Overall Study|Inclusion/exclusion criteria not met|3
4409903|NCT00251693|7189665|FG002|Overall Study|Inclusion/exclusion criteria not met|8
4409904|NCT00251693|7189663|FG000|Overall Study|Noncompliant|0
4409905|NCT00251693|7189664|FG001|Overall Study|Noncompliant|0
4409906|NCT00251693|7189665|FG002|Overall Study|Noncompliant|2
4409907|NCT00251693|7189663|FG000|Overall Study|Possible Barrett's esophagus|3
4409908|NCT00251693|7189664|FG001|Overall Study|Possible Barrett's esophagus|5
4409909|NCT00251693|7189665|FG002|Overall Study|Possible Barrett's esophagus|2
4409910|NCT00251693|7189663|FG000|Overall Study|Subject request/subject unavailable|1
4409911|NCT00251693|7189664|FG001|Overall Study|Subject request/subject unavailable|2
4409912|NCT00251693|7189665|FG002|Overall Study|Subject request/subject unavailable|0
4409913|NCT00251693|7189663|FG000|Overall Study|Abnormal laboratory findings|0
4409914|NCT00251693|7189664|FG001|Overall Study|Abnormal laboratory findings|0
4409915|NCT00251693|7189665|FG002|Overall Study|Abnormal laboratory findings|1
4409916|NCT00251719|7189676|FG000|Overall Study|Adverse Event|14
4409917|NCT00251719|7189677|FG001|Overall Study|Adverse Event|8
4409918|NCT00251719|7189678|FG002|Overall Study|Adverse Event|7
4409919|NCT00251719|7189676|FG000|Overall Study|Protocol Violation|1
4409920|NCT00251719|7189677|FG001|Overall Study|Protocol Violation|1
4409921|NCT00251719|7189678|FG002|Overall Study|Protocol Violation|1
4409922|NCT00251719|7189676|FG000|Overall Study|Lost to Follow-up|5
4409923|NCT00251719|7189677|FG001|Overall Study|Lost to Follow-up|11
4409924|NCT00251719|7189678|FG002|Overall Study|Lost to Follow-up|8
4409925|NCT00251719|7189676|FG000|Overall Study|Withdrawal by Subject|14
4409926|NCT00251719|7189677|FG001|Overall Study|Withdrawal by Subject|12
4409927|NCT00251719|7189678|FG002|Overall Study|Withdrawal by Subject|11
4409928|NCT00251719|7189676|FG000|Overall Study|Lack of Efficacy|2
4409929|NCT00251719|7189677|FG001|Overall Study|Lack of Efficacy|1
4409930|NCT00251719|7189678|FG002|Overall Study|Lack of Efficacy|0
4409931|NCT00251719|7189676|FG000|Overall Study|Inclusion/exclusion criteria not met|12
4409932|NCT00251719|7189677|FG001|Overall Study|Inclusion/exclusion criteria not met|6
4409933|NCT00251719|7189678|FG002|Overall Study|Inclusion/exclusion criteria not met|2
4409934|NCT00251719|7189676|FG000|Overall Study|Investigator decision|1
4409935|NCT00251719|7189677|FG001|Overall Study|Investigator decision|1
4409936|NCT00251719|7189678|FG002|Overall Study|Investigator decision|0
4409937|NCT00251719|7189676|FG000|Overall Study|Noncompliance|2
4409938|NCT00251719|7189677|FG001|Overall Study|Noncompliance|3
4409939|NCT00251719|7189678|FG002|Overall Study|Noncompliance|1
4409940|NCT00251719|7189676|FG000|Overall Study|Barrett's esophagus|2
4409941|NCT00251719|7189677|FG001|Overall Study|Barrett's esophagus|2
4409942|NCT00251719|7189678|FG002|Overall Study|Barrett's esophagus|0
4409943|NCT00251745|7189689|FG000|Overall Study|Adverse Event|7
4409944|NCT00251745|7189690|FG001|Overall Study|Adverse Event|9
4409945|NCT00251745|7189691|FG002|Overall Study|Adverse Event|11
4409946|NCT00251745|7189689|FG000|Overall Study|Lost to Follow-up|4
4409947|NCT00251745|7189690|FG001|Overall Study|Lost to Follow-up|2
4409948|NCT00251745|7189691|FG002|Overall Study|Lost to Follow-up|5
4409949|NCT00251745|7189689|FG000|Overall Study|Withdrawal by Subject|13
4409950|NCT00251745|7189690|FG001|Overall Study|Withdrawal by Subject|7
4409951|NCT00251745|7189691|FG002|Overall Study|Withdrawal by Subject|3
4409952|NCT00251745|7189689|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0
4409953|NCT00251745|7189690|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6
4409954|NCT00251745|7189691|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5
4409955|NCT00251745|7189689|FG000|Overall Study|Lack of Efficacy|3
4409956|NCT00251745|7189690|FG001|Overall Study|Lack of Efficacy|0
4409957|NCT00251745|7189691|FG002|Overall Study|Lack of Efficacy|0
4409958|NCT00251745|7189689|FG000|Overall Study|Noncompliant|0
4409959|NCT00251745|7189690|FG001|Overall Study|Noncompliant|2
4409960|NCT00251745|7189691|FG002|Overall Study|Noncompliant|2
4409961|NCT00251745|7189689|FG000|Overall Study|Pregnancy|0
4409962|NCT00251745|7189690|FG001|Overall Study|Pregnancy|1
4409963|NCT00251745|7189691|FG002|Overall Study|Pregnancy|0
4409964|NCT00251745|7189689|FG000|Overall Study|Per Subject Request|0
4409965|NCT00251745|7189690|FG001|Overall Study|Per Subject Request|0
4409966|NCT00251745|7189691|FG002|Overall Study|Per Subject Request|1
4409967|NCT00251745|7189689|FG000|Overall Study|Per Investigator Request|1
4409968|NCT00251745|7189690|FG001|Overall Study|Per Investigator Request|0
4409969|NCT00251745|7189691|FG002|Overall Study|Per Investigator Request|0
4409970|NCT00251758|7189702|FG000|Overall Study|Adverse Event|7
4409971|NCT00251758|7189703|FG001|Overall Study|Adverse Event|9
4409972|NCT00251758|7189704|FG002|Overall Study|Adverse Event|11
4409973|NCT00251758|7189702|FG000|Overall Study|Lost to Follow-up|4
4409974|NCT00251758|7189703|FG001|Overall Study|Lost to Follow-up|2
4409975|NCT00251758|7189704|FG002|Overall Study|Lost to Follow-up|5
4409976|NCT00251758|7189702|FG000|Overall Study|Withdrawal by Subject|13
4409977|NCT00251758|7189703|FG001|Overall Study|Withdrawal by Subject|7
4409978|NCT00251758|7189704|FG002|Overall Study|Withdrawal by Subject|3
4409979|NCT00251758|7189702|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0
4409980|NCT00251758|7189703|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6
4409981|NCT00251758|7189704|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5
4409982|NCT00251758|7189702|FG000|Overall Study|Lack of Efficacy|3
4409983|NCT00251758|7189703|FG001|Overall Study|Lack of Efficacy|0
4409984|NCT00251758|7189704|FG002|Overall Study|Lack of Efficacy|0
4409985|NCT00251758|7189702|FG000|Overall Study|Noncompliant|0
4409986|NCT00251758|7189703|FG001|Overall Study|Noncompliant|2
4409987|NCT00251758|7189704|FG002|Overall Study|Noncompliant|2
4409988|NCT00251758|7189702|FG000|Overall Study|Pregnancy|0
4409989|NCT00251758|7189703|FG001|Overall Study|Pregnancy|1
4409990|NCT00251758|7189704|FG002|Overall Study|Pregnancy|0
4409991|NCT00251758|7189702|FG000|Overall Study|Per Subject Request|0
4409992|NCT00251758|7189703|FG001|Overall Study|Per Subject Request|0
4409993|NCT00251758|7189704|FG002|Overall Study|Per Subject Request|1
4409994|NCT00251758|7189702|FG000|Overall Study|Per Investigator Request|1
4409995|NCT00251758|7189703|FG001|Overall Study|Per Investigator Request|0
4409996|NCT00251758|7189704|FG002|Overall Study|Per Investigator Request|0
4409997|NCT00251927|7189727|FG000|Overall Study|Adverse Event|3
4409998|NCT00251927|7189728|FG001|Overall Study|Adverse Event|15
4409999|NCT00251927|7189727|FG000|Overall Study|Lack of Efficacy|22
4410000|NCT00251927|7189728|FG001|Overall Study|Lack of Efficacy|16
4410001|NCT00251927|7189727|FG000|Overall Study|Lost to Follow-up|22
4410002|NCT00251927|7189728|FG001|Overall Study|Lost to Follow-up|8
4410003|NCT00251927|7189727|FG000|Overall Study|Protocol Violation|1
4410004|NCT00251927|7189728|FG001|Overall Study|Protocol Violation|2
4410005|NCT00251927|7189727|FG000|Overall Study|Pregnancy|2
4410006|NCT00251927|7189728|FG001|Overall Study|Pregnancy|0
4410007|NCT00251927|7189727|FG000|Overall Study|Withdrawal by Subject|40
4410008|NCT00251927|7189728|FG001|Overall Study|Withdrawal by Subject|25
4410009|NCT00251927|7189727|FG000|Overall Study|Study-specific discont. achieved|13
4410010|NCT00251927|7189728|FG001|Overall Study|Study-specific discont. achieved|2
4410011|NCT00251927|7189727|FG000|Overall Study|Study procedure non-compliance|5
4410012|NCT00251927|7189728|FG001|Overall Study|Study procedure non-compliance|6
4410013|NCT00251979|7189737|FG000|Overall Study|Protocol Violation|3
4410014|NCT00251979|7189738|FG001|Overall Study|Protocol Violation|5
4410015|NCT00251979|7189737|FG000|Overall Study|Adverse Event|11
4410016|NCT00251979|7189738|FG001|Overall Study|Adverse Event|17
4410017|NCT00251979|7189737|FG000|Overall Study|Withdrawal by Subject|13
4410018|NCT00251979|7189738|FG001|Overall Study|Withdrawal by Subject|7
4410019|NCT00251979|7189737|FG000|Overall Study|Lost to Follow-up|8
4410020|NCT00251979|7189738|FG001|Overall Study|Lost to Follow-up|6
4410021|NCT00251979|7189737|FG000|Overall Study|Death|3
4410022|NCT00251979|7189738|FG001|Overall Study|Death|5
4410023|NCT00252057|7189746|FG000|Overall Study|Withdrawal by Subject|2
4410024|NCT00252057|7189747|FG001|Overall Study|Withdrawal by Subject|5
4410025|NCT00252057|7189746|FG000|Overall Study|Death|1
4410026|NCT00252057|7189747|FG001|Overall Study|Death|2
4410027|NCT00252057|7189746|FG000|Overall Study|Participant previously enrolled|0
4410028|NCT00252057|7189747|FG001|Overall Study|Participant previously enrolled|1
4410029|NCT00252187|7189755|FG000|Overall Study|Adverse Event|3
4410030|NCT00252187|7189756|FG001|Overall Study|Adverse Event|1
4410031|NCT00252187|7189755|FG000|Overall Study|Withdrawal by Subject|1
4410032|NCT00252187|7189756|FG001|Overall Study|Withdrawal by Subject|0
4410033|NCT00252239|7189766|FG000|Overall Study|Withdrawal by Subject|1
4410034|NCT00252239|7189767|FG001|Overall Study|Withdrawal by Subject|0
4410035|NCT00252239|7189768|FG002|Overall Study|Withdrawal by Subject|0
4410036|NCT00252239|7189769|FG003|Overall Study|Withdrawal by Subject|1
4410037|NCT00252239|7189766|FG000|Overall Study|Lost to Follow-up|0
4410038|NCT00252239|7189767|FG001|Overall Study|Lost to Follow-up|0
4410039|NCT00252239|7189768|FG002|Overall Study|Lost to Follow-up|2
4410040|NCT00252239|7189769|FG003|Overall Study|Lost to Follow-up|0
4410041|NCT00252499|7189786|FG000|Overall Study|Lost to Follow-up|1
4410042|NCT00252499|7189787|FG001|Overall Study|Lost to Follow-up|0
4410043|NCT00252499|7189788|FG002|Overall Study|Lost to Follow-up|0
4410044|NCT00252564|7189813|FG000|Overall Study|Adverse Event|17
4410045|NCT00252564|7189814|FG001|Overall Study|Adverse Event|13
4410046|NCT00252564|7189813|FG000|Overall Study|Unrelated Complication|2
4410047|NCT00252564|7189814|FG001|Overall Study|Unrelated Complication|1
4410048|NCT00252564|7189813|FG000|Overall Study|Disease Progression|14
4410049|NCT00252564|7189814|FG001|Overall Study|Disease Progression|20
4410050|NCT00252564|7189813|FG000|Overall Study|Death|0
4410051|NCT00252564|7189814|FG001|Overall Study|Death|3
4410052|NCT00252564|7189813|FG000|Overall Study|Physician Decision|1
4410053|NCT00252564|7189814|FG001|Overall Study|Physician Decision|0
4410054|NCT00252564|7189813|FG000|Overall Study|Lost to Follow-up|1
4410055|NCT00252564|7189814|FG001|Overall Study|Lost to Follow-up|0
4410056|NCT00252564|7189813|FG000|Overall Study|Patient Request|4
4410057|NCT00252564|7189814|FG001|Overall Study|Patient Request|5
4410058|NCT00252564|7189813|FG000|Overall Study|Withdrawal by Subject|0
4410059|NCT00252564|7189814|FG001|Overall Study|Withdrawal by Subject|2
4410060|NCT00252577|7189820|FG000|Overall Study|Lost to Follow-up|20
4410061|NCT00252694|7189857|FG000|Overall Study|Withdrawal by Subject|83
4410062|NCT00252694|7189858|FG001|Overall Study|Withdrawal by Subject|91
4410063|NCT00252694|7189857|FG000|Overall Study|Death|36
4410064|NCT00252694|7189858|FG001|Overall Study|Death|34
4410065|NCT00252694|7189857|FG000|Overall Study|Mostly Lost to Follow Up|8
4410066|NCT00252694|7189858|FG001|Overall Study|Mostly Lost to Follow Up|13
4410067|NCT00252694|7189857|FG000|Overall Study|Patient Moving|17
4410068|NCT00252694|7189858|FG001|Overall Study|Patient Moving|16
4410069|NCT00252720|7189866|FG000|Overall Study|Withdrawal by Subject|95
4410070|NCT00252720|7189867|FG001|Overall Study|Withdrawal by Subject|97
4410071|NCT00252720|7189866|FG000|Overall Study|Death|7
4410072|NCT00252720|7189867|FG001|Overall Study|Death|8
4410073|NCT00252720|7189866|FG000|Overall Study|Moving|23
4410074|NCT00252720|7189867|FG001|Overall Study|Moving|42
4410075|NCT00252720|7189866|FG000|Overall Study|Mainly patients lost to follow-up|7
4410076|NCT00252720|7189867|FG001|Overall Study|Mainly patients lost to follow-up|18
4629055|NCT01867710|7496626|FG001|Overall Study|Progressive disease|0
4629056|NCT01867710|7496627|FG002|Overall Study|Progressive disease|0
4629057|NCT01867710|7496628|FG003|Overall Study|Progressive disease|0
4410077|NCT00252733|7189875|FG000|Overall Study|Withdrawal by Subject|73
4410078|NCT00252733|7189876|FG001|Overall Study|Withdrawal by Subject|67
4410079|NCT00252733|7189875|FG000|Overall Study|Death|7
4410080|NCT00252733|7189876|FG001|Overall Study|Death|5
4410081|NCT00252733|7189875|FG000|Overall Study|Lost to Follow-up|12
4410082|NCT00252733|7189876|FG001|Overall Study|Lost to Follow-up|6
4410083|NCT00252733|7189875|FG000|Overall Study|Multiple Reasons|14
4410084|NCT00252733|7189876|FG001|Overall Study|Multiple Reasons|14
4511674|NCT00928434|7321030|FG001|Overall Study|Lost to Follow-up|0
4511675|NCT00928434|7321031|FG002|Overall Study|Lost to Follow-up|3
4511676|NCT00928434|7321029|FG000|Overall Study|Withdrawal by Subject|5
4511677|NCT00928434|7321030|FG001|Overall Study|Withdrawal by Subject|3
4511678|NCT00928434|7321031|FG002|Overall Study|Withdrawal by Subject|2
4511679|NCT00928434|7321029|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10
4511680|NCT00928434|7321030|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4
4511681|NCT00928434|7321031|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7
4511682|NCT00928434|7321029|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2
4511683|NCT00928434|7321030|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1
4511684|NCT00928434|7321031|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1
4511685|NCT00928434|7321029|FG000|Overall Study|Other (not meeting above criteria)|5
4511686|NCT00928434|7321030|FG001|Overall Study|Other (not meeting above criteria)|1
4629058|NCT01867710|7496625|FG000|Overall Study|Protocol Violation|0
4511687|NCT00928434|7321031|FG002|Overall Study|Other (not meeting above criteria)|2
4511688|NCT00928486|7321047|FG000|Overall Study|Adverse Event|2
4511689|NCT00928486|7321047|FG000|Overall Study|Disease Progression|7
4511690|NCT00928486|7321047|FG000|Overall Study|Withdrawal by Subject|1
4511691|NCT00928512|7321056|FG000|Overall Study|Adverse Event|4
4511692|NCT00928512|7321057|FG001|Overall Study|Adverse Event|3
4511693|NCT00928512|7321058|FG002|Overall Study|Adverse Event|2
4629059|NCT01867710|7496626|FG001|Overall Study|Protocol Violation|0
4410085|NCT00253370|7189904|FG000|Overall Study|Adverse Event|18
4410086|NCT00253370|7189904|FG000|Overall Study|Disease progression|13
4410087|NCT00253370|7189904|FG000|Overall Study|Death|2
4410088|NCT00253370|7189904|FG000|Overall Study|Withdrawal by Subject|6
4410089|NCT00253370|7189904|FG000|Overall Study|Non-protocol therapy|1
4410090|NCT00253370|7189904|FG000|Overall Study|Physician Decision|1
4410091|NCT00253370|7189904|FG000|Overall Study|Protocol Violation|1
4410092|NCT00253370|7189904|FG000|Overall Study|Abdominal pain due to disease|1
4410093|NCT00253448|7189918|FG000|Overall Study|Withdrawal by Subject|1
4410094|NCT00253630|7189926|FG000|Overall Study|ineligible|2
4410095|NCT00253643|7189934|FG000|Overall Study|Withdrawal by Subject|0
4410096|NCT00253643|7189935|FG001|Overall Study|Withdrawal by Subject|0
4410097|NCT00253643|7189936|FG002|Overall Study|Withdrawal by Subject|1
4410098|NCT00253643|7189937|FG003|Overall Study|Withdrawal by Subject|1
4410099|NCT00253643|7189934|FG000|Overall Study|Non-Compliance|0
4410100|NCT00253643|7189935|FG001|Overall Study|Non-Compliance|0
4410101|NCT00253643|7189936|FG002|Overall Study|Non-Compliance|0
4410102|NCT00253643|7189937|FG003|Overall Study|Non-Compliance|2
4410103|NCT00253747|7189962|FG000|Overall Study|Lost to Follow-up|13
4410104|NCT00253747|7189963|FG001|Overall Study|Lost to Follow-up|14
4410105|NCT00253747|7189962|FG000|Overall Study|Withdrawal by Subject|10
4410106|NCT00253747|7189963|FG001|Overall Study|Withdrawal by Subject|11
4410107|NCT00253747|7189962|FG000|Overall Study|Administrative Discharge (1), Other (2)|1
4410108|NCT00253747|7189963|FG001|Overall Study|Administrative Discharge (1), Other (2)|2
4410109|NCT00254163|7189999|FG000|Overall Study|Adverse Event|29
4410110|NCT00254163|7190000|FG001|Overall Study|Adverse Event|26
4410111|NCT00254163|7189999|FG000|Overall Study|Patient request/withdrew consent|6
4410112|NCT00254163|7190000|FG001|Overall Study|Patient request/withdrew consent|4
4410113|NCT00254163|7189999|FG000|Overall Study|Investigator request|1
4410114|NCT00254163|7190000|FG001|Overall Study|Investigator request|3
4410115|NCT00254163|7189999|FG000|Overall Study|Failed entry|1
4410116|NCT00254163|7190000|FG001|Overall Study|Failed entry|3
4410117|NCT00254163|7189999|FG000|Overall Study|Progressive disease|0
4410118|NCT00254163|7190000|FG001|Overall Study|Progressive disease|1
4410119|NCT00254163|7189999|FG000|Overall Study|Death|0
4410120|NCT00254163|7190000|FG001|Overall Study|Death|1
4410121|NCT00254163|7189999|FG000|Overall Study|Other|8
4410122|NCT00254163|7190000|FG001|Overall Study|Other|8
4410123|NCT00254293|7190012|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0
4410124|NCT00254293|7190013|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1
4410125|NCT00254293|7190014|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0
4410126|NCT00254293|7190015|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1
4410127|NCT00254293|7190016|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0
4410128|NCT00254293|7190017|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0
4410129|NCT00254293|7190018|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0
4410130|NCT00254293|7190012|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
4410131|NCT00254293|7190013|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
4410132|NCT00254293|7190014|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1
4410133|NCT00254293|7190015|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
4410134|NCT00254293|7190016|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
4410135|NCT00254293|7190017|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
4410136|NCT00254293|7190018|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
4410137|NCT00254293|7190012|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
4410138|NCT00254293|7190013|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
4410139|NCT00254293|7190014|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2
4410140|NCT00254293|7190015|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
4410141|NCT00254293|7190016|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
4410142|NCT00254293|7190017|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
4410143|NCT00254293|7190018|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
4410144|NCT00254293|7190012|FG000|LTE Open Label Variable SC Dosing|Death|0
4410145|NCT00254293|7190013|FG001|LTE Open Label Variable SC Dosing|Death|0
4410146|NCT00254293|7190014|FG002|LTE Open Label Variable SC Dosing|Death|1
4410147|NCT00254293|7190015|FG003|LTE Open Label Variable SC Dosing|Death|0
4410148|NCT00254293|7190016|FG004|LTE Open Label Variable SC Dosing|Death|0
4410149|NCT00254293|7190017|FG005|LTE Open Label Variable SC Dosing|Death|0
4410150|NCT00254293|7190018|FG006|LTE Open Label Variable SC Dosing|Death|0
4410151|NCT00254293|7190012|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1
4410152|NCT00254293|7190013|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0
4410153|NCT00254293|7190014|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2
4410154|NCT00254293|7190015|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0
4410155|NCT00254293|7190016|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1
4410156|NCT00254293|7190017|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0
4410157|NCT00254293|7190018|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0
4410158|NCT00254293|7190012|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2
4410159|NCT00254293|7190013|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
4410160|NCT00254293|7190014|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2
4410161|NCT00254293|7190015|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
4713666|NCT02951780|7641475|FG000|Period 1|Scheduling Conflicts|0
4713667|NCT02951780|7641476|FG001|Period 1|Scheduling Conflicts|0
4713668|NCT02951780|7641477|FG002|Period 1|Scheduling Conflicts|0
4410162|NCT00254293|7190016|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1
4410163|NCT00254293|7190017|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
4410164|NCT00254293|7190018|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
4410165|NCT00254293|7190012|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
4410166|NCT00254293|7190013|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
4410167|NCT00254293|7190014|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1
4410168|NCT00254293|7190015|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
4410169|NCT00254293|7190016|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
4410170|NCT00254293|7190017|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
4410171|NCT00254293|7190018|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
4410172|NCT00254293|7190012|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
4410173|NCT00254293|7190013|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
4410174|NCT00254293|7190014|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1
4410175|NCT00254293|7190015|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
4410176|NCT00254293|7190016|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
4410177|NCT00254293|7190017|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
4410178|NCT00254293|7190018|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
4410179|NCT00254293|7190012|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
4410180|NCT00254293|7190013|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
4410181|NCT00254293|7190014|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1
4410182|NCT00254293|7190015|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
4410183|NCT00254293|7190016|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
4410184|NCT00254293|7190017|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
4410185|NCT00254293|7190018|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
4410186|NCT00254293|7190012|FG000|LTE Open Label Variable SC Dosing|Other|0
4410187|NCT00254293|7190013|FG001|LTE Open Label Variable SC Dosing|Other|0
4410188|NCT00254293|7190014|FG002|LTE Open Label Variable SC Dosing|Other|2
4410189|NCT00254293|7190015|FG003|LTE Open Label Variable SC Dosing|Other|0
4410190|NCT00254293|7190016|FG004|LTE Open Label Variable SC Dosing|Other|0
4410191|NCT00254293|7190017|FG005|LTE Open Label Variable SC Dosing|Other|0
4410192|NCT00254293|7190018|FG006|LTE Open Label Variable SC Dosing|Other|0
4410193|NCT00254293|7190012|FG000|LTE Open Label Fixed Dosing|Death|0
4410194|NCT00254293|7190013|FG001|LTE Open Label Fixed Dosing|Death|0
4410195|NCT00254293|7190014|FG002|LTE Open Label Fixed Dosing|Death|0
4410196|NCT00254293|7190015|FG003|LTE Open Label Fixed Dosing|Death|0
4410197|NCT00254293|7190016|FG004|LTE Open Label Fixed Dosing|Death|0
4410198|NCT00254293|7190017|FG005|LTE Open Label Fixed Dosing|Death|0
4410199|NCT00254293|7190018|FG006|LTE Open Label Fixed Dosing|Death|3
4410200|NCT00254293|7190012|FG000|LTE Open Label Fixed Dosing|Adverse Event|0
4410201|NCT00254293|7190013|FG001|LTE Open Label Fixed Dosing|Adverse Event|0
4410202|NCT00254293|7190014|FG002|LTE Open Label Fixed Dosing|Adverse Event|0
4410203|NCT00254293|7190015|FG003|LTE Open Label Fixed Dosing|Adverse Event|0
4410204|NCT00254293|7190016|FG004|LTE Open Label Fixed Dosing|Adverse Event|0
4410205|NCT00254293|7190017|FG005|LTE Open Label Fixed Dosing|Adverse Event|0
4410206|NCT00254293|7190018|FG006|LTE Open Label Fixed Dosing|Adverse Event|1
4410207|NCT00254293|7190012|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0
4410208|NCT00254293|7190013|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0
4410209|NCT00254293|7190014|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0
4410210|NCT00254293|7190015|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0
4410211|NCT00254293|7190016|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0
4410212|NCT00254293|7190017|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0
4410213|NCT00254293|7190018|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3
4410214|NCT00254293|7190012|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0
4410215|NCT00254293|7190013|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0
4410216|NCT00254293|7190014|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0
4410217|NCT00254293|7190015|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0
4410218|NCT00254293|7190016|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0
4410219|NCT00254293|7190017|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0
4410220|NCT00254293|7190018|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1
4410221|NCT00254293|7190012|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
4410222|NCT00254293|7190013|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
4410223|NCT00254293|7190014|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
4410224|NCT00254293|7190015|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
4410225|NCT00254293|7190016|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
4410226|NCT00254293|7190017|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
4410227|NCT00254293|7190018|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3
4410228|NCT00254293|7190012|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0
4410229|NCT00254293|7190013|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0
4410230|NCT00254293|7190014|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0
4410231|NCT00254293|7190015|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0
4410232|NCT00254293|7190016|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0
4410233|NCT00254293|7190017|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0
4410234|NCT00254293|7190018|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1
4410235|NCT00254293|7190012|FG000|LTE Open Label Fixed Dosing|Other|0
4410236|NCT00254293|7190013|FG001|LTE Open Label Fixed Dosing|Other|0
4410237|NCT00254293|7190014|FG002|LTE Open Label Fixed Dosing|Other|0
4410238|NCT00254293|7190015|FG003|LTE Open Label Fixed Dosing|Other|0
4410239|NCT00254293|7190016|FG004|LTE Open Label Fixed Dosing|Other|0
4410240|NCT00254293|7190017|FG005|LTE Open Label Fixed Dosing|Other|0
4410241|NCT00254293|7190018|FG006|LTE Open Label Fixed Dosing|Other|1
4410242|NCT00254397|7190065|FG000|Overall Study|Disease Progression|4
4410243|NCT00254397|7190066|FG001|Overall Study|Disease Progression|1
4410244|NCT00254397|7190067|FG002|Overall Study|Disease Progression|16
4410245|NCT00254397|7190068|FG003|Overall Study|Disease Progression|23
4410246|NCT00254397|7190065|FG000|Overall Study|Non-Compliant|0
4629060|NCT01867710|7496627|FG002|Overall Study|Protocol Violation|0
4629061|NCT01867710|7496628|FG003|Overall Study|Protocol Violation|1
4629062|NCT01867710|7496625|FG000|Overall Study|PSA-progression|0
4629063|NCT01867710|7496626|FG001|Overall Study|PSA-progression|1
4410247|NCT00254397|7190066|FG001|Overall Study|Non-Compliant|0
4410248|NCT00254397|7190067|FG002|Overall Study|Non-Compliant|0
4410249|NCT00254397|7190068|FG003|Overall Study|Non-Compliant|1
4410250|NCT00254397|7190065|FG000|Overall Study|Adverse Event|2
4410251|NCT00254397|7190066|FG001|Overall Study|Adverse Event|0
4410252|NCT00254397|7190067|FG002|Overall Study|Adverse Event|3
4629064|NCT01867710|7496627|FG002|Overall Study|PSA-progression|0
4629065|NCT01867710|7496628|FG003|Overall Study|PSA-progression|0
4629066|NCT01867710|7496625|FG000|Overall Study|Study medication no longer effective|0
4629067|NCT01867710|7496626|FG001|Overall Study|Study medication no longer effective|1
4629068|NCT01867710|7496627|FG002|Overall Study|Study medication no longer effective|0
4629069|NCT01867710|7496628|FG003|Overall Study|Study medication no longer effective|0
4629070|NCT01868009|7496638|FG000|Period 1 (5-9 Days)|Adverse Event|0
4629071|NCT01868009|7496639|FG001|Period 1 (5-9 Days)|Adverse Event|2
4629072|NCT01868009|7496638|FG000|Period 2 (5-9 Days)|Adverse Event|1
4629073|NCT01868009|7496639|FG001|Period 2 (5-9 Days)|Adverse Event|0
4629074|NCT01868009|7496638|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1
4629075|NCT01868009|7496639|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0
4629076|NCT01868022|7496654|FG000|Overall Study|Withdrawal by Subject|0
4410253|NCT00254397|7190068|FG003|Overall Study|Adverse Event|1
4410254|NCT00254501|7190103|FG000|Overall Study|Lost to Follow-up|1
4410255|NCT00254501|7190104|FG001|Overall Study|Lost to Follow-up|1
4410256|NCT00254540|7190114|FG000|Overall Study|Adverse Event|6
4410257|NCT00254540|7190115|FG001|Overall Study|Adverse Event|7
4410258|NCT00254540|7190114|FG000|Overall Study|Lack of Efficacy|13
4410259|NCT00254540|7190115|FG001|Overall Study|Lack of Efficacy|13
4410260|NCT00254540|7190114|FG000|Overall Study|Death|0
4410261|NCT00254540|7190115|FG001|Overall Study|Death|1
4410262|NCT00254540|7190114|FG000|Overall Study|Laboratory Test Abnormality|0
4410263|NCT00254540|7190115|FG001|Overall Study|Laboratory Test Abnormality|1
4410264|NCT00254566|7190124|FG000|Overall Study|Death|1
4410265|NCT00254566|7190125|FG001|Overall Study|Death|0
4410266|NCT00254566|7190124|FG000|Overall Study|Adverse Event|5
4410267|NCT00254566|7190125|FG001|Overall Study|Adverse Event|4
4410268|NCT00254566|7190124|FG000|Overall Study|Lack of Efficacy|12
4410269|NCT00254566|7190125|FG001|Overall Study|Lack of Efficacy|9
4410270|NCT00254566|7190124|FG000|Overall Study|Other|1
4410271|NCT00254566|7190125|FG001|Overall Study|Other|5
4410272|NCT00254566|7190124|FG000|Overall Study|Withdrawal by Subject|5
4410273|NCT00254566|7190125|FG001|Overall Study|Withdrawal by Subject|6
4410274|NCT00254566|7190124|FG000|Overall Study|Lost to Follow-up|7
4410275|NCT00254566|7190125|FG001|Overall Study|Lost to Follow-up|2
4410276|NCT00254982|7190137|FG000|Overall Study|Other|2
4410277|NCT00254982|7190138|FG001|Overall Study|Other|1
4410278|NCT00254982|7190137|FG000|Overall Study|Lack of Efficacy|5
4410279|NCT00254982|7190138|FG001|Overall Study|Lack of Efficacy|3
4410280|NCT00254982|7190137|FG000|Overall Study|Lost to Follow-up|5
4410281|NCT00254982|7190138|FG001|Overall Study|Lost to Follow-up|3
4410282|NCT00254982|7190137|FG000|Overall Study|Adverse Event|18
4410283|NCT00254982|7190138|FG001|Overall Study|Adverse Event|16
4410284|NCT00254982|7190137|FG000|Overall Study|Withdrawal by Subject|1
4410285|NCT00254982|7190138|FG001|Overall Study|Withdrawal by Subject|1
4410286|NCT00254982|7190137|FG000|Overall Study|Inclusion/exclusion criteria violation|0
4410287|NCT00254982|7190138|FG001|Overall Study|Inclusion/exclusion criteria violation|2
4410288|NCT00254982|7190137|FG000|Overall Study|Protocol deviation|1
4410289|NCT00254982|7190138|FG001|Overall Study|Protocol deviation|1
4410290|NCT00254982|7190137|FG000|Overall Study|Diagnosis of Tuberculosis|1
4410291|NCT00254982|7190138|FG001|Overall Study|Diagnosis of Tuberculosis|1
4410292|NCT00254982|7190137|FG000|Overall Study|Malignancy|0
4410293|NCT00254982|7190138|FG001|Overall Study|Malignancy|2
4410294|NCT00254982|7190137|FG000|Overall Study|Opportunistic infection|1
4410295|NCT00254982|7190138|FG001|Overall Study|Opportunistic infection|0
4410296|NCT00254982|7190137|FG000|Overall Study|Abnormal liver function tests|2
4410297|NCT00254982|7190138|FG001|Overall Study|Abnormal liver function tests|1
4410298|NCT00255008|7190159|FG000|Overall Study|Adverse Event|1
4410299|NCT00255008|7190160|FG001|Overall Study|Adverse Event|1
4410300|NCT00255008|7190161|FG002|Overall Study|Adverse Event|2
4410301|NCT00255008|7190162|FG003|Overall Study|Adverse Event|0
4410302|NCT00255008|7190159|FG000|Overall Study|Lost to Follow-up|1
4410303|NCT00255008|7190160|FG001|Overall Study|Lost to Follow-up|0
4410304|NCT00255008|7190161|FG002|Overall Study|Lost to Follow-up|1
4410305|NCT00255008|7190162|FG003|Overall Study|Lost to Follow-up|2
4410306|NCT00255008|7190159|FG000|Overall Study|Did not meet viral reduction criteria|4
4410307|NCT00255008|7190160|FG001|Overall Study|Did not meet viral reduction criteria|5
4410308|NCT00255008|7190161|FG002|Overall Study|Did not meet viral reduction criteria|0
4410309|NCT00255008|7190162|FG003|Overall Study|Did not meet viral reduction criteria|1
4410310|NCT00255008|7190159|FG000|Overall Study|Withdrew consent|0
4410311|NCT00255008|7190160|FG001|Overall Study|Withdrew consent|0
4410312|NCT00255008|7190161|FG002|Overall Study|Withdrew consent|2
4410313|NCT00255008|7190162|FG003|Overall Study|Withdrew consent|0
4410314|NCT00255008|7190159|FG000|Overall Study|Sponsor request|18
4410315|NCT00255008|7190160|FG001|Overall Study|Sponsor request|3
4410316|NCT00255008|7190161|FG002|Overall Study|Sponsor request|8
4410317|NCT00255008|7190162|FG003|Overall Study|Sponsor request|17
4410318|NCT00255008|7190159|FG000|Overall Study|Adverse lab experience|1
4410319|NCT00255008|7190160|FG001|Overall Study|Adverse lab experience|0
4410320|NCT00255008|7190161|FG002|Overall Study|Adverse lab experience|0
4410321|NCT00255008|7190162|FG003|Overall Study|Adverse lab experience|0
4410322|NCT00255008|7190159|FG000|Overall Study|Other|7
4410323|NCT00255008|7190160|FG001|Overall Study|Other|0
4410324|NCT00255008|7190161|FG002|Overall Study|Other|3
4410325|NCT00255008|7190162|FG003|Overall Study|Other|2
4410326|NCT00255034|7190174|FG000|Overall Study|Withdrawal by Subject|15
4410327|NCT00255034|7190175|FG001|Overall Study|Withdrawal by Subject|38
4410328|NCT00255047|7190185|FG000|Overall Study|Serious Adverse Events|2
4410329|NCT00255047|7190186|FG001|Overall Study|Serious Adverse Events|1
4410330|NCT00255047|7190187|FG002|Overall Study|Serious Adverse Events|2
4410331|NCT00255047|7190188|FG003|Overall Study|Serious Adverse Events|1
4410332|NCT00255047|7190185|FG000|Overall Study|Adverse Event|0
4410333|NCT00255047|7190186|FG001|Overall Study|Adverse Event|3
4410334|NCT00255047|7190187|FG002|Overall Study|Adverse Event|2
4410335|NCT00255047|7190188|FG003|Overall Study|Adverse Event|1
4410336|NCT00255047|7190185|FG000|Overall Study|Protocol Violation|13
4410337|NCT00255047|7190186|FG001|Overall Study|Protocol Violation|13
4410338|NCT00255047|7190187|FG002|Overall Study|Protocol Violation|16
4410339|NCT00255047|7190188|FG003|Overall Study|Protocol Violation|20
4410340|NCT00255047|7190185|FG000|Overall Study|Lost to Follow-up|9
4410341|NCT00255047|7190186|FG001|Overall Study|Lost to Follow-up|8
4410342|NCT00255047|7190187|FG002|Overall Study|Lost to Follow-up|5
4410343|NCT00255047|7190188|FG003|Overall Study|Lost to Follow-up|6
4410344|NCT00255047|7190185|FG000|Overall Study|Withdrawal by Subject|24
4410345|NCT00255047|7190186|FG001|Overall Study|Withdrawal by Subject|23
4410346|NCT00255047|7190187|FG002|Overall Study|Withdrawal by Subject|25
4410347|NCT00255047|7190188|FG003|Overall Study|Withdrawal by Subject|18
4410348|NCT00255086|7190200|FG000|Overall Study|Adverse Event|1
4410349|NCT00255086|7190201|FG001|Overall Study|Adverse Event|1
4410350|NCT00255086|7190200|FG000|Overall Study|Protocol Violation|1
4410351|NCT00255086|7190201|FG001|Overall Study|Protocol Violation|1
4410352|NCT00255151|7190222|FG000|Overall Study|Adverse Event|10
4410353|NCT00255151|7190223|FG001|Overall Study|Adverse Event|6
4410354|NCT00255151|7190224|FG002|Overall Study|Adverse Event|9
4410355|NCT00255151|7190222|FG000|Overall Study|Lost to Follow-up|4
4410356|NCT00255151|7190223|FG001|Overall Study|Lost to Follow-up|3
4410357|NCT00255151|7190224|FG002|Overall Study|Lost to Follow-up|4
4410358|NCT00255151|7190222|FG000|Overall Study|Withdrawal by Subject|18
4410359|NCT00255151|7190223|FG001|Overall Study|Withdrawal by Subject|17
4410360|NCT00255151|7190224|FG002|Overall Study|Withdrawal by Subject|8
4410361|NCT00255151|7190222|FG000|Overall Study|Noncompliance|0
4410362|NCT00255151|7190223|FG001|Overall Study|Noncompliance|1
4410363|NCT00255151|7190224|FG002|Overall Study|Noncompliance|2
4410364|NCT00255151|7190222|FG000|Overall Study|Subject Request/Subject Unavailable|1
4410365|NCT00255151|7190223|FG001|Overall Study|Subject Request/Subject Unavailable|1
4410366|NCT00255151|7190224|FG002|Overall Study|Subject Request/Subject Unavailable|2
4410367|NCT00255151|7190222|FG000|Overall Study|Relapse of Erosive Esophagitis|78
4410368|NCT00255151|7190223|FG001|Overall Study|Relapse of Erosive Esophagitis|16
4410369|NCT00255151|7190224|FG002|Overall Study|Relapse of Erosive Esophagitis|12
4410370|NCT00255151|7190222|FG000|Overall Study|Possible Barrett's Esophagus|1
4629077|NCT01868022|7496655|FG001|Overall Study|Withdrawal by Subject|0
4410371|NCT00255151|7190223|FG001|Overall Study|Possible Barrett's Esophagus|3
4410372|NCT00255151|7190224|FG002|Overall Study|Possible Barrett's Esophagus|8
4410373|NCT00255151|7190222|FG000|Overall Study|Esophageal Stricture|0
4410374|NCT00255151|7190223|FG001|Overall Study|Esophageal Stricture|0
4410375|NCT00255151|7190224|FG002|Overall Study|Esophageal Stricture|1
4410376|NCT00255151|7190222|FG000|Overall Study|Therapeutic Failure|11
4410377|NCT00255151|7190223|FG001|Overall Study|Therapeutic Failure|2
4410378|NCT00255151|7190224|FG002|Overall Study|Therapeutic Failure|3
4410379|NCT00255164|7190235|FG000|Overall Study|Adverse Event|10
4410380|NCT00255164|7190236|FG001|Overall Study|Adverse Event|6
4410381|NCT00255164|7190237|FG002|Overall Study|Adverse Event|9
4410382|NCT00255164|7190235|FG000|Overall Study|Lost to Follow-up|4
4410383|NCT00255164|7190236|FG001|Overall Study|Lost to Follow-up|3
4410384|NCT00255164|7190237|FG002|Overall Study|Lost to Follow-up|4
4713669|NCT02951780|7641478|FG003|Period 1|Scheduling Conflicts|0
4713670|NCT02951780|7641479|FG004|Period 1|Scheduling Conflicts|0
4713671|NCT02951780|7641480|FG005|Period 1|Scheduling Conflicts|0
4410385|NCT00255164|7190235|FG000|Overall Study|Withdrawal by Subject|18
4410386|NCT00255164|7190236|FG001|Overall Study|Withdrawal by Subject|17
4410387|NCT00255164|7190237|FG002|Overall Study|Withdrawal by Subject|8
4410388|NCT00255164|7190235|FG000|Overall Study|Noncompliance|0
4410389|NCT00255164|7190236|FG001|Overall Study|Noncompliance|1
4410390|NCT00255164|7190237|FG002|Overall Study|Noncompliance|2
4410391|NCT00255164|7190235|FG000|Overall Study|Subject Request/Subject Unavailable|1
4410392|NCT00255164|7190236|FG001|Overall Study|Subject Request/Subject Unavailable|1
4410393|NCT00255164|7190237|FG002|Overall Study|Subject Request/Subject Unavailable|2
4410394|NCT00255164|7190235|FG000|Overall Study|Relapse of Erosive Esophagitis|78
4410395|NCT00255164|7190236|FG001|Overall Study|Relapse of Erosive Esophagitis|16
4410396|NCT00255164|7190237|FG002|Overall Study|Relapse of Erosive Esophagitis|12
4410397|NCT00255164|7190235|FG000|Overall Study|Possible Barrett's Esophagus|1
4410398|NCT00255164|7190236|FG001|Overall Study|Possible Barrett's Esophagus|3
4410399|NCT00255164|7190237|FG002|Overall Study|Possible Barrett's Esophagus|8
4410400|NCT00255164|7190235|FG000|Overall Study|Esophageal Stricture|0
4410401|NCT00255164|7190236|FG001|Overall Study|Esophageal Stricture|0
4410402|NCT00255164|7190237|FG002|Overall Study|Esophageal Stricture|1
4410403|NCT00255164|7190235|FG000|Overall Study|Therapeutic Failure|11
4410404|NCT00255164|7190236|FG001|Overall Study|Therapeutic Failure|2
4410405|NCT00255164|7190237|FG002|Overall Study|Therapeutic Failure|3
4410406|NCT00255190|7190264|FG000|Overall Study|Adverse Event|17
4410407|NCT00255190|7190265|FG001|Overall Study|Adverse Event|36
4410408|NCT00255190|7190264|FG000|Overall Study|Protocol Violation|2
4410409|NCT00255190|7190265|FG001|Overall Study|Protocol Violation|2
4410410|NCT00255190|7190264|FG000|Overall Study|Lost to Follow-up|10
4410411|NCT00255190|7190265|FG001|Overall Study|Lost to Follow-up|27
4410412|NCT00255190|7190264|FG000|Overall Study|Withdrew Consent|17
4410413|NCT00255190|7190265|FG001|Overall Study|Withdrew Consent|48
4410414|NCT00255190|7190264|FG000|Overall Study|Inclusion/Exclusion criteria not met|0
4410415|NCT00255190|7190265|FG001|Overall Study|Inclusion/Exclusion criteria not met|1
4410416|NCT00255190|7190264|FG000|Overall Study|Erosive esophagitis not healed|0
4410417|NCT00255190|7190265|FG001|Overall Study|Erosive esophagitis not healed|20
4410418|NCT00255190|7190264|FG000|Overall Study|Various|4
4410419|NCT00255190|7190265|FG001|Overall Study|Various|23
4410420|NCT00255346|7190276|FG000|Overall Study|Adverse Event|1
4410421|NCT00255346|7190277|FG001|Overall Study|Adverse Event|0
4410422|NCT00255346|7190278|FG002|Overall Study|Adverse Event|0
4410423|NCT00255346|7190279|FG003|Overall Study|Adverse Event|0
4410424|NCT00255346|7190280|FG004|Overall Study|Adverse Event|0
4410425|NCT00255723|7190294|FG000|Overall Study|Adverse Event|1
4410426|NCT00255723|7190295|FG001|Overall Study|Adverse Event|1
4410427|NCT00255723|7190294|FG000|Overall Study|Death|0
4410428|NCT00255723|7190295|FG001|Overall Study|Death|1
4410429|NCT00255723|7190294|FG000|Overall Study|Response Data Not Available|1
4410430|NCT00255723|7190295|FG001|Overall Study|Response Data Not Available|0
4410431|NCT00255840|7190307|FG000|Overall Study|Lost to Follow-up|10
4410432|NCT00255840|7190308|FG001|Overall Study|Lost to Follow-up|14
4410433|NCT00255840|7190307|FG000|Overall Study|Discontinued intervention|53
4410434|NCT00255840|7190308|FG001|Overall Study|Discontinued intervention|56
4410435|NCT00255944|7190316|FG000|Overall Study|Lost to Follow-up|797
4410436|NCT00255944|7190317|FG001|Overall Study|Lost to Follow-up|834
4410437|NCT00256126|7190334|FG000|Overall Study|Adverse Event|1
4410438|NCT00256126|7190335|FG001|Overall Study|Adverse Event|0
4410439|NCT00256126|7190334|FG000|Overall Study|Other|1
4410440|NCT00256126|7190335|FG001|Overall Study|Other|2
4410441|NCT00256204|7190345|FG000|Overall Study|Adverse Event|10
4410442|NCT00256204|7190346|FG001|Overall Study|Adverse Event|14
4410443|NCT00256204|7190347|FG002|Overall Study|Adverse Event|16
4410444|NCT00256204|7190348|FG003|Overall Study|Adverse Event|14
4410445|NCT00256204|7190345|FG000|Overall Study|Death|0
4410446|NCT00256204|7190346|FG001|Overall Study|Death|1
4410447|NCT00256204|7190347|FG002|Overall Study|Death|0
4410448|NCT00256204|7190348|FG003|Overall Study|Death|0
4410449|NCT00256204|7190345|FG000|Overall Study|Lost to Follow-up|1
4410450|NCT00256204|7190346|FG001|Overall Study|Lost to Follow-up|1
4410451|NCT00256204|7190347|FG002|Overall Study|Lost to Follow-up|1
4410452|NCT00256204|7190348|FG003|Overall Study|Lost to Follow-up|2
4410453|NCT00256204|7190345|FG000|Overall Study|Protocol Violation|1
4410454|NCT00256204|7190346|FG001|Overall Study|Protocol Violation|0
4410455|NCT00256204|7190347|FG002|Overall Study|Protocol Violation|2
4410456|NCT00256204|7190348|FG003|Overall Study|Protocol Violation|1
4410457|NCT00256204|7190345|FG000|Overall Study|Physician Decision|0
4410458|NCT00256204|7190346|FG001|Overall Study|Physician Decision|0
4410459|NCT00256204|7190347|FG002|Overall Study|Physician Decision|1
4410460|NCT00256204|7190348|FG003|Overall Study|Physician Decision|2
4410461|NCT00256204|7190345|FG000|Overall Study|Withdrawal by Subject|17
4713672|NCT02951780|7641481|FG006|Period 1|Scheduling Conflicts|0
4410462|NCT00256204|7190346|FG001|Overall Study|Withdrawal by Subject|6
4410463|NCT00256204|7190347|FG002|Overall Study|Withdrawal by Subject|7
4410464|NCT00256204|7190348|FG003|Overall Study|Withdrawal by Subject|5
4410465|NCT00256204|7190345|FG000|Overall Study|Need for additional prohibited treatment|38
4410466|NCT00256204|7190346|FG001|Overall Study|Need for additional prohibited treatment|28
4410467|NCT00256204|7190347|FG002|Overall Study|Need for additional prohibited treatment|27
4410468|NCT00256204|7190348|FG003|Overall Study|Need for additional prohibited treatment|25
4410469|NCT00256243|7190365|FG000|Overall Study|Lost to Follow-up|2
4410470|NCT00256243|7190365|FG000|Overall Study|Death|7
4410471|NCT00256243|7190365|FG000|Overall Study|Not treated|1
4410472|NCT00256282|7190370|FG000|Overall Study|Disease progression, relapse during acti|12
4410473|NCT00256282|7190370|FG000|Overall Study|Adverse Event|3
4410474|NCT00256282|7190370|FG000|Overall Study|Physician Decision|1
4410475|NCT00256308|7190374|FG000|Overall Study|Death|2
4410476|NCT00256698|7190393|FG000|Overall Study|Withdrawal by Subject|7
4410477|NCT00256698|7190394|FG001|Overall Study|Withdrawal by Subject|7
4410478|NCT00256698|7190393|FG000|Overall Study|Adverse Event|13
4410479|NCT00256698|7190394|FG001|Overall Study|Adverse Event|6
4410480|NCT00256698|7190393|FG000|Overall Study|Protocol Violation|6
4410481|NCT00256698|7190394|FG001|Overall Study|Protocol Violation|5
4410482|NCT00256698|7190393|FG000|Overall Study|Lost to Follow-up|1
4410483|NCT00256698|7190394|FG001|Overall Study|Lost to Follow-up|3
4410484|NCT00256698|7190393|FG000|Overall Study|disease progression|97
4410485|NCT00256698|7190394|FG001|Overall Study|disease progression|105
4410486|NCT00256698|7190393|FG000|Overall Study|still ongoing at data cut-off|41
4410487|NCT00256698|7190394|FG001|Overall Study|still ongoing at data cut-off|46
4410488|NCT00256698|7190393|FG000|Overall Study|withdrawn due to osteoporosis|1
4410489|NCT00256698|7190394|FG001|Overall Study|withdrawn due to osteoporosis|0
4410490|NCT00256698|7190393|FG000|Overall Study|Prematurely Discontinued|1
4410491|NCT00256698|7190394|FG001|Overall Study|Prematurely Discontinued|0
4410492|NCT00256724|7190402|FG000|Overall Study|Physician Decision|2
4410493|NCT00256724|7190403|FG001|Overall Study|Physician Decision|5
4410494|NCT00256724|7190402|FG000|Overall Study|Protocol Violation|3
4410495|NCT00256724|7190403|FG001|Overall Study|Protocol Violation|3
4410496|NCT00256750|7190412|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3
4410497|NCT00256750|7190413|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0
4410498|NCT00256750|7190414|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0
4410499|NCT00256750|7190412|FG000|Transplanted Pre-Treatment|Other|2
4410500|NCT00256750|7190413|FG001|Transplanted Pre-Treatment|Other|0
4410501|NCT00256750|7190414|FG002|Transplanted Pre-Treatment|Other|0
4410502|NCT00256750|7190412|FG000|Transplanted Pre-Treatment|Death|1
4410503|NCT00256750|7190413|FG001|Transplanted Pre-Treatment|Death|0
4410504|NCT00256750|7190414|FG002|Transplanted Pre-Treatment|Death|0
4410505|NCT00256750|7190412|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20
4410506|NCT00256750|7190413|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12
4410507|NCT00256750|7190414|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8
4410508|NCT00256750|7190412|FG000|Post-Transplant Treated (12 Months)|Death|3
4410509|NCT00256750|7190413|FG001|Post-Transplant Treated (12 Months)|Death|2
4410510|NCT00256750|7190414|FG002|Post-Transplant Treated (12 Months)|Death|4
4410511|NCT00256750|7190412|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10
4410512|NCT00256750|7190413|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22
4410513|NCT00256750|7190414|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27
4410514|NCT00256750|7190412|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1
4410515|NCT00256750|7190413|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0
4410516|NCT00256750|7190414|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0
4410517|NCT00256750|7190412|FG000|Post-Transplant Treated (12 Months)|Other|5
4410518|NCT00256750|7190413|FG001|Post-Transplant Treated (12 Months)|Other|4
4410519|NCT00256750|7190414|FG002|Post-Transplant Treated (12 Months)|Other|2
4410520|NCT00256750|7190412|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0
4410521|NCT00256750|7190413|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3
4410522|NCT00256750|7190414|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5
4410523|NCT00256750|7190412|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2
4410524|NCT00256750|7190413|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0
4410525|NCT00256750|7190414|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0
4410526|NCT00256750|7190412|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7
4410527|NCT00256750|7190413|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3
4410528|NCT00256750|7190414|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6
4410529|NCT00256750|7190412|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5
4410530|NCT00256750|7190413|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1
4410531|NCT00256750|7190414|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0
4410532|NCT00256750|7190412|FG000|Post-Transplant Treated (24 Months)|Death|3
4410533|NCT00256750|7190413|FG001|Post-Transplant Treated (24 Months)|Death|0
4410534|NCT00256750|7190414|FG002|Post-Transplant Treated (24 Months)|Death|0
4410535|NCT00256750|7190412|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4
4410536|NCT00256750|7190413|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3
4410537|NCT00256750|7190414|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2
4410538|NCT00256750|7190412|FG000|Post-Transplant Treated (24 Months)|Other|2
4410539|NCT00256750|7190413|FG001|Post-Transplant Treated (24 Months)|Other|0
4410540|NCT00256750|7190414|FG002|Post-Transplant Treated (24 Months)|Other|1
4410541|NCT00256750|7190412|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5
4410542|NCT00256750|7190413|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1
4410543|NCT00256750|7190414|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2
4410544|NCT00256750|7190412|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1
4410545|NCT00256750|7190413|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0
4410546|NCT00256750|7190414|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1
4410547|NCT00256750|7190412|FG000|Post-Transplant Treated (36 Months)|Death|0
4410548|NCT00256750|7190413|FG001|Post-Transplant Treated (36 Months)|Death|2
4410549|NCT00256750|7190414|FG002|Post-Transplant Treated (36 Months)|Death|1
4410550|NCT00256750|7190412|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0
4410551|NCT00256750|7190413|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0
4410552|NCT00256750|7190414|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1
4410553|NCT00256750|7190412|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4
4410554|NCT00256750|7190413|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1
4410555|NCT00256750|7190414|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0
4410556|NCT00256750|7190412|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0
4410557|NCT00256750|7190413|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1
4410558|NCT00256750|7190414|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0
4410559|NCT00256750|7190412|FG000|Post-Transplant Treated (36 Months)|Other|0
4410560|NCT00256750|7190413|FG001|Post-Transplant Treated (36 Months)|Other|1
4410561|NCT00256750|7190414|FG002|Post-Transplant Treated (36 Months)|Other|1
4410562|NCT00256750|7190412|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13
4410563|NCT00256750|7190413|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11
4410564|NCT00256750|7190414|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14
4410565|NCT00256750|7190412|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5
4410566|NCT00256750|7190413|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4
4410567|NCT00256750|7190414|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1
4410568|NCT00256750|7190412|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4
4410569|NCT00256750|7190413|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1
4410570|NCT00256750|7190414|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1
4410571|NCT00256750|7190412|FG000|Long Term Extension (LTE; 84 Months)|Death|9
4410572|NCT00256750|7190413|FG001|Long Term Extension (LTE; 84 Months)|Death|4
4410573|NCT00256750|7190414|FG002|Long Term Extension (LTE; 84 Months)|Death|4
4410574|NCT00256750|7190412|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6
4410575|NCT00256750|7190413|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3
4410576|NCT00256750|7190414|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0
4410577|NCT00256750|7190412|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4
4410578|NCT00256750|7190413|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1
4410579|NCT00256750|7190414|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1
4410580|NCT00256750|7190412|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0
4410581|NCT00256750|7190413|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1
4410582|NCT00256750|7190414|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2
4410583|NCT00256750|7190412|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1
4410584|NCT00256750|7190413|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1
4410585|NCT00256750|7190414|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0
4410586|NCT00256750|7190412|FG000|Long Term Extension (LTE; 84 Months)|Other|5
4410587|NCT00256750|7190413|FG001|Long Term Extension (LTE; 84 Months)|Other|4
4410588|NCT00256750|7190414|FG002|Long Term Extension (LTE; 84 Months)|Other|5
4410589|NCT00256854|7190440|FG000|Overall Study|Withdrawal by Subject|2
4410590|NCT00256854|7190441|FG001|Overall Study|Withdrawal by Subject|3
4410591|NCT00256854|7190442|FG002|Overall Study|Withdrawal by Subject|0
4410592|NCT00256854|7190443|FG003|Overall Study|Withdrawal by Subject|0
4410593|NCT00256854|7190444|FG004|Overall Study|Withdrawal by Subject|0
4410594|NCT00256854|7190445|FG005|Overall Study|Withdrawal by Subject|0
4410595|NCT00256854|7190440|FG000|Overall Study|Lack of Efficacy|1
4410596|NCT00256854|7190441|FG001|Overall Study|Lack of Efficacy|0
4410597|NCT00256854|7190442|FG002|Overall Study|Lack of Efficacy|0
4410598|NCT00256854|7190443|FG003|Overall Study|Lack of Efficacy|0
4410599|NCT00256854|7190444|FG004|Overall Study|Lack of Efficacy|0
4410600|NCT00256854|7190445|FG005|Overall Study|Lack of Efficacy|0
4410601|NCT00256854|7190440|FG000|Overall Study|Protocol Violation|0
4410602|NCT00256854|7190441|FG001|Overall Study|Protocol Violation|1
4410603|NCT00256854|7190442|FG002|Overall Study|Protocol Violation|1
4410604|NCT00256854|7190443|FG003|Overall Study|Protocol Violation|1
4410605|NCT00256854|7190444|FG004|Overall Study|Protocol Violation|0
4410606|NCT00256854|7190445|FG005|Overall Study|Protocol Violation|0
4410607|NCT00256854|7190440|FG000|Overall Study|Adverse Event|0
4410608|NCT00256854|7190441|FG001|Overall Study|Adverse Event|0
4410609|NCT00256854|7190442|FG002|Overall Study|Adverse Event|2
4410610|NCT00256854|7190443|FG003|Overall Study|Adverse Event|2
4410611|NCT00256854|7190444|FG004|Overall Study|Adverse Event|0
4410612|NCT00256854|7190445|FG005|Overall Study|Adverse Event|1
4410613|NCT00256854|7190440|FG000|Overall Study|Not compliant with the study drug|0
4410614|NCT00256854|7190441|FG001|Overall Study|Not compliant with the study drug|0
4410615|NCT00256854|7190442|FG002|Overall Study|Not compliant with the study drug|0
4410616|NCT00256854|7190443|FG003|Overall Study|Not compliant with the study drug|0
4410617|NCT00256854|7190444|FG004|Overall Study|Not compliant with the study drug|1
4410618|NCT00256854|7190445|FG005|Overall Study|Not compliant with the study drug|0
4410619|NCT00256867|7190468|FG000|Overall Study|Adverse Event|0
4410620|NCT00256867|7190469|FG001|Overall Study|Adverse Event|1
4410621|NCT00256867|7190470|FG002|Overall Study|Adverse Event|1
4410622|NCT00256867|7190471|FG003|Overall Study|Adverse Event|1
4410623|NCT00256867|7190472|FG004|Overall Study|Adverse Event|2
4410624|NCT00256867|7190473|FG005|Overall Study|Adverse Event|2
4410625|NCT00256867|7190474|FG006|Overall Study|Adverse Event|1
4410626|NCT00256867|7190475|FG007|Overall Study|Adverse Event|4
4410627|NCT00256867|7190468|FG000|Overall Study|Lost to Follow-up|2
4410628|NCT00256867|7190469|FG001|Overall Study|Lost to Follow-up|2
4410629|NCT00256867|7190470|FG002|Overall Study|Lost to Follow-up|2
4410630|NCT00256867|7190471|FG003|Overall Study|Lost to Follow-up|3
4410631|NCT00256867|7190472|FG004|Overall Study|Lost to Follow-up|2
4410632|NCT00256867|7190473|FG005|Overall Study|Lost to Follow-up|0
4410633|NCT00256867|7190474|FG006|Overall Study|Lost to Follow-up|1
4410634|NCT00256867|7190475|FG007|Overall Study|Lost to Follow-up|2
4410635|NCT00256867|7190468|FG000|Overall Study|Protocol Violation|0
4410636|NCT00256867|7190469|FG001|Overall Study|Protocol Violation|0
4410637|NCT00256867|7190470|FG002|Overall Study|Protocol Violation|0
4410638|NCT00256867|7190471|FG003|Overall Study|Protocol Violation|1
4410639|NCT00256867|7190472|FG004|Overall Study|Protocol Violation|0
4410640|NCT00256867|7190473|FG005|Overall Study|Protocol Violation|1
4410641|NCT00256867|7190474|FG006|Overall Study|Protocol Violation|0
4410642|NCT00256867|7190475|FG007|Overall Study|Protocol Violation|1
4410643|NCT00256867|7190468|FG000|Overall Study|Withdrawal by Subject|0
4410644|NCT00256867|7190469|FG001|Overall Study|Withdrawal by Subject|0
4410645|NCT00256867|7190470|FG002|Overall Study|Withdrawal by Subject|1
4410646|NCT00256867|7190471|FG003|Overall Study|Withdrawal by Subject|1
4410647|NCT00256867|7190472|FG004|Overall Study|Withdrawal by Subject|2
4410648|NCT00256867|7190473|FG005|Overall Study|Withdrawal by Subject|2
4410649|NCT00256867|7190474|FG006|Overall Study|Withdrawal by Subject|3
4410650|NCT00256867|7190475|FG007|Overall Study|Withdrawal by Subject|2
4410651|NCT00256867|7190468|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0
4410652|NCT00256867|7190469|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1
4410653|NCT00256867|7190470|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0
4410654|NCT00256867|7190471|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0
4410655|NCT00256867|7190472|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0
4410656|NCT00256867|7190473|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0
4410657|NCT00256867|7190474|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0
4410658|NCT00256867|7190475|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0
4410659|NCT00256867|7190468|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0
4410660|NCT00256867|7190469|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0
4410661|NCT00256867|7190470|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0
4410662|NCT00256867|7190471|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0
4410663|NCT00256867|7190472|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0
4410664|NCT00256867|7190473|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0
4410665|NCT00256867|7190474|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0
4410666|NCT00256867|7190475|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1
4410667|NCT00256867|7190468|FG000|Overall Study|Investigator's Decision|0
4410668|NCT00256867|7190469|FG001|Overall Study|Investigator's Decision|0
4410669|NCT00256867|7190470|FG002|Overall Study|Investigator's Decision|0
4410670|NCT00256867|7190471|FG003|Overall Study|Investigator's Decision|0
4410671|NCT00256867|7190472|FG004|Overall Study|Investigator's Decision|1
4410672|NCT00256867|7190473|FG005|Overall Study|Investigator's Decision|0
4410673|NCT00256867|7190474|FG006|Overall Study|Investigator's Decision|0
4410674|NCT00256867|7190475|FG007|Overall Study|Investigator's Decision|0
4410675|NCT00256867|7190468|FG000|Overall Study|Non-compliance with study medication|0
4410676|NCT00256867|7190469|FG001|Overall Study|Non-compliance with study medication|0
4410677|NCT00256867|7190470|FG002|Overall Study|Non-compliance with study medication|0
4410678|NCT00256867|7190471|FG003|Overall Study|Non-compliance with study medication|0
4410679|NCT00256867|7190472|FG004|Overall Study|Non-compliance with study medication|0
4410680|NCT00256867|7190473|FG005|Overall Study|Non-compliance with study medication|0
4410681|NCT00256867|7190474|FG006|Overall Study|Non-compliance with study medication|0
4410682|NCT00256867|7190475|FG007|Overall Study|Non-compliance with study medication|1
4410683|NCT00256867|7190468|FG000|Overall Study|Participant travelled Overseas|0
4410684|NCT00256867|7190469|FG001|Overall Study|Participant travelled Overseas|1
4410685|NCT00256867|7190470|FG002|Overall Study|Participant travelled Overseas|0
4410686|NCT00256867|7190471|FG003|Overall Study|Participant travelled Overseas|0
4410687|NCT00256867|7190472|FG004|Overall Study|Participant travelled Overseas|0
4410688|NCT00256867|7190473|FG005|Overall Study|Participant travelled Overseas|0
4410689|NCT00256867|7190474|FG006|Overall Study|Participant travelled Overseas|0
4410690|NCT00256867|7190475|FG007|Overall Study|Participant travelled Overseas|0
4410691|NCT00256867|7190468|FG000|Overall Study|Participant out of assessment window|0
4410692|NCT00256867|7190469|FG001|Overall Study|Participant out of assessment window|0
4410693|NCT00256867|7190470|FG002|Overall Study|Participant out of assessment window|1
4410694|NCT00256867|7190471|FG003|Overall Study|Participant out of assessment window|0
4410695|NCT00256867|7190472|FG004|Overall Study|Participant out of assessment window|0
4410696|NCT00256867|7190473|FG005|Overall Study|Participant out of assessment window|0
4410697|NCT00256867|7190474|FG006|Overall Study|Participant out of assessment window|0
4410698|NCT00256867|7190475|FG007|Overall Study|Participant out of assessment window|0
4410699|NCT00256867|7190468|FG000|Overall Study|Withdrawal by participant|0
4410700|NCT00256867|7190469|FG001|Overall Study|Withdrawal by participant|0
4410701|NCT00256867|7190470|FG002|Overall Study|Withdrawal by participant|0
4410702|NCT00256867|7190471|FG003|Overall Study|Withdrawal by participant|0
4410703|NCT00256867|7190472|FG004|Overall Study|Withdrawal by participant|0
4410704|NCT00256867|7190473|FG005|Overall Study|Withdrawal by participant|1
4410705|NCT00256867|7190474|FG006|Overall Study|Withdrawal by participant|0
4410706|NCT00256867|7190475|FG007|Overall Study|Withdrawal by participant|0
4410707|NCT00256997|7190504|FG000|Overall Study|Protocol Violation|1
4410708|NCT00256997|7190505|FG001|Overall Study|Protocol Violation|4
4410709|NCT00256997|7190504|FG000|Overall Study|Lack of Efficacy|1
4410710|NCT00256997|7190505|FG001|Overall Study|Lack of Efficacy|4
4410711|NCT00256997|7190504|FG000|Overall Study|Death|2
4410712|NCT00256997|7190505|FG001|Overall Study|Death|0
4410713|NCT00256997|7190504|FG000|Overall Study|Adverse Event|4
4410714|NCT00256997|7190505|FG001|Overall Study|Adverse Event|0
4410715|NCT00256997|7190504|FG000|Overall Study|Lost to Follow-up|3
4410716|NCT00256997|7190505|FG001|Overall Study|Lost to Follow-up|5
4410717|NCT00256997|7190504|FG000|Overall Study|Withdrawal by Subject|13
4410718|NCT00256997|7190505|FG001|Overall Study|Withdrawal by Subject|3
4410719|NCT00256997|7190504|FG000|Overall Study|Started but not treated|2
4410720|NCT00256997|7190505|FG001|Overall Study|Started but not treated|0
4410721|NCT00256997|7190504|FG000|Overall Study|Other|5
4410722|NCT00256997|7190505|FG001|Overall Study|Other|8
4410723|NCT00256997|7190504|FG000|Overall Study|End of Study (As Per Sponsor)|12
4410724|NCT00256997|7190505|FG001|Overall Study|End of Study (As Per Sponsor)|24
4410725|NCT00256997|7190504|FG000|Overall Study|Participant Non-compliant|3
4410726|NCT00256997|7190505|FG001|Overall Study|Participant Non-compliant|6
4410727|NCT00256997|7190504|FG000|Overall Study|Investigator Withdrew Participant|2
4410728|NCT00256997|7190505|FG001|Overall Study|Investigator Withdrew Participant|1
4410729|NCT00257010|7190512|FG000|Overall Study|Lack of Efficacy|11
4410730|NCT00257010|7190512|FG000|Overall Study|Lost to Follow-up|53
4410731|NCT00257010|7190512|FG000|Overall Study|Withdrawal by Subject|34
4410732|NCT00257010|7190512|FG000|Overall Study|Adverse Event|10
4410733|NCT00257010|7190512|FG000|Overall Study|various|11
4410734|NCT00257010|7190512|FG000|Overall Study|no headache reported|9
4410735|NCT00257166|7190518|FG000|Overall Study|Adverse Event|18
4410736|NCT00257166|7190519|FG001|Overall Study|Adverse Event|13
4410737|NCT00257166|7190518|FG000|Overall Study|Laboratory abnormality|1
4410738|NCT00257166|7190519|FG001|Overall Study|Laboratory abnormality|0
4410739|NCT00257166|7190518|FG000|Overall Study|Lost to Follow-up|8
4410740|NCT00257166|7190519|FG001|Overall Study|Lost to Follow-up|1
4410741|NCT00257166|7190518|FG000|Overall Study|Withdrawal by Subject|9
4410742|NCT00257166|7190519|FG001|Overall Study|Withdrawal by Subject|2
4410743|NCT00257166|7190518|FG000|Overall Study|Other|16
4410744|NCT00257166|7190519|FG001|Overall Study|Other|21
4410745|NCT00257166|7190518|FG000|Overall Study|Randomized, but not treated|1
4410746|NCT00257166|7190519|FG001|Overall Study|Randomized, but not treated|0
4410747|NCT00257192|7190527|FG000|Overall Study|Adverse Event|21
4410748|NCT00257192|7190528|FG001|Overall Study|Adverse Event|10
4410749|NCT00257192|7190527|FG000|Overall Study|Laboratory abnormality|1
4410750|NCT00257192|7190528|FG001|Overall Study|Laboratory abnormality|1
4410751|NCT00257192|7190527|FG000|Overall Study|Lost to Follow-up|3
4410752|NCT00257192|7190528|FG001|Overall Study|Lost to Follow-up|3
4410753|NCT00257192|7190527|FG000|Overall Study|Insufficient clinical response|18
4410754|NCT00257192|7190528|FG001|Overall Study|Insufficient clinical response|18
4410755|NCT00257192|7190527|FG000|Overall Study|Withdrawal by Subject|14
4410756|NCT00257192|7190528|FG001|Overall Study|Withdrawal by Subject|2
4410757|NCT00257192|7190527|FG000|Overall Study|Randomized but not treated|0
4410758|NCT00257192|7190528|FG001|Overall Study|Randomized but not treated|1
4410759|NCT00257192|7190527|FG000|Overall Study|Study terminated by sponsor|1
4410760|NCT00257192|7190528|FG001|Overall Study|Study terminated by sponsor|0
4410761|NCT00257192|7190527|FG000|Overall Study|Miscellaneous|0
4410762|NCT00257192|7190528|FG001|Overall Study|Miscellaneous|4
4410763|NCT00257556|7190549|FG000|Overall Study|Adverse Event|1
4410764|NCT00257556|7190550|FG001|Overall Study|Adverse Event|4
4410765|NCT00257556|7190549|FG000|Overall Study|Physician Decision|6
4410766|NCT00257556|7190550|FG001|Overall Study|Physician Decision|0
4410767|NCT00257556|7190549|FG000|Overall Study|Did not meet hCG criterion|3
4410768|NCT00257556|7190550|FG001|Overall Study|Did not meet hCG criterion|0
4410769|NCT00257556|7190549|FG000|Overall Study|other reason|4
4410770|NCT00257556|7190550|FG001|Overall Study|other reason|6
4410771|NCT00257608|7190558|FG000|Chemotherapy Phase|Adverse Event|138
4410772|NCT00257608|7190559|FG001|Chemotherapy Phase|Adverse Event|0
4410773|NCT00257608|7190560|FG002|Chemotherapy Phase|Adverse Event|0
4410774|NCT00257608|7190558|FG000|Chemotherapy Phase|Disease progression|139
4410775|NCT00257608|7190559|FG001|Chemotherapy Phase|Disease progression|0
4410776|NCT00257608|7190560|FG002|Chemotherapy Phase|Disease progression|0
4410777|NCT00257608|7190558|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6
4410778|NCT00257608|7190559|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0
4410779|NCT00257608|7190560|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0
4410780|NCT00257608|7190558|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27
4410781|NCT00257608|7190559|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0
4410782|NCT00257608|7190560|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0
4410783|NCT00257608|7190558|FG000|Chemotherapy Phase|Patient's decision to discontinue|35
4410784|NCT00257608|7190559|FG001|Chemotherapy Phase|Patient's decision to discontinue|0
4410785|NCT00257608|7190560|FG002|Chemotherapy Phase|Patient's decision to discontinue|0
4410786|NCT00257608|7190558|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3
4410787|NCT00257608|7190559|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0
4410788|NCT00257608|7190560|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0
4410789|NCT00257608|7190558|FG000|Chemotherapy Phase|Physician Decision|28
4410790|NCT00257608|7190559|FG001|Chemotherapy Phase|Physician Decision|0
4410791|NCT00257608|7190560|FG002|Chemotherapy Phase|Physician Decision|0
4410792|NCT00257608|7190558|FG000|Post Chemotherapy Phase|Adverse Event|0
4410793|NCT00257608|7190559|FG001|Post Chemotherapy Phase|Adverse Event|34
4410794|NCT00257608|7190560|FG002|Post Chemotherapy Phase|Adverse Event|38
4410795|NCT00257608|7190558|FG000|Post Chemotherapy Phase|Disease progression|0
4410796|NCT00257608|7190559|FG001|Post Chemotherapy Phase|Disease progression|204
4410797|NCT00257608|7190560|FG002|Post Chemotherapy Phase|Disease progression|168
4410798|NCT00257608|7190558|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0
4410799|NCT00257608|7190559|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4
4410800|NCT00257608|7190560|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5
4410801|NCT00257608|7190558|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0
4410802|NCT00257608|7190559|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5
4410803|NCT00257608|7190560|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5
4410804|NCT00257608|7190558|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0
4410805|NCT00257608|7190559|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4
4410806|NCT00257608|7190560|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8
4410807|NCT00257608|7190558|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0
4410808|NCT00257608|7190559|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0
4410809|NCT00257608|7190560|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1
4410810|NCT00257608|7190558|FG000|Post Chemotherapy Phase|Lost to Follow-up|0
4410811|NCT00257608|7190559|FG001|Post Chemotherapy Phase|Lost to Follow-up|0
4410812|NCT00257608|7190560|FG002|Post Chemotherapy Phase|Lost to Follow-up|1
4410813|NCT00257608|7190558|FG000|Post Chemotherapy Phase|Physician Decision|0
4410814|NCT00257608|7190559|FG001|Post Chemotherapy Phase|Physician Decision|8
4410815|NCT00257608|7190560|FG002|Post Chemotherapy Phase|Physician Decision|11
4410816|NCT00257608|7190558|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0
4410817|NCT00257608|7190559|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1
4410818|NCT00257608|7190560|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0
4410819|NCT00257608|7190558|FG000|Post Chemotherapy Phase|Not treated|0
4410820|NCT00257608|7190559|FG001|Post Chemotherapy Phase|Not treated|4
4410821|NCT00257608|7190560|FG002|Post Chemotherapy Phase|Not treated|7
4410822|NCT00257660|7190575|FG000|Overall Study|Lack of Efficacy|5
4410823|NCT00257660|7190576|FG001|Overall Study|Lack of Efficacy|23
4410824|NCT00257660|7190575|FG000|Overall Study|Withdrawal by Subject|2
4410825|NCT00257660|7190576|FG001|Overall Study|Withdrawal by Subject|0
4410826|NCT00257660|7190575|FG000|Overall Study|Lost to Follow-up|1
4410827|NCT00257660|7190576|FG001|Overall Study|Lost to Follow-up|0
4410828|NCT00257660|7190575|FG000|Overall Study|PI & Subject Schedule Conflicts|1
4410829|NCT00257660|7190576|FG001|Overall Study|PI & Subject Schedule Conflicts|0
4410830|NCT00257660|7190575|FG000|Overall Study|No longer wanted to do blood draws|1
4410831|NCT00257660|7190576|FG001|Overall Study|No longer wanted to do blood draws|0
4410832|NCT00257725|7190607|FG000|Overall Study|Adverse Event|3
4410833|NCT00257920|7190623|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0
4410834|NCT00257920|7190624|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1
4410835|NCT00257920|7190623|FG000|Period: Second Intervention|Other|2
4410836|NCT00257920|7190624|FG001|Period: Second Intervention|Other|1
4410837|NCT00258154|7190657|FG000|Overall Study|Adverse Event|1
4410838|NCT00258154|7190658|FG001|Overall Study|Adverse Event|0
4410839|NCT00258154|7190657|FG000|Overall Study|Lost to Follow-up|0
4410840|NCT00258154|7190658|FG001|Overall Study|Lost to Follow-up|1
4410841|NCT00258154|7190657|FG000|Overall Study|Protocol Violation|2
4410842|NCT00258154|7190658|FG001|Overall Study|Protocol Violation|1
4410843|NCT00258154|7190657|FG000|Overall Study|Withdrawal by Subject|3
4410844|NCT00258154|7190658|FG001|Overall Study|Withdrawal by Subject|4
4410845|NCT00258154|7190657|FG000|Overall Study|Patient Moved|3
4410846|NCT00258154|7190658|FG001|Overall Study|Patient Moved|1
4410847|NCT00258440|7190691|FG000|Overall Study|Withdrawal by Subject|0
4410848|NCT00258440|7190692|FG001|Overall Study|Withdrawal by Subject|0
4410849|NCT00258440|7190693|FG002|Overall Study|Withdrawal by Subject|1
4410850|NCT00258674|7190704|FG000|Overall Study|Death|32
4713673|NCT02951780|7641482|FG007|Period 1|Scheduling Conflicts|1
4410851|NCT00258674|7190705|FG001|Overall Study|Death|53
4410852|NCT00258674|7190706|FG002|Overall Study|Death|34
4410853|NCT00258856|7190736|FG000|Overall Study|Lost to Follow-up|1
4410854|NCT00258856|7190737|FG001|Overall Study|Lost to Follow-up|0
4410855|NCT00258856|7190738|FG002|Overall Study|Lost to Follow-up|2
4410856|NCT00258856|7190739|FG003|Overall Study|Lost to Follow-up|0
4410857|NCT00258856|7190736|FG000|Overall Study|Non-compliance|2
4410858|NCT00258856|7190737|FG001|Overall Study|Non-compliance|0
4410859|NCT00258856|7190738|FG002|Overall Study|Non-compliance|0
4410860|NCT00258856|7190739|FG003|Overall Study|Non-compliance|1
4410861|NCT00258895|7190762|FG000|Overall Study|Lost to Follow-up|3
4410862|NCT00258895|7190763|FG001|Overall Study|Lost to Follow-up|1
4410863|NCT00258895|7190762|FG000|Overall Study|Protocol Violation|6
4410864|NCT00258895|7190763|FG001|Overall Study|Protocol Violation|2
4410865|NCT00258895|7190762|FG000|Overall Study|Withdrawal by Subject|1
4410866|NCT00258895|7190763|FG001|Overall Study|Withdrawal by Subject|0
4410867|NCT00258960|7190773|FG000|Overall Study|Death|2
4410868|NCT00258960|7190773|FG000|Overall Study|Disease Progression|7
4410869|NCT00258960|7190773|FG000|Overall Study|Adverse Event|4
4410870|NCT00258960|7190773|FG000|Overall Study|Physician Decision|1
4410871|NCT00258960|7190773|FG000|Overall Study|Withdrawal by Subject|1
4410872|NCT00258960|7190773|FG000|Overall Study|Mistake|2
4410873|NCT00259012|7190779|FG000|Overall Study|Adverse Event|0
4410874|NCT00259012|7190780|FG001|Overall Study|Adverse Event|1
4410875|NCT00259012|7190779|FG000|Overall Study|Withdrawal by Subject|1
4410876|NCT00259012|7190780|FG001|Overall Study|Withdrawal by Subject|0
4410877|NCT00259012|7190779|FG000|Overall Study|Physician Decision|0
4410878|NCT00259012|7190780|FG001|Overall Study|Physician Decision|1
4410879|NCT00259012|7190779|FG000|Overall Study|Lost to Follow-up|0
4410880|NCT00259012|7190780|FG001|Overall Study|Lost to Follow-up|1
4410881|NCT00259012|7190779|FG000|Overall Study|Protocol Violation|1
4410882|NCT00259012|7190780|FG001|Overall Study|Protocol Violation|1
4410883|NCT00259272|7190803|FG000|Overall Study|Adverse Event|2
4410884|NCT00259272|7190804|FG001|Overall Study|Adverse Event|1
4410885|NCT00259272|7190805|FG002|Overall Study|Adverse Event|0
4410886|NCT00259272|7190806|FG003|Overall Study|Adverse Event|3
4410887|NCT00259272|7190803|FG000|Overall Study|Lack of Efficacy|5
4410888|NCT00259272|7190804|FG001|Overall Study|Lack of Efficacy|1
4410889|NCT00259272|7190805|FG002|Overall Study|Lack of Efficacy|2
4410890|NCT00259272|7190806|FG003|Overall Study|Lack of Efficacy|6
4410891|NCT00259272|7190803|FG000|Overall Study|Physician Decision|1
4410892|NCT00259272|7190804|FG001|Overall Study|Physician Decision|2
4410893|NCT00259272|7190805|FG002|Overall Study|Physician Decision|1
4410894|NCT00259272|7190806|FG003|Overall Study|Physician Decision|3
4410895|NCT00259272|7190803|FG000|Overall Study|Protocol Violation|2
4410896|NCT00259272|7190804|FG001|Overall Study|Protocol Violation|0
4410897|NCT00259272|7190805|FG002|Overall Study|Protocol Violation|0
4410898|NCT00259272|7190806|FG003|Overall Study|Protocol Violation|1
4410899|NCT00259272|7190803|FG000|Overall Study|Sponsor Decision|0
4410900|NCT00259272|7190804|FG001|Overall Study|Sponsor Decision|1
4410901|NCT00259272|7190805|FG002|Overall Study|Sponsor Decision|0
4410902|NCT00259272|7190806|FG003|Overall Study|Sponsor Decision|0
4410903|NCT00259272|7190803|FG000|Overall Study|Withdrawal by Subject|4
4410904|NCT00259272|7190804|FG001|Overall Study|Withdrawal by Subject|2
4410905|NCT00259272|7190805|FG002|Overall Study|Withdrawal by Subject|2
4410906|NCT00259272|7190806|FG003|Overall Study|Withdrawal by Subject|7
4410907|NCT00259272|7190803|FG000|Overall Study|Lost to Follow-up|1
4713674|NCT02951780|7641483|FG008|Period 1|Scheduling Conflicts|0
4713675|NCT02951780|7641475|FG000|Period 2|Scheduling Conflicts|0
4410908|NCT00259272|7190804|FG001|Overall Study|Lost to Follow-up|0
4410909|NCT00259272|7190805|FG002|Overall Study|Lost to Follow-up|0
4410910|NCT00259272|7190806|FG003|Overall Study|Lost to Follow-up|1
4410911|NCT00259298|7190825|FG000|Overall Study|Withdrawal by Subject|1
4410912|NCT00259298|7190825|FG000|Overall Study|Physician Decision|2
4410913|NCT00259610|7190833|FG000|Overall Study|Withdrawal by Subject|33
4410914|NCT00259610|7190834|FG001|Overall Study|Withdrawal by Subject|25
4410915|NCT00259610|7190835|FG002|Overall Study|Withdrawal by Subject|29
4410916|NCT00259610|7190836|FG003|Overall Study|Withdrawal by Subject|19
4410917|NCT00259610|7190833|FG000|Overall Study|Lost to Follow-up|19
4410918|NCT00259610|7190834|FG001|Overall Study|Lost to Follow-up|8
4410919|NCT00259610|7190835|FG002|Overall Study|Lost to Follow-up|18
4410920|NCT00259610|7190836|FG003|Overall Study|Lost to Follow-up|15
4410921|NCT00259610|7190833|FG000|Overall Study|Physician Decision|6
4410922|NCT00259610|7190834|FG001|Overall Study|Physician Decision|4
4410923|NCT00259610|7190835|FG002|Overall Study|Physician Decision|7
4410924|NCT00259610|7190836|FG003|Overall Study|Physician Decision|2
4410925|NCT00259610|7190833|FG000|Overall Study|Death|1
4410926|NCT00259610|7190834|FG001|Overall Study|Death|1
4410927|NCT00259610|7190835|FG002|Overall Study|Death|2
4410928|NCT00259610|7190836|FG003|Overall Study|Death|0
4410929|NCT00259610|7190833|FG000|Overall Study|non medical reason|6
4410930|NCT00259610|7190834|FG001|Overall Study|non medical reason|2
4410931|NCT00259610|7190835|FG002|Overall Study|non medical reason|10
4410932|NCT00259610|7190836|FG003|Overall Study|non medical reason|3
4410933|NCT00259610|7190833|FG000|Overall Study|Adverse Event|3
4410934|NCT00259610|7190834|FG001|Overall Study|Adverse Event|4
4410935|NCT00259610|7190835|FG002|Overall Study|Adverse Event|5
4410936|NCT00259610|7190836|FG003|Overall Study|Adverse Event|2
4410937|NCT00259610|7190833|FG000|Overall Study|Serious Adverse Event|8
4410938|NCT00259610|7190834|FG001|Overall Study|Serious Adverse Event|2
4410939|NCT00259610|7190835|FG002|Overall Study|Serious Adverse Event|2
4410940|NCT00259610|7190836|FG003|Overall Study|Serious Adverse Event|2
4713676|NCT02951780|7641476|FG001|Period 2|Scheduling Conflicts|0
4713677|NCT02951780|7641477|FG002|Period 2|Scheduling Conflicts|0
4713678|NCT02951780|7641478|FG003|Period 2|Scheduling Conflicts|0
4713679|NCT02951780|7641479|FG004|Period 2|Scheduling Conflicts|0
4713680|NCT02951780|7641480|FG005|Period 2|Scheduling Conflicts|0
4410941|NCT00259649|7190846|FG000|Overall Study|Lost to Follow-up|7
4410942|NCT00259649|7190846|FG000|Overall Study|irregular menses|3
4410943|NCT00259740|7190852|FG000|Overall Study|Physician Decision|1
4410944|NCT00259740|7190853|FG001|Overall Study|Physician Decision|1
4410945|NCT00259740|7190852|FG000|Overall Study|Adverse Event|0
4410946|NCT00259740|7190853|FG001|Overall Study|Adverse Event|2
4410947|NCT00259740|7190852|FG000|Overall Study|Withdrawal by Subject|2
4410948|NCT00259740|7190853|FG001|Overall Study|Withdrawal by Subject|6
4410949|NCT00259740|7190852|FG000|Overall Study|Death|1
4410950|NCT00259740|7190853|FG001|Overall Study|Death|1
4410951|NCT00259740|7190852|FG000|Overall Study|Disease progression|19
4410952|NCT00259740|7190853|FG001|Overall Study|Disease progression|36
4410953|NCT00259740|7190852|FG000|Overall Study|Ongoing|17
4410954|NCT00259740|7190853|FG001|Overall Study|Ongoing|3
4410955|NCT00259740|7190852|FG000|Overall Study|Other|3
4410956|NCT00259740|7190853|FG001|Overall Study|Other|0
4410957|NCT00259740|7190852|FG000|Overall Study|Requirement for alternative therapy|0
4410958|NCT00259740|7190853|FG001|Overall Study|Requirement for alternative therapy|4
4410959|NCT00259857|7190861|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1
4410960|NCT00259857|7190862|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2
4410961|NCT00259857|7190861|FG000|24 Months Treatment|Lost to Follow-up|0
4410962|NCT00259857|7190862|FG001|24 Months Treatment|Lost to Follow-up|3
4410963|NCT00260065|7190868|FG000|Overall Study|Progressive Disease|22
4410964|NCT00260065|7190868|FG000|Overall Study|Adverse Event|17
4410965|NCT00260065|7190868|FG000|Overall Study|Death|13
4410966|NCT00260065|7190868|FG000|Overall Study|Withdrawal by Subject|13
4410967|NCT00260065|7190868|FG000|Overall Study|Physician Decision|19
4410968|NCT00260065|7190868|FG000|Overall Study|Not otherwise specified|8
4410969|NCT00260065|7190868|FG000|Overall Study|Medication Noncompliance|1
4410970|NCT00260208|7190884|FG000|Overall Study|Subject withdrew consent|11
4410971|NCT00260208|7190885|FG001|Overall Study|Subject withdrew consent|7
4410972|NCT00260208|7190884|FG000|Overall Study|Lost to Follow-up|6
4410973|NCT00260208|7190885|FG001|Overall Study|Lost to Follow-up|1
4410974|NCT00260208|7190884|FG000|Overall Study|Death|12
4410975|NCT00260208|7190885|FG001|Overall Study|Death|10
4410976|NCT00260208|7190884|FG000|Overall Study|Missing|18
4410977|NCT00260208|7190885|FG001|Overall Study|Missing|16
4410978|NCT00260429|7190893|FG000|Overall Study|failure to follow appointments|1
4410979|NCT00260429|7190894|FG001|Overall Study|failure to follow appointments|0
4410980|NCT00260429|7190893|FG000|Overall Study|scheduled hand surgery|1
4410981|NCT00260429|7190894|FG001|Overall Study|scheduled hand surgery|0
4410982|NCT00260533|7190902|FG000|Overall Study|Other|3
4410983|NCT00260533|7190903|FG001|Overall Study|Other|3
4410984|NCT00260832|7190924|FG000|Overall Study|Adverse Event|26
4410985|NCT00260832|7190925|FG001|Overall Study|Adverse Event|19
4410986|NCT00260832|7190924|FG000|Overall Study|Progression|116
4410987|NCT00260832|7190925|FG001|Overall Study|Progression|96
4410988|NCT00260832|7190924|FG000|Overall Study|Withdrawal by Subject|15
4410989|NCT00260832|7190925|FG001|Overall Study|Withdrawal by Subject|17
4410990|NCT00260832|7190924|FG000|Overall Study|Physician Decision|15
4410991|NCT00260832|7190925|FG001|Overall Study|Physician Decision|9
4629078|NCT01868022|7496656|FG002|Overall Study|Withdrawal by Subject|1
4629079|NCT01868022|7496657|FG003|Overall Study|Withdrawal by Subject|1
4410992|NCT00260832|7190924|FG000|Overall Study|Death|43
4410993|NCT00260832|7190925|FG001|Overall Study|Death|62
4410994|NCT00260832|7190924|FG000|Overall Study|Other|10
4629080|NCT01868022|7496658|FG004|Overall Study|Withdrawal by Subject|0
4713681|NCT02951780|7641481|FG006|Period 2|Scheduling Conflicts|0
4713682|NCT02951780|7641482|FG007|Period 2|Scheduling Conflicts|1
4713683|NCT02951780|7641483|FG008|Period 2|Scheduling Conflicts|0
4713684|NCT02951819|7641505|FG000|Overall Study|Death|9
4713685|NCT02951819|7641506|FG001|Overall Study|Death|7
4713686|NCT02951819|7641505|FG000|Overall Study|Withdrawal by Subject|3
4713687|NCT02951819|7641506|FG001|Overall Study|Withdrawal by Subject|0
4713688|NCT02951819|7641505|FG000|Overall Study|Adverse Event|1
4713689|NCT02951819|7641506|FG001|Overall Study|Adverse Event|0
4713690|NCT02951819|7641505|FG000|Overall Study|Lack of Efficacy|4
4713691|NCT02951819|7641506|FG001|Overall Study|Lack of Efficacy|0
4713692|NCT02951819|7641505|FG000|Overall Study|Lost to Follow-up|1
4713693|NCT02951819|7641506|FG001|Overall Study|Lost to Follow-up|0
4713694|NCT02951819|7641505|FG000|Overall Study|Progressive Disease|1
4713695|NCT02951819|7641506|FG001|Overall Study|Progressive Disease|0
4713696|NCT02951819|7641505|FG000|Overall Study|Other|9
4713697|NCT02951819|7641506|FG001|Overall Study|Other|0
4410995|NCT00260832|7190925|FG001|Overall Study|Other|7
4410996|NCT00260832|7190924|FG000|Overall Study|Protocol Violation|3
4629081|NCT01868022|7496659|FG005|Overall Study|Withdrawal by Subject|0
4713698|NCT02951988|7641528|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8
4410997|NCT00260832|7190925|FG001|Overall Study|Protocol Violation|1
4511694|NCT00928512|7321059|FG003|Overall Study|Adverse Event|8
4511695|NCT00928512|7321060|FG004|Overall Study|Adverse Event|6
4629082|NCT01868022|7496660|FG006|Overall Study|Withdrawal by Subject|0
4410998|NCT00261443|7190951|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33
4410999|NCT00261443|7190952|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0
4411000|NCT00261443|7190953|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0
4411001|NCT00261443|7190951|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93
4411002|NCT00261443|7190952|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0
4411003|NCT00261443|7190953|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0
4411004|NCT00261443|7190951|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111
4411005|NCT00261443|7190952|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0
4411006|NCT00261443|7190953|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0
4411007|NCT00261443|7190951|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23
4411008|NCT00261443|7190952|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0
4411009|NCT00261443|7190953|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0
4411010|NCT00261443|7190951|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1
4411011|NCT00261443|7190952|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0
4411012|NCT00261443|7190953|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0
4411013|NCT00261443|7190951|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307
4411014|NCT00261443|7190952|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0
4411015|NCT00261443|7190953|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0
4411016|NCT00261443|7190951|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16
4411017|NCT00261443|7190952|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0
4411018|NCT00261443|7190953|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0
4411019|NCT00261443|7190951|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43
4411020|NCT00261443|7190952|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0
4411021|NCT00261443|7190953|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0
4411022|NCT00261443|7190951|FG000|2: Stability & Maintenance of Stability|Adverse Event|93
4411023|NCT00261443|7190952|FG001|2: Stability & Maintenance of Stability|Adverse Event|0
4411024|NCT00261443|7190953|FG002|2: Stability & Maintenance of Stability|Adverse Event|0
4411025|NCT00261443|7190951|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65
4411026|NCT00261443|7190952|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0
4411027|NCT00261443|7190953|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0
4411028|NCT00261443|7190951|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59
4411029|NCT00261443|7190952|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0
4411030|NCT00261443|7190953|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0
4411031|NCT00261443|7190951|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33
4411032|NCT00261443|7190952|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0
4411033|NCT00261443|7190953|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0
4411034|NCT00261443|7190951|FG000|2: Stability & Maintenance of Stability|Pregnancy|1
4411035|NCT00261443|7190952|FG001|2: Stability & Maintenance of Stability|Pregnancy|0
4411036|NCT00261443|7190953|FG002|2: Stability & Maintenance of Stability|Pregnancy|0
4411037|NCT00261443|7190951|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32
4411038|NCT00261443|7190952|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0
4411039|NCT00261443|7190953|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0
4411040|NCT00261443|7190951|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1
4411041|NCT00261443|7190952|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0
4411042|NCT00261443|7190953|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0
4411043|NCT00261443|7190951|FG000|2: Stability & Maintenance of Stability|Other Reasons|13
4411044|NCT00261443|7190952|FG001|2: Stability & Maintenance of Stability|Other Reasons|0
4411045|NCT00261443|7190953|FG002|2: Stability & Maintenance of Stability|Other Reasons|0
4411046|NCT00261443|7190951|FG000|3: Assessment of Relapse|Lack of Efficacy|0
4411047|NCT00261443|7190952|FG001|3: Assessment of Relapse|Lack of Efficacy|31
4411048|NCT00261443|7190953|FG002|3: Assessment of Relapse|Lack of Efficacy|14
4411049|NCT00261443|7190951|FG000|3: Assessment of Relapse|Adverse Event|0
4411050|NCT00261443|7190952|FG001|3: Assessment of Relapse|Adverse Event|15
4411051|NCT00261443|7190953|FG002|3: Assessment of Relapse|Adverse Event|19
4411052|NCT00261443|7190951|FG000|3: Assessment of Relapse|Withdrawal by Subject|0
4411053|NCT00261443|7190952|FG001|3: Assessment of Relapse|Withdrawal by Subject|14
4411054|NCT00261443|7190953|FG002|3: Assessment of Relapse|Withdrawal by Subject|15
4411055|NCT00261443|7190951|FG000|3: Assessment of Relapse|Death|0
4411056|NCT00261443|7190952|FG001|3: Assessment of Relapse|Death|0
4411057|NCT00261443|7190953|FG002|3: Assessment of Relapse|Death|1
4411058|NCT00261443|7190951|FG000|3: Assessment of Relapse|Lost to Follow-up|0
4411059|NCT00261443|7190952|FG001|3: Assessment of Relapse|Lost to Follow-up|7
4411060|NCT00261443|7190953|FG002|3: Assessment of Relapse|Lost to Follow-up|6
4411061|NCT00261443|7190951|FG000|3: Assessment of Relapse|Poor/Noncompliance|0
4411062|NCT00261443|7190952|FG001|3: Assessment of Relapse|Poor/Noncompliance|5
4411063|NCT00261443|7190953|FG002|3: Assessment of Relapse|Poor/Noncompliance|3
4411064|NCT00261443|7190951|FG000|3: Assessment of Relapse|Pregnancy|0
4411065|NCT00261443|7190952|FG001|3: Assessment of Relapse|Pregnancy|2
4411066|NCT00261443|7190953|FG002|3: Assessment of Relapse|Pregnancy|1
4411067|NCT00261443|7190951|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0
4411068|NCT00261443|7190952|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2
4411069|NCT00261443|7190953|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1
4411070|NCT00261443|7190951|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0
4411071|NCT00261443|7190952|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0
4411072|NCT00261443|7190953|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2
4411073|NCT00261443|7190951|FG000|3: Assessment of Relapse|Other Reasons|0
4411074|NCT00261443|7190952|FG001|3: Assessment of Relapse|Other Reasons|4
4411075|NCT00261443|7190953|FG002|3: Assessment of Relapse|Other Reasons|3
4411076|NCT00261443|7190951|FG000|4: Extension Phase|Adverse Event|0
4411077|NCT00261443|7190952|FG001|4: Extension Phase|Adverse Event|1
4411078|NCT00261443|7190953|FG002|4: Extension Phase|Adverse Event|0
4411079|NCT00261443|7190951|FG000|4: Extension Phase|Withdrawal by Subject|0
4411080|NCT00261443|7190952|FG001|4: Extension Phase|Withdrawal by Subject|1
4411081|NCT00261443|7190953|FG002|4: Extension Phase|Withdrawal by Subject|2
4411082|NCT00261443|7190951|FG000|4: Extension Phase|Lost to Follow-up|0
4411083|NCT00261443|7190952|FG001|4: Extension Phase|Lost to Follow-up|1
4411084|NCT00261443|7190953|FG002|4: Extension Phase|Lost to Follow-up|0
4411085|NCT00261495|7190966|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28
4411086|NCT00261495|7190967|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36
4411087|NCT00261495|7190966|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6
4411088|NCT00261495|7190967|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11
4411089|NCT00261495|7190966|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8
4411090|NCT00261495|7190967|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8
4411091|NCT00261495|7190966|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3
4411092|NCT00261495|7190967|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1
4411093|NCT00261495|7190966|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2
4411094|NCT00261495|7190967|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5
4411095|NCT00261495|7190966|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1
4411096|NCT00261495|7190967|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4
4411097|NCT00261495|7190966|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29
4411098|NCT00261495|7190967|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20
4411099|NCT00261495|7190966|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14
4411100|NCT00261495|7190967|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10
4411101|NCT00261495|7190966|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6
4411102|NCT00261495|7190967|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5
4411103|NCT00261495|7190966|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1
4411104|NCT00261495|7190967|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5
4411105|NCT00261495|7190966|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5
4411106|NCT00261495|7190967|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2
4411107|NCT00261495|7190966|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6
4411108|NCT00261495|7190967|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5
4411109|NCT00261495|7190966|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1
4411110|NCT00261495|7190967|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1
4411111|NCT00261495|7190966|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2
4411112|NCT00261495|7190967|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0
4411113|NCT00261495|7190966|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2
4411114|NCT00261495|7190967|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0
4411115|NCT00261495|7190966|FG000|Extension Phase (Weeks 24 to 52)|Other|4
4411116|NCT00261495|7190967|FG001|Extension Phase (Weeks 24 to 52)|Other|2
4411117|NCT00261495|7190966|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4
4411118|NCT00261495|7190967|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1
4411119|NCT00261495|7190966|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0
4411120|NCT00261495|7190967|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1
4411121|NCT00261495|7190966|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
4411122|NCT00261495|7190967|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1
4411123|NCT00261495|7190966|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1
4411124|NCT00261495|7190967|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0
4411125|NCT00261495|7190966|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1
4411126|NCT00261495|7190967|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
4411127|NCT00261716|7190975|FG000|Overall Study|Withdrawal by Subject|6
4411128|NCT00261716|7190976|FG001|Overall Study|Withdrawal by Subject|8
4411129|NCT00261716|7190975|FG000|Overall Study|Lost to Follow-up|0
4411130|NCT00261716|7190976|FG001|Overall Study|Lost to Follow-up|2
4411131|NCT00261833|7190988|FG000|Overall Study|Death|1
4411132|NCT00261833|7190989|FG001|Overall Study|Death|3
4411133|NCT00261833|7190988|FG000|Overall Study|Adverse Event|1
4411134|NCT00261833|7190989|FG001|Overall Study|Adverse Event|4
4411135|NCT00261833|7190988|FG000|Overall Study|Withdrawal by Subject|5
4411136|NCT00261833|7190989|FG001|Overall Study|Withdrawal by Subject|7
4411137|NCT00261833|7190988|FG000|Overall Study|Protocol Violation|0
4411138|NCT00261833|7190989|FG001|Overall Study|Protocol Violation|1
4411139|NCT00261833|7190988|FG000|Overall Study|Suspicion of pulmonary cancer|0
4411140|NCT00261833|7190989|FG001|Overall Study|Suspicion of pulmonary cancer|1
4411141|NCT00261833|7190988|FG000|Overall Study|Lung transplantation|1
4411142|NCT00261833|7190989|FG001|Overall Study|Lung transplantation|1
4411143|NCT00261833|7190988|FG000|Overall Study|Missing reason|1
4411144|NCT00261833|7190989|FG001|Overall Study|Missing reason|0
4411145|NCT00261833|7190988|FG000|Overall Study|Not interested in being participant|0
4411146|NCT00261833|7190989|FG001|Overall Study|Not interested in being participant|1
4411147|NCT00261846|7191005|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3
4411148|NCT00261846|7191006|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3
4411149|NCT00261846|7191007|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12
4411150|NCT00261846|7191008|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
4411151|NCT00261846|7191009|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
4411152|NCT00261846|7191010|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
4411153|NCT00261846|7191011|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
4411154|NCT00261846|7191012|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
4411155|NCT00261846|7191013|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
4411156|NCT00261846|7191014|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
4411157|NCT00261846|7191015|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
4411158|NCT00261846|7191016|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
4411159|NCT00261846|7191005|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
4411160|NCT00261846|7191006|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
4411161|NCT00261846|7191007|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
4411162|NCT00261846|7191008|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1
4411163|NCT00261846|7191009|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
4411164|NCT00261846|7191010|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
4411165|NCT00261846|7191011|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
4411166|NCT00261846|7191012|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
4411167|NCT00261846|7191013|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1
4411168|NCT00261846|7191014|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
4411169|NCT00261846|7191015|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
4411170|NCT00261846|7191016|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
4411171|NCT00261846|7191005|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
4411172|NCT00261846|7191006|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
4411173|NCT00261846|7191007|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
4411174|NCT00261846|7191008|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9
4411175|NCT00261846|7191009|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8
4411176|NCT00261846|7191010|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1
4411177|NCT00261846|7191011|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3
4411178|NCT00261846|7191012|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3
4411179|NCT00261846|7191013|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
4411180|NCT00261846|7191014|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2
4411181|NCT00261846|7191015|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
4411182|NCT00261846|7191016|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
4411183|NCT00261846|7191005|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
4411184|NCT00261846|7191006|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
4411185|NCT00261846|7191007|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
4411186|NCT00261846|7191008|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12
4411187|NCT00261846|7191009|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
4411188|NCT00261846|7191010|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
4411189|NCT00261846|7191011|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
4629083|NCT01868022|7496661|FG007|Overall Study|Withdrawal by Subject|1
4629084|NCT01868022|7496662|FG008|Overall Study|Withdrawal by Subject|0
4411190|NCT00261846|7191012|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
4411191|NCT00261846|7191013|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1
4411192|NCT00261846|7191014|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
4411193|NCT00261846|7191015|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
4411194|NCT00261846|7191016|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
4411195|NCT00261846|7191005|FG000|Period 2: Part 2 (Efficacy)|Other|0
4411196|NCT00261846|7191006|FG001|Period 2: Part 2 (Efficacy)|Other|0
4411197|NCT00261846|7191007|FG002|Period 2: Part 2 (Efficacy)|Other|0
4411198|NCT00261846|7191008|FG003|Period 2: Part 2 (Efficacy)|Other|15
4411199|NCT00261846|7191009|FG004|Period 2: Part 2 (Efficacy)|Other|4
4411200|NCT00261846|7191010|FG005|Period 2: Part 2 (Efficacy)|Other|0
4411201|NCT00261846|7191011|FG006|Period 2: Part 2 (Efficacy)|Other|1
4411202|NCT00261846|7191012|FG007|Period 2: Part 2 (Efficacy)|Other|5
4411203|NCT00261846|7191013|FG008|Period 2: Part 2 (Efficacy)|Other|4
4411204|NCT00261846|7191014|FG009|Period 2: Part 2 (Efficacy)|Other|4
4411205|NCT00261846|7191015|FG010|Period 2: Part 2 (Efficacy)|Other|0
4411206|NCT00261846|7191016|FG011|Period 2: Part 2 (Efficacy)|Other|0
4411207|NCT00261846|7191005|FG000|Period 2: Part 2 (Efficacy)|Death|0
4411208|NCT00261846|7191006|FG001|Period 2: Part 2 (Efficacy)|Death|0
4411209|NCT00261846|7191007|FG002|Period 2: Part 2 (Efficacy)|Death|0
4411210|NCT00261846|7191008|FG003|Period 2: Part 2 (Efficacy)|Death|37
4411211|NCT00261846|7191009|FG004|Period 2: Part 2 (Efficacy)|Death|7
4411212|NCT00261846|7191010|FG005|Period 2: Part 2 (Efficacy)|Death|1
4629085|NCT01868022|7496654|FG000|Overall Study|Adverse Event|0
4411213|NCT00261846|7191011|FG006|Period 2: Part 2 (Efficacy)|Death|10
4411214|NCT00261846|7191012|FG007|Period 2: Part 2 (Efficacy)|Death|12
4411215|NCT00261846|7191013|FG008|Period 2: Part 2 (Efficacy)|Death|3
4411216|NCT00261846|7191014|FG009|Period 2: Part 2 (Efficacy)|Death|30
4411217|NCT00261846|7191015|FG010|Period 2: Part 2 (Efficacy)|Death|44
4411218|NCT00261846|7191016|FG011|Period 2: Part 2 (Efficacy)|Death|22
4411219|NCT00261846|7191005|FG000|Period 2: Part 2 (Efficacy)|Extension study|0
4411220|NCT00261846|7191006|FG001|Period 2: Part 2 (Efficacy)|Extension study|0
4411221|NCT00261846|7191007|FG002|Period 2: Part 2 (Efficacy)|Extension study|0
4411222|NCT00261846|7191008|FG003|Period 2: Part 2 (Efficacy)|Extension study|61
4411223|NCT00261846|7191009|FG004|Period 2: Part 2 (Efficacy)|Extension study|27
4411224|NCT00261846|7191010|FG005|Period 2: Part 2 (Efficacy)|Extension study|0
4411225|NCT00261846|7191011|FG006|Period 2: Part 2 (Efficacy)|Extension study|4
4411226|NCT00261846|7191012|FG007|Period 2: Part 2 (Efficacy)|Extension study|9
4411227|NCT00261846|7191013|FG008|Period 2: Part 2 (Efficacy)|Extension study|5
4411228|NCT00261846|7191014|FG009|Period 2: Part 2 (Efficacy)|Extension study|9
4411229|NCT00261846|7191015|FG010|Period 2: Part 2 (Efficacy)|Extension study|1
4411230|NCT00261846|7191016|FG011|Period 2: Part 2 (Efficacy)|Extension study|1
4411231|NCT00261950|7191055|FG000|Overall Study|Lost to Follow-up|2
4411232|NCT00261950|7191055|FG000|Overall Study|Death|6
4411233|NCT00261950|7191055|FG000|Overall Study|Withdrawal by Subject|5
4411234|NCT00261950|7191055|FG000|Overall Study|Other|1
4411235|NCT00261950|7191055|FG000|Overall Study|Physician Decision|1
4411236|NCT00261950|7191055|FG000|Overall Study|Protocol specified Criteria|11
4411237|NCT00262002|7191066|FG000|Overall Study|Adverse Event|2
4411238|NCT00262002|7191067|FG001|Overall Study|Adverse Event|1
4411239|NCT00262002|7191068|FG002|Overall Study|Adverse Event|0
4411240|NCT00262002|7191069|FG003|Overall Study|Adverse Event|0
4411241|NCT00262002|7191070|FG004|Overall Study|Adverse Event|0
4411242|NCT00262002|7191071|FG005|Overall Study|Adverse Event|1
4411243|NCT00262002|7191072|FG006|Overall Study|Adverse Event|0
4411244|NCT00262002|7191066|FG000|Overall Study|Withdrawal by Subject|4
4411245|NCT00262002|7191067|FG001|Overall Study|Withdrawal by Subject|2
4411246|NCT00262002|7191068|FG002|Overall Study|Withdrawal by Subject|0
4411247|NCT00262002|7191069|FG003|Overall Study|Withdrawal by Subject|1
4411248|NCT00262002|7191070|FG004|Overall Study|Withdrawal by Subject|2
4411249|NCT00262002|7191071|FG005|Overall Study|Withdrawal by Subject|2
4411250|NCT00262002|7191072|FG006|Overall Study|Withdrawal by Subject|2
4411251|NCT00262002|7191066|FG000|Overall Study|Lost to Follow-up|2
4411252|NCT00262002|7191067|FG001|Overall Study|Lost to Follow-up|0
4411253|NCT00262002|7191068|FG002|Overall Study|Lost to Follow-up|0
4411254|NCT00262002|7191069|FG003|Overall Study|Lost to Follow-up|2
4411255|NCT00262002|7191070|FG004|Overall Study|Lost to Follow-up|0
4411256|NCT00262002|7191071|FG005|Overall Study|Lost to Follow-up|1
4411257|NCT00262002|7191072|FG006|Overall Study|Lost to Follow-up|0
4411258|NCT00262002|7191066|FG000|Overall Study|Inapropriate enrollment|0
4411259|NCT00262002|7191067|FG001|Overall Study|Inapropriate enrollment|1
4411260|NCT00262002|7191068|FG002|Overall Study|Inapropriate enrollment|0
4411261|NCT00262002|7191069|FG003|Overall Study|Inapropriate enrollment|0
4411262|NCT00262002|7191070|FG004|Overall Study|Inapropriate enrollment|0
4411263|NCT00262002|7191071|FG005|Overall Study|Inapropriate enrollment|0
4411264|NCT00262002|7191072|FG006|Overall Study|Inapropriate enrollment|0
4411265|NCT00262002|7191066|FG000|Overall Study|Protocol Violation|3
4411266|NCT00262002|7191067|FG001|Overall Study|Protocol Violation|2
4411267|NCT00262002|7191068|FG002|Overall Study|Protocol Violation|0
4411268|NCT00262002|7191069|FG003|Overall Study|Protocol Violation|2
4411269|NCT00262002|7191070|FG004|Overall Study|Protocol Violation|5
4411270|NCT00262002|7191071|FG005|Overall Study|Protocol Violation|3
4411271|NCT00262002|7191072|FG006|Overall Study|Protocol Violation|2
4411272|NCT00262002|7191066|FG000|Overall Study|Unable to classify|0
4411273|NCT00262002|7191067|FG001|Overall Study|Unable to classify|0
4411274|NCT00262002|7191068|FG002|Overall Study|Unable to classify|0
4411275|NCT00262002|7191069|FG003|Overall Study|Unable to classify|0
4411276|NCT00262002|7191070|FG004|Overall Study|Unable to classify|0
4411277|NCT00262002|7191071|FG005|Overall Study|Unable to classify|0
4411278|NCT00262002|7191072|FG006|Overall Study|Unable to classify|2
4411279|NCT00262028|7191146|FG000|Overall Study|Withdrawal by Subject|6
4411280|NCT00262028|7191147|FG001|Overall Study|Withdrawal by Subject|3
4629086|NCT01868022|7496655|FG001|Overall Study|Adverse Event|0
4629087|NCT01868022|7496656|FG002|Overall Study|Adverse Event|0
4411281|NCT00262028|7191148|FG002|Overall Study|Withdrawal by Subject|6
4411282|NCT00262028|7191149|FG003|Overall Study|Withdrawal by Subject|5
4411283|NCT00262028|7191150|FG004|Overall Study|Withdrawal by Subject|2
4411284|NCT00262028|7191151|FG005|Overall Study|Withdrawal by Subject|3
4411285|NCT00262028|7191152|FG006|Overall Study|Withdrawal by Subject|5
4411286|NCT00262028|7191153|FG007|Overall Study|Withdrawal by Subject|7
4411287|NCT00262028|7191154|FG008|Overall Study|Withdrawal by Subject|2
4411288|NCT00262028|7191146|FG000|Overall Study|Lost to Follow-up|7
4411289|NCT00262028|7191147|FG001|Overall Study|Lost to Follow-up|7
4411290|NCT00262028|7191148|FG002|Overall Study|Lost to Follow-up|5
4411291|NCT00262028|7191149|FG003|Overall Study|Lost to Follow-up|5
4411292|NCT00262028|7191150|FG004|Overall Study|Lost to Follow-up|4
4411293|NCT00262028|7191151|FG005|Overall Study|Lost to Follow-up|3
4411294|NCT00262028|7191152|FG006|Overall Study|Lost to Follow-up|3
4411295|NCT00262028|7191153|FG007|Overall Study|Lost to Follow-up|5
4629088|NCT01868022|7496657|FG003|Overall Study|Adverse Event|0
4629089|NCT01868022|7496658|FG004|Overall Study|Adverse Event|2
4629090|NCT01868022|7496659|FG005|Overall Study|Adverse Event|0
4411296|NCT00262028|7191154|FG008|Overall Study|Lost to Follow-up|6
4411297|NCT00262028|7191146|FG000|Overall Study|Administrative Reason|11
4411298|NCT00262028|7191147|FG001|Overall Study|Administrative Reason|14
4411299|NCT00262028|7191148|FG002|Overall Study|Administrative Reason|9
4411300|NCT00262028|7191149|FG003|Overall Study|Administrative Reason|12
4411301|NCT00262028|7191150|FG004|Overall Study|Administrative Reason|6
4411302|NCT00262028|7191151|FG005|Overall Study|Administrative Reason|7
4411303|NCT00262028|7191152|FG006|Overall Study|Administrative Reason|4
4411304|NCT00262028|7191153|FG007|Overall Study|Administrative Reason|6
4411305|NCT00262028|7191154|FG008|Overall Study|Administrative Reason|10
4411306|NCT00262028|7191146|FG000|Overall Study|Protocol Violation|0
4411307|NCT00262028|7191147|FG001|Overall Study|Protocol Violation|0
4411308|NCT00262028|7191148|FG002|Overall Study|Protocol Violation|0
4411309|NCT00262028|7191149|FG003|Overall Study|Protocol Violation|1
4411310|NCT00262028|7191150|FG004|Overall Study|Protocol Violation|0
4411311|NCT00262028|7191151|FG005|Overall Study|Protocol Violation|0
4411312|NCT00262028|7191152|FG006|Overall Study|Protocol Violation|0
4411313|NCT00262028|7191153|FG007|Overall Study|Protocol Violation|0
4411314|NCT00262028|7191154|FG008|Overall Study|Protocol Violation|0
4411315|NCT00262028|7191146|FG000|Overall Study|Unable to classify|0
4411316|NCT00262028|7191147|FG001|Overall Study|Unable to classify|3
4411317|NCT00262028|7191148|FG002|Overall Study|Unable to classify|0
4411318|NCT00262028|7191149|FG003|Overall Study|Unable to classify|0
4411319|NCT00262028|7191150|FG004|Overall Study|Unable to classify|0
4411320|NCT00262028|7191151|FG005|Overall Study|Unable to classify|0
4411321|NCT00262028|7191152|FG006|Overall Study|Unable to classify|0
4411322|NCT00262028|7191153|FG007|Overall Study|Unable to classify|0
4411323|NCT00262028|7191154|FG008|Overall Study|Unable to classify|1
4411324|NCT00262041|7191200|FG000|Overall Study|Withdrawal by Subject|0
4411325|NCT00262041|7191201|FG001|Overall Study|Withdrawal by Subject|3
4411326|NCT00262041|7191202|FG002|Overall Study|Withdrawal by Subject|1
4411327|NCT00262041|7191200|FG000|Overall Study|Lost to Follow-up|1
4411328|NCT00262041|7191201|FG001|Overall Study|Lost to Follow-up|1
4411329|NCT00262041|7191202|FG002|Overall Study|Lost to Follow-up|5
4411330|NCT00262041|7191200|FG000|Overall Study|Unable to classify|1
4411331|NCT00262041|7191201|FG001|Overall Study|Unable to classify|0
4411332|NCT00262041|7191202|FG002|Overall Study|Unable to classify|0
4411333|NCT00262067|7191220|FG000|Overall Study|Death|190
4411334|NCT00262067|7191221|FG001|Overall Study|Death|89
4411335|NCT00262067|7191222|FG002|Overall Study|Death|186
4411336|NCT00262067|7191223|FG003|Overall Study|Death|99
4411337|NCT00262067|7191220|FG000|Overall Study|Lost to Follow-up|5
4411338|NCT00262067|7191221|FG001|Overall Study|Lost to Follow-up|4
4411339|NCT00262067|7191222|FG002|Overall Study|Lost to Follow-up|7
4411340|NCT00262067|7191223|FG003|Overall Study|Lost to Follow-up|5
4411341|NCT00262067|7191220|FG000|Overall Study|Sponsor's Decision to Terminate Study|1
4411342|NCT00262067|7191221|FG001|Overall Study|Sponsor's Decision to Terminate Study|0
4411343|NCT00262067|7191222|FG002|Overall Study|Sponsor's Decision to Terminate Study|0
4411344|NCT00262067|7191223|FG003|Overall Study|Sponsor's Decision to Terminate Study|0
4411345|NCT00262067|7191220|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23
4411346|NCT00262067|7191221|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7
4411347|NCT00262067|7191222|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23
4411348|NCT00262067|7191223|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9
4411349|NCT00262080|7191236|FG000|Double Blind Treatment Period|Lost to Follow-up|1
4411350|NCT00262080|7191237|FG001|Double Blind Treatment Period|Lost to Follow-up|0
4411351|NCT00262080|7191238|FG002|Double Blind Treatment Period|Lost to Follow-up|0
4411352|NCT00262080|7191236|FG000|Repeat Dose Treatment Period|Adverse Event|1
4411353|NCT00262080|7191237|FG001|Repeat Dose Treatment Period|Adverse Event|0
4411354|NCT00262080|7191238|FG002|Repeat Dose Treatment Period|Adverse Event|0
4411355|NCT00262080|7191236|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0
4411356|NCT00262080|7191237|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1
4411357|NCT00262080|7191238|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1
4411358|NCT00262080|7191236|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2
4629091|NCT01868022|7496660|FG006|Overall Study|Adverse Event|0
4629092|NCT01868022|7496661|FG007|Overall Study|Adverse Event|2
4629093|NCT01868022|7496662|FG008|Overall Study|Adverse Event|2
4629094|NCT01868022|7496654|FG000|Overall Study|Physician Decision|0
4629095|NCT01868022|7496655|FG001|Overall Study|Physician Decision|0
4629096|NCT01868022|7496656|FG002|Overall Study|Physician Decision|0
4629097|NCT01868022|7496657|FG003|Overall Study|Physician Decision|0
4629098|NCT01868022|7496658|FG004|Overall Study|Physician Decision|0
4629099|NCT01868022|7496659|FG005|Overall Study|Physician Decision|1
4411359|NCT00262080|7191237|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0
4411360|NCT00262080|7191238|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2
4411361|NCT00262080|7191236|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0
4411362|NCT00262080|7191237|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0
4411363|NCT00262080|7191238|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2
4411364|NCT00262080|7191236|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1
4411365|NCT00262080|7191237|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0
4411366|NCT00262080|7191238|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0
4629100|NCT01868022|7496660|FG006|Overall Study|Physician Decision|0
4411367|NCT00262119|7191249|FG000|Overall Study|Lost to Follow-up|38
4411368|NCT00262119|7191250|FG001|Overall Study|Lost to Follow-up|51
4411369|NCT00262119|7191251|FG002|Overall Study|Lost to Follow-up|42
4411370|NCT00262119|7191249|FG000|Overall Study|Death|20
4411371|NCT00262119|7191250|FG001|Overall Study|Death|19
4411372|NCT00262119|7191251|FG002|Overall Study|Death|16
4411373|NCT00262223|7191261|FG000|Treatment Phase|Withdrawal by Subject|3
4411374|NCT00262223|7191262|FG001|Treatment Phase|Withdrawal by Subject|6
4411375|NCT00262223|7191261|FG000|Treatment Phase|Adverse Event|1
4411376|NCT00262223|7191262|FG001|Treatment Phase|Adverse Event|2
4411377|NCT00262223|7191261|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4
4411378|NCT00262223|7191262|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4
4411379|NCT00262223|7191261|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6
4411380|NCT00262223|7191262|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1
4411381|NCT00262223|7191261|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7
4411382|NCT00262223|7191262|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7
4411383|NCT00262301|7191272|FG000|Double-blind Phase|Lost to Follow-up|1
4411384|NCT00262301|7191273|FG001|Double-blind Phase|Lost to Follow-up|0
4411385|NCT00262301|7191274|FG002|Double-blind Phase|Lost to Follow-up|0
4411386|NCT00262301|7191272|FG000|Double-blind Phase|"worsening of HAE symptoms"|0
4411387|NCT00262301|7191273|FG001|Double-blind Phase|"worsening of HAE symptoms"|1
4411388|NCT00262301|7191274|FG002|Double-blind Phase|"worsening of HAE symptoms"|0
4411389|NCT00262314|7191282|FG000|Overall Study|Changing physicians|38
4411390|NCT00262314|7191282|FG000|Overall Study|Death|12
4411391|NCT00262314|7191282|FG000|Overall Study|Patient's decision|92
4411392|NCT00262314|7191282|FG000|Overall Study|Other|95
4411393|NCT00262314|7191282|FG000|Overall Study|Lost to Follow-up|70
4411394|NCT00262314|7191282|FG000|Overall Study|Administrative withdrawal|30
4411395|NCT00262522|7191299|FG000|Study Start Through 8 Weeks|Adverse Event|1
4411396|NCT00262522|7191300|FG001|Study Start Through 8 Weeks|Adverse Event|2
4411397|NCT00262522|7191301|FG002|Study Start Through 8 Weeks|Adverse Event|3
4411398|NCT00262522|7191302|FG003|Study Start Through 8 Weeks|Adverse Event|1
4411399|NCT00262522|7191299|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1
4411400|NCT00262522|7191300|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1
4411401|NCT00262522|7191301|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3
4411402|NCT00262522|7191302|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0
4411403|NCT00262522|7191299|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1
4411404|NCT00262522|7191300|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2
4411405|NCT00262522|7191301|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3
4411406|NCT00262522|7191302|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2
4411407|NCT00262522|7191299|FG000|Study Start Through 8 Weeks|Noncompliance|0
4411408|NCT00262522|7191300|FG001|Study Start Through 8 Weeks|Noncompliance|0
4411409|NCT00262522|7191301|FG002|Study Start Through 8 Weeks|Noncompliance|2
4411410|NCT00262522|7191302|FG003|Study Start Through 8 Weeks|Noncompliance|2
4411411|NCT00262522|7191299|FG000|Study Start Through 8 Weeks|Death|1
4411412|NCT00262522|7191300|FG001|Study Start Through 8 Weeks|Death|0
4411413|NCT00262522|7191301|FG002|Study Start Through 8 Weeks|Death|0
4411414|NCT00262522|7191302|FG003|Study Start Through 8 Weeks|Death|0
4629101|NCT01868022|7496661|FG007|Overall Study|Physician Decision|2
4629102|NCT01868022|7496662|FG008|Overall Study|Physician Decision|0
4629103|NCT01868022|7496654|FG000|Overall Study|Study closed/terminated|0
4629104|NCT01868022|7496655|FG001|Overall Study|Study closed/terminated|0
4629105|NCT01868022|7496656|FG002|Overall Study|Study closed/terminated|0
4629106|NCT01868022|7496657|FG003|Overall Study|Study closed/terminated|0
4629107|NCT01868022|7496658|FG004|Overall Study|Study closed/terminated|0
4629108|NCT01868022|7496659|FG005|Overall Study|Study closed/terminated|0
4629109|NCT01868022|7496660|FG006|Overall Study|Study closed/terminated|0
4629110|NCT01868022|7496661|FG007|Overall Study|Study closed/terminated|1
4629111|NCT01868022|7496662|FG008|Overall Study|Study closed/terminated|0
4629112|NCT01868022|7496654|FG000|Overall Study|Ongoing|0
4629113|NCT01868022|7496655|FG001|Overall Study|Ongoing|0
4629114|NCT01868022|7496656|FG002|Overall Study|Ongoing|0
4629115|NCT01868022|7496657|FG003|Overall Study|Ongoing|0
4629116|NCT01868022|7496658|FG004|Overall Study|Ongoing|0
4629117|NCT01868022|7496659|FG005|Overall Study|Ongoing|0
4629118|NCT01868022|7496660|FG006|Overall Study|Ongoing|0
4629119|NCT01868022|7496661|FG007|Overall Study|Ongoing|3
4629120|NCT01868022|7496662|FG008|Overall Study|Ongoing|0
4629121|NCT01868035|7496688|FG000|Overall Study|Lost to Follow-up|3
4629122|NCT01868035|7496688|FG000|Overall Study|Withdrawal by Subject|1
4629123|NCT01868035|7496688|FG000|Overall Study|Progressive Disease|2
4411415|NCT00262522|7191299|FG000|Study Start Through 48 Weeks|Adverse Event|16
4411416|NCT00262522|7191300|FG001|Study Start Through 48 Weeks|Adverse Event|0
4411417|NCT00262522|7191301|FG002|Study Start Through 48 Weeks|Adverse Event|10
4411418|NCT00262522|7191302|FG003|Study Start Through 48 Weeks|Adverse Event|0
4411419|NCT00262522|7191299|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10
4411420|NCT00262522|7191300|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0
4411421|NCT00262522|7191301|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11
4411422|NCT00262522|7191302|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0
4411423|NCT00262522|7191299|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8
4629124|NCT01868035|7496688|FG000|Overall Study|Non-compliance|1
4629125|NCT01868074|7496694|FG000|Overall Study|Lost to Follow-up|3
4411424|NCT00262522|7191300|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0
4411425|NCT00262522|7191301|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14
4411426|NCT00262522|7191302|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0
4411427|NCT00262522|7191299|FG000|Study Start Through 48 Weeks|Noncompliance|3
4411428|NCT00262522|7191300|FG001|Study Start Through 48 Weeks|Noncompliance|0
4411429|NCT00262522|7191301|FG002|Study Start Through 48 Weeks|Noncompliance|8
4411430|NCT00262522|7191302|FG003|Study Start Through 48 Weeks|Noncompliance|0
4411431|NCT00262522|7191299|FG000|Study Start Through 48 Weeks|Death|2
4411432|NCT00262522|7191300|FG001|Study Start Through 48 Weeks|Death|0
4411433|NCT00262522|7191301|FG002|Study Start Through 48 Weeks|Death|1
4411434|NCT00262522|7191302|FG003|Study Start Through 48 Weeks|Death|0
4411435|NCT00262522|7191299|FG000|Study Start Through 48 Weeks|Virologic failure|2
4411436|NCT00262522|7191300|FG001|Study Start Through 48 Weeks|Virologic failure|0
4411437|NCT00262522|7191301|FG002|Study Start Through 48 Weeks|Virologic failure|4
4411438|NCT00262522|7191302|FG003|Study Start Through 48 Weeks|Virologic failure|0
4411439|NCT00262522|7191299|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8
4411440|NCT00262522|7191300|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0
4411441|NCT00262522|7191301|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7
4411442|NCT00262522|7191302|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0
4411443|NCT00262522|7191299|FG000|Study Start Through 96 Weeks|Adverse Event|20
4411444|NCT00262522|7191300|FG001|Study Start Through 96 Weeks|Adverse Event|0
4411445|NCT00262522|7191301|FG002|Study Start Through 96 Weeks|Adverse Event|16
4411446|NCT00262522|7191302|FG003|Study Start Through 96 Weeks|Adverse Event|0
4411447|NCT00262522|7191299|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15
4411448|NCT00262522|7191300|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0
4411449|NCT00262522|7191301|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13
4411450|NCT00262522|7191302|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0
4411451|NCT00262522|7191299|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19
4411452|NCT00262522|7191300|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0
4411453|NCT00262522|7191301|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18
4411454|NCT00262522|7191302|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0
4411455|NCT00262522|7191299|FG000|Study Start Through 96 Weeks|Noncompliance|6
4411456|NCT00262522|7191300|FG001|Study Start Through 96 Weeks|Noncompliance|0
4411457|NCT00262522|7191301|FG002|Study Start Through 96 Weeks|Noncompliance|11
4411458|NCT00262522|7191302|FG003|Study Start Through 96 Weeks|Noncompliance|0
4411459|NCT00262522|7191299|FG000|Study Start Through 96 Weeks|Death|2
4411460|NCT00262522|7191300|FG001|Study Start Through 96 Weeks|Death|0
4411461|NCT00262522|7191301|FG002|Study Start Through 96 Weeks|Death|2
4411462|NCT00262522|7191302|FG003|Study Start Through 96 Weeks|Death|0
4411463|NCT00262522|7191299|FG000|Study Start Through 96 Weeks|Virologic failure|5
4411464|NCT00262522|7191300|FG001|Study Start Through 96 Weeks|Virologic failure|0
4411465|NCT00262522|7191301|FG002|Study Start Through 96 Weeks|Virologic failure|8
4411466|NCT00262522|7191302|FG003|Study Start Through 96 Weeks|Virologic failure|0
4411467|NCT00262522|7191299|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10
4411468|NCT00262522|7191300|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0
4411469|NCT00262522|7191301|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9
4411470|NCT00262522|7191302|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0
4411471|NCT00262600|7191313|FG000|Overall Study|Lost to Follow-up|17
4411472|NCT00262600|7191314|FG001|Overall Study|Lost to Follow-up|31
4411473|NCT00262600|7191315|FG002|Overall Study|Lost to Follow-up|41
4411474|NCT00262600|7191313|FG000|Overall Study|Withdrawal by Subject|128
4411475|NCT00262600|7191314|FG001|Overall Study|Withdrawal by Subject|145
4411476|NCT00262600|7191315|FG002|Overall Study|Withdrawal by Subject|139
4411477|NCT00262600|7191313|FG000|Overall Study|Not Treated|32
4411478|NCT00262600|7191314|FG001|Overall Study|Not Treated|17
4411479|NCT00262600|7191315|FG002|Overall Study|Not Treated|24
4411480|NCT00262600|7191313|FG000|Overall Study|Other|58
4411481|NCT00262600|7191314|FG001|Overall Study|Other|59
4411482|NCT00262600|7191315|FG002|Overall Study|Other|62
4411483|NCT00262743|7191346|FG000|Overall Study|Adverse Event|0
4411484|NCT00262743|7191347|FG001|Overall Study|Adverse Event|9
4411485|NCT00262743|7191346|FG000|Overall Study|Disease progression|0
4411486|NCT00262743|7191347|FG001|Overall Study|Disease progression|3
4411487|NCT00262821|7191353|FG000|Overall Study|Ineligible - wrong stage|0
4411488|NCT00262821|7191354|FG001|Overall Study|Ineligible - wrong stage|3
4411489|NCT00262821|7191353|FG000|Overall Study|Ineligible - wrong cell type|2
4411490|NCT00262821|7191354|FG001|Overall Study|Ineligible - wrong cell type|2
4411491|NCT00262821|7191353|FG000|Overall Study|Ineligible - wrong primary|0
4411492|NCT00262821|7191354|FG001|Overall Study|Ineligible - wrong primary|1
4411493|NCT00262821|7191353|FG000|Overall Study|Ineligible - inadequate pathology|1
4411494|NCT00262821|7191354|FG001|Overall Study|Ineligible - inadequate pathology|3
4411495|NCT00262821|7191353|FG000|Overall Study|Ineligible - elevated creatinine|0
4411496|NCT00262821|7191354|FG001|Overall Study|Ineligible - elevated creatinine|2
4411497|NCT00262821|7191353|FG000|Overall Study|Ineligible - required test not done|1
4411498|NCT00262821|7191354|FG001|Overall Study|Ineligible - required test not done|4
4411499|NCT00262821|7191353|FG000|Overall Study|Inevaluable - inadequate data|0
4411500|NCT00262821|7191354|FG001|Overall Study|Inevaluable - inadequate data|4
4411501|NCT00262834|7191362|FG000|Overall Study|Surgery delayed/tissue not collected|1
4411502|NCT00262834|7191363|FG001|Overall Study|Surgery delayed/tissue not collected|4
4411503|NCT00262847|7191372|FG000|Overall Study|Disease Progression|309
4411504|NCT00262847|7191373|FG001|Overall Study|Disease Progression|274
4411505|NCT00262847|7191374|FG002|Overall Study|Disease Progression|195
4411506|NCT00262847|7191372|FG000|Overall Study|Patient Refusal|41
4411507|NCT00262847|7191373|FG001|Overall Study|Patient Refusal|52
4411508|NCT00262847|7191374|FG002|Overall Study|Patient Refusal|47
4411509|NCT00262847|7191372|FG000|Overall Study|Adverse Event|74
4411510|NCT00262847|7191373|FG001|Overall Study|Adverse Event|88
4411511|NCT00262847|7191374|FG002|Overall Study|Adverse Event|108
4411512|NCT00262847|7191372|FG000|Overall Study|Death|8
4411513|NCT00262847|7191373|FG001|Overall Study|Death|8
4411514|NCT00262847|7191374|FG002|Overall Study|Death|11
4411515|NCT00262847|7191372|FG000|Overall Study|Concomitant disease|3
4411516|NCT00262847|7191373|FG001|Overall Study|Concomitant disease|2
4411517|NCT00262847|7191374|FG002|Overall Study|Concomitant disease|4
4411518|NCT00262847|7191372|FG000|Overall Study|Other Reasons|79
4411519|NCT00262847|7191373|FG001|Overall Study|Other Reasons|88
4411520|NCT00262847|7191374|FG002|Overall Study|Other Reasons|27
4411521|NCT00262847|7191372|FG000|Overall Study|Did not receive study treatment|4
4411522|NCT00262847|7191373|FG001|Overall Study|Did not receive study treatment|1
4411523|NCT00262847|7191374|FG002|Overall Study|Did not receive study treatment|4
4411524|NCT00262860|7191385|FG000|Overall Study|Adverse Event|2
4411525|NCT00262873|7191389|FG000|Overall Study|Adverse Event|3
4411526|NCT00262873|7191389|FG000|Overall Study|Withdrawal by Subject|5
4411527|NCT00262925|7191393|FG000|Overall Study|Lack of Efficacy|3
4411528|NCT00262925|7191393|FG000|Overall Study|Adverse Event|4
4411529|NCT00262925|7191393|FG000|Overall Study|Death|2
4411530|NCT00262925|7191393|FG000|Overall Study|alternative therapy|1
4411531|NCT00262925|7191393|FG000|Overall Study|Other|1
4411532|NCT00262951|7191399|FG000|Overall Study|Progressive disease/relapse|3
4411533|NCT00262951|7191399|FG000|Overall Study|Adverse Event|7
4411534|NCT00262951|7191399|FG000|Overall Study|Death|1
4411535|NCT00262951|7191399|FG000|Overall Study|Withdrawal by Subject|1
4411536|NCT00262951|7191399|FG000|Overall Study|Alternative treatment|3
4411537|NCT00262951|7191399|FG000|Overall Study|Off treatment for other disease|1
4411538|NCT00263211|7191432|FG000|Overall Study|Death|1
4411539|NCT00263211|7191433|FG001|Overall Study|Death|0
4411540|NCT00263211|7191432|FG000|Overall Study|Withdrawal by Subject|3
4411541|NCT00263211|7191433|FG001|Overall Study|Withdrawal by Subject|0
4411542|NCT00263211|7191432|FG000|Overall Study|Protocol Violation|1
4411543|NCT00263211|7191433|FG001|Overall Study|Protocol Violation|0
4411544|NCT00263211|7191432|FG000|Overall Study|Disease Progression|0
4411545|NCT00263211|7191433|FG001|Overall Study|Disease Progression|1
4411546|NCT00263328|7191445|FG000|Overall Study|Death|0
4411547|NCT00263328|7191446|FG001|Overall Study|Death|0
4411548|NCT00263328|7191447|FG002|Overall Study|Death|1
4411549|NCT00263328|7191445|FG000|Overall Study|Lost to Follow-up|1
4411550|NCT00263328|7191446|FG001|Overall Study|Lost to Follow-up|1
4411551|NCT00263328|7191447|FG002|Overall Study|Lost to Follow-up|0
4411552|NCT00263328|7191445|FG000|Overall Study|Withdrawal by Subject|3
4411553|NCT00263328|7191446|FG001|Overall Study|Withdrawal by Subject|0
4411554|NCT00263328|7191447|FG002|Overall Study|Withdrawal by Subject|1
4411555|NCT00263328|7191445|FG000|Overall Study|Other|3
4411556|NCT00263328|7191446|FG001|Overall Study|Other|0
4411557|NCT00263328|7191447|FG002|Overall Study|Other|1
4411558|NCT00263328|7191445|FG000|Overall Study|Adverse Event|1
4411559|NCT00263328|7191446|FG001|Overall Study|Adverse Event|1
4411560|NCT00263328|7191447|FG002|Overall Study|Adverse Event|4
4411561|NCT00263562|7191459|FG000|Overall Study|Protocol Violation|3
4411562|NCT00263562|7191460|FG001|Overall Study|Protocol Violation|0
4411563|NCT00263575|7191468|FG000|Titration Period|Adverse Event|14
4411564|NCT00263575|7191468|FG000|Titration Period|Withdrawal by Subject|10
4411565|NCT00263575|7191468|FG000|Titration Period|Protocol Violation|9
4411566|NCT00263575|7191468|FG000|Titration Period|Sponsor Decision|2
4411567|NCT00263575|7191468|FG000|Titration Period|Other|2
4411568|NCT00263575|7191468|FG000|Titration Period|Lack of Efficacy|6
4411569|NCT00263575|7191468|FG000|Maintence Period|Adverse Event|23
4411570|NCT00263575|7191468|FG000|Maintence Period|Withdrawal by Subject|8
4411571|NCT00263575|7191468|FG000|Maintence Period|Protocol Violation|4
4411572|NCT00263575|7191468|FG000|Maintence Period|Lack of Efficacy|4
4411573|NCT00263575|7191468|FG000|Maintence Period|Physician Decision|6
4411574|NCT00263575|7191468|FG000|Maintence Period|Lost to Follow-up|1
4411575|NCT00263575|7191468|FG000|Maintence Period|Sponsor Decision|24
4411576|NCT00263575|7191468|FG000|Maintence Period|Other|7
4411577|NCT00263588|7191476|FG000|Overall Study|Death|54
4411578|NCT00263588|7191477|FG001|Overall Study|Death|90
4411579|NCT00263588|7191476|FG000|Overall Study|disease progression, coma, 1 unknown|10
4411580|NCT00263588|7191477|FG001|Overall Study|disease progression, coma, 1 unknown|11
4411581|NCT00263588|7191476|FG000|Overall Study|Lost to Follow-up|7
4411582|NCT00263588|7191477|FG001|Overall Study|Lost to Follow-up|10
4411583|NCT00263588|7191476|FG000|Overall Study|Withdrawal by Subject|3
4411584|NCT00263588|7191477|FG001|Overall Study|Withdrawal by Subject|4
4411585|NCT00263588|7191476|FG000|Overall Study|Protocol Violation|0
4411586|NCT00263588|7191477|FG001|Overall Study|Protocol Violation|1
4411587|NCT00263588|7191476|FG000|Overall Study|Investigator decision|7
4411588|NCT00263588|7191477|FG001|Overall Study|Investigator decision|15
4411589|NCT00263588|7191476|FG000|Overall Study|Sponsor terminated study|0
4411590|NCT00263588|7191477|FG001|Overall Study|Sponsor terminated study|1
4411591|NCT00263666|7191486|FG000|Overall Study|Adverse Event|6
4411592|NCT00263666|7191487|FG001|Overall Study|Adverse Event|8
4411593|NCT00263666|7191486|FG000|Overall Study|Lost to Follow-up|1
4411594|NCT00263666|7191487|FG001|Overall Study|Lost to Follow-up|2
4411595|NCT00263666|7191486|FG000|Overall Study|Withdrawal by Subject|0
4411596|NCT00263666|7191487|FG001|Overall Study|Withdrawal by Subject|1
4411597|NCT00263757|7191495|FG000|Overall Study|Withdrawal by Subject|5
4411598|NCT00263757|7191496|FG001|Overall Study|Withdrawal by Subject|4
4411599|NCT00263757|7191495|FG000|Overall Study|Screen failure|0
4411600|NCT00263757|7191496|FG001|Overall Study|Screen failure|1
4411601|NCT00263757|7191495|FG000|Overall Study|Adverse Event|3
4411602|NCT00263757|7191496|FG001|Overall Study|Adverse Event|3
4411603|NCT00263887|7191504|FG000|Overall Study|Withdrawal by Subject|1
4411604|NCT00263887|7191505|FG001|Overall Study|Withdrawal by Subject|1
4411605|NCT00263887|7191504|FG000|Overall Study|Lung transplantation|1
4411606|NCT00263887|7191505|FG001|Overall Study|Lung transplantation|2
4411607|NCT00263887|7191504|FG000|Overall Study|Too ill to attend visit|1
4411608|NCT00263887|7191505|FG001|Overall Study|Too ill to attend visit|0
4411609|NCT00263887|7191504|FG000|Overall Study|Adverse Event|0
4411610|NCT00263887|7191505|FG001|Overall Study|Adverse Event|2
4713699|NCT02951988|7641529|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0
4713700|NCT02951988|7641530|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0
4713701|NCT02951988|7641531|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0
4713702|NCT02951988|7641528|FG000|Open-Label Treatment Period|Study terminated by sponsor|9
4713703|NCT02951988|7641529|FG001|Open-Label Treatment Period|Study terminated by sponsor|0
4713704|NCT02951988|7641530|FG002|Open-Label Treatment Period|Study terminated by sponsor|0
4713705|NCT02951988|7641531|FG003|Open-Label Treatment Period|Study terminated by sponsor|0
4713706|NCT02951988|7641528|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2
4713707|NCT02951988|7641529|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0
4713708|NCT02951988|7641530|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0
4713709|NCT02951988|7641531|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0
4713710|NCT02951988|7641528|FG000|Open-Label Treatment Period|Non-compliance with study drug|5
4713711|NCT02951988|7641529|FG001|Open-Label Treatment Period|Non-compliance with study drug|0
4713712|NCT02951988|7641530|FG002|Open-Label Treatment Period|Non-compliance with study drug|0
4713713|NCT02951988|7641531|FG003|Open-Label Treatment Period|Non-compliance with study drug|0
4713714|NCT02951988|7641528|FG000|Open-Label Treatment Period|Protocol Violation|22
4713715|NCT02951988|7641529|FG001|Open-Label Treatment Period|Protocol Violation|0
4713716|NCT02951988|7641530|FG002|Open-Label Treatment Period|Protocol Violation|0
4713717|NCT02951988|7641531|FG003|Open-Label Treatment Period|Protocol Violation|0
4713718|NCT02951988|7641528|FG000|Open-Label Treatment Period|Pregnancy|2
4713719|NCT02951988|7641529|FG001|Open-Label Treatment Period|Pregnancy|0
4713720|NCT02951988|7641530|FG002|Open-Label Treatment Period|Pregnancy|0
4713721|NCT02951988|7641531|FG003|Open-Label Treatment Period|Pregnancy|0
4713722|NCT02951988|7641528|FG000|Open-Label Treatment Period|Lost to Follow-up|28
4713723|NCT02951988|7641529|FG001|Open-Label Treatment Period|Lost to Follow-up|0
4713724|NCT02951988|7641530|FG002|Open-Label Treatment Period|Lost to Follow-up|0
4713725|NCT02951988|7641531|FG003|Open-Label Treatment Period|Lost to Follow-up|0
4713726|NCT02951988|7641528|FG000|Open-Label Treatment Period|Withdrawal by Subject|78
4713727|NCT02951988|7641529|FG001|Open-Label Treatment Period|Withdrawal by Subject|0
4713728|NCT02951988|7641530|FG002|Open-Label Treatment Period|Withdrawal by Subject|0
4713729|NCT02951988|7641531|FG003|Open-Label Treatment Period|Withdrawal by Subject|0
4713730|NCT02951988|7641528|FG000|Open-Label Treatment Period|Lack of Efficacy|49
4713731|NCT02951988|7641529|FG001|Open-Label Treatment Period|Lack of Efficacy|0
4713732|NCT02951988|7641530|FG002|Open-Label Treatment Period|Lack of Efficacy|0
4713733|NCT02951988|7641531|FG003|Open-Label Treatment Period|Lack of Efficacy|0
4713734|NCT02951988|7641528|FG000|Open-Label Treatment Period|Adverse Event|45
4713735|NCT02951988|7641529|FG001|Open-Label Treatment Period|Adverse Event|0
4713736|NCT02951988|7641530|FG002|Open-Label Treatment Period|Adverse Event|0
4713737|NCT02951988|7641531|FG003|Open-Label Treatment Period|Adverse Event|0
4713738|NCT02951988|7641528|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0
4713739|NCT02951988|7641529|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0
4713740|NCT02951988|7641530|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1
4713741|NCT02951988|7641531|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1
4713742|NCT02951988|7641528|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0
4713743|NCT02951988|7641529|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58
4713744|NCT02951988|7641530|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54
4713745|NCT02951988|7641531|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69
4411611|NCT00263887|7191504|FG000|Overall Study|Disease progression|0
4411612|NCT00263887|7191505|FG001|Overall Study|Disease progression|1
4411613|NCT00263887|7191504|FG000|Overall Study|Lack of Efficacy|0
4411614|NCT00263887|7191505|FG001|Overall Study|Lack of Efficacy|1
4411615|NCT00264004|7191515|FG000|Overall Study|Adverse Event|2
4411616|NCT00264004|7191516|FG001|Overall Study|Adverse Event|3
4411617|NCT00264004|7191517|FG002|Overall Study|Adverse Event|6
4411618|NCT00264004|7191518|FG003|Overall Study|Adverse Event|4
4411619|NCT00264004|7191515|FG000|Overall Study|Withdrawal by Subject|0
4411620|NCT00264004|7191516|FG001|Overall Study|Withdrawal by Subject|1
4411621|NCT00264004|7191517|FG002|Overall Study|Withdrawal by Subject|2
4411622|NCT00264004|7191518|FG003|Overall Study|Withdrawal by Subject|2
4411623|NCT00264004|7191515|FG000|Overall Study|Other|2
4411624|NCT00264004|7191516|FG001|Overall Study|Other|2
4411625|NCT00264004|7191517|FG002|Overall Study|Other|0
4411626|NCT00264004|7191518|FG003|Overall Study|Other|3
4411627|NCT00264004|7191515|FG000|Overall Study|Development study specific disc. crit.|1
4411628|NCT00264004|7191516|FG001|Overall Study|Development study specific disc. crit.|0
4411629|NCT00264004|7191517|FG002|Overall Study|Development study specific disc. crit.|1
4411630|NCT00264004|7191518|FG003|Overall Study|Development study specific disc. crit.|0
4411631|NCT00264004|7191515|FG000|Overall Study|Cond. under inv. worsened|9
4411632|NCT00264004|7191516|FG001|Overall Study|Cond. under inv. worsened|5
4411633|NCT00264004|7191517|FG002|Overall Study|Cond. under inv. worsened|3
4411634|NCT00264004|7191518|FG003|Overall Study|Cond. under inv. worsened|4
4411635|NCT00264004|7191515|FG000|Overall Study|Not treated|3
4411636|NCT00264004|7191516|FG001|Overall Study|Not treated|0
4411637|NCT00264004|7191517|FG002|Overall Study|Not treated|2
4411638|NCT00264004|7191518|FG003|Overall Study|Not treated|2
4411639|NCT00264238|7191528|FG000|Overall Study|Protocol Violation|1
4411640|NCT00264290|7191536|FG000|Intervention (8 Weeks)|Adverse Event|1
4411641|NCT00264290|7191537|FG001|Intervention (8 Weeks)|Adverse Event|0
4411642|NCT00264303|7191549|FG000|Overall Study|Adverse Event|4
4411643|NCT00264303|7191550|FG001|Overall Study|Adverse Event|3
4411644|NCT00264303|7191549|FG000|Overall Study|Lack of Efficacy|10
4411645|NCT00264303|7191550|FG001|Overall Study|Lack of Efficacy|13
4411646|NCT00264303|7191549|FG000|Overall Study|Lost to Follow-up|3
4411647|NCT00264303|7191550|FG001|Overall Study|Lost to Follow-up|3
4411648|NCT00264303|7191549|FG000|Overall Study|Withdrawal by Subject|2
4629126|NCT01868074|7496695|FG001|Overall Study|Lost to Follow-up|2
4629127|NCT01868074|7496694|FG000|Overall Study|Withdrawal by Subject|4
4629128|NCT01868074|7496695|FG001|Overall Study|Withdrawal by Subject|2
4629129|NCT01868165|7496701|FG000|Overall Study|Withdrawal by Subject|36
4629130|NCT01868165|7496701|FG000|Overall Study|Physician Decision|2
4629131|NCT01868165|7496701|FG000|Overall Study|Lost to Follow-up|3
4629132|NCT01868165|7496701|FG000|Overall Study|Death|4
4629133|NCT01868243|7496707|FG000|Overall Study|Death|0
4629134|NCT01868243|7496708|FG001|Overall Study|Death|1
4629135|NCT01868477|7496770|FG000|Overall Study|Adverse Event|2
4629136|NCT01868477|7496771|FG001|Overall Study|Adverse Event|4
4629137|NCT01868477|7496770|FG000|Overall Study|Disease progression|1
4629138|NCT01868477|7496771|FG001|Overall Study|Disease progression|1
4629139|NCT01868477|7496770|FG000|Overall Study|Withdrawal by Subject|1
4629140|NCT01868477|7496771|FG001|Overall Study|Withdrawal by Subject|0
4629141|NCT01868503|7496784|FG000|Overall Study|Withdrawal by Subject|1
4629142|NCT01868503|7496784|FG000|Overall Study|Protocol Violation|1
4629143|NCT01868542|7496792|FG000|Overall Study|Protocol Violation|0
4629144|NCT01868542|7496793|FG001|Overall Study|Protocol Violation|1
4629145|NCT01868542|7496792|FG000|Overall Study|Unclassified|0
4629146|NCT01868542|7496793|FG001|Overall Study|Unclassified|1
4629147|NCT01868594|7496801|FG000|Overall Study|Do not meet inclusion criteria|4
4629148|NCT01868594|7496802|FG001|Overall Study|Do not meet inclusion criteria|3
4629149|NCT01868646|7496821|FG000|Overall Study|Do not meet inclusion criteria|3
4629150|NCT01868646|7496822|FG001|Overall Study|Do not meet inclusion criteria|5
4629151|NCT01868893|7496846|FG000|Overall Study|Adverse Event|2
4629152|NCT01868893|7496846|FG000|Overall Study|Commercial availability of study drug|17
4629153|NCT01868893|7496846|FG000|Overall Study|Neutropenia|1
4629154|NCT01868997|7496854|FG000|Overall Study|Adverse Event|2
4629155|NCT01868997|7496855|FG001|Overall Study|Adverse Event|5
4629156|NCT01868997|7496854|FG000|Overall Study|Lack of Efficacy|2
4629157|NCT01868997|7496855|FG001|Overall Study|Lack of Efficacy|0
4629158|NCT01868997|7496854|FG000|Overall Study|Other|3
4629159|NCT01868997|7496855|FG001|Overall Study|Other|1
4629160|NCT01869192|7496888|FG000|Preoperative Chemotherapy to Surgery|patient choice|2
4629161|NCT01869192|7496889|FG001|Preoperative Chemotherapy to Surgery|patient choice|1
4629162|NCT01869192|7496888|FG000|Postoperative Chemotherapy|Physician Decision|0
4629163|NCT01869192|7496889|FG001|Postoperative Chemotherapy|Physician Decision|2
4629164|NCT01869348|7496897|FG000|Overall Study|Withdrawal by Subject|1
4629165|NCT01869348|7496898|FG001|Overall Study|Withdrawal by Subject|1
4411649|NCT00264303|7191550|FG001|Overall Study|Withdrawal by Subject|3
4411650|NCT00264303|7191549|FG000|Overall Study|Various reasons listed in study report|6
4411651|NCT00264303|7191550|FG001|Overall Study|Various reasons listed in study report|7
4411652|NCT00264498|7191567|FG000|Randomized Treatment|Death|0
4411653|NCT00264498|7191568|FG001|Randomized Treatment|Death|3
4411654|NCT00264498|7191567|FG000|Randomized Treatment|Withdrawal by Subject|0
4629166|NCT01869699|7496945|FG000|Overall Study|Withdrawal by Subject|1
4629167|NCT01869699|7496946|FG001|Overall Study|Withdrawal by Subject|0
4629168|NCT01869725|7496952|FG000|Overall Study|ineligible after registration|1
4629169|NCT01869725|7496952|FG000|Overall Study|Death|1
4411655|NCT00264498|7191568|FG001|Randomized Treatment|Withdrawal by Subject|1
4411656|NCT00264498|7191567|FG000|Randomized Treatment|Objective disease Progression|13
4411657|NCT00264498|7191568|FG001|Randomized Treatment|Objective disease Progression|14
4411658|NCT00264498|7191567|FG000|Randomized Treatment|Physician Decision|1
4411659|NCT00264498|7191568|FG001|Randomized Treatment|Physician Decision|0
4411660|NCT00264498|7191567|FG000|Randomized Treatment|Incorrectly randomized|1
4411661|NCT00264498|7191568|FG001|Randomized Treatment|Incorrectly randomized|0
4411662|NCT00264498|7191567|FG000|Randomized Treatment|Study Closure|1
4411663|NCT00264498|7191568|FG001|Randomized Treatment|Study Closure|0
4411664|NCT00264498|7191567|FG000|Randomized Treatment|Protocol Violation|1
4411665|NCT00264498|7191568|FG001|Randomized Treatment|Protocol Violation|0
4411666|NCT00264498|7191567|FG000|Crossover Treatment|Death|1
4411667|NCT00264498|7191568|FG001|Crossover Treatment|Death|3
4411668|NCT00264498|7191567|FG000|Crossover Treatment|Objective disease progression|4
4411669|NCT00264498|7191568|FG001|Crossover Treatment|Objective disease progression|5
4411670|NCT00264498|7191567|FG000|Crossover Treatment|Study closure|0
4411671|NCT00264498|7191568|FG001|Crossover Treatment|Study closure|1
4411672|NCT00264498|7191567|FG000|Crossover Treatment|Withdrawal by Subject|1
4411673|NCT00264498|7191568|FG001|Crossover Treatment|Withdrawal by Subject|0
4411674|NCT00264537|7191578|FG000|Overall Study|Death|0
4411675|NCT00264537|7191579|FG001|Overall Study|Death|3
4411676|NCT00264537|7191580|FG002|Overall Study|Death|3
4411677|NCT00264537|7191581|FG003|Overall Study|Death|2
4411678|NCT00264537|7191578|FG000|Overall Study|Lost to Follow-up|3
4411679|NCT00264537|7191579|FG001|Overall Study|Lost to Follow-up|4
4411680|NCT00264537|7191580|FG002|Overall Study|Lost to Follow-up|7
4411681|NCT00264537|7191581|FG003|Overall Study|Lost to Follow-up|6
4411682|NCT00264537|7191578|FG000|Overall Study|Adverse Event|21
4411683|NCT00264537|7191579|FG001|Overall Study|Adverse Event|32
4411684|NCT00264537|7191580|FG002|Overall Study|Adverse Event|24
4411685|NCT00264537|7191581|FG003|Overall Study|Adverse Event|34
4411686|NCT00264537|7191578|FG000|Overall Study|Unsatisfactory therapeutic effect|5
4411687|NCT00264537|7191579|FG001|Overall Study|Unsatisfactory therapeutic effect|6
4411688|NCT00264537|7191580|FG002|Overall Study|Unsatisfactory therapeutic effect|5
4411689|NCT00264537|7191581|FG003|Overall Study|Unsatisfactory therapeutic effect|7
4411690|NCT00264537|7191578|FG000|Overall Study|Other|21
4411691|NCT00264537|7191579|FG001|Overall Study|Other|11
4411692|NCT00264537|7191580|FG002|Overall Study|Other|10
4411693|NCT00264537|7191581|FG003|Overall Study|Other|11
4411694|NCT00264537|7191578|FG000|Overall Study|Not treated|0
4411695|NCT00264537|7191579|FG001|Overall Study|Not treated|2
4411696|NCT00264537|7191580|FG002|Overall Study|Not treated|1
4411697|NCT00264537|7191581|FG003|Overall Study|Not treated|0
4411698|NCT00264550|7191597|FG000|Overall Study|Death|0
4411699|NCT00264550|7191598|FG001|Overall Study|Death|3
4511696|NCT00928512|7321056|FG000|Overall Study|Lack of Efficacy|2
4629170|NCT01869725|7496952|FG000|Overall Study|Lost to Follow-up|2
4629171|NCT01869764|7496958|FG000|Overall Study|Withdrawal by Subject|0
4629172|NCT01869764|7496959|FG001|Overall Study|Withdrawal by Subject|2
4629173|NCT01869777|7496965|FG000|Overall Study|Excluded from the analysis, ineligible|1
4629174|NCT01869959|7496973|FG000|Randomization Period|Physician Decision|0
4629175|NCT01869959|7496974|FG001|Randomization Period|Physician Decision|0
4629176|NCT01869959|7496975|FG002|Randomization Period|Physician Decision|0
4713746|NCT02951988|7641528|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0
4713747|NCT02951988|7641529|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1
4713748|NCT02951988|7641530|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3
4713749|NCT02951988|7641531|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0
4713750|NCT02951988|7641528|FG000|Double-Blind Treatment Period|Protocol Violation|0
4713751|NCT02951988|7641529|FG001|Double-Blind Treatment Period|Protocol Violation|4
4713752|NCT02951988|7641530|FG002|Double-Blind Treatment Period|Protocol Violation|4
4713753|NCT02951988|7641531|FG003|Double-Blind Treatment Period|Protocol Violation|8
4713754|NCT02951988|7641528|FG000|Double-Blind Treatment Period|Pregnancy|0
4713755|NCT02951988|7641529|FG001|Double-Blind Treatment Period|Pregnancy|1
4713756|NCT02951988|7641530|FG002|Double-Blind Treatment Period|Pregnancy|1
4713757|NCT02951988|7641531|FG003|Double-Blind Treatment Period|Pregnancy|0
4629177|NCT01869959|7496976|FG003|Randomization Period|Physician Decision|0
4629178|NCT01869959|7496977|FG004|Randomization Period|Physician Decision|1
4629179|NCT01869959|7496973|FG000|Treatment Period|Adverse Event|1
4629180|NCT01869959|7496974|FG001|Treatment Period|Adverse Event|0
4411700|NCT00264550|7191599|FG002|Overall Study|Death|0
4411701|NCT00264550|7191600|FG003|Overall Study|Death|0
4411702|NCT00264550|7191597|FG000|Overall Study|Lost to Follow-up|3
4411703|NCT00264550|7191598|FG001|Overall Study|Lost to Follow-up|1
4411704|NCT00264550|7191599|FG002|Overall Study|Lost to Follow-up|1
4411705|NCT00264550|7191600|FG003|Overall Study|Lost to Follow-up|1
4411706|NCT00264550|7191597|FG000|Overall Study|Adverse Event|23
4411707|NCT00264550|7191598|FG001|Overall Study|Adverse Event|18
4411708|NCT00264550|7191599|FG002|Overall Study|Adverse Event|9
4411709|NCT00264550|7191600|FG003|Overall Study|Adverse Event|14
4411710|NCT00264550|7191597|FG000|Overall Study|Unsatisfactory therapeutic effect|4
4411711|NCT00264550|7191598|FG001|Overall Study|Unsatisfactory therapeutic effect|11
4511697|NCT00928512|7321057|FG001|Overall Study|Lack of Efficacy|0
4629181|NCT01869959|7496975|FG002|Treatment Period|Adverse Event|3
4411712|NCT00264550|7191599|FG002|Overall Study|Unsatisfactory therapeutic effect|4
4411713|NCT00264550|7191600|FG003|Overall Study|Unsatisfactory therapeutic effect|6
4411714|NCT00264550|7191597|FG000|Overall Study|Discontinued oral study agent|0
4411715|NCT00264550|7191598|FG001|Overall Study|Discontinued oral study agent|1
4411716|NCT00264550|7191599|FG002|Overall Study|Discontinued oral study agent|0
4411717|NCT00264550|7191600|FG003|Overall Study|Discontinued oral study agent|0
4411718|NCT00264550|7191597|FG000|Overall Study|Other|13
4411719|NCT00264550|7191598|FG001|Overall Study|Other|7
4411720|NCT00264550|7191599|FG002|Overall Study|Other|3
4411721|NCT00264550|7191600|FG003|Overall Study|Other|9
4411722|NCT00264576|7191612|FG000|Overall Study|Lost to Follow-up|1
4411723|NCT00264576|7191613|FG001|Overall Study|Lost to Follow-up|1
4411724|NCT00264797|7191630|FG000|Overall Study|Withdrawal by Subject|11
4411725|NCT00264797|7191631|FG001|Overall Study|Withdrawal by Subject|11
4411726|NCT00264797|7191630|FG000|Overall Study|Lost to Follow-up|9
4411727|NCT00264797|7191631|FG001|Overall Study|Lost to Follow-up|17
4411728|NCT00264797|7191630|FG000|Overall Study|Moved from area|3
4411729|NCT00264797|7191631|FG001|Overall Study|Moved from area|1
4411730|NCT00264797|7191630|FG000|Overall Study|Practical Problems|2
4411731|NCT00264797|7191631|FG001|Overall Study|Practical Problems|3
4411732|NCT00264797|7191630|FG000|Overall Study|Incarceration|4
4411733|NCT00264797|7191631|FG001|Overall Study|Incarceration|5
4411734|NCT00264797|7191630|FG000|Overall Study|Pressure/advice from Outsiders|1
4411735|NCT00264797|7191631|FG001|Overall Study|Pressure/advice from Outsiders|1
4411736|NCT00264797|7191630|FG000|Overall Study|Feels treatment not necessary, not worki|0
4411737|NCT00264797|7191631|FG001|Overall Study|Feels treatment not necessary, not worki|1
4411738|NCT00264797|7191630|FG000|Overall Study|Other|3
4411739|NCT00264797|7191631|FG001|Overall Study|Other|4
4411740|NCT00264810|7191639|FG000|Baseline|Withdrawal by Subject|10
4411741|NCT00264810|7191640|FG001|Baseline|Withdrawal by Subject|10
4411742|NCT00264810|7191639|FG000|Baseline|Physician Decision|7
4411743|NCT00264810|7191640|FG001|Baseline|Physician Decision|8
4411744|NCT00264810|7191639|FG000|Baseline|Subject Compliance Failure|3
4411745|NCT00264810|7191640|FG001|Baseline|Subject Compliance Failure|3
4411746|NCT00264810|7191639|FG000|Baseline|Insufficient Seizure Frequency|2
4411747|NCT00264810|7191640|FG001|Baseline|Insufficient Seizure Frequency|2
4411748|NCT00264810|7191639|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1
4411749|NCT00264810|7191640|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2
4411750|NCT00264810|7191639|FG000|Baseline|Other|0
4411751|NCT00264810|7191640|FG001|Baseline|Other|1
4411752|NCT00264810|7191639|FG000|Stimulation Optimization Period|Withdrawal by Subject|1
4411753|NCT00264810|7191640|FG001|Stimulation Optimization Period|Withdrawal by Subject|0
4411754|NCT00264810|7191639|FG000|Stimulation Optimization Period|Death|0
4411755|NCT00264810|7191640|FG001|Stimulation Optimization Period|Death|1
4411756|NCT00264810|7191639|FG000|Blinded Evaluation Period|Explant due to infection|1
4590366|NCT01520922|7436340|FG001|Treatment Phase|Physician Decision|1
4590367|NCT01520922|7436339|FG000|Treatment Phase|Progression|0
4590368|NCT01520922|7436340|FG001|Treatment Phase|Progression|2
4590369|NCT01520922|7436339|FG000|Treatment Phase|Adverse Event|3
4590370|NCT01520922|7436340|FG001|Treatment Phase|Adverse Event|5
4590371|NCT01520922|7436339|FG000|Follow up|Lost to Follow-up|0
4411757|NCT00264810|7191640|FG001|Blinded Evaluation Period|Explant due to infection|1
4411758|NCT00264810|7191639|FG000|Open Label Evaluation Period|Explant due to infection|1
4411759|NCT00264810|7191640|FG001|Open Label Evaluation Period|Explant due to infection|1
4411760|NCT00264810|7191639|FG000|Open Label Evaluation Period|Death|3
4411761|NCT00264810|7191640|FG001|Open Label Evaluation Period|Death|2
4411762|NCT00264810|7191639|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2
4411763|NCT00264810|7191640|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3
4411764|NCT00264849|7191650|FG000|Overall Study|Adverse Event|7
4411765|NCT00264849|7191651|FG001|Overall Study|Adverse Event|2
4411766|NCT00264849|7191650|FG000|Overall Study|Withdrawal by Subject|7
4411767|NCT00264849|7191651|FG001|Overall Study|Withdrawal by Subject|11
4411768|NCT00264849|7191650|FG000|Overall Study|Protocol Violation|5
4590372|NCT01520922|7436340|FG001|Follow up|Lost to Follow-up|1
4590373|NCT01520922|7436339|FG000|Survival Follow-up|Withdrawal by Subject|1
4590374|NCT01520922|7436340|FG001|Survival Follow-up|Withdrawal by Subject|0
4590375|NCT01520987|7436354|FG000|Overall Study|Withdrawal by Subject|1
4590376|NCT01520987|7436355|FG001|Overall Study|Withdrawal by Subject|0
4590377|NCT01520987|7436356|FG002|Overall Study|Withdrawal by Subject|0
4590378|NCT01520987|7436357|FG003|Overall Study|Withdrawal by Subject|0
4411769|NCT00264849|7191651|FG001|Overall Study|Protocol Violation|3
4411770|NCT00264849|7191650|FG000|Overall Study|Lack of Efficacy|1
4411771|NCT00264849|7191651|FG001|Overall Study|Lack of Efficacy|6
4411772|NCT00264849|7191650|FG000|Overall Study|Lost to Follow-up|0
4411773|NCT00264849|7191651|FG001|Overall Study|Lost to Follow-up|2
4411774|NCT00264849|7191650|FG000|Overall Study|Death|0
4411775|NCT00264849|7191651|FG001|Overall Study|Death|1
4411776|NCT00264849|7191650|FG000|Overall Study|Administrative Problems|2
4411777|NCT00264849|7191651|FG001|Overall Study|Administrative Problems|0
4411778|NCT00264875|7191657|FG000|Overall Study|Adverse Event|6
4411779|NCT00264875|7191657|FG000|Overall Study|Lost to Follow-up|6
4411780|NCT00264875|7191657|FG000|Overall Study|Protocol Violation|11
4590379|NCT01520987|7436358|FG004|Overall Study|Withdrawal by Subject|0
4411781|NCT00264875|7191657|FG000|Overall Study|Withdrawal by Subject|7
4411782|NCT00265083|7191664|FG000|Overall Study|Adverse Event|5
4411783|NCT00265083|7191665|FG001|Overall Study|Adverse Event|13
4411784|NCT00265083|7191666|FG002|Overall Study|Adverse Event|15
4411785|NCT00265083|7191664|FG000|Overall Study|Lost to Follow-up|3
4411786|NCT00265083|7191665|FG001|Overall Study|Lost to Follow-up|4
4411787|NCT00265083|7191666|FG002|Overall Study|Lost to Follow-up|4
4411788|NCT00265083|7191664|FG000|Overall Study|Unsatisfactory therapeutic effect|8
4411789|NCT00265083|7191665|FG001|Overall Study|Unsatisfactory therapeutic effect|13
4411790|NCT00265083|7191666|FG002|Overall Study|Unsatisfactory therapeutic effect|14
4411791|NCT00265083|7191664|FG000|Overall Study|Other|1
4411792|NCT00265083|7191665|FG001|Overall Study|Other|12
4411793|NCT00265083|7191666|FG002|Overall Study|Other|9
4411794|NCT00265096|7191678|FG000|Overall Study|Adverse Event|14
4411795|NCT00265096|7191679|FG001|Overall Study|Adverse Event|18
4411796|NCT00265096|7191680|FG002|Overall Study|Adverse Event|18
4411797|NCT00265096|7191678|FG000|Overall Study|Lost to Follow-up|2
4411798|NCT00265096|7191679|FG001|Overall Study|Lost to Follow-up|5
4411799|NCT00265096|7191680|FG002|Overall Study|Lost to Follow-up|3
4411800|NCT00265096|7191678|FG000|Overall Study|Death|0
4411801|NCT00265096|7191679|FG001|Overall Study|Death|1
4411802|NCT00265096|7191680|FG002|Overall Study|Death|2
4411803|NCT00265096|7191678|FG000|Overall Study|Unsatisfactory therapeutic effect|9
4411804|NCT00265096|7191679|FG001|Overall Study|Unsatisfactory therapeutic effect|8
4411805|NCT00265096|7191680|FG002|Overall Study|Unsatisfactory therapeutic effect|6
4411806|NCT00265096|7191678|FG000|Overall Study|Other|11
4411807|NCT00265096|7191679|FG001|Overall Study|Other|19
4411808|NCT00265096|7191680|FG002|Overall Study|Other|10
4411809|NCT00265109|7191690|FG000|Overall Study|Withdrawal by Subject|5
4411810|NCT00265109|7191690|FG000|Overall Study|Adverse Event|1
4411811|NCT00265122|7191701|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
4411812|NCT00265122|7191702|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
4411813|NCT00265122|7191703|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3
4411814|NCT00265122|7191704|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0
4411815|NCT00265122|7191705|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
4411816|NCT00265122|7191706|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0
4411817|NCT00265122|7191701|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1
4411818|NCT00265122|7191702|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
4411819|NCT00265122|7191703|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
4411820|NCT00265122|7191704|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1
4411821|NCT00265122|7191705|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
4411822|NCT00265122|7191706|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
4411823|NCT00265122|7191701|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0
4411824|NCT00265122|7191702|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1
4411825|NCT00265122|7191703|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2
4411826|NCT00265122|7191704|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1
4411827|NCT00265122|7191705|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0
4411828|NCT00265122|7191706|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0
4411829|NCT00265122|7191701|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2
4411830|NCT00265122|7191702|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1
4411831|NCT00265122|7191703|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3
4411832|NCT00265122|7191704|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1
4411833|NCT00265122|7191705|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3
4411834|NCT00265122|7191706|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0
4411835|NCT00265122|7191701|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1
4411836|NCT00265122|7191702|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0
4411837|NCT00265122|7191703|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0
4411838|NCT00265122|7191704|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2
4411839|NCT00265122|7191705|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2
4713758|NCT02951988|7641528|FG000|Double-Blind Treatment Period|Lost to Follow-up|0
4713759|NCT02951988|7641529|FG001|Double-Blind Treatment Period|Lost to Follow-up|4
4713760|NCT02951988|7641530|FG002|Double-Blind Treatment Period|Lost to Follow-up|12
4713761|NCT02951988|7641531|FG003|Double-Blind Treatment Period|Lost to Follow-up|3
4713762|NCT02951988|7641528|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0
4713763|NCT02951988|7641529|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23
4713764|NCT02951988|7641530|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22
4713765|NCT02951988|7641531|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28
4713766|NCT02951988|7641528|FG000|Double-Blind Treatment Period|Adverse Event|0
4713767|NCT02951988|7641529|FG001|Double-Blind Treatment Period|Adverse Event|8
4713768|NCT02951988|7641530|FG002|Double-Blind Treatment Period|Adverse Event|3
4713769|NCT02951988|7641531|FG003|Double-Blind Treatment Period|Adverse Event|6
4713770|NCT02951988|7641528|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0
4713771|NCT02951988|7641529|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2
4713772|NCT02951988|7641530|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1
4713773|NCT02951988|7641531|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0
4713774|NCT02952001|7641543|FG000|Overall Study|Adverse Event|3
4411840|NCT00265122|7191706|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1
4411841|NCT00265122|7191701|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4
4411842|NCT00265122|7191702|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0
4411843|NCT00265122|7191703|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1
4411844|NCT00265122|7191704|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1
4411845|NCT00265122|7191705|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0
4411846|NCT00265122|7191706|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0
4411847|NCT00265148|7191727|FG000|Overall Study|Adverse Event|2
4411848|NCT00265148|7191728|FG001|Overall Study|Adverse Event|2
4411849|NCT00265148|7191727|FG000|Overall Study|Lack of Efficacy|0
4411850|NCT00265148|7191728|FG001|Overall Study|Lack of Efficacy|2
4411851|NCT00265148|7191727|FG000|Overall Study|Protocol Violation|3
4411852|NCT00265148|7191728|FG001|Overall Study|Protocol Violation|2
4411853|NCT00265148|7191727|FG000|Overall Study|Lost to Follow-up|0
4411854|NCT00265148|7191728|FG001|Overall Study|Lost to Follow-up|1
4411855|NCT00265148|7191727|FG000|Overall Study|Withdrawal by Subject|2
4411856|NCT00265148|7191728|FG001|Overall Study|Withdrawal by Subject|1
4411857|NCT00265148|7191727|FG000|Overall Study|Physician Decision|1
4411858|NCT00265148|7191728|FG001|Overall Study|Physician Decision|0
4411859|NCT00265148|7191727|FG000|Overall Study|Increasing frailty|0
4411860|NCT00265148|7191728|FG001|Overall Study|Increasing frailty|1
4411861|NCT00265148|7191727|FG000|Overall Study|Subject chose to change of the dose|1
4411862|NCT00265148|7191728|FG001|Overall Study|Subject chose to change of the dose|0
4411863|NCT00265239|7191741|FG000|Overall Study|Adverse Event|2
4411864|NCT00265239|7191742|FG001|Overall Study|Adverse Event|1
4411865|NCT00265317|7191752|FG000|Lead-In|Objective progression or relapse|6
4411866|NCT00265317|7191753|FG001|Lead-In|Objective progression or relapse|11
4411867|NCT00265317|7191754|FG002|Lead-In|Objective progression or relapse|0
4411868|NCT00265317|7191755|FG003|Lead-In|Objective progression or relapse|0
4411869|NCT00265317|7191752|FG000|Lead-In|Adverse Event|2
4411870|NCT00265317|7191753|FG001|Lead-In|Adverse Event|1
4411871|NCT00265317|7191754|FG002|Lead-In|Adverse Event|0
4411872|NCT00265317|7191755|FG003|Lead-In|Adverse Event|0
4411873|NCT00265317|7191752|FG000|Lead-In|Death|3
4411874|NCT00265317|7191753|FG001|Lead-In|Death|5
4411875|NCT00265317|7191754|FG002|Lead-In|Death|0
4411876|NCT00265317|7191755|FG003|Lead-In|Death|0
4411877|NCT00265317|7191752|FG000|Lead-In|Withdrawal/other than adverse event|1
4411878|NCT00265317|7191753|FG001|Lead-In|Withdrawal/other than adverse event|0
4629182|NCT01869959|7496976|FG003|Treatment Period|Adverse Event|1
4629183|NCT01869959|7496977|FG004|Treatment Period|Adverse Event|0
4629184|NCT01869959|7496973|FG000|Treatment Period|Sponsor decision|0
4629185|NCT01869959|7496974|FG001|Treatment Period|Sponsor decision|1
4629186|NCT01869959|7496975|FG002|Treatment Period|Sponsor decision|0
4629187|NCT01869959|7496976|FG003|Treatment Period|Sponsor decision|1
4629188|NCT01869959|7496977|FG004|Treatment Period|Sponsor decision|0
4629189|NCT01869959|7496973|FG000|Treatment Period|Withdrawal by Subject|0
4629190|NCT01869959|7496974|FG001|Treatment Period|Withdrawal by Subject|1
4629191|NCT01869959|7496975|FG002|Treatment Period|Withdrawal by Subject|0
4629192|NCT01869959|7496976|FG003|Treatment Period|Withdrawal by Subject|0
4629193|NCT01869959|7496977|FG004|Treatment Period|Withdrawal by Subject|0
4629194|NCT01870076|7496991|FG000|Overall Study|Withdrawal by Subject|1
4629195|NCT01870076|7496992|FG001|Overall Study|Withdrawal by Subject|0
4629196|NCT01870076|7496993|FG002|Overall Study|Withdrawal by Subject|1
4629197|NCT01870076|7496994|FG003|Overall Study|Withdrawal by Subject|0
4629198|NCT01870297|7497011|FG000|Overall Study|Adverse Event|0
4629199|NCT01870297|7497012|FG001|Overall Study|Adverse Event|0
4629200|NCT01870297|7497013|FG002|Overall Study|Adverse Event|0
4629201|NCT01870297|7497014|FG003|Overall Study|Adverse Event|0
4629202|NCT01870297|7497015|FG004|Overall Study|Adverse Event|2
4629203|NCT01870297|7497016|FG005|Overall Study|Adverse Event|0
4629204|NCT01870297|7497017|FG006|Overall Study|Adverse Event|0
4629205|NCT01870297|7497011|FG000|Overall Study|Lost to Follow-up|0
4629206|NCT01870297|7497012|FG001|Overall Study|Lost to Follow-up|1
4629207|NCT01870297|7497013|FG002|Overall Study|Lost to Follow-up|1
4629208|NCT01870297|7497014|FG003|Overall Study|Lost to Follow-up|0
4629209|NCT01870297|7497015|FG004|Overall Study|Lost to Follow-up|0
4629210|NCT01870297|7497016|FG005|Overall Study|Lost to Follow-up|0
4629211|NCT01870297|7497017|FG006|Overall Study|Lost to Follow-up|0
4629212|NCT01870297|7497011|FG000|Overall Study|Withdrawal by Subject|0
4629213|NCT01870297|7497012|FG001|Overall Study|Withdrawal by Subject|0
4629214|NCT01870297|7497013|FG002|Overall Study|Withdrawal by Subject|0
4629215|NCT01870297|7497014|FG003|Overall Study|Withdrawal by Subject|0
4629216|NCT01870297|7497015|FG004|Overall Study|Withdrawal by Subject|1
4629217|NCT01870297|7497016|FG005|Overall Study|Withdrawal by Subject|1
4629218|NCT01870297|7497017|FG006|Overall Study|Withdrawal by Subject|1
4411879|NCT00265317|7191754|FG002|Lead-In|Withdrawal/other than adverse event|0
4411880|NCT00265317|7191755|FG003|Lead-In|Withdrawal/other than adverse event|0
4411881|NCT00265317|7191752|FG000|Phase 2|Objective progression or relapse|0
4411882|NCT00265317|7191753|FG001|Phase 2|Objective progression or relapse|0
4411883|NCT00265317|7191754|FG002|Phase 2|Objective progression or relapse|37
4411884|NCT00265317|7191755|FG003|Phase 2|Objective progression or relapse|38
4411885|NCT00265317|7191752|FG000|Phase 2|Global deterioration of health status|0
4629219|NCT01870297|7497011|FG000|Overall Study|Sponsor Decision|0
4411886|NCT00265317|7191753|FG001|Phase 2|Global deterioration of health status|0
4411887|NCT00265317|7191754|FG002|Phase 2|Global deterioration of health status|3
4411888|NCT00265317|7191755|FG003|Phase 2|Global deterioration of health status|0
4411889|NCT00265317|7191752|FG000|Phase 2|Adverse Event|0
4411890|NCT00265317|7191753|FG001|Phase 2|Adverse Event|0
4411891|NCT00265317|7191754|FG002|Phase 2|Adverse Event|7
4411892|NCT00265317|7191755|FG003|Phase 2|Adverse Event|5
4411893|NCT00265317|7191752|FG000|Phase 2|Death|0
4411894|NCT00265317|7191753|FG001|Phase 2|Death|0
4411895|NCT00265317|7191754|FG002|Phase 2|Death|12
4411896|NCT00265317|7191755|FG003|Phase 2|Death|15
4411897|NCT00265317|7191752|FG000|Phase 2|Protocol Violation|0
4411898|NCT00265317|7191753|FG001|Phase 2|Protocol Violation|0
4411899|NCT00265317|7191754|FG002|Phase 2|Protocol Violation|1
4411900|NCT00265317|7191755|FG003|Phase 2|Protocol Violation|4
4411901|NCT00265317|7191752|FG000|Phase 2|Lost to Follow-up|0
4411902|NCT00265317|7191753|FG001|Phase 2|Lost to Follow-up|0
4411903|NCT00265317|7191754|FG002|Phase 2|Lost to Follow-up|0
4411904|NCT00265317|7191755|FG003|Phase 2|Lost to Follow-up|1
4411905|NCT00265317|7191752|FG000|Phase 2|Withdrawal/other than adverse event|0
4411906|NCT00265317|7191753|FG001|Phase 2|Withdrawal/other than adverse event|0
4411907|NCT00265317|7191754|FG002|Phase 2|Withdrawal/other than adverse event|2
4411908|NCT00265317|7191755|FG003|Phase 2|Withdrawal/other than adverse event|1
4411909|NCT00265317|7191752|FG000|Phase 2|Study terminated by sponsor|0
4411910|NCT00265317|7191753|FG001|Phase 2|Study terminated by sponsor|0
4411911|NCT00265317|7191754|FG002|Phase 2|Study terminated by sponsor|1
4411912|NCT00265317|7191755|FG003|Phase 2|Study terminated by sponsor|0
4411913|NCT00265317|7191752|FG000|Phase 2|Other|0
4411914|NCT00265317|7191753|FG001|Phase 2|Other|0
4411915|NCT00265317|7191754|FG002|Phase 2|Other|1
4411916|NCT00265317|7191755|FG003|Phase 2|Other|1
4411917|NCT00265330|7191774|FG000|Overall Study|Adverse Event|41
4411918|NCT00265330|7191774|FG000|Overall Study|Lost to Follow-up|8
4411919|NCT00265330|7191774|FG000|Overall Study|Withdrawal by Subject|34
4411920|NCT00265330|7191774|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1
4411921|NCT00265330|7191774|FG000|Overall Study|Lack of Efficacy|4
4411922|NCT00265330|7191774|FG000|Overall Study|Family Scheduling Conflicts|1
4411923|NCT00265330|7191774|FG000|Overall Study|Began Taking Formulary Geodon|1
4411924|NCT00265330|7191774|FG000|Overall Study|Discharged from Unit for Long Term Care|1
4411925|NCT00265330|7191774|FG000|Overall Study|Site Closed by Sponsor|1
4411926|NCT00265330|7191774|FG000|Overall Study|Principal Investigators Request|1
4411927|NCT00265330|7191774|FG000|Overall Study|Withdrew Consent|1
4411928|NCT00265330|7191774|FG000|Overall Study|Protocol Violation|1
4411929|NCT00265382|7191778|FG000|Overall Study|Adverse Event|21
4411930|NCT00265382|7191778|FG000|Overall Study|Laboratory Abnormality|1
4411931|NCT00265382|7191778|FG000|Overall Study|Lost to Follow-up|3
4411932|NCT00265382|7191778|FG000|Overall Study|Lack of Efficacy|6
4411933|NCT00265382|7191778|FG000|Overall Study|Miscellaneous|6
4713775|NCT02952001|7641544|FG001|Overall Study|Adverse Event|0
4713776|NCT02952001|7641543|FG000|Overall Study|Prohibited therapy|10
4713777|NCT02952001|7641544|FG001|Overall Study|Prohibited therapy|3
4713778|NCT02952001|7641543|FG000|Overall Study|Due to Posterior Capsular Opacity|1
4713779|NCT02952001|7641544|FG001|Overall Study|Due to Posterior Capsular Opacity|0
4713780|NCT02952261|7641553|FG000|Overall Study|Withdrawal by Subject|4
4713781|NCT02952261|7641554|FG001|Overall Study|Withdrawal by Subject|5
4713782|NCT02952261|7641553|FG000|Overall Study|Protocol Violation|1
4713783|NCT02952261|7641554|FG001|Overall Study|Protocol Violation|0
4713784|NCT02952313|7641560|FG000|Primary Endpoint|Lost to Follow-up|4
4713785|NCT02952313|7641560|FG000|Primary Endpoint|Withdrawal by Subject|1
4713786|NCT02952313|7641560|FG000|Primary Endpoint|Lack of Efficacy|1
4713787|NCT02952313|7641560|FG000|Primary Endpoint|Missed visit|1
4713788|NCT02952313|7641560|FG000|Long-term Follow-up|Lost to Follow-up|12
4713789|NCT02952313|7641560|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7
4713790|NCT02952313|7641560|FG000|Long-term Follow-up|Lack of Efficacy|6
4713791|NCT02952313|7641560|FG000|Long-term Follow-up|Withdrawal by Subject|5
4713792|NCT02952313|7641560|FG000|Long-term Follow-up|Physician Decision|1
4713793|NCT02952313|7641560|FG000|Long-term Follow-up|Death|1
4713794|NCT02952586|7641567|FG000|Lead-In Phase (7 Days)|Death|0
4713795|NCT02952586|7641568|FG001|Lead-In Phase (7 Days)|Death|1
4713796|NCT02952586|7641567|FG000|Lead-In Phase (7 Days)|Adverse Event|3
4713797|NCT02952586|7641568|FG001|Lead-In Phase (7 Days)|Adverse Event|0
4713798|NCT02952586|7641567|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0
4713799|NCT02952586|7641568|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1
4713800|NCT02952586|7641567|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2
4411934|NCT00265382|7191778|FG000|Overall Study|Withdrawal by Subject|13
4411935|NCT00265382|7191778|FG000|Overall Study|Study terminated by sponsor|94
4411936|NCT00265382|7191778|FG000|Overall Study|Death|1
4411937|NCT00265395|7191784|FG000|Overall Study|Adverse Event|3
4411938|NCT00265395|7191785|FG001|Overall Study|Adverse Event|6
4411939|NCT00265395|7191784|FG000|Overall Study|Lost to Follow-up|2
4411940|NCT00265395|7191785|FG001|Overall Study|Lost to Follow-up|1
4411941|NCT00265395|7191784|FG000|Overall Study|Withdrawal by Subject|1
4411942|NCT00265395|7191785|FG001|Overall Study|Withdrawal by Subject|6
4713801|NCT02952586|7641568|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2
4713802|NCT02952586|7641567|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5
4411943|NCT00265395|7191784|FG000|Overall Study|Protocol Violation|2
4411944|NCT00265395|7191785|FG001|Overall Study|Protocol Violation|2
4411945|NCT00265395|7191784|FG000|Overall Study|Lack of Efficacy|0
4411946|NCT00265395|7191785|FG001|Overall Study|Lack of Efficacy|1
4411947|NCT00265395|7191784|FG000|Overall Study|Administrative|0
4411948|NCT00265395|7191785|FG001|Overall Study|Administrative|1
4411949|NCT00265564|7191823|FG000|Overall Study|Lost to Follow-up|5
4411950|NCT00265564|7191824|FG001|Overall Study|Lost to Follow-up|7
4411951|NCT00265564|7191823|FG000|Overall Study|met exclusion criteria|5
4411952|NCT00265564|7191824|FG001|Overall Study|met exclusion criteria|2
4411953|NCT00265759|7191845|FG000|Overall Study|Withdrawal by Subject|0
4411954|NCT00265759|7191846|FG001|Overall Study|Withdrawal by Subject|1
4411955|NCT00265759|7191847|FG002|Overall Study|Withdrawal by Subject|2
4411956|NCT00265759|7191848|FG003|Overall Study|Withdrawal by Subject|2
4411957|NCT00265759|7191845|FG000|Overall Study|Cancel|0
4411958|NCT00265759|7191846|FG001|Overall Study|Cancel|0
4411959|NCT00265759|7191847|FG002|Overall Study|Cancel|0
4411960|NCT00265759|7191848|FG003|Overall Study|Cancel|3
4411961|NCT00265759|7191845|FG000|Overall Study|Ineligible|0
4411962|NCT00265759|7191846|FG001|Overall Study|Ineligible|0
4411963|NCT00265759|7191847|FG002|Overall Study|Ineligible|0
4411964|NCT00265759|7191848|FG003|Overall Study|Ineligible|1
4411965|NCT00265759|7191845|FG000|Overall Study|Bilateral disease|0
4411966|NCT00265759|7191846|FG001|Overall Study|Bilateral disease|0
4411967|NCT00265759|7191847|FG002|Overall Study|Bilateral disease|0
4411968|NCT00265759|7191848|FG003|Overall Study|Bilateral disease|2
4411969|NCT00265759|7191845|FG000|Overall Study|Discontinued due to intolerability|0
4411970|NCT00265759|7191846|FG001|Overall Study|Discontinued due to intolerability|0
4411971|NCT00265759|7191847|FG002|Overall Study|Discontinued due to intolerability|0
4411972|NCT00265759|7191848|FG003|Overall Study|Discontinued due to intolerability|1
4411973|NCT00265785|7191859|FG000|Overall Study|Adverse Event|4
4411974|NCT00265785|7191859|FG000|Overall Study|Withdrawal by Subject|3
4411975|NCT00265785|7191859|FG000|Overall Study|Progression/Relapse|15
4411976|NCT00265785|7191859|FG000|Overall Study|Not protocol specified|2
4411977|NCT00265785|7191859|FG000|Overall Study|Ineligible|1
4411978|NCT00265785|7191859|FG000|Overall Study|Did not receive protocol treatment|2
4411979|NCT00265889|7191875|FG000|Overall Study|Physician Decision|1
4411980|NCT00265889|7191875|FG000|Overall Study|Protocol Violation|1
4411981|NCT00265889|7191875|FG000|Overall Study|Insurance denied the request|3
4411982|NCT00265941|7191881|FG000|Overall Study|Protocol Violation|22
4411983|NCT00265941|7191882|FG001|Overall Study|Protocol Violation|25
4411984|NCT00265941|7191881|FG000|Overall Study|Lost to Follow-up|1
4411985|NCT00265941|7191882|FG001|Overall Study|Lost to Follow-up|1
4411986|NCT00266032|7191903|FG000|Treatment|Adverse Event|42
4411987|NCT00266032|7191904|FG001|Treatment|Adverse Event|26
4411988|NCT00266032|7191905|FG002|Treatment|Adverse Event|10
4411989|NCT00266032|7191903|FG000|Treatment|Lost to Follow-up|19
4411990|NCT00266032|7191904|FG001|Treatment|Lost to Follow-up|4
4411991|NCT00266032|7191905|FG002|Treatment|Lost to Follow-up|2
4411992|NCT00266032|7191903|FG000|Treatment|Pregnancy|3
4411993|NCT00266032|7191904|FG001|Treatment|Pregnancy|2
4411994|NCT00266032|7191905|FG002|Treatment|Pregnancy|2
4411995|NCT00266032|7191903|FG000|Treatment|Protocol Violation|6
4411996|NCT00266032|7191904|FG001|Treatment|Protocol Violation|14
4411997|NCT00266032|7191905|FG002|Treatment|Protocol Violation|13
4411998|NCT00266032|7191903|FG000|Treatment|Withdrawal by Subject|28
4411999|NCT00266032|7191904|FG001|Treatment|Withdrawal by Subject|13
4412000|NCT00266032|7191905|FG002|Treatment|Withdrawal by Subject|12
4412001|NCT00266032|7191903|FG000|Treatment|patient moved/wish for pregnancy/no need|13
4412002|NCT00266032|7191904|FG001|Treatment|patient moved/wish for pregnancy/no need|5
4629220|NCT01870297|7497012|FG001|Overall Study|Sponsor Decision|6
4629221|NCT01870297|7497013|FG002|Overall Study|Sponsor Decision|0
4412003|NCT00266032|7191905|FG002|Treatment|patient moved/wish for pregnancy/no need|8
4412004|NCT00266032|7191903|FG000|Open-label Safety Extension|Adverse Event|5
4412005|NCT00266032|7191904|FG001|Open-label Safety Extension|Adverse Event|0
4412006|NCT00266032|7191905|FG002|Open-label Safety Extension|Adverse Event|4
4412007|NCT00266032|7191903|FG000|Open-label Safety Extension|Lost to Follow-up|2
4412008|NCT00266032|7191904|FG001|Open-label Safety Extension|Lost to Follow-up|5
4412009|NCT00266032|7191905|FG002|Open-label Safety Extension|Lost to Follow-up|4
4412010|NCT00266032|7191903|FG000|Open-label Safety Extension|Pregnancy|4
4412011|NCT00266032|7191904|FG001|Open-label Safety Extension|Pregnancy|1
4412012|NCT00266032|7191905|FG002|Open-label Safety Extension|Pregnancy|2
4412013|NCT00266032|7191903|FG000|Open-label Safety Extension|Protocol Violation|1
4412014|NCT00266032|7191904|FG001|Open-label Safety Extension|Protocol Violation|3
4412015|NCT00266032|7191905|FG002|Open-label Safety Extension|Protocol Violation|2
4412016|NCT00266032|7191903|FG000|Open-label Safety Extension|Withdrawal by Subject|19
4412017|NCT00266032|7191904|FG001|Open-label Safety Extension|Withdrawal by Subject|3
4412018|NCT00266032|7191905|FG002|Open-label Safety Extension|Withdrawal by Subject|12
4412019|NCT00266032|7191903|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10
4412020|NCT00266032|7191904|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2
4412021|NCT00266032|7191905|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1
4412022|NCT00266227|7191920|FG000|Initial Treatment|Adverse Event|0
4412023|NCT00266227|7191921|FG001|Initial Treatment|Adverse Event|0
4412024|NCT00266227|7191922|FG002|Initial Treatment|Adverse Event|13
4412025|NCT00266227|7191920|FG000|Initial Treatment|Lost to Follow-up|0
4412026|NCT00266227|7191921|FG001|Initial Treatment|Lost to Follow-up|0
4412027|NCT00266227|7191922|FG002|Initial Treatment|Lost to Follow-up|6
4412028|NCT00266227|7191920|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0
4412029|NCT00266227|7191921|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0
4412030|NCT00266227|7191922|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45
4412031|NCT00266227|7191920|FG000|Initial Treatment|Physician decision to withdraw|0
4412032|NCT00266227|7191921|FG001|Initial Treatment|Physician decision to withdraw|0
4412033|NCT00266227|7191922|FG002|Initial Treatment|Physician decision to withdraw|12
4412034|NCT00266227|7191920|FG000|Initial Treatment|Pregnancy|0
4412035|NCT00266227|7191921|FG001|Initial Treatment|Pregnancy|0
4412036|NCT00266227|7191922|FG002|Initial Treatment|Pregnancy|1
4412037|NCT00266227|7191920|FG000|Retreatment: Up to Week 48|Death|1
4412038|NCT00266227|7191921|FG001|Retreatment: Up to Week 48|Death|0
4412039|NCT00266227|7191922|FG002|Retreatment: Up to Week 48|Death|0
4412040|NCT00266227|7191920|FG000|Retreatment: Up to Week 48|Adverse Event|7
4412041|NCT00266227|7191921|FG001|Retreatment: Up to Week 48|Adverse Event|7
4412042|NCT00266227|7191922|FG002|Retreatment: Up to Week 48|Adverse Event|0
4412043|NCT00266227|7191920|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3
4412044|NCT00266227|7191921|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0
4412045|NCT00266227|7191922|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0
4412046|NCT00266227|7191920|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11
4412047|NCT00266227|7191921|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14
4412048|NCT00266227|7191922|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0
4412049|NCT00266227|7191920|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4
4412050|NCT00266227|7191921|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2
4412051|NCT00266227|7191922|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0
4412052|NCT00266227|7191920|FG000|Retreatment: Up to Week 48|Pregnancy|1
4412053|NCT00266227|7191921|FG001|Retreatment: Up to Week 48|Pregnancy|0
4412054|NCT00266227|7191922|FG002|Retreatment: Up to Week 48|Pregnancy|0
4412055|NCT00266227|7191920|FG000|Retreatment: Week 48 to Week 72|Death|1
4412056|NCT00266227|7191921|FG001|Retreatment: Week 48 to Week 72|Death|1
4412057|NCT00266227|7191922|FG002|Retreatment: Week 48 to Week 72|Death|0
4412058|NCT00266227|7191920|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6
4412059|NCT00266227|7191921|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2
4412060|NCT00266227|7191922|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0
4412061|NCT00266227|7191920|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1
4412062|NCT00266227|7191921|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0
4412063|NCT00266227|7191922|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0
4412064|NCT00266227|7191920|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41
4412065|NCT00266227|7191921|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29
4412066|NCT00266227|7191922|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0
4412067|NCT00266227|7191920|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15
4412068|NCT00266227|7191921|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10
4412069|NCT00266227|7191922|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0
4412070|NCT00266409|7191940|FG000|Overall Study|Lack of Efficacy|2
4412071|NCT00266409|7191941|FG001|Overall Study|Lack of Efficacy|6
4412072|NCT00266409|7191942|FG002|Overall Study|Lack of Efficacy|1
4412073|NCT00266409|7191943|FG003|Overall Study|Lack of Efficacy|2
4412074|NCT00266409|7191940|FG000|Overall Study|Adverse Event|7
4412075|NCT00266409|7191941|FG001|Overall Study|Adverse Event|2
4412076|NCT00266409|7191942|FG002|Overall Study|Adverse Event|1
4412077|NCT00266409|7191943|FG003|Overall Study|Adverse Event|1
4412078|NCT00266409|7191940|FG000|Overall Study|Lost to Follow-up|18
4412079|NCT00266409|7191941|FG001|Overall Study|Lost to Follow-up|21
4412080|NCT00266409|7191942|FG002|Overall Study|Lost to Follow-up|6
4412081|NCT00266409|7191943|FG003|Overall Study|Lost to Follow-up|8
4412082|NCT00266409|7191940|FG000|Overall Study|Withdrawal by Subject|6
4412083|NCT00266409|7191941|FG001|Overall Study|Withdrawal by Subject|10
4412084|NCT00266409|7191942|FG002|Overall Study|Withdrawal by Subject|3
4412085|NCT00266409|7191943|FG003|Overall Study|Withdrawal by Subject|9
4412086|NCT00266409|7191940|FG000|Overall Study|Protocol Violation|5
4412087|NCT00266409|7191941|FG001|Overall Study|Protocol Violation|3
4412088|NCT00266409|7191942|FG002|Overall Study|Protocol Violation|4
4412089|NCT00266409|7191943|FG003|Overall Study|Protocol Violation|2
4412090|NCT00266409|7191940|FG000|Overall Study|Other|7
4412091|NCT00266409|7191941|FG001|Overall Study|Other|4
4412092|NCT00266409|7191942|FG002|Overall Study|Other|2
4412093|NCT00266409|7191943|FG003|Overall Study|Other|0
4412094|NCT00266630|7191955|FG000|Overall Study|Adverse Event|8
4629222|NCT01870297|7497014|FG003|Overall Study|Sponsor Decision|0
4629223|NCT01870297|7497015|FG004|Overall Study|Sponsor Decision|0
4629224|NCT01870297|7497016|FG005|Overall Study|Sponsor Decision|0
4629225|NCT01870297|7497017|FG006|Overall Study|Sponsor Decision|1
4629226|NCT01870583|7497056|FG000|Overall Study|Protocol Violation|0
4412095|NCT00266630|7191956|FG001|Overall Study|Adverse Event|6
4412096|NCT00266630|7191955|FG000|Overall Study|Lack of Efficacy|1
4412097|NCT00266630|7191956|FG001|Overall Study|Lack of Efficacy|4
4412098|NCT00266630|7191955|FG000|Overall Study|Entry Criteria not met|1
4412099|NCT00266630|7191956|FG001|Overall Study|Entry Criteria not met|0
4412100|NCT00266630|7191955|FG000|Overall Study|Protocol Violation|1
4412101|NCT00266630|7191956|FG001|Overall Study|Protocol Violation|3
4412102|NCT00266630|7191955|FG000|Overall Study|Physician Decision|1
4412103|NCT00266630|7191956|FG001|Overall Study|Physician Decision|2
4412104|NCT00266630|7191955|FG000|Overall Study|Withdrawal by Subject|10
4412105|NCT00266630|7191956|FG001|Overall Study|Withdrawal by Subject|2
4412106|NCT00266630|7191955|FG000|Overall Study|Lost to Follow-up|1
4412107|NCT00266630|7191956|FG001|Overall Study|Lost to Follow-up|0
4412108|NCT00266630|7191955|FG000|Overall Study|Other|19
4412109|NCT00266630|7191956|FG001|Overall Study|Other|11
4412110|NCT00266656|7191966|FG000|Overall Study|Death|1
4412111|NCT00266656|7191967|FG001|Overall Study|Death|0
4412112|NCT00266656|7191966|FG000|Overall Study|Lost to Follow-up|4
4412113|NCT00266656|7191967|FG001|Overall Study|Lost to Follow-up|1
4412114|NCT00266656|7191966|FG000|Overall Study|Withdrawal by Subject|4
4412115|NCT00266656|7191967|FG001|Overall Study|Withdrawal by Subject|2
4412116|NCT00266656|7191966|FG000|Overall Study|Did Not Reach Final Height|4
4412117|NCT00266656|7191967|FG001|Overall Study|Did Not Reach Final Height|8
4412118|NCT00266656|7191966|FG000|Overall Study|Parent/Caregiver Decision|1
4412119|NCT00266656|7191967|FG001|Overall Study|Parent/Caregiver Decision|2
4412120|NCT00266695|7191973|FG000|Overall Study|Adverse Event|1
4412121|NCT00266695|7191973|FG000|Overall Study|Death|9
4412122|NCT00266695|7191973|FG000|Overall Study|Physician Decision|1
4412123|NCT00266695|7191973|FG000|Overall Study|Lost to Follow-up|3
4412124|NCT00266695|7191973|FG000|Overall Study|Withdrawal by Subject|15
4412125|NCT00266708|7191979|FG000|Overall Study|No renal function|1
4412126|NCT00266708|7191980|FG001|Overall Study|No renal function|1
4412127|NCT00266708|7191979|FG000|Overall Study|Refused biopsy|3
4412128|NCT00266708|7191980|FG001|Overall Study|Refused biopsy|6
4412129|NCT00266708|7191979|FG000|Overall Study|Asthma|0
4412130|NCT00266708|7191980|FG001|Overall Study|Asthma|2
4412131|NCT00266812|7191997|FG000|Overall Study|Disease Progression|9
4713803|NCT02952586|7641568|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8
4713804|NCT02952586|7641567|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12
4713805|NCT02952586|7641568|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12
4713806|NCT02952586|7641567|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2
4713807|NCT02952586|7641568|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1
4713808|NCT02952586|7641567|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1
4713809|NCT02952586|7641568|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0
4713810|NCT02952586|7641567|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10
4713811|NCT02952586|7641568|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4
4713812|NCT02952586|7641567|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1
4713813|NCT02952586|7641568|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1
4713814|NCT02952586|7641567|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2
4713815|NCT02952586|7641568|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1
4713816|NCT02952586|7641567|FG000|CRT for Cisplatin (63 Days)|Death|3
4713817|NCT02952586|7641568|FG001|CRT for Cisplatin (63 Days)|Death|8
4713818|NCT02952586|7641567|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82
4713819|NCT02952586|7641568|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81
4713820|NCT02952586|7641567|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12
4713821|NCT02952586|7641568|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10
4713822|NCT02952586|7641567|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1
4713823|NCT02952586|7641568|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0
4713824|NCT02952586|7641567|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11
4713825|NCT02952586|7641568|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3
4713826|NCT02952586|7641567|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1
4713827|NCT02952586|7641568|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1
4713828|NCT02952586|7641567|FG000|CRT for Cisplatin (63 Days)|Other|1
4713829|NCT02952586|7641568|FG001|CRT for Cisplatin (63 Days)|Other|1
4713830|NCT02952586|7641567|FG000|CRT for IMRT (63 Days)|Death|5
4713831|NCT02952586|7641568|FG001|CRT for IMRT (63 Days)|Death|8
4713832|NCT02952586|7641567|FG000|CRT for IMRT (63 Days)|Adverse Event|5
4713833|NCT02952586|7641568|FG001|CRT for IMRT (63 Days)|Adverse Event|5
4713834|NCT02952586|7641567|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1
4713835|NCT02952586|7641568|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0
4713836|NCT02952586|7641567|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10
4713837|NCT02952586|7641568|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6
4713838|NCT02952586|7641567|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1
4713839|NCT02952586|7641568|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1
4713840|NCT02952586|7641567|FG000|CRT for IMRT (63 Days)|Other|1
4713841|NCT02952586|7641568|FG001|CRT for IMRT (63 Days)|Other|0
4713842|NCT02952586|7641567|FG000|Maintenance Phase (12 Months)|Death|17
4713843|NCT02952586|7641568|FG001|Maintenance Phase (12 Months)|Death|11
4713844|NCT02952586|7641567|FG000|Maintenance Phase (12 Months)|Progressive disease|60
4713845|NCT02952586|7641568|FG001|Maintenance Phase (12 Months)|Progressive disease|54
4412132|NCT00266812|7191998|FG001|Overall Study|Disease Progression|3
4412133|NCT00266812|7191997|FG000|Overall Study|Death|5
4412134|NCT00266812|7191998|FG001|Overall Study|Death|4
4713846|NCT02952586|7641567|FG000|Maintenance Phase (12 Months)|Adverse Event|24
4713847|NCT02952586|7641568|FG001|Maintenance Phase (12 Months)|Adverse Event|21
4713848|NCT02952586|7641567|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1
4713849|NCT02952586|7641568|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1
4713850|NCT02952586|7641567|FG000|Maintenance Phase (12 Months)|Physician Decision|1
4713851|NCT02952586|7641568|FG001|Maintenance Phase (12 Months)|Physician Decision|1
4713852|NCT02952586|7641567|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14
4713853|NCT02952586|7641568|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5
4713854|NCT02952586|7641567|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31
4713855|NCT02952586|7641568|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25
4713856|NCT02952586|7641567|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1
4412135|NCT00266812|7191997|FG000|Overall Study|Adverse Event|3
4412136|NCT00266812|7191998|FG001|Overall Study|Adverse Event|1
4412137|NCT00266812|7191997|FG000|Overall Study|Protocol Violation|0
4412138|NCT00266812|7191998|FG001|Overall Study|Protocol Violation|1
4412139|NCT00266812|7191997|FG000|Overall Study|Withdrawal by Subject|0
4412140|NCT00266812|7191998|FG001|Overall Study|Withdrawal by Subject|2
4412141|NCT00266812|7191997|FG000|Overall Study|Discontinued before starting study drug|4
4412142|NCT00266812|7191998|FG001|Overall Study|Discontinued before starting study drug|0
4412143|NCT00266825|7192006|FG000|Completed Follow-Up|Lost to Follow-up|14
4412144|NCT00266825|7192007|FG001|Completed Follow-Up|Lost to Follow-up|19
4412145|NCT00266825|7192006|FG000|Completed Follow-Up|Withdrawal by Subject|11
4412146|NCT00266825|7192007|FG001|Completed Follow-Up|Withdrawal by Subject|5
4629227|NCT01870583|7497057|FG001|Overall Study|Protocol Violation|5
4629228|NCT01870583|7497058|FG002|Overall Study|Protocol Violation|3
4629229|NCT01870583|7497056|FG000|Overall Study|Lost to Follow-up|11
4629230|NCT01870583|7497057|FG001|Overall Study|Lost to Follow-up|13
4713857|NCT02952586|7641568|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2
4713858|NCT02952586|7641567|FG000|Maintenance Phase (12 Months)|Other|2
4713859|NCT02952586|7641568|FG001|Maintenance Phase (12 Months)|Other|1
4713860|NCT02952586|7641567|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1
4412147|NCT00266864|7192034|FG000|Overall Study|Lost to Follow-up|4
4412148|NCT00266864|7192035|FG001|Overall Study|Lost to Follow-up|1
4412149|NCT00266864|7192034|FG000|Overall Study|Withdrawal by Subject|1
4412150|NCT00266864|7192035|FG001|Overall Study|Withdrawal by Subject|1
4412151|NCT00266877|7192044|FG000|Overall Study|Death|1
4412152|NCT00266877|7192045|FG001|Overall Study|Death|1
4412153|NCT00266877|7192046|FG002|Overall Study|Death|1
4412154|NCT00266877|7192044|FG000|Overall Study|Adverse Event|6
4412155|NCT00266877|7192045|FG001|Overall Study|Adverse Event|4
4412156|NCT00266877|7192046|FG002|Overall Study|Adverse Event|1
4412157|NCT00266877|7192044|FG000|Overall Study|Physician Decision|2
4412158|NCT00266877|7192045|FG001|Overall Study|Physician Decision|1
4412159|NCT00266877|7192046|FG002|Overall Study|Physician Decision|1
4412160|NCT00266877|7192044|FG000|Overall Study|Withdrawal by Subject|3
4412161|NCT00266877|7192045|FG001|Overall Study|Withdrawal by Subject|1
4412162|NCT00266877|7192046|FG002|Overall Study|Withdrawal by Subject|1
4412163|NCT00266877|7192044|FG000|Overall Study|Disease Progression|72
4412164|NCT00266877|7192045|FG001|Overall Study|Disease Progression|37
4412165|NCT00266877|7192046|FG002|Overall Study|Disease Progression|23
4412166|NCT00266877|7192044|FG000|Overall Study|Symptomatic Deterioration|6
4412167|NCT00266877|7192045|FG001|Overall Study|Symptomatic Deterioration|3
4412168|NCT00266877|7192046|FG002|Overall Study|Symptomatic Deterioration|1
4412169|NCT00266877|7192044|FG000|Overall Study|Hospitalization|1
4412170|NCT00266877|7192045|FG001|Overall Study|Hospitalization|0
4412171|NCT00266877|7192046|FG002|Overall Study|Hospitalization|0
4412172|NCT00266877|7192044|FG000|Overall Study|Concomitant Radiotherapy|0
4412173|NCT00266877|7192045|FG001|Overall Study|Concomitant Radiotherapy|1
4713861|NCT02952586|7641568|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6
4713862|NCT02952586|7641567|FG000|Follow-Up Phase (90 Days)|Death|12
4412174|NCT00266877|7192046|FG002|Overall Study|Concomitant Radiotherapy|0
4412175|NCT00267007|7192056|FG000|Overall Study|Withdrawal by Subject|6
4412176|NCT00267007|7192057|FG001|Overall Study|Withdrawal by Subject|0
4629231|NCT01870583|7497058|FG002|Overall Study|Lost to Follow-up|5
4629232|NCT01870726|7497082|FG000|Overall Study|Withdrawal of informed consent|0
4629233|NCT01870726|7497083|FG001|Overall Study|Withdrawal of informed consent|0
4629234|NCT01870726|7497084|FG002|Overall Study|Withdrawal of informed consent|0
4629235|NCT01870726|7497085|FG003|Overall Study|Withdrawal of informed consent|1
4629236|NCT01870726|7497086|FG004|Overall Study|Withdrawal of informed consent|0
4629237|NCT01870726|7497087|FG005|Overall Study|Withdrawal of informed consent|0
4629238|NCT01870726|7497088|FG006|Overall Study|Withdrawal of informed consent|0
4629239|NCT01870726|7497082|FG000|Overall Study|Withdrawal by Subject|0
4629240|NCT01870726|7497083|FG001|Overall Study|Withdrawal by Subject|1
4629241|NCT01870726|7497084|FG002|Overall Study|Withdrawal by Subject|0
4629242|NCT01870726|7497085|FG003|Overall Study|Withdrawal by Subject|0
4629243|NCT01870726|7497086|FG004|Overall Study|Withdrawal by Subject|0
4629244|NCT01870726|7497087|FG005|Overall Study|Withdrawal by Subject|0
4629245|NCT01870726|7497088|FG006|Overall Study|Withdrawal by Subject|0
4629246|NCT01870726|7497082|FG000|Overall Study|Adverse Event|0
4629247|NCT01870726|7497083|FG001|Overall Study|Adverse Event|0
4412177|NCT00267007|7192056|FG000|Overall Study|Lost to Follow-up|1
4412178|NCT00267007|7192057|FG001|Overall Study|Lost to Follow-up|0
4412179|NCT00267007|7192056|FG000|Overall Study|Non-compliance|0
4412180|NCT00267007|7192057|FG001|Overall Study|Non-compliance|1
4412181|NCT00267007|7192056|FG000|Overall Study|Adverse Event|1
4412182|NCT00267007|7192057|FG001|Overall Study|Adverse Event|0
4412183|NCT00267020|7192065|FG000|Overall Study|Adverse Event|22
4412184|NCT00267020|7192066|FG001|Overall Study|Adverse Event|5
4412185|NCT00267020|7192065|FG000|Overall Study|Death|2
4412186|NCT00267020|7192066|FG001|Overall Study|Death|1
4412187|NCT00267020|7192065|FG000|Overall Study|Withdrawal by Subject|17
4412188|NCT00267020|7192066|FG001|Overall Study|Withdrawal by Subject|7
4412189|NCT00267020|7192065|FG000|Overall Study|Physician Decision|3
4412190|NCT00267020|7192066|FG001|Overall Study|Physician Decision|2
4412191|NCT00267020|7192065|FG000|Overall Study|Disease Progression|39
4412192|NCT00267020|7192066|FG001|Overall Study|Disease Progression|25
4412193|NCT00267020|7192065|FG000|Overall Study|Unrelated Complication|1
4412194|NCT00267020|7192066|FG001|Overall Study|Unrelated Complication|1
4412195|NCT00267020|7192065|FG000|Overall Study|Sponsor Request|1
4412196|NCT00267020|7192066|FG001|Overall Study|Sponsor Request|0
4412197|NCT00267020|7192065|FG000|Overall Study|Other|1
4412198|NCT00267020|7192066|FG001|Overall Study|Other|2
4412199|NCT00267046|7192074|FG000|Overall Study|Disease progression|4
4412200|NCT00267046|7192075|FG001|Overall Study|Disease progression|2
4412201|NCT00267046|7192074|FG000|Overall Study|Chemotoxicity|2
4412202|NCT00267046|7192075|FG001|Overall Study|Chemotoxicity|0
4412203|NCT00267046|7192074|FG000|Overall Study|Open-label palifermin|2
4412204|NCT00267046|7192075|FG001|Overall Study|Open-label palifermin|7
4713863|NCT02952586|7641568|FG001|Follow-Up Phase (90 Days)|Death|10
4713864|NCT02952586|7641567|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6
4713865|NCT02952586|7641568|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2
4713866|NCT02952586|7641567|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1
4713867|NCT02952586|7641568|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1
4713868|NCT02952586|7641567|FG000|Follow-Up Phase (90 Days)|Other|7
4713869|NCT02952586|7641568|FG001|Follow-Up Phase (90 Days)|Other|5
4713870|NCT02952586|7641567|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32
4713871|NCT02952586|7641568|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50
4713872|NCT02952586|7641567|FG000|LT Follow-up (up to 45 Months)|Death|51
4713873|NCT02952586|7641568|FG001|LT Follow-up (up to 45 Months)|Death|31
4713874|NCT02952586|7641567|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7
4713875|NCT02952586|7641568|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1
4713876|NCT02952586|7641567|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2
4713877|NCT02952586|7641568|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4
4713878|NCT02952586|7641567|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187
4713879|NCT02952586|7641568|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201
4713880|NCT02952820|7641578|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8
4713881|NCT02952820|7641579|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9
4713882|NCT02952820|7641580|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16
4713883|NCT02952820|7641578|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7
4713884|NCT02952820|7641579|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7
4713885|NCT02952820|7641580|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6
4713886|NCT02952820|7641578|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15
4713887|NCT02952820|7641579|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12
4713888|NCT02952820|7641580|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17
4713889|NCT02952820|7641578|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17
4713890|NCT02952820|7641579|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12
4713891|NCT02952820|7641580|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11
4713892|NCT02952820|7641578|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0
4713893|NCT02952820|7641579|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14
4713894|NCT02952820|7641580|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13
4713895|NCT02952820|7641578|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13
4713896|NCT02952820|7641579|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11
4713897|NCT02952820|7641580|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21
4713898|NCT02952820|7641578|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4
4713899|NCT02952820|7641579|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4
4713900|NCT02952820|7641580|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4
4713901|NCT02952820|7641578|FG000|Active Treatment Period (6 Months)|Adverse Event|0
4713902|NCT02952820|7641579|FG001|Active Treatment Period (6 Months)|Adverse Event|6
4713903|NCT02952820|7641580|FG002|Active Treatment Period (6 Months)|Adverse Event|5
4713904|NCT02952820|7641578|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0
4713905|NCT02952820|7641579|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4
4412205|NCT00267046|7192074|FG000|Overall Study|Surgery|3
4412206|NCT00267046|7192075|FG001|Overall Study|Surgery|1
4412207|NCT00267046|7192074|FG000|Overall Study|Withdrawal by Subject|1
4412208|NCT00267046|7192075|FG001|Overall Study|Withdrawal by Subject|0
4412209|NCT00267046|7192074|FG000|Overall Study|Radiation|0
4412210|NCT00267046|7192075|FG001|Overall Study|Radiation|1
4412211|NCT00267098|7192097|FG000|Overall Study|Death|0
4412212|NCT00267098|7192098|FG001|Overall Study|Death|0
4412213|NCT00267098|7192099|FG002|Overall Study|Death|57
4412214|NCT00267098|7192100|FG003|Overall Study|Death|66
4412215|NCT00267098|7192101|FG004|Overall Study|Death|14
4412216|NCT00267098|7192102|FG005|Overall Study|Death|23
4412217|NCT00267098|7192103|FG006|Overall Study|Death|28
4412218|NCT00267098|7192104|FG007|Overall Study|Death|9
4412219|NCT00267098|7192097|FG000|Overall Study|Lost to Follow-up|0
4412220|NCT00267098|7192098|FG001|Overall Study|Lost to Follow-up|0
4412221|NCT00267098|7192099|FG002|Overall Study|Lost to Follow-up|6
4412222|NCT00267098|7192100|FG003|Overall Study|Lost to Follow-up|5
4412223|NCT00267098|7192101|FG004|Overall Study|Lost to Follow-up|2
4412224|NCT00267098|7192102|FG005|Overall Study|Lost to Follow-up|3
4412225|NCT00267098|7192103|FG006|Overall Study|Lost to Follow-up|1
4412226|NCT00267098|7192104|FG007|Overall Study|Lost to Follow-up|1
4412227|NCT00267098|7192097|FG000|Overall Study|Withdrawal by Subject|8
4412228|NCT00267098|7192098|FG001|Overall Study|Withdrawal by Subject|0
4412229|NCT00267098|7192099|FG002|Overall Study|Withdrawal by Subject|24
4412230|NCT00267098|7192100|FG003|Overall Study|Withdrawal by Subject|21
4412231|NCT00267098|7192101|FG004|Overall Study|Withdrawal by Subject|12
4412232|NCT00267098|7192102|FG005|Overall Study|Withdrawal by Subject|9
4412233|NCT00267098|7192103|FG006|Overall Study|Withdrawal by Subject|12
4412234|NCT00267098|7192104|FG007|Overall Study|Withdrawal by Subject|5
4412235|NCT00267098|7192097|FG000|Overall Study|Physician Decision|5
4412236|NCT00267098|7192098|FG001|Overall Study|Physician Decision|0
4412237|NCT00267098|7192099|FG002|Overall Study|Physician Decision|7
4412238|NCT00267098|7192100|FG003|Overall Study|Physician Decision|11
4412239|NCT00267098|7192101|FG004|Overall Study|Physician Decision|5
4412240|NCT00267098|7192102|FG005|Overall Study|Physician Decision|4
4412241|NCT00267098|7192103|FG006|Overall Study|Physician Decision|3
4412242|NCT00267098|7192104|FG007|Overall Study|Physician Decision|0
4412243|NCT00267098|7192097|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96
4412244|NCT00267098|7192098|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0
4412245|NCT00267098|7192099|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0
4412246|NCT00267098|7192100|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0
4412247|NCT00267098|7192101|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2
4412248|NCT00267098|7192102|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0
4412249|NCT00267098|7192103|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0
4412250|NCT00267098|7192104|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0
4412251|NCT00267098|7192097|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0
4412252|NCT00267098|7192098|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51
4412253|NCT00267098|7192099|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0
4412254|NCT00267098|7192100|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0
4412255|NCT00267098|7192101|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0
4412256|NCT00267098|7192102|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0
4412257|NCT00267098|7192103|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0
4412258|NCT00267098|7192104|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0
4412259|NCT00267098|7192097|FG000|Overall Study|Site closure|0
4412260|NCT00267098|7192098|FG001|Overall Study|Site closure|0
4412261|NCT00267098|7192099|FG002|Overall Study|Site closure|0
4412262|NCT00267098|7192100|FG003|Overall Study|Site closure|1
4412263|NCT00267098|7192101|FG004|Overall Study|Site closure|0
4412264|NCT00267098|7192102|FG005|Overall Study|Site closure|1
4412265|NCT00267098|7192103|FG006|Overall Study|Site closure|1
4412266|NCT00267098|7192104|FG007|Overall Study|Site closure|0
4412267|NCT00267098|7192097|FG000|Overall Study|Explanted Medtronic device|0
4412268|NCT00267098|7192098|FG001|Overall Study|Explanted Medtronic device|0
4412269|NCT00267098|7192099|FG002|Overall Study|Explanted Medtronic device|0
4412270|NCT00267098|7192100|FG003|Overall Study|Explanted Medtronic device|1
4412271|NCT00267098|7192101|FG004|Overall Study|Explanted Medtronic device|0
4412272|NCT00267098|7192102|FG005|Overall Study|Explanted Medtronic device|0
4412273|NCT00267098|7192103|FG006|Overall Study|Explanted Medtronic device|0
4412274|NCT00267098|7192104|FG007|Overall Study|Explanted Medtronic device|0
4412275|NCT00267098|7192097|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0
4412276|NCT00267098|7192098|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0
4412277|NCT00267098|7192099|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0
4412278|NCT00267098|7192100|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0
4412279|NCT00267098|7192101|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2
4412280|NCT00267098|7192102|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0
4412281|NCT00267098|7192103|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0
4412282|NCT00267098|7192104|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0
4412283|NCT00267098|7192097|FG000|Overall Study|Subject listed for heart transplant|0
4412284|NCT00267098|7192098|FG001|Overall Study|Subject listed for heart transplant|0
4412285|NCT00267098|7192099|FG002|Overall Study|Subject listed for heart transplant|0
4412286|NCT00267098|7192100|FG003|Overall Study|Subject listed for heart transplant|0
4412287|NCT00267098|7192101|FG004|Overall Study|Subject listed for heart transplant|0
4412288|NCT00267098|7192102|FG005|Overall Study|Subject listed for heart transplant|0
4412289|NCT00267098|7192103|FG006|Overall Study|Subject listed for heart transplant|1
4412290|NCT00267098|7192104|FG007|Overall Study|Subject listed for heart transplant|0
4412291|NCT00267098|7192097|FG000|Overall Study|Sponsor withdrew subject|0
4412292|NCT00267098|7192098|FG001|Overall Study|Sponsor withdrew subject|0
4412293|NCT00267098|7192099|FG002|Overall Study|Sponsor withdrew subject|0
4412294|NCT00267098|7192100|FG003|Overall Study|Sponsor withdrew subject|1
4412295|NCT00267098|7192101|FG004|Overall Study|Sponsor withdrew subject|0
4412296|NCT00267098|7192102|FG005|Overall Study|Sponsor withdrew subject|0
4412297|NCT00267098|7192103|FG006|Overall Study|Sponsor withdrew subject|0
4412298|NCT00267098|7192104|FG007|Overall Study|Sponsor withdrew subject|0
4412299|NCT00267150|7192137|FG000|Overall Study|Adverse Event|1
4412300|NCT00267189|7192143|FG000|Overall Study|Patient withdrew consent|1
4412301|NCT00267189|7192144|FG001|Overall Study|Patient withdrew consent|1
4412302|NCT00267189|7192143|FG000|Overall Study|Death|1
4412303|NCT00267189|7192144|FG001|Overall Study|Death|0
4412304|NCT00267189|7192143|FG000|Overall Study|Missing|3
4412305|NCT00267189|7192144|FG001|Overall Study|Missing|0
4412306|NCT00267202|7192152|FG000|Overall Study|Unsatisfactory therapeutic effect|21
4412307|NCT00267202|7192153|FG001|Overall Study|Unsatisfactory therapeutic effect|8
4412308|NCT00267202|7192152|FG000|Overall Study|Withdrawal by Subject|12
4412309|NCT00267202|7192153|FG001|Overall Study|Withdrawal by Subject|15
4412310|NCT00267202|7192152|FG000|Overall Study|Adverse Event|13
4412311|NCT00267202|7192153|FG001|Overall Study|Adverse Event|7
4412312|NCT00267202|7192152|FG000|Overall Study|Protocol Violation|2
4412313|NCT00267202|7192153|FG001|Overall Study|Protocol Violation|3
4412314|NCT00267202|7192152|FG000|Overall Study|Administrative problems|2
4412315|NCT00267202|7192153|FG001|Overall Study|Administrative problems|1
4412316|NCT00267202|7192152|FG000|Overall Study|Lost to Follow-up|3
4412317|NCT00267202|7192153|FG001|Overall Study|Lost to Follow-up|0
4511698|NCT00928512|7321058|FG002|Overall Study|Lack of Efficacy|4
4511699|NCT00928512|7321059|FG003|Overall Study|Lack of Efficacy|7
4511700|NCT00928512|7321060|FG004|Overall Study|Lack of Efficacy|3
4511701|NCT00928512|7321056|FG000|Overall Study|Protocol Violation|0
4511702|NCT00928512|7321057|FG001|Overall Study|Protocol Violation|1
4511703|NCT00928512|7321058|FG002|Overall Study|Protocol Violation|0
4511704|NCT00928512|7321059|FG003|Overall Study|Protocol Violation|1
4511705|NCT00928512|7321060|FG004|Overall Study|Protocol Violation|3
4511706|NCT00928512|7321056|FG000|Overall Study|Withdrawal by Subject|3
4511707|NCT00928512|7321057|FG001|Overall Study|Withdrawal by Subject|0
4511708|NCT00928512|7321058|FG002|Overall Study|Withdrawal by Subject|3
4511709|NCT00928512|7321059|FG003|Overall Study|Withdrawal by Subject|4
4511710|NCT00928512|7321060|FG004|Overall Study|Withdrawal by Subject|0
4511711|NCT00928512|7321056|FG000|Overall Study|Lost to Follow-up|1
4511712|NCT00928512|7321057|FG001|Overall Study|Lost to Follow-up|1
4511713|NCT00928512|7321058|FG002|Overall Study|Lost to Follow-up|2
4511714|NCT00928512|7321059|FG003|Overall Study|Lost to Follow-up|1
4511715|NCT00928512|7321060|FG004|Overall Study|Lost to Follow-up|3
4511716|NCT00928512|7321056|FG000|Overall Study|Administrative Problems|0
4511717|NCT00928512|7321057|FG001|Overall Study|Administrative Problems|1
4511718|NCT00928512|7321058|FG002|Overall Study|Administrative Problems|0
4511719|NCT00928512|7321059|FG003|Overall Study|Administrative Problems|0
4511720|NCT00928512|7321060|FG004|Overall Study|Administrative Problems|0
4511721|NCT00928564|7321078|FG000|Overall Study|Lost to Follow-up|6
4511722|NCT00928564|7321079|FG001|Overall Study|Lost to Follow-up|0
4511723|NCT00928668|7321092|FG000|Overall Study|Adverse Event|1
4511724|NCT00928668|7321093|FG001|Overall Study|Adverse Event|0
4511725|NCT00928668|7321094|FG002|Overall Study|Adverse Event|0
4511726|NCT00928668|7321095|FG003|Overall Study|Adverse Event|0
4511727|NCT00928668|7321096|FG004|Overall Study|Adverse Event|0
4511728|NCT00928668|7321092|FG000|Overall Study|Protocol Violation|0
4511729|NCT00928668|7321093|FG001|Overall Study|Protocol Violation|0
4511730|NCT00928668|7321094|FG002|Overall Study|Protocol Violation|0
4629248|NCT01870726|7497084|FG002|Overall Study|Adverse Event|0
4713906|NCT02952820|7641580|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6
4713907|NCT02952820|7641578|FG000|Active Treatment Period (6 Months)|Subject choice|0
4713908|NCT02952820|7641579|FG001|Active Treatment Period (6 Months)|Subject choice|10
4713909|NCT02952820|7641580|FG002|Active Treatment Period (6 Months)|Subject choice|7
4511731|NCT00928668|7321095|FG003|Overall Study|Protocol Violation|0
4511732|NCT00928668|7321096|FG004|Overall Study|Protocol Violation|1
4511733|NCT00928668|7321092|FG000|Overall Study|Withdrawal by Subject|0
4511734|NCT00928668|7321093|FG001|Overall Study|Withdrawal by Subject|1
4511735|NCT00928668|7321094|FG002|Overall Study|Withdrawal by Subject|1
4511736|NCT00928668|7321095|FG003|Overall Study|Withdrawal by Subject|0
4511737|NCT00928668|7321096|FG004|Overall Study|Withdrawal by Subject|0
4511738|NCT00928668|7321092|FG000|Overall Study|Other reasons not listed above|0
4511739|NCT00928668|7321093|FG001|Overall Study|Other reasons not listed above|0
4511740|NCT00928668|7321094|FG002|Overall Study|Other reasons not listed above|0
4511741|NCT00928668|7321095|FG003|Overall Study|Other reasons not listed above|1
4629249|NCT01870726|7497085|FG003|Overall Study|Adverse Event|0
4511742|NCT00928668|7321096|FG004|Overall Study|Other reasons not listed above|0
4511743|NCT00928707|7321122|FG000|Overall Study|Protocol Violation|1
4511744|NCT00928707|7321123|FG001|Overall Study|Protocol Violation|0
4511745|NCT00928746|7321145|FG000|Overall Study|Adverse Event|2
4511746|NCT00928746|7321145|FG000|Overall Study|Protocol Violation|1
4511747|NCT00928746|7321145|FG000|Overall Study|Withdrawal by Subject|1
4511748|NCT00928746|7321145|FG000|Overall Study|Other|2
4412318|NCT00267488|7192173|FG000|Overall Study|Sponsor Terminated Study|9
4412319|NCT00267488|7192173|FG000|Overall Study|Protocol Violation|1
4412320|NCT00267488|7192173|FG000|Overall Study|Other (Disease Progression)|1
4412321|NCT00267748|7192214|FG000|Non-randomized Period|Progressive disease|10
4412322|NCT00267748|7192215|FG001|Non-randomized Period|Progressive disease|0
4412323|NCT00267748|7192216|FG002|Non-randomized Period|Progressive disease|0
4412324|NCT00267748|7192214|FG000|Non-randomized Period|Adverse Event|8
4412325|NCT00267748|7192215|FG001|Non-randomized Period|Adverse Event|0
4412326|NCT00267748|7192216|FG002|Non-randomized Period|Adverse Event|0
4412327|NCT00267748|7192214|FG000|Non-randomized Period|Death|1
4412328|NCT00267748|7192215|FG001|Non-randomized Period|Death|0
4412329|NCT00267748|7192216|FG002|Non-randomized Period|Death|0
4412330|NCT00267748|7192214|FG000|Non-randomized Period|Participant not willing to participate|1
4412331|NCT00267748|7192215|FG001|Non-randomized Period|Participant not willing to participate|0
4412332|NCT00267748|7192216|FG002|Non-randomized Period|Participant not willing to participate|0
4412333|NCT00267748|7192214|FG000|Non-randomized Period|Other|3
4412334|NCT00267748|7192215|FG001|Non-randomized Period|Other|0
4412335|NCT00267748|7192216|FG002|Non-randomized Period|Other|0
4412336|NCT00267748|7192214|FG000|Randomized Period|Death|0
4412337|NCT00267748|7192215|FG001|Randomized Period|Death|2
4412338|NCT00267748|7192216|FG002|Randomized Period|Death|3
4412339|NCT00267748|7192214|FG000|Randomized Period|Adverse Event|0
4412340|NCT00267748|7192215|FG001|Randomized Period|Adverse Event|23
4412341|NCT00267748|7192216|FG002|Randomized Period|Adverse Event|25
4412342|NCT00267748|7192214|FG000|Randomized Period|Global deterioration of health status|0
4412343|NCT00267748|7192215|FG001|Randomized Period|Global deterioration of health status|6
4412344|NCT00267748|7192216|FG002|Randomized Period|Global deterioration of health status|7
4412345|NCT00267748|7192214|FG000|Randomized Period|Lost to Follow-up|0
4412346|NCT00267748|7192215|FG001|Randomized Period|Lost to Follow-up|1
4412347|NCT00267748|7192216|FG002|Randomized Period|Lost to Follow-up|0
4412348|NCT00267748|7192214|FG000|Randomized Period|Objective progression or relapse|0
4412349|NCT00267748|7192215|FG001|Randomized Period|Objective progression or relapse|77
4412350|NCT00267748|7192216|FG002|Randomized Period|Objective progression or relapse|86
4412351|NCT00267748|7192214|FG000|Randomized Period|Withdrawal by Subject|0
4412352|NCT00267748|7192215|FG001|Randomized Period|Withdrawal by Subject|9
4412353|NCT00267748|7192216|FG002|Randomized Period|Withdrawal by Subject|2
4412354|NCT00267748|7192214|FG000|Randomized Period|Other|0
4412355|NCT00267748|7192215|FG001|Randomized Period|Other|9
4412356|NCT00267748|7192216|FG002|Randomized Period|Other|6
4412357|NCT00267748|7192214|FG000|Randomized Period|randomized but not treated|0
4412358|NCT00267748|7192215|FG001|Randomized Period|randomized but not treated|0
4412359|NCT00267748|7192216|FG002|Randomized Period|randomized but not treated|3
4412360|NCT00267865|7192232|FG000|Induction Treatment|Died before completing.|2
4412361|NCT00267865|7192232|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1
4412362|NCT00267956|7192238|FG000|Controlled Period|Adverse Event|4
4412363|NCT00267956|7192239|FG001|Controlled Period|Adverse Event|1
4412364|NCT00267956|7192240|FG002|Controlled Period|Adverse Event|0
4412365|NCT00267956|7192241|FG003|Controlled Period|Adverse Event|0
4412366|NCT00267956|7192238|FG000|Controlled Period|Lack of Efficacy|4
4412367|NCT00267956|7192239|FG001|Controlled Period|Lack of Efficacy|2
4412368|NCT00267956|7192240|FG002|Controlled Period|Lack of Efficacy|0
4412369|NCT00267956|7192241|FG003|Controlled Period|Lack of Efficacy|0
4412370|NCT00267956|7192238|FG000|Controlled Period|Lost to Follow-up|2
4412371|NCT00267956|7192239|FG001|Controlled Period|Lost to Follow-up|0
4412372|NCT00267956|7192240|FG002|Controlled Period|Lost to Follow-up|0
4412373|NCT00267956|7192241|FG003|Controlled Period|Lost to Follow-up|0
4412374|NCT00267956|7192238|FG000|Controlled Period|Withdrew consent|3
4412375|NCT00267956|7192239|FG001|Controlled Period|Withdrew consent|1
4412376|NCT00267956|7192240|FG002|Controlled Period|Withdrew consent|0
4412377|NCT00267956|7192241|FG003|Controlled Period|Withdrew consent|0
4713910|NCT02952820|7641578|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0
4713911|NCT02952820|7641579|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6
4713912|NCT02952820|7641580|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2
4713913|NCT02952820|7641578|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0
4713914|NCT02952820|7641579|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6
4713915|NCT02952820|7641580|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8
4713916|NCT02952820|7641578|FG000|Active Treatment Period (6 Months)|Other than specified|0
4713917|NCT02952820|7641579|FG001|Active Treatment Period (6 Months)|Other than specified|6
4713918|NCT02952820|7641580|FG002|Active Treatment Period (6 Months)|Other than specified|2
4713919|NCT02952820|7641578|FG000|Active Treatment Period (6 Months)|Not treated|0
4713920|NCT02952820|7641579|FG001|Active Treatment Period (6 Months)|Not treated|0
4713921|NCT02952820|7641580|FG002|Active Treatment Period (6 Months)|Not treated|1
4713922|NCT02952898|7641659|FG000|Overall Study|Withdrawal by Subject|10
4412378|NCT00267956|7192238|FG000|After Controlled Period|Adverse Event|0
4412379|NCT00267956|7192239|FG001|After Controlled Period|Adverse Event|0
4412380|NCT00267956|7192240|FG002|After Controlled Period|Adverse Event|2
4412381|NCT00267956|7192241|FG003|After Controlled Period|Adverse Event|1
4412382|NCT00267956|7192238|FG000|After Controlled Period|Lack of Efficacy|0
4412383|NCT00267956|7192239|FG001|After Controlled Period|Lack of Efficacy|0
4412384|NCT00267956|7192240|FG002|After Controlled Period|Lack of Efficacy|1
4412385|NCT00267956|7192241|FG003|After Controlled Period|Lack of Efficacy|1
4412386|NCT00267956|7192238|FG000|After Controlled Period|Lost to Follow-up|0
4412387|NCT00267956|7192239|FG001|After Controlled Period|Lost to Follow-up|0
4412388|NCT00267956|7192240|FG002|After Controlled Period|Lost to Follow-up|1
4412389|NCT00267956|7192241|FG003|After Controlled Period|Lost to Follow-up|0
4412390|NCT00267956|7192238|FG000|After Controlled Period|Withdrew consent|0
4412391|NCT00267956|7192239|FG001|After Controlled Period|Withdrew consent|0
4412392|NCT00267956|7192240|FG002|After Controlled Period|Withdrew consent|1
4412393|NCT00267956|7192241|FG003|After Controlled Period|Withdrew consent|0
4629250|NCT01870726|7497086|FG004|Overall Study|Adverse Event|1
4629251|NCT01870726|7497087|FG005|Overall Study|Adverse Event|1
4629252|NCT01870726|7497088|FG006|Overall Study|Adverse Event|0
4629253|NCT01870726|7497082|FG000|Overall Study|Progressive disease|5
4629254|NCT01870726|7497083|FG001|Overall Study|Progressive disease|5
4629255|NCT01870726|7497084|FG002|Overall Study|Progressive disease|4
4412394|NCT00267969|7192252|FG000|Controlled Period|Adverse Event|6
4412395|NCT00267969|7192253|FG001|Controlled Period|Adverse Event|0
4412396|NCT00267969|7192254|FG002|Controlled Period|Adverse Event|2
4412397|NCT00267969|7192255|FG003|Controlled Period|Adverse Event|0
4412398|NCT00267969|7192256|FG004|Controlled Period|Adverse Event|0
4412399|NCT00267969|7192257|FG005|Controlled Period|Adverse Event|0
4412400|NCT00267969|7192258|FG006|Controlled Period|Adverse Event|0
4412401|NCT00267969|7192252|FG000|Controlled Period|Lack of Efficacy|3
4412402|NCT00267969|7192253|FG001|Controlled Period|Lack of Efficacy|0
4412403|NCT00267969|7192254|FG002|Controlled Period|Lack of Efficacy|1
4412404|NCT00267969|7192255|FG003|Controlled Period|Lack of Efficacy|0
4412405|NCT00267969|7192256|FG004|Controlled Period|Lack of Efficacy|0
4412406|NCT00267969|7192257|FG005|Controlled Period|Lack of Efficacy|0
4412407|NCT00267969|7192258|FG006|Controlled Period|Lack of Efficacy|0
4412408|NCT00267969|7192252|FG000|Controlled Period|Lost to Follow-up|1
4412409|NCT00267969|7192253|FG001|Controlled Period|Lost to Follow-up|0
4412410|NCT00267969|7192254|FG002|Controlled Period|Lost to Follow-up|1
4412411|NCT00267969|7192255|FG003|Controlled Period|Lost to Follow-up|0
4412412|NCT00267969|7192256|FG004|Controlled Period|Lost to Follow-up|0
4412413|NCT00267969|7192257|FG005|Controlled Period|Lost to Follow-up|0
4412414|NCT00267969|7192258|FG006|Controlled Period|Lost to Follow-up|0
4412415|NCT00267969|7192252|FG000|Controlled Period|Randomized but not treated|0
4412416|NCT00267969|7192253|FG001|Controlled Period|Randomized but not treated|0
4412417|NCT00267969|7192254|FG002|Controlled Period|Randomized but not treated|1
4412418|NCT00267969|7192255|FG003|Controlled Period|Randomized but not treated|0
4412419|NCT00267969|7192256|FG004|Controlled Period|Randomized but not treated|0
4412420|NCT00267969|7192257|FG005|Controlled Period|Randomized but not treated|0
4412421|NCT00267969|7192258|FG006|Controlled Period|Randomized but not treated|0
4412422|NCT00267969|7192252|FG000|Controlled Period|Other|2
4412423|NCT00267969|7192253|FG001|Controlled Period|Other|1
4412424|NCT00267969|7192254|FG002|Controlled Period|Other|6
4412425|NCT00267969|7192255|FG003|Controlled Period|Other|0
4412426|NCT00267969|7192256|FG004|Controlled Period|Other|0
4412427|NCT00267969|7192257|FG005|Controlled Period|Other|0
4412428|NCT00267969|7192258|FG006|Controlled Period|Other|0
4412429|NCT00267969|7192252|FG000|After Controlled Period|Adverse Event|0
4412430|NCT00267969|7192253|FG001|After Controlled Period|Adverse Event|0
4412431|NCT00267969|7192254|FG002|After Controlled Period|Adverse Event|0
4412432|NCT00267969|7192255|FG003|After Controlled Period|Adverse Event|7
4412433|NCT00267969|7192256|FG004|After Controlled Period|Adverse Event|8
4412434|NCT00267969|7192257|FG005|After Controlled Period|Adverse Event|23
4412435|NCT00267969|7192258|FG006|After Controlled Period|Adverse Event|21
4412436|NCT00267969|7192252|FG000|After Controlled Period|Death|0
4412437|NCT00267969|7192253|FG001|After Controlled Period|Death|0
4412438|NCT00267969|7192254|FG002|After Controlled Period|Death|0
4412439|NCT00267969|7192255|FG003|After Controlled Period|Death|1
4412440|NCT00267969|7192256|FG004|After Controlled Period|Death|2
4412441|NCT00267969|7192257|FG005|After Controlled Period|Death|0
4412442|NCT00267969|7192258|FG006|After Controlled Period|Death|1
4412443|NCT00267969|7192252|FG000|After Controlled Period|Lack of Efficacy|0
4412444|NCT00267969|7192253|FG001|After Controlled Period|Lack of Efficacy|0
4412445|NCT00267969|7192254|FG002|After Controlled Period|Lack of Efficacy|0
4412446|NCT00267969|7192255|FG003|After Controlled Period|Lack of Efficacy|10
4412447|NCT00267969|7192256|FG004|After Controlled Period|Lack of Efficacy|6
4412448|NCT00267969|7192257|FG005|After Controlled Period|Lack of Efficacy|28
4412449|NCT00267969|7192258|FG006|After Controlled Period|Lack of Efficacy|15
4412450|NCT00267969|7192252|FG000|After Controlled Period|Lost to Follow-up|0
4412451|NCT00267969|7192253|FG001|After Controlled Period|Lost to Follow-up|0
4412452|NCT00267969|7192254|FG002|After Controlled Period|Lost to Follow-up|0
4412453|NCT00267969|7192255|FG003|After Controlled Period|Lost to Follow-up|5
4412454|NCT00267969|7192256|FG004|After Controlled Period|Lost to Follow-up|8
4412455|NCT00267969|7192257|FG005|After Controlled Period|Lost to Follow-up|9
4412456|NCT00267969|7192258|FG006|After Controlled Period|Lost to Follow-up|10
4629256|NCT01870726|7497085|FG003|Overall Study|Progressive disease|5
4629257|NCT01870726|7497086|FG004|Overall Study|Progressive disease|6
4629258|NCT01870726|7497087|FG005|Overall Study|Progressive disease|4
4629259|NCT01870726|7497088|FG006|Overall Study|Progressive disease|10
4412457|NCT00267969|7192252|FG000|After Controlled Period|Other|0
4412458|NCT00267969|7192253|FG001|After Controlled Period|Other|0
4412459|NCT00267969|7192254|FG002|After Controlled Period|Other|0
4412460|NCT00267969|7192255|FG003|After Controlled Period|Other|13
4412461|NCT00267969|7192256|FG004|After Controlled Period|Other|11
4412462|NCT00267969|7192257|FG005|After Controlled Period|Other|22
4412463|NCT00267969|7192258|FG006|After Controlled Period|Other|25
4412464|NCT00268203|7192276|FG000|Overall Study|Lost to Follow-up|92
4412465|NCT00268203|7192276|FG000|Overall Study|Withdrawal by Subject|9
4412466|NCT00268203|7192276|FG000|Overall Study|Received Other NHL Therapy|7
4412467|NCT00268203|7192276|FG000|Overall Study|Progressive Disease|359
4412468|NCT00268203|7192276|FG000|Overall Study|Death|84
4412469|NCT00268203|7192276|FG000|Overall Study|Reason Not Specified|34
4412470|NCT00268203|7192276|FG000|Overall Study|Completed 2 Years of Follow-up|62
4412471|NCT00268242|7192280|FG000|Overall Study|Death|1
4412472|NCT00268346|7192286|FG000|Overall Study|Adverse Event|0
4412473|NCT00268346|7192287|FG001|Overall Study|Adverse Event|1
4412474|NCT00268346|7192286|FG000|Overall Study|Death|0
4412475|NCT00268346|7192287|FG001|Overall Study|Death|1
4412476|NCT00268346|7192286|FG000|Overall Study|Withdrawal by Subject|0
4412477|NCT00268346|7192287|FG001|Overall Study|Withdrawal by Subject|1
4412478|NCT00268437|7192293|FG000|Overall Study|Ineligible|1
4412479|NCT00268892|7192305|FG000|Overall Study|Adverse Event|14
4412480|NCT00268892|7192306|FG001|Overall Study|Adverse Event|17
4412481|NCT00268892|7192307|FG002|Overall Study|Adverse Event|20
4412482|NCT00268892|7192305|FG000|Overall Study|Lack of Efficacy|1
4412483|NCT00268892|7192306|FG001|Overall Study|Lack of Efficacy|3
4412484|NCT00268892|7192307|FG002|Overall Study|Lack of Efficacy|0
4412485|NCT00268892|7192305|FG000|Overall Study|Withdrawal by Subject|14
4412486|NCT00268892|7192306|FG001|Overall Study|Withdrawal by Subject|15
4412487|NCT00268892|7192307|FG002|Overall Study|Withdrawal by Subject|13
4412488|NCT00268892|7192305|FG000|Overall Study|Physician Decision|0
4412489|NCT00268892|7192306|FG001|Overall Study|Physician Decision|1
4412490|NCT00268892|7192307|FG002|Overall Study|Physician Decision|0
4412491|NCT00268892|7192305|FG000|Overall Study|Lost to Follow-up|5
4412492|NCT00268892|7192306|FG001|Overall Study|Lost to Follow-up|2
4412493|NCT00268892|7192307|FG002|Overall Study|Lost to Follow-up|4
4412494|NCT00268892|7192305|FG000|Overall Study|Protocol Violation|0
4412495|NCT00268892|7192306|FG001|Overall Study|Protocol Violation|1
4412496|NCT00268892|7192307|FG002|Overall Study|Protocol Violation|0
4412497|NCT00268892|7192305|FG000|Overall Study|Disease Progression|1
4412498|NCT00268892|7192306|FG001|Overall Study|Disease Progression|1
4412499|NCT00268892|7192307|FG002|Overall Study|Disease Progression|0
4412500|NCT00268892|7192305|FG000|Overall Study|Trial Site Closed|4
4412501|NCT00268892|7192306|FG001|Overall Study|Trial Site Closed|2
4412502|NCT00268892|7192307|FG002|Overall Study|Trial Site Closed|2
4412503|NCT00268905|7192318|FG000|Overall Study|Adverse Event|3
4412504|NCT00268905|7192319|FG001|Overall Study|Adverse Event|0
4412505|NCT00268905|7192320|FG002|Overall Study|Adverse Event|4
4412506|NCT00268905|7192318|FG000|Overall Study|Lost to Follow-up|0
4412507|NCT00268905|7192319|FG001|Overall Study|Lost to Follow-up|1
4412508|NCT00268905|7192320|FG002|Overall Study|Lost to Follow-up|0
4412509|NCT00268905|7192318|FG000|Overall Study|Withdrawal by Subject|0
4412510|NCT00268905|7192319|FG001|Overall Study|Withdrawal by Subject|0
4412511|NCT00268905|7192320|FG002|Overall Study|Withdrawal by Subject|3
4412512|NCT00268905|7192318|FG000|Overall Study|Progressive Disease|28
4412513|NCT00268905|7192319|FG001|Overall Study|Progressive Disease|4
4412514|NCT00268905|7192320|FG002|Overall Study|Progressive Disease|3
4412515|NCT00268905|7192318|FG000|Overall Study|Physician Decision|3
4412516|NCT00268905|7192319|FG001|Overall Study|Physician Decision|0
4412517|NCT00268905|7192320|FG002|Overall Study|Physician Decision|1
4412518|NCT00268905|7192318|FG000|Overall Study|Clinical Progression|9
4412519|NCT00268905|7192319|FG001|Overall Study|Clinical Progression|4
4412520|NCT00268905|7192320|FG002|Overall Study|Clinical Progression|1
4412521|NCT00268983|7192330|FG000|Overall Study|Death|3
4412522|NCT00268983|7192331|FG001|Overall Study|Death|0
4412523|NCT00268996|7192339|FG000|Overall Study|Adverse Event|11
4412524|NCT00268996|7192340|FG001|Overall Study|Adverse Event|7
4412525|NCT00268996|7192339|FG000|Overall Study|Lost to Follow-up|3
4412526|NCT00268996|7192340|FG001|Overall Study|Lost to Follow-up|1
4412527|NCT00268996|7192339|FG000|Overall Study|Withdrawal by Subject|5
4412528|NCT00268996|7192340|FG001|Overall Study|Withdrawal by Subject|11
4412529|NCT00268996|7192339|FG000|Overall Study|Non-compliance|1
4412530|NCT00268996|7192340|FG001|Overall Study|Non-compliance|0
4412531|NCT00268996|7192339|FG000|Overall Study|Other|1
4412532|NCT00268996|7192340|FG001|Overall Study|Other|1
4412533|NCT00269087|7192348|FG000|Overall Study|Adverse Event|20
4412534|NCT00269087|7192348|FG000|Overall Study|Withdrawal by Subject|1
4412535|NCT00269087|7192348|FG000|Overall Study|Exacerbation of COPD|13
4412536|NCT00269113|7192354|FG000|Overall Study|Adverse Event|14
4412537|NCT00269113|7192355|FG001|Overall Study|Adverse Event|7
4412538|NCT00269113|7192354|FG000|Overall Study|Lack of Efficacy|35
4412539|NCT00269113|7192355|FG001|Overall Study|Lack of Efficacy|18
4412540|NCT00269113|7192354|FG000|Overall Study|Early Improvement|2
4412541|NCT00269113|7192355|FG001|Overall Study|Early Improvement|0
4412542|NCT00269113|7192354|FG000|Overall Study|Withdrawal by Subject|0
4412543|NCT00269113|7192355|FG001|Overall Study|Withdrawal by Subject|2
4412544|NCT00269113|7192354|FG000|Overall Study|Death|6
4412545|NCT00269113|7192355|FG001|Overall Study|Death|2
4412546|NCT00269113|7192354|FG000|Overall Study|Lost to Follow-up|2
4412547|NCT00269113|7192355|FG001|Overall Study|Lost to Follow-up|1
4412548|NCT00269113|7192354|FG000|Overall Study|Protocol Violation|15
4412549|NCT00269113|7192355|FG001|Overall Study|Protocol Violation|5
4412550|NCT00269113|7192354|FG000|Overall Study|Other|0
4412551|NCT00269113|7192355|FG001|Overall Study|Other|2
4412552|NCT00269152|7192363|FG000|Overall Study|Adverse Event|9
4412553|NCT00269152|7192364|FG001|Overall Study|Adverse Event|3
4412554|NCT00269152|7192363|FG000|Overall Study|Withdrawal by Subject|7
4412555|NCT00269152|7192364|FG001|Overall Study|Withdrawal by Subject|3
4412556|NCT00269152|7192363|FG000|Overall Study|Physician Decision|2
4412557|NCT00269152|7192364|FG001|Overall Study|Physician Decision|3
4412558|NCT00269152|7192363|FG000|Overall Study|Protocol Violation|0
4412559|NCT00269152|7192364|FG001|Overall Study|Protocol Violation|1
4412560|NCT00269399|7192372|FG000|Overall Study|Lack of Efficacy|27
4412561|NCT00269399|7192373|FG001|Overall Study|Lack of Efficacy|10
4412562|NCT00269399|7192372|FG000|Overall Study|Adverse Event|10
4412563|NCT00269399|7192373|FG001|Overall Study|Adverse Event|4
4412564|NCT00269399|7192372|FG000|Overall Study|Withdrawal by Subject|2
4412565|NCT00269399|7192373|FG001|Overall Study|Withdrawal by Subject|5
4412566|NCT00269399|7192372|FG000|Overall Study|Negative Lab Result for C. difficile|2
4412567|NCT00269399|7192373|FG001|Overall Study|Negative Lab Result for C. difficile|3
4412568|NCT00269399|7192372|FG000|Overall Study|Other|0
4412569|NCT00269399|7192373|FG001|Overall Study|Other|4
4412570|NCT00269399|7192372|FG000|Overall Study|Development of exclusion criteria|0
4412571|NCT00269399|7192373|FG001|Overall Study|Development of exclusion criteria|1
4412572|NCT00269477|7192383|FG000|Overall Study|Protocol Violation|5
4412573|NCT00269477|7192384|FG001|Overall Study|Protocol Violation|5
4412574|NCT00269477|7192385|FG002|Overall Study|Protocol Violation|1
4412575|NCT00269477|7192386|FG003|Overall Study|Protocol Violation|0
4412576|NCT00269477|7192383|FG000|Overall Study|Missed post-vaccination blood draw|0
4412577|NCT00269477|7192384|FG001|Overall Study|Missed post-vaccination blood draw|1
4412578|NCT00269477|7192385|FG002|Overall Study|Missed post-vaccination blood draw|0
4412579|NCT00269477|7192386|FG003|Overall Study|Missed post-vaccination blood draw|0
4412580|NCT00269633|7192398|FG000|Overall Study|Withdrawal by Subject|1
4412581|NCT00269633|7192399|FG001|Overall Study|Withdrawal by Subject|0
4412582|NCT00269919|7192405|FG000|Overall Study|Other|26
4412583|NCT00269919|7192405|FG000|Overall Study|Started but not treated|1
4412584|NCT00270205|7192414|FG000|Overall Study|Lost to Follow-up|1
4412585|NCT00270205|7192415|FG001|Overall Study|Lost to Follow-up|0
4412586|NCT00270205|7192416|FG002|Overall Study|Lost to Follow-up|0
4412587|NCT00270205|7192417|FG003|Overall Study|Lost to Follow-up|1
4412588|NCT00270231|7192427|FG000|First Intervention|Lost to Follow-up|1
4412589|NCT00270231|7192428|FG001|First Intervention|Lost to Follow-up|1
4412590|NCT00270231|7192427|FG000|Washout Period|Lost to Follow-up|1
4412591|NCT00270231|7192428|FG001|Washout Period|Lost to Follow-up|0
4412592|NCT00270231|7192427|FG000|Second Intervention|Lost to Follow-up|0
4412593|NCT00270231|7192428|FG001|Second Intervention|Lost to Follow-up|1
4412594|NCT00270257|7192436|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412
4412595|NCT00270257|7192437|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424
4412596|NCT00270855|7192498|FG000|Overall Study|Withdrawal by Subject|8
4412597|NCT00270855|7192499|FG001|Overall Study|Withdrawal by Subject|8
4412598|NCT00270894|7192507|FG000|Overall Study|Adverse Event|1
4412599|NCT00270894|7192507|FG000|Overall Study|Withdrawal by Subject|1
4412600|NCT00270998|7192514|FG000|3 Month Follow-up|Adverse Event|1
4412601|NCT00270998|7192515|FG001|3 Month Follow-up|Adverse Event|0
4412602|NCT00270998|7192516|FG002|3 Month Follow-up|Adverse Event|0
4412603|NCT00270998|7192514|FG000|3 Month Follow-up|Lack of Efficacy|1
4412604|NCT00270998|7192515|FG001|3 Month Follow-up|Lack of Efficacy|2
4412605|NCT00270998|7192516|FG002|3 Month Follow-up|Lack of Efficacy|1
4412606|NCT00270998|7192514|FG000|3 Month Follow-up|Withdrawal by Subject|11
4412607|NCT00270998|7192515|FG001|3 Month Follow-up|Withdrawal by Subject|14
4412608|NCT00270998|7192516|FG002|3 Month Follow-up|Withdrawal by Subject|15
4412609|NCT00270998|7192514|FG000|3 Month Follow-up|Pessary did not fit|12
4412610|NCT00270998|7192515|FG001|3 Month Follow-up|Pessary did not fit|0
4412611|NCT00270998|7192516|FG002|3 Month Follow-up|Pessary did not fit|0
4412612|NCT00270998|7192514|FG000|3 Month Follow-up|Personal/family health|1
4412613|NCT00270998|7192515|FG001|3 Month Follow-up|Personal/family health|1
4412614|NCT00270998|7192516|FG002|3 Month Follow-up|Personal/family health|0
4412615|NCT00270998|7192514|FG000|3 Month Follow-up|Received/desired alternate treatment|13
4412616|NCT00270998|7192515|FG001|3 Month Follow-up|Received/desired alternate treatment|5
4412617|NCT00270998|7192516|FG002|3 Month Follow-up|Received/desired alternate treatment|2
4412618|NCT00270998|7192514|FG000|12 Month Follow-up|Lack of Efficacy|5
4412619|NCT00270998|7192515|FG001|12 Month Follow-up|Lack of Efficacy|4
4412620|NCT00270998|7192516|FG002|12 Month Follow-up|Lack of Efficacy|3
4412621|NCT00270998|7192514|FG000|12 Month Follow-up|Withdrawal by Subject|7
4412622|NCT00270998|7192515|FG001|12 Month Follow-up|Withdrawal by Subject|12
4412623|NCT00270998|7192516|FG002|12 Month Follow-up|Withdrawal by Subject|16
4412624|NCT00270998|7192514|FG000|12 Month Follow-up|Pessary did not fit|1
4412625|NCT00270998|7192515|FG001|12 Month Follow-up|Pessary did not fit|0
4412626|NCT00270998|7192516|FG002|12 Month Follow-up|Pessary did not fit|0
4412627|NCT00270998|7192514|FG000|12 Month Follow-up|Personal/family health|0
4412628|NCT00270998|7192515|FG001|12 Month Follow-up|Personal/family health|5
4412629|NCT00270998|7192516|FG002|12 Month Follow-up|Personal/family health|1
4412630|NCT00270998|7192514|FG000|12 Month Follow-up|Received/desired alternate treatment|1
4412631|NCT00270998|7192515|FG001|12 Month Follow-up|Received/desired alternate treatment|4
4412632|NCT00270998|7192516|FG002|12 Month Follow-up|Received/desired alternate treatment|1
4412633|NCT00271024|7192530|FG000|Overall Study|Lost Interest|3
4412634|NCT00271024|7192531|FG001|Overall Study|Lost Interest|4
4412635|NCT00271024|7192532|FG002|Overall Study|Lost Interest|2
4412636|NCT00271024|7192533|FG003|Overall Study|Lost Interest|3
4412637|NCT00271024|7192530|FG000|Overall Study|Unknown/Unspecified|11
4412638|NCT00271024|7192531|FG001|Overall Study|Unknown/Unspecified|11
4412639|NCT00271024|7192532|FG002|Overall Study|Unknown/Unspecified|8
4412640|NCT00271024|7192533|FG003|Overall Study|Unknown/Unspecified|4
4412641|NCT00271024|7192530|FG000|Overall Study|Protocol Violation|1
4412642|NCT00271024|7192531|FG001|Overall Study|Protocol Violation|6
4412643|NCT00271024|7192532|FG002|Overall Study|Protocol Violation|5
4412644|NCT00271024|7192533|FG003|Overall Study|Protocol Violation|11
4412645|NCT00271024|7192530|FG000|Overall Study|Unpleasant Reaction To Tablet|1
4412646|NCT00271024|7192531|FG001|Overall Study|Unpleasant Reaction To Tablet|3
4412647|NCT00271024|7192532|FG002|Overall Study|Unpleasant Reaction To Tablet|4
4590380|NCT01520987|7436359|FG005|Overall Study|Withdrawal by Subject|1
4590381|NCT01520987|7436360|FG006|Overall Study|Withdrawal by Subject|0
4590382|NCT01520987|7436361|FG007|Overall Study|Withdrawal by Subject|0
4590383|NCT01521117|7436386|FG000|First Intervention (6 Weeks)|Adverse Event|5
4590384|NCT01521117|7436387|FG001|First Intervention (6 Weeks)|Adverse Event|1
4590385|NCT01521117|7436386|FG000|First Intervention (6 Weeks)|Scheduling Issues|0
4590386|NCT01521117|7436387|FG001|First Intervention (6 Weeks)|Scheduling Issues|2
4590387|NCT01521117|7436386|FG000|Second Intervention (6 Weeks)|Adverse Event|0
4590388|NCT01521117|7436387|FG001|Second Intervention (6 Weeks)|Adverse Event|3
4590389|NCT01521364|7436402|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1
4590390|NCT01521364|7436402|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1
4590391|NCT01521494|7436418|FG000|Overall Study|Adverse Event|1
4590392|NCT01521494|7436419|FG001|Overall Study|Adverse Event|2
4590393|NCT01521494|7436420|FG002|Overall Study|Adverse Event|9
4590394|NCT01521494|7436421|FG003|Overall Study|Adverse Event|6
4590395|NCT01521494|7436422|FG004|Overall Study|Adverse Event|2
4590396|NCT01521494|7436418|FG000|Overall Study|Lack of Efficacy|0
4590397|NCT01521494|7436419|FG001|Overall Study|Lack of Efficacy|0
4590398|NCT01521494|7436420|FG002|Overall Study|Lack of Efficacy|0
4590399|NCT01521494|7436421|FG003|Overall Study|Lack of Efficacy|0
4590400|NCT01521494|7436422|FG004|Overall Study|Lack of Efficacy|2
4590401|NCT01521494|7436418|FG000|Overall Study|Withdrawal by Subject|1
4590402|NCT01521494|7436419|FG001|Overall Study|Withdrawal by Subject|1
4590403|NCT01521494|7436420|FG002|Overall Study|Withdrawal by Subject|0
4590404|NCT01521494|7436421|FG003|Overall Study|Withdrawal by Subject|2
4629260|NCT01870739|7497115|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0
4629261|NCT01870739|7497116|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1
4629262|NCT01870739|7497115|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0
4412648|NCT00271024|7192533|FG003|Overall Study|Unpleasant Reaction To Tablet|2
4412649|NCT00271024|7192530|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6
4412650|NCT00271024|7192531|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2
4412651|NCT00271024|7192532|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4
4412652|NCT00271024|7192533|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4
4412653|NCT00271505|7192580|FG000|Overall Study|Screen Failure|3
4412654|NCT00271505|7192580|FG000|Overall Study|Adverse Event|1
4412655|NCT00271505|7192580|FG000|Overall Study|Death|1
4412656|NCT00271596|7192596|FG000|Overall Study|Protocol Violation|1
4412657|NCT00271596|7192597|FG001|Overall Study|Protocol Violation|0
4412658|NCT00271596|7192596|FG000|Overall Study|Withdrawal by Subject|0
4412659|NCT00271596|7192597|FG001|Overall Study|Withdrawal by Subject|1
4412660|NCT00271609|7192605|FG000|Overall Study|Adverse Event|11
4412661|NCT00271609|7192606|FG001|Overall Study|Adverse Event|3
4412662|NCT00271609|7192605|FG000|Overall Study|Withdrawal by Subject|2
4412663|NCT00271609|7192606|FG001|Overall Study|Withdrawal by Subject|0
4412664|NCT00271856|7192623|FG000|Overall Study|Withdrawal by Subject|1
4412665|NCT00271856|7192624|FG001|Overall Study|Withdrawal by Subject|7
4590405|NCT01521494|7436422|FG004|Overall Study|Withdrawal by Subject|0
4629263|NCT01870739|7497116|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1
4713923|NCT02952898|7641660|FG001|Overall Study|Withdrawal by Subject|8
4713924|NCT02952898|7641661|FG002|Overall Study|Withdrawal by Subject|8
4713925|NCT02952898|7641659|FG000|Overall Study|Adverse Event|8
4713926|NCT02952898|7641660|FG001|Overall Study|Adverse Event|8
4412666|NCT00271856|7192623|FG000|Overall Study|Lost to Follow-up|10
4412667|NCT00271856|7192624|FG001|Overall Study|Lost to Follow-up|11
4412668|NCT00272038|7192630|FG000|Overall Study|withdrew before they received 2 cycles|7
4412669|NCT00272779|7192688|FG000|Baseline Through Week 48|Adverse event before Week 48|10
4412670|NCT00272779|7192689|FG001|Baseline Through Week 48|Adverse event before Week 48|14
4412671|NCT00272779|7192688|FG000|Baseline Through Week 48|Death before Week 48|4
4412672|NCT00272779|7192689|FG001|Baseline Through Week 48|Death before Week 48|4
4629264|NCT01870739|7497115|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3
4629265|NCT01870739|7497116|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2
4713927|NCT02952898|7641661|FG002|Overall Study|Adverse Event|3
4412673|NCT00272779|7192688|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5
4412674|NCT00272779|7192689|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8
4412675|NCT00272779|7192688|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6
4412676|NCT00272779|7192689|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6
4412677|NCT00272779|7192688|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1
4412678|NCT00272779|7192689|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0
4412679|NCT00272779|7192688|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6
4412680|NCT00272779|7192689|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9
4412681|NCT00272779|7192688|FG000|Baseline Through Week 48|Pregnancy before Week 48|2
4412682|NCT00272779|7192689|FG001|Baseline Through Week 48|Pregnancy before Week 48|2
4412683|NCT00272779|7192688|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1
4412684|NCT00272779|7192689|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0
4412685|NCT00272779|7192688|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4
4412686|NCT00272779|7192689|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13
4412687|NCT00272779|7192688|FG000|Baseline Through Week 48|Participant's decision before wk 48|0
4412688|NCT00272779|7192689|FG001|Baseline Through Week 48|Participant's decision before wk 48|1
4412689|NCT00272779|7192688|FG000|Baseline Through Week 48|Chose different site before wk 48|0
4412690|NCT00272779|7192689|FG001|Baseline Through Week 48|Chose different site before wk 48|1
4412691|NCT00272779|7192688|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1
4412692|NCT00272779|7192689|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1
4412693|NCT00272779|7192688|FG000|Baseline Through Week 48|Death on/after Week 48|1
4412694|NCT00272779|7192689|FG001|Baseline Through Week 48|Death on/after Week 48|1
4412695|NCT00272779|7192688|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7
4412696|NCT00272779|7192689|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1
4412697|NCT00272779|7192688|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2
4412698|NCT00272779|7192689|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2
4412699|NCT00272779|7192688|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2
4412700|NCT00272779|7192689|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2
4412701|NCT00272779|7192688|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1
4412702|NCT00272779|7192689|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2
4412703|NCT00272779|7192688|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0
4412704|NCT00272779|7192689|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2
4412705|NCT00272779|7192688|FG000|Baseline Through Week 48|Continuing treatment|385
4412706|NCT00272779|7192689|FG001|Baseline Through Week 48|Continuing treatment|368
4412707|NCT00272779|7192688|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0
4412708|NCT00272779|7192689|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3
4412709|NCT00272779|7192688|FG000|Baseline Through Week 48|Never treated|2
4713928|NCT02952898|7641659|FG000|Overall Study|Lost to Follow-up|3
4713929|NCT02952898|7641660|FG001|Overall Study|Lost to Follow-up|2
4713930|NCT02952898|7641661|FG002|Overall Study|Lost to Follow-up|2
4713931|NCT02952898|7641659|FG000|Overall Study|Non-compliance with study drug|1
4713932|NCT02952898|7641660|FG001|Overall Study|Non-compliance with study drug|1
4412710|NCT00272779|7192689|FG001|Baseline Through Week 48|Never treated|3
4629266|NCT01870739|7497115|FG000|Add-on Period (40 Weeks)|Adverse Event|0
4629267|NCT01870739|7497116|FG001|Add-on Period (40 Weeks)|Adverse Event|1
4629268|NCT01870739|7497115|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1
4629269|NCT01870739|7497116|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0
4629270|NCT01870739|7497115|FG000|Add-on Period (40 Weeks)|Protocol deviation|1
4629271|NCT01870739|7497116|FG001|Add-on Period (40 Weeks)|Protocol deviation|1
4629272|NCT01870739|7497115|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1
4629273|NCT01870739|7497116|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0
4629274|NCT01870778|7497134|FG000|Overall Study|Withdrawal by Subject|8
4629275|NCT01870778|7497135|FG001|Overall Study|Withdrawal by Subject|7
4629276|NCT01870778|7497134|FG000|Overall Study|Lost to Follow-up|0
4629277|NCT01870778|7497135|FG001|Overall Study|Lost to Follow-up|2
4629278|NCT01870843|7497141|FG000|Overall Study|Adverse Event|10
4629279|NCT01870843|7497141|FG000|Overall Study|Lost to Follow-up|24
4629280|NCT01870843|7497141|FG000|Overall Study|Death|1
4629281|NCT01870843|7497141|FG000|Overall Study|Withdrawal by Subject|18
4629282|NCT01870869|7497160|FG000|Overall Study|Implanted with nonstudy device|1
4629283|NCT01870869|7497161|FG001|Overall Study|Implanted with nonstudy device|3
4629284|NCT01870869|7497162|FG002|Overall Study|Implanted with nonstudy device|14
4629285|NCT01870869|7497163|FG003|Overall Study|Implanted with nonstudy device|4
4629286|NCT01870869|7497160|FG000|Overall Study|Death|0
4629287|NCT01870869|7497161|FG001|Overall Study|Death|0
4629288|NCT01870869|7497162|FG002|Overall Study|Death|7
4629289|NCT01870869|7497163|FG003|Overall Study|Death|1
4629290|NCT01870869|7497160|FG000|Overall Study|Subject choice|6
4629291|NCT01870869|7497161|FG001|Overall Study|Subject choice|2
4629292|NCT01870869|7497162|FG002|Overall Study|Subject choice|22
4412711|NCT00272779|7192688|FG000|Baseline Through Week 96|Adverse event before Week 96|13
4412712|NCT00272779|7192689|FG001|Baseline Through Week 96|Adverse event before Week 96|22
4412713|NCT00272779|7192688|FG000|Baseline Through Week 96|Death before Week 96|6
4412714|NCT00272779|7192689|FG001|Baseline Through Week 96|Death before Week 96|5
4412715|NCT00272779|7192688|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16
4412716|NCT00272779|7192689|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10
4412717|NCT00272779|7192688|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10
4412718|NCT00272779|7192689|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13
4412719|NCT00272779|7192688|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1
4412720|NCT00272779|7192689|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0
4412721|NCT00272779|7192688|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12
4412722|NCT00272779|7192689|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16
4412723|NCT00272779|7192688|FG000|Baseline Through Week 96|Pregnancy before Week 96|5
4412724|NCT00272779|7192689|FG001|Baseline Through Week 96|Pregnancy before Week 96|7
4412725|NCT00272779|7192688|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4
4412726|NCT00272779|7192689|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3
4412727|NCT00272779|7192688|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5
4412728|NCT00272779|7192689|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18
4412729|NCT00272779|7192688|FG000|Baseline Through Week 96|Changed address before Week 96|0
4412730|NCT00272779|7192689|FG001|Baseline Through Week 96|Changed address before Week 96|1
4412731|NCT00272779|7192688|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1
4412732|NCT00272779|7192689|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0
4412733|NCT00272779|7192688|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2
4412734|NCT00272779|7192689|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0
4713933|NCT02952898|7641661|FG002|Overall Study|Non-compliance with study drug|2
4713934|NCT02953262|7641673|FG000|Overall Study|Used portal during 6 months prior to randomization|3
4713935|NCT02953262|7641674|FG001|Overall Study|Used portal during 6 months prior to randomization|6
4713936|NCT02953262|7641675|FG002|Overall Study|Used portal during 6 months prior to randomization|3
4412735|NCT00272779|7192688|FG000|Baseline Through Week 96|Pregnancy at Week 96|1
4713937|NCT02953262|7641676|FG003|Overall Study|Used portal during 6 months prior to randomization|3
4713938|NCT02953314|7641692|FG000|Overall Study|Adverse Event|0
4713939|NCT02953314|7641693|FG001|Overall Study|Adverse Event|1
4713940|NCT02953314|7641692|FG000|Overall Study|Withdrawal of consent (not due to AE)|0
4713941|NCT02953314|7641693|FG001|Overall Study|Withdrawal of consent (not due to AE)|2
4713942|NCT02953639|7641718|FG000|Overall Study|Adverse Event|2
4713943|NCT02953639|7641719|FG001|Overall Study|Adverse Event|0
4713944|NCT02953639|7641720|FG002|Overall Study|Adverse Event|1
4713945|NCT02953639|7641718|FG000|Overall Study|Lost to Follow-up|8
4713946|NCT02953639|7641719|FG001|Overall Study|Lost to Follow-up|4
4713947|NCT02953639|7641720|FG002|Overall Study|Lost to Follow-up|3
4713948|NCT02953639|7641718|FG000|Overall Study|Non-Compliance With Study Drug|0
4713949|NCT02953639|7641719|FG001|Overall Study|Non-Compliance With Study Drug|2
4713950|NCT02953639|7641720|FG002|Overall Study|Non-Compliance With Study Drug|1
4713951|NCT02953639|7641718|FG000|Overall Study|Multiple Reasons|1
4713952|NCT02953639|7641719|FG001|Overall Study|Multiple Reasons|0
4713953|NCT02953639|7641720|FG002|Overall Study|Multiple Reasons|1
4713954|NCT02953639|7641718|FG000|Overall Study|Physician Decision|1
4713955|NCT02953639|7641719|FG001|Overall Study|Physician Decision|0
4713956|NCT02953639|7641720|FG002|Overall Study|Physician Decision|0
4713957|NCT02953639|7641718|FG000|Overall Study|Withdrawal by Subject|7
4713958|NCT02953639|7641719|FG001|Overall Study|Withdrawal by Subject|8
4713959|NCT02953639|7641720|FG002|Overall Study|Withdrawal by Subject|10
4713960|NCT02953639|7641718|FG000|Overall Study|Completed or Discontinued information is missing|1
4713961|NCT02953639|7641719|FG001|Overall Study|Completed or Discontinued information is missing|0
4713962|NCT02953639|7641720|FG002|Overall Study|Completed or Discontinued information is missing|0
4713963|NCT02953678|7641730|FG000|Overall Study|Adverse Event|20
4713964|NCT02953678|7641730|FG000|Overall Study|Death|7
4713965|NCT02953678|7641730|FG000|Overall Study|Physician Decision|23
4713966|NCT02953678|7641730|FG000|Overall Study|Progressive Disease of GVHD|7
4713967|NCT02953678|7641730|FG000|Overall Study|Relapse of Underlying Malignancy|3
4713968|NCT02953678|7641730|FG000|Overall Study|Withdrawal by participant|3
4713969|NCT02953678|7641730|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5
4713970|NCT02953678|7641730|FG000|Overall Study|Participants were transferred to commercial product.|3
4713971|NCT02953782|7641743|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5
4713972|NCT02953782|7641744|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2
4713973|NCT02953782|7641745|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6
4713974|NCT02953782|7641746|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6
4713975|NCT02953782|7641747|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4
4713976|NCT02953782|7641748|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0
4713977|NCT02953782|7641749|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0
4713978|NCT02953782|7641750|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0
4713979|NCT02953782|7641743|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1
4713980|NCT02953782|7641744|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0
4412736|NCT00272779|7192689|FG001|Baseline Through Week 96|Pregnancy at Week 96|0
4412737|NCT00272779|7192688|FG000|Baseline Through Week 96|Never treated|2
4412738|NCT00272779|7192689|FG001|Baseline Through Week 96|Never treated|3
4412739|NCT00272779|7192688|FG000|Baseline Through Week 96|Continuing on treatment|61
4412740|NCT00272779|7192689|FG001|Baseline Through Week 96|Continuing on treatment|38
4412741|NCT00272792|7192698|FG000|Part 1: Responsiveness|Lost to Follow-up|1
4412742|NCT00272792|7192699|FG001|Part 1: Responsiveness|Lost to Follow-up|0
4412743|NCT00272792|7192698|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0
4412744|NCT00272792|7192699|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2
4412745|NCT00272792|7192698|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1
4412746|NCT00272792|7192699|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0
4412747|NCT00272792|7192698|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0
4412748|NCT00272792|7192699|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1
4412749|NCT00272844|7192705|FG000|Overall Study|Withdrawal by Subject|5
4412750|NCT00272961|7192714|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1
4412751|NCT00272961|7192715|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
4412752|NCT00272961|7192716|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
4412753|NCT00272961|7192717|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
4412754|NCT00272961|7192718|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
4412755|NCT00272961|7192714|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1
4412756|NCT00272961|7192715|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
4412757|NCT00272961|7192716|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
4412758|NCT00272961|7192717|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
4412759|NCT00272961|7192718|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
4412760|NCT00272961|7192714|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5
4412761|NCT00272961|7192715|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
4412762|NCT00272961|7192716|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
4412763|NCT00272961|7192717|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
4412764|NCT00272961|7192718|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
4412765|NCT00272961|7192714|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2
4412766|NCT00272961|7192715|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
4412767|NCT00272961|7192716|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
4412768|NCT00272961|7192717|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
4412769|NCT00272961|7192718|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
4412770|NCT00272961|7192714|FG000|Placebo Run-in Phase: Up to Week 2|Other|2
4412771|NCT00272961|7192715|FG001|Placebo Run-in Phase: Up to Week 2|Other|0
4412772|NCT00272961|7192716|FG002|Placebo Run-in Phase: Up to Week 2|Other|0
4412773|NCT00272961|7192717|FG003|Placebo Run-in Phase: Up to Week 2|Other|0
4412774|NCT00272961|7192718|FG004|Placebo Run-in Phase: Up to Week 2|Other|0
4412775|NCT00272961|7192714|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0
4412776|NCT00272961|7192715|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1
4412777|NCT00272961|7192716|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0
4412778|NCT00272961|7192717|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1
4412779|NCT00272961|7192718|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2
4412780|NCT00272961|7192714|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1
4412781|NCT00272961|7192715|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
4412782|NCT00272961|7192716|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1
4412783|NCT00272961|7192717|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
4412784|NCT00272961|7192718|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
4412785|NCT00272961|7192714|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1
4412786|NCT00272961|7192715|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3
4713981|NCT02953782|7641745|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2
4713982|NCT02953782|7641746|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0
4713983|NCT02953782|7641747|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1
4713984|NCT02953782|7641748|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0
4713985|NCT02953782|7641749|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0
4713986|NCT02953782|7641750|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0
4713987|NCT02953782|7641743|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0
4713988|NCT02953782|7641744|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1
4713989|NCT02953782|7641745|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0
4713990|NCT02953782|7641746|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1
4713991|NCT02953782|7641747|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1
4713992|NCT02953782|7641748|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0
4713993|NCT02953782|7641749|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0
4713994|NCT02953782|7641750|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0
4713995|NCT02953782|7641743|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0
4713996|NCT02953782|7641744|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0
4713997|NCT02953782|7641745|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1
4412787|NCT00272961|7192716|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3
4412788|NCT00272961|7192717|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2
4412789|NCT00272961|7192718|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2
4412790|NCT00272987|7192733|FG000|Overall Study|Adverse Event|1
4412791|NCT00272987|7192734|FG001|Overall Study|Adverse Event|0
4412792|NCT00272987|7192735|FG002|Overall Study|Adverse Event|0
4412793|NCT00272987|7192733|FG000|Overall Study|Lost to Follow-up|3
4412794|NCT00272987|7192734|FG001|Overall Study|Lost to Follow-up|1
4412795|NCT00272987|7192735|FG002|Overall Study|Lost to Follow-up|1
4412796|NCT00272987|7192733|FG000|Overall Study|Withdrawal by Subject|1
4412797|NCT00272987|7192734|FG001|Overall Study|Withdrawal by Subject|0
4412798|NCT00272987|7192735|FG002|Overall Study|Withdrawal by Subject|3
4412799|NCT00272987|7192733|FG000|Overall Study|Sponsor Terminated study|0
4412800|NCT00272987|7192734|FG001|Overall Study|Sponsor Terminated study|1
4412801|NCT00272987|7192735|FG002|Overall Study|Sponsor Terminated study|1
4412802|NCT00272987|7192733|FG000|Overall Study|Disease progression|1
4412803|NCT00272987|7192734|FG001|Overall Study|Disease progression|1
4412804|NCT00272987|7192735|FG002|Overall Study|Disease progression|2
4412805|NCT00272987|7192733|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2
4412806|NCT00272987|7192734|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1
4412807|NCT00272987|7192735|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4
4412808|NCT00272987|7192733|FG000|Overall Study|Death|1
4412809|NCT00272987|7192734|FG001|Overall Study|Death|0
4412810|NCT00272987|7192735|FG002|Overall Study|Death|0
4412811|NCT00273052|7192745|FG000|Overall Study|Withdrawal by Subject|16
4412812|NCT00273052|7192746|FG001|Overall Study|Withdrawal by Subject|19
4412813|NCT00273052|7192745|FG000|Overall Study|Adverse Event|21
4412814|NCT00273052|7192746|FG001|Overall Study|Adverse Event|19
4412815|NCT00273052|7192745|FG000|Overall Study|Protocol Violation|14
4412816|NCT00273052|7192746|FG001|Overall Study|Protocol Violation|18
4412817|NCT00273052|7192745|FG000|Overall Study|Lost to Follow-up|7
4412818|NCT00273052|7192746|FG001|Overall Study|Lost to Follow-up|25
4412819|NCT00273052|7192745|FG000|Overall Study|Lack of Efficacy|6
4412820|NCT00273052|7192746|FG001|Overall Study|Lack of Efficacy|4
4412821|NCT00273052|7192745|FG000|Overall Study|Non-Compliance|3
4412822|NCT00273052|7192746|FG001|Overall Study|Non-Compliance|1
4412823|NCT00273052|7192745|FG000|Overall Study|Other|2
4412824|NCT00273052|7192746|FG001|Overall Study|Other|0
4412825|NCT00273052|7192745|FG000|Overall Study|Worsening serum lipid levels|0
4412826|NCT00273052|7192746|FG001|Overall Study|Worsening serum lipid levels|2
4412827|NCT00273182|7192752|FG000|Overall Study|Death|450
4412828|NCT00273182|7192752|FG000|Overall Study|Lost to Follow-up|88
4412829|NCT00273182|7192752|FG000|Overall Study|Withdrawal by Subject|257
4412830|NCT00273182|7192752|FG000|Overall Study|Device/System Explant|154
4412831|NCT00273182|7192752|FG000|Overall Study|Site exit, system change, 36 m FU missed|36
4412832|NCT00273858|7192800|FG000|Overall Study|Not completed 24 month observation time|334
4412833|NCT00273858|7192800|FG000|Overall Study|Lost to Follow-up|101
4412834|NCT00273858|7192800|FG000|Overall Study|Withdrawal by Subject|21
4412835|NCT00273858|7192800|FG000|Overall Study|Adverse Event|81
4412836|NCT00274261|7192831|FG000|Overall Study|Adverse Event|19
4412837|NCT00274261|7192832|FG001|Overall Study|Adverse Event|11
4412838|NCT00274261|7192831|FG000|Overall Study|Pregnancy|114
4412839|NCT00274261|7192832|FG001|Overall Study|Pregnancy|83
4412840|NCT00274261|7192831|FG000|Overall Study|Withdrawal by Subject|179
4412841|NCT00274261|7192832|FG001|Overall Study|Withdrawal by Subject|126
4412842|NCT00274261|7192831|FG000|Overall Study|Protocol Violation|71
4412843|NCT00274261|7192832|FG001|Overall Study|Protocol Violation|42
4412844|NCT00274261|7192831|FG000|Overall Study|Lost to Follow-up|106
4412845|NCT00274261|7192832|FG001|Overall Study|Lost to Follow-up|75
4412846|NCT00274287|7192840|FG000|Overall Study|Withdrawal by Subject|1
4412847|NCT00274287|7192840|FG000|Overall Study|subject non-compliance|1
4412848|NCT00274456|7192849|FG000|Overall Study|Still on treatment|2
4412849|NCT00274456|7192850|FG001|Overall Study|Still on treatment|3
4412850|NCT00274456|7192851|FG002|Overall Study|Still on treatment|5
4412851|NCT00274456|7192852|FG003|Overall Study|Still on treatment|1
4412852|NCT00274456|7192849|FG000|Overall Study|Unacceptable toxicity|10
4412853|NCT00274456|7192850|FG001|Overall Study|Unacceptable toxicity|5
4412854|NCT00274456|7192851|FG002|Overall Study|Unacceptable toxicity|12
4412855|NCT00274456|7192852|FG003|Overall Study|Unacceptable toxicity|16
4412856|NCT00274456|7192849|FG000|Overall Study|Adverse Event|0
4412857|NCT00274456|7192850|FG001|Overall Study|Adverse Event|1
4412858|NCT00274456|7192851|FG002|Overall Study|Adverse Event|2
4412859|NCT00274456|7192852|FG003|Overall Study|Adverse Event|2
4412860|NCT00274456|7192849|FG000|Overall Study|Physician Decision|7
4412861|NCT00274456|7192850|FG001|Overall Study|Physician Decision|5
4412862|NCT00274456|7192851|FG002|Overall Study|Physician Decision|6
4412863|NCT00274456|7192852|FG003|Overall Study|Physician Decision|13
4412864|NCT00274456|7192849|FG000|Overall Study|Lost to Follow-up|0
4412865|NCT00274456|7192850|FG001|Overall Study|Lost to Follow-up|0
4412866|NCT00274456|7192851|FG002|Overall Study|Lost to Follow-up|1
4412867|NCT00274456|7192852|FG003|Overall Study|Lost to Follow-up|0
4412868|NCT00274456|7192849|FG000|Overall Study|Withdrawal by Subject|18
4412869|NCT00274456|7192850|FG001|Overall Study|Withdrawal by Subject|13
4412870|NCT00274456|7192851|FG002|Overall Study|Withdrawal by Subject|9
4412871|NCT00274456|7192852|FG003|Overall Study|Withdrawal by Subject|13
4412872|NCT00274469|7192864|FG000|Overall Study|Death|63
4412873|NCT00274469|7192865|FG001|Overall Study|Death|74
4412874|NCT00274469|7192864|FG000|Overall Study|Did not consent to OS follow-up|16
4412875|NCT00274469|7192865|FG001|Overall Study|Did not consent to OS follow-up|19
4412876|NCT00274625|7192873|FG000|Overall Study|Lost to Follow-up|46
4412877|NCT00274625|7192874|FG001|Overall Study|Lost to Follow-up|54
4412878|NCT00274625|7192873|FG000|Overall Study|Excluded from analysis|14
4412879|NCT00274625|7192874|FG001|Overall Study|Excluded from analysis|8
4412880|NCT00274651|7192882|FG000|Overall Study|Adverse Event|6
4412881|NCT00274651|7192883|FG001|Overall Study|Adverse Event|3
4412882|NCT00274651|7192882|FG000|Overall Study|Lack of Efficacy|13
4412883|NCT00274651|7192883|FG001|Overall Study|Lack of Efficacy|6
4412884|NCT00274651|7192882|FG000|Overall Study|Death|1
4412885|NCT00274651|7192883|FG001|Overall Study|Death|3
4412886|NCT00274651|7192882|FG000|Overall Study|Withdrawal by Subject|0
4412887|NCT00274651|7192883|FG001|Overall Study|Withdrawal by Subject|1
4412888|NCT00274651|7192882|FG000|Overall Study|Physician Decision|8
4412889|NCT00274651|7192883|FG001|Overall Study|Physician Decision|7
4412890|NCT00274716|7192896|FG000|Phase A|Other non-reported reason|4
4412891|NCT00274716|7192897|FG001|Phase A|Other non-reported reason|2
4412892|NCT00274716|7192898|FG002|Phase A|Other non-reported reason|1
4412893|NCT00274716|7192899|FG003|Phase A|Other non-reported reason|2
4412894|NCT00274716|7192900|FG004|Phase A|Other non-reported reason|0
4412895|NCT00274716|7192901|FG005|Phase A|Other non-reported reason|1
4412896|NCT00274716|7192896|FG000|Phase A|Participant moved|0
4412897|NCT00274716|7192897|FG001|Phase A|Participant moved|0
4412898|NCT00274716|7192898|FG002|Phase A|Participant moved|1
4412899|NCT00274716|7192899|FG003|Phase A|Participant moved|0
4412900|NCT00274716|7192900|FG004|Phase A|Participant moved|0
4412901|NCT00274716|7192901|FG005|Phase A|Participant moved|1
4412902|NCT00274716|7192896|FG000|Phase A|Site Terminated|0
4412903|NCT00274716|7192897|FG001|Phase A|Site Terminated|0
4412904|NCT00274716|7192898|FG002|Phase A|Site Terminated|0
4412905|NCT00274716|7192899|FG003|Phase A|Site Terminated|1
4412906|NCT00274716|7192900|FG004|Phase A|Site Terminated|0
4412907|NCT00274716|7192901|FG005|Phase A|Site Terminated|0
4412908|NCT00274716|7192896|FG000|Phase A|Protocol Violation|1
4412909|NCT00274716|7192897|FG001|Phase A|Protocol Violation|0
4412910|NCT00274716|7192898|FG002|Phase A|Protocol Violation|0
4412911|NCT00274716|7192899|FG003|Phase A|Protocol Violation|1
4412912|NCT00274716|7192900|FG004|Phase A|Protocol Violation|0
4412913|NCT00274716|7192901|FG005|Phase A|Protocol Violation|0
4412914|NCT00274716|7192896|FG000|Phase A|Met criteria for discontinuation|1
4412915|NCT00274716|7192897|FG001|Phase A|Met criteria for discontinuation|1
4412916|NCT00274716|7192898|FG002|Phase A|Met criteria for discontinuation|0
4412917|NCT00274716|7192899|FG003|Phase A|Met criteria for discontinuation|0
4412918|NCT00274716|7192900|FG004|Phase A|Met criteria for discontinuation|0
4412919|NCT00274716|7192901|FG005|Phase A|Met criteria for discontinuation|0
4412920|NCT00274716|7192896|FG000|Phase A|Withdrawal by Subject|2
4412921|NCT00274716|7192897|FG001|Phase A|Withdrawal by Subject|2
4412922|NCT00274716|7192898|FG002|Phase A|Withdrawal by Subject|1
4412923|NCT00274716|7192899|FG003|Phase A|Withdrawal by Subject|3
4713998|NCT02953782|7641746|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1
4713999|NCT02953782|7641747|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0
4714000|NCT02953782|7641748|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0
4714001|NCT02953782|7641749|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0
4714002|NCT02953782|7641750|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0
4714003|NCT02953782|7641743|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0
4714004|NCT02953782|7641744|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0
4714005|NCT02953782|7641745|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0
4714006|NCT02953782|7641746|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0
4714007|NCT02953782|7641747|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0
4714008|NCT02953782|7641748|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14
4714009|NCT02953782|7641749|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11
4714010|NCT02953782|7641750|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8
4714011|NCT02953782|7641743|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0
4714012|NCT02953782|7641744|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0
4714013|NCT02953782|7641745|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0
4714014|NCT02953782|7641746|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0
4714015|NCT02953782|7641747|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0
4412924|NCT00274716|7192900|FG004|Phase A|Withdrawal by Subject|0
4412925|NCT00274716|7192901|FG005|Phase A|Withdrawal by Subject|1
4412926|NCT00274716|7192896|FG000|Phase A|Adverse Event|2
4412927|NCT00274716|7192897|FG001|Phase A|Adverse Event|3
4412928|NCT00274716|7192898|FG002|Phase A|Adverse Event|3
4412929|NCT00274716|7192899|FG003|Phase A|Adverse Event|0
4412930|NCT00274716|7192900|FG004|Phase A|Adverse Event|2
4412931|NCT00274716|7192901|FG005|Phase A|Adverse Event|0
4412932|NCT00274716|7192896|FG000|Phase A|Completed but did not enter Phase B|1
4412933|NCT00274716|7192897|FG001|Phase A|Completed but did not enter Phase B|2
4412934|NCT00274716|7192898|FG002|Phase A|Completed but did not enter Phase B|2
4412935|NCT00274716|7192899|FG003|Phase A|Completed but did not enter Phase B|2
4412936|NCT00274716|7192900|FG004|Phase A|Completed but did not enter Phase B|1
4412937|NCT00274716|7192901|FG005|Phase A|Completed but did not enter Phase B|1
4412938|NCT00274716|7192896|FG000|Phase B|Adverse Event|0
4412939|NCT00274716|7192897|FG001|Phase B|Adverse Event|0
4412940|NCT00274716|7192898|FG002|Phase B|Adverse Event|2
4412941|NCT00274716|7192899|FG003|Phase B|Adverse Event|0
4412942|NCT00274716|7192900|FG004|Phase B|Adverse Event|0
4412943|NCT00274716|7192901|FG005|Phase B|Adverse Event|1
4412944|NCT00274716|7192896|FG000|Phase B|Protocol Violation|0
4412945|NCT00274716|7192897|FG001|Phase B|Protocol Violation|2
4412946|NCT00274716|7192898|FG002|Phase B|Protocol Violation|0
4412947|NCT00274716|7192899|FG003|Phase B|Protocol Violation|0
4412948|NCT00274716|7192900|FG004|Phase B|Protocol Violation|0
4412949|NCT00274716|7192901|FG005|Phase B|Protocol Violation|0
4412950|NCT00274716|7192896|FG000|Phase B|Withdrawal by Subject|0
4412951|NCT00274716|7192897|FG001|Phase B|Withdrawal by Subject|1
4412952|NCT00274716|7192898|FG002|Phase B|Withdrawal by Subject|0
4412953|NCT00274716|7192899|FG003|Phase B|Withdrawal by Subject|0
4412954|NCT00274716|7192900|FG004|Phase B|Withdrawal by Subject|0
4412955|NCT00274716|7192901|FG005|Phase B|Withdrawal by Subject|0
4412956|NCT00274716|7192896|FG000|Phase B|Participant moved|1
4412957|NCT00274716|7192897|FG001|Phase B|Participant moved|0
4412958|NCT00274716|7192898|FG002|Phase B|Participant moved|0
4412959|NCT00274716|7192899|FG003|Phase B|Participant moved|0
4412960|NCT00274716|7192900|FG004|Phase B|Participant moved|0
4412961|NCT00274716|7192901|FG005|Phase B|Participant moved|0
4412962|NCT00274716|7192896|FG000|Phase B|Other non-reported reason|0
4412963|NCT00274716|7192897|FG001|Phase B|Other non-reported reason|0
4412964|NCT00274716|7192898|FG002|Phase B|Other non-reported reason|1
4412965|NCT00274716|7192899|FG003|Phase B|Other non-reported reason|1
4412966|NCT00274716|7192900|FG004|Phase B|Other non-reported reason|0
4412967|NCT00274716|7192901|FG005|Phase B|Other non-reported reason|0
4412968|NCT00274716|7192896|FG000|Phase B|Lost to Follow-up|0
4412969|NCT00274716|7192897|FG001|Phase B|Lost to Follow-up|1
4412970|NCT00274716|7192898|FG002|Phase B|Lost to Follow-up|0
4412971|NCT00274716|7192899|FG003|Phase B|Lost to Follow-up|0
4412972|NCT00274716|7192900|FG004|Phase B|Lost to Follow-up|0
4412973|NCT00274716|7192901|FG005|Phase B|Lost to Follow-up|0
4412974|NCT00274742|7192925|FG000|Overall Study|Adverse Event|0
4412975|NCT00274742|7192926|FG001|Overall Study|Adverse Event|4
4412976|NCT00274742|7192927|FG002|Overall Study|Adverse Event|1
4412977|NCT00274742|7192928|FG003|Overall Study|Adverse Event|4
4412978|NCT00274742|7192929|FG004|Overall Study|Adverse Event|12
4412979|NCT00274742|7192930|FG005|Overall Study|Adverse Event|3
4412980|NCT00274742|7192925|FG000|Overall Study|Lost to Follow-up|0
4412981|NCT00274742|7192926|FG001|Overall Study|Lost to Follow-up|0
4412982|NCT00274742|7192927|FG002|Overall Study|Lost to Follow-up|0
4412983|NCT00274742|7192928|FG003|Overall Study|Lost to Follow-up|0
4412984|NCT00274742|7192929|FG004|Overall Study|Lost to Follow-up|1
4412985|NCT00274742|7192930|FG005|Overall Study|Lost to Follow-up|0
4412986|NCT00274742|7192925|FG000|Overall Study|End of Study|0
4412987|NCT00274742|7192926|FG001|Overall Study|End of Study|0
4412988|NCT00274742|7192927|FG002|Overall Study|End of Study|0
4412989|NCT00274742|7192928|FG003|Overall Study|End of Study|1
4412990|NCT00274742|7192929|FG004|Overall Study|End of Study|0
4412991|NCT00274742|7192930|FG005|Overall Study|End of Study|0
4714016|NCT02953782|7641748|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1
4714017|NCT02953782|7641749|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2
4714018|NCT02953782|7641750|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3
4714019|NCT02953782|7641743|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0
4714020|NCT02953782|7641744|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0
4714021|NCT02953782|7641745|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0
4714022|NCT02953782|7641746|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0
4714023|NCT02953782|7641747|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0
4714024|NCT02953782|7641748|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1
4714025|NCT02953782|7641749|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1
4714026|NCT02953782|7641750|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4
4714027|NCT02953782|7641743|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0
4714028|NCT02953782|7641744|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0
4412992|NCT00274742|7192925|FG000|Overall Study|Disease Progression|0
4412993|NCT00274742|7192926|FG001|Overall Study|Disease Progression|1
4412994|NCT00274742|7192927|FG002|Overall Study|Disease Progression|1
4412995|NCT00274742|7192928|FG003|Overall Study|Disease Progression|0
4412996|NCT00274742|7192929|FG004|Overall Study|Disease Progression|1
4412997|NCT00274742|7192930|FG005|Overall Study|Disease Progression|0
4412998|NCT00274742|7192925|FG000|Overall Study|Other|0
4412999|NCT00274742|7192926|FG001|Overall Study|Other|3
4413000|NCT00274742|7192927|FG002|Overall Study|Other|0
4413001|NCT00274742|7192928|FG003|Overall Study|Other|0
4413002|NCT00274742|7192929|FG004|Overall Study|Other|2
4413003|NCT00274742|7192930|FG005|Overall Study|Other|0
4413004|NCT00274846|7192959|FG000|Overall Study|Did not receive adequate NK cells|1
4413005|NCT00274924|7192967|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4
4413006|NCT00274924|7192968|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14
4413007|NCT00274924|7192969|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1
4413008|NCT00274924|7192967|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0
4413009|NCT00274924|7192968|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0
4413010|NCT00274924|7192969|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1
4413011|NCT00274924|7192967|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0
4413012|NCT00274924|7192968|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0
4413013|NCT00274924|7192969|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1
4413014|NCT00274924|7192967|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0
4590406|NCT01521494|7436418|FG000|Overall Study|Decrease in serum phosphate|0
4590407|NCT01521494|7436419|FG001|Overall Study|Decrease in serum phosphate|2
4590408|NCT01521494|7436420|FG002|Overall Study|Decrease in serum phosphate|3
4590409|NCT01521494|7436421|FG003|Overall Study|Decrease in serum phosphate|12
4590410|NCT01521494|7436422|FG004|Overall Study|Decrease in serum phosphate|0
4590411|NCT01521494|7436418|FG000|Overall Study|Decrease in serum calcium|0
4590412|NCT01521494|7436419|FG001|Overall Study|Decrease in serum calcium|0
4629293|NCT01870869|7497163|FG003|Overall Study|Subject choice|8
4629294|NCT01870869|7497160|FG000|Overall Study|Lost to Follow-up|10
4629295|NCT01870869|7497161|FG001|Overall Study|Lost to Follow-up|2
4629296|NCT01870869|7497162|FG002|Overall Study|Lost to Follow-up|25
4629297|NCT01870869|7497163|FG003|Overall Study|Lost to Follow-up|3
4629298|NCT01870869|7497160|FG000|Overall Study|Reason not Specified|1
4629299|NCT01870869|7497161|FG001|Overall Study|Reason not Specified|2
4629300|NCT01870869|7497162|FG002|Overall Study|Reason not Specified|20
4629301|NCT01870869|7497163|FG003|Overall Study|Reason not Specified|4
4629302|NCT01870869|7497160|FG000|Overall Study|Not evaluable|10
4629303|NCT01870869|7497161|FG001|Overall Study|Not evaluable|5
4714029|NCT02953782|7641745|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0
4629304|NCT01870869|7497162|FG002|Overall Study|Not evaluable|42
4629305|NCT01870869|7497163|FG003|Overall Study|Not evaluable|10
4714030|NCT02953782|7641746|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0
4413015|NCT00274924|7192968|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0
4590413|NCT01521494|7436420|FG002|Overall Study|Decrease in serum calcium|0
4714031|NCT02953782|7641747|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0
4714032|NCT02953782|7641748|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0
4714033|NCT02953782|7641749|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1
4714034|NCT02953782|7641750|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0
4714035|NCT02953821|7641773|FG000|Overall Study|Adverse Event|0
4714036|NCT02953821|7641774|FG001|Overall Study|Adverse Event|4
4714037|NCT02953821|7641773|FG000|Overall Study|Death|1
4714038|NCT02953821|7641774|FG001|Overall Study|Death|0
4714039|NCT02953821|7641773|FG000|Overall Study|Progressive Disease|5
4714040|NCT02953821|7641774|FG001|Overall Study|Progressive Disease|1
4714041|NCT02953821|7641773|FG000|Overall Study|Lost to Follow-up|2
4714042|NCT02953821|7641774|FG001|Overall Study|Lost to Follow-up|0
4714043|NCT02953821|7641773|FG000|Overall Study|Physician Decision|1
4714044|NCT02953821|7641774|FG001|Overall Study|Physician Decision|1
4714045|NCT02953821|7641773|FG000|Overall Study|Withdrawal by Subject|3
4714046|NCT02953821|7641774|FG001|Overall Study|Withdrawal by Subject|3
4714047|NCT02953821|7641773|FG000|Overall Study|Change of address|0
4714048|NCT02953821|7641774|FG001|Overall Study|Change of address|1
4714049|NCT02953821|7641773|FG000|Overall Study|Lack of Efficacy|1
4714050|NCT02953821|7641774|FG001|Overall Study|Lack of Efficacy|0
4714051|NCT02953821|7641773|FG000|Overall Study|Out of state for indeterminate time|0
4714052|NCT02953821|7641774|FG001|Overall Study|Out of state for indeterminate time|1
4714053|NCT02953821|7641773|FG000|Overall Study|No improvement|0
4714054|NCT02953821|7641774|FG001|Overall Study|No improvement|1
4714055|NCT02953821|7641773|FG000|Overall Study|Refused follow-up visit|2
4714056|NCT02953821|7641774|FG001|Overall Study|Refused follow-up visit|1
4714057|NCT02953938|7641796|FG000|Overall Study|Adverse Event|0
4714058|NCT02953938|7641797|FG001|Overall Study|Adverse Event|1
4714059|NCT02953938|7641796|FG000|Overall Study|Withdrawal by Subject|1
4714060|NCT02953938|7641797|FG001|Overall Study|Withdrawal by Subject|1
4714061|NCT02954172|7641806|FG000|Overall Study|Protocol Violation|3
4714062|NCT02954172|7641807|FG001|Overall Study|Protocol Violation|0
4714063|NCT02954172|7641806|FG000|Overall Study|allergic reaction|2
4714064|NCT02954172|7641807|FG001|Overall Study|allergic reaction|1
4714065|NCT02954172|7641806|FG000|Overall Study|non-measurable lesions at baseline|1
4714066|NCT02954172|7641807|FG001|Overall Study|non-measurable lesions at baseline|2
4714067|NCT02954354|7641826|FG000|Overall Study|Adverse Event|2
4714068|NCT02954354|7641827|FG001|Overall Study|Adverse Event|2
4714069|NCT02954354|7641828|FG002|Overall Study|Adverse Event|4
4714070|NCT02954354|7641826|FG000|Overall Study|Failure to Meet Eligibility Criteria|1
4714071|NCT02954354|7641827|FG001|Overall Study|Failure to Meet Eligibility Criteria|0
4714072|NCT02954354|7641828|FG002|Overall Study|Failure to Meet Eligibility Criteria|0
4714073|NCT02954354|7641826|FG000|Overall Study|Lack of Efficacy|0
4714074|NCT02954354|7641827|FG001|Overall Study|Lack of Efficacy|2
4714075|NCT02954354|7641828|FG002|Overall Study|Lack of Efficacy|0
4714076|NCT02954354|7641826|FG000|Overall Study|Withdrawal by Subject|17
4714077|NCT02954354|7641827|FG001|Overall Study|Withdrawal by Subject|9
4714078|NCT02954354|7641828|FG002|Overall Study|Withdrawal by Subject|11
4629306|NCT01870921|7497173|FG000|Overall Study|Subject decision|80
4629307|NCT01870921|7497173|FG000|Overall Study|Severe non-compliance to protocol|7
4413016|NCT00274924|7192969|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1
4413017|NCT00274924|7192967|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0
4413018|NCT00274924|7192968|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0
4413019|NCT00274924|7192969|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1
4413020|NCT00274924|7192967|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0
4413021|NCT00274924|7192968|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0
4413022|NCT00274924|7192969|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1
4413023|NCT00274924|7192967|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4
4413024|NCT00274924|7192968|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15
4413025|NCT00274924|7192969|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0
4413026|NCT00274924|7192967|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1
4413027|NCT00274924|7192968|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0
4413028|NCT00274924|7192969|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0
4413029|NCT00274924|7192967|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1
4413030|NCT00274924|7192968|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0
4413031|NCT00274924|7192969|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0
4413032|NCT00274924|7192967|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1
4413033|NCT00274924|7192968|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0
4413034|NCT00274924|7192969|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0
4413035|NCT00274924|7192967|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0
4413036|NCT00274924|7192968|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1
4413037|NCT00274924|7192969|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0
4413038|NCT00274924|7192967|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0
4413039|NCT00274924|7192968|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1
4413040|NCT00274924|7192969|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0
4413041|NCT00274924|7192967|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0
4413042|NCT00274924|7192968|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1
4413043|NCT00274924|7192969|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0
4714079|NCT02954354|7641826|FG000|Overall Study|Lost to Follow-up|12
4714080|NCT02954354|7641827|FG001|Overall Study|Lost to Follow-up|5
4714081|NCT02954354|7641828|FG002|Overall Study|Lost to Follow-up|0
4714082|NCT02954354|7641826|FG000|Overall Study|Miscellaneous|2
4714083|NCT02954354|7641827|FG001|Overall Study|Miscellaneous|2
4714084|NCT02954354|7641828|FG002|Overall Study|Miscellaneous|1
4714085|NCT02954458|7641842|FG000|Overall Study|Adverse Event|0
4714086|NCT02954458|7641843|FG001|Overall Study|Adverse Event|0
4714087|NCT02954458|7641844|FG002|Overall Study|Adverse Event|0
4714088|NCT02954458|7641845|FG003|Overall Study|Adverse Event|1
4714089|NCT02954458|7641842|FG000|Overall Study|Withdrawal by Subject|0
4714090|NCT02954458|7641843|FG001|Overall Study|Withdrawal by Subject|0
4714091|NCT02954458|7641844|FG002|Overall Study|Withdrawal by Subject|0
4714092|NCT02954458|7641845|FG003|Overall Study|Withdrawal by Subject|1
4714093|NCT02954458|7641842|FG000|Overall Study|Physician Decision|0
4714094|NCT02954458|7641843|FG001|Overall Study|Physician Decision|0
4714095|NCT02954458|7641844|FG002|Overall Study|Physician Decision|1
4714096|NCT02954458|7641845|FG003|Overall Study|Physician Decision|1
4714097|NCT02954458|7641842|FG000|Overall Study|Lost to Follow-up|1
4714098|NCT02954458|7641843|FG001|Overall Study|Lost to Follow-up|0
4714099|NCT02954458|7641844|FG002|Overall Study|Lost to Follow-up|0
4714100|NCT02954458|7641845|FG003|Overall Study|Lost to Follow-up|1
4714101|NCT02954458|7641842|FG000|Overall Study|Death|0
4714102|NCT02954458|7641843|FG001|Overall Study|Death|0
4714103|NCT02954458|7641844|FG002|Overall Study|Death|0
4714104|NCT02954458|7641845|FG003|Overall Study|Death|1
4714105|NCT02954458|7641842|FG000|Overall Study|Other|0
4714106|NCT02954458|7641843|FG001|Overall Study|Other|0
4714107|NCT02954458|7641844|FG002|Overall Study|Other|0
4714108|NCT02954458|7641845|FG003|Overall Study|Other|7
4714109|NCT02954575|7641859|FG000|Overall Study|Withdrawal by Subject|2
4714110|NCT02954575|7641859|FG000|Overall Study|Adverse Event|1
4714111|NCT02954601|7641871|FG000|First Intervention (Five Days)|Withdrawal by Subject|0
4714112|NCT02954601|7641872|FG001|First Intervention (Five Days)|Withdrawal by Subject|0
4714113|NCT02954601|7641873|FG002|First Intervention (Five Days)|Withdrawal by Subject|1
4714114|NCT02954601|7641874|FG003|First Intervention (Five Days)|Withdrawal by Subject|0
4714115|NCT02954653|7641886|FG000|Overall Study|Death|3
4714116|NCT02954653|7641887|FG001|Overall Study|Death|1
4714117|NCT02954653|7641888|FG002|Overall Study|Death|0
4714118|NCT02954653|7641889|FG003|Overall Study|Death|0
4714119|NCT02954653|7641890|FG004|Overall Study|Death|0
4714120|NCT02954653|7641891|FG005|Overall Study|Death|0
4714121|NCT02954653|7641892|FG006|Overall Study|Death|0
4714122|NCT02954653|7641893|FG007|Overall Study|Death|0
4714123|NCT02954653|7641894|FG008|Overall Study|Death|0
4714124|NCT02954653|7641886|FG000|Overall Study|Randomized but did not receive treatment|1
4714125|NCT02954653|7641887|FG001|Overall Study|Randomized but did not receive treatment|0
4714126|NCT02954653|7641888|FG002|Overall Study|Randomized but did not receive treatment|0
4714127|NCT02954653|7641889|FG003|Overall Study|Randomized but did not receive treatment|0
4714128|NCT02954653|7641890|FG004|Overall Study|Randomized but did not receive treatment|0
4714129|NCT02954653|7641891|FG005|Overall Study|Randomized but did not receive treatment|0
4413044|NCT00274937|7192976|FG000|Overall Study|Physician Decision|10
4413045|NCT00274937|7192976|FG000|Overall Study|Withdrawal by Subject|6
4413046|NCT00274937|7192976|FG000|Overall Study|Progressive Disease|4
4413047|NCT00275002|7192982|FG000|Overall Study|Death|1
4413048|NCT00275002|7192983|FG001|Overall Study|Death|0
4413049|NCT00275002|7192982|FG000|Overall Study|Disease progression|21
4413050|NCT00275002|7192983|FG001|Overall Study|Disease progression|15
4413051|NCT00275002|7192982|FG000|Overall Study|Adverse Event|0
4413052|NCT00275002|7192983|FG001|Overall Study|Adverse Event|1
4413053|NCT00275028|7192989|FG000|Overall Study|Withdrew consent before treatment began|1
4413054|NCT00275028|7192989|FG000|Overall Study|Withdrawal by Subject|5
4413055|NCT00275028|7192989|FG000|Overall Study|Adverse Event|9
4413056|NCT00275028|7192989|FG000|Overall Study|Progressive Disease|30
4413057|NCT00275028|7192989|FG000|Overall Study|Physician Decision|2
4413058|NCT00275262|7192995|FG000|Overall Study|Adverse Event|2
4413059|NCT00275262|7192996|FG001|Overall Study|Adverse Event|0
4413060|NCT00275262|7192995|FG000|Overall Study|Disease progression|2
4413061|NCT00275262|7192996|FG001|Overall Study|Disease progression|5
4413062|NCT00275262|7192995|FG000|Overall Study|Lost to Follow-up|0
4413063|NCT00275262|7192996|FG001|Overall Study|Lost to Follow-up|2
4413064|NCT00275262|7192995|FG000|Overall Study|Protocol Violation|0
4413065|NCT00275262|7192996|FG001|Overall Study|Protocol Violation|2
4413066|NCT00275262|7192995|FG000|Overall Study|Death|1
4714130|NCT02954653|7641892|FG006|Overall Study|Randomized but did not receive treatment|0
4714131|NCT02954653|7641893|FG007|Overall Study|Randomized but did not receive treatment|0
4714132|NCT02954653|7641894|FG008|Overall Study|Randomized but did not receive treatment|0
4714133|NCT02954653|7641886|FG000|Overall Study|Started another anti-cancer therapy|0
4714134|NCT02954653|7641887|FG001|Overall Study|Started another anti-cancer therapy|1
4714135|NCT02954653|7641888|FG002|Overall Study|Started another anti-cancer therapy|0
4714136|NCT02954653|7641889|FG003|Overall Study|Started another anti-cancer therapy|0
4714137|NCT02954653|7641890|FG004|Overall Study|Started another anti-cancer therapy|0
4714138|NCT02954653|7641891|FG005|Overall Study|Started another anti-cancer therapy|0
4714139|NCT02954653|7641892|FG006|Overall Study|Started another anti-cancer therapy|0
4714140|NCT02954653|7641893|FG007|Overall Study|Started another anti-cancer therapy|0
4714141|NCT02954653|7641894|FG008|Overall Study|Started another anti-cancer therapy|0
4714142|NCT02954653|7641886|FG000|Overall Study|Treatment failure and consent withdrawal|0
4714143|NCT02954653|7641887|FG001|Overall Study|Treatment failure and consent withdrawal|1
4714144|NCT02954653|7641888|FG002|Overall Study|Treatment failure and consent withdrawal|0
4714145|NCT02954653|7641889|FG003|Overall Study|Treatment failure and consent withdrawal|0
4714146|NCT02954653|7641890|FG004|Overall Study|Treatment failure and consent withdrawal|0
4714147|NCT02954653|7641891|FG005|Overall Study|Treatment failure and consent withdrawal|0
4714148|NCT02954653|7641892|FG006|Overall Study|Treatment failure and consent withdrawal|0
4714149|NCT02954653|7641893|FG007|Overall Study|Treatment failure and consent withdrawal|0
4714150|NCT02954653|7641894|FG008|Overall Study|Treatment failure and consent withdrawal|0
4714151|NCT02954848|7641908|FG000|Overall Study|Randomized but Not Treated|0
4714152|NCT02954848|7641909|FG001|Overall Study|Randomized but Not Treated|1
4714153|NCT02954848|7641908|FG000|Overall Study|Adverse Event|2
4714154|NCT02954848|7641909|FG001|Overall Study|Adverse Event|3
4714155|NCT02954848|7641908|FG000|Overall Study|Withdrawal by Participant|0
4714156|NCT02954848|7641909|FG001|Overall Study|Withdrawal by Participant|1
4714157|NCT02954887|7641915|FG000|Overall Study|Withdrawal by Subject|3
4714158|NCT02954887|7641915|FG000|Overall Study|Lack of Efficacy|3
4714159|NCT02954887|7641915|FG000|Overall Study|Other|1
4714160|NCT02955069|7641921|FG000|Overall Study|Adverse Event|7
4714161|NCT02955069|7641922|FG001|Overall Study|Adverse Event|2
4714162|NCT02955069|7641921|FG000|Overall Study|Death|7
4714163|NCT02955069|7641922|FG001|Overall Study|Death|3
4714164|NCT02955069|7641921|FG000|Overall Study|Physician Decision|10
4714165|NCT02955069|7641922|FG001|Overall Study|Physician Decision|2
4714166|NCT02955069|7641921|FG000|Overall Study|Progressive disease|64
4714167|NCT02955069|7641922|FG001|Overall Study|Progressive disease|13
4714168|NCT02955069|7641921|FG000|Overall Study|Study terminated by sponsor|4
4714169|NCT02955069|7641922|FG001|Overall Study|Study terminated by sponsor|0
4714170|NCT02955069|7641921|FG000|Overall Study|Subject/Guardian decision|3
4714171|NCT02955069|7641922|FG001|Overall Study|Subject/Guardian decision|1
4714172|NCT02955186|7641936|FG000|Overall Study|Withdrawal by Subject|6
4714173|NCT02955186|7641937|FG001|Overall Study|Withdrawal by Subject|2
4714174|NCT02955186|7641936|FG000|Overall Study|Protocol Violation|1
4714175|NCT02955186|7641937|FG001|Overall Study|Protocol Violation|0
4714176|NCT02955212|7641945|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4
4714177|NCT02955212|7641946|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7
4714178|NCT02955212|7641945|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8
4714179|NCT02955212|7641946|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3
4714180|NCT02955212|7641945|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1
4714181|NCT02955212|7641946|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0
4413067|NCT00275262|7192996|FG001|Overall Study|Death|0
4413068|NCT00275262|7192995|FG000|Overall Study|Started Chemotherapy|1
4413069|NCT00275262|7192996|FG001|Overall Study|Started Chemotherapy|0
4413070|NCT00275301|7193015|FG000|Overall Study|Adverse Event|5
4413071|NCT00275509|7193030|FG000|Overall Study|graft thrombosis, post-operative day #8|0
4413072|NCT00275509|7193031|FG001|Overall Study|graft thrombosis, post-operative day #8|1
4413073|NCT00275561|7193039|FG000|Overall Study|Withdrawal by Subject|0
4413074|NCT00275561|7193040|FG001|Overall Study|Withdrawal by Subject|1
4413075|NCT00275561|7193039|FG000|Overall Study|Travel|1
4413076|NCT00275561|7193040|FG001|Overall Study|Travel|1
4413077|NCT00275561|7193039|FG000|Overall Study|Scheduling|1
4413078|NCT00275561|7193040|FG001|Overall Study|Scheduling|2
4413079|NCT00275561|7193039|FG000|Overall Study|Family Issues|0
4413080|NCT00275561|7193040|FG001|Overall Study|Family Issues|2
4413081|NCT00275821|7193049|FG000|Overall Study|Adverse Event|4
4413082|NCT00275821|7193050|FG001|Overall Study|Adverse Event|12
4413083|NCT00275821|7193051|FG002|Overall Study|Adverse Event|5
4413084|NCT00275821|7193049|FG000|Overall Study|Administrative problems|3
4714182|NCT02955212|7641945|FG000|Period 1: Double-blind Treatment Period|Other|3
4714183|NCT02955212|7641946|FG001|Period 1: Double-blind Treatment Period|Other|2
4714184|NCT02955212|7641945|FG000|Period 2: Open-label Extension|Adverse Event|11
4714185|NCT02955212|7641946|FG001|Period 2: Open-label Extension|Adverse Event|7
4714186|NCT02955212|7641945|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1
4714187|NCT02955212|7641946|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4
4714188|NCT02955212|7641945|FG000|Period 2: Open-label Extension|Lack of Efficacy|3
4714189|NCT02955212|7641946|FG001|Period 2: Open-label Extension|Lack of Efficacy|2
4714190|NCT02955212|7641945|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0
4714191|NCT02955212|7641946|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1
4714192|NCT02955212|7641945|FG000|Period 2: Open-label Extension|Other|2
4714193|NCT02955212|7641946|FG001|Period 2: Open-label Extension|Other|4
4714194|NCT02956057|7641994|FG000|Overall Study|Discontinued intervention|14
4714195|NCT02956057|7641995|FG001|Overall Study|Discontinued intervention|10
4714196|NCT02956057|7641996|FG002|Overall Study|Discontinued intervention|7
4714197|NCT02956057|7641997|FG003|Overall Study|Discontinued intervention|14
4714198|NCT02956057|7641998|FG004|Overall Study|Discontinued intervention|4
4714199|NCT02956057|7641999|FG005|Overall Study|Discontinued intervention|17
4714200|NCT02956057|7641994|FG000|Overall Study|Lost to Follow-up|0
4714201|NCT02956057|7641995|FG001|Overall Study|Lost to Follow-up|2
4714202|NCT02956057|7641996|FG002|Overall Study|Lost to Follow-up|1
4714203|NCT02956057|7641997|FG003|Overall Study|Lost to Follow-up|1
4714204|NCT02956057|7641998|FG004|Overall Study|Lost to Follow-up|1
4714205|NCT02956057|7641999|FG005|Overall Study|Lost to Follow-up|0
4714206|NCT02956278|7642036|FG000|Overall Study|Withdrawal by Subject|6
4714207|NCT02956278|7642037|FG001|Overall Study|Withdrawal by Subject|2
4714208|NCT02956278|7642038|FG002|Overall Study|Withdrawal by Subject|0
4714209|NCT02956460|7642048|FG000|Lens 1|Lost to Follow-up|1
4714210|NCT02956460|7642049|FG001|Lens 1|Lost to Follow-up|0
4714211|NCT02956486|7642057|FG000|Core Phase|Adverse Event|51
4714212|NCT02956486|7642058|FG001|Core Phase|Adverse Event|88
4714213|NCT02956486|7642059|FG002|Core Phase|Adverse Event|0
4714214|NCT02956486|7642057|FG000|Core Phase|Lost to Follow-up|8
4714215|NCT02956486|7642058|FG001|Core Phase|Lost to Follow-up|6
4714216|NCT02956486|7642059|FG002|Core Phase|Lost to Follow-up|0
4714217|NCT02956486|7642057|FG000|Core Phase|Inadequate therapeutic effect|4
4714218|NCT02956486|7642058|FG001|Core Phase|Inadequate therapeutic effect|5
4714219|NCT02956486|7642059|FG002|Core Phase|Inadequate therapeutic effect|0
4714220|NCT02956486|7642057|FG000|Core Phase|Withdrawal by Subject|101
4714221|NCT02956486|7642058|FG001|Core Phase|Withdrawal by Subject|104
4714222|NCT02956486|7642059|FG002|Core Phase|Withdrawal by Subject|0
4714223|NCT02956486|7642057|FG000|Core Phase|Study terminated by sponsor|888
4714224|NCT02956486|7642058|FG001|Core Phase|Study terminated by sponsor|848
4714225|NCT02956486|7642059|FG002|Core Phase|Study terminated by sponsor|0
4714226|NCT02956486|7642057|FG000|Core Phase|Other|27
4714227|NCT02956486|7642058|FG001|Core Phase|Other|18
4714228|NCT02956486|7642059|FG002|Core Phase|Other|0
4714229|NCT02956486|7642057|FG000|Core Phase|Not treated|0
4714230|NCT02956486|7642058|FG001|Core Phase|Not treated|3
4714231|NCT02956486|7642059|FG002|Core Phase|Not treated|0
4714232|NCT02956486|7642057|FG000|Extension Phase|Adverse Event|0
4714233|NCT02956486|7642058|FG001|Extension Phase|Adverse Event|0
4714234|NCT02956486|7642059|FG002|Extension Phase|Adverse Event|2
4714235|NCT02956486|7642057|FG000|Extension Phase|Study terminated by sponsor|0
4714236|NCT02956486|7642058|FG001|Extension Phase|Study terminated by sponsor|0
4714237|NCT02956486|7642059|FG002|Extension Phase|Study terminated by sponsor|16
4714238|NCT02956486|7642057|FG000|Extension Phase|Not Treated|0
4714239|NCT02956486|7642058|FG001|Extension Phase|Not Treated|0
4714240|NCT02956486|7642059|FG002|Extension Phase|Not Treated|1
4714241|NCT02956629|7642083|FG000|Overall Study|Adverse Event|0
4714242|NCT02956629|7642084|FG001|Overall Study|Adverse Event|0
4714243|NCT02956629|7642085|FG002|Overall Study|Adverse Event|1
4714244|NCT02956629|7642086|FG003|Overall Study|Adverse Event|0
4714245|NCT02956629|7642087|FG004|Overall Study|Adverse Event|0
4714246|NCT02956629|7642088|FG005|Overall Study|Adverse Event|0
4714247|NCT02956629|7642083|FG000|Overall Study|Lost to Follow-up|2
4714248|NCT02956629|7642084|FG001|Overall Study|Lost to Follow-up|5
4714249|NCT02956629|7642085|FG002|Overall Study|Lost to Follow-up|3
4413085|NCT00275821|7193050|FG001|Overall Study|Administrative problems|4
4413086|NCT00275821|7193051|FG002|Overall Study|Administrative problems|4
4413087|NCT00275821|7193049|FG000|Overall Study|Withdrawal by Subject|0
4413088|NCT00275821|7193050|FG001|Overall Study|Withdrawal by Subject|2
4413089|NCT00275821|7193051|FG002|Overall Study|Withdrawal by Subject|1
4413090|NCT00275821|7193049|FG000|Overall Study|Lost to Follow-up|0
4413091|NCT00275821|7193050|FG001|Overall Study|Lost to Follow-up|1
4413092|NCT00275821|7193051|FG002|Overall Study|Lost to Follow-up|1
4714250|NCT02956629|7642086|FG003|Overall Study|Lost to Follow-up|1
4714251|NCT02956629|7642087|FG004|Overall Study|Lost to Follow-up|0
4714252|NCT02956629|7642088|FG005|Overall Study|Lost to Follow-up|1
4714253|NCT02956629|7642083|FG000|Overall Study|Withdrawal by Subject|3
4714254|NCT02956629|7642084|FG001|Overall Study|Withdrawal by Subject|1
4714255|NCT02956629|7642085|FG002|Overall Study|Withdrawal by Subject|0
4714256|NCT02956629|7642086|FG003|Overall Study|Withdrawal by Subject|0
4714257|NCT02956629|7642087|FG004|Overall Study|Withdrawal by Subject|0
4714258|NCT02956629|7642088|FG005|Overall Study|Withdrawal by Subject|0
4714259|NCT02956837|7642124|FG000|Overall Study|Serious Adverse Events|0
4714260|NCT02956837|7642125|FG001|Overall Study|Serious Adverse Events|1
4714261|NCT02956837|7642126|FG002|Overall Study|Serious Adverse Events|0
4714262|NCT02956837|7642127|FG003|Overall Study|Serious Adverse Events|0
4714263|NCT02956837|7642124|FG000|Overall Study|Withdrawal by Subject|0
4714264|NCT02956837|7642125|FG001|Overall Study|Withdrawal by Subject|1
4714265|NCT02956837|7642126|FG002|Overall Study|Withdrawal by Subject|0
4714266|NCT02956837|7642127|FG003|Overall Study|Withdrawal by Subject|3
4714267|NCT02956837|7642124|FG000|Overall Study|Lost to Follow-up|0
4714268|NCT02956837|7642125|FG001|Overall Study|Lost to Follow-up|1
4714269|NCT02956837|7642126|FG002|Overall Study|Lost to Follow-up|2
4714270|NCT02956837|7642127|FG003|Overall Study|Lost to Follow-up|0
4714271|NCT02956967|7642140|FG000|Overall Study|Adverse Event|3
4714272|NCT02956967|7642140|FG000|Overall Study|Reason non-related to neutropenia|10
4714273|NCT02956967|7642140|FG000|Overall Study|Lost to Follow-up|5
4714274|NCT02956967|7642140|FG000|Overall Study|Missing|1
4714275|NCT02956967|7642140|FG000|Overall Study|Termination of Nivestim administration|29
4714276|NCT02957136|7642150|FG000|Overall Study|Withdrawal by Subject|2
4714277|NCT02957136|7642151|FG001|Overall Study|Withdrawal by Subject|1
4714278|NCT02957331|7642168|FG000|Overall Study|Protocol Violation|1
4714279|NCT02957331|7642169|FG001|Overall Study|Protocol Violation|0
4714280|NCT02957682|7642193|FG000|Overall Study|Adverse Event|64
4714281|NCT02957682|7642194|FG001|Overall Study|Adverse Event|67
4714282|NCT02957682|7642193|FG000|Overall Study|Poor Compliance to Protocol|30
4714283|NCT02957682|7642194|FG001|Overall Study|Poor Compliance to Protocol|26
4714284|NCT02957682|7642193|FG000|Overall Study|Physician Decision|4
4714285|NCT02957682|7642194|FG001|Overall Study|Physician Decision|4
4714286|NCT02957682|7642193|FG000|Overall Study|Study Terminated by Sponsor|4
4714287|NCT02957682|7642194|FG001|Overall Study|Study Terminated by Sponsor|3
4714288|NCT02957682|7642193|FG000|Overall Study|Subject Moved|10
4714289|NCT02957682|7642194|FG001|Overall Study|Subject Moved|16
4714290|NCT02957682|7642193|FG000|Overall Study|Withdrawal by Subject|64
4714291|NCT02957682|7642194|FG001|Overall Study|Withdrawal by Subject|33
4714292|NCT02957682|7642193|FG000|Overall Study|Related to IMP Administration|3
4714293|NCT02957682|7642194|FG001|Overall Study|Related to IMP Administration|6
4714294|NCT02957682|7642193|FG000|Overall Study|Non-disclosed|16
4714295|NCT02957682|7642194|FG001|Overall Study|Non-disclosed|12
4714296|NCT02957682|7642193|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3
4714297|NCT02957682|7642194|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2
4714298|NCT02957747|7642202|FG000|Overall Study|Withdrawal by Subject|0
4714299|NCT02957747|7642203|FG001|Overall Study|Withdrawal by Subject|3
4714300|NCT02957747|7642202|FG000|Overall Study|Lost to Follow-up|10
4714301|NCT02957747|7642203|FG001|Overall Study|Lost to Follow-up|5
4714302|NCT02957942|7642212|FG000|Overall Study|Withdrawal by Subject|0
4714303|NCT02957942|7642213|FG001|Overall Study|Withdrawal by Subject|1
4714304|NCT02957942|7642212|FG000|Overall Study|Practicing experiment protocol|0
4714305|NCT02957942|7642213|FG001|Overall Study|Practicing experiment protocol|6
4714306|NCT02958267|7642221|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1
4714307|NCT02958267|7642222|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0
4714308|NCT02958267|7642221|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1
4714309|NCT02958267|7642222|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0
4714310|NCT02958267|7642221|FG000|Follow-up Visits|Additional treatment pursued|2
4714311|NCT02958267|7642222|FG001|Follow-up Visits|Additional treatment pursued|1
4714312|NCT02958527|7642237|FG000|Overall Study|Not collected CRFs|12
4714313|NCT02958553|7642250|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1
4714314|NCT02958553|7642250|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2
4714315|NCT02959138|7642350|FG000|Overall Study|Enrolled but Never Treated|0
4714316|NCT02959138|7642351|FG001|Overall Study|Enrolled but Never Treated|1
4714317|NCT02959138|7642352|FG002|Overall Study|Enrolled but Never Treated|0
4714318|NCT02959177|7642367|FG000|Double-Blind Treatment Phase|Adverse Event|5
4714319|NCT02959177|7642368|FG001|Double-Blind Treatment Phase|Adverse Event|2
4714320|NCT02959177|7642369|FG002|Double-Blind Treatment Phase|Adverse Event|0
4714321|NCT02959177|7642367|FG000|Double-Blind Treatment Phase|Physician Decision|1
4714322|NCT02959177|7642368|FG001|Double-Blind Treatment Phase|Physician Decision|0
4714323|NCT02959177|7642369|FG002|Double-Blind Treatment Phase|Physician Decision|0
4413093|NCT00275821|7193049|FG000|Overall Study|Death|0
4413094|NCT00275821|7193050|FG001|Overall Study|Death|2
4413095|NCT00275821|7193051|FG002|Overall Study|Death|1
4714324|NCT02959177|7642367|FG000|Double-Blind Treatment Phase|Protocol Violation|0
4714325|NCT02959177|7642368|FG001|Double-Blind Treatment Phase|Protocol Violation|1
4714326|NCT02959177|7642369|FG002|Double-Blind Treatment Phase|Protocol Violation|0
4714327|NCT02959177|7642367|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5
4714328|NCT02959177|7642368|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0
4714329|NCT02959177|7642369|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5
4714330|NCT02959177|7642367|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1
4714331|NCT02959177|7642368|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0
4714332|NCT02959177|7642369|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0
4714333|NCT02959177|7642367|FG000|Follow-up Post Treatment Phase|Adverse Event|0
4714334|NCT02959177|7642368|FG001|Follow-up Post Treatment Phase|Adverse Event|1
4714335|NCT02959177|7642369|FG002|Follow-up Post Treatment Phase|Adverse Event|0
4714336|NCT02959177|7642367|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0
4714337|NCT02959177|7642368|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0
4714338|NCT02959177|7642369|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2
4714339|NCT02959190|7642387|FG000|Open Label|Adverse Event|5
4714340|NCT02959190|7642388|FG001|Open Label|Adverse Event|7
4714341|NCT02959190|7642389|FG002|Open Label|Adverse Event|3
4714342|NCT02959190|7642390|FG003|Open Label|Adverse Event|4
4714343|NCT02959190|7642387|FG000|Open Label|Pregnancy|0
4714344|NCT02959190|7642388|FG001|Open Label|Pregnancy|1
4714345|NCT02959190|7642389|FG002|Open Label|Pregnancy|0
4714346|NCT02959190|7642390|FG003|Open Label|Pregnancy|0
4714347|NCT02959190|7642387|FG000|Open Label|Withdrawal by Subject|2
4714348|NCT02959190|7642388|FG001|Open Label|Withdrawal by Subject|8
4714349|NCT02959190|7642389|FG002|Open Label|Withdrawal by Subject|0
4714350|NCT02959190|7642390|FG003|Open Label|Withdrawal by Subject|0
4714351|NCT02959190|7642387|FG000|Open Label|Physician Decision|0
4714352|NCT02959190|7642388|FG001|Open Label|Physician Decision|0
4714353|NCT02959190|7642389|FG002|Open Label|Physician Decision|1
4714354|NCT02959190|7642390|FG003|Open Label|Physician Decision|0
4714355|NCT02959190|7642387|FG000|Open Label|Protocol Violation|0
4714356|NCT02959190|7642388|FG001|Open Label|Protocol Violation|0
4714357|NCT02959190|7642389|FG002|Open Label|Protocol Violation|0
4714358|NCT02959190|7642390|FG003|Open Label|Protocol Violation|2
4714359|NCT02959190|7642387|FG000|Post Treatment Follow Up|Adverse Event|1
4714360|NCT02959190|7642388|FG001|Post Treatment Follow Up|Adverse Event|1
4714361|NCT02959190|7642389|FG002|Post Treatment Follow Up|Adverse Event|0
4714362|NCT02959190|7642390|FG003|Post Treatment Follow Up|Adverse Event|0
4714363|NCT02959190|7642387|FG000|Post Treatment Follow Up|Withdrawal by Subject|2
4714364|NCT02959190|7642388|FG001|Post Treatment Follow Up|Withdrawal by Subject|0
4714365|NCT02959190|7642389|FG002|Post Treatment Follow Up|Withdrawal by Subject|1
4714366|NCT02959190|7642390|FG003|Post Treatment Follow Up|Withdrawal by Subject|0
4736155|NCT03559257|7685081|FG001|Open-label Treatment Period|Lack of Efficacy|2
4736156|NCT03559257|7685080|FG000|Open-label Treatment Period|Withdrawal by Subject|3
4736157|NCT03559257|7685081|FG001|Open-label Treatment Period|Withdrawal by Subject|0
4736158|NCT03559257|7685080|FG000|Open-label Treatment Period|Protocol Violation|2
4736159|NCT03559257|7685081|FG001|Open-label Treatment Period|Protocol Violation|0
4736160|NCT03559257|7685080|FG000|Open-label Treatment Period|Lost to Follow-up|1
4736161|NCT03559257|7685081|FG001|Open-label Treatment Period|Lost to Follow-up|0
4736162|NCT03559257|7685080|FG000|Open-label Treatment Period|Physician Decision|0
4736163|NCT03559257|7685081|FG001|Open-label Treatment Period|Physician Decision|1
4736164|NCT03559517|7685093|FG000|Overall Study|Withdrawal by Subject|1
4736165|NCT03559517|7685094|FG001|Overall Study|Withdrawal by Subject|0
4736166|NCT03559517|7685095|FG002|Overall Study|Withdrawal by Subject|0
4736167|NCT03559530|7685103|FG000|Overall Study|non-location of medical records|44
4736168|NCT03559530|7685104|FG001|Overall Study|non-location of medical records|0
4736169|NCT03559530|7685103|FG000|Overall Study|culture results not considered for treat|29
4736170|NCT03559530|7685104|FG001|Overall Study|culture results not considered for treat|0
4736171|NCT03559530|7685103|FG000|Overall Study|duplicate cases|8
4736172|NCT03559530|7685104|FG001|Overall Study|duplicate cases|0
4736173|NCT03559530|7685103|FG000|Overall Study|other species of Acinetobacte|7
4736174|NCT03559530|7685104|FG001|Overall Study|other species of Acinetobacte|0
4736175|NCT03559530|7685103|FG000|Overall Study|contamination / colonization|3
4736176|NCT03559530|7685104|FG001|Overall Study|contamination / colonization|0
4736177|NCT03560245|7685144|FG000|Overall Study|Withdrawal by Subject|3
4736178|NCT03560245|7685145|FG001|Overall Study|Withdrawal by Subject|2
4736179|NCT03560245|7685144|FG000|Overall Study|Adverse Event|1
4736180|NCT03560245|7685145|FG001|Overall Study|Adverse Event|1
4736181|NCT03560245|7685144|FG000|Overall Study|Protocol Violation|1
4736182|NCT03560245|7685145|FG001|Overall Study|Protocol Violation|0
4736183|NCT03560245|7685144|FG000|Overall Study|Death|0
4736184|NCT03560245|7685145|FG001|Overall Study|Death|1
4736185|NCT03560245|7685144|FG000|Overall Study|Lost to Follow-up|0
4736186|NCT03560245|7685145|FG001|Overall Study|Lost to Follow-up|1
4736187|NCT03560245|7685144|FG000|Overall Study|Physician Decision|0
4736188|NCT03560245|7685145|FG001|Overall Study|Physician Decision|1
4736189|NCT03560245|7685144|FG000|Overall Study|Other|0
4736190|NCT03560245|7685145|FG001|Overall Study|Other|1
4736191|NCT03560518|7685156|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1
4413096|NCT00275821|7193049|FG000|Overall Study|Lack of Efficacy|2
4413097|NCT00275821|7193050|FG001|Overall Study|Lack of Efficacy|1
4714367|NCT02959437|7642422|FG000|Overall Study|Death|33
4714368|NCT02959437|7642423|FG001|Overall Study|Death|3
4714369|NCT02959437|7642424|FG002|Overall Study|Death|0
4714370|NCT02959437|7642425|FG003|Overall Study|Death|0
4714371|NCT02959437|7642422|FG000|Overall Study|Lost to Follow-up|3
4714372|NCT02959437|7642423|FG001|Overall Study|Lost to Follow-up|1
4714373|NCT02959437|7642424|FG002|Overall Study|Lost to Follow-up|0
4714374|NCT02959437|7642425|FG003|Overall Study|Lost to Follow-up|0
4714375|NCT02959437|7642422|FG000|Overall Study|Withdrawal by Subject|11
4714376|NCT02959437|7642423|FG001|Overall Study|Withdrawal by Subject|3
4714377|NCT02959437|7642424|FG002|Overall Study|Withdrawal by Subject|0
4714378|NCT02959437|7642425|FG003|Overall Study|Withdrawal by Subject|0
4714379|NCT02959437|7642422|FG000|Overall Study|Progressive Disease|9
4714380|NCT02959437|7642423|FG001|Overall Study|Progressive Disease|1
4714381|NCT02959437|7642424|FG002|Overall Study|Progressive Disease|0
4714382|NCT02959437|7642425|FG003|Overall Study|Progressive Disease|0
4714383|NCT02959437|7642422|FG000|Overall Study|Study Terminated by Sponsor|4
4714384|NCT02959437|7642423|FG001|Overall Study|Study Terminated by Sponsor|0
4714385|NCT02959437|7642424|FG002|Overall Study|Study Terminated by Sponsor|0
4714386|NCT02959437|7642425|FG003|Overall Study|Study Terminated by Sponsor|0
4714387|NCT02959437|7642422|FG000|Overall Study|Other Unspecified|2
4714388|NCT02959437|7642423|FG001|Overall Study|Other Unspecified|0
4714389|NCT02959437|7642424|FG002|Overall Study|Other Unspecified|0
4714390|NCT02959437|7642425|FG003|Overall Study|Other Unspecified|0
4714391|NCT02959671|7642436|FG000|Overall Study|Adverse Event|2
4714392|NCT02959671|7642436|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3
4714393|NCT02959814|7642440|FG000|Overall Study|Excluded based on diagnostic angiography|16
4714394|NCT02959814|7642440|FG000|Overall Study|Excluded based on anatomical criteria|2
4714395|NCT02959814|7642440|FG000|Overall Study|Protocol Violation|7
4714396|NCT02959814|7642440|FG000|Overall Study|FFR not measured|2
4714397|NCT02959814|7642440|FG000|Overall Study|In-procedure QFR not computed|6
4714398|NCT02959814|7642440|FG000|Overall Study|Excluded by FFR core-lab|24
4714399|NCT02959866|7642476|FG000|Overall Study|Withdrawal by Subject|1
4714400|NCT02959892|7642483|FG000|Overall Study|PET tracer synthesis failure|1
4714401|NCT02959892|7642484|FG001|Overall Study|PET tracer synthesis failure|0
4714402|NCT02959892|7642483|FG000|Overall Study|Study termination|0
4714403|NCT02959892|7642484|FG001|Overall Study|Study termination|1
4714404|NCT02959970|7642492|FG000|Overall Study|Adverse Event|1
4714405|NCT02959970|7642493|FG001|Overall Study|Adverse Event|0
4714406|NCT02959970|7642492|FG000|Overall Study|Withdrawal by Subject|0
4714407|NCT02959970|7642493|FG001|Overall Study|Withdrawal by Subject|2
4714408|NCT02959970|7642492|FG000|Overall Study|Lost to Follow-up|1
4714409|NCT02959970|7642493|FG001|Overall Study|Lost to Follow-up|5
4714410|NCT02959983|7642503|FG000|Overall Study|Protocol Violation|0
4714411|NCT02959983|7642504|FG001|Overall Study|Protocol Violation|1
4714412|NCT02959983|7642503|FG000|Overall Study|Lack of Efficacy|0
4714413|NCT02959983|7642504|FG001|Overall Study|Lack of Efficacy|1
4714414|NCT02959983|7642503|FG000|Overall Study|Lost to Follow-up|12
4714415|NCT02959983|7642504|FG001|Overall Study|Lost to Follow-up|9
4714416|NCT02959983|7642503|FG000|Overall Study|Other|1
4714417|NCT02959983|7642504|FG001|Overall Study|Other|1
4714418|NCT02959983|7642503|FG000|Overall Study|Physician Decision|1
4714419|NCT02959983|7642504|FG001|Overall Study|Physician Decision|0
4714420|NCT02959983|7642503|FG000|Overall Study|Adverse Event|5
4714421|NCT02959983|7642504|FG001|Overall Study|Adverse Event|1
4714422|NCT02959983|7642503|FG000|Overall Study|Withdrawal by Subject|7
4714423|NCT02959983|7642504|FG001|Overall Study|Withdrawal by Subject|12
4714424|NCT02960217|7642521|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1
4714425|NCT02960217|7642522|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0
4714426|NCT02960217|7642521|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0
4714427|NCT02960217|7642522|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1
4714428|NCT02960217|7642521|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0
4714429|NCT02960217|7642522|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1
4714430|NCT02960217|7642521|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1
4714431|NCT02960217|7642522|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0
4714432|NCT02960217|7642521|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0
4714433|NCT02960217|7642522|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1
4714434|NCT02960217|7642521|FG000|Open-Label Extension Phase|Adverse Event|1
4714435|NCT02960217|7642522|FG001|Open-Label Extension Phase|Adverse Event|0
4714436|NCT02960217|7642521|FG000|Open-Label Extension Phase|Sponsor Decision|18
4714437|NCT02960217|7642522|FG001|Open-Label Extension Phase|Sponsor Decision|11
4714438|NCT02960217|7642521|FG000|Open-Label Extension Phase|Lack of Efficacy|1
4714439|NCT02960217|7642522|FG001|Open-Label Extension Phase|Lack of Efficacy|1
4714440|NCT02960217|7642521|FG000|Open-Label Extension Phase|Other, Not Specified|0
4714441|NCT02960217|7642522|FG001|Open-Label Extension Phase|Other, Not Specified|1
4714442|NCT02960438|7642541|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2
4714443|NCT02960438|7642542|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1
4413098|NCT00275821|7193051|FG002|Overall Study|Lack of Efficacy|0
4413099|NCT00275821|7193049|FG000|Overall Study|Protocol Violation|5
4413100|NCT00275821|7193050|FG001|Overall Study|Protocol Violation|1
4413101|NCT00275821|7193051|FG002|Overall Study|Protocol Violation|0
4413102|NCT00276094|7193077|FG000|Overall Study|Adverse Event|15
4413103|NCT00276094|7193078|FG001|Overall Study|Adverse Event|13
4413104|NCT00276094|7193079|FG002|Overall Study|Adverse Event|11
4413105|NCT00276094|7193077|FG000|Overall Study|Withdrawal by Subject|14
4413106|NCT00276094|7193078|FG001|Overall Study|Withdrawal by Subject|14
4413107|NCT00276094|7193079|FG002|Overall Study|Withdrawal by Subject|12
4413108|NCT00276094|7193077|FG000|Overall Study|Protocol Violation|16
4413109|NCT00276094|7193078|FG001|Overall Study|Protocol Violation|7
4413110|NCT00276094|7193079|FG002|Overall Study|Protocol Violation|10
4413111|NCT00276094|7193077|FG000|Overall Study|Lost to Follow-up|8
4413112|NCT00276094|7193078|FG001|Overall Study|Lost to Follow-up|6
4413113|NCT00276094|7193079|FG002|Overall Study|Lost to Follow-up|4
4413114|NCT00276094|7193077|FG000|Overall Study|Other-Subject moved out of country|1
4413115|NCT00276094|7193078|FG001|Overall Study|Other-Subject moved out of country|0
4413116|NCT00276094|7193079|FG002|Overall Study|Other-Subject moved out of country|0
4413117|NCT00276094|7193077|FG000|Overall Study|Other-Scheduled gastroplasty|1
4413118|NCT00276094|7193078|FG001|Overall Study|Other-Scheduled gastroplasty|0
4413119|NCT00276094|7193079|FG002|Overall Study|Other-Scheduled gastroplasty|0
4413120|NCT00276094|7193077|FG000|Overall Study|Other-Lack of efficacy|1
4413121|NCT00276094|7193078|FG001|Overall Study|Other-Lack of efficacy|0
4413122|NCT00276094|7193079|FG002|Overall Study|Other-Lack of efficacy|0
4413123|NCT00276094|7193077|FG000|Overall Study|Other-Refused follow-up visit|1
4413124|NCT00276094|7193078|FG001|Overall Study|Other-Refused follow-up visit|0
4413125|NCT00276094|7193079|FG002|Overall Study|Other-Refused follow-up visit|0
4413126|NCT00276094|7193077|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0
4413127|NCT00276094|7193078|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1
4413128|NCT00276094|7193079|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0
4413129|NCT00276094|7193077|FG000|Overall Study|Other-Relocation|0
4413130|NCT00276094|7193078|FG001|Overall Study|Other-Relocation|1
4413131|NCT00276094|7193079|FG002|Overall Study|Other-Relocation|0
4413132|NCT00276094|7193077|FG000|Overall Study|Other-Study medication lost|0
4714444|NCT02960438|7642543|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2
4714445|NCT02960438|7642544|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5
4714446|NCT02960438|7642541|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2
4714447|NCT02960438|7642542|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1
4714448|NCT02960438|7642543|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0
4714449|NCT02960438|7642544|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3
4714450|NCT02960438|7642541|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2
4714451|NCT02960438|7642542|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0
4714452|NCT02960438|7642543|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0
4714453|NCT02960438|7642544|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0
4714454|NCT02960438|7642541|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1
4714455|NCT02960438|7642542|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0
4714456|NCT02960438|7642543|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1
4714457|NCT02960438|7642544|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0
4714458|NCT02960438|7642541|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0
4714459|NCT02960438|7642542|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0
4714460|NCT02960438|7642543|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1
4714461|NCT02960438|7642544|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0
4714462|NCT02960438|7642541|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2
4714463|NCT02960438|7642542|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1
4714464|NCT02960438|7642543|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0
4714465|NCT02960438|7642544|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1
4714466|NCT02960438|7642541|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1
4714467|NCT02960438|7642542|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2
4714468|NCT02960438|7642543|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4
4714469|NCT02960438|7642544|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1
4714470|NCT02960438|7642541|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0
4714471|NCT02960438|7642542|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0
4714472|NCT02960438|7642543|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1
4714473|NCT02960438|7642544|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0
4714474|NCT02960438|7642541|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1
4714475|NCT02960438|7642542|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1
4714476|NCT02960438|7642543|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0
4714477|NCT02960438|7642544|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1
4714478|NCT02960438|7642541|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7
4714479|NCT02960438|7642542|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5
4413133|NCT00276094|7193078|FG001|Overall Study|Other-Study medication lost|0
4413134|NCT00276094|7193079|FG002|Overall Study|Other-Study medication lost|1
4413135|NCT00276159|7193087|FG000|Overall Study|Did not receive all 24 doses of 852A|6
4413136|NCT00276380|7193106|FG000|Overall Study|Adverse Event|5
4413137|NCT00276380|7193107|FG001|Overall Study|Adverse Event|3
4413138|NCT00276380|7193106|FG000|Overall Study|Lost to Follow-up|1
4413139|NCT00276380|7193107|FG001|Overall Study|Lost to Follow-up|1
4413140|NCT00276380|7193106|FG000|Overall Study|Withdrawal by Subject|3
4413141|NCT00276380|7193107|FG001|Overall Study|Withdrawal by Subject|6
4413142|NCT00276380|7193106|FG000|Overall Study|Death|5
4413143|NCT00276380|7193107|FG001|Overall Study|Death|3
4413144|NCT00276380|7193106|FG000|Overall Study|Abnormal aPPT Levels|0
4413145|NCT00276380|7193107|FG001|Overall Study|Abnormal aPPT Levels|1
4413146|NCT00276614|7193127|FG000|Overall Study|Progression of disease under study|3
4413147|NCT00276744|7193131|FG000|PART A|Reason unknown|98
4413148|NCT00277095|7193140|FG000|Overall Study|Death|2
4413149|NCT00277095|7193140|FG000|Overall Study|Explanted|7
4413150|NCT00277095|7193140|FG000|Overall Study|Lost to Follow-up|2
4413151|NCT00277095|7193140|FG000|Overall Study|Missed Follow-up|9
4413152|NCT00277095|7193140|FG000|Overall Study|Physician Decision|1
4413153|NCT00277212|7193144|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61
4413154|NCT00277212|7193145|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0
4413155|NCT00277212|7193146|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0
4714480|NCT02960438|7642543|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7
4714481|NCT02960438|7642544|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6
4714482|NCT02960438|7642541|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2
4714483|NCT02960438|7642542|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1
4714484|NCT02960438|7642543|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1
4714485|NCT02960438|7642544|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2
4714486|NCT02960438|7642541|FG000|Extension Phase (Open-label): 80 Weeks|Other|0
4714487|NCT02960438|7642542|FG001|Extension Phase (Open-label): 80 Weeks|Other|0
4714488|NCT02960438|7642543|FG002|Extension Phase (Open-label): 80 Weeks|Other|1
4714489|NCT02960438|7642544|FG003|Extension Phase (Open-label): 80 Weeks|Other|1
4714490|NCT02960490|7642564|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3
4714491|NCT02960490|7642565|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2
4714492|NCT02960490|7642566|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0
4714493|NCT02960490|7642567|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0
4714494|NCT02960490|7642568|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0
4714495|NCT02960490|7642569|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0
4714496|NCT02960490|7642570|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0
4714497|NCT02960490|7642571|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0
4714498|NCT02960490|7642572|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0
4714499|NCT02960490|7642573|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0
4714500|NCT02960490|7642564|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
4714501|NCT02960490|7642565|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1
4714502|NCT02960490|7642566|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
4714503|NCT02960490|7642567|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
4714504|NCT02960490|7642568|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
4714505|NCT02960490|7642569|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
4714506|NCT02960490|7642570|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
4714507|NCT02960490|7642571|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
4714508|NCT02960490|7642572|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
4714509|NCT02960490|7642573|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0
4714510|NCT02960490|7642564|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1
4714511|NCT02960490|7642565|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2
4714512|NCT02960490|7642566|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0
4714513|NCT02960490|7642567|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0
4714514|NCT02960490|7642568|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0
4714515|NCT02960490|7642569|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0
4714516|NCT02960490|7642570|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0
4714517|NCT02960490|7642571|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0
4714518|NCT02960490|7642572|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0
4714519|NCT02960490|7642573|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0
4714520|NCT02960490|7642564|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1
4714521|NCT02960490|7642565|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1
4714522|NCT02960490|7642566|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0
4714523|NCT02960490|7642567|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0
4714524|NCT02960490|7642568|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0
4714525|NCT02960490|7642569|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0
4714526|NCT02960490|7642570|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0
4714527|NCT02960490|7642571|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0
4714528|NCT02960490|7642572|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0
4714529|NCT02960490|7642573|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0
4714530|NCT02960490|7642564|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0
4413156|NCT00277212|7193144|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93
4413157|NCT00277212|7193145|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0
4413158|NCT00277212|7193146|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0
4413159|NCT00277212|7193144|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96
4413160|NCT00277212|7193145|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0
4413161|NCT00277212|7193146|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0
4413162|NCT00277212|7193144|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87
4413163|NCT00277212|7193145|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0
4413164|NCT00277212|7193146|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0
4413165|NCT00277212|7193144|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35
4413166|NCT00277212|7193145|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0
4413167|NCT00277212|7193146|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0
4413168|NCT00277212|7193144|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6
4413169|NCT00277212|7193145|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0
4413170|NCT00277212|7193146|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0
4413171|NCT00277212|7193144|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44
4413172|NCT00277212|7193145|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0
4413173|NCT00277212|7193146|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0
4413174|NCT00277212|7193144|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1
4413175|NCT00277212|7193145|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0
4413176|NCT00277212|7193146|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0
4413177|NCT00277212|7193144|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12
4413178|NCT00277212|7193145|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0
4413179|NCT00277212|7193146|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0
4413180|NCT00277212|7193144|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0
4413181|NCT00277212|7193145|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54
4413182|NCT00277212|7193146|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39
4413183|NCT00277212|7193144|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0
4413184|NCT00277212|7193145|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10
4413185|NCT00277212|7193146|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16
4413186|NCT00277212|7193144|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0
4413187|NCT00277212|7193145|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17
4413188|NCT00277212|7193146|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16
4413189|NCT00277212|7193144|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0
4413190|NCT00277212|7193145|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18
4413191|NCT00277212|7193146|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18
4413192|NCT00277212|7193144|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0
4413193|NCT00277212|7193145|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7
4413194|NCT00277212|7193146|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8
4413195|NCT00277212|7193144|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0
4413196|NCT00277212|7193145|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2
4413197|NCT00277212|7193146|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2
4413198|NCT00277212|7193144|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0
4413199|NCT00277212|7193145|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4
4413200|NCT00277212|7193146|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6
4413201|NCT00277212|7193144|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0
4413202|NCT00277212|7193145|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1
4413203|NCT00277212|7193146|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3
4413204|NCT00277212|7193144|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0
4413205|NCT00277212|7193145|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7
4413206|NCT00277212|7193146|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5
4413207|NCT00277355|7193156|FG000|Overall Study|Withdrawal by Subject|3
4413208|NCT00277355|7193157|FG001|Overall Study|Withdrawal by Subject|3
4413209|NCT00277355|7193156|FG000|Overall Study|Lost to Follow-up|2
4413210|NCT00277355|7193157|FG001|Overall Study|Lost to Follow-up|2
4413211|NCT00277355|7193156|FG000|Overall Study|Adverse Event|5
4413212|NCT00277355|7193157|FG001|Overall Study|Adverse Event|0
4413213|NCT00277355|7193156|FG000|Overall Study|Death|3
4413214|NCT00277355|7193157|FG001|Overall Study|Death|0
4413215|NCT00277355|7193156|FG000|Overall Study|Physician Decision|1
4413216|NCT00277355|7193157|FG001|Overall Study|Physician Decision|0
4511749|NCT00928889|7321166|FG000|Overall Study|Lost to Follow-up|3
4511750|NCT00928889|7321167|FG001|Overall Study|Lost to Follow-up|1
4511751|NCT00928889|7321166|FG000|Overall Study|Protocol Violation|0
4511752|NCT00928889|7321167|FG001|Overall Study|Protocol Violation|1
4511753|NCT00928889|7321166|FG000|Overall Study|Adverse Event|1
4511754|NCT00928889|7321167|FG001|Overall Study|Adverse Event|0
4511755|NCT00928889|7321166|FG000|Overall Study|Other|1
4511756|NCT00928889|7321167|FG001|Overall Study|Other|0
4511757|NCT00929110|7321190|FG000|Overall Study|Adverse Event|40
4511758|NCT00929110|7321191|FG001|Overall Study|Adverse Event|29
4511759|NCT00929110|7321192|FG002|Overall Study|Adverse Event|18
4511760|NCT00929110|7321190|FG000|Overall Study|Subject withdrew consent|40
4511761|NCT00929110|7321191|FG001|Overall Study|Subject withdrew consent|23
4511762|NCT00929110|7321192|FG002|Overall Study|Subject withdrew consent|26
4413217|NCT00278109|7193198|FG000|Overall Study|Adverse Event|3
4413218|NCT00278109|7193198|FG000|Overall Study|social circumstances|1
4413219|NCT00278148|7193202|FG000|Phase II - Expansion Phase|Disease progression|0
4413220|NCT00278148|7193203|FG001|Phase II - Expansion Phase|Disease progression|0
4413221|NCT00278148|7193204|FG002|Phase II - Expansion Phase|Disease progression|4
4413222|NCT00278148|7193202|FG000|Phase II - Expansion Phase|Adverse Event|0
4413223|NCT00278148|7193203|FG001|Phase II - Expansion Phase|Adverse Event|0
4413224|NCT00278148|7193204|FG002|Phase II - Expansion Phase|Adverse Event|2
4413225|NCT00278161|7193211|FG000|Overall Study|Death|11
4413226|NCT00278200|7193217|FG000|Overall Study|Death|1
4413227|NCT00278200|7193218|FG001|Overall Study|Death|3
4413228|NCT00278200|7193217|FG000|Overall Study|Physician Decision|0
4413229|NCT00278200|7193218|FG001|Overall Study|Physician Decision|1
4714531|NCT02960490|7642565|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0
4714532|NCT02960490|7642566|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1
4714533|NCT02960490|7642567|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1
4714534|NCT02960490|7642568|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0
4714535|NCT02960490|7642569|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2
4714536|NCT02960490|7642570|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0
4714537|NCT02960490|7642571|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0
4714538|NCT02960490|7642572|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0
4714539|NCT02960490|7642573|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0
4714540|NCT02960490|7642564|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0
4714541|NCT02960490|7642565|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0
4714542|NCT02960490|7642566|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1
4714543|NCT02960490|7642567|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0
4714544|NCT02960490|7642568|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1
4714545|NCT02960490|7642569|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0
4714546|NCT02960490|7642570|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0
4714547|NCT02960490|7642571|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0
4714548|NCT02960490|7642572|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0
4714549|NCT02960490|7642573|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0
4714550|NCT02960490|7642564|FG000|Re-randomized Participants: 12 Weeks|Other|0
4714551|NCT02960490|7642565|FG001|Re-randomized Participants: 12 Weeks|Other|0
4714552|NCT02960490|7642566|FG002|Re-randomized Participants: 12 Weeks|Other|0
4714553|NCT02960490|7642567|FG003|Re-randomized Participants: 12 Weeks|Other|1
4714554|NCT02960490|7642568|FG004|Re-randomized Participants: 12 Weeks|Other|0
4714555|NCT02960490|7642569|FG005|Re-randomized Participants: 12 Weeks|Other|0
4714556|NCT02960490|7642570|FG006|Re-randomized Participants: 12 Weeks|Other|0
4714557|NCT02960490|7642571|FG007|Re-randomized Participants: 12 Weeks|Other|0
4714558|NCT02960490|7642572|FG008|Re-randomized Participants: 12 Weeks|Other|0
4714559|NCT02960490|7642573|FG009|Re-randomized Participants: 12 Weeks|Other|0
4714560|NCT02960490|7642564|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0
4714561|NCT02960490|7642565|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0
4714562|NCT02960490|7642566|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0
4714563|NCT02960490|7642567|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0
4714564|NCT02960490|7642568|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0
4714565|NCT02960490|7642569|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0
4714566|NCT02960490|7642570|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3
4714567|NCT02960490|7642571|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1
4714568|NCT02960490|7642572|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1
4714569|NCT02960490|7642573|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0
4714570|NCT02960490|7642564|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
4714571|NCT02960490|7642565|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
4714572|NCT02960490|7642566|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
4714573|NCT02960490|7642567|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
4714574|NCT02960490|7642568|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
4714575|NCT02960490|7642569|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
4714576|NCT02960490|7642570|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
4714577|NCT02960490|7642571|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1
4714578|NCT02960490|7642572|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
4714579|NCT02960490|7642573|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0
4714580|NCT02960490|7642564|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0
4714581|NCT02960490|7642565|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0
4714582|NCT02960490|7642566|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0
4714583|NCT02960490|7642567|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0
4714584|NCT02960490|7642568|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0
4714585|NCT02960490|7642569|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0
4714586|NCT02960490|7642570|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4
4714587|NCT02960490|7642571|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3
4714588|NCT02960490|7642572|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3
4714589|NCT02960490|7642573|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7
4413230|NCT00278395|7193224|FG000|Overall Study|Adverse Event|2
4413231|NCT00278395|7193224|FG000|Overall Study|Nonevaluable|1
4413232|NCT00278473|7193233|FG000|Overall Study|drop out|4
4413233|NCT00278473|7193234|FG001|Overall Study|drop out|3
4413234|NCT00278512|7193242|FG000|Overall Study|Death|1
4413235|NCT00278512|7193243|FG001|Overall Study|Death|0
4413236|NCT00278564|7193262|FG000|Overall Study|Lack of Efficacy|4
4413237|NCT00278629|7193266|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14
4413238|NCT00278889|7193292|FG000|Overall Study|Withdrawal by Subject|0
4413239|NCT00278889|7193293|FG001|Overall Study|Withdrawal by Subject|5
4413240|NCT00278889|7193294|FG002|Overall Study|Withdrawal by Subject|3
4413241|NCT00278889|7193292|FG000|Overall Study|Lost to Follow-up|1
4413242|NCT00278889|7193293|FG001|Overall Study|Lost to Follow-up|1
4413243|NCT00278889|7193294|FG002|Overall Study|Lost to Follow-up|0
4413244|NCT00278889|7193292|FG000|Overall Study|Death|24
4413245|NCT00278889|7193293|FG001|Overall Study|Death|21
4413246|NCT00278889|7193294|FG002|Overall Study|Death|17
4413247|NCT00278954|7193302|FG000|Overall Study|Adverse Event|3
4413248|NCT00278954|7193302|FG000|Overall Study|Lost to Follow-up|1
4413249|NCT00278954|7193302|FG000|Overall Study|Withdrawal by Subject|1
4413250|NCT00278993|7193306|FG000|Overall Study|Adverse Event|24
4413251|NCT00278993|7193306|FG000|Overall Study|Withdrawal by Subject|5
4413252|NCT00278993|7193306|FG000|Overall Study|Progressive Disease|65
4413253|NCT00278993|7193306|FG000|Overall Study|Physician Decision|9
4413254|NCT00278993|7193306|FG000|Overall Study|Not Otherwise Specified|4
4413255|NCT00279201|7193312|FG000|Initiation|Death|1
4413256|NCT00279201|7193313|FG001|Initiation|Death|5
4413257|NCT00279201|7193314|FG002|Initiation|Death|0
4413258|NCT00279201|7193315|FG003|Initiation|Death|0
4413259|NCT00279201|7193316|FG004|Initiation|Death|0
4413260|NCT00279201|7193317|FG005|Initiation|Death|0
4413261|NCT00279201|7193312|FG000|Initiation|Adverse Event|6
4413262|NCT00279201|7193313|FG001|Initiation|Adverse Event|15
4413263|NCT00279201|7193314|FG002|Initiation|Adverse Event|0
4413264|NCT00279201|7193315|FG003|Initiation|Adverse Event|0
4714590|NCT02960490|7642564|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
4714591|NCT02960490|7642565|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
4714592|NCT02960490|7642566|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
4714593|NCT02960490|7642567|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
4714594|NCT02960490|7642568|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
4714595|NCT02960490|7642569|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
4714596|NCT02960490|7642570|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2
4714597|NCT02960490|7642571|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
4714598|NCT02960490|7642572|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
4714599|NCT02960490|7642573|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0
4714600|NCT02960490|7642564|FG000|Extension Phase(Open-label): 80 Weeks|Other|0
4714601|NCT02960490|7642565|FG001|Extension Phase(Open-label): 80 Weeks|Other|0
4714602|NCT02960490|7642566|FG002|Extension Phase(Open-label): 80 Weeks|Other|0
4714603|NCT02960490|7642567|FG003|Extension Phase(Open-label): 80 Weeks|Other|0
4714604|NCT02960490|7642568|FG004|Extension Phase(Open-label): 80 Weeks|Other|0
4714605|NCT02960490|7642569|FG005|Extension Phase(Open-label): 80 Weeks|Other|0
4714606|NCT02960490|7642570|FG006|Extension Phase(Open-label): 80 Weeks|Other|0
4714607|NCT02960490|7642571|FG007|Extension Phase(Open-label): 80 Weeks|Other|1
4714608|NCT02960490|7642572|FG008|Extension Phase(Open-label): 80 Weeks|Other|0
4714609|NCT02960490|7642573|FG009|Extension Phase(Open-label): 80 Weeks|Other|0
4714610|NCT02960854|7642597|FG000|Overall Study|Not Disclosed|2
4714611|NCT02960854|7642598|FG001|Overall Study|Not Disclosed|2
4714612|NCT02960854|7642597|FG000|Overall Study|Subject No Longer Meets Study Criteria|1
4714613|NCT02960854|7642598|FG001|Overall Study|Subject No Longer Meets Study Criteria|0
4714614|NCT02960854|7642597|FG000|Overall Study|Subject Withdrew Consent|0
4714615|NCT02960854|7642598|FG001|Overall Study|Subject Withdrew Consent|1
4714616|NCT02960854|7642597|FG000|Overall Study|Death|4
4714617|NCT02960854|7642598|FG001|Overall Study|Death|6
4771663|NCT01665144|7748476|FG001|Overall Study|Death|1
4771664|NCT01665144|7748475|FG000|Overall Study|Protocol deviation|3
4771665|NCT01665144|7748476|FG001|Overall Study|Protocol deviation|1
4771666|NCT01665144|7748475|FG000|Overall Study|Non-compliance w/study treatment|5
4771667|NCT01665144|7748476|FG001|Overall Study|Non-compliance w/study treatment|0
4771668|NCT01665144|7748475|FG000|Overall Study|Progressive disease|8
4771669|NCT01665144|7748476|FG001|Overall Study|Progressive disease|4
4771670|NCT01665144|7748475|FG000|Overall Study|Lost to Follow-up|9
4771671|NCT01665144|7748476|FG001|Overall Study|Lost to Follow-up|8
4771672|NCT01665144|7748475|FG000|Overall Study|Physician Decision|13
4771673|NCT01665144|7748476|FG001|Overall Study|Physician Decision|1
4413265|NCT00279201|7193316|FG004|Initiation|Adverse Event|0
4413266|NCT00279201|7193317|FG005|Initiation|Adverse Event|0
4771674|NCT01665144|7748475|FG000|Overall Study|Lack of Efficacy|16
4771675|NCT01665144|7748476|FG001|Overall Study|Lack of Efficacy|11
4771676|NCT01665144|7748475|FG000|Overall Study|Adverse Event|45
4413267|NCT00279201|7193312|FG000|Initiation|Lost to Follow-up|42
4413268|NCT00279201|7193313|FG001|Initiation|Lost to Follow-up|41
4413269|NCT00279201|7193314|FG002|Initiation|Lost to Follow-up|0
4413270|NCT00279201|7193315|FG003|Initiation|Lost to Follow-up|0
4413271|NCT00279201|7193316|FG004|Initiation|Lost to Follow-up|0
4413272|NCT00279201|7193317|FG005|Initiation|Lost to Follow-up|0
4413273|NCT00279201|7193312|FG000|Initiation|Entry Criteria Exclusion|7
4413274|NCT00279201|7193313|FG001|Initiation|Entry Criteria Exclusion|9
4413275|NCT00279201|7193314|FG002|Initiation|Entry Criteria Exclusion|0
4413276|NCT00279201|7193315|FG003|Initiation|Entry Criteria Exclusion|0
4413277|NCT00279201|7193316|FG004|Initiation|Entry Criteria Exclusion|0
4413278|NCT00279201|7193317|FG005|Initiation|Entry Criteria Exclusion|0
4413279|NCT00279201|7193312|FG000|Initiation|Protocol Violation|9
4413280|NCT00279201|7193313|FG001|Initiation|Protocol Violation|10
4413281|NCT00279201|7193314|FG002|Initiation|Protocol Violation|0
4413282|NCT00279201|7193315|FG003|Initiation|Protocol Violation|0
4413283|NCT00279201|7193316|FG004|Initiation|Protocol Violation|0
4413284|NCT00279201|7193317|FG005|Initiation|Protocol Violation|0
4413285|NCT00279201|7193312|FG000|Initiation|Withdrawal by Subject|35
4413286|NCT00279201|7193313|FG001|Initiation|Withdrawal by Subject|41
4413287|NCT00279201|7193314|FG002|Initiation|Withdrawal by Subject|0
4413288|NCT00279201|7193315|FG003|Initiation|Withdrawal by Subject|0
4413289|NCT00279201|7193316|FG004|Initiation|Withdrawal by Subject|0
4413290|NCT00279201|7193317|FG005|Initiation|Withdrawal by Subject|0
4413291|NCT00279201|7193312|FG000|Initiation|Physician Decision|15
4413292|NCT00279201|7193313|FG001|Initiation|Physician Decision|18
4413293|NCT00279201|7193314|FG002|Initiation|Physician Decision|0
4413294|NCT00279201|7193315|FG003|Initiation|Physician Decision|0
4413295|NCT00279201|7193316|FG004|Initiation|Physician Decision|0
4413296|NCT00279201|7193317|FG005|Initiation|Physician Decision|0
4413297|NCT00279201|7193312|FG000|Initiation|Sponsor Decision|13
4413298|NCT00279201|7193313|FG001|Initiation|Sponsor Decision|5
4413299|NCT00279201|7193314|FG002|Initiation|Sponsor Decision|0
4413300|NCT00279201|7193315|FG003|Initiation|Sponsor Decision|0
4413301|NCT00279201|7193316|FG004|Initiation|Sponsor Decision|0
4413302|NCT00279201|7193317|FG005|Initiation|Sponsor Decision|0
4413303|NCT00279201|7193312|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0
4413304|NCT00279201|7193313|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1
4413305|NCT00279201|7193314|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0
4413306|NCT00279201|7193315|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0
4413307|NCT00279201|7193316|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0
4413308|NCT00279201|7193317|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0
4413309|NCT00279201|7193312|FG000|Maintenance|Lack of Efficacy|32
4413310|NCT00279201|7193313|FG001|Maintenance|Lack of Efficacy|30
4413311|NCT00279201|7193314|FG002|Maintenance|Lack of Efficacy|0
4413312|NCT00279201|7193315|FG003|Maintenance|Lack of Efficacy|0
4413313|NCT00279201|7193316|FG004|Maintenance|Lack of Efficacy|0
4413314|NCT00279201|7193317|FG005|Maintenance|Lack of Efficacy|0
4413315|NCT00279201|7193312|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3
4413316|NCT00279201|7193313|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2
4413317|NCT00279201|7193314|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0
4413318|NCT00279201|7193315|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0
4413319|NCT00279201|7193316|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0
4413320|NCT00279201|7193317|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0
4413321|NCT00279201|7193312|FG000|Maintenance|Adverse Event|4
4413322|NCT00279201|7193313|FG001|Maintenance|Adverse Event|4
4413323|NCT00279201|7193314|FG002|Maintenance|Adverse Event|0
4413324|NCT00279201|7193315|FG003|Maintenance|Adverse Event|0
4413325|NCT00279201|7193316|FG004|Maintenance|Adverse Event|0
4413326|NCT00279201|7193317|FG005|Maintenance|Adverse Event|0
4413327|NCT00279201|7193312|FG000|Maintenance|Death|4
4413328|NCT00279201|7193313|FG001|Maintenance|Death|4
4413329|NCT00279201|7193314|FG002|Maintenance|Death|0
4413330|NCT00279201|7193315|FG003|Maintenance|Death|0
4413331|NCT00279201|7193316|FG004|Maintenance|Death|0
4413332|NCT00279201|7193317|FG005|Maintenance|Death|0
4413333|NCT00279201|7193312|FG000|Maintenance|Lost to Follow-up|17
4413334|NCT00279201|7193313|FG001|Maintenance|Lost to Follow-up|13
4413335|NCT00279201|7193314|FG002|Maintenance|Lost to Follow-up|0
4413336|NCT00279201|7193315|FG003|Maintenance|Lost to Follow-up|0
4413337|NCT00279201|7193316|FG004|Maintenance|Lost to Follow-up|0
4413338|NCT00279201|7193317|FG005|Maintenance|Lost to Follow-up|0
4413339|NCT00279201|7193312|FG000|Maintenance|Entry Criteria Exclusion|1
4413340|NCT00279201|7193313|FG001|Maintenance|Entry Criteria Exclusion|4
4413341|NCT00279201|7193314|FG002|Maintenance|Entry Criteria Exclusion|0
4413342|NCT00279201|7193315|FG003|Maintenance|Entry Criteria Exclusion|0
4413343|NCT00279201|7193316|FG004|Maintenance|Entry Criteria Exclusion|0
4413344|NCT00279201|7193317|FG005|Maintenance|Entry Criteria Exclusion|0
4413345|NCT00279201|7193312|FG000|Maintenance|Protocol Violation|16
4413346|NCT00279201|7193313|FG001|Maintenance|Protocol Violation|24
4413347|NCT00279201|7193314|FG002|Maintenance|Protocol Violation|0
4413348|NCT00279201|7193315|FG003|Maintenance|Protocol Violation|0
4413349|NCT00279201|7193316|FG004|Maintenance|Protocol Violation|0
4413350|NCT00279201|7193317|FG005|Maintenance|Protocol Violation|0
4413351|NCT00279201|7193312|FG000|Maintenance|Withdrawal by Subject|18
4413352|NCT00279201|7193313|FG001|Maintenance|Withdrawal by Subject|18
4413353|NCT00279201|7193314|FG002|Maintenance|Withdrawal by Subject|0
4413354|NCT00279201|7193315|FG003|Maintenance|Withdrawal by Subject|0
4413355|NCT00279201|7193316|FG004|Maintenance|Withdrawal by Subject|0
4413356|NCT00279201|7193317|FG005|Maintenance|Withdrawal by Subject|0
4413357|NCT00279201|7193312|FG000|Maintenance|Physician Decision|9
4413358|NCT00279201|7193313|FG001|Maintenance|Physician Decision|9
4413359|NCT00279201|7193314|FG002|Maintenance|Physician Decision|0
4413360|NCT00279201|7193315|FG003|Maintenance|Physician Decision|0
4629308|NCT01870921|7497173|FG000|Overall Study|Subject Lost to Follow up|2
4771677|NCT01665144|7748476|FG001|Overall Study|Adverse Event|18
4771678|NCT01665144|7748475|FG000|Overall Study|Withdrawal by Subject|96
4771679|NCT01665144|7748476|FG001|Overall Study|Withdrawal by Subject|77
4771680|NCT01307787|7748484|FG000|Overall Study|Withdrawal by Subject|2
4714634|NCT02961218|7642631|FG000|Overall Study|Lost to Follow-up|0
4714635|NCT02961218|7642632|FG001|Overall Study|Lost to Follow-up|2
4714636|NCT02961218|7642631|FG000|Overall Study|Physician Decision|0
4714637|NCT02961218|7642632|FG001|Overall Study|Physician Decision|2
4714638|NCT02961218|7642631|FG000|Overall Study|Subject/Guardian Decision|3
4714639|NCT02961218|7642632|FG001|Overall Study|Subject/Guardian Decision|1
4714640|NCT02961244|7642642|FG000|Overall Study|Protocol Violation|0
4714641|NCT02961244|7642643|FG001|Overall Study|Protocol Violation|1
4714642|NCT02961244|7642642|FG000|Overall Study|Withdrawal by Subject|1
4714643|NCT02961244|7642643|FG001|Overall Study|Withdrawal by Subject|2
4714644|NCT02961244|7642642|FG000|Overall Study|Surgery plan change after study approval|0
4714645|NCT02961244|7642643|FG001|Overall Study|Surgery plan change after study approval|2
4714646|NCT02961244|7642642|FG000|Overall Study|Lost to Follow-up|0
4714647|NCT02961244|7642643|FG001|Overall Study|Lost to Follow-up|2
4714648|NCT02961244|7642642|FG000|Overall Study|İnadequate data|0
4714649|NCT02961244|7642643|FG001|Overall Study|İnadequate data|2
4714650|NCT02961374|7642649|FG000|Overall Study|Adverse Event|4
4714651|NCT02961751|7642653|FG000|Overall Study|Lost to Follow-up|11
4714652|NCT02961751|7642653|FG000|Overall Study|Physician Decision|2
4714653|NCT02961751|7642653|FG000|Overall Study|Not Eligible at Enrollment|1
4714654|NCT02961751|7642653|FG000|Overall Study|Protocol Violation|1
4714655|NCT02961764|7642659|FG000|Overall Study|Protocol Violation|0
4714656|NCT02961764|7642660|FG001|Overall Study|Protocol Violation|1
4714657|NCT02961764|7642659|FG000|Overall Study|Death|2
4714658|NCT02961764|7642660|FG001|Overall Study|Death|0
4714659|NCT02961764|7642659|FG000|Overall Study|Lost to Follow-up|35
4714660|NCT02961764|7642660|FG001|Overall Study|Lost to Follow-up|24
4714661|NCT02961764|7642659|FG000|Overall Study|Withdrawal by Subject|2
4714662|NCT02961764|7642660|FG001|Overall Study|Withdrawal by Subject|0
4714663|NCT02961790|7642670|FG000|Overall Study|Canceled|4
4714664|NCT02961790|7642671|FG001|Overall Study|Canceled|5
4714665|NCT02961790|7642672|FG002|Overall Study|Canceled|1
4714666|NCT02961790|7642673|FG003|Overall Study|Canceled|4
4714667|NCT02961790|7642670|FG000|Overall Study|without baseline data|4
4714668|NCT02961790|7642671|FG001|Overall Study|without baseline data|0
4714669|NCT02961790|7642672|FG002|Overall Study|without baseline data|1
4714670|NCT02961790|7642673|FG003|Overall Study|without baseline data|0
4714671|NCT02961790|7642670|FG000|Overall Study|without post baseline data|7
4714672|NCT02961790|7642671|FG001|Overall Study|without post baseline data|6
4714673|NCT02961790|7642672|FG002|Overall Study|without post baseline data|4
4714674|NCT02961790|7642673|FG003|Overall Study|without post baseline data|1
4714675|NCT02961920|7642690|FG000|Overall Study|did not achive stydy protocol schedule|1
4714676|NCT02961920|7642691|FG001|Overall Study|did not achive stydy protocol schedule|1
4714677|NCT02962284|7642712|FG000|Overall Study|Death|2
4714678|NCT02962284|7642713|FG001|Overall Study|Death|0
4714679|NCT02962284|7642712|FG000|Overall Study|Progressive disease|2
4714680|NCT02962284|7642713|FG001|Overall Study|Progressive disease|3
4714681|NCT02962284|7642712|FG000|Overall Study|Withdrawal by Subject|1
4714682|NCT02962284|7642713|FG001|Overall Study|Withdrawal by Subject|0
4714683|NCT02962648|7642741|FG000|Overall Study|Withdrawal by Subject|3
4714684|NCT02962648|7642741|FG000|Overall Study|Lost to Follow-up|3
4714685|NCT02962648|7642741|FG000|Overall Study|Physician Decision|1
4714686|NCT02962648|7642741|FG000|Overall Study|Subject had problems with transportation|2
4714687|NCT02962674|7642745|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49
4714688|NCT02962739|7642762|FG000|Overall Study|Withdrawal by Subject|0
4714689|NCT02962739|7642763|FG001|Overall Study|Withdrawal by Subject|1
4714690|NCT02962739|7642764|FG002|Overall Study|Withdrawal by Subject|0
4714691|NCT02962739|7642765|FG003|Overall Study|Withdrawal by Subject|0
4714692|NCT02962739|7642766|FG004|Overall Study|Withdrawal by Subject|0
4714693|NCT02962739|7642767|FG005|Overall Study|Withdrawal by Subject|0
4714694|NCT02962739|7642762|FG000|Overall Study|Protocol Violation|0
4714695|NCT02962739|7642763|FG001|Overall Study|Protocol Violation|0
4714696|NCT02962739|7642764|FG002|Overall Study|Protocol Violation|1
4714697|NCT02962739|7642765|FG003|Overall Study|Protocol Violation|0
4714698|NCT02962739|7642766|FG004|Overall Study|Protocol Violation|1
4714699|NCT02962739|7642767|FG005|Overall Study|Protocol Violation|0
4629309|NCT01870921|7497173|FG000|Overall Study|Other|1
4629310|NCT01870973|7497179|FG000|Overall Study|Lost to Follow-up|10
4629311|NCT01870973|7497180|FG001|Overall Study|Lost to Follow-up|3
4714700|NCT02962765|7642773|FG000|Overall Study|Protocol Violation|9
4714701|NCT02962765|7642773|FG000|Overall Study|Withdrawal by Subject|3
4714702|NCT02962765|7642773|FG000|Overall Study|Lost to Follow-up|1
4714703|NCT02962765|7642773|FG000|Overall Study|Death|1
4714704|NCT02962765|7642773|FG000|Overall Study|Limited access to study medication|3
4413361|NCT00279201|7193316|FG004|Maintenance|Physician Decision|0
4629312|NCT01870999|7497189|FG000|Overall Study|Adverse Event|0
4413362|NCT00279201|7193317|FG005|Maintenance|Physician Decision|0
4413363|NCT00279201|7193312|FG000|Maintenance|Sponsor Decision|4
4413364|NCT00279201|7193313|FG001|Maintenance|Sponsor Decision|0
4413365|NCT00279201|7193314|FG002|Maintenance|Sponsor Decision|0
4714705|NCT02962882|7642784|FG000|Overall Study|Adverse Event|2
4714706|NCT02962882|7642784|FG000|Overall Study|Withdrawal by Subject|2
4714707|NCT02962882|7642784|FG000|Overall Study|Transfer from ICU|32
4714708|NCT02962908|7642793|FG000|Overall Study|Lost to Follow-up|0
4714709|NCT02962908|7642794|FG001|Overall Study|Lost to Follow-up|3
4714710|NCT02962908|7642795|FG002|Overall Study|Lost to Follow-up|0
4714711|NCT02962908|7642796|FG003|Overall Study|Lost to Follow-up|1
4714712|NCT02962908|7642793|FG000|Overall Study|Withdrawal by Subject|0
4714713|NCT02962908|7642794|FG001|Overall Study|Withdrawal by Subject|3
4714714|NCT02962908|7642795|FG002|Overall Study|Withdrawal by Subject|0
4714715|NCT02962908|7642796|FG003|Overall Study|Withdrawal by Subject|2
4714716|NCT02962908|7642793|FG000|Overall Study|Protocol Violation|0
4714717|NCT02962908|7642794|FG001|Overall Study|Protocol Violation|1
4714718|NCT02962908|7642795|FG002|Overall Study|Protocol Violation|0
4714719|NCT02962908|7642796|FG003|Overall Study|Protocol Violation|0
4714720|NCT02962908|7642793|FG000|Overall Study|Physician Decision|0
4714721|NCT02962908|7642794|FG001|Overall Study|Physician Decision|1
4714722|NCT02962908|7642795|FG002|Overall Study|Physician Decision|0
4714723|NCT02962908|7642796|FG003|Overall Study|Physician Decision|0
4714724|NCT02962960|7642824|FG000|Overall Study|Withdrawal by Subject|1
4714725|NCT02962960|7642825|FG001|Overall Study|Withdrawal by Subject|1
4714726|NCT02962960|7642826|FG002|Overall Study|Withdrawal by Subject|0
4714727|NCT02962960|7642824|FG000|Overall Study|Adverse Event|1
4714728|NCT02962960|7642825|FG001|Overall Study|Adverse Event|1
4714729|NCT02962960|7642826|FG002|Overall Study|Adverse Event|0
4714730|NCT02962960|7642824|FG000|Overall Study|Protocol Violation|1
4714731|NCT02962960|7642825|FG001|Overall Study|Protocol Violation|0
4714732|NCT02962960|7642826|FG002|Overall Study|Protocol Violation|0
4714733|NCT02963311|7642836|FG000|Overall Study|Withdrawal by Subject|1
4714734|NCT02963311|7642836|FG000|Overall Study|Screen Failure|4
4714735|NCT02963441|7642871|FG000|Overall Study|Protocol violation or withdrawn|8
4714736|NCT02963441|7642871|FG000|Overall Study|Ungradeable by FPRC or IDx|40
4714737|NCT02963441|7642871|FG000|Overall Study|IDx-DR insufficient quality|33
4714738|NCT02963506|7642881|FG000|Double-Blind Period|Adverse Event|0
4714739|NCT02963506|7642882|FG001|Double-Blind Period|Adverse Event|0
4714740|NCT02963506|7642883|FG002|Double-Blind Period|Adverse Event|1
4714741|NCT02963506|7642884|FG003|Double-Blind Period|Adverse Event|0
4714742|NCT02963506|7642885|FG004|Double-Blind Period|Adverse Event|0
4714743|NCT02963506|7642886|FG005|Double-Blind Period|Adverse Event|0
4714744|NCT02963506|7642887|FG006|Double-Blind Period|Adverse Event|0
4714745|NCT02963506|7642888|FG007|Double-Blind Period|Adverse Event|0
4714746|NCT02963506|7642889|FG008|Double-Blind Period|Adverse Event|0
4714747|NCT02963506|7642890|FG009|Double-Blind Period|Adverse Event|0
4714748|NCT02963506|7642891|FG010|Double-Blind Period|Adverse Event|0
4714749|NCT02963506|7642892|FG011|Double-Blind Period|Adverse Event|0
4714750|NCT02963506|7642893|FG012|Double-Blind Period|Adverse Event|0
4714751|NCT02963506|7642881|FG000|Double-Blind Period|Death|0
4714752|NCT02963506|7642882|FG001|Double-Blind Period|Death|0
4714753|NCT02963506|7642883|FG002|Double-Blind Period|Death|0
4714754|NCT02963506|7642884|FG003|Double-Blind Period|Death|1
4714755|NCT02963506|7642885|FG004|Double-Blind Period|Death|0
4714756|NCT02963506|7642886|FG005|Double-Blind Period|Death|0
4714757|NCT02963506|7642887|FG006|Double-Blind Period|Death|0
4714758|NCT02963506|7642888|FG007|Double-Blind Period|Death|0
4714759|NCT02963506|7642889|FG008|Double-Blind Period|Death|0
4714760|NCT02963506|7642890|FG009|Double-Blind Period|Death|0
4714761|NCT02963506|7642891|FG010|Double-Blind Period|Death|0
4714762|NCT02963506|7642892|FG011|Double-Blind Period|Death|0
4714763|NCT02963506|7642893|FG012|Double-Blind Period|Death|0
4714764|NCT02963506|7642881|FG000|Double-Blind Period|Lost to Follow-up|0
4714765|NCT02963506|7642882|FG001|Double-Blind Period|Lost to Follow-up|1
4714766|NCT02963506|7642883|FG002|Double-Blind Period|Lost to Follow-up|0
4714767|NCT02963506|7642884|FG003|Double-Blind Period|Lost to Follow-up|0
4714768|NCT02963506|7642885|FG004|Double-Blind Period|Lost to Follow-up|0
4714769|NCT02963506|7642886|FG005|Double-Blind Period|Lost to Follow-up|0
4714770|NCT02963506|7642887|FG006|Double-Blind Period|Lost to Follow-up|0
4714771|NCT02963506|7642888|FG007|Double-Blind Period|Lost to Follow-up|0
4714772|NCT02963506|7642889|FG008|Double-Blind Period|Lost to Follow-up|0
4714773|NCT02963506|7642890|FG009|Double-Blind Period|Lost to Follow-up|0
4714774|NCT02963506|7642891|FG010|Double-Blind Period|Lost to Follow-up|0
4714775|NCT02963506|7642892|FG011|Double-Blind Period|Lost to Follow-up|0
4714776|NCT02963506|7642893|FG012|Double-Blind Period|Lost to Follow-up|0
4714777|NCT02963506|7642881|FG000|Double-Blind Period|Withdrawal by Subject|0
4714778|NCT02963506|7642882|FG001|Double-Blind Period|Withdrawal by Subject|0
4714779|NCT02963506|7642883|FG002|Double-Blind Period|Withdrawal by Subject|1
4714780|NCT02963506|7642884|FG003|Double-Blind Period|Withdrawal by Subject|1
4714781|NCT02963506|7642885|FG004|Double-Blind Period|Withdrawal by Subject|0
4714782|NCT02963506|7642886|FG005|Double-Blind Period|Withdrawal by Subject|0
4413366|NCT00279201|7193315|FG003|Maintenance|Sponsor Decision|0
4714783|NCT02963506|7642887|FG006|Double-Blind Period|Withdrawal by Subject|0
4714784|NCT02963506|7642888|FG007|Double-Blind Period|Withdrawal by Subject|0
4714785|NCT02963506|7642889|FG008|Double-Blind Period|Withdrawal by Subject|0
4413367|NCT00279201|7193316|FG004|Maintenance|Sponsor Decision|0
4413368|NCT00279201|7193317|FG005|Maintenance|Sponsor Decision|0
4413369|NCT00279201|7193312|FG000|Maintenance|HbA1c>7.5%|123
4413370|NCT00279201|7193313|FG001|Maintenance|HbA1c>7.5%|126
4714786|NCT02963506|7642890|FG009|Double-Blind Period|Withdrawal by Subject|0
4714787|NCT02963506|7642891|FG010|Double-Blind Period|Withdrawal by Subject|0
4714788|NCT02963506|7642892|FG011|Double-Blind Period|Withdrawal by Subject|0
4714789|NCT02963506|7642893|FG012|Double-Blind Period|Withdrawal by Subject|0
4714790|NCT02963506|7642881|FG000|Double-Blind Period|No compliance|0
4714791|NCT02963506|7642882|FG001|Double-Blind Period|No compliance|1
4714792|NCT02963506|7642883|FG002|Double-Blind Period|No compliance|0
4714793|NCT02963506|7642884|FG003|Double-Blind Period|No compliance|0
4714794|NCT02963506|7642885|FG004|Double-Blind Period|No compliance|0
4714795|NCT02963506|7642886|FG005|Double-Blind Period|No compliance|0
4714796|NCT02963506|7642887|FG006|Double-Blind Period|No compliance|0
4714797|NCT02963506|7642888|FG007|Double-Blind Period|No compliance|0
4714798|NCT02963506|7642889|FG008|Double-Blind Period|No compliance|0
4714799|NCT02963506|7642890|FG009|Double-Blind Period|No compliance|0
4714800|NCT02963506|7642891|FG010|Double-Blind Period|No compliance|0
4714801|NCT02963506|7642892|FG011|Double-Blind Period|No compliance|0
4714802|NCT02963506|7642893|FG012|Double-Blind Period|No compliance|0
4714803|NCT02963506|7642881|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0
4714804|NCT02963506|7642882|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1
4714805|NCT02963506|7642883|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0
4714806|NCT02963506|7642884|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0
4714807|NCT02963506|7642885|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0
4714808|NCT02963506|7642886|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0
4714809|NCT02963506|7642887|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0
4714810|NCT02963506|7642888|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0
4714811|NCT02963506|7642889|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0
4714812|NCT02963506|7642890|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0
4714813|NCT02963506|7642891|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0
4714814|NCT02963506|7642892|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0
4714815|NCT02963506|7642893|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0
4714816|NCT02963506|7642881|FG000|Dose-Blind Period|Adverse Event|0
4714817|NCT02963506|7642882|FG001|Dose-Blind Period|Adverse Event|0
4714818|NCT02963506|7642883|FG002|Dose-Blind Period|Adverse Event|0
4714819|NCT02963506|7642884|FG003|Dose-Blind Period|Adverse Event|0
4714820|NCT02963506|7642885|FG004|Dose-Blind Period|Adverse Event|0
4714821|NCT02963506|7642886|FG005|Dose-Blind Period|Adverse Event|1
4714822|NCT02963506|7642887|FG006|Dose-Blind Period|Adverse Event|3
4714823|NCT02963506|7642888|FG007|Dose-Blind Period|Adverse Event|2
4714824|NCT02963506|7642889|FG008|Dose-Blind Period|Adverse Event|2
4714825|NCT02963506|7642890|FG009|Dose-Blind Period|Adverse Event|2
4714826|NCT02963506|7642891|FG010|Dose-Blind Period|Adverse Event|1
4714827|NCT02963506|7642892|FG011|Dose-Blind Period|Adverse Event|1
4714828|NCT02963506|7642893|FG012|Dose-Blind Period|Adverse Event|6
4714829|NCT02963506|7642881|FG000|Dose-Blind Period|Lack of Efficacy|0
4714830|NCT02963506|7642882|FG001|Dose-Blind Period|Lack of Efficacy|0
4714831|NCT02963506|7642883|FG002|Dose-Blind Period|Lack of Efficacy|0
4714832|NCT02963506|7642884|FG003|Dose-Blind Period|Lack of Efficacy|0
4714833|NCT02963506|7642885|FG004|Dose-Blind Period|Lack of Efficacy|0
4714834|NCT02963506|7642886|FG005|Dose-Blind Period|Lack of Efficacy|0
4714835|NCT02963506|7642887|FG006|Dose-Blind Period|Lack of Efficacy|0
4714836|NCT02963506|7642888|FG007|Dose-Blind Period|Lack of Efficacy|1
4714837|NCT02963506|7642889|FG008|Dose-Blind Period|Lack of Efficacy|0
4714838|NCT02963506|7642890|FG009|Dose-Blind Period|Lack of Efficacy|1
4714839|NCT02963506|7642891|FG010|Dose-Blind Period|Lack of Efficacy|0
4714840|NCT02963506|7642892|FG011|Dose-Blind Period|Lack of Efficacy|0
4714841|NCT02963506|7642893|FG012|Dose-Blind Period|Lack of Efficacy|0
4714842|NCT02963506|7642881|FG000|Dose-Blind Period|Lost to Follow-up|0
4714843|NCT02963506|7642882|FG001|Dose-Blind Period|Lost to Follow-up|0
4714844|NCT02963506|7642883|FG002|Dose-Blind Period|Lost to Follow-up|0
4714845|NCT02963506|7642884|FG003|Dose-Blind Period|Lost to Follow-up|0
4714846|NCT02963506|7642885|FG004|Dose-Blind Period|Lost to Follow-up|0
4714847|NCT02963506|7642886|FG005|Dose-Blind Period|Lost to Follow-up|1
4714848|NCT02963506|7642887|FG006|Dose-Blind Period|Lost to Follow-up|0
4714849|NCT02963506|7642888|FG007|Dose-Blind Period|Lost to Follow-up|0
4714850|NCT02963506|7642889|FG008|Dose-Blind Period|Lost to Follow-up|1
4714851|NCT02963506|7642890|FG009|Dose-Blind Period|Lost to Follow-up|0
4714852|NCT02963506|7642891|FG010|Dose-Blind Period|Lost to Follow-up|0
4714853|NCT02963506|7642892|FG011|Dose-Blind Period|Lost to Follow-up|1
4714854|NCT02963506|7642893|FG012|Dose-Blind Period|Lost to Follow-up|0
4714855|NCT02963506|7642881|FG000|Dose-Blind Period|Withdrawal by Subject|0
4413371|NCT00279201|7193314|FG002|Maintenance|HbA1c>7.5%|0
4413372|NCT00279201|7193315|FG003|Maintenance|HbA1c>7.5%|0
4714856|NCT02963506|7642882|FG001|Dose-Blind Period|Withdrawal by Subject|0
4714857|NCT02963506|7642883|FG002|Dose-Blind Period|Withdrawal by Subject|0
4714858|NCT02963506|7642884|FG003|Dose-Blind Period|Withdrawal by Subject|0
4714859|NCT02963506|7642885|FG004|Dose-Blind Period|Withdrawal by Subject|0
4714860|NCT02963506|7642886|FG005|Dose-Blind Period|Withdrawal by Subject|1
4714861|NCT02963506|7642887|FG006|Dose-Blind Period|Withdrawal by Subject|2
4413373|NCT00279201|7193316|FG004|Maintenance|HbA1c>7.5%|0
4413374|NCT00279201|7193317|FG005|Maintenance|HbA1c>7.5%|0
4413375|NCT00279201|7193312|FG000|Intensification Addendum|Withdrawal by Subject|0
4413376|NCT00279201|7193313|FG001|Intensification Addendum|Withdrawal by Subject|0
4413377|NCT00279201|7193314|FG002|Intensification Addendum|Withdrawal by Subject|12
4413378|NCT00279201|7193315|FG003|Intensification Addendum|Withdrawal by Subject|14
4413379|NCT00279201|7193316|FG004|Intensification Addendum|Withdrawal by Subject|9
4413380|NCT00279201|7193317|FG005|Intensification Addendum|Withdrawal by Subject|18
4413381|NCT00279201|7193312|FG000|Intensification Addendum|Lost to Follow-up|0
4629313|NCT01870999|7497190|FG001|Overall Study|Adverse Event|4
4629314|NCT01870999|7497191|FG002|Overall Study|Adverse Event|1
4413382|NCT00279201|7193313|FG001|Intensification Addendum|Lost to Follow-up|0
4413383|NCT00279201|7193314|FG002|Intensification Addendum|Lost to Follow-up|4
4413384|NCT00279201|7193315|FG003|Intensification Addendum|Lost to Follow-up|6
4413385|NCT00279201|7193316|FG004|Intensification Addendum|Lost to Follow-up|7
4413386|NCT00279201|7193317|FG005|Intensification Addendum|Lost to Follow-up|7
4413387|NCT00279201|7193312|FG000|Intensification Addendum|Protocol Violation|0
4413388|NCT00279201|7193313|FG001|Intensification Addendum|Protocol Violation|0
4413389|NCT00279201|7193314|FG002|Intensification Addendum|Protocol Violation|2
4413390|NCT00279201|7193315|FG003|Intensification Addendum|Protocol Violation|2
4413391|NCT00279201|7193316|FG004|Intensification Addendum|Protocol Violation|6
4413392|NCT00279201|7193317|FG005|Intensification Addendum|Protocol Violation|6
4590414|NCT01521494|7436421|FG003|Overall Study|Decrease in serum calcium|1
4590415|NCT01521494|7436422|FG004|Overall Study|Decrease in serum calcium|1
4629315|NCT01870999|7497189|FG000|Overall Study|Subject met withdrawal criteria|3
4629316|NCT01870999|7497190|FG001|Overall Study|Subject met withdrawal criteria|2
4590416|NCT01521494|7436418|FG000|Overall Study|Physician Decision|0
4590417|NCT01521494|7436419|FG001|Overall Study|Physician Decision|0
4590418|NCT01521494|7436420|FG002|Overall Study|Physician Decision|0
4590419|NCT01521494|7436421|FG003|Overall Study|Physician Decision|0
4590420|NCT01521494|7436422|FG004|Overall Study|Physician Decision|2
4590421|NCT01521507|7436436|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2
4413393|NCT00279201|7193312|FG000|Intensification Addendum|Adverse Event|0
4413394|NCT00279201|7193313|FG001|Intensification Addendum|Adverse Event|0
4413395|NCT00279201|7193314|FG002|Intensification Addendum|Adverse Event|0
4413396|NCT00279201|7193315|FG003|Intensification Addendum|Adverse Event|4
4413397|NCT00279201|7193316|FG004|Intensification Addendum|Adverse Event|1
4413398|NCT00279201|7193317|FG005|Intensification Addendum|Adverse Event|3
4413399|NCT00279201|7193312|FG000|Intensification Addendum|Physician Decision|0
4413400|NCT00279201|7193313|FG001|Intensification Addendum|Physician Decision|0
4413401|NCT00279201|7193314|FG002|Intensification Addendum|Physician Decision|4
4413402|NCT00279201|7193315|FG003|Intensification Addendum|Physician Decision|1
4413403|NCT00279201|7193316|FG004|Intensification Addendum|Physician Decision|3
4413404|NCT00279201|7193317|FG005|Intensification Addendum|Physician Decision|2
4413405|NCT00279201|7193312|FG000|Intensification Addendum|Sponsor Decision|0
4413406|NCT00279201|7193313|FG001|Intensification Addendum|Sponsor Decision|0
4413407|NCT00279201|7193314|FG002|Intensification Addendum|Sponsor Decision|0
4413408|NCT00279201|7193315|FG003|Intensification Addendum|Sponsor Decision|0
4413409|NCT00279201|7193316|FG004|Intensification Addendum|Sponsor Decision|1
4413410|NCT00279201|7193317|FG005|Intensification Addendum|Sponsor Decision|1
4413411|NCT00279201|7193312|FG000|Intensification Addendum|Entry Criteria Exclusion|0
4413412|NCT00279201|7193313|FG001|Intensification Addendum|Entry Criteria Exclusion|0
4413413|NCT00279201|7193314|FG002|Intensification Addendum|Entry Criteria Exclusion|1
4413414|NCT00279201|7193315|FG003|Intensification Addendum|Entry Criteria Exclusion|0
4413415|NCT00279201|7193316|FG004|Intensification Addendum|Entry Criteria Exclusion|0
4413416|NCT00279201|7193317|FG005|Intensification Addendum|Entry Criteria Exclusion|0
4413417|NCT00279201|7193312|FG000|Intensification Addendum|Lack of Efficacy|0
4413418|NCT00279201|7193313|FG001|Intensification Addendum|Lack of Efficacy|0
4413419|NCT00279201|7193314|FG002|Intensification Addendum|Lack of Efficacy|0
4413420|NCT00279201|7193315|FG003|Intensification Addendum|Lack of Efficacy|1
4413421|NCT00279201|7193316|FG004|Intensification Addendum|Lack of Efficacy|1
4413422|NCT00279201|7193317|FG005|Intensification Addendum|Lack of Efficacy|0
4413423|NCT00279201|7193312|FG000|Intensification Addendum|Death|0
4413424|NCT00279201|7193313|FG001|Intensification Addendum|Death|0
4413425|NCT00279201|7193314|FG002|Intensification Addendum|Death|0
4413426|NCT00279201|7193315|FG003|Intensification Addendum|Death|0
4413427|NCT00279201|7193316|FG004|Intensification Addendum|Death|1
4413428|NCT00279201|7193317|FG005|Intensification Addendum|Death|0
4413429|NCT00279214|7193352|FG000|Overall Study|Physician Decision|3
4413430|NCT00279214|7193353|FG001|Overall Study|Physician Decision|2
4413431|NCT00279305|7193361|FG000|Overall Study|Pregnancy|1
4413432|NCT00279305|7193362|FG001|Overall Study|Pregnancy|0
4413433|NCT00279305|7193361|FG000|Overall Study|Withdrawal by Subject|2
4413434|NCT00279305|7193362|FG001|Overall Study|Withdrawal by Subject|0
4413435|NCT00279305|7193361|FG000|Overall Study|Dificulting establishing IV|1
4413436|NCT00279305|7193362|FG001|Overall Study|Dificulting establishing IV|0
4413437|NCT00279305|7193361|FG000|Overall Study|FDA Safety Alert|4
4413438|NCT00279305|7193362|FG001|Overall Study|FDA Safety Alert|1
4590422|NCT01521507|7436437|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0
4629317|NCT01870999|7497191|FG002|Overall Study|Subject met withdrawal criteria|0
4413439|NCT00279708|7193385|FG000|Overall Study|Withdrawal by Subject|2
4413440|NCT00279708|7193386|FG001|Overall Study|Withdrawal by Subject|3
4413441|NCT00279708|7193385|FG000|Overall Study|Adverse Event|1
4413442|NCT00279708|7193386|FG001|Overall Study|Adverse Event|1
4413443|NCT00279812|7193398|FG000|Overall Study|Protocol Violation|1
4413444|NCT00279812|7193399|FG001|Overall Study|Protocol Violation|1
4413445|NCT00279812|7193400|FG002|Overall Study|Protocol Violation|0
4413446|NCT00279812|7193401|FG003|Overall Study|Protocol Violation|0
4413447|NCT00279812|7193402|FG004|Overall Study|Protocol Violation|1
4413448|NCT00279812|7193403|FG005|Overall Study|Protocol Violation|0
4413449|NCT00279812|7193398|FG000|Overall Study|Withdrawal by Subject|0
4413450|NCT00279812|7193399|FG001|Overall Study|Withdrawal by Subject|4
4413451|NCT00279812|7193400|FG002|Overall Study|Withdrawal by Subject|2
4413452|NCT00279812|7193401|FG003|Overall Study|Withdrawal by Subject|0
4413453|NCT00279812|7193402|FG004|Overall Study|Withdrawal by Subject|0
4413454|NCT00279812|7193403|FG005|Overall Study|Withdrawal by Subject|0
4413455|NCT00279812|7193398|FG000|Overall Study|Adverse Event|0
4413456|NCT00279812|7193399|FG001|Overall Study|Adverse Event|1
4413457|NCT00279812|7193400|FG002|Overall Study|Adverse Event|1
4413458|NCT00279812|7193401|FG003|Overall Study|Adverse Event|0
4413459|NCT00279812|7193402|FG004|Overall Study|Adverse Event|2
4413460|NCT00279812|7193403|FG005|Overall Study|Adverse Event|1
4413461|NCT00279916|7193419|FG000|Overall Study|Withdrawal by Subject|4
4413462|NCT00279916|7193420|FG001|Overall Study|Withdrawal by Subject|3
4413463|NCT00279916|7193419|FG000|Overall Study|Lost to Follow-up|3
4629318|NCT01870999|7497189|FG000|Overall Study|Subject withdrawn by Investigator|1
4629319|NCT01870999|7497190|FG001|Overall Study|Subject withdrawn by Investigator|0
4413464|NCT00279916|7193420|FG001|Overall Study|Lost to Follow-up|2
4413465|NCT00280059|7193440|FG000|Efficacy Assessment Phase|Death|2
4413466|NCT00280059|7193441|FG001|Efficacy Assessment Phase|Death|0
4413467|NCT00280059|7193440|FG000|Efficacy Assessment Phase|Adverse Event|33
4413468|NCT00280059|7193441|FG001|Efficacy Assessment Phase|Adverse Event|31
4413469|NCT00280059|7193440|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1
4413470|NCT00280059|7193441|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0
4413471|NCT00280059|7193440|FG000|Efficacy Assessment Phase|Lack of Efficacy|19
4413472|NCT00280059|7193441|FG001|Efficacy Assessment Phase|Lack of Efficacy|3
4413473|NCT00280059|7193440|FG000|Efficacy Assessment Phase|Lost to Follow-up|6
4413474|NCT00280059|7193441|FG001|Efficacy Assessment Phase|Lost to Follow-up|13
4413475|NCT00280059|7193440|FG000|Efficacy Assessment Phase|Other|7
4413476|NCT00280059|7193441|FG001|Efficacy Assessment Phase|Other|8
4413477|NCT00280059|7193440|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26
4413478|NCT00280059|7193441|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25
4413479|NCT00280150|7193459|FG000|Overall Study|Adverse Event|0
4413480|NCT00280150|7193460|FG001|Overall Study|Adverse Event|1
4413481|NCT00280150|7193461|FG002|Overall Study|Adverse Event|2
4413482|NCT00280150|7193462|FG003|Overall Study|Adverse Event|3
4413483|NCT00280150|7193459|FG000|Overall Study|Lack of Efficacy|0
4413484|NCT00280150|7193460|FG001|Overall Study|Lack of Efficacy|0
4413485|NCT00280150|7193461|FG002|Overall Study|Lack of Efficacy|0
4413486|NCT00280150|7193462|FG003|Overall Study|Lack of Efficacy|3
4413487|NCT00280150|7193459|FG000|Overall Study|Physician Decision|0
4413488|NCT00280150|7193460|FG001|Overall Study|Physician Decision|0
4413489|NCT00280150|7193461|FG002|Overall Study|Physician Decision|0
4413490|NCT00280150|7193462|FG003|Overall Study|Physician Decision|1
4413491|NCT00280150|7193459|FG000|Overall Study|Protocol Violation|0
4413492|NCT00280150|7193460|FG001|Overall Study|Protocol Violation|0
4413493|NCT00280150|7193461|FG002|Overall Study|Protocol Violation|0
4413494|NCT00280150|7193462|FG003|Overall Study|Protocol Violation|1
4413495|NCT00280150|7193459|FG000|Overall Study|Withdrawal by Subject|0
4413496|NCT00280150|7193460|FG001|Overall Study|Withdrawal by Subject|0
4413497|NCT00280150|7193461|FG002|Overall Study|Withdrawal by Subject|0
4413498|NCT00280150|7193462|FG003|Overall Study|Withdrawal by Subject|1
4413499|NCT00280150|7193459|FG000|Overall Study|Did not get consolidation therapy|3
4413500|NCT00280150|7193460|FG001|Overall Study|Did not get consolidation therapy|0
4413501|NCT00280150|7193461|FG002|Overall Study|Did not get consolidation therapy|3
4413502|NCT00280150|7193462|FG003|Overall Study|Did not get consolidation therapy|0
4413503|NCT00280150|7193459|FG000|Overall Study|Declining Performance Status|0
4413504|NCT00280150|7193460|FG001|Overall Study|Declining Performance Status|0
4413505|NCT00280150|7193461|FG002|Overall Study|Declining Performance Status|0
4413506|NCT00280150|7193462|FG003|Overall Study|Declining Performance Status|1
4413507|NCT00280293|7193479|FG000|Overall Study|Protocol Violation|3
4413508|NCT00280293|7193480|FG001|Overall Study|Protocol Violation|0
4413509|NCT00280293|7193479|FG000|Overall Study|Physician Decision|5
4413510|NCT00280293|7193480|FG001|Overall Study|Physician Decision|4
4413511|NCT00280293|7193479|FG000|Overall Study|Lost to Follow-up|14
4413512|NCT00280293|7193480|FG001|Overall Study|Lost to Follow-up|12
4413513|NCT00280293|7193479|FG000|Overall Study|Withdrawal by Subject|3
4413514|NCT00280293|7193480|FG001|Overall Study|Withdrawal by Subject|5
4413515|NCT00280293|7193479|FG000|Overall Study|Incarceration/Legal Reasons|1
4413516|NCT00280293|7193480|FG001|Overall Study|Incarceration/Legal Reasons|1
4413517|NCT00280293|7193479|FG000|Overall Study|Adverse Event|0
4413518|NCT00280293|7193480|FG001|Overall Study|Adverse Event|1
4413519|NCT00280397|7193519|FG000|Overall Study|Adverse Event|1
4413520|NCT00280566|7193527|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31
4413521|NCT00280566|7193528|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0
4413522|NCT00280566|7193529|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0
4413523|NCT00280566|7193527|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3
4413524|NCT00280566|7193528|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0
4413525|NCT00280566|7193529|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0
4413526|NCT00280566|7193527|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148
4413527|NCT00280566|7193528|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0
4413528|NCT00280566|7193529|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0
4413529|NCT00280566|7193527|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35
4413530|NCT00280566|7193528|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0
4413531|NCT00280566|7193529|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0
4413532|NCT00280566|7193527|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76
4413533|NCT00280566|7193528|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0
4413534|NCT00280566|7193529|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0
4413535|NCT00280566|7193527|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50
4413536|NCT00280566|7193528|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0
4413537|NCT00280566|7193529|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0
4413538|NCT00280566|7193527|FG000|Period 2 Double Blind|Lack of Efficacy|0
4413539|NCT00280566|7193528|FG001|Period 2 Double Blind|Lack of Efficacy|9
4413540|NCT00280566|7193529|FG002|Period 2 Double Blind|Lack of Efficacy|22
4413541|NCT00280566|7193527|FG000|Period 2 Double Blind|Laboratory Abnormality|0
4413542|NCT00280566|7193528|FG001|Period 2 Double Blind|Laboratory Abnormality|1
4413543|NCT00280566|7193529|FG002|Period 2 Double Blind|Laboratory Abnormality|0
4413544|NCT00280566|7193527|FG000|Period 2 Double Blind|Adverse Event|0
4413545|NCT00280566|7193528|FG001|Period 2 Double Blind|Adverse Event|11
4413546|NCT00280566|7193529|FG002|Period 2 Double Blind|Adverse Event|15
4413547|NCT00280566|7193527|FG000|Period 2 Double Blind|Lost to Follow-up|0
4413548|NCT00280566|7193528|FG001|Period 2 Double Blind|Lost to Follow-up|3
4413549|NCT00280566|7193529|FG002|Period 2 Double Blind|Lost to Follow-up|6
4413550|NCT00280566|7193527|FG000|Period 2 Double Blind|Withdrawal by Subject|0
4413551|NCT00280566|7193528|FG001|Period 2 Double Blind|Withdrawal by Subject|9
4413552|NCT00280566|7193529|FG002|Period 2 Double Blind|Withdrawal by Subject|9
4413553|NCT00280566|7193527|FG000|Period 2 Double Blind|miscellaneous|0
4413554|NCT00280566|7193528|FG001|Period 2 Double Blind|miscellaneous|10
4413555|NCT00280566|7193529|FG002|Period 2 Double Blind|miscellaneous|5
4413556|NCT00280683|7193538|FG000|Overall Study|Withdrawal by Subject|1
4413557|NCT00280683|7193539|FG001|Overall Study|Withdrawal by Subject|2
4413558|NCT00280683|7193538|FG000|Overall Study|Adverse Event|1
4413559|NCT00280683|7193539|FG001|Overall Study|Adverse Event|1
4413560|NCT00280735|7193547|FG000|Overall Study|Adverse Event|5
4413561|NCT00280735|7193547|FG000|Overall Study|Lack of Efficacy|3
4413562|NCT00280735|7193547|FG000|Overall Study|Withdrawal by Subject|8
4413563|NCT00280735|7193547|FG000|Overall Study|Intercurrent Illness|2
4413564|NCT00280748|7193555|FG000|Overall Study|Decline in performance|3
4413565|NCT00280748|7193555|FG000|Overall Study|Extra-cranial disease progression|1
4413566|NCT00280917|7193572|FG000|Overall Study|Adverse Event|1
4413567|NCT00280917|7193573|FG001|Overall Study|Adverse Event|1
4413568|NCT00280917|7193574|FG002|Overall Study|Adverse Event|4
4413569|NCT00280917|7193575|FG003|Overall Study|Adverse Event|1
4413570|NCT00280917|7193572|FG000|Overall Study|Change Therapy|1
4413571|NCT00280917|7193573|FG001|Overall Study|Change Therapy|2
4413572|NCT00280917|7193574|FG002|Overall Study|Change Therapy|0
4413573|NCT00280917|7193575|FG003|Overall Study|Change Therapy|0
4413574|NCT00280917|7193572|FG000|Overall Study|Withdrawal by Subject|0
4413575|NCT00280917|7193573|FG001|Overall Study|Withdrawal by Subject|2
4413576|NCT00280917|7193574|FG002|Overall Study|Withdrawal by Subject|0
4413577|NCT00280917|7193575|FG003|Overall Study|Withdrawal by Subject|1
4413578|NCT00280917|7193572|FG000|Overall Study|Noncompliance|0
4413579|NCT00280917|7193573|FG001|Overall Study|Noncompliance|1
4413580|NCT00280917|7193574|FG002|Overall Study|Noncompliance|2
4413581|NCT00280917|7193575|FG003|Overall Study|Noncompliance|0
4413582|NCT00281099|7193591|FG000|Overall Study|Death|46
4413583|NCT00281099|7193592|FG001|Overall Study|Death|57
4413584|NCT00281099|7193591|FG000|Overall Study|Lost to Follow-up|10
4413585|NCT00281099|7193592|FG001|Overall Study|Lost to Follow-up|19
4413586|NCT00281099|7193591|FG000|Overall Study|Withdrawal by Subject|65
4413587|NCT00281099|7193592|FG001|Overall Study|Withdrawal by Subject|70
4413588|NCT00281099|7193591|FG000|Overall Study|Physician Decision|79
4413589|NCT00281099|7193592|FG001|Overall Study|Physician Decision|72
4413590|NCT00281099|7193591|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5
4413591|NCT00281099|7193592|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4
4413592|NCT00281528|7193606|FG000|Overall Study|Progressive Disease|28
4413593|NCT00281528|7193607|FG001|Overall Study|Progressive Disease|18
4413594|NCT00281528|7193608|FG002|Overall Study|Progressive Disease|27
4413595|NCT00281528|7193606|FG000|Overall Study|Unacceptable Toxicity-related to trt|21
4413596|NCT00281528|7193607|FG001|Overall Study|Unacceptable Toxicity-related to trt|24
4413597|NCT00281528|7193608|FG002|Overall Study|Unacceptable Toxicity-related to trt|32
4413598|NCT00281528|7193606|FG000|Overall Study|Adverse Event-unrelated to treatment|3
4518729|NCT00975884|7330974|FG001|Overall Study|Other|3
4413599|NCT00281528|7193607|FG001|Overall Study|Adverse Event-unrelated to treatment|0
4413600|NCT00281528|7193608|FG002|Overall Study|Adverse Event-unrelated to treatment|2
4413601|NCT00281528|7193606|FG000|Overall Study|Physician Decision|11
4413602|NCT00281528|7193607|FG001|Overall Study|Physician Decision|4
4413603|NCT00281528|7193608|FG002|Overall Study|Physician Decision|5
4413604|NCT00281528|7193606|FG000|Overall Study|Protocol Violation|1
4413605|NCT00281528|7193607|FG001|Overall Study|Protocol Violation|0
4413606|NCT00281528|7193608|FG002|Overall Study|Protocol Violation|1
4413607|NCT00281528|7193606|FG000|Overall Study|Withdrawal by Subject|5
4413608|NCT00281528|7193607|FG001|Overall Study|Withdrawal by Subject|5
4413609|NCT00281528|7193608|FG002|Overall Study|Withdrawal by Subject|7
4413610|NCT00281528|7193606|FG000|Overall Study|Other|6
4413611|NCT00281528|7193607|FG001|Overall Study|Other|3
4413612|NCT00281528|7193608|FG002|Overall Study|Other|5
4413613|NCT00281580|7193632|FG000|Overall Study|Adverse Event|2
4413614|NCT00281580|7193633|FG001|Overall Study|Adverse Event|0
4413615|NCT00281580|7193634|FG002|Overall Study|Adverse Event|2
4413616|NCT00281580|7193635|FG003|Overall Study|Adverse Event|4
4413617|NCT00281580|7193636|FG004|Overall Study|Adverse Event|1
4413618|NCT00281580|7193637|FG005|Overall Study|Adverse Event|0
4413619|NCT00281580|7193638|FG006|Overall Study|Adverse Event|1
4413620|NCT00281580|7193639|FG007|Overall Study|Adverse Event|0
4413621|NCT00281580|7193640|FG008|Overall Study|Adverse Event|1
4413622|NCT00281580|7193641|FG009|Overall Study|Adverse Event|6
4413623|NCT00281580|7193642|FG010|Overall Study|Adverse Event|0
4413624|NCT00281580|7193643|FG011|Overall Study|Adverse Event|5
4413625|NCT00281580|7193644|FG012|Overall Study|Adverse Event|8
4413626|NCT00281580|7193645|FG013|Overall Study|Adverse Event|2
4413627|NCT00281580|7193646|FG014|Overall Study|Adverse Event|3
4413628|NCT00281580|7193647|FG015|Overall Study|Adverse Event|3
4413629|NCT00281580|7193632|FG000|Overall Study|Protocol Violation|0
4413630|NCT00281580|7193633|FG001|Overall Study|Protocol Violation|0
4413631|NCT00281580|7193634|FG002|Overall Study|Protocol Violation|1
4413632|NCT00281580|7193635|FG003|Overall Study|Protocol Violation|1
4413633|NCT00281580|7193636|FG004|Overall Study|Protocol Violation|0
4413634|NCT00281580|7193637|FG005|Overall Study|Protocol Violation|0
4413635|NCT00281580|7193638|FG006|Overall Study|Protocol Violation|1
4413636|NCT00281580|7193639|FG007|Overall Study|Protocol Violation|0
4413637|NCT00281580|7193640|FG008|Overall Study|Protocol Violation|2
4413638|NCT00281580|7193641|FG009|Overall Study|Protocol Violation|0
4413639|NCT00281580|7193642|FG010|Overall Study|Protocol Violation|1
4413640|NCT00281580|7193643|FG011|Overall Study|Protocol Violation|2
4413641|NCT00281580|7193644|FG012|Overall Study|Protocol Violation|0
4413642|NCT00281580|7193645|FG013|Overall Study|Protocol Violation|1
4413643|NCT00281580|7193646|FG014|Overall Study|Protocol Violation|1
4413644|NCT00281580|7193647|FG015|Overall Study|Protocol Violation|3
4413645|NCT00281580|7193632|FG000|Overall Study|Withdrawal by Subject|3
4413646|NCT00281580|7193633|FG001|Overall Study|Withdrawal by Subject|0
4413647|NCT00281580|7193634|FG002|Overall Study|Withdrawal by Subject|1
4413648|NCT00281580|7193635|FG003|Overall Study|Withdrawal by Subject|1
4413649|NCT00281580|7193636|FG004|Overall Study|Withdrawal by Subject|1
4413650|NCT00281580|7193637|FG005|Overall Study|Withdrawal by Subject|2
4413651|NCT00281580|7193638|FG006|Overall Study|Withdrawal by Subject|2
4413652|NCT00281580|7193639|FG007|Overall Study|Withdrawal by Subject|0
4413653|NCT00281580|7193640|FG008|Overall Study|Withdrawal by Subject|1
4413654|NCT00281580|7193641|FG009|Overall Study|Withdrawal by Subject|4
4413655|NCT00281580|7193642|FG010|Overall Study|Withdrawal by Subject|1
4413656|NCT00281580|7193643|FG011|Overall Study|Withdrawal by Subject|1
4413657|NCT00281580|7193644|FG012|Overall Study|Withdrawal by Subject|2
4413658|NCT00281580|7193645|FG013|Overall Study|Withdrawal by Subject|2
4413659|NCT00281580|7193646|FG014|Overall Study|Withdrawal by Subject|1
4413660|NCT00281580|7193647|FG015|Overall Study|Withdrawal by Subject|5
4413661|NCT00281580|7193632|FG000|Overall Study|Lack of Efficacy|2
4413662|NCT00281580|7193633|FG001|Overall Study|Lack of Efficacy|1
4413663|NCT00281580|7193634|FG002|Overall Study|Lack of Efficacy|1
4413664|NCT00281580|7193635|FG003|Overall Study|Lack of Efficacy|6
4413665|NCT00281580|7193636|FG004|Overall Study|Lack of Efficacy|2
4413666|NCT00281580|7193637|FG005|Overall Study|Lack of Efficacy|0
4413667|NCT00281580|7193638|FG006|Overall Study|Lack of Efficacy|0
4413668|NCT00281580|7193639|FG007|Overall Study|Lack of Efficacy|0
4413669|NCT00281580|7193640|FG008|Overall Study|Lack of Efficacy|0
4413670|NCT00281580|7193641|FG009|Overall Study|Lack of Efficacy|0
4413671|NCT00281580|7193642|FG010|Overall Study|Lack of Efficacy|0
4413672|NCT00281580|7193643|FG011|Overall Study|Lack of Efficacy|1
4413673|NCT00281580|7193644|FG012|Overall Study|Lack of Efficacy|0
4413674|NCT00281580|7193645|FG013|Overall Study|Lack of Efficacy|2
4413675|NCT00281580|7193646|FG014|Overall Study|Lack of Efficacy|1
4413676|NCT00281580|7193647|FG015|Overall Study|Lack of Efficacy|0
4413677|NCT00281580|7193632|FG000|Overall Study|Lost to Follow-up|0
4413678|NCT00281580|7193633|FG001|Overall Study|Lost to Follow-up|0
4413679|NCT00281580|7193634|FG002|Overall Study|Lost to Follow-up|0
4413680|NCT00281580|7193635|FG003|Overall Study|Lost to Follow-up|3
4413681|NCT00281580|7193636|FG004|Overall Study|Lost to Follow-up|0
4413682|NCT00281580|7193637|FG005|Overall Study|Lost to Follow-up|1
4413683|NCT00281580|7193638|FG006|Overall Study|Lost to Follow-up|0
4413684|NCT00281580|7193639|FG007|Overall Study|Lost to Follow-up|1
4413685|NCT00281580|7193640|FG008|Overall Study|Lost to Follow-up|2
4413686|NCT00281580|7193641|FG009|Overall Study|Lost to Follow-up|1
4413687|NCT00281580|7193642|FG010|Overall Study|Lost to Follow-up|1
4413688|NCT00281580|7193643|FG011|Overall Study|Lost to Follow-up|0
4413689|NCT00281580|7193644|FG012|Overall Study|Lost to Follow-up|1
4413690|NCT00281580|7193645|FG013|Overall Study|Lost to Follow-up|0
4413691|NCT00281580|7193646|FG014|Overall Study|Lost to Follow-up|0
4413692|NCT00281580|7193647|FG015|Overall Study|Lost to Follow-up|0
4413693|NCT00281580|7193632|FG000|Overall Study|Randomised in error; pregnancy; moving|0
4413694|NCT00281580|7193633|FG001|Overall Study|Randomised in error; pregnancy; moving|0
4413695|NCT00281580|7193634|FG002|Overall Study|Randomised in error; pregnancy; moving|0
4413696|NCT00281580|7193635|FG003|Overall Study|Randomised in error; pregnancy; moving|2
4413697|NCT00281580|7193636|FG004|Overall Study|Randomised in error; pregnancy; moving|0
4413698|NCT00281580|7193637|FG005|Overall Study|Randomised in error; pregnancy; moving|0
4413699|NCT00281580|7193638|FG006|Overall Study|Randomised in error; pregnancy; moving|1
4413700|NCT00281580|7193639|FG007|Overall Study|Randomised in error; pregnancy; moving|0
4413701|NCT00281580|7193640|FG008|Overall Study|Randomised in error; pregnancy; moving|2
4413702|NCT00281580|7193641|FG009|Overall Study|Randomised in error; pregnancy; moving|1
4413703|NCT00281580|7193642|FG010|Overall Study|Randomised in error; pregnancy; moving|1
4413704|NCT00281580|7193643|FG011|Overall Study|Randomised in error; pregnancy; moving|1
4413705|NCT00281580|7193644|FG012|Overall Study|Randomised in error; pregnancy; moving|2
4413706|NCT00281580|7193645|FG013|Overall Study|Randomised in error; pregnancy; moving|0
4413707|NCT00281580|7193646|FG014|Overall Study|Randomised in error; pregnancy; moving|1
4413708|NCT00281580|7193647|FG015|Overall Study|Randomised in error; pregnancy; moving|2
4413709|NCT00281632|7193716|FG000|Overall Study|Adverse Event|7
4413710|NCT00281632|7193716|FG000|Overall Study|Withdrawal by Subject|2
4413711|NCT00281632|7193716|FG000|Overall Study|Disease Progression|22
4413712|NCT00281632|7193716|FG000|Overall Study|Death|1
4413713|NCT00281632|7193716|FG000|Overall Study|Physician Decision|1
4413714|NCT00281632|7193716|FG000|Overall Study|Ongoing|3
4413715|NCT00281684|7193742|FG000|Overall Study|Lost to Follow-up|0
4413716|NCT00281684|7193743|FG001|Overall Study|Lost to Follow-up|0
4413717|NCT00281684|7193744|FG002|Overall Study|Lost to Follow-up|1
4413718|NCT00281684|7193745|FG003|Overall Study|Lost to Follow-up|0
4413719|NCT00281684|7193742|FG000|Overall Study|Withdrawal by Subject|1
4413720|NCT00281684|7193743|FG001|Overall Study|Withdrawal by Subject|0
4413721|NCT00281684|7193744|FG002|Overall Study|Withdrawal by Subject|0
4413722|NCT00281684|7193745|FG003|Overall Study|Withdrawal by Subject|0
4413723|NCT00281697|7193759|FG000|Overall Study|> 60 days since last dose of study drug|4
4413724|NCT00281697|7193760|FG001|Overall Study|> 60 days since last dose of study drug|4
4413725|NCT00281697|7193759|FG000|Overall Study|Adverse Event|54
4413726|NCT00281697|7193760|FG001|Overall Study|Adverse Event|15
4413727|NCT00281697|7193759|FG000|Overall Study|Death|8
4413728|NCT00281697|7193760|FG001|Overall Study|Death|3
4413729|NCT00281697|7193759|FG000|Overall Study|Disease progression|279
4413730|NCT00281697|7193760|FG001|Overall Study|Disease progression|149
4413731|NCT00281697|7193759|FG000|Overall Study|Other|5
4629320|NCT01870999|7497191|FG002|Overall Study|Subject withdrawn by Investigator|0
4629321|NCT01870999|7497189|FG000|Overall Study|Withdrawal by Subject|0
4629322|NCT01870999|7497190|FG001|Overall Study|Withdrawal by Subject|2
4413732|NCT00281697|7193760|FG001|Overall Study|Other|6
4413733|NCT00281697|7193759|FG000|Overall Study|Physician's decision to withdraw|15
4413734|NCT00281697|7193760|FG001|Overall Study|Physician's decision to withdraw|12
4413735|NCT00281697|7193759|FG000|Overall Study|Subject/guardian's decision to withdraw|33
4413736|NCT00281697|7193760|FG001|Overall Study|Subject/guardian's decision to withdraw|6
4413737|NCT00281697|7193759|FG000|Overall Study|Did not receive study drug|3
4413738|NCT00281697|7193760|FG001|Overall Study|Did not receive study drug|2
4413739|NCT00281840|7193772|FG000|Overall Study|Adverse Event|12
4413740|NCT00281840|7193772|FG000|Overall Study|Physician Decision|6
4413741|NCT00281840|7193772|FG000|Overall Study|Withdrawal by Subject|3
4413742|NCT00281840|7193772|FG000|Overall Study|Disease Progression|2
4413743|NCT00281840|7193772|FG000|Overall Study|exceed maximum delay in treatment|1
4413744|NCT00281840|7193772|FG000|Overall Study|Complicating Disease|1
4413745|NCT00281957|7193788|FG000|Overall Study|Adverse Event|7
4413746|NCT00281957|7193789|FG001|Overall Study|Adverse Event|2
4413747|NCT00281957|7193788|FG000|Overall Study|Death|1
4413748|NCT00281957|7193789|FG001|Overall Study|Death|0
4413749|NCT00281957|7193788|FG000|Overall Study|Progression/relapse|47
4413750|NCT00281957|7193789|FG001|Overall Study|Progression/relapse|35
4413751|NCT00281957|7193788|FG000|Overall Study|Not protocol specified|8
4413752|NCT00281957|7193789|FG001|Overall Study|Not protocol specified|1
4413753|NCT00281957|7193788|FG000|Overall Study|Not eligible|1
4413754|NCT00281957|7193789|FG001|Overall Study|Not eligible|2
4413755|NCT00281957|7193788|FG000|Overall Study|Did not start treatment|3
4413756|NCT00281957|7193789|FG001|Overall Study|Did not start treatment|1
4413757|NCT00281957|7193788|FG000|Overall Study|Refusal unrelated to adverse events|0
4413758|NCT00281957|7193789|FG001|Overall Study|Refusal unrelated to adverse events|1
4413759|NCT00282048|7193797|FG000|Overall Study|Lack of Efficacy|30
4413760|NCT00282048|7193797|FG000|Overall Study|Adverse Event|22
4629323|NCT01870999|7497191|FG002|Overall Study|Withdrawal by Subject|5
4714862|NCT02963506|7642888|FG007|Dose-Blind Period|Withdrawal by Subject|2
4413761|NCT00282048|7193797|FG000|Overall Study|Withdrawal by Subject|1
4413762|NCT00282048|7193797|FG000|Overall Study|Other|8
4413763|NCT00282048|7193797|FG000|Overall Study|Ongoing|1
4413764|NCT00282087|7193801|FG000|Overall Study|Death|1
4413765|NCT00282113|7193809|FG000|Overall Study|Removed at parents request|1
4413766|NCT00282113|7193810|FG001|Overall Study|Removed at parents request|0
4413767|NCT00282113|7193811|FG002|Overall Study|Removed at parents request|0
4413768|NCT00282152|7193821|FG000|Overall Study|Withdrawal by Subject|1
4413769|NCT00282152|7193822|FG001|Overall Study|Withdrawal by Subject|0
4413770|NCT00282243|7193829|FG000|Pharmacokinetic Treatment Period|Adverse Event|3
4413771|NCT00282243|7193829|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2
4413772|NCT00282243|7193829|FG000|Extension Treatment Period|Adverse Event|15
4413773|NCT00282243|7193829|FG000|Extension Treatment Period|Withdrawal by Subject|4
4413774|NCT00282243|7193829|FG000|Extension Treatment Period|Non-compliance|2
4413775|NCT00282243|7193829|FG000|Extension Treatment Period|Physician Decision|1
4413776|NCT00282256|7193833|FG000|Pharmacokinetic Treatment Period|Poor venous access|1
4413777|NCT00282256|7193833|FG000|Extension Treatment Period|Adverse Event|2
4413778|NCT00282295|7193845|FG000|Overall Study|Adverse Event|0
4413779|NCT00282295|7193846|FG001|Overall Study|Adverse Event|1
4413780|NCT00282295|7193847|FG002|Overall Study|Adverse Event|0
4413781|NCT00282295|7193845|FG000|Overall Study|Serious Adverse Events|0
4413782|NCT00282295|7193846|FG001|Overall Study|Serious Adverse Events|0
4413783|NCT00282295|7193847|FG002|Overall Study|Serious Adverse Events|1
4413784|NCT00282295|7193845|FG000|Overall Study|Protocol Violation|0
4413785|NCT00282295|7193846|FG001|Overall Study|Protocol Violation|2
4413786|NCT00282295|7193847|FG002|Overall Study|Protocol Violation|1
4413787|NCT00282295|7193845|FG000|Overall Study|Withdrawal by Subject|2
4413788|NCT00282295|7193846|FG001|Overall Study|Withdrawal by Subject|6
4413789|NCT00282295|7193847|FG002|Overall Study|Withdrawal by Subject|4
4413790|NCT00282295|7193845|FG000|Overall Study|Lost to Follow-up|1
4413791|NCT00282295|7193846|FG001|Overall Study|Lost to Follow-up|7
4413792|NCT00282295|7193847|FG002|Overall Study|Lost to Follow-up|2
4413793|NCT00282295|7193845|FG000|Overall Study|Other|0
4413794|NCT00282295|7193846|FG001|Overall Study|Other|1
4413795|NCT00282295|7193847|FG002|Overall Study|Other|0
4413796|NCT00282308|7193862|FG000|Treatment Period|Lost to Follow-up|1
4413797|NCT00282308|7193863|FG001|Treatment Period|Lost to Follow-up|0
4413798|NCT00282308|7193864|FG002|Treatment Period|Lost to Follow-up|0
4413799|NCT00282308|7193862|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2
4413800|NCT00282308|7193863|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4
4413801|NCT00282308|7193864|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0
4413802|NCT00282308|7193862|FG000|Treatment Period|Adverse Event|0
4413803|NCT00282308|7193863|FG001|Treatment Period|Adverse Event|2
4413804|NCT00282308|7193864|FG002|Treatment Period|Adverse Event|0
4413805|NCT00282308|7193862|FG000|Treatment Period|Not Treated with Study Drug|1
4413806|NCT00282308|7193863|FG001|Treatment Period|Not Treated with Study Drug|0
4413807|NCT00282308|7193864|FG002|Treatment Period|Not Treated with Study Drug|0
4413808|NCT00282308|7193862|FG000|Optional Extension Re-treatment Period|Adverse Event|0
4413809|NCT00282308|7193863|FG001|Optional Extension Re-treatment Period|Adverse Event|0
4413810|NCT00282308|7193864|FG002|Optional Extension Re-treatment Period|Adverse Event|4
4413811|NCT00282308|7193862|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0
4413812|NCT00282308|7193863|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0
4413813|NCT00282308|7193864|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1
4413814|NCT00282308|7193862|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0
4413815|NCT00282308|7193863|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0
4413816|NCT00282308|7193864|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1
4413817|NCT00282308|7193862|FG000|Safety Follow-up Period|Adverse Event|0
4413818|NCT00282308|7193863|FG001|Safety Follow-up Period|Adverse Event|0
4413819|NCT00282308|7193864|FG002|Safety Follow-up Period|Adverse Event|1
4413820|NCT00282308|7193862|FG000|Safety Follow-up Period|Lost to Follow-up|0
4413821|NCT00282308|7193863|FG001|Safety Follow-up Period|Lost to Follow-up|0
4413822|NCT00282308|7193864|FG002|Safety Follow-up Period|Lost to Follow-up|5
4413823|NCT00282308|7193862|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0
4413824|NCT00282308|7193863|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0
4413825|NCT00282308|7193864|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1
4413826|NCT00282308|7193862|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0
4413827|NCT00282308|7193863|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0
4413828|NCT00282308|7193864|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12
4413829|NCT00282334|7193876|FG000|Overall Study|Withdrawal by Subject|8
4413830|NCT00282334|7193877|FG001|Overall Study|Withdrawal by Subject|5
4413831|NCT00282347|7193885|FG000|Treatment Period|Death|2
4413832|NCT00282347|7193886|FG001|Treatment Period|Death|0
4413833|NCT00282347|7193885|FG000|Treatment Period|Lost to Follow-up|2
4413834|NCT00282347|7193886|FG001|Treatment Period|Lost to Follow-up|5
4413835|NCT00282347|7193885|FG000|Treatment Period|Withdrawal by Subject|1
4413836|NCT00282347|7193886|FG001|Treatment Period|Withdrawal by Subject|3
4413837|NCT00282347|7193885|FG000|Treatment Period|Physician Decision|0
4413838|NCT00282347|7193886|FG001|Treatment Period|Physician Decision|1
4413839|NCT00282347|7193885|FG000|Safety Follow-up Period|Lost to Follow-up|0
4413840|NCT00282347|7193886|FG001|Safety Follow-up Period|Lost to Follow-up|2
4413841|NCT00282347|7193885|FG000|Safety Follow-up Period|Withdrawal by Subject|2
4413842|NCT00282347|7193886|FG001|Safety Follow-up Period|Withdrawal by Subject|1
4413843|NCT00282347|7193885|FG000|Safety Follow-up Period|Physician Decision|1
4413844|NCT00282347|7193886|FG001|Safety Follow-up Period|Physician Decision|1
4413845|NCT00282347|7193885|FG000|Safety Follow-up Period|Protocol Deviation|0
4413846|NCT00282347|7193886|FG001|Safety Follow-up Period|Protocol Deviation|2
4413847|NCT00282347|7193885|FG000|B Cell Follow-up Period|Withdrawal by Subject|2
4413848|NCT00282347|7193886|FG001|B Cell Follow-up Period|Withdrawal by Subject|0
4413849|NCT00282347|7193885|FG000|B Cell Follow-up Period|Physician Decision|1
4413850|NCT00282347|7193886|FG001|B Cell Follow-up Period|Physician Decision|0
4413851|NCT00282347|7193885|FG000|B Cell Follow-up Period|Reason Not Specified|2
4413852|NCT00282347|7193886|FG001|B Cell Follow-up Period|Reason Not Specified|0
4413853|NCT00282412|7193894|FG000|Overall Study|Death|2
4413854|NCT00282438|7193900|FG000|Overall Study|Lack of Efficacy|1
4413855|NCT00282438|7193901|FG001|Overall Study|Lack of Efficacy|0
4413856|NCT00282438|7193900|FG000|Overall Study|Death|0
4413857|NCT00282438|7193901|FG001|Overall Study|Death|1
4413858|NCT00282464|7193909|FG000|Overall Study|Adverse Event|26
4413859|NCT00282464|7193910|FG001|Overall Study|Adverse Event|20
4413860|NCT00282464|7193909|FG000|Overall Study|Lack of Efficacy|8
4413861|NCT00282464|7193910|FG001|Overall Study|Lack of Efficacy|8
4413862|NCT00282464|7193909|FG000|Overall Study|Lost to Follow-up|10
4413863|NCT00282464|7193910|FG001|Overall Study|Lost to Follow-up|10
4413864|NCT00282464|7193909|FG000|Overall Study|Withdrawal by Subject|24
4413865|NCT00282464|7193910|FG001|Overall Study|Withdrawal by Subject|10
4413866|NCT00282464|7193909|FG000|Overall Study|laboratory abnormality|1
4413867|NCT00282464|7193910|FG001|Overall Study|laboratory abnormality|2
4413868|NCT00282464|7193909|FG000|Overall Study|Protocol Violation|0
4413869|NCT00282464|7193910|FG001|Overall Study|Protocol Violation|7
4413870|NCT00282464|7193909|FG000|Overall Study|Patient moved|1
4413871|NCT00282464|7193910|FG001|Overall Study|Patient moved|0
4413872|NCT00282464|7193909|FG000|Overall Study|patient non-compliant|3
4413873|NCT00282464|7193910|FG001|Overall Study|patient non-compliant|0
4413874|NCT00282464|7193909|FG000|Overall Study|patient no show|0
4413875|NCT00282464|7193910|FG001|Overall Study|patient no show|1
4413876|NCT00282464|7193909|FG000|Overall Study|patient incarcerated|0
4413877|NCT00282464|7193910|FG001|Overall Study|patient incarcerated|1
4413878|NCT00282464|7193909|FG000|Overall Study|family crisis|0
4413879|NCT00282464|7193910|FG001|Overall Study|family crisis|1
4413880|NCT00282464|7193909|FG000|Overall Study|dispensed wrong kit|0
4413881|NCT00282464|7193910|FG001|Overall Study|dispensed wrong kit|1
4413882|NCT00282464|7193909|FG000|Overall Study|dropped due to missed visits|0
4413883|NCT00282464|7193910|FG001|Overall Study|dropped due to missed visits|1
4413884|NCT00282568|7193916|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2
4413885|NCT00282568|7193916|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1
4413886|NCT00282568|7193916|FG000|Extended Treatment Period|Adverse Event|17
4413887|NCT00282568|7193916|FG000|Extended Treatment Period|Non-compliance|4
4413888|NCT00282568|7193916|FG000|Extended Treatment Period|Physician Decision|1
4413889|NCT00282568|7193916|FG000|Extended Treatment Period|Lost to Follow-up|2
4413890|NCT00282919|7193991|FG000|Overall Study|Lack of Efficacy|4
4413891|NCT00282919|7193991|FG000|Overall Study|Withdrawal by Subject|1
4413892|NCT00282919|7193991|FG000|Overall Study|Asymptomatic Parasitemia|2
4413893|NCT00282984|7194006|FG000|Overall Study|Death|2
4413894|NCT00282984|7194007|FG001|Overall Study|Death|5
4413895|NCT00282984|7194006|FG000|Overall Study|Adverse Event|8
4413896|NCT00282984|7194007|FG001|Overall Study|Adverse Event|5
4413897|NCT00282984|7194006|FG000|Overall Study|Lack of Efficacy|0
4413898|NCT00282984|7194007|FG001|Overall Study|Lack of Efficacy|2
4413899|NCT00282984|7194006|FG000|Overall Study|Lost to Follow-up|14
4413900|NCT00282984|7194007|FG001|Overall Study|Lost to Follow-up|10
4413901|NCT00282984|7194006|FG000|Overall Study|Withdrawal by Participant|22
4413902|NCT00282984|7194007|FG001|Overall Study|Withdrawal by Participant|34
4413903|NCT00282984|7194006|FG000|Overall Study|Participant stopped study medication|2
4413904|NCT00282984|7194007|FG001|Overall Study|Participant stopped study medication|2
4413905|NCT00282984|7194006|FG000|Overall Study|Participant only allowed phone follow-up|0
4413906|NCT00282984|7194007|FG001|Overall Study|Participant only allowed phone follow-up|1
4413907|NCT00282984|7194006|FG000|Overall Study|Participant used antipsychosis meds|0
4413908|NCT00282984|7194007|FG001|Overall Study|Participant used antipsychosis meds|1
4413909|NCT00282984|7194006|FG000|Overall Study|lack of motivation|1
4413910|NCT00282984|7194007|FG001|Overall Study|lack of motivation|0
4413911|NCT00282984|7194006|FG000|Overall Study|in prison|0
4413912|NCT00282984|7194007|FG001|Overall Study|in prison|1
4413913|NCT00282984|7194006|FG000|Overall Study|Protocol Violation|2
4413914|NCT00282984|7194007|FG001|Overall Study|Protocol Violation|0
4413915|NCT00283049|7194016|FG000|Overall Study|Adverse Event|6
4413916|NCT00283049|7194017|FG001|Overall Study|Adverse Event|1
4413917|NCT00283049|7194018|FG002|Overall Study|Adverse Event|4
4413918|NCT00283049|7194016|FG000|Overall Study|Protocol Violation|3
4413919|NCT00283049|7194017|FG001|Overall Study|Protocol Violation|0
4413920|NCT00283049|7194018|FG002|Overall Study|Protocol Violation|3
4413921|NCT00283049|7194016|FG000|Overall Study|Death|1
4413922|NCT00283049|7194017|FG001|Overall Study|Death|1
4413923|NCT00283049|7194018|FG002|Overall Study|Death|1
4413924|NCT00283049|7194016|FG000|Overall Study|Lack of Efficacy|0
4413925|NCT00283049|7194017|FG001|Overall Study|Lack of Efficacy|1
4413926|NCT00283049|7194018|FG002|Overall Study|Lack of Efficacy|1
4413927|NCT00283049|7194016|FG000|Overall Study|Lost to Follow-up|4
4413928|NCT00283049|7194017|FG001|Overall Study|Lost to Follow-up|2
4413929|NCT00283049|7194018|FG002|Overall Study|Lost to Follow-up|5
4413930|NCT00283049|7194016|FG000|Overall Study|Withdrawal by Subject|26
4413931|NCT00283049|7194017|FG001|Overall Study|Withdrawal by Subject|24
4413932|NCT00283049|7194018|FG002|Overall Study|Withdrawal by Subject|19
4413933|NCT00283049|7194016|FG000|Overall Study|Discontinuation of Study|18
4413934|NCT00283049|7194017|FG001|Overall Study|Discontinuation of Study|16
4413935|NCT00283049|7194018|FG002|Overall Study|Discontinuation of Study|20
4413936|NCT00283049|7194016|FG000|Overall Study|No longer requires study treatment|0
4413937|NCT00283049|7194017|FG001|Overall Study|No longer requires study treatment|0
4413938|NCT00283049|7194018|FG002|Overall Study|No longer requires study treatment|1
4413939|NCT00283062|7194030|FG000|Overall Study|Did not receive any study medication|5
4413940|NCT00283062|7194031|FG001|Overall Study|Did not receive any study medication|4
4413941|NCT00283062|7194032|FG002|Overall Study|Did not receive any study medication|36
4413942|NCT00283062|7194033|FG003|Overall Study|Did not receive any study medication|45
4413943|NCT00283062|7194030|FG000|Overall Study|Adverse Event|2
4413944|NCT00283062|7194031|FG001|Overall Study|Adverse Event|0
4413945|NCT00283062|7194032|FG002|Overall Study|Adverse Event|1
4413946|NCT00283062|7194033|FG003|Overall Study|Adverse Event|0
4413947|NCT00283062|7194030|FG000|Overall Study|Lost to Follow-up|1
4413948|NCT00283062|7194031|FG001|Overall Study|Lost to Follow-up|0
4413949|NCT00283062|7194032|FG002|Overall Study|Lost to Follow-up|1
4413950|NCT00283062|7194033|FG003|Overall Study|Lost to Follow-up|0
4413951|NCT00283062|7194030|FG000|Overall Study|Progressive disease|0
4413952|NCT00283062|7194031|FG001|Overall Study|Progressive disease|0
4629324|NCT01870999|7497189|FG000|Overall Study|Protocol Violation|0
4629325|NCT01870999|7497190|FG001|Overall Study|Protocol Violation|0
4629326|NCT01870999|7497191|FG002|Overall Study|Protocol Violation|1
4413953|NCT00283062|7194032|FG002|Overall Study|Progressive disease|1
4413954|NCT00283062|7194033|FG003|Overall Study|Progressive disease|0
4413955|NCT00283062|7194030|FG000|Overall Study|Participant did not wish to continue|3
4413956|NCT00283062|7194031|FG001|Overall Study|Participant did not wish to continue|2
4413957|NCT00283062|7194032|FG002|Overall Study|Participant did not wish to continue|1
4413958|NCT00283062|7194033|FG003|Overall Study|Participant did not wish to continue|0
4413959|NCT00283062|7194030|FG000|Overall Study|Undefined|0
4413960|NCT00283062|7194031|FG001|Overall Study|Undefined|1
4413961|NCT00283062|7194032|FG002|Overall Study|Undefined|1
4413962|NCT00283062|7194033|FG003|Overall Study|Undefined|4
4413963|NCT00283062|7194030|FG000|Overall Study|chemotherapy not completed (cycle 6)|1
4413964|NCT00283062|7194031|FG001|Overall Study|chemotherapy not completed (cycle 6)|0
4413965|NCT00283062|7194032|FG002|Overall Study|chemotherapy not completed (cycle 6)|0
4413966|NCT00283062|7194033|FG003|Overall Study|chemotherapy not completed (cycle 6)|0
4413967|NCT00283244|7194058|FG000|Overall Study|Adverse Event|0
4413968|NCT00283244|7194059|FG001|Overall Study|Adverse Event|8
4413969|NCT00283244|7194060|FG002|Overall Study|Adverse Event|11
4413970|NCT00283244|7194058|FG000|Overall Study|Death|4
4413971|NCT00283244|7194059|FG001|Overall Study|Death|3
4413972|NCT00283244|7194060|FG002|Overall Study|Death|2
4413973|NCT00283244|7194058|FG000|Overall Study|Lack of Efficacy|8
4413974|NCT00283244|7194059|FG001|Overall Study|Lack of Efficacy|32
4413975|NCT00283244|7194060|FG002|Overall Study|Lack of Efficacy|26
4413976|NCT00283244|7194058|FG000|Overall Study|Withdrawal by Subject|1
4413977|NCT00283244|7194059|FG001|Overall Study|Withdrawal by Subject|2
4413978|NCT00283244|7194060|FG002|Overall Study|Withdrawal by Subject|2
4413979|NCT00283244|7194058|FG000|Overall Study|Physician Decision|0
4413980|NCT00283244|7194059|FG001|Overall Study|Physician Decision|0
4413981|NCT00283244|7194060|FG002|Overall Study|Physician Decision|1
4413982|NCT00283244|7194058|FG000|Overall Study|Medical illness (other complicating dz)|4
4413983|NCT00283244|7194059|FG001|Overall Study|Medical illness (other complicating dz)|3
4413984|NCT00283244|7194060|FG002|Overall Study|Medical illness (other complicating dz)|6
4413985|NCT00283244|7194058|FG000|Overall Study|Clinical deterioration|1
4413986|NCT00283244|7194059|FG001|Overall Study|Clinical deterioration|3
4413987|NCT00283244|7194060|FG002|Overall Study|Clinical deterioration|3
4413988|NCT00283296|7194091|FG000|Overall Study|in-home trial not completed|5
4413989|NCT00283387|7194096|FG000|First Intervention|Subject non-compliant|1
4413990|NCT00283387|7194097|FG001|First Intervention|Subject non-compliant|1
4413991|NCT00283387|7194096|FG000|First Intervention|Withdrawal by Subject|0
4413992|NCT00283387|7194097|FG001|First Intervention|Withdrawal by Subject|1
4413993|NCT00283400|7194107|FG000|Overall Study|Withdrawal by Subject|1
4413994|NCT00283400|7194108|FG001|Overall Study|Withdrawal by Subject|1
4511763|NCT00929110|7321190|FG000|Overall Study|Unsatisfactory therapeutic effect|20
4413995|NCT00283400|7194109|FG002|Overall Study|Withdrawal by Subject|0
4413996|NCT00283400|7194110|FG003|Overall Study|Withdrawal by Subject|0
4413997|NCT00283400|7194107|FG000|Overall Study|Death|1
4413998|NCT00283400|7194108|FG001|Overall Study|Death|0
4413999|NCT00283400|7194109|FG002|Overall Study|Death|1
4633283|NCT01909804|7503306|FG010|Overall Study|Protocol Violation|0
4414000|NCT00283400|7194110|FG003|Overall Study|Death|0
4414001|NCT00283439|7194124|FG000|Overall Study|Adverse Event|0
4414002|NCT00283439|7194125|FG001|Overall Study|Adverse Event|0
4414003|NCT00283439|7194126|FG002|Overall Study|Adverse Event|0
4414004|NCT00283439|7194127|FG003|Overall Study|Adverse Event|1
4414005|NCT00283439|7194124|FG000|Overall Study|Death|0
4414006|NCT00283439|7194125|FG001|Overall Study|Death|0
4414007|NCT00283439|7194126|FG002|Overall Study|Death|1
4414008|NCT00283439|7194127|FG003|Overall Study|Death|0
4414009|NCT00283439|7194124|FG000|Overall Study|Disease progression|0
4414010|NCT00283439|7194125|FG001|Overall Study|Disease progression|1
4414011|NCT00283439|7194126|FG002|Overall Study|Disease progression|0
4414012|NCT00283439|7194127|FG003|Overall Study|Disease progression|0
4414013|NCT00283439|7194124|FG000|Overall Study|Requirement for alternative therapy|1
4414014|NCT00283439|7194125|FG001|Overall Study|Requirement for alternative therapy|2
4414015|NCT00283439|7194126|FG002|Overall Study|Requirement for alternative therapy|5
4414016|NCT00283439|7194127|FG003|Overall Study|Requirement for alternative therapy|2
4414017|NCT00283439|7194124|FG000|Overall Study|Stem cell transplant|6
4414018|NCT00283439|7194125|FG001|Overall Study|Stem cell transplant|6
4414019|NCT00283439|7194126|FG002|Overall Study|Stem cell transplant|4
4414020|NCT00283439|7194127|FG003|Overall Study|Stem cell transplant|3
4414021|NCT00283439|7194124|FG000|Overall Study|Treatment discontinued|0
4414022|NCT00283439|7194125|FG001|Overall Study|Treatment discontinued|2
4414023|NCT00283439|7194126|FG002|Overall Study|Treatment discontinued|1
4414024|NCT00283439|7194127|FG003|Overall Study|Treatment discontinued|3
4414025|NCT00283439|7194124|FG000|Overall Study|Other|1
4414026|NCT00283439|7194125|FG001|Overall Study|Other|0
4414027|NCT00283439|7194126|FG002|Overall Study|Other|0
4414028|NCT00283439|7194127|FG003|Overall Study|Other|0
4414029|NCT00283595|7194150|FG000|Overall Study|Withdrawal by Subject|1
4414030|NCT00283595|7194151|FG001|Overall Study|Withdrawal by Subject|2
4414031|NCT00283686|7194161|FG000|Overall Study|Death|1
4414032|NCT00283686|7194162|FG001|Overall Study|Death|1
4414033|NCT00283686|7194163|FG002|Overall Study|Death|1
4414034|NCT00283686|7194164|FG003|Overall Study|Death|0
4414035|NCT00283686|7194161|FG000|Overall Study|Lost to Follow-up|21
4414036|NCT00283686|7194162|FG001|Overall Study|Lost to Follow-up|31
4414037|NCT00283686|7194163|FG002|Overall Study|Lost to Follow-up|26
4414038|NCT00283686|7194164|FG003|Overall Study|Lost to Follow-up|20
4414039|NCT00283686|7194161|FG000|Overall Study|Less than full participation|7
4414040|NCT00283686|7194162|FG001|Overall Study|Less than full participation|9
4414041|NCT00283686|7194163|FG002|Overall Study|Less than full participation|6
4414042|NCT00283686|7194164|FG003|Overall Study|Less than full participation|12
4414043|NCT00283712|7194176|FG000|Overall Study|Death|0
4414044|NCT00283712|7194177|FG001|Overall Study|Death|1
4414045|NCT00283803|7194183|FG000|Overall Study|Physician Decision|9
4414046|NCT00283803|7194183|FG000|Overall Study|Withdrawal by Subject|4
4414047|NCT00283842|7194203|FG000|Overall Study|Adverse Event|8
4414048|NCT00283842|7194204|FG001|Overall Study|Adverse Event|7
4414049|NCT00283842|7194205|FG002|Overall Study|Adverse Event|21
4414050|NCT00283842|7194206|FG003|Overall Study|Adverse Event|21
4414051|NCT00283842|7194207|FG004|Overall Study|Adverse Event|5
4414052|NCT00283842|7194203|FG000|Overall Study|Protocol Violation|1
4414053|NCT00283842|7194204|FG001|Overall Study|Protocol Violation|5
4414054|NCT00283842|7194205|FG002|Overall Study|Protocol Violation|4
4414055|NCT00283842|7194206|FG003|Overall Study|Protocol Violation|0
4414056|NCT00283842|7194207|FG004|Overall Study|Protocol Violation|0
4414057|NCT00283842|7194203|FG000|Overall Study|Protocol deviation|0
4414058|NCT00283842|7194204|FG001|Overall Study|Protocol deviation|0
4414059|NCT00283842|7194205|FG002|Overall Study|Protocol deviation|0
4414060|NCT00283842|7194206|FG003|Overall Study|Protocol deviation|0
4414061|NCT00283842|7194207|FG004|Overall Study|Protocol deviation|2
4414062|NCT00283842|7194203|FG000|Overall Study|Withdrawal by Subject|2
4414063|NCT00283842|7194204|FG001|Overall Study|Withdrawal by Subject|1
4414064|NCT00283842|7194205|FG002|Overall Study|Withdrawal by Subject|1
4414065|NCT00283842|7194206|FG003|Overall Study|Withdrawal by Subject|5
4414066|NCT00283842|7194207|FG004|Overall Study|Withdrawal by Subject|4
4414067|NCT00283842|7194203|FG000|Overall Study|Lack of Efficacy|1
4414068|NCT00283842|7194204|FG001|Overall Study|Lack of Efficacy|3
4414069|NCT00283842|7194205|FG002|Overall Study|Lack of Efficacy|1
4414070|NCT00283842|7194206|FG003|Overall Study|Lack of Efficacy|0
4414071|NCT00283842|7194207|FG004|Overall Study|Lack of Efficacy|3
4414072|NCT00283842|7194203|FG000|Overall Study|Lost to Follow-up|0
4414073|NCT00283842|7194204|FG001|Overall Study|Lost to Follow-up|2
4414074|NCT00283842|7194205|FG002|Overall Study|Lost to Follow-up|4
4414075|NCT00283842|7194206|FG003|Overall Study|Lost to Follow-up|1
4414076|NCT00283842|7194207|FG004|Overall Study|Lost to Follow-up|1
4414077|NCT00284050|7194226|FG000|Overall Study|Adverse Event|1
4414078|NCT00284050|7194227|FG001|Overall Study|Adverse Event|1
4414079|NCT00284050|7194228|FG002|Overall Study|Adverse Event|1
4414080|NCT00284050|7194226|FG000|Overall Study|Lack of Efficacy|0
4414081|NCT00284050|7194227|FG001|Overall Study|Lack of Efficacy|1
4414082|NCT00284050|7194228|FG002|Overall Study|Lack of Efficacy|3
4414083|NCT00284050|7194226|FG000|Overall Study|Protocol Violation|0
4414084|NCT00284050|7194227|FG001|Overall Study|Protocol Violation|1
4414085|NCT00284050|7194228|FG002|Overall Study|Protocol Violation|2
4414086|NCT00284050|7194226|FG000|Overall Study|Withdrawal by Subject|2
4414087|NCT00284050|7194227|FG001|Overall Study|Withdrawal by Subject|2
4414088|NCT00284050|7194228|FG002|Overall Study|Withdrawal by Subject|2
4414089|NCT00284050|7194226|FG000|Overall Study|Lost to Follow-up|1
4414090|NCT00284050|7194227|FG001|Overall Study|Lost to Follow-up|0
4414091|NCT00284050|7194228|FG002|Overall Study|Lost to Follow-up|1
4414092|NCT00284050|7194226|FG000|Overall Study|Death|1
4414093|NCT00284050|7194227|FG001|Overall Study|Death|0
4414094|NCT00284050|7194228|FG002|Overall Study|Death|0
4414095|NCT00284089|7194240|FG000|Multiple Dose Phase|Adverse Event|1
4414096|NCT00284089|7194241|FG001|Multiple Dose Phase|Adverse Event|0
4414097|NCT00284089|7194242|FG002|Multiple Dose Phase|Adverse Event|1
4414098|NCT00284089|7194243|FG003|Multiple Dose Phase|Adverse Event|1
4414099|NCT00284089|7194240|FG000|Multiple Dose Phase|Protocol Violation|0
4414100|NCT00284089|7194241|FG001|Multiple Dose Phase|Protocol Violation|0
4414101|NCT00284089|7194242|FG002|Multiple Dose Phase|Protocol Violation|1
4414102|NCT00284089|7194243|FG003|Multiple Dose Phase|Protocol Violation|0
4414103|NCT00284089|7194240|FG000|Multiple Dose Phase|Withdrawal by Subject|0
4414104|NCT00284089|7194241|FG001|Multiple Dose Phase|Withdrawal by Subject|0
4414105|NCT00284089|7194242|FG002|Multiple Dose Phase|Withdrawal by Subject|1
4414106|NCT00284089|7194243|FG003|Multiple Dose Phase|Withdrawal by Subject|2
4414107|NCT00284089|7194240|FG000|Multiple Dose Phase|Death|0
4414108|NCT00284089|7194241|FG001|Multiple Dose Phase|Death|0
4414109|NCT00284089|7194242|FG002|Multiple Dose Phase|Death|1
4414110|NCT00284089|7194243|FG003|Multiple Dose Phase|Death|1
4414111|NCT00284089|7194240|FG000|Extension Phase|Adverse Event|0
4414112|NCT00284089|7194241|FG001|Extension Phase|Adverse Event|0
4414113|NCT00284089|7194242|FG002|Extension Phase|Adverse Event|2
4414114|NCT00284089|7194243|FG003|Extension Phase|Adverse Event|2
4414115|NCT00284089|7194240|FG000|Extension Phase|condition no longer requires study drug|2
4414116|NCT00284089|7194241|FG001|Extension Phase|condition no longer requires study drug|0
4414117|NCT00284089|7194242|FG002|Extension Phase|condition no longer requires study drug|2
4414118|NCT00284089|7194243|FG003|Extension Phase|condition no longer requires study drug|7
4414119|NCT00284089|7194240|FG000|Extension Phase|Protocol Violation|0
4414120|NCT00284089|7194241|FG001|Extension Phase|Protocol Violation|0
4414121|NCT00284089|7194242|FG002|Extension Phase|Protocol Violation|1
4414122|NCT00284089|7194243|FG003|Extension Phase|Protocol Violation|0
4414123|NCT00284089|7194240|FG000|Extension Phase|Withdrawal by Subject|0
4414124|NCT00284089|7194241|FG001|Extension Phase|Withdrawal by Subject|0
4414125|NCT00284089|7194242|FG002|Extension Phase|Withdrawal by Subject|1
4414126|NCT00284089|7194243|FG003|Extension Phase|Withdrawal by Subject|3
4414127|NCT00284141|7194253|FG000|Overall Study|Disease Progression / Lack of efficacy|51
4414128|NCT00284141|7194253|FG000|Overall Study|Adverse Event|19
4414129|NCT00284141|7194253|FG000|Overall Study|Participant's request|9
4414130|NCT00284141|7194253|FG000|Overall Study|Symptomatic / Clinical Progression|11
4414131|NCT00284141|7194253|FG000|Overall Study|Clinical deterioration / death|2
4414132|NCT00284141|7194253|FG000|Overall Study|General decline|1
4414133|NCT00284141|7194253|FG000|Overall Study|Pneumonia|1
4414134|NCT00284141|7194253|FG000|Overall Study|Did not take study medication|2
4414135|NCT00284141|7194253|FG000|Overall Study|Ongoing treatment|2
4511764|NCT00929110|7321191|FG001|Overall Study|Unsatisfactory therapeutic effect|9
4511765|NCT00929110|7321192|FG002|Overall Study|Unsatisfactory therapeutic effect|6
4511766|NCT00929110|7321190|FG000|Overall Study|Lost to Follow-up|7
4511767|NCT00929110|7321191|FG001|Overall Study|Lost to Follow-up|7
4511768|NCT00929110|7321192|FG002|Overall Study|Lost to Follow-up|3
4511769|NCT00929110|7321190|FG000|Overall Study|Protocol deviation|5
4511770|NCT00929110|7321191|FG001|Overall Study|Protocol deviation|2
4511771|NCT00929110|7321192|FG002|Overall Study|Protocol deviation|4
4511772|NCT00929110|7321190|FG000|Overall Study|Administrative problems|4
4511773|NCT00929110|7321191|FG001|Overall Study|Administrative problems|1
4511774|NCT00929110|7321192|FG002|Overall Study|Administrative problems|2
4511775|NCT00929110|7321190|FG000|Overall Study|Death|2
4511776|NCT00929110|7321191|FG001|Overall Study|Death|2
4511777|NCT00929110|7321192|FG002|Overall Study|Death|2
4511778|NCT00929110|7321190|FG000|Overall Study|Abnormal laboratory value(s)|0
4511779|NCT00929110|7321191|FG001|Overall Study|Abnormal laboratory value(s)|1
4511780|NCT00929110|7321192|FG002|Overall Study|Abnormal laboratory value(s)|0
4511781|NCT00929110|7321190|FG000|Overall Study|Abnormal test procedure result(s)|0
4511782|NCT00929110|7321191|FG001|Overall Study|Abnormal test procedure result(s)|1
4511783|NCT00929110|7321192|FG002|Overall Study|Abnormal test procedure result(s)|1
4511784|NCT00929110|7321190|FG000|Overall Study|Patient inability to use the device|0
4511785|NCT00929110|7321191|FG001|Overall Study|Patient inability to use the device|1
4511786|NCT00929110|7321192|FG002|Overall Study|Patient inability to use the device|0
4511787|NCT00929162|7321202|FG000|Overall Study|Adverse Event|8
4511788|NCT00929162|7321203|FG001|Overall Study|Adverse Event|5
4511789|NCT00929162|7321202|FG000|Overall Study|Withdrawal by Subject|3
4511790|NCT00929162|7321203|FG001|Overall Study|Withdrawal by Subject|1
4511791|NCT00929162|7321202|FG000|Overall Study|Protocol Violation|32
4511792|NCT00929162|7321203|FG001|Overall Study|Protocol Violation|30
4511793|NCT00929162|7321202|FG000|Overall Study|Other termination reason|5
4511794|NCT00929162|7321203|FG001|Overall Study|Other termination reason|6
4511795|NCT00929201|7321209|FG000|Period 1|Withdrawal by Subject|0
4511796|NCT00929201|7321210|FG001|Period 1|Withdrawal by Subject|1
4511797|NCT00929240|7321217|FG000|Initial Treatment Phase|Adverse Event|31
4414136|NCT00284934|7194309|FG000|Overall Study|Adverse Event|1
4414137|NCT00284934|7194310|FG001|Overall Study|Adverse Event|2
4414138|NCT00284934|7194309|FG000|Overall Study|Other reasons|3
4414139|NCT00284934|7194310|FG001|Overall Study|Other reasons|1
4414140|NCT00285012|7194318|FG000|Assigned to Study Treatment (Tx)|Other|2
4414141|NCT00285012|7194319|FG001|Assigned to Study Treatment (Tx)|Other|3
4629327|NCT01871090|7497205|FG000|Overall Study|Interrogation not done in Emergency Room|1
4629328|NCT01871090|7497206|FG001|Overall Study|Interrogation not done in Emergency Room|22
4629329|NCT01871090|7497205|FG000|Overall Study|Interrogation not completed correctly|1
4629330|NCT01871090|7497206|FG001|Overall Study|Interrogation not completed correctly|0
4629331|NCT01871090|7497205|FG000|Overall Study|Subject Non-Compliance|0
4629332|NCT01871090|7497206|FG001|Overall Study|Subject Non-Compliance|1
4629333|NCT01871142|7497212|FG000|Overall Study|Adverse Event|1
4629334|NCT01871285|7497228|FG000|First Intervention (1 Day)|Adverse Event|1
4414142|NCT00285012|7194318|FG000|Received Study Tx|Death|2
4414143|NCT00285012|7194319|FG001|Received Study Tx|Death|1
4414144|NCT00285012|7194318|FG000|Received Study Tx|Adverse Event|5
4414145|NCT00285012|7194319|FG001|Received Study Tx|Adverse Event|11
4414146|NCT00285012|7194318|FG000|Received Study Tx|Lack of Efficacy|0
4414147|NCT00285012|7194319|FG001|Received Study Tx|Lack of Efficacy|3
4414148|NCT00285012|7194318|FG000|Received Study Tx|Lost to Follow-up|29
4414149|NCT00285012|7194319|FG001|Received Study Tx|Lost to Follow-up|31
4414150|NCT00285012|7194318|FG000|Received Study Tx|Withdrawal by Subject|31
4414151|NCT00285012|7194319|FG001|Received Study Tx|Withdrawal by Subject|43
4414152|NCT00285012|7194318|FG000|Received Study Tx|Other|5
4414153|NCT00285012|7194319|FG001|Received Study Tx|Other|5
4414154|NCT00285207|7194327|FG000|Overall Study|Lost to Follow-up|3
4414155|NCT00285207|7194328|FG001|Overall Study|Lost to Follow-up|2
4414156|NCT00285207|7194327|FG000|Overall Study|Withdrawal by Subject|5
4414157|NCT00285207|7194328|FG001|Overall Study|Withdrawal by Subject|2
4414158|NCT00285207|7194327|FG000|Overall Study|Pregnancy|1
4414159|NCT00285207|7194328|FG001|Overall Study|Pregnancy|1
4414160|NCT00285207|7194327|FG000|Overall Study|non-compliance|0
4414161|NCT00285207|7194328|FG001|Overall Study|non-compliance|1
4414162|NCT00285584|7194349|FG000|Month 3|Lost to Follow-up|3
4414163|NCT00285584|7194350|FG001|Month 3|Lost to Follow-up|3
4414164|NCT00285584|7194349|FG000|Month 3|Withdrawal by Subject|1
4414165|NCT00285584|7194350|FG001|Month 3|Withdrawal by Subject|0
4414166|NCT00285584|7194349|FG000|Month 6|Lost to Follow-up|0
4414167|NCT00285584|7194350|FG001|Month 6|Lost to Follow-up|1
4414168|NCT00285649|7194363|FG000|Overall Study|Lost to Follow-up|6
4414169|NCT00285649|7194364|FG001|Overall Study|Lost to Follow-up|4
4414170|NCT00285649|7194365|FG002|Overall Study|Lost to Follow-up|4
4414171|NCT00285649|7194363|FG000|Overall Study|Withdrawal by Subject|3
4414172|NCT00285649|7194364|FG001|Overall Study|Withdrawal by Subject|2
4414173|NCT00285649|7194365|FG002|Overall Study|Withdrawal by Subject|2
4414174|NCT00285818|7194384|FG000|Overall Study|Withdrawal by Subject|3
4414175|NCT00285818|7194385|FG001|Overall Study|Withdrawal by Subject|2
4414176|NCT00285818|7194384|FG000|Overall Study|Lost to Follow-up|1
4414177|NCT00285818|7194385|FG001|Overall Study|Lost to Follow-up|0
4414178|NCT00285857|7194391|FG000|Overall Study|Withdrawal by Subject|2
4414179|NCT00285857|7194391|FG000|Overall Study|Inadequate initial breast cytology|1
4414180|NCT00285857|7194391|FG000|Overall Study|Adverse Event|1
4414181|NCT00286091|7194411|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103
4414182|NCT00286091|7194412|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113
4414183|NCT00286091|7194411|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307
4414184|NCT00286091|7194412|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269
4414185|NCT00286091|7194411|FG000|Double-blind Treatment Phase|Death|58
4414186|NCT00286091|7194412|FG001|Double-blind Treatment Phase|Death|65
4414187|NCT00286091|7194411|FG000|Double-blind Treatment Phase|Adverse Event|28
4414188|NCT00286091|7194412|FG001|Double-blind Treatment Phase|Adverse Event|40
4414189|NCT00286091|7194411|FG000|Double-blind Treatment Phase|Disease Progression|22
4414190|NCT00286091|7194412|FG001|Double-blind Treatment Phase|Disease Progression|35
4414191|NCT00286091|7194411|FG000|Double-blind Treatment Phase|Other|25
4414192|NCT00286091|7194412|FG001|Double-blind Treatment Phase|Other|33
4414193|NCT00286091|7194411|FG000|Double-blind Treatment Phase|Administrative Decision|20
4414194|NCT00286091|7194412|FG001|Double-blind Treatment Phase|Administrative Decision|21
4414195|NCT00286091|7194411|FG000|Double-blind Treatment Phase|Noncompliance|8
4414196|NCT00286091|7194412|FG001|Double-blind Treatment Phase|Noncompliance|8
4414197|NCT00286091|7194411|FG000|Double-blind Treatment Phase|Lost to Follow-up|11
4414198|NCT00286091|7194412|FG001|Double-blind Treatment Phase|Lost to Follow-up|4
4414199|NCT00286091|7194411|FG000|Double-blind Treatment Phase|Protocol Deviation|1
4414200|NCT00286091|7194412|FG001|Double-blind Treatment Phase|Protocol Deviation|3
4414201|NCT00286091|7194411|FG000|Double-blind Treatment Phase|Ineligibility Determined|1
4414202|NCT00286091|7194412|FG001|Double-blind Treatment Phase|Ineligibility Determined|2
4414203|NCT00286091|7194411|FG000|Open-label Treatment Phase|Physician Decision|24
4414204|NCT00286091|7194412|FG001|Open-label Treatment Phase|Physician Decision|21
4414205|NCT00286091|7194411|FG000|Open-label Treatment Phase|Adverse Event|5
4414206|NCT00286091|7194412|FG001|Open-label Treatment Phase|Adverse Event|16
4414207|NCT00286091|7194411|FG000|Open-label Treatment Phase|Other|11
4629335|NCT01871285|7497229|FG001|First Intervention (1 Day)|Adverse Event|0
4414208|NCT00286091|7194412|FG001|Open-label Treatment Phase|Other|11
4414209|NCT00286091|7194411|FG000|Open-label Treatment Phase|Withdrawal by Subject|14
4414210|NCT00286091|7194412|FG001|Open-label Treatment Phase|Withdrawal by Subject|10
4414211|NCT00286091|7194411|FG000|Open-label Treatment Phase|Death|10
4414212|NCT00286091|7194412|FG001|Open-label Treatment Phase|Death|7
4414213|NCT00286091|7194411|FG000|Open-label Treatment Phase|Disease Progression|9
4414214|NCT00286091|7194412|FG001|Open-label Treatment Phase|Disease Progression|3
4414215|NCT00286091|7194411|FG000|Open-label Treatment Phase|Noncompliance|3
4414216|NCT00286091|7194412|FG001|Open-label Treatment Phase|Noncompliance|1
4414217|NCT00286091|7194411|FG000|Open-label Treatment Phase|Lost to Follow-up|0
4414218|NCT00286091|7194412|FG001|Open-label Treatment Phase|Lost to Follow-up|1
4414219|NCT00286091|7194411|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1
4414220|NCT00286091|7194412|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0
4414221|NCT00286091|7194411|FG000|Open-label Treatment Phase|Missing End of Study Information|0
4414222|NCT00286091|7194412|FG001|Open-label Treatment Phase|Missing End of Study Information|1
4414223|NCT00286156|7194423|FG000|Overall Study|Missed 12 month visit|0
4414224|NCT00286156|7194424|FG001|Overall Study|Missed 12 month visit|0
4414225|NCT00286156|7194425|FG002|Overall Study|Missed 12 month visit|1
4414226|NCT00286156|7194423|FG000|Overall Study|AE: pulmonary embolus|0
4414227|NCT00286156|7194424|FG001|Overall Study|AE: pulmonary embolus|1
4414228|NCT00286156|7194425|FG002|Overall Study|AE: pulmonary embolus|0
4414229|NCT00286156|7194423|FG000|Overall Study|AE: nephrotic-range proteinuruia|1
4414230|NCT00286156|7194424|FG001|Overall Study|AE: nephrotic-range proteinuruia|0
4414231|NCT00286156|7194425|FG002|Overall Study|AE: nephrotic-range proteinuruia|0
4414232|NCT00286156|7194423|FG000|Overall Study|AE: pneumonia|1
4414233|NCT00286156|7194424|FG001|Overall Study|AE: pneumonia|0
4414234|NCT00286156|7194425|FG002|Overall Study|AE: pneumonia|0
4414235|NCT00286221|7194446|FG000|Overall Study|Protocol Violation|2
4414236|NCT00286221|7194447|FG001|Overall Study|Protocol Violation|1
4414237|NCT00286221|7194448|FG002|Overall Study|Protocol Violation|6
4414238|NCT00286221|7194449|FG003|Overall Study|Protocol Violation|4
4414239|NCT00286221|7194446|FG000|Overall Study|Unanticipated Neurosurgical Complication|6
4414240|NCT00286221|7194447|FG001|Overall Study|Unanticipated Neurosurgical Complication|3
4414241|NCT00286221|7194448|FG002|Overall Study|Unanticipated Neurosurgical Complication|3
4414242|NCT00286221|7194449|FG003|Overall Study|Unanticipated Neurosurgical Complication|2
4414243|NCT00286221|7194446|FG000|Overall Study|Inability to trigger PCA|2
4414244|NCT00286221|7194447|FG001|Overall Study|Inability to trigger PCA|0
4414245|NCT00286221|7194448|FG002|Overall Study|Inability to trigger PCA|0
4414246|NCT00286221|7194449|FG003|Overall Study|Inability to trigger PCA|0
4414247|NCT00286221|7194446|FG000|Overall Study|Unrecognized exclusion criteria met|0
4414248|NCT00286221|7194447|FG001|Overall Study|Unrecognized exclusion criteria met|1
4414249|NCT00286221|7194448|FG002|Overall Study|Unrecognized exclusion criteria met|0
4414250|NCT00286221|7194449|FG003|Overall Study|Unrecognized exclusion criteria met|0
4414251|NCT00286234|7194463|FG000|Overall Study|Protocol Violation|1
4414252|NCT00286234|7194464|FG001|Overall Study|Protocol Violation|2
4414253|NCT00286234|7194465|FG002|Overall Study|Protocol Violation|0
4414254|NCT00286234|7194466|FG003|Overall Study|Protocol Violation|1
4414255|NCT00286234|7194463|FG000|Overall Study|Physician Decision|1
4414256|NCT00286234|7194464|FG001|Overall Study|Physician Decision|0
4414257|NCT00286234|7194465|FG002|Overall Study|Physician Decision|0
4414258|NCT00286234|7194466|FG003|Overall Study|Physician Decision|1
4414259|NCT00286234|7194463|FG000|Overall Study|Adverse Event|0
4414260|NCT00286234|7194464|FG001|Overall Study|Adverse Event|0
4414261|NCT00286234|7194465|FG002|Overall Study|Adverse Event|0
4414262|NCT00286234|7194466|FG003|Overall Study|Adverse Event|1
4414263|NCT00286234|7194463|FG000|Overall Study|Adverse Event|0
4414264|NCT00286234|7194464|FG001|Overall Study|Adverse Event|0
4414265|NCT00286234|7194465|FG002|Overall Study|Adverse Event|0
4414266|NCT00286234|7194466|FG003|Overall Study|Adverse Event|1
4414267|NCT00286429|7194483|FG000|Overall Study|Adverse Event|4
4414268|NCT00286429|7194484|FG001|Overall Study|Adverse Event|1
4414269|NCT00286429|7194485|FG002|Overall Study|Adverse Event|6
4414270|NCT00286429|7194483|FG000|Overall Study|Lack of Efficacy|52
4414271|NCT00286429|7194484|FG001|Overall Study|Lack of Efficacy|27
4414272|NCT00286429|7194485|FG002|Overall Study|Lack of Efficacy|25
4414273|NCT00286429|7194483|FG000|Overall Study|Lost to Follow-up|2
4414274|NCT00286429|7194484|FG001|Overall Study|Lost to Follow-up|4
4414275|NCT00286429|7194485|FG002|Overall Study|Lost to Follow-up|3
4414276|NCT00286429|7194483|FG000|Overall Study|Physician Decision|10
4414277|NCT00286429|7194484|FG001|Overall Study|Physician Decision|7
4414278|NCT00286429|7194485|FG002|Overall Study|Physician Decision|7
4414279|NCT00286429|7194483|FG000|Overall Study|Protocol Violation|3
4414280|NCT00286429|7194484|FG001|Overall Study|Protocol Violation|5
4414281|NCT00286429|7194485|FG002|Overall Study|Protocol Violation|4
4414282|NCT00286429|7194483|FG000|Overall Study|Withdrawal by Subject|3
4414283|NCT00286429|7194484|FG001|Overall Study|Withdrawal by Subject|2
4414284|NCT00286429|7194485|FG002|Overall Study|Withdrawal by Subject|6
4414285|NCT00286429|7194483|FG000|Overall Study|Administrative Error|1
4414286|NCT00286429|7194484|FG001|Overall Study|Administrative Error|1
4414287|NCT00286429|7194485|FG002|Overall Study|Administrative Error|1
4414288|NCT00286429|7194483|FG000|Overall Study|Administrative Decision|0
4414289|NCT00286429|7194484|FG001|Overall Study|Administrative Decision|1
4414290|NCT00286429|7194485|FG002|Overall Study|Administrative Decision|0
4414291|NCT00286442|7194496|FG000|Overall Study|Hyperglycemic Rescue|19
4414292|NCT00286442|7194497|FG001|Overall Study|Hyperglycemic Rescue|17
4414293|NCT00286442|7194498|FG002|Overall Study|Hyperglycemic Rescue|25
4414294|NCT00286442|7194496|FG000|Overall Study|Adverse Event|7
4414295|NCT00286442|7194497|FG001|Overall Study|Adverse Event|6
4414296|NCT00286442|7194498|FG002|Overall Study|Adverse Event|1
4414297|NCT00286442|7194496|FG000|Overall Study|Protocol Violation|2
4414298|NCT00286442|7194497|FG001|Overall Study|Protocol Violation|4
4414299|NCT00286442|7194498|FG002|Overall Study|Protocol Violation|2
4414300|NCT00286442|7194496|FG000|Overall Study|Lost to Follow-up|5
4414301|NCT00286442|7194497|FG001|Overall Study|Lost to Follow-up|2
4414302|NCT00286442|7194498|FG002|Overall Study|Lost to Follow-up|1
4414303|NCT00286442|7194496|FG000|Overall Study|Physician Decision|1
4414304|NCT00286442|7194497|FG001|Overall Study|Physician Decision|1
4414305|NCT00286442|7194498|FG002|Overall Study|Physician Decision|1
4414306|NCT00286442|7194496|FG000|Overall Study|Administrative Error|1
4414307|NCT00286442|7194497|FG001|Overall Study|Administrative Error|1
4414308|NCT00286442|7194498|FG002|Overall Study|Administrative Error|0
4414309|NCT00286442|7194496|FG000|Overall Study|Withdrawal by Subject|2
4414310|NCT00286442|7194497|FG001|Overall Study|Withdrawal by Subject|14
4414311|NCT00286442|7194498|FG002|Overall Study|Withdrawal by Subject|2
4414312|NCT00286455|7194509|FG000|Overall Study|Hyperglycemia rescue|19
4414313|NCT00286455|7194510|FG001|Overall Study|Hyperglycemia rescue|13
4414314|NCT00286455|7194511|FG002|Overall Study|Hyperglycemia rescue|10
4414315|NCT00286455|7194509|FG000|Overall Study|Adverse Event|1
4414316|NCT00286455|7194510|FG001|Overall Study|Adverse Event|3
4414317|NCT00286455|7194511|FG002|Overall Study|Adverse Event|2
4414318|NCT00286455|7194509|FG000|Overall Study|Lost to Follow-up|0
4414319|NCT00286455|7194510|FG001|Overall Study|Lost to Follow-up|3
4414320|NCT00286455|7194511|FG002|Overall Study|Lost to Follow-up|3
4414321|NCT00286455|7194509|FG000|Overall Study|Physician Decision|3
4414322|NCT00286455|7194510|FG001|Overall Study|Physician Decision|0
4414323|NCT00286455|7194511|FG002|Overall Study|Physician Decision|2
4414324|NCT00286455|7194509|FG000|Overall Study|Protocol Violation|1
4414325|NCT00286455|7194510|FG001|Overall Study|Protocol Violation|1
4414326|NCT00286455|7194511|FG002|Overall Study|Protocol Violation|0
4414327|NCT00286455|7194509|FG000|Overall Study|Participant Non-compliance|1
4414328|NCT00286455|7194510|FG001|Overall Study|Participant Non-compliance|0
4414329|NCT00286455|7194511|FG002|Overall Study|Participant Non-compliance|0
4414330|NCT00286455|7194509|FG000|Overall Study|Withdrawal by Subject|0
4414331|NCT00286455|7194510|FG001|Overall Study|Withdrawal by Subject|8
4414332|NCT00286455|7194511|FG002|Overall Study|Withdrawal by Subject|7
4414333|NCT00286468|7194522|FG000|Overall Study|Hyperglycemic Rescue|28
4414334|NCT00286468|7194523|FG001|Overall Study|Hyperglycemic Rescue|30
4414335|NCT00286468|7194524|FG002|Overall Study|Hyperglycemic Rescue|31
4414336|NCT00286468|7194522|FG000|Overall Study|Adverse Event|2
4414337|NCT00286468|7194523|FG001|Overall Study|Adverse Event|6
4414338|NCT00286468|7194524|FG002|Overall Study|Adverse Event|4
4414339|NCT00286468|7194522|FG000|Overall Study|Protocol Violation|0
4414340|NCT00286468|7194523|FG001|Overall Study|Protocol Violation|3
4414341|NCT00286468|7194524|FG002|Overall Study|Protocol Violation|1
4414342|NCT00286468|7194522|FG000|Overall Study|Lost to Follow-up|1
4414343|NCT00286468|7194523|FG001|Overall Study|Lost to Follow-up|1
4414344|NCT00286468|7194524|FG002|Overall Study|Lost to Follow-up|2
4414345|NCT00286468|7194522|FG000|Overall Study|Withdrawal by Subject|3
4414346|NCT00286468|7194523|FG001|Overall Study|Withdrawal by Subject|8
4414347|NCT00286468|7194524|FG002|Overall Study|Withdrawal by Subject|11
4414348|NCT00286468|7194522|FG000|Overall Study|Physician Decision|3
4414349|NCT00286468|7194523|FG001|Overall Study|Physician Decision|2
4414350|NCT00286468|7194524|FG002|Overall Study|Physician Decision|1
4414351|NCT00286494|7194535|FG000|Overall Study|Hyperglycemic rescue|12
4414352|NCT00286494|7194536|FG001|Overall Study|Hyperglycemic rescue|19
4414353|NCT00286494|7194537|FG002|Overall Study|Hyperglycemic rescue|18
4414354|NCT00286494|7194535|FG000|Overall Study|Withdrawal by Subject|2
4414355|NCT00286494|7194536|FG001|Overall Study|Withdrawal by Subject|10
4414356|NCT00286494|7194537|FG002|Overall Study|Withdrawal by Subject|9
4414357|NCT00286494|7194535|FG000|Overall Study|Adverse Event|3
4414358|NCT00286494|7194536|FG001|Overall Study|Adverse Event|8
4414359|NCT00286494|7194537|FG002|Overall Study|Adverse Event|6
4414360|NCT00286494|7194535|FG000|Overall Study|Physician Decision|5
4590423|NCT01521507|7436436|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1
4590424|NCT01521507|7436437|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3
4590425|NCT01521507|7436436|FG000|Stage 1: Randomized Design|Lost to Follow-up|0
4590426|NCT01521507|7436437|FG001|Stage 1: Randomized Design|Lost to Follow-up|2
4590427|NCT01521507|7436436|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0
4590428|NCT01521507|7436437|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1
4590429|NCT01521507|7436436|FG000|Stage 2: Observational Design|Withdrawal by Subject|3
4414361|NCT00286494|7194536|FG001|Overall Study|Physician Decision|5
4414362|NCT00286494|7194537|FG002|Overall Study|Physician Decision|1
4414363|NCT00286494|7194535|FG000|Overall Study|Lost to Follow-up|3
4414364|NCT00286494|7194536|FG001|Overall Study|Lost to Follow-up|1
4414365|NCT00286494|7194537|FG002|Overall Study|Lost to Follow-up|3
4414366|NCT00286494|7194535|FG000|Overall Study|Protocol Violation|1
4590430|NCT01521507|7436437|FG001|Stage 2: Observational Design|Withdrawal by Subject|1
4590431|NCT01521507|7436436|FG000|Stage 2: Observational Design|Physician Decision|1
4590432|NCT01521507|7436437|FG001|Stage 2: Observational Design|Physician Decision|0
4590433|NCT01521559|7436461|FG000|Overall Study|Adverse Event|0
4590434|NCT01521559|7436462|FG001|Overall Study|Adverse Event|4
4590435|NCT01521559|7436461|FG000|Overall Study|Death|1
4590436|NCT01521559|7436462|FG001|Overall Study|Death|0
4590437|NCT01521559|7436461|FG000|Overall Study|Withdrawal by Subject|9
4590438|NCT01521559|7436462|FG001|Overall Study|Withdrawal by Subject|11
4590439|NCT01521559|7436461|FG000|Overall Study|Lost to Follow-up|3
4590440|NCT01521559|7436462|FG001|Overall Study|Lost to Follow-up|1
4590441|NCT01521559|7436461|FG000|Overall Study|Protocol Violation|1
4590442|NCT01521559|7436462|FG001|Overall Study|Protocol Violation|0
4590443|NCT01521559|7436461|FG000|Overall Study|Other|1
4590444|NCT01521559|7436462|FG001|Overall Study|Other|2
4590445|NCT01521884|7436498|FG000|Overall Study|Non Responders|10
4590446|NCT01521884|7436498|FG000|Overall Study|Adverse Event|5
4414367|NCT00286494|7194536|FG001|Overall Study|Protocol Violation|1
4414368|NCT00286494|7194537|FG002|Overall Study|Protocol Violation|2
4414369|NCT00286754|7194569|FG000|Overall Study|Adverse Event|2
4414370|NCT00286754|7194570|FG001|Overall Study|Adverse Event|2
4414371|NCT00286754|7194571|FG002|Overall Study|Adverse Event|3
4414372|NCT00286754|7194569|FG000|Overall Study|Withdrawal by Subject|6
4414373|NCT00286754|7194570|FG001|Overall Study|Withdrawal by Subject|2
4414374|NCT00286754|7194571|FG002|Overall Study|Withdrawal by Subject|0
4414375|NCT00286754|7194569|FG000|Overall Study|Lost to Follow-up|12
4414376|NCT00286754|7194570|FG001|Overall Study|Lost to Follow-up|14
4414377|NCT00286754|7194571|FG002|Overall Study|Lost to Follow-up|6
4414378|NCT00286754|7194569|FG000|Overall Study|Moved out of state|0
4414379|NCT00286754|7194570|FG001|Overall Study|Moved out of state|0
4414380|NCT00286754|7194571|FG002|Overall Study|Moved out of state|1
4414381|NCT00287079|7194602|FG000|Overall Study|Qualifying relapse|12
4414382|NCT00287079|7194603|FG001|Overall Study|Qualifying relapse|1
4414383|NCT00287079|7194602|FG000|Overall Study|Non-qualifying relapse|1
4414384|NCT00287079|7194603|FG001|Overall Study|Non-qualifying relapse|0
4414385|NCT00287079|7194602|FG000|Overall Study|Adverse Event|5
4414386|NCT00287079|7194603|FG001|Overall Study|Adverse Event|0
4414387|NCT00287079|7194602|FG000|Overall Study|Protocol Violation|1
4414388|NCT00287079|7194603|FG001|Overall Study|Protocol Violation|0
4414389|NCT00287079|7194602|FG000|Overall Study|Other|3
4414390|NCT00287079|7194603|FG001|Overall Study|Other|0
4414391|NCT00287118|7194609|FG000|Overall Study|Adverse Event|30
4414392|NCT00287118|7194609|FG000|Overall Study|Death|1
4414393|NCT00287118|7194609|FG000|Overall Study|Lack of Efficacy|11
4414394|NCT00287118|7194609|FG000|Overall Study|Lost to Follow-up|1
4414395|NCT00287118|7194609|FG000|Overall Study|Protocol Violation|2
4414396|NCT00287118|7194609|FG000|Overall Study|Other|7
4414397|NCT00287365|7194630|FG000|Overall Study|sample not acquired|13
4414398|NCT00287469|7194637|FG000|Overall Study|serious adverse event|1
4414399|NCT00287469|7194638|FG001|Overall Study|serious adverse event|6
4414400|NCT00287469|7194637|FG000|Overall Study|Adverse Event|1
4414401|NCT00287469|7194638|FG001|Overall Study|Adverse Event|1
4414402|NCT00287469|7194637|FG000|Overall Study|moved from area|144
4414403|NCT00287469|7194638|FG001|Overall Study|moved from area|138
4414404|NCT00287469|7194637|FG000|Overall Study|Lost to Follow-up|74
4414405|NCT00287469|7194638|FG001|Overall Study|Lost to Follow-up|69
4414406|NCT00287586|7194648|FG000|Overall Study|Withdrew Consent|19
4414407|NCT00287586|7194649|FG001|Overall Study|Withdrew Consent|30
4414408|NCT00287586|7194648|FG000|Overall Study|Lost to Follow-up|5
4414409|NCT00287586|7194649|FG001|Overall Study|Lost to Follow-up|4
4414410|NCT00287586|7194648|FG000|Overall Study|Death|2
4414411|NCT00287586|7194649|FG001|Overall Study|Death|3
4414412|NCT00287586|7194648|FG000|Overall Study|Elevated Hematocrit|3
4414413|NCT00287586|7194649|FG001|Overall Study|Elevated Hematocrit|0
4414414|NCT00287586|7194648|FG000|Overall Study|Rash|3
4414415|NCT00287586|7194649|FG001|Overall Study|Rash|0
4414416|NCT00287586|7194648|FG000|Overall Study|Elevated Prostate Specific Antigen|2
4414417|NCT00287586|7194649|FG001|Overall Study|Elevated Prostate Specific Antigen|0
4414418|NCT00287586|7194648|FG000|Overall Study|Stroke|2
4414419|NCT00287586|7194649|FG001|Overall Study|Stroke|0
4414420|NCT00287586|7194648|FG000|Overall Study|Myocardial Infarction|1
4414421|NCT00287586|7194649|FG001|Overall Study|Myocardial Infarction|0
4414422|NCT00287586|7194648|FG000|Overall Study|Lower Urinary Tract Symptoms|1
4414423|NCT00287586|7194649|FG001|Overall Study|Lower Urinary Tract Symptoms|0
4414424|NCT00287586|7194648|FG000|Overall Study|Cognitive Impairment|1
4414425|NCT00287586|7194649|FG001|Overall Study|Cognitive Impairment|0
4414426|NCT00287586|7194648|FG000|Overall Study|Pancreatic Cancer|1
4414427|NCT00287586|7194649|FG001|Overall Study|Pancreatic Cancer|3
4414428|NCT00287586|7194648|FG000|Overall Study|Sleep Apnea|1
4414429|NCT00287586|7194649|FG001|Overall Study|Sleep Apnea|0
4414430|NCT00287586|7194648|FG000|Overall Study|Shoulder Pain|1
4414431|NCT00287586|7194649|FG001|Overall Study|Shoulder Pain|0
4414432|NCT00287586|7194648|FG000|Overall Study|Inappropriate Behaviour with Staff|1
4414433|NCT00287586|7194649|FG001|Overall Study|Inappropriate Behaviour with Staff|0
4414434|NCT00287586|7194648|FG000|Overall Study|Nonadherence|1
4590447|NCT01521884|7436498|FG000|Overall Study|Pregnancy|1
4590448|NCT01521884|7436498|FG000|Overall Study|Withdrawal by Subject|1
4414435|NCT00287586|7194649|FG001|Overall Study|Nonadherence|1
4414436|NCT00287586|7194648|FG000|Overall Study|Enrolled in Another Study|1
4414437|NCT00287586|7194649|FG001|Overall Study|Enrolled in Another Study|0
4414438|NCT00287586|7194648|FG000|Overall Study|Major Depression|0
4414439|NCT00287586|7194649|FG001|Overall Study|Major Depression|2
4414440|NCT00287586|7194648|FG000|Overall Study|Lung Cancer|0
4414441|NCT00287586|7194649|FG001|Overall Study|Lung Cancer|2
4414442|NCT00287586|7194648|FG000|Overall Study|Elevated IPSS Score|0
4414443|NCT00287586|7194649|FG001|Overall Study|Elevated IPSS Score|1
4414444|NCT00287586|7194648|FG000|Overall Study|Retroperitoneal Cancer|0
4414445|NCT00287586|7194649|FG001|Overall Study|Retroperitoneal Cancer|1
4414446|NCT00287586|7194648|FG000|Overall Study|Mastodynia and Gynecomastia|0
4414447|NCT00287586|7194649|FG001|Overall Study|Mastodynia and Gynecomastia|1
4414448|NCT00287586|7194648|FG000|Overall Study|Mood Swings and Irritability|0
4414449|NCT00287586|7194649|FG001|Overall Study|Mood Swings and Irritability|1
4414450|NCT00287586|7194648|FG000|Overall Study|Bradycardia|0
4414451|NCT00287586|7194649|FG001|Overall Study|Bradycardia|1
4414452|NCT00287586|7194648|FG000|Overall Study|Itchy Swollen Eyes|0
4414453|NCT00287586|7194649|FG001|Overall Study|Itchy Swollen Eyes|1
4414454|NCT00287586|7194648|FG000|Overall Study|Recurrent Melanoma|0
4414455|NCT00287586|7194649|FG001|Overall Study|Recurrent Melanoma|1
4414456|NCT00287690|7194657|FG000|Overall Study|Protocol Violation|20
4414457|NCT00287690|7194658|FG001|Overall Study|Protocol Violation|26
4414458|NCT00288015|7194704|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1
4414459|NCT00288015|7194704|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1
4414460|NCT00288015|7194704|FG000|First Response Assessment|Withdrawal by Subject|1
4414461|NCT00288015|7194704|FG000|First Response Assessment|Death|1
4414462|NCT00288015|7194704|FG000|First Response Assessment|Physician Decision|2
4414463|NCT00288015|7194704|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7
4414464|NCT00288015|7194704|FG000|Follow up for Survival x 2 Years|Death|13
4414465|NCT00288015|7194704|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4
4414466|NCT00288015|7194704|FG000|Follow up for Survival x 2 Years|Other|9
4414467|NCT00288054|7194708|FG000|Overall Study|Protocol Violation|2
4414468|NCT00288054|7194708|FG000|Overall Study|Lack of Efficacy|16
4414469|NCT00288054|7194708|FG000|Overall Study|Adverse Event|3
4414470|NCT00288054|7194708|FG000|Overall Study|Withdrawal by Subject|1
4414471|NCT00288054|7194708|FG000|Overall Study|Not protocol specified|2
4414472|NCT00288509|7194729|FG000|Treatment Cycle 1|Adverse Event|1
4414473|NCT00288509|7194729|FG000|Treatment Cycle 1|Lack of Efficacy|1
4414474|NCT00288509|7194729|FG000|Treatment Cycle 1|Withdrawal by Subject|1
4414475|NCT00288509|7194729|FG000|Treatment Cycle 1|Lost to Follow-up|2
4414476|NCT00288509|7194729|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1
4414477|NCT00288509|7194729|FG000|Treatment Cycle 2|Lack of Efficacy|1
4414478|NCT00288509|7194729|FG000|Treatment Cycle 2|Withdrawal by Subject|2
4414479|NCT00288509|7194729|FG000|Treatment Cycle 3|Lack of Efficacy|1
4414480|NCT00288509|7194729|FG000|Treatment Cycle 3|Withdrawal by Subject|1
4414481|NCT00288509|7194729|FG000|Treatment Cycle 3|Lost to Follow-up|2
4414482|NCT00288509|7194729|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1
4414483|NCT00288509|7194729|FG000|Treatment Cycle 4|Withdrawal by Subject|3
4414484|NCT00288509|7194729|FG000|Treatment Cycle 4|Physician Decision|4
4414485|NCT00288509|7194729|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1
4414486|NCT00288587|7194747|FG000|Overall Study|Death|4
4414487|NCT00288587|7194748|FG001|Overall Study|Death|4
4414488|NCT00288587|7194747|FG000|Overall Study|Transplant|0
4414489|NCT00288587|7194748|FG001|Overall Study|Transplant|3
4414490|NCT00288587|7194747|FG000|Overall Study|Adverse Event|0
4414491|NCT00288587|7194748|FG001|Overall Study|Adverse Event|1
4414492|NCT00288587|7194747|FG000|Overall Study|Physician Decision|0
4414493|NCT00288587|7194748|FG001|Overall Study|Physician Decision|2
4414494|NCT00288587|7194747|FG000|Overall Study|Severe Aortic Stenosis|1
4414495|NCT00288587|7194748|FG001|Overall Study|Severe Aortic Stenosis|0
4414496|NCT00288626|7194763|FG000|Overall Study|Death|3
4414497|NCT00288626|7194763|FG000|Overall Study|Withdrawal by Subject|4
4414498|NCT00288639|7194769|FG000|Overall Study|Adverse Event|5
4414499|NCT00288639|7194769|FG000|Overall Study|Lack of Efficacy|4
4414500|NCT00288639|7194769|FG000|Overall Study|Withdrawal by Subject|2
4414501|NCT00288639|7194769|FG000|Overall Study|Other|1
4414502|NCT00288704|7194776|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0
4414503|NCT00288704|7194777|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1
4414504|NCT00288704|7194778|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0
4414505|NCT00288704|7194776|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0
4414506|NCT00288704|7194777|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1
4414507|NCT00288704|7194778|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0
4414508|NCT00288704|7194776|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0
4414509|NCT00288704|7194777|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0
4414510|NCT00288704|7194778|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1
4414511|NCT00288704|7194776|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0
4414512|NCT00288704|7194777|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0
4414513|NCT00288704|7194778|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1
4414514|NCT00288704|7194776|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0
4414515|NCT00288704|7194777|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0
4414516|NCT00288704|7194778|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2
4414517|NCT00288704|7194776|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0
4414518|NCT00288704|7194777|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0
4414519|NCT00288704|7194778|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15
4414520|NCT00288704|7194776|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0
4414521|NCT00288704|7194777|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0
4414522|NCT00288704|7194778|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1
4414523|NCT00288860|7194787|FG000|Overall Study|Did not complete intake|4
4414524|NCT00288860|7194788|FG001|Overall Study|Did not complete intake|8
4414525|NCT00288860|7194787|FG000|Overall Study|Death|4
4414526|NCT00288860|7194788|FG001|Overall Study|Death|3
4414527|NCT00288860|7194787|FG000|Overall Study|Withdrawal by Subject|20
4414528|NCT00288860|7194788|FG001|Overall Study|Withdrawal by Subject|15
4414529|NCT00288860|7194787|FG000|Overall Study|Lost to Follow-up|74
4414530|NCT00288860|7194788|FG001|Overall Study|Lost to Follow-up|71
4414531|NCT00288912|7194809|FG000|Overall Study|Developed exclusion criterion|4
4414532|NCT00288912|7194810|FG001|Overall Study|Developed exclusion criterion|6
4414533|NCT00288912|7194811|FG002|Overall Study|Developed exclusion criterion|7
4414534|NCT00288912|7194809|FG000|Overall Study|Lost to Follow-up|9
4414535|NCT00288912|7194810|FG001|Overall Study|Lost to Follow-up|6
4414536|NCT00288912|7194811|FG002|Overall Study|Lost to Follow-up|9
4414537|NCT00288912|7194809|FG000|Overall Study|Withdrawal by Subject|4
4414538|NCT00288912|7194810|FG001|Overall Study|Withdrawal by Subject|5
4414539|NCT00288912|7194811|FG002|Overall Study|Withdrawal by Subject|12
4414540|NCT00289016|7194819|FG000|Overall Study|Disease Progression|29
4414541|NCT00289016|7194819|FG000|Overall Study|Death|2
4414542|NCT00289016|7194819|FG000|Overall Study|Unrelated Medical Condition or Accident|2
4414543|NCT00289016|7194819|FG000|Overall Study|Withdrawal by Subject|2
4414544|NCT00289016|7194819|FG000|Overall Study|Adverse Event|1
4414545|NCT00289016|7194819|FG000|Overall Study|Other|1
4414546|NCT00289133|7194851|FG000|Overall Study|Non-study device implanted|12
4414547|NCT00289133|7194852|FG001|Overall Study|Non-study device implanted|0
4414548|NCT00289133|7194851|FG000|Overall Study|Protocol Violation|32
4414549|NCT00289133|7194852|FG001|Overall Study|Protocol Violation|38
4414550|NCT00289133|7194851|FG000|Overall Study|Withdrawal by Subject|9
4414551|NCT00289133|7194852|FG001|Overall Study|Withdrawal by Subject|10
4414552|NCT00289133|7194851|FG000|Overall Study|Death|5
4414553|NCT00289133|7194852|FG001|Overall Study|Death|10
4414554|NCT00289133|7194851|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73
4414555|NCT00289133|7194852|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74
4414556|NCT00289133|7194851|FG000|Overall Study|Physician Decision|41
4414557|NCT00289133|7194852|FG001|Overall Study|Physician Decision|45
4414558|NCT00289133|7194851|FG000|Overall Study|Revision|8
4414559|NCT00289133|7194852|FG001|Overall Study|Revision|6
4414560|NCT00289133|7194851|FG000|Overall Study|Lost to Follow-up|92
4414561|NCT00289133|7194852|FG001|Overall Study|Lost to Follow-up|115
4414562|NCT00289185|7194864|FG000|Overall Study|Withdrawal by Subject|4
4414563|NCT00289185|7194865|FG001|Overall Study|Withdrawal by Subject|8
4414564|NCT00289185|7194864|FG000|Overall Study|Lost to Follow-up|23
4414565|NCT00289185|7194865|FG001|Overall Study|Lost to Follow-up|17
4414566|NCT00289185|7194864|FG000|Overall Study|Death|1
4414567|NCT00289185|7194865|FG001|Overall Study|Death|1
4414568|NCT00289198|7194874|FG000|Overall Study|Adverse Event|0
4414569|NCT00289198|7194875|FG001|Overall Study|Adverse Event|2
4414570|NCT00289198|7194874|FG000|Overall Study|Protocol Violation|2
4414571|NCT00289198|7194875|FG001|Overall Study|Protocol Violation|1
4414572|NCT00289198|7194874|FG000|Overall Study|Withdrawal by Subject|4
4414573|NCT00289198|7194875|FG001|Overall Study|Withdrawal by Subject|1
4414574|NCT00289198|7194874|FG000|Overall Study|Lack of Efficacy|2
4414575|NCT00289198|7194875|FG001|Overall Study|Lack of Efficacy|0
4414576|NCT00289198|7194874|FG000|Overall Study|Other: Low compliance|0
4414577|NCT00289198|7194875|FG001|Overall Study|Other: Low compliance|1
4414578|NCT00289198|7194874|FG000|Overall Study|Other: Physician's decision|0
4414579|NCT00289198|7194875|FG001|Overall Study|Other: Physician's decision|1
4414580|NCT00289198|7194874|FG000|Overall Study|Other: Unable to attend on schedule|2
4414581|NCT00289198|7194875|FG001|Overall Study|Other: Unable to attend on schedule|1
4414582|NCT00289198|7194874|FG000|Overall Study|Other: Miscalculation of the visit date|21
4414583|NCT00289198|7194875|FG001|Overall Study|Other: Miscalculation of the visit date|22
4414584|NCT00289198|7194874|FG000|Overall Study|Other: Impossible to come on visit|0
4414585|NCT00289198|7194875|FG001|Overall Study|Other: Impossible to come on visit|1
4414586|NCT00289276|7194895|FG000|Second Part of FAST Study (Expansion)|Death|0
4414587|NCT00289276|7194896|FG001|Second Part of FAST Study (Expansion)|Death|2
4414588|NCT00289276|7194895|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0
4414589|NCT00289276|7194896|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1
4414590|NCT00289289|7194905|FG000|Overall Study|Withdrawal by Subject|5
4414591|NCT00289289|7194906|FG001|Overall Study|Withdrawal by Subject|3
4414592|NCT00289289|7194907|FG002|Overall Study|Withdrawal by Subject|15
4414593|NCT00289289|7194905|FG000|Overall Study|Lost to Follow-up|1
4414594|NCT00289289|7194906|FG001|Overall Study|Lost to Follow-up|0
4414595|NCT00289289|7194907|FG002|Overall Study|Lost to Follow-up|1
4414596|NCT00289289|7194905|FG000|Overall Study|Death|4
4414597|NCT00289289|7194906|FG001|Overall Study|Death|2
4414598|NCT00289289|7194907|FG002|Overall Study|Death|5
4414599|NCT00289289|7194905|FG000|Overall Study|No implant attempted|0
4414600|NCT00289289|7194906|FG001|Overall Study|No implant attempted|0
4414601|NCT00289289|7194907|FG002|Overall Study|No implant attempted|1
4414602|NCT00289289|7194905|FG000|Overall Study|Physician Decision|1
4414603|NCT00289289|7194906|FG001|Overall Study|Physician Decision|0
4414604|NCT00289289|7194907|FG002|Overall Study|Physician Decision|6
4414605|NCT00289289|7194905|FG000|Overall Study|Non-study device implanted|2
4414606|NCT00289289|7194906|FG001|Overall Study|Non-study device implanted|1
4414607|NCT00289289|7194907|FG002|Overall Study|Non-study device implanted|3
4414608|NCT00289289|7194905|FG000|Overall Study|Did not meet inclusion/exclusion|0
4414609|NCT00289289|7194906|FG001|Overall Study|Did not meet inclusion/exclusion|0
4414610|NCT00289289|7194907|FG002|Overall Study|Did not meet inclusion/exclusion|6
4414611|NCT00289289|7194905|FG000|Overall Study|Other Exit Reason|6
4414612|NCT00289289|7194906|FG001|Overall Study|Other Exit Reason|4
4414613|NCT00289289|7194907|FG002|Overall Study|Other Exit Reason|12
4414614|NCT00289458|7194943|FG000|Overall Study|Death|1
4414615|NCT00289458|7194944|FG001|Overall Study|Death|0
4414616|NCT00289458|7194945|FG002|Overall Study|Death|0
4414617|NCT00289458|7194943|FG000|Overall Study|Physician Decision|3
4414618|NCT00289458|7194944|FG001|Overall Study|Physician Decision|4
4414619|NCT00289458|7194945|FG002|Overall Study|Physician Decision|2
4414620|NCT00289458|7194943|FG000|Overall Study|Withdrawal by Subject|2
4414621|NCT00289458|7194944|FG001|Overall Study|Withdrawal by Subject|2
4414622|NCT00289458|7194945|FG002|Overall Study|Withdrawal by Subject|4
4414623|NCT00289536|7194957|FG000|Period 3|Lost to Follow-up|0
4414624|NCT00289536|7194958|FG001|Period 3|Lost to Follow-up|0
4414625|NCT00289536|7194959|FG002|Period 3|Lost to Follow-up|1
4414626|NCT00289731|7194982|FG000|Overall Study|Adverse Event|1
4414627|NCT00289731|7194983|FG001|Overall Study|Adverse Event|2
4414628|NCT00289731|7194984|FG002|Overall Study|Adverse Event|2
4414629|NCT00289731|7194982|FG000|Overall Study|Other|1
4414630|NCT00289731|7194983|FG001|Overall Study|Other|0
4414631|NCT00289731|7194984|FG002|Overall Study|Other|0
4414632|NCT00289770|7195008|FG000|Year 15|Withdrawal by Subject|1
4414633|NCT00289783|7195014|FG000|Primary Phase|Adverse Event|10
4414634|NCT00289783|7195015|FG001|Primary Phase|Adverse Event|1
4414635|NCT00289783|7195014|FG000|Primary Phase|Protocol Violation|27
4414636|NCT00289783|7195015|FG001|Primary Phase|Protocol Violation|6
4414637|NCT00289783|7195014|FG000|Primary Phase|Withdrawal by Subject|93
4414638|NCT00289783|7195015|FG001|Primary Phase|Withdrawal by Subject|40
4414639|NCT00289783|7195014|FG000|Primary Phase|Lost to Follow-up|60
4414640|NCT00289783|7195015|FG001|Primary Phase|Lost to Follow-up|14
4414641|NCT00289783|7195014|FG000|Primary Phase|Migration from the study area|26
4414642|NCT00289783|7195015|FG001|Primary Phase|Migration from the study area|10
4414643|NCT00289783|7195014|FG000|Primary Phase|Other|32
4414644|NCT00289783|7195015|FG001|Primary Phase|Other|12
4414645|NCT00289783|7195014|FG000|Fourth Dose Phase|Adverse Event|1
4414646|NCT00289783|7195015|FG001|Fourth Dose Phase|Adverse Event|0
4414647|NCT00289783|7195014|FG000|Fourth Dose Phase|Withdrawal by Subject|10
4414648|NCT00289783|7195015|FG001|Fourth Dose Phase|Withdrawal by Subject|1
4414649|NCT00289783|7195014|FG000|Fourth Dose Phase|Lost to Follow-up|53
4414650|NCT00289783|7195015|FG001|Fourth Dose Phase|Lost to Follow-up|12
4414651|NCT00289783|7195014|FG000|Fourth Dose Phase|Migration from the study area|1
4414652|NCT00289783|7195015|FG001|Fourth Dose Phase|Migration from the study area|1
4414653|NCT00289783|7195014|FG000|Fourth Dose Phase|Other|22
4414654|NCT00289783|7195015|FG001|Fourth Dose Phase|Other|10
4414655|NCT00289848|7195031|FG000|Overall Study|Adverse Event|6
4414656|NCT00289848|7195032|FG001|Overall Study|Adverse Event|4
4414657|NCT00289848|7195031|FG000|Overall Study|Death|1
4414658|NCT00289848|7195032|FG001|Overall Study|Death|0
4414659|NCT00289848|7195031|FG000|Overall Study|Lack of Efficacy|20
4414660|NCT00289848|7195032|FG001|Overall Study|Lack of Efficacy|24
4414661|NCT00289848|7195031|FG000|Overall Study|Lost to Follow-up|3
4414662|NCT00289848|7195032|FG001|Overall Study|Lost to Follow-up|1
4414663|NCT00289848|7195031|FG000|Overall Study|Protocol Violation|5
4414664|NCT00289848|7195032|FG001|Overall Study|Protocol Violation|2
4414665|NCT00289848|7195031|FG000|Overall Study|Withdrawal by Subject|5
4414666|NCT00289848|7195032|FG001|Overall Study|Withdrawal by Subject|11
4414667|NCT00289848|7195031|FG000|Overall Study|Patient Moved|6
4414668|NCT00289848|7195032|FG001|Overall Study|Patient Moved|2
4414669|NCT00289848|7195031|FG000|Overall Study|Open-Label AHA Treatment Requested|0
4414670|NCT00289848|7195032|FG001|Overall Study|Open-Label AHA Treatment Requested|1
4414671|NCT00289900|7195044|FG000|Overall Study|Adverse Event|28
4414672|NCT00289900|7195045|FG001|Overall Study|Adverse Event|40
4414673|NCT00289900|7195046|FG002|Overall Study|Adverse Event|13
4414674|NCT00289900|7195047|FG003|Overall Study|Adverse Event|19
4414675|NCT00289900|7195048|FG004|Overall Study|Adverse Event|20
4414676|NCT00289900|7195049|FG005|Overall Study|Adverse Event|33
4414677|NCT00289900|7195044|FG000|Overall Study|Lost to Follow-up|7
4414678|NCT00289900|7195045|FG001|Overall Study|Lost to Follow-up|7
4414679|NCT00289900|7195046|FG002|Overall Study|Lost to Follow-up|8
4414680|NCT00289900|7195047|FG003|Overall Study|Lost to Follow-up|8
4414681|NCT00289900|7195048|FG004|Overall Study|Lost to Follow-up|4
4414682|NCT00289900|7195049|FG005|Overall Study|Lost to Follow-up|8
4414683|NCT00289900|7195044|FG000|Overall Study|Participant had flushing|18
4414684|NCT00289900|7195045|FG001|Overall Study|Participant had flushing|42
4414685|NCT00289900|7195046|FG002|Overall Study|Participant had flushing|1
4414686|NCT00289900|7195047|FG003|Overall Study|Participant had flushing|2
4414687|NCT00289900|7195048|FG004|Overall Study|Participant had flushing|0
4414688|NCT00289900|7195049|FG005|Overall Study|Participant had flushing|4
4414689|NCT00289900|7195044|FG000|Overall Study|Other|0
4414690|NCT00289900|7195045|FG001|Overall Study|Other|0
4414691|NCT00289900|7195046|FG002|Overall Study|Other|0
4414692|NCT00289900|7195047|FG003|Overall Study|Other|5
4414693|NCT00289900|7195048|FG004|Overall Study|Other|1
4414694|NCT00289900|7195049|FG005|Overall Study|Other|0
4414695|NCT00289900|7195044|FG000|Overall Study|Participant moved|1
4414696|NCT00289900|7195045|FG001|Overall Study|Participant moved|0
4414697|NCT00289900|7195046|FG002|Overall Study|Participant moved|0
4414698|NCT00289900|7195047|FG003|Overall Study|Participant moved|1
4414699|NCT00289900|7195048|FG004|Overall Study|Participant moved|1
4414700|NCT00289900|7195049|FG005|Overall Study|Participant moved|1
4414701|NCT00289900|7195044|FG000|Overall Study|Withdrawal by Subject|10
4414702|NCT00289900|7195045|FG001|Overall Study|Withdrawal by Subject|21
4414703|NCT00289900|7195046|FG002|Overall Study|Withdrawal by Subject|8
4414704|NCT00289900|7195047|FG003|Overall Study|Withdrawal by Subject|18
4414705|NCT00289900|7195048|FG004|Overall Study|Withdrawal by Subject|12
4414706|NCT00289900|7195049|FG005|Overall Study|Withdrawal by Subject|11
4414707|NCT00289900|7195044|FG000|Overall Study|Protocol Violation|3
4414708|NCT00289900|7195045|FG001|Overall Study|Protocol Violation|9
4414709|NCT00289900|7195046|FG002|Overall Study|Protocol Violation|2
4414710|NCT00289900|7195047|FG003|Overall Study|Protocol Violation|6
4414711|NCT00289900|7195048|FG004|Overall Study|Protocol Violation|7
4414712|NCT00289900|7195049|FG005|Overall Study|Protocol Violation|4
4414713|NCT00289900|7195044|FG000|Overall Study|site terminated|1
4414714|NCT00289900|7195045|FG001|Overall Study|site terminated|0
4414715|NCT00289900|7195046|FG002|Overall Study|site terminated|1
4414716|NCT00289900|7195047|FG003|Overall Study|site terminated|0
4414717|NCT00289900|7195048|FG004|Overall Study|site terminated|0
4414718|NCT00289900|7195049|FG005|Overall Study|site terminated|0
4414719|NCT00289900|7195044|FG000|Overall Study|Not treated|0
4414720|NCT00289900|7195045|FG001|Overall Study|Not treated|1
4414721|NCT00289900|7195046|FG002|Overall Study|Not treated|0
4414722|NCT00289900|7195047|FG003|Overall Study|Not treated|0
4414723|NCT00289900|7195048|FG004|Overall Study|Not treated|0
4414724|NCT00289900|7195049|FG005|Overall Study|Not treated|0
4414725|NCT00289913|7195071|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
4414726|NCT00289913|7195072|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1
4414727|NCT00289913|7195073|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
4414728|NCT00289913|7195074|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
4414729|NCT00289913|7195075|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
4414730|NCT00289913|7195071|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3
4414731|NCT00289913|7195072|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
4414732|NCT00289913|7195073|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
4414733|NCT00289913|7195074|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
4414734|NCT00289913|7195075|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1
4414735|NCT00289913|7195071|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
4414736|NCT00289913|7195072|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
4414737|NCT00289913|7195073|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0
4414738|NCT00289913|7195074|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
4414739|NCT00289913|7195075|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
4414740|NCT00289913|7195071|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
4414741|NCT00289913|7195072|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
4414742|NCT00289913|7195073|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
4414743|NCT00289913|7195074|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
4414744|NCT00289913|7195075|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1
4414745|NCT00289913|7195071|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
4414746|NCT00289913|7195072|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
4414747|NCT00289913|7195073|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
4414748|NCT00289913|7195074|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1
4414749|NCT00289913|7195075|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
4414750|NCT00289913|7195071|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1
4414751|NCT00289913|7195072|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2
4414752|NCT00289913|7195073|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
4414753|NCT00289913|7195074|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
4414754|NCT00289913|7195075|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
4414755|NCT00289913|7195071|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2
4414756|NCT00289913|7195072|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1
4414757|NCT00289913|7195073|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0
4414758|NCT00289913|7195074|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0
4414759|NCT00289913|7195075|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5
4414760|NCT00289913|7195071|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
4414761|NCT00289913|7195072|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8
4414762|NCT00289913|7195073|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5
4629336|NCT01871285|7497230|FG002|First Intervention (1 Day)|Adverse Event|0
4629337|NCT01871285|7497231|FG003|First Intervention (1 Day)|Adverse Event|0
4629338|NCT01871285|7497228|FG000|First Intervention (1 Day)|Lost to Follow-up|0
4629339|NCT01871285|7497229|FG001|First Intervention (1 Day)|Lost to Follow-up|1
4629340|NCT01871285|7497230|FG002|First Intervention (1 Day)|Lost to Follow-up|1
4629341|NCT01871285|7497231|FG003|First Intervention (1 Day)|Lost to Follow-up|0
4629342|NCT01871402|7497243|FG000|Overall Study|Lost to Follow-up|1
4414763|NCT00289913|7195074|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6
4414764|NCT00289913|7195075|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
4414765|NCT00289913|7195071|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1
4414766|NCT00289913|7195072|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
4414767|NCT00289913|7195073|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2
4414768|NCT00289913|7195074|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
4414769|NCT00289913|7195075|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
4414770|NCT00289913|7195071|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
4414771|NCT00289913|7195072|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
4414772|NCT00289913|7195073|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1
4414773|NCT00289913|7195074|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
4414774|NCT00289913|7195075|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
4414775|NCT00289913|7195071|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8
4414776|NCT00289913|7195072|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11
4414777|NCT00289913|7195073|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2
4414778|NCT00289913|7195074|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2
4414779|NCT00289913|7195075|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0
4414780|NCT00289913|7195071|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
4414781|NCT00289913|7195072|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1
4414782|NCT00289913|7195073|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
4414783|NCT00289913|7195074|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
4414784|NCT00289913|7195075|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
4414785|NCT00289913|7195071|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3
4414786|NCT00289913|7195072|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2
4414787|NCT00289913|7195073|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1
4414788|NCT00289913|7195074|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0
4414789|NCT00289913|7195075|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0
4414790|NCT00289913|7195071|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1
4414791|NCT00289913|7195072|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
4414792|NCT00289913|7195073|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1
4414793|NCT00289913|7195074|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
4414794|NCT00289913|7195075|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
4414795|NCT00289913|7195071|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0
4414796|NCT00289913|7195072|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1
4414797|NCT00289913|7195073|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3
4414798|NCT00289913|7195074|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1
4414799|NCT00289913|7195075|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0
4414800|NCT00289913|7195071|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2
4414801|NCT00289913|7195072|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5
4414802|NCT00289913|7195073|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0
4414803|NCT00289913|7195074|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3
4414804|NCT00289913|7195075|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0
4414805|NCT00289913|7195071|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
4414806|NCT00289913|7195072|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1
4414807|NCT00289913|7195073|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2
4414808|NCT00289913|7195074|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
4414809|NCT00289913|7195075|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
4414810|NCT00289913|7195071|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1
4414811|NCT00289913|7195072|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
4414812|NCT00289913|7195073|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
4414813|NCT00289913|7195074|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
4414814|NCT00289913|7195075|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
4414815|NCT00289913|7195071|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
4414816|NCT00289913|7195072|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
4414817|NCT00289913|7195073|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
4414818|NCT00289913|7195074|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
4629343|NCT01871402|7497244|FG001|Overall Study|Lost to Follow-up|0
4414819|NCT00289913|7195075|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7
4414820|NCT00289913|7195071|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
4414821|NCT00289913|7195072|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
4414822|NCT00289913|7195073|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
4414823|NCT00289913|7195074|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
4414824|NCT00289913|7195075|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11
4414825|NCT00289913|7195071|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
4414826|NCT00289913|7195072|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
4414827|NCT00289913|7195073|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
4414828|NCT00289913|7195074|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
4414829|NCT00289913|7195075|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6
4414830|NCT00289913|7195071|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
4414831|NCT00289913|7195072|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
4414832|NCT00289913|7195073|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
4414833|NCT00289913|7195074|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
4414834|NCT00289913|7195075|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7
4414835|NCT00289913|7195071|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
4414836|NCT00289913|7195072|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
4414837|NCT00289913|7195073|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
4414838|NCT00289913|7195074|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
4414839|NCT00289913|7195075|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9
4414840|NCT00289913|7195071|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
4414841|NCT00289913|7195072|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1
4414842|NCT00289913|7195073|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
4414843|NCT00289913|7195074|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
4414844|NCT00289913|7195075|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
4414845|NCT00289913|7195071|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8
4414846|NCT00289913|7195072|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3
4414847|NCT00289913|7195073|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1
4414848|NCT00289913|7195074|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2
4414849|NCT00289913|7195075|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2
4414850|NCT00289913|7195071|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
4414851|NCT00289913|7195072|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
4414852|NCT00289913|7195073|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
4414853|NCT00289913|7195074|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1
4414854|NCT00289913|7195075|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
4414855|NCT00289913|7195071|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
4414856|NCT00289913|7195072|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
4414857|NCT00289913|7195073|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
4414858|NCT00289913|7195074|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
4414859|NCT00289913|7195075|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1
4414860|NCT00289913|7195071|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1
4414861|NCT00289913|7195072|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2
4414862|NCT00289913|7195073|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0
4414863|NCT00289913|7195074|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1
4414864|NCT00289913|7195075|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4
4414865|NCT00289913|7195071|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
4414866|NCT00289913|7195072|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1
4414867|NCT00289913|7195073|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1
4414868|NCT00289913|7195074|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
4414869|NCT00289913|7195075|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
4414870|NCT00289913|7195071|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
4414871|NCT00289913|7195072|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
4414872|NCT00289913|7195073|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
4414873|NCT00289913|7195074|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
4414874|NCT00289913|7195075|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1
4414875|NCT00289913|7195071|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
4414876|NCT00289913|7195072|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1
4414877|NCT00289913|7195073|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
4414878|NCT00289913|7195074|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
4414879|NCT00289913|7195075|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
4414880|NCT00289978|7195093|FG000|Overall Study|Withdrawal by Subject|31
4414881|NCT00289978|7195094|FG001|Overall Study|Withdrawal by Subject|17
4414882|NCT00289978|7195095|FG002|Overall Study|Withdrawal by Subject|28
4414883|NCT00289978|7195093|FG000|Overall Study|Adverse Event|22
4414884|NCT00289978|7195094|FG001|Overall Study|Adverse Event|13
4414885|NCT00289978|7195095|FG002|Overall Study|Adverse Event|18
4414886|NCT00289978|7195093|FG000|Overall Study|Lack of Efficacy|13
4414887|NCT00289978|7195094|FG001|Overall Study|Lack of Efficacy|6
4414888|NCT00289978|7195095|FG002|Overall Study|Lack of Efficacy|25
4414889|NCT00289978|7195093|FG000|Overall Study|Abnormal laboratory value(s)|20
4414890|NCT00289978|7195094|FG001|Overall Study|Abnormal laboratory value(s)|9
4414891|NCT00289978|7195095|FG002|Overall Study|Abnormal laboratory value(s)|1
4414892|NCT00289978|7195093|FG000|Overall Study|Lost to Follow-up|3
4414893|NCT00289978|7195094|FG001|Overall Study|Lost to Follow-up|5
4414894|NCT00289978|7195095|FG002|Overall Study|Lost to Follow-up|7
4414895|NCT00289978|7195093|FG000|Overall Study|Protocol Violation|5
4414896|NCT00289978|7195094|FG001|Overall Study|Protocol Violation|5
4414897|NCT00289978|7195095|FG002|Overall Study|Protocol Violation|4
4414898|NCT00289978|7195093|FG000|Overall Study|Abnormal test procedure result(s)|2
4414899|NCT00289978|7195094|FG001|Overall Study|Abnormal test procedure result(s)|1
4414900|NCT00289978|7195095|FG002|Overall Study|Abnormal test procedure result(s)|1
4414901|NCT00289978|7195093|FG000|Overall Study|Death|1
4414902|NCT00289978|7195094|FG001|Overall Study|Death|0
4414903|NCT00289978|7195095|FG002|Overall Study|Death|2
4414904|NCT00289991|7195105|FG000|Overall Study|Death|35
4414905|NCT00289991|7195106|FG001|Overall Study|Death|38
4414906|NCT00289991|7195105|FG000|Overall Study|Adverse Event|15
4414907|NCT00289991|7195106|FG001|Overall Study|Adverse Event|13
4414908|NCT00289991|7195105|FG000|Overall Study|Failure of prophylaxis|1
4414909|NCT00289991|7195106|FG001|Overall Study|Failure of prophylaxis|1
4414910|NCT00289991|7195105|FG000|Overall Study|Fungal breakthrough infection|0
4414911|NCT00289991|7195106|FG001|Overall Study|Fungal breakthrough infection|1
4414912|NCT00289991|7195105|FG000|Overall Study|Lost to Follow-up|0
4414913|NCT00289991|7195106|FG001|Overall Study|Lost to Follow-up|1
4414914|NCT00289991|7195105|FG000|Overall Study|Withdrawal by Subject|2
4414915|NCT00289991|7195106|FG001|Overall Study|Withdrawal by Subject|12
4414916|NCT00289991|7195105|FG000|Overall Study|Other|5
4414917|NCT00289991|7195106|FG001|Overall Study|Other|14
4414918|NCT00290186|7195123|FG000|Overall Study|Adverse Event|1
4414919|NCT00290186|7195124|FG001|Overall Study|Adverse Event|1
4414920|NCT00290186|7195123|FG000|Overall Study|Lost to Follow-up|3
4414921|NCT00290186|7195124|FG001|Overall Study|Lost to Follow-up|2
4414922|NCT00290186|7195123|FG000|Overall Study|Study was terminated prior to 3-month te|1
4414923|NCT00290186|7195124|FG001|Overall Study|Study was terminated prior to 3-month te|1
4414924|NCT00290186|7195123|FG000|Overall Study|Withdrawal by Subject|0
4414925|NCT00290186|7195124|FG001|Overall Study|Withdrawal by Subject|1
4414926|NCT00290238|7195145|FG000|Overall Study|Study terminated|27
4414927|NCT00290238|7195146|FG001|Overall Study|Study terminated|27
4414928|NCT00290238|7195145|FG000|Overall Study|Lost to Follow-up|0
4414929|NCT00290238|7195146|FG001|Overall Study|Lost to Follow-up|1
4414930|NCT00290238|7195145|FG000|Overall Study|Withdrawal by Subject|15
4414931|NCT00290238|7195146|FG001|Overall Study|Withdrawal by Subject|13
4414932|NCT00290290|7195154|FG000|Overall Study|Death|3
4414933|NCT00290290|7195155|FG001|Overall Study|Death|4
4414934|NCT00290290|7195154|FG000|Overall Study|Withdrawal by Subject|2
4414935|NCT00290290|7195155|FG001|Overall Study|Withdrawal by Subject|2
4414936|NCT00290290|7195154|FG000|Overall Study|Underwent clean surgical procedure|13
4414937|NCT00290290|7195155|FG001|Overall Study|Underwent clean surgical procedure|12
4414938|NCT00290342|7195178|FG000|Overall Study|Other|0
4414939|NCT00290342|7195179|FG001|Overall Study|Other|1
4414940|NCT00290342|7195178|FG000|Overall Study|Withdrawal by Subject|6
4414941|NCT00290342|7195179|FG001|Overall Study|Withdrawal by Subject|4
4414942|NCT00290342|7195178|FG000|Overall Study|Lost to Follow-up|1
4414943|NCT00290342|7195179|FG001|Overall Study|Lost to Follow-up|0
4414944|NCT00290355|7195187|FG000|Overall Study|Serious adverse event|7
4414945|NCT00290355|7195188|FG001|Overall Study|Serious adverse event|4
4414946|NCT00290355|7195187|FG000|Overall Study|Study product reactogenicity|1
4414947|NCT00290355|7195188|FG001|Overall Study|Study product reactogenicity|0
4414948|NCT00290355|7195187|FG000|Overall Study|Protocol Violation|1
4414949|NCT00290355|7195188|FG001|Overall Study|Protocol Violation|0
4414950|NCT00290355|7195187|FG000|Overall Study|Withdrawal by Subject|2
4629344|NCT01871402|7497243|FG000|Overall Study|Withdrawal by Subject|0
4629345|NCT01871402|7497244|FG001|Overall Study|Withdrawal by Subject|2
4414951|NCT00290355|7195188|FG001|Overall Study|Withdrawal by Subject|0
4414952|NCT00290355|7195187|FG000|Overall Study|Migrated / moved from the study area|1
4414953|NCT00290355|7195188|FG001|Overall Study|Migrated / moved from the study area|0
4414954|NCT00290355|7195187|FG000|Overall Study|Lost to Follow-up|3
4414955|NCT00290355|7195188|FG001|Overall Study|Lost to Follow-up|1
4414956|NCT00290355|7195187|FG000|Overall Study|Other|2
4414957|NCT00290355|7195188|FG001|Overall Study|Other|0
4414958|NCT00290433|7195194|FG000|Overall Study|Disease Progression|13
4414959|NCT00290433|7195194|FG000|Overall Study|Adverse Event|14
4414960|NCT00290433|7195194|FG000|Overall Study|Withdrawal by Subject|1
4414961|NCT00290433|7195194|FG000|Overall Study|Non-Compliance|1
4414962|NCT00290433|7195194|FG000|Overall Study|Congestive Heart Failure|1
4414963|NCT00290433|7195194|FG000|Overall Study|Transplant in CR|5
4414964|NCT00290433|7195194|FG000|Overall Study|Unrelated Infection/Death|1
4414965|NCT00290498|7195211|FG000|Overall Study|Death|2
4414966|NCT00290498|7195212|FG001|Overall Study|Death|0
4414967|NCT00290498|7195211|FG000|Overall Study|Physician Decision|1
4414968|NCT00290498|7195212|FG001|Overall Study|Physician Decision|0
4414969|NCT00290498|7195211|FG000|Overall Study|Withdrawal by Subject|1
4414970|NCT00290498|7195212|FG001|Overall Study|Withdrawal by Subject|0
4414971|NCT00290498|7195211|FG000|Overall Study|Ineligible|3
4414972|NCT00290498|7195212|FG001|Overall Study|Ineligible|0
4414973|NCT00290498|7195211|FG000|Overall Study|Non-Compliance|1
4414974|NCT00290498|7195212|FG001|Overall Study|Non-Compliance|0
4414975|NCT00290589|7195227|FG000|Overall Study|Lost to Follow-up|2
4414976|NCT00290589|7195228|FG001|Overall Study|Lost to Follow-up|2
4414977|NCT00290693|7195242|FG000|Overall Study|Withdrawal by Subject|2
4414978|NCT00290706|7195251|FG000|Overall Study|Withdrawal by Subject|2
4414979|NCT00290706|7195252|FG001|Overall Study|Withdrawal by Subject|0
4414980|NCT00290706|7195253|FG002|Overall Study|Withdrawal by Subject|0
4414981|NCT00290706|7195254|FG003|Overall Study|Withdrawal by Subject|0
4414982|NCT00290706|7195251|FG000|Overall Study|Progressive Disease|3
4414983|NCT00290706|7195252|FG001|Overall Study|Progressive Disease|5
4414984|NCT00290706|7195253|FG002|Overall Study|Progressive Disease|4
4414985|NCT00290706|7195254|FG003|Overall Study|Progressive Disease|10
4414986|NCT00290706|7195251|FG000|Overall Study|Adverse Event|0
4714863|NCT02963506|7642889|FG008|Dose-Blind Period|Withdrawal by Subject|0
4414987|NCT00290706|7195252|FG001|Overall Study|Adverse Event|1
4414988|NCT00290706|7195253|FG002|Overall Study|Adverse Event|2
4414989|NCT00290706|7195254|FG003|Overall Study|Adverse Event|0
4414990|NCT00290706|7195251|FG000|Overall Study|Receive auto transplant or radiation|0
4414991|NCT00290706|7195252|FG001|Overall Study|Receive auto transplant or radiation|0
4414992|NCT00290706|7195253|FG002|Overall Study|Receive auto transplant or radiation|0
4414993|NCT00290706|7195254|FG003|Overall Study|Receive auto transplant or radiation|1
4414994|NCT00290706|7195251|FG000|Overall Study|Physician Decision|0
4414995|NCT00290706|7195252|FG001|Overall Study|Physician Decision|0
4414996|NCT00290706|7195253|FG002|Overall Study|Physician Decision|0
4414997|NCT00290706|7195254|FG003|Overall Study|Physician Decision|1
4414998|NCT00290732|7195267|FG000|Overall Study|Inability to instill drug intraductally.|0
4414999|NCT00290732|7195268|FG001|Overall Study|Inability to instill drug intraductally.|1
4415000|NCT00290732|7195269|FG002|Overall Study|Inability to instill drug intraductally.|1
4415001|NCT00290732|7195270|FG003|Overall Study|Inability to instill drug intraductally.|0
4415002|NCT00290732|7195271|FG004|Overall Study|Inability to instill drug intraductally.|0
4415003|NCT00290745|7195284|FG000|Overall Study|Withdrawal by Subject|4
4415004|NCT00290745|7195284|FG000|Overall Study|Physician Decision|2
4415005|NCT00290745|7195284|FG000|Overall Study|Surgery after 3 months for progression|3
4415006|NCT00290745|7195284|FG000|Overall Study|Baseline MRI not available|3
4511798|NCT00929240|7321218|FG001|Initial Treatment Phase|Adverse Event|0
4511799|NCT00929240|7321219|FG002|Initial Treatment Phase|Adverse Event|0
4511800|NCT00929240|7321217|FG000|Initial Treatment Phase|Disease progression|41
4511801|NCT00929240|7321218|FG001|Initial Treatment Phase|Disease progression|0
4511802|NCT00929240|7321219|FG002|Initial Treatment Phase|Disease progression|0
4511803|NCT00929240|7321217|FG000|Initial Treatment Phase|Withdrawal by Subject|13
4511804|NCT00929240|7321218|FG001|Initial Treatment Phase|Withdrawal by Subject|0
4511805|NCT00929240|7321219|FG002|Initial Treatment Phase|Withdrawal by Subject|0
4511806|NCT00929240|7321217|FG000|Initial Treatment Phase|Protocol Violation|5
4511807|NCT00929240|7321218|FG001|Initial Treatment Phase|Protocol Violation|0
4511808|NCT00929240|7321219|FG002|Initial Treatment Phase|Protocol Violation|0
4511809|NCT00929240|7321217|FG000|Initial Treatment Phase|Death|2
4511810|NCT00929240|7321218|FG001|Initial Treatment Phase|Death|0
4511811|NCT00929240|7321219|FG002|Initial Treatment Phase|Death|0
4511812|NCT00929240|7321217|FG000|Initial Treatment Phase|Health authority/Study termination|3
4511813|NCT00929240|7321218|FG001|Initial Treatment Phase|Health authority/Study termination|0
4511814|NCT00929240|7321219|FG002|Initial Treatment Phase|Health authority/Study termination|0
4511815|NCT00929240|7321217|FG000|Initial Treatment Phase|Physician Decision|4
4511816|NCT00929240|7321218|FG001|Initial Treatment Phase|Physician Decision|0
4511817|NCT00929240|7321219|FG002|Initial Treatment Phase|Physician Decision|0
4511818|NCT00929240|7321217|FG000|Maintenance Phase|Disease progression|0
4511819|NCT00929240|7321218|FG001|Maintenance Phase|Disease progression|73
4511820|NCT00929240|7321219|FG002|Maintenance Phase|Disease progression|60
4511821|NCT00929240|7321217|FG000|Maintenance Phase|Adverse Event|0
4511822|NCT00929240|7321218|FG001|Maintenance Phase|Adverse Event|9
4511823|NCT00929240|7321219|FG002|Maintenance Phase|Adverse Event|12
4511824|NCT00929240|7321217|FG000|Maintenance Phase|Withdrawal by Subject|0
4511825|NCT00929240|7321218|FG001|Maintenance Phase|Withdrawal by Subject|2
4511826|NCT00929240|7321219|FG002|Maintenance Phase|Withdrawal by Subject|6
4511827|NCT00929240|7321217|FG000|Maintenance Phase|Protocol Violation|0
4590449|NCT01521884|7436498|FG000|Overall Study|Physician Decision|2
4590450|NCT01521884|7436498|FG000|Overall Study|Protocol Violation|3
4590451|NCT01521884|7436498|FG000|Overall Study|Participant non-eligible|1
4590452|NCT01521884|7436498|FG000|Overall Study|Lost to Follow-up|4
4593705|NCT01554618|7442283|FG000|Open-Label Extension Period|Withdrawal by Subject|2
4593706|NCT01554618|7442284|FG001|Open-Label Extension Period|Withdrawal by Subject|3
4511828|NCT00929240|7321218|FG001|Maintenance Phase|Protocol Violation|1
4593707|NCT01554618|7442283|FG000|Open-Label Extension Period|Physician Decision|0
4593708|NCT01554618|7442284|FG001|Open-Label Extension Period|Physician Decision|1
4593709|NCT01554618|7442283|FG000|Open-Label Extension Period|Lost to Follow-up|1
4593710|NCT01554618|7442284|FG001|Open-Label Extension Period|Lost to Follow-up|1
4415007|NCT00290771|7195290|FG000|Overall Study|Disease progression|95
4415008|NCT00290771|7195291|FG001|Overall Study|Disease progression|73
4415009|NCT00290771|7195290|FG000|Overall Study|Death|11
4415010|NCT00290771|7195291|FG001|Overall Study|Death|10
4415011|NCT00290771|7195290|FG000|Overall Study|Adverse Event|12
4415012|NCT00290771|7195291|FG001|Overall Study|Adverse Event|6
4415013|NCT00290771|7195290|FG000|Overall Study|Withdrawal by Subject|5
4415014|NCT00290771|7195291|FG001|Overall Study|Withdrawal by Subject|6
4415015|NCT00290771|7195290|FG000|Overall Study|Administrative problems|2
4415016|NCT00290771|7195291|FG001|Overall Study|Administrative problems|1
4415017|NCT00290771|7195290|FG000|Overall Study|Protocol Violation|2
4415018|NCT00290771|7195291|FG001|Overall Study|Protocol Violation|0
4415019|NCT00290771|7195290|FG000|Overall Study|Lost to Follow-up|0
4415020|NCT00290771|7195291|FG001|Overall Study|Lost to Follow-up|1
4415021|NCT00290888|7195304|FG000|Overall Study|Physician Decision|3
4415022|NCT00290888|7195305|FG001|Overall Study|Physician Decision|1
4415023|NCT00291018|7195315|FG000|Overall Study|Not Consented or Declined PAS|12
4415024|NCT00291018|7195316|FG001|Overall Study|Not Consented or Declined PAS|15
4415025|NCT00291018|7195317|FG002|Overall Study|Not Consented or Declined PAS|15
4415026|NCT00291018|7195315|FG000|Overall Study|Death|3
4415027|NCT00291018|7195316|FG001|Overall Study|Death|3
4415028|NCT00291018|7195317|FG002|Overall Study|Death|4
4415029|NCT00291018|7195315|FG000|Overall Study|Withdrawal by Subject|2
4415030|NCT00291018|7195316|FG001|Overall Study|Withdrawal by Subject|8
4415031|NCT00291018|7195317|FG002|Overall Study|Withdrawal by Subject|1
4415032|NCT00291018|7195315|FG000|Overall Study|Failures|5
4415033|NCT00291018|7195316|FG001|Overall Study|Failures|12
4415034|NCT00291018|7195317|FG002|Overall Study|Failures|5
4415035|NCT00291018|7195315|FG000|Overall Study|Lost to Follow-up|3
4415036|NCT00291018|7195316|FG001|Overall Study|Lost to Follow-up|4
4415037|NCT00291018|7195317|FG002|Overall Study|Lost to Follow-up|18
4415038|NCT00291187|7195351|FG000|Overall Study|Protocol Violation- No Drug Administered|0
4415039|NCT00291187|7195352|FG001|Overall Study|Protocol Violation- No Drug Administered|0
4415040|NCT00291187|7195353|FG002|Overall Study|Protocol Violation- No Drug Administered|1
4415041|NCT00291187|7195354|FG003|Overall Study|Protocol Violation- No Drug Administered|0
4415042|NCT00291330|7195384|FG000|Overall Study|Adverse Event|47
4415043|NCT00291330|7195385|FG001|Overall Study|Adverse Event|40
4415044|NCT00291330|7195384|FG000|Overall Study|Protocol Violation|13
4415045|NCT00291330|7195385|FG001|Overall Study|Protocol Violation|20
4415046|NCT00291330|7195384|FG000|Overall Study|Lost to Follow-up|16
4415047|NCT00291330|7195385|FG001|Overall Study|Lost to Follow-up|11
4415048|NCT00291330|7195384|FG000|Overall Study|Withdrawal by Subject|22
4415049|NCT00291330|7195385|FG001|Overall Study|Withdrawal by Subject|25
4415050|NCT00291330|7195384|FG000|Overall Study|Other|3
4415051|NCT00291330|7195385|FG001|Overall Study|Other|1
4415052|NCT00291499|7195420|FG000|Overall Study|Adverse Event|3
4415053|NCT00291499|7195421|FG001|Overall Study|Adverse Event|8
4415054|NCT00291499|7195420|FG000|Overall Study|Change to other therapy|2
4415055|NCT00291499|7195421|FG001|Overall Study|Change to other therapy|1
4415056|NCT00291499|7195420|FG000|Overall Study|Intercurrent illness|1
4415057|NCT00291499|7195421|FG001|Overall Study|Intercurrent illness|0
4415058|NCT00291499|7195420|FG000|Overall Study|Protocol Violation|2
4415059|NCT00291499|7195421|FG001|Overall Study|Protocol Violation|2
4415060|NCT00291499|7195420|FG000|Overall Study|Other reasons|1
4415061|NCT00291499|7195421|FG001|Overall Study|Other reasons|4
4415062|NCT00291551|7195427|FG000|Overall Study|Death|7
4415063|NCT00291551|7195427|FG000|Overall Study|Withdrawal by Subject|6
4415064|NCT00291577|7195432|FG000|Overall Study|Adverse Event|1
4415065|NCT00291577|7195432|FG000|Overall Study|Other|4
4415066|NCT00291577|7195432|FG000|Overall Study|Withdrawal by Subject|2
4415067|NCT00291577|7195432|FG000|Overall Study|Lack of Efficacy|14
4415068|NCT00291642|7195441|FG000|Overall Study|Adverse Event|1
4415069|NCT00291642|7195442|FG001|Overall Study|Adverse Event|0
4415070|NCT00291642|7195443|FG002|Overall Study|Adverse Event|1
4415071|NCT00291642|7195444|FG003|Overall Study|Adverse Event|0
4415072|NCT00291642|7195445|FG004|Overall Study|Adverse Event|1
4415073|NCT00291642|7195441|FG000|Overall Study|Patient missed visit|0
4415074|NCT00291642|7195442|FG001|Overall Study|Patient missed visit|0
4415075|NCT00291642|7195443|FG002|Overall Study|Patient missed visit|1
4415076|NCT00291642|7195444|FG003|Overall Study|Patient missed visit|0
4415077|NCT00291642|7195445|FG004|Overall Study|Patient missed visit|0
4415078|NCT00291642|7195441|FG000|Overall Study|Intake of prohibited medication|1
4415079|NCT00291642|7195442|FG001|Overall Study|Intake of prohibited medication|0
4415080|NCT00291642|7195443|FG002|Overall Study|Intake of prohibited medication|0
4415081|NCT00291642|7195444|FG003|Overall Study|Intake of prohibited medication|0
4415082|NCT00291642|7195445|FG004|Overall Study|Intake of prohibited medication|0
4415083|NCT00291668|7195464|FG000|Overall Study|Lack of Efficacy|1
4415084|NCT00291668|7195465|FG001|Overall Study|Lack of Efficacy|0
4415085|NCT00291668|7195466|FG002|Overall Study|Lack of Efficacy|0
4415086|NCT00291668|7195464|FG000|Overall Study|SAE, non-fatal|1
4415087|NCT00291668|7195465|FG001|Overall Study|SAE, non-fatal|1
4415088|NCT00291668|7195466|FG002|Overall Study|SAE, non-fatal|1
4415089|NCT00291668|7195464|FG000|Overall Study|AE, non-serious non-fatal|1
4415090|NCT00291668|7195465|FG001|Overall Study|AE, non-serious non-fatal|0
4415091|NCT00291668|7195466|FG002|Overall Study|AE, non-serious non-fatal|0
4415092|NCT00291668|7195464|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
4415093|NCT00291668|7195465|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
4415094|NCT00291668|7195466|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
4415095|NCT00292045|7195489|FG000|Core Study (Through Week 13)|Adverse Event|1
4415096|NCT00292045|7195489|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1
4415097|NCT00292188|7195504|FG000|Single-Blind|Adverse Event|14
4415098|NCT00292188|7195505|FG001|Single-Blind|Adverse Event|0
4415099|NCT00292188|7195506|FG002|Single-Blind|Adverse Event|0
4415100|NCT00292188|7195504|FG000|Single-Blind|Lack of Efficacy|2
4415101|NCT00292188|7195505|FG001|Single-Blind|Lack of Efficacy|0
4415102|NCT00292188|7195506|FG002|Single-Blind|Lack of Efficacy|0
4415103|NCT00292188|7195504|FG000|Single-Blind|Laboratory Abnormality|5
4415104|NCT00292188|7195505|FG001|Single-Blind|Laboratory Abnormality|0
4415105|NCT00292188|7195506|FG002|Single-Blind|Laboratory Abnormality|0
4415106|NCT00292188|7195504|FG000|Single-Blind|Lost to Follow-up|3
4415107|NCT00292188|7195505|FG001|Single-Blind|Lost to Follow-up|0
4415108|NCT00292188|7195506|FG002|Single-Blind|Lost to Follow-up|0
4415109|NCT00292188|7195504|FG000|Single-Blind|Other|77
4415110|NCT00292188|7195505|FG001|Single-Blind|Other|0
4415111|NCT00292188|7195506|FG002|Single-Blind|Other|0
4415112|NCT00292188|7195504|FG000|Single-Blind|Withdrawal by Subject|12
4415113|NCT00292188|7195505|FG001|Single-Blind|Withdrawal by Subject|0
4415114|NCT00292188|7195506|FG002|Single-Blind|Withdrawal by Subject|0
4415115|NCT00292188|7195504|FG000|Single-Blind|Did not receive treatment|1
4415116|NCT00292188|7195505|FG001|Single-Blind|Did not receive treatment|0
4415117|NCT00292188|7195506|FG002|Single-Blind|Did not receive treatment|0
4415118|NCT00292188|7195504|FG000|Double-Blind|Adverse Event|0
4415119|NCT00292188|7195505|FG001|Double-Blind|Adverse Event|25
4415120|NCT00292188|7195506|FG002|Double-Blind|Adverse Event|9
4415121|NCT00292188|7195504|FG000|Double-Blind|Lack of Efficacy|0
4415122|NCT00292188|7195505|FG001|Double-Blind|Lack of Efficacy|2
4415123|NCT00292188|7195506|FG002|Double-Blind|Lack of Efficacy|12
4415124|NCT00292188|7195504|FG000|Double-Blind|Lost to Follow-up|0
4415125|NCT00292188|7195505|FG001|Double-Blind|Lost to Follow-up|1
4415126|NCT00292188|7195506|FG002|Double-Blind|Lost to Follow-up|0
4415127|NCT00292188|7195504|FG000|Double-Blind|Other|0
4415128|NCT00292188|7195505|FG001|Double-Blind|Other|3
4415129|NCT00292188|7195506|FG002|Double-Blind|Other|4
4415130|NCT00292188|7195504|FG000|Double-Blind|Withdrawal by Subject|0
4415131|NCT00292188|7195505|FG001|Double-Blind|Withdrawal by Subject|0
4415132|NCT00292188|7195506|FG002|Double-Blind|Withdrawal by Subject|3
4415133|NCT00292188|7195504|FG000|Double-Blind|Laboratory Abnormality|0
4415134|NCT00292188|7195505|FG001|Double-Blind|Laboratory Abnormality|0
4415135|NCT00292188|7195506|FG002|Double-Blind|Laboratory Abnormality|1
4415136|NCT00292227|7195515|FG000|Patch Period|Adverse Event|1
4415137|NCT00292227|7195516|FG001|Patch Period|Adverse Event|0
4415138|NCT00292227|7195517|FG002|Patch Period|Adverse Event|2
4415139|NCT00292227|7195515|FG000|Patch Period|Withdrawal by Subject|0
4415140|NCT00292227|7195516|FG001|Patch Period|Withdrawal by Subject|0
4415141|NCT00292227|7195517|FG002|Patch Period|Withdrawal by Subject|1
4415142|NCT00292318|7195527|FG000|Overall Study|Study terminated by officials|2
4415143|NCT00292318|7195528|FG001|Overall Study|Study terminated by officials|1
4415144|NCT00292370|7195537|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12
4415145|NCT00292370|7195538|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0
4415146|NCT00292370|7195539|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0
4415147|NCT00292370|7195537|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22
4415148|NCT00292370|7195538|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0
4415149|NCT00292370|7195539|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0
4415150|NCT00292370|7195537|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8
4415151|NCT00292370|7195538|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0
4415152|NCT00292370|7195539|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0
4415153|NCT00292370|7195537|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4
4415154|NCT00292370|7195538|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0
4415155|NCT00292370|7195539|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0
4415156|NCT00292370|7195537|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0
4415157|NCT00292370|7195538|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3
4415158|NCT00292370|7195539|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2
4415159|NCT00292370|7195537|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0
4415160|NCT00292370|7195538|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1
4415161|NCT00292370|7195539|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5
4415162|NCT00292461|7195548|FG000|Overall Study|Adverse Event|4
4415163|NCT00292461|7195549|FG001|Overall Study|Adverse Event|2
4415164|NCT00292461|7195548|FG000|Overall Study|Lack of Efficacy|1
4415165|NCT00292461|7195549|FG001|Overall Study|Lack of Efficacy|0
4415166|NCT00292461|7195548|FG000|Overall Study|Withdrawal by Subject|0
4415167|NCT00292461|7195549|FG001|Overall Study|Withdrawal by Subject|1
4415168|NCT00292461|7195548|FG000|Overall Study|Protocol Violation|4
4415169|NCT00292461|7195549|FG001|Overall Study|Protocol Violation|3
4415170|NCT00292461|7195548|FG000|Overall Study|Lost to Follow-up|1
4415171|NCT00292461|7195549|FG001|Overall Study|Lost to Follow-up|0
4415172|NCT00292942|7195572|FG000|Overall Study|Withdrawal by Subject|0
4415173|NCT00292942|7195573|FG001|Overall Study|Withdrawal by Subject|0
4415174|NCT00292942|7195574|FG002|Overall Study|Withdrawal by Subject|1
4415175|NCT00292942|7195575|FG003|Overall Study|Withdrawal by Subject|0
4415176|NCT00292942|7195572|FG000|Overall Study|Adverse Event|0
4415177|NCT00292942|7195573|FG001|Overall Study|Adverse Event|0
4415178|NCT00292942|7195574|FG002|Overall Study|Adverse Event|0
4415179|NCT00292942|7195575|FG003|Overall Study|Adverse Event|1
4415180|NCT00292981|7195588|FG000|Overall Study|Adverse Event|1
4415181|NCT00292981|7195588|FG000|Overall Study|Lost to Follow-up|13
4415182|NCT00292981|7195588|FG000|Overall Study|Withdrawal by Subject|22
4415183|NCT00292981|7195588|FG000|Overall Study|Other|3
4415184|NCT00293020|7195592|FG000|Overall Study|Withdrawal by Subject|34
4415185|NCT00293020|7195592|FG000|Overall Study|Adverse Event|30
4415186|NCT00293020|7195592|FG000|Overall Study|Death|32
4415187|NCT00293020|7195592|FG000|Overall Study|Lack of Efficacy|12
4415188|NCT00293020|7195592|FG000|Overall Study|Lost to Follow-up|4
4415189|NCT00293020|7195592|FG000|Overall Study|Protocol Violation|6
4415190|NCT00293020|7195592|FG000|Overall Study|Physician Decision|21
4415191|NCT00293020|7195592|FG000|Overall Study|Other Reason|22
4415192|NCT00293020|7195592|FG000|Overall Study|No dose taken|1
4415193|NCT00293033|7195596|FG000|Open-label Titration Period|Adverse Event|10
4415194|NCT00293033|7195596|FG000|Open-label Titration Period|Death|3
4415195|NCT00293033|7195596|FG000|Open-label Titration Period|Lack of Efficacy|5
4415196|NCT00293033|7195596|FG000|Open-label Titration Period|Protocol Violation|2
4415197|NCT00293033|7195596|FG000|Open-label Titration Period|Withdrawal by Subject|22
4415198|NCT00293033|7195596|FG000|Open-label Titration Period|Noncompliance and other|27
4415199|NCT00293033|7195596|FG000|Double-blind Treatment Period|Adverse Event|3
4415200|NCT00293033|7195596|FG000|Double-blind Treatment Period|Lack of Efficacy|1
4415201|NCT00293033|7195596|FG000|Double-blind Treatment Period|Withdrawal by Subject|4
4415202|NCT00293033|7195596|FG000|Double-blind Treatment Period|Noncompliance|4
4415203|NCT00293059|7195606|FG000|Overall Study|Adverse Event|12
4415204|NCT00293059|7195607|FG001|Overall Study|Adverse Event|4
4415205|NCT00293059|7195606|FG000|Overall Study|Lack of Efficacy|2
4415206|NCT00293059|7195607|FG001|Overall Study|Lack of Efficacy|0
4415207|NCT00293059|7195606|FG000|Overall Study|Lost to Follow-up|2
4415208|NCT00293059|7195607|FG001|Overall Study|Lost to Follow-up|3
4415209|NCT00293059|7195606|FG000|Overall Study|Pregnancy|1
4415210|NCT00293059|7195607|FG001|Overall Study|Pregnancy|1
4415211|NCT00293059|7195606|FG000|Overall Study|Protocol Violation|2
4415212|NCT00293059|7195607|FG001|Overall Study|Protocol Violation|0
4415213|NCT00293059|7195606|FG000|Overall Study|Withdrawal by Subject|11
4415214|NCT00293059|7195607|FG001|Overall Study|Withdrawal by Subject|5
4415215|NCT00293059|7195606|FG000|Overall Study|Participant moved out of state|1
4415216|NCT00293059|7195607|FG001|Overall Study|Participant moved out of state|0
4415217|NCT00293059|7195606|FG000|Overall Study|Participant stopped study drug|1
4415218|NCT00293059|7195607|FG001|Overall Study|Participant stopped study drug|0
4415219|NCT00293059|7195606|FG000|Overall Study|Noncompliant - sanitary pads collection|0
4415220|NCT00293059|7195607|FG001|Overall Study|Noncompliant - sanitary pads collection|1
4415221|NCT00293059|7195606|FG000|Overall Study|missing|3
4415222|NCT00293059|7195607|FG001|Overall Study|missing|5
4415223|NCT00293202|7195615|FG000|Overall Study|Withdrawal by Subject|1
4415224|NCT00293202|7195616|FG001|Overall Study|Withdrawal by Subject|2
4415225|NCT00293202|7195615|FG000|Overall Study|positive ANA (antinuclear antibody)|1
4415226|NCT00293202|7195616|FG001|Overall Study|positive ANA (antinuclear antibody)|0
4415227|NCT00293202|7195615|FG000|Overall Study|on-hold due to fistula maturation time|1
4415228|NCT00293202|7195616|FG001|Overall Study|on-hold due to fistula maturation time|0
4415229|NCT00293215|7195628|FG000|Overall Study|Progressive disease|3
4415230|NCT00293215|7195629|FG001|Overall Study|Progressive disease|1
4415231|NCT00293215|7195628|FG000|Overall Study|Adverse Event|2
4415232|NCT00293215|7195629|FG001|Overall Study|Adverse Event|2
4415233|NCT00293241|7195637|FG000|Overall Study|Lost to Follow-up|9
4415234|NCT00293241|7195638|FG001|Overall Study|Lost to Follow-up|16
4415235|NCT00293241|7195637|FG000|Overall Study|Physician Decision|23
4415236|NCT00293241|7195638|FG001|Overall Study|Physician Decision|17
4415237|NCT00293241|7195637|FG000|Overall Study|Withdrawal by Subject|4
4415238|NCT00293241|7195638|FG001|Overall Study|Withdrawal by Subject|8
4415239|NCT00293254|7195649|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2
4415240|NCT00293254|7195650|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0
4415241|NCT00293254|7195649|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2
4415242|NCT00293254|7195650|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1
4415243|NCT00293254|7195649|FG000|Primary Study - Double-Blind Week 0-48|Death|5
4415244|NCT00293254|7195650|FG001|Primary Study - Double-Blind Week 0-48|Death|2
4415245|NCT00293254|7195649|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
4415246|NCT00293254|7195650|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
4415247|NCT00293254|7195649|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3
4415248|NCT00293254|7195650|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
4415249|NCT00293254|7195649|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5
4415250|NCT00293254|7195650|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
4415251|NCT00293254|7195649|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1
4415252|NCT00293254|7195650|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0
4415253|NCT00293254|7195649|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35
4415254|NCT00293254|7195650|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57
4415255|NCT00293254|7195649|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4
4415256|NCT00293254|7195650|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1
4415257|NCT00293254|7195649|FG000|Extension - Double-Blind Week 49-156|Death|4
4415258|NCT00293254|7195650|FG001|Extension - Double-Blind Week 49-156|Death|1
4415259|NCT00293254|7195649|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3
4415260|NCT00293254|7195650|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4
4415261|NCT00293254|7195649|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3
4415262|NCT00293254|7195650|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3
4415263|NCT00293254|7195649|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12
4415264|NCT00293254|7195650|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8
4415265|NCT00293254|7195649|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6
4415266|NCT00293254|7195650|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3
4415267|NCT00293254|7195649|FG000|Extension - Double-Blind Week 49-156|Other Reason|10
4415268|NCT00293254|7195650|FG001|Extension - Double-Blind Week 49-156|Other Reason|2
4415269|NCT00293254|7195649|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15
4415270|NCT00293254|7195650|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7
4415271|NCT00293254|7195649|FG000|Extension - Open-Label Week 157-240|Adverse Event|2
4415272|NCT00293254|7195650|FG001|Extension - Open-Label Week 157-240|Adverse Event|1
4415273|NCT00293254|7195649|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1
4415274|NCT00293254|7195650|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0
4415275|NCT00293254|7195649|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1
4415276|NCT00293254|7195650|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0
4415277|NCT00293254|7195649|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2
4415278|NCT00293254|7195650|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0
4415279|NCT00293254|7195649|FG000|Extension - Open-Label Week 157-240|Other Reason|4
4415280|NCT00293254|7195650|FG001|Extension - Open-Label Week 157-240|Other Reason|0
4415281|NCT00293254|7195649|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4
4415282|NCT00293254|7195650|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7
4415283|NCT00293254|7195649|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16
4415284|NCT00293254|7195650|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14
4415285|NCT00293254|7195649|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6
4415286|NCT00293254|7195650|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3
4415287|NCT00293254|7195649|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3
4415288|NCT00293254|7195650|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0
4415289|NCT00293254|7195649|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1
4415290|NCT00293254|7195650|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1
4415291|NCT00293254|7195649|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1
4415292|NCT00293254|7195650|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2
4415293|NCT00293267|7195660|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2
4415294|NCT00293267|7195661|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0
4415295|NCT00293267|7195660|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1
4629346|NCT01871402|7497243|FG000|Overall Study|Non-compliance|0
4629347|NCT01871402|7497244|FG001|Overall Study|Non-compliance|1
4415296|NCT00293267|7195661|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1
4415297|NCT00293267|7195660|FG000|Primary Study - Double-Blind Week 0-48|Death|3
4415298|NCT00293267|7195661|FG001|Primary Study - Double-Blind Week 0-48|Death|3
4415299|NCT00293267|7195660|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0
4415300|NCT00293267|7195661|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
4415301|NCT00293267|7195660|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
4415302|NCT00293267|7195661|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
4415303|NCT00293267|7195660|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
4415304|NCT00293267|7195661|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
4415305|NCT00293267|7195660|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33
4415306|NCT00293267|7195661|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60
4415307|NCT00293267|7195660|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1
4415308|NCT00293267|7195661|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4
4415309|NCT00293267|7195660|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7
4415310|NCT00293267|7195661|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1
4415311|NCT00293267|7195660|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4
4415312|NCT00293267|7195661|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0
4415313|NCT00293267|7195660|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13
4415314|NCT00293267|7195661|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4
4415315|NCT00293267|7195660|FG000|Extension - Double-Blind Week 49-156|Death|3
4415316|NCT00293267|7195661|FG001|Extension - Double-Blind Week 49-156|Death|0
4511829|NCT00929240|7321219|FG002|Maintenance Phase|Protocol Violation|0
4629348|NCT01871519|7497277|FG000|Overall Study|Death|26
4415317|NCT00293267|7195660|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2
4415318|NCT00293267|7195661|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0
4415319|NCT00293267|7195660|FG000|Extension - Double-Blind Week 49-156|Other Reason|7
4415320|NCT00293267|7195661|FG001|Extension - Double-Blind Week 49-156|Other Reason|0
4415321|NCT00293267|7195660|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15
4415322|NCT00293267|7195661|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6
4415323|NCT00293267|7195660|FG000|Extension - Open-Label Week 157-240|Adverse Event|5
4415324|NCT00293267|7195661|FG001|Extension - Open-Label Week 157-240|Adverse Event|0
4415325|NCT00293267|7195660|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7
4415326|NCT00293267|7195661|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0
4415327|NCT00293267|7195660|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1
4415328|NCT00293267|7195661|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0
4415329|NCT00293267|7195660|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2
4415330|NCT00293267|7195661|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1
4415331|NCT00293267|7195660|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2
4415332|NCT00293267|7195661|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0
4415333|NCT00293267|7195660|FG000|Extension - Open-Label Week 157-240|Other Reason|3
4415334|NCT00293267|7195661|FG001|Extension - Open-Label Week 157-240|Other Reason|1
4415335|NCT00293267|7195660|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2
4415336|NCT00293267|7195661|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3
4415337|NCT00293267|7195660|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23
4415338|NCT00293267|7195661|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19
4415339|NCT00293267|7195660|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2
4415340|NCT00293267|7195661|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4
4415341|NCT00293267|7195660|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2
4415342|NCT00293267|7195661|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2
4415343|NCT00293267|7195660|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0
4415344|NCT00293267|7195661|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2
4415345|NCT00293267|7195660|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0
4415346|NCT00293267|7195661|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2
4415347|NCT00293267|7195660|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4
4415348|NCT00293267|7195661|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5
4415349|NCT00293293|7195671|FG000|Overall Study|Withdrawal by Subject|1
4415350|NCT00293293|7195672|FG001|Overall Study|Withdrawal by Subject|1
4415351|NCT00293293|7195671|FG000|Overall Study|"Patient too anxious to complete trial"|1
4415352|NCT00293293|7195672|FG001|Overall Study|"Patient too anxious to complete trial"|0
4415353|NCT00293293|7195671|FG000|Overall Study|Patient discontinued chemotherapy|0
4415354|NCT00293293|7195672|FG001|Overall Study|Patient discontinued chemotherapy|1
4415355|NCT00293384|7195679|FG000|Overall Study|Non-compliance|2
4415356|NCT00293384|7195679|FG000|Overall Study|Missed dosage/study drug|1
4415357|NCT00293384|7195679|FG000|Overall Study|Ineligible|2
4415358|NCT00293397|7195683|FG000|Overall Study|Death|2
4415359|NCT00293423|7195690|FG000|Surgical Resection|Less than a 90% extent of resection|0
4415360|NCT00293423|7195691|FG001|Surgical Resection|Less than a 90% extent of resection|1
4415361|NCT00293423|7195690|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0
4415362|NCT00293423|7195691|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4
4415363|NCT00293423|7195690|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9
4415364|NCT00293423|7195691|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13
4415365|NCT00293423|7195690|FG000|Surgical Resection|disease progression prior to initial vaccination|2
4415366|NCT00293423|7195691|FG001|Surgical Resection|disease progression prior to initial vaccination|9
4415367|NCT00293423|7195690|FG000|Surgical Resection|processing error during surgical resection|1
4415368|NCT00293423|7195691|FG001|Surgical Resection|processing error during surgical resection|0
4415369|NCT00293423|7195690|FG000|Surgical Resection|Withdrawal by Subject|4
4415370|NCT00293423|7195691|FG001|Surgical Resection|Withdrawal by Subject|0
4415371|NCT00293423|7195690|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0
4415372|NCT00293423|7195691|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3
4415373|NCT00293462|7195700|FG000|Overall Study|Withdrawal by Subject|4
4415374|NCT00293462|7195701|FG001|Overall Study|Withdrawal by Subject|3
4415375|NCT00293462|7195702|FG002|Overall Study|Withdrawal by Subject|8
4415376|NCT00293462|7195700|FG000|Overall Study|Death|1
4415377|NCT00293462|7195701|FG001|Overall Study|Death|0
4415378|NCT00293462|7195702|FG002|Overall Study|Death|0
4415379|NCT00293462|7195700|FG000|Overall Study|Lost to Follow-up|0
4415380|NCT00293462|7195701|FG001|Overall Study|Lost to Follow-up|1
4415381|NCT00293462|7195702|FG002|Overall Study|Lost to Follow-up|0
4415382|NCT00293462|7195700|FG000|Overall Study|Change Treatment Regimen (ineligible)|1
4415383|NCT00293462|7195701|FG001|Overall Study|Change Treatment Regimen (ineligible)|0
4629349|NCT01871519|7497277|FG000|Overall Study|Lost to Follow-up|15
4629350|NCT01871519|7497277|FG000|Overall Study|Withdrawal by Subject|49
4415384|NCT00293462|7195702|FG002|Overall Study|Change Treatment Regimen (ineligible)|0
4629351|NCT01871532|7497284|FG000|Overall Study|Withdrawal by Subject|1
4415385|NCT00293462|7195700|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0
4415386|NCT00293462|7195701|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1
4415387|NCT00293462|7195702|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0
4415388|NCT00293462|7195700|FG000|Overall Study|Refuse Radiation Treatment|1
4415389|NCT00293462|7195701|FG001|Overall Study|Refuse Radiation Treatment|0
4415390|NCT00293462|7195702|FG002|Overall Study|Refuse Radiation Treatment|0
4415391|NCT00293462|7195700|FG000|Overall Study|No Show|0
4415392|NCT00293462|7195701|FG001|Overall Study|No Show|0
4415393|NCT00293462|7195702|FG002|Overall Study|No Show|1
4415394|NCT00293462|7195700|FG000|Overall Study|Went back to his home country|0
4415395|NCT00293462|7195701|FG001|Overall Study|Went back to his home country|0
4415396|NCT00293462|7195702|FG002|Overall Study|Went back to his home country|1
4415397|NCT00293462|7195700|FG000|Overall Study|Blood clot after chemotherapy|0
4415398|NCT00293462|7195701|FG001|Overall Study|Blood clot after chemotherapy|0
4415399|NCT00293462|7195702|FG002|Overall Study|Blood clot after chemotherapy|1
4415400|NCT00293462|7195700|FG000|Overall Study|Ischemic stroke after chemotherapy|0
4415401|NCT00293462|7195701|FG001|Overall Study|Ischemic stroke after chemotherapy|0
4415402|NCT00293462|7195702|FG002|Overall Study|Ischemic stroke after chemotherapy|1
4415403|NCT00293462|7195700|FG000|Overall Study|Possible Tracheostomy leakage|0
4415404|NCT00293462|7195701|FG001|Overall Study|Possible Tracheostomy leakage|1
4714864|NCT02963506|7642890|FG009|Dose-Blind Period|Withdrawal by Subject|1
4714865|NCT02963506|7642891|FG010|Dose-Blind Period|Withdrawal by Subject|0
4714866|NCT02963506|7642892|FG011|Dose-Blind Period|Withdrawal by Subject|0
4714867|NCT02963506|7642893|FG012|Dose-Blind Period|Withdrawal by Subject|0
4415405|NCT00293462|7195702|FG002|Overall Study|Possible Tracheostomy leakage|0
4415406|NCT00293462|7195700|FG000|Overall Study|Low radiation dose in oral cavity|0
4415407|NCT00293462|7195701|FG001|Overall Study|Low radiation dose in oral cavity|1
4415408|NCT00293462|7195702|FG002|Overall Study|Low radiation dose in oral cavity|0
4415409|NCT00293462|7195700|FG000|Overall Study|Physician Decision|0
4415410|NCT00293462|7195701|FG001|Overall Study|Physician Decision|1
4415411|NCT00293462|7195702|FG002|Overall Study|Physician Decision|0
4415412|NCT00293579|7195719|FG000|Overall Study|Withdrawal by Subject|1
4415413|NCT00293709|7195724|FG000|Overall Study|Other|47
4415414|NCT00293722|7195728|FG000|Overall Study|Other|427
4415415|NCT00293813|7195735|FG000|Overall Study|Physician Decision|0
4415416|NCT00293813|7195736|FG001|Overall Study|Physician Decision|1
4415417|NCT00293813|7195737|FG002|Overall Study|Physician Decision|0
4415418|NCT00293813|7195735|FG000|Overall Study|Adverse Event|3
4415419|NCT00293813|7195736|FG001|Overall Study|Adverse Event|1
4415420|NCT00293813|7195737|FG002|Overall Study|Adverse Event|1
4415421|NCT00293813|7195735|FG000|Overall Study|Withdrawal by Subject|7
4415422|NCT00293813|7195736|FG001|Overall Study|Withdrawal by Subject|4
4415423|NCT00293813|7195737|FG002|Overall Study|Withdrawal by Subject|4
4415424|NCT00293813|7195735|FG000|Overall Study|Lost to Follow-up|3
4415425|NCT00293813|7195736|FG001|Overall Study|Lost to Follow-up|2
4415426|NCT00293813|7195737|FG002|Overall Study|Lost to Follow-up|3
4714868|NCT02963506|7642881|FG000|Dose-Blind Period|Sponsor decision|0
4714869|NCT02963506|7642882|FG001|Dose-Blind Period|Sponsor decision|0
4714870|NCT02963506|7642883|FG002|Dose-Blind Period|Sponsor decision|0
4415427|NCT00293813|7195735|FG000|Overall Study|Noncompliance|0
4415428|NCT00293813|7195736|FG001|Overall Study|Noncompliance|1
4415429|NCT00293813|7195737|FG002|Overall Study|Noncompliance|0
4415430|NCT00294047|7195747|FG000|Month 48|Adverse Event|28
4415431|NCT00294047|7195748|FG001|Month 48|Adverse Event|13
4415432|NCT00294047|7195747|FG000|Month 48|Protocol Violation|4
4415433|NCT00294047|7195748|FG001|Month 48|Protocol Violation|4
4415434|NCT00294047|7195747|FG000|Month 48|Withdrawal by Subject|111
4415435|NCT00294047|7195748|FG001|Month 48|Withdrawal by Subject|115
4415436|NCT00294047|7195747|FG000|Month 48|Lost to Follow-up|272
4415437|NCT00294047|7195748|FG001|Month 48|Lost to Follow-up|287
4415438|NCT00294047|7195747|FG000|Month 48|Other|10
4415439|NCT00294047|7195748|FG001|Month 48|Other|14
4415440|NCT00294047|7195747|FG000|Month 84|Adverse Event|4
4415441|NCT00294047|7195748|FG001|Month 84|Adverse Event|2
4415442|NCT00294047|7195747|FG000|Month 84|Protocol Violation|1
4415443|NCT00294047|7195748|FG001|Month 84|Protocol Violation|1
4415444|NCT00294047|7195747|FG000|Month 84|Withdrawal by Subject|33
4415445|NCT00294047|7195748|FG001|Month 84|Withdrawal by Subject|31
4415446|NCT00294047|7195747|FG000|Month 84|Lost to Follow-up|187
4415447|NCT00294047|7195748|FG001|Month 84|Lost to Follow-up|190
4415448|NCT00294047|7195747|FG000|Month 84|Absent Cervix|2
4415449|NCT00294047|7195748|FG001|Month 84|Absent Cervix|0
4415450|NCT00294047|7195747|FG000|Month 84|Work related reasons|4
4415451|NCT00294047|7195748|FG001|Month 84|Work related reasons|2
4415452|NCT00294047|7195747|FG000|Month 84|Center closed, subject did not transfer|1
4415453|NCT00294047|7195748|FG001|Month 84|Center closed, subject did not transfer|0
4415454|NCT00294047|7195747|FG000|Month 84|Family problems|2
4415455|NCT00294047|7195748|FG001|Month 84|Family problems|2
4415456|NCT00294047|7195747|FG000|Month 84|Lack of time|3
4415457|NCT00294047|7195748|FG001|Month 84|Lack of time|1
4415458|NCT00294047|7195747|FG000|Month 84|Personal reason|2
4415459|NCT00294047|7195748|FG001|Month 84|Personal reason|4
4415460|NCT00294047|7195747|FG000|Month 84|Subject does not want male physician|1
4415461|NCT00294047|7195748|FG001|Month 84|Subject does not want male physician|0
4415462|NCT00294047|7195747|FG000|Month 84|Transport reimbursement delayed|0
4415463|NCT00294047|7195748|FG001|Month 84|Transport reimbursement delayed|1
4415464|NCT00294047|7195747|FG000|Month 84|Unable to reach study site|1
4415465|NCT00294047|7195748|FG001|Month 84|Unable to reach study site|0
4415466|NCT00294047|7195747|FG000|Month 84|Under investigation locally|1
4415467|NCT00294047|7195748|FG001|Month 84|Under investigation locally|0
4415468|NCT00294047|7195747|FG000|Month 84|Visit missed|0
4415469|NCT00294047|7195748|FG001|Month 84|Visit missed|1
4415470|NCT00294047|7195747|FG000|Month 84|No consent for Month 84 Follow-up|731
4415471|NCT00294047|7195748|FG001|Month 84|No consent for Month 84 Follow-up|754
4415472|NCT00294060|7195755|FG000|Overall Study|Death|225
4415473|NCT00294060|7195755|FG000|Overall Study|Other|59
4415474|NCT00294060|7195755|FG000|Overall Study|Lost to Follow-up|55
4415475|NCT00294060|7195755|FG000|Overall Study|Withdrawal by Subject|11
4415476|NCT00294060|7195755|FG000|Overall Study|Physician Decision|797
4415477|NCT00294060|7195755|FG000|Overall Study|Medical condition|3
4415478|NCT00294060|7195755|FG000|Overall Study|Device explanted/not replaced|23
4415479|NCT00294398|7195761|FG000|Overall Study|Lost to Follow-up|21
4415480|NCT00294398|7195762|FG001|Overall Study|Lost to Follow-up|26
4415481|NCT00294554|7195779|FG000|Overall Study|Lack of Efficacy|0
4415482|NCT00294554|7195780|FG001|Overall Study|Lack of Efficacy|1
4415483|NCT00294554|7195779|FG000|Overall Study|Physician Decision|0
4415484|NCT00294554|7195780|FG001|Overall Study|Physician Decision|1
4415485|NCT00294645|7195798|FG000|Overall Study|Death|10
4415486|NCT00294645|7195799|FG001|Overall Study|Death|18
4415487|NCT00294645|7195798|FG000|Overall Study|Lost to Follow-up|1
4415488|NCT00294645|7195799|FG001|Overall Study|Lost to Follow-up|10
4415489|NCT00294645|7195798|FG000|Overall Study|Withdrawal by Subject|18
4415490|NCT00294645|7195799|FG001|Overall Study|Withdrawal by Subject|34
4415491|NCT00294645|7195798|FG000|Overall Study|Physician Decision|15
4415492|NCT00294645|7195799|FG001|Overall Study|Physician Decision|20
4415493|NCT00294645|7195798|FG000|Overall Study|Other|4
4415494|NCT00294645|7195799|FG001|Overall Study|Other|10
4415495|NCT00294658|7195807|FG000|Overall Study|Death|0
4415496|NCT00294658|7195808|FG001|Overall Study|Death|1
4415497|NCT00294658|7195807|FG000|Overall Study|Lost to Follow-up|4
4415498|NCT00294658|7195808|FG001|Overall Study|Lost to Follow-up|0
4415499|NCT00294658|7195807|FG000|Overall Study|Physician Decision|1
4415500|NCT00294658|7195808|FG001|Overall Study|Physician Decision|2
4415501|NCT00294658|7195807|FG000|Overall Study|Pregnancy|0
4415502|NCT00294658|7195808|FG001|Overall Study|Pregnancy|1
4415503|NCT00294658|7195807|FG000|Overall Study|Withdrawal by Subject|0
4415504|NCT00294658|7195808|FG001|Overall Study|Withdrawal by Subject|4
4415505|NCT00294658|7195807|FG000|Overall Study|Found to have invasive thymoma|1
4415506|NCT00294658|7195808|FG001|Overall Study|Found to have invasive thymoma|0
4415507|NCT00294658|7195807|FG000|Overall Study|Patient and family were not satisfied|0
4415508|NCT00294658|7195808|FG001|Overall Study|Patient and family were not satisfied|1
4415509|NCT00294671|7195816|FG000|Overall Study|Lack of Efficacy|11
4415510|NCT00294671|7195817|FG001|Overall Study|Lack of Efficacy|23
4415511|NCT00294671|7195816|FG000|Overall Study|Liver transplant|7
4415512|NCT00294671|7195817|FG001|Overall Study|Liver transplant|9
4415513|NCT00294671|7195816|FG000|Overall Study|Drug related adverse event (AE)|4
4415514|NCT00294671|7195817|FG001|Overall Study|Drug related adverse event (AE)|2
4415515|NCT00294671|7195816|FG000|Overall Study|Non-drug related AE|3
4415516|NCT00294671|7195817|FG001|Overall Study|Non-drug related AE|2
4415517|NCT00294671|7195816|FG000|Overall Study|Lost to Follow-up|1
4415518|NCT00294671|7195817|FG001|Overall Study|Lost to Follow-up|3
4415519|NCT00294671|7195816|FG000|Overall Study|Non-compliance|1
4415520|NCT00294671|7195817|FG001|Overall Study|Non-compliance|0
4415521|NCT00294671|7195816|FG000|Overall Study|Death|0
4415522|NCT00294671|7195817|FG001|Overall Study|Death|1
4415523|NCT00294684|7195825|FG000|Overall Study|Lost to Follow-up|5
4415524|NCT00294684|7195826|FG001|Overall Study|Lost to Follow-up|8
4415525|NCT00294723|7195835|FG000|Double-Blind Period 52 Weeks|Adverse Event|18
4629352|NCT01871532|7497285|FG001|Overall Study|Withdrawal by Subject|2
4415526|NCT00294723|7195836|FG001|Double-Blind Period 52 Weeks|Adverse Event|25
4415527|NCT00294723|7195837|FG002|Double-Blind Period 52 Weeks|Adverse Event|15
4415528|NCT00294723|7195835|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9
4415529|NCT00294723|7195836|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15
4415530|NCT00294723|7195837|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25
4415531|NCT00294723|7195835|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11
4415532|NCT00294723|7195836|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11
4415533|NCT00294723|7195837|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5
4415534|NCT00294723|7195835|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36
4415535|NCT00294723|7195836|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38
4415536|NCT00294723|7195837|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51
4415537|NCT00294723|7195835|FG000|Open-Label Extension 52 Weeks|Adverse Event|5
4415538|NCT00294723|7195836|FG001|Open-Label Extension 52 Weeks|Adverse Event|5
4415539|NCT00294723|7195837|FG002|Open-Label Extension 52 Weeks|Adverse Event|2
4415540|NCT00294723|7195835|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12
4415541|NCT00294723|7195836|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15
4415542|NCT00294723|7195837|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21
4415543|NCT00294723|7195835|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4
4518730|NCT00975923|7330992|FG000|Overall Study|Withdrawal by Subject|0
4415544|NCT00294723|7195836|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3
4415545|NCT00294723|7195837|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3
4415546|NCT00294723|7195835|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19
4415547|NCT00294723|7195836|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16
4415548|NCT00294723|7195837|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14
4415549|NCT00294723|7195835|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1
4415550|NCT00294723|7195836|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1
4415551|NCT00294723|7195837|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0
4415552|NCT00294723|7195835|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24
4415553|NCT00294723|7195836|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14
4415554|NCT00294723|7195837|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16
4415555|NCT00294723|7195835|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
4415556|NCT00294723|7195836|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
4415557|NCT00294723|7195837|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
4415558|NCT00294723|7195835|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2
4415559|NCT00294723|7195836|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5
4415560|NCT00294723|7195837|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3
4415561|NCT00294762|7195850|FG000|Overall Study|Did not receive study treatment|3
4415562|NCT00294762|7195851|FG001|Overall Study|Did not receive study treatment|3
4415563|NCT00295022|7195885|FG000|Overall Study|Adverse Event|1
4415564|NCT00295022|7195886|FG001|Overall Study|Adverse Event|1
4415565|NCT00295022|7195887|FG002|Overall Study|Adverse Event|2
4415566|NCT00295022|7195885|FG000|Overall Study|Lost to Follow-up|0
4415567|NCT00295022|7195886|FG001|Overall Study|Lost to Follow-up|0
4415568|NCT00295022|7195887|FG002|Overall Study|Lost to Follow-up|1
4415569|NCT00295022|7195885|FG000|Overall Study|Withdrawal by Subject|0
4415570|NCT00295022|7195886|FG001|Overall Study|Withdrawal by Subject|0
4415571|NCT00295022|7195887|FG002|Overall Study|Withdrawal by Subject|2
4415572|NCT00295620|7195913|FG000|Overall Study|Lost to Follow-up|9
4415573|NCT00295620|7195914|FG001|Overall Study|Lost to Follow-up|5
4415574|NCT00295620|7195913|FG000|Overall Study|Withdrawal by Subject|37
4415575|NCT00295620|7195914|FG001|Overall Study|Withdrawal by Subject|50
4415576|NCT00295620|7195913|FG000|Overall Study|Death|206
4415577|NCT00295620|7195914|FG001|Overall Study|Death|207
4415578|NCT00295620|7195913|FG000|Overall Study|Other reasons|10
4415579|NCT00295620|7195914|FG001|Overall Study|Other reasons|9
4415580|NCT00295620|7195913|FG000|Overall Study|Discontinuation by sponsor|580
4415581|NCT00295620|7195914|FG001|Overall Study|Discontinuation by sponsor|593
4415582|NCT00295620|7195913|FG000|Overall Study|Protocol Violation|30
4415583|NCT00295620|7195914|FG001|Overall Study|Protocol Violation|32
4415584|NCT00295633|7195923|FG000|Overall Study|Lack of Efficacy|19
4415585|NCT00295633|7195924|FG001|Overall Study|Lack of Efficacy|7
4415586|NCT00295633|7195925|FG002|Overall Study|Lack of Efficacy|16
4415587|NCT00295633|7195923|FG000|Overall Study|Withdrawal of consent by subject|16
4415588|NCT00295633|7195924|FG001|Overall Study|Withdrawal of consent by subject|16
4415589|NCT00295633|7195925|FG002|Overall Study|Withdrawal of consent by subject|26
4415590|NCT00295633|7195923|FG000|Overall Study|Adverse Event|9
4415591|NCT00295633|7195924|FG001|Overall Study|Adverse Event|17
4415592|NCT00295633|7195925|FG002|Overall Study|Adverse Event|9
4415593|NCT00295633|7195923|FG000|Overall Study|Lost to Follow-up|6
4415594|NCT00295633|7195924|FG001|Overall Study|Lost to Follow-up|11
4415595|NCT00295633|7195925|FG002|Overall Study|Lost to Follow-up|7
4415596|NCT00295633|7195923|FG000|Overall Study|Physician Decision|9
4415597|NCT00295633|7195924|FG001|Overall Study|Physician Decision|10
4415598|NCT00295633|7195925|FG002|Overall Study|Physician Decision|8
4415599|NCT00295633|7195923|FG000|Overall Study|Poor/Noncompliance|2
4415600|NCT00295633|7195924|FG001|Overall Study|Poor/Noncompliance|2
4415601|NCT00295633|7195925|FG002|Overall Study|Poor/Noncompliance|6
4415602|NCT00295633|7195923|FG000|Overall Study|Subject No Longer Meets Study Criteria|0
4415603|NCT00295633|7195924|FG001|Overall Study|Subject No Longer Meets Study Criteria|3
4415604|NCT00295633|7195925|FG002|Overall Study|Subject No Longer Meets Study Criteria|3
4415605|NCT00295633|7195923|FG000|Overall Study|Death|1
4415606|NCT00295633|7195924|FG001|Overall Study|Death|1
4629353|NCT01871545|7497293|FG000|Overall Study|Death|2
4415607|NCT00295633|7195925|FG002|Overall Study|Death|0
4415608|NCT00295633|7195923|FG000|Overall Study|Administrative reason by sponsor|0
4415609|NCT00295633|7195924|FG001|Overall Study|Administrative reason by sponsor|0
4415610|NCT00295633|7195925|FG002|Overall Study|Administrative reason by sponsor|1
4629354|NCT01871545|7497294|FG001|Overall Study|Death|0
4415611|NCT00295750|7195936|FG000|Overall Study|Adverse Event|19
4415612|NCT00295750|7195937|FG001|Overall Study|Adverse Event|15
4415613|NCT00295750|7195938|FG002|Overall Study|Adverse Event|12
4415614|NCT00295750|7195936|FG000|Overall Study|Lack of Efficacy|1
4415615|NCT00295750|7195937|FG001|Overall Study|Lack of Efficacy|1
4415616|NCT00295750|7195938|FG002|Overall Study|Lack of Efficacy|0
4415617|NCT00295750|7195936|FG000|Overall Study|Lost to Follow-up|1
4415618|NCT00295750|7195937|FG001|Overall Study|Lost to Follow-up|4
4415619|NCT00295750|7195938|FG002|Overall Study|Lost to Follow-up|1
4415620|NCT00295750|7195936|FG000|Overall Study|Taking prohibited therapy|2
4714871|NCT02963506|7642884|FG003|Dose-Blind Period|Sponsor decision|0
4415621|NCT00295750|7195937|FG001|Overall Study|Taking prohibited therapy|3
4415622|NCT00295750|7195938|FG002|Overall Study|Taking prohibited therapy|2
4415623|NCT00295750|7195936|FG000|Overall Study|Administrative errors|2
4415624|NCT00295750|7195937|FG001|Overall Study|Administrative errors|4
4415625|NCT00295750|7195938|FG002|Overall Study|Administrative errors|5
4415626|NCT00295750|7195936|FG000|Overall Study|Trial drug errors|1
4415627|NCT00295750|7195937|FG001|Overall Study|Trial drug errors|1
4415628|NCT00295750|7195938|FG002|Overall Study|Trial drug errors|0
4415629|NCT00295750|7195936|FG000|Overall Study|Disease progression|2
4415630|NCT00295750|7195937|FG001|Overall Study|Disease progression|1
4415631|NCT00295750|7195938|FG002|Overall Study|Disease progression|0
4415632|NCT00295750|7195936|FG000|Overall Study|Personal reasons|0
4415633|NCT00295750|7195937|FG001|Overall Study|Personal reasons|1
4415634|NCT00295750|7195938|FG002|Overall Study|Personal reasons|0
4415635|NCT00295750|7195936|FG000|Overall Study|Randomized but never received trial drug|4
4415636|NCT00295750|7195937|FG001|Overall Study|Randomized but never received trial drug|3
4415637|NCT00295750|7195938|FG002|Overall Study|Randomized but never received trial drug|3
4415638|NCT00295750|7195936|FG000|Overall Study|Withdrawal by Subject|9
4415639|NCT00295750|7195937|FG001|Overall Study|Withdrawal by Subject|4
4415640|NCT00295750|7195938|FG002|Overall Study|Withdrawal by Subject|7
4415641|NCT00295750|7195936|FG000|Overall Study|Protocol Violation|2
4415642|NCT00295750|7195937|FG001|Overall Study|Protocol Violation|4
4415643|NCT00295750|7195938|FG002|Overall Study|Protocol Violation|2
4415644|NCT00295854|7195949|FG000|Overall Study|Adverse Event|7
4415645|NCT00295854|7195950|FG001|Overall Study|Adverse Event|7
4415646|NCT00295854|7195951|FG002|Overall Study|Adverse Event|6
4415647|NCT00295854|7195949|FG000|Overall Study|Protocol Violation|1
4415648|NCT00295854|7195950|FG001|Overall Study|Protocol Violation|1
4415649|NCT00295854|7195951|FG002|Overall Study|Protocol Violation|1
4415650|NCT00295854|7195949|FG000|Overall Study|Lost to Follow-up|2
4415651|NCT00295854|7195950|FG001|Overall Study|Lost to Follow-up|0
4415652|NCT00295854|7195951|FG002|Overall Study|Lost to Follow-up|1
4415653|NCT00295854|7195949|FG000|Overall Study|Withdrawal by Subject|3
4415654|NCT00295854|7195950|FG001|Overall Study|Withdrawal by Subject|7
4415655|NCT00295854|7195951|FG002|Overall Study|Withdrawal by Subject|4
4415656|NCT00295854|7195949|FG000|Overall Study|did not continue to meet criteria|1
4415657|NCT00295854|7195950|FG001|Overall Study|did not continue to meet criteria|1
4415658|NCT00295854|7195951|FG002|Overall Study|did not continue to meet criteria|2
4415659|NCT00295854|7195949|FG000|Overall Study|required a prohibited medication|1
4415660|NCT00295854|7195950|FG001|Overall Study|required a prohibited medication|0
4415661|NCT00295854|7195951|FG002|Overall Study|required a prohibited medication|0
4415662|NCT00295854|7195949|FG000|Overall Study|Other|3
4415663|NCT00295854|7195950|FG001|Overall Study|Other|5
4415664|NCT00295854|7195951|FG002|Overall Study|Other|1
4415665|NCT00295880|7195963|FG000|Overall Study|IBMI unit could not be volume reduced|1
4415666|NCT00295880|7195963|FG000|Overall Study|Unit randomization did not occur|1
4415667|NCT00295932|7195978|FG000|Overall Study|Not Treated|0
4415668|NCT00295932|7195979|FG001|Overall Study|Not Treated|0
4415669|NCT00295932|7195980|FG002|Overall Study|Not Treated|0
4415670|NCT00295932|7195981|FG003|Overall Study|Not Treated|0
4415671|NCT00295932|7195982|FG004|Overall Study|Not Treated|0
4415672|NCT00295932|7195983|FG005|Overall Study|Not Treated|0
4415673|NCT00295932|7195984|FG006|Overall Study|Not Treated|0
4415674|NCT00295932|7195985|FG007|Overall Study|Not Treated|0
4415675|NCT00295932|7195986|FG008|Overall Study|Not Treated|0
4415676|NCT00295932|7195987|FG009|Overall Study|Not Treated|0
4415677|NCT00295932|7195988|FG010|Overall Study|Not Treated|1
4415678|NCT00296036|7196016|FG000|Overall Study|Withdrawal by Subject|1
4415679|NCT00296036|7196017|FG001|Overall Study|Withdrawal by Subject|0
4415680|NCT00296036|7196018|FG002|Overall Study|Withdrawal by Subject|2
4415681|NCT00296036|7196019|FG003|Overall Study|Withdrawal by Subject|1
4415682|NCT00296036|7196020|FG004|Overall Study|Withdrawal by Subject|2
4415683|NCT00296036|7196021|FG005|Overall Study|Withdrawal by Subject|1
4415684|NCT00296036|7196016|FG000|Overall Study|Protocol Violation|0
4415685|NCT00296036|7196017|FG001|Overall Study|Protocol Violation|0
4415686|NCT00296036|7196018|FG002|Overall Study|Protocol Violation|0
4415687|NCT00296036|7196019|FG003|Overall Study|Protocol Violation|0
4415688|NCT00296036|7196020|FG004|Overall Study|Protocol Violation|0
4415689|NCT00296036|7196021|FG005|Overall Study|Protocol Violation|3
4415690|NCT00296140|7196040|FG000|Overall Study|Lost to Follow-up|1
4415691|NCT00296140|7196041|FG001|Overall Study|Lost to Follow-up|0
4415692|NCT00296140|7196040|FG000|Overall Study|Withdrawal by Subject|1
4415693|NCT00296140|7196041|FG001|Overall Study|Withdrawal by Subject|0
4415694|NCT00296140|7196040|FG000|Overall Study|Discharge to Nursing Home|1
4415695|NCT00296140|7196041|FG001|Overall Study|Discharge to Nursing Home|0
4415696|NCT00296244|7196074|FG000|Overall Study|Underwent retransplant|0
4415697|NCT00296244|7196075|FG001|Overall Study|Underwent retransplant|1
4415698|NCT00296335|7196106|FG000|Overall Study|Recurrence|3
4415699|NCT00296335|7196107|FG001|Overall Study|Recurrence|51
4415700|NCT00296335|7196106|FG000|Overall Study|Adverse Event|17
4415701|NCT00296335|7196107|FG001|Overall Study|Adverse Event|27
4415702|NCT00296335|7196106|FG000|Overall Study|Lost to Follow-up|7
4415703|NCT00296335|7196107|FG001|Overall Study|Lost to Follow-up|33
4415704|NCT00296335|7196106|FG000|Overall Study|Physician Decision|3
4415705|NCT00296335|7196107|FG001|Overall Study|Physician Decision|11
4415706|NCT00296374|7196118|FG000|Overall Study|Adverse Event|14
4415707|NCT00296374|7196119|FG001|Overall Study|Adverse Event|10
4415708|NCT00296374|7196120|FG002|Overall Study|Adverse Event|7
4415709|NCT00296374|7196118|FG000|Overall Study|Withdrawal by Subject|3
4415710|NCT00296374|7196119|FG001|Overall Study|Withdrawal by Subject|5
4415711|NCT00296374|7196120|FG002|Overall Study|Withdrawal by Subject|11
4415712|NCT00296374|7196118|FG000|Overall Study|Incorrect enrollment|3
4415713|NCT00296374|7196119|FG001|Overall Study|Incorrect enrollment|3
4415714|NCT00296374|7196120|FG002|Overall Study|Incorrect enrollment|4
4415715|NCT00296374|7196118|FG000|Overall Study|Protocol Violation|1
4415716|NCT00296374|7196119|FG001|Overall Study|Protocol Violation|2
4415717|NCT00296374|7196120|FG002|Overall Study|Protocol Violation|3
4415718|NCT00296374|7196118|FG000|Overall Study|Lost to Follow-up|3
4415719|NCT00296374|7196119|FG001|Overall Study|Lost to Follow-up|1
4415720|NCT00296374|7196120|FG002|Overall Study|Lost to Follow-up|1
4415721|NCT00296374|7196118|FG000|Overall Study|Relocated to another state|1
4415722|NCT00296374|7196119|FG001|Overall Study|Relocated to another state|0
4415723|NCT00296374|7196120|FG002|Overall Study|Relocated to another state|0
4415724|NCT00296374|7196118|FG000|Overall Study|Stopped drug before end of study visit|0
4415725|NCT00296374|7196119|FG001|Overall Study|Stopped drug before end of study visit|1
4415726|NCT00296374|7196120|FG002|Overall Study|Stopped drug before end of study visit|0
4415727|NCT00296374|7196118|FG000|Overall Study|Nephrologist introduced ACE|0
4415728|NCT00296374|7196119|FG001|Overall Study|Nephrologist introduced ACE|1
4415729|NCT00296374|7196120|FG002|Overall Study|Nephrologist introduced ACE|0
4415730|NCT00296374|7196118|FG000|Overall Study|Pregnancy|0
4415731|NCT00296374|7196119|FG001|Overall Study|Pregnancy|0
4415732|NCT00296374|7196120|FG002|Overall Study|Pregnancy|2
4415733|NCT00296374|7196118|FG000|Overall Study|Other|0
4415734|NCT00296374|7196119|FG001|Overall Study|Other|0
4415735|NCT00296374|7196120|FG002|Overall Study|Other|1
4415736|NCT00296400|7196137|FG000|Overall Study|Adverse Event|7
4415737|NCT00296400|7196138|FG001|Overall Study|Adverse Event|7
4415738|NCT00296400|7196139|FG002|Overall Study|Adverse Event|7
4415739|NCT00296400|7196137|FG000|Overall Study|Withdrawal by Subject|5
4415740|NCT00296400|7196138|FG001|Overall Study|Withdrawal by Subject|6
4415741|NCT00296400|7196139|FG002|Overall Study|Withdrawal by Subject|2
4415742|NCT00296400|7196137|FG000|Overall Study|Incorrect enrollment|2
4415743|NCT00296400|7196138|FG001|Overall Study|Incorrect enrollment|0
4629355|NCT01871545|7497293|FG000|Overall Study|Lack of Efficacy|11
4629356|NCT01871545|7497294|FG001|Overall Study|Lack of Efficacy|2
4629357|NCT01871545|7497293|FG000|Overall Study|Physician Decision|4
4629358|NCT01871545|7497294|FG001|Overall Study|Physician Decision|0
4415744|NCT00296400|7196139|FG002|Overall Study|Incorrect enrollment|0
4415745|NCT00296400|7196137|FG000|Overall Study|Protocol Violation|1
4415746|NCT00296400|7196138|FG001|Overall Study|Protocol Violation|1
4415747|NCT00296400|7196139|FG002|Overall Study|Protocol Violation|1
4415748|NCT00296400|7196137|FG000|Overall Study|Lost to Follow-up|1
4415749|NCT00296400|7196138|FG001|Overall Study|Lost to Follow-up|1
4415750|NCT00296400|7196139|FG002|Overall Study|Lost to Follow-up|2
4415751|NCT00296400|7196137|FG000|Overall Study|Study specific discontinuation criteria|0
4415752|NCT00296400|7196138|FG001|Overall Study|Study specific discontinuation criteria|0
4415753|NCT00296400|7196139|FG002|Overall Study|Study specific discontinuation criteria|1
4415754|NCT00296400|7196137|FG000|Overall Study|Visit 10 was performed earlier|0
4415755|NCT00296400|7196138|FG001|Overall Study|Visit 10 was performed earlier|1
4415756|NCT00296400|7196139|FG002|Overall Study|Visit 10 was performed earlier|0
4415757|NCT00296400|7196137|FG000|Overall Study|Pregnancy|1
4415758|NCT00296400|7196138|FG001|Overall Study|Pregnancy|2
4415759|NCT00296400|7196139|FG002|Overall Study|Pregnancy|0
4415760|NCT00296491|7196154|FG000|Overall Study|Low Pollen Counts|18
4415761|NCT00296491|7196155|FG001|Overall Study|Low Pollen Counts|26
4415762|NCT00296491|7196156|FG002|Overall Study|Low Pollen Counts|25
4415763|NCT00296491|7196157|FG003|Overall Study|Low Pollen Counts|16
4415764|NCT00296491|7196154|FG000|Overall Study|Protocol Violation|4
4415765|NCT00296491|7196155|FG001|Overall Study|Protocol Violation|6
4415766|NCT00296491|7196156|FG002|Overall Study|Protocol Violation|2
4415767|NCT00296491|7196157|FG003|Overall Study|Protocol Violation|3
4415768|NCT00296491|7196154|FG000|Overall Study|Adverse Event|1
4415769|NCT00296491|7196155|FG001|Overall Study|Adverse Event|3
4415770|NCT00296491|7196156|FG002|Overall Study|Adverse Event|1
4415771|NCT00296491|7196157|FG003|Overall Study|Adverse Event|4
4415772|NCT00296491|7196154|FG000|Overall Study|Withdrawn due to Asthma|0
4415773|NCT00296491|7196155|FG001|Overall Study|Withdrawn due to Asthma|0
4415774|NCT00296491|7196156|FG002|Overall Study|Withdrawn due to Asthma|0
4415775|NCT00296491|7196157|FG003|Overall Study|Withdrawn due to Asthma|4
4415776|NCT00296491|7196154|FG000|Overall Study|Withdrawal by Subject|7
4415777|NCT00296491|7196155|FG001|Overall Study|Withdrawal by Subject|3
4415778|NCT00296491|7196156|FG002|Overall Study|Withdrawal by Subject|3
4415779|NCT00296491|7196157|FG003|Overall Study|Withdrawal by Subject|2
4415780|NCT00296491|7196154|FG000|Overall Study|Non-Compliance|12
4415781|NCT00296491|7196155|FG001|Overall Study|Non-Compliance|13
4629359|NCT01871545|7497293|FG000|Overall Study|Withdrawal by Subject|0
4415782|NCT00296491|7196156|FG002|Overall Study|Non-Compliance|10
4415783|NCT00296491|7196157|FG003|Overall Study|Non-Compliance|14
4415784|NCT00296491|7196154|FG000|Overall Study|Lost to Follow-up|0
4415785|NCT00296491|7196155|FG001|Overall Study|Lost to Follow-up|2
4415786|NCT00296491|7196156|FG002|Overall Study|Lost to Follow-up|2
4415787|NCT00296491|7196157|FG003|Overall Study|Lost to Follow-up|0
4415788|NCT00296504|7196182|FG000|Interim Analysis|Withdrawal by Subject|8
4415789|NCT00296504|7196183|FG001|Interim Analysis|Withdrawal by Subject|0
4415790|NCT00296504|7196184|FG002|Interim Analysis|Withdrawal by Subject|12
4415791|NCT00296504|7196185|FG003|Interim Analysis|Withdrawal by Subject|0
4415792|NCT00296504|7196186|FG004|Interim Analysis|Withdrawal by Subject|5
4415793|NCT00296504|7196187|FG005|Interim Analysis|Withdrawal by Subject|5
4415794|NCT00296504|7196188|FG006|Interim Analysis|Withdrawal by Subject|9
4415795|NCT00296504|7196189|FG007|Interim Analysis|Withdrawal by Subject|3
4415796|NCT00296504|7196190|FG008|Interim Analysis|Withdrawal by Subject|0
4415797|NCT00296504|7196182|FG000|Interim Analysis|Lost to Follow-up|13
4415798|NCT00296504|7196183|FG001|Interim Analysis|Lost to Follow-up|3
4415799|NCT00296504|7196184|FG002|Interim Analysis|Lost to Follow-up|26
4415800|NCT00296504|7196185|FG003|Interim Analysis|Lost to Follow-up|8
4415801|NCT00296504|7196186|FG004|Interim Analysis|Lost to Follow-up|14
4415802|NCT00296504|7196187|FG005|Interim Analysis|Lost to Follow-up|4
4415803|NCT00296504|7196188|FG006|Interim Analysis|Lost to Follow-up|11
4415804|NCT00296504|7196189|FG007|Interim Analysis|Lost to Follow-up|4
4415805|NCT00296504|7196190|FG008|Interim Analysis|Lost to Follow-up|0
4415806|NCT00296504|7196182|FG000|Interim Analysis|Clinical Progression|1
4415807|NCT00296504|7196183|FG001|Interim Analysis|Clinical Progression|0
4415808|NCT00296504|7196184|FG002|Interim Analysis|Clinical Progression|1
4415809|NCT00296504|7196185|FG003|Interim Analysis|Clinical Progression|1
4415810|NCT00296504|7196186|FG004|Interim Analysis|Clinical Progression|0
4415811|NCT00296504|7196187|FG005|Interim Analysis|Clinical Progression|2
4415812|NCT00296504|7196188|FG006|Interim Analysis|Clinical Progression|1
4415813|NCT00296504|7196189|FG007|Interim Analysis|Clinical Progression|2
4415814|NCT00296504|7196190|FG008|Interim Analysis|Clinical Progression|0
4415815|NCT00296504|7196182|FG000|Interim Analysis|Insufficient Viral Load Response|5
4415816|NCT00296504|7196183|FG001|Interim Analysis|Insufficient Viral Load Response|1
4415817|NCT00296504|7196184|FG002|Interim Analysis|Insufficient Viral Load Response|12
4415818|NCT00296504|7196185|FG003|Interim Analysis|Insufficient Viral Load Response|2
4415819|NCT00296504|7196186|FG004|Interim Analysis|Insufficient Viral Load Response|7
4415820|NCT00296504|7196187|FG005|Interim Analysis|Insufficient Viral Load Response|9
4415821|NCT00296504|7196188|FG006|Interim Analysis|Insufficient Viral Load Response|2
4415822|NCT00296504|7196189|FG007|Interim Analysis|Insufficient Viral Load Response|24
4415823|NCT00296504|7196190|FG008|Interim Analysis|Insufficient Viral Load Response|0
4415824|NCT00296504|7196182|FG000|Interim Analysis|Adverse Event|0
4415825|NCT00296504|7196183|FG001|Interim Analysis|Adverse Event|0
4415826|NCT00296504|7196184|FG002|Interim Analysis|Adverse Event|13
4415827|NCT00296504|7196185|FG003|Interim Analysis|Adverse Event|4
4415828|NCT00296504|7196186|FG004|Interim Analysis|Adverse Event|6
4415829|NCT00296504|7196187|FG005|Interim Analysis|Adverse Event|3
4415830|NCT00296504|7196188|FG006|Interim Analysis|Adverse Event|4
4415831|NCT00296504|7196189|FG007|Interim Analysis|Adverse Event|5
4415832|NCT00296504|7196190|FG008|Interim Analysis|Adverse Event|0
4415833|NCT00296504|7196182|FG000|Interim Analysis|Protocol Violation|0
4415834|NCT00296504|7196183|FG001|Interim Analysis|Protocol Violation|0
4415835|NCT00296504|7196184|FG002|Interim Analysis|Protocol Violation|2
4415836|NCT00296504|7196185|FG003|Interim Analysis|Protocol Violation|0
4415837|NCT00296504|7196186|FG004|Interim Analysis|Protocol Violation|1
4415838|NCT00296504|7196187|FG005|Interim Analysis|Protocol Violation|0
4415839|NCT00296504|7196188|FG006|Interim Analysis|Protocol Violation|0
4415840|NCT00296504|7196189|FG007|Interim Analysis|Protocol Violation|1
4415841|NCT00296504|7196190|FG008|Interim Analysis|Protocol Violation|0
4415842|NCT00296504|7196182|FG000|Interim Analysis|Insufficient CD4 Response|0
4415843|NCT00296504|7196183|FG001|Interim Analysis|Insufficient CD4 Response|0
4415844|NCT00296504|7196184|FG002|Interim Analysis|Insufficient CD4 Response|0
4415845|NCT00296504|7196185|FG003|Interim Analysis|Insufficient CD4 Response|0
4415846|NCT00296504|7196186|FG004|Interim Analysis|Insufficient CD4 Response|1
4415847|NCT00296504|7196187|FG005|Interim Analysis|Insufficient CD4 Response|1
4415848|NCT00296504|7196188|FG006|Interim Analysis|Insufficient CD4 Response|0
4415849|NCT00296504|7196189|FG007|Interim Analysis|Insufficient CD4 Response|0
4415850|NCT00296504|7196190|FG008|Interim Analysis|Insufficient CD4 Response|0
4415851|NCT00296504|7196182|FG000|Interim Analysis|Switched to Commercially Available Drug|2
4415852|NCT00296504|7196183|FG001|Interim Analysis|Switched to Commercially Available Drug|0
4415853|NCT00296504|7196184|FG002|Interim Analysis|Switched to Commercially Available Drug|4
4415854|NCT00296504|7196185|FG003|Interim Analysis|Switched to Commercially Available Drug|1
4415855|NCT00296504|7196186|FG004|Interim Analysis|Switched to Commercially Available Drug|0
4415856|NCT00296504|7196187|FG005|Interim Analysis|Switched to Commercially Available Drug|5
4415857|NCT00296504|7196188|FG006|Interim Analysis|Switched to Commercially Available Drug|3
4415858|NCT00296504|7196189|FG007|Interim Analysis|Switched to Commercially Available Drug|4
4415859|NCT00296504|7196190|FG008|Interim Analysis|Switched to Commercially Available Drug|0
4415860|NCT00296504|7196182|FG000|Interim Analysis|Pregnancy|4
4415861|NCT00296504|7196183|FG001|Interim Analysis|Pregnancy|1
4415862|NCT00296504|7196184|FG002|Interim Analysis|Pregnancy|4
4415863|NCT00296504|7196185|FG003|Interim Analysis|Pregnancy|2
4415864|NCT00296504|7196186|FG004|Interim Analysis|Pregnancy|0
4415865|NCT00296504|7196187|FG005|Interim Analysis|Pregnancy|1
4415866|NCT00296504|7196188|FG006|Interim Analysis|Pregnancy|1
4415867|NCT00296504|7196189|FG007|Interim Analysis|Pregnancy|1
4415868|NCT00296504|7196190|FG008|Interim Analysis|Pregnancy|0
4415869|NCT00296504|7196182|FG000|Interim Analysis|Death|1
4415870|NCT00296504|7196183|FG001|Interim Analysis|Death|0
4415871|NCT00296504|7196184|FG002|Interim Analysis|Death|3
4415872|NCT00296504|7196185|FG003|Interim Analysis|Death|0
4415873|NCT00296504|7196186|FG004|Interim Analysis|Death|0
4415874|NCT00296504|7196187|FG005|Interim Analysis|Death|0
4415875|NCT00296504|7196188|FG006|Interim Analysis|Death|0
4415876|NCT00296504|7196189|FG007|Interim Analysis|Death|0
4415877|NCT00296504|7196190|FG008|Interim Analysis|Death|0
4415878|NCT00296504|7196182|FG000|Interim Analysis|Participant Non-compliant|0
4415879|NCT00296504|7196183|FG001|Interim Analysis|Participant Non-compliant|1
4415880|NCT00296504|7196184|FG002|Interim Analysis|Participant Non-compliant|2
4415881|NCT00296504|7196185|FG003|Interim Analysis|Participant Non-compliant|1
4415882|NCT00296504|7196186|FG004|Interim Analysis|Participant Non-compliant|1
4415883|NCT00296504|7196187|FG005|Interim Analysis|Participant Non-compliant|3
4415884|NCT00296504|7196188|FG006|Interim Analysis|Participant Non-compliant|6
4415885|NCT00296504|7196189|FG007|Interim Analysis|Participant Non-compliant|2
4415886|NCT00296504|7196190|FG008|Interim Analysis|Participant Non-compliant|0
4415887|NCT00296504|7196182|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0
4415888|NCT00296504|7196183|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0
4415889|NCT00296504|7196184|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2
4415890|NCT00296504|7196185|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0
4415891|NCT00296504|7196186|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0
4415892|NCT00296504|7196187|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1
4415893|NCT00296504|7196188|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0
4415894|NCT00296504|7196189|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0
4415895|NCT00296504|7196190|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0
4415896|NCT00296504|7196182|FG000|Interim Analysis|To Simplify Treatment|0
4415897|NCT00296504|7196183|FG001|Interim Analysis|To Simplify Treatment|0
4415898|NCT00296504|7196184|FG002|Interim Analysis|To Simplify Treatment|1
4415899|NCT00296504|7196185|FG003|Interim Analysis|To Simplify Treatment|0
4415900|NCT00296504|7196186|FG004|Interim Analysis|To Simplify Treatment|0
4415901|NCT00296504|7196187|FG005|Interim Analysis|To Simplify Treatment|0
4415902|NCT00296504|7196188|FG006|Interim Analysis|To Simplify Treatment|2
4415903|NCT00296504|7196189|FG007|Interim Analysis|To Simplify Treatment|0
4415904|NCT00296504|7196190|FG008|Interim Analysis|To Simplify Treatment|0
4415905|NCT00296504|7196182|FG000|Interim Analysis|Participant Had Problems with Alcohol|0
4415906|NCT00296504|7196183|FG001|Interim Analysis|Participant Had Problems with Alcohol|0
4415907|NCT00296504|7196184|FG002|Interim Analysis|Participant Had Problems with Alcohol|1
4415908|NCT00296504|7196185|FG003|Interim Analysis|Participant Had Problems with Alcohol|0
4415909|NCT00296504|7196186|FG004|Interim Analysis|Participant Had Problems with Alcohol|0
4415910|NCT00296504|7196187|FG005|Interim Analysis|Participant Had Problems with Alcohol|0
4415911|NCT00296504|7196188|FG006|Interim Analysis|Participant Had Problems with Alcohol|0
4415912|NCT00296504|7196189|FG007|Interim Analysis|Participant Had Problems with Alcohol|0
4415913|NCT00296504|7196190|FG008|Interim Analysis|Participant Had Problems with Alcohol|0
4415914|NCT00296504|7196182|FG000|Interim Analysis|Participant Moved|1
4415915|NCT00296504|7196183|FG001|Interim Analysis|Participant Moved|0
4415916|NCT00296504|7196184|FG002|Interim Analysis|Participant Moved|1
4415917|NCT00296504|7196185|FG003|Interim Analysis|Participant Moved|0
4415918|NCT00296504|7196186|FG004|Interim Analysis|Participant Moved|0
4415919|NCT00296504|7196187|FG005|Interim Analysis|Participant Moved|1
4415920|NCT00296504|7196188|FG006|Interim Analysis|Participant Moved|1
4415921|NCT00296504|7196189|FG007|Interim Analysis|Participant Moved|0
4415922|NCT00296504|7196190|FG008|Interim Analysis|Participant Moved|0
4415923|NCT00296504|7196182|FG000|Interim Analysis|Participant Was Incarcerated|2
4415924|NCT00296504|7196183|FG001|Interim Analysis|Participant Was Incarcerated|0
4415925|NCT00296504|7196184|FG002|Interim Analysis|Participant Was Incarcerated|1
4415926|NCT00296504|7196185|FG003|Interim Analysis|Participant Was Incarcerated|0
4415927|NCT00296504|7196186|FG004|Interim Analysis|Participant Was Incarcerated|0
4415928|NCT00296504|7196187|FG005|Interim Analysis|Participant Was Incarcerated|0
4415929|NCT00296504|7196188|FG006|Interim Analysis|Participant Was Incarcerated|0
4415930|NCT00296504|7196189|FG007|Interim Analysis|Participant Was Incarcerated|0
4415931|NCT00296504|7196190|FG008|Interim Analysis|Participant Was Incarcerated|0
4415932|NCT00296504|7196182|FG000|Interim Analysis|Resistance to FPV|0
4415933|NCT00296504|7196183|FG001|Interim Analysis|Resistance to FPV|0
4415934|NCT00296504|7196184|FG002|Interim Analysis|Resistance to FPV|1
4415935|NCT00296504|7196185|FG003|Interim Analysis|Resistance to FPV|0
4415936|NCT00296504|7196186|FG004|Interim Analysis|Resistance to FPV|0
4415937|NCT00296504|7196187|FG005|Interim Analysis|Resistance to FPV|0
4415938|NCT00296504|7196188|FG006|Interim Analysis|Resistance to FPV|0
4415939|NCT00296504|7196189|FG007|Interim Analysis|Resistance to FPV|0
4415940|NCT00296504|7196190|FG008|Interim Analysis|Resistance to FPV|0
4415941|NCT00296504|7196182|FG000|Interim Analysis|Physician Decision|0
4415942|NCT00296504|7196183|FG001|Interim Analysis|Physician Decision|0
4415943|NCT00296504|7196184|FG002|Interim Analysis|Physician Decision|1
4415944|NCT00296504|7196185|FG003|Interim Analysis|Physician Decision|0
4415945|NCT00296504|7196186|FG004|Interim Analysis|Physician Decision|0
4415946|NCT00296504|7196187|FG005|Interim Analysis|Physician Decision|0
4415947|NCT00296504|7196188|FG006|Interim Analysis|Physician Decision|0
4415948|NCT00296504|7196189|FG007|Interim Analysis|Physician Decision|0
4415949|NCT00296504|7196190|FG008|Interim Analysis|Physician Decision|0
4415950|NCT00296504|7196182|FG000|Interim Analysis|Principle Investigator Discretion|2
4415951|NCT00296504|7196183|FG001|Interim Analysis|Principle Investigator Discretion|0
4415952|NCT00296504|7196184|FG002|Interim Analysis|Principle Investigator Discretion|1
4415953|NCT00296504|7196185|FG003|Interim Analysis|Principle Investigator Discretion|1
4415954|NCT00296504|7196186|FG004|Interim Analysis|Principle Investigator Discretion|0
4415955|NCT00296504|7196187|FG005|Interim Analysis|Principle Investigator Discretion|0
4415956|NCT00296504|7196188|FG006|Interim Analysis|Principle Investigator Discretion|0
4415957|NCT00296504|7196189|FG007|Interim Analysis|Principle Investigator Discretion|0
4415958|NCT00296504|7196190|FG008|Interim Analysis|Principle Investigator Discretion|0
4415959|NCT00296504|7196182|FG000|Interim Analysis|Principle Investigator Terminated Study|0
4415960|NCT00296504|7196183|FG001|Interim Analysis|Principle Investigator Terminated Study|0
4415961|NCT00296504|7196184|FG002|Interim Analysis|Principle Investigator Terminated Study|1
4415962|NCT00296504|7196185|FG003|Interim Analysis|Principle Investigator Terminated Study|0
4415963|NCT00296504|7196186|FG004|Interim Analysis|Principle Investigator Terminated Study|0
4415964|NCT00296504|7196187|FG005|Interim Analysis|Principle Investigator Terminated Study|0
4415965|NCT00296504|7196188|FG006|Interim Analysis|Principle Investigator Terminated Study|0
4415966|NCT00296504|7196189|FG007|Interim Analysis|Principle Investigator Terminated Study|0
4415967|NCT00296504|7196190|FG008|Interim Analysis|Principle Investigator Terminated Study|0
4415968|NCT00296504|7196182|FG000|Interim Analysis|Non-adherence|2
4415969|NCT00296504|7196183|FG001|Interim Analysis|Non-adherence|0
4415970|NCT00296504|7196184|FG002|Interim Analysis|Non-adherence|0
4415971|NCT00296504|7196185|FG003|Interim Analysis|Non-adherence|0
4415972|NCT00296504|7196186|FG004|Interim Analysis|Non-adherence|1
4415973|NCT00296504|7196187|FG005|Interim Analysis|Non-adherence|0
4415974|NCT00296504|7196188|FG006|Interim Analysis|Non-adherence|0
4415975|NCT00296504|7196189|FG007|Interim Analysis|Non-adherence|1
4415976|NCT00296504|7196190|FG008|Interim Analysis|Non-adherence|0
4415977|NCT00296504|7196182|FG000|Interim Analysis|Site Closing|1
4415978|NCT00296504|7196183|FG001|Interim Analysis|Site Closing|0
4415979|NCT00296504|7196184|FG002|Interim Analysis|Site Closing|0
4415980|NCT00296504|7196185|FG003|Interim Analysis|Site Closing|0
4415981|NCT00296504|7196186|FG004|Interim Analysis|Site Closing|0
4415982|NCT00296504|7196187|FG005|Interim Analysis|Site Closing|1
4629360|NCT01871545|7497294|FG001|Overall Study|Withdrawal by Subject|1
4629361|NCT01871558|7497305|FG000|Overall Study|Other reason|0
4629362|NCT01871558|7497306|FG001|Overall Study|Other reason|1
4629363|NCT01871558|7497305|FG000|Overall Study|antidiabetic drug prematurely stopped|1
4629364|NCT01871558|7497306|FG001|Overall Study|antidiabetic drug prematurely stopped|1
4629365|NCT01871558|7497305|FG000|Overall Study|Withdrawal by Subject|2
4629366|NCT01871558|7497306|FG001|Overall Study|Withdrawal by Subject|0
4629367|NCT01871805|7497318|FG000|Phase I|Death|7
4629368|NCT01871805|7497319|FG001|Phase I|Death|4
4629369|NCT01871805|7497320|FG002|Phase I|Death|6
4629370|NCT01871805|7497321|FG003|Phase I|Death|2
4415983|NCT00296504|7196188|FG006|Interim Analysis|Site Closing|2
4415984|NCT00296504|7196189|FG007|Interim Analysis|Site Closing|0
4415985|NCT00296504|7196190|FG008|Interim Analysis|Site Closing|0
4415986|NCT00296504|7196182|FG000|Interim Analysis|Lack of Personnel at Site|1
4415987|NCT00296504|7196183|FG001|Interim Analysis|Lack of Personnel at Site|0
4415988|NCT00296504|7196184|FG002|Interim Analysis|Lack of Personnel at Site|0
4415989|NCT00296504|7196185|FG003|Interim Analysis|Lack of Personnel at Site|0
4415990|NCT00296504|7196186|FG004|Interim Analysis|Lack of Personnel at Site|0
4415991|NCT00296504|7196187|FG005|Interim Analysis|Lack of Personnel at Site|0
4415992|NCT00296504|7196188|FG006|Interim Analysis|Lack of Personnel at Site|0
4415993|NCT00296504|7196189|FG007|Interim Analysis|Lack of Personnel at Site|0
4415994|NCT00296504|7196190|FG008|Interim Analysis|Lack of Personnel at Site|0
4415995|NCT00296504|7196182|FG000|Interim Analysis|Missed Schedule Date|1
4415996|NCT00296504|7196183|FG001|Interim Analysis|Missed Schedule Date|0
4415997|NCT00296504|7196184|FG002|Interim Analysis|Missed Schedule Date|0
4415998|NCT00296504|7196185|FG003|Interim Analysis|Missed Schedule Date|0
4415999|NCT00296504|7196186|FG004|Interim Analysis|Missed Schedule Date|0
4416000|NCT00296504|7196187|FG005|Interim Analysis|Missed Schedule Date|0
4416001|NCT00296504|7196188|FG006|Interim Analysis|Missed Schedule Date|0
4416002|NCT00296504|7196189|FG007|Interim Analysis|Missed Schedule Date|0
4416003|NCT00296504|7196190|FG008|Interim Analysis|Missed Schedule Date|0
4416004|NCT00296504|7196182|FG000|Interim Analysis|Inclusion in Other Protocol|0
4416005|NCT00296504|7196183|FG001|Interim Analysis|Inclusion in Other Protocol|0
4416006|NCT00296504|7196184|FG002|Interim Analysis|Inclusion in Other Protocol|0
4416007|NCT00296504|7196185|FG003|Interim Analysis|Inclusion in Other Protocol|1
4629371|NCT01871805|7497322|FG004|Phase I|Death|9
4629372|NCT01871805|7497323|FG005|Phase I|Death|0
4629373|NCT01871805|7497318|FG000|Phase I|Alive in Survival Follow-up|0
4416008|NCT00296504|7196186|FG004|Interim Analysis|Inclusion in Other Protocol|0
4416009|NCT00296504|7196187|FG005|Interim Analysis|Inclusion in Other Protocol|0
4416010|NCT00296504|7196188|FG006|Interim Analysis|Inclusion in Other Protocol|0
4416011|NCT00296504|7196189|FG007|Interim Analysis|Inclusion in Other Protocol|0
4416012|NCT00296504|7196190|FG008|Interim Analysis|Inclusion in Other Protocol|0
4416013|NCT00296504|7196182|FG000|Interim Analysis|Participant Stopped|0
4416014|NCT00296504|7196183|FG001|Interim Analysis|Participant Stopped|0
4416015|NCT00296504|7196184|FG002|Interim Analysis|Participant Stopped|0
4416016|NCT00296504|7196185|FG003|Interim Analysis|Participant Stopped|0
4416017|NCT00296504|7196186|FG004|Interim Analysis|Participant Stopped|1
4416018|NCT00296504|7196187|FG005|Interim Analysis|Participant Stopped|0
4416019|NCT00296504|7196188|FG006|Interim Analysis|Participant Stopped|0
4416020|NCT00296504|7196189|FG007|Interim Analysis|Participant Stopped|0
4416021|NCT00296504|7196190|FG008|Interim Analysis|Participant Stopped|0
4416022|NCT00296504|7196182|FG000|Interim Analysis|Physician and Participant Decision|0
4416023|NCT00296504|7196183|FG001|Interim Analysis|Physician and Participant Decision|0
4416024|NCT00296504|7196184|FG002|Interim Analysis|Physician and Participant Decision|0
4416025|NCT00296504|7196185|FG003|Interim Analysis|Physician and Participant Decision|0
4416026|NCT00296504|7196186|FG004|Interim Analysis|Physician and Participant Decision|0
4416027|NCT00296504|7196187|FG005|Interim Analysis|Physician and Participant Decision|1
4416028|NCT00296504|7196188|FG006|Interim Analysis|Physician and Participant Decision|0
4416029|NCT00296504|7196189|FG007|Interim Analysis|Physician and Participant Decision|0
4416030|NCT00296504|7196190|FG008|Interim Analysis|Physician and Participant Decision|0
4416031|NCT00296504|7196182|FG000|Interim Analysis|Participant Stopped HIV Medications|0
4416032|NCT00296504|7196183|FG001|Interim Analysis|Participant Stopped HIV Medications|0
4416033|NCT00296504|7196184|FG002|Interim Analysis|Participant Stopped HIV Medications|0
4416034|NCT00296504|7196185|FG003|Interim Analysis|Participant Stopped HIV Medications|0
4416035|NCT00296504|7196186|FG004|Interim Analysis|Participant Stopped HIV Medications|0
4416036|NCT00296504|7196187|FG005|Interim Analysis|Participant Stopped HIV Medications|0
4416037|NCT00296504|7196188|FG006|Interim Analysis|Participant Stopped HIV Medications|1
4416038|NCT00296504|7196189|FG007|Interim Analysis|Participant Stopped HIV Medications|0
4416039|NCT00296504|7196190|FG008|Interim Analysis|Participant Stopped HIV Medications|0
4416040|NCT00296504|7196182|FG000|Interim Analysis|Study Ended|0
4416041|NCT00296504|7196183|FG001|Interim Analysis|Study Ended|0
4416042|NCT00296504|7196184|FG002|Interim Analysis|Study Ended|0
4416043|NCT00296504|7196185|FG003|Interim Analysis|Study Ended|0
4416044|NCT00296504|7196186|FG004|Interim Analysis|Study Ended|0
4416045|NCT00296504|7196187|FG005|Interim Analysis|Study Ended|0
4416046|NCT00296504|7196188|FG006|Interim Analysis|Study Ended|1
4416047|NCT00296504|7196189|FG007|Interim Analysis|Study Ended|0
4416048|NCT00296504|7196190|FG008|Interim Analysis|Study Ended|0
4416049|NCT00296504|7196182|FG000|Interim Analysis|Participant Needed Interferon|0
4416050|NCT00296504|7196183|FG001|Interim Analysis|Participant Needed Interferon|0
4416051|NCT00296504|7196184|FG002|Interim Analysis|Participant Needed Interferon|0
4416052|NCT00296504|7196185|FG003|Interim Analysis|Participant Needed Interferon|0
4416053|NCT00296504|7196186|FG004|Interim Analysis|Participant Needed Interferon|0
4416054|NCT00296504|7196187|FG005|Interim Analysis|Participant Needed Interferon|0
4416055|NCT00296504|7196188|FG006|Interim Analysis|Participant Needed Interferon|0
4416056|NCT00296504|7196189|FG007|Interim Analysis|Participant Needed Interferon|1
4416057|NCT00296504|7196190|FG008|Interim Analysis|Participant Needed Interferon|0
4416058|NCT00296504|7196182|FG000|Interim Analysis|Ongoing|32
4416059|NCT00296504|7196183|FG001|Interim Analysis|Ongoing|12
4416060|NCT00296504|7196184|FG002|Interim Analysis|Ongoing|16
4416061|NCT00296504|7196185|FG003|Interim Analysis|Ongoing|22
4416062|NCT00296504|7196186|FG004|Interim Analysis|Ongoing|0
4416063|NCT00296504|7196187|FG005|Interim Analysis|Ongoing|0
4416064|NCT00296504|7196188|FG006|Interim Analysis|Ongoing|30
4416065|NCT00296504|7196189|FG007|Interim Analysis|Ongoing|1
4416066|NCT00296504|7196190|FG008|Interim Analysis|Ongoing|0
4416067|NCT00296504|7196182|FG000|Final Analysis|Withdrawal by Subject|0
4416068|NCT00296504|7196183|FG001|Final Analysis|Withdrawal by Subject|0
4416069|NCT00296504|7196184|FG002|Final Analysis|Withdrawal by Subject|0
4416070|NCT00296504|7196185|FG003|Final Analysis|Withdrawal by Subject|0
4416071|NCT00296504|7196186|FG004|Final Analysis|Withdrawal by Subject|0
4416072|NCT00296504|7196187|FG005|Final Analysis|Withdrawal by Subject|0
4416073|NCT00296504|7196188|FG006|Final Analysis|Withdrawal by Subject|0
4416074|NCT00296504|7196189|FG007|Final Analysis|Withdrawal by Subject|0
4416075|NCT00296504|7196190|FG008|Final Analysis|Withdrawal by Subject|1
4416076|NCT00296504|7196182|FG000|Final Analysis|Lost to Follow-up|0
4416077|NCT00296504|7196183|FG001|Final Analysis|Lost to Follow-up|0
4416078|NCT00296504|7196184|FG002|Final Analysis|Lost to Follow-up|0
4416079|NCT00296504|7196185|FG003|Final Analysis|Lost to Follow-up|0
4416080|NCT00296504|7196186|FG004|Final Analysis|Lost to Follow-up|0
4416081|NCT00296504|7196187|FG005|Final Analysis|Lost to Follow-up|0
4416082|NCT00296504|7196188|FG006|Final Analysis|Lost to Follow-up|0
4416083|NCT00296504|7196189|FG007|Final Analysis|Lost to Follow-up|0
4416084|NCT00296504|7196190|FG008|Final Analysis|Lost to Follow-up|5
4416085|NCT00296504|7196182|FG000|Final Analysis|Insufficient Viral Load Response|0
4416086|NCT00296504|7196183|FG001|Final Analysis|Insufficient Viral Load Response|0
4416087|NCT00296504|7196184|FG002|Final Analysis|Insufficient Viral Load Response|0
4416088|NCT00296504|7196185|FG003|Final Analysis|Insufficient Viral Load Response|0
4416089|NCT00296504|7196186|FG004|Final Analysis|Insufficient Viral Load Response|0
4416090|NCT00296504|7196187|FG005|Final Analysis|Insufficient Viral Load Response|0
4416091|NCT00296504|7196188|FG006|Final Analysis|Insufficient Viral Load Response|0
4416092|NCT00296504|7196189|FG007|Final Analysis|Insufficient Viral Load Response|0
4416093|NCT00296504|7196190|FG008|Final Analysis|Insufficient Viral Load Response|6
4416094|NCT00296504|7196182|FG000|Final Analysis|Adverse Event|0
4416095|NCT00296504|7196183|FG001|Final Analysis|Adverse Event|0
4416096|NCT00296504|7196184|FG002|Final Analysis|Adverse Event|0
4416097|NCT00296504|7196185|FG003|Final Analysis|Adverse Event|0
4416098|NCT00296504|7196186|FG004|Final Analysis|Adverse Event|0
4416099|NCT00296504|7196187|FG005|Final Analysis|Adverse Event|0
4416100|NCT00296504|7196188|FG006|Final Analysis|Adverse Event|0
4416101|NCT00296504|7196189|FG007|Final Analysis|Adverse Event|0
4416102|NCT00296504|7196190|FG008|Final Analysis|Adverse Event|2
4416103|NCT00296504|7196182|FG000|Final Analysis|Pregnancy|0
4416104|NCT00296504|7196183|FG001|Final Analysis|Pregnancy|0
4416105|NCT00296504|7196184|FG002|Final Analysis|Pregnancy|0
4416106|NCT00296504|7196185|FG003|Final Analysis|Pregnancy|0
4416107|NCT00296504|7196186|FG004|Final Analysis|Pregnancy|0
4416108|NCT00296504|7196187|FG005|Final Analysis|Pregnancy|0
4416109|NCT00296504|7196188|FG006|Final Analysis|Pregnancy|0
4416110|NCT00296504|7196189|FG007|Final Analysis|Pregnancy|0
4416111|NCT00296504|7196190|FG008|Final Analysis|Pregnancy|4
4416112|NCT00296504|7196182|FG000|Final Analysis|Tuberculosis|0
4416113|NCT00296504|7196183|FG001|Final Analysis|Tuberculosis|0
4416114|NCT00296504|7196184|FG002|Final Analysis|Tuberculosis|0
4416115|NCT00296504|7196185|FG003|Final Analysis|Tuberculosis|0
4416116|NCT00296504|7196186|FG004|Final Analysis|Tuberculosis|0
4416117|NCT00296504|7196187|FG005|Final Analysis|Tuberculosis|0
4416118|NCT00296504|7196188|FG006|Final Analysis|Tuberculosis|0
4416119|NCT00296504|7196189|FG007|Final Analysis|Tuberculosis|0
4416120|NCT00296504|7196190|FG008|Final Analysis|Tuberculosis|1
4416121|NCT00296504|7196182|FG000|Final Analysis|Participant Moved to Another Country|0
4416122|NCT00296504|7196183|FG001|Final Analysis|Participant Moved to Another Country|0
4416123|NCT00296504|7196184|FG002|Final Analysis|Participant Moved to Another Country|0
4416124|NCT00296504|7196185|FG003|Final Analysis|Participant Moved to Another Country|0
4416125|NCT00296504|7196186|FG004|Final Analysis|Participant Moved to Another Country|0
4416126|NCT00296504|7196187|FG005|Final Analysis|Participant Moved to Another Country|0
4416127|NCT00296504|7196188|FG006|Final Analysis|Participant Moved to Another Country|0
4416128|NCT00296504|7196189|FG007|Final Analysis|Participant Moved to Another Country|0
4416129|NCT00296504|7196190|FG008|Final Analysis|Participant Moved to Another Country|1
4416130|NCT00296504|7196182|FG000|Final Analysis|Poor Adherence|0
4416131|NCT00296504|7196183|FG001|Final Analysis|Poor Adherence|0
4416132|NCT00296504|7196184|FG002|Final Analysis|Poor Adherence|0
4416133|NCT00296504|7196185|FG003|Final Analysis|Poor Adherence|0
4416134|NCT00296504|7196186|FG004|Final Analysis|Poor Adherence|0
4416135|NCT00296504|7196187|FG005|Final Analysis|Poor Adherence|0
4416136|NCT00296504|7196188|FG006|Final Analysis|Poor Adherence|0
4416137|NCT00296504|7196189|FG007|Final Analysis|Poor Adherence|0
4416138|NCT00296504|7196190|FG008|Final Analysis|Poor Adherence|1
4416139|NCT00296517|7196217|FG000|Dose Level 2 - Week 2|Adverse Event|1
4416140|NCT00296517|7196218|FG001|Dose Level 2 - Week 2|Adverse Event|5
4416141|NCT00296517|7196217|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1
4416142|NCT00296517|7196218|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0
4416143|NCT00296517|7196217|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30
4416144|NCT00296517|7196218|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34
4416145|NCT00296517|7196217|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3
4416146|NCT00296517|7196218|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6
4416147|NCT00296517|7196217|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3
4416148|NCT00296517|7196218|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2
4416149|NCT00296517|7196217|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1
4416150|NCT00296517|7196218|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0
4416151|NCT00296517|7196217|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7
4416152|NCT00296517|7196218|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18
4416153|NCT00296517|7196217|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1
4416154|NCT00296517|7196218|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0
4416155|NCT00296517|7196217|FG000|Dose Level 3 - Weeks 3-12|Other|0
4416156|NCT00296517|7196218|FG001|Dose Level 3 - Weeks 3-12|Other|2
4416157|NCT00296647|7196229|FG000|Overall Study|Death|4
4416158|NCT00296647|7196230|FG001|Overall Study|Death|1
4416159|NCT00296647|7196231|FG002|Overall Study|Death|2
4416160|NCT00296647|7196232|FG003|Overall Study|Death|1
4416161|NCT00296647|7196233|FG004|Overall Study|Death|1
4416162|NCT00296647|7196229|FG000|Overall Study|Withdrawal by Subject|28
4416163|NCT00296647|7196230|FG001|Overall Study|Withdrawal by Subject|27
4416164|NCT00296647|7196231|FG002|Overall Study|Withdrawal by Subject|32
4416165|NCT00296647|7196232|FG003|Overall Study|Withdrawal by Subject|16
4416166|NCT00296647|7196233|FG004|Overall Study|Withdrawal by Subject|19
4416167|NCT00296725|7196245|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1
4416168|NCT00296725|7196245|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4
4416169|NCT00296725|7196245|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1
4416170|NCT00296816|7196253|FG000|Overall Study|Disease Progression|37
4416171|NCT00296816|7196253|FG000|Overall Study|Adverse Event|18
4416172|NCT00296816|7196253|FG000|Overall Study|Investigator/Participant request|5
4416173|NCT00296816|7196253|FG000|Overall Study|Non-compliance|1
4416174|NCT00296816|7196253|FG000|Overall Study|Missing for end of treatment|4
4416175|NCT00296816|7196253|FG000|Overall Study|Progression based on CA-125 (biomarker)|2
4416176|NCT00296816|7196253|FG000|Overall Study|Poor performance status|1
4416177|NCT00296816|7196253|FG000|Overall Study|Relocation to Florida|1
4416178|NCT00296816|7196253|FG000|Overall Study|Noncompliance/decision to discontinue|1
4416179|NCT00296816|7196253|FG000|Overall Study|Urine protein/creatinine ratio delay|1
4416180|NCT00296816|7196253|FG000|Overall Study|Neuropathy/patient preference|1
4416181|NCT00296816|7196253|FG000|Overall Study|Proteinuria|1
4416182|NCT00296816|7196253|FG000|Overall Study|ineligibility due to radiation treatment|1
4416183|NCT00297037|7196259|FG000|Overall Study|Withdrawal by Subject|2
4416184|NCT00297037|7196260|FG001|Overall Study|Withdrawal by Subject|0
4416185|NCT00297167|7196286|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0
4416186|NCT00297167|7196287|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0
4416187|NCT00297167|7196288|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1
4416188|NCT00297167|7196286|FG000|Second Double-blind Intervention Period|Protocol Violation|1
4416189|NCT00297167|7196287|FG001|Second Double-blind Intervention Period|Protocol Violation|0
4416190|NCT00297167|7196288|FG002|Second Double-blind Intervention Period|Protocol Violation|0
4416191|NCT00297232|7196295|FG000|Overall Study|Lack of Efficacy|7
4416192|NCT00297232|7196295|FG000|Overall Study|Lost to Follow-up|10
4416193|NCT00297232|7196295|FG000|Overall Study|Adverse Event|63
4416194|NCT00297232|7196295|FG000|Overall Study|Voluntary Withdrawal|120
4416195|NCT00297232|7196295|FG000|Overall Study|Subject was Noncompliant|9
4416196|NCT00297232|7196295|FG000|Overall Study|Death|9
4416197|NCT00297232|7196295|FG000|Overall Study|Anti-natalizumab Positive|8
4416198|NCT00297232|7196295|FG000|Overall Study|Switched to Commercial Tysabri|22
4416199|NCT00297232|7196295|FG000|Overall Study|Disease Progression|8
4416200|NCT00297232|7196295|FG000|Overall Study|Fear of PML|10
4416201|NCT00297232|7196295|FG000|Overall Study|Anti-JCV Antibody Positive|13
4416202|NCT00297232|7196295|FG000|Overall Study|Miscellaneous|5
4416203|NCT00297232|7196295|FG000|Overall Study|Sponsor Decision|34
4416204|NCT00297232|7196295|FG000|Overall Study|Subject Relocated|7
4416205|NCT00297232|7196295|FG000|Overall Study|Subject Withdrew Consent|37
4416206|NCT00297232|7196295|FG000|Overall Study|Persistently Positive Antibodies|11
4416207|NCT00297232|7196295|FG000|Overall Study|Investigator Withdrew From Program|19
4416208|NCT00297232|7196295|FG000|Overall Study|Did Not Enroll to Week 264|34
4416209|NCT00297232|7196295|FG000|Overall Study|Did Not Enroll to Week 480|17
4416210|NCT00297232|7196295|FG000|Overall Study|No data available after Week 264|161
4416211|NCT00297232|7196295|FG000|Overall Study|Other|1
4416212|NCT00297258|7196299|FG000|Overall Study|Disease Progression, Relapse, Death|120
4416213|NCT00297258|7196299|FG000|Overall Study|Toxicity (or Toxic Death)|10
4416214|NCT00297258|7196299|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2
4416215|NCT00297258|7196299|FG000|Overall Study|Intercurrent Illness|3
4416216|NCT00297258|7196299|FG000|Overall Study|Intercurrent Death|2
4416217|NCT00297258|7196299|FG000|Overall Study|Deteriorization of General Condition|1
4416218|NCT00297258|7196299|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1
4416219|NCT00297258|7196299|FG000|Overall Study|Surgery Performed on Target Lesion|1
4416220|NCT00297258|7196299|FG000|Overall Study|Switch to Commercial Treatment|1
4416221|NCT00297258|7196299|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1
4416222|NCT00297427|7196308|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8
4416223|NCT00297427|7196309|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5
4416224|NCT00297427|7196308|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0
4416225|NCT00297427|7196309|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3
4416226|NCT00297427|7196308|FG000|Phase 1: Initial Intervention|Death|0
4416227|NCT00297427|7196309|FG001|Phase 1: Initial Intervention|Death|1
4416228|NCT00297427|7196308|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15
4416229|NCT00297427|7196309|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0
4416230|NCT00297427|7196308|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1
4416231|NCT00297427|7196309|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0
4416232|NCT00297427|7196308|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29
4416233|NCT00297427|7196309|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0
4416234|NCT00297427|7196308|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3
4416235|NCT00297427|7196309|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0
4416236|NCT00297427|7196308|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2
4416237|NCT00297427|7196309|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0
4416238|NCT00297479|7196326|FG000|Overall Study|Lost to Follow-up|37
4416239|NCT00297479|7196327|FG001|Overall Study|Lost to Follow-up|54
4416240|NCT00297479|7196328|FG002|Overall Study|Lost to Follow-up|51
4416241|NCT00297492|7196339|FG000|Set Quit Date|Lost to Follow-up|7
4416242|NCT00297492|7196340|FG001|Set Quit Date|Lost to Follow-up|13
4416243|NCT00297492|7196341|FG002|Set Quit Date|Lost to Follow-up|5
4416244|NCT00297492|7196339|FG000|6 Month Follow-up|Lost to Follow-up|63
4416245|NCT00297492|7196340|FG001|6 Month Follow-up|Lost to Follow-up|49
4416246|NCT00297492|7196341|FG002|6 Month Follow-up|Lost to Follow-up|27
4416247|NCT00297648|7196353|FG000|Overall Study|Adverse Event|13
4416248|NCT00297648|7196353|FG000|Overall Study|Lack of Efficacy|18
4416249|NCT00297648|7196353|FG000|Overall Study|Lost to Follow-up|1
4416250|NCT00297648|7196353|FG000|Overall Study|Withdrawal by Subject|3
4416251|NCT00297648|7196353|FG000|Overall Study|Other: Incompliance|1
4416252|NCT00297778|7196359|FG000|Overall Study|Adverse Event|16
4416253|NCT00297778|7196360|FG001|Overall Study|Adverse Event|10
4416254|NCT00297778|7196359|FG000|Overall Study|Withdrawal by Subject|1
4416255|NCT00297778|7196360|FG001|Overall Study|Withdrawal by Subject|5
4416256|NCT00297778|7196359|FG000|Overall Study|Lack of Efficacy|2
4416257|NCT00297778|7196360|FG001|Overall Study|Lack of Efficacy|1
4416258|NCT00297778|7196359|FG000|Overall Study|Non-compliant with trial protocol|0
4416259|NCT00297778|7196360|FG001|Overall Study|Non-compliant with trial protocol|3
4416260|NCT00297778|7196359|FG000|Overall Study|Other|0
4416261|NCT00297778|7196360|FG001|Overall Study|Other|1
4416262|NCT00297830|7196369|FG000|6 Month Visit|Death|1
4416263|NCT00297830|7196370|FG001|6 Month Visit|Death|0
4416264|NCT00297830|7196371|FG002|6 Month Visit|Death|2
4416265|NCT00297830|7196369|FG000|6 Month Visit|Withdrawal by Subject|2
4416266|NCT00297830|7196370|FG001|6 Month Visit|Withdrawal by Subject|1
4416267|NCT00297830|7196371|FG002|6 Month Visit|Withdrawal by Subject|1
4416268|NCT00297830|7196369|FG000|6 Month Visit|Adverse Event|0
4416269|NCT00297830|7196370|FG001|6 Month Visit|Adverse Event|1
4416270|NCT00297830|7196371|FG002|6 Month Visit|Adverse Event|0
4416271|NCT00297830|7196369|FG000|12 Month Visit|Lost to Follow-up|1
4416272|NCT00297830|7196370|FG001|12 Month Visit|Lost to Follow-up|0
4416273|NCT00297830|7196371|FG002|12 Month Visit|Lost to Follow-up|0
4416274|NCT00297830|7196369|FG000|12 Month Visit|Adverse Event|0
4416275|NCT00297830|7196370|FG001|12 Month Visit|Adverse Event|3
4416276|NCT00297830|7196371|FG002|12 Month Visit|Adverse Event|0
4416277|NCT00297830|7196369|FG000|12 Month Visit|Withdrawal by Subject|0
4416278|NCT00297830|7196370|FG001|12 Month Visit|Withdrawal by Subject|3
4416279|NCT00297830|7196371|FG002|12 Month Visit|Withdrawal by Subject|0
4511830|NCT00929240|7321217|FG000|Maintenance Phase|Health authority/Study termination|0
4511831|NCT00929240|7321218|FG001|Maintenance Phase|Health authority/Study termination|1
4511832|NCT00929240|7321219|FG002|Maintenance Phase|Health authority/Study termination|2
4511833|NCT00929240|7321217|FG000|Maintenance Phase|Physician Decision|0
4511834|NCT00929240|7321218|FG001|Maintenance Phase|Physician Decision|2
4511835|NCT00929240|7321219|FG002|Maintenance Phase|Physician Decision|1
4511836|NCT00929240|7321217|FG000|Maintenance Phase|Change of treatment|0
4511837|NCT00929240|7321218|FG001|Maintenance Phase|Change of treatment|4
4511838|NCT00929240|7321219|FG002|Maintenance Phase|Change of treatment|0
4511839|NCT00929240|7321217|FG000|Maintenance Phase|Treatment ongoing at study closure|0
4511840|NCT00929240|7321218|FG001|Maintenance Phase|Treatment ongoing at study closure|0
4511841|NCT00929240|7321219|FG002|Maintenance Phase|Treatment ongoing at study closure|10
4511842|NCT00929240|7321217|FG000|Maintenance Phase|Participant not treated|0
4511843|NCT00929240|7321218|FG001|Maintenance Phase|Participant not treated|2
4511844|NCT00929240|7321219|FG002|Maintenance Phase|Participant not treated|0
4511845|NCT00929526|7321284|FG000|Overall Study|Withdrawal by Subject|1
4511846|NCT00929526|7321285|FG001|Overall Study|Withdrawal by Subject|11
4511847|NCT00929526|7321284|FG000|Overall Study|Lost to Follow-up|8
4511848|NCT00929526|7321285|FG001|Overall Study|Lost to Follow-up|12
4511849|NCT00929526|7321284|FG000|Overall Study|Other|8
4511850|NCT00929526|7321285|FG001|Overall Study|Other|6
4511851|NCT00929643|7321300|FG000|Overall Study|Protocol Violation|2
4511852|NCT00929656|7321306|FG000|Overall Study|Lost to Follow-up|0
4511853|NCT00929656|7321307|FG001|Overall Study|Lost to Follow-up|1
4511854|NCT00929669|7321313|FG000|Overall Study|elevated glucose levels|1
4511855|NCT00929695|7321319|FG000|Overall Study|Death|2
4511856|NCT00929695|7321320|FG001|Overall Study|Death|1
4511857|NCT00929695|7321319|FG000|Overall Study|Withdrawal by Subject|0
4511858|NCT00929695|7321320|FG001|Overall Study|Withdrawal by Subject|2
4511859|NCT00929695|7321319|FG000|Overall Study|discharge home|4
4511860|NCT00929695|7321320|FG001|Overall Study|discharge home|3
4511861|NCT00929695|7321319|FG000|Overall Study|incorrect stratification|2
4511862|NCT00929695|7321320|FG001|Overall Study|incorrect stratification|0
4511863|NCT00929708|7321336|FG000|Overall Study|Protocol Violation|2
4511864|NCT00929708|7321337|FG001|Overall Study|Protocol Violation|1
4511865|NCT00929708|7321338|FG002|Overall Study|Protocol Violation|1
4511866|NCT00929708|7321339|FG003|Overall Study|Protocol Violation|1
4511867|NCT00929708|7321340|FG004|Overall Study|Protocol Violation|1
4511868|NCT00929708|7321336|FG000|Overall Study|Withdrawal by Subject|2
4511869|NCT00929708|7321337|FG001|Overall Study|Withdrawal by Subject|0
4511870|NCT00929708|7321338|FG002|Overall Study|Withdrawal by Subject|0
4511871|NCT00929708|7321339|FG003|Overall Study|Withdrawal by Subject|2
4511872|NCT00929708|7321340|FG004|Overall Study|Withdrawal by Subject|1
4511873|NCT00929708|7321336|FG000|Overall Study|Adverse Event|0
4511874|NCT00929708|7321337|FG001|Overall Study|Adverse Event|0
4511875|NCT00929708|7321338|FG002|Overall Study|Adverse Event|0
4511876|NCT00929708|7321339|FG003|Overall Study|Adverse Event|0
4511877|NCT00929708|7321340|FG004|Overall Study|Adverse Event|3
4511878|NCT00929708|7321336|FG000|Overall Study|Physician Decision|0
4511879|NCT00929708|7321337|FG001|Overall Study|Physician Decision|2
4416280|NCT00297882|7196381|FG000|Day 14|Lack of Efficacy|12
4416281|NCT00297882|7196382|FG001|Day 14|Lack of Efficacy|49
4416282|NCT00297882|7196381|FG000|Day 28|Lost to Follow-up|13
4416283|NCT00297882|7196382|FG001|Day 28|Lost to Follow-up|23
4416284|NCT00297882|7196381|FG000|Day 28|Lack of Efficacy|3
4416285|NCT00297882|7196382|FG001|Day 28|Lack of Efficacy|0
4416286|NCT00298038|7196392|FG000|Overall Study|Lost to Follow-up|0
4416287|NCT00298038|7196393|FG001|Overall Study|Lost to Follow-up|1
4416288|NCT00298038|7196392|FG000|Overall Study|Liver Transplant|0
4416289|NCT00298038|7196393|FG001|Overall Study|Liver Transplant|1
4416290|NCT00298038|7196392|FG000|Overall Study|Protocol Violation|1
4416291|NCT00298038|7196393|FG001|Overall Study|Protocol Violation|3
4416292|NCT00298038|7196392|FG000|Overall Study|Death|6
4416293|NCT00298038|7196393|FG001|Overall Study|Death|3
4416294|NCT00298038|7196392|FG000|Overall Study|Withdrawal by Subject|6
4416295|NCT00298038|7196393|FG001|Overall Study|Withdrawal by Subject|9
4416296|NCT00298038|7196392|FG000|Overall Study|Adverse Event|8
4416297|NCT00298038|7196393|FG001|Overall Study|Adverse Event|7
4416298|NCT00298038|7196392|FG000|Overall Study|Breakthrough overt HE episode|28
4416299|NCT00298038|7196393|FG001|Overall Study|Breakthrough overt HE episode|69
4416300|NCT00298038|7196392|FG000|Overall Study|Noncompliance|1
4416301|NCT00298038|7196393|FG001|Overall Study|Noncompliance|0
4416302|NCT00298038|7196392|FG000|Overall Study|Cocaine Abuse|1
4416303|NCT00298038|7196393|FG001|Overall Study|Cocaine Abuse|0
4416304|NCT00298038|7196392|FG000|Overall Study|Severe Gastrointestinal Bleed|1
4416305|NCT00298038|7196393|FG001|Overall Study|Severe Gastrointestinal Bleed|0
4416306|NCT00298272|7196429|FG000|Double-blind Phase|Adverse Event|2
4416307|NCT00298272|7196430|FG001|Double-blind Phase|Adverse Event|0
4416308|NCT00298272|7196429|FG000|Double-blind Phase|Failure to Return|2
4416309|NCT00298272|7196430|FG001|Double-blind Phase|Failure to Return|0
4416310|NCT00298272|7196429|FG000|Double-blind Phase|Protocol Violation|2
4416311|NCT00298272|7196430|FG001|Double-blind Phase|Protocol Violation|0
4416312|NCT00298272|7196429|FG000|Double-blind Phase|Withdrawal by Subject|2
4416313|NCT00298272|7196430|FG001|Double-blind Phase|Withdrawal by Subject|0
4416314|NCT00298272|7196429|FG000|Open Label Retreatment Phase|Adverse Event|1
4416315|NCT00298272|7196430|FG001|Open Label Retreatment Phase|Adverse Event|2
4416316|NCT00298272|7196429|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2
4416317|NCT00298272|7196430|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1
4416318|NCT00298272|7196429|FG000|Open Label Retreatment Phase|Failure to Return|1
4416319|NCT00298272|7196430|FG001|Open Label Retreatment Phase|Failure to Return|0
4416320|NCT00298272|7196429|FG000|Open Label Retreatment Phase|Protocol Violation|2
4416321|NCT00298272|7196430|FG001|Open Label Retreatment Phase|Protocol Violation|1
4416322|NCT00298272|7196429|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1
4416323|NCT00298272|7196430|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0
4416324|NCT00298272|7196429|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2
4416325|NCT00298272|7196430|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0
4416326|NCT00298272|7196429|FG000|Safety Follow-up Phase|Failure to Return|1
4416327|NCT00298272|7196430|FG001|Safety Follow-up Phase|Failure to Return|1
4416328|NCT00298272|7196429|FG000|Safety Follow-up Phase|Withdrawal by Subject|2
4416329|NCT00298272|7196430|FG001|Safety Follow-up Phase|Withdrawal by Subject|2
4416330|NCT00298272|7196429|FG000|Safety Follow-up Phase|Administrative/Other Reason|1
4416331|NCT00298272|7196430|FG001|Safety Follow-up Phase|Administrative/Other Reason|1
4416332|NCT00298363|7196442|FG000|Overall Study|Lost to Follow-up|0
4416333|NCT00298363|7196443|FG001|Overall Study|Lost to Follow-up|0
4416334|NCT00298363|7196444|FG002|Overall Study|Lost to Follow-up|1
4416335|NCT00298363|7196442|FG000|Overall Study|Physician Decision|4
4416336|NCT00298363|7196443|FG001|Overall Study|Physician Decision|1
4416337|NCT00298363|7196444|FG002|Overall Study|Physician Decision|0
4416338|NCT00298363|7196442|FG000|Overall Study|Protocol Violation|1
4416339|NCT00298363|7196443|FG001|Overall Study|Protocol Violation|1
4416340|NCT00298363|7196444|FG002|Overall Study|Protocol Violation|0
4416341|NCT00298363|7196442|FG000|Overall Study|Withdrawal by Subject|5
4416342|NCT00298363|7196443|FG001|Overall Study|Withdrawal by Subject|1
4416343|NCT00298363|7196444|FG002|Overall Study|Withdrawal by Subject|3
4416344|NCT00298363|7196442|FG000|Overall Study|Adverse Event|5
4416345|NCT00298363|7196443|FG001|Overall Study|Adverse Event|2
4416346|NCT00298363|7196444|FG002|Overall Study|Adverse Event|2
4416347|NCT00298363|7196442|FG000|Overall Study|Lack of Efficacy|2
4416348|NCT00298363|7196443|FG001|Overall Study|Lack of Efficacy|3
4416349|NCT00298363|7196444|FG002|Overall Study|Lack of Efficacy|0
4416350|NCT00298766|7196492|FG000|Overall Study|Adverse Event|18
4416351|NCT00298766|7196492|FG000|Overall Study|Death|2
4416352|NCT00298766|7196492|FG000|Overall Study|Withdrawal by Subject|9
4416353|NCT00298766|7196492|FG000|Overall Study|Treatment ongoing|4
4416354|NCT00298766|7196492|FG000|Overall Study|Progression of amyloid markers|4
4416355|NCT00298766|7196492|FG000|Overall Study|Deterioration in KPS and organ function|1
4416356|NCT00298766|7196492|FG000|Overall Study|Subjects overall condition deterioration|4
4416357|NCT00298766|7196492|FG000|Overall Study|Other|4
4416358|NCT00298831|7196496|FG000|Overall Study|Adverse Event|1
4416359|NCT00298831|7196496|FG000|Overall Study|Lost to Follow-up|3
4416360|NCT00298831|7196496|FG000|Overall Study|Withdrawal by Subject|1
4416361|NCT00298831|7196496|FG000|Overall Study|Participants did not receive treatment|27
4416362|NCT00298896|7196500|FG000|Overall Study|Death|3
4416363|NCT00298896|7196500|FG000|Overall Study|Physician Decision|2
4416364|NCT00298896|7196500|FG000|Overall Study|Intercurrent Illness|1
4416365|NCT00298896|7196500|FG000|Overall Study|Disease Progression|41
4416366|NCT00298896|7196500|FG000|Overall Study|Withdrawal by Subject|2
4416367|NCT00298896|7196500|FG000|Overall Study|Assigned to treatment in error|1
4416368|NCT00299104|7196516|FG000|Treatment Period|Adverse Event|14
4416369|NCT00299104|7196517|FG001|Treatment Period|Adverse Event|9
4416370|NCT00299104|7196518|FG002|Treatment Period|Adverse Event|7
4416371|NCT00299104|7196516|FG000|Treatment Period|Death|1
4416372|NCT00299104|7196517|FG001|Treatment Period|Death|1
4416373|NCT00299104|7196518|FG002|Treatment Period|Death|1
4416374|NCT00299104|7196516|FG000|Treatment Period|Insufficient therapeutic response|34
4416375|NCT00299104|7196517|FG001|Treatment Period|Insufficient therapeutic response|13
4416376|NCT00299104|7196518|FG002|Treatment Period|Insufficient therapeutic response|8
4416377|NCT00299104|7196516|FG000|Treatment Period|Failure to return|9
4416378|NCT00299104|7196517|FG001|Treatment Period|Failure to return|8
4416379|NCT00299104|7196518|FG002|Treatment Period|Failure to return|8
4416380|NCT00299104|7196516|FG000|Treatment Period|Violation of selection criteria|1
4416381|NCT00299104|7196517|FG001|Treatment Period|Violation of selection criteria|2
4416382|NCT00299104|7196518|FG002|Treatment Period|Violation of selection criteria|0
4416383|NCT00299104|7196516|FG000|Treatment Period|Protocol Violation|1
4416384|NCT00299104|7196517|FG001|Treatment Period|Protocol Violation|1
4416385|NCT00299104|7196518|FG002|Treatment Period|Protocol Violation|0
4416386|NCT00299104|7196516|FG000|Treatment Period|Refused treatment|9
4416387|NCT00299104|7196517|FG001|Treatment Period|Refused treatment|2
4416388|NCT00299104|7196518|FG002|Treatment Period|Refused treatment|2
4416389|NCT00299104|7196516|FG000|Treatment Period|Withdrew consent|14
4416390|NCT00299104|7196517|FG001|Treatment Period|Withdrew consent|19
4416391|NCT00299104|7196518|FG002|Treatment Period|Withdrew consent|9
4416392|NCT00299104|7196516|FG000|Treatment Period|Administrative reasons|106
4416393|NCT00299104|7196517|FG001|Treatment Period|Administrative reasons|120
4416394|NCT00299104|7196518|FG002|Treatment Period|Administrative reasons|137
4416395|NCT00299104|7196516|FG000|Safety Follow-Up (SFU) Period|Death|3
4416396|NCT00299104|7196517|FG001|Safety Follow-Up (SFU) Period|Death|2
4416397|NCT00299104|7196518|FG002|Safety Follow-Up (SFU) Period|Death|1
4416398|NCT00299104|7196516|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9
4416399|NCT00299104|7196517|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11
4416400|NCT00299104|7196518|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20
4416401|NCT00299104|7196516|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16
4416402|NCT00299104|7196517|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21
4416403|NCT00299104|7196518|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11
4416404|NCT00299104|7196516|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27
4416405|NCT00299104|7196517|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7
4416406|NCT00299104|7196518|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5
4416407|NCT00299104|7196516|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0
4416408|NCT00299104|7196517|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1
4416409|NCT00299104|7196518|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0
4416410|NCT00299104|7196516|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
4629374|NCT01871805|7497319|FG001|Phase I|Alive in Survival Follow-up|2
4629375|NCT01871805|7497320|FG002|Phase I|Alive in Survival Follow-up|4
4629376|NCT01871805|7497321|FG003|Phase I|Alive in Survival Follow-up|5
4629377|NCT01871805|7497322|FG004|Phase I|Alive in Survival Follow-up|4
4629378|NCT01871805|7497323|FG005|Phase I|Alive in Survival Follow-up|0
4629379|NCT01871805|7497318|FG000|Phase I|Lost to Follow-up|0
4629380|NCT01871805|7497319|FG001|Phase I|Lost to Follow-up|1
4416411|NCT00299104|7196517|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
4416412|NCT00299104|7196518|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
4416413|NCT00299104|7196516|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2
4416414|NCT00299104|7196517|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4
4416415|NCT00299104|7196518|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8
4416416|NCT00299104|7196516|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1
4416417|NCT00299104|7196517|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2
4416418|NCT00299104|7196518|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2
4416419|NCT00299130|7196529|FG000|Treatment Period (up to 5 Years)|Adverse Event|13
4416420|NCT00299130|7196530|FG001|Treatment Period (up to 5 Years)|Adverse Event|8
4416421|NCT00299130|7196531|FG002|Treatment Period (up to 5 Years)|Adverse Event|13
4416422|NCT00299130|7196529|FG000|Treatment Period (up to 5 Years)|Death|1
4416423|NCT00299130|7196530|FG001|Treatment Period (up to 5 Years)|Death|3
4416424|NCT00299130|7196531|FG002|Treatment Period (up to 5 Years)|Death|1
4416425|NCT00299130|7196529|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19
4416426|NCT00299130|7196530|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6
4416427|NCT00299130|7196531|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6
4416428|NCT00299130|7196529|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0
4416429|NCT00299130|7196530|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1
4511880|NCT00929708|7321338|FG002|Overall Study|Physician Decision|2
4629381|NCT01871805|7497320|FG002|Phase I|Lost to Follow-up|3
4629382|NCT01871805|7497321|FG003|Phase I|Lost to Follow-up|0
4416430|NCT00299130|7196531|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0
4416431|NCT00299130|7196529|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12
4416432|NCT00299130|7196530|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12
4416433|NCT00299130|7196531|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19
4416434|NCT00299130|7196529|FG000|Treatment Period (up to 5 Years)|Failure to Return|4
4416435|NCT00299130|7196530|FG001|Treatment Period (up to 5 Years)|Failure to Return|6
4416436|NCT00299130|7196531|FG002|Treatment Period (up to 5 Years)|Failure to Return|6
4416437|NCT00299130|7196529|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4
4416438|NCT00299130|7196530|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6
4416439|NCT00299130|7196531|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4
4416440|NCT00299130|7196529|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0
4416441|NCT00299130|7196530|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1
4416442|NCT00299130|7196531|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1
4416443|NCT00299130|7196529|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4
4416444|NCT00299130|7196530|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9
4416445|NCT00299130|7196531|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4
4416446|NCT00299130|7196529|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4
4416447|NCT00299130|7196530|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5
4416448|NCT00299130|7196531|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3
4416449|NCT00299130|7196529|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1
4416450|NCT00299130|7196530|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1
4416451|NCT00299130|7196531|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2
4416452|NCT00299130|7196529|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14
4416453|NCT00299130|7196530|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7
4416454|NCT00299130|7196531|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15
4416455|NCT00299130|7196529|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0
4416456|NCT00299130|7196530|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1
4416457|NCT00299130|7196531|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0
4416458|NCT00299130|7196529|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22
4416459|NCT00299130|7196530|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22
4416460|NCT00299130|7196531|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21
4416461|NCT00299130|7196529|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0
4416462|NCT00299130|7196530|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3
4416463|NCT00299130|7196531|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0
4416464|NCT00299130|7196529|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0
4416465|NCT00299130|7196530|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2
4416466|NCT00299130|7196531|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2
4416467|NCT00299130|7196529|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0
4416468|NCT00299130|7196530|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3
4416469|NCT00299130|7196531|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4
4416470|NCT00299156|7196549|FG000|Period 2 (Randomized)|Screen Failure|0
4416471|NCT00299156|7196550|FG001|Period 2 (Randomized)|Screen Failure|1
4416472|NCT00299156|7196551|FG002|Period 2 (Randomized)|Screen Failure|0
4416473|NCT00299182|7196566|FG000|Overall Study|Withdrawal by Subject|0
4416474|NCT00299182|7196567|FG001|Overall Study|Withdrawal by Subject|0
4416475|NCT00299182|7196568|FG002|Overall Study|Withdrawal by Subject|1
4416476|NCT00299182|7196569|FG003|Overall Study|Withdrawal by Subject|0
4416477|NCT00299182|7196570|FG004|Overall Study|Withdrawal by Subject|1
4416478|NCT00299182|7196571|FG005|Overall Study|Withdrawal by Subject|2
4416479|NCT00299182|7196572|FG006|Overall Study|Withdrawal by Subject|0
4416480|NCT00299182|7196566|FG000|Overall Study|Chemotherapy Changed|0
4416481|NCT00299182|7196567|FG001|Overall Study|Chemotherapy Changed|0
4416482|NCT00299182|7196568|FG002|Overall Study|Chemotherapy Changed|1
4416483|NCT00299182|7196569|FG003|Overall Study|Chemotherapy Changed|0
4416484|NCT00299182|7196570|FG004|Overall Study|Chemotherapy Changed|1
4416485|NCT00299182|7196571|FG005|Overall Study|Chemotherapy Changed|0
4416486|NCT00299182|7196572|FG006|Overall Study|Chemotherapy Changed|1
4416487|NCT00299182|7196566|FG000|Overall Study|Adverse Event|0
4416488|NCT00299182|7196567|FG001|Overall Study|Adverse Event|0
4416489|NCT00299182|7196568|FG002|Overall Study|Adverse Event|0
4416490|NCT00299182|7196569|FG003|Overall Study|Adverse Event|0
4416491|NCT00299182|7196570|FG004|Overall Study|Adverse Event|0
4416492|NCT00299182|7196571|FG005|Overall Study|Adverse Event|1
4416493|NCT00299182|7196572|FG006|Overall Study|Adverse Event|0
4416494|NCT00299182|7196566|FG000|Overall Study|Not Eligible|0
4416495|NCT00299182|7196567|FG001|Overall Study|Not Eligible|0
4416496|NCT00299182|7196568|FG002|Overall Study|Not Eligible|0
4416497|NCT00299182|7196569|FG003|Overall Study|Not Eligible|0
4416498|NCT00299182|7196570|FG004|Overall Study|Not Eligible|1
4629383|NCT01871805|7497322|FG004|Phase I|Lost to Follow-up|0
4629384|NCT01871805|7497323|FG005|Phase I|Lost to Follow-up|0
4416499|NCT00299182|7196571|FG005|Overall Study|Not Eligible|0
4416500|NCT00299182|7196572|FG006|Overall Study|Not Eligible|0
4416501|NCT00299494|7196609|FG000|Overall Study|Withdrawal by Subject|0
4629385|NCT01871805|7497318|FG000|Phase II|Death|0
4629386|NCT01871805|7497319|FG001|Phase II|Death|0
4629387|NCT01871805|7497320|FG002|Phase II|Death|0
4416502|NCT00299494|7196610|FG001|Overall Study|Withdrawal by Subject|0
4416503|NCT00299494|7196611|FG002|Overall Study|Withdrawal by Subject|0
4416504|NCT00299494|7196612|FG003|Overall Study|Withdrawal by Subject|3
4416505|NCT00299494|7196613|FG004|Overall Study|Withdrawal by Subject|1
4416506|NCT00299494|7196614|FG005|Overall Study|Withdrawal by Subject|4
4416507|NCT00299494|7196609|FG000|Overall Study|Physician Decision|0
4416508|NCT00299494|7196610|FG001|Overall Study|Physician Decision|0
4416509|NCT00299494|7196611|FG002|Overall Study|Physician Decision|0
4416510|NCT00299494|7196612|FG003|Overall Study|Physician Decision|0
4416511|NCT00299494|7196613|FG004|Overall Study|Physician Decision|1
4416512|NCT00299494|7196614|FG005|Overall Study|Physician Decision|0
4416513|NCT00299494|7196609|FG000|Overall Study|Death|3
4416514|NCT00299494|7196610|FG001|Overall Study|Death|1
4416515|NCT00299494|7196611|FG002|Overall Study|Death|4
4416516|NCT00299494|7196612|FG003|Overall Study|Death|6
4416517|NCT00299494|7196613|FG004|Overall Study|Death|18
4416518|NCT00299494|7196614|FG005|Overall Study|Death|19
4416519|NCT00299494|7196609|FG000|Overall Study|Lost to Follow-up|0
4416520|NCT00299494|7196610|FG001|Overall Study|Lost to Follow-up|0
4416521|NCT00299494|7196611|FG002|Overall Study|Lost to Follow-up|0
4416522|NCT00299494|7196612|FG003|Overall Study|Lost to Follow-up|0
4416523|NCT00299494|7196613|FG004|Overall Study|Lost to Follow-up|3
4416524|NCT00299494|7196614|FG005|Overall Study|Lost to Follow-up|1
4416525|NCT00299494|7196609|FG000|Overall Study|Other - Unspecified|0
4416526|NCT00299494|7196610|FG001|Overall Study|Other - Unspecified|0
4416527|NCT00299494|7196611|FG002|Overall Study|Other - Unspecified|0
4416528|NCT00299494|7196612|FG003|Overall Study|Other - Unspecified|0
4416529|NCT00299494|7196613|FG004|Overall Study|Other - Unspecified|3
4416530|NCT00299494|7196614|FG005|Overall Study|Other - Unspecified|1
4416531|NCT00299494|7196609|FG000|Overall Study|Other - site closure|0
4416532|NCT00299494|7196610|FG001|Overall Study|Other - site closure|0
4416533|NCT00299494|7196611|FG002|Overall Study|Other - site closure|0
4416534|NCT00299494|7196612|FG003|Overall Study|Other - site closure|1
4416535|NCT00299494|7196613|FG004|Overall Study|Other - site closure|1
4416536|NCT00299494|7196614|FG005|Overall Study|Other - site closure|1
4416537|NCT00299546|7196642|FG000|Overall Study|Death|3
4416538|NCT00299546|7196643|FG001|Overall Study|Death|2
4416539|NCT00299546|7196644|FG002|Overall Study|Death|0
4416540|NCT00299546|7196642|FG000|Overall Study|Lost to Follow-up|2
4416541|NCT00299546|7196643|FG001|Overall Study|Lost to Follow-up|2
4416542|NCT00299546|7196644|FG002|Overall Study|Lost to Follow-up|5
4416543|NCT00299546|7196642|FG000|Overall Study|Adverse Event|37
4416544|NCT00299546|7196643|FG001|Overall Study|Adverse Event|22
4416545|NCT00299546|7196644|FG002|Overall Study|Adverse Event|27
4416546|NCT00299546|7196642|FG000|Overall Study|Unsatisfactory therapeutic effect|34
4416547|NCT00299546|7196643|FG001|Overall Study|Unsatisfactory therapeutic effect|39
4416548|NCT00299546|7196644|FG002|Overall Study|Unsatisfactory therapeutic effect|34
4416549|NCT00299546|7196642|FG000|Overall Study|Other|24
4416550|NCT00299546|7196643|FG001|Overall Study|Other|26
4416551|NCT00299546|7196644|FG002|Overall Study|Other|19
4416552|NCT00299546|7196642|FG000|Overall Study|Not treated|0
4416553|NCT00299546|7196643|FG001|Overall Study|Not treated|1
4416554|NCT00299546|7196644|FG002|Overall Study|Not treated|1
4416555|NCT00299702|7196659|FG000|Overall Study|Death|1
4416556|NCT00299702|7196660|FG001|Overall Study|Death|0
4416557|NCT00299702|7196659|FG000|Overall Study|Adverse Event|0
4416558|NCT00299702|7196660|FG001|Overall Study|Adverse Event|4
4416559|NCT00299702|7196659|FG000|Overall Study|Lost to Follow-up|18
4629388|NCT01871805|7497321|FG003|Phase II|Death|0
4629389|NCT01871805|7497322|FG004|Phase II|Death|0
4416560|NCT00299702|7196660|FG001|Overall Study|Lost to Follow-up|10
4416561|NCT00299702|7196659|FG000|Overall Study|Withdrawal by Subject|25
4416562|NCT00299702|7196660|FG001|Overall Study|Withdrawal by Subject|23
4416563|NCT00299702|7196659|FG000|Overall Study|Pregnancy|0
4416564|NCT00299702|7196660|FG001|Overall Study|Pregnancy|1
4416565|NCT00299702|7196659|FG000|Overall Study|Insufficient Response|4
4416566|NCT00299702|7196660|FG001|Overall Study|Insufficient Response|3
4416567|NCT00299702|7196659|FG000|Overall Study|Admin issues, sponsor decision, etc.|5
4416568|NCT00299702|7196660|FG001|Overall Study|Admin issues, sponsor decision, etc.|9
4416569|NCT00299975|7196673|FG000|Overall Study|Adverse Event|1
4416570|NCT00299975|7196674|FG001|Overall Study|Adverse Event|0
4416571|NCT00299975|7196675|FG002|Overall Study|Adverse Event|2
4416572|NCT00299975|7196673|FG000|Overall Study|Pregnancy|0
4416573|NCT00299975|7196674|FG001|Overall Study|Pregnancy|0
4416574|NCT00299975|7196675|FG002|Overall Study|Pregnancy|1
4416575|NCT00299975|7196673|FG000|Overall Study|Lack of Efficacy|1
4416576|NCT00299975|7196674|FG001|Overall Study|Lack of Efficacy|0
4416577|NCT00299975|7196675|FG002|Overall Study|Lack of Efficacy|1
4416578|NCT00299975|7196673|FG000|Overall Study|Lost to Follow-up|1
4416579|NCT00299975|7196674|FG001|Overall Study|Lost to Follow-up|0
4416580|NCT00299975|7196675|FG002|Overall Study|Lost to Follow-up|0
4416581|NCT00299975|7196673|FG000|Overall Study|Withdrawal by Subject|0
4416582|NCT00299975|7196674|FG001|Overall Study|Withdrawal by Subject|1
4416583|NCT00299975|7196675|FG002|Overall Study|Withdrawal by Subject|3
4416584|NCT00299975|7196673|FG000|Overall Study|Physician Decision|0
4416585|NCT00299975|7196674|FG001|Overall Study|Physician Decision|0
4416586|NCT00299975|7196675|FG002|Overall Study|Physician Decision|1
4629390|NCT01871805|7497323|FG005|Phase II|Death|45
4416587|NCT00300053|7196696|FG000|Overall Study|Patient/Caregiver Preference|2
4416588|NCT00300053|7196697|FG001|Overall Study|Patient/Caregiver Preference|2
4416589|NCT00300053|7196698|FG002|Overall Study|Patient/Caregiver Preference|3
4416590|NCT00300053|7196696|FG000|Overall Study|Death|0
4416591|NCT00300053|7196697|FG001|Overall Study|Death|0
4416592|NCT00300053|7196698|FG002|Overall Study|Death|3
4416593|NCT00300053|7196696|FG000|Overall Study|Lost to Follow-up|0
4416594|NCT00300053|7196697|FG001|Overall Study|Lost to Follow-up|1
4416595|NCT00300053|7196698|FG002|Overall Study|Lost to Follow-up|0
4416596|NCT00300274|7196731|FG000|Overall Study|Withdrawal by Subject|12
4416597|NCT00300274|7196732|FG001|Overall Study|Withdrawal by Subject|3
4416598|NCT00300274|7196733|FG002|Overall Study|Withdrawal by Subject|14
4416599|NCT00300274|7196731|FG000|Overall Study|Lost to Follow-up|3
4416600|NCT00300274|7196732|FG001|Overall Study|Lost to Follow-up|4
4416601|NCT00300274|7196733|FG002|Overall Study|Lost to Follow-up|5
4416602|NCT00300274|7196731|FG000|Overall Study|Death|31
4416603|NCT00300274|7196732|FG001|Overall Study|Death|20
4416604|NCT00300274|7196733|FG002|Overall Study|Death|25
4416605|NCT00300274|7196731|FG000|Overall Study|Re-transplant|0
4416606|NCT00300274|7196732|FG001|Overall Study|Re-transplant|0
4416607|NCT00300274|7196733|FG002|Overall Study|Re-transplant|1
4416608|NCT00300365|7196743|FG000|Overall Study|Lost to Follow-up|1
4416609|NCT00300365|7196744|FG001|Overall Study|Lost to Follow-up|0
4416610|NCT00300365|7196743|FG000|Overall Study|Physician Decision|2
4416611|NCT00300365|7196744|FG001|Overall Study|Physician Decision|0
4416612|NCT00300365|7196743|FG000|Overall Study|Withdrawal by Subject|1
4416613|NCT00300365|7196744|FG001|Overall Study|Withdrawal by Subject|0
4416614|NCT00300365|7196743|FG000|Overall Study|Adverse Event|0
4416615|NCT00300365|7196744|FG001|Overall Study|Adverse Event|2
4416616|NCT00300495|7196850|FG000|Overall Study|Protocol Violation|4
4416617|NCT00300495|7196851|FG001|Overall Study|Protocol Violation|1
4416618|NCT00300755|7196869|FG000|Overall Study|Adverse Event|1
4416619|NCT00300755|7196870|FG001|Overall Study|Adverse Event|2
4416620|NCT00300755|7196871|FG002|Overall Study|Adverse Event|1
4416621|NCT00300755|7196869|FG000|Overall Study|Withdrawal by Subject|0
4416622|NCT00300755|7196870|FG001|Overall Study|Withdrawal by Subject|2
4416623|NCT00300755|7196871|FG002|Overall Study|Withdrawal by Subject|0
4416624|NCT00300755|7196869|FG000|Overall Study|Protocol Violation|0
4416625|NCT00300755|7196870|FG001|Overall Study|Protocol Violation|0
4416626|NCT00300755|7196871|FG002|Overall Study|Protocol Violation|1
4416627|NCT00300781|7196881|FG000|Overall Study|Disease Progression|55
4416628|NCT00300781|7196882|FG001|Overall Study|Disease Progression|52
4416629|NCT00300781|7196881|FG000|Overall Study|Adverse Event|5
4416630|NCT00300781|7196882|FG001|Overall Study|Adverse Event|6
4416631|NCT00300781|7196881|FG000|Overall Study|Withdrawal by Subject|1
4416632|NCT00300781|7196882|FG001|Overall Study|Withdrawal by Subject|2
4416633|NCT00300781|7196881|FG000|Overall Study|Physician Decision|1
4416634|NCT00300781|7196882|FG001|Overall Study|Physician Decision|0
4416635|NCT00300781|7196881|FG000|Overall Study|Not Recorded|0
4416636|NCT00300781|7196882|FG001|Overall Study|Not Recorded|1
4416637|NCT00300781|7196881|FG000|Overall Study|Symptomatic Deterioration|1
4416638|NCT00300781|7196882|FG001|Overall Study|Symptomatic Deterioration|0
4416639|NCT00300781|7196881|FG000|Overall Study|Lost to Follow-up|0
4416640|NCT00300781|7196882|FG001|Overall Study|Lost to Follow-up|1
4416641|NCT00300885|7196890|FG000|Treatment|Adverse Event|134
4416642|NCT00300885|7196891|FG001|Treatment|Adverse Event|82
4416643|NCT00300885|7196890|FG000|Treatment|Death|20
4416644|NCT00300885|7196891|FG001|Treatment|Death|7
4714872|NCT02963506|7642885|FG004|Dose-Blind Period|Sponsor decision|0
4714873|NCT02963506|7642886|FG005|Dose-Blind Period|Sponsor decision|1
4714874|NCT02963506|7642887|FG006|Dose-Blind Period|Sponsor decision|0
4714875|NCT02963506|7642888|FG007|Dose-Blind Period|Sponsor decision|0
4714876|NCT02963506|7642889|FG008|Dose-Blind Period|Sponsor decision|0
4714877|NCT02963506|7642890|FG009|Dose-Blind Period|Sponsor decision|0
4714878|NCT02963506|7642891|FG010|Dose-Blind Period|Sponsor decision|0
4714879|NCT02963506|7642892|FG011|Dose-Blind Period|Sponsor decision|0
4714880|NCT02963506|7642893|FG012|Dose-Blind Period|Sponsor decision|0
4714881|NCT02963506|7642881|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0
4714882|NCT02963506|7642882|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0
4714883|NCT02963506|7642883|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0
4714884|NCT02963506|7642884|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0
4416645|NCT00300885|7196890|FG000|Treatment|Lack of Efficacy|1
4416646|NCT00300885|7196891|FG001|Treatment|Lack of Efficacy|1
4416647|NCT00300885|7196890|FG000|Treatment|Lost to Follow-up|3
4714885|NCT02963506|7642885|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0
4416648|NCT00300885|7196891|FG001|Treatment|Lost to Follow-up|2
4416649|NCT00300885|7196890|FG000|Treatment|Physician Decision|4
4416650|NCT00300885|7196891|FG001|Treatment|Physician Decision|5
4416651|NCT00300885|7196890|FG000|Treatment|Protocol Violation|11
4416652|NCT00300885|7196891|FG001|Treatment|Protocol Violation|11
4714886|NCT02963506|7642886|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0
4714887|NCT02963506|7642887|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0
4416653|NCT00300885|7196890|FG000|Treatment|Withdrawal by Subject|26
4416654|NCT00300885|7196891|FG001|Treatment|Withdrawal by Subject|23
4416655|NCT00300885|7196890|FG000|Treatment|Disease progression|171
4416656|NCT00300885|7196891|FG001|Treatment|Disease progression|238
4416657|NCT00300885|7196890|FG000|Treatment|Random code broken (subject died)|0
4416658|NCT00300885|7196891|FG001|Treatment|Random code broken (subject died)|1
4416659|NCT00300885|7196890|FG000|Treatment|Non-compliant with study medication|3
4416660|NCT00300885|7196891|FG001|Treatment|Non-compliant with study medication|4
4416661|NCT00300885|7196890|FG000|Follow-up|Death|141
4416662|NCT00300885|7196891|FG001|Follow-up|Death|163
4416663|NCT00300885|7196890|FG000|Follow-up|Lost to Follow-up|11
4416664|NCT00300885|7196891|FG001|Follow-up|Lost to Follow-up|7
4416665|NCT00300885|7196890|FG000|Follow-up|Withdrawal by Subject|26
4416666|NCT00300885|7196891|FG001|Follow-up|Withdrawal by Subject|25
4416667|NCT00301067|7196901|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1
4416668|NCT00301067|7196902|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0
4416669|NCT00301067|7196903|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0
4416670|NCT00301067|7196904|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1
4416671|NCT00301067|7196901|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2
4416672|NCT00301067|7196902|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1
4416673|NCT00301067|7196903|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1
4416674|NCT00301067|7196904|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2
4416675|NCT00301067|7196901|FG000|Completed 4 Cycles of Treatment|Progressive disease|1
4416676|NCT00301067|7196902|FG001|Completed 4 Cycles of Treatment|Progressive disease|1
4416677|NCT00301067|7196903|FG002|Completed 4 Cycles of Treatment|Progressive disease|2
4416678|NCT00301067|7196904|FG003|Completed 4 Cycles of Treatment|Progressive disease|5
4416679|NCT00301067|7196901|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0
4416680|NCT00301067|7196902|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1
4416681|NCT00301067|7196903|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0
4416682|NCT00301067|7196904|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1
4416683|NCT00301067|7196901|FG000|Completed 12 Cycles of Treatment|Adverse Event|0
4416684|NCT00301067|7196902|FG001|Completed 12 Cycles of Treatment|Adverse Event|0
4416685|NCT00301067|7196903|FG002|Completed 12 Cycles of Treatment|Adverse Event|0
4629391|NCT01871805|7497318|FG000|Phase II|Alive in Survival Follow-up|0
4629392|NCT01871805|7497319|FG001|Phase II|Alive in Survival Follow-up|0
4416686|NCT00301067|7196904|FG003|Completed 12 Cycles of Treatment|Adverse Event|1
4416687|NCT00301067|7196901|FG000|Follow up Until Death|Alive at last data cut point|1
4416688|NCT00301067|7196902|FG001|Follow up Until Death|Alive at last data cut point|0
4416689|NCT00301067|7196903|FG002|Follow up Until Death|Alive at last data cut point|0
4416690|NCT00301067|7196904|FG003|Follow up Until Death|Alive at last data cut point|1
4416691|NCT00301366|7196915|FG000|Overall Study|Adverse Event|1
4416692|NCT00301808|7196929|FG000|Overall Study|Adverse Event|5
4416693|NCT00301808|7196929|FG000|Overall Study|Death|3
4416694|NCT00301808|7196929|FG000|Overall Study|Lack of Efficacy|4
4416695|NCT00301821|7196933|FG000|Overall Study|Ineligible|25
4416696|NCT00301821|7196933|FG000|Overall Study|Cancel|1
4416697|NCT00301834|7196937|FG000|Overall Study|Death|1
4416698|NCT00301964|7196948|FG000|Overall Study|Second primary|2
4416699|NCT00301964|7196948|FG000|Overall Study|Wrong primary|1
4416700|NCT00301964|7196948|FG000|Overall Study|Inadequate pathology|1
4416701|NCT00302003|7196958|FG000|Overall Study|Lack of Efficacy|62
4416702|NCT00302003|7196958|FG000|Overall Study|Lost to Follow-up|1
4416703|NCT00302003|7196958|FG000|Overall Study|Physician Decision|2
4416704|NCT00302003|7196958|FG000|Overall Study|Withdrawal by Subject|5
4416705|NCT00302003|7196958|FG000|Overall Study|Ineligible|9
4416706|NCT00302003|7196958|FG000|Overall Study|Protocol Violation|1
4416707|NCT00302081|7196997|FG000|Overall Study|Adverse Event|6
4416708|NCT00302081|7196998|FG001|Overall Study|Adverse Event|5
4416709|NCT00302081|7196999|FG002|Overall Study|Adverse Event|4
4416710|NCT00302081|7196997|FG000|Overall Study|Lost to Follow-up|21
4416711|NCT00302081|7196998|FG001|Overall Study|Lost to Follow-up|18
4416712|NCT00302081|7196999|FG002|Overall Study|Lost to Follow-up|28
4416713|NCT00302081|7196997|FG000|Overall Study|Withdrawal by Subject|8
4416714|NCT00302081|7196998|FG001|Overall Study|Withdrawal by Subject|12
4416715|NCT00302081|7196999|FG002|Overall Study|Withdrawal by Subject|8
4416716|NCT00302081|7196997|FG000|Overall Study|Protocol Violation|5
4416717|NCT00302081|7196998|FG001|Overall Study|Protocol Violation|1
4416718|NCT00302081|7196999|FG002|Overall Study|Protocol Violation|2
4416719|NCT00302081|7196997|FG000|Overall Study|Lack of Efficacy|1
4416720|NCT00302081|7196998|FG001|Overall Study|Lack of Efficacy|0
4416721|NCT00302081|7196999|FG002|Overall Study|Lack of Efficacy|5
4416722|NCT00302081|7196997|FG000|Overall Study|Death|2
4416723|NCT00302081|7196998|FG001|Overall Study|Death|1
4416724|NCT00302081|7196999|FG002|Overall Study|Death|0
4416725|NCT00302081|7196997|FG000|Overall Study|Other|13
4416726|NCT00302081|7196998|FG001|Overall Study|Other|6
4416727|NCT00302081|7196999|FG002|Overall Study|Other|5
4416728|NCT00302107|7197009|FG000|Overall Study|Lost to Follow-up|6
4416729|NCT00302107|7197010|FG001|Overall Study|Lost to Follow-up|5
4416730|NCT00302107|7197009|FG000|Overall Study|Protocol Violation|1
4416731|NCT00302107|7197010|FG001|Overall Study|Protocol Violation|0
4416732|NCT00302107|7197009|FG000|Overall Study|Relocation|0
4416733|NCT00302107|7197010|FG001|Overall Study|Relocation|1
4416734|NCT00302107|7197009|FG000|Overall Study|Withdrawal by Subject|0
4416735|NCT00302107|7197010|FG001|Overall Study|Withdrawal by Subject|3
4416736|NCT00302107|7197009|FG000|Overall Study|Adverse Event|1
4416737|NCT00302107|7197010|FG001|Overall Study|Adverse Event|0
4416738|NCT00302159|7197025|FG000|Overall Study|pt declined before treatment started|1
4416739|NCT00302159|7197025|FG000|Overall Study|pt started Avastin|1
4416740|NCT00302211|7197033|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2
4416741|NCT00302211|7197034|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1
4416742|NCT00302211|7197035|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0
4416743|NCT00302211|7197036|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0
4416744|NCT00302211|7197037|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0
4416745|NCT00302211|7197033|FG000|Double Blind Period (New Patients)|Adverse Event|0
4416746|NCT00302211|7197034|FG001|Double Blind Period (New Patients)|Adverse Event|0
4416747|NCT00302211|7197035|FG002|Double Blind Period (New Patients)|Adverse Event|3
4416748|NCT00302211|7197036|FG003|Double Blind Period (New Patients)|Adverse Event|0
4416749|NCT00302211|7197037|FG004|Double Blind Period (New Patients)|Adverse Event|0
4416750|NCT00302211|7197033|FG000|Double Blind Period (New Patients)|Investigator's judgement|1
4416751|NCT00302211|7197034|FG001|Double Blind Period (New Patients)|Investigator's judgement|0
4416752|NCT00302211|7197035|FG002|Double Blind Period (New Patients)|Investigator's judgement|0
4416753|NCT00302211|7197036|FG003|Double Blind Period (New Patients)|Investigator's judgement|0
4416754|NCT00302211|7197037|FG004|Double Blind Period (New Patients)|Investigator's judgement|0
4416755|NCT00302211|7197033|FG000|Double Blind Period (New Patients)|Disease progression|0
4416756|NCT00302211|7197034|FG001|Double Blind Period (New Patients)|Disease progression|1
4416757|NCT00302211|7197035|FG002|Double Blind Period (New Patients)|Disease progression|1
4416758|NCT00302211|7197036|FG003|Double Blind Period (New Patients)|Disease progression|0
4416759|NCT00302211|7197037|FG004|Double Blind Period (New Patients)|Disease progression|0
4416760|NCT00302211|7197033|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
4416761|NCT00302211|7197034|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
4416762|NCT00302211|7197035|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
4416763|NCT00302211|7197036|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3
4416764|NCT00302211|7197037|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3
4416765|NCT00302211|7197033|FG000|Open Label-Patients From Double-Blind|Adverse Event|0
4416766|NCT00302211|7197034|FG001|Open Label-Patients From Double-Blind|Adverse Event|0
4416767|NCT00302211|7197035|FG002|Open Label-Patients From Double-Blind|Adverse Event|0
4416768|NCT00302211|7197036|FG003|Open Label-Patients From Double-Blind|Adverse Event|1
4416769|NCT00302211|7197037|FG004|Open Label-Patients From Double-Blind|Adverse Event|0
4416770|NCT00302211|7197033|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0
4416771|NCT00302211|7197034|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0
4416772|NCT00302211|7197035|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0
4416773|NCT00302211|7197036|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1
4416774|NCT00302211|7197037|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0
4629393|NCT01871805|7497320|FG002|Phase II|Alive in Survival Follow-up|0
4629394|NCT01871805|7497321|FG003|Phase II|Alive in Survival Follow-up|0
4416775|NCT00302211|7197033|FG000|Open Label-Patients From Double-Blind|Disease progression|0
4416776|NCT00302211|7197034|FG001|Open Label-Patients From Double-Blind|Disease progression|0
4416777|NCT00302211|7197035|FG002|Open Label-Patients From Double-Blind|Disease progression|0
4416778|NCT00302211|7197036|FG003|Open Label-Patients From Double-Blind|Disease progression|1
4416779|NCT00302211|7197037|FG004|Open Label-Patients From Double-Blind|Disease progression|2
4416780|NCT00302211|7197033|FG000|Open Label-Patients From Double-Blind|Death|0
4416781|NCT00302211|7197034|FG001|Open Label-Patients From Double-Blind|Death|0
4416782|NCT00302211|7197035|FG002|Open Label-Patients From Double-Blind|Death|0
4416783|NCT00302211|7197036|FG003|Open Label-Patients From Double-Blind|Death|1
4416784|NCT00302211|7197037|FG004|Open Label-Patients From Double-Blind|Death|1
4416785|NCT00302211|7197033|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0
4416786|NCT00302211|7197034|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0
4416787|NCT00302211|7197035|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0
4416788|NCT00302211|7197036|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0
4416789|NCT00302211|7197037|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1
4416790|NCT00302211|7197033|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
4416791|NCT00302211|7197034|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
4416792|NCT00302211|7197035|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
4416793|NCT00302211|7197036|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
4416794|NCT00302211|7197037|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1
4416795|NCT00302211|7197033|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
4416796|NCT00302211|7197034|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
4416797|NCT00302211|7197035|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
4416798|NCT00302211|7197036|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1
4416799|NCT00302211|7197037|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
4416800|NCT00302328|7197052|FG000|Overall Study|Physician Decision|0
4416801|NCT00302328|7197053|FG001|Overall Study|Physician Decision|1
4416802|NCT00302328|7197054|FG002|Overall Study|Physician Decision|0
4629395|NCT01871805|7497322|FG004|Phase II|Alive in Survival Follow-up|0
4416803|NCT00302458|7197065|FG000|Overall Study|Lost to Follow-up|1
4416804|NCT00302458|7197065|FG000|Overall Study|Ineligible after screening|1
4416805|NCT00302458|7197065|FG000|Overall Study|Withdrawal by Subject|1
4416806|NCT00302718|7197077|FG000|Overall Study|Participant left the hospital|1
4416807|NCT00302718|7197078|FG001|Overall Study|Participant left the hospital|0
4416808|NCT00302718|7197079|FG002|Overall Study|Participant left the hospital|0
4416809|NCT00302718|7197080|FG003|Overall Study|Participant left the hospital|1
4416810|NCT00302718|7197077|FG000|Overall Study|Withdrawal by Subject|0
4416811|NCT00302718|7197078|FG001|Overall Study|Withdrawal by Subject|1
4416812|NCT00302718|7197079|FG002|Overall Study|Withdrawal by Subject|0
4416813|NCT00302718|7197080|FG003|Overall Study|Withdrawal by Subject|0
4629396|NCT01871805|7497323|FG005|Phase II|Alive in Survival Follow-up|29
4629397|NCT01871805|7497318|FG000|Phase II|Lost to Follow-up|0
4629398|NCT01871805|7497319|FG001|Phase II|Lost to Follow-up|0
4629399|NCT01871805|7497320|FG002|Phase II|Lost to Follow-up|0
4629400|NCT01871805|7497321|FG003|Phase II|Lost to Follow-up|0
4629401|NCT01871805|7497322|FG004|Phase II|Lost to Follow-up|0
4416814|NCT00302718|7197077|FG000|Overall Study|Participant left primary care setting|0
4416815|NCT00302718|7197078|FG001|Overall Study|Participant left primary care setting|0
4416816|NCT00302718|7197079|FG002|Overall Study|Participant left primary care setting|2
4416817|NCT00302718|7197080|FG003|Overall Study|Participant left primary care setting|1
4416818|NCT00302731|7197099|FG000|Overall Study|Lost to Follow-up|1
4416819|NCT00302731|7197100|FG001|Overall Study|Lost to Follow-up|2
4416820|NCT00302731|7197101|FG002|Overall Study|Lost to Follow-up|0
4416821|NCT00302731|7197102|FG003|Overall Study|Lost to Follow-up|0
4416822|NCT00302731|7197099|FG000|Overall Study|Adverse Event|0
4416823|NCT00302731|7197100|FG001|Overall Study|Adverse Event|2
4416824|NCT00302731|7197101|FG002|Overall Study|Adverse Event|2
4416825|NCT00302731|7197102|FG003|Overall Study|Adverse Event|0
4416826|NCT00302731|7197099|FG000|Overall Study|Withdrawal by Subject|1
4416827|NCT00302731|7197100|FG001|Overall Study|Withdrawal by Subject|1
4416828|NCT00302731|7197101|FG002|Overall Study|Withdrawal by Subject|0
4416829|NCT00302731|7197102|FG003|Overall Study|Withdrawal by Subject|0
4416830|NCT00302731|7197099|FG000|Overall Study|Protocol Violation|1
4416831|NCT00302731|7197100|FG001|Overall Study|Protocol Violation|0
4416832|NCT00302731|7197101|FG002|Overall Study|Protocol Violation|0
4416833|NCT00302731|7197102|FG003|Overall Study|Protocol Violation|0
4416834|NCT00302731|7197099|FG000|Overall Study|cancer unrelated to study discovered|1
4416835|NCT00302731|7197100|FG001|Overall Study|cancer unrelated to study discovered|0
4416836|NCT00302731|7197101|FG002|Overall Study|cancer unrelated to study discovered|1
4416837|NCT00302731|7197102|FG003|Overall Study|cancer unrelated to study discovered|0
4416838|NCT00302952|7197126|FG000|Overall Study|Physician Decision|1
4416839|NCT00302952|7197127|FG001|Overall Study|Physician Decision|1
4416840|NCT00302952|7197126|FG000|Overall Study|Withdrawal by Subject|2
4416841|NCT00302952|7197127|FG001|Overall Study|Withdrawal by Subject|3
4416842|NCT00302952|7197126|FG000|Overall Study|Elevated SGOT (AST) lab value|0
4416843|NCT00302952|7197127|FG001|Overall Study|Elevated SGOT (AST) lab value|1
4416844|NCT00303069|7197137|FG000|Overall Study|Lost to Follow-up|1
4416845|NCT00303069|7197138|FG001|Overall Study|Lost to Follow-up|0
4416846|NCT00303069|7197139|FG002|Overall Study|Lost to Follow-up|0
4416847|NCT00303069|7197140|FG003|Overall Study|Lost to Follow-up|2
4416848|NCT00303069|7197137|FG000|Overall Study|subject moved|1
4416849|NCT00303069|7197138|FG001|Overall Study|subject moved|0
4416850|NCT00303069|7197139|FG002|Overall Study|subject moved|0
4416851|NCT00303069|7197140|FG003|Overall Study|subject moved|0
4416852|NCT00303069|7197137|FG000|Overall Study|Recruitment into Army Reserves|0
4416853|NCT00303069|7197138|FG001|Overall Study|Recruitment into Army Reserves|0
4416854|NCT00303069|7197139|FG002|Overall Study|Recruitment into Army Reserves|1
4416855|NCT00303069|7197140|FG003|Overall Study|Recruitment into Army Reserves|0
4416856|NCT00303108|7197153|FG000|Overall Study|Adverse Event|5
4416857|NCT00303108|7197154|FG001|Overall Study|Adverse Event|6
4416858|NCT00303108|7197155|FG002|Overall Study|Adverse Event|7
4416859|NCT00303108|7197153|FG000|Overall Study|Patient Request|4
4629402|NCT01871805|7497323|FG005|Phase II|Lost to Follow-up|13
4629403|NCT01871870|7497354|FG000|Overall Study|Hardware issues|7
4416860|NCT00303108|7197154|FG001|Overall Study|Patient Request|2
4416861|NCT00303108|7197155|FG002|Overall Study|Patient Request|8
4416862|NCT00303108|7197153|FG000|Overall Study|Failed Entry|1
4416863|NCT00303108|7197154|FG001|Overall Study|Failed Entry|0
4416864|NCT00303108|7197155|FG002|Overall Study|Failed Entry|1
4416865|NCT00303108|7197153|FG000|Overall Study|ineligible|2
4416866|NCT00303108|7197154|FG001|Overall Study|ineligible|1
4416867|NCT00303108|7197155|FG002|Overall Study|ineligible|0
4416868|NCT00303186|7197162|FG000|Overall Study|Other|52
4416869|NCT00303316|7197168|FG000|Overall Study|Protocol Violation|1
4416870|NCT00303316|7197169|FG001|Overall Study|Protocol Violation|0
4416871|NCT00303316|7197168|FG000|Overall Study|Lost to Follow-up|0
4416872|NCT00303316|7197169|FG001|Overall Study|Lost to Follow-up|1
4416873|NCT00303316|7197168|FG000|Overall Study|Withdrawal by Subject|1
4416874|NCT00303316|7197169|FG001|Overall Study|Withdrawal by Subject|2
4416875|NCT00303329|7197177|FG000|Overall Study|Adverse Event|7
4629404|NCT01871870|7497354|FG000|Overall Study|hyperglycemia|2
4629405|NCT01872078|7497362|FG000|Overall Study|Adverse Event|0
4416876|NCT00303329|7197178|FG001|Overall Study|Adverse Event|14
4416877|NCT00303329|7197177|FG000|Overall Study|Abnormal Laboratory Values|0
4416878|NCT00303329|7197178|FG001|Overall Study|Abnormal Laboratory Values|1
4416879|NCT00303329|7197177|FG000|Overall Study|Unsatisfactory therapeutic effect|9
4416880|NCT00303329|7197178|FG001|Overall Study|Unsatisfactory therapeutic effect|2
4416881|NCT00303329|7197177|FG000|Overall Study|Condition no longer requires study drug|0
4416882|NCT00303329|7197178|FG001|Overall Study|Condition no longer requires study drug|8
4416883|NCT00303329|7197177|FG000|Overall Study|Protocol Violation|3
4416884|NCT00303329|7197178|FG001|Overall Study|Protocol Violation|0
4416885|NCT00303329|7197177|FG000|Overall Study|Withdrawal by Subject|9
4416886|NCT00303329|7197178|FG001|Overall Study|Withdrawal by Subject|15
4416887|NCT00303329|7197177|FG000|Overall Study|Lost to Follow-up|0
4416888|NCT00303329|7197178|FG001|Overall Study|Lost to Follow-up|1
4416889|NCT00303329|7197177|FG000|Overall Study|Administrative problems|1
4416890|NCT00303329|7197178|FG001|Overall Study|Administrative problems|0
4416891|NCT00303329|7197177|FG000|Overall Study|Death|2
4416892|NCT00303329|7197178|FG001|Overall Study|Death|12
4416893|NCT00303329|7197177|FG000|Overall Study|Stopped at end of core|3
4416894|NCT00303329|7197178|FG001|Overall Study|Stopped at end of core|9
4416895|NCT00303329|7197177|FG000|Overall Study|Stopped at end of extension 1|1
4416896|NCT00303329|7197178|FG001|Overall Study|Stopped at end of extension 1|0
4416897|NCT00303446|7197186|FG000|Overall Study|Withdrawal by Subject|2
4416898|NCT00303446|7197187|FG001|Overall Study|Withdrawal by Subject|2
4416899|NCT00303446|7197186|FG000|Overall Study|Death|0
4416900|NCT00303446|7197187|FG001|Overall Study|Death|1
4416901|NCT00303446|7197186|FG000|Overall Study|Physician Decision|0
4416902|NCT00303446|7197187|FG001|Overall Study|Physician Decision|1
4416903|NCT00303459|7197195|FG000|Overall Study|Death|33
4416904|NCT00303459|7197196|FG001|Overall Study|Death|44
4416905|NCT00303459|7197195|FG000|Overall Study|Withdrawal of consent|32
4416906|NCT00303459|7197196|FG001|Overall Study|Withdrawal of consent|26
4416907|NCT00303459|7197195|FG000|Overall Study|Lost to Follow-up|5
4416908|NCT00303459|7197196|FG001|Overall Study|Lost to Follow-up|4
4416909|NCT00303459|7197195|FG000|Overall Study|Administrative reason|7
4416910|NCT00303459|7197196|FG001|Overall Study|Administrative reason|7
4416911|NCT00303459|7197195|FG000|Overall Study|Decision by the investigator|5
4416912|NCT00303459|7197196|FG001|Overall Study|Decision by the investigator|7
4416913|NCT00303459|7197195|FG000|Overall Study|Lung transplantation|1
4416914|NCT00303459|7197196|FG001|Overall Study|Lung transplantation|1
4416915|NCT00303472|7197210|FG000|Treatment Period|Adverse Event|0
4416916|NCT00303472|7197211|FG001|Treatment Period|Adverse Event|0
4416917|NCT00303472|7197212|FG002|Treatment Period|Adverse Event|0
4416918|NCT00303472|7197213|FG003|Treatment Period|Adverse Event|0
4416919|NCT00303472|7197214|FG004|Treatment Period|Adverse Event|1
4416920|NCT00303472|7197215|FG005|Treatment Period|Adverse Event|0
4416921|NCT00303472|7197216|FG006|Treatment Period|Adverse Event|0
4416922|NCT00303472|7197210|FG000|Treatment Period|Death|0
4416923|NCT00303472|7197211|FG001|Treatment Period|Death|0
4416924|NCT00303472|7197212|FG002|Treatment Period|Death|0
4416925|NCT00303472|7197213|FG003|Treatment Period|Death|1
4416926|NCT00303472|7197214|FG004|Treatment Period|Death|0
4416927|NCT00303472|7197215|FG005|Treatment Period|Death|0
4416928|NCT00303472|7197216|FG006|Treatment Period|Death|1
4416929|NCT00303472|7197210|FG000|Treatment Period|Withdrawal by Subject|0
4416930|NCT00303472|7197211|FG001|Treatment Period|Withdrawal by Subject|0
4416931|NCT00303472|7197212|FG002|Treatment Period|Withdrawal by Subject|0
4416932|NCT00303472|7197213|FG003|Treatment Period|Withdrawal by Subject|1
4416933|NCT00303472|7197214|FG004|Treatment Period|Withdrawal by Subject|0
4416934|NCT00303472|7197215|FG005|Treatment Period|Withdrawal by Subject|1
4416935|NCT00303472|7197216|FG006|Treatment Period|Withdrawal by Subject|0
4416936|NCT00303472|7197210|FG000|Treatment Period|Other|0
4416937|NCT00303472|7197211|FG001|Treatment Period|Other|0
4416938|NCT00303472|7197212|FG002|Treatment Period|Other|0
4416939|NCT00303472|7197213|FG003|Treatment Period|Other|0
4416940|NCT00303472|7197214|FG004|Treatment Period|Other|1
4416941|NCT00303472|7197215|FG005|Treatment Period|Other|0
4416942|NCT00303472|7197216|FG006|Treatment Period|Other|1
4416943|NCT00303472|7197210|FG000|Treatment Period|Disease Progression (to AML)|0
4416944|NCT00303472|7197211|FG001|Treatment Period|Disease Progression (to AML)|0
4416945|NCT00303472|7197212|FG002|Treatment Period|Disease Progression (to AML)|0
4416946|NCT00303472|7197213|FG003|Treatment Period|Disease Progression (to AML)|0
4416947|NCT00303472|7197214|FG004|Treatment Period|Disease Progression (to AML)|1
4416948|NCT00303472|7197215|FG005|Treatment Period|Disease Progression (to AML)|0
4416949|NCT00303472|7197216|FG006|Treatment Period|Disease Progression (to AML)|0
4416950|NCT00303472|7197210|FG000|Treatment Extension (Optional)|Adverse Event|1
4416951|NCT00303472|7197211|FG001|Treatment Extension (Optional)|Adverse Event|0
4416952|NCT00303472|7197212|FG002|Treatment Extension (Optional)|Adverse Event|1
4416953|NCT00303472|7197213|FG003|Treatment Extension (Optional)|Adverse Event|0
4416954|NCT00303472|7197214|FG004|Treatment Extension (Optional)|Adverse Event|0
4416955|NCT00303472|7197215|FG005|Treatment Extension (Optional)|Adverse Event|0
4416956|NCT00303472|7197216|FG006|Treatment Extension (Optional)|Adverse Event|0
4416957|NCT00303472|7197210|FG000|Treatment Extension (Optional)|Death|2
4416958|NCT00303472|7197211|FG001|Treatment Extension (Optional)|Death|0
4416959|NCT00303472|7197212|FG002|Treatment Extension (Optional)|Death|1
4416960|NCT00303472|7197213|FG003|Treatment Extension (Optional)|Death|0
4416961|NCT00303472|7197214|FG004|Treatment Extension (Optional)|Death|0
4416962|NCT00303472|7197215|FG005|Treatment Extension (Optional)|Death|0
4416963|NCT00303472|7197216|FG006|Treatment Extension (Optional)|Death|0
4416964|NCT00303472|7197210|FG000|Treatment Extension (Optional)|Lost to Follow-up|0
4416965|NCT00303472|7197211|FG001|Treatment Extension (Optional)|Lost to Follow-up|0
4416966|NCT00303472|7197212|FG002|Treatment Extension (Optional)|Lost to Follow-up|0
4416967|NCT00303472|7197213|FG003|Treatment Extension (Optional)|Lost to Follow-up|1
4416968|NCT00303472|7197214|FG004|Treatment Extension (Optional)|Lost to Follow-up|0
4416969|NCT00303472|7197215|FG005|Treatment Extension (Optional)|Lost to Follow-up|0
4416970|NCT00303472|7197216|FG006|Treatment Extension (Optional)|Lost to Follow-up|0
4416971|NCT00303472|7197210|FG000|Treatment Extension (Optional)|Physician Decision|0
4416972|NCT00303472|7197211|FG001|Treatment Extension (Optional)|Physician Decision|4
4416973|NCT00303472|7197212|FG002|Treatment Extension (Optional)|Physician Decision|2
4416974|NCT00303472|7197213|FG003|Treatment Extension (Optional)|Physician Decision|3
4416975|NCT00303472|7197214|FG004|Treatment Extension (Optional)|Physician Decision|2
4416976|NCT00303472|7197215|FG005|Treatment Extension (Optional)|Physician Decision|0
4416977|NCT00303472|7197216|FG006|Treatment Extension (Optional)|Physician Decision|0
4416978|NCT00303472|7197210|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1
4416979|NCT00303472|7197211|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0
4416980|NCT00303472|7197212|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1
4416981|NCT00303472|7197213|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2
4416982|NCT00303472|7197214|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1
4416983|NCT00303472|7197215|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0
4416984|NCT00303472|7197216|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0
4416985|NCT00303472|7197210|FG000|Treatment Extension (Optional)|Other|0
4416986|NCT00303472|7197211|FG001|Treatment Extension (Optional)|Other|2
4416987|NCT00303472|7197212|FG002|Treatment Extension (Optional)|Other|4
4416988|NCT00303472|7197213|FG003|Treatment Extension (Optional)|Other|2
4416989|NCT00303472|7197214|FG004|Treatment Extension (Optional)|Other|1
4416990|NCT00303472|7197215|FG005|Treatment Extension (Optional)|Other|0
4416991|NCT00303472|7197216|FG006|Treatment Extension (Optional)|Other|0
4416992|NCT00303472|7197210|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1
4416993|NCT00303472|7197211|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0
4416994|NCT00303472|7197212|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0
4416995|NCT00303472|7197213|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0
4416996|NCT00303472|7197214|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0
4416997|NCT00303472|7197215|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1
4416998|NCT00303472|7197216|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0
4416999|NCT00303485|7197234|FG000|Overall Study|Adverse Event/Intercurrent Illness|0
4417000|NCT00303485|7197235|FG001|Overall Study|Adverse Event/Intercurrent Illness|1
4417001|NCT00303485|7197234|FG000|Overall Study|Failure to return|0
4417002|NCT00303485|7197235|FG001|Overall Study|Failure to return|1
4417003|NCT00303485|7197234|FG000|Overall Study|Withdrawal by Subject|1
4417004|NCT00303485|7197235|FG001|Overall Study|Withdrawal by Subject|0
4417005|NCT00303602|7197247|FG000|Overall Study|Adverse Event|2
4417006|NCT00303602|7197248|FG001|Overall Study|Adverse Event|2
4417007|NCT00303602|7197247|FG000|Overall Study|Withdrawal by Subject|5
4417008|NCT00303602|7197248|FG001|Overall Study|Withdrawal by Subject|6
4417009|NCT00303602|7197247|FG000|Overall Study|Lost to Follow-up|5
4417010|NCT00303602|7197248|FG001|Overall Study|Lost to Follow-up|2
4417011|NCT00303602|7197247|FG000|Overall Study|Protocol entry criteria not met|2
4417012|NCT00303602|7197248|FG001|Overall Study|Protocol entry criteria not met|2
4417013|NCT00303602|7197247|FG000|Overall Study|Physician Decision|2
4417014|NCT00303602|7197248|FG001|Overall Study|Physician Decision|1
4417015|NCT00303602|7197247|FG000|Overall Study|Noncompliance|2
4417016|NCT00303602|7197248|FG001|Overall Study|Noncompliance|2
4417017|NCT00303602|7197247|FG000|Overall Study|Protocol Violation|1
4417018|NCT00303602|7197248|FG001|Overall Study|Protocol Violation|0
4417019|NCT00303628|7197256|FG000|Overall Study|Disease progression|0
4417020|NCT00303628|7197257|FG001|Overall Study|Disease progression|1
4417021|NCT00303628|7197256|FG000|Overall Study|Adverse Event|26
4417022|NCT00303628|7197257|FG001|Overall Study|Adverse Event|36
4417023|NCT00303628|7197256|FG000|Overall Study|Death|0
4417024|NCT00303628|7197257|FG001|Overall Study|Death|1
4417025|NCT00303628|7197256|FG000|Overall Study|Withdrawal by Subject|11
4417026|NCT00303628|7197257|FG001|Overall Study|Withdrawal by Subject|20
4417027|NCT00303628|7197256|FG000|Overall Study|Alternative therapy|2
4417028|NCT00303628|7197257|FG001|Overall Study|Alternative therapy|0
4511881|NCT00929708|7321339|FG003|Overall Study|Physician Decision|2
4511882|NCT00929708|7321340|FG004|Overall Study|Physician Decision|1
4417029|NCT00303628|7197256|FG000|Overall Study|Other complicating disease|0
4417030|NCT00303628|7197257|FG001|Overall Study|Other complicating disease|1
4417031|NCT00303628|7197256|FG000|Overall Study|Not start protocol therapy|3
4417032|NCT00303628|7197257|FG001|Overall Study|Not start protocol therapy|5
4417033|NCT00303628|7197256|FG000|Overall Study|Other|8
4417034|NCT00303628|7197257|FG001|Overall Study|Other|9
4417035|NCT00303667|7197265|FG000|Overall Study|Death|0
4417036|NCT00303667|7197266|FG001|Overall Study|Death|4
4417037|NCT00303719|7197274|FG000|Overall Study|Not evaluable, prior therapies|0
4417038|NCT00303719|7197275|FG001|Overall Study|Not evaluable, prior therapies|30
4417039|NCT00303719|7197274|FG000|Overall Study|Lost to Follow-up|0
4417040|NCT00303719|7197275|FG001|Overall Study|Lost to Follow-up|7
4417041|NCT00303953|7197299|FG000|Overall Study|Ineligible|1
4417042|NCT00303953|7197299|FG000|Overall Study|Death|1
4417043|NCT00303953|7197299|FG000|Overall Study|Adverse Event|4
4417044|NCT00303953|7197299|FG000|Overall Study|Lack of Efficacy|12
4417045|NCT00303953|7197299|FG000|Overall Study|Physician Decision|1
4417046|NCT00304031|7197332|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144
4417047|NCT00304031|7197333|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0
4417048|NCT00304031|7197334|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0
4417049|NCT00304031|7197332|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48
4417050|NCT00304031|7197333|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0
4417051|NCT00304031|7197334|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0
4417052|NCT00304031|7197332|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19
4417053|NCT00304031|7197333|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0
4417054|NCT00304031|7197334|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0
4417055|NCT00304031|7197332|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18
4417056|NCT00304031|7197333|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0
4417057|NCT00304031|7197334|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0
4417058|NCT00304031|7197332|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15
4417059|NCT00304031|7197333|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0
4417060|NCT00304031|7197334|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0
4417061|NCT00304031|7197332|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10
4417062|NCT00304031|7197333|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0
4417063|NCT00304031|7197334|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0
4417064|NCT00304031|7197332|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1
4417065|NCT00304031|7197333|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0
4417066|NCT00304031|7197334|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0
4417067|NCT00304031|7197332|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37
4417068|NCT00304031|7197333|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0
4417069|NCT00304031|7197334|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0
4417070|NCT00304031|7197332|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0
4417071|NCT00304031|7197333|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0
4417072|NCT00304031|7197334|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2
4417073|NCT00304083|7197351|FG000|Overall Study|Withdrawal by Subject|4
4417074|NCT00304083|7197352|FG001|Overall Study|Withdrawal by Subject|2
4417075|NCT00304083|7197351|FG000|Overall Study|Physician Decision|8
4417076|NCT00304083|7197352|FG001|Overall Study|Physician Decision|3
4417077|NCT00304083|7197351|FG000|Overall Study|Disease Progression|5
4417078|NCT00304083|7197352|FG001|Overall Study|Disease Progression|1
4417079|NCT00304083|7197351|FG000|Overall Study|Other|5
4417080|NCT00304083|7197352|FG001|Overall Study|Other|2
4417081|NCT00304278|7197396|FG000|Overall Study|lack of insurance coverage for chemoRT|1
4417082|NCT00304278|7197396|FG000|Overall Study|PT had medical condition preventing TX|1
4417083|NCT00304356|7197400|FG000|Nitazoxanide|Physician Decision|5
4417084|NCT00304356|7197400|FG000|Nitazoxanide|Physician Decision|1
4417085|NCT00304356|7197400|FG000|Nitazoxanide|number is 0|1
4417086|NCT00304356|7197400|FG000|Nitazoxanide|Physician Decision|1
4417087|NCT00304356|7197400|FG000|Nitazoxanide|Physician Decision|1
4417088|NCT00304356|7197400|FG000|Nitazoxanide|Physician Decision|1
4511883|NCT00929708|7321336|FG000|Overall Study|Lost to Follow-up|0
4511884|NCT00929708|7321337|FG001|Overall Study|Lost to Follow-up|0
4511885|NCT00929708|7321338|FG002|Overall Study|Lost to Follow-up|0
4511886|NCT00929708|7321339|FG003|Overall Study|Lost to Follow-up|1
4511887|NCT00929708|7321340|FG004|Overall Study|Lost to Follow-up|0
4511888|NCT00929734|7321354|FG000|Overall Study|Lost to Follow-up|2
4511889|NCT00929734|7321355|FG001|Overall Study|Lost to Follow-up|1
4511890|NCT00929734|7321354|FG000|Overall Study|Withdrawal by Subject|0
4511891|NCT00929734|7321355|FG001|Overall Study|Withdrawal by Subject|2
4511892|NCT00929864|7321390|FG000|Overall Study|Death|1
4511893|NCT00929864|7321391|FG001|Overall Study|Death|1
4511894|NCT00929864|7321390|FG000|Overall Study|Adverse Event|11
4511895|NCT00929864|7321391|FG001|Overall Study|Adverse Event|30
4511896|NCT00929864|7321390|FG000|Overall Study|Lack of Efficacy|19
4511897|NCT00929864|7321391|FG001|Overall Study|Lack of Efficacy|16
4511898|NCT00929864|7321390|FG000|Overall Study|Lost to Follow-up|7
4511899|NCT00929864|7321391|FG001|Overall Study|Lost to Follow-up|12
4511900|NCT00929864|7321390|FG000|Overall Study|Withdrawal by Subject|20
4511901|NCT00929864|7321391|FG001|Overall Study|Withdrawal by Subject|9
4511902|NCT00929864|7321390|FG000|Overall Study|No longer met criteria|2
4511903|NCT00929864|7321391|FG001|Overall Study|No longer met criteria|1
4511904|NCT00929864|7321390|FG000|Overall Study|Poor or non-compliance|3
4511905|NCT00929864|7321391|FG001|Overall Study|Poor or non-compliance|3
4511906|NCT00929864|7321390|FG000|Overall Study|Pregnancy|0
4511907|NCT00929864|7321391|FG001|Overall Study|Pregnancy|3
4511908|NCT00929864|7321390|FG000|Overall Study|Administrative reason by Sponsor|1
4417089|NCT04493931|7197475|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1
4417090|NCT04493931|7197476|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0
4417091|NCT04493931|7197477|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0
4417092|NCT04493931|7197478|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0
4417093|NCT04493931|7197479|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0
4417094|NCT04493931|7197480|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0
4417095|NCT04493931|7197481|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0
4417096|NCT04493931|7197475|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0
4417097|NCT04493931|7197476|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2
4417098|NCT04493931|7197477|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0
4417099|NCT04493931|7197478|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0
4417100|NCT04493931|7197479|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0
4417101|NCT04493931|7197480|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0
4417102|NCT04493931|7197481|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0
4417103|NCT04493931|7197475|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0
4417104|NCT04493931|7197476|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1
4417105|NCT04493931|7197477|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0
4417106|NCT04493931|7197478|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0
4417107|NCT04493931|7197479|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0
4417108|NCT04493931|7197480|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0
4417109|NCT04493931|7197481|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0
4417110|NCT04493931|7197475|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0
4417111|NCT04493931|7197476|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0
4417112|NCT04493931|7197477|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1
4417113|NCT04493931|7197478|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0
4417114|NCT04493931|7197479|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0
4714888|NCT02963506|7642888|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0
4714889|NCT02963506|7642889|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0
4714890|NCT02963506|7642890|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0
4714891|NCT02963506|7642891|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0
4714892|NCT02963506|7642892|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0
4417115|NCT04493931|7197480|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0
4417116|NCT04493931|7197481|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0
4417117|NCT04428034|7197511|FG000|Enrollment to Intervention Completion|Protocol Violation|9
4417118|NCT04428034|7197511|FG000|Enrollment to Intervention Completion|Suspected Fraudulent Case|1
4417119|NCT03999554|7197540|FG000|Overall Study|Lost to Follow-up|4
4417120|NCT03999554|7197541|FG001|Overall Study|Lost to Follow-up|5
4417121|NCT03999554|7197542|FG002|Overall Study|Lost to Follow-up|4
4417122|NCT03999554|7197543|FG003|Overall Study|Lost to Follow-up|5
4417123|NCT03999554|7197544|FG004|Overall Study|Lost to Follow-up|8
4417124|NCT03999554|7197540|FG000|Overall Study|Protocol Violation|0
4417125|NCT03999554|7197541|FG001|Overall Study|Protocol Violation|0
4417126|NCT03999554|7197542|FG002|Overall Study|Protocol Violation|5
4417127|NCT03999554|7197543|FG003|Overall Study|Protocol Violation|0
4417128|NCT03999554|7197544|FG004|Overall Study|Protocol Violation|0
4417129|NCT03999554|7197540|FG000|Overall Study|Pregnancy|0
4417130|NCT03999554|7197541|FG001|Overall Study|Pregnancy|0
4417131|NCT03999554|7197542|FG002|Overall Study|Pregnancy|1
4417132|NCT03999554|7197543|FG003|Overall Study|Pregnancy|0
4417133|NCT03999554|7197544|FG004|Overall Study|Pregnancy|0
4417134|NCT03999554|7197540|FG000|Overall Study|Withdrawal by Subject|2
4417135|NCT03999554|7197541|FG001|Overall Study|Withdrawal by Subject|2
4417136|NCT03999554|7197542|FG002|Overall Study|Withdrawal by Subject|2
4417137|NCT03999554|7197543|FG003|Overall Study|Withdrawal by Subject|1
4417138|NCT03999554|7197544|FG004|Overall Study|Withdrawal by Subject|1
4417139|NCT03999554|7197540|FG000|Overall Study|failure to comply with protocol requirements|0
4417140|NCT03999554|7197541|FG001|Overall Study|failure to comply with protocol requirements|0
4417141|NCT03999554|7197542|FG002|Overall Study|failure to comply with protocol requirements|0
4417142|NCT03999554|7197543|FG003|Overall Study|failure to comply with protocol requirements|1
4417143|NCT03999554|7197544|FG004|Overall Study|failure to comply with protocol requirements|0
4417144|NCT03651622|7197560|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0
4417145|NCT03651622|7197561|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6
4417146|NCT03651622|7197562|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2
4417147|NCT03651622|7197560|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4
4417148|NCT03651622|7197561|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1
4417149|NCT03651622|7197562|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7
4417150|NCT03651622|7197560|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0
4417151|NCT03651622|7197561|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2
4417152|NCT03651622|7197562|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3
4417153|NCT03651622|7197560|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2
4417154|NCT03651622|7197561|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0
4417155|NCT03651622|7197562|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0
4771681|NCT01307787|7748485|FG001|Overall Study|Withdrawal by Subject|0
4417156|NCT03651622|7197560|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0
4417157|NCT03651622|7197561|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0
4417158|NCT03651622|7197562|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1
4417159|NCT03563716|7197572|FG000|Overall Study|Death|20
4417160|NCT03563716|7197573|FG001|Overall Study|Death|14
4417161|NCT03563716|7197572|FG000|Overall Study|Withdrawal by Subject|3
4417162|NCT03563716|7197573|FG001|Overall Study|Withdrawal by Subject|3
4417163|NCT03563716|7197572|FG000|Overall Study|Still on Study|45
4417164|NCT03563716|7197573|FG001|Overall Study|Still on Study|50
4417165|NCT03410992|7197581|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0
4417166|NCT03410992|7197582|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5
4417167|NCT03410992|7197583|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0
4417168|NCT03410992|7197584|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0
4417169|NCT03410992|7197585|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0
4417170|NCT03410992|7197586|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0
4417171|NCT03410992|7197587|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0
4417172|NCT03410992|7197588|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0
4417173|NCT03410992|7197589|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0
4417174|NCT03410992|7197590|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0
4417175|NCT03410992|7197591|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0
4417176|NCT03410992|7197581|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2
4417177|NCT03410992|7197582|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1
4417178|NCT03410992|7197583|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0
4417179|NCT03410992|7197584|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0
4417180|NCT03410992|7197585|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0
4417181|NCT03410992|7197586|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0
4417182|NCT03410992|7197587|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0
4417183|NCT03410992|7197588|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0
4417184|NCT03410992|7197589|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0
4417185|NCT03410992|7197590|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0
4417186|NCT03410992|7197591|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0
4417187|NCT03410992|7197581|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1
4417188|NCT03410992|7197582|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3
4417189|NCT03410992|7197583|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0
4417190|NCT03410992|7197584|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0
4417191|NCT03410992|7197585|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0
4417192|NCT03410992|7197586|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0
4417193|NCT03410992|7197587|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0
4417194|NCT03410992|7197588|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0
4417195|NCT03410992|7197589|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0
4417196|NCT03410992|7197590|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0
4417197|NCT03410992|7197591|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0
4417198|NCT03410992|7197581|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1
4417199|NCT03410992|7197582|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0
4417200|NCT03410992|7197583|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0
4417201|NCT03410992|7197584|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0
4417202|NCT03410992|7197585|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0
4417203|NCT03410992|7197586|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0
4629406|NCT01872078|7497363|FG001|Overall Study|Adverse Event|0
4417204|NCT03410992|7197587|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0
4417205|NCT03410992|7197588|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0
4417206|NCT03410992|7197589|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0
4417207|NCT03410992|7197590|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0
4417208|NCT03410992|7197591|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0
4417209|NCT03410992|7197581|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81
4417210|NCT03410992|7197582|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23
4417211|NCT03410992|7197583|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0
4417212|NCT03410992|7197584|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0
4417213|NCT03410992|7197585|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0
4417214|NCT03410992|7197586|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0
4417215|NCT03410992|7197587|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0
4417216|NCT03410992|7197588|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0
4417217|NCT03410992|7197589|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0
4417218|NCT03410992|7197590|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0
4417219|NCT03410992|7197591|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0
4417220|NCT03410992|7197581|FG000|Week 16 Assessment|Incorrect escapers|0
4417221|NCT03410992|7197582|FG001|Week 16 Assessment|Incorrect escapers|6
4417222|NCT03410992|7197583|FG002|Week 16 Assessment|Incorrect escapers|0
4417223|NCT03410992|7197584|FG003|Week 16 Assessment|Incorrect escapers|0
4417224|NCT03410992|7197585|FG004|Week 16 Assessment|Incorrect escapers|0
4629407|NCT01872078|7497364|FG002|Overall Study|Adverse Event|1
4629408|NCT01872078|7497365|FG003|Overall Study|Adverse Event|0
4417225|NCT03410992|7197586|FG005|Week 16 Assessment|Incorrect escapers|0
4417226|NCT03410992|7197587|FG006|Week 16 Assessment|Incorrect escapers|0
4417227|NCT03410992|7197588|FG007|Week 16 Assessment|Incorrect escapers|0
4417228|NCT03410992|7197589|FG008|Week 16 Assessment|Incorrect escapers|0
4417229|NCT03410992|7197590|FG009|Week 16 Assessment|Incorrect escapers|0
4417230|NCT03410992|7197591|FG010|Week 16 Assessment|Incorrect escapers|0
4417231|NCT03410992|7197581|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0
4417232|NCT03410992|7197582|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0
4417233|NCT03410992|7197583|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0
4417234|NCT03410992|7197584|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3
4417235|NCT03410992|7197585|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2
4417236|NCT03410992|7197586|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0
4417237|NCT03410992|7197587|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0
4417238|NCT03410992|7197588|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0
4417239|NCT03410992|7197589|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0
4417240|NCT03410992|7197590|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0
4417241|NCT03410992|7197591|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0
4417242|NCT03410992|7197581|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0
4417243|NCT03410992|7197582|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0
4417244|NCT03410992|7197583|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0
4417245|NCT03410992|7197584|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2
4417246|NCT03410992|7197585|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1
4417247|NCT03410992|7197586|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2
4417248|NCT03410992|7197587|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0
4417249|NCT03410992|7197588|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0
4417250|NCT03410992|7197589|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0
4417251|NCT03410992|7197590|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0
4417252|NCT03410992|7197591|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0
4417253|NCT03410992|7197581|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0
4417254|NCT03410992|7197582|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0
4417255|NCT03410992|7197583|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0
4417256|NCT03410992|7197584|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0
4417257|NCT03410992|7197585|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0
4417258|NCT03410992|7197586|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3
4417259|NCT03410992|7197587|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0
4417260|NCT03410992|7197588|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0
4417261|NCT03410992|7197589|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0
4417262|NCT03410992|7197590|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0
4417263|NCT03410992|7197591|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0
4417264|NCT03410992|7197581|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0
4417265|NCT03410992|7197582|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0
4417266|NCT03410992|7197583|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0
4417267|NCT03410992|7197584|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67
4417268|NCT03410992|7197585|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4
4417269|NCT03410992|7197586|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7
4417270|NCT03410992|7197587|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0
4417271|NCT03410992|7197588|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0
4417272|NCT03410992|7197589|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0
4417273|NCT03410992|7197590|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0
4417274|NCT03410992|7197591|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0
4417275|NCT03410992|7197581|FG000|Escape Treatment: 12 Weeks|Adverse Event|0
4417276|NCT03410992|7197582|FG001|Escape Treatment: 12 Weeks|Adverse Event|0
4417277|NCT03410992|7197583|FG002|Escape Treatment: 12 Weeks|Adverse Event|0
4417278|NCT03410992|7197584|FG003|Escape Treatment: 12 Weeks|Adverse Event|0
4417279|NCT03410992|7197585|FG004|Escape Treatment: 12 Weeks|Adverse Event|0
4417280|NCT03410992|7197586|FG005|Escape Treatment: 12 Weeks|Adverse Event|0
4417281|NCT03410992|7197587|FG006|Escape Treatment: 12 Weeks|Adverse Event|0
4417282|NCT03410992|7197588|FG007|Escape Treatment: 12 Weeks|Adverse Event|1
4417283|NCT03410992|7197589|FG008|Escape Treatment: 12 Weeks|Adverse Event|0
4417284|NCT03410992|7197590|FG009|Escape Treatment: 12 Weeks|Adverse Event|0
4417285|NCT03410992|7197591|FG010|Escape Treatment: 12 Weeks|Adverse Event|0
4417286|NCT03410992|7197581|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0
4417287|NCT03410992|7197582|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0
4417288|NCT03410992|7197583|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0
4417289|NCT03410992|7197584|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0
4417290|NCT03410992|7197585|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0
4417291|NCT03410992|7197586|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0
4417292|NCT03410992|7197587|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0
4417293|NCT03410992|7197588|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0
4417294|NCT03410992|7197589|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1
4417295|NCT03410992|7197590|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0
4417296|NCT03410992|7197591|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0
4417297|NCT03197935|7197623|FG000|Overall Study|Death due to any cause|9
4417298|NCT03197935|7197624|FG001|Overall Study|Death due to any cause|7
4417299|NCT03197935|7197623|FG000|Overall Study|Lost to Follow-up|0
4417300|NCT03197935|7197624|FG001|Overall Study|Lost to Follow-up|3
4417301|NCT03197935|7197623|FG000|Overall Study|Physician Decision|0
4417302|NCT03197935|7197624|FG001|Overall Study|Physician Decision|1
4417303|NCT03197935|7197623|FG000|Overall Study|Withdrawal by Subject|11
4417304|NCT03197935|7197624|FG001|Overall Study|Withdrawal by Subject|7
4417305|NCT03197935|7197623|FG000|Overall Study|On-Going in Study|147
4417306|NCT03197935|7197624|FG001|Overall Study|On-Going in Study|146
4417307|NCT03197935|7197623|FG000|Overall Study|Did not receive any study treatment|1
4417308|NCT03197935|7197624|FG001|Overall Study|Did not receive any study treatment|1
4511909|NCT00929864|7321391|FG001|Overall Study|Administrative reason by Sponsor|1
4511910|NCT00929864|7321390|FG000|Overall Study|Non-specified|2
4511911|NCT00929864|7321391|FG001|Overall Study|Non-specified|7
4511912|NCT00929994|7321401|FG000|Overall Study|Withdrawal by Subject|1
4511913|NCT00929994|7321401|FG000|Overall Study|medical issue unrelated to intervention|4
4511914|NCT00929994|7321401|FG000|Overall Study|employment|1
4511915|NCT00930046|7321410|FG000|Overall Study|Wound catheter malfunctioned|1
4511916|NCT00930046|7321411|FG001|Overall Study|Wound catheter malfunctioned|2
4511917|NCT00930059|7321419|FG000|Overall Study|Death|1
4511918|NCT00930059|7321420|FG001|Overall Study|Death|0
4511919|NCT00930059|7321419|FG000|Overall Study|Did not meet entrance criteria|1
4511920|NCT00930059|7321420|FG001|Overall Study|Did not meet entrance criteria|1
4511921|NCT00930059|7321419|FG000|Overall Study|Withdrawal by Subject|3
4511922|NCT00930059|7321420|FG001|Overall Study|Withdrawal by Subject|4
4511923|NCT00930059|7321419|FG000|Overall Study|Other|1
4511924|NCT00930059|7321420|FG001|Overall Study|Other|0
4511925|NCT00930059|7321419|FG000|Overall Study|1 site terminated by sponsor|1
4511926|NCT00930059|7321420|FG001|Overall Study|1 site terminated by sponsor|1
4511927|NCT00930059|7321419|FG000|Overall Study|Adverse Event|1
4511928|NCT00930059|7321420|FG001|Overall Study|Adverse Event|6
4511929|NCT00930176|7321426|FG000|Overall Study|Death|1
4511930|NCT00930553|7321439|FG000|Overall Study|Adverse Event|1
4511931|NCT00930553|7321439|FG000|Overall Study|Lack of Efficacy|7
4511932|NCT00930553|7321439|FG000|Overall Study|Physician Decision|39
4629409|NCT01872078|7497362|FG000|Overall Study|Dose administration non-compliance|0
4629410|NCT01872078|7497363|FG001|Overall Study|Dose administration non-compliance|0
4511933|NCT00930553|7321439|FG000|Overall Study|Protocol Violation|1
4511934|NCT00930553|7321439|FG000|Overall Study|Pregnancy|1
4511935|NCT00930553|7321439|FG000|Overall Study|Withdrawal by Subject|88
4511936|NCT00930553|7321439|FG000|Overall Study|Lost to Follow-up|25
4511937|NCT00930553|7321439|FG000|Overall Study|Death|9
4511938|NCT00930553|7321439|FG000|Overall Study|Study terminated by sponsor|24
4511939|NCT00930553|7321439|FG000|Overall Study|Other than specified above|28
4511940|NCT00930644|7321461|FG000|Overall Study|Withdrawal by Subject|4
4511941|NCT00930644|7321461|FG000|Overall Study|Physician Decision|2
4511942|NCT00930644|7321461|FG000|Overall Study|Death|1
4511943|NCT00930644|7321461|FG000|Overall Study|Adverse Event|16
4511944|NCT00930761|7321470|FG000|Overall Study|3 newborns died; 1 mother quit the study|4
4511945|NCT00930761|7321471|FG001|Overall Study|3 newborns died; 1 mother quit the study|0
4511946|NCT00930761|7321470|FG000|Overall Study|less than 3 music therapy sessions|0
4511947|NCT00930761|7321471|FG001|Overall Study|less than 3 music therapy sessions|3
4511948|NCT00930774|7321481|FG000|Overall Study|Withdrawal by Subject|1
4511949|NCT00930774|7321482|FG001|Overall Study|Withdrawal by Subject|9
4511950|NCT00930774|7321483|FG002|Overall Study|Withdrawal by Subject|2
4511951|NCT00930774|7321484|FG003|Overall Study|Withdrawal by Subject|0
4511952|NCT00930813|7321497|FG000|Overall Study|Death|4
4511953|NCT00930813|7321498|FG001|Overall Study|Death|5
4511954|NCT00930813|7321497|FG000|Overall Study|Withdrawal by Subject|2
4511955|NCT00930813|7321498|FG001|Overall Study|Withdrawal by Subject|5
4511956|NCT00930813|7321497|FG000|Overall Study|Lost to Follow-up|2
4511957|NCT00930813|7321498|FG001|Overall Study|Lost to Follow-up|4
4511958|NCT00930930|7321508|FG000|Overall Study|Death|1
4511959|NCT00930930|7321509|FG001|Overall Study|Death|0
4511960|NCT00930930|7321508|FG000|Overall Study|Physician Decision|1
4511961|NCT00930930|7321509|FG001|Overall Study|Physician Decision|0
4511962|NCT00930930|7321508|FG000|Overall Study|Adverse Event|13
4511963|NCT00930930|7321509|FG001|Overall Study|Adverse Event|3
4511964|NCT00930930|7321508|FG000|Overall Study|Withdrawal by Subject|3
4511965|NCT00930930|7321509|FG001|Overall Study|Withdrawal by Subject|1
4511966|NCT00930930|7321508|FG000|Overall Study|Disease progression|2
4511967|NCT00930930|7321509|FG001|Overall Study|Disease progression|3
4511968|NCT00930930|7321508|FG000|Overall Study|excessive lapse btw txs, not eligible|0
4511969|NCT00930930|7321509|FG001|Overall Study|excessive lapse btw txs, not eligible|1
4511970|NCT00930930|7321508|FG000|Overall Study|patients not compliant|1
4511971|NCT00930930|7321509|FG001|Overall Study|patients not compliant|1
4511972|NCT00930969|7321515|FG000|Overall Study|Death|5
4511973|NCT00930969|7321515|FG000|Overall Study|Lost to Follow-up|1
4511974|NCT00930969|7321515|FG000|Overall Study|Physician Decision|13
4417309|NCT02678351|7197663|FG000|Overall Study|Withdrawal by Subject|1
4417310|NCT02272790|7197677|FG000|Overall Study|Physician Decision|0
4417311|NCT02272790|7197678|FG001|Overall Study|Physician Decision|1
4417312|NCT02272790|7197679|FG002|Overall Study|Physician Decision|0
4417313|NCT02272790|7197680|FG003|Overall Study|Physician Decision|0
4417314|NCT02272790|7197681|FG004|Overall Study|Physician Decision|0
4417315|NCT02272790|7197682|FG005|Overall Study|Physician Decision|0
4417316|NCT01693692|7197718|FG000|Overall Study|Withdrawal by Subject|12
4417317|NCT01693692|7197719|FG001|Overall Study|Withdrawal by Subject|10
4417318|NCT01693692|7197720|FG002|Overall Study|Withdrawal by Subject|11
4417319|NCT01693692|7197718|FG000|Overall Study|Adverse Event|7
4417320|NCT01693692|7197719|FG001|Overall Study|Adverse Event|14
4417321|NCT01693692|7197720|FG002|Overall Study|Adverse Event|9
4417322|NCT01693692|7197718|FG000|Overall Study|Physician Decision|0
4417323|NCT01693692|7197719|FG001|Overall Study|Physician Decision|0
4417324|NCT01693692|7197720|FG002|Overall Study|Physician Decision|1
4417325|NCT01693692|7197718|FG000|Overall Study|Protocol Violation|5
4417326|NCT01693692|7197719|FG001|Overall Study|Protocol Violation|4
4417327|NCT01693692|7197720|FG002|Overall Study|Protocol Violation|6
4417328|NCT01693692|7197718|FG000|Overall Study|Lost to Follow-up|2
4417329|NCT01693692|7197719|FG001|Overall Study|Lost to Follow-up|2
4417330|NCT01693692|7197720|FG002|Overall Study|Lost to Follow-up|3
4417331|NCT01693692|7197718|FG000|Overall Study|Other|4
4417332|NCT01693692|7197719|FG001|Overall Study|Other|4
4417333|NCT01693692|7197720|FG002|Overall Study|Other|6
4417334|NCT01685606|7197728|FG000|Overall Study|Withdrawal by Subject|1
4417335|NCT01650285|7197738|FG000|Overall Study|Adverse Event|1
4417336|NCT01083771|7197742|FG000|Overall Study|non-compliant|2
4417337|NCT01083771|7197742|FG000|Overall Study|Withdrawal by Subject|3
4417338|NCT00743197|7197748|FG000|Overall Study|Study terminated due to departure of PI.|1
4417339|NCT00743197|7197749|FG001|Overall Study|Study terminated due to departure of PI.|2
4417340|NCT00304915|7197757|FG000|Overall Study|Lost to Follow-up|11
4417341|NCT00304915|7197758|FG001|Overall Study|Lost to Follow-up|11
4417342|NCT00304915|7197757|FG000|Overall Study|Death|4
4417343|NCT00304915|7197758|FG001|Overall Study|Death|5
4417344|NCT00304915|7197757|FG000|Overall Study|Withdrawal by Subject|3
4417345|NCT00304915|7197758|FG001|Overall Study|Withdrawal by Subject|0
4417346|NCT00304954|7197768|FG000|Overall Study|Withdrawal by Subject|0
4417347|NCT00304954|7197769|FG001|Overall Study|Withdrawal by Subject|0
4417348|NCT00304954|7197770|FG002|Overall Study|Withdrawal by Subject|1
4417349|NCT00304954|7197771|FG003|Overall Study|Withdrawal by Subject|0
4417350|NCT00304954|7197768|FG000|Overall Study|Adverse Event|1
4417351|NCT00304954|7197769|FG001|Overall Study|Adverse Event|0
4417352|NCT00304954|7197770|FG002|Overall Study|Adverse Event|0
4417353|NCT00304954|7197771|FG003|Overall Study|Adverse Event|0
4417354|NCT00305006|7197791|FG000|Overall Study|Withdrawal by Subject|1
4417355|NCT00305006|7197792|FG001|Overall Study|Withdrawal by Subject|0
4417356|NCT00305006|7197791|FG000|Overall Study|Failure to complete pretest|0
4417357|NCT00305006|7197792|FG001|Overall Study|Failure to complete pretest|1
4417358|NCT00305058|7197800|FG000|Overall Study|Participant too young|1
4417359|NCT00305058|7197801|FG001|Overall Study|Participant too young|0
4417360|NCT00305058|7197800|FG000|Overall Study|Missing data collection instrument|3
4417361|NCT00305058|7197801|FG001|Overall Study|Missing data collection instrument|2
4417362|NCT00305058|7197800|FG000|Overall Study|Missing outcome data|3
4417363|NCT00305058|7197801|FG001|Overall Study|Missing outcome data|2
4417364|NCT00305110|7197856|FG000|Overall Study|Missing data|29
4417365|NCT00305227|7197872|FG000|Overall Study|Lost to Follow-up|7
4417366|NCT00305227|7197873|FG001|Overall Study|Lost to Follow-up|6
4417367|NCT00305253|7197881|FG000|Overall Study|Withdrawal by Subject|0
4417368|NCT00305253|7197882|FG001|Overall Study|Withdrawal by Subject|1
4417369|NCT00305448|7197891|FG000|Overall Study|Protocol Violation|0
4417370|NCT00305448|7197892|FG001|Overall Study|Protocol Violation|1
4417371|NCT00305448|7197893|FG002|Overall Study|Protocol Violation|0
4417372|NCT00305448|7197891|FG000|Overall Study|Withdrawal by Subject|2
4417373|NCT00305448|7197892|FG001|Overall Study|Withdrawal by Subject|0
4417374|NCT00305448|7197893|FG002|Overall Study|Withdrawal by Subject|1
4417375|NCT00305448|7197891|FG000|Overall Study|Adverse Event|1
4417376|NCT00305448|7197892|FG001|Overall Study|Adverse Event|0
4417377|NCT00305448|7197893|FG002|Overall Study|Adverse Event|1
4417378|NCT00305448|7197891|FG000|Overall Study|Disease Progression|27
4417379|NCT00305448|7197892|FG001|Overall Study|Disease Progression|31
4417380|NCT00305448|7197893|FG002|Overall Study|Disease Progression|28
4417381|NCT00305448|7197891|FG000|Overall Study|Subjective Disease Progression|1
4417382|NCT00305448|7197892|FG001|Overall Study|Subjective Disease Progression|2
4417383|NCT00305448|7197893|FG002|Overall Study|Subjective Disease Progression|2
4417384|NCT00305448|7197891|FG000|Overall Study|Tumor Marker Elevation|0
4417385|NCT00305448|7197892|FG001|Overall Study|Tumor Marker Elevation|0
4417386|NCT00305448|7197893|FG002|Overall Study|Tumor Marker Elevation|1
4417387|NCT00305604|7197927|FG000|Overall Study|Adverse Event|6
4417388|NCT00305604|7197928|FG001|Overall Study|Adverse Event|3
4417389|NCT00305604|7197927|FG000|Overall Study|Lack of Efficacy|11
4417390|NCT00305604|7197928|FG001|Overall Study|Lack of Efficacy|18
4417391|NCT00305604|7197927|FG000|Overall Study|Lost to Follow-up|0
4417392|NCT00305604|7197928|FG001|Overall Study|Lost to Follow-up|4
4417393|NCT00305604|7197927|FG000|Overall Study|Protocol Violation|2
4417394|NCT00305604|7197928|FG001|Overall Study|Protocol Violation|1
4417395|NCT00305604|7197927|FG000|Overall Study|Withdrawal by Subject|12
4417396|NCT00305604|7197928|FG001|Overall Study|Withdrawal by Subject|21
4417397|NCT00305604|7197927|FG000|Overall Study|Patient moved|1
4417398|NCT00305604|7197928|FG001|Overall Study|Patient moved|0
4417399|NCT00305695|7197961|FG000|Overall Study|Withdrawal by subject prior to 18 month|40
4417400|NCT00305695|7197962|FG001|Overall Study|Withdrawal by subject prior to 18 month|26
4417401|NCT00305695|7197961|FG000|Overall Study|Did not have baseline scan|1
4417402|NCT00305695|7197962|FG001|Overall Study|Did not have baseline scan|1
4417403|NCT00305773|7197974|FG000|Overall Study|Death|3
4417404|NCT00305773|7197975|FG001|Overall Study|Death|2
4417405|NCT00305773|7197974|FG000|Overall Study|Adverse Event|1
4417406|NCT00305773|7197975|FG001|Overall Study|Adverse Event|2
4417407|NCT00305773|7197974|FG000|Overall Study|Alternative Treatment|4
4417408|NCT00305773|7197975|FG001|Overall Study|Alternative Treatment|4
4417409|NCT00305773|7197974|FG000|Overall Study|Physician Decision|1
4417410|NCT00305773|7197975|FG001|Overall Study|Physician Decision|1
4417411|NCT00305773|7197974|FG000|Overall Study|Withdrawal by Subject|1
4417412|NCT00305773|7197975|FG001|Overall Study|Withdrawal by Subject|4
4417413|NCT00305773|7197974|FG000|Overall Study|Disease Progression|1
4417414|NCT00305773|7197975|FG001|Overall Study|Disease Progression|3
4417415|NCT00305773|7197974|FG000|Overall Study|All other reasons|3
4417416|NCT00305773|7197975|FG001|Overall Study|All other reasons|2
4417417|NCT00305864|7197985|FG000|Overall Study|Ineligible / No protocol treatment|0
4417418|NCT00305864|7197986|FG001|Overall Study|Ineligible / No protocol treatment|1
4417419|NCT00305864|7197987|FG002|Overall Study|Ineligible / No protocol treatment|1
4417420|NCT00305864|7197988|FG003|Overall Study|Ineligible / No protocol treatment|13
4417421|NCT00305877|7198000|FG000|Overall Study|Lack of Efficacy|6
4417422|NCT00305877|7198001|FG001|Overall Study|Lack of Efficacy|9
4417423|NCT00305877|7198000|FG000|Overall Study|Adverse Event|9
4417424|NCT00305877|7198001|FG001|Overall Study|Adverse Event|14
4417425|NCT00305877|7198000|FG000|Overall Study|Death|0
4417426|NCT00305877|7198001|FG001|Overall Study|Death|1
4417427|NCT00305877|7198000|FG000|Overall Study|Withdrawal by Subject|4
4417428|NCT00305877|7198001|FG001|Overall Study|Withdrawal by Subject|2
4417429|NCT00305877|7198000|FG000|Overall Study|Physician Decision|1
4417430|NCT00305877|7198001|FG001|Overall Study|Physician Decision|1
4417431|NCT00305877|7198000|FG000|Overall Study|Never start treatment|2
4417432|NCT00305877|7198001|FG001|Overall Study|Never start treatment|5
4417433|NCT00305877|7198000|FG000|Overall Study|Ineligible|2
4417434|NCT00305877|7198001|FG001|Overall Study|Ineligible|1
4417435|NCT00305877|7198000|FG000|Overall Study|Transportation issue with daily RT|0
4417436|NCT00305877|7198001|FG001|Overall Study|Transportation issue with daily RT|1
4417437|NCT00306189|7198024|FG000|Overall Study|Physician Decision|0
4417438|NCT00306189|7198025|FG001|Overall Study|Physician Decision|0
4417439|NCT00306189|7198026|FG002|Overall Study|Physician Decision|0
4417440|NCT00306189|7198027|FG003|Overall Study|Physician Decision|1
4417441|NCT00306189|7198024|FG000|Overall Study|Adverse Event|3
4417442|NCT00306189|7198025|FG001|Overall Study|Adverse Event|3
4417443|NCT00306189|7198026|FG002|Overall Study|Adverse Event|2
4417444|NCT00306189|7198027|FG003|Overall Study|Adverse Event|2
4417445|NCT00306189|7198024|FG000|Overall Study|Withdrawal by Subject|4
4417446|NCT00306189|7198025|FG001|Overall Study|Withdrawal by Subject|2
4417447|NCT00306189|7198026|FG002|Overall Study|Withdrawal by Subject|8
4417448|NCT00306189|7198027|FG003|Overall Study|Withdrawal by Subject|1
4417449|NCT00306189|7198024|FG000|Overall Study|Ineligibility determined|1
4417450|NCT00306189|7198025|FG001|Overall Study|Ineligibility determined|1
4417451|NCT00306189|7198026|FG002|Overall Study|Ineligibility determined|1
4417452|NCT00306189|7198027|FG003|Overall Study|Ineligibility determined|1
4417453|NCT00306189|7198024|FG000|Overall Study|Other|1
4417454|NCT00306189|7198025|FG001|Overall Study|Other|0
4417455|NCT00306189|7198026|FG002|Overall Study|Other|0
4417456|NCT00306189|7198027|FG003|Overall Study|Other|0
4417457|NCT00306293|7198088|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1
4417458|NCT00306293|7198089|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0
4417459|NCT00306293|7198088|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3
4417460|NCT00306293|7198089|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4
4417461|NCT00306293|7198088|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2
4417462|NCT00306293|7198089|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2
4417463|NCT00306293|7198088|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2
4417464|NCT00306293|7198089|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2
4417465|NCT00306293|7198088|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1
4417466|NCT00306293|7198089|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0
4417467|NCT00306293|7198088|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1
4417468|NCT00306293|7198089|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0
4417469|NCT00306293|7198088|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0
4417470|NCT00306293|7198089|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1
4417471|NCT00306293|7198088|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1
4417472|NCT00306293|7198089|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0
4417473|NCT00306384|7198100|FG000|Overall Study|Adverse Event|103
4417474|NCT00306384|7198101|FG001|Overall Study|Adverse Event|87
4417475|NCT00306384|7198102|FG002|Overall Study|Adverse Event|40
4417476|NCT00306384|7198100|FG000|Overall Study|Major protocol deviation|43
4417477|NCT00306384|7198101|FG001|Overall Study|Major protocol deviation|51
4417478|NCT00306384|7198102|FG002|Overall Study|Major protocol deviation|18
4417479|NCT00306384|7198100|FG000|Overall Study|Lost to Follow-up|57
4417480|NCT00306384|7198101|FG001|Overall Study|Lost to Follow-up|41
4417481|NCT00306384|7198102|FG002|Overall Study|Lost to Follow-up|35
4417482|NCT00306384|7198100|FG000|Overall Study|Voluntary withdrawal|199
4417483|NCT00306384|7198101|FG001|Overall Study|Voluntary withdrawal|187
4417484|NCT00306384|7198102|FG002|Overall Study|Voluntary withdrawal|91
4417485|NCT00306384|7198100|FG000|Overall Study|Study termination|1
4417486|NCT00306384|7198101|FG001|Overall Study|Study termination|0
4417487|NCT00306384|7198102|FG002|Overall Study|Study termination|1
4417488|NCT00306384|7198100|FG000|Overall Study|Pregnancy|3
4417489|NCT00306384|7198101|FG001|Overall Study|Pregnancy|1
4417490|NCT00306384|7198102|FG002|Overall Study|Pregnancy|1
4417491|NCT00306384|7198100|FG000|Overall Study|Lack of Efficacy|26
4417492|NCT00306384|7198101|FG001|Overall Study|Lack of Efficacy|40
4417493|NCT00306384|7198102|FG002|Overall Study|Lack of Efficacy|38
4417494|NCT00306384|7198100|FG000|Overall Study|Investigator discretion|28
4417495|NCT00306384|7198101|FG001|Overall Study|Investigator discretion|31
4417496|NCT00306384|7198102|FG002|Overall Study|Investigator discretion|21
4417497|NCT00306384|7198100|FG000|Overall Study|Other|80
4417498|NCT00306384|7198101|FG001|Overall Study|Other|70
4417499|NCT00306384|7198102|FG002|Overall Study|Other|32
4417500|NCT00306384|7198100|FG000|Overall Study|Site closure|2
4417501|NCT00306384|7198101|FG001|Overall Study|Site closure|0
4417502|NCT00306384|7198102|FG002|Overall Study|Site closure|0
4417503|NCT00306527|7198119|FG000|Overall Study|Lost to Follow-up|3
4417504|NCT00306527|7198120|FG001|Overall Study|Lost to Follow-up|4
4417505|NCT00306527|7198121|FG002|Overall Study|Lost to Follow-up|3
4417506|NCT00306527|7198122|FG003|Overall Study|Lost to Follow-up|0
4417507|NCT00306527|7198119|FG000|Overall Study|Withdrawal by Subject|2
4417508|NCT00306527|7198120|FG001|Overall Study|Withdrawal by Subject|3
4417509|NCT00306527|7198121|FG002|Overall Study|Withdrawal by Subject|0
4417510|NCT00306527|7198122|FG003|Overall Study|Withdrawal by Subject|3
4417511|NCT00306527|7198119|FG000|Overall Study|Adverse Event|0
4417512|NCT00306527|7198120|FG001|Overall Study|Adverse Event|0
4417513|NCT00306527|7198121|FG002|Overall Study|Adverse Event|1
4417514|NCT00306527|7198122|FG003|Overall Study|Adverse Event|1
4417515|NCT00306527|7198119|FG000|Overall Study|Death|1
4417516|NCT00306527|7198120|FG001|Overall Study|Death|0
4417517|NCT00306527|7198121|FG002|Overall Study|Death|1
4417518|NCT00306527|7198122|FG003|Overall Study|Death|2
4417519|NCT00306592|7198136|FG000|Overall Study|Adverse Event|8
4417520|NCT00306592|7198137|FG001|Overall Study|Adverse Event|15
4417521|NCT00306592|7198136|FG000|Overall Study|Lost to Follow-up|1
4417522|NCT00306592|7198137|FG001|Overall Study|Lost to Follow-up|0
4714893|NCT02963506|7642893|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1
4714894|NCT02963701|7642921|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1
4714895|NCT02963701|7642922|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0
4714896|NCT02963922|7642930|FG000|Overall Study|Adverse Event|15
4417523|NCT00306592|7198136|FG000|Overall Study|Noncompliance|0
4417524|NCT00306592|7198137|FG001|Overall Study|Noncompliance|2
4417525|NCT00306592|7198136|FG000|Overall Study|Persistent Antibodies|6
4417526|NCT00306592|7198137|FG001|Overall Study|Persistent Antibodies|3
4417527|NCT00306592|7198136|FG000|Overall Study|Voluntary|10
4417528|NCT00306592|7198137|FG001|Overall Study|Voluntary|6
4417529|NCT00306592|7198136|FG000|Overall Study|Other|5
4417530|NCT00306592|7198137|FG001|Overall Study|Other|10
4417531|NCT00306592|7198136|FG000|Overall Study|Other|1
4417532|NCT00306592|7198137|FG001|Overall Study|Other|2
4417533|NCT00306592|7198136|FG000|Overall Study|48-week Treatment Period Ongoing|0
4417534|NCT00306592|7198137|FG001|Overall Study|48-week Treatment Period Ongoing|20
4511975|NCT00930969|7321515|FG000|Overall Study|Withdrawal by Subject|19
4511976|NCT00930982|7321521|FG000|Overall Study|Adverse Event|19
4511977|NCT00930982|7321522|FG001|Overall Study|Adverse Event|23
4511978|NCT00930982|7321521|FG000|Overall Study|Protocol Violation|1
4511979|NCT00930982|7321522|FG001|Overall Study|Protocol Violation|5
4511980|NCT00930982|7321521|FG000|Overall Study|Withdrawal by Subject|1
4511981|NCT00930982|7321522|FG001|Overall Study|Withdrawal by Subject|1
4511982|NCT00931268|7321539|FG000|Overall Study|Lost to Follow-up|6
4511983|NCT00931307|7321543|FG000|Overall Study|Lack of Efficacy|12
4511984|NCT00931307|7321543|FG000|Overall Study|Biomicroscopy|1
4511985|NCT00931385|7321556|FG000|Overall Study|Adverse Event|2
4511986|NCT00931385|7321557|FG001|Overall Study|Adverse Event|1
4511987|NCT00931385|7321558|FG002|Overall Study|Adverse Event|0
4511988|NCT00931385|7321559|FG003|Overall Study|Adverse Event|3
4511989|NCT00931385|7321556|FG000|Overall Study|Protocol Violation|0
4511990|NCT00931385|7321557|FG001|Overall Study|Protocol Violation|0
4511991|NCT00931385|7321558|FG002|Overall Study|Protocol Violation|1
4511992|NCT00931385|7321559|FG003|Overall Study|Protocol Violation|0
4511993|NCT00931385|7321556|FG000|Overall Study|Withdrawal by Subject|0
4511994|NCT00931385|7321557|FG001|Overall Study|Withdrawal by Subject|1
4511995|NCT00931385|7321558|FG002|Overall Study|Withdrawal by Subject|0
4511996|NCT00931385|7321559|FG003|Overall Study|Withdrawal by Subject|1
4511997|NCT00931385|7321556|FG000|Overall Study|Lost to Follow-up|0
4511998|NCT00931385|7321557|FG001|Overall Study|Lost to Follow-up|0
4417535|NCT00306670|7198143|FG000|Overall Study|patients recruited; Genentech, the st|0
4417536|NCT00306670|7198144|FG001|Overall Study|patients recruited; Genentech, the st|2
4417537|NCT00306787|7198152|FG000|Overall Study|Discontinued without taking study drug|208
4417538|NCT00306787|7198153|FG001|Overall Study|Discontinued without taking study drug|215
4417539|NCT00306787|7198152|FG000|Overall Study|Adverse Event|1
4417540|NCT00306787|7198153|FG001|Overall Study|Adverse Event|1
4417541|NCT00306787|7198152|FG000|Overall Study|Lack of Efficacy|1
4417542|NCT00306787|7198153|FG001|Overall Study|Lack of Efficacy|0
4417543|NCT00306787|7198152|FG000|Overall Study|Protocol Violation|8
4417544|NCT00306787|7198153|FG001|Overall Study|Protocol Violation|10
4417545|NCT00306787|7198152|FG000|Overall Study|Withdrawal by Subject|2
4417546|NCT00306787|7198153|FG001|Overall Study|Withdrawal by Subject|9
4417547|NCT00306787|7198152|FG000|Overall Study|Lost to Follow-up|9
4417548|NCT00306787|7198153|FG001|Overall Study|Lost to Follow-up|6
4417549|NCT00306787|7198152|FG000|Overall Study|Administrative problems|4
4417550|NCT00306787|7198153|FG001|Overall Study|Administrative problems|0
4417551|NCT00306787|7198152|FG000|Overall Study|Abnormal laboratory value(s)|1
4417552|NCT00306787|7198153|FG001|Overall Study|Abnormal laboratory value(s)|0
4417553|NCT00306852|7198161|FG000|Overall Study|Death|14
4417554|NCT00306852|7198162|FG001|Overall Study|Death|14
4417555|NCT00306852|7198161|FG000|Overall Study|Lost to Follow-up|15
4417556|NCT00306852|7198162|FG001|Overall Study|Lost to Follow-up|24
4417557|NCT00306891|7198172|FG000|Part A|Withdrawal by Subject|1
4417558|NCT00306891|7198173|FG001|Part A|Withdrawal by Subject|1
4417559|NCT00306891|7198174|FG002|Part A|Withdrawal by Subject|0
4417560|NCT00306891|7198175|FG003|Part A|Withdrawal by Subject|0
4417561|NCT00306891|7198172|FG000|Part A|Condition under investigation worsened|2
4417562|NCT00306891|7198173|FG001|Part A|Condition under investigation worsened|2
4417563|NCT00306891|7198174|FG002|Part A|Condition under investigation worsened|0
4417564|NCT00306891|7198175|FG003|Part A|Condition under investigation worsened|0
4417565|NCT00306891|7198172|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0
4417566|NCT00306891|7198173|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1
4417567|NCT00306891|7198174|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0
4417568|NCT00306891|7198175|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0
4417569|NCT00306891|7198172|FG000|Part A|Partial bowel obstruction|1
4417570|NCT00306891|7198173|FG001|Part A|Partial bowel obstruction|0
4417571|NCT00306891|7198174|FG002|Part A|Partial bowel obstruction|0
4417572|NCT00306891|7198175|FG003|Part A|Partial bowel obstruction|0
4417573|NCT00306891|7198172|FG000|Part A|Reaccumul. of ascites following drainage|0
4417574|NCT00306891|7198173|FG001|Part A|Reaccumul. of ascites following drainage|1
4417575|NCT00306891|7198174|FG002|Part A|Reaccumul. of ascites following drainage|0
4417576|NCT00306891|7198175|FG003|Part A|Reaccumul. of ascites following drainage|0
4417577|NCT00306891|7198172|FG000|Part A|Suspicion of second malignancy|0
4417578|NCT00306891|7198173|FG001|Part A|Suspicion of second malignancy|1
4417579|NCT00306891|7198174|FG002|Part A|Suspicion of second malignancy|0
4417580|NCT00306891|7198175|FG003|Part A|Suspicion of second malignancy|0
4417581|NCT00306891|7198172|FG000|Part A|QTC interval outwith elig. criteria|1
4417582|NCT00306891|7198173|FG001|Part A|QTC interval outwith elig. criteria|0
4417583|NCT00306891|7198174|FG002|Part A|QTC interval outwith elig. criteria|0
4417584|NCT00306891|7198175|FG003|Part A|QTC interval outwith elig. criteria|0
4417585|NCT00306891|7198172|FG000|Part B|Death|0
4417586|NCT00306891|7198173|FG001|Part B|Death|0
4417587|NCT00306891|7198174|FG002|Part B|Death|1
4417588|NCT00306891|7198175|FG003|Part B|Death|2
4417589|NCT00306891|7198172|FG000|Part B|Adverse Event|0
4417590|NCT00306891|7198173|FG001|Part B|Adverse Event|0
4417591|NCT00306891|7198174|FG002|Part B|Adverse Event|5
4417592|NCT00306891|7198175|FG003|Part B|Adverse Event|5
4417593|NCT00306891|7198172|FG000|Part B|Withdrawal by Subject|0
4417594|NCT00306891|7198173|FG001|Part B|Withdrawal by Subject|0
4417595|NCT00306891|7198174|FG002|Part B|Withdrawal by Subject|3
4417596|NCT00306891|7198175|FG003|Part B|Withdrawal by Subject|1
4417597|NCT00306891|7198172|FG000|Part B|Condition under investigation worsened|0
4417598|NCT00306891|7198173|FG001|Part B|Condition under investigation worsened|0
4417599|NCT00306891|7198174|FG002|Part B|Condition under investigation worsened|2
4417600|NCT00306891|7198175|FG003|Part B|Condition under investigation worsened|8
4417601|NCT00306891|7198172|FG000|Part B|Development of study specific disc crit.|0
4417602|NCT00306891|7198173|FG001|Part B|Development of study specific disc crit.|0
4417603|NCT00306891|7198174|FG002|Part B|Development of study specific disc crit.|0
4417604|NCT00306891|7198175|FG003|Part B|Development of study specific disc crit.|1
4417605|NCT00306995|7198202|FG000|Study Part I|Withdrawal by Subject|0
4417606|NCT00306995|7198203|FG001|Study Part I|Withdrawal by Subject|0
4417607|NCT00306995|7198204|FG002|Study Part I|Withdrawal by Subject|0
4417608|NCT00306995|7198205|FG003|Study Part I|Withdrawal by Subject|0
4417609|NCT00306995|7198206|FG004|Study Part I|Withdrawal by Subject|0
4417610|NCT00306995|7198207|FG005|Study Part I|Withdrawal by Subject|0
4417611|NCT00306995|7198208|FG006|Study Part I|Withdrawal by Subject|1
4417612|NCT00306995|7198202|FG000|Study Part II for Subset 2|Serious Adverse Event|0
4417613|NCT00306995|7198203|FG001|Study Part II for Subset 2|Serious Adverse Event|1
4417614|NCT00306995|7198204|FG002|Study Part II for Subset 2|Serious Adverse Event|0
4417615|NCT00306995|7198205|FG003|Study Part II for Subset 2|Serious Adverse Event|0
4511999|NCT00931385|7321558|FG002|Overall Study|Lost to Follow-up|0
4417616|NCT00306995|7198206|FG004|Study Part II for Subset 2|Serious Adverse Event|0
4417617|NCT00306995|7198207|FG005|Study Part II for Subset 2|Serious Adverse Event|0
4417618|NCT00306995|7198208|FG006|Study Part II for Subset 2|Serious Adverse Event|0
4417619|NCT00307034|7198255|FG000|Overall Study|Adverse Event|1
4417620|NCT00307034|7198256|FG001|Overall Study|Adverse Event|2
4417621|NCT00307034|7198255|FG000|Overall Study|Withdrawal by Subject|1
4417622|NCT00307034|7198256|FG001|Overall Study|Withdrawal by Subject|2
4417623|NCT00307034|7198255|FG000|Overall Study|Lost to Follow-up|0
4417624|NCT00307034|7198256|FG001|Overall Study|Lost to Follow-up|3
4417625|NCT00307047|7198264|FG000|Overall Study|Lost to Follow-up|35
4417626|NCT00307047|7198265|FG001|Overall Study|Lost to Follow-up|24
4417627|NCT00307047|7198264|FG000|Overall Study|Withdrawal by Subject|6
4417628|NCT00307047|7198265|FG001|Overall Study|Withdrawal by Subject|6
4417629|NCT00307047|7198264|FG000|Overall Study|Physician Decision|1
4417630|NCT00307047|7198265|FG001|Overall Study|Physician Decision|2
4417631|NCT00307047|7198264|FG000|Overall Study|Lost to follow-up for other reasons|0
4417632|NCT00307047|7198265|FG001|Overall Study|Lost to follow-up for other reasons|1
4417633|NCT00307047|7198264|FG000|Overall Study|All death, all MI, all Revascularization|27
4417634|NCT00307047|7198265|FG001|Overall Study|All death, all MI, all Revascularization|16
4417635|NCT00307086|7198271|FG000|Overall Study|ineligible|5
4417636|NCT00307125|7198277|FG000|Screening Phase|Adverse Event|1
4417637|NCT00307125|7198278|FG001|Screening Phase|Adverse Event|0
4417638|NCT00307125|7198279|FG002|Screening Phase|Adverse Event|0
4417639|NCT00307125|7198277|FG000|Screening Phase|Protocol Violation|27
4417640|NCT00307125|7198278|FG001|Screening Phase|Protocol Violation|0
4417641|NCT00307125|7198279|FG002|Screening Phase|Protocol Violation|0
4417642|NCT00307125|7198277|FG000|Screening Phase|Lost to Follow-up|87
4417643|NCT00307125|7198278|FG001|Screening Phase|Lost to Follow-up|0
4417644|NCT00307125|7198279|FG002|Screening Phase|Lost to Follow-up|0
4417645|NCT00307125|7198277|FG000|Screening Phase|Death|10
4417646|NCT00307125|7198278|FG001|Screening Phase|Death|0
4417647|NCT00307125|7198279|FG002|Screening Phase|Death|0
4417648|NCT00307125|7198277|FG000|Screening Phase|Withdrawal by Subject|77
4417649|NCT00307125|7198278|FG001|Screening Phase|Withdrawal by Subject|0
4417650|NCT00307125|7198279|FG002|Screening Phase|Withdrawal by Subject|0
4417651|NCT00307125|7198277|FG000|Screening Phase|Physician Decision|26
4417652|NCT00307125|7198278|FG001|Screening Phase|Physician Decision|0
4417653|NCT00307125|7198279|FG002|Screening Phase|Physician Decision|0
4417654|NCT00307125|7198277|FG000|Screening Phase|Sponsor Decision|4
4417655|NCT00307125|7198278|FG001|Screening Phase|Sponsor Decision|0
4417656|NCT00307125|7198279|FG002|Screening Phase|Sponsor Decision|0
4417657|NCT00307125|7198277|FG000|Screening Phase|Study Terminated|17
4417658|NCT00307125|7198278|FG001|Screening Phase|Study Terminated|0
4417659|NCT00307125|7198279|FG002|Screening Phase|Study Terminated|0
4417660|NCT00307125|7198277|FG000|Screening Phase|Graft Loss|3
4629411|NCT01872078|7497364|FG002|Overall Study|Dose administration non-compliance|0
4629412|NCT01872078|7497365|FG003|Overall Study|Dose administration non-compliance|1
4629413|NCT01872078|7497362|FG000|Overall Study|Protocol Violation|0
4629414|NCT01872078|7497363|FG001|Overall Study|Protocol Violation|0
4629415|NCT01872078|7497364|FG002|Overall Study|Protocol Violation|1
4629416|NCT01872078|7497365|FG003|Overall Study|Protocol Violation|0
4629417|NCT01872078|7497362|FG000|Overall Study|Withdrawal by Subject|0
4629418|NCT01872078|7497363|FG001|Overall Study|Withdrawal by Subject|0
4629419|NCT01872078|7497364|FG002|Overall Study|Withdrawal by Subject|1
4629420|NCT01872078|7497365|FG003|Overall Study|Withdrawal by Subject|0
4629421|NCT01872078|7497362|FG000|Overall Study|Patient met exclusion criterion 16.|0
4629422|NCT01872078|7497363|FG001|Overall Study|Patient met exclusion criterion 16.|0
4629423|NCT01872078|7497364|FG002|Overall Study|Patient met exclusion criterion 16.|0
4629424|NCT01872078|7497365|FG003|Overall Study|Patient met exclusion criterion 16.|1
4629425|NCT01872611|7497395|FG000|Overall Study|Adverse Event|3
4629426|NCT01872611|7497396|FG001|Overall Study|Adverse Event|1
4417661|NCT00307125|7198278|FG001|Screening Phase|Graft Loss|0
4417662|NCT00307125|7198279|FG002|Screening Phase|Graft Loss|0
4417663|NCT00307125|7198277|FG000|Screening Phase|Graft Failure|8
4417664|NCT00307125|7198278|FG001|Screening Phase|Graft Failure|0
4417665|NCT00307125|7198279|FG002|Screening Phase|Graft Failure|0
4417666|NCT00307125|7198277|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83
4417667|NCT00307125|7198278|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0
4417668|NCT00307125|7198279|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0
4417669|NCT00307125|7198277|FG000|Screening Phase|Scheduling issues/Non-compliance|55
4417670|NCT00307125|7198278|FG001|Screening Phase|Scheduling issues/Non-compliance|0
4417671|NCT00307125|7198279|FG002|Screening Phase|Scheduling issues/Non-compliance|0
4417672|NCT00307125|7198277|FG000|Screening Phase|Moved or transferred facilities|34
4417673|NCT00307125|7198278|FG001|Screening Phase|Moved or transferred facilities|0
4417674|NCT00307125|7198279|FG002|Screening Phase|Moved or transferred facilities|0
4417675|NCT00307125|7198277|FG000|Screening Phase|Received Pancreas Transplant|8
4417676|NCT00307125|7198278|FG001|Screening Phase|Received Pancreas Transplant|0
4417677|NCT00307125|7198279|FG002|Screening Phase|Received Pancreas Transplant|0
4629427|NCT01872611|7497395|FG000|Overall Study|Adverse Event, prior to treatment|0
4629428|NCT01872611|7497396|FG001|Overall Study|Adverse Event, prior to treatment|1
4629429|NCT01872611|7497395|FG000|Overall Study|Death|0
4629430|NCT01872611|7497396|FG001|Overall Study|Death|1
4417678|NCT00307125|7198277|FG000|Screening Phase|Ineligible for pilot|4
4417679|NCT00307125|7198278|FG001|Screening Phase|Ineligible for pilot|0
4417680|NCT00307125|7198279|FG002|Screening Phase|Ineligible for pilot|0
4417681|NCT00307125|7198277|FG000|Screening Phase|Try to get pregnant|1
4417682|NCT00307125|7198278|FG001|Screening Phase|Try to get pregnant|0
4417683|NCT00307125|7198279|FG002|Screening Phase|Try to get pregnant|0
4417684|NCT00307125|7198277|FG000|Screening Phase|Developed acute leukemia|1
4417685|NCT00307125|7198278|FG001|Screening Phase|Developed acute leukemia|0
4417686|NCT00307125|7198279|FG002|Screening Phase|Developed acute leukemia|0
4417687|NCT00307125|7198277|FG000|Screening Phase|Metastatic colon cancer|1
4417688|NCT00307125|7198278|FG001|Screening Phase|Metastatic colon cancer|0
4417689|NCT00307125|7198279|FG002|Screening Phase|Metastatic colon cancer|0
4417690|NCT00307125|7198277|FG000|Screening Phase|Malignancy|1
4417691|NCT00307125|7198278|FG001|Screening Phase|Malignancy|0
4417692|NCT00307125|7198279|FG002|Screening Phase|Malignancy|0
4417693|NCT00307125|7198277|FG000|Screening Phase|PAK|1
4417694|NCT00307125|7198278|FG001|Screening Phase|PAK|0
4417695|NCT00307125|7198279|FG002|Screening Phase|PAK|0
4417696|NCT00307125|7198277|FG000|Screening Phase|Ineligible|1
4417697|NCT00307125|7198278|FG001|Screening Phase|Ineligible|0
4417698|NCT00307125|7198279|FG002|Screening Phase|Ineligible|0
4417699|NCT00307125|7198277|FG000|Screening Phase|Screen Error|1
4417700|NCT00307125|7198278|FG001|Screening Phase|Screen Error|0
4417701|NCT00307125|7198279|FG002|Screening Phase|Screen Error|0
4417702|NCT00307125|7198277|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1
4417703|NCT00307125|7198278|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0
4417704|NCT00307125|7198279|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0
4417705|NCT00307125|7198277|FG000|Screening Phase|AMR and treated with rituximab|1
4417706|NCT00307125|7198278|FG001|Screening Phase|AMR and treated with rituximab|0
4417707|NCT00307125|7198279|FG002|Screening Phase|AMR and treated with rituximab|0
4417708|NCT00307125|7198277|FG000|Screening Phase|Coronary artery bypass|1
4417709|NCT00307125|7198278|FG001|Screening Phase|Coronary artery bypass|0
4417710|NCT00307125|7198279|FG002|Screening Phase|Coronary artery bypass|0
4417711|NCT00307125|7198277|FG000|Pilot Phase|Lost to Follow-up|0
4417712|NCT00307125|7198278|FG001|Pilot Phase|Lost to Follow-up|1
4417713|NCT00307125|7198279|FG002|Pilot Phase|Lost to Follow-up|0
4417714|NCT00307125|7198277|FG000|Pilot Phase|Withdrawal by Subject|0
4417715|NCT00307125|7198278|FG001|Pilot Phase|Withdrawal by Subject|1
4417716|NCT00307125|7198279|FG002|Pilot Phase|Withdrawal by Subject|1
4417717|NCT00307151|7198293|FG000|Overall Study|Death|4
4417718|NCT00307151|7198294|FG001|Overall Study|Death|3
4417719|NCT00307151|7198295|FG002|Overall Study|Death|10
4417720|NCT00307151|7198296|FG003|Overall Study|Death|3
4417721|NCT00307151|7198293|FG000|Overall Study|Severe debilitation, unable to continue|1
4417722|NCT00307151|7198294|FG001|Overall Study|Severe debilitation, unable to continue|0
4417723|NCT00307151|7198295|FG002|Overall Study|Severe debilitation, unable to continue|0
4417724|NCT00307151|7198296|FG003|Overall Study|Severe debilitation, unable to continue|0
4417725|NCT00307151|7198293|FG000|Overall Study|Subject unable to get to clinic|1
4417726|NCT00307151|7198294|FG001|Overall Study|Subject unable to get to clinic|0
4417727|NCT00307151|7198295|FG002|Overall Study|Subject unable to get to clinic|6
4417728|NCT00307151|7198296|FG003|Overall Study|Subject unable to get to clinic|2
4417729|NCT00307151|7198293|FG000|Overall Study|Withdrew consent|0
4417730|NCT00307151|7198294|FG001|Overall Study|Withdrew consent|1
4417731|NCT00307151|7198295|FG002|Overall Study|Withdrew consent|1
4417732|NCT00307151|7198296|FG003|Overall Study|Withdrew consent|3
4417733|NCT00307151|7198293|FG000|Overall Study|Not willing to adhere to study reqs|2
4417734|NCT00307151|7198294|FG001|Overall Study|Not willing to adhere to study reqs|0
4417735|NCT00307151|7198295|FG002|Overall Study|Not willing to adhere to study reqs|2
4417736|NCT00307151|7198296|FG003|Overall Study|Not willing to adhere to study reqs|2
4417737|NCT00307151|7198293|FG000|Overall Study|Clinic unable to contact subject|3
4417738|NCT00307151|7198294|FG001|Overall Study|Clinic unable to contact subject|3
4417739|NCT00307151|7198295|FG002|Overall Study|Clinic unable to contact subject|1
4417740|NCT00307151|7198296|FG003|Overall Study|Clinic unable to contact subject|1
4417741|NCT00307164|7198308|FG000|Overall Study|Death|1
4417742|NCT00307164|7198309|FG001|Overall Study|Death|0
4417743|NCT00307164|7198308|FG000|Overall Study|Severe debilitation, unable to continue|1
4714897|NCT02963922|7642931|FG001|Overall Study|Adverse Event|6
4714898|NCT02963922|7642930|FG000|Overall Study|Protocol deviation|6
4714899|NCT02963922|7642931|FG001|Overall Study|Protocol deviation|6
4714900|NCT02963922|7642930|FG000|Overall Study|Lack of Efficacy|1
4714901|NCT02963922|7642931|FG001|Overall Study|Lack of Efficacy|1
4417744|NCT00307164|7198309|FG001|Overall Study|Severe debilitation, unable to continue|0
4417745|NCT00307164|7198308|FG000|Overall Study|Subject/parent not able to get to clinic|2
4417746|NCT00307164|7198309|FG001|Overall Study|Subject/parent not able to get to clinic|1
4417747|NCT00307164|7198308|FG000|Overall Study|Withdrawal by Subject|1
4417748|NCT00307164|7198309|FG001|Overall Study|Withdrawal by Subject|8
4417749|NCT00307164|7198308|FG000|Overall Study|Not compliant with requirements|4
4417750|NCT00307164|7198309|FG001|Overall Study|Not compliant with requirements|4
4417751|NCT00307164|7198308|FG000|Overall Study|Lost to Follow-up|6
4417752|NCT00307164|7198309|FG001|Overall Study|Lost to Follow-up|1
4417753|NCT00307294|7198315|FG000|Overall Study|Withdrawal by Subject|1
4417754|NCT00307333|7198322|FG000|Overall Study|Lost to Follow-up|11
4417755|NCT00307333|7198323|FG001|Overall Study|Lost to Follow-up|3
4417756|NCT00307437|7198332|FG000|Controlled Period|Adverse Event|7
4417757|NCT00307437|7198333|FG001|Controlled Period|Adverse Event|2
4417758|NCT00307437|7198334|FG002|Controlled Period|Adverse Event|5
4417759|NCT00307437|7198335|FG003|Controlled Period|Adverse Event|0
4417760|NCT00307437|7198336|FG004|Controlled Period|Adverse Event|0
4417761|NCT00307437|7198337|FG005|Controlled Period|Adverse Event|0
4417762|NCT00307437|7198338|FG006|Controlled Period|Adverse Event|0
4417763|NCT00307437|7198332|FG000|Controlled Period|Death|0
4417764|NCT00307437|7198333|FG001|Controlled Period|Death|0
4417765|NCT00307437|7198334|FG002|Controlled Period|Death|1
4417766|NCT00307437|7198335|FG003|Controlled Period|Death|0
4417767|NCT00307437|7198336|FG004|Controlled Period|Death|0
4417768|NCT00307437|7198337|FG005|Controlled Period|Death|0
4417769|NCT00307437|7198338|FG006|Controlled Period|Death|0
4417770|NCT00307437|7198332|FG000|Controlled Period|Lack of Efficacy|2
4417771|NCT00307437|7198333|FG001|Controlled Period|Lack of Efficacy|0
4417772|NCT00307437|7198334|FG002|Controlled Period|Lack of Efficacy|0
4417773|NCT00307437|7198335|FG003|Controlled Period|Lack of Efficacy|0
4417774|NCT00307437|7198336|FG004|Controlled Period|Lack of Efficacy|0
4417775|NCT00307437|7198337|FG005|Controlled Period|Lack of Efficacy|0
4417776|NCT00307437|7198338|FG006|Controlled Period|Lack of Efficacy|0
4417777|NCT00307437|7198332|FG000|Controlled Period|Lost to Follow-up|2
4417778|NCT00307437|7198333|FG001|Controlled Period|Lost to Follow-up|3
4417779|NCT00307437|7198334|FG002|Controlled Period|Lost to Follow-up|0
4417780|NCT00307437|7198335|FG003|Controlled Period|Lost to Follow-up|0
4417781|NCT00307437|7198336|FG004|Controlled Period|Lost to Follow-up|0
4417782|NCT00307437|7198337|FG005|Controlled Period|Lost to Follow-up|0
4417783|NCT00307437|7198338|FG006|Controlled Period|Lost to Follow-up|0
4417784|NCT00307437|7198332|FG000|Controlled Period|Other|5
4417785|NCT00307437|7198333|FG001|Controlled Period|Other|1
4417786|NCT00307437|7198334|FG002|Controlled Period|Other|3
4417787|NCT00307437|7198335|FG003|Controlled Period|Other|0
4417788|NCT00307437|7198336|FG004|Controlled Period|Other|0
4417789|NCT00307437|7198337|FG005|Controlled Period|Other|0
4417790|NCT00307437|7198338|FG006|Controlled Period|Other|0
4417791|NCT00307437|7198332|FG000|After Controlled Period|Adverse Event|0
4417792|NCT00307437|7198333|FG001|After Controlled Period|Adverse Event|0
4417793|NCT00307437|7198334|FG002|After Controlled Period|Adverse Event|0
4417794|NCT00307437|7198335|FG003|After Controlled Period|Adverse Event|18
4417795|NCT00307437|7198336|FG004|After Controlled Period|Adverse Event|16
4417796|NCT00307437|7198337|FG005|After Controlled Period|Adverse Event|31
4417797|NCT00307437|7198338|FG006|After Controlled Period|Adverse Event|40
4417798|NCT00307437|7198332|FG000|After Controlled Period|Death|0
4417799|NCT00307437|7198333|FG001|After Controlled Period|Death|0
4417800|NCT00307437|7198334|FG002|After Controlled Period|Death|0
4417801|NCT00307437|7198335|FG003|After Controlled Period|Death|3
4417802|NCT00307437|7198336|FG004|After Controlled Period|Death|1
4417803|NCT00307437|7198337|FG005|After Controlled Period|Death|1
4417804|NCT00307437|7198338|FG006|After Controlled Period|Death|3
4417805|NCT00307437|7198332|FG000|After Controlled Period|Lack of Efficacy|0
4417806|NCT00307437|7198333|FG001|After Controlled Period|Lack of Efficacy|0
4417807|NCT00307437|7198334|FG002|After Controlled Period|Lack of Efficacy|0
4417808|NCT00307437|7198335|FG003|After Controlled Period|Lack of Efficacy|15
4417809|NCT00307437|7198336|FG004|After Controlled Period|Lack of Efficacy|17
4417810|NCT00307437|7198337|FG005|After Controlled Period|Lack of Efficacy|37
4417811|NCT00307437|7198338|FG006|After Controlled Period|Lack of Efficacy|24
4417812|NCT00307437|7198332|FG000|After Controlled Period|Lost to Follow-up|0
4417813|NCT00307437|7198333|FG001|After Controlled Period|Lost to Follow-up|0
4417814|NCT00307437|7198334|FG002|After Controlled Period|Lost to Follow-up|0
4417815|NCT00307437|7198335|FG003|After Controlled Period|Lost to Follow-up|7
4417816|NCT00307437|7198336|FG004|After Controlled Period|Lost to Follow-up|12
4417817|NCT00307437|7198337|FG005|After Controlled Period|Lost to Follow-up|13
4417818|NCT00307437|7198338|FG006|After Controlled Period|Lost to Follow-up|18
4417819|NCT00307437|7198332|FG000|After Controlled Period|Other|0
4417820|NCT00307437|7198333|FG001|After Controlled Period|Other|0
4417821|NCT00307437|7198334|FG002|After Controlled Period|Other|0
4417822|NCT00307437|7198335|FG003|After Controlled Period|Other|15
4417823|NCT00307437|7198336|FG004|After Controlled Period|Other|9
4417824|NCT00307437|7198337|FG005|After Controlled Period|Other|40
4417825|NCT00307437|7198338|FG006|After Controlled Period|Other|28
4417826|NCT00307489|7198362|FG000|Baseline Through Week 48|Lost to Follow-up|0
4417827|NCT00307489|7198363|FG001|Baseline Through Week 48|Lost to Follow-up|1
4417828|NCT00307489|7198362|FG000|Baseline Through Week 48|Physician Decision|1
4417829|NCT00307489|7198363|FG001|Baseline Through Week 48|Physician Decision|0
4417830|NCT00307489|7198362|FG000|Baseline Through Week 48|Withdrawal by Subject|0
4417831|NCT00307489|7198363|FG001|Baseline Through Week 48|Withdrawal by Subject|1
4417832|NCT00307489|7198362|FG000|Week 48 Through Week 168|Adverse Event|1
4417833|NCT00307489|7198363|FG001|Week 48 Through Week 168|Adverse Event|0
4417834|NCT00307489|7198362|FG000|Week 48 Through Week 168|Physician Decision|1
4417835|NCT00307489|7198363|FG001|Week 48 Through Week 168|Physician Decision|0
4417836|NCT00307489|7198362|FG000|Week 48 Through Week 168|Withdrawal by Subject|1
4417837|NCT00307489|7198363|FG001|Week 48 Through Week 168|Withdrawal by Subject|2
4417838|NCT00307489|7198362|FG000|Week 48 Through Week 168|Lack of Efficacy|2
4417839|NCT00307489|7198363|FG001|Week 48 Through Week 168|Lack of Efficacy|2
4417840|NCT00307489|7198362|FG000|Week 48 Through Week 168|Death|0
4417841|NCT00307489|7198363|FG001|Week 48 Through Week 168|Death|1
4417842|NCT00307489|7198362|FG000|Week 48 Through Week 168|Lost to Follow-up|0
4417843|NCT00307489|7198363|FG001|Week 48 Through Week 168|Lost to Follow-up|1
4417844|NCT00307489|7198362|FG000|Week 48 Through Week 168|Seroconversion|1
4417845|NCT00307489|7198363|FG001|Week 48 Through Week 168|Seroconversion|0
4417846|NCT00307684|7198369|FG000|Open Label Phase|Lack of Efficacy|0
4417847|NCT00307684|7198370|FG001|Open Label Phase|Lack of Efficacy|0
4417848|NCT00307684|7198371|FG002|Open Label Phase|Lack of Efficacy|3
4417849|NCT00307684|7198369|FG000|Open Label Phase|Adverse Event|0
4417850|NCT00307684|7198370|FG001|Open Label Phase|Adverse Event|0
4417851|NCT00307684|7198371|FG002|Open Label Phase|Adverse Event|16
4417852|NCT00307684|7198369|FG000|Open Label Phase|Withdrawal by Subject|0
4417853|NCT00307684|7198370|FG001|Open Label Phase|Withdrawal by Subject|0
4417854|NCT00307684|7198371|FG002|Open Label Phase|Withdrawal by Subject|15
4417855|NCT00307684|7198369|FG000|Open Label Phase|Lost to Follow-up|0
4417856|NCT00307684|7198370|FG001|Open Label Phase|Lost to Follow-up|0
4417857|NCT00307684|7198371|FG002|Open Label Phase|Lost to Follow-up|11
4417858|NCT00307684|7198369|FG000|Open Label Phase|non compliance|0
4417859|NCT00307684|7198370|FG001|Open Label Phase|non compliance|0
4417860|NCT00307684|7198371|FG002|Open Label Phase|non compliance|5
4417861|NCT00307684|7198369|FG000|Open Label Phase|other|0
4417862|NCT00307684|7198370|FG001|Open Label Phase|other|0
4417863|NCT00307684|7198371|FG002|Open Label Phase|other|6
4417864|NCT00307684|7198369|FG000|Double Blind Phase|Lack of Efficacy|2
4417865|NCT00307684|7198370|FG001|Double Blind Phase|Lack of Efficacy|5
4417866|NCT00307684|7198371|FG002|Double Blind Phase|Lack of Efficacy|0
4417867|NCT00307736|7198379|FG000|Overall Study|Adverse Event|0
4417868|NCT00307736|7198380|FG001|Overall Study|Adverse Event|0
4417869|NCT00307736|7198381|FG002|Overall Study|Adverse Event|1
4417870|NCT00307736|7198382|FG003|Overall Study|Adverse Event|3
4417871|NCT00307736|7198379|FG000|Overall Study|Withdrawal by Subject|0
4417872|NCT00307736|7198380|FG001|Overall Study|Withdrawal by Subject|0
4417873|NCT00307736|7198381|FG002|Overall Study|Withdrawal by Subject|2
4417874|NCT00307736|7198382|FG003|Overall Study|Withdrawal by Subject|0
4417875|NCT00307801|7198395|FG000|Overall Study|Adverse Event|12
4417876|NCT00307801|7198396|FG001|Overall Study|Adverse Event|4
4417877|NCT00307801|7198395|FG000|Overall Study|Withdrawal by Subject|9
4417878|NCT00307801|7198396|FG001|Overall Study|Withdrawal by Subject|4
4417879|NCT00307801|7198395|FG000|Overall Study|Non-compliance, not taken all tablets|1
4417880|NCT00307801|7198396|FG001|Overall Study|Non-compliance, not taken all tablets|2
4417881|NCT00307801|7198395|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2
4417882|NCT00307801|7198396|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0
4417883|NCT00307801|7198395|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0
4417884|NCT00307801|7198396|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1
4417885|NCT00307801|7198395|FG000|Overall Study|Wrong Randomization|1
4417886|NCT00307801|7198396|FG001|Overall Study|Wrong Randomization|0
4417887|NCT00307801|7198395|FG000|Overall Study|Lack of Efficacy|0
4417888|NCT00307801|7198396|FG001|Overall Study|Lack of Efficacy|2
4417889|NCT00307801|7198395|FG000|Overall Study|Lost to Follow-up, moved abroad|1
4417890|NCT00307801|7198396|FG001|Overall Study|Lost to Follow-up, moved abroad|1
4417891|NCT00307801|7198395|FG000|Overall Study|Frustration with e-diary|1
4417892|NCT00307801|7198396|FG001|Overall Study|Frustration with e-diary|0
4417893|NCT00307801|7198395|FG000|Overall Study|Protocol Violation|3
4417894|NCT00307801|7198396|FG001|Overall Study|Protocol Violation|2
4417895|NCT00307801|7198395|FG000|Overall Study|No reason specified|2
4417896|NCT00307801|7198396|FG001|Overall Study|No reason specified|0
4417897|NCT00307801|7198395|FG000|Overall Study|Pregnancy|0
4417898|NCT00307801|7198396|FG001|Overall Study|Pregnancy|1
4417899|NCT00307931|7198403|FG000|Overall Study|Adverse Event|1
4417900|NCT00308074|7198417|FG000|Overall Study|Withdrawal by Subject|1
4417901|NCT00308087|7198423|FG000|Overall Study|Progressive Disease|19
4417902|NCT00308087|7198424|FG001|Overall Study|Progressive Disease|21
4417903|NCT00308087|7198423|FG000|Overall Study|Study Closure|11
4417904|NCT00308087|7198424|FG001|Overall Study|Study Closure|12
4417905|NCT00308087|7198423|FG000|Overall Study|Withdrawal by Subject|2
4417906|NCT00308087|7198424|FG001|Overall Study|Withdrawal by Subject|1
4417907|NCT00308087|7198423|FG000|Overall Study|Other|4
4417908|NCT00308087|7198424|FG001|Overall Study|Other|3
4512000|NCT00931385|7321559|FG003|Overall Study|Lost to Follow-up|1
4417909|NCT00308139|7198432|FG000|Overall Study|Adverse Event|20
4417910|NCT00308139|7198433|FG001|Overall Study|Adverse Event|14
4417911|NCT00308139|7198432|FG000|Overall Study|Lost to Follow-up|13
4417912|NCT00308139|7198433|FG001|Overall Study|Lost to Follow-up|8
4417913|NCT00308139|7198432|FG000|Overall Study|Protocol Violation|3
4417914|NCT00308139|7198433|FG001|Overall Study|Protocol Violation|2
4417915|NCT00308139|7198432|FG000|Overall Study|Withdrawal of Consent|40
4417916|NCT00308139|7198433|FG001|Overall Study|Withdrawal of Consent|42
4417917|NCT00308139|7198432|FG000|Overall Study|Investigator Decision|11
4417918|NCT00308139|7198433|FG001|Overall Study|Investigator Decision|10
4417919|NCT00308139|7198432|FG000|Overall Study|Loss of Glucose Control|5
4417920|NCT00308139|7198433|FG001|Overall Study|Loss of Glucose Control|7
4417921|NCT00308139|7198432|FG000|Overall Study|Administrative|1
4417922|NCT00308139|7198433|FG001|Overall Study|Administrative|4
4417923|NCT00308139|7198432|FG000|Overall Study|Other|1
4417924|NCT00308139|7198433|FG001|Overall Study|Other|0
4417925|NCT00308308|7198494|FG000|Overall Study|Adverse Event|17
4417926|NCT00308308|7198495|FG001|Overall Study|Adverse Event|2
4417927|NCT00308308|7198494|FG000|Overall Study|Lost to Follow-up|5
4417928|NCT00308308|7198495|FG001|Overall Study|Lost to Follow-up|5
4417929|NCT00308308|7198494|FG000|Overall Study|Physician Decision|15
4417930|NCT00308308|7198495|FG001|Overall Study|Physician Decision|7
4417931|NCT00308308|7198494|FG000|Overall Study|Protocol Violation|3
4417932|NCT00308308|7198495|FG001|Overall Study|Protocol Violation|14
4417933|NCT00308308|7198494|FG000|Overall Study|Withdrawal by Subject|47
4417934|NCT00308308|7198495|FG001|Overall Study|Withdrawal by Subject|19
4417935|NCT00308308|7198494|FG000|Overall Study|Various|7
4417936|NCT00308308|7198495|FG001|Overall Study|Various|5
4417937|NCT00308308|7198494|FG000|Overall Study|Randomized but not dosed|8
4417938|NCT00308308|7198495|FG001|Overall Study|Randomized but not dosed|16
4417939|NCT00308308|7198494|FG000|Overall Study|Other|1
4417940|NCT00308308|7198495|FG001|Overall Study|Other|0
4417941|NCT00308555|7198503|FG000|Overall Study|Withdrawal by Subject|1
4417942|NCT00308555|7198504|FG001|Overall Study|Withdrawal by Subject|0
4417943|NCT00308555|7198503|FG000|Overall Study|Physician Decision|2
4417944|NCT00308555|7198504|FG001|Overall Study|Physician Decision|0
4417945|NCT00308581|7198510|FG000|Induction Phase|Adverse Event|0
4417946|NCT00308581|7198511|FG001|Induction Phase|Adverse Event|0
4417947|NCT00308581|7198512|FG002|Induction Phase|Adverse Event|37
4417948|NCT00308581|7198510|FG000|Induction Phase|Lack of Efficacy|0
4417949|NCT00308581|7198511|FG001|Induction Phase|Lack of Efficacy|0
4417950|NCT00308581|7198512|FG002|Induction Phase|Lack of Efficacy|121
4417951|NCT00308581|7198510|FG000|Induction Phase|Withdrawal by Subject|0
4417952|NCT00308581|7198511|FG001|Induction Phase|Withdrawal by Subject|0
4417953|NCT00308581|7198512|FG002|Induction Phase|Withdrawal by Subject|5
4417954|NCT00308581|7198510|FG000|Induction Phase|Unknown reason|0
4417955|NCT00308581|7198511|FG001|Induction Phase|Unknown reason|0
4417956|NCT00308581|7198512|FG002|Induction Phase|Unknown reason|3
4417957|NCT00308581|7198510|FG000|Randomized Maintenance Phase|Adverse Event|10
4417958|NCT00308581|7198511|FG001|Randomized Maintenance Phase|Adverse Event|17
4417959|NCT00308581|7198512|FG002|Randomized Maintenance Phase|Adverse Event|0
4417960|NCT00308581|7198510|FG000|Randomized Maintenance Phase|Lack of Efficacy|9
4417961|NCT00308581|7198511|FG001|Randomized Maintenance Phase|Lack of Efficacy|21
4417962|NCT00308581|7198512|FG002|Randomized Maintenance Phase|Lack of Efficacy|0
4417963|NCT00308581|7198510|FG000|Randomized Maintenance Phase|Lost to Follow-up|0
4417964|NCT00308581|7198511|FG001|Randomized Maintenance Phase|Lost to Follow-up|2
4417965|NCT00308581|7198512|FG002|Randomized Maintenance Phase|Lost to Follow-up|0
4417966|NCT00308581|7198510|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1
4417967|NCT00308581|7198511|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4
4417968|NCT00308581|7198512|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0
4417969|NCT00308581|7198510|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82
4417970|NCT00308581|7198511|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59
4417971|NCT00308581|7198512|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0
4417972|NCT00308581|7198510|FG000|Randomized Maintenance Phase|Unknown reason|3
4417973|NCT00308581|7198511|FG001|Randomized Maintenance Phase|Unknown reason|0
4417974|NCT00308581|7198512|FG002|Randomized Maintenance Phase|Unknown reason|0
4417975|NCT00308620|7198523|FG000|Overall Study|Death|1
4417976|NCT00308620|7198524|FG001|Overall Study|Death|1
4417977|NCT00308620|7198525|FG002|Overall Study|Death|0
4417978|NCT00308620|7198523|FG000|Overall Study|Lost to Follow-up|0
4417979|NCT00308620|7198524|FG001|Overall Study|Lost to Follow-up|0
4417980|NCT00308620|7198525|FG002|Overall Study|Lost to Follow-up|1
4417981|NCT00308711|7198536|FG000|Overall Study|Withdrawal by Subject|1
4417982|NCT00308711|7198537|FG001|Overall Study|Withdrawal by Subject|0
4417983|NCT00308711|7198538|FG002|Overall Study|Withdrawal by Subject|1
4417984|NCT00308711|7198536|FG000|Overall Study|Protocol Violation|0
4417985|NCT00308711|7198537|FG001|Overall Study|Protocol Violation|1
4417986|NCT00308711|7198538|FG002|Overall Study|Protocol Violation|1
4417987|NCT00308711|7198536|FG000|Overall Study|Lost to Follow-up|0
4417988|NCT00308711|7198537|FG001|Overall Study|Lost to Follow-up|1
4714902|NCT02963922|7642930|FG000|Overall Study|Lost to Follow-up|2
4714903|NCT02963922|7642931|FG001|Overall Study|Lost to Follow-up|3
4417989|NCT00308711|7198538|FG002|Overall Study|Lost to Follow-up|0
4417990|NCT00308711|7198536|FG000|Overall Study|Baby not born within 7 days of treatment|1
4417991|NCT00308711|7198537|FG001|Overall Study|Baby not born within 7 days of treatment|2
4417992|NCT00308711|7198538|FG002|Overall Study|Baby not born within 7 days of treatment|2
4417993|NCT00308711|7198536|FG000|Overall Study|Subject incarcerated, data not allowed|0
4417994|NCT00308711|7198537|FG001|Overall Study|Subject incarcerated, data not allowed|0
4417995|NCT00308711|7198538|FG002|Overall Study|Subject incarcerated, data not allowed|1
4417996|NCT00308737|7198549|FG000|Overall Study|Adverse Event|104
4417997|NCT00308737|7198550|FG001|Overall Study|Adverse Event|9
4417998|NCT00308737|7198551|FG002|Overall Study|Adverse Event|0
4417999|NCT00308737|7198549|FG000|Overall Study|Death|4
4418000|NCT00308737|7198550|FG001|Overall Study|Death|3
4418001|NCT00308737|7198551|FG002|Overall Study|Death|0
4418002|NCT00308737|7198549|FG000|Overall Study|Lost to Follow-up|56
4418003|NCT00308737|7198550|FG001|Overall Study|Lost to Follow-up|80
4418004|NCT00308737|7198551|FG002|Overall Study|Lost to Follow-up|5
4418005|NCT00308737|7198549|FG000|Overall Study|Physician Decision|15
4418006|NCT00308737|7198550|FG001|Overall Study|Physician Decision|2
4418007|NCT00308737|7198551|FG002|Overall Study|Physician Decision|1
4418008|NCT00308737|7198549|FG000|Overall Study|Protocol Violation|34
4418009|NCT00308737|7198550|FG001|Overall Study|Protocol Violation|9
4418010|NCT00308737|7198551|FG002|Overall Study|Protocol Violation|5
4418011|NCT00308737|7198549|FG000|Overall Study|Withdrawal by Subject|218
4418012|NCT00308737|7198550|FG001|Overall Study|Withdrawal by Subject|166
4418013|NCT00308737|7198551|FG002|Overall Study|Withdrawal by Subject|18
4418014|NCT00308737|7198549|FG000|Overall Study|Various|32
4418015|NCT00308737|7198550|FG001|Overall Study|Various|20
4418016|NCT00308737|7198551|FG002|Overall Study|Various|8
4418017|NCT00308750|7198562|FG000|Overall Study|Adverse Event|9
4418018|NCT00308750|7198563|FG001|Overall Study|Adverse Event|9
4418019|NCT00308750|7198564|FG002|Overall Study|Adverse Event|13
4418020|NCT00308750|7198562|FG000|Overall Study|Withdrawal by Subject|6
4418021|NCT00308750|7198563|FG001|Overall Study|Withdrawal by Subject|2
4418022|NCT00308750|7198564|FG002|Overall Study|Withdrawal by Subject|3
4418023|NCT00308750|7198562|FG000|Overall Study|Physician Decision|3
4418024|NCT00308750|7198563|FG001|Overall Study|Physician Decision|4
4418025|NCT00308750|7198564|FG002|Overall Study|Physician Decision|3
4418026|NCT00308750|7198562|FG000|Overall Study|Sponsor Decision|1
4418027|NCT00308750|7198563|FG001|Overall Study|Sponsor Decision|0
4418028|NCT00308750|7198564|FG002|Overall Study|Sponsor Decision|0
4418029|NCT00308750|7198562|FG000|Overall Study|Disease Progression|47
4418030|NCT00308750|7198563|FG001|Overall Study|Disease Progression|24
4418031|NCT00308750|7198564|FG002|Overall Study|Disease Progression|28
4418032|NCT00308750|7198562|FG000|Overall Study|Unrelated Complication|3
4418033|NCT00308750|7198563|FG001|Overall Study|Unrelated Complication|0
4418034|NCT00308750|7198564|FG002|Overall Study|Unrelated Complication|1
4418035|NCT00308750|7198562|FG000|Overall Study|Death|1
4418036|NCT00308750|7198563|FG001|Overall Study|Death|0
4418037|NCT00308750|7198564|FG002|Overall Study|Death|1
4418038|NCT00308750|7198562|FG000|Overall Study|Protocol Violation|1
4418039|NCT00308750|7198563|FG001|Overall Study|Protocol Violation|0
4418040|NCT00308750|7198564|FG002|Overall Study|Protocol Violation|0
4418041|NCT00308750|7198562|FG000|Overall Study|New Primary Disease Identified|1
4418042|NCT00308750|7198563|FG001|Overall Study|New Primary Disease Identified|1
4418043|NCT00308750|7198564|FG002|Overall Study|New Primary Disease Identified|0
4418044|NCT00308997|7198575|FG000|Overall Study|Subject feigned clinical data|0
4418045|NCT00308997|7198576|FG001|Overall Study|Subject feigned clinical data|1
4418046|NCT00308997|7198575|FG000|Overall Study|Unable to tolerate intervention|1
4418047|NCT00308997|7198576|FG001|Overall Study|Unable to tolerate intervention|0
4418048|NCT00309166|7198588|FG000|Overall Study|Adverse event, non-fatal|1
4418049|NCT00309166|7198589|FG001|Overall Study|Adverse event, non-fatal|0
4418050|NCT00309166|7198588|FG000|Overall Study|Withdrawal by Subject|4
4418051|NCT00309166|7198589|FG001|Overall Study|Withdrawal by Subject|3
4418052|NCT00309244|7198597|FG000|Overall Study|Adverse Event|29
4418053|NCT00309244|7198598|FG001|Overall Study|Adverse Event|12
4418054|NCT00309244|7198597|FG000|Overall Study|Lost to Follow-up|6
4418055|NCT00309244|7198598|FG001|Overall Study|Lost to Follow-up|22
4418056|NCT00309244|7198597|FG000|Overall Study|Physician Decision|5
4418057|NCT00309244|7198598|FG001|Overall Study|Physician Decision|8
4418058|NCT00309244|7198597|FG000|Overall Study|Protocol Violation|6
4418059|NCT00309244|7198598|FG001|Overall Study|Protocol Violation|3
4418060|NCT00309244|7198597|FG000|Overall Study|Withdrawal by Subject|50
4418061|NCT00309244|7198598|FG001|Overall Study|Withdrawal by Subject|32
4418062|NCT00309244|7198597|FG000|Overall Study|Various|7
4418063|NCT00309244|7198598|FG001|Overall Study|Various|7
4418064|NCT00309244|7198597|FG000|Overall Study|Randomized but not dosed|11
4418065|NCT00309244|7198598|FG001|Overall Study|Randomized but not dosed|12
4418066|NCT00309244|7198597|FG000|Overall Study|Death|4
4418067|NCT00309244|7198598|FG001|Overall Study|Death|1
4418068|NCT00309387|7198606|FG000|Overall Study|Death|72
4418069|NCT00309387|7198607|FG001|Overall Study|Death|73
4418070|NCT00309387|7198606|FG000|Overall Study|Lost to Follow-up|70
4418071|NCT00309387|7198607|FG001|Overall Study|Lost to Follow-up|86
4418072|NCT00309452|7198616|FG000|Overall Study|Withdrawal by Subject|3
4418073|NCT00309452|7198617|FG001|Overall Study|Withdrawal by Subject|0
4418074|NCT00309608|7198653|FG000|Overall Study|Adverse Event|1
4418075|NCT00309608|7198654|FG001|Overall Study|Adverse Event|5
4418076|NCT00309608|7198655|FG002|Overall Study|Adverse Event|3
4418077|NCT00309608|7198656|FG003|Overall Study|Adverse Event|2
4418078|NCT00309608|7198657|FG004|Overall Study|Adverse Event|3
4418079|NCT00309608|7198653|FG000|Overall Study|Protocol Violation|2
4418080|NCT00309608|7198654|FG001|Overall Study|Protocol Violation|0
4418081|NCT00309608|7198655|FG002|Overall Study|Protocol Violation|0
4418082|NCT00309608|7198656|FG003|Overall Study|Protocol Violation|0
4418083|NCT00309608|7198657|FG004|Overall Study|Protocol Violation|0
4418084|NCT00309608|7198653|FG000|Overall Study|Lost to Follow-up|0
4418085|NCT00309608|7198654|FG001|Overall Study|Lost to Follow-up|0
4418086|NCT00309608|7198655|FG002|Overall Study|Lost to Follow-up|2
4418087|NCT00309608|7198656|FG003|Overall Study|Lost to Follow-up|0
4418088|NCT00309608|7198657|FG004|Overall Study|Lost to Follow-up|1
4418089|NCT00309608|7198653|FG000|Overall Study|Withdrawal by Subject|1
4418090|NCT00309608|7198654|FG001|Overall Study|Withdrawal by Subject|4
4418091|NCT00309608|7198655|FG002|Overall Study|Withdrawal by Subject|2
4418092|NCT00309608|7198656|FG003|Overall Study|Withdrawal by Subject|0
4418093|NCT00309608|7198657|FG004|Overall Study|Withdrawal by Subject|0
4418094|NCT00309608|7198653|FG000|Overall Study|Other incl. Lack of efficacy|10
4418095|NCT00309608|7198654|FG001|Overall Study|Other incl. Lack of efficacy|4
4418096|NCT00309608|7198655|FG002|Overall Study|Other incl. Lack of efficacy|3
4418097|NCT00309608|7198656|FG003|Overall Study|Other incl. Lack of efficacy|4
4418098|NCT00309608|7198657|FG004|Overall Study|Other incl. Lack of efficacy|0
4418099|NCT00309777|7198691|FG000|Overall Study|Adverse Event|13
4418100|NCT00309777|7198692|FG001|Overall Study|Adverse Event|2
4418101|NCT00309777|7198693|FG002|Overall Study|Adverse Event|8
4418102|NCT00309777|7198694|FG003|Overall Study|Adverse Event|1
4418103|NCT00309777|7198691|FG000|Overall Study|Protocol Violation|4
4418104|NCT00309777|7198692|FG001|Overall Study|Protocol Violation|1
4418105|NCT00309777|7198693|FG002|Overall Study|Protocol Violation|3
4418106|NCT00309777|7198694|FG003|Overall Study|Protocol Violation|1
4418107|NCT00309777|7198691|FG000|Overall Study|Withdrawal by Subject|6
4418108|NCT00309777|7198692|FG001|Overall Study|Withdrawal by Subject|5
4418109|NCT00309777|7198693|FG002|Overall Study|Withdrawal by Subject|7
4418110|NCT00309777|7198694|FG003|Overall Study|Withdrawal by Subject|2
4418111|NCT00309777|7198691|FG000|Overall Study|Lost to Follow-up|0
4418112|NCT00309777|7198692|FG001|Overall Study|Lost to Follow-up|0
4418113|NCT00309777|7198693|FG002|Overall Study|Lost to Follow-up|1
4418114|NCT00309777|7198694|FG003|Overall Study|Lost to Follow-up|0
4418115|NCT00309777|7198691|FG000|Overall Study|Death|0
4418116|NCT00309777|7198692|FG001|Overall Study|Death|1
4418117|NCT00309777|7198693|FG002|Overall Study|Death|0
4418118|NCT00309777|7198694|FG003|Overall Study|Death|0
4418119|NCT00309842|7198704|FG000|Overall Study|Lost to Follow-up|1
4418120|NCT00309907|7198708|FG000|Overall Study|Death|4
4418121|NCT00309907|7198708|FG000|Overall Study|Physician Decision|1
4418122|NCT00309907|7198708|FG000|Overall Study|Ineligible|11
4418123|NCT00309907|7198708|FG000|Overall Study|Major infectious event|4
4418124|NCT00309946|7198713|FG000|Overall Study|Withdrawal by Subject|1
4418125|NCT00309959|7198717|FG000|Overall Study|Ineligible - no prior chemotherapy|2
4418126|NCT00310037|7198728|FG000|Overall Study|Adverse Event|7
4418127|NCT00310037|7198729|FG001|Overall Study|Adverse Event|14
4418128|NCT00310037|7198728|FG000|Overall Study|Withdrawal by Subject|4
4418129|NCT00310037|7198729|FG001|Overall Study|Withdrawal by Subject|3
4418130|NCT00310037|7198728|FG000|Overall Study|Progression|6
4418131|NCT00310037|7198729|FG001|Overall Study|Progression|0
4418132|NCT00310037|7198728|FG000|Overall Study|Non-protocol treatment|1
4418133|NCT00310037|7198729|FG001|Overall Study|Non-protocol treatment|0
4418134|NCT00310375|7198773|FG000|Primary Reporting Phase|Adverse Event|28
4418135|NCT00310375|7198774|FG001|Primary Reporting Phase|Adverse Event|22
4418136|NCT00310375|7198775|FG002|Primary Reporting Phase|Adverse Event|0
4418137|NCT00310375|7198773|FG000|Primary Reporting Phase|Lack of Efficacy|24
4418138|NCT00310375|7198774|FG001|Primary Reporting Phase|Lack of Efficacy|19
4418139|NCT00310375|7198775|FG002|Primary Reporting Phase|Lack of Efficacy|0
4418140|NCT00310375|7198773|FG000|Primary Reporting Phase|Pregnancy|2
4418141|NCT00310375|7198774|FG001|Primary Reporting Phase|Pregnancy|2
4418142|NCT00310375|7198775|FG002|Primary Reporting Phase|Pregnancy|0
4418143|NCT00310375|7198773|FG000|Primary Reporting Phase|Withdrawal by Subject|10
4418144|NCT00310375|7198774|FG001|Primary Reporting Phase|Withdrawal by Subject|7
4418145|NCT00310375|7198775|FG002|Primary Reporting Phase|Withdrawal by Subject|0
4418146|NCT00310375|7198773|FG000|Primary Reporting Phase|Protocol Violation|8
4418147|NCT00310375|7198774|FG001|Primary Reporting Phase|Protocol Violation|5
4418148|NCT00310375|7198775|FG002|Primary Reporting Phase|Protocol Violation|0
4418149|NCT00310375|7198773|FG000|Primary Reporting Phase|Change in Par medical condition|2
4418150|NCT00310375|7198774|FG001|Primary Reporting Phase|Change in Par medical condition|0
4418151|NCT00310375|7198775|FG002|Primary Reporting Phase|Change in Par medical condition|0
4418152|NCT00310375|7198773|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2
4418153|NCT00310375|7198774|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1
4418154|NCT00310375|7198775|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0
4418155|NCT00310375|7198773|FG000|Primary Reporting Phase|Physician Decision|5
4418156|NCT00310375|7198774|FG001|Primary Reporting Phase|Physician Decision|3
4418157|NCT00310375|7198775|FG002|Primary Reporting Phase|Physician Decision|0
4418158|NCT00310375|7198773|FG000|Primary Reporting Phase|Request of the sponsor|2
4418159|NCT00310375|7198774|FG001|Primary Reporting Phase|Request of the sponsor|2
4418160|NCT00310375|7198775|FG002|Primary Reporting Phase|Request of the sponsor|0
4629431|NCT01872611|7497395|FG000|Overall Study|Death, prior to treatment|0
4629432|NCT01872611|7497396|FG001|Overall Study|Death, prior to treatment|1
4629433|NCT01872611|7497395|FG000|Overall Study|Lost to Follow-up|8
4629434|NCT01872611|7497396|FG001|Overall Study|Lost to Follow-up|1
4629435|NCT01872611|7497395|FG000|Overall Study|Physician Decision|1
4418161|NCT00310375|7198773|FG000|Primary Reporting Phase|Failed to return|1
4418162|NCT00310375|7198774|FG001|Primary Reporting Phase|Failed to return|3
4629436|NCT01872611|7497396|FG001|Overall Study|Physician Decision|0
4629437|NCT01872611|7497395|FG000|Overall Study|Withdrawal by Subject|6
4629438|NCT01872611|7497396|FG001|Overall Study|Withdrawal by Subject|1
4629439|NCT01872611|7497395|FG000|Overall Study|Reason not provided|6
4629440|NCT01872611|7497396|FG001|Overall Study|Reason not provided|6
4629441|NCT01872689|7497408|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0
4629442|NCT01872689|7497409|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1
4629443|NCT01872689|7497410|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0
4418163|NCT00310375|7198775|FG002|Primary Reporting Phase|Failed to return|0
4418164|NCT00310375|7198773|FG000|Primary Reporting Phase|Participant request unrelated to study|1
4418165|NCT00310375|7198774|FG001|Primary Reporting Phase|Participant request unrelated to study|2
4418166|NCT00310375|7198775|FG002|Primary Reporting Phase|Participant request unrelated to study|0
4418167|NCT00310375|7198773|FG000|Primary Reporting Phase|Going for temporal lobectomy|1
4418168|NCT00310375|7198774|FG001|Primary Reporting Phase|Going for temporal lobectomy|0
4418169|NCT00310375|7198775|FG002|Primary Reporting Phase|Going for temporal lobectomy|0
4418170|NCT00310375|7198773|FG000|Primary Reporting Phase|Missed study drug >5 days|1
4418171|NCT00310375|7198774|FG001|Primary Reporting Phase|Missed study drug >5 days|0
4418172|NCT00310375|7198775|FG002|Primary Reporting Phase|Missed study drug >5 days|0
4418173|NCT00310375|7198773|FG000|Primary Reporting Phase|Site closure|3
4418174|NCT00310375|7198774|FG001|Primary Reporting Phase|Site closure|0
4418175|NCT00310375|7198775|FG002|Primary Reporting Phase|Site closure|0
4418176|NCT00310375|7198773|FG000|Primary Reporting Phase|Missed study drug for 2 months|1
4418177|NCT00310375|7198774|FG001|Primary Reporting Phase|Missed study drug for 2 months|0
4418178|NCT00310375|7198775|FG002|Primary Reporting Phase|Missed study drug for 2 months|0
4418179|NCT00310375|7198773|FG000|Primary Reporting Phase|Par. switched to commercial product|0
4418180|NCT00310375|7198774|FG001|Primary Reporting Phase|Par. switched to commercial product|1
4418181|NCT00310375|7198775|FG002|Primary Reporting Phase|Par. switched to commercial product|0
4418182|NCT00310375|7198773|FG000|Primary Reporting Phase|Request of Ethics Committee|0
4418183|NCT00310375|7198774|FG001|Primary Reporting Phase|Request of Ethics Committee|1
4418184|NCT00310375|7198775|FG002|Primary Reporting Phase|Request of Ethics Committee|0
4418185|NCT00310375|7198773|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0
4418186|NCT00310375|7198774|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0
4418187|NCT00310375|7198775|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1
4418188|NCT00310440|7198806|FG000|Overall Study|Lost to Follow-up|17
4418189|NCT00310440|7198807|FG001|Overall Study|Lost to Follow-up|8
4418190|NCT00310440|7198806|FG000|Overall Study|Withdrawal by Subject|2
4418191|NCT00310440|7198807|FG001|Overall Study|Withdrawal by Subject|1
4418192|NCT00310440|7198806|FG000|Overall Study|Missed 12 Month Visit|7
4418193|NCT00310440|7198807|FG001|Overall Study|Missed 12 Month Visit|4
4418194|NCT00310804|7198833|FG000|Overall Study|Lost to Follow-up|2
4418195|NCT00310804|7198834|FG001|Overall Study|Lost to Follow-up|0
4418196|NCT00310804|7198833|FG000|Overall Study|Withdrawal by Subject|3
4418197|NCT00310804|7198834|FG001|Overall Study|Withdrawal by Subject|0
4418198|NCT00310817|7198858|FG000|Overall Study|AE or Death|3
4418199|NCT00310817|7198859|FG001|Overall Study|AE or Death|1
4418200|NCT00310817|7198860|FG002|Overall Study|AE or Death|0
4418201|NCT00310817|7198861|FG003|Overall Study|AE or Death|0
4418202|NCT00310817|7198858|FG000|Overall Study|Withdrawal by Subject|1
4418203|NCT00310817|7198859|FG001|Overall Study|Withdrawal by Subject|4
4418204|NCT00310817|7198860|FG002|Overall Study|Withdrawal by Subject|6
4418205|NCT00310817|7198861|FG003|Overall Study|Withdrawal by Subject|7
4418206|NCT00310817|7198858|FG000|Overall Study|Lost to Follow-up|2
4418207|NCT00310817|7198859|FG001|Overall Study|Lost to Follow-up|1
4418208|NCT00310817|7198860|FG002|Overall Study|Lost to Follow-up|0
4418209|NCT00310817|7198861|FG003|Overall Study|Lost to Follow-up|0
4418210|NCT00310817|7198858|FG000|Overall Study|Inappropriate Enrollment|1
4418211|NCT00310817|7198859|FG001|Overall Study|Inappropriate Enrollment|0
4418212|NCT00310817|7198860|FG002|Overall Study|Inappropriate Enrollment|1
4418213|NCT00310817|7198861|FG003|Overall Study|Inappropriate Enrollment|0
4418214|NCT00310817|7198858|FG000|Overall Study|Protocol Violation|1
4418215|NCT00310817|7198859|FG001|Overall Study|Protocol Violation|1
4418216|NCT00310817|7198860|FG002|Overall Study|Protocol Violation|1
4418217|NCT00310817|7198861|FG003|Overall Study|Protocol Violation|1
4418218|NCT00310817|7198858|FG000|Overall Study|Unable to classify|3
4418219|NCT00310817|7198859|FG001|Overall Study|Unable to classify|1
4418220|NCT00310817|7198860|FG002|Overall Study|Unable to classify|0
4418221|NCT00310817|7198861|FG003|Overall Study|Unable to classify|0
4418222|NCT00310856|7198907|FG000|Overall Study|Withdrawal by Subject|2
4418223|NCT00310856|7198908|FG001|Overall Study|Withdrawal by Subject|2
4418224|NCT00310856|7198909|FG002|Overall Study|Withdrawal by Subject|2
4418225|NCT00310856|7198907|FG000|Overall Study|Lost to Follow-up|1
4418226|NCT00310856|7198908|FG001|Overall Study|Lost to Follow-up|2
4418227|NCT00310856|7198909|FG002|Overall Study|Lost to Follow-up|6
4418228|NCT00310856|7198907|FG000|Overall Study|Inappropriate enrollment|1
4418229|NCT00310856|7198908|FG001|Overall Study|Inappropriate enrollment|1
4418230|NCT00310856|7198909|FG002|Overall Study|Inappropriate enrollment|0
4418231|NCT00310856|7198907|FG000|Overall Study|Unable to classify|1
4418232|NCT00310856|7198908|FG001|Overall Study|Unable to classify|0
4418233|NCT00310856|7198909|FG002|Overall Study|Unable to classify|0
4629444|NCT01872689|7497411|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0
4418234|NCT00311155|7198918|FG000|Overall Study|Adverse Event|21
4418235|NCT00311155|7198918|FG000|Overall Study|Withdrawal by Subject|17
4418236|NCT00311155|7198918|FG000|Overall Study|Did not meet entry criteria|55
4418237|NCT00311168|7198924|FG000|First Intervention|Withdrawal by Subject|2
4418238|NCT00311168|7198925|FG001|First Intervention|Withdrawal by Subject|2
4418239|NCT00311168|7198924|FG000|First Intervention|Lost to Follow-up|1
4418240|NCT00311168|7198925|FG001|First Intervention|Lost to Follow-up|1
4418241|NCT00311168|7198924|FG000|First Intervention|Protocol Violation|1
4418242|NCT00311168|7198925|FG001|First Intervention|Protocol Violation|1
4418243|NCT00311168|7198924|FG000|First Intervention|Adverse Event|1
4418244|NCT00311168|7198925|FG001|First Intervention|Adverse Event|0
4418245|NCT00311168|7198924|FG000|First Intervention|Other|2
4418246|NCT00311168|7198925|FG001|First Intervention|Other|2
4629445|NCT01872689|7497408|FG000|Double-Blind/Placebo-Controlled Period|Other|1
4629446|NCT01872689|7497409|FG001|Double-Blind/Placebo-Controlled Period|Other|1
4629447|NCT01872689|7497410|FG002|Double-Blind/Placebo-Controlled Period|Other|6
4629448|NCT01872689|7497411|FG003|Double-Blind/Placebo-Controlled Period|Other|3
4629449|NCT01872689|7497408|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9
4629450|NCT01872689|7497409|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8
4629451|NCT01872689|7497410|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14
4629452|NCT01872689|7497411|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16
4629453|NCT01872689|7497408|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0
4418247|NCT00311168|7198924|FG000|Second Intervention|Lost to Follow-up|9
4418248|NCT00311168|7198925|FG001|Second Intervention|Lost to Follow-up|2
4418249|NCT00311168|7198924|FG000|Second Intervention|Withdrawal by Subject|0
4418250|NCT00311168|7198925|FG001|Second Intervention|Withdrawal by Subject|1
4418251|NCT00311168|7198924|FG000|Second Intervention|Other|1
4418252|NCT00311168|7198925|FG001|Second Intervention|Other|1
4418253|NCT00311181|7198933|FG000|Overall Study|Final DFTs were not obtained|96
4418254|NCT00311311|7198946|FG000|Overall Study|Adverse Event|3
4418255|NCT00311311|7198947|FG001|Overall Study|Adverse Event|2
4418256|NCT00311311|7198946|FG000|Overall Study|Withdrawal by Subject|1
4418257|NCT00311311|7198947|FG001|Overall Study|Withdrawal by Subject|1
4418258|NCT00311311|7198946|FG000|Overall Study|Noncompliance|0
4418259|NCT00311311|7198947|FG001|Overall Study|Noncompliance|1
4418260|NCT00311311|7198946|FG000|Overall Study|Study Termination by Sponsor|3
4418261|NCT00311311|7198947|FG001|Overall Study|Study Termination by Sponsor|4
4418262|NCT00311311|7198946|FG000|Overall Study|Death|1
4418263|NCT00311311|7198947|FG001|Overall Study|Death|0
4418264|NCT00311311|7198946|FG000|Overall Study|Lack of ancillary assistance|0
4418265|NCT00311311|7198947|FG001|Overall Study|Lack of ancillary assistance|1
4418266|NCT00311363|7198956|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42
4418267|NCT00311363|7198957|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0
4418268|NCT00311363|7198958|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0
4418269|NCT00311363|7198956|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13
4418270|NCT00311363|7198957|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0
4418271|NCT00311363|7198958|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0
4418272|NCT00311363|7198956|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27
4418273|NCT00311363|7198957|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0
4418274|NCT00311363|7198958|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0
4418275|NCT00311363|7198956|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12
4418276|NCT00311363|7198957|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0
4418277|NCT00311363|7198958|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0
4418278|NCT00311363|7198956|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8
4418279|NCT00311363|7198957|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0
4418280|NCT00311363|7198958|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0
4418281|NCT00311363|7198956|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1
4418282|NCT00311363|7198957|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0
4418283|NCT00311363|7198958|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0
4418284|NCT00311363|7198956|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1
4418285|NCT00311363|7198957|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0
4418286|NCT00311363|7198958|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0
4418287|NCT00311363|7198956|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1
4418288|NCT00311363|7198957|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0
4418289|NCT00311363|7198958|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0
4418290|NCT00311363|7198956|FG000|24-Week Single-Blind Treatment Period|Death|1
4418291|NCT00311363|7198957|FG001|24-Week Single-Blind Treatment Period|Death|0
4418292|NCT00311363|7198958|FG002|24-Week Single-Blind Treatment Period|Death|0
4418293|NCT00311363|7198956|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0
4418294|NCT00311363|7198957|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3
4418295|NCT00311363|7198958|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0
4418296|NCT00311363|7198956|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0
4418297|NCT00311363|7198957|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1
4418298|NCT00311363|7198958|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2
4629454|NCT01872689|7497409|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0
4418299|NCT00311363|7198956|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0
4418300|NCT00311363|7198957|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6
4418301|NCT00311363|7198958|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4
4418302|NCT00311363|7198956|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0
4418303|NCT00311363|7198957|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2
4418304|NCT00311363|7198958|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4
4418305|NCT00311363|7198956|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0
4418306|NCT00311363|7198957|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1
4418307|NCT00311363|7198958|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2
4418308|NCT00311363|7198956|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0
4418309|NCT00311363|7198957|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1
4418310|NCT00311363|7198958|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0
4418311|NCT00311402|7198983|FG000|Overall Study|Adverse Event|118
4418312|NCT00311402|7198984|FG001|Overall Study|Adverse Event|105
4418313|NCT00311402|7198983|FG000|Overall Study|Lost to Follow-up|0
4418314|NCT00311402|7198984|FG001|Overall Study|Lost to Follow-up|3
4418315|NCT00311402|7198983|FG000|Overall Study|Withdrawal by Subject|17
4418316|NCT00311402|7198984|FG001|Overall Study|Withdrawal by Subject|18
4418317|NCT00311402|7198983|FG000|Overall Study|Lack of Efficacy|58
4418318|NCT00311402|7198984|FG001|Overall Study|Lack of Efficacy|42
4418319|NCT00311402|7198983|FG000|Overall Study|Protocol Violation|7
4418320|NCT00311402|7198984|FG001|Overall Study|Protocol Violation|6
4418321|NCT00311402|7198983|FG000|Overall Study|IRB's rejection etc.|10
4418322|NCT00311402|7198984|FG001|Overall Study|IRB's rejection etc.|3
4418323|NCT00311584|7198992|FG000|Overall Study|Death|1
4418324|NCT00311584|7198993|FG001|Overall Study|Death|0
4418325|NCT00311584|7198992|FG000|Overall Study|Lack of Efficacy|12
4418326|NCT00311584|7198993|FG001|Overall Study|Lack of Efficacy|15
4418327|NCT00311584|7198992|FG000|Overall Study|Physician Decision|4
4418328|NCT00311584|7198993|FG001|Overall Study|Physician Decision|5
4418329|NCT00311584|7198992|FG000|Overall Study|Withdrawal by Subject|1
4418330|NCT00311584|7198993|FG001|Overall Study|Withdrawal by Subject|1
4418331|NCT00311584|7198992|FG000|Overall Study|ineligible|2
4418332|NCT00311584|7198993|FG001|Overall Study|ineligible|2
4418333|NCT00311623|7199002|FG000|Overall Study|Physician Decision|0
4418334|NCT00311623|7199003|FG001|Overall Study|Physician Decision|0
4418335|NCT00311623|7199004|FG002|Overall Study|Physician Decision|2
4418336|NCT00312195|7199024|FG000|Overall Study|Adverse Event|4
4418337|NCT00312195|7199025|FG001|Overall Study|Adverse Event|6
4418338|NCT00312195|7199024|FG000|Overall Study|Lost to Follow-up|1
4418339|NCT00312195|7199025|FG001|Overall Study|Lost to Follow-up|0
4418340|NCT00312195|7199024|FG000|Overall Study|Protocol Violation|1
4418341|NCT00312195|7199025|FG001|Overall Study|Protocol Violation|0
4418342|NCT00312208|7199035|FG000|Overall Study|Adverse Event|97
4418343|NCT00312208|7199036|FG001|Overall Study|Adverse Event|61
4418344|NCT00312208|7199035|FG000|Overall Study|Protocol Violation|5
4418345|NCT00312208|7199036|FG001|Overall Study|Protocol Violation|3
4418346|NCT00312208|7199035|FG000|Overall Study|Death|2
4418347|NCT00312208|7199036|FG001|Overall Study|Death|1
4418348|NCT00312208|7199035|FG000|Overall Study|Lack of Efficacy|7
4418349|NCT00312208|7199036|FG001|Overall Study|Lack of Efficacy|4
4418350|NCT00312208|7199035|FG000|Overall Study|Lost to Follow-up|3
4418351|NCT00312208|7199036|FG001|Overall Study|Lost to Follow-up|5
4418352|NCT00312208|7199035|FG000|Overall Study|Withdrawal by Subject|53
4418353|NCT00312208|7199036|FG001|Overall Study|Withdrawal by Subject|42
4418354|NCT00312208|7199035|FG000|Overall Study|Other|5
4418355|NCT00312208|7199036|FG001|Overall Study|Other|7
4418356|NCT00312221|7199045|FG000|Open-label Run-in Period|Withdrawal by Subject|6
4418357|NCT00312221|7199046|FG001|Open-label Run-in Period|Withdrawal by Subject|0
4418358|NCT00312221|7199047|FG002|Open-label Run-in Period|Withdrawal by Subject|0
4418359|NCT00312221|7199048|FG003|Open-label Run-in Period|Withdrawal by Subject|0
4418360|NCT00312221|7199045|FG000|Open-label Run-in Period|Adverse Event|74
4418361|NCT00312221|7199046|FG001|Open-label Run-in Period|Adverse Event|0
4418362|NCT00312221|7199047|FG002|Open-label Run-in Period|Adverse Event|0
4418363|NCT00312221|7199048|FG003|Open-label Run-in Period|Adverse Event|0
4418364|NCT00312221|7199045|FG000|Open-label Run-in Period|Lost to Follow-up|5
4418365|NCT00312221|7199046|FG001|Open-label Run-in Period|Lost to Follow-up|0
4418366|NCT00312221|7199047|FG002|Open-label Run-in Period|Lost to Follow-up|0
4418367|NCT00312221|7199048|FG003|Open-label Run-in Period|Lost to Follow-up|0
4418368|NCT00312221|7199045|FG000|Open-label Run-in Period|Administrative|42
4418369|NCT00312221|7199046|FG001|Open-label Run-in Period|Administrative|0
4418370|NCT00312221|7199047|FG002|Open-label Run-in Period|Administrative|0
4418371|NCT00312221|7199048|FG003|Open-label Run-in Period|Administrative|0
4418372|NCT00312221|7199045|FG000|Open-label Run-in Period|Lack of Efficacy|102
4418373|NCT00312221|7199046|FG001|Open-label Run-in Period|Lack of Efficacy|0
4418374|NCT00312221|7199047|FG002|Open-label Run-in Period|Lack of Efficacy|0
4418375|NCT00312221|7199048|FG003|Open-label Run-in Period|Lack of Efficacy|0
4418376|NCT00312221|7199045|FG000|Open-label Run-in Period|Did not qualify|5
4418377|NCT00312221|7199046|FG001|Open-label Run-in Period|Did not qualify|0
4418378|NCT00312221|7199047|FG002|Open-label Run-in Period|Did not qualify|0
4418379|NCT00312221|7199048|FG003|Open-label Run-in Period|Did not qualify|0
4418380|NCT00312221|7199045|FG000|Double-blind Phase|Withdrawal by Subject|0
4418381|NCT00312221|7199046|FG001|Double-blind Phase|Withdrawal by Subject|6
4418382|NCT00312221|7199047|FG002|Double-blind Phase|Withdrawal by Subject|8
4418383|NCT00312221|7199048|FG003|Double-blind Phase|Withdrawal by Subject|7
4418384|NCT00312221|7199045|FG000|Double-blind Phase|Adverse Event|0
4418385|NCT00312221|7199046|FG001|Double-blind Phase|Adverse Event|10
4418386|NCT00312221|7199047|FG002|Double-blind Phase|Adverse Event|19
4418387|NCT00312221|7199048|FG003|Double-blind Phase|Adverse Event|18
4418388|NCT00312221|7199045|FG000|Double-blind Phase|Lost to Follow-up|0
4418389|NCT00312221|7199046|FG001|Double-blind Phase|Lost to Follow-up|0
4418390|NCT00312221|7199047|FG002|Double-blind Phase|Lost to Follow-up|2
4418391|NCT00312221|7199048|FG003|Double-blind Phase|Lost to Follow-up|2
4418392|NCT00312221|7199045|FG000|Double-blind Phase|Administrative|0
4418393|NCT00312221|7199046|FG001|Double-blind Phase|Administrative|26
4418394|NCT00312221|7199047|FG002|Double-blind Phase|Administrative|37
4418395|NCT00312221|7199048|FG003|Double-blind Phase|Administrative|33
4418396|NCT00312221|7199045|FG000|Double-blind Phase|Lack of Efficacy|0
4418397|NCT00312221|7199046|FG001|Double-blind Phase|Lack of Efficacy|17
4418398|NCT00312221|7199047|FG002|Double-blind Phase|Lack of Efficacy|6
4418399|NCT00312221|7199048|FG003|Double-blind Phase|Lack of Efficacy|10
4418400|NCT00312338|7199059|FG000|Overall Study|Adverse Event|7
4418401|NCT00312338|7199060|FG001|Overall Study|Adverse Event|2
4418402|NCT00312338|7199059|FG000|Overall Study|Lost to Follow-up|9
4418403|NCT00312338|7199060|FG001|Overall Study|Lost to Follow-up|1
4418404|NCT00312338|7199059|FG000|Overall Study|Withdrawal by Subject|4
4418405|NCT00312338|7199060|FG001|Overall Study|Withdrawal by Subject|0
4418406|NCT00312338|7199059|FG000|Overall Study|Subsequent infection|2
4418407|NCT00312338|7199060|FG001|Overall Study|Subsequent infection|0
4418408|NCT00312377|7199068|FG000|Overall Study|Death|403
4418409|NCT00312377|7199069|FG001|Overall Study|Death|418
4418410|NCT00312377|7199068|FG000|Overall Study|Withdrawal by Subject|23
4418411|NCT00312377|7199069|FG001|Overall Study|Withdrawal by Subject|30
4418412|NCT00312377|7199068|FG000|Overall Study|Lost to Follow-up|9
4418413|NCT00312377|7199069|FG001|Overall Study|Lost to Follow-up|12
4418414|NCT00312377|7199068|FG000|Overall Study|Non-compliance|0
4418415|NCT00312377|7199069|FG001|Overall Study|Non-compliance|2
4418416|NCT00312377|7199068|FG000|Overall Study|Randomised but never received treatment|6
4418417|NCT00312377|7199069|FG001|Overall Study|Randomised but never received treatment|6
4418418|NCT00312377|7199068|FG000|Overall Study|Discontinue treatment survival follow up|202
4418419|NCT00312377|7199069|FG001|Overall Study|Discontinue treatment survival follow up|200
4418420|NCT00312377|7199068|FG000|Overall Study|Site ended participation in study|1
4418421|NCT00312377|7199069|FG001|Overall Study|Site ended participation in study|0
4418422|NCT00312494|7199078|FG000|Overall Study|Randomized; not treated with study drug|9
4418423|NCT00312494|7199079|FG001|Overall Study|Randomized; not treated with study drug|10
4418424|NCT00312494|7199080|FG002|Overall Study|Randomized; not treated with study drug|5
4418425|NCT00312494|7199078|FG000|Overall Study|Adverse Event|33
4418426|NCT00312494|7199079|FG001|Overall Study|Adverse Event|15
4418427|NCT00312494|7199080|FG002|Overall Study|Adverse Event|11
4418428|NCT00312494|7199078|FG000|Overall Study|Lack of Efficacy|4
4418429|NCT00312494|7199079|FG001|Overall Study|Lack of Efficacy|6
4418430|NCT00312494|7199080|FG002|Overall Study|Lack of Efficacy|8
4418431|NCT00312494|7199078|FG000|Overall Study|Laboratory abnormality|1
4418432|NCT00312494|7199079|FG001|Overall Study|Laboratory abnormality|0
4418433|NCT00312494|7199080|FG002|Overall Study|Laboratory abnormality|0
4418434|NCT00312494|7199078|FG000|Overall Study|Lost to Follow-up|8
4418435|NCT00312494|7199079|FG001|Overall Study|Lost to Follow-up|8
4418436|NCT00312494|7199080|FG002|Overall Study|Lost to Follow-up|8
4418437|NCT00312494|7199078|FG000|Overall Study|Withdrawal by Subject|6
4418438|NCT00312494|7199079|FG001|Overall Study|Withdrawal by Subject|9
4418439|NCT00312494|7199080|FG002|Overall Study|Withdrawal by Subject|10
4418440|NCT00312494|7199078|FG000|Overall Study|Other|10
4418441|NCT00312494|7199079|FG001|Overall Study|Other|10
4418442|NCT00312494|7199080|FG002|Overall Study|Other|1
4418443|NCT00312572|7199090|FG000|Overall Study|Adverse Event|10
4418444|NCT00312572|7199091|FG001|Overall Study|Adverse Event|16
4418445|NCT00312572|7199090|FG000|Overall Study|Lost to Follow-up|1
4418446|NCT00312572|7199091|FG001|Overall Study|Lost to Follow-up|1
4418447|NCT00312572|7199090|FG000|Overall Study|Administrative|4
4418448|NCT00312572|7199091|FG001|Overall Study|Administrative|2
4418449|NCT00312572|7199090|FG000|Overall Study|Lack of Efficacy|1
4418450|NCT00312572|7199091|FG001|Overall Study|Lack of Efficacy|2
4418451|NCT00312663|7199102|FG000|Immunization Phase|Adverse Event|0
4418452|NCT00312663|7199103|FG001|Immunization Phase|Adverse Event|1
4418453|NCT00312663|7199104|FG002|Immunization Phase|Adverse Event|0
4418454|NCT00312702|7199116|FG000|Immunization Phase|Lost to Follow-up|0
4418455|NCT00312702|7199117|FG001|Immunization Phase|Lost to Follow-up|1
4418456|NCT00312702|7199118|FG002|Immunization Phase|Lost to Follow-up|0
4418457|NCT00312728|7199126|FG000|Overall Study|Progressive disease|53
4418458|NCT00312728|7199126|FG000|Overall Study|Adverse Event|32
4418459|NCT00312728|7199126|FG000|Overall Study|Withdrawal by Subject|10
4418460|NCT00312728|7199126|FG000|Overall Study|Required non-protocol cancer treatment|2
4418461|NCT00312728|7199126|FG000|Overall Study|Protocol Violation|2
4418462|NCT00312728|7199126|FG000|Overall Study|Other|10
4418463|NCT00312728|7199126|FG000|Overall Study|Other|1
4418464|NCT00312845|7199132|FG000|Overall Study|Adverse Event|19
4418465|NCT00312845|7199133|FG001|Overall Study|Adverse Event|5
4418466|NCT00312845|7199132|FG000|Overall Study|Death|2
4418467|NCT00312845|7199133|FG001|Overall Study|Death|2
4418468|NCT00312845|7199132|FG000|Overall Study|Withdrawal by Subject|14
4418469|NCT00312845|7199133|FG001|Overall Study|Withdrawal by Subject|6
4418470|NCT00312845|7199132|FG000|Overall Study|Disease Progression|56
4418471|NCT00312845|7199133|FG001|Overall Study|Disease Progression|77
4418472|NCT00312845|7199132|FG000|Overall Study|Lost to Follow-up|2
4418473|NCT00312845|7199133|FG001|Overall Study|Lost to Follow-up|0
4418474|NCT00312845|7199132|FG000|Overall Study|Other|6
4714904|NCT02963922|7642930|FG000|Overall Study|Other|8
4418475|NCT00312845|7199133|FG001|Overall Study|Other|5
4418476|NCT00312858|7199141|FG000|Overall Study|Adverse Event|0
4418477|NCT00312858|7199142|FG001|Overall Study|Adverse Event|1
4418478|NCT00312858|7199141|FG000|Overall Study|Lost to Follow-up|25
4418479|NCT00312858|7199142|FG001|Overall Study|Lost to Follow-up|42
4418480|NCT00312858|7199141|FG000|Overall Study|Protocol Violation|3
4418481|NCT00312858|7199142|FG001|Overall Study|Protocol Violation|8
4418482|NCT00312858|7199141|FG000|Overall Study|Withdraw by Participant|20
4418483|NCT00312858|7199142|FG001|Overall Study|Withdraw by Participant|20
4418484|NCT00312858|7199141|FG000|Overall Study|Participant Moved|11
4418485|NCT00312858|7199142|FG001|Overall Study|Participant Moved|10
4418486|NCT00312858|7199141|FG000|Overall Study|Other|9
4418487|NCT00312858|7199142|FG001|Overall Study|Other|12
4418488|NCT00312897|7199159|FG000|Overall Study|Adverse Event|1
4418489|NCT00312897|7199160|FG001|Overall Study|Adverse Event|0
4418490|NCT00312897|7199159|FG000|Overall Study|Lost to Follow-up|2
4418491|NCT00312897|7199160|FG001|Overall Study|Lost to Follow-up|0
4418492|NCT00312897|7199159|FG000|Overall Study|Physician Decision|1
4418493|NCT00312897|7199160|FG001|Overall Study|Physician Decision|0
4418494|NCT00312897|7199159|FG000|Overall Study|Withdrawal by Subject|1
4418495|NCT00312897|7199160|FG001|Overall Study|Withdrawal by Subject|3
4418496|NCT00312897|7199159|FG000|Overall Study|Pregnancy|1
4418497|NCT00312897|7199160|FG001|Overall Study|Pregnancy|0
4418498|NCT00312897|7199159|FG000|Overall Study|discontinued prior to getting treatment|0
4418499|NCT00312897|7199160|FG001|Overall Study|discontinued prior to getting treatment|3
4418500|NCT00313014|7199178|FG000|Overall Study|Withdrawal by Subject|11
4418501|NCT00313014|7199179|FG001|Overall Study|Withdrawal by Subject|7
4418502|NCT00313014|7199180|FG002|Overall Study|Withdrawal by Subject|5
4418503|NCT00313014|7199178|FG000|Overall Study|Adverse Event|14
4418504|NCT00313014|7199179|FG001|Overall Study|Adverse Event|29
4418505|NCT00313014|7199180|FG002|Overall Study|Adverse Event|16
4418506|NCT00313014|7199178|FG000|Overall Study|Lost to Follow-up|7
4418507|NCT00313014|7199179|FG001|Overall Study|Lost to Follow-up|6
4418508|NCT00313014|7199180|FG002|Overall Study|Lost to Follow-up|10
4418509|NCT00313014|7199178|FG000|Overall Study|Administrative|9
4418510|NCT00313014|7199179|FG001|Overall Study|Administrative|6
4418511|NCT00313014|7199180|FG002|Overall Study|Administrative|14
4418512|NCT00313014|7199178|FG000|Overall Study|Lack of Efficacy|52
4418513|NCT00313014|7199179|FG001|Overall Study|Lack of Efficacy|25
4418514|NCT00313014|7199180|FG002|Overall Study|Lack of Efficacy|16
4418515|NCT00313144|7199189|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12
4418516|NCT00313144|7199189|FG000|Overall Study|Death|7
4418517|NCT00313144|7199189|FG000|Overall Study|Lost to Follow-up|5
4418518|NCT00313144|7199189|FG000|Overall Study|Withdrawal by Subject|4
4418519|NCT00313144|7199189|FG000|Overall Study|Terminated by sponsor/ homecare provider|4
4418520|NCT00313144|7199189|FG000|Overall Study|Physician Decision|4
4418521|NCT00313144|7199189|FG000|Overall Study|Adverse event - transient|5
4418522|NCT00313144|7199189|FG000|Overall Study|Liver transplant|1
4418523|NCT00313144|7199189|FG000|Overall Study|Insurance (homecare provider) change|1
4418524|NCT00313144|7199189|FG000|Overall Study|Change to different product|1
4418525|NCT00313144|7199189|FG000|Overall Study|Due to termination of the study|66
4418526|NCT00313170|7199205|FG000|Overall Study|Death|2
4418527|NCT00313170|7199206|FG001|Overall Study|Death|4
4418528|NCT00313170|7199207|FG002|Overall Study|Death|2
4418529|NCT00313170|7199205|FG000|Overall Study|Adverse Event|1
4418530|NCT00313170|7199206|FG001|Overall Study|Adverse Event|2
4418531|NCT00313170|7199207|FG002|Overall Study|Adverse Event|0
4418532|NCT00313170|7199205|FG000|Overall Study|Disease progression|31
4418533|NCT00313170|7199206|FG001|Overall Study|Disease progression|26
4418534|NCT00313170|7199207|FG002|Overall Study|Disease progression|27
4418535|NCT00313170|7199205|FG000|Overall Study|Withdrawal by Subject|1
4418536|NCT00313170|7199206|FG001|Overall Study|Withdrawal by Subject|0
4418537|NCT00313170|7199207|FG002|Overall Study|Withdrawal by Subject|1
4418538|NCT00313170|7199205|FG000|Overall Study|Incorrect enrollment|0
4418539|NCT00313170|7199206|FG001|Overall Study|Incorrect enrollment|2
4418540|NCT00313170|7199207|FG002|Overall Study|Incorrect enrollment|1
4418541|NCT00313170|7199205|FG000|Overall Study|Lost to Follow-up|0
4418542|NCT00313170|7199206|FG001|Overall Study|Lost to Follow-up|0
4418543|NCT00313170|7199207|FG002|Overall Study|Lost to Follow-up|1
4418544|NCT00313170|7199205|FG000|Overall Study|Progression (investigators opinion)|1
4418545|NCT00313170|7199206|FG001|Overall Study|Progression (investigators opinion)|0
4418546|NCT00313170|7199207|FG002|Overall Study|Progression (investigators opinion)|0
4418547|NCT00313300|7199230|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19
4714905|NCT02963922|7642931|FG001|Overall Study|Other|14
4418548|NCT00313300|7199231|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14
4418549|NCT00313300|7199232|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17
4418550|NCT00313300|7199233|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0
4418551|NCT00313300|7199234|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0
4418552|NCT00313300|7199230|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20
4418553|NCT00313300|7199231|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12
4418554|NCT00313300|7199232|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13
4418555|NCT00313300|7199233|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0
4418556|NCT00313300|7199234|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0
4418557|NCT00313300|7199230|FG000|Randomized in Phase A (26 Weeks)|Death|3
4418558|NCT00313300|7199231|FG001|Randomized in Phase A (26 Weeks)|Death|4
4418559|NCT00313300|7199232|FG002|Randomized in Phase A (26 Weeks)|Death|0
4418560|NCT00313300|7199233|FG003|Randomized in Phase A (26 Weeks)|Death|0
4418561|NCT00313300|7199234|FG004|Randomized in Phase A (26 Weeks)|Death|0
4418562|NCT00313300|7199230|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4
4418563|NCT00313300|7199231|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4
4418564|NCT00313300|7199232|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2
4418565|NCT00313300|7199233|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0
4418566|NCT00313300|7199234|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0
4418567|NCT00313300|7199230|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3
4418568|NCT00313300|7199231|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2
4418569|NCT00313300|7199232|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1
4418570|NCT00313300|7199233|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0
4418571|NCT00313300|7199234|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0
4418572|NCT00313300|7199230|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4
4418573|NCT00313300|7199231|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3
4418574|NCT00313300|7199232|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2
4418575|NCT00313300|7199233|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0
4418576|NCT00313300|7199234|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0
4418577|NCT00313300|7199230|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1
4418578|NCT00313300|7199231|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
4418579|NCT00313300|7199232|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
4418580|NCT00313300|7199233|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
4418581|NCT00313300|7199234|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
4418582|NCT00313300|7199230|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34
4418583|NCT00313300|7199231|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9
4418584|NCT00313300|7199232|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12
4418585|NCT00313300|7199233|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23
4418586|NCT00313300|7199234|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19
4418587|NCT00313300|7199230|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35
4418588|NCT00313300|7199231|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14
4418589|NCT00313300|7199232|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19
4418590|NCT00313300|7199233|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15
4418591|NCT00313300|7199234|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19
4418592|NCT00313300|7199230|FG000|Randomized in Phase B (26 Weeks)|Death|5
4418593|NCT00313300|7199231|FG001|Randomized in Phase B (26 Weeks)|Death|3
4418594|NCT00313300|7199232|FG002|Randomized in Phase B (26 Weeks)|Death|1
4418595|NCT00313300|7199233|FG003|Randomized in Phase B (26 Weeks)|Death|0
4418596|NCT00313300|7199234|FG004|Randomized in Phase B (26 Weeks)|Death|1
4418597|NCT00313300|7199230|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5
4418598|NCT00313300|7199231|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2
4418599|NCT00313300|7199232|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3
4418600|NCT00313300|7199233|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2
4418601|NCT00313300|7199234|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3
4418602|NCT00313300|7199230|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3
4418603|NCT00313300|7199231|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1
4418604|NCT00313300|7199232|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3
4418605|NCT00313300|7199233|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0
4418606|NCT00313300|7199234|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0
4418607|NCT00313300|7199230|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9
4418608|NCT00313300|7199231|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3
4418609|NCT00313300|7199232|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2
4418610|NCT00313300|7199233|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0
4418611|NCT00313300|7199234|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2
4418612|NCT00313300|7199230|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2
4418613|NCT00313300|7199231|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1
4418614|NCT00313300|7199232|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0
4418615|NCT00313300|7199233|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193
4418616|NCT00313300|7199234|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164
4418617|NCT00313300|7199230|FG000|Randomized in Phase B (26 Weeks)|non-specified|1
4418618|NCT00313300|7199231|FG001|Randomized in Phase B (26 Weeks)|non-specified|0
4418619|NCT00313300|7199232|FG002|Randomized in Phase B (26 Weeks)|non-specified|0
4418620|NCT00313300|7199233|FG003|Randomized in Phase B (26 Weeks)|non-specified|0
4418621|NCT00313300|7199234|FG004|Randomized in Phase B (26 Weeks)|non-specified|0
4418622|NCT00313300|7199230|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5
4418623|NCT00313300|7199231|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5
4418624|NCT00313300|7199232|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2
4418625|NCT00313300|7199233|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0
4418626|NCT00313300|7199234|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0
4418627|NCT00313300|7199230|FG000|Follow-Up(30days)-Randomized Phase A|Death|0
4418628|NCT00313300|7199231|FG001|Follow-Up(30days)-Randomized Phase A|Death|1
4418629|NCT00313300|7199232|FG002|Follow-Up(30days)-Randomized Phase A|Death|0
4418630|NCT00313300|7199233|FG003|Follow-Up(30days)-Randomized Phase A|Death|0
4418631|NCT00313300|7199234|FG004|Follow-Up(30days)-Randomized Phase A|Death|0
4418632|NCT00313300|7199230|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
4418633|NCT00313300|7199231|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0
4418634|NCT00313300|7199232|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2
4418635|NCT00313300|7199233|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
4418636|NCT00313300|7199234|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
4418637|NCT00313300|7199230|FG000|Follow-Up(30days)-Randomized Phase B|Death|1
4418638|NCT00313300|7199231|FG001|Follow-Up(30days)-Randomized Phase B|Death|0
4418639|NCT00313300|7199232|FG002|Follow-Up(30days)-Randomized Phase B|Death|0
4418640|NCT00313300|7199233|FG003|Follow-Up(30days)-Randomized Phase B|Death|0
4418641|NCT00313300|7199234|FG004|Follow-Up(30days)-Randomized Phase B|Death|0
4418642|NCT00313300|7199230|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
4418643|NCT00313300|7199231|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
4418644|NCT00313300|7199232|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
4418645|NCT00313300|7199233|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2
4418646|NCT00313300|7199234|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1
4418647|NCT00313300|7199230|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1
4418648|NCT00313300|7199231|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
4418649|NCT00313300|7199232|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
4418650|NCT00313300|7199233|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2
4418651|NCT00313300|7199234|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
4418652|NCT00313313|7199255|FG000|Overall Study|Lack of Efficacy|14
4418653|NCT00313313|7199256|FG001|Overall Study|Lack of Efficacy|9
4418654|NCT00313313|7199257|FG002|Overall Study|Lack of Efficacy|20
4418655|NCT00313313|7199255|FG000|Overall Study|Withdrawal of consent by subject|18
4418656|NCT00313313|7199256|FG001|Overall Study|Withdrawal of consent by subject|17
4418657|NCT00313313|7199257|FG002|Overall Study|Withdrawal of consent by subject|31
4418658|NCT00313313|7199255|FG000|Overall Study|Lost to Follow-up|10
4418659|NCT00313313|7199256|FG001|Overall Study|Lost to Follow-up|7
4418660|NCT00313313|7199257|FG002|Overall Study|Lost to Follow-up|9
4418661|NCT00313313|7199255|FG000|Overall Study|Adverse Event|15
4418662|NCT00313313|7199256|FG001|Overall Study|Adverse Event|16
4418663|NCT00313313|7199257|FG002|Overall Study|Adverse Event|12
4418664|NCT00313313|7199255|FG000|Overall Study|Physician Decision|2
4418665|NCT00313313|7199256|FG001|Overall Study|Physician Decision|6
4418666|NCT00313313|7199257|FG002|Overall Study|Physician Decision|4
4418667|NCT00313313|7199255|FG000|Overall Study|Poor/Noncompliance|3
4418668|NCT00313313|7199256|FG001|Overall Study|Poor/Noncompliance|6
4418669|NCT00313313|7199257|FG002|Overall Study|Poor/Noncompliance|2
4418670|NCT00313313|7199255|FG000|Overall Study|Pregnancy|1
4418671|NCT00313313|7199256|FG001|Overall Study|Pregnancy|2
4418672|NCT00313313|7199257|FG002|Overall Study|Pregnancy|0
4418673|NCT00313313|7199255|FG000|Overall Study|Death|0
4418674|NCT00313313|7199256|FG001|Overall Study|Death|0
4418675|NCT00313313|7199257|FG002|Overall Study|Death|2
4418676|NCT00313313|7199255|FG000|Overall Study|Subject No Longer Meets Study Criteria|0
4418677|NCT00313313|7199256|FG001|Overall Study|Subject No Longer Meets Study Criteria|3
4418678|NCT00313313|7199257|FG002|Overall Study|Subject No Longer Meets Study Criteria|2
4418679|NCT00313586|7199281|FG000|Overall Study|Disease progression|14
4418680|NCT00313586|7199282|FG001|Overall Study|Disease progression|19
4418681|NCT00313586|7199283|FG002|Overall Study|Disease progression|10
4418682|NCT00313586|7199284|FG003|Overall Study|Disease progression|3
4418683|NCT00313586|7199281|FG000|Overall Study|Adverse Event|12
4418684|NCT00313586|7199282|FG001|Overall Study|Adverse Event|18
4418685|NCT00313586|7199283|FG002|Overall Study|Adverse Event|3
4418686|NCT00313586|7199284|FG003|Overall Study|Adverse Event|10
4418687|NCT00313586|7199281|FG000|Overall Study|Death|11
4418688|NCT00313586|7199282|FG001|Overall Study|Death|8
4418689|NCT00313586|7199283|FG002|Overall Study|Death|1
4418690|NCT00313586|7199284|FG003|Overall Study|Death|7
4418691|NCT00313586|7199281|FG000|Overall Study|Withdrawal by Subject|13
4418692|NCT00313586|7199282|FG001|Overall Study|Withdrawal by Subject|6
4418693|NCT00313586|7199283|FG002|Overall Study|Withdrawal by Subject|6
4418694|NCT00313586|7199284|FG003|Overall Study|Withdrawal by Subject|2
4418695|NCT00313586|7199281|FG000|Overall Study|Alternative therapy|3
4418696|NCT00313586|7199282|FG001|Overall Study|Alternative therapy|6
4418697|NCT00313586|7199283|FG002|Overall Study|Alternative therapy|2
4418698|NCT00313586|7199284|FG003|Overall Study|Alternative therapy|0
4418699|NCT00313586|7199281|FG000|Overall Study|Other complicating disease|2
4418700|NCT00313586|7199282|FG001|Overall Study|Other complicating disease|2
4418701|NCT00313586|7199283|FG002|Overall Study|Other complicating disease|0
4418702|NCT00313586|7199284|FG003|Overall Study|Other complicating disease|0
4418703|NCT00313586|7199281|FG000|Overall Study|Did not achieve HI-major/better response|10
4418704|NCT00313586|7199282|FG001|Overall Study|Did not achieve HI-major/better response|7
4418705|NCT00313586|7199283|FG002|Overall Study|Did not achieve HI-major/better response|2
4418706|NCT00313586|7199284|FG003|Overall Study|Did not achieve HI-major/better response|1
4418707|NCT00313586|7199281|FG000|Overall Study|Physician Decision|2
4418708|NCT00313586|7199282|FG001|Overall Study|Physician Decision|1
4418709|NCT00313586|7199283|FG002|Overall Study|Physician Decision|0
4629455|NCT01872689|7497410|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1
4629456|NCT01872689|7497411|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1
4418710|NCT00313586|7199284|FG003|Overall Study|Physician Decision|0
4418711|NCT00313586|7199281|FG000|Overall Study|Absolute neutrophil count not recovered|2
4418712|NCT00313586|7199282|FG001|Overall Study|Absolute neutrophil count not recovered|1
4418713|NCT00313586|7199283|FG002|Overall Study|Absolute neutrophil count not recovered|0
4418714|NCT00313586|7199284|FG003|Overall Study|Absolute neutrophil count not recovered|0
4418715|NCT00313586|7199281|FG000|Overall Study|Lost insurance|0
4418716|NCT00313586|7199282|FG001|Overall Study|Lost insurance|1
4418717|NCT00313586|7199283|FG002|Overall Study|Lost insurance|0
4418718|NCT00313586|7199284|FG003|Overall Study|Lost insurance|0
4418719|NCT00313586|7199281|FG000|Overall Study|Moved|0
4418720|NCT00313586|7199282|FG001|Overall Study|Moved|1
4418721|NCT00313586|7199283|FG002|Overall Study|Moved|0
4418722|NCT00313586|7199284|FG003|Overall Study|Moved|0
4418723|NCT00313586|7199281|FG000|Overall Study|Death before starting treatment|1
4418724|NCT00313586|7199282|FG001|Overall Study|Death before starting treatment|0
4418725|NCT00313586|7199283|FG002|Overall Study|Death before starting treatment|0
4418726|NCT00313586|7199284|FG003|Overall Study|Death before starting treatment|0
4418727|NCT00313612|7199294|FG000|Overall Study|Patient never received treatment|0
4418728|NCT00313612|7199295|FG001|Overall Study|Patient never received treatment|1
4418729|NCT00313703|7199305|FG000|Overall Study|Lost to Follow-up|11
4418730|NCT00313703|7199306|FG001|Overall Study|Lost to Follow-up|2
4418731|NCT00313703|7199307|FG002|Overall Study|Lost to Follow-up|5
4418732|NCT00313703|7199308|FG003|Overall Study|Lost to Follow-up|12
4418733|NCT00313716|7199324|FG000|Overall Study|Death|3
4418734|NCT00313716|7199325|FG001|Overall Study|Death|2
4418735|NCT00313716|7199326|FG002|Overall Study|Death|9
4418736|NCT00313716|7199327|FG003|Overall Study|Death|3
4418737|NCT00313716|7199328|FG004|Overall Study|Death|5
4418738|NCT00313716|7199329|FG005|Overall Study|Death|9
4418739|NCT00313716|7199324|FG000|Overall Study|Lost to Follow-up|2
4418740|NCT00313716|7199325|FG001|Overall Study|Lost to Follow-up|5
4418741|NCT00313716|7199326|FG002|Overall Study|Lost to Follow-up|2
4418742|NCT00313716|7199327|FG003|Overall Study|Lost to Follow-up|1
4418743|NCT00313716|7199328|FG004|Overall Study|Lost to Follow-up|0
4418744|NCT00313716|7199329|FG005|Overall Study|Lost to Follow-up|4
4418745|NCT00313716|7199324|FG000|Overall Study|Withdrawal by Subject|0
4418746|NCT00313716|7199325|FG001|Overall Study|Withdrawal by Subject|1
4418747|NCT00313716|7199326|FG002|Overall Study|Withdrawal by Subject|1
4418748|NCT00313716|7199327|FG003|Overall Study|Withdrawal by Subject|0
4418749|NCT00313716|7199328|FG004|Overall Study|Withdrawal by Subject|1
4418750|NCT00313716|7199329|FG005|Overall Study|Withdrawal by Subject|0
4512001|NCT00931411|7321575|FG000|First Intervention - 42 Days|Adverse Event|2
4512002|NCT00931411|7321576|FG001|First Intervention - 42 Days|Adverse Event|3
4512003|NCT00931411|7321575|FG000|First Intervention - 42 Days|Lost to Follow-up|2
4512004|NCT00931411|7321576|FG001|First Intervention - 42 Days|Lost to Follow-up|0
4512005|NCT00931411|7321575|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0
4512006|NCT00931411|7321576|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1
4512007|NCT00931463|7321588|FG000|Overall Study|Death|8
4512008|NCT00931463|7321589|FG001|Overall Study|Death|4
4512009|NCT00931463|7321588|FG000|Overall Study|Withdrawal by Subject|5
4512010|NCT00931463|7321589|FG001|Overall Study|Withdrawal by Subject|0
4512011|NCT00931463|7321588|FG000|Overall Study|Lost to Follow-up|4
4512012|NCT00931463|7321589|FG001|Overall Study|Lost to Follow-up|1
4512013|NCT00931515|7321617|FG000|Overall Study|Lost to Follow-up|2
4512014|NCT00931515|7321618|FG001|Overall Study|Lost to Follow-up|5
4512015|NCT00931528|7321626|FG000|Overall Study|Protocol Violation|9
4512016|NCT00931528|7321627|FG001|Overall Study|Protocol Violation|12
4512017|NCT00931528|7321626|FG000|Overall Study|Withdrawal by Subject|4
4512018|NCT00931528|7321627|FG001|Overall Study|Withdrawal by Subject|12
4512019|NCT00931528|7321626|FG000|Overall Study|Lost to Follow-up|6
4512020|NCT00931528|7321627|FG001|Overall Study|Lost to Follow-up|13
4512021|NCT00931528|7321626|FG000|Overall Study|Assessment outside of Time Frame|22
4512022|NCT00931528|7321627|FG001|Overall Study|Assessment outside of Time Frame|23
4512023|NCT00931632|7321636|FG000|Overall Study|Withdrawal by Subject|2
4512024|NCT00931632|7321637|FG001|Overall Study|Withdrawal by Subject|3
4512025|NCT00931632|7321636|FG000|Overall Study|Adverse Event|19
4512026|NCT00931632|7321637|FG001|Overall Study|Adverse Event|15
4418751|NCT00313781|7199353|FG000|Before Crossover|Death|22
4418752|NCT00313781|7199354|FG001|Before Crossover|Death|8
4418753|NCT00313781|7199355|FG002|Before Crossover|Death|0
4418754|NCT00313781|7199353|FG000|Before Crossover|Lost to Follow-up|0
4418755|NCT00313781|7199354|FG001|Before Crossover|Lost to Follow-up|3
4418756|NCT00313781|7199355|FG002|Before Crossover|Lost to Follow-up|0
4418757|NCT00313781|7199353|FG000|Before Crossover|Withdrawal by Subject|3
4418758|NCT00313781|7199354|FG001|Before Crossover|Withdrawal by Subject|1
4418759|NCT00313781|7199355|FG002|Before Crossover|Withdrawal by Subject|0
4418760|NCT00313781|7199353|FG000|Before Crossover|Other|45
4418761|NCT00313781|7199354|FG001|Before Crossover|Other|30
4418762|NCT00313781|7199355|FG002|Before Crossover|Other|0
4418763|NCT00313781|7199353|FG000|Before Crossover|Crossover|0
4418764|NCT00313781|7199354|FG001|Before Crossover|Crossover|37
4418765|NCT00313781|7199355|FG002|Before Crossover|Crossover|0
4418766|NCT00313781|7199353|FG000|Before Crossover|Randomized, not treated|5
4418767|NCT00313781|7199354|FG001|Before Crossover|Randomized, not treated|0
4418768|NCT00313781|7199355|FG002|Before Crossover|Randomized, not treated|0
4418769|NCT00313781|7199353|FG000|After Crossover|Death|0
4418770|NCT00313781|7199354|FG001|After Crossover|Death|0
4418771|NCT00313781|7199355|FG002|After Crossover|Death|6
4418772|NCT00313781|7199353|FG000|After Crossover|Withdrawal by Subject|0
4418773|NCT00313781|7199354|FG001|After Crossover|Withdrawal by Subject|0
4418774|NCT00313781|7199355|FG002|After Crossover|Withdrawal by Subject|3
4418775|NCT00313781|7199353|FG000|After Crossover|Other|0
4418776|NCT00313781|7199354|FG001|After Crossover|Other|0
4418777|NCT00313781|7199355|FG002|After Crossover|Other|18
4418778|NCT00313820|7199366|FG000|Assigned to Treatment|Other|1
4418779|NCT00313820|7199367|FG001|Assigned to Treatment|Other|0
4418780|NCT00313820|7199366|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9
4418781|NCT00313820|7199367|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4
4418782|NCT00313820|7199366|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0
4418783|NCT00313820|7199367|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1
4418784|NCT00313820|7199366|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0
4418785|NCT00313820|7199367|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7
4418786|NCT00313820|7199366|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6
4418787|NCT00313820|7199367|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4
4418788|NCT00313820|7199366|FG000|Pregabalin or Placebo Treatment Period|Other|2
4418789|NCT00313820|7199367|FG001|Pregabalin or Placebo Treatment Period|Other|3
4418790|NCT00313846|7199375|FG000|Overall Study|Withdrawal by Subject|2
4418791|NCT00313846|7199376|FG001|Overall Study|Withdrawal by Subject|0
4418792|NCT00313846|7199375|FG000|Overall Study|Adverse Event|1
4418793|NCT00313846|7199376|FG001|Overall Study|Adverse Event|8
4418794|NCT00313846|7199375|FG000|Overall Study|Administrative|2
4418795|NCT00313846|7199376|FG001|Overall Study|Administrative|3
4418796|NCT00313911|7199385|FG000|Overall Study|Serious adverse event|6
4418797|NCT00313911|7199386|FG001|Overall Study|Serious adverse event|1
4418798|NCT00313911|7199385|FG000|Overall Study|Adverse Event|2
4418799|NCT00313911|7199386|FG001|Overall Study|Adverse Event|3
4418800|NCT00313911|7199385|FG000|Overall Study|Protocol Violation|19
4418801|NCT00313911|7199386|FG001|Overall Study|Protocol Violation|10
4418802|NCT00313911|7199385|FG000|Overall Study|Lost to Follow-up|27
4418803|NCT00313911|7199386|FG001|Overall Study|Lost to Follow-up|14
4418804|NCT00313911|7199385|FG000|Overall Study|Withdrawal by Subject|39
4418805|NCT00313911|7199386|FG001|Overall Study|Withdrawal by Subject|12
4418806|NCT00313911|7199385|FG000|Overall Study|Did not meet age criteria|1
4418807|NCT00313911|7199386|FG001|Overall Study|Did not meet age criteria|1
4418808|NCT00314132|7199403|FG000|Overall Study|Lost to Follow-up|3
4418809|NCT00314132|7199404|FG001|Overall Study|Lost to Follow-up|13
4418810|NCT00314132|7199403|FG000|Overall Study|Withdrawal by Subject|3
4418811|NCT00314132|7199404|FG001|Overall Study|Withdrawal by Subject|5
4418812|NCT00314132|7199403|FG000|Overall Study|Adverse Event|1
4418813|NCT00314132|7199404|FG001|Overall Study|Adverse Event|0
4418814|NCT00314132|7199403|FG000|Overall Study|Physician Decision|1
4418815|NCT00314132|7199404|FG001|Overall Study|Physician Decision|0
4418816|NCT00314145|7199414|FG000|Overall Study|Withdrawal by Subject|8
4418817|NCT00314145|7199415|FG001|Overall Study|Withdrawal by Subject|10
4418818|NCT00314145|7199414|FG000|Overall Study|Lost to Follow-up|5
4418819|NCT00314145|7199415|FG001|Overall Study|Lost to Follow-up|12
4418820|NCT00314145|7199414|FG000|Overall Study|Physician Decision|3
4418821|NCT00314145|7199415|FG001|Overall Study|Physician Decision|4
4418822|NCT00314145|7199414|FG000|Overall Study|Adverse Event|0
4418823|NCT00314145|7199415|FG001|Overall Study|Adverse Event|3
4418824|NCT00314145|7199414|FG000|Overall Study|Protocol Violation|3
4418825|NCT00314145|7199415|FG001|Overall Study|Protocol Violation|0
4418826|NCT00314145|7199414|FG000|Overall Study|Sponsor Decision|2
4418827|NCT00314145|7199415|FG001|Overall Study|Sponsor Decision|0
4418828|NCT00314249|7199433|FG000|Overall Study|Adverse Event|73
4418829|NCT00314249|7199434|FG001|Overall Study|Adverse Event|94
4418830|NCT00314249|7199433|FG000|Overall Study|Lack of Efficacy|33
4418831|NCT00314249|7199434|FG001|Overall Study|Lack of Efficacy|24
4418832|NCT00314249|7199433|FG000|Overall Study|Withdrawal by Subject|21
4418833|NCT00314249|7199434|FG001|Overall Study|Withdrawal by Subject|28
4418834|NCT00314249|7199433|FG000|Overall Study|Lost to Follow-up|15
4418835|NCT00314249|7199434|FG001|Overall Study|Lost to Follow-up|9
4418836|NCT00314249|7199433|FG000|Overall Study|Physician Decision|1
4418837|NCT00314249|7199434|FG001|Overall Study|Physician Decision|1
4418838|NCT00314249|7199433|FG000|Overall Study|Withdrawn for other reasons|4
4418839|NCT00314249|7199434|FG001|Overall Study|Withdrawn for other reasons|1
4418840|NCT00314249|7199433|FG000|Overall Study|Non-Compliant|5
4418841|NCT00314249|7199434|FG001|Overall Study|Non-Compliant|6
4418842|NCT00314262|7199440|FG000|Overall Study|Adverse Event|2
4418843|NCT00314262|7199440|FG000|Overall Study|Withdrawal by Subject|2
4418844|NCT00314262|7199440|FG000|Overall Study|Physician Decision|1
4418845|NCT00314340|7199444|FG000|Overall Study|lost interest|1
4418846|NCT00314366|7199452|FG000|Overall Study|not treated due to patient medical condi|1
4418847|NCT00314366|7199453|FG001|Overall Study|not treated due to patient medical condi|0
4418848|NCT00314574|7199464|FG000|Overall Study|Death|3
4418849|NCT00314574|7199465|FG001|Overall Study|Death|0
4418850|NCT00314574|7199464|FG000|Overall Study|Adverse Event|11
4418851|NCT00314574|7199465|FG001|Overall Study|Adverse Event|16
4418852|NCT00314574|7199464|FG000|Overall Study|Lost to Follow-up|19
4418853|NCT00314574|7199465|FG001|Overall Study|Lost to Follow-up|25
4418854|NCT00314574|7199464|FG000|Overall Study|Withdrawal by Subject|33
4418855|NCT00314574|7199465|FG001|Overall Study|Withdrawal by Subject|22
4418856|NCT00314574|7199464|FG000|Overall Study|Physician Decision|22
4418857|NCT00314574|7199465|FG001|Overall Study|Physician Decision|15
4418858|NCT00314574|7199464|FG000|Overall Study|Pregnancy|6
4418859|NCT00314574|7199465|FG001|Overall Study|Pregnancy|4
4418860|NCT00314574|7199464|FG000|Overall Study|Data unknown at database lock|0
4418861|NCT00314574|7199465|FG001|Overall Study|Data unknown at database lock|1
4418862|NCT00314795|7199471|FG000|Overall Study|Adverse Event|8
4418863|NCT00314795|7199471|FG000|Overall Study|Death|4
4418864|NCT00314795|7199471|FG000|Overall Study|Reason not Specified|3
4418865|NCT00314795|7199471|FG000|Overall Study|Renal Transplant|3
4418866|NCT00314795|7199471|FG000|Overall Study|Participants Withdrew Consent|2
4418867|NCT00314808|7199475|FG000|Overall Study|Disease Progression without AE|4
4418868|NCT00314808|7199475|FG000|Overall Study|Withdrawal by Subject/PI without AE|4
4418869|NCT00314951|7199481|FG000|Treatment|Didn't meet criteria for mITT population|16
4418870|NCT00314951|7199482|FG001|Treatment|Didn't meet criteria for mITT population|11
4418871|NCT00314951|7199481|FG000|Follow-up|mITT failure|44
4418872|NCT00314951|7199482|FG001|Follow-up|mITT failure|34
4418873|NCT00315055|7199490|FG000|Overall Study|Protocol Violation|2
4418874|NCT00315055|7199491|FG001|Overall Study|Protocol Violation|4
4418875|NCT00315055|7199490|FG000|Overall Study|Lost to Follow-up|1
4418876|NCT00315055|7199491|FG001|Overall Study|Lost to Follow-up|1
4418877|NCT00315445|7199586|FG000|Overall Study|Adverse Event|7
4418878|NCT00315445|7199587|FG001|Overall Study|Adverse Event|12
4418879|NCT00315445|7199588|FG002|Overall Study|Adverse Event|15
4418880|NCT00315445|7199586|FG000|Overall Study|Lack of Efficacy|16
4418881|NCT00315445|7199587|FG001|Overall Study|Lack of Efficacy|1
4418882|NCT00315445|7199588|FG002|Overall Study|Lack of Efficacy|7
4418883|NCT00315445|7199586|FG000|Overall Study|Lost to Follow-up|1
4418884|NCT00315445|7199587|FG001|Overall Study|Lost to Follow-up|0
4418885|NCT00315445|7199588|FG002|Overall Study|Lost to Follow-up|1
4418886|NCT00315445|7199586|FG000|Overall Study|Protocol Violation|2
4418887|NCT00315445|7199587|FG001|Overall Study|Protocol Violation|0
4418888|NCT00315445|7199588|FG002|Overall Study|Protocol Violation|1
4418889|NCT00315445|7199586|FG000|Overall Study|Other|1
4418890|NCT00315445|7199587|FG001|Overall Study|Other|3
4418891|NCT00315445|7199588|FG002|Overall Study|Other|0
4418892|NCT00315458|7199598|FG000|Overall Study|Administrative|0
4418893|NCT00315458|7199599|FG001|Overall Study|Administrative|3
4418894|NCT00315458|7199600|FG002|Overall Study|Administrative|8
4418895|NCT00315458|7199601|FG003|Overall Study|Administrative|21
4418896|NCT00315458|7199598|FG000|Overall Study|Adverse Event|2
4418897|NCT00315458|7199599|FG001|Overall Study|Adverse Event|4
4418898|NCT00315458|7199600|FG002|Overall Study|Adverse Event|23
4418899|NCT00315458|7199601|FG003|Overall Study|Adverse Event|3
4418900|NCT00315458|7199598|FG000|Overall Study|Lost to Follow-up|1
4418901|NCT00315458|7199599|FG001|Overall Study|Lost to Follow-up|2
4418902|NCT00315458|7199600|FG002|Overall Study|Lost to Follow-up|0
4418903|NCT00315458|7199601|FG003|Overall Study|Lost to Follow-up|2
4418904|NCT00315458|7199598|FG000|Overall Study|Withdrawal by Subject|0
4418905|NCT00315458|7199599|FG001|Overall Study|Withdrawal by Subject|3
4418906|NCT00315458|7199600|FG002|Overall Study|Withdrawal by Subject|0
4418907|NCT00315458|7199601|FG003|Overall Study|Withdrawal by Subject|2
4418908|NCT00315458|7199598|FG000|Overall Study|Lack of Efficacy|0
4418909|NCT00315458|7199599|FG001|Overall Study|Lack of Efficacy|0
4418910|NCT00315458|7199600|FG002|Overall Study|Lack of Efficacy|20
4418911|NCT00315458|7199601|FG003|Overall Study|Lack of Efficacy|1
4418912|NCT00315458|7199598|FG000|Overall Study|Did not qualify|0
4418913|NCT00315458|7199599|FG001|Overall Study|Did not qualify|0
4418914|NCT00315458|7199600|FG002|Overall Study|Did not qualify|1
4418915|NCT00315458|7199601|FG003|Overall Study|Did not qualify|0
4418916|NCT00315705|7199630|FG000|Phase 1|Refused further treatment|1
4418917|NCT00315705|7199630|FG000|Phase 1|Failure to achieve response|8
4418918|NCT00315705|7199630|FG000|Phase 1|Disease relapse|4
4418919|NCT00315705|7199630|FG000|Phase 1|Scheduled for transplant|9
4418920|NCT00315705|7199630|FG000|Phase 1|Death|3
4418921|NCT00315705|7199630|FG000|Phase 2|Physician Decision|4
4418922|NCT00315705|7199630|FG000|Phase 2|Adverse Event|1
4418923|NCT00315705|7199630|FG000|Phase 2|Failure to achieve response|3
4418924|NCT00315705|7199630|FG000|Phase 2|Disease relapse|1
4418925|NCT00315705|7199630|FG000|Phase 2|Scheduled for transplant|8
4418926|NCT00315705|7199630|FG000|Phase 2|Other|1
4418927|NCT00315705|7199630|FG000|Phase 2|Death|7
4418928|NCT00315731|7199647|FG000|Overall Study|Lost to Follow-up|1
4418929|NCT00315731|7199647|FG000|Overall Study|Death|5
4418930|NCT00316004|7199673|FG000|Overall Study|Subject was not given study fluid.|14
4418931|NCT00316004|7199674|FG001|Overall Study|Subject was not given study fluid.|14
4418932|NCT00316004|7199675|FG002|Overall Study|Subject was not given study fluid.|21
4418933|NCT00316017|7199686|FG000|Overall Study|Protocol Violation|11
4418934|NCT00316017|7199687|FG001|Overall Study|Protocol Violation|13
4418935|NCT00316017|7199688|FG002|Overall Study|Protocol Violation|19
4418936|NCT00316082|7199701|FG000|Overall Study|Lack of Efficacy|2
4418937|NCT00316082|7199702|FG001|Overall Study|Lack of Efficacy|3
4418938|NCT00316082|7199703|FG002|Overall Study|Lack of Efficacy|3
4418939|NCT00316082|7199704|FG003|Overall Study|Lack of Efficacy|4
4418940|NCT00316082|7199705|FG004|Overall Study|Lack of Efficacy|6
4418941|NCT00316082|7199701|FG000|Overall Study|Withdrawal of Consent by Subject|10
4418942|NCT00316082|7199702|FG001|Overall Study|Withdrawal of Consent by Subject|8
4418943|NCT00316082|7199703|FG002|Overall Study|Withdrawal of Consent by Subject|2
4418944|NCT00316082|7199704|FG003|Overall Study|Withdrawal of Consent by Subject|9
4418945|NCT00316082|7199705|FG004|Overall Study|Withdrawal of Consent by Subject|5
4418946|NCT00316082|7199701|FG000|Overall Study|Lost to Follow-up|7
4418947|NCT00316082|7199702|FG001|Overall Study|Lost to Follow-up|6
4418948|NCT00316082|7199703|FG002|Overall Study|Lost to Follow-up|7
4418949|NCT00316082|7199704|FG003|Overall Study|Lost to Follow-up|8
4418950|NCT00316082|7199705|FG004|Overall Study|Lost to Follow-up|6
4418951|NCT00316082|7199701|FG000|Overall Study|Poor/noncompliance|6
4418952|NCT00316082|7199702|FG001|Overall Study|Poor/noncompliance|1
4418953|NCT00316082|7199703|FG002|Overall Study|Poor/noncompliance|4
4418954|NCT00316082|7199704|FG003|Overall Study|Poor/noncompliance|1
4418955|NCT00316082|7199705|FG004|Overall Study|Poor/noncompliance|4
4418956|NCT00316082|7199701|FG000|Overall Study|Adverse Event|4
4418957|NCT00316082|7199702|FG001|Overall Study|Adverse Event|2
4418958|NCT00316082|7199703|FG002|Overall Study|Adverse Event|5
4418959|NCT00316082|7199704|FG003|Overall Study|Adverse Event|1
4418960|NCT00316082|7199705|FG004|Overall Study|Adverse Event|3
4418961|NCT00316082|7199701|FG000|Overall Study|Subject no longer meets study criteria|3
4418962|NCT00316082|7199702|FG001|Overall Study|Subject no longer meets study criteria|1
4418963|NCT00316082|7199703|FG002|Overall Study|Subject no longer meets study criteria|2
4418964|NCT00316082|7199704|FG003|Overall Study|Subject no longer meets study criteria|2
4418965|NCT00316082|7199705|FG004|Overall Study|Subject no longer meets study criteria|1
4418966|NCT00316082|7199701|FG000|Overall Study|Physician Decision|1
4418967|NCT00316082|7199702|FG001|Overall Study|Physician Decision|1
4418968|NCT00316082|7199703|FG002|Overall Study|Physician Decision|2
4418969|NCT00316082|7199704|FG003|Overall Study|Physician Decision|1
4418970|NCT00316082|7199705|FG004|Overall Study|Physician Decision|1
4418971|NCT00316082|7199701|FG000|Overall Study|Death|0
4418972|NCT00316082|7199702|FG001|Overall Study|Death|0
4418973|NCT00316082|7199703|FG002|Overall Study|Death|1
4418974|NCT00316082|7199704|FG003|Overall Study|Death|0
4418975|NCT00316082|7199705|FG004|Overall Study|Death|0
4418976|NCT00316082|7199701|FG000|Overall Study|Administrative reason by sponsor|0
4418977|NCT00316082|7199702|FG001|Overall Study|Administrative reason by sponsor|0
4418978|NCT00316082|7199703|FG002|Overall Study|Administrative reason by sponsor|1
4418979|NCT00316082|7199704|FG003|Overall Study|Administrative reason by sponsor|0
4418980|NCT00316082|7199705|FG004|Overall Study|Administrative reason by sponsor|0
4418981|NCT00316121|7199723|FG000|Overall Study|Death|1
4418982|NCT00316121|7199724|FG001|Overall Study|Death|0
4418983|NCT00316121|7199723|FG000|Overall Study|Lost to Follow-up|14
4418984|NCT00316121|7199724|FG001|Overall Study|Lost to Follow-up|8
4418985|NCT00316121|7199723|FG000|Overall Study|Withdrawal by Subject|2
4418986|NCT00316121|7199724|FG001|Overall Study|Withdrawal by Subject|0
4418987|NCT00316121|7199723|FG000|Overall Study|Reason is missing|1
4418988|NCT00316121|7199724|FG001|Overall Study|Reason is missing|0
4418989|NCT00316121|7199723|FG000|Overall Study|Subject relocated|1
4418990|NCT00316121|7199724|FG001|Overall Study|Subject relocated|1
4418991|NCT00316121|7199723|FG000|Overall Study|Subject refused to return|1
4418992|NCT00316121|7199724|FG001|Overall Study|Subject refused to return|0
4418993|NCT00316121|7199723|FG000|Overall Study|Subject no show for visit x 3|1
4418994|NCT00316121|7199724|FG001|Overall Study|Subject no show for visit x 3|0
4418995|NCT00316121|7199723|FG000|Overall Study|Subject did not have 24 month visit|1
4418996|NCT00316121|7199724|FG001|Overall Study|Subject did not have 24 month visit|0
4418997|NCT00316173|7199732|FG000|Run-in Phase|Adverse Event|1
4418998|NCT00316173|7199733|FG001|Run-in Phase|Adverse Event|0
4418999|NCT00316173|7199732|FG000|Run-in Phase|Protocol Violation|1
4419000|NCT00316173|7199733|FG001|Run-in Phase|Protocol Violation|0
4419001|NCT00316173|7199732|FG000|Run-in Phase|Study Follow-up Stopped|5
4419002|NCT00316173|7199733|FG001|Run-in Phase|Study Follow-up Stopped|0
4419003|NCT00316173|7199732|FG000|Treatment Phase|Adverse Event|0
4419004|NCT00316173|7199733|FG001|Treatment Phase|Adverse Event|1
4419005|NCT00316173|7199732|FG000|Treatment Phase|Lack of Efficacy|0
4419006|NCT00316173|7199733|FG001|Treatment Phase|Lack of Efficacy|3
4419007|NCT00316173|7199732|FG000|Treatment Phase|Lost to Follow-up|0
4419008|NCT00316173|7199733|FG001|Treatment Phase|Lost to Follow-up|3
4419009|NCT00316173|7199732|FG000|Treatment Phase|Withdrawal by Subject|0
4419010|NCT00316173|7199733|FG001|Treatment Phase|Withdrawal by Subject|1
4419011|NCT00316173|7199732|FG000|Treatment Phase|Study Follow-up Stopped|0
4419012|NCT00316173|7199733|FG001|Treatment Phase|Study Follow-up Stopped|34
4419013|NCT00316186|7199738|FG000|Overall Study|Adverse Event|6
4419014|NCT00316186|7199738|FG000|Overall Study|Disease Progression|4
4419015|NCT00316186|7199738|FG000|Overall Study|Lost to Follow-up|1
4419016|NCT00316186|7199738|FG000|Overall Study|Other|1
4419017|NCT00316199|7199742|FG000|Overall Study|Adverse Event|2
4419018|NCT00316199|7199742|FG000|Overall Study|Death|8
4419019|NCT00316199|7199742|FG000|Overall Study|Lost to Follow-up|2
4419020|NCT00316225|7199746|FG000|Overall Study|Adverse Event|2
4419021|NCT00316225|7199746|FG000|Overall Study|Physician Decision|3
4419022|NCT00316225|7199746|FG000|Overall Study|Progressive Disease|15
4419023|NCT00316225|7199746|FG000|Overall Study|Withdrawal by Subject|3
4419024|NCT00316225|7199746|FG000|Overall Study|Death|2
4419025|NCT00316264|7199753|FG000|Overall Study|Lost to Follow-up|0
4419026|NCT00316264|7199754|FG001|Overall Study|Lost to Follow-up|1
4419027|NCT00316264|7199755|FG002|Overall Study|Lost to Follow-up|0
4419028|NCT00316264|7199753|FG000|Overall Study|Withdrawal of Consent|3
4419029|NCT00316264|7199754|FG001|Overall Study|Withdrawal of Consent|5
4419030|NCT00316264|7199755|FG002|Overall Study|Withdrawal of Consent|6
4419031|NCT00316264|7199753|FG000|Overall Study|Death|2
4419032|NCT00316264|7199754|FG001|Overall Study|Death|0
4419033|NCT00316264|7199755|FG002|Overall Study|Death|0
4419034|NCT00316264|7199753|FG000|Overall Study|Other|1
4419035|NCT00316264|7199754|FG001|Overall Study|Other|1
4419036|NCT00316264|7199755|FG002|Overall Study|Other|0
4419037|NCT00316277|7199765|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88
4419038|NCT00316277|7199766|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75
4419039|NCT00316277|7199765|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2
4419040|NCT00316277|7199766|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0
4419041|NCT00316277|7199765|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220
4419042|NCT00316277|7199766|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225
4419043|NCT00316277|7199765|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19
4419044|NCT00316277|7199766|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18
4419045|NCT00316277|7199765|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0
4419046|NCT00316277|7199766|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1
4419047|NCT00316303|7199782|FG000|Overall Study|Lost to Follow-up|11
4419048|NCT00316303|7199783|FG001|Overall Study|Lost to Follow-up|16
4419049|NCT00316589|7199826|FG000|Overall Study|Withdrawal by Subject|0
4419050|NCT00316589|7199827|FG001|Overall Study|Withdrawal by Subject|5
4419051|NCT00316589|7199828|FG002|Overall Study|Withdrawal by Subject|0
4419052|NCT00316589|7199829|FG003|Overall Study|Withdrawal by Subject|1
4419053|NCT00316589|7199826|FG000|Overall Study|Subject unwilling/unable to comply|0
4419054|NCT00316589|7199827|FG001|Overall Study|Subject unwilling/unable to comply|6
4419055|NCT00316589|7199828|FG002|Overall Study|Subject unwilling/unable to comply|0
4419056|NCT00316589|7199829|FG003|Overall Study|Subject unwilling/unable to comply|2
4419057|NCT00316589|7199826|FG000|Overall Study|Adverse Event|1
4629457|NCT01872689|7497408|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0
4629458|NCT01872689|7497409|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3
4629459|NCT01872689|7497410|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3
4629460|NCT01872689|7497411|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1
4629461|NCT01872689|7497408|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1
4629462|NCT01872689|7497409|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0
4629463|NCT01872689|7497410|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0
4629464|NCT01872689|7497411|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1
4629465|NCT01872689|7497408|FG000|Double-Blind/Placebo-Controlled Period|Death|3
4629466|NCT01872689|7497409|FG001|Double-Blind/Placebo-Controlled Period|Death|4
4419058|NCT00316589|7199827|FG001|Overall Study|Adverse Event|0
4419059|NCT00316589|7199828|FG002|Overall Study|Adverse Event|0
4419060|NCT00316589|7199829|FG003|Overall Study|Adverse Event|1
4419061|NCT00316589|7199826|FG000|Overall Study|Physician Decision|0
4419062|NCT00316589|7199827|FG001|Overall Study|Physician Decision|1
4419063|NCT00316589|7199828|FG002|Overall Study|Physician Decision|0
4419064|NCT00316589|7199829|FG003|Overall Study|Physician Decision|0
4419065|NCT00316589|7199826|FG000|Overall Study|Other reason|0
4419066|NCT00316589|7199827|FG001|Overall Study|Other reason|12
4419067|NCT00316589|7199828|FG002|Overall Study|Other reason|1
4419068|NCT00316589|7199829|FG003|Overall Study|Other reason|1
4419069|NCT00316602|7199843|FG000|Overall Study|Withdrawal by Subject|3
4419070|NCT00316602|7199844|FG001|Overall Study|Withdrawal by Subject|2
4419071|NCT00316602|7199843|FG000|Overall Study|Subject unwilling/unable to comply with|3
4419072|NCT00316602|7199844|FG001|Overall Study|Subject unwilling/unable to comply with|17
4419073|NCT00316602|7199843|FG000|Overall Study|Adverse Event|1
4419074|NCT00316602|7199844|FG001|Overall Study|Adverse Event|0
4419075|NCT00316602|7199843|FG000|Overall Study|Other|3
4419076|NCT00316602|7199844|FG001|Overall Study|Other|6
4419077|NCT00316693|7199852|FG000|Overall Study|Adverse Event|6
4419078|NCT00316693|7199853|FG001|Overall Study|Adverse Event|1
4629467|NCT01872689|7497410|FG002|Double-Blind/Placebo-Controlled Period|Death|14
4629468|NCT01872689|7497411|FG003|Double-Blind/Placebo-Controlled Period|Death|9
4629469|NCT01872689|7497408|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6
4629470|NCT01872689|7497409|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3
4629471|NCT01872689|7497410|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10
4629472|NCT01872689|7497411|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7
4629473|NCT01872689|7497408|FG000|Open-Label Period (Only For Monotherapy)|Other|2
4629474|NCT01872689|7497409|FG001|Open-Label Period (Only For Monotherapy)|Other|3
4629475|NCT01872689|7497410|FG002|Open-Label Period (Only For Monotherapy)|Other|0
4629476|NCT01872689|7497411|FG003|Open-Label Period (Only For Monotherapy)|Other|0
4629477|NCT01872689|7497408|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11
4629478|NCT01872689|7497409|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12
4629479|NCT01872689|7497410|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0
4629480|NCT01872689|7497411|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0
4629481|NCT01872689|7497408|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0
4629482|NCT01872689|7497409|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1
4629483|NCT01872689|7497410|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0
4629484|NCT01872689|7497411|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0
4629485|NCT01872689|7497408|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1
4629486|NCT01872689|7497409|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3
4629487|NCT01872689|7497410|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0
4629488|NCT01872689|7497411|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0
4629489|NCT01872689|7497408|FG000|Open-Label Period (Only For Monotherapy)|Death|5
4629490|NCT01872689|7497409|FG001|Open-Label Period (Only For Monotherapy)|Death|3
4629491|NCT01872689|7497410|FG002|Open-Label Period (Only For Monotherapy)|Death|0
4629492|NCT01872689|7497411|FG003|Open-Label Period (Only For Monotherapy)|Death|0
4629493|NCT01872689|7497408|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2
4629494|NCT01872689|7497409|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1
4629495|NCT01872689|7497410|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0
4629496|NCT01872689|7497411|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0
4629497|NCT01872715|7497424|FG000|Overall Study|Adverse Event|1
4629498|NCT01872715|7497424|FG000|Overall Study|Protocol Violation|1
4629499|NCT01872715|7497424|FG000|Overall Study|Withdrawal by Subject|2
4629500|NCT01872910|7497449|FG000|Overall Study|Lost to Follow-up|2
4629501|NCT01872910|7497450|FG001|Overall Study|Lost to Follow-up|0
4419079|NCT00316693|7199852|FG000|Overall Study|Protocol Violation|1
4419080|NCT00316693|7199853|FG001|Overall Study|Protocol Violation|0
4419081|NCT00316693|7199852|FG000|Overall Study|Withdrawal by Subject|6
4419082|NCT00316693|7199853|FG001|Overall Study|Withdrawal by Subject|6
4419083|NCT00316693|7199852|FG000|Overall Study|Lost to Follow-up|26
4419084|NCT00316693|7199853|FG001|Overall Study|Lost to Follow-up|34
4419085|NCT00316693|7199852|FG000|Overall Study|Other|38
4419086|NCT00316693|7199853|FG001|Overall Study|Other|44
4419087|NCT00316706|7199861|FG000|Overall Study|Lost to Follow-up|38
4419088|NCT00316706|7199862|FG001|Overall Study|Lost to Follow-up|48
4419089|NCT00316719|7199870|FG000|Overall Study|Adverse Event|0
4419090|NCT00316719|7199871|FG001|Overall Study|Adverse Event|6
4419091|NCT00316719|7199870|FG000|Overall Study|Consent withdrawn|2
4419092|NCT00316719|7199871|FG001|Overall Study|Consent withdrawn|0
4419093|NCT00316888|7199883|FG000|Overall Study|Adverse Event|4
4419094|NCT00316888|7199884|FG001|Overall Study|Adverse Event|5
4419095|NCT00316888|7199883|FG000|Overall Study|Withdrawal by Subject|2
4419096|NCT00316888|7199884|FG001|Overall Study|Withdrawal by Subject|2
4419097|NCT00316888|7199883|FG000|Overall Study|Not start protocol therapy|0
4419098|NCT00316888|7199884|FG001|Overall Study|Not start protocol therapy|1
4419099|NCT00316914|7199892|FG000|Overall Study|Withdrawal by Subject|5
4419100|NCT00316914|7199893|FG001|Overall Study|Withdrawal by Subject|3
4419101|NCT00316914|7199892|FG000|Overall Study|Adverse Event|8
4419102|NCT00316914|7199893|FG001|Overall Study|Adverse Event|7
4419103|NCT00316914|7199892|FG000|Overall Study|Other Problems|6
4419104|NCT00316914|7199893|FG001|Overall Study|Other Problems|11
4419105|NCT00316914|7199892|FG000|Overall Study|Missing end of treatment documentation|14
4419106|NCT00316914|7199893|FG001|Overall Study|Missing end of treatment documentation|15
4419107|NCT00317044|7199902|FG000|Overall Study|Protocol Violation|28
4419108|NCT00317044|7199903|FG001|Overall Study|Protocol Violation|22
4419109|NCT00317044|7199904|FG002|Overall Study|Protocol Violation|20
4419110|NCT00317044|7199902|FG000|Overall Study|Adverse Event|4
4419111|NCT00317044|7199903|FG001|Overall Study|Adverse Event|7
4419112|NCT00317044|7199904|FG002|Overall Study|Adverse Event|4
4419113|NCT00317044|7199902|FG000|Overall Study|Withdrawal by Subject|10
4419114|NCT00317044|7199903|FG001|Overall Study|Withdrawal by Subject|7
4419115|NCT00317044|7199904|FG002|Overall Study|Withdrawal by Subject|12
4419116|NCT00317044|7199902|FG000|Overall Study|Lost to Follow-up|0
4419117|NCT00317044|7199903|FG001|Overall Study|Lost to Follow-up|2
4419118|NCT00317044|7199904|FG002|Overall Study|Lost to Follow-up|3
4419119|NCT00317044|7199902|FG000|Overall Study|Multiple Reasons|6
4419120|NCT00317044|7199903|FG001|Overall Study|Multiple Reasons|2
4419121|NCT00317044|7199904|FG002|Overall Study|Multiple Reasons|6
4419122|NCT00317109|7199914|FG000|Overall Study|Withdrawal by Subject|2
4419123|NCT00317109|7199915|FG001|Overall Study|Withdrawal by Subject|0
4419124|NCT00317109|7199914|FG000|Overall Study|Migated/moved from study area|1
4419125|NCT00317109|7199915|FG001|Overall Study|Migated/moved from study area|0
4419126|NCT00317356|7199938|FG000|Overall Study|Adverse Event|0
4419127|NCT00317356|7199939|FG001|Overall Study|Adverse Event|0
4419128|NCT00317356|7199940|FG002|Overall Study|Adverse Event|1
4419129|NCT00317356|7199941|FG003|Overall Study|Adverse Event|0
4419130|NCT00317356|7199938|FG000|Overall Study|Lack of Efficacy|1
4419131|NCT00317356|7199939|FG001|Overall Study|Lack of Efficacy|1
4419132|NCT00317356|7199940|FG002|Overall Study|Lack of Efficacy|0
4419133|NCT00317356|7199941|FG003|Overall Study|Lack of Efficacy|3
4419134|NCT00317356|7199938|FG000|Overall Study|Physician Decision|0
4419135|NCT00317356|7199939|FG001|Overall Study|Physician Decision|1
4419136|NCT00317356|7199940|FG002|Overall Study|Physician Decision|0
4419137|NCT00317356|7199941|FG003|Overall Study|Physician Decision|0
4419138|NCT00317369|7199954|FG000|Overall Study|Adverse Event|2
4419139|NCT00317369|7199955|FG001|Overall Study|Adverse Event|1
4419140|NCT00317369|7199956|FG002|Overall Study|Adverse Event|0
4419141|NCT00317369|7199954|FG000|Overall Study|Lack of Efficacy|0
4419142|NCT00317369|7199955|FG001|Overall Study|Lack of Efficacy|1
4419143|NCT00317369|7199956|FG002|Overall Study|Lack of Efficacy|1
4419144|NCT00317369|7199954|FG000|Overall Study|Withdrawal by Subject|0
4419145|NCT00317369|7199955|FG001|Overall Study|Withdrawal by Subject|0
4419146|NCT00317369|7199956|FG002|Overall Study|Withdrawal by Subject|1
4419147|NCT00317473|7199970|FG000|Overall Study|Withdrawal by Subject|2
4419148|NCT00317473|7199971|FG001|Overall Study|Withdrawal by Subject|1
4419149|NCT00317473|7199972|FG002|Overall Study|Withdrawal by Subject|2
4419150|NCT00317473|7199973|FG003|Overall Study|Withdrawal by Subject|1
4419151|NCT00317473|7199974|FG004|Overall Study|Withdrawal by Subject|3
4419152|NCT00317473|7199975|FG005|Overall Study|Withdrawal by Subject|1
4419153|NCT00317473|7199970|FG000|Overall Study|Relocation|1
4419154|NCT00317473|7199971|FG001|Overall Study|Relocation|0
4419155|NCT00317473|7199972|FG002|Overall Study|Relocation|1
4419156|NCT00317473|7199973|FG003|Overall Study|Relocation|1
4419157|NCT00317473|7199974|FG004|Overall Study|Relocation|5
4419158|NCT00317473|7199975|FG005|Overall Study|Relocation|2
4419159|NCT00317473|7199970|FG000|Overall Study|Death|1
4419160|NCT00317473|7199971|FG001|Overall Study|Death|0
4419161|NCT00317473|7199972|FG002|Overall Study|Death|0
4419162|NCT00317473|7199973|FG003|Overall Study|Death|0
4419163|NCT00317473|7199974|FG004|Overall Study|Death|0
4419164|NCT00317473|7199975|FG005|Overall Study|Death|0
4419165|NCT00317473|7199970|FG000|Overall Study|Other|0
4419166|NCT00317473|7199971|FG001|Overall Study|Other|2
4419167|NCT00317473|7199972|FG002|Overall Study|Other|0
4419168|NCT00317473|7199973|FG003|Overall Study|Other|0
4419169|NCT00317473|7199974|FG004|Overall Study|Other|0
4419170|NCT00317473|7199975|FG005|Overall Study|Other|0
4419171|NCT00317603|7199999|FG000|Overall Study|Progressive Disease|3
4419172|NCT00317642|7200005|FG000|Overall Study|Not Received Either Study Drug|1
4419173|NCT00317642|7200006|FG001|Overall Study|Not Received Either Study Drug|3
4419174|NCT00317642|7200005|FG000|Overall Study|Physician Decision|15
4419175|NCT00317642|7200006|FG001|Overall Study|Physician Decision|7
4419176|NCT00317642|7200005|FG000|Overall Study|Participant declined treatment|14
4419177|NCT00317642|7200006|FG001|Overall Study|Participant declined treatment|3
4419178|NCT00317642|7200005|FG000|Overall Study|Adverse Event|17
4419179|NCT00317642|7200006|FG001|Overall Study|Adverse Event|5
4419180|NCT00317642|7200005|FG000|Overall Study|Treatment Failure|56
4419181|NCT00317642|7200006|FG001|Overall Study|Treatment Failure|102
4419182|NCT00317642|7200005|FG000|Overall Study|Disease Recurrence|1
4419183|NCT00317642|7200006|FG001|Overall Study|Disease Recurrence|2
4419184|NCT00317642|7200005|FG000|Overall Study|Death|14
4419185|NCT00317642|7200006|FG001|Overall Study|Death|7
4419186|NCT00317642|7200005|FG000|Overall Study|Not Continue to Consolidation|2
4419187|NCT00317642|7200006|FG001|Overall Study|Not Continue to Consolidation|0
4419188|NCT00317642|7200005|FG000|Overall Study|Withdrawal by Subject|0
4419189|NCT00317642|7200006|FG001|Overall Study|Withdrawal by Subject|1
4419190|NCT00317642|7200005|FG000|Overall Study|Referred For Transplantation|1
4419191|NCT00317642|7200006|FG001|Overall Study|Referred For Transplantation|0
4419192|NCT00317642|7200005|FG000|Overall Study|AML Not Centrally Confirmed|1
4419193|NCT00317642|7200006|FG001|Overall Study|AML Not Centrally Confirmed|5
4419194|NCT00318149|7200047|FG000|Overall Study|Adverse Event|0
4419195|NCT00318149|7200048|FG001|Overall Study|Adverse Event|0
4419196|NCT00318149|7200049|FG002|Overall Study|Adverse Event|0
4419197|NCT00318149|7200050|FG003|Overall Study|Adverse Event|0
4419198|NCT00318149|7200051|FG004|Overall Study|Adverse Event|0
4419199|NCT00318149|7200052|FG005|Overall Study|Adverse Event|2
4419200|NCT00318370|7200086|FG000|Period 1|Lack of Efficacy|5
4419201|NCT00318370|7200087|FG001|Period 1|Lack of Efficacy|0
4419202|NCT00318370|7200088|FG002|Period 1|Lack of Efficacy|0
4419203|NCT00318370|7200086|FG000|Period 1|Physician Decision|1
4419204|NCT00318370|7200087|FG001|Period 1|Physician Decision|0
4419205|NCT00318370|7200088|FG002|Period 1|Physician Decision|0
4419206|NCT00318370|7200086|FG000|Period 1|Withdrawal by Subject|1
4419207|NCT00318370|7200087|FG001|Period 1|Withdrawal by Subject|0
4419208|NCT00318370|7200088|FG002|Period 1|Withdrawal by Subject|0
4419209|NCT00318370|7200086|FG000|Period 2|Adverse Event|0
4419210|NCT00318370|7200087|FG001|Period 2|Adverse Event|3
4419211|NCT00318370|7200088|FG002|Period 2|Adverse Event|0
4419212|NCT00318370|7200086|FG000|Period 2|Lack of Efficacy|0
4419213|NCT00318370|7200087|FG001|Period 2|Lack of Efficacy|5
4419214|NCT00318370|7200088|FG002|Period 2|Lack of Efficacy|0
4419215|NCT00318370|7200086|FG000|Period 2|Physician Decision|0
4419216|NCT00318370|7200087|FG001|Period 2|Physician Decision|1
4419217|NCT00318370|7200088|FG002|Period 2|Physician Decision|0
4419218|NCT00318370|7200086|FG000|Period 2|Withdrawal by Subject|0
4419219|NCT00318370|7200087|FG001|Period 2|Withdrawal by Subject|1
4419220|NCT00318370|7200088|FG002|Period 2|Withdrawal by Subject|0
4419221|NCT00318370|7200086|FG000|Period 2|Other|0
4419222|NCT00318370|7200087|FG001|Period 2|Other|1
4419223|NCT00318370|7200088|FG002|Period 2|Other|0
4419224|NCT00318370|7200086|FG000|Period 3|Adverse Event|0
4419225|NCT00318370|7200087|FG001|Period 3|Adverse Event|0
4419226|NCT00318370|7200088|FG002|Period 3|Adverse Event|1
4419227|NCT00318370|7200086|FG000|Period 3|Lack of Efficacy|0
4419228|NCT00318370|7200087|FG001|Period 3|Lack of Efficacy|0
4419229|NCT00318370|7200088|FG002|Period 3|Lack of Efficacy|24
4419230|NCT00318370|7200086|FG000|Period 3|Death|0
4419231|NCT00318370|7200087|FG001|Period 3|Death|0
4419232|NCT00318370|7200088|FG002|Period 3|Death|1
4419233|NCT00318370|7200086|FG000|Period 3|Physician Decision|0
4419234|NCT00318370|7200087|FG001|Period 3|Physician Decision|0
4419235|NCT00318370|7200088|FG002|Period 3|Physician Decision|1
4419236|NCT00318370|7200086|FG000|Period 3|Withdrawal by Subject|0
4419237|NCT00318370|7200087|FG001|Period 3|Withdrawal by Subject|0
4419238|NCT00318370|7200088|FG002|Period 3|Withdrawal by Subject|3
4419239|NCT00318370|7200086|FG000|Period 3|Other|0
4419240|NCT00318370|7200087|FG001|Period 3|Other|0
4419241|NCT00318370|7200088|FG002|Period 3|Other|3
4419242|NCT00318461|7200109|FG000|Double-Blind, 6 Months|Adverse Event|11
4419243|NCT00318461|7200110|FG001|Double-Blind, 6 Months|Adverse Event|23
4419244|NCT00318461|7200111|FG002|Double-Blind, 6 Months|Adverse Event|29
4419245|NCT00318461|7200112|FG003|Double-Blind, 6 Months|Adverse Event|2
4419246|NCT00318461|7200113|FG004|Double-Blind, 6 Months|Adverse Event|8
4419247|NCT00318461|7200109|FG000|Double-Blind, 6 Months|Lack of Efficacy|19
4419248|NCT00318461|7200110|FG001|Double-Blind, 6 Months|Lack of Efficacy|8
4419249|NCT00318461|7200111|FG002|Double-Blind, 6 Months|Lack of Efficacy|13
4419250|NCT00318461|7200112|FG003|Double-Blind, 6 Months|Lack of Efficacy|29
4419251|NCT00318461|7200113|FG004|Double-Blind, 6 Months|Lack of Efficacy|9
4419252|NCT00318461|7200109|FG000|Double-Blind, 6 Months|Protocol Violation|2
4419253|NCT00318461|7200110|FG001|Double-Blind, 6 Months|Protocol Violation|4
4419254|NCT00318461|7200111|FG002|Double-Blind, 6 Months|Protocol Violation|4
4419255|NCT00318461|7200112|FG003|Double-Blind, 6 Months|Protocol Violation|4
4419256|NCT00318461|7200113|FG004|Double-Blind, 6 Months|Protocol Violation|5
4419257|NCT00318461|7200109|FG000|Double-Blind, 6 Months|Lost to follow up|0
4419258|NCT00318461|7200110|FG001|Double-Blind, 6 Months|Lost to follow up|1
4419259|NCT00318461|7200111|FG002|Double-Blind, 6 Months|Lost to follow up|0
4419260|NCT00318461|7200112|FG003|Double-Blind, 6 Months|Lost to follow up|0
4419261|NCT00318461|7200113|FG004|Double-Blind, 6 Months|Lost to follow up|0
4419262|NCT00318461|7200109|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
4419263|NCT00318461|7200110|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1
4419264|NCT00318461|7200111|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
4419265|NCT00318461|7200112|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
4419266|NCT00318461|7200113|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
4419267|NCT00318461|7200109|FG000|Double-Blind, 6 Months|Consent withdrawn|0
4419268|NCT00318461|7200110|FG001|Double-Blind, 6 Months|Consent withdrawn|3
4419269|NCT00318461|7200111|FG002|Double-Blind, 6 Months|Consent withdrawn|4
4419270|NCT00318461|7200112|FG003|Double-Blind, 6 Months|Consent withdrawn|10
4419271|NCT00318461|7200113|FG004|Double-Blind, 6 Months|Consent withdrawn|4
4419272|NCT00318461|7200109|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0
4419273|NCT00318461|7200110|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2
4419274|NCT00318461|7200111|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1
4419275|NCT00318461|7200112|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0
4419276|NCT00318461|7200113|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2
4419277|NCT00318461|7200109|FG000|Double-Blind, 6 Months|Move|0
4419278|NCT00318461|7200110|FG001|Double-Blind, 6 Months|Move|1
4419279|NCT00318461|7200111|FG002|Double-Blind, 6 Months|Move|0
4419280|NCT00318461|7200112|FG003|Double-Blind, 6 Months|Move|0
4419281|NCT00318461|7200113|FG004|Double-Blind, 6 Months|Move|0
4419282|NCT00318461|7200109|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
4419283|NCT00318461|7200110|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
4419284|NCT00318461|7200111|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
4419285|NCT00318461|7200112|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
4419286|NCT00318461|7200113|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1
4419287|NCT00318461|7200109|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1
4419288|NCT00318461|7200110|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0
4419289|NCT00318461|7200111|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0
4419290|NCT00318461|7200112|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2
4512027|NCT00931710|7321645|FG000|Overall Study|Adverse Event|16
4419291|NCT00318461|7200113|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0
4419292|NCT00318461|7200109|FG000|Double-Blind, 6 Months|Work commitment|0
4419293|NCT00318461|7200110|FG001|Double-Blind, 6 Months|Work commitment|0
4419294|NCT00318461|7200111|FG002|Double-Blind, 6 Months|Work commitment|0
4419295|NCT00318461|7200112|FG003|Double-Blind, 6 Months|Work commitment|0
4419296|NCT00318461|7200113|FG004|Double-Blind, 6 Months|Work commitment|1
4419297|NCT00318461|7200109|FG000|Double-Blind, 6 Months|Investigator decision|0
4419298|NCT00318461|7200110|FG001|Double-Blind, 6 Months|Investigator decision|0
4419299|NCT00318461|7200111|FG002|Double-Blind, 6 Months|Investigator decision|0
4419300|NCT00318461|7200112|FG003|Double-Blind, 6 Months|Investigator decision|0
4419301|NCT00318461|7200113|FG004|Double-Blind, 6 Months|Investigator decision|1
4419302|NCT00318461|7200109|FG000|Double-Blind, 6 Months|Lack of time|1
4419303|NCT00318461|7200110|FG001|Double-Blind, 6 Months|Lack of time|0
4419304|NCT00318461|7200111|FG002|Double-Blind, 6 Months|Lack of time|0
4419305|NCT00318461|7200112|FG003|Double-Blind, 6 Months|Lack of time|0
4419306|NCT00318461|7200113|FG004|Double-Blind, 6 Months|Lack of time|0
4419307|NCT00318461|7200109|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
4419308|NCT00318461|7200110|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
4419309|NCT00318461|7200111|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
4419310|NCT00318461|7200112|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
4419311|NCT00318461|7200113|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2
4419312|NCT00318461|7200109|FG000|Double-Blind, 6 Months|Hyperglicaemia|0
4419313|NCT00318461|7200110|FG001|Double-Blind, 6 Months|Hyperglicaemia|0
4419314|NCT00318461|7200111|FG002|Double-Blind, 6 Months|Hyperglicaemia|0
4419315|NCT00318461|7200112|FG003|Double-Blind, 6 Months|Hyperglicaemia|1
4419316|NCT00318461|7200113|FG004|Double-Blind, 6 Months|Hyperglicaemia|0
4419317|NCT00318461|7200109|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
4419318|NCT00318461|7200110|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
4419319|NCT00318461|7200111|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
4419320|NCT00318461|7200112|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
4419321|NCT00318461|7200113|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1
4419322|NCT00318461|7200109|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0
4419323|NCT00318461|7200110|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1
4419324|NCT00318461|7200111|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0
4419325|NCT00318461|7200112|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0
4419326|NCT00318461|7200113|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0
4419327|NCT00318461|7200109|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19
4419328|NCT00318461|7200110|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14
4419329|NCT00318461|7200111|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27
4419330|NCT00318461|7200112|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11
4419331|NCT00318461|7200113|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22
4419332|NCT00318461|7200109|FG000|Open-Label Extension, 18 Months|Adverse Event|11
4419333|NCT00318461|7200110|FG001|Open-Label Extension, 18 Months|Adverse Event|8
4419334|NCT00318461|7200111|FG002|Open-Label Extension, 18 Months|Adverse Event|6
4419335|NCT00318461|7200112|FG003|Open-Label Extension, 18 Months|Adverse Event|1
4419336|NCT00318461|7200113|FG004|Open-Label Extension, 18 Months|Adverse Event|6
4419337|NCT00318461|7200109|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41
4419338|NCT00318461|7200110|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33
4419339|NCT00318461|7200111|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37
4419340|NCT00318461|7200112|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27
4419341|NCT00318461|7200113|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63
4419342|NCT00318461|7200109|FG000|Open-Label Extension, 18 Months|Protocol Violation|7
4419343|NCT00318461|7200110|FG001|Open-Label Extension, 18 Months|Protocol Violation|5
4419344|NCT00318461|7200111|FG002|Open-Label Extension, 18 Months|Protocol Violation|3
4419345|NCT00318461|7200112|FG003|Open-Label Extension, 18 Months|Protocol Violation|4
4419346|NCT00318461|7200113|FG004|Open-Label Extension, 18 Months|Protocol Violation|6
4419347|NCT00318474|7200127|FG000|Overall Study|Adverse Event|1
4419348|NCT00318474|7200128|FG001|Overall Study|Adverse Event|1
4419349|NCT00318474|7200127|FG000|Overall Study|Lost to Follow-up|0
4419350|NCT00318474|7200128|FG001|Overall Study|Lost to Follow-up|1
4419351|NCT00318474|7200127|FG000|Overall Study|Pregnancy|0
4419352|NCT00318474|7200128|FG001|Overall Study|Pregnancy|2
4419353|NCT00318474|7200127|FG000|Overall Study|Protocol Violation|1
4419354|NCT00318474|7200128|FG001|Overall Study|Protocol Violation|0
4419355|NCT00318474|7200127|FG000|Overall Study|Withdrawal by Subject|3
4419356|NCT00318474|7200128|FG001|Overall Study|Withdrawal by Subject|2
4419357|NCT00318474|7200127|FG000|Overall Study|Fall in GFR|3
4419358|NCT00318474|7200128|FG001|Overall Study|Fall in GFR|3
4419359|NCT00318474|7200127|FG000|Overall Study|Post-therapy hyperflycemia|0
4419360|NCT00318474|7200128|FG001|Overall Study|Post-therapy hyperflycemia|1
4419361|NCT00318474|7200127|FG000|Overall Study|Trial terminated|10
4419362|NCT00318474|7200128|FG001|Overall Study|Trial terminated|7
4419363|NCT00318565|7200134|FG000|Overall Study|Excluded per protocol|24
4419364|NCT00318643|7200154|FG000|Overall Study|Adverse Event|0
4419365|NCT00318643|7200155|FG001|Overall Study|Adverse Event|0
4419366|NCT00318643|7200156|FG002|Overall Study|Adverse Event|0
4419367|NCT00318643|7200157|FG003|Overall Study|Adverse Event|0
4419368|NCT00318643|7200158|FG004|Overall Study|Adverse Event|1
4419369|NCT00318643|7200154|FG000|Overall Study|Participant's Decision|0
4419370|NCT00318643|7200155|FG001|Overall Study|Participant's Decision|0
4419371|NCT00318643|7200156|FG002|Overall Study|Participant's Decision|0
4419372|NCT00318643|7200157|FG003|Overall Study|Participant's Decision|0
4419373|NCT00318643|7200158|FG004|Overall Study|Participant's Decision|1
4419374|NCT00318643|7200154|FG000|Overall Study|Investigator's Decision|0
4419375|NCT00318643|7200155|FG001|Overall Study|Investigator's Decision|0
4419376|NCT00318643|7200156|FG002|Overall Study|Investigator's Decision|0
4419377|NCT00318643|7200157|FG003|Overall Study|Investigator's Decision|0
4419378|NCT00318643|7200158|FG004|Overall Study|Investigator's Decision|1
4419379|NCT00319020|7200199|FG000|Overall Study|Death|2
4419380|NCT00319020|7200200|FG001|Overall Study|Death|2
4419381|NCT00319020|7200199|FG000|Overall Study|Withdrawal by Subject|4
4419382|NCT00319020|7200200|FG001|Overall Study|Withdrawal by Subject|1
4419383|NCT00319020|7200199|FG000|Overall Study|F-1 completed but not enrolled in F-2|1
4419384|NCT00319020|7200200|FG001|Overall Study|F-1 completed but not enrolled in F-2|0
4419385|NCT00319020|7200199|FG000|Overall Study|Administrative reason|0
4419386|NCT00319020|7200200|FG001|Overall Study|Administrative reason|5
4419387|NCT00319020|7200199|FG000|Overall Study|Disease progression|0
4419388|NCT00319020|7200200|FG001|Overall Study|Disease progression|2
4419389|NCT00319020|7200199|FG000|Overall Study|Transplant|0
4419390|NCT00319020|7200200|FG001|Overall Study|Transplant|1
4419391|NCT00319020|7200199|FG000|Overall Study|Treatment failure|0
4419392|NCT00319020|7200200|FG001|Overall Study|Treatment failure|1
4419393|NCT00319020|7200199|FG000|Overall Study|Adverse Event|0
4419394|NCT00319020|7200200|FG001|Overall Study|Adverse Event|1
4419395|NCT00319046|7200208|FG000|Overall Study|withdrawal of subject's consent|7
4419396|NCT00319046|7200208|FG000|Overall Study|administrative reason|1
4419397|NCT00319098|7200216|FG000|Overall Study|Serious adverse event|3
4419398|NCT00319098|7200217|FG001|Overall Study|Serious adverse event|0
4419399|NCT00319098|7200216|FG000|Overall Study|Adverse Event|20
4419400|NCT00319098|7200217|FG001|Overall Study|Adverse Event|1
4419401|NCT00319098|7200216|FG000|Overall Study|Withdrawal by Subject|37
4419402|NCT00319098|7200217|FG001|Overall Study|Withdrawal by Subject|8
4419403|NCT00319098|7200216|FG000|Overall Study|Migrated/moved from study area|2
4419404|NCT00319098|7200217|FG001|Overall Study|Migrated/moved from study area|1
4419405|NCT00319098|7200216|FG000|Overall Study|Lost to Follow-up|37
4419406|NCT00319098|7200217|FG001|Overall Study|Lost to Follow-up|13
4419407|NCT00319098|7200216|FG000|Overall Study|Others|33
4419408|NCT00319098|7200217|FG001|Overall Study|Others|8
4419409|NCT00319098|7200216|FG000|Overall Study|Protocol Violation|3
4419410|NCT00319098|7200217|FG001|Overall Study|Protocol Violation|1
4419411|NCT00319111|7200227|FG000|Overall Study|Adverse Event|20
4419412|NCT00319111|7200227|FG000|Overall Study|Withdrawal of consent|11
4419413|NCT00319111|7200227|FG000|Overall Study|Death|9
4419414|NCT00319111|7200227|FG000|Overall Study|Lack of clinical improvement|4
4419415|NCT00319111|7200227|FG000|Overall Study|Administrative|2
4419416|NCT00319111|7200227|FG000|Overall Study|Treatment failure|1
4419417|NCT00319254|7200231|FG000|Overall Study|Withdrawal by Subject|4
4419418|NCT00319254|7200231|FG000|Overall Study|Death|46
4419419|NCT00319254|7200231|FG000|Overall Study|Lost to Follow-up|2
4419420|NCT00319254|7200231|FG000|Overall Study|Enrolled, Not Treated|2
4419421|NCT00319436|7200237|FG000|Overall Study|Withdrawal by Subject|6
4419422|NCT00319436|7200238|FG001|Overall Study|Withdrawal by Subject|7
4419423|NCT00319501|7200246|FG000|Double-blind Period|Withdrawal by Subject|0
4419424|NCT00319501|7200247|FG001|Double-blind Period|Withdrawal by Subject|3
4419425|NCT00319501|7200246|FG000|Double-blind Period|Sponsor Request|1
4419426|NCT00319501|7200247|FG001|Double-blind Period|Sponsor Request|0
4419427|NCT00319501|7200246|FG000|Double-blind Period|Did not receive treatment|42
4419428|NCT00319501|7200247|FG001|Double-blind Period|Did not receive treatment|29
4419429|NCT00319501|7200246|FG000|Open-label Period|Adverse Event|5
4419430|NCT00319501|7200247|FG001|Open-label Period|Adverse Event|0
4419431|NCT00319501|7200246|FG000|Open-label Period|Protocol Violation|6
4419432|NCT00319501|7200247|FG001|Open-label Period|Protocol Violation|0
4419433|NCT00319501|7200246|FG000|Open-label Period|Withdrawal by Subject|38
4419434|NCT00319501|7200247|FG001|Open-label Period|Withdrawal by Subject|0
4419435|NCT00319501|7200246|FG000|Open-label Period|Principal Investigator decision|6
4419436|NCT00319501|7200247|FG001|Open-label Period|Principal Investigator decision|0
4419437|NCT00319501|7200246|FG000|Open-label Period|Sponsor request|12
4419438|NCT00319501|7200247|FG001|Open-label Period|Sponsor request|0
4419439|NCT00319501|7200246|FG000|Open-label Period|Lost to Follow-up|5
4419440|NCT00319501|7200247|FG001|Open-label Period|Lost to Follow-up|0
4419441|NCT00319501|7200246|FG000|Open-label Period|Did not receive treatment|33
4419442|NCT00319501|7200247|FG001|Open-label Period|Did not receive treatment|0
4419443|NCT00319501|7200246|FG000|Open-label Period|Other|11
4419444|NCT00319501|7200247|FG001|Open-label Period|Other|0
4419445|NCT00319501|7200246|FG000|Open-label Extension Period|Adverse Event|2
4419446|NCT00319501|7200247|FG001|Open-label Extension Period|Adverse Event|0
4419447|NCT00319501|7200246|FG000|Open-label Extension Period|Did not receive treatment|18
4419448|NCT00319501|7200247|FG001|Open-label Extension Period|Did not receive treatment|0
4419449|NCT00319501|7200246|FG000|Open-label Extension Period|Other|1
4419450|NCT00319501|7200247|FG001|Open-label Extension Period|Other|0
4419451|NCT00319501|7200246|FG000|Open-label Extension Period|Principal investigator decision|2
4419452|NCT00319501|7200247|FG001|Open-label Extension Period|Principal investigator decision|0
4419453|NCT00319501|7200246|FG000|Open-label Extension Period|Sponsor request|26
4419454|NCT00319501|7200247|FG001|Open-label Extension Period|Sponsor request|0
4419455|NCT00319501|7200246|FG000|Open-label Extension Period|Withdrawal by Subject|2
4419456|NCT00319501|7200247|FG001|Open-label Extension Period|Withdrawal by Subject|0
4419457|NCT00319553|7200260|FG000|Overall Study|Protocol Violation|1
4419458|NCT00319553|7200261|FG001|Overall Study|Protocol Violation|2
4419459|NCT00319553|7200260|FG000|Overall Study|Lost to Follow-up|2
4419460|NCT00319553|7200261|FG001|Overall Study|Lost to Follow-up|1
4419461|NCT00319553|7200260|FG000|Overall Study|Withdrawal by Subject|1
4419462|NCT00319553|7200261|FG001|Overall Study|Withdrawal by Subject|1
4419463|NCT00319592|7200269|FG000|Overall Study|Protocol Violation|1
4419464|NCT00319592|7200270|FG001|Overall Study|Protocol Violation|0
4419465|NCT00319592|7200269|FG000|Overall Study|Physician Decision|0
4419466|NCT00319592|7200270|FG001|Overall Study|Physician Decision|1
4419467|NCT00319696|7200285|FG000|Overall Study|Adverse Event|36
4419468|NCT00319696|7200285|FG000|Overall Study|withdrawal of consent|14
4419469|NCT00319696|7200285|FG000|Overall Study|administrative|7
4419470|NCT00319696|7200285|FG000|Overall Study|Lost to Follow-up|3
4419471|NCT00319735|7200295|FG000|Overall Study|Death|2
4419472|NCT00319956|7200312|FG000|Overall Study|Death|20
4419473|NCT00319956|7200313|FG001|Overall Study|Death|24
4419474|NCT00319982|7200321|FG000|Overall Study|Withdrawal by Subject|1
4419475|NCT00319982|7200322|FG001|Overall Study|Withdrawal by Subject|0
4419476|NCT00320112|7200330|FG000|Overall Study|Lost to Follow-up|3
4419477|NCT00320112|7200331|FG001|Overall Study|Lost to Follow-up|4
4419478|NCT00320112|7200330|FG000|Overall Study|Withdrawal by Subject|3
4419479|NCT00320112|7200331|FG001|Overall Study|Withdrawal by Subject|0
4419480|NCT00320112|7200330|FG000|Overall Study|Death|2
4419481|NCT00320112|7200331|FG001|Overall Study|Death|1
4419482|NCT00320190|7200345|FG000|First 12 Months|Completed but did not enter extension|5
4419483|NCT00320190|7200346|FG001|First 12 Months|Completed but did not enter extension|3
4419484|NCT00320190|7200345|FG000|First 12 Months|Sponsor terminated study|2
4419485|NCT00320190|7200346|FG001|First 12 Months|Sponsor terminated study|2
4419486|NCT00320190|7200345|FG000|First 12 Months|Lost to Follow-up|0
4419487|NCT00320190|7200346|FG001|First 12 Months|Lost to Follow-up|1
4419488|NCT00320190|7200345|FG000|First 12 Months|Enrollment failure|0
4419489|NCT00320190|7200346|FG001|First 12 Months|Enrollment failure|1
4419490|NCT00320190|7200345|FG000|First 12 Months|Adverse event unrelated to study drug|1
4419491|NCT00320190|7200346|FG001|First 12 Months|Adverse event unrelated to study drug|0
4419492|NCT00320190|7200345|FG000|First 12 Months|Investigator request|0
4419493|NCT00320190|7200346|FG001|First 12 Months|Investigator request|1
4419494|NCT00320190|7200345|FG000|First 12 Months|Study drug toxicity|0
4419495|NCT00320190|7200346|FG001|First 12 Months|Study drug toxicity|1
4419496|NCT00320190|7200345|FG000|First 12 Months|Withdrawal by Subject|0
4419497|NCT00320190|7200346|FG001|First 12 Months|Withdrawal by Subject|1
4419498|NCT00320190|7200345|FG000|Long-term (12-month) Extension|Sponsor terminated study|7
4419499|NCT00320190|7200346|FG001|Long-term (12-month) Extension|Sponsor terminated study|0
4419500|NCT00320190|7200345|FG000|Long-term (12-month) Extension|Lack of major molecular response|1
4419501|NCT00320190|7200346|FG001|Long-term (12-month) Extension|Lack of major molecular response|2
4419502|NCT00320190|7200345|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1
4419503|NCT00320190|7200346|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0
4419504|NCT00320216|7200357|FG000|Overall Study|Adverse Event|0
4419505|NCT00320216|7200358|FG001|Overall Study|Adverse Event|6
4419506|NCT00320216|7200359|FG002|Overall Study|Adverse Event|0
4419507|NCT00320216|7200360|FG003|Overall Study|Adverse Event|2
4419508|NCT00320216|7200361|FG004|Overall Study|Adverse Event|2
4419509|NCT00320216|7200357|FG000|Overall Study|Lack of Efficacy|6
4419510|NCT00320216|7200358|FG001|Overall Study|Lack of Efficacy|2
4419511|NCT00320216|7200359|FG002|Overall Study|Lack of Efficacy|1
4419512|NCT00320216|7200360|FG003|Overall Study|Lack of Efficacy|0
4419513|NCT00320216|7200361|FG004|Overall Study|Lack of Efficacy|1
4419514|NCT00320216|7200357|FG000|Overall Study|Lost to Follow-up|3
4419515|NCT00320216|7200358|FG001|Overall Study|Lost to Follow-up|0
4419516|NCT00320216|7200359|FG002|Overall Study|Lost to Follow-up|0
4419517|NCT00320216|7200360|FG003|Overall Study|Lost to Follow-up|0
4419518|NCT00320216|7200361|FG004|Overall Study|Lost to Follow-up|0
4419519|NCT00320216|7200357|FG000|Overall Study|Other|7
4419520|NCT00320216|7200358|FG001|Overall Study|Other|2
4419521|NCT00320216|7200359|FG002|Overall Study|Other|5
4419522|NCT00320216|7200360|FG003|Overall Study|Other|1
4419523|NCT00320216|7200361|FG004|Overall Study|Other|3
4419524|NCT00320255|7200392|FG000|Overall Study|Lack of Efficacy|1
4419525|NCT00320255|7200393|FG001|Overall Study|Lack of Efficacy|0
4419526|NCT00320255|7200394|FG002|Overall Study|Lack of Efficacy|0
4419527|NCT00320255|7200395|FG003|Overall Study|Lack of Efficacy|0
4419528|NCT00320255|7200396|FG004|Overall Study|Lack of Efficacy|0
4419529|NCT00320255|7200397|FG005|Overall Study|Lack of Efficacy|0
4419530|NCT00320255|7200392|FG000|Overall Study|Adverse Event|5
4419531|NCT00320255|7200393|FG001|Overall Study|Adverse Event|2
4419532|NCT00320255|7200394|FG002|Overall Study|Adverse Event|3
4419533|NCT00320255|7200395|FG003|Overall Study|Adverse Event|2
4419534|NCT00320255|7200396|FG004|Overall Study|Adverse Event|0
4419535|NCT00320255|7200397|FG005|Overall Study|Adverse Event|0
4419536|NCT00320255|7200392|FG000|Overall Study|Withdrawal by Subject|1
4419537|NCT00320255|7200393|FG001|Overall Study|Withdrawal by Subject|2
4419538|NCT00320255|7200394|FG002|Overall Study|Withdrawal by Subject|2
4419539|NCT00320255|7200395|FG003|Overall Study|Withdrawal by Subject|4
4419540|NCT00320255|7200396|FG004|Overall Study|Withdrawal by Subject|0
4419541|NCT00320255|7200397|FG005|Overall Study|Withdrawal by Subject|0
4419542|NCT00320255|7200392|FG000|Overall Study|Poor compliance/noncompliance|1
4419543|NCT00320255|7200393|FG001|Overall Study|Poor compliance/noncompliance|1
4419544|NCT00320255|7200394|FG002|Overall Study|Poor compliance/noncompliance|0
4419545|NCT00320255|7200395|FG003|Overall Study|Poor compliance/noncompliance|1
4419546|NCT00320255|7200396|FG004|Overall Study|Poor compliance/noncompliance|0
4419547|NCT00320255|7200397|FG005|Overall Study|Poor compliance/noncompliance|0
4419548|NCT00320255|7200392|FG000|Overall Study|No longer meets study criteria|0
4419549|NCT00320255|7200393|FG001|Overall Study|No longer meets study criteria|0
4419550|NCT00320255|7200394|FG002|Overall Study|No longer meets study criteria|0
4419551|NCT00320255|7200395|FG003|Overall Study|No longer meets study criteria|1
4419552|NCT00320255|7200396|FG004|Overall Study|No longer meets study criteria|0
4419553|NCT00320255|7200397|FG005|Overall Study|No longer meets study criteria|0
4419554|NCT00320255|7200392|FG000|Overall Study|Other|3
4419555|NCT00320255|7200393|FG001|Overall Study|Other|2
4419556|NCT00320255|7200394|FG002|Overall Study|Other|1
4419557|NCT00320255|7200395|FG003|Overall Study|Other|0
4419558|NCT00320255|7200396|FG004|Overall Study|Other|0
4419559|NCT00320255|7200397|FG005|Overall Study|Other|0
4419560|NCT00320372|7200426|FG000|Overall Study|Physician Decision|4
4419561|NCT00320372|7200427|FG001|Overall Study|Physician Decision|7
4419562|NCT00320372|7200426|FG000|Overall Study|Death|7
4419563|NCT00320372|7200427|FG001|Overall Study|Death|8
4419564|NCT00320372|7200426|FG000|Overall Study|Withdrawal by Subject|55
4419565|NCT00320372|7200427|FG001|Overall Study|Withdrawal by Subject|37
4419566|NCT00320372|7200426|FG000|Overall Study|Non-Compliance|40
4419567|NCT00320372|7200427|FG001|Overall Study|Non-Compliance|39
4419568|NCT00320372|7200426|FG000|Overall Study|Did not Meet (I/E)|3
4419569|NCT00320372|7200427|FG001|Overall Study|Did not Meet (I/E)|1
4419570|NCT00320372|7200426|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86
4419571|NCT00320372|7200427|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71
4512028|NCT00931710|7321646|FG001|Overall Study|Adverse Event|10
4512029|NCT00931710|7321645|FG000|Overall Study|Abnormal test procedure results|2
4512030|NCT00931710|7321646|FG001|Overall Study|Abnormal test procedure results|0
4512031|NCT00931710|7321645|FG000|Overall Study|Unsatisfactory therapeutic effects|5
4512032|NCT00931710|7321646|FG001|Overall Study|Unsatisfactory therapeutic effects|12
4512033|NCT00931710|7321645|FG000|Overall Study|Patient withdrew consent|4
4512034|NCT00931710|7321646|FG001|Overall Study|Patient withdrew consent|9
4512035|NCT00931710|7321645|FG000|Overall Study|Lost to Follow-up|6
4512036|NCT00931710|7321646|FG001|Overall Study|Lost to Follow-up|5
4512037|NCT00931710|7321645|FG000|Overall Study|Protocol deviation|1
4512038|NCT00931710|7321646|FG001|Overall Study|Protocol deviation|2
4512039|NCT00931723|7321654|FG000|Overall Study|Withdrawal by Subject|11
4512040|NCT00931723|7321655|FG001|Overall Study|Withdrawal by Subject|13
4512041|NCT00931723|7321654|FG000|Overall Study|Adverse Event|6
4512042|NCT00931723|7321655|FG001|Overall Study|Adverse Event|13
4512043|NCT00931723|7321654|FG000|Overall Study|Lithium found in blood|0
4512044|NCT00931723|7321655|FG001|Overall Study|Lithium found in blood|1
4512045|NCT00931723|7321654|FG000|Overall Study|Condition under investigation worsened|1
4512046|NCT00931723|7321655|FG001|Overall Study|Condition under investigation worsened|2
4512047|NCT00931723|7321654|FG000|Overall Study|Lost to Follow-up|1
4512048|NCT00931723|7321655|FG001|Overall Study|Lost to Follow-up|2
4512049|NCT00931723|7321654|FG000|Overall Study|Study-specific discontinuation criteria|1
4512050|NCT00931723|7321655|FG001|Overall Study|Study-specific discontinuation criteria|1
4512051|NCT00931723|7321654|FG000|Overall Study|Severe non-compliance to protocol|2
4512052|NCT00931723|7321655|FG001|Overall Study|Severe non-compliance to protocol|0
4512053|NCT00931723|7321654|FG000|Overall Study|Safety reasons|0
4512054|NCT00931723|7321655|FG001|Overall Study|Safety reasons|1
4512055|NCT00931723|7321654|FG000|Overall Study|Took prohibited concomitant medication|0
4512056|NCT00931723|7321655|FG001|Overall Study|Took prohibited concomitant medication|1
4512057|NCT00931723|7321654|FG000|Overall Study|Lack or insufficient theraputic response|2
4512058|NCT00931723|7321655|FG001|Overall Study|Lack or insufficient theraputic response|5
4512059|NCT00931723|7321654|FG000|Overall Study|Sponsor decision|1
4512060|NCT00931723|7321655|FG001|Overall Study|Sponsor decision|0
4512061|NCT00931723|7321654|FG000|Overall Study|Late hospital discharge|1
4512062|NCT00931723|7321655|FG001|Overall Study|Late hospital discharge|0
4512063|NCT00931762|7321661|FG000|Overall Study|Abnormal Laboratory Value (s)|2
4512064|NCT00931762|7321661|FG000|Overall Study|Administrative Problems|5
4512065|NCT00931762|7321661|FG000|Overall Study|Death|1
4512066|NCT00931762|7321661|FG000|Overall Study|Disease Progression|3
4512067|NCT00931762|7321661|FG000|Overall Study|Adverse Event (s)|11
4512068|NCT00931762|7321661|FG000|Overall Study|Subject withdrew consent|13
4512069|NCT00931801|7321668|FG000|Overall Study|Adverse Event|0
4419572|NCT00320385|7200443|FG000|Overall Study|Lost to Follow-up|7
4419573|NCT00320385|7200444|FG001|Overall Study|Lost to Follow-up|10
4419574|NCT00320385|7200443|FG000|Overall Study|Withdrawal by Subject|6
4419575|NCT00320385|7200444|FG001|Overall Study|Withdrawal by Subject|7
4419576|NCT00320385|7200443|FG000|Overall Study|Sponsor Terminated Study|2
4419577|NCT00320385|7200444|FG001|Overall Study|Sponsor Terminated Study|1
4419578|NCT00320385|7200443|FG000|Overall Study|Investigator Decision|0
4419579|NCT00320385|7200444|FG001|Overall Study|Investigator Decision|1
4419580|NCT00320385|7200443|FG000|Overall Study|Death|1
4419581|NCT00320385|7200444|FG001|Overall Study|Death|2
4419582|NCT00320385|7200443|FG000|Overall Study|Serious Adverse Event|1
4419583|NCT00320385|7200444|FG001|Overall Study|Serious Adverse Event|0
4419584|NCT00320385|7200443|FG000|Overall Study|Withdrew Consent|1
4419585|NCT00320385|7200444|FG001|Overall Study|Withdrew Consent|0
4419586|NCT00320385|7200443|FG000|Overall Study|Adverse Event|0
4419587|NCT00320385|7200444|FG001|Overall Study|Adverse Event|1
4419588|NCT00320398|7200452|FG000|Overall Study|Adverse Event|1
4419589|NCT00320398|7200453|FG001|Overall Study|Adverse Event|4
4419590|NCT00320398|7200452|FG000|Overall Study|Other|1
4419591|NCT00320398|7200453|FG001|Overall Study|Other|0
4419592|NCT00320411|7200460|FG000|Overall Study|No investigational product admin.|4
4419593|NCT00320424|7200464|FG000|Overall Study|Adverse Event|3
4419594|NCT00320424|7200464|FG000|Overall Study|Other|3
4419595|NCT00320489|7200470|FG000|Overall Study|Adverse Event|26
4419596|NCT00320489|7200471|FG001|Overall Study|Adverse Event|25
4419597|NCT00320489|7200470|FG000|Overall Study|Clinical Relapse|26
4419598|NCT00320489|7200471|FG001|Overall Study|Clinical Relapse|20
4419599|NCT00320489|7200470|FG000|Overall Study|Death|0
4419600|NCT00320489|7200471|FG001|Overall Study|Death|2
4419601|NCT00320489|7200470|FG000|Overall Study|Entry Criteria Exclusion|2
4419602|NCT00320489|7200471|FG001|Overall Study|Entry Criteria Exclusion|4
4419603|NCT00320489|7200470|FG000|Overall Study|Lack of Efficacy|16
4419604|NCT00320489|7200471|FG001|Overall Study|Lack of Efficacy|7
4419605|NCT00320489|7200470|FG000|Overall Study|Lost to Follow-up|21
4419606|NCT00320489|7200471|FG001|Overall Study|Lost to Follow-up|22
4419607|NCT00320489|7200470|FG000|Overall Study|Physician Decision|8
4419608|NCT00320489|7200471|FG001|Overall Study|Physician Decision|8
4419609|NCT00320489|7200470|FG000|Overall Study|Protocol Violation|4
4419610|NCT00320489|7200471|FG001|Overall Study|Protocol Violation|4
4419611|NCT00320489|7200470|FG000|Overall Study|Sponsor Decision|3
4419612|NCT00320489|7200471|FG001|Overall Study|Sponsor Decision|3
4419613|NCT00320489|7200470|FG000|Overall Study|Withdrawal by Subject|39
4419614|NCT00320489|7200471|FG001|Overall Study|Withdrawal by Subject|41
4419615|NCT00320515|7200477|FG000|Overall Study|Death|33
4419616|NCT00320515|7200477|FG000|Overall Study|Lost to Follow-up|6
4419617|NCT00320515|7200477|FG000|Overall Study|Physician Decision|2
4419618|NCT00320515|7200477|FG000|Overall Study|Withdrawal by Subject|8
4419619|NCT00320528|7200484|FG000|Study Period II|Adverse Event|3
4419620|NCT00320528|7200485|FG001|Study Period II|Adverse Event|4
4419621|NCT00320528|7200486|FG002|Study Period II|Adverse Event|8
4419622|NCT00320528|7200484|FG000|Study Period II|Parent/Caregiver Decision|8
4419623|NCT00320528|7200485|FG001|Study Period II|Parent/Caregiver Decision|3
4419624|NCT00320528|7200486|FG002|Study Period II|Parent/Caregiver Decision|11
4419625|NCT00320528|7200484|FG000|Study Period II|Withdrawal by Subject|0
4419626|NCT00320528|7200485|FG001|Study Period II|Withdrawal by Subject|1
4419627|NCT00320528|7200486|FG002|Study Period II|Withdrawal by Subject|1
4419628|NCT00320528|7200484|FG000|Study Period II|Entry Criteria Exclusion|0
4419629|NCT00320528|7200485|FG001|Study Period II|Entry Criteria Exclusion|2
4419630|NCT00320528|7200486|FG002|Study Period II|Entry Criteria Exclusion|2
4419631|NCT00320528|7200484|FG000|Study Period III|Adverse Event|1
4419632|NCT00320528|7200485|FG001|Study Period III|Adverse Event|0
4419633|NCT00320528|7200486|FG002|Study Period III|Adverse Event|0
4419634|NCT00320528|7200484|FG000|Study Period III|Lost to Follow-up|1
4419635|NCT00320528|7200485|FG001|Study Period III|Lost to Follow-up|0
4419636|NCT00320528|7200486|FG002|Study Period III|Lost to Follow-up|0
4419637|NCT00320528|7200484|FG000|Study Period III|Withdrawal by Subject|1
4419638|NCT00320528|7200485|FG001|Study Period III|Withdrawal by Subject|1
4419639|NCT00320528|7200486|FG002|Study Period III|Withdrawal by Subject|2
4419640|NCT00320528|7200484|FG000|Study Period III|Lack of Efficacy|2
4419641|NCT00320528|7200485|FG001|Study Period III|Lack of Efficacy|0
4419642|NCT00320528|7200486|FG002|Study Period III|Lack of Efficacy|0
4419643|NCT00320528|7200484|FG000|Study Period III|Parent/Caregiver Decision|14
4419644|NCT00320528|7200485|FG001|Study Period III|Parent/Caregiver Decision|3
4419645|NCT00320528|7200486|FG002|Study Period III|Parent/Caregiver Decision|11
4419646|NCT00320528|7200484|FG000|Study Period III|Protocol Violation|0
4419647|NCT00320528|7200485|FG001|Study Period III|Protocol Violation|1
4419648|NCT00320528|7200486|FG002|Study Period III|Protocol Violation|0
4419649|NCT00320528|7200484|FG000|Study Period III|Physician Decision|0
4419650|NCT00320528|7200485|FG001|Study Period III|Physician Decision|1
4419651|NCT00320528|7200486|FG002|Study Period III|Physician Decision|2
4419652|NCT00320528|7200484|FG000|Study Period III|Sponsor Decision|0
4419653|NCT00320528|7200485|FG001|Study Period III|Sponsor Decision|0
4419654|NCT00320528|7200486|FG002|Study Period III|Sponsor Decision|1
4419655|NCT00320528|7200484|FG000|Study Period III|Atomoxetine Commercially Available|68
4512070|NCT00931801|7321669|FG001|Overall Study|Adverse Event|0
4419656|NCT00320528|7200485|FG001|Study Period III|Atomoxetine Commercially Available|25
4419657|NCT00320528|7200486|FG002|Study Period III|Atomoxetine Commercially Available|90
4419658|NCT00320541|7200496|FG000|Overall Study|Adverse Event|21
4419659|NCT00320541|7200497|FG001|Overall Study|Adverse Event|19
4419660|NCT00320541|7200496|FG000|Overall Study|Protocol Violation|0
4419661|NCT00320541|7200497|FG001|Overall Study|Protocol Violation|1
4419662|NCT00320541|7200496|FG000|Overall Study|Withdrawal by Subject|12
4419663|NCT00320541|7200497|FG001|Overall Study|Withdrawal by Subject|16
4419664|NCT00320541|7200496|FG000|Overall Study|Physician Decision|9
4419665|NCT00320541|7200497|FG001|Overall Study|Physician Decision|13
4419666|NCT00320541|7200496|FG000|Overall Study|Other|3
4419667|NCT00320541|7200497|FG001|Overall Study|Other|4
4419668|NCT00320541|7200496|FG000|Overall Study|Sponsor Decision|2
4419669|NCT00320541|7200497|FG001|Overall Study|Sponsor Decision|1
4419670|NCT00320541|7200496|FG000|Overall Study|Death due to Study Disease|1
4419671|NCT00320541|7200497|FG001|Overall Study|Death due to Study Disease|3
4419672|NCT00320541|7200496|FG000|Overall Study|Death due to Adverse Event(s)|1
4419673|NCT00320541|7200497|FG001|Overall Study|Death due to Adverse Event(s)|0
4419674|NCT00320541|7200496|FG000|Overall Study|Protocol Entry Criterion Not Met|1
4419675|NCT00320541|7200497|FG001|Overall Study|Protocol Entry Criterion Not Met|0
4419676|NCT00320593|7200505|FG000|Overall Study|Lost to Follow-up|3
4419677|NCT00320593|7200506|FG001|Overall Study|Lost to Follow-up|0
4419678|NCT00320593|7200505|FG000|Overall Study|Moved to another state|1
4419679|NCT00320593|7200506|FG001|Overall Study|Moved to another state|0
4419680|NCT00320593|7200505|FG000|Overall Study|Withdrawal by Subject|2
4419681|NCT00320593|7200506|FG001|Overall Study|Withdrawal by Subject|1
4419682|NCT00320593|7200505|FG000|Overall Study|Withdrawal by clinical center|1
4419683|NCT00320593|7200506|FG001|Overall Study|Withdrawal by clinical center|0
4419684|NCT00320606|7200512|FG000|Overall Study|Adverse Event|1
4419685|NCT00320606|7200512|FG000|Overall Study|Protocol Violation|1
4419686|NCT00320606|7200512|FG000|Overall Study|Withdrawal by Subject|1
4419687|NCT00320710|7200529|FG000|Overall Study|Disease progression|24
4419688|NCT00320710|7200530|FG001|Overall Study|Disease progression|19
4419689|NCT00320710|7200531|FG002|Overall Study|Disease progression|2
4419690|NCT00320710|7200529|FG000|Overall Study|Death|10
4419691|NCT00320710|7200530|FG001|Overall Study|Death|7
4419692|NCT00320710|7200531|FG002|Overall Study|Death|1
4419693|NCT00320710|7200529|FG000|Overall Study|Administrative problems|1
4419694|NCT00320710|7200530|FG001|Overall Study|Administrative problems|2
4419695|NCT00320710|7200531|FG002|Overall Study|Administrative problems|0
4419696|NCT00320710|7200529|FG000|Overall Study|Withdrawal by Subject|20
4419697|NCT00320710|7200530|FG001|Overall Study|Withdrawal by Subject|26
4419698|NCT00320710|7200531|FG002|Overall Study|Withdrawal by Subject|1
4419699|NCT00320710|7200529|FG000|Overall Study|Protocol Violation|6
4419700|NCT00320710|7200530|FG001|Overall Study|Protocol Violation|5
4419701|NCT00320710|7200531|FG002|Overall Study|Protocol Violation|0
4419702|NCT00320710|7200529|FG000|Overall Study|Abnormal test procedure result(s)|2
4419703|NCT00320710|7200530|FG001|Overall Study|Abnormal test procedure result(s)|0
4419704|NCT00320710|7200531|FG002|Overall Study|Abnormal test procedure result(s)|0
4419705|NCT00320710|7200529|FG000|Overall Study|Abnormal laboratory value(s)|12
4419706|NCT00320710|7200530|FG001|Overall Study|Abnormal laboratory value(s)|3
4419707|NCT00320710|7200531|FG002|Overall Study|Abnormal laboratory value(s)|0
4419708|NCT00320710|7200529|FG000|Overall Study|Adverse Event|18
4419709|NCT00320710|7200530|FG001|Overall Study|Adverse Event|14
4419710|NCT00320710|7200531|FG002|Overall Study|Adverse Event|1
4419711|NCT00320710|7200529|FG000|Overall Study|Lost to Follow-up|1
4419712|NCT00320710|7200530|FG001|Overall Study|Lost to Follow-up|0
4419713|NCT00320710|7200531|FG002|Overall Study|Lost to Follow-up|0
4419714|NCT00320788|7200550|FG000|Overall Study|Adverse Event|0
4419715|NCT00320788|7200551|FG001|Overall Study|Adverse Event|0
4419716|NCT00320788|7200552|FG002|Overall Study|Adverse Event|0
4419717|NCT00320788|7200553|FG003|Overall Study|Adverse Event|1
4419718|NCT00320788|7200554|FG004|Overall Study|Adverse Event|0
4419719|NCT00320788|7200550|FG000|Overall Study|Death|0
4419720|NCT00320788|7200551|FG001|Overall Study|Death|0
4419721|NCT00320788|7200552|FG002|Overall Study|Death|1
4419722|NCT00320788|7200553|FG003|Overall Study|Death|0
4419723|NCT00320788|7200554|FG004|Overall Study|Death|1
4419724|NCT00320788|7200550|FG000|Overall Study|Lost to Follow-up|0
4419725|NCT00320788|7200551|FG001|Overall Study|Lost to Follow-up|2
4419726|NCT00320788|7200552|FG002|Overall Study|Lost to Follow-up|1
4419727|NCT00320788|7200553|FG003|Overall Study|Lost to Follow-up|0
4419728|NCT00320788|7200554|FG004|Overall Study|Lost to Follow-up|0
4419729|NCT00320788|7200550|FG000|Overall Study|Decision by the Sponsor|1
4419730|NCT00320788|7200551|FG001|Overall Study|Decision by the Sponsor|1
4419731|NCT00320788|7200552|FG002|Overall Study|Decision by the Sponsor|0
4419732|NCT00320788|7200553|FG003|Overall Study|Decision by the Sponsor|0
4419733|NCT00320788|7200554|FG004|Overall Study|Decision by the Sponsor|1
4419734|NCT00320788|7200550|FG000|Overall Study|Other|1
4419735|NCT00320788|7200551|FG001|Overall Study|Other|2
4419736|NCT00320788|7200552|FG002|Overall Study|Other|1
4419737|NCT00320788|7200553|FG003|Overall Study|Other|1
4419738|NCT00320788|7200554|FG004|Overall Study|Other|1
4419739|NCT00320788|7200550|FG000|Overall Study|Physician Decision|1
4419740|NCT00320788|7200551|FG001|Overall Study|Physician Decision|1
4419741|NCT00320788|7200552|FG002|Overall Study|Physician Decision|0
4419742|NCT00320788|7200553|FG003|Overall Study|Physician Decision|0
4419743|NCT00320788|7200554|FG004|Overall Study|Physician Decision|0
4419744|NCT00320788|7200550|FG000|Overall Study|Protocol Violation|0
4419745|NCT00320788|7200551|FG001|Overall Study|Protocol Violation|0
4419746|NCT00320788|7200552|FG002|Overall Study|Protocol Violation|0
4419747|NCT00320788|7200553|FG003|Overall Study|Protocol Violation|0
4419748|NCT00320788|7200554|FG004|Overall Study|Protocol Violation|1
4419749|NCT00320788|7200550|FG000|Overall Study|Withdrawal by Subject|3
4419750|NCT00320788|7200551|FG001|Overall Study|Withdrawal by Subject|0
4419751|NCT00320788|7200552|FG002|Overall Study|Withdrawal by Subject|0
4419752|NCT00320788|7200553|FG003|Overall Study|Withdrawal by Subject|3
4419753|NCT00320788|7200554|FG004|Overall Study|Withdrawal by Subject|1
4419754|NCT00320801|7200574|FG000|Open-label Run-in Period|Withdrawal by Subject|2
4419755|NCT00320801|7200575|FG001|Open-label Run-in Period|Withdrawal by Subject|0
4419756|NCT00320801|7200576|FG002|Open-label Run-in Period|Withdrawal by Subject|0
4419757|NCT00320801|7200577|FG003|Open-label Run-in Period|Withdrawal by Subject|0
4419758|NCT00320801|7200574|FG000|Open-label Run-in Period|Adverse Event|33
4419759|NCT00320801|7200575|FG001|Open-label Run-in Period|Adverse Event|0
4419760|NCT00320801|7200576|FG002|Open-label Run-in Period|Adverse Event|0
4419761|NCT00320801|7200577|FG003|Open-label Run-in Period|Adverse Event|0
4419762|NCT00320801|7200574|FG000|Open-label Run-in Period|Administrative|10
4419763|NCT00320801|7200575|FG001|Open-label Run-in Period|Administrative|0
4419764|NCT00320801|7200576|FG002|Open-label Run-in Period|Administrative|0
4419765|NCT00320801|7200577|FG003|Open-label Run-in Period|Administrative|0
4419766|NCT00320801|7200574|FG000|Open-label Run-in Period|Lack of Efficacy|44
4419767|NCT00320801|7200575|FG001|Open-label Run-in Period|Lack of Efficacy|0
4419768|NCT00320801|7200576|FG002|Open-label Run-in Period|Lack of Efficacy|0
4419769|NCT00320801|7200577|FG003|Open-label Run-in Period|Lack of Efficacy|0
4419770|NCT00320801|7200574|FG000|Open-label Run-in Period|Lost to Follow-up|2
4419771|NCT00320801|7200575|FG001|Open-label Run-in Period|Lost to Follow-up|0
4419772|NCT00320801|7200576|FG002|Open-label Run-in Period|Lost to Follow-up|0
4419773|NCT00320801|7200577|FG003|Open-label Run-in Period|Lost to Follow-up|0
4419774|NCT00320801|7200574|FG000|Open-label Run-in Period|Did not qualify|1
4419775|NCT00320801|7200575|FG001|Open-label Run-in Period|Did not qualify|0
4419776|NCT00320801|7200576|FG002|Open-label Run-in Period|Did not qualify|0
4419777|NCT00320801|7200577|FG003|Open-label Run-in Period|Did not qualify|0
4419778|NCT00320801|7200574|FG000|Double-blind Phase|Withdrawal by Subject|0
4419779|NCT00320801|7200575|FG001|Double-blind Phase|Withdrawal by Subject|0
4419780|NCT00320801|7200576|FG002|Double-blind Phase|Withdrawal by Subject|1
4419781|NCT00320801|7200577|FG003|Double-blind Phase|Withdrawal by Subject|0
4419782|NCT00320801|7200574|FG000|Double-blind Phase|Adverse Event|0
4419783|NCT00320801|7200575|FG001|Double-blind Phase|Adverse Event|2
4419784|NCT00320801|7200576|FG002|Double-blind Phase|Adverse Event|8
4419785|NCT00320801|7200577|FG003|Double-blind Phase|Adverse Event|0
4419786|NCT00320801|7200574|FG000|Double-blind Phase|Administrative|0
4419787|NCT00320801|7200575|FG001|Double-blind Phase|Administrative|0
4419788|NCT00320801|7200576|FG002|Double-blind Phase|Administrative|4
4419789|NCT00320801|7200577|FG003|Double-blind Phase|Administrative|0
4419790|NCT00320801|7200574|FG000|Double-blind Phase|Lack of Efficacy|0
4419791|NCT00320801|7200575|FG001|Double-blind Phase|Lack of Efficacy|9
4419792|NCT00320801|7200576|FG002|Double-blind Phase|Lack of Efficacy|1
4419793|NCT00320801|7200577|FG003|Double-blind Phase|Lack of Efficacy|0
4419794|NCT00320801|7200574|FG000|Extension Phase|Withdrawal by Subject|0
4419795|NCT00320801|7200575|FG001|Extension Phase|Withdrawal by Subject|0
4419796|NCT00320801|7200576|FG002|Extension Phase|Withdrawal by Subject|0
4419797|NCT00320801|7200577|FG003|Extension Phase|Withdrawal by Subject|6
4419798|NCT00320801|7200574|FG000|Extension Phase|Adverse Event|0
4419799|NCT00320801|7200575|FG001|Extension Phase|Adverse Event|0
4419800|NCT00320801|7200576|FG002|Extension Phase|Adverse Event|0
4419801|NCT00320801|7200577|FG003|Extension Phase|Adverse Event|8
4419802|NCT00320801|7200574|FG000|Extension Phase|Administrative|0
4419803|NCT00320801|7200575|FG001|Extension Phase|Administrative|0
4419804|NCT00320801|7200576|FG002|Extension Phase|Administrative|0
4419805|NCT00320801|7200577|FG003|Extension Phase|Administrative|29
4419806|NCT00320801|7200574|FG000|Extension Phase|Lack of Efficacy|0
4419807|NCT00320801|7200575|FG001|Extension Phase|Lack of Efficacy|0
4419808|NCT00320801|7200576|FG002|Extension Phase|Lack of Efficacy|0
4419809|NCT00320801|7200577|FG003|Extension Phase|Lack of Efficacy|2
4419810|NCT00320801|7200574|FG000|Extension Phase|Lost to Follow-up|0
4419811|NCT00320801|7200575|FG001|Extension Phase|Lost to Follow-up|0
4419812|NCT00320801|7200576|FG002|Extension Phase|Lost to Follow-up|0
4419813|NCT00320801|7200577|FG003|Extension Phase|Lost to Follow-up|3
4419814|NCT00321048|7200589|FG000|Overall Study|Withdrawal by Subject|6
4419815|NCT00321048|7200590|FG001|Overall Study|Withdrawal by Subject|8
4419816|NCT00321373|7200614|FG000|Overall Study|Adverse Event|0
4419817|NCT00321373|7200615|FG001|Overall Study|Adverse Event|0
4419818|NCT00321373|7200616|FG002|Overall Study|Adverse Event|1
4419819|NCT00321373|7200614|FG000|Overall Study|Lost to Follow-up|1
4419820|NCT00321373|7200615|FG001|Overall Study|Lost to Follow-up|0
4419821|NCT00321373|7200616|FG002|Overall Study|Lost to Follow-up|1
4419822|NCT00321373|7200614|FG000|Overall Study|Withdrawal by Subject|1
4419823|NCT00321373|7200615|FG001|Overall Study|Withdrawal by Subject|0
4419824|NCT00321373|7200616|FG002|Overall Study|Withdrawal by Subject|0
4419825|NCT00321373|7200614|FG000|Overall Study|Other|0
4419826|NCT00321373|7200615|FG001|Overall Study|Other|0
4419827|NCT00321373|7200616|FG002|Overall Study|Other|1
4419828|NCT00321464|7200626|FG000|Overall Study|Death|169
4419829|NCT00321464|7200627|FG001|Overall Study|Death|174
4419830|NCT00321464|7200626|FG000|Overall Study|Disease progression|124
4419831|NCT00321464|7200627|FG001|Overall Study|Disease progression|124
4419832|NCT00321464|7200626|FG000|Overall Study|Withdrawal by Subject|117
4419833|NCT00321464|7200627|FG001|Overall Study|Withdrawal by Subject|118
4419834|NCT00321464|7200626|FG000|Overall Study|Participant request|57
4419835|NCT00321464|7200627|FG001|Overall Study|Participant request|61
4419836|NCT00321464|7200626|FG000|Overall Study|Adverse Event|43
4419837|NCT00321464|7200627|FG001|Overall Study|Adverse Event|28
4419838|NCT00321464|7200626|FG000|Overall Study|Physician Decision|15
4419839|NCT00321464|7200627|FG001|Overall Study|Physician Decision|14
4419840|NCT00321464|7200626|FG000|Overall Study|Noncompliance|4
4419841|NCT00321464|7200627|FG001|Overall Study|Noncompliance|10
4419842|NCT00321464|7200626|FG000|Overall Study|Lost to Follow-up|7
4419843|NCT00321464|7200627|FG001|Overall Study|Lost to Follow-up|8
4419844|NCT00321464|7200626|FG000|Overall Study|Protocol deviation|0
4419845|NCT00321464|7200627|FG001|Overall Study|Protocol deviation|2
4419846|NCT00321464|7200626|FG000|Overall Study|Ineligibility determined|2
4419847|NCT00321464|7200627|FG001|Overall Study|Ineligibility determined|1
4419848|NCT00321464|7200626|FG000|Overall Study|Other|21
4419849|NCT00321464|7200627|FG001|Overall Study|Other|18
4419850|NCT00321555|7200633|FG000|Overall Study|Developed antibodies|1
4419851|NCT00321555|7200633|FG000|Overall Study|Switched to alternative treatment|3
4419852|NCT00321555|7200633|FG000|Overall Study|Physician Decision|1
4419853|NCT00321555|7200633|FG000|Overall Study|Disease progression on study|1
4419854|NCT00321620|7200657|FG000|Overall Study|Death|269
4419855|NCT00321620|7200658|FG001|Overall Study|Death|294
4419856|NCT00321620|7200657|FG000|Overall Study|Withdrawal by Subject|164
4419857|NCT00321620|7200658|FG001|Overall Study|Withdrawal by Subject|147
4419858|NCT00321620|7200657|FG000|Overall Study|Disease progression|113
4419859|NCT00321620|7200658|FG001|Overall Study|Disease progression|117
4419860|NCT00321620|7200657|FG000|Overall Study|Adverse Event|43
4419861|NCT00321620|7200658|FG001|Overall Study|Adverse Event|56
4419862|NCT00321620|7200657|FG000|Overall Study|Lost to Follow-up|13
4419863|NCT00321620|7200658|FG001|Overall Study|Lost to Follow-up|9
4419864|NCT00321620|7200657|FG000|Overall Study|Physician Decision|4
4419865|NCT00321620|7200658|FG001|Overall Study|Physician Decision|1
4419866|NCT00321620|7200657|FG000|Overall Study|Noncompliance|14
4419867|NCT00321620|7200658|FG001|Overall Study|Noncompliance|7
4419868|NCT00321620|7200657|FG000|Overall Study|Protocol deviation|4
4419869|NCT00321620|7200658|FG001|Overall Study|Protocol deviation|3
4419870|NCT00321620|7200657|FG000|Overall Study|Ineligibility determined|2
4419871|NCT00321620|7200658|FG001|Overall Study|Ineligibility determined|3
4419872|NCT00321620|7200657|FG000|Overall Study|Participant request|75
4419873|NCT00321620|7200658|FG001|Overall Study|Participant request|52
4419874|NCT00321620|7200657|FG000|Overall Study|Other|42
4419875|NCT00321620|7200658|FG001|Overall Study|Other|33
4419876|NCT00321646|7200664|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1
4419877|NCT00321646|7200664|FG000|Neoadjuvant Chemotherapy|Adverse Event|2
4419878|NCT00321646|7200664|FG000|Neoadjuvant Chemotherapy|Disease progression|1
4419879|NCT00321672|7200672|FG000|Overall Study|Withdrawal by Subject|5
4419880|NCT00321672|7200673|FG001|Overall Study|Withdrawal by Subject|1
4419881|NCT00321672|7200674|FG002|Overall Study|Withdrawal by Subject|2
4419882|NCT00321672|7200675|FG003|Overall Study|Withdrawal by Subject|0
4419883|NCT00321672|7200672|FG000|Overall Study|Noncompliance|1
4419884|NCT00321672|7200673|FG001|Overall Study|Noncompliance|2
4419885|NCT00321672|7200674|FG002|Overall Study|Noncompliance|1
4419886|NCT00321672|7200675|FG003|Overall Study|Noncompliance|0
4419887|NCT00321672|7200672|FG000|Overall Study|Adverse Event|1
4419888|NCT00321672|7200673|FG001|Overall Study|Adverse Event|1
4419889|NCT00321672|7200674|FG002|Overall Study|Adverse Event|0
4419890|NCT00321672|7200675|FG003|Overall Study|Adverse Event|0
4419891|NCT00321672|7200672|FG000|Overall Study|Lack of Efficacy|1
4419892|NCT00321672|7200673|FG001|Overall Study|Lack of Efficacy|1
4419893|NCT00321672|7200674|FG002|Overall Study|Lack of Efficacy|0
4419894|NCT00321672|7200675|FG003|Overall Study|Lack of Efficacy|0
4419895|NCT00321672|7200672|FG000|Overall Study|Lost to Follow-up|2
4419896|NCT00321672|7200673|FG001|Overall Study|Lost to Follow-up|0
4419897|NCT00321672|7200674|FG002|Overall Study|Lost to Follow-up|4
4419898|NCT00321672|7200675|FG003|Overall Study|Lost to Follow-up|2
4419899|NCT00321672|7200672|FG000|Overall Study|Death|1
4419900|NCT00321672|7200673|FG001|Overall Study|Death|0
4419901|NCT00321672|7200674|FG002|Overall Study|Death|0
4419902|NCT00321672|7200675|FG003|Overall Study|Death|0
4419903|NCT00321672|7200672|FG000|Overall Study|Too far to travel for visits|1
4419904|NCT00321672|7200673|FG001|Overall Study|Too far to travel for visits|0
4419905|NCT00321672|7200674|FG002|Overall Study|Too far to travel for visits|0
4419906|NCT00321672|7200675|FG003|Overall Study|Too far to travel for visits|0
4419907|NCT00321672|7200672|FG000|Overall Study|Incarcerated|0
4419908|NCT00321672|7200673|FG001|Overall Study|Incarcerated|0
4419909|NCT00321672|7200674|FG002|Overall Study|Incarcerated|2
4419910|NCT00321672|7200675|FG003|Overall Study|Incarcerated|0
4419911|NCT00321672|7200672|FG000|Overall Study|Moved out of state|0
4419912|NCT00321672|7200673|FG001|Overall Study|Moved out of state|1
4419913|NCT00321672|7200674|FG002|Overall Study|Moved out of state|1
4419914|NCT00321672|7200675|FG003|Overall Study|Moved out of state|0
4419915|NCT00321672|7200672|FG000|Overall Study|Protocol Violation|0
4419916|NCT00321672|7200673|FG001|Overall Study|Protocol Violation|0
4419917|NCT00321672|7200674|FG002|Overall Study|Protocol Violation|1
4419918|NCT00321672|7200675|FG003|Overall Study|Protocol Violation|0
4419919|NCT00321672|7200672|FG000|Overall Study|Diagnosis of testicular cancer|0
4419920|NCT00321672|7200673|FG001|Overall Study|Diagnosis of testicular cancer|1
4419921|NCT00321672|7200674|FG002|Overall Study|Diagnosis of testicular cancer|0
4419922|NCT00321672|7200675|FG003|Overall Study|Diagnosis of testicular cancer|0
4419923|NCT00321672|7200672|FG000|Overall Study|Extensive travel required for new job|0
4419924|NCT00321672|7200673|FG001|Overall Study|Extensive travel required for new job|1
4419925|NCT00321672|7200674|FG002|Overall Study|Extensive travel required for new job|0
4419926|NCT00321672|7200675|FG003|Overall Study|Extensive travel required for new job|0
4419927|NCT00321685|7200689|FG000|Overall Study|Adverse Event|18
4419928|NCT00321685|7200689|FG000|Overall Study|Death|2
4419929|NCT00321685|7200689|FG000|Overall Study|Withdrawal by Subject|8
4419930|NCT00321685|7200689|FG000|Overall Study|Alternative therapy|1
4419931|NCT00321685|7200689|FG000|Overall Study|Complicating disese|1
4419932|NCT00321685|7200689|FG000|Overall Study|Other|5
4419933|NCT00321685|7200689|FG000|Overall Study|Not start protocol therapy|2
4419934|NCT00321685|7200689|FG000|Overall Study|Ineligible|2
4419935|NCT00321711|7200719|FG000|Part A|Adverse Event|3
4419936|NCT00321711|7200720|FG001|Part A|Adverse Event|3
4419937|NCT00321711|7200721|FG002|Part A|Adverse Event|2
4419938|NCT00321711|7200722|FG003|Part A|Adverse Event|0
4419939|NCT00321711|7200723|FG004|Part A|Adverse Event|0
4419940|NCT00321711|7200719|FG000|Part A|Withdrawal by Subject|1
4419941|NCT00321711|7200720|FG001|Part A|Withdrawal by Subject|1
4419942|NCT00321711|7200721|FG002|Part A|Withdrawal by Subject|1
4419943|NCT00321711|7200722|FG003|Part A|Withdrawal by Subject|0
4419944|NCT00321711|7200723|FG004|Part A|Withdrawal by Subject|0
4419945|NCT00321711|7200719|FG000|Part A|Disease progression|0
4419946|NCT00321711|7200720|FG001|Part A|Disease progression|1
4419947|NCT00321711|7200721|FG002|Part A|Disease progression|0
4419948|NCT00321711|7200722|FG003|Part A|Disease progression|0
4419949|NCT00321711|7200723|FG004|Part A|Disease progression|0
4419950|NCT00321711|7200719|FG000|Part A|Requirement for alternative therapy|0
4419951|NCT00321711|7200720|FG001|Part A|Requirement for alternative therapy|2
4419952|NCT00321711|7200721|FG002|Part A|Requirement for alternative therapy|1
4419953|NCT00321711|7200722|FG003|Part A|Requirement for alternative therapy|0
4419954|NCT00321711|7200723|FG004|Part A|Requirement for alternative therapy|0
4419955|NCT00321711|7200719|FG000|Part A|Physician Decision|0
4419956|NCT00321711|7200720|FG001|Part A|Physician Decision|1
4419957|NCT00321711|7200721|FG002|Part A|Physician Decision|3
4419958|NCT00321711|7200722|FG003|Part A|Physician Decision|0
4419959|NCT00321711|7200723|FG004|Part A|Physician Decision|0
4419960|NCT00321711|7200719|FG000|Part A|Other|1
4419961|NCT00321711|7200720|FG001|Part A|Other|2
4419962|NCT00321711|7200721|FG002|Part A|Other|3
4419963|NCT00321711|7200722|FG003|Part A|Other|0
4419964|NCT00321711|7200723|FG004|Part A|Other|0
4419965|NCT00321711|7200719|FG000|Part A|Protocol deviation|0
4419966|NCT00321711|7200720|FG001|Part A|Protocol deviation|0
4419967|NCT00321711|7200721|FG002|Part A|Protocol deviation|1
4419968|NCT00321711|7200722|FG003|Part A|Protocol deviation|0
4419969|NCT00321711|7200723|FG004|Part A|Protocol deviation|0
4419970|NCT00321711|7200719|FG000|Part B|Noncompliance|0
4419971|NCT00321711|7200720|FG001|Part B|Noncompliance|0
4419972|NCT00321711|7200721|FG002|Part B|Noncompliance|0
4419973|NCT00321711|7200722|FG003|Part B|Noncompliance|0
4419974|NCT00321711|7200723|FG004|Part B|Noncompliance|1
4419975|NCT00321711|7200719|FG000|Part B|Adverse Event|0
4419976|NCT00321711|7200720|FG001|Part B|Adverse Event|0
4419977|NCT00321711|7200721|FG002|Part B|Adverse Event|0
4419978|NCT00321711|7200722|FG003|Part B|Adverse Event|2
4419979|NCT00321711|7200723|FG004|Part B|Adverse Event|1
4419980|NCT00321711|7200719|FG000|Part B|Disease progression|0
4419981|NCT00321711|7200720|FG001|Part B|Disease progression|0
4419982|NCT00321711|7200721|FG002|Part B|Disease progression|0
4419983|NCT00321711|7200722|FG003|Part B|Disease progression|1
4419984|NCT00321711|7200723|FG004|Part B|Disease progression|0
4419985|NCT00321711|7200719|FG000|Part B|Physician Decision|0
4419986|NCT00321711|7200720|FG001|Part B|Physician Decision|0
4419987|NCT00321711|7200721|FG002|Part B|Physician Decision|0
4419988|NCT00321711|7200722|FG003|Part B|Physician Decision|1
4419989|NCT00321711|7200723|FG004|Part B|Physician Decision|2
4419990|NCT00321711|7200719|FG000|Part B|Death|0
4419991|NCT00321711|7200720|FG001|Part B|Death|0
4419992|NCT00321711|7200721|FG002|Part B|Death|0
4419993|NCT00321711|7200722|FG003|Part B|Death|2
4419994|NCT00321711|7200723|FG004|Part B|Death|1
4419995|NCT00321737|7200738|FG000|Overall Study|Relapse of Erosive Esophagitis|76
4419996|NCT00321737|7200739|FG001|Overall Study|Relapse of Erosive Esophagitis|25
4419997|NCT00321737|7200740|FG002|Overall Study|Relapse of Erosive Esophagitis|19
4419998|NCT00321737|7200738|FG000|Overall Study|Adverse Event|11
4419999|NCT00321737|7200739|FG001|Overall Study|Adverse Event|3
4420000|NCT00321737|7200740|FG002|Overall Study|Adverse Event|6
4420001|NCT00321737|7200738|FG000|Overall Study|Lost to Follow-up|5
4420002|NCT00321737|7200739|FG001|Overall Study|Lost to Follow-up|5
4420003|NCT00321737|7200740|FG002|Overall Study|Lost to Follow-up|6
4420004|NCT00321737|7200738|FG000|Overall Study|Withdrawal by Subject|19
4420005|NCT00321737|7200739|FG001|Overall Study|Withdrawal by Subject|12
4420006|NCT00321737|7200740|FG002|Overall Study|Withdrawal by Subject|17
4420007|NCT00321737|7200738|FG000|Overall Study|Protocol Violation|0
4420008|NCT00321737|7200739|FG001|Overall Study|Protocol Violation|0
4420009|NCT00321737|7200740|FG002|Overall Study|Protocol Violation|1
4420010|NCT00321737|7200738|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1
4420011|NCT00321737|7200739|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0
4420012|NCT00321737|7200740|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0
4420013|NCT00321737|7200738|FG000|Overall Study|Possible Barrett's Esophagus|2
4420014|NCT00321737|7200739|FG001|Overall Study|Possible Barrett's Esophagus|1
4420015|NCT00321737|7200740|FG002|Overall Study|Possible Barrett's Esophagus|1
4420016|NCT00321737|7200738|FG000|Overall Study|Therapeutic Failure|6
4420017|NCT00321737|7200739|FG001|Overall Study|Therapeutic Failure|0
4420018|NCT00321737|7200740|FG002|Overall Study|Therapeutic Failure|2
4420019|NCT00321737|7200738|FG000|Overall Study|Pregnancy|0
4420020|NCT00321737|7200739|FG001|Overall Study|Pregnancy|2
4420021|NCT00321737|7200740|FG002|Overall Study|Pregnancy|0
4420022|NCT00321737|7200738|FG000|Overall Study|Noncompliance|2
4420023|NCT00321737|7200739|FG001|Overall Study|Noncompliance|0
4420024|NCT00321737|7200740|FG002|Overall Study|Noncompliance|0
4420025|NCT00321737|7200738|FG000|Overall Study|Subject Request/ Subject Unavailable|0
4420026|NCT00321737|7200739|FG001|Overall Study|Subject Request/ Subject Unavailable|0
4420027|NCT00321737|7200740|FG002|Overall Study|Subject Request/ Subject Unavailable|2
4420028|NCT00321763|7200752|FG000|Overall Study|Adverse Event|1
4420029|NCT00321763|7200753|FG001|Overall Study|Adverse Event|1
4420030|NCT00321763|7200754|FG002|Overall Study|Adverse Event|0
4420031|NCT00321763|7200755|FG003|Overall Study|Adverse Event|1
4420032|NCT00321763|7200752|FG000|Overall Study|Withdrawal by Subject|2
4420033|NCT00321763|7200753|FG001|Overall Study|Withdrawal by Subject|0
4420034|NCT00321763|7200754|FG002|Overall Study|Withdrawal by Subject|1
4420035|NCT00321763|7200755|FG003|Overall Study|Withdrawal by Subject|0
4420036|NCT00321763|7200752|FG000|Overall Study|Lost to Follow-up|3
4420037|NCT00321763|7200753|FG001|Overall Study|Lost to Follow-up|1
4420038|NCT00321763|7200754|FG002|Overall Study|Lost to Follow-up|5
4420039|NCT00321763|7200755|FG003|Overall Study|Lost to Follow-up|4
4420040|NCT00321789|7200769|FG000|Overall Study|Lost to Follow-up|4
4420041|NCT00321789|7200770|FG001|Overall Study|Lost to Follow-up|7
4420042|NCT00321789|7200769|FG000|Overall Study|Withdrawal by Subject|6
4420043|NCT00321789|7200770|FG001|Overall Study|Withdrawal by Subject|6
4420044|NCT00321789|7200769|FG000|Overall Study|Protocol Violation|5
4420045|NCT00321789|7200770|FG001|Overall Study|Protocol Violation|3
4420046|NCT00321828|7200776|FG000|Overall Study|Ineligible|3
4420047|NCT00321828|7200776|FG000|Overall Study|No follow up data|1
4420048|NCT00321854|7200782|FG000|Overall Study|Adverse Event|41
4420049|NCT00321854|7200783|FG001|Overall Study|Adverse Event|43
4420050|NCT00321854|7200782|FG000|Overall Study|Lack of Efficacy|9
4420051|NCT00321854|7200783|FG001|Overall Study|Lack of Efficacy|14
4420052|NCT00321854|7200782|FG000|Overall Study|Protocol Violation|6
4420053|NCT00321854|7200783|FG001|Overall Study|Protocol Violation|5
4420054|NCT00321854|7200782|FG000|Overall Study|Lost to Follow-up|0
4420055|NCT00321854|7200783|FG001|Overall Study|Lost to Follow-up|2
4420056|NCT00321854|7200782|FG000|Overall Study|Withdrawal by Subject|6
4420057|NCT00321854|7200783|FG001|Overall Study|Withdrawal by Subject|17
4420058|NCT00321854|7200782|FG000|Overall Study|Other|1
4420059|NCT00321854|7200783|FG001|Overall Study|Other|1
4420060|NCT00321893|7200793|FG000|Overall Study|Non-Compliance/Refusal|16
4420061|NCT00321893|7200794|FG001|Overall Study|Non-Compliance/Refusal|10
4420062|NCT00321893|7200793|FG000|Overall Study|Lost to Follow-up|2
4420063|NCT00321893|7200794|FG001|Overall Study|Lost to Follow-up|1
4420064|NCT00321893|7200793|FG000|Overall Study|Adverse Event|6
4420065|NCT00321893|7200794|FG001|Overall Study|Adverse Event|3
4420066|NCT00321906|7200802|FG000|Overall Study|Adverse Event|36
4420067|NCT00321906|7200803|FG001|Overall Study|Adverse Event|44
4420068|NCT00321906|7200802|FG000|Overall Study|Death|9
4420069|NCT00321906|7200803|FG001|Overall Study|Death|6
4420070|NCT00321906|7200802|FG000|Overall Study|Lost to Follow-up|1
4420071|NCT00321906|7200803|FG001|Overall Study|Lost to Follow-up|2
4420072|NCT00321906|7200802|FG000|Overall Study|Withdrawal by Subject|0
4420073|NCT00321906|7200803|FG001|Overall Study|Withdrawal by Subject|4
4420074|NCT00321919|7200811|FG000|Overall Study|Adverse Event|17
4420075|NCT00321919|7200812|FG001|Overall Study|Adverse Event|10
4420076|NCT00321919|7200811|FG000|Overall Study|Death|21
4420077|NCT00321919|7200812|FG001|Overall Study|Death|17
4420078|NCT00321919|7200811|FG000|Overall Study|Insufficient Therapeutic Response|1
4420079|NCT00321919|7200812|FG001|Overall Study|Insufficient Therapeutic Response|0
4420080|NCT00321919|7200811|FG000|Overall Study|Violation of Selection Criteria at Entry|1
4420081|NCT00321919|7200812|FG001|Overall Study|Violation of Selection Criteria at Entry|1
4420082|NCT00321919|7200811|FG000|Overall Study|Refused Treatment|23
4420083|NCT00321919|7200812|FG001|Overall Study|Refused Treatment|14
4420084|NCT00321919|7200811|FG000|Overall Study|Other Protocol Violation|2
4420085|NCT00321919|7200812|FG001|Overall Study|Other Protocol Violation|3
4420086|NCT00321919|7200811|FG000|Overall Study|Failure to Return|3
4420087|NCT00321919|7200812|FG001|Overall Study|Failure to Return|1
4420088|NCT00321919|7200811|FG000|Overall Study|Other withdrawal reason|7
4420089|NCT00321919|7200812|FG001|Overall Study|Other withdrawal reason|6
4420090|NCT00321932|7200821|FG000|Overall Study|Death|3
4420091|NCT00321932|7200822|FG001|Overall Study|Death|6
4420092|NCT00321932|7200821|FG000|Overall Study|Withdrawal by Subject|3
4420093|NCT00321932|7200822|FG001|Overall Study|Withdrawal by Subject|6
4420094|NCT00321932|7200821|FG000|Overall Study|Early relapse|2
4420095|NCT00321932|7200822|FG001|Overall Study|Early relapse|8
4420096|NCT00321932|7200821|FG000|Overall Study|Missing data|2
4420097|NCT00321932|7200822|FG001|Overall Study|Missing data|1
4420098|NCT00321984|7200841|FG000|Overall Study|Adverse Event|9
4420099|NCT00321984|7200842|FG001|Overall Study|Adverse Event|6
4420100|NCT00321984|7200843|FG002|Overall Study|Adverse Event|8
4420101|NCT00321984|7200841|FG000|Overall Study|Protocol Violation|0
4420102|NCT00321984|7200842|FG001|Overall Study|Protocol Violation|1
4420103|NCT00321984|7200843|FG002|Overall Study|Protocol Violation|1
4420104|NCT00321984|7200841|FG000|Overall Study|Lost to Follow-up|2
4420105|NCT00321984|7200842|FG001|Overall Study|Lost to Follow-up|4
4420106|NCT00321984|7200843|FG002|Overall Study|Lost to Follow-up|2
4420107|NCT00321984|7200841|FG000|Overall Study|Withdrawal by Subject|8
4420108|NCT00321984|7200842|FG001|Overall Study|Withdrawal by Subject|6
4420109|NCT00321984|7200843|FG002|Overall Study|Withdrawal by Subject|5
4420110|NCT00321984|7200841|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3
4420111|NCT00321984|7200842|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1
4420112|NCT00321984|7200843|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5
4420113|NCT00321984|7200841|FG000|Overall Study|Lack of Efficacy|3
4420114|NCT00321984|7200842|FG001|Overall Study|Lack of Efficacy|1
4420115|NCT00321984|7200843|FG002|Overall Study|Lack of Efficacy|3
4420116|NCT00321984|7200841|FG000|Overall Study|Noncompliant|0
4420117|NCT00321984|7200842|FG001|Overall Study|Noncompliant|0
4420118|NCT00321984|7200843|FG002|Overall Study|Noncompliant|2
4420119|NCT00321984|7200841|FG000|Overall Study|Pregnancy|0
4420120|NCT00321984|7200842|FG001|Overall Study|Pregnancy|1
4420121|NCT00321984|7200843|FG002|Overall Study|Pregnancy|0
4420122|NCT00321984|7200841|FG000|Overall Study|Per Subject Request|1
4420123|NCT00321984|7200842|FG001|Overall Study|Per Subject Request|0
4420124|NCT00321984|7200843|FG002|Overall Study|Per Subject Request|0
4420125|NCT00321984|7200841|FG000|Overall Study|Per Investigator Request|1
4420126|NCT00321984|7200842|FG001|Overall Study|Per Investigator Request|0
4420127|NCT00321984|7200843|FG002|Overall Study|Per Investigator Request|0
4420128|NCT00321984|7200841|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0
4420129|NCT00321984|7200842|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1
4420130|NCT00321984|7200843|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0
4420131|NCT00322023|7200854|FG000|Overall Study|various|0
4420132|NCT00322023|7200855|FG001|Overall Study|various|2
4420133|NCT00322023|7200856|FG002|Overall Study|various|6
4420134|NCT00322049|7200868|FG000|Overall Study|Moved out of area|0
4420135|NCT00322049|7200869|FG001|Overall Study|Moved out of area|0
4420136|NCT00322049|7200870|FG002|Overall Study|Moved out of area|0
4420137|NCT00322049|7200871|FG003|Overall Study|Moved out of area|1
4420138|NCT00322049|7200868|FG000|Overall Study|Infected with Dengue during study|0
4420139|NCT00322049|7200869|FG001|Overall Study|Infected with Dengue during study|1
4420140|NCT00322049|7200870|FG002|Overall Study|Infected with Dengue during study|0
4420141|NCT00322049|7200871|FG003|Overall Study|Infected with Dengue during study|0
4420142|NCT00322153|7200901|FG000|Overall Study|Adverse Event|21
4420143|NCT00322153|7200902|FG001|Overall Study|Adverse Event|34
4420144|NCT00322153|7200901|FG000|Overall Study|Protocol Violation|6
4512071|NCT00931801|7321670|FG002|Overall Study|Adverse Event|1
4512072|NCT00931801|7321668|FG000|Overall Study|Lost to Follow-up|0
4512073|NCT00931801|7321669|FG001|Overall Study|Lost to Follow-up|1
4512074|NCT00931801|7321670|FG002|Overall Study|Lost to Follow-up|0
4512075|NCT00931801|7321668|FG000|Overall Study|Withdrawal by Subject|1
4629502|NCT01872910|7497451|FG002|Overall Study|Lost to Follow-up|2
4629503|NCT01872910|7497452|FG003|Overall Study|Lost to Follow-up|0
4629504|NCT01872910|7497453|FG004|Overall Study|Lost to Follow-up|0
4629505|NCT01872910|7497454|FG005|Overall Study|Lost to Follow-up|0
4629506|NCT01873417|7497478|FG000|Overall Study|Did Not Receive Any Study Drug|4
4629507|NCT01873417|7497478|FG000|Overall Study|Adverse Event|24
4629508|NCT01873417|7497478|FG000|Overall Study|Lost to Follow-up|2
4629509|NCT01873417|7497478|FG000|Overall Study|Withdrawal by Subject|2
4629510|NCT01873417|7497478|FG000|Overall Study|Physician Decision|3
4629511|NCT01873495|7497482|FG000|Overall Study|Withdrawal by Subject|1
4420145|NCT00322153|7200902|FG001|Overall Study|Protocol Violation|14
4420146|NCT00322153|7200901|FG000|Overall Study|Withdrawal by Subject|18
4420147|NCT00322153|7200902|FG001|Overall Study|Withdrawal by Subject|10
4420148|NCT00322153|7200901|FG000|Overall Study|Lack of Efficacy|8
4420149|NCT00322153|7200902|FG001|Overall Study|Lack of Efficacy|3
4420150|NCT00322153|7200901|FG000|Overall Study|Lost to Follow-up|5
4420151|NCT00322153|7200902|FG001|Overall Study|Lost to Follow-up|4
4420152|NCT00322153|7200901|FG000|Overall Study|Withdrawn for other reasons|5
4512076|NCT00931801|7321669|FG001|Overall Study|Withdrawal by Subject|0
4629512|NCT01873495|7497482|FG000|Overall Study|Physician Decision|3
4629513|NCT01873495|7497482|FG000|Overall Study|Adverse Event|1
4420153|NCT00322153|7200902|FG001|Overall Study|Withdrawn for other reasons|4
4420154|NCT00322348|7200948|FG000|Overall Study|Adverse Event|0
4420155|NCT00322348|7200949|FG001|Overall Study|Adverse Event|1
4420156|NCT00322348|7200948|FG000|Overall Study|Withdrawal by Subject|1
4420157|NCT00322348|7200949|FG001|Overall Study|Withdrawal by Subject|4
4420158|NCT00322348|7200948|FG000|Overall Study|Lost to Follow-up|1
4420159|NCT00322348|7200949|FG001|Overall Study|Lost to Follow-up|0
4420160|NCT00322348|7200948|FG000|Overall Study|Death|0
4420161|NCT00322348|7200949|FG001|Overall Study|Death|2
4420162|NCT00322348|7200948|FG000|Overall Study|Disease Progression|30
4420163|NCT00322348|7200949|FG001|Overall Study|Disease Progression|25
4420164|NCT00322348|7200948|FG000|Overall Study|Reasons not specified|5
4420165|NCT00322348|7200949|FG001|Overall Study|Reasons not specified|1
4420166|NCT00322374|7200958|FG000|Starting Dose|Physician Decision|2
4629514|NCT01873495|7497482|FG000|Overall Study|Removed for Transplantation|1
4629515|NCT01873495|7497482|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1
4629516|NCT01873586|7497486|FG000|Overall Study|Lost to Follow-up|3
4629517|NCT01873729|7497493|FG000|Overall Study|Withdrawal by Subject|1
4420167|NCT00322374|7200959|FG001|Starting Dose|Physician Decision|0
4420168|NCT00322374|7200960|FG002|Starting Dose|Physician Decision|0
4420169|NCT00322374|7200961|FG003|Starting Dose|Physician Decision|0
4420170|NCT00322374|7200958|FG000|Starting Dose|Study Drug Toxicity|4
4420171|NCT00322374|7200959|FG001|Starting Dose|Study Drug Toxicity|0
4420172|NCT00322374|7200960|FG002|Starting Dose|Study Drug Toxicity|0
4420173|NCT00322374|7200961|FG003|Starting Dose|Study Drug Toxicity|0
4420174|NCT00322374|7200958|FG000|First Escalation|Documented Disease Progression|0
4420175|NCT00322374|7200959|FG001|First Escalation|Documented Disease Progression|6
4420176|NCT00322374|7200960|FG002|First Escalation|Documented Disease Progression|0
4420177|NCT00322374|7200961|FG003|First Escalation|Documented Disease Progression|0
4420178|NCT00322374|7200958|FG000|First Escalation|Physician Decision|0
4420179|NCT00322374|7200959|FG001|First Escalation|Physician Decision|12
4420180|NCT00322374|7200960|FG002|First Escalation|Physician Decision|0
4420181|NCT00322374|7200961|FG003|First Escalation|Physician Decision|0
4420182|NCT00322374|7200958|FG000|First Escalation|Study Drug Toxicity|0
4420183|NCT00322374|7200959|FG001|First Escalation|Study Drug Toxicity|11
4420184|NCT00322374|7200960|FG002|First Escalation|Study Drug Toxicity|0
4420185|NCT00322374|7200961|FG003|First Escalation|Study Drug Toxicity|0
4420186|NCT00322374|7200958|FG000|First Escalation|Participant Request|0
4420187|NCT00322374|7200959|FG001|First Escalation|Participant Request|1
4420188|NCT00322374|7200960|FG002|First Escalation|Participant Request|0
4420189|NCT00322374|7200961|FG003|First Escalation|Participant Request|0
4420190|NCT00322374|7200958|FG000|Second Escalation|Physician Decision|0
4420191|NCT00322374|7200959|FG001|Second Escalation|Physician Decision|0
4420192|NCT00322374|7200960|FG002|Second Escalation|Physician Decision|5
4420193|NCT00322374|7200961|FG003|Second Escalation|Physician Decision|0
4420194|NCT00322374|7200958|FG000|Second Escalation|Study Drug Toxicity|0
4420195|NCT00322374|7200959|FG001|Second Escalation|Study Drug Toxicity|0
4420196|NCT00322374|7200960|FG002|Second Escalation|Study Drug Toxicity|1
4420197|NCT00322374|7200961|FG003|Second Escalation|Study Drug Toxicity|0
4420198|NCT00322387|7200976|FG000|Treatment Period|Adverse Event|0
4420199|NCT00322387|7200977|FG001|Treatment Period|Adverse Event|1
4420200|NCT00322387|7200976|FG000|Follow-up Period|Final assessment not done|1
4420201|NCT00322387|7200977|FG001|Follow-up Period|Final assessment not done|3
4420202|NCT00322387|7200976|FG000|Follow-up Period|Death|1
4420203|NCT00322387|7200977|FG001|Follow-up Period|Death|0
4420204|NCT00322452|7201000|FG000|Overall Study|Eligibility criteria not fulfilled|0
4420205|NCT00322452|7201001|FG001|Overall Study|Eligibility criteria not fulfilled|1
4420206|NCT00322452|7201000|FG000|Overall Study|Lost to Follow-up|5
4420207|NCT00322452|7201001|FG001|Overall Study|Lost to Follow-up|2
4420208|NCT00322452|7201000|FG000|Overall Study|Withdrawal by Subject|19
4420209|NCT00322452|7201001|FG001|Overall Study|Withdrawal by Subject|46
4420210|NCT00322452|7201000|FG000|Overall Study|Death|223
4420211|NCT00322452|7201001|FG001|Overall Study|Death|227
4420212|NCT00322491|7201029|FG000|Overall Study|Adverse Event|1
4420213|NCT00322491|7201030|FG001|Overall Study|Adverse Event|0
4420214|NCT00322491|7201029|FG000|Overall Study|Death|1
4420215|NCT00322491|7201030|FG001|Overall Study|Death|2
4420216|NCT00322556|7201037|FG000|Overall Study|Adverse Event|1
4420217|NCT00322556|7201037|FG000|Overall Study|Withdrawal by Subject|1
4420218|NCT00322556|7201037|FG000|Overall Study|Lost to Follow-up|3
4420219|NCT00322556|7201037|FG000|Overall Study|Other Reason|7
4420220|NCT00322621|7201044|FG000|Period II - Acute Therapy Phase|Adverse Event|20
4420221|NCT00322621|7201045|FG001|Period II - Acute Therapy Phase|Adverse Event|0
4420222|NCT00322621|7201046|FG002|Period II - Acute Therapy Phase|Adverse Event|0
4420223|NCT00322621|7201044|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1
4420224|NCT00322621|7201045|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0
4420225|NCT00322621|7201046|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0
4420226|NCT00322621|7201044|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8
4420227|NCT00322621|7201045|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0
4420228|NCT00322621|7201046|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0
4420229|NCT00322621|7201044|FG000|Period II - Acute Therapy Phase|Protocol Violation|2
4420230|NCT00322621|7201045|FG001|Period II - Acute Therapy Phase|Protocol Violation|0
4420231|NCT00322621|7201046|FG002|Period II - Acute Therapy Phase|Protocol Violation|0
4420232|NCT00322621|7201044|FG000|Period II - Acute Therapy Phase|Physician Decision|1
4420233|NCT00322621|7201045|FG001|Period II - Acute Therapy Phase|Physician Decision|0
4420234|NCT00322621|7201046|FG002|Period II - Acute Therapy Phase|Physician Decision|0
4420235|NCT00322621|7201044|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0
4420236|NCT00322621|7201045|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14
4420237|NCT00322621|7201046|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5
4420238|NCT00322621|7201044|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0
4420239|NCT00322621|7201045|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4
4420240|NCT00322621|7201046|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24
4420241|NCT00322621|7201044|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0
4420242|NCT00322621|7201045|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7
4420243|NCT00322621|7201046|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1
4420244|NCT00322621|7201044|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0
4420245|NCT00322621|7201045|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2
4420246|NCT00322621|7201046|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5
4420247|NCT00322621|7201044|FG000|Period III - Maintenance / Rescue Phase|Death|0
4420248|NCT00322621|7201045|FG001|Period III - Maintenance / Rescue Phase|Death|1
4420249|NCT00322621|7201046|FG002|Period III - Maintenance / Rescue Phase|Death|0
4420250|NCT00322621|7201044|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0
4420251|NCT00322621|7201045|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1
4420252|NCT00322621|7201046|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1
4420253|NCT00322712|7201059|FG000|Overall Study|treated with bevacizumab not cetuximab|1
4420254|NCT00322842|7201074|FG000|Overall Study|Withdrawal by Subject|0
4420255|NCT00322842|7201075|FG001|Overall Study|Withdrawal by Subject|1
4420256|NCT00322842|7201074|FG000|Overall Study|Lost to Follow-up|0
4420257|NCT00322842|7201075|FG001|Overall Study|Lost to Follow-up|1
4420258|NCT00322842|7201074|FG000|Overall Study|Refused transplant|1
4420259|NCT00322842|7201075|FG001|Overall Study|Refused transplant|0
4420260|NCT00322842|7201074|FG000|Overall Study|Death|1
4420261|NCT00322842|7201075|FG001|Overall Study|Death|0
4420262|NCT00322868|7201082|FG000|Overall Study|disease progression|1
4420263|NCT00322881|7201087|FG000|Overall Study|Death|2
4420264|NCT00322881|7201087|FG000|Overall Study|Adverse Event|1
4420265|NCT00322881|7201087|FG000|Overall Study|Disease Progression|2
4420266|NCT00323063|7201093|FG000|Overall Study|Adverse Event|1
4420267|NCT00323063|7201094|FG001|Overall Study|Adverse Event|0
4420268|NCT00323063|7201093|FG000|Overall Study|brain mets discovered prior to treatment|1
4420269|NCT00323063|7201094|FG001|Overall Study|brain mets discovered prior to treatment|0
4420270|NCT00323115|7201100|FG000|Vaccine Administration|Adverse Event|1
4420271|NCT00323115|7201100|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8
4420272|NCT00323258|7201120|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1
4420273|NCT00323258|7201121|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2
4420274|NCT00323258|7201120|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12
4420275|NCT00323258|7201121|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11
4420276|NCT00323258|7201120|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1
4420277|NCT00323258|7201121|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5
4420278|NCT00323258|7201120|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2
4420279|NCT00323258|7201121|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1
4420280|NCT00323258|7201120|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1
4420281|NCT00323258|7201121|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2
4420282|NCT00323258|7201120|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12
4420283|NCT00323258|7201121|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10
4420284|NCT00323258|7201120|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1
4420285|NCT00323258|7201121|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2
4420286|NCT00323297|7201147|FG000|Part A (Double Blind Randomized)|Reason unspecified|0
4420287|NCT00323297|7201148|FG001|Part A (Double Blind Randomized)|Reason unspecified|1
4420288|NCT00323297|7201147|FG000|Part A (Double Blind Randomized)|Death|0
4420289|NCT00323297|7201148|FG001|Part A (Double Blind Randomized)|Death|1
4420290|NCT00323297|7201147|FG000|Part A (Double Blind Randomized)|Protocol Violation|1
4420291|NCT00323297|7201148|FG001|Part A (Double Blind Randomized)|Protocol Violation|3
4420292|NCT00323297|7201147|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1
4420293|NCT00323297|7201148|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0
4420294|NCT00323297|7201147|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1
4420295|NCT00323297|7201148|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0
4420296|NCT00323297|7201147|FG000|Part A (Double Blind Randomized)|Related adverse event|2
4420297|NCT00323297|7201148|FG001|Part A (Double Blind Randomized)|Related adverse event|2
4420298|NCT00323297|7201147|FG000|Part B (Open-label)|Death|0
4420299|NCT00323297|7201148|FG001|Part B (Open-label)|Death|1
4420300|NCT00323297|7201147|FG000|Part B (Open-label)|Reason unspecified|0
4420301|NCT00323297|7201148|FG001|Part B (Open-label)|Reason unspecified|1
4420302|NCT00323297|7201147|FG000|Part B (Open-label)|Withdrawal by Subject|1
4420303|NCT00323297|7201148|FG001|Part B (Open-label)|Withdrawal by Subject|3
4420304|NCT00323297|7201147|FG000|Part B (Open-label)|Lack of Efficacy|3
4420305|NCT00323297|7201148|FG001|Part B (Open-label)|Lack of Efficacy|1
4420306|NCT00323297|7201147|FG000|Part B (Open-label)|Adverse Event|5
4420307|NCT00323297|7201148|FG001|Part B (Open-label)|Adverse Event|5
4420308|NCT00323297|7201147|FG000|Part B (Open-label)|Protocol Violation|0
4420309|NCT00323297|7201148|FG001|Part B (Open-label)|Protocol Violation|1
4420310|NCT00323310|7201154|FG000|Overall Study|Withdrawal by Subject|1
4420311|NCT00323310|7201154|FG000|Overall Study|a parent refused blood draw|1
4420312|NCT00323310|7201154|FG000|Overall Study|did not complete the 24-hr f-up visit|1
4420313|NCT00323414|7201164|FG000|Overall Study|Withdrawal by Subject|0
4420314|NCT00323414|7201165|FG001|Overall Study|Withdrawal by Subject|1
4420315|NCT00323479|7201189|FG000|Overall Study|Adverse Event|2
4420316|NCT00323479|7201189|FG000|Overall Study|Withdrawal by Subject|2
4420317|NCT00323479|7201189|FG000|Overall Study|Protocol Violation|3
4420318|NCT00323479|7201189|FG000|Overall Study|house moving|1
4420319|NCT00323492|7201195|FG000|Study Phase 1|Adverse Event|2
4420320|NCT00323492|7201196|FG001|Study Phase 1|Adverse Event|0
4420321|NCT00323492|7201197|FG002|Study Phase 1|Adverse Event|0
4420322|NCT00323492|7201195|FG000|Study Phase 2|Adverse Event|1
4420323|NCT00323492|7201196|FG001|Study Phase 2|Adverse Event|0
4420324|NCT00323492|7201197|FG002|Study Phase 2|Adverse Event|0
4420325|NCT00323492|7201195|FG000|Study Phase 2|Physician Decision|1
4420326|NCT00323492|7201196|FG001|Study Phase 2|Physician Decision|0
4420327|NCT00323492|7201197|FG002|Study Phase 2|Physician Decision|0
4420328|NCT00323492|7201195|FG000|Study Phase 2|Lost to Follow-up|1
4420329|NCT00323492|7201196|FG001|Study Phase 2|Lost to Follow-up|0
4420330|NCT00323492|7201197|FG002|Study Phase 2|Lost to Follow-up|0
4420331|NCT00323492|7201195|FG000|Study Phase 2|Withdrawal by Subject|0
4420332|NCT00323492|7201196|FG001|Study Phase 2|Withdrawal by Subject|1
4420333|NCT00323492|7201197|FG002|Study Phase 2|Withdrawal by Subject|0
4420334|NCT00323492|7201195|FG000|Study Phase 2|Noncompliance with study schedule|0
4420335|NCT00323492|7201196|FG001|Study Phase 2|Noncompliance with study schedule|0
4420336|NCT00323492|7201197|FG002|Study Phase 2|Noncompliance with study schedule|1
4420337|NCT00323492|7201195|FG000|Study Phase 2|Protocol Violation|1
4420338|NCT00323492|7201196|FG001|Study Phase 2|Protocol Violation|0
4420339|NCT00323492|7201197|FG002|Study Phase 2|Protocol Violation|0
4420340|NCT00323557|7201206|FG000|Overall Study|Physician Decision|1
4420341|NCT00323557|7201207|FG001|Overall Study|Physician Decision|0
4420342|NCT00323609|7201216|FG000|Overall Study|Death|16
4420343|NCT00323609|7201217|FG001|Overall Study|Death|21
4420344|NCT00323609|7201218|FG002|Overall Study|Death|0
4420345|NCT00323609|7201219|FG003|Overall Study|Death|0
4629518|NCT01873742|7497499|FG000|Overall Study|Lost to Follow-up|68
4420346|NCT00323609|7201216|FG000|Overall Study|Lost to Follow-up|9
4420347|NCT00323609|7201217|FG001|Overall Study|Lost to Follow-up|10
4420348|NCT00323609|7201218|FG002|Overall Study|Lost to Follow-up|0
4420349|NCT00323609|7201219|FG003|Overall Study|Lost to Follow-up|0
4420350|NCT00323609|7201216|FG000|Overall Study|Physician Decision|2
4420351|NCT00323609|7201217|FG001|Overall Study|Physician Decision|0
4420352|NCT00323609|7201218|FG002|Overall Study|Physician Decision|0
4420353|NCT00323609|7201219|FG003|Overall Study|Physician Decision|1
4420354|NCT00323609|7201216|FG000|Overall Study|Withdrawal by Subject|11
4420355|NCT00323609|7201217|FG001|Overall Study|Withdrawal by Subject|23
4420356|NCT00323609|7201218|FG002|Overall Study|Withdrawal by Subject|4
4420357|NCT00323609|7201219|FG003|Overall Study|Withdrawal by Subject|4
4420358|NCT00323609|7201216|FG000|Overall Study|Other non-VCF-related medical condition|3
4420359|NCT00323609|7201217|FG001|Overall Study|Other non-VCF-related medical condition|2
4420360|NCT00323609|7201218|FG002|Overall Study|Other non-VCF-related medical condition|0
4420361|NCT00323609|7201219|FG003|Overall Study|Other non-VCF-related medical condition|0
4420362|NCT00323609|7201216|FG000|Overall Study|Sponsor discontinued trial|29
4420363|NCT00323609|7201217|FG001|Overall Study|Sponsor discontinued trial|29
4420364|NCT00323609|7201218|FG002|Overall Study|Sponsor discontinued trial|0
4420365|NCT00323609|7201219|FG003|Overall Study|Sponsor discontinued trial|0
4420366|NCT00323609|7201216|FG000|Overall Study|Unrelenting or severe back pain|1
4420367|NCT00323609|7201217|FG001|Overall Study|Unrelenting or severe back pain|1
4420368|NCT00323609|7201218|FG002|Overall Study|Unrelenting or severe back pain|0
4420369|NCT00323609|7201219|FG003|Overall Study|Unrelenting or severe back pain|0
4420370|NCT00323609|7201216|FG000|Overall Study|Logistical withdrawal|9
4420371|NCT00323609|7201217|FG001|Overall Study|Logistical withdrawal|5
4420372|NCT00323609|7201218|FG002|Overall Study|Logistical withdrawal|0
4420373|NCT00323609|7201219|FG003|Overall Study|Logistical withdrawal|1
4420374|NCT00323609|7201216|FG000|Overall Study|Other reason|11
4420375|NCT00323609|7201217|FG001|Overall Study|Other reason|8
4629519|NCT01873742|7497500|FG001|Overall Study|Lost to Follow-up|76
4420376|NCT00323609|7201218|FG002|Overall Study|Other reason|4
4420377|NCT00323609|7201219|FG003|Overall Study|Other reason|9
4420378|NCT00323622|7201233|FG000|Overall Study|Other|30
4420379|NCT00323622|7201234|FG001|Overall Study|Other|91
4420380|NCT00323622|7201235|FG002|Overall Study|Other|4
4420381|NCT00323622|7201236|FG003|Overall Study|Other|12
4420382|NCT00323622|7201237|FG004|Overall Study|Other|32
4420383|NCT00323622|7201238|FG005|Overall Study|Other|74
4420384|NCT00323622|7201239|FG006|Overall Study|Other|5
4420385|NCT00323622|7201240|FG007|Overall Study|Other|13
4420386|NCT00323622|7201233|FG000|Overall Study|Death|1
4420387|NCT00323622|7201234|FG001|Overall Study|Death|1
4420388|NCT00323622|7201235|FG002|Overall Study|Death|0
4420389|NCT00323622|7201236|FG003|Overall Study|Death|0
4420390|NCT00323622|7201237|FG004|Overall Study|Death|7
4420391|NCT00323622|7201238|FG005|Overall Study|Death|0
4420392|NCT00323622|7201239|FG006|Overall Study|Death|0
4420393|NCT00323622|7201240|FG007|Overall Study|Death|2
4420394|NCT00323869|7201270|FG000|Overall Study|Death|1
4420395|NCT00323882|7201279|FG000|Overall Study|Adverse Event|2
4420396|NCT00323882|7201280|FG001|Overall Study|Adverse Event|1
4420397|NCT00323882|7201281|FG002|Overall Study|Adverse Event|1
4420398|NCT00323882|7201282|FG003|Overall Study|Adverse Event|1
4420399|NCT00323882|7201283|FG004|Overall Study|Adverse Event|3
4420400|NCT00323882|7201279|FG000|Overall Study|Disease Progression|6
4420401|NCT00323882|7201280|FG001|Overall Study|Disease Progression|4
4420402|NCT00323882|7201281|FG002|Overall Study|Disease Progression|10
4420403|NCT00323882|7201282|FG003|Overall Study|Disease Progression|5
4420404|NCT00323882|7201283|FG004|Overall Study|Disease Progression|22
4420405|NCT00323882|7201279|FG000|Overall Study|Death|0
4420406|NCT00323882|7201280|FG001|Overall Study|Death|1
4420407|NCT00323882|7201281|FG002|Overall Study|Death|1
4420408|NCT00323882|7201282|FG003|Overall Study|Death|0
4420409|NCT00323882|7201283|FG004|Overall Study|Death|5
4420410|NCT00323882|7201279|FG000|Overall Study|Lost to Follow-up|0
4420411|NCT00323882|7201280|FG001|Overall Study|Lost to Follow-up|0
4420412|NCT00323882|7201281|FG002|Overall Study|Lost to Follow-up|1
4420413|NCT00323882|7201282|FG003|Overall Study|Lost to Follow-up|0
4420414|NCT00323882|7201283|FG004|Overall Study|Lost to Follow-up|1
4420415|NCT00323882|7201279|FG000|Overall Study|Other|0
4420416|NCT00323882|7201280|FG001|Overall Study|Other|0
4420417|NCT00323882|7201281|FG002|Overall Study|Other|0
4420418|NCT00323882|7201282|FG003|Overall Study|Other|1
4420419|NCT00323882|7201283|FG004|Overall Study|Other|1
4420420|NCT00324038|7201322|FG000|Overall Study|Adverse Event|38
4420421|NCT00324038|7201323|FG001|Overall Study|Adverse Event|23
4420422|NCT00324038|7201322|FG000|Overall Study|Lack of Efficacy|5
4420423|NCT00324038|7201323|FG001|Overall Study|Lack of Efficacy|13
4420424|NCT00324038|7201322|FG000|Overall Study|Lost to Follow-up|0
4420425|NCT00324038|7201323|FG001|Overall Study|Lost to Follow-up|2
4420426|NCT00324038|7201322|FG000|Overall Study|Other|6
4420427|NCT00324038|7201323|FG001|Overall Study|Other|13
4420428|NCT00324116|7201329|FG000|Overall Study|Adverse Event|5
4420429|NCT00324116|7201329|FG000|Overall Study|Lack of Efficacy|17
4420430|NCT00324116|7201329|FG000|Overall Study|Withdrawal by Subject|5
4420431|NCT00324116|7201329|FG000|Overall Study|Other|5
4420432|NCT00324155|7201335|FG000|Enrolled and Randomized|No longer met study criteria|3
4420433|NCT00324155|7201336|FG001|Enrolled and Randomized|No longer met study criteria|0
4420434|NCT00324155|7201335|FG000|Enrolled and Randomized|Lost to Follow-up|0
4420435|NCT00324155|7201336|FG001|Enrolled and Randomized|Lost to Follow-up|1
4420436|NCT00324155|7201335|FG000|Received Treatment in Induction Phase|Disease Progression|88
4420437|NCT00324155|7201336|FG001|Received Treatment in Induction Phase|Disease Progression|152
4420438|NCT00324155|7201335|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83
4420439|NCT00324155|7201336|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10
4420440|NCT00324155|7201335|FG000|Received Treatment in Induction Phase|Death|8
4420441|NCT00324155|7201336|FG001|Received Treatment in Induction Phase|Death|15
4420442|NCT00324155|7201335|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9
4420443|NCT00324155|7201336|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8
4420444|NCT00324155|7201335|FG000|Received Treatment in Induction Phase|Adverse Event|6
4420445|NCT00324155|7201336|FG001|Received Treatment in Induction Phase|Adverse Event|7
4420446|NCT00324155|7201335|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6
4420447|NCT00324155|7201336|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5
4420448|NCT00324155|7201335|FG000|Received Treatment in Induction Phase|Physician Decision|2
4420449|NCT00324155|7201336|FG001|Received Treatment in Induction Phase|Physician Decision|0
4420450|NCT00324155|7201335|FG000|Received Treatment in Maintenance Phase|Disease Progression|26
4420451|NCT00324155|7201336|FG001|Received Treatment in Maintenance Phase|Disease Progression|41
4420452|NCT00324155|7201335|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4
4420453|NCT00324155|7201336|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0
4420454|NCT00324155|7201335|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1
4420455|NCT00324155|7201336|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3
4420456|NCT00324155|7201335|FG000|Received Treatment in Maintenance Phase|Adverse Event|0
4420457|NCT00324155|7201336|FG001|Received Treatment in Maintenance Phase|Adverse Event|3
4420458|NCT00324155|7201335|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1
4420459|NCT00324155|7201336|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0
4420460|NCT00324155|7201335|FG000|Follow-up Phase|On-going participants still on drug|11
4420461|NCT00324155|7201336|FG001|Follow-up Phase|On-going participants still on drug|6
4420462|NCT00324168|7201357|FG000|Overall Study|Lost to Follow-up|19
4420463|NCT00324168|7201358|FG001|Overall Study|Lost to Follow-up|18
4420464|NCT00324168|7201357|FG000|Overall Study|Death|3
4420465|NCT00324168|7201358|FG001|Overall Study|Death|3
4420466|NCT00324168|7201357|FG000|Overall Study|Patient did not visit in f/u window|6
4420467|NCT00324168|7201358|FG001|Overall Study|Patient did not visit in f/u window|9
4420468|NCT00324233|7201366|FG000|First Period|unable to insert catheter|1
4420469|NCT00324233|7201367|FG001|First Period|unable to insert catheter|0
4420470|NCT00324233|7201366|FG000|Second Period|unable to insert catheter|1
4420471|NCT00324233|7201367|FG001|Second Period|unable to insert catheter|1
4420472|NCT00324233|7201366|FG000|Second Period|Protocol Violation|4
4420473|NCT00324233|7201367|FG001|Second Period|Protocol Violation|6
4420474|NCT00324649|7201417|FG000|Overall Study|Adverse Event|1
4420475|NCT00324649|7201418|FG001|Overall Study|Adverse Event|4
4420476|NCT00324649|7201417|FG000|Overall Study|Withdrawal by Subject|0
4420477|NCT00324649|7201418|FG001|Overall Study|Withdrawal by Subject|1
4420478|NCT00324649|7201417|FG000|Overall Study|Noncompliance|1
4420479|NCT00324649|7201418|FG001|Overall Study|Noncompliance|0
4420480|NCT00324675|7201426|FG000|Overall Study|Adverse Event|1
4420481|NCT00324675|7201427|FG001|Overall Study|Adverse Event|0
4420482|NCT00324740|7201442|FG000|Overall Study|Withdrawal by Subject|1
4420483|NCT00324740|7201443|FG001|Overall Study|Withdrawal by Subject|0
4420484|NCT00324740|7201444|FG002|Overall Study|Withdrawal by Subject|1
4420485|NCT00324961|7201496|FG000|Overall Study|Adverse Event|5
4420486|NCT00324961|7201496|FG000|Overall Study|Consent Withdrawn|11
4420487|NCT00324961|7201496|FG000|Overall Study|Lost to Follow-up|22
4420488|NCT00324961|7201496|FG000|Overall Study|Protocol Violation|3
4420489|NCT00324961|7201496|FG000|Overall Study|Other|2
4420490|NCT00324987|7201504|FG000|Overall Study|Adverse Event|2
4420491|NCT00324987|7201505|FG001|Overall Study|Adverse Event|1
4420492|NCT00324987|7201504|FG000|Overall Study|Withdrawal by Subject|1
4420493|NCT00324987|7201505|FG001|Overall Study|Withdrawal by Subject|1
4420494|NCT00324987|7201504|FG000|Overall Study|Progression|1
4420495|NCT00324987|7201505|FG001|Overall Study|Progression|1
4420496|NCT00324987|7201504|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2
4420497|NCT00324987|7201505|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3
4512077|NCT00931801|7321670|FG002|Overall Study|Withdrawal by Subject|0
4512078|NCT00931801|7321668|FG000|Overall Study|Confirmed Virologic Failure|0
4512079|NCT00931801|7321669|FG001|Overall Study|Confirmed Virologic Failure|0
4512080|NCT00931801|7321670|FG002|Overall Study|Confirmed Virologic Failure|3
4518436|NCT00973973|7330572|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1
4518437|NCT00973973|7330571|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1
4518438|NCT00973973|7330572|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2
4518439|NCT00973973|7330571|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1
4518440|NCT00973973|7330572|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0
4518441|NCT00973973|7330571|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1
4518442|NCT00973973|7330572|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0
4518443|NCT00973973|7330571|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1
4518444|NCT00973973|7330572|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3
4518445|NCT00973973|7330571|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1
4518446|NCT00973973|7330572|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0
4518447|NCT00973973|7330571|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1
4518448|NCT00973973|7330572|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0
4518449|NCT00974090|7330591|FG000|Period 1: Double Blind Period|Adverse Event|2
4518450|NCT00974090|7330592|FG001|Period 1: Double Blind Period|Adverse Event|1
4518451|NCT00974090|7330591|FG000|Period 1: Double Blind Period|Physician Decision|1
4518452|NCT00974090|7330592|FG001|Period 1: Double Blind Period|Physician Decision|0
4518453|NCT00974090|7330591|FG000|Period 2: Open-label Period|Adverse Event|4
4518454|NCT00974090|7330592|FG001|Period 2: Open-label Period|Adverse Event|6
4518455|NCT00974090|7330591|FG000|Period 2: Open-label Period|Lack of Efficacy|3
4518456|NCT00974090|7330592|FG001|Period 2: Open-label Period|Lack of Efficacy|1
4518457|NCT00974090|7330591|FG000|Period 2: Open-label Period|Physician Decision|0
4518458|NCT00974090|7330592|FG001|Period 2: Open-label Period|Physician Decision|3
4518459|NCT00974090|7330591|FG000|Period 2: Open-label Period|Withdrawal by Subject|1
4518460|NCT00974090|7330592|FG001|Period 2: Open-label Period|Withdrawal by Subject|0
4518461|NCT00974220|7330611|FG000|Treatment Period 1|Adverse Event|2
4518462|NCT00974220|7330612|FG001|Treatment Period 1|Adverse Event|1
4518463|NCT00974220|7330611|FG000|Treatment Period 1|noncompliant subjects|0
4518464|NCT00974220|7330612|FG001|Treatment Period 1|noncompliant subjects|1
4518465|NCT00974233|7330618|FG000|Induction Chemoimmunotherapy|Death|2
4518466|NCT00974233|7330618|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5
4518467|NCT00974233|7330618|FG000|Induction Chemoimmunotherapy|Adverse Event|7
4518468|NCT00974233|7330618|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1
4518469|NCT00974233|7330618|FG000|Maintenance Lenalidomide|Lack of Efficacy|5
4518470|NCT00974233|7330618|FG000|Maintenance Lenalidomide|Adverse Event|8
4518471|NCT00974259|7330637|FG000|Overall Study|Technically inadequate PbtO2 recordings|2
4518472|NCT00974259|7330638|FG001|Overall Study|Technically inadequate PbtO2 recordings|1
4518473|NCT00974311|7330646|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5
4518474|NCT00974311|7330647|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2
4518475|NCT00974311|7330646|FG000|DB Phase (up to 24 Months)|Death|561
4518476|NCT00974311|7330647|FG001|DB Phase (up to 24 Months)|Death|298
4629520|NCT01873859|7497512|FG000|Overall Study|Withdrawal by Subject|0
4420498|NCT00325039|7201513|FG000|Overall Study|Lost to Follow-up|18
4420499|NCT00325039|7201514|FG001|Overall Study|Lost to Follow-up|14
4420500|NCT00325130|7201536|FG000|Overall Study|Lost to Follow-up|6
4420501|NCT00325130|7201537|FG001|Overall Study|Lost to Follow-up|14
4714906|NCT02963935|7642939|FG000|Overall Study|Adverse Event|12
4714907|NCT02963935|7642940|FG001|Overall Study|Adverse Event|6
4629521|NCT01873859|7497513|FG001|Overall Study|Withdrawal by Subject|4
4714908|NCT02963935|7642939|FG000|Overall Study|Protocol Violation|2
4714909|NCT02963935|7642940|FG001|Overall Study|Protocol Violation|1
4714910|NCT02963935|7642939|FG000|Overall Study|Lack of Efficacy|0
4714911|NCT02963935|7642940|FG001|Overall Study|Lack of Efficacy|2
4714912|NCT02963935|7642939|FG000|Overall Study|Lost to Follow-up|1
4714913|NCT02963935|7642940|FG001|Overall Study|Lost to Follow-up|6
4420502|NCT00325130|7201536|FG000|Overall Study|Withdrawal by Subject|12
4420503|NCT00325130|7201537|FG001|Overall Study|Withdrawal by Subject|14
4420504|NCT00325130|7201536|FG000|Overall Study|Protocol Deviation|0
4420505|NCT00325130|7201537|FG001|Overall Study|Protocol Deviation|1
4420506|NCT00325130|7201536|FG000|Overall Study|Moved|0
4420507|NCT00325130|7201537|FG001|Overall Study|Moved|1
4420508|NCT00325130|7201536|FG000|Overall Study|Patient Discontinued for Other|1
4420509|NCT00325130|7201537|FG001|Overall Study|Patient Discontinued for Other|0
4420510|NCT00325143|7201543|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13
4420511|NCT00325143|7201543|FG000|Overall Study|Migrated/moved from study area|1
4420512|NCT00325143|7201543|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4
4420513|NCT00325143|7201543|FG000|Overall Study|Withdrawal by Subject|8
4420514|NCT00325156|7201547|FG000|Overall Study|Protocol Violation|8
4420515|NCT00325156|7201547|FG000|Overall Study|Lost to follow-up (complete vaccination)|41
4420516|NCT00325156|7201547|FG000|Overall Study|Migrated/moved from study area|12
4420517|NCT00325156|7201547|FG000|Overall Study|Adverse event, non-fatal|3
4420518|NCT00325156|7201547|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16
4420519|NCT00325156|7201547|FG000|Overall Study|Other|1
4420520|NCT00325156|7201547|FG000|Overall Study|Withdrawal by Subject|31
4420521|NCT00325195|7201554|FG000|Randomized|Not dosed|5
4420522|NCT00325195|7201555|FG001|Randomized|Not dosed|5
4420523|NCT00325195|7201556|FG002|Randomized|Not dosed|3
4420524|NCT00325195|7201554|FG000|Received Intervention: ITT Population|Adverse Event|15
4420525|NCT00325195|7201555|FG001|Received Intervention: ITT Population|Adverse Event|17
4420526|NCT00325195|7201556|FG002|Received Intervention: ITT Population|Adverse Event|1
4420527|NCT00325195|7201554|FG000|Received Intervention: ITT Population|Death|3
4420528|NCT00325195|7201555|FG001|Received Intervention: ITT Population|Death|1
4420529|NCT00325195|7201556|FG002|Received Intervention: ITT Population|Death|0
4420530|NCT00325195|7201554|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7
4420531|NCT00325195|7201555|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6
4420532|NCT00325195|7201556|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1
4420533|NCT00325195|7201554|FG000|Received Intervention: ITT Population|Lost to Follow-up|0
4420534|NCT00325195|7201555|FG001|Received Intervention: ITT Population|Lost to Follow-up|0
4420535|NCT00325195|7201556|FG002|Received Intervention: ITT Population|Lost to Follow-up|2
4420536|NCT00325195|7201554|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1
4420537|NCT00325195|7201555|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1
4420538|NCT00325195|7201556|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0
4420539|NCT00325234|7201566|FG000|Overall Study|Adverse Event|10
4420540|NCT00325234|7201567|FG001|Overall Study|Adverse Event|7
4420541|NCT00325234|7201566|FG000|Overall Study|Death due to Study Disease|1
4420542|NCT00325234|7201567|FG001|Overall Study|Death due to Study Disease|0
4420543|NCT00325234|7201566|FG000|Overall Study|Entry Criteria Not Met|1
4420544|NCT00325234|7201567|FG001|Overall Study|Entry Criteria Not Met|2
4420545|NCT00325234|7201566|FG000|Overall Study|Subject Decision|6
4420546|NCT00325234|7201567|FG001|Overall Study|Subject Decision|8
4420547|NCT00325234|7201566|FG000|Overall Study|Physician Decision|17
4420548|NCT00325234|7201567|FG001|Overall Study|Physician Decision|12
4420549|NCT00325234|7201566|FG000|Overall Study|Progressive Disease|34
4420550|NCT00325234|7201567|FG001|Overall Study|Progressive Disease|37
4420551|NCT00325416|7201588|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8
4420552|NCT00325416|7201589|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9
4420553|NCT00325416|7201588|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7
4420554|NCT00325416|7201589|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4
4420555|NCT00325416|7201588|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7
4420556|NCT00325416|7201589|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2
4420557|NCT00325416|7201588|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0
4420558|NCT00325416|7201589|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1
4420559|NCT00325416|7201588|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0
4420560|NCT00325416|7201589|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1
4420561|NCT00325416|7201588|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0
4420562|NCT00325416|7201589|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1
4420563|NCT00325468|7201612|FG000|Overall Study|Adverse Event|1
4420564|NCT00325468|7201613|FG001|Overall Study|Adverse Event|1
4714914|NCT02963935|7642939|FG000|Overall Study|Unclassified|13
4714915|NCT02963935|7642940|FG001|Overall Study|Unclassified|22
4420565|NCT00325468|7201614|FG002|Overall Study|Adverse Event|0
4420566|NCT00325468|7201615|FG003|Overall Study|Adverse Event|5
4420567|NCT00325468|7201616|FG004|Overall Study|Adverse Event|1
4420568|NCT00325468|7201612|FG000|Overall Study|Death|2
4420569|NCT00325468|7201613|FG001|Overall Study|Death|0
4420570|NCT00325468|7201614|FG002|Overall Study|Death|2
4420571|NCT00325468|7201615|FG003|Overall Study|Death|4
4420572|NCT00325468|7201616|FG004|Overall Study|Death|0
4420573|NCT00325468|7201612|FG000|Overall Study|Lost to Follow-up|0
4420574|NCT00325468|7201613|FG001|Overall Study|Lost to Follow-up|0
4420575|NCT00325468|7201614|FG002|Overall Study|Lost to Follow-up|1
4420576|NCT00325468|7201615|FG003|Overall Study|Lost to Follow-up|2
4420577|NCT00325468|7201616|FG004|Overall Study|Lost to Follow-up|2
4420578|NCT00325468|7201612|FG000|Overall Study|Physician Decision|1
4420579|NCT00325468|7201613|FG001|Overall Study|Physician Decision|1
4420580|NCT00325468|7201614|FG002|Overall Study|Physician Decision|0
4420581|NCT00325468|7201615|FG003|Overall Study|Physician Decision|1
4420582|NCT00325468|7201616|FG004|Overall Study|Physician Decision|0
4420583|NCT00325468|7201612|FG000|Overall Study|Withdrawal by Subject|3
4420584|NCT00325468|7201613|FG001|Overall Study|Withdrawal by Subject|1
4420585|NCT00325468|7201614|FG002|Overall Study|Withdrawal by Subject|0
4420586|NCT00325468|7201615|FG003|Overall Study|Withdrawal by Subject|14
4420587|NCT00325468|7201616|FG004|Overall Study|Withdrawal by Subject|4
4420588|NCT00325468|7201612|FG000|Overall Study|site closure etc|4
4420589|NCT00325468|7201613|FG001|Overall Study|site closure etc|2
4420590|NCT00325468|7201614|FG002|Overall Study|site closure etc|1
4420591|NCT00325468|7201615|FG003|Overall Study|site closure etc|8
4420592|NCT00325468|7201616|FG004|Overall Study|site closure etc|1
4420593|NCT00325754|7201642|FG000|Overall Study|Adverse Event|4
4420594|NCT00325754|7201643|FG001|Overall Study|Adverse Event|1
4420595|NCT00325819|7201655|FG000|Overall Study|Study product lost in mail|2
4420596|NCT00325819|7201656|FG001|Overall Study|Study product lost in mail|1
4420597|NCT00325819|7201655|FG000|Overall Study|Did not take a dose of study product|4
4420598|NCT00325819|7201656|FG001|Overall Study|Did not take a dose of study product|9
4420599|NCT00325819|7201655|FG000|Overall Study|Lost to Follow-up|3
4420600|NCT00325819|7201656|FG001|Overall Study|Lost to Follow-up|3
4420601|NCT00325897|7201666|FG000|Overall Study|Lost to Follow-up|12
4420602|NCT00325897|7201667|FG001|Overall Study|Lost to Follow-up|13
4420603|NCT00326001|7201678|FG000|Overall Study|Adverse Event|4
4420604|NCT00326001|7201679|FG001|Overall Study|Adverse Event|5
4420605|NCT00326001|7201678|FG000|Overall Study|Physician Decision|3
4420606|NCT00326001|7201679|FG001|Overall Study|Physician Decision|3
4420607|NCT00326118|7201687|FG000|Active Phase|Withdrawal by Subject|4
4420608|NCT00326118|7201688|FG001|Active Phase|Withdrawal by Subject|1
4420609|NCT00326209|7201708|FG000|Overall Study|Adverse Event|28
4420610|NCT00326209|7201708|FG000|Overall Study|Withdrawal by Subject|22
4420611|NCT00326209|7201708|FG000|Overall Study|Lack of Efficacy|31
4420612|NCT00326209|7201708|FG000|Overall Study|Lost to Follow-up|18
4420613|NCT00326209|7201708|FG000|Overall Study|Participant non-compliant|6
4420614|NCT00326209|7201708|FG000|Overall Study|Sponsor closed study|173
4420615|NCT00326209|7201708|FG000|Overall Study|Prohibited medication use|1
4420616|NCT00326209|7201708|FG000|Overall Study|Violation of entry criteria|1
4420617|NCT00326209|7201708|FG000|Overall Study|Withdrawn in error|1
4420618|NCT00326209|7201708|FG000|Overall Study|Pregnancy|1
4420619|NCT00326417|7201714|FG000|Overall Study|Withdrawal by Subject|0
4420620|NCT00326417|7201715|FG001|Overall Study|Withdrawal by Subject|0
4420621|NCT00326417|7201716|FG002|Overall Study|Withdrawal by Subject|1
4420622|NCT00326417|7201717|FG003|Overall Study|Withdrawal by Subject|0
4420623|NCT00326417|7201714|FG000|Overall Study|Arm Closed|7
4420624|NCT00326417|7201715|FG001|Overall Study|Arm Closed|0
4420625|NCT00326417|7201716|FG002|Overall Study|Arm Closed|0
4420626|NCT00326417|7201717|FG003|Overall Study|Arm Closed|3
4420627|NCT00326417|7201714|FG000|Overall Study|Death|7
4420628|NCT00326417|7201715|FG001|Overall Study|Death|0
4420629|NCT00326417|7201716|FG002|Overall Study|Death|0
4420630|NCT00326417|7201717|FG003|Overall Study|Death|0
4420631|NCT00326495|7201725|FG000|Overall Study|Switched to alternative treatment|1
4420632|NCT00326495|7201725|FG000|Overall Study|Disease progression before treatment|1
4420633|NCT00326495|7201725|FG000|Overall Study|Refused further treatment|2
4420634|NCT00326495|7201725|FG000|Overall Study|Subject off study before assessment|1
4420635|NCT00326599|7201733|FG000|Overall Study|Withdrawal by Subject|1
4420636|NCT00326599|7201734|FG001|Overall Study|Withdrawal by Subject|0
4420637|NCT00326599|7201735|FG002|Overall Study|Withdrawal by Subject|5
4420638|NCT00326599|7201736|FG003|Overall Study|Withdrawal by Subject|2
4420639|NCT00326599|7201733|FG000|Overall Study|Adverse Event|1
4420640|NCT00326599|7201734|FG001|Overall Study|Adverse Event|0
4420641|NCT00326599|7201735|FG002|Overall Study|Adverse Event|32
4420642|NCT00326599|7201736|FG003|Overall Study|Adverse Event|3
4420643|NCT00326599|7201733|FG000|Overall Study|Disease Progression|3
4420644|NCT00326599|7201734|FG001|Overall Study|Disease Progression|1
4420645|NCT00326599|7201735|FG002|Overall Study|Disease Progression|13
4420646|NCT00326599|7201736|FG003|Overall Study|Disease Progression|11
4420647|NCT00326599|7201733|FG000|Overall Study|Alternate Treatment|1
4420648|NCT00326599|7201734|FG001|Overall Study|Alternate Treatment|0
4420649|NCT00326599|7201735|FG002|Overall Study|Alternate Treatment|0
4420650|NCT00326599|7201736|FG003|Overall Study|Alternate Treatment|0
4420651|NCT00326599|7201733|FG000|Overall Study|Death|0
4420652|NCT00326599|7201734|FG001|Overall Study|Death|0
4420653|NCT00326599|7201735|FG002|Overall Study|Death|1
4420654|NCT00326599|7201736|FG003|Overall Study|Death|2
4420655|NCT00326599|7201733|FG000|Overall Study|Other Unspecified Reason|0
4420656|NCT00326599|7201734|FG001|Overall Study|Other Unspecified Reason|0
4420657|NCT00326599|7201735|FG002|Overall Study|Other Unspecified Reason|2
4420658|NCT00326599|7201736|FG003|Overall Study|Other Unspecified Reason|1
4420659|NCT00326612|7201747|FG000|Overall Study|They did not have a seizure requiring tx|129
4420660|NCT00326612|7201748|FG001|Overall Study|They did not have a seizure requiring tx|137
4420661|NCT00326625|7201760|FG000|Overall Study|Adverse Event|20
4420662|NCT00326625|7201761|FG001|Overall Study|Adverse Event|9
4420663|NCT00326625|7201760|FG000|Overall Study|Withdrawal by Subject|15
4420664|NCT00326625|7201761|FG001|Overall Study|Withdrawal by Subject|12
4420665|NCT00326625|7201760|FG000|Overall Study|Death|18
4420666|NCT00326625|7201761|FG001|Overall Study|Death|16
4420667|NCT00326625|7201760|FG000|Overall Study|Lost to Follow-up|1
4420668|NCT00326625|7201761|FG001|Overall Study|Lost to Follow-up|0
4420669|NCT00326625|7201760|FG000|Overall Study|prescheduled medical intervention|0
4420670|NCT00326625|7201761|FG001|Overall Study|prescheduled medical intervention|1
4420671|NCT00326716|7201769|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1
4420672|NCT00326716|7201770|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2
4420673|NCT00326716|7201771|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0
4420674|NCT00326716|7201772|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0
4420675|NCT00326885|7201815|FG000|Overall Study|Adverse Event|1
4420676|NCT00326885|7201815|FG000|Overall Study|Withdrawal by Subject|3
4420677|NCT00326885|7201815|FG000|Overall Study|Physician Decision|1
4420678|NCT00326885|7201815|FG000|Overall Study|Hospice withdrew consent|2
4420679|NCT00326911|7201822|FG000|Overall Study|Hospitalization prior to treatment|0
4420680|NCT00326911|7201823|FG001|Overall Study|Hospitalization prior to treatment|1
4420681|NCT00326911|7201822|FG000|Overall Study|Physician decision prior to treatment|1
4420682|NCT00326911|7201823|FG001|Overall Study|Physician decision prior to treatment|0
4420683|NCT00326911|7201822|FG000|Overall Study|Withdrawal by subject prior to treatment|0
4420684|NCT00326911|7201823|FG001|Overall Study|Withdrawal by subject prior to treatment|1
4420685|NCT00326950|7201838|FG000|Overall Study|Progressive Disease|1
4420686|NCT00326963|7201842|FG000|Overall Study|Adverse Event|2
4420687|NCT00326963|7201842|FG000|Overall Study|Injection site reaction|1
4420688|NCT00326963|7201842|FG000|Overall Study|Death|1
4420689|NCT00326963|7201842|FG000|Overall Study|Failure to return|10
4420690|NCT00326963|7201842|FG000|Overall Study|Withdrawal by Subject|10
4420691|NCT00326963|7201842|FG000|Overall Study|Refused treatment / did not cooperate|5
4420692|NCT00326963|7201842|FG000|Overall Study|Violation of selection criteria at entry|2
4420693|NCT00326963|7201842|FG000|Overall Study|Other protocol violation|1
4420694|NCT00326963|7201842|FG000|Overall Study|Administrative / other|1
4420695|NCT00327015|7201851|FG000|Overall Study|Lack of Efficacy|18
4420696|NCT00327015|7201852|FG001|Overall Study|Lack of Efficacy|18
4420697|NCT00327015|7201853|FG002|Overall Study|Lack of Efficacy|35
4420698|NCT00327015|7201854|FG003|Overall Study|Lack of Efficacy|29
4420699|NCT00327015|7201851|FG000|Overall Study|Withdrawal of Consent by Subject|20
4420700|NCT00327015|7201852|FG001|Overall Study|Withdrawal of Consent by Subject|24
4629522|NCT01873950|7497520|FG000|Period 5|Withdrawal by Subject|0
4629523|NCT01873950|7497521|FG001|Period 5|Withdrawal by Subject|0
4629524|NCT01873950|7497522|FG002|Period 5|Withdrawal by Subject|0
4629525|NCT01873950|7497523|FG003|Period 5|Withdrawal by Subject|1
4629526|NCT01873950|7497524|FG004|Period 5|Withdrawal by Subject|0
4629527|NCT01874054|7497547|FG000|Overall Study|Withdrawal by Subject|3
4629528|NCT01874054|7497547|FG000|Overall Study|Study Termination by Sponsor|42
4629529|NCT01874054|7497547|FG000|Overall Study|Lost to Follow-up|5
4629530|NCT01874054|7497547|FG000|Overall Study|Death|5
4629531|NCT01874145|7497573|FG000|Core Period|Non-compliance|1
4629532|NCT01874145|7497574|FG001|Core Period|Non-compliance|0
4629533|NCT01874145|7497573|FG000|Core Period|Protocol Violation|1
4629534|NCT01874145|7497574|FG001|Core Period|Protocol Violation|1
4629535|NCT01874145|7497573|FG000|Core Period|Physician Decision|1
4629536|NCT01874145|7497574|FG001|Core Period|Physician Decision|1
4629537|NCT01874145|7497573|FG000|Core Period|Adverse Event|0
4629538|NCT01874145|7497574|FG001|Core Period|Adverse Event|1
4629539|NCT01874145|7497573|FG000|Core Period|Withdrawal by Subject|0
4629540|NCT01874145|7497574|FG001|Core Period|Withdrawal by Subject|4
4420701|NCT00327015|7201853|FG002|Overall Study|Withdrawal of Consent by Subject|28
4420702|NCT00327015|7201854|FG003|Overall Study|Withdrawal of Consent by Subject|25
4420703|NCT00327015|7201851|FG000|Overall Study|Lost to Follow-up|22
4420704|NCT00327015|7201852|FG001|Overall Study|Lost to Follow-up|23
4420705|NCT00327015|7201853|FG002|Overall Study|Lost to Follow-up|29
4420706|NCT00327015|7201854|FG003|Overall Study|Lost to Follow-up|22
4629541|NCT01874145|7497573|FG000|Extension Period|Adverse Event|3
4629542|NCT01874145|7497574|FG001|Extension Period|Adverse Event|2
4629543|NCT01874145|7497573|FG000|Extension Period|Withdrawal by Subject|2
4420707|NCT00327015|7201851|FG000|Overall Study|Adverse Event|14
4420708|NCT00327015|7201852|FG001|Overall Study|Adverse Event|10
4420709|NCT00327015|7201853|FG002|Overall Study|Adverse Event|14
4420710|NCT00327015|7201854|FG003|Overall Study|Adverse Event|14
4420711|NCT00327015|7201851|FG000|Overall Study|Subject no longer meets study criteria|4
4420712|NCT00327015|7201852|FG001|Overall Study|Subject no longer meets study criteria|2
4420713|NCT00327015|7201853|FG002|Overall Study|Subject no longer meets study criteria|8
4420714|NCT00327015|7201854|FG003|Overall Study|Subject no longer meets study criteria|7
4420715|NCT00327015|7201851|FG000|Overall Study|Poor/Noncompliance|11
4420716|NCT00327015|7201852|FG001|Overall Study|Poor/Noncompliance|8
4420717|NCT00327015|7201853|FG002|Overall Study|Poor/Noncompliance|4
4420718|NCT00327015|7201854|FG003|Overall Study|Poor/Noncompliance|5
4420719|NCT00327015|7201851|FG000|Overall Study|Physician Decision|0
4420720|NCT00327015|7201852|FG001|Overall Study|Physician Decision|1
4420721|NCT00327015|7201853|FG002|Overall Study|Physician Decision|3
4420722|NCT00327015|7201854|FG003|Overall Study|Physician Decision|2
4420723|NCT00327015|7201851|FG000|Overall Study|Death|1
4420724|NCT00327015|7201852|FG001|Overall Study|Death|2
4420725|NCT00327015|7201853|FG002|Overall Study|Death|2
4420726|NCT00327015|7201854|FG003|Overall Study|Death|3
4420727|NCT00327015|7201851|FG000|Overall Study|Pregnancy|0
4420728|NCT00327015|7201852|FG001|Overall Study|Pregnancy|2
4420729|NCT00327015|7201853|FG002|Overall Study|Pregnancy|1
4420730|NCT00327015|7201854|FG003|Overall Study|Pregnancy|1
4420731|NCT00327015|7201851|FG000|Overall Study|Administrative Reason by Sponsor|1
4420732|NCT00327015|7201852|FG001|Overall Study|Administrative Reason by Sponsor|2
4420733|NCT00327015|7201853|FG002|Overall Study|Administrative Reason by Sponsor|2
4420734|NCT00327015|7201854|FG003|Overall Study|Administrative Reason by Sponsor|1
4420735|NCT00327171|7201866|FG000|Overall Study|Did not receive study medication|3
4420736|NCT00327171|7201867|FG001|Overall Study|Did not receive study medication|0
4420737|NCT00327171|7201866|FG000|Overall Study|Adverse Event|23
4420738|NCT00327171|7201867|FG001|Overall Study|Adverse Event|23
4420739|NCT00327171|7201866|FG000|Overall Study|Disease progression/lack of efficacy|68
4420740|NCT00327171|7201867|FG001|Overall Study|Disease progression/lack of efficacy|69
4420741|NCT00327171|7201866|FG000|Overall Study|Investigator/participant request|1
4420742|NCT00327171|7201867|FG001|Overall Study|Investigator/participant request|8
4420743|NCT00327171|7201866|FG000|Overall Study|Clinical progression|12
4420744|NCT00327171|7201867|FG001|Overall Study|Clinical progression|8
4420745|NCT00327171|7201866|FG000|Overall Study|Undisclosed history of ischemia|0
4420746|NCT00327171|7201867|FG001|Overall Study|Undisclosed history of ischemia|1
4420747|NCT00327171|7201866|FG000|Overall Study|Other|1
4420748|NCT00327171|7201867|FG001|Overall Study|Other|0
4420749|NCT00327340|7201875|FG000|Overall Study|Withdrawal by Subject|1
4420750|NCT00327340|7201876|FG001|Overall Study|Withdrawal by Subject|5
4420751|NCT00327340|7201875|FG000|Overall Study|Physician Decision|1
4420752|NCT00327340|7201876|FG001|Overall Study|Physician Decision|1
4420753|NCT00327340|7201875|FG000|Overall Study|Disease Progression|10
4420754|NCT00327340|7201876|FG001|Overall Study|Disease Progression|19
4420755|NCT00327340|7201875|FG000|Overall Study|Symptomatic Disease|0
4420756|NCT00327340|7201876|FG001|Overall Study|Symptomatic Disease|2
4420757|NCT00327340|7201875|FG000|Overall Study|Adverse Event|3
4420758|NCT00327340|7201876|FG001|Overall Study|Adverse Event|3
4420759|NCT00327444|7201890|FG000|Double Blind Treatment (DB) Period|Disease progression|10
4420760|NCT00327444|7201891|FG001|Double Blind Treatment (DB) Period|Disease progression|13
4420761|NCT00327444|7201890|FG000|Double Blind Treatment (DB) Period|Adverse Event|5
4420762|NCT00327444|7201891|FG001|Double Blind Treatment (DB) Period|Adverse Event|5
4420763|NCT00327444|7201890|FG000|Double Blind Treatment (DB) Period|Subject request|0
4420764|NCT00327444|7201891|FG001|Double Blind Treatment (DB) Period|Subject request|1
4420765|NCT00327444|7201890|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11
4420766|NCT00327444|7201891|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10
4420767|NCT00327444|7201890|FG000|Open Label Treatment (OL) Period|Disease progression|8
4420768|NCT00327444|7201891|FG001|Open Label Treatment (OL) Period|Disease progression|7
4420769|NCT00327444|7201890|FG000|Open Label Treatment (OL) Period|Adverse Event|2
4420770|NCT00327444|7201891|FG001|Open Label Treatment (OL) Period|Adverse Event|2
4420771|NCT00327444|7201890|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0
4420772|NCT00327444|7201891|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1
4420773|NCT00327444|7201890|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1
4420774|NCT00327444|7201891|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0
4420775|NCT00327470|7201901|FG000|Overall Study|Randomized, but not treated|0
4420776|NCT00327470|7201902|FG001|Overall Study|Randomized, but not treated|2
4420777|NCT00327470|7201901|FG000|Overall Study|Adverse Event|9
4420778|NCT00327470|7201902|FG001|Overall Study|Adverse Event|14
4420779|NCT00327470|7201901|FG000|Overall Study|Lack of Efficacy|7
4420780|NCT00327470|7201902|FG001|Overall Study|Lack of Efficacy|19
4420781|NCT00327470|7201901|FG000|Overall Study|Other|5
4420782|NCT00327470|7201902|FG001|Overall Study|Other|9
4420783|NCT00327470|7201901|FG000|Overall Study|Lost to Follow-up|1
4420784|NCT00327470|7201902|FG001|Overall Study|Lost to Follow-up|3
4420785|NCT00327470|7201901|FG000|Overall Study|Withdrawal by Subject|6
4420786|NCT00327470|7201902|FG001|Overall Study|Withdrawal by Subject|12
4420787|NCT00327470|7201901|FG000|Overall Study|Death|1
4420788|NCT00327470|7201902|FG001|Overall Study|Death|4
4420789|NCT00327717|7201910|FG000|Overall Study|Adverse Event|6
4420790|NCT00327717|7201911|FG001|Overall Study|Adverse Event|6
4420791|NCT00327717|7201910|FG000|Overall Study|Lack of Efficacy|0
4420792|NCT00327717|7201911|FG001|Overall Study|Lack of Efficacy|1
4420793|NCT00327717|7201910|FG000|Overall Study|Withdrawal by Subject|3
4420794|NCT00327717|7201911|FG001|Overall Study|Withdrawal by Subject|7
4420795|NCT00328094|7201940|FG000|Overall Study|Physician Decision|3
4420796|NCT00328094|7201941|FG001|Overall Study|Physician Decision|3
4420797|NCT00328172|7201952|FG000|Overall Study|Adverse Event|3
4420798|NCT00328172|7201953|FG001|Overall Study|Adverse Event|2
4420799|NCT00328172|7201954|FG002|Overall Study|Adverse Event|1
4420800|NCT00328172|7201955|FG003|Overall Study|Adverse Event|2
4420801|NCT00328172|7201956|FG004|Overall Study|Adverse Event|1
4420802|NCT00328172|7201952|FG000|Overall Study|Protocol Violation|0
4420803|NCT00328172|7201953|FG001|Overall Study|Protocol Violation|1
4420804|NCT00328172|7201954|FG002|Overall Study|Protocol Violation|1
4420805|NCT00328172|7201955|FG003|Overall Study|Protocol Violation|0
4420806|NCT00328172|7201956|FG004|Overall Study|Protocol Violation|0
4420807|NCT00328172|7201952|FG000|Overall Study|Lost to Follow-up|1
4420808|NCT00328172|7201953|FG001|Overall Study|Lost to Follow-up|1
4420809|NCT00328172|7201954|FG002|Overall Study|Lost to Follow-up|2
4420810|NCT00328172|7201955|FG003|Overall Study|Lost to Follow-up|1
4420811|NCT00328172|7201956|FG004|Overall Study|Lost to Follow-up|1
4420812|NCT00328172|7201952|FG000|Overall Study|Withdrawal by Subject|1
4420813|NCT00328172|7201953|FG001|Overall Study|Withdrawal by Subject|1
4420814|NCT00328172|7201954|FG002|Overall Study|Withdrawal by Subject|1
4420815|NCT00328172|7201955|FG003|Overall Study|Withdrawal by Subject|6
4420816|NCT00328172|7201956|FG004|Overall Study|Withdrawal by Subject|0
4420817|NCT00328172|7201952|FG000|Overall Study|Lack of Efficacy|14
4420818|NCT00328172|7201953|FG001|Overall Study|Lack of Efficacy|9
4420819|NCT00328172|7201954|FG002|Overall Study|Lack of Efficacy|4
4420820|NCT00328172|7201955|FG003|Overall Study|Lack of Efficacy|4
4420821|NCT00328172|7201956|FG004|Overall Study|Lack of Efficacy|3
4420822|NCT00328172|7201952|FG000|Overall Study|Other reason (not specified)|3
4420823|NCT00328172|7201953|FG001|Overall Study|Other reason (not specified)|0
4420824|NCT00328172|7201954|FG002|Overall Study|Other reason (not specified)|1
4420825|NCT00328172|7201955|FG003|Overall Study|Other reason (not specified)|0
4420826|NCT00328172|7201956|FG004|Overall Study|Other reason (not specified)|0
4420827|NCT00328198|7201968|FG000|Treatment|Adverse Event|21
4420828|NCT00328198|7201968|FG000|Treatment|Death|1
4629544|NCT01874145|7497574|FG001|Extension Period|Withdrawal by Subject|1
4629545|NCT01874145|7497573|FG000|Extension Period|Lost to Follow-up|1
4629546|NCT01874145|7497574|FG001|Extension Period|Lost to Follow-up|1
4629547|NCT01874275|7497595|FG000|Overall Study|Lost to Follow-up|1
4629548|NCT01874275|7497596|FG001|Overall Study|Lost to Follow-up|0
4629549|NCT01874288|7497613|FG000|Overall Study|Withdrawal by Subject|1
4629550|NCT01874288|7497614|FG001|Overall Study|Withdrawal by Subject|0
4629551|NCT01874288|7497615|FG002|Overall Study|Withdrawal by Subject|2
4629552|NCT01874288|7497616|FG003|Overall Study|Withdrawal by Subject|1
4629553|NCT01874288|7497617|FG004|Overall Study|Withdrawal by Subject|1
4629554|NCT01874288|7497613|FG000|Overall Study|Physician Decision|0
4629555|NCT01874288|7497614|FG001|Overall Study|Physician Decision|0
4629556|NCT01874288|7497615|FG002|Overall Study|Physician Decision|0
4420829|NCT00328198|7201968|FG000|Treatment|Physician Decision|5
4420830|NCT00328198|7201968|FG000|Treatment|Withdrawal by Subject|5
4420831|NCT00328198|7201968|FG000|Treatment|Evidence of disease progression|2
4420832|NCT00328198|7201968|FG000|Treatment|Non-compliance|1
4420833|NCT00328198|7201968|FG000|Treatment|Confirmed complete response, MRD -|3
4420834|NCT00328198|7201968|FG000|Follow-up|Lost to Follow-up|4
4420835|NCT00328198|7201968|FG000|Follow-up|Death|31
4420836|NCT00328510|7201983|FG000|Overall Study|Gag disorder, could not use frame|4
4420837|NCT00328510|7201984|FG001|Overall Study|Gag disorder, could not use frame|0
4420838|NCT00328510|7201983|FG000|Overall Study|Dentition problems, could not use frame|1
4420839|NCT00328510|7201984|FG001|Overall Study|Dentition problems, could not use frame|0
4420840|NCT00328510|7201983|FG000|Overall Study|Withdrawal by Subject|4
4420841|NCT00328510|7201984|FG001|Overall Study|Withdrawal by Subject|2
4420842|NCT00328510|7201983|FG000|Overall Study|Severe kyphosis, could not use mask|0
4420843|NCT00328510|7201984|FG001|Overall Study|Severe kyphosis, could not use mask|1
4420844|NCT00328510|7201983|FG000|Overall Study|Treatment changed to a single fraction|1
4420845|NCT00328510|7201984|FG001|Overall Study|Treatment changed to a single fraction|1
4420846|NCT00328562|7201990|FG000|Overall Study|Disease progression|1
4420847|NCT00328627|7202026|FG000|Overall Study|Hyperglycemic Rescue|41
4420848|NCT00328627|7202027|FG001|Overall Study|Hyperglycemic Rescue|18
4420849|NCT00328627|7202028|FG002|Overall Study|Hyperglycemic Rescue|16
4420850|NCT00328627|7202029|FG003|Overall Study|Hyperglycemic Rescue|13
4420851|NCT00328627|7202030|FG004|Overall Study|Hyperglycemic Rescue|6
4420852|NCT00328627|7202031|FG005|Overall Study|Hyperglycemic Rescue|5
4629557|NCT01874288|7497616|FG003|Overall Study|Physician Decision|1
4629558|NCT01874288|7497617|FG004|Overall Study|Physician Decision|0
4629559|NCT01874288|7497613|FG000|Overall Study|Progressive disease|2
4629560|NCT01874288|7497614|FG001|Overall Study|Progressive disease|0
4420853|NCT00328627|7202032|FG006|Overall Study|Hyperglycemic Rescue|19
4420854|NCT00328627|7202033|FG007|Overall Study|Hyperglycemic Rescue|6
4420855|NCT00328627|7202034|FG008|Overall Study|Hyperglycemic Rescue|6
4420856|NCT00328627|7202035|FG009|Overall Study|Hyperglycemic Rescue|11
4420857|NCT00328627|7202036|FG010|Overall Study|Hyperglycemic Rescue|3
4420858|NCT00328627|7202037|FG011|Overall Study|Hyperglycemic Rescue|2
4420859|NCT00328627|7202026|FG000|Overall Study|Adverse Event|3
4420860|NCT00328627|7202027|FG001|Overall Study|Adverse Event|1
4420861|NCT00328627|7202028|FG002|Overall Study|Adverse Event|2
4420862|NCT00328627|7202029|FG003|Overall Study|Adverse Event|3
4420863|NCT00328627|7202030|FG004|Overall Study|Adverse Event|1
4420864|NCT00328627|7202031|FG005|Overall Study|Adverse Event|2
4420865|NCT00328627|7202032|FG006|Overall Study|Adverse Event|1
4420866|NCT00328627|7202033|FG007|Overall Study|Adverse Event|2
4420867|NCT00328627|7202034|FG008|Overall Study|Adverse Event|0
4420868|NCT00328627|7202035|FG009|Overall Study|Adverse Event|7
4420869|NCT00328627|7202036|FG010|Overall Study|Adverse Event|5
4420870|NCT00328627|7202037|FG011|Overall Study|Adverse Event|4
4420871|NCT00328627|7202026|FG000|Overall Study|Protocol Violation|2
4420872|NCT00328627|7202027|FG001|Overall Study|Protocol Violation|2
4420873|NCT00328627|7202028|FG002|Overall Study|Protocol Violation|2
4420874|NCT00328627|7202029|FG003|Overall Study|Protocol Violation|8
4420875|NCT00328627|7202030|FG004|Overall Study|Protocol Violation|5
4420876|NCT00328627|7202031|FG005|Overall Study|Protocol Violation|5
4420877|NCT00328627|7202032|FG006|Overall Study|Protocol Violation|6
4420878|NCT00328627|7202033|FG007|Overall Study|Protocol Violation|2
4420879|NCT00328627|7202034|FG008|Overall Study|Protocol Violation|1
4420880|NCT00328627|7202035|FG009|Overall Study|Protocol Violation|4
4420881|NCT00328627|7202036|FG010|Overall Study|Protocol Violation|6
4420882|NCT00328627|7202037|FG011|Overall Study|Protocol Violation|2
4420883|NCT00328627|7202026|FG000|Overall Study|Lost to Follow-up|4
4420884|NCT00328627|7202027|FG001|Overall Study|Lost to Follow-up|2
4420885|NCT00328627|7202028|FG002|Overall Study|Lost to Follow-up|2
4420886|NCT00328627|7202029|FG003|Overall Study|Lost to Follow-up|4
4420887|NCT00328627|7202030|FG004|Overall Study|Lost to Follow-up|0
4420888|NCT00328627|7202031|FG005|Overall Study|Lost to Follow-up|2
4420889|NCT00328627|7202032|FG006|Overall Study|Lost to Follow-up|3
4420890|NCT00328627|7202033|FG007|Overall Study|Lost to Follow-up|0
4420891|NCT00328627|7202034|FG008|Overall Study|Lost to Follow-up|3
4420892|NCT00328627|7202035|FG009|Overall Study|Lost to Follow-up|2
4420893|NCT00328627|7202036|FG010|Overall Study|Lost to Follow-up|0
4420894|NCT00328627|7202037|FG011|Overall Study|Lost to Follow-up|1
4420895|NCT00328627|7202026|FG000|Overall Study|Withdrawal by Subject|5
4420896|NCT00328627|7202027|FG001|Overall Study|Withdrawal by Subject|4
4420897|NCT00328627|7202028|FG002|Overall Study|Withdrawal by Subject|5
4420898|NCT00328627|7202029|FG003|Overall Study|Withdrawal by Subject|6
4420899|NCT00328627|7202030|FG004|Overall Study|Withdrawal by Subject|2
4420900|NCT00328627|7202031|FG005|Overall Study|Withdrawal by Subject|5
4420901|NCT00328627|7202032|FG006|Overall Study|Withdrawal by Subject|4
4420902|NCT00328627|7202033|FG007|Overall Study|Withdrawal by Subject|4
4420903|NCT00328627|7202034|FG008|Overall Study|Withdrawal by Subject|4
4420904|NCT00328627|7202035|FG009|Overall Study|Withdrawal by Subject|5
4420905|NCT00328627|7202036|FG010|Overall Study|Withdrawal by Subject|2
4420906|NCT00328627|7202037|FG011|Overall Study|Withdrawal by Subject|7
4420907|NCT00328627|7202026|FG000|Overall Study|Pregnancy|0
4420908|NCT00328627|7202027|FG001|Overall Study|Pregnancy|1
4420909|NCT00328627|7202028|FG002|Overall Study|Pregnancy|0
4420910|NCT00328627|7202029|FG003|Overall Study|Pregnancy|0
4420911|NCT00328627|7202030|FG004|Overall Study|Pregnancy|0
4420912|NCT00328627|7202031|FG005|Overall Study|Pregnancy|0
4420913|NCT00328627|7202032|FG006|Overall Study|Pregnancy|0
4420914|NCT00328627|7202033|FG007|Overall Study|Pregnancy|0
4420915|NCT00328627|7202034|FG008|Overall Study|Pregnancy|0
4420916|NCT00328627|7202035|FG009|Overall Study|Pregnancy|0
4420917|NCT00328627|7202036|FG010|Overall Study|Pregnancy|0
4420918|NCT00328627|7202037|FG011|Overall Study|Pregnancy|0
4420919|NCT00328627|7202026|FG000|Overall Study|Physician Decision|4
4420920|NCT00328627|7202027|FG001|Overall Study|Physician Decision|3
4420921|NCT00328627|7202028|FG002|Overall Study|Physician Decision|1
4420922|NCT00328627|7202029|FG003|Overall Study|Physician Decision|2
4420923|NCT00328627|7202030|FG004|Overall Study|Physician Decision|1
4420924|NCT00328627|7202031|FG005|Overall Study|Physician Decision|1
4420925|NCT00328627|7202032|FG006|Overall Study|Physician Decision|1
4420926|NCT00328627|7202033|FG007|Overall Study|Physician Decision|0
4420927|NCT00328627|7202034|FG008|Overall Study|Physician Decision|3
4420928|NCT00328627|7202035|FG009|Overall Study|Physician Decision|2
4420929|NCT00328627|7202036|FG010|Overall Study|Physician Decision|1
4420930|NCT00328627|7202037|FG011|Overall Study|Physician Decision|0
4420931|NCT00328627|7202026|FG000|Overall Study|Other|0
4420932|NCT00328627|7202027|FG001|Overall Study|Other|0
4420933|NCT00328627|7202028|FG002|Overall Study|Other|0
4420934|NCT00328627|7202029|FG003|Overall Study|Other|1
4420935|NCT00328627|7202030|FG004|Overall Study|Other|0
4420936|NCT00328627|7202031|FG005|Overall Study|Other|0
4420937|NCT00328627|7202032|FG006|Overall Study|Other|1
4420938|NCT00328627|7202033|FG007|Overall Study|Other|0
4420939|NCT00328627|7202034|FG008|Overall Study|Other|0
4420940|NCT00328627|7202035|FG009|Overall Study|Other|1
4420941|NCT00328627|7202036|FG010|Overall Study|Other|1
4420942|NCT00328627|7202037|FG011|Overall Study|Other|0
4420943|NCT00328783|7202076|FG000|Overall Study|Could not tolerate ABC|21
4420944|NCT00328783|7202076|FG000|Overall Study|No heart in RT field|4
4420945|NCT00328783|7202076|FG000|Overall Study|Withdrawal by Subject|1
4420946|NCT00328926|7202094|FG000|Overall Study|Pregnancy|2
4420947|NCT00328926|7202095|FG001|Overall Study|Pregnancy|1
4420948|NCT00328926|7202096|FG002|Overall Study|Pregnancy|0
4420949|NCT00328926|7202094|FG000|Overall Study|Lost to Follow-up|0
4420950|NCT00328926|7202095|FG001|Overall Study|Lost to Follow-up|1
4420951|NCT00328926|7202096|FG002|Overall Study|Lost to Follow-up|0
4420952|NCT00328926|7202094|FG000|Overall Study|Death|0
4420953|NCT00328926|7202095|FG001|Overall Study|Death|0
4420954|NCT00328926|7202096|FG002|Overall Study|Death|1
4420955|NCT00328926|7202094|FG000|Overall Study|In vitro fertilization treatment|0
4420956|NCT00328926|7202095|FG001|Overall Study|In vitro fertilization treatment|0
4420957|NCT00328926|7202096|FG002|Overall Study|In vitro fertilization treatment|1
4420958|NCT00328926|7202094|FG000|Overall Study|Lack of ovarian response|0
4420959|NCT00328926|7202095|FG001|Overall Study|Lack of ovarian response|1
4420960|NCT00328926|7202096|FG002|Overall Study|Lack of ovarian response|0
4420961|NCT00329030|7202106|FG000|Overall Study|Withdrawal by Subject|1
4420962|NCT00329030|7202107|FG001|Overall Study|Withdrawal by Subject|3
4420963|NCT00329030|7202106|FG000|Overall Study|Progressive Disease|6
4420964|NCT00329030|7202107|FG001|Overall Study|Progressive Disease|2
4420965|NCT00329030|7202106|FG000|Overall Study|Ineligible Pathology|1
4420966|NCT00329030|7202107|FG001|Overall Study|Ineligible Pathology|1
4420967|NCT00329160|7202113|FG000|Overall Study|Adverse Event|27
4420968|NCT00329160|7202113|FG000|Overall Study|Withdrawal by Subject|13
4420969|NCT00329160|7202113|FG000|Overall Study|Protocol Violation|2
4420970|NCT00329160|7202113|FG000|Overall Study|Did not Receive Study Drug|1
4420971|NCT00329160|7202113|FG000|Overall Study|Incomplete IVUS|45
4420972|NCT00329238|7202119|FG000|Overall Study|Adverse Event|147
4420973|NCT00329238|7202120|FG001|Overall Study|Adverse Event|129
4420974|NCT00329238|7202119|FG000|Overall Study|Protocol Violation|23
4420975|NCT00329238|7202120|FG001|Overall Study|Protocol Violation|34
4420976|NCT00329238|7202119|FG000|Overall Study|Lost to Follow-up|2
4420977|NCT00329238|7202120|FG001|Overall Study|Lost to Follow-up|6
4420978|NCT00329238|7202119|FG000|Overall Study|Withdrawal by Subject|64
4420979|NCT00329238|7202120|FG001|Overall Study|Withdrawal by Subject|58
4420980|NCT00329238|7202119|FG000|Overall Study|Other reason (not specified)|40
4420981|NCT00329238|7202120|FG001|Overall Study|Other reason (not specified)|54
4420982|NCT00329303|7202130|FG000|Overall Study|Lack of Efficacy|1
4420983|NCT00329303|7202131|FG001|Overall Study|Lack of Efficacy|0
4420984|NCT00329303|7202130|FG000|Overall Study|Decision of the sponsor|0
4420985|NCT00329303|7202131|FG001|Overall Study|Decision of the sponsor|1
4420986|NCT00329303|7202130|FG000|Overall Study|Patient no longer available|1
4420987|NCT00329303|7202131|FG001|Overall Study|Patient no longer available|0
4420988|NCT00329303|7202130|FG000|Overall Study|Patient relocated|0
4420989|NCT00329303|7202131|FG001|Overall Study|Patient relocated|1
4420990|NCT00329407|7202138|FG000|Overall Study|Withdrawal by Subject|1
4420991|NCT00329420|7202145|FG000|Re-induction Phase|Lack of Efficacy|0
4420992|NCT00329420|7202146|FG001|Re-induction Phase|Lack of Efficacy|1
4420993|NCT00329420|7202147|FG002|Re-induction Phase|Lack of Efficacy|0
4420994|NCT00329420|7202145|FG000|Re-induction Phase|Withdrawal of Consent|0
4420995|NCT00329420|7202146|FG001|Re-induction Phase|Withdrawal of Consent|0
4420996|NCT00329420|7202147|FG002|Re-induction Phase|Withdrawal of Consent|1
4420997|NCT00329420|7202145|FG000|Re-induction Phase|Did not respond to re-induction|6
4420998|NCT00329420|7202146|FG001|Re-induction Phase|Did not respond to re-induction|5
4420999|NCT00329420|7202147|FG002|Re-induction Phase|Did not respond to re-induction|7
4421000|NCT00329420|7202145|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2
4421001|NCT00329420|7202146|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1
4421002|NCT00329420|7202147|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1
4421003|NCT00329420|7202145|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1
4421004|NCT00329420|7202146|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1
4421005|NCT00329420|7202147|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0
4421006|NCT00329420|7202145|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1
4421007|NCT00329420|7202146|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0
4421008|NCT00329420|7202147|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0
4421009|NCT00329550|7202173|FG000|Overall Study|Adverse Event|3
4421010|NCT00329550|7202174|FG001|Overall Study|Adverse Event|4
4629561|NCT01874288|7497615|FG002|Overall Study|Progressive disease|3
4629562|NCT01874288|7497616|FG003|Overall Study|Progressive disease|5
4421011|NCT00329550|7202175|FG002|Overall Study|Adverse Event|2
4421012|NCT00329550|7202173|FG000|Overall Study|Withdrawal of Consent|1
4421013|NCT00329550|7202174|FG001|Overall Study|Withdrawal of Consent|0
4421014|NCT00329550|7202175|FG002|Overall Study|Withdrawal of Consent|1
4421015|NCT00329550|7202173|FG000|Overall Study|Due to Relocation|0
4421016|NCT00329550|7202174|FG001|Overall Study|Due to Relocation|0
4421017|NCT00329550|7202175|FG002|Overall Study|Due to Relocation|1
4421018|NCT00329602|7202187|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119
4421019|NCT00329602|7202188|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99
4421020|NCT00329602|7202189|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0
4421021|NCT00329602|7202187|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0
4421022|NCT00329602|7202188|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0
4421023|NCT00329602|7202189|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20
4629563|NCT01874288|7497617|FG004|Overall Study|Progressive disease|1
4629564|NCT01874340|7497634|FG000|Overall Study|Study terminated by Sponsor|6
4421024|NCT00329602|7202187|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0
4421025|NCT00329602|7202188|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0
4421026|NCT00329602|7202189|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1
4421027|NCT00329602|7202187|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0
4421028|NCT00329602|7202188|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0
4421029|NCT00329602|7202189|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2
4421030|NCT00329602|7202187|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0
4421031|NCT00329602|7202188|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0
4421032|NCT00329602|7202189|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9
4421033|NCT00329602|7202187|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0
4421034|NCT00329602|7202188|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0
4421035|NCT00329602|7202189|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4
4421036|NCT00329641|7202205|FG000|Overall Study|Did not start treatment|1
4421037|NCT00329641|7202205|FG000|Overall Study|Not eligible|1
4421038|NCT00329641|7202205|FG000|Overall Study|Adverse Event|3
4421039|NCT00329641|7202205|FG000|Overall Study|Other reason, not protocol specified|1
4421040|NCT00329719|7202214|FG000|Overall Study|Lost to Follow-up|0
4421041|NCT00329719|7202215|FG001|Overall Study|Lost to Follow-up|0
4421042|NCT00329719|7202216|FG002|Overall Study|Lost to Follow-up|0
4421043|NCT00329719|7202217|FG003|Overall Study|Lost to Follow-up|1
4421044|NCT00329745|7202229|FG000|Overall Study|Protocol Violation|1
4421045|NCT00329745|7202230|FG001|Overall Study|Protocol Violation|0
4421046|NCT00329745|7202229|FG000|Overall Study|Withdrawal by Subject|0
4421047|NCT00329745|7202230|FG001|Overall Study|Withdrawal by Subject|1
4421048|NCT00329745|7202229|FG000|Overall Study|Lost to Follow-up|86
4421049|NCT00329745|7202230|FG001|Overall Study|Lost to Follow-up|101
4629565|NCT01874340|7497635|FG001|Overall Study|Study terminated by Sponsor|8
4629566|NCT01874340|7497636|FG002|Overall Study|Study terminated by Sponsor|8
4629567|NCT01874340|7497637|FG003|Overall Study|Study terminated by Sponsor|4
4629568|NCT01874340|7497634|FG000|Overall Study|Withdrawal by Subject|0
4629569|NCT01874340|7497635|FG001|Overall Study|Withdrawal by Subject|0
4421050|NCT00329784|7202244|FG000|Overall Study|Lost to Follow-up|0
4421051|NCT00329784|7202245|FG001|Overall Study|Lost to Follow-up|1
4421052|NCT00329784|7202246|FG002|Overall Study|Lost to Follow-up|0
4421053|NCT00329784|7202247|FG003|Overall Study|Lost to Follow-up|0
4421054|NCT00329784|7202244|FG000|Overall Study|Withdrawal by Subject|4
4421055|NCT00329784|7202245|FG001|Overall Study|Withdrawal by Subject|2
4421056|NCT00329784|7202246|FG002|Overall Study|Withdrawal by Subject|0
4421057|NCT00329784|7202247|FG003|Overall Study|Withdrawal by Subject|0
4421058|NCT00329784|7202244|FG000|Overall Study|Other|1
4421059|NCT00329784|7202245|FG001|Overall Study|Other|2
4421060|NCT00329784|7202246|FG002|Overall Study|Other|0
4421061|NCT00329784|7202247|FG003|Overall Study|Other|0
4421062|NCT00329797|7202261|FG000|Overall Study|Protocol Violation|1
4421063|NCT00329797|7202262|FG001|Overall Study|Protocol Violation|0
4421064|NCT00329797|7202261|FG000|Overall Study|Withdrawal by Subject|6
4421065|NCT00329797|7202262|FG001|Overall Study|Withdrawal by Subject|6
4421066|NCT00329849|7202274|FG000|Overall Study|Withdrawal by Subject|6
4421067|NCT00329849|7202275|FG001|Overall Study|Withdrawal by Subject|4
4421068|NCT00329901|7202288|FG000|Overall Study|Withdrawal by Subject|4
4421069|NCT00329901|7202289|FG001|Overall Study|Withdrawal by Subject|3
4421070|NCT00329901|7202290|FG002|Overall Study|Withdrawal by Subject|2
4421071|NCT00329901|7202288|FG000|Overall Study|Lost to Follow-up|2
4421072|NCT00329901|7202289|FG001|Overall Study|Lost to Follow-up|0
4421073|NCT00329901|7202290|FG002|Overall Study|Lost to Follow-up|1
4421074|NCT00329901|7202288|FG000|Overall Study|Protocol Violation|1
4421075|NCT00329901|7202289|FG001|Overall Study|Protocol Violation|0
4421076|NCT00329901|7202290|FG002|Overall Study|Protocol Violation|1
4421077|NCT00329901|7202288|FG000|Overall Study|Unable to classify|2
4421078|NCT00329901|7202289|FG001|Overall Study|Unable to classify|2
4421079|NCT00329901|7202290|FG002|Overall Study|Unable to classify|0
4421080|NCT00330174|7202308|FG000|Overall Study|Withdrawal by Subject|7
4421081|NCT00330174|7202309|FG001|Overall Study|Withdrawal by Subject|7
4421082|NCT00330174|7202308|FG000|Overall Study|Lost to Follow-up|4
4421083|NCT00330174|7202309|FG001|Overall Study|Lost to Follow-up|1
4421084|NCT00330174|7202308|FG000|Overall Study|Clinical deterioration|1
4421085|NCT00330174|7202309|FG001|Overall Study|Clinical deterioration|2
4421086|NCT00330174|7202308|FG000|Overall Study|Excessive missed visits|3
4421087|NCT00330174|7202309|FG001|Overall Study|Excessive missed visits|8
4421088|NCT00330174|7202308|FG000|Overall Study|Miscellaneous reasons|7
4421089|NCT00330174|7202309|FG001|Overall Study|Miscellaneous reasons|1
4421090|NCT00330187|7202319|FG000|Overall Study|Lost to Follow-up|12
4421091|NCT00330187|7202320|FG001|Overall Study|Lost to Follow-up|13
4421092|NCT00330187|7202321|FG002|Overall Study|Lost to Follow-up|14
4421093|NCT00330187|7202322|FG003|Overall Study|Lost to Follow-up|10
4421094|NCT00330187|7202319|FG000|Overall Study|Withdrawal by Subject|8
4421095|NCT00330187|7202320|FG001|Overall Study|Withdrawal by Subject|5
4421096|NCT00330187|7202321|FG002|Overall Study|Withdrawal by Subject|4
4421097|NCT00330187|7202322|FG003|Overall Study|Withdrawal by Subject|4
4421098|NCT00330343|7202332|FG000|Overall Study|Lost to Follow-up|5
4421099|NCT00330460|7202353|FG000|Overall Study|Physician Decision|1
4421100|NCT00330460|7202354|FG001|Overall Study|Physician Decision|0
4421101|NCT00330460|7202353|FG000|Overall Study|Adverse Event|10
4421102|NCT00330460|7202354|FG001|Overall Study|Adverse Event|8
4421103|NCT00330460|7202353|FG000|Overall Study|Withdrawal by Subject|18
4421104|NCT00330460|7202354|FG001|Overall Study|Withdrawal by Subject|17
4421105|NCT00330460|7202353|FG000|Overall Study|Death|1
4421106|NCT00330460|7202354|FG001|Overall Study|Death|1
4421107|NCT00330460|7202353|FG000|Overall Study|Ineligibility determined|1
4421108|NCT00330460|7202354|FG001|Overall Study|Ineligibility determined|3
4421109|NCT00330460|7202353|FG000|Overall Study|Lost to Follow-up|8
4421110|NCT00330460|7202354|FG001|Overall Study|Lost to Follow-up|3
4421111|NCT00330460|7202353|FG000|Overall Study|Noncompliance|2
4421112|NCT00330460|7202354|FG001|Overall Study|Noncompliance|1
4421113|NCT00330460|7202353|FG000|Overall Study|Other|1
4421114|NCT00330460|7202354|FG001|Overall Study|Other|0
4421115|NCT00330616|7202375|FG000|Overall Study|Adverse Event|13
4421116|NCT00330616|7202375|FG000|Overall Study|Lack of Efficacy|1
4421117|NCT00330616|7202375|FG000|Overall Study|Lost to Follow-up|2
4421118|NCT00330616|7202375|FG000|Overall Study|Withdrawal by Subject|4
4421119|NCT00330616|7202375|FG000|Overall Study|Other|1
4421120|NCT00330668|7202379|FG000|BID Dosing Period|Adverse Event|1
4421121|NCT00330668|7202379|FG000|BID Dosing Period|Lost to Follow-up|7
4421122|NCT00330668|7202379|FG000|BID Dosing Period|Non-Compliance|5
4421123|NCT00330668|7202379|FG000|BID Dosing Period|Withdrawal by Subject|19
4421124|NCT00330668|7202379|FG000|BID Dosing Period|Sponsor's decision|1
4421125|NCT00330668|7202379|FG000|BID Dosing Period|Other|3
4421126|NCT00330668|7202379|FG000|QD Dosing Period|Sponsor decision to terminate study|74
4421127|NCT00330668|7202379|FG000|QD Dosing Period|Other|1
4421128|NCT00330668|7202379|FG000|QD Dosing Period|Withdrawal by Subject|1
4421129|NCT00330668|7202379|FG000|QD Dosing Period|Lost to Follow-up|2
4421130|NCT00330681|7202385|FG000|Overall Study|Adverse Event|3
4421131|NCT00330681|7202386|FG001|Overall Study|Adverse Event|6
4421132|NCT00330681|7202385|FG000|Overall Study|Protocol Violation|0
4421133|NCT00330681|7202386|FG001|Overall Study|Protocol Violation|1
4421134|NCT00330681|7202385|FG000|Overall Study|Withdrawal by Subject|5
4421135|NCT00330681|7202386|FG001|Overall Study|Withdrawal by Subject|5
4421136|NCT00330681|7202385|FG000|Overall Study|Tracheotomy due to worsening of ALS|1
4421137|NCT00330681|7202386|FG001|Overall Study|Tracheotomy due to worsening of ALS|2
4421138|NCT00330759|7202403|FG000|Overall Study|Death|316
4421139|NCT00330759|7202404|FG001|Overall Study|Death|310
4421140|NCT00330759|7202403|FG000|Overall Study|Disease progression|104
4421141|NCT00330759|7202404|FG001|Overall Study|Disease progression|126
4421142|NCT00330759|7202403|FG000|Overall Study|Withdrawal by Subject|143
4421143|NCT00330759|7202404|FG001|Overall Study|Withdrawal by Subject|124
4421144|NCT00330759|7202403|FG000|Overall Study|Adverse Event|48
4421145|NCT00330759|7202404|FG001|Overall Study|Adverse Event|36
4421146|NCT00330759|7202403|FG000|Overall Study|Participant request|31
4421147|NCT00330759|7202404|FG001|Overall Study|Participant request|22
4421148|NCT00330759|7202403|FG000|Overall Study|Lost to Follow-up|16
4421149|NCT00330759|7202404|FG001|Overall Study|Lost to Follow-up|22
4421150|NCT00330759|7202403|FG000|Overall Study|Noncompliance|15
4421151|NCT00330759|7202404|FG001|Overall Study|Noncompliance|17
4421152|NCT00330759|7202403|FG000|Overall Study|Physician Decision|1
4421153|NCT00330759|7202404|FG001|Overall Study|Physician Decision|2
4421154|NCT00330759|7202403|FG000|Overall Study|Protocol deviation|0
4421155|NCT00330759|7202404|FG001|Overall Study|Protocol deviation|2
4421156|NCT00330759|7202403|FG000|Overall Study|Ineligibility determined|2
4421157|NCT00330759|7202404|FG001|Overall Study|Ineligibility determined|1
4421158|NCT00330759|7202403|FG000|Overall Study|Other|36
4421159|NCT00330759|7202404|FG001|Overall Study|Other|44
4421160|NCT00330928|7202430|FG000|Overall Study|Lost to Follow-up|6
4421161|NCT00330928|7202430|FG000|Overall Study|Physician Decision|9
4421162|NCT00330928|7202430|FG000|Overall Study|Death|1
4421163|NCT00330928|7202430|FG000|Overall Study|IVUS could not be performed.|1
4421164|NCT00330967|7202436|FG000|Overall Study|Withdrawal by Subject|0
4421165|NCT00330967|7202437|FG001|Overall Study|Withdrawal by Subject|5
4421166|NCT00330967|7202436|FG000|Overall Study|Physician Decision|0
4421167|NCT00330967|7202437|FG001|Overall Study|Physician Decision|9
4421168|NCT00331006|7202443|FG000|Screening Phase|Withdrawal by Subject|1
4421169|NCT00331006|7202443|FG000|Screening Phase|enrollment halted|1
4421170|NCT00331006|7202443|FG000|Screening Phase|Lost to Follow-up|1
4421171|NCT00331006|7202443|FG000|Screening Phase|Ineligible for treatment phase|4
4421172|NCT00331006|7202443|FG000|Treatment Phase|Withdrawal by Subject|1
4421173|NCT00331006|7202443|FG000|Follow-Up Phase I|Lost to Follow-up|1
4421174|NCT00331006|7202443|FG000|Follow-Up Phase II|Lost to Follow-up|3
4421175|NCT00331136|7202451|FG000|Overall Study|Adverse Event|3
4421176|NCT00331136|7202452|FG001|Overall Study|Adverse Event|5
4421177|NCT00331136|7202453|FG002|Overall Study|Adverse Event|0
4421178|NCT00331136|7202454|FG003|Overall Study|Adverse Event|1
4421179|NCT00331136|7202451|FG000|Overall Study|Withdrawal by Subject|0
4421180|NCT00331136|7202452|FG001|Overall Study|Withdrawal by Subject|1
4421181|NCT00331136|7202453|FG002|Overall Study|Withdrawal by Subject|0
4421182|NCT00331136|7202454|FG003|Overall Study|Withdrawal by Subject|0
4421183|NCT00331136|7202451|FG000|Overall Study|Lost to Follow-up|0
4421184|NCT00331136|7202452|FG001|Overall Study|Lost to Follow-up|1
4421185|NCT00331136|7202453|FG002|Overall Study|Lost to Follow-up|0
4421186|NCT00331136|7202454|FG003|Overall Study|Lost to Follow-up|0
4421187|NCT00331136|7202451|FG000|Overall Study|Protocol Violation|1
4421188|NCT00331136|7202452|FG001|Overall Study|Protocol Violation|0
4421189|NCT00331136|7202453|FG002|Overall Study|Protocol Violation|0
4421190|NCT00331136|7202454|FG003|Overall Study|Protocol Violation|0
4421191|NCT00331136|7202451|FG000|Overall Study|Not treated|1
4421192|NCT00331136|7202452|FG001|Overall Study|Not treated|0
4421193|NCT00331136|7202453|FG002|Overall Study|Not treated|0
4421194|NCT00331136|7202454|FG003|Overall Study|Not treated|0
4421195|NCT00331344|7202473|FG000|Phase I|Adverse Event|0
4421196|NCT00331344|7202474|FG001|Phase I|Adverse Event|0
4421197|NCT00331344|7202475|FG002|Phase I|Adverse Event|0
4421198|NCT00331344|7202476|FG003|Phase I|Adverse Event|1
4421199|NCT00331344|7202477|FG004|Phase I|Adverse Event|2
4421200|NCT00331344|7202478|FG005|Phase I|Adverse Event|2
4421201|NCT00331344|7202479|FG006|Phase I|Adverse Event|0
4421202|NCT00331344|7202480|FG007|Phase I|Adverse Event|1
4421203|NCT00331344|7202481|FG008|Phase I|Adverse Event|0
4421204|NCT00331344|7202473|FG000|Phase II|Death|0
4421205|NCT00331344|7202474|FG001|Phase II|Death|0
4421206|NCT00331344|7202475|FG002|Phase II|Death|0
4421207|NCT00331344|7202476|FG003|Phase II|Death|0
4421208|NCT00331344|7202477|FG004|Phase II|Death|0
4421209|NCT00331344|7202478|FG005|Phase II|Death|0
4421210|NCT00331344|7202479|FG006|Phase II|Death|0
4421211|NCT00331344|7202480|FG007|Phase II|Death|0
4421212|NCT00331344|7202481|FG008|Phase II|Death|4
4421213|NCT00331409|7202494|FG000|Overall Study|Lack of Efficacy|4
4421214|NCT00331422|7202498|FG000|Overall Study|Did not receive entire study regimen|5
4421215|NCT00331552|7202505|FG000|Period 3: Phase II|Neurological Symptoms|1
4421216|NCT00331552|7202506|FG001|Period 3: Phase II|Neurological Symptoms|0
4421217|NCT00331552|7202505|FG000|Period 3: Phase II|Severe Nausea|1
4421218|NCT00331552|7202506|FG001|Period 3: Phase II|Severe Nausea|0
4512081|NCT00931892|7321694|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0
4512082|NCT00931892|7321695|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1
4512083|NCT00931918|7321743|FG000|Overall Study|Adverse Event|4
4512084|NCT00931918|7321744|FG001|Overall Study|Adverse Event|6
4629570|NCT01874340|7497636|FG002|Overall Study|Withdrawal by Subject|0
4629571|NCT01874340|7497637|FG003|Overall Study|Withdrawal by Subject|1
4629572|NCT01874431|7497659|FG000|Overall Study|Physician Decision|0
4629573|NCT01874431|7497660|FG001|Overall Study|Physician Decision|0
4629574|NCT01874431|7497661|FG002|Overall Study|Physician Decision|1
4629575|NCT01874431|7497662|FG003|Overall Study|Physician Decision|0
4512085|NCT00931918|7321743|FG000|Overall Study|Progressive Disease|2
4512086|NCT00931918|7321744|FG001|Overall Study|Progressive Disease|1
4512087|NCT00931918|7321743|FG000|Overall Study|Symptomatic Deterioration|1
4512088|NCT00931918|7321744|FG001|Overall Study|Symptomatic Deterioration|0
4512089|NCT00931918|7321743|FG000|Overall Study|Withdrawal by Patient|3
4512090|NCT00931918|7321744|FG001|Overall Study|Withdrawal by Patient|4
4512091|NCT00931918|7321743|FG000|Overall Study|Other Reason not Specified|4
4512092|NCT00931918|7321744|FG001|Overall Study|Other Reason not Specified|4
4512093|NCT00931918|7321743|FG000|Overall Study|Did not receive study drug|3
4512094|NCT00931918|7321744|FG001|Overall Study|Did not receive study drug|2
4512095|NCT00931944|7321750|FG000|Overall Study|Adverse Event|4
4512096|NCT00931944|7321750|FG000|Overall Study|W/D Consent (due to ALS progression))|19
4512097|NCT00931944|7321750|FG000|Overall Study|Withdrawal Consent (due to other)|2
4512098|NCT00931944|7321750|FG000|Overall Study|Death|28
4512099|NCT00931944|7321750|FG000|Overall Study|Other|2
4512100|NCT00932113|7321778|FG000|Overall Study|Lost to Follow-up|1
4512101|NCT00932113|7321779|FG001|Overall Study|Lost to Follow-up|0
4512102|NCT00932126|7321785|FG000|Overall Study|Adverse Event|0
4512103|NCT00932126|7321786|FG001|Overall Study|Adverse Event|0
4512104|NCT00932126|7321787|FG002|Overall Study|Adverse Event|0
4512105|NCT00932126|7321788|FG003|Overall Study|Adverse Event|0
4512106|NCT00932126|7321789|FG004|Overall Study|Adverse Event|0
4512107|NCT00932126|7321790|FG005|Overall Study|Adverse Event|0
4512108|NCT00932126|7321791|FG006|Overall Study|Adverse Event|1
4512109|NCT00932126|7321792|FG007|Overall Study|Adverse Event|2
4512110|NCT00932126|7321785|FG000|Overall Study|Protocol Violation|0
4512111|NCT00932126|7321786|FG001|Overall Study|Protocol Violation|0
4512112|NCT00932126|7321787|FG002|Overall Study|Protocol Violation|0
4512113|NCT00932126|7321788|FG003|Overall Study|Protocol Violation|0
4512114|NCT00932126|7321789|FG004|Overall Study|Protocol Violation|1
4512115|NCT00932126|7321790|FG005|Overall Study|Protocol Violation|0
4512116|NCT00932126|7321791|FG006|Overall Study|Protocol Violation|0
4512117|NCT00932126|7321792|FG007|Overall Study|Protocol Violation|0
4512118|NCT00932126|7321785|FG000|Overall Study|Withdrawal by Subject|0
4512119|NCT00932126|7321786|FG001|Overall Study|Withdrawal by Subject|0
4512120|NCT00932126|7321787|FG002|Overall Study|Withdrawal by Subject|1
4512121|NCT00932126|7321788|FG003|Overall Study|Withdrawal by Subject|0
4512122|NCT00932126|7321789|FG004|Overall Study|Withdrawal by Subject|0
4512123|NCT00932126|7321790|FG005|Overall Study|Withdrawal by Subject|0
4629576|NCT01874431|7497663|FG004|Overall Study|Physician Decision|0
4512124|NCT00932126|7321791|FG006|Overall Study|Withdrawal by Subject|0
4512125|NCT00932126|7321792|FG007|Overall Study|Withdrawal by Subject|1
4512126|NCT00932126|7321785|FG000|Overall Study|Objective progression or relapse|3
4512127|NCT00932126|7321786|FG001|Overall Study|Objective progression or relapse|3
4512128|NCT00932126|7321787|FG002|Overall Study|Objective progression or relapse|2
4421219|NCT00331630|7202517|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1
4421220|NCT00331630|7202517|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1
4421221|NCT00331630|7202517|FG000|Follow up for 5 Years|Death|5
4421222|NCT00331630|7202517|FG000|Follow up for 5 Years|Data collection was stopped|24
4421223|NCT00331682|7202521|FG000|Overall Study|Adverse Event|1
4629577|NCT01874431|7497664|FG005|Overall Study|Physician Decision|0
4629578|NCT01874431|7497665|FG006|Overall Study|Physician Decision|0
4629579|NCT01874431|7497666|FG007|Overall Study|Physician Decision|0
4629580|NCT01874431|7497659|FG000|Overall Study|Adverse Event|5
4629581|NCT01874431|7497660|FG001|Overall Study|Adverse Event|4
4629582|NCT01874431|7497661|FG002|Overall Study|Adverse Event|6
4629583|NCT01874431|7497662|FG003|Overall Study|Adverse Event|5
4629584|NCT01874431|7497663|FG004|Overall Study|Adverse Event|2
4629585|NCT01874431|7497664|FG005|Overall Study|Adverse Event|8
4629586|NCT01874431|7497665|FG006|Overall Study|Adverse Event|2
4421224|NCT00331760|7202527|FG000|Overall Study|Ineligible / no protocol treatment|15
4421225|NCT00331760|7202528|FG001|Overall Study|Ineligible / no protocol treatment|8
4421226|NCT00331773|7202537|FG000|Overall Study|Withdrawal by Subject|6
4421227|NCT00331773|7202538|FG001|Overall Study|Withdrawal by Subject|4
4421228|NCT00331773|7202537|FG000|Overall Study|Protocol Violation|10
4421229|NCT00331773|7202538|FG001|Overall Study|Protocol Violation|3
4421230|NCT00331799|7202545|FG000|Overall Study|Withdrawal by Subject|2
4421231|NCT00331799|7202545|FG000|Overall Study|Sedation|1
4421232|NCT00331864|7202551|FG000|Overall Study|Adverse Event|30
4421233|NCT00331864|7202552|FG001|Overall Study|Adverse Event|1
4421234|NCT00331864|7202551|FG000|Overall Study|Lack of Efficacy|4
4421235|NCT00331864|7202552|FG001|Overall Study|Lack of Efficacy|0
4421236|NCT00331864|7202551|FG000|Overall Study|Protocol Violation|3
4421237|NCT00331864|7202552|FG001|Overall Study|Protocol Violation|0
4421238|NCT00331864|7202551|FG000|Overall Study|Withdrawal by Subject|10
4421239|NCT00331864|7202552|FG001|Overall Study|Withdrawal by Subject|0
4421240|NCT00331864|7202551|FG000|Overall Study|Lost to Follow-up|4
4421241|NCT00331864|7202552|FG001|Overall Study|Lost to Follow-up|3
4421242|NCT00331864|7202551|FG000|Overall Study|Administrative Problems|1
4421243|NCT00331864|7202552|FG001|Overall Study|Administrative Problems|0
4421244|NCT00331864|7202551|FG000|Overall Study|Death|6
4421245|NCT00331864|7202552|FG001|Overall Study|Death|0
4629587|NCT01874431|7497666|FG007|Overall Study|Adverse Event|3
4421246|NCT00332189|7202567|FG000|Overall Study|Adverse Event|3
4421247|NCT00332189|7202567|FG000|Overall Study|Uncooperative/Noncompliant|3
4421248|NCT00332189|7202567|FG000|Overall Study|Withdrawal by Subject|9
4421249|NCT00332189|7202567|FG000|Overall Study|Lack of Efficacy|4
4421250|NCT00332189|7202567|FG000|Overall Study|Moved out of country|2
4421251|NCT00332202|7202574|FG000|Overall Study|Adverse Event|72
4421252|NCT00332202|7202575|FG001|Overall Study|Adverse Event|28
4421253|NCT00332202|7202574|FG000|Overall Study|Lost to Follow-up|2
4421254|NCT00332202|7202575|FG001|Overall Study|Lost to Follow-up|1
4421255|NCT00332202|7202574|FG000|Overall Study|Physician Decision|6
4421256|NCT00332202|7202575|FG001|Overall Study|Physician Decision|8
4421257|NCT00332202|7202574|FG000|Overall Study|Protocol Entry Criteria Not Met|6
4421258|NCT00332202|7202575|FG001|Overall Study|Protocol Entry Criteria Not Met|5
4421259|NCT00332202|7202574|FG000|Overall Study|Protocol Violation|7
4421260|NCT00332202|7202575|FG001|Overall Study|Protocol Violation|2
4421261|NCT00332202|7202574|FG000|Overall Study|Sponsor Decision|1
4421262|NCT00332202|7202575|FG001|Overall Study|Sponsor Decision|2
4421263|NCT00332202|7202574|FG000|Overall Study|Withdrawal by Subject|36
4421264|NCT00332202|7202575|FG001|Overall Study|Withdrawal by Subject|17
4421265|NCT00332202|7202574|FG000|Overall Study|Progressive Disease|106
4421266|NCT00332202|7202575|FG001|Overall Study|Progressive Disease|60
4421267|NCT00332202|7202574|FG000|Overall Study|Death|5
4421268|NCT00332202|7202575|FG001|Overall Study|Death|2
4421269|NCT00332241|7202592|FG000|Overall Study|Lack of Efficacy|6
4421270|NCT00332241|7202593|FG001|Overall Study|Lack of Efficacy|1
4421271|NCT00332241|7202592|FG000|Overall Study|Adverse Event|3
4421272|NCT00332241|7202593|FG001|Overall Study|Adverse Event|5
4421273|NCT00332241|7202592|FG000|Overall Study|Withdrawal by Subject|2
4421274|NCT00332241|7202593|FG001|Overall Study|Withdrawal by Subject|1
4421275|NCT00332241|7202592|FG000|Overall Study|Lost to Follow-up|4
4421276|NCT00332241|7202593|FG001|Overall Study|Lost to Follow-up|1
4421277|NCT00332332|7202599|FG000|Overall Study|Adverse Event|13
4421278|NCT00332332|7202599|FG000|Overall Study|Death|1
4421279|NCT00332332|7202599|FG000|Overall Study|Withdrawal by Subject|8
4421280|NCT00332332|7202599|FG000|Overall Study|Physician Decision|1
4421281|NCT00332332|7202599|FG000|Overall Study|Lost to Follow-up|3
4629588|NCT01874431|7497659|FG000|Overall Study|Protocol Violation|1
4629589|NCT01874431|7497660|FG001|Overall Study|Protocol Violation|1
4421282|NCT00332332|7202599|FG000|Overall Study|Protocol deviation|4
4421283|NCT00332332|7202599|FG000|Overall Study|Noncompliance|2
4421284|NCT00332332|7202599|FG000|Overall Study|Disease progression|2
4421285|NCT00332332|7202599|FG000|Overall Study|Other|18
4421286|NCT00332332|7202599|FG000|Overall Study|Did not receive study treatment|16
4421287|NCT00332462|7202603|FG000|Overall Study|Adverse Event|5
4421288|NCT00332462|7202603|FG000|Overall Study|Abnormal Lab Value|1
4421289|NCT00332462|7202603|FG000|Overall Study|Unsatisfactory therapeutic effect|4
4421290|NCT00332462|7202603|FG000|Overall Study|no longer requires study drug|1
4421291|NCT00332462|7202603|FG000|Overall Study|Death|3
4421292|NCT00332462|7202603|FG000|Overall Study|Graft Loss|2
4421293|NCT00332488|7202613|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8
4421294|NCT00332488|7202614|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2
4421295|NCT00332488|7202615|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6
4421296|NCT00332488|7202613|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13
4421297|NCT00332488|7202614|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2
4421298|NCT00332488|7202615|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10
4421299|NCT00332488|7202613|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21
4421300|NCT00332488|7202614|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10
4421301|NCT00332488|7202615|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20
4421302|NCT00332488|7202613|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4
4421303|NCT00332488|7202614|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0
4421304|NCT00332488|7202615|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20
4421305|NCT00332488|7202613|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1
4421306|NCT00332488|7202614|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3
4421307|NCT00332488|7202615|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0
4421308|NCT00332488|7202613|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3
4421309|NCT00332488|7202614|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1
4421310|NCT00332488|7202615|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0
4421311|NCT00332488|7202613|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0
4421312|NCT00332488|7202614|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0
4421313|NCT00332488|7202615|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3
4421314|NCT00332488|7202613|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0
4421315|NCT00332488|7202614|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0
4421316|NCT00332488|7202615|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1
4421317|NCT00332488|7202613|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0
4421318|NCT00332488|7202614|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0
4421319|NCT00332488|7202615|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3
4421320|NCT00332488|7202613|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0
4421321|NCT00332488|7202614|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0
4421322|NCT00332488|7202615|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1
4421323|NCT00332488|7202613|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2
4421324|NCT00332488|7202614|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2
4421325|NCT00332488|7202615|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8
4421326|NCT00332488|7202613|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0
4421327|NCT00332488|7202614|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0
4421328|NCT00332488|7202615|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5
4421329|NCT00332696|7202674|FG000|Overall Study|Death|24
4421330|NCT00332696|7202675|FG001|Overall Study|Death|14
4421331|NCT00332696|7202674|FG000|Overall Study|Insufficient therapeutic effect|4
4421332|NCT00332696|7202675|FG001|Overall Study|Insufficient therapeutic effect|11
4421333|NCT00332696|7202674|FG000|Overall Study|Adverse Event|1
4421334|NCT00332696|7202675|FG001|Overall Study|Adverse Event|2
4421335|NCT00332696|7202674|FG000|Overall Study|Condition does not justify treatment|0
4421336|NCT00332696|7202675|FG001|Overall Study|Condition does not justify treatment|2
4421337|NCT00332696|7202674|FG000|Overall Study|Lost to Follow-up|0
4421338|NCT00332696|7202675|FG001|Overall Study|Lost to Follow-up|1
4421339|NCT00332696|7202674|FG000|Overall Study|Withdrawal by Subject|1
4421340|NCT00332696|7202675|FG001|Overall Study|Withdrawal by Subject|0
4421341|NCT00332709|7202683|FG000|Overall Study|Adverse Event|11
4421342|NCT00332709|7202684|FG001|Overall Study|Adverse Event|14
4421343|NCT00332709|7202683|FG000|Overall Study|Withdrawal by Subject|2
4421344|NCT00332709|7202684|FG001|Overall Study|Withdrawal by Subject|3
4421345|NCT00332709|7202683|FG000|Overall Study|Lost to Follow-up|2
4421346|NCT00332709|7202684|FG001|Overall Study|Lost to Follow-up|0
4421347|NCT00332709|7202683|FG000|Overall Study|Administrative Problems|0
4421348|NCT00332709|7202684|FG001|Overall Study|Administrative Problems|3
4421349|NCT00332709|7202683|FG000|Overall Study|Abnormal test procedure result|1
4421350|NCT00332709|7202684|FG001|Overall Study|Abnormal test procedure result|0
4421351|NCT00332839|7202701|FG000|Core (Months 0 - 12)|Administrative problems|1
4421352|NCT00332839|7202702|FG001|Core (Months 0 - 12)|Administrative problems|1
4421353|NCT00332839|7202701|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3
4421354|NCT00332839|7202702|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1
4421355|NCT00332839|7202701|FG000|Core (Months 0 - 12)|Protocol deviation|1
4421356|NCT00332839|7202702|FG001|Core (Months 0 - 12)|Protocol deviation|1
4421357|NCT00332839|7202701|FG000|Core (Months 0 - 12)|Adverse Event|5
4421358|NCT00332839|7202702|FG001|Core (Months 0 - 12)|Adverse Event|15
4421359|NCT00332839|7202701|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1
4421360|NCT00332839|7202702|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1
4421361|NCT00332839|7202701|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2
4421362|NCT00332839|7202702|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1
4421363|NCT00332839|7202701|FG000|Follow-up (Months 12 - 60)|Death|1
4421364|NCT00332839|7202702|FG001|Follow-up (Months 12 - 60)|Death|1
4421365|NCT00333138|7202711|FG000|Core Study (6 Months)|Adverse Event|4
4421366|NCT00333138|7202712|FG001|Core Study (6 Months)|Adverse Event|5
4421367|NCT00333138|7202713|FG002|Core Study (6 Months)|Adverse Event|8
4421368|NCT00333138|7202711|FG000|Core Study (6 Months)|Withdrawal by Subject|1
4421369|NCT00333138|7202712|FG001|Core Study (6 Months)|Withdrawal by Subject|1
4421370|NCT00333138|7202713|FG002|Core Study (6 Months)|Withdrawal by Subject|2
4421371|NCT00333138|7202711|FG000|Core Study (6 Months)|Lack of Efficacy|1
4421372|NCT00333138|7202712|FG001|Core Study (6 Months)|Lack of Efficacy|0
4421373|NCT00333138|7202713|FG002|Core Study (6 Months)|Lack of Efficacy|0
4421374|NCT00333138|7202711|FG000|Core Study (6 Months)|Protocol Violation|1
4421375|NCT00333138|7202712|FG001|Core Study (6 Months)|Protocol Violation|0
4421376|NCT00333138|7202713|FG002|Core Study (6 Months)|Protocol Violation|1
4421377|NCT00333138|7202711|FG000|Core Study (6 Months)|Laboratory abnormality|0
4421378|NCT00333138|7202712|FG001|Core Study (6 Months)|Laboratory abnormality|0
4421379|NCT00333138|7202713|FG002|Core Study (6 Months)|Laboratory abnormality|1
4421380|NCT00333138|7202711|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3
4421381|NCT00333138|7202712|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2
4421382|NCT00333138|7202713|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2
4421383|NCT00333138|7202711|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1
4421384|NCT00333138|7202712|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1
4421385|NCT00333138|7202713|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2
4421386|NCT00333138|7202711|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15
4421387|NCT00333138|7202712|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19
4421388|NCT00333138|7202713|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15
4421389|NCT00333138|7202711|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0
4421390|NCT00333138|7202712|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0
4421391|NCT00333138|7202713|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3
4421392|NCT00333138|7202711|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14
4421393|NCT00333138|7202712|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13
4421394|NCT00333138|7202713|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14
4421395|NCT00333138|7202711|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7
4421396|NCT00333138|7202712|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4
4421397|NCT00333138|7202713|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7
4421398|NCT00333138|7202711|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2
4421399|NCT00333138|7202712|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1
4421400|NCT00333138|7202713|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0
4421401|NCT00333138|7202711|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1
4421402|NCT00333138|7202712|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1
4421403|NCT00333138|7202713|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0
4421404|NCT00333138|7202711|FG000|Extension Study (Month6 to End of Study)|Death|0
4421405|NCT00333138|7202712|FG001|Extension Study (Month6 to End of Study)|Death|1
4421406|NCT00333138|7202713|FG002|Extension Study (Month6 to End of Study)|Death|0
4421407|NCT00333359|7202744|FG000|Overall Study|Adverse Event|29
4421408|NCT00333359|7202745|FG001|Overall Study|Adverse Event|35
4421409|NCT00333359|7202744|FG000|Overall Study|Withdrawal by Subject|19
4421410|NCT00333359|7202745|FG001|Overall Study|Withdrawal by Subject|37
4421411|NCT00333359|7202744|FG000|Overall Study|Physician Decision|2
4421412|NCT00333359|7202745|FG001|Overall Study|Physician Decision|2
4421413|NCT00333359|7202744|FG000|Overall Study|Protocol Non-compliance|2
4421414|NCT00333359|7202745|FG001|Overall Study|Protocol Non-compliance|8
4421415|NCT00333359|7202744|FG000|Overall Study|Lost to Follow-up|15
4421416|NCT00333359|7202745|FG001|Overall Study|Lost to Follow-up|25
4421417|NCT00333359|7202744|FG000|Overall Study|Termination or Withdrawal by Sponsor|1
4421418|NCT00333359|7202745|FG001|Overall Study|Termination or Withdrawal by Sponsor|1
4421419|NCT00333359|7202744|FG000|Overall Study|Treatment Failure|3
4421420|NCT00333359|7202745|FG001|Overall Study|Treatment Failure|8
4421421|NCT00333359|7202744|FG000|Overall Study|Withdrew before Receiving One Dose|2
4421422|NCT00333359|7202745|FG001|Overall Study|Withdrew before Receiving One Dose|6
4421423|NCT00333619|7202771|FG000|Overall Study|Death|12
4421424|NCT00333619|7202772|FG001|Overall Study|Death|6
4421425|NCT00333619|7202771|FG000|Overall Study|Withdrawal by Subject|6
4421426|NCT00333619|7202772|FG001|Overall Study|Withdrawal by Subject|1
4421427|NCT00333619|7202771|FG000|Overall Study|Lost to Follow-up|3
4421428|NCT00333619|7202772|FG001|Overall Study|Lost to Follow-up|3
4421429|NCT00333775|7202796|FG000|Overall Study|Death|144
4421430|NCT00333775|7202797|FG001|Overall Study|Death|149
4421431|NCT00333775|7202798|FG002|Overall Study|Death|143
4421432|NCT00333775|7202796|FG000|Overall Study|In Follow-up When Study Stopped|87
4421433|NCT00333775|7202797|FG001|Overall Study|In Follow-up When Study Stopped|92
4421434|NCT00333775|7202798|FG002|Overall Study|In Follow-up When Study Stopped|96
4421435|NCT00333775|7202796|FG000|Overall Study|Lost to Follow-up|10
4421436|NCT00333775|7202797|FG001|Overall Study|Lost to Follow-up|7
4421437|NCT00333775|7202798|FG002|Overall Study|Lost to Follow-up|8
4421438|NCT00333788|7202806|FG000|Overall Study|Adverse Event|44
4421439|NCT00333788|7202806|FG000|Overall Study|Lack of Efficacy|80
4421440|NCT00333788|7202806|FG000|Overall Study|Lost to Follow-up|2
4421441|NCT00333788|7202806|FG000|Overall Study|Withdrawal by Subject|24
4421442|NCT00333788|7202806|FG000|Overall Study|Other: Non-compliance|2
4421443|NCT00333788|7202806|FG000|Overall Study|Other: Moved|2
4421444|NCT00333788|7202806|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1
4421445|NCT00333788|7202806|FG000|Overall Study|Other: Investigator decision|1
4421446|NCT00333788|7202806|FG000|Overall Study|Other: Quality of life concern|1
4421447|NCT00333788|7202806|FG000|Overall Study|Other: Sponsor decision|1
4421448|NCT00333788|7202806|FG000|Overall Study|Other: Subject in need of an Entocort|1
4421449|NCT00333788|7202806|FG000|Overall Study|Other: Medical monitor decision|1
4421450|NCT00333788|7202806|FG000|Overall Study|Other: Physician decision|1
4421451|NCT00333788|7202806|FG000|Overall Study|Other: Signed consent for another study|1
4421452|NCT00333801|7202812|FG000|Overall Study|Moved to another state|5
4421453|NCT00333801|7202813|FG001|Overall Study|Moved to another state|3
4421454|NCT00333801|7202812|FG000|Overall Study|Lost to Follow-up|2
4421455|NCT00333801|7202813|FG001|Overall Study|Lost to Follow-up|0
4421456|NCT00333801|7202812|FG000|Overall Study|Incarcerated|1
4421457|NCT00333801|7202813|FG001|Overall Study|Incarcerated|2
4421458|NCT00333801|7202812|FG000|Overall Study|Withdrawal by Subject|0
4421459|NCT00333801|7202813|FG001|Overall Study|Withdrawal by Subject|1
4421460|NCT00333840|7202834|FG000|First-line Treatment Period|Adverse Event|38
4421461|NCT00333840|7202835|FG001|First-line Treatment Period|Adverse Event|37
4421462|NCT00333840|7202836|FG002|First-line Treatment Period|Adverse Event|0
4421463|NCT00333840|7202837|FG003|First-line Treatment Period|Adverse Event|0
4421464|NCT00333840|7202834|FG000|First-line Treatment Period|Abnormal laboratory values|3
4421465|NCT00333840|7202835|FG001|First-line Treatment Period|Abnormal laboratory values|1
4421466|NCT00333840|7202836|FG002|First-line Treatment Period|Abnormal laboratory values|0
4421467|NCT00333840|7202837|FG003|First-line Treatment Period|Abnormal laboratory values|0
4421468|NCT00333840|7202834|FG000|First-line Treatment Period|Abnormal procedure|2
4421469|NCT00333840|7202835|FG001|First-line Treatment Period|Abnormal procedure|0
4421470|NCT00333840|7202836|FG002|First-line Treatment Period|Abnormal procedure|0
4421471|NCT00333840|7202837|FG003|First-line Treatment Period|Abnormal procedure|0
4421472|NCT00333840|7202834|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88
4421473|NCT00333840|7202835|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29
4421474|NCT00333840|7202836|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0
4421475|NCT00333840|7202837|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0
4421476|NCT00333840|7202834|FG000|First-line Treatment Period|No longer required study drug|21
4421477|NCT00333840|7202835|FG001|First-line Treatment Period|No longer required study drug|8
4421478|NCT00333840|7202836|FG002|First-line Treatment Period|No longer required study drug|0
4421479|NCT00333840|7202837|FG003|First-line Treatment Period|No longer required study drug|0
4421480|NCT00333840|7202834|FG000|First-line Treatment Period|Protocol Violation|17
4421481|NCT00333840|7202835|FG001|First-line Treatment Period|Protocol Violation|17
4421482|NCT00333840|7202836|FG002|First-line Treatment Period|Protocol Violation|0
4421483|NCT00333840|7202837|FG003|First-line Treatment Period|Protocol Violation|0
4421484|NCT00333840|7202834|FG000|First-line Treatment Period|Subject withdrew consent|57
4421485|NCT00333840|7202835|FG001|First-line Treatment Period|Subject withdrew consent|77
4421486|NCT00333840|7202836|FG002|First-line Treatment Period|Subject withdrew consent|0
4421487|NCT00333840|7202837|FG003|First-line Treatment Period|Subject withdrew consent|0
4421488|NCT00333840|7202834|FG000|First-line Treatment Period|Lost to Follow-up|15
4421489|NCT00333840|7202835|FG001|First-line Treatment Period|Lost to Follow-up|6
4421490|NCT00333840|7202836|FG002|First-line Treatment Period|Lost to Follow-up|0
4421491|NCT00333840|7202837|FG003|First-line Treatment Period|Lost to Follow-up|0
4421492|NCT00333840|7202834|FG000|First-line Treatment Period|Administrative problems|12
4421493|NCT00333840|7202835|FG001|First-line Treatment Period|Administrative problems|6
4421494|NCT00333840|7202836|FG002|First-line Treatment Period|Administrative problems|0
4421495|NCT00333840|7202837|FG003|First-line Treatment Period|Administrative problems|0
4421496|NCT00333840|7202834|FG000|First-line Treatment Period|Death|19
4421497|NCT00333840|7202835|FG001|First-line Treatment Period|Death|2
4421498|NCT00333840|7202836|FG002|First-line Treatment Period|Death|0
4421499|NCT00333840|7202837|FG003|First-line Treatment Period|Death|0
4421500|NCT00333840|7202834|FG000|First-line Treatment Period|Crossed over to other treatment arm|14
4421501|NCT00333840|7202835|FG001|First-line Treatment Period|Crossed over to other treatment arm|363
4421502|NCT00333840|7202836|FG002|First-line Treatment Period|Crossed over to other treatment arm|0
4421503|NCT00333840|7202837|FG003|First-line Treatment Period|Crossed over to other treatment arm|0
4421504|NCT00333840|7202834|FG000|Second-line Treatment Period|Adverse Event|0
4421505|NCT00333840|7202835|FG001|Second-line Treatment Period|Adverse Event|0
4421506|NCT00333840|7202836|FG002|Second-line Treatment Period|Adverse Event|3
4421507|NCT00333840|7202837|FG003|Second-line Treatment Period|Adverse Event|34
4421508|NCT00333840|7202834|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0
4421509|NCT00333840|7202835|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0
4421510|NCT00333840|7202836|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0
4421511|NCT00333840|7202837|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3
4421512|NCT00333840|7202834|FG000|Second-line Treatment Period|Abnormal procedure|0
4421513|NCT00333840|7202835|FG001|Second-line Treatment Period|Abnormal procedure|0
4421514|NCT00333840|7202836|FG002|Second-line Treatment Period|Abnormal procedure|0
4421515|NCT00333840|7202837|FG003|Second-line Treatment Period|Abnormal procedure|1
4421516|NCT00333840|7202834|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0
4421517|NCT00333840|7202835|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0
4421518|NCT00333840|7202836|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9
4421519|NCT00333840|7202837|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70
4421520|NCT00333840|7202834|FG000|Second-line Treatment Period|No longer required study drug|0
4421521|NCT00333840|7202835|FG001|Second-line Treatment Period|No longer required study drug|0
4421522|NCT00333840|7202836|FG002|Second-line Treatment Period|No longer required study drug|1
4421523|NCT00333840|7202837|FG003|Second-line Treatment Period|No longer required study drug|14
4421524|NCT00333840|7202834|FG000|Second-line Treatment Period|Protocol Violation|0
4421525|NCT00333840|7202835|FG001|Second-line Treatment Period|Protocol Violation|0
4421526|NCT00333840|7202836|FG002|Second-line Treatment Period|Protocol Violation|1
4421527|NCT00333840|7202837|FG003|Second-line Treatment Period|Protocol Violation|10
4421528|NCT00333840|7202834|FG000|Second-line Treatment Period|Subject withdrew consent|0
4421529|NCT00333840|7202835|FG001|Second-line Treatment Period|Subject withdrew consent|0
4421530|NCT00333840|7202836|FG002|Second-line Treatment Period|Subject withdrew consent|0
4421531|NCT00333840|7202837|FG003|Second-line Treatment Period|Subject withdrew consent|34
4421532|NCT00333840|7202834|FG000|Second-line Treatment Period|Lost to Follow-up|0
4421533|NCT00333840|7202835|FG001|Second-line Treatment Period|Lost to Follow-up|0
4421534|NCT00333840|7202836|FG002|Second-line Treatment Period|Lost to Follow-up|0
4421535|NCT00333840|7202837|FG003|Second-line Treatment Period|Lost to Follow-up|6
4421536|NCT00333840|7202834|FG000|Second-line Treatment Period|Administrative problems|0
4421537|NCT00333840|7202835|FG001|Second-line Treatment Period|Administrative problems|0
4421538|NCT00333840|7202836|FG002|Second-line Treatment Period|Administrative problems|0
4421539|NCT00333840|7202837|FG003|Second-line Treatment Period|Administrative problems|7
4421540|NCT00333840|7202834|FG000|Second-line Treatment Period|Death|0
4421541|NCT00333840|7202835|FG001|Second-line Treatment Period|Death|0
4421542|NCT00333840|7202836|FG002|Second-line Treatment Period|Death|0
4421543|NCT00333840|7202837|FG003|Second-line Treatment Period|Death|9
4421544|NCT00333866|7202855|FG000|Overall Study|Adverse Event|23
4421545|NCT00333866|7202856|FG001|Overall Study|Adverse Event|37
4421546|NCT00333866|7202857|FG002|Overall Study|Adverse Event|38
4421547|NCT00333866|7202858|FG003|Overall Study|Adverse Event|47
4421548|NCT00333866|7202855|FG000|Overall Study|Other|3
4421549|NCT00333866|7202856|FG001|Overall Study|Other|2
4421550|NCT00333866|7202857|FG002|Overall Study|Other|2
4421551|NCT00333866|7202858|FG003|Overall Study|Other|2
4421552|NCT00333866|7202855|FG000|Overall Study|Lack of Efficacy|8
4421553|NCT00333866|7202856|FG001|Overall Study|Lack of Efficacy|6
4421554|NCT00333866|7202857|FG002|Overall Study|Lack of Efficacy|3
4421555|NCT00333866|7202858|FG003|Overall Study|Lack of Efficacy|5
4421556|NCT00333866|7202855|FG000|Overall Study|Lost to Follow-up|1
4421557|NCT00333866|7202856|FG001|Overall Study|Lost to Follow-up|2
4421558|NCT00333866|7202857|FG002|Overall Study|Lost to Follow-up|2
4421559|NCT00333866|7202858|FG003|Overall Study|Lost to Follow-up|2
4421560|NCT00333866|7202855|FG000|Overall Study|Withdrawal by Subject|8
4421561|NCT00333866|7202856|FG001|Overall Study|Withdrawal by Subject|14
4421562|NCT00333866|7202857|FG002|Overall Study|Withdrawal by Subject|4
4421563|NCT00333866|7202858|FG003|Overall Study|Withdrawal by Subject|9
4421564|NCT00333866|7202855|FG000|Overall Study|Randomized but not Treated|5
4421565|NCT00333866|7202856|FG001|Overall Study|Randomized but not Treated|3
4421566|NCT00333866|7202857|FG002|Overall Study|Randomized but not Treated|2
4421567|NCT00333866|7202858|FG003|Overall Study|Randomized but not Treated|1
4421568|NCT00333970|7202874|FG000|Overall Study|Withdrawal by Subject|13
4421569|NCT00333970|7202875|FG001|Overall Study|Withdrawal by Subject|7
4421570|NCT00333983|7202884|FG000|Overall Study|Lost to Follow-up|2
4421571|NCT00333983|7202885|FG001|Overall Study|Lost to Follow-up|1
4421572|NCT00333983|7202886|FG002|Overall Study|Lost to Follow-up|0
4421573|NCT00333983|7202884|FG000|Overall Study|Adverse Event|1
4421574|NCT00333983|7202885|FG001|Overall Study|Adverse Event|1
4421575|NCT00333983|7202886|FG002|Overall Study|Adverse Event|1
4421576|NCT00333983|7202884|FG000|Overall Study|Withdrawal by Subject|0
4421577|NCT00333983|7202885|FG001|Overall Study|Withdrawal by Subject|3
4421578|NCT00333983|7202886|FG002|Overall Study|Withdrawal by Subject|1
4421579|NCT00334113|7202905|FG000|Overall Study|Lost to Follow-up|2
4421580|NCT00334113|7202906|FG001|Overall Study|Lost to Follow-up|2
4421581|NCT00334113|7202905|FG000|Overall Study|Withdrawal by Subject|0
4421582|NCT00334113|7202906|FG001|Overall Study|Withdrawal by Subject|1
4421583|NCT00334282|7202919|FG000|Overall Study|Lost to Follow-up|11
4421584|NCT00334282|7202920|FG001|Overall Study|Lost to Follow-up|5
4421585|NCT00334282|7202919|FG000|Overall Study|Withdrawal by Subject|17
4421586|NCT00334282|7202920|FG001|Overall Study|Withdrawal by Subject|3
4421587|NCT00334282|7202919|FG000|Overall Study|Death|194
4421588|NCT00334282|7202920|FG001|Overall Study|Death|100
4421589|NCT00334295|7202930|FG000|Overall Study|Patients received fewer than 3 injection|5
4421590|NCT00334542|7202934|FG000|Overall Study|Adverse Event|3
4421591|NCT00334542|7202934|FG000|Overall Study|Withdrawal by Subject|1
4421592|NCT00334542|7202934|FG000|Overall Study|New cancer diagnosis|1
4421593|NCT00334737|7202958|FG000|Hospital Phase|Death|1
4421594|NCT00334737|7202959|FG001|Hospital Phase|Death|2
4421595|NCT00334737|7202960|FG002|Hospital Phase|Death|3
4421596|NCT00334737|7202958|FG000|Hospital Phase|Withdrawal by Subject|0
4421597|NCT00334737|7202959|FG001|Hospital Phase|Withdrawal by Subject|0
4421598|NCT00334737|7202960|FG002|Hospital Phase|Withdrawal by Subject|1
4421599|NCT00334737|7202958|FG000|Hospital Phase|Did not receive study drug|1
4421600|NCT00334737|7202959|FG001|Hospital Phase|Did not receive study drug|0
4421601|NCT00334737|7202960|FG002|Hospital Phase|Did not receive study drug|0
4421602|NCT00334737|7202958|FG000|Follow up Phase|Lost to Follow-up|5
4421603|NCT00334737|7202959|FG001|Follow up Phase|Lost to Follow-up|3
4421604|NCT00334737|7202960|FG002|Follow up Phase|Lost to Follow-up|6
4421605|NCT00334802|7202970|FG000|Overall Study|Progressive Disease|2
4421606|NCT00334802|7202971|FG001|Overall Study|Progressive Disease|24
4421607|NCT00334802|7202970|FG000|Overall Study|Toxicity|1
4421608|NCT00334802|7202971|FG001|Overall Study|Toxicity|5
4421609|NCT00334802|7202970|FG000|Overall Study|Lack of Efficacy|1
4421610|NCT00334802|7202971|FG001|Overall Study|Lack of Efficacy|3
4421611|NCT00334802|7202970|FG000|Overall Study|Patient Condition Aggrevated|1
4421612|NCT00334802|7202971|FG001|Overall Study|Patient Condition Aggrevated|0
4421613|NCT00334802|7202970|FG000|Overall Study|Physician Decision|1
4421614|NCT00334802|7202971|FG001|Overall Study|Physician Decision|0
4421615|NCT00334802|7202970|FG000|Overall Study|Withdrawal by Subject|0
4421616|NCT00334802|7202971|FG001|Overall Study|Withdrawal by Subject|4
4421617|NCT00334802|7202970|FG000|Overall Study|Adverse Event|0
4421618|NCT00334802|7202971|FG001|Overall Study|Adverse Event|3
4421619|NCT00334802|7202970|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0
4421620|NCT00334802|7202971|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1
4421621|NCT00334815|7202982|FG000|Overall Study|Adverse Event|3
4421622|NCT00334815|7202983|FG001|Overall Study|Adverse Event|2
4421623|NCT00334815|7202982|FG000|Overall Study|Death|0
4421624|NCT00334815|7202983|FG001|Overall Study|Death|2
4421625|NCT00334815|7202982|FG000|Overall Study|Progression|1
4421626|NCT00334815|7202983|FG001|Overall Study|Progression|0
4421627|NCT00334815|7202982|FG000|Overall Study|ineligible|1
4421628|NCT00334815|7202983|FG001|Overall Study|ineligible|1
4421629|NCT00334815|7202982|FG000|Overall Study|patient refused treatment|0
4421630|NCT00334815|7202983|FG001|Overall Study|patient refused treatment|1
4421631|NCT00334815|7202982|FG000|Overall Study|Physician Decision|2
4421632|NCT00334815|7202983|FG001|Overall Study|Physician Decision|4
4421633|NCT00334893|7202993|FG000|Overall Study|Not Treated|1
4421634|NCT00334893|7202994|FG001|Overall Study|Not Treated|0
4421635|NCT00334958|7203004|FG000|Overall Study|Medication Noncompliance|0
4421636|NCT00334958|7203005|FG001|Overall Study|Medication Noncompliance|3
4421637|NCT00334958|7203004|FG000|Overall Study|Protocol Violation|2
4421638|NCT00334958|7203005|FG001|Overall Study|Protocol Violation|2
4421639|NCT00334958|7203004|FG000|Overall Study|Request of the investigator or sponsor|0
4421640|NCT00334958|7203005|FG001|Overall Study|Request of the investigator or sponsor|1
4421641|NCT00334958|7203004|FG000|Overall Study|Withdrawal by Subject|7
4421642|NCT00334958|7203005|FG001|Overall Study|Withdrawal by Subject|4
4421643|NCT00334958|7203004|FG000|Overall Study|Adverse Event|27
4421644|NCT00334958|7203005|FG001|Overall Study|Adverse Event|12
4421645|NCT00334958|7203004|FG000|Overall Study|Other|1
4421646|NCT00334958|7203005|FG001|Overall Study|Other|2
4421647|NCT00335140|7203011|FG000|Overall Study|Ineligible|1
4421648|NCT00335153|7203015|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5
4421649|NCT00335153|7203015|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5
4421650|NCT00335153|7203015|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12
4421651|NCT00335153|7203015|FG000|Nasojejunal (NJ) Test Period|Administrative|1
4421652|NCT00335153|7203015|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7
4421653|NCT00335153|7203015|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22
4421654|NCT00335153|7203015|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2
4421655|NCT00335153|7203015|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13
4421656|NCT00335153|7203015|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13
4421657|NCT00335153|7203015|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2
4421658|NCT00335322|7203050|FG000|Overall Study|Randomised but withdrew prior to ART sta|1
4421659|NCT00335322|7203051|FG001|Overall Study|Randomised but withdrew prior to ART sta|2
4421660|NCT00335322|7203052|FG002|Overall Study|Randomised but withdrew prior to ART sta|2
4421661|NCT00335452|7203067|FG000|Overall Study|Death|156
4421662|NCT00335452|7203068|FG001|Overall Study|Death|144
4421663|NCT00335452|7203069|FG002|Overall Study|Death|158
4421664|NCT00335452|7203070|FG003|Overall Study|Death|129
4421665|NCT00335452|7203067|FG000|Overall Study|Lost to Follow-up|2
4421666|NCT00335452|7203068|FG001|Overall Study|Lost to Follow-up|3
4421667|NCT00335452|7203069|FG002|Overall Study|Lost to Follow-up|1
4421668|NCT00335452|7203070|FG003|Overall Study|Lost to Follow-up|2
4421669|NCT00335556|7203116|FG000|Overall Study|Death|0
4421670|NCT00335556|7203117|FG001|Overall Study|Death|5
4421671|NCT00335556|7203118|FG002|Overall Study|Death|0
4421672|NCT00335556|7203119|FG003|Overall Study|Death|0
4421673|NCT00335556|7203120|FG004|Overall Study|Death|1
4421674|NCT00335556|7203121|FG005|Overall Study|Death|0
4421675|NCT00335556|7203116|FG000|Overall Study|Lack of Efficacy|0
4421676|NCT00335556|7203117|FG001|Overall Study|Lack of Efficacy|19
4421677|NCT00335556|7203118|FG002|Overall Study|Lack of Efficacy|3
4421678|NCT00335556|7203119|FG003|Overall Study|Lack of Efficacy|3
4421679|NCT00335556|7203120|FG004|Overall Study|Lack of Efficacy|0
4421680|NCT00335556|7203121|FG005|Overall Study|Lack of Efficacy|1
4421681|NCT00335556|7203116|FG000|Overall Study|Physician Decision|0
4421682|NCT00335556|7203117|FG001|Overall Study|Physician Decision|6
4421683|NCT00335556|7203118|FG002|Overall Study|Physician Decision|2
4421684|NCT00335556|7203119|FG003|Overall Study|Physician Decision|1
4421685|NCT00335556|7203120|FG004|Overall Study|Physician Decision|0
4421686|NCT00335556|7203121|FG005|Overall Study|Physician Decision|0
4421687|NCT00335556|7203116|FG000|Overall Study|Ineligible|2
4421688|NCT00335556|7203117|FG001|Overall Study|Ineligible|0
4421689|NCT00335556|7203118|FG002|Overall Study|Ineligible|0
4421690|NCT00335556|7203119|FG003|Overall Study|Ineligible|0
4421691|NCT00335556|7203120|FG004|Overall Study|Ineligible|0
4421692|NCT00335556|7203121|FG005|Overall Study|Ineligible|0
4421693|NCT00335556|7203116|FG000|Overall Study|Refusal of further protocol therapy|0
4421694|NCT00335556|7203117|FG001|Overall Study|Refusal of further protocol therapy|4
4421695|NCT00335556|7203118|FG002|Overall Study|Refusal of further protocol therapy|0
4421696|NCT00335556|7203119|FG003|Overall Study|Refusal of further protocol therapy|1
4421697|NCT00335556|7203120|FG004|Overall Study|Refusal of further protocol therapy|0
4421698|NCT00335556|7203121|FG005|Overall Study|Refusal of further protocol therapy|0
4421699|NCT00335738|7203152|FG000|Overall Study|Physician Decision|6
4421700|NCT00335738|7203153|FG001|Overall Study|Physician Decision|0
4421701|NCT00335738|7203152|FG000|Overall Study|Withdrawal by Subject|2
4421702|NCT00335738|7203153|FG001|Overall Study|Withdrawal by Subject|0
4421703|NCT00335738|7203152|FG000|Overall Study|Ineligible|3
4421704|NCT00335738|7203153|FG001|Overall Study|Ineligible|4
4421705|NCT00335764|7203165|FG000|Overall Study|wrong histology|1
4421706|NCT00335764|7203166|FG001|Overall Study|wrong histology|0
4421707|NCT00335764|7203167|FG002|Overall Study|wrong histology|0
4421708|NCT00335764|7203168|FG003|Overall Study|wrong histology|0
4421709|NCT00335764|7203169|FG004|Overall Study|wrong histology|1
4421710|NCT00335829|7203205|FG000|Overall Study|Withdrawal by Subject|1
4421711|NCT00335829|7203205|FG000|Overall Study|Lost to Follow-up|1
4421712|NCT00335829|7203205|FG000|Overall Study|Adverse Event|1
4421713|NCT00335959|7203209|FG000|Overall Study|Adverse Event|2
4421714|NCT00335959|7203209|FG000|Overall Study|Ineligible|1
4421715|NCT00335972|7203216|FG000|Overall Study|not given treatments|0
4421716|NCT00335972|7203217|FG001|Overall Study|not given treatments|3
4421717|NCT00336024|7203225|FG000|Overall Study|Death|2
4421718|NCT00336024|7203226|FG001|Overall Study|Death|1
4421719|NCT00336024|7203225|FG000|Overall Study|Physician Decision|4
4421720|NCT00336024|7203226|FG001|Overall Study|Physician Decision|1
4421721|NCT00336024|7203225|FG000|Overall Study|Protocol Violation|1
4421722|NCT00336024|7203226|FG001|Overall Study|Protocol Violation|0
4421723|NCT00336024|7203225|FG000|Overall Study|Withdrawal by Subject|1
4421724|NCT00336024|7203226|FG001|Overall Study|Withdrawal by Subject|2
4421725|NCT00336024|7203225|FG000|Overall Study|Failure to fulfill consolidation|1
4421726|NCT00336024|7203226|FG001|Overall Study|Failure to fulfill consolidation|1
4421727|NCT00336024|7203225|FG000|Overall Study|Progressive Disease|4
4421728|NCT00336024|7203226|FG001|Overall Study|Progressive Disease|7
4421729|NCT00336024|7203225|FG000|Overall Study|Ineligible|7
4421730|NCT00336024|7203226|FG001|Overall Study|Ineligible|7
4421731|NCT00336284|7203238|FG000|Overall Study|Death|52
4421732|NCT00336284|7203239|FG001|Overall Study|Death|26
4421733|NCT00336284|7203238|FG000|Overall Study|Lost to Follow-up|82
4421734|NCT00336284|7203239|FG001|Overall Study|Lost to Follow-up|61
4421735|NCT00336284|7203238|FG000|Overall Study|Withdrawal by Physician or Subject|102
4421736|NCT00336284|7203239|FG001|Overall Study|Withdrawal by Physician or Subject|64
4421737|NCT00336479|7203274|FG000|Overall Study|Adverse Event|8
4421738|NCT00336479|7203275|FG001|Overall Study|Adverse Event|11
4421739|NCT00336479|7203276|FG002|Overall Study|Adverse Event|18
4421740|NCT00336479|7203277|FG003|Overall Study|Adverse Event|4
4421741|NCT00336479|7203274|FG000|Overall Study|Noncompliant|1
4421742|NCT00336479|7203275|FG001|Overall Study|Noncompliant|7
4421743|NCT00336479|7203276|FG002|Overall Study|Noncompliant|3
4421744|NCT00336479|7203277|FG003|Overall Study|Noncompliant|0
4421745|NCT00336479|7203274|FG000|Overall Study|Physician Decision|2
4421746|NCT00336479|7203275|FG001|Overall Study|Physician Decision|3
4421747|NCT00336479|7203276|FG002|Overall Study|Physician Decision|1
4421748|NCT00336479|7203277|FG003|Overall Study|Physician Decision|0
4421749|NCT00336479|7203274|FG000|Overall Study|Lost to Follow-up|3
4421750|NCT00336479|7203275|FG001|Overall Study|Lost to Follow-up|2
4421751|NCT00336479|7203276|FG002|Overall Study|Lost to Follow-up|0
4421752|NCT00336479|7203277|FG003|Overall Study|Lost to Follow-up|0
4421753|NCT00336479|7203274|FG000|Overall Study|Withdrawal by Subject|3
4421754|NCT00336479|7203275|FG001|Overall Study|Withdrawal by Subject|2
4421755|NCT00336479|7203276|FG002|Overall Study|Withdrawal by Subject|3
4421756|NCT00336479|7203277|FG003|Overall Study|Withdrawal by Subject|0
4421757|NCT00336479|7203274|FG000|Overall Study|Other|0
4421758|NCT00336479|7203275|FG001|Overall Study|Other|0
4421759|NCT00336479|7203276|FG002|Overall Study|Other|1
4421760|NCT00336479|7203277|FG003|Overall Study|Other|0
4421761|NCT00336479|7203274|FG000|Overall Study|Virologic Stopping Rule|20
4421762|NCT00336479|7203275|FG001|Overall Study|Virologic Stopping Rule|0
4421763|NCT00336479|7203276|FG002|Overall Study|Virologic Stopping Rule|0
4421764|NCT00336479|7203277|FG003|Overall Study|Virologic Stopping Rule|0
4421765|NCT00336492|7203291|FG000|Overall Study|Adverse Event|4
4421766|NCT00336492|7203292|FG001|Overall Study|Adverse Event|3
4421767|NCT00336492|7203293|FG002|Overall Study|Adverse Event|6
4421768|NCT00336492|7203291|FG000|Overall Study|Lack of Efficacy|6
4421769|NCT00336492|7203292|FG001|Overall Study|Lack of Efficacy|1
4421770|NCT00336492|7203293|FG002|Overall Study|Lack of Efficacy|4
4421771|NCT00336492|7203291|FG000|Overall Study|Other|5
4421772|NCT00336492|7203292|FG001|Overall Study|Other|0
4421773|NCT00336492|7203293|FG002|Overall Study|Other|1
4421774|NCT00336505|7203303|FG000|Overall Study|Adverse Event|10
4421775|NCT00336505|7203304|FG001|Overall Study|Adverse Event|9
4421776|NCT00336505|7203303|FG000|Overall Study|Lack of Efficacy|8
4421777|NCT00336505|7203304|FG001|Overall Study|Lack of Efficacy|4
4421778|NCT00336505|7203303|FG000|Overall Study|Lost to Follow-up|7
4421779|NCT00336505|7203304|FG001|Overall Study|Lost to Follow-up|4
4421780|NCT00336505|7203303|FG000|Overall Study|Withdrawal by Subject|5
4421781|NCT00336505|7203304|FG001|Overall Study|Withdrawal by Subject|3
4421782|NCT00336505|7203303|FG000|Overall Study|Other|7
4421783|NCT00336505|7203304|FG001|Overall Study|Other|7
4421784|NCT00336544|7203312|FG000|Overall Study|Lack of Efficacy|8
4421785|NCT00336544|7203313|FG001|Overall Study|Lack of Efficacy|5
4421786|NCT00336544|7203312|FG000|Overall Study|Adverse Event|4
4421787|NCT00336544|7203313|FG001|Overall Study|Adverse Event|9
4421788|NCT00336544|7203312|FG000|Overall Study|Withdrawal by Subject|4
4421789|NCT00336544|7203313|FG001|Overall Study|Withdrawal by Subject|3
4421790|NCT00336544|7203312|FG000|Overall Study|Other|3
4421791|NCT00336544|7203313|FG001|Overall Study|Other|5
4421792|NCT00336583|7203319|FG000|Overall Study|Lost to Follow-up|1
4421793|NCT00336583|7203319|FG000|Overall Study|Death|1
4421794|NCT00336856|7203338|FG000|Overall Study|Withdrawal by Subject|3
4421795|NCT00336856|7203338|FG000|Overall Study|Found ineligible at time of analysis|1
4421796|NCT00336895|7203342|FG000|Overall Study|diarrhea|1
4421797|NCT00336895|7203342|FG000|Overall Study|nausea and upset stomach|1
4421798|NCT00336895|7203342|FG000|Overall Study|Physician Decision|1
4421799|NCT00336895|7203342|FG000|Overall Study|screen failed|1
4421800|NCT00337077|7203349|FG000|Overall Study|Progressive disease|25
4421801|NCT00337077|7203350|FG001|Overall Study|Progressive disease|37
4421802|NCT00337077|7203351|FG002|Overall Study|Progressive disease|19
4421803|NCT00337077|7203349|FG000|Overall Study|Adverse Event|7
4421804|NCT00337077|7203350|FG001|Overall Study|Adverse Event|7
4421805|NCT00337077|7203351|FG002|Overall Study|Adverse Event|1
4421806|NCT00337077|7203349|FG000|Overall Study|Death|0
4421807|NCT00337077|7203350|FG001|Overall Study|Death|1
4421808|NCT00337077|7203351|FG002|Overall Study|Death|0
4421809|NCT00337077|7203349|FG000|Overall Study|Withdrawal by Subject|7
4421810|NCT00337077|7203350|FG001|Overall Study|Withdrawal by Subject|2
4421811|NCT00337077|7203351|FG002|Overall Study|Withdrawal by Subject|2
4421812|NCT00337077|7203349|FG000|Overall Study|Alternative therapy|1
4421813|NCT00337077|7203350|FG001|Overall Study|Alternative therapy|0
4421814|NCT00337077|7203351|FG002|Overall Study|Alternative therapy|0
4421815|NCT00337077|7203349|FG000|Overall Study|Physician Decision|1
4421816|NCT00337077|7203350|FG001|Overall Study|Physician Decision|4
4421817|NCT00337077|7203351|FG002|Overall Study|Physician Decision|2
4421818|NCT00337077|7203349|FG000|Overall Study|Never started treatment|1
4421819|NCT00337077|7203350|FG001|Overall Study|Never started treatment|1
4421820|NCT00337077|7203351|FG002|Overall Study|Never started treatment|0
4421821|NCT00337077|7203349|FG000|Overall Study|Ineligible|1
4421822|NCT00337077|7203350|FG001|Overall Study|Ineligible|1
4421823|NCT00337077|7203351|FG002|Overall Study|Ineligible|1
4421824|NCT00337103|7203359|FG000|Overall Study|Progressive Disease|414
4421825|NCT00337103|7203360|FG001|Overall Study|Progressive Disease|410
4421826|NCT00337103|7203359|FG000|Overall Study|Adverse Event|45
4421827|NCT00337103|7203360|FG001|Overall Study|Adverse Event|59
4421828|NCT00337103|7203359|FG000|Overall Study|Subject Choice|34
4421829|NCT00337103|7203360|FG001|Overall Study|Subject Choice|27
4421830|NCT00337103|7203359|FG000|Overall Study|Clinical Progression|27
4421831|NCT00337103|7203360|FG001|Overall Study|Clinical Progression|24
4421832|NCT00337103|7203359|FG000|Overall Study|Physician Decision|15
4421833|NCT00337103|7203360|FG001|Overall Study|Physician Decision|14
4421834|NCT00337103|7203359|FG000|Overall Study|Withdrawal by Subject|8
4421835|NCT00337103|7203360|FG001|Overall Study|Withdrawal by Subject|5
4421836|NCT00337103|7203359|FG000|Overall Study|Other|5
4421837|NCT00337103|7203360|FG001|Overall Study|Other|6
4421838|NCT00337103|7203359|FG000|Overall Study|Entry Criteria Not Met|4
4421839|NCT00337103|7203360|FG001|Overall Study|Entry Criteria Not Met|1
4421840|NCT00337103|7203359|FG000|Overall Study|Lost to Follow-up|1
4421841|NCT00337103|7203360|FG001|Overall Study|Lost to Follow-up|2
4421842|NCT00337103|7203359|FG000|Overall Study|Death|1
4421843|NCT00337103|7203360|FG001|Overall Study|Death|0
4421844|NCT00337129|7203367|FG000|Overall Study|Adverse Event|4
4421845|NCT00337129|7203367|FG000|Overall Study|Withdrawal by Subject|1
4421846|NCT00337129|7203367|FG000|Overall Study|Lack of Efficacy|32
4421847|NCT00337129|7203367|FG000|Overall Study|Death|2
4421848|NCT00337129|7203367|FG000|Overall Study|not protocol specified|1
4421849|NCT00337168|7203371|FG000|Overall Study|Death|5
4421850|NCT00337168|7203371|FG000|Overall Study|Not protocol specified|2
4421851|NCT00337168|7203371|FG000|Overall Study|Did not start therapy|1
4421852|NCT00337194|7203387|FG000|Overall Study|Adverse Event|5
4421853|NCT00337194|7203388|FG001|Overall Study|Adverse Event|1
4421854|NCT00337194|7203387|FG000|Overall Study|Death|2
4421855|NCT00337194|7203388|FG001|Overall Study|Death|0
4421856|NCT00337194|7203387|FG000|Overall Study|Withdrawal by Subject|1
4421857|NCT00337194|7203388|FG001|Overall Study|Withdrawal by Subject|0
4421858|NCT00337194|7203387|FG000|Overall Study|Disease progression|1
4421859|NCT00337194|7203388|FG001|Overall Study|Disease progression|2
4421860|NCT00337194|7203387|FG000|Overall Study|Subsequent non-protocol therapy|3
4421861|NCT00337194|7203388|FG001|Overall Study|Subsequent non-protocol therapy|1
4421862|NCT00337207|7203396|FG000|Overall Study|Withdrawal by Subject|3
4421863|NCT00337272|7203403|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2
4421864|NCT00337272|7203404|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0
4421865|NCT00337272|7203403|FG000|Screening Period (Pre-randomization)|Non-compliance|1
4421866|NCT00337272|7203404|FG001|Screening Period (Pre-randomization)|Non-compliance|0
4421867|NCT00337272|7203403|FG000|Screening Period (Pre-randomization)|Screen failure|3
4421868|NCT00337272|7203404|FG001|Screening Period (Pre-randomization)|Screen failure|0
4421869|NCT00337272|7203403|FG000|Treatment Period|Non-compliance|1
4421870|NCT00337272|7203404|FG001|Treatment Period|Non-compliance|1
4421871|NCT00337272|7203403|FG000|Treatment Period|Withdrawal by Subject|0
4421872|NCT00337272|7203404|FG001|Treatment Period|Withdrawal by Subject|1
4421873|NCT00337272|7203403|FG000|Withdrawal Period|Non-compliance|0
4421874|NCT00337272|7203404|FG001|Withdrawal Period|Non-compliance|1
4421875|NCT00337285|7203410|FG000|Overall Study|Withdrawal by Subject|42
4421876|NCT00337285|7203410|FG000|Overall Study|Lost to Follow-up|41
4421877|NCT00337285|7203410|FG000|Overall Study|Adverse Event|28
4421878|NCT00337285|7203410|FG000|Overall Study|Protocol Violation|27
4421879|NCT00337285|7203410|FG000|Overall Study|Lack of Efficacy|11
4421880|NCT00337285|7203410|FG000|Overall Study|Death|1
4421881|NCT00337285|7203410|FG000|Overall Study|Physician Decision|1
4421882|NCT00337285|7203410|FG000|Overall Study|Lack of protocol compliance|7
4421883|NCT00337428|7203425|FG000|Overall Study|Withdrawal by Subject|1
4421884|NCT00337428|7203426|FG001|Overall Study|Withdrawal by Subject|2
4421885|NCT00337428|7203425|FG000|Overall Study|Lack of Time|1
4421886|NCT00337428|7203426|FG001|Overall Study|Lack of Time|1
4421887|NCT00337428|7203425|FG000|Overall Study|Unwilling to Continue|1
4421888|NCT00337428|7203426|FG001|Overall Study|Unwilling to Continue|0
4421889|NCT00337428|7203425|FG000|Overall Study|Anorexia|1
4421890|NCT00337428|7203426|FG001|Overall Study|Anorexia|0
4421891|NCT00337467|7203432|FG000|Overall Study|Adverse Event|3
4421892|NCT00337467|7203432|FG000|Overall Study|Subject Withdrew Consent|2
4421893|NCT00337467|7203432|FG000|Overall Study|Pregnancy|1
4421894|NCT00337467|7203432|FG000|Overall Study|Lost to Follow-up|2
4421895|NCT00337467|7203432|FG000|Overall Study|Subject No Longer Met Study Criteria|2
4421896|NCT00337571|7203443|FG000|Overall Study|Lack of Efficacy|3
4421897|NCT00337571|7203444|FG001|Overall Study|Lack of Efficacy|0
4421898|NCT00337571|7203445|FG002|Overall Study|Lack of Efficacy|0
4421899|NCT00337571|7203446|FG003|Overall Study|Lack of Efficacy|0
4421900|NCT00337571|7203443|FG000|Overall Study|Adverse Event|4
4421901|NCT00337571|7203444|FG001|Overall Study|Adverse Event|5
4421902|NCT00337571|7203445|FG002|Overall Study|Adverse Event|8
4421903|NCT00337571|7203446|FG003|Overall Study|Adverse Event|4
4421904|NCT00337571|7203443|FG000|Overall Study|Withdrawal by Subject|2
4421905|NCT00337571|7203444|FG001|Overall Study|Withdrawal by Subject|2
4421906|NCT00337571|7203445|FG002|Overall Study|Withdrawal by Subject|1
4421907|NCT00337571|7203446|FG003|Overall Study|Withdrawal by Subject|0
4421908|NCT00337571|7203443|FG000|Overall Study|Lost to Follow-up|3
4421909|NCT00337571|7203444|FG001|Overall Study|Lost to Follow-up|1
4421910|NCT00337571|7203445|FG002|Overall Study|Lost to Follow-up|0
4421911|NCT00337571|7203446|FG003|Overall Study|Lost to Follow-up|1
4421912|NCT00337571|7203443|FG000|Overall Study|Poor/noncompliance|1
4421913|NCT00337571|7203444|FG001|Overall Study|Poor/noncompliance|1
4421914|NCT00337571|7203445|FG002|Overall Study|Poor/noncompliance|1
4421915|NCT00337571|7203446|FG003|Overall Study|Poor/noncompliance|1
4421916|NCT00337571|7203443|FG000|Overall Study|No longer met study criteria|1
4421917|NCT00337571|7203444|FG001|Overall Study|No longer met study criteria|0
4421918|NCT00337571|7203445|FG002|Overall Study|No longer met study criteria|0
4421919|NCT00337571|7203446|FG003|Overall Study|No longer met study criteria|0
4421920|NCT00337571|7203443|FG000|Overall Study|High Potassium level|0
4421921|NCT00337571|7203444|FG001|Overall Study|High Potassium level|0
4421922|NCT00337571|7203445|FG002|Overall Study|High Potassium level|0
4421923|NCT00337571|7203446|FG003|Overall Study|High Potassium level|1
4421924|NCT00337610|7203458|FG000|Overall Study|Adverse Event|2
4421925|NCT00337610|7203459|FG001|Overall Study|Adverse Event|2
4421926|NCT00337610|7203458|FG000|Overall Study|Death|0
4421927|NCT00337610|7203459|FG001|Overall Study|Death|1
4421928|NCT00337610|7203458|FG000|Overall Study|Lack of Efficacy|6
4421929|NCT00337610|7203459|FG001|Overall Study|Lack of Efficacy|3
4421930|NCT00337610|7203458|FG000|Overall Study|Lost to Follow-up|3
4421931|NCT00337610|7203459|FG001|Overall Study|Lost to Follow-up|3
4421932|NCT00337610|7203458|FG000|Overall Study|Withdrawal by Subject|6
4421933|NCT00337610|7203459|FG001|Overall Study|Withdrawal by Subject|5
4421934|NCT00337662|7203468|FG000|Study Period II|Lost to Follow-up|0
4421935|NCT00337662|7203469|FG001|Study Period II|Lost to Follow-up|0
4421936|NCT00337662|7203470|FG002|Study Period II|Lost to Follow-up|0
4421937|NCT00337662|7203471|FG003|Study Period II|Lost to Follow-up|35
4421938|NCT00337662|7203468|FG000|Study Period II|Withdrawal by Subject|0
4421939|NCT00337662|7203469|FG001|Study Period II|Withdrawal by Subject|0
4421940|NCT00337662|7203470|FG002|Study Period II|Withdrawal by Subject|0
4421941|NCT00337662|7203471|FG003|Study Period II|Withdrawal by Subject|20
4421942|NCT00337662|7203468|FG000|Study Period II|Adverse Event|0
4421943|NCT00337662|7203469|FG001|Study Period II|Adverse Event|0
4421944|NCT00337662|7203470|FG002|Study Period II|Adverse Event|0
4421945|NCT00337662|7203471|FG003|Study Period II|Adverse Event|16
4421946|NCT00337662|7203468|FG000|Study Period II|Physician Decision|0
4421947|NCT00337662|7203469|FG001|Study Period II|Physician Decision|0
4421948|NCT00337662|7203470|FG002|Study Period II|Physician Decision|0
4421949|NCT00337662|7203471|FG003|Study Period II|Physician Decision|13
4421950|NCT00337662|7203468|FG000|Study Period II|Entry Criteria Not Met|0
4421951|NCT00337662|7203469|FG001|Study Period II|Entry Criteria Not Met|0
4421952|NCT00337662|7203470|FG002|Study Period II|Entry Criteria Not Met|0
4421953|NCT00337662|7203471|FG003|Study Period II|Entry Criteria Not Met|6
4421954|NCT00337662|7203468|FG000|Study Period II|Protocol Violation|0
4421955|NCT00337662|7203469|FG001|Study Period II|Protocol Violation|0
4421956|NCT00337662|7203470|FG002|Study Period II|Protocol Violation|0
4421957|NCT00337662|7203471|FG003|Study Period II|Protocol Violation|6
4421958|NCT00337662|7203468|FG000|Study Period II|Lack of Efficacy|0
4421959|NCT00337662|7203469|FG001|Study Period II|Lack of Efficacy|0
4421960|NCT00337662|7203470|FG002|Study Period II|Lack of Efficacy|0
4421961|NCT00337662|7203471|FG003|Study Period II|Lack of Efficacy|7
4421962|NCT00337662|7203468|FG000|Study Period II|Sponsor Decision|0
4421963|NCT00337662|7203469|FG001|Study Period II|Sponsor Decision|0
4421964|NCT00337662|7203470|FG002|Study Period II|Sponsor Decision|0
4421965|NCT00337662|7203471|FG003|Study Period II|Sponsor Decision|2
4421966|NCT00337662|7203468|FG000|Study Period II|Parent/Caregiver Decision|0
4421967|NCT00337662|7203469|FG001|Study Period II|Parent/Caregiver Decision|0
4421968|NCT00337662|7203470|FG002|Study Period II|Parent/Caregiver Decision|0
4421969|NCT00337662|7203471|FG003|Study Period II|Parent/Caregiver Decision|1
4421970|NCT00337662|7203468|FG000|Study Period III|Lost to Follow-up|14
4421971|NCT00337662|7203469|FG001|Study Period III|Lost to Follow-up|16
4421972|NCT00337662|7203470|FG002|Study Period III|Lost to Follow-up|14
4421973|NCT00337662|7203471|FG003|Study Period III|Lost to Follow-up|0
4421974|NCT00337662|7203468|FG000|Study Period III|Withdrawal by Subject|18
4421975|NCT00337662|7203469|FG001|Study Period III|Withdrawal by Subject|14
4421976|NCT00337662|7203470|FG002|Study Period III|Withdrawal by Subject|12
4421977|NCT00337662|7203471|FG003|Study Period III|Withdrawal by Subject|0
4421978|NCT00337662|7203468|FG000|Study Period III|Adverse Event|9
4421979|NCT00337662|7203469|FG001|Study Period III|Adverse Event|10
4421980|NCT00337662|7203470|FG002|Study Period III|Adverse Event|8
4421981|NCT00337662|7203471|FG003|Study Period III|Adverse Event|0
4421982|NCT00337662|7203468|FG000|Study Period III|Protocol Violation|3
4421983|NCT00337662|7203469|FG001|Study Period III|Protocol Violation|8
4421984|NCT00337662|7203470|FG002|Study Period III|Protocol Violation|2
4421985|NCT00337662|7203471|FG003|Study Period III|Protocol Violation|0
4421986|NCT00337662|7203468|FG000|Study Period III|Physician Decision|6
4421987|NCT00337662|7203469|FG001|Study Period III|Physician Decision|5
4421988|NCT00337662|7203470|FG002|Study Period III|Physician Decision|0
4421989|NCT00337662|7203471|FG003|Study Period III|Physician Decision|0
4421990|NCT00337662|7203468|FG000|Study Period III|Entry Criteria Not Met|4
4421991|NCT00337662|7203469|FG001|Study Period III|Entry Criteria Not Met|1
4421992|NCT00337662|7203470|FG002|Study Period III|Entry Criteria Not Met|3
4421993|NCT00337662|7203471|FG003|Study Period III|Entry Criteria Not Met|0
4421994|NCT00337662|7203468|FG000|Study Period III|Lack of Efficacy|4
4421995|NCT00337662|7203469|FG001|Study Period III|Lack of Efficacy|4
4421996|NCT00337662|7203470|FG002|Study Period III|Lack of Efficacy|2
4421997|NCT00337662|7203471|FG003|Study Period III|Lack of Efficacy|0
4421998|NCT00337662|7203468|FG000|Study Period III|Parent/Caregiver Decision|0
4421999|NCT00337662|7203469|FG001|Study Period III|Parent/Caregiver Decision|0
4422000|NCT00337662|7203470|FG002|Study Period III|Parent/Caregiver Decision|2
4422001|NCT00337662|7203471|FG003|Study Period III|Parent/Caregiver Decision|0
4422002|NCT00337662|7203468|FG000|Study Period III|Sponsor Decision|1
4422003|NCT00337662|7203469|FG001|Study Period III|Sponsor Decision|0
4422004|NCT00337662|7203470|FG002|Study Period III|Sponsor Decision|1
4422005|NCT00337662|7203471|FG003|Study Period III|Sponsor Decision|0
4422006|NCT00337662|7203468|FG000|Study Period III|Clinical Relapse|1
4422007|NCT00337662|7203469|FG001|Study Period III|Clinical Relapse|0
4422008|NCT00337662|7203470|FG002|Study Period III|Clinical Relapse|0
4422009|NCT00337662|7203471|FG003|Study Period III|Clinical Relapse|0
4422010|NCT00337727|7203484|FG000|Overall Study|Adverse Event|5
4422011|NCT00337727|7203485|FG001|Overall Study|Adverse Event|3
4422012|NCT00337727|7203484|FG000|Overall Study|Lost to Follow-up|5
4422013|NCT00337727|7203485|FG001|Overall Study|Lost to Follow-up|4
4422014|NCT00337727|7203484|FG000|Overall Study|Physician Decision|1
4422015|NCT00337727|7203485|FG001|Overall Study|Physician Decision|0
4422016|NCT00337727|7203484|FG000|Overall Study|Protocol Violation|4
4422017|NCT00337727|7203485|FG001|Overall Study|Protocol Violation|0
4422018|NCT00337727|7203484|FG000|Overall Study|Withdrawal by Subject|3
4422019|NCT00337727|7203485|FG001|Overall Study|Withdrawal by Subject|5
4422020|NCT00337779|7203493|FG000|Overall Study|Withdrawal by Subject|10
4422021|NCT00337779|7203494|FG001|Overall Study|Withdrawal by Subject|12
4422022|NCT00337779|7203493|FG000|Overall Study|Sponsor decision|1
4422023|NCT00337779|7203494|FG001|Overall Study|Sponsor decision|1
4422024|NCT00337779|7203493|FG000|Overall Study|Physician Decision|3
4422025|NCT00337779|7203494|FG001|Overall Study|Physician Decision|6
4422026|NCT00337779|7203493|FG000|Overall Study|Protocol Violation|1
4422027|NCT00337779|7203494|FG001|Overall Study|Protocol Violation|1
4422028|NCT00337779|7203493|FG000|Overall Study|Lost to Follow-up|6
4422029|NCT00337779|7203494|FG001|Overall Study|Lost to Follow-up|5
4422030|NCT00337779|7203493|FG000|Overall Study|Adverse Event|28
4422031|NCT00337779|7203494|FG001|Overall Study|Adverse Event|51
4422032|NCT00337779|7203493|FG000|Overall Study|Pregnancy|3
4422033|NCT00337779|7203494|FG001|Overall Study|Pregnancy|2
4422034|NCT00337779|7203493|FG000|Overall Study|Death|0
4422035|NCT00337779|7203494|FG001|Overall Study|Death|1
4422036|NCT00337818|7203503|FG000|Overall Study|Lost to Follow-up|289
4422037|NCT00337818|7203504|FG001|Overall Study|Lost to Follow-up|91
4422038|NCT00337818|7203505|FG002|Overall Study|Lost to Follow-up|107
4422039|NCT00337935|7203515|FG000|Overall Study|Adverse Event|2
4422040|NCT00337935|7203516|FG001|Overall Study|Adverse Event|5
4422041|NCT00337935|7203515|FG000|Overall Study|Death|2
4422042|NCT00337935|7203516|FG001|Overall Study|Death|8
4422043|NCT00337935|7203515|FG000|Overall Study|Physician Decision|1
4422044|NCT00337935|7203516|FG001|Overall Study|Physician Decision|1
4422045|NCT00337935|7203515|FG000|Overall Study|Lost to Follow-up|0
4422046|NCT00337935|7203516|FG001|Overall Study|Lost to Follow-up|1
4422047|NCT00337935|7203515|FG000|Overall Study|Protocol Violation|4
4422048|NCT00337935|7203516|FG001|Overall Study|Protocol Violation|3
4422049|NCT00337935|7203515|FG000|Overall Study|Withdrawal by Subject|1
4422050|NCT00337935|7203516|FG001|Overall Study|Withdrawal by Subject|7
4422051|NCT00337935|7203515|FG000|Overall Study|Other|0
4422052|NCT00337935|7203516|FG001|Overall Study|Other|1
4422053|NCT00337935|7203515|FG000|Overall Study|Lack of Efficacy|0
4422054|NCT00337935|7203516|FG001|Overall Study|Lack of Efficacy|1
4422055|NCT00338286|7203533|FG000|Overall Study|Withdrawal by Subject|50
4422056|NCT00338286|7203534|FG001|Overall Study|Withdrawal by Subject|54
4422057|NCT00338286|7203533|FG000|Overall Study|Lost to Follow-up|80
4422058|NCT00338286|7203534|FG001|Overall Study|Lost to Follow-up|66
4422059|NCT00338286|7203533|FG000|Overall Study|Other|103
4422060|NCT00338286|7203534|FG001|Overall Study|Other|93
4512129|NCT00932126|7321788|FG003|Overall Study|Objective progression or relapse|3
4512130|NCT00932126|7321789|FG004|Overall Study|Objective progression or relapse|3
4512131|NCT00932126|7321790|FG005|Overall Study|Objective progression or relapse|3
4512132|NCT00932126|7321791|FG006|Overall Study|Objective progression or relapse|3
4512133|NCT00932126|7321792|FG007|Overall Study|Objective progression or relapse|5
4512134|NCT00932126|7321785|FG000|Overall Study|Other|0
4512135|NCT00932126|7321786|FG001|Overall Study|Other|0
4512136|NCT00932126|7321787|FG002|Overall Study|Other|0
4512137|NCT00932126|7321788|FG003|Overall Study|Other|0
4512138|NCT00932126|7321789|FG004|Overall Study|Other|1
4512139|NCT00932126|7321790|FG005|Overall Study|Other|0
4512140|NCT00932126|7321791|FG006|Overall Study|Other|1
4512141|NCT00932126|7321792|FG007|Overall Study|Other|2
4512142|NCT00932165|7321812|FG000|Overall Study|Lost to Follow-up|1
4512143|NCT00932360|7321835|FG000|Washout (One Week)|Withdrawal by Subject|0
4512144|NCT00932360|7321836|FG001|Washout (One Week)|Withdrawal by Subject|0
4512145|NCT00932360|7321837|FG002|Washout (One Week)|Withdrawal by Subject|0
4512146|NCT00932360|7321838|FG003|Washout (One Week)|Withdrawal by Subject|0
4512147|NCT00932360|7321839|FG004|Washout (One Week)|Withdrawal by Subject|2
4512148|NCT00932360|7321840|FG005|Washout (One Week)|Withdrawal by Subject|0
4512149|NCT00932373|7321865|FG000|Overall Study|Progressive disease|3
4512150|NCT00932373|7321866|FG001|Overall Study|Progressive disease|1
4512151|NCT00932373|7321867|FG002|Overall Study|Progressive disease|0
4512152|NCT00932373|7321868|FG003|Overall Study|Progressive disease|0
4512153|NCT00932373|7321869|FG004|Overall Study|Progressive disease|10
4512154|NCT00932373|7321870|FG005|Overall Study|Progressive disease|1
4512155|NCT00932373|7321871|FG006|Overall Study|Progressive disease|0
4512156|NCT00932373|7321872|FG007|Overall Study|Progressive disease|2
4512157|NCT00932373|7321873|FG008|Overall Study|Progressive disease|1
4512158|NCT00932373|7321874|FG009|Overall Study|Progressive disease|9
4512159|NCT00932373|7321875|FG010|Overall Study|Progressive disease|2
4512160|NCT00932373|7321865|FG000|Overall Study|Adverse Event|0
4512161|NCT00932373|7321866|FG001|Overall Study|Adverse Event|0
4512162|NCT00932373|7321867|FG002|Overall Study|Adverse Event|0
4512163|NCT00932373|7321868|FG003|Overall Study|Adverse Event|0
4512164|NCT00932373|7321869|FG004|Overall Study|Adverse Event|2
4512165|NCT00932373|7321870|FG005|Overall Study|Adverse Event|1
4512166|NCT00932373|7321871|FG006|Overall Study|Adverse Event|0
4512167|NCT00932373|7321872|FG007|Overall Study|Adverse Event|1
4512168|NCT00932373|7321873|FG008|Overall Study|Adverse Event|0
4512169|NCT00932373|7321874|FG009|Overall Study|Adverse Event|2
4512170|NCT00932373|7321875|FG010|Overall Study|Adverse Event|1
4512171|NCT00932373|7321865|FG000|Overall Study|Physician Decision|0
4512172|NCT00932373|7321866|FG001|Overall Study|Physician Decision|0
4512173|NCT00932373|7321867|FG002|Overall Study|Physician Decision|1
4512174|NCT00932373|7321868|FG003|Overall Study|Physician Decision|0
4512175|NCT00932373|7321869|FG004|Overall Study|Physician Decision|2
4512176|NCT00932373|7321870|FG005|Overall Study|Physician Decision|0
4512177|NCT00932373|7321871|FG006|Overall Study|Physician Decision|0
4422061|NCT00338728|7203549|FG000|Overall Study|Screen Failure|14
4422062|NCT00338741|7203555|FG000|Overall Study|Lost to Follow-up|2
4422063|NCT00338741|7203556|FG001|Overall Study|Lost to Follow-up|0
4422064|NCT00338806|7203564|FG000|Acute Phase|Withdrawal by Subject|0
4422065|NCT00338806|7203565|FG001|Acute Phase|Withdrawal by Subject|1
4422066|NCT00338806|7203564|FG000|Follow-up|Lost to Follow-up|1
4422067|NCT00338806|7203565|FG001|Follow-up|Lost to Follow-up|3
4422068|NCT00338884|7203573|FG000|Overall Study|Objective Disease Progression or Relapse|44
4422069|NCT00338884|7203573|FG000|Overall Study|Adverse Event|14
4422070|NCT00338884|7203573|FG000|Overall Study|Death|8
4422071|NCT00338884|7203573|FG000|Overall Study|Other|4
4422072|NCT00338884|7203573|FG000|Overall Study|Global Deterioration of Health Status|3
4422073|NCT00338884|7203573|FG000|Overall Study|Withdrawal by Subject|3
4422074|NCT00338884|7203573|FG000|Overall Study|Lost to Follow-up|1
4422075|NCT00338884|7203573|FG000|Overall Study|Randomized But Did Not Receive Treatment|1
4422076|NCT00338949|7203579|FG000|Subject Screening|Screen failures|11
4422077|NCT00338949|7203580|FG001|Subject Screening|Screen failures|11
4422078|NCT00338949|7203579|FG000|Randomization|Withdrawal by Subject|1
4422079|NCT00338949|7203580|FG001|Randomization|Withdrawal by Subject|0
4422080|NCT00338949|7203579|FG000|Randomization|Adverse Event|0
4422081|NCT00338949|7203580|FG001|Randomization|Adverse Event|5
4422082|NCT00338962|7203590|FG000|Overall Study|Lost to Follow-up|3
4422083|NCT00338962|7203591|FG001|Overall Study|Lost to Follow-up|3
4422084|NCT00338962|7203592|FG002|Overall Study|Lost to Follow-up|2
4422085|NCT00338962|7203593|FG003|Overall Study|Lost to Follow-up|3
4422086|NCT00338962|7203590|FG000|Overall Study|Withdrawal by Subject|1
4422087|NCT00338962|7203591|FG001|Overall Study|Withdrawal by Subject|0
4422088|NCT00338962|7203592|FG002|Overall Study|Withdrawal by Subject|0
4422089|NCT00338962|7203593|FG003|Overall Study|Withdrawal by Subject|0
4422090|NCT00338962|7203590|FG000|Overall Study|No Transportation|2
4422091|NCT00338962|7203591|FG001|Overall Study|No Transportation|0
4422092|NCT00338962|7203592|FG002|Overall Study|No Transportation|0
4422093|NCT00338962|7203593|FG003|Overall Study|No Transportation|0
4422094|NCT00338962|7203590|FG000|Overall Study|Time Constraint|2
4422095|NCT00338962|7203591|FG001|Overall Study|Time Constraint|0
4422096|NCT00338962|7203592|FG002|Overall Study|Time Constraint|0
4422097|NCT00338962|7203593|FG003|Overall Study|Time Constraint|0
4422098|NCT00338962|7203590|FG000|Overall Study|Moved|0
4422099|NCT00338962|7203591|FG001|Overall Study|Moved|1
4422100|NCT00338962|7203592|FG002|Overall Study|Moved|0
4422101|NCT00338962|7203593|FG003|Overall Study|Moved|0
4422102|NCT00338962|7203590|FG000|Overall Study|Adverse Event|0
4422103|NCT00338962|7203591|FG001|Overall Study|Adverse Event|0
4422104|NCT00338962|7203592|FG002|Overall Study|Adverse Event|2
4422105|NCT00338962|7203593|FG003|Overall Study|Adverse Event|0
4422106|NCT00338962|7203590|FG000|Overall Study|Poor Compliance|0
4422107|NCT00338962|7203591|FG001|Overall Study|Poor Compliance|0
4422108|NCT00338962|7203592|FG002|Overall Study|Poor Compliance|2
4422109|NCT00338962|7203593|FG003|Overall Study|Poor Compliance|0
4422110|NCT00339040|7203610|FG000|Stage I|Not able to attend clinic|1
4422111|NCT00339040|7203611|FG001|Stage I|Not able to attend clinic|0
4422112|NCT00339040|7203610|FG000|Stage I|Protocol Violation|1
4422113|NCT00339040|7203611|FG001|Stage I|Protocol Violation|1
4422114|NCT00339040|7203610|FG000|Stage II|Lost to Follow-up|3
4422115|NCT00339040|7203611|FG001|Stage II|Lost to Follow-up|0
4422116|NCT00339040|7203610|FG000|Stage II|Withdrawal by Subject|1
4422117|NCT00339040|7203611|FG001|Stage II|Withdrawal by Subject|2
4422118|NCT00339040|7203610|FG000|Stage II|Protocol Violation|3
4422119|NCT00339040|7203611|FG001|Stage II|Protocol Violation|0
4422120|NCT00339040|7203610|FG000|Stage II|Not able to attend clinic|1
4422121|NCT00339040|7203611|FG001|Stage II|Not able to attend clinic|0
4422122|NCT00339040|7203610|FG000|Stage II|Site closing|2
4422123|NCT00339040|7203611|FG001|Stage II|Site closing|0
4422124|NCT00339144|7203641|FG000|Overall Study|Disease progression|5
4422125|NCT00339144|7203642|FG001|Overall Study|Disease progression|2
4422126|NCT00339144|7203643|FG002|Overall Study|Disease progression|2
4422127|NCT00339144|7203641|FG000|Overall Study|Study drug toxicity|3
4422128|NCT00339144|7203642|FG001|Overall Study|Study drug toxicity|1
4422129|NCT00339144|7203643|FG002|Overall Study|Study drug toxicity|1
4422130|NCT00339144|7203641|FG000|Overall Study|Participant's request to discontinuation|1
4422131|NCT00339144|7203642|FG001|Overall Study|Participant's request to discontinuation|0
4422132|NCT00339144|7203643|FG002|Overall Study|Participant's request to discontinuation|1
4422133|NCT00339183|7203654|FG000|Overall Study|Adverse Event|5
4422134|NCT00339183|7203655|FG001|Overall Study|Adverse Event|3
4422135|NCT00339183|7203654|FG000|Overall Study|Withdrawal by Subject|16
4422136|NCT00339183|7203655|FG001|Overall Study|Withdrawal by Subject|19
4422137|NCT00339183|7203654|FG000|Overall Study|Physician Decision|2
4422138|NCT00339183|7203655|FG001|Overall Study|Physician Decision|4
4422139|NCT00339183|7203654|FG000|Overall Study|Lost to Follow-up|17
4422140|NCT00339183|7203655|FG001|Overall Study|Lost to Follow-up|17
4422141|NCT00339183|7203654|FG000|Overall Study|Protocol-specified criteria|12
4422142|NCT00339183|7203655|FG001|Overall Study|Protocol-specified criteria|8
4422143|NCT00339183|7203654|FG000|Overall Study|Missing reason|3
4422144|NCT00339183|7203655|FG001|Overall Study|Missing reason|1
4422145|NCT00339183|7203654|FG000|Overall Study|Other|46
4422146|NCT00339183|7203655|FG001|Overall Study|Other|40
4422147|NCT00339183|7203654|FG000|Overall Study|Ongoing|20
4422148|NCT00339183|7203655|FG001|Overall Study|Ongoing|13
4422149|NCT00339833|7203667|FG000|Overall Study|Withdrawal by Subject|1
4422150|NCT00339833|7203668|FG001|Overall Study|Withdrawal by Subject|2
4422151|NCT00339833|7203667|FG000|Overall Study|toothache|0
4422152|NCT00339833|7203668|FG001|Overall Study|toothache|1
4422153|NCT00339833|7203667|FG000|Overall Study|indigestion|0
4422154|NCT00339833|7203668|FG001|Overall Study|indigestion|1
4422155|NCT00339833|7203667|FG000|Overall Study|Chest pain|0
4422156|NCT00339833|7203668|FG001|Overall Study|Chest pain|1
4422157|NCT00339833|7203667|FG000|Overall Study|minor infection|0
4422158|NCT00339833|7203668|FG001|Overall Study|minor infection|1
4422159|NCT00339833|7203667|FG000|Overall Study|Poor venous access|2
4422160|NCT00339833|7203668|FG001|Overall Study|Poor venous access|2
4422161|NCT00339833|7203667|FG000|Overall Study|anaemia or excess drop in glycaemia|2
4422162|NCT00339833|7203668|FG001|Overall Study|anaemia or excess drop in glycaemia|0
4422163|NCT00339833|7203667|FG000|Overall Study|Error in data records|1
4422164|NCT00339833|7203668|FG001|Overall Study|Error in data records|0
4422165|NCT00340678|7203687|FG000|Overall Study|Lost to Follow-up|1
4422166|NCT00340678|7203688|FG001|Overall Study|Lost to Follow-up|0
4422167|NCT00340678|7203689|FG002|Overall Study|Lost to Follow-up|0
4422168|NCT00340678|7203690|FG003|Overall Study|Lost to Follow-up|0
4422169|NCT00340704|7203707|FG000|PK Study|Adverse Event|0
4422170|NCT00340704|7203708|FG001|PK Study|Adverse Event|1
4422171|NCT00340704|7203709|FG002|PK Study|Adverse Event|0
4422172|NCT00340704|7203710|FG003|PK Study|Adverse Event|0
4422173|NCT00340704|7203711|FG004|PK Study|Adverse Event|0
4422174|NCT00340704|7203712|FG005|PK Study|Adverse Event|0
4422175|NCT00340704|7203713|FG006|PK Study|Adverse Event|0
4422176|NCT00340704|7203714|FG007|PK Study|Adverse Event|0
4422177|NCT00340704|7203715|FG008|PK Study|Adverse Event|0
4422178|NCT00340704|7203707|FG000|PK Study|Not treated|0
4422179|NCT00340704|7203708|FG001|PK Study|Not treated|0
4422180|NCT00340704|7203709|FG002|PK Study|Not treated|1
4422181|NCT00340704|7203710|FG003|PK Study|Not treated|0
4422182|NCT00340704|7203711|FG004|PK Study|Not treated|0
4422183|NCT00340704|7203712|FG005|PK Study|Not treated|0
4422184|NCT00340704|7203713|FG006|PK Study|Not treated|0
4422185|NCT00340704|7203714|FG007|PK Study|Not treated|0
4422186|NCT00340704|7203715|FG008|PK Study|Not treated|0
4422187|NCT00340704|7203707|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
4422188|NCT00340704|7203708|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
4422189|NCT00340704|7203709|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
4422190|NCT00340704|7203710|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2
4422191|NCT00340704|7203711|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4
4422192|NCT00340704|7203712|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
4422193|NCT00340704|7203713|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
4422194|NCT00340704|7203714|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1
4422195|NCT00340704|7203715|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1
4422196|NCT00340704|7203707|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
4422197|NCT00340704|7203708|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
4422198|NCT00340704|7203709|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
4422199|NCT00340704|7203710|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
4422200|NCT00340704|7203711|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
4422201|NCT00340704|7203712|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1
4422202|NCT00340704|7203713|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
4422203|NCT00340704|7203714|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
4422204|NCT00340704|7203715|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
4422205|NCT00340704|7203707|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
4422206|NCT00340704|7203708|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
4422207|NCT00340704|7203709|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
4422208|NCT00340704|7203710|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
4422209|NCT00340704|7203711|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1
4422210|NCT00340704|7203712|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3
4422211|NCT00340704|7203713|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
4422212|NCT00340704|7203714|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
4422213|NCT00340704|7203715|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
4422214|NCT00340704|7203707|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
4422215|NCT00340704|7203708|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
4422216|NCT00340704|7203709|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
4629590|NCT01874431|7497661|FG002|Overall Study|Protocol Violation|1
4629591|NCT01874431|7497662|FG003|Overall Study|Protocol Violation|0
4629592|NCT01874431|7497663|FG004|Overall Study|Protocol Violation|3
4629593|NCT01874431|7497664|FG005|Overall Study|Protocol Violation|2
4422217|NCT00340704|7203710|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
4422218|NCT00340704|7203711|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
4422219|NCT00340704|7203712|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3
4422220|NCT00340704|7203713|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53
4629594|NCT01874431|7497665|FG006|Overall Study|Protocol Violation|1
4714916|NCT02964234|7642961|FG000|Overall Study|Lost to Follow-up|22
4422221|NCT00340704|7203714|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11
4422222|NCT00340704|7203715|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28
4422223|NCT00340834|7203746|FG000|Core Phase of Study|Adverse Event|26
4422224|NCT00340834|7203747|FG001|Core Phase of Study|Adverse Event|9
4422225|NCT00340834|7203748|FG002|Core Phase of Study|Adverse Event|9
4422226|NCT00340834|7203749|FG003|Core Phase of Study|Adverse Event|0
4422227|NCT00340834|7203750|FG004|Core Phase of Study|Adverse Event|0
4422228|NCT00340834|7203746|FG000|Core Phase of Study|Withdrawal by Subject|11
4422229|NCT00340834|7203747|FG001|Core Phase of Study|Withdrawal by Subject|9
4422230|NCT00340834|7203748|FG002|Core Phase of Study|Withdrawal by Subject|16
4422231|NCT00340834|7203749|FG003|Core Phase of Study|Withdrawal by Subject|0
4422232|NCT00340834|7203750|FG004|Core Phase of Study|Withdrawal by Subject|0
4422233|NCT00340834|7203746|FG000|Core Phase of Study|Administrative Problems|6
4422234|NCT00340834|7203747|FG001|Core Phase of Study|Administrative Problems|2
4422235|NCT00340834|7203748|FG002|Core Phase of Study|Administrative Problems|7
4422236|NCT00340834|7203749|FG003|Core Phase of Study|Administrative Problems|0
4422237|NCT00340834|7203750|FG004|Core Phase of Study|Administrative Problems|0
4422238|NCT00340834|7203746|FG000|Core Phase of Study|Lack of Efficacy|3
4422239|NCT00340834|7203747|FG001|Core Phase of Study|Lack of Efficacy|3
4422240|NCT00340834|7203748|FG002|Core Phase of Study|Lack of Efficacy|7
4422241|NCT00340834|7203749|FG003|Core Phase of Study|Lack of Efficacy|0
4422242|NCT00340834|7203750|FG004|Core Phase of Study|Lack of Efficacy|0
4422243|NCT00340834|7203746|FG000|Core Phase of Study|Abnormal laboratory value(s)|4
4422244|NCT00340834|7203747|FG001|Core Phase of Study|Abnormal laboratory value(s)|6
4422245|NCT00340834|7203748|FG002|Core Phase of Study|Abnormal laboratory value(s)|1
4422246|NCT00340834|7203749|FG003|Core Phase of Study|Abnormal laboratory value(s)|0
4422247|NCT00340834|7203750|FG004|Core Phase of Study|Abnormal laboratory value(s)|0
4422248|NCT00340834|7203746|FG000|Core Phase of Study|Abnormal test procedure result(s)|4
4422249|NCT00340834|7203747|FG001|Core Phase of Study|Abnormal test procedure result(s)|3
4422250|NCT00340834|7203748|FG002|Core Phase of Study|Abnormal test procedure result(s)|3
4422251|NCT00340834|7203749|FG003|Core Phase of Study|Abnormal test procedure result(s)|0
4422252|NCT00340834|7203750|FG004|Core Phase of Study|Abnormal test procedure result(s)|0
4422253|NCT00340834|7203746|FG000|Core Phase of Study|Lost to Follow-up|1
4714917|NCT02964234|7642962|FG001|Overall Study|Lost to Follow-up|13
4714918|NCT02964247|7642970|FG000|Overall Study|Lost to Follow-up|2
4714919|NCT02964247|7642971|FG001|Overall Study|Lost to Follow-up|0
4714920|NCT02964247|7642970|FG000|Overall Study|Withdrawal by Subject|1
4714921|NCT02964247|7642971|FG001|Overall Study|Withdrawal by Subject|2
4714922|NCT02964312|7642977|FG000|Overall Study|Lost to Follow-up|28
4714923|NCT02964312|7642977|FG000|Overall Study|Withdrawal by Subject|11
4714924|NCT02964312|7642977|FG000|Overall Study|Lack of Efficacy|10
4422254|NCT00340834|7203747|FG001|Core Phase of Study|Lost to Follow-up|1
4422255|NCT00340834|7203748|FG002|Core Phase of Study|Lost to Follow-up|4
4422256|NCT00340834|7203749|FG003|Core Phase of Study|Lost to Follow-up|0
4422257|NCT00340834|7203750|FG004|Core Phase of Study|Lost to Follow-up|0
4422258|NCT00340834|7203746|FG000|Core Phase of Study|Death|2
4422259|NCT00340834|7203747|FG001|Core Phase of Study|Death|0
4422260|NCT00340834|7203748|FG002|Core Phase of Study|Death|0
4422261|NCT00340834|7203749|FG003|Core Phase of Study|Death|0
4422262|NCT00340834|7203750|FG004|Core Phase of Study|Death|0
4422263|NCT00340834|7203746|FG000|Core Phase of Study|Protocol Violation|0
4422264|NCT00340834|7203747|FG001|Core Phase of Study|Protocol Violation|0
4422265|NCT00340834|7203748|FG002|Core Phase of Study|Protocol Violation|2
4422266|NCT00340834|7203749|FG003|Core Phase of Study|Protocol Violation|0
4422267|NCT00340834|7203750|FG004|Core Phase of Study|Protocol Violation|0
4422268|NCT00340834|7203746|FG000|Extension Phase of Study|Subject did not receive study drug|0
4422269|NCT00340834|7203747|FG001|Extension Phase of Study|Subject did not receive study drug|1
4422270|NCT00340834|7203748|FG002|Extension Phase of Study|Subject did not receive study drug|0
4422271|NCT00340834|7203749|FG003|Extension Phase of Study|Subject did not receive study drug|2
4422272|NCT00340834|7203750|FG004|Extension Phase of Study|Subject did not receive study drug|0
4422273|NCT00340834|7203746|FG000|Extension Phase of Study|Subject withdrew consent|26
4422274|NCT00340834|7203747|FG001|Extension Phase of Study|Subject withdrew consent|31
4422275|NCT00340834|7203748|FG002|Extension Phase of Study|Subject withdrew consent|0
4422276|NCT00340834|7203749|FG003|Extension Phase of Study|Subject withdrew consent|12
4422277|NCT00340834|7203750|FG004|Extension Phase of Study|Subject withdrew consent|15
4422278|NCT00340834|7203746|FG000|Extension Phase of Study|Adverse Event|21
4422279|NCT00340834|7203747|FG001|Extension Phase of Study|Adverse Event|22
4422280|NCT00340834|7203748|FG002|Extension Phase of Study|Adverse Event|0
4422281|NCT00340834|7203749|FG003|Extension Phase of Study|Adverse Event|19
4422282|NCT00340834|7203750|FG004|Extension Phase of Study|Adverse Event|7
4422283|NCT00340834|7203746|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14
4422284|NCT00340834|7203747|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13
4422285|NCT00340834|7203748|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0
4422286|NCT00340834|7203749|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13
4714925|NCT02964312|7642977|FG000|Overall Study|Did not consent to long-term FU|14
4714926|NCT02964312|7642977|FG000|Overall Study|Death|1
4422287|NCT00340834|7203750|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4
4422288|NCT00340834|7203746|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13
4422289|NCT00340834|7203747|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7
4422290|NCT00340834|7203748|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0
4422291|NCT00340834|7203749|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4
4422292|NCT00340834|7203750|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9
4422293|NCT00340834|7203746|FG000|Extension Phase of Study|Lost to Follow-up|1
4422294|NCT00340834|7203747|FG001|Extension Phase of Study|Lost to Follow-up|1
4422295|NCT00340834|7203748|FG002|Extension Phase of Study|Lost to Follow-up|0
4422296|NCT00340834|7203749|FG003|Extension Phase of Study|Lost to Follow-up|2
4422297|NCT00340834|7203750|FG004|Extension Phase of Study|Lost to Follow-up|3
4422298|NCT00340834|7203746|FG000|Extension Phase of Study|Subject no longer requires study drug|4
4422299|NCT00340834|7203747|FG001|Extension Phase of Study|Subject no longer requires study drug|0
4422300|NCT00340834|7203748|FG002|Extension Phase of Study|Subject no longer requires study drug|0
4422301|NCT00340834|7203749|FG003|Extension Phase of Study|Subject no longer requires study drug|0
4422302|NCT00340834|7203750|FG004|Extension Phase of Study|Subject no longer requires study drug|2
4422303|NCT00340834|7203746|FG000|Extension Phase of Study|Administrative problems|3
4422304|NCT00340834|7203747|FG001|Extension Phase of Study|Administrative problems|0
4422305|NCT00340834|7203748|FG002|Extension Phase of Study|Administrative problems|0
4422306|NCT00340834|7203749|FG003|Extension Phase of Study|Administrative problems|1
4422307|NCT00340834|7203750|FG004|Extension Phase of Study|Administrative problems|1
4422308|NCT00340834|7203746|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0
4422309|NCT00340834|7203747|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1
4422310|NCT00340834|7203748|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0
4422311|NCT00340834|7203749|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0
4422312|NCT00340834|7203750|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2
4422313|NCT00340834|7203746|FG000|Extension Phase of Study|Protocol Violation|3
4422314|NCT00340834|7203747|FG001|Extension Phase of Study|Protocol Violation|0
4422315|NCT00340834|7203748|FG002|Extension Phase of Study|Protocol Violation|0
4422316|NCT00340834|7203749|FG003|Extension Phase of Study|Protocol Violation|0
4422317|NCT00340834|7203750|FG004|Extension Phase of Study|Protocol Violation|0
4422318|NCT00340834|7203746|FG000|Extension Phase of Study|Death|0
4422319|NCT00340834|7203747|FG001|Extension Phase of Study|Death|0
4422320|NCT00340834|7203748|FG002|Extension Phase of Study|Death|0
4422321|NCT00340834|7203749|FG003|Extension Phase of Study|Death|0
4422322|NCT00340834|7203750|FG004|Extension Phase of Study|Death|1
4422323|NCT00342628|7203799|FG000|Overall Study|Withdrawal by Subject|19
4422324|NCT00342628|7203800|FG001|Overall Study|Withdrawal by Subject|19
4422325|NCT00342628|7203801|FG002|Overall Study|Withdrawal by Subject|18
4422326|NCT00342628|7203799|FG000|Overall Study|Death|1
4422327|NCT00342628|7203800|FG001|Overall Study|Death|1
4422328|NCT00342628|7203801|FG002|Overall Study|Death|0
4422329|NCT00342628|7203799|FG000|Overall Study|moved residence|0
4422330|NCT00342628|7203800|FG001|Overall Study|moved residence|1
4422331|NCT00342628|7203801|FG002|Overall Study|moved residence|1
4422332|NCT00343252|7203820|FG000|6 Months (All Treated Participants)|Adverse Event|17
4422333|NCT00343252|7203821|FG001|6 Months (All Treated Participants)|Adverse Event|11
4422334|NCT00343252|7203820|FG000|6 Months (All Treated Participants)|Death|0
4422335|NCT00343252|7203821|FG001|6 Months (All Treated Participants)|Death|2
4422336|NCT00343252|7203820|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10
4422337|NCT00343252|7203821|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8
4422338|NCT00343252|7203820|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0
4422339|NCT00343252|7203821|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1
4422340|NCT00343252|7203820|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0
4422341|NCT00343252|7203821|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4
4422342|NCT00343252|7203820|FG000|6 Months (All Treated Participants)|Physician Decision|1
4422343|NCT00343252|7203821|FG001|6 Months (All Treated Participants)|Physician Decision|3
4422344|NCT00343252|7203820|FG000|6 Months (All Treated Participants)|Protocol Violation|2
4422345|NCT00343252|7203821|FG001|6 Months (All Treated Participants)|Protocol Violation|2
4422346|NCT00343252|7203820|FG000|6 Months (All Treated Participants)|Sponsor Decision|7
4422347|NCT00343252|7203821|FG001|6 Months (All Treated Participants)|Sponsor Decision|4
4422348|NCT00343252|7203820|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19
4422349|NCT00343252|7203821|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9
4422350|NCT00343252|7203820|FG000|12 Months (All Treated Participants)|Adverse Event|22
4422351|NCT00343252|7203821|FG001|12 Months (All Treated Participants)|Adverse Event|20
4422352|NCT00343252|7203820|FG000|12 Months (All Treated Participants)|Death|3
4422353|NCT00343252|7203821|FG001|12 Months (All Treated Participants)|Death|3
4422354|NCT00343252|7203820|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10
4422355|NCT00343252|7203821|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10
4422356|NCT00343252|7203820|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1
4422357|NCT00343252|7203821|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1
4422358|NCT00343252|7203820|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1
4422359|NCT00343252|7203821|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5
4422360|NCT00343252|7203820|FG000|12 Months (All Treated Participants)|Physician Decision|4
4422361|NCT00343252|7203821|FG001|12 Months (All Treated Participants)|Physician Decision|5
4422362|NCT00343252|7203820|FG000|12 Months (All Treated Participants)|Protocol Violation|3
4422363|NCT00343252|7203821|FG001|12 Months (All Treated Participants)|Protocol Violation|2
4422364|NCT00343252|7203820|FG000|12 Months (All Treated Participants)|Sponsor Decision|9
4422365|NCT00343252|7203821|FG001|12 Months (All Treated Participants)|Sponsor Decision|6
4422366|NCT00343252|7203820|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33
4422367|NCT00343252|7203821|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17
4422368|NCT00343252|7203820|FG000|18 Months (All Treated Participants)|Adverse Event|31
4422369|NCT00343252|7203821|FG001|18 Months (All Treated Participants)|Adverse Event|23
4422370|NCT00343252|7203820|FG000|18 Months (All Treated Participants)|Death|4
4422371|NCT00343252|7203821|FG001|18 Months (All Treated Participants)|Death|5
4422372|NCT00343252|7203820|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11
4422373|NCT00343252|7203821|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10
4422374|NCT00343252|7203820|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1
4422375|NCT00343252|7203821|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1
4422376|NCT00343252|7203820|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3
4422377|NCT00343252|7203821|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7
4422378|NCT00343252|7203820|FG000|18 Months (All Treated Participants)|Physician Decision|4
4422379|NCT00343252|7203821|FG001|18 Months (All Treated Participants)|Physician Decision|7
4422380|NCT00343252|7203820|FG000|18 Months (All Treated Participants)|Protocol Violation|3
4422381|NCT00343252|7203821|FG001|18 Months (All Treated Participants)|Protocol Violation|3
4422382|NCT00343252|7203820|FG000|18 Months (All Treated Participants)|Sponsor Decision|8
4422383|NCT00343252|7203821|FG001|18 Months (All Treated Participants)|Sponsor Decision|5
4422384|NCT00343252|7203820|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36
4422385|NCT00343252|7203821|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20
4422386|NCT00343291|7203829|FG000|Overall Study|Adverse Event|13
4422387|NCT00343291|7203830|FG001|Overall Study|Adverse Event|13
4422388|NCT00343291|7203829|FG000|Overall Study|Death|3
4422389|NCT00343291|7203830|FG001|Overall Study|Death|2
4422390|NCT00343291|7203829|FG000|Overall Study|Progressive disease|33
4422391|NCT00343291|7203830|FG001|Overall Study|Progressive disease|34
4422392|NCT00343291|7203829|FG000|Overall Study|Withdrawal by Subject|0
4422393|NCT00343291|7203830|FG001|Overall Study|Withdrawal by Subject|2
4422394|NCT00343291|7203829|FG000|Overall Study|Other|8
4422395|NCT00343291|7203830|FG001|Overall Study|Other|5
4422396|NCT00343382|7203839|FG000|Overall Study|Adverse Event|2
4422397|NCT00343382|7203840|FG001|Overall Study|Adverse Event|10
4422398|NCT00343382|7203841|FG002|Overall Study|Adverse Event|7
4422399|NCT00343382|7203839|FG000|Overall Study|Withdrawal by Subject|1
4422400|NCT00343382|7203840|FG001|Overall Study|Withdrawal by Subject|2
4422401|NCT00343382|7203841|FG002|Overall Study|Withdrawal by Subject|6
4422402|NCT00343382|7203839|FG000|Overall Study|Other Reason Not Specified|1
4422403|NCT00343382|7203840|FG001|Overall Study|Other Reason Not Specified|2
4422404|NCT00343382|7203841|FG002|Overall Study|Other Reason Not Specified|4
4422405|NCT00343512|7203875|FG000|Overall Study|Withdrawal by Subject|2
4422406|NCT00343642|7203999|FG000|Overall Study|Lost to Follow-up|0
4422407|NCT00343642|7204000|FG001|Overall Study|Lost to Follow-up|1
4422408|NCT00343642|7204001|FG002|Overall Study|Lost to Follow-up|0
4422409|NCT00343642|7203999|FG000|Overall Study|Pregnancy|1
4422410|NCT00343642|7204000|FG001|Overall Study|Pregnancy|0
4422411|NCT00343642|7204001|FG002|Overall Study|Pregnancy|2
4422412|NCT00343642|7203999|FG000|Overall Study|Withdrawal by Subject|2
4422413|NCT00343642|7204000|FG001|Overall Study|Withdrawal by Subject|3
4422414|NCT00343642|7204001|FG002|Overall Study|Withdrawal by Subject|4
4422415|NCT00343642|7203999|FG000|Overall Study|Adverse Event|0
4422416|NCT00343642|7204000|FG001|Overall Study|Adverse Event|0
4422417|NCT00343642|7204001|FG002|Overall Study|Adverse Event|1
4422418|NCT00343642|7203999|FG000|Overall Study|Flare up|6
4422419|NCT00343642|7204000|FG001|Overall Study|Flare up|4
4422420|NCT00343642|7204001|FG002|Overall Study|Flare up|0
4422421|NCT00343889|7204030|FG000|Overall Study|Lost to Follow-up|2
4422422|NCT00343889|7204031|FG001|Overall Study|Lost to Follow-up|0
4422423|NCT00343889|7204030|FG000|Overall Study|Withdrawal by Subject|0
4422424|NCT00343889|7204031|FG001|Overall Study|Withdrawal by Subject|1
4422425|NCT00343889|7204030|FG000|Overall Study|Protocol Violation|1
4422426|NCT00343889|7204031|FG001|Overall Study|Protocol Violation|0
4422427|NCT00343915|7204039|FG000|Primary Study|Withdrawal by Subject|1
4422428|NCT00343915|7204040|FG001|Primary Study|Withdrawal by Subject|0
4422429|NCT00343915|7204039|FG000|Primary Study|Lost to Follow-up|2
4422430|NCT00343915|7204040|FG001|Primary Study|Lost to Follow-up|3
4422431|NCT00343915|7204039|FG000|Primary Study|Other|1
4422432|NCT00343915|7204040|FG001|Primary Study|Other|0
4629595|NCT01874431|7497666|FG007|Overall Study|Protocol Violation|1
4629596|NCT01874431|7497659|FG000|Overall Study|Non-compliance|0
4422433|NCT00344032|7204051|FG000|Overall Study|Adverse Event|0
4422434|NCT00344032|7204052|FG001|Overall Study|Adverse Event|1
4422435|NCT00344032|7204051|FG000|Overall Study|Withdrawal by Subject|6
4422436|NCT00344032|7204052|FG001|Overall Study|Withdrawal by Subject|2
4629597|NCT01874431|7497660|FG001|Overall Study|Non-compliance|0
4422437|NCT00344032|7204051|FG000|Overall Study|Lost to Follow-up|4
4422438|NCT00344032|7204052|FG001|Overall Study|Lost to Follow-up|6
4422439|NCT00344032|7204051|FG000|Overall Study|Physician Decision|4
4422440|NCT00344032|7204052|FG001|Overall Study|Physician Decision|1
4422441|NCT00344305|7204069|FG000|Overall Study|Lost to Follow-up|2
4422442|NCT00344305|7204070|FG001|Overall Study|Lost to Follow-up|0
4422443|NCT00344305|7204069|FG000|Overall Study|Participant was not contacted in window|0
4422444|NCT00344305|7204070|FG001|Overall Study|Participant was not contacted in window|1
4422445|NCT00344318|7204081|FG000|Overall Study|Adverse Event|0
4422446|NCT00344318|7204082|FG001|Overall Study|Adverse Event|3
4422447|NCT00344318|7204083|FG002|Overall Study|Adverse Event|0
4422448|NCT00344318|7204084|FG003|Overall Study|Adverse Event|1
4422449|NCT00344318|7204081|FG000|Overall Study|Withdrawal by Subject|2
4422450|NCT00344318|7204082|FG001|Overall Study|Withdrawal by Subject|2
4422451|NCT00344318|7204083|FG002|Overall Study|Withdrawal by Subject|0
4422452|NCT00344318|7204084|FG003|Overall Study|Withdrawal by Subject|2
4422453|NCT00344318|7204081|FG000|Overall Study|Lost to Follow-up|2
4422454|NCT00344318|7204082|FG001|Overall Study|Lost to Follow-up|0
4422455|NCT00344318|7204083|FG002|Overall Study|Lost to Follow-up|1
4422456|NCT00344318|7204084|FG003|Overall Study|Lost to Follow-up|0
4422457|NCT00344448|7204107|FG000|Screening|Withdrawal by Subject|0
4422458|NCT00344448|7204108|FG001|Screening|Withdrawal by Subject|1
4422459|NCT00344448|7204107|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1
4422460|NCT00344448|7204108|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0
4422461|NCT00344448|7204107|FG000|Double Blind, Placebo Controlled|Study terminated|1
4422462|NCT00344448|7204108|FG001|Double Blind, Placebo Controlled|Study terminated|0
4422463|NCT00344448|7204107|FG000|Open Label|Withdrawal by Subject|1
4422464|NCT00344448|7204108|FG001|Open Label|Withdrawal by Subject|1
4422465|NCT00344448|7204107|FG000|Open Label|Study terminated|1
4422466|NCT00344448|7204108|FG001|Open Label|Study terminated|0
4422467|NCT00344461|7204114|FG000|Overall Study|Adverse Event|6
4422468|NCT00344461|7204114|FG000|Overall Study|Death|1
4422469|NCT00344461|7204114|FG000|Overall Study|Lack of Efficacy|2
4422470|NCT00344461|7204114|FG000|Overall Study|Lost to Follow-up|2
4422471|NCT00344461|7204114|FG000|Overall Study|Physician Decision|2
4422472|NCT00344461|7204114|FG000|Overall Study|Protocol Violation|6
4422473|NCT00344461|7204114|FG000|Overall Study|Withdrawal by Subject|2
4422474|NCT00344500|7204121|FG000|Overall Study|Adverse Event|6
4422475|NCT00344500|7204122|FG001|Overall Study|Adverse Event|2
4422476|NCT00344500|7204123|FG002|Overall Study|Adverse Event|0
4422477|NCT00344500|7204121|FG000|Overall Study|Lost to Follow-up|5
4422478|NCT00344500|7204122|FG001|Overall Study|Lost to Follow-up|13
4422479|NCT00344500|7204123|FG002|Overall Study|Lost to Follow-up|1
4422480|NCT00344500|7204121|FG000|Overall Study|Withdrawal by Subject|7
4422481|NCT00344500|7204122|FG001|Overall Study|Withdrawal by Subject|10
4422482|NCT00344500|7204123|FG002|Overall Study|Withdrawal by Subject|0
4422483|NCT00344500|7204121|FG000|Overall Study|Protocol Violation|4
4422484|NCT00344500|7204122|FG001|Overall Study|Protocol Violation|7
4422485|NCT00344500|7204123|FG002|Overall Study|Protocol Violation|1
4422486|NCT00344500|7204121|FG000|Overall Study|Not Noted|1
4422487|NCT00344500|7204122|FG001|Overall Study|Not Noted|3
4422488|NCT00344500|7204123|FG002|Overall Study|Not Noted|0
4422489|NCT00344773|7204139|FG000|Overall Study|Adverse Event|2
4629598|NCT01874431|7497661|FG002|Overall Study|Non-compliance|0
4629599|NCT01874431|7497662|FG003|Overall Study|Non-compliance|0
4629600|NCT01874431|7497663|FG004|Overall Study|Non-compliance|1
4629601|NCT01874431|7497664|FG005|Overall Study|Non-compliance|0
4629602|NCT01874431|7497665|FG006|Overall Study|Non-compliance|1
4629603|NCT01874431|7497666|FG007|Overall Study|Non-compliance|0
4629604|NCT01874431|7497659|FG000|Overall Study|Logistical difficulties|0
4629605|NCT01874431|7497660|FG001|Overall Study|Logistical difficulties|0
4629606|NCT01874431|7497661|FG002|Overall Study|Logistical difficulties|0
4629607|NCT01874431|7497662|FG003|Overall Study|Logistical difficulties|0
4422490|NCT00344773|7204139|FG000|Overall Study|Objective Disease Progression|16
4422491|NCT00344773|7204139|FG000|Overall Study|Withdrawal by Subject|1
4422492|NCT00344773|7204139|FG000|Overall Study|Not Eligible for the study|2
4422493|NCT00344968|7204146|FG000|Overall Study|Adverse Event|5
4422494|NCT00344968|7204147|FG001|Overall Study|Adverse Event|4
4422495|NCT00344968|7204148|FG002|Overall Study|Adverse Event|15
4422496|NCT00344968|7204146|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3
4422497|NCT00344968|7204147|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0
4422498|NCT00344968|7204148|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1
4422499|NCT00344968|7204146|FG000|Overall Study|Protocol Violation|2
4422500|NCT00344968|7204147|FG001|Overall Study|Protocol Violation|2
4422501|NCT00344968|7204148|FG002|Overall Study|Protocol Violation|5
4422502|NCT00344968|7204146|FG000|Overall Study|Withdrawal by Subject|14
4422503|NCT00344968|7204147|FG001|Overall Study|Withdrawal by Subject|31
4422504|NCT00344968|7204148|FG002|Overall Study|Withdrawal by Subject|27
4422505|NCT00344968|7204146|FG000|Overall Study|Lost to Follow-up|24
4422506|NCT00344968|7204147|FG001|Overall Study|Lost to Follow-up|37
4422507|NCT00344968|7204148|FG002|Overall Study|Lost to Follow-up|37
4422508|NCT00344968|7204146|FG000|Overall Study|Death|11
4422509|NCT00344968|7204147|FG001|Overall Study|Death|27
4629608|NCT01874431|7497663|FG004|Overall Study|Logistical difficulties|0
4629609|NCT01874431|7497664|FG005|Overall Study|Logistical difficulties|0
4422510|NCT00344968|7204148|FG002|Overall Study|Death|31
4422511|NCT00344968|7204146|FG000|Overall Study|Other|0
4422512|NCT00344968|7204147|FG001|Overall Study|Other|1
4422513|NCT00344968|7204148|FG002|Overall Study|Other|0
4422514|NCT00345046|7204169|FG000|Overall Study|Protocol Violation|1
4422515|NCT00345046|7204170|FG001|Overall Study|Protocol Violation|1
4422516|NCT00345046|7204171|FG002|Overall Study|Protocol Violation|2
4422517|NCT00345293|7204207|FG000|Overall Study|Unable to access line for sample|1
4422518|NCT00345293|7204208|FG001|Overall Study|Unable to access line for sample|0
4422519|NCT00345293|7204207|FG000|Overall Study|Withdrawal by Subject|1
4422520|NCT00345293|7204208|FG001|Overall Study|Withdrawal by Subject|0
4422521|NCT00345397|7204243|FG000|Overall Study|Death|1
4422522|NCT00345540|7204248|FG000|Overall Study|Withdrawal by Subject|1
4422523|NCT00345579|7204254|FG000|Overall Study|Adverse Event|9
4422524|NCT00345579|7204255|FG001|Overall Study|Adverse Event|6
4422525|NCT00345579|7204254|FG000|Overall Study|Protocol Violation|14
4422526|NCT00345579|7204255|FG001|Overall Study|Protocol Violation|5
4422527|NCT00345579|7204254|FG000|Overall Study|Withdrawal by Subject|50
4422528|NCT00345579|7204255|FG001|Overall Study|Withdrawal by Subject|17
4422529|NCT00345579|7204254|FG000|Overall Study|Lost to Follow-up|82
4422530|NCT00345579|7204255|FG001|Overall Study|Lost to Follow-up|36
4422531|NCT00345579|7204254|FG000|Overall Study|Other|9
4422532|NCT00345579|7204255|FG001|Overall Study|Other|1
4422533|NCT00345592|7204264|FG000|Overall Study|Death|14
4422534|NCT00345592|7204265|FG001|Overall Study|Death|16
4422535|NCT00345592|7204264|FG000|Overall Study|Withdrawal by Subject|11
4422536|NCT00345592|7204265|FG001|Overall Study|Withdrawal by Subject|8
4422537|NCT00345605|7204271|FG000|Arm 1|Adverse Event|0
4422538|NCT00345605|7204272|FG001|Arm 1|Adverse Event|1
4422539|NCT00345605|7204271|FG000|Arm 2, Opposite Treatment|Adverse Event|1
4422540|NCT00345605|7204272|FG001|Arm 2, Opposite Treatment|Adverse Event|0
4422541|NCT00345631|7204283|FG000|Overall Study|Withdrawal by Subject|1
4422542|NCT00345631|7204284|FG001|Overall Study|Withdrawal by Subject|0
4422543|NCT00345631|7204285|FG002|Overall Study|Withdrawal by Subject|1
4422544|NCT00345631|7204283|FG000|Overall Study|Adverse Event|0
4422545|NCT00345631|7204284|FG001|Overall Study|Adverse Event|1
4422546|NCT00345631|7204285|FG002|Overall Study|Adverse Event|0
4422547|NCT00345631|7204283|FG000|Overall Study|Lost to Follow-up|3
4422548|NCT00345631|7204284|FG001|Overall Study|Lost to Follow-up|7
4422549|NCT00345631|7204285|FG002|Overall Study|Lost to Follow-up|4
4422550|NCT00345631|7204283|FG000|Overall Study|Other reasons|0
4422551|NCT00345631|7204284|FG001|Overall Study|Other reasons|0
4422552|NCT00345631|7204285|FG002|Overall Study|Other reasons|1
4422553|NCT00345683|7204297|FG000|Overall Study|Lost to Follow-up|19
4422554|NCT00345683|7204298|FG001|Overall Study|Lost to Follow-up|7
4422555|NCT00345683|7204297|FG000|Overall Study|Other|6
4422556|NCT00345683|7204298|FG001|Overall Study|Other|2
4422557|NCT00345839|7204306|FG000|Overall Study|Withdrawal by Subject|91
4422558|NCT00345839|7204307|FG001|Overall Study|Withdrawal by Subject|98
4422559|NCT00345839|7204306|FG000|Overall Study|Lost to Follow-up|58
4422560|NCT00345839|7204307|FG001|Overall Study|Lost to Follow-up|61
4422561|NCT00345878|7204336|FG000|Overall Study|Adverse Event|1
4422562|NCT00345878|7204337|FG001|Overall Study|Adverse Event|0
4422563|NCT00345878|7204336|FG000|Overall Study|Lost to Follow-up|2
4422564|NCT00345878|7204337|FG001|Overall Study|Lost to Follow-up|1
4422565|NCT00345878|7204336|FG000|Overall Study|Other|1
4422566|NCT00345878|7204337|FG001|Overall Study|Other|0
4422567|NCT00346034|7204352|FG000|Overall Study|Adverse Event|34
4422568|NCT00346034|7204352|FG000|Overall Study|Lack of Efficacy|8
4422569|NCT00346034|7204352|FG000|Overall Study|Withdrawal by Subject|13
4422570|NCT00346034|7204352|FG000|Overall Study|Patient Stopped Taking Study Drug|1
4422571|NCT00346034|7204352|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1
4422572|NCT00346073|7204358|FG000|Overall Study|Serious Adverse Event|2
4422573|NCT00346073|7204359|FG001|Overall Study|Serious Adverse Event|0
4422574|NCT00346073|7204358|FG000|Overall Study|Lost to Follow-up|39
4422575|NCT00346073|7204359|FG001|Overall Study|Lost to Follow-up|24
4422576|NCT00346151|7204365|FG000|Overall Study|Withdrawal by Subject|3
4771682|NCT01250912|7748496|FG000|Overall Study|Lost to Follow-up|1
4771683|NCT01141712|7748512|FG000|Overall Study|Disease progression|3
4771684|NCT00659646|7748529|FG000|Overall Study|Protocol Violation|12
4771685|NCT00659646|7748530|FG001|Overall Study|Protocol Violation|8
4771686|NCT00659646|7748529|FG000|Overall Study|Adverse Event|1
4771687|NCT00659646|7748530|FG001|Overall Study|Adverse Event|0
4771688|NCT00659646|7748529|FG000|Overall Study|Lost to Follow-up|1
4771689|NCT00659646|7748530|FG001|Overall Study|Lost to Follow-up|0
4771690|NCT00659646|7748529|FG000|Overall Study|protocol noncompliance after randomized|1
4771691|NCT00659646|7748530|FG001|Overall Study|protocol noncompliance after randomized|0
4771692|NCT00567580|7748541|FG000|Overall Study|Protocol Violation|28
4771693|NCT00567580|7748542|FG001|Overall Study|Protocol Violation|24
4771694|NCT00567580|7748543|FG002|Overall Study|Protocol Violation|24
4771695|NCT00477412|7748558|FG000|Overall Study|Death|0
4771696|NCT00477412|7748559|FG001|Overall Study|Death|0
4771697|NCT00477412|7748560|FG002|Overall Study|Death|0
4771698|NCT00477412|7748561|FG003|Overall Study|Death|4
4771699|NCT00477412|7748558|FG000|Overall Study|Lost to Follow-up|0
4771700|NCT00477412|7748559|FG001|Overall Study|Lost to Follow-up|0
4771701|NCT00477412|7748560|FG002|Overall Study|Lost to Follow-up|0
4771702|NCT00477412|7748561|FG003|Overall Study|Lost to Follow-up|1
4771703|NCT00477412|7748558|FG000|Overall Study|Withdrawal by Subject|0
4771704|NCT00477412|7748559|FG001|Overall Study|Withdrawal by Subject|0
4771705|NCT00477412|7748560|FG002|Overall Study|Withdrawal by Subject|0
4771706|NCT00477412|7748561|FG003|Overall Study|Withdrawal by Subject|2
4771707|NCT00477412|7748558|FG000|Overall Study|Second Malignancy|0
4771708|NCT00477412|7748559|FG001|Overall Study|Second Malignancy|0
4771709|NCT00477412|7748560|FG002|Overall Study|Second Malignancy|0
4771710|NCT00477412|7748561|FG003|Overall Study|Second Malignancy|1
4771711|NCT00477412|7748558|FG000|Overall Study|Adverse Event|1
4771712|NCT00477412|7748559|FG001|Overall Study|Adverse Event|0
4771713|NCT00477412|7748560|FG002|Overall Study|Adverse Event|1
4422609|NCT00346216|7204405|FG000|Overall Study|Other|181
4422610|NCT00346216|7204406|FG001|Overall Study|Other|231
4422611|NCT00346216|7204407|FG002|Overall Study|Other|205
4422612|NCT00346216|7204405|FG000|Overall Study|No longer willing to participate|600
4422613|NCT00346216|7204406|FG001|Overall Study|No longer willing to participate|606
4422614|NCT00346216|7204407|FG002|Overall Study|No longer willing to participate|585
4422615|NCT00346216|7204405|FG000|Overall Study|Withdrawal by Subject|661
4422616|NCT00346216|7204406|FG001|Overall Study|Withdrawal by Subject|692
4422617|NCT00346216|7204407|FG002|Overall Study|Withdrawal by Subject|651
4422618|NCT00346216|7204405|FG000|Overall Study|Lost to Follow-up|611
4422619|NCT00346216|7204406|FG001|Overall Study|Lost to Follow-up|588
4422620|NCT00346216|7204407|FG002|Overall Study|Lost to Follow-up|542
4422621|NCT00346216|7204405|FG000|Overall Study|Physician Decision|80
4422622|NCT00346216|7204406|FG001|Overall Study|Physician Decision|76
4422623|NCT00346216|7204407|FG002|Overall Study|Physician Decision|59
4422624|NCT00346216|7204405|FG000|Overall Study|Does not meet entrance criteria|13
4422625|NCT00346216|7204406|FG001|Overall Study|Does not meet entrance criteria|10
4422626|NCT00346216|7204407|FG002|Overall Study|Does not meet entrance criteria|8
4422627|NCT00346216|7204405|FG000|Overall Study|Death|189
4422628|NCT00346216|7204406|FG001|Overall Study|Death|192
4422629|NCT00346216|7204407|FG002|Overall Study|Death|228
4422630|NCT00346216|7204405|FG000|Overall Study|Study terminated by sponsor|11
4422631|NCT00346216|7204406|FG001|Overall Study|Study terminated by sponsor|4
4422632|NCT00346216|7204407|FG002|Overall Study|Study terminated by sponsor|8
4422633|NCT00346216|7204405|FG000|Overall Study|Missing Subject Summary Status|62
4422634|NCT00346216|7204406|FG001|Overall Study|Missing Subject Summary Status|61
4422635|NCT00346216|7204407|FG002|Overall Study|Missing Subject Summary Status|62
4422636|NCT00346268|7204417|FG000|Overall Study|Adverse Event|1
4422637|NCT00346268|7204418|FG001|Overall Study|Adverse Event|0
4422638|NCT00346268|7204417|FG000|Overall Study|Protocol Violation|1
4422639|NCT00346268|7204418|FG001|Overall Study|Protocol Violation|0
4422640|NCT00346268|7204417|FG000|Overall Study|Participant refused|0
4422641|NCT00346268|7204418|FG001|Overall Study|Participant refused|3
4422642|NCT00346333|7204426|FG000|Overall Study|Death|1
4422643|NCT00346333|7204427|FG001|Overall Study|Death|0
4422644|NCT00346333|7204426|FG000|Overall Study|unwilling or unable to continue|4
4422645|NCT00346333|7204427|FG001|Overall Study|unwilling or unable to continue|8
4422646|NCT00346398|7204437|FG000|Overall Study|Lost to Follow-up|3
4422647|NCT00346398|7204438|FG001|Overall Study|Lost to Follow-up|0
4422648|NCT00346398|7204437|FG000|Overall Study|Withdrawal by Subject|0
4422649|NCT00346398|7204438|FG001|Overall Study|Withdrawal by Subject|2
4422650|NCT00346632|7204450|FG000|Overall Study|Progressive Disease|2
4422651|NCT00346632|7204451|FG001|Overall Study|Progressive Disease|2
4422652|NCT00346632|7204452|FG002|Overall Study|Progressive Disease|4
4422653|NCT00346632|7204453|FG003|Overall Study|Progressive Disease|3
4422654|NCT00346632|7204454|FG004|Overall Study|Progressive Disease|3
4422655|NCT00346632|7204455|FG005|Overall Study|Progressive Disease|1
4422656|NCT00346632|7204456|FG006|Overall Study|Progressive Disease|2
4422657|NCT00346632|7204457|FG007|Overall Study|Progressive Disease|2
4422658|NCT00346632|7204458|FG008|Overall Study|Progressive Disease|2
4422659|NCT00346632|7204459|FG009|Overall Study|Progressive Disease|2
4422660|NCT00346632|7204450|FG000|Overall Study|Adverse Event|0
4422661|NCT00346632|7204451|FG001|Overall Study|Adverse Event|0
4422662|NCT00346632|7204452|FG002|Overall Study|Adverse Event|0
4422663|NCT00346632|7204453|FG003|Overall Study|Adverse Event|0
4422664|NCT00346632|7204454|FG004|Overall Study|Adverse Event|1
4422665|NCT00346632|7204455|FG005|Overall Study|Adverse Event|1
4422666|NCT00346632|7204456|FG006|Overall Study|Adverse Event|1
4629610|NCT01874431|7497665|FG006|Overall Study|Logistical difficulties|1
4422667|NCT00346632|7204457|FG007|Overall Study|Adverse Event|0
4422668|NCT00346632|7204458|FG008|Overall Study|Adverse Event|0
4422669|NCT00346632|7204459|FG009|Overall Study|Adverse Event|0
4422670|NCT00346632|7204450|FG000|Overall Study|Death|0
4422671|NCT00346632|7204451|FG001|Overall Study|Death|0
4422672|NCT00346632|7204452|FG002|Overall Study|Death|1
4422673|NCT00346632|7204453|FG003|Overall Study|Death|0
4422674|NCT00346632|7204454|FG004|Overall Study|Death|0
4422675|NCT00346632|7204455|FG005|Overall Study|Death|0
4422676|NCT00346632|7204456|FG006|Overall Study|Death|0
4422677|NCT00346632|7204457|FG007|Overall Study|Death|0
4422678|NCT00346632|7204458|FG008|Overall Study|Death|0
4422679|NCT00346632|7204459|FG009|Overall Study|Death|0
4422680|NCT00346632|7204450|FG000|Overall Study|Protocol Violation|0
4422681|NCT00346632|7204451|FG001|Overall Study|Protocol Violation|0
4771714|NCT00477412|7748561|FG003|Overall Study|Adverse Event|0
4422682|NCT00346632|7204452|FG002|Overall Study|Protocol Violation|0
4422683|NCT00346632|7204453|FG003|Overall Study|Protocol Violation|0
4422684|NCT00346632|7204454|FG004|Overall Study|Protocol Violation|0
4422685|NCT00346632|7204455|FG005|Overall Study|Protocol Violation|0
4422686|NCT00346632|7204456|FG006|Overall Study|Protocol Violation|1
4422687|NCT00346632|7204457|FG007|Overall Study|Protocol Violation|0
4422688|NCT00346632|7204458|FG008|Overall Study|Protocol Violation|0
4422689|NCT00346632|7204459|FG009|Overall Study|Protocol Violation|0
4422690|NCT00346632|7204450|FG000|Overall Study|Withdrawal by Subject|0
4422691|NCT00346632|7204451|FG001|Overall Study|Withdrawal by Subject|0
4422692|NCT00346632|7204452|FG002|Overall Study|Withdrawal by Subject|0
4422693|NCT00346632|7204453|FG003|Overall Study|Withdrawal by Subject|0
4422694|NCT00346632|7204454|FG004|Overall Study|Withdrawal by Subject|0
4422695|NCT00346632|7204455|FG005|Overall Study|Withdrawal by Subject|0
4422696|NCT00346632|7204456|FG006|Overall Study|Withdrawal by Subject|1
4422697|NCT00346632|7204457|FG007|Overall Study|Withdrawal by Subject|0
4422698|NCT00346632|7204458|FG008|Overall Study|Withdrawal by Subject|0
4422699|NCT00346632|7204459|FG009|Overall Study|Withdrawal by Subject|0
4422700|NCT00346632|7204450|FG000|Overall Study|Switched to alternative treatment|0
4422701|NCT00346632|7204451|FG001|Overall Study|Switched to alternative treatment|0
4422702|NCT00346632|7204452|FG002|Overall Study|Switched to alternative treatment|1
4422703|NCT00346632|7204453|FG003|Overall Study|Switched to alternative treatment|0
4422704|NCT00346632|7204454|FG004|Overall Study|Switched to alternative treatment|0
4422705|NCT00346632|7204455|FG005|Overall Study|Switched to alternative treatment|0
4422706|NCT00346632|7204456|FG006|Overall Study|Switched to alternative treatment|0
4422707|NCT00346632|7204457|FG007|Overall Study|Switched to alternative treatment|0
4422708|NCT00346632|7204458|FG008|Overall Study|Switched to alternative treatment|0
4422709|NCT00346632|7204459|FG009|Overall Study|Switched to alternative treatment|0
4422710|NCT00346632|7204450|FG000|Overall Study|Not Stated|1
4422711|NCT00346632|7204451|FG001|Overall Study|Not Stated|1
4422712|NCT00346632|7204452|FG002|Overall Study|Not Stated|0
4422713|NCT00346632|7204453|FG003|Overall Study|Not Stated|0
4422714|NCT00346632|7204454|FG004|Overall Study|Not Stated|0
4422715|NCT00346632|7204455|FG005|Overall Study|Not Stated|0
4422716|NCT00346632|7204456|FG006|Overall Study|Not Stated|0
4422717|NCT00346632|7204457|FG007|Overall Study|Not Stated|2
4422718|NCT00346632|7204458|FG008|Overall Study|Not Stated|2
4422719|NCT00346632|7204459|FG009|Overall Study|Not Stated|1
4422720|NCT00346697|7204523|FG000|Overall Study|Lost to Follow-up|0
4422721|NCT00346697|7204524|FG001|Overall Study|Lost to Follow-up|1
4422722|NCT00346775|7204532|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1
4422723|NCT00346775|7204533|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1
4422724|NCT00346775|7204532|FG000|Period 1: Intervention Period 1|Protocol Violation|3
4422725|NCT00346775|7204533|FG001|Period 1: Intervention Period 1|Protocol Violation|2
4422726|NCT00346775|7204532|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1
4422727|NCT00346775|7204533|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0
4422728|NCT00347009|7204547|FG000|Overall Study|Death|1
4422729|NCT00347009|7204547|FG000|Overall Study|Adverse Event|6
4422730|NCT00347009|7204547|FG000|Overall Study|Withdrawal by Subject|3
4422731|NCT00347009|7204547|FG000|Overall Study|Physician Decision|5
4422732|NCT00347009|7204547|FG000|Overall Study|Lost to Follow-up|4
4422733|NCT00347009|7204547|FG000|Overall Study|Protocol Violation|2
4422734|NCT00347009|7204547|FG000|Overall Study|Adverse Laboratory Experience|1
4422735|NCT00347009|7204547|FG000|Overall Study|Insufficient Viral Suppression|3
4422736|NCT00347009|7204547|FG000|Overall Study|Increased ALT/HBV DNA|1
4422737|NCT00347009|7204547|FG000|Overall Study|Serious Adverse Event|1
4422738|NCT00347269|7204562|FG000|Overall Study|Lost to Follow-up|74
4422739|NCT00347269|7204563|FG001|Overall Study|Lost to Follow-up|65
4422740|NCT00347269|7204562|FG000|Overall Study|Withdrawal by Subject|18
4422741|NCT00347269|7204563|FG001|Overall Study|Withdrawal by Subject|38
4422742|NCT00347269|7204562|FG000|Overall Study|Death|2
4422743|NCT00347269|7204563|FG001|Overall Study|Death|3
4422744|NCT00347360|7204588|FG000|Overall Study|Adverse Event|1
4422745|NCT00347360|7204589|FG001|Overall Study|Adverse Event|2
4422746|NCT00347360|7204590|FG002|Overall Study|Adverse Event|0
4422747|NCT00347360|7204591|FG003|Overall Study|Adverse Event|4
4422748|NCT00347360|7204592|FG004|Overall Study|Adverse Event|1
4422749|NCT00347360|7204593|FG005|Overall Study|Adverse Event|2
4422750|NCT00347360|7204594|FG006|Overall Study|Adverse Event|2
4422751|NCT00347360|7204595|FG007|Overall Study|Adverse Event|0
4422752|NCT00347360|7204596|FG008|Overall Study|Adverse Event|2
4422753|NCT00347360|7204597|FG009|Overall Study|Adverse Event|3
4422754|NCT00347360|7204598|FG010|Overall Study|Adverse Event|3
4422755|NCT00347360|7204599|FG011|Overall Study|Adverse Event|1
4422756|NCT00347360|7204600|FG012|Overall Study|Adverse Event|3
4422757|NCT00347360|7204601|FG013|Overall Study|Adverse Event|2
4422758|NCT00347360|7204602|FG014|Overall Study|Adverse Event|2
4422759|NCT00347360|7204588|FG000|Overall Study|Lost to Follow-up|0
4422760|NCT00347360|7204589|FG001|Overall Study|Lost to Follow-up|0
4422761|NCT00347360|7204590|FG002|Overall Study|Lost to Follow-up|0
4422762|NCT00347360|7204591|FG003|Overall Study|Lost to Follow-up|2
4422763|NCT00347360|7204592|FG004|Overall Study|Lost to Follow-up|1
4422764|NCT00347360|7204593|FG005|Overall Study|Lost to Follow-up|1
4422765|NCT00347360|7204594|FG006|Overall Study|Lost to Follow-up|0
4422766|NCT00347360|7204595|FG007|Overall Study|Lost to Follow-up|1
4422767|NCT00347360|7204596|FG008|Overall Study|Lost to Follow-up|1
4422768|NCT00347360|7204597|FG009|Overall Study|Lost to Follow-up|2
4422769|NCT00347360|7204598|FG010|Overall Study|Lost to Follow-up|0
4422770|NCT00347360|7204599|FG011|Overall Study|Lost to Follow-up|0
4422771|NCT00347360|7204600|FG012|Overall Study|Lost to Follow-up|1
4422772|NCT00347360|7204601|FG013|Overall Study|Lost to Follow-up|0
4422773|NCT00347360|7204602|FG014|Overall Study|Lost to Follow-up|0
4422774|NCT00347360|7204588|FG000|Overall Study|Protocol Violation|2
4422775|NCT00347360|7204589|FG001|Overall Study|Protocol Violation|3
4422776|NCT00347360|7204590|FG002|Overall Study|Protocol Violation|1
4422777|NCT00347360|7204591|FG003|Overall Study|Protocol Violation|2
4422778|NCT00347360|7204592|FG004|Overall Study|Protocol Violation|1
4422779|NCT00347360|7204593|FG005|Overall Study|Protocol Violation|2
4422780|NCT00347360|7204594|FG006|Overall Study|Protocol Violation|0
4422781|NCT00347360|7204595|FG007|Overall Study|Protocol Violation|0
4422782|NCT00347360|7204596|FG008|Overall Study|Protocol Violation|1
4422783|NCT00347360|7204597|FG009|Overall Study|Protocol Violation|2
4422784|NCT00347360|7204598|FG010|Overall Study|Protocol Violation|0
4422785|NCT00347360|7204599|FG011|Overall Study|Protocol Violation|0
4422786|NCT00347360|7204600|FG012|Overall Study|Protocol Violation|0
4422787|NCT00347360|7204601|FG013|Overall Study|Protocol Violation|1
4422788|NCT00347360|7204602|FG014|Overall Study|Protocol Violation|0
4422789|NCT00347360|7204588|FG000|Overall Study|Withdrawal by Subject|0
4422790|NCT00347360|7204589|FG001|Overall Study|Withdrawal by Subject|1
4422791|NCT00347360|7204590|FG002|Overall Study|Withdrawal by Subject|2
4422792|NCT00347360|7204591|FG003|Overall Study|Withdrawal by Subject|4
4422793|NCT00347360|7204592|FG004|Overall Study|Withdrawal by Subject|1
4422794|NCT00347360|7204593|FG005|Overall Study|Withdrawal by Subject|2
4422795|NCT00347360|7204594|FG006|Overall Study|Withdrawal by Subject|1
4422796|NCT00347360|7204595|FG007|Overall Study|Withdrawal by Subject|1
4422797|NCT00347360|7204596|FG008|Overall Study|Withdrawal by Subject|1
4422798|NCT00347360|7204597|FG009|Overall Study|Withdrawal by Subject|1
4422799|NCT00347360|7204598|FG010|Overall Study|Withdrawal by Subject|0
4422800|NCT00347360|7204599|FG011|Overall Study|Withdrawal by Subject|3
4422801|NCT00347360|7204600|FG012|Overall Study|Withdrawal by Subject|4
4422802|NCT00347360|7204601|FG013|Overall Study|Withdrawal by Subject|2
4422803|NCT00347360|7204602|FG014|Overall Study|Withdrawal by Subject|1
4422804|NCT00347360|7204588|FG000|Overall Study|Lack of Efficacy|1
4422805|NCT00347360|7204589|FG001|Overall Study|Lack of Efficacy|1
4422806|NCT00347360|7204590|FG002|Overall Study|Lack of Efficacy|3
4422807|NCT00347360|7204591|FG003|Overall Study|Lack of Efficacy|1
4422808|NCT00347360|7204592|FG004|Overall Study|Lack of Efficacy|0
4422809|NCT00347360|7204593|FG005|Overall Study|Lack of Efficacy|1
4422810|NCT00347360|7204594|FG006|Overall Study|Lack of Efficacy|0
4422811|NCT00347360|7204595|FG007|Overall Study|Lack of Efficacy|1
4422812|NCT00347360|7204596|FG008|Overall Study|Lack of Efficacy|1
4422813|NCT00347360|7204597|FG009|Overall Study|Lack of Efficacy|0
4422814|NCT00347360|7204598|FG010|Overall Study|Lack of Efficacy|0
4422815|NCT00347360|7204599|FG011|Overall Study|Lack of Efficacy|0
4422816|NCT00347360|7204600|FG012|Overall Study|Lack of Efficacy|0
4422817|NCT00347360|7204601|FG013|Overall Study|Lack of Efficacy|0
4422818|NCT00347360|7204602|FG014|Overall Study|Lack of Efficacy|0
4422819|NCT00347360|7204588|FG000|Overall Study|Reason not listed/blank|1
4422820|NCT00347360|7204589|FG001|Overall Study|Reason not listed/blank|0
4422821|NCT00347360|7204590|FG002|Overall Study|Reason not listed/blank|0
4422822|NCT00347360|7204591|FG003|Overall Study|Reason not listed/blank|0
4422823|NCT00347360|7204592|FG004|Overall Study|Reason not listed/blank|0
4422824|NCT00347360|7204593|FG005|Overall Study|Reason not listed/blank|0
4422825|NCT00347360|7204594|FG006|Overall Study|Reason not listed/blank|1
4422826|NCT00347360|7204595|FG007|Overall Study|Reason not listed/blank|0
4422827|NCT00347360|7204596|FG008|Overall Study|Reason not listed/blank|0
4422828|NCT00347360|7204597|FG009|Overall Study|Reason not listed/blank|0
4422829|NCT00347360|7204598|FG010|Overall Study|Reason not listed/blank|0
4422830|NCT00347360|7204599|FG011|Overall Study|Reason not listed/blank|0
4422831|NCT00347360|7204600|FG012|Overall Study|Reason not listed/blank|0
4422832|NCT00347360|7204601|FG013|Overall Study|Reason not listed/blank|1
4422833|NCT00347360|7204602|FG014|Overall Study|Reason not listed/blank|0
4422834|NCT00347360|7204588|FG000|Overall Study|Per sponsors instruction|0
4422835|NCT00347360|7204589|FG001|Overall Study|Per sponsors instruction|1
4422836|NCT00347360|7204590|FG002|Overall Study|Per sponsors instruction|0
4422837|NCT00347360|7204591|FG003|Overall Study|Per sponsors instruction|0
4422838|NCT00347360|7204592|FG004|Overall Study|Per sponsors instruction|0
4422839|NCT00347360|7204593|FG005|Overall Study|Per sponsors instruction|0
4422840|NCT00347360|7204594|FG006|Overall Study|Per sponsors instruction|0
4422841|NCT00347360|7204595|FG007|Overall Study|Per sponsors instruction|0
4422842|NCT00347360|7204596|FG008|Overall Study|Per sponsors instruction|0
4422843|NCT00347360|7204597|FG009|Overall Study|Per sponsors instruction|0
4422844|NCT00347360|7204598|FG010|Overall Study|Per sponsors instruction|0
4422845|NCT00347360|7204599|FG011|Overall Study|Per sponsors instruction|0
4422846|NCT00347360|7204600|FG012|Overall Study|Per sponsors instruction|0
4422847|NCT00347360|7204601|FG013|Overall Study|Per sponsors instruction|0
4422848|NCT00347360|7204602|FG014|Overall Study|Per sponsors instruction|0
4422849|NCT00347360|7204588|FG000|Overall Study|P.I. recommended due to blood pressure|0
4422850|NCT00347360|7204589|FG001|Overall Study|P.I. recommended due to blood pressure|0
4422851|NCT00347360|7204590|FG002|Overall Study|P.I. recommended due to blood pressure|0
4422852|NCT00347360|7204591|FG003|Overall Study|P.I. recommended due to blood pressure|0
4422853|NCT00347360|7204592|FG004|Overall Study|P.I. recommended due to blood pressure|1
4422854|NCT00347360|7204593|FG005|Overall Study|P.I. recommended due to blood pressure|0
4422855|NCT00347360|7204594|FG006|Overall Study|P.I. recommended due to blood pressure|0
4422856|NCT00347360|7204595|FG007|Overall Study|P.I. recommended due to blood pressure|0
4422857|NCT00347360|7204596|FG008|Overall Study|P.I. recommended due to blood pressure|0
4422858|NCT00347360|7204597|FG009|Overall Study|P.I. recommended due to blood pressure|0
4422859|NCT00347360|7204598|FG010|Overall Study|P.I. recommended due to blood pressure|0
4422860|NCT00347360|7204599|FG011|Overall Study|P.I. recommended due to blood pressure|0
4422861|NCT00347360|7204600|FG012|Overall Study|P.I. recommended due to blood pressure|0
4422862|NCT00347360|7204601|FG013|Overall Study|P.I. recommended due to blood pressure|0
4422863|NCT00347360|7204602|FG014|Overall Study|P.I. recommended due to blood pressure|0
4422864|NCT00347360|7204588|FG000|Overall Study|Subject did not meet end of study ABPM|0
4422865|NCT00347360|7204589|FG001|Overall Study|Subject did not meet end of study ABPM|0
4422866|NCT00347360|7204590|FG002|Overall Study|Subject did not meet end of study ABPM|0
4422867|NCT00347360|7204591|FG003|Overall Study|Subject did not meet end of study ABPM|0
4422868|NCT00347360|7204592|FG004|Overall Study|Subject did not meet end of study ABPM|0
4422869|NCT00347360|7204593|FG005|Overall Study|Subject did not meet end of study ABPM|0
4422870|NCT00347360|7204594|FG006|Overall Study|Subject did not meet end of study ABPM|1
4422871|NCT00347360|7204595|FG007|Overall Study|Subject did not meet end of study ABPM|0
4422872|NCT00347360|7204596|FG008|Overall Study|Subject did not meet end of study ABPM|0
4422873|NCT00347360|7204597|FG009|Overall Study|Subject did not meet end of study ABPM|0
4422874|NCT00347360|7204598|FG010|Overall Study|Subject did not meet end of study ABPM|1
4422875|NCT00347360|7204599|FG011|Overall Study|Subject did not meet end of study ABPM|0
4422876|NCT00347360|7204600|FG012|Overall Study|Subject did not meet end of study ABPM|1
4422877|NCT00347360|7204601|FG013|Overall Study|Subject did not meet end of study ABPM|1
4422878|NCT00347360|7204602|FG014|Overall Study|Subject did not meet end of study ABPM|0
4422879|NCT00347360|7204588|FG000|Overall Study|Abnormal lab values|0
4422880|NCT00347360|7204589|FG001|Overall Study|Abnormal lab values|0
4422881|NCT00347360|7204590|FG002|Overall Study|Abnormal lab values|0
4422882|NCT00347360|7204591|FG003|Overall Study|Abnormal lab values|0
4422883|NCT00347360|7204592|FG004|Overall Study|Abnormal lab values|0
4422884|NCT00347360|7204593|FG005|Overall Study|Abnormal lab values|0
4422885|NCT00347360|7204594|FG006|Overall Study|Abnormal lab values|1
4422886|NCT00347360|7204595|FG007|Overall Study|Abnormal lab values|0
4422887|NCT00347360|7204596|FG008|Overall Study|Abnormal lab values|0
4422888|NCT00347360|7204597|FG009|Overall Study|Abnormal lab values|0
4422889|NCT00347360|7204598|FG010|Overall Study|Abnormal lab values|0
4422890|NCT00347360|7204599|FG011|Overall Study|Abnormal lab values|0
4422891|NCT00347360|7204600|FG012|Overall Study|Abnormal lab values|0
4422892|NCT00347360|7204601|FG013|Overall Study|Abnormal lab values|0
4422893|NCT00347360|7204602|FG014|Overall Study|Abnormal lab values|0
4422894|NCT00347360|7204588|FG000|Overall Study|PI recommended early withdrawal|0
4422895|NCT00347360|7204589|FG001|Overall Study|PI recommended early withdrawal|0
4422896|NCT00347360|7204590|FG002|Overall Study|PI recommended early withdrawal|0
4422897|NCT00347360|7204591|FG003|Overall Study|PI recommended early withdrawal|0
4422898|NCT00347360|7204592|FG004|Overall Study|PI recommended early withdrawal|0
4422899|NCT00347360|7204593|FG005|Overall Study|PI recommended early withdrawal|0
4422900|NCT00347360|7204594|FG006|Overall Study|PI recommended early withdrawal|0
4422901|NCT00347360|7204595|FG007|Overall Study|PI recommended early withdrawal|0
4422902|NCT00347360|7204596|FG008|Overall Study|PI recommended early withdrawal|0
4422903|NCT00347360|7204597|FG009|Overall Study|PI recommended early withdrawal|1
4422904|NCT00347360|7204598|FG010|Overall Study|PI recommended early withdrawal|0
4422905|NCT00347360|7204599|FG011|Overall Study|PI recommended early withdrawal|0
4422906|NCT00347360|7204600|FG012|Overall Study|PI recommended early withdrawal|0
4422907|NCT00347360|7204601|FG013|Overall Study|PI recommended early withdrawal|0
4422908|NCT00347360|7204602|FG014|Overall Study|PI recommended early withdrawal|0
4422909|NCT00347360|7204588|FG000|Overall Study|Did not meet criteria before ABPM|0
4422910|NCT00347360|7204589|FG001|Overall Study|Did not meet criteria before ABPM|0
4422911|NCT00347360|7204590|FG002|Overall Study|Did not meet criteria before ABPM|0
4422912|NCT00347360|7204591|FG003|Overall Study|Did not meet criteria before ABPM|0
4422913|NCT00347360|7204592|FG004|Overall Study|Did not meet criteria before ABPM|0
4422914|NCT00347360|7204593|FG005|Overall Study|Did not meet criteria before ABPM|0
4422915|NCT00347360|7204594|FG006|Overall Study|Did not meet criteria before ABPM|0
4422916|NCT00347360|7204595|FG007|Overall Study|Did not meet criteria before ABPM|0
4422917|NCT00347360|7204596|FG008|Overall Study|Did not meet criteria before ABPM|0
4422918|NCT00347360|7204597|FG009|Overall Study|Did not meet criteria before ABPM|0
4422919|NCT00347360|7204598|FG010|Overall Study|Did not meet criteria before ABPM|1
4422920|NCT00347360|7204599|FG011|Overall Study|Did not meet criteria before ABPM|0
4422921|NCT00347360|7204600|FG012|Overall Study|Did not meet criteria before ABPM|0
4422922|NCT00347360|7204601|FG013|Overall Study|Did not meet criteria before ABPM|0
4422923|NCT00347360|7204602|FG014|Overall Study|Did not meet criteria before ABPM|0
4422924|NCT00347360|7204588|FG000|Overall Study|Randomized in error|0
4422925|NCT00347360|7204589|FG001|Overall Study|Randomized in error|0
4422926|NCT00347360|7204590|FG002|Overall Study|Randomized in error|0
4422927|NCT00347360|7204591|FG003|Overall Study|Randomized in error|0
4422928|NCT00347360|7204592|FG004|Overall Study|Randomized in error|0
4422929|NCT00347360|7204593|FG005|Overall Study|Randomized in error|0
4422930|NCT00347360|7204594|FG006|Overall Study|Randomized in error|0
4422931|NCT00347360|7204595|FG007|Overall Study|Randomized in error|0
4422932|NCT00347360|7204596|FG008|Overall Study|Randomized in error|0
4422933|NCT00347360|7204597|FG009|Overall Study|Randomized in error|0
4422934|NCT00347360|7204598|FG010|Overall Study|Randomized in error|0
4422935|NCT00347360|7204599|FG011|Overall Study|Randomized in error|1
4422936|NCT00347360|7204600|FG012|Overall Study|Randomized in error|0
4422937|NCT00347360|7204601|FG013|Overall Study|Randomized in error|0
4422938|NCT00347360|7204602|FG014|Overall Study|Randomized in error|0
4422939|NCT00347360|7204588|FG000|Overall Study|Failed inclusion criteria #4|0
4422940|NCT00347360|7204589|FG001|Overall Study|Failed inclusion criteria #4|0
4422941|NCT00347360|7204590|FG002|Overall Study|Failed inclusion criteria #4|0
4422942|NCT00347360|7204591|FG003|Overall Study|Failed inclusion criteria #4|0
4422943|NCT00347360|7204592|FG004|Overall Study|Failed inclusion criteria #4|0
4422944|NCT00347360|7204593|FG005|Overall Study|Failed inclusion criteria #4|0
4422945|NCT00347360|7204594|FG006|Overall Study|Failed inclusion criteria #4|0
4422946|NCT00347360|7204595|FG007|Overall Study|Failed inclusion criteria #4|0
4422947|NCT00347360|7204596|FG008|Overall Study|Failed inclusion criteria #4|0
4422948|NCT00347360|7204597|FG009|Overall Study|Failed inclusion criteria #4|0
4422949|NCT00347360|7204598|FG010|Overall Study|Failed inclusion criteria #4|0
4422950|NCT00347360|7204599|FG011|Overall Study|Failed inclusion criteria #4|1
4422951|NCT00347360|7204600|FG012|Overall Study|Failed inclusion criteria #4|0
4422952|NCT00347360|7204601|FG013|Overall Study|Failed inclusion criteria #4|0
4422953|NCT00347360|7204602|FG014|Overall Study|Failed inclusion criteria #4|0
4422954|NCT00347360|7204588|FG000|Overall Study|Prolonged duration between visits|0
4422955|NCT00347360|7204589|FG001|Overall Study|Prolonged duration between visits|0
4422956|NCT00347360|7204590|FG002|Overall Study|Prolonged duration between visits|0
4422957|NCT00347360|7204591|FG003|Overall Study|Prolonged duration between visits|0
4422958|NCT00347360|7204592|FG004|Overall Study|Prolonged duration between visits|0
4422959|NCT00347360|7204593|FG005|Overall Study|Prolonged duration between visits|0
4422960|NCT00347360|7204594|FG006|Overall Study|Prolonged duration between visits|0
4422961|NCT00347360|7204595|FG007|Overall Study|Prolonged duration between visits|0
4422962|NCT00347360|7204596|FG008|Overall Study|Prolonged duration between visits|0
4422963|NCT00347360|7204597|FG009|Overall Study|Prolonged duration between visits|0
4422964|NCT00347360|7204598|FG010|Overall Study|Prolonged duration between visits|0
4422965|NCT00347360|7204599|FG011|Overall Study|Prolonged duration between visits|0
4422966|NCT00347360|7204600|FG012|Overall Study|Prolonged duration between visits|1
4422967|NCT00347360|7204601|FG013|Overall Study|Prolonged duration between visits|0
4422968|NCT00347360|7204602|FG014|Overall Study|Prolonged duration between visits|0
4422969|NCT00347360|7204588|FG000|Overall Study|Subject left town, ran out of study drug|0
4422970|NCT00347360|7204589|FG001|Overall Study|Subject left town, ran out of study drug|0
4422971|NCT00347360|7204590|FG002|Overall Study|Subject left town, ran out of study drug|0
4422972|NCT00347360|7204591|FG003|Overall Study|Subject left town, ran out of study drug|0
4422973|NCT00347360|7204592|FG004|Overall Study|Subject left town, ran out of study drug|0
4422974|NCT00347360|7204593|FG005|Overall Study|Subject left town, ran out of study drug|0
4422975|NCT00347360|7204594|FG006|Overall Study|Subject left town, ran out of study drug|0
4422976|NCT00347360|7204595|FG007|Overall Study|Subject left town, ran out of study drug|0
4422977|NCT00347360|7204596|FG008|Overall Study|Subject left town, ran out of study drug|0
4422978|NCT00347360|7204597|FG009|Overall Study|Subject left town, ran out of study drug|0
4422979|NCT00347360|7204598|FG010|Overall Study|Subject left town, ran out of study drug|0
4422980|NCT00347360|7204599|FG011|Overall Study|Subject left town, ran out of study drug|0
4422981|NCT00347360|7204600|FG012|Overall Study|Subject left town, ran out of study drug|0
4422982|NCT00347360|7204601|FG013|Overall Study|Subject left town, ran out of study drug|1
4422983|NCT00347360|7204602|FG014|Overall Study|Subject left town, ran out of study drug|0
4422984|NCT00347360|7204588|FG000|Overall Study|Subject refuse to sign updated consent|0
4422985|NCT00347360|7204589|FG001|Overall Study|Subject refuse to sign updated consent|0
4422986|NCT00347360|7204590|FG002|Overall Study|Subject refuse to sign updated consent|0
4422987|NCT00347360|7204591|FG003|Overall Study|Subject refuse to sign updated consent|0
4422988|NCT00347360|7204592|FG004|Overall Study|Subject refuse to sign updated consent|0
4422989|NCT00347360|7204593|FG005|Overall Study|Subject refuse to sign updated consent|0
4422990|NCT00347360|7204594|FG006|Overall Study|Subject refuse to sign updated consent|0
4422991|NCT00347360|7204595|FG007|Overall Study|Subject refuse to sign updated consent|0
4422992|NCT00347360|7204596|FG008|Overall Study|Subject refuse to sign updated consent|0
4422993|NCT00347360|7204597|FG009|Overall Study|Subject refuse to sign updated consent|0
4422994|NCT00347360|7204598|FG010|Overall Study|Subject refuse to sign updated consent|0
4422995|NCT00347360|7204599|FG011|Overall Study|Subject refuse to sign updated consent|0
4422996|NCT00347360|7204600|FG012|Overall Study|Subject refuse to sign updated consent|0
4422997|NCT00347360|7204601|FG013|Overall Study|Subject refuse to sign updated consent|0
4422998|NCT00347360|7204602|FG014|Overall Study|Subject refuse to sign updated consent|1
4422999|NCT00347360|7204588|FG000|Overall Study|Visits conflicted with new job|0
4423000|NCT00347360|7204589|FG001|Overall Study|Visits conflicted with new job|0
4423001|NCT00347360|7204590|FG002|Overall Study|Visits conflicted with new job|0
4423002|NCT00347360|7204591|FG003|Overall Study|Visits conflicted with new job|0
4423003|NCT00347360|7204592|FG004|Overall Study|Visits conflicted with new job|0
4423004|NCT00347360|7204593|FG005|Overall Study|Visits conflicted with new job|0
4423005|NCT00347360|7204594|FG006|Overall Study|Visits conflicted with new job|1
4423006|NCT00347360|7204595|FG007|Overall Study|Visits conflicted with new job|0
4423007|NCT00347360|7204596|FG008|Overall Study|Visits conflicted with new job|0
4423008|NCT00347360|7204597|FG009|Overall Study|Visits conflicted with new job|0
4423009|NCT00347360|7204598|FG010|Overall Study|Visits conflicted with new job|0
4423010|NCT00347360|7204599|FG011|Overall Study|Visits conflicted with new job|0
4423011|NCT00347360|7204600|FG012|Overall Study|Visits conflicted with new job|0
4423012|NCT00347360|7204601|FG013|Overall Study|Visits conflicted with new job|0
4423013|NCT00347360|7204602|FG014|Overall Study|Visits conflicted with new job|0
4423014|NCT00347438|7204634|FG000|Overall Study|Withdrawal by Subject|1
4423015|NCT00347438|7204634|FG000|Overall Study|Physician Decision|1
4423016|NCT00347776|7204641|FG000|1.5 Month Follow-up|Death|2
4423017|NCT00347776|7204642|FG001|1.5 Month Follow-up|Death|0
4423018|NCT00347776|7204643|FG002|1.5 Month Follow-up|Death|0
4423019|NCT00347776|7204641|FG000|1.5 Month Follow-up|reached the endpoint|12
4423020|NCT00347776|7204642|FG001|1.5 Month Follow-up|reached the endpoint|8
4423021|NCT00347776|7204643|FG002|1.5 Month Follow-up|reached the endpoint|12
4423022|NCT00347776|7204641|FG000|6 Month Follow-up|Death|2
4423023|NCT00347776|7204642|FG001|6 Month Follow-up|Death|1
4423024|NCT00347776|7204643|FG002|6 Month Follow-up|Death|3
4423025|NCT00347776|7204641|FG000|6 Month Follow-up|reached endpont|20
4423026|NCT00347776|7204642|FG001|6 Month Follow-up|reached endpont|12
4423027|NCT00347776|7204643|FG002|6 Month Follow-up|reached endpont|15
4423028|NCT00347776|7204641|FG000|12 Month Follow-up|Lost to Follow-up|7
4423029|NCT00347776|7204642|FG001|12 Month Follow-up|Lost to Follow-up|6
4423030|NCT00347776|7204643|FG002|12 Month Follow-up|Lost to Follow-up|6
4423031|NCT00347776|7204641|FG000|12 Month Follow-up|Death|3
4423032|NCT00347776|7204642|FG001|12 Month Follow-up|Death|4
4423033|NCT00347776|7204643|FG002|12 Month Follow-up|Death|4
4423034|NCT00347776|7204641|FG000|12 Month Follow-up|Reached endpoint|13
4423035|NCT00347776|7204642|FG001|12 Month Follow-up|Reached endpoint|6
4423036|NCT00347776|7204643|FG002|12 Month Follow-up|Reached endpoint|9
4423037|NCT00347919|7204654|FG000|Overall Study|Lost to Follow-up|11
4423038|NCT00347919|7204655|FG001|Overall Study|Lost to Follow-up|13
4423039|NCT00347919|7204656|FG002|Overall Study|Lost to Follow-up|0
4423040|NCT00347919|7204654|FG000|Overall Study|Withdrawal by Subject|6
4423041|NCT00347919|7204655|FG001|Overall Study|Withdrawal by Subject|8
4423042|NCT00347919|7204656|FG002|Overall Study|Withdrawal by Subject|0
4423043|NCT00347919|7204654|FG000|Overall Study|Physician Decision|1
4423044|NCT00347919|7204655|FG001|Overall Study|Physician Decision|1
4423045|NCT00347919|7204656|FG002|Overall Study|Physician Decision|0
4423046|NCT00347919|7204654|FG000|Overall Study|Sponsor terminated study|15
4423047|NCT00347919|7204655|FG001|Overall Study|Sponsor terminated study|10
4423048|NCT00347919|7204656|FG002|Overall Study|Sponsor terminated study|16
4423049|NCT00347919|7204654|FG000|Overall Study|Death|35
4423050|NCT00347919|7204655|FG001|Overall Study|Death|42
4423051|NCT00347919|7204656|FG002|Overall Study|Death|19
4423052|NCT00347919|7204654|FG000|Overall Study|Par. Started Other Treatment|1
4423053|NCT00347919|7204655|FG001|Overall Study|Par. Started Other Treatment|1
4423054|NCT00347919|7204656|FG002|Overall Study|Par. Started Other Treatment|1
4423055|NCT00347919|7204654|FG000|Overall Study|Missing|2
4423056|NCT00347919|7204655|FG001|Overall Study|Missing|1
4423057|NCT00347919|7204656|FG002|Overall Study|Missing|2
4423058|NCT00347932|7204668|FG000|Overall Study|Adverse Event|4
4423059|NCT00347932|7204669|FG001|Overall Study|Adverse Event|5
4423060|NCT00347932|7204668|FG000|Overall Study|Lack of Efficacy|3
4423061|NCT00347932|7204669|FG001|Overall Study|Lack of Efficacy|14
4423062|NCT00347932|7204668|FG000|Overall Study|Lost to Follow-up|10
4423063|NCT00347932|7204669|FG001|Overall Study|Lost to Follow-up|9
4423064|NCT00347932|7204668|FG000|Overall Study|Withdrawal by Subject|10
4423065|NCT00347932|7204669|FG001|Overall Study|Withdrawal by Subject|16
4423066|NCT00347932|7204668|FG000|Overall Study|Did not meet inclusion criteria|4
4423067|NCT00347932|7204669|FG001|Overall Study|Did not meet inclusion criteria|8
4423068|NCT00347958|7204675|FG000|Overall Study|Adverse Event|1
4423069|NCT00347958|7204675|FG000|Overall Study|Protocol Violation|2
4423070|NCT00347958|7204675|FG000|Overall Study|Withdrawal by Subject|1
4423071|NCT00348140|7204682|FG000|Overall Study|Adverse Event|46
4423072|NCT00348140|7204683|FG001|Overall Study|Adverse Event|49
4423073|NCT00348140|7204684|FG002|Overall Study|Adverse Event|78
4423074|NCT00348140|7204682|FG000|Overall Study|Lost to Follow-up|4
4423075|NCT00348140|7204683|FG001|Overall Study|Lost to Follow-up|4
4423076|NCT00348140|7204684|FG002|Overall Study|Lost to Follow-up|4
4423077|NCT00348140|7204682|FG000|Overall Study|Protocol Violation|12
4423078|NCT00348140|7204683|FG001|Overall Study|Protocol Violation|13
4423079|NCT00348140|7204684|FG002|Overall Study|Protocol Violation|14
4423080|NCT00348140|7204682|FG000|Overall Study|Withdrawal by Subject|32
4423081|NCT00348140|7204683|FG001|Overall Study|Withdrawal by Subject|40
4423082|NCT00348140|7204684|FG002|Overall Study|Withdrawal by Subject|40
4423083|NCT00348140|7204682|FG000|Overall Study|Non-compliance|8
4423084|NCT00348140|7204683|FG001|Overall Study|Non-compliance|13
4423085|NCT00348140|7204684|FG002|Overall Study|Non-compliance|5
4423086|NCT00348140|7204682|FG000|Overall Study|Participant at risk due to study drug|2
4423087|NCT00348140|7204683|FG001|Overall Study|Participant at risk due to study drug|0
4423088|NCT00348140|7204684|FG002|Overall Study|Participant at risk due to study drug|0
4423089|NCT00348140|7204682|FG000|Overall Study|Conditional medication increased dose|1
4423090|NCT00348140|7204683|FG001|Overall Study|Conditional medication increased dose|0
4423091|NCT00348140|7204684|FG002|Overall Study|Conditional medication increased dose|0
4423092|NCT00348140|7204682|FG000|Overall Study|Caregiver related|4
4423093|NCT00348140|7204683|FG001|Overall Study|Caregiver related|7
4423094|NCT00348140|7204684|FG002|Overall Study|Caregiver related|3
4423095|NCT00348140|7204682|FG000|Overall Study|Participant hospitalised|3
4423096|NCT00348140|7204683|FG001|Overall Study|Participant hospitalised|0
4423097|NCT00348140|7204684|FG002|Overall Study|Participant hospitalised|0
4423098|NCT00348140|7204682|FG000|Overall Study|Efficacy related|1
4423099|NCT00348140|7204683|FG001|Overall Study|Efficacy related|1
4423100|NCT00348140|7204684|FG002|Overall Study|Efficacy related|0
4423101|NCT00348140|7204682|FG000|Overall Study|Administration related|3
4423102|NCT00348140|7204683|FG001|Overall Study|Administration related|1
4423103|NCT00348140|7204684|FG002|Overall Study|Administration related|1
4423104|NCT00348140|7204682|FG000|Overall Study|Unmet inclusion-exclusion criteria|1
4423105|NCT00348140|7204683|FG001|Overall Study|Unmet inclusion-exclusion criteria|0
4423106|NCT00348140|7204684|FG002|Overall Study|Unmet inclusion-exclusion criteria|1
4423107|NCT00348140|7204682|FG000|Overall Study|Participant unwell|1
4423108|NCT00348140|7204683|FG001|Overall Study|Participant unwell|0
4423109|NCT00348140|7204684|FG002|Overall Study|Participant unwell|0
4423110|NCT00348140|7204682|FG000|Overall Study|Screen failure|1
4423111|NCT00348140|7204683|FG001|Overall Study|Screen failure|0
4423112|NCT00348140|7204684|FG002|Overall Study|Screen failure|0
4423113|NCT00348140|7204682|FG000|Overall Study|Investigator decided to discontinue|4
4423114|NCT00348140|7204683|FG001|Overall Study|Investigator decided to discontinue|1
4423115|NCT00348140|7204684|FG002|Overall Study|Investigator decided to discontinue|4
4423116|NCT00348140|7204682|FG000|Overall Study|Decided to discontinue on their own|1
4423117|NCT00348140|7204683|FG001|Overall Study|Decided to discontinue on their own|4
4423118|NCT00348140|7204684|FG002|Overall Study|Decided to discontinue on their own|1
4423119|NCT00348140|7204682|FG000|Overall Study|Use of prohibited drug|1
4423120|NCT00348140|7204683|FG001|Overall Study|Use of prohibited drug|0
4423121|NCT00348140|7204684|FG002|Overall Study|Use of prohibited drug|2
4423122|NCT00348140|7204682|FG000|Overall Study|Disease progression|1
4423123|NCT00348140|7204683|FG001|Overall Study|Disease progression|2
4423124|NCT00348140|7204684|FG002|Overall Study|Disease progression|5
4423125|NCT00348140|7204682|FG000|Overall Study|Increased risk of cardiac infarction|0
4423126|NCT00348140|7204683|FG001|Overall Study|Increased risk of cardiac infarction|1
4423127|NCT00348140|7204684|FG002|Overall Study|Increased risk of cardiac infarction|0
4423128|NCT00348140|7204682|FG000|Overall Study|Serious adverse event|0
4423129|NCT00348140|7204683|FG001|Overall Study|Serious adverse event|1
4423130|NCT00348140|7204684|FG002|Overall Study|Serious adverse event|0
4423131|NCT00348140|7204682|FG000|Overall Study|Abnormal ECG|0
4423132|NCT00348140|7204683|FG001|Overall Study|Abnormal ECG|1
4423133|NCT00348140|7204684|FG002|Overall Study|Abnormal ECG|3
4423134|NCT00348140|7204682|FG000|Overall Study|Participant died|0
4423135|NCT00348140|7204683|FG001|Overall Study|Participant died|1
4423136|NCT00348140|7204684|FG002|Overall Study|Participant died|0
4423137|NCT00348140|7204682|FG000|Overall Study|Exclusion criteria met|0
4423138|NCT00348140|7204683|FG001|Overall Study|Exclusion criteria met|0
4423139|NCT00348140|7204684|FG002|Overall Study|Exclusion criteria met|1
4423140|NCT00348140|7204682|FG000|Overall Study|Memory declined|0
4423141|NCT00348140|7204683|FG001|Overall Study|Memory declined|0
4423142|NCT00348140|7204684|FG002|Overall Study|Memory declined|1
4423143|NCT00348283|7204699|FG000|Induction|Adverse Event|0
4423144|NCT00348283|7204700|FG001|Induction|Adverse Event|2
4423145|NCT00348283|7204699|FG000|Induction|Protocol Violation|0
4423146|NCT00348283|7204700|FG001|Induction|Protocol Violation|4
4423147|NCT00348283|7204699|FG000|Double Blind|Adverse Event|2
4423148|NCT00348283|7204700|FG001|Double Blind|Adverse Event|5
4423149|NCT00348283|7204699|FG000|Double Blind|Withdrawal by Subject|1
4423150|NCT00348283|7204700|FG001|Double Blind|Withdrawal by Subject|1
4423151|NCT00348283|7204699|FG000|Double Blind|Protocol Violation|0
4423152|NCT00348283|7204700|FG001|Double Blind|Protocol Violation|1
4423153|NCT00348283|7204699|FG000|Double Blind|Lack of Efficacy|2
4423154|NCT00348283|7204700|FG001|Double Blind|Lack of Efficacy|2
4423155|NCT00348283|7204699|FG000|Double Blind|Pregnancy|0
4423156|NCT00348283|7204700|FG001|Double Blind|Pregnancy|1
4423157|NCT00348283|7204699|FG000|Open Label|Adverse Event|0
4423158|NCT00348283|7204700|FG001|Open Label|Adverse Event|8
4423159|NCT00348283|7204699|FG000|Open Label|Withdrawal by Subject|0
4423160|NCT00348283|7204700|FG001|Open Label|Withdrawal by Subject|4
4423161|NCT00348283|7204699|FG000|Open Label|Lost to Follow-up|0
4423162|NCT00348283|7204700|FG001|Open Label|Lost to Follow-up|1
4423163|NCT00348283|7204699|FG000|Open Label|Lack of Efficacy|0
4423164|NCT00348283|7204700|FG001|Open Label|Lack of Efficacy|13
4423165|NCT00348283|7204699|FG000|Open Label|Administrative reasons|0
4423166|NCT00348283|7204700|FG001|Open Label|Administrative reasons|5
4423167|NCT00348283|7204699|FG000|Open Label|Subject moved to the United States|0
4423168|NCT00348283|7204700|FG001|Open Label|Subject moved to the United States|1
4423169|NCT00348283|7204699|FG000|Open Label|Pregnancy|0
4423170|NCT00348283|7204700|FG001|Open Label|Pregnancy|1
4423171|NCT00348283|7204699|FG000|Open Label|Sponsor decision|0
4423172|NCT00348283|7204700|FG001|Open Label|Sponsor decision|1
4423173|NCT00348309|7204709|FG000|Overall Study|Adverse Event|56
4423174|NCT00348309|7204710|FG001|Overall Study|Adverse Event|28
4423175|NCT00348309|7204711|FG002|Overall Study|Adverse Event|63
4423176|NCT00348309|7204709|FG000|Overall Study|Lost to Follow-up|6
4423177|NCT00348309|7204710|FG001|Overall Study|Lost to Follow-up|7
4423178|NCT00348309|7204711|FG002|Overall Study|Lost to Follow-up|4
4423179|NCT00348309|7204709|FG000|Overall Study|Protocol Violation|7
4423180|NCT00348309|7204710|FG001|Overall Study|Protocol Violation|12
4423181|NCT00348309|7204711|FG002|Overall Study|Protocol Violation|7
4423182|NCT00348309|7204709|FG000|Overall Study|Withdrawal by Subject|33
4423183|NCT00348309|7204710|FG001|Overall Study|Withdrawal by Subject|37
4423184|NCT00348309|7204711|FG002|Overall Study|Withdrawal by Subject|40
4423185|NCT00348309|7204709|FG000|Overall Study|Non-compliance|8
4423186|NCT00348309|7204710|FG001|Overall Study|Non-compliance|6
4423187|NCT00348309|7204711|FG002|Overall Study|Non-compliance|8
4423188|NCT00348309|7204709|FG000|Overall Study|Death of caregiver|1
4423189|NCT00348309|7204710|FG001|Overall Study|Death of caregiver|0
4423190|NCT00348309|7204711|FG002|Overall Study|Death of caregiver|1
4423191|NCT00348309|7204709|FG000|Overall Study|Lack of insight, dementia|1
4423192|NCT00348309|7204710|FG001|Overall Study|Lack of insight, dementia|0
4629611|NCT01874431|7497666|FG007|Overall Study|Logistical difficulties|0
4629612|NCT01874431|7497659|FG000|Overall Study|Withdrawal by Subject|0
4629613|NCT01874431|7497660|FG001|Overall Study|Withdrawal by Subject|0
4629614|NCT01874431|7497661|FG002|Overall Study|Withdrawal by Subject|1
4629615|NCT01874431|7497662|FG003|Overall Study|Withdrawal by Subject|2
4423193|NCT00348309|7204711|FG002|Overall Study|Lack of insight, dementia|0
4423194|NCT00348309|7204709|FG000|Overall Study|Wrong bottle allocated|1
4423195|NCT00348309|7204710|FG001|Overall Study|Wrong bottle allocated|0
4423196|NCT00348309|7204711|FG002|Overall Study|Wrong bottle allocated|0
4423197|NCT00348309|7204709|FG000|Overall Study|Caregiver sick|1
4423198|NCT00348309|7204710|FG001|Overall Study|Caregiver sick|0
4423199|NCT00348309|7204711|FG002|Overall Study|Caregiver sick|0
4423200|NCT00348309|7204709|FG000|Overall Study|Use of prohibited medication|5
4423201|NCT00348309|7204710|FG001|Overall Study|Use of prohibited medication|2
4423202|NCT00348309|7204711|FG002|Overall Study|Use of prohibited medication|2
4423203|NCT00348309|7204709|FG000|Overall Study|Caregiver withdrawal|3
4423204|NCT00348309|7204710|FG001|Overall Study|Caregiver withdrawal|0
4423205|NCT00348309|7204711|FG002|Overall Study|Caregiver withdrawal|7
4423206|NCT00348309|7204709|FG000|Overall Study|Unable to complete ET visit|1
4423207|NCT00348309|7204710|FG001|Overall Study|Unable to complete ET visit|0
4423208|NCT00348309|7204711|FG002|Overall Study|Unable to complete ET visit|0
4423209|NCT00348309|7204709|FG000|Overall Study|PI closing medical practice|1
4423210|NCT00348309|7204710|FG001|Overall Study|PI closing medical practice|0
4423211|NCT00348309|7204711|FG002|Overall Study|PI closing medical practice|0
4423212|NCT00348309|7204709|FG000|Overall Study|Principal investigator's decision|1
4423213|NCT00348309|7204710|FG001|Overall Study|Principal investigator's decision|0
4423214|NCT00348309|7204711|FG002|Overall Study|Principal investigator's decision|0
4423215|NCT00348309|7204709|FG000|Overall Study|No disponibility of medication|1
4423216|NCT00348309|7204710|FG001|Overall Study|No disponibility of medication|0
4423217|NCT00348309|7204711|FG002|Overall Study|No disponibility of medication|0
4423218|NCT00348309|7204709|FG000|Overall Study|Worsened neurodegenerative disease|1
4423219|NCT00348309|7204710|FG001|Overall Study|Worsened neurodegenerative disease|0
4423220|NCT00348309|7204711|FG002|Overall Study|Worsened neurodegenerative disease|0
4423221|NCT00348309|7204709|FG000|Overall Study|Cognitive and behaviour worsening|2
4423222|NCT00348309|7204710|FG001|Overall Study|Cognitive and behaviour worsening|0
4423223|NCT00348309|7204711|FG002|Overall Study|Cognitive and behaviour worsening|0
4423224|NCT00348309|7204709|FG000|Overall Study|Worsening of alzheimer|1
4423225|NCT00348309|7204710|FG001|Overall Study|Worsening of alzheimer|0
4423226|NCT00348309|7204711|FG002|Overall Study|Worsening of alzheimer|1
4423227|NCT00348309|7204709|FG000|Overall Study|Did not appear in time for Visit 3|1
4423228|NCT00348309|7204710|FG001|Overall Study|Did not appear in time for Visit 3|0
4423229|NCT00348309|7204711|FG002|Overall Study|Did not appear in time for Visit 3|0
4423230|NCT00348309|7204709|FG000|Overall Study|Participant died|2
4423231|NCT00348309|7204710|FG001|Overall Study|Participant died|1
4423232|NCT00348309|7204711|FG002|Overall Study|Participant died|1
4423233|NCT00348309|7204709|FG000|Overall Study|Decision of sponsor|1
4423234|NCT00348309|7204710|FG001|Overall Study|Decision of sponsor|0
4423235|NCT00348309|7204711|FG002|Overall Study|Decision of sponsor|0
4423236|NCT00348309|7204709|FG000|Overall Study|Ineffectiveness of treatment|0
4423237|NCT00348309|7204710|FG001|Overall Study|Ineffectiveness of treatment|1
4423238|NCT00348309|7204711|FG002|Overall Study|Ineffectiveness of treatment|0
4423239|NCT00348309|7204709|FG000|Overall Study|A foul of exclusion criteria|0
4423240|NCT00348309|7204710|FG001|Overall Study|A foul of exclusion criteria|1
4629616|NCT01874431|7497663|FG004|Overall Study|Withdrawal by Subject|1
4423241|NCT00348309|7204711|FG002|Overall Study|A foul of exclusion criteria|0
4423242|NCT00348309|7204709|FG000|Overall Study|Participant was hospitalized|0
4423243|NCT00348309|7204710|FG001|Overall Study|Participant was hospitalized|1
4423244|NCT00348309|7204711|FG002|Overall Study|Participant was hospitalized|0
4423245|NCT00348309|7204709|FG000|Overall Study|Sponsor refuseal|0
4423246|NCT00348309|7204710|FG001|Overall Study|Sponsor refuseal|1
4423247|NCT00348309|7204711|FG002|Overall Study|Sponsor refuseal|1
4423248|NCT00348309|7204709|FG000|Overall Study|Forgot often medication|0
4423249|NCT00348309|7204710|FG001|Overall Study|Forgot often medication|1
4423250|NCT00348309|7204711|FG002|Overall Study|Forgot often medication|0
4423251|NCT00348309|7204709|FG000|Overall Study|Medical Monitor decision|0
4423252|NCT00348309|7204710|FG001|Overall Study|Medical Monitor decision|0
4423253|NCT00348309|7204711|FG002|Overall Study|Medical Monitor decision|1
4423254|NCT00348309|7204709|FG000|Overall Study|Increased dose of Aricept|0
4423255|NCT00348309|7204710|FG001|Overall Study|Increased dose of Aricept|0
4423256|NCT00348309|7204711|FG002|Overall Study|Increased dose of Aricept|1
4423257|NCT00348309|7204709|FG000|Overall Study|Site closure|0
4423258|NCT00348309|7204710|FG001|Overall Study|Site closure|0
4423259|NCT00348309|7204711|FG002|Overall Study|Site closure|1
4423260|NCT00348309|7204709|FG000|Overall Study|Adverse event not attended|0
4423261|NCT00348309|7204710|FG001|Overall Study|Adverse event not attended|0
4423262|NCT00348309|7204711|FG002|Overall Study|Adverse event not attended|1
4423263|NCT00348309|7204709|FG000|Overall Study|ECG abnormal|0
4423264|NCT00348309|7204710|FG001|Overall Study|ECG abnormal|0
4423265|NCT00348309|7204711|FG002|Overall Study|ECG abnormal|2
4423266|NCT00348309|7204709|FG000|Overall Study|Cardiologist recommendations|0
4423267|NCT00348309|7204710|FG001|Overall Study|Cardiologist recommendations|0
4423268|NCT00348309|7204711|FG002|Overall Study|Cardiologist recommendations|1
4423269|NCT00348309|7204709|FG000|Overall Study|HCV career|0
4423270|NCT00348309|7204710|FG001|Overall Study|HCV career|0
4423271|NCT00348309|7204711|FG002|Overall Study|HCV career|1
4423272|NCT00348348|7204722|FG000|Overall Study|Adverse event - unrelated to study drug|0
4423273|NCT00348348|7204723|FG001|Overall Study|Adverse event - unrelated to study drug|1
4423274|NCT00348348|7204722|FG000|Overall Study|Lack of Efficacy|1
4423275|NCT00348348|7204723|FG001|Overall Study|Lack of Efficacy|1
4423276|NCT00348348|7204722|FG000|Overall Study|Lost to Follow-up|8
4423277|NCT00348348|7204723|FG001|Overall Study|Lost to Follow-up|10
4423278|NCT00348348|7204722|FG000|Overall Study|Withdrawal by Subject|4
4423279|NCT00348348|7204723|FG001|Overall Study|Withdrawal by Subject|1
4423280|NCT00348348|7204722|FG000|Overall Study|Other|7
4423281|NCT00348348|7204723|FG001|Overall Study|Other|4
4423282|NCT00348348|7204722|FG000|Overall Study|Dissallowed Meds - unrelated to study|1
4423283|NCT00348348|7204723|FG001|Overall Study|Dissallowed Meds - unrelated to study|3
4423284|NCT00348348|7204722|FG000|Overall Study|Dissallowed Meds - unlikley related|1
4423285|NCT00348348|7204723|FG001|Overall Study|Dissallowed Meds - unlikley related|1
4423286|NCT00348348|7204722|FG000|Overall Study|Dissallowed Meds - possibly releated|1
4423287|NCT00348348|7204723|FG001|Overall Study|Dissallowed Meds - possibly releated|1
4423288|NCT00348348|7204722|FG000|Overall Study|Worsening of BC - Unrelated to study|0
4423289|NCT00348348|7204723|FG001|Overall Study|Worsening of BC - Unrelated to study|3
4423290|NCT00348348|7204722|FG000|Overall Study|Worsening of BC - Unlikely related|1
4423291|NCT00348348|7204723|FG001|Overall Study|Worsening of BC - Unlikely related|2
4423292|NCT00348348|7204722|FG000|Overall Study|Adverse event probably related to study|1
4423293|NCT00348348|7204723|FG001|Overall Study|Adverse event probably related to study|0
4423294|NCT00348374|7204731|FG000|Overall Study|Adverse Event|1
4423295|NCT00348374|7204732|FG001|Overall Study|Adverse Event|4
4423296|NCT00348374|7204731|FG000|Overall Study|Lost to Follow-up|1
4423297|NCT00348374|7204732|FG001|Overall Study|Lost to Follow-up|3
4423298|NCT00348374|7204731|FG000|Overall Study|Withdrawal by Subject|5
4423299|NCT00348374|7204732|FG001|Overall Study|Withdrawal by Subject|5
4423300|NCT00348374|7204731|FG000|Overall Study|Other|11
4423301|NCT00348374|7204732|FG001|Overall Study|Other|12
4423302|NCT00348374|7204731|FG000|Overall Study|ongoing at date of cutoff|1
4423303|NCT00348374|7204732|FG001|Overall Study|ongoing at date of cutoff|1
4423304|NCT00348374|7204731|FG000|Overall Study|randomized but did not receive treatment|0
4423305|NCT00348374|7204732|FG001|Overall Study|randomized but did not receive treatment|7
4423306|NCT00348595|7204741|FG000|Overall Study|Adverse Event|5
4423307|NCT00348595|7204742|FG001|Overall Study|Adverse Event|8
4423308|NCT00348673|7204756|FG000|Stage 1|Randomized but not Treated|0
4423309|NCT00348673|7204757|FG001|Stage 1|Randomized but not Treated|0
4423310|NCT00348673|7204758|FG002|Stage 1|Randomized but not Treated|1
4423311|NCT00348673|7204759|FG003|Stage 1|Randomized but not Treated|0
4423312|NCT00348673|7204760|FG004|Stage 1|Randomized but not Treated|0
4423313|NCT00348673|7204761|FG005|Stage 1|Randomized but not Treated|0
4423314|NCT00348673|7204762|FG006|Stage 1|Randomized but not Treated|0
4423315|NCT00348673|7204763|FG007|Stage 1|Randomized but not Treated|0
4423316|NCT00348673|7204764|FG008|Stage 1|Randomized but not Treated|0
4423317|NCT00348686|7204782|FG000|Overall Study|Withdrawal by Subject|45
4423318|NCT00348686|7204782|FG000|Overall Study|Adverse Event|5
4423319|NCT00348686|7204782|FG000|Overall Study|Protocol Violation|6
4423320|NCT00348686|7204782|FG000|Overall Study|Lost to Follow-up|2
4423321|NCT00348686|7204782|FG000|Overall Study|Multiple Reasons|8
4423322|NCT00348790|7204786|FG000|Completed Treatment|Withdrawal by Subject|4
4423323|NCT00348790|7204786|FG000|Completed Treatment|Disease progression|14
4423324|NCT00348790|7204786|FG000|Completed Treatment|Adverse Event|4
4423325|NCT00348790|7204786|FG000|Completed Treatment|Required surgery|2
4423326|NCT00348790|7204786|FG000|Completed Treatment|Unable to travel to study site|1
4423327|NCT00348816|7204791|FG000|Overall Study|Noncompliance with radiation treatment|1
4423328|NCT00348881|7204799|FG000|Overall Study|Lost to Follow-up|12
4423329|NCT00348881|7204800|FG001|Overall Study|Lost to Follow-up|6
4423330|NCT00348881|7204799|FG000|Overall Study|Withdrawal by Subject|3
4423331|NCT00348881|7204800|FG001|Overall Study|Withdrawal by Subject|4
4423332|NCT00348881|7204799|FG000|Overall Study|Adverse Event|2
4423333|NCT00348881|7204800|FG001|Overall Study|Adverse Event|0
4423334|NCT00348881|7204799|FG000|Overall Study|Serious Adverse Event|0
4423335|NCT00348881|7204800|FG001|Overall Study|Serious Adverse Event|2
4423336|NCT00348933|7204810|FG000|Overall Study|Withdrawal by Subject|10
4423337|NCT00348933|7204810|FG000|Overall Study|Lost to Follow-up|6
4423338|NCT00348933|7204810|FG000|Overall Study|Protocol Violation|2
4423339|NCT00348933|7204810|FG000|Overall Study|Adverse Event|7
4512178|NCT00932373|7321872|FG007|Overall Study|Physician Decision|0
4512179|NCT00932373|7321873|FG008|Overall Study|Physician Decision|0
4512180|NCT00932373|7321874|FG009|Overall Study|Physician Decision|1
4512181|NCT00932373|7321875|FG010|Overall Study|Physician Decision|0
4512182|NCT00932373|7321865|FG000|Overall Study|Dose limiting toxicity|0
4512183|NCT00932373|7321866|FG001|Overall Study|Dose limiting toxicity|0
4512184|NCT00932373|7321867|FG002|Overall Study|Dose limiting toxicity|0
4512185|NCT00932373|7321868|FG003|Overall Study|Dose limiting toxicity|0
4512186|NCT00932373|7321869|FG004|Overall Study|Dose limiting toxicity|0
4512187|NCT00932373|7321870|FG005|Overall Study|Dose limiting toxicity|1
4512188|NCT00932373|7321871|FG006|Overall Study|Dose limiting toxicity|0
4512189|NCT00932373|7321872|FG007|Overall Study|Dose limiting toxicity|0
4512190|NCT00932373|7321873|FG008|Overall Study|Dose limiting toxicity|0
4512191|NCT00932373|7321874|FG009|Overall Study|Dose limiting toxicity|0
4512192|NCT00932373|7321875|FG010|Overall Study|Dose limiting toxicity|0
4512193|NCT00932373|7321865|FG000|Overall Study|Withdrawal by Subject|0
4512194|NCT00932373|7321866|FG001|Overall Study|Withdrawal by Subject|0
4512195|NCT00932373|7321867|FG002|Overall Study|Withdrawal by Subject|0
4512196|NCT00932373|7321868|FG003|Overall Study|Withdrawal by Subject|0
4512197|NCT00932373|7321869|FG004|Overall Study|Withdrawal by Subject|0
4512198|NCT00932373|7321870|FG005|Overall Study|Withdrawal by Subject|0
4512199|NCT00932373|7321871|FG006|Overall Study|Withdrawal by Subject|0
4512200|NCT00932373|7321872|FG007|Overall Study|Withdrawal by Subject|0
4512201|NCT00932373|7321873|FG008|Overall Study|Withdrawal by Subject|1
4512202|NCT00932373|7321874|FG009|Overall Study|Withdrawal by Subject|0
4512203|NCT00932373|7321875|FG010|Overall Study|Withdrawal by Subject|0
4512204|NCT00932373|7321865|FG000|Overall Study|Clinical progression|0
4512205|NCT00932373|7321866|FG001|Overall Study|Clinical progression|0
4512206|NCT00932373|7321867|FG002|Overall Study|Clinical progression|0
4512207|NCT00932373|7321868|FG003|Overall Study|Clinical progression|0
4512208|NCT00932373|7321869|FG004|Overall Study|Clinical progression|0
4512209|NCT00932373|7321870|FG005|Overall Study|Clinical progression|0
4512210|NCT00932373|7321871|FG006|Overall Study|Clinical progression|1
4512211|NCT00932373|7321872|FG007|Overall Study|Clinical progression|0
4512212|NCT00932373|7321873|FG008|Overall Study|Clinical progression|0
4512213|NCT00932373|7321874|FG009|Overall Study|Clinical progression|0
4512214|NCT00932373|7321875|FG010|Overall Study|Clinical progression|0
4512215|NCT00932373|7321865|FG000|Overall Study|Lack of Efficacy|0
4512216|NCT00932373|7321866|FG001|Overall Study|Lack of Efficacy|0
4512217|NCT00932373|7321867|FG002|Overall Study|Lack of Efficacy|0
4512218|NCT00932373|7321868|FG003|Overall Study|Lack of Efficacy|0
4512219|NCT00932373|7321869|FG004|Overall Study|Lack of Efficacy|0
4512220|NCT00932373|7321870|FG005|Overall Study|Lack of Efficacy|0
4512221|NCT00932373|7321871|FG006|Overall Study|Lack of Efficacy|0
4512222|NCT00932373|7321872|FG007|Overall Study|Lack of Efficacy|0
4512223|NCT00932373|7321873|FG008|Overall Study|Lack of Efficacy|0
4512224|NCT00932373|7321874|FG009|Overall Study|Lack of Efficacy|1
4512225|NCT00932373|7321875|FG010|Overall Study|Lack of Efficacy|0
4512226|NCT00932425|7321918|FG000|Overall Study|Lost to Follow-up|0
4512227|NCT00932425|7321919|FG001|Overall Study|Lost to Follow-up|1
4512228|NCT00932425|7321918|FG000|Overall Study|Withdrawal by Subject|0
4512229|NCT00932425|7321919|FG001|Overall Study|Withdrawal by Subject|1
4512230|NCT00932451|7321936|FG000|Overall Study|Withdrawal by Subject|69
4512231|NCT00932451|7321936|FG000|Overall Study|Lost to Follow-up|22
4512232|NCT00932451|7321936|FG000|Overall Study|Death|726
4512233|NCT00932451|7321936|FG000|Overall Study|Other reasons|5
4512234|NCT00932646|7321968|FG000|Overall Study|Adverse Event|2
4512235|NCT00932646|7321969|FG001|Overall Study|Adverse Event|1
4512236|NCT00932646|7321970|FG002|Overall Study|Adverse Event|1
4512237|NCT00932646|7321971|FG003|Overall Study|Adverse Event|1
4512238|NCT00932646|7321968|FG000|Overall Study|Lost to Follow-up|2
4512239|NCT00932646|7321969|FG001|Overall Study|Lost to Follow-up|1
4512240|NCT00932646|7321970|FG002|Overall Study|Lost to Follow-up|0
4512241|NCT00932646|7321971|FG003|Overall Study|Lost to Follow-up|0
4512242|NCT00932646|7321968|FG000|Overall Study|Withdrawal by Subject|1
4423340|NCT00349349|7204838|FG000|Overall Study|Adverse Event|5
4423341|NCT00349349|7204839|FG001|Overall Study|Adverse Event|6
4423342|NCT00349349|7204840|FG002|Overall Study|Adverse Event|2
4423343|NCT00349349|7204838|FG000|Overall Study|Withdrawal by Subject|5
4423344|NCT00349349|7204839|FG001|Overall Study|Withdrawal by Subject|2
4423345|NCT00349349|7204840|FG002|Overall Study|Withdrawal by Subject|1
4423346|NCT00349349|7204838|FG000|Overall Study|Withdrawn due to Disease Progression|27
4423347|NCT00349349|7204839|FG001|Overall Study|Withdrawn due to Disease Progression|37
4423348|NCT00349349|7204840|FG002|Overall Study|Withdrawn due to Disease Progression|1
4423349|NCT00349349|7204838|FG000|Overall Study|Death|13
4423350|NCT00349349|7204839|FG001|Overall Study|Death|10
4423351|NCT00349349|7204840|FG002|Overall Study|Death|1
4423352|NCT00349349|7204838|FG000|Overall Study|Other Treatment Selected|2
4423353|NCT00349349|7204839|FG001|Overall Study|Other Treatment Selected|0
4423354|NCT00349349|7204840|FG002|Overall Study|Other Treatment Selected|0
4423355|NCT00349349|7204838|FG000|Overall Study|Participant Reduced General Condition|0
4423356|NCT00349349|7204839|FG001|Overall Study|Participant Reduced General Condition|1
4423357|NCT00349349|7204840|FG002|Overall Study|Participant Reduced General Condition|0
4423358|NCT00349349|7204838|FG000|Overall Study|Physician Decision|1
4423359|NCT00349349|7204839|FG001|Overall Study|Physician Decision|2
4423360|NCT00349349|7204840|FG002|Overall Study|Physician Decision|1
4423361|NCT00349349|7204838|FG000|Overall Study|No Response|0
4423362|NCT00349349|7204839|FG001|Overall Study|No Response|3
4423363|NCT00349349|7204840|FG002|Overall Study|No Response|0
4423364|NCT00349349|7204838|FG000|Overall Study|New Malignancy (Bladder Cancer)|0
4423365|NCT00349349|7204839|FG001|Overall Study|New Malignancy (Bladder Cancer)|1
4423366|NCT00349349|7204840|FG002|Overall Study|New Malignancy (Bladder Cancer)|0
4423367|NCT00349622|7204870|FG000|Overall Study|Death|168
4423368|NCT00349622|7204871|FG001|Overall Study|Death|86
4423369|NCT00349622|7204870|FG000|Overall Study|Lost to Follow-up|5
4423370|NCT00349622|7204871|FG001|Overall Study|Lost to Follow-up|1
4423371|NCT00349622|7204870|FG000|Overall Study|Withdrawal by Subject|5
4423372|NCT00349622|7204871|FG001|Overall Study|Withdrawal by Subject|9
4423373|NCT00349752|7204892|FG000|Overall Study|Adverse Event|8
4423374|NCT00349752|7204893|FG001|Overall Study|Adverse Event|12
4423375|NCT00349752|7204892|FG000|Overall Study|Lack of Efficacy|37
4423376|NCT00349752|7204893|FG001|Overall Study|Lack of Efficacy|42
4423377|NCT00349752|7204892|FG000|Overall Study|Lost to Follow-up|4
4423378|NCT00349752|7204893|FG001|Overall Study|Lost to Follow-up|2
4423379|NCT00349752|7204892|FG000|Overall Study|Personal reasons|6
4423380|NCT00349752|7204893|FG001|Overall Study|Personal reasons|5
4423381|NCT00349752|7204892|FG000|Overall Study|Other: Required exclusionary medication|0
4423382|NCT00349752|7204893|FG001|Overall Study|Other: Required exclusionary medication|1
4423383|NCT00349752|7204892|FG000|Overall Study|Other: Non compliance|0
4423384|NCT00349752|7204893|FG001|Overall Study|Other: Non compliance|1
4423385|NCT00349752|7204892|FG000|Overall Study|Other: Patient stopped steroids|0
4423386|NCT00349752|7204893|FG001|Overall Study|Other: Patient stopped steroids|1
4423387|NCT00349752|7204892|FG000|Overall Study|Other: Patient's steroid use|1
4423388|NCT00349752|7204893|FG001|Overall Study|Other: Patient's steroid use|0
4423389|NCT00349752|7204892|FG000|Overall Study|Other: Ineligible|1
4423390|NCT00349752|7204893|FG001|Overall Study|Other: Ineligible|0
4423391|NCT00349752|7204892|FG000|Overall Study|Other: Inadvertently unblinded|1
4423392|NCT00349752|7204893|FG001|Overall Study|Other: Inadvertently unblinded|0
4423393|NCT00349752|7204892|FG000|Overall Study|Other:History of squamous cell carcinoma|1
4423394|NCT00349752|7204893|FG001|Overall Study|Other:History of squamous cell carcinoma|0
4423395|NCT00349908|7204905|FG000|Overall Study|Withdrawal by Subject|0
4714927|NCT02964325|7642986|FG000|Overall Study|Lost to Follow-up|3
4714928|NCT02964325|7642987|FG001|Overall Study|Lost to Follow-up|3
4714929|NCT02964325|7642986|FG000|Overall Study|Physician Decision|5
4714930|NCT02964325|7642987|FG001|Overall Study|Physician Decision|4
4714931|NCT02964325|7642986|FG000|Overall Study|Death|1
4714932|NCT02964325|7642987|FG001|Overall Study|Death|3
4714933|NCT02964325|7642986|FG000|Overall Study|Withdrawal by Subject|2
4714934|NCT02964325|7642987|FG001|Overall Study|Withdrawal by Subject|1
4714935|NCT02964325|7642986|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10
4714936|NCT02964325|7642987|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12
4714937|NCT02964338|7642996|FG000|Overall Study|Sponsor terminated study for futility|12
4714938|NCT02964338|7642997|FG001|Overall Study|Sponsor terminated study for futility|15
4714939|NCT02964338|7642998|FG002|Overall Study|Sponsor terminated study for futility|14
4714940|NCT02964338|7642996|FG000|Overall Study|Lack of Efficacy|0
4714941|NCT02964338|7642997|FG001|Overall Study|Lack of Efficacy|3
4714942|NCT02964338|7642998|FG002|Overall Study|Lack of Efficacy|0
4423396|NCT00349908|7204906|FG001|Overall Study|Withdrawal by Subject|4
4423397|NCT00349921|7204917|FG000|First Spinal Injection|Physician Decision|1
4423398|NCT00349921|7204918|FG001|First Spinal Injection|Physician Decision|0
4423399|NCT00349921|7204919|FG002|First Spinal Injection|Physician Decision|0
4714943|NCT02964338|7642996|FG000|Overall Study|Lost to Follow-up|1
4714944|NCT02964338|7642997|FG001|Overall Study|Lost to Follow-up|0
4714945|NCT02964338|7642998|FG002|Overall Study|Lost to Follow-up|3
4714946|NCT02964338|7642996|FG000|Overall Study|Protocol Violation|0
4714947|NCT02964338|7642997|FG001|Overall Study|Protocol Violation|1
4714948|NCT02964338|7642998|FG002|Overall Study|Protocol Violation|0
4423400|NCT00349921|7204920|FG003|First Spinal Injection|Physician Decision|0
4423401|NCT00349921|7204917|FG000|First Spinal Injection|Adverse Event|0
4423402|NCT00349921|7204918|FG001|First Spinal Injection|Adverse Event|0
4423403|NCT00349921|7204919|FG002|First Spinal Injection|Adverse Event|1
4423404|NCT00349921|7204920|FG003|First Spinal Injection|Adverse Event|0
4423405|NCT00349973|7204931|FG000|Overall Study|Adverse Event|3
4423406|NCT00349973|7204932|FG001|Overall Study|Adverse Event|3
4423407|NCT00349973|7204931|FG000|Overall Study|Withdrawal by Subject|1
4423408|NCT00349973|7204932|FG001|Overall Study|Withdrawal by Subject|0
4629617|NCT01874431|7497664|FG005|Overall Study|Withdrawal by Subject|1
4629618|NCT01874431|7497665|FG006|Overall Study|Withdrawal by Subject|3
4629619|NCT01874431|7497666|FG007|Overall Study|Withdrawal by Subject|0
4629620|NCT01874431|7497659|FG000|Overall Study|Sponsor decision|0
4714949|NCT02964338|7642996|FG000|Overall Study|Withdrawal by Subject|1
4714950|NCT02964338|7642997|FG001|Overall Study|Withdrawal by Subject|3
4423409|NCT00350207|7204955|FG000|Overall Study|Adverse Event|5
4423410|NCT00350207|7204956|FG001|Overall Study|Adverse Event|2
4423411|NCT00350207|7204957|FG002|Overall Study|Adverse Event|2
4423412|NCT00350207|7204955|FG000|Overall Study|Lack of Efficacy|1
4423413|NCT00350207|7204956|FG001|Overall Study|Lack of Efficacy|0
4423414|NCT00350207|7204957|FG002|Overall Study|Lack of Efficacy|2
4423415|NCT00350207|7204955|FG000|Overall Study|Lost to Follow-up|1
4423416|NCT00350207|7204956|FG001|Overall Study|Lost to Follow-up|0
4423417|NCT00350207|7204957|FG002|Overall Study|Lost to Follow-up|1
4423418|NCT00350207|7204955|FG000|Overall Study|Withdrawal by Subject|0
4423419|NCT00350207|7204956|FG001|Overall Study|Withdrawal by Subject|1
4423420|NCT00350207|7204957|FG002|Overall Study|Withdrawal by Subject|1
4423421|NCT00350207|7204955|FG000|Overall Study|Other|1
4423422|NCT00350207|7204956|FG001|Overall Study|Other|3
4423423|NCT00350207|7204957|FG002|Overall Study|Other|1
4423424|NCT00350272|7204976|FG000|Blinded 12 Week Treatment|Adverse Event|1
4423425|NCT00350272|7204977|FG001|Blinded 12 Week Treatment|Adverse Event|0
4423426|NCT00350272|7204976|FG000|Blinded 12 Week Treatment|Death|1
4423427|NCT00350272|7204977|FG001|Blinded 12 Week Treatment|Death|0
4423428|NCT00350272|7204976|FG000|Blinded 12 Week Treatment|Lost to Follow-up|2
4423429|NCT00350272|7204977|FG001|Blinded 12 Week Treatment|Lost to Follow-up|0
4423430|NCT00350272|7204976|FG000|Blinded 12 Week Treatment|Withdrawal by Subject|3
4423431|NCT00350272|7204977|FG001|Blinded 12 Week Treatment|Withdrawal by Subject|0
4423432|NCT00350272|7204976|FG000|Blinded 12 Week Treatment|Physician Decision|2
4423433|NCT00350272|7204977|FG001|Blinded 12 Week Treatment|Physician Decision|1
4423434|NCT00350272|7204976|FG000|Blinded 12 Week Treatment|Sponsor decision|0
4423435|NCT00350272|7204977|FG001|Blinded 12 Week Treatment|Sponsor decision|1
4423436|NCT00350272|7204976|FG000|Open-Label 84 Week Treatment|Adverse Event|2
4423437|NCT00350272|7204977|FG001|Open-Label 84 Week Treatment|Adverse Event|1
4423438|NCT00350272|7204976|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3
4423439|NCT00350272|7204977|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2
4423440|NCT00350272|7204976|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1
4423441|NCT00350272|7204977|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2
4423442|NCT00350272|7204976|FG000|Open-Label 84 Week Treatment|Physician Decision|1
4423443|NCT00350272|7204977|FG001|Open-Label 84 Week Treatment|Physician Decision|2
4423444|NCT00350272|7204976|FG000|Open-Label 84 Week Treatment|Sponsor decision|2
4423445|NCT00350272|7204977|FG001|Open-Label 84 Week Treatment|Sponsor decision|1
4423446|NCT00350298|7204987|FG000|Overall Study|Death|7
4423447|NCT00350298|7204988|FG001|Overall Study|Death|8
4423448|NCT00350298|7204987|FG000|Overall Study|Lost to Follow-up|1
4423449|NCT00350298|7204988|FG001|Overall Study|Lost to Follow-up|2
4423450|NCT00350298|7204987|FG000|Overall Study|Withdrawal by Subject|1
4423451|NCT00350298|7204988|FG001|Overall Study|Withdrawal by Subject|3
4423452|NCT00350402|7205018|FG000|Overall Study|Lost to Follow-up|1
4423453|NCT00350402|7205019|FG001|Overall Study|Lost to Follow-up|1
4423454|NCT00350519|7205033|FG000|Overall Study|Death|0
4423455|NCT00350519|7205034|FG001|Overall Study|Death|1
4423456|NCT00350519|7205033|FG000|Overall Study|Physician Decision|0
4423457|NCT00350519|7205034|FG001|Overall Study|Physician Decision|1
4423458|NCT00350519|7205033|FG000|Overall Study|Protocol Violation|1
4423459|NCT00350519|7205034|FG001|Overall Study|Protocol Violation|2
4423460|NCT00350519|7205033|FG000|Overall Study|Withdrawal by Subject|3
4423461|NCT00350519|7205034|FG001|Overall Study|Withdrawal by Subject|2
4423462|NCT00350545|7205049|FG000|Overall Study|Withdrawal by Subject|2
4423463|NCT00350636|7205055|FG000|Overall Study|Adverse Event|19
4423464|NCT00350636|7205056|FG001|Overall Study|Adverse Event|13
4423465|NCT00350636|7205055|FG000|Overall Study|Protocol Violation|1
4423466|NCT00350636|7205056|FG001|Overall Study|Protocol Violation|3
4423467|NCT00350636|7205055|FG000|Overall Study|Withdrawal by Subject|13
4423468|NCT00350636|7205056|FG001|Overall Study|Withdrawal by Subject|17
4423469|NCT00350636|7205055|FG000|Overall Study|Lost to Follow-up|9
4423470|NCT00350636|7205056|FG001|Overall Study|Lost to Follow-up|8
4423471|NCT00350636|7205055|FG000|Overall Study|Physician Decision|0
4714951|NCT02964338|7642998|FG002|Overall Study|Withdrawal by Subject|1
4714952|NCT02964338|7642996|FG000|Overall Study|Adverse Event|2
4629621|NCT01874431|7497660|FG001|Overall Study|Sponsor decision|0
4714953|NCT02964338|7642997|FG001|Overall Study|Adverse Event|1
4423472|NCT00350636|7205056|FG001|Overall Study|Physician Decision|2
4423473|NCT00350636|7205055|FG000|Overall Study|Other|1
4423474|NCT00350636|7205056|FG001|Overall Study|Other|2
4423475|NCT00350727|7205065|FG000|Phase I: Dose Escalation|Adverse Event|4
4423476|NCT00350727|7205066|FG001|Phase I: Dose Escalation|Adverse Event|0
4423477|NCT00350727|7205067|FG002|Phase I: Dose Escalation|Adverse Event|0
4423478|NCT00350727|7205065|FG000|Phase I: Dose Escalation|Lack of Efficacy|25
4423479|NCT00350727|7205066|FG001|Phase I: Dose Escalation|Lack of Efficacy|0
4423480|NCT00350727|7205067|FG002|Phase I: Dose Escalation|Lack of Efficacy|0
4423481|NCT00350727|7205065|FG000|Phase I: Dose Escalation|Death|1
4423482|NCT00350727|7205066|FG001|Phase I: Dose Escalation|Death|0
4423483|NCT00350727|7205067|FG002|Phase I: Dose Escalation|Death|0
4423484|NCT00350727|7205065|FG000|Phase I: Dose Escalation|Physician Decision|1
4423485|NCT00350727|7205066|FG001|Phase I: Dose Escalation|Physician Decision|0
4423486|NCT00350727|7205067|FG002|Phase I: Dose Escalation|Physician Decision|0
4423487|NCT00350727|7205065|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3
4423488|NCT00350727|7205066|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0
4423489|NCT00350727|7205067|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0
4423490|NCT00350727|7205065|FG000|Phase II|Disease Progression|0
4423491|NCT00350727|7205066|FG001|Phase II|Disease Progression|15
4423492|NCT00350727|7205067|FG002|Phase II|Disease Progression|16
4423493|NCT00350727|7205065|FG000|Phase II|Clinical Deterioration|0
4423494|NCT00350727|7205066|FG001|Phase II|Clinical Deterioration|1
4423495|NCT00350727|7205067|FG002|Phase II|Clinical Deterioration|0
4423496|NCT00350727|7205065|FG000|Phase II|Withdrawal by Subject|0
4423497|NCT00350727|7205066|FG001|Phase II|Withdrawal by Subject|2
4423498|NCT00350727|7205067|FG002|Phase II|Withdrawal by Subject|1
4423499|NCT00350727|7205065|FG000|Phase II|Adverse Event|0
4423500|NCT00350727|7205066|FG001|Phase II|Adverse Event|1
4423501|NCT00350727|7205067|FG002|Phase II|Adverse Event|1
4423502|NCT00350727|7205065|FG000|Phase II|Death|0
4423503|NCT00350727|7205066|FG001|Phase II|Death|0
4423504|NCT00350727|7205067|FG002|Phase II|Death|2
4423505|NCT00350727|7205065|FG000|Phase II|Sponsor Terminated Study|0
4423506|NCT00350727|7205066|FG001|Phase II|Sponsor Terminated Study|0
4423507|NCT00350727|7205067|FG002|Phase II|Sponsor Terminated Study|1
4423508|NCT00350727|7205065|FG000|Phase II|Enrolled in Rollover Study|0
4423509|NCT00350727|7205066|FG001|Phase II|Enrolled in Rollover Study|0
4423510|NCT00350727|7205067|FG002|Phase II|Enrolled in Rollover Study|1
4423511|NCT00350779|7205088|FG000|Overall Study|Adverse Event|4
4423512|NCT00350779|7205089|FG001|Overall Study|Adverse Event|2
4423513|NCT00350779|7205088|FG000|Overall Study|Lack of Efficacy|0
4423514|NCT00350779|7205089|FG001|Overall Study|Lack of Efficacy|4
4423515|NCT00350779|7205088|FG000|Overall Study|Lost to Follow-up|2
4423516|NCT00350779|7205089|FG001|Overall Study|Lost to Follow-up|0
4423517|NCT00350779|7205088|FG000|Overall Study|Physician Decision|2
4423518|NCT00350779|7205089|FG001|Overall Study|Physician Decision|4
4423519|NCT00350779|7205088|FG000|Overall Study|Protocol Violation|3
4423520|NCT00350779|7205089|FG001|Overall Study|Protocol Violation|1
4423521|NCT00350779|7205088|FG000|Overall Study|Withdrawal by Subject|9
4423522|NCT00350779|7205089|FG001|Overall Study|Withdrawal by Subject|8
4423523|NCT00350779|7205088|FG000|Overall Study|Patient Moved|2
4423524|NCT00350779|7205089|FG001|Overall Study|Patient Moved|1
4423525|NCT00350779|7205088|FG000|Overall Study|Non-compliance with study procedures|0
4423526|NCT00350779|7205089|FG001|Overall Study|Non-compliance with study procedures|1
4423527|NCT00350792|7205097|FG000|Overall Study|Adverse Event|11
4423528|NCT00350792|7205097|FG000|Overall Study|Death from Study Disease|1
4423529|NCT00350792|7205097|FG000|Overall Study|Death from Study Drug Toxicity|1
4423530|NCT00350792|7205097|FG000|Overall Study|Death Not Study Drug Related|2
4423531|NCT00350792|7205097|FG000|Overall Study|Protocol Violation|1
4423532|NCT00350792|7205097|FG000|Overall Study|Withdrawal by Subject|4
4423533|NCT00350792|7205097|FG000|Overall Study|Physician Decision|2
4423534|NCT00350792|7205097|FG000|Overall Study|Lack of Efficacy|11
4423535|NCT00350870|7205105|FG000|Overall Study|Withdrawal by Subject|21
4423536|NCT00350870|7205106|FG001|Overall Study|Withdrawal by Subject|17
4423537|NCT00350870|7205107|FG002|Overall Study|Withdrawal by Subject|15
4423538|NCT00350870|7205108|FG003|Overall Study|Withdrawal by Subject|14
4423539|NCT00350870|7205105|FG000|Overall Study|Physician Decision|1
4423540|NCT00350870|7205106|FG001|Overall Study|Physician Decision|0
4423541|NCT00350870|7205107|FG002|Overall Study|Physician Decision|1
4423542|NCT00350870|7205108|FG003|Overall Study|Physician Decision|1
4423543|NCT00351273|7205133|FG000|Overall Study|Lost to Follow-up|1
4423544|NCT00351273|7205134|FG001|Overall Study|Lost to Follow-up|2
4423545|NCT00351273|7205135|FG002|Overall Study|Lost to Follow-up|5
4423546|NCT00351351|7205163|FG000|Overall Study|surgical access pbs; device issues|9
4423547|NCT00351351|7205164|FG001|Overall Study|surgical access pbs; device issues|4
4423548|NCT00351377|7205170|FG000|Overall Study|Adverse Event|5
4423549|NCT00351377|7205170|FG000|Overall Study|Death|1
4423550|NCT00351377|7205170|FG000|Overall Study|Unsatisfactory therapeutic effect|1
4423551|NCT00351468|7205183|FG000|Overall Study|Adverse Event|42
4423552|NCT00351468|7205183|FG000|Overall Study|Withdrawal by Subject|39
4423553|NCT00351468|7205183|FG000|Overall Study|Various -follow up w clinical team|39
4423554|NCT00351468|7205183|FG000|Overall Study|Lack of Efficacy|32
4423555|NCT00351468|7205183|FG000|Overall Study|Non-compliance|8
4423556|NCT00351468|7205183|FG000|Overall Study|Lost to Follow-up|4
4423557|NCT00351468|7205183|FG000|Overall Study|Protocol Violation|3
4423558|NCT00351533|7205190|FG000|Overall Study|Extubated before first BAL|1
4423559|NCT00351533|7205191|FG001|Overall Study|Extubated before first BAL|0
4423560|NCT00351533|7205190|FG000|Overall Study|Lost to Follow-up|1
4423561|NCT00351533|7205191|FG001|Overall Study|Lost to Follow-up|3
4423562|NCT00351533|7205190|FG000|Overall Study|Physician Decision|0
4423563|NCT00351533|7205191|FG001|Overall Study|Physician Decision|1
4423564|NCT00351533|7205190|FG000|Overall Study|Withdrawal by Subject|0
4423565|NCT00351533|7205191|FG001|Overall Study|Withdrawal by Subject|1
4423566|NCT00351611|7205199|FG000|Overall Study|Adverse Event|11
4423567|NCT00351611|7205200|FG001|Overall Study|Adverse Event|3
4423568|NCT00351611|7205199|FG000|Overall Study|Death|1
4423569|NCT00351611|7205200|FG001|Overall Study|Death|0
4423570|NCT00351611|7205199|FG000|Overall Study|Lost to Follow-up|1
4423571|NCT00351611|7205200|FG001|Overall Study|Lost to Follow-up|0
4423572|NCT00351611|7205199|FG000|Overall Study|No Longer Willing to Participate in Study|0
4423573|NCT00351611|7205200|FG001|Overall Study|No Longer Willing to Participate in Study|5
4423574|NCT00351611|7205199|FG000|Overall Study|Other|1
4423575|NCT00351611|7205200|FG001|Overall Study|Other|0
4423576|NCT00351611|7205199|FG000|Overall Study|Protocol Violation|0
4423577|NCT00351611|7205200|FG001|Overall Study|Protocol Violation|2
4423578|NCT00351819|7205217|FG000|Overall Study|Lost to Follow-up|4
4423579|NCT00351819|7205218|FG001|Overall Study|Lost to Follow-up|4
4423580|NCT00351819|7205217|FG000|Overall Study|Withdrawal by Subject|0
4423581|NCT00351819|7205218|FG001|Overall Study|Withdrawal by Subject|4
4423582|NCT00351819|7205217|FG000|Overall Study|Elevated PSA|1
4423583|NCT00351819|7205218|FG001|Overall Study|Elevated PSA|1
4423584|NCT00351819|7205217|FG000|Overall Study|Traumatic ankle fracture|1
4423585|NCT00351819|7205218|FG001|Overall Study|Traumatic ankle fracture|0
4423586|NCT00351819|7205217|FG000|Overall Study|Unprofessional behavior|1
4423587|NCT00351819|7205218|FG001|Overall Study|Unprofessional behavior|0
4423588|NCT00351819|7205217|FG000|Overall Study|Non-compliance|0
4423589|NCT00351819|7205218|FG001|Overall Study|Non-compliance|1
4423590|NCT00351819|7205217|FG000|Overall Study|Incarcerated|0
4423591|NCT00351819|7205218|FG001|Overall Study|Incarcerated|1
4423592|NCT00351819|7205217|FG000|Overall Study|Enrolled in another trial|0
4423593|NCT00351819|7205218|FG001|Overall Study|Enrolled in another trial|1
4423594|NCT00352027|7205233|FG000|Overall Study|Progressive disease|3
4423595|NCT00352053|7205261|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14
4423596|NCT00352053|7205262|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10
4423597|NCT00352053|7205261|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2
4423598|NCT00352053|7205262|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2
4423599|NCT00352053|7205261|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1
4423600|NCT00352053|7205262|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0
4423601|NCT00352053|7205261|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0
4423602|NCT00352053|7205262|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1
4423603|NCT00352053|7205261|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1
4423604|NCT00352053|7205262|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0
4423605|NCT00352053|7205261|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9
4423606|NCT00352053|7205262|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13
4423607|NCT00352053|7205261|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1
4423608|NCT00352053|7205262|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4
4423609|NCT00352053|7205261|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1
4423610|NCT00352053|7205262|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0
4423611|NCT00352053|7205261|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1
4423612|NCT00352053|7205262|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0
4423613|NCT00352053|7205261|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4
4423614|NCT00352053|7205262|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4
4423615|NCT00352053|7205261|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1
4423616|NCT00352053|7205262|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1
4423617|NCT00352053|7205261|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1
4423618|NCT00352053|7205262|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1
4423619|NCT00352053|7205261|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0
4423620|NCT00352053|7205262|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1
4423621|NCT00352105|7205276|FG000|Overall Study|Death|5
4423622|NCT00352105|7205276|FG000|Overall Study|Withdrawal by Subject|5
4423623|NCT00352105|7205276|FG000|Overall Study|Lack of Efficacy|9
4423624|NCT00352105|7205276|FG000|Overall Study|Adverse Event|19
4423625|NCT00352105|7205276|FG000|Overall Study|Protocol Violation|2
4423626|NCT00352365|7205280|FG000|Induction Therapy|Adverse Event|7
4423627|NCT00352365|7205280|FG000|Induction Therapy|Progression/Relapse|8
4423628|NCT00352365|7205280|FG000|Induction Therapy|Death|7
4423629|NCT00352365|7205280|FG000|Induction Therapy|Not protocol specified|1
4423630|NCT00352365|7205280|FG000|Induction Therapy|Not eligible|3
4423631|NCT00352365|7205280|FG000|Induction Therapy|Death before starting protocol therapy|1
4423632|NCT00352365|7205280|FG000|Maintenance Therapy|Progression/Relapse|3
4423633|NCT00352365|7205280|FG000|Maintenance Therapy|Death|2
4423634|NCT00352365|7205280|FG000|Maintenance Therapy|Not protocol specified|3
4423635|NCT00352365|7205280|FG000|Maintenance Therapy|Not eligible|4
4423636|NCT00352417|7205290|FG000|Overall Study|Adverse Event|1
4423637|NCT00352417|7205291|FG001|Overall Study|Adverse Event|0
4423638|NCT00352417|7205290|FG000|Overall Study|Protocol Violation|0
4423639|NCT00352417|7205291|FG001|Overall Study|Protocol Violation|2
4423640|NCT00352417|7205290|FG000|Overall Study|Withdrawal by Subject|1
4423641|NCT00352417|7205291|FG001|Overall Study|Withdrawal by Subject|2
4423642|NCT00352417|7205290|FG000|Overall Study|Lost to Follow-up|1
4423643|NCT00352417|7205291|FG001|Overall Study|Lost to Follow-up|0
4423644|NCT00352417|7205290|FG000|Overall Study|Schedule Change|2
4423645|NCT00352417|7205291|FG001|Overall Study|Schedule Change|1
4423646|NCT00352664|7205308|FG000|Overall Study|Withdrawal by Subject|7
4423647|NCT00352664|7205309|FG001|Overall Study|Withdrawal by Subject|0
4423648|NCT00352690|7205317|FG000|Overall Study|Determined to be ineligible|2
4423649|NCT00352690|7205318|FG001|Overall Study|Determined to be ineligible|0
4423650|NCT00352755|7205324|FG000|Overall Study|Physician Decision|1
4423651|NCT00352755|7205324|FG000|Overall Study|Adverse Event|1
4423652|NCT00352846|7205338|FG000|Overall Study|Disease progression|0
4423653|NCT00352846|7205339|FG001|Overall Study|Disease progression|2
4423654|NCT00352846|7205338|FG000|Overall Study|Withdrawal by Subject|3
4423655|NCT00352846|7205339|FG001|Overall Study|Withdrawal by Subject|8
4423656|NCT00352846|7205338|FG000|Overall Study|Ineligible|3
4423657|NCT00352846|7205339|FG001|Overall Study|Ineligible|2
4423658|NCT00352846|7205338|FG000|Overall Study|Non-compliance|2
4423659|NCT00352846|7205339|FG001|Overall Study|Non-compliance|0
4423660|NCT00352846|7205338|FG000|Overall Study|Death|0
4423661|NCT00352846|7205339|FG001|Overall Study|Death|1
4423662|NCT00352885|7205347|FG000|Overall Study|Withdrawal by Subject|0
4423663|NCT00352885|7205348|FG001|Overall Study|Withdrawal by Subject|3
4423664|NCT00352885|7205347|FG000|Overall Study|Development of major depression|0
4423665|NCT00352885|7205348|FG001|Overall Study|Development of major depression|1
4423666|NCT00352885|7205347|FG000|Overall Study|Progression of metastatic melanoma|5
4423667|NCT00352885|7205348|FG001|Overall Study|Progression of metastatic melanoma|3
4423668|NCT00352885|7205347|FG000|Overall Study|Side effects of IL-2 administration|1
4423669|NCT00352885|7205348|FG001|Overall Study|Side effects of IL-2 administration|0
4423670|NCT00353262|7205380|FG000|Overall Study|Adverse Event|8
4423671|NCT00353262|7205380|FG000|Overall Study|Withdrawal by Subject|2
4423672|NCT00353262|7205380|FG000|Overall Study|Insufficient Therapeutic Response|13
4423673|NCT00353262|7205380|FG000|Overall Study|Progression|1
4423674|NCT00353262|7205380|FG000|Overall Study|Surgery|4
4423675|NCT00353262|7205380|FG000|Overall Study|Break from Chemotherapy|1
4423676|NCT00353366|7205388|FG000|Overall Study|Adverse Event|8
4423677|NCT00353366|7205388|FG000|Overall Study|Protocol Violation|12
4423678|NCT00353366|7205388|FG000|Overall Study|Withdrawal by Subject|12
4423679|NCT00353366|7205388|FG000|Overall Study|Lost to Follow-up|92
4423680|NCT00353366|7205388|FG000|Overall Study|Other|19
4423681|NCT00353496|7205412|FG000|Overall Study|Adverse Event|1
4423682|NCT00353496|7205413|FG001|Overall Study|Adverse Event|0
4423683|NCT00353496|7205412|FG000|Overall Study|Protocol Violation|2
4423684|NCT00353496|7205413|FG001|Overall Study|Protocol Violation|2
4423685|NCT00353496|7205412|FG000|Overall Study|Withdrawal by Subject|3
4423686|NCT00353496|7205413|FG001|Overall Study|Withdrawal by Subject|4
4423687|NCT00353496|7205412|FG000|Overall Study|Physician Decision|6
4423688|NCT00353496|7205413|FG001|Overall Study|Physician Decision|9
4423689|NCT00353496|7205412|FG000|Overall Study|Not otherwise specified|4
4423690|NCT00353496|7205413|FG001|Overall Study|Not otherwise specified|2
4423691|NCT00353704|7205455|FG000|Overall Study|Protocol Violation|3
4423692|NCT00353704|7205456|FG001|Overall Study|Protocol Violation|1
4423693|NCT00353873|7205477|FG000|Overall Study|Protocol Violation|1
4423694|NCT00353873|7205478|FG001|Overall Study|Protocol Violation|2
4423695|NCT00353873|7205477|FG000|Overall Study|Exacerbation|1
4423696|NCT00353873|7205478|FG001|Overall Study|Exacerbation|0
4423697|NCT00353873|7205477|FG000|Overall Study|Adverse Event|1
4423698|NCT00353873|7205478|FG001|Overall Study|Adverse Event|0
4423699|NCT00353873|7205477|FG000|Overall Study|Physician Decision|2
4423700|NCT00353873|7205478|FG001|Overall Study|Physician Decision|0
4423701|NCT00353873|7205477|FG000|Overall Study|Withdrawal by Subject|1
4423702|NCT00353873|7205478|FG001|Overall Study|Withdrawal by Subject|1
4423703|NCT00354029|7205490|FG000|Overall Study|Protocol Violation|4
4423704|NCT00354029|7205491|FG001|Overall Study|Protocol Violation|2
4423705|NCT00354107|7205497|FG000|Overall Study|Adverse Event|2
4423706|NCT00354107|7205497|FG000|Overall Study|Physician Decision|2
4423707|NCT00354107|7205497|FG000|Overall Study|Withdrawal by Subject|1
4423708|NCT00354159|7205503|FG000|Randomized Study Period|Withdrawal by Subject|5
4423709|NCT00354159|7205504|FG001|Randomized Study Period|Withdrawal by Subject|3
4423710|NCT00354159|7205503|FG000|Randomized Study Period|Physician Decision|6
4423711|NCT00354159|7205504|FG001|Randomized Study Period|Physician Decision|10
4423712|NCT00354159|7205503|FG000|Randomized Study Period|Lost to Follow-up|4
4423713|NCT00354159|7205504|FG001|Randomized Study Period|Lost to Follow-up|0
4423714|NCT00354159|7205503|FG000|Randomized Study Period|Death|7
4423715|NCT00354159|7205504|FG001|Randomized Study Period|Death|9
4423716|NCT00354159|7205503|FG000|Long-term Follow-up|Withdrawal by Subject|9
4423717|NCT00354159|7205504|FG001|Long-term Follow-up|Withdrawal by Subject|9
4423718|NCT00354159|7205503|FG000|Long-term Follow-up|Physician Decision|127
4423719|NCT00354159|7205504|FG001|Long-term Follow-up|Physician Decision|122
4423720|NCT00354159|7205503|FG000|Long-term Follow-up|Lost to Follow-up|1
4423721|NCT00354159|7205504|FG001|Long-term Follow-up|Lost to Follow-up|0
4423722|NCT00354159|7205503|FG000|Long-term Follow-up|Death|14
4423723|NCT00354159|7205504|FG001|Long-term Follow-up|Death|11
4423724|NCT00354159|7205503|FG000|Long-term Follow-up|Study Closed|29
4423725|NCT00354159|7205504|FG001|Long-term Follow-up|Study Closed|34
4423726|NCT00354172|7205517|FG000|Overall Study|Did not receive transplant|1
4423727|NCT00354341|7205527|FG000|Overall Study|Adverse Event|1
4423728|NCT00354341|7205528|FG001|Overall Study|Adverse Event|0
4423729|NCT00354341|7205527|FG000|Overall Study|Death|0
4423730|NCT00354341|7205528|FG001|Overall Study|Death|2
4423731|NCT00354341|7205527|FG000|Overall Study|Refused treatment|1
4423732|NCT00354341|7205528|FG001|Overall Study|Refused treatment|2
4423733|NCT00354341|7205527|FG000|Overall Study|Failure to return|0
4423734|NCT00354341|7205528|FG001|Overall Study|Failure to return|1
4423735|NCT00354341|7205527|FG000|Overall Study|Other|1
4423736|NCT00354341|7205528|FG001|Overall Study|Other|2
4423737|NCT00354432|7205538|FG000|Overall Study|Adverse Event|3
4423738|NCT00354432|7205539|FG001|Overall Study|Adverse Event|1
4423739|NCT00354432|7205540|FG002|Overall Study|Adverse Event|5
4423740|NCT00354432|7205541|FG003|Overall Study|Adverse Event|5
4423741|NCT00354432|7205538|FG000|Overall Study|Off/Toxicity|3
4423742|NCT00354432|7205539|FG001|Overall Study|Off/Toxicity|7
4423743|NCT00354432|7205540|FG002|Overall Study|Off/Toxicity|5
4423744|NCT00354432|7205541|FG003|Overall Study|Off/Toxicity|5
4423745|NCT00354601|7205560|FG000|Overall Study|Protocol Violation|1
4423746|NCT00354601|7205560|FG000|Overall Study|progression|1
4423747|NCT00354614|7205564|FG000|Overall Study|Lack of Efficacy|28
4423748|NCT00354679|7205572|FG000|Overall Study|Patient Not Treated|1
4423749|NCT00354744|7205576|FG000|Overall Study|Adverse Event|2
4423750|NCT00354744|7205576|FG000|Overall Study|Death|2
4423751|NCT00354744|7205576|FG000|Overall Study|Lack of Efficacy|11
4423752|NCT00354744|7205576|FG000|Overall Study|Lost to Follow-up|2
4423753|NCT00354744|7205576|FG000|Overall Study|Physician Decision|11
4423754|NCT00354744|7205576|FG000|Overall Study|Withdrawal by Subject|14
4423755|NCT00355030|7205605|FG000|Study Period 1 Treatment|Adverse Event|1
4423756|NCT00355030|7205606|FG001|Study Period 1 Treatment|Adverse Event|1
4423757|NCT00355030|7205605|FG000|Study Period 1 Treatment|Lost to Follow-up|3
4423758|NCT00355030|7205606|FG001|Study Period 1 Treatment|Lost to Follow-up|0
4423759|NCT00355030|7205605|FG000|Study Period 1 Treatment|Withdrawal by Subject|4
4423760|NCT00355030|7205606|FG001|Study Period 1 Treatment|Withdrawal by Subject|1
4423761|NCT00355030|7205605|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1
4423762|NCT00355030|7205606|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2
4423763|NCT00355030|7205605|FG000|Study Period 1 Treatment|Physician Decision|0
4423764|NCT00355030|7205606|FG001|Study Period 1 Treatment|Physician Decision|1
4629622|NCT01874431|7497661|FG002|Overall Study|Sponsor decision|0
4629623|NCT01874431|7497662|FG003|Overall Study|Sponsor decision|0
4629624|NCT01874431|7497663|FG004|Overall Study|Sponsor decision|1
4423765|NCT00355030|7205605|FG000|Study Period 1 Treatment|Sponsor Decision|34
4423766|NCT00355030|7205606|FG001|Study Period 1 Treatment|Sponsor Decision|32
4423767|NCT00355030|7205605|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0
4423768|NCT00355030|7205606|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1
4423769|NCT00355030|7205605|FG000|Study Period 1 Treatment|Other|2
4423770|NCT00355030|7205606|FG001|Study Period 1 Treatment|Other|6
4423771|NCT00355030|7205605|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0
4423772|NCT00355030|7205606|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1
4423773|NCT00355030|7205605|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1
4423774|NCT00355030|7205606|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1
4423775|NCT00355056|7205614|FG000|Randomization Period|Early Termination|4
4423776|NCT00355056|7205615|FG001|Randomization Period|Early Termination|6
4423777|NCT00355082|7205631|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4
4423778|NCT00355082|7205632|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10
4423779|NCT00355082|7205633|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0
4423780|NCT00355082|7205631|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9
4423781|NCT00355082|7205632|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8
4423782|NCT00355082|7205633|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0
4423783|NCT00355082|7205631|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6
4423784|NCT00355082|7205632|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7
4423785|NCT00355082|7205633|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0
4423786|NCT00355082|7205631|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0
4423787|NCT00355082|7205632|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4
4423788|NCT00355082|7205633|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0
4423789|NCT00355082|7205631|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0
4423790|NCT00355082|7205632|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4
4423791|NCT00355082|7205633|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0
4423792|NCT00355082|7205631|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0
4423793|NCT00355082|7205632|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1
4423794|NCT00355082|7205633|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0
4423795|NCT00355082|7205631|FG000|Continuation Phase|Adverse Event|2
4629625|NCT01874431|7497664|FG005|Overall Study|Sponsor decision|0
4629626|NCT01874431|7497665|FG006|Overall Study|Sponsor decision|0
4423796|NCT00355082|7205632|FG001|Continuation Phase|Adverse Event|0
4423797|NCT00355082|7205633|FG002|Continuation Phase|Adverse Event|1
4423798|NCT00355082|7205631|FG000|Continuation Phase|Lost to Follow-up|2
4629627|NCT01874431|7497666|FG007|Overall Study|Sponsor decision|0
4629628|NCT01874431|7497659|FG000|Overall Study|Lost to Follow-up|0
4629629|NCT01874431|7497660|FG001|Overall Study|Lost to Follow-up|0
4629630|NCT01874431|7497661|FG002|Overall Study|Lost to Follow-up|1
4629631|NCT01874431|7497662|FG003|Overall Study|Lost to Follow-up|0
4629632|NCT01874431|7497663|FG004|Overall Study|Lost to Follow-up|0
4629633|NCT01874431|7497664|FG005|Overall Study|Lost to Follow-up|0
4629634|NCT01874431|7497665|FG006|Overall Study|Lost to Follow-up|0
4629635|NCT01874431|7497666|FG007|Overall Study|Lost to Follow-up|0
4629636|NCT01874535|7497686|FG000|Overall Study|Lost to Follow-up|10
4423799|NCT00355082|7205632|FG001|Continuation Phase|Lost to Follow-up|0
4423800|NCT00355082|7205633|FG002|Continuation Phase|Lost to Follow-up|1
4423801|NCT00355082|7205631|FG000|Continuation Phase|Protocol Violation|1
4629637|NCT01874535|7497687|FG001|Overall Study|Lost to Follow-up|9
4423802|NCT00355082|7205632|FG001|Continuation Phase|Protocol Violation|0
4423803|NCT00355082|7205633|FG002|Continuation Phase|Protocol Violation|1
4423804|NCT00355082|7205631|FG000|Continuation Phase|Withdrawal by Subject|4
4423805|NCT00355082|7205632|FG001|Continuation Phase|Withdrawal by Subject|0
4423806|NCT00355082|7205633|FG002|Continuation Phase|Withdrawal by Subject|0
4423807|NCT00355082|7205631|FG000|Continuation Phase|Lack of Efficacy|5
4423808|NCT00355082|7205632|FG001|Continuation Phase|Lack of Efficacy|0
4423809|NCT00355082|7205633|FG002|Continuation Phase|Lack of Efficacy|0
4423810|NCT00355082|7205631|FG000|Continuation Phase|Site Closed by Sponsor|8
4423811|NCT00355082|7205632|FG001|Continuation Phase|Site Closed by Sponsor|0
4423812|NCT00355082|7205633|FG002|Continuation Phase|Site Closed by Sponsor|0
4423813|NCT00355082|7205631|FG000|Continuation Phase|Scheduling Error|1
4423814|NCT00355082|7205632|FG001|Continuation Phase|Scheduling Error|0
4423815|NCT00355082|7205633|FG002|Continuation Phase|Scheduling Error|0
4423816|NCT00355082|7205631|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1
4423817|NCT00355082|7205632|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0
4423818|NCT00355082|7205633|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0
4423819|NCT00355121|7205647|FG000|Overall Study|Did not receive study vaccine|1
4423820|NCT00355121|7205648|FG001|Overall Study|Did not receive study vaccine|0
4423821|NCT00355121|7205649|FG002|Overall Study|Did not receive study vaccine|1
4423822|NCT00355121|7205647|FG000|Overall Study|Adverse Event|0
4423823|NCT00355121|7205648|FG001|Overall Study|Adverse Event|1
4423824|NCT00355121|7205649|FG002|Overall Study|Adverse Event|0
4423825|NCT00355121|7205647|FG000|Overall Study|Protocol Violation|7
4423826|NCT00355121|7205648|FG001|Overall Study|Protocol Violation|9
4423827|NCT00355121|7205649|FG002|Overall Study|Protocol Violation|1
4423828|NCT00355121|7205647|FG000|Overall Study|Lost to Follow-up|4
4423829|NCT00355121|7205648|FG001|Overall Study|Lost to Follow-up|7
4423830|NCT00355121|7205649|FG002|Overall Study|Lost to Follow-up|1
4423831|NCT00355121|7205647|FG000|Overall Study|Withdrawal by Subject|9
4423832|NCT00355121|7205648|FG001|Overall Study|Withdrawal by Subject|10
4423833|NCT00355121|7205649|FG002|Overall Study|Withdrawal by Subject|2
4423834|NCT00355121|7205647|FG000|Overall Study|Serious adverse events|0
4423835|NCT00355121|7205648|FG001|Overall Study|Serious adverse events|2
4423836|NCT00355121|7205649|FG002|Overall Study|Serious adverse events|0
4423837|NCT00355134|7205665|FG000|Core Phase|Withdrawal by Subject|35
4423838|NCT00355134|7205666|FG001|Core Phase|Withdrawal by Subject|24
4423839|NCT00355134|7205667|FG002|Core Phase|Withdrawal by Subject|35
4423840|NCT00355134|7205668|FG003|Core Phase|Withdrawal by Subject|0
4423841|NCT00355134|7205669|FG004|Core Phase|Withdrawal by Subject|0
4423842|NCT00355134|7205665|FG000|Core Phase|Adverse Event|28
4423843|NCT00355134|7205666|FG001|Core Phase|Adverse Event|22
4423844|NCT00355134|7205667|FG002|Core Phase|Adverse Event|16
4423845|NCT00355134|7205668|FG003|Core Phase|Adverse Event|0
4423846|NCT00355134|7205669|FG004|Core Phase|Adverse Event|0
4423847|NCT00355134|7205665|FG000|Core Phase|Lost to Follow-up|17
4423848|NCT00355134|7205666|FG001|Core Phase|Lost to Follow-up|13
4423849|NCT00355134|7205667|FG002|Core Phase|Lost to Follow-up|21
4423850|NCT00355134|7205668|FG003|Core Phase|Lost to Follow-up|0
4423851|NCT00355134|7205669|FG004|Core Phase|Lost to Follow-up|0
4423852|NCT00355134|7205665|FG000|Core Phase|Abnormal laboratory value(s)|19
4423853|NCT00355134|7205666|FG001|Core Phase|Abnormal laboratory value(s)|14
4423854|NCT00355134|7205667|FG002|Core Phase|Abnormal laboratory value(s)|2
4423855|NCT00355134|7205668|FG003|Core Phase|Abnormal laboratory value(s)|0
4423856|NCT00355134|7205669|FG004|Core Phase|Abnormal laboratory value(s)|0
4423857|NCT00355134|7205665|FG000|Core Phase|Unsatisfactory therapeutic effect|10
4423858|NCT00355134|7205666|FG001|Core Phase|Unsatisfactory therapeutic effect|6
4423859|NCT00355134|7205667|FG002|Core Phase|Unsatisfactory therapeutic effect|17
4423860|NCT00355134|7205668|FG003|Core Phase|Unsatisfactory therapeutic effect|0
4423861|NCT00355134|7205669|FG004|Core Phase|Unsatisfactory therapeutic effect|0
4423862|NCT00355134|7205665|FG000|Core Phase|Administrative problems|5
4629638|NCT01874535|7497686|FG000|Overall Study|incomplete symptom resolution|45
4629639|NCT01874535|7497687|FG001|Overall Study|incomplete symptom resolution|35
4629640|NCT01874665|7497695|FG000|Overall Study|Adverse Event|6
4629641|NCT01874665|7497696|FG001|Overall Study|Adverse Event|2
4423863|NCT00355134|7205666|FG001|Core Phase|Administrative problems|3
4423864|NCT00355134|7205667|FG002|Core Phase|Administrative problems|5
4423865|NCT00355134|7205668|FG003|Core Phase|Administrative problems|0
4423866|NCT00355134|7205669|FG004|Core Phase|Administrative problems|0
4423867|NCT00355134|7205665|FG000|Core Phase|Protocol Violation|3
4423868|NCT00355134|7205666|FG001|Core Phase|Protocol Violation|2
4423869|NCT00355134|7205667|FG002|Core Phase|Protocol Violation|2
4423870|NCT00355134|7205668|FG003|Core Phase|Protocol Violation|0
4423871|NCT00355134|7205669|FG004|Core Phase|Protocol Violation|0
4423872|NCT00355134|7205665|FG000|Core Phase|Abnormal test procedure result(s)|1
4423873|NCT00355134|7205666|FG001|Core Phase|Abnormal test procedure result(s)|2
4423874|NCT00355134|7205667|FG002|Core Phase|Abnormal test procedure result(s)|1
4423875|NCT00355134|7205668|FG003|Core Phase|Abnormal test procedure result(s)|0
4423876|NCT00355134|7205669|FG004|Core Phase|Abnormal test procedure result(s)|0
4423877|NCT00355134|7205665|FG000|Core Phase|Condition no longer requires study drug|1
4423878|NCT00355134|7205666|FG001|Core Phase|Condition no longer requires study drug|0
4423879|NCT00355134|7205667|FG002|Core Phase|Condition no longer requires study drug|1
4423880|NCT00355134|7205668|FG003|Core Phase|Condition no longer requires study drug|0
4423881|NCT00355134|7205669|FG004|Core Phase|Condition no longer requires study drug|0
4423882|NCT00355134|7205665|FG000|Extension Phase|Withdrawal by Subject|7
4423883|NCT00355134|7205666|FG001|Extension Phase|Withdrawal by Subject|11
4423884|NCT00355134|7205667|FG002|Extension Phase|Withdrawal by Subject|0
4423885|NCT00355134|7205668|FG003|Extension Phase|Withdrawal by Subject|7
4423886|NCT00355134|7205669|FG004|Extension Phase|Withdrawal by Subject|5
4423887|NCT00355134|7205665|FG000|Extension Phase|Adverse Event|13
4423888|NCT00355134|7205666|FG001|Extension Phase|Adverse Event|9
4423889|NCT00355134|7205667|FG002|Extension Phase|Adverse Event|0
4423890|NCT00355134|7205668|FG003|Extension Phase|Adverse Event|3
4423891|NCT00355134|7205669|FG004|Extension Phase|Adverse Event|5
4423892|NCT00355134|7205665|FG000|Extension Phase|Lost to Follow-up|2
4423893|NCT00355134|7205666|FG001|Extension Phase|Lost to Follow-up|6
4423894|NCT00355134|7205667|FG002|Extension Phase|Lost to Follow-up|0
4423895|NCT00355134|7205668|FG003|Extension Phase|Lost to Follow-up|2
4423896|NCT00355134|7205669|FG004|Extension Phase|Lost to Follow-up|4
4423897|NCT00355134|7205665|FG000|Extension Phase|Abnormal laboratory value(s)|4
4423898|NCT00355134|7205666|FG001|Extension Phase|Abnormal laboratory value(s)|2
4423899|NCT00355134|7205667|FG002|Extension Phase|Abnormal laboratory value(s)|0
4423900|NCT00355134|7205668|FG003|Extension Phase|Abnormal laboratory value(s)|2
4423901|NCT00355134|7205669|FG004|Extension Phase|Abnormal laboratory value(s)|2
4423902|NCT00355134|7205665|FG000|Extension Phase|Administrative problems|2
4423903|NCT00355134|7205666|FG001|Extension Phase|Administrative problems|4
4423904|NCT00355134|7205667|FG002|Extension Phase|Administrative problems|0
4423905|NCT00355134|7205668|FG003|Extension Phase|Administrative problems|1
4423906|NCT00355134|7205669|FG004|Extension Phase|Administrative problems|1
4423907|NCT00355134|7205665|FG000|Extension Phase|Unsatisfactory therapeutic effect|3
4423908|NCT00355134|7205666|FG001|Extension Phase|Unsatisfactory therapeutic effect|4
4423909|NCT00355134|7205667|FG002|Extension Phase|Unsatisfactory therapeutic effect|0
4423910|NCT00355134|7205668|FG003|Extension Phase|Unsatisfactory therapeutic effect|0
4423911|NCT00355134|7205669|FG004|Extension Phase|Unsatisfactory therapeutic effect|1
4423912|NCT00355134|7205665|FG000|Extension Phase|Abnormal test procedure result(s)|0
4423913|NCT00355134|7205666|FG001|Extension Phase|Abnormal test procedure result(s)|1
4423914|NCT00355134|7205667|FG002|Extension Phase|Abnormal test procedure result(s)|0
4423915|NCT00355134|7205668|FG003|Extension Phase|Abnormal test procedure result(s)|0
4423916|NCT00355134|7205669|FG004|Extension Phase|Abnormal test procedure result(s)|1
4423917|NCT00355134|7205665|FG000|Extension Phase|Protocol Violation|0
4423918|NCT00355134|7205666|FG001|Extension Phase|Protocol Violation|0
4423919|NCT00355134|7205667|FG002|Extension Phase|Protocol Violation|0
4423920|NCT00355134|7205668|FG003|Extension Phase|Protocol Violation|1
4423921|NCT00355134|7205669|FG004|Extension Phase|Protocol Violation|0
4423922|NCT00355147|7205681|FG000|Overall Study|Lost to Follow-up|10
4423923|NCT00355147|7205682|FG001|Overall Study|Lost to Follow-up|8
4423924|NCT00355147|7205681|FG000|Overall Study|Withdrawal by Subject|8
4423925|NCT00355147|7205682|FG001|Overall Study|Withdrawal by Subject|12
4423926|NCT00355264|7205701|FG000|Extension (Variable Duration)|Adverse Event|1
4423927|NCT00355264|7205701|FG000|Extension (Variable Duration)|Withdrew Consent|1
4423928|NCT00355342|7205712|FG000|Overall Study|Adverse Event|13
4423929|NCT00355342|7205713|FG001|Overall Study|Adverse Event|15
4423930|NCT00355342|7205712|FG000|Overall Study|Lost to Follow-up|4
4423931|NCT00355342|7205713|FG001|Overall Study|Lost to Follow-up|2
4423932|NCT00355342|7205712|FG000|Overall Study|Withdrawal by Subject|14
4423933|NCT00355342|7205713|FG001|Overall Study|Withdrawal by Subject|11
4423934|NCT00355342|7205712|FG000|Overall Study|Sponsor terminated study|2
4423935|NCT00355342|7205713|FG001|Overall Study|Sponsor terminated study|2
4423936|NCT00355342|7205712|FG000|Overall Study|Overcompliant-PI discretion|1
4423937|NCT00355342|7205713|FG001|Overall Study|Overcompliant-PI discretion|0
4423938|NCT00355342|7205712|FG000|Overall Study|Use of prohibited medication|1
4423939|NCT00355342|7205713|FG001|Overall Study|Use of prohibited medication|0
4423940|NCT00355342|7205712|FG000|Overall Study|COPD exacerbation|1
4423941|NCT00355342|7205713|FG001|Overall Study|COPD exacerbation|1
4423942|NCT00355342|7205712|FG000|Overall Study|Dispensed wrong study drug kit|1
4423943|NCT00355342|7205713|FG001|Overall Study|Dispensed wrong study drug kit|0
4423944|NCT00355342|7205712|FG000|Overall Study|Non-compliance with Dexa scans|1
4423945|NCT00355342|7205713|FG001|Overall Study|Non-compliance with Dexa scans|0
4423946|NCT00355342|7205712|FG000|Overall Study|Withdrawal by participant and physician|1
4423947|NCT00355342|7205713|FG001|Overall Study|Withdrawal by participant and physician|0
4423948|NCT00355342|7205712|FG000|Overall Study|Participant relocated|0
4423949|NCT00355342|7205713|FG001|Overall Study|Participant relocated|1
4423950|NCT00355342|7205712|FG000|Overall Study|Participant discontinued study drug|0
4423951|NCT00355342|7205713|FG001|Overall Study|Participant discontinued study drug|1
4423952|NCT00355342|7205712|FG000|Overall Study|Study management|0
4423953|NCT00355342|7205713|FG001|Overall Study|Study management|1
4423954|NCT00355342|7205712|FG000|Overall Study|Protocol Violation|0
4423955|NCT00355342|7205713|FG001|Overall Study|Protocol Violation|1
4423956|NCT00355342|7205712|FG000|Overall Study|Use of protocol excluded medication|0
4423957|NCT00355342|7205713|FG001|Overall Study|Use of protocol excluded medication|1
4423958|NCT00355368|7205721|FG000|Overall Study|Protocol Violation|8
4423959|NCT00355368|7205722|FG001|Overall Study|Protocol Violation|7
4423960|NCT00355368|7205721|FG000|Overall Study|cardiac arrest prior to intubation|2
4423961|NCT00355368|7205722|FG001|Overall Study|cardiac arrest prior to intubation|2
4423962|NCT00355472|7205739|FG000|Overall Study|Physician Decision|1
4512243|NCT00932646|7321969|FG001|Overall Study|Withdrawal by Subject|1
4512244|NCT00932646|7321970|FG002|Overall Study|Withdrawal by Subject|3
4512245|NCT00932646|7321971|FG003|Overall Study|Withdrawal by Subject|0
4512246|NCT00932698|7322000|FG000|Part 1 (Dose Escalation)|Progressive Disease|3
4512247|NCT00932698|7322001|FG001|Part 1 (Dose Escalation)|Progressive Disease|2
4512248|NCT00932698|7322002|FG002|Part 1 (Dose Escalation)|Progressive Disease|2
4512249|NCT00932698|7322003|FG003|Part 1 (Dose Escalation)|Progressive Disease|2
4512250|NCT00932698|7322004|FG004|Part 1 (Dose Escalation)|Progressive Disease|3
4512251|NCT00932698|7322005|FG005|Part 1 (Dose Escalation)|Progressive Disease|5
4512252|NCT00932698|7322006|FG006|Part 1 (Dose Escalation)|Progressive Disease|2
4512253|NCT00932698|7322007|FG007|Part 1 (Dose Escalation)|Progressive Disease|0
4512254|NCT00932698|7322008|FG008|Part 1 (Dose Escalation)|Progressive Disease|0
4512255|NCT00932698|7322009|FG009|Part 1 (Dose Escalation)|Progressive Disease|0
4512256|NCT00932698|7322010|FG010|Part 1 (Dose Escalation)|Progressive Disease|0
4512257|NCT00932698|7322000|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0
4512258|NCT00932698|7322001|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1
4512259|NCT00932698|7322002|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0
4512260|NCT00932698|7322003|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1
4512261|NCT00932698|7322004|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0
4512262|NCT00932698|7322005|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1
4512263|NCT00932698|7322006|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1
4512264|NCT00932698|7322007|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0
4512265|NCT00932698|7322008|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0
4512266|NCT00932698|7322009|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0
4512267|NCT00932698|7322010|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0
4512268|NCT00932698|7322000|FG000|Part 1 (Dose Escalation)|Adverse Event|0
4512269|NCT00932698|7322001|FG001|Part 1 (Dose Escalation)|Adverse Event|0
4512270|NCT00932698|7322002|FG002|Part 1 (Dose Escalation)|Adverse Event|0
4512271|NCT00932698|7322003|FG003|Part 1 (Dose Escalation)|Adverse Event|0
4512272|NCT00932698|7322004|FG004|Part 1 (Dose Escalation)|Adverse Event|0
4512273|NCT00932698|7322005|FG005|Part 1 (Dose Escalation)|Adverse Event|1
4512274|NCT00932698|7322006|FG006|Part 1 (Dose Escalation)|Adverse Event|0
4512275|NCT00932698|7322007|FG007|Part 1 (Dose Escalation)|Adverse Event|0
4512276|NCT00932698|7322008|FG008|Part 1 (Dose Escalation)|Adverse Event|0
4512277|NCT00932698|7322009|FG009|Part 1 (Dose Escalation)|Adverse Event|0
4512278|NCT00932698|7322010|FG010|Part 1 (Dose Escalation)|Adverse Event|0
4512279|NCT00932698|7322000|FG000|Part 1 (Dose Escalation)|Other|0
4512280|NCT00932698|7322001|FG001|Part 1 (Dose Escalation)|Other|0
4512281|NCT00932698|7322002|FG002|Part 1 (Dose Escalation)|Other|1
4512282|NCT00932698|7322003|FG003|Part 1 (Dose Escalation)|Other|0
4512283|NCT00932698|7322004|FG004|Part 1 (Dose Escalation)|Other|0
4512284|NCT00932698|7322005|FG005|Part 1 (Dose Escalation)|Other|0
4512285|NCT00932698|7322006|FG006|Part 1 (Dose Escalation)|Other|1
4512286|NCT00932698|7322007|FG007|Part 1 (Dose Escalation)|Other|0
4512287|NCT00932698|7322008|FG008|Part 1 (Dose Escalation)|Other|0
4512288|NCT00932698|7322009|FG009|Part 1 (Dose Escalation)|Other|0
4512289|NCT00932698|7322010|FG010|Part 1 (Dose Escalation)|Other|0
4512290|NCT00932698|7322000|FG000|Part 2 (Dose Expansion)|Progressive Disease|0
4512291|NCT00932698|7322001|FG001|Part 2 (Dose Expansion)|Progressive Disease|0
4512292|NCT00932698|7322002|FG002|Part 2 (Dose Expansion)|Progressive Disease|0
4512293|NCT00932698|7322003|FG003|Part 2 (Dose Expansion)|Progressive Disease|0
4512294|NCT00932698|7322004|FG004|Part 2 (Dose Expansion)|Progressive Disease|0
4512295|NCT00932698|7322005|FG005|Part 2 (Dose Expansion)|Progressive Disease|0
4512296|NCT00932698|7322006|FG006|Part 2 (Dose Expansion)|Progressive Disease|0
4512297|NCT00932698|7322007|FG007|Part 2 (Dose Expansion)|Progressive Disease|14
4512298|NCT00932698|7322008|FG008|Part 2 (Dose Expansion)|Progressive Disease|8
4512299|NCT00932698|7322009|FG009|Part 2 (Dose Expansion)|Progressive Disease|3
4512300|NCT00932698|7322010|FG010|Part 2 (Dose Expansion)|Progressive Disease|2
4512301|NCT00932698|7322000|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0
4512302|NCT00932698|7322001|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0
4423963|NCT00355615|7205755|FG000|Randomized Double Blind Period|Adverse Event|1
4423964|NCT00355615|7205756|FG001|Randomized Double Blind Period|Adverse Event|0
4423965|NCT00355615|7205757|FG002|Randomized Double Blind Period|Adverse Event|0
4423966|NCT00355615|7205758|FG003|Randomized Double Blind Period|Adverse Event|0
4423967|NCT00355615|7205759|FG004|Randomized Double Blind Period|Adverse Event|0
4423968|NCT00355615|7205755|FG000|Randomized Double Blind Period|Protocol Violation|0
4423969|NCT00355615|7205756|FG001|Randomized Double Blind Period|Protocol Violation|0
4423970|NCT00355615|7205757|FG002|Randomized Double Blind Period|Protocol Violation|1
4423971|NCT00355615|7205758|FG003|Randomized Double Blind Period|Protocol Violation|1
4423972|NCT00355615|7205759|FG004|Randomized Double Blind Period|Protocol Violation|0
4423973|NCT00355615|7205755|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0
4423974|NCT00355615|7205756|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0
4423975|NCT00355615|7205757|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0
4423976|NCT00355615|7205758|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0
4423977|NCT00355615|7205759|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4
4423978|NCT00355615|7205755|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0
4423979|NCT00355615|7205756|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0
4423980|NCT00355615|7205757|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0
4423981|NCT00355615|7205758|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0
4423982|NCT00355615|7205759|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1
4423983|NCT00355615|7205755|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
4423984|NCT00355615|7205756|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
4423985|NCT00355615|7205757|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
4423986|NCT00355615|7205758|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
4423987|NCT00355615|7205759|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3
4423988|NCT00355615|7205755|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0
4423989|NCT00355615|7205756|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0
4423990|NCT00355615|7205757|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0
4423991|NCT00355615|7205758|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0
4423992|NCT00355615|7205759|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1
4423993|NCT00355784|7205784|FG000|Overall Study|Withdrawal by Subject|0
4423994|NCT00355784|7205785|FG001|Overall Study|Withdrawal by Subject|0
4423995|NCT00355784|7205786|FG002|Overall Study|Withdrawal by Subject|2
4423996|NCT00356122|7205842|FG000|TREATMENT|Lack of Efficacy|26
4423997|NCT00356122|7205842|FG000|TREATMENT|Adverse Event|10
4423998|NCT00356122|7205842|FG000|TREATMENT|Subject's request|4
4423999|NCT00356122|7205842|FG000|TREATMENT|Other|4
4424000|NCT00356122|7205842|FG000|TREATMENT|Did not receive study medication|1
4424001|NCT00356122|7205842|FG000|FOLLOW-UP|Death|37
4424002|NCT00356122|7205842|FG000|FOLLOW-UP|Lost to Follow-up|2
4424003|NCT00356122|7205842|FG000|FOLLOW-UP|Other|2
4424004|NCT00356135|7205849|FG000|Overall Study|Protocol Violation|1
4424005|NCT00356135|7205850|FG001|Overall Study|Protocol Violation|0
4424006|NCT00356135|7205851|FG002|Overall Study|Protocol Violation|0
4424007|NCT00356135|7205849|FG000|Overall Study|Adverse Event|1
4424008|NCT00356135|7205850|FG001|Overall Study|Adverse Event|0
4424009|NCT00356135|7205851|FG002|Overall Study|Adverse Event|0
4424010|NCT00356135|7205849|FG000|Overall Study|Lost to Follow-up|0
4424011|NCT00356135|7205850|FG001|Overall Study|Lost to Follow-up|0
4424012|NCT00356135|7205851|FG002|Overall Study|Lost to Follow-up|1
4424013|NCT00356135|7205849|FG000|Overall Study|Physician Decision|1
4424014|NCT00356135|7205850|FG001|Overall Study|Physician Decision|1
4424015|NCT00356135|7205851|FG002|Overall Study|Physician Decision|1
4424016|NCT00356135|7205849|FG000|Overall Study|Subject non-compliance|1
4424017|NCT00356135|7205850|FG001|Overall Study|Subject non-compliance|1
4424018|NCT00356135|7205851|FG002|Overall Study|Subject non-compliance|3
4424019|NCT00356148|7205863|FG000|Overall Study|Reoperation within 30 days|2
4424020|NCT00356148|7205864|FG001|Overall Study|Reoperation within 30 days|1
4424021|NCT00356200|7205873|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1
4424022|NCT00356200|7205874|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0
4424023|NCT00356200|7205873|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0
4424024|NCT00356200|7205874|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2
4424025|NCT00356265|7205889|FG000|Overall Study|Withdrawal by Subject|0
4424026|NCT00356265|7205890|FG001|Overall Study|Withdrawal by Subject|0
4424027|NCT00356265|7205891|FG002|Overall Study|Withdrawal by Subject|1
4424028|NCT00356278|7205903|FG000|Overall Study|Withdrawal by Subject|25
4424029|NCT00356278|7205904|FG001|Overall Study|Withdrawal by Subject|15
4424030|NCT00356278|7205905|FG002|Overall Study|Withdrawal by Subject|19
4424031|NCT00356369|7205924|FG000|Active Phase|Withdrawal by Subject|2
4424032|NCT00356369|7205925|FG001|Active Phase|Withdrawal by Subject|1
4424033|NCT00356408|7205935|FG000|Overall Study|Adverse Event|9
4424034|NCT00356408|7205935|FG000|Overall Study|Lack of Efficacy|36
4424035|NCT00356408|7205935|FG000|Overall Study|Lost to Follow-up|2
4424036|NCT00356408|7205935|FG000|Overall Study|Withdrawal by Subject|6
4424037|NCT00356408|7205935|FG000|Overall Study|Other: Principal investigator discretion|3
4424038|NCT00356408|7205935|FG000|Overall Study|Other: Sponsor request|1
4424039|NCT00356408|7205935|FG000|Overall Study|Other: Azathioprine stopped|1
4424040|NCT00356408|7205935|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1
4424041|NCT00356408|7205935|FG000|Overall Study|Other: Subject chose commerical dosing|1
4424042|NCT00356525|7205960|FG000|Overall Study|Progressive Disease|8
4424043|NCT00356525|7205961|FG001|Overall Study|Progressive Disease|5
4424044|NCT00356525|7205962|FG002|Overall Study|Progressive Disease|4
4424045|NCT00356525|7205963|FG003|Overall Study|Progressive Disease|2
4424046|NCT00356525|7205960|FG000|Overall Study|Adverse Event|1
4424047|NCT00356525|7205961|FG001|Overall Study|Adverse Event|3
4424048|NCT00356525|7205962|FG002|Overall Study|Adverse Event|1
4424049|NCT00356525|7205963|FG003|Overall Study|Adverse Event|1
4424050|NCT00356525|7205960|FG000|Overall Study|Lost to Follow-up|1
4424051|NCT00356525|7205961|FG001|Overall Study|Lost to Follow-up|0
4424052|NCT00356525|7205962|FG002|Overall Study|Lost to Follow-up|0
4424053|NCT00356525|7205963|FG003|Overall Study|Lost to Follow-up|0
4424054|NCT00356525|7205960|FG000|Overall Study|Physician Decision|2
4424055|NCT00356525|7205961|FG001|Overall Study|Physician Decision|2
4424056|NCT00356525|7205962|FG002|Overall Study|Physician Decision|2
4424057|NCT00356525|7205963|FG003|Overall Study|Physician Decision|1
4424058|NCT00356525|7205960|FG000|Overall Study|Protocol Entry Criteria Not Met|1
4424059|NCT00356525|7205961|FG001|Overall Study|Protocol Entry Criteria Not Met|0
4424060|NCT00356525|7205962|FG002|Overall Study|Protocol Entry Criteria Not Met|0
4424061|NCT00356525|7205963|FG003|Overall Study|Protocol Entry Criteria Not Met|0
4424062|NCT00356525|7205960|FG000|Overall Study|Withdrawal by Subject|1
4424063|NCT00356525|7205961|FG001|Overall Study|Withdrawal by Subject|1
4424064|NCT00356525|7205962|FG002|Overall Study|Withdrawal by Subject|0
4424065|NCT00356525|7205963|FG003|Overall Study|Withdrawal by Subject|3
4424066|NCT00356525|7205960|FG000|Overall Study|Death|0
4424067|NCT00356525|7205961|FG001|Overall Study|Death|0
4424068|NCT00356525|7205962|FG002|Overall Study|Death|0
4424069|NCT00356525|7205963|FG003|Overall Study|Death|1
4424070|NCT00356525|7205960|FG000|Overall Study|Sponsor Decision|0
4424071|NCT00356525|7205961|FG001|Overall Study|Sponsor Decision|0
4424072|NCT00356525|7205962|FG002|Overall Study|Sponsor Decision|0
4424073|NCT00356525|7205963|FG003|Overall Study|Sponsor Decision|1
4424074|NCT00356590|7205973|FG000|Overall Study|Adverse Event|54
4424075|NCT00356590|7205973|FG000|Overall Study|Death|10
4424076|NCT00356590|7205973|FG000|Overall Study|Lost to Follow-up|35
4424077|NCT00356590|7205973|FG000|Overall Study|Physician Decision|46
4424078|NCT00356590|7205973|FG000|Overall Study|Withdrawal by Subject|41
4424079|NCT00356590|7205973|FG000|Overall Study|Completed month 12 only|2
4424080|NCT00356590|7205973|FG000|Overall Study|Protocol issues|6
4424081|NCT00356590|7205973|FG000|Overall Study|Response status|28
4424082|NCT00356590|7205973|FG000|Overall Study|Other|52
4424083|NCT00356603|7205979|FG000|Overall Study|Other|6
4424084|NCT00356603|7205980|FG001|Overall Study|Other|3
4424085|NCT00356759|7205990|FG000|Overall Study|Death|5
4424086|NCT00356759|7205991|FG001|Overall Study|Death|2
4424087|NCT00356759|7205990|FG000|Overall Study|Withdrawal by Subject|2
4512303|NCT00932698|7322002|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0
4629642|NCT01874665|7497695|FG000|Overall Study|Withdrawal by Subject|4
4629643|NCT01874665|7497696|FG001|Overall Study|Withdrawal by Subject|1
4629644|NCT01874665|7497695|FG000|Overall Study|Physician Decision|3
4629645|NCT01874665|7497696|FG001|Overall Study|Physician Decision|0
4629646|NCT01874665|7497695|FG000|Overall Study|Clinical Progressive Disease|4
4629647|NCT01874665|7497696|FG001|Overall Study|Clinical Progressive Disease|3
4629648|NCT01874665|7497695|FG000|Overall Study|Study Terminated by Sponsor|0
4629649|NCT01874665|7497696|FG001|Overall Study|Study Terminated by Sponsor|2
4629650|NCT01874665|7497695|FG000|Overall Study|Documented Progressive Disease|11
4629651|NCT01874665|7497696|FG001|Overall Study|Documented Progressive Disease|7
4629652|NCT01874665|7497695|FG000|Overall Study|Other|2
4629653|NCT01874665|7497696|FG001|Overall Study|Other|0
4629654|NCT01875237|7497743|FG000|Overall Study|GVDH before DLI|1
4629655|NCT01875237|7497744|FG001|Overall Study|GVDH before DLI|0
4629656|NCT01875237|7497743|FG000|Overall Study|DLI cells could not be produced|1
4629657|NCT01875237|7497744|FG001|Overall Study|DLI cells could not be produced|0
4629658|NCT01875250|7497754|FG000|Overall Study|Adverse Event|2
4629659|NCT01875250|7497755|FG001|Overall Study|Adverse Event|0
4629660|NCT01875367|7497765|FG000|Overall Study|Not complete at least 2 questionaries|4
4629661|NCT01875367|7497766|FG001|Overall Study|Not complete at least 2 questionaries|2
4629662|NCT01875367|7497765|FG000|Overall Study|Not receive study treatment|1
4629663|NCT01875367|7497766|FG001|Overall Study|Not receive study treatment|0
4629664|NCT01875445|7497778|FG000|Overall Study|Lost to Follow-up|5
4629665|NCT01875445|7497779|FG001|Overall Study|Lost to Follow-up|0
4424088|NCT00356759|7205991|FG001|Overall Study|Withdrawal by Subject|2
4424089|NCT00356759|7205990|FG000|Overall Study|Adverse Event|1
4424090|NCT00356759|7205991|FG001|Overall Study|Adverse Event|3
4424091|NCT00356759|7205990|FG000|Overall Study|Lost to Follow-up|1
4424092|NCT00356759|7205991|FG001|Overall Study|Lost to Follow-up|1
4424093|NCT00356759|7205990|FG000|Overall Study|Intercurrent disease or persistent extre|5
4424094|NCT00356759|7205991|FG001|Overall Study|Intercurrent disease or persistent extre|2
4424095|NCT00356811|7205997|FG000|Overall Study|Death|35
4424096|NCT00356811|7205997|FG000|Overall Study|Lost to Follow-up|2
4424097|NCT00356811|7205997|FG000|Overall Study|Withdrawal by Subject|6
4424098|NCT00356811|7205997|FG000|Overall Study|Participant Could Not Make a Checkup|1
4629666|NCT01875445|7497778|FG000|Overall Study|Withdrawal by Subject|2
4629667|NCT01875445|7497779|FG001|Overall Study|Withdrawal by Subject|0
4629668|NCT01875471|7497787|FG000|Overall Study|Adverse Event|0
4629669|NCT01875471|7497788|FG001|Overall Study|Adverse Event|1
4629670|NCT01875471|7497787|FG000|Overall Study|Unsatisfactory Lens Fitting|1
4629671|NCT01875471|7497788|FG001|Overall Study|Unsatisfactory Lens Fitting|0
4629672|NCT01875731|7497805|FG000|Overall Study|Fail to obtain lab sample|1
4629673|NCT01875731|7497806|FG001|Overall Study|Fail to obtain lab sample|0
4629674|NCT01875848|7497820|FG000|Overall Study|Withdrawal by Subject|2
4629675|NCT01875848|7497821|FG001|Overall Study|Withdrawal by Subject|0
4629676|NCT01875874|7497837|FG000|Overall Study|Death|3
4629677|NCT01875991|7497855|FG000|Overall Study|Withdrawal by Subject|6
4629678|NCT01875991|7497856|FG001|Overall Study|Withdrawal by Subject|6
4629679|NCT01875991|7497855|FG000|Overall Study|Sponsor Decision|1
4629680|NCT01875991|7497856|FG001|Overall Study|Sponsor Decision|0
4424099|NCT00356811|7205997|FG000|Overall Study|Study Is Terminating|3
4424100|NCT00356811|7205997|FG000|Overall Study|Site Closed during Follow-up|2
4424101|NCT00356863|7206004|FG000|Overall Study|Death|16
4424102|NCT00356863|7206005|FG001|Overall Study|Death|32
4424103|NCT00356863|7206004|FG000|Overall Study|Lost to Follow-up|76
4424104|NCT00356863|7206005|FG001|Overall Study|Lost to Follow-up|43
4424105|NCT00356889|7206015|FG000|Overall Study|Protocol Violation|2
4424106|NCT00356889|7206015|FG000|Overall Study|Adverse Event|1
4424107|NCT00356915|7206023|FG000|Overall Study|Non compliance|1
4424108|NCT00356915|7206024|FG001|Overall Study|Non compliance|2
4424109|NCT00356915|7206025|FG002|Overall Study|Non compliance|1
4424110|NCT00356915|7206023|FG000|Overall Study|Protocol Violation|2
4424111|NCT00356915|7206024|FG001|Overall Study|Protocol Violation|3
4424112|NCT00356915|7206025|FG002|Overall Study|Protocol Violation|2
4424113|NCT00356915|7206023|FG000|Overall Study|Withdrawal by Subject|14
4424114|NCT00356915|7206024|FG001|Overall Study|Withdrawal by Subject|14
4424115|NCT00356915|7206025|FG002|Overall Study|Withdrawal by Subject|10
4424116|NCT00356915|7206023|FG000|Overall Study|Lack of Efficacy|0
4424117|NCT00356915|7206024|FG001|Overall Study|Lack of Efficacy|0
4424118|NCT00356915|7206025|FG002|Overall Study|Lack of Efficacy|3
4424119|NCT00356915|7206023|FG000|Overall Study|Lost to Follow-up|27
4424120|NCT00356915|7206024|FG001|Overall Study|Lost to Follow-up|34
4424121|NCT00356915|7206025|FG002|Overall Study|Lost to Follow-up|14
4424122|NCT00356915|7206023|FG000|Overall Study|Administrative Decision|0
4424123|NCT00356915|7206024|FG001|Overall Study|Administrative Decision|0
4424124|NCT00356915|7206025|FG002|Overall Study|Administrative Decision|1
4424125|NCT00356915|7206023|FG000|Overall Study|Physician Decision|0
4424126|NCT00356915|7206024|FG001|Overall Study|Physician Decision|2
4424127|NCT00356915|7206025|FG002|Overall Study|Physician Decision|0
4424128|NCT00356915|7206023|FG000|Overall Study|Adverse Event|21
4424129|NCT00356915|7206024|FG001|Overall Study|Adverse Event|31
4424130|NCT00356915|7206025|FG002|Overall Study|Adverse Event|8
4424131|NCT00356915|7206023|FG000|Overall Study|Miscellaneous reasons|11
4424132|NCT00356915|7206024|FG001|Overall Study|Miscellaneous reasons|8
4424133|NCT00356915|7206025|FG002|Overall Study|Miscellaneous reasons|3
4424134|NCT00357006|7206046|FG000|Overall Study|Lost to Follow-up|1
4424135|NCT00357006|7206047|FG001|Overall Study|Lost to Follow-up|2
4424136|NCT00357006|7206048|FG002|Overall Study|Lost to Follow-up|1
4424137|NCT00357006|7206046|FG000|Overall Study|Withdrawal by Subject|1
4424138|NCT00357006|7206047|FG001|Overall Study|Withdrawal by Subject|3
4424139|NCT00357006|7206048|FG002|Overall Study|Withdrawal by Subject|2
4424140|NCT00357097|7206062|FG000|Overall Study|Did not meet inclusion criteria|5
4424141|NCT00357097|7206063|FG001|Overall Study|Did not meet inclusion criteria|3
4424142|NCT00357097|7206062|FG000|Overall Study|Adverse Event|34
4424143|NCT00357097|7206063|FG001|Overall Study|Adverse Event|6
4424144|NCT00357097|7206062|FG000|Overall Study|Withdrawal by Subject|8
4424145|NCT00357097|7206063|FG001|Overall Study|Withdrawal by Subject|7
4424146|NCT00357097|7206062|FG000|Overall Study|Non-compliance|1
4424147|NCT00357097|7206063|FG001|Overall Study|Non-compliance|2
4424148|NCT00357097|7206062|FG000|Overall Study|Lack of Efficacy|2
4424149|NCT00357097|7206063|FG001|Overall Study|Lack of Efficacy|8
4424150|NCT00357097|7206062|FG000|Overall Study|Met Exclusion Criteria|3
4424151|NCT00357097|7206063|FG001|Overall Study|Met Exclusion Criteria|1
4424152|NCT00357097|7206062|FG000|Overall Study|Other|1
4424153|NCT00357097|7206063|FG001|Overall Study|Other|1
4424154|NCT00357097|7206062|FG000|Overall Study|Increase of RLS Symptoms|0
4424155|NCT00357097|7206063|FG001|Overall Study|Increase of RLS Symptoms|1
4424156|NCT00357110|7206071|FG000|Overall Study|Early study termination|5
4629681|NCT01876043|7497865|FG000|Overall Study|Death|1
4629682|NCT01876043|7497865|FG000|Overall Study|Withdrawal by Subject|1
4424157|NCT00357110|7206072|FG001|Overall Study|Early study termination|5
4629683|NCT01876082|7497871|FG000|Overall Study|Withdrawal by Subject|0
4629684|NCT01876082|7497872|FG001|Overall Study|Withdrawal by Subject|2
4629685|NCT01876082|7497871|FG000|Overall Study|Protocol Violation|1
4424158|NCT00357370|7206111|FG000|Cohort 2|Lack of Efficacy|0
4424159|NCT00357370|7206112|FG001|Cohort 2|Lack of Efficacy|2
4424160|NCT00357370|7206113|FG002|Cohort 2|Lack of Efficacy|1
4424161|NCT00357370|7206111|FG000|Cohort 2|Adverse Event|1
4424162|NCT00357370|7206112|FG001|Cohort 2|Adverse Event|1
4424163|NCT00357370|7206113|FG002|Cohort 2|Adverse Event|1
4629686|NCT01876082|7497872|FG001|Overall Study|Protocol Violation|0
4424164|NCT00357370|7206111|FG000|Cohort 2|Lost to Follow-up|0
4424165|NCT00357370|7206112|FG001|Cohort 2|Lost to Follow-up|1
4424166|NCT00357370|7206113|FG002|Cohort 2|Lost to Follow-up|0
4424167|NCT00357370|7206111|FG000|Cohort 2|non-compliance, not met criteria, etc|1
4424168|NCT00357370|7206112|FG001|Cohort 2|non-compliance, not met criteria, etc|1
4424169|NCT00357370|7206113|FG002|Cohort 2|non-compliance, not met criteria, etc|0
4424170|NCT00357370|7206111|FG000|Cohort 2|Withdrawal by Subject|0
4424171|NCT00357370|7206112|FG001|Cohort 2|Withdrawal by Subject|2
4424172|NCT00357370|7206113|FG002|Cohort 2|Withdrawal by Subject|0
4424173|NCT00357396|7206123|FG000|Overall Study|Adverse Event|1
4424174|NCT00357396|7206124|FG001|Overall Study|Adverse Event|0
4424175|NCT00357500|7206129|FG000|Overall Study|Adverse Event|3
4424176|NCT00357500|7206129|FG000|Overall Study|Withdrawal by Subject|5
4424177|NCT00357500|7206129|FG000|Overall Study|Progressive Disease|65
4424178|NCT00357500|7206129|FG000|Overall Study|Not Started Protocol Therapy|4
4424179|NCT00357552|7206133|FG000|Screening|Did not meet eligibility criteria|84
4424180|NCT00357552|7206133|FG000|Weeks 0 to 24|Death|1
4424181|NCT00357552|7206133|FG000|Weeks 24 to 104|Death|3
4424182|NCT00357552|7206133|FG000|Weeks 24 to 104|Not able to get to clinic|2
4424183|NCT00357656|7206143|FG000|Overall Study|Other, No surgery performed|0
4424184|NCT00357656|7206144|FG001|Overall Study|Other, No surgery performed|3
4424185|NCT00357760|7206168|FG000|Overall Study|Disease progression|44
4424186|NCT00357760|7206169|FG001|Overall Study|Disease progression|17
4424187|NCT00357760|7206168|FG000|Overall Study|Adverse Event|10
4424188|NCT00357760|7206169|FG001|Overall Study|Adverse Event|7
4424189|NCT00357760|7206168|FG000|Overall Study|Death|0
4629687|NCT01876082|7497871|FG000|Overall Study|Adverse Event|1
4629688|NCT01876082|7497872|FG001|Overall Study|Adverse Event|1
4629689|NCT01876082|7497871|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0
4629690|NCT01876082|7497872|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1
4629691|NCT01876251|7497890|FG000|Overall Study|Clinical progression|1
4424190|NCT00357760|7206169|FG001|Overall Study|Death|3
4424191|NCT00357760|7206168|FG000|Overall Study|Alternative therapy|1
4424192|NCT00357760|7206169|FG001|Overall Study|Alternative therapy|0
4424193|NCT00357760|7206168|FG000|Overall Study|Withdrawal by Subject|0
4424194|NCT00357760|7206169|FG001|Overall Study|Withdrawal by Subject|2
4424195|NCT00357760|7206168|FG000|Overall Study|Never started treatment|2
4424196|NCT00357760|7206169|FG001|Overall Study|Never started treatment|1
4424197|NCT00357760|7206168|FG000|Overall Study|Ineligible|0
4424198|NCT00357760|7206169|FG001|Overall Study|Ineligible|2
4424199|NCT00357760|7206168|FG000|Overall Study|Physician Decision|2
4424200|NCT00357760|7206169|FG001|Overall Study|Physician Decision|1
4424201|NCT00357760|7206168|FG000|Overall Study|Protocol Violation|0
4424202|NCT00357760|7206169|FG001|Overall Study|Protocol Violation|1
4424203|NCT00357760|7206168|FG000|Overall Study|To receive hospice care|0
4424204|NCT00357760|7206169|FG001|Overall Study|To receive hospice care|1
4424205|NCT00357877|7206177|FG000|Overall Study|Death|2
4424206|NCT00357877|7206178|FG001|Overall Study|Death|1
4424207|NCT00357877|7206177|FG000|Overall Study|Lost to Follow-up|20
4424208|NCT00357877|7206178|FG001|Overall Study|Lost to Follow-up|23
4424209|NCT00357877|7206177|FG000|Overall Study|Withdrawal by Subject|3
4424210|NCT00357877|7206178|FG001|Overall Study|Withdrawal by Subject|3
4424211|NCT00357877|7206177|FG000|Overall Study|Administrative withdrawal|1
4424212|NCT00357877|7206178|FG001|Overall Study|Administrative withdrawal|1
4424213|NCT00357877|7206177|FG000|Overall Study|Other|0
4424214|NCT00357877|7206178|FG001|Overall Study|Other|2
4424215|NCT00357903|7206188|FG000|Overall Study|Adverse Event|87
4424216|NCT00357903|7206189|FG001|Overall Study|Adverse Event|4
4424217|NCT00357903|7206188|FG000|Overall Study|Death|33
4424218|NCT00357903|7206189|FG001|Overall Study|Death|0
4424219|NCT00357903|7206188|FG000|Overall Study|Lost to Follow-up|23
4424220|NCT00357903|7206189|FG001|Overall Study|Lost to Follow-up|4
4424221|NCT00357903|7206188|FG000|Overall Study|Physician Decision|39
4424222|NCT00357903|7206189|FG001|Overall Study|Physician Decision|5
4424223|NCT00357903|7206188|FG000|Overall Study|Withdrawal by Subject|57
4424224|NCT00357903|7206189|FG001|Overall Study|Withdrawal by Subject|7
4424225|NCT00357903|7206188|FG000|Overall Study|Completed month 12 only|0
4424226|NCT00357903|7206189|FG001|Overall Study|Completed month 12 only|1
4424227|NCT00357903|7206188|FG000|Overall Study|Protocol issues|14
4424228|NCT00357903|7206189|FG001|Overall Study|Protocol issues|3
4424229|NCT00357903|7206188|FG000|Overall Study|Response status|61
4424230|NCT00357903|7206189|FG001|Overall Study|Response status|9
4424231|NCT00357903|7206188|FG000|Overall Study|Other|49
4424232|NCT00357903|7206189|FG001|Overall Study|Other|10
4424233|NCT00357968|7206207|FG000|First Maintenance Dose Phase|Not a PCI patient|47
4424234|NCT00357968|7206208|FG001|First Maintenance Dose Phase|Not a PCI patient|42
4424235|NCT00357968|7206207|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1
4424236|NCT00357968|7206208|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2
4424237|NCT00357994|7206231|FG000|Overall Study|Adverse Event|1
4424238|NCT00357994|7206232|FG001|Overall Study|Adverse Event|2
4424239|NCT00357994|7206231|FG000|Overall Study|Lack of Efficacy|0
4424240|NCT00357994|7206232|FG001|Overall Study|Lack of Efficacy|1
4424241|NCT00357994|7206231|FG000|Overall Study|Protocol Violation|1
4424242|NCT00357994|7206232|FG001|Overall Study|Protocol Violation|0
4424243|NCT00358150|7206242|FG000|Overall Study|Adverse Event|3
4424244|NCT00358150|7206242|FG000|Overall Study|Withdrawal by Subject|1
4424245|NCT00358150|7206242|FG000|Overall Study|Undefined|3
4424246|NCT00358215|7206251|FG000|Overall Study|Ineligibility determined|4
4424247|NCT00358215|7206252|FG001|Overall Study|Ineligibility determined|3
4424248|NCT00358215|7206251|FG000|Overall Study|Adverse Event|83
4424249|NCT00358215|7206252|FG001|Overall Study|Adverse Event|65
4424250|NCT00358215|7206251|FG000|Overall Study|Withdrawal by Subject|111
4424251|NCT00358215|7206252|FG001|Overall Study|Withdrawal by Subject|102
4424252|NCT00358215|7206251|FG000|Overall Study|Participant request|65
4424253|NCT00358215|7206252|FG001|Overall Study|Participant request|64
4424254|NCT00358215|7206251|FG000|Overall Study|Physician Decision|47
4424255|NCT00358215|7206252|FG001|Overall Study|Physician Decision|39
4424256|NCT00358215|7206251|FG000|Overall Study|Lost to Follow-up|16
4424257|NCT00358215|7206252|FG001|Overall Study|Lost to Follow-up|22
4424258|NCT00358215|7206251|FG000|Overall Study|Death|265
4424259|NCT00358215|7206252|FG001|Overall Study|Death|281
4424260|NCT00358215|7206251|FG000|Overall Study|Protocol Violation|64
4424261|NCT00358215|7206252|FG001|Overall Study|Protocol Violation|59
4424262|NCT00358215|7206251|FG000|Overall Study|Pregnancy|1
4424263|NCT00358215|7206252|FG001|Overall Study|Pregnancy|0
4424264|NCT00358215|7206251|FG000|Overall Study|Other|21
4424265|NCT00358215|7206252|FG001|Overall Study|Other|14
4424266|NCT00358215|7206251|FG000|Overall Study|Did not receive investigational product|2
4424267|NCT00358215|7206252|FG001|Overall Study|Did not receive investigational product|3
4424268|NCT00358436|7206277|FG000|Overall Study|Adverse Event|29
4424269|NCT00358436|7206278|FG001|Overall Study|Adverse Event|13
4424270|NCT00358436|7206277|FG000|Overall Study|Lack of Efficacy|34
4424271|NCT00358436|7206278|FG001|Overall Study|Lack of Efficacy|36
4424272|NCT00358436|7206277|FG000|Overall Study|Lost to Follow-up|11
4424273|NCT00358436|7206278|FG001|Overall Study|Lost to Follow-up|6
4424274|NCT00358436|7206277|FG000|Overall Study|Protocol Violation|8
4424275|NCT00358436|7206278|FG001|Overall Study|Protocol Violation|3
4424276|NCT00358436|7206277|FG000|Overall Study|Withdrawal by Subject|40
4424277|NCT00358436|7206278|FG001|Overall Study|Withdrawal by Subject|17
4424278|NCT00358436|7206277|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4
4424279|NCT00358436|7206278|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0
4424280|NCT00358436|7206277|FG000|Overall Study|COPD exacerbation|22
4424281|NCT00358436|7206278|FG001|Overall Study|COPD exacerbation|10
4424282|NCT00358436|7206277|FG000|Overall Study|Other|6
4424283|NCT00358436|7206278|FG001|Overall Study|Other|1
4424284|NCT00358449|7206289|FG000|Overall Study|Adverse Event|1
4424285|NCT00358449|7206290|FG001|Overall Study|Adverse Event|0
4424286|NCT00358449|7206291|FG002|Overall Study|Adverse Event|1
4424287|NCT00358449|7206289|FG000|Overall Study|Lost to Follow-up|1
4424288|NCT00358449|7206290|FG001|Overall Study|Lost to Follow-up|0
4424289|NCT00358449|7206291|FG002|Overall Study|Lost to Follow-up|0
4424290|NCT00358449|7206289|FG000|Overall Study|Withdrawal by Subject|2
4424291|NCT00358449|7206290|FG001|Overall Study|Withdrawal by Subject|0
4424292|NCT00358449|7206291|FG002|Overall Study|Withdrawal by Subject|0
4424293|NCT00358449|7206289|FG000|Overall Study|Lack of Efficacy|0
4424294|NCT00358449|7206290|FG001|Overall Study|Lack of Efficacy|1
4424295|NCT00358449|7206291|FG002|Overall Study|Lack of Efficacy|0
4424296|NCT00358449|7206289|FG000|Overall Study|Steriod Inhaler was Increased|0
4424297|NCT00358449|7206290|FG001|Overall Study|Steriod Inhaler was Increased|0
4424298|NCT00358449|7206291|FG002|Overall Study|Steriod Inhaler was Increased|1
4424299|NCT00358644|7206339|FG000|Overall Study|Progressive Disease|21
4424300|NCT00358644|7206339|FG000|Overall Study|Adverse Event|7
4424301|NCT00358644|7206339|FG000|Overall Study|Death|11
4424302|NCT00358644|7206339|FG000|Overall Study|Withdrawal by Subject|4
4424303|NCT00358644|7206339|FG000|Overall Study|Physician Decision|6
4424304|NCT00358644|7206339|FG000|Overall Study|Patient not eligible for study|1
4424305|NCT00358670|7206349|FG000|Overall Study|Adverse Event|26
4424306|NCT00358670|7206350|FG001|Overall Study|Adverse Event|29
4424307|NCT00358670|7206349|FG000|Overall Study|Lack of Efficacy|20
4424308|NCT00358670|7206350|FG001|Overall Study|Lack of Efficacy|23
4424309|NCT00358670|7206349|FG000|Overall Study|Protocol Violation|6
4424310|NCT00358670|7206350|FG001|Overall Study|Protocol Violation|9
4424311|NCT00358670|7206349|FG000|Overall Study|Lost to Follow-up|4
4424312|NCT00358670|7206350|FG001|Overall Study|Lost to Follow-up|5
4424313|NCT00358670|7206349|FG000|Overall Study|Withdrawal by Subject|13
4424314|NCT00358670|7206350|FG001|Overall Study|Withdrawal by Subject|24
4424315|NCT00358670|7206349|FG000|Overall Study|Protocol Defined Clinical Event|0
4424316|NCT00358670|7206350|FG001|Overall Study|Protocol Defined Clinical Event|1
4424317|NCT00358670|7206349|FG000|Overall Study|Did Not Meet Protocol Eligibility|0
4424318|NCT00358670|7206350|FG001|Overall Study|Did Not Meet Protocol Eligibility|3
4424319|NCT00358670|7206349|FG000|Overall Study|Administrative|153
4424320|NCT00358670|7206350|FG001|Overall Study|Administrative|125
4424321|NCT00358826|7206369|FG000|Core Study|Adverse Event|1
4424322|NCT00358826|7206370|FG001|Core Study|Adverse Event|3
4424323|NCT00358826|7206371|FG002|Core Study|Adverse Event|1
4424324|NCT00358826|7206372|FG003|Core Study|Adverse Event|1
4424325|NCT00358826|7206373|FG004|Core Study|Adverse Event|0
4424326|NCT00358826|7206374|FG005|Core Study|Adverse Event|0
4424327|NCT00358826|7206375|FG006|Core Study|Adverse Event|0
4424328|NCT00358826|7206376|FG007|Core Study|Adverse Event|0
4424329|NCT00358826|7206369|FG000|Core Study|Withdrawal by Subject|2
4424330|NCT00358826|7206370|FG001|Core Study|Withdrawal by Subject|2
4424331|NCT00358826|7206371|FG002|Core Study|Withdrawal by Subject|0
4424332|NCT00358826|7206372|FG003|Core Study|Withdrawal by Subject|0
4424333|NCT00358826|7206373|FG004|Core Study|Withdrawal by Subject|0
4424334|NCT00358826|7206374|FG005|Core Study|Withdrawal by Subject|0
4424335|NCT00358826|7206375|FG006|Core Study|Withdrawal by Subject|0
4424336|NCT00358826|7206376|FG007|Core Study|Withdrawal by Subject|0
4424337|NCT00358826|7206369|FG000|Core Study|Lost to Follow-up|0
4424338|NCT00358826|7206370|FG001|Core Study|Lost to Follow-up|0
4424339|NCT00358826|7206371|FG002|Core Study|Lost to Follow-up|0
4424340|NCT00358826|7206372|FG003|Core Study|Lost to Follow-up|1
4424341|NCT00358826|7206373|FG004|Core Study|Lost to Follow-up|0
4424342|NCT00358826|7206374|FG005|Core Study|Lost to Follow-up|0
4424343|NCT00358826|7206375|FG006|Core Study|Lost to Follow-up|0
4424344|NCT00358826|7206376|FG007|Core Study|Lost to Follow-up|0
4424345|NCT00358826|7206369|FG000|Core Study|Physician Decision|0
4424346|NCT00358826|7206370|FG001|Core Study|Physician Decision|0
4424347|NCT00358826|7206371|FG002|Core Study|Physician Decision|1
4424348|NCT00358826|7206372|FG003|Core Study|Physician Decision|0
4424349|NCT00358826|7206373|FG004|Core Study|Physician Decision|0
4424350|NCT00358826|7206374|FG005|Core Study|Physician Decision|0
4424351|NCT00358826|7206375|FG006|Core Study|Physician Decision|0
4424352|NCT00358826|7206376|FG007|Core Study|Physician Decision|0
4424353|NCT00358826|7206369|FG000|MDCT Substudy|Adverse Event|0
4424354|NCT00358826|7206370|FG001|MDCT Substudy|Adverse Event|0
4424355|NCT00358826|7206371|FG002|MDCT Substudy|Adverse Event|0
4424356|NCT00358826|7206372|FG003|MDCT Substudy|Adverse Event|0
4424357|NCT00358826|7206373|FG004|MDCT Substudy|Adverse Event|1
4424358|NCT00358826|7206374|FG005|MDCT Substudy|Adverse Event|0
4424359|NCT00358826|7206375|FG006|MDCT Substudy|Adverse Event|0
4424360|NCT00358826|7206376|FG007|MDCT Substudy|Adverse Event|0
4424361|NCT00358826|7206369|FG000|MDCT Substudy|Lost to Follow-up|0
4424362|NCT00358826|7206370|FG001|MDCT Substudy|Lost to Follow-up|0
4424363|NCT00358826|7206371|FG002|MDCT Substudy|Lost to Follow-up|0
4424364|NCT00358826|7206372|FG003|MDCT Substudy|Lost to Follow-up|0
4424365|NCT00358826|7206373|FG004|MDCT Substudy|Lost to Follow-up|0
4424366|NCT00358826|7206374|FG005|MDCT Substudy|Lost to Follow-up|1
4424367|NCT00358826|7206375|FG006|MDCT Substudy|Lost to Follow-up|0
4424368|NCT00358826|7206376|FG007|MDCT Substudy|Lost to Follow-up|0
4424369|NCT00358826|7206369|FG000|MDCT Substudy|Withdrawal by Subject|0
4424370|NCT00358826|7206370|FG001|MDCT Substudy|Withdrawal by Subject|0
4424371|NCT00358826|7206371|FG002|MDCT Substudy|Withdrawal by Subject|0
4424372|NCT00358826|7206372|FG003|MDCT Substudy|Withdrawal by Subject|0
4424373|NCT00358826|7206373|FG004|MDCT Substudy|Withdrawal by Subject|0
4424374|NCT00358826|7206374|FG005|MDCT Substudy|Withdrawal by Subject|1
4424375|NCT00358826|7206375|FG006|MDCT Substudy|Withdrawal by Subject|0
4424376|NCT00358826|7206376|FG007|MDCT Substudy|Withdrawal by Subject|0
4424377|NCT00358917|7206392|FG000|Overall Study|Adverse Event|14
4424378|NCT00358917|7206393|FG001|Overall Study|Adverse Event|21
4424379|NCT00358917|7206392|FG000|Overall Study|Withdrawal by Subject|5
4424380|NCT00358917|7206393|FG001|Overall Study|Withdrawal by Subject|7
4424381|NCT00358917|7206392|FG000|Overall Study|Lost to Follow-up|20
4424382|NCT00358917|7206393|FG001|Overall Study|Lost to Follow-up|17
4424383|NCT00358917|7206392|FG000|Overall Study|Noncompliance|12
4424384|NCT00358917|7206393|FG001|Overall Study|Noncompliance|11
4424385|NCT00358917|7206392|FG000|Overall Study|Death|2
4424386|NCT00358917|7206393|FG001|Overall Study|Death|3
4424387|NCT00358917|7206392|FG000|Overall Study|Virologic failure|11
4424388|NCT00358917|7206393|FG001|Overall Study|Virologic failure|8
4424389|NCT00358917|7206392|FG000|Overall Study|Unable to Continue Participation|2
4424390|NCT00358917|7206393|FG001|Overall Study|Unable to Continue Participation|2
4424391|NCT00358956|7206401|FG000|Overall Study|Adverse Event|3
4424392|NCT00358956|7206401|FG000|Overall Study|condition under investigation worsened|4
4424393|NCT00358956|7206401|FG000|Overall Study|Withdrawal by Subject|1
4424394|NCT00359021|7206407|FG000|Overall Study|Adverse Event|26
4424395|NCT00359021|7206408|FG001|Overall Study|Adverse Event|8
4424396|NCT00359021|7206407|FG000|Overall Study|Subject Non-Compliant|1
4424397|NCT00359021|7206408|FG001|Overall Study|Subject Non-Compliant|2
4424398|NCT00359021|7206407|FG000|Overall Study|Subject Ineligible To Continue The Trial|1
4424399|NCT00359021|7206408|FG001|Overall Study|Subject Ineligible To Continue The Trial|0
4424400|NCT00359021|7206407|FG000|Overall Study|Subject Reached A Virologic Endpoint|45
4424401|NCT00359021|7206408|FG001|Overall Study|Subject Reached A Virologic Endpoint|32
4424402|NCT00359021|7206407|FG000|Overall Study|Withdrawal by Subject|2
4424403|NCT00359021|7206408|FG001|Overall Study|Withdrawal by Subject|9
4424404|NCT00359021|7206407|FG000|Overall Study|Lost to Follow-up|1
4424405|NCT00359021|7206408|FG001|Overall Study|Lost to Follow-up|0
4424406|NCT00359021|7206407|FG000|Overall Study|Other|4
4424407|NCT00359021|7206408|FG001|Overall Study|Other|1
4424408|NCT00359021|7206407|FG000|Overall Study|Pregnancy|1
4424409|NCT00359021|7206408|FG001|Overall Study|Pregnancy|0
4424410|NCT00359073|7206418|FG000|Overall Study|Withdrawal by Subject|1
4424411|NCT00359073|7206419|FG001|Overall Study|Withdrawal by Subject|1
4424412|NCT00359073|7206418|FG000|Overall Study|Eligibility criteria no longer met|3
4424413|NCT00359073|7206419|FG001|Overall Study|Eligibility criteria no longer met|0
4424414|NCT00359073|7206418|FG000|Overall Study|developed RV16 antibody|0
4424415|NCT00359073|7206419|FG001|Overall Study|developed RV16 antibody|1
4424416|NCT00359281|7206445|FG000|Overall Study|Adverse Event|1
4424417|NCT00359281|7206446|FG001|Overall Study|Adverse Event|0
4424418|NCT00359281|7206447|FG002|Overall Study|Adverse Event|0
4424419|NCT00359281|7206448|FG003|Overall Study|Adverse Event|0
4424420|NCT00359281|7206449|FG004|Overall Study|Adverse Event|0
4424421|NCT00359281|7206450|FG005|Overall Study|Adverse Event|0
4424422|NCT00359281|7206451|FG006|Overall Study|Adverse Event|1
4424423|NCT00359281|7206452|FG007|Overall Study|Adverse Event|0
4424424|NCT00359281|7206453|FG008|Overall Study|Adverse Event|0
4424425|NCT00359281|7206445|FG000|Overall Study|Withdrawal by Subject|0
4424426|NCT00359281|7206446|FG001|Overall Study|Withdrawal by Subject|0
4424427|NCT00359281|7206447|FG002|Overall Study|Withdrawal by Subject|0
4424428|NCT00359281|7206448|FG003|Overall Study|Withdrawal by Subject|0
4424429|NCT00359281|7206449|FG004|Overall Study|Withdrawal by Subject|0
4424430|NCT00359281|7206450|FG005|Overall Study|Withdrawal by Subject|0
4424431|NCT00359281|7206451|FG006|Overall Study|Withdrawal by Subject|1
4424432|NCT00359281|7206452|FG007|Overall Study|Withdrawal by Subject|0
4424433|NCT00359281|7206453|FG008|Overall Study|Withdrawal by Subject|0
4424434|NCT00359294|7206485|FG000|Overall Study|Progressive disease|1
4424435|NCT00359294|7206486|FG001|Overall Study|Progressive disease|1
4424436|NCT00359294|7206487|FG002|Overall Study|Progressive disease|2
4424437|NCT00359294|7206488|FG003|Overall Study|Progressive disease|3
4424438|NCT00359294|7206489|FG004|Overall Study|Progressive disease|2
4424439|NCT00359294|7206485|FG000|Overall Study|Withdrawal by Subject|0
4424440|NCT00359294|7206486|FG001|Overall Study|Withdrawal by Subject|0
4424441|NCT00359294|7206487|FG002|Overall Study|Withdrawal by Subject|0
4424442|NCT00359294|7206488|FG003|Overall Study|Withdrawal by Subject|0
4424443|NCT00359294|7206489|FG004|Overall Study|Withdrawal by Subject|1
4424444|NCT00359294|7206485|FG000|Overall Study|Not treated|0
4424445|NCT00359294|7206486|FG001|Overall Study|Not treated|0
4424446|NCT00359294|7206487|FG002|Overall Study|Not treated|0
4424447|NCT00359294|7206488|FG003|Overall Study|Not treated|1
4424448|NCT00359294|7206489|FG004|Overall Study|Not treated|0
4424449|NCT00359294|7206485|FG000|Overall Study|Physician Decision|0
4424450|NCT00359294|7206486|FG001|Overall Study|Physician Decision|0
4424451|NCT00359294|7206487|FG002|Overall Study|Physician Decision|1
4424452|NCT00359294|7206488|FG003|Overall Study|Physician Decision|0
4424453|NCT00359294|7206489|FG004|Overall Study|Physician Decision|0
4424454|NCT00359424|7206499|FG000|Overall Study|Death|99
4424455|NCT00359424|7206500|FG001|Overall Study|Death|58
4424456|NCT00359424|7206499|FG000|Overall Study|Lost to Follow-up|19
4424457|NCT00359424|7206500|FG001|Overall Study|Lost to Follow-up|7
4424458|NCT00359424|7206499|FG000|Overall Study|Withdrawal by Subject|10
4424459|NCT00359424|7206500|FG001|Overall Study|Withdrawal by Subject|2
4424460|NCT00359424|7206499|FG000|Overall Study|follow up not conducted|2
4424461|NCT00359424|7206500|FG001|Overall Study|follow up not conducted|0
4424462|NCT00359619|7206513|FG000|Overall Study|Adverse Event|0
4424463|NCT00359619|7206514|FG001|Overall Study|Adverse Event|0
4424464|NCT00359619|7206515|FG002|Overall Study|Adverse Event|1
4424465|NCT00359619|7206516|FG003|Overall Study|Adverse Event|0
4424466|NCT00359619|7206517|FG004|Overall Study|Adverse Event|0
4424467|NCT00359619|7206518|FG005|Overall Study|Adverse Event|0
4424468|NCT00359619|7206519|FG006|Overall Study|Adverse Event|1
4424469|NCT00359619|7206513|FG000|Overall Study|Withdrawal by Subject|3
4424470|NCT00359619|7206514|FG001|Overall Study|Withdrawal by Subject|1
4424471|NCT00359619|7206515|FG002|Overall Study|Withdrawal by Subject|4
4424472|NCT00359619|7206516|FG003|Overall Study|Withdrawal by Subject|2
4424473|NCT00359619|7206517|FG004|Overall Study|Withdrawal by Subject|2
4424474|NCT00359619|7206518|FG005|Overall Study|Withdrawal by Subject|0
4424475|NCT00359619|7206519|FG006|Overall Study|Withdrawal by Subject|3
4424476|NCT00359619|7206513|FG000|Overall Study|Other|1
4424477|NCT00359619|7206514|FG001|Overall Study|Other|0
4424478|NCT00359619|7206515|FG002|Overall Study|Other|0
4424479|NCT00359619|7206516|FG003|Overall Study|Other|0
4424480|NCT00359619|7206517|FG004|Overall Study|Other|0
4424481|NCT00359619|7206518|FG005|Overall Study|Other|0
4424482|NCT00359619|7206519|FG006|Overall Study|Other|0
4424483|NCT00359619|7206513|FG000|Overall Study|Lost to Follow-up|4
4424484|NCT00359619|7206514|FG001|Overall Study|Lost to Follow-up|4
4424485|NCT00359619|7206515|FG002|Overall Study|Lost to Follow-up|2
4424486|NCT00359619|7206516|FG003|Overall Study|Lost to Follow-up|1
4424487|NCT00359619|7206517|FG004|Overall Study|Lost to Follow-up|1
4424488|NCT00359619|7206518|FG005|Overall Study|Lost to Follow-up|5
4424489|NCT00359619|7206519|FG006|Overall Study|Lost to Follow-up|0
4424490|NCT00359632|7206537|FG000|Overall Study|Death|2
4424491|NCT00359632|7206538|FG001|Overall Study|Death|0
4424492|NCT00359632|7206537|FG000|Overall Study|Adverse Event|1
4424493|NCT00359632|7206538|FG001|Overall Study|Adverse Event|0
4424494|NCT00359632|7206537|FG000|Overall Study|Non-compliance with visit schedule|1
4424495|NCT00359632|7206538|FG001|Overall Study|Non-compliance with visit schedule|0
4424496|NCT00359762|7206557|FG000|Period II|Adverse Event|17
4424497|NCT00359762|7206558|FG001|Period II|Adverse Event|0
4424498|NCT00359762|7206559|FG002|Period II|Adverse Event|0
4424499|NCT00359762|7206560|FG003|Period II|Adverse Event|0
4424500|NCT00359762|7206561|FG004|Period II|Adverse Event|49
4424501|NCT00359762|7206557|FG000|Period II|Protocol Violation|18
4424502|NCT00359762|7206558|FG001|Period II|Protocol Violation|0
4424503|NCT00359762|7206559|FG002|Period II|Protocol Violation|0
4424504|NCT00359762|7206560|FG003|Period II|Protocol Violation|0
4424505|NCT00359762|7206561|FG004|Period II|Protocol Violation|11
4424506|NCT00359762|7206557|FG000|Period II|Physician Decision|17
4424507|NCT00359762|7206558|FG001|Period II|Physician Decision|0
4424508|NCT00359762|7206559|FG002|Period II|Physician Decision|0
4424509|NCT00359762|7206560|FG003|Period II|Physician Decision|0
4424510|NCT00359762|7206561|FG004|Period II|Physician Decision|23
4424511|NCT00359762|7206557|FG000|Period II|Death|2
4424512|NCT00359762|7206558|FG001|Period II|Death|0
4424513|NCT00359762|7206559|FG002|Period II|Death|0
4424514|NCT00359762|7206560|FG003|Period II|Death|0
4424515|NCT00359762|7206561|FG004|Period II|Death|4
4424516|NCT00359762|7206557|FG000|Period II|Lack of Efficacy|11
4424517|NCT00359762|7206558|FG001|Period II|Lack of Efficacy|0
4424518|NCT00359762|7206559|FG002|Period II|Lack of Efficacy|0
4424519|NCT00359762|7206560|FG003|Period II|Lack of Efficacy|0
4424520|NCT00359762|7206561|FG004|Period II|Lack of Efficacy|8
4424521|NCT00359762|7206557|FG000|Period II|Lost to follow up|5
4424522|NCT00359762|7206558|FG001|Period II|Lost to follow up|0
4424523|NCT00359762|7206559|FG002|Period II|Lost to follow up|0
4424524|NCT00359762|7206560|FG003|Period II|Lost to follow up|0
4424525|NCT00359762|7206561|FG004|Period II|Lost to follow up|5
4424526|NCT00359762|7206557|FG000|Period II|Entry Criteria Not Met|8
4424527|NCT00359762|7206558|FG001|Period II|Entry Criteria Not Met|0
4424528|NCT00359762|7206559|FG002|Period II|Entry Criteria Not Met|0
4424529|NCT00359762|7206560|FG003|Period II|Entry Criteria Not Met|0
4424530|NCT00359762|7206561|FG004|Period II|Entry Criteria Not Met|4
4424531|NCT00359762|7206557|FG000|Period II|Subject Decision|50
4424532|NCT00359762|7206558|FG001|Period II|Subject Decision|0
4424533|NCT00359762|7206559|FG002|Period II|Subject Decision|0
4424534|NCT00359762|7206560|FG003|Period II|Subject Decision|0
4424535|NCT00359762|7206561|FG004|Period II|Subject Decision|70
4424536|NCT00359762|7206557|FG000|Period III|Protocol Violation|0
4424537|NCT00359762|7206558|FG001|Period III|Protocol Violation|5
4424538|NCT00359762|7206559|FG002|Period III|Protocol Violation|3
4424539|NCT00359762|7206560|FG003|Period III|Protocol Violation|8
4424540|NCT00359762|7206561|FG004|Period III|Protocol Violation|0
4424541|NCT00359762|7206557|FG000|Period III|Adverse Event|0
4424542|NCT00359762|7206558|FG001|Period III|Adverse Event|3
4424543|NCT00359762|7206559|FG002|Period III|Adverse Event|4
4424544|NCT00359762|7206560|FG003|Period III|Adverse Event|10
4424545|NCT00359762|7206561|FG004|Period III|Adverse Event|0
4424546|NCT00359762|7206557|FG000|Period III|Physician Decision|0
4424547|NCT00359762|7206558|FG001|Period III|Physician Decision|5
4424548|NCT00359762|7206559|FG002|Period III|Physician Decision|9
4424549|NCT00359762|7206560|FG003|Period III|Physician Decision|15
4424550|NCT00359762|7206561|FG004|Period III|Physician Decision|0
4424551|NCT00359762|7206557|FG000|Period III|Lack of Efficacy|0
4424552|NCT00359762|7206558|FG001|Period III|Lack of Efficacy|7
4424553|NCT00359762|7206559|FG002|Period III|Lack of Efficacy|5
4424554|NCT00359762|7206560|FG003|Period III|Lack of Efficacy|9
4424555|NCT00359762|7206561|FG004|Period III|Lack of Efficacy|0
4424556|NCT00359762|7206557|FG000|Period III|Lost to follow up|0
4424557|NCT00359762|7206558|FG001|Period III|Lost to follow up|1
4424558|NCT00359762|7206559|FG002|Period III|Lost to follow up|1
4424559|NCT00359762|7206560|FG003|Period III|Lost to follow up|2
4424560|NCT00359762|7206561|FG004|Period III|Lost to follow up|0
4424561|NCT00359762|7206557|FG000|Period III|Entry Criteria Not Met|0
4424562|NCT00359762|7206558|FG001|Period III|Entry Criteria Not Met|1
4424563|NCT00359762|7206559|FG002|Period III|Entry Criteria Not Met|0
4424564|NCT00359762|7206560|FG003|Period III|Entry Criteria Not Met|1
4424565|NCT00359762|7206561|FG004|Period III|Entry Criteria Not Met|0
4424566|NCT00359762|7206557|FG000|Period III|Subject Decision|0
4424567|NCT00359762|7206558|FG001|Period III|Subject Decision|7
4424568|NCT00359762|7206559|FG002|Period III|Subject Decision|8
4424569|NCT00359762|7206560|FG003|Period III|Subject Decision|20
4424570|NCT00359762|7206561|FG004|Period III|Subject Decision|0
4424571|NCT00359788|7206577|FG000|Overall Study|Adverse Event|11
4424572|NCT00359788|7206578|FG001|Overall Study|Adverse Event|10
4424573|NCT00359788|7206577|FG000|Overall Study|Lack of Efficacy|1
4424574|NCT00359788|7206578|FG001|Overall Study|Lack of Efficacy|2
4424575|NCT00359788|7206577|FG000|Overall Study|Lost to Follow-up|3
4424576|NCT00359788|7206578|FG001|Overall Study|Lost to Follow-up|2
4424577|NCT00359788|7206577|FG000|Overall Study|Withdrawal by Subject|4
4424578|NCT00359788|7206578|FG001|Overall Study|Withdrawal by Subject|1
4424579|NCT00359788|7206577|FG000|Overall Study|Protocol Violation|4
4512304|NCT00932698|7322003|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0
4424580|NCT00359788|7206578|FG001|Overall Study|Protocol Violation|2
4424581|NCT00359801|7206586|FG000|Overall Study|Lost to Follow-up|72
4424582|NCT00359801|7206587|FG001|Overall Study|Lost to Follow-up|58
4424583|NCT00359801|7206586|FG000|Overall Study|Withdrawal by Subject|143
4424584|NCT00359801|7206587|FG001|Overall Study|Withdrawal by Subject|96
4424585|NCT00359801|7206586|FG000|Overall Study|Other|66
4424586|NCT00359801|7206587|FG001|Overall Study|Other|46
4424587|NCT00359801|7206586|FG000|Overall Study|Final Status Unknown: missing data|7
4424588|NCT00359801|7206587|FG001|Overall Study|Final Status Unknown: missing data|4
4424589|NCT00359801|7206586|FG000|Overall Study|Sponsor Decision|17
4424590|NCT00359801|7206587|FG001|Overall Study|Sponsor Decision|16
4424591|NCT00360230|7206643|FG000|Overall Study|Withdrawal by Subject|1
4424592|NCT00360230|7206644|FG001|Overall Study|Withdrawal by Subject|1
4424593|NCT00360230|7206645|FG002|Overall Study|Withdrawal by Subject|0
4424594|NCT00360230|7206646|FG003|Overall Study|Withdrawal by Subject|1
4424595|NCT00360230|7206647|FG004|Overall Study|Withdrawal by Subject|1
4424596|NCT00360230|7206648|FG005|Overall Study|Withdrawal by Subject|1
4424597|NCT00360230|7206649|FG006|Overall Study|Withdrawal by Subject|0
4424598|NCT00360230|7206643|FG000|Overall Study|Migrated|4
4424599|NCT00360230|7206644|FG001|Overall Study|Migrated|1
4424600|NCT00360230|7206645|FG002|Overall Study|Migrated|3
4424601|NCT00360230|7206646|FG003|Overall Study|Migrated|1
4424602|NCT00360230|7206647|FG004|Overall Study|Migrated|4
4424603|NCT00360230|7206648|FG005|Overall Study|Migrated|1
4424604|NCT00360230|7206649|FG006|Overall Study|Migrated|1
4424605|NCT00360230|7206643|FG000|Overall Study|Other|1
4629692|NCT01876251|7497891|FG001|Overall Study|Clinical progression|0
4424606|NCT00360230|7206644|FG001|Overall Study|Other|0
4424607|NCT00360230|7206645|FG002|Overall Study|Other|0
4424608|NCT00360230|7206646|FG003|Overall Study|Other|0
4424609|NCT00360230|7206647|FG004|Overall Study|Other|0
4424610|NCT00360230|7206648|FG005|Overall Study|Other|0
4424611|NCT00360230|7206649|FG006|Overall Study|Other|0
4424612|NCT00360230|7206643|FG000|Overall Study|Protocol Violation|0
4424613|NCT00360230|7206644|FG001|Overall Study|Protocol Violation|0
4424614|NCT00360230|7206645|FG002|Overall Study|Protocol Violation|0
4424615|NCT00360230|7206646|FG003|Overall Study|Protocol Violation|0
4424616|NCT00360230|7206647|FG004|Overall Study|Protocol Violation|0
4424617|NCT00360230|7206648|FG005|Overall Study|Protocol Violation|1
4424618|NCT00360230|7206649|FG006|Overall Study|Protocol Violation|0
4424619|NCT00360230|7206643|FG000|Overall Study|Death|0
4424620|NCT00360230|7206644|FG001|Overall Study|Death|1
4424621|NCT00360230|7206645|FG002|Overall Study|Death|0
4424622|NCT00360230|7206646|FG003|Overall Study|Death|0
4424623|NCT00360230|7206647|FG004|Overall Study|Death|0
4424624|NCT00360230|7206648|FG005|Overall Study|Death|1
4424625|NCT00360230|7206649|FG006|Overall Study|Death|1
4424626|NCT00360269|7206686|FG000|Overall Study|Lost to Follow-up|7
4424627|NCT00360269|7206687|FG001|Overall Study|Lost to Follow-up|9
4424628|NCT00360269|7206686|FG000|Overall Study|Physician Decision|1
4424629|NCT00360269|7206687|FG001|Overall Study|Physician Decision|2
4424630|NCT00360269|7206686|FG000|Overall Study|Adverse Event|1
4424631|NCT00360269|7206687|FG001|Overall Study|Adverse Event|0
4424632|NCT00360269|7206686|FG000|Overall Study|Withdrawal by Subject|1
4424633|NCT00360269|7206687|FG001|Overall Study|Withdrawal by Subject|1
4424634|NCT00360282|7206693|FG000|Washout 1-3 Weeks|Lost to Follow-up|0
4424635|NCT00360282|7206694|FG001|Washout 1-3 Weeks|Lost to Follow-up|0
4424636|NCT00360282|7206695|FG002|Washout 1-3 Weeks|Lost to Follow-up|1
4424637|NCT00360282|7206696|FG003|Washout 1-3 Weeks|Lost to Follow-up|0
4424638|NCT00360282|7206693|FG000|Second Intervention|Adverse Event|0
4424639|NCT00360282|7206694|FG001|Second Intervention|Adverse Event|1
4424640|NCT00360282|7206695|FG002|Second Intervention|Adverse Event|0
4424641|NCT00360282|7206696|FG003|Second Intervention|Adverse Event|0
4424642|NCT00360308|7206707|FG000|Overall Study|Adverse Event|15
4424643|NCT00360308|7206708|FG001|Overall Study|Adverse Event|14
4424644|NCT00360308|7206709|FG002|Overall Study|Adverse Event|25
4424645|NCT00360308|7206707|FG000|Overall Study|Abnormal Laboratory Value(s)|0
4424646|NCT00360308|7206708|FG001|Overall Study|Abnormal Laboratory Value(s)|1
4424647|NCT00360308|7206709|FG002|Overall Study|Abnormal Laboratory Value(s)|0
4424648|NCT00360308|7206707|FG000|Overall Study|Protocol Violation|2
4424649|NCT00360308|7206708|FG001|Overall Study|Protocol Violation|1
4424650|NCT00360308|7206709|FG002|Overall Study|Protocol Violation|2
4424651|NCT00360308|7206707|FG000|Overall Study|Withdrawal by Subject|11
4424652|NCT00360308|7206708|FG001|Overall Study|Withdrawal by Subject|7
4424653|NCT00360308|7206709|FG002|Overall Study|Withdrawal by Subject|14
4424654|NCT00360308|7206707|FG000|Overall Study|Lack of Efficacy|3
4424655|NCT00360308|7206708|FG001|Overall Study|Lack of Efficacy|0
4424656|NCT00360308|7206709|FG002|Overall Study|Lack of Efficacy|2
4424657|NCT00360308|7206707|FG000|Overall Study|Other|2
4424658|NCT00360308|7206708|FG001|Overall Study|Other|1
4424659|NCT00360308|7206709|FG002|Overall Study|Other|1
4424660|NCT00360308|7206707|FG000|Overall Study|Study termination by sponsor|43
4424661|NCT00360308|7206708|FG001|Overall Study|Study termination by sponsor|55
4424662|NCT00360308|7206709|FG002|Overall Study|Study termination by sponsor|44
4424663|NCT00360334|7206723|FG000|Overall Study|Adverse Event|7
4424664|NCT00360334|7206724|FG001|Overall Study|Adverse Event|4
4424665|NCT00360334|7206723|FG000|Overall Study|Protocol Violation|1
4424666|NCT00360334|7206724|FG001|Overall Study|Protocol Violation|1
4424667|NCT00360334|7206723|FG000|Overall Study|Physician Decision|2
4424668|NCT00360334|7206724|FG001|Overall Study|Physician Decision|3
4424669|NCT00360334|7206723|FG000|Overall Study|Lack of Efficacy|0
4424670|NCT00360334|7206724|FG001|Overall Study|Lack of Efficacy|1
4424671|NCT00360334|7206723|FG000|Overall Study|Entry criterion not met|1
4424672|NCT00360334|7206724|FG001|Overall Study|Entry criterion not met|2
4424673|NCT00360334|7206723|FG000|Overall Study|Subject decision|8
4424674|NCT00360334|7206724|FG001|Overall Study|Subject decision|2
4424675|NCT00360412|7206749|FG000|Overall Study|Adverse Event|37
4424676|NCT00360412|7206750|FG001|Overall Study|Adverse Event|65
4424677|NCT00360412|7206749|FG000|Overall Study|Protocol Violation|2
4424678|NCT00360412|7206750|FG001|Overall Study|Protocol Violation|5
4424679|NCT00360412|7206749|FG000|Overall Study|Patient withdrew consent|27
4424680|NCT00360412|7206750|FG001|Overall Study|Patient withdrew consent|52
4424681|NCT00360412|7206749|FG000|Overall Study|Lack of therapeutic efficacy|46
4424682|NCT00360412|7206750|FG001|Overall Study|Lack of therapeutic efficacy|61
4424683|NCT00360412|7206749|FG000|Overall Study|Physician Decision|2
4424684|NCT00360412|7206750|FG001|Overall Study|Physician Decision|4
4424685|NCT00360412|7206749|FG000|Overall Study|Other|5
4424686|NCT00360412|7206750|FG001|Overall Study|Other|6
4424687|NCT00360412|7206749|FG000|Overall Study|Study termination by Sponsor|214
4424688|NCT00360412|7206750|FG001|Overall Study|Study termination by Sponsor|469
4424689|NCT00360490|7206758|FG000|Overall Study|Adverse Event|4
4424690|NCT00360490|7206759|FG001|Overall Study|Adverse Event|2
4424691|NCT00360490|7206758|FG000|Overall Study|Lost to Follow-up|2
4424692|NCT00360490|7206759|FG001|Overall Study|Lost to Follow-up|1
4424693|NCT00360490|7206758|FG000|Overall Study|Physician Decision|2
4424694|NCT00360490|7206759|FG001|Overall Study|Physician Decision|1
4424695|NCT00360490|7206758|FG000|Overall Study|Protocol Violation|0
4424696|NCT00360490|7206759|FG001|Overall Study|Protocol Violation|4
4424697|NCT00360490|7206758|FG000|Overall Study|Withdrawal by Subject|1
4424698|NCT00360490|7206759|FG001|Overall Study|Withdrawal by Subject|3
4424699|NCT00360529|7206768|FG000|Overall Study|Adverse Event|10
4424700|NCT00360529|7206769|FG001|Overall Study|Adverse Event|23
4424701|NCT00360529|7206770|FG002|Overall Study|Adverse Event|33
4424702|NCT00360529|7206768|FG000|Overall Study|Protocol Violation|3
4424703|NCT00360529|7206769|FG001|Overall Study|Protocol Violation|3
4424704|NCT00360529|7206770|FG002|Overall Study|Protocol Violation|11
4424705|NCT00360529|7206768|FG000|Overall Study|Lost to Follow-up|14
4424706|NCT00360529|7206769|FG001|Overall Study|Lost to Follow-up|10
4424707|NCT00360529|7206770|FG002|Overall Study|Lost to Follow-up|13
4424708|NCT00360529|7206768|FG000|Overall Study|Withdrawal by Subject|22
4424709|NCT00360529|7206769|FG001|Overall Study|Withdrawal by Subject|14
4424710|NCT00360529|7206770|FG002|Overall Study|Withdrawal by Subject|18
4424711|NCT00360529|7206768|FG000|Overall Study|Lack of Efficacy|8
4424712|NCT00360529|7206769|FG001|Overall Study|Lack of Efficacy|6
4424713|NCT00360529|7206770|FG002|Overall Study|Lack of Efficacy|5
4424714|NCT00360529|7206768|FG000|Overall Study|Reason discontinued not explained above|4
4424715|NCT00360529|7206769|FG001|Overall Study|Reason discontinued not explained above|9
4424716|NCT00360529|7206770|FG002|Overall Study|Reason discontinued not explained above|11
4424717|NCT00360568|7206797|FG000|Overall Study|Adverse Event|1
4424718|NCT00360568|7206798|FG001|Overall Study|Adverse Event|2
4424719|NCT00360568|7206797|FG000|Overall Study|Lack of Efficacy|1
4424720|NCT00360568|7206798|FG001|Overall Study|Lack of Efficacy|0
4424721|NCT00360568|7206797|FG000|Overall Study|Withdrawal by Subject|0
4424722|NCT00360568|7206798|FG001|Overall Study|Withdrawal by Subject|3
4424723|NCT00360698|7206822|FG000|Run-In|Physician Decision|0
4424724|NCT00360698|7206823|FG001|Run-In|Physician Decision|1
4424725|NCT00360698|7206822|FG000|Run-In|Withdrawal by Subject|0
4424726|NCT00360698|7206823|FG001|Run-In|Withdrawal by Subject|2
4424727|NCT00360698|7206822|FG000|Run-In|Non compliance with treatment procedure|0
4424728|NCT00360698|7206823|FG001|Run-In|Non compliance with treatment procedure|1
4424729|NCT00360698|7206822|FG000|Run-In|Sponsor request|0
4424730|NCT00360698|7206823|FG001|Run-In|Sponsor request|2
4424731|NCT00360698|7206822|FG000|Run-In|Patient did not meet inclusion criteria|0
4424732|NCT00360698|7206823|FG001|Run-In|Patient did not meet inclusion criteria|1
4424733|NCT00360698|7206822|FG000|Run-In|Patient personal reasons|0
4424734|NCT00360698|7206823|FG001|Run-In|Patient personal reasons|2
4424735|NCT00360698|7206822|FG000|Run-In|Need of insulin with meals|0
4424736|NCT00360698|7206823|FG001|Run-In|Need of insulin with meals|1
4424737|NCT00360698|7206822|FG000|Treatment Period|Non compliance with treatment procedure|1
4424738|NCT00360698|7206823|FG001|Treatment Period|Non compliance with treatment procedure|0
4424739|NCT00360698|7206822|FG000|Treatment Period|Early termination by error|0
4424740|NCT00360698|7206823|FG001|Treatment Period|Early termination by error|1
4424741|NCT00361218|7206867|FG000|Overall Study|Lost to Follow-up|11
4424742|NCT00361218|7206867|FG000|Overall Study|Personal Reasons|7
4424743|NCT00361218|7206867|FG000|Overall Study|terminated / withdrawn due to toxicity /|5
4424744|NCT00361231|7206871|FG000|Overall Study|Physician Decision|3
4424745|NCT00361231|7206871|FG000|Overall Study|Symptomatic deterioration|5
4424746|NCT00361231|7206871|FG000|Overall Study|Radiographic disease progression|16
4424747|NCT00361231|7206871|FG000|Overall Study|Withdrawal by Subject|4
4424748|NCT00361231|7206871|FG000|Overall Study|Adverse Event|6
4512305|NCT00932698|7322004|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0
4512306|NCT00932698|7322005|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0
4512307|NCT00932698|7322006|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0
4512308|NCT00932698|7322007|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1
4512309|NCT00932698|7322008|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3
4512310|NCT00932698|7322009|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2
4512311|NCT00932698|7322010|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0
4512312|NCT00932698|7322000|FG000|Part 2 (Dose Expansion)|Adverse Event|0
4512313|NCT00932698|7322001|FG001|Part 2 (Dose Expansion)|Adverse Event|0
4512314|NCT00932698|7322002|FG002|Part 2 (Dose Expansion)|Adverse Event|0
4512315|NCT00932698|7322003|FG003|Part 2 (Dose Expansion)|Adverse Event|0
4424749|NCT00361270|7206890|FG000|Overall Study|Death|0
4424750|NCT00361270|7206891|FG001|Overall Study|Death|0
4424751|NCT00361270|7206892|FG002|Overall Study|Death|0
4424752|NCT00361270|7206893|FG003|Overall Study|Death|2
4424753|NCT00361270|7206890|FG000|Overall Study|Lost to Follow-up|4
4424754|NCT00361270|7206891|FG001|Overall Study|Lost to Follow-up|1
4424755|NCT00361270|7206892|FG002|Overall Study|Lost to Follow-up|0
4424756|NCT00361270|7206893|FG003|Overall Study|Lost to Follow-up|0
4424757|NCT00361270|7206890|FG000|Overall Study|Physician Decision|0
4424758|NCT00361270|7206891|FG001|Overall Study|Physician Decision|0
4424759|NCT00361270|7206892|FG002|Overall Study|Physician Decision|1
4424760|NCT00361270|7206893|FG003|Overall Study|Physician Decision|0
4424761|NCT00361270|7206890|FG000|Overall Study|Protocol Violation|9
4424762|NCT00361270|7206891|FG001|Overall Study|Protocol Violation|4
4424763|NCT00361270|7206892|FG002|Overall Study|Protocol Violation|5
4424764|NCT00361270|7206893|FG003|Overall Study|Protocol Violation|4
4424765|NCT00361270|7206890|FG000|Overall Study|Withdrawal by Subject|6
4424766|NCT00361270|7206891|FG001|Overall Study|Withdrawal by Subject|6
4424767|NCT00361270|7206892|FG002|Overall Study|Withdrawal by Subject|3
4424768|NCT00361270|7206893|FG003|Overall Study|Withdrawal by Subject|7
4424769|NCT00361270|7206890|FG000|Overall Study|Afraid of Hypnosis|1
4424770|NCT00361270|7206891|FG001|Overall Study|Afraid of Hypnosis|2
4424771|NCT00361270|7206892|FG002|Overall Study|Afraid of Hypnosis|0
4424772|NCT00361270|7206893|FG003|Overall Study|Afraid of Hypnosis|0
4424773|NCT00361270|7206890|FG000|Overall Study|Problems with Transportation|4
4424774|NCT00361270|7206891|FG001|Overall Study|Problems with Transportation|0
4424775|NCT00361270|7206892|FG002|Overall Study|Problems with Transportation|0
4424776|NCT00361270|7206893|FG003|Overall Study|Problems with Transportation|0
4424777|NCT00361270|7206890|FG000|Overall Study|Adverse Event|0
4424778|NCT00361270|7206891|FG001|Overall Study|Adverse Event|1
4424779|NCT00361270|7206892|FG002|Overall Study|Adverse Event|1
4424780|NCT00361270|7206893|FG003|Overall Study|Adverse Event|0
4424781|NCT00361283|7206910|FG000|Overall Study|Lost to Follow-up|27
4424782|NCT00361296|7206914|FG000|Overall Study|Physician Decision|1
4424783|NCT00361296|7206914|FG000|Overall Study|Lack of Efficacy|2
4424784|NCT00361335|7206923|FG000|IV Period: Baseline to E0|Adverse Event|9
4424785|NCT00361335|7206924|FG001|IV Period: Baseline to E0|Adverse Event|4
4424786|NCT00361335|7206925|FG002|IV Period: Baseline to E0|Adverse Event|5
4424787|NCT00361335|7206926|FG003|IV Period: Baseline to E0|Adverse Event|9
4424788|NCT00361335|7206927|FG004|IV Period: Baseline to E0|Adverse Event|8
4424789|NCT00361335|7206928|FG005|IV Period: Baseline to E0|Adverse Event|0
4424790|NCT00361335|7206929|FG006|IV Period: Baseline to E0|Adverse Event|0
4424791|NCT00361335|7206923|FG000|IV Period: Baseline to E0|Lost to Follow-up|1
4424792|NCT00361335|7206924|FG001|IV Period: Baseline to E0|Lost to Follow-up|0
4424793|NCT00361335|7206925|FG002|IV Period: Baseline to E0|Lost to Follow-up|0
4424794|NCT00361335|7206926|FG003|IV Period: Baseline to E0|Lost to Follow-up|2
4424795|NCT00361335|7206927|FG004|IV Period: Baseline to E0|Lost to Follow-up|2
4424796|NCT00361335|7206928|FG005|IV Period: Baseline to E0|Lost to Follow-up|0
4424797|NCT00361335|7206929|FG006|IV Period: Baseline to E0|Lost to Follow-up|0
4424798|NCT00361335|7206923|FG000|IV Period: Baseline to E0|Death|1
4424799|NCT00361335|7206924|FG001|IV Period: Baseline to E0|Death|1
4424800|NCT00361335|7206925|FG002|IV Period: Baseline to E0|Death|1
4424801|NCT00361335|7206926|FG003|IV Period: Baseline to E0|Death|1
4424802|NCT00361335|7206927|FG004|IV Period: Baseline to E0|Death|0
4424803|NCT00361335|7206928|FG005|IV Period: Baseline to E0|Death|0
4424804|NCT00361335|7206929|FG006|IV Period: Baseline to E0|Death|0
4424805|NCT00361335|7206923|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2
4424806|NCT00361335|7206924|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1
4424807|NCT00361335|7206925|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1
4424808|NCT00361335|7206926|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1
4424809|NCT00361335|7206927|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2
4424810|NCT00361335|7206928|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0
4424811|NCT00361335|7206929|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0
4424812|NCT00361335|7206923|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0
4424813|NCT00361335|7206924|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0
4424814|NCT00361335|7206925|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1
4424815|NCT00361335|7206926|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0
4424816|NCT00361335|7206927|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0
4424817|NCT00361335|7206928|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0
4424818|NCT00361335|7206929|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0
4424819|NCT00361335|7206923|FG000|IV Period: Baseline to E0|Worsening of RA|0
4424820|NCT00361335|7206924|FG001|IV Period: Baseline to E0|Worsening of RA|5
4424821|NCT00361335|7206925|FG002|IV Period: Baseline to E0|Worsening of RA|1
4424822|NCT00361335|7206926|FG003|IV Period: Baseline to E0|Worsening of RA|4
4424823|NCT00361335|7206927|FG004|IV Period: Baseline to E0|Worsening of RA|2
4424824|NCT00361335|7206928|FG005|IV Period: Baseline to E0|Worsening of RA|0
4424825|NCT00361335|7206929|FG006|IV Period: Baseline to E0|Worsening of RA|0
4424826|NCT00361335|7206923|FG000|IV Period: Baseline to E0|Other|2
4424827|NCT00361335|7206924|FG001|IV Period: Baseline to E0|Other|9
4424828|NCT00361335|7206925|FG002|IV Period: Baseline to E0|Other|9
4424829|NCT00361335|7206926|FG003|IV Period: Baseline to E0|Other|3
4424830|NCT00361335|7206927|FG004|IV Period: Baseline to E0|Other|2
4424831|NCT00361335|7206928|FG005|IV Period: Baseline to E0|Other|0
4424832|NCT00361335|7206929|FG006|IV Period: Baseline to E0|Other|0
4424833|NCT00361335|7206923|FG000|IV Period: Baseline to E0|Lack of Efficacy|5
4424834|NCT00361335|7206924|FG001|IV Period: Baseline to E0|Lack of Efficacy|9
4424835|NCT00361335|7206925|FG002|IV Period: Baseline to E0|Lack of Efficacy|3
4424836|NCT00361335|7206926|FG003|IV Period: Baseline to E0|Lack of Efficacy|7
4424837|NCT00361335|7206927|FG004|IV Period: Baseline to E0|Lack of Efficacy|8
4424838|NCT00361335|7206928|FG005|IV Period: Baseline to E0|Lack of Efficacy|0
4424839|NCT00361335|7206929|FG006|IV Period: Baseline to E0|Lack of Efficacy|0
4424840|NCT00361335|7206923|FG000|SC Period: Week E0 to Week E24|Adverse Event|0
4424841|NCT00361335|7206924|FG001|SC Period: Week E0 to Week E24|Adverse Event|2
4424842|NCT00361335|7206925|FG002|SC Period: Week E0 to Week E24|Adverse Event|1
4424843|NCT00361335|7206926|FG003|SC Period: Week E0 to Week E24|Adverse Event|2
4424844|NCT00361335|7206927|FG004|SC Period: Week E0 to Week E24|Adverse Event|0
4424845|NCT00361335|7206928|FG005|SC Period: Week E0 to Week E24|Adverse Event|0
4424846|NCT00361335|7206929|FG006|SC Period: Week E0 to Week E24|Adverse Event|2
4424847|NCT00361335|7206923|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1
4424848|NCT00361335|7206924|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0
4424849|NCT00361335|7206925|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1
4424850|NCT00361335|7206926|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0
4424851|NCT00361335|7206927|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0
4424852|NCT00361335|7206928|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0
4424853|NCT00361335|7206929|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1
4424854|NCT00361335|7206923|FG000|SC Period: Week E0 to Week E24|Death|0
4424855|NCT00361335|7206924|FG001|SC Period: Week E0 to Week E24|Death|0
4424856|NCT00361335|7206925|FG002|SC Period: Week E0 to Week E24|Death|0
4424857|NCT00361335|7206926|FG003|SC Period: Week E0 to Week E24|Death|0
4424858|NCT00361335|7206927|FG004|SC Period: Week E0 to Week E24|Death|0
4424859|NCT00361335|7206928|FG005|SC Period: Week E0 to Week E24|Death|0
4424860|NCT00361335|7206929|FG006|SC Period: Week E0 to Week E24|Death|1
4424861|NCT00361335|7206923|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0
4424862|NCT00361335|7206924|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1
4424863|NCT00361335|7206925|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1
4424864|NCT00361335|7206926|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1
4424865|NCT00361335|7206927|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0
4424866|NCT00361335|7206928|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0
4424867|NCT00361335|7206929|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0
4424868|NCT00361335|7206923|FG000|SC Period: Week E0 to Week E24|Other|1
4424869|NCT00361335|7206924|FG001|SC Period: Week E0 to Week E24|Other|0
4424870|NCT00361335|7206925|FG002|SC Period: Week E0 to Week E24|Other|0
4424871|NCT00361335|7206926|FG003|SC Period: Week E0 to Week E24|Other|1
4629693|NCT01876251|7497892|FG002|Overall Study|Clinical progression|0
4629694|NCT01876251|7497890|FG000|Overall Study|Death|2
4629695|NCT01876251|7497891|FG001|Overall Study|Death|0
4629696|NCT01876251|7497892|FG002|Overall Study|Death|1
4629697|NCT01876251|7497890|FG000|Overall Study|Participant started new treatment|1
4629698|NCT01876251|7497891|FG001|Overall Study|Participant started new treatment|0
4629699|NCT01876251|7497892|FG002|Overall Study|Participant started new treatment|1
4714954|NCT02964338|7642998|FG002|Overall Study|Adverse Event|1
4714955|NCT02964338|7642996|FG000|Overall Study|Non-compliant with e-diary|0
4714956|NCT02964338|7642997|FG001|Overall Study|Non-compliant with e-diary|1
4714957|NCT02964338|7642998|FG002|Overall Study|Non-compliant with e-diary|0
4424872|NCT00361335|7206927|FG004|SC Period: Week E0 to Week E24|Other|0
4424873|NCT00361335|7206928|FG005|SC Period: Week E0 to Week E24|Other|1
4424874|NCT00361335|7206929|FG006|SC Period: Week E0 to Week E24|Other|2
4424875|NCT00361335|7206923|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0
4424876|NCT00361335|7206924|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0
4424877|NCT00361335|7206925|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2
4424878|NCT00361335|7206926|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0
4424879|NCT00361335|7206927|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0
4424880|NCT00361335|7206928|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0
4424881|NCT00361335|7206929|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3
4424882|NCT00361504|7206969|FG000|Overall Study|Withdrawal by Subject|94
4424883|NCT00361504|7206970|FG001|Overall Study|Withdrawal by Subject|31
4424884|NCT00361504|7206969|FG000|Overall Study|Lost to Follow-up|40
4424885|NCT00361504|7206970|FG001|Overall Study|Lost to Follow-up|7
4424886|NCT00361504|7206969|FG000|Overall Study|Adverse Event|203
4424887|NCT00361504|7206970|FG001|Overall Study|Adverse Event|82
4424888|NCT00361504|7206969|FG000|Overall Study|Lack of Efficacy|72
4424889|NCT00361504|7206970|FG001|Overall Study|Lack of Efficacy|7
4424890|NCT00361504|7206969|FG000|Overall Study|Resolution of Pain|2
4714958|NCT02964338|7642996|FG000|Overall Study|Did not meet criteria|1
4424891|NCT00361504|7206970|FG001|Overall Study|Resolution of Pain|0
4424892|NCT00361504|7206969|FG000|Overall Study|Study medication non compliant|42
4424893|NCT00361504|7206970|FG001|Overall Study|Study medication non compliant|15
4424894|NCT00361504|7206969|FG000|Overall Study|All other|28
4424895|NCT00361504|7206970|FG001|Overall Study|All other|3
4424896|NCT00361569|7206980|FG000|Overall Study|Protocol Violation|3
4424897|NCT00361569|7206981|FG001|Overall Study|Protocol Violation|2
4424898|NCT00361569|7206982|FG002|Overall Study|Protocol Violation|4
4424899|NCT00361569|7206983|FG003|Overall Study|Protocol Violation|2
4424900|NCT00361569|7206980|FG000|Overall Study|Withdrawal by Subject|2
4424901|NCT00361569|7206981|FG001|Overall Study|Withdrawal by Subject|1
4424902|NCT00361569|7206982|FG002|Overall Study|Withdrawal by Subject|9
4424903|NCT00361569|7206983|FG003|Overall Study|Withdrawal by Subject|14
4424904|NCT00361569|7206980|FG000|Overall Study|Adverse Event|3
4424905|NCT00361569|7206981|FG001|Overall Study|Adverse Event|5
4424906|NCT00361569|7206982|FG002|Overall Study|Adverse Event|2
4424907|NCT00361569|7206983|FG003|Overall Study|Adverse Event|2
4424908|NCT00361569|7206980|FG000|Overall Study|Lost to Follow-up|2
4424909|NCT00361569|7206981|FG001|Overall Study|Lost to Follow-up|3
4424910|NCT00361569|7206982|FG002|Overall Study|Lost to Follow-up|3
4424911|NCT00361569|7206983|FG003|Overall Study|Lost to Follow-up|2
4424912|NCT00361569|7206980|FG000|Overall Study|Not specified by investigator|2
4424913|NCT00361569|7206981|FG001|Overall Study|Not specified by investigator|0
4424914|NCT00361569|7206982|FG002|Overall Study|Not specified by investigator|0
4424915|NCT00361569|7206983|FG003|Overall Study|Not specified by investigator|1
4424916|NCT00361634|7206997|FG000|Overall Study|Lost to Follow-up|1
4424917|NCT00361634|7206997|FG000|Overall Study|Withdrawal by Subject|1
4424918|NCT00361842|7207012|FG000|Overall Study|Withdrawal by Subject|2
4424919|NCT00361842|7207013|FG001|Overall Study|Withdrawal by Subject|3
4424920|NCT00361842|7207012|FG000|Overall Study|Death|2
4424921|NCT00361842|7207013|FG001|Overall Study|Death|1
4424922|NCT00361842|7207012|FG000|Overall Study|Disease progression|19
4424923|NCT00361842|7207013|FG001|Overall Study|Disease progression|20
4424924|NCT00361842|7207012|FG000|Overall Study|Adverse Event|2
4424925|NCT00361842|7207013|FG001|Overall Study|Adverse Event|3
4424926|NCT00361842|7207012|FG000|Overall Study|Occurrence of unacceptable toxicity|1
4714959|NCT02964338|7642997|FG001|Overall Study|Did not meet criteria|0
4714960|NCT02964338|7642998|FG002|Overall Study|Did not meet criteria|0
4714961|NCT02965378|7643046|FG000|Overall Study|Progression|16
4714962|NCT02965378|7643047|FG001|Overall Study|Progression|4
4714963|NCT02965378|7643046|FG000|Overall Study|Adverse Event|5
4629700|NCT01876251|7497890|FG000|Overall Study|Participant refused further follow-up|0
4629701|NCT01876251|7497891|FG001|Overall Study|Participant refused further follow-up|0
4629702|NCT01876251|7497892|FG002|Overall Study|Participant refused further follow-up|1
4424927|NCT00361842|7207013|FG001|Overall Study|Occurrence of unacceptable toxicity|5
4424928|NCT00361842|7207012|FG000|Overall Study|Other|1
4424929|NCT00361842|7207013|FG001|Overall Study|Other|0
4424930|NCT00361842|7207012|FG000|Overall Study|Other|0
4424931|NCT00361842|7207013|FG001|Overall Study|Other|2
4424932|NCT00362115|7207038|FG000|Overall Study|Adverse Event|0
4424933|NCT00362115|7207039|FG001|Overall Study|Adverse Event|1
4424934|NCT00362115|7207040|FG002|Overall Study|Adverse Event|1
4424935|NCT00362115|7207041|FG003|Overall Study|Adverse Event|1
4424936|NCT00362115|7207042|FG004|Overall Study|Adverse Event|2
4424937|NCT00362115|7207043|FG005|Overall Study|Adverse Event|2
4424938|NCT00362115|7207044|FG006|Overall Study|Adverse Event|1
4714964|NCT02965378|7643047|FG001|Overall Study|Adverse Event|2
4714965|NCT02965378|7643046|FG000|Overall Study|Death|2
4714966|NCT02965378|7643047|FG001|Overall Study|Death|0
4714967|NCT02965378|7643046|FG000|Overall Study|Refusal|2
4424939|NCT00362115|7207038|FG000|Overall Study|Protocol Violation|0
4424940|NCT00362115|7207039|FG001|Overall Study|Protocol Violation|0
4424941|NCT00362115|7207040|FG002|Overall Study|Protocol Violation|0
4424942|NCT00362115|7207041|FG003|Overall Study|Protocol Violation|0
4424943|NCT00362115|7207042|FG004|Overall Study|Protocol Violation|0
4424944|NCT00362115|7207043|FG005|Overall Study|Protocol Violation|1
4424945|NCT00362115|7207044|FG006|Overall Study|Protocol Violation|0
4424946|NCT00362115|7207038|FG000|Overall Study|Lost to Follow-up|0
4424947|NCT00362115|7207039|FG001|Overall Study|Lost to Follow-up|1
4424948|NCT00362115|7207040|FG002|Overall Study|Lost to Follow-up|0
4424949|NCT00362115|7207041|FG003|Overall Study|Lost to Follow-up|0
4424950|NCT00362115|7207042|FG004|Overall Study|Lost to Follow-up|2
4424951|NCT00362115|7207043|FG005|Overall Study|Lost to Follow-up|0
4424952|NCT00362115|7207044|FG006|Overall Study|Lost to Follow-up|1
4424953|NCT00362115|7207038|FG000|Overall Study|Withdrawal by Subject|1
4424954|NCT00362115|7207039|FG001|Overall Study|Withdrawal by Subject|3
4424955|NCT00362115|7207040|FG002|Overall Study|Withdrawal by Subject|1
4424956|NCT00362115|7207041|FG003|Overall Study|Withdrawal by Subject|0
4424957|NCT00362115|7207042|FG004|Overall Study|Withdrawal by Subject|1
4424958|NCT00362115|7207043|FG005|Overall Study|Withdrawal by Subject|3
4424959|NCT00362115|7207044|FG006|Overall Study|Withdrawal by Subject|4
4424960|NCT00362115|7207038|FG000|Overall Study|Lack of Efficacy|1
4424961|NCT00362115|7207039|FG001|Overall Study|Lack of Efficacy|0
4424962|NCT00362115|7207040|FG002|Overall Study|Lack of Efficacy|5
4424963|NCT00362115|7207041|FG003|Overall Study|Lack of Efficacy|2
4424964|NCT00362115|7207042|FG004|Overall Study|Lack of Efficacy|2
4714968|NCT02965378|7643047|FG001|Overall Study|Refusal|1
4424965|NCT00362115|7207043|FG005|Overall Study|Lack of Efficacy|0
4714969|NCT02965378|7643046|FG000|Overall Study|Not protocol specified|0
4714970|NCT02965378|7643047|FG001|Overall Study|Not protocol specified|2
4424966|NCT00362115|7207044|FG006|Overall Study|Lack of Efficacy|3
4424967|NCT00362115|7207038|FG000|Overall Study|Physician Decision|0
4424968|NCT00362115|7207039|FG001|Overall Study|Physician Decision|0
4424969|NCT00362115|7207040|FG002|Overall Study|Physician Decision|0
4424970|NCT00362115|7207041|FG003|Overall Study|Physician Decision|0
4424971|NCT00362115|7207042|FG004|Overall Study|Physician Decision|0
4424972|NCT00362115|7207043|FG005|Overall Study|Physician Decision|0
4424973|NCT00362115|7207044|FG006|Overall Study|Physician Decision|3
4424974|NCT00362115|7207038|FG000|Overall Study|Other|0
4424975|NCT00362115|7207039|FG001|Overall Study|Other|1
4424976|NCT00362115|7207040|FG002|Overall Study|Other|0
4629703|NCT01876251|7497890|FG000|Overall Study|Study terminated|1
4424977|NCT00362115|7207041|FG003|Overall Study|Other|1
4424978|NCT00362115|7207042|FG004|Overall Study|Other|0
4424979|NCT00362115|7207043|FG005|Overall Study|Other|1
4424980|NCT00362115|7207044|FG006|Overall Study|Other|0
4424981|NCT00362180|7207073|FG000|Treated Period|Withdrawal by Subject|1
4424982|NCT00362180|7207074|FG001|Treated Period|Withdrawal by Subject|0
4424983|NCT00362180|7207075|FG002|Treated Period|Withdrawal by Subject|0
4424984|NCT00362180|7207076|FG003|Treated Period|Withdrawal by Subject|0
4424985|NCT00362180|7207077|FG004|Treated Period|Withdrawal by Subject|0
4424986|NCT00362180|7207078|FG005|Treated Period|Withdrawal by Subject|0
4424987|NCT00362180|7207079|FG006|Treated Period|Withdrawal by Subject|0
4424988|NCT00362180|7207080|FG007|Treated Period|Withdrawal by Subject|0
4424989|NCT00362180|7207081|FG008|Treated Period|Withdrawal by Subject|0
4424990|NCT00362180|7207073|FG000|Treated Period|Adverse Event|0
4424991|NCT00362180|7207074|FG001|Treated Period|Adverse Event|0
4424992|NCT00362180|7207075|FG002|Treated Period|Adverse Event|0
4424993|NCT00362180|7207076|FG003|Treated Period|Adverse Event|0
4424994|NCT00362180|7207077|FG004|Treated Period|Adverse Event|0
4424995|NCT00362180|7207078|FG005|Treated Period|Adverse Event|1
4424996|NCT00362180|7207079|FG006|Treated Period|Adverse Event|0
4424997|NCT00362180|7207080|FG007|Treated Period|Adverse Event|1
4424998|NCT00362180|7207081|FG008|Treated Period|Adverse Event|0
4424999|NCT00362232|7207101|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62
4425000|NCT00362232|7207102|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56
4425001|NCT00362232|7207101|FG000|Treatment (12 +/- 2 Days)|Death|1
4425002|NCT00362232|7207102|FG001|Treatment (12 +/- 2 Days)|Death|3
4425003|NCT00362232|7207101|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3
4425004|NCT00362232|7207102|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1
4425005|NCT00362232|7207101|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2
4425006|NCT00362232|7207102|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5
4425007|NCT00362232|7207101|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22
4425008|NCT00362232|7207102|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21
4425009|NCT00362232|7207101|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49
4425010|NCT00362232|7207102|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47
4425011|NCT00362232|7207101|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9
4425012|NCT00362232|7207102|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0
4425013|NCT00362232|7207101|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1
4425014|NCT00362232|7207102|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0
4425015|NCT00362232|7207101|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10
4425016|NCT00362232|7207102|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18
4425017|NCT00362232|7207101|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2
4425018|NCT00362232|7207102|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3
4425019|NCT00362232|7207101|FG000|Follow-up (30 (+ 5) Days)|Death|1
4425020|NCT00362232|7207102|FG001|Follow-up (30 (+ 5) Days)|Death|1
4425021|NCT00362232|7207101|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27
4425022|NCT00362232|7207102|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28
4425023|NCT00362232|7207101|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8
4425024|NCT00362232|7207102|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7
4425025|NCT00362297|7207110|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0
4425026|NCT00362297|7207111|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4
4425027|NCT00362336|7207120|FG000|Overall Study|Serious Adverse Event|1
4425028|NCT00362336|7207121|FG001|Overall Study|Serious Adverse Event|0
4425029|NCT00362336|7207122|FG002|Overall Study|Serious Adverse Event|1
4425030|NCT00362336|7207120|FG000|Overall Study|Protocol Violation|0
4425031|NCT00362336|7207121|FG001|Overall Study|Protocol Violation|0
4425032|NCT00362336|7207122|FG002|Overall Study|Protocol Violation|1
4425033|NCT00362336|7207120|FG000|Overall Study|Lost to Follow-up|6
4425034|NCT00362336|7207121|FG001|Overall Study|Lost to Follow-up|4
4425035|NCT00362336|7207122|FG002|Overall Study|Lost to Follow-up|0
4425036|NCT00362336|7207120|FG000|Overall Study|Withdrawal by Subject|3
4714971|NCT02965456|7643055|FG000|Overall Study|Lost to Follow-up|40
4714972|NCT02965456|7643056|FG001|Overall Study|Lost to Follow-up|18
4714973|NCT02965456|7643055|FG000|Overall Study|Subject Request|22
4714974|NCT02965456|7643056|FG001|Overall Study|Subject Request|13
4714975|NCT02965456|7643055|FG000|Overall Study|Withdrawal by Parent or Guardian|3
4714976|NCT02965456|7643056|FG001|Overall Study|Withdrawal by Parent or Guardian|6
4714977|NCT02965456|7643055|FG000|Overall Study|Adverse Event|3
4714978|NCT02965456|7643056|FG001|Overall Study|Adverse Event|0
4425037|NCT00362336|7207121|FG001|Overall Study|Withdrawal by Subject|3
4425038|NCT00362336|7207122|FG002|Overall Study|Withdrawal by Subject|1
4425039|NCT00362375|7207139|FG000|Overall Study|Lost to Follow-up|40
4425040|NCT00362375|7207140|FG001|Overall Study|Lost to Follow-up|35
4425041|NCT00362414|7207146|FG000|Overall Study|Death|2
4714979|NCT02965456|7643055|FG000|Overall Study|Noncompliance with Study Drug|1
4714980|NCT02965456|7643056|FG001|Overall Study|Noncompliance with Study Drug|1
4714981|NCT02965456|7643055|FG000|Overall Study|Worsening Condition|0
4714982|NCT02965456|7643056|FG001|Overall Study|Worsening Condition|2
4714983|NCT02965456|7643055|FG000|Overall Study|Lack of Efficacy|1
4714984|NCT02965456|7643056|FG001|Overall Study|Lack of Efficacy|0
4714985|NCT02965456|7643055|FG000|Overall Study|Physician Decision|0
4714986|NCT02965456|7643056|FG001|Overall Study|Physician Decision|1
4714987|NCT02965456|7643055|FG000|Overall Study|Pregnancy|1
4714988|NCT02965456|7643056|FG001|Overall Study|Pregnancy|0
4714989|NCT02965456|7643055|FG000|Overall Study|Protocol Violation|0
4714990|NCT02965456|7643056|FG001|Overall Study|Protocol Violation|1
4714991|NCT02965456|7643055|FG000|Overall Study|Participant ran out of study drug|0
4714992|NCT02965456|7643056|FG001|Overall Study|Participant ran out of study drug|1
4714993|NCT02965573|7643072|FG000|Overall Study|Lack of Efficacy|1
4714994|NCT02965573|7643073|FG001|Overall Study|Lack of Efficacy|0
4714995|NCT02965599|7643081|FG000|Overall Study|Protocol-defined stop criteria reached|1
4714996|NCT02965599|7643082|FG001|Overall Study|Protocol-defined stop criteria reached|0
4714997|NCT02965820|7643102|FG000|Period 2, Second 30 Days|Adverse Event|1
4714998|NCT02965820|7643103|FG001|Period 2, Second 30 Days|Adverse Event|1
4714999|NCT02965833|7643109|FG000|Period 1, First 30 Days of Wear|Adverse Event|0
4715000|NCT02965833|7643110|FG001|Period 1, First 30 Days of Wear|Adverse Event|1
4715001|NCT02965833|7643109|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1
4425042|NCT00362414|7207146|FG000|Overall Study|Adverse Event|1
4425043|NCT00362609|7207182|FG000|Overall Study|Withdrawal by Subject|0
4425044|NCT00362609|7207183|FG001|Overall Study|Withdrawal by Subject|1
4425045|NCT00362609|7207182|FG000|Overall Study|Protocol Violation|0
4425046|NCT00362609|7207183|FG001|Overall Study|Protocol Violation|1
4425047|NCT00362648|7207193|FG000|Overall Study|Adverse Event|12
4425048|NCT00362648|7207194|FG001|Overall Study|Adverse Event|21
4425049|NCT00362648|7207195|FG002|Overall Study|Adverse Event|1
4425050|NCT00362648|7207196|FG003|Overall Study|Adverse Event|0
4425051|NCT00362648|7207193|FG000|Overall Study|Lost to Follow-up|62
4425052|NCT00362648|7207194|FG001|Overall Study|Lost to Follow-up|69
4425053|NCT00362648|7207195|FG002|Overall Study|Lost to Follow-up|4
4425054|NCT00362648|7207196|FG003|Overall Study|Lost to Follow-up|3
4425055|NCT00362648|7207193|FG000|Overall Study|Protocol Violation|4
4425056|NCT00362648|7207194|FG001|Overall Study|Protocol Violation|2
4425057|NCT00362648|7207195|FG002|Overall Study|Protocol Violation|2
4425058|NCT00362648|7207196|FG003|Overall Study|Protocol Violation|2
4425059|NCT00362648|7207193|FG000|Overall Study|Withdrawal by Subject|48
4425060|NCT00362648|7207194|FG001|Overall Study|Withdrawal by Subject|42
4425061|NCT00362648|7207195|FG002|Overall Study|Withdrawal by Subject|2
4425062|NCT00362648|7207196|FG003|Overall Study|Withdrawal by Subject|6
4425063|NCT00363051|7207226|FG000|Overall Study|Adminstrative problems|1
4425064|NCT00363051|7207227|FG001|Overall Study|Adminstrative problems|1
4425065|NCT00363051|7207226|FG000|Overall Study|Adverse Event|21
4425066|NCT00363051|7207227|FG001|Overall Study|Adverse Event|12
4425067|NCT00363051|7207226|FG000|Overall Study|New Cancer Therapy|2
4425068|NCT00363051|7207227|FG001|Overall Study|New Cancer Therapy|1
4425069|NCT00363051|7207226|FG000|Overall Study|Withdrawal by Subject|11
4425070|NCT00363051|7207227|FG001|Overall Study|Withdrawal by Subject|3
4425071|NCT00363051|7207226|FG000|Overall Study|Lost to Follow-up|0
4425072|NCT00363051|7207227|FG001|Overall Study|Lost to Follow-up|1
4425073|NCT00363051|7207226|FG000|Overall Study|Protocol Violation|0
4425074|NCT00363051|7207227|FG001|Overall Study|Protocol Violation|2
4425075|NCT00363051|7207226|FG000|Overall Study|Death|3
4425076|NCT00363051|7207227|FG001|Overall Study|Death|2
4425077|NCT00363129|7207246|FG000|Overall Study|Withdrawal by Subject|11
4425078|NCT00363129|7207247|FG001|Overall Study|Withdrawal by Subject|18
4425079|NCT00363129|7207246|FG000|Overall Study|Adverse Event|8
4425080|NCT00363129|7207247|FG001|Overall Study|Adverse Event|3
4425081|NCT00363129|7207246|FG000|Overall Study|Alternate Treatment|2
4425082|NCT00363129|7207247|FG001|Overall Study|Alternate Treatment|4
4425083|NCT00363129|7207246|FG000|Overall Study|Other Medical Problems|2
4425084|NCT00363129|7207247|FG001|Overall Study|Other Medical Problems|4
4425085|NCT00363129|7207246|FG000|Overall Study|Death|0
4425086|NCT00363129|7207247|FG001|Overall Study|Death|1
4425087|NCT00363129|7207246|FG000|Overall Study|Other Reasons|6
4425088|NCT00363129|7207247|FG001|Overall Study|Other Reasons|3
4425089|NCT00363142|7207255|FG000|Overall Study|Adverse Event|2
4425090|NCT00363142|7207256|FG001|Overall Study|Adverse Event|0
4425091|NCT00363142|7207255|FG000|Overall Study|Lack of Efficacy|0
4425092|NCT00363142|7207256|FG001|Overall Study|Lack of Efficacy|1
4425093|NCT00363142|7207255|FG000|Overall Study|Lost to Follow-up|1
4425094|NCT00363142|7207256|FG001|Overall Study|Lost to Follow-up|0
4425095|NCT00363142|7207255|FG000|Overall Study|Non-compliance|1
4425096|NCT00363142|7207256|FG001|Overall Study|Non-compliance|1
4425097|NCT00363142|7207255|FG000|Overall Study|Withdrawal by Subject|3
4715002|NCT02965833|7643110|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1
4715003|NCT02965833|7643109|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1
4425098|NCT00363142|7207256|FG001|Overall Study|Withdrawal by Subject|1
4425099|NCT00363246|7207274|FG000|Overall Study|Death|40
4425100|NCT00363246|7207274|FG000|Overall Study|Withdrawal by Subject|19
4425101|NCT00363246|7207274|FG000|Overall Study|Lost to Follow-up|14
4425102|NCT00363246|7207274|FG000|Overall Study|Bad health|6
4425103|NCT00363246|7207274|FG000|Overall Study|Stopped using wheelchair|11
4629704|NCT01876251|7497891|FG001|Overall Study|Study terminated|0
4629705|NCT01876251|7497892|FG002|Overall Study|Study terminated|0
4629706|NCT01876251|7497890|FG000|Overall Study|Objective progression or relapse|10
4629707|NCT01876251|7497891|FG001|Overall Study|Objective progression or relapse|3
4629708|NCT01876251|7497892|FG002|Overall Study|Objective progression or relapse|8
4629709|NCT01876368|7497916|FG000|Overall Study|Adverse Event|2
4629710|NCT01876368|7497917|FG001|Overall Study|Adverse Event|5
4629711|NCT01876368|7497916|FG000|Overall Study|Lack of Efficacy|1
4629712|NCT01876368|7497917|FG001|Overall Study|Lack of Efficacy|0
4629713|NCT01876368|7497916|FG000|Overall Study|Lost to Follow-up|0
4629714|NCT01876368|7497917|FG001|Overall Study|Lost to Follow-up|1
4629715|NCT01876368|7497916|FG000|Overall Study|Non-compliance with study treatment|0
4425104|NCT00363246|7207274|FG000|Overall Study|Subject expressed security concerns|2
4425105|NCT00363246|7207274|FG000|Overall Study|Eligibility changed due to Hospice move|5
4425106|NCT00363298|7207281|FG000|First Study Week|Lack of Efficacy|6
4425107|NCT00363298|7207282|FG001|First Study Week|Lack of Efficacy|5
4425108|NCT00363298|7207281|FG000|4-week Study Continuation Phase|Lack of Efficacy|1
4425109|NCT00363298|7207282|FG001|4-week Study Continuation Phase|Lack of Efficacy|0
4425110|NCT00363311|7207291|FG000|Overall Study|Adverse Event|6
4425111|NCT00363311|7207292|FG001|Overall Study|Adverse Event|4
4425112|NCT00363311|7207291|FG000|Overall Study|Lost to Follow-up|3
4425113|NCT00363311|7207292|FG001|Overall Study|Lost to Follow-up|0
4425114|NCT00363311|7207291|FG000|Overall Study|Protocol Violation|1
4425115|NCT00363311|7207292|FG001|Overall Study|Protocol Violation|2
4425116|NCT00363311|7207291|FG000|Overall Study|Withdrawal by Subject|12
4425117|NCT00363311|7207292|FG001|Overall Study|Withdrawal by Subject|6
4425118|NCT00363311|7207291|FG000|Overall Study|Physician Decision|1
4425119|NCT00363311|7207292|FG001|Overall Study|Physician Decision|1
4425120|NCT00363311|7207291|FG000|Overall Study|Sponsor Terminated Study|2
4425121|NCT00363311|7207292|FG001|Overall Study|Sponsor Terminated Study|2
4425122|NCT00363311|7207291|FG000|Overall Study|Disease Progression|46
4425123|NCT00363311|7207292|FG001|Overall Study|Disease Progression|26
4425124|NCT00363311|7207291|FG000|Overall Study|Non-Compliance|1
4425125|NCT00363311|7207292|FG001|Overall Study|Non-Compliance|1
4425126|NCT00363311|7207291|FG000|Overall Study|Participant Refused Biopsy|1
4425127|NCT00363311|7207292|FG001|Overall Study|Participant Refused Biopsy|0
4425128|NCT00363311|7207291|FG000|Overall Study|Prostate Volume/PSA Doubled|1
4425129|NCT00363311|7207292|FG001|Overall Study|Prostate Volume/PSA Doubled|0
4425130|NCT00363311|7207291|FG000|Overall Study|Participant Opted for Treatment|1
4425131|NCT00363311|7207292|FG001|Overall Study|Participant Opted for Treatment|0
4425132|NCT00363311|7207291|FG000|Overall Study|Participant Moved to Another Country|1
4425133|NCT00363311|7207292|FG001|Overall Study|Participant Moved to Another Country|0
4425134|NCT00363311|7207291|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0
4425135|NCT00363311|7207292|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1
4425136|NCT00363311|7207291|FG000|Overall Study|Withdrawn per Instructions of Monitor|0
4425137|NCT00363311|7207292|FG001|Overall Study|Withdrawn per Instructions of Monitor|1
4425138|NCT00363311|7207291|FG000|Overall Study|Participant Moved to Louisiana|0
4425139|NCT00363311|7207292|FG001|Overall Study|Participant Moved to Louisiana|1
4425140|NCT00363415|7207300|FG000|Overall Study|Progressive Disease|196
4425141|NCT00363415|7207301|FG001|Overall Study|Progressive Disease|107
4425142|NCT00363415|7207300|FG000|Overall Study|Sponsor Decision|67
4425143|NCT00363415|7207301|FG001|Overall Study|Sponsor Decision|31
4425144|NCT00363415|7207300|FG000|Overall Study|Death|32
4425145|NCT00363415|7207301|FG001|Overall Study|Death|29
4425146|NCT00363415|7207300|FG000|Overall Study|Adverse Event|24
4425147|NCT00363415|7207301|FG001|Overall Study|Adverse Event|15
4425148|NCT00363415|7207300|FG000|Overall Study|Physician Decision|18
4425149|NCT00363415|7207301|FG001|Overall Study|Physician Decision|35
4425150|NCT00363415|7207300|FG000|Overall Study|Entry Criteria Not Met|11
4425151|NCT00363415|7207301|FG001|Overall Study|Entry Criteria Not Met|10
4425152|NCT00363415|7207300|FG000|Overall Study|Withdrawal by Subject|9
4425153|NCT00363415|7207301|FG001|Overall Study|Withdrawal by Subject|15
4425154|NCT00363415|7207300|FG000|Overall Study|Lost to Follow-up|3
4425155|NCT00363415|7207301|FG001|Overall Study|Lost to Follow-up|3
4425156|NCT00363415|7207300|FG000|Overall Study|Protocol Violation|1
4425157|NCT00363415|7207301|FG001|Overall Study|Protocol Violation|4
4425158|NCT00363467|7207307|FG000|Overall Study|Physician Decision|1
4425159|NCT00363480|7207311|FG000|Overall Study|Criteria for treatment period not fulfil|1
4425160|NCT00363480|7207311|FG000|Overall Study|Adverse Event|4
4425161|NCT00363480|7207311|FG000|Overall Study|Lost to Follow-up|5
4425162|NCT00363480|7207311|FG000|Overall Study|Withdrawal by Subject|5
4425163|NCT00363480|7207311|FG000|Overall Study|Non-compliance of subject|1
4425164|NCT00363480|7207311|FG000|Overall Study|Participant discontinued on its own|1
4425165|NCT00363545|7207317|FG000|Overall Study|Serious Adverse Event|0
4425166|NCT00363545|7207318|FG001|Overall Study|Serious Adverse Event|1
4425167|NCT00363545|7207317|FG000|Overall Study|Withdrawal by Subject|12
4425168|NCT00363545|7207318|FG001|Overall Study|Withdrawal by Subject|15
4629716|NCT01876368|7497917|FG001|Overall Study|Non-compliance with study treatment|1
4425169|NCT00363545|7207317|FG000|Overall Study|Migrated/moved from study area|3
4425170|NCT00363545|7207318|FG001|Overall Study|Migrated/moved from study area|6
4425171|NCT00363545|7207317|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14
4425172|NCT00363545|7207318|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18
4425173|NCT00363545|7207317|FG000|Overall Study|Lost to follow-up (complete vaccination)|14
4425174|NCT00363545|7207318|FG001|Overall Study|Lost to follow-up (complete vaccination)|17
4425175|NCT00363545|7207317|FG000|Overall Study|Others|1
4425176|NCT00363545|7207318|FG001|Overall Study|Others|0
4425177|NCT00363649|7207326|FG000|Overall Study|Withdrawal by Subject|1
4425178|NCT00363649|7207327|FG001|Overall Study|Withdrawal by Subject|1
4425179|NCT00363649|7207326|FG000|Overall Study|Adverse Event|6
4425180|NCT00363649|7207327|FG001|Overall Study|Adverse Event|0
4425181|NCT00363766|7207340|FG000|Overall Study|Progressive Disease|15
4425182|NCT00363766|7207341|FG001|Overall Study|Progressive Disease|9
4425183|NCT00363766|7207340|FG000|Overall Study|Adverse Event|10
4425184|NCT00363766|7207341|FG001|Overall Study|Adverse Event|2
4425185|NCT00363766|7207340|FG000|Overall Study|Disease Related Death|1
4425186|NCT00363766|7207341|FG001|Overall Study|Disease Related Death|3
4425187|NCT00363766|7207340|FG000|Overall Study|Not Disease Related Death|3
4425188|NCT00363766|7207341|FG001|Overall Study|Not Disease Related Death|4
4425189|NCT00363766|7207340|FG000|Overall Study|Withdrawal by Subject|2
4425190|NCT00363766|7207341|FG001|Overall Study|Withdrawal by Subject|0
4425191|NCT00363766|7207340|FG000|Overall Study|Physician Decision|1
4425192|NCT00363766|7207341|FG001|Overall Study|Physician Decision|2
4425193|NCT00363896|7207371|FG000|Overall Study|Withdrawal by Subject|29
4425194|NCT00363896|7207372|FG001|Overall Study|Withdrawal by Subject|16
4425195|NCT00363896|7207371|FG000|Overall Study|Adverse Event|24
4425196|NCT00363896|7207372|FG001|Overall Study|Adverse Event|13
4425197|NCT00363896|7207371|FG000|Overall Study|COPD exacerbation|13
4425198|NCT00363896|7207372|FG001|Overall Study|COPD exacerbation|7
4425199|NCT00363896|7207371|FG000|Overall Study|Lack of Efficacy|12
4425200|NCT00363896|7207372|FG001|Overall Study|Lack of Efficacy|8
4425201|NCT00363896|7207371|FG000|Overall Study|Protocol Violation|6
4425202|NCT00363896|7207372|FG001|Overall Study|Protocol Violation|1
4425203|NCT00363896|7207371|FG000|Overall Study|Lost to Follow-up|3
4425204|NCT00363896|7207372|FG001|Overall Study|Lost to Follow-up|0
4425205|NCT00363896|7207371|FG000|Overall Study|Non-fulfilment of entry criteria|1
4425206|NCT00363896|7207372|FG001|Overall Study|Non-fulfilment of entry criteria|0
4425207|NCT00363896|7207371|FG000|Overall Study|Other|1
4425208|NCT00363896|7207372|FG001|Overall Study|Other|2
4425209|NCT00364013|7207383|FG000|Overall Study|Ineligibility determined|4
4425210|NCT00364013|7207384|FG001|Overall Study|Ineligibility determined|2
4425211|NCT00364013|7207383|FG000|Overall Study|Adverse Event|4
4425212|NCT00364013|7207384|FG001|Overall Study|Adverse Event|3
4425213|NCT00364013|7207383|FG000|Overall Study|Withdrawal by Subject|13
4425214|NCT00364013|7207384|FG001|Overall Study|Withdrawal by Subject|18
4425215|NCT00364013|7207383|FG000|Overall Study|Physician Decision|3
4425216|NCT00364013|7207384|FG001|Overall Study|Physician Decision|3
4425217|NCT00364013|7207383|FG000|Overall Study|Lost to Follow-up|10
4425218|NCT00364013|7207384|FG001|Overall Study|Lost to Follow-up|3
4425219|NCT00364013|7207383|FG000|Overall Study|Protocol-specified criteria|6
4425220|NCT00364013|7207384|FG001|Overall Study|Protocol-specified criteria|6
4425221|NCT00364013|7207383|FG000|Overall Study|Other|41
4425222|NCT00364013|7207384|FG001|Overall Study|Other|47
4425223|NCT00364013|7207383|FG000|Overall Study|Ongoing|20
4425224|NCT00364013|7207384|FG001|Overall Study|Ongoing|13
4425225|NCT00364130|7207396|FG000|Intervention Period|Lost to Follow-up|4
4425226|NCT00364130|7207397|FG001|Intervention Period|Lost to Follow-up|3
4425227|NCT00364130|7207396|FG000|Intervention Period|Pregnancy|1
4425228|NCT00364130|7207397|FG001|Intervention Period|Pregnancy|0
4425229|NCT00364130|7207396|FG000|Intervention Period|Withdrawal by Subject|4
4425230|NCT00364130|7207397|FG001|Intervention Period|Withdrawal by Subject|5
4425231|NCT00364130|7207396|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5
4425232|NCT00364130|7207397|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11
4425233|NCT00364156|7207407|FG000|Overall Study|Withdrawal by Subject|73
4425234|NCT00364156|7207408|FG001|Overall Study|Withdrawal by Subject|80
4425235|NCT00364156|7207407|FG000|Overall Study|Protocol Violation|6
4425236|NCT00364156|7207408|FG001|Overall Study|Protocol Violation|1
4425237|NCT00364182|7207417|FG000|First Intervention|Secondary prophylaxis|1
4425238|NCT00364182|7207418|FG001|First Intervention|Secondary prophylaxis|0
4425239|NCT00364182|7207419|FG002|First Intervention|Secondary prophylaxis|0
4425240|NCT00364182|7207417|FG000|First Intervention|Withdrawal by Subject|2
4425241|NCT00364182|7207418|FG001|First Intervention|Withdrawal by Subject|0
4425242|NCT00364182|7207419|FG002|First Intervention|Withdrawal by Subject|0
4425243|NCT00364182|7207417|FG000|Second Intervention|non-compliance|0
4425244|NCT00364182|7207418|FG001|Second Intervention|non-compliance|1
4425245|NCT00364182|7207419|FG002|Second Intervention|non-compliance|1
4425246|NCT00364182|7207417|FG000|Second Intervention|Protocol Violation|0
4425247|NCT00364182|7207418|FG001|Second Intervention|Protocol Violation|1
4425248|NCT00364182|7207419|FG002|Second Intervention|Protocol Violation|0
4425249|NCT00364182|7207417|FG000|Second Intervention|Adverse Event|0
4425250|NCT00364182|7207418|FG001|Second Intervention|Adverse Event|0
4425251|NCT00364182|7207419|FG002|Second Intervention|Adverse Event|1
4425252|NCT00364182|7207417|FG000|Third Intervention|non-compliance|0
4425253|NCT00364182|7207418|FG001|Third Intervention|non-compliance|1
4425254|NCT00364182|7207419|FG002|Third Intervention|non-compliance|0
4425255|NCT00364182|7207417|FG000|Third Intervention|Lost to Follow-up|0
4425256|NCT00364182|7207418|FG001|Third Intervention|Lost to Follow-up|0
4425257|NCT00364182|7207419|FG002|Third Intervention|Lost to Follow-up|1
4425258|NCT00364286|7207429|FG000|Overall Study|Withdrawal by Subject|1
4425259|NCT00364286|7207429|FG000|Overall Study|Adverse Event|2
4425260|NCT00364351|7207435|FG000|Overall Study|Adverse Event|90
4425261|NCT00364351|7207436|FG001|Overall Study|Adverse Event|44
4425262|NCT00364351|7207435|FG000|Overall Study|Condition under investigation worsened|469
4425263|NCT00364351|7207436|FG001|Overall Study|Condition under investigation worsened|497
4425264|NCT00364351|7207435|FG000|Overall Study|Prohibited concomitant medication|0
4425265|NCT00364351|7207436|FG001|Overall Study|Prohibited concomitant medication|2
4425266|NCT00364351|7207435|FG000|Overall Study|Lost to Follow-up|1
4425267|NCT00364351|7207436|FG001|Overall Study|Lost to Follow-up|1
4425268|NCT00364351|7207435|FG000|Overall Study|Withdrawal by Subject|30
4425269|NCT00364351|7207436|FG001|Overall Study|Withdrawal by Subject|29
4425270|NCT00364351|7207435|FG000|Overall Study|Incorrect enrollment|1
4425271|NCT00364351|7207436|FG001|Overall Study|Incorrect enrollment|1
4425272|NCT00364351|7207435|FG000|Overall Study|Sponsor decision|1
4425273|NCT00364351|7207436|FG001|Overall Study|Sponsor decision|0
4425274|NCT00364351|7207435|FG000|Overall Study|Poor treatment compliance|0
4425275|NCT00364351|7207436|FG001|Overall Study|Poor treatment compliance|3
4425276|NCT00364351|7207435|FG000|Overall Study|Investigator error|0
4425277|NCT00364351|7207436|FG001|Overall Study|Investigator error|2
4425278|NCT00364351|7207435|FG000|Overall Study|Patient could not travel to site|0
4425279|NCT00364351|7207436|FG001|Overall Study|Patient could not travel to site|1
4425280|NCT00364351|7207435|FG000|Overall Study|Randomised treatment not started|0
4425281|NCT00364351|7207436|FG001|Overall Study|Randomised treatment not started|3
4425282|NCT00364533|7207456|FG000|Overall Study|Adverse Event|8
4425283|NCT00364533|7207457|FG001|Overall Study|Adverse Event|7
4425284|NCT00364533|7207458|FG002|Overall Study|Adverse Event|15
4425285|NCT00364533|7207459|FG003|Overall Study|Adverse Event|5
4425286|NCT00364533|7207460|FG004|Overall Study|Adverse Event|2
4425287|NCT00364533|7207456|FG000|Overall Study|Withdrawal by Subject|4
4425288|NCT00364533|7207457|FG001|Overall Study|Withdrawal by Subject|8
4425289|NCT00364533|7207458|FG002|Overall Study|Withdrawal by Subject|6
4425290|NCT00364533|7207459|FG003|Overall Study|Withdrawal by Subject|6
4425291|NCT00364533|7207460|FG004|Overall Study|Withdrawal by Subject|6
4425292|NCT00364533|7207456|FG000|Overall Study|Lack of Efficacy|22
4425293|NCT00364533|7207457|FG001|Overall Study|Lack of Efficacy|22
4425294|NCT00364533|7207458|FG002|Overall Study|Lack of Efficacy|21
4425295|NCT00364533|7207459|FG003|Overall Study|Lack of Efficacy|17
4425296|NCT00364533|7207460|FG004|Overall Study|Lack of Efficacy|42
4425297|NCT00364533|7207456|FG000|Overall Study|Subject discharged from hospital|4
4425298|NCT00364533|7207457|FG001|Overall Study|Subject discharged from hospital|1
4425299|NCT00364533|7207458|FG002|Overall Study|Subject discharged from hospital|2
4425300|NCT00364533|7207459|FG003|Overall Study|Subject discharged from hospital|3
4425301|NCT00364533|7207460|FG004|Overall Study|Subject discharged from hospital|1
4425302|NCT00364533|7207456|FG000|Overall Study|Variations in drug compliance|2
4425303|NCT00364533|7207457|FG001|Overall Study|Variations in drug compliance|1
4425304|NCT00364533|7207458|FG002|Overall Study|Variations in drug compliance|1
4425305|NCT00364533|7207459|FG003|Overall Study|Variations in drug compliance|0
4425306|NCT00364533|7207460|FG004|Overall Study|Variations in drug compliance|0
4425307|NCT00364533|7207456|FG000|Overall Study|Non-compliance|1
4425308|NCT00364533|7207457|FG001|Overall Study|Non-compliance|0
4425309|NCT00364533|7207458|FG002|Overall Study|Non-compliance|0
4425310|NCT00364533|7207459|FG003|Overall Study|Non-compliance|0
4425311|NCT00364533|7207460|FG004|Overall Study|Non-compliance|0
4425312|NCT00364533|7207456|FG000|Overall Study|Protocol Violation|1
4425313|NCT00364533|7207457|FG001|Overall Study|Protocol Violation|1
4425314|NCT00364533|7207458|FG002|Overall Study|Protocol Violation|0
4425315|NCT00364533|7207459|FG003|Overall Study|Protocol Violation|0
4425316|NCT00364533|7207460|FG004|Overall Study|Protocol Violation|0
4425317|NCT00364611|7207474|FG000|Overall Study|Did not receive study medication|0
4425318|NCT00364611|7207475|FG001|Overall Study|Did not receive study medication|1
4425319|NCT00364611|7207474|FG000|Overall Study|Adverse Event|7
4425320|NCT00364611|7207475|FG001|Overall Study|Adverse Event|4
4425321|NCT00364611|7207474|FG000|Overall Study|Participant's Request|3
4425322|NCT00364611|7207475|FG001|Overall Study|Participant's Request|4
4425323|NCT00364611|7207474|FG000|Overall Study|Disease Progression|38
4425324|NCT00364611|7207475|FG001|Overall Study|Disease Progression|8
4425325|NCT00364611|7207474|FG000|Overall Study|Investigator decision|2
4425326|NCT00364611|7207475|FG001|Overall Study|Investigator decision|2
4425327|NCT00364611|7207474|FG000|Overall Study|Found Ineligible|1
4425328|NCT00364611|7207475|FG001|Overall Study|Found Ineligible|0
4425329|NCT00364611|7207474|FG000|Overall Study|Presumed CR on Study|0
4425330|NCT00364611|7207475|FG001|Overall Study|Presumed CR on Study|1
4425331|NCT00364611|7207474|FG000|Overall Study|Receiving Liver Ablation|0
4425332|NCT00364611|7207475|FG001|Overall Study|Receiving Liver Ablation|1
4425333|NCT00364793|7207485|FG000|Overall Study|Adverse Event|2
4425334|NCT00364793|7207486|FG001|Overall Study|Adverse Event|0
4425335|NCT00364793|7207487|FG002|Overall Study|Adverse Event|0
4425336|NCT00364793|7207488|FG003|Overall Study|Adverse Event|0
4425337|NCT00364793|7207485|FG000|Overall Study|Death|1
4425338|NCT00364793|7207486|FG001|Overall Study|Death|0
4425339|NCT00364793|7207487|FG002|Overall Study|Death|1
4425340|NCT00364793|7207488|FG003|Overall Study|Death|0
4425341|NCT00364793|7207485|FG000|Overall Study|Lack of Efficacy|3
4425342|NCT00364793|7207486|FG001|Overall Study|Lack of Efficacy|3
4425343|NCT00364793|7207487|FG002|Overall Study|Lack of Efficacy|1
4425344|NCT00364793|7207488|FG003|Overall Study|Lack of Efficacy|1
4425345|NCT00364793|7207485|FG000|Overall Study|Lost to Follow-up|1
4425346|NCT00364793|7207486|FG001|Overall Study|Lost to Follow-up|0
4425347|NCT00364793|7207487|FG002|Overall Study|Lost to Follow-up|2
4425348|NCT00364793|7207488|FG003|Overall Study|Lost to Follow-up|0
4425349|NCT00364793|7207485|FG000|Overall Study|Poor or non-compliance|1
4425350|NCT00364793|7207486|FG001|Overall Study|Poor or non-compliance|1
4425351|NCT00364793|7207487|FG002|Overall Study|Poor or non-compliance|0
4425352|NCT00364793|7207488|FG003|Overall Study|Poor or non-compliance|1
4425353|NCT00364793|7207485|FG000|Overall Study|No longer meets criteria|0
4425354|NCT00364793|7207486|FG001|Overall Study|No longer meets criteria|0
4425355|NCT00364793|7207487|FG002|Overall Study|No longer meets criteria|0
4425356|NCT00364793|7207488|FG003|Overall Study|No longer meets criteria|1
4425357|NCT00364793|7207485|FG000|Overall Study|Withdrawal by Subject|0
4425358|NCT00364793|7207486|FG001|Overall Study|Withdrawal by Subject|1
4425359|NCT00364793|7207487|FG002|Overall Study|Withdrawal by Subject|0
4425360|NCT00364793|7207488|FG003|Overall Study|Withdrawal by Subject|0
4425361|NCT00364832|7207514|FG000|Core Period|Early Withdrawals|2
4425362|NCT00364832|7207515|FG001|Core Period|Early Withdrawals|2
4425363|NCT00364832|7207516|FG002|Core Period|Early Withdrawals|1
4425364|NCT00364832|7207517|FG003|Core Period|Early Withdrawals|1
4425365|NCT00364832|7207518|FG004|Core Period|Early Withdrawals|0
4425366|NCT00364832|7207519|FG005|Core Period|Early Withdrawals|0
4425367|NCT00364832|7207520|FG006|Core Period|Early Withdrawals|4
4425368|NCT00364832|7207521|FG007|Core Period|Early Withdrawals|1
4425369|NCT00364832|7207522|FG008|Core Period|Early Withdrawals|0
4425370|NCT00364832|7207523|FG009|Core Period|Early Withdrawals|0
4425371|NCT00364832|7207524|FG010|Core Period|Early Withdrawals|0
4425372|NCT00364832|7207525|FG011|Core Period|Early Withdrawals|0
4425373|NCT00364832|7207514|FG000|Extension Year 1|Early Withdrawals|0
4425374|NCT00364832|7207515|FG001|Extension Year 1|Early Withdrawals|0
4425375|NCT00364832|7207516|FG002|Extension Year 1|Early Withdrawals|0
4425376|NCT00364832|7207517|FG003|Extension Year 1|Early Withdrawals|0
4425377|NCT00364832|7207518|FG004|Extension Year 1|Early Withdrawals|0
4425378|NCT00364832|7207519|FG005|Extension Year 1|Early Withdrawals|0
4425379|NCT00364832|7207520|FG006|Extension Year 1|Early Withdrawals|0
4425380|NCT00364832|7207521|FG007|Extension Year 1|Early Withdrawals|0
4425381|NCT00364832|7207522|FG008|Extension Year 1|Early Withdrawals|0
4425382|NCT00364832|7207523|FG009|Extension Year 1|Early Withdrawals|4
4425383|NCT00364832|7207524|FG010|Extension Year 1|Early Withdrawals|2
4425384|NCT00364832|7207525|FG011|Extension Year 1|Early Withdrawals|10
4425385|NCT00364832|7207514|FG000|Extension Year 2|Early Withdrawals|0
4425386|NCT00364832|7207515|FG001|Extension Year 2|Early Withdrawals|0
4425387|NCT00364832|7207516|FG002|Extension Year 2|Early Withdrawals|0
4425388|NCT00364832|7207517|FG003|Extension Year 2|Early Withdrawals|0
4425389|NCT00364832|7207518|FG004|Extension Year 2|Early Withdrawals|0
4425390|NCT00364832|7207519|FG005|Extension Year 2|Early Withdrawals|0
4425391|NCT00364832|7207520|FG006|Extension Year 2|Early Withdrawals|0
4425392|NCT00364832|7207521|FG007|Extension Year 2|Early Withdrawals|0
4425393|NCT00364832|7207522|FG008|Extension Year 2|Early Withdrawals|0
4425394|NCT00364832|7207523|FG009|Extension Year 2|Early Withdrawals|5
4425395|NCT00364832|7207524|FG010|Extension Year 2|Early Withdrawals|5
4425396|NCT00364832|7207525|FG011|Extension Year 2|Early Withdrawals|3
4425397|NCT00364845|7207544|FG000|Overall Study|Adverse Event|1
4425398|NCT00364845|7207545|FG001|Overall Study|Adverse Event|0
4425399|NCT00364845|7207544|FG000|Overall Study|Withdrawal by Subject|2
4425400|NCT00364845|7207545|FG001|Overall Study|Withdrawal by Subject|1
4425401|NCT00364845|7207544|FG000|Overall Study|Physician Decision|8
4425402|NCT00364845|7207545|FG001|Overall Study|Physician Decision|8
4425403|NCT00364845|7207544|FG000|Overall Study|Lost to Follow-up|0
4425404|NCT00364845|7207545|FG001|Overall Study|Lost to Follow-up|1
4425405|NCT00364845|7207544|FG000|Overall Study|Death|0
4425406|NCT00364845|7207545|FG001|Overall Study|Death|1
4425407|NCT00364858|7207553|FG000|Overall Study|Adverse Event|1
4425408|NCT00364858|7207554|FG001|Overall Study|Adverse Event|5
4425409|NCT00364858|7207553|FG000|Overall Study|Withdrawal by Subject|1
4425410|NCT00364858|7207554|FG001|Overall Study|Withdrawal by Subject|1
4425411|NCT00364858|7207553|FG000|Overall Study|Pregnancy|1
4425412|NCT00364858|7207554|FG001|Overall Study|Pregnancy|1
4425413|NCT00364858|7207553|FG000|Overall Study|Clinical failure|2
4425414|NCT00364858|7207554|FG001|Overall Study|Clinical failure|13
4425415|NCT00364858|7207553|FG000|Overall Study|Discontinuation at baseline|1
4425416|NCT00364858|7207554|FG001|Overall Study|Discontinuation at baseline|0
4425417|NCT00364858|7207553|FG000|Overall Study|Non-compliant|1
4425418|NCT00364858|7207554|FG001|Overall Study|Non-compliant|0
4425419|NCT00364858|7207553|FG000|Overall Study|Return to Q2 regimen|0
4425420|NCT00364858|7207554|FG001|Overall Study|Return to Q2 regimen|1
4425421|NCT00364858|7207553|FG000|Overall Study|Clinical baseline issue|0
4425422|NCT00364858|7207554|FG001|Overall Study|Clinical baseline issue|1
4425423|NCT00364923|7207561|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4
4425424|NCT00364923|7207561|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24
4425425|NCT00365105|7207580|FG000|Overall Study|Protocol Violation|5
4425426|NCT00365105|7207581|FG001|Overall Study|Protocol Violation|8
4425427|NCT00365300|7207614|FG000|Open-label Phase|Adverse Event|4
4425428|NCT00365300|7207615|FG001|Open-label Phase|Adverse Event|0
4425429|NCT00365300|7207614|FG000|Open-label Phase|Failed to Return|1
4425430|NCT00365300|7207615|FG001|Open-label Phase|Failed to Return|0
4425431|NCT00365300|7207614|FG000|Open-label Phase|Physician Decision|1
4425432|NCT00365300|7207615|FG001|Open-label Phase|Physician Decision|0
4425433|NCT00365300|7207614|FG000|Open-label Phase|Noncompliance|9
4425434|NCT00365300|7207615|FG001|Open-label Phase|Noncompliance|0
4425435|NCT00365300|7207614|FG000|Open-label Phase|Parent/Legal Guardian Request|4
4425436|NCT00365300|7207615|FG001|Open-label Phase|Parent/Legal Guardian Request|0
4425437|NCT00365300|7207614|FG000|Open-label Phase|Protocol Violation|1
4425438|NCT00365300|7207615|FG001|Open-label Phase|Protocol Violation|0
4425439|NCT00365300|7207614|FG000|Open-label Phase|Lack of Efficacy|1
4425440|NCT00365300|7207615|FG001|Open-label Phase|Lack of Efficacy|0
4425441|NCT00365300|7207614|FG000|Open-label Phase|Patient skipped open label phase|1
4425442|NCT00365300|7207615|FG001|Open-label Phase|Patient skipped open label phase|0
4425443|NCT00365300|7207614|FG000|Double-blind Phase|Failed to return|1
4425444|NCT00365300|7207615|FG001|Double-blind Phase|Failed to return|0
4425445|NCT00365300|7207614|FG000|Double-blind Phase|Noncompliance|1
4425446|NCT00365300|7207615|FG001|Double-blind Phase|Noncompliance|1
4425447|NCT00365300|7207614|FG000|Double-blind Phase|Withdrawal by Subject|0
4425448|NCT00365300|7207615|FG001|Double-blind Phase|Withdrawal by Subject|1
4425449|NCT00365300|7207614|FG000|Double-blind Phase|Protocol Violation|3
4425450|NCT00365300|7207615|FG001|Double-blind Phase|Protocol Violation|1
4425451|NCT00365300|7207614|FG000|Double-blind Phase|Lack of Efficacy|6
4425452|NCT00365300|7207615|FG001|Double-blind Phase|Lack of Efficacy|6
4425453|NCT00365352|7207627|FG000|Overall Study|Adverse Event|6
4425454|NCT00365352|7207628|FG001|Overall Study|Adverse Event|7
4425455|NCT00365352|7207629|FG002|Overall Study|Adverse Event|8
4425456|NCT00365352|7207627|FG000|Overall Study|Participant Withdrew Consent|8
4425457|NCT00365352|7207628|FG001|Overall Study|Participant Withdrew Consent|3
4425458|NCT00365352|7207629|FG002|Overall Study|Participant Withdrew Consent|4
4425459|NCT00365352|7207627|FG000|Overall Study|Lack of Efficacy|3
4425460|NCT00365352|7207628|FG001|Overall Study|Lack of Efficacy|0
4425461|NCT00365352|7207629|FG002|Overall Study|Lack of Efficacy|0
4425462|NCT00365352|7207627|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0
4425463|NCT00365352|7207628|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0
4425464|NCT00365352|7207629|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2
4425465|NCT00365352|7207627|FG000|Overall Study|Non-Compliance (after Randomization)|1
4425466|NCT00365352|7207628|FG001|Overall Study|Non-Compliance (after Randomization)|0
4425467|NCT00365352|7207629|FG002|Overall Study|Non-Compliance (after Randomization)|1
4425468|NCT00365352|7207627|FG000|Overall Study|Lost to Follow-up|1
4425469|NCT00365352|7207628|FG001|Overall Study|Lost to Follow-up|1
4425470|NCT00365352|7207629|FG002|Overall Study|Lost to Follow-up|0
4425471|NCT00365352|7207627|FG000|Overall Study|Withdrawal of Participant by Sponsor|1
4425472|NCT00365352|7207628|FG001|Overall Study|Withdrawal of Participant by Sponsor|0
4425473|NCT00365352|7207629|FG002|Overall Study|Withdrawal of Participant by Sponsor|0
4425474|NCT00365365|7207643|FG000|Overall Study|Randomized but not treated|0
4425475|NCT00365365|7207644|FG001|Overall Study|Randomized but not treated|2
4425476|NCT00365365|7207645|FG002|Overall Study|Randomized but not treated|0
4425477|NCT00365365|7207643|FG000|Overall Study|Poor compliance to protocol|0
4629717|NCT01876368|7497916|FG000|Overall Study|Physician Decision|0
4629718|NCT01876368|7497917|FG001|Overall Study|Physician Decision|2
4629719|NCT01876368|7497916|FG000|Overall Study|Protocol deviation|3
4629720|NCT01876368|7497917|FG001|Overall Study|Protocol deviation|3
4715004|NCT02965833|7643110|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0
4715005|NCT02965833|7643109|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1
4715006|NCT02965833|7643110|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0
4715007|NCT02965833|7643109|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2
4715008|NCT02965833|7643110|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0
4629721|NCT01876368|7497916|FG000|Overall Study|Subject/guardian decision|3
4629722|NCT01876368|7497917|FG001|Overall Study|Subject/guardian decision|1
4629723|NCT01876381|7497923|FG000|Overall Study|Lack of Efficacy|5
4629724|NCT01876381|7497923|FG000|Overall Study|Physician Decision|1
4629725|NCT01876381|7497923|FG000|Overall Study|Withdrawal by Subject|1
4629726|NCT01876420|7497927|FG000|Overall Study|Missed 30 day visit|1
4629727|NCT01876446|7497933|FG000|Overall Study|Death|0
4629728|NCT01876446|7497934|FG001|Overall Study|Death|1
4629729|NCT01876446|7497933|FG000|Overall Study|Withdrawal by Subject|1
4629730|NCT01876446|7497934|FG001|Overall Study|Withdrawal by Subject|2
4715009|NCT02966002|7643135|FG000|Overall Study|Withdrawal by Subject|2
4715010|NCT02966002|7643135|FG000|Overall Study|Adverse Event|1
4425478|NCT00365365|7207644|FG001|Overall Study|Poor compliance to protocol|1
4425479|NCT00365365|7207645|FG002|Overall Study|Poor compliance to protocol|0
4425480|NCT00365365|7207643|FG000|Overall Study|Lost to Follow-up|3
4425481|NCT00365365|7207644|FG001|Overall Study|Lost to Follow-up|3
4629731|NCT01876446|7497933|FG000|Overall Study|Physician Decision|1
4629732|NCT01876446|7497934|FG001|Overall Study|Physician Decision|3
4629733|NCT01876511|7497952|FG000|Overall Study|Disease Progression-clinical/radiologic|11
4629734|NCT01876511|7497953|FG001|Overall Study|Disease Progression-clinical/radiologic|24
4629735|NCT01876511|7497954|FG002|Overall Study|Disease Progression-clinical/radiologic|16
4629736|NCT01876511|7497952|FG000|Overall Study|Death (unrelated)|3
4629737|NCT01876511|7497953|FG001|Overall Study|Death (unrelated)|0
4629738|NCT01876511|7497954|FG002|Overall Study|Death (unrelated)|2
4629739|NCT01876511|7497952|FG000|Overall Study|Drug-related Toxicity|5
4629740|NCT01876511|7497953|FG001|Overall Study|Drug-related Toxicity|1
4629741|NCT01876511|7497954|FG002|Overall Study|Drug-related Toxicity|6
4629742|NCT01876511|7497952|FG000|Overall Study|Patient Decision|3
4629743|NCT01876511|7497953|FG001|Overall Study|Patient Decision|0
4629744|NCT01876511|7497954|FG002|Overall Study|Patient Decision|6
4629745|NCT01876511|7497952|FG000|Overall Study|Physician Decision|1
4629746|NCT01876511|7497953|FG001|Overall Study|Physician Decision|0
4629747|NCT01876511|7497954|FG002|Overall Study|Physician Decision|1
4629748|NCT01876706|7497964|FG000|Overall Study|BPH Intervention|9
4629749|NCT01876706|7497964|FG000|Overall Study|Lost to Follow-up|7
4629750|NCT01876706|7497964|FG000|Overall Study|Withdrawals|6
4629751|NCT01876706|7497964|FG000|Overall Study|Death|3
4629752|NCT01876732|7497968|FG000|Overall Study|MMA was not over 800mg/dL|75
4629753|NCT01876784|7497975|FG000|Overall Study|Withdrawal by Subject|17
4629754|NCT01876784|7497976|FG001|Overall Study|Withdrawal by Subject|2
4629755|NCT01876784|7497975|FG000|Overall Study|Adverse Event|15
4629756|NCT01876784|7497976|FG001|Overall Study|Adverse Event|2
4629757|NCT01876784|7497975|FG000|Overall Study|Protocol Violation|1
4629758|NCT01876784|7497976|FG001|Overall Study|Protocol Violation|0
4629759|NCT01876784|7497975|FG000|Overall Study|Disease progression|37
4629760|NCT01876784|7497976|FG001|Overall Study|Disease progression|67
4629761|NCT01876784|7497975|FG000|Overall Study|Lost to Follow-up|0
4629762|NCT01876784|7497976|FG001|Overall Study|Lost to Follow-up|1
4629763|NCT01876784|7497975|FG000|Overall Study|Death|1
4629764|NCT01876784|7497976|FG001|Overall Study|Death|0
4629765|NCT01876784|7497975|FG000|Overall Study|Randomized but not treated|2
4629766|NCT01876784|7497976|FG001|Overall Study|Randomized but not treated|1
4629767|NCT01876784|7497975|FG000|Overall Study|Other than specified above|5
4629768|NCT01876784|7497976|FG001|Overall Study|Other than specified above|6
4629769|NCT01876784|7497975|FG000|Overall Study|Ongoing|41
4629770|NCT01876784|7497976|FG001|Overall Study|Ongoing|40
4629771|NCT01876810|7497982|FG000|Overall Study|Physician Decision|0
4629772|NCT01876810|7497983|FG001|Overall Study|Physician Decision|1
4629773|NCT01876823|7497992|FG000|Overall Study|Withdrawal by Subject|5
4629774|NCT01876823|7497992|FG000|Overall Study|Physician Decision|2
4629775|NCT01876823|7497992|FG000|Overall Study|Patients moved|2
4629776|NCT01876901|7497998|FG000|Overall Study|Protocol Violation|10
4629777|NCT01876901|7497999|FG001|Overall Study|Protocol Violation|2
4629778|NCT01876901|7497998|FG000|Overall Study|No or other surgical intervention|7
4629779|NCT01876901|7497999|FG001|Overall Study|No or other surgical intervention|5
4629780|NCT01876979|7498008|FG000|Overall Study|Physician Decision|2
4629781|NCT01876979|7498009|FG001|Overall Study|Physician Decision|3
4629782|NCT01877083|7498025|FG000|Treatment Phase|Disease Progression|10
4629783|NCT01877083|7498025|FG000|Treatment Phase|Clinical Progression|1
4629784|NCT01877083|7498025|FG000|Treatment Phase|Adverse Event|6
4629785|NCT01877083|7498025|FG000|Treatment Phase|Withdrawal by Subject|2
4629786|NCT01877083|7498025|FG000|Treatment Phase|Lost to Follow-up|1
4629787|NCT01877083|7498025|FG000|Extension Phase|Disease Progression|3
4629788|NCT01877083|7498025|FG000|Extension Phase|Adverse Event|2
4629789|NCT01877187|7498046|FG000|Overall Study|Death|2
4629790|NCT01877187|7498046|FG000|Overall Study|Withdrawal by Subject|4
4629791|NCT01877187|7498046|FG000|Overall Study|Lost to Follow-up|3
4629792|NCT01877187|7498046|FG000|Overall Study|Declining clinical status|11
4629793|NCT01877187|7498046|FG000|Overall Study|Liver transplant|2
4629794|NCT01877239|7498053|FG000|Overall Study|Adverse Event|4
4629795|NCT01877239|7498053|FG000|Overall Study|Disease Remission|1
4629796|NCT01877239|7498053|FG000|Overall Study|Withdrawal by Subject|4
4629797|NCT01877239|7498053|FG000|Overall Study|Other|2
4629798|NCT01877239|7498053|FG000|Overall Study|Lack of Efficacy|4
4629799|NCT01877239|7498053|FG000|Overall Study|Data not available|35
4629800|NCT01877265|7498057|FG000|Treatment Period 1|Sponsor Decision|0
4629801|NCT01877265|7498058|FG001|Treatment Period 1|Sponsor Decision|0
4629802|NCT01877265|7498059|FG002|Treatment Period 1|Sponsor Decision|1
4629803|NCT01877265|7498060|FG003|Treatment Period 1|Sponsor Decision|0
4425482|NCT00365365|7207645|FG002|Overall Study|Lost to Follow-up|3
4512316|NCT00932698|7322004|FG004|Part 2 (Dose Expansion)|Adverse Event|0
4629804|NCT01877265|7498061|FG004|Treatment Period 1|Sponsor Decision|0
4629805|NCT01877265|7498062|FG005|Treatment Period 1|Sponsor Decision|0
4512317|NCT00932698|7322005|FG005|Part 2 (Dose Expansion)|Adverse Event|0
4629806|NCT01877265|7498057|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
4629807|NCT01877265|7498058|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
4629808|NCT01877265|7498059|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
4629809|NCT01877265|7498060|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
4629810|NCT01877265|7498061|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
4629811|NCT01877265|7498062|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1
4425483|NCT00365365|7207643|FG000|Overall Study|Death|1
4425484|NCT00365365|7207644|FG001|Overall Study|Death|3
4425485|NCT00365365|7207645|FG002|Overall Study|Death|0
4425486|NCT00365365|7207643|FG000|Overall Study|Subject's request|11
4425487|NCT00365365|7207644|FG001|Overall Study|Subject's request|13
4425488|NCT00365365|7207645|FG002|Overall Study|Subject's request|1
4425489|NCT00365365|7207643|FG000|Overall Study|Disease progression/relapse|9
4425490|NCT00365365|7207644|FG001|Overall Study|Disease progression/relapse|6
4425491|NCT00365365|7207645|FG002|Overall Study|Disease progression/relapse|7
4425492|NCT00365365|7207643|FG000|Overall Study|Adverse Event|6
4425493|NCT00365365|7207644|FG001|Overall Study|Adverse Event|6
4425494|NCT00365365|7207645|FG002|Overall Study|Adverse Event|3
4425495|NCT00365365|7207643|FG000|Overall Study|Moved|2
4425496|NCT00365365|7207644|FG001|Overall Study|Moved|0
4425497|NCT00365365|7207645|FG002|Overall Study|Moved|0
4425498|NCT00365365|7207643|FG000|Overall Study|New cancer|1
4425499|NCT00365365|7207644|FG001|Overall Study|New cancer|0
4425500|NCT00365365|7207645|FG002|Overall Study|New cancer|0
4425501|NCT00365365|7207643|FG000|Overall Study|Withdrew consent|1
4425502|NCT00365365|7207644|FG001|Overall Study|Withdrew consent|1
4425503|NCT00365365|7207645|FG002|Overall Study|Withdrew consent|0
4425504|NCT00365365|7207643|FG000|Overall Study|Second malignancy|0
4425505|NCT00365365|7207644|FG001|Overall Study|Second malignancy|1
4425506|NCT00365365|7207645|FG002|Overall Study|Second malignancy|0
4425507|NCT00365365|7207643|FG000|Overall Study|Patient/physician decision|0
4425508|NCT00365365|7207644|FG001|Overall Study|Patient/physician decision|0
4425509|NCT00365365|7207645|FG002|Overall Study|Patient/physician decision|1
4425510|NCT00365378|7207655|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11
4425511|NCT00365378|7207656|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7
4425512|NCT00365378|7207657|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0
4425513|NCT00365378|7207655|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4
4425514|NCT00365378|7207656|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5
4425515|NCT00365378|7207657|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0
4425516|NCT00365378|7207655|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88
4425517|NCT00365378|7207656|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75
4425518|NCT00365378|7207657|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0
4425519|NCT00365378|7207655|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19
4425520|NCT00365378|7207656|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14
4425521|NCT00365378|7207657|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0
4425522|NCT00365378|7207655|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22
4425523|NCT00365378|7207656|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13
4425524|NCT00365378|7207657|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0
4425525|NCT00365378|7207655|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50
4425526|NCT00365378|7207656|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44
4425527|NCT00365378|7207657|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0
4425528|NCT00365378|7207655|FG000|Vaccination (Day 1 to Month 7)|Other|17
4425529|NCT00365378|7207656|FG001|Vaccination (Day 1 to Month 7)|Other|9
4425530|NCT00365378|7207657|FG002|Vaccination (Day 1 to Month 7)|Other|0
4425531|NCT00365378|7207655|FG000|Follow-up (Month 7 Though Month 48)|Moved|6
4425532|NCT00365378|7207656|FG001|Follow-up (Month 7 Though Month 48)|Moved|5
4425533|NCT00365378|7207657|FG002|Follow-up (Month 7 Though Month 48)|Moved|0
4425534|NCT00365378|7207655|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67
4425535|NCT00365378|7207656|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69
4425536|NCT00365378|7207657|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0
4425537|NCT00365378|7207655|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0
4425538|NCT00365378|7207656|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1
4425539|NCT00365378|7207657|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0
4425540|NCT00365378|7207655|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1
4425541|NCT00365378|7207656|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2
4425542|NCT00365378|7207657|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0
4425543|NCT00365378|7207655|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73
4425544|NCT00365378|7207656|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104
4425545|NCT00365378|7207657|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0
4425546|NCT00365378|7207655|FG000|Follow-up (Month 7 Though Month 48)|Other|11
4425547|NCT00365378|7207656|FG001|Follow-up (Month 7 Though Month 48)|Other|21
4425548|NCT00365378|7207657|FG002|Follow-up (Month 7 Though Month 48)|Other|0
4425549|NCT00365378|7207655|FG000|Extension|Adverse Event|0
4425550|NCT00365378|7207656|FG001|Extension|Adverse Event|0
4425551|NCT00365378|7207657|FG002|Extension|Adverse Event|1
4425552|NCT00365378|7207655|FG000|Extension|Moved|0
4425553|NCT00365378|7207656|FG001|Extension|Moved|0
4425554|NCT00365378|7207657|FG002|Extension|Moved|8
4425555|NCT00365378|7207655|FG000|Extension|Lost to Follow-up|0
4425556|NCT00365378|7207656|FG001|Extension|Lost to Follow-up|0
4425557|NCT00365378|7207657|FG002|Extension|Lost to Follow-up|57
4425558|NCT00365378|7207655|FG000|Extension|Protocol Violation|0
4425559|NCT00365378|7207656|FG001|Extension|Protocol Violation|0
4425560|NCT00365378|7207657|FG002|Extension|Protocol Violation|2
4425561|NCT00365378|7207655|FG000|Extension|Withdrawal by Subject|0
4425562|NCT00365378|7207656|FG001|Extension|Withdrawal by Subject|0
4425563|NCT00365378|7207657|FG002|Extension|Withdrawal by Subject|98
4425564|NCT00365378|7207655|FG000|Extension|Other|0
4425565|NCT00365378|7207656|FG001|Extension|Other|0
4425566|NCT00365378|7207657|FG002|Extension|Other|31
4425567|NCT00365456|7207673|FG000|Trial Period I (12 Months)|Adverse Event|84
4425568|NCT00365456|7207674|FG001|Trial Period I (12 Months)|Adverse Event|0
4425569|NCT00365456|7207673|FG000|Trial Period I (12 Months)|Non-compliance|3
4629812|NCT01877265|7498057|FG000|Treatment Period 3|Lost to Follow-up|1
4629813|NCT01877265|7498058|FG001|Treatment Period 3|Lost to Follow-up|0
4629814|NCT01877265|7498059|FG002|Treatment Period 3|Lost to Follow-up|0
4629815|NCT01877265|7498060|FG003|Treatment Period 3|Lost to Follow-up|0
4629816|NCT01877265|7498061|FG004|Treatment Period 3|Lost to Follow-up|0
4629817|NCT01877265|7498062|FG005|Treatment Period 3|Lost to Follow-up|0
4629818|NCT01877278|7498075|FG000|Overall Study|Lost to Follow-up|3
4629819|NCT01877278|7498076|FG001|Overall Study|Lost to Follow-up|3
4629820|NCT01877408|7498084|FG000|Overall Study|Lost to Follow-up|0
4629821|NCT01877408|7498085|FG001|Overall Study|Lost to Follow-up|2
4629822|NCT01877421|7498124|FG000|Phase 2|Lost to Follow-up|0
4629823|NCT01877421|7498125|FG001|Phase 2|Lost to Follow-up|0
4629824|NCT01877421|7498126|FG002|Phase 2|Lost to Follow-up|0
4629825|NCT01877421|7498127|FG003|Phase 2|Lost to Follow-up|0
4629826|NCT01877421|7498128|FG004|Phase 2|Lost to Follow-up|0
4629827|NCT01877421|7498129|FG005|Phase 2|Lost to Follow-up|0
4629828|NCT01877421|7498130|FG006|Phase 2|Lost to Follow-up|1
4629829|NCT01877421|7498131|FG007|Phase 2|Lost to Follow-up|0
4629830|NCT01877421|7498132|FG008|Phase 2|Lost to Follow-up|0
4629831|NCT01877421|7498133|FG009|Phase 2|Lost to Follow-up|0
4629832|NCT01877421|7498134|FG010|Phase 2|Lost to Follow-up|0
4629833|NCT01877421|7498135|FG011|Phase 2|Lost to Follow-up|0
4629834|NCT01877421|7498136|FG012|Phase 2|Lost to Follow-up|0
4715011|NCT02966002|7643135|FG000|Overall Study|Lost to Follow-up|1
4715012|NCT02966015|7643141|FG000|Inclusion Visit|did not answer questionnaire|8
4715013|NCT02966015|7643142|FG001|Inclusion Visit|did not answer questionnaire|3
4715014|NCT02966028|7643151|FG000|Overall Study|Adverse Event|7
4715015|NCT02966028|7643152|FG001|Overall Study|Adverse Event|13
4425570|NCT00365456|7207674|FG001|Trial Period I (12 Months)|Non-compliance|0
4425571|NCT00365456|7207673|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27
4425572|NCT00365456|7207674|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0
4425573|NCT00365456|7207673|FG000|Trial Period I (12 Months)|Other|11
4425574|NCT00365456|7207674|FG001|Trial Period I (12 Months)|Other|0
4425575|NCT00365456|7207673|FG000|Trial Period II (12 Months)|Adverse Event|0
4425576|NCT00365456|7207674|FG001|Trial Period II (12 Months)|Adverse Event|6
4425577|NCT00365456|7207673|FG000|Trial Period II (12 Months)|Non-compliance|0
4425578|NCT00365456|7207674|FG001|Trial Period II (12 Months)|Non-compliance|2
4425579|NCT00365456|7207673|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0
4425580|NCT00365456|7207674|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5
4425581|NCT00365456|7207673|FG000|Trial Period II (12 Months)|Other|0
4425582|NCT00365456|7207674|FG001|Trial Period II (12 Months)|Other|1
4425583|NCT00365456|7207673|FG000|Trial Period III (12 Months)|Adverse Event|13
4425584|NCT00365456|7207674|FG001|Trial Period III (12 Months)|Adverse Event|3
4425585|NCT00365456|7207673|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4
4425586|NCT00365456|7207674|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1
4425587|NCT00365456|7207673|FG000|Trial Period III (12 Months)|Other|1
4425588|NCT00365456|7207674|FG001|Trial Period III (12 Months)|Other|1
4425589|NCT00365508|7207682|FG000|Overall Study|Lost to Follow-up|139
4425590|NCT00365508|7207683|FG001|Overall Study|Lost to Follow-up|154
4425591|NCT00365547|7207689|FG000|Overall Study|Insurance did not cover Avastin|1
4425592|NCT00365547|7207689|FG000|Overall Study|Screen failure|1
4425593|NCT00365547|7207689|FG000|Overall Study|Withdrawal by Subject|1
4425594|NCT00365716|7207705|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1
4425595|NCT00365716|7207706|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2
4425596|NCT00365716|7207707|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
4425597|NCT00365716|7207708|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
4425598|NCT00365716|7207709|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
4425599|NCT00365716|7207710|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
4425600|NCT00365716|7207711|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
4425601|NCT00365716|7207705|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0
4425602|NCT00365716|7207706|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2
4425603|NCT00365716|7207707|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0
4425604|NCT00365716|7207708|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0
4425605|NCT00365716|7207709|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1
4425606|NCT00365716|7207710|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0
4425607|NCT00365716|7207711|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0
4425608|NCT00365716|7207705|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4
4425609|NCT00365716|7207706|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6
4425610|NCT00365716|7207707|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6
4425611|NCT00365716|7207708|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4
4425612|NCT00365716|7207709|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
4629835|NCT01877421|7498137|FG013|Phase 2|Lost to Follow-up|0
4629836|NCT01877421|7498138|FG014|Phase 2|Lost to Follow-up|0
4629837|NCT01877421|7498139|FG015|Phase 2|Lost to Follow-up|0
4629838|NCT01877421|7498140|FG016|Phase 2|Lost to Follow-up|0
4629839|NCT01877421|7498141|FG017|Phase 2|Lost to Follow-up|0
4629840|NCT01877421|7498124|FG000|Phase 2|Withdrawal by Subject|0
4425613|NCT00365716|7207710|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
4425614|NCT00365716|7207711|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
4425615|NCT00365716|7207705|FG000|Base Study (Day 1 to Month 7)|Other|0
4425616|NCT00365716|7207706|FG001|Base Study (Day 1 to Month 7)|Other|1
4425617|NCT00365716|7207707|FG002|Base Study (Day 1 to Month 7)|Other|0
4425618|NCT00365716|7207708|FG003|Base Study (Day 1 to Month 7)|Other|0
4425619|NCT00365716|7207709|FG004|Base Study (Day 1 to Month 7)|Other|0
4425620|NCT00365716|7207710|FG005|Base Study (Day 1 to Month 7)|Other|0
4425621|NCT00365716|7207711|FG006|Base Study (Day 1 to Month 7)|Other|0
4425622|NCT00365716|7207705|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3
4425623|NCT00365716|7207706|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2
4425624|NCT00365716|7207707|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3
4425625|NCT00365716|7207708|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1
4425626|NCT00365716|7207709|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1
4425627|NCT00365716|7207710|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0
4425628|NCT00365716|7207711|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0
4425629|NCT00365716|7207705|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1
4425630|NCT00365716|7207706|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2
4425631|NCT00365716|7207707|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0
4425632|NCT00365716|7207708|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1
4425633|NCT00365716|7207709|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2
4425634|NCT00365716|7207710|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0
4425635|NCT00365716|7207711|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0
4425636|NCT00365716|7207705|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12
4425637|NCT00365716|7207706|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9
4425638|NCT00365716|7207707|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12
4425639|NCT00365716|7207708|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4
4425640|NCT00365716|7207709|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3
4425641|NCT00365716|7207710|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0
4425642|NCT00365716|7207711|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0
4425643|NCT00365716|7207705|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114
4425644|NCT00365716|7207706|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
4425645|NCT00365716|7207707|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
4425646|NCT00365716|7207708|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69
4425647|NCT00365716|7207709|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75
4425648|NCT00365716|7207710|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
4425649|NCT00365716|7207711|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
4425650|NCT00365716|7207705|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6
4425651|NCT00365716|7207706|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8
4425652|NCT00365716|7207707|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5
4425653|NCT00365716|7207708|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4
4425654|NCT00365716|7207709|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3
4425655|NCT00365716|7207710|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0
4425656|NCT00365716|7207711|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0
4425657|NCT00365716|7207705|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3
4425658|NCT00365716|7207706|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2
4425659|NCT00365716|7207707|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1
4425660|NCT00365716|7207708|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2
4425661|NCT00365716|7207709|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
4425662|NCT00365716|7207710|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
4425663|NCT00365716|7207711|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
4425664|NCT00365716|7207705|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2
4425665|NCT00365716|7207706|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0
4425666|NCT00365716|7207707|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0
4425667|NCT00365716|7207708|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0
4425668|NCT00365716|7207709|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1
4425669|NCT00365716|7207710|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0
4425670|NCT00365716|7207711|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0
4425671|NCT00365716|7207705|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
4425672|NCT00365716|7207706|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1
4425673|NCT00365716|7207707|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1
4425674|NCT00365716|7207708|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
4425675|NCT00365716|7207709|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
4425676|NCT00365716|7207710|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
4425677|NCT00365716|7207711|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
4425678|NCT00365716|7207705|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7
4425679|NCT00365716|7207706|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4
4425680|NCT00365716|7207707|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13
4425681|NCT00365716|7207708|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4
4425682|NCT00365716|7207709|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3
4425683|NCT00365716|7207710|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0
4425684|NCT00365716|7207711|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0
4425685|NCT00365716|7207705|FG000|Extension 1|Lost to Follow-up|0
4425686|NCT00365716|7207706|FG001|Extension 1|Lost to Follow-up|0
4425687|NCT00365716|7207707|FG002|Extension 1|Lost to Follow-up|0
4425688|NCT00365716|7207708|FG003|Extension 1|Lost to Follow-up|0
4425689|NCT00365716|7207709|FG004|Extension 1|Lost to Follow-up|0
4425690|NCT00365716|7207710|FG005|Extension 1|Lost to Follow-up|1
4425691|NCT00365716|7207711|FG006|Extension 1|Lost to Follow-up|0
4425692|NCT00365716|7207705|FG000|Extension 1|Other|0
4425693|NCT00365716|7207706|FG001|Extension 1|Other|0
4425694|NCT00365716|7207707|FG002|Extension 1|Other|0
4425695|NCT00365716|7207708|FG003|Extension 1|Other|0
4425696|NCT00365716|7207709|FG004|Extension 1|Other|0
4425697|NCT00365716|7207710|FG005|Extension 1|Other|9
4425698|NCT00365716|7207711|FG006|Extension 1|Other|0
4425699|NCT00365716|7207705|FG000|Extension 1|Moved|0
4425700|NCT00365716|7207706|FG001|Extension 1|Moved|0
4425701|NCT00365716|7207707|FG002|Extension 1|Moved|0
4425702|NCT00365716|7207708|FG003|Extension 1|Moved|0
4425703|NCT00365716|7207709|FG004|Extension 1|Moved|0
4425704|NCT00365716|7207710|FG005|Extension 1|Moved|4
4425705|NCT00365716|7207711|FG006|Extension 1|Moved|0
4425706|NCT00365716|7207705|FG000|Extension 1|Withdrawal by Subject|0
4425707|NCT00365716|7207706|FG001|Extension 1|Withdrawal by Subject|0
4425708|NCT00365716|7207707|FG002|Extension 1|Withdrawal by Subject|0
4425709|NCT00365716|7207708|FG003|Extension 1|Withdrawal by Subject|0
4425710|NCT00365716|7207709|FG004|Extension 1|Withdrawal by Subject|0
4425711|NCT00365716|7207710|FG005|Extension 1|Withdrawal by Subject|3
4425712|NCT00365716|7207711|FG006|Extension 1|Withdrawal by Subject|0
4425713|NCT00365716|7207705|FG000|Extension 1|Pregnancy|0
4425714|NCT00365716|7207706|FG001|Extension 1|Pregnancy|0
4425715|NCT00365716|7207707|FG002|Extension 1|Pregnancy|0
4425716|NCT00365716|7207708|FG003|Extension 1|Pregnancy|0
4425717|NCT00365716|7207709|FG004|Extension 1|Pregnancy|0
4425718|NCT00365716|7207710|FG005|Extension 1|Pregnancy|4
4425719|NCT00365716|7207711|FG006|Extension 1|Pregnancy|0
4425720|NCT00365716|7207705|FG000|Extension 1|Protocol Violation|0
4425721|NCT00365716|7207706|FG001|Extension 1|Protocol Violation|0
4425722|NCT00365716|7207707|FG002|Extension 1|Protocol Violation|0
4425723|NCT00365716|7207708|FG003|Extension 1|Protocol Violation|0
4425724|NCT00365716|7207709|FG004|Extension 1|Protocol Violation|0
4425725|NCT00365716|7207710|FG005|Extension 1|Protocol Violation|1
4425726|NCT00365716|7207711|FG006|Extension 1|Protocol Violation|0
4425727|NCT00365716|7207705|FG000|Extension 2|Lost to Follow-up|0
4425728|NCT00365716|7207706|FG001|Extension 2|Lost to Follow-up|0
4425729|NCT00365716|7207707|FG002|Extension 2|Lost to Follow-up|0
4425730|NCT00365716|7207708|FG003|Extension 2|Lost to Follow-up|0
4425731|NCT00365716|7207709|FG004|Extension 2|Lost to Follow-up|0
4425732|NCT00365716|7207710|FG005|Extension 2|Lost to Follow-up|0
4425733|NCT00365716|7207711|FG006|Extension 2|Lost to Follow-up|2
4425734|NCT00365716|7207705|FG000|Extension 2|Other|0
4425735|NCT00365716|7207706|FG001|Extension 2|Other|0
4425736|NCT00365716|7207707|FG002|Extension 2|Other|0
4425737|NCT00365716|7207708|FG003|Extension 2|Other|0
4425738|NCT00365716|7207709|FG004|Extension 2|Other|0
4425739|NCT00365716|7207710|FG005|Extension 2|Other|0
4425740|NCT00365716|7207711|FG006|Extension 2|Other|3
4425741|NCT00365716|7207705|FG000|Extension 2|Withdrawal by Subject|0
4425742|NCT00365716|7207706|FG001|Extension 2|Withdrawal by Subject|0
4425743|NCT00365716|7207707|FG002|Extension 2|Withdrawal by Subject|0
4425744|NCT00365716|7207708|FG003|Extension 2|Withdrawal by Subject|0
4425745|NCT00365716|7207709|FG004|Extension 2|Withdrawal by Subject|0
4425746|NCT00365716|7207710|FG005|Extension 2|Withdrawal by Subject|0
4425747|NCT00365716|7207711|FG006|Extension 2|Withdrawal by Subject|5
4425748|NCT00365794|7207734|FG000|Overall Study|Withdrawal by Subject|2
4425749|NCT00365846|7207739|FG000|Overall Study|Lost to Follow-up|1
4425750|NCT00365976|7207774|FG000|Overall Study|Withdrawal by Subject|1
4425751|NCT00365976|7207775|FG001|Overall Study|Withdrawal by Subject|5
4425752|NCT00365989|7207781|FG000|Overall Study|Withdrawal by Subject|1
4425753|NCT00365989|7207781|FG000|Overall Study|Non-compliance|1
4425754|NCT00366249|7207803|FG000|Overall Study|Adverse Event|53
4425755|NCT00366249|7207804|FG001|Overall Study|Adverse Event|28
4425756|NCT00366249|7207803|FG000|Overall Study|Death|0
4425757|NCT00366249|7207804|FG001|Overall Study|Death|1
4425758|NCT00366249|7207803|FG000|Overall Study|Physician Decision|5
4425759|NCT00366249|7207804|FG001|Overall Study|Physician Decision|2
4425760|NCT00366249|7207803|FG000|Overall Study|Lost to Follow-up|2
4425761|NCT00366249|7207804|FG001|Overall Study|Lost to Follow-up|0
4425762|NCT00366249|7207803|FG000|Overall Study|Protocol Violation|1
4425763|NCT00366249|7207804|FG001|Overall Study|Protocol Violation|2
4425764|NCT00366249|7207803|FG000|Overall Study|Withdrawal by Subject|18
4425765|NCT00366249|7207804|FG001|Overall Study|Withdrawal by Subject|4
4425766|NCT00366249|7207803|FG000|Overall Study|Lack of Efficacy|21
4425767|NCT00366249|7207804|FG001|Overall Study|Lack of Efficacy|21
4425768|NCT00366249|7207803|FG000|Overall Study|Most due to osteomylitis status|31
4425769|NCT00366249|7207804|FG001|Overall Study|Most due to osteomylitis status|20
4425770|NCT00366301|7207818|FG000|Overall Study|Lost to Follow-up|4
4425771|NCT00366301|7207819|FG001|Overall Study|Lost to Follow-up|4
4425772|NCT00366301|7207820|FG002|Overall Study|Lost to Follow-up|3
4425773|NCT00366301|7207821|FG003|Overall Study|Lost to Follow-up|7
4425774|NCT00366301|7207818|FG000|Overall Study|Withdrawal by Subject|4
4425775|NCT00366301|7207819|FG001|Overall Study|Withdrawal by Subject|2
4425776|NCT00366301|7207820|FG002|Overall Study|Withdrawal by Subject|1
4425777|NCT00366301|7207821|FG003|Overall Study|Withdrawal by Subject|1
4425778|NCT00366340|7207833|FG000|Infant Series|Protocol Violation|3
4425779|NCT00366340|7207834|FG001|Infant Series|Protocol Violation|4
4590453|NCT01521897|7436502|FG000|Overall Study|Protocol Violation|18
4590454|NCT01521897|7436502|FG000|Overall Study|Lost to Follow-up|5
4590455|NCT01521923|7436510|FG000|Overall Study|AE, serious fatal|1
4590456|NCT01521923|7436511|FG001|Overall Study|AE, serious fatal|0
4590457|NCT01521923|7436512|FG002|Overall Study|AE, serious fatal|0
4590458|NCT01521923|7436513|FG003|Overall Study|AE, serious fatal|0
4590459|NCT01521923|7436510|FG000|Overall Study|SAE, non-fatal|0
4590460|NCT01521923|7436511|FG001|Overall Study|SAE, non-fatal|2
4590461|NCT01521923|7436512|FG002|Overall Study|SAE, non-fatal|2
4590462|NCT01521923|7436513|FG003|Overall Study|SAE, non-fatal|0
4590463|NCT01521923|7436510|FG000|Overall Study|AE, non-serious, non-fatal|1
4590464|NCT01521923|7436511|FG001|Overall Study|AE, non-serious, non-fatal|3
4590465|NCT01521923|7436512|FG002|Overall Study|AE, non-serious, non-fatal|6
4590466|NCT01521923|7436513|FG003|Overall Study|AE, non-serious, non-fatal|2
4425780|NCT00366340|7207833|FG000|Infant Series|Withdrawal by Subject|3
4425781|NCT00366340|7207834|FG001|Infant Series|Withdrawal by Subject|3
4425782|NCT00366340|7207833|FG000|Infant Series|Adverse Event|0
4425783|NCT00366340|7207834|FG001|Infant Series|Adverse Event|2
4425784|NCT00366340|7207833|FG000|Infant Series|Lost to Follow-up|1
4425785|NCT00366340|7207834|FG001|Infant Series|Lost to Follow-up|1
4425786|NCT00366340|7207833|FG000|Infant Series|Failure to return|1
4425787|NCT00366340|7207834|FG001|Infant Series|Failure to return|0
4425788|NCT00366340|7207833|FG000|After the Infant Series|Parent/legal guardian request|1
4425789|NCT00366340|7207834|FG001|After the Infant Series|Parent/legal guardian request|1
4425790|NCT00366340|7207833|FG000|After the Infant Series|Failed to return|0
4425791|NCT00366340|7207834|FG001|After the Infant Series|Failed to return|1
4425792|NCT00366340|7207833|FG000|After the Infant Series|Protocol Violation|2
4425793|NCT00366340|7207834|FG001|After the Infant Series|Protocol Violation|2
4425794|NCT00366340|7207833|FG000|After the Infant Series|Adverse Event|0
4425795|NCT00366340|7207834|FG001|After the Infant Series|Adverse Event|1
4425796|NCT00366340|7207833|FG000|After the Infant Series|Lost to Follow-up|0
4425797|NCT00366340|7207834|FG001|After the Infant Series|Lost to Follow-up|1
4425798|NCT00366340|7207833|FG000|Toddler Dose|Failed to return|1
4425799|NCT00366340|7207834|FG001|Toddler Dose|Failed to return|0
4425800|NCT00366340|7207833|FG000|Toddler Dose|Parent/legal guardian request|0
4425801|NCT00366340|7207834|FG001|Toddler Dose|Parent/legal guardian request|1
4425802|NCT00366444|7207866|FG000|Overall Study|Withdrawal by Subject|1
4425803|NCT00366444|7207867|FG001|Overall Study|Withdrawal by Subject|1
4425804|NCT00366444|7207866|FG000|Overall Study|Lack of Efficacy|0
4425805|NCT00366444|7207867|FG001|Overall Study|Lack of Efficacy|1
4425806|NCT00366457|7207873|FG000|Overall Study|never began study therapy|2
4425807|NCT00366535|7207879|FG000|First Phase: 12 Weeks|Adverse Event|1
4425808|NCT00366535|7207880|FG001|First Phase: 12 Weeks|Adverse Event|3
4425809|NCT00366535|7207879|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2
4425810|NCT00366535|7207880|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5
4425811|NCT00366535|7207879|FG000|Second Phase: 12 Weeks|Adverse Event|1
4425812|NCT00366535|7207880|FG001|Second Phase: 12 Weeks|Adverse Event|1
4425813|NCT00366535|7207879|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2
4425814|NCT00366535|7207880|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2
4425815|NCT00366548|7207896|FG000|Infant Series|Adverse Event|1
4425816|NCT00366548|7207897|FG001|Infant Series|Adverse Event|3
4425817|NCT00366548|7207896|FG000|Infant Series|Protocol Violation|0
4425818|NCT00366548|7207897|FG001|Infant Series|Protocol Violation|1
4425819|NCT00366548|7207896|FG000|Infant Series|Withdrawal by Subject|3
4425820|NCT00366548|7207897|FG001|Infant Series|Withdrawal by Subject|1
4425821|NCT00366548|7207896|FG000|After Infant Series|Withdrawal by Subject|3
4425822|NCT00366548|7207897|FG001|After Infant Series|Withdrawal by Subject|1
4425823|NCT00366548|7207896|FG000|After Infant Series|Adverse Event|2
4425824|NCT00366548|7207897|FG001|After Infant Series|Adverse Event|0
4425825|NCT00366548|7207896|FG000|After Infant Series|Lost to Follow-up|1
4425826|NCT00366548|7207897|FG001|After Infant Series|Lost to Follow-up|0
4425827|NCT00366678|7207934|FG000|Infant Series|Withdrawal by Subject|8
4425828|NCT00366678|7207935|FG001|Infant Series|Withdrawal by Subject|6
4425829|NCT00366678|7207936|FG002|Infant Series|Withdrawal by Subject|0
4425830|NCT00366678|7207934|FG000|Infant Series|Protocol Violation|4
4425831|NCT00366678|7207935|FG001|Infant Series|Protocol Violation|3
4425832|NCT00366678|7207936|FG002|Infant Series|Protocol Violation|0
4425833|NCT00366678|7207934|FG000|Infant Series|Failed to return|1
4425834|NCT00366678|7207935|FG001|Infant Series|Failed to return|1
4425835|NCT00366678|7207936|FG002|Infant Series|Failed to return|0
4425836|NCT00366678|7207934|FG000|Infant Series|Adverse Event|1
4425837|NCT00366678|7207935|FG001|Infant Series|Adverse Event|0
4425838|NCT00366678|7207936|FG002|Infant Series|Adverse Event|0
4425839|NCT00366678|7207934|FG000|After Infant|Withdrawal by Subject|8
4425840|NCT00366678|7207935|FG001|After Infant|Withdrawal by Subject|4
4425841|NCT00366678|7207936|FG002|After Infant|Withdrawal by Subject|0
4425842|NCT00366678|7207934|FG000|After Infant|Lost to Follow-up|2
4590467|NCT01521923|7436510|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
4425843|NCT00366678|7207935|FG001|After Infant|Lost to Follow-up|1
4425844|NCT00366678|7207936|FG002|After Infant|Lost to Follow-up|0
4425845|NCT00366678|7207934|FG000|After Infant|Failed to return|5
4425846|NCT00366678|7207935|FG001|After Infant|Failed to return|5
4425847|NCT00366678|7207936|FG002|After Infant|Failed to return|0
4425848|NCT00366678|7207934|FG000|After Infant|Adverse Event|1
4425849|NCT00366678|7207935|FG001|After Infant|Adverse Event|0
4425850|NCT00366678|7207936|FG002|After Infant|Adverse Event|0
4425851|NCT00366678|7207934|FG000|After Infant|Protocol Violation|1
4425852|NCT00366678|7207935|FG001|After Infant|Protocol Violation|0
4425853|NCT00366678|7207936|FG002|After Infant|Protocol Violation|0
4425854|NCT00366678|7207934|FG000|Toddler Dose|Protocol Violation|2
4425855|NCT00366678|7207935|FG001|Toddler Dose|Protocol Violation|1
4425856|NCT00366678|7207936|FG002|Toddler Dose|Protocol Violation|0
4425857|NCT00366678|7207934|FG000|Toddler Dose|Failed to return|1
4425858|NCT00366678|7207935|FG001|Toddler Dose|Failed to return|0
4425859|NCT00366678|7207936|FG002|Toddler Dose|Failed to return|0
4425860|NCT00366678|7207934|FG000|Toddler Dose|Withdrawal by Subject|1
4425861|NCT00366678|7207935|FG001|Toddler Dose|Withdrawal by Subject|0
4425862|NCT00366678|7207936|FG002|Toddler Dose|Withdrawal by Subject|0
4425863|NCT00366678|7207934|FG000|Toddler Dose|protocol deviation|1
4425864|NCT00366678|7207935|FG001|Toddler Dose|protocol deviation|0
4425865|NCT00366678|7207936|FG002|Toddler Dose|protocol deviation|0
4425866|NCT00366899|7207983|FG000|Infant Series|Withdrawal by Subject|4
4425867|NCT00366899|7207984|FG001|Infant Series|Withdrawal by Subject|7
4425868|NCT00366899|7207983|FG000|Infant Series|Protocol Violation|2
4425869|NCT00366899|7207984|FG001|Infant Series|Protocol Violation|1
4425870|NCT00366899|7207983|FG000|Infant Series|Failed to return|1
4425871|NCT00366899|7207984|FG001|Infant Series|Failed to return|1
4425872|NCT00366899|7207983|FG000|Infant Series|Lost to Follow-up|0
4425873|NCT00366899|7207984|FG001|Infant Series|Lost to Follow-up|2
4425874|NCT00366899|7207983|FG000|Infant Series|Adverse Event|0
4425875|NCT00366899|7207984|FG001|Infant Series|Adverse Event|1
4425876|NCT00366899|7207983|FG000|Infant Series|Physician Decision|1
4425877|NCT00366899|7207984|FG001|Infant Series|Physician Decision|0
4425878|NCT00366899|7207983|FG000|Infant Series|Randomized but not consented|1
4425879|NCT00366899|7207984|FG001|Infant Series|Randomized but not consented|0
4425880|NCT00366899|7207983|FG000|After Infant Series|Lost to Follow-up|4
4425881|NCT00366899|7207984|FG001|After Infant Series|Lost to Follow-up|3
4425882|NCT00366899|7207983|FG000|After Infant Series|Withdrawal by Subject|1
4425883|NCT00366899|7207984|FG001|After Infant Series|Withdrawal by Subject|4
4425884|NCT00366899|7207983|FG000|After Infant Series|Adverse Event|1
4425885|NCT00366899|7207984|FG001|After Infant Series|Adverse Event|2
4425886|NCT00366899|7207983|FG000|After Infant Series|Protocol Violation|1
4425887|NCT00366899|7207984|FG001|After Infant Series|Protocol Violation|0
4425888|NCT00366899|7207983|FG000|Toddler Dose|Withdrawal by Subject|1
4425889|NCT00366899|7207984|FG001|Toddler Dose|Withdrawal by Subject|1
4425890|NCT00366899|7207983|FG000|Toddler Dose|Protocol Violation|1
4425891|NCT00366899|7207984|FG001|Toddler Dose|Protocol Violation|0
4512318|NCT00932698|7322006|FG006|Part 2 (Dose Expansion)|Adverse Event|0
4512319|NCT00932698|7322007|FG007|Part 2 (Dose Expansion)|Adverse Event|5
4512320|NCT00932698|7322008|FG008|Part 2 (Dose Expansion)|Adverse Event|1
4512321|NCT00932698|7322009|FG009|Part 2 (Dose Expansion)|Adverse Event|1
4512322|NCT00932698|7322010|FG010|Part 2 (Dose Expansion)|Adverse Event|0
4512323|NCT00932893|7322042|FG000|Overall Study|Death|115
4512324|NCT00932893|7322043|FG001|Overall Study|Death|24
4512325|NCT00932893|7322042|FG000|Overall Study|Lost to Follow-up|8
4512326|NCT00932893|7322043|FG001|Overall Study|Lost to Follow-up|0
4512327|NCT00932893|7322042|FG000|Overall Study|Withdrawal by Subject|5
4512328|NCT00932893|7322043|FG001|Overall Study|Withdrawal by Subject|2
4512329|NCT00932893|7322042|FG000|Overall Study|Other|5
4512330|NCT00932893|7322043|FG001|Overall Study|Other|144
4512331|NCT00933166|7322050|FG000|Overall Study|Lost to Follow-up|4
4512332|NCT00933166|7322050|FG000|Overall Study|Lack of Efficacy|9
4512333|NCT00933166|7322050|FG000|Overall Study|Unavailable|4
4512334|NCT00933166|7322050|FG000|Overall Study|Withdrawal by Subject|1
4512335|NCT00933244|7322057|FG000|Overall Study|Withdrawal by Subject|5
4512336|NCT00933244|7322058|FG001|Overall Study|Withdrawal by Subject|1
4512337|NCT00933244|7322059|FG002|Overall Study|Withdrawal by Subject|3
4512338|NCT00933270|7322067|FG000|Overall Study|Withdrawal by Subject|26
4512339|NCT00933270|7322067|FG000|Overall Study|Insufficient Follow-up|10
4512340|NCT00933270|7322067|FG000|Overall Study|Lost to Follow-up|14
4512341|NCT00933270|7322067|FG000|Overall Study|Adverse Event|1
4512342|NCT00933270|7322067|FG000|Overall Study|Missed Visit|2
4512343|NCT00933270|7322067|FG000|Overall Study|Death|24
4512344|NCT00933270|7322067|FG000|Overall Study|Moved or would not return|10
4512345|NCT00933335|7322074|FG000|Overall Study|Lost to Follow-up|1
4512346|NCT00933335|7322075|FG001|Overall Study|Lost to Follow-up|3
4512347|NCT00933335|7322074|FG000|Overall Study|Withdrawal by Subject|0
4512348|NCT00933335|7322075|FG001|Overall Study|Withdrawal by Subject|1
4512349|NCT00933335|7322074|FG000|Overall Study|Progressive Disease|0
4512350|NCT00933335|7322075|FG001|Overall Study|Progressive Disease|11
4512351|NCT00933335|7322074|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0
4512352|NCT00933335|7322075|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1
4512353|NCT00933335|7322074|FG000|Overall Study|Co-morbid Illness|1
4425892|NCT00367055|7208033|FG000|Overall Study|Adverse Event|6
4425893|NCT00367055|7208034|FG001|Overall Study|Adverse Event|3
4425894|NCT00367055|7208033|FG000|Overall Study|Patient's Willing|3
4425895|NCT00367055|7208034|FG001|Overall Study|Patient's Willing|2
4425896|NCT00367055|7208033|FG000|Overall Study|Lack of Efficacy|1
4425897|NCT00367055|7208034|FG001|Overall Study|Lack of Efficacy|2
4425898|NCT00367055|7208033|FG000|Overall Study|Lost to Follow-up|1
4425899|NCT00367055|7208034|FG001|Overall Study|Lost to Follow-up|1
4425900|NCT00367055|7208033|FG000|Overall Study|Protocol Violation|0
4425901|NCT00367055|7208034|FG001|Overall Study|Protocol Violation|1
4425902|NCT00367055|7208033|FG000|Overall Study|Stopping Criterion Met|0
4425903|NCT00367055|7208034|FG001|Overall Study|Stopping Criterion Met|1
4425904|NCT00367055|7208033|FG000|Overall Study|Participant Living too Far from Hospital|0
4425905|NCT00367055|7208034|FG001|Overall Study|Participant Living too Far from Hospital|1
4425906|NCT00367133|7208043|FG000|2 Years|Death|20
4425907|NCT00367133|7208044|FG001|2 Years|Death|12
4425908|NCT00367133|7208045|FG002|2 Years|Death|12
4425909|NCT00367133|7208043|FG000|2 Years|Dropped|34
4425910|NCT00367133|7208044|FG001|2 Years|Dropped|19
4425911|NCT00367133|7208045|FG002|2 Years|Dropped|33
4425912|NCT00367133|7208043|FG000|2 Years|Missed visit|4
4425913|NCT00367133|7208044|FG001|2 Years|Missed visit|5
4425914|NCT00367133|7208045|FG002|2 Years|Missed visit|4
4425915|NCT00367237|7208055|FG000|Overall Study|Adverse Event|7
4425916|NCT00367237|7208056|FG001|Overall Study|Adverse Event|2
4425917|NCT00367237|7208055|FG000|Overall Study|Lost to Follow-up|1
4425918|NCT00367237|7208056|FG001|Overall Study|Lost to Follow-up|0
4425919|NCT00367237|7208055|FG000|Overall Study|Withdrawal by Subject|0
4425920|NCT00367237|7208056|FG001|Overall Study|Withdrawal by Subject|4
4425921|NCT00367237|7208055|FG000|Overall Study|Protocol Violation|2
4425922|NCT00367237|7208056|FG001|Overall Study|Protocol Violation|5
4425923|NCT00367341|7208064|FG000|Overall Study|Physician Decision|1
4425924|NCT00367341|7208065|FG001|Overall Study|Physician Decision|0
4425925|NCT00367341|7208064|FG000|Overall Study|Protocol Violation|1
4425926|NCT00367341|7208065|FG001|Overall Study|Protocol Violation|0
4425927|NCT00367432|7208084|FG000|First Period (16 Weeks)|Adverse Event|6
4425928|NCT00367432|7208085|FG001|First Period (16 Weeks)|Adverse Event|0
4425929|NCT00367432|7208084|FG000|First Period (16 Weeks)|Lack of Efficacy|24
4425930|NCT00367432|7208085|FG001|First Period (16 Weeks)|Lack of Efficacy|0
4425931|NCT00367432|7208084|FG000|First Period (16 Weeks)|Withdrawal by Subject|6
4425932|NCT00367432|7208085|FG001|First Period (16 Weeks)|Withdrawal by Subject|0
4425933|NCT00367432|7208084|FG000|First Period (16 Weeks)|Other Reason|2
4425934|NCT00367432|7208085|FG001|First Period (16 Weeks)|Other Reason|0
4425935|NCT00367432|7208084|FG000|Second Period (up to 54 Months)|Adverse Event|14
4425936|NCT00367432|7208085|FG001|Second Period (up to 54 Months)|Adverse Event|3
4425937|NCT00367432|7208084|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59
4425938|NCT00367432|7208085|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5
4425939|NCT00367432|7208084|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0
4425940|NCT00367432|7208085|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1
4425941|NCT00367432|7208084|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8
4425942|NCT00367432|7208085|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5
4425943|NCT00367432|7208084|FG000|Second Period (up to 54 Months)|Other Reason|6
4425944|NCT00367432|7208085|FG001|Second Period (up to 54 Months)|Other Reason|2
4425945|NCT00367458|7208091|FG000|First Intervention - 8 Weeks|Adverse Event|2
4425946|NCT00367458|7208092|FG001|First Intervention - 8 Weeks|Adverse Event|0
4425947|NCT00367484|7208098|FG000|Overall Study|Adverse Event|7
4425948|NCT00367484|7208098|FG000|Overall Study|Withdrew informed consent|5
4425949|NCT00367484|7208098|FG000|Overall Study|Travel to USA|1
4425950|NCT00367484|7208098|FG000|Overall Study|Lost to Follow-up|1
4425951|NCT00367484|7208098|FG000|Overall Study|Protocol Violation|1
4425952|NCT00367484|7208098|FG000|Overall Study|The choice of the patient|1
4425953|NCT00367484|7208098|FG000|Overall Study|Lack of Efficacy|1
4425954|NCT00367640|7208111|FG000|Overall Study|Adverse Event|3
4425955|NCT00367640|7208112|FG001|Overall Study|Adverse Event|6
4425956|NCT00367640|7208113|FG002|Overall Study|Adverse Event|8
4425957|NCT00367640|7208114|FG003|Overall Study|Adverse Event|0
4425958|NCT00367640|7208111|FG000|Overall Study|Withdrawal by Subject|8
4425959|NCT00367640|7208112|FG001|Overall Study|Withdrawal by Subject|11
4425960|NCT00367640|7208113|FG002|Overall Study|Withdrawal by Subject|8
4425961|NCT00367640|7208114|FG003|Overall Study|Withdrawal by Subject|6
4425962|NCT00367640|7208111|FG000|Overall Study|Any other reason not above-mentioned|7
4425963|NCT00367640|7208112|FG001|Overall Study|Any other reason not above-mentioned|5
4425964|NCT00367640|7208113|FG002|Overall Study|Any other reason not above-mentioned|3
4425965|NCT00367640|7208114|FG003|Overall Study|Any other reason not above-mentioned|4
4425966|NCT00367744|7208132|FG000|Overall Study|Lost to Follow-up|4
4425967|NCT00367744|7208133|FG001|Overall Study|Lost to Follow-up|5
4425968|NCT00367770|7208140|FG000|Overall Study|Adverse Event|1
4425969|NCT00367770|7208140|FG000|Overall Study|Withdrawal by Subject|1
4425970|NCT00367835|7208146|FG000|Overall Study|Adverse Event|14
4425971|NCT00367835|7208147|FG001|Overall Study|Adverse Event|1
4425972|NCT00367835|7208146|FG000|Overall Study|Protocol Violation|1
4425973|NCT00367835|7208147|FG001|Overall Study|Protocol Violation|7
4425974|NCT00367835|7208146|FG000|Overall Study|Withdrawal by Subject|7
4425975|NCT00367835|7208147|FG001|Overall Study|Withdrawal by Subject|6
4425976|NCT00367835|7208146|FG000|Overall Study|Lost to Follow-up|1
4425977|NCT00367835|7208147|FG001|Overall Study|Lost to Follow-up|4
4425978|NCT00367835|7208146|FG000|Overall Study|Lack of Efficacy|3
4425979|NCT00367835|7208147|FG001|Overall Study|Lack of Efficacy|12
4425980|NCT00367835|7208146|FG000|Overall Study|Subject in juvenile detention center|1
4425981|NCT00367835|7208147|FG001|Overall Study|Subject in juvenile detention center|0
4425982|NCT00367835|7208146|FG000|Overall Study|refused blood collection|1
4425983|NCT00367835|7208147|FG001|Overall Study|refused blood collection|0
4425984|NCT00367835|7208146|FG000|Overall Study|Did not respond to calls|1
4425985|NCT00367835|7208147|FG001|Overall Study|Did not respond to calls|0
4425986|NCT00367835|7208146|FG000|Overall Study|History of lead poisoning|0
4425987|NCT00367835|7208147|FG001|Overall Study|History of lead poisoning|1
4425988|NCT00367991|7208155|FG000|Overall Study|Withdrawal by Subject|1
4425989|NCT00367991|7208156|FG001|Overall Study|Withdrawal by Subject|1
4425990|NCT00367991|7208155|FG000|Overall Study|Adverse Event|1
4425991|NCT00367991|7208156|FG001|Overall Study|Adverse Event|1
4425992|NCT00368069|7208164|FG000|Overall Study|Adverse Event|5
4425993|NCT00368069|7208165|FG001|Overall Study|Adverse Event|2
4425994|NCT00368069|7208164|FG000|Overall Study|Lack of Efficacy|0
4425995|NCT00368069|7208165|FG001|Overall Study|Lack of Efficacy|1
4425996|NCT00368069|7208164|FG000|Overall Study|Lost to Follow-up|1
4425997|NCT00368069|7208165|FG001|Overall Study|Lost to Follow-up|0
4425998|NCT00368069|7208164|FG000|Overall Study|Protocol Violation|0
4425999|NCT00368069|7208165|FG001|Overall Study|Protocol Violation|2
4426000|NCT00368069|7208164|FG000|Overall Study|Withdrawal of Consent|2
4426001|NCT00368069|7208165|FG001|Overall Study|Withdrawal of Consent|1
4426002|NCT00368069|7208164|FG000|Overall Study|no blood sampling possible|0
4426003|NCT00368069|7208165|FG001|Overall Study|no blood sampling possible|1
4426004|NCT00368108|7208174|FG000|Overall Study|Adverse Event|38
4426005|NCT00368108|7208175|FG001|Overall Study|Adverse Event|26
4426006|NCT00368108|7208176|FG002|Overall Study|Adverse Event|44
4426007|NCT00368108|7208174|FG000|Overall Study|Abnormal Laboratory Value|0
4426008|NCT00368108|7208175|FG001|Overall Study|Abnormal Laboratory Value|0
4426009|NCT00368108|7208176|FG002|Overall Study|Abnormal Laboratory Value|3
4426010|NCT00368108|7208174|FG000|Overall Study|Protocol Violation|5
4426011|NCT00368108|7208175|FG001|Overall Study|Protocol Violation|9
4426012|NCT00368108|7208176|FG002|Overall Study|Protocol Violation|9
4426013|NCT00368108|7208174|FG000|Overall Study|Withdrawal by Subject|9
4426014|NCT00368108|7208175|FG001|Overall Study|Withdrawal by Subject|3
4426015|NCT00368108|7208176|FG002|Overall Study|Withdrawal by Subject|5
4426016|NCT00368108|7208174|FG000|Overall Study|Lack of Efficacy|7
4426017|NCT00368108|7208175|FG001|Overall Study|Lack of Efficacy|8
4426018|NCT00368108|7208176|FG002|Overall Study|Lack of Efficacy|5
4426019|NCT00368108|7208174|FG000|Overall Study|Physician Decision|2
4715016|NCT02966028|7643153|FG002|Overall Study|Adverse Event|10
4426020|NCT00368108|7208175|FG001|Overall Study|Physician Decision|0
4426021|NCT00368108|7208176|FG002|Overall Study|Physician Decision|1
4426022|NCT00368108|7208174|FG000|Overall Study|Other|3
4426023|NCT00368108|7208175|FG001|Overall Study|Other|7
4426024|NCT00368108|7208176|FG002|Overall Study|Other|1
4426025|NCT00368251|7208187|FG000|Overall Study|SAE, non-fatal|1
4426026|NCT00368251|7208188|FG001|Overall Study|SAE, non-fatal|0
4426027|NCT00368251|7208189|FG002|Overall Study|SAE, non-fatal|0
4426028|NCT00368251|7208187|FG000|Overall Study|AE, non-serious non-fatal|0
4426029|NCT00368251|7208188|FG001|Overall Study|AE, non-serious non-fatal|0
4426030|NCT00368251|7208189|FG002|Overall Study|AE, non-serious non-fatal|1
4426031|NCT00368277|7208199|FG000|Overall Study|Adverse Event|33
4426032|NCT00368277|7208200|FG001|Overall Study|Adverse Event|49
4426033|NCT00368277|7208199|FG000|Overall Study|Death|2
4426034|NCT00368277|7208200|FG001|Overall Study|Death|1
4426035|NCT00368277|7208199|FG000|Overall Study|Unsatisfactory therapeutic effect|31
4426036|NCT00368277|7208200|FG001|Overall Study|Unsatisfactory therapeutic effect|24
4426037|NCT00368277|7208199|FG000|Overall Study|Protocol deviation|7
4426038|NCT00368277|7208200|FG001|Overall Study|Protocol deviation|0
4426039|NCT00368277|7208199|FG000|Overall Study|Patient withdrew consent|32
4426040|NCT00368277|7208200|FG001|Overall Study|Patient withdrew consent|28
4426041|NCT00368277|7208199|FG000|Overall Study|Lost to Follow-up|8
4426042|NCT00368277|7208200|FG001|Overall Study|Lost to Follow-up|6
4426043|NCT00368355|7208226|FG000|Overall Study|Adverse Event|1
4426044|NCT00368355|7208227|FG001|Overall Study|Adverse Event|0
4512354|NCT00933335|7322075|FG001|Overall Study|Co-morbid Illness|0
4426045|NCT00368355|7208226|FG000|Overall Study|Death|2
4426046|NCT00368355|7208227|FG001|Overall Study|Death|4
4426047|NCT00368355|7208226|FG000|Overall Study|Relapse|6
4426048|NCT00368355|7208227|FG001|Overall Study|Relapse|10
4426049|NCT00368355|7208226|FG000|Overall Study|Subsequent transplant|0
4426050|NCT00368355|7208227|FG001|Overall Study|Subsequent transplant|3
4426051|NCT00368355|7208226|FG000|Overall Study|Treatment - hematopoietic cell product|2
4426052|NCT00368355|7208227|FG001|Overall Study|Treatment - hematopoietic cell product|0
4426053|NCT00368472|7208242|FG000|Overall Study|Adverse Event|22
4512355|NCT00933543|7322098|FG000|Overall Study|Adverse Event|2
4426054|NCT00368472|7208242|FG000|Overall Study|Medication non-compliance|4
4426055|NCT00368472|7208242|FG000|Overall Study|Protocol Violation|2
4426056|NCT00368472|7208242|FG000|Overall Study|Request of Investigator or Sponsor|3
4426057|NCT00368472|7208242|FG000|Overall Study|Withdrawal by Subject|40
4426058|NCT00368472|7208242|FG000|Overall Study|Diary non-compliance|1
4426059|NCT00368472|7208242|FG000|Overall Study|Other|32
4426060|NCT00368472|7208242|FG000|Overall Study|Missing Final Disposition Date|1
4426061|NCT00368537|7208248|FG000|Randomization|No study drug dosed|13
4426062|NCT00368537|7208249|FG001|Randomization|No study drug dosed|6
4426063|NCT00368537|7208248|FG000|Baseline Participants|Lost to Follow-up|16
4426064|NCT00368537|7208249|FG001|Baseline Participants|Lost to Follow-up|17
4426065|NCT00368537|7208248|FG000|Baseline Participants|Withdrawal by Subject|6
4426066|NCT00368537|7208249|FG001|Baseline Participants|Withdrawal by Subject|4
4426067|NCT00368537|7208248|FG000|Baseline Participants|Death|1
4426068|NCT00368537|7208249|FG001|Baseline Participants|Death|2
4426069|NCT00368537|7208248|FG000|Baseline Participants|No susceptibility|1
4426070|NCT00368537|7208249|FG001|Baseline Participants|No susceptibility|0
4426071|NCT00368537|7208248|FG000|Baseline Participants|Patient uncompliant|0
4426072|NCT00368537|7208249|FG001|Baseline Participants|Patient uncompliant|1
4426073|NCT00368550|7208257|FG000|Overall Study|Adverse Event|7
4426074|NCT00368550|7208258|FG001|Overall Study|Adverse Event|4
4426075|NCT00368550|7208257|FG000|Overall Study|Lack of Efficacy|4
4426076|NCT00368550|7208258|FG001|Overall Study|Lack of Efficacy|9
4426077|NCT00368550|7208257|FG000|Overall Study|Withdrawal by Subject|17
4426078|NCT00368550|7208258|FG001|Overall Study|Withdrawal by Subject|10
4426079|NCT00368641|7208266|FG000|Overall Study|Adverse Event|2
4426080|NCT00368641|7208267|FG001|Overall Study|Adverse Event|1
4426081|NCT00368641|7208266|FG000|Overall Study|Death|1
4426082|NCT00368641|7208267|FG001|Overall Study|Death|0
4426083|NCT00368641|7208266|FG000|Overall Study|Withdrawal by Subject|1
4426084|NCT00368641|7208267|FG001|Overall Study|Withdrawal by Subject|0
4426085|NCT00368641|7208266|FG000|Overall Study|Sponsor decision to terminate study|2
4426086|NCT00368641|7208267|FG001|Overall Study|Sponsor decision to terminate study|5
4426087|NCT00368745|7208275|FG000|Double-blind Treatment Period|Adverse Event|6
4426088|NCT00368745|7208276|FG001|Double-blind Treatment Period|Adverse Event|6
4426089|NCT00368745|7208275|FG000|Double-blind Treatment Period|Lack of Efficacy|7
4426090|NCT00368745|7208276|FG001|Double-blind Treatment Period|Lack of Efficacy|16
4426091|NCT00368745|7208275|FG000|Double-blind Treatment Period|Lost to Follow-up|1
4426092|NCT00368745|7208276|FG001|Double-blind Treatment Period|Lost to Follow-up|0
4426093|NCT00368745|7208275|FG000|Double-blind Treatment Period|Withdrawal by Subject|5
4426094|NCT00368745|7208276|FG001|Double-blind Treatment Period|Withdrawal by Subject|3
4426095|NCT00368745|7208275|FG000|Double-blind Treatment Period|Other|7
4426096|NCT00368745|7208276|FG001|Double-blind Treatment Period|Other|6
4426097|NCT00368849|7208282|FG000|Overall Study|Withdrawal by Subject|0
4426098|NCT00368849|7208283|FG001|Overall Study|Withdrawal by Subject|1
4629841|NCT01877421|7498125|FG001|Phase 2|Withdrawal by Subject|0
4426099|NCT00368849|7208282|FG000|Overall Study|Physician Decision|0
4426100|NCT00368849|7208283|FG001|Overall Study|Physician Decision|1
4426101|NCT00368875|7208290|FG000|Overall Study|Adverse Event|0
4426102|NCT00368875|7208291|FG001|Overall Study|Adverse Event|12
4426103|NCT00368875|7208290|FG000|Overall Study|Progressive disease|3
4426104|NCT00368875|7208291|FG001|Overall Study|Progressive disease|27
4426105|NCT00368875|7208290|FG000|Overall Study|Withdrawal by Subject|2
4426106|NCT00368875|7208291|FG001|Overall Study|Withdrawal by Subject|6
4426107|NCT00368875|7208290|FG000|Overall Study|Other Reason|0
4426108|NCT00368875|7208291|FG001|Overall Study|Other Reason|2
4426109|NCT00368875|7208290|FG000|Overall Study|Alternative Therapy|1
4426110|NCT00368875|7208291|FG001|Overall Study|Alternative Therapy|1
4426111|NCT00368927|7208299|FG000|Overall Study|Lost to Follow-up|2
4426112|NCT00368927|7208300|FG001|Overall Study|Lost to Follow-up|0
4426113|NCT00368927|7208299|FG000|Overall Study|Adverse Event|1
4426114|NCT00368927|7208300|FG001|Overall Study|Adverse Event|1
4426115|NCT00368927|7208299|FG000|Overall Study|Withdrawal by Subject|1
4426116|NCT00368927|7208300|FG001|Overall Study|Withdrawal by Subject|2
4426117|NCT00368927|7208299|FG000|Overall Study|Physician Decision|1
4426118|NCT00368927|7208300|FG001|Overall Study|Physician Decision|0
4426119|NCT00368966|7208318|FG000|Infant Series|Withdrawal by Subject|11
4426120|NCT00368966|7208319|FG001|Infant Series|Withdrawal by Subject|6
4426121|NCT00368966|7208318|FG000|Infant Series|Protocol Violation|2
4426122|NCT00368966|7208319|FG001|Infant Series|Protocol Violation|1
4426123|NCT00368966|7208318|FG000|Infant Series|Lost to Follow-up|2
4426124|NCT00368966|7208319|FG001|Infant Series|Lost to Follow-up|0
4426125|NCT00368966|7208318|FG000|Infant Series|Randomization error|0
4426126|NCT00368966|7208319|FG001|Infant Series|Randomization error|1
4426127|NCT00368966|7208318|FG000|Infant Series|Failed to meet eligibility criteria|0
4426128|NCT00368966|7208319|FG001|Infant Series|Failed to meet eligibility criteria|1
4426129|NCT00368966|7208318|FG000|Infant Series|Adverse Event|0
4426130|NCT00368966|7208319|FG001|Infant Series|Adverse Event|1
4715017|NCT02966028|7643151|FG000|Overall Study|Physician Decision|1
4426131|NCT00368966|7208318|FG000|Infant Series|Failed to return|1
4426132|NCT00368966|7208319|FG001|Infant Series|Failed to return|0
4426133|NCT00368966|7208318|FG000|After Infant|Failed to return|3
4426134|NCT00368966|7208319|FG001|After Infant|Failed to return|1
4426135|NCT00368966|7208318|FG000|After Infant|Adverse Event|1
4426136|NCT00368966|7208319|FG001|After Infant|Adverse Event|2
4426137|NCT00368966|7208318|FG000|After Infant|Withdrawal by Subject|1
4426138|NCT00368966|7208319|FG001|After Infant|Withdrawal by Subject|1
4426139|NCT00368966|7208318|FG000|After Infant|Death|1
4426140|NCT00368966|7208319|FG001|After Infant|Death|0
4426141|NCT00368966|7208318|FG000|After Infant|Lost to Follow-up|0
4426142|NCT00368966|7208319|FG001|After Infant|Lost to Follow-up|1
4426143|NCT00368966|7208318|FG000|Toddler Dose|Withdrawal by Subject|1
4426144|NCT00368966|7208319|FG001|Toddler Dose|Withdrawal by Subject|1
4426145|NCT00368966|7208318|FG000|Toddler Dose|Lost to Follow-up|0
4426146|NCT00368966|7208319|FG001|Toddler Dose|Lost to Follow-up|2
4426147|NCT00368979|7208352|FG000|Overall Study|Adverse Event|9
4426148|NCT00368979|7208353|FG001|Overall Study|Adverse Event|16
4426149|NCT00368979|7208352|FG000|Overall Study|Lack of Efficacy|5
4426150|NCT00368979|7208353|FG001|Overall Study|Lack of Efficacy|3
4426151|NCT00368979|7208352|FG000|Overall Study|Other|3
4426152|NCT00368979|7208353|FG001|Overall Study|Other|1
4426153|NCT00368979|7208352|FG000|Overall Study|Lost to Follow-up|1
4426154|NCT00368979|7208353|FG001|Overall Study|Lost to Follow-up|0
4426155|NCT00368979|7208352|FG000|Overall Study|Protocol Violation|2
4426156|NCT00368979|7208353|FG001|Overall Study|Protocol Violation|1
4426157|NCT00368979|7208352|FG000|Overall Study|Withdrawal by Subject|5
4426158|NCT00368979|7208353|FG001|Overall Study|Withdrawal by Subject|9
4426159|NCT00368992|7208359|FG000|Overall Study|Ineligible|5
4426160|NCT00368992|7208359|FG000|Overall Study|Refused treatment|3
4426161|NCT00368992|7208359|FG000|Overall Study|Lack of Efficacy|63
4426162|NCT00368992|7208359|FG000|Overall Study|Adverse Event|26
4426163|NCT00368992|7208359|FG000|Overall Study|Death|4
4426164|NCT00368992|7208359|FG000|Overall Study|Other|9
4426165|NCT00369122|7208364|FG000|Overall Study|Ineligible|10
4426166|NCT00369122|7208364|FG000|Overall Study|No protocol treatment|1
4426167|NCT00369161|7208370|FG000|Overall Study|Adverse Event|15
4426168|NCT00369161|7208371|FG001|Overall Study|Adverse Event|13
4426169|NCT00369161|7208370|FG000|Overall Study|Abnormal laboratory value|0
4426170|NCT00369161|7208371|FG001|Overall Study|Abnormal laboratory value|1
4426171|NCT00369161|7208370|FG000|Overall Study|Lack of Efficacy|3
4426172|NCT00369161|7208371|FG001|Overall Study|Lack of Efficacy|1
4426173|NCT00369161|7208370|FG000|Overall Study|Protocol Violation|0
4426174|NCT00369161|7208371|FG001|Overall Study|Protocol Violation|2
4426175|NCT00369161|7208370|FG000|Overall Study|Withdrawal by Subject|2
4426176|NCT00369161|7208371|FG001|Overall Study|Withdrawal by Subject|3
4426177|NCT00369161|7208370|FG000|Overall Study|Death|1
4426178|NCT00369161|7208371|FG001|Overall Study|Death|2
4426179|NCT00369161|7208370|FG000|Overall Study|Graft loss|4
4426180|NCT00369161|7208371|FG001|Overall Study|Graft loss|0
4426181|NCT00369161|7208370|FG000|Overall Study|Administrative Problem|2
4426182|NCT00369161|7208371|FG001|Overall Study|Administrative Problem|2
4426183|NCT00369278|7208391|FG000|Overall Study|Adverse Event|14
4426184|NCT00369278|7208392|FG001|Overall Study|Adverse Event|11
4426185|NCT00369278|7208391|FG000|Overall Study|Unsatisfactory therapeutic effect|4
4426186|NCT00369278|7208392|FG001|Overall Study|Unsatisfactory therapeutic effect|5
4426187|NCT00369278|7208391|FG000|Overall Study|Protocol Violation|2
4426188|NCT00369278|7208392|FG001|Overall Study|Protocol Violation|1
4426189|NCT00369278|7208391|FG000|Overall Study|Withdrawal by Subject|2
4426190|NCT00369278|7208392|FG001|Overall Study|Withdrawal by Subject|2
4426191|NCT00369278|7208391|FG000|Overall Study|Lost to Follow-up|1
4426192|NCT00369278|7208392|FG001|Overall Study|Lost to Follow-up|0
4426193|NCT00369278|7208391|FG000|Overall Study|Graft loss|1
4426194|NCT00369278|7208392|FG001|Overall Study|Graft loss|2
4426195|NCT00369343|7208400|FG000|Double-blind Phase|Adverse Event|19
4426196|NCT00369343|7208401|FG001|Double-blind Phase|Adverse Event|4
4426197|NCT00369343|7208400|FG000|Double-blind Phase|Failed to return|2
4426198|NCT00369343|7208401|FG001|Double-blind Phase|Failed to return|0
4426199|NCT00369343|7208400|FG000|Double-blind Phase|Lost to Follow-up|9
4426200|NCT00369343|7208401|FG001|Double-blind Phase|Lost to Follow-up|2
4426201|NCT00369343|7208400|FG000|Double-blind Phase|Protocol Violation|2
4426202|NCT00369343|7208401|FG001|Double-blind Phase|Protocol Violation|0
4426203|NCT00369343|7208400|FG000|Double-blind Phase|Withdrawal by Subject|8
4426204|NCT00369343|7208401|FG001|Double-blind Phase|Withdrawal by Subject|6
4426205|NCT00369343|7208400|FG000|Double-blind Phase|Lack of Efficacy|0
4426206|NCT00369343|7208401|FG001|Double-blind Phase|Lack of Efficacy|4
4426207|NCT00369343|7208400|FG000|Double-blind Phase|Protocol deviation|4
4426208|NCT00369343|7208401|FG001|Double-blind Phase|Protocol deviation|0
4426209|NCT00369343|7208400|FG000|Open-label Phase|Adverse Event|19
4426210|NCT00369343|7208401|FG001|Open-label Phase|Adverse Event|7
4426211|NCT00369343|7208400|FG000|Open-label Phase|Failed to return|4
4426212|NCT00369343|7208401|FG001|Open-label Phase|Failed to return|0
4426213|NCT00369343|7208400|FG000|Open-label Phase|Physician Decision|2
4426214|NCT00369343|7208401|FG001|Open-label Phase|Physician Decision|0
4426215|NCT00369343|7208400|FG000|Open-label Phase|Lost to Follow-up|5
4426216|NCT00369343|7208401|FG001|Open-label Phase|Lost to Follow-up|3
4426217|NCT00369343|7208400|FG000|Open-label Phase|inadvertently reported study completers|3
4426218|NCT00369343|7208401|FG001|Open-label Phase|inadvertently reported study completers|2
4426219|NCT00369343|7208400|FG000|Open-label Phase|Protocol Violation|1
4426220|NCT00369343|7208401|FG001|Open-label Phase|Protocol Violation|3
4426221|NCT00369343|7208400|FG000|Open-label Phase|Withdrawal by Subject|15
4426222|NCT00369343|7208401|FG001|Open-label Phase|Withdrawal by Subject|6
4426223|NCT00369343|7208400|FG000|Open-label Phase|Lack of Efficacy|4
4426224|NCT00369343|7208401|FG001|Open-label Phase|Lack of Efficacy|3
4426225|NCT00369343|7208400|FG000|Open-label Phase|Lack of continuance tolerability|3
4426226|NCT00369343|7208401|FG001|Open-label Phase|Lack of continuance tolerability|4
4426227|NCT00369343|7208400|FG000|Open-label Phase|did not take study drug|1
4426228|NCT00369343|7208401|FG001|Open-label Phase|did not take study drug|2
4426229|NCT00369382|7208416|FG000|Overall Study|Death|0
4426230|NCT00369382|7208417|FG001|Overall Study|Death|2
4426231|NCT00369382|7208416|FG000|Overall Study|Physician Decision|2
4426232|NCT00369382|7208417|FG001|Overall Study|Physician Decision|1
4426233|NCT00369382|7208416|FG000|Overall Study|Withdrawal by Subject|5
4426234|NCT00369382|7208417|FG001|Overall Study|Withdrawal by Subject|0
4426235|NCT00369382|7208416|FG000|Overall Study|Randomized, not treated|2
4426236|NCT00369382|7208417|FG001|Overall Study|Randomized, not treated|0
4426237|NCT00369382|7208416|FG000|Overall Study|Other|1
4426238|NCT00369382|7208417|FG001|Overall Study|Other|0
4426239|NCT00369486|7208429|FG000|4-Week Visit|Missed visit|2
4426240|NCT00369486|7208430|FG001|4-Week Visit|Missed visit|2
4426241|NCT00369486|7208431|FG002|4-Week Visit|Missed visit|0
4426242|NCT00369486|7208432|FG003|4-Week Visit|Missed visit|2
4426243|NCT00369486|7208433|FG004|4-Week Visit|Missed visit|1
4426244|NCT00369486|7208429|FG000|4-Week Visit|Dropped|0
4426245|NCT00369486|7208430|FG001|4-Week Visit|Dropped|0
4426246|NCT00369486|7208431|FG002|4-Week Visit|Dropped|1
4426247|NCT00369486|7208432|FG003|4-Week Visit|Dropped|0
4426248|NCT00369486|7208433|FG004|4-Week Visit|Dropped|0
4426249|NCT00369486|7208429|FG000|8-Week Visit|Missed visit|0
4426250|NCT00369486|7208430|FG001|8-Week Visit|Missed visit|1
4426251|NCT00369486|7208431|FG002|8-Week Visit|Missed visit|0
4426252|NCT00369486|7208432|FG003|8-Week Visit|Missed visit|0
4426253|NCT00369486|7208433|FG004|8-Week Visit|Missed visit|1
4426254|NCT00369486|7208429|FG000|8-Week Visit|Dropped|0
4426255|NCT00369486|7208430|FG001|8-Week Visit|Dropped|0
4426256|NCT00369486|7208431|FG002|8-Week Visit|Dropped|0
4426257|NCT00369486|7208432|FG003|8-Week Visit|Dropped|1
4426258|NCT00369486|7208433|FG004|8-Week Visit|Dropped|0
4426259|NCT00369486|7208429|FG000|17-Week Visit|Missed visit|0
4426260|NCT00369486|7208430|FG001|17-Week Visit|Missed visit|0
4426261|NCT00369486|7208431|FG002|17-Week Visit|Missed visit|1
4426262|NCT00369486|7208432|FG003|17-Week Visit|Missed visit|1
4426263|NCT00369486|7208433|FG004|17-Week Visit|Missed visit|1
4426264|NCT00369486|7208429|FG000|34-Week Visit|Dropped|0
4426265|NCT00369486|7208430|FG001|34-Week Visit|Dropped|1
4426266|NCT00369486|7208431|FG002|34-Week Visit|Dropped|1
4426267|NCT00369486|7208432|FG003|34-Week Visit|Dropped|3
4426268|NCT00369486|7208433|FG004|34-Week Visit|Dropped|3
4426269|NCT00369577|7208465|FG000|Overall Study|Withdrawal by Subject|0
4426270|NCT00369577|7208466|FG001|Overall Study|Withdrawal by Subject|0
4426271|NCT00369577|7208467|FG002|Overall Study|Withdrawal by Subject|1
4426272|NCT00369629|7208483|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0
4426273|NCT00369629|7208484|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1
4426274|NCT00369629|7208485|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1
4426275|NCT00369629|7208486|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0
4426276|NCT00369629|7208483|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0
4426277|NCT00369629|7208484|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0
4426278|NCT00369629|7208485|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1
4426279|NCT00369629|7208486|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0
4426280|NCT00369629|7208483|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2
4426281|NCT00369629|7208484|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0
4426282|NCT00369629|7208485|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0
4426283|NCT00369629|7208486|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0
4426284|NCT00369629|7208483|FG000|Moved on to 4 More Cycles|Progressive Disease|0
4426285|NCT00369629|7208484|FG001|Moved on to 4 More Cycles|Progressive Disease|0
4426286|NCT00369629|7208485|FG002|Moved on to 4 More Cycles|Progressive Disease|1
4426287|NCT00369629|7208486|FG003|Moved on to 4 More Cycles|Progressive Disease|0
4426288|NCT00369629|7208483|FG000|Completed 4 More Cycles|Withdrawal by Subject|2
4426289|NCT00369629|7208484|FG001|Completed 4 More Cycles|Withdrawal by Subject|1
4426290|NCT00369629|7208485|FG002|Completed 4 More Cycles|Withdrawal by Subject|0
4426291|NCT00369629|7208486|FG003|Completed 4 More Cycles|Withdrawal by Subject|0
4426292|NCT00369629|7208483|FG000|Completed 4 More Cycles|Progressive disease|2
4426293|NCT00369629|7208484|FG001|Completed 4 More Cycles|Progressive disease|1
4426294|NCT00369629|7208485|FG002|Completed 4 More Cycles|Progressive disease|2
4426295|NCT00369629|7208486|FG003|Completed 4 More Cycles|Progressive disease|0
4426296|NCT00369629|7208483|FG000|Follow up for 1 Year|Death|2
4426297|NCT00369629|7208484|FG001|Follow up for 1 Year|Death|1
4426298|NCT00369629|7208485|FG002|Follow up for 1 Year|Death|1
4426299|NCT00369629|7208486|FG003|Follow up for 1 Year|Death|0
4426300|NCT00369629|7208483|FG000|Follow up for 1 Year|Lost to Follow-up|0
4426301|NCT00369629|7208484|FG001|Follow up for 1 Year|Lost to Follow-up|1
4426302|NCT00369629|7208485|FG002|Follow up for 1 Year|Lost to Follow-up|0
4426303|NCT00369629|7208486|FG003|Follow up for 1 Year|Lost to Follow-up|0
4426304|NCT00369629|7208483|FG000|Follow up for 1 Year|stopped being followed as study closed|0
4426305|NCT00369629|7208484|FG001|Follow up for 1 Year|stopped being followed as study closed|0
4426306|NCT00369629|7208485|FG002|Follow up for 1 Year|stopped being followed as study closed|2
4426307|NCT00369629|7208486|FG003|Follow up for 1 Year|stopped being followed as study closed|0
4426308|NCT00369655|7208496|FG000|Overall Study|Refusal of further treatment|2
4426309|NCT00369668|7208503|FG000|Overall Study|Lack of Efficacy|4
4426310|NCT00369668|7208504|FG001|Overall Study|Lack of Efficacy|5
4426311|NCT00369668|7208505|FG002|Overall Study|Lack of Efficacy|7
4426312|NCT00369681|7208516|FG000|Overall Study|Death|1
4426313|NCT00369707|7208520|FG000|Induction Part B (2 Cycles)|Adverse Event|3
4426314|NCT00369707|7208520|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2
4426315|NCT00369707|7208520|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1
4426316|NCT00369707|7208520|FG000|Induction Part B (2 Cycles)|Progressive disease|1
4426317|NCT00369707|7208520|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2
4426318|NCT00369707|7208520|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2
4426319|NCT00369707|7208520|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4
4426320|NCT00369707|7208520|FG000|Follow up for 2 Years After Treatment|Death|1
4426321|NCT00369707|7208520|FG000|Follow up for 2 Years After Treatment|Other|2
4426322|NCT00369785|7208535|FG000|Overall Study|Physician Decision|3
4426323|NCT00369785|7208536|FG001|Overall Study|Physician Decision|2
4426324|NCT00369785|7208535|FG000|Overall Study|Death|1
4426325|NCT00369785|7208536|FG001|Overall Study|Death|2
4426326|NCT00369785|7208535|FG000|Overall Study|Withdrawal by Subject|7
4426327|NCT00369785|7208536|FG001|Overall Study|Withdrawal by Subject|6
4426328|NCT00369785|7208535|FG000|Overall Study|Toxicity|6
4426329|NCT00369785|7208536|FG001|Overall Study|Toxicity|4
4426330|NCT00369785|7208535|FG000|Overall Study|Never started|0
4426331|NCT00369785|7208536|FG001|Overall Study|Never started|2
4426332|NCT00369785|7208535|FG000|Overall Study|Progression|4
4426333|NCT00369785|7208536|FG001|Overall Study|Progression|4
4426334|NCT00369785|7208535|FG000|Overall Study|Multiple reasons|6
4426335|NCT00369785|7208536|FG001|Overall Study|Multiple reasons|5
4426336|NCT00369824|7208548|FG000|Overall Study|Adverse Event|0
4426337|NCT00369824|7208549|FG001|Overall Study|Adverse Event|2
4426338|NCT00369824|7208550|FG002|Overall Study|Adverse Event|0
4426339|NCT00369824|7208551|FG003|Overall Study|Adverse Event|0
4426340|NCT00369824|7208552|FG004|Overall Study|Adverse Event|1
4426341|NCT00369824|7208553|FG005|Overall Study|Adverse Event|0
4426342|NCT00369824|7208548|FG000|Overall Study|Protocol Violation|0
4426343|NCT00369824|7208549|FG001|Overall Study|Protocol Violation|1
4426344|NCT00369824|7208550|FG002|Overall Study|Protocol Violation|0
4426345|NCT00369824|7208551|FG003|Overall Study|Protocol Violation|1
4426346|NCT00369824|7208552|FG004|Overall Study|Protocol Violation|1
4426347|NCT00369824|7208553|FG005|Overall Study|Protocol Violation|0
4426348|NCT00369824|7208548|FG000|Overall Study|Withdrawal by Subject|9
4426349|NCT00369824|7208549|FG001|Overall Study|Withdrawal by Subject|5
4426350|NCT00369824|7208550|FG002|Overall Study|Withdrawal by Subject|5
4426351|NCT00369824|7208551|FG003|Overall Study|Withdrawal by Subject|4
4426352|NCT00369824|7208552|FG004|Overall Study|Withdrawal by Subject|6
4426353|NCT00369824|7208553|FG005|Overall Study|Withdrawal by Subject|2
4426354|NCT00369824|7208548|FG000|Overall Study|Lost to Follow-up|6
4426355|NCT00369824|7208549|FG001|Overall Study|Lost to Follow-up|11
4426356|NCT00369824|7208550|FG002|Overall Study|Lost to Follow-up|7
4426357|NCT00369824|7208551|FG003|Overall Study|Lost to Follow-up|8
4426358|NCT00369824|7208552|FG004|Overall Study|Lost to Follow-up|9
4426359|NCT00369824|7208553|FG005|Overall Study|Lost to Follow-up|6
4426360|NCT00369824|7208548|FG000|Overall Study|Other|0
4426361|NCT00369824|7208549|FG001|Overall Study|Other|0
4426362|NCT00369824|7208550|FG002|Overall Study|Other|0
4426363|NCT00369824|7208551|FG003|Overall Study|Other|2
4426364|NCT00369824|7208552|FG004|Overall Study|Other|1
4426365|NCT00369824|7208553|FG005|Overall Study|Other|3
4426366|NCT00369915|7208569|FG000|Overall Study|expected side effects|2
4426367|NCT00369915|7208570|FG001|Overall Study|expected side effects|1
4426368|NCT00369915|7208569|FG000|Overall Study|Withdrawal by Subject|4
4426369|NCT00369915|7208570|FG001|Overall Study|Withdrawal by Subject|1
4426370|NCT00369915|7208569|FG000|Overall Study|W/drawl by investigators|0
4426371|NCT00369915|7208570|FG001|Overall Study|W/drawl by investigators|1
4426372|NCT00369941|7208591|FG000|Overall Study|Never Treated|1
4426373|NCT00369941|7208592|FG001|Overall Study|Never Treated|2
4426374|NCT00369941|7208591|FG000|Overall Study|Adverse Event|14
4426375|NCT00369941|7208592|FG001|Overall Study|Adverse Event|28
4426376|NCT00369941|7208591|FG000|Overall Study|Lack of Efficacy|6
4426377|NCT00369941|7208592|FG001|Overall Study|Lack of Efficacy|10
4426378|NCT00369941|7208591|FG000|Overall Study|Lost to Follow-up|12
4426379|NCT00369941|7208592|FG001|Overall Study|Lost to Follow-up|22
4426380|NCT00369941|7208591|FG000|Overall Study|Protocol Violation|5
4426381|NCT00369941|7208592|FG001|Overall Study|Protocol Violation|3
4426382|NCT00369941|7208591|FG000|Overall Study|Withdrawal by Subject|5
4426383|NCT00369941|7208592|FG001|Overall Study|Withdrawal by Subject|18
4426384|NCT00369941|7208591|FG000|Overall Study|Pregnancy|4
4426385|NCT00369941|7208592|FG001|Overall Study|Pregnancy|2
4426386|NCT00369941|7208591|FG000|Overall Study|Completed, Did Not Enter Extension|5
4426387|NCT00369941|7208592|FG001|Overall Study|Completed, Did Not Enter Extension|6
4426388|NCT00369941|7208591|FG000|Overall Study|Moved|11
4426389|NCT00369941|7208592|FG001|Overall Study|Moved|5
4426390|NCT00369941|7208591|FG000|Overall Study|Treatment with Prohibited Medication|3
4426391|NCT00369941|7208592|FG001|Overall Study|Treatment with Prohibited Medication|1
4426392|NCT00369941|7208591|FG000|Overall Study|Employment Interfered with Study Visits|1
4426393|NCT00369941|7208592|FG001|Overall Study|Employment Interfered with Study Visits|0
4426394|NCT00369941|7208591|FG000|Overall Study|Study Site Terminated|2
4426395|NCT00369941|7208592|FG001|Overall Study|Study Site Terminated|0
4629842|NCT01877421|7498126|FG002|Phase 2|Withdrawal by Subject|0
4629843|NCT01877421|7498127|FG003|Phase 2|Withdrawal by Subject|0
4629844|NCT01877421|7498128|FG004|Phase 2|Withdrawal by Subject|0
4715018|NCT02966028|7643152|FG001|Overall Study|Physician Decision|0
4426396|NCT00369941|7208591|FG000|Overall Study|Miscellaneous|3
4426397|NCT00369941|7208592|FG001|Overall Study|Miscellaneous|3
4426398|NCT00369967|7208601|FG000|Overall Study|Lost to Follow-up|23
4426399|NCT00369967|7208602|FG001|Overall Study|Lost to Follow-up|12
4426400|NCT00370032|7208614|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0
4426401|NCT00370032|7208615|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1
4426402|NCT00370032|7208614|FG000|Washout Period|Withdrawal by Subject|0
4426403|NCT00370032|7208615|FG001|Washout Period|Withdrawal by Subject|1
4426404|NCT00370032|7208614|FG000|Washout Period|Lost to Follow-up|0
4426405|NCT00370032|7208615|FG001|Washout Period|Lost to Follow-up|1
4426406|NCT00370032|7208614|FG000|Washout Period|Adverse Event|1
4426407|NCT00370032|7208615|FG001|Washout Period|Adverse Event|0
4426408|NCT00370032|7208614|FG000|Follow-up Period|Withdrawal by Subject|1
4426409|NCT00370032|7208615|FG001|Follow-up Period|Withdrawal by Subject|0
4426410|NCT00370071|7208630|FG000|Overall Study|Withdrawal by Subject|2
4426411|NCT00370149|7208636|FG000|Overall Study|Physician Decision|16
4426412|NCT00370149|7208637|FG001|Overall Study|Physician Decision|16
4426413|NCT00370149|7208636|FG000|Overall Study|Protocol Violation|1
4426414|NCT00370149|7208637|FG001|Overall Study|Protocol Violation|0
4426415|NCT00370149|7208636|FG000|Overall Study|Catheter inserted in wrong vessel-|2
4426416|NCT00370149|7208637|FG001|Overall Study|Catheter inserted in wrong vessel-|1
4426417|NCT00370149|7208636|FG000|Overall Study|Pre-existing infection|0
4426418|NCT00370149|7208637|FG001|Overall Study|Pre-existing infection|1
4426419|NCT00370149|7208636|FG000|Overall Study|Antibiotic coated dressing placed|0
4426420|NCT00370149|7208637|FG001|Overall Study|Antibiotic coated dressing placed|1
4426421|NCT00370292|7208648|FG000|Overall Study|Disease Progression|4
4426422|NCT00370292|7208648|FG000|Overall Study|Adverse Event|7
4426423|NCT00370292|7208648|FG000|Overall Study|Physician Decision|2
4512356|NCT00933543|7322099|FG001|Overall Study|Adverse Event|1
4512357|NCT00933543|7322098|FG000|Overall Study|Lost to Follow-up|0
4512358|NCT00933543|7322099|FG001|Overall Study|Lost to Follow-up|1
4512359|NCT00933543|7322098|FG000|Overall Study|Withdrawal by Subject|0
4512360|NCT00933543|7322099|FG001|Overall Study|Withdrawal by Subject|1
4512361|NCT00933543|7322098|FG000|Overall Study|Lack of Efficacy|0
4512362|NCT00933543|7322099|FG001|Overall Study|Lack of Efficacy|3
4512363|NCT00933543|7322098|FG000|Overall Study|Other|1
4512364|NCT00933543|7322099|FG001|Overall Study|Other|1
4512365|NCT00933608|7322107|FG000|Overall Study|Adverse Event|4
4512366|NCT00933608|7322108|FG001|Overall Study|Adverse Event|2
4512367|NCT00933608|7322107|FG000|Overall Study|Physician Decision|1
4512368|NCT00933608|7322108|FG001|Overall Study|Physician Decision|0
4512369|NCT00933686|7322116|FG000|Overall Study|Protocol Violation|0
4512370|NCT00933686|7322117|FG001|Overall Study|Protocol Violation|1
4512371|NCT00933686|7322116|FG000|Overall Study|Lost to Follow-up|2
4512372|NCT00933686|7322117|FG001|Overall Study|Lost to Follow-up|2
4512373|NCT00933686|7322116|FG000|Overall Study|Withdrawal by Subject|6
4512374|NCT00933686|7322117|FG001|Overall Study|Withdrawal by Subject|5
4512375|NCT00933686|7322116|FG000|Overall Study|Adverse Event|1
4512376|NCT00933686|7322117|FG001|Overall Study|Adverse Event|1
4512377|NCT00933686|7322116|FG000|Overall Study|Physician Decision|1
4512378|NCT00933686|7322117|FG001|Overall Study|Physician Decision|0
4512379|NCT00933686|7322116|FG000|Overall Study|Failure to show up at endpoint visits|0
4512380|NCT00933686|7322117|FG001|Overall Study|Failure to show up at endpoint visits|2
4512381|NCT00933933|7322128|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0
4512382|NCT00933933|7322129|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20
4512383|NCT00933933|7322130|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0
4512384|NCT00933933|7322128|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0
4512385|NCT00933933|7322129|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2
4512386|NCT00933933|7322130|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0
4512387|NCT00934050|7322160|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1
4512388|NCT00934050|7322161|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0
4512389|NCT00934050|7322162|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0
4512390|NCT00934050|7322163|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1
4512391|NCT00934050|7322164|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0
4512392|NCT00934050|7322165|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0
4512393|NCT00934050|7322160|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11
4512394|NCT00934050|7322161|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12
4512395|NCT00934050|7322162|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11
4512396|NCT00934050|7322163|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13
4512397|NCT00934050|7322164|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0
4512398|NCT00934050|7322165|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0
4629845|NCT01877421|7498129|FG005|Phase 2|Withdrawal by Subject|0
4426424|NCT04876274|7208661|FG000|Overall Study|Lost to Follow-up|9
4426425|NCT04876274|7208662|FG001|Overall Study|Lost to Follow-up|12
4426426|NCT04656691|7208668|FG000|Overall Study|Adverse Event|1
4426427|NCT04555096|7208683|FG000|Overall Study|Death|4
4426428|NCT04555096|7208684|FG001|Overall Study|Death|4
4426429|NCT04555096|7208683|FG000|Overall Study|Withdrawal by Subject|1
4426430|NCT04555096|7208684|FG001|Overall Study|Withdrawal by Subject|0
4426431|NCT04555096|7208683|FG000|Overall Study|Other|0
4426432|NCT04555096|7208684|FG001|Overall Study|Other|1
4426433|NCT04150341|7208690|FG000|Overall Study|Physician Decision|0
4426434|NCT04150341|7208691|FG001|Overall Study|Physician Decision|0
4426435|NCT04150341|7208692|FG002|Overall Study|Physician Decision|1
4426436|NCT04150341|7208693|FG003|Overall Study|Physician Decision|0
4426437|NCT04150341|7208694|FG004|Overall Study|Physician Decision|0
4426438|NCT04150341|7208695|FG005|Overall Study|Physician Decision|0
4426439|NCT04150341|7208690|FG000|Overall Study|Adverse Event|0
4426440|NCT04150341|7208691|FG001|Overall Study|Adverse Event|0
4426441|NCT04150341|7208692|FG002|Overall Study|Adverse Event|0
4426442|NCT04150341|7208693|FG003|Overall Study|Adverse Event|0
4426443|NCT04150341|7208694|FG004|Overall Study|Adverse Event|1
4426444|NCT04150341|7208695|FG005|Overall Study|Adverse Event|0
4426445|NCT04115839|7208708|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14
4426446|NCT04115839|7208709|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13
4426447|NCT04115839|7208710|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14
4426448|NCT04115839|7208711|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0
4426449|NCT04115839|7208712|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0
4426450|NCT04115839|7208713|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0
4426451|NCT04115839|7208714|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0
4426452|NCT04115839|7208708|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2
4426453|NCT04115839|7208709|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1
4426454|NCT04115839|7208710|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3
4426455|NCT04115839|7208711|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0
4426456|NCT04115839|7208712|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0
4426457|NCT04115839|7208713|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0
4426458|NCT04115839|7208714|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0
4426459|NCT04115839|7208708|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2
4426460|NCT04115839|7208709|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0
4426461|NCT04115839|7208710|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0
4426462|NCT04115839|7208711|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0
4426463|NCT04115839|7208712|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0
4426464|NCT04115839|7208713|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0
4426465|NCT04115839|7208714|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0
4426466|NCT04115839|7208708|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0
4426467|NCT04115839|7208709|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0
4426468|NCT04115839|7208710|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1
4426469|NCT04115839|7208711|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0
4426470|NCT04115839|7208712|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0
4426471|NCT04115839|7208713|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0
4426472|NCT04115839|7208714|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0
4426473|NCT04115839|7208708|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0
4426474|NCT04115839|7208709|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0
4426475|NCT04115839|7208710|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0
4426476|NCT04115839|7208711|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17
4426477|NCT04115839|7208712|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19
4426478|NCT04115839|7208713|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10
4426479|NCT04115839|7208714|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8
4426480|NCT04115839|7208708|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0
4426481|NCT04115839|7208709|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0
4426482|NCT04115839|7208710|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0
4426483|NCT04115839|7208711|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1
4426484|NCT04115839|7208712|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1
4426485|NCT04115839|7208713|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0
4426486|NCT04115839|7208714|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0
4426487|NCT04078126|7208739|FG000|Washout|Study put on hold due to COVID-19|0
4426488|NCT04078126|7208740|FG001|Washout|Study put on hold due to COVID-19|2
4426489|NCT04078126|7208739|FG000|Period 2|Study put on hold due to COVID-19|1
4426490|NCT04078126|7208740|FG001|Period 2|Study put on hold due to COVID-19|1
4426491|NCT03825341|7208748|FG000|Overall Study|Withdrawal by Subject|0
4426492|NCT03825341|7208749|FG001|Overall Study|Withdrawal by Subject|1
4426493|NCT03751631|7208757|FG000|Overall Study|Withdrawal by Subject|0
4426494|NCT03751631|7208758|FG001|Overall Study|Withdrawal by Subject|0
4426495|NCT03751631|7208759|FG002|Overall Study|Withdrawal by Subject|1
4426496|NCT03751631|7208760|FG003|Overall Study|Withdrawal by Subject|1
4426497|NCT03751631|7208761|FG004|Overall Study|Withdrawal by Subject|0
4426498|NCT03751631|7208762|FG005|Overall Study|Withdrawal by Subject|0
4426499|NCT03751098|7208773|FG000|Overall Study|Withdrawal by Subject|0
4426500|NCT03751098|7208774|FG001|Overall Study|Withdrawal by Subject|1
4426501|NCT03673345|7208790|FG000|Overall Study|Lost to Follow-up|1
4426502|NCT03673345|7208791|FG001|Overall Study|Lost to Follow-up|0
4426503|NCT03673345|7208792|FG002|Overall Study|Lost to Follow-up|3
4426504|NCT03673345|7208793|FG003|Overall Study|Lost to Follow-up|3
4426505|NCT03673345|7208794|FG004|Overall Study|Lost to Follow-up|2
4426506|NCT03673345|7208795|FG005|Overall Study|Lost to Follow-up|1
4426507|NCT03673345|7208796|FG006|Overall Study|Lost to Follow-up|0
4426508|NCT03673345|7208797|FG007|Overall Study|Lost to Follow-up|0
4426509|NCT03673345|7208790|FG000|Overall Study|Withdrawal by Subject|1
4426510|NCT03673345|7208791|FG001|Overall Study|Withdrawal by Subject|0
4426511|NCT03673345|7208792|FG002|Overall Study|Withdrawal by Subject|4
4426512|NCT03673345|7208793|FG003|Overall Study|Withdrawal by Subject|2
4426513|NCT03673345|7208794|FG004|Overall Study|Withdrawal by Subject|0
4426514|NCT03673345|7208795|FG005|Overall Study|Withdrawal by Subject|0
4426515|NCT03673345|7208796|FG006|Overall Study|Withdrawal by Subject|0
4426516|NCT03673345|7208797|FG007|Overall Study|Withdrawal by Subject|0
4426517|NCT03673345|7208790|FG000|Overall Study|Physician Decision|0
4426518|NCT03673345|7208791|FG001|Overall Study|Physician Decision|0
4426519|NCT03673345|7208792|FG002|Overall Study|Physician Decision|2
4426520|NCT03673345|7208793|FG003|Overall Study|Physician Decision|0
4426521|NCT03673345|7208794|FG004|Overall Study|Physician Decision|0
4426522|NCT03673345|7208795|FG005|Overall Study|Physician Decision|0
4426523|NCT03673345|7208796|FG006|Overall Study|Physician Decision|0
4426524|NCT03673345|7208797|FG007|Overall Study|Physician Decision|0
4426525|NCT03418675|7208817|FG000|Overall Study|Lost to Follow-up|13
4426526|NCT03418675|7208818|FG001|Overall Study|Lost to Follow-up|10
4426527|NCT03418675|7208817|FG000|Overall Study|Adverse Event|2
4426528|NCT03418675|7208818|FG001|Overall Study|Adverse Event|0
4426529|NCT03329690|7208833|FG000|Overall Study|Progressive disease per RECIST|85
4426530|NCT03329690|7208834|FG001|Overall Study|Progressive disease per RECIST|44
4426531|NCT03329690|7208835|FG002|Overall Study|Progressive disease per RECIST|6
4426532|NCT03329690|7208836|FG003|Overall Study|Progressive disease per RECIST|16
4426533|NCT03329690|7208837|FG004|Overall Study|Progressive disease per RECIST|20
4426534|NCT03329690|7208833|FG000|Overall Study|Clinical progression|7
4426535|NCT03329690|7208834|FG001|Overall Study|Clinical progression|4
4426536|NCT03329690|7208835|FG002|Overall Study|Clinical progression|1
4426537|NCT03329690|7208836|FG003|Overall Study|Clinical progression|1
4426538|NCT03329690|7208837|FG004|Overall Study|Clinical progression|1
4426539|NCT03329690|7208833|FG000|Overall Study|Adverse Event|22
4426540|NCT03329690|7208834|FG001|Overall Study|Adverse Event|4
4426541|NCT03329690|7208835|FG002|Overall Study|Adverse Event|0
4426542|NCT03329690|7208836|FG003|Overall Study|Adverse Event|1
4426543|NCT03329690|7208837|FG004|Overall Study|Adverse Event|2
4426544|NCT03329690|7208833|FG000|Overall Study|Death|2
4426545|NCT03329690|7208834|FG001|Overall Study|Death|0
4426546|NCT03329690|7208835|FG002|Overall Study|Death|0
4426547|NCT03329690|7208836|FG003|Overall Study|Death|1
4426548|NCT03329690|7208837|FG004|Overall Study|Death|0
4426549|NCT03329690|7208833|FG000|Overall Study|Withdrawal by Subject|2
4426550|NCT03329690|7208834|FG001|Overall Study|Withdrawal by Subject|3
4426551|NCT03329690|7208835|FG002|Overall Study|Withdrawal by Subject|0
4426552|NCT03329690|7208836|FG003|Overall Study|Withdrawal by Subject|1
4426553|NCT03329690|7208837|FG004|Overall Study|Withdrawal by Subject|0
4426554|NCT03329690|7208833|FG000|Overall Study|Physician Decision|1
4426555|NCT03329690|7208834|FG001|Overall Study|Physician Decision|0
4426556|NCT03329690|7208835|FG002|Overall Study|Physician Decision|0
4426557|NCT03329690|7208836|FG003|Overall Study|Physician Decision|0
4426558|NCT03329690|7208837|FG004|Overall Study|Physician Decision|1
4426559|NCT03329690|7208833|FG000|Overall Study|Miscellaneous|6
4426560|NCT03329690|7208834|FG001|Overall Study|Miscellaneous|0
4426561|NCT03329690|7208835|FG002|Overall Study|Miscellaneous|0
4426562|NCT03329690|7208836|FG003|Overall Study|Miscellaneous|0
4426563|NCT03329690|7208837|FG004|Overall Study|Miscellaneous|0
4426564|NCT03329690|7208833|FG000|Overall Study|Did not receive treatment|1
4426565|NCT03329690|7208834|FG001|Overall Study|Did not receive treatment|0
4426566|NCT03329690|7208835|FG002|Overall Study|Did not receive treatment|0
4426567|NCT03329690|7208836|FG003|Overall Study|Did not receive treatment|1
4426568|NCT03329690|7208837|FG004|Overall Study|Did not receive treatment|0
4426569|NCT03320564|7208855|FG000|Overall Study|Protocol Violation|1
4426570|NCT03302234|7208861|FG000|Overall Study|Death|137
4426571|NCT03302234|7208862|FG001|Overall Study|Death|135
4426572|NCT03302234|7208861|FG000|Overall Study|Withdrawal by Subject|1
4426573|NCT03302234|7208862|FG001|Overall Study|Withdrawal by Subject|1
4426574|NCT03302234|7208861|FG000|Overall Study|Laryngeal carcinoma|0
4426575|NCT03302234|7208862|FG001|Overall Study|Laryngeal carcinoma|1
4512399|NCT00934050|7322160|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
4512400|NCT00934050|7322161|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
4512401|NCT00934050|7322162|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1
4512402|NCT00934050|7322163|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
4512403|NCT00934050|7322164|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
4512404|NCT00934050|7322165|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
4512405|NCT00934050|7322160|FG000|Enrolled After 15 Dec 2009|Adverse Event|0
4512406|NCT00934050|7322161|FG001|Enrolled After 15 Dec 2009|Adverse Event|0
4512407|NCT00934050|7322162|FG002|Enrolled After 15 Dec 2009|Adverse Event|0
4426576|NCT03165955|7208883|FG000|Treatment|Withdrawal by Subject|3
4426577|NCT03165955|7208883|FG000|Treatment|Death|1
4426578|NCT03165955|7208883|FG000|Treatment|Adverse Event|1
4426579|NCT03165955|7208883|FG000|Treatment|Progressive disease|3
4426580|NCT03133793|7208891|FG000|Overall Study|Withdrawal by Subject|0
4426581|NCT03133793|7208892|FG001|Overall Study|Withdrawal by Subject|4
4426582|NCT03133793|7208893|FG002|Overall Study|Withdrawal by Subject|2
4426583|NCT03133793|7208894|FG003|Overall Study|Withdrawal by Subject|4
4426584|NCT03133793|7208891|FG000|Overall Study|Lost to Follow-up|1
4426585|NCT03133793|7208892|FG001|Overall Study|Lost to Follow-up|0
4426586|NCT03133793|7208893|FG002|Overall Study|Lost to Follow-up|2
4426587|NCT03133793|7208894|FG003|Overall Study|Lost to Follow-up|0
4426588|NCT03133793|7208891|FG000|Overall Study|Death|0
4426589|NCT03133793|7208892|FG001|Overall Study|Death|0
4426590|NCT03133793|7208893|FG002|Overall Study|Death|0
4426591|NCT03133793|7208894|FG003|Overall Study|Death|1
4426592|NCT03103542|7208908|FG000|Overall Study|Physician Decision|2
4426593|NCT03103542|7208908|FG000|Overall Study|Adverse Event|2
4426594|NCT03103542|7208908|FG000|Overall Study|Other|2
4426595|NCT03103542|7208908|FG000|Overall Study|Withdrawal by Subject|1
4426596|NCT03063203|7208922|FG000|Overall Study|Chose alternative therapy|3
4426597|NCT03063203|7208922|FG000|Overall Study|Death|2
4426598|NCT03063203|7208922|FG000|Overall Study|Disease progression|4
4426599|NCT03063203|7208922|FG000|Overall Study|Physician Decision|5
4426600|NCT02676765|7208935|FG000|Overall Study|Lost to Follow-up|0
4426601|NCT02676765|7208936|FG001|Overall Study|Lost to Follow-up|1
4771715|NCT00369317|7748569|FG000|Overall Study|Adverse Event|3
4771716|NCT00369317|7748569|FG000|Overall Study|Death|1
4771717|NCT00369317|7748569|FG000|Overall Study|Lack of Efficacy|5
4771718|NCT00369317|7748569|FG000|Overall Study|Physician Decision|2
4426606|NCT02362451|7208966|FG000|Overall Study|Withdrawal by Subject|0
4426607|NCT02362451|7208967|FG001|Overall Study|Withdrawal by Subject|1
4426608|NCT02362451|7208966|FG000|Overall Study|Lack of Efficacy|2
4426609|NCT02362451|7208967|FG001|Overall Study|Lack of Efficacy|0
4426610|NCT02362451|7208966|FG000|Overall Study|Progression|1
4426611|NCT02362451|7208967|FG001|Overall Study|Progression|0
4426612|NCT02362451|7208966|FG000|Overall Study|Participant chose other therapy.|1
4426613|NCT02362451|7208967|FG001|Overall Study|Participant chose other therapy.|0
4426614|NCT02282020|7208975|FG000|Overall Study|Objective Disease Progression|111
4426615|NCT02282020|7208976|FG001|Overall Study|Objective Disease Progression|30
4426616|NCT02282020|7208975|FG000|Overall Study|Adverse Event|13
4426617|NCT02282020|7208976|FG001|Overall Study|Adverse Event|15
4426618|NCT02282020|7208975|FG000|Overall Study|Withdrawal by Subject|5
4426619|NCT02282020|7208976|FG001|Overall Study|Withdrawal by Subject|10
4426620|NCT02282020|7208975|FG000|Overall Study|Miscellaneous|4
4426621|NCT02282020|7208976|FG001|Overall Study|Miscellaneous|17
4426622|NCT02282020|7208975|FG000|Overall Study|Severe Non-compliance to Protocol|1
4426623|NCT02282020|7208976|FG001|Overall Study|Severe Non-compliance to Protocol|0
4426624|NCT02282020|7208975|FG000|Overall Study|Developed Discontinuation Criteria|1
4426625|NCT02282020|7208976|FG001|Overall Study|Developed Discontinuation Criteria|3
4426626|NCT02282020|7208975|FG000|Overall Study|Withdrew Consent Prior to Dosing|0
4426627|NCT02282020|7208976|FG001|Overall Study|Withdrew Consent Prior to Dosing|12
4426628|NCT02180724|7209001|FG000|Overall Study|Death|12
4426629|NCT02180724|7209002|FG001|Overall Study|Death|1
4426630|NCT02180724|7209001|FG000|Overall Study|Lost to Follow-up|1
4426631|NCT02180724|7209002|FG001|Overall Study|Lost to Follow-up|0
4426632|NCT02180724|7209001|FG000|Overall Study|Withdrawal by Subject|1
4426633|NCT02180724|7209002|FG001|Overall Study|Withdrawal by Subject|2
4426634|NCT02180724|7209001|FG000|Overall Study|Ongoing Study|78
4426635|NCT02180724|7209002|FG001|Overall Study|Ongoing Study|11
4426636|NCT02038777|7209016|FG000|Overall Study|Death|0
4426637|NCT02038777|7209017|FG001|Overall Study|Death|2
4426638|NCT02038777|7209018|FG002|Overall Study|Death|0
4426639|NCT02038777|7209019|FG003|Overall Study|Death|1
4426640|NCT02038777|7209020|FG004|Overall Study|Death|2
4426641|NCT02038777|7209021|FG005|Overall Study|Death|4
4426642|NCT02038777|7209022|FG006|Overall Study|Death|0
4426643|NCT02038777|7209023|FG007|Overall Study|Death|10
4426644|NCT02038777|7209016|FG000|Overall Study|Lost to Follow-up|0
4426645|NCT02038777|7209017|FG001|Overall Study|Lost to Follow-up|0
4426646|NCT02038777|7209018|FG002|Overall Study|Lost to Follow-up|0
4426647|NCT02038777|7209019|FG003|Overall Study|Lost to Follow-up|1
4426648|NCT02038777|7209020|FG004|Overall Study|Lost to Follow-up|0
4426649|NCT02038777|7209021|FG005|Overall Study|Lost to Follow-up|0
4426650|NCT02038777|7209022|FG006|Overall Study|Lost to Follow-up|0
4426651|NCT02038777|7209023|FG007|Overall Study|Lost to Follow-up|0
4426652|NCT02038777|7209016|FG000|Overall Study|Other|0
4426653|NCT02038777|7209017|FG001|Overall Study|Other|1
4426654|NCT02038777|7209018|FG002|Overall Study|Other|0
4426655|NCT02038777|7209019|FG003|Overall Study|Other|2
4426656|NCT02038777|7209020|FG004|Overall Study|Other|1
4426657|NCT02038777|7209021|FG005|Overall Study|Other|0
4426658|NCT02038777|7209022|FG006|Overall Study|Other|0
4426659|NCT02038777|7209023|FG007|Overall Study|Other|0
4426660|NCT02038777|7209016|FG000|Overall Study|Randomized but not treated|0
4426661|NCT02038777|7209017|FG001|Overall Study|Randomized but not treated|1
4426662|NCT02038777|7209018|FG002|Overall Study|Randomized but not treated|0
4771719|NCT00369317|7748569|FG000|Overall Study|Withdrawal by Subject|8
4715019|NCT02966028|7643153|FG002|Overall Study|Physician Decision|2
4715020|NCT02966028|7643151|FG000|Overall Study|Withdrawal by Subject|7
4426663|NCT02038777|7209019|FG003|Overall Study|Randomized but not treated|0
4715021|NCT02966028|7643152|FG001|Overall Study|Withdrawal by Subject|5
4715022|NCT02966028|7643153|FG002|Overall Study|Withdrawal by Subject|5
4715023|NCT02966028|7643151|FG000|Overall Study|Kidney transplant Changed dialysis units|9
4715024|NCT02966028|7643152|FG001|Overall Study|Kidney transplant Changed dialysis units|16
4715025|NCT02966028|7643153|FG002|Overall Study|Kidney transplant Changed dialysis units|14
4715026|NCT02966314|7643174|FG000|Overall Study|Lost to Follow-up|1
4715027|NCT02966314|7643175|FG001|Overall Study|Lost to Follow-up|0
4715028|NCT02966340|7643181|FG000|Overall Study|Adverse Event|0
4715029|NCT02966340|7643182|FG001|Overall Study|Adverse Event|1
4715030|NCT02966340|7643181|FG000|Overall Study|Lost to Follow-up|0
4715031|NCT02966340|7643182|FG001|Overall Study|Lost to Follow-up|1
4715032|NCT02966340|7643181|FG000|Overall Study|Withdrawal by Subject|1
4715033|NCT02966340|7643182|FG001|Overall Study|Withdrawal by Subject|0
4715034|NCT02966340|7643181|FG000|Overall Study|data acquisition error|1
4715035|NCT02966340|7643182|FG001|Overall Study|data acquisition error|0
4715036|NCT02966340|7643181|FG000|Overall Study|startle non-responder|1
4426664|NCT02038777|7209020|FG004|Overall Study|Randomized but not treated|0
4426665|NCT02038777|7209021|FG005|Overall Study|Randomized but not treated|0
4426666|NCT02038777|7209022|FG006|Overall Study|Randomized but not treated|0
4426667|NCT02038777|7209023|FG007|Overall Study|Randomized but not treated|0
4426668|NCT02038777|7209016|FG000|Overall Study|Started Chemotherapy|1
4426669|NCT02038777|7209017|FG001|Overall Study|Started Chemotherapy|0
4426670|NCT02038777|7209018|FG002|Overall Study|Started Chemotherapy|3
4426671|NCT02038777|7209019|FG003|Overall Study|Started Chemotherapy|0
4426672|NCT02038777|7209020|FG004|Overall Study|Started Chemotherapy|0
4426673|NCT02038777|7209021|FG005|Overall Study|Started Chemotherapy|0
4426674|NCT02038777|7209022|FG006|Overall Study|Started Chemotherapy|0
4426675|NCT02038777|7209023|FG007|Overall Study|Started Chemotherapy|0
4426676|NCT01927419|7209053|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0
4426677|NCT01927419|7209054|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1
4426678|NCT01927419|7209053|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1
4426679|NCT01927419|7209054|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0
4426680|NCT01927419|7209053|FG000|Treatment Period|Disease progression|17
4426681|NCT01927419|7209054|FG001|Treatment Period|Disease progression|20
4426682|NCT01927419|7209053|FG000|Treatment Period|Study drug toxicity|48
4426683|NCT01927419|7209054|FG001|Treatment Period|Study drug toxicity|10
4426684|NCT01927419|7209053|FG000|Treatment Period|Death|0
4426685|NCT01927419|7209054|FG001|Treatment Period|Death|1
4426686|NCT01927419|7209053|FG000|Treatment Period|Adverse event unrelated to study drug|6
4426687|NCT01927419|7209054|FG001|Treatment Period|Adverse event unrelated to study drug|3
4426688|NCT01927419|7209053|FG000|Treatment Period|Participant request to discontinue|12
4426689|NCT01927419|7209054|FG001|Treatment Period|Participant request to discontinue|4
4426690|NCT01927419|7209053|FG000|Treatment Period|Withdrawal by Subject|1
4426691|NCT01927419|7209054|FG001|Treatment Period|Withdrawal by Subject|1
4426692|NCT01927419|7209053|FG000|Treatment Period|Maximum Clinical Benefit|6
4426693|NCT01927419|7209054|FG001|Treatment Period|Maximum Clinical Benefit|2
4426694|NCT01927419|7209053|FG000|Treatment Period|Other reasons|3
4426695|NCT01927419|7209054|FG001|Treatment Period|Other reasons|4
4426696|NCT01927419|7209053|FG000|Treatment Period|Not Reported|1
4426697|NCT01927419|7209054|FG001|Treatment Period|Not Reported|1
4426698|NCT01924533|7209062|FG000|Overall Study|Death|181
4426699|NCT01924533|7209063|FG001|Overall Study|Death|200
4426700|NCT01924533|7209062|FG000|Overall Study|Lost to Follow-up|0
4426701|NCT01924533|7209063|FG001|Overall Study|Lost to Follow-up|1
4426702|NCT01924533|7209062|FG000|Overall Study|Withdrawal by Subject|7
4426703|NCT01924533|7209063|FG001|Overall Study|Withdrawal by Subject|3
4426704|NCT01924533|7209062|FG000|Overall Study|Other Eligibility criteria|1
4426705|NCT01924533|7209063|FG001|Overall Study|Other Eligibility criteria|1
4426706|NCT01711879|7209089|FG000|Overall Study|Death|1
4426707|NCT01711879|7209090|FG001|Overall Study|Death|0
4426708|NCT01697267|7209100|FG000|Overall Study|Death|3
4426709|NCT01697267|7209101|FG001|Overall Study|Death|1
4426710|NCT01697267|7209100|FG000|Overall Study|Withdrawal by Subject|5
4426711|NCT01697267|7209101|FG001|Overall Study|Withdrawal by Subject|5
4426712|NCT01697267|7209100|FG000|Overall Study|Adverse Event|2
4426713|NCT01697267|7209101|FG001|Overall Study|Adverse Event|1
4426714|NCT01697267|7209100|FG000|Overall Study|Lost to Follow-up|2
4426715|NCT01697267|7209101|FG001|Overall Study|Lost to Follow-up|4
4426716|NCT01697267|7209100|FG000|Overall Study|Physician Decision|2
4426717|NCT01697267|7209101|FG001|Overall Study|Physician Decision|4
4426718|NCT01527149|7209107|FG000|Overall Study|Death|2
4512408|NCT00934050|7322163|FG003|Enrolled After 15 Dec 2009|Adverse Event|0
4512409|NCT00934050|7322164|FG004|Enrolled After 15 Dec 2009|Adverse Event|3
4512410|NCT00934050|7322165|FG005|Enrolled After 15 Dec 2009|Adverse Event|0
4512411|NCT00934050|7322160|FG000|Enrolled After 15 Dec 2009|Death|0
4715037|NCT02966340|7643182|FG001|Overall Study|startle non-responder|1
4715038|NCT02966353|7643188|FG000|Overall Study|Withdrawal by Subject|7
4715039|NCT02966353|7643188|FG000|Overall Study|Adverse Event|4
4715040|NCT02966353|7643188|FG000|Overall Study|Death|4
4426719|NCT00554840|7209137|FG000|Overall Study|Physician Decision|0
4426720|NCT00554840|7209138|FG001|Overall Study|Physician Decision|1
4426721|NCT00003656|7209148|FG000|Overall Study|Adverse Event|0
4426722|NCT00003656|7209149|FG001|Overall Study|Adverse Event|1
4426723|NCT00370331|7209158|FG000|Overall Study|Adverse Event|4
4426724|NCT00370331|7209159|FG001|Overall Study|Adverse Event|13
4426725|NCT00370331|7209158|FG000|Overall Study|Withdrawal by Subject|2
4426726|NCT00370331|7209159|FG001|Overall Study|Withdrawal by Subject|4
4426727|NCT00370331|7209158|FG000|Overall Study|Lost to Follow-up|0
4426728|NCT00370331|7209159|FG001|Overall Study|Lost to Follow-up|3
4426729|NCT00370331|7209158|FG000|Overall Study|Lack of Efficacy|0
4426730|NCT00370331|7209159|FG001|Overall Study|Lack of Efficacy|1
4426731|NCT00370331|7209158|FG000|Overall Study|Non-compliance|0
4426732|NCT00370331|7209159|FG001|Overall Study|Non-compliance|1
4426733|NCT00370331|7209158|FG000|Overall Study|Protocol Violation|1
4426734|NCT00370331|7209159|FG001|Overall Study|Protocol Violation|1
4426735|NCT00370396|7209168|FG000|Overall Study|Withdrawal by Subject|0
4426736|NCT00370396|7209169|FG001|Overall Study|Withdrawal by Subject|0
4426737|NCT00370396|7209170|FG002|Overall Study|Withdrawal by Subject|1
4426738|NCT00370396|7209168|FG000|Overall Study|Lost to Follow-up|11
4426739|NCT00370396|7209169|FG001|Overall Study|Lost to Follow-up|1
4426740|NCT00370396|7209170|FG002|Overall Study|Lost to Follow-up|0
4426741|NCT00370552|7209181|FG000|Overall Study|Adverse Event|2
4426742|NCT00370552|7209182|FG001|Overall Study|Adverse Event|2
4426743|NCT00370552|7209183|FG002|Overall Study|Adverse Event|2
4426744|NCT00370552|7209181|FG000|Overall Study|Disease progression|23
4426745|NCT00370552|7209182|FG001|Overall Study|Disease progression|23
4426746|NCT00370552|7209183|FG002|Overall Study|Disease progression|15
4426747|NCT00370552|7209181|FG000|Overall Study|Maximum clinical benefit|3
4426748|NCT00370552|7209182|FG001|Overall Study|Maximum clinical benefit|5
4426749|NCT00370552|7209183|FG002|Overall Study|Maximum clinical benefit|5
4426750|NCT00370552|7209181|FG000|Overall Study|Poor or noncompliance|0
4426751|NCT00370552|7209182|FG001|Overall Study|Poor or noncompliance|0
4426752|NCT00370552|7209183|FG002|Overall Study|Poor or noncompliance|1
4426753|NCT00370552|7209181|FG000|Overall Study|Study drug toxicity|11
4426754|NCT00370552|7209182|FG001|Overall Study|Study drug toxicity|8
4426755|NCT00370552|7209183|FG002|Overall Study|Study drug toxicity|6
4426756|NCT00370552|7209181|FG000|Overall Study|Withdrawal by Subject|2
4426757|NCT00370552|7209182|FG001|Overall Study|Withdrawal by Subject|0
4426758|NCT00370552|7209183|FG002|Overall Study|Withdrawal by Subject|1
4426759|NCT00370552|7209181|FG000|Overall Study|Still on treatment|1
4426760|NCT00370552|7209182|FG001|Overall Study|Still on treatment|3
4426761|NCT00370552|7209183|FG002|Overall Study|Still on treatment|2
4426762|NCT00370552|7209181|FG000|Overall Study|Never treated|1
4426763|NCT00370552|7209182|FG001|Overall Study|Never treated|0
4426764|NCT00370552|7209183|FG002|Overall Study|Never treated|0
4426765|NCT00370552|7209181|FG000|Overall Study|Physician Decision|1
4426766|NCT00370552|7209182|FG001|Overall Study|Physician Decision|1
4426767|NCT00370552|7209183|FG002|Overall Study|Physician Decision|0
4426768|NCT00370552|7209181|FG000|Overall Study|Investigator decision|2
4426769|NCT00370552|7209182|FG001|Overall Study|Investigator decision|1
4426770|NCT00370552|7209183|FG002|Overall Study|Investigator decision|0
4426771|NCT00370552|7209181|FG000|Overall Study|High risk of allergic reaction|0
4426772|NCT00370552|7209182|FG001|Overall Study|High risk of allergic reaction|1
4426773|NCT00370552|7209183|FG002|Overall Study|High risk of allergic reaction|0
4426774|NCT00370552|7209181|FG000|Overall Study|Planned radiation for palliation|0
4426775|NCT00370552|7209182|FG001|Overall Study|Planned radiation for palliation|1
4426776|NCT00370552|7209183|FG002|Overall Study|Planned radiation for palliation|0
4426777|NCT00370682|7209194|FG000|Overall Study|Moved from area|0
4426778|NCT00370682|7209195|FG001|Overall Study|Moved from area|2
4426779|NCT00370682|7209196|FG002|Overall Study|Moved from area|0
4426780|NCT00370682|7209194|FG000|Overall Study|Lost to Follow-up|0
4426781|NCT00370682|7209195|FG001|Overall Study|Lost to Follow-up|1
4426782|NCT00370682|7209196|FG002|Overall Study|Lost to Follow-up|1
4426783|NCT00371137|7209229|FG000|Overall Study|Adverse Event|20
4426784|NCT00371137|7209230|FG001|Overall Study|Adverse Event|35
4426785|NCT00371137|7209231|FG002|Overall Study|Adverse Event|42
4426786|NCT00371137|7209229|FG000|Overall Study|Withdrawal by Subject|11
4426787|NCT00371137|7209230|FG001|Overall Study|Withdrawal by Subject|10
4426788|NCT00371137|7209231|FG002|Overall Study|Withdrawal by Subject|15
4426789|NCT00371137|7209229|FG000|Overall Study|Lost to Follow-up|6
4426790|NCT00371137|7209230|FG001|Overall Study|Lost to Follow-up|3
4426791|NCT00371137|7209231|FG002|Overall Study|Lost to Follow-up|5
4426792|NCT00371137|7209229|FG000|Overall Study|Lack of Efficacy|30
4426793|NCT00371137|7209230|FG001|Overall Study|Lack of Efficacy|12
4426794|NCT00371137|7209231|FG002|Overall Study|Lack of Efficacy|13
4426795|NCT00371137|7209229|FG000|Overall Study|Sponsor Decision|2
4426796|NCT00371137|7209230|FG001|Overall Study|Sponsor Decision|1
4426797|NCT00371137|7209231|FG002|Overall Study|Sponsor Decision|2
4426798|NCT00371137|7209229|FG000|Overall Study|Physician Decision|1
4426799|NCT00371137|7209230|FG001|Overall Study|Physician Decision|1
4426800|NCT00371137|7209231|FG002|Overall Study|Physician Decision|1
4426801|NCT00371137|7209229|FG000|Overall Study|Protocol Violation|2
4426802|NCT00371137|7209230|FG001|Overall Study|Protocol Violation|1
4426803|NCT00371137|7209231|FG002|Overall Study|Protocol Violation|1
4426804|NCT00371150|7209241|FG000|Overall Study|Lost to Follow-up|3
4426805|NCT00371150|7209242|FG001|Overall Study|Lost to Follow-up|2
4426806|NCT00371254|7209263|FG000|Overall Study|Disease progression|13
4426807|NCT00371254|7209264|FG001|Overall Study|Disease progression|13
4426808|NCT00371254|7209263|FG000|Overall Study|Study drug toxicity|3
4426809|NCT00371254|7209264|FG001|Overall Study|Study drug toxicity|5
4426810|NCT00371254|7209263|FG000|Overall Study|Subject request|5
4426811|NCT00371254|7209264|FG001|Overall Study|Subject request|0
4426812|NCT00371254|7209263|FG000|Overall Study|Investigator Decision|2
4426813|NCT00371254|7209264|FG001|Overall Study|Investigator Decision|0
4426814|NCT00371254|7209263|FG000|Overall Study|Adverse event unrelated to study drug|0
4426815|NCT00371254|7209264|FG001|Overall Study|Adverse event unrelated to study drug|1
4426816|NCT00371254|7209263|FG000|Overall Study|Lost to Follow-up|0
4426817|NCT00371254|7209264|FG001|Overall Study|Lost to Follow-up|1
4426818|NCT00371254|7209263|FG000|Overall Study|Withdrawal by Subject|0
4426819|NCT00371254|7209264|FG001|Overall Study|Withdrawal by Subject|1
4426820|NCT00371345|7209295|FG000|Overall Study|Disease Progression|21
4426821|NCT00371345|7209296|FG001|Overall Study|Disease Progression|35
4426822|NCT00371345|7209295|FG000|Overall Study|Study Drug Toxicity|1
4426823|NCT00371345|7209296|FG001|Overall Study|Study Drug Toxicity|7
4426824|NCT00371345|7209295|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1
4426825|NCT00371345|7209296|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2
4426826|NCT00371345|7209295|FG000|Overall Study|Participant Request|1
4426827|NCT00371345|7209296|FG001|Overall Study|Participant Request|1
4426828|NCT00371345|7209295|FG000|Overall Study|Participant Withdrew Consent|0
4426829|NCT00371345|7209296|FG001|Overall Study|Participant Withdrew Consent|1
4426830|NCT00371397|7209316|FG000|Session 1|Withdrawal by Subject|1
4426831|NCT00371397|7209317|FG001|Session 1|Withdrawal by Subject|0
4426832|NCT00371397|7209318|FG002|Session 1|Withdrawal by Subject|0
4426833|NCT00371397|7209319|FG003|Session 1|Withdrawal by Subject|0
4426834|NCT00371397|7209320|FG004|Session 1|Withdrawal by Subject|0
4426835|NCT00371397|7209321|FG005|Session 1|Withdrawal by Subject|0
4426836|NCT00371397|7209322|FG006|Session 1|Withdrawal by Subject|0
4426837|NCT00371397|7209323|FG007|Session 1|Withdrawal by Subject|1
4426838|NCT00371397|7209324|FG008|Session 1|Withdrawal by Subject|0
4426839|NCT00371397|7209325|FG009|Session 1|Withdrawal by Subject|0
4426840|NCT00371397|7209326|FG010|Session 1|Withdrawal by Subject|0
4426841|NCT00371397|7209327|FG011|Session 1|Withdrawal by Subject|0
4426842|NCT00371566|7209359|FG000|Treatment Phase|Withdrawal by Subject|0
4426843|NCT00371566|7209360|FG001|Treatment Phase|Withdrawal by Subject|1
4426844|NCT00371566|7209359|FG000|Treatment Phase|Adverse Event|0
4426845|NCT00371566|7209360|FG001|Treatment Phase|Adverse Event|1
4426846|NCT00371566|7209359|FG000|Treatment Phase|Protocol Violation|0
4426847|NCT00371566|7209360|FG001|Treatment Phase|Protocol Violation|1
4426848|NCT00371566|7209359|FG000|Chemoradiation Phase|Physician Decision|2
4426849|NCT00371566|7209360|FG001|Chemoradiation Phase|Physician Decision|0
4426850|NCT00371566|7209359|FG000|Chemoradiation Phase|Withdrawal by Subject|0
4426851|NCT00371566|7209360|FG001|Chemoradiation Phase|Withdrawal by Subject|1
4426852|NCT00371566|7209359|FG000|Chemoradiation Phase|Non compliant|0
4426853|NCT00371566|7209360|FG001|Chemoradiation Phase|Non compliant|1
4426854|NCT00371566|7209359|FG000|Chemoradiation Phase|Progressive Disease|1
4426855|NCT00371566|7209360|FG001|Chemoradiation Phase|Progressive Disease|1
4426856|NCT00371566|7209359|FG000|Chemoradiation Phase|Death|2
4426857|NCT00371566|7209360|FG001|Chemoradiation Phase|Death|0
4426858|NCT00371566|7209359|FG000|Follow Up Phase|Death|0
4426859|NCT00371566|7209360|FG001|Follow Up Phase|Death|5
4426860|NCT00371566|7209359|FG000|Follow Up Phase|Disease progression|1
4426861|NCT00371566|7209360|FG001|Follow Up Phase|Disease progression|0
4426862|NCT00371566|7209359|FG000|Follow Up Phase|Withdrawal by Subject|0
4426863|NCT00371566|7209360|FG001|Follow Up Phase|Withdrawal by Subject|1
4426864|NCT00371566|7209359|FG000|Follow Up Phase|Physician Decision|1
4426865|NCT00371566|7209360|FG001|Follow Up Phase|Physician Decision|1
4426866|NCT00371566|7209359|FG000|Follow Up Phase|Lost to Follow-up|1
4426867|NCT00371566|7209360|FG001|Follow Up Phase|Lost to Follow-up|0
4426868|NCT00371683|7209381|FG000|DB Treatment Period-Randomized Patients|Death|1
4426869|NCT00371683|7209382|FG001|DB Treatment Period-Randomized Patients|Death|1
4426870|NCT00371683|7209381|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60
4426871|NCT00371683|7209382|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58
4426872|NCT00371683|7209381|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18
4426873|NCT00371683|7209382|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37
4426874|NCT00371683|7209381|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0
4426875|NCT00371683|7209382|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1
4426876|NCT00371683|7209381|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1
4426877|NCT00371683|7209382|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2
4426878|NCT00371683|7209381|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1
4426879|NCT00371683|7209382|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0
4426880|NCT00371683|7209381|FG000|DB Treatment Period-Randomized Patients|non-specified|9
4426881|NCT00371683|7209382|FG001|DB Treatment Period-Randomized Patients|non-specified|8
4426882|NCT00371683|7209381|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17
4512412|NCT00934050|7322161|FG001|Enrolled After 15 Dec 2009|Death|0
4426883|NCT00371683|7209382|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19
4426884|NCT00371683|7209381|FG000|Follow-Up Period - Randomized Patients|Death|0
4426885|NCT00371683|7209382|FG001|Follow-Up Period - Randomized Patients|Death|2
4426886|NCT00371683|7209381|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38
4426887|NCT00371683|7209382|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39
4426888|NCT00371683|7209381|FG000|Follow-Up Period - Randomized Patients|non-specified|6
4426889|NCT00371683|7209382|FG001|Follow-Up Period - Randomized Patients|non-specified|12
4426890|NCT00371761|7209400|FG000|Overall Study|Adverse Event|1
4426891|NCT00371761|7209401|FG001|Overall Study|Adverse Event|1
4426892|NCT00371761|7209400|FG000|Overall Study|Withdrawal by Subject|1
4426893|NCT00371761|7209401|FG001|Overall Study|Withdrawal by Subject|3
4426894|NCT00371761|7209400|FG000|Overall Study|Investigator Judgment|2
4426895|NCT00371761|7209401|FG001|Overall Study|Investigator Judgment|3
4426896|NCT00371761|7209400|FG000|Overall Study|Study termination|4
4426897|NCT00371761|7209401|FG001|Overall Study|Study termination|3
4426898|NCT00371787|7209409|FG000|Overall Study|Withdrawal by Subject|3
4426899|NCT00371787|7209410|FG001|Overall Study|Withdrawal by Subject|1
4426900|NCT00371826|7209419|FG000|Core Phase (12 Months)|Adverse Event|15
4426901|NCT00371826|7209420|FG001|Core Phase (12 Months)|Adverse Event|4
4426902|NCT00371826|7209421|FG002|Core Phase (12 Months)|Adverse Event|9
4426903|NCT00371826|7209419|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1
4426904|NCT00371826|7209420|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0
4426905|NCT00371826|7209421|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1
4426906|NCT00371826|7209419|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6
4426907|NCT00371826|7209420|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3
4426908|NCT00371826|7209421|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2
4426909|NCT00371826|7209419|FG000|Core Phase (12 Months)|Protocol Violation|1
4426910|NCT00371826|7209420|FG001|Core Phase (12 Months)|Protocol Violation|0
4426911|NCT00371826|7209421|FG002|Core Phase (12 Months)|Protocol Violation|1
4426912|NCT00371826|7209419|FG000|Core Phase (12 Months)|Subject withdrew consent|0
4426913|NCT00371826|7209420|FG001|Core Phase (12 Months)|Subject withdrew consent|0
4426914|NCT00371826|7209421|FG002|Core Phase (12 Months)|Subject withdrew consent|3
4426915|NCT00371826|7209419|FG000|Core Phase (12 Months)|Administrative problems|1
4426916|NCT00371826|7209420|FG001|Core Phase (12 Months)|Administrative problems|0
4426917|NCT00371826|7209421|FG002|Core Phase (12 Months)|Administrative problems|8
4426918|NCT00371826|7209419|FG000|Core Phase (12 Months)|Graft Loss|0
4426919|NCT00371826|7209420|FG001|Core Phase (12 Months)|Graft Loss|1
4426920|NCT00371826|7209421|FG002|Core Phase (12 Months)|Graft Loss|0
4426921|NCT00371826|7209419|FG000|Extension Phase (24 Months)|Adverse Event|4
4426922|NCT00371826|7209420|FG001|Extension Phase (24 Months)|Adverse Event|5
4426923|NCT00371826|7209421|FG002|Extension Phase (24 Months)|Adverse Event|0
4426924|NCT00371826|7209419|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0
4426925|NCT00371826|7209420|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1
4426926|NCT00371826|7209421|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0
4426927|NCT00371826|7209419|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0
4426928|NCT00371826|7209420|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2
4426929|NCT00371826|7209421|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0
4426930|NCT00371826|7209419|FG000|Extension Phase (24 Months)|Subject withdrew consent|1
4426931|NCT00371826|7209420|FG001|Extension Phase (24 Months)|Subject withdrew consent|2
4426932|NCT00371826|7209421|FG002|Extension Phase (24 Months)|Subject withdrew consent|0
4426933|NCT00371826|7209419|FG000|Extension Phase (24 Months)|Administrative problems|0
4426934|NCT00371826|7209420|FG001|Extension Phase (24 Months)|Administrative problems|0
4426935|NCT00371826|7209421|FG002|Extension Phase (24 Months)|Administrative problems|2
4426936|NCT00371839|7209432|FG000|Overall Study|Death|4
4426937|NCT00371839|7209433|FG001|Overall Study|Death|0
4426938|NCT00371839|7209434|FG002|Overall Study|Death|0
4426939|NCT00371839|7209432|FG000|Overall Study|Withdrawal by Subject|7
4426940|NCT00371839|7209433|FG001|Overall Study|Withdrawal by Subject|4
4426941|NCT00371839|7209434|FG002|Overall Study|Withdrawal by Subject|0
4426942|NCT00371839|7209432|FG000|Overall Study|Lost to Follow-up|6
4426943|NCT00371839|7209433|FG001|Overall Study|Lost to Follow-up|3
4426944|NCT00371839|7209434|FG002|Overall Study|Lost to Follow-up|2
4426945|NCT00371865|7209442|FG000|Overall Study|Lack of Efficacy|0
4426946|NCT00371865|7209443|FG001|Overall Study|Lack of Efficacy|2
4426947|NCT00371865|7209442|FG000|Overall Study|Protocol Violation|3
4426948|NCT00371865|7209443|FG001|Overall Study|Protocol Violation|2
4426949|NCT00371865|7209442|FG000|Overall Study|Withdrawal by Subject|12
4426950|NCT00371865|7209443|FG001|Overall Study|Withdrawal by Subject|10
4426951|NCT00372060|7209451|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2
4426952|NCT00372060|7209452|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0
4426953|NCT00372060|7209451|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0
4426954|NCT00372060|7209452|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1
4426955|NCT00372060|7209451|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1
4426956|NCT00372060|7209452|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0
4426957|NCT00372060|7209451|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3
4426958|NCT00372060|7209452|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0
4426959|NCT00372060|7209451|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9
4426960|NCT00372060|7209452|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8
4426961|NCT00372060|7209451|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2
4426962|NCT00372060|7209452|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0
4426963|NCT00372112|7209465|FG000|Overall Study|Adverse Event|0
4426964|NCT00372112|7209466|FG001|Overall Study|Adverse Event|1
4426965|NCT00372112|7209467|FG002|Overall Study|Adverse Event|1
4426966|NCT00372112|7209468|FG003|Overall Study|Adverse Event|1
4426967|NCT00372112|7209465|FG000|Overall Study|Withdrawal by Subject|0
4426968|NCT00372112|7209466|FG001|Overall Study|Withdrawal by Subject|0
4426969|NCT00372112|7209467|FG002|Overall Study|Withdrawal by Subject|2
4426970|NCT00372112|7209468|FG003|Overall Study|Withdrawal by Subject|1
4426971|NCT00372112|7209465|FG000|Overall Study|Exacerbation|0
4426972|NCT00372112|7209466|FG001|Overall Study|Exacerbation|0
4426973|NCT00372112|7209467|FG002|Overall Study|Exacerbation|0
4426974|NCT00372112|7209468|FG003|Overall Study|Exacerbation|1
4426975|NCT00372112|7209465|FG000|Overall Study|PR >240 at Visit 3|0
4426976|NCT00372112|7209466|FG001|Overall Study|PR >240 at Visit 3|0
4426977|NCT00372112|7209467|FG002|Overall Study|PR >240 at Visit 3|0
4426978|NCT00372112|7209468|FG003|Overall Study|PR >240 at Visit 3|1
4426979|NCT00372112|7209465|FG000|Overall Study|Hepatitis B|1
4426980|NCT00372112|7209466|FG001|Overall Study|Hepatitis B|0
4426981|NCT00372112|7209467|FG002|Overall Study|Hepatitis B|0
4426982|NCT00372112|7209468|FG003|Overall Study|Hepatitis B|0
4426983|NCT00372112|7209465|FG000|Overall Study|Other-protocol violation|0
4426984|NCT00372112|7209466|FG001|Overall Study|Other-protocol violation|0
4426985|NCT00372112|7209467|FG002|Overall Study|Other-protocol violation|1
4426986|NCT00372112|7209468|FG003|Overall Study|Other-protocol violation|0
4426987|NCT00372190|7209483|FG000|Overall Study|Lost to Follow-up|3
4715041|NCT02966353|7643188|FG000|Overall Study|Physician Decision|3
4715042|NCT02966353|7643188|FG000|Overall Study|Progressive disease|2
4715043|NCT02966353|7643188|FG000|Overall Study|Protocol deviation|2
4426988|NCT00372190|7209484|FG001|Overall Study|Lost to Follow-up|1
4426989|NCT00372255|7209494|FG000|Overall Study|Withdrawn for other reasons|2
4426990|NCT00372255|7209495|FG001|Overall Study|Withdrawn for other reasons|1
4426991|NCT00372385|7209506|FG000|Overall Study|Adverse Event|6
4426992|NCT00372385|7209507|FG001|Overall Study|Adverse Event|11
4426993|NCT00372385|7209508|FG002|Overall Study|Adverse Event|9
4426994|NCT00372385|7209509|FG003|Overall Study|Adverse Event|7
4426995|NCT00372385|7209506|FG000|Overall Study|Noncompliance|0
4426996|NCT00372385|7209507|FG001|Overall Study|Noncompliance|1
4426997|NCT00372385|7209508|FG002|Overall Study|Noncompliance|1
4426998|NCT00372385|7209509|FG003|Overall Study|Noncompliance|1
4426999|NCT00372385|7209506|FG000|Overall Study|Physician Decision|1
4427000|NCT00372385|7209507|FG001|Overall Study|Physician Decision|0
4427001|NCT00372385|7209508|FG002|Overall Study|Physician Decision|0
4427002|NCT00372385|7209509|FG003|Overall Study|Physician Decision|0
4427003|NCT00372385|7209506|FG000|Overall Study|Lost to Follow-up|2
4427004|NCT00372385|7209507|FG001|Overall Study|Lost to Follow-up|0
4427005|NCT00372385|7209508|FG002|Overall Study|Lost to Follow-up|0
4427006|NCT00372385|7209509|FG003|Overall Study|Lost to Follow-up|0
4427007|NCT00372385|7209506|FG000|Overall Study|Withdrawal by Subject|2
4427008|NCT00372385|7209507|FG001|Overall Study|Withdrawal by Subject|1
4427009|NCT00372385|7209508|FG002|Overall Study|Withdrawal by Subject|0
4427010|NCT00372385|7209509|FG003|Overall Study|Withdrawal by Subject|0
4427011|NCT00372385|7209506|FG000|Overall Study|Refusal of Treatment|3
4427012|NCT00372385|7209507|FG001|Overall Study|Refusal of Treatment|6
4427013|NCT00372385|7209508|FG002|Overall Study|Refusal of Treatment|0
4427014|NCT00372385|7209509|FG003|Overall Study|Refusal of Treatment|0
4427015|NCT00372385|7209506|FG000|Overall Study|No Response|1
4427016|NCT00372385|7209507|FG001|Overall Study|No Response|1
4427017|NCT00372385|7209508|FG002|Overall Study|No Response|0
4427018|NCT00372385|7209509|FG003|Overall Study|No Response|0
4427019|NCT00372385|7209506|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1
4427020|NCT00372385|7209507|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0
4427021|NCT00372385|7209508|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0
4427022|NCT00372385|7209509|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0
4427023|NCT00372385|7209506|FG000|Overall Study|Virologic Stopping Rule|17
4427024|NCT00372385|7209507|FG001|Overall Study|Virologic Stopping Rule|0
4427025|NCT00372385|7209508|FG002|Overall Study|Virologic Stopping Rule|0
4427026|NCT00372385|7209509|FG003|Overall Study|Virologic Stopping Rule|0
4427027|NCT00372411|7209523|FG000|Overall Study|Withdrawal by Subject|3
4427028|NCT00372411|7209524|FG001|Overall Study|Withdrawal by Subject|4
4427029|NCT00372411|7209525|FG002|Overall Study|Withdrawal by Subject|1
4427030|NCT00372411|7209523|FG000|Overall Study|Death|0
4427031|NCT00372411|7209524|FG001|Overall Study|Death|2
4427032|NCT00372411|7209525|FG002|Overall Study|Death|1
4427033|NCT00372411|7209523|FG000|Overall Study|Lost to Follow-up|1
4427034|NCT00372411|7209524|FG001|Overall Study|Lost to Follow-up|1
4427035|NCT00372411|7209525|FG002|Overall Study|Lost to Follow-up|1
4427036|NCT00372411|7209523|FG000|Overall Study|Adverse Event|1
4427037|NCT00372411|7209524|FG001|Overall Study|Adverse Event|1
4427038|NCT00372411|7209525|FG002|Overall Study|Adverse Event|0
4427039|NCT00372424|7209533|FG000|Overall Study|Adverse Event|2
4771720|NCT00369317|7748569|FG000|Overall Study|Ineligible|1
4427040|NCT00372424|7209533|FG000|Overall Study|Withdrawal by Subject|1
4427041|NCT00372424|7209533|FG000|Overall Study|Death|1
4427042|NCT00372424|7209533|FG000|Overall Study|Objective Progression or Relapse|14
4427043|NCT00372424|7209533|FG000|Overall Study|Other|7
4427044|NCT00372424|7209533|FG000|Overall Study|Enrolled, Not Treated|1
4427045|NCT00372489|7209537|FG000|Overall Study|Adverse Event|18
4427046|NCT00372489|7209537|FG000|Overall Study|Lack of Efficacy|1
4427047|NCT00372489|7209537|FG000|Overall Study|Lost to Follow-up|3
4427048|NCT00372489|7209537|FG000|Overall Study|Physician Decision|3
4427049|NCT00372489|7209537|FG000|Overall Study|Withdrawal by Subject|5
4427050|NCT00372489|7209537|FG000|Overall Study|Patient Relocation|2
4427051|NCT00372489|7209537|FG000|Overall Study|Renal transplant|6
4427052|NCT00372489|7209537|FG000|Overall Study|Sponsor Decision to Terminate Study|41
4427053|NCT00372528|7209541|FG000|Overall Study|Lack of Efficacy|1
4427054|NCT00372528|7209541|FG000|Overall Study|Adverse Event|1
4427055|NCT00372528|7209541|FG000|Overall Study|Study Terminated by Sponsor|18
4427056|NCT00372528|7209541|FG000|Overall Study|Other|1
4427057|NCT00372567|7209548|FG000|Phase 3 Study|Adverse Event|5
4715044|NCT02966509|7643194|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2
4715045|NCT02966509|7643195|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3
4715046|NCT02966509|7643194|FG000|Baseline Satisfaction Survey|Death|0
4715047|NCT02966509|7643195|FG001|Baseline Satisfaction Survey|Death|1
4715048|NCT02966509|7643194|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1
4715049|NCT02966509|7643195|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1
4715050|NCT02966509|7643194|FG000|Baseline Satisfaction Survey|Refused to Answer|1
4427058|NCT00372567|7209549|FG001|Phase 3 Study|Adverse Event|1
4427059|NCT00372567|7209550|FG002|Phase 3 Study|Adverse Event|1
4427060|NCT00372567|7209548|FG000|Phase 3 Study|Death|1
4427061|NCT00372567|7209549|FG001|Phase 3 Study|Death|1
4427062|NCT00372567|7209550|FG002|Phase 3 Study|Death|0
4427063|NCT00372567|7209548|FG000|Phase 3 Study|Protocol Violation|0
4427064|NCT00372567|7209549|FG001|Phase 3 Study|Protocol Violation|0
4427065|NCT00372567|7209550|FG002|Phase 3 Study|Protocol Violation|1
4427066|NCT00372567|7209548|FG000|Phase 3 Study|Objective progression or relapse|10
4427067|NCT00372567|7209549|FG001|Phase 3 Study|Objective progression or relapse|13
4427068|NCT00372567|7209550|FG002|Phase 3 Study|Objective progression or relapse|4
4427069|NCT00372567|7209548|FG000|Phase 3 Study|Global deterioration of health status|0
4427070|NCT00372567|7209549|FG001|Phase 3 Study|Global deterioration of health status|1
4427071|NCT00372567|7209550|FG002|Phase 3 Study|Global deterioration of health status|0
4427072|NCT00372567|7209548|FG000|Phase 3 Study|Other|2
4427073|NCT00372567|7209549|FG001|Phase 3 Study|Other|2
4427074|NCT00372567|7209550|FG002|Phase 3 Study|Other|1
4427075|NCT00372567|7209548|FG000|Phase 3 Study|study terminated by sponsor|13
4427076|NCT00372567|7209549|FG001|Phase 3 Study|study terminated by sponsor|8
4427077|NCT00372567|7209550|FG002|Phase 3 Study|study terminated by sponsor|5
4427078|NCT00372593|7209561|FG000|Overall Study|Adverse Event|43
4427079|NCT00372593|7209562|FG001|Overall Study|Adverse Event|45
4427080|NCT00372593|7209563|FG002|Overall Study|Adverse Event|0
4427081|NCT00372593|7209561|FG000|Overall Study|Death|16
4427082|NCT00372593|7209562|FG001|Overall Study|Death|20
4427083|NCT00372593|7209563|FG002|Overall Study|Death|1
4427084|NCT00372593|7209561|FG000|Overall Study|Lack of Efficacy|82
4427085|NCT00372593|7209562|FG001|Overall Study|Lack of Efficacy|71
4427086|NCT00372593|7209563|FG002|Overall Study|Lack of Efficacy|2
4427087|NCT00372593|7209561|FG000|Overall Study|Lost to Follow-up|1
4427088|NCT00372593|7209562|FG001|Overall Study|Lost to Follow-up|0
4427089|NCT00372593|7209563|FG002|Overall Study|Lost to Follow-up|0
4427090|NCT00372593|7209561|FG000|Overall Study|Physician Decision|42
4427091|NCT00372593|7209562|FG001|Overall Study|Physician Decision|41
4427092|NCT00372593|7209563|FG002|Overall Study|Physician Decision|0
4427093|NCT00372593|7209561|FG000|Overall Study|Ineligible|20
4427094|NCT00372593|7209562|FG001|Overall Study|Ineligible|21
4427095|NCT00372593|7209563|FG002|Overall Study|Ineligible|1
4427096|NCT00372619|7209579|FG000|Overall Study|Ineligible|0
4427097|NCT00372619|7209580|FG001|Overall Study|Ineligible|0
4427098|NCT00372619|7209581|FG002|Overall Study|Ineligible|0
4427099|NCT00372619|7209582|FG003|Overall Study|Ineligible|0
4427100|NCT00372619|7209583|FG004|Overall Study|Ineligible|0
4427101|NCT00372619|7209584|FG005|Overall Study|Ineligible|2
4427102|NCT00372619|7209585|FG006|Overall Study|Ineligible|0
4427103|NCT00372619|7209579|FG000|Overall Study|Inevaluable|0
4427104|NCT00372619|7209580|FG001|Overall Study|Inevaluable|0
4427105|NCT00372619|7209581|FG002|Overall Study|Inevaluable|0
4427106|NCT00372619|7209582|FG003|Overall Study|Inevaluable|0
4427107|NCT00372619|7209583|FG004|Overall Study|Inevaluable|0
4427108|NCT00372619|7209584|FG005|Overall Study|Inevaluable|1
4427109|NCT00372619|7209585|FG006|Overall Study|Inevaluable|0
4427110|NCT00372697|7209603|FG000|Overall Study|Protocol Violation|1
4427111|NCT00372697|7209604|FG001|Overall Study|Protocol Violation|1
4427112|NCT00372775|7209610|FG000|Overall Study|Adverse Event|8
4427113|NCT00372775|7209610|FG000|Overall Study|Death|15
4427114|NCT00372775|7209610|FG000|Overall Study|Objective progression or relapse|30
4427115|NCT00372775|7209610|FG000|Overall Study|Global deterioration of health status|6
4427116|NCT00372775|7209610|FG000|Overall Study|Withdrawal by Subject|1
4427117|NCT00372775|7209610|FG000|Overall Study|Other|1
4427118|NCT00372775|7209610|FG000|Overall Study|Not Treated|2
4427119|NCT00372905|7209614|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2
4427120|NCT00372905|7209615|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0
4427121|NCT00372905|7209616|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0
4427122|NCT00372905|7209617|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0
4427123|NCT00372905|7209614|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0
4427124|NCT00372905|7209615|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0
4427125|NCT00372905|7209616|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2
4427126|NCT00372905|7209617|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0
4715051|NCT02966509|7643195|FG001|Baseline Satisfaction Survey|Refused to Answer|2
4715052|NCT02966509|7643194|FG000|6 Month Satisfaction Decision Survey|Death|22
4715053|NCT02966509|7643195|FG001|6 Month Satisfaction Decision Survey|Death|25
4715054|NCT02966509|7643194|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2
4715055|NCT02966509|7643195|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3
4715056|NCT02966509|7643194|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1
4715057|NCT02966509|7643195|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1
4715058|NCT02966509|7643194|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0
4715059|NCT02966509|7643195|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2
4715060|NCT02966509|7643194|FG000|6 Month Satisfaction Survey|Death|36
4715061|NCT02966509|7643195|FG001|6 Month Satisfaction Survey|Death|33
4715062|NCT02966509|7643194|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2
4715063|NCT02966509|7643195|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3
4715064|NCT02966509|7643194|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1
4715065|NCT02966509|7643195|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1
4427127|NCT00372905|7209614|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0
4427128|NCT00372905|7209615|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0
4427129|NCT00372905|7209616|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1
4427130|NCT00372905|7209617|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0
4427131|NCT00372905|7209614|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0
4427132|NCT00372905|7209615|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0
4427133|NCT00372905|7209616|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0
4427134|NCT00372905|7209617|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2
4427135|NCT00372905|7209614|FG000|Follow up Until Relapse or Progression|Study closed|0
4427136|NCT00372905|7209615|FG001|Follow up Until Relapse or Progression|Study closed|0
4427137|NCT00372905|7209616|FG002|Follow up Until Relapse or Progression|Study closed|0
4427138|NCT00372905|7209617|FG003|Follow up Until Relapse or Progression|Study closed|3
4427139|NCT00372905|7209614|FG000|Follow up Until Relapse or Progression|Other|0
4427140|NCT00372905|7209615|FG001|Follow up Until Relapse or Progression|Other|1
4427141|NCT00372905|7209616|FG002|Follow up Until Relapse or Progression|Other|0
4427142|NCT00372905|7209617|FG003|Follow up Until Relapse or Progression|Other|0
4427143|NCT00372996|7209653|FG000|Overall Study|Death|11
4427144|NCT00372996|7209654|FG001|Overall Study|Death|4
4427145|NCT00372996|7209655|FG002|Overall Study|Death|8
4427146|NCT00372996|7209656|FG003|Overall Study|Death|7
4427147|NCT00372996|7209653|FG000|Overall Study|Lost to Follow-up|0
4427148|NCT00372996|7209654|FG001|Overall Study|Lost to Follow-up|2
4427149|NCT00372996|7209655|FG002|Overall Study|Lost to Follow-up|0
4427150|NCT00372996|7209656|FG003|Overall Study|Lost to Follow-up|1
4427151|NCT00372996|7209653|FG000|Overall Study|Withdrawal by Subject|12
4427152|NCT00372996|7209654|FG001|Overall Study|Withdrawal by Subject|6
4427153|NCT00372996|7209655|FG002|Overall Study|Withdrawal by Subject|9
4427154|NCT00372996|7209656|FG003|Overall Study|Withdrawal by Subject|5
4427155|NCT00372996|7209653|FG000|Overall Study|Study Terminated by Sponsor|4
4427156|NCT00372996|7209654|FG001|Overall Study|Study Terminated by Sponsor|0
4427157|NCT00372996|7209655|FG002|Overall Study|Study Terminated by Sponsor|4
4427158|NCT00372996|7209656|FG003|Overall Study|Study Terminated by Sponsor|0
4427159|NCT00372996|7209653|FG000|Overall Study|Other|10
4427160|NCT00372996|7209654|FG001|Overall Study|Other|2
4427161|NCT00372996|7209655|FG002|Overall Study|Other|7
4427162|NCT00372996|7209656|FG003|Overall Study|Other|7
4715066|NCT02966509|7643194|FG000|6 Month Satisfaction Survey|Refused to Answer|8
4715067|NCT02966509|7643195|FG001|6 Month Satisfaction Survey|Refused to Answer|11
4715068|NCT02966509|7643194|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69
4715069|NCT02966509|7643195|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75
4715070|NCT02966509|7643194|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45
4715071|NCT02966509|7643195|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48
4715072|NCT02966795|7643203|FG000|Overall Study|Patient Left the Country|0
4715073|NCT02966795|7643204|FG001|Overall Study|Patient Left the Country|1
4715074|NCT02966834|7643215|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0
4715075|NCT02966834|7643216|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0
4715076|NCT02966834|7643217|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0
4715077|NCT02966834|7643218|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0
4715078|NCT02966834|7643219|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1
4715079|NCT02966834|7643220|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0
4715080|NCT02966834|7643215|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1
4715081|NCT02966834|7643216|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0
4715082|NCT02966834|7643217|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0
4427163|NCT00373113|7209668|FG000|Overall Study|Death|1
4427164|NCT00373113|7209669|FG001|Overall Study|Death|7
4427165|NCT00373113|7209668|FG000|Overall Study|Adverse Event|38
4427166|NCT00373113|7209669|FG001|Overall Study|Adverse Event|24
4427167|NCT00373113|7209668|FG000|Overall Study|Study terminated by sponsor|9
4427168|NCT00373113|7209669|FG001|Overall Study|Study terminated by sponsor|1
4427169|NCT00373113|7209668|FG000|Overall Study|Global deterioration of health status|10
4427170|NCT00373113|7209669|FG001|Overall Study|Global deterioration of health status|7
4427171|NCT00373113|7209668|FG000|Overall Study|Lost to Follow-up|1
4427172|NCT00373113|7209669|FG001|Overall Study|Lost to Follow-up|3
4427173|NCT00373113|7209668|FG000|Overall Study|Objective progression or relapse|150
4427174|NCT00373113|7209669|FG001|Overall Study|Objective progression or relapse|169
4427175|NCT00373113|7209668|FG000|Overall Study|Other|14
4427176|NCT00373113|7209669|FG001|Overall Study|Other|17
4427177|NCT00373113|7209668|FG000|Overall Study|Protocol Violation|5
4427178|NCT00373113|7209669|FG001|Overall Study|Protocol Violation|1
4427179|NCT00373113|7209668|FG000|Overall Study|Withdrawal by Subject|10
4427180|NCT00373113|7209669|FG001|Overall Study|Withdrawal by Subject|15
4427181|NCT00373256|7209677|FG000|Overall Study|Adverse Event (AE)|1
4427182|NCT00373256|7209678|FG001|Overall Study|Adverse Event (AE)|5
4427183|NCT00373256|7209677|FG000|Overall Study|Lost to Follow-up|2
4427184|NCT00373256|7209678|FG001|Overall Study|Lost to Follow-up|1
4427185|NCT00373256|7209677|FG000|Overall Study|Death|9
4427186|NCT00373256|7209678|FG001|Overall Study|Death|8
4427187|NCT00373256|7209677|FG000|Overall Study|Objective Progression or Relapse|111
4427188|NCT00373256|7209678|FG001|Overall Study|Objective Progression or Relapse|104
4427189|NCT00373256|7209677|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4
4427190|NCT00373256|7209678|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7
4427191|NCT00373256|7209677|FG000|Overall Study|Other|73
4427192|NCT00373256|7209678|FG001|Overall Study|Other|107
4427193|NCT00373256|7209677|FG000|Overall Study|Protocol Violation|0
4427194|NCT00373256|7209678|FG001|Overall Study|Protocol Violation|2
4427195|NCT00373256|7209677|FG000|Overall Study|Study Terminated by Sponsor|41
4427196|NCT00373256|7209678|FG001|Overall Study|Study Terminated by Sponsor|13
4427197|NCT00373295|7209693|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0
4427198|NCT00373295|7209694|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2
4427199|NCT00373295|7209695|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0
4427200|NCT00373295|7209696|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0
4427201|NCT00373295|7209697|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1
4427202|NCT00373295|7209698|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0
4427203|NCT00373425|7209747|FG000|Overall Study|Relapse of NSCLC|116
4427204|NCT00373425|7209748|FG001|Overall Study|Relapse of NSCLC|104
4427205|NCT00373425|7209749|FG002|Overall Study|Relapse of NSCLC|19
4427206|NCT00373425|7209750|FG003|Overall Study|Relapse of NSCLC|2
4427207|NCT00373425|7209751|FG004|Overall Study|Relapse of NSCLC|26
4427208|NCT00373425|7209747|FG000|Overall Study|Adverse Event|191
4427209|NCT00373425|7209748|FG001|Overall Study|Adverse Event|22
4427210|NCT00373425|7209749|FG002|Overall Study|Adverse Event|59
4427211|NCT00373425|7209750|FG003|Overall Study|Adverse Event|0
4427212|NCT00373425|7209751|FG004|Overall Study|Adverse Event|34
4427213|NCT00373425|7209747|FG000|Overall Study|Patient request|35
4427214|NCT00373425|7209748|FG001|Overall Study|Patient request|18
4427215|NCT00373425|7209749|FG002|Overall Study|Patient request|43
4427216|NCT00373425|7209750|FG003|Overall Study|Patient request|6
4427217|NCT00373425|7209751|FG004|Overall Study|Patient request|7
4427218|NCT00373425|7209747|FG000|Overall Study|Medical/ethical/noncompliance reason|21
4427219|NCT00373425|7209748|FG001|Overall Study|Medical/ethical/noncompliance reason|9
4427220|NCT00373425|7209749|FG002|Overall Study|Medical/ethical/noncompliance reason|10
4427221|NCT00373425|7209750|FG003|Overall Study|Medical/ethical/noncompliance reason|2
4427222|NCT00373425|7209751|FG004|Overall Study|Medical/ethical/noncompliance reason|5
4427223|NCT00373425|7209747|FG000|Overall Study|Death|7
4427224|NCT00373425|7209748|FG001|Overall Study|Death|0
4427225|NCT00373425|7209749|FG002|Overall Study|Death|3
4427226|NCT00373425|7209750|FG003|Overall Study|Death|1
4427227|NCT00373425|7209751|FG004|Overall Study|Death|0
4427228|NCT00373490|7209762|FG000|Overall Study|Adverse Event|0
4427229|NCT00373490|7209763|FG001|Overall Study|Adverse Event|1
4427230|NCT00373490|7209762|FG000|Overall Study|Lack of Efficacy|9
4427231|NCT00373490|7209763|FG001|Overall Study|Lack of Efficacy|4
4427232|NCT00373490|7209762|FG000|Overall Study|Withdrawal by Subject|0
4715083|NCT02966834|7643218|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0
4427233|NCT00373490|7209763|FG001|Overall Study|Withdrawal by Subject|1
4427234|NCT00373529|7209769|FG000|Overall Study|Physician Decision|19
4427235|NCT00373529|7209769|FG000|Overall Study|Withdrawal by Subject|7
4427236|NCT00373529|7209769|FG000|Overall Study|Adverse Event|7
4427237|NCT00373529|7209769|FG000|Overall Study|Treatment failure|36
4427238|NCT00373529|7209769|FG000|Overall Study|Disease recurrence|10
4427239|NCT00373529|7209769|FG000|Overall Study|Death|16
4427240|NCT00373529|7209769|FG000|Overall Study|Need for treatment prohibited by study|1
4427241|NCT00373529|7209769|FG000|Overall Study|Other|8
4427242|NCT00373529|7209769|FG000|Overall Study|Failed independent confirmation of AML|3
4715084|NCT02966834|7643219|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0
4427243|NCT00373529|7209769|FG000|Overall Study|Consent violation|1
4427244|NCT00373685|7209775|FG000|Overall Study|Death|2
4427245|NCT00373685|7209776|FG001|Overall Study|Death|1
4629846|NCT01877421|7498130|FG006|Phase 2|Withdrawal by Subject|0
4629847|NCT01877421|7498131|FG007|Phase 2|Withdrawal by Subject|0
4771721|NCT00261807|7748574|FG000|Overall Study|Lost to Follow-up|2
4427246|NCT00373685|7209775|FG000|Overall Study|Adverse Event|278
4427247|NCT00373685|7209776|FG001|Overall Study|Adverse Event|253
4427248|NCT00373685|7209775|FG000|Overall Study|Insufficient clinical response|169
4427249|NCT00373685|7209776|FG001|Overall Study|Insufficient clinical response|119
4427250|NCT00373685|7209775|FG000|Overall Study|Did not meet entrance criteria|167
4427251|NCT00373685|7209776|FG001|Overall Study|Did not meet entrance criteria|184
4427252|NCT00373685|7209775|FG000|Overall Study|Lost to follow up|83
4427253|NCT00373685|7209776|FG001|Overall Study|Lost to follow up|103
4427254|NCT00373685|7209775|FG000|Overall Study|No longer willing to participate|337
4427255|NCT00373685|7209776|FG001|Overall Study|No longer willing to participate|352
4427256|NCT00373685|7209775|FG000|Overall Study|Other|149
4427257|NCT00373685|7209776|FG001|Overall Study|Other|146
4427258|NCT00373685|7209775|FG000|Overall Study|Protocol Violation|191
4427259|NCT00373685|7209776|FG001|Overall Study|Protocol Violation|182
4427260|NCT00373685|7209775|FG000|Overall Study|Final Status Unknown|12
4427261|NCT00373685|7209776|FG001|Overall Study|Final Status Unknown|4
4427262|NCT00373685|7209775|FG000|Overall Study|Randomized, not treated|51
4427263|NCT00373685|7209776|FG001|Overall Study|Randomized, not treated|77
4427264|NCT00373880|7209793|FG000|Overall Study|Physician Decision|3
4427265|NCT00373880|7209793|FG000|Overall Study|Arrested|1
4427266|NCT00373880|7209793|FG000|Overall Study|Protocol Violation|14
4427267|NCT00373958|7209807|FG000|Infant Series|Withdrawal by Subject|13
4427268|NCT00373958|7209808|FG001|Infant Series|Withdrawal by Subject|15
4427269|NCT00373958|7209807|FG000|Infant Series|Failed to return|8
4427270|NCT00373958|7209808|FG001|Infant Series|Failed to return|13
4427271|NCT00373958|7209807|FG000|Infant Series|Lost to Follow-up|6
4427272|NCT00373958|7209808|FG001|Infant Series|Lost to Follow-up|5
4427273|NCT00373958|7209807|FG000|Infant Series|Protocol Violation|3
4427274|NCT00373958|7209808|FG001|Infant Series|Protocol Violation|7
4427275|NCT00373958|7209807|FG000|Infant Series|Lost Kaiser coverage|4
4427276|NCT00373958|7209808|FG001|Infant Series|Lost Kaiser coverage|0
4427277|NCT00373958|7209807|FG000|Infant Series|Child relocated|1
4427278|NCT00373958|7209808|FG001|Infant Series|Child relocated|0
4427279|NCT00373958|7209807|FG000|Infant Series|Consent was not received|1
4427280|NCT00373958|7209808|FG001|Infant Series|Consent was not received|0
4427281|NCT00373958|7209807|FG000|Infant Series|Adverse Event|3
4427282|NCT00373958|7209808|FG001|Infant Series|Adverse Event|1
4427283|NCT00373958|7209807|FG000|Infant Series|Physician Decision|1
4427284|NCT00373958|7209808|FG001|Infant Series|Physician Decision|1
4427285|NCT00373958|7209807|FG000|Toddler Dose|Lost to Follow-up|5
4427286|NCT00373958|7209808|FG001|Toddler Dose|Lost to Follow-up|8
4427287|NCT00373958|7209807|FG000|Toddler Dose|Withdrawal by Subject|2
4427288|NCT00373958|7209808|FG001|Toddler Dose|Withdrawal by Subject|2
4427289|NCT00373958|7209807|FG000|Toddler Dose|Failed to return|1
4427290|NCT00373958|7209808|FG001|Toddler Dose|Failed to return|2
4427291|NCT00373958|7209807|FG000|Toddler Dose|Protocol Violation|0
4427292|NCT00373958|7209808|FG001|Toddler Dose|Protocol Violation|1
4427293|NCT00373958|7209807|FG000|Toddler Dose|Withdrawn after infant series|22
4427294|NCT00373958|7209808|FG001|Toddler Dose|Withdrawn after infant series|25
4427295|NCT00374127|7209846|FG000|Overall Study|Did not inhale during smoking procedure.|3
4427296|NCT00374127|7209846|FG000|Overall Study|Blood could not be drawn.|2
4427297|NCT00374127|7209846|FG000|Overall Study|Protocol Violation|5
4427298|NCT00374127|7209846|FG000|Overall Study|Pregnancy|1
4427299|NCT00374140|7209856|FG000|Overall Study|Lost to Follow-up|1
4427300|NCT00374140|7209856|FG000|Overall Study|Protocol Violation|1
4427301|NCT00374322|7209876|FG000|Overall Study|Lost to Follow-up|92
4427302|NCT00374322|7209877|FG001|Overall Study|Lost to Follow-up|90
4427303|NCT00374322|7209876|FG000|Overall Study|Protocol Violation|8
4427304|NCT00374322|7209877|FG001|Overall Study|Protocol Violation|3
4427305|NCT00374322|7209876|FG000|Overall Study|Withdrawal by Subject|235
4427306|NCT00374322|7209877|FG001|Overall Study|Withdrawal by Subject|167
4427307|NCT00374322|7209876|FG000|Overall Study|Sponsor Terminated Study|866
4427308|NCT00374322|7209877|FG001|Overall Study|Sponsor Terminated Study|990
4427309|NCT00374322|7209876|FG000|Overall Study|Physician Decision|36
4427310|NCT00374322|7209877|FG001|Overall Study|Physician Decision|32
4427311|NCT00374322|7209876|FG000|Overall Study|Par. Consented to Survival FU Only|3
4427312|NCT00374322|7209877|FG001|Overall Study|Par. Consented to Survival FU Only|1
4427313|NCT00374322|7209876|FG000|Overall Study|Sponsor Decision|2
4427314|NCT00374322|7209877|FG001|Overall Study|Sponsor Decision|3
4427315|NCT00374322|7209876|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2
4427316|NCT00374322|7209877|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3
4427317|NCT00374322|7209876|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1
4427318|NCT00374322|7209877|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0
4427319|NCT00374322|7209876|FG000|Overall Study|Severe Toxicity|1
4427320|NCT00374322|7209877|FG001|Overall Study|Severe Toxicity|0
4427321|NCT00374322|7209876|FG000|Overall Study|Site Closed|2
4427322|NCT00374322|7209877|FG001|Overall Study|Site Closed|2
4427323|NCT00374322|7209876|FG000|Overall Study|Participant Changed Physician|1
4427324|NCT00374322|7209877|FG001|Overall Study|Participant Changed Physician|0
4629848|NCT01877421|7498132|FG008|Phase 2|Withdrawal by Subject|1
4427325|NCT00374322|7209876|FG000|Overall Study|Started Another Chemotherapy Regimen|0
4427326|NCT00374322|7209877|FG001|Overall Study|Started Another Chemotherapy Regimen|1
4427327|NCT00374322|7209876|FG000|Overall Study|Noncompliance with Study Requirements|0
4427328|NCT00374322|7209877|FG001|Overall Study|Noncompliance with Study Requirements|1
4427329|NCT00374322|7209876|FG000|Overall Study|Withdrew Consent During Follow-up|0
4427330|NCT00374322|7209877|FG001|Overall Study|Withdrew Consent During Follow-up|5
4427331|NCT00374322|7209876|FG000|Overall Study|Did Not Receive Study Medication|8
4427332|NCT00374322|7209877|FG001|Overall Study|Did Not Receive Study Medication|6
4427333|NCT00374452|7209890|FG000|Overall Study|Left clinic before intervention started|4
4427334|NCT00374452|7209891|FG001|Overall Study|Left clinic before intervention started|1
4427335|NCT00374452|7209890|FG000|Overall Study|Change in job role before intervention|0
4427336|NCT00374452|7209891|FG001|Overall Study|Change in job role before intervention|1
4427337|NCT00374452|7209890|FG000|Overall Study|Left clinic after intervention started|1
4427338|NCT00374452|7209891|FG001|Overall Study|Left clinic after intervention started|1
4427339|NCT00374452|7209890|FG000|Overall Study|Withdrawal by Subject|0
4427340|NCT00374452|7209891|FG001|Overall Study|Withdrawal by Subject|2
4427341|NCT00374556|7209899|FG000|Overall Study|Lost to Follow-up|1
4427342|NCT00374556|7209900|FG001|Overall Study|Lost to Follow-up|0
4427343|NCT00374556|7209899|FG000|Overall Study|Removed at baseline due to medical cond|0
4427344|NCT00374556|7209900|FG001|Overall Study|Removed at baseline due to medical cond|1
4427345|NCT00374868|7209932|FG000|Overall Study|Adverse Event|12
4427346|NCT00374868|7209932|FG000|Overall Study|Progressive Disease|7
4427347|NCT00374868|7209932|FG000|Overall Study|Physician Decision|13
4427348|NCT00374868|7209932|FG000|Overall Study|Lost to Follow-up|1
4427349|NCT00374868|7209932|FG000|Overall Study|Death|2
4427350|NCT00374868|7209932|FG000|Overall Study|Other - Not Specified|1
4427351|NCT00374907|7209938|FG000|12-Week Short-term Period|Subject Withdrew Consent|3
4427352|NCT00374907|7209939|FG001|12-Week Short-term Period|Subject Withdrew Consent|1
4427353|NCT00374907|7209938|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8
4427354|NCT00374907|7209939|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9
4427355|NCT00374907|7209938|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4
4427356|NCT00374907|7209939|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2
4427357|NCT00374907|7209938|FG000|116-Week Short-term + Long-term Period|Adverse Event|0
4427358|NCT00374907|7209939|FG001|116-Week Short-term + Long-term Period|Adverse Event|2
4427359|NCT00374907|7209938|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1
4427360|NCT00374907|7209939|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1
4427361|NCT00375219|7209961|FG000|Overall Study|Failure to achieve a response|16
4427362|NCT00375219|7209962|FG001|Overall Study|Failure to achieve a response|2
4427363|NCT00375219|7209963|FG002|Overall Study|Failure to achieve a response|0
4427364|NCT00375219|7209961|FG000|Overall Study|Adverse Event|8
4427365|NCT00375219|7209962|FG001|Overall Study|Adverse Event|2
4427366|NCT00375219|7209963|FG002|Overall Study|Adverse Event|1
4427367|NCT00375219|7209961|FG000|Overall Study|Protocol Violation|1
4427368|NCT00375219|7209962|FG001|Overall Study|Protocol Violation|0
4427369|NCT00375219|7209963|FG002|Overall Study|Protocol Violation|1
4427370|NCT00375219|7209961|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5
4427371|NCT00375219|7209962|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3
4427372|NCT00375219|7209963|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0
4427373|NCT00375219|7209961|FG000|Overall Study|Lost to Follow-up|1
4427374|NCT00375219|7209962|FG001|Overall Study|Lost to Follow-up|1
4427375|NCT00375219|7209963|FG002|Overall Study|Lost to Follow-up|0
4427376|NCT00375219|7209961|FG000|Overall Study|Disease progression|18
4427377|NCT00375219|7209962|FG001|Overall Study|Disease progression|9
4427378|NCT00375219|7209963|FG002|Overall Study|Disease progression|12
4427379|NCT00375219|7209961|FG000|Overall Study|Death|4
4427380|NCT00375219|7209962|FG001|Overall Study|Death|3
4427381|NCT00375219|7209963|FG002|Overall Study|Death|7
4427382|NCT00375219|7209961|FG000|Overall Study|Hematologic resistance|1
4427383|NCT00375219|7209962|FG001|Overall Study|Hematologic resistance|0
4427384|NCT00375219|7209963|FG002|Overall Study|Hematologic resistance|0
4427385|NCT00375219|7209961|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1
4427386|NCT00375219|7209962|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0
4427387|NCT00375219|7209963|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0
4427388|NCT00375219|7209961|FG000|Overall Study|Allograft|2
4427389|NCT00375219|7209962|FG001|Overall Study|Allograft|0
4427390|NCT00375219|7209963|FG002|Overall Study|Allograft|0
4427391|NCT00375219|7209961|FG000|Overall Study|Cord blood transplantation|1
4427392|NCT00375219|7209962|FG001|Overall Study|Cord blood transplantation|0
4427393|NCT00375219|7209963|FG002|Overall Study|Cord blood transplantation|0
4427394|NCT00375219|7209961|FG000|Overall Study|Withdrawal by Subject|1
4427395|NCT00375219|7209962|FG001|Overall Study|Withdrawal by Subject|0
4427396|NCT00375219|7209963|FG002|Overall Study|Withdrawal by Subject|0
4427397|NCT00375427|7209972|FG000|Overall Study|Adverse Event|21
4427398|NCT00375427|7209973|FG001|Overall Study|Adverse Event|27
4427399|NCT00375427|7209972|FG000|Overall Study|Abnormal test procedure result(s)|0
4427400|NCT00375427|7209973|FG001|Overall Study|Abnormal test procedure result(s)|1
4427401|NCT00375427|7209972|FG000|Overall Study|Abnormal laboratory value(s)|1
4427402|NCT00375427|7209973|FG001|Overall Study|Abnormal laboratory value(s)|2
4427403|NCT00375427|7209972|FG000|Overall Study|Unsatisfactory therapeutic effect|4
4427404|NCT00375427|7209973|FG001|Overall Study|Unsatisfactory therapeutic effect|4
4427405|NCT00375427|7209972|FG000|Overall Study|Patient no longer requires study drug|3
4427406|NCT00375427|7209973|FG001|Overall Study|Patient no longer requires study drug|7
4427407|NCT00375427|7209972|FG000|Overall Study|Protocol Violation|10
4427408|NCT00375427|7209973|FG001|Overall Study|Protocol Violation|8
4427409|NCT00375427|7209972|FG000|Overall Study|Withdrawal by Subject|9
4427410|NCT00375427|7209973|FG001|Overall Study|Withdrawal by Subject|13
4427411|NCT00375427|7209972|FG000|Overall Study|Lost to Follow-up|1
4427412|NCT00375427|7209973|FG001|Overall Study|Lost to Follow-up|1
4427413|NCT00375427|7209972|FG000|Overall Study|Administrative reasons|0
4427414|NCT00375427|7209973|FG001|Overall Study|Administrative reasons|1
4427415|NCT00375427|7209972|FG000|Overall Study|Death|11
4427416|NCT00375427|7209973|FG001|Overall Study|Death|10
4427417|NCT00375492|7209981|FG000|Overall Study|Adverse Event|4
4427418|NCT00375492|7209982|FG001|Overall Study|Adverse Event|5
4427419|NCT00375492|7209981|FG000|Overall Study|Entry Criteria Not Met|0
4427420|NCT00375492|7209982|FG001|Overall Study|Entry Criteria Not Met|1
4427421|NCT00375492|7209981|FG000|Overall Study|Loss of Glucose Control|0
4427422|NCT00375492|7209982|FG001|Overall Study|Loss of Glucose Control|1
4427423|NCT00375492|7209981|FG000|Overall Study|Lost to Follow-up|10
4427424|NCT00375492|7209982|FG001|Overall Study|Lost to Follow-up|5
4427425|NCT00375492|7209981|FG000|Overall Study|Physician Decision|0
4427426|NCT00375492|7209982|FG001|Overall Study|Physician Decision|4
4427427|NCT00375492|7209981|FG000|Overall Study|Protocol Violation|6
4427428|NCT00375492|7209982|FG001|Overall Study|Protocol Violation|3
4427429|NCT00375492|7209981|FG000|Overall Study|Sponsor Decision|0
4427430|NCT00375492|7209982|FG001|Overall Study|Sponsor Decision|1
4427431|NCT00375492|7209981|FG000|Overall Study|Withdrawal by Subject|6
4427432|NCT00375492|7209982|FG001|Overall Study|Withdrawal by Subject|6
4427433|NCT00375505|7209990|FG000|Overall Study|Adverse Event|1
4427434|NCT00375505|7209991|FG001|Overall Study|Adverse Event|2
4427435|NCT00375518|7209999|FG000|Overall Study|Withdrawal by Subject|2
4427436|NCT00375518|7210000|FG001|Overall Study|Withdrawal by Subject|10
4427437|NCT00375518|7209999|FG000|Overall Study|Patient Not Treated|6
4427438|NCT00375518|7210000|FG001|Overall Study|Patient Not Treated|6
4427439|NCT00375518|7209999|FG000|Overall Study|Death|0
4427440|NCT00375518|7210000|FG001|Overall Study|Death|1
4427441|NCT00375609|7210009|FG000|Overall Study|Did not receive treatment|1
4427442|NCT00375609|7210010|FG001|Overall Study|Did not receive treatment|0
4427443|NCT00375609|7210011|FG002|Overall Study|Did not receive treatment|0
4427444|NCT00375609|7210009|FG000|Overall Study|Adverse Event|0
4427445|NCT00375609|7210010|FG001|Overall Study|Adverse Event|3
4427446|NCT00375609|7210011|FG002|Overall Study|Adverse Event|0
4427447|NCT00375609|7210009|FG000|Overall Study|Lost to Follow-up|1
4427448|NCT00375609|7210010|FG001|Overall Study|Lost to Follow-up|0
4427449|NCT00375609|7210011|FG002|Overall Study|Lost to Follow-up|0
4427450|NCT00375609|7210009|FG000|Overall Study|Physician Decision|0
4427451|NCT00375609|7210010|FG001|Overall Study|Physician Decision|0
4427452|NCT00375609|7210011|FG002|Overall Study|Physician Decision|1
4427453|NCT00375609|7210009|FG000|Overall Study|Withdrawal by Subject|1
4427454|NCT00375609|7210010|FG001|Overall Study|Withdrawal by Subject|4
4427455|NCT00375609|7210011|FG002|Overall Study|Withdrawal by Subject|0
4427456|NCT00375609|7210009|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1
4427457|NCT00375609|7210010|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0
4427458|NCT00375609|7210011|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0
4427459|NCT00375674|7210021|FG000|Overall Study|Other|26
4512413|NCT00934050|7322162|FG002|Enrolled After 15 Dec 2009|Death|0
4715085|NCT02966834|7643220|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0
4715086|NCT02966834|7643215|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0
4715087|NCT02966834|7643216|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0
4715088|NCT02966834|7643217|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4
4715089|NCT02966834|7643218|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8
4715090|NCT02966834|7643219|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0
4715091|NCT02966834|7643220|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5
4715092|NCT02966834|7643215|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0
4715093|NCT02966834|7643216|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0
4715094|NCT02966834|7643217|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1
4715095|NCT02966834|7643218|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2
4715096|NCT02966834|7643219|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0
4715097|NCT02966834|7643220|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1
4715098|NCT02966834|7643215|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0
4715099|NCT02966834|7643216|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0
4427460|NCT00375674|7210022|FG001|Overall Study|Other|18
4427461|NCT00375674|7210021|FG000|Overall Study|Death|67
4427462|NCT00375674|7210022|FG001|Overall Study|Death|76
4427463|NCT00375674|7210021|FG000|Overall Study|Participants refused further follow-up|31
4427464|NCT00375674|7210022|FG001|Overall Study|Participants refused further follow-up|30
4427465|NCT00375674|7210021|FG000|Overall Study|Lost to Follow-up|17
4427466|NCT00375674|7210022|FG001|Overall Study|Lost to Follow-up|15
4427467|NCT00375674|7210021|FG000|Overall Study|Enrolled but not treated|3
4427468|NCT00375674|7210022|FG001|Overall Study|Enrolled but not treated|2
4427469|NCT00375752|7210039|FG000|Overall Study|Lack of Efficacy|4
4427470|NCT00375752|7210040|FG001|Overall Study|Lack of Efficacy|4
4427471|NCT00375752|7210039|FG000|Overall Study|Adverse Event|1
4427472|NCT00375752|7210040|FG001|Overall Study|Adverse Event|6
4427473|NCT00375752|7210039|FG000|Overall Study|Withdrawal by Subject|6
4427474|NCT00375752|7210040|FG001|Overall Study|Withdrawal by Subject|1
4427475|NCT00375752|7210039|FG000|Overall Study|Abnormal Laboratory Value(s)|1
4427476|NCT00375752|7210040|FG001|Overall Study|Abnormal Laboratory Value(s)|1
4427477|NCT00375752|7210039|FG000|Overall Study|Protocol Violation|0
4427478|NCT00375752|7210040|FG001|Overall Study|Protocol Violation|2
4427479|NCT00375752|7210039|FG000|Overall Study|Administrative Problems|0
4427480|NCT00375752|7210040|FG001|Overall Study|Administrative Problems|1
4427481|NCT00375934|7210073|FG000|Overall Study|Adverse Event|1
4427482|NCT00375934|7210074|FG001|Overall Study|Adverse Event|1
4427483|NCT00375934|7210073|FG000|Overall Study|Withdrawal by Subject|2
4427484|NCT00375934|7210074|FG001|Overall Study|Withdrawal by Subject|2
4427485|NCT00375934|7210073|FG000|Overall Study|Lack of Efficacy|0
4427486|NCT00375934|7210074|FG001|Overall Study|Lack of Efficacy|2
4427487|NCT00375934|7210073|FG000|Overall Study|Physician Decision|0
4427488|NCT00375934|7210074|FG001|Overall Study|Physician Decision|1
4512414|NCT00934050|7322163|FG003|Enrolled After 15 Dec 2009|Death|0
4512415|NCT00934050|7322164|FG004|Enrolled After 15 Dec 2009|Death|0
4512416|NCT00934050|7322165|FG005|Enrolled After 15 Dec 2009|Death|1
4512417|NCT00934050|7322160|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0
4512418|NCT00934050|7322161|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0
4512419|NCT00934050|7322162|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0
4512420|NCT00934050|7322163|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0
4512421|NCT00934050|7322164|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0
4512422|NCT00934050|7322165|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1
4629849|NCT01877421|7498133|FG009|Phase 2|Withdrawal by Subject|0
4629850|NCT01877421|7498134|FG010|Phase 2|Withdrawal by Subject|1
4629851|NCT01877421|7498135|FG011|Phase 2|Withdrawal by Subject|0
4629852|NCT01877421|7498136|FG012|Phase 2|Withdrawal by Subject|1
4629853|NCT01877421|7498137|FG013|Phase 2|Withdrawal by Subject|0
4629854|NCT01877421|7498138|FG014|Phase 2|Withdrawal by Subject|0
4629855|NCT01877421|7498139|FG015|Phase 2|Withdrawal by Subject|1
4629856|NCT01877421|7498140|FG016|Phase 2|Withdrawal by Subject|0
4629857|NCT01877421|7498141|FG017|Phase 2|Withdrawal by Subject|0
4629858|NCT01877421|7498124|FG000|Phase 2|Protocol Violation|0
4629859|NCT01877421|7498125|FG001|Phase 2|Protocol Violation|0
4629860|NCT01877421|7498126|FG002|Phase 2|Protocol Violation|0
4629861|NCT01877421|7498127|FG003|Phase 2|Protocol Violation|0
4629862|NCT01877421|7498128|FG004|Phase 2|Protocol Violation|0
4629863|NCT01877421|7498129|FG005|Phase 2|Protocol Violation|0
4629864|NCT01877421|7498130|FG006|Phase 2|Protocol Violation|0
4629865|NCT01877421|7498131|FG007|Phase 2|Protocol Violation|0
4629866|NCT01877421|7498132|FG008|Phase 2|Protocol Violation|0
4629867|NCT01877421|7498133|FG009|Phase 2|Protocol Violation|0
4629868|NCT01877421|7498134|FG010|Phase 2|Protocol Violation|1
4629869|NCT01877421|7498135|FG011|Phase 2|Protocol Violation|0
4629870|NCT01877421|7498136|FG012|Phase 2|Protocol Violation|0
4629871|NCT01877421|7498137|FG013|Phase 2|Protocol Violation|0
4629872|NCT01877421|7498138|FG014|Phase 2|Protocol Violation|0
4629873|NCT01877421|7498139|FG015|Phase 2|Protocol Violation|0
4629874|NCT01877421|7498140|FG016|Phase 2|Protocol Violation|0
4629875|NCT01877421|7498141|FG017|Phase 2|Protocol Violation|0
4629876|NCT01877551|7498227|FG000|Overall Study|Physician Decision|0
4629877|NCT01877551|7498228|FG001|Overall Study|Physician Decision|1
4629878|NCT01877668|7498256|FG000|Overall Study|Death|0
4629879|NCT01877668|7498257|FG001|Overall Study|Death|0
4629880|NCT01877668|7498258|FG002|Overall Study|Death|0
4629881|NCT01877668|7498259|FG003|Overall Study|Death|1
4629882|NCT01877668|7498260|FG004|Overall Study|Death|0
4629883|NCT01877668|7498256|FG000|Overall Study|No longer met study criteria|1
4629884|NCT01877668|7498257|FG001|Overall Study|No longer met study criteria|0
4629885|NCT01877668|7498258|FG002|Overall Study|No longer met study criteria|1
4629886|NCT01877668|7498259|FG003|Overall Study|No longer met study criteria|0
4629887|NCT01877668|7498260|FG004|Overall Study|No longer met study criteria|0
4629888|NCT01877668|7498256|FG000|Overall Study|Insufficient clinical response|0
4512423|NCT00934050|7322160|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
4512424|NCT00934050|7322161|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
4512425|NCT00934050|7322162|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
4512426|NCT00934050|7322163|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
4512427|NCT00934050|7322164|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4
4629889|NCT01877668|7498257|FG001|Overall Study|Insufficient clinical response|1
4629890|NCT01877668|7498258|FG002|Overall Study|Insufficient clinical response|2
4629891|NCT01877668|7498259|FG003|Overall Study|Insufficient clinical response|2
4629892|NCT01877668|7498260|FG004|Overall Study|Insufficient clinical response|0
4629893|NCT01877668|7498256|FG000|Overall Study|Lost to Follow-up|0
4629894|NCT01877668|7498257|FG001|Overall Study|Lost to Follow-up|2
4629895|NCT01877668|7498258|FG002|Overall Study|Lost to Follow-up|1
4629896|NCT01877668|7498259|FG003|Overall Study|Lost to Follow-up|0
4629897|NCT01877668|7498260|FG004|Overall Study|Lost to Follow-up|0
4629898|NCT01877668|7498256|FG000|Overall Study|Withdrawal by Subject|2
4427489|NCT00376168|7210095|FG000|Overall Study|Adverse Event|1
4427490|NCT00376168|7210096|FG001|Overall Study|Adverse Event|1
4427491|NCT00376168|7210095|FG000|Overall Study|Pregnancy|1
4427492|NCT00376168|7210096|FG001|Overall Study|Pregnancy|0
4427493|NCT00376220|7210104|FG000|Overall Study|Lost to Follow-up|7
4427494|NCT00376220|7210105|FG001|Overall Study|Lost to Follow-up|10
4427495|NCT00376220|7210104|FG000|Overall Study|Withdrawal by Subject|3
4427496|NCT00376220|7210105|FG001|Overall Study|Withdrawal by Subject|2
4427497|NCT00376246|7210111|FG000|First Intervention (2 Weeks)|Adverse Event|2
4427498|NCT00376246|7210112|FG001|First Intervention (2 Weeks)|Adverse Event|0
4427499|NCT00376246|7210111|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1
4427500|NCT00376246|7210112|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2
4427501|NCT00376246|7210111|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1
4427502|NCT00376246|7210112|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0
4427503|NCT00376259|7210122|FG000|Overall Study|Sponsor request - study termination|21
4427504|NCT00376259|7210123|FG001|Overall Study|Sponsor request - study termination|21
4427505|NCT00376259|7210122|FG000|Overall Study|Patient request|1
4427506|NCT00376259|7210123|FG001|Overall Study|Patient request|0
4427507|NCT00376506|7210140|FG000|Overall Study|Death|0
4427508|NCT00376506|7210141|FG001|Overall Study|Death|2
4427509|NCT00376532|7210152|FG000|Overall Study|Lack sufficient blood sample|6
4427510|NCT00376532|7210153|FG001|Overall Study|Lack sufficient blood sample|6
4427511|NCT00376675|7210182|FG000|Overall Study|Withdrawal by Subject|9
4427512|NCT00376675|7210183|FG001|Overall Study|Withdrawal by Subject|2
4427513|NCT00376675|7210182|FG000|Overall Study|Adverse Event|10
4427514|NCT00376675|7210183|FG001|Overall Study|Adverse Event|5
4427515|NCT00376675|7210182|FG000|Overall Study|Other Reason|1
4427516|NCT00376675|7210183|FG001|Overall Study|Other Reason|7
4427517|NCT00376688|7210189|FG000|Overall Study|Adverse Event|3
4427518|NCT00376688|7210189|FG000|Overall Study|Death|1
4427519|NCT00376961|7210218|FG000|Initial Registration|Adverse Event|1
4427520|NCT00376961|7210219|FG001|Initial Registration|Adverse Event|0
4427521|NCT00376961|7210218|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2
4427522|NCT00376961|7210219|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0
4427523|NCT00376961|7210218|FG000|Initial Registration|Progression/relapse|1
4427524|NCT00376961|7210219|FG001|Initial Registration|Progression/relapse|0
4427525|NCT00376961|7210218|FG000|Initial Registration|Ineligible|3
4427526|NCT00376961|7210219|FG001|Initial Registration|Ineligible|0
4427527|NCT00376961|7210218|FG000|Maintenance|Adverse Event|0
4427528|NCT00376961|7210219|FG001|Maintenance|Adverse Event|1
4427529|NCT00376961|7210218|FG000|Maintenance|Refusal Unrelated to Adverse Event|0
4427530|NCT00376961|7210219|FG001|Maintenance|Refusal Unrelated to Adverse Event|1
4629899|NCT01877668|7498257|FG001|Overall Study|Withdrawal by Subject|0
4629900|NCT01877668|7498258|FG002|Overall Study|Withdrawal by Subject|3
4629901|NCT01877668|7498259|FG003|Overall Study|Withdrawal by Subject|2
4629902|NCT01877668|7498260|FG004|Overall Study|Withdrawal by Subject|2
4629903|NCT01877668|7498256|FG000|Overall Study|Other|1
4629904|NCT01877668|7498257|FG001|Overall Study|Other|1
4629905|NCT01877668|7498258|FG002|Overall Study|Other|1
4629906|NCT01877668|7498259|FG003|Overall Study|Other|1
4629907|NCT01877668|7498260|FG004|Overall Study|Other|3
4629908|NCT01877668|7498256|FG000|Overall Study|Protocol Violation|1
4629909|NCT01877668|7498257|FG001|Overall Study|Protocol Violation|1
4629910|NCT01877668|7498258|FG002|Overall Study|Protocol Violation|0
4629911|NCT01877668|7498259|FG003|Overall Study|Protocol Violation|0
4629912|NCT01877668|7498260|FG004|Overall Study|Protocol Violation|3
4629913|NCT01877668|7498256|FG000|Overall Study|Adverse event related to study drug|2
4427531|NCT00376961|7210218|FG000|Maintenance|Progression/relapse|0
4427532|NCT00376961|7210219|FG001|Maintenance|Progression/relapse|18
4427533|NCT00376961|7210218|FG000|Maintenance|Ineligible|0
4427534|NCT00376961|7210219|FG001|Maintenance|Ineligible|3
4427535|NCT00377156|7210229|FG000|Overall Study|Death|23
4427536|NCT00377156|7210230|FG001|Overall Study|Death|19
4427537|NCT00377156|7210229|FG000|Overall Study|Withdrawal by Subject|16
4427538|NCT00377156|7210230|FG001|Overall Study|Withdrawal by Subject|24
4427539|NCT00377156|7210229|FG000|Overall Study|Had follow-up <90 d|3
4427540|NCT00377156|7210230|FG001|Overall Study|Had follow-up <90 d|6
4427541|NCT00377156|7210229|FG000|Overall Study|Cancellation|1
4427542|NCT00377156|7210230|FG001|Overall Study|Cancellation|0
4427543|NCT00377156|7210229|FG000|Overall Study|Refused testing|0
4427544|NCT00377156|7210230|FG001|Overall Study|Refused testing|1
4427545|NCT00377156|7210229|FG000|Overall Study|Ineligible|0
4427546|NCT00377156|7210230|FG001|Overall Study|Ineligible|1
4427547|NCT00377156|7210229|FG000|Overall Study|Disability or language problem|0
4427548|NCT00377156|7210230|FG001|Overall Study|Disability or language problem|1
4427549|NCT00377156|7210229|FG000|Overall Study|Other|5
4427550|NCT00377156|7210230|FG001|Overall Study|Other|2
4427551|NCT00377234|7210240|FG000|Overall Study|Adverse Event|14
4427552|NCT00377234|7210241|FG001|Overall Study|Adverse Event|17
4427553|NCT00377234|7210240|FG000|Overall Study|Withdrawal by Subject|11
4629914|NCT01877668|7498257|FG001|Overall Study|Adverse event related to study drug|2
4629915|NCT01877668|7498258|FG002|Overall Study|Adverse event related to study drug|2
4629916|NCT01877668|7498259|FG003|Overall Study|Adverse event related to study drug|2
4427554|NCT00377234|7210241|FG001|Overall Study|Withdrawal by Subject|9
4427555|NCT00377234|7210240|FG000|Overall Study|Lost to Follow-up|4
4427556|NCT00377234|7210241|FG001|Overall Study|Lost to Follow-up|2
4427557|NCT00377234|7210240|FG000|Overall Study|Administrative|2
4427558|NCT00377234|7210241|FG001|Overall Study|Administrative|1
4427559|NCT00377234|7210240|FG000|Overall Study|Not assigned|3
4427560|NCT00377234|7210241|FG001|Overall Study|Not assigned|2
4427561|NCT00377260|7210255|FG000|Overall Study|Lost to Follow-up|0
4629917|NCT01877668|7498260|FG004|Overall Study|Adverse event related to study drug|1
4629918|NCT01877668|7498256|FG000|Overall Study|Adverse event unrelated to study drug|4
4629919|NCT01877668|7498257|FG001|Overall Study|Adverse event unrelated to study drug|1
4629920|NCT01877668|7498258|FG002|Overall Study|Adverse event unrelated to study drug|2
4629921|NCT01877668|7498259|FG003|Overall Study|Adverse event unrelated to study drug|0
4629922|NCT01877668|7498260|FG004|Overall Study|Adverse event unrelated to study drug|1
4629923|NCT01877720|7498276|FG000|Overall Study|Adverse Event|1
4629924|NCT01877720|7498277|FG001|Overall Study|Adverse Event|0
4629925|NCT01877915|7498285|FG000|Overall Study|Lost to Follow-up|10
4629926|NCT01877915|7498286|FG001|Overall Study|Lost to Follow-up|9
4629927|NCT01877915|7498285|FG000|Overall Study|Withdrawal by Subject|42
4629928|NCT01877915|7498286|FG001|Overall Study|Withdrawal by Subject|55
4629929|NCT01877915|7498285|FG000|Overall Study|Other|2
4427562|NCT00377260|7210256|FG001|Overall Study|Lost to Follow-up|1
4427563|NCT00377260|7210255|FG000|Overall Study|Withdrawal by Subject|2
4427564|NCT00377260|7210256|FG001|Overall Study|Withdrawal by Subject|4
4427565|NCT00377299|7210264|FG000|Overall Study|Lost to Follow-up|14
4427566|NCT00377299|7210265|FG001|Overall Study|Lost to Follow-up|19
4427567|NCT00377299|7210264|FG000|Overall Study|Adverse Event|0
4427568|NCT00377299|7210265|FG001|Overall Study|Adverse Event|1
4427569|NCT00377299|7210264|FG000|Overall Study|Withdrawal by Subject|5
4427570|NCT00377299|7210265|FG001|Overall Study|Withdrawal by Subject|4
4427571|NCT00377312|7210274|FG000|Overall Study|Adverse Event|1
4427572|NCT00377312|7210275|FG001|Overall Study|Adverse Event|1
4427573|NCT00377364|7210283|FG000|Overall Study|Lost to Follow-up|1
4427574|NCT00377364|7210284|FG001|Overall Study|Lost to Follow-up|0
4427575|NCT00377364|7210283|FG000|Overall Study|Withdrawal by Subject|1
4427576|NCT00377364|7210284|FG001|Overall Study|Withdrawal by Subject|0
4427577|NCT00377403|7210294|FG000|Overall Study|Unable to contact for telephone intervie|4
4427578|NCT00377403|7210295|FG001|Overall Study|Unable to contact for telephone intervie|7
4427579|NCT00377429|7210301|FG000|Overall Study|Withdrawal by Subject|5
4427580|NCT00377429|7210301|FG000|Overall Study|Adverse Event|8
4427581|NCT00377429|7210301|FG000|Overall Study|Physician Decision|1
4427582|NCT00377429|7210301|FG000|Overall Study|Patient non-compliance|1
4427583|NCT00377520|7210305|FG000|Overall Study|Ineligible (Prior radiation)|1
4427584|NCT00377611|7210320|FG000|Overall Study|Adverse Event|2
4427585|NCT00377611|7210321|FG001|Overall Study|Adverse Event|9
4427586|NCT00377611|7210320|FG000|Overall Study|Protocol Violation|2
4427587|NCT00377611|7210321|FG001|Overall Study|Protocol Violation|0
4427588|NCT00377611|7210320|FG000|Overall Study|Withdrawal by Subject|0
4427589|NCT00377611|7210321|FG001|Overall Study|Withdrawal by Subject|5
4427590|NCT00377611|7210320|FG000|Overall Study|Lost to Follow-up|18
4427591|NCT00377611|7210321|FG001|Overall Study|Lost to Follow-up|16
4427592|NCT00377611|7210320|FG000|Overall Study|Other|0
4427593|NCT00377611|7210321|FG001|Overall Study|Other|3
4427594|NCT00377637|7210332|FG000|Induction Phase|Adverse Event|12
4427595|NCT00377637|7210333|FG001|Induction Phase|Adverse Event|21
4427596|NCT00377637|7210334|FG002|Induction Phase|Adverse Event|0
4427597|NCT00377637|7210335|FG003|Induction Phase|Adverse Event|0
4427598|NCT00377637|7210332|FG000|Induction Phase|Deterioration/serum creatinine|2
4427599|NCT00377637|7210333|FG001|Induction Phase|Deterioration/serum creatinine|0
4427600|NCT00377637|7210334|FG002|Induction Phase|Deterioration/serum creatinine|0
4427601|NCT00377637|7210335|FG003|Induction Phase|Deterioration/serum creatinine|0
4427602|NCT00377637|7210332|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
4427603|NCT00377637|7210333|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1
4427604|NCT00377637|7210334|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
4427605|NCT00377637|7210335|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
4427606|NCT00377637|7210332|FG000|Induction Phase|Lost to Follow-up|2
4427607|NCT00377637|7210333|FG001|Induction Phase|Lost to Follow-up|1
4427608|NCT00377637|7210334|FG002|Induction Phase|Lost to Follow-up|0
4427609|NCT00377637|7210335|FG003|Induction Phase|Lost to Follow-up|0
4427610|NCT00377637|7210332|FG000|Induction Phase|Death|1
4427611|NCT00377637|7210333|FG001|Induction Phase|Death|3
4427612|NCT00377637|7210334|FG002|Induction Phase|Death|0
4427613|NCT00377637|7210335|FG003|Induction Phase|Death|0
4427614|NCT00377637|7210332|FG000|Induction Phase|Withdrawal by Subject|5
4427615|NCT00377637|7210333|FG001|Induction Phase|Withdrawal by Subject|6
4427616|NCT00377637|7210334|FG002|Induction Phase|Withdrawal by Subject|0
4427617|NCT00377637|7210335|FG003|Induction Phase|Withdrawal by Subject|0
4629930|NCT01877915|7498286|FG001|Overall Study|Other|4
4427618|NCT00377637|7210332|FG000|Induction Phase|Physician Decision|3
4427619|NCT00377637|7210333|FG001|Induction Phase|Physician Decision|1
4427620|NCT00377637|7210334|FG002|Induction Phase|Physician Decision|0
4427621|NCT00377637|7210335|FG003|Induction Phase|Physician Decision|0
4427622|NCT00377637|7210332|FG000|Induction Phase|Sponsor decision|1
4427623|NCT00377637|7210333|FG001|Induction Phase|Sponsor decision|2
4427624|NCT00377637|7210334|FG002|Induction Phase|Sponsor decision|0
4427625|NCT00377637|7210335|FG003|Induction Phase|Sponsor decision|0
4427626|NCT00377637|7210332|FG000|Induction Phase|Non-Compliance|1
4427627|NCT00377637|7210333|FG001|Induction Phase|Non-Compliance|0
4427628|NCT00377637|7210334|FG002|Induction Phase|Non-Compliance|0
4427629|NCT00377637|7210335|FG003|Induction Phase|Non-Compliance|0
4427630|NCT00377637|7210332|FG000|Induction Phase|Reason for withdrawal is not noted|2
4427631|NCT00377637|7210333|FG001|Induction Phase|Reason for withdrawal is not noted|0
4427632|NCT00377637|7210334|FG002|Induction Phase|Reason for withdrawal is not noted|0
4427633|NCT00377637|7210335|FG003|Induction Phase|Reason for withdrawal is not noted|0
4427634|NCT00377637|7210332|FG000|Maintenance Phase|Adverse Event|0
4427635|NCT00377637|7210333|FG001|Maintenance Phase|Adverse Event|0
4427636|NCT00377637|7210334|FG002|Maintenance Phase|Adverse Event|29
4427637|NCT00377637|7210335|FG003|Maintenance Phase|Adverse Event|43
4427638|NCT00377637|7210332|FG000|Maintenance Phase|Physician Decision|0
4427639|NCT00377637|7210333|FG001|Maintenance Phase|Physician Decision|0
4427640|NCT00377637|7210334|FG002|Maintenance Phase|Physician Decision|5
4427641|NCT00377637|7210335|FG003|Maintenance Phase|Physician Decision|4
4427642|NCT00377637|7210332|FG000|Maintenance Phase|Lost to Follow-up|0
4427643|NCT00377637|7210333|FG001|Maintenance Phase|Lost to Follow-up|0
4427644|NCT00377637|7210334|FG002|Maintenance Phase|Lost to Follow-up|3
4427645|NCT00377637|7210335|FG003|Maintenance Phase|Lost to Follow-up|1
4427646|NCT00377637|7210332|FG000|Maintenance Phase|Withdrawal by Subject|0
4427647|NCT00377637|7210333|FG001|Maintenance Phase|Withdrawal by Subject|0
4427648|NCT00377637|7210334|FG002|Maintenance Phase|Withdrawal by Subject|3
4427649|NCT00377637|7210335|FG003|Maintenance Phase|Withdrawal by Subject|3
4427650|NCT00377637|7210332|FG000|Maintenance Phase|Sponsor decision|0
4427651|NCT00377637|7210333|FG001|Maintenance Phase|Sponsor decision|0
4427652|NCT00377637|7210334|FG002|Maintenance Phase|Sponsor decision|2
4427653|NCT00377637|7210335|FG003|Maintenance Phase|Sponsor decision|3
4427654|NCT00377637|7210332|FG000|Maintenance Phase|Non-compliance|0
4427655|NCT00377637|7210333|FG001|Maintenance Phase|Non-compliance|0
4427656|NCT00377637|7210334|FG002|Maintenance Phase|Non-compliance|1
4427657|NCT00377637|7210335|FG003|Maintenance Phase|Non-compliance|1
4427658|NCT00377637|7210332|FG000|Maintenance Phase|Study medication stopped > 14 days|0
4427659|NCT00377637|7210333|FG001|Maintenance Phase|Study medication stopped > 14 days|0
4427660|NCT00377637|7210334|FG002|Maintenance Phase|Study medication stopped > 14 days|0
4427661|NCT00377637|7210335|FG003|Maintenance Phase|Study medication stopped > 14 days|1
4427662|NCT00377637|7210332|FG000|Maintenance Phase|Death|0
4427663|NCT00377637|7210333|FG001|Maintenance Phase|Death|0
4427664|NCT00377637|7210334|FG002|Maintenance Phase|Death|0
4427665|NCT00377637|7210335|FG003|Maintenance Phase|Death|1
4427666|NCT00377676|7210351|FG000|Overall Study|Adverse Event|498
4427667|NCT00377676|7210352|FG001|Overall Study|Adverse Event|107
4427668|NCT00377676|7210351|FG000|Overall Study|Protocol Violation|33
4427669|NCT00377676|7210352|FG001|Overall Study|Protocol Violation|27
4427670|NCT00377676|7210351|FG000|Overall Study|Death|5
4427671|NCT00377676|7210352|FG001|Overall Study|Death|2
4427672|NCT00377676|7210351|FG000|Overall Study|Withdrawal by Subject|187
4427673|NCT00377676|7210352|FG001|Overall Study|Withdrawal by Subject|72
4427674|NCT00377676|7210351|FG000|Overall Study|Lost to Follow-up|120
4427675|NCT00377676|7210352|FG001|Overall Study|Lost to Follow-up|56
4427676|NCT00377676|7210351|FG000|Overall Study|Other|118
4427677|NCT00377676|7210352|FG001|Overall Study|Other|58
4427678|NCT00377819|7210369|FG000|Overall Study|Adverse Event|2
4427679|NCT00377819|7210370|FG001|Overall Study|Adverse Event|3
4427680|NCT00377819|7210369|FG000|Overall Study|Withdrawal by Subject|10
4427681|NCT00377819|7210370|FG001|Overall Study|Withdrawal by Subject|4
4427682|NCT00377819|7210369|FG000|Overall Study|Death|0
4427683|NCT00377819|7210370|FG001|Overall Study|Death|1
4427684|NCT00377819|7210369|FG000|Overall Study|Lost to Follow-up|0
4427685|NCT00377819|7210370|FG001|Overall Study|Lost to Follow-up|1
4427686|NCT00377819|7210369|FG000|Overall Study|Protocol Violation|1
4427687|NCT00377819|7210370|FG001|Overall Study|Protocol Violation|1
4427688|NCT00377858|7210390|FG000|Overall Study|Withdrawal by Subject|12
4427689|NCT00377858|7210391|FG001|Overall Study|Withdrawal by Subject|11
4427690|NCT00377858|7210390|FG000|Overall Study|Lost to Follow-up|6
4427691|NCT00377858|7210391|FG001|Overall Study|Lost to Follow-up|1
4427692|NCT00377858|7210390|FG000|Overall Study|Physician Decision|5
4427693|NCT00377858|7210391|FG001|Overall Study|Physician Decision|5
4427694|NCT00377858|7210390|FG000|Overall Study|Protocol Violation|3
4427695|NCT00377858|7210391|FG001|Overall Study|Protocol Violation|4
4427696|NCT00377858|7210390|FG000|Overall Study|Adverse Event|2
4427697|NCT00377858|7210391|FG001|Overall Study|Adverse Event|1
4427698|NCT00377858|7210390|FG000|Overall Study|Entry Criteria Not Met|2
4427699|NCT00377858|7210391|FG001|Overall Study|Entry Criteria Not Met|0
4427700|NCT00377858|7210390|FG000|Overall Study|Sponsor Decision|1
4427701|NCT00377858|7210391|FG001|Overall Study|Sponsor Decision|2
4427702|NCT00377858|7210390|FG000|Overall Study|Death|0
4427703|NCT00377858|7210391|FG001|Overall Study|Death|3
4427704|NCT00377962|7210399|FG000|Core Study: 0-12 Months|Adverse Event|18
4427705|NCT00377962|7210400|FG001|Core Study: 0-12 Months|Adverse Event|2
4427706|NCT00377962|7210399|FG000|Core Study: 0-12 Months|Death|3
4427707|NCT00377962|7210400|FG001|Core Study: 0-12 Months|Death|0
4427708|NCT00377962|7210399|FG000|Core Study: 0-12 Months|Withdrew Consent|5
4427709|NCT00377962|7210400|FG001|Core Study: 0-12 Months|Withdrew Consent|2
4427710|NCT00377962|7210399|FG000|Core Study: 0-12 Months|Administrative Reason|1
4427711|NCT00377962|7210400|FG001|Core Study: 0-12 Months|Administrative Reason|1
4427712|NCT00377962|7210399|FG000|Core Study: 0-12 Months|Unspecified reasons|1
4427713|NCT00377962|7210400|FG001|Core Study: 0-12 Months|Unspecified reasons|4
4427714|NCT00377962|7210399|FG000|Extension Study: 12-24 Months|Death|1
4427715|NCT00377962|7210400|FG001|Extension Study: 12-24 Months|Death|1
4427716|NCT00377962|7210399|FG000|Extension Study: 12-24 Months|Adverse Event|8
4427717|NCT00377962|7210400|FG001|Extension Study: 12-24 Months|Adverse Event|0
4427718|NCT00377962|7210399|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1
4427719|NCT00377962|7210400|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0
4427720|NCT00377962|7210399|FG000|Extension Study: 12-24 Months|Unspecified reason|0
4427721|NCT00377962|7210400|FG001|Extension Study: 12-24 Months|Unspecified reason|3
4427722|NCT00378014|7210414|FG000|Core (Randomization to Month 11)|Adverse Event|1
4427723|NCT00378014|7210415|FG001|Core (Randomization to Month 11)|Adverse Event|0
4427724|NCT00378014|7210414|FG000|Core (Randomization to Month 11)|Graft loss|1
4427725|NCT00378014|7210415|FG001|Core (Randomization to Month 11)|Graft loss|2
4427726|NCT00378014|7210414|FG000|Core (Randomization to Month 11)|Death|5
4427727|NCT00378014|7210415|FG001|Core (Randomization to Month 11)|Death|3
4427728|NCT00378014|7210414|FG000|Core (Randomization to Month 11)|Administrative Problems|2
4427729|NCT00378014|7210415|FG001|Core (Randomization to Month 11)|Administrative Problems|2
4427730|NCT00378014|7210414|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0
4427731|NCT00378014|7210415|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1
4427732|NCT00378014|7210414|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5
4427733|NCT00378014|7210415|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2
4427734|NCT00378014|7210414|FG000|Core (Randomization to Month 11)|Protocol deviation|0
4427735|NCT00378014|7210415|FG001|Core (Randomization to Month 11)|Protocol deviation|1
4427736|NCT00378014|7210414|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0
4427737|NCT00378014|7210415|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1
4427738|NCT00378014|7210414|FG000|Extension (Month 12 to Month 59)|Adverse Event|8
4427739|NCT00378014|7210415|FG001|Extension (Month 12 to Month 59)|Adverse Event|7
4427740|NCT00378014|7210414|FG000|Extension (Month 12 to Month 59)|Death|1
4427741|NCT00378014|7210415|FG001|Extension (Month 12 to Month 59)|Death|2
4427742|NCT00378014|7210414|FG000|Extension (Month 12 to Month 59)|Administrative problems|1
4427743|NCT00378014|7210415|FG001|Extension (Month 12 to Month 59)|Administrative problems|0
4427744|NCT00378014|7210414|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1
4427745|NCT00378014|7210415|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1
4427746|NCT00378014|7210414|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0
4427747|NCT00378014|7210415|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3
4427748|NCT00378014|7210414|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3
4427749|NCT00378014|7210415|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1
4427750|NCT00378079|7210426|FG000|Overall Study|Lost to Follow-up|6
4427751|NCT00378079|7210427|FG001|Overall Study|Lost to Follow-up|1
4427752|NCT00378079|7210428|FG002|Overall Study|Lost to Follow-up|0
4427753|NCT00378105|7210438|FG000|Overall Study|Adverse Event|3
4427754|NCT00378105|7210439|FG001|Overall Study|Adverse Event|1
4427755|NCT00378105|7210438|FG000|Overall Study|Withdrawal by Subject|3
4427756|NCT00378105|7210439|FG001|Overall Study|Withdrawal by Subject|3
4427757|NCT00378105|7210438|FG000|Overall Study|Death|1
4427758|NCT00378105|7210439|FG001|Overall Study|Death|0
4427759|NCT00378105|7210438|FG000|Overall Study|Going to transplant|7
4427760|NCT00378105|7210439|FG001|Overall Study|Going to transplant|8
4427761|NCT00378105|7210438|FG000|Overall Study|Progressive disease|3
4427762|NCT00378105|7210439|FG001|Overall Study|Progressive disease|3
4427763|NCT00378105|7210438|FG000|Overall Study|remain on study|3
4427764|NCT00378105|7210439|FG001|Overall Study|remain on study|11
4427765|NCT00378105|7210438|FG000|Overall Study|Physician Decision|0
4427766|NCT00378105|7210439|FG001|Overall Study|Physician Decision|2
4427767|NCT00378105|7210438|FG000|Overall Study|Going non-protocol therapy|0
4427768|NCT00378105|7210439|FG001|Overall Study|Going non-protocol therapy|1
4427769|NCT00378105|7210438|FG000|Overall Study|necessity to increase lenalidomide dose|0
4427770|NCT00378105|7210439|FG001|Overall Study|necessity to increase lenalidomide dose|1
4427771|NCT00378209|7210446|FG000|Overall Study|Progressive disease|11
4427772|NCT00378209|7210446|FG000|Overall Study|Adverse Event|3
4427773|NCT00378209|7210446|FG000|Overall Study|Initiation of non-protocol therapy|3
4427774|NCT00378209|7210446|FG000|Overall Study|Physician Decision|3
4427775|NCT00378209|7210446|FG000|Overall Study|Death|1
4427776|NCT00378209|7210446|FG000|Overall Study|Treatment delay|1
4427777|NCT00378508|7210474|FG000|Overall Study|Withdrawal by Subject|1
4427778|NCT00378508|7210475|FG001|Overall Study|Withdrawal by Subject|3
4427779|NCT00378508|7210474|FG000|Overall Study|Lost to Follow-up|1
4427780|NCT00378508|7210475|FG001|Overall Study|Lost to Follow-up|0
4427781|NCT00378534|7210484|FG000|Overall Study|Participants did not receive transplant|3
4427782|NCT00378534|7210485|FG001|Overall Study|Participants did not receive transplant|0
4427783|NCT00378560|7210492|FG000|Overall Study|Adverse Event|1
4427784|NCT00378560|7210493|FG001|Overall Study|Adverse Event|0
4427785|NCT00378560|7210492|FG000|Overall Study|Lost to Follow-up|24
4427786|NCT00378560|7210493|FG001|Overall Study|Lost to Follow-up|29
4427787|NCT00378560|7210492|FG000|Overall Study|Protocol Violation|2
4427788|NCT00378560|7210493|FG001|Overall Study|Protocol Violation|0
4427789|NCT00378560|7210492|FG000|Overall Study|Withdrawal by Subject|17
4427790|NCT00378560|7210493|FG001|Overall Study|Withdrawal by Subject|21
4427791|NCT00378560|7210492|FG000|Overall Study|Moved|4
4427792|NCT00378560|7210493|FG001|Overall Study|Moved|3
4427793|NCT00378560|7210492|FG000|Overall Study|Pregnancy|7
4427794|NCT00378560|7210493|FG001|Overall Study|Pregnancy|5
4427795|NCT00378560|7210492|FG000|Overall Study|Laboratory test values abnormal|1
4427796|NCT00378560|7210493|FG001|Overall Study|Laboratory test values abnormal|0
4427797|NCT00378573|7210499|FG000|Treatment Period|Adverse Event|9
4427798|NCT00378573|7210499|FG000|Treatment Period|Physician Decision|1
4427799|NCT00378573|7210499|FG000|Treatment Period|Withdrawal by Subject|2
4427800|NCT00378573|7210499|FG000|Treatment Period|Disease Progression|4
4427801|NCT00378573|7210499|FG000|Treatment Period|Sponsor decision to close study|1
4427802|NCT00378573|7210499|FG000|Follow-up|Death|12
4427803|NCT00378573|7210499|FG000|Follow-up|Lost to Follow-up|1
4427804|NCT00378573|7210499|FG000|Follow-up|Withdrawal by Subject|1
4427805|NCT00378599|7210503|FG000|Overall Study|Adverse Event|38
4427806|NCT00378599|7210503|FG000|Overall Study|Protocol Violation|2
4427807|NCT00378599|7210503|FG000|Overall Study|Treatment failure|7
4427808|NCT00378599|7210503|FG000|Overall Study|Withdrawal by Subject|5
4427809|NCT00378703|7210511|FG000|Overall Study|Disease progression|59
4427810|NCT00378703|7210512|FG001|Overall Study|Disease progression|43
4427811|NCT00378703|7210513|FG002|Overall Study|Disease progression|48
4427812|NCT00378703|7210514|FG003|Overall Study|Disease progression|49
4427813|NCT00378703|7210511|FG000|Overall Study|Adverse Event|11
4427814|NCT00378703|7210512|FG001|Overall Study|Adverse Event|17
4427815|NCT00378703|7210513|FG002|Overall Study|Adverse Event|20
4427816|NCT00378703|7210514|FG003|Overall Study|Adverse Event|18
4427817|NCT00378703|7210511|FG000|Overall Study|Death|2
4427818|NCT00378703|7210512|FG001|Overall Study|Death|2
4427819|NCT00378703|7210513|FG002|Overall Study|Death|4
4427820|NCT00378703|7210514|FG003|Overall Study|Death|3
4427821|NCT00378703|7210511|FG000|Overall Study|Withdrawal by Subject|4
4427822|NCT00378703|7210512|FG001|Overall Study|Withdrawal by Subject|8
4427823|NCT00378703|7210513|FG002|Overall Study|Withdrawal by Subject|5
4427824|NCT00378703|7210514|FG003|Overall Study|Withdrawal by Subject|7
4427825|NCT00378703|7210511|FG000|Overall Study|Physician Decision|1
4427826|NCT00378703|7210512|FG001|Overall Study|Physician Decision|4
4427827|NCT00378703|7210513|FG002|Overall Study|Physician Decision|1
4427828|NCT00378703|7210514|FG003|Overall Study|Physician Decision|0
4427829|NCT00378703|7210511|FG000|Overall Study|Alternative therapy|4
4427830|NCT00378703|7210512|FG001|Overall Study|Alternative therapy|2
4427831|NCT00378703|7210513|FG002|Overall Study|Alternative therapy|0
4427832|NCT00378703|7210514|FG003|Overall Study|Alternative therapy|0
4427833|NCT00378703|7210511|FG000|Overall Study|Other complicated disease|0
4427834|NCT00378703|7210512|FG001|Overall Study|Other complicated disease|2
4427835|NCT00378703|7210513|FG002|Overall Study|Other complicated disease|2
4427836|NCT00378703|7210514|FG003|Overall Study|Other complicated disease|0
4427837|NCT00378703|7210511|FG000|Overall Study|Symptomatic deterioration|0
4427838|NCT00378703|7210512|FG001|Overall Study|Symptomatic deterioration|1
4427839|NCT00378703|7210513|FG002|Overall Study|Symptomatic deterioration|0
4427840|NCT00378703|7210514|FG003|Overall Study|Symptomatic deterioration|2
4427841|NCT00378703|7210511|FG000|Overall Study|Surgery|1
4427842|NCT00378703|7210512|FG001|Overall Study|Surgery|0
4427843|NCT00378703|7210513|FG002|Overall Study|Surgery|0
4427844|NCT00378703|7210514|FG003|Overall Study|Surgery|1
4427845|NCT00378703|7210511|FG000|Overall Study|Joint decision of physician and patient|1
4427846|NCT00378703|7210512|FG001|Overall Study|Joint decision of physician and patient|0
4427847|NCT00378703|7210513|FG002|Overall Study|Joint decision of physician and patient|0
4427848|NCT00378703|7210514|FG003|Overall Study|Joint decision of physician and patient|0
4427849|NCT00378703|7210511|FG000|Overall Study|Adverse events and progressive disease|0
4427850|NCT00378703|7210512|FG001|Overall Study|Adverse events and progressive disease|0
4427851|NCT00378703|7210513|FG002|Overall Study|Adverse events and progressive disease|0
4427852|NCT00378703|7210514|FG003|Overall Study|Adverse events and progressive disease|1
4427853|NCT00378703|7210511|FG000|Overall Study|Relocation|0
4427854|NCT00378703|7210512|FG001|Overall Study|Relocation|0
4427855|NCT00378703|7210513|FG002|Overall Study|Relocation|1
4427856|NCT00378703|7210514|FG003|Overall Study|Relocation|0
4427857|NCT00378703|7210511|FG000|Overall Study|Ineligible|4
4427858|NCT00378703|7210512|FG001|Overall Study|Ineligible|7
4427859|NCT00378703|7210513|FG002|Overall Study|Ineligible|7
4427860|NCT00378703|7210514|FG003|Overall Study|Ineligible|7
4427861|NCT00378703|7210511|FG000|Overall Study|Never started treatment|1
4427862|NCT00378703|7210512|FG001|Overall Study|Never started treatment|4
4427863|NCT00378703|7210513|FG002|Overall Study|Never started treatment|0
4427864|NCT00378703|7210514|FG003|Overall Study|Never started treatment|0
4427865|NCT00378703|7210511|FG000|Overall Study|Other|1
4427866|NCT00378703|7210512|FG001|Overall Study|Other|1
4427867|NCT00378703|7210513|FG002|Overall Study|Other|2
4427868|NCT00378703|7210514|FG003|Overall Study|Other|3
4427869|NCT00378898|7210526|FG000|Overall Study|Withdrawal by Subject|10
4427870|NCT00378898|7210527|FG001|Overall Study|Withdrawal by Subject|5
4427871|NCT00378898|7210526|FG000|Overall Study|Protocol Violation|1
4427872|NCT00378898|7210527|FG001|Overall Study|Protocol Violation|1
4427873|NCT00379080|7210538|FG000|Overall Study|Withdrawal by Subject|0
4427874|NCT00379080|7210539|FG001|Overall Study|Withdrawal by Subject|4
4427875|NCT00379080|7210540|FG002|Overall Study|Withdrawal by Subject|0
4427876|NCT00379210|7210579|FG000|Overall Study|Withdrawal by Subject|10
4427877|NCT00379210|7210580|FG001|Overall Study|Withdrawal by Subject|7
4427878|NCT00379236|7210588|FG000|Double-blind|Adverse Event|11
4427879|NCT00379236|7210589|FG001|Double-blind|Adverse Event|6
4427880|NCT00379236|7210590|FG002|Double-blind|Adverse Event|0
4427881|NCT00379236|7210588|FG000|Double-blind|Protocol Violation|3
4427882|NCT00379236|7210589|FG001|Double-blind|Protocol Violation|3
4427883|NCT00379236|7210590|FG002|Double-blind|Protocol Violation|0
4427884|NCT00379236|7210588|FG000|Double-blind|Withdrawal by Subject|12
4427885|NCT00379236|7210589|FG001|Double-blind|Withdrawal by Subject|13
4427886|NCT00379236|7210590|FG002|Double-blind|Withdrawal by Subject|0
4427887|NCT00379236|7210588|FG000|Double-blind|Lost to Follow-up|4
4427888|NCT00379236|7210589|FG001|Double-blind|Lost to Follow-up|3
4427889|NCT00379236|7210590|FG002|Double-blind|Lost to Follow-up|0
4427890|NCT00379236|7210588|FG000|Double-blind|Use of exclusionary medication|1
4427891|NCT00379236|7210589|FG001|Double-blind|Use of exclusionary medication|2
4427892|NCT00379236|7210590|FG002|Double-blind|Use of exclusionary medication|0
4427893|NCT00379236|7210588|FG000|Double-blind|Other|3
4629931|NCT01878084|7498304|FG000|Overall Study|Physician Decision|2
4427894|NCT00379236|7210589|FG001|Double-blind|Other|7
4427895|NCT00379236|7210590|FG002|Double-blind|Other|0
4427896|NCT00379236|7210588|FG000|Double-blind|Data could not be retrieved|2
4427897|NCT00379236|7210589|FG001|Double-blind|Data could not be retrieved|2
4427898|NCT00379236|7210590|FG002|Double-blind|Data could not be retrieved|0
4427899|NCT00379236|7210588|FG000|Open-label Extension|Adverse Event|0
4427900|NCT00379236|7210589|FG001|Open-label Extension|Adverse Event|0
4427901|NCT00379236|7210590|FG002|Open-label Extension|Adverse Event|13
4427902|NCT00379236|7210588|FG000|Open-label Extension|Protocol Violation|0
4427903|NCT00379236|7210589|FG001|Open-label Extension|Protocol Violation|0
4427904|NCT00379236|7210590|FG002|Open-label Extension|Protocol Violation|7
4427905|NCT00379236|7210588|FG000|Open-label Extension|Withdrawal by Subject|0
4427906|NCT00379236|7210589|FG001|Open-label Extension|Withdrawal by Subject|0
4427907|NCT00379236|7210590|FG002|Open-label Extension|Withdrawal by Subject|13
4427908|NCT00379236|7210588|FG000|Open-label Extension|Lost to Follow-up|0
4427909|NCT00379236|7210589|FG001|Open-label Extension|Lost to Follow-up|0
4427910|NCT00379236|7210590|FG002|Open-label Extension|Lost to Follow-up|12
4427911|NCT00379236|7210588|FG000|Open-label Extension|Use of exclusionary medication|0
4427912|NCT00379236|7210589|FG001|Open-label Extension|Use of exclusionary medication|0
4427913|NCT00379236|7210590|FG002|Open-label Extension|Use of exclusionary medication|3
4427914|NCT00379236|7210588|FG000|Open-label Extension|Other|0
4427915|NCT00379236|7210589|FG001|Open-label Extension|Other|0
4427916|NCT00379236|7210590|FG002|Open-label Extension|Other|7
4427917|NCT00379353|7210604|FG000|Overall Study|Hospitalization|3
4427918|NCT00379353|7210605|FG001|Overall Study|Hospitalization|3
4427919|NCT00379353|7210604|FG000|Overall Study|Withdrawal by Subject|5
4427920|NCT00379353|7210605|FG001|Overall Study|Withdrawal by Subject|2
4427921|NCT00379353|7210604|FG000|Overall Study|Death|1
4427922|NCT00379353|7210605|FG001|Overall Study|Death|0
4427923|NCT00379353|7210604|FG000|Overall Study|Cardiac Tamponade|1
4427924|NCT00379353|7210605|FG001|Overall Study|Cardiac Tamponade|0
4427925|NCT00379353|7210604|FG000|Overall Study|Non-compliance|1
4427926|NCT00379353|7210605|FG001|Overall Study|Non-compliance|0
4427927|NCT00379353|7210604|FG000|Overall Study|Conflicting drug treatment|0
4427928|NCT00379353|7210605|FG001|Overall Study|Conflicting drug treatment|1
4427929|NCT00379587|7210625|FG000|Overall Study|Lost to Follow-up|2
4427930|NCT00379639|7210634|FG000|Overall Study|Disease Progression|3
4427931|NCT00379639|7210635|FG001|Overall Study|Disease Progression|3
4427932|NCT00379639|7210636|FG002|Overall Study|Disease Progression|3
4427933|NCT00379639|7210637|FG003|Overall Study|Disease Progression|4
4427934|NCT00379639|7210638|FG004|Overall Study|Disease Progression|4
4427935|NCT00379639|7210634|FG000|Overall Study|Physician Decision|0
4427936|NCT00379639|7210635|FG001|Overall Study|Physician Decision|2
4427937|NCT00379639|7210636|FG002|Overall Study|Physician Decision|1
4427938|NCT00379639|7210637|FG003|Overall Study|Physician Decision|1
4427939|NCT00379639|7210638|FG004|Overall Study|Physician Decision|0
4427940|NCT00379639|7210634|FG000|Overall Study|Symptomatic Deterioration|0
4427941|NCT00379639|7210635|FG001|Overall Study|Symptomatic Deterioration|0
4427942|NCT00379639|7210636|FG002|Overall Study|Symptomatic Deterioration|1
4427943|NCT00379639|7210637|FG003|Overall Study|Symptomatic Deterioration|0
4427944|NCT00379639|7210638|FG004|Overall Study|Symptomatic Deterioration|1
4427945|NCT00379639|7210634|FG000|Overall Study|Adverse Event|0
4427946|NCT00379639|7210635|FG001|Overall Study|Adverse Event|0
4427947|NCT00379639|7210636|FG002|Overall Study|Adverse Event|1
4427948|NCT00379639|7210637|FG003|Overall Study|Adverse Event|0
4427949|NCT00379639|7210638|FG004|Overall Study|Adverse Event|1
4427950|NCT00379639|7210634|FG000|Overall Study|Lost to Follow-up|0
4427951|NCT00379639|7210635|FG001|Overall Study|Lost to Follow-up|0
4427952|NCT00379639|7210636|FG002|Overall Study|Lost to Follow-up|0
4427953|NCT00379639|7210637|FG003|Overall Study|Lost to Follow-up|1
4427954|NCT00379639|7210638|FG004|Overall Study|Lost to Follow-up|0
4427955|NCT00379639|7210634|FG000|Overall Study|Other|0
4427956|NCT00379639|7210635|FG001|Overall Study|Other|0
4427957|NCT00379639|7210636|FG002|Overall Study|Other|3
4427958|NCT00379639|7210637|FG003|Overall Study|Other|0
4427959|NCT00379639|7210638|FG004|Overall Study|Other|0
4427960|NCT00379769|7210654|FG000|Main Study|Death|57
4427961|NCT00379769|7210655|FG001|Main Study|Death|67
4427962|NCT00379769|7210656|FG002|Main Study|Death|54
4427963|NCT00379769|7210657|FG003|Main Study|Death|72
4427964|NCT00379769|7210658|FG004|Main Study|Death|0
4427965|NCT00379769|7210659|FG005|Main Study|Death|0
4427966|NCT00379769|7210654|FG000|Main Study|Adverse Event|5
4427967|NCT00379769|7210655|FG001|Main Study|Adverse Event|8
4427968|NCT00379769|7210656|FG002|Main Study|Adverse Event|10
4427969|NCT00379769|7210657|FG003|Main Study|Adverse Event|11
4427970|NCT00379769|7210658|FG004|Main Study|Adverse Event|0
4427971|NCT00379769|7210659|FG005|Main Study|Adverse Event|0
4427972|NCT00379769|7210654|FG000|Main Study|Lost to Follow-up|29
4427973|NCT00379769|7210655|FG001|Main Study|Lost to Follow-up|29
4427974|NCT00379769|7210656|FG002|Main Study|Lost to Follow-up|25
4427975|NCT00379769|7210657|FG003|Main Study|Lost to Follow-up|26
4427976|NCT00379769|7210658|FG004|Main Study|Lost to Follow-up|0
4427977|NCT00379769|7210659|FG005|Main Study|Lost to Follow-up|0
4427978|NCT00379769|7210654|FG000|Main Study|Withdrawal by Subject|46
4427979|NCT00379769|7210655|FG001|Main Study|Withdrawal by Subject|56
4427980|NCT00379769|7210656|FG002|Main Study|Withdrawal by Subject|72
4427981|NCT00379769|7210657|FG003|Main Study|Withdrawal by Subject|70
4427982|NCT00379769|7210658|FG004|Main Study|Withdrawal by Subject|0
4427983|NCT00379769|7210659|FG005|Main Study|Withdrawal by Subject|0
4427984|NCT00379769|7210654|FG000|Main Study|Moved to survival status follow-up only|27
4427985|NCT00379769|7210655|FG001|Main Study|Moved to survival status follow-up only|25
4427986|NCT00379769|7210656|FG002|Main Study|Moved to survival status follow-up only|32
4427987|NCT00379769|7210657|FG003|Main Study|Moved to survival status follow-up only|36
4427988|NCT00379769|7210658|FG004|Main Study|Moved to survival status follow-up only|0
4427989|NCT00379769|7210659|FG005|Main Study|Moved to survival status follow-up only|0
4427990|NCT00379769|7210654|FG000|Main Study|Participant moved|3
4427991|NCT00379769|7210655|FG001|Main Study|Participant moved|2
4427992|NCT00379769|7210656|FG002|Main Study|Participant moved|3
4427993|NCT00379769|7210657|FG003|Main Study|Participant moved|3
4427994|NCT00379769|7210658|FG004|Main Study|Participant moved|0
4427995|NCT00379769|7210659|FG005|Main Study|Participant moved|0
4427996|NCT00379769|7210654|FG000|Main Study|Poor compliance|3
4427997|NCT00379769|7210655|FG001|Main Study|Poor compliance|2
4427998|NCT00379769|7210656|FG002|Main Study|Poor compliance|2
4427999|NCT00379769|7210657|FG003|Main Study|Poor compliance|1
4428000|NCT00379769|7210658|FG004|Main Study|Poor compliance|0
4428001|NCT00379769|7210659|FG005|Main Study|Poor compliance|0
4428002|NCT00379769|7210654|FG000|Main Study|Prohibited glucose lowering medication|0
4428003|NCT00379769|7210655|FG001|Main Study|Prohibited glucose lowering medication|3
4428004|NCT00379769|7210656|FG002|Main Study|Prohibited glucose lowering medication|0
4428005|NCT00379769|7210657|FG003|Main Study|Prohibited glucose lowering medication|1
4428006|NCT00379769|7210658|FG004|Main Study|Prohibited glucose lowering medication|0
4428007|NCT00379769|7210659|FG005|Main Study|Prohibited glucose lowering medication|0
4428008|NCT00379769|7210654|FG000|Main Study|Site closed|4
4428009|NCT00379769|7210655|FG001|Main Study|Site closed|4
4428010|NCT00379769|7210656|FG002|Main Study|Site closed|4
4428011|NCT00379769|7210657|FG003|Main Study|Site closed|8
4428012|NCT00379769|7210658|FG004|Main Study|Site closed|0
4428013|NCT00379769|7210659|FG005|Main Study|Site closed|0
4715100|NCT02966834|7643217|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0
4715101|NCT02966834|7643218|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2
4715102|NCT02966834|7643219|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0
4715103|NCT02966834|7643220|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0
4715104|NCT02966834|7643215|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0
4715105|NCT02966834|7643216|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0
4715106|NCT02966834|7643217|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0
4715107|NCT02966834|7643218|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1
4715108|NCT02966834|7643219|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0
4715109|NCT02966834|7643220|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0
4715110|NCT02967055|7643278|FG000|Overall Study|Excluded|40
4715111|NCT02967055|7643278|FG000|Overall Study|Screen fail|3
4715112|NCT02967055|7643278|FG000|Overall Study|Lost to Follow-up|2
4715113|NCT02967055|7643278|FG000|Overall Study|Stopped due to side effects|3
4428014|NCT00379769|7210654|FG000|Main Study|Entry criteria violation|0
4715114|NCT02967055|7643278|FG000|Overall Study|Stopped due to drug cost|1
4428015|NCT00379769|7210655|FG001|Main Study|Entry criteria violation|0
4428016|NCT00379769|7210656|FG002|Main Study|Entry criteria violation|1
4428017|NCT00379769|7210657|FG003|Main Study|Entry criteria violation|1
4428018|NCT00379769|7210658|FG004|Main Study|Entry criteria violation|0
4715115|NCT02967562|7643347|FG000|Overall Study|Consent not obtained|1
4715116|NCT02967562|7643348|FG001|Overall Study|Consent not obtained|0
4715117|NCT02967562|7643347|FG000|Overall Study|High leak precluding analysis|1
4428019|NCT00379769|7210659|FG005|Main Study|Entry criteria violation|0
4428020|NCT00379769|7210654|FG000|Main Study|Participant did not take study drug|0
4428021|NCT00379769|7210655|FG001|Main Study|Participant did not take study drug|0
4428022|NCT00379769|7210656|FG002|Main Study|Participant did not take study drug|1
4428023|NCT00379769|7210657|FG003|Main Study|Participant did not take study drug|0
4428024|NCT00379769|7210658|FG004|Main Study|Participant did not take study drug|0
4428025|NCT00379769|7210659|FG005|Main Study|Participant did not take study drug|0
4428026|NCT00379769|7210654|FG000|Main Study|Physician Decision|2
4428027|NCT00379769|7210655|FG001|Main Study|Physician Decision|2
4428028|NCT00379769|7210656|FG002|Main Study|Physician Decision|1
4428029|NCT00379769|7210657|FG003|Main Study|Physician Decision|1
4428030|NCT00379769|7210658|FG004|Main Study|Physician Decision|0
4428031|NCT00379769|7210659|FG005|Main Study|Physician Decision|0
4428032|NCT00379769|7210654|FG000|Main Study|Participant completed study at visit 27|1
4428033|NCT00379769|7210655|FG001|Main Study|Participant completed study at visit 27|0
4428034|NCT00379769|7210656|FG002|Main Study|Participant completed study at visit 27|0
4428035|NCT00379769|7210657|FG003|Main Study|Participant completed study at visit 27|0
4428036|NCT00379769|7210658|FG004|Main Study|Participant completed study at visit 27|0
4428037|NCT00379769|7210659|FG005|Main Study|Participant completed study at visit 27|0
4428038|NCT00379769|7210654|FG000|Main Study|Personal reasons|1
4428039|NCT00379769|7210655|FG001|Main Study|Personal reasons|0
4428040|NCT00379769|7210656|FG002|Main Study|Personal reasons|0
4428041|NCT00379769|7210657|FG003|Main Study|Personal reasons|0
4428042|NCT00379769|7210658|FG004|Main Study|Personal reasons|0
4428043|NCT00379769|7210659|FG005|Main Study|Personal reasons|0
4428044|NCT00379769|7210654|FG000|Main Study|Risk of heart failure|0
4428045|NCT00379769|7210655|FG001|Main Study|Risk of heart failure|1
4428046|NCT00379769|7210656|FG002|Main Study|Risk of heart failure|0
4428047|NCT00379769|7210657|FG003|Main Study|Risk of heart failure|0
4428048|NCT00379769|7210658|FG004|Main Study|Risk of heart failure|0
4428049|NCT00379769|7210659|FG005|Main Study|Risk of heart failure|0
4428050|NCT00379769|7210654|FG000|Main Study|Investigator refused to log temperature|0
4428051|NCT00379769|7210655|FG001|Main Study|Investigator refused to log temperature|0
4428052|NCT00379769|7210656|FG002|Main Study|Investigator refused to log temperature|1
4428053|NCT00379769|7210657|FG003|Main Study|Investigator refused to log temperature|0
4428054|NCT00379769|7210658|FG004|Main Study|Investigator refused to log temperature|0
4428055|NCT00379769|7210659|FG005|Main Study|Investigator refused to log temperature|0
4428056|NCT00379769|7210654|FG000|Main Study|Reason unspecified|0
4428057|NCT00379769|7210655|FG001|Main Study|Reason unspecified|0
4428058|NCT00379769|7210656|FG002|Main Study|Reason unspecified|1
4428059|NCT00379769|7210657|FG003|Main Study|Reason unspecified|0
4428060|NCT00379769|7210658|FG004|Main Study|Reason unspecified|0
4428061|NCT00379769|7210659|FG005|Main Study|Reason unspecified|0
4428062|NCT00379769|7210654|FG000|Observational Follow-up|Death|0
4428063|NCT00379769|7210655|FG001|Observational Follow-up|Death|0
4428064|NCT00379769|7210656|FG002|Observational Follow-up|Death|0
4428065|NCT00379769|7210657|FG003|Observational Follow-up|Death|0
4428066|NCT00379769|7210658|FG004|Observational Follow-up|Death|78
4428067|NCT00379769|7210659|FG005|Observational Follow-up|Death|70
4428068|NCT00379769|7210654|FG000|Observational Follow-up|Adverse Event|0
4428069|NCT00379769|7210655|FG001|Observational Follow-up|Adverse Event|0
4428070|NCT00379769|7210656|FG002|Observational Follow-up|Adverse Event|0
4428071|NCT00379769|7210657|FG003|Observational Follow-up|Adverse Event|0
4428072|NCT00379769|7210658|FG004|Observational Follow-up|Adverse Event|1
4428073|NCT00379769|7210659|FG005|Observational Follow-up|Adverse Event|0
4428074|NCT00379769|7210654|FG000|Observational Follow-up|Lost to Follow-up|0
4428075|NCT00379769|7210655|FG001|Observational Follow-up|Lost to Follow-up|0
4428076|NCT00379769|7210656|FG002|Observational Follow-up|Lost to Follow-up|0
4428077|NCT00379769|7210657|FG003|Observational Follow-up|Lost to Follow-up|0
4428078|NCT00379769|7210658|FG004|Observational Follow-up|Lost to Follow-up|25
4428079|NCT00379769|7210659|FG005|Observational Follow-up|Lost to Follow-up|27
4428080|NCT00379769|7210654|FG000|Observational Follow-up|Withdrawal by Subject|0
4428081|NCT00379769|7210655|FG001|Observational Follow-up|Withdrawal by Subject|0
4428082|NCT00379769|7210656|FG002|Observational Follow-up|Withdrawal by Subject|0
4428083|NCT00379769|7210657|FG003|Observational Follow-up|Withdrawal by Subject|0
4428084|NCT00379769|7210658|FG004|Observational Follow-up|Withdrawal by Subject|12
4428085|NCT00379769|7210659|FG005|Observational Follow-up|Withdrawal by Subject|12
4428086|NCT00379769|7210654|FG000|Observational Follow-up|Entered into Another Clinical Trial|0
4428087|NCT00379769|7210655|FG001|Observational Follow-up|Entered into Another Clinical Trial|0
4428088|NCT00379769|7210656|FG002|Observational Follow-up|Entered into Another Clinical Trial|0
4428089|NCT00379769|7210657|FG003|Observational Follow-up|Entered into Another Clinical Trial|0
4428090|NCT00379769|7210658|FG004|Observational Follow-up|Entered into Another Clinical Trial|18
4428091|NCT00379769|7210659|FG005|Observational Follow-up|Entered into Another Clinical Trial|22
4428092|NCT00379769|7210654|FG000|Observational Follow-up|Physician Decision|0
4428093|NCT00379769|7210655|FG001|Observational Follow-up|Physician Decision|0
4428094|NCT00379769|7210656|FG002|Observational Follow-up|Physician Decision|0
4428095|NCT00379769|7210657|FG003|Observational Follow-up|Physician Decision|0
4428096|NCT00379769|7210658|FG004|Observational Follow-up|Physician Decision|8
4428097|NCT00379769|7210659|FG005|Observational Follow-up|Physician Decision|8
4428098|NCT00379769|7210654|FG000|Observational Follow-up|Site Closed Early|0
4428099|NCT00379769|7210655|FG001|Observational Follow-up|Site Closed Early|0
4428100|NCT00379769|7210656|FG002|Observational Follow-up|Site Closed Early|0
4629932|NCT01878097|7498311|FG000|Baseline|Surveys not fully completed|2497
4629933|NCT01878097|7498312|FG001|Baseline|Surveys not fully completed|1800
4428101|NCT00379769|7210657|FG003|Observational Follow-up|Site Closed Early|0
4428102|NCT00379769|7210658|FG004|Observational Follow-up|Site Closed Early|6
4428103|NCT00379769|7210659|FG005|Observational Follow-up|Site Closed Early|7
4428104|NCT00379769|7210654|FG000|Observational Follow-up|Participant Moved|0
4428105|NCT00379769|7210655|FG001|Observational Follow-up|Participant Moved|0
4428106|NCT00379769|7210656|FG002|Observational Follow-up|Participant Moved|0
4428107|NCT00379769|7210657|FG003|Observational Follow-up|Participant Moved|0
4428108|NCT00379769|7210658|FG004|Observational Follow-up|Participant Moved|0
4428109|NCT00379769|7210659|FG005|Observational Follow-up|Participant Moved|1
4428110|NCT00379769|7210654|FG000|Observational Follow-up|Unknown; Reason Not Provided|0
4428111|NCT00379769|7210655|FG001|Observational Follow-up|Unknown; Reason Not Provided|0
4428112|NCT00379769|7210656|FG002|Observational Follow-up|Unknown; Reason Not Provided|0
4428113|NCT00379769|7210657|FG003|Observational Follow-up|Unknown; Reason Not Provided|0
4428114|NCT00379769|7210658|FG004|Observational Follow-up|Unknown; Reason Not Provided|1
4428115|NCT00379769|7210659|FG005|Observational Follow-up|Unknown; Reason Not Provided|1
4428116|NCT00379795|7210691|FG000|Overall Study|Death|31
4428117|NCT00379795|7210692|FG001|Overall Study|Death|8
4428118|NCT00379795|7210693|FG002|Overall Study|Death|6
4428119|NCT00379795|7210694|FG003|Overall Study|Death|4
4428120|NCT00379795|7210695|FG004|Overall Study|Death|7
4428121|NCT00379795|7210691|FG000|Overall Study|Adverse Event|17
4428122|NCT00379795|7210692|FG001|Overall Study|Adverse Event|3
4428123|NCT00379795|7210693|FG002|Overall Study|Adverse Event|3
4428124|NCT00379795|7210694|FG003|Overall Study|Adverse Event|1
4428125|NCT00379795|7210695|FG004|Overall Study|Adverse Event|4
4428126|NCT00379795|7210691|FG000|Overall Study|Lost to Follow-up|8
4428127|NCT00379795|7210692|FG001|Overall Study|Lost to Follow-up|1
4428128|NCT00379795|7210693|FG002|Overall Study|Lost to Follow-up|2
4428129|NCT00379795|7210694|FG003|Overall Study|Lost to Follow-up|1
4428130|NCT00379795|7210695|FG004|Overall Study|Lost to Follow-up|4
4428131|NCT00379795|7210691|FG000|Overall Study|Physician Decision|25
4428132|NCT00379795|7210692|FG001|Overall Study|Physician Decision|0
4428133|NCT00379795|7210693|FG002|Overall Study|Physician Decision|2
4428134|NCT00379795|7210694|FG003|Overall Study|Physician Decision|2
4428135|NCT00379795|7210695|FG004|Overall Study|Physician Decision|2
4428136|NCT00379795|7210691|FG000|Overall Study|Withdrawal by Subject|94
4428137|NCT00379795|7210692|FG001|Overall Study|Withdrawal by Subject|11
4428138|NCT00379795|7210693|FG002|Overall Study|Withdrawal by Subject|19
4428139|NCT00379795|7210694|FG003|Overall Study|Withdrawal by Subject|7
4428140|NCT00379795|7210695|FG004|Overall Study|Withdrawal by Subject|14
4428141|NCT00379795|7210691|FG000|Overall Study|Subject non-compliance|7
4428142|NCT00379795|7210692|FG001|Overall Study|Subject non-compliance|2
4428143|NCT00379795|7210693|FG002|Overall Study|Subject non-compliance|0
4428144|NCT00379795|7210694|FG003|Overall Study|Subject non-compliance|0
4428145|NCT00379795|7210695|FG004|Overall Study|Subject non-compliance|1
4428146|NCT00379795|7210691|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3
4428147|NCT00379795|7210692|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0
4428148|NCT00379795|7210693|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0
4428149|NCT00379795|7210694|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1
4428150|NCT00379795|7210695|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0
4428151|NCT00379795|7210691|FG000|Overall Study|Subjects condition mandated intervention|34
4428152|NCT00379795|7210692|FG001|Overall Study|Subjects condition mandated intervention|9
4428153|NCT00379795|7210693|FG002|Overall Study|Subjects condition mandated intervention|7
4428154|NCT00379795|7210694|FG003|Overall Study|Subjects condition mandated intervention|5
4428155|NCT00379795|7210695|FG004|Overall Study|Subjects condition mandated intervention|7
4428156|NCT00379795|7210691|FG000|Overall Study|Sponsor's decision|257
4428157|NCT00379795|7210692|FG001|Overall Study|Sponsor's decision|17
4428158|NCT00379795|7210693|FG002|Overall Study|Sponsor's decision|54
4428159|NCT00379795|7210694|FG003|Overall Study|Sponsor's decision|47
4428160|NCT00379795|7210695|FG004|Overall Study|Sponsor's decision|10
4428161|NCT00379808|7210710|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0
4428162|NCT00379808|7210711|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1
4428163|NCT00379834|7210741|FG000|Overall Study|Time constraints|2
4428164|NCT00379899|7210747|FG000|Overall Study|Adverse Event|7
4428165|NCT00379899|7210748|FG001|Overall Study|Adverse Event|3
4428166|NCT00379899|7210747|FG000|Overall Study|Death|10
4428167|NCT00379899|7210748|FG001|Overall Study|Death|10
4428168|NCT00379899|7210747|FG000|Overall Study|Lost to Follow-up|2
4428169|NCT00379899|7210748|FG001|Overall Study|Lost to Follow-up|4
4428170|NCT00379899|7210747|FG000|Overall Study|Physician Decision|3
4428171|NCT00379899|7210748|FG001|Overall Study|Physician Decision|4
4428172|NCT00379899|7210747|FG000|Overall Study|Withdrawal by Subject|5
4428173|NCT00379899|7210748|FG001|Overall Study|Withdrawal by Subject|5
4629934|NCT01878097|7498311|FG000|Implementation Year 1|Surveys not fully completed|3202
4428174|NCT00379899|7210747|FG000|Overall Study|Ineligibility determined|0
4428175|NCT00379899|7210748|FG001|Overall Study|Ineligibility determined|1
4428176|NCT00379899|7210747|FG000|Overall Study|Noncompliance|1
4428177|NCT00379899|7210748|FG001|Overall Study|Noncompliance|1
4428178|NCT00379899|7210747|FG000|Overall Study|Parathyroidectomy|0
4428179|NCT00379899|7210748|FG001|Overall Study|Parathyroidectomy|2
4428180|NCT00379899|7210747|FG000|Overall Study|Renal transplantation|5
4428181|NCT00379899|7210748|FG001|Overall Study|Renal transplantation|4
4428182|NCT00379899|7210747|FG000|Overall Study|Coronary artery bypass graft|1
4428183|NCT00379899|7210748|FG001|Overall Study|Coronary artery bypass graft|1
4428184|NCT00379899|7210747|FG000|Overall Study|Other protocol-specified criteria|3
4428185|NCT00379899|7210748|FG001|Overall Study|Other protocol-specified criteria|4
4428186|NCT00379899|7210747|FG000|Overall Study|Other|3
4428187|NCT00379899|7210748|FG001|Overall Study|Other|1
4428188|NCT00379912|7210756|FG000|Overall Study|Lack of Efficacy|1
4428189|NCT00379912|7210757|FG001|Overall Study|Lack of Efficacy|0
4428190|NCT00380068|7210777|FG000|Overall Study|Adverse Event|40
4428191|NCT00380068|7210777|FG000|Overall Study|Withdrawal by Subject|10
4428192|NCT00380068|7210777|FG000|Overall Study|Not compliant|6
4428193|NCT00380068|7210777|FG000|Overall Study|Lost to Follow-up|1
4428194|NCT00380068|7210777|FG000|Overall Study|Addition of other PAH therapeutic agent|1
4428195|NCT00380068|7210777|FG000|Overall Study|Lung transplant|3
4428196|NCT00380068|7210777|FG000|Overall Study|Physician Decision|2
4428197|NCT00380068|7210777|FG000|Overall Study|Partipant moved away|1
4428198|NCT00380068|7210777|FG000|Overall Study|Lack of Efficacy|5
4428199|NCT00380081|7210787|FG000|Overall Study|Withdrawal by Subject|0
4428200|NCT00380081|7210788|FG001|Overall Study|Withdrawal by Subject|0
4428201|NCT00380081|7210789|FG002|Overall Study|Withdrawal by Subject|0
4428202|NCT00380081|7210790|FG003|Overall Study|Withdrawal by Subject|0
4428203|NCT00380081|7210791|FG004|Overall Study|Withdrawal by Subject|1
4428204|NCT00380081|7210792|FG005|Overall Study|Withdrawal by Subject|0
4428205|NCT00380081|7210787|FG000|Overall Study|Family Emergency|0
4428206|NCT00380081|7210788|FG001|Overall Study|Family Emergency|0
4428207|NCT00380081|7210789|FG002|Overall Study|Family Emergency|0
4428208|NCT00380081|7210790|FG003|Overall Study|Family Emergency|0
4428209|NCT00380081|7210791|FG004|Overall Study|Family Emergency|0
4428210|NCT00380081|7210792|FG005|Overall Study|Family Emergency|1
4428211|NCT00380250|7210802|FG000|Overall Study|Withdrawal by Subject|39
4428212|NCT00380250|7210803|FG001|Overall Study|Withdrawal by Subject|28
4428213|NCT00380250|7210802|FG000|Overall Study|Adverse Event|20
4428214|NCT00380250|7210803|FG001|Overall Study|Adverse Event|9
4428215|NCT00380250|7210802|FG000|Overall Study|Lack of Efficacy|10
4428216|NCT00380250|7210803|FG001|Overall Study|Lack of Efficacy|8
4428217|NCT00380250|7210802|FG000|Overall Study|Protocol Violation|15
4428218|NCT00380250|7210803|FG001|Overall Study|Protocol Violation|5
4428219|NCT00380250|7210802|FG000|Overall Study|Lost to Follow-up|14
4428220|NCT00380250|7210803|FG001|Overall Study|Lost to Follow-up|5
4428221|NCT00380250|7210802|FG000|Overall Study|Physician Decision|1
4428222|NCT00380250|7210803|FG001|Overall Study|Physician Decision|0
4428223|NCT00380367|7210809|FG000|Overall Study|Lost to Follow-up|1
4428224|NCT00380367|7210809|FG000|Overall Study|Withdrawal by Subject|1
4428225|NCT00380393|7210815|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6
4428226|NCT00380393|7210816|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5
4428227|NCT00380393|7210815|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0
4428228|NCT00380393|7210816|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1
4428229|NCT00380393|7210815|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37
4428230|NCT00380393|7210816|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29
4428231|NCT00380393|7210815|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1
4428232|NCT00380393|7210816|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1
4428233|NCT00380393|7210815|FG000|Month 8 (Cross-sectional Visit)|Others|5
4428234|NCT00380393|7210816|FG001|Month 8 (Cross-sectional Visit)|Others|4
4428235|NCT00380393|7210815|FG000|Month 14|Withdrawal by Subject|9
4428236|NCT00380393|7210816|FG001|Month 14|Withdrawal by Subject|7
4428237|NCT00380393|7210815|FG000|Month 14|Death|1
4428238|NCT00380393|7210816|FG001|Month 14|Death|0
4428239|NCT00380393|7210815|FG000|Month 14|Lost to Follow-up|0
4428240|NCT00380393|7210816|FG001|Month 14|Lost to Follow-up|1
4428241|NCT00380393|7210815|FG000|Month 14|Migrated/moved from study area|39
4428242|NCT00380393|7210816|FG001|Month 14|Migrated/moved from study area|42
4428243|NCT00380393|7210815|FG000|Month 14|Protocol Violation|2
4428244|NCT00380393|7210816|FG001|Month 14|Protocol Violation|0
4428245|NCT00380393|7210815|FG000|Month 14|Others|6
4428246|NCT00380393|7210816|FG001|Month 14|Others|6
4428247|NCT00380588|7210824|FG000|Overall Study|Unequivocal Disease Progression|25
4428248|NCT00380588|7210825|FG001|Overall Study|Unequivocal Disease Progression|34
4428249|NCT00380588|7210824|FG000|Overall Study|Next Cycle Not Started|4
4428250|NCT00380588|7210825|FG001|Overall Study|Next Cycle Not Started|0
4428251|NCT00380588|7210824|FG000|Overall Study|Adverse Event|7
4428252|NCT00380588|7210825|FG001|Overall Study|Adverse Event|3
4428253|NCT00380588|7210824|FG000|Overall Study|Withdrawal by Subject|1
4428254|NCT00380588|7210825|FG001|Overall Study|Withdrawal by Subject|3
4428255|NCT00380588|7210824|FG000|Overall Study|Physician Decision|2
4428256|NCT00380588|7210825|FG001|Overall Study|Physician Decision|0
4428257|NCT00380692|7210833|FG000|Study Period II - Double Blind|Adverse Event|1
4428258|NCT00380692|7210834|FG001|Study Period II - Double Blind|Adverse Event|0
4428259|NCT00380692|7210833|FG000|Study Period II - Double Blind|Protocol Violation|2
4428260|NCT00380692|7210834|FG001|Study Period II - Double Blind|Protocol Violation|2
4428261|NCT00380692|7210833|FG000|Study Period II - Double Blind|Withdrawal by Subject|0
4428262|NCT00380692|7210834|FG001|Study Period II - Double Blind|Withdrawal by Subject|0
4428263|NCT00380692|7210833|FG000|Study Period II - Double Blind|Physician Decision|0
4428264|NCT00380692|7210834|FG001|Study Period II - Double Blind|Physician Decision|1
4428265|NCT00380692|7210833|FG000|Study Period II - Double Blind|Lack of Efficacy|1
4428266|NCT00380692|7210834|FG001|Study Period II - Double Blind|Lack of Efficacy|0
4428267|NCT00380692|7210833|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1
4428268|NCT00380692|7210834|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0
4428269|NCT00380692|7210833|FG000|Study Period III - Open Label|Adverse Event|5
4428270|NCT00380692|7210834|FG001|Study Period III - Open Label|Adverse Event|3
4428271|NCT00380692|7210833|FG000|Study Period III - Open Label|Protocol Violation|0
4428272|NCT00380692|7210834|FG001|Study Period III - Open Label|Protocol Violation|0
4428273|NCT00380692|7210833|FG000|Study Period III - Open Label|Withdrawal by Subject|0
4428274|NCT00380692|7210834|FG001|Study Period III - Open Label|Withdrawal by Subject|1
4428275|NCT00380692|7210833|FG000|Study Period III - Open Label|Physician Decision|0
4428276|NCT00380692|7210834|FG001|Study Period III - Open Label|Physician Decision|3
4428277|NCT00380692|7210833|FG000|Study Period III - Open Label|Lack of Efficacy|0
4428278|NCT00380692|7210834|FG001|Study Period III - Open Label|Lack of Efficacy|4
4428279|NCT00380692|7210833|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1
4428280|NCT00380692|7210834|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1
4428281|NCT00380718|7210840|FG000|Overall Study|Adverse Event|1
4428282|NCT00380718|7210840|FG000|Overall Study|Death after 30-day post-therapy followup|17
4428283|NCT00380744|7210851|FG000|Overall Study|Death|0
4428284|NCT00380744|7210852|FG001|Overall Study|Death|0
4428285|NCT00380744|7210853|FG002|Overall Study|Death|0
4428286|NCT00380744|7210854|FG003|Overall Study|Death|0
4428287|NCT00380744|7210855|FG004|Overall Study|Death|0
4428288|NCT00380744|7210856|FG005|Overall Study|Death|0
4428289|NCT00380744|7210857|FG006|Overall Study|Death|1
4428290|NCT00380744|7210851|FG000|Overall Study|Withdrawal by Subject|1
4428291|NCT00380744|7210852|FG001|Overall Study|Withdrawal by Subject|0
4428292|NCT00380744|7210853|FG002|Overall Study|Withdrawal by Subject|0
4428293|NCT00380744|7210854|FG003|Overall Study|Withdrawal by Subject|0
4428294|NCT00380744|7210855|FG004|Overall Study|Withdrawal by Subject|0
4428295|NCT00380744|7210856|FG005|Overall Study|Withdrawal by Subject|0
4428296|NCT00380744|7210857|FG006|Overall Study|Withdrawal by Subject|0
4428297|NCT00380874|7210885|FG000|Overall Study|Adverse Event|7
4428298|NCT00380874|7210886|FG001|Overall Study|Adverse Event|7
4428299|NCT00380874|7210885|FG000|Overall Study|Death|1
4428300|NCT00380874|7210886|FG001|Overall Study|Death|0
4428301|NCT00380874|7210885|FG000|Overall Study|Withdrawal by Subject|2
4428302|NCT00380874|7210886|FG001|Overall Study|Withdrawal by Subject|1
4428303|NCT00380874|7210885|FG000|Overall Study|Not related to study drug|3
4428304|NCT00380874|7210886|FG001|Overall Study|Not related to study drug|2
4428305|NCT00380978|7210894|FG000|Overall Study|Refused allocated intervention|0
4428306|NCT00380978|7210895|FG001|Overall Study|Refused allocated intervention|6
4629935|NCT01878097|7498312|FG001|Implementation Year 1|Surveys not fully completed|2549
4629936|NCT01878097|7498311|FG000|Implementation Year 2|Surveys not fully completed|3281
4629937|NCT01878097|7498312|FG001|Implementation Year 2|Surveys not fully completed|2841
4629938|NCT01878097|7498311|FG000|Implementation Year 3|Surveys not fully completed|3494
4629939|NCT01878097|7498312|FG001|Implementation Year 3|Surveys not fully completed|2980
4629940|NCT01878097|7498311|FG000|Implementation Year 4|Surveys not fully completed|3604
4629941|NCT01878097|7498312|FG001|Implementation Year 4|Surveys not fully completed|3007
4428307|NCT00380978|7210894|FG000|Overall Study|Wrong study envelope|0
4428308|NCT00380978|7210895|FG001|Overall Study|Wrong study envelope|2
4428309|NCT00380978|7210894|FG000|Overall Study|Allocation prior to analgesia request|1
4428310|NCT00380978|7210895|FG001|Overall Study|Allocation prior to analgesia request|2
4428311|NCT00380978|7210894|FG000|Overall Study|Parous patient|1
4428312|NCT00380978|7210895|FG001|Overall Study|Parous patient|0
4428313|NCT00381043|7210907|FG000|Overall Study|Lost to Follow-up|8
4428314|NCT00381043|7210908|FG001|Overall Study|Lost to Follow-up|6
4428315|NCT00381043|7210907|FG000|Overall Study|Withdrawal by Subject|3
4428316|NCT00381043|7210908|FG001|Overall Study|Withdrawal by Subject|1
4428317|NCT00381043|7210907|FG000|Overall Study|wanted more care|0
4428318|NCT00381043|7210908|FG001|Overall Study|wanted more care|1
4428319|NCT00381043|7210907|FG000|Overall Study|incarcerated|1
4428320|NCT00381043|7210908|FG001|Overall Study|incarcerated|0
4428321|NCT00381095|7210916|FG000|Overall Study|Death|3
4428322|NCT00381095|7210917|FG001|Overall Study|Death|4
4428323|NCT00381095|7210916|FG000|Overall Study|Lack of Efficacy|2
4428324|NCT00381095|7210917|FG001|Overall Study|Lack of Efficacy|4
4428325|NCT00381095|7210916|FG000|Overall Study|Other|2
4428326|NCT00381095|7210917|FG001|Overall Study|Other|2
4428327|NCT00381095|7210916|FG000|Overall Study|Protocol Violation|1
4428328|NCT00381095|7210917|FG001|Overall Study|Protocol Violation|1
4428329|NCT00381095|7210916|FG000|Overall Study|Withdrawal by Subject|3
4428330|NCT00381095|7210917|FG001|Overall Study|Withdrawal by Subject|3
4428331|NCT00381095|7210916|FG000|Overall Study|Adverse Event|2
4428332|NCT00381095|7210917|FG001|Overall Study|Adverse Event|7
4428333|NCT00381238|7210923|FG000|Overall Study|Adverse Event|3
4428334|NCT00381238|7210923|FG000|Overall Study|Protocol Violation|1
4629942|NCT01878149|7498320|FG000|Overall Study|Did Not Meet Eligibility Criteria|2
4428335|NCT00381238|7210923|FG000|Overall Study|Withdrawal by Subject|4
4428336|NCT00381238|7210923|FG000|Overall Study|Lack of Efficacy|2
4428337|NCT00381238|7210923|FG000|Overall Study|Withdrew by physician|1
4428338|NCT00381238|7210923|FG000|Overall Study|Disease progression|1
4428339|NCT00381303|7210929|FG000|Overall Study|Lost to Follow-up|25
4428340|NCT00381303|7210930|FG001|Overall Study|Lost to Follow-up|9
4428341|NCT00381303|7210929|FG000|Overall Study|AE/HIV-related event|22
4428342|NCT00381303|7210930|FG001|Overall Study|AE/HIV-related event|6
4428343|NCT00381303|7210929|FG000|Overall Study|Non-Adherence|13
4428344|NCT00381303|7210930|FG001|Overall Study|Non-Adherence|6
4428345|NCT00381303|7210929|FG000|Overall Study|Withdrawal by Subject|13
4428346|NCT00381303|7210930|FG001|Overall Study|Withdrawal by Subject|6
4428347|NCT00381303|7210929|FG000|Overall Study|Virologic failure|6
4428348|NCT00381303|7210930|FG001|Overall Study|Virologic failure|4
4428349|NCT00381303|7210929|FG000|Overall Study|Ineligible to continue the trial|2
4428350|NCT00381303|7210930|FG001|Overall Study|Ineligible to continue the trial|1
4428351|NCT00381303|7210929|FG000|Overall Study|Pregnancy|2
4428352|NCT00381303|7210930|FG001|Overall Study|Pregnancy|0
4428353|NCT00381303|7210929|FG000|Overall Study|Physician Decision|1
4428354|NCT00381303|7210930|FG001|Overall Study|Physician Decision|0
4428355|NCT00381303|7210929|FG000|Overall Study|Physician's decision to close the site|3
4428356|NCT00381303|7210930|FG001|Overall Study|Physician's decision to close the site|1
4428357|NCT00381303|7210929|FG000|Overall Study|Subject moved out of state|2
4428358|NCT00381303|7210930|FG001|Overall Study|Subject moved out of state|0
4428359|NCT00381303|7210929|FG000|Overall Study|Subject taking too many different meds|1
4428360|NCT00381303|7210930|FG001|Overall Study|Subject taking too many different meds|0
4428361|NCT00381303|7210929|FG000|Overall Study|No virologic response by week 12|1
4428362|NCT00381303|7210930|FG001|Overall Study|No virologic response by week 12|0
4428363|NCT00381303|7210929|FG000|Overall Study|Subject was too busy for appointments|1
4428364|NCT00381303|7210930|FG001|Overall Study|Subject was too busy for appointments|0
4428365|NCT00381303|7210929|FG000|Overall Study|Subject did not continue visits|1
4428366|NCT00381303|7210930|FG001|Overall Study|Subject did not continue visits|0
4428367|NCT00381303|7210929|FG000|Overall Study|Subject primary physician's decision|1
4428368|NCT00381303|7210930|FG001|Overall Study|Subject primary physician's decision|0
4428369|NCT00381563|7210954|FG000|Overall Study|Withdrawal by Subject|5
4428370|NCT00381563|7210955|FG001|Overall Study|Withdrawal by Subject|5
4428371|NCT00381563|7210954|FG000|Overall Study|Lost to Follow-up|2
4428372|NCT00381563|7210955|FG001|Overall Study|Lost to Follow-up|0
4428373|NCT00381563|7210954|FG000|Overall Study|Protocol Violation|0
4428374|NCT00381563|7210955|FG001|Overall Study|Protocol Violation|1
4428375|NCT00381615|7210964|FG000|Overall Study|Withdrawal by Subject|1
4428376|NCT00381615|7210965|FG001|Overall Study|Withdrawal by Subject|3
4428377|NCT00381615|7210966|FG002|Overall Study|Withdrawal by Subject|0
4428378|NCT00381615|7210967|FG003|Overall Study|Withdrawal by Subject|1
4428379|NCT00381615|7210964|FG000|Overall Study|Lost to Follow-up|3
4428380|NCT00381615|7210965|FG001|Overall Study|Lost to Follow-up|2
4428381|NCT00381615|7210966|FG002|Overall Study|Lost to Follow-up|0
4428382|NCT00381615|7210967|FG003|Overall Study|Lost to Follow-up|1
4428383|NCT00381615|7210964|FG000|Overall Study|Protocol Violation|0
4428384|NCT00381615|7210965|FG001|Overall Study|Protocol Violation|0
4428385|NCT00381615|7210966|FG002|Overall Study|Protocol Violation|1
4428386|NCT00381615|7210967|FG003|Overall Study|Protocol Violation|0
4428387|NCT00381680|7210998|FG000|Overall Study|Adverse Event|9
4428388|NCT00381680|7210999|FG001|Overall Study|Adverse Event|3
4428389|NCT00381680|7210998|FG000|Overall Study|Death|10
4428390|NCT00381680|7210999|FG001|Overall Study|Death|7
4428391|NCT00381680|7210998|FG000|Overall Study|Lost to Follow-up|3
4715118|NCT02967562|7643348|FG001|Overall Study|High leak precluding analysis|1
4715119|NCT02967679|7643354|FG000|Overall Study|Adverse Event|1
4715120|NCT02968004|7643371|FG000|Overall Study|Adverse Event|1
4715121|NCT02968004|7643372|FG001|Overall Study|Adverse Event|0
4715122|NCT02968004|7643371|FG000|Overall Study|Withdrawal by Subject|0
4715123|NCT02968004|7643372|FG001|Overall Study|Withdrawal by Subject|1
4715124|NCT02968173|7643382|FG000|Overall Study|Withdrawal by Subject|1
4428392|NCT00381680|7210999|FG001|Overall Study|Lost to Follow-up|2
4428393|NCT00381680|7210998|FG000|Overall Study|Physician Decision|25
4428394|NCT00381680|7210999|FG001|Overall Study|Physician Decision|6
4428395|NCT00381680|7210998|FG000|Overall Study|Withdrawal by Subject|3
4428396|NCT00381680|7210999|FG001|Overall Study|Withdrawal by Subject|1
4428397|NCT00381680|7210998|FG000|Overall Study|Entry onto another COG Trial|1
4428398|NCT00381680|7210999|FG001|Overall Study|Entry onto another COG Trial|2
4428399|NCT00381680|7210998|FG000|Overall Study|Alternative Therapy|11
4428400|NCT00381680|7210999|FG001|Overall Study|Alternative Therapy|5
4428401|NCT00381680|7210998|FG000|Overall Study|Secondary Malignancy|3
4428402|NCT00381680|7210999|FG001|Overall Study|Secondary Malignancy|0
4715125|NCT02968433|7643428|FG000|Overall Study|Withdrawal by Subject|1
4715126|NCT02968576|7643438|FG000|Overall Study|Pregnancy|0
4715127|NCT02968576|7643439|FG001|Overall Study|Pregnancy|1
4715128|NCT02968979|7643460|FG000|Overall Study|Protocol Violation|7
4428403|NCT00381680|7210998|FG000|Overall Study|Delay initiation|1
4428404|NCT00381680|7210999|FG001|Overall Study|Delay initiation|0
4428405|NCT00381680|7210998|FG000|Overall Study|Stem Cell Transplant|26
4428406|NCT00381680|7210999|FG001|Overall Study|Stem Cell Transplant|10
4428407|NCT00381680|7210998|FG000|Overall Study|Relapse|18
4428408|NCT00381680|7210999|FG001|Overall Study|Relapse|9
4428409|NCT00381680|7210998|FG000|Overall Study|Induction Failure|4
4428410|NCT00381680|7210999|FG001|Overall Study|Induction Failure|1
4428411|NCT00381680|7210998|FG000|Overall Study|Progression|1
4428412|NCT00381680|7210999|FG001|Overall Study|Progression|1
4428413|NCT00381680|7210998|FG000|Overall Study|Other not otherwise specified|7
4428414|NCT00381680|7210999|FG001|Overall Study|Other not otherwise specified|2
4428415|NCT00381680|7210998|FG000|Overall Study|Ineligible|3
4428416|NCT00381680|7210999|FG001|Overall Study|Ineligible|1
4428417|NCT00381693|7211009|FG000|Overall Study|Death|1
4428418|NCT00381693|7211009|FG000|Overall Study|Adverse Event|4
4428419|NCT00381693|7211009|FG000|Overall Study|Patient Choice|1
4428420|NCT00381693|7211009|FG000|Overall Study|Progression|2
4428421|NCT00381706|7211019|FG000|Overall Study|Never treated|7
4428422|NCT00381706|7211020|FG001|Overall Study|Never treated|2
4428423|NCT00381706|7211021|FG002|Overall Study|Never treated|1
4428424|NCT00381797|7211040|FG000|Overall Study|Withdrawal by Subject|1
4428425|NCT00381797|7211041|FG001|Overall Study|Withdrawal by Subject|1
4428426|NCT00381797|7211042|FG002|Overall Study|Withdrawal by Subject|0
4428427|NCT00381797|7211043|FG003|Overall Study|Withdrawal by Subject|0
4428428|NCT00381797|7211044|FG004|Overall Study|Withdrawal by Subject|2
4428429|NCT00381797|7211040|FG000|Overall Study|Ineligible|0
4428430|NCT00381797|7211041|FG001|Overall Study|Ineligible|0
4428431|NCT00381797|7211042|FG002|Overall Study|Ineligible|0
4428432|NCT00381797|7211043|FG003|Overall Study|Ineligible|1
4428433|NCT00381797|7211044|FG004|Overall Study|Ineligible|0
4428434|NCT00381849|7211083|FG000|Wash Out|Withdrawal by Subject|0
4428435|NCT00381849|7211084|FG001|Wash Out|Withdrawal by Subject|1
4428436|NCT00381888|7211094|FG000|Overall Study|Death|1
4428437|NCT00381888|7211094|FG000|Overall Study|Withdrawal by Subject|1
4428438|NCT00381888|7211094|FG000|Overall Study|Physician Decision|1
4428439|NCT00381888|7211094|FG000|Overall Study|Protocol Violation|9
4428440|NCT00381888|7211094|FG000|Overall Study|Had laparoscopic surgery|2
4428441|NCT00381888|7211094|FG000|Overall Study|Surgery was cancelled|2
4428442|NCT00381888|7211094|FG000|Overall Study|Adverse Event|1
4428443|NCT00381940|7211098|FG000|Overall Study|Lack of Efficacy|3
4428444|NCT00381940|7211098|FG000|Overall Study|Protocol Violation|1
4428445|NCT00381940|7211098|FG000|Overall Study|Ineligible|1
4428446|NCT00382018|7211110|FG000|Overall Study|Progression|0
4428447|NCT00382018|7211111|FG001|Overall Study|Progression|136
4428448|NCT00382018|7211112|FG002|Overall Study|Progression|51
4428449|NCT00382018|7211113|FG003|Overall Study|Progression|43
4428450|NCT00382018|7211110|FG000|Overall Study|Death|0
4428451|NCT00382018|7211111|FG001|Overall Study|Death|9
4428452|NCT00382018|7211112|FG002|Overall Study|Death|7
4428453|NCT00382018|7211113|FG003|Overall Study|Death|11
4428454|NCT00382018|7211110|FG000|Overall Study|Withdrawal by Subject|0
4428455|NCT00382018|7211111|FG001|Overall Study|Withdrawal by Subject|4
4428456|NCT00382018|7211112|FG002|Overall Study|Withdrawal by Subject|3
4428457|NCT00382018|7211113|FG003|Overall Study|Withdrawal by Subject|4
4428458|NCT00382018|7211110|FG000|Overall Study|Other, not protocol specified|0
4428459|NCT00382018|7211111|FG001|Overall Study|Other, not protocol specified|16
4428460|NCT00382018|7211112|FG002|Overall Study|Other, not protocol specified|3
4428461|NCT00382018|7211113|FG003|Overall Study|Other, not protocol specified|1
4428462|NCT00382070|7211137|FG000|Overall Study|No follow up data mapped to Other|17
4428463|NCT00382070|7211138|FG001|Overall Study|No follow up data mapped to Other|19
4428464|NCT00382070|7211137|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7
4428465|NCT00382070|7211138|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0
4428466|NCT00382070|7211137|FG000|Overall Study|No clinical assessment|9
4428467|NCT00382070|7211138|FG001|Overall Study|No clinical assessment|11
4428468|NCT00382109|7211146|FG000|Overall Study|Adverse Event|3
4428469|NCT00382109|7211147|FG001|Overall Study|Adverse Event|0
4428470|NCT00382109|7211146|FG000|Overall Study|Physician Decision|6
4428471|NCT00382109|7211147|FG001|Overall Study|Physician Decision|1
4428472|NCT00382109|7211146|FG000|Overall Study|Withdrawal by Subject|1
4428473|NCT00382109|7211147|FG001|Overall Study|Withdrawal by Subject|0
4428474|NCT00382109|7211146|FG000|Overall Study|ineligible|2
4428475|NCT00382109|7211147|FG001|Overall Study|ineligible|0
4428476|NCT00382109|7211146|FG000|Overall Study|Other|0
4428477|NCT00382109|7211147|FG001|Overall Study|Other|2
4428478|NCT00382109|7211146|FG000|Overall Study|consent withdrawal|0
4428479|NCT00382109|7211147|FG001|Overall Study|consent withdrawal|1
4512428|NCT00934050|7322165|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2
4512429|NCT00934089|7322177|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1
4512430|NCT00934089|7322178|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0
4512431|NCT00934089|7322177|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1
4512432|NCT00934089|7322178|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0
4512433|NCT00934102|7322184|FG000|Period 1, One Night of Wear|Personal Reasons|1
4512434|NCT00934102|7322185|FG001|Period 1, One Night of Wear|Personal Reasons|0
4512435|NCT00934102|7322186|FG002|Period 1, One Night of Wear|Personal Reasons|0
4512436|NCT00934128|7322196|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0
4512437|NCT00934128|7322197|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1
4512438|NCT00934128|7322196|FG000|First Intervention (2 Hours)|Adverse Event|4
4428480|NCT00382174|7211167|FG000|Overall Study|Lost to Follow-up|1
4428481|NCT00382174|7211168|FG001|Overall Study|Lost to Follow-up|4
4428482|NCT00382174|7211169|FG002|Overall Study|Lost to Follow-up|5
4428483|NCT00382174|7211167|FG000|Overall Study|Adverse Event|1
4428484|NCT00382174|7211168|FG001|Overall Study|Adverse Event|4
4428485|NCT00382174|7211169|FG002|Overall Study|Adverse Event|5
4428486|NCT00382174|7211167|FG000|Overall Study|Withdrawal by Subject|1
4428487|NCT00382174|7211168|FG001|Overall Study|Withdrawal by Subject|4
4428488|NCT00382174|7211169|FG002|Overall Study|Withdrawal by Subject|5
4428489|NCT00382174|7211167|FG000|Overall Study|Non compliance|1
4428490|NCT00382174|7211168|FG001|Overall Study|Non compliance|0
4428491|NCT00382174|7211169|FG002|Overall Study|Non compliance|1
4428492|NCT00382174|7211167|FG000|Overall Study|Physician Decision|0
4428493|NCT00382174|7211168|FG001|Overall Study|Physician Decision|2
4428494|NCT00382174|7211169|FG002|Overall Study|Physician Decision|2
4428495|NCT00382174|7211167|FG000|Overall Study|Failed to meet criteria|0
4428496|NCT00382174|7211168|FG001|Overall Study|Failed to meet criteria|1
4428497|NCT00382174|7211169|FG002|Overall Study|Failed to meet criteria|1
4428498|NCT00382174|7211167|FG000|Overall Study|Wounds merged|0
4428499|NCT00382174|7211168|FG001|Overall Study|Wounds merged|2
4428500|NCT00382174|7211169|FG002|Overall Study|Wounds merged|2
4428501|NCT00382291|7211193|FG000|Overall Study|Adverse Event|1
4428502|NCT00382291|7211194|FG001|Overall Study|Adverse Event|2
4428503|NCT00382291|7211195|FG002|Overall Study|Adverse Event|2
4428504|NCT00382291|7211193|FG000|Overall Study|Protocol Violation|1
4428505|NCT00382291|7211194|FG001|Overall Study|Protocol Violation|0
4428506|NCT00382291|7211195|FG002|Overall Study|Protocol Violation|0
4428507|NCT00382291|7211193|FG000|Overall Study|Temporary study suspension|2
4428508|NCT00382291|7211194|FG001|Overall Study|Temporary study suspension|2
4428509|NCT00382291|7211195|FG002|Overall Study|Temporary study suspension|5
4428510|NCT00382291|7211193|FG000|Overall Study|Withdrawal by Subject|0
4428511|NCT00382291|7211194|FG001|Overall Study|Withdrawal by Subject|2
4428512|NCT00382291|7211195|FG002|Overall Study|Withdrawal by Subject|0
4428513|NCT00382291|7211193|FG000|Overall Study|Physician Decision|0
4428514|NCT00382291|7211194|FG001|Overall Study|Physician Decision|1
4428515|NCT00382291|7211195|FG002|Overall Study|Physician Decision|0
4428516|NCT00382291|7211193|FG000|Overall Study|Lack of Efficacy|0
4428517|NCT00382291|7211194|FG001|Overall Study|Lack of Efficacy|0
4428518|NCT00382291|7211195|FG002|Overall Study|Lack of Efficacy|1
4428519|NCT00382408|7211207|FG000|Overall Study|Did not meet protocol requirement|3
4428520|NCT00382408|7211208|FG001|Overall Study|Did not meet protocol requirement|3
4428521|NCT00382408|7211207|FG000|Overall Study|Protocol Violation|2
4428522|NCT00382408|7211208|FG001|Overall Study|Protocol Violation|2
4428523|NCT00382408|7211207|FG000|Overall Study|Physician Decision|1
4428524|NCT00382408|7211208|FG001|Overall Study|Physician Decision|0
4428525|NCT00382408|7211207|FG000|Overall Study|Withdrawal by Subject|17
4428526|NCT00382408|7211208|FG001|Overall Study|Withdrawal by Subject|6
4428527|NCT00382408|7211207|FG000|Overall Study|Pregnancy|2
4428528|NCT00382408|7211208|FG001|Overall Study|Pregnancy|0
4428529|NCT00382408|7211207|FG000|Overall Study|Lost to Follow-up|19
4428530|NCT00382408|7211208|FG001|Overall Study|Lost to Follow-up|8
4428531|NCT00382408|7211207|FG000|Overall Study|Other|100
4428532|NCT00382408|7211208|FG001|Overall Study|Other|35
4428533|NCT00382720|7211226|FG000|Overall Study|Adverse Event|21
4428534|NCT00382720|7211227|FG001|Overall Study|Adverse Event|23
4428535|NCT00382720|7211228|FG002|Overall Study|Adverse Event|15
4428536|NCT00382720|7211226|FG000|Overall Study|Protocol Violation|2
4428537|NCT00382720|7211227|FG001|Overall Study|Protocol Violation|5
4428538|NCT00382720|7211228|FG002|Overall Study|Protocol Violation|1
4428539|NCT00382720|7211226|FG000|Overall Study|Death|0
4428540|NCT00382720|7211227|FG001|Overall Study|Death|1
4428541|NCT00382720|7211228|FG002|Overall Study|Death|2
4428542|NCT00382720|7211226|FG000|Overall Study|Progressive disease|37
4428543|NCT00382720|7211227|FG001|Overall Study|Progressive disease|28
4428544|NCT00382720|7211228|FG002|Overall Study|Progressive disease|38
4428545|NCT00382720|7211226|FG000|Overall Study|Withdrew consent|1
4428546|NCT00382720|7211227|FG001|Overall Study|Withdrew consent|1
4428547|NCT00382720|7211228|FG002|Overall Study|Withdrew consent|2
4428548|NCT00382720|7211226|FG000|Overall Study|Withdrawal by Subject|11
4428549|NCT00382720|7211227|FG001|Overall Study|Withdrawal by Subject|20
4428550|NCT00382720|7211228|FG002|Overall Study|Withdrawal by Subject|12
4428551|NCT00382720|7211226|FG000|Overall Study|Surgery|1
4428552|NCT00382720|7211227|FG001|Overall Study|Surgery|1
4428553|NCT00382720|7211228|FG002|Overall Study|Surgery|4
4428554|NCT00382720|7211226|FG000|Overall Study|Patient did not receive study medication|1
4428555|NCT00382720|7211227|FG001|Overall Study|Patient did not receive study medication|1
4428556|NCT00382720|7211228|FG002|Overall Study|Patient did not receive study medication|4
4428557|NCT00382720|7211226|FG000|Overall Study|Clinically progressive disease|0
4428558|NCT00382720|7211227|FG001|Overall Study|Clinically progressive disease|1
4428559|NCT00382720|7211228|FG002|Overall Study|Clinically progressive disease|0
4428560|NCT00382720|7211226|FG000|Overall Study|Good prognosis|0
4428561|NCT00382720|7211227|FG001|Overall Study|Good prognosis|1
4428562|NCT00382720|7211228|FG002|Overall Study|Good prognosis|0
4428563|NCT00382720|7211226|FG000|Overall Study|Investigator/Clinical decision|5
4428564|NCT00382720|7211227|FG001|Overall Study|Investigator/Clinical decision|6
4518731|NCT00975923|7330993|FG001|Overall Study|Withdrawal by Subject|1
4428565|NCT00382720|7211228|FG002|Overall Study|Investigator/Clinical decision|6
4428566|NCT00382720|7211226|FG000|Overall Study|Discontinued at end of study|0
4428567|NCT00382720|7211227|FG001|Overall Study|Discontinued at end of study|1
4428568|NCT00382720|7211228|FG002|Overall Study|Discontinued at end of study|2
4428569|NCT00382733|7211236|FG000|Overall Study|Withdrawal by Subject|0
4428570|NCT00382733|7211237|FG001|Overall Study|Withdrawal by Subject|1
4428571|NCT00382733|7211238|FG002|Overall Study|Withdrawal by Subject|0
4428572|NCT00382733|7211239|FG003|Overall Study|Withdrawal by Subject|0
4428573|NCT00382733|7211240|FG004|Overall Study|Withdrawal by Subject|0
4428574|NCT00382863|7211273|FG000|Overall Study|Death|9
4428575|NCT00382863|7211274|FG001|Overall Study|Death|9
4428576|NCT00382863|7211273|FG000|Overall Study|Lost to Follow-up|1
4428577|NCT00382863|7211274|FG001|Overall Study|Lost to Follow-up|2
4428578|NCT00382863|7211273|FG000|Overall Study|Withdrawal by Subject|5
4428579|NCT00382863|7211274|FG001|Overall Study|Withdrawal by Subject|25
4428580|NCT00382967|7211296|FG000|Overall Study|Protocol Violation|1
4428581|NCT00382967|7211297|FG001|Overall Study|Protocol Violation|1
4428582|NCT00382993|7211303|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7
4428583|NCT00382993|7211304|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2
4428584|NCT00382993|7211303|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1
4428585|NCT00382993|7211304|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3
4428586|NCT00382993|7211303|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0
4428587|NCT00382993|7211304|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5
4428588|NCT00382993|7211303|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3
4428589|NCT00382993|7211304|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3
4428590|NCT00382993|7211303|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3
4428591|NCT00382993|7211304|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5
4428592|NCT00382993|7211303|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1
4428593|NCT00382993|7211304|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0
4428594|NCT00382993|7211303|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0
4428595|NCT00382993|7211304|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1
4428596|NCT00382993|7211303|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0
4428597|NCT00382993|7211304|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1
4428598|NCT00382993|7211303|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0
4428599|NCT00382993|7211304|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1
4428600|NCT00382993|7211303|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1
4428601|NCT00382993|7211304|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1
4428602|NCT00383019|7211312|FG000|Overall Study|Adverse Event|5
4428603|NCT00383019|7211313|FG001|Overall Study|Adverse Event|1
4428604|NCT00383019|7211312|FG000|Overall Study|Withdrawal by Subject|0
4428605|NCT00383019|7211313|FG001|Overall Study|Withdrawal by Subject|1
4428606|NCT00383084|7211338|FG000|Overall Study|Withdrawal by Subject|12
4428607|NCT00383084|7211339|FG001|Overall Study|Withdrawal by Subject|10
4428608|NCT00383123|7211357|FG000|Overall Study|Adverse Event|1
4428609|NCT00383123|7211358|FG001|Overall Study|Adverse Event|0
4428610|NCT00383123|7211357|FG000|Overall Study|Lost to Follow-up|68
4428611|NCT00383123|7211358|FG001|Overall Study|Lost to Follow-up|61
4428612|NCT00383123|7211357|FG000|Overall Study|Protocol Violation|5
4428613|NCT00383123|7211358|FG001|Overall Study|Protocol Violation|1
4428614|NCT00383123|7211357|FG000|Overall Study|Withdrawal by Subject|27
4428615|NCT00383123|7211358|FG001|Overall Study|Withdrawal by Subject|18
4428616|NCT00383123|7211357|FG000|Overall Study|Other reason|10
4428617|NCT00383123|7211358|FG001|Overall Study|Other reason|6
4428618|NCT00383149|7211364|FG000|Overall Study|Adverse Event not Related to Study Drug|3
4428619|NCT00383149|7211364|FG000|Overall Study|Death|2
4428620|NCT00383149|7211364|FG000|Overall Study|Disease Progression|38
4428621|NCT00383149|7211364|FG000|Overall Study|Lost to Follow-up|1
4428622|NCT00383149|7211364|FG000|Overall Study|Other|1
4428623|NCT00383149|7211364|FG000|Overall Study|Study Drug Toxicity|4
4428624|NCT00383149|7211364|FG000|Overall Study|Request to Discontinue Treatment|4
4428625|NCT00383149|7211364|FG000|Overall Study|Participant Withdrew Consent|1
4428626|NCT00383162|7211370|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3
4428627|NCT00383162|7211371|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4
4428628|NCT00383162|7211370|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8
4428629|NCT00383162|7211371|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7
4428630|NCT00383162|7211370|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4
4715129|NCT02968979|7643460|FG000|Overall Study|Withdrawal by Subject|1
4736192|NCT03560518|7685157|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0
4736193|NCT03560518|7685158|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0
4736194|NCT03560518|7685156|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6
4428631|NCT00383162|7211371|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2
4428632|NCT00383162|7211370|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2
4428633|NCT00383162|7211371|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0
4428634|NCT00383162|7211370|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3
4428635|NCT00383162|7211371|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0
4428636|NCT00383162|7211370|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1
4428637|NCT00383162|7211371|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3
4428638|NCT00383162|7211370|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0
4428639|NCT00383162|7211371|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1
4428640|NCT00383162|7211370|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1
4428641|NCT00383162|7211371|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0
4428642|NCT00383162|7211370|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0
4428643|NCT00383162|7211371|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3
4428644|NCT00383188|7211382|FG000|Overall Study|Adverse Event|4
4428645|NCT00383188|7211383|FG001|Overall Study|Adverse Event|7
4428646|NCT00383188|7211384|FG002|Overall Study|Adverse Event|9
4428647|NCT00383188|7211385|FG003|Overall Study|Adverse Event|8
4428648|NCT00383188|7211386|FG004|Overall Study|Adverse Event|8
4428649|NCT00383188|7211382|FG000|Overall Study|Lack of Efficacy|9
4428650|NCT00383188|7211383|FG001|Overall Study|Lack of Efficacy|3
4428651|NCT00383188|7211384|FG002|Overall Study|Lack of Efficacy|3
4428652|NCT00383188|7211385|FG003|Overall Study|Lack of Efficacy|2
4428653|NCT00383188|7211386|FG004|Overall Study|Lack of Efficacy|6
4428654|NCT00383188|7211382|FG000|Overall Study|Other|3
4428655|NCT00383188|7211383|FG001|Overall Study|Other|1
4428656|NCT00383188|7211384|FG002|Overall Study|Other|0
4428657|NCT00383188|7211385|FG003|Overall Study|Other|2
4428658|NCT00383188|7211386|FG004|Overall Study|Other|6
4428659|NCT00383188|7211382|FG000|Overall Study|No longer willing to participate|1
4428660|NCT00383188|7211383|FG001|Overall Study|No longer willing to participate|0
4428661|NCT00383188|7211384|FG002|Overall Study|No longer willing to participate|1
4428662|NCT00383188|7211385|FG003|Overall Study|No longer willing to participate|0
4428663|NCT00383188|7211386|FG004|Overall Study|No longer willing to participate|2
4428664|NCT00383188|7211382|FG000|Overall Study|Lost to Follow-up|0
4428665|NCT00383188|7211383|FG001|Overall Study|Lost to Follow-up|0
4428666|NCT00383188|7211384|FG002|Overall Study|Lost to Follow-up|0
4428667|NCT00383188|7211385|FG003|Overall Study|Lost to Follow-up|0
4428668|NCT00383188|7211386|FG004|Overall Study|Lost to Follow-up|1
4428669|NCT00383292|7211407|FG000|Overall Study|Adverse Event|4
4428670|NCT00383292|7211408|FG001|Overall Study|Adverse Event|1
4428671|NCT00383292|7211409|FG002|Overall Study|Adverse Event|2
4428672|NCT00383292|7211407|FG000|Overall Study|Death|3
4428673|NCT00383292|7211408|FG001|Overall Study|Death|3
4428674|NCT00383292|7211409|FG002|Overall Study|Death|3
4428675|NCT00383292|7211407|FG000|Overall Study|Physician Decision|4
4428676|NCT00383292|7211408|FG001|Overall Study|Physician Decision|0
4428677|NCT00383292|7211409|FG002|Overall Study|Physician Decision|1
4428678|NCT00383292|7211407|FG000|Overall Study|Withdrawal by Subject|3
4428679|NCT00383292|7211408|FG001|Overall Study|Withdrawal by Subject|2
4428680|NCT00383292|7211409|FG002|Overall Study|Withdrawal by Subject|2
4428681|NCT00383292|7211407|FG000|Overall Study|Other|1
4428682|NCT00383292|7211408|FG001|Overall Study|Other|0
4428683|NCT00383292|7211409|FG002|Overall Study|Other|0
4428684|NCT00383331|7211420|FG000|Overall Study|Protocol Violation|0
4428685|NCT00383331|7211421|FG001|Overall Study|Protocol Violation|1
4428686|NCT00383500|7211435|FG000|Overall Study|Withdrawal by Subject|8
4428687|NCT00383500|7211436|FG001|Overall Study|Withdrawal by Subject|3
4428688|NCT00383500|7211437|FG002|Overall Study|Withdrawal by Subject|0
4428689|NCT00383500|7211435|FG000|Overall Study|Lost to Follow-up|0
4428690|NCT00383500|7211436|FG001|Overall Study|Lost to Follow-up|0
4428691|NCT00383500|7211437|FG002|Overall Study|Lost to Follow-up|2
4428692|NCT00383786|7211488|FG000|Overall Study|Protocol Violation|2
4428693|NCT00383786|7211489|FG001|Overall Study|Protocol Violation|6
4428694|NCT00383786|7211488|FG000|Overall Study|Withdrawal by Subject|2
4428695|NCT00383786|7211489|FG001|Overall Study|Withdrawal by Subject|5
4428696|NCT00383786|7211488|FG000|Overall Study|Physician Decision|0
4428697|NCT00383786|7211489|FG001|Overall Study|Physician Decision|1
4428698|NCT00384033|7211508|FG000|Overall Study|Adverse Event|10
4428699|NCT00384033|7211509|FG001|Overall Study|Adverse Event|8
4428700|NCT00384033|7211510|FG002|Overall Study|Adverse Event|11
4428701|NCT00384033|7211511|FG003|Overall Study|Adverse Event|20
4428702|NCT00384033|7211508|FG000|Overall Study|Failed to return|1
4428703|NCT00384033|7211509|FG001|Overall Study|Failed to return|3
4428704|NCT00384033|7211510|FG002|Overall Study|Failed to return|2
4428705|NCT00384033|7211511|FG003|Overall Study|Failed to return|2
4428706|NCT00384033|7211508|FG000|Overall Study|Physician Decision|1
4428707|NCT00384033|7211509|FG001|Overall Study|Physician Decision|0
4428708|NCT00384033|7211510|FG002|Overall Study|Physician Decision|0
4428709|NCT00384033|7211511|FG003|Overall Study|Physician Decision|0
4428710|NCT00384033|7211508|FG000|Overall Study|Lost to Follow-up|6
4428711|NCT00384033|7211509|FG001|Overall Study|Lost to Follow-up|12
4428712|NCT00384033|7211510|FG002|Overall Study|Lost to Follow-up|7
4428713|NCT00384033|7211511|FG003|Overall Study|Lost to Follow-up|7
4428714|NCT00384033|7211508|FG000|Overall Study|Other|2
4428715|NCT00384033|7211509|FG001|Overall Study|Other|0
4428716|NCT00384033|7211510|FG002|Overall Study|Other|0
4428717|NCT00384033|7211511|FG003|Overall Study|Other|0
4428718|NCT00384033|7211508|FG000|Overall Study|Protocol Violation|5
4428719|NCT00384033|7211509|FG001|Overall Study|Protocol Violation|0
4428720|NCT00384033|7211510|FG002|Overall Study|Protocol Violation|5
4428721|NCT00384033|7211511|FG003|Overall Study|Protocol Violation|6
4428722|NCT00384033|7211508|FG000|Overall Study|Withdrawal by Subject|6
4428723|NCT00384033|7211509|FG001|Overall Study|Withdrawal by Subject|2
4428724|NCT00384033|7211510|FG002|Overall Study|Withdrawal by Subject|5
4428725|NCT00384033|7211511|FG003|Overall Study|Withdrawal by Subject|2
4428726|NCT00384033|7211508|FG000|Overall Study|Lack of Efficacy|7
4428727|NCT00384033|7211509|FG001|Overall Study|Lack of Efficacy|3
4428728|NCT00384033|7211510|FG002|Overall Study|Lack of Efficacy|3
4428729|NCT00384033|7211511|FG003|Overall Study|Lack of Efficacy|1
4428730|NCT00384033|7211508|FG000|Overall Study|Randomized but not treated|3
4428731|NCT00384033|7211509|FG001|Overall Study|Randomized but not treated|7
4428732|NCT00384033|7211510|FG002|Overall Study|Randomized but not treated|10
4428733|NCT00384033|7211511|FG003|Overall Study|Randomized but not treated|2
4428734|NCT00384059|7211523|FG000|Infant Series|Not consented|2
4428735|NCT00384059|7211524|FG001|Infant Series|Not consented|6
4428736|NCT00384059|7211523|FG000|Infant Series|Withdrawal by Subject|2
4428737|NCT00384059|7211524|FG001|Infant Series|Withdrawal by Subject|2
4428738|NCT00384059|7211523|FG000|Infant Series|Adverse Event|1
4428739|NCT00384059|7211524|FG001|Infant Series|Adverse Event|2
4428740|NCT00384059|7211523|FG000|Infant Series|Protocol Violation|1
4428741|NCT00384059|7211524|FG001|Infant Series|Protocol Violation|2
4428742|NCT00384059|7211523|FG000|Infant Series|Lost to Follow-up|0
4428743|NCT00384059|7211524|FG001|Infant Series|Lost to Follow-up|1
4428744|NCT00384059|7211523|FG000|After Infant Series|Protocol Violation|2
4428745|NCT00384059|7211524|FG001|After Infant Series|Protocol Violation|3
4428746|NCT00384059|7211523|FG000|After Infant Series|Withdrawal by Subject|2
4428747|NCT00384059|7211524|FG001|After Infant Series|Withdrawal by Subject|2
4428748|NCT00384059|7211523|FG000|After Infant Series|Failed to Return|0
4428749|NCT00384059|7211524|FG001|After Infant Series|Failed to Return|2
4428750|NCT00384059|7211523|FG000|After Infant Series|Adverse Event|0
4428751|NCT00384059|7211524|FG001|After Infant Series|Adverse Event|1
4428752|NCT00384059|7211523|FG000|After Infant Series|Physician Decision|0
4428753|NCT00384059|7211524|FG001|After Infant Series|Physician Decision|1
4428754|NCT00384059|7211523|FG000|After Infant Series|Lost to Follow-up|0
4428755|NCT00384059|7211524|FG001|After Infant Series|Lost to Follow-up|1
4428756|NCT00384059|7211523|FG000|Toddler Dose|Lost to Follow-up|1
4428757|NCT00384059|7211524|FG001|Toddler Dose|Lost to Follow-up|1
4428758|NCT00384059|7211523|FG000|Toddler Dose|Failed to return|0
4428759|NCT00384059|7211524|FG001|Toddler Dose|Failed to return|1
4428760|NCT00384085|7211554|FG000|Overall Study|Adverse Event|5
4428761|NCT00384085|7211555|FG001|Overall Study|Adverse Event|5
4428762|NCT00384085|7211556|FG002|Overall Study|Adverse Event|4
4428763|NCT00384085|7211554|FG000|Overall Study|Lack of Efficacy|0
4428764|NCT00384085|7211555|FG001|Overall Study|Lack of Efficacy|3
4428765|NCT00384085|7211556|FG002|Overall Study|Lack of Efficacy|2
4428766|NCT00384085|7211554|FG000|Overall Study|No longer Requires Study Treatment|1
4428767|NCT00384085|7211555|FG001|Overall Study|No longer Requires Study Treatment|0
4428768|NCT00384085|7211556|FG002|Overall Study|No longer Requires Study Treatment|1
4428769|NCT00384085|7211554|FG000|Overall Study|Protocol Violation|2
4428770|NCT00384085|7211555|FG001|Overall Study|Protocol Violation|2
4428771|NCT00384085|7211556|FG002|Overall Study|Protocol Violation|2
4428772|NCT00384085|7211554|FG000|Overall Study|Lost to Follow-up|9
4428773|NCT00384085|7211555|FG001|Overall Study|Lost to Follow-up|9
4428774|NCT00384085|7211556|FG002|Overall Study|Lost to Follow-up|10
4428775|NCT00384085|7211554|FG000|Overall Study|Progressive Disease|0
4428776|NCT00384085|7211555|FG001|Overall Study|Progressive Disease|1
4428777|NCT00384085|7211556|FG002|Overall Study|Progressive Disease|0
4428778|NCT00384085|7211554|FG000|Overall Study|Withdrawal by Subject|14
4428779|NCT00384085|7211555|FG001|Overall Study|Withdrawal by Subject|19
4428780|NCT00384085|7211556|FG002|Overall Study|Withdrawal by Subject|29
4428781|NCT00384085|7211554|FG000|Overall Study|Patient non-compliant|4
4428782|NCT00384085|7211555|FG001|Overall Study|Patient non-compliant|4
4428783|NCT00384085|7211556|FG002|Overall Study|Patient non-compliant|5
4428784|NCT00384085|7211554|FG000|Overall Study|Physician Decision|1
4428785|NCT00384085|7211555|FG001|Overall Study|Physician Decision|0
4428786|NCT00384085|7211556|FG002|Overall Study|Physician Decision|0
4428787|NCT00384085|7211554|FG000|Overall Study|Loss of site personnel|1
4428788|NCT00384085|7211555|FG001|Overall Study|Loss of site personnel|0
4428789|NCT00384085|7211556|FG002|Overall Study|Loss of site personnel|1
4428790|NCT00384085|7211554|FG000|Overall Study|Sponsor decision|1
4428791|NCT00384085|7211555|FG001|Overall Study|Sponsor decision|2
4428792|NCT00384085|7211556|FG002|Overall Study|Sponsor decision|1
4428793|NCT00384085|7211554|FG000|Overall Study|Patient moved|1
4428794|NCT00384085|7211555|FG001|Overall Study|Patient moved|0
4428795|NCT00384085|7211556|FG002|Overall Study|Patient moved|1
4428796|NCT00384085|7211554|FG000|Overall Study|Patient required surgery|0
4428797|NCT00384085|7211555|FG001|Overall Study|Patient required surgery|1
4428798|NCT00384085|7211556|FG002|Overall Study|Patient required surgery|0
4428799|NCT00384176|7211569|FG000|Overall Study|Death|239
4428800|NCT00384176|7211570|FG001|Overall Study|Death|247
4428801|NCT00384176|7211571|FG002|Overall Study|Death|105
4428802|NCT00384176|7211569|FG000|Overall Study|Withdrawal by Subject|52
4428803|NCT00384176|7211570|FG001|Overall Study|Withdrawal by Subject|48
4428804|NCT00384176|7211571|FG002|Overall Study|Withdrawal by Subject|22
4428805|NCT00384176|7211569|FG000|Overall Study|Lost to Follow-up|16
4428806|NCT00384176|7211570|FG001|Overall Study|Lost to Follow-up|18
4428807|NCT00384176|7211571|FG002|Overall Study|Lost to Follow-up|4
4428808|NCT00384176|7211569|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2
4428809|NCT00384176|7211570|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3
4428810|NCT00384176|7211571|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0
4428811|NCT00384176|7211569|FG000|Overall Study|Longer QTC as Visit 1|1
4428812|NCT00384176|7211570|FG001|Overall Study|Longer QTC as Visit 1|0
4428813|NCT00384176|7211571|FG002|Overall Study|Longer QTC as Visit 1|0
4428814|NCT00384176|7211569|FG000|Overall Study|Toxicity of treatment|1
4428815|NCT00384176|7211570|FG001|Overall Study|Toxicity of treatment|0
4428816|NCT00384176|7211571|FG002|Overall Study|Toxicity of treatment|0
4428817|NCT00384176|7211569|FG000|Overall Study|Did not receive study treatment|0
4428818|NCT00384176|7211570|FG001|Overall Study|Did not receive study treatment|1
4428819|NCT00384176|7211571|FG002|Overall Study|Did not receive study treatment|1
4428820|NCT00384176|7211569|FG000|Overall Study|Physician Decision|0
4428821|NCT00384176|7211570|FG001|Overall Study|Physician Decision|2
4428822|NCT00384176|7211571|FG002|Overall Study|Physician Decision|0
4428823|NCT00384176|7211569|FG000|Overall Study|Liver metastases, colon resec. planned|1
4428824|NCT00384176|7211570|FG001|Overall Study|Liver metastases, colon resec. planned|0
4428825|NCT00384176|7211571|FG002|Overall Study|Liver metastases, colon resec. planned|0
4428826|NCT00384189|7211583|FG000|Overall Study|Reason Not Specified|50
4428827|NCT00384189|7211584|FG001|Overall Study|Reason Not Specified|57
4428828|NCT00384189|7211585|FG002|Overall Study|Reason Not Specified|58
4428829|NCT00384189|7211586|FG003|Overall Study|Reason Not Specified|40
4428830|NCT00384332|7211606|FG000|Overall Study|Lost to Follow-up|4
4428831|NCT00384332|7211607|FG001|Overall Study|Lost to Follow-up|0
4428832|NCT00384397|7211618|FG000|Overall Study|Adverse Event|0
4428833|NCT00384397|7211619|FG001|Overall Study|Adverse Event|1
4428834|NCT00384397|7211620|FG002|Overall Study|Adverse Event|2
4428835|NCT00384397|7211618|FG000|Overall Study|Protocol Violation|7
4428836|NCT00384397|7211619|FG001|Overall Study|Protocol Violation|15
4428837|NCT00384397|7211620|FG002|Overall Study|Protocol Violation|13
4428838|NCT00384397|7211618|FG000|Overall Study|Lost to Follow-up|11
4428839|NCT00384397|7211619|FG001|Overall Study|Lost to Follow-up|13
4428840|NCT00384397|7211620|FG002|Overall Study|Lost to Follow-up|3
4428841|NCT00384397|7211618|FG000|Overall Study|Withdrawal by Subject|14
4428842|NCT00384397|7211619|FG001|Overall Study|Withdrawal by Subject|17
4428843|NCT00384397|7211620|FG002|Overall Study|Withdrawal by Subject|15
4428844|NCT00384839|7211683|FG000|Overall Study|Adverse Event|4
4428845|NCT00384839|7211683|FG000|Overall Study|Investigator Request|1
4428846|NCT00384839|7211683|FG000|Overall Study|Patient Request|1
4428847|NCT00384839|7211683|FG000|Overall Study|Ineligible|2
4512439|NCT00934128|7322197|FG001|First Intervention (2 Hours)|Adverse Event|1
4512440|NCT00934128|7322196|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1
4512441|NCT00934128|7322197|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0
4512442|NCT00934128|7322196|FG000|Washout Period (1 Hour)|Patient preference|1
4512443|NCT00934128|7322197|FG001|Washout Period (1 Hour)|Patient preference|3
4512444|NCT00934128|7322196|FG000|Washout Period (1 Hour)|Pain|1
4512445|NCT00934128|7322197|FG001|Washout Period (1 Hour)|Pain|0
4512446|NCT00934128|7322196|FG000|Washout Period (1 Hour)|Too tired|1
4512447|NCT00934128|7322197|FG001|Washout Period (1 Hour)|Too tired|0
4512448|NCT00934128|7322196|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4
4512449|NCT00934128|7322197|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2
4512450|NCT00934128|7322196|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0
4512451|NCT00934128|7322197|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3
4512452|NCT00934362|7322224|FG000|Overall Study|Adverse Event|1
4512453|NCT00934362|7322225|FG001|Overall Study|Adverse Event|0
4512454|NCT00934440|7322240|FG000|Overall Study|Lost to Follow-up|1
4512455|NCT00934544|7322247|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12
4512456|NCT00934544|7322248|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4
4512457|NCT00934544|7322249|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0
4512458|NCT00934544|7322247|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2
4512459|NCT00934544|7322248|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9
4512460|NCT00934544|7322249|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0
4512461|NCT00934544|7322247|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2
4512462|NCT00934544|7322248|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0
4512463|NCT00934544|7322249|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0
4512464|NCT00934544|7322247|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1
4512465|NCT00934544|7322248|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3
4629943|NCT01878149|7498321|FG001|Overall Study|Did Not Meet Eligibility Criteria|2
4715130|NCT02969018|7643527|FG000|Overall Study|Adverse Event|2
4512466|NCT00934544|7322249|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0
4512467|NCT00934544|7322247|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2
4512468|NCT00934544|7322248|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0
4512469|NCT00934544|7322249|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0
4512470|NCT00934544|7322247|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0
4512471|NCT00934544|7322248|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1
4512472|NCT00934544|7322249|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0
4518732|NCT00975975|7331000|FG000|Overall Study|Death|6
4428848|NCT00384930|7211709|FG000|Overall Study|Adverse Event|5
4428849|NCT00384930|7211710|FG001|Overall Study|Adverse Event|4
4428850|NCT00384930|7211711|FG002|Overall Study|Adverse Event|12
4428851|NCT00384930|7211712|FG003|Overall Study|Adverse Event|11
4428852|NCT00384930|7211713|FG004|Overall Study|Adverse Event|14
4428853|NCT00384930|7211709|FG000|Overall Study|Entry Criteria Not Met|2
4428854|NCT00384930|7211710|FG001|Overall Study|Entry Criteria Not Met|6
4428855|NCT00384930|7211711|FG002|Overall Study|Entry Criteria Not Met|7
4428856|NCT00384930|7211712|FG003|Overall Study|Entry Criteria Not Met|8
4428857|NCT00384930|7211713|FG004|Overall Study|Entry Criteria Not Met|4
4428858|NCT00384930|7211709|FG000|Overall Study|Lack of Efficacy|1
4428859|NCT00384930|7211710|FG001|Overall Study|Lack of Efficacy|1
4428860|NCT00384930|7211711|FG002|Overall Study|Lack of Efficacy|2
4428861|NCT00384930|7211712|FG003|Overall Study|Lack of Efficacy|1
4428862|NCT00384930|7211713|FG004|Overall Study|Lack of Efficacy|2
4428863|NCT00384930|7211709|FG000|Overall Study|Lost to Follow-up|5
4428864|NCT00384930|7211710|FG001|Overall Study|Lost to Follow-up|3
4428865|NCT00384930|7211711|FG002|Overall Study|Lost to Follow-up|0
4428866|NCT00384930|7211712|FG003|Overall Study|Lost to Follow-up|4
4428867|NCT00384930|7211713|FG004|Overall Study|Lost to Follow-up|6
4428868|NCT00384930|7211709|FG000|Overall Study|Physician Decision|0
4428869|NCT00384930|7211710|FG001|Overall Study|Physician Decision|1
4428870|NCT00384930|7211711|FG002|Overall Study|Physician Decision|1
4428871|NCT00384930|7211712|FG003|Overall Study|Physician Decision|0
4428872|NCT00384930|7211713|FG004|Overall Study|Physician Decision|1
4428873|NCT00384930|7211709|FG000|Overall Study|Protocol Violation|1
4428874|NCT00384930|7211710|FG001|Overall Study|Protocol Violation|0
4428875|NCT00384930|7211711|FG002|Overall Study|Protocol Violation|1
4428876|NCT00384930|7211712|FG003|Overall Study|Protocol Violation|6
4428877|NCT00384930|7211713|FG004|Overall Study|Protocol Violation|4
4428878|NCT00384930|7211709|FG000|Overall Study|Sponsor Decision|3
4428879|NCT00384930|7211710|FG001|Overall Study|Sponsor Decision|4
4428880|NCT00384930|7211711|FG002|Overall Study|Sponsor Decision|0
4428881|NCT00384930|7211712|FG003|Overall Study|Sponsor Decision|5
4428882|NCT00384930|7211713|FG004|Overall Study|Sponsor Decision|0
4428883|NCT00384930|7211709|FG000|Overall Study|Withdrawal by Subject|9
4428884|NCT00384930|7211710|FG001|Overall Study|Withdrawal by Subject|7
4428885|NCT00384930|7211711|FG002|Overall Study|Withdrawal by Subject|7
4428886|NCT00384930|7211712|FG003|Overall Study|Withdrawal by Subject|6
4428887|NCT00384930|7211713|FG004|Overall Study|Withdrawal by Subject|16
4428888|NCT00384930|7211709|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1
4428889|NCT00384930|7211710|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1
4428890|NCT00384930|7211711|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0
4428891|NCT00384930|7211712|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0
4428892|NCT00384930|7211713|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0
4715131|NCT02969018|7643528|FG001|Overall Study|Adverse Event|4
4715132|NCT02969018|7643529|FG002|Overall Study|Adverse Event|1
4715133|NCT02969018|7643530|FG003|Overall Study|Adverse Event|2
4715134|NCT02969018|7643531|FG004|Overall Study|Adverse Event|0
4715135|NCT02969018|7643532|FG005|Overall Study|Adverse Event|1
4715136|NCT02969018|7643533|FG006|Overall Study|Adverse Event|2
4715137|NCT02969018|7643534|FG007|Overall Study|Adverse Event|0
4715138|NCT02969018|7643527|FG000|Overall Study|Lack of Efficacy|0
4715139|NCT02969018|7643528|FG001|Overall Study|Lack of Efficacy|1
4715140|NCT02969018|7643529|FG002|Overall Study|Lack of Efficacy|0
4715141|NCT02969018|7643530|FG003|Overall Study|Lack of Efficacy|0
4715142|NCT02969018|7643531|FG004|Overall Study|Lack of Efficacy|1
4715143|NCT02969018|7643532|FG005|Overall Study|Lack of Efficacy|1
4715144|NCT02969018|7643533|FG006|Overall Study|Lack of Efficacy|1
4715145|NCT02969018|7643534|FG007|Overall Study|Lack of Efficacy|1
4715146|NCT02969018|7643527|FG000|Overall Study|Lost to Follow-up|1
4715147|NCT02969018|7643528|FG001|Overall Study|Lost to Follow-up|2
4715148|NCT02969018|7643529|FG002|Overall Study|Lost to Follow-up|2
4715149|NCT02969018|7643530|FG003|Overall Study|Lost to Follow-up|0
4715150|NCT02969018|7643531|FG004|Overall Study|Lost to Follow-up|1
4715151|NCT02969018|7643532|FG005|Overall Study|Lost to Follow-up|1
4715152|NCT02969018|7643533|FG006|Overall Study|Lost to Follow-up|0
4715153|NCT02969018|7643534|FG007|Overall Study|Lost to Follow-up|1
4715154|NCT02969018|7643527|FG000|Overall Study|No Longer Meets Eligibility Criteria|0
4428893|NCT00384956|7211728|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3
4428894|NCT00385203|7211753|FG000|Overall Study|Adverse Event|5
4428895|NCT00385203|7211754|FG001|Overall Study|Adverse Event|4
4428896|NCT00385203|7211753|FG000|Overall Study|Death|1
4428897|NCT00385203|7211754|FG001|Overall Study|Death|0
4428898|NCT00385203|7211753|FG000|Overall Study|Condition under investigation worsened|18
4715155|NCT02969018|7643528|FG001|Overall Study|No Longer Meets Eligibility Criteria|0
4715156|NCT02969018|7643529|FG002|Overall Study|No Longer Meets Eligibility Criteria|0
4715157|NCT02969018|7643530|FG003|Overall Study|No Longer Meets Eligibility Criteria|0
4428899|NCT00385203|7211754|FG001|Overall Study|Condition under investigation worsened|3
4428900|NCT00385203|7211753|FG000|Overall Study|Incorrect enrollment|2
4428901|NCT00385203|7211754|FG001|Overall Study|Incorrect enrollment|0
4428902|NCT00385255|7211770|FG000|Overall Study|Serious Adverse Event|1
4428903|NCT00385255|7211771|FG001|Overall Study|Serious Adverse Event|2
4428904|NCT00385255|7211770|FG000|Overall Study|Protocol Violation|0
4428905|NCT00385255|7211771|FG001|Overall Study|Protocol Violation|4
4428906|NCT00385255|7211770|FG000|Overall Study|Withdrawal by Subject|0
4428907|NCT00385255|7211771|FG001|Overall Study|Withdrawal by Subject|8
4428908|NCT00385255|7211770|FG000|Overall Study|Migrated/moved from study area|0
4428909|NCT00385255|7211771|FG001|Overall Study|Migrated/moved from study area|1
4428910|NCT00385255|7211770|FG000|Overall Study|Lost to Follow-up|20
4428911|NCT00385255|7211771|FG001|Overall Study|Lost to Follow-up|58
4428912|NCT00385541|7211792|FG000|Overall Study|severe pain, clinician requested unblind|0
4428913|NCT00385541|7211793|FG001|Overall Study|severe pain, clinician requested unblind|1
4428914|NCT00385593|7211820|FG000|Overall Study|Adverse Event|3
4428915|NCT00385593|7211821|FG001|Overall Study|Adverse Event|2
4428916|NCT00385593|7211820|FG000|Overall Study|Withdrawal by Subject|17
4428917|NCT00385593|7211821|FG001|Overall Study|Withdrawal by Subject|7
4428918|NCT00385593|7211820|FG000|Overall Study|Lost to Follow-up|12
4428919|NCT00385593|7211821|FG001|Overall Study|Lost to Follow-up|8
4428920|NCT00385593|7211820|FG000|Overall Study|Protocol Violation|7
4428921|NCT00385593|7211821|FG001|Overall Study|Protocol Violation|4
4428922|NCT00385593|7211820|FG000|Overall Study|Several reasons|17
4428923|NCT00385593|7211821|FG001|Overall Study|Several reasons|15
4428924|NCT00385593|7211820|FG000|Overall Study|Incorrect inclusion|2
4428925|NCT00385593|7211821|FG001|Overall Study|Incorrect inclusion|0
4428926|NCT00385593|7211820|FG000|Overall Study|Incorrect randomization|0
4428927|NCT00385593|7211821|FG001|Overall Study|Incorrect randomization|1
4428928|NCT00385671|7211830|FG000|Overall Study|Adverse Event|14
4428929|NCT00385671|7211831|FG001|Overall Study|Adverse Event|27
4428930|NCT00385671|7211832|FG002|Overall Study|Adverse Event|18
4428931|NCT00385671|7211830|FG000|Overall Study|Lack of Efficacy|5
4428932|NCT00385671|7211831|FG001|Overall Study|Lack of Efficacy|9
4428933|NCT00385671|7211832|FG002|Overall Study|Lack of Efficacy|5
4428934|NCT00385671|7211830|FG000|Overall Study|Lost to Follow-up|6
4428935|NCT00385671|7211831|FG001|Overall Study|Lost to Follow-up|6
4428936|NCT00385671|7211832|FG002|Overall Study|Lost to Follow-up|5
4428937|NCT00385671|7211830|FG000|Overall Study|Physician Decision|2
4428938|NCT00385671|7211831|FG001|Overall Study|Physician Decision|1
4428939|NCT00385671|7211832|FG002|Overall Study|Physician Decision|2
4428940|NCT00385671|7211830|FG000|Overall Study|Protocol Violation|5
4428941|NCT00385671|7211831|FG001|Overall Study|Protocol Violation|2
4428942|NCT00385671|7211832|FG002|Overall Study|Protocol Violation|1
4428943|NCT00385671|7211830|FG000|Overall Study|Sponsor Decision|2
4428944|NCT00385671|7211831|FG001|Overall Study|Sponsor Decision|2
4428945|NCT00385671|7211832|FG002|Overall Study|Sponsor Decision|1
4428946|NCT00385671|7211830|FG000|Overall Study|Withdrawal by Subject|4
4428947|NCT00385671|7211831|FG001|Overall Study|Withdrawal by Subject|4
4428948|NCT00385671|7211832|FG002|Overall Study|Withdrawal by Subject|4
4428949|NCT00385684|7211842|FG000|FIRST INTERVENTION OF PHASE A|Death|1
4428950|NCT00385684|7211843|FG001|FIRST INTERVENTION OF PHASE A|Death|0
4428951|NCT00385684|7211842|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0
4428952|NCT00385684|7211843|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1
4428953|NCT00385684|7211842|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0
4428954|NCT00385684|7211843|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1
4428955|NCT00385723|7211852|FG000|Overall Study|Lost to Follow-up|1
4428956|NCT00385723|7211853|FG001|Overall Study|Lost to Follow-up|1
4428957|NCT00385723|7211854|FG002|Overall Study|Lost to Follow-up|0
4428958|NCT00385723|7211852|FG000|Overall Study|Withdrawal by Subject|1
4428959|NCT00385723|7211853|FG001|Overall Study|Withdrawal by Subject|0
4428960|NCT00385723|7211854|FG002|Overall Study|Withdrawal by Subject|2
4428961|NCT00385736|7211865|FG000|Efficacy Analysis Set - Induction|Adverse Event|5
4428962|NCT00385736|7211866|FG001|Efficacy Analysis Set - Induction|Adverse Event|6
4428963|NCT00385736|7211867|FG002|Efficacy Analysis Set - Induction|Adverse Event|4
4428964|NCT00385736|7211865|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0
4428965|NCT00385736|7211866|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2
4428966|NCT00385736|7211867|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1
4428967|NCT00385736|7211865|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0
4428968|NCT00385736|7211866|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2
4428969|NCT00385736|7211867|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0
4428970|NCT00385736|7211865|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4
4428971|NCT00385736|7211866|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2
4428972|NCT00385736|7211867|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1
4428973|NCT00385736|7211865|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0
4428974|NCT00385736|7211866|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0
4428975|NCT00385736|7211867|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2
4428976|NCT00385736|7211865|FG000|Efficacy Analysis Set - Induction|Other|0
4428977|NCT00385736|7211866|FG001|Efficacy Analysis Set - Induction|Other|0
4428978|NCT00385736|7211867|FG002|Efficacy Analysis Set - Induction|Other|1
4428979|NCT00385736|7211865|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23
4428980|NCT00385736|7211866|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15
4428981|NCT00385736|7211867|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23
4428982|NCT00385736|7211865|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6
4428983|NCT00385736|7211866|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6
4428984|NCT00385736|7211867|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14
4428985|NCT00385736|7211865|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0
4428986|NCT00385736|7211866|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2
4428987|NCT00385736|7211867|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2
4428988|NCT00385736|7211865|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38
4428989|NCT00385736|7211866|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16
4428990|NCT00385736|7211867|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31
4428991|NCT00385736|7211865|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2
4428992|NCT00385736|7211866|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1
4428993|NCT00385736|7211867|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6
4428994|NCT00385736|7211865|FG000|Efficacy Analysis Set - Maintenance|Other|0
4428995|NCT00385736|7211866|FG001|Efficacy Analysis Set - Maintenance|Other|4
4428996|NCT00385736|7211867|FG002|Efficacy Analysis Set - Maintenance|Other|4
4428997|NCT00385736|7211865|FG000|Safety Analysis Set|Adverse Event|23
4428998|NCT00385736|7211866|FG001|Safety Analysis Set|Adverse Event|15
4428999|NCT00385736|7211867|FG002|Safety Analysis Set|Adverse Event|23
4429000|NCT00385736|7211865|FG000|Safety Analysis Set|Withdrawal by Subject|6
4429001|NCT00385736|7211866|FG001|Safety Analysis Set|Withdrawal by Subject|6
4429002|NCT00385736|7211867|FG002|Safety Analysis Set|Withdrawal by Subject|14
4429003|NCT00385736|7211865|FG000|Safety Analysis Set|Lost to Follow-up|0
4429004|NCT00385736|7211866|FG001|Safety Analysis Set|Lost to Follow-up|2
4429005|NCT00385736|7211867|FG002|Safety Analysis Set|Lost to Follow-up|2
4429006|NCT00385736|7211865|FG000|Safety Analysis Set|Lack of Efficacy|38
4429007|NCT00385736|7211866|FG001|Safety Analysis Set|Lack of Efficacy|16
4429008|NCT00385736|7211867|FG002|Safety Analysis Set|Lack of Efficacy|31
4429009|NCT00385736|7211865|FG000|Safety Analysis Set|Protocol Violation|2
4429010|NCT00385736|7211866|FG001|Safety Analysis Set|Protocol Violation|1
4429011|NCT00385736|7211867|FG002|Safety Analysis Set|Protocol Violation|6
4429012|NCT00385736|7211865|FG000|Safety Analysis Set|Other|1
4429013|NCT00385736|7211866|FG001|Safety Analysis Set|Other|4
4429014|NCT00385736|7211867|FG002|Safety Analysis Set|Other|4
4429015|NCT00385762|7211878|FG000|Overall Study|Adverse Event|1
4429016|NCT00385762|7211878|FG000|Overall Study|Lost to Follow-up|1
4429017|NCT00385827|7211904|FG000|Part 1|Adverse Event|1
4429018|NCT00385827|7211905|FG001|Part 1|Adverse Event|0
4429019|NCT00385827|7211906|FG002|Part 1|Adverse Event|0
4429020|NCT00385827|7211904|FG000|Part 1|Death|2
4429021|NCT00385827|7211905|FG001|Part 1|Death|0
4429022|NCT00385827|7211906|FG002|Part 1|Death|0
4429023|NCT00385827|7211904|FG000|Part 1|Lack of Efficacy|5
4429024|NCT00385827|7211905|FG001|Part 1|Lack of Efficacy|0
4429025|NCT00385827|7211906|FG002|Part 1|Lack of Efficacy|0
4429026|NCT00385827|7211904|FG000|Part 1|Other|1
4429027|NCT00385827|7211905|FG001|Part 1|Other|0
4429028|NCT00385827|7211906|FG002|Part 1|Other|0
4429029|NCT00385827|7211904|FG000|Part 2|Adverse Event|0
4429030|NCT00385827|7211905|FG001|Part 2|Adverse Event|6
4429031|NCT00385827|7211906|FG002|Part 2|Adverse Event|10
4429032|NCT00385827|7211904|FG000|Part 2|Death|0
4429033|NCT00385827|7211905|FG001|Part 2|Death|0
4429034|NCT00385827|7211906|FG002|Part 2|Death|2
4429035|NCT00385827|7211904|FG000|Part 2|Lack of Efficacy|0
4429036|NCT00385827|7211905|FG001|Part 2|Lack of Efficacy|14
4429037|NCT00385827|7211906|FG002|Part 2|Lack of Efficacy|13
4429038|NCT00385827|7211904|FG000|Part 2|Randomized but not treated|0
4429039|NCT00385827|7211905|FG001|Part 2|Randomized but not treated|2
4429040|NCT00385827|7211906|FG002|Part 2|Randomized but not treated|2
4429041|NCT00385827|7211904|FG000|Part 2|Other|0
4429042|NCT00385827|7211905|FG001|Part 2|Other|11
4429043|NCT00385827|7211906|FG002|Part 2|Other|21
4429044|NCT00385840|7211918|FG000|Overall Study|Adverse Event|1
4429045|NCT00385840|7211919|FG001|Overall Study|Adverse Event|1
4429046|NCT00385840|7211918|FG000|Overall Study|Lost to Follow-up|3
4429047|NCT00385840|7211919|FG001|Overall Study|Lost to Follow-up|13
4429048|NCT00385918|7211927|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0
4429049|NCT00385918|7211928|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0
4429050|NCT00385918|7211929|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8
4429051|NCT00385918|7211927|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0
4429052|NCT00385918|7211928|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0
4429053|NCT00385918|7211929|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5
4429054|NCT00385918|7211927|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0
4429055|NCT00385918|7211928|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0
4429056|NCT00385918|7211929|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1
4429057|NCT00385918|7211927|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1
4429058|NCT00385918|7211928|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0
4429059|NCT00385918|7211929|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0
4429060|NCT00385918|7211927|FG000|Intervention Phase After Randomization|Physician Decision|1
4429061|NCT00385918|7211928|FG001|Intervention Phase After Randomization|Physician Decision|0
4429062|NCT00385918|7211929|FG002|Intervention Phase After Randomization|Physician Decision|0
4429063|NCT00385918|7211927|FG000|Intervention Phase After Randomization|Lost to Follow-up|1
4429064|NCT00385918|7211928|FG001|Intervention Phase After Randomization|Lost to Follow-up|0
4429065|NCT00385918|7211929|FG002|Intervention Phase After Randomization|Lost to Follow-up|0
4518733|NCT00976027|7331006|FG000|Overall Study|Serious Adverse Event|36
4429066|NCT00385944|7211938|FG000|1st Maintenance Dose Period|Physician Decision|1
4429067|NCT00385944|7211939|FG001|1st Maintenance Dose Period|Physician Decision|0
4429068|NCT00385944|7211940|FG002|1st Maintenance Dose Period|Physician Decision|0
4429069|NCT00385944|7211938|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0
4429070|NCT00385944|7211939|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1
4429071|NCT00385944|7211940|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0
4429072|NCT00385944|7211938|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3
4429073|NCT00385944|7211939|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0
4429074|NCT00385944|7211940|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0
4429075|NCT00385944|7211938|FG000|2nd Maintenance Dose Period|Invalid PD Data|2
4429076|NCT00385944|7211939|FG001|2nd Maintenance Dose Period|Invalid PD Data|3
4429077|NCT00385944|7211940|FG002|2nd Maintenance Dose Period|Invalid PD Data|0
4429078|NCT00386009|7211962|FG000|Overall Study|Adverse Event|0
4429079|NCT00386009|7211963|FG001|Overall Study|Adverse Event|2
4429080|NCT00386009|7211962|FG000|Overall Study|Death|1
4429081|NCT00386009|7211963|FG001|Overall Study|Death|0
4429082|NCT00386009|7211962|FG000|Overall Study|Entry Criteria Not Met|0
4429083|NCT00386009|7211963|FG001|Overall Study|Entry Criteria Not Met|2
4429084|NCT00386009|7211962|FG000|Overall Study|Lost to Follow-up|1
4429085|NCT00386009|7211963|FG001|Overall Study|Lost to Follow-up|1
4429086|NCT00386009|7211962|FG000|Overall Study|Protocol Violation|1
4429087|NCT00386009|7211963|FG001|Overall Study|Protocol Violation|0
4429088|NCT00386009|7211962|FG000|Overall Study|Sponsor Decision|1
4429089|NCT00386009|7211963|FG001|Overall Study|Sponsor Decision|1
4429090|NCT00386009|7211962|FG000|Overall Study|Withdrawal by Subject|5
4429091|NCT00386009|7211963|FG001|Overall Study|Withdrawal by Subject|4
4429092|NCT00386022|7211971|FG000|Plus Estrogen|Lost to Follow-up|2
4429093|NCT00386022|7211972|FG001|Plus Estrogen|Lost to Follow-up|0
4429094|NCT00386022|7211971|FG000|Plus Estrogen|Adverse Event|0
4429095|NCT00386022|7211972|FG001|Plus Estrogen|Adverse Event|1
4429096|NCT00386100|7211982|FG000|Overall Study|Did not receive study medication|6
4429097|NCT00386100|7211983|FG001|Overall Study|Did not receive study medication|4
4429098|NCT00386100|7211982|FG000|Overall Study|Adverse Event|15
4429099|NCT00386100|7211983|FG001|Overall Study|Adverse Event|25
4429100|NCT00386100|7211982|FG000|Overall Study|Death|0
4429101|NCT00386100|7211983|FG001|Overall Study|Death|1
4429102|NCT00386100|7211982|FG000|Overall Study|Insufficient therapeutic effect|30
4429103|NCT00386100|7211983|FG001|Overall Study|Insufficient therapeutic effect|6
4429104|NCT00386100|7211982|FG000|Overall Study|Lost to Follow-up|29
4429105|NCT00386100|7211983|FG001|Overall Study|Lost to Follow-up|29
4429106|NCT00386100|7211982|FG000|Overall Study|Non-compliance|18
4429107|NCT00386100|7211983|FG001|Overall Study|Non-compliance|19
4429108|NCT00386100|7211982|FG000|Overall Study|Protocol Violation|5
4429109|NCT00386100|7211983|FG001|Overall Study|Protocol Violation|3
4429110|NCT00386100|7211982|FG000|Overall Study|Withdrawal by Subject|32
4429111|NCT00386100|7211983|FG001|Overall Study|Withdrawal by Subject|31
4429112|NCT00386100|7211982|FG000|Overall Study|Bone mass density (BMD) loss >6%|4
4429113|NCT00386100|7211983|FG001|Overall Study|Bone mass density (BMD) loss >6%|4
4429114|NCT00386100|7211982|FG000|Overall Study|BMD <2.5|1
4429115|NCT00386100|7211983|FG001|Overall Study|BMD <2.5|0
4429116|NCT00386100|7211982|FG000|Overall Study|Consecutive elevated Hba1C|1
4429117|NCT00386100|7211983|FG001|Overall Study|Consecutive elevated Hba1C|0
4429118|NCT00386100|7211982|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0
4429119|NCT00386100|7211983|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1
4429120|NCT00386100|7211982|FG000|Overall Study|Laboratory findings|1
4429121|NCT00386100|7211983|FG001|Overall Study|Laboratory findings|0
4429122|NCT00386100|7211982|FG000|Overall Study|Participant's concern due to CPK levels|1
4429123|NCT00386100|7211983|FG001|Overall Study|Participant's concern due to CPK levels|0
4429124|NCT00386100|7211982|FG000|Overall Study|Participant moving out of state|2
4429125|NCT00386100|7211983|FG001|Overall Study|Participant moving out of state|0
4429126|NCT00386100|7211982|FG000|Overall Study|Excessive bone loss vs. baseline value|0
4429127|NCT00386100|7211983|FG001|Overall Study|Excessive bone loss vs. baseline value|1
4429128|NCT00386100|7211982|FG000|Overall Study|Didn't meet entry criteria|1
4429129|NCT00386100|7211983|FG001|Overall Study|Didn't meet entry criteria|1
4629944|NCT01878175|7498327|FG000|Overall Study|Developed contraindicated health problem|2
4629945|NCT01878214|7498334|FG000|Overall Study|Withdrawal by Subject|18
4629946|NCT01878214|7498335|FG001|Overall Study|Withdrawal by Subject|7
4629947|NCT01878214|7498334|FG000|Overall Study|Death|0
4629948|NCT01878214|7498335|FG001|Overall Study|Death|1
4629949|NCT01878214|7498334|FG000|Overall Study|Lost to Follow-up|35
4629950|NCT01878214|7498335|FG001|Overall Study|Lost to Follow-up|36
4633284|NCT01909804|7503307|FG011|Overall Study|Protocol Violation|1
4633285|NCT01909973|7503331|FG000|Overall Study|Lost to Follow-up|1
4633286|NCT01909973|7503332|FG001|Overall Study|Lost to Follow-up|0
4633287|NCT01910116|7503344|FG000|Overall Study|Adverse Event|0
4633288|NCT01910116|7503345|FG001|Overall Study|Adverse Event|3
4633289|NCT01910116|7503344|FG000|Overall Study|Lack of Efficacy|3
4633290|NCT01910116|7503345|FG001|Overall Study|Lack of Efficacy|4
4429130|NCT00386100|7211982|FG000|Overall Study|Participant's PCP wanted to stop drug|1
4429131|NCT00386100|7211983|FG001|Overall Study|Participant's PCP wanted to stop drug|0
4633291|NCT01910116|7503344|FG000|Overall Study|Lost to Follow-up|1
4629951|NCT01878253|7498341|FG000|Overall Study|Death|1
4429132|NCT00386100|7211982|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0
4429133|NCT00386100|7211983|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1
4429134|NCT00386100|7211982|FG000|Overall Study|Bad metabolic control & patient security|1
4429135|NCT00386100|7211983|FG001|Overall Study|Bad metabolic control & patient security|0
4429136|NCT00386100|7211982|FG000|Overall Study|Bone loss by DXA bone scan|1
4429137|NCT00386100|7211983|FG001|Overall Study|Bone loss by DXA bone scan|0
4429138|NCT00386100|7211982|FG000|Overall Study|DBP 93 mmHg at randomization|1
4429139|NCT00386100|7211983|FG001|Overall Study|DBP 93 mmHg at randomization|0
4429140|NCT00386100|7211982|FG000|Overall Study|7.6% bone loss|1
4429141|NCT00386100|7211983|FG001|Overall Study|7.6% bone loss|0
4429142|NCT00386100|7211982|FG000|Overall Study|Osteoporosis|0
4429143|NCT00386100|7211983|FG001|Overall Study|Osteoporosis|1
4429144|NCT00386100|7211982|FG000|Overall Study|Positive pregnancy test|1
4429145|NCT00386100|7211983|FG001|Overall Study|Positive pregnancy test|3
4429146|NCT00386100|7211982|FG000|Overall Study|Out of country for 5 months|1
4429147|NCT00386100|7211983|FG001|Overall Study|Out of country for 5 months|0
4429148|NCT00386100|7211982|FG000|Overall Study|Hb1Ac >8%|0
4429149|NCT00386100|7211983|FG001|Overall Study|Hb1Ac >8%|1
4429150|NCT00386100|7211982|FG000|Overall Study|Participant randomized in error|1
4429151|NCT00386100|7211983|FG001|Overall Study|Participant randomized in error|0
4429152|NCT00386152|7211992|FG000|Overall Study|Adverse Event|6
4429153|NCT00386152|7211993|FG001|Overall Study|Adverse Event|5
4429154|NCT00386152|7211994|FG002|Overall Study|Adverse Event|4
4429155|NCT00386152|7211992|FG000|Overall Study|Chang from original chemo stratification|4
4429156|NCT00386152|7211993|FG001|Overall Study|Chang from original chemo stratification|5
4429157|NCT00386152|7211994|FG002|Overall Study|Chang from original chemo stratification|6
4429158|NCT00386152|7211992|FG000|Overall Study|Death|3
4429159|NCT00386152|7211993|FG001|Overall Study|Death|0
4429160|NCT00386152|7211994|FG002|Overall Study|Death|1
4429161|NCT00386152|7211992|FG000|Overall Study|Disease progression|7
4429162|NCT00386152|7211993|FG001|Overall Study|Disease progression|4
4429163|NCT00386152|7211994|FG002|Overall Study|Disease progression|5
4429164|NCT00386152|7211992|FG000|Overall Study|Physician Decision|13
4429165|NCT00386152|7211993|FG001|Overall Study|Physician Decision|10
4429166|NCT00386152|7211994|FG002|Overall Study|Physician Decision|4
4429167|NCT00386152|7211992|FG000|Overall Study|Lost to Follow-up|1
4429168|NCT00386152|7211993|FG001|Overall Study|Lost to Follow-up|0
4429169|NCT00386152|7211994|FG002|Overall Study|Lost to Follow-up|0
4429170|NCT00386152|7211992|FG000|Overall Study|Completed chemotherapy|4
4429171|NCT00386152|7211993|FG001|Overall Study|Completed chemotherapy|5
4429172|NCT00386152|7211994|FG002|Overall Study|Completed chemotherapy|1
4429173|NCT00386152|7211992|FG000|Overall Study|Protocol Violation|3
4429174|NCT00386152|7211993|FG001|Overall Study|Protocol Violation|5
4429175|NCT00386152|7211994|FG002|Overall Study|Protocol Violation|2
4429176|NCT00386152|7211992|FG000|Overall Study|Withdrawal by Subject|3
4429177|NCT00386152|7211993|FG001|Overall Study|Withdrawal by Subject|6
4429178|NCT00386152|7211994|FG002|Overall Study|Withdrawal by Subject|10
4429179|NCT00386308|7212030|FG000|Overall Study|Adverse Event|3
4429180|NCT00386308|7212031|FG001|Overall Study|Adverse Event|3
4429181|NCT00386308|7212030|FG000|Overall Study|Protocol Violation|2
4429182|NCT00386308|7212031|FG001|Overall Study|Protocol Violation|5
4429183|NCT00386308|7212030|FG000|Overall Study|Lack of Efficacy|0
4429184|NCT00386308|7212031|FG001|Overall Study|Lack of Efficacy|2
4429185|NCT00386308|7212030|FG000|Overall Study|Lost to Follow-up|10
4429186|NCT00386308|7212031|FG001|Overall Study|Lost to Follow-up|6
4429187|NCT00386308|7212030|FG000|Overall Study|Withdrawal by Subject|6
4429188|NCT00386308|7212031|FG001|Overall Study|Withdrawal by Subject|2
4429189|NCT00386308|7212030|FG000|Overall Study|Other Event|8
4429190|NCT00386308|7212031|FG001|Overall Study|Other Event|1
4429191|NCT00386334|7212039|FG000|Double Blind Period|Adverse Event|9
4429192|NCT00386334|7212040|FG001|Double Blind Period|Adverse Event|14
4429193|NCT00386334|7212039|FG000|Double Blind Period|Protocol Violation|1
4429194|NCT00386334|7212040|FG001|Double Blind Period|Protocol Violation|1
4429195|NCT00386334|7212039|FG000|Double Blind Period|Withdrawal by Subject|9
4429196|NCT00386334|7212040|FG001|Double Blind Period|Withdrawal by Subject|13
4429197|NCT00386334|7212039|FG000|Double Blind Period|Lack of Efficacy|20
4429198|NCT00386334|7212040|FG001|Double Blind Period|Lack of Efficacy|11
4429199|NCT00386334|7212039|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4
4429200|NCT00386334|7212040|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5
4429201|NCT00386334|7212039|FG000|Double Blind Period|Other|3
4429202|NCT00386334|7212040|FG001|Double Blind Period|Other|3
4429203|NCT00386334|7212039|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3
4429204|NCT00386334|7212040|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1
4429205|NCT00386360|7212048|FG000|Overall Study|Adverse Event|4
4429206|NCT00386360|7212049|FG001|Overall Study|Adverse Event|2
4429207|NCT00386360|7212048|FG000|Overall Study|Physician Decision|2
4429208|NCT00386360|7212049|FG001|Overall Study|Physician Decision|2
4429209|NCT00386360|7212048|FG000|Overall Study|Lost to Follow-up|0
4429210|NCT00386360|7212049|FG001|Overall Study|Lost to Follow-up|2
4429211|NCT00386360|7212048|FG000|Overall Study|Protocol Violation|0
4429212|NCT00386360|7212049|FG001|Overall Study|Protocol Violation|3
4429213|NCT00386360|7212048|FG000|Overall Study|Withdrawal by Subject|3
4429214|NCT00386360|7212049|FG001|Overall Study|Withdrawal by Subject|6
4429215|NCT00386360|7212048|FG000|Overall Study|Did not take any study medication|0
4429216|NCT00386360|7212049|FG001|Overall Study|Did not take any study medication|2
4629952|NCT01878253|7498341|FG000|Overall Study|SIdus System Removal|3
4629953|NCT01878253|7498341|FG000|Overall Study|Withdrawal by Subject|1
4429217|NCT00386425|7212058|FG000|Overall Study|Physician Decision|3
4429218|NCT00386425|7212059|FG001|Overall Study|Physician Decision|0
4429219|NCT00386425|7212060|FG002|Overall Study|Physician Decision|0
4429220|NCT00386425|7212058|FG000|Overall Study|Withdrawal by Subject|0
4429221|NCT00386425|7212059|FG001|Overall Study|Withdrawal by Subject|1
4429222|NCT00386425|7212060|FG002|Overall Study|Withdrawal by Subject|0
4429223|NCT00386607|7212081|FG000|Core|Adverse Event|40
4429224|NCT00386607|7212082|FG001|Core|Adverse Event|0
4429225|NCT00386607|7212081|FG000|Core|Abnormal laboratory value(s)|3
4429226|NCT00386607|7212082|FG001|Core|Abnormal laboratory value(s)|0
4429227|NCT00386607|7212081|FG000|Core|Unsatisfactory therapeutic effect|23
4429228|NCT00386607|7212082|FG001|Core|Unsatisfactory therapeutic effect|0
4429229|NCT00386607|7212081|FG000|Core|Condition no longer requires study drug|4
4429230|NCT00386607|7212082|FG001|Core|Condition no longer requires study drug|0
4429231|NCT00386607|7212081|FG000|Core|Patient withdrew consent|15
4429232|NCT00386607|7212082|FG001|Core|Patient withdrew consent|0
4429233|NCT00386607|7212081|FG000|Core|Lost to Follow-up|23
4429234|NCT00386607|7212082|FG001|Core|Lost to Follow-up|0
4429235|NCT00386607|7212081|FG000|Core|Administrative problems|1
4429236|NCT00386607|7212082|FG001|Core|Administrative problems|0
4429237|NCT00386607|7212081|FG000|Core|Protocol Deviation|6
4429238|NCT00386607|7212082|FG001|Core|Protocol Deviation|0
4429239|NCT00386607|7212081|FG000|Extension|Adverse Event|0
4429240|NCT00386607|7212082|FG001|Extension|Adverse Event|6
4429241|NCT00386607|7212081|FG000|Extension|Abnormal laboratory value(s)|0
4429242|NCT00386607|7212082|FG001|Extension|Abnormal laboratory value(s)|1
4429243|NCT00386607|7212081|FG000|Extension|Administrative problems|0
4429244|NCT00386607|7212082|FG001|Extension|Administrative problems|1
4429245|NCT00386607|7212081|FG000|Extension|Lost to Follow-up|0
4429246|NCT00386607|7212082|FG001|Extension|Lost to Follow-up|3
4429247|NCT00386607|7212081|FG000|Extension|Patient withdrew consent|0
4429248|NCT00386607|7212082|FG001|Extension|Patient withdrew consent|5
4429249|NCT00386607|7212081|FG000|Extension|Unsatisfactory therapeutic effect|0
4429250|NCT00386607|7212082|FG001|Extension|Unsatisfactory therapeutic effect|1
4429251|NCT00386776|7212094|FG000|Overall Study|Withdrawal by Subject|8
4429252|NCT00387010|7212106|FG000|Dose Titration Period|Adverse Event|12
4429253|NCT00387010|7212106|FG000|Dose Titration Period|Lack of Efficacy|5
4429254|NCT00387010|7212106|FG000|Dose Titration Period|Withdrawal by Subject|3
4429255|NCT00387010|7212106|FG000|Dose Titration Period|Protocol Violation|1
4429256|NCT00387010|7212106|FG000|Dose Titration Period|Lost to Follow-up|2
4429257|NCT00387010|7212106|FG000|Dose Titration Period|Noncompliance with study medication|8
4429258|NCT00387010|7212106|FG000|Dose Titration Period|Noncompliance with study procedures|7
4429259|NCT00387010|7212106|FG000|Treatment Period|Adverse Event|4
4429260|NCT00387010|7212106|FG000|Treatment Period|Withdrawal by Subject|1
4429261|NCT00387010|7212106|FG000|Treatment Period|Noncompliance with study medication|2
4429262|NCT00387010|7212106|FG000|Treatment Period|Noncompliance with study procedures|3
4429263|NCT00387010|7212106|FG000|Treatment Period|Participant reported study drug stolen|1
4429264|NCT00387088|7212123|FG000|Overall Study|Adverse Event|143
4429265|NCT00387088|7212124|FG001|Overall Study|Adverse Event|156
4429266|NCT00387088|7212123|FG000|Overall Study|Protocol Violation|47
4429267|NCT00387088|7212124|FG001|Overall Study|Protocol Violation|35
4429268|NCT00387088|7212123|FG000|Overall Study|Withdrawal by Subject|20
4429269|NCT00387088|7212124|FG001|Overall Study|Withdrawal by Subject|35
4429270|NCT00387088|7212123|FG000|Overall Study|Lack of Efficacy|28
4429271|NCT00387088|7212124|FG001|Overall Study|Lack of Efficacy|67
4429272|NCT00387088|7212123|FG000|Overall Study|Lost to Follow-up|22
4429273|NCT00387088|7212124|FG001|Overall Study|Lost to Follow-up|28
4429274|NCT00387088|7212123|FG000|Overall Study|Other|58
4429275|NCT00387088|7212124|FG001|Overall Study|Other|52
4429276|NCT00387127|7212132|FG000|Overall Study|Lost to Follow-up|0
4429277|NCT00387127|7212133|FG001|Overall Study|Lost to Follow-up|4
4429278|NCT00387127|7212132|FG000|Overall Study|Death|16
4429279|NCT00387127|7212133|FG001|Overall Study|Death|16
4429280|NCT00387127|7212132|FG000|Overall Study|Physician Decision|0
4715158|NCT02969018|7643531|FG004|Overall Study|No Longer Meets Eligibility Criteria|0
4429281|NCT00387127|7212133|FG001|Overall Study|Physician Decision|1
4429282|NCT00387127|7212132|FG000|Overall Study|Withdrawal by Subject|3
4429283|NCT00387127|7212133|FG001|Overall Study|Withdrawal by Subject|2
4429284|NCT00387127|7212132|FG000|Overall Study|Required by Protocol Amendment #4|12
4429285|NCT00387127|7212133|FG001|Overall Study|Required by Protocol Amendment #4|10
4429286|NCT00387127|7212132|FG000|Overall Study|Serious Adverse Event|1
4429287|NCT00387127|7212133|FG001|Overall Study|Serious Adverse Event|1
4429288|NCT00387127|7212132|FG000|Overall Study|Sponsor Unblinded|1
4429289|NCT00387127|7212133|FG001|Overall Study|Sponsor Unblinded|0
4429290|NCT00387153|7212141|FG000|Overall Study|Adverse Event|1
4429291|NCT00387153|7212141|FG000|Overall Study|Disease Progression|3
4429292|NCT00387153|7212141|FG000|Overall Study|Lack of Response|4
4429293|NCT00387348|7212157|FG000|Overall Study|Death|1
4429294|NCT00387348|7212158|FG001|Overall Study|Death|1
4429295|NCT00387348|7212159|FG002|Overall Study|Death|0
4429296|NCT00387348|7212157|FG000|Overall Study|Physician Decision|1
4429297|NCT00387348|7212158|FG001|Overall Study|Physician Decision|0
4429298|NCT00387348|7212159|FG002|Overall Study|Physician Decision|1
4429299|NCT00387348|7212157|FG000|Overall Study|Withdrawal by Subject|0
4429300|NCT00387348|7212158|FG001|Overall Study|Withdrawal by Subject|2
4429301|NCT00387348|7212159|FG002|Overall Study|Withdrawal by Subject|2
4429302|NCT00387348|7212157|FG000|Overall Study|Adverse Event|1
4429303|NCT00387348|7212158|FG001|Overall Study|Adverse Event|0
4429304|NCT00387348|7212159|FG002|Overall Study|Adverse Event|1
4429305|NCT00387426|7212172|FG000|Overall Study|Lack of Response|7
4429306|NCT00387426|7212172|FG000|Overall Study|Toxicities|4
4429307|NCT00387426|7212172|FG000|Overall Study|Disease Progression|3
4429308|NCT00387465|7212179|FG000|Overall Study|Withdrawal by Subject|0
4429309|NCT00387465|7212180|FG001|Overall Study|Withdrawal by Subject|1
4429310|NCT00387465|7212181|FG002|Overall Study|Withdrawal by Subject|0
4429311|NCT00387647|7212205|FG000|Overall Study|Death|18
4429312|NCT00387712|7212220|FG000|Overall Study|Physician Decision|6
4429313|NCT00387712|7212221|FG001|Overall Study|Physician Decision|4
4429314|NCT00387712|7212220|FG000|Overall Study|Lost to Follow-up|17
4429315|NCT00387712|7212221|FG001|Overall Study|Lost to Follow-up|20
4429316|NCT00387712|7212220|FG000|Overall Study|Withdrawal by Subject|6
4429317|NCT00387712|7212221|FG001|Overall Study|Withdrawal by Subject|12
4429318|NCT00387725|7212231|FG000|Overall Study|Adverse Event|0
4429319|NCT00387725|7212232|FG001|Overall Study|Adverse Event|0
4429320|NCT00387725|7212233|FG002|Overall Study|Adverse Event|0
4429321|NCT00387725|7212234|FG003|Overall Study|Adverse Event|1
4429322|NCT00387725|7212231|FG000|Overall Study|Protocol Violation|0
4429323|NCT00387725|7212232|FG001|Overall Study|Protocol Violation|1
4429324|NCT00387725|7212233|FG002|Overall Study|Protocol Violation|0
4429325|NCT00387725|7212234|FG003|Overall Study|Protocol Violation|0
4429326|NCT00387725|7212231|FG000|Overall Study|Withdrawal by Subject|1
4429327|NCT00387725|7212232|FG001|Overall Study|Withdrawal by Subject|0
4429328|NCT00387725|7212233|FG002|Overall Study|Withdrawal by Subject|1
4429329|NCT00387725|7212234|FG003|Overall Study|Withdrawal by Subject|0
4429330|NCT00387725|7212231|FG000|Overall Study|Parent/legal guardian request|0
4429331|NCT00387725|7212232|FG001|Overall Study|Parent/legal guardian request|0
4429332|NCT00387725|7212233|FG002|Overall Study|Parent/legal guardian request|1
4429333|NCT00387725|7212234|FG003|Overall Study|Parent/legal guardian request|1
4512473|NCT00934544|7322247|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7
4512474|NCT00934544|7322248|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7
4512475|NCT00934544|7322249|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0
4512476|NCT00934544|7322247|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29
4512477|NCT00934544|7322248|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18
4512478|NCT00934544|7322249|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0
4512479|NCT00934544|7322247|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16
4512480|NCT00934544|7322248|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9
4512481|NCT00934544|7322249|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6
4512482|NCT00934544|7322247|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35
4512483|NCT00934544|7322248|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5
4512484|NCT00934544|7322249|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10
4512485|NCT00934544|7322247|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10
4512486|NCT00934544|7322248|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9
4512487|NCT00934544|7322249|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0
4512488|NCT00934544|7322247|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2
4512489|NCT00934544|7322248|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0
4512490|NCT00934544|7322249|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5
4512491|NCT00934544|7322247|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32
4512492|NCT00934544|7322248|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4
4512493|NCT00934544|7322249|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7
4512494|NCT00934544|7322247|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4
4512495|NCT00934544|7322248|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0
4512496|NCT00934544|7322249|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1
4512497|NCT00934544|7322247|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0
4512498|NCT00934544|7322248|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1
4512499|NCT00934544|7322249|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0
4512500|NCT00934544|7322247|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8
4512501|NCT00934544|7322248|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0
4512502|NCT00934544|7322249|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5
4512503|NCT00934622|7322279|FG000|Overall Study|Lost to Follow-up|7
4512504|NCT00934622|7322279|FG000|Overall Study|2nd Intraoperative exclusion criteria|1
4512505|NCT00934648|7322320|FG000|Overall Study|Failure to return|8
4512506|NCT00934648|7322320|FG000|Overall Study|Withdrawal by Subject|1
4512507|NCT00934661|7322326|FG000|Overall Study|Failure of Combined/Spinal Epidural|1
4518734|NCT00976027|7331007|FG001|Overall Study|Serious Adverse Event|17
4429334|NCT00387764|7212250|FG000|Overall Study|Adverse Event|12
4429335|NCT00387764|7212250|FG000|Overall Study|Withdrawal by Subject|8
4429336|NCT00387764|7212250|FG000|Overall Study|Sponsor Terminated Study|1
4429337|NCT00387764|7212250|FG000|Overall Study|Physician Decision|1
4429338|NCT00387764|7212250|FG000|Overall Study|Other|2
4429339|NCT00387764|7212250|FG000|Overall Study|Death|7
4429340|NCT00387790|7212254|FG000|Overall Study|Adverse Event|5
4429341|NCT00387790|7212254|FG000|Overall Study|Lack of Efficacy|2
4429342|NCT00387790|7212254|FG000|Overall Study|Physician Decision|2
4429343|NCT00387790|7212254|FG000|Overall Study|Withdrawal by Subject|3
4429344|NCT00387790|7212254|FG000|Overall Study|Ineligible for study|2
4429345|NCT00387881|7212269|FG000|Overall Study|Lost to Follow-up|23
4429346|NCT00387881|7212270|FG001|Overall Study|Lost to Follow-up|23
4429347|NCT00387881|7212269|FG000|Overall Study|Protocol Violation|2
4429348|NCT00387881|7212270|FG001|Overall Study|Protocol Violation|12
4429349|NCT00387881|7212269|FG000|Overall Study|Withdrawal by Subject|15
4429350|NCT00387881|7212270|FG001|Overall Study|Withdrawal by Subject|18
4429351|NCT00387881|7212269|FG000|Overall Study|Sponsor terminated Study|0
4429352|NCT00387881|7212270|FG001|Overall Study|Sponsor terminated Study|1
4429353|NCT00387881|7212269|FG000|Overall Study|Not eligible|6
4429354|NCT00387881|7212270|FG001|Overall Study|Not eligible|7
4429355|NCT00387881|7212269|FG000|Overall Study|No opportunity to treat headache|32
4429356|NCT00387881|7212270|FG001|Overall Study|No opportunity to treat headache|34
4429357|NCT00387881|7212269|FG000|Overall Study|Not otherwise specified|11
4429358|NCT00387881|7212270|FG001|Overall Study|Not otherwise specified|7
4429359|NCT00387894|7212276|FG000|Overall Study|Withdrawal by Subject|1
4429360|NCT00388037|7212284|FG000|Overall Study|Protocol Violation|1
4429361|NCT00388154|7212288|FG000|Overall Study|Withdrawal by Subject|1
4429362|NCT00388297|7212296|FG000|Overall Study|Lost to Follow-up|16
4429363|NCT00388297|7212297|FG001|Overall Study|Lost to Follow-up|12
4429364|NCT00388297|7212298|FG002|Overall Study|Lost to Follow-up|11
4429365|NCT00388297|7212299|FG003|Overall Study|Lost to Follow-up|8
4429366|NCT00388349|7212309|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0
4429367|NCT00388349|7212310|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3
4429368|NCT00388362|7212318|FG000|Enrolled|Ineligible|1
4429369|NCT00388362|7212318|FG000|Enrolled|Adverse Event|9
4429370|NCT00388362|7212318|FG000|Enrolled|Death|1
4429371|NCT00388362|7212318|FG000|Enrolled|Loss insurance|1
4429372|NCT00388362|7212318|FG000|Enrolled|Withdrawal by Subject|1
4429373|NCT00388362|7212318|FG000|Remained on Study Median of 514 Days|Death|2
4429374|NCT00388505|7212348|FG000|Overall Study|Adverse Event or Death|43
4429375|NCT00388505|7212349|FG001|Overall Study|Adverse Event or Death|17
4429376|NCT00388505|7212348|FG000|Overall Study|Withdrawal by Subject|24
4429377|NCT00388505|7212349|FG001|Overall Study|Withdrawal by Subject|9
4429378|NCT00388505|7212348|FG000|Overall Study|Lost to Follow-up|5
4429379|NCT00388505|7212349|FG001|Overall Study|Lost to Follow-up|3
4429380|NCT00388505|7212348|FG000|Overall Study|Inappropriate Enrollment|0
4429381|NCT00388505|7212349|FG001|Overall Study|Inappropriate Enrollment|1
4429382|NCT00388505|7212348|FG000|Overall Study|Administrative Reason|1
4429383|NCT00388505|7212349|FG001|Overall Study|Administrative Reason|0
4429384|NCT00388505|7212348|FG000|Overall Study|Protocol Violation|6
4429385|NCT00388505|7212349|FG001|Overall Study|Protocol Violation|5
4429386|NCT00388505|7212348|FG000|Overall Study|Unable to classify|4
4429387|NCT00388505|7212349|FG001|Overall Study|Unable to classify|3
4429388|NCT00388583|7212357|FG000|Overall Study|Protocol Violation|1
4429389|NCT00388583|7212358|FG001|Overall Study|Protocol Violation|0
4429390|NCT00388583|7212357|FG000|Overall Study|Withdrawal by Subject|3
4429391|NCT00388583|7212358|FG001|Overall Study|Withdrawal by Subject|3
4429392|NCT00388583|7212357|FG000|Overall Study|Serious Adverse Event|2
4429393|NCT00388583|7212358|FG001|Overall Study|Serious Adverse Event|0
4429394|NCT00388583|7212357|FG000|Overall Study|Did not receive vaccine|0
4429395|NCT00388583|7212358|FG001|Overall Study|Did not receive vaccine|1
4429396|NCT00388674|7212366|FG000|Initial Treatment|Administrative Reason by Sponsor|241
4429397|NCT00388674|7212367|FG001|Initial Treatment|Administrative Reason by Sponsor|158
4429398|NCT00388674|7212366|FG000|Initial Treatment|Adverse Event|22
4429399|NCT00388674|7212367|FG001|Initial Treatment|Adverse Event|87
4429400|NCT00388674|7212366|FG000|Initial Treatment|Death|215
4429401|NCT00388674|7212367|FG001|Initial Treatment|Death|216
4429402|NCT00388674|7212366|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11
4429403|NCT00388674|7212367|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17
4429404|NCT00388674|7212366|FG000|Initial Treatment|HCC|12
4429405|NCT00388674|7212367|FG001|Initial Treatment|HCC|20
4429406|NCT00388674|7212366|FG000|Initial Treatment|Lost to Follow-up|526
4429407|NCT00388674|7212367|FG001|Initial Treatment|Lost to Follow-up|624
4429408|NCT00388674|7212366|FG000|Initial Treatment|Malignancy (Non-HCC)|7
4429409|NCT00388674|7212367|FG001|Initial Treatment|Malignancy (Non-HCC)|3
4429410|NCT00388674|7212366|FG000|Initial Treatment|Never Treated with Study Medication|1
4429411|NCT00388674|7212367|FG001|Initial Treatment|Never Treated with Study Medication|7
4429412|NCT00388674|7212366|FG000|Initial Treatment|Non-Study related Comorbidities|3
4429413|NCT00388674|7212367|FG001|Initial Treatment|Non-Study related Comorbidities|4
4429414|NCT00388674|7212366|FG000|Initial Treatment|Not Defined|125
4429415|NCT00388674|7212367|FG001|Initial Treatment|Not Defined|172
4429416|NCT00388674|7212366|FG000|Initial Treatment|Partial or inadequate Treatment|112
4429417|NCT00388674|7212367|FG001|Initial Treatment|Partial or inadequate Treatment|472
4429418|NCT00388674|7212366|FG000|Initial Treatment|Pregnancy|26
4429419|NCT00388674|7212367|FG001|Initial Treatment|Pregnancy|16
4429420|NCT00388674|7212366|FG000|Initial Treatment|Study Drug Toxicity|5
4429421|NCT00388674|7212367|FG001|Initial Treatment|Study Drug Toxicity|92
4429422|NCT00388674|7212366|FG000|Initial Treatment|Participant Request|501
4429423|NCT00388674|7212367|FG001|Initial Treatment|Participant Request|673
4429424|NCT00388674|7212366|FG000|Initial Treatment|No Off-Treatment Status Data|11
4429425|NCT00388674|7212367|FG001|Initial Treatment|No Off-Treatment Status Data|13
4429426|NCT00388674|7212366|FG000|Initial Treatment|Not Reported|10
4429427|NCT00388674|7212367|FG001|Initial Treatment|Not Reported|12
4429428|NCT00388674|7212366|FG000|End of Study|Administrative Reason By Sponsor|299
4429429|NCT00388674|7212367|FG001|End of Study|Administrative Reason By Sponsor|253
4429430|NCT00388674|7212366|FG000|End of Study|Death|239
4429431|NCT00388674|7212367|FG001|End of Study|Death|262
4429432|NCT00388674|7212366|FG000|End of Study|HBV Disease Progression (Non-HCC)|3
4429433|NCT00388674|7212367|FG001|End of Study|HBV Disease Progression (Non-HCC)|9
4429434|NCT00388674|7212366|FG000|End of Study|HCC|8
4429435|NCT00388674|7212367|FG001|End of Study|HCC|7
4429436|NCT00388674|7212366|FG000|End of Study|Lost to Follow-up|587
4429437|NCT00388674|7212367|FG001|End of Study|Lost to Follow-up|715
4429438|NCT00388674|7212366|FG000|End of Study|Malignancy (Non-HCC)|1
4429439|NCT00388674|7212367|FG001|End of Study|Malignancy (Non-HCC)|1
4429440|NCT00388674|7212366|FG000|End of Study|Non-Study Related Comorbidities|3
4429441|NCT00388674|7212367|FG001|End of Study|Non-Study Related Comorbidities|4
4429442|NCT00388674|7212366|FG000|End of Study|Not Defined|135
4429443|NCT00388674|7212367|FG001|End of Study|Not Defined|214
4429444|NCT00388674|7212366|FG000|End of Study|Participant Withdrew Consent|437
4429445|NCT00388674|7212367|FG001|End of Study|Participant Withdrew Consent|673
4429446|NCT00388674|7212366|FG000|End of Study|No Off-Treatment Status Data|22
4429447|NCT00388674|7212367|FG001|End of Study|No Off-Treatment Status Data|30
4429448|NCT00388674|7212366|FG000|End of Study|Not Reported|0
4429449|NCT00388674|7212367|FG001|End of Study|Not Reported|1
4429450|NCT00388726|7212375|FG000|Overall Study|Adverse Event|50
4429451|NCT00388726|7212376|FG001|Overall Study|Adverse Event|24
4429452|NCT00388726|7212375|FG000|Overall Study|Progressive Disease|336
4429453|NCT00388726|7212376|FG001|Overall Study|Progressive Disease|153
4429454|NCT00388726|7212375|FG000|Overall Study|Clinical Progression|61
4429455|NCT00388726|7212376|FG001|Overall Study|Clinical Progression|36
4429456|NCT00388726|7212375|FG000|Overall Study|Withdrawal by Subject|10
4429457|NCT00388726|7212376|FG001|Overall Study|Withdrawal by Subject|7
4429458|NCT00388726|7212375|FG000|Overall Study|Administrative|6
4429459|NCT00388726|7212376|FG001|Overall Study|Administrative|9
4429460|NCT00388726|7212375|FG000|Overall Study|Physician Decision|18
4429461|NCT00388726|7212376|FG001|Overall Study|Physician Decision|13
4429462|NCT00388726|7212375|FG000|Overall Study|Death|3
4429463|NCT00388726|7212376|FG001|Overall Study|Death|2
4429464|NCT00388947|7212391|FG000|Overall Study|Protocol Violation|47
4429465|NCT00388973|7212397|FG000|Overall Study|Adverse Event|16
4429466|NCT00388973|7212398|FG001|Overall Study|Adverse Event|6
4429467|NCT00388973|7212397|FG000|Overall Study|Lack of Efficacy|1
4429468|NCT00388973|7212398|FG001|Overall Study|Lack of Efficacy|12
4429469|NCT00388973|7212397|FG000|Overall Study|Protocol Violation|3
4429470|NCT00388973|7212398|FG001|Overall Study|Protocol Violation|0
4429471|NCT00388973|7212397|FG000|Overall Study|Withdrawal by Subject|14
4429472|NCT00388973|7212398|FG001|Overall Study|Withdrawal by Subject|17
4429473|NCT00388973|7212397|FG000|Overall Study|Study specific Discontinuation Criteria|0
4429474|NCT00388973|7212398|FG001|Overall Study|Study specific Discontinuation Criteria|1
4429475|NCT00388973|7212397|FG000|Overall Study|Did not complete 61 days of treatment|5
4429476|NCT00388973|7212398|FG001|Overall Study|Did not complete 61 days of treatment|4
4429477|NCT00388973|7212397|FG000|Overall Study|Left region|0
4429478|NCT00388973|7212398|FG001|Overall Study|Left region|1
4429479|NCT00388973|7212397|FG000|Overall Study|Did not complete 2-week follow-up visit|17
4429480|NCT00388973|7212398|FG001|Overall Study|Did not complete 2-week follow-up visit|17
4429481|NCT00389064|7212406|FG000|Overall Study|Adverse Event|11
4429482|NCT00389064|7212407|FG001|Overall Study|Adverse Event|3
4429483|NCT00389064|7212406|FG000|Overall Study|Lack of Efficacy|3
4429484|NCT00389064|7212407|FG001|Overall Study|Lack of Efficacy|14
4429485|NCT00389064|7212406|FG000|Overall Study|Withdrawal by Subject|17
4429486|NCT00389064|7212407|FG001|Overall Study|Withdrawal by Subject|27
4429487|NCT00389064|7212406|FG000|Overall Study|Physician Decision|2
4429488|NCT00389064|7212407|FG001|Overall Study|Physician Decision|2
4429489|NCT00389064|7212406|FG000|Overall Study|Lost to Follow-up|1
4429490|NCT00389064|7212407|FG001|Overall Study|Lost to Follow-up|2
4429491|NCT00389064|7212406|FG000|Overall Study|Protocol Violation|2
4715159|NCT02969018|7643532|FG005|Overall Study|No Longer Meets Eligibility Criteria|0
4715160|NCT02969018|7643533|FG006|Overall Study|No Longer Meets Eligibility Criteria|1
4715161|NCT02969018|7643534|FG007|Overall Study|No Longer Meets Eligibility Criteria|0
4715162|NCT02969018|7643527|FG000|Overall Study|Non-Compliance With Study Drug|1
4429492|NCT00389064|7212407|FG001|Overall Study|Protocol Violation|0
4715163|NCT02969018|7643528|FG001|Overall Study|Non-Compliance With Study Drug|0
4429493|NCT00389064|7212406|FG000|Overall Study|Multiple Reasons|9
4429494|NCT00389064|7212407|FG001|Overall Study|Multiple Reasons|11
4429495|NCT00389207|7212425|FG000|Overall Study|Adverse Event|26
4429496|NCT00389207|7212426|FG001|Overall Study|Adverse Event|32
4429497|NCT00389207|7212427|FG002|Overall Study|Adverse Event|10
4429498|NCT00389207|7212425|FG000|Overall Study|Protocol Violation|3
4429499|NCT00389207|7212426|FG001|Overall Study|Protocol Violation|1
4429500|NCT00389207|7212427|FG002|Overall Study|Protocol Violation|4
4429501|NCT00389207|7212425|FG000|Overall Study|Lost to Follow-up|12
4429502|NCT00389207|7212426|FG001|Overall Study|Lost to Follow-up|9
4429503|NCT00389207|7212427|FG002|Overall Study|Lost to Follow-up|7
4429504|NCT00389207|7212425|FG000|Overall Study|Withdrawal by Subject|5
4429505|NCT00389207|7212426|FG001|Overall Study|Withdrawal by Subject|7
4429506|NCT00389207|7212427|FG002|Overall Study|Withdrawal by Subject|11
4429507|NCT00389207|7212425|FG000|Overall Study|Other|17
4429508|NCT00389207|7212426|FG001|Overall Study|Other|23
4429509|NCT00389207|7212427|FG002|Overall Study|Other|9
4429510|NCT00389324|7212440|FG000|Run-In Phase|Adverse Event|1
4429511|NCT00389324|7212440|FG000|Run-In Phase|Lost to Follow-up|1
4429512|NCT00389324|7212440|FG000|Run-In Phase|Withdrawal by Subject|1
4429513|NCT00389324|7212440|FG000|Subcutaneous Phase|Adverse Event|2
4429514|NCT00389324|7212440|FG000|Subcutaneous Phase|Non-compliance with study medication|2
4429515|NCT00389324|7212440|FG000|Subcutaneous Phase|Withdrawal by Subject|2
4429516|NCT00389324|7212440|FG000|Subcutaneous Phase|Lost to Follow-up|1
4429517|NCT00389441|7212447|FG000|Overall Study|Adverse Event|7
4429518|NCT00389441|7212447|FG000|Overall Study|Death|4
4429519|NCT00389441|7212447|FG000|Overall Study|Lost to Follow-up|2
4429520|NCT00389441|7212447|FG000|Overall Study|Withdrawal by Subject|4
4429521|NCT00389441|7212447|FG000|Overall Study|Physician Decision|1
4429522|NCT00389441|7212447|FG000|Overall Study|Protocol Violation|1
4429523|NCT00389441|7212447|FG000|Overall Study|Global deterioration of health status|4
4629954|NCT01878253|7498341|FG000|Overall Study|Lost to Follow-up|2
4629955|NCT01878253|7498341|FG000|Overall Study|Completed Study w/o Follow-up Data|2
4629956|NCT01878292|7498353|FG000|Randomized|Protocol Violation|1
4629957|NCT01878292|7498354|FG001|Randomized|Protocol Violation|0
4629958|NCT01878292|7498355|FG002|Randomized|Protocol Violation|0
4629959|NCT01878292|7498353|FG000|Randomized|Lost to Follow-up|1
4629960|NCT01878292|7498354|FG001|Randomized|Lost to Follow-up|0
4629961|NCT01878292|7498355|FG002|Randomized|Lost to Follow-up|0
4629962|NCT01878292|7498353|FG000|Randomized|Adverse Event|1
4629963|NCT01878292|7498354|FG001|Randomized|Adverse Event|0
4629964|NCT01878292|7498355|FG002|Randomized|Adverse Event|0
4629965|NCT01878292|7498353|FG000|Double-blind Treatment Period|Other Reasons|2
4629966|NCT01878292|7498354|FG001|Double-blind Treatment Period|Other Reasons|0
4629967|NCT01878292|7498355|FG002|Double-blind Treatment Period|Other Reasons|0
4629968|NCT01878292|7498353|FG000|Double-blind Treatment Period|Lost to Follow-up|6
4629969|NCT01878292|7498354|FG001|Double-blind Treatment Period|Lost to Follow-up|3
4629970|NCT01878292|7498355|FG002|Double-blind Treatment Period|Lost to Follow-up|1
4629971|NCT01878292|7498353|FG000|Double-blind Treatment Period|Withdrawal by Subject|9
4715164|NCT02969018|7643529|FG002|Overall Study|Non-Compliance With Study Drug|0
4715165|NCT02969018|7643530|FG003|Overall Study|Non-Compliance With Study Drug|0
4429524|NCT00389441|7212447|FG000|Overall Study|Objective progression or relapse|26
4429525|NCT00389441|7212447|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2
4429526|NCT00389441|7212447|FG000|Overall Study|Clinical progression|1
4429527|NCT00389519|7212489|FG000|Placebo Run-In|Did not meet blood pressure criteria|119
4429528|NCT00389519|7212490|FG001|Placebo Run-In|Did not meet blood pressure criteria|0
4429529|NCT00389519|7212491|FG002|Placebo Run-In|Did not meet blood pressure criteria|0
4429530|NCT00389519|7212492|FG003|Placebo Run-In|Did not meet blood pressure criteria|0
4715166|NCT02969018|7643531|FG004|Overall Study|Non-Compliance With Study Drug|0
4715167|NCT02969018|7643532|FG005|Overall Study|Non-Compliance With Study Drug|0
4429531|NCT00389519|7212489|FG000|Placebo Run-In|Withdrawal by Subject|19
4429532|NCT00389519|7212490|FG001|Placebo Run-In|Withdrawal by Subject|0
4429533|NCT00389519|7212491|FG002|Placebo Run-In|Withdrawal by Subject|0
4429534|NCT00389519|7212492|FG003|Placebo Run-In|Withdrawal by Subject|0
4429535|NCT00389519|7212489|FG000|Placebo Run-In|Reason not specified|40
4429536|NCT00389519|7212490|FG001|Placebo Run-In|Reason not specified|0
4429537|NCT00389519|7212491|FG002|Placebo Run-In|Reason not specified|0
4429538|NCT00389519|7212492|FG003|Placebo Run-In|Reason not specified|0
4429539|NCT00389519|7212489|FG000|Randomized|Did not receive study drug|2
4429540|NCT00389519|7212490|FG001|Randomized|Did not receive study drug|0
4429541|NCT00389519|7212491|FG002|Randomized|Did not receive study drug|0
4429542|NCT00389519|7212492|FG003|Randomized|Did not receive study drug|0
4629972|NCT01878292|7498354|FG001|Double-blind Treatment Period|Withdrawal by Subject|7
4629973|NCT01878292|7498355|FG002|Double-blind Treatment Period|Withdrawal by Subject|8
4629974|NCT01878292|7498353|FG000|Double-blind Treatment Period|Protocol Violation|3
4715168|NCT02969018|7643533|FG006|Overall Study|Non-Compliance With Study Drug|0
4715169|NCT02969018|7643534|FG007|Overall Study|Non-Compliance With Study Drug|0
4715170|NCT02969018|7643527|FG000|Overall Study|Other|0
4429543|NCT00389519|7212489|FG000|Treated|Adverse Event|1
4429544|NCT00389519|7212490|FG001|Treated|Adverse Event|0
4629975|NCT01878292|7498354|FG001|Double-blind Treatment Period|Protocol Violation|4
4633292|NCT01910116|7503345|FG001|Overall Study|Lost to Follow-up|0
4429545|NCT00389519|7212491|FG002|Treated|Adverse Event|0
4429546|NCT00389519|7212492|FG003|Treated|Adverse Event|2
4429547|NCT00389519|7212489|FG000|Treated|Reason not specified|1
4429548|NCT00389519|7212490|FG001|Treated|Reason not specified|1
4429549|NCT00389519|7212491|FG002|Treated|Reason not specified|0
4429550|NCT00389519|7212492|FG003|Treated|Reason not specified|2
4429551|NCT00389597|7212515|FG000|Overall Study|Lost to Follow-up|8
4429552|NCT00389597|7212516|FG001|Overall Study|Lost to Follow-up|6
4429553|NCT00389597|7212517|FG002|Overall Study|Lost to Follow-up|4
4429554|NCT00389597|7212518|FG003|Overall Study|Lost to Follow-up|6
4429555|NCT00389831|7212543|FG000|Overall Study|Lack of Efficacy|0
4429556|NCT00389831|7212544|FG001|Overall Study|Lack of Efficacy|2
4429557|NCT00389831|7212543|FG000|Overall Study|Did not receive treatment.|0
4429558|NCT00389831|7212544|FG001|Overall Study|Did not receive treatment.|2
4429559|NCT00389831|7212543|FG000|Overall Study|Other reasons|0
4429560|NCT00389831|7212544|FG001|Overall Study|Other reasons|2
4429561|NCT00389831|7212543|FG000|Overall Study|Lost to Follow-up|0
4429562|NCT00389831|7212544|FG001|Overall Study|Lost to Follow-up|1
4429563|NCT00390013|7212578|FG000|Phase 1|tired|0
4429564|NCT00390013|7212579|FG001|Phase 1|tired|0
4429565|NCT00390013|7212580|FG002|Phase 1|tired|0
4429566|NCT00390013|7212581|FG003|Phase 1|tired|1
4429567|NCT00390013|7212578|FG000|Phase 2 First Treatment|tired|1
4429568|NCT00390013|7212579|FG001|Phase 2 First Treatment|tired|0
4429569|NCT00390013|7212580|FG002|Phase 2 First Treatment|tired|0
4429570|NCT00390013|7212581|FG003|Phase 2 First Treatment|tired|0
4429571|NCT00390013|7212578|FG000|Phase 2 First Treatment|Withdrawal by Subject|0
4429572|NCT00390013|7212579|FG001|Phase 2 First Treatment|Withdrawal by Subject|1
4429573|NCT00390013|7212580|FG002|Phase 2 First Treatment|Withdrawal by Subject|0
4429574|NCT00390013|7212581|FG003|Phase 2 First Treatment|Withdrawal by Subject|0
4429575|NCT00390221|7212594|FG000|Overall Study|Lost to Follow-up|0
4429576|NCT00390221|7212595|FG001|Overall Study|Lost to Follow-up|3
4429577|NCT00390221|7212596|FG002|Overall Study|Lost to Follow-up|0
4429578|NCT00390221|7212594|FG000|Overall Study|Adverse Event|1
4429579|NCT00390221|7212595|FG001|Overall Study|Adverse Event|4
4429580|NCT00390221|7212596|FG002|Overall Study|Adverse Event|3
4429581|NCT00390221|7212594|FG000|Overall Study|Investigator Decision|0
4429582|NCT00390221|7212595|FG001|Overall Study|Investigator Decision|0
4429583|NCT00390221|7212596|FG002|Overall Study|Investigator Decision|1
4429584|NCT00390221|7212594|FG000|Overall Study|Withdrawal by Subject|13
4429585|NCT00390221|7212595|FG001|Overall Study|Withdrawal by Subject|9
4429586|NCT00390221|7212596|FG002|Overall Study|Withdrawal by Subject|7
4429587|NCT00390221|7212594|FG000|Overall Study|Subject Non-compliance|1
4429588|NCT00390221|7212595|FG001|Overall Study|Subject Non-compliance|0
4429589|NCT00390221|7212596|FG002|Overall Study|Subject Non-compliance|2
4429590|NCT00390221|7212594|FG000|Overall Study|Other|3
4429591|NCT00390221|7212595|FG001|Overall Study|Other|4
4429592|NCT00390221|7212596|FG002|Overall Study|Other|2
4429593|NCT00390299|7212615|FG000|Overall Study|Cancellation|1
4429594|NCT00390299|7212616|FG001|Overall Study|Cancellation|0
4429595|NCT00390299|7212617|FG002|Overall Study|Cancellation|0
4429596|NCT00390299|7212618|FG003|Overall Study|Cancellation|0
4429597|NCT00390299|7212619|FG004|Overall Study|Cancellation|0
4429598|NCT00390416|7212650|FG000|Overall Study|Withdrawal by Subject|1
4429599|NCT00390416|7212650|FG000|Overall Study|Not treated|3
4429600|NCT00390455|7212673|FG000|Overall Study|Adverse Event|17
4429601|NCT00390455|7212674|FG001|Overall Study|Adverse Event|3
4429602|NCT00390455|7212673|FG000|Overall Study|Withdrawal by Subject|8
4429603|NCT00390455|7212674|FG001|Overall Study|Withdrawal by Subject|8
4429604|NCT00390455|7212673|FG000|Overall Study|Alternate Treatment|0
4429605|NCT00390455|7212674|FG001|Overall Study|Alternate Treatment|1
4429606|NCT00390455|7212673|FG000|Overall Study|Other Medical Reasons|7
4429607|NCT00390455|7212674|FG001|Overall Study|Other Medical Reasons|11
4429608|NCT00390468|7212680|FG000|Overall Study|Protocol Violation|2
4429609|NCT00390468|7212680|FG000|Overall Study|Lack of Efficacy|1
4429610|NCT00390546|7212686|FG000|Overall Study|Renal impairment|1
4429611|NCT00390546|7212687|FG001|Overall Study|Renal impairment|0
4429612|NCT00390546|7212686|FG000|Overall Study|Physician Decision|5
4429613|NCT00390546|7212687|FG001|Overall Study|Physician Decision|5
4429614|NCT00390572|7212706|FG000|Overall Study|Lost to Follow-up|8
4429615|NCT00390572|7212707|FG001|Overall Study|Lost to Follow-up|4
4429616|NCT00390572|7212706|FG000|Overall Study|health condition|0
4429617|NCT00390572|7212707|FG001|Overall Study|health condition|1
4429618|NCT00390689|7212727|FG000|Overall Study|Adverse Event|2
4429619|NCT00390689|7212728|FG001|Overall Study|Adverse Event|5
4429620|NCT00390689|7212729|FG002|Overall Study|Adverse Event|2
4429621|NCT00390689|7212727|FG000|Overall Study|Lack of Efficacy|0
4429622|NCT00390689|7212728|FG001|Overall Study|Lack of Efficacy|0
4429623|NCT00390689|7212729|FG002|Overall Study|Lack of Efficacy|1
4429624|NCT00390689|7212727|FG000|Overall Study|Protocol Violation|1
4429625|NCT00390689|7212728|FG001|Overall Study|Protocol Violation|0
4429626|NCT00390689|7212729|FG002|Overall Study|Protocol Violation|0
4429627|NCT00390689|7212727|FG000|Overall Study|Investigator's judgement|2
4429628|NCT00390689|7212728|FG001|Overall Study|Investigator's judgement|0
4429629|NCT00390689|7212729|FG002|Overall Study|Investigator's judgement|0
4429630|NCT00390780|7212748|FG000|Overall Study|Not completed|10
4429631|NCT00390780|7212749|FG001|Overall Study|Not completed|4
4429632|NCT00390780|7212748|FG000|Overall Study|Protocol Violation|6
4429633|NCT00390780|7212749|FG001|Overall Study|Protocol Violation|4
4429634|NCT00390780|7212748|FG000|Overall Study|Lost to Follow-up|3
4429635|NCT00390780|7212749|FG001|Overall Study|Lost to Follow-up|6
4429636|NCT00390780|7212748|FG000|Overall Study|Adverse Event|2
4429637|NCT00390780|7212749|FG001|Overall Study|Adverse Event|3
4429638|NCT00390780|7212748|FG000|Overall Study|Death|1
4429639|NCT00390780|7212749|FG001|Overall Study|Death|3
4429640|NCT00390780|7212748|FG000|Overall Study|Withdrawal by Subject|1
4429641|NCT00390780|7212749|FG001|Overall Study|Withdrawal by Subject|2
4429642|NCT00390780|7212748|FG000|Overall Study|Inclusion criteria not satisfied|0
4429643|NCT00390780|7212749|FG001|Overall Study|Inclusion criteria not satisfied|2
4429644|NCT00390780|7212748|FG000|Overall Study|Lost to follow up and other reasons|0
4429645|NCT00390780|7212749|FG001|Overall Study|Lost to follow up and other reasons|1
4429646|NCT00390780|7212748|FG000|Overall Study|Investigator decision, SAE, other reason|0
4429647|NCT00390780|7212749|FG001|Overall Study|Investigator decision, SAE, other reason|1
4429648|NCT00390780|7212748|FG000|Overall Study|SAE, death|0
4429649|NCT00390780|7212749|FG001|Overall Study|SAE, death|1
4429650|NCT00390806|7212757|FG000|Overall Study|Lost to Follow-up|7
4429651|NCT00390806|7212758|FG001|Overall Study|Lost to Follow-up|6
4429652|NCT00390806|7212757|FG000|Overall Study|Protocol Violation|2
4429653|NCT00390806|7212758|FG001|Overall Study|Protocol Violation|2
4429654|NCT00390806|7212757|FG000|Overall Study|Withdrawal by Subject|12
4429655|NCT00390806|7212758|FG001|Overall Study|Withdrawal by Subject|15
4429656|NCT00390806|7212757|FG000|Overall Study|Investigator Decision|4
4429657|NCT00390806|7212758|FG001|Overall Study|Investigator Decision|6
4429658|NCT00390806|7212757|FG000|Overall Study|Death|1
4429659|NCT00390806|7212758|FG001|Overall Study|Death|0
4429660|NCT00390806|7212757|FG000|Overall Study|Physician Decision|0
4429661|NCT00390806|7212758|FG001|Overall Study|Physician Decision|1
4429662|NCT00390806|7212757|FG000|Overall Study|Ongoing|4
4429663|NCT00390806|7212758|FG001|Overall Study|Ongoing|2
4429664|NCT00390858|7212766|FG000|Overall Study|Adverse Event|6
4429665|NCT00390858|7212767|FG001|Overall Study|Adverse Event|2
4429666|NCT00390858|7212766|FG000|Overall Study|Lack of Efficacy|0
4429667|NCT00390858|7212767|FG001|Overall Study|Lack of Efficacy|1
4429668|NCT00390858|7212766|FG000|Overall Study|Withdrawal by Subject|3
4429669|NCT00390858|7212767|FG001|Overall Study|Withdrawal by Subject|4
4429670|NCT00390884|7212775|FG000|Overall Study|Withdrawal by Subject|2
4715171|NCT02969018|7643528|FG001|Overall Study|Other|0
4715172|NCT02969018|7643529|FG002|Overall Study|Other|0
4715173|NCT02969018|7643530|FG003|Overall Study|Other|1
4715174|NCT02969018|7643531|FG004|Overall Study|Other|0
4715175|NCT02969018|7643532|FG005|Overall Study|Other|0
4715176|NCT02969018|7643533|FG006|Overall Study|Other|0
4715177|NCT02969018|7643534|FG007|Overall Study|Other|2
4715178|NCT02969018|7643527|FG000|Overall Study|Pregnancy|0
4715179|NCT02969018|7643528|FG001|Overall Study|Pregnancy|0
4715180|NCT02969018|7643529|FG002|Overall Study|Pregnancy|0
4715181|NCT02969018|7643530|FG003|Overall Study|Pregnancy|0
4715182|NCT02969018|7643531|FG004|Overall Study|Pregnancy|0
4715183|NCT02969018|7643532|FG005|Overall Study|Pregnancy|1
4715184|NCT02969018|7643533|FG006|Overall Study|Pregnancy|0
4715185|NCT02969018|7643534|FG007|Overall Study|Pregnancy|0
4715186|NCT02969018|7643527|FG000|Overall Study|Protocol Violation|0
4715187|NCT02969018|7643528|FG001|Overall Study|Protocol Violation|0
4715188|NCT02969018|7643529|FG002|Overall Study|Protocol Violation|1
4715189|NCT02969018|7643530|FG003|Overall Study|Protocol Violation|1
4715190|NCT02969018|7643531|FG004|Overall Study|Protocol Violation|0
4715191|NCT02969018|7643532|FG005|Overall Study|Protocol Violation|0
4715192|NCT02969018|7643533|FG006|Overall Study|Protocol Violation|0
4715193|NCT02969018|7643534|FG007|Overall Study|Protocol Violation|0
4715194|NCT02969018|7643527|FG000|Overall Study|Withdrawal by Subject|0
4715195|NCT02969018|7643528|FG001|Overall Study|Withdrawal by Subject|1
4715196|NCT02969018|7643529|FG002|Overall Study|Withdrawal by Subject|2
4715197|NCT02969018|7643530|FG003|Overall Study|Withdrawal by Subject|1
4715198|NCT02969018|7643531|FG004|Overall Study|Withdrawal by Subject|0
4715199|NCT02969018|7643532|FG005|Overall Study|Withdrawal by Subject|4
4715200|NCT02969018|7643533|FG006|Overall Study|Withdrawal by Subject|4
4715201|NCT02969018|7643534|FG007|Overall Study|Withdrawal by Subject|3
4715202|NCT02969044|7643566|FG000|Overall Study|Withdrawal by Subject|2
4715203|NCT02969044|7643567|FG001|Overall Study|Withdrawal by Subject|6
4715204|NCT02969044|7643566|FG000|Overall Study|Adverse Event|3
4715205|NCT02969044|7643567|FG001|Overall Study|Adverse Event|0
4715206|NCT02969187|7643575|FG000|Overall Study|Physician Decision|12
4715207|NCT02969187|7643576|FG001|Overall Study|Physician Decision|13
4715208|NCT02969356|7643589|FG000|Overall Study|Adverse Event|7
4715209|NCT02969356|7643589|FG000|Overall Study|Consent withdrawn|2
4429671|NCT00390884|7212776|FG001|Overall Study|Withdrawal by Subject|2
4429672|NCT00390910|7212785|FG000|Overall Study|Adverse Event|1
4429673|NCT00390910|7212786|FG001|Overall Study|Adverse Event|0
4429674|NCT00390910|7212787|FG002|Overall Study|Adverse Event|0
4429675|NCT00390910|7212785|FG000|Overall Study|Lost to Follow-up|0
4715210|NCT02969356|7643589|FG000|Overall Study|Lost to Follow-up|3
4715211|NCT02969356|7643589|FG000|Overall Study|Did not need to be reinjected|6
4715212|NCT02969356|7643589|FG000|Overall Study|Personal reasons|5
4715213|NCT02969382|7643595|FG000|Overall Study|Adverse Event|8
4715214|NCT02969382|7643596|FG001|Overall Study|Adverse Event|10
4715215|NCT02969382|7643595|FG000|Overall Study|Lack of Efficacy|4
4715216|NCT02969382|7643596|FG001|Overall Study|Lack of Efficacy|5
4715217|NCT02969382|7643595|FG000|Overall Study|Death|0
4429676|NCT00390910|7212786|FG001|Overall Study|Lost to Follow-up|1
4429677|NCT00390910|7212787|FG002|Overall Study|Lost to Follow-up|5
4429678|NCT00390910|7212785|FG000|Overall Study|Withdrawal by Subject|1
4429679|NCT00390910|7212786|FG001|Overall Study|Withdrawal by Subject|3
4629976|NCT01878292|7498355|FG002|Double-blind Treatment Period|Protocol Violation|2
4715218|NCT02969382|7643596|FG001|Overall Study|Death|1
4429680|NCT00390910|7212787|FG002|Overall Study|Withdrawal by Subject|2
4429681|NCT00390910|7212785|FG000|Overall Study|Migrated/moved from study area|0
4429682|NCT00390910|7212786|FG001|Overall Study|Migrated/moved from study area|0
4429683|NCT00390910|7212787|FG002|Overall Study|Migrated/moved from study area|3
4429684|NCT00391027|7212808|FG000|Overall Study|Adverse Event|8
4429685|NCT00391027|7212809|FG001|Overall Study|Adverse Event|8
4429686|NCT00391027|7212808|FG000|Overall Study|Lack of Efficacy|3
4429687|NCT00391027|7212809|FG001|Overall Study|Lack of Efficacy|0
4429688|NCT00391027|7212808|FG000|Overall Study|Withdrawal by Subject|10
4429689|NCT00391027|7212809|FG001|Overall Study|Withdrawal by Subject|1
4429690|NCT00391027|7212808|FG000|Overall Study|Other|4
4429691|NCT00391027|7212809|FG001|Overall Study|Other|3
4429692|NCT00391053|7212819|FG000|Overall Study|Serious Adverse Events|1
4429693|NCT00391053|7212820|FG001|Overall Study|Serious Adverse Events|0
4429694|NCT00391053|7212821|FG002|Overall Study|Serious Adverse Events|1
4429695|NCT00391053|7212822|FG003|Overall Study|Serious Adverse Events|4
4429696|NCT00391053|7212819|FG000|Overall Study|Protocol Violation|2
4429697|NCT00391053|7212820|FG001|Overall Study|Protocol Violation|0
4429698|NCT00391053|7212821|FG002|Overall Study|Protocol Violation|0
4429699|NCT00391053|7212822|FG003|Overall Study|Protocol Violation|0
4429700|NCT00391053|7212819|FG000|Overall Study|Lost to Follow-up|1
4429701|NCT00391053|7212820|FG001|Overall Study|Lost to Follow-up|0
4429702|NCT00391053|7212821|FG002|Overall Study|Lost to Follow-up|0
4429703|NCT00391053|7212822|FG003|Overall Study|Lost to Follow-up|5
4429704|NCT00391053|7212819|FG000|Overall Study|Withdrawal by Subject|5
4429705|NCT00391053|7212820|FG001|Overall Study|Withdrawal by Subject|1
4429706|NCT00391053|7212821|FG002|Overall Study|Withdrawal by Subject|1
4429707|NCT00391053|7212822|FG003|Overall Study|Withdrawal by Subject|1
4429708|NCT00391092|7212843|FG000|Overall Study|Death|78
4429709|NCT00391092|7212844|FG001|Overall Study|Death|81
4429710|NCT00391092|7212843|FG000|Overall Study|Lost to Follow-up|13
4429711|NCT00391092|7212844|FG001|Overall Study|Lost to Follow-up|18
4429712|NCT00391092|7212843|FG000|Overall Study|Alive on treatment|29
4429713|NCT00391092|7212844|FG001|Overall Study|Alive on treatment|33
4429714|NCT00391092|7212843|FG000|Overall Study|Alive in follow-up|88
4429715|NCT00391092|7212844|FG001|Overall Study|Alive in follow-up|84
4429716|NCT00391118|7212853|FG000|Overall Study|Adverse Event|3
4429717|NCT00391118|7212854|FG001|Overall Study|Adverse Event|10
4429718|NCT00391118|7212855|FG002|Overall Study|Adverse Event|7
4429719|NCT00391118|7212853|FG000|Overall Study|Lost to Follow-up|0
4429720|NCT00391118|7212854|FG001|Overall Study|Lost to Follow-up|2
4429721|NCT00391118|7212855|FG002|Overall Study|Lost to Follow-up|3
4429722|NCT00391118|7212853|FG000|Overall Study|Withdrawal by Subject|0
4429723|NCT00391118|7212854|FG001|Overall Study|Withdrawal by Subject|9
4429724|NCT00391118|7212855|FG002|Overall Study|Withdrawal by Subject|1
4429725|NCT00391118|7212853|FG000|Overall Study|Death|0
4429726|NCT00391118|7212854|FG001|Overall Study|Death|1
4429727|NCT00391118|7212855|FG002|Overall Study|Death|0
4429728|NCT00391118|7212853|FG000|Overall Study|Physician Decision|0
4429729|NCT00391118|7212854|FG001|Overall Study|Physician Decision|3
4429730|NCT00391118|7212855|FG002|Overall Study|Physician Decision|0
4429731|NCT00391118|7212853|FG000|Overall Study|Protocol Entry Criteria Not Met|0
4429732|NCT00391118|7212854|FG001|Overall Study|Protocol Entry Criteria Not Met|3
4429733|NCT00391118|7212855|FG002|Overall Study|Protocol Entry Criteria Not Met|1
4429734|NCT00391118|7212853|FG000|Overall Study|Progressive Disease|7
4429735|NCT00391118|7212854|FG001|Overall Study|Progressive Disease|26
4429736|NCT00391118|7212855|FG002|Overall Study|Progressive Disease|43
4429737|NCT00391118|7212853|FG000|Overall Study|Sponsor Decision|0
4429738|NCT00391118|7212854|FG001|Overall Study|Sponsor Decision|1
4429739|NCT00391118|7212855|FG002|Overall Study|Sponsor Decision|3
4429740|NCT00391118|7212853|FG000|Overall Study|Protocol Violation|1
4429741|NCT00391118|7212854|FG001|Overall Study|Protocol Violation|0
4429742|NCT00391118|7212855|FG002|Overall Study|Protocol Violation|0
4429743|NCT00391222|7212869|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
4429744|NCT00391222|7212870|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
4715219|NCT02969382|7643595|FG000|Overall Study|PROTOCOL DEVIATION|0
4715220|NCT02969382|7643596|FG001|Overall Study|PROTOCOL DEVIATION|1
4715221|NCT02969382|7643595|FG000|Overall Study|Withdrawal by Subject|14
4429745|NCT00391222|7212871|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
4429746|NCT00391222|7212872|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26
4429747|NCT00391222|7212869|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
4429748|NCT00391222|7212870|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
4429749|NCT00391222|7212871|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
4429750|NCT00391222|7212872|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5
4629977|NCT01878292|7498353|FG000|Double-blind Treatment Period|Lack of Efficacy|5
4715222|NCT02969382|7643596|FG001|Overall Study|Withdrawal by Subject|9
4429751|NCT00391222|7212869|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0
4429752|NCT00391222|7212870|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0
4429753|NCT00391222|7212871|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0
4429754|NCT00391222|7212872|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10
4429755|NCT00391222|7212869|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0
4429756|NCT00391222|7212870|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0
4429757|NCT00391222|7212871|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0
4429758|NCT00391222|7212872|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97
4429759|NCT00391222|7212869|FG000|Period II (Open-label Risperidone LAI)|Other|0
4429760|NCT00391222|7212870|FG001|Period II (Open-label Risperidone LAI)|Other|0
4429761|NCT00391222|7212871|FG002|Period II (Open-label Risperidone LAI)|Other|0
4429762|NCT00391222|7212872|FG003|Period II (Open-label Risperidone LAI)|Other|24
4429763|NCT00391222|7212869|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15
4429764|NCT00391222|7212870|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12
4429765|NCT00391222|7212871|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6
4429766|NCT00391222|7212872|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0
4429767|NCT00391222|7212869|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2
4429768|NCT00391222|7212870|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4
4429769|NCT00391222|7212871|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4
4429770|NCT00391222|7212872|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0
4429771|NCT00391222|7212869|FG000|Period III (Double-Blind Treatment)|Adverse Event|5
4429772|NCT00391222|7212870|FG001|Period III (Double-Blind Treatment)|Adverse Event|2
4429773|NCT00391222|7212871|FG002|Period III (Double-Blind Treatment)|Adverse Event|4
4429774|NCT00391222|7212872|FG003|Period III (Double-Blind Treatment)|Adverse Event|0
4429775|NCT00391222|7212869|FG000|Period III (Double-Blind Treatment)|Pregnancy|0
4429776|NCT00391222|7212870|FG001|Period III (Double-Blind Treatment)|Pregnancy|2
4429777|NCT00391222|7212871|FG002|Period III (Double-Blind Treatment)|Pregnancy|0
4429778|NCT00391222|7212872|FG003|Period III (Double-Blind Treatment)|Pregnancy|0
4429779|NCT00391222|7212869|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0
4715223|NCT02969408|7643602|FG000|Overall Study|Adverse Event|2
4715224|NCT02969408|7643602|FG000|Overall Study|Withdrawal by Subject|8
4715225|NCT02969408|7643602|FG000|Overall Study|Lost to Follow-up|4
4715226|NCT02969408|7643602|FG000|Overall Study|Protocol Violation|1
4715227|NCT02969408|7643602|FG000|Overall Study|Other than specified|1
4715228|NCT02969525|7643624|FG000|Double-Blind Period|Adverse Event|0
4715229|NCT02969525|7643625|FG001|Double-Blind Period|Adverse Event|0
4715230|NCT02969525|7643626|FG002|Double-Blind Period|Adverse Event|1
4715231|NCT02969525|7643627|FG003|Double-Blind Period|Adverse Event|1
4715232|NCT02969525|7643628|FG004|Double-Blind Period|Adverse Event|0
4715233|NCT02969525|7643629|FG005|Double-Blind Period|Adverse Event|0
4715234|NCT02969525|7643630|FG006|Double-Blind Period|Adverse Event|0
4715235|NCT02969525|7643631|FG007|Double-Blind Period|Adverse Event|0
4715236|NCT02969525|7643632|FG008|Double-Blind Period|Adverse Event|0
4715237|NCT02969525|7643633|FG009|Double-Blind Period|Adverse Event|0
4715238|NCT02969525|7643634|FG010|Double-Blind Period|Adverse Event|0
4715239|NCT02969525|7643635|FG011|Double-Blind Period|Adverse Event|0
4715240|NCT02969525|7643624|FG000|Double-Blind Period|LOW EGFR|0
4715241|NCT02969525|7643625|FG001|Double-Blind Period|LOW EGFR|0
4715242|NCT02969525|7643626|FG002|Double-Blind Period|LOW EGFR|0
4715243|NCT02969525|7643627|FG003|Double-Blind Period|LOW EGFR|1
4715244|NCT02969525|7643628|FG004|Double-Blind Period|LOW EGFR|0
4715245|NCT02969525|7643629|FG005|Double-Blind Period|LOW EGFR|0
4715246|NCT02969525|7643630|FG006|Double-Blind Period|LOW EGFR|0
4715247|NCT02969525|7643631|FG007|Double-Blind Period|LOW EGFR|0
4715248|NCT02969525|7643632|FG008|Double-Blind Period|LOW EGFR|0
4715249|NCT02969525|7643633|FG009|Double-Blind Period|LOW EGFR|0
4715250|NCT02969525|7643634|FG010|Double-Blind Period|LOW EGFR|0
4715251|NCT02969525|7643635|FG011|Double-Blind Period|LOW EGFR|0
4715252|NCT02969525|7643624|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2
4715253|NCT02969525|7643625|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0
4715254|NCT02969525|7643626|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0
4715255|NCT02969525|7643627|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2
4715256|NCT02969525|7643628|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0
4715257|NCT02969525|7643629|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0
4715258|NCT02969525|7643630|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0
4715259|NCT02969525|7643631|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0
4715260|NCT02969525|7643632|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0
4715261|NCT02969525|7643633|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0
4715262|NCT02969525|7643634|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0
4715263|NCT02969525|7643635|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0
4715264|NCT02969525|7643624|FG000|Dose-Blind Period|Adverse Event|0
4715265|NCT02969525|7643625|FG001|Dose-Blind Period|Adverse Event|0
4715266|NCT02969525|7643626|FG002|Dose-Blind Period|Adverse Event|0
4518735|NCT00976027|7331006|FG000|Overall Study|Adverse Event|0
4715267|NCT02969525|7643627|FG003|Dose-Blind Period|Adverse Event|0
4715268|NCT02969525|7643628|FG004|Dose-Blind Period|Adverse Event|0
4715269|NCT02969525|7643629|FG005|Dose-Blind Period|Adverse Event|0
4715270|NCT02969525|7643630|FG006|Dose-Blind Period|Adverse Event|0
4429780|NCT00391222|7212870|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1
4429781|NCT00391222|7212871|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3
4429782|NCT00391222|7212872|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0
4429783|NCT00391222|7212869|FG000|Period III (Double-Blind Treatment)|Other|6
4429784|NCT00391222|7212870|FG001|Period III (Double-Blind Treatment)|Other|1
4429785|NCT00391222|7212871|FG002|Period III (Double-Blind Treatment)|Other|6
4429786|NCT00391222|7212872|FG003|Period III (Double-Blind Treatment)|Other|0
4429787|NCT00391274|7212884|FG000|Overall Study|Death Due to Study Disease|55
4429788|NCT00391274|7212885|FG001|Overall Study|Death Due to Study Disease|45
4429789|NCT00391274|7212884|FG000|Overall Study|Lost to Follow-up|0
4429790|NCT00391274|7212885|FG001|Overall Study|Lost to Follow-up|3
4429791|NCT00391274|7212884|FG000|Overall Study|Physician Decision|4
4429792|NCT00391274|7212885|FG001|Overall Study|Physician Decision|2
4429793|NCT00391274|7212884|FG000|Overall Study|Withdrawal by Subject|0
4429794|NCT00391274|7212885|FG001|Overall Study|Withdrawal by Subject|3
4429795|NCT00391274|7212884|FG000|Overall Study|Death Due to Adverse Event|1
4429796|NCT00391274|7212885|FG001|Overall Study|Death Due to Adverse Event|3
4429797|NCT00391274|7212884|FG000|Overall Study|Death Due to Indeterminate Cause|1
4429798|NCT00391274|7212885|FG001|Overall Study|Death Due to Indeterminate Cause|0
4429799|NCT00391274|7212884|FG000|Overall Study|Death Not Study Related|0
4429800|NCT00391274|7212885|FG001|Overall Study|Death Not Study Related|1
4429801|NCT00391391|7212905|FG000|Overall Study|Adverse Event|0
4429802|NCT00391391|7212906|FG001|Overall Study|Adverse Event|0
4429803|NCT00391391|7212907|FG002|Overall Study|Adverse Event|0
4429804|NCT00391391|7212908|FG003|Overall Study|Adverse Event|1
4429805|NCT00391391|7212905|FG000|Overall Study|Lost to Follow-up|1
4429806|NCT00391391|7212906|FG001|Overall Study|Lost to Follow-up|3
4429807|NCT00391391|7212907|FG002|Overall Study|Lost to Follow-up|7
4429808|NCT00391391|7212908|FG003|Overall Study|Lost to Follow-up|4
4429809|NCT00391391|7212905|FG000|Overall Study|Protocol Violation|2
4429810|NCT00391391|7212906|FG001|Overall Study|Protocol Violation|3
4429811|NCT00391391|7212907|FG002|Overall Study|Protocol Violation|6
4429812|NCT00391391|7212908|FG003|Overall Study|Protocol Violation|7
4429813|NCT00391391|7212905|FG000|Overall Study|Withdrawal by Subject|6
4429814|NCT00391391|7212906|FG001|Overall Study|Withdrawal by Subject|4
4429815|NCT00391391|7212907|FG002|Overall Study|Withdrawal by Subject|10
4429816|NCT00391391|7212908|FG003|Overall Study|Withdrawal by Subject|7
4429817|NCT00391586|7212940|FG000|Overall Study|Progressive disease|13
4429818|NCT00391586|7212940|FG000|Overall Study|Adverse Event|5
4429819|NCT00391586|7212940|FG000|Overall Study|Physician Decision|2
4429820|NCT00391586|7212940|FG000|Overall Study|Death|4
4429821|NCT00391625|7212955|FG000|Month 14|Withdrawal by Subject|1
4429822|NCT00391625|7212955|FG000|Month 50|Physician Decision|1
4429823|NCT00391768|7213002|FG000|Overall Study|Withdrawal by Subject|0
4429824|NCT00391768|7213003|FG001|Overall Study|Withdrawal by Subject|0
4429825|NCT00391768|7213004|FG002|Overall Study|Withdrawal by Subject|1
4429826|NCT00391768|7213005|FG003|Overall Study|Withdrawal by Subject|0
4429827|NCT00391768|7213006|FG004|Overall Study|Withdrawal by Subject|0
4429828|NCT00391768|7213007|FG005|Overall Study|Withdrawal by Subject|1
4429829|NCT00391768|7213008|FG006|Overall Study|Withdrawal by Subject|1
4429830|NCT00391768|7213002|FG000|Overall Study|Lost to Follow-up|0
4429831|NCT00391768|7213003|FG001|Overall Study|Lost to Follow-up|0
4429832|NCT00391768|7213004|FG002|Overall Study|Lost to Follow-up|0
4429833|NCT00391768|7213005|FG003|Overall Study|Lost to Follow-up|1
4429834|NCT00391768|7213006|FG004|Overall Study|Lost to Follow-up|2
4429835|NCT00391768|7213007|FG005|Overall Study|Lost to Follow-up|2
4429836|NCT00391768|7213008|FG006|Overall Study|Lost to Follow-up|3
4429837|NCT00391807|7213042|FG000|Overall Study|Did not receive study medication|23
4429838|NCT00391807|7213042|FG000|Overall Study|Adverse Event|177
4429839|NCT00391807|7213042|FG000|Overall Study|Pregnancy|25
4429840|NCT00391807|7213042|FG000|Overall Study|Lost to Follow-up|227
4429841|NCT00391807|7213042|FG000|Overall Study|Withdrawal by Subject|147
4429842|NCT00391807|7213042|FG000|Overall Study|Protocol Violation|20
4429843|NCT00391807|7213042|FG000|Overall Study|Various|96
4429844|NCT00391846|7213048|FG000|Overall Study|Adverse Event|4
4429845|NCT00391846|7213049|FG001|Overall Study|Adverse Event|1
4429846|NCT00391846|7213048|FG000|Overall Study|Did not meet the required elig. crit|2
4429847|NCT00391846|7213049|FG001|Overall Study|Did not meet the required elig. crit|2
4429848|NCT00391846|7213048|FG000|Overall Study|Withdrawal by Subject|2
4429849|NCT00391846|7213049|FG001|Overall Study|Withdrawal by Subject|3
4429850|NCT00391846|7213048|FG000|Overall Study|Developed study specific DC criteria|0
4429851|NCT00391846|7213049|FG001|Overall Study|Developed study specific DC criteria|1
4429852|NCT00391872|7213057|FG000|Overall Study|Protocol Violation|7
4429853|NCT00391872|7213058|FG001|Overall Study|Protocol Violation|2
4429854|NCT00391872|7213057|FG000|Overall Study|Withdrawal by Subject|296
4429855|NCT00391872|7213058|FG001|Overall Study|Withdrawal by Subject|249
4429856|NCT00391872|7213057|FG000|Overall Study|Reason unknown|2
4429857|NCT00391872|7213058|FG001|Overall Study|Reason unknown|4
4429858|NCT00391872|7213057|FG000|Overall Study|Lost to Follow-up|2
4429859|NCT00391872|7213058|FG001|Overall Study|Lost to Follow-up|0
4429860|NCT00391898|7213066|FG000|Overall Study|Adverse Event|3
4429861|NCT00391898|7213067|FG001|Overall Study|Adverse Event|0
4429862|NCT00391898|7213066|FG000|Overall Study|Other|8
4429863|NCT00391898|7213067|FG001|Overall Study|Other|10
4429864|NCT00391976|7213076|FG000|Overall Study|Adverse Event|0
4429865|NCT00391976|7213077|FG001|Overall Study|Adverse Event|0
4429866|NCT00391976|7213078|FG002|Overall Study|Adverse Event|1
4429867|NCT00391976|7213076|FG000|Overall Study|Withdrawal of consent|0
4429868|NCT00391976|7213077|FG001|Overall Study|Withdrawal of consent|1
4429869|NCT00391976|7213078|FG002|Overall Study|Withdrawal of consent|1
4429870|NCT00391976|7213076|FG000|Overall Study|Lost to Follow-up|1
4429871|NCT00391976|7213077|FG001|Overall Study|Lost to Follow-up|2
4429872|NCT00391976|7213078|FG002|Overall Study|Lost to Follow-up|0
4429873|NCT00391976|7213076|FG000|Overall Study|Inappropriate enrollment|1
4429874|NCT00391976|7213077|FG001|Overall Study|Inappropriate enrollment|1
4429875|NCT00391976|7213078|FG002|Overall Study|Inappropriate enrollment|0
4429876|NCT00391976|7213076|FG000|Overall Study|Protocol deviation/violation|4
4429877|NCT00391976|7213077|FG001|Overall Study|Protocol deviation/violation|2
4429878|NCT00391976|7213078|FG002|Overall Study|Protocol deviation/violation|1
4429879|NCT00391976|7213076|FG000|Overall Study|Recurrence/no eradication of infection|21
4429880|NCT00391976|7213077|FG001|Overall Study|Recurrence/no eradication of infection|19
4429881|NCT00391976|7213078|FG002|Overall Study|Recurrence/no eradication of infection|0
4429882|NCT00391976|7213076|FG000|Overall Study|Unable to classify|0
4429883|NCT00391976|7213077|FG001|Overall Study|Unable to classify|0
4429884|NCT00391976|7213078|FG002|Overall Study|Unable to classify|1
4429885|NCT00391976|7213076|FG000|Overall Study|Positive P. aeruginosa antibody test|0
4429886|NCT00391976|7213077|FG001|Overall Study|Positive P. aeruginosa antibody test|0
4429887|NCT00391976|7213078|FG002|Overall Study|Positive P. aeruginosa antibody test|31
4429888|NCT00392015|7213098|FG000|Overall Study|Lost to Follow-up|2
4429889|NCT00392015|7213099|FG001|Overall Study|Lost to Follow-up|0
4429890|NCT00392015|7213100|FG002|Overall Study|Lost to Follow-up|2
4429891|NCT00392015|7213101|FG003|Overall Study|Lost to Follow-up|1
4429892|NCT00392015|7213102|FG004|Overall Study|Lost to Follow-up|1
4429893|NCT00392015|7213103|FG005|Overall Study|Lost to Follow-up|0
4429894|NCT00392015|7213098|FG000|Overall Study|Withdrawal by Subject|0
4429895|NCT00392015|7213099|FG001|Overall Study|Withdrawal by Subject|0
4429896|NCT00392015|7213100|FG002|Overall Study|Withdrawal by Subject|2
4429897|NCT00392015|7213101|FG003|Overall Study|Withdrawal by Subject|0
4429898|NCT00392015|7213102|FG004|Overall Study|Withdrawal by Subject|0
4429899|NCT00392015|7213103|FG005|Overall Study|Withdrawal by Subject|0
4429900|NCT00392015|7213098|FG000|Overall Study|Adverse Event|0
4429901|NCT00392015|7213099|FG001|Overall Study|Adverse Event|0
4429902|NCT00392015|7213100|FG002|Overall Study|Adverse Event|0
4429903|NCT00392015|7213101|FG003|Overall Study|Adverse Event|0
4429904|NCT00392015|7213102|FG004|Overall Study|Adverse Event|1
4429905|NCT00392015|7213103|FG005|Overall Study|Adverse Event|0
4429906|NCT00392015|7213098|FG000|Overall Study|Previous trial recipient|0
4429907|NCT00392015|7213099|FG001|Overall Study|Previous trial recipient|0
4429908|NCT00392015|7213100|FG002|Overall Study|Previous trial recipient|0
4429909|NCT00392015|7213101|FG003|Overall Study|Previous trial recipient|0
4429910|NCT00392015|7213102|FG004|Overall Study|Previous trial recipient|1
4429911|NCT00392015|7213103|FG005|Overall Study|Previous trial recipient|0
4429912|NCT00392171|7213144|FG000|Overall Study|Did not meet inclusion criteria|4
4429913|NCT00392171|7213144|FG000|Overall Study|Disease progression|101
4429914|NCT00392197|7213150|FG000|Overall Study|Adverse Event|4
4429915|NCT00392197|7213151|FG001|Overall Study|Adverse Event|12
4429916|NCT00392197|7213150|FG000|Overall Study|Lack of Efficacy|3
4429917|NCT00392197|7213151|FG001|Overall Study|Lack of Efficacy|4
4429918|NCT00392197|7213150|FG000|Overall Study|Lost to Follow-up|0
4429919|NCT00392197|7213151|FG001|Overall Study|Lost to Follow-up|1
4429920|NCT00392197|7213150|FG000|Overall Study|Physician Decision|3
4429921|NCT00392197|7213151|FG001|Overall Study|Physician Decision|2
4429922|NCT00392197|7213150|FG000|Overall Study|Protocol Violation|7
4429923|NCT00392197|7213151|FG001|Overall Study|Protocol Violation|5
4429924|NCT00392197|7213150|FG000|Overall Study|Withdrawal by Subject|4
4429925|NCT00392197|7213151|FG001|Overall Study|Withdrawal by Subject|6
4429926|NCT00392210|7213159|FG000|First Voiding Trial|Physician Decision|2
4429927|NCT00392210|7213160|FG001|First Voiding Trial|Physician Decision|2
4429928|NCT00392223|7213168|FG000|Overall Study|Adverse Event|5
4429929|NCT00392223|7213169|FG001|Overall Study|Adverse Event|4
4429930|NCT00392223|7213168|FG000|Overall Study|Lost to Follow-up|1
4429931|NCT00392223|7213169|FG001|Overall Study|Lost to Follow-up|4
4429932|NCT00392223|7213168|FG000|Overall Study|Protocol Violation|0
4429933|NCT00392223|7213169|FG001|Overall Study|Protocol Violation|3
4429934|NCT00392223|7213168|FG000|Overall Study|Withdrawal by Subject|3
4429935|NCT00392223|7213169|FG001|Overall Study|Withdrawal by Subject|2
4429936|NCT00392288|7213187|FG000|Overall Study|Adverse Event|17
4429937|NCT00392288|7213188|FG001|Overall Study|Adverse Event|7
4429938|NCT00392288|7213189|FG002|Overall Study|Adverse Event|8
4429939|NCT00392288|7213187|FG000|Overall Study|Lack of Efficacy|8
4429940|NCT00392288|7213188|FG001|Overall Study|Lack of Efficacy|5
4429941|NCT00392288|7213189|FG002|Overall Study|Lack of Efficacy|3
4429942|NCT00392288|7213187|FG000|Overall Study|Protocol Violation|1
4429943|NCT00392288|7213188|FG001|Overall Study|Protocol Violation|3
4429944|NCT00392288|7213189|FG002|Overall Study|Protocol Violation|1
4429945|NCT00392288|7213187|FG000|Overall Study|Lost to Follow-up|1
4429946|NCT00392288|7213188|FG001|Overall Study|Lost to Follow-up|1
4429947|NCT00392288|7213189|FG002|Overall Study|Lost to Follow-up|1
4429948|NCT00392288|7213187|FG000|Overall Study|Withdrawal by Subject|1
4429949|NCT00392288|7213188|FG001|Overall Study|Withdrawal by Subject|0
4429950|NCT00392288|7213189|FG002|Overall Study|Withdrawal by Subject|2
4429951|NCT00392288|7213187|FG000|Overall Study|Parent/legal guardian withdrawal|1
4429952|NCT00392288|7213188|FG001|Overall Study|Parent/legal guardian withdrawal|2
4429953|NCT00392288|7213189|FG002|Overall Study|Parent/legal guardian withdrawal|1
4429954|NCT00392288|7213187|FG000|Overall Study|Other|3
4429955|NCT00392288|7213188|FG001|Overall Study|Other|4
4429956|NCT00392288|7213189|FG002|Overall Study|Other|1
4429957|NCT00392379|7213199|FG000|Overall Study|Withdrawal by Subject|17
4429958|NCT00392379|7213200|FG001|Overall Study|Withdrawal by Subject|28
4429959|NCT00392379|7213199|FG000|Overall Study|Lost to Follow-up|4
4429960|NCT00392379|7213200|FG001|Overall Study|Lost to Follow-up|9
4429961|NCT00392379|7213199|FG000|Overall Study|Adverse Event|1
4429962|NCT00392379|7213200|FG001|Overall Study|Adverse Event|1
4429963|NCT00392665|7213220|FG000|Overall Study|Death|16
4429964|NCT00392665|7213221|FG001|Overall Study|Death|14
4429965|NCT00392665|7213220|FG000|Overall Study|Lost to Follow-up|1
4429966|NCT00392665|7213221|FG001|Overall Study|Lost to Follow-up|1
4429967|NCT00392769|7213257|FG000|Overall Study|Clinical Deterioration|9
4429968|NCT00392769|7213257|FG000|Overall Study|Adverse Event|1
4429969|NCT00392808|7213269|FG000|Overall Study|Lost to Follow-up|3
4429970|NCT00392808|7213270|FG001|Overall Study|Lost to Follow-up|2
4429971|NCT00392808|7213271|FG002|Overall Study|Lost to Follow-up|1
4429972|NCT00392808|7213272|FG003|Overall Study|Lost to Follow-up|2
4429973|NCT00392808|7213269|FG000|Overall Study|Unable to withdraw blood|3
4429974|NCT00392808|7213270|FG001|Overall Study|Unable to withdraw blood|1
4429975|NCT00392808|7213271|FG002|Overall Study|Unable to withdraw blood|1
4429976|NCT00392808|7213272|FG003|Overall Study|Unable to withdraw blood|2
4512508|NCT00934661|7322327|FG001|Overall Study|Failure of Combined/Spinal Epidural|0
4512509|NCT00934843|7322335|FG000|Overall Study|Protocol Violation|0
4512510|NCT00934843|7322336|FG001|Overall Study|Protocol Violation|1
4512511|NCT00934856|7322348|FG000|Feasibility Part|Progressive disease|4
4512512|NCT00934856|7322349|FG001|Feasibility Part|Progressive disease|4
4512513|NCT00934856|7322350|FG002|Feasibility Part|Progressive disease|2
4512514|NCT00934856|7322351|FG003|Feasibility Part|Progressive disease|3
4512515|NCT00934856|7322352|FG004|Feasibility Part|Progressive disease|0
4512516|NCT00934856|7322353|FG005|Feasibility Part|Progressive disease|0
4512517|NCT00934856|7322348|FG000|Feasibility Part|Physician Decision|0
4512518|NCT00934856|7322349|FG001|Feasibility Part|Physician Decision|0
4512519|NCT00934856|7322350|FG002|Feasibility Part|Physician Decision|1
4512520|NCT00934856|7322351|FG003|Feasibility Part|Physician Decision|0
4512521|NCT00934856|7322352|FG004|Feasibility Part|Physician Decision|0
4512522|NCT00934856|7322353|FG005|Feasibility Part|Physician Decision|0
4512523|NCT00934856|7322348|FG000|Feasibility Part|Adverse Event|1
4512524|NCT00934856|7322349|FG001|Feasibility Part|Adverse Event|1
4715271|NCT02969525|7643631|FG007|Dose-Blind Period|Adverse Event|0
4715272|NCT02969525|7643632|FG008|Dose-Blind Period|Adverse Event|0
4715273|NCT02969525|7643633|FG009|Dose-Blind Period|Adverse Event|1
4715274|NCT02969525|7643634|FG010|Dose-Blind Period|Adverse Event|1
4715275|NCT02969525|7643635|FG011|Dose-Blind Period|Adverse Event|1
4715276|NCT02969525|7643624|FG000|Dose-Blind Period|Withdrawal by Subject|0
4715277|NCT02969525|7643625|FG001|Dose-Blind Period|Withdrawal by Subject|0
4715278|NCT02969525|7643626|FG002|Dose-Blind Period|Withdrawal by Subject|0
4715279|NCT02969525|7643627|FG003|Dose-Blind Period|Withdrawal by Subject|0
4715280|NCT02969525|7643628|FG004|Dose-Blind Period|Withdrawal by Subject|0
4715281|NCT02969525|7643629|FG005|Dose-Blind Period|Withdrawal by Subject|0
4715282|NCT02969525|7643630|FG006|Dose-Blind Period|Withdrawal by Subject|2
4715283|NCT02969525|7643631|FG007|Dose-Blind Period|Withdrawal by Subject|0
4715284|NCT02969525|7643632|FG008|Dose-Blind Period|Withdrawal by Subject|1
4715285|NCT02969525|7643633|FG009|Dose-Blind Period|Withdrawal by Subject|2
4715286|NCT02969525|7643634|FG010|Dose-Blind Period|Withdrawal by Subject|0
4715287|NCT02969525|7643635|FG011|Dose-Blind Period|Withdrawal by Subject|0
4715288|NCT02969525|7643624|FG000|Dose-Blind Period|Non-cooperating patient|0
4715289|NCT02969525|7643625|FG001|Dose-Blind Period|Non-cooperating patient|0
4715290|NCT02969525|7643626|FG002|Dose-Blind Period|Non-cooperating patient|0
4715291|NCT02969525|7643627|FG003|Dose-Blind Period|Non-cooperating patient|0
4715292|NCT02969525|7643628|FG004|Dose-Blind Period|Non-cooperating patient|0
4715293|NCT02969525|7643629|FG005|Dose-Blind Period|Non-cooperating patient|0
4512525|NCT00934856|7322350|FG002|Feasibility Part|Adverse Event|0
4512526|NCT00934856|7322351|FG003|Feasibility Part|Adverse Event|1
4512527|NCT00934856|7322352|FG004|Feasibility Part|Adverse Event|0
4512528|NCT00934856|7322353|FG005|Feasibility Part|Adverse Event|2
4512529|NCT00934856|7322348|FG000|Feasibility Part|Withdrawal by Subject|0
4512530|NCT00934856|7322349|FG001|Feasibility Part|Withdrawal by Subject|0
4512531|NCT00934856|7322350|FG002|Feasibility Part|Withdrawal by Subject|0
4512532|NCT00934856|7322351|FG003|Feasibility Part|Withdrawal by Subject|1
4512533|NCT00934856|7322352|FG004|Feasibility Part|Withdrawal by Subject|0
4512534|NCT00934856|7322353|FG005|Feasibility Part|Withdrawal by Subject|1
4715294|NCT02969525|7643630|FG006|Dose-Blind Period|Non-cooperating patient|0
4715295|NCT02969525|7643631|FG007|Dose-Blind Period|Non-cooperating patient|0
4715296|NCT02969525|7643632|FG008|Dose-Blind Period|Non-cooperating patient|0
4512535|NCT00934856|7322348|FG000|Extension Part|Adverse Event|0
4429977|NCT00392925|7213299|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11
4429978|NCT00392925|7213300|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
4429979|NCT00392925|7213301|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
4429980|NCT00392925|7213302|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
4429981|NCT00392925|7213299|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5
4429982|NCT00392925|7213300|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
4429983|NCT00392925|7213301|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
4429984|NCT00392925|7213302|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
4429985|NCT00392925|7213299|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1
4429986|NCT00392925|7213300|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
4429987|NCT00392925|7213301|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
4429988|NCT00392925|7213302|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
4429989|NCT00392925|7213299|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5
4429990|NCT00392925|7213300|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
4429991|NCT00392925|7213301|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
4429992|NCT00392925|7213302|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
4429993|NCT00392925|7213299|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16
4429994|NCT00392925|7213300|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
4429995|NCT00392925|7213301|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
4429996|NCT00392925|7213302|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
4429997|NCT00392925|7213299|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0
4429998|NCT00392925|7213300|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2
4429999|NCT00392925|7213301|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6
4430000|NCT00392925|7213302|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8
4512536|NCT00934856|7322349|FG001|Extension Part|Adverse Event|0
4629978|NCT01878292|7498354|FG001|Double-blind Treatment Period|Lack of Efficacy|3
4629979|NCT01878292|7498355|FG002|Double-blind Treatment Period|Lack of Efficacy|0
4629980|NCT01878292|7498353|FG000|Double-blind Treatment Period|Adverse Event|4
4629981|NCT01878292|7498354|FG001|Double-blind Treatment Period|Adverse Event|9
4629982|NCT01878292|7498355|FG002|Double-blind Treatment Period|Adverse Event|8
4715297|NCT02969525|7643633|FG009|Dose-Blind Period|Non-cooperating patient|0
4715298|NCT02969525|7643634|FG010|Dose-Blind Period|Non-cooperating patient|0
4715299|NCT02969525|7643635|FG011|Dose-Blind Period|Non-cooperating patient|1
4715300|NCT02969525|7643624|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
4715301|NCT02969525|7643625|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
4715302|NCT02969525|7643626|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
4715303|NCT02969525|7643627|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
4715304|NCT02969525|7643628|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
4715305|NCT02969525|7643629|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
4715306|NCT02969525|7643630|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
4629983|NCT01878292|7498353|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5
4629984|NCT01878292|7498354|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8
4629985|NCT01878292|7498355|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4
4629986|NCT01878383|7498365|FG000|Overall Study|Lost to Follow-up|0
4629987|NCT01878383|7498366|FG001|Overall Study|Lost to Follow-up|1499
4629988|NCT01878890|7498436|FG000|Overall Study|Protocol Violation|0
4629989|NCT01878890|7498437|FG001|Overall Study|Protocol Violation|1
4715307|NCT02969525|7643631|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
4715308|NCT02969525|7643632|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
4715309|NCT02969525|7643633|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
4715310|NCT02969525|7643634|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1
4715311|NCT02969525|7643635|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0
4715312|NCT02969590|7643657|FG000|Screening Period|Hormones not suppressed post Lupron|1
4715313|NCT02969590|7643658|FG001|Screening Period|Hormones not suppressed post Lupron|0
4715314|NCT02969590|7643659|FG002|Screening Period|Hormones not suppressed post Lupron|0
4715315|NCT02969655|7643671|FG000|Overall Study|Withdrawal by Subject|3
4715316|NCT02969655|7643672|FG001|Overall Study|Withdrawal by Subject|2
4715317|NCT02969655|7643671|FG000|Overall Study|Physician Decision|4
4715318|NCT02969655|7643672|FG001|Overall Study|Physician Decision|3
4715319|NCT02969655|7643671|FG000|Overall Study|Protocol-specified withdrawal criteria|4
4715320|NCT02969655|7643672|FG001|Overall Study|Protocol-specified withdrawal criteria|2
4715321|NCT02969655|7643671|FG000|Overall Study|Adverse Event|10
4715322|NCT02969655|7643672|FG001|Overall Study|Adverse Event|8
4715323|NCT02969707|7643681|FG000|Overall Study|Adverse Event|1
4715324|NCT02969707|7643682|FG001|Overall Study|Adverse Event|2
4715325|NCT02969707|7643681|FG000|Overall Study|Lost to Follow-up|3
4715326|NCT02969707|7643682|FG001|Overall Study|Lost to Follow-up|0
4715327|NCT02969707|7643681|FG000|Overall Study|Physician Decision|0
4715328|NCT02969707|7643682|FG001|Overall Study|Physician Decision|1
4715329|NCT02969707|7643681|FG000|Overall Study|Protocol Violation|1
4715330|NCT02969707|7643682|FG001|Overall Study|Protocol Violation|1
4715331|NCT02969707|7643681|FG000|Overall Study|Withdrawal by Subject|3
4715332|NCT02969707|7643682|FG001|Overall Study|Withdrawal by Subject|4
4430001|NCT00392925|7213299|FG000|Randomization to Treatment Group Period|Adverse Event|0
4430002|NCT00392925|7213300|FG001|Randomization to Treatment Group Period|Adverse Event|3
4430003|NCT00392925|7213301|FG002|Randomization to Treatment Group Period|Adverse Event|3
4430004|NCT00392925|7213302|FG003|Randomization to Treatment Group Period|Adverse Event|5
4430005|NCT00392925|7213299|FG000|Randomization to Treatment Group Period|Protocol Violation|0
4430006|NCT00392925|7213300|FG001|Randomization to Treatment Group Period|Protocol Violation|0
4430007|NCT00392925|7213301|FG002|Randomization to Treatment Group Period|Protocol Violation|2
4430008|NCT00392925|7213302|FG003|Randomization to Treatment Group Period|Protocol Violation|1
4430009|NCT00392925|7213299|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0
4430010|NCT00392925|7213300|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3
4430011|NCT00392925|7213301|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8
4430012|NCT00392925|7213302|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4
4430013|NCT00392990|7213324|FG000|Treatment on Study|Adverse Event|3
4430014|NCT00392990|7213325|FG001|Treatment on Study|Adverse Event|1
4430015|NCT00392990|7213324|FG000|Follow up for 2 Years|Death|4
4430016|NCT00392990|7213325|FG001|Follow up for 2 Years|Death|0
4430017|NCT00393029|7213333|FG000|Overall Study|Not treated|0
4430018|NCT00393029|7213334|FG001|Overall Study|Not treated|1
4430019|NCT00393042|7213341|FG000|First Intervention|Withdrawal by Subject|1
4430020|NCT00393042|7213342|FG001|First Intervention|Withdrawal by Subject|2
4430021|NCT00393042|7213341|FG000|First Intervention|Lost to Follow-up|3
4430022|NCT00393042|7213342|FG001|First Intervention|Lost to Follow-up|3
4430023|NCT00393042|7213341|FG000|First Intervention|Protocol Violation|1
4430024|NCT00393042|7213342|FG001|First Intervention|Protocol Violation|0
4430025|NCT00393042|7213341|FG000|First Intervention|Adverse Event|0
4430026|NCT00393042|7213342|FG001|First Intervention|Adverse Event|1
4430027|NCT00393042|7213341|FG000|Second Intervetion|Adverse Event|0
4430028|NCT00393042|7213342|FG001|Second Intervetion|Adverse Event|3
4430029|NCT00393042|7213341|FG000|Second Intervetion|Withdrawal by Subject|0
4430030|NCT00393042|7213342|FG001|Second Intervetion|Withdrawal by Subject|2
4430031|NCT00393042|7213341|FG000|Second Intervetion|Lack of Efficacy|1
4430032|NCT00393042|7213342|FG001|Second Intervetion|Lack of Efficacy|0
4430033|NCT00393042|7213341|FG000|Second Intervetion|Lost to Follow-up|0
4430034|NCT00393042|7213342|FG001|Second Intervetion|Lost to Follow-up|2
4430035|NCT00393042|7213341|FG000|Second Intervetion|Protocol Violation|1
4430036|NCT00393042|7213342|FG001|Second Intervetion|Protocol Violation|1
4430037|NCT00393094|7213396|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1
4430038|NCT00393094|7213396|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1
4430039|NCT00393367|7213404|FG000|Overall Study|Protocol Violation|2
4430040|NCT00393367|7213405|FG001|Overall Study|Protocol Violation|5
4430041|NCT00393367|7213404|FG000|Overall Study|Withdrawal by Subject|0
4430042|NCT00393367|7213405|FG001|Overall Study|Withdrawal by Subject|2
4430043|NCT00393458|7213421|FG000|Overall Study|Adverse Event|35
4430044|NCT00393458|7213422|FG001|Overall Study|Adverse Event|24
4430045|NCT00393458|7213423|FG002|Overall Study|Adverse Event|40
4430046|NCT00393458|7213424|FG003|Overall Study|Adverse Event|35
4430047|NCT00393458|7213421|FG000|Overall Study|Subject withdrew consent|27
4430048|NCT00393458|7213422|FG001|Overall Study|Subject withdrew consent|40
4430049|NCT00393458|7213423|FG002|Overall Study|Subject withdrew consent|33
4430050|NCT00393458|7213424|FG003|Overall Study|Subject withdrew consent|50
4430051|NCT00393458|7213421|FG000|Overall Study|Unsatisfactory therapeutic effect|12
4430052|NCT00393458|7213422|FG001|Overall Study|Unsatisfactory therapeutic effect|9
4430053|NCT00393458|7213423|FG002|Overall Study|Unsatisfactory therapeutic effect|12
4430054|NCT00393458|7213424|FG003|Overall Study|Unsatisfactory therapeutic effect|30
4430055|NCT00393458|7213421|FG000|Overall Study|Protocol deviation|11
4430056|NCT00393458|7213422|FG001|Overall Study|Protocol deviation|11
4430057|NCT00393458|7213423|FG002|Overall Study|Protocol deviation|11
4430058|NCT00393458|7213424|FG003|Overall Study|Protocol deviation|10
4430059|NCT00393458|7213421|FG000|Overall Study|Administrative problems|7
4430060|NCT00393458|7213422|FG001|Overall Study|Administrative problems|8
4430061|NCT00393458|7213423|FG002|Overall Study|Administrative problems|5
4430062|NCT00393458|7213424|FG003|Overall Study|Administrative problems|2
4430063|NCT00393458|7213421|FG000|Overall Study|Lost to Follow-up|5
4430064|NCT00393458|7213422|FG001|Overall Study|Lost to Follow-up|6
4430065|NCT00393458|7213423|FG002|Overall Study|Lost to Follow-up|5
4430066|NCT00393458|7213424|FG003|Overall Study|Lost to Follow-up|3
4430067|NCT00393458|7213421|FG000|Overall Study|Abnormal laboratory value(s)|1
4430068|NCT00393458|7213422|FG001|Overall Study|Abnormal laboratory value(s)|1
4430069|NCT00393458|7213423|FG002|Overall Study|Abnormal laboratory value(s)|0
4430070|NCT00393458|7213424|FG003|Overall Study|Abnormal laboratory value(s)|0
4430071|NCT00393458|7213421|FG000|Overall Study|Death|1
4430072|NCT00393458|7213422|FG001|Overall Study|Death|1
4430073|NCT00393458|7213423|FG002|Overall Study|Death|5
4430074|NCT00393458|7213424|FG003|Overall Study|Death|5
4430075|NCT00393458|7213421|FG000|Overall Study|Abnormal test procedure result(s)|0
4430076|NCT00393458|7213422|FG001|Overall Study|Abnormal test procedure result(s)|1
4430077|NCT00393458|7213423|FG002|Overall Study|Abnormal test procedure result(s)|1
4430078|NCT00393458|7213424|FG003|Overall Study|Abnormal test procedure result(s)|2
4430079|NCT00393458|7213421|FG000|Overall Study|Subject no longer requires study drug|0
4512537|NCT00934856|7322350|FG002|Extension Part|Adverse Event|0
4430080|NCT00393458|7213422|FG001|Overall Study|Subject no longer requires study drug|1
4430081|NCT00393458|7213423|FG002|Overall Study|Subject no longer requires study drug|0
4430082|NCT00393458|7213424|FG003|Overall Study|Subject no longer requires study drug|0
4430083|NCT00393484|7213436|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0
4430084|NCT00393484|7213437|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1
4430085|NCT00393484|7213436|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2
4430086|NCT00393484|7213437|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0
4430087|NCT00393484|7213436|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0
4430088|NCT00393484|7213437|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3
4430089|NCT00393484|7213436|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0
4430090|NCT00393484|7213437|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6
4430091|NCT00393484|7213436|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0
4430092|NCT00393484|7213437|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2
4430093|NCT00393484|7213436|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4
4430094|NCT00393484|7213437|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1
4430095|NCT00393484|7213436|FG000|Open-label Period (Weeks 96 to 240)|Death|1
4430096|NCT00393484|7213437|FG001|Open-label Period (Weeks 96 to 240)|Death|0
4430097|NCT00393484|7213436|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1
4430098|NCT00393484|7213437|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2
4430099|NCT00393484|7213436|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2
4430100|NCT00393484|7213437|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2
4430101|NCT00393484|7213436|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0
4430102|NCT00393484|7213437|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18
4430103|NCT00393510|7213447|FG000|Overall Study|Physician Decision|3
4430104|NCT00393510|7213448|FG001|Overall Study|Physician Decision|9
4430105|NCT00393523|7213459|FG000|Overall Study|Lost to Follow-up|0
4430106|NCT00393523|7213460|FG001|Overall Study|Lost to Follow-up|0
4430107|NCT00393523|7213461|FG002|Overall Study|Lost to Follow-up|0
4430108|NCT00393523|7213462|FG003|Overall Study|Lost to Follow-up|2
4430109|NCT00393523|7213463|FG004|Overall Study|Lost to Follow-up|1
4430110|NCT00393523|7213459|FG000|Overall Study|Protocol Violation|6
4715333|NCT02969863|7643693|FG000|Overall Study|Physician Decision|1
4715334|NCT02969863|7643694|FG001|Overall Study|Physician Decision|0
4715335|NCT02969863|7643695|FG002|Overall Study|Physician Decision|0
4715336|NCT02969863|7643696|FG003|Overall Study|Physician Decision|0
4715337|NCT02969863|7643697|FG004|Overall Study|Physician Decision|0
4715338|NCT02969863|7643698|FG005|Overall Study|Physician Decision|0
4715339|NCT02970292|7643737|FG000|Overall Study|Physician Decision|1
4715340|NCT02970292|7643738|FG001|Overall Study|Physician Decision|1
4715341|NCT02970292|7643737|FG000|Overall Study|Withdrawal by Subject|11
4715342|NCT02970292|7643738|FG001|Overall Study|Withdrawal by Subject|5
4715343|NCT02970292|7643737|FG000|Overall Study|Noncompliance with study drug|2
4715344|NCT02970292|7643738|FG001|Overall Study|Noncompliance with study drug|2
4715345|NCT02970292|7643737|FG000|Overall Study|Adverse Event|5
4715346|NCT02970292|7643738|FG001|Overall Study|Adverse Event|0
4715347|NCT02970292|7643737|FG000|Overall Study|Lack of Efficacy|1
4715348|NCT02970292|7643738|FG001|Overall Study|Lack of Efficacy|0
4715349|NCT02970292|7643737|FG000|Overall Study|Lost to Follow-up|1
4715350|NCT02970292|7643738|FG001|Overall Study|Lost to Follow-up|0
4715351|NCT02970292|7643737|FG000|Overall Study|Protocol Violation|2
4715352|NCT02970292|7643738|FG001|Overall Study|Protocol Violation|0
4715353|NCT02970292|7643737|FG000|Overall Study|Other|1
4715354|NCT02970292|7643738|FG001|Overall Study|Other|0
4715355|NCT02970305|7643746|FG000|Overall Study|Adverse Event|10
4715356|NCT02970305|7643747|FG001|Overall Study|Adverse Event|6
4715357|NCT02970305|7643746|FG000|Overall Study|Lack of Efficacy|1
4715358|NCT02970305|7643747|FG001|Overall Study|Lack of Efficacy|1
4715359|NCT02970305|7643746|FG000|Overall Study|Noncompliance with study drug|2
4715360|NCT02970305|7643747|FG001|Overall Study|Noncompliance with study drug|4
4715361|NCT02970305|7643746|FG000|Overall Study|Protocol Violation|2
4715362|NCT02970305|7643747|FG001|Overall Study|Protocol Violation|2
4715363|NCT02970305|7643746|FG000|Overall Study|Withdrawal by Subject|12
4715364|NCT02970305|7643747|FG001|Overall Study|Withdrawal by Subject|11
4715365|NCT02970305|7643746|FG000|Overall Study|Not further specified|1
4715366|NCT02970305|7643747|FG001|Overall Study|Not further specified|2
4715367|NCT02970305|7643746|FG000|Overall Study|Lost to Follow-up|1
4715368|NCT02970305|7643747|FG001|Overall Study|Lost to Follow-up|2
4715369|NCT02970669|7643791|FG000|Double-blind Period|Adverse Event|4
4715370|NCT02970669|7643792|FG001|Double-blind Period|Adverse Event|0
4715371|NCT02970669|7643791|FG000|Double-blind Period|Death|1
4715372|NCT02970669|7643792|FG001|Double-blind Period|Death|0
4715373|NCT02970669|7643791|FG000|Double-blind Period|Study terminated by sponsor|1
4715374|NCT02970669|7643792|FG001|Double-blind Period|Study terminated by sponsor|2
4715375|NCT02970669|7643791|FG000|Double-blind Period|Physician Decision|0
4715376|NCT02970669|7643792|FG001|Double-blind Period|Physician Decision|2
4715377|NCT02970669|7643791|FG000|Double-blind Period|Withdrawal by Subject|2
4715378|NCT02970669|7643792|FG001|Double-blind Period|Withdrawal by Subject|2
4715379|NCT02970669|7643791|FG000|Open-label Period|Withdrawal by Subject|2
4715380|NCT02970669|7643792|FG001|Open-label Period|Withdrawal by Subject|2
4715381|NCT02970669|7643791|FG000|Open-label Period|Adverse Event|1
4430111|NCT00393523|7213460|FG001|Overall Study|Protocol Violation|2
4430112|NCT00393523|7213461|FG002|Overall Study|Protocol Violation|0
4430113|NCT00393523|7213462|FG003|Overall Study|Protocol Violation|1
4430114|NCT00393523|7213463|FG004|Overall Study|Protocol Violation|0
4430115|NCT00393523|7213459|FG000|Overall Study|Withdrawal by Subject|6
4430116|NCT00393523|7213460|FG001|Overall Study|Withdrawal by Subject|7
4430117|NCT00393523|7213461|FG002|Overall Study|Withdrawal by Subject|2
4430118|NCT00393523|7213462|FG003|Overall Study|Withdrawal by Subject|3
4430119|NCT00393523|7213463|FG004|Overall Study|Withdrawal by Subject|0
4430120|NCT00393523|7213459|FG000|Overall Study|Difficulties in specimen collection|0
4430121|NCT00393523|7213460|FG001|Overall Study|Difficulties in specimen collection|0
4430122|NCT00393523|7213461|FG002|Overall Study|Difficulties in specimen collection|1
4430123|NCT00393523|7213462|FG003|Overall Study|Difficulties in specimen collection|0
4430124|NCT00393523|7213463|FG004|Overall Study|Difficulties in specimen collection|0
4430125|NCT00393523|7213459|FG000|Overall Study|Vaccine supply issue|0
4430126|NCT00393523|7213460|FG001|Overall Study|Vaccine supply issue|0
4430127|NCT00393523|7213461|FG002|Overall Study|Vaccine supply issue|1
4430128|NCT00393523|7213462|FG003|Overall Study|Vaccine supply issue|0
4430129|NCT00393523|7213463|FG004|Overall Study|Vaccine supply issue|0
4430130|NCT00393705|7213476|FG000|Overall Study|Adverse Event|0
4430131|NCT00393705|7213477|FG001|Overall Study|Adverse Event|2
4430132|NCT00393705|7213476|FG000|Overall Study|Death|0
4430133|NCT00393705|7213477|FG001|Overall Study|Death|1
4430134|NCT00393705|7213476|FG000|Overall Study|Lost to Follow-up|2
4430135|NCT00393705|7213477|FG001|Overall Study|Lost to Follow-up|2
4430136|NCT00393705|7213476|FG000|Overall Study|Entry Criteria Not Met|10
4430137|NCT00393705|7213477|FG001|Overall Study|Entry Criteria Not Met|10
4430138|NCT00393705|7213476|FG000|Overall Study|Protocol Violation|4
4715382|NCT02970669|7643792|FG001|Open-label Period|Adverse Event|0
4715383|NCT02970669|7643791|FG000|Open-label Period|Physician Decision|1
4715384|NCT02970669|7643792|FG001|Open-label Period|Physician Decision|0
4715385|NCT02970942|7643813|FG000|Overall Study|Death|0
4715386|NCT02970942|7643814|FG001|Overall Study|Death|1
4715387|NCT02970942|7643815|FG002|Overall Study|Death|0
4715388|NCT02970942|7643816|FG003|Overall Study|Death|0
4715389|NCT02970942|7643813|FG000|Overall Study|Lost to Follow-up|1
4715390|NCT02970942|7643814|FG001|Overall Study|Lost to Follow-up|0
4715391|NCT02970942|7643815|FG002|Overall Study|Lost to Follow-up|2
4715392|NCT02970942|7643816|FG003|Overall Study|Lost to Follow-up|1
4715393|NCT02970942|7643813|FG000|Overall Study|Withdrawal by Subject|3
4715394|NCT02970942|7643814|FG001|Overall Study|Withdrawal by Subject|5
4715395|NCT02970942|7643815|FG002|Overall Study|Withdrawal by Subject|3
4715396|NCT02970942|7643816|FG003|Overall Study|Withdrawal by Subject|2
4715397|NCT02971007|7643829|FG000|Overall Study|Adverse Event|1
4715398|NCT02971007|7643830|FG001|Overall Study|Adverse Event|0
4715399|NCT02971007|7643831|FG002|Overall Study|Adverse Event|0
4715400|NCT02971007|7643829|FG000|Overall Study|Lost to Follow-up|0
4715401|NCT02971007|7643830|FG001|Overall Study|Lost to Follow-up|1
4715402|NCT02971007|7643831|FG002|Overall Study|Lost to Follow-up|1
4715403|NCT02971007|7643829|FG000|Overall Study|Withdrawal by Subject|0
4715404|NCT02971007|7643830|FG001|Overall Study|Withdrawal by Subject|1
4715405|NCT02971007|7643831|FG002|Overall Study|Withdrawal by Subject|0
4715406|NCT02971007|7643829|FG000|Overall Study|Patient had yeast at Day 5 visit|1
4715407|NCT02971007|7643830|FG001|Overall Study|Patient had yeast at Day 5 visit|0
4715408|NCT02971007|7643831|FG002|Overall Study|Patient had yeast at Day 5 visit|0
4715409|NCT02971007|7643829|FG000|Overall Study|Patient discontinued study drug|0
4715410|NCT02971007|7643830|FG001|Overall Study|Patient discontinued study drug|1
4715411|NCT02971007|7643831|FG002|Overall Study|Patient discontinued study drug|0
4715412|NCT02971163|7643841|FG000|Overall Study|Lost to Follow-up|4
4715413|NCT02971163|7643842|FG001|Overall Study|Lost to Follow-up|2
4715414|NCT02971202|7643851|FG000|Overall Study|Pregnancy|1
4715415|NCT02971202|7643852|FG001|Overall Study|Pregnancy|0
4715416|NCT02971202|7643853|FG002|Overall Study|Pregnancy|0
4715417|NCT02971202|7643851|FG000|Overall Study|screen fail after consent|1
4715418|NCT02971202|7643852|FG001|Overall Study|screen fail after consent|0
4715419|NCT02971202|7643853|FG002|Overall Study|screen fail after consent|1
4715420|NCT02971228|7643861|FG000|Overall Study|Withdrawal by Subject|1
4715421|NCT02971228|7643862|FG001|Overall Study|Withdrawal by Subject|1
4715422|NCT02971228|7643863|FG002|Overall Study|Withdrawal by Subject|0
4715423|NCT02971228|7643864|FG003|Overall Study|Withdrawal by Subject|0
4430139|NCT00393705|7213477|FG001|Overall Study|Protocol Violation|3
4430140|NCT00393705|7213476|FG000|Overall Study|Withdrawal by Subject|5
4430141|NCT00393705|7213477|FG001|Overall Study|Withdrawal by Subject|3
4430142|NCT00393705|7213476|FG000|Overall Study|Physician Decision|2
4715424|NCT02971228|7643865|FG004|Overall Study|Withdrawal by Subject|0
4715425|NCT02971228|7643861|FG000|Overall Study|Logistical challenges|0
4715426|NCT02971228|7643862|FG001|Overall Study|Logistical challenges|1
4715427|NCT02971228|7643863|FG002|Overall Study|Logistical challenges|0
4715428|NCT02971228|7643864|FG003|Overall Study|Logistical challenges|0
4715429|NCT02971228|7643865|FG004|Overall Study|Logistical challenges|0
4715430|NCT02971605|7643891|FG000|Overall Study|Withdrawal by Subject|1
4715431|NCT02971670|7643909|FG000|Overall Study|Withdrawal by Subject|4
4715432|NCT02971670|7643910|FG001|Overall Study|Withdrawal by Subject|1
4715433|NCT02971670|7643911|FG002|Overall Study|Withdrawal by Subject|1
4430143|NCT00393705|7213477|FG001|Overall Study|Physician Decision|2
4430144|NCT00393718|7213485|FG000|Overall Study|Adverse Event|20
4430145|NCT00393718|7213486|FG001|Overall Study|Adverse Event|8
4430146|NCT00393718|7213485|FG000|Overall Study|Protocol Violation|1
4430147|NCT00393718|7213486|FG001|Overall Study|Protocol Violation|2
4430148|NCT00393718|7213485|FG000|Overall Study|Lack of Efficacy|10
4430149|NCT00393718|7213486|FG001|Overall Study|Lack of Efficacy|9
4430150|NCT00393718|7213485|FG000|Overall Study|Hypoglycaemia|3
4430151|NCT00393718|7213486|FG001|Overall Study|Hypoglycaemia|2
4430152|NCT00393718|7213485|FG000|Overall Study|Subject decision|5
4430153|NCT00393718|7213486|FG001|Overall Study|Subject decision|0
4430154|NCT00393718|7213485|FG000|Overall Study|Withdrawal of consent|2
4430155|NCT00393718|7213486|FG001|Overall Study|Withdrawal of consent|1
4430156|NCT00393718|7213485|FG000|Overall Study|Missed measurement|1
4430157|NCT00393718|7213486|FG001|Overall Study|Missed measurement|0
4430158|NCT00393718|7213485|FG000|Overall Study|Move|1
4430159|NCT00393718|7213486|FG001|Overall Study|Move|0
4430160|NCT00393848|7213505|FG000|Overall Study|Surgical schedule|0
4430161|NCT00393848|7213506|FG001|Overall Study|Surgical schedule|0
4430162|NCT00393848|7213507|FG002|Overall Study|Surgical schedule|0
4430163|NCT00393848|7213508|FG003|Overall Study|Surgical schedule|1
4430164|NCT00393848|7213505|FG000|Overall Study|Personal reasons|0
4430165|NCT00393848|7213506|FG001|Overall Study|Personal reasons|0
4430166|NCT00393848|7213507|FG002|Overall Study|Personal reasons|2
4430167|NCT00393848|7213508|FG003|Overall Study|Personal reasons|0
4430168|NCT00393861|7213519|FG000|Overall Study|Adverse Event|2
4430169|NCT00393861|7213519|FG000|Overall Study|Disease Progression|24
4430170|NCT00393887|7213541|FG000|Overall Study|Physician Decision|5
4430171|NCT00393887|7213542|FG001|Overall Study|Physician Decision|0
4430172|NCT00393887|7213541|FG000|Overall Study|Lost to Follow-up|11
4430173|NCT00393887|7213542|FG001|Overall Study|Lost to Follow-up|9
4430174|NCT00393913|7213548|FG000|Initial Assessment|diagnosed with other sleep disorder|21
4430175|NCT00393913|7213548|FG000|Initial Assessment|Withdrawal by Subject|16
4430176|NCT00393913|7213548|FG000|CPAP|Withdrawal by Subject|3
4430177|NCT00393913|7213548|FG000|CPAP|Physician Decision|1
4430178|NCT00393913|7213548|FG000|CPAP|TEchnical problem with CPAP|3
4430179|NCT00393939|7213555|FG000|Overall Study|Protocol Violation|1
4430180|NCT00393939|7213556|FG001|Overall Study|Protocol Violation|1
4430181|NCT00393939|7213555|FG000|Overall Study|Lost to Follow-up|2
4430182|NCT00393939|7213556|FG001|Overall Study|Lost to Follow-up|4
4430183|NCT00393939|7213555|FG000|Overall Study|Death|10
4430184|NCT00393939|7213556|FG001|Overall Study|Death|4
4430185|NCT00393939|7213555|FG000|Overall Study|Sponsor|5
4430186|NCT00393939|7213556|FG001|Overall Study|Sponsor|13
4430187|NCT00393939|7213555|FG000|Overall Study|Objective progression or relapse|239
4430188|NCT00393939|7213556|FG001|Overall Study|Objective progression or relapse|223
4430189|NCT00393939|7213555|FG000|Overall Study|Withdrawal by Subject|2
4430190|NCT00393939|7213556|FG001|Overall Study|Withdrawal by Subject|7
4430191|NCT00393939|7213555|FG000|Overall Study|Other|37
4430192|NCT00393939|7213556|FG001|Overall Study|Other|45
4430193|NCT00394082|7213571|FG000|Overall Study|Unacceptable toxicity|15
4430194|NCT00394082|7213571|FG000|Overall Study|Adverse Event|4
4430195|NCT00394082|7213571|FG000|Overall Study|Physician Decision|4
4430196|NCT00394082|7213571|FG000|Overall Study|Withdrawal by Subject|2
4430197|NCT00394082|7213571|FG000|Overall Study|Other|1
4430198|NCT00394095|7213577|FG000|Overall Study|Adverse Event|1
4430199|NCT00394095|7213578|FG001|Overall Study|Adverse Event|0
4715434|NCT02971670|7643912|FG003|Overall Study|Withdrawal by Subject|2
4715435|NCT02971800|7643931|FG000|Overall Study|Protocol Violation|1
4430200|NCT00394212|7213587|FG000|Overall Study|Lost to Follow-up|3
4430201|NCT00394212|7213588|FG001|Overall Study|Lost to Follow-up|0
4430202|NCT00394212|7213587|FG000|Overall Study|Withdrawal by Subject|4
4430203|NCT00394212|7213588|FG001|Overall Study|Withdrawal by Subject|1
4430204|NCT00394251|7213596|FG000|Overall Study|Adverse Event|7
4430205|NCT00394251|7213597|FG001|Overall Study|Adverse Event|5
4430206|NCT00394251|7213596|FG000|Overall Study|Unacceptable Toxicity|20
4430207|NCT00394251|7213597|FG001|Overall Study|Unacceptable Toxicity|18
4430208|NCT00394251|7213596|FG000|Overall Study|Physician Decision|1
4430209|NCT00394251|7213597|FG001|Overall Study|Physician Decision|1
4430210|NCT00394251|7213596|FG000|Overall Study|Protocol Violation|0
4430211|NCT00394251|7213597|FG001|Overall Study|Protocol Violation|1
4430212|NCT00394251|7213596|FG000|Overall Study|Withdrawal by Subject|7
4430213|NCT00394251|7213597|FG001|Overall Study|Withdrawal by Subject|11
4430214|NCT00394251|7213596|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2
4430215|NCT00394251|7213597|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2
4430216|NCT00394433|7213647|FG000|Overall Study|Adverse Event|2
4430217|NCT00394433|7213647|FG000|Overall Study|Alternative Therapy|1
4715436|NCT02971800|7643931|FG000|Overall Study|Withdrawal by Subject|1
4430218|NCT00394472|7213653|FG000|Overall Study|Protocol Violation|1
4430219|NCT00394472|7213654|FG001|Overall Study|Protocol Violation|3
4430220|NCT00394472|7213653|FG000|Overall Study|incorrect enrolment|4
4430221|NCT00394472|7213654|FG001|Overall Study|incorrect enrolment|2
4430222|NCT00394472|7213653|FG000|Overall Study|Adverse Event|4
4430223|NCT00394472|7213654|FG001|Overall Study|Adverse Event|2
4430224|NCT00394472|7213653|FG000|Overall Study|Withdrawal by Subject|0
4430225|NCT00394472|7213654|FG001|Overall Study|Withdrawal by Subject|2
4430226|NCT00394472|7213653|FG000|Overall Study|Physician Decision|0
4430227|NCT00394472|7213654|FG001|Overall Study|Physician Decision|1
4430228|NCT00394472|7213653|FG000|Overall Study|Lost to Follow-up|0
4430229|NCT00394472|7213654|FG001|Overall Study|Lost to Follow-up|1
4629990|NCT01878890|7498438|FG002|Overall Study|Protocol Violation|0
4629991|NCT01878890|7498439|FG003|Overall Study|Protocol Violation|0
4629992|NCT01879072|7498454|FG000|Overall Study|Withdrawal by Subject|121
4430230|NCT00394524|7213662|FG000|Overall Study|Protocol Violation|2
4430231|NCT00394524|7213663|FG001|Overall Study|Protocol Violation|3
4430232|NCT00394524|7213662|FG000|Overall Study|Death|1
4430233|NCT00394524|7213663|FG001|Overall Study|Death|0
4430234|NCT00394524|7213662|FG000|Overall Study|Withdrawal by Subject|0
4430235|NCT00394524|7213663|FG001|Overall Study|Withdrawal by Subject|1
4430236|NCT00394589|7213674|FG000|Overall Study|Adverse Event|2
4430237|NCT00394589|7213675|FG001|Overall Study|Adverse Event|1
4430238|NCT00394589|7213676|FG002|Overall Study|Adverse Event|2
4430239|NCT00394589|7213674|FG000|Overall Study|Lack of Efficacy|2
4430240|NCT00394589|7213675|FG001|Overall Study|Lack of Efficacy|2
4430241|NCT00394589|7213676|FG002|Overall Study|Lack of Efficacy|3
4430242|NCT00394589|7213674|FG000|Overall Study|Protocol Violation|4
4430243|NCT00394589|7213675|FG001|Overall Study|Protocol Violation|0
4430244|NCT00394589|7213676|FG002|Overall Study|Protocol Violation|2
4430245|NCT00394654|7213686|FG000|Overall Study|Lost to Follow-up|1
4430246|NCT00394654|7213687|FG001|Overall Study|Lost to Follow-up|0
4430247|NCT00394654|7213686|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1
4430248|NCT00394654|7213687|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0
4430249|NCT00394706|7213701|FG000|Overall Study|Withdrawal by Subject|2
4430250|NCT00394706|7213702|FG001|Overall Study|Withdrawal by Subject|0
4430251|NCT00394706|7213703|FG002|Overall Study|Withdrawal by Subject|1
4430252|NCT00394706|7213704|FG003|Overall Study|Withdrawal by Subject|0
4430253|NCT00394706|7213705|FG004|Overall Study|Withdrawal by Subject|0
4430254|NCT00394706|7213706|FG005|Overall Study|Withdrawal by Subject|2
4430255|NCT00394706|7213707|FG006|Overall Study|Withdrawal by Subject|1
4430256|NCT00394706|7213708|FG007|Overall Study|Withdrawal by Subject|0
4430257|NCT00394706|7213701|FG000|Overall Study|Lost to Follow-up|2
4430258|NCT00394706|7213702|FG001|Overall Study|Lost to Follow-up|2
4430259|NCT00394706|7213703|FG002|Overall Study|Lost to Follow-up|8
4430260|NCT00394706|7213704|FG003|Overall Study|Lost to Follow-up|1
4430261|NCT00394706|7213705|FG004|Overall Study|Lost to Follow-up|2
4430262|NCT00394706|7213706|FG005|Overall Study|Lost to Follow-up|5
4430263|NCT00394706|7213707|FG006|Overall Study|Lost to Follow-up|2
4430264|NCT00394706|7213708|FG007|Overall Study|Lost to Follow-up|0
4430265|NCT00394771|7213726|FG000|Overall Study|Did not meet protocol requirements|1
4430266|NCT00394771|7213727|FG001|Overall Study|Did not meet protocol requirements|0
4430267|NCT00394771|7213728|FG002|Overall Study|Did not meet protocol requirements|2
4430268|NCT00394771|7213729|FG003|Overall Study|Did not meet protocol requirements|0
4715437|NCT02971800|7643931|FG000|Overall Study|Exclusion criteria prior intervention|1
4715438|NCT02971800|7643931|FG000|Overall Study|Number evaluable participant already reached|4
4715439|NCT02972242|7643937|FG000|Overall Study|Withdrawal by Subject|1
4715440|NCT02972242|7643938|FG001|Overall Study|Withdrawal by Subject|0
4715441|NCT02972359|7643944|FG000|Overall Study|Incl. criteria not met/Exclusion met|2
4715442|NCT02972359|7643944|FG000|Overall Study|Lack of Efficacy|1
4715443|NCT02972359|7643944|FG000|Overall Study|Adverse Event|4
4715444|NCT02972359|7643944|FG000|Overall Study|Death|1
4715445|NCT02972359|7643944|FG000|Overall Study|Withdrawal by Subject|30
4715446|NCT02972359|7643944|FG000|Overall Study|Protocol Violation|1
4715447|NCT02972359|7643944|FG000|Overall Study|Lost to Follow-up|26
4715448|NCT02972359|7643944|FG000|Overall Study|Other reasons|5
4715449|NCT02972359|7643944|FG000|Overall Study|Missing|1
4715450|NCT02972502|7643950|FG000|Overall Study|Lost to Follow-up|3
4715451|NCT02972502|7643951|FG001|Overall Study|Lost to Follow-up|1
4715452|NCT02972502|7643950|FG000|Overall Study|Withdrawal by Subject|1
4715453|NCT02972502|7643951|FG001|Overall Study|Withdrawal by Subject|1
4715454|NCT02972515|7643957|FG000|Overall Study|Lost to Follow-up|78
4715455|NCT02972632|7643970|FG000|Overall Study|Pretreatment Event/Adverse Event|3
4715456|NCT02972632|7643970|FG000|Overall Study|Lost to Follow-up|4
4715457|NCT02972632|7643970|FG000|Overall Study|Voluntary Withdrawal|10
4715458|NCT02972658|7643978|FG000|Overall Study|Adverse Event|0
4715459|NCT02972658|7643979|FG001|Overall Study|Adverse Event|3
4715460|NCT02972658|7643980|FG002|Overall Study|Adverse Event|0
4715461|NCT02972658|7643981|FG003|Overall Study|Adverse Event|2
4715462|NCT02972658|7643978|FG000|Overall Study|Other-determined by Investigator|1
4715463|NCT02972658|7643979|FG001|Overall Study|Other-determined by Investigator|1
4715464|NCT02972658|7643980|FG002|Overall Study|Other-determined by Investigator|0
4430269|NCT00394771|7213726|FG000|Overall Study|Protocol Violation|2
4430270|NCT00394771|7213727|FG001|Overall Study|Protocol Violation|4
4629993|NCT01879072|7498454|FG000|Overall Study|Not Transplanted|30
4629994|NCT01879319|7498469|FG000|Overall Study|Withdrawal by Subject|1
4715465|NCT02972658|7643981|FG003|Overall Study|Other-determined by Investigator|0
4715466|NCT02972658|7643978|FG000|Overall Study|Death|0
4715467|NCT02972658|7643979|FG001|Overall Study|Death|0
4715468|NCT02972658|7643980|FG002|Overall Study|Death|0
4715469|NCT02972658|7643981|FG003|Overall Study|Death|1
4715470|NCT02972658|7643978|FG000|Overall Study|Lost to Follow-up|0
4430271|NCT00394771|7213728|FG002|Overall Study|Protocol Violation|9
4430272|NCT00394771|7213729|FG003|Overall Study|Protocol Violation|7
4430273|NCT00394771|7213726|FG000|Overall Study|Withdrawal by Subject|10
4430274|NCT00394771|7213727|FG001|Overall Study|Withdrawal by Subject|6
4430275|NCT00394771|7213728|FG002|Overall Study|Withdrawal by Subject|8
4430276|NCT00394771|7213729|FG003|Overall Study|Withdrawal by Subject|12
4430277|NCT00394771|7213726|FG000|Overall Study|Adverse Event|10
4430278|NCT00394771|7213727|FG001|Overall Study|Adverse Event|5
4430279|NCT00394771|7213728|FG002|Overall Study|Adverse Event|12
4430280|NCT00394771|7213729|FG003|Overall Study|Adverse Event|8
4430281|NCT00394771|7213726|FG000|Overall Study|Participant pregnant|0
4430282|NCT00394771|7213727|FG001|Overall Study|Participant pregnant|1
4430283|NCT00394771|7213728|FG002|Overall Study|Participant pregnant|2
4430284|NCT00394771|7213729|FG003|Overall Study|Participant pregnant|2
4430285|NCT00394771|7213726|FG000|Overall Study|Lost to Follow-up|15
4430286|NCT00394771|7213727|FG001|Overall Study|Lost to Follow-up|15
4430287|NCT00394771|7213728|FG002|Overall Study|Lost to Follow-up|13
4430288|NCT00394771|7213729|FG003|Overall Study|Lost to Follow-up|10
4430289|NCT00394771|7213726|FG000|Overall Study|Other|3
4430290|NCT00394771|7213727|FG001|Overall Study|Other|3
4430291|NCT00394771|7213728|FG002|Overall Study|Other|1
4430292|NCT00394771|7213729|FG003|Overall Study|Other|0
4430293|NCT00394836|7213741|FG000|Teatment or Follow-up Phase|Adverse Event|0
4430294|NCT00394836|7213742|FG001|Teatment or Follow-up Phase|Adverse Event|2
4430295|NCT00394836|7213741|FG000|Teatment or Follow-up Phase|Protocol Violation|0
4430296|NCT00394836|7213742|FG001|Teatment or Follow-up Phase|Protocol Violation|2
4430297|NCT00394836|7213741|FG000|Teatment or Follow-up Phase|Disease Progression|27
4629995|NCT01879319|7498470|FG001|Overall Study|Withdrawal by Subject|0
4715471|NCT02972658|7643979|FG001|Overall Study|Lost to Follow-up|1
4715472|NCT02972658|7643980|FG002|Overall Study|Lost to Follow-up|1
4715473|NCT02972658|7643981|FG003|Overall Study|Lost to Follow-up|2
4715474|NCT02972658|7643978|FG000|Overall Study|Progressive Disease|0
4715475|NCT02972658|7643979|FG001|Overall Study|Progressive Disease|1
4715476|NCT02972658|7643980|FG002|Overall Study|Progressive Disease|0
4715477|NCT02972658|7643981|FG003|Overall Study|Progressive Disease|1
4715478|NCT02972658|7643978|FG000|Overall Study|Withdrawal by Subject|4
4715479|NCT02972658|7643979|FG001|Overall Study|Withdrawal by Subject|4
4715480|NCT02972658|7643980|FG002|Overall Study|Withdrawal by Subject|1
4715481|NCT02972658|7643981|FG003|Overall Study|Withdrawal by Subject|6
4715482|NCT02972658|7643978|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1
4715483|NCT02972658|7643979|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1
4715484|NCT02972658|7643980|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1
4715485|NCT02972658|7643981|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0
4715486|NCT02972658|7643978|FG000|Overall Study|Sponsor Decision|70
4715487|NCT02972658|7643979|FG001|Overall Study|Sponsor Decision|127
4715488|NCT02972658|7643980|FG002|Overall Study|Sponsor Decision|72
4715489|NCT02972658|7643981|FG003|Overall Study|Sponsor Decision|119
4715490|NCT02973048|7643993|FG000|Overall Study|Epidural catheter insertion failure|1
4715491|NCT02973048|7643994|FG001|Overall Study|Epidural catheter insertion failure|0
4715492|NCT02973048|7643993|FG000|Overall Study|Withdrawal by Subject|0
4715493|NCT02973048|7643994|FG001|Overall Study|Withdrawal by Subject|3
4715494|NCT02973087|7644002|FG000|Overall Study|Withdrawal by Subject|2
4715495|NCT02973087|7644003|FG001|Overall Study|Withdrawal by Subject|1
4715496|NCT02973087|7644002|FG000|Overall Study|Adverse Event|1
4715497|NCT02973087|7644003|FG001|Overall Study|Adverse Event|0
4715498|NCT02973087|7644002|FG000|Overall Study|other|1
4715499|NCT02973087|7644003|FG001|Overall Study|other|1
4715500|NCT02973100|7644014|FG000|Overall Study|Adverse Event|1
4715501|NCT02973100|7644015|FG001|Overall Study|Adverse Event|2
4715502|NCT02973100|7644016|FG002|Overall Study|Adverse Event|1
4715503|NCT02973100|7644017|FG003|Overall Study|Adverse Event|2
4715504|NCT02973100|7644014|FG000|Overall Study|Lost to Follow-up|3
4715505|NCT02973100|7644015|FG001|Overall Study|Lost to Follow-up|1
4715506|NCT02973100|7644016|FG002|Overall Study|Lost to Follow-up|1
4715507|NCT02973100|7644017|FG003|Overall Study|Lost to Follow-up|0
4715508|NCT02973100|7644014|FG000|Overall Study|Withdrawal by Subject|3
4715509|NCT02973100|7644015|FG001|Overall Study|Withdrawal by Subject|5
4715510|NCT02973100|7644016|FG002|Overall Study|Withdrawal by Subject|1
4715511|NCT02973100|7644017|FG003|Overall Study|Withdrawal by Subject|4
4715512|NCT02973100|7644014|FG000|Overall Study|Notification of change in address|0
4715513|NCT02973100|7644015|FG001|Overall Study|Notification of change in address|0
4715514|NCT02973100|7644016|FG002|Overall Study|Notification of change in address|0
4715515|NCT02973100|7644017|FG003|Overall Study|Notification of change in address|1
4430298|NCT00394836|7213742|FG001|Teatment or Follow-up Phase|Disease Progression|60
4629996|NCT01879319|7498469|FG000|Overall Study|Lost to Follow-up|1
4629997|NCT01879319|7498470|FG001|Overall Study|Lost to Follow-up|5
4715516|NCT02973100|7644014|FG000|Overall Study|Failed to attend Safety followup period|0
4715517|NCT02973100|7644015|FG001|Overall Study|Failed to attend Safety followup period|0
4715518|NCT02973100|7644016|FG002|Overall Study|Failed to attend Safety followup period|1
4715519|NCT02973100|7644017|FG003|Overall Study|Failed to attend Safety followup period|0
4715520|NCT02973477|7644050|FG000|First Intervention|Lost to Follow-up|0
4715521|NCT02973477|7644051|FG001|First Intervention|Lost to Follow-up|2
4715522|NCT02973477|7644050|FG000|Washout|Withdrawal by Subject|1
4715523|NCT02973477|7644051|FG001|Washout|Withdrawal by Subject|0
4715524|NCT02973477|7644050|FG000|Second Intervention|Lost to Follow-up|1
4715525|NCT02973477|7644051|FG001|Second Intervention|Lost to Follow-up|0
4715526|NCT02973802|7644081|FG000|Overall Study|Lost to Follow-up|1
4715527|NCT02973802|7644081|FG000|Overall Study|Withdrawal by Subject|1
4715528|NCT02974010|7644090|FG000|Overall Study|Lost to Follow-up|3
4715529|NCT02974010|7644091|FG001|Overall Study|Lost to Follow-up|1
4715530|NCT02974010|7644092|FG002|Overall Study|Lost to Follow-up|0
4715531|NCT02974010|7644093|FG003|Overall Study|Lost to Follow-up|0
4715532|NCT02974010|7644090|FG000|Overall Study|Withdrawal by Subject|2
4715533|NCT02974010|7644091|FG001|Overall Study|Withdrawal by Subject|1
4629998|NCT01879410|7498525|FG000|Overall Study|Adverse Event|9
4629999|NCT01879410|7498526|FG001|Overall Study|Adverse Event|14
4630000|NCT01879410|7498525|FG000|Overall Study|Lack of Efficacy|4
4630001|NCT01879410|7498526|FG001|Overall Study|Lack of Efficacy|6
4630002|NCT01879410|7498525|FG000|Overall Study|Protocol Violation|1
4630003|NCT01879410|7498526|FG001|Overall Study|Protocol Violation|7
4630004|NCT01879410|7498525|FG000|Overall Study|Lost to Follow-up|2
4630005|NCT01879410|7498526|FG001|Overall Study|Lost to Follow-up|1
4630006|NCT01879410|7498525|FG000|Overall Study|Withdrawal by Subject|7
4630007|NCT01879410|7498526|FG001|Overall Study|Withdrawal by Subject|8
4630008|NCT01879410|7498525|FG000|Overall Study|Randomised in Error|1
4630009|NCT01879410|7498526|FG001|Overall Study|Randomised in Error|2
4630010|NCT01879553|7498538|FG000|Overall Study|Withdrawal by Subject|1
4630011|NCT01879553|7498539|FG001|Overall Study|Withdrawal by Subject|0
4630012|NCT01879579|7498548|FG000|Overall Study|Phone incompatible with texting platform|3
4630013|NCT01879579|7498549|FG001|Overall Study|Phone incompatible with texting platform|0
4630014|NCT01879579|7498548|FG000|Overall Study|Did not enroll in texting platform|1
4630015|NCT01879579|7498549|FG001|Overall Study|Did not enroll in texting platform|0
4630016|NCT01879579|7498548|FG000|Overall Study|Did not initiate insulin treatment|1
4630017|NCT01879579|7498549|FG001|Overall Study|Did not initiate insulin treatment|0
4630018|NCT01879579|7498548|FG000|Overall Study|Phenotypic type 1 diabetes|0
4630019|NCT01879579|7498549|FG001|Overall Study|Phenotypic type 1 diabetes|1
4630020|NCT01879579|7498548|FG000|Overall Study|Discontinued insulin - possible allergy|0
4630021|NCT01879579|7498549|FG001|Overall Study|Discontinued insulin - possible allergy|1
4630022|NCT01879618|7498558|FG000|Overall Study|Does not meet entrance criteria|1
4630023|NCT01879618|7498558|FG000|Overall Study|Withdrawal by Subject|1
4630024|NCT01879618|7498558|FG000|Overall Study|Surgery;changed schedule; not available|8
4630025|NCT01879618|7498558|FG000|Overall Study|Protocol Violation|6
4630026|NCT01879618|7498558|FG000|Overall Study|Adverse Event|5
4630027|NCT01879683|7498562|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1
4630028|NCT01879722|7498576|FG000|Overall Study|Pretreatment Event/Adverse Event|0
4630029|NCT01879722|7498577|FG001|Overall Study|Pretreatment Event/Adverse Event|1
4630030|NCT01879722|7498578|FG002|Overall Study|Pretreatment Event/Adverse Event|0
4715534|NCT02974010|7644092|FG002|Overall Study|Withdrawal by Subject|0
4715535|NCT02974010|7644093|FG003|Overall Study|Withdrawal by Subject|0
4715536|NCT02974010|7644090|FG000|Overall Study|Adverse Event|0
4715537|NCT02974010|7644091|FG001|Overall Study|Adverse Event|1
4715538|NCT02974010|7644092|FG002|Overall Study|Adverse Event|0
4715539|NCT02974010|7644093|FG003|Overall Study|Adverse Event|0
4715540|NCT02974010|7644090|FG000|Overall Study|Completed day 42 but did not return for day 70|1
4715541|NCT02974010|7644091|FG001|Overall Study|Completed day 42 but did not return for day 70|0
4715542|NCT02974010|7644092|FG002|Overall Study|Completed day 42 but did not return for day 70|1
4715543|NCT02974010|7644093|FG003|Overall Study|Completed day 42 but did not return for day 70|0
4715544|NCT02974010|7644090|FG000|Overall Study|Lack of Efficacy|0
4715545|NCT02974010|7644091|FG001|Overall Study|Lack of Efficacy|0
4715546|NCT02974010|7644092|FG002|Overall Study|Lack of Efficacy|1
4715547|NCT02974010|7644093|FG003|Overall Study|Lack of Efficacy|0
4715548|NCT02974088|7644105|FG000|Overall Study|Lost to Follow-up|0
4715549|NCT02974088|7644106|FG001|Overall Study|Lost to Follow-up|2
4715550|NCT02974088|7644105|FG000|Overall Study|Adverse Event|0
4715551|NCT02974088|7644106|FG001|Overall Study|Adverse Event|1
4715552|NCT02974114|7644115|FG000|Overall Study|Other (Not specified)|0
4715553|NCT02974114|7644116|FG001|Overall Study|Other (Not specified)|1
4715554|NCT02974114|7644117|FG002|Overall Study|Other (Not specified)|2
4715555|NCT02974140|7644127|FG000|Overall Study|Adverse Event|2
4715556|NCT02974140|7644127|FG000|Overall Study|Lost to Follow-up|1
4715557|NCT02974140|7644127|FG000|Overall Study|Study Terminated by Sponsor|36
4715558|NCT02974153|7644137|FG000|Overall Study|Adverse Event|6
4715559|NCT02974153|7644138|FG001|Overall Study|Adverse Event|0
4715560|NCT02974153|7644139|FG002|Overall Study|Adverse Event|1
4715561|NCT02974153|7644137|FG000|Overall Study|Lack of Efficacy|6
4715562|NCT02974153|7644138|FG001|Overall Study|Lack of Efficacy|5
4715563|NCT02974153|7644139|FG002|Overall Study|Lack of Efficacy|10
4715564|NCT02974153|7644137|FG000|Overall Study|Lost to Follow-up|9
4715565|NCT02974153|7644138|FG001|Overall Study|Lost to Follow-up|10
4715566|NCT02974153|7644139|FG002|Overall Study|Lost to Follow-up|17
4715567|NCT02974153|7644137|FG000|Overall Study|Physician Decision|0
4715568|NCT02974153|7644138|FG001|Overall Study|Physician Decision|2
4715569|NCT02974153|7644139|FG002|Overall Study|Physician Decision|1
4715570|NCT02974153|7644137|FG000|Overall Study|Withdrawal by Subject|9
4715571|NCT02974153|7644138|FG001|Overall Study|Withdrawal by Subject|16
4630031|NCT01879722|7498579|FG003|Overall Study|Pretreatment Event/Adverse Event|1
4630032|NCT01879722|7498580|FG004|Overall Study|Pretreatment Event/Adverse Event|1
4630033|NCT01879722|7498581|FG005|Overall Study|Pretreatment Event/Adverse Event|0
4630034|NCT01879722|7498582|FG006|Overall Study|Pretreatment Event/Adverse Event|0
4630035|NCT01879722|7498583|FG007|Overall Study|Pretreatment Event/Adverse Event|1
4630036|NCT01879722|7498584|FG008|Overall Study|Pretreatment Event/Adverse Event|1
4630037|NCT01879722|7498585|FG009|Overall Study|Pretreatment Event/Adverse Event|0
4630038|NCT01879722|7498576|FG000|Overall Study|Voluntary Withdrawal|0
4630039|NCT01879722|7498577|FG001|Overall Study|Voluntary Withdrawal|0
4630040|NCT01879722|7498578|FG002|Overall Study|Voluntary Withdrawal|0
4630041|NCT01879722|7498579|FG003|Overall Study|Voluntary Withdrawal|0
4630042|NCT01879722|7498580|FG004|Overall Study|Voluntary Withdrawal|0
4715572|NCT02974153|7644139|FG002|Overall Study|Withdrawal by Subject|11
4715573|NCT02974153|7644137|FG000|Overall Study|Study Burden|8
4715574|NCT02974153|7644138|FG001|Overall Study|Study Burden|7
4715575|NCT02974153|7644139|FG002|Overall Study|Study Burden|3
4715576|NCT02974153|7644137|FG000|Overall Study|Other|14
4715577|NCT02974153|7644138|FG001|Overall Study|Other|8
4715578|NCT02974153|7644139|FG002|Overall Study|Other|7
4715579|NCT02974543|7644158|FG000|Overall Study|Withdrawal by Subject|1
4715580|NCT02974543|7644159|FG001|Overall Study|Withdrawal by Subject|0
4630043|NCT01879722|7498581|FG005|Overall Study|Voluntary Withdrawal|0
4630044|NCT01879722|7498582|FG006|Overall Study|Voluntary Withdrawal|0
4630045|NCT01879722|7498583|FG007|Overall Study|Voluntary Withdrawal|0
4630046|NCT01879722|7498584|FG008|Overall Study|Voluntary Withdrawal|1
4630047|NCT01879722|7498585|FG009|Overall Study|Voluntary Withdrawal|0
4633293|NCT01910116|7503344|FG000|Overall Study|Protocol Violation|1
4633294|NCT01910116|7503345|FG001|Overall Study|Protocol Violation|2
4633295|NCT01910116|7503344|FG000|Overall Study|Withdrawal by Subject|8
4633296|NCT01910116|7503345|FG001|Overall Study|Withdrawal by Subject|3
4633297|NCT01910116|7503344|FG000|Overall Study|uncertain allocation|1
4715581|NCT02974634|7644175|FG000|Overall Study|Advanced disease|12
4715582|NCT02974634|7644176|FG001|Overall Study|Advanced disease|3
4715583|NCT02974634|7644175|FG000|Overall Study|Noncompliance|3
4715584|NCT02974634|7644176|FG001|Overall Study|Noncompliance|7
4715585|NCT02974634|7644175|FG000|Overall Study|intervention technology related issues|5
4715586|NCT02974634|7644176|FG001|Overall Study|intervention technology related issues|0
4715587|NCT02974634|7644175|FG000|Overall Study|Death|8
4715588|NCT02974634|7644176|FG001|Overall Study|Death|11
4715589|NCT02974842|7644183|FG000|Overall Study|Withdrawal by Subject|4
4715590|NCT02974842|7644183|FG000|Overall Study|Screen failures|4
4715591|NCT02974855|7644191|FG000|Overall Study|Adverse Event|0
4715592|NCT02974855|7644192|FG001|Overall Study|Adverse Event|1
4715593|NCT02974855|7644193|FG002|Overall Study|Adverse Event|0
4715594|NCT02974855|7644194|FG003|Overall Study|Adverse Event|1
4715595|NCT02974868|7644211|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1
4715596|NCT02974868|7644212|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1
4715597|NCT02974868|7644213|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2
4715598|NCT02974868|7644214|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4
4715599|NCT02974868|7644211|FG000|Initial 24-Week Treatment Period (TP)|others|3
4715600|NCT02974868|7644212|FG001|Initial 24-Week Treatment Period (TP)|others|8
4715601|NCT02974868|7644213|FG002|Initial 24-Week Treatment Period (TP)|others|1
4715602|NCT02974868|7644214|FG003|Initial 24-Week Treatment Period (TP)|others|8
4715603|NCT02974868|7644211|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2
4715604|NCT02974868|7644212|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1
4715605|NCT02974868|7644213|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11
4715606|NCT02974868|7644214|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6
4715607|NCT02974868|7644211|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2
4715608|NCT02974868|7644212|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1
4715609|NCT02974868|7644213|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3
4715610|NCT02974868|7644214|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0
4715611|NCT02975206|7644258|FG000|Overall Study|Withdrawal by Subject|14
4715612|NCT02975206|7644259|FG001|Overall Study|Withdrawal by Subject|11
4715613|NCT02975206|7644260|FG002|Overall Study|Withdrawal by Subject|11
4715614|NCT02975206|7644258|FG000|Overall Study|Other (e.g., lost to follow up)|13
4715615|NCT02975206|7644259|FG001|Overall Study|Other (e.g., lost to follow up)|6
4715616|NCT02975206|7644260|FG002|Overall Study|Other (e.g., lost to follow up)|6
4715617|NCT02975336|7644281|FG000|DBPC (52 Weeks)|Adverse Event|16
4715618|NCT02975336|7644282|FG001|DBPC (52 Weeks)|Adverse Event|17
4715619|NCT02975336|7644283|FG002|DBPC (52 Weeks)|Adverse Event|13
4715620|NCT02975336|7644284|FG003|DBPC (52 Weeks)|Adverse Event|18
4715621|NCT02975336|7644285|FG004|DBPC (52 Weeks)|Adverse Event|0
4715622|NCT02975336|7644286|FG005|DBPC (52 Weeks)|Adverse Event|0
4715623|NCT02975336|7644287|FG006|DBPC (52 Weeks)|Adverse Event|0
4715624|NCT02975336|7644288|FG007|DBPC (52 Weeks)|Adverse Event|0
4633298|NCT01910116|7503345|FG001|Overall Study|uncertain allocation|3
4633299|NCT01910116|7503344|FG000|Overall Study|incomplete data|0
4633300|NCT01910116|7503345|FG001|Overall Study|incomplete data|1
4633301|NCT01910129|7503353|FG000|Randomized Phase 2|Withdrawal by Subject|2
4633302|NCT01910129|7503354|FG001|Randomized Phase 2|Withdrawal by Subject|1
4715625|NCT02975336|7644281|FG000|DBPC (52 Weeks)|Lost to Follow-up|2
4715626|NCT02975336|7644282|FG001|DBPC (52 Weeks)|Lost to Follow-up|1
4715627|NCT02975336|7644283|FG002|DBPC (52 Weeks)|Lost to Follow-up|2
4630048|NCT04495829|7498619|FG000|Overall Study|Lost to Follow-up|2
4630049|NCT04495829|7498619|FG000|Overall Study|Inclusion criterion not met|3
4630050|NCT03861052|7498627|FG000|Overall Study|Adverse Event|1
4630051|NCT03861052|7498628|FG001|Overall Study|Adverse Event|1
4630052|NCT03861052|7498629|FG002|Overall Study|Adverse Event|2
4630053|NCT03861052|7498630|FG003|Overall Study|Adverse Event|4
4630054|NCT03861052|7498627|FG000|Overall Study|Lost to Follow-up|0
4630055|NCT03861052|7498628|FG001|Overall Study|Lost to Follow-up|0
4715628|NCT02975336|7644284|FG003|DBPC (52 Weeks)|Lost to Follow-up|4
4715629|NCT02975336|7644285|FG004|DBPC (52 Weeks)|Lost to Follow-up|0
4715630|NCT02975336|7644286|FG005|DBPC (52 Weeks)|Lost to Follow-up|0
4715631|NCT02975336|7644287|FG006|DBPC (52 Weeks)|Lost to Follow-up|0
4715632|NCT02975336|7644288|FG007|DBPC (52 Weeks)|Lost to Follow-up|0
4715633|NCT02975336|7644281|FG000|DBPC (52 Weeks)|Protocol Violation|4
4715634|NCT02975336|7644282|FG001|DBPC (52 Weeks)|Protocol Violation|1
4715635|NCT02975336|7644283|FG002|DBPC (52 Weeks)|Protocol Violation|3
4715636|NCT02975336|7644284|FG003|DBPC (52 Weeks)|Protocol Violation|1
4715637|NCT02975336|7644285|FG004|DBPC (52 Weeks)|Protocol Violation|0
4715638|NCT02975336|7644286|FG005|DBPC (52 Weeks)|Protocol Violation|0
4715639|NCT02975336|7644287|FG006|DBPC (52 Weeks)|Protocol Violation|0
4715640|NCT02975336|7644288|FG007|DBPC (52 Weeks)|Protocol Violation|0
4715641|NCT02975336|7644281|FG000|DBPC (52 Weeks)|Lack of Efficacy|4
4715642|NCT02975336|7644282|FG001|DBPC (52 Weeks)|Lack of Efficacy|4
4715643|NCT02975336|7644283|FG002|DBPC (52 Weeks)|Lack of Efficacy|2
4715644|NCT02975336|7644284|FG003|DBPC (52 Weeks)|Lack of Efficacy|3
4715645|NCT02975336|7644285|FG004|DBPC (52 Weeks)|Lack of Efficacy|0
4715646|NCT02975336|7644286|FG005|DBPC (52 Weeks)|Lack of Efficacy|0
4715647|NCT02975336|7644287|FG006|DBPC (52 Weeks)|Lack of Efficacy|0
4715648|NCT02975336|7644288|FG007|DBPC (52 Weeks)|Lack of Efficacy|0
4715649|NCT02975336|7644281|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1
4715650|NCT02975336|7644282|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0
4715651|NCT02975336|7644283|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1
4715652|NCT02975336|7644284|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3
4715653|NCT02975336|7644285|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0
4715654|NCT02975336|7644286|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0
4715655|NCT02975336|7644287|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0
4715656|NCT02975336|7644288|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0
4715657|NCT02975336|7644281|FG000|DBPC (52 Weeks)|Premature termination of the study|5
4715658|NCT02975336|7644282|FG001|DBPC (52 Weeks)|Premature termination of the study|6
4715659|NCT02975336|7644283|FG002|DBPC (52 Weeks)|Premature termination of the study|6
4715660|NCT02975336|7644284|FG003|DBPC (52 Weeks)|Premature termination of the study|4
4715661|NCT02975336|7644285|FG004|DBPC (52 Weeks)|Premature termination of the study|0
4715662|NCT02975336|7644286|FG005|DBPC (52 Weeks)|Premature termination of the study|0
4715663|NCT02975336|7644287|FG006|DBPC (52 Weeks)|Premature termination of the study|0
4715664|NCT02975336|7644288|FG007|DBPC (52 Weeks)|Premature termination of the study|0
4715665|NCT02975336|7644281|FG000|LTE (104 Weeks)|Adverse Event|0
4715666|NCT02975336|7644282|FG001|LTE (104 Weeks)|Adverse Event|0
4715667|NCT02975336|7644283|FG002|LTE (104 Weeks)|Adverse Event|0
4715668|NCT02975336|7644284|FG003|LTE (104 Weeks)|Adverse Event|0
4715669|NCT02975336|7644285|FG004|LTE (104 Weeks)|Adverse Event|7
4715670|NCT02975336|7644286|FG005|LTE (104 Weeks)|Adverse Event|4
4715671|NCT02975336|7644287|FG006|LTE (104 Weeks)|Adverse Event|2
4715672|NCT02975336|7644288|FG007|LTE (104 Weeks)|Adverse Event|0
4715673|NCT02975336|7644281|FG000|LTE (104 Weeks)|Lost to Follow-up|0
4715674|NCT02975336|7644282|FG001|LTE (104 Weeks)|Lost to Follow-up|0
4715675|NCT02975336|7644283|FG002|LTE (104 Weeks)|Lost to Follow-up|0
4715676|NCT02975336|7644284|FG003|LTE (104 Weeks)|Lost to Follow-up|0
4715677|NCT02975336|7644285|FG004|LTE (104 Weeks)|Lost to Follow-up|0
4715678|NCT02975336|7644286|FG005|LTE (104 Weeks)|Lost to Follow-up|1
4715679|NCT02975336|7644287|FG006|LTE (104 Weeks)|Lost to Follow-up|0
4715680|NCT02975336|7644288|FG007|LTE (104 Weeks)|Lost to Follow-up|0
4715681|NCT02975336|7644281|FG000|LTE (104 Weeks)|Lack of Efficacy|0
4715682|NCT02975336|7644282|FG001|LTE (104 Weeks)|Lack of Efficacy|0
4715683|NCT02975336|7644283|FG002|LTE (104 Weeks)|Lack of Efficacy|0
4715684|NCT02975336|7644284|FG003|LTE (104 Weeks)|Lack of Efficacy|0
4715685|NCT02975336|7644285|FG004|LTE (104 Weeks)|Lack of Efficacy|0
4715686|NCT02975336|7644286|FG005|LTE (104 Weeks)|Lack of Efficacy|1
4630056|NCT03861052|7498629|FG002|Overall Study|Lost to Follow-up|0
4630057|NCT03861052|7498630|FG003|Overall Study|Lost to Follow-up|1
4715687|NCT02975336|7644287|FG006|LTE (104 Weeks)|Lack of Efficacy|2
4715688|NCT02975336|7644288|FG007|LTE (104 Weeks)|Lack of Efficacy|0
4715689|NCT02975336|7644281|FG000|LTE (104 Weeks)|Other|0
4715690|NCT02975336|7644282|FG001|LTE (104 Weeks)|Other|0
4715691|NCT02975336|7644283|FG002|LTE (104 Weeks)|Other|0
4715692|NCT02975336|7644284|FG003|LTE (104 Weeks)|Other|0
4715693|NCT02975336|7644285|FG004|LTE (104 Weeks)|Other|55
4715694|NCT02975336|7644286|FG005|LTE (104 Weeks)|Other|63
4715695|NCT02975336|7644287|FG006|LTE (104 Weeks)|Other|76
4715696|NCT02975336|7644288|FG007|LTE (104 Weeks)|Other|72
4715697|NCT02975349|7644307|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0
4715698|NCT02975349|7644308|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0
4715699|NCT02975349|7644309|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3
4630058|NCT03861052|7498627|FG000|Overall Study|Physician Decision|0
4630059|NCT03861052|7498628|FG001|Overall Study|Physician Decision|1
4715700|NCT02975349|7644310|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3
4715701|NCT02975349|7644311|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0
4430299|NCT00394836|7213741|FG000|Teatment or Follow-up Phase|Patient Refusal|1
4430300|NCT00394836|7213742|FG001|Teatment or Follow-up Phase|Patient Refusal|2
4430301|NCT00394836|7213741|FG000|Teatment or Follow-up Phase|Death|0
4430302|NCT00394836|7213742|FG001|Teatment or Follow-up Phase|Death|1
4430303|NCT00394836|7213741|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0
4430304|NCT00394836|7213742|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1
4430305|NCT00394836|7213741|FG000|Teatment or Follow-up Phase|Started alternative treatment|0
4430306|NCT00394836|7213742|FG001|Teatment or Follow-up Phase|Started alternative treatment|6
4430307|NCT00394836|7213741|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0
4430308|NCT00394836|7213742|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1
4430309|NCT00394836|7213741|FG000|Teatment or Follow-up Phase|Physician Decision|0
4430310|NCT00394836|7213742|FG001|Teatment or Follow-up Phase|Physician Decision|1
4430311|NCT00394836|7213741|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0
4430312|NCT00394836|7213742|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1
4430313|NCT00394836|7213741|FG000|Teatment or Follow-up Phase|Non compliance|0
4430314|NCT00394836|7213742|FG001|Teatment or Follow-up Phase|Non compliance|1
4430315|NCT00394836|7213741|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0
4430316|NCT00394836|7213742|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1
4430317|NCT00394836|7213741|FG000|Extended Follow-up Phase (2-5 Years)|Death|0
4430318|NCT00394836|7213742|FG001|Extended Follow-up Phase (2-5 Years)|Death|1
4430319|NCT00394836|7213741|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13
4430320|NCT00394836|7213742|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41
4430321|NCT00394836|7213741|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7
4430322|NCT00394836|7213742|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10
4430323|NCT00394901|7213765|FG000|Baseline Phase|Protocol Violation|0
4430324|NCT00394901|7213766|FG001|Baseline Phase|Protocol Violation|0
4430325|NCT00394901|7213767|FG002|Baseline Phase|Protocol Violation|1
4430326|NCT00394901|7213768|FG003|Baseline Phase|Protocol Violation|0
4430327|NCT00394901|7213765|FG000|Double-blind Phase|Adverse Event|5
4430328|NCT00394901|7213766|FG001|Double-blind Phase|Adverse Event|7
4430329|NCT00394901|7213767|FG002|Double-blind Phase|Adverse Event|16
4430330|NCT00394901|7213768|FG003|Double-blind Phase|Adverse Event|20
4430331|NCT00394901|7213765|FG000|Double-blind Phase|Lack of Efficacy|6
4430332|NCT00394901|7213766|FG001|Double-blind Phase|Lack of Efficacy|4
4430333|NCT00394901|7213767|FG002|Double-blind Phase|Lack of Efficacy|1
4430334|NCT00394901|7213768|FG003|Double-blind Phase|Lack of Efficacy|3
4430335|NCT00394901|7213765|FG000|Double-blind Phase|Withdrawal by Subject|2
4430336|NCT00394901|7213766|FG001|Double-blind Phase|Withdrawal by Subject|0
4430337|NCT00394901|7213767|FG002|Double-blind Phase|Withdrawal by Subject|0
4430338|NCT00394901|7213768|FG003|Double-blind Phase|Withdrawal by Subject|0
4430339|NCT00394901|7213765|FG000|Double-blind Phase|Lost to Follow-up|0
4430340|NCT00394901|7213766|FG001|Double-blind Phase|Lost to Follow-up|0
4430341|NCT00394901|7213767|FG002|Double-blind Phase|Lost to Follow-up|0
4430342|NCT00394901|7213768|FG003|Double-blind Phase|Lost to Follow-up|1
4430343|NCT00394901|7213765|FG000|Double-blind Phase|Protocol Violation|0
4430344|NCT00394901|7213766|FG001|Double-blind Phase|Protocol Violation|0
4430345|NCT00394901|7213767|FG002|Double-blind Phase|Protocol Violation|0
4430346|NCT00394901|7213768|FG003|Double-blind Phase|Protocol Violation|1
4430347|NCT00394901|7213765|FG000|Double-blind Phase|Death|1
4430348|NCT00394901|7213766|FG001|Double-blind Phase|Death|0
4430349|NCT00394901|7213767|FG002|Double-blind Phase|Death|0
4430350|NCT00394901|7213768|FG003|Double-blind Phase|Death|0
4430351|NCT00394901|7213765|FG000|Double-blind Phase|Subject's Personal Reason|1
4430352|NCT00394901|7213766|FG001|Double-blind Phase|Subject's Personal Reason|0
4430353|NCT00394901|7213767|FG002|Double-blind Phase|Subject's Personal Reason|0
4430354|NCT00394901|7213768|FG003|Double-blind Phase|Subject's Personal Reason|1
4430355|NCT00394901|7213765|FG000|Double-blind Phase|Lack of Compliance|0
4715702|NCT02975349|7644312|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0
4715703|NCT02975349|7644307|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1
4715704|NCT02975349|7644308|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0
4715705|NCT02975349|7644309|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0
4715706|NCT02975349|7644310|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0
4715707|NCT02975349|7644311|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0
4715708|NCT02975349|7644312|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0
4715709|NCT02975349|7644307|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4
4715710|NCT02975349|7644308|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0
4715711|NCT02975349|7644309|FG002|Active Treatment Period (24 Weeks)|Adverse Event|1
4715712|NCT02975349|7644310|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2
4715713|NCT02975349|7644311|FG004|Active Treatment Period (24 Weeks)|Adverse Event|6
4430356|NCT00394901|7213766|FG001|Double-blind Phase|Lack of Compliance|3
4430357|NCT00394901|7213767|FG002|Double-blind Phase|Lack of Compliance|0
4630060|NCT03861052|7498629|FG002|Overall Study|Physician Decision|0
4630061|NCT03861052|7498630|FG003|Overall Study|Physician Decision|0
4430358|NCT00394901|7213768|FG003|Double-blind Phase|Lack of Compliance|0
4430359|NCT00394901|7213765|FG000|Double-blind Phase|Entry into another study was found|0
4430360|NCT00394901|7213766|FG001|Double-blind Phase|Entry into another study was found|0
4430361|NCT00394901|7213767|FG002|Double-blind Phase|Entry into another study was found|1
4430362|NCT00394901|7213768|FG003|Double-blind Phase|Entry into another study was found|0
4430363|NCT00394901|7213765|FG000|Double-blind Phase|Found not to meet entrance criteria|0
4430364|NCT00394901|7213766|FG001|Double-blind Phase|Found not to meet entrance criteria|0
4430365|NCT00394901|7213767|FG002|Double-blind Phase|Found not to meet entrance criteria|0
4430366|NCT00394901|7213768|FG003|Double-blind Phase|Found not to meet entrance criteria|1
4430367|NCT00394914|7213783|FG000|Treatment Period|Adverse Event|0
4430368|NCT00394914|7213784|FG001|Treatment Period|Adverse Event|3
4430369|NCT00394914|7213785|FG002|Treatment Period|Adverse Event|1
4430370|NCT00394914|7213783|FG000|Treatment Period|Lost to Follow-up|0
4430371|NCT00394914|7213784|FG001|Treatment Period|Lost to Follow-up|1
4430372|NCT00394914|7213785|FG002|Treatment Period|Lost to Follow-up|0
4430373|NCT00394914|7213783|FG000|Treatment Period|Withdrawal by Subject|0
4430374|NCT00394914|7213784|FG001|Treatment Period|Withdrawal by Subject|2
4430375|NCT00394914|7213785|FG002|Treatment Period|Withdrawal by Subject|2
4430376|NCT00394914|7213783|FG000|Treatment Period|Noncompliance with protocol|0
4430377|NCT00394914|7213784|FG001|Treatment Period|Noncompliance with protocol|3
4430378|NCT00394914|7213785|FG002|Treatment Period|Noncompliance with protocol|2
4430379|NCT00394914|7213783|FG000|Treatment Period|Did not meet protocol eligibility|0
4430380|NCT00394914|7213784|FG001|Treatment Period|Did not meet protocol eligibility|1
4430381|NCT00394914|7213785|FG002|Treatment Period|Did not meet protocol eligibility|1
4430382|NCT00394953|7213793|FG000|First Treatment Period|Adverse Event|1
4430383|NCT00394953|7213794|FG001|First Treatment Period|Adverse Event|2
4430384|NCT00394953|7213793|FG000|First Treatment Period|Death|6
4430385|NCT00394953|7213794|FG001|First Treatment Period|Death|7
4430386|NCT00394953|7213793|FG000|First Treatment Period|Lack of Efficacy|1
4430387|NCT00394953|7213794|FG001|First Treatment Period|Lack of Efficacy|1
4430388|NCT00394953|7213793|FG000|First Treatment Period|Withdrawal by Subject|6
4430389|NCT00394953|7213794|FG001|First Treatment Period|Withdrawal by Subject|3
4430390|NCT00394953|7213793|FG000|First Treatment Period|Lost to Follow-up|0
4430391|NCT00394953|7213794|FG001|First Treatment Period|Lost to Follow-up|1
4430392|NCT00394953|7213793|FG000|First Treatment Period|Renal transplant|11
4430393|NCT00394953|7213794|FG001|First Treatment Period|Renal transplant|7
4430394|NCT00394953|7213793|FG000|First Treatment Period|Not defined|4
4430395|NCT00394953|7213794|FG001|First Treatment Period|Not defined|1
4430396|NCT00394953|7213793|FG000|Second Treatment Period|Adverse Event|2
4430397|NCT00394953|7213794|FG001|Second Treatment Period|Adverse Event|5
4430398|NCT00394953|7213793|FG000|Second Treatment Period|Death|8
4430399|NCT00394953|7213794|FG001|Second Treatment Period|Death|4
4430400|NCT00394953|7213793|FG000|Second Treatment Period|Lack of Efficacy|9
4430401|NCT00394953|7213794|FG001|Second Treatment Period|Lack of Efficacy|47
4430402|NCT00394953|7213793|FG000|Second Treatment Period|Withdrawal by Subject|3
4430403|NCT00394953|7213794|FG001|Second Treatment Period|Withdrawal by Subject|3
4430404|NCT00394953|7213793|FG000|Second Treatment Period|Lost to Follow-up|0
4430405|NCT00394953|7213794|FG001|Second Treatment Period|Lost to Follow-up|1
4430406|NCT00394953|7213793|FG000|Second Treatment Period|Renal transplant|4
4430407|NCT00394953|7213794|FG001|Second Treatment Period|Renal transplant|6
4430408|NCT00394953|7213793|FG000|Second Treatment Period|Not defined|3
4430409|NCT00394953|7213794|FG001|Second Treatment Period|Not defined|8
4430410|NCT00395018|7213800|FG000|On-Treatment|Death|4
4430411|NCT00395018|7213800|FG000|On-Treatment|Other Reason|2
4430412|NCT00395018|7213800|FG000|On-Treatment|Poor/non-compliance|2
4430413|NCT00395018|7213800|FG000|On-Treatment|Subject no longer meets study criteria|2
4430414|NCT00395018|7213800|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1
4430415|NCT00395018|7213800|FG000|Off-Treatment Follow-up|Lost to Follow-up|2
4430416|NCT00395018|7213800|FG000|Off-Treatment Follow-up|Poor/non-compliance|1
4430417|NCT00395083|7213832|FG000|Overall Study|Withdrawal by Subject|6
4430418|NCT00395083|7213833|FG001|Overall Study|Withdrawal by Subject|5
4430419|NCT00395083|7213832|FG000|Overall Study|Developed another disease|4
4430420|NCT00395083|7213833|FG001|Overall Study|Developed another disease|3
4430421|NCT00395226|7213872|FG000|Overall Study|Adverse Event|4
4430422|NCT00395226|7213873|FG001|Overall Study|Adverse Event|3
4430423|NCT00395226|7213872|FG000|Overall Study|Withdrawal by Subject|0
4430424|NCT00395226|7213873|FG001|Overall Study|Withdrawal by Subject|1
4430425|NCT00395226|7213872|FG000|Overall Study|Lost to Follow-up|0
4430426|NCT00395226|7213873|FG001|Overall Study|Lost to Follow-up|1
4430427|NCT00395304|7213886|FG000|Treatment Period 1|Withdrawal by Subject|0
4430428|NCT00395304|7213887|FG001|Treatment Period 1|Withdrawal by Subject|3
4430429|NCT00395304|7213888|FG002|Treatment Period 1|Withdrawal by Subject|0
4430430|NCT00395304|7213889|FG003|Treatment Period 1|Withdrawal by Subject|2
4430431|NCT00395304|7213890|FG004|Treatment Period 1|Withdrawal by Subject|1
4430432|NCT00395304|7213891|FG005|Treatment Period 1|Withdrawal by Subject|1
4430433|NCT00395304|7213886|FG000|Treatment Period 1|Lost to Follow-up|1
4430434|NCT00395304|7213887|FG001|Treatment Period 1|Lost to Follow-up|0
4430435|NCT00395304|7213888|FG002|Treatment Period 1|Lost to Follow-up|0
4430436|NCT00395304|7213889|FG003|Treatment Period 1|Lost to Follow-up|1
4430437|NCT00395304|7213890|FG004|Treatment Period 1|Lost to Follow-up|0
4430438|NCT00395304|7213891|FG005|Treatment Period 1|Lost to Follow-up|1
4430439|NCT00395304|7213886|FG000|Treatment Period 1|Physician Decision|0
4430440|NCT00395304|7213887|FG001|Treatment Period 1|Physician Decision|1
4430441|NCT00395304|7213888|FG002|Treatment Period 1|Physician Decision|0
4430442|NCT00395304|7213889|FG003|Treatment Period 1|Physician Decision|0
4430443|NCT00395304|7213890|FG004|Treatment Period 1|Physician Decision|0
4430444|NCT00395304|7213891|FG005|Treatment Period 1|Physician Decision|0
4430445|NCT00395304|7213886|FG000|Treatment Period 2|Withdrawal by Subject|0
4430446|NCT00395304|7213887|FG001|Treatment Period 2|Withdrawal by Subject|0
4430447|NCT00395304|7213888|FG002|Treatment Period 2|Withdrawal by Subject|0
4430448|NCT00395304|7213889|FG003|Treatment Period 2|Withdrawal by Subject|1
4430449|NCT00395304|7213890|FG004|Treatment Period 2|Withdrawal by Subject|0
4430450|NCT00395304|7213891|FG005|Treatment Period 2|Withdrawal by Subject|2
4430451|NCT00395304|7213886|FG000|Treatment Period 2|Lost to Follow-up|0
4430452|NCT00395304|7213887|FG001|Treatment Period 2|Lost to Follow-up|3
4430453|NCT00395304|7213888|FG002|Treatment Period 2|Lost to Follow-up|0
4430454|NCT00395304|7213889|FG003|Treatment Period 2|Lost to Follow-up|0
4430455|NCT00395304|7213890|FG004|Treatment Period 2|Lost to Follow-up|0
4430456|NCT00395304|7213891|FG005|Treatment Period 2|Lost to Follow-up|0
4430457|NCT00395304|7213886|FG000|Treatment Period 2|Physician Decision|0
4430458|NCT00395304|7213887|FG001|Treatment Period 2|Physician Decision|0
4430459|NCT00395304|7213888|FG002|Treatment Period 2|Physician Decision|1
4430460|NCT00395304|7213889|FG003|Treatment Period 2|Physician Decision|0
4430461|NCT00395304|7213890|FG004|Treatment Period 2|Physician Decision|0
4430462|NCT00395304|7213891|FG005|Treatment Period 2|Physician Decision|0
4430463|NCT00395304|7213886|FG000|Treatment Period 2|Other|0
4430464|NCT00395304|7213887|FG001|Treatment Period 2|Other|1
4430465|NCT00395304|7213888|FG002|Treatment Period 2|Other|0
4430466|NCT00395304|7213889|FG003|Treatment Period 2|Other|0
4430467|NCT00395304|7213890|FG004|Treatment Period 2|Other|0
4430468|NCT00395304|7213891|FG005|Treatment Period 2|Other|0
4430469|NCT00395304|7213886|FG000|Treatment Period 3|Withdrawal by Subject|0
4430470|NCT00395304|7213887|FG001|Treatment Period 3|Withdrawal by Subject|0
4430471|NCT00395304|7213888|FG002|Treatment Period 3|Withdrawal by Subject|0
4430472|NCT00395304|7213889|FG003|Treatment Period 3|Withdrawal by Subject|1
4430473|NCT00395304|7213890|FG004|Treatment Period 3|Withdrawal by Subject|0
4430474|NCT00395304|7213891|FG005|Treatment Period 3|Withdrawal by Subject|1
4715714|NCT02975349|7644312|FG005|Active Treatment Period (24 Weeks)|Adverse Event|2
4715715|NCT02975349|7644307|FG000|Active Treatment Period (24 Weeks)|Un-specified|0
4715716|NCT02975349|7644308|FG001|Active Treatment Period (24 Weeks)|Un-specified|0
4715717|NCT02975349|7644309|FG002|Active Treatment Period (24 Weeks)|Un-specified|1
4715718|NCT02975349|7644310|FG003|Active Treatment Period (24 Weeks)|Un-specified|0
4715719|NCT02975349|7644311|FG004|Active Treatment Period (24 Weeks)|Un-specified|0
4715720|NCT02975349|7644312|FG005|Active Treatment Period (24 Weeks)|Un-specified|0
4715721|NCT02975349|7644307|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0
4715722|NCT02975349|7644308|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1
4715723|NCT02975349|7644309|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|1
4715724|NCT02975349|7644310|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|2
4715725|NCT02975349|7644311|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|1
4715726|NCT02975349|7644312|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|0
4715727|NCT02975349|7644307|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0
4715728|NCT02975349|7644308|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5
4715729|NCT02975349|7644309|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2
4715730|NCT02975349|7644310|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1
4715731|NCT02975349|7644311|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1
4715732|NCT02975349|7644312|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0
4715733|NCT02975349|7644307|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0
4715734|NCT02975349|7644308|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0
4715735|NCT02975349|7644309|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1
4715736|NCT02975349|7644310|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0
4715737|NCT02975349|7644311|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0
4715738|NCT02975349|7644312|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0
4715739|NCT02975349|7644307|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0
4715740|NCT02975349|7644308|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1
4715741|NCT02975349|7644309|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0
4715742|NCT02975349|7644310|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0
4715743|NCT02975349|7644311|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0
4715744|NCT02975349|7644312|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0
4430475|NCT00395304|7213886|FG000|Treatment Period 3|Lost to Follow-up|1
4430476|NCT00395304|7213887|FG001|Treatment Period 3|Lost to Follow-up|1
4430477|NCT00395304|7213888|FG002|Treatment Period 3|Lost to Follow-up|0
4430478|NCT00395304|7213889|FG003|Treatment Period 3|Lost to Follow-up|0
4430479|NCT00395304|7213890|FG004|Treatment Period 3|Lost to Follow-up|0
4430480|NCT00395304|7213891|FG005|Treatment Period 3|Lost to Follow-up|0
4430481|NCT00395304|7213886|FG000|Treatment Period 3|Physician Decision|0
4430482|NCT00395304|7213887|FG001|Treatment Period 3|Physician Decision|1
4430483|NCT00395304|7213888|FG002|Treatment Period 3|Physician Decision|0
4430484|NCT00395304|7213889|FG003|Treatment Period 3|Physician Decision|0
4430485|NCT00395304|7213890|FG004|Treatment Period 3|Physician Decision|0
4430486|NCT00395304|7213891|FG005|Treatment Period 3|Physician Decision|0
4430487|NCT00395304|7213886|FG000|Treatment Period 3|Other|0
4430488|NCT00395304|7213887|FG001|Treatment Period 3|Other|0
4430489|NCT00395304|7213888|FG002|Treatment Period 3|Other|0
4430490|NCT00395304|7213889|FG003|Treatment Period 3|Other|1
4430491|NCT00395304|7213890|FG004|Treatment Period 3|Other|0
4430492|NCT00395304|7213891|FG005|Treatment Period 3|Other|0
4430493|NCT00395343|7213900|FG000|Overall Study|Adverse Event|13
4430494|NCT00395343|7213901|FG001|Overall Study|Adverse Event|5
4430495|NCT00395343|7213900|FG000|Overall Study|Lack of Efficacy|0
4430496|NCT00395343|7213901|FG001|Overall Study|Lack of Efficacy|1
4430497|NCT00395343|7213900|FG000|Overall Study|Lost to Follow-up|4
4430498|NCT00395343|7213901|FG001|Overall Study|Lost to Follow-up|4
4430499|NCT00395343|7213900|FG000|Overall Study|Physician Decision|2
4430500|NCT00395343|7213901|FG001|Overall Study|Physician Decision|4
4430501|NCT00395343|7213900|FG000|Overall Study|Protocol Violation|6
4430502|NCT00395343|7213901|FG001|Overall Study|Protocol Violation|8
4430503|NCT00395343|7213900|FG000|Overall Study|Withdrawal by Subject|11
4430504|NCT00395343|7213901|FG001|Overall Study|Withdrawal by Subject|12
4715745|NCT02975349|7644307|FG000|Blinded Extension Period (24 Weeks)|Un-specified|0
4715746|NCT02975349|7644308|FG001|Blinded Extension Period (24 Weeks)|Un-specified|0
4715747|NCT02975349|7644309|FG002|Blinded Extension Period (24 Weeks)|Un-specified|0
4715748|NCT02975349|7644310|FG003|Blinded Extension Period (24 Weeks)|Un-specified|1
4715749|NCT02975349|7644311|FG004|Blinded Extension Period (24 Weeks)|Un-specified|0
4715750|NCT02975349|7644312|FG005|Blinded Extension Period (24 Weeks)|Un-specified|0
4715751|NCT02975973|7644357|FG000|Overall Study|Adverse Event|1
4715752|NCT02975973|7644358|FG001|Overall Study|Adverse Event|1
4715753|NCT02975973|7644359|FG002|Overall Study|Adverse Event|1
4715754|NCT02975973|7644360|FG003|Overall Study|Adverse Event|0
4715755|NCT02976103|7644372|FG000|Overall Study|Withdrawal by Subject|1
4715756|NCT02976103|7644373|FG001|Overall Study|Withdrawal by Subject|0
4715757|NCT02976103|7644372|FG000|Overall Study|Lost to Follow-up|12
4715758|NCT02976103|7644373|FG001|Overall Study|Lost to Follow-up|8
4715759|NCT02976519|7644392|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
4715760|NCT02976519|7644393|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1
4715761|NCT02976519|7644394|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
4715762|NCT02976519|7644395|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
4715763|NCT02976519|7644396|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
4715764|NCT02976519|7644397|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
4715765|NCT02976519|7644398|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
4715766|NCT02976519|7644392|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
4715767|NCT02976519|7644393|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
4715768|NCT02976519|7644394|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
4430505|NCT00395343|7213900|FG000|Overall Study|Other|5
4430506|NCT00395343|7213901|FG001|Overall Study|Other|2
4430507|NCT00395447|7213909|FG000|Overall Study|Death|37
4430508|NCT00395447|7213910|FG001|Overall Study|Death|32
4430509|NCT00395447|7213909|FG000|Overall Study|Lost to Follow-up|52
4430510|NCT00395447|7213910|FG001|Overall Study|Lost to Follow-up|43
4430511|NCT00395447|7213909|FG000|Overall Study|Withdrawal by Subject|24
4430512|NCT00395447|7213910|FG001|Overall Study|Withdrawal by Subject|19
4430513|NCT00395447|7213909|FG000|Overall Study|Withdrawl - Other (not subject)|8
4430514|NCT00395447|7213910|FG001|Overall Study|Withdrawl - Other (not subject)|17
4715769|NCT02976519|7644395|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1
4715770|NCT02976519|7644396|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
4715771|NCT02976519|7644397|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
4715772|NCT02976519|7644398|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
4715773|NCT02976519|7644392|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0
4715774|NCT02976519|7644393|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0
4715775|NCT02976519|7644394|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0
4715776|NCT02976519|7644395|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0
4715777|NCT02976519|7644396|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0
4715778|NCT02976519|7644397|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0
4715779|NCT02976519|7644398|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1
4715780|NCT02976519|7644392|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
4715781|NCT02976519|7644393|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
4715782|NCT02976519|7644394|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
4715783|NCT02976519|7644395|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
4715784|NCT02976519|7644396|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
4715785|NCT02976519|7644397|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
4715786|NCT02976519|7644398|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1
4715787|NCT02976519|7644392|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0
4430515|NCT00395460|7213918|FG000|Overall Study|Withdrawal by Subject|1
4430516|NCT00395460|7213919|FG001|Overall Study|Withdrawal by Subject|0
4430517|NCT00395486|7213927|FG000|Overall Study|Adverse Event|1
4430518|NCT00395486|7213928|FG001|Overall Study|Adverse Event|2
4430519|NCT00395486|7213927|FG000|Overall Study|Withdrawal by Subject|5
4430520|NCT00395486|7213928|FG001|Overall Study|Withdrawal by Subject|2
4430521|NCT00395486|7213927|FG000|Overall Study|Lost to Follow-up|0
4430522|NCT00395486|7213928|FG001|Overall Study|Lost to Follow-up|1
4430523|NCT00395512|7213938|FG000|Overall Study|Adverse Event|3
4430524|NCT00395512|7213939|FG001|Overall Study|Adverse Event|8
4430525|NCT00395512|7213940|FG002|Overall Study|Adverse Event|6
4430526|NCT00395512|7213941|FG003|Overall Study|Adverse Event|6
4430527|NCT00395512|7213938|FG000|Overall Study|Protocol Violation|2
4430528|NCT00395512|7213939|FG001|Overall Study|Protocol Violation|3
4430529|NCT00395512|7213940|FG002|Overall Study|Protocol Violation|6
4430530|NCT00395512|7213941|FG003|Overall Study|Protocol Violation|7
4430531|NCT00395512|7213938|FG000|Overall Study|Lost to Follow-up|2
4430532|NCT00395512|7213939|FG001|Overall Study|Lost to Follow-up|6
4430533|NCT00395512|7213940|FG002|Overall Study|Lost to Follow-up|5
4715788|NCT02976519|7644393|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0
4715789|NCT02976519|7644394|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0
4715790|NCT02976519|7644395|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0
4715791|NCT02976519|7644396|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0
4715792|NCT02976519|7644397|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0
4715793|NCT02976519|7644398|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1
4715794|NCT02977507|7644418|FG000|Overall Study|Protocol Deviation|1
4715795|NCT02977507|7644419|FG001|Overall Study|Protocol Deviation|0
4715796|NCT02977507|7644418|FG000|Overall Study|Lost to Follow-up|1
4715797|NCT02977507|7644419|FG001|Overall Study|Lost to Follow-up|0
4715798|NCT02977572|7644428|FG000|Overall Study|Exclusion criterion|2
4715799|NCT02977572|7644429|FG001|Overall Study|Exclusion criterion|2
4715800|NCT02978417|7644463|FG000|Overall Study|Lost to Follow-up|2
4715801|NCT02978417|7644464|FG001|Overall Study|Lost to Follow-up|2
4715802|NCT02979197|7644491|FG000|Overall Study|Adverse Event|4
4715803|NCT02979197|7644492|FG001|Overall Study|Adverse Event|2
4715804|NCT02979197|7644493|FG002|Overall Study|Adverse Event|0
4715805|NCT02979197|7644491|FG000|Overall Study|Protocol Violation|0
4715806|NCT02979197|7644492|FG001|Overall Study|Protocol Violation|1
4715807|NCT02979197|7644493|FG002|Overall Study|Protocol Violation|0
4715808|NCT02979197|7644491|FG000|Overall Study|Subject unable to commit to study dates|0
4715809|NCT02979197|7644492|FG001|Overall Study|Subject unable to commit to study dates|1
4715810|NCT02979197|7644493|FG002|Overall Study|Subject unable to commit to study dates|0
4715811|NCT02979249|7644501|FG000|Overall Study|Lost to Follow-up|2
4715812|NCT02979249|7644501|FG000|Overall Study|Withdrawal by Subject|4
4715813|NCT02979431|7644527|FG000|Overall Study|Parent/guardian withdrew consent|2
4715814|NCT02979431|7644528|FG001|Overall Study|Parent/guardian withdrew consent|1
4715815|NCT02979431|7644529|FG002|Overall Study|Parent/guardian withdrew consent|1
4715816|NCT02979431|7644530|FG003|Overall Study|Parent/guardian withdrew consent|1
4715817|NCT02979431|7644527|FG000|Overall Study|Randomized but received no study drug|1
4715818|NCT02979431|7644528|FG001|Overall Study|Randomized but received no study drug|1
4715819|NCT02979431|7644529|FG002|Overall Study|Randomized but received no study drug|0
4715820|NCT02979431|7644530|FG003|Overall Study|Randomized but received no study drug|0
4715821|NCT02979431|7644527|FG000|Overall Study|Adverse Event|0
4715822|NCT02979431|7644528|FG001|Overall Study|Adverse Event|0
4715823|NCT02979431|7644529|FG002|Overall Study|Adverse Event|1
4715824|NCT02979431|7644530|FG003|Overall Study|Adverse Event|0
4715825|NCT02979431|7644527|FG000|Overall Study|Subject left country after Day14|1
4715826|NCT02979431|7644528|FG001|Overall Study|Subject left country after Day14|0
4715827|NCT02979431|7644529|FG002|Overall Study|Subject left country after Day14|0
4715828|NCT02979431|7644530|FG003|Overall Study|Subject left country after Day14|0
4715829|NCT02979613|7644564|FG000|Double-Blind Phase|Withdrew Consent|2
4715830|NCT02979613|7644565|FG001|Double-Blind Phase|Withdrew Consent|4
4715831|NCT02979613|7644564|FG000|Double-Blind Phase|Pregnancy|2
4715832|NCT02979613|7644565|FG001|Double-Blind Phase|Pregnancy|2
4715833|NCT02979613|7644564|FG000|Double-Blind Phase|Adverse Event|2
4715834|NCT02979613|7644565|FG001|Double-Blind Phase|Adverse Event|0
4715835|NCT02979613|7644564|FG000|Double-Blind Phase|Lost to Follow-up|1
4715836|NCT02979613|7644565|FG001|Double-Blind Phase|Lost to Follow-up|1
4715837|NCT02979613|7644564|FG000|Double-Blind Phase|Protocol Violation|1
4715838|NCT02979613|7644565|FG001|Double-Blind Phase|Protocol Violation|1
4715839|NCT02979613|7644564|FG000|Double-Blind Phase|Randomized but Never Treated|2
4715840|NCT02979613|7644565|FG001|Double-Blind Phase|Randomized but Never Treated|0
4715841|NCT02979613|7644564|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2
4715842|NCT02979613|7644565|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4
4715843|NCT02979613|7644564|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1
4715844|NCT02979613|7644565|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0
4715845|NCT02979613|7644564|FG000|Open-Label Extension (OLE) Phase|Death|0
4715846|NCT02979613|7644565|FG001|Open-Label Extension (OLE) Phase|Death|1
4715847|NCT02979613|7644564|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0
4715848|NCT02979613|7644565|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1
4715849|NCT02979639|7644582|FG000|Overall Study|Withdrawal based on medical judgement|1
4715850|NCT02979639|7644582|FG000|Overall Study|Lost to Follow-up|8
4715851|NCT02979639|7644582|FG000|Overall Study|Withdrawal by Subject|3
4715852|NCT02979639|7644582|FG000|Overall Study|Adverse Event|2
4430534|NCT00395512|7213941|FG003|Overall Study|Lost to Follow-up|5
4430535|NCT00395512|7213938|FG000|Overall Study|Withdrawal by Subject|6
4430536|NCT00395512|7213939|FG001|Overall Study|Withdrawal by Subject|5
4430537|NCT00395512|7213940|FG002|Overall Study|Withdrawal by Subject|5
4430538|NCT00395512|7213941|FG003|Overall Study|Withdrawal by Subject|12
4430539|NCT00395512|7213938|FG000|Overall Study|Physician Decision|6
4630062|NCT03861052|7498627|FG000|Overall Study|Withdrawal by Subject|2
4715853|NCT02980042|7644606|FG000|Overall Study|Lost to Follow-up|5
4715854|NCT02980042|7644607|FG001|Overall Study|Lost to Follow-up|0
4715855|NCT02980042|7644606|FG000|Overall Study|Insurance issues/treatment plan changes|2
4715856|NCT02980042|7644607|FG001|Overall Study|Insurance issues/treatment plan changes|0
4715857|NCT02980107|7644627|FG000|Overall Study|Withdrawal by Subject|51
4715858|NCT02980107|7644628|FG001|Overall Study|Withdrawal by Subject|62
4715859|NCT02980133|7644638|FG000|Overall Study|Other than specified|1
4715860|NCT02980133|7644639|FG001|Overall Study|Other than specified|1
4715861|NCT02980133|7644640|FG002|Overall Study|Other than specified|2
4715862|NCT02980133|7644641|FG003|Overall Study|Other than specified|2
4715863|NCT02980133|7644638|FG000|Overall Study|Lost to Follow-up|0
4715864|NCT02980133|7644639|FG001|Overall Study|Lost to Follow-up|0
4715865|NCT02980133|7644640|FG002|Overall Study|Lost to Follow-up|1
4715866|NCT02980133|7644641|FG003|Overall Study|Lost to Follow-up|3
4715867|NCT02980133|7644638|FG000|Overall Study|Protocol Violation|0
4715868|NCT02980133|7644639|FG001|Overall Study|Protocol Violation|1
4715869|NCT02980133|7644640|FG002|Overall Study|Protocol Violation|0
4715870|NCT02980133|7644641|FG003|Overall Study|Protocol Violation|0
4715871|NCT02980133|7644638|FG000|Overall Study|Withdrawal by parent/guardian|6
4715872|NCT02980133|7644639|FG001|Overall Study|Withdrawal by parent/guardian|3
4715873|NCT02980133|7644640|FG002|Overall Study|Withdrawal by parent/guardian|3
4715874|NCT02980133|7644641|FG003|Overall Study|Withdrawal by parent/guardian|1
4715875|NCT02980133|7644638|FG000|Overall Study|Withdrawal by Subject|0
4715876|NCT02980133|7644639|FG001|Overall Study|Withdrawal by Subject|0
4715877|NCT02980133|7644640|FG002|Overall Study|Withdrawal by Subject|1
4715878|NCT02980133|7644641|FG003|Overall Study|Withdrawal by Subject|0
4715879|NCT02980224|7644660|FG000|Overall Study|Adverse Event|4
4715880|NCT02980224|7644661|FG001|Overall Study|Adverse Event|1
4715881|NCT02980224|7644660|FG000|Overall Study|Withdrawal by Subject|0
4715882|NCT02980224|7644661|FG001|Overall Study|Withdrawal by Subject|2
4715883|NCT02980523|7644672|FG000|Overall Study|Lost to Follow-up|1
4715884|NCT02980523|7644673|FG001|Overall Study|Lost to Follow-up|4
4715885|NCT02980523|7644674|FG002|Overall Study|Lost to Follow-up|1
4715886|NCT02980523|7644675|FG003|Overall Study|Lost to Follow-up|2
4715887|NCT02980523|7644676|FG004|Overall Study|Lost to Follow-up|1
4715888|NCT02980523|7644672|FG000|Overall Study|Excluded from analysis|1
4715889|NCT02980523|7644673|FG001|Overall Study|Excluded from analysis|3
4630063|NCT03861052|7498628|FG001|Overall Study|Withdrawal by Subject|5
4630064|NCT03861052|7498629|FG002|Overall Study|Withdrawal by Subject|3
4630065|NCT03861052|7498630|FG003|Overall Study|Withdrawal by Subject|0
4630066|NCT03861052|7498627|FG000|Overall Study|Relocation to other city|1
4630067|NCT03861052|7498628|FG001|Overall Study|Relocation to other city|0
4630068|NCT03861052|7498629|FG002|Overall Study|Relocation to other city|0
4630069|NCT03861052|7498630|FG003|Overall Study|Relocation to other city|0
4630070|NCT03846453|7498647|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465
4630071|NCT03846453|7498648|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0
4630072|NCT03846453|7498649|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0
4630073|NCT03846453|7498647|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3
4630074|NCT03846453|7498648|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0
4430540|NCT00395512|7213939|FG001|Overall Study|Physician Decision|4
4430541|NCT00395512|7213940|FG002|Overall Study|Physician Decision|2
4430542|NCT00395512|7213941|FG003|Overall Study|Physician Decision|2
4430543|NCT00395512|7213938|FG000|Overall Study|Other|1
4430544|NCT00395512|7213939|FG001|Overall Study|Other|1
4630075|NCT03846453|7498649|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0
4630076|NCT03846453|7498647|FG000|Placebo Run-in (14 Days)|Physician Decision|1
4715890|NCT02980523|7644674|FG002|Overall Study|Excluded from analysis|1
4715891|NCT02980523|7644675|FG003|Overall Study|Excluded from analysis|1
4715892|NCT02980523|7644676|FG004|Overall Study|Excluded from analysis|1
4715893|NCT02980523|7644672|FG000|Overall Study|Lack of Efficacy|1
4715894|NCT02980523|7644673|FG001|Overall Study|Lack of Efficacy|4
4715895|NCT02980523|7644674|FG002|Overall Study|Lack of Efficacy|4
4715896|NCT02980523|7644675|FG003|Overall Study|Lack of Efficacy|5
4715897|NCT02980523|7644676|FG004|Overall Study|Lack of Efficacy|8
4715898|NCT02980523|7644672|FG000|Overall Study|Did not receive intervention|0
4715899|NCT02980523|7644673|FG001|Overall Study|Did not receive intervention|0
4715900|NCT02980523|7644674|FG002|Overall Study|Did not receive intervention|0
4715901|NCT02980523|7644675|FG003|Overall Study|Did not receive intervention|1
4715902|NCT02980523|7644676|FG004|Overall Study|Did not receive intervention|0
4736195|NCT03560518|7685157|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9
4736196|NCT03560518|7685158|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10
4736197|NCT03560518|7685156|FG000|Double Blind Treatment Period|Protocol Violation|1
4736198|NCT03560518|7685157|FG001|Double Blind Treatment Period|Protocol Violation|2
4736199|NCT03560518|7685158|FG002|Double Blind Treatment Period|Protocol Violation|0
4736200|NCT03560518|7685156|FG000|Double Blind Treatment Period|Pregnancy|0
4430545|NCT00395512|7213940|FG002|Overall Study|Other|0
4430546|NCT00395512|7213941|FG003|Overall Study|Other|0
4430547|NCT00395512|7213938|FG000|Overall Study|Hyperglycemic Rescue|18
4430548|NCT00395512|7213939|FG001|Overall Study|Hyperglycemic Rescue|10
4430549|NCT00395512|7213940|FG002|Overall Study|Hyperglycemic Rescue|4
4430550|NCT00395512|7213941|FG003|Overall Study|Hyperglycemic Rescue|6
4430551|NCT00395538|7213954|FG000|Overall Study|Did not re-consent to revised protocol|1
4430552|NCT00395538|7213955|FG001|Overall Study|Did not re-consent to revised protocol|10
4430553|NCT00395538|7213956|FG002|Overall Study|Did not re-consent to revised protocol|0
4430554|NCT00395538|7213954|FG000|Overall Study|FDA partial hold on PTH|0
4430555|NCT00395538|7213955|FG001|Overall Study|FDA partial hold on PTH|0
4430556|NCT00395538|7213956|FG002|Overall Study|FDA partial hold on PTH|11
4430557|NCT00395538|7213954|FG000|Overall Study|Failed screening|0
4430558|NCT00395538|7213955|FG001|Overall Study|Failed screening|0
4430559|NCT00395538|7213956|FG002|Overall Study|Failed screening|4
4430560|NCT00395538|7213954|FG000|Overall Study|Switch to Natpara|0
4430561|NCT00395538|7213955|FG001|Overall Study|Switch to Natpara|0
4430562|NCT00395538|7213956|FG002|Overall Study|Switch to Natpara|3
4430563|NCT00395538|7213954|FG000|Overall Study|Adverse Event|1
4630077|NCT03846453|7498648|FG001|Placebo Run-in (14 Days)|Physician Decision|0
4715903|NCT02980601|7644693|FG000|Overall Study|Lost to Follow-up|2
4715904|NCT02980601|7644694|FG001|Overall Study|Lost to Follow-up|2
4715905|NCT02980601|7644693|FG000|Overall Study|Death|0
4715906|NCT02980601|7644694|FG001|Overall Study|Death|1
4715907|NCT02980601|7644693|FG000|Overall Study|Graft loss|1
4715908|NCT02980601|7644694|FG001|Overall Study|Graft loss|0
4715909|NCT02980601|7644693|FG000|Overall Study|Failed to sign consent|2
4715910|NCT02980601|7644694|FG001|Overall Study|Failed to sign consent|0
4715911|NCT02980692|7644705|FG000|Overall Study|Adverse Event|0
4715912|NCT02980692|7644706|FG001|Overall Study|Adverse Event|2
4715913|NCT02980692|7644707|FG002|Overall Study|Adverse Event|0
4715914|NCT02980692|7644708|FG003|Overall Study|Adverse Event|0
4715915|NCT02980692|7644709|FG004|Overall Study|Adverse Event|1
4715916|NCT02980692|7644705|FG000|Overall Study|Withdrawal by Subject|4
4715917|NCT02980692|7644706|FG001|Overall Study|Withdrawal by Subject|3
4715918|NCT02980692|7644707|FG002|Overall Study|Withdrawal by Subject|6
4715919|NCT02980692|7644708|FG003|Overall Study|Withdrawal by Subject|6
4715920|NCT02980692|7644709|FG004|Overall Study|Withdrawal by Subject|7
4715921|NCT02980692|7644705|FG000|Overall Study|Lost to Follow-up|3
4715922|NCT02980692|7644706|FG001|Overall Study|Lost to Follow-up|0
4715923|NCT02980692|7644707|FG002|Overall Study|Lost to Follow-up|4
4715924|NCT02980692|7644708|FG003|Overall Study|Lost to Follow-up|1
4715925|NCT02980692|7644709|FG004|Overall Study|Lost to Follow-up|1
4715926|NCT02980692|7644705|FG000|Overall Study|Death|1
4715927|NCT02980692|7644706|FG001|Overall Study|Death|0
4715928|NCT02980692|7644707|FG002|Overall Study|Death|0
4715929|NCT02980692|7644708|FG003|Overall Study|Death|0
4715930|NCT02980692|7644709|FG004|Overall Study|Death|0
4715931|NCT02980692|7644705|FG000|Overall Study|Physician Decision|0
4715932|NCT02980692|7644706|FG001|Overall Study|Physician Decision|0
4715933|NCT02980692|7644707|FG002|Overall Study|Physician Decision|1
4715934|NCT02980692|7644708|FG003|Overall Study|Physician Decision|1
4715935|NCT02980692|7644709|FG004|Overall Study|Physician Decision|0
4715936|NCT02980692|7644705|FG000|Overall Study|NON COMPLIANCE|1
4715937|NCT02980692|7644706|FG001|Overall Study|NON COMPLIANCE|0
4715938|NCT02980692|7644707|FG002|Overall Study|NON COMPLIANCE|0
4715939|NCT02980692|7644708|FG003|Overall Study|NON COMPLIANCE|0
4715940|NCT02980692|7644709|FG004|Overall Study|NON COMPLIANCE|0
4715941|NCT02980692|7644705|FG000|Overall Study|DOES NOT WANT TO RETURN FOR FOLLOW UP VISITS|0
4715942|NCT02980692|7644706|FG001|Overall Study|DOES NOT WANT TO RETURN FOR FOLLOW UP VISITS|1
4715943|NCT02980692|7644707|FG002|Overall Study|DOES NOT WANT TO RETURN FOR FOLLOW UP VISITS|0
4715944|NCT02980692|7644708|FG003|Overall Study|DOES NOT WANT TO RETURN FOR FOLLOW UP VISITS|0
4715945|NCT02980692|7644709|FG004|Overall Study|DOES NOT WANT TO RETURN FOR FOLLOW UP VISITS|0
4715946|NCT02980692|7644705|FG000|Overall Study|LACK OF EFFICACY OF THE STUDY TREATMENT|0
4715947|NCT02980692|7644706|FG001|Overall Study|LACK OF EFFICACY OF THE STUDY TREATMENT|0
4715948|NCT02980692|7644707|FG002|Overall Study|LACK OF EFFICACY OF THE STUDY TREATMENT|1
4715949|NCT02980692|7644708|FG003|Overall Study|LACK OF EFFICACY OF THE STUDY TREATMENT|0
4715950|NCT02980692|7644709|FG004|Overall Study|LACK OF EFFICACY OF THE STUDY TREATMENT|0
4715951|NCT02980692|7644705|FG000|Overall Study|Lack of Efficacy|0
4715952|NCT02980692|7644706|FG001|Overall Study|Lack of Efficacy|0
4715953|NCT02980692|7644707|FG002|Overall Study|Lack of Efficacy|0
4715954|NCT02980692|7644708|FG003|Overall Study|Lack of Efficacy|1
4715955|NCT02980692|7644709|FG004|Overall Study|Lack of Efficacy|0
4715956|NCT02980692|7644705|FG000|Overall Study|RELOCATION|0
4715957|NCT02980692|7644706|FG001|Overall Study|RELOCATION|0
4715958|NCT02980692|7644707|FG002|Overall Study|RELOCATION|0
4715959|NCT02980692|7644708|FG003|Overall Study|RELOCATION|0
4715960|NCT02980692|7644709|FG004|Overall Study|RELOCATION|1
4715961|NCT02980692|7644705|FG000|Overall Study|SUBJECT ENROLLED IN STUDY WITH POSITIVE QUANT & DISCHARGED FROM STUDY BY SPONSOR|0
4430564|NCT00395538|7213955|FG001|Overall Study|Adverse Event|0
4430565|NCT00395538|7213956|FG002|Overall Study|Adverse Event|2
4430566|NCT00395538|7213954|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0
4430567|NCT00395538|7213955|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2
4512538|NCT00934856|7322351|FG003|Extension Part|Adverse Event|1
4430568|NCT00395538|7213956|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0
4430569|NCT00395538|7213954|FG000|Overall Study|Non-compliance with study protocol|0
4430570|NCT00395538|7213955|FG001|Overall Study|Non-compliance with study protocol|1
4430571|NCT00395538|7213956|FG002|Overall Study|Non-compliance with study protocol|0
4430572|NCT00395538|7213954|FG000|Overall Study|PTH resistance|0
4430573|NCT00395538|7213955|FG001|Overall Study|PTH resistance|0
4430574|NCT00395538|7213956|FG002|Overall Study|PTH resistance|1
4430575|NCT00395538|7213954|FG000|Overall Study|Pregnancy|1
4430576|NCT00395538|7213955|FG001|Overall Study|Pregnancy|0
4430577|NCT00395538|7213956|FG002|Overall Study|Pregnancy|0
4430578|NCT00395538|7213954|FG000|Overall Study|Partial recovery of parathyroid function|0
4430579|NCT00395538|7213955|FG001|Overall Study|Partial recovery of parathyroid function|0
4430580|NCT00395538|7213956|FG002|Overall Study|Partial recovery of parathyroid function|1
4430581|NCT00395538|7213954|FG000|Overall Study|Participant elected to discontinue|0
4430582|NCT00395538|7213955|FG001|Overall Study|Participant elected to discontinue|0
4430583|NCT00395538|7213956|FG002|Overall Study|Participant elected to discontinue|1
4430584|NCT00395629|7213967|FG000|Core Study|Adverse Event|0
4430585|NCT00395629|7213968|FG001|Core Study|Adverse Event|3
4430586|NCT00395629|7213969|FG002|Core Study|Adverse Event|4
4430587|NCT00395629|7213967|FG000|Core Study|Abnormal laboratory value(s)|0
4430588|NCT00395629|7213968|FG001|Core Study|Abnormal laboratory value(s)|0
4430589|NCT00395629|7213969|FG002|Core Study|Abnormal laboratory value(s)|1
4430590|NCT00395629|7213967|FG000|Core Study|Protocol Violation|1
4430591|NCT00395629|7213968|FG001|Core Study|Protocol Violation|0
4430592|NCT00395629|7213969|FG002|Core Study|Protocol Violation|0
4430593|NCT00395629|7213967|FG000|Core Study|Withdrawal by Subject|0
4430594|NCT00395629|7213968|FG001|Core Study|Withdrawal by Subject|1
4430595|NCT00395629|7213969|FG002|Core Study|Withdrawal by Subject|1
4430596|NCT00395629|7213967|FG000|Core Study|Lost to Follow-up|0
4430597|NCT00395629|7213968|FG001|Core Study|Lost to Follow-up|0
4430598|NCT00395629|7213969|FG002|Core Study|Lost to Follow-up|1
4430599|NCT00395629|7213967|FG000|Extension Study|Adverse Event|0
4430600|NCT00395629|7213968|FG001|Extension Study|Adverse Event|0
4430601|NCT00395629|7213969|FG002|Extension Study|Adverse Event|2
4430602|NCT00395629|7213967|FG000|Extension Study|Administrative problems|0
4430603|NCT00395629|7213968|FG001|Extension Study|Administrative problems|0
4430604|NCT00395629|7213969|FG002|Extension Study|Administrative problems|1
4430605|NCT00395642|7213980|FG000|Overall Study|Death|4
4430606|NCT00395642|7213980|FG000|Overall Study|Lost to Follow-up|1
4430607|NCT00395642|7213980|FG000|Overall Study|Physician Decision|7
4430608|NCT00395642|7213980|FG000|Overall Study|Withdrawal by Subject|1
4430609|NCT00395694|7213986|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1
4430610|NCT00395694|7213987|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2
4430611|NCT00395694|7213986|FG000|Continuation Phase|Adverse Event|1
4430612|NCT00395694|7213987|FG001|Continuation Phase|Adverse Event|0
4430613|NCT00395694|7213986|FG000|Continuation Phase|Lack of Efficacy|12
4430614|NCT00395694|7213987|FG001|Continuation Phase|Lack of Efficacy|11
4430615|NCT00395694|7213986|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1
4430616|NCT00395694|7213987|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0
4430617|NCT00395694|7213986|FG000|Continuation Phase|Poor Compliance|1
4430618|NCT00395694|7213987|FG001|Continuation Phase|Poor Compliance|0
4430619|NCT00395694|7213986|FG000|Continuation Phase|Withdrawal by Subject|0
4430620|NCT00395694|7213987|FG001|Continuation Phase|Withdrawal by Subject|2
4430621|NCT00395733|7213998|FG000|Period 2|Withdrawal by Subject|1
4430622|NCT00395733|7213999|FG001|Period 2|Withdrawal by Subject|2
4430623|NCT00395733|7213998|FG000|Period 2|Protocol Violation|0
4430624|NCT00395733|7213999|FG001|Period 2|Protocol Violation|1
4715962|NCT02980692|7644706|FG001|Overall Study|SUBJECT ENROLLED IN STUDY WITH POSITIVE QUANT & DISCHARGED FROM STUDY BY SPONSOR|0
4715963|NCT02980692|7644707|FG002|Overall Study|SUBJECT ENROLLED IN STUDY WITH POSITIVE QUANT & DISCHARGED FROM STUDY BY SPONSOR|0
4715964|NCT02980692|7644708|FG003|Overall Study|SUBJECT ENROLLED IN STUDY WITH POSITIVE QUANT & DISCHARGED FROM STUDY BY SPONSOR|0
4715965|NCT02980692|7644709|FG004|Overall Study|SUBJECT ENROLLED IN STUDY WITH POSITIVE QUANT & DISCHARGED FROM STUDY BY SPONSOR|1
4715966|NCT02980705|7644724|FG000|Overall Study|Adverse Event|0
4715967|NCT02980705|7644725|FG001|Overall Study|Adverse Event|1
4715968|NCT02980705|7644724|FG000|Overall Study|Withdrawal by Subject|6
4715969|NCT02980705|7644725|FG001|Overall Study|Withdrawal by Subject|9
4715970|NCT02980705|7644724|FG000|Overall Study|withdrew participation|0
4715971|NCT02980705|7644725|FG001|Overall Study|withdrew participation|1
4715972|NCT02980705|7644724|FG000|Overall Study|Lost to Follow-up|2
4715973|NCT02980705|7644725|FG001|Overall Study|Lost to Follow-up|0
4715974|NCT02980783|7644732|FG000|Overall Study|Lost to Follow-up|1
4430625|NCT00395733|7213998|FG000|Period 2|Adverse Event|0
4430626|NCT00395733|7213999|FG001|Period 2|Adverse Event|2
4430627|NCT00395733|7213998|FG000|Period 2|Technical problems|1
4430628|NCT00395733|7213999|FG001|Period 2|Technical problems|0
4430629|NCT00395746|7214008|FG000|Overall Study|Adverse Event|5
4430630|NCT00395746|7214009|FG001|Overall Study|Adverse Event|2
4430631|NCT00395746|7214010|FG002|Overall Study|Adverse Event|2
4430632|NCT00395746|7214008|FG000|Overall Study|Protocol Violation|0
4430633|NCT00395746|7214009|FG001|Overall Study|Protocol Violation|1
4430634|NCT00395746|7214010|FG002|Overall Study|Protocol Violation|0
4430635|NCT00395746|7214008|FG000|Overall Study|Lack of Efficacy|2
4430636|NCT00395746|7214009|FG001|Overall Study|Lack of Efficacy|0
4430637|NCT00395746|7214010|FG002|Overall Study|Lack of Efficacy|17
4715975|NCT02980874|7644738|FG000|Overall Study|Adverse Event|2
4715976|NCT02980874|7644739|FG001|Overall Study|Adverse Event|7
4715977|NCT02980874|7644738|FG000|Overall Study|Withdrawal by Subject|7
4715978|NCT02980874|7644739|FG001|Overall Study|Withdrawal by Subject|2
4715979|NCT02980874|7644738|FG000|Overall Study|Lost to Follow-up|5
4715980|NCT02980874|7644739|FG001|Overall Study|Lost to Follow-up|5
4715981|NCT02980874|7644738|FG000|Overall Study|Includes premature discontinuation due to study termination.|88
4715982|NCT02980874|7644739|FG001|Overall Study|Includes premature discontinuation due to study termination.|88
4715983|NCT02980874|7644738|FG000|Overall Study|Unknown study completion status|1
4715984|NCT02980874|7644739|FG001|Overall Study|Unknown study completion status|0
4715985|NCT02981342|7644758|FG000|Overall Study|Adverse Event|0
4715986|NCT02981342|7644759|FG001|Overall Study|Adverse Event|0
4715987|NCT02981342|7644760|FG002|Overall Study|Adverse Event|0
4715988|NCT02981342|7644761|FG003|Overall Study|Adverse Event|1
4715989|NCT02981342|7644758|FG000|Overall Study|Death|0
4715990|NCT02981342|7644759|FG001|Overall Study|Death|9
4715991|NCT02981342|7644760|FG002|Overall Study|Death|9
4715992|NCT02981342|7644761|FG003|Overall Study|Death|4
4715993|NCT02981342|7644758|FG000|Overall Study|Withdrawal by Subject|0
4715994|NCT02981342|7644759|FG001|Overall Study|Withdrawal by Subject|0
4715995|NCT02981342|7644760|FG002|Overall Study|Withdrawal by Subject|3
4715996|NCT02981342|7644761|FG003|Overall Study|Withdrawal by Subject|1
4715997|NCT02981342|7644758|FG000|Overall Study|Study closed by sponsor|0
4715998|NCT02981342|7644759|FG001|Overall Study|Study closed by sponsor|0
4715999|NCT02981342|7644760|FG002|Overall Study|Study closed by sponsor|1
4716000|NCT02981342|7644761|FG003|Overall Study|Study closed by sponsor|1
4716001|NCT02981342|7644758|FG000|Overall Study|Randomized, Never Treated|0
4716002|NCT02981342|7644759|FG001|Overall Study|Randomized, Never Treated|1
4716003|NCT02981342|7644760|FG002|Overall Study|Randomized, Never Treated|0
4716004|NCT02981342|7644761|FG003|Overall Study|Randomized, Never Treated|7
4716005|NCT02981342|7644758|FG000|Overall Study|Lost to Follow-up|0
4716006|NCT02981342|7644759|FG001|Overall Study|Lost to Follow-up|1
4716007|NCT02981342|7644760|FG002|Overall Study|Lost to Follow-up|0
4716008|NCT02981342|7644761|FG003|Overall Study|Lost to Follow-up|0
4716009|NCT02981524|7644809|FG000|Overall Study|Progressive Disease|14
4716010|NCT02981524|7644809|FG000|Overall Study|Death (unrelated)|1
4716011|NCT02981524|7644809|FG000|Overall Study|Treatment Related Toxicity|1
4716012|NCT02981524|7644809|FG000|Overall Study|Withdrawal by Subject|1
4716013|NCT02981602|7644818|FG000|Overall Study|Adverse Event|0
4716014|NCT02981602|7644819|FG001|Overall Study|Adverse Event|0
4716015|NCT02981602|7644820|FG002|Overall Study|Adverse Event|0
4716016|NCT02981602|7644821|FG003|Overall Study|Adverse Event|1
4716017|NCT02981602|7644822|FG004|Overall Study|Adverse Event|0
4716018|NCT02981953|7644835|FG000|Overall Study|Death|9
4716019|NCT02981953|7644835|FG000|Overall Study|Withdrawal by Subject|1
4716020|NCT02981953|7644835|FG000|Overall Study|Withdrawal to non-compliance|1
4716021|NCT02982018|7644841|FG000|Overall Study|Incorrect Lens Dispensed|1
4716022|NCT02982018|7644842|FG001|Overall Study|Incorrect Lens Dispensed|0
4716023|NCT02982018|7644841|FG000|Overall Study|Protocol Violation|1
4716024|NCT02982018|7644842|FG001|Overall Study|Protocol Violation|1
4716025|NCT02982018|7644841|FG000|Overall Study|Adverse Event|1
4716026|NCT02982018|7644842|FG001|Overall Study|Adverse Event|1
4716027|NCT02982018|7644841|FG000|Overall Study|Lens Discomfort|2
4716028|NCT02982018|7644842|FG001|Overall Study|Lens Discomfort|0
4716029|NCT02982018|7644841|FG000|Overall Study|Withdrawal by Subject|0
4716030|NCT02982018|7644842|FG001|Overall Study|Withdrawal by Subject|1
4716031|NCT02982187|7644850|FG000|Overall Study|Withdrawal by Subject|0
4716032|NCT02982187|7644851|FG001|Overall Study|Withdrawal by Subject|0
4716033|NCT02982187|7644852|FG002|Overall Study|Withdrawal by Subject|0
4716034|NCT02982187|7644853|FG003|Overall Study|Withdrawal by Subject|0
4716035|NCT02982187|7644854|FG004|Overall Study|Withdrawal by Subject|0
4716036|NCT02982187|7644855|FG005|Overall Study|Withdrawal by Subject|0
4716037|NCT02982187|7644856|FG006|Overall Study|Withdrawal by Subject|1
4716038|NCT02982187|7644857|FG007|Overall Study|Withdrawal by Subject|0
4716039|NCT02982213|7644869|FG000|Overall Study|Did not complete follow up questionnaire|5
4716040|NCT02982213|7644870|FG001|Overall Study|Did not complete follow up questionnaire|1
4716041|NCT02982239|7644878|FG000|Overall Study|Lost to Follow-up|3
4716042|NCT02982239|7644879|FG001|Overall Study|Lost to Follow-up|2
4716043|NCT02982590|7644888|FG000|Overall Study|Lost to Follow-up|0
4716044|NCT02982590|7644889|FG001|Overall Study|Lost to Follow-up|1
4716045|NCT02982590|7644888|FG000|Overall Study|Death|4
4716046|NCT02982590|7644889|FG001|Overall Study|Death|0
4716047|NCT02982772|7644897|FG000|Intervention|Lost to Follow-up|19
4716048|NCT02982772|7644898|FG001|Intervention|Lost to Follow-up|13
4716049|NCT02982772|7644897|FG000|1M Follow-Up|Lost to Follow-up|21
4716050|NCT02982772|7644898|FG001|1M Follow-Up|Lost to Follow-up|18
4716051|NCT02982772|7644897|FG000|3M Follow-Up|Lost to Follow-up|17
4716052|NCT02982772|7644898|FG001|3M Follow-Up|Lost to Follow-up|11
4716053|NCT02982772|7644897|FG000|6M Follow-Up|Lost to Follow-up|11
4716054|NCT02982772|7644898|FG001|6M Follow-Up|Lost to Follow-up|9
4716055|NCT02982772|7644897|FG000|12M Follow-Up|Lost to Follow-up|11
4716056|NCT02982772|7644898|FG001|12M Follow-Up|Lost to Follow-up|5
4430638|NCT00395746|7214008|FG000|Overall Study|Hypoglycaemia|2
4430639|NCT00395746|7214009|FG001|Overall Study|Hypoglycaemia|1
4430640|NCT00395746|7214010|FG002|Overall Study|Hypoglycaemia|0
4430641|NCT00395746|7214008|FG000|Overall Study|Subject decision|0
4430642|NCT00395746|7214009|FG001|Overall Study|Subject decision|0
4430643|NCT00395746|7214010|FG002|Overall Study|Subject decision|1
4716057|NCT02982863|7644911|FG000|Overall Study|Not eligible patients|809
4716058|NCT02982863|7644912|FG001|Overall Study|Not eligible patients|4261
4716059|NCT02982863|7644913|FG002|Overall Study|Not eligible patients|1852
4716060|NCT02982863|7644914|FG003|Overall Study|Not eligible patients|1400
4716061|NCT02982863|7644915|FG004|Overall Study|Not eligible patients|492
4716062|NCT02982954|7644939|FG000|Treatment Period|Disease progression|62
4716063|NCT02982954|7644940|FG001|Treatment Period|Disease progression|26
4716064|NCT02982954|7644941|FG002|Treatment Period|Disease progression|12
4716065|NCT02982954|7644942|FG003|Treatment Period|Disease progression|10
4716066|NCT02982954|7644939|FG000|Treatment Period|study drug toxicity|20
4716067|NCT02982954|7644940|FG001|Treatment Period|study drug toxicity|10
4716068|NCT02982954|7644941|FG002|Treatment Period|study drug toxicity|8
4716069|NCT02982954|7644942|FG003|Treatment Period|study drug toxicity|0
4716070|NCT02982954|7644939|FG000|Treatment Period|Death|1
4716071|NCT02982954|7644940|FG001|Treatment Period|Death|3
4716072|NCT02982954|7644941|FG002|Treatment Period|Death|2
4716073|NCT02982954|7644942|FG003|Treatment Period|Death|4
4716074|NCT02982954|7644939|FG000|Treatment Period|Adverse events unrelated to study drug|4
4716075|NCT02982954|7644940|FG001|Treatment Period|Adverse events unrelated to study drug|1
4716076|NCT02982954|7644941|FG002|Treatment Period|Adverse events unrelated to study drug|1
4716077|NCT02982954|7644942|FG003|Treatment Period|Adverse events unrelated to study drug|3
4716078|NCT02982954|7644939|FG000|Treatment Period|participant request to discontinue|2
4716079|NCT02982954|7644940|FG001|Treatment Period|participant request to discontinue|2
4716080|NCT02982954|7644941|FG002|Treatment Period|participant request to discontinue|1
4716081|NCT02982954|7644942|FG003|Treatment Period|participant request to discontinue|2
4716082|NCT02982954|7644939|FG000|Treatment Period|participant withdrew consent|1
4716083|NCT02982954|7644940|FG001|Treatment Period|participant withdrew consent|1
4716084|NCT02982954|7644941|FG002|Treatment Period|participant withdrew consent|0
4716085|NCT02982954|7644942|FG003|Treatment Period|participant withdrew consent|1
4716086|NCT02982954|7644939|FG000|Treatment Period|maximum clinical benefit|1
4716087|NCT02982954|7644940|FG001|Treatment Period|maximum clinical benefit|0
4716088|NCT02982954|7644941|FG002|Treatment Period|maximum clinical benefit|0
4716089|NCT02982954|7644942|FG003|Treatment Period|maximum clinical benefit|0
4716090|NCT02982954|7644939|FG000|Treatment Period|no longer meets study criteria|0
4716091|NCT02982954|7644940|FG001|Treatment Period|no longer meets study criteria|1
4716092|NCT02982954|7644941|FG002|Treatment Period|no longer meets study criteria|0
4716093|NCT02982954|7644942|FG003|Treatment Period|no longer meets study criteria|0
4716094|NCT02982954|7644939|FG000|Treatment Period|Admin reason by sponsor|3
4716095|NCT02982954|7644940|FG001|Treatment Period|Admin reason by sponsor|0
4716096|NCT02982954|7644941|FG002|Treatment Period|Admin reason by sponsor|0
4716097|NCT02982954|7644942|FG003|Treatment Period|Admin reason by sponsor|0
4716098|NCT02982954|7644939|FG000|Treatment Period|other reasons|12
4716099|NCT02982954|7644940|FG001|Treatment Period|other reasons|8
4716100|NCT02982954|7644941|FG002|Treatment Period|other reasons|4
4716101|NCT02982954|7644942|FG003|Treatment Period|other reasons|5
4716102|NCT02982954|7644939|FG000|Continuing in Study|Death|44
4716103|NCT02982954|7644940|FG001|Continuing in Study|Death|27
4716104|NCT02982954|7644941|FG002|Continuing in Study|Death|10
4716105|NCT02982954|7644942|FG003|Continuing in Study|Death|17
4716106|NCT02982954|7644939|FG000|Continuing in Study|participant withdrew consent|9
4716107|NCT02982954|7644940|FG001|Continuing in Study|participant withdrew consent|5
4716108|NCT02982954|7644941|FG002|Continuing in Study|participant withdrew consent|1
4716109|NCT02982954|7644942|FG003|Continuing in Study|participant withdrew consent|1
4716110|NCT02982954|7644939|FG000|Continuing in Study|Lost to Follow-up|1
4716111|NCT02982954|7644940|FG001|Continuing in Study|Lost to Follow-up|0
4716112|NCT02982954|7644941|FG002|Continuing in Study|Lost to Follow-up|0
4716113|NCT02982954|7644942|FG003|Continuing in Study|Lost to Follow-up|0
4716114|NCT02982954|7644939|FG000|Continuing in Study|other reasons|0
4716115|NCT02982954|7644940|FG001|Continuing in Study|other reasons|1
4716116|NCT02982954|7644941|FG002|Continuing in Study|other reasons|0
4716117|NCT02982954|7644942|FG003|Continuing in Study|other reasons|0
4716118|NCT02983227|7644963|FG000|Overall Study|Adverse Event|21
4716119|NCT02983227|7644964|FG001|Overall Study|Adverse Event|3
4716120|NCT02983227|7644963|FG000|Overall Study|Death|3
4716121|NCT02983227|7644964|FG001|Overall Study|Death|0
4716122|NCT02983227|7644963|FG000|Overall Study|Lack of Efficacy|8
4430644|NCT00395746|7214008|FG000|Overall Study|Withdrawal of consent|0
4430645|NCT00395746|7214009|FG001|Overall Study|Withdrawal of consent|0
4716123|NCT02983227|7644964|FG001|Overall Study|Lack of Efficacy|1
4716124|NCT02983227|7644963|FG000|Overall Study|Lost to Follow-up|3
4716125|NCT02983227|7644964|FG001|Overall Study|Lost to Follow-up|0
4716126|NCT02983227|7644963|FG000|Overall Study|Multiple Reasons|2
4716127|NCT02983227|7644964|FG001|Overall Study|Multiple Reasons|1
4716128|NCT02983227|7644963|FG000|Overall Study|Physician Decision|3
4716129|NCT02983227|7644964|FG001|Overall Study|Physician Decision|1
4716130|NCT02983227|7644963|FG000|Overall Study|Withdrawal by Subject|19
4430646|NCT00395746|7214010|FG002|Overall Study|Withdrawal of consent|1
4430647|NCT00395746|7214008|FG000|Overall Study|Difficultulty in use of device|0
4430648|NCT00395746|7214009|FG001|Overall Study|Difficultulty in use of device|0
4430649|NCT00395746|7214010|FG002|Overall Study|Difficultulty in use of device|1
4430650|NCT00395746|7214008|FG000|Overall Study|Unable to visit site on schedule|1
4430651|NCT00395746|7214009|FG001|Overall Study|Unable to visit site on schedule|0
4430652|NCT00395746|7214010|FG002|Overall Study|Unable to visit site on schedule|0
4430653|NCT00395850|7214022|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6
4430654|NCT00395850|7214023|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
4430655|NCT00395850|7214024|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
4716131|NCT02983227|7644964|FG001|Overall Study|Withdrawal by Subject|8
4716132|NCT02983305|7644972|FG000|Overall Study|incomplete data|2
4716133|NCT02983305|7644973|FG001|Overall Study|incomplete data|0
4716134|NCT02983604|7645013|FG000|Overall Study|Enrolled but not Treated|0
4716135|NCT02983604|7645014|FG001|Overall Study|Enrolled but not Treated|0
4716136|NCT02983604|7645015|FG002|Overall Study|Enrolled but not Treated|1
4716137|NCT02983604|7645016|FG003|Overall Study|Enrolled but not Treated|0
4716138|NCT02984267|7645041|FG000|Overall Study|Protocol Violation|1
4716139|NCT02984267|7645042|FG001|Overall Study|Protocol Violation|0
4716140|NCT02984267|7645041|FG000|Overall Study|Withdrawal by Subject|0
4716141|NCT02984267|7645042|FG001|Overall Study|Withdrawal by Subject|1
4716142|NCT02984683|7645080|FG000|Overall Study|Adverse Event|3
4716143|NCT02984683|7645081|FG001|Overall Study|Adverse Event|3
4716144|NCT02984683|7645080|FG000|Overall Study|Withdrawal by Subject|1
4716145|NCT02984683|7645081|FG001|Overall Study|Withdrawal by Subject|0
4716146|NCT02984683|7645080|FG000|Overall Study|Disease progression|7
4716147|NCT02984683|7645081|FG001|Overall Study|Disease progression|9
4716148|NCT02984943|7645110|FG000|Overall Study|Withdrawal by Subject|3
4716149|NCT02984943|7645110|FG000|Overall Study|Physician Decision|1
4716150|NCT02984982|7645116|FG000|Overall Study|Adverse Event|2
4716151|NCT02984982|7645117|FG001|Overall Study|Adverse Event|5
4716152|NCT02984982|7645116|FG000|Overall Study|Poor Compliance to Protocol|4
4716153|NCT02984982|7645117|FG001|Overall Study|Poor Compliance to Protocol|4
4716154|NCT02984982|7645116|FG000|Overall Study|Withdrawal by Subject|2
4716155|NCT02984982|7645117|FG001|Overall Study|Withdrawal by Subject|0
4716156|NCT02984982|7645116|FG000|Overall Study|Randomized but not treated|0
4716157|NCT02984982|7645117|FG001|Overall Study|Randomized but not treated|1
4716158|NCT02984995|7645126|FG000|Overall Study|Required stem cell transplant|13
4716159|NCT02984995|7645127|FG001|Overall Study|Required stem cell transplant|2
4716160|NCT02984995|7645126|FG000|Overall Study|Progressive disease|11
4716161|NCT02984995|7645127|FG001|Overall Study|Progressive disease|1
4716162|NCT02984995|7645126|FG000|Overall Study|Adverse Event|1
4716163|NCT02984995|7645127|FG001|Overall Study|Adverse Event|0
4716164|NCT02985021|7645139|FG000|Overall Study|Inability to comply with study procedures|1
4716165|NCT02985398|7645143|FG000|Overall Study|Adverse Event|1
4716166|NCT02985398|7645143|FG000|Overall Study|Lost to Follow-up|4
4716167|NCT02985398|7645143|FG000|Overall Study|Withdrawal by Subject|8
4716168|NCT02985398|7645143|FG000|Overall Study|Study Burden|9
4716169|NCT02985450|7645147|FG000|Overall Study|Lost to Follow-up|7
4716170|NCT02985879|7645175|FG000|Overall Study|Adverse Event|7
4716171|NCT02985879|7645176|FG001|Overall Study|Adverse Event|9
4716172|NCT02985879|7645177|FG002|Overall Study|Adverse Event|7
4716173|NCT02985879|7645175|FG000|Overall Study|Withdrew consent|6
4716174|NCT02985879|7645176|FG001|Overall Study|Withdrew consent|8
4716175|NCT02985879|7645177|FG002|Overall Study|Withdrew consent|10
4716176|NCT02985879|7645175|FG000|Overall Study|Lost to Follow-up|1
4716177|NCT02985879|7645176|FG001|Overall Study|Lost to Follow-up|0
4716178|NCT02985879|7645177|FG002|Overall Study|Lost to Follow-up|2
4716179|NCT02985879|7645175|FG000|Overall Study|Other, not specified|62
4716180|NCT02985879|7645176|FG001|Overall Study|Other, not specified|58
4716181|NCT02985879|7645177|FG002|Overall Study|Other, not specified|58
4716182|NCT02985996|7645196|FG000|Overall Study|Withdrawal by Subject|0
4716183|NCT02985996|7645197|FG001|Overall Study|Withdrawal by Subject|0
4716184|NCT02985996|7645198|FG002|Overall Study|Withdrawal by Subject|1
4716185|NCT02985996|7645199|FG003|Overall Study|Withdrawal by Subject|0
4716186|NCT02985996|7645200|FG004|Overall Study|Withdrawal by Subject|0
4716187|NCT02985996|7645196|FG000|Overall Study|Protocol Violation|0
4716188|NCT02985996|7645197|FG001|Overall Study|Protocol Violation|1
4716189|NCT02985996|7645198|FG002|Overall Study|Protocol Violation|0
4430656|NCT00395850|7214025|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
4430657|NCT00395850|7214022|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4
4716190|NCT02985996|7645199|FG003|Overall Study|Protocol Violation|0
4716191|NCT02985996|7645200|FG004|Overall Study|Protocol Violation|0
4716192|NCT02986074|7645216|FG000|First Trial Period|Adverse Event|1
4716193|NCT02986074|7645217|FG001|First Trial Period|Adverse Event|0
4716194|NCT02986074|7645218|FG002|First Trial Period|Adverse Event|0
4716195|NCT02986074|7645219|FG003|First Trial Period|Adverse Event|0
4716196|NCT02986074|7645216|FG000|Follow up Period|system explant|0
4716197|NCT02986074|7645217|FG001|Follow up Period|system explant|0
4716198|NCT02986074|7645218|FG002|Follow up Period|system explant|1
4716199|NCT02986074|7645219|FG003|Follow up Period|system explant|2
4716200|NCT02986074|7645216|FG000|Follow up Period|Physician Decision|0
4430658|NCT00395850|7214023|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
4430659|NCT00395850|7214024|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
4430660|NCT00395850|7214025|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
4430661|NCT00395850|7214022|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1
4430662|NCT00395850|7214023|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0
4430663|NCT00395850|7214024|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0
4430664|NCT00395850|7214025|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0
4430665|NCT00395850|7214022|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2
4430666|NCT00395850|7214023|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2
4716201|NCT02986074|7645217|FG001|Follow up Period|Physician Decision|0
4716202|NCT02986074|7645218|FG002|Follow up Period|Physician Decision|0
4716203|NCT02986074|7645219|FG003|Follow up Period|Physician Decision|1
4716204|NCT02986139|7645226|FG000|Overall Study|Sponsor Decision|1
4716205|NCT02986139|7645227|FG001|Overall Study|Sponsor Decision|2
4716206|NCT02986139|7645226|FG000|Overall Study|Withdrawal by Subject|0
4716207|NCT02986139|7645227|FG001|Overall Study|Withdrawal by Subject|1
4716208|NCT02986139|7645226|FG000|Overall Study|Lost to Follow-up|0
4716209|NCT02986139|7645227|FG001|Overall Study|Lost to Follow-up|1
4716210|NCT02986373|7645241|FG000|Overall Study|Adverse Event|4
4716211|NCT02986373|7645241|FG000|Overall Study|Lost to Follow-up|1
4716212|NCT02986373|7645241|FG000|Overall Study|Withdrawal by Subject|10
4716213|NCT02986373|7645241|FG000|Overall Study|Other|24
4716214|NCT02986854|7645274|FG000|Overall Study|Withdrawal by Subject|0
4716215|NCT02986854|7645275|FG001|Overall Study|Withdrawal by Subject|1
4716216|NCT02986854|7645276|FG002|Overall Study|Withdrawal by Subject|1
4716217|NCT02986854|7645274|FG000|Overall Study|Lost to Follow-up|3
4716218|NCT02986854|7645275|FG001|Overall Study|Lost to Follow-up|11
4716219|NCT02986854|7645276|FG002|Overall Study|Lost to Follow-up|2
4716220|NCT02987205|7645295|FG000|Overall Study|Adverse Event|1
4716221|NCT02987205|7645295|FG000|Overall Study|Withdrawal by Subject|3
4716222|NCT02987660|7645325|FG000|Overall Study|Study terminated by sponsor|10
4716223|NCT02987660|7645326|FG001|Overall Study|Study terminated by sponsor|10
4771722|NCT00261807|7748574|FG000|Overall Study|Adverse Event|2
4716225|NCT02987972|7645374|FG000|Overall Study|Adverse Event|1
4716226|NCT02987972|7645375|FG001|Overall Study|Adverse Event|1
4716227|NCT02987972|7645376|FG002|Overall Study|Adverse Event|0
4716228|NCT02987972|7645374|FG000|Overall Study|Death|1
4716229|NCT02987972|7645375|FG001|Overall Study|Death|0
4716230|NCT02987972|7645376|FG002|Overall Study|Death|0
4716231|NCT02987972|7645374|FG000|Overall Study|Lack of Efficacy|9
4716232|NCT02987972|7645375|FG001|Overall Study|Lack of Efficacy|12
4716233|NCT02987972|7645376|FG002|Overall Study|Lack of Efficacy|12
4716234|NCT02987972|7645374|FG000|Overall Study|Lost to Follow-up|7
4716235|NCT02987972|7645375|FG001|Overall Study|Lost to Follow-up|8
4716236|NCT02987972|7645376|FG002|Overall Study|Lost to Follow-up|4
4716237|NCT02987972|7645374|FG000|Overall Study|Physician Decision|1
4716238|NCT02987972|7645375|FG001|Overall Study|Physician Decision|6
4716239|NCT02987972|7645376|FG002|Overall Study|Physician Decision|0
4716240|NCT02987972|7645374|FG000|Overall Study|Protocol Violation|2
4716241|NCT02987972|7645375|FG001|Overall Study|Protocol Violation|1
4716242|NCT02987972|7645376|FG002|Overall Study|Protocol Violation|5
4716243|NCT02987972|7645374|FG000|Overall Study|Withdrawal by Subject|22
4716244|NCT02987972|7645375|FG001|Overall Study|Withdrawal by Subject|17
4716245|NCT02987972|7645376|FG002|Overall Study|Withdrawal by Subject|21
4716246|NCT02988115|7645395|FG000|Overall Study|Adverse Event|6
4716247|NCT02988115|7645396|FG001|Overall Study|Adverse Event|1
4716248|NCT02988115|7645395|FG000|Overall Study|Sponsor Decision|5
4716249|NCT02988115|7645396|FG001|Overall Study|Sponsor Decision|2
4716250|NCT02988115|7645395|FG000|Overall Study|Withdrawal by Subject|1
4716251|NCT02988115|7645396|FG001|Overall Study|Withdrawal by Subject|1
4716252|NCT02988115|7645395|FG000|Overall Study|Withdrawn by Mistake|1
4716253|NCT02988115|7645396|FG001|Overall Study|Withdrawn by Mistake|0
4716254|NCT02988115|7645395|FG000|Overall Study|Lost to Follow-up|1
4716255|NCT02988115|7645396|FG001|Overall Study|Lost to Follow-up|0
4716256|NCT02988219|7645413|FG000|Overall Study|Lack of Efficacy|1
4716257|NCT02988219|7645414|FG001|Overall Study|Lack of Efficacy|1
4716258|NCT02988219|7645413|FG000|Overall Study|Withdrawal by Subject|0
4716259|NCT02988219|7645414|FG001|Overall Study|Withdrawal by Subject|2
4716260|NCT02988622|7645429|FG000|Overall Study|Lost to Follow-up|17
4716261|NCT02989168|7645459|FG000|Overall Study|Withdrawal by Subject|2
4716262|NCT02989168|7645460|FG001|Overall Study|Withdrawal by Subject|0
4716263|NCT02989168|7645459|FG000|Overall Study|Physician Decision|0
4716264|NCT02989168|7645460|FG001|Overall Study|Physician Decision|1
4716265|NCT02989168|7645459|FG000|Overall Study|Adverse Event|1
4716266|NCT02989168|7645460|FG001|Overall Study|Adverse Event|2
4716267|NCT02989168|7645459|FG000|Overall Study|Sponsor stopped study.|1
4716268|NCT02989168|7645460|FG001|Overall Study|Sponsor stopped study.|0
4716269|NCT02989389|7645482|FG000|Period 1|Lost to Follow-up|0
4716270|NCT02989389|7645483|FG001|Period 1|Lost to Follow-up|1
4716271|NCT02989389|7645484|FG002|Period 1|Lost to Follow-up|0
4716272|NCT02989389|7645485|FG003|Period 1|Lost to Follow-up|0
4716273|NCT02989389|7645486|FG004|Period 1|Lost to Follow-up|0
4716274|NCT02989389|7645487|FG005|Period 1|Lost to Follow-up|0
4430667|NCT00395850|7214024|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6
4430668|NCT00395850|7214025|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4
4430669|NCT00395850|7214022|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1
4430670|NCT00395850|7214023|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
4430671|NCT00395850|7214024|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
4430672|NCT00395850|7214025|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
4430673|NCT00395850|7214022|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1
4430674|NCT00395850|7214023|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
4430675|NCT00395850|7214024|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
4430676|NCT00395850|7214025|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
4430677|NCT00395850|7214022|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1
4430678|NCT00395850|7214023|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
4430679|NCT00395850|7214024|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
4430680|NCT00395850|7214025|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
4430681|NCT00395863|7214037|FG000|Overall Study|Patients did not complete both exams|2
4430682|NCT00395863|7214038|FG001|Overall Study|Patients did not complete both exams|3
4430683|NCT00395967|7214056|FG000|Treatment Period|Failed Mobilization|1
4430684|NCT00395967|7214056|FG000|Follow-up Period|Death|1
4630078|NCT03846453|7498649|FG002|Placebo Run-in (14 Days)|Physician Decision|0
4630079|NCT03846453|7498647|FG000|Placebo Run-in (14 Days)|Other|2
4630080|NCT03846453|7498648|FG001|Placebo Run-in (14 Days)|Other|0
4430685|NCT00395967|7214056|FG000|Follow-up Period|Lost to Follow-up|1
4430686|NCT00396084|7214103|FG000|Overall Study|Adverse Event|0
4430687|NCT00396084|7214104|FG001|Overall Study|Adverse Event|0
4630081|NCT03846453|7498649|FG002|Placebo Run-in (14 Days)|Other|0
4630082|NCT03846453|7498647|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0
4630083|NCT03846453|7498648|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16
4630084|NCT03846453|7498649|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8
4430688|NCT00396084|7214105|FG002|Overall Study|Adverse Event|0
4430689|NCT00396084|7214106|FG003|Overall Study|Adverse Event|0
4430690|NCT00396084|7214107|FG004|Overall Study|Adverse Event|1
4430691|NCT00396084|7214108|FG005|Overall Study|Adverse Event|2
4430692|NCT00396084|7214103|FG000|Overall Study|Withdrawal by Subject|0
4430693|NCT00396084|7214104|FG001|Overall Study|Withdrawal by Subject|0
4430694|NCT00396084|7214105|FG002|Overall Study|Withdrawal by Subject|0
4430695|NCT00396084|7214106|FG003|Overall Study|Withdrawal by Subject|1
4430696|NCT00396084|7214107|FG004|Overall Study|Withdrawal by Subject|0
4430697|NCT00396084|7214108|FG005|Overall Study|Withdrawal by Subject|0
4430698|NCT00396097|7214128|FG000|Overall Study|Withdrawal by Subject|17
4430699|NCT00396097|7214129|FG001|Overall Study|Withdrawal by Subject|17
4430700|NCT00396097|7214128|FG000|Overall Study|Lost to Follow-up|4
4430701|NCT00396097|7214129|FG001|Overall Study|Lost to Follow-up|9
4430702|NCT00396097|7214128|FG000|Overall Study|Other|3
4430703|NCT00396097|7214129|FG001|Overall Study|Other|5
4430704|NCT00396097|7214128|FG000|Overall Study|Protocol Violation|0
4430705|NCT00396097|7214129|FG001|Overall Study|Protocol Violation|6
4430706|NCT00396097|7214128|FG000|Overall Study|Adverse Event|1
4430707|NCT00396097|7214129|FG001|Overall Study|Adverse Event|5
4430708|NCT00396097|7214128|FG000|Overall Study|Insufficient Clinical Response|1
4430709|NCT00396097|7214129|FG001|Overall Study|Insufficient Clinical Response|4
4430710|NCT00396136|7214139|FG000|Overall Study|Death|43
4430711|NCT00396136|7214139|FG000|Overall Study|Withdrawal by Subject|59
4430712|NCT00396136|7214139|FG000|Overall Study|Lost to Follow-up|15
4430713|NCT00396136|7214139|FG000|Overall Study|Study device explanted|8
4430714|NCT00396162|7214145|FG000|Overall Study|Withdrawal by Subject|2
4430715|NCT00396162|7214146|FG001|Overall Study|Withdrawal by Subject|3
4430716|NCT00396253|7214161|FG000|Overall Study|Protocol Violation|1
4430717|NCT00396253|7214161|FG000|Overall Study|Withdrawal by Subject|7
4430718|NCT00396253|7214161|FG000|Overall Study|Death|3
4430719|NCT00396253|7214161|FG000|Overall Study|Physician Decision|1
4430720|NCT00396253|7214161|FG000|Overall Study|Change in eligibility status|1
4430721|NCT00396279|7214178|FG000|Overall Study|Ongoing in study|26
4430722|NCT00396279|7214178|FG000|Overall Study|Disease progression|2
4430723|NCT00396279|7214178|FG000|Overall Study|Withdrawal by Subject|1
4430724|NCT00396279|7214178|FG000|Overall Study|Physician Decision|1
4430725|NCT00396318|7214191|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5
4430726|NCT00396331|7214199|FG000|Overall Study|Failed to mobilize - no transplant|8
4430727|NCT00396331|7214199|FG000|Overall Study|Did not go on to transplant|5
4430728|NCT00396331|7214199|FG000|Overall Study|Lost to Follow-up|3
4430729|NCT00396331|7214199|FG000|Overall Study|Death|16
4630085|NCT03846453|7498647|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0
4430730|NCT00396383|7214211|FG000|Overall Study|Death|2
4430731|NCT00396383|7214211|FG000|Overall Study|Lost to Follow-up|1
4430732|NCT00396409|7214217|FG000|Period 1 - 2007|Adverse Event|0
4430733|NCT00396409|7214218|FG001|Period 1 - 2007|Adverse Event|1
4430734|NCT00396409|7214217|FG000|Period 1 - 2007|Lack of Efficacy|0
4430735|NCT00396409|7214218|FG001|Period 1 - 2007|Lack of Efficacy|1
4430736|NCT00396409|7214217|FG000|Period 1 - 2007|Withdrawal by Subject|1
4430737|NCT00396409|7214218|FG001|Period 1 - 2007|Withdrawal by Subject|1
4430738|NCT00396409|7214217|FG000|Period 1 - 2007|Lost to Follow-up|2
4430739|NCT00396409|7214218|FG001|Period 1 - 2007|Lost to Follow-up|3
4430740|NCT00396409|7214217|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3
4430741|NCT00396409|7214218|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2
4430742|NCT00396409|7214217|FG000|Period 2 - 2008|Protocol Violation|1
4430743|NCT00396409|7214218|FG001|Period 2 - 2008|Protocol Violation|0
4430744|NCT00396409|7214217|FG000|Period 2 - 2008|Withdrawal by Subject|3
4430745|NCT00396409|7214218|FG001|Period 2 - 2008|Withdrawal by Subject|1
4430746|NCT00396409|7214217|FG000|Period 2 - 2008|Lost to Follow-up|3
4430747|NCT00396409|7214218|FG001|Period 2 - 2008|Lost to Follow-up|1
4430748|NCT00396565|7214229|FG000|Overall Study|Physician Decision|3
4430749|NCT00396565|7214230|FG001|Overall Study|Physician Decision|1
4430750|NCT00396565|7214231|FG002|Overall Study|Physician Decision|2
4430751|NCT00396565|7214229|FG000|Overall Study|Adverse Event|5
4430752|NCT00396565|7214230|FG001|Overall Study|Adverse Event|13
4430753|NCT00396565|7214231|FG002|Overall Study|Adverse Event|3
4430754|NCT00396565|7214229|FG000|Overall Study|Withdrawal by Subject|8
4430755|NCT00396565|7214230|FG001|Overall Study|Withdrawal by Subject|13
4430756|NCT00396565|7214231|FG002|Overall Study|Withdrawal by Subject|1
4430757|NCT00396565|7214229|FG000|Overall Study|Lack of Efficacy|32
4430758|NCT00396565|7214230|FG001|Overall Study|Lack of Efficacy|64
4430759|NCT00396565|7214231|FG002|Overall Study|Lack of Efficacy|11
4430760|NCT00396591|7214239|FG000|Overall Study|Disease Progression|13
4430761|NCT00396591|7214239|FG000|Overall Study|Adverse Event|2
4430762|NCT00396591|7214239|FG000|Overall Study|Participant request|1
4430763|NCT00396630|7214245|FG000|Overall Study|Lost to Follow-up|1
4430764|NCT00396630|7214246|FG001|Overall Study|Lost to Follow-up|1
4430765|NCT00396630|7214245|FG000|Overall Study|Withdrawal by Subject|1
4430766|NCT00396630|7214246|FG001|Overall Study|Withdrawal by Subject|1
4430767|NCT00396630|7214245|FG000|Overall Study|Not vaccinated at Visit 3|3
4430768|NCT00396630|7214246|FG001|Overall Study|Not vaccinated at Visit 3|3
4430769|NCT00396656|7214253|FG000|First Treatment Period|Withdrawal by Subject|0
4430770|NCT00396656|7214254|FG001|First Treatment Period|Withdrawal by Subject|2
4430771|NCT00396656|7214253|FG000|Second Treatment Period|Adverse Event|0
4430772|NCT00396656|7214254|FG001|Second Treatment Period|Adverse Event|1
4430773|NCT00396812|7214260|FG000|Overall Study|Physician Decision|1
4430774|NCT00396877|7214266|FG000|Overall Study|Lost to Follow-up|2
4430775|NCT00396877|7214267|FG001|Overall Study|Lost to Follow-up|1
4430776|NCT00396877|7214266|FG000|Overall Study|Parent(s)/guardian(s)'s request|4
4430777|NCT00396877|7214267|FG001|Overall Study|Parent(s)/guardian(s)'s request|7
4430778|NCT00397033|7214294|FG000|Overall Study|Adverse Event|7
4430779|NCT00397033|7214295|FG001|Overall Study|Adverse Event|10
4430780|NCT00397033|7214296|FG002|Overall Study|Adverse Event|4
4430781|NCT00397033|7214294|FG000|Overall Study|Lack of Efficacy|22
4430782|NCT00397033|7214295|FG001|Overall Study|Lack of Efficacy|12
4430783|NCT00397033|7214296|FG002|Overall Study|Lack of Efficacy|9
4430784|NCT00397033|7214294|FG000|Overall Study|Lost to Follow-up|3
4430785|NCT00397033|7214295|FG001|Overall Study|Lost to Follow-up|3
4430786|NCT00397033|7214296|FG002|Overall Study|Lost to Follow-up|3
4430787|NCT00397033|7214294|FG000|Overall Study|Withdrawal by Subject|12
4430788|NCT00397033|7214295|FG001|Overall Study|Withdrawal by Subject|7
4430789|NCT00397033|7214296|FG002|Overall Study|Withdrawal by Subject|5
4430790|NCT00397033|7214294|FG000|Overall Study|Other|0
4430791|NCT00397033|7214295|FG001|Overall Study|Other|5
4430792|NCT00397033|7214296|FG002|Overall Study|Other|2
4430793|NCT00397046|7214308|FG000|Overall Study|Disease Progression|3
4430794|NCT00397046|7214309|FG001|Overall Study|Disease Progression|3
4430795|NCT00397046|7214310|FG002|Overall Study|Disease Progression|10
4430796|NCT00397046|7214311|FG003|Overall Study|Disease Progression|5
4430797|NCT00397189|7214333|FG000|3 Weeks Period|Lost to Follow-up|5
4430798|NCT00397189|7214334|FG001|3 Weeks Period|Lost to Follow-up|4
4430799|NCT00397189|7214333|FG000|3 Weeks Period|Adverse Event|3
4430800|NCT00397189|7214334|FG001|3 Weeks Period|Adverse Event|2
4430801|NCT00397189|7214333|FG000|3 Weeks Period|Withdrawal by Subject|13
4430802|NCT00397189|7214334|FG001|3 Weeks Period|Withdrawal by Subject|9
4430803|NCT00397189|7214333|FG000|3 Weeks Period|Physician Decision|0
4512539|NCT00934856|7322352|FG004|Extension Part|Adverse Event|4
4430804|NCT00397189|7214334|FG001|3 Weeks Period|Physician Decision|2
4430805|NCT00397189|7214333|FG000|3 Weeks Period|Protocol Violation|0
4430806|NCT00397189|7214334|FG001|3 Weeks Period|Protocol Violation|3
4430807|NCT00397189|7214333|FG000|3 Weeks Period|Other|0
4430808|NCT00397189|7214334|FG001|3 Weeks Period|Other|2
4430809|NCT00397215|7214346|FG000|Month 0 (Day 0)|Adverse Event|0
4430810|NCT00397215|7214347|FG001|Month 0 (Day 0)|Adverse Event|1
4430811|NCT00397215|7214348|FG002|Month 0 (Day 0)|Adverse Event|0
4430812|NCT00397215|7214349|FG003|Month 0 (Day 0)|Adverse Event|0
4430813|NCT00397215|7214346|FG000|Month 0 (Day 0)|Withdrawal by Subject|3
4430814|NCT00397215|7214347|FG001|Month 0 (Day 0)|Withdrawal by Subject|3
4430815|NCT00397215|7214348|FG002|Month 0 (Day 0)|Withdrawal by Subject|3
4430816|NCT00397215|7214349|FG003|Month 0 (Day 0)|Withdrawal by Subject|1
4430817|NCT00397215|7214346|FG000|Month 0 (Day 0)|Other|4
4430818|NCT00397215|7214347|FG001|Month 0 (Day 0)|Other|1
4430819|NCT00397215|7214348|FG002|Month 0 (Day 0)|Other|3
4430820|NCT00397215|7214349|FG003|Month 0 (Day 0)|Other|3
4430821|NCT00397215|7214346|FG000|Month 6 (Day 180)|Adverse Event|0
4430822|NCT00397215|7214347|FG001|Month 6 (Day 180)|Adverse Event|3
4430823|NCT00397215|7214348|FG002|Month 6 (Day 180)|Adverse Event|2
4430824|NCT00397215|7214349|FG003|Month 6 (Day 180)|Adverse Event|0
4430825|NCT00397215|7214346|FG000|Month 6 (Day 180)|Other|2
4430826|NCT00397215|7214347|FG001|Month 6 (Day 180)|Other|0
4430827|NCT00397215|7214348|FG002|Month 6 (Day 180)|Other|3
4430828|NCT00397215|7214349|FG003|Month 6 (Day 180)|Other|0
4430829|NCT00397488|7214375|FG000|Overall Study|Withdrawal by Subject|3
4430830|NCT00397488|7214375|FG000|Overall Study|Adverse Event|3
4430831|NCT00397488|7214375|FG000|Overall Study|Death|1
4430832|NCT00397514|7214379|FG000|Overall Study|Withdrawal by Subject|1
4430833|NCT00397514|7214379|FG000|Overall Study|Pacing wire malfunction|1
4430834|NCT00397514|7214379|FG000|Overall Study|Not able to capture & pace LV intraoper.|4
4430835|NCT00397514|7214379|FG000|Overall Study|early extubation|2
4633303|NCT01910129|7503355|FG002|Randomized Phase 2|Withdrawal by Subject|0
4430836|NCT00397514|7214379|FG000|Overall Study|poor echocardiographic windows|1
4430837|NCT00397540|7214391|FG000|Overall Study|short follow-up duration < 12 months|1
4430838|NCT00397540|7214392|FG001|Overall Study|short follow-up duration < 12 months|0
4512540|NCT00934856|7322353|FG005|Extension Part|Adverse Event|4
4512541|NCT00934856|7322348|FG000|Extension Part|Progressive disease|0
4512542|NCT00934856|7322349|FG001|Extension Part|Progressive disease|0
4512543|NCT00934856|7322350|FG002|Extension Part|Progressive disease|0
4512544|NCT00934856|7322351|FG003|Extension Part|Progressive disease|1
4512545|NCT00934856|7322352|FG004|Extension Part|Progressive disease|0
4512546|NCT00934856|7322353|FG005|Extension Part|Progressive disease|0
4512547|NCT00934856|7322348|FG000|Extension Part|Non-compliance with drug|0
4512548|NCT00934856|7322349|FG001|Extension Part|Non-compliance with drug|0
4512549|NCT00934856|7322350|FG002|Extension Part|Non-compliance with drug|0
4512550|NCT00934856|7322351|FG003|Extension Part|Non-compliance with drug|0
4512551|NCT00934856|7322352|FG004|Extension Part|Non-compliance with drug|0
4512552|NCT00934856|7322353|FG005|Extension Part|Non-compliance with drug|1
4512553|NCT00934947|7322399|FG000|Overall Study|Adverse Event|0
4512554|NCT00934947|7322400|FG001|Overall Study|Adverse Event|2
4512555|NCT00935012|7322408|FG000|Overall Study|Death|19
4512556|NCT00935012|7322408|FG000|Overall Study|Withdrawal by Subject|3
4512557|NCT00935012|7322408|FG000|Overall Study|Other|5
4512558|NCT00935012|7322408|FG000|Overall Study|Adverse Event|2
4512559|NCT00935220|7322421|FG000|Overall Study|Adverse Event|1
4512560|NCT00935220|7322421|FG000|Overall Study|Other reason (not specified)|1
4512561|NCT00935259|7322425|FG000|Period 1|Administrative (scheduling conflict)|1
4512562|NCT00935259|7322426|FG001|Period 1|Administrative (scheduling conflict)|1
4512563|NCT00935272|7322436|FG000|Overall Study|Lost to Follow-up|10
4512564|NCT00935272|7322437|FG001|Overall Study|Lost to Follow-up|3
4512565|NCT00935272|7322436|FG000|Overall Study|Withdrawal by Subject|8
4512566|NCT00935272|7322437|FG001|Overall Study|Withdrawal by Subject|2
4512567|NCT00935272|7322436|FG000|Overall Study|Physician Decision|1
4512568|NCT00935272|7322437|FG001|Overall Study|Physician Decision|0
4512569|NCT00935272|7322436|FG000|Overall Study|Protocol Violation|0
4512570|NCT00935272|7322437|FG001|Overall Study|Protocol Violation|1
4512571|NCT00935493|7322470|FG000|Overall Study|Lost to Follow-up|1
4512572|NCT00935493|7322471|FG001|Overall Study|Lost to Follow-up|1
4512573|NCT00935493|7322472|FG002|Overall Study|Lost to Follow-up|1
4512574|NCT00935493|7322470|FG000|Overall Study|Treatment Discontinued|0
4512575|NCT00935493|7322471|FG001|Overall Study|Treatment Discontinued|1
4512576|NCT00935493|7322472|FG002|Overall Study|Treatment Discontinued|0
4512577|NCT00935532|7322482|FG000|Overall Study|Adverse Event|11
4512578|NCT00935532|7322483|FG001|Overall Study|Adverse Event|6
4512579|NCT00935532|7322482|FG000|Overall Study|Death|1
4512580|NCT00935532|7322483|FG001|Overall Study|Death|0
4512581|NCT00935532|7322482|FG000|Overall Study|Lost to Follow-up|1
4512582|NCT00935532|7322483|FG001|Overall Study|Lost to Follow-up|0
4512583|NCT00935532|7322482|FG000|Overall Study|Physician Decision|1
4512584|NCT00935532|7322483|FG001|Overall Study|Physician Decision|2
4512585|NCT00935532|7322482|FG000|Overall Study|Protocol Violation|2
4512586|NCT00935532|7322483|FG001|Overall Study|Protocol Violation|1
4512587|NCT00935532|7322482|FG000|Overall Study|Subject Decision|2
4512588|NCT00935532|7322483|FG001|Overall Study|Subject Decision|1
4512589|NCT00935532|7322482|FG000|Overall Study|Sponsor Decision|0
4512590|NCT00935532|7322483|FG001|Overall Study|Sponsor Decision|1
4512591|NCT00935532|7322482|FG000|Overall Study|Loss Glucose Control|4
4512592|NCT00935532|7322483|FG001|Overall Study|Loss Glucose Control|0
4512593|NCT00935584|7322491|FG000|Overall Study|Withdrawal by Subject|9
4512594|NCT00935584|7322492|FG001|Overall Study|Withdrawal by Subject|0
4512595|NCT00935584|7322491|FG000|Overall Study|Death|3
4512596|NCT00935584|7322492|FG001|Overall Study|Death|0
4512597|NCT00935584|7322491|FG000|Overall Study|Lost to Follow-up|8
4512598|NCT00935584|7322492|FG001|Overall Study|Lost to Follow-up|0
4512599|NCT00935584|7322491|FG000|Overall Study|No show|9
4512600|NCT00935584|7322492|FG001|Overall Study|No show|0
4512601|NCT00935584|7322491|FG000|Overall Study|Relocated|3
4512602|NCT00935584|7322492|FG001|Overall Study|Relocated|0
4512603|NCT00935584|7322491|FG000|Overall Study|Patient changed provider|3
4512604|NCT00935584|7322492|FG001|Overall Study|Patient changed provider|0
4512605|NCT00935584|7322491|FG000|Overall Study|Provider dropped out of study|14
4512606|NCT00935584|7322492|FG001|Overall Study|Provider dropped out of study|4
4512607|NCT00935701|7322496|FG000|Overall Study|Failure to Transition to Acupuncture|1
4430839|NCT00397631|7214405|FG000|Overall Study|Adverse Event|5
4430840|NCT00397631|7214406|FG001|Overall Study|Adverse Event|6
4430841|NCT00397631|7214405|FG000|Overall Study|Lack of Efficacy|7
4430842|NCT00397631|7214406|FG001|Overall Study|Lack of Efficacy|10
4430843|NCT00397631|7214405|FG000|Overall Study|Lost to Follow-up|8
4430844|NCT00397631|7214406|FG001|Overall Study|Lost to Follow-up|9
4430845|NCT00397631|7214405|FG000|Overall Study|Physician Decision|2
4430846|NCT00397631|7214406|FG001|Overall Study|Physician Decision|0
4430847|NCT00397631|7214405|FG000|Overall Study|Protocol Violation|0
4430848|NCT00397631|7214406|FG001|Overall Study|Protocol Violation|1
4430849|NCT00397631|7214405|FG000|Overall Study|Withdrawal by Subject|7
4430850|NCT00397631|7214406|FG001|Overall Study|Withdrawal by Subject|14
4430851|NCT00397631|7214405|FG000|Overall Study|protocol discontinuation criteria|1
4430852|NCT00397631|7214406|FG001|Overall Study|protocol discontinuation criteria|4
4430853|NCT00397891|7214455|FG000|Overall Study|Withdrawal by Subject|1
4430854|NCT00397891|7214456|FG001|Overall Study|Withdrawal by Subject|0
4430855|NCT00397891|7214457|FG002|Overall Study|Withdrawal by Subject|0
4430856|NCT00397891|7214458|FG003|Overall Study|Withdrawal by Subject|0
4430857|NCT00397891|7214459|FG004|Overall Study|Withdrawal by Subject|1
4430858|NCT00397930|7214477|FG000|Overall Study|Personal reasons|14
4430859|NCT00397930|7214478|FG001|Overall Study|Personal reasons|8
4430860|NCT00397930|7214477|FG000|Overall Study|Other medical|9
4430861|NCT00397930|7214478|FG001|Overall Study|Other medical|4
4430862|NCT00397930|7214477|FG000|Overall Study|Unknown reasons|9
4430863|NCT00397930|7214478|FG001|Overall Study|Unknown reasons|14
4430864|NCT00397930|7214477|FG000|Overall Study|Noncompliant|3
4430865|NCT00397930|7214478|FG001|Overall Study|Noncompliant|2
4430866|NCT00397930|7214477|FG000|Overall Study|Too time-consuming|2
4430867|NCT00397930|7214478|FG001|Overall Study|Too time-consuming|9
4430868|NCT00397930|7214477|FG000|Overall Study|Started own yoga program|1
4430869|NCT00397930|7214478|FG001|Overall Study|Started own yoga program|1
4430870|NCT00397930|7214477|FG000|Overall Study|Did not want to be in control group|0
4430871|NCT00397930|7214478|FG001|Overall Study|Did not want to be in control group|1
4430872|NCT00397930|7214477|FG000|Overall Study|Withdrawal by Subject|0
4430873|NCT00397930|7214478|FG001|Overall Study|Withdrawal by Subject|8
4430874|NCT00397930|7214477|FG000|Overall Study|Missing data|0
4430875|NCT00397930|7214478|FG001|Overall Study|Missing data|4
4430876|NCT00397943|7214489|FG000|Overall Study|Unspecified reasons|12
4430877|NCT00397943|7214490|FG001|Overall Study|Unspecified reasons|9
4430878|NCT00397943|7214491|FG002|Overall Study|Unspecified reasons|0
4430879|NCT00397943|7214492|FG003|Overall Study|Unspecified reasons|0
4430880|NCT00397943|7214493|FG004|Overall Study|Unspecified reasons|0
4430881|NCT00397982|7214505|FG000|Overall Study|Withdrawal by Subject|1
4430882|NCT00397982|7214505|FG000|Overall Study|Adverse Event|1
4430883|NCT00397982|7214505|FG000|Overall Study|noncompliance|1
4430884|NCT00397982|7214505|FG000|Overall Study|Unrelated health issues|1
4430885|NCT00398047|7214510|FG000|Overall Study|all patient progressed before completion|3
4430886|NCT00398073|7214517|FG000|Overall Study|Withdrawal by Subject|1
4430887|NCT00398073|7214518|FG001|Overall Study|Withdrawal by Subject|0
4430888|NCT00398086|7214527|FG000|Overall Study|Unacceptable Toxicity|2
4430889|NCT00398086|7214528|FG001|Overall Study|Unacceptable Toxicity|8
4430890|NCT00398086|7214529|FG002|Overall Study|Unacceptable Toxicity|2
4430891|NCT00398086|7214527|FG000|Overall Study|Adverse Event|1
4430892|NCT00398086|7214528|FG001|Overall Study|Adverse Event|4
4430893|NCT00398086|7214529|FG002|Overall Study|Adverse Event|0
4430894|NCT00398086|7214527|FG000|Overall Study|Physician Decision|1
4430895|NCT00398086|7214528|FG001|Overall Study|Physician Decision|4
4430896|NCT00398086|7214529|FG002|Overall Study|Physician Decision|0
4430897|NCT00398086|7214527|FG000|Overall Study|Withdrawal by Subject|5
4430898|NCT00398086|7214528|FG001|Overall Study|Withdrawal by Subject|7
4430899|NCT00398086|7214529|FG002|Overall Study|Withdrawal by Subject|0
4430900|NCT00398112|7214537|FG000|Overall Study|Adverse Event|4
4430901|NCT00398112|7214537|FG000|Overall Study|Disease progression|9
4430902|NCT00398112|7214537|FG000|Overall Study|Alternative treatment|1
4430903|NCT00398112|7214537|FG000|Overall Study|Withdrawal by Subject|3
4430904|NCT00398112|7214537|FG000|Overall Study|Death|1
4430905|NCT00398138|7214541|FG000|Overall Study|Adverse Event|2
4430906|NCT00398216|7214550|FG000|Overall Study|Adverse Event|4
4430907|NCT00398216|7214551|FG001|Overall Study|Adverse Event|2
4430908|NCT00398216|7214552|FG002|Overall Study|Adverse Event|5
4430909|NCT00398216|7214553|FG003|Overall Study|Adverse Event|7
4430910|NCT00398216|7214554|FG004|Overall Study|Adverse Event|2
4430911|NCT00398216|7214550|FG000|Overall Study|Protocol Violation|2
4430912|NCT00398216|7214551|FG001|Overall Study|Protocol Violation|4
4430913|NCT00398216|7214552|FG002|Overall Study|Protocol Violation|5
4430914|NCT00398216|7214553|FG003|Overall Study|Protocol Violation|7
4430915|NCT00398216|7214554|FG004|Overall Study|Protocol Violation|5
4430916|NCT00398216|7214550|FG000|Overall Study|Lost to Follow-up|1
4430917|NCT00398216|7214551|FG001|Overall Study|Lost to Follow-up|6
4430918|NCT00398216|7214552|FG002|Overall Study|Lost to Follow-up|4
4430919|NCT00398216|7214553|FG003|Overall Study|Lost to Follow-up|4
4430920|NCT00398216|7214554|FG004|Overall Study|Lost to Follow-up|1
4430921|NCT00398216|7214550|FG000|Overall Study|Death|0
4430922|NCT00398216|7214551|FG001|Overall Study|Death|3
4430923|NCT00398216|7214552|FG002|Overall Study|Death|0
4430924|NCT00398216|7214553|FG003|Overall Study|Death|0
4430925|NCT00398216|7214554|FG004|Overall Study|Death|0
4430926|NCT00398216|7214550|FG000|Overall Study|Withdrawal by Subject|1
4430927|NCT00398216|7214551|FG001|Overall Study|Withdrawal by Subject|0
4430928|NCT00398216|7214552|FG002|Overall Study|Withdrawal by Subject|3
4430929|NCT00398216|7214553|FG003|Overall Study|Withdrawal by Subject|1
4430930|NCT00398216|7214554|FG004|Overall Study|Withdrawal by Subject|2
4430931|NCT00398216|7214550|FG000|Overall Study|administrative reasons|3
4430932|NCT00398216|7214551|FG001|Overall Study|administrative reasons|4
4430933|NCT00398216|7214552|FG002|Overall Study|administrative reasons|4
4430934|NCT00398216|7214553|FG003|Overall Study|administrative reasons|3
4430935|NCT00398216|7214554|FG004|Overall Study|administrative reasons|3
4430936|NCT00398216|7214550|FG000|Overall Study|entrance criteria|0
4430937|NCT00398216|7214551|FG001|Overall Study|entrance criteria|0
4430938|NCT00398216|7214552|FG002|Overall Study|entrance criteria|0
4430939|NCT00398216|7214553|FG003|Overall Study|entrance criteria|0
4430940|NCT00398216|7214554|FG004|Overall Study|entrance criteria|2
4430941|NCT00398320|7214566|FG000|Overall Study|Death|1
4430942|NCT00398320|7214566|FG000|Overall Study|Adverse Event|4
4430943|NCT00398320|7214566|FG000|Overall Study|Physician Decision|1
4430944|NCT00398411|7214576|FG000|Overall Study|Death|0
4430945|NCT00398411|7214577|FG001|Overall Study|Death|1
4430946|NCT00398567|7214595|FG000|Overall Study|Disease Progression|3
4430947|NCT00398567|7214596|FG001|Overall Study|Disease Progression|4
4430948|NCT00398567|7214597|FG002|Overall Study|Disease Progression|27
4430949|NCT00398567|7214595|FG000|Overall Study|Withdrawal by Subject|1
4430950|NCT00398567|7214596|FG001|Overall Study|Withdrawal by Subject|0
4430951|NCT00398567|7214597|FG002|Overall Study|Withdrawal by Subject|4
4430952|NCT00398567|7214595|FG000|Overall Study|Adverse Event|0
4430953|NCT00398567|7214596|FG001|Overall Study|Adverse Event|0
4430954|NCT00398567|7214597|FG002|Overall Study|Adverse Event|2
4430955|NCT00398567|7214595|FG000|Overall Study|Protocol Violation|0
4430956|NCT00398567|7214596|FG001|Overall Study|Protocol Violation|0
4430957|NCT00398567|7214597|FG002|Overall Study|Protocol Violation|1
4430958|NCT00398632|7214603|FG000|Overall Study|Withdrawal by Subject|1
4430959|NCT00398632|7214603|FG000|Overall Study|Lack of Efficacy|1
4430960|NCT00398866|7214611|FG000|Overall Study|Adverse Event|1
4430961|NCT00398866|7214612|FG001|Overall Study|Adverse Event|0
4430962|NCT00398866|7214613|FG002|Overall Study|Adverse Event|0
4430963|NCT00398866|7214611|FG000|Overall Study|Lack of Efficacy|0
4430964|NCT00398866|7214612|FG001|Overall Study|Lack of Efficacy|0
4430965|NCT00398866|7214613|FG002|Overall Study|Lack of Efficacy|1
4430966|NCT00398866|7214611|FG000|Overall Study|Lost to Follow-up|7
4430967|NCT00398866|7214612|FG001|Overall Study|Lost to Follow-up|6
4430968|NCT00398866|7214613|FG002|Overall Study|Lost to Follow-up|4
4430969|NCT00398866|7214611|FG000|Overall Study|Withdrawal by Subject|5
4430970|NCT00398866|7214612|FG001|Overall Study|Withdrawal by Subject|1
4430971|NCT00398866|7214613|FG002|Overall Study|Withdrawal by Subject|2
4430972|NCT00398866|7214611|FG000|Overall Study|Unable to complete requirements of study|1
4430973|NCT00398866|7214612|FG001|Overall Study|Unable to complete requirements of study|1
4430974|NCT00398866|7214613|FG002|Overall Study|Unable to complete requirements of study|1
4430975|NCT00399035|7214638|FG000|Overall Study|Death|289
4430976|NCT00399035|7214639|FG001|Overall Study|Death|141
4430977|NCT00399035|7214640|FG002|Overall Study|Death|234
4430978|NCT00399035|7214638|FG000|Overall Study|Lost to Follow-up|2
4430979|NCT00399035|7214639|FG001|Overall Study|Lost to Follow-up|1
4430980|NCT00399035|7214640|FG002|Overall Study|Lost to Follow-up|5
4430981|NCT00399035|7214638|FG000|Overall Study|Withdrawal by Subject|19
4430982|NCT00399035|7214639|FG001|Overall Study|Withdrawal by Subject|15
4430983|NCT00399035|7214640|FG002|Overall Study|Withdrawal by Subject|12
4430984|NCT00399035|7214638|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1
4430985|NCT00399035|7214639|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0
4430986|NCT00399035|7214640|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1
4430987|NCT00399035|7214638|FG000|Overall Study|Severe non-compliance with protocol|2
4430988|NCT00399035|7214639|FG001|Overall Study|Severe non-compliance with protocol|1
4430989|NCT00399035|7214640|FG002|Overall Study|Severe non-compliance with protocol|0
4430990|NCT00399360|7214664|FG000|Overall Study|Lost to Follow-up|2
4430991|NCT00399360|7214665|FG001|Overall Study|Lost to Follow-up|1
4430992|NCT00399360|7214666|FG002|Overall Study|Lost to Follow-up|2
4430993|NCT00399360|7214667|FG003|Overall Study|Lost to Follow-up|4
4430994|NCT00399360|7214664|FG000|Overall Study|Adverse Event|0
4430995|NCT00399360|7214665|FG001|Overall Study|Adverse Event|0
4430996|NCT00399360|7214666|FG002|Overall Study|Adverse Event|1
4430997|NCT00399360|7214667|FG003|Overall Study|Adverse Event|0
4430998|NCT00399360|7214664|FG000|Overall Study|Withdrawal by Subject|0
4430999|NCT00399360|7214665|FG001|Overall Study|Withdrawal by Subject|2
4431000|NCT00399360|7214666|FG002|Overall Study|Withdrawal by Subject|0
4431001|NCT00399360|7214667|FG003|Overall Study|Withdrawal by Subject|2
4431002|NCT00399490|7214682|FG000|Overall Study|Adverse Event|19
4431003|NCT00399490|7214682|FG000|Overall Study|Lack of Efficacy|31
4431004|NCT00399490|7214682|FG000|Overall Study|Lost to Follow-up|5
4431005|NCT00399490|7214682|FG000|Overall Study|Withdrawal by Subject|18
4431006|NCT00399490|7214682|FG000|Overall Study|Other|25
4431007|NCT00399516|7214688|FG000|Overall Study|Lost to Follow-up|2
4431008|NCT00399529|7214692|FG000|Overall Study|Off Study Prior to Treatment|2
4431009|NCT00399542|7214699|FG000|Overall Study|Adverse Event|18
4431010|NCT00399542|7214700|FG001|Overall Study|Adverse Event|15
4431011|NCT00399542|7214699|FG000|Overall Study|Protocol Violation|13
4431012|NCT00399542|7214700|FG001|Overall Study|Protocol Violation|3
4431013|NCT00399542|7214699|FG000|Overall Study|Withdrawal by Subject|28
4431014|NCT00399542|7214700|FG001|Overall Study|Withdrawal by Subject|10
4431015|NCT00399542|7214699|FG000|Overall Study|Lack of Efficacy|18
4431016|NCT00399542|7214700|FG001|Overall Study|Lack of Efficacy|8
4431017|NCT00399542|7214699|FG000|Overall Study|Lost to Follow-up|6
4431018|NCT00399542|7214700|FG001|Overall Study|Lost to Follow-up|6
4431019|NCT00399542|7214699|FG000|Overall Study|Other|1
4431020|NCT00399542|7214700|FG001|Overall Study|Other|0
4431021|NCT00399542|7214699|FG000|Overall Study|Physician Decision|0
4716275|NCT02989389|7645488|FG006|Period 1|Lost to Follow-up|0
4431022|NCT00399542|7214700|FG001|Overall Study|Physician Decision|1
4431023|NCT00399568|7214708|FG000|Overall Study|Adverse Event|1
4431024|NCT00399568|7214709|FG001|Overall Study|Adverse Event|2
4431025|NCT00399568|7214708|FG000|Overall Study|Withdrawal by Subject|7
4431026|NCT00399568|7214709|FG001|Overall Study|Withdrawal by Subject|3
4431027|NCT00399568|7214708|FG000|Overall Study|Protocol non-compliance|2
4431028|NCT00399568|7214709|FG001|Overall Study|Protocol non-compliance|2
4431029|NCT00399568|7214708|FG000|Overall Study|Lost to Follow-up|2
4431030|NCT00399568|7214709|FG001|Overall Study|Lost to Follow-up|2
4431031|NCT00399763|7214719|FG000|Overall Study|Lost to Follow-up|2
4431032|NCT00399763|7214720|FG001|Overall Study|Lost to Follow-up|3
4431033|NCT00399802|7214728|FG000|Overall Study|Adverse Event|0
4431034|NCT00399802|7214729|FG001|Overall Study|Adverse Event|2
4431035|NCT00399802|7214728|FG000|Overall Study|Participant discontinued by mistake|0
4431036|NCT00399802|7214729|FG001|Overall Study|Participant discontinued by mistake|1
4431037|NCT00399893|7214746|FG000|Overall Study|Withdrawal by Subject|1
4431038|NCT00399893|7214747|FG001|Overall Study|Withdrawal by Subject|0
4431039|NCT00400153|7214756|FG000|Overall Study|AE due to study disease worsening|14
4431040|NCT00400153|7214757|FG001|Overall Study|AE due to study disease worsening|19
4431041|NCT00400153|7214758|FG002|Overall Study|AE due to study disease worsening|20
4431042|NCT00400153|7214756|FG000|Overall Study|AE due to other disease worsening|2
4431043|NCT00400153|7214757|FG001|Overall Study|AE due to other disease worsening|1
4431044|NCT00400153|7214758|FG002|Overall Study|AE due to other disease worsening|0
4431045|NCT00400153|7214756|FG000|Overall Study|AE due to other condition|3
4431046|NCT00400153|7214757|FG001|Overall Study|AE due to other condition|14
4431047|NCT00400153|7214758|FG002|Overall Study|AE due to other condition|15
4431048|NCT00400153|7214756|FG000|Overall Study|Protocol Violation|7
4431049|NCT00400153|7214757|FG001|Overall Study|Protocol Violation|4
4431050|NCT00400153|7214758|FG002|Overall Study|Protocol Violation|9
4431051|NCT00400153|7214756|FG000|Overall Study|Lost to Follow-up|2
4431052|NCT00400153|7214757|FG001|Overall Study|Lost to Follow-up|1
4431053|NCT00400153|7214758|FG002|Overall Study|Lost to Follow-up|4
4431054|NCT00400153|7214756|FG000|Overall Study|Withdrawal by Subject|12
4431055|NCT00400153|7214757|FG001|Overall Study|Withdrawal by Subject|11
4431056|NCT00400153|7214758|FG002|Overall Study|Withdrawal by Subject|10
4431057|NCT00400153|7214756|FG000|Overall Study|Other reasons - not mentioned above|8
4431058|NCT00400153|7214757|FG001|Overall Study|Other reasons - not mentioned above|5
4431059|NCT00400153|7214758|FG002|Overall Study|Other reasons - not mentioned above|3
4431060|NCT00400179|7214773|FG000|Overall Study|Adverse Event|2
4431061|NCT00400179|7214774|FG001|Overall Study|Adverse Event|2
4431062|NCT00400179|7214773|FG000|Overall Study|Death|1
4431063|NCT00400179|7214774|FG001|Overall Study|Death|2
4431064|NCT00400179|7214773|FG000|Overall Study|Withdrew Consent|1
4431065|NCT00400179|7214774|FG001|Overall Study|Withdrew Consent|5
4431066|NCT00400179|7214773|FG000|Overall Study|Disease progression|1
4431067|NCT00400179|7214774|FG001|Overall Study|Disease progression|1
4431068|NCT00400179|7214773|FG000|Overall Study|Intercurrent illness|0
4431069|NCT00400179|7214774|FG001|Overall Study|Intercurrent illness|1
4431070|NCT00400179|7214773|FG000|Overall Study|Investigator judgment|0
4431071|NCT00400179|7214774|FG001|Overall Study|Investigator judgment|1
4431072|NCT00400179|7214773|FG000|Overall Study|Randomization error/patient ineligible|1
4431073|NCT00400179|7214774|FG001|Overall Study|Randomization error/patient ineligible|6
4431074|NCT00400400|7214787|FG000|Overall Study|Adverse Event|9
4431075|NCT00400400|7214788|FG001|Overall Study|Adverse Event|8
4431076|NCT00400400|7214787|FG000|Overall Study|Protocol Violation|2
4431077|NCT00400400|7214788|FG001|Overall Study|Protocol Violation|0
4431078|NCT00400400|7214787|FG000|Overall Study|Withdrawal by Subject|1
4431079|NCT00400400|7214788|FG001|Overall Study|Withdrawal by Subject|3
4431080|NCT00400400|7214787|FG000|Overall Study|Administrative Problem|1
4431081|NCT00400400|7214788|FG001|Overall Study|Administrative Problem|0
4431082|NCT00400400|7214787|FG000|Overall Study|Lost to Follow-up|0
4431083|NCT00400400|7214788|FG001|Overall Study|Lost to Follow-up|1
4431084|NCT00400400|7214787|FG000|Overall Study|Did not receive study drug|1
4431085|NCT00400400|7214788|FG001|Overall Study|Did not receive study drug|3
4431086|NCT00400517|7214803|FG000|Overall Study|Withdrawal by Subject|1
4431087|NCT00400517|7214803|FG000|Overall Study|Physician Decision|1
4431088|NCT00400569|7214807|FG000|Overall Study|Death|1
4431089|NCT00400712|7214829|FG000|Overall Study|Death|1
4431090|NCT00400712|7214830|FG001|Overall Study|Death|0
4431091|NCT00400712|7214829|FG000|Overall Study|Withdrawal by Subject|11
4431092|NCT00400712|7214830|FG001|Overall Study|Withdrawal by Subject|12
4431093|NCT00400712|7214829|FG000|Overall Study|Physician Decision|5
4431094|NCT00400712|7214830|FG001|Overall Study|Physician Decision|4
4431095|NCT00400764|7214843|FG000|Phase Ib|Adverse Event|1
4431096|NCT00400764|7214844|FG001|Phase Ib|Adverse Event|0
4431097|NCT00400764|7214845|FG002|Phase Ib|Adverse Event|0
4431098|NCT00400764|7214846|FG003|Phase Ib|Adverse Event|0
4431099|NCT00400764|7214847|FG004|Phase Ib|Adverse Event|0
4431100|NCT00400764|7214843|FG000|Phase Ib|Death|1
4431101|NCT00400764|7214844|FG001|Phase Ib|Death|0
4431102|NCT00400764|7214845|FG002|Phase Ib|Death|0
4431103|NCT00400764|7214846|FG003|Phase Ib|Death|0
4431104|NCT00400764|7214847|FG004|Phase Ib|Death|0
4431105|NCT00400764|7214843|FG000|Phase Ib|Disease Progression|4
4431106|NCT00400764|7214844|FG001|Phase Ib|Disease Progression|4
4431107|NCT00400764|7214845|FG002|Phase Ib|Disease Progression|0
4431108|NCT00400764|7214846|FG003|Phase Ib|Disease Progression|0
4431109|NCT00400764|7214847|FG004|Phase Ib|Disease Progression|0
4431110|NCT00400764|7214843|FG000|Phase II|Death|0
4431111|NCT00400764|7214844|FG001|Phase II|Death|0
4431112|NCT00400764|7214845|FG002|Phase II|Death|1
4431113|NCT00400764|7214846|FG003|Phase II|Death|2
4431114|NCT00400764|7214847|FG004|Phase II|Death|0
4431115|NCT00400764|7214843|FG000|Phase II|Lost to Follow-up|0
4431116|NCT00400764|7214844|FG001|Phase II|Lost to Follow-up|0
4431117|NCT00400764|7214845|FG002|Phase II|Lost to Follow-up|1
4431118|NCT00400764|7214846|FG003|Phase II|Lost to Follow-up|0
4431119|NCT00400764|7214847|FG004|Phase II|Lost to Follow-up|0
4431120|NCT00400764|7214843|FG000|Phase II|Physician Decision|0
4431121|NCT00400764|7214844|FG001|Phase II|Physician Decision|0
4431122|NCT00400764|7214845|FG002|Phase II|Physician Decision|1
4431123|NCT00400764|7214846|FG003|Phase II|Physician Decision|1
4431124|NCT00400764|7214847|FG004|Phase II|Physician Decision|0
4431125|NCT00400764|7214843|FG000|Phase II|Sponsor's decision to terminate|0
4431126|NCT00400764|7214844|FG001|Phase II|Sponsor's decision to terminate|0
4431127|NCT00400764|7214845|FG002|Phase II|Sponsor's decision to terminate|18
4431128|NCT00400764|7214846|FG003|Phase II|Sponsor's decision to terminate|22
4431129|NCT00400764|7214847|FG004|Phase II|Sponsor's decision to terminate|11
4431130|NCT00400764|7214843|FG000|Phase II|Patient began new, non-protocol, therapy|0
4431131|NCT00400764|7214844|FG001|Phase II|Patient began new, non-protocol, therapy|0
4431132|NCT00400764|7214845|FG002|Phase II|Patient began new, non-protocol, therapy|1
4431133|NCT00400764|7214846|FG003|Phase II|Patient began new, non-protocol, therapy|0
4431134|NCT00400764|7214847|FG004|Phase II|Patient began new, non-protocol, therapy|0
4431135|NCT00400764|7214843|FG000|Phase II|Withdrawal by Subject|0
4431136|NCT00400764|7214844|FG001|Phase II|Withdrawal by Subject|0
4431137|NCT00400764|7214845|FG002|Phase II|Withdrawal by Subject|1
4431138|NCT00400764|7214846|FG003|Phase II|Withdrawal by Subject|1
4431139|NCT00400764|7214847|FG004|Phase II|Withdrawal by Subject|0
4431140|NCT00400946|7214891|FG000|Overall Study|Ineligible|0
4431141|NCT00400946|7214892|FG001|Overall Study|Ineligible|0
4431142|NCT00400946|7214893|FG002|Overall Study|Ineligible|0
4431143|NCT00400946|7214894|FG003|Overall Study|Ineligible|5
4431144|NCT00400946|7214895|FG004|Overall Study|Ineligible|1
4431145|NCT00400946|7214891|FG000|Overall Study|Induction Failure|0
4431146|NCT00400946|7214892|FG001|Overall Study|Induction Failure|0
4431147|NCT00400946|7214893|FG002|Overall Study|Induction Failure|0
4431148|NCT00400946|7214894|FG003|Overall Study|Induction Failure|11
4431149|NCT00400946|7214895|FG004|Overall Study|Induction Failure|8
4431150|NCT00400946|7214891|FG000|Overall Study|Induction Death|0
4431151|NCT00400946|7214892|FG001|Overall Study|Induction Death|0
4431152|NCT00400946|7214893|FG002|Overall Study|Induction Death|0
4431153|NCT00400946|7214894|FG003|Overall Study|Induction Death|13
4431154|NCT00400946|7214895|FG004|Overall Study|Induction Death|3
4431155|NCT00400946|7214891|FG000|Overall Study|Lost to Follow-up|1
4431156|NCT00400946|7214892|FG001|Overall Study|Lost to Follow-up|1
4431157|NCT00400946|7214893|FG002|Overall Study|Lost to Follow-up|0
4431158|NCT00400946|7214894|FG003|Overall Study|Lost to Follow-up|0
4431159|NCT00400946|7214895|FG004|Overall Study|Lost to Follow-up|1
4431160|NCT00400946|7214891|FG000|Overall Study|Remission Death|1
4431161|NCT00400946|7214892|FG001|Overall Study|Remission Death|1
4431162|NCT00400946|7214893|FG002|Overall Study|Remission Death|0
4431163|NCT00400946|7214894|FG003|Overall Study|Remission Death|0
4431164|NCT00400946|7214895|FG004|Overall Study|Remission Death|1
4431165|NCT00400946|7214891|FG000|Overall Study|Relapse|9
4431166|NCT00400946|7214892|FG001|Overall Study|Relapse|2
4431167|NCT00400946|7214893|FG002|Overall Study|Relapse|1
4431168|NCT00400946|7214894|FG003|Overall Study|Relapse|1
4431169|NCT00400946|7214895|FG004|Overall Study|Relapse|5
4431170|NCT00400946|7214891|FG000|Overall Study|Transplant in CR1|0
4431171|NCT00400946|7214892|FG001|Overall Study|Transplant in CR1|0
4431172|NCT00400946|7214893|FG002|Overall Study|Transplant in CR1|0
4431173|NCT00400946|7214894|FG003|Overall Study|Transplant in CR1|10
4431174|NCT00400946|7214895|FG004|Overall Study|Transplant in CR1|1
4431175|NCT00400946|7214891|FG000|Overall Study|Withdrawal by Subject|2
4431176|NCT00400946|7214892|FG001|Overall Study|Withdrawal by Subject|5
4431177|NCT00400946|7214893|FG002|Overall Study|Withdrawal by Subject|1
4431178|NCT00400946|7214894|FG003|Overall Study|Withdrawal by Subject|5
4431179|NCT00400946|7214895|FG004|Overall Study|Withdrawal by Subject|8
4431180|NCT00400946|7214891|FG000|Overall Study|Clinical|1
4431181|NCT00400946|7214892|FG001|Overall Study|Clinical|2
4431182|NCT00400946|7214893|FG002|Overall Study|Clinical|0
4431183|NCT00400946|7214894|FG003|Overall Study|Clinical|2
4431184|NCT00400946|7214895|FG004|Overall Study|Clinical|9
4431185|NCT00400946|7214891|FG000|Overall Study|Other|0
4431186|NCT00400946|7214892|FG001|Overall Study|Other|0
4431187|NCT00400946|7214893|FG002|Overall Study|Other|0
4431188|NCT00400946|7214894|FG003|Overall Study|Other|0
4431189|NCT00400946|7214895|FG004|Overall Study|Other|1
4431190|NCT00400985|7214913|FG000|Overall Study|Withdrawal by Subject|5
4431191|NCT00400985|7214913|FG000|Overall Study|system modification|8
4431192|NCT00400985|7214913|FG000|Overall Study|Death|30
4431193|NCT00400985|7214913|FG000|Overall Study|Lost to Follow-up|9
4431194|NCT00401193|7214924|FG000|Overall Study|Adverse Event|1
4431195|NCT00401193|7214925|FG001|Overall Study|Adverse Event|3
4431196|NCT00401193|7214926|FG002|Overall Study|Adverse Event|1
4431197|NCT00401193|7214924|FG000|Overall Study|Protocol Violation|3
4431198|NCT00401193|7214925|FG001|Overall Study|Protocol Violation|1
4431199|NCT00401193|7214926|FG002|Overall Study|Protocol Violation|1
4431200|NCT00401193|7214924|FG000|Overall Study|Lost to Follow-up|6
4431201|NCT00401193|7214925|FG001|Overall Study|Lost to Follow-up|5
4431202|NCT00401193|7214926|FG002|Overall Study|Lost to Follow-up|1
4431203|NCT00401193|7214924|FG000|Overall Study|Withdrawal by Subject|2
4431204|NCT00401193|7214925|FG001|Overall Study|Withdrawal by Subject|0
4630086|NCT03846453|7498648|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6
4630087|NCT03846453|7498649|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5
4630088|NCT03846453|7498647|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0
4630089|NCT03846453|7498648|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2
4431205|NCT00401193|7214926|FG002|Overall Study|Withdrawal by Subject|1
4630090|NCT03846453|7498649|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4
4630091|NCT03846453|7498647|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0
4630092|NCT03846453|7498648|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2
4630093|NCT03846453|7498649|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4
4630094|NCT03846453|7498647|FG000|Randomized Treatment Period (Days 57±3)|Other|0
4630095|NCT03846453|7498648|FG001|Randomized Treatment Period (Days 57±3)|Other|1
4630096|NCT03846453|7498649|FG002|Randomized Treatment Period (Days 57±3)|Other|4
4633304|NCT01910129|7503353|FG000|Randomized Phase 3|Withdrawal by Subject|0
4633305|NCT01910129|7503354|FG001|Randomized Phase 3|Withdrawal by Subject|1
4633306|NCT01910129|7503355|FG002|Randomized Phase 3|Withdrawal by Subject|0
4633307|NCT01910181|7503373|FG000|Overall Study|Death|37
4633308|NCT01910181|7503373|FG000|Overall Study|Lost to Follow-up|3
4633309|NCT01910181|7503373|FG000|Overall Study|Study Terminated by Sponsor|6
4633310|NCT01910298|7503380|FG000|Overall Study|Adverse Event|1
4716276|NCT02989389|7645489|FG007|Period 1|Lost to Follow-up|0
4431206|NCT00401193|7214924|FG000|Overall Study|Other Event|3
4431207|NCT00401193|7214925|FG001|Overall Study|Other Event|2
4431208|NCT00401193|7214926|FG002|Overall Study|Other Event|2
4431209|NCT00401245|7214939|FG000|Double Blind Titration Phase|Adverse Event|3
4431210|NCT00401245|7214940|FG001|Double Blind Titration Phase|Adverse Event|2
4431211|NCT00401245|7214941|FG002|Double Blind Titration Phase|Adverse Event|5
4431212|NCT00401245|7214942|FG003|Double Blind Titration Phase|Adverse Event|12
4431213|NCT00401245|7214943|FG004|Double Blind Titration Phase|Adverse Event|0
4431214|NCT00401245|7214944|FG005|Double Blind Titration Phase|Adverse Event|0
4431215|NCT00401245|7214945|FG006|Double Blind Titration Phase|Adverse Event|0
4431216|NCT00401245|7214946|FG007|Double Blind Titration Phase|Adverse Event|0
4431217|NCT00401245|7214939|FG000|Double Blind Titration Phase|Other|0
4431218|NCT00401245|7214940|FG001|Double Blind Titration Phase|Other|0
4431219|NCT00401245|7214941|FG002|Double Blind Titration Phase|Other|1
4431220|NCT00401245|7214942|FG003|Double Blind Titration Phase|Other|0
4431221|NCT00401245|7214943|FG004|Double Blind Titration Phase|Other|0
4431222|NCT00401245|7214944|FG005|Double Blind Titration Phase|Other|0
4431223|NCT00401245|7214945|FG006|Double Blind Titration Phase|Other|0
4431224|NCT00401245|7214946|FG007|Double Blind Titration Phase|Other|0
4431225|NCT00401245|7214939|FG000|Double Blind Titration Phase|Protocol Violation|0
4431226|NCT00401245|7214940|FG001|Double Blind Titration Phase|Protocol Violation|0
4431227|NCT00401245|7214941|FG002|Double Blind Titration Phase|Protocol Violation|0
4431228|NCT00401245|7214942|FG003|Double Blind Titration Phase|Protocol Violation|1
4431229|NCT00401245|7214943|FG004|Double Blind Titration Phase|Protocol Violation|0
4633311|NCT01910298|7503381|FG001|Overall Study|Adverse Event|0
4716277|NCT02989389|7645490|FG008|Period 1|Lost to Follow-up|0
4716278|NCT02989389|7645491|FG009|Period 1|Lost to Follow-up|0
4716279|NCT02989389|7645482|FG000|Period 1|Physician Decision|0
4716280|NCT02989389|7645483|FG001|Period 1|Physician Decision|0
4716281|NCT02989389|7645484|FG002|Period 1|Physician Decision|0
4716282|NCT02989389|7645485|FG003|Period 1|Physician Decision|0
4431230|NCT00401245|7214944|FG005|Double Blind Titration Phase|Protocol Violation|0
4431231|NCT00401245|7214945|FG006|Double Blind Titration Phase|Protocol Violation|0
4431232|NCT00401245|7214946|FG007|Double Blind Titration Phase|Protocol Violation|0
4431233|NCT00401245|7214939|FG000|Double Blind Titration Phase|Withdrawal by Subject|1
4431234|NCT00401245|7214940|FG001|Double Blind Titration Phase|Withdrawal by Subject|1
4431235|NCT00401245|7214941|FG002|Double Blind Titration Phase|Withdrawal by Subject|0
4633312|NCT01910298|7503380|FG000|Overall Study|Withdrawal by Subject|2
4431236|NCT00401245|7214942|FG003|Double Blind Titration Phase|Withdrawal by Subject|2
4431237|NCT00401245|7214943|FG004|Double Blind Titration Phase|Withdrawal by Subject|0
4431238|NCT00401245|7214944|FG005|Double Blind Titration Phase|Withdrawal by Subject|0
4431239|NCT00401245|7214945|FG006|Double Blind Titration Phase|Withdrawal by Subject|0
4431240|NCT00401245|7214946|FG007|Double Blind Titration Phase|Withdrawal by Subject|0
4431241|NCT00401245|7214939|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0
4431242|NCT00401245|7214940|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2
4431243|NCT00401245|7214941|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0
4431244|NCT00401245|7214942|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2
4431245|NCT00401245|7214943|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0
4431246|NCT00401245|7214944|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0
4431247|NCT00401245|7214945|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0
4431248|NCT00401245|7214946|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0
4431249|NCT00401245|7214939|FG000|Open Label Phase|Adverse Event|5
4431250|NCT00401245|7214940|FG001|Open Label Phase|Adverse Event|14
4431251|NCT00401245|7214941|FG002|Open Label Phase|Adverse Event|6
4431252|NCT00401245|7214942|FG003|Open Label Phase|Adverse Event|7
4431253|NCT00401245|7214943|FG004|Open Label Phase|Adverse Event|0
4431254|NCT00401245|7214944|FG005|Open Label Phase|Adverse Event|0
4431255|NCT00401245|7214945|FG006|Open Label Phase|Adverse Event|0
4431256|NCT00401245|7214946|FG007|Open Label Phase|Adverse Event|0
4431257|NCT00401245|7214939|FG000|Open Label Phase|Lost to Follow-up|5
4431258|NCT00401245|7214940|FG001|Open Label Phase|Lost to Follow-up|7
4431259|NCT00401245|7214941|FG002|Open Label Phase|Lost to Follow-up|5
4431260|NCT00401245|7214942|FG003|Open Label Phase|Lost to Follow-up|4
4431261|NCT00401245|7214943|FG004|Open Label Phase|Lost to Follow-up|0
4431262|NCT00401245|7214944|FG005|Open Label Phase|Lost to Follow-up|0
4431263|NCT00401245|7214945|FG006|Open Label Phase|Lost to Follow-up|0
4431264|NCT00401245|7214946|FG007|Open Label Phase|Lost to Follow-up|0
4431265|NCT00401245|7214939|FG000|Open Label Phase|Other|4
4431266|NCT00401245|7214940|FG001|Open Label Phase|Other|8
4431267|NCT00401245|7214941|FG002|Open Label Phase|Other|7
4431268|NCT00401245|7214942|FG003|Open Label Phase|Other|8
4431269|NCT00401245|7214943|FG004|Open Label Phase|Other|0
4431270|NCT00401245|7214944|FG005|Open Label Phase|Other|0
4431271|NCT00401245|7214945|FG006|Open Label Phase|Other|0
4431272|NCT00401245|7214946|FG007|Open Label Phase|Other|0
4431273|NCT00401245|7214939|FG000|Open Label Phase|Protocol Violation|0
4431274|NCT00401245|7214940|FG001|Open Label Phase|Protocol Violation|1
4431275|NCT00401245|7214941|FG002|Open Label Phase|Protocol Violation|0
4431276|NCT00401245|7214942|FG003|Open Label Phase|Protocol Violation|1
4431277|NCT00401245|7214943|FG004|Open Label Phase|Protocol Violation|0
4431278|NCT00401245|7214944|FG005|Open Label Phase|Protocol Violation|0
4431279|NCT00401245|7214945|FG006|Open Label Phase|Protocol Violation|0
4431280|NCT00401245|7214946|FG007|Open Label Phase|Protocol Violation|0
4431281|NCT00401245|7214939|FG000|Open Label Phase|Withdrawal by Subject|3
4431282|NCT00401245|7214940|FG001|Open Label Phase|Withdrawal by Subject|3
4431283|NCT00401245|7214941|FG002|Open Label Phase|Withdrawal by Subject|2
4431284|NCT00401245|7214942|FG003|Open Label Phase|Withdrawal by Subject|1
4431285|NCT00401245|7214943|FG004|Open Label Phase|Withdrawal by Subject|0
4431286|NCT00401245|7214944|FG005|Open Label Phase|Withdrawal by Subject|0
4431287|NCT00401245|7214945|FG006|Open Label Phase|Withdrawal by Subject|0
4431288|NCT00401245|7214946|FG007|Open Label Phase|Withdrawal by Subject|0
4431289|NCT00401245|7214939|FG000|Open Label Phase|Lack of Efficacy|4
4431290|NCT00401245|7214940|FG001|Open Label Phase|Lack of Efficacy|2
4431291|NCT00401245|7214941|FG002|Open Label Phase|Lack of Efficacy|3
4431292|NCT00401245|7214942|FG003|Open Label Phase|Lack of Efficacy|0
4431293|NCT00401245|7214943|FG004|Open Label Phase|Lack of Efficacy|0
4431294|NCT00401245|7214944|FG005|Open Label Phase|Lack of Efficacy|0
4431295|NCT00401245|7214945|FG006|Open Label Phase|Lack of Efficacy|0
4431296|NCT00401245|7214946|FG007|Open Label Phase|Lack of Efficacy|0
4431297|NCT00401245|7214939|FG000|Double Blind Tapering Phase|Adverse Event|0
4431298|NCT00401245|7214940|FG001|Double Blind Tapering Phase|Adverse Event|0
4431299|NCT00401245|7214941|FG002|Double Blind Tapering Phase|Adverse Event|0
4431300|NCT00401245|7214942|FG003|Double Blind Tapering Phase|Adverse Event|0
4431301|NCT00401245|7214943|FG004|Double Blind Tapering Phase|Adverse Event|1
4431302|NCT00401245|7214944|FG005|Double Blind Tapering Phase|Adverse Event|1
4431303|NCT00401245|7214945|FG006|Double Blind Tapering Phase|Adverse Event|2
4431304|NCT00401245|7214946|FG007|Double Blind Tapering Phase|Adverse Event|4
4431305|NCT00401245|7214939|FG000|Double Blind Tapering Phase|Investigator request|0
4431306|NCT00401245|7214940|FG001|Double Blind Tapering Phase|Investigator request|0
4431307|NCT00401245|7214941|FG002|Double Blind Tapering Phase|Investigator request|0
4431308|NCT00401245|7214942|FG003|Double Blind Tapering Phase|Investigator request|0
4431309|NCT00401245|7214943|FG004|Double Blind Tapering Phase|Investigator request|0
4431310|NCT00401245|7214944|FG005|Double Blind Tapering Phase|Investigator request|0
4431311|NCT00401245|7214945|FG006|Double Blind Tapering Phase|Investigator request|0
4431312|NCT00401245|7214946|FG007|Double Blind Tapering Phase|Investigator request|1
4431313|NCT00401245|7214939|FG000|Double Blind Tapering Phase|Other|0
4431314|NCT00401245|7214940|FG001|Double Blind Tapering Phase|Other|0
4431315|NCT00401245|7214941|FG002|Double Blind Tapering Phase|Other|0
4431316|NCT00401245|7214942|FG003|Double Blind Tapering Phase|Other|0
4431317|NCT00401245|7214943|FG004|Double Blind Tapering Phase|Other|1
4431318|NCT00401245|7214944|FG005|Double Blind Tapering Phase|Other|0
4431319|NCT00401245|7214945|FG006|Double Blind Tapering Phase|Other|2
4431320|NCT00401245|7214946|FG007|Double Blind Tapering Phase|Other|2
4431321|NCT00401245|7214939|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0
4431322|NCT00401245|7214940|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0
4431323|NCT00401245|7214941|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0
4431324|NCT00401245|7214942|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0
4431325|NCT00401245|7214943|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2
4431326|NCT00401245|7214944|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2
4431327|NCT00401245|7214945|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3
4431328|NCT00401245|7214946|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0
4431329|NCT00401245|7214939|FG000|Double Blind Tapering Phase|Lack of Efficacy|0
4431330|NCT00401245|7214940|FG001|Double Blind Tapering Phase|Lack of Efficacy|0
4431331|NCT00401245|7214941|FG002|Double Blind Tapering Phase|Lack of Efficacy|0
4431332|NCT00401245|7214942|FG003|Double Blind Tapering Phase|Lack of Efficacy|0
4431333|NCT00401245|7214943|FG004|Double Blind Tapering Phase|Lack of Efficacy|0
4431334|NCT00401245|7214944|FG005|Double Blind Tapering Phase|Lack of Efficacy|1
4431335|NCT00401245|7214945|FG006|Double Blind Tapering Phase|Lack of Efficacy|0
4431336|NCT00401245|7214946|FG007|Double Blind Tapering Phase|Lack of Efficacy|0
4431337|NCT00401258|7214966|FG000|Overall Study|Adverse Event|7
4431338|NCT00401375|7214973|FG000|Overall Study|Protocol Violation|2
4431339|NCT00401375|7214974|FG001|Overall Study|Protocol Violation|2
4431340|NCT00401375|7214975|FG002|Overall Study|Protocol Violation|1
4431341|NCT00401375|7214973|FG000|Overall Study|Adverse Event|6
4431342|NCT00401375|7214974|FG001|Overall Study|Adverse Event|11
4431343|NCT00401375|7214975|FG002|Overall Study|Adverse Event|10
4431344|NCT00401375|7214973|FG000|Overall Study|Withdrawal by Subject|9
4431345|NCT00401375|7214974|FG001|Overall Study|Withdrawal by Subject|7
4431346|NCT00401375|7214975|FG002|Overall Study|Withdrawal by Subject|7
4431347|NCT00401375|7214973|FG000|Overall Study|Lost to Follow-up|0
4431348|NCT00401375|7214974|FG001|Overall Study|Lost to Follow-up|1
4431349|NCT00401375|7214975|FG002|Overall Study|Lost to Follow-up|1
4431350|NCT00401375|7214973|FG000|Overall Study|Other than specified|2
4431351|NCT00401375|7214974|FG001|Overall Study|Other than specified|1
4431352|NCT00401375|7214975|FG002|Overall Study|Other than specified|3
4431353|NCT00401375|7214973|FG000|Overall Study|Randomized but not treated|3
4431354|NCT00401375|7214974|FG001|Overall Study|Randomized but not treated|3
4431355|NCT00401375|7214975|FG002|Overall Study|Randomized but not treated|3
4431356|NCT00401531|7215034|FG000|Overall Study|Adverse Event|2
4431357|NCT00401531|7215035|FG001|Overall Study|Adverse Event|0
4431358|NCT00401531|7215034|FG000|Overall Study|Protocol Violation|3
4431359|NCT00401531|7215035|FG001|Overall Study|Protocol Violation|7
4431360|NCT00401531|7215034|FG000|Overall Study|Lost to Follow-up|1
4431361|NCT00401531|7215035|FG001|Overall Study|Lost to Follow-up|1
4431362|NCT00401531|7215034|FG000|Overall Study|Withdrawal by Subject|3
4431363|NCT00401531|7215035|FG001|Overall Study|Withdrawal by Subject|2
4431364|NCT00401544|7215045|FG000|Overall Study|Adverse Event|5
4431365|NCT00401544|7215046|FG001|Overall Study|Adverse Event|1
4431366|NCT00401544|7215047|FG002|Overall Study|Adverse Event|1
4431367|NCT00401544|7215048|FG003|Overall Study|Adverse Event|1
4431368|NCT00401544|7215045|FG000|Overall Study|Death|3
4431369|NCT00401544|7215046|FG001|Overall Study|Death|6
4431370|NCT00401544|7215047|FG002|Overall Study|Death|2
4431371|NCT00401544|7215048|FG003|Overall Study|Death|5
4431372|NCT00401544|7215045|FG000|Overall Study|Lost to Follow-up|2
4431373|NCT00401544|7215046|FG001|Overall Study|Lost to Follow-up|0
4431374|NCT00401544|7215047|FG002|Overall Study|Lost to Follow-up|1
4431375|NCT00401544|7215048|FG003|Overall Study|Lost to Follow-up|1
4431376|NCT00401544|7215045|FG000|Overall Study|Withdrawal by Subject|7
4431377|NCT00401544|7215046|FG001|Overall Study|Withdrawal by Subject|6
4431378|NCT00401544|7215047|FG002|Overall Study|Withdrawal by Subject|6
4431379|NCT00401544|7215048|FG003|Overall Study|Withdrawal by Subject|5
4431380|NCT00401544|7215045|FG000|Overall Study|Physician Decision|1
4431381|NCT00401544|7215046|FG001|Overall Study|Physician Decision|3
4431382|NCT00401544|7215047|FG002|Overall Study|Physician Decision|0
4431383|NCT00401544|7215048|FG003|Overall Study|Physician Decision|0
4431384|NCT00401544|7215045|FG000|Overall Study|Ineligibility determined|0
4431385|NCT00401544|7215046|FG001|Overall Study|Ineligibility determined|1
4431386|NCT00401544|7215047|FG002|Overall Study|Ineligibility determined|0
4431387|NCT00401544|7215048|FG003|Overall Study|Ineligibility determined|2
4431388|NCT00401544|7215045|FG000|Overall Study|Disease progression|0
4431389|NCT00401544|7215046|FG001|Overall Study|Disease progression|1
4431390|NCT00401544|7215047|FG002|Overall Study|Disease progression|0
4431391|NCT00401544|7215048|FG003|Overall Study|Disease progression|0
4431392|NCT00401544|7215045|FG000|Overall Study|Other|0
4431393|NCT00401544|7215046|FG001|Overall Study|Other|0
4431394|NCT00401544|7215047|FG002|Overall Study|Other|2
4431395|NCT00401544|7215048|FG003|Overall Study|Other|2
4431396|NCT00401726|7215074|FG000|Overall Study|Adverse Event|34
4431397|NCT00401726|7215075|FG001|Overall Study|Adverse Event|45
4431398|NCT00401726|7215074|FG000|Overall Study|Death|0
4431399|NCT00401726|7215075|FG001|Overall Study|Death|3
4431400|NCT00401726|7215074|FG000|Overall Study|Sponsor Request|0
4431401|NCT00401726|7215075|FG001|Overall Study|Sponsor Request|1
4431402|NCT00401726|7215074|FG000|Overall Study|Physician Decision|3
4431403|NCT00401726|7215075|FG001|Overall Study|Physician Decision|6
4431404|NCT00401726|7215074|FG000|Overall Study|Lost to Follow-up|23
4431405|NCT00401726|7215075|FG001|Overall Study|Lost to Follow-up|20
4431406|NCT00401726|7215074|FG000|Overall Study|Protocol Violation|6
4431407|NCT00401726|7215075|FG001|Overall Study|Protocol Violation|3
4431408|NCT00401726|7215074|FG000|Overall Study|Withdrawal by Subject|18
4431409|NCT00401726|7215075|FG001|Overall Study|Withdrawal by Subject|24
4431410|NCT00401726|7215074|FG000|Overall Study|Lack of Efficacy|4
4431411|NCT00401726|7215075|FG001|Overall Study|Lack of Efficacy|6
4431412|NCT00401726|7215074|FG000|Overall Study|Protocol Deviation|9
4431413|NCT00401726|7215075|FG001|Overall Study|Protocol Deviation|4
4431414|NCT00401752|7215083|FG000|Overall Study|Adverse Event|2
4431415|NCT00401752|7215084|FG001|Overall Study|Adverse Event|5
4431416|NCT00401752|7215083|FG000|Overall Study|Withdrawal by Subject|2
4431417|NCT00401752|7215084|FG001|Overall Study|Withdrawal by Subject|6
4431418|NCT00401752|7215083|FG000|Overall Study|Lost to Follow-up|1
4431419|NCT00401752|7215084|FG001|Overall Study|Lost to Follow-up|4
4431420|NCT00401752|7215083|FG000|Overall Study|Development of any exclusion criteria|4
4431421|NCT00401752|7215084|FG001|Overall Study|Development of any exclusion criteria|2
4431422|NCT00401752|7215083|FG000|Overall Study|Physician Decision|1
4431423|NCT00401752|7215084|FG001|Overall Study|Physician Decision|1
4431424|NCT00401830|7215110|FG000|Overall Study|Adverse Event|10
4431425|NCT00401830|7215111|FG001|Overall Study|Adverse Event|18
4431426|NCT00401830|7215110|FG000|Overall Study|Lack of Efficacy|11
4431427|NCT00401830|7215111|FG001|Overall Study|Lack of Efficacy|5
4431428|NCT00401830|7215110|FG000|Overall Study|Withdrawal by Subject|4
4431429|NCT00401830|7215111|FG001|Overall Study|Withdrawal by Subject|3
4431430|NCT00401830|7215110|FG000|Overall Study|Protocol Violation|3
4431431|NCT00401830|7215111|FG001|Overall Study|Protocol Violation|3
4431432|NCT00401830|7215110|FG000|Overall Study|Non-compliance with drug study|1
4431433|NCT00401830|7215111|FG001|Overall Study|Non-compliance with drug study|0
4431434|NCT00401830|7215110|FG000|Overall Study|Lost to Follow-up|1
4431435|NCT00401830|7215111|FG001|Overall Study|Lost to Follow-up|3
4431436|NCT00401830|7215110|FG000|Overall Study|Other: Personal / Family problems|1
4431437|NCT00401830|7215111|FG001|Overall Study|Other: Personal / Family problems|0
4431438|NCT00401843|7215120|FG000|Overall Study|Achieved Complete Response|1
4431439|NCT00401843|7215121|FG001|Overall Study|Achieved Complete Response|5
4431440|NCT00401843|7215122|FG002|Overall Study|Achieved Complete Response|11
4431441|NCT00401843|7215120|FG000|Overall Study|Adverse Event|7
4431442|NCT00401843|7215121|FG001|Overall Study|Adverse Event|26
4431443|NCT00401843|7215122|FG002|Overall Study|Adverse Event|27
4431444|NCT00401843|7215120|FG000|Overall Study|Death|0
4431445|NCT00401843|7215121|FG001|Overall Study|Death|8
4431446|NCT00401843|7215122|FG002|Overall Study|Death|10
4431447|NCT00401843|7215120|FG000|Overall Study|Disease progression|10
4431448|NCT00401843|7215121|FG001|Overall Study|Disease progression|60
4431449|NCT00401843|7215122|FG002|Overall Study|Disease progression|49
4431450|NCT00401843|7215120|FG000|Overall Study|End of Study|1
4431451|NCT00401843|7215121|FG001|Overall Study|End of Study|1
4431452|NCT00401843|7215122|FG002|Overall Study|End of Study|2
4431453|NCT00401843|7215120|FG000|Overall Study|Lost to Follow-up|0
4431454|NCT00401843|7215121|FG001|Overall Study|Lost to Follow-up|0
4431455|NCT00401843|7215122|FG002|Overall Study|Lost to Follow-up|2
4431456|NCT00401843|7215120|FG000|Overall Study|Other Unspecified|0
4431457|NCT00401843|7215121|FG001|Overall Study|Other Unspecified|3
4431458|NCT00401843|7215122|FG002|Overall Study|Other Unspecified|5
4431459|NCT00401843|7215120|FG000|Overall Study|Physician Decision|0
4431460|NCT00401843|7215121|FG001|Overall Study|Physician Decision|16
4431461|NCT00401843|7215122|FG002|Overall Study|Physician Decision|10
4431462|NCT00401843|7215120|FG000|Overall Study|Protocol Violation|0
4431463|NCT00401843|7215121|FG001|Overall Study|Protocol Violation|0
4431464|NCT00401843|7215122|FG002|Overall Study|Protocol Violation|1
4431465|NCT00401843|7215120|FG000|Overall Study|Withdrawal by Subject|1
4431466|NCT00401843|7215121|FG001|Overall Study|Withdrawal by Subject|5
4431467|NCT00401843|7215122|FG002|Overall Study|Withdrawal by Subject|5
4431468|NCT00401843|7215120|FG000|Overall Study|Withdrawal of consent to study agent|1
4431469|NCT00401843|7215121|FG001|Overall Study|Withdrawal of consent to study agent|15
4431470|NCT00401843|7215122|FG002|Overall Study|Withdrawal of consent to study agent|17
4431471|NCT00401843|7215120|FG000|Overall Study|Randomized but not Treated|0
4431472|NCT00401843|7215121|FG001|Overall Study|Randomized but not Treated|2
4431473|NCT00401843|7215122|FG002|Overall Study|Randomized but not Treated|3
4431474|NCT00401843|7215120|FG000|Overall Study|Received incorrect treatment|0
4431475|NCT00401843|7215121|FG001|Overall Study|Received incorrect treatment|3
4431476|NCT00401843|7215122|FG002|Overall Study|Received incorrect treatment|0
4431477|NCT00401960|7215149|FG000|Overall Study|Lost to Follow-up|3
4431478|NCT00401960|7215150|FG001|Overall Study|Lost to Follow-up|0
4431479|NCT00401960|7215149|FG000|Overall Study|Death|2
4431480|NCT00401960|7215150|FG001|Overall Study|Death|0
4431481|NCT00401973|7215161|FG000|Overall Study|Adverse Event|2
4431482|NCT00401973|7215162|FG001|Overall Study|Adverse Event|8
4431483|NCT00401973|7215163|FG002|Overall Study|Adverse Event|4
4431484|NCT00401973|7215161|FG000|Overall Study|Clinical Relapse|0
4431485|NCT00401973|7215162|FG001|Overall Study|Clinical Relapse|1
4431486|NCT00401973|7215163|FG002|Overall Study|Clinical Relapse|1
4431487|NCT00401973|7215161|FG000|Overall Study|Lack of Efficacy|0
4431488|NCT00401973|7215162|FG001|Overall Study|Lack of Efficacy|0
4431489|NCT00401973|7215163|FG002|Overall Study|Lack of Efficacy|3
4431490|NCT00401973|7215161|FG000|Overall Study|Lost to Follow-up|2
4431491|NCT00401973|7215162|FG001|Overall Study|Lost to Follow-up|2
4431492|NCT00401973|7215163|FG002|Overall Study|Lost to Follow-up|2
4431493|NCT00401973|7215161|FG000|Overall Study|Physician Decision|2
4431494|NCT00401973|7215162|FG001|Overall Study|Physician Decision|0
4431495|NCT00401973|7215163|FG002|Overall Study|Physician Decision|1
4431496|NCT00401973|7215161|FG000|Overall Study|Protocol Violation|1
4431497|NCT00401973|7215162|FG001|Overall Study|Protocol Violation|2
4431498|NCT00401973|7215163|FG002|Overall Study|Protocol Violation|3
4431499|NCT00401973|7215161|FG000|Overall Study|Sponsor Decision|0
4431500|NCT00401973|7215162|FG001|Overall Study|Sponsor Decision|1
4431501|NCT00401973|7215163|FG002|Overall Study|Sponsor Decision|0
4431502|NCT00401973|7215161|FG000|Overall Study|Withdrawal by Subject|4
4431503|NCT00401973|7215162|FG001|Overall Study|Withdrawal by Subject|12
4431504|NCT00401973|7215163|FG002|Overall Study|Withdrawal by Subject|9
4431505|NCT00402025|7215185|FG000|Overall Study|Adverse Event|0
4431506|NCT00402025|7215186|FG001|Overall Study|Adverse Event|0
4431507|NCT00402025|7215187|FG002|Overall Study|Adverse Event|2
4431508|NCT00402025|7215185|FG000|Overall Study|Death|0
4431509|NCT00402025|7215186|FG001|Overall Study|Death|1
4431510|NCT00402025|7215187|FG002|Overall Study|Death|5
4431511|NCT00402025|7215185|FG000|Overall Study|Disease Progression|1
4431512|NCT00402025|7215186|FG001|Overall Study|Disease Progression|1
4431513|NCT00402025|7215187|FG002|Overall Study|Disease Progression|2
4431514|NCT00402025|7215185|FG000|Overall Study|Physician Decision|1
4431515|NCT00402025|7215186|FG001|Overall Study|Physician Decision|1
4431516|NCT00402025|7215187|FG002|Overall Study|Physician Decision|0
4431517|NCT00402025|7215185|FG000|Overall Study|Participant Decision|0
4431518|NCT00402025|7215186|FG001|Overall Study|Participant Decision|0
4431519|NCT00402025|7215187|FG002|Overall Study|Participant Decision|1
4431520|NCT00402051|7215197|FG000|Overall Study|Progressive Disease|13
4431521|NCT00402051|7215198|FG001|Overall Study|Progressive Disease|20
4431522|NCT00402051|7215197|FG000|Overall Study|Adverse Event|11
4431523|NCT00402051|7215198|FG001|Overall Study|Adverse Event|4
4431524|NCT00402051|7215197|FG000|Overall Study|Physician Decision|7
4431525|NCT00402051|7215198|FG001|Overall Study|Physician Decision|3
4431526|NCT00402051|7215197|FG000|Overall Study|Withdrawal by Subject|3
4431527|NCT00402051|7215198|FG001|Overall Study|Withdrawal by Subject|3
4431528|NCT00402051|7215197|FG000|Overall Study|Death - Related to Study Drug|1
4431529|NCT00402051|7215198|FG001|Overall Study|Death - Related to Study Drug|2
4431530|NCT00402051|7215197|FG000|Overall Study|Death Due to Study Disease|2
4431531|NCT00402051|7215198|FG001|Overall Study|Death Due to Study Disease|1
4431532|NCT00402051|7215197|FG000|Overall Study|Death Due to Adverse Event|0
4431533|NCT00402051|7215198|FG001|Overall Study|Death Due to Adverse Event|2
4431534|NCT00402051|7215197|FG000|Overall Study|Lost to Follow-up|1
4431535|NCT00402051|7215198|FG001|Overall Study|Lost to Follow-up|0
4431536|NCT00402103|7215206|FG000|Overall Study|Adverse Event|60
4431537|NCT00402103|7215207|FG001|Overall Study|Adverse Event|7
4431538|NCT00402103|7215206|FG000|Overall Study|Unsatisfactory therapeutic effect|1
4431539|NCT00402103|7215207|FG001|Overall Study|Unsatisfactory therapeutic effect|2
4431540|NCT00402103|7215206|FG000|Overall Study|Condition no longer requires study drug|2
4431541|NCT00402103|7215207|FG001|Overall Study|Condition no longer requires study drug|0
4431542|NCT00402103|7215206|FG000|Overall Study|Protocol Deviation|8
4431543|NCT00402103|7215207|FG001|Overall Study|Protocol Deviation|0
4431544|NCT00402103|7215206|FG000|Overall Study|Patient withdrew consent|12
4431545|NCT00402103|7215207|FG001|Overall Study|Patient withdrew consent|1
4431546|NCT00402103|7215206|FG000|Overall Study|Lost to Follow-up|6
4431547|NCT00402103|7215207|FG001|Overall Study|Lost to Follow-up|3
4431548|NCT00402103|7215206|FG000|Overall Study|Administrative problems|2
4431549|NCT00402103|7215207|FG001|Overall Study|Administrative problems|0
4431550|NCT00402116|7215220|FG000|Overall Study|Jaw infection after surgery-other|1
4431551|NCT00402116|7215221|FG001|Overall Study|Jaw infection after surgery-other|0
4431552|NCT00402116|7215222|FG002|Overall Study|Jaw infection after surgery-other|0
4431553|NCT00402116|7215220|FG000|Overall Study|Withdrawal by Subject|1
4431554|NCT00402116|7215221|FG001|Overall Study|Withdrawal by Subject|0
4431555|NCT00402116|7215222|FG002|Overall Study|Withdrawal by Subject|5
4431556|NCT00402116|7215220|FG000|Overall Study|Treatment completed per protocol|1
4431557|NCT00402116|7215221|FG001|Overall Study|Treatment completed per protocol|1
4431558|NCT00402116|7215222|FG002|Overall Study|Treatment completed per protocol|2
4431559|NCT00402116|7215220|FG000|Overall Study|other complicating disease|0
4431560|NCT00402116|7215221|FG001|Overall Study|other complicating disease|0
4431561|NCT00402116|7215222|FG002|Overall Study|other complicating disease|2
4431562|NCT00402116|7215220|FG000|Overall Study|Disease Progression|0
4431563|NCT00402116|7215221|FG001|Overall Study|Disease Progression|4
4431564|NCT00402116|7215222|FG002|Overall Study|Disease Progression|38
4431565|NCT00402116|7215220|FG000|Overall Study|mistaken thrombocytopenia|0
4431566|NCT00402116|7215221|FG001|Overall Study|mistaken thrombocytopenia|0
4431567|NCT00402116|7215222|FG002|Overall Study|mistaken thrombocytopenia|1
4431568|NCT00402116|7215220|FG000|Overall Study|decline related hyponatremia/tumor|0
4431569|NCT00402116|7215221|FG001|Overall Study|decline related hyponatremia/tumor|0
4431570|NCT00402116|7215222|FG002|Overall Study|decline related hyponatremia/tumor|1
4431571|NCT00402116|7215220|FG000|Overall Study|Adverse Event|0
4431572|NCT00402116|7215221|FG001|Overall Study|Adverse Event|1
4431573|NCT00402116|7215222|FG002|Overall Study|Adverse Event|6
4431574|NCT00402168|7215252|FG000|Randomized|Lost to Follow-up|1
4431575|NCT00402168|7215253|FG001|Randomized|Lost to Follow-up|0
4431576|NCT00402168|7215252|FG000|Randomized|Withdrawal by Subject|0
4431577|NCT00402168|7215253|FG001|Randomized|Withdrawal by Subject|1
4431578|NCT00402168|7215252|FG000|Treatment (up to 12 Months)|Death|0
4431579|NCT00402168|7215253|FG001|Treatment (up to 12 Months)|Death|1
4431580|NCT00402168|7215252|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2
4431581|NCT00402168|7215253|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0
4431582|NCT00402168|7215252|FG000|Treatment (up to 12 Months)|non-specified|0
4431583|NCT00402168|7215253|FG001|Treatment (up to 12 Months)|non-specified|1
4431584|NCT00402168|7215252|FG000|Long Term (LT)|Adverse Event|1
4431585|NCT00402168|7215253|FG001|Long Term (LT)|Adverse Event|5
4431586|NCT00402168|7215252|FG000|Long Term (LT)|Withdrawal by Subject|4
4431587|NCT00402168|7215253|FG001|Long Term (LT)|Withdrawal by Subject|7
4431588|NCT00402168|7215252|FG000|Long Term (LT)|Pregnancy|0
4431589|NCT00402168|7215253|FG001|Long Term (LT)|Pregnancy|1
4431590|NCT00402168|7215252|FG000|Long Term (LT)|Lost to Follow-up|1
4431591|NCT00402168|7215253|FG001|Long Term (LT)|Lost to Follow-up|0
4431592|NCT00402168|7215252|FG000|Long Term (LT)|Death|4
4431593|NCT00402168|7215253|FG001|Long Term (LT)|Death|0
4431594|NCT00402168|7215252|FG000|Long Term (LT)|Lack of Efficacy|0
4431595|NCT00402168|7215253|FG001|Long Term (LT)|Lack of Efficacy|2
4431596|NCT00402168|7215252|FG000|Long Term (LT)|non-specified|1
4431597|NCT00402168|7215253|FG001|Long Term (LT)|non-specified|2
4431598|NCT00402168|7215252|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2
4431599|NCT00402168|7215253|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0
4431600|NCT00402168|7215252|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4
4431601|NCT00402168|7215253|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0
4431602|NCT00402233|7215280|FG000|Overall Study|Adverse Event|1
4431603|NCT00402233|7215281|FG001|Overall Study|Adverse Event|7
4431604|NCT00402233|7215282|FG002|Overall Study|Adverse Event|9
4431605|NCT00402233|7215283|FG003|Overall Study|Adverse Event|9
4431606|NCT00402233|7215280|FG000|Overall Study|Protocol Violation|0
4431607|NCT00402233|7215281|FG001|Overall Study|Protocol Violation|1
4431608|NCT00402233|7215282|FG002|Overall Study|Protocol Violation|0
4431609|NCT00402233|7215283|FG003|Overall Study|Protocol Violation|0
4431610|NCT00402233|7215280|FG000|Overall Study|Withdrawal by Subject|2
4431611|NCT00402233|7215281|FG001|Overall Study|Withdrawal by Subject|1
4431612|NCT00402233|7215282|FG002|Overall Study|Withdrawal by Subject|2
4431613|NCT00402233|7215283|FG003|Overall Study|Withdrawal by Subject|2
4431614|NCT00402233|7215280|FG000|Overall Study|Worsening of disease under study|2
4431615|NCT00402233|7215281|FG001|Overall Study|Worsening of disease under study|0
4431616|NCT00402233|7215282|FG002|Overall Study|Worsening of disease under study|0
4431617|NCT00402233|7215283|FG003|Overall Study|Worsening of disease under study|0
4431618|NCT00402233|7215280|FG000|Overall Study|Worsening of other pre-existing disease|0
4431619|NCT00402233|7215281|FG001|Overall Study|Worsening of other pre-existing disease|1
4431620|NCT00402233|7215282|FG002|Overall Study|Worsening of other pre-existing disease|0
4431621|NCT00402233|7215283|FG003|Overall Study|Worsening of other pre-existing disease|0
4431622|NCT00402246|7215295|FG000|Overall Study|Death|62
4431623|NCT00402246|7215296|FG001|Overall Study|Death|58
4431624|NCT00402246|7215295|FG000|Overall Study|Lost to Follow-up|20
4431625|NCT00402246|7215296|FG001|Overall Study|Lost to Follow-up|28
4431626|NCT00402246|7215295|FG000|Overall Study|Withdrawal by Subject|72
4431627|NCT00402246|7215296|FG001|Overall Study|Withdrawal by Subject|87
4431628|NCT00402246|7215295|FG000|Overall Study|Physician Decision|24
4431629|NCT00402246|7215296|FG001|Overall Study|Physician Decision|26
4431630|NCT00402246|7215295|FG000|Overall Study|Protocol Violation|25
4431631|NCT00402246|7215296|FG001|Overall Study|Protocol Violation|24
4431632|NCT00402246|7215295|FG000|Overall Study|Missed Final Visit|1
4431633|NCT00402246|7215296|FG001|Overall Study|Missed Final Visit|2
4431634|NCT00402246|7215295|FG000|Overall Study|Insurance Issues|2
4431635|NCT00402246|7215296|FG001|Overall Study|Insurance Issues|1
4431636|NCT00402246|7215295|FG000|Overall Study|Heart Transplant|0
4431637|NCT00402246|7215296|FG001|Overall Study|Heart Transplant|1
4431638|NCT00402246|7215295|FG000|Overall Study|Patient's device explanted|6
4431639|NCT00402246|7215296|FG001|Overall Study|Patient's device explanted|2
4431640|NCT00402246|7215295|FG000|Overall Study|Center Closure|5
4431641|NCT00402246|7215296|FG001|Overall Study|Center Closure|3
4716283|NCT02989389|7645486|FG004|Period 1|Physician Decision|0
4716284|NCT02989389|7645487|FG005|Period 1|Physician Decision|0
4431642|NCT00402246|7215295|FG000|Overall Study|Deterioriating Condition|3
4431643|NCT00402246|7215296|FG001|Overall Study|Deterioriating Condition|2
4431644|NCT00402285|7215307|FG000|Overall Study|insufficient RNA quality|7
4431645|NCT00402285|7215308|FG001|Overall Study|insufficient RNA quality|6
4431646|NCT00402285|7215309|FG002|Overall Study|insufficient RNA quality|2
4431647|NCT00402298|7215317|FG000|Overall Study|Withdrawal by Subject|1
4431648|NCT00402298|7215318|FG001|Overall Study|Withdrawal by Subject|0
4431649|NCT00402324|7215326|FG000|Overall Study|Lost to Follow-up|11
4431650|NCT00402324|7215327|FG001|Overall Study|Lost to Follow-up|11
4716285|NCT02989389|7645488|FG006|Period 1|Physician Decision|0
4431651|NCT00402324|7215326|FG000|Overall Study|Protocol Entry Criteria Not Met|5
4431652|NCT00402324|7215327|FG001|Overall Study|Protocol Entry Criteria Not Met|4
4431653|NCT00402324|7215326|FG000|Overall Study|Protocol Violation|8
4431654|NCT00402324|7215327|FG001|Overall Study|Protocol Violation|7
4630097|NCT03607994|7498659|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1
4630098|NCT03607994|7498660|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1
4431655|NCT00402324|7215326|FG000|Overall Study|Withdrawal by Subject|5
4431656|NCT00402324|7215327|FG001|Overall Study|Withdrawal by Subject|2
4431657|NCT00402324|7215326|FG000|Overall Study|Physician Decision|2
4431658|NCT00402324|7215327|FG001|Overall Study|Physician Decision|4
4431659|NCT00402324|7215326|FG000|Overall Study|Sponsor Decision|4
4431660|NCT00402324|7215327|FG001|Overall Study|Sponsor Decision|5
4431661|NCT00402324|7215326|FG000|Overall Study|Lack of Efficacy|1
4431662|NCT00402324|7215327|FG001|Overall Study|Lack of Efficacy|4
4431663|NCT00402324|7215326|FG000|Overall Study|Adverse Event|6
4431664|NCT00402324|7215327|FG001|Overall Study|Adverse Event|4
4431665|NCT00402324|7215326|FG000|Overall Study|Death|1
4431666|NCT00402324|7215327|FG001|Overall Study|Death|0
4431667|NCT00402337|7215338|FG000|Overall Study|Adverse Event|0
4431668|NCT00402337|7215339|FG001|Overall Study|Adverse Event|2
4431669|NCT00402337|7215340|FG002|Overall Study|Adverse Event|2
4431670|NCT00402337|7215341|FG003|Overall Study|Adverse Event|3
4431671|NCT00402337|7215342|FG004|Overall Study|Adverse Event|2
4431672|NCT00402337|7215338|FG000|Overall Study|Noncompliance|0
4431673|NCT00402337|7215339|FG001|Overall Study|Noncompliance|0
4431674|NCT00402337|7215340|FG002|Overall Study|Noncompliance|0
4431675|NCT00402337|7215341|FG003|Overall Study|Noncompliance|0
4431676|NCT00402337|7215342|FG004|Overall Study|Noncompliance|2
4431677|NCT00402337|7215338|FG000|Overall Study|Withdrawal by Subject|5
4431678|NCT00402337|7215339|FG001|Overall Study|Withdrawal by Subject|3
4431679|NCT00402337|7215340|FG002|Overall Study|Withdrawal by Subject|1
4431680|NCT00402337|7215341|FG003|Overall Study|Withdrawal by Subject|6
4431681|NCT00402337|7215342|FG004|Overall Study|Withdrawal by Subject|4
4431682|NCT00402337|7215338|FG000|Overall Study|Lost to Follow-up|0
4431683|NCT00402337|7215339|FG001|Overall Study|Lost to Follow-up|0
4431684|NCT00402337|7215340|FG002|Overall Study|Lost to Follow-up|1
4431685|NCT00402337|7215341|FG003|Overall Study|Lost to Follow-up|2
4431686|NCT00402337|7215342|FG004|Overall Study|Lost to Follow-up|0
4431687|NCT00402337|7215338|FG000|Overall Study|Physician Decision|0
4431688|NCT00402337|7215339|FG001|Overall Study|Physician Decision|0
4431689|NCT00402337|7215340|FG002|Overall Study|Physician Decision|0
4431690|NCT00402337|7215341|FG003|Overall Study|Physician Decision|1
4431691|NCT00402337|7215342|FG004|Overall Study|Physician Decision|0
4431692|NCT00402337|7215338|FG000|Overall Study|Other Reason|0
4431693|NCT00402337|7215339|FG001|Overall Study|Other Reason|1
4431694|NCT00402337|7215340|FG002|Overall Study|Other Reason|0
4431695|NCT00402337|7215341|FG003|Overall Study|Other Reason|0
4431696|NCT00402337|7215342|FG004|Overall Study|Other Reason|0
4431697|NCT00402363|7215358|FG000|Overall Study|Adverse Event|9
4431698|NCT00402363|7215359|FG001|Overall Study|Adverse Event|14
4431699|NCT00402363|7215360|FG002|Overall Study|Adverse Event|2
4431700|NCT00402363|7215361|FG003|Overall Study|Adverse Event|2
4431701|NCT00402363|7215358|FG000|Overall Study|Withdrew Consent|10
4431702|NCT00402363|7215359|FG001|Overall Study|Withdrew Consent|5
4431703|NCT00402363|7215360|FG002|Overall Study|Withdrew Consent|2
4431704|NCT00402363|7215361|FG003|Overall Study|Withdrew Consent|1
4431705|NCT00402363|7215358|FG000|Overall Study|Protocol Violation|3
4431706|NCT00402363|7215359|FG001|Overall Study|Protocol Violation|5
4431707|NCT00402363|7215360|FG002|Overall Study|Protocol Violation|0
4431708|NCT00402363|7215361|FG003|Overall Study|Protocol Violation|3
4431709|NCT00402363|7215358|FG000|Overall Study|Lost to Follow-up|5
4630099|NCT03605862|7498668|FG000|Overall Study|Withdrawal by Subject|12
4630100|NCT03605862|7498669|FG001|Overall Study|Withdrawal by Subject|9
4630101|NCT03605862|7498668|FG000|Overall Study|Adverse Event|2
4630102|NCT03605862|7498669|FG001|Overall Study|Adverse Event|1
4630103|NCT03605862|7498668|FG000|Overall Study|Physician Decision|3
4630104|NCT03605862|7498669|FG001|Overall Study|Physician Decision|1
4630105|NCT03605862|7498668|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11
4630106|NCT03605862|7498669|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15
4630107|NCT03541252|7498676|FG000|Overall Study|Withdrawal by Subject|1
4431710|NCT00402363|7215359|FG001|Overall Study|Lost to Follow-up|4
4431711|NCT00402363|7215360|FG002|Overall Study|Lost to Follow-up|0
4431712|NCT00402363|7215361|FG003|Overall Study|Lost to Follow-up|2
4431713|NCT00402363|7215358|FG000|Overall Study|"Captured as Other"|6
4431714|NCT00402363|7215359|FG001|Overall Study|"Captured as Other"|2
4431715|NCT00402363|7215360|FG002|Overall Study|"Captured as Other"|2
4431716|NCT00402363|7215361|FG003|Overall Study|"Captured as Other"|2
4431717|NCT00402597|7215382|FG000|Overall Study|Death|15
4431718|NCT00402597|7215383|FG001|Overall Study|Death|7
4431719|NCT00402597|7215384|FG002|Overall Study|Death|6
4431720|NCT00402597|7215385|FG003|Overall Study|Death|4
4431721|NCT00402597|7215386|FG004|Overall Study|Death|6
4431722|NCT00402597|7215382|FG000|Overall Study|Adverse Event|81
4431723|NCT00402597|7215383|FG001|Overall Study|Adverse Event|18
4431724|NCT00402597|7215384|FG002|Overall Study|Adverse Event|106
4431725|NCT00402597|7215385|FG003|Overall Study|Adverse Event|39
4431726|NCT00402597|7215386|FG004|Overall Study|Adverse Event|71
4431727|NCT00402597|7215382|FG000|Overall Study|Lost to Follow-up|8
4431728|NCT00402597|7215383|FG001|Overall Study|Lost to Follow-up|1
4431729|NCT00402597|7215384|FG002|Overall Study|Lost to Follow-up|8
4431730|NCT00402597|7215385|FG003|Overall Study|Lost to Follow-up|2
4431731|NCT00402597|7215386|FG004|Overall Study|Lost to Follow-up|3
4431732|NCT00402597|7215382|FG000|Overall Study|Withdrawal by Subject|57
4431733|NCT00402597|7215383|FG001|Overall Study|Withdrawal by Subject|16
4431734|NCT00402597|7215384|FG002|Overall Study|Withdrawal by Subject|65
4431735|NCT00402597|7215385|FG003|Overall Study|Withdrawal by Subject|15
4431736|NCT00402597|7215386|FG004|Overall Study|Withdrawal by Subject|24
4431737|NCT00402597|7215382|FG000|Overall Study|reason not specified|30
4431738|NCT00402597|7215383|FG001|Overall Study|reason not specified|4
4431739|NCT00402597|7215384|FG002|Overall Study|reason not specified|27
4431740|NCT00402597|7215385|FG003|Overall Study|reason not specified|14
4431741|NCT00402597|7215386|FG004|Overall Study|reason not specified|20
4431742|NCT00402649|7215398|FG000|Overall Study|Lost to Follow-up|1
4431743|NCT00402649|7215398|FG000|Overall Study|Withdrawal by Subject|1
4431744|NCT00402688|7215405|FG000|Overall Study|Adverse Event|12
4431745|NCT00402688|7215406|FG001|Overall Study|Adverse Event|9
4431746|NCT00402688|7215407|FG002|Overall Study|Adverse Event|3
4431747|NCT00402688|7215405|FG000|Overall Study|Withdrawal by Subject|3
4431748|NCT00402688|7215406|FG001|Overall Study|Withdrawal by Subject|1
4431749|NCT00402688|7215407|FG002|Overall Study|Withdrawal by Subject|1
4431750|NCT00402688|7215405|FG000|Overall Study|Physician Decision|0
4431751|NCT00402688|7215406|FG001|Overall Study|Physician Decision|0
4431752|NCT00402688|7215407|FG002|Overall Study|Physician Decision|1
4431753|NCT00402688|7215405|FG000|Overall Study|Lack of Efficacy|4
4431754|NCT00402688|7215406|FG001|Overall Study|Lack of Efficacy|4
4431755|NCT00402688|7215407|FG002|Overall Study|Lack of Efficacy|5
4431756|NCT00402688|7215405|FG000|Overall Study|Protocol Violation|1
4431757|NCT00402688|7215406|FG001|Overall Study|Protocol Violation|1
4431758|NCT00402688|7215407|FG002|Overall Study|Protocol Violation|1
4431759|NCT00402688|7215405|FG000|Overall Study|Lost to Follow-up|1
4431760|NCT00402688|7215406|FG001|Overall Study|Lost to Follow-up|0
4431761|NCT00402688|7215407|FG002|Overall Study|Lost to Follow-up|2
4431762|NCT00402688|7215405|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0
4431763|NCT00402688|7215406|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1
4431764|NCT00402688|7215407|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0
4431765|NCT00402688|7215405|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0
4431766|NCT00402688|7215406|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0
4431767|NCT00402688|7215407|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1
4431768|NCT00402688|7215405|FG000|Overall Study|Patient Left Town and Forgot Medication|0
4431769|NCT00402688|7215406|FG001|Overall Study|Patient Left Town and Forgot Medication|0
4431770|NCT00402688|7215407|FG002|Overall Study|Patient Left Town and Forgot Medication|1
4431771|NCT00402727|7215428|FG000|Overall Study|Adverse Event|10
4431772|NCT00402727|7215429|FG001|Overall Study|Adverse Event|6
4431773|NCT00402727|7215428|FG000|Overall Study|Death|1
4431774|NCT00402727|7215429|FG001|Overall Study|Death|0
4431775|NCT00402727|7215428|FG000|Overall Study|Lack of Efficacy|1
4431776|NCT00402727|7215429|FG001|Overall Study|Lack of Efficacy|3
4431777|NCT00402727|7215428|FG000|Overall Study|Lost to Follow-up|24
4431778|NCT00402727|7215429|FG001|Overall Study|Lost to Follow-up|11
4431779|NCT00402727|7215428|FG000|Overall Study|Physician Decision|1
4431780|NCT00402727|7215429|FG001|Overall Study|Physician Decision|1
4431781|NCT00402727|7215428|FG000|Overall Study|Protocol Violation|0
4431782|NCT00402727|7215429|FG001|Overall Study|Protocol Violation|4
4431783|NCT00402727|7215428|FG000|Overall Study|Withdrawal by Subject|3
4431784|NCT00402727|7215429|FG001|Overall Study|Withdrawal by Subject|7
4431785|NCT00402727|7215428|FG000|Overall Study|supply problems|2
4431786|NCT00402727|7215429|FG001|Overall Study|supply problems|1
4431787|NCT00402727|7215428|FG000|Overall Study|non-compliance|0
4431788|NCT00402727|7215429|FG001|Overall Study|non-compliance|1
4431789|NCT00402740|7215435|FG000|Overall Study|Withdrawal by Subject|18
4431790|NCT00402740|7215435|FG000|Overall Study|Death|50
4431791|NCT00402740|7215435|FG000|Overall Study|Lost to Follow-up|6
4431792|NCT00402740|7215435|FG000|Overall Study|No stent. Completed FU at 30 days.|5
4431793|NCT00402740|7215435|FG000|Overall Study|Subject disposition unknown.|1
4431794|NCT00402779|7215445|FG000|Overall Study|Screen Failure|77
4431795|NCT00402779|7215446|FG001|Overall Study|Screen Failure|76
4431796|NCT00402831|7215454|FG000|Overall Study|Lost to Follow-up|1
4431797|NCT00402831|7215455|FG001|Overall Study|Lost to Follow-up|2
4431798|NCT00402831|7215454|FG000|Overall Study|Non-compliance with protocol|0
4431799|NCT00402831|7215455|FG001|Overall Study|Non-compliance with protocol|1
4431800|NCT00402987|7215471|FG000|Overall Study|Lack of Efficacy|0
4431801|NCT00402987|7215472|FG001|Overall Study|Lack of Efficacy|0
4431802|NCT00402987|7215473|FG002|Overall Study|Lack of Efficacy|1
4431803|NCT00402987|7215474|FG003|Overall Study|Lack of Efficacy|0
4431804|NCT00403130|7215529|FG000|2 Years From Start of Treatment|Not Eligible|3
4431805|NCT00403130|7215529|FG000|2 Years From Start of Treatment|Lost to Follow up|1
4431806|NCT00403130|7215529|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1
4431807|NCT00403130|7215529|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10
4431808|NCT00403234|7215537|FG000|Overall Study|Withdrawal by Subject|0
4431809|NCT00403234|7215538|FG001|Overall Study|Withdrawal by Subject|1
4431810|NCT00403234|7215539|FG002|Overall Study|Withdrawal by Subject|0
4431811|NCT00403234|7215540|FG003|Overall Study|Withdrawal by Subject|0
4431812|NCT00403234|7215537|FG000|Overall Study|Adverse Event|1
4431813|NCT00403234|7215538|FG001|Overall Study|Adverse Event|0
4431814|NCT00403234|7215539|FG002|Overall Study|Adverse Event|1
4431815|NCT00403234|7215540|FG003|Overall Study|Adverse Event|0
4431816|NCT00403260|7215552|FG000|Overall Study|Adverse Event|5
4431817|NCT00403260|7215553|FG001|Overall Study|Adverse Event|4
4431818|NCT00403260|7215552|FG000|Overall Study|Withdrawal by Subject|5
4431819|NCT00403260|7215553|FG001|Overall Study|Withdrawal by Subject|6
4431820|NCT00403260|7215552|FG000|Overall Study|Lost to Follow-up|49
4431821|NCT00403260|7215553|FG001|Overall Study|Lost to Follow-up|25
4431822|NCT00403260|7215552|FG000|Overall Study|Re-appearance of P. falciparum|34
4431823|NCT00403260|7215553|FG001|Overall Study|Re-appearance of P. falciparum|25
4431824|NCT00403260|7215552|FG000|Overall Study|P. vivax infection|26
4431825|NCT00403260|7215553|FG001|Overall Study|P. vivax infection|4
4431826|NCT00403260|7215552|FG000|Overall Study|Mixed infection with P. vivax|2
4431827|NCT00403260|7215553|FG001|Overall Study|Mixed infection with P. vivax|0
4431828|NCT00403260|7215552|FG000|Overall Study|Mixed infection with P. falciparum|1
4431829|NCT00403260|7215553|FG001|Overall Study|Mixed infection with P. falciparum|0
4431830|NCT00403260|7215552|FG000|Overall Study|P. vivax infection at screening|1
4431831|NCT00403260|7215553|FG001|Overall Study|P. vivax infection at screening|0
4431832|NCT00403260|7215552|FG000|Overall Study|P. ovale infection|1
4431833|NCT00403260|7215553|FG001|Overall Study|P. ovale infection|0
4431834|NCT00403260|7215552|FG000|Overall Study|Gametocyte re-appearance|1
4431835|NCT00403260|7215553|FG001|Overall Study|Gametocyte re-appearance|1
4431836|NCT00403260|7215552|FG000|Overall Study|Withdrawn from study accidentally|0
4431837|NCT00403260|7215553|FG001|Overall Study|Withdrawn from study accidentally|1
4512608|NCT00935818|7322527|FG000|Overall Study|Withdrawal by Subject|45
4512609|NCT00935818|7322528|FG001|Overall Study|Withdrawal by Subject|50
4512610|NCT00935818|7322527|FG000|Overall Study|Lost to Follow-up|40
4512611|NCT00935818|7322528|FG001|Overall Study|Lost to Follow-up|42
4512612|NCT00935818|7322527|FG000|Overall Study|Adverse Event|6
4512613|NCT00935818|7322528|FG001|Overall Study|Adverse Event|7
4512614|NCT00935818|7322527|FG000|Overall Study|Physician Decision|0
4512615|NCT00935818|7322528|FG001|Overall Study|Physician Decision|1
4512616|NCT00935883|7322545|FG000|Treatment Period|Physician Decision|1
4512617|NCT00935883|7322546|FG001|Treatment Period|Physician Decision|0
4512618|NCT00935883|7322545|FG000|Treatment Period|Withdrawal by Subject|0
4512619|NCT00935883|7322546|FG001|Treatment Period|Withdrawal by Subject|2
4512620|NCT00936065|7322555|FG000|Overall Study|Adverse Event|1
4512621|NCT00936065|7322556|FG001|Overall Study|Adverse Event|0
4512622|NCT00936065|7322557|FG002|Overall Study|Adverse Event|1
4512623|NCT00936065|7322555|FG000|Overall Study|Lack of Efficacy|1
4512624|NCT00936065|7322556|FG001|Overall Study|Lack of Efficacy|0
4512625|NCT00936065|7322557|FG002|Overall Study|Lack of Efficacy|1
4512626|NCT00936065|7322555|FG000|Overall Study|Lost to Follow-up|1
4512627|NCT00936065|7322556|FG001|Overall Study|Lost to Follow-up|0
4512628|NCT00936065|7322557|FG002|Overall Study|Lost to Follow-up|0
4512629|NCT00936065|7322555|FG000|Overall Study|Protocol Violation|1
4512630|NCT00936065|7322556|FG001|Overall Study|Protocol Violation|2
4512631|NCT00936065|7322557|FG002|Overall Study|Protocol Violation|1
4512632|NCT00936065|7322555|FG000|Overall Study|Withdrawal by Subject|0
4512633|NCT00936065|7322556|FG001|Overall Study|Withdrawal by Subject|2
4512634|NCT00936065|7322557|FG002|Overall Study|Withdrawal by Subject|4
4512635|NCT00936117|7322565|FG000|Overall Study|Adverse Event|7
4512636|NCT00936117|7322565|FG000|Overall Study|Unable to continue oral medication|3
4512637|NCT00936208|7322572|FG000|Overall Study|Protocol Violation|37
4512638|NCT00936208|7322573|FG001|Overall Study|Protocol Violation|22
4512639|NCT00936221|7322581|FG000|Overall Study|Withdrawal by Subject|1
4512640|NCT00936221|7322582|FG001|Overall Study|Withdrawal by Subject|1
4512641|NCT00936611|7322645|FG000|Overall Study|Progressive Disease|3
4512642|NCT00936611|7322645|FG000|Overall Study|New Systemic Therapy|22
4512643|NCT00936611|7322645|FG000|Overall Study|Lost to Follow-up|1
4512644|NCT00936611|7322645|FG000|Overall Study|Withdrawal by Subject|2
4512645|NCT00936611|7322645|FG000|Overall Study|Still on Follow-up|1
4512646|NCT00936611|7322645|FG000|Overall Study|Still on Active Therapy|7
4512647|NCT00936611|7322645|FG000|Overall Study|Ineligible for Study Drug|3
4512648|NCT00936702|7322658|FG000|Overall Study|Disease progression|34
4512649|NCT00936702|7322658|FG000|Overall Study|Adverse Event|8
4512650|NCT00936702|7322658|FG000|Overall Study|Withdrawal by Subject|2
4512651|NCT00936702|7322658|FG000|Overall Study|Alternative Treatment|1
4512652|NCT00936702|7322658|FG000|Overall Study|Other|1
4512653|NCT00936715|7322662|FG000|Overall Study|Investigators Discretion|1
4512654|NCT00936715|7322662|FG000|Overall Study|Protocol Violation|1
4512655|NCT00936715|7322662|FG000|Overall Study|Safety or Tolerability Reasons|4
4512656|NCT00936858|7322670|FG000|Overall Study|Death|3
4512657|NCT00936858|7322670|FG000|Overall Study|Progression|29
4512658|NCT00936858|7322670|FG000|Overall Study|Withdrawal by Subject|5
4512659|NCT00936858|7322670|FG000|Overall Study|Adverse Event|1
4512660|NCT00936858|7322670|FG000|Overall Study|Physician Decision|7
4431838|NCT00403273|7215561|FG000|Overall Study|Lost to Follow-up|3
4431839|NCT00403273|7215562|FG001|Overall Study|Lost to Follow-up|2
4431840|NCT00403273|7215561|FG000|Overall Study|Physician Decision|0
4431841|NCT00403273|7215562|FG001|Overall Study|Physician Decision|1
4431842|NCT00403273|7215561|FG000|Overall Study|pt. wanted to have a surgical procedure|0
4431843|NCT00403273|7215562|FG001|Overall Study|pt. wanted to have a surgical procedure|1
4431844|NCT00403390|7215572|FG000|Overall Study|Withdrawal by Subject|1
4431845|NCT00403390|7215573|FG001|Overall Study|Withdrawal by Subject|0
4431846|NCT00403390|7215572|FG000|Overall Study|samples lost|1
4431847|NCT00403390|7215573|FG001|Overall Study|samples lost|0
4431848|NCT00403390|7215572|FG000|Overall Study|non-compliant|1
4431849|NCT00403390|7215573|FG001|Overall Study|non-compliant|0
4431850|NCT00403455|7215588|FG000|Overall Study|Withdrawal by Subject|1
4431851|NCT00403481|7215592|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1
4431852|NCT00403481|7215592|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1
4431853|NCT00403481|7215592|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3
4431854|NCT00403481|7215592|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1
4431855|NCT00403481|7215592|FG000|Olm 40 mg|Adverse Event|2
4431856|NCT00403481|7215592|FG000|Olm 40 mg|Protocol Violation|1
4431857|NCT00403481|7215592|FG000|Olm 40 mg|Withdrawal by Subject|1
4431858|NCT00403481|7215592|FG000|Olm 40 mg|Other|1
4431859|NCT00403481|7215592|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2
4431860|NCT00403481|7215592|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1
4431861|NCT00403481|7215592|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1
4431862|NCT00403481|7215592|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1
4431863|NCT00403481|7215592|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1
4431864|NCT00403481|7215592|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1
4431865|NCT00403494|7215601|FG000|Overall Study|Adverse Event|10
4431866|NCT00403494|7215602|FG001|Overall Study|Adverse Event|8
4431867|NCT00403494|7215601|FG000|Overall Study|Withdrew Consent|3
4431868|NCT00403494|7215602|FG001|Overall Study|Withdrew Consent|2
4431869|NCT00403494|7215601|FG000|Overall Study|Inappropriately enrolled|0
4431870|NCT00403494|7215602|FG001|Overall Study|Inappropriately enrolled|1
4431871|NCT00403494|7215601|FG000|Overall Study|Lost to Follow-up|0
4431872|NCT00403494|7215602|FG001|Overall Study|Lost to Follow-up|2
4431873|NCT00403494|7215601|FG000|Overall Study|Protocol noncompliance|0
4431874|NCT00403494|7215602|FG001|Overall Study|Protocol noncompliance|1
4431875|NCT00403494|7215601|FG000|Overall Study|Death|1
4431876|NCT00403494|7215602|FG001|Overall Study|Death|0
4431877|NCT00403494|7215601|FG000|Overall Study|Sponsor Request|1
4431878|NCT00403494|7215602|FG001|Overall Study|Sponsor Request|0
4431879|NCT00403546|7215612|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6
4431880|NCT00403546|7215613|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0
4431881|NCT00403546|7215614|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0
4431882|NCT00403546|7215612|FG000|Signed Informed Consent/Open-Label|Early Termination|8
4431883|NCT00403546|7215613|FG001|Signed Informed Consent/Open-Label|Early Termination|0
4431884|NCT00403546|7215614|FG002|Signed Informed Consent/Open-Label|Early Termination|0
4431885|NCT00403546|7215612|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9
4431886|NCT00403546|7215613|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0
4431887|NCT00403546|7215614|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0
4431888|NCT00403546|7215612|FG000|Signed Informed Consent/Open-Label|Adverse Event|5
4431889|NCT00403546|7215613|FG001|Signed Informed Consent/Open-Label|Adverse Event|0
4431890|NCT00403546|7215614|FG002|Signed Informed Consent/Open-Label|Adverse Event|0
4431891|NCT00403546|7215612|FG000|Screening Phase|Screening Failure|22
4431892|NCT00403546|7215613|FG001|Screening Phase|Screening Failure|0
4431893|NCT00403546|7215614|FG002|Screening Phase|Screening Failure|0
4431894|NCT00403546|7215612|FG000|Screening Phase|Adverse Event|1
4431895|NCT00403546|7215613|FG001|Screening Phase|Adverse Event|0
4431896|NCT00403546|7215614|FG002|Screening Phase|Adverse Event|0
4431897|NCT00403546|7215612|FG000|Screening Phase|Terminated Prior to Randomization|5
4431898|NCT00403546|7215613|FG001|Screening Phase|Terminated Prior to Randomization|0
4431899|NCT00403546|7215614|FG002|Screening Phase|Terminated Prior to Randomization|0
4431900|NCT00403546|7215612|FG000|Randomized Trial|Early Terminations|0
4431901|NCT00403546|7215613|FG001|Randomized Trial|Early Terminations|17
4431902|NCT00403546|7215614|FG002|Randomized Trial|Early Terminations|16
4431903|NCT00403585|7215623|FG000|Initial Treatment Phase|Lost to Follow-up|2
4431904|NCT00403585|7215623|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2
4431905|NCT00403585|7215623|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4
4431906|NCT00403754|7215627|FG000|Core Treatment Period 1|Withdrawal by Subject|0
4431907|NCT00403754|7215628|FG001|Core Treatment Period 1|Withdrawal by Subject|1
4431908|NCT00403754|7215629|FG002|Core Treatment Period 1|Withdrawal by Subject|0
4431909|NCT00403754|7215630|FG003|Core Treatment Period 1|Withdrawal by Subject|0
4431910|NCT00403754|7215627|FG000|Core Treatment Period 2|Lack of Efficacy|0
4431911|NCT00403754|7215628|FG001|Core Treatment Period 2|Lack of Efficacy|0
4431912|NCT00403754|7215629|FG002|Core Treatment Period 2|Lack of Efficacy|1
4431913|NCT00403754|7215630|FG003|Core Treatment Period 2|Lack of Efficacy|0
4431914|NCT00403767|7215644|FG000|Overall Study|Adverse Event|993
4431915|NCT00403767|7215645|FG001|Overall Study|Adverse Event|919
4431916|NCT00403767|7215644|FG000|Overall Study|Non-compliant with study medication|134
4431917|NCT00403767|7215645|FG001|Overall Study|Non-compliant with study medication|164
4431918|NCT00403767|7215644|FG000|Overall Study|Consent withdrawn|671
4431919|NCT00403767|7215645|FG001|Overall Study|Consent withdrawn|673
4431920|NCT00403767|7215644|FG000|Overall Study|Investigator dec./not protocol-related|191
4431921|NCT00403767|7215645|FG001|Overall Study|Investigator dec./not protocol-related|178
4431922|NCT00403767|7215644|FG000|Overall Study|Lost to Follow-up|6
4431923|NCT00403767|7215645|FG001|Overall Study|Lost to Follow-up|8
4431924|NCT00403767|7215644|FG000|Overall Study|Protocol Violation|142
4431925|NCT00403767|7215645|FG001|Overall Study|Protocol Violation|124
4431926|NCT00403767|7215644|FG000|Overall Study|Clinical efficacy endpoint reached|300
4431927|NCT00403767|7215645|FG001|Overall Study|Clinical efficacy endpoint reached|332
4431928|NCT00403767|7215644|FG000|Overall Study|Study terminated by sponsor|82
4431929|NCT00403767|7215645|FG001|Overall Study|Study terminated by sponsor|69
4431930|NCT00403767|7215644|FG000|Overall Study|Missing/incomplete data|1
4431931|NCT00403767|7215645|FG001|Overall Study|Missing/incomplete data|1
4431932|NCT00403845|7215651|FG000|Treatment Period 1|Subject withdrew consent|1
4431933|NCT00403845|7215652|FG001|Treatment Period 1|Subject withdrew consent|0
4431934|NCT00403845|7215653|FG002|Treatment Period 1|Subject withdrew consent|0
4431935|NCT00403845|7215654|FG003|Treatment Period 1|Subject withdrew consent|0
4431936|NCT00403845|7215651|FG000|Treatment Period 1|Subject no longer needs study drug|0
4431937|NCT00403845|7215652|FG001|Treatment Period 1|Subject no longer needs study drug|0
4431938|NCT00403845|7215653|FG002|Treatment Period 1|Subject no longer needs study drug|0
4431939|NCT00403845|7215654|FG003|Treatment Period 1|Subject no longer needs study drug|1
4431940|NCT00403845|7215651|FG000|Treatment Period 2|Subject withdrew consent|1
4431941|NCT00403845|7215652|FG001|Treatment Period 2|Subject withdrew consent|0
4431942|NCT00403845|7215653|FG002|Treatment Period 2|Subject withdrew consent|0
4431943|NCT00403845|7215654|FG003|Treatment Period 2|Subject withdrew consent|0
4431944|NCT00403845|7215651|FG000|Treatment Period 3|Subject withdrew consent|0
4431945|NCT00403845|7215652|FG001|Treatment Period 3|Subject withdrew consent|0
4431946|NCT00403845|7215653|FG002|Treatment Period 3|Subject withdrew consent|0
4431947|NCT00403845|7215654|FG003|Treatment Period 3|Subject withdrew consent|1
4431948|NCT00403845|7215651|FG000|Treatment Period 3|Adverse Event|0
4431949|NCT00403845|7215652|FG001|Treatment Period 3|Adverse Event|0
4431950|NCT00403845|7215653|FG002|Treatment Period 3|Adverse Event|0
4431951|NCT00403845|7215654|FG003|Treatment Period 3|Adverse Event|1
4431952|NCT00404066|7215664|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1
4431953|NCT00404066|7215664|FG000|Overall Study|Withdrawal by Subject - Adverse event|2
4431954|NCT00404079|7215670|FG000|Overall Study|Lost to follow up, adverse event etc|22
4431955|NCT00404079|7215671|FG001|Overall Study|Lost to follow up, adverse event etc|20
4431956|NCT00404092|7215681|FG000|Overall Study|Death|1
4431957|NCT00404092|7215682|FG001|Overall Study|Death|0
4431958|NCT00404092|7215683|FG002|Overall Study|Death|0
4431959|NCT00404092|7215684|FG003|Overall Study|Death|0
4431960|NCT00404092|7215681|FG000|Overall Study|Adverse Event|0
4431961|NCT00404092|7215682|FG001|Overall Study|Adverse Event|0
4431962|NCT00404092|7215683|FG002|Overall Study|Adverse Event|1
4431963|NCT00404092|7215684|FG003|Overall Study|Adverse Event|0
4431964|NCT00404235|7215696|FG000|Overall Study|Withdrawal by Subject|1
4431965|NCT00404235|7215697|FG001|Overall Study|Withdrawal by Subject|2
4431966|NCT00404248|7215706|FG000|Overall Study|pts declining status|0
4431967|NCT00404248|7215707|FG001|Overall Study|pts declining status|1
4431968|NCT00404248|7215708|FG002|Overall Study|pts declining status|0
4431969|NCT00404248|7215709|FG003|Overall Study|pts declining status|0
4431970|NCT00404248|7215710|FG004|Overall Study|pts declining status|0
4431971|NCT00404248|7215711|FG005|Overall Study|pts declining status|0
4431972|NCT00404248|7215712|FG006|Overall Study|pts declining status|0
4431973|NCT00404248|7215713|FG007|Overall Study|pts declining status|0
4431974|NCT00404248|7215714|FG008|Overall Study|pts declining status|0
4431975|NCT00404352|7215743|FG000|Double Blind (up to 24 Month)|Adverse Event|5
4431976|NCT00404352|7215744|FG001|Double Blind (up to 24 Month)|Adverse Event|4
4431977|NCT00404352|7215745|FG002|Double Blind (up to 24 Month)|Adverse Event|6
4431978|NCT00404352|7215746|FG003|Double Blind (up to 24 Month)|Adverse Event|0
4431979|NCT00404352|7215747|FG004|Double Blind (up to 24 Month)|Adverse Event|0
4431980|NCT00404352|7215748|FG005|Double Blind (up to 24 Month)|Adverse Event|0
4431981|NCT00404352|7215749|FG006|Double Blind (up to 24 Month)|Adverse Event|0
4431982|NCT00404352|7215750|FG007|Double Blind (up to 24 Month)|Adverse Event|0
4431983|NCT00404352|7215751|FG008|Double Blind (up to 24 Month)|Adverse Event|0
4431984|NCT00404352|7215743|FG000|Double Blind (up to 24 Month)|Pregnancy|0
4431985|NCT00404352|7215744|FG001|Double Blind (up to 24 Month)|Pregnancy|0
4431986|NCT00404352|7215745|FG002|Double Blind (up to 24 Month)|Pregnancy|2
4431987|NCT00404352|7215746|FG003|Double Blind (up to 24 Month)|Pregnancy|0
4431988|NCT00404352|7215747|FG004|Double Blind (up to 24 Month)|Pregnancy|0
4431989|NCT00404352|7215748|FG005|Double Blind (up to 24 Month)|Pregnancy|0
4431990|NCT00404352|7215749|FG006|Double Blind (up to 24 Month)|Pregnancy|0
4431991|NCT00404352|7215750|FG007|Double Blind (up to 24 Month)|Pregnancy|0
4431992|NCT00404352|7215751|FG008|Double Blind (up to 24 Month)|Pregnancy|0
4431993|NCT00404352|7215743|FG000|Double Blind (up to 24 Month)|Death|0
4431994|NCT00404352|7215744|FG001|Double Blind (up to 24 Month)|Death|0
4431995|NCT00404352|7215745|FG002|Double Blind (up to 24 Month)|Death|1
4431996|NCT00404352|7215746|FG003|Double Blind (up to 24 Month)|Death|0
4431997|NCT00404352|7215747|FG004|Double Blind (up to 24 Month)|Death|0
4431998|NCT00404352|7215748|FG005|Double Blind (up to 24 Month)|Death|0
4431999|NCT00404352|7215749|FG006|Double Blind (up to 24 Month)|Death|0
4432000|NCT00404352|7215750|FG007|Double Blind (up to 24 Month)|Death|0
4432001|NCT00404352|7215751|FG008|Double Blind (up to 24 Month)|Death|0
4432002|NCT00404352|7215743|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1
4432003|NCT00404352|7215744|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2
4432004|NCT00404352|7215745|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1
4432005|NCT00404352|7215746|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0
4432006|NCT00404352|7215747|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0
4432007|NCT00404352|7215748|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0
4432008|NCT00404352|7215749|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0
4432009|NCT00404352|7215750|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0
4432010|NCT00404352|7215751|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0
4432011|NCT00404352|7215743|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11
4432012|NCT00404352|7215744|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8
4432013|NCT00404352|7215745|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7
4432014|NCT00404352|7215746|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0
4432015|NCT00404352|7215747|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0
4432016|NCT00404352|7215748|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0
4432017|NCT00404352|7215749|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0
4432018|NCT00404352|7215750|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0
4432019|NCT00404352|7215751|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0
4432020|NCT00404352|7215743|FG000|Double Blind (up to 24 Month)|Disease progression|3
4432021|NCT00404352|7215744|FG001|Double Blind (up to 24 Month)|Disease progression|0
4432022|NCT00404352|7215745|FG002|Double Blind (up to 24 Month)|Disease progression|2
4432023|NCT00404352|7215746|FG003|Double Blind (up to 24 Month)|Disease progression|0
4432024|NCT00404352|7215747|FG004|Double Blind (up to 24 Month)|Disease progression|0
4432025|NCT00404352|7215748|FG005|Double Blind (up to 24 Month)|Disease progression|0
4432026|NCT00404352|7215749|FG006|Double Blind (up to 24 Month)|Disease progression|0
4432027|NCT00404352|7215750|FG007|Double Blind (up to 24 Month)|Disease progression|0
4432028|NCT00404352|7215751|FG008|Double Blind (up to 24 Month)|Disease progression|0
4432029|NCT00404352|7215743|FG000|Double Blind (up to 24 Month)|Poor compliance|1
4432030|NCT00404352|7215744|FG001|Double Blind (up to 24 Month)|Poor compliance|0
4432031|NCT00404352|7215745|FG002|Double Blind (up to 24 Month)|Poor compliance|0
4432032|NCT00404352|7215746|FG003|Double Blind (up to 24 Month)|Poor compliance|0
4432033|NCT00404352|7215747|FG004|Double Blind (up to 24 Month)|Poor compliance|0
4432034|NCT00404352|7215748|FG005|Double Blind (up to 24 Month)|Poor compliance|0
4432035|NCT00404352|7215749|FG006|Double Blind (up to 24 Month)|Poor compliance|0
4432036|NCT00404352|7215750|FG007|Double Blind (up to 24 Month)|Poor compliance|0
4432037|NCT00404352|7215751|FG008|Double Blind (up to 24 Month)|Poor compliance|0
4432038|NCT00404352|7215743|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31
4432039|NCT00404352|7215744|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30
4432040|NCT00404352|7215745|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59
4432041|NCT00404352|7215746|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0
4432042|NCT00404352|7215747|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0
4432043|NCT00404352|7215748|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0
4432044|NCT00404352|7215749|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0
4432045|NCT00404352|7215750|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0
4432046|NCT00404352|7215751|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0
4432047|NCT00404352|7215743|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0
4432048|NCT00404352|7215744|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2
4432049|NCT00404352|7215745|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0
4432050|NCT00404352|7215746|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0
4432051|NCT00404352|7215747|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0
4432052|NCT00404352|7215748|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0
4432053|NCT00404352|7215749|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0
4432054|NCT00404352|7215750|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0
4432055|NCT00404352|7215751|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0
4432056|NCT00404352|7215743|FG000|Double Blind (up to 24 Month)|Physician Decision|0
4432057|NCT00404352|7215744|FG001|Double Blind (up to 24 Month)|Physician Decision|0
4432058|NCT00404352|7215745|FG002|Double Blind (up to 24 Month)|Physician Decision|1
4432059|NCT00404352|7215746|FG003|Double Blind (up to 24 Month)|Physician Decision|0
4432060|NCT00404352|7215747|FG004|Double Blind (up to 24 Month)|Physician Decision|0
4432061|NCT00404352|7215748|FG005|Double Blind (up to 24 Month)|Physician Decision|0
4432062|NCT00404352|7215749|FG006|Double Blind (up to 24 Month)|Physician Decision|0
4432063|NCT00404352|7215750|FG007|Double Blind (up to 24 Month)|Physician Decision|0
4432064|NCT00404352|7215751|FG008|Double Blind (up to 24 Month)|Physician Decision|0
4432065|NCT00404352|7215743|FG000|Double Blind (up to 24 Month)|Other|0
4432066|NCT00404352|7215744|FG001|Double Blind (up to 24 Month)|Other|1
4432067|NCT00404352|7215745|FG002|Double Blind (up to 24 Month)|Other|0
4432068|NCT00404352|7215746|FG003|Double Blind (up to 24 Month)|Other|0
4432069|NCT00404352|7215747|FG004|Double Blind (up to 24 Month)|Other|0
4432070|NCT00404352|7215748|FG005|Double Blind (up to 24 Month)|Other|0
4432071|NCT00404352|7215749|FG006|Double Blind (up to 24 Month)|Other|0
4432072|NCT00404352|7215750|FG007|Double Blind (up to 24 Month)|Other|0
4432073|NCT00404352|7215751|FG008|Double Blind (up to 24 Month)|Other|0
4432074|NCT00404352|7215743|FG000|Open Label (up to 24 Month)|Adverse Event|0
4432075|NCT00404352|7215744|FG001|Open Label (up to 24 Month)|Adverse Event|0
4432076|NCT00404352|7215745|FG002|Open Label (up to 24 Month)|Adverse Event|0
4432077|NCT00404352|7215746|FG003|Open Label (up to 24 Month)|Adverse Event|2
4432078|NCT00404352|7215747|FG004|Open Label (up to 24 Month)|Adverse Event|1
4432079|NCT00404352|7215748|FG005|Open Label (up to 24 Month)|Adverse Event|1
4432080|NCT00404352|7215749|FG006|Open Label (up to 24 Month)|Adverse Event|0
4432081|NCT00404352|7215750|FG007|Open Label (up to 24 Month)|Adverse Event|0
4432082|NCT00404352|7215751|FG008|Open Label (up to 24 Month)|Adverse Event|0
4432083|NCT00404352|7215743|FG000|Open Label (up to 24 Month)|Pregnancy|0
4432084|NCT00404352|7215744|FG001|Open Label (up to 24 Month)|Pregnancy|0
4432085|NCT00404352|7215745|FG002|Open Label (up to 24 Month)|Pregnancy|0
4432086|NCT00404352|7215746|FG003|Open Label (up to 24 Month)|Pregnancy|0
4432087|NCT00404352|7215747|FG004|Open Label (up to 24 Month)|Pregnancy|0
4432088|NCT00404352|7215748|FG005|Open Label (up to 24 Month)|Pregnancy|1
4432089|NCT00404352|7215749|FG006|Open Label (up to 24 Month)|Pregnancy|0
4432090|NCT00404352|7215750|FG007|Open Label (up to 24 Month)|Pregnancy|0
4432091|NCT00404352|7215751|FG008|Open Label (up to 24 Month)|Pregnancy|0
4432092|NCT00404352|7215743|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0
4432093|NCT00404352|7215744|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0
4432094|NCT00404352|7215745|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0
4432095|NCT00404352|7215746|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0
4432096|NCT00404352|7215747|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1
4432097|NCT00404352|7215748|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0
4432098|NCT00404352|7215749|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0
4432099|NCT00404352|7215750|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0
4432100|NCT00404352|7215751|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0
4432101|NCT00404352|7215743|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0
4432102|NCT00404352|7215744|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0
4432103|NCT00404352|7215745|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0
4432104|NCT00404352|7215746|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0
4432105|NCT00404352|7215747|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0
4432106|NCT00404352|7215748|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5
4432107|NCT00404352|7215749|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0
4432108|NCT00404352|7215750|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0
4432109|NCT00404352|7215751|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0
4432110|NCT00404352|7215743|FG000|Open Label (up to 24 Month)|Disease progression|0
4432111|NCT00404352|7215744|FG001|Open Label (up to 24 Month)|Disease progression|0
4432112|NCT00404352|7215745|FG002|Open Label (up to 24 Month)|Disease progression|0
4432113|NCT00404352|7215746|FG003|Open Label (up to 24 Month)|Disease progression|1
4432114|NCT00404352|7215747|FG004|Open Label (up to 24 Month)|Disease progression|0
4432115|NCT00404352|7215748|FG005|Open Label (up to 24 Month)|Disease progression|0
4432116|NCT00404352|7215749|FG006|Open Label (up to 24 Month)|Disease progression|0
4432117|NCT00404352|7215750|FG007|Open Label (up to 24 Month)|Disease progression|0
4432118|NCT00404352|7215751|FG008|Open Label (up to 24 Month)|Disease progression|0
4432119|NCT00404352|7215743|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0
4432120|NCT00404352|7215744|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0
4432121|NCT00404352|7215745|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0
4432122|NCT00404352|7215746|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0
4432123|NCT00404352|7215747|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0
4432124|NCT00404352|7215748|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0
4432125|NCT00404352|7215749|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1
4432126|NCT00404352|7215750|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1
4432127|NCT00404352|7215751|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0
4432128|NCT00404352|7215743|FG000|Open Label Extension (up to 36 Months)|Other|0
4432129|NCT00404352|7215744|FG001|Open Label Extension (up to 36 Months)|Other|0
4432130|NCT00404352|7215745|FG002|Open Label Extension (up to 36 Months)|Other|0
4432131|NCT00404352|7215746|FG003|Open Label Extension (up to 36 Months)|Other|0
4432132|NCT00404352|7215747|FG004|Open Label Extension (up to 36 Months)|Other|0
4432133|NCT00404352|7215748|FG005|Open Label Extension (up to 36 Months)|Other|0
4432134|NCT00404352|7215749|FG006|Open Label Extension (up to 36 Months)|Other|0
4432135|NCT00404352|7215750|FG007|Open Label Extension (up to 36 Months)|Other|0
4432136|NCT00404352|7215751|FG008|Open Label Extension (up to 36 Months)|Other|2
4432137|NCT00404495|7215770|FG000|Overall Study|Death|37
4432138|NCT00404495|7215771|FG001|Overall Study|Death|11
4432139|NCT00404495|7215770|FG000|Overall Study|Lost to Follow-up|5
4432140|NCT00404495|7215771|FG001|Overall Study|Lost to Follow-up|0
4432141|NCT00404495|7215770|FG000|Overall Study|Other|1
4432142|NCT00404495|7215771|FG001|Overall Study|Other|0
4432143|NCT00404495|7215770|FG000|Overall Study|Withdrawal by Subject|1
4432144|NCT00404495|7215771|FG001|Overall Study|Withdrawal by Subject|0
4432145|NCT00404547|7215779|FG000|Overall Study|Adverse Event|39
4432146|NCT00404547|7215780|FG001|Overall Study|Adverse Event|6
4432147|NCT00404547|7215779|FG000|Overall Study|Withdrawal by Subject|19
4432148|NCT00404547|7215780|FG001|Overall Study|Withdrawal by Subject|2
4432149|NCT00404547|7215779|FG000|Overall Study|Protocol Violation|0
4432150|NCT00404547|7215780|FG001|Overall Study|Protocol Violation|1
4432151|NCT00404547|7215779|FG000|Overall Study|Lost to Follow-up|20
4432152|NCT00404547|7215780|FG001|Overall Study|Lost to Follow-up|9
4432153|NCT00404547|7215779|FG000|Overall Study|Lack of compliance|5
4432154|NCT00404547|7215780|FG001|Overall Study|Lack of compliance|1
4432155|NCT00404547|7215779|FG000|Overall Study|Other|4
4432156|NCT00404547|7215780|FG001|Overall Study|Other|0
4432157|NCT00404547|7215779|FG000|Overall Study|Reason not stated|3
4432158|NCT00404547|7215780|FG001|Overall Study|Reason not stated|6
4432159|NCT00404651|7215790|FG000|Overall Study|Serious Adverse Event|0
4432160|NCT00404651|7215791|FG001|Overall Study|Serious Adverse Event|0
4432161|NCT00404651|7215792|FG002|Overall Study|Serious Adverse Event|2
4432162|NCT00404651|7215793|FG003|Overall Study|Serious Adverse Event|0
4432163|NCT00404651|7215790|FG000|Overall Study|Protocol Violation|10
4432164|NCT00404651|7215791|FG001|Overall Study|Protocol Violation|5
4432165|NCT00404651|7215792|FG002|Overall Study|Protocol Violation|14
4432166|NCT00404651|7215793|FG003|Overall Study|Protocol Violation|5
4432167|NCT00404651|7215790|FG000|Overall Study|Lost to Follow-up|15
4432168|NCT00404651|7215791|FG001|Overall Study|Lost to Follow-up|11
4432169|NCT00404651|7215792|FG002|Overall Study|Lost to Follow-up|13
4432170|NCT00404651|7215793|FG003|Overall Study|Lost to Follow-up|10
4432171|NCT00404651|7215790|FG000|Overall Study|Withdrawal by Subject|14
4432172|NCT00404651|7215791|FG001|Overall Study|Withdrawal by Subject|12
4432173|NCT00404651|7215792|FG002|Overall Study|Withdrawal by Subject|16
4432174|NCT00404651|7215793|FG003|Overall Study|Withdrawal by Subject|6
4432175|NCT00404755|7215803|FG000|Phase I (Bupropion)|Adverse Event|3
4432176|NCT00404755|7215803|FG000|Phase I (Bupropion)|Other|1
4432177|NCT00404755|7215803|FG000|Phase II (Escitalopram)|Lost to Follow-up|2
4432178|NCT00404768|7215815|FG000|Part A and B|Withdrawn due to labor progression|1
4432179|NCT00404768|7215816|FG001|Part A and B|Withdrawn due to labor progression|0
4432180|NCT00404768|7215817|FG002|Part A and B|Withdrawn due to labor progression|0
4432181|NCT00404768|7215818|FG003|Part A and B|Withdrawn due to labor progression|0
4432182|NCT00404768|7215815|FG000|Part A and B|Withdrawn as delivery imminemnt|0
4432183|NCT00404768|7215816|FG001|Part A and B|Withdrawn as delivery imminemnt|1
4432184|NCT00404768|7215817|FG002|Part A and B|Withdrawn as delivery imminemnt|0
4432185|NCT00404768|7215818|FG003|Part A and B|Withdrawn as delivery imminemnt|0
4432186|NCT00404768|7215815|FG000|Part C|Adverse Event|0
4432187|NCT00404768|7215816|FG001|Part C|Adverse Event|0
4432188|NCT00404768|7215817|FG002|Part C|Adverse Event|0
4432189|NCT00404768|7215818|FG003|Part C|Adverse Event|3
4432190|NCT00404768|7215815|FG000|Part C|Lost to Follow-up|0
4432191|NCT00404768|7215816|FG001|Part C|Lost to Follow-up|0
4432192|NCT00404768|7215817|FG002|Part C|Lost to Follow-up|3
4432193|NCT00404768|7215818|FG003|Part C|Lost to Follow-up|1
4432194|NCT00404768|7215815|FG000|Part C|Withdrawal by Subject|0
4432195|NCT00404768|7215816|FG001|Part C|Withdrawal by Subject|0
4432196|NCT00404768|7215817|FG002|Part C|Withdrawal by Subject|2
4432197|NCT00404768|7215818|FG003|Part C|Withdrawal by Subject|1
4432198|NCT00404768|7215815|FG000|Part C|Early withdrawal from study medication|0
4432199|NCT00404768|7215816|FG001|Part C|Early withdrawal from study medication|0
4432200|NCT00404768|7215817|FG002|Part C|Early withdrawal from study medication|1
4432201|NCT00404768|7215818|FG003|Part C|Early withdrawal from study medication|0
4432202|NCT00404768|7215815|FG000|Part C|Participant did not respond to therapy|0
4432203|NCT00404768|7215816|FG001|Part C|Participant did not respond to therapy|0
4432204|NCT00404768|7215817|FG002|Part C|Participant did not respond to therapy|1
4432205|NCT00404768|7215818|FG003|Part C|Participant did not respond to therapy|1
4432206|NCT00404768|7215815|FG000|Part C|Physician withdrew the study medication|0
4432207|NCT00404768|7215816|FG001|Part C|Physician withdrew the study medication|0
4432208|NCT00404768|7215817|FG002|Part C|Physician withdrew the study medication|1
4432209|NCT00404768|7215818|FG003|Part C|Physician withdrew the study medication|0
4432210|NCT00404768|7215815|FG000|Part C|Participant delivered baby|0
4432211|NCT00404768|7215816|FG001|Part C|Participant delivered baby|0
4432212|NCT00404768|7215817|FG002|Part C|Participant delivered baby|0
4432213|NCT00404768|7215818|FG003|Part C|Participant delivered baby|1
4630108|NCT03401112|7498685|FG000|Overall Study|Adverse Event|1
4432214|NCT00404768|7215815|FG000|Part C|Unsatisfactory uterine response to IP|0
4432215|NCT00404768|7215816|FG001|Part C|Unsatisfactory uterine response to IP|0
4432216|NCT00404768|7215817|FG002|Part C|Unsatisfactory uterine response to IP|0
4432217|NCT00404768|7215818|FG003|Part C|Unsatisfactory uterine response to IP|1
4432218|NCT00404768|7215815|FG000|Part C|Active labor|0
4432219|NCT00404768|7215816|FG001|Part C|Active labor|0
4432220|NCT00404768|7215817|FG002|Part C|Active labor|0
4432221|NCT00404768|7215818|FG003|Part C|Active labor|1
4432222|NCT00404768|7215815|FG000|Part C|Lack of Efficacy|0
4432223|NCT00404768|7215816|FG001|Part C|Lack of Efficacy|0
4432224|NCT00404768|7215817|FG002|Part C|Lack of Efficacy|0
4432225|NCT00404768|7215818|FG003|Part C|Lack of Efficacy|2
4432226|NCT00404768|7215815|FG000|Part C|Treatment failure|0
4432227|NCT00404768|7215816|FG001|Part C|Treatment failure|0
4432228|NCT00404768|7215817|FG002|Part C|Treatment failure|0
4432229|NCT00404768|7215818|FG003|Part C|Treatment failure|1
4432230|NCT00404768|7215815|FG000|Part C|Investigator discretion|0
4432231|NCT00404768|7215816|FG001|Part C|Investigator discretion|0
4432232|NCT00404768|7215817|FG002|Part C|Investigator discretion|0
4432233|NCT00404768|7215818|FG003|Part C|Investigator discretion|1
4432234|NCT00404768|7215815|FG000|Part C|Researcher suspended study medication|0
4432235|NCT00404768|7215816|FG001|Part C|Researcher suspended study medication|0
4432236|NCT00404768|7215817|FG002|Part C|Researcher suspended study medication|0
4432237|NCT00404768|7215818|FG003|Part C|Researcher suspended study medication|1
4432238|NCT00404820|7215835|FG000|Overall Study|Adverse Event|4
4432239|NCT00404820|7215836|FG001|Overall Study|Adverse Event|16
4432240|NCT00404820|7215835|FG000|Overall Study|Withdrawal by Subject|5
4432241|NCT00404820|7215836|FG001|Overall Study|Withdrawal by Subject|3
4432242|NCT00404820|7215835|FG000|Overall Study|Lost to Follow-up|7
4432243|NCT00404820|7215836|FG001|Overall Study|Lost to Follow-up|3
4432244|NCT00404820|7215835|FG000|Overall Study|Administrative problems|2
4432245|NCT00404820|7215836|FG001|Overall Study|Administrative problems|0
4432246|NCT00404820|7215835|FG000|Overall Study|Death|1
4432247|NCT00404820|7215836|FG001|Overall Study|Death|0
4432248|NCT00404820|7215835|FG000|Overall Study|Other|0
4432249|NCT00404820|7215836|FG001|Overall Study|Other|2
4432250|NCT00404924|7215844|FG000|Overall Study|Adverse Event|75
4432251|NCT00404924|7215845|FG001|Overall Study|Adverse Event|16
4432252|NCT00404924|7215844|FG000|Overall Study|Condition under investigation worsened|475
4432253|NCT00404924|7215845|FG001|Overall Study|Condition under investigation worsened|264
4432254|NCT00404924|7215844|FG000|Overall Study|Lost to Follow-up|1
4432255|NCT00404924|7215845|FG001|Overall Study|Lost to Follow-up|1
4432256|NCT00404924|7215844|FG000|Overall Study|Withdrawal by Subject|26
4432257|NCT00404924|7215845|FG001|Overall Study|Withdrawal by Subject|13
4432258|NCT00404924|7215844|FG000|Overall Study|Other|25
4432259|NCT00404924|7215845|FG001|Overall Study|Other|11
4432260|NCT00404924|7215844|FG000|Overall Study|Randomised but not received treatment|1
4432261|NCT00404924|7215845|FG001|Overall Study|Randomised but not received treatment|1
4432262|NCT00405067|7215854|FG000|Overall Study|Adverse Event|4
4432263|NCT00405067|7215855|FG001|Overall Study|Adverse Event|9
4432264|NCT00405067|7215856|FG002|Overall Study|Adverse Event|4
4432265|NCT00405067|7215854|FG000|Overall Study|Lost to Follow-up|0
4432266|NCT00405067|7215855|FG001|Overall Study|Lost to Follow-up|0
4432267|NCT00405067|7215856|FG002|Overall Study|Lost to Follow-up|1
4432268|NCT00405275|7215866|FG000|Overall Study|Death|1
4432269|NCT00405275|7215867|FG001|Overall Study|Death|0
4432270|NCT00405275|7215866|FG000|Overall Study|Lost to Follow-up|5
4432271|NCT00405275|7215867|FG001|Overall Study|Lost to Follow-up|1
4432272|NCT00405275|7215866|FG000|Overall Study|Withdrawal by Subject|7
4432273|NCT00405275|7215867|FG001|Overall Study|Withdrawal by Subject|9
4432274|NCT00405275|7215866|FG000|Overall Study|Unwilling to continue|10
4432275|NCT00405275|7215867|FG001|Overall Study|Unwilling to continue|9
4432276|NCT00405392|7215888|FG000|Overall Study|Adverse Event|15
4432277|NCT00405392|7215889|FG001|Overall Study|Adverse Event|14
4432278|NCT00405392|7215888|FG000|Overall Study|Did not meet Eligibility criteria|7
4432279|NCT00405392|7215889|FG001|Overall Study|Did not meet Eligibility criteria|2
4432280|NCT00405392|7215888|FG000|Overall Study|Withdrawal by Subject|4
4432281|NCT00405392|7215889|FG001|Overall Study|Withdrawal by Subject|3
4432282|NCT00405392|7215888|FG000|Overall Study|Lost to Follow-up|1
4432283|NCT00405392|7215889|FG001|Overall Study|Lost to Follow-up|2
4432284|NCT00405392|7215888|FG000|Overall Study|Data missing|2
4432285|NCT00405392|7215889|FG001|Overall Study|Data missing|0
4432286|NCT00405392|7215888|FG000|Overall Study|Non-compliance|0
4432287|NCT00405392|7215889|FG001|Overall Study|Non-compliance|1
4432288|NCT00405392|7215888|FG000|Overall Study|Other|1
4432289|NCT00405392|7215889|FG001|Overall Study|Other|5
4432290|NCT00405548|7215915|FG000|Overall Study|Cognitive Memory problems on study day|1
4432291|NCT00405548|7215916|FG001|Overall Study|Cognitive Memory problems on study day|0
4432292|NCT00405548|7215915|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0
4432293|NCT00405548|7215916|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1
4432294|NCT00405548|7215915|FG000|Overall Study|Unable to self-administer shots|1
4432295|NCT00405548|7215916|FG001|Overall Study|Unable to self-administer shots|0
4432296|NCT00405548|7215915|FG000|Overall Study|Venous access failed during study day|1
4432297|NCT00405548|7215916|FG001|Overall Study|Venous access failed during study day|0
4432298|NCT00405548|7215915|FG000|Overall Study|Withdrawal by Subject|1
4432299|NCT00405548|7215916|FG001|Overall Study|Withdrawal by Subject|0
4432300|NCT00405587|7215926|FG000|Overall Study|Death|0
4432301|NCT00405587|7215927|FG001|Overall Study|Death|0
4432302|NCT00405587|7215928|FG002|Overall Study|Death|0
4432303|NCT00405587|7215929|FG003|Overall Study|Death|1
4432304|NCT00405587|7215926|FG000|Overall Study|Disease Progression|22
4432305|NCT00405587|7215927|FG001|Overall Study|Disease Progression|23
4432306|NCT00405587|7215928|FG002|Overall Study|Disease Progression|21
4432307|NCT00405587|7215929|FG003|Overall Study|Disease Progression|17
4432308|NCT00405587|7215926|FG000|Overall Study|Physician Decision|3
4432309|NCT00405587|7215927|FG001|Overall Study|Physician Decision|2
4432310|NCT00405587|7215928|FG002|Overall Study|Physician Decision|0
4432311|NCT00405587|7215929|FG003|Overall Study|Physician Decision|0
4432312|NCT00405587|7215926|FG000|Overall Study|Adverse Event|1
4432313|NCT00405587|7215927|FG001|Overall Study|Adverse Event|0
4432314|NCT00405587|7215928|FG002|Overall Study|Adverse Event|0
4432315|NCT00405587|7215929|FG003|Overall Study|Adverse Event|0
4432316|NCT00405587|7215926|FG000|Overall Study|Lost to Follow-up|0
4432317|NCT00405587|7215927|FG001|Overall Study|Lost to Follow-up|1
4432318|NCT00405587|7215928|FG002|Overall Study|Lost to Follow-up|1
4630109|NCT03401112|7498686|FG001|Overall Study|Adverse Event|2
4432319|NCT00405587|7215929|FG003|Overall Study|Lost to Follow-up|0
4432320|NCT00405587|7215926|FG000|Overall Study|Radiation induced necrosis|0
4432321|NCT00405587|7215927|FG001|Overall Study|Radiation induced necrosis|1
4432322|NCT00405587|7215928|FG002|Overall Study|Radiation induced necrosis|0
4432323|NCT00405587|7215929|FG003|Overall Study|Radiation induced necrosis|0
4432324|NCT00405587|7215926|FG000|Overall Study|Withdrawal by Subject|0
4432325|NCT00405587|7215927|FG001|Overall Study|Withdrawal by Subject|0
4432326|NCT00405587|7215928|FG002|Overall Study|Withdrawal by Subject|0
4432327|NCT00405587|7215929|FG003|Overall Study|Withdrawal by Subject|2
4432328|NCT00405587|7215926|FG000|Overall Study|Participant not dosed|0
4432329|NCT00405587|7215927|FG001|Overall Study|Participant not dosed|1
4432330|NCT00405587|7215928|FG002|Overall Study|Participant not dosed|0
4432331|NCT00405587|7215929|FG003|Overall Study|Participant not dosed|0
4432332|NCT00405639|7215967|FG000|Overall Study|Withdrawal by Subject|1
4432333|NCT00405639|7215968|FG001|Overall Study|Withdrawal by Subject|0
4432334|NCT00405639|7215967|FG000|Overall Study|Adverse Event|1
4432335|NCT00405639|7215968|FG001|Overall Study|Adverse Event|0
4432336|NCT00405639|7215967|FG000|Overall Study|Seizure prior to receiving BNP|1
4432337|NCT00405639|7215968|FG001|Overall Study|Seizure prior to receiving BNP|0
4432338|NCT00405652|7215974|FG000|Overall Study|Adverse Event|4
4432339|NCT00405756|7215991|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45
4432340|NCT00405756|7215992|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24
4432341|NCT00405756|7215993|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18
4432342|NCT00405756|7215991|FG000|Double-blind Treatment|Adverse Event|31
4432343|NCT00405756|7215992|FG001|Double-blind Treatment|Adverse Event|27
4432344|NCT00405756|7215993|FG002|Double-blind Treatment|Adverse Event|12
4432345|NCT00405756|7215991|FG000|Double-blind Treatment|Disease Progression|47
4432346|NCT00405756|7215992|FG001|Double-blind Treatment|Disease Progression|81
4432347|NCT00405756|7215993|FG002|Double-blind Treatment|Disease Progression|102
4432348|NCT00405756|7215991|FG000|Double-blind Treatment|Lack of Efficacy|1
4432349|NCT00405756|7215992|FG001|Double-blind Treatment|Lack of Efficacy|4
4432350|NCT00405756|7215993|FG002|Double-blind Treatment|Lack of Efficacy|2
4432351|NCT00405756|7215991|FG000|Double-blind Treatment|Withdrawal by Subject|15
4432352|NCT00405756|7215992|FG001|Double-blind Treatment|Withdrawal by Subject|9
4432353|NCT00405756|7215993|FG002|Double-blind Treatment|Withdrawal by Subject|10
4432354|NCT00405756|7215991|FG000|Double-blind Treatment|Lost to Follow-up|1
4432355|NCT00405756|7215992|FG001|Double-blind Treatment|Lost to Follow-up|0
4432356|NCT00405756|7215993|FG002|Double-blind Treatment|Lost to Follow-up|0
4432357|NCT00405756|7215991|FG000|Double-blind Treatment|Death|4
4432358|NCT00405756|7215992|FG001|Double-blind Treatment|Death|4
4432359|NCT00405756|7215993|FG002|Double-blind Treatment|Death|4
4432360|NCT00405756|7215991|FG000|Double-blind Treatment|Protocol Violation|1
4630110|NCT03401112|7498687|FG002|Overall Study|Adverse Event|3
4630111|NCT03401112|7498688|FG003|Overall Study|Adverse Event|2
4630112|NCT03401112|7498689|FG004|Overall Study|Adverse Event|0
4630113|NCT03401112|7498685|FG000|Overall Study|Lost to Follow-up|1
4630114|NCT03401112|7498686|FG001|Overall Study|Lost to Follow-up|0
4432361|NCT00405756|7215992|FG001|Double-blind Treatment|Protocol Violation|0
4432362|NCT00405756|7215993|FG002|Double-blind Treatment|Protocol Violation|2
4432363|NCT00405756|7215991|FG000|Double-blind Treatment|Other|7
4432364|NCT00405756|7215992|FG001|Double-blind Treatment|Other|4
4432365|NCT00405756|7215993|FG002|Double-blind Treatment|Other|4
4432366|NCT00405756|7215991|FG000|Open-label Extension|Ongoing in Open Label Period|7
4432367|NCT00405756|7215992|FG001|Open-label Extension|Ongoing in Open Label Period|15
4432368|NCT00405756|7215993|FG002|Open-label Extension|Ongoing in Open Label Period|25
4432369|NCT00405756|7215991|FG000|Open-label Extension|Adverse Event|1
4432370|NCT00405756|7215992|FG001|Open-label Extension|Adverse Event|3
4432371|NCT00405756|7215993|FG002|Open-label Extension|Adverse Event|7
4432372|NCT00405756|7215991|FG000|Open-label Extension|Disease Progression|8
4432373|NCT00405756|7215992|FG001|Open-label Extension|Disease Progression|23
4432374|NCT00405756|7215993|FG002|Open-label Extension|Disease Progression|26
4432375|NCT00405756|7215991|FG000|Open-label Extension|Withdrawal by Subject|2
4432376|NCT00405756|7215992|FG001|Open-label Extension|Withdrawal by Subject|3
4432377|NCT00405756|7215993|FG002|Open-label Extension|Withdrawal by Subject|3
4432378|NCT00405756|7215991|FG000|Open-label Extension|Death|1
4432379|NCT00405756|7215992|FG001|Open-label Extension|Death|2
4432380|NCT00405756|7215993|FG002|Open-label Extension|Death|4
4432381|NCT00405756|7215991|FG000|Open-label Extension|Other|0
4432382|NCT00405756|7215992|FG001|Open-label Extension|Other|1
4432383|NCT00405756|7215993|FG002|Open-label Extension|Other|7
4432384|NCT00405756|7215991|FG000|Follow-up|Ongoing in Follow-up Period|52
4630115|NCT03401112|7498687|FG002|Overall Study|Lost to Follow-up|0
4630116|NCT03401112|7498688|FG003|Overall Study|Lost to Follow-up|0
4432385|NCT00405756|7215992|FG001|Follow-up|Ongoing in Follow-up Period|51
4432386|NCT00405756|7215993|FG002|Follow-up|Ongoing in Follow-up Period|60
4432387|NCT00405756|7215991|FG000|Follow-up|Death|21
4432388|NCT00405756|7215992|FG001|Follow-up|Death|31
4432389|NCT00405756|7215993|FG002|Follow-up|Death|24
4432390|NCT00405756|7215991|FG000|Follow-up|Lost to Follow-up|2
4432391|NCT00405756|7215992|FG001|Follow-up|Lost to Follow-up|8
4432392|NCT00405756|7215993|FG002|Follow-up|Lost to Follow-up|4
4432393|NCT00405821|7216003|FG000|Overall Study|Death|5
4432394|NCT00405821|7216004|FG001|Overall Study|Death|7
4432395|NCT00405821|7216003|FG000|Overall Study|Lost to Follow-up|7
4432396|NCT00405821|7216004|FG001|Overall Study|Lost to Follow-up|7
4432397|NCT00405821|7216003|FG000|Overall Study|Protocol Violation|1
4432398|NCT00405821|7216004|FG001|Overall Study|Protocol Violation|0
4432399|NCT00405821|7216003|FG000|Overall Study|initiated ART|9
4432400|NCT00405821|7216004|FG001|Overall Study|initiated ART|8
4432401|NCT00405912|7216013|FG000|Overall Study|Withdrawal by Subject|12
4432402|NCT00405912|7216014|FG001|Overall Study|Withdrawal by Subject|11
4432403|NCT00405912|7216015|FG002|Overall Study|Withdrawal by Subject|12
4432404|NCT00405912|7216013|FG000|Overall Study|Lost to Follow-up|4
4432405|NCT00405912|7216014|FG001|Overall Study|Lost to Follow-up|8
4432406|NCT00405912|7216015|FG002|Overall Study|Lost to Follow-up|4
4432407|NCT00406029|7216037|FG000|Overall Study|Adverse Event|12
4432408|NCT00406029|7216038|FG001|Overall Study|Adverse Event|2
4432409|NCT00406029|7216039|FG002|Overall Study|Adverse Event|5
4432410|NCT00406029|7216040|FG003|Overall Study|Adverse Event|10
4432411|NCT00406029|7216041|FG004|Overall Study|Adverse Event|7
4432412|NCT00406029|7216037|FG000|Overall Study|Withdrawal by Subject|3
4432413|NCT00406029|7216038|FG001|Overall Study|Withdrawal by Subject|4
4432414|NCT00406029|7216039|FG002|Overall Study|Withdrawal by Subject|2
4432415|NCT00406029|7216040|FG003|Overall Study|Withdrawal by Subject|2
4432416|NCT00406029|7216041|FG004|Overall Study|Withdrawal by Subject|0
4432417|NCT00406029|7216037|FG000|Overall Study|Protocol Violation|1
4432418|NCT00406029|7216038|FG001|Overall Study|Protocol Violation|2
4432419|NCT00406029|7216039|FG002|Overall Study|Protocol Violation|0
4432420|NCT00406029|7216040|FG003|Overall Study|Protocol Violation|2
4432421|NCT00406029|7216041|FG004|Overall Study|Protocol Violation|0
4432422|NCT00406029|7216037|FG000|Overall Study|Did Not Meet Eligibility Criteria|0
4432423|NCT00406029|7216038|FG001|Overall Study|Did Not Meet Eligibility Criteria|0
4432424|NCT00406029|7216039|FG002|Overall Study|Did Not Meet Eligibility Criteria|1
4432425|NCT00406029|7216040|FG003|Overall Study|Did Not Meet Eligibility Criteria|0
4432426|NCT00406029|7216041|FG004|Overall Study|Did Not Meet Eligibility Criteria|0
4432427|NCT00406029|7216037|FG000|Overall Study|Randomized in Error|0
4432428|NCT00406029|7216038|FG001|Overall Study|Randomized in Error|0
4432429|NCT00406029|7216039|FG002|Overall Study|Randomized in Error|2
4432430|NCT00406029|7216040|FG003|Overall Study|Randomized in Error|3
4432431|NCT00406029|7216041|FG004|Overall Study|Randomized in Error|1
4432432|NCT00406315|7216090|FG000|Overall Study|Death|1
4432433|NCT00406315|7216090|FG000|Overall Study|Adverse Event|39
4432434|NCT00406315|7216090|FG000|Overall Study|Laboratory Abnormality|4
4432435|NCT00406315|7216090|FG000|Overall Study|Lack of Efficacy|13
4432436|NCT00406315|7216090|FG000|Overall Study|Other|33
4432437|NCT00406315|7216090|FG000|Overall Study|Lost to Follow-up|21
4432438|NCT00406315|7216090|FG000|Overall Study|Withdrawal by Subject|30
4432439|NCT00406354|7216097|FG000|All Randomized Patients|Protocol Violation|0
4432440|NCT00406354|7216098|FG001|All Randomized Patients|Protocol Violation|0
4432441|NCT00406354|7216099|FG002|All Randomized Patients|Protocol Violation|1
4432442|NCT00406354|7216097|FG000|All Randomized and Treated Patients|Lack of Efficacy|7
4432443|NCT00406354|7216098|FG001|All Randomized and Treated Patients|Lack of Efficacy|4
4432444|NCT00406354|7216099|FG002|All Randomized and Treated Patients|Lack of Efficacy|17
4432445|NCT00406354|7216097|FG000|All Randomized and Treated Patients|Adverse Event|6
4432446|NCT00406354|7216098|FG001|All Randomized and Treated Patients|Adverse Event|2
4432447|NCT00406354|7216099|FG002|All Randomized and Treated Patients|Adverse Event|1
4432448|NCT00406354|7216097|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2
4432449|NCT00406354|7216098|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6
4432450|NCT00406354|7216099|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1
4432451|NCT00406354|7216097|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1
4432452|NCT00406354|7216098|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1
4432453|NCT00406354|7216099|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2
4432454|NCT00406354|7216097|FG000|All Randomized and Treated Patients|Physician Decision|0
4432455|NCT00406354|7216098|FG001|All Randomized and Treated Patients|Physician Decision|0
4432456|NCT00406354|7216099|FG002|All Randomized and Treated Patients|Physician Decision|1
4432457|NCT00406367|7216109|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4
4432458|NCT00406367|7216110|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0
4432459|NCT00406367|7216109|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1
4432460|NCT00406367|7216110|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0
4432461|NCT00406367|7216109|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0
4432462|NCT00406367|7216110|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1
4432463|NCT00406367|7216109|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0
4432464|NCT00406367|7216110|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1
4432465|NCT00406367|7216109|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2
4432466|NCT00406367|7216110|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0
4432467|NCT00406367|7216109|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6
4432468|NCT00406367|7216110|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0
4432469|NCT00406367|7216109|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4
4432470|NCT00406367|7216110|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0
4432471|NCT00406367|7216109|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4
4432472|NCT00406367|7216110|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0
4432473|NCT00406367|7216109|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1
4432474|NCT00406367|7216110|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0
4432475|NCT00406367|7216109|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1
4432476|NCT00406367|7216110|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0
4432477|NCT00406367|7216109|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1
4432478|NCT00406367|7216110|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0
4432479|NCT00406367|7216109|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1
4432480|NCT00406367|7216110|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0
4432481|NCT00406393|7216118|FG000|Overall Study|Did not undergo transplantation|2
4432482|NCT00406393|7216119|FG001|Overall Study|Did not undergo transplantation|1
4432483|NCT00406419|7216128|FG000|Overall Study|Death|3
4432484|NCT00406419|7216129|FG001|Overall Study|Death|1
4432485|NCT00406419|7216130|FG002|Overall Study|Death|4
4432486|NCT00406419|7216128|FG000|Overall Study|Protocol Violation|6
4432487|NCT00406419|7216129|FG001|Overall Study|Protocol Violation|2
4432488|NCT00406419|7216130|FG002|Overall Study|Protocol Violation|5
4432489|NCT00406419|7216128|FG000|Overall Study|Study Terminated by Sponsor|260
4432490|NCT00406419|7216129|FG001|Overall Study|Study Terminated by Sponsor|288
4432491|NCT00406419|7216130|FG002|Overall Study|Study Terminated by Sponsor|282
4432492|NCT00406419|7216128|FG000|Overall Study|Withdrawal by Subject|17
4432493|NCT00406419|7216129|FG001|Overall Study|Withdrawal by Subject|24
4432494|NCT00406419|7216130|FG002|Overall Study|Withdrawal by Subject|26
4432495|NCT00406419|7216128|FG000|Overall Study|Lack of Efficacy|12
4432496|NCT00406419|7216129|FG001|Overall Study|Lack of Efficacy|1
4432497|NCT00406419|7216130|FG002|Overall Study|Lack of Efficacy|6
4432498|NCT00406419|7216128|FG000|Overall Study|Non-Compliance with Study Drug|5
4432499|NCT00406419|7216129|FG001|Overall Study|Non-Compliance with Study Drug|6
4432500|NCT00406419|7216130|FG002|Overall Study|Non-Compliance with Study Drug|3
4432501|NCT00406419|7216128|FG000|Overall Study|Adverse Event|10
4432502|NCT00406419|7216129|FG001|Overall Study|Adverse Event|12
4432503|NCT00406419|7216130|FG002|Overall Study|Adverse Event|16
4432504|NCT00406419|7216128|FG000|Overall Study|Lost to Follow-up|11
4432505|NCT00406419|7216129|FG001|Overall Study|Lost to Follow-up|10
4432506|NCT00406419|7216130|FG002|Overall Study|Lost to Follow-up|5
4432507|NCT00406640|7216140|FG000|Acute Phase|Adverse Event|18
4432508|NCT00406640|7216141|FG001|Acute Phase|Adverse Event|13
4432509|NCT00406640|7216140|FG000|Acute Phase|Failed to Return|5
4432510|NCT00406640|7216141|FG001|Acute Phase|Failed to Return|1
4432511|NCT00406640|7216140|FG000|Acute Phase|Physician Decision|0
4432512|NCT00406640|7216141|FG001|Acute Phase|Physician Decision|1
4432513|NCT00406640|7216140|FG000|Acute Phase|Lost to Follow-up|7
4432514|NCT00406640|7216141|FG001|Acute Phase|Lost to Follow-up|4
4432515|NCT00406640|7216140|FG000|Acute Phase|Protocol deviation|4
4432516|NCT00406640|7216141|FG001|Acute Phase|Protocol deviation|10
4432517|NCT00406640|7216140|FG000|Acute Phase|Protocol Violation|3
4432518|NCT00406640|7216141|FG001|Acute Phase|Protocol Violation|2
4432519|NCT00406640|7216140|FG000|Acute Phase|Withdrawal by Subject|11
4432520|NCT00406640|7216141|FG001|Acute Phase|Withdrawal by Subject|9
4432521|NCT00406640|7216140|FG000|Acute Phase|Lack of Efficacy|3
4432522|NCT00406640|7216141|FG001|Acute Phase|Lack of Efficacy|3
4432523|NCT00406640|7216140|FG000|DB Continuation Phase for Responders|Adverse Event|11
4432524|NCT00406640|7216141|FG001|DB Continuation Phase for Responders|Adverse Event|11
4432525|NCT00406640|7216140|FG000|DB Continuation Phase for Responders|Death|1
4432526|NCT00406640|7216141|FG001|DB Continuation Phase for Responders|Death|0
4432527|NCT00406640|7216140|FG000|DB Continuation Phase for Responders|Failed to Return|0
4432528|NCT00406640|7216141|FG001|DB Continuation Phase for Responders|Failed to Return|2
4432529|NCT00406640|7216140|FG000|DB Continuation Phase for Responders|Physician Decision|2
4432530|NCT00406640|7216141|FG001|DB Continuation Phase for Responders|Physician Decision|3
4432531|NCT00406640|7216140|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1
4432532|NCT00406640|7216141|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7
4432533|NCT00406640|7216140|FG000|DB Continuation Phase for Responders|non-compliance|7
4432534|NCT00406640|7216141|FG001|DB Continuation Phase for Responders|non-compliance|5
4432535|NCT00406640|7216140|FG000|DB Continuation Phase for Responders|Protocol Violation|2
4432536|NCT00406640|7216141|FG001|DB Continuation Phase for Responders|Protocol Violation|2
4432537|NCT00406640|7216140|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8
4432538|NCT00406640|7216141|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6
4432539|NCT00406640|7216140|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1
4432540|NCT00406640|7216141|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1
4432541|NCT00406640|7216140|FG000|OL Extension Phase for Non-Responders|Adverse Event|6
4432542|NCT00406640|7216141|FG001|OL Extension Phase for Non-Responders|Adverse Event|6
4432543|NCT00406640|7216140|FG000|OL Extension Phase for Non-Responders|Failed to Return|1
4432544|NCT00406640|7216141|FG001|OL Extension Phase for Non-Responders|Failed to Return|0
4432545|NCT00406640|7216140|FG000|OL Extension Phase for Non-Responders|Physician Decision|1
4432546|NCT00406640|7216141|FG001|OL Extension Phase for Non-Responders|Physician Decision|0
4432547|NCT00406640|7216140|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2
4432548|NCT00406640|7216141|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3
4432549|NCT00406640|7216140|FG000|OL Extension Phase for Non-Responders|non-compliance|3
4432550|NCT00406640|7216141|FG001|OL Extension Phase for Non-Responders|non-compliance|2
4432551|NCT00406640|7216140|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3
4432552|NCT00406640|7216141|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6
4432553|NCT00406640|7216140|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6
4432554|NCT00406640|7216141|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7
4432555|NCT00406653|7216157|FG000|Induction Period|Adverse Event|1
4432556|NCT00406653|7216158|FG001|Induction Period|Adverse Event|10
4432557|NCT00406653|7216159|FG002|Induction Period|Adverse Event|4
4432558|NCT00406653|7216160|FG003|Induction Period|Adverse Event|11
4432559|NCT00406653|7216161|FG004|Induction Period|Adverse Event|0
4432560|NCT00406653|7216162|FG005|Induction Period|Adverse Event|0
4432561|NCT00406653|7216163|FG006|Induction Period|Adverse Event|0
4432562|NCT00406653|7216157|FG000|Induction Period|Lack of Efficacy|11
4432563|NCT00406653|7216158|FG001|Induction Period|Lack of Efficacy|14
4432564|NCT00406653|7216159|FG002|Induction Period|Lack of Efficacy|8
4432565|NCT00406653|7216160|FG003|Induction Period|Lack of Efficacy|10
4432566|NCT00406653|7216161|FG004|Induction Period|Lack of Efficacy|0
4432567|NCT00406653|7216162|FG005|Induction Period|Lack of Efficacy|0
4432568|NCT00406653|7216163|FG006|Induction Period|Lack of Efficacy|0
4432569|NCT00406653|7216157|FG000|Induction Period|Lost to Follow-up|0
4432570|NCT00406653|7216158|FG001|Induction Period|Lost to Follow-up|2
4432571|NCT00406653|7216159|FG002|Induction Period|Lost to Follow-up|0
4432572|NCT00406653|7216160|FG003|Induction Period|Lost to Follow-up|0
4432573|NCT00406653|7216161|FG004|Induction Period|Lost to Follow-up|0
4432574|NCT00406653|7216162|FG005|Induction Period|Lost to Follow-up|0
4432575|NCT00406653|7216163|FG006|Induction Period|Lost to Follow-up|0
4432576|NCT00406653|7216157|FG000|Induction Period|Withdrawal of Consent|2
4432577|NCT00406653|7216158|FG001|Induction Period|Withdrawal of Consent|5
4432578|NCT00406653|7216159|FG002|Induction Period|Withdrawal of Consent|1
4432579|NCT00406653|7216160|FG003|Induction Period|Withdrawal of Consent|2
4432580|NCT00406653|7216161|FG004|Induction Period|Withdrawal of Consent|0
4432581|NCT00406653|7216162|FG005|Induction Period|Withdrawal of Consent|0
4432582|NCT00406653|7216163|FG006|Induction Period|Withdrawal of Consent|0
4432583|NCT00406653|7216157|FG000|Induction Period|Subject No Longer Meets Study Criteria|0
4432584|NCT00406653|7216158|FG001|Induction Period|Subject No Longer Meets Study Criteria|0
4432585|NCT00406653|7216159|FG002|Induction Period|Subject No Longer Meets Study Criteria|0
4432586|NCT00406653|7216160|FG003|Induction Period|Subject No Longer Meets Study Criteria|2
4432587|NCT00406653|7216161|FG004|Induction Period|Subject No Longer Meets Study Criteria|0
4432588|NCT00406653|7216162|FG005|Induction Period|Subject No Longer Meets Study Criteria|0
4432589|NCT00406653|7216163|FG006|Induction Period|Subject No Longer Meets Study Criteria|0
4432590|NCT00406653|7216157|FG000|Induction Period|Pregnancy|1
4432591|NCT00406653|7216158|FG001|Induction Period|Pregnancy|0
4432592|NCT00406653|7216159|FG002|Induction Period|Pregnancy|0
4432593|NCT00406653|7216160|FG003|Induction Period|Pregnancy|0
4432594|NCT00406653|7216161|FG004|Induction Period|Pregnancy|0
4432595|NCT00406653|7216162|FG005|Induction Period|Pregnancy|0
4432596|NCT00406653|7216163|FG006|Induction Period|Pregnancy|0
4432597|NCT00406653|7216157|FG000|Induction Period|Declined participation but followup done|0
4432598|NCT00406653|7216158|FG001|Induction Period|Declined participation but followup done|2
4432599|NCT00406653|7216159|FG002|Induction Period|Declined participation but followup done|1
4432600|NCT00406653|7216160|FG003|Induction Period|Declined participation but followup done|1
4432601|NCT00406653|7216161|FG004|Induction Period|Declined participation but followup done|0
4432602|NCT00406653|7216162|FG005|Induction Period|Declined participation but followup done|0
4432603|NCT00406653|7216163|FG006|Induction Period|Declined participation but followup done|0
4432604|NCT00406653|7216157|FG000|Induction Period|Given prohibited drug|0
4432605|NCT00406653|7216158|FG001|Induction Period|Given prohibited drug|1
4432606|NCT00406653|7216159|FG002|Induction Period|Given prohibited drug|2
4432607|NCT00406653|7216160|FG003|Induction Period|Given prohibited drug|0
4432608|NCT00406653|7216161|FG004|Induction Period|Given prohibited drug|0
4432609|NCT00406653|7216162|FG005|Induction Period|Given prohibited drug|0
4432610|NCT00406653|7216163|FG006|Induction Period|Given prohibited drug|0
4432611|NCT00406653|7216157|FG000|Induction Period|Incarcerated|0
4432612|NCT00406653|7216158|FG001|Induction Period|Incarcerated|0
4432613|NCT00406653|7216159|FG002|Induction Period|Incarcerated|1
4432614|NCT00406653|7216160|FG003|Induction Period|Incarcerated|0
4432615|NCT00406653|7216161|FG004|Induction Period|Incarcerated|0
4432616|NCT00406653|7216162|FG005|Induction Period|Incarcerated|0
4432617|NCT00406653|7216163|FG006|Induction Period|Incarcerated|0
4432618|NCT00406653|7216157|FG000|Induction Period|Patient relocated|0
4432619|NCT00406653|7216158|FG001|Induction Period|Patient relocated|0
4432620|NCT00406653|7216159|FG002|Induction Period|Patient relocated|1
4432621|NCT00406653|7216160|FG003|Induction Period|Patient relocated|0
4432622|NCT00406653|7216161|FG004|Induction Period|Patient relocated|0
4432623|NCT00406653|7216162|FG005|Induction Period|Patient relocated|0
4432624|NCT00406653|7216163|FG006|Induction Period|Patient relocated|0
4432625|NCT00406653|7216157|FG000|Maintenance Period|Adverse Event|0
4432626|NCT00406653|7216158|FG001|Maintenance Period|Adverse Event|0
4432627|NCT00406653|7216159|FG002|Maintenance Period|Adverse Event|0
4432628|NCT00406653|7216160|FG003|Maintenance Period|Adverse Event|0
4432629|NCT00406653|7216161|FG004|Maintenance Period|Adverse Event|1
4432630|NCT00406653|7216162|FG005|Maintenance Period|Adverse Event|1
4432631|NCT00406653|7216163|FG006|Maintenance Period|Adverse Event|0
4432632|NCT00406653|7216157|FG000|Maintenance Period|Lack of Efficacy|0
4432633|NCT00406653|7216158|FG001|Maintenance Period|Lack of Efficacy|0
4432634|NCT00406653|7216159|FG002|Maintenance Period|Lack of Efficacy|0
4432635|NCT00406653|7216160|FG003|Maintenance Period|Lack of Efficacy|0
4432636|NCT00406653|7216161|FG004|Maintenance Period|Lack of Efficacy|20
4432637|NCT00406653|7216162|FG005|Maintenance Period|Lack of Efficacy|26
4432638|NCT00406653|7216163|FG006|Maintenance Period|Lack of Efficacy|0
4432639|NCT00406653|7216157|FG000|Maintenance Period|Lost to Follow-up|0
4432640|NCT00406653|7216158|FG001|Maintenance Period|Lost to Follow-up|0
4432641|NCT00406653|7216159|FG002|Maintenance Period|Lost to Follow-up|0
4432642|NCT00406653|7216160|FG003|Maintenance Period|Lost to Follow-up|0
4432643|NCT00406653|7216161|FG004|Maintenance Period|Lost to Follow-up|2
4432644|NCT00406653|7216162|FG005|Maintenance Period|Lost to Follow-up|1
4432645|NCT00406653|7216163|FG006|Maintenance Period|Lost to Follow-up|0
4432646|NCT00406653|7216157|FG000|Maintenance Period|Withdrawal of Consent|0
4432647|NCT00406653|7216158|FG001|Maintenance Period|Withdrawal of Consent|0
4432648|NCT00406653|7216159|FG002|Maintenance Period|Withdrawal of Consent|0
4432649|NCT00406653|7216160|FG003|Maintenance Period|Withdrawal of Consent|0
4432650|NCT00406653|7216161|FG004|Maintenance Period|Withdrawal of Consent|2
4432651|NCT00406653|7216162|FG005|Maintenance Period|Withdrawal of Consent|0
4432652|NCT00406653|7216163|FG006|Maintenance Period|Withdrawal of Consent|0
4432653|NCT00406653|7216157|FG000|Maintenance Period|Pregnancy|0
4432654|NCT00406653|7216158|FG001|Maintenance Period|Pregnancy|0
4432655|NCT00406653|7216159|FG002|Maintenance Period|Pregnancy|0
4432656|NCT00406653|7216160|FG003|Maintenance Period|Pregnancy|0
4432657|NCT00406653|7216161|FG004|Maintenance Period|Pregnancy|0
4432658|NCT00406653|7216162|FG005|Maintenance Period|Pregnancy|1
4432659|NCT00406653|7216163|FG006|Maintenance Period|Pregnancy|0
4432660|NCT00406653|7216157|FG000|Maintenance Period|Administrative Reason By Sponsor|0
4432661|NCT00406653|7216158|FG001|Maintenance Period|Administrative Reason By Sponsor|0
4432662|NCT00406653|7216159|FG002|Maintenance Period|Administrative Reason By Sponsor|0
4432663|NCT00406653|7216160|FG003|Maintenance Period|Administrative Reason By Sponsor|0
4432664|NCT00406653|7216161|FG004|Maintenance Period|Administrative Reason By Sponsor|4
4432665|NCT00406653|7216162|FG005|Maintenance Period|Administrative Reason By Sponsor|7
4432666|NCT00406653|7216163|FG006|Maintenance Period|Administrative Reason By Sponsor|0
4432667|NCT00406653|7216157|FG000|Maintenance Period|Error in disease score evaluation|0
4432668|NCT00406653|7216158|FG001|Maintenance Period|Error in disease score evaluation|0
4432669|NCT00406653|7216159|FG002|Maintenance Period|Error in disease score evaluation|0
4432670|NCT00406653|7216160|FG003|Maintenance Period|Error in disease score evaluation|0
4432671|NCT00406653|7216161|FG004|Maintenance Period|Error in disease score evaluation|1
4432672|NCT00406653|7216162|FG005|Maintenance Period|Error in disease score evaluation|0
4432673|NCT00406653|7216163|FG006|Maintenance Period|Error in disease score evaluation|0
4432674|NCT00406653|7216157|FG000|Open-Label Period|Death|0
4432675|NCT00406653|7216158|FG001|Open-Label Period|Death|0
4432676|NCT00406653|7216159|FG002|Open-Label Period|Death|0
4432677|NCT00406653|7216160|FG003|Open-Label Period|Death|0
4432678|NCT00406653|7216161|FG004|Open-Label Period|Death|0
4432679|NCT00406653|7216162|FG005|Open-Label Period|Death|0
4432680|NCT00406653|7216163|FG006|Open-Label Period|Death|1
4432681|NCT00406653|7216157|FG000|Open-Label Period|Adverse Event|0
4432682|NCT00406653|7216158|FG001|Open-Label Period|Adverse Event|0
4432683|NCT00406653|7216159|FG002|Open-Label Period|Adverse Event|0
4432684|NCT00406653|7216160|FG003|Open-Label Period|Adverse Event|0
4432685|NCT00406653|7216161|FG004|Open-Label Period|Adverse Event|0
4432686|NCT00406653|7216162|FG005|Open-Label Period|Adverse Event|0
4432687|NCT00406653|7216163|FG006|Open-Label Period|Adverse Event|18
4432688|NCT00406653|7216157|FG000|Open-Label Period|Lack of Efficacy|0
4432689|NCT00406653|7216158|FG001|Open-Label Period|Lack of Efficacy|0
4432690|NCT00406653|7216159|FG002|Open-Label Period|Lack of Efficacy|0
4432691|NCT00406653|7216160|FG003|Open-Label Period|Lack of Efficacy|0
4432692|NCT00406653|7216161|FG004|Open-Label Period|Lack of Efficacy|0
4432693|NCT00406653|7216162|FG005|Open-Label Period|Lack of Efficacy|0
4432694|NCT00406653|7216163|FG006|Open-Label Period|Lack of Efficacy|160
4432695|NCT00406653|7216157|FG000|Open-Label Period|Lost to Follow-up|0
4432696|NCT00406653|7216158|FG001|Open-Label Period|Lost to Follow-up|0
4432697|NCT00406653|7216159|FG002|Open-Label Period|Lost to Follow-up|0
4432698|NCT00406653|7216160|FG003|Open-Label Period|Lost to Follow-up|0
4432699|NCT00406653|7216161|FG004|Open-Label Period|Lost to Follow-up|0
4432700|NCT00406653|7216162|FG005|Open-Label Period|Lost to Follow-up|0
4432701|NCT00406653|7216163|FG006|Open-Label Period|Lost to Follow-up|6
4432702|NCT00406653|7216157|FG000|Open-Label Period|Withdrawal of Consent|0
4432703|NCT00406653|7216158|FG001|Open-Label Period|Withdrawal of Consent|0
4432704|NCT00406653|7216159|FG002|Open-Label Period|Withdrawal of Consent|0
4432705|NCT00406653|7216160|FG003|Open-Label Period|Withdrawal of Consent|0
4432706|NCT00406653|7216161|FG004|Open-Label Period|Withdrawal of Consent|0
4432707|NCT00406653|7216162|FG005|Open-Label Period|Withdrawal of Consent|0
4432708|NCT00406653|7216163|FG006|Open-Label Period|Withdrawal of Consent|11
4432709|NCT00406653|7216157|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0
4432710|NCT00406653|7216158|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0
4432711|NCT00406653|7216159|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0
4432712|NCT00406653|7216160|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0
4432713|NCT00406653|7216161|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0
4432714|NCT00406653|7216162|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0
4432715|NCT00406653|7216163|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1
4432716|NCT00406653|7216157|FG000|Open-Label Period|Pregnancy|0
4432717|NCT00406653|7216158|FG001|Open-Label Period|Pregnancy|0
4432718|NCT00406653|7216159|FG002|Open-Label Period|Pregnancy|0
4432719|NCT00406653|7216160|FG003|Open-Label Period|Pregnancy|0
4432720|NCT00406653|7216161|FG004|Open-Label Period|Pregnancy|0
4432721|NCT00406653|7216162|FG005|Open-Label Period|Pregnancy|0
4432722|NCT00406653|7216163|FG006|Open-Label Period|Pregnancy|2
4432723|NCT00406653|7216157|FG000|Open-Label Period|Administrative Reason By Sponsor|0
4432724|NCT00406653|7216158|FG001|Open-Label Period|Administrative Reason By Sponsor|0
4432725|NCT00406653|7216159|FG002|Open-Label Period|Administrative Reason By Sponsor|0
4432726|NCT00406653|7216160|FG003|Open-Label Period|Administrative Reason By Sponsor|0
4432727|NCT00406653|7216161|FG004|Open-Label Period|Administrative Reason By Sponsor|0
4432728|NCT00406653|7216162|FG005|Open-Label Period|Administrative Reason By Sponsor|0
4432729|NCT00406653|7216163|FG006|Open-Label Period|Administrative Reason By Sponsor|115
4432730|NCT00406653|7216157|FG000|Open-Label Period|Declined participation but followup done|0
4432731|NCT00406653|7216158|FG001|Open-Label Period|Declined participation but followup done|0
4432732|NCT00406653|7216159|FG002|Open-Label Period|Declined participation but followup done|0
4432733|NCT00406653|7216160|FG003|Open-Label Period|Declined participation but followup done|0
4432734|NCT00406653|7216161|FG004|Open-Label Period|Declined participation but followup done|0
4432735|NCT00406653|7216162|FG005|Open-Label Period|Declined participation but followup done|0
4432736|NCT00406653|7216163|FG006|Open-Label Period|Declined participation but followup done|8
4432737|NCT00406653|7216157|FG000|Open-Label Period|Discontinued by Sponsor|0
4432738|NCT00406653|7216158|FG001|Open-Label Period|Discontinued by Sponsor|0
4432739|NCT00406653|7216159|FG002|Open-Label Period|Discontinued by Sponsor|0
4432740|NCT00406653|7216160|FG003|Open-Label Period|Discontinued by Sponsor|0
4432741|NCT00406653|7216161|FG004|Open-Label Period|Discontinued by Sponsor|0
4432742|NCT00406653|7216162|FG005|Open-Label Period|Discontinued by Sponsor|0
4432743|NCT00406653|7216163|FG006|Open-Label Period|Discontinued by Sponsor|1
4432744|NCT00406653|7216157|FG000|Open-Label Period|Refused followup|0
4432745|NCT00406653|7216158|FG001|Open-Label Period|Refused followup|0
4432746|NCT00406653|7216159|FG002|Open-Label Period|Refused followup|0
4432747|NCT00406653|7216160|FG003|Open-Label Period|Refused followup|0
4432748|NCT00406653|7216161|FG004|Open-Label Period|Refused followup|0
4432749|NCT00406653|7216162|FG005|Open-Label Period|Refused followup|0
4432750|NCT00406653|7216163|FG006|Open-Label Period|Refused followup|1
4432751|NCT00406692|7216183|FG000|Overall Study|Withdrawal by Subject|4
4432752|NCT00406692|7216183|FG000|Overall Study|Physician Decision|1
4432753|NCT00406692|7216183|FG000|Overall Study|Adverse Event|1
4432754|NCT00406692|7216183|FG000|Overall Study|Lack of Efficacy|1
4432755|NCT00406718|7216190|FG000|Overall Study|Withdrawal by Subject|2
4432756|NCT00406718|7216191|FG001|Overall Study|Withdrawal by Subject|9
4432757|NCT00406718|7216192|FG002|Overall Study|Withdrawal by Subject|4
4432758|NCT00406718|7216190|FG000|Overall Study|Lost to Follow-up|2
4432759|NCT00406718|7216191|FG001|Overall Study|Lost to Follow-up|5
4432760|NCT00406718|7216192|FG002|Overall Study|Lost to Follow-up|4
4432761|NCT00406848|7216204|FG000|Overall Study|Withdrawal by Subject|27
4432762|NCT00406848|7216205|FG001|Overall Study|Withdrawal by Subject|22
4432763|NCT00406848|7216204|FG000|Overall Study|Adverse Event|38
4432764|NCT00406848|7216205|FG001|Overall Study|Adverse Event|7
4432765|NCT00406848|7216204|FG000|Overall Study|Lack of Efficacy|9
4432766|NCT00406848|7216205|FG001|Overall Study|Lack of Efficacy|14
4432767|NCT00406848|7216204|FG000|Overall Study|Protocol Violation|10
4432768|NCT00406848|7216205|FG001|Overall Study|Protocol Violation|6
4432769|NCT00406848|7216204|FG000|Overall Study|Lost to Follow-up|6
4432770|NCT00406848|7216205|FG001|Overall Study|Lost to Follow-up|2
4432771|NCT00406848|7216204|FG000|Overall Study|Physician Decision|2
4432772|NCT00406848|7216205|FG001|Overall Study|Physician Decision|2
4432773|NCT00406848|7216204|FG000|Overall Study|Sponsor Decision|1
4432774|NCT00406848|7216205|FG001|Overall Study|Sponsor Decision|1
4432775|NCT00407030|7216217|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2
4432776|NCT00407030|7216218|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1
4716286|NCT02989389|7645489|FG007|Period 1|Physician Decision|0
4432777|NCT00407030|7216219|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0
4432778|NCT00407030|7216217|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0
4432779|NCT00407030|7216218|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0
4432780|NCT00407030|7216219|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3
4432781|NCT00407030|7216217|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
4432782|NCT00407030|7216218|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
4432783|NCT00407030|7216219|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
4432784|NCT00407030|7216217|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
4432785|NCT00407030|7216218|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
4432786|NCT00407030|7216219|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
4432787|NCT00407030|7216217|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0
4432788|NCT00407030|7216218|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0
4432789|NCT00407030|7216219|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1
4432790|NCT00407030|7216217|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1
4432791|NCT00407030|7216218|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0
4432792|NCT00407030|7216219|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0
4432793|NCT00407030|7216217|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4
4432794|NCT00407030|7216218|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5
4432795|NCT00407030|7216219|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0
4432796|NCT00407030|7216217|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11
4432797|NCT00407030|7216218|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11
4432798|NCT00407030|7216219|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0
4432799|NCT00407030|7216217|FG000|Extension Period - up to 68 Weeks|Adverse Event|1
4432800|NCT00407030|7216218|FG001|Extension Period - up to 68 Weeks|Adverse Event|0
4432801|NCT00407030|7216219|FG002|Extension Period - up to 68 Weeks|Adverse Event|0
4432802|NCT00407030|7216217|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4
4432803|NCT00407030|7216218|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4
4432804|NCT00407030|7216219|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0
4432805|NCT00407030|7216217|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5
4432806|NCT00407030|7216218|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5
4432807|NCT00407030|7216219|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0
4432808|NCT00407030|7216217|FG000|Extension Period - up to 68 Weeks|Patient Decision|1
4432809|NCT00407030|7216218|FG001|Extension Period - up to 68 Weeks|Patient Decision|2
4432810|NCT00407030|7216219|FG002|Extension Period - up to 68 Weeks|Patient Decision|0
4432811|NCT00407030|7216217|FG000|Extension Period - up to 68 Weeks|Physician Decision|1
4432812|NCT00407030|7216218|FG001|Extension Period - up to 68 Weeks|Physician Decision|2
4432813|NCT00407030|7216219|FG002|Extension Period - up to 68 Weeks|Physician Decision|0
4432814|NCT00407511|7216267|FG000|Overall Study|Adverse Event|9
4432815|NCT00407511|7216267|FG000|Overall Study|Lost to Follow-up|4
4432816|NCT00407511|7216267|FG000|Overall Study|Other|5
4432817|NCT00407511|7216267|FG000|Overall Study|Withdrawal by Subject|4
4432818|NCT00407537|7216273|FG000|Overall Study|Death|5
4432819|NCT00407537|7216274|FG001|Overall Study|Death|2
4432820|NCT00407537|7216273|FG000|Overall Study|Adverse Event|36
4432821|NCT00407537|7216274|FG001|Overall Study|Adverse Event|0
4432822|NCT00407537|7216273|FG000|Overall Study|Lost to Follow-up|12
4432823|NCT00407537|7216274|FG001|Overall Study|Lost to Follow-up|19
4432824|NCT00407537|7216273|FG000|Overall Study|Other|6
4432825|NCT00407537|7216274|FG001|Overall Study|Other|7
4432826|NCT00407537|7216273|FG000|Overall Study|Withdrawal by Subject|34
4432827|NCT00407537|7216274|FG001|Overall Study|Withdrawal by Subject|16
4432828|NCT00407550|7216282|FG000|Overall Study|Adverse Event|0
4432829|NCT00407550|7216283|FG001|Overall Study|Adverse Event|1
4432830|NCT00407550|7216282|FG000|Overall Study|Withdrawal by Subject|0
4432831|NCT00407550|7216283|FG001|Overall Study|Withdrawal by Subject|2
4432832|NCT00407550|7216282|FG000|Overall Study|Death|1
4432833|NCT00407550|7216283|FG001|Overall Study|Death|0
4432834|NCT00407550|7216282|FG000|Overall Study|Insurance or Other medical condition|2
4432835|NCT00407550|7216283|FG001|Overall Study|Insurance or Other medical condition|1
4432836|NCT00407563|7216289|FG000|Overall Study|Patient continues on treatment|1
4432837|NCT00407745|7216300|FG000|Overall Study|Lack of Efficacy|1
4432838|NCT00407745|7216301|FG001|Overall Study|Lack of Efficacy|2
4432839|NCT00407745|7216300|FG000|Overall Study|Withdrawal by Subject|3
4432840|NCT00407745|7216301|FG001|Overall Study|Withdrawal by Subject|3
4432841|NCT00407745|7216300|FG000|Overall Study|Protocol Violation|5
4432842|NCT00407745|7216301|FG001|Overall Study|Protocol Violation|3
4432843|NCT00407745|7216300|FG000|Overall Study|Adverse Event|8
4432844|NCT00407745|7216301|FG001|Overall Study|Adverse Event|8
4432845|NCT00407745|7216300|FG000|Overall Study|Other|2
4432846|NCT00407745|7216301|FG001|Overall Study|Other|0
4432847|NCT00407745|7216300|FG000|Overall Study|Randomized, unknown if treated|0
4432848|NCT00407745|7216301|FG001|Overall Study|Randomized, unknown if treated|1
4432849|NCT00407758|7216307|FG000|Overall Study|ineligible -improper prior treatment|1
4432850|NCT00407797|7216311|FG000|Overall Study|Lost to Follow-up|2
4432851|NCT00407797|7216311|FG000|Overall Study|Adverse Event|6
4432852|NCT00407797|7216311|FG000|Overall Study|Other|7
4432853|NCT00407797|7216311|FG000|Overall Study|Withdrawal by Subject|3
4432854|NCT00408317|7216336|FG000|First Intervention Period|Adverse Event|0
4432855|NCT00408317|7216337|FG001|First Intervention Period|Adverse Event|1
4432856|NCT00408317|7216336|FG000|Second Intervention Period|Adverse Event|2
4432857|NCT00408317|7216337|FG001|Second Intervention Period|Adverse Event|0
4432858|NCT00408317|7216336|FG000|Second Intervention Period|Protocol Violation|0
4432859|NCT00408317|7216337|FG001|Second Intervention Period|Protocol Violation|1
4432860|NCT00408317|7216336|FG000|Second Intervention Period|Withdrawal of consent|0
4432861|NCT00408317|7216337|FG001|Second Intervention Period|Withdrawal of consent|1
4432862|NCT00408408|7216349|FG000|Overall Study|No follow up data|2
4432863|NCT00408408|7216350|FG001|Overall Study|No follow up data|3
4432864|NCT00408408|7216351|FG002|Overall Study|No follow up data|0
4432865|NCT00408408|7216352|FG003|Overall Study|No follow up data|7
4432866|NCT00408408|7216353|FG004|Overall Study|No follow up data|5
4432867|NCT00408408|7216354|FG005|Overall Study|No follow up data|3
4432868|NCT00408421|7216370|FG000|Treatment Initial Randomization|Adverse Event|5
4432869|NCT00408421|7216371|FG001|Treatment Initial Randomization|Adverse Event|9
4432870|NCT00408421|7216372|FG002|Treatment Initial Randomization|Adverse Event|0
4432871|NCT00408421|7216370|FG000|Treatment Initial Randomization|Lack of Efficacy|2
4432872|NCT00408421|7216371|FG001|Treatment Initial Randomization|Lack of Efficacy|2
4432873|NCT00408421|7216372|FG002|Treatment Initial Randomization|Lack of Efficacy|0
4432874|NCT00408421|7216370|FG000|Treatment Initial Randomization|Lost to Follow-up|0
4432875|NCT00408421|7216371|FG001|Treatment Initial Randomization|Lost to Follow-up|3
4432876|NCT00408421|7216372|FG002|Treatment Initial Randomization|Lost to Follow-up|0
4432877|NCT00408421|7216370|FG000|Treatment Initial Randomization|Physician Decision|1
4432878|NCT00408421|7216371|FG001|Treatment Initial Randomization|Physician Decision|0
4432879|NCT00408421|7216372|FG002|Treatment Initial Randomization|Physician Decision|0
4432880|NCT00408421|7216370|FG000|Treatment Initial Randomization|Protocol Violation|0
4432881|NCT00408421|7216371|FG001|Treatment Initial Randomization|Protocol Violation|1
4432882|NCT00408421|7216372|FG002|Treatment Initial Randomization|Protocol Violation|0
4432883|NCT00408421|7216370|FG000|Treatment Initial Randomization|Withdrawal by Subject|7
4432884|NCT00408421|7216371|FG001|Treatment Initial Randomization|Withdrawal by Subject|7
4432885|NCT00408421|7216372|FG002|Treatment Initial Randomization|Withdrawal by Subject|0
4432886|NCT00408421|7216370|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1
4432887|NCT00408421|7216371|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0
4432888|NCT00408421|7216372|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0
4432889|NCT00408421|7216370|FG000|Treatment Initial Randomization|Sponsor Decision|1
4432890|NCT00408421|7216371|FG001|Treatment Initial Randomization|Sponsor Decision|0
4432891|NCT00408421|7216372|FG002|Treatment Initial Randomization|Sponsor Decision|0
4432892|NCT00408421|7216370|FG000|Treatment Re-Randomization|Adverse Event|2
4432893|NCT00408421|7216371|FG001|Treatment Re-Randomization|Adverse Event|2
4432894|NCT00408421|7216372|FG002|Treatment Re-Randomization|Adverse Event|4
4432895|NCT00408421|7216370|FG000|Treatment Re-Randomization|Lack of Efficacy|1
4432896|NCT00408421|7216371|FG001|Treatment Re-Randomization|Lack of Efficacy|0
4432897|NCT00408421|7216372|FG002|Treatment Re-Randomization|Lack of Efficacy|0
4432898|NCT00408421|7216370|FG000|Treatment Re-Randomization|Lost to Follow-up|0
4432899|NCT00408421|7216371|FG001|Treatment Re-Randomization|Lost to Follow-up|0
4432900|NCT00408421|7216372|FG002|Treatment Re-Randomization|Lost to Follow-up|1
4432901|NCT00408421|7216370|FG000|Treatment Re-Randomization|Physician Decision|1
4432902|NCT00408421|7216371|FG001|Treatment Re-Randomization|Physician Decision|3
4432903|NCT00408421|7216372|FG002|Treatment Re-Randomization|Physician Decision|0
4432904|NCT00408421|7216370|FG000|Treatment Re-Randomization|Protocol Violation|1
4432905|NCT00408421|7216371|FG001|Treatment Re-Randomization|Protocol Violation|1
4432906|NCT00408421|7216372|FG002|Treatment Re-Randomization|Protocol Violation|0
4432907|NCT00408421|7216370|FG000|Treatment Re-Randomization|Withdrawal by Subject|2
4432908|NCT00408421|7216371|FG001|Treatment Re-Randomization|Withdrawal by Subject|1
4432909|NCT00408421|7216372|FG002|Treatment Re-Randomization|Withdrawal by Subject|0
4432910|NCT00408434|7216387|FG000|Overall Study|Adverse Event|0
4432911|NCT00408434|7216388|FG001|Overall Study|Adverse Event|0
4432912|NCT00408434|7216389|FG002|Overall Study|Adverse Event|1
4432913|NCT00408434|7216390|FG003|Overall Study|Adverse Event|0
4432914|NCT00408434|7216391|FG004|Overall Study|Adverse Event|0
4432915|NCT00408434|7216392|FG005|Overall Study|Adverse Event|0
4432916|NCT00408434|7216393|FG006|Overall Study|Adverse Event|0
4432917|NCT00408434|7216387|FG000|Overall Study|Progressive disease|6
4432918|NCT00408434|7216388|FG001|Overall Study|Progressive disease|3
4432919|NCT00408434|7216389|FG002|Overall Study|Progressive disease|4
4432920|NCT00408434|7216390|FG003|Overall Study|Progressive disease|3
4432921|NCT00408434|7216391|FG004|Overall Study|Progressive disease|3
4432922|NCT00408434|7216392|FG005|Overall Study|Progressive disease|1
4432923|NCT00408434|7216393|FG006|Overall Study|Progressive disease|4
4432924|NCT00408434|7216387|FG000|Overall Study|Other|0
4432925|NCT00408434|7216388|FG001|Overall Study|Other|0
4432926|NCT00408434|7216389|FG002|Overall Study|Other|1
4432927|NCT00408434|7216390|FG003|Overall Study|Other|0
4432928|NCT00408434|7216391|FG004|Overall Study|Other|2
4432929|NCT00408434|7216392|FG005|Overall Study|Other|1
4432930|NCT00408434|7216393|FG006|Overall Study|Other|0
4432931|NCT00408434|7216387|FG000|Overall Study|Terminated by Investigator|0
4432932|NCT00408434|7216388|FG001|Overall Study|Terminated by Investigator|0
4432933|NCT00408434|7216389|FG002|Overall Study|Terminated by Investigator|0
4432934|NCT00408434|7216390|FG003|Overall Study|Terminated by Investigator|0
4432935|NCT00408434|7216391|FG004|Overall Study|Terminated by Investigator|1
4432936|NCT00408434|7216392|FG005|Overall Study|Terminated by Investigator|1
4432937|NCT00408434|7216393|FG006|Overall Study|Terminated by Investigator|0
4432938|NCT00408499|7216414|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0
4432939|NCT00408499|7216415|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0
4630117|NCT03401112|7498689|FG004|Overall Study|Lost to Follow-up|0
4432940|NCT00408499|7216416|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1
4432941|NCT00408499|7216417|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0
4432942|NCT00408499|7216418|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0
4432943|NCT00408499|7216414|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1
4432944|NCT00408499|7216415|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1
4432945|NCT00408499|7216416|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
4432946|NCT00408499|7216417|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
4432947|NCT00408499|7216418|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
4432948|NCT00408499|7216414|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1
4432949|NCT00408499|7216415|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1
4432950|NCT00408499|7216416|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0
4432951|NCT00408499|7216417|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0
4432952|NCT00408499|7216418|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0
4432953|NCT00408499|7216414|FG000|Phase II- MTD Expansion|Adverse Event|0
4432954|NCT00408499|7216415|FG001|Phase II- MTD Expansion|Adverse Event|0
4432955|NCT00408499|7216416|FG002|Phase II- MTD Expansion|Adverse Event|0
4432956|NCT00408499|7216417|FG003|Phase II- MTD Expansion|Adverse Event|0
4432957|NCT00408499|7216418|FG004|Phase II- MTD Expansion|Adverse Event|9
4432958|NCT00408499|7216414|FG000|Phase II- MTD Expansion|Death|0
4432959|NCT00408499|7216415|FG001|Phase II- MTD Expansion|Death|0
4432960|NCT00408499|7216416|FG002|Phase II- MTD Expansion|Death|0
4432961|NCT00408499|7216417|FG003|Phase II- MTD Expansion|Death|0
4432962|NCT00408499|7216418|FG004|Phase II- MTD Expansion|Death|2
4432963|NCT00408499|7216414|FG000|Phase II- MTD Expansion|Physician Decision|0
4432964|NCT00408499|7216415|FG001|Phase II- MTD Expansion|Physician Decision|0
4432965|NCT00408499|7216416|FG002|Phase II- MTD Expansion|Physician Decision|0
4432966|NCT00408499|7216417|FG003|Phase II- MTD Expansion|Physician Decision|0
4432967|NCT00408499|7216418|FG004|Phase II- MTD Expansion|Physician Decision|1
4432968|NCT00408499|7216414|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0
4432969|NCT00408499|7216415|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0
4432970|NCT00408499|7216416|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0
4432971|NCT00408499|7216417|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0
4432972|NCT00408499|7216418|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5
4432973|NCT00408499|7216414|FG000|Phase II- MTD Expansion|treatment delay|0
4432974|NCT00408499|7216415|FG001|Phase II- MTD Expansion|treatment delay|0
4432975|NCT00408499|7216416|FG002|Phase II- MTD Expansion|treatment delay|0
4432976|NCT00408499|7216417|FG003|Phase II- MTD Expansion|treatment delay|0
4432977|NCT00408499|7216418|FG004|Phase II- MTD Expansion|treatment delay|3
4630118|NCT03401112|7498685|FG000|Overall Study|Noncompliance|1
4432978|NCT00408629|7216474|FG000|Overall Study|Adverse Event|13
4432979|NCT00408629|7216475|FG001|Overall Study|Adverse Event|27
4432980|NCT00408629|7216474|FG000|Overall Study|Withdrawal by Subject|8
4432981|NCT00408629|7216475|FG001|Overall Study|Withdrawal by Subject|4
4432982|NCT00408629|7216474|FG000|Overall Study|Lost to Follow-up|1
4432983|NCT00408629|7216475|FG001|Overall Study|Lost to Follow-up|1
4432984|NCT00408629|7216474|FG000|Overall Study|Lack of Efficacy|63
4432985|NCT00408629|7216475|FG001|Overall Study|Lack of Efficacy|73
4432986|NCT00408629|7216474|FG000|Overall Study|Protocol Violation|1
4432987|NCT00408629|7216475|FG001|Overall Study|Protocol Violation|5
4432988|NCT00408629|7216474|FG000|Overall Study|Miscellaneous|11
4432989|NCT00408629|7216475|FG001|Overall Study|Miscellaneous|15
4432990|NCT00408681|7216482|FG000|Overall Study|Lack of Efficacy|2
4432991|NCT00408681|7216482|FG000|Overall Study|Adverse Event|7
4432992|NCT00408694|7216487|FG000|Overall Study|Ineligible|1
4432993|NCT00408694|7216487|FG000|Overall Study|No protocol treatment|1
4432994|NCT00408876|7216495|FG000|Overall Study|Adverse Event|9
4432995|NCT00408876|7216496|FG001|Overall Study|Adverse Event|17
4432996|NCT00408876|7216497|FG002|Overall Study|Adverse Event|27
4432997|NCT00408876|7216498|FG003|Overall Study|Adverse Event|10
4432998|NCT00408876|7216495|FG000|Overall Study|Withdrawal by Subject|3
4432999|NCT00408876|7216496|FG001|Overall Study|Withdrawal by Subject|6
4433000|NCT00408876|7216497|FG002|Overall Study|Withdrawal by Subject|6
4433001|NCT00408876|7216498|FG003|Overall Study|Withdrawal by Subject|14
4433002|NCT00408876|7216495|FG000|Overall Study|Lack of Efficacy|2
4433003|NCT00408876|7216496|FG001|Overall Study|Lack of Efficacy|4
4433004|NCT00408876|7216497|FG002|Overall Study|Lack of Efficacy|5
4433005|NCT00408876|7216498|FG003|Overall Study|Lack of Efficacy|6
4433006|NCT00408876|7216495|FG000|Overall Study|Lost to Follow-up|1
4433007|NCT00408876|7216496|FG001|Overall Study|Lost to Follow-up|6
4433008|NCT00408876|7216497|FG002|Overall Study|Lost to Follow-up|5
4433009|NCT00408876|7216498|FG003|Overall Study|Lost to Follow-up|2
4433010|NCT00408876|7216495|FG000|Overall Study|Protocol Violation|0
4433011|NCT00408876|7216496|FG001|Overall Study|Protocol Violation|3
4433012|NCT00408876|7216497|FG002|Overall Study|Protocol Violation|4
4630119|NCT03401112|7498686|FG001|Overall Study|Noncompliance|2
4433013|NCT00408876|7216498|FG003|Overall Study|Protocol Violation|3
4433014|NCT00408876|7216495|FG000|Overall Study|Physician Decision|1
4433015|NCT00408876|7216496|FG001|Overall Study|Physician Decision|0
4433016|NCT00408876|7216497|FG002|Overall Study|Physician Decision|3
4433017|NCT00408876|7216498|FG003|Overall Study|Physician Decision|0
4433018|NCT00408902|7216508|FG000|Overall Study|Lack of Efficacy|7
4630120|NCT03401112|7498687|FG002|Overall Study|Noncompliance|3
4433019|NCT00408902|7216508|FG000|Overall Study|Adverse Event|3
4433020|NCT00408928|7216513|FG000|Overall Study|Withdrawal by Subject|1
4433021|NCT00408928|7216513|FG000|Overall Study|Death|1
4433022|NCT00408928|7216513|FG000|Overall Study|Infection indistinguishable from GVHD|1
4433023|NCT00408993|7216519|FG000|Overall Study|Adverse Event|15
4433024|NCT00408993|7216520|FG001|Overall Study|Adverse Event|4
4433025|NCT00408993|7216519|FG000|Overall Study|Protocol Violation|1
4433026|NCT00408993|7216520|FG001|Overall Study|Protocol Violation|6
4433027|NCT00408993|7216519|FG000|Overall Study|Lack of Efficacy|1
4433028|NCT00408993|7216520|FG001|Overall Study|Lack of Efficacy|4
4433029|NCT00408993|7216519|FG000|Overall Study|Withdrawal by Subject|2
4433030|NCT00408993|7216520|FG001|Overall Study|Withdrawal by Subject|3
4433031|NCT00409006|7216532|FG000|Overall Study|Death|15
4433032|NCT00409006|7216533|FG001|Overall Study|Death|6
4433033|NCT00409006|7216532|FG000|Overall Study|Lost to Follow-up|1
4433034|NCT00409006|7216533|FG001|Overall Study|Lost to Follow-up|2
4433035|NCT00409006|7216532|FG000|Overall Study|Withdrawal by Subject|3
4433036|NCT00409006|7216533|FG001|Overall Study|Withdrawal by Subject|2
4433037|NCT00409006|7216532|FG000|Overall Study|Physician Decision|1
4433038|NCT00409006|7216533|FG001|Overall Study|Physician Decision|2
4433039|NCT00409175|7216541|FG000|Overall Study|Adverse Event|4
4433040|NCT00409175|7216542|FG001|Overall Study|Adverse Event|3
4433041|NCT00409175|7216541|FG000|Overall Study|Withdrawal by Subject|1
4433042|NCT00409175|7216542|FG001|Overall Study|Withdrawal by Subject|2
4433043|NCT00409175|7216541|FG000|Overall Study|Negative genotype|0
4433044|NCT00409175|7216542|FG001|Overall Study|Negative genotype|1
4433045|NCT00409175|7216541|FG000|Overall Study|Liver transplantation|13
4433046|NCT00409175|7216542|FG001|Overall Study|Liver transplantation|13
4433047|NCT00409188|7216550|FG000|Overall Study|Ongoing at data cut-off|383
4433048|NCT00409188|7216551|FG001|Overall Study|Ongoing at data cut-off|175
4433049|NCT00409409|7216574|FG000|Overall Study|Adverse Event|7
4433050|NCT00409409|7216575|FG001|Overall Study|Adverse Event|2
4433051|NCT00409409|7216574|FG000|Overall Study|Withdrawal by Subject|1
4433052|NCT00409409|7216575|FG001|Overall Study|Withdrawal by Subject|1
4433053|NCT00409409|7216574|FG000|Overall Study|Any other reason not above-mentioned|0
4433054|NCT00409409|7216575|FG001|Overall Study|Any other reason not above-mentioned|1
4433055|NCT00409578|7216610|FG000|Overall Study|Adverse Event|27
4433056|NCT00409578|7216611|FG001|Overall Study|Adverse Event|37
4433057|NCT00409578|7216612|FG002|Overall Study|Adverse Event|25
4433058|NCT00409578|7216613|FG003|Overall Study|Adverse Event|33
4433059|NCT00409578|7216610|FG000|Overall Study|Abnormal laboratory value(s)|2
4433060|NCT00409578|7216611|FG001|Overall Study|Abnormal laboratory value(s)|2
4433061|NCT00409578|7216612|FG002|Overall Study|Abnormal laboratory value(s)|2
4433062|NCT00409578|7216613|FG003|Overall Study|Abnormal laboratory value(s)|4
4433063|NCT00409578|7216610|FG000|Overall Study|Lack of Efficacy|0
4433064|NCT00409578|7216611|FG001|Overall Study|Lack of Efficacy|0
4433065|NCT00409578|7216612|FG002|Overall Study|Lack of Efficacy|0
4433066|NCT00409578|7216613|FG003|Overall Study|Lack of Efficacy|2
4433067|NCT00409578|7216610|FG000|Overall Study|Subject no longer requires study drug|0
4433068|NCT00409578|7216611|FG001|Overall Study|Subject no longer requires study drug|0
4433069|NCT00409578|7216612|FG002|Overall Study|Subject no longer requires study drug|0
4433070|NCT00409578|7216613|FG003|Overall Study|Subject no longer requires study drug|1
4433071|NCT00409578|7216610|FG000|Overall Study|Withdrawal by Subject|8
4433072|NCT00409578|7216611|FG001|Overall Study|Withdrawal by Subject|15
4433073|NCT00409578|7216612|FG002|Overall Study|Withdrawal by Subject|16
4433074|NCT00409578|7216613|FG003|Overall Study|Withdrawal by Subject|17
4433075|NCT00409578|7216610|FG000|Overall Study|Lost to Follow-up|2
4433076|NCT00409578|7216611|FG001|Overall Study|Lost to Follow-up|0
4433077|NCT00409578|7216612|FG002|Overall Study|Lost to Follow-up|2
4433078|NCT00409578|7216613|FG003|Overall Study|Lost to Follow-up|2
4433079|NCT00409578|7216610|FG000|Overall Study|Administrative problems|8
4433080|NCT00409578|7216611|FG001|Overall Study|Administrative problems|9
4433081|NCT00409578|7216612|FG002|Overall Study|Administrative problems|2
4433082|NCT00409578|7216613|FG003|Overall Study|Administrative problems|4
4433083|NCT00409578|7216610|FG000|Overall Study|Death|2
4433084|NCT00409578|7216611|FG001|Overall Study|Death|4
4433085|NCT00409578|7216612|FG002|Overall Study|Death|4
4433086|NCT00409578|7216613|FG003|Overall Study|Death|2
4433087|NCT00409578|7216610|FG000|Overall Study|Protocol Violation|3
4433088|NCT00409578|7216611|FG001|Overall Study|Protocol Violation|2
4433089|NCT00409578|7216612|FG002|Overall Study|Protocol Violation|3
4433090|NCT00409578|7216613|FG003|Overall Study|Protocol Violation|1
4433091|NCT00409578|7216610|FG000|Overall Study|Missing|0
4433092|NCT00409578|7216611|FG001|Overall Study|Missing|1
4433093|NCT00409578|7216612|FG002|Overall Study|Missing|0
4433094|NCT00409578|7216613|FG003|Overall Study|Missing|1
4433095|NCT00409617|7216623|FG000|Overall Study|Adverse Event|57
4433096|NCT00409617|7216623|FG000|Overall Study|Lack of Efficacy|54
4433097|NCT00409617|7216623|FG000|Overall Study|Lost to Follow-up|2
4433098|NCT00409617|7216623|FG000|Overall Study|Protocol Violation|24
4433099|NCT00409617|7216623|FG000|Overall Study|Withdrawal by Subject|8
4433100|NCT00409617|7216623|FG000|Overall Study|Administrative reasons|1
4433101|NCT00409617|7216623|FG000|Overall Study|Not described|14
4433102|NCT00409682|7216630|FG000|Open-label Induction Period|Adverse Event|1
4433103|NCT00409682|7216631|FG001|Open-label Induction Period|Adverse Event|0
4433104|NCT00409682|7216632|FG002|Open-label Induction Period|Adverse Event|0
4433105|NCT00409682|7216630|FG000|Open-label Induction Period|Lack of Efficacy|1
4433106|NCT00409682|7216631|FG001|Open-label Induction Period|Lack of Efficacy|0
4433107|NCT00409682|7216632|FG002|Open-label Induction Period|Lack of Efficacy|0
4433108|NCT00409682|7216630|FG000|Open-label Induction Period|Protocol Violation|1
4433109|NCT00409682|7216631|FG001|Open-label Induction Period|Protocol Violation|0
4433110|NCT00409682|7216632|FG002|Open-label Induction Period|Protocol Violation|0
4433111|NCT00409682|7216630|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1
4433112|NCT00409682|7216631|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0
4433113|NCT00409682|7216632|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0
4433114|NCT00409682|7216630|FG000|EOW Double-blind Maintenance Period|Adverse Event|0
4433115|NCT00409682|7216631|FG001|EOW Double-blind Maintenance Period|Adverse Event|10
4433116|NCT00409682|7216632|FG002|EOW Double-blind Maintenance Period|Adverse Event|12
4433117|NCT00409682|7216630|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0
4433118|NCT00409682|7216631|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18
4433119|NCT00409682|7216632|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11
4433120|NCT00409682|7216630|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0
4433121|NCT00409682|7216631|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1
4433122|NCT00409682|7216632|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0
4433123|NCT00409682|7216630|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0
4433124|NCT00409682|7216631|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4
4433125|NCT00409682|7216632|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2
4433126|NCT00409682|7216630|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0
4433127|NCT00409682|7216631|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4
4433128|NCT00409682|7216632|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1
4433129|NCT00409682|7216630|FG000|EOW Double-blind Maintenance Period|Non-compliance|0
4433130|NCT00409682|7216631|FG001|EOW Double-blind Maintenance Period|Non-compliance|0
4433131|NCT00409682|7216632|FG002|EOW Double-blind Maintenance Period|Non-compliance|1
4433132|NCT00409708|7216641|FG000|Treatment|Abnormal test procedure result(s)|1
4433133|NCT00409708|7216642|FG001|Treatment|Abnormal test procedure result(s)|0
4433134|NCT00409708|7216641|FG000|Treatment|Lack of Efficacy|0
4433135|NCT00409708|7216642|FG001|Treatment|Lack of Efficacy|1
4433136|NCT00409708|7216641|FG000|Treatment|Protocol Violation|6
4433137|NCT00409708|7216642|FG001|Treatment|Protocol Violation|2
4433138|NCT00409708|7216641|FG000|Treatment|Withdrawal by Subject|3
4433139|NCT00409708|7216642|FG001|Treatment|Withdrawal by Subject|8
4433140|NCT00409708|7216641|FG000|Treatment|Lost to Follow-up|0
4433141|NCT00409708|7216642|FG001|Treatment|Lost to Follow-up|6
4433142|NCT00409708|7216641|FG000|Treatment|Administrative problems|5
4433143|NCT00409708|7216642|FG001|Treatment|Administrative problems|0
4433144|NCT00409708|7216641|FG000|Washout|Lack of Efficacy|9
4433145|NCT00409708|7216642|FG001|Washout|Lack of Efficacy|1
4433146|NCT00409708|7216641|FG000|Washout|Protocol Violation|0
4433147|NCT00409708|7216642|FG001|Washout|Protocol Violation|1
4433148|NCT00409708|7216641|FG000|Washout|Withdrawal by Subject|11
4433149|NCT00409708|7216642|FG001|Washout|Withdrawal by Subject|5
4716287|NCT02989389|7645490|FG008|Period 1|Physician Decision|1
4433150|NCT00409708|7216641|FG000|Washout|Lost to Follow-up|1
4433151|NCT00409708|7216642|FG001|Washout|Lost to Follow-up|3
4433152|NCT00409747|7216648|FG000|Overall Study|Withdrawal by Subject|1
4512661|NCT00936858|7322670|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4
4512662|NCT00936858|7322670|FG000|Overall Study|Lost to Follow-up|1
4512663|NCT00936884|7322677|FG000|Double-blind|Withdrawal by Subject|6
4512664|NCT00936884|7322678|FG001|Double-blind|Withdrawal by Subject|4
4512665|NCT00936884|7322679|FG002|Double-blind|Withdrawal by Subject|0
4512666|NCT00936884|7322677|FG000|Double-blind|Death|2
4512667|NCT00936884|7322678|FG001|Double-blind|Death|1
4512668|NCT00936884|7322679|FG002|Double-blind|Death|0
4512669|NCT00936884|7322677|FG000|Double-blind|Lack of Efficacy|1
4512670|NCT00936884|7322678|FG001|Double-blind|Lack of Efficacy|1
4512671|NCT00936884|7322679|FG002|Double-blind|Lack of Efficacy|0
4512672|NCT00936884|7322677|FG000|Double-blind|Adverse Event|1
4512673|NCT00936884|7322678|FG001|Double-blind|Adverse Event|0
4512674|NCT00936884|7322679|FG002|Double-blind|Adverse Event|0
4512675|NCT00936884|7322677|FG000|Double-blind|Physician Decision|1
4512676|NCT00936884|7322678|FG001|Double-blind|Physician Decision|0
4512677|NCT00936884|7322679|FG002|Double-blind|Physician Decision|0
4512678|NCT00936884|7322677|FG000|Double-blind|No post baseline diary entry|1
4512679|NCT00936884|7322678|FG001|Double-blind|No post baseline diary entry|0
4512680|NCT00936884|7322679|FG002|Double-blind|No post baseline diary entry|0
4512681|NCT00936884|7322677|FG000|Double-blind|Did not receive study drug|0
4512682|NCT00936884|7322678|FG001|Double-blind|Did not receive study drug|1
4512683|NCT00936884|7322679|FG002|Double-blind|Did not receive study drug|0
4512684|NCT00936897|7322688|FG000|Overall Study|Withdrawal by Subject|9
4512685|NCT00936897|7322689|FG001|Overall Study|Withdrawal by Subject|19
4512686|NCT00936897|7322688|FG000|Overall Study|Adverse Event|4
4512687|NCT00936897|7322689|FG001|Overall Study|Adverse Event|13
4512688|NCT00936897|7322688|FG000|Overall Study|Other|3
4512689|NCT00936897|7322689|FG001|Overall Study|Other|9
4512690|NCT00936897|7322688|FG000|Overall Study|Lost to Follow-up|1
4433153|NCT00409786|7216652|FG000|Overall Study|Withdrawal by Subject|3
4433154|NCT00409838|7216662|FG000|Short-term Period|Adverse Event|0
4433155|NCT00409838|7216663|FG001|Short-term Period|Adverse Event|1
4433156|NCT00409838|7216662|FG000|Short-term Period|Lost to Follow-up|0
4433157|NCT00409838|7216663|FG001|Short-term Period|Lost to Follow-up|1
4433158|NCT00409838|7216662|FG000|Short-term Period|Withdrawal by Subject|2
4433159|NCT00409838|7216663|FG001|Short-term Period|Withdrawal by Subject|3
4433160|NCT00409838|7216662|FG000|Short-term Period|Never Treated|1
4433161|NCT00409838|7216663|FG001|Short-term Period|Never Treated|0
4433162|NCT00409838|7216662|FG000|Long-term Extension Period|Adverse Event|10
4433163|NCT00409838|7216663|FG001|Long-term Extension Period|Adverse Event|0
4433164|NCT00409838|7216662|FG000|Long-term Extension Period|Death|1
4433165|NCT00409838|7216663|FG001|Long-term Extension Period|Death|0
4433166|NCT00409838|7216662|FG000|Long-term Extension Period|Lack of Efficacy|2
4433167|NCT00409838|7216663|FG001|Long-term Extension Period|Lack of Efficacy|0
4433168|NCT00409838|7216662|FG000|Long-term Extension Period|Withdrawal by Subject|3
4433169|NCT00409838|7216663|FG001|Long-term Extension Period|Withdrawal by Subject|0
4433170|NCT00409838|7216662|FG000|Long-term Extension Period|Poor compliance/noncompliance|1
4433171|NCT00409838|7216663|FG001|Long-term Extension Period|Poor compliance/noncompliance|0
4433172|NCT00409838|7216662|FG000|Long-term Extension Period|Pregnancy|1
4433173|NCT00409838|7216663|FG001|Long-term Extension Period|Pregnancy|0
4433174|NCT00410046|7216686|FG000|Overall Study|Adverse Event|3
4433175|NCT00410046|7216686|FG000|Overall Study|Withdrawal by Subject|1
4433176|NCT00410046|7216686|FG000|Overall Study|Lost to Follow-up|1
4433177|NCT00410072|7216697|FG000|Day 1 to Week 48|Adverse Event|1
4433178|NCT00410072|7216698|FG001|Day 1 to Week 48|Adverse Event|2
4433179|NCT00410072|7216697|FG000|Day 1 to Week 48|Lost to Follow-up|5
4433180|NCT00410072|7216698|FG001|Day 1 to Week 48|Lost to Follow-up|2
4433181|NCT00410072|7216697|FG000|Day 1 to Week 48|Other|0
4433182|NCT00410072|7216698|FG001|Day 1 to Week 48|Other|1
4433183|NCT00410072|7216697|FG000|Day 1 to Week 48|poor compliance/noncompliance|0
4433184|NCT00410072|7216698|FG001|Day 1 to Week 48|poor compliance/noncompliance|3
4433185|NCT00410072|7216697|FG000|Day 1 to Week 48|Pregnancy|0
4433186|NCT00410072|7216698|FG001|Day 1 to Week 48|Pregnancy|2
4433187|NCT00410072|7216697|FG000|Day 1 to Week 48|Withdrawal by Subject|0
4433188|NCT00410072|7216698|FG001|Day 1 to Week 48|Withdrawal by Subject|2
4433189|NCT00410072|7216697|FG000|After Week 48 to Week 96|Adverse Event|1
4433190|NCT00410072|7216698|FG001|After Week 48 to Week 96|Adverse Event|2
4433191|NCT00410072|7216697|FG000|After Week 48 to Week 96|Death|0
4433192|NCT00410072|7216698|FG001|After Week 48 to Week 96|Death|1
4433193|NCT00410072|7216697|FG000|After Week 48 to Week 96|Lack of Efficacy|1
4433194|NCT00410072|7216698|FG001|After Week 48 to Week 96|Lack of Efficacy|0
4433195|NCT00410072|7216697|FG000|After Week 48 to Week 96|Lost to Follow-up|2
4433196|NCT00410072|7216698|FG001|After Week 48 to Week 96|Lost to Follow-up|4
4433197|NCT00410072|7216697|FG000|After Week 48 to Week 96|Other|2
4433198|NCT00410072|7216698|FG001|After Week 48 to Week 96|Other|0
4433199|NCT00410072|7216697|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0
4433200|NCT00410072|7216698|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1
4433201|NCT00410072|7216697|FG000|After Week 48 to Week 96|Pregnancy|0
4433202|NCT00410072|7216698|FG001|After Week 48 to Week 96|Pregnancy|2
4433203|NCT00410072|7216697|FG000|After Week 48 to Week 96|Withdrawal by Subject|0
4433204|NCT00410072|7216698|FG001|After Week 48 to Week 96|Withdrawal by Subject|1
4433205|NCT00410124|7216706|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36
4433206|NCT00410124|7216707|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2
4433207|NCT00410124|7216706|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1
4433208|NCT00410124|7216707|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0
4433209|NCT00410124|7216706|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2
4433210|NCT00410124|7216707|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1
4433211|NCT00410124|7216706|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13
4433212|NCT00410124|7216707|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2
4433213|NCT00410124|7216706|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4
4433214|NCT00410124|7216707|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0
4433215|NCT00410124|7216706|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2
4433216|NCT00410124|7216707|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0
4433217|NCT00410124|7216706|FG000|Core Phase Double Blind (15 Months)|Death|7
4433218|NCT00410124|7216707|FG001|Core Phase Double Blind (15 Months)|Death|4
4433219|NCT00410124|7216706|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137
4433220|NCT00410124|7216707|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124
4433221|NCT00410124|7216706|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7
4433222|NCT00410124|7216707|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19
4433223|NCT00410124|7216706|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0
4433224|NCT00410124|7216707|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1
4433225|NCT00410124|7216706|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0
4433226|NCT00410124|7216707|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1
4433227|NCT00410124|7216706|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1
4433228|NCT00410124|7216707|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1
4433229|NCT00410124|7216706|FG000|Extension Phase - Open Label (45 Months)|Death|2
4433230|NCT00410124|7216707|FG001|Extension Phase - Open Label (45 Months)|Death|10
4433231|NCT00410124|7216706|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56
4433232|NCT00410124|7216707|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78
4433233|NCT00410124|7216706|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1
4433234|NCT00410124|7216707|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0
4433235|NCT00410124|7216706|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0
4433236|NCT00410124|7216707|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1
4433237|NCT00410163|7216728|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4
4433238|NCT00410163|7216729|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2
4433239|NCT00410163|7216728|FG000|Treatment and Follow-up Phase (2 Years)|Death|1
4433240|NCT00410163|7216729|FG001|Treatment and Follow-up Phase (2 Years)|Death|1
4433241|NCT00410163|7216728|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2
4433242|NCT00410163|7216729|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1
4433243|NCT00410163|7216728|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0
4433244|NCT00410163|7216729|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4
4433245|NCT00410163|7216728|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2
4433246|NCT00410163|7216729|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1
4433247|NCT00410163|7216728|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1
4433248|NCT00410163|7216729|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0
4433249|NCT00410163|7216728|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1
4433250|NCT00410163|7216729|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1
4433251|NCT00410163|7216728|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1
4433252|NCT00410163|7216729|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0
4433253|NCT00410163|7216728|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0
4433254|NCT00410163|7216729|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1
4433255|NCT00410163|7216728|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3
4433256|NCT00410163|7216729|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1
4433257|NCT00410163|7216728|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1
4433258|NCT00410163|7216729|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1
4433259|NCT00410163|7216728|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1
4433260|NCT00410163|7216729|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0
4433261|NCT00410163|7216728|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4
4433262|NCT00410163|7216729|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8
4433263|NCT00410163|7216728|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1
4433264|NCT00410163|7216729|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0
4433265|NCT00410202|7216746|FG000|On-Treatment|Continuing treatment|69
4433266|NCT00410202|7216747|FG001|On-Treatment|Continuing treatment|71
4433267|NCT00410202|7216748|FG002|On-Treatment|Continuing treatment|66
4433268|NCT00410202|7216746|FG000|On-Treatment|Adverse Event|1
4433269|NCT00410202|7216747|FG001|On-Treatment|Adverse Event|3
4433270|NCT00410202|7216748|FG002|On-Treatment|Adverse Event|2
4433271|NCT00410202|7216746|FG000|On-Treatment|Death|1
4433272|NCT00410202|7216747|FG001|On-Treatment|Death|0
4433273|NCT00410202|7216748|FG002|On-Treatment|Death|0
4433274|NCT00410202|7216746|FG000|On-Treatment|Lost to Follow-up|1
4433275|NCT00410202|7216747|FG001|On-Treatment|Lost to Follow-up|0
4433276|NCT00410202|7216748|FG002|On-Treatment|Lost to Follow-up|1
4433277|NCT00410202|7216746|FG000|On-Treatment|Lack of Efficacy|1
4433278|NCT00410202|7216747|FG001|On-Treatment|Lack of Efficacy|4
4433279|NCT00410202|7216748|FG002|On-Treatment|Lack of Efficacy|0
4433280|NCT00410202|7216746|FG000|On-Treatment|Withdrawal by Subject|2
4433281|NCT00410202|7216747|FG001|On-Treatment|Withdrawal by Subject|1
4433282|NCT00410202|7216748|FG002|On-Treatment|Withdrawal by Subject|1
4433283|NCT00410202|7216746|FG000|On-Treatment|Other Reason|0
4433284|NCT00410202|7216747|FG001|On-Treatment|Other Reason|0
4433285|NCT00410202|7216748|FG002|On-Treatment|Other Reason|1
4433286|NCT00410202|7216746|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10
4433287|NCT00410202|7216747|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8
4433288|NCT00410202|7216748|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11
4433289|NCT00410202|7216746|FG000|Off-treatment Follow up|Follow up not required per protocol|3
4433290|NCT00410202|7216747|FG001|Off-treatment Follow up|Follow up not required per protocol|0
4433291|NCT00410202|7216748|FG002|Off-treatment Follow up|Follow up not required per protocol|1
4433292|NCT00410202|7216746|FG000|Off-treatment Follow up|Lost to Follow-up|1
4433293|NCT00410202|7216747|FG001|Off-treatment Follow up|Lost to Follow-up|0
4433294|NCT00410202|7216748|FG002|Off-treatment Follow up|Lost to Follow-up|0
4433295|NCT00410384|7216769|FG000|Overall Study|Withdrawal by Subject|28
4433296|NCT00410384|7216770|FG001|Overall Study|Withdrawal by Subject|17
4433297|NCT00410384|7216771|FG002|Overall Study|Withdrawal by Subject|20
4433298|NCT00410384|7216769|FG000|Overall Study|Adverse Event|23
4433299|NCT00410384|7216770|FG001|Overall Study|Adverse Event|18
4433300|NCT00410384|7216771|FG002|Overall Study|Adverse Event|23
4433301|NCT00410384|7216769|FG000|Overall Study|Lack of Efficacy|20
4433302|NCT00410384|7216770|FG001|Overall Study|Lack of Efficacy|12
4433303|NCT00410384|7216771|FG002|Overall Study|Lack of Efficacy|17
4433304|NCT00410384|7216769|FG000|Overall Study|Lack of Compliance|2
4433305|NCT00410384|7216770|FG001|Overall Study|Lack of Compliance|2
4433306|NCT00410384|7216771|FG002|Overall Study|Lack of Compliance|2
4433307|NCT00410384|7216769|FG000|Overall Study|Lost to Follow-up|4
4433308|NCT00410384|7216770|FG001|Overall Study|Lost to Follow-up|6
4433309|NCT00410384|7216771|FG002|Overall Study|Lost to Follow-up|6
4433310|NCT00410384|7216769|FG000|Overall Study|Protocol Violation|6
4433311|NCT00410384|7216770|FG001|Overall Study|Protocol Violation|6
4433312|NCT00410384|7216771|FG002|Overall Study|Protocol Violation|6
4433313|NCT00410384|7216769|FG000|Overall Study|Physician Decision|3
4433314|NCT00410384|7216770|FG001|Overall Study|Physician Decision|3
4433315|NCT00410384|7216771|FG002|Overall Study|Physician Decision|4
4433316|NCT00410384|7216769|FG000|Overall Study|Other|3
4433317|NCT00410384|7216770|FG001|Overall Study|Other|8
4433318|NCT00410384|7216771|FG002|Overall Study|Other|4
4433319|NCT00410410|7216785|FG000|Induction Period (IP)|Death|1
4433320|NCT00410410|7216786|FG001|Induction Period (IP)|Death|0
4433321|NCT00410410|7216787|FG002|Induction Period (IP)|Death|0
4433322|NCT00410410|7216788|FG003|Induction Period (IP)|Death|0
4433323|NCT00410410|7216789|FG004|Induction Period (IP)|Death|0
4433324|NCT00410410|7216790|FG005|Induction Period (IP)|Death|0
4433325|NCT00410410|7216791|FG006|Induction Period (IP)|Death|0
4433326|NCT00410410|7216792|FG007|Induction Period (IP)|Death|0
4433327|NCT00410410|7216793|FG008|Induction Period (IP)|Death|0
4433328|NCT00410410|7216785|FG000|Induction Period (IP)|Adverse Event|3
4433329|NCT00410410|7216786|FG001|Induction Period (IP)|Adverse Event|4
4433330|NCT00410410|7216787|FG002|Induction Period (IP)|Adverse Event|2
4433331|NCT00410410|7216788|FG003|Induction Period (IP)|Adverse Event|4
4433332|NCT00410410|7216789|FG004|Induction Period (IP)|Adverse Event|1
4433333|NCT00410410|7216790|FG005|Induction Period (IP)|Adverse Event|0
4433334|NCT00410410|7216791|FG006|Induction Period (IP)|Adverse Event|0
4433335|NCT00410410|7216792|FG007|Induction Period (IP)|Adverse Event|0
4433336|NCT00410410|7216793|FG008|Induction Period (IP)|Adverse Event|0
4433337|NCT00410410|7216785|FG000|Induction Period (IP)|Lack of Efficacy|26
4433338|NCT00410410|7216786|FG001|Induction Period (IP)|Lack of Efficacy|24
4433339|NCT00410410|7216787|FG002|Induction Period (IP)|Lack of Efficacy|8
4433340|NCT00410410|7216788|FG003|Induction Period (IP)|Lack of Efficacy|8
4433341|NCT00410410|7216789|FG004|Induction Period (IP)|Lack of Efficacy|7
4433342|NCT00410410|7216790|FG005|Induction Period (IP)|Lack of Efficacy|7
4433343|NCT00410410|7216791|FG006|Induction Period (IP)|Lack of Efficacy|0
4433344|NCT00410410|7216792|FG007|Induction Period (IP)|Lack of Efficacy|0
4433345|NCT00410410|7216793|FG008|Induction Period (IP)|Lack of Efficacy|0
4433346|NCT00410410|7216785|FG000|Induction Period (IP)|Lost to Follow-up|2
4433347|NCT00410410|7216786|FG001|Induction Period (IP)|Lost to Follow-up|2
4433348|NCT00410410|7216787|FG002|Induction Period (IP)|Lost to Follow-up|2
4433349|NCT00410410|7216788|FG003|Induction Period (IP)|Lost to Follow-up|3
4433350|NCT00410410|7216789|FG004|Induction Period (IP)|Lost to Follow-up|0
4433351|NCT00410410|7216790|FG005|Induction Period (IP)|Lost to Follow-up|1
4433352|NCT00410410|7216791|FG006|Induction Period (IP)|Lost to Follow-up|0
4433353|NCT00410410|7216792|FG007|Induction Period (IP)|Lost to Follow-up|0
4433354|NCT00410410|7216793|FG008|Induction Period (IP)|Lost to Follow-up|0
4433355|NCT00410410|7216785|FG000|Induction Period (IP)|Withdrawal by Subject|3
4433356|NCT00410410|7216786|FG001|Induction Period (IP)|Withdrawal by Subject|5
4433357|NCT00410410|7216787|FG002|Induction Period (IP)|Withdrawal by Subject|3
4433358|NCT00410410|7216788|FG003|Induction Period (IP)|Withdrawal by Subject|5
4433359|NCT00410410|7216789|FG004|Induction Period (IP)|Withdrawal by Subject|2
4433360|NCT00410410|7216790|FG005|Induction Period (IP)|Withdrawal by Subject|0
4433361|NCT00410410|7216791|FG006|Induction Period (IP)|Withdrawal by Subject|0
4433362|NCT00410410|7216792|FG007|Induction Period (IP)|Withdrawal by Subject|0
4433363|NCT00410410|7216793|FG008|Induction Period (IP)|Withdrawal by Subject|0
4433364|NCT00410410|7216785|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
4433365|NCT00410410|7216786|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
4433366|NCT00410410|7216787|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1
4433367|NCT00410410|7216788|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
4433368|NCT00410410|7216789|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
4433369|NCT00410410|7216790|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
4433370|NCT00410410|7216791|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
4433371|NCT00410410|7216792|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
4433372|NCT00410410|7216793|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
4433373|NCT00410410|7216785|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0
4433374|NCT00410410|7216786|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0
4433375|NCT00410410|7216787|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0
4433376|NCT00410410|7216788|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0
4433377|NCT00410410|7216789|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22
4433378|NCT00410410|7216790|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21
4433379|NCT00410410|7216791|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0
4433380|NCT00410410|7216792|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0
4433381|NCT00410410|7216793|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0
4433382|NCT00410410|7216785|FG000|Induction Period (IP)|Other|0
4433383|NCT00410410|7216786|FG001|Induction Period (IP)|Other|0
4433384|NCT00410410|7216787|FG002|Induction Period (IP)|Other|1
4433385|NCT00410410|7216788|FG003|Induction Period (IP)|Other|0
4433386|NCT00410410|7216789|FG004|Induction Period (IP)|Other|0
4433387|NCT00410410|7216790|FG005|Induction Period (IP)|Other|0
4433388|NCT00410410|7216791|FG006|Induction Period (IP)|Other|0
4433389|NCT00410410|7216792|FG007|Induction Period (IP)|Other|0
4433390|NCT00410410|7216793|FG008|Induction Period (IP)|Other|0
4433391|NCT00410410|7216785|FG000|Maintenance Period (MP)|Death|0
4433392|NCT00410410|7216786|FG001|Maintenance Period (MP)|Death|0
4433393|NCT00410410|7216787|FG002|Maintenance Period (MP)|Death|0
4433394|NCT00410410|7216788|FG003|Maintenance Period (MP)|Death|0
4433395|NCT00410410|7216789|FG004|Maintenance Period (MP)|Death|0
4433396|NCT00410410|7216790|FG005|Maintenance Period (MP)|Death|0
4433397|NCT00410410|7216791|FG006|Maintenance Period (MP)|Death|1
4433398|NCT00410410|7216792|FG007|Maintenance Period (MP)|Death|0
4433399|NCT00410410|7216793|FG008|Maintenance Period (MP)|Death|0
4433400|NCT00410410|7216785|FG000|Maintenance Period (MP)|Adverse Event|0
4433401|NCT00410410|7216786|FG001|Maintenance Period (MP)|Adverse Event|0
4433402|NCT00410410|7216787|FG002|Maintenance Period (MP)|Adverse Event|0
4433403|NCT00410410|7216788|FG003|Maintenance Period (MP)|Adverse Event|0
4433404|NCT00410410|7216789|FG004|Maintenance Period (MP)|Adverse Event|0
4433405|NCT00410410|7216790|FG005|Maintenance Period (MP)|Adverse Event|0
4433406|NCT00410410|7216791|FG006|Maintenance Period (MP)|Adverse Event|1
4433407|NCT00410410|7216792|FG007|Maintenance Period (MP)|Adverse Event|3
4433408|NCT00410410|7216793|FG008|Maintenance Period (MP)|Adverse Event|0
4433409|NCT00410410|7216785|FG000|Maintenance Period (MP)|Lack of Efficacy|0
4433410|NCT00410410|7216786|FG001|Maintenance Period (MP)|Lack of Efficacy|0
4433411|NCT00410410|7216787|FG002|Maintenance Period (MP)|Lack of Efficacy|0
4433412|NCT00410410|7216788|FG003|Maintenance Period (MP)|Lack of Efficacy|0
4433413|NCT00410410|7216789|FG004|Maintenance Period (MP)|Lack of Efficacy|0
4433414|NCT00410410|7216790|FG005|Maintenance Period (MP)|Lack of Efficacy|0
4433415|NCT00410410|7216791|FG006|Maintenance Period (MP)|Lack of Efficacy|25
4433416|NCT00410410|7216792|FG007|Maintenance Period (MP)|Lack of Efficacy|24
4433417|NCT00410410|7216793|FG008|Maintenance Period (MP)|Lack of Efficacy|0
4433418|NCT00410410|7216785|FG000|Maintenance Period (MP)|Lost to Follow-up|0
4433419|NCT00410410|7216786|FG001|Maintenance Period (MP)|Lost to Follow-up|0
4433420|NCT00410410|7216787|FG002|Maintenance Period (MP)|Lost to Follow-up|0
4433421|NCT00410410|7216788|FG003|Maintenance Period (MP)|Lost to Follow-up|0
4433422|NCT00410410|7216789|FG004|Maintenance Period (MP)|Lost to Follow-up|0
4433423|NCT00410410|7216790|FG005|Maintenance Period (MP)|Lost to Follow-up|0
4433424|NCT00410410|7216791|FG006|Maintenance Period (MP)|Lost to Follow-up|1
4433425|NCT00410410|7216792|FG007|Maintenance Period (MP)|Lost to Follow-up|2
4433426|NCT00410410|7216793|FG008|Maintenance Period (MP)|Lost to Follow-up|0
4433427|NCT00410410|7216785|FG000|Maintenance Period (MP)|Withdrawal by Subject|0
4433428|NCT00410410|7216786|FG001|Maintenance Period (MP)|Withdrawal by Subject|0
4433429|NCT00410410|7216787|FG002|Maintenance Period (MP)|Withdrawal by Subject|0
4433430|NCT00410410|7216788|FG003|Maintenance Period (MP)|Withdrawal by Subject|0
4433431|NCT00410410|7216789|FG004|Maintenance Period (MP)|Withdrawal by Subject|0
4433432|NCT00410410|7216790|FG005|Maintenance Period (MP)|Withdrawal by Subject|0
4433433|NCT00410410|7216791|FG006|Maintenance Period (MP)|Withdrawal by Subject|1
4433434|NCT00410410|7216792|FG007|Maintenance Period (MP)|Withdrawal by Subject|1
4433435|NCT00410410|7216793|FG008|Maintenance Period (MP)|Withdrawal by Subject|0
4433436|NCT00410410|7216785|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0
4433437|NCT00410410|7216786|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0
4433438|NCT00410410|7216787|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0
4433439|NCT00410410|7216788|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0
4433440|NCT00410410|7216789|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0
4590468|NCT01521923|7436511|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
4590469|NCT01521923|7436512|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
4590470|NCT01521923|7436513|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1
4590471|NCT01521923|7436510|FG000|Overall Study|Lack of Efficacy|1
4590472|NCT01521923|7436511|FG001|Overall Study|Lack of Efficacy|1
4590473|NCT01521923|7436512|FG002|Overall Study|Lack of Efficacy|0
4433441|NCT00410410|7216790|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0
4433442|NCT00410410|7216791|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21
4433443|NCT00410410|7216792|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25
4433444|NCT00410410|7216793|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0
4433445|NCT00410410|7216785|FG000|Open-Label Period (OL)|Death|0
4433446|NCT00410410|7216786|FG001|Open-Label Period (OL)|Death|0
4590474|NCT01521923|7436513|FG003|Overall Study|Lack of Efficacy|0
4433447|NCT00410410|7216787|FG002|Open-Label Period (OL)|Death|0
4433448|NCT00410410|7216788|FG003|Open-Label Period (OL)|Death|0
4433449|NCT00410410|7216789|FG004|Open-Label Period (OL)|Death|0
4433450|NCT00410410|7216790|FG005|Open-Label Period (OL)|Death|0
4433451|NCT00410410|7216791|FG006|Open-Label Period (OL)|Death|0
4433452|NCT00410410|7216792|FG007|Open-Label Period (OL)|Death|0
4433453|NCT00410410|7216793|FG008|Open-Label Period (OL)|Death|1
4433454|NCT00410410|7216785|FG000|Open-Label Period (OL)|Adverse Event|0
4433455|NCT00410410|7216786|FG001|Open-Label Period (OL)|Adverse Event|0
4433456|NCT00410410|7216787|FG002|Open-Label Period (OL)|Adverse Event|0
4433457|NCT00410410|7216788|FG003|Open-Label Period (OL)|Adverse Event|0
4433458|NCT00410410|7216789|FG004|Open-Label Period (OL)|Adverse Event|0
4433459|NCT00410410|7216790|FG005|Open-Label Period (OL)|Adverse Event|0
4433460|NCT00410410|7216791|FG006|Open-Label Period (OL)|Adverse Event|0
4433461|NCT00410410|7216792|FG007|Open-Label Period (OL)|Adverse Event|0
4433462|NCT00410410|7216793|FG008|Open-Label Period (OL)|Adverse Event|10
4433463|NCT00410410|7216785|FG000|Open-Label Period (OL)|Lack of Efficacy|0
4433464|NCT00410410|7216786|FG001|Open-Label Period (OL)|Lack of Efficacy|0
4433465|NCT00410410|7216787|FG002|Open-Label Period (OL)|Lack of Efficacy|0
4433466|NCT00410410|7216788|FG003|Open-Label Period (OL)|Lack of Efficacy|0
4433467|NCT00410410|7216789|FG004|Open-Label Period (OL)|Lack of Efficacy|0
4433468|NCT00410410|7216790|FG005|Open-Label Period (OL)|Lack of Efficacy|0
4433469|NCT00410410|7216791|FG006|Open-Label Period (OL)|Lack of Efficacy|0
4433470|NCT00410410|7216792|FG007|Open-Label Period (OL)|Lack of Efficacy|0
4433471|NCT00410410|7216793|FG008|Open-Label Period (OL)|Lack of Efficacy|161
4433472|NCT00410410|7216785|FG000|Open-Label Period (OL)|Lost to Follow-up|0
4433473|NCT00410410|7216786|FG001|Open-Label Period (OL)|Lost to Follow-up|0
4433474|NCT00410410|7216787|FG002|Open-Label Period (OL)|Lost to Follow-up|0
4433475|NCT00410410|7216788|FG003|Open-Label Period (OL)|Lost to Follow-up|0
4433476|NCT00410410|7216789|FG004|Open-Label Period (OL)|Lost to Follow-up|0
4433477|NCT00410410|7216790|FG005|Open-Label Period (OL)|Lost to Follow-up|0
4433478|NCT00410410|7216791|FG006|Open-Label Period (OL)|Lost to Follow-up|0
4433479|NCT00410410|7216792|FG007|Open-Label Period (OL)|Lost to Follow-up|0
4433480|NCT00410410|7216793|FG008|Open-Label Period (OL)|Lost to Follow-up|4
4433481|NCT00410410|7216785|FG000|Open-Label Period (OL)|Withdrawal by Subject|0
4433482|NCT00410410|7216786|FG001|Open-Label Period (OL)|Withdrawal by Subject|0
4433483|NCT00410410|7216787|FG002|Open-Label Period (OL)|Withdrawal by Subject|0
4433484|NCT00410410|7216788|FG003|Open-Label Period (OL)|Withdrawal by Subject|0
4433485|NCT00410410|7216789|FG004|Open-Label Period (OL)|Withdrawal by Subject|0
4433486|NCT00410410|7216790|FG005|Open-Label Period (OL)|Withdrawal by Subject|0
4433487|NCT00410410|7216791|FG006|Open-Label Period (OL)|Withdrawal by Subject|0
4433488|NCT00410410|7216792|FG007|Open-Label Period (OL)|Withdrawal by Subject|0
4433489|NCT00410410|7216793|FG008|Open-Label Period (OL)|Withdrawal by Subject|20
4433490|NCT00410410|7216785|FG000|Open-Label Period (OL)|Pregnancy|0
4630121|NCT03401112|7498688|FG003|Overall Study|Noncompliance|0
4630122|NCT03401112|7498689|FG004|Overall Study|Noncompliance|0
4630123|NCT03401112|7498685|FG000|Overall Study|Did not Meet Inclusion Criteria|1
4630124|NCT03401112|7498686|FG001|Overall Study|Did not Meet Inclusion Criteria|0
4630125|NCT03401112|7498687|FG002|Overall Study|Did not Meet Inclusion Criteria|0
4630126|NCT03401112|7498688|FG003|Overall Study|Did not Meet Inclusion Criteria|0
4630127|NCT03401112|7498689|FG004|Overall Study|Did not Meet Inclusion Criteria|0
4630128|NCT03401112|7498685|FG000|Overall Study|Withdrawal by Subject|0
4630129|NCT03401112|7498686|FG001|Overall Study|Withdrawal by Subject|3
4630130|NCT03401112|7498687|FG002|Overall Study|Withdrawal by Subject|2
4630131|NCT03401112|7498688|FG003|Overall Study|Withdrawal by Subject|1
4630132|NCT03401112|7498689|FG004|Overall Study|Withdrawal by Subject|0
4630133|NCT03401112|7498685|FG000|Overall Study|Physician Decision|0
4630134|NCT03401112|7498686|FG001|Overall Study|Physician Decision|0
4630135|NCT03401112|7498687|FG002|Overall Study|Physician Decision|0
4630136|NCT03401112|7498688|FG003|Overall Study|Physician Decision|2
4630137|NCT03401112|7498689|FG004|Overall Study|Physician Decision|0
4630138|NCT03401112|7498685|FG000|Overall Study|Study was Terminated by Sponsor|0
4630139|NCT03401112|7498686|FG001|Overall Study|Study was Terminated by Sponsor|0
4630140|NCT03401112|7498687|FG002|Overall Study|Study was Terminated by Sponsor|0
4630141|NCT03401112|7498688|FG003|Overall Study|Study was Terminated by Sponsor|1
4433491|NCT00410410|7216786|FG001|Open-Label Period (OL)|Pregnancy|0
4433492|NCT00410410|7216787|FG002|Open-Label Period (OL)|Pregnancy|0
4433493|NCT00410410|7216788|FG003|Open-Label Period (OL)|Pregnancy|0
4433494|NCT00410410|7216789|FG004|Open-Label Period (OL)|Pregnancy|0
4433495|NCT00410410|7216790|FG005|Open-Label Period (OL)|Pregnancy|0
4433496|NCT00410410|7216791|FG006|Open-Label Period (OL)|Pregnancy|0
4433497|NCT00410410|7216792|FG007|Open-Label Period (OL)|Pregnancy|0
4433498|NCT00410410|7216793|FG008|Open-Label Period (OL)|Pregnancy|1
4433499|NCT00410410|7216785|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0
4433500|NCT00410410|7216786|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0
4433501|NCT00410410|7216787|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0
4630142|NCT03401112|7498689|FG004|Overall Study|Study was Terminated by Sponsor|0
4630143|NCT03401112|7498685|FG000|Overall Study|Day 1 Assessment not Done|1
4433502|NCT00410410|7216788|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0
4433503|NCT00410410|7216789|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0
4433504|NCT00410410|7216790|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0
4433505|NCT00410410|7216791|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0
4433506|NCT00410410|7216792|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0
4433507|NCT00410410|7216793|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145
4433508|NCT00410410|7216785|FG000|Open-Label Period (OL)|Other|0
4433509|NCT00410410|7216786|FG001|Open-Label Period (OL)|Other|0
4433510|NCT00410410|7216787|FG002|Open-Label Period (OL)|Other|0
4433511|NCT00410410|7216788|FG003|Open-Label Period (OL)|Other|0
4433512|NCT00410410|7216789|FG004|Open-Label Period (OL)|Other|0
4433513|NCT00410410|7216790|FG005|Open-Label Period (OL)|Other|0
4433514|NCT00410410|7216791|FG006|Open-Label Period (OL)|Other|0
4433515|NCT00410410|7216792|FG007|Open-Label Period (OL)|Other|0
4433516|NCT00410410|7216793|FG008|Open-Label Period (OL)|Other|7
4433517|NCT00410514|7216849|FG000|Overall Study|Adverse Event|2
4433518|NCT00410514|7216850|FG001|Overall Study|Adverse Event|2
4433519|NCT00410514|7216851|FG002|Overall Study|Adverse Event|2
4433520|NCT00410514|7216849|FG000|Overall Study|Protocol Violation|0
4433521|NCT00410514|7216850|FG001|Overall Study|Protocol Violation|1
4433522|NCT00410514|7216851|FG002|Overall Study|Protocol Violation|1
4433523|NCT00410514|7216849|FG000|Overall Study|Lost to Follow-up|0
4433524|NCT00410514|7216850|FG001|Overall Study|Lost to Follow-up|0
4433525|NCT00410514|7216851|FG002|Overall Study|Lost to Follow-up|2
4433526|NCT00410514|7216849|FG000|Overall Study|Non-compliant with study procedures|0
4433527|NCT00410514|7216850|FG001|Overall Study|Non-compliant with study procedures|0
4433528|NCT00410514|7216851|FG002|Overall Study|Non-compliant with study procedures|2
4433529|NCT00410605|7216859|FG000|Overall Study|Adverse Event|12
4433530|NCT00410605|7216859|FG000|Overall Study|Physician Decision|3
4433531|NCT00410605|7216859|FG000|Overall Study|Withdrawal by Subject|5
4433532|NCT00410605|7216859|FG000|Overall Study|Started Non-Protocol Therapy|3
4433533|NCT00410605|7216859|FG000|Overall Study|Stopped treatmen to collect stem cells|1
4433534|NCT00410605|7216859|FG000|Overall Study|Transferred to another Institution|1
4433535|NCT00410761|7216865|FG000|Overall Study|Adverse Event|29
4433536|NCT00410761|7216866|FG001|Overall Study|Adverse Event|3
4433537|NCT00410761|7216865|FG000|Overall Study|objective disease progression|71
4433538|NCT00410761|7216866|FG001|Overall Study|objective disease progression|55
4433539|NCT00410761|7216865|FG000|Overall Study|Withdrawal by Subject|8
4433540|NCT00410761|7216866|FG001|Overall Study|Withdrawal by Subject|4
4433541|NCT00410761|7216865|FG000|Overall Study|Other|12
4433542|NCT00410761|7216866|FG001|Overall Study|Other|9
4433543|NCT00410761|7216865|FG000|Overall Study|Never received randomised treatment|0
4433544|NCT00410761|7216866|FG001|Overall Study|Never received randomised treatment|1
4433545|NCT00410813|7216874|FG000|Overall Study|Adverse Event|6
4433546|NCT00410813|7216875|FG001|Overall Study|Adverse Event|11
4433547|NCT00410813|7216874|FG000|Overall Study|Progression|32
4433548|NCT00410813|7216875|FG001|Overall Study|Progression|21
4433549|NCT00410813|7216874|FG000|Overall Study|Not protocol specified|3
4433550|NCT00410813|7216875|FG001|Overall Study|Not protocol specified|4
4433551|NCT00410813|7216874|FG000|Overall Study|Ineligible|2
4433552|NCT00410813|7216875|FG001|Overall Study|Ineligible|4
4433553|NCT00410813|7216874|FG000|Overall Study|Death|0
4433554|NCT00410813|7216875|FG001|Overall Study|Death|2
4433555|NCT00411151|7216931|FG000|Overall Study|Death|38
4433556|NCT00411151|7216931|FG000|Overall Study|Withdrawal by Subject|2
4433557|NCT00411151|7216931|FG000|Overall Study|Lost to Follow-up|2
4433558|NCT00411151|7216931|FG000|Overall Study|Protocol Violation|1
4433559|NCT00411151|7216931|FG000|Overall Study|Trial prematurely closed|4
4433560|NCT00411216|7216937|FG000|Overall Study|Ten participants were entered into the c|0
4433561|NCT00411216|7216938|FG001|Overall Study|Ten participants were entered into the c|2
4433562|NCT00411450|7216958|FG000|Overall Study|Ongoing at time of data cut-off.|3
4433563|NCT00411554|7216978|FG000|Overall Study|Adverse Event|2
4433564|NCT00411554|7216979|FG001|Overall Study|Adverse Event|4
4433565|NCT00411554|7216978|FG000|Overall Study|Lack of Efficacy|2
4433566|NCT00411554|7216979|FG001|Overall Study|Lack of Efficacy|5
4433567|NCT00411554|7216978|FG000|Overall Study|Withdrawal by Subject|3
4433568|NCT00411554|7216979|FG001|Overall Study|Withdrawal by Subject|0
4433569|NCT00411554|7216978|FG000|Overall Study|Patient Moved|1
4433570|NCT00411554|7216979|FG001|Overall Study|Patient Moved|0
4433571|NCT00411632|7216990|FG000|Overall Study|Death|1
4433572|NCT00411645|7216996|FG000|Overall Study|Consent Withdrawn|13
4433573|NCT00411645|7216997|FG001|Overall Study|Consent Withdrawn|22
4433574|NCT00411645|7216996|FG000|Overall Study|Death|56
4433575|NCT00411645|7216997|FG001|Overall Study|Death|135
4433576|NCT00411645|7216996|FG000|Overall Study|Investigator/Sponsor Decision|10
4433577|NCT00411645|7216997|FG001|Overall Study|Investigator/Sponsor Decision|7
4433578|NCT00411645|7216996|FG000|Overall Study|Lost to Follow-up|2
4433579|NCT00411645|7216997|FG001|Overall Study|Lost to Follow-up|0
4433580|NCT00411671|7217004|FG000|Overall Study|Adverse Event|15
4433581|NCT00411671|7217004|FG000|Overall Study|Death|2
4433582|NCT00411671|7217004|FG000|Overall Study|Lost to Follow-up|3
4433583|NCT00411762|7217025|FG000|Overall Study|Withdrawal by Subject|5
4433584|NCT00411788|7217029|FG000|Overall Study|Protocol Violation|1
4433585|NCT00411788|7217029|FG000|Overall Study|Adverse Event|1
4433586|NCT00412061|7217035|FG000|Double Blind Phase|Disease Progression|101
4433587|NCT00412061|7217036|FG001|Double Blind Phase|Disease Progression|154
4433588|NCT00412061|7217035|FG000|Double Blind Phase|Adverse Event|61
4433589|NCT00412061|7217036|FG001|Double Blind Phase|Adverse Event|16
4433590|NCT00412061|7217035|FG000|Double Blind Phase|Final Primary Analysis|26
4433591|NCT00412061|7217036|FG001|Double Blind Phase|Final Primary Analysis|14
4433592|NCT00412061|7217035|FG000|Double Blind Phase|Withdrawal by Subject|18
4433593|NCT00412061|7217036|FG001|Double Blind Phase|Withdrawal by Subject|20
4433594|NCT00412061|7217035|FG000|Double Blind Phase|Death|6
4433595|NCT00412061|7217036|FG001|Double Blind Phase|Death|3
4433596|NCT00412061|7217035|FG000|Double Blind Phase|Protocol Violation|3
4433597|NCT00412061|7217036|FG001|Double Blind Phase|Protocol Violation|4
4716288|NCT02989389|7645491|FG009|Period 1|Physician Decision|0
4630144|NCT03401112|7498686|FG001|Overall Study|Day 1 Assessment not Done|0
4630145|NCT03401112|7498687|FG002|Overall Study|Day 1 Assessment not Done|0
4630146|NCT03401112|7498688|FG003|Overall Study|Day 1 Assessment not Done|0
4433598|NCT00412061|7217035|FG000|Double Blind Phase|New Cander Therapy|1
4433599|NCT00412061|7217036|FG001|Double Blind Phase|New Cander Therapy|1
4433600|NCT00412061|7217035|FG000|Double Blind Phase|Lost to Follow-up|0
4433601|NCT00412061|7217036|FG001|Double Blind Phase|Lost to Follow-up|1
4433602|NCT00412061|7217035|FG000|Open Label Phase|Disease Progression|0
4433603|NCT00412061|7217036|FG001|Open Label Phase|Disease Progression|86
4433604|NCT00412061|7217035|FG000|Open Label Phase|Adverse Event|0
4433605|NCT00412061|7217036|FG001|Open Label Phase|Adverse Event|46
4433606|NCT00412061|7217035|FG000|Open Label Phase|Withdrawal by Subject|0
4433607|NCT00412061|7217036|FG001|Open Label Phase|Withdrawal by Subject|15
4433608|NCT00412061|7217035|FG000|Open Label Phase|Administrative Problems|0
4433609|NCT00412061|7217036|FG001|Open Label Phase|Administrative Problems|13
4433610|NCT00412061|7217035|FG000|Open Label Phase|Death|0
4433611|NCT00412061|7217036|FG001|Open Label Phase|Death|7
4433612|NCT00412061|7217035|FG000|Open Label Phase|Lost to Follow-up|0
4433613|NCT00412061|7217036|FG001|Open Label Phase|Lost to Follow-up|2
4433614|NCT00412061|7217035|FG000|Open Label Phase|New Cancer Therapy|0
4433615|NCT00412061|7217036|FG001|Open Label Phase|New Cancer Therapy|1
4433616|NCT00412113|7217072|FG000|Overall Study|Adverse Event|11
4433617|NCT00412113|7217073|FG001|Overall Study|Adverse Event|15
4433618|NCT00412113|7217072|FG000|Overall Study|did not receive treatment|1
4433619|NCT00412113|7217073|FG001|Overall Study|did not receive treatment|0
4433620|NCT00412217|7217081|FG000|Overall Study|Insufficient Data Available|8
4433621|NCT00412217|7217082|FG001|Overall Study|Insufficient Data Available|3
4433622|NCT00412217|7217081|FG000|Overall Study|Death|5
4433623|NCT00412217|7217082|FG001|Overall Study|Death|4
4433624|NCT00412217|7217081|FG000|Overall Study|Disease Progression|2
4433625|NCT00412217|7217082|FG001|Overall Study|Disease Progression|3
4433626|NCT00412217|7217081|FG000|Overall Study|Investigator Decision|1
4433627|NCT00412217|7217082|FG001|Overall Study|Investigator Decision|0
4433628|NCT00412217|7217081|FG000|Overall Study|Withdrawal by Subject|2
4433629|NCT00412217|7217082|FG001|Overall Study|Withdrawal by Subject|0
4433630|NCT00412217|7217081|FG000|Overall Study|Lost to Follow-up|1
4433631|NCT00412217|7217082|FG001|Overall Study|Lost to Follow-up|4
4433632|NCT00412217|7217081|FG000|Overall Study|Study Terminated by Sponsor|26
4433633|NCT00412217|7217082|FG001|Overall Study|Study Terminated by Sponsor|33
4433634|NCT00412217|7217081|FG000|Overall Study|Other|1
4433635|NCT00412217|7217082|FG001|Overall Study|Other|1
4433636|NCT00412360|7217094|FG000|Overall Study|Lost to Follow-up|0
4433637|NCT00412360|7217095|FG001|Overall Study|Lost to Follow-up|1
4433638|NCT00412360|7217094|FG000|Overall Study|Not Transplanted|1
4433639|NCT00412360|7217095|FG001|Overall Study|Not Transplanted|2
4433640|NCT00412373|7217103|FG000|Overall Study|Adverse Event|8
4433641|NCT00412373|7217104|FG001|Overall Study|Adverse Event|13
4433642|NCT00412373|7217103|FG000|Overall Study|Lack of Efficacy|16
4433643|NCT00412373|7217104|FG001|Overall Study|Lack of Efficacy|22
4433644|NCT00412373|7217103|FG000|Overall Study|Lost to Follow-up|7
4433645|NCT00412373|7217104|FG001|Overall Study|Lost to Follow-up|13
4433646|NCT00412373|7217103|FG000|Overall Study|Withdrawal by Subject|8
4433647|NCT00412373|7217104|FG001|Overall Study|Withdrawal by Subject|27
4433648|NCT00412373|7217103|FG000|Overall Study|Other|2
4433649|NCT00412373|7217104|FG001|Overall Study|Other|2
4433650|NCT00412542|7217164|FG000|Overall Study|Withdrawal by Subject|0
4433651|NCT00412542|7217165|FG001|Overall Study|Withdrawal by Subject|2
4433652|NCT00412542|7217164|FG000|Overall Study|Not Eligible|0
4433653|NCT00412542|7217165|FG001|Overall Study|Not Eligible|1
4433654|NCT00412607|7217169|FG000|Overall Study|Withdrawal by Subject|9
4433655|NCT00412607|7217169|FG000|Overall Study|Lost to Follow-up|19
4433656|NCT00412607|7217169|FG000|Overall Study|Death|61
4433657|NCT00412607|7217169|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15
4433658|NCT00412737|7217178|FG000|Overall Study|Death|1
4433659|NCT00412737|7217179|FG001|Overall Study|Death|0
4433660|NCT00412737|7217178|FG000|Overall Study|Adverse Event|3
4433661|NCT00412737|7217179|FG001|Overall Study|Adverse Event|2
4630147|NCT03401112|7498689|FG004|Overall Study|Day 1 Assessment not Done|0
4433662|NCT00412737|7217178|FG000|Overall Study|Refused Treatment|6
4433663|NCT00412737|7217179|FG001|Overall Study|Refused Treatment|2
4433664|NCT00412737|7217178|FG000|Overall Study|Failure to Return|6
4433665|NCT00412737|7217179|FG001|Overall Study|Failure to Return|2
4433666|NCT00412750|7217188|FG000|Overall Study|Abnormal laboratory value(s)|1
4433667|NCT00412750|7217189|FG001|Overall Study|Abnormal laboratory value(s)|0
4433668|NCT00412750|7217190|FG002|Overall Study|Abnormal laboratory value(s)|0
4433669|NCT00412750|7217188|FG000|Overall Study|Administrative problems|21
4433670|NCT00412750|7217189|FG001|Overall Study|Administrative problems|17
4433671|NCT00412750|7217190|FG002|Overall Study|Administrative problems|14
4433672|NCT00412750|7217188|FG000|Overall Study|Adverse Event|8
4433673|NCT00412750|7217189|FG001|Overall Study|Adverse Event|3
4433674|NCT00412750|7217190|FG002|Overall Study|Adverse Event|3
4433675|NCT00412750|7217188|FG000|Overall Study|Lost to Follow-up|1
4433676|NCT00412750|7217189|FG001|Overall Study|Lost to Follow-up|0
4433677|NCT00412750|7217190|FG002|Overall Study|Lost to Follow-up|1
4433678|NCT00412750|7217188|FG000|Overall Study|Withdrawal by Subject|0
4433679|NCT00412750|7217189|FG001|Overall Study|Withdrawal by Subject|1
4433680|NCT00412750|7217190|FG002|Overall Study|Withdrawal by Subject|2
4433681|NCT00412750|7217188|FG000|Overall Study|Lack of Efficacy|0
4433682|NCT00412750|7217189|FG001|Overall Study|Lack of Efficacy|0
4433683|NCT00412750|7217190|FG002|Overall Study|Lack of Efficacy|3
4433684|NCT00412854|7217212|FG000|Overall Study|Withdrawn due to adverse events|1
4433685|NCT00412854|7217213|FG001|Overall Study|Withdrawn due to adverse events|5
4433686|NCT00412854|7217212|FG000|Overall Study|Withdrawn for other reasons|13
4433687|NCT00412854|7217213|FG001|Overall Study|Withdrawn for other reasons|11
4433688|NCT00412893|7217226|FG000|Overall Study|Adverse Event|31
4433689|NCT00412893|7217227|FG001|Overall Study|Adverse Event|53
4433690|NCT00412893|7217226|FG000|Overall Study|Death|17
4433691|NCT00412893|7217227|FG001|Overall Study|Death|21
4433692|NCT00412893|7217226|FG000|Overall Study|Insufficient Therapeutic Response|39
4433693|NCT00412893|7217227|FG001|Overall Study|Insufficient Therapeutic Response|23
4433694|NCT00412893|7217226|FG000|Overall Study|Lost to Follow-up|2
4433695|NCT00412893|7217227|FG001|Overall Study|Lost to Follow-up|1
4433696|NCT00412893|7217226|FG000|Overall Study|Violation of Selection at Entry|17
4433697|NCT00412893|7217227|FG001|Overall Study|Violation of Selection at Entry|10
4433698|NCT00412893|7217226|FG000|Overall Study|Other Protocol Violation|10
4433699|NCT00412893|7217227|FG001|Overall Study|Other Protocol Violation|6
4433700|NCT00412893|7217226|FG000|Overall Study|Did Not Cooperate|12
4433701|NCT00412893|7217227|FG001|Overall Study|Did Not Cooperate|9
4433702|NCT00412893|7217226|FG000|Overall Study|Administrative Reason|12
4433703|NCT00412893|7217227|FG001|Overall Study|Administrative Reason|15
4433704|NCT00412893|7217226|FG000|Overall Study|Randomized but Never Received Study Drug|5
4433705|NCT00412893|7217227|FG001|Overall Study|Randomized but Never Received Study Drug|6
4433706|NCT00412958|7217237|FG000|Overall Study|Withdrawal by Subject|3
4433707|NCT00412958|7217238|FG001|Overall Study|Withdrawal by Subject|0
4433708|NCT00412958|7217239|FG002|Overall Study|Withdrawal by Subject|0
4433709|NCT00412958|7217240|FG003|Overall Study|Withdrawal by Subject|1
4433710|NCT00412958|7217237|FG000|Overall Study|Adverse Event|0
4433711|NCT00412958|7217238|FG001|Overall Study|Adverse Event|1
4433712|NCT00412958|7217239|FG002|Overall Study|Adverse Event|0
4433713|NCT00412958|7217240|FG003|Overall Study|Adverse Event|0
4433714|NCT00412958|7217237|FG000|Overall Study|Lost to Follow-up|0
4433715|NCT00412958|7217238|FG001|Overall Study|Lost to Follow-up|1
4433716|NCT00412958|7217239|FG002|Overall Study|Lost to Follow-up|0
4433717|NCT00412958|7217240|FG003|Overall Study|Lost to Follow-up|0
4433718|NCT00412958|7217237|FG000|Overall Study|Death|0
4433719|NCT00412958|7217238|FG001|Overall Study|Death|1
4433720|NCT00412958|7217239|FG002|Overall Study|Death|0
4433721|NCT00412958|7217240|FG003|Overall Study|Death|0
4433722|NCT00412958|7217237|FG000|Overall Study|Transport issue|0
4433723|NCT00412958|7217238|FG001|Overall Study|Transport issue|1
4433724|NCT00412958|7217239|FG002|Overall Study|Transport issue|0
4433725|NCT00412958|7217240|FG003|Overall Study|Transport issue|0
4433726|NCT00412971|7217252|FG000|Overall Study|Lost to Follow-up|17
4433727|NCT00412971|7217253|FG001|Overall Study|Lost to Follow-up|9
4433728|NCT00412971|7217252|FG000|Overall Study|Protocol Violation|13
4433729|NCT00412971|7217253|FG001|Overall Study|Protocol Violation|1
4433730|NCT00412984|7217261|FG000|Overall Study|Death|331
4433731|NCT00412984|7217262|FG001|Overall Study|Death|349
4433732|NCT00412984|7217261|FG000|Overall Study|Adverse Event|679
4433733|NCT00412984|7217262|FG001|Overall Study|Adverse Event|738
4433734|NCT00412984|7217261|FG000|Overall Study|Withdrawal by Subject|921
4433735|NCT00412984|7217262|FG001|Overall Study|Withdrawal by Subject|989
4433736|NCT00412984|7217261|FG000|Overall Study|Lost to Follow-up|51
4433737|NCT00412984|7217262|FG001|Overall Study|Lost to Follow-up|39
4433738|NCT00412984|7217261|FG000|Overall Study|Poor/Noncompliance|57
4630148|NCT03401112|7498685|FG000|Overall Study|Not Dosed|0
4630149|NCT03401112|7498686|FG001|Overall Study|Not Dosed|0
4630150|NCT03401112|7498687|FG002|Overall Study|Not Dosed|1
4630151|NCT03401112|7498688|FG003|Overall Study|Not Dosed|0
4630152|NCT03401112|7498689|FG004|Overall Study|Not Dosed|0
4630153|NCT03401112|7498685|FG000|Overall Study|Missed Clinical Visit|0
4630154|NCT03401112|7498686|FG001|Overall Study|Missed Clinical Visit|0
4630155|NCT03401112|7498687|FG002|Overall Study|Missed Clinical Visit|1
4630156|NCT03401112|7498688|FG003|Overall Study|Missed Clinical Visit|0
4433739|NCT00412984|7217262|FG001|Overall Study|Poor/Noncompliance|77
4433740|NCT00412984|7217261|FG000|Overall Study|Pregnancy|1
4433741|NCT00412984|7217262|FG001|Overall Study|Pregnancy|0
4433742|NCT00412984|7217261|FG000|Overall Study|Subject No Longer Meets Study Criteria|87
4433743|NCT00412984|7217262|FG001|Overall Study|Subject No Longer Meets Study Criteria|100
4433744|NCT00412984|7217261|FG000|Overall Study|Administrative Reason by Sponsor|11
4433745|NCT00412984|7217262|FG001|Overall Study|Administrative Reason by Sponsor|8
4433746|NCT00412984|7217261|FG000|Overall Study|Physician Refused to Continue Treatment|81
4433747|NCT00412984|7217262|FG001|Overall Study|Physician Refused to Continue Treatment|89
4433748|NCT00412984|7217261|FG000|Overall Study|Other Reason|80
4433749|NCT00412984|7217262|FG001|Overall Study|Other Reason|92
4433750|NCT00412984|7217261|FG000|Overall Study|Not Reported|11
4433751|NCT00412984|7217262|FG001|Overall Study|Not Reported|12
4433752|NCT00413010|7217270|FG000|Overall Study|Adverse Event|8
4630157|NCT03401112|7498689|FG004|Overall Study|Missed Clinical Visit|0
4630158|NCT03401112|7498685|FG000|Overall Study|Missed Doses|0
4630159|NCT03401112|7498686|FG001|Overall Study|Missed Doses|0
4630160|NCT03401112|7498687|FG002|Overall Study|Missed Doses|1
4630161|NCT03401112|7498688|FG003|Overall Study|Missed Doses|0
4630162|NCT03401112|7498689|FG004|Overall Study|Missed Doses|0
4630163|NCT03391232|7498718|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0
4630164|NCT03391232|7498719|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1
4630165|NCT03391232|7498718|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0
4630166|NCT03391232|7498719|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2
4630167|NCT03383666|7498727|FG000|Overall Study|Withdrawal by Subject|2
4630168|NCT03383666|7498727|FG000|Overall Study|Lost to Follow-up|2
4433753|NCT00413010|7217271|FG001|Overall Study|Adverse Event|4
4433754|NCT00413010|7217270|FG000|Overall Study|Laboratory abnormality|0
4433755|NCT00413010|7217271|FG001|Overall Study|Laboratory abnormality|2
4433756|NCT00413010|7217270|FG000|Overall Study|Lack of Efficacy|0
4433757|NCT00413010|7217271|FG001|Overall Study|Lack of Efficacy|3
4433758|NCT00413010|7217270|FG000|Overall Study|Lost to Follow-up|3
4433759|NCT00413010|7217271|FG001|Overall Study|Lost to Follow-up|0
4433760|NCT00413010|7217270|FG000|Overall Study|Withdrawal by Subject|7
4433761|NCT00413010|7217271|FG001|Overall Study|Withdrawal by Subject|2
4433762|NCT00413010|7217270|FG000|Overall Study|Due to termination of the study|54
4433763|NCT00413010|7217271|FG001|Overall Study|Due to termination of the study|52
4433764|NCT00413036|7217277|FG000|Overall Study|Adverse Event|44
4433765|NCT00413036|7217277|FG000|Overall Study|Lack of Efficacy|129
4433766|NCT00413036|7217277|FG000|Overall Study|Withdrawal by Subject|7
4433767|NCT00413036|7217277|FG000|Overall Study|Death|9
4433768|NCT00413036|7217277|FG000|Overall Study|Other|26
4433769|NCT00413036|7217277|FG000|Overall Study|Missing|2
4433770|NCT00413049|7217283|FG000|Overall Study|Adverse Event|10
4433771|NCT00413049|7217284|FG001|Overall Study|Adverse Event|8
4433772|NCT00413049|7217283|FG000|Overall Study|Withdrawal by Subject|7
4433773|NCT00413049|7217284|FG001|Overall Study|Withdrawal by Subject|5
4433774|NCT00413049|7217283|FG000|Overall Study|Lost to Follow-up|2
4433775|NCT00413049|7217284|FG001|Overall Study|Lost to Follow-up|3
4433776|NCT00413049|7217283|FG000|Overall Study|Protocol Violation|3
4433777|NCT00413049|7217284|FG001|Overall Study|Protocol Violation|1
4433778|NCT00413049|7217283|FG000|Overall Study|Subject no longer requires study drug|0
4433779|NCT00413049|7217284|FG001|Overall Study|Subject no longer requires study drug|1
4433780|NCT00413049|7217283|FG000|Overall Study|Abnormal laboratory value(s)|1
4433781|NCT00413049|7217284|FG001|Overall Study|Abnormal laboratory value(s)|0
4433782|NCT00413049|7217283|FG000|Overall Study|Lack of Efficacy|1
4433783|NCT00413049|7217284|FG001|Overall Study|Lack of Efficacy|0
4433784|NCT00413153|7217292|FG000|Overall Study|Withdrawal by Subject|1
4433785|NCT00413153|7217293|FG001|Overall Study|Withdrawal by Subject|1
4433786|NCT00413153|7217292|FG000|Overall Study|Adverse Event|1
4433787|NCT00413153|7217293|FG001|Overall Study|Adverse Event|0
4433788|NCT00413192|7217316|FG000|Overall Study|Disease progression|26
4433789|NCT00413192|7217317|FG001|Overall Study|Disease progression|31
4433790|NCT00413192|7217318|FG002|Overall Study|Disease progression|16
4433791|NCT00413192|7217319|FG003|Overall Study|Disease progression|25
4433792|NCT00413192|7217316|FG000|Overall Study|Toxicity|3
4433793|NCT00413192|7217317|FG001|Overall Study|Toxicity|2
4433794|NCT00413192|7217318|FG002|Overall Study|Toxicity|2
4433795|NCT00413192|7217319|FG003|Overall Study|Toxicity|2
4433796|NCT00413192|7217316|FG000|Overall Study|Withdrawal by Subject|3
4433797|NCT00413192|7217317|FG001|Overall Study|Withdrawal by Subject|5
4433798|NCT00413192|7217318|FG002|Overall Study|Withdrawal by Subject|0
4433799|NCT00413192|7217319|FG003|Overall Study|Withdrawal by Subject|1
4433800|NCT00413192|7217316|FG000|Overall Study|Intercurrent illness|0
4433801|NCT00413192|7217317|FG001|Overall Study|Intercurrent illness|0
4433802|NCT00413192|7217318|FG002|Overall Study|Intercurrent illness|0
4433803|NCT00413192|7217319|FG003|Overall Study|Intercurrent illness|1
4433804|NCT00413192|7217316|FG000|Overall Study|Intercurrent death|0
4433805|NCT00413192|7217317|FG001|Overall Study|Intercurrent death|1
4433806|NCT00413192|7217318|FG002|Overall Study|Intercurrent death|0
4433807|NCT00413192|7217319|FG003|Overall Study|Intercurrent death|0
4433808|NCT00413192|7217316|FG000|Overall Study|Other|5
4433809|NCT00413192|7217317|FG001|Overall Study|Other|1
4433810|NCT00413192|7217318|FG002|Overall Study|Other|1
4433811|NCT00413192|7217319|FG003|Overall Study|Other|2
4433812|NCT00413192|7217316|FG000|Overall Study|Not treated|0
4433813|NCT00413192|7217317|FG001|Overall Study|Not treated|0
4433814|NCT00413192|7217318|FG002|Overall Study|Not treated|0
4433815|NCT00413192|7217319|FG003|Overall Study|Not treated|1
4433816|NCT00413218|7217331|FG000|Overall Study|Randomized but didn't receive study drug|2
4433817|NCT00413218|7217332|FG001|Overall Study|Randomized but didn't receive study drug|8
4433818|NCT00413218|7217331|FG000|Overall Study|Death|57
4433819|NCT00413218|7217332|FG001|Overall Study|Death|56
4433820|NCT00413218|7217331|FG000|Overall Study|Lost to Follow-up|14
4433821|NCT00413218|7217332|FG001|Overall Study|Lost to Follow-up|17
4433822|NCT00413218|7217331|FG000|Overall Study|Admin|20
4433823|NCT00413218|7217332|FG001|Overall Study|Admin|14
4433824|NCT00413218|7217331|FG000|Overall Study|Missing|1
4433825|NCT00413218|7217332|FG001|Overall Study|Missing|0
4433826|NCT00413218|7217331|FG000|Overall Study|Withdrawal by Subject|9
4433827|NCT00413218|7217332|FG001|Overall Study|Withdrawal by Subject|1
4433828|NCT00413231|7217339|FG000|0 to 30-day Post Treatment|Death|5
4433829|NCT00413231|7217339|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3
4433830|NCT00413231|7217339|FG000|30-day to 365-day Post Treatment|Death|13
4433831|NCT00413231|7217339|FG000|365-day to 60-month Post Treatment|Death|36
4433832|NCT00413231|7217339|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5
4433833|NCT00413231|7217339|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4
4433834|NCT00413231|7217339|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1
4433835|NCT00413244|7217346|FG000|Overall Study|Withdrawal by Subject|10
4433836|NCT00413244|7217347|FG001|Overall Study|Withdrawal by Subject|1
4433837|NCT00413283|7217357|FG000|Overall Study|Withdrawal by Subject|1
4433838|NCT00413283|7217358|FG001|Overall Study|Withdrawal by Subject|0
4433839|NCT00413283|7217359|FG002|Overall Study|Withdrawal by Subject|0
4433840|NCT00413283|7217360|FG003|Overall Study|Withdrawal by Subject|1
4433841|NCT00413283|7217357|FG000|Overall Study|Death|0
4433842|NCT00413283|7217358|FG001|Overall Study|Death|0
4433843|NCT00413283|7217359|FG002|Overall Study|Death|1
4630169|NCT03299049|7498737|FG000|Overall Study|On-going|486
4630170|NCT03299049|7498738|FG001|Overall Study|On-going|481
4630171|NCT03299049|7498737|FG000|Overall Study|Withdrawal by Subject|6
4433844|NCT00413283|7217360|FG003|Overall Study|Death|1
4433845|NCT00413283|7217357|FG000|Overall Study|Adverse Event|0
4433846|NCT00413283|7217358|FG001|Overall Study|Adverse Event|0
4433847|NCT00413283|7217359|FG002|Overall Study|Adverse Event|0
4433848|NCT00413283|7217360|FG003|Overall Study|Adverse Event|1
4433849|NCT00413283|7217357|FG000|Overall Study|Ineligibility determined|0
4433850|NCT00413283|7217358|FG001|Overall Study|Ineligibility determined|0
4433851|NCT00413283|7217359|FG002|Overall Study|Ineligibility determined|0
4433852|NCT00413283|7217360|FG003|Overall Study|Ineligibility determined|1
4433853|NCT00413283|7217357|FG000|Overall Study|Protocol deviation|0
4433854|NCT00413283|7217358|FG001|Overall Study|Protocol deviation|1
4433855|NCT00413283|7217359|FG002|Overall Study|Protocol deviation|0
4433856|NCT00413283|7217360|FG003|Overall Study|Protocol deviation|0
4433857|NCT00413283|7217357|FG000|Overall Study|Requirement for alternative therapy|0
4433858|NCT00413283|7217358|FG001|Overall Study|Requirement for alternative therapy|2
4433859|NCT00413283|7217359|FG002|Overall Study|Requirement for alternative therapy|0
4433860|NCT00413283|7217360|FG003|Overall Study|Requirement for alternative therapy|0
4433861|NCT00413283|7217357|FG000|Overall Study|Other|0
4433862|NCT00413283|7217358|FG001|Overall Study|Other|0
4433863|NCT00413283|7217359|FG002|Overall Study|Other|1
4433864|NCT00413283|7217360|FG003|Overall Study|Other|0
4433865|NCT00413374|7217381|FG000|Overall Study|Ineligible due to screening criteria.|3
4433866|NCT00413374|7217382|FG001|Overall Study|Ineligible due to screening criteria.|0
4433867|NCT00413374|7217381|FG000|Overall Study|Adverse Event|1
4433868|NCT00413374|7217382|FG001|Overall Study|Adverse Event|0
4433869|NCT00413374|7217381|FG000|Overall Study|Lost to Follow-up|1
4433870|NCT00413374|7217382|FG001|Overall Study|Lost to Follow-up|0
4433871|NCT00413374|7217381|FG000|Overall Study|Surgery|1
4433872|NCT00413374|7217382|FG001|Overall Study|Surgery|0
4433873|NCT00413413|7217403|FG000|Single-Blind|Adverse Event|0
4433874|NCT00413413|7217404|FG001|Single-Blind|Adverse Event|9
4433875|NCT00413413|7217405|FG002|Single-Blind|Adverse Event|0
4433876|NCT00413413|7217403|FG000|Single-Blind|Lack of Efficacy|0
4433877|NCT00413413|7217404|FG001|Single-Blind|Lack of Efficacy|5
4433878|NCT00413413|7217405|FG002|Single-Blind|Lack of Efficacy|0
4433879|NCT00413413|7217403|FG000|Single-Blind|Subject no longer requires study drug|0
4433880|NCT00413413|7217404|FG001|Single-Blind|Subject no longer requires study drug|151
4433881|NCT00413413|7217405|FG002|Single-Blind|Subject no longer requires study drug|0
4433882|NCT00413413|7217403|FG000|Single-Blind|Protocol Violation|0
4433883|NCT00413413|7217404|FG001|Single-Blind|Protocol Violation|16
4433884|NCT00413413|7217405|FG002|Single-Blind|Protocol Violation|0
4433885|NCT00413413|7217403|FG000|Single-Blind|Withdrawal by Subject|0
4433886|NCT00413413|7217404|FG001|Single-Blind|Withdrawal by Subject|27
4433887|NCT00413413|7217405|FG002|Single-Blind|Withdrawal by Subject|0
4433888|NCT00413413|7217403|FG000|Single-Blind|Lost to Follow-up|0
4433889|NCT00413413|7217404|FG001|Single-Blind|Lost to Follow-up|8
4433890|NCT00413413|7217405|FG002|Single-Blind|Lost to Follow-up|0
4433891|NCT00413413|7217403|FG000|Double-Blind|Adverse Event|6
4433892|NCT00413413|7217404|FG001|Double-Blind|Adverse Event|0
4433893|NCT00413413|7217405|FG002|Double-Blind|Adverse Event|5
4433894|NCT00413413|7217403|FG000|Double-Blind|Unsatisfactory therapeutic effect|1
4433895|NCT00413413|7217404|FG001|Double-Blind|Unsatisfactory therapeutic effect|2
4433896|NCT00413413|7217405|FG002|Double-Blind|Unsatisfactory therapeutic effect|1
4433897|NCT00413413|7217403|FG000|Double-Blind|Protocol deviation|1
4433898|NCT00413413|7217404|FG001|Double-Blind|Protocol deviation|2
4433899|NCT00413413|7217405|FG002|Double-Blind|Protocol deviation|1
4433900|NCT00413413|7217403|FG000|Double-Blind|Subject withdrew consent|4
4433901|NCT00413413|7217404|FG001|Double-Blind|Subject withdrew consent|6
4433902|NCT00413413|7217405|FG002|Double-Blind|Subject withdrew consent|9
4433903|NCT00413413|7217403|FG000|Double-Blind|Lost to Follow-up|3
4433904|NCT00413413|7217404|FG001|Double-Blind|Lost to Follow-up|4
4433905|NCT00413413|7217405|FG002|Double-Blind|Lost to Follow-up|2
4433906|NCT00413660|7217444|FG000|Up To Week 12|Adverse Event|1
4433907|NCT00413660|7217445|FG001|Up To Week 12|Adverse Event|3
4433908|NCT00413660|7217446|FG002|Up To Week 12|Adverse Event|1
4433909|NCT00413660|7217447|FG003|Up To Week 12|Adverse Event|4
4433910|NCT00413660|7217448|FG004|Up To Week 12|Adverse Event|6
4433911|NCT00413660|7217449|FG005|Up To Week 12|Adverse Event|4
4433912|NCT00413660|7217450|FG006|Up To Week 12|Adverse Event|1
4433913|NCT00413660|7217451|FG007|Up To Week 12|Adverse Event|0
4433914|NCT00413660|7217452|FG008|Up To Week 12|Adverse Event|0
4433915|NCT00413660|7217453|FG009|Up To Week 12|Adverse Event|0
4433916|NCT00413660|7217454|FG010|Up To Week 12|Adverse Event|0
4433917|NCT00413660|7217444|FG000|Up To Week 12|Lack of Efficacy|2
4433918|NCT00413660|7217445|FG001|Up To Week 12|Lack of Efficacy|0
4433919|NCT00413660|7217446|FG002|Up To Week 12|Lack of Efficacy|0
4433920|NCT00413660|7217447|FG003|Up To Week 12|Lack of Efficacy|0
4433921|NCT00413660|7217448|FG004|Up To Week 12|Lack of Efficacy|0
4433922|NCT00413660|7217449|FG005|Up To Week 12|Lack of Efficacy|0
4433923|NCT00413660|7217450|FG006|Up To Week 12|Lack of Efficacy|5
4433924|NCT00413660|7217451|FG007|Up To Week 12|Lack of Efficacy|0
4433925|NCT00413660|7217452|FG008|Up To Week 12|Lack of Efficacy|0
4433926|NCT00413660|7217453|FG009|Up To Week 12|Lack of Efficacy|0
4433927|NCT00413660|7217454|FG010|Up To Week 12|Lack of Efficacy|0
4433928|NCT00413660|7217444|FG000|Up To Week 12|Lost to Follow-up|0
4433929|NCT00413660|7217445|FG001|Up To Week 12|Lost to Follow-up|1
4433930|NCT00413660|7217446|FG002|Up To Week 12|Lost to Follow-up|0
4433931|NCT00413660|7217447|FG003|Up To Week 12|Lost to Follow-up|0
4433932|NCT00413660|7217448|FG004|Up To Week 12|Lost to Follow-up|1
4433933|NCT00413660|7217449|FG005|Up To Week 12|Lost to Follow-up|0
4433934|NCT00413660|7217450|FG006|Up To Week 12|Lost to Follow-up|0
4433935|NCT00413660|7217451|FG007|Up To Week 12|Lost to Follow-up|0
4433936|NCT00413660|7217452|FG008|Up To Week 12|Lost to Follow-up|0
4433937|NCT00413660|7217453|FG009|Up To Week 12|Lost to Follow-up|0
4433938|NCT00413660|7217454|FG010|Up To Week 12|Lost to Follow-up|0
4433939|NCT00413660|7217444|FG000|Up To Week 12|Withdrawal by Subject|0
4433940|NCT00413660|7217445|FG001|Up To Week 12|Withdrawal by Subject|2
4433941|NCT00413660|7217446|FG002|Up To Week 12|Withdrawal by Subject|0
4433942|NCT00413660|7217447|FG003|Up To Week 12|Withdrawal by Subject|2
4433943|NCT00413660|7217448|FG004|Up To Week 12|Withdrawal by Subject|0
4433944|NCT00413660|7217449|FG005|Up To Week 12|Withdrawal by Subject|2
4433945|NCT00413660|7217450|FG006|Up To Week 12|Withdrawal by Subject|2
4433946|NCT00413660|7217451|FG007|Up To Week 12|Withdrawal by Subject|0
4433947|NCT00413660|7217452|FG008|Up To Week 12|Withdrawal by Subject|0
4433948|NCT00413660|7217453|FG009|Up To Week 12|Withdrawal by Subject|0
4433949|NCT00413660|7217454|FG010|Up To Week 12|Withdrawal by Subject|0
4433950|NCT00413660|7217444|FG000|Up To Week 12|Randomized, Not Treated|1
4433951|NCT00413660|7217445|FG001|Up To Week 12|Randomized, Not Treated|0
4433952|NCT00413660|7217446|FG002|Up To Week 12|Randomized, Not Treated|0
4433953|NCT00413660|7217447|FG003|Up To Week 12|Randomized, Not Treated|1
4433954|NCT00413660|7217448|FG004|Up To Week 12|Randomized, Not Treated|0
4433955|NCT00413660|7217449|FG005|Up To Week 12|Randomized, Not Treated|0
4433956|NCT00413660|7217450|FG006|Up To Week 12|Randomized, Not Treated|0
4433957|NCT00413660|7217451|FG007|Up To Week 12|Randomized, Not Treated|0
4433958|NCT00413660|7217452|FG008|Up To Week 12|Randomized, Not Treated|0
4433959|NCT00413660|7217453|FG009|Up To Week 12|Randomized, Not Treated|0
4433960|NCT00413660|7217454|FG010|Up To Week 12|Randomized, Not Treated|0
4433961|NCT00413660|7217444|FG000|Up To Week 12|Other|3
4433962|NCT00413660|7217445|FG001|Up To Week 12|Other|1
4433963|NCT00413660|7217446|FG002|Up To Week 12|Other|6
4433964|NCT00413660|7217447|FG003|Up To Week 12|Other|1
4433965|NCT00413660|7217448|FG004|Up To Week 12|Other|2
4433966|NCT00413660|7217449|FG005|Up To Week 12|Other|4
4433967|NCT00413660|7217450|FG006|Up To Week 12|Other|3
4433968|NCT00413660|7217451|FG007|Up To Week 12|Other|0
4433969|NCT00413660|7217452|FG008|Up To Week 12|Other|0
4433970|NCT00413660|7217453|FG009|Up To Week 12|Other|0
4433971|NCT00413660|7217454|FG010|Up To Week 12|Other|0
4433972|NCT00413660|7217444|FG000|Post Week 12|Adverse Event|2
4433973|NCT00413660|7217445|FG001|Post Week 12|Adverse Event|0
4433974|NCT00413660|7217446|FG002|Post Week 12|Adverse Event|2
4433975|NCT00413660|7217447|FG003|Post Week 12|Adverse Event|1
4433976|NCT00413660|7217448|FG004|Post Week 12|Adverse Event|4
4433977|NCT00413660|7217449|FG005|Post Week 12|Adverse Event|2
4433978|NCT00413660|7217450|FG006|Post Week 12|Adverse Event|2
4433979|NCT00413660|7217451|FG007|Post Week 12|Adverse Event|0
4433980|NCT00413660|7217452|FG008|Post Week 12|Adverse Event|0
4433981|NCT00413660|7217453|FG009|Post Week 12|Adverse Event|0
4433982|NCT00413660|7217454|FG010|Post Week 12|Adverse Event|0
4433983|NCT00413660|7217444|FG000|Post Week 12|Lack of Efficacy|0
4433984|NCT00413660|7217445|FG001|Post Week 12|Lack of Efficacy|0
4433985|NCT00413660|7217446|FG002|Post Week 12|Lack of Efficacy|1
4433986|NCT00413660|7217447|FG003|Post Week 12|Lack of Efficacy|0
4433987|NCT00413660|7217448|FG004|Post Week 12|Lack of Efficacy|0
4433988|NCT00413660|7217449|FG005|Post Week 12|Lack of Efficacy|0
4433989|NCT00413660|7217450|FG006|Post Week 12|Lack of Efficacy|0
4433990|NCT00413660|7217451|FG007|Post Week 12|Lack of Efficacy|0
4433991|NCT00413660|7217452|FG008|Post Week 12|Lack of Efficacy|0
4433992|NCT00413660|7217453|FG009|Post Week 12|Lack of Efficacy|1
4433993|NCT00413660|7217454|FG010|Post Week 12|Lack of Efficacy|0
4433994|NCT00413660|7217444|FG000|Post Week 12|Lost to Follow-up|0
4433995|NCT00413660|7217445|FG001|Post Week 12|Lost to Follow-up|1
4433996|NCT00413660|7217446|FG002|Post Week 12|Lost to Follow-up|1
4433997|NCT00413660|7217447|FG003|Post Week 12|Lost to Follow-up|0
4433998|NCT00413660|7217448|FG004|Post Week 12|Lost to Follow-up|0
4433999|NCT00413660|7217449|FG005|Post Week 12|Lost to Follow-up|0
4434000|NCT00413660|7217450|FG006|Post Week 12|Lost to Follow-up|0
4434001|NCT00413660|7217451|FG007|Post Week 12|Lost to Follow-up|0
4434002|NCT00413660|7217452|FG008|Post Week 12|Lost to Follow-up|0
4434003|NCT00413660|7217453|FG009|Post Week 12|Lost to Follow-up|0
4434004|NCT00413660|7217454|FG010|Post Week 12|Lost to Follow-up|0
4434005|NCT00413660|7217444|FG000|Post Week 12|Withdrawal by Subject|0
4434006|NCT00413660|7217445|FG001|Post Week 12|Withdrawal by Subject|1
4434007|NCT00413660|7217446|FG002|Post Week 12|Withdrawal by Subject|1
4434008|NCT00413660|7217447|FG003|Post Week 12|Withdrawal by Subject|0
4434009|NCT00413660|7217448|FG004|Post Week 12|Withdrawal by Subject|1
4434010|NCT00413660|7217449|FG005|Post Week 12|Withdrawal by Subject|0
4434011|NCT00413660|7217450|FG006|Post Week 12|Withdrawal by Subject|0
4434012|NCT00413660|7217451|FG007|Post Week 12|Withdrawal by Subject|0
4434013|NCT00413660|7217452|FG008|Post Week 12|Withdrawal by Subject|0
4434014|NCT00413660|7217453|FG009|Post Week 12|Withdrawal by Subject|0
4434015|NCT00413660|7217454|FG010|Post Week 12|Withdrawal by Subject|1
4434016|NCT00413660|7217444|FG000|Post Week 12|Other|1
4434017|NCT00413660|7217445|FG001|Post Week 12|Other|2
4434018|NCT00413660|7217446|FG002|Post Week 12|Other|3
4434019|NCT00413660|7217447|FG003|Post Week 12|Other|0
4434020|NCT00413660|7217448|FG004|Post Week 12|Other|1
4434021|NCT00413660|7217449|FG005|Post Week 12|Other|1
4434022|NCT00413660|7217450|FG006|Post Week 12|Other|1
4434023|NCT00413660|7217451|FG007|Post Week 12|Other|0
4434024|NCT00413660|7217452|FG008|Post Week 12|Other|0
4434025|NCT00413660|7217453|FG009|Post Week 12|Other|0
4434026|NCT00413660|7217454|FG010|Post Week 12|Other|0
4434027|NCT00413777|7217486|FG000|Fixed-dose Period|Lost to Follow-up|1
4434028|NCT00413777|7217487|FG001|Fixed-dose Period|Lost to Follow-up|1
4434029|NCT00413777|7217486|FG000|Fixed-dose Period|Adverse Event|2
4434030|NCT00413777|7217487|FG001|Fixed-dose Period|Adverse Event|1
4434031|NCT00413777|7217486|FG000|Fixed-dose Period|Met Withdrawal Criteria|1
4434032|NCT00413777|7217487|FG001|Fixed-dose Period|Met Withdrawal Criteria|0
4434033|NCT00413777|7217486|FG000|Fixed-dose Period|Withdrew Consent|0
4434034|NCT00413777|7217487|FG001|Fixed-dose Period|Withdrew Consent|1
4434035|NCT00413894|7217493|FG000|Overall Study|Withdrawal by Subject|10
4434036|NCT00413894|7217493|FG000|Overall Study|Administrative Reasons|1
4434037|NCT00413894|7217493|FG000|Overall Study|Hb <10 grams/deciliter|12
4434038|NCT00413894|7217493|FG000|Overall Study|Adverse Event|28
4434039|NCT00413894|7217493|FG000|Overall Study|Protocol Violation|11
4434040|NCT00413894|7217493|FG000|Overall Study|Other|18
4434041|NCT00413920|7217502|FG000|Overall Study|Adverse Event|9
4434042|NCT00413920|7217503|FG001|Overall Study|Adverse Event|11
4434043|NCT00413920|7217502|FG000|Overall Study|Lack of Efficacy|11
4434044|NCT00413920|7217503|FG001|Overall Study|Lack of Efficacy|9
4434045|NCT00413920|7217502|FG000|Overall Study|Death|3
4434046|NCT00413920|7217503|FG001|Overall Study|Death|5
4434047|NCT00413920|7217502|FG000|Overall Study|Graft Loss|5
4434048|NCT00413920|7217503|FG001|Overall Study|Graft Loss|3
4434049|NCT00413959|7217509|FG000|Overall Study|Pt had only one cycle.|1
4434050|NCT00414011|7217513|FG000|Overall Study|Physician Decision|3
4434051|NCT00414011|7217513|FG000|Overall Study|Withdrawal by Subject|2
4434052|NCT00414050|7217522|FG000|Overall Study|Adverse Event|1
4434053|NCT00414050|7217523|FG001|Overall Study|Adverse Event|1
4434054|NCT00414050|7217524|FG002|Overall Study|Adverse Event|1
4434055|NCT00414050|7217525|FG003|Overall Study|Adverse Event|1
4434056|NCT00414050|7217522|FG000|Overall Study|Lost to Follow-up|2
4434057|NCT00414050|7217523|FG001|Overall Study|Lost to Follow-up|2
4434058|NCT00414050|7217524|FG002|Overall Study|Lost to Follow-up|1
4434059|NCT00414050|7217525|FG003|Overall Study|Lost to Follow-up|1
4434060|NCT00414050|7217522|FG000|Overall Study|Withdrawal by Subject|5
4434061|NCT00414050|7217523|FG001|Overall Study|Withdrawal by Subject|3
4434062|NCT00414050|7217524|FG002|Overall Study|Withdrawal by Subject|2
4434063|NCT00414050|7217525|FG003|Overall Study|Withdrawal by Subject|4
4434064|NCT00414050|7217522|FG000|Overall Study|Subject discontinued for other reason|1
4434065|NCT00414050|7217523|FG001|Overall Study|Subject discontinued for other reason|2
4434066|NCT00414050|7217524|FG002|Overall Study|Subject discontinued for other reason|2
4434067|NCT00414050|7217525|FG003|Overall Study|Subject discontinued for other reason|1
4434068|NCT00414050|7217522|FG000|Overall Study|Subject Moved|0
4434069|NCT00414050|7217523|FG001|Overall Study|Subject Moved|0
4434070|NCT00414050|7217524|FG002|Overall Study|Subject Moved|0
4434071|NCT00414050|7217525|FG003|Overall Study|Subject Moved|1
4434072|NCT00414076|7217537|FG000|Overall Study|Progression|1
4434073|NCT00414076|7217538|FG001|Overall Study|Progression|2
4434074|NCT00414076|7217537|FG000|Overall Study|Withdrawal by Subject|1
4434075|NCT00414076|7217538|FG001|Overall Study|Withdrawal by Subject|3
4434076|NCT00414076|7217537|FG000|Overall Study|Adverse Event|1
4434077|NCT00414076|7217538|FG001|Overall Study|Adverse Event|0
4434078|NCT00414310|7217574|FG000|Overall Study|Not treated|1
4434079|NCT00414310|7217575|FG001|Overall Study|Not treated|0
4434080|NCT00414388|7217583|FG000|Overall Study|Adverse Event|1
4434081|NCT00414440|7217590|FG000|Core Period|Withdrawal by Subject|70
4434082|NCT00414440|7217591|FG001|Core Period|Withdrawal by Subject|32
4434083|NCT00414440|7217590|FG000|Extension Period|Lost to Follow-up|44
4434084|NCT00414440|7217591|FG001|Extension Period|Lost to Follow-up|52
4434085|NCT00414440|7217590|FG000|Extension Period|Did not consent to continue follow up|61
4434086|NCT00414440|7217591|FG001|Extension Period|Did not consent to continue follow up|54
4434087|NCT00414440|7217590|FG000|Extension Period|Other|1
4434088|NCT00414440|7217591|FG001|Extension Period|Other|1
4434089|NCT00414440|7217590|FG000|Extension Period|Administrative|16
4434090|NCT00414440|7217591|FG001|Extension Period|Administrative|16
4434091|NCT00414440|7217590|FG000|Extension Period|Death|1
4434092|NCT00414440|7217591|FG001|Extension Period|Death|2
4434093|NCT00414440|7217590|FG000|Extension Period|Withdrawal by Subject|9
4434094|NCT00414440|7217591|FG001|Extension Period|Withdrawal by Subject|7
4434095|NCT00414440|7217590|FG000|Extension Period|Not included in follow up period|18
4434096|NCT00414440|7217591|FG001|Extension Period|Not included in follow up period|8
4434097|NCT00414466|7217601|FG000|Overall Study|Adverse Event|0
4434098|NCT00414466|7217602|FG001|Overall Study|Adverse Event|0
4434099|NCT00414466|7217603|FG002|Overall Study|Adverse Event|1
4434100|NCT00414466|7217604|FG003|Overall Study|Adverse Event|1
4434101|NCT00414466|7217601|FG000|Overall Study|Lack of Efficacy|1
4434102|NCT00414466|7217602|FG001|Overall Study|Lack of Efficacy|0
4434103|NCT00414466|7217603|FG002|Overall Study|Lack of Efficacy|0
4434104|NCT00414466|7217604|FG003|Overall Study|Lack of Efficacy|0
4434105|NCT00414466|7217601|FG000|Overall Study|Withdrawn by Sponsor|1
4434106|NCT00414466|7217602|FG001|Overall Study|Withdrawn by Sponsor|0
4434107|NCT00414466|7217603|FG002|Overall Study|Withdrawn by Sponsor|0
4434108|NCT00414466|7217604|FG003|Overall Study|Withdrawn by Sponsor|0
4434109|NCT00414544|7217630|FG000|Overall Study|Lost to Follow-up|14
4434110|NCT00414596|7217636|FG000|Overall Study|Protocol Violation|2
4434111|NCT00414609|7217642|FG000|Core Study|Adverse Event|9
4434112|NCT00414609|7217643|FG001|Core Study|Adverse Event|11
4434113|NCT00414609|7217644|FG002|Core Study|Adverse Event|0
4434114|NCT00414609|7217642|FG000|Core Study|Abnormal laboratory values|0
4434115|NCT00414609|7217643|FG001|Core Study|Abnormal laboratory values|1
4434116|NCT00414609|7217644|FG002|Core Study|Abnormal laboratory values|0
4434117|NCT00414609|7217642|FG000|Core Study|Abnormal test procedure results|1
4434118|NCT00414609|7217643|FG001|Core Study|Abnormal test procedure results|1
4434119|NCT00414609|7217644|FG002|Core Study|Abnormal test procedure results|0
4434120|NCT00414609|7217642|FG000|Core Study|Protocol deviation|0
4434121|NCT00414609|7217643|FG001|Core Study|Protocol deviation|1
4434122|NCT00414609|7217644|FG002|Core Study|Protocol deviation|0
4434123|NCT00414609|7217642|FG000|Core Study|Patient withdrew consent|10
4434124|NCT00414609|7217643|FG001|Core Study|Patient withdrew consent|11
4434125|NCT00414609|7217644|FG002|Core Study|Patient withdrew consent|0
4434126|NCT00414609|7217642|FG000|Core Study|Lost to Follow-up|7
4434127|NCT00414609|7217643|FG001|Core Study|Lost to Follow-up|4
4434128|NCT00414609|7217644|FG002|Core Study|Lost to Follow-up|0
4434129|NCT00414609|7217642|FG000|Core Study|Administrative problems|0
4434130|NCT00414609|7217643|FG001|Core Study|Administrative problems|2
4434131|NCT00414609|7217644|FG002|Core Study|Administrative problems|0
4434132|NCT00414609|7217642|FG000|Core Study|Death|7
4434133|NCT00414609|7217643|FG001|Core Study|Death|14
4434134|NCT00414609|7217644|FG002|Core Study|Death|0
4434135|NCT00414609|7217642|FG000|Extension Study|Adverse Event|0
4434136|NCT00414609|7217643|FG001|Extension Study|Adverse Event|0
4434137|NCT00414609|7217644|FG002|Extension Study|Adverse Event|14
4434138|NCT00414609|7217642|FG000|Extension Study|Unsatisfactory therapeutic effect|0
4434139|NCT00414609|7217643|FG001|Extension Study|Unsatisfactory therapeutic effect|0
4434140|NCT00414609|7217644|FG002|Extension Study|Unsatisfactory therapeutic effect|2
4434141|NCT00414609|7217642|FG000|Extension Study|Withdrawal by Subject|0
4434142|NCT00414609|7217643|FG001|Extension Study|Withdrawal by Subject|0
4434143|NCT00414609|7217644|FG002|Extension Study|Withdrawal by Subject|13
4434144|NCT00414609|7217642|FG000|Extension Study|Lost to Follow-up|0
4434145|NCT00414609|7217643|FG001|Extension Study|Lost to Follow-up|0
4434146|NCT00414609|7217644|FG002|Extension Study|Lost to Follow-up|10
4434147|NCT00414609|7217642|FG000|Extension Study|Administrative problems|0
4434148|NCT00414609|7217643|FG001|Extension Study|Administrative problems|0
4434149|NCT00414609|7217644|FG002|Extension Study|Administrative problems|1
4434150|NCT00414609|7217642|FG000|Extension Study|Death|0
4434151|NCT00414609|7217643|FG001|Extension Study|Death|0
4434152|NCT00414609|7217644|FG002|Extension Study|Death|17
4512691|NCT00936897|7322689|FG001|Overall Study|Lost to Follow-up|10
4512692|NCT00936897|7322688|FG000|Overall Study|Administrative Decision|1
4512693|NCT00936897|7322689|FG001|Overall Study|Administrative Decision|2
4512694|NCT00936897|7322688|FG000|Overall Study|Protocol Violation|1
4512695|NCT00936897|7322689|FG001|Overall Study|Protocol Violation|1
4512696|NCT00936897|7322688|FG000|Overall Study|Ineligibility Determined|0
4512697|NCT00936897|7322689|FG001|Overall Study|Ineligibility Determined|3
4512698|NCT00936897|7322688|FG000|Overall Study|Noncompliance|0
4512699|NCT00936897|7322689|FG001|Overall Study|Noncompliance|2
4512700|NCT00936897|7322688|FG000|Overall Study|Death|0
4512701|NCT00936897|7322689|FG001|Overall Study|Death|1
4512702|NCT00936910|7322695|FG000|Overall Study|Lack of Efficacy|3
4512703|NCT00936975|7322700|FG000|Overall Study|Withdrawal by Subject|1
4434153|NCT00414661|7217666|FG000|Overall Study|Death|2
4434154|NCT00414661|7217667|FG001|Overall Study|Death|5
4434155|NCT00414661|7217668|FG002|Overall Study|Death|0
4434156|NCT00414661|7217669|FG003|Overall Study|Death|0
4434157|NCT00414661|7217666|FG000|Overall Study|Lost to Follow-up|1
4434158|NCT00414661|7217667|FG001|Overall Study|Lost to Follow-up|4
4434159|NCT00414661|7217668|FG002|Overall Study|Lost to Follow-up|0
4434160|NCT00414661|7217669|FG003|Overall Study|Lost to Follow-up|1
4434161|NCT00414661|7217666|FG000|Overall Study|Withdrawal by Subject|5
4434162|NCT00414661|7217667|FG001|Overall Study|Withdrawal by Subject|2
4434163|NCT00414661|7217668|FG002|Overall Study|Withdrawal by Subject|2
4434164|NCT00414661|7217669|FG003|Overall Study|Withdrawal by Subject|2
4434165|NCT00414661|7217666|FG000|Overall Study|Other|6
4434166|NCT00414661|7217667|FG001|Overall Study|Other|3
4434167|NCT00414661|7217668|FG002|Overall Study|Other|0
4434168|NCT00414661|7217669|FG003|Overall Study|Other|0
4434169|NCT00414726|7217690|FG000|Overall Study|Withdrawal by Subject|0
4434170|NCT00414726|7217691|FG001|Overall Study|Withdrawal by Subject|1
4434171|NCT00414765|7217699|FG000|Overall Study|Adverse Event|5
4434172|NCT00414765|7217700|FG001|Overall Study|Adverse Event|9
4434173|NCT00414765|7217699|FG000|Overall Study|Withdrawal by Subject|1
4434174|NCT00414765|7217700|FG001|Overall Study|Withdrawal by Subject|1
4434175|NCT00414765|7217699|FG000|Overall Study|Disease Progression|0
4434176|NCT00414765|7217700|FG001|Overall Study|Disease Progression|1
4434177|NCT00414908|7217717|FG000|Overall Study|Protocol Violation|1
4434178|NCT00414908|7217718|FG001|Overall Study|Protocol Violation|1
4434179|NCT00414960|7217728|FG000|Overall Study|Adverse Event|4
4434180|NCT00414960|7217729|FG001|Overall Study|Adverse Event|0
4434181|NCT00414960|7217728|FG000|Overall Study|Withdrawal by Subject|3
4434182|NCT00414960|7217729|FG001|Overall Study|Withdrawal by Subject|0
4434183|NCT00414960|7217728|FG000|Overall Study|Physician Decision|0
4434184|NCT00414960|7217729|FG001|Overall Study|Physician Decision|1
4434185|NCT00414973|7217739|FG000|Overall Study|Withdrawal by Subject|14
4434186|NCT00414973|7217740|FG001|Overall Study|Withdrawal by Subject|4
4434187|NCT00414973|7217741|FG002|Overall Study|Withdrawal by Subject|1
4434188|NCT00414973|7217742|FG003|Overall Study|Withdrawal by Subject|0
4434189|NCT00414973|7217739|FG000|Overall Study|Adverse Event|10
4434190|NCT00414973|7217740|FG001|Overall Study|Adverse Event|0
4434191|NCT00414973|7217741|FG002|Overall Study|Adverse Event|1
4434192|NCT00414973|7217742|FG003|Overall Study|Adverse Event|0
4434193|NCT00414973|7217739|FG000|Overall Study|Protocol Violation|3
4434194|NCT00414973|7217740|FG001|Overall Study|Protocol Violation|4
4434195|NCT00414973|7217741|FG002|Overall Study|Protocol Violation|0
4434196|NCT00414973|7217742|FG003|Overall Study|Protocol Violation|0
4434197|NCT00414973|7217739|FG000|Overall Study|Lost to Follow-up|0
4434198|NCT00414973|7217740|FG001|Overall Study|Lost to Follow-up|2
4434199|NCT00414973|7217741|FG002|Overall Study|Lost to Follow-up|0
4434200|NCT00414973|7217742|FG003|Overall Study|Lost to Follow-up|0
4434201|NCT00414973|7217739|FG000|Overall Study|Sponsor Decision|1
4434202|NCT00414973|7217740|FG001|Overall Study|Sponsor Decision|0
4434203|NCT00414973|7217741|FG002|Overall Study|Sponsor Decision|0
4434204|NCT00414973|7217742|FG003|Overall Study|Sponsor Decision|0
4434205|NCT00414973|7217739|FG000|Overall Study|Death|0
4434206|NCT00414973|7217740|FG001|Overall Study|Death|0
4434207|NCT00414973|7217741|FG002|Overall Study|Death|1
4434208|NCT00414973|7217742|FG003|Overall Study|Death|0
4434209|NCT00415051|7217752|FG000|Overall Study|Protocol Violation|1
4434210|NCT00415168|7217756|FG000|Overall Study|Death|26
4434211|NCT00415168|7217756|FG000|Overall Study|Lost to Follow-up|3
4434212|NCT00415168|7217756|FG000|Overall Study|Physician Decision|13
4434213|NCT00415168|7217756|FG000|Overall Study|Sponsor Decision|4
4434214|NCT00415168|7217756|FG000|Overall Study|Withdrawal by Subject|6
4434215|NCT00415194|7217762|FG000|Overall Study|Adverse Event|37
4434216|NCT00415194|7217763|FG001|Overall Study|Adverse Event|32
4434217|NCT00415194|7217762|FG000|Overall Study|Entry Criteria Not Met|4
4434218|NCT00415194|7217763|FG001|Overall Study|Entry Criteria Not Met|8
4434219|NCT00415194|7217762|FG000|Overall Study|Lost to Follow-up|1
4434220|NCT00415194|7217763|FG001|Overall Study|Lost to Follow-up|0
4434221|NCT00415194|7217762|FG000|Overall Study|Physician Decision|10
4434222|NCT00415194|7217763|FG001|Overall Study|Physician Decision|16
4434223|NCT00415194|7217762|FG000|Overall Study|Progressive Disease|180
4434224|NCT00415194|7217763|FG001|Overall Study|Progressive Disease|217
4434225|NCT00415194|7217762|FG000|Overall Study|Protocol Violation|4
4434226|NCT00415194|7217763|FG001|Overall Study|Protocol Violation|2
4434227|NCT00415194|7217762|FG000|Overall Study|Withdrawal by Subject|28
4434228|NCT00415194|7217763|FG001|Overall Study|Withdrawal by Subject|21
4434229|NCT00415194|7217762|FG000|Overall Study|Death Due to Study Disease|26
4434230|NCT00415194|7217763|FG001|Overall Study|Death Due to Study Disease|29
4434231|NCT00415194|7217762|FG000|Overall Study|Death Due to Study Drug Related AE|11
4434232|NCT00415194|7217763|FG001|Overall Study|Death Due to Study Drug Related AE|1
4434233|NCT00415194|7217762|FG000|Overall Study|Death Due to Procedural Related AE|0
4434234|NCT00415194|7217763|FG001|Overall Study|Death Due to Procedural Related AE|1
4434235|NCT00415194|7217762|FG000|Overall Study|Death Due to AE (Other Causes)|27
4434236|NCT00415194|7217763|FG001|Overall Study|Death Due to AE (Other Causes)|15
4434237|NCT00415363|7217771|FG000|Overall Study|Withdrawal by Subject|4
4434238|NCT00415363|7217772|FG001|Overall Study|Withdrawal by Subject|4
4434239|NCT00415363|7217771|FG000|Overall Study|Adverse Event|4
4434240|NCT00415363|7217772|FG001|Overall Study|Adverse Event|4
4434241|NCT00415363|7217771|FG000|Overall Study|Lost to Follow-up|2
4434242|NCT00415363|7217772|FG001|Overall Study|Lost to Follow-up|1
4434243|NCT00415363|7217771|FG000|Overall Study|Physician Decision|3
4434244|NCT00415363|7217772|FG001|Overall Study|Physician Decision|1
4434245|NCT00415363|7217771|FG000|Overall Study|Death|16
4434246|NCT00415363|7217772|FG001|Overall Study|Death|12
4434247|NCT00415363|7217771|FG000|Overall Study|Progressive disease|26
4434248|NCT00415363|7217772|FG001|Overall Study|Progressive disease|32
4434249|NCT00415519|7217799|FG000|Overall Study|Adverse Event|1
4434250|NCT00415519|7217800|FG001|Overall Study|Adverse Event|0
4434251|NCT00415519|7217799|FG000|Overall Study|Withdrawal by Subject|2
4434252|NCT00415519|7217800|FG001|Overall Study|Withdrawal by Subject|0
4434253|NCT00415519|7217799|FG000|Overall Study|Patient's convenience|1
4434254|NCT00415519|7217800|FG001|Overall Study|Patient's convenience|0
4434255|NCT00415532|7217808|FG000|Treatment Period|Adverse Event|2
4434256|NCT00415532|7217809|FG001|Treatment Period|Adverse Event|3
4434257|NCT00415532|7217808|FG000|Treatment Period|Death|2
4434258|NCT00415532|7217809|FG001|Treatment Period|Death|1
4434259|NCT00415532|7217808|FG000|Treatment Period|Lost to Follow-up|1
4434260|NCT00415532|7217809|FG001|Treatment Period|Lost to Follow-up|1
4434261|NCT00415532|7217808|FG000|Treatment Period|Protocol Violation|1
4434262|NCT00415532|7217809|FG001|Treatment Period|Protocol Violation|0
4434263|NCT00415532|7217808|FG000|Treatment Period|Withdrawal by Subject|6
4434264|NCT00415532|7217809|FG001|Treatment Period|Withdrawal by Subject|6
4434265|NCT00415532|7217808|FG000|Treatment Period|Other|2
4434266|NCT00415532|7217809|FG001|Treatment Period|Other|2
4434267|NCT00415532|7217808|FG000|Treatment Period|Ineligibility determined|1
4434268|NCT00415532|7217809|FG001|Treatment Period|Ineligibility determined|1
4434269|NCT00415532|7217808|FG000|Treatment Period|Noncompliance|1
4434270|NCT00415532|7217809|FG001|Treatment Period|Noncompliance|1
4434271|NCT00415532|7217808|FG000|Treatment Period|Requirement for alternative therapy|1
4434272|NCT00415532|7217809|FG001|Treatment Period|Requirement for alternative therapy|0
4434273|NCT00415532|7217808|FG000|Safety Follow Up Period|Adverse Event|1
4434274|NCT00415532|7217809|FG001|Safety Follow Up Period|Adverse Event|3
4434275|NCT00415532|7217808|FG000|Safety Follow Up Period|Death|3
4434276|NCT00415532|7217809|FG001|Safety Follow Up Period|Death|0
4434277|NCT00415532|7217808|FG000|Safety Follow Up Period|Withdrawal by Subject|2
4434278|NCT00415532|7217809|FG001|Safety Follow Up Period|Withdrawal by Subject|3
4434279|NCT00415532|7217808|FG000|Safety Follow Up Period|Other|1
4434280|NCT00415532|7217809|FG001|Safety Follow Up Period|Other|4
4434281|NCT00415532|7217808|FG000|Safety Follow Up Period|Ineligibility determined|1
4434282|NCT00415532|7217809|FG001|Safety Follow Up Period|Ineligibility determined|1
4434283|NCT00415532|7217808|FG000|Safety Follow Up Period|Noncompliance|1
4434284|NCT00415532|7217809|FG001|Safety Follow Up Period|Noncompliance|0
4434285|NCT00415532|7217808|FG000|Safety Follow Up Period|Requirement for alternative therapy|0
4434286|NCT00415532|7217809|FG001|Safety Follow Up Period|Requirement for alternative therapy|1
4434287|NCT00415597|7217815|FG000|Enrollment|Withdrawal by Subject|1
4434288|NCT00415597|7217815|FG000|Enrollment|Protocol Violation|1
4434289|NCT00415597|7217815|FG000|Treatment|Adverse Event|110
4434290|NCT00415597|7217815|FG000|Treatment|Lack of Efficacy|39
4434291|NCT00415597|7217815|FG000|Treatment|Protocol Violation|67
4434292|NCT00415597|7217815|FG000|Treatment|Physician Decision|3
4434293|NCT00415597|7217815|FG000|Treatment|Withdrawal by Subject|51
4434294|NCT00415597|7217815|FG000|Treatment|Lost to Follow-up|28
4434295|NCT00415597|7217815|FG000|Treatment|Drug Screen|2
4434296|NCT00415597|7217815|FG000|Treatment|Administrative|3
4434297|NCT00415597|7217815|FG000|Treatment|Sponsor Decision|1
4434298|NCT00415597|7217815|FG000|Treatment|Multiple Reasons|1
4434299|NCT00415610|7217822|FG000|Overall Study|Death|3
4434300|NCT00415610|7217823|FG001|Overall Study|Death|2
4434301|NCT00415610|7217824|FG002|Overall Study|Death|5
4434302|NCT00415636|7217838|FG000|Overall Study|Symptomatic deterioration|1
4434303|NCT00415636|7217839|FG001|Overall Study|Symptomatic deterioration|0
4434304|NCT00415636|7217840|FG002|Overall Study|Symptomatic deterioration|1
4434305|NCT00415636|7217841|FG003|Overall Study|Symptomatic deterioration|2
4434306|NCT00415636|7217842|FG004|Overall Study|Symptomatic deterioration|0
4434307|NCT00415636|7217843|FG005|Overall Study|Symptomatic deterioration|1
4434308|NCT00415636|7217838|FG000|Overall Study|Adverse Event|0
4434309|NCT00415636|7217839|FG001|Overall Study|Adverse Event|0
4434310|NCT00415636|7217840|FG002|Overall Study|Adverse Event|0
4434311|NCT00415636|7217841|FG003|Overall Study|Adverse Event|1
4434312|NCT00415636|7217842|FG004|Overall Study|Adverse Event|1
4434313|NCT00415636|7217843|FG005|Overall Study|Adverse Event|0
4434314|NCT00415636|7217838|FG000|Overall Study|Withdrawal by Subject|0
4434315|NCT00415636|7217839|FG001|Overall Study|Withdrawal by Subject|0
4434316|NCT00415636|7217840|FG002|Overall Study|Withdrawal by Subject|0
4434317|NCT00415636|7217841|FG003|Overall Study|Withdrawal by Subject|0
4434318|NCT00415636|7217842|FG004|Overall Study|Withdrawal by Subject|1
4434319|NCT00415636|7217843|FG005|Overall Study|Withdrawal by Subject|0
4434320|NCT00415636|7217838|FG000|Overall Study|Disease progression|0
4434321|NCT00415636|7217839|FG001|Overall Study|Disease progression|0
4434322|NCT00415636|7217840|FG002|Overall Study|Disease progression|0
4434323|NCT00415636|7217841|FG003|Overall Study|Disease progression|3
4434324|NCT00415636|7217842|FG004|Overall Study|Disease progression|0
4434325|NCT00415636|7217843|FG005|Overall Study|Disease progression|1
4434326|NCT00415909|7217883|FG000|Overall Study|Withdrawal by Subject|2
4434327|NCT00415909|7217883|FG000|Overall Study|Death|1
4434328|NCT00416078|7217889|FG000|Overall Study|Death|3
4434329|NCT00416078|7217890|FG001|Overall Study|Death|4
4434330|NCT00416078|7217889|FG000|Overall Study|Withdrawal by Subject|3
4434331|NCT00416078|7217890|FG001|Overall Study|Withdrawal by Subject|2
4434332|NCT00416078|7217889|FG000|Overall Study|Physician Decision|1
4434333|NCT00416078|7217890|FG001|Overall Study|Physician Decision|0
4434334|NCT00416078|7217889|FG000|Overall Study|Lost to Follow-up|4
4434335|NCT00416078|7217890|FG001|Overall Study|Lost to Follow-up|2
4434336|NCT00416195|7217913|FG000|Overall Study|Adverse Event|1
4434337|NCT00416195|7217914|FG001|Overall Study|Adverse Event|2
4434338|NCT00416195|7217913|FG000|Overall Study|Protocol Violation|1
4434339|NCT00416195|7217914|FG001|Overall Study|Protocol Violation|1
4434340|NCT00416195|7217913|FG000|Overall Study|Other|0
4434341|NCT00416195|7217914|FG001|Overall Study|Other|1
4434342|NCT00416312|7217920|FG000|Overall Study|tumors not visible on imaging|2
4434343|NCT00416455|7217926|FG000|Overall Study|PET / CT not done|3
4434344|NCT00416455|7217927|FG001|Overall Study|PET / CT not done|5
4434345|NCT00416455|7217926|FG000|Overall Study|PET / CT poor quality|2
4434346|NCT00416455|7217927|FG001|Overall Study|PET / CT poor quality|1
4434347|NCT00416455|7217926|FG000|Overall Study|Inadequate pathology|11
4434348|NCT00416455|7217927|FG001|Overall Study|Inadequate pathology|2
4434349|NCT00416520|7217955|FG000|Open-label Period|Adverse Event|28
4434350|NCT00416520|7217956|FG001|Open-label Period|Adverse Event|10
4434351|NCT00416520|7217957|FG002|Open-label Period|Adverse Event|0
4434352|NCT00416520|7217958|FG003|Open-label Period|Adverse Event|0
4434353|NCT00416520|7217955|FG000|Open-label Period|Death|2
4434354|NCT00416520|7217956|FG001|Open-label Period|Death|1
4434355|NCT00416520|7217957|FG002|Open-label Period|Death|0
4434356|NCT00416520|7217958|FG003|Open-label Period|Death|0
4434357|NCT00416520|7217955|FG000|Open-label Period|Lack of Efficacy|8
4434358|NCT00416520|7217956|FG001|Open-label Period|Lack of Efficacy|1
4434359|NCT00416520|7217957|FG002|Open-label Period|Lack of Efficacy|0
4434360|NCT00416520|7217958|FG003|Open-label Period|Lack of Efficacy|0
4434361|NCT00416520|7217955|FG000|Open-label Period|Protocol Violation|3
4434362|NCT00416520|7217956|FG001|Open-label Period|Protocol Violation|3
4434363|NCT00416520|7217957|FG002|Open-label Period|Protocol Violation|0
4434364|NCT00416520|7217958|FG003|Open-label Period|Protocol Violation|0
4434365|NCT00416520|7217955|FG000|Open-label Period|Withdrawal by Subject|16
4434366|NCT00416520|7217956|FG001|Open-label Period|Withdrawal by Subject|5
4434367|NCT00416520|7217957|FG002|Open-label Period|Withdrawal by Subject|0
4434368|NCT00416520|7217958|FG003|Open-label Period|Withdrawal by Subject|0
4434369|NCT00416520|7217955|FG000|Open-label Period|Other Reasons|3
4434370|NCT00416520|7217956|FG001|Open-label Period|Other Reasons|12
4434371|NCT00416520|7217957|FG002|Open-label Period|Other Reasons|0
4434372|NCT00416520|7217958|FG003|Open-label Period|Other Reasons|0
4434373|NCT00416520|7217955|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0
4434374|NCT00416520|7217956|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0
4434375|NCT00416520|7217957|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0
4434376|NCT00416520|7217958|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1
4434377|NCT00416520|7217955|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
4434378|NCT00416520|7217956|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
4434379|NCT00416520|7217957|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
4434380|NCT00416520|7217958|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3
4434381|NCT00416520|7217955|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0
4434382|NCT00416520|7217956|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0
4434383|NCT00416520|7217957|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1
4434384|NCT00416520|7217958|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1
4434385|NCT00416598|7217981|FG000|Induction & Intensification|Adverse Event|38
4434386|NCT00416598|7217981|FG000|Induction & Intensification|Death|32
4434387|NCT00416598|7217981|FG000|Induction & Intensification|Withdrawal by Subject|46
4434388|NCT00416598|7217981|FG000|Induction & Intensification|Alternative Treatment|135
4434389|NCT00416598|7217981|FG000|Induction & Intensification|Physician discretion/other medical issue|45
4434390|NCT00416598|7217981|FG000|Induction & Intensification|Relapse/progression|29
4434391|NCT00416598|7217981|FG000|Induction & Intensification|Failed induction|87
4434392|NCT00416598|7217981|FG000|Decitabine Maintenance|Adverse Event|5
4434393|NCT00416598|7217981|FG000|Decitabine Maintenance|Withdrawal by Subject|18
4434394|NCT00416598|7217981|FG000|Decitabine Maintenance|Progression/relapse|38
4434395|NCT00416598|7217981|FG000|Decitabine Maintenance|Alternative treatment|2
4434396|NCT00416598|7217981|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9
4434397|NCT00416624|7217989|FG000|Overall Study|Withdrawal by Subject|1
4434398|NCT00416624|7217990|FG001|Overall Study|Withdrawal by Subject|6
4434399|NCT00416624|7217991|FG002|Overall Study|Withdrawal by Subject|4
4434400|NCT00416624|7217992|FG003|Overall Study|Withdrawal by Subject|9
4434401|NCT00416624|7217989|FG000|Overall Study|Death|4
4434402|NCT00416624|7217990|FG001|Overall Study|Death|7
4434403|NCT00416624|7217991|FG002|Overall Study|Death|7
4434404|NCT00416624|7217992|FG003|Overall Study|Death|1
4434405|NCT00416624|7217989|FG000|Overall Study|Adverse Event|8
4434406|NCT00416624|7217990|FG001|Overall Study|Adverse Event|3
4434407|NCT00416624|7217991|FG002|Overall Study|Adverse Event|2
4434408|NCT00416624|7217992|FG003|Overall Study|Adverse Event|2
4434409|NCT00416624|7217989|FG000|Overall Study|Other|8
4434410|NCT00416624|7217990|FG001|Overall Study|Other|11
4434411|NCT00416624|7217991|FG002|Overall Study|Other|5
4434412|NCT00416624|7217992|FG003|Overall Study|Other|5
4434413|NCT00416624|7217989|FG000|Overall Study|Cancel|1
4434414|NCT00416624|7217990|FG001|Overall Study|Cancel|0
4434415|NCT00416624|7217991|FG002|Overall Study|Cancel|0
4434416|NCT00416624|7217992|FG003|Overall Study|Cancel|0
4434417|NCT00416715|7218002|FG000|Overall Study|Not evaluable for joint aches|7
4434418|NCT00416715|7218002|FG000|Overall Study|Vitamin D levels not evaluable|8
4434419|NCT00416884|7218013|FG000|Overall Study|Study terminated due to low accrual|1
4434420|NCT00416949|7218017|FG000|Overall Study|Patients refused to participate|5
4434421|NCT00417027|7218024|FG000|Overall Study|Protocol Violation|0
4434422|NCT00417027|7218025|FG001|Overall Study|Protocol Violation|5
4434423|NCT00417027|7218026|FG002|Overall Study|Protocol Violation|5
4434424|NCT00417079|7218036|FG000|Overall Study|Disease progression|267
4434425|NCT00417079|7218037|FG001|Overall Study|Disease progression|180
4434426|NCT00417079|7218036|FG000|Overall Study|Adverse Event|32
4434427|NCT00417079|7218037|FG001|Overall Study|Adverse Event|67
4434428|NCT00417079|7218036|FG000|Overall Study|Non-compliance to protocol|0
4434429|NCT00417079|7218037|FG001|Overall Study|Non-compliance to protocol|1
4434430|NCT00417079|7218036|FG000|Overall Study|Lost to Follow-up|2
4434431|NCT00417079|7218037|FG001|Overall Study|Lost to Follow-up|0
4434432|NCT00417079|7218036|FG000|Overall Study|Withdrawal by Subject|17
4434433|NCT00417079|7218037|FG001|Overall Study|Withdrawal by Subject|8
4434434|NCT00417079|7218036|FG000|Overall Study|Not treated|6
4434435|NCT00417079|7218037|FG001|Overall Study|Not treated|7
4434436|NCT00417079|7218036|FG000|Overall Study|Screened failure|2
4434437|NCT00417079|7218037|FG001|Overall Study|Screened failure|1
4630172|NCT03299049|7498738|FG001|Overall Study|Withdrawal by Subject|21
4630173|NCT03299049|7498737|FG000|Overall Study|Physician Decision|5
4630174|NCT03299049|7498738|FG001|Overall Study|Physician Decision|1
4630175|NCT03299049|7498737|FG000|Overall Study|Lost to Follow-up|2
4434438|NCT00417079|7218036|FG000|Overall Study|Investigator's decision|1
4434439|NCT00417079|7218037|FG001|Overall Study|Investigator's decision|4
4434440|NCT00417079|7218036|FG000|Overall Study|Non-confirmed Disease progression|1
4434441|NCT00417079|7218037|FG001|Overall Study|Non-confirmed Disease progression|1
4434442|NCT00417079|7218036|FG000|Overall Study|Clinical deterioration|1
4434443|NCT00417079|7218037|FG001|Overall Study|Clinical deterioration|0
4434444|NCT00417079|7218036|FG000|Overall Study|Screening error|2
4434445|NCT00417079|7218037|FG001|Overall Study|Screening error|1
4434446|NCT00417079|7218036|FG000|Overall Study|Withdrawal by subject's family|0
4434447|NCT00417079|7218037|FG001|Overall Study|Withdrawal by subject's family|1
4434448|NCT00417079|7218036|FG000|Overall Study|Patient unable to come to the clinic|0
4434449|NCT00417079|7218037|FG001|Overall Study|Patient unable to come to the clinic|1
4434450|NCT00417079|7218036|FG000|Overall Study|abnormal liver function tests|0
4434451|NCT00417079|7218037|FG001|Overall Study|abnormal liver function tests|1
4434452|NCT00417170|7218045|FG000|Overall Study|Adverse Event|1
4434453|NCT00417170|7218046|FG001|Overall Study|Adverse Event|1
4434454|NCT00417170|7218045|FG000|Overall Study|Withdrawal by Subject|1
4434455|NCT00417170|7218046|FG001|Overall Study|Withdrawal by Subject|1
4434456|NCT00417170|7218045|FG000|Overall Study|Lost to Follow-up|0
4434457|NCT00417170|7218046|FG001|Overall Study|Lost to Follow-up|1
4434458|NCT00417482|7218070|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14
4434459|NCT00417482|7218071|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8
4434460|NCT00417482|7218072|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24
4434461|NCT00417482|7218070|FG000|Phase B 1st 16 Weeks|Adverse Event|2
4434462|NCT00417482|7218071|FG001|Phase B 1st 16 Weeks|Adverse Event|0
4434463|NCT00417482|7218072|FG002|Phase B 1st 16 Weeks|Adverse Event|1
4434464|NCT00417482|7218070|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2
4434465|NCT00417482|7218071|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3
4434466|NCT00417482|7218072|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2
4434467|NCT00417482|7218070|FG000|Phase B 1st 16 Weeks|Death|1
4434468|NCT00417482|7218071|FG001|Phase B 1st 16 Weeks|Death|0
4434469|NCT00417482|7218072|FG002|Phase B 1st 16 Weeks|Death|0
4434470|NCT00417482|7218070|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1
4434471|NCT00417482|7218071|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12
4630176|NCT03299049|7498738|FG001|Overall Study|Lost to Follow-up|0
4434472|NCT00417482|7218072|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2
4434473|NCT00417482|7218070|FG000|Phase B 2nd 16 Weeks|Adverse Event|0
4434474|NCT00417482|7218071|FG001|Phase B 2nd 16 Weeks|Adverse Event|0
4434475|NCT00417482|7218072|FG002|Phase B 2nd 16 Weeks|Adverse Event|1
4434476|NCT00417482|7218070|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1
4434477|NCT00417482|7218071|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0
4434478|NCT00417482|7218072|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0
4434479|NCT00417482|7218070|FG000|Phase B 2nd 16 Weeks|Death|1
4434480|NCT00417482|7218071|FG001|Phase B 2nd 16 Weeks|Death|1
4434481|NCT00417482|7218072|FG002|Phase B 2nd 16 Weeks|Death|0
4434482|NCT00417612|7218088|FG000|Overall Study|Errant diagnosis|0
4434483|NCT00417612|7218089|FG001|Overall Study|Errant diagnosis|1
4434484|NCT00417612|7218088|FG000|Overall Study|Adverse Event|2
4434485|NCT00417612|7218089|FG001|Overall Study|Adverse Event|0
4434486|NCT00417612|7218088|FG000|Overall Study|Protocol Violation|0
4434487|NCT00417612|7218089|FG001|Overall Study|Protocol Violation|2
4434488|NCT00417612|7218088|FG000|Overall Study|Lost to Follow-up|1
4434489|NCT00417612|7218089|FG001|Overall Study|Lost to Follow-up|0
4434490|NCT00417885|7218108|FG000|Overall Study|Adverse Event|1
4434491|NCT00417885|7218108|FG000|Overall Study|Objective Progression or Relapse|3
4434492|NCT00417885|7218108|FG000|Overall Study|Transferred to Another Sunitinib Study|2
4434493|NCT00417963|7218112|FG000|Overall Study|Lost to Follow-up|3
4434494|NCT00417963|7218112|FG000|Overall Study|Withdrawal by Subject|18
4434495|NCT00417963|7218112|FG000|Overall Study|Death|17
4434496|NCT00417963|7218112|FG000|Overall Study|Study device could not be deployed|3
4434497|NCT00417976|7218121|FG000|Overall Study|Non compliance unrelated to toxicity|1
4434498|NCT00417976|7218121|FG000|Overall Study|Treatment -related toxicity|2
4434499|NCT00417989|7218128|FG000|Overall Study|Withdrawal by Subject|13
4434500|NCT00417989|7218129|FG001|Overall Study|Withdrawal by Subject|13
4434501|NCT00417989|7218128|FG000|Overall Study|Lost to Follow-up|1
4434502|NCT00417989|7218129|FG001|Overall Study|Lost to Follow-up|6
4434503|NCT00417989|7218128|FG000|Overall Study|Protocol Violation|1
4434504|NCT00417989|7218129|FG001|Overall Study|Protocol Violation|0
4434505|NCT00417989|7218128|FG000|Overall Study|Death|0
4434506|NCT00417989|7218129|FG001|Overall Study|Death|1
4434507|NCT00417989|7218128|FG000|Overall Study|Physician Decision|5
4434508|NCT00417989|7218129|FG001|Overall Study|Physician Decision|2
4434509|NCT00418184|7218169|FG000|Double-blind Phase|Withdrawal by Subject|22
4434510|NCT00418184|7218170|FG001|Double-blind Phase|Withdrawal by Subject|9
4434511|NCT00418184|7218169|FG000|Double-blind Phase|Adverse Event|2
4434512|NCT00418184|7218170|FG001|Double-blind Phase|Adverse Event|1
4434513|NCT00418184|7218169|FG000|Double-blind Phase|Poor compliance|3
4434514|NCT00418184|7218170|FG001|Double-blind Phase|Poor compliance|1
4434515|NCT00418314|7218186|FG000|Overall Study|Withdrawal by Subject|1
4434516|NCT00418314|7218187|FG001|Overall Study|Withdrawal by Subject|2
4434517|NCT00418379|7218196|FG000|Year 1|Adverse Event|9
4434518|NCT00418379|7218197|FG001|Year 1|Adverse Event|15
4434519|NCT00418379|7218198|FG002|Year 1|Adverse Event|3
4434520|NCT00418379|7218196|FG000|Year 1|Withdrawal by Subject|7
4434521|NCT00418379|7218197|FG001|Year 1|Withdrawal by Subject|8
4434522|NCT00418379|7218198|FG002|Year 1|Withdrawal by Subject|5
4434523|NCT00418379|7218196|FG000|Year 1|Any other reason not above-mentioned|2
4434524|NCT00418379|7218197|FG001|Year 1|Any other reason not above-mentioned|5
4434525|NCT00418379|7218198|FG002|Year 1|Any other reason not above-mentioned|7
4434526|NCT00418379|7218196|FG000|Year 2|Adverse Event|5
4434527|NCT00418379|7218197|FG001|Year 2|Adverse Event|2
4434528|NCT00418379|7218198|FG002|Year 2|Adverse Event|1
4434529|NCT00418379|7218196|FG000|Year 2|Withdrawal by Subject|1
4434530|NCT00418379|7218197|FG001|Year 2|Withdrawal by Subject|1
4434531|NCT00418379|7218198|FG002|Year 2|Withdrawal by Subject|3
4434532|NCT00418379|7218196|FG000|Year 2|Any other reason not above-mentioned|2
4434533|NCT00418379|7218197|FG001|Year 2|Any other reason not above-mentioned|1
4434534|NCT00418379|7218198|FG002|Year 2|Any other reason not above-mentioned|6
4434535|NCT00418379|7218196|FG000|Year 3|Withdrawal by Subject|1
4434536|NCT00418379|7218197|FG001|Year 3|Withdrawal by Subject|1
4434537|NCT00418379|7218198|FG002|Year 3|Withdrawal by Subject|2
4434538|NCT00418379|7218196|FG000|Year 3|Any other reason not above-mentioned|2
4434539|NCT00418379|7218197|FG001|Year 3|Any other reason not above-mentioned|1
4434540|NCT00418379|7218198|FG002|Year 3|Any other reason not above-mentioned|1
4434541|NCT00418379|7218196|FG000|Year 4|Adverse Event|0
4434542|NCT00418379|7218197|FG001|Year 4|Adverse Event|1
4630177|NCT03299049|7498737|FG000|Overall Study|Pregnancy|1
4630178|NCT03299049|7498738|FG001|Overall Study|Pregnancy|3
4630179|NCT03299049|7498737|FG000|Overall Study|Protocol Violation|1
4630180|NCT03299049|7498738|FG001|Overall Study|Protocol Violation|1
4434543|NCT00418379|7218198|FG002|Year 4|Adverse Event|0
4434544|NCT00418379|7218196|FG000|Year 4|Withdrawal by Subject|2
4434545|NCT00418379|7218197|FG001|Year 4|Withdrawal by Subject|3
4434546|NCT00418379|7218198|FG002|Year 4|Withdrawal by Subject|2
4434547|NCT00418379|7218196|FG000|Year 4|Any other reason not above-mentioned|1
4434548|NCT00418379|7218197|FG001|Year 4|Any other reason not above-mentioned|1
4434549|NCT00418379|7218198|FG002|Year 4|Any other reason not above-mentioned|0
4434550|NCT00418379|7218196|FG000|Year 5|Adverse Event|0
4434551|NCT00418379|7218197|FG001|Year 5|Adverse Event|1
4434552|NCT00418379|7218198|FG002|Year 5|Adverse Event|0
4434553|NCT00418379|7218196|FG000|Year 5|Any other reason not above-mentioned|2
4434554|NCT00418379|7218197|FG001|Year 5|Any other reason not above-mentioned|4
4434555|NCT00418379|7218198|FG002|Year 5|Any other reason not above-mentioned|3
4434556|NCT00418522|7218217|FG000|Overall Study|Adverse Event|7
4434557|NCT00418522|7218218|FG001|Overall Study|Adverse Event|1
4434558|NCT00418522|7218217|FG000|Overall Study|Lack of Efficacy|1
4434559|NCT00418522|7218218|FG001|Overall Study|Lack of Efficacy|3
4434560|NCT00418522|7218217|FG000|Overall Study|Lost to Follow-up|10
4434561|NCT00418522|7218218|FG001|Overall Study|Lost to Follow-up|4
4434562|NCT00418522|7218217|FG000|Overall Study|Withdrawal by Subject|31
4434563|NCT00418522|7218218|FG001|Overall Study|Withdrawal by Subject|7
4630181|NCT03299049|7498737|FG000|Overall Study|Lack of Efficacy|9
4434564|NCT00418522|7218217|FG000|Overall Study|Other|27
4434565|NCT00418522|7218218|FG001|Overall Study|Other|23
4434566|NCT00418522|7218217|FG000|Overall Study|Randomized but did not receive treatment|7
4434567|NCT00418522|7218218|FG001|Overall Study|Randomized but did not receive treatment|4
4630182|NCT03299049|7498738|FG001|Overall Study|Lack of Efficacy|3
4434568|NCT00418561|7218227|FG000|Overall Study|Participant's (guardian's) decision|0
4434569|NCT00418561|7218228|FG001|Overall Study|Participant's (guardian's) decision|1
4434570|NCT00418561|7218229|FG002|Overall Study|Participant's (guardian's) decision|0
4434571|NCT00418665|7218249|FG000|Treatment Period|Ineligibility determined|1
4434572|NCT00418665|7218250|FG001|Treatment Period|Ineligibility determined|1
4434573|NCT00418665|7218251|FG002|Treatment Period|Ineligibility determined|0
4434574|NCT00418665|7218249|FG000|Treatment Period|Adverse Event|2
4434575|NCT00418665|7218250|FG001|Treatment Period|Adverse Event|2
4434576|NCT00418665|7218251|FG002|Treatment Period|Adverse Event|0
4434577|NCT00418665|7218249|FG000|Treatment Period|Withdrawal by Subject|0
4434578|NCT00418665|7218250|FG001|Treatment Period|Withdrawal by Subject|3
4434579|NCT00418665|7218251|FG002|Treatment Period|Withdrawal by Subject|1
4434580|NCT00418665|7218249|FG000|Treatment Period|Requirement for alternative therapy|1
4434581|NCT00418665|7218250|FG001|Treatment Period|Requirement for alternative therapy|0
4434582|NCT00418665|7218251|FG002|Treatment Period|Requirement for alternative therapy|0
4434583|NCT00418665|7218249|FG000|Treatment Period|Physician Decision|1
4434584|NCT00418665|7218250|FG001|Treatment Period|Physician Decision|0
4434585|NCT00418665|7218251|FG002|Treatment Period|Physician Decision|3
4434586|NCT00418665|7218249|FG000|Treatment Extension|Adverse Event|1
4434587|NCT00418665|7218250|FG001|Treatment Extension|Adverse Event|0
4434588|NCT00418665|7218251|FG002|Treatment Extension|Adverse Event|0
4434589|NCT00418665|7218249|FG000|Treatment Extension|Withdrawal by Subject|1
4434590|NCT00418665|7218250|FG001|Treatment Extension|Withdrawal by Subject|0
4434591|NCT00418665|7218251|FG002|Treatment Extension|Withdrawal by Subject|0
4434592|NCT00418665|7218249|FG000|Treatment Extension|Requirement for alternative therapy|2
4434593|NCT00418665|7218250|FG001|Treatment Extension|Requirement for alternative therapy|2
4434594|NCT00418665|7218251|FG002|Treatment Extension|Requirement for alternative therapy|0
4434595|NCT00418665|7218249|FG000|Treatment Extension|Physician Decision|2
4434596|NCT00418665|7218250|FG001|Treatment Extension|Physician Decision|2
4434597|NCT00418665|7218251|FG002|Treatment Extension|Physician Decision|1
4434598|NCT00418665|7218249|FG000|Treatment Extension|Death|0
4434599|NCT00418665|7218250|FG001|Treatment Extension|Death|0
4434600|NCT00418665|7218251|FG002|Treatment Extension|Death|1
4434601|NCT00418691|7218262|FG000|Overall Study|Lost to Follow-up|1
4434602|NCT00418691|7218263|FG001|Overall Study|Lost to Follow-up|2
4434603|NCT00418691|7218264|FG002|Overall Study|Lost to Follow-up|3
4434604|NCT00418691|7218262|FG000|Overall Study|Started new medication voiding entry|0
4434605|NCT00418691|7218263|FG001|Overall Study|Started new medication voiding entry|0
4434606|NCT00418691|7218264|FG002|Overall Study|Started new medication voiding entry|1
4434607|NCT00418691|7218262|FG000|Overall Study|Progressive Disease|1
4434608|NCT00418691|7218263|FG001|Overall Study|Progressive Disease|0
4434609|NCT00418691|7218264|FG002|Overall Study|Progressive Disease|1
4434610|NCT00418717|7218272|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1
4434611|NCT00418717|7218272|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2
4434612|NCT00418886|7218278|FG000|Overall Study|discontinue treatment survival follow up|90
4434613|NCT00418886|7218279|FG001|Overall Study|discontinue treatment survival follow up|91
4434614|NCT00418886|7218278|FG000|Overall Study|Death|122
4434615|NCT00418886|7218279|FG001|Overall Study|Death|147
4434616|NCT00418886|7218278|FG000|Overall Study|Withdrawal by Subject|9
4434617|NCT00418886|7218279|FG001|Overall Study|Withdrawal by Subject|10
4434618|NCT00418886|7218278|FG000|Overall Study|Lost to Follow-up|4
4434619|NCT00418886|7218279|FG001|Overall Study|Lost to Follow-up|6
4434620|NCT00418886|7218278|FG000|Overall Study|withdrawn due to other reason|1
4434621|NCT00418886|7218279|FG001|Overall Study|withdrawn due to other reason|0
4434622|NCT00418886|7218278|FG000|Overall Study|randomised but no treatment received|0
4434623|NCT00418886|7218279|FG001|Overall Study|randomised but no treatment received|1
4434624|NCT00418938|7218287|FG000|Overall Study|Reimbursement|1
4434625|NCT00418938|7218288|FG001|Overall Study|Reimbursement|0
4434626|NCT00418938|7218287|FG000|Overall Study|Administrative decision|3
4434627|NCT00418938|7218288|FG001|Overall Study|Administrative decision|3
4434628|NCT00418938|7218287|FG000|Overall Study|Withdrawal by Subject|16
4434629|NCT00418938|7218288|FG001|Overall Study|Withdrawal by Subject|15
4434630|NCT00418938|7218287|FG000|Overall Study|Lost to Follow-up|1
4434631|NCT00418938|7218288|FG001|Overall Study|Lost to Follow-up|3
4434632|NCT00418938|7218287|FG000|Overall Study|Adverse Event|1
4434633|NCT00418938|7218288|FG001|Overall Study|Adverse Event|1
4434634|NCT00418938|7218287|FG000|Overall Study|On-going|1
4434635|NCT00418938|7218288|FG001|Overall Study|On-going|1
4434636|NCT00418938|7218287|FG000|Overall Study|Ineligibility Determined|1
4434637|NCT00418938|7218288|FG001|Overall Study|Ineligibility Determined|0
4434638|NCT00419003|7218331|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6
4434639|NCT00419003|7218332|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6
4434640|NCT00419003|7218331|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1
4434641|NCT00419003|7218332|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0
4434642|NCT00419094|7218343|FG000|Overall Study|Adverse Event|3
4434643|NCT00419094|7218344|FG001|Overall Study|Adverse Event|7
4434644|NCT00419094|7218343|FG000|Overall Study|Lack of Efficacy|1
4434645|NCT00419094|7218344|FG001|Overall Study|Lack of Efficacy|0
4434646|NCT00419094|7218343|FG000|Overall Study|Lost to Follow-up|0
4434647|NCT00419094|7218344|FG001|Overall Study|Lost to Follow-up|2
4434648|NCT00419094|7218343|FG000|Overall Study|Protocol Violation|1
4434649|NCT00419094|7218344|FG001|Overall Study|Protocol Violation|14
4434650|NCT00419094|7218343|FG000|Overall Study|Withdrawal of consent|1
4434651|NCT00419094|7218344|FG001|Overall Study|Withdrawal of consent|5
4434652|NCT00419094|7218343|FG000|Overall Study|Other: Error determining exit criteria|1
4434653|NCT00419094|7218344|FG001|Overall Study|Other: Error determining exit criteria|0
4434654|NCT00419094|7218343|FG000|Overall Study|Other: Patient non-compliant|0
4434655|NCT00419094|7218344|FG001|Overall Study|Other: Patient non-compliant|1
4434656|NCT00419094|7218343|FG000|Overall Study|Other: No contact for extended period|0
4434657|NCT00419094|7218344|FG001|Overall Study|Other: No contact for extended period|1
4434658|NCT00419120|7218350|FG000|Long Term Follow up Period|study ongoing|10
4434659|NCT00419159|7218356|FG000|Overall Study|Adverse Event|7
4434660|NCT00419159|7218357|FG001|Overall Study|Adverse Event|15
4434661|NCT00419159|7218356|FG000|Overall Study|Abnormal laboratory value(s)|0
4434662|NCT00419159|7218357|FG001|Overall Study|Abnormal laboratory value(s)|2
4434663|NCT00419159|7218356|FG000|Overall Study|Subject's no longer requires study drug|0
4434664|NCT00419159|7218357|FG001|Overall Study|Subject's no longer requires study drug|1
4434665|NCT00419159|7218356|FG000|Overall Study|Protocol Violation|1
4434666|NCT00419159|7218357|FG001|Overall Study|Protocol Violation|0
4434667|NCT00419159|7218356|FG000|Overall Study|Withdrawal by Subject|10
4434668|NCT00419159|7218357|FG001|Overall Study|Withdrawal by Subject|3
4434669|NCT00419159|7218356|FG000|Overall Study|Lost to Follow-up|0
4434670|NCT00419159|7218357|FG001|Overall Study|Lost to Follow-up|1
4434671|NCT00419159|7218356|FG000|Overall Study|Death|2
4434672|NCT00419159|7218357|FG001|Overall Study|Death|2
4434673|NCT00419159|7218356|FG000|Overall Study|Disease progression|79
4434674|NCT00419159|7218357|FG001|Overall Study|Disease progression|76
4434675|NCT00419263|7218374|FG000|Overall Study|Lost to Follow-up|2
4434676|NCT00419263|7218375|FG001|Overall Study|Lost to Follow-up|1
4434677|NCT00419263|7218376|FG002|Overall Study|Lost to Follow-up|1
4434678|NCT00419263|7218374|FG000|Overall Study|Randomized in Error, Not Treated|1
4434679|NCT00419263|7218375|FG001|Overall Study|Randomized in Error, Not Treated|1
4434680|NCT00419263|7218376|FG002|Overall Study|Randomized in Error, Not Treated|0
4434681|NCT00419263|7218374|FG000|Overall Study|Adverse Event|0
4434682|NCT00419263|7218375|FG001|Overall Study|Adverse Event|0
4434683|NCT00419263|7218376|FG002|Overall Study|Adverse Event|1
4434684|NCT00419263|7218374|FG000|Overall Study|Withdrawal by Subject|0
4434685|NCT00419263|7218375|FG001|Overall Study|Withdrawal by Subject|0
4434686|NCT00419263|7218376|FG002|Overall Study|Withdrawal by Subject|1
4434687|NCT00419341|7218394|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8
4434688|NCT00419341|7218394|FG000|Wash in/Wash Out Period|Adverse Event|2
4434689|NCT00419341|7218394|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1
4434690|NCT00419341|7218394|FG000|Efficacy Period|Withdrawal by Subject|6
4434691|NCT00419341|7218394|FG000|Efficacy Period|Protocol Violation|1
4434692|NCT00419341|7218394|FG000|Efficacy Period|Lost to Follow-up|1
4434693|NCT00419341|7218394|FG000|Efficacy Period|Non-compliance|1
4434694|NCT00419341|7218394|FG000|Efficacy Period|Termination of study site|1
4434695|NCT00419380|7218402|FG000|Overall Study|Lack of Efficacy|1
4434696|NCT00419380|7218403|FG001|Overall Study|Lack of Efficacy|7
4434697|NCT00419380|7218402|FG000|Overall Study|Physician Decision|0
4434698|NCT00419380|7218403|FG001|Overall Study|Physician Decision|1
4434699|NCT00419380|7218402|FG000|Overall Study|Lost to Follow-up|0
4434700|NCT00419380|7218403|FG001|Overall Study|Lost to Follow-up|1
4434701|NCT00419380|7218402|FG000|Overall Study|Withdrawal by Subject|0
4434702|NCT00419380|7218403|FG001|Overall Study|Withdrawal by Subject|1
4434703|NCT00419393|7218409|FG000|Overall Study|Adverse Event|5
4434704|NCT00419393|7218409|FG000|Overall Study|Protocol Violation|5
4434705|NCT00419393|7218409|FG000|Overall Study|Withdrawal by Subject|7
4434706|NCT00419393|7218409|FG000|Overall Study|Other: Sponsor request|3
4434707|NCT00419393|7218409|FG000|Overall Study|Other: Subject had temporal lobectomy|1
4434708|NCT00419393|7218409|FG000|Overall Study|Other: Site closure|1
4434709|NCT00419393|7218409|FG000|Overall Study|Other: Other health problems|1
4434710|NCT00419393|7218409|FG000|Overall Study|Other: Investigator decision|1
4434711|NCT00419562|7218428|FG000|Overall Study|Lost to Follow-up|12
4630183|NCT03299049|7498737|FG000|Overall Study|Adverse Event|12
4630184|NCT03299049|7498738|FG001|Overall Study|Adverse Event|13
4434712|NCT00419562|7218429|FG001|Overall Study|Lost to Follow-up|13
4434713|NCT00419562|7218428|FG000|Overall Study|Withdrawal by Subject|20
4434714|NCT00419562|7218429|FG001|Overall Study|Withdrawal by Subject|18
4434715|NCT00419562|7218428|FG000|Overall Study|Participant Institutionalized|1
4434716|NCT00419562|7218429|FG001|Overall Study|Participant Institutionalized|0
4434717|NCT00419744|7218442|FG000|Overall Study|Adverse Event|39
4434718|NCT00419744|7218443|FG001|Overall Study|Adverse Event|40
4434719|NCT00419744|7218444|FG002|Overall Study|Adverse Event|50
4434720|NCT00419744|7218442|FG000|Overall Study|Withdrawal by Subject|45
4434721|NCT00419744|7218443|FG001|Overall Study|Withdrawal by Subject|49
4434722|NCT00419744|7218444|FG002|Overall Study|Withdrawal by Subject|52
4434723|NCT00419744|7218442|FG000|Overall Study|Lost to Follow-up|8
4434724|NCT00419744|7218443|FG001|Overall Study|Lost to Follow-up|10
4434725|NCT00419744|7218444|FG002|Overall Study|Lost to Follow-up|6
4434726|NCT00419744|7218442|FG000|Overall Study|Protocol Violation|4
4434727|NCT00419744|7218443|FG001|Overall Study|Protocol Violation|7
4434728|NCT00419744|7218444|FG002|Overall Study|Protocol Violation|8
4434729|NCT00419744|7218442|FG000|Overall Study|Randomized in error|9
4434730|NCT00419744|7218443|FG001|Overall Study|Randomized in error|6
4434731|NCT00419744|7218444|FG002|Overall Study|Randomized in error|7
4434732|NCT00419744|7218442|FG000|Overall Study|Moving out of state|2
4434733|NCT00419744|7218443|FG001|Overall Study|Moving out of state|0
4434734|NCT00419744|7218444|FG002|Overall Study|Moving out of state|1
4434735|NCT00419744|7218442|FG000|Overall Study|Physician Decision|10
4434736|NCT00419744|7218443|FG001|Overall Study|Physician Decision|5
4434737|NCT00419744|7218444|FG002|Overall Study|Physician Decision|6
4434738|NCT00419744|7218442|FG000|Overall Study|Spirometry mouthpiece issues|0
4434739|NCT00419744|7218443|FG001|Overall Study|Spirometry mouthpiece issues|1
4434740|NCT00419744|7218444|FG002|Overall Study|Spirometry mouthpiece issues|2
4434741|NCT00419744|7218442|FG000|Overall Study|Incorrect medication kit dispensed|0
4434742|NCT00419744|7218443|FG001|Overall Study|Incorrect medication kit dispensed|0
4434743|NCT00419744|7218444|FG002|Overall Study|Incorrect medication kit dispensed|1
4434744|NCT00419757|7218454|FG000|Overall Study|Adverse Event|1
4434745|NCT00419757|7218455|FG001|Overall Study|Adverse Event|4
4434746|NCT00419757|7218454|FG000|Overall Study|Lost to Follow-up|1
4434747|NCT00419757|7218455|FG001|Overall Study|Lost to Follow-up|4
4434748|NCT00419757|7218454|FG000|Overall Study|Withdrawal by Subject|7
4434749|NCT00419757|7218455|FG001|Overall Study|Withdrawal by Subject|1
4434750|NCT00419757|7218454|FG000|Overall Study|Protocol Violation|2
4434751|NCT00419757|7218455|FG001|Overall Study|Protocol Violation|3
4434752|NCT00419757|7218454|FG000|Overall Study|Study specific discontinuation criteria|4
4434753|NCT00419757|7218455|FG001|Overall Study|Study specific discontinuation criteria|8
4434754|NCT00419757|7218454|FG000|Overall Study|Multiple reasons|3
4434755|NCT00419757|7218455|FG001|Overall Study|Multiple reasons|1
4434756|NCT00419770|7218465|FG000|Overall Study|Withdrawal by Subject|5
4434757|NCT00419770|7218466|FG001|Overall Study|Withdrawal by Subject|1
4434758|NCT00419926|7218474|FG000|Overall Study|Withdrawal by Subject|7
4434759|NCT00419926|7218475|FG001|Overall Study|Withdrawal by Subject|3
4434760|NCT00419926|7218474|FG000|Overall Study|Administrative Problem|4
4434761|NCT00419926|7218475|FG001|Overall Study|Administrative Problem|4
4434762|NCT00419926|7218474|FG000|Overall Study|Lost to Follow-up|1
4434763|NCT00419926|7218475|FG001|Overall Study|Lost to Follow-up|2
4434764|NCT00419926|7218474|FG000|Overall Study|Death|2
4434765|NCT00419926|7218475|FG001|Overall Study|Death|1
4434766|NCT00419952|7218483|FG000|Overall Study|Adverse Event|8
4434767|NCT00419952|7218484|FG001|Overall Study|Adverse Event|10
4434768|NCT00419952|7218483|FG000|Overall Study|Withdrawal by Subject|44
4434769|NCT00419952|7218484|FG001|Overall Study|Withdrawal by Subject|43
4434770|NCT00419952|7218483|FG000|Overall Study|Lost to Follow-up|43
4434771|NCT00419952|7218484|FG001|Overall Study|Lost to Follow-up|34
4434772|NCT00419952|7218483|FG000|Overall Study|Protocol Violation|32
4434773|NCT00419952|7218484|FG001|Overall Study|Protocol Violation|24
4434774|NCT00419952|7218483|FG000|Overall Study|Pregnancy|4
4434775|NCT00419952|7218484|FG001|Overall Study|Pregnancy|2
4434776|NCT00419952|7218483|FG000|Overall Study|Physician Decision|1
4434777|NCT00419952|7218484|FG001|Overall Study|Physician Decision|3
4434778|NCT00419952|7218483|FG000|Overall Study|Incorrectly enrolled|10
4630185|NCT03041701|7498758|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1
4630186|NCT03041701|7498759|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1
4630187|NCT03041701|7498760|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0
4630188|NCT03041701|7498758|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0
4630189|NCT03041701|7498759|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0
4630190|NCT03041701|7498760|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1
4630191|NCT03000179|7498771|FG000|Overall Study|Lost to Follow-up|2
4434779|NCT00419952|7218484|FG001|Overall Study|Incorrectly enrolled|3
4434780|NCT00419952|7218483|FG000|Overall Study|Intake of prohibited medication|2
4434781|NCT00419952|7218484|FG001|Overall Study|Intake of prohibited medication|2
4434782|NCT00419952|7218483|FG000|Overall Study|Occurence of 2 or more exacerbations|2
4434783|NCT00419952|7218484|FG001|Overall Study|Occurence of 2 or more exacerbations|0
4434784|NCT00419952|7218483|FG000|Overall Study|Diary or medication non-compliance|2
4434785|NCT00419952|7218484|FG001|Overall Study|Diary or medication non-compliance|4
4434786|NCT00419952|7218483|FG000|Overall Study|Abnormal ECG|1
4434787|NCT00419952|7218484|FG001|Overall Study|Abnormal ECG|0
4434788|NCT00420004|7218493|FG000|Overall Study|Adverse Event|4
4434789|NCT00420004|7218494|FG001|Overall Study|Adverse Event|1
4434790|NCT00420004|7218495|FG002|Overall Study|Adverse Event|1
4434791|NCT00420004|7218493|FG000|Overall Study|Lack of Efficacy|5
4434792|NCT00420004|7218494|FG001|Overall Study|Lack of Efficacy|4
4434793|NCT00420004|7218495|FG002|Overall Study|Lack of Efficacy|1
4434794|NCT00420004|7218493|FG000|Overall Study|Lost to Follow-up|31
4434795|NCT00420004|7218494|FG001|Overall Study|Lost to Follow-up|12
4434796|NCT00420004|7218495|FG002|Overall Study|Lost to Follow-up|10
4434797|NCT00420004|7218493|FG000|Overall Study|Entry Criteria Not Met|0
4434798|NCT00420004|7218494|FG001|Overall Study|Entry Criteria Not Met|1
4434799|NCT00420004|7218495|FG002|Overall Study|Entry Criteria Not Met|0
4434800|NCT00420004|7218493|FG000|Overall Study|Physician Decision|14
4434801|NCT00420004|7218494|FG001|Overall Study|Physician Decision|4
4434802|NCT00420004|7218495|FG002|Overall Study|Physician Decision|2
4434803|NCT00420004|7218493|FG000|Overall Study|Protocol Violation|5
4434804|NCT00420004|7218494|FG001|Overall Study|Protocol Violation|4
4434805|NCT00420004|7218495|FG002|Overall Study|Protocol Violation|3
4434806|NCT00420004|7218493|FG000|Overall Study|Withdrawal by Subject|67
4434807|NCT00420004|7218494|FG001|Overall Study|Withdrawal by Subject|42
4434808|NCT00420004|7218495|FG002|Overall Study|Withdrawal by Subject|14
4434809|NCT00420004|7218493|FG000|Overall Study|Sponsor Decision|3
4434810|NCT00420004|7218494|FG001|Overall Study|Sponsor Decision|3
4434811|NCT00420004|7218495|FG002|Overall Study|Sponsor Decision|1
4434812|NCT00420056|7218516|FG000|Overall Study|Objective progression or relapse|17
4434813|NCT00420095|7218522|FG000|Overall Study|Adverse Event|1
4434814|NCT00420095|7218523|FG001|Overall Study|Adverse Event|0
4434815|NCT00420095|7218522|FG000|Overall Study|Protocol Violation|1
4434816|NCT00420095|7218523|FG001|Overall Study|Protocol Violation|1
4434817|NCT00420095|7218522|FG000|Overall Study|Lost to Follow-up|1
4434818|NCT00420095|7218523|FG001|Overall Study|Lost to Follow-up|0
4434819|NCT00420199|7218540|FG000|Overall Study|Participant no longer met study criteria|1
4434820|NCT00420199|7218541|FG001|Overall Study|Participant no longer met study criteria|0
4434821|NCT00420212|7218555|FG000|Overall Study|Adverse Event|22
4434822|NCT00420212|7218556|FG001|Overall Study|Adverse Event|40
4434823|NCT00420212|7218557|FG002|Overall Study|Adverse Event|36
4434824|NCT00420212|7218555|FG000|Overall Study|Lost to Follow-up|9
4434825|NCT00420212|7218556|FG001|Overall Study|Lost to Follow-up|11
4434826|NCT00420212|7218557|FG002|Overall Study|Lost to Follow-up|11
4434827|NCT00420212|7218555|FG000|Overall Study|Withdrawal by Subject|31
4434828|NCT00420212|7218556|FG001|Overall Study|Withdrawal by Subject|22
4434829|NCT00420212|7218557|FG002|Overall Study|Withdrawal by Subject|19
4434830|NCT00420212|7218555|FG000|Overall Study|Physician Decision|4
4434831|NCT00420212|7218556|FG001|Overall Study|Physician Decision|4
4434832|NCT00420212|7218557|FG002|Overall Study|Physician Decision|3
4434833|NCT00420212|7218555|FG000|Overall Study|Protocol Violation|4
4434834|NCT00420212|7218556|FG001|Overall Study|Protocol Violation|4
4434835|NCT00420212|7218557|FG002|Overall Study|Protocol Violation|8
4434836|NCT00420212|7218555|FG000|Overall Study|Death|0
4434837|NCT00420212|7218556|FG001|Overall Study|Death|0
4434838|NCT00420212|7218557|FG002|Overall Study|Death|1
4434839|NCT00420212|7218555|FG000|Overall Study|Other-Unspecified|21
4434840|NCT00420212|7218556|FG001|Overall Study|Other-Unspecified|14
4434841|NCT00420212|7218557|FG002|Overall Study|Other-Unspecified|18
4434842|NCT00420238|7218570|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1
4434843|NCT00420238|7218571|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0
4434844|NCT00420238|7218570|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0
4434845|NCT00420238|7218571|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2
4434846|NCT00420238|7218570|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0
4434847|NCT00420238|7218571|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1
4434848|NCT00420238|7218570|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0
4434849|NCT00420238|7218571|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1
4434850|NCT00420238|7218570|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1
4434851|NCT00420238|7218571|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0
4434852|NCT00420238|7218570|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1
4434853|NCT00420238|7218571|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1
4434854|NCT00420290|7218585|FG000|Overall Study|Adverse Event|3
4434855|NCT00420290|7218586|FG001|Overall Study|Adverse Event|1
4434856|NCT00420290|7218585|FG000|Overall Study|Withdrawal by Subject|0
4434857|NCT00420290|7218586|FG001|Overall Study|Withdrawal by Subject|2
4434858|NCT00420290|7218585|FG000|Overall Study|did not meet inclusion/exclusion|1
4434859|NCT00420290|7218586|FG001|Overall Study|did not meet inclusion/exclusion|1
4434860|NCT00420303|7218594|FG000|Overall Study|Serious Adverse Event|1
4434861|NCT00420303|7218595|FG001|Overall Study|Serious Adverse Event|0
4434862|NCT00420303|7218594|FG000|Overall Study|Lack of Efficacy|0
4434863|NCT00420303|7218595|FG001|Overall Study|Lack of Efficacy|3
4434864|NCT00420303|7218594|FG000|Overall Study|Physician Decision|0
4434865|NCT00420303|7218595|FG001|Overall Study|Physician Decision|1
4434866|NCT00420316|7218603|FG000|Overall Study|Withdrawal by Subject|0
4434867|NCT00420316|7218604|FG001|Overall Study|Withdrawal by Subject|1
4434868|NCT00420316|7218603|FG000|Overall Study|Lost to Follow-up|12
4434869|NCT00420316|7218604|FG001|Overall Study|Lost to Follow-up|8
4434870|NCT00420342|7218613|FG000|Overall Study|Lost to Follow-up|1
4434871|NCT00420342|7218614|FG001|Overall Study|Lost to Follow-up|0
4434872|NCT00420342|7218615|FG002|Overall Study|Lost to Follow-up|1
4434873|NCT00420342|7218613|FG000|Overall Study|Withdrawal by Subject|0
4434874|NCT00420342|7218614|FG001|Overall Study|Withdrawal by Subject|2
4434875|NCT00420342|7218615|FG002|Overall Study|Withdrawal by Subject|0
4434876|NCT00420381|7218623|FG000|Overall Study|Protocol Violation|1
4434877|NCT00420407|7218629|FG000|Overall Study|Lost to Follow-up|0
4434878|NCT00420407|7218630|FG001|Overall Study|Lost to Follow-up|3
4434879|NCT00420407|7218629|FG000|Overall Study|Physician Decision|2
4434880|NCT00420407|7218630|FG001|Overall Study|Physician Decision|1
4434881|NCT00420407|7218629|FG000|Overall Study|subject identified as detainee|1
4434882|NCT00420407|7218630|FG001|Overall Study|subject identified as detainee|0
4434883|NCT00420407|7218629|FG000|Overall Study|subject identified as Jehovah's witness|1
4434884|NCT00420407|7218630|FG001|Overall Study|subject identified as Jehovah's witness|0
4434885|NCT00420407|7218629|FG000|Overall Study|Withdrawal by Subject|0
4434886|NCT00420407|7218630|FG001|Overall Study|Withdrawal by Subject|2
4434887|NCT00420420|7218639|FG000|Overall Study|Adverse Event|5
4434888|NCT00420420|7218640|FG001|Overall Study|Adverse Event|3
4434889|NCT00420420|7218639|FG000|Overall Study|Protocol Violation|1
4434890|NCT00420420|7218640|FG001|Overall Study|Protocol Violation|1
4434891|NCT00420420|7218639|FG000|Overall Study|Withdrawal by Subject|1
4434892|NCT00420420|7218640|FG001|Overall Study|Withdrawal by Subject|0
4434893|NCT00420420|7218639|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1
4434894|NCT00420420|7218640|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0
4512704|NCT00936975|7322700|FG000|Overall Study|Disease progression|3
4512705|NCT00936975|7322700|FG000|Overall Study|Post-Tx scan uninterpretable|2
4512706|NCT00937040|7322707|FG000|Overall Study|Adverse Event|5
4512707|NCT00937040|7322708|FG001|Overall Study|Adverse Event|8
4512708|NCT00937040|7322707|FG000|Overall Study|Lost to Follow-up|12
4512709|NCT00937040|7322708|FG001|Overall Study|Lost to Follow-up|12
4512710|NCT00937040|7322707|FG000|Overall Study|Protocol Violation|3
4512711|NCT00937040|7322708|FG001|Overall Study|Protocol Violation|0
4512712|NCT00937040|7322707|FG000|Overall Study|Withdrawal by Subject|13
4512713|NCT00937040|7322708|FG001|Overall Study|Withdrawal by Subject|7
4512714|NCT00937040|7322707|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3
4512715|NCT00937040|7322708|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2
4512716|NCT00937040|7322707|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5
4512717|NCT00937040|7322708|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8
4512718|NCT00937157|7322739|FG000|Overall Study|Pregnancy|1
4512719|NCT00937157|7322739|FG000|Overall Study|Lost to Follow-up|3
4512720|NCT00937326|7322757|FG000|Overall Study|Adverse Event|0
4512721|NCT00937326|7322758|FG001|Overall Study|Adverse Event|3
4512722|NCT00937326|7322759|FG002|Overall Study|Adverse Event|1
4512723|NCT00937326|7322760|FG003|Overall Study|Adverse Event|1
4512724|NCT00937326|7322761|FG004|Overall Study|Adverse Event|2
4512725|NCT00937326|7322757|FG000|Overall Study|Death|0
4512726|NCT00937326|7322758|FG001|Overall Study|Death|0
4512727|NCT00937326|7322759|FG002|Overall Study|Death|1
4512728|NCT00937326|7322760|FG003|Overall Study|Death|0
4512729|NCT00937326|7322761|FG004|Overall Study|Death|0
4512730|NCT00937326|7322757|FG000|Overall Study|Withdrawal by Subject|3
4512731|NCT00937326|7322758|FG001|Overall Study|Withdrawal by Subject|4
4512732|NCT00937326|7322759|FG002|Overall Study|Withdrawal by Subject|1
4512733|NCT00937326|7322760|FG003|Overall Study|Withdrawal by Subject|4
4512734|NCT00937326|7322761|FG004|Overall Study|Withdrawal by Subject|3
4512735|NCT00937326|7322757|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0
4512736|NCT00937326|7322758|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0
4512737|NCT00937326|7322759|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1
4512738|NCT00937326|7322760|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0
4512739|NCT00937326|7322761|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0
4512740|NCT00937391|7322789|FG000|Stage 2|Withdrawal by Subject|1
4512741|NCT00937404|7322806|FG000|Overall Study|Protocol Violation|1
4512742|NCT00937404|7322806|FG000|Overall Study|Withdrawal by Subject|1
4512743|NCT00937495|7322810|FG000|Overall Study|Protocol Violation|2
4512744|NCT00937521|7322822|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0
4512745|NCT00937521|7322823|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0
4512746|NCT00937521|7322824|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2
4512747|NCT00937521|7322825|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0
4512748|NCT00937521|7322826|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0
4512749|NCT00937521|7322827|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0
4512750|NCT00937521|7322828|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1
4512751|NCT00937521|7322829|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0
4512752|NCT00937521|7322822|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2
4512753|NCT00937521|7322823|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
4512754|NCT00937521|7322824|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3
4512755|NCT00937521|7322825|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0
4716289|NCT02989610|7645548|FG000|Overall Study|Withdrawal/Other reasons|39
4716290|NCT02989649|7645552|FG000|Overall Study|Patient/Investigator's Decision to Stop|403
4716291|NCT02989649|7645552|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1
4716292|NCT02989649|7645552|FG000|Overall Study|Lost For Observation During Study|3
4716293|NCT02989649|7645552|FG000|Overall Study|Reason Not Specified|13
4716294|NCT02989805|7645578|FG000|Overall Study|invalid consent|6
4716295|NCT02989805|7645579|FG001|Overall Study|invalid consent|4
4716296|NCT02990000|7645587|FG000|Overall Study|Failed to provide data beyond baseline|36
4736201|NCT03560518|7685157|FG001|Double Blind Treatment Period|Pregnancy|2
4512756|NCT00937521|7322826|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
4512757|NCT00937521|7322827|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0
4512758|NCT00937521|7322828|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2
4512759|NCT00937521|7322829|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
4434895|NCT00420511|7218654|FG000|Overall Study|Adverse Event|1
4434896|NCT00420511|7218655|FG001|Overall Study|Adverse Event|1
4434897|NCT00420511|7218654|FG000|Overall Study|Lost to Follow-up|1
4434898|NCT00420511|7218655|FG001|Overall Study|Lost to Follow-up|0
4434899|NCT00420628|7218665|FG000|Overall Study|Withdrawn by parent or gaurdian|5
4434900|NCT00420628|7218666|FG001|Overall Study|Withdrawn by parent or gaurdian|2
4434901|NCT00420628|7218665|FG000|Overall Study|Lost to Follow-up|3
4434902|NCT00420628|7218666|FG001|Overall Study|Lost to Follow-up|2
4434903|NCT00420628|7218665|FG000|Overall Study|Adverse Event|1
4434904|NCT00420628|7218666|FG001|Overall Study|Adverse Event|0
4434905|NCT00420641|7218675|FG000|Overall Study|Adverse Event|3
4434906|NCT00420641|7218676|FG001|Overall Study|Adverse Event|25
4434907|NCT00420641|7218677|FG002|Overall Study|Adverse Event|10
4434908|NCT00420641|7218675|FG000|Overall Study|Lost to Follow-up|2
4434909|NCT00420641|7218676|FG001|Overall Study|Lost to Follow-up|4
4434910|NCT00420641|7218677|FG002|Overall Study|Lost to Follow-up|2
4434911|NCT00420641|7218675|FG000|Overall Study|Protocol Violation|8
4434912|NCT00420641|7218676|FG001|Overall Study|Protocol Violation|8
4434913|NCT00420641|7218677|FG002|Overall Study|Protocol Violation|7
4434914|NCT00420641|7218675|FG000|Overall Study|Withdrawal by Subject|15
4434915|NCT00420641|7218676|FG001|Overall Study|Withdrawal by Subject|21
4434916|NCT00420641|7218677|FG002|Overall Study|Withdrawal by Subject|14
4434917|NCT00420641|7218675|FG000|Overall Study|Lack of Efficacy|6
4434918|NCT00420641|7218676|FG001|Overall Study|Lack of Efficacy|5
4434919|NCT00420641|7218677|FG002|Overall Study|Lack of Efficacy|4
4434920|NCT00420641|7218675|FG000|Overall Study|Non-compliance|7
4434921|NCT00420641|7218676|FG001|Overall Study|Non-compliance|5
4434922|NCT00420641|7218677|FG002|Overall Study|Non-compliance|4
4434923|NCT00420641|7218675|FG000|Overall Study|Other|4
4434924|NCT00420641|7218676|FG001|Overall Study|Other|4
4434925|NCT00420641|7218677|FG002|Overall Study|Other|3
4434926|NCT00420745|7218687|FG000|Overall Study|Adverse Event|2
4434927|NCT00420745|7218688|FG001|Overall Study|Adverse Event|2
4434928|NCT00420745|7218687|FG000|Overall Study|Lost to Follow-up|10
4434929|NCT00420745|7218688|FG001|Overall Study|Lost to Follow-up|2
4434930|NCT00420745|7218687|FG000|Overall Study|Protocol Violation|1
4434931|NCT00420745|7218688|FG001|Overall Study|Protocol Violation|0
4434932|NCT00420745|7218687|FG000|Overall Study|Physician Decision|1
4434933|NCT00420745|7218688|FG001|Overall Study|Physician Decision|1
4434934|NCT00420745|7218687|FG000|Overall Study|Recurrent pneumonia & bronchitis|0
4434935|NCT00420745|7218688|FG001|Overall Study|Recurrent pneumonia & bronchitis|1
4434936|NCT00420745|7218687|FG000|Overall Study|Age limit exceeded for Dose 2|1
4434937|NCT00420745|7218688|FG001|Overall Study|Age limit exceeded for Dose 2|0
4434938|NCT00420784|7218707|FG000|Overall Study|Adverse Event|11
4434939|NCT00420784|7218708|FG001|Overall Study|Adverse Event|29
4434940|NCT00420784|7218709|FG002|Overall Study|Adverse Event|10
4434941|NCT00420784|7218710|FG003|Overall Study|Adverse Event|5
4434942|NCT00420784|7218707|FG000|Overall Study|Withdrawal by Subject|0
4434943|NCT00420784|7218708|FG001|Overall Study|Withdrawal by Subject|1
4434944|NCT00420784|7218709|FG002|Overall Study|Withdrawal by Subject|0
4434945|NCT00420784|7218710|FG003|Overall Study|Withdrawal by Subject|0
4434946|NCT00420784|7218707|FG000|Overall Study|Lost to Follow-up|0
4434947|NCT00420784|7218708|FG001|Overall Study|Lost to Follow-up|0
4434948|NCT00420784|7218709|FG002|Overall Study|Lost to Follow-up|2
4434949|NCT00420784|7218710|FG003|Overall Study|Lost to Follow-up|1
4434950|NCT00420784|7218707|FG000|Overall Study|Virologic Stopping Rule|17
4434951|NCT00420784|7218708|FG001|Overall Study|Virologic Stopping Rule|26
4434952|NCT00420784|7218709|FG002|Overall Study|Virologic Stopping Rule|41
4434953|NCT00420784|7218710|FG003|Overall Study|Virologic Stopping Rule|67
4434954|NCT00420784|7218707|FG000|Overall Study|Other|1
4434955|NCT00420784|7218708|FG001|Overall Study|Other|2
4434956|NCT00420784|7218709|FG002|Overall Study|Other|0
4434957|NCT00420784|7218710|FG003|Overall Study|Other|5
4434958|NCT00420849|7218721|FG000|Overall Study|Lack of Efficacy|154
4434959|NCT00420849|7218721|FG000|Overall Study|Adverse Event|107
4630192|NCT02876835|7498777|FG000|Treatment Period (51.1 Month)|Other|1
4630193|NCT02876835|7498778|FG001|Treatment Period (51.1 Month)|Other|0
4630194|NCT02876835|7498777|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6
4630195|NCT02876835|7498778|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13
4434960|NCT00420849|7218721|FG000|Overall Study|Withdrawal by Subject|28
4434961|NCT00420849|7218721|FG000|Overall Study|Death|18
4434962|NCT00420849|7218721|FG000|Overall Study|Other|14
4434963|NCT00420849|7218721|FG000|Overall Study|Transplant|8
4434964|NCT00420849|7218721|FG000|Overall Study|Protocol Violation|1
4434965|NCT00420849|7218721|FG000|Overall Study|Lost to Follow-up|1
4434966|NCT00420927|7218735|FG000|Period 1|Adverse Event|19
4434967|NCT00420927|7218736|FG001|Period 1|Adverse Event|15
4434968|NCT00420927|7218737|FG002|Period 1|Adverse Event|0
4434969|NCT00420927|7218738|FG003|Period 1|Adverse Event|0
4434970|NCT00420927|7218739|FG004|Period 1|Adverse Event|0
4434971|NCT00420927|7218740|FG005|Period 1|Adverse Event|0
4630196|NCT02876835|7498777|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32
4630197|NCT02876835|7498778|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23
4434972|NCT00420927|7218741|FG006|Period 1|Adverse Event|0
4434973|NCT00420927|7218735|FG000|Period 1|Withdrawal by Subject|7
4434974|NCT00420927|7218736|FG001|Period 1|Withdrawal by Subject|12
4434975|NCT00420927|7218737|FG002|Period 1|Withdrawal by Subject|0
4434976|NCT00420927|7218738|FG003|Period 1|Withdrawal by Subject|0
4434977|NCT00420927|7218739|FG004|Period 1|Withdrawal by Subject|0
4434978|NCT00420927|7218740|FG005|Period 1|Withdrawal by Subject|0
4434979|NCT00420927|7218741|FG006|Period 1|Withdrawal by Subject|0
4434980|NCT00420927|7218735|FG000|Period 1|Lost to Follow-up|8
4434981|NCT00420927|7218736|FG001|Period 1|Lost to Follow-up|6
4434982|NCT00420927|7218737|FG002|Period 1|Lost to Follow-up|0
4434983|NCT00420927|7218738|FG003|Period 1|Lost to Follow-up|0
4434984|NCT00420927|7218739|FG004|Period 1|Lost to Follow-up|0
4434985|NCT00420927|7218740|FG005|Period 1|Lost to Follow-up|0
4434986|NCT00420927|7218741|FG006|Period 1|Lost to Follow-up|0
4434987|NCT00420927|7218735|FG000|Period 1|Lack of efficacy/Loss of efficacy|1
4434988|NCT00420927|7218736|FG001|Period 1|Lack of efficacy/Loss of efficacy|6
4434989|NCT00420927|7218737|FG002|Period 1|Lack of efficacy/Loss of efficacy|0
4434990|NCT00420927|7218738|FG003|Period 1|Lack of efficacy/Loss of efficacy|0
4434991|NCT00420927|7218739|FG004|Period 1|Lack of efficacy/Loss of efficacy|0
4434992|NCT00420927|7218740|FG005|Period 1|Lack of efficacy/Loss of efficacy|0
4434993|NCT00420927|7218741|FG006|Period 1|Lack of efficacy/Loss of efficacy|0
4434994|NCT00420927|7218735|FG000|Period 1|Death|2
4434995|NCT00420927|7218736|FG001|Period 1|Death|0
4434996|NCT00420927|7218737|FG002|Period 1|Death|0
4434997|NCT00420927|7218738|FG003|Period 1|Death|0
4434998|NCT00420927|7218739|FG004|Period 1|Death|0
4434999|NCT00420927|7218740|FG005|Period 1|Death|0
4435000|NCT00420927|7218741|FG006|Period 1|Death|0
4435001|NCT00420927|7218735|FG000|Period 1|Subject moved/relocated|0
4435002|NCT00420927|7218736|FG001|Period 1|Subject moved/relocated|2
4435003|NCT00420927|7218737|FG002|Period 1|Subject moved/relocated|0
4435004|NCT00420927|7218738|FG003|Period 1|Subject moved/relocated|0
4435005|NCT00420927|7218739|FG004|Period 1|Subject moved/relocated|0
4435006|NCT00420927|7218740|FG005|Period 1|Subject moved/relocated|0
4435007|NCT00420927|7218741|FG006|Period 1|Subject moved/relocated|0
4435008|NCT00420927|7218735|FG000|Period 1|Noncompliant with study drug|1
4435009|NCT00420927|7218736|FG001|Period 1|Noncompliant with study drug|1
4435010|NCT00420927|7218737|FG002|Period 1|Noncompliant with study drug|0
4435011|NCT00420927|7218738|FG003|Period 1|Noncompliant with study drug|0
4435012|NCT00420927|7218739|FG004|Period 1|Noncompliant with study drug|0
4435013|NCT00420927|7218740|FG005|Period 1|Noncompliant with study drug|0
4435014|NCT00420927|7218741|FG006|Period 1|Noncompliant with study drug|0
4435015|NCT00420927|7218735|FG000|Period 1|Randomization error|1
4435016|NCT00420927|7218736|FG001|Period 1|Randomization error|0
4435017|NCT00420927|7218737|FG002|Period 1|Randomization error|0
4435018|NCT00420927|7218738|FG003|Period 1|Randomization error|0
4435019|NCT00420927|7218739|FG004|Period 1|Randomization error|0
4435020|NCT00420927|7218740|FG005|Period 1|Randomization error|0
4435021|NCT00420927|7218741|FG006|Period 1|Randomization error|0
4435022|NCT00420927|7218735|FG000|Period 1|Suspected tuberculosis/positive test|1
4435023|NCT00420927|7218736|FG001|Period 1|Suspected tuberculosis/positive test|1
4435024|NCT00420927|7218737|FG002|Period 1|Suspected tuberculosis/positive test|0
4435025|NCT00420927|7218738|FG003|Period 1|Suspected tuberculosis/positive test|0
4435026|NCT00420927|7218739|FG004|Period 1|Suspected tuberculosis/positive test|0
4435027|NCT00420927|7218740|FG005|Period 1|Suspected tuberculosis/positive test|0
4435028|NCT00420927|7218741|FG006|Period 1|Suspected tuberculosis/positive test|0
4435029|NCT00420927|7218735|FG000|Period 1|Study site closure|0
4435030|NCT00420927|7218736|FG001|Period 1|Study site closure|1
4435031|NCT00420927|7218737|FG002|Period 1|Study site closure|0
4435032|NCT00420927|7218738|FG003|Period 1|Study site closure|0
4435033|NCT00420927|7218739|FG004|Period 1|Study site closure|0
4435034|NCT00420927|7218740|FG005|Period 1|Study site closure|0
4435035|NCT00420927|7218741|FG006|Period 1|Study site closure|0
4435036|NCT00420927|7218735|FG000|Period 1|Subject received new diagnosis|0
4435037|NCT00420927|7218736|FG001|Period 1|Subject received new diagnosis|2
4435038|NCT00420927|7218737|FG002|Period 1|Subject received new diagnosis|0
4435039|NCT00420927|7218738|FG003|Period 1|Subject received new diagnosis|0
4435040|NCT00420927|7218739|FG004|Period 1|Subject received new diagnosis|0
4435041|NCT00420927|7218740|FG005|Period 1|Subject received new diagnosis|0
4435042|NCT00420927|7218741|FG006|Period 1|Subject received new diagnosis|0
4435043|NCT00420927|7218735|FG000|Period 1|Received wrong treatment/incorrect dose|0
4435044|NCT00420927|7218736|FG001|Period 1|Received wrong treatment/incorrect dose|1
4435045|NCT00420927|7218737|FG002|Period 1|Received wrong treatment/incorrect dose|0
4435046|NCT00420927|7218738|FG003|Period 1|Received wrong treatment/incorrect dose|0
4435047|NCT00420927|7218739|FG004|Period 1|Received wrong treatment/incorrect dose|0
4435048|NCT00420927|7218740|FG005|Period 1|Received wrong treatment/incorrect dose|0
4435049|NCT00420927|7218741|FG006|Period 1|Received wrong treatment/incorrect dose|0
4435050|NCT00420927|7218735|FG000|Period 1|Failed to meet entry criteria|8
4435051|NCT00420927|7218736|FG001|Period 1|Failed to meet entry criteria|7
4435052|NCT00420927|7218737|FG002|Period 1|Failed to meet entry criteria|0
4435053|NCT00420927|7218738|FG003|Period 1|Failed to meet entry criteria|0
4435054|NCT00420927|7218739|FG004|Period 1|Failed to meet entry criteria|0
4435055|NCT00420927|7218740|FG005|Period 1|Failed to meet entry criteria|0
4435056|NCT00420927|7218741|FG006|Period 1|Failed to meet entry criteria|0
4435057|NCT00420927|7218735|FG000|Period 1|Took prohibited medication|1
4435058|NCT00420927|7218736|FG001|Period 1|Took prohibited medication|3
4435059|NCT00420927|7218737|FG002|Period 1|Took prohibited medication|0
4435060|NCT00420927|7218738|FG003|Period 1|Took prohibited medication|0
4435061|NCT00420927|7218739|FG004|Period 1|Took prohibited medication|0
4435062|NCT00420927|7218740|FG005|Period 1|Took prohibited medication|0
4435063|NCT00420927|7218741|FG006|Period 1|Took prohibited medication|0
4435064|NCT00420927|7218735|FG000|Period 2|Adverse Event|0
4435065|NCT00420927|7218736|FG001|Period 2|Adverse Event|0
4435066|NCT00420927|7218737|FG002|Period 2|Adverse Event|7
4435067|NCT00420927|7218738|FG003|Period 2|Adverse Event|3
4435068|NCT00420927|7218739|FG004|Period 2|Adverse Event|17
4435069|NCT00420927|7218740|FG005|Period 2|Adverse Event|6
4435070|NCT00420927|7218741|FG006|Period 2|Adverse Event|20
4435071|NCT00420927|7218735|FG000|Period 2|Withdrawal by Subject|0
4435072|NCT00420927|7218736|FG001|Period 2|Withdrawal by Subject|0
4435073|NCT00420927|7218737|FG002|Period 2|Withdrawal by Subject|1
4435074|NCT00420927|7218738|FG003|Period 2|Withdrawal by Subject|3
4435075|NCT00420927|7218739|FG004|Period 2|Withdrawal by Subject|11
4435076|NCT00420927|7218740|FG005|Period 2|Withdrawal by Subject|2
4435077|NCT00420927|7218741|FG006|Period 2|Withdrawal by Subject|12
4435078|NCT00420927|7218735|FG000|Period 2|Lost to Follow-up|0
4435079|NCT00420927|7218736|FG001|Period 2|Lost to Follow-up|0
4435080|NCT00420927|7218737|FG002|Period 2|Lost to Follow-up|2
4435081|NCT00420927|7218738|FG003|Period 2|Lost to Follow-up|2
4435082|NCT00420927|7218739|FG004|Period 2|Lost to Follow-up|6
4435083|NCT00420927|7218740|FG005|Period 2|Lost to Follow-up|3
4435084|NCT00420927|7218741|FG006|Period 2|Lost to Follow-up|9
4435085|NCT00420927|7218735|FG000|Period 2|Lack of efficacy/Loss of efficacy|0
4435086|NCT00420927|7218736|FG001|Period 2|Lack of efficacy/Loss of efficacy|0
4435087|NCT00420927|7218737|FG002|Period 2|Lack of efficacy/Loss of efficacy|2
4435088|NCT00420927|7218738|FG003|Period 2|Lack of efficacy/Loss of efficacy|1
4435089|NCT00420927|7218739|FG004|Period 2|Lack of efficacy/Loss of efficacy|6
4435090|NCT00420927|7218740|FG005|Period 2|Lack of efficacy/Loss of efficacy|2
4435091|NCT00420927|7218741|FG006|Period 2|Lack of efficacy/Loss of efficacy|6
4435092|NCT00420927|7218735|FG000|Period 2|Received wrong treatment/incorrect dose|0
4435093|NCT00420927|7218736|FG001|Period 2|Received wrong treatment/incorrect dose|0
4435094|NCT00420927|7218737|FG002|Period 2|Received wrong treatment/incorrect dose|0
4435095|NCT00420927|7218738|FG003|Period 2|Received wrong treatment/incorrect dose|0
4435096|NCT00420927|7218739|FG004|Period 2|Received wrong treatment/incorrect dose|0
4435097|NCT00420927|7218740|FG005|Period 2|Received wrong treatment/incorrect dose|0
4630198|NCT02876835|7498777|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25
4435098|NCT00420927|7218741|FG006|Period 2|Received wrong treatment/incorrect dose|1
4435099|NCT00420927|7218735|FG000|Period 2|Subject unable to find transportation|0
4435100|NCT00420927|7218736|FG001|Period 2|Subject unable to find transportation|0
4435101|NCT00420927|7218737|FG002|Period 2|Subject unable to find transportation|0
4435102|NCT00420927|7218738|FG003|Period 2|Subject unable to find transportation|0
4435103|NCT00420927|7218739|FG004|Period 2|Subject unable to find transportation|0
4435104|NCT00420927|7218740|FG005|Period 2|Subject unable to find transportation|0
4435105|NCT00420927|7218741|FG006|Period 2|Subject unable to find transportation|1
4435106|NCT00420927|7218735|FG000|Period 2|Physician Decision|0
4435107|NCT00420927|7218736|FG001|Period 2|Physician Decision|0
4435108|NCT00420927|7218737|FG002|Period 2|Physician Decision|0
4435109|NCT00420927|7218738|FG003|Period 2|Physician Decision|0
4435110|NCT00420927|7218739|FG004|Period 2|Physician Decision|1
4435111|NCT00420927|7218740|FG005|Period 2|Physician Decision|1
4435112|NCT00420927|7218741|FG006|Period 2|Physician Decision|0
4435113|NCT00420927|7218735|FG000|Period 2|Sponsor decision|0
4435114|NCT00420927|7218736|FG001|Period 2|Sponsor decision|0
4435115|NCT00420927|7218737|FG002|Period 2|Sponsor decision|1
4435116|NCT00420927|7218738|FG003|Period 2|Sponsor decision|0
4435117|NCT00420927|7218739|FG004|Period 2|Sponsor decision|0
4435118|NCT00420927|7218740|FG005|Period 2|Sponsor decision|0
4435119|NCT00420927|7218741|FG006|Period 2|Sponsor decision|1
4435120|NCT00420927|7218735|FG000|Period 2|Randomization error|0
4435121|NCT00420927|7218736|FG001|Period 2|Randomization error|0
4435122|NCT00420927|7218737|FG002|Period 2|Randomization error|0
4435123|NCT00420927|7218738|FG003|Period 2|Randomization error|0
4435124|NCT00420927|7218739|FG004|Period 2|Randomization error|1
4435125|NCT00420927|7218740|FG005|Period 2|Randomization error|1
4435126|NCT00420927|7218741|FG006|Period 2|Randomization error|0
4435127|NCT00420927|7218735|FG000|Period 2|Noncompliant with study drug|0
4435128|NCT00420927|7218736|FG001|Period 2|Noncompliant with study drug|0
4435129|NCT00420927|7218737|FG002|Period 2|Noncompliant with study drug|0
4435130|NCT00420927|7218738|FG003|Period 2|Noncompliant with study drug|1
4435131|NCT00420927|7218739|FG004|Period 2|Noncompliant with study drug|0
4435132|NCT00420927|7218740|FG005|Period 2|Noncompliant with study drug|0
4435133|NCT00420927|7218741|FG006|Period 2|Noncompliant with study drug|2
4435134|NCT00420927|7218735|FG000|Period 2|Methotrexate intolerance|0
4435135|NCT00420927|7218736|FG001|Period 2|Methotrexate intolerance|0
4435136|NCT00420927|7218737|FG002|Period 2|Methotrexate intolerance|0
4435137|NCT00420927|7218738|FG003|Period 2|Methotrexate intolerance|0
4435138|NCT00420927|7218739|FG004|Period 2|Methotrexate intolerance|0
4435139|NCT00420927|7218740|FG005|Period 2|Methotrexate intolerance|0
4435140|NCT00420927|7218741|FG006|Period 2|Methotrexate intolerance|1
4435141|NCT00420927|7218735|FG000|Period 2|Took prohibited medication|0
4435142|NCT00420927|7218736|FG001|Period 2|Took prohibited medication|0
4435143|NCT00420927|7218737|FG002|Period 2|Took prohibited medication|0
4435144|NCT00420927|7218738|FG003|Period 2|Took prohibited medication|0
4435145|NCT00420927|7218739|FG004|Period 2|Took prohibited medication|1
4435146|NCT00420927|7218740|FG005|Period 2|Took prohibited medication|0
4435147|NCT00420927|7218741|FG006|Period 2|Took prohibited medication|0
4435148|NCT00421148|7218785|FG000|Overall Study|Lost to Follow-up|0
4435149|NCT00421148|7218786|FG001|Overall Study|Lost to Follow-up|0
4435150|NCT00421148|7218787|FG002|Overall Study|Lost to Follow-up|0
4435151|NCT00421148|7218788|FG003|Overall Study|Lost to Follow-up|0
4435152|NCT00421148|7218789|FG004|Overall Study|Lost to Follow-up|0
4435153|NCT00421148|7218790|FG005|Overall Study|Lost to Follow-up|0
4435154|NCT00421148|7218791|FG006|Overall Study|Lost to Follow-up|0
4435155|NCT00421148|7218792|FG007|Overall Study|Lost to Follow-up|0
4435156|NCT00421148|7218793|FG008|Overall Study|Lost to Follow-up|0
4435157|NCT00421148|7218794|FG009|Overall Study|Lost to Follow-up|0
4435158|NCT00421148|7218795|FG010|Overall Study|Lost to Follow-up|0
4435159|NCT00421148|7218796|FG011|Overall Study|Lost to Follow-up|0
4435160|NCT00421148|7218797|FG012|Overall Study|Lost to Follow-up|0
4435161|NCT00421148|7218798|FG013|Overall Study|Lost to Follow-up|0
4435162|NCT00421148|7218799|FG014|Overall Study|Lost to Follow-up|0
4435163|NCT00421148|7218800|FG015|Overall Study|Lost to Follow-up|0
4435164|NCT00421148|7218801|FG016|Overall Study|Lost to Follow-up|0
4435165|NCT00421148|7218802|FG017|Overall Study|Lost to Follow-up|1
4435166|NCT00421148|7218803|FG018|Overall Study|Lost to Follow-up|0
4435167|NCT00421148|7218804|FG019|Overall Study|Lost to Follow-up|0
4435168|NCT00421148|7218785|FG000|Overall Study|Withdrawal by Subject|0
4435169|NCT00421148|7218786|FG001|Overall Study|Withdrawal by Subject|0
4435170|NCT00421148|7218787|FG002|Overall Study|Withdrawal by Subject|0
4435171|NCT00421148|7218788|FG003|Overall Study|Withdrawal by Subject|0
4435172|NCT00421148|7218789|FG004|Overall Study|Withdrawal by Subject|0
4435173|NCT00421148|7218790|FG005|Overall Study|Withdrawal by Subject|0
4435174|NCT00421148|7218791|FG006|Overall Study|Withdrawal by Subject|0
4435175|NCT00421148|7218792|FG007|Overall Study|Withdrawal by Subject|0
4435176|NCT00421148|7218793|FG008|Overall Study|Withdrawal by Subject|0
4435177|NCT00421148|7218794|FG009|Overall Study|Withdrawal by Subject|0
4435178|NCT00421148|7218795|FG010|Overall Study|Withdrawal by Subject|0
4435179|NCT00421148|7218796|FG011|Overall Study|Withdrawal by Subject|0
4435180|NCT00421148|7218797|FG012|Overall Study|Withdrawal by Subject|0
4435181|NCT00421148|7218798|FG013|Overall Study|Withdrawal by Subject|0
4435182|NCT00421148|7218799|FG014|Overall Study|Withdrawal by Subject|0
4435183|NCT00421148|7218800|FG015|Overall Study|Withdrawal by Subject|0
4435184|NCT00421148|7218801|FG016|Overall Study|Withdrawal by Subject|0
4435185|NCT00421148|7218802|FG017|Overall Study|Withdrawal by Subject|1
4435186|NCT00421148|7218803|FG018|Overall Study|Withdrawal by Subject|0
4435187|NCT00421148|7218804|FG019|Overall Study|Withdrawal by Subject|0
4435188|NCT00421148|7218785|FG000|Overall Study|Protocol Violation|0
4435189|NCT00421148|7218786|FG001|Overall Study|Protocol Violation|0
4435190|NCT00421148|7218787|FG002|Overall Study|Protocol Violation|0
4435191|NCT00421148|7218788|FG003|Overall Study|Protocol Violation|0
4435192|NCT00421148|7218789|FG004|Overall Study|Protocol Violation|0
4435193|NCT00421148|7218790|FG005|Overall Study|Protocol Violation|1
4435194|NCT00421148|7218791|FG006|Overall Study|Protocol Violation|0
4435195|NCT00421148|7218792|FG007|Overall Study|Protocol Violation|0
4435196|NCT00421148|7218793|FG008|Overall Study|Protocol Violation|0
4435197|NCT00421148|7218794|FG009|Overall Study|Protocol Violation|0
4435198|NCT00421148|7218795|FG010|Overall Study|Protocol Violation|0
4435199|NCT00421148|7218796|FG011|Overall Study|Protocol Violation|0
4435200|NCT00421148|7218797|FG012|Overall Study|Protocol Violation|0
4435201|NCT00421148|7218798|FG013|Overall Study|Protocol Violation|0
4435202|NCT00421148|7218799|FG014|Overall Study|Protocol Violation|0
4435203|NCT00421148|7218800|FG015|Overall Study|Protocol Violation|0
4435204|NCT00421148|7218801|FG016|Overall Study|Protocol Violation|0
4435205|NCT00421148|7218802|FG017|Overall Study|Protocol Violation|0
4435206|NCT00421148|7218803|FG018|Overall Study|Protocol Violation|1
4435207|NCT00421148|7218804|FG019|Overall Study|Protocol Violation|0
4435208|NCT00421174|7218848|FG000|Overall Study|Withdrawal by Subject|0
4435209|NCT00421174|7218849|FG001|Overall Study|Withdrawal by Subject|1
4435210|NCT00421174|7218848|FG000|Overall Study|Ineligible due to infection|2
4435211|NCT00421174|7218849|FG001|Overall Study|Ineligible due to infection|0
4435212|NCT00421304|7218858|FG000|Overall Study|Lost to Follow-up|5
4435213|NCT00421304|7218859|FG001|Overall Study|Lost to Follow-up|2
4435214|NCT00421304|7218860|FG002|Overall Study|Lost to Follow-up|5
4435215|NCT00421304|7218858|FG000|Overall Study|Withdrawal by Subject|2
4435216|NCT00421304|7218859|FG001|Overall Study|Withdrawal by Subject|2
4435217|NCT00421304|7218860|FG002|Overall Study|Withdrawal by Subject|2
4435218|NCT00421304|7218858|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1
4435219|NCT00421304|7218859|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0
4435220|NCT00421304|7218860|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0
4435221|NCT00421304|7218858|FG000|Overall Study|Did not attend Day 360 visit|0
4435222|NCT00421304|7218859|FG001|Overall Study|Did not attend Day 360 visit|0
4435223|NCT00421304|7218860|FG002|Overall Study|Did not attend Day 360 visit|1
4435224|NCT00421343|7218870|FG000|Overall Study|Death|1
4435225|NCT00421343|7218870|FG000|Overall Study|Withdrawal by Subject|2
4435226|NCT00421343|7218870|FG000|Overall Study|Lost to Follow-up|3
4435227|NCT00421408|7218876|FG000|Overall Study|Lost to Follow-up|30
4435228|NCT00421408|7218877|FG001|Overall Study|Lost to Follow-up|20
4435229|NCT00421408|7218876|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12
4435230|NCT00421408|7218877|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25
4435231|NCT00421707|7218894|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1
4435232|NCT00421707|7218895|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5
4435233|NCT00421707|7218894|FG000|Period 1: Treatment Period 1|Adverse Event|7
4435234|NCT00421707|7218895|FG001|Period 1: Treatment Period 1|Adverse Event|2
4435235|NCT00421707|7218894|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2
4435236|NCT00421707|7218895|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2
4435237|NCT00421707|7218894|FG000|Period 1: Treatment Period 1|Protocol Violation|1
4435238|NCT00421707|7218895|FG001|Period 1: Treatment Period 1|Protocol Violation|0
4435239|NCT00421707|7218894|FG000|Period 2: Washout|Adverse Event|1
4435240|NCT00421707|7218895|FG001|Period 2: Washout|Adverse Event|1
4435241|NCT00421707|7218894|FG000|Period 2: Washout|Withdrawal by Subject|0
4435242|NCT00421707|7218895|FG001|Period 2: Washout|Withdrawal by Subject|1
4435243|NCT00421707|7218894|FG000|Period 2: Washout|Lost to Follow-up|0
4435244|NCT00421707|7218895|FG001|Period 2: Washout|Lost to Follow-up|1
4435245|NCT00421707|7218894|FG000|Period 2: Washout|Other: Pregnancy|0
4435246|NCT00421707|7218895|FG001|Period 2: Washout|Other: Pregnancy|1
4435247|NCT00421707|7218894|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1
4435248|NCT00421707|7218895|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1
4435249|NCT00421707|7218894|FG000|Period 3:Treatment Period 2|Protocol Violation|1
4435250|NCT00421707|7218895|FG001|Period 3:Treatment Period 2|Protocol Violation|0
4435251|NCT00421707|7218894|FG000|Period 3:Treatment Period 2|Adverse Event|0
4435252|NCT00421707|7218895|FG001|Period 3:Treatment Period 2|Adverse Event|2
4435253|NCT00421733|7218907|FG000|Overall Study|Adverse Event|4
4435254|NCT00421733|7218908|FG001|Overall Study|Adverse Event|9
4435255|NCT00421733|7218909|FG002|Overall Study|Adverse Event|2
4435256|NCT00421733|7218907|FG000|Overall Study|Lost to Follow-up|1
4435257|NCT00421733|7218908|FG001|Overall Study|Lost to Follow-up|2
4435258|NCT00421733|7218909|FG002|Overall Study|Lost to Follow-up|4
4435259|NCT00421733|7218907|FG000|Overall Study|Withdrawal by Subject|1
4435260|NCT00421733|7218908|FG001|Overall Study|Withdrawal by Subject|2
4435261|NCT00421733|7218909|FG002|Overall Study|Withdrawal by Subject|7
4435262|NCT00421733|7218907|FG000|Overall Study|Death|0
4435263|NCT00421733|7218908|FG001|Overall Study|Death|3
4435264|NCT00421733|7218909|FG002|Overall Study|Death|0
4435265|NCT00421733|7218907|FG000|Overall Study|Required dialysis|1
4435266|NCT00421733|7218908|FG001|Overall Study|Required dialysis|0
4435267|NCT00421733|7218909|FG002|Overall Study|Required dialysis|0
4435268|NCT00421733|7218907|FG000|Overall Study|Administrative|2
4435269|NCT00421733|7218908|FG001|Overall Study|Administrative|0
4435270|NCT00421733|7218909|FG002|Overall Study|Administrative|0
4435271|NCT00421733|7218907|FG000|Overall Study|Did not satisfy entry criteria|1
4435272|NCT00421733|7218908|FG001|Overall Study|Did not satisfy entry criteria|3
4435273|NCT00421733|7218909|FG002|Overall Study|Did not satisfy entry criteria|2
4435274|NCT00421733|7218907|FG000|Overall Study|Sponsor request|1
4435275|NCT00421733|7218908|FG001|Overall Study|Sponsor request|0
4435276|NCT00421733|7218909|FG002|Overall Study|Sponsor request|3
4435277|NCT00421733|7218907|FG000|Overall Study|Protocol deviation|4
4435278|NCT00421733|7218908|FG001|Overall Study|Protocol deviation|7
4630199|NCT02876835|7498778|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29
4630200|NCT02860039|7498787|FG000|Overall Study|Death|4
4630201|NCT02860039|7498788|FG001|Overall Study|Death|0
4630202|NCT02860039|7498787|FG000|Overall Study|Lost to Follow-up|2
4630203|NCT02860039|7498788|FG001|Overall Study|Lost to Follow-up|2
4630204|NCT02860039|7498787|FG000|Overall Study|Protocol Violation|3
4630205|NCT02860039|7498788|FG001|Overall Study|Protocol Violation|1
4630206|NCT02860039|7498787|FG000|Overall Study|Withdrawal by Subject|1
4630207|NCT02860039|7498788|FG001|Overall Study|Withdrawal by Subject|0
4630208|NCT02860039|7498787|FG000|Overall Study|Not otherwise eligible|1
4630209|NCT02860039|7498788|FG001|Overall Study|Not otherwise eligible|1
4630210|NCT02362503|7498805|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0
4435279|NCT00421733|7218909|FG002|Overall Study|Protocol deviation|2
4435280|NCT00421889|7218930|FG000|Overall Study|Adverse Event|1
4435281|NCT00421889|7218931|FG001|Overall Study|Adverse Event|0
4435282|NCT00421889|7218932|FG002|Overall Study|Adverse Event|1
4435283|NCT00421889|7218933|FG003|Overall Study|Adverse Event|1
4435284|NCT00421889|7218934|FG004|Overall Study|Adverse Event|1
4435285|NCT00421889|7218935|FG005|Overall Study|Adverse Event|4
4435286|NCT00421889|7218936|FG006|Overall Study|Adverse Event|1
4435287|NCT00421889|7218937|FG007|Overall Study|Adverse Event|0
4435288|NCT00421889|7218938|FG008|Overall Study|Adverse Event|2
4435289|NCT00421889|7218930|FG000|Overall Study|Withdrawal by Subject|1
4435290|NCT00421889|7218931|FG001|Overall Study|Withdrawal by Subject|3
4435291|NCT00421889|7218932|FG002|Overall Study|Withdrawal by Subject|0
4435292|NCT00421889|7218933|FG003|Overall Study|Withdrawal by Subject|0
4736202|NCT03560518|7685158|FG002|Double Blind Treatment Period|Pregnancy|0
4630211|NCT02362503|7498806|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2
4630212|NCT02362503|7498807|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0
4435293|NCT00421889|7218934|FG004|Overall Study|Withdrawal by Subject|2
4435294|NCT00421889|7218935|FG005|Overall Study|Withdrawal by Subject|0
4435295|NCT00421889|7218936|FG006|Overall Study|Withdrawal by Subject|0
4435296|NCT00421889|7218937|FG007|Overall Study|Withdrawal by Subject|0
4435297|NCT00421889|7218938|FG008|Overall Study|Withdrawal by Subject|0
4435298|NCT00421889|7218930|FG000|Overall Study|Death|0
4435299|NCT00421889|7218931|FG001|Overall Study|Death|0
4435300|NCT00421889|7218932|FG002|Overall Study|Death|0
4435301|NCT00421889|7218933|FG003|Overall Study|Death|0
4435302|NCT00421889|7218934|FG004|Overall Study|Death|1
4435303|NCT00421889|7218935|FG005|Overall Study|Death|1
4435304|NCT00421889|7218936|FG006|Overall Study|Death|0
4435305|NCT00421889|7218937|FG007|Overall Study|Death|0
4435306|NCT00421889|7218938|FG008|Overall Study|Death|0
4435307|NCT00421889|7218930|FG000|Overall Study|Progressive disease|3
4435308|NCT00421889|7218931|FG001|Overall Study|Progressive disease|2
4435309|NCT00421889|7218932|FG002|Overall Study|Progressive disease|2
4435310|NCT00421889|7218933|FG003|Overall Study|Progressive disease|3
4435311|NCT00421889|7218934|FG004|Overall Study|Progressive disease|2
4435312|NCT00421889|7218935|FG005|Overall Study|Progressive disease|21
4435313|NCT00421889|7218936|FG006|Overall Study|Progressive disease|3
4435314|NCT00421889|7218937|FG007|Overall Study|Progressive disease|1
4435315|NCT00421889|7218938|FG008|Overall Study|Progressive disease|5
4435316|NCT00421889|7218930|FG000|Overall Study|Patient/Investigator request|0
4435317|NCT00421889|7218931|FG001|Overall Study|Patient/Investigator request|0
4435318|NCT00421889|7218932|FG002|Overall Study|Patient/Investigator request|0
4435319|NCT00421889|7218933|FG003|Overall Study|Patient/Investigator request|0
4435320|NCT00421889|7218934|FG004|Overall Study|Patient/Investigator request|0
4435321|NCT00421889|7218935|FG005|Overall Study|Patient/Investigator request|9
4435322|NCT00421889|7218936|FG006|Overall Study|Patient/Investigator request|0
4435323|NCT00421889|7218937|FG007|Overall Study|Patient/Investigator request|1
4435324|NCT00421889|7218938|FG008|Overall Study|Patient/Investigator request|3
4435325|NCT00421889|7218930|FG000|Overall Study|Lost to Follow-up|0
4435326|NCT00421889|7218931|FG001|Overall Study|Lost to Follow-up|0
4435327|NCT00421889|7218932|FG002|Overall Study|Lost to Follow-up|0
4435328|NCT00421889|7218933|FG003|Overall Study|Lost to Follow-up|0
4435329|NCT00421889|7218934|FG004|Overall Study|Lost to Follow-up|0
4435330|NCT00421889|7218935|FG005|Overall Study|Lost to Follow-up|0
4435331|NCT00421889|7218936|FG006|Overall Study|Lost to Follow-up|0
4435332|NCT00421889|7218937|FG007|Overall Study|Lost to Follow-up|0
4435333|NCT00421889|7218938|FG008|Overall Study|Lost to Follow-up|1
4435334|NCT00421928|7218965|FG000|Overall Study|Adverse Event|61
4435335|NCT00421928|7218966|FG001|Overall Study|Adverse Event|140
4435336|NCT00421928|7218967|FG002|Overall Study|Adverse Event|22
4435337|NCT00421928|7218965|FG000|Overall Study|Lost to Follow-up|5
4435338|NCT00421928|7218966|FG001|Overall Study|Lost to Follow-up|0
4435339|NCT00421928|7218967|FG002|Overall Study|Lost to Follow-up|3
4435340|NCT00421928|7218965|FG000|Overall Study|Withdrawal by Subject|50
4435341|NCT00421928|7218966|FG001|Overall Study|Withdrawal by Subject|48
4435342|NCT00421928|7218967|FG002|Overall Study|Withdrawal by Subject|43
4435343|NCT00421928|7218965|FG000|Overall Study|Lack of Efficacy|15
4435344|NCT00421928|7218966|FG001|Overall Study|Lack of Efficacy|7
4435345|NCT00421928|7218967|FG002|Overall Study|Lack of Efficacy|35
4435346|NCT00421928|7218965|FG000|Overall Study|Study drug non-compliant|6
4435347|NCT00421928|7218966|FG001|Overall Study|Study drug non-compliant|7
4435348|NCT00421928|7218967|FG002|Overall Study|Study drug non-compliant|4
4435349|NCT00421928|7218965|FG000|Overall Study|All other|26
4435350|NCT00421928|7218966|FG001|Overall Study|All other|21
4435351|NCT00421928|7218967|FG002|Overall Study|All other|27
4435352|NCT00421928|7218965|FG000|Overall Study|Death|0
4435353|NCT00421928|7218966|FG001|Overall Study|Death|1
4435354|NCT00421928|7218967|FG002|Overall Study|Death|0
4435355|NCT00421993|7218979|FG000|Overall Study|Withdrawal by Subject|22
4435356|NCT00421993|7218980|FG001|Overall Study|Withdrawal by Subject|23
4435357|NCT00421993|7218981|FG002|Overall Study|Withdrawal by Subject|23
4435358|NCT00421993|7218982|FG003|Overall Study|Withdrawal by Subject|24
4435359|NCT00421993|7218979|FG000|Overall Study|Lost to Follow-up|18
4435360|NCT00421993|7218980|FG001|Overall Study|Lost to Follow-up|19
4435361|NCT00421993|7218981|FG002|Overall Study|Lost to Follow-up|22
4435362|NCT00421993|7218982|FG003|Overall Study|Lost to Follow-up|20
4435363|NCT00421993|7218979|FG000|Overall Study|Adverse Event|11
4435364|NCT00421993|7218980|FG001|Overall Study|Adverse Event|1
4435365|NCT00421993|7218981|FG002|Overall Study|Adverse Event|6
4435366|NCT00421993|7218982|FG003|Overall Study|Adverse Event|4
4435367|NCT00421993|7218979|FG000|Overall Study|Protocol Violation|2
4435368|NCT00421993|7218980|FG001|Overall Study|Protocol Violation|2
4435369|NCT00421993|7218981|FG002|Overall Study|Protocol Violation|0
4435370|NCT00421993|7218982|FG003|Overall Study|Protocol Violation|1
4435371|NCT00421993|7218979|FG000|Overall Study|Lack of Efficacy|0
4435372|NCT00421993|7218980|FG001|Overall Study|Lack of Efficacy|3
4435373|NCT00421993|7218981|FG002|Overall Study|Lack of Efficacy|0
4435374|NCT00421993|7218982|FG003|Overall Study|Lack of Efficacy|5
4435375|NCT00421993|7218979|FG000|Overall Study|Pregnancy|0
4435376|NCT00421993|7218980|FG001|Overall Study|Pregnancy|1
4435377|NCT00421993|7218981|FG002|Overall Study|Pregnancy|1
4435378|NCT00421993|7218982|FG003|Overall Study|Pregnancy|2
4435379|NCT00421993|7218979|FG000|Overall Study|Subject transportation issues|0
4435380|NCT00421993|7218980|FG001|Overall Study|Subject transportation issues|0
4435381|NCT00421993|7218981|FG002|Overall Study|Subject transportation issues|0
4435382|NCT00421993|7218982|FG003|Overall Study|Subject transportation issues|1
4435383|NCT00422058|7219007|FG000|Double-Blind, Week 0-20|Adverse Event|3
4435384|NCT00422058|7219008|FG001|Double-Blind, Week 0-20|Adverse Event|4
4435385|NCT00422058|7219009|FG002|Double-Blind, Week 0-20|Adverse Event|5
4435386|NCT00422058|7219010|FG003|Double-Blind, Week 0-20|Adverse Event|9
4435387|NCT00422058|7219011|FG004|Double-Blind, Week 0-20|Adverse Event|5
4435388|NCT00422058|7219012|FG005|Double-Blind, Week 0-20|Adverse Event|3
4435389|NCT00422058|7219007|FG000|Double-Blind, Week 0-20|Protocol Violation|3
4435390|NCT00422058|7219008|FG001|Double-Blind, Week 0-20|Protocol Violation|2
4435391|NCT00422058|7219009|FG002|Double-Blind, Week 0-20|Protocol Violation|2
4435392|NCT00422058|7219010|FG003|Double-Blind, Week 0-20|Protocol Violation|3
4435393|NCT00422058|7219011|FG004|Double-Blind, Week 0-20|Protocol Violation|2
4435394|NCT00422058|7219012|FG005|Double-Blind, Week 0-20|Protocol Violation|2
4435395|NCT00422058|7219007|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2
4435396|NCT00422058|7219008|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1
4435397|NCT00422058|7219009|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1
4435398|NCT00422058|7219010|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0
4435399|NCT00422058|7219011|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0
4435400|NCT00422058|7219012|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1
4435401|NCT00422058|7219007|FG000|Double-Blind, Week 0-20|Other|11
4435402|NCT00422058|7219008|FG001|Double-Blind, Week 0-20|Other|3
4435403|NCT00422058|7219009|FG002|Double-Blind, Week 0-20|Other|8
4435404|NCT00422058|7219010|FG003|Double-Blind, Week 0-20|Other|8
4435405|NCT00422058|7219011|FG004|Double-Blind, Week 0-20|Other|4
4435406|NCT00422058|7219012|FG005|Double-Blind, Week 0-20|Other|10
4435407|NCT00422058|7219007|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12
4435408|NCT00422058|7219008|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17
4435409|NCT00422058|7219009|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15
4435410|NCT00422058|7219010|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8
4435411|NCT00422058|7219011|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10
4435412|NCT00422058|7219012|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12
4435413|NCT00422058|7219007|FG000|Open-Label Extension, Week 20-104|Adverse Event|3
4435414|NCT00422058|7219008|FG001|Open-Label Extension, Week 20-104|Adverse Event|4
4435415|NCT00422058|7219009|FG002|Open-Label Extension, Week 20-104|Adverse Event|7
4435416|NCT00422058|7219010|FG003|Open-Label Extension, Week 20-104|Adverse Event|4
4435417|NCT00422058|7219011|FG004|Open-Label Extension, Week 20-104|Adverse Event|4
4435418|NCT00422058|7219012|FG005|Open-Label Extension, Week 20-104|Adverse Event|0
4435419|NCT00422058|7219007|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1
4435420|NCT00422058|7219008|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2
4435421|NCT00422058|7219009|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3
4435422|NCT00422058|7219010|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1
4435423|NCT00422058|7219011|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5
4435424|NCT00422058|7219012|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3
4435425|NCT00422058|7219007|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3
4435426|NCT00422058|7219008|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2
4435427|NCT00422058|7219009|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5
4435428|NCT00422058|7219010|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2
4435429|NCT00422058|7219011|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0
4435430|NCT00422058|7219012|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1
4435431|NCT00422058|7219007|FG000|Open-Label Extension, Week 20-104|Other|13
4435432|NCT00422058|7219008|FG001|Open-Label Extension, Week 20-104|Other|14
4435433|NCT00422058|7219009|FG002|Open-Label Extension, Week 20-104|Other|6
4630213|NCT02362503|7498805|FG000|Double-blind Period-Up to 8 Days|Death|1
4630214|NCT02362503|7498806|FG001|Double-blind Period-Up to 8 Days|Death|0
4630215|NCT02362503|7498807|FG002|Double-blind Period-Up to 8 Days|Death|0
4630216|NCT02362503|7498805|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0
4435434|NCT00422058|7219010|FG003|Open-Label Extension, Week 20-104|Other|13
4435435|NCT00422058|7219011|FG004|Open-Label Extension, Week 20-104|Other|16
4435436|NCT00422058|7219012|FG005|Open-Label Extension, Week 20-104|Other|18
4435437|NCT00422084|7219028|FG000|Overall Study|Adverse Event|21
4435438|NCT00422084|7219029|FG001|Overall Study|Adverse Event|7
4435439|NCT00422084|7219028|FG000|Overall Study|Withdrawal by Subject|12
4435440|NCT00422084|7219029|FG001|Overall Study|Withdrawal by Subject|9
4435441|NCT00422084|7219028|FG000|Overall Study|Lost to Follow-up|14
4435442|NCT00422084|7219029|FG001|Overall Study|Lost to Follow-up|9
4435443|NCT00422084|7219028|FG000|Overall Study|Protocol Violation|4
4435444|NCT00422084|7219029|FG001|Overall Study|Protocol Violation|1
4435445|NCT00422084|7219028|FG000|Overall Study|Lack of Efficacy|40
4435446|NCT00422084|7219029|FG001|Overall Study|Lack of Efficacy|42
4435447|NCT00422084|7219028|FG000|Overall Study|P. vivax infection|3
4435448|NCT00422084|7219029|FG001|Overall Study|P. vivax infection|6
4435449|NCT00422084|7219028|FG000|Overall Study|Cyesis|1
4435450|NCT00422084|7219029|FG001|Overall Study|Cyesis|0
4435451|NCT00422084|7219028|FG000|Overall Study|Withdrawn from study accidentally|1
4435452|NCT00422084|7219029|FG001|Overall Study|Withdrawn from study accidentally|0
4435453|NCT00422084|7219028|FG000|Overall Study|Non-compliance|1
4435454|NCT00422084|7219029|FG001|Overall Study|Non-compliance|0
4435455|NCT00422084|7219028|FG000|Overall Study|Re-location|0
4435456|NCT00422084|7219029|FG001|Overall Study|Re-location|1
4435457|NCT00422084|7219028|FG000|Overall Study|Not defined|1
4435458|NCT00422084|7219029|FG001|Overall Study|Not defined|1
4435459|NCT00422097|7219041|FG000|Dose Level 2|Still on treatment|0
4435460|NCT00422097|7219042|FG001|Dose Level 2|Still on treatment|1
4435461|NCT00422097|7219043|FG002|Dose Level 2|Still on treatment|0
4630217|NCT02362503|7498806|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1
4630218|NCT02362503|7498807|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0
4630219|NCT02362503|7498805|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0
4435462|NCT00422097|7219044|FG003|Dose Level 2|Still on treatment|0
4435463|NCT00422097|7219045|FG004|Dose Level 2|Still on treatment|0
4435464|NCT00422097|7219046|FG005|Dose Level 2|Still on treatment|0
4435465|NCT00422097|7219047|FG006|Dose Level 2|Still on treatment|0
4435466|NCT00422097|7219048|FG007|Dose Level 2|Still on treatment|0
4435467|NCT00422162|7219074|FG000|Overall Study|Adverse Event|11
4435468|NCT00422162|7219075|FG001|Overall Study|Adverse Event|9
4435469|NCT00422162|7219074|FG000|Overall Study|Lack of Efficacy|4
4435470|NCT00422162|7219075|FG001|Overall Study|Lack of Efficacy|10
4435471|NCT00422162|7219074|FG000|Overall Study|Withdrawal by Subject|7
4435472|NCT00422162|7219075|FG001|Overall Study|Withdrawal by Subject|6
4435473|NCT00422162|7219074|FG000|Overall Study|Lost to Follow-up|1
4435474|NCT00422162|7219075|FG001|Overall Study|Lost to Follow-up|2
4435475|NCT00422162|7219074|FG000|Overall Study|Non-Compliant with Protocol|1
4435476|NCT00422162|7219075|FG001|Overall Study|Non-Compliant with Protocol|1
4435477|NCT00422162|7219074|FG000|Overall Study|Other|0
4435478|NCT00422162|7219075|FG001|Overall Study|Other|1
4435479|NCT00422162|7219074|FG000|Overall Study|Didn't Receive Treatment|0
4435480|NCT00422162|7219075|FG001|Overall Study|Didn't Receive Treatment|1
4435481|NCT00422227|7219098|FG000|Overall Study|Adverse Event|3
4435482|NCT00422227|7219099|FG001|Overall Study|Adverse Event|8
4435483|NCT00422227|7219098|FG000|Overall Study|Lost to Follow-up|1
4435484|NCT00422227|7219099|FG001|Overall Study|Lost to Follow-up|3
4435485|NCT00422227|7219098|FG000|Overall Study|Withdrawal by Subject|0
4435486|NCT00422227|7219099|FG001|Overall Study|Withdrawal by Subject|4
4435487|NCT00422292|7219120|FG000|Overall Study|Serious adverse events|1
4435488|NCT00422292|7219121|FG001|Overall Study|Serious adverse events|4
4435489|NCT00422292|7219122|FG002|Overall Study|Serious adverse events|0
4435490|NCT00422292|7219123|FG003|Overall Study|Serious adverse events|0
4435491|NCT00422292|7219120|FG000|Overall Study|Adverse Event|1
4435492|NCT00422292|7219121|FG001|Overall Study|Adverse Event|0
4435493|NCT00422292|7219122|FG002|Overall Study|Adverse Event|1
4435494|NCT00422292|7219123|FG003|Overall Study|Adverse Event|0
4435495|NCT00422292|7219120|FG000|Overall Study|Protocol Violation|4
4435496|NCT00422292|7219121|FG001|Overall Study|Protocol Violation|25
4435497|NCT00422292|7219122|FG002|Overall Study|Protocol Violation|8
4435498|NCT00422292|7219123|FG003|Overall Study|Protocol Violation|5
4435499|NCT00422292|7219120|FG000|Overall Study|Lost to Follow-up|6
4435500|NCT00422292|7219121|FG001|Overall Study|Lost to Follow-up|12
4435501|NCT00422292|7219122|FG002|Overall Study|Lost to Follow-up|6
4435502|NCT00422292|7219123|FG003|Overall Study|Lost to Follow-up|6
4435503|NCT00422292|7219120|FG000|Overall Study|Withdrawal by Subject|6
4435504|NCT00422292|7219121|FG001|Overall Study|Withdrawal by Subject|25
4435505|NCT00422292|7219122|FG002|Overall Study|Withdrawal by Subject|7
4435506|NCT00422292|7219123|FG003|Overall Study|Withdrawal by Subject|13
4435507|NCT00422383|7219138|FG000|Overall Study|Adverse Event|5
4435508|NCT00422383|7219139|FG001|Overall Study|Adverse Event|3
4435509|NCT00422383|7219140|FG002|Overall Study|Adverse Event|1
4435510|NCT00422383|7219141|FG003|Overall Study|Adverse Event|1
4435511|NCT00422383|7219142|FG004|Overall Study|Adverse Event|0
4435512|NCT00422383|7219138|FG000|Overall Study|Lack of Efficacy|4
4435513|NCT00422383|7219139|FG001|Overall Study|Lack of Efficacy|4
4435514|NCT00422383|7219140|FG002|Overall Study|Lack of Efficacy|2
4435515|NCT00422383|7219141|FG003|Overall Study|Lack of Efficacy|1
4435516|NCT00422383|7219142|FG004|Overall Study|Lack of Efficacy|1
4435517|NCT00422383|7219138|FG000|Overall Study|Lost to Follow-up|0
4435518|NCT00422383|7219139|FG001|Overall Study|Lost to Follow-up|1
4435519|NCT00422383|7219140|FG002|Overall Study|Lost to Follow-up|0
4435520|NCT00422383|7219141|FG003|Overall Study|Lost to Follow-up|0
4435521|NCT00422383|7219142|FG004|Overall Study|Lost to Follow-up|1
4435522|NCT00422383|7219138|FG000|Overall Study|Protocol Violation|1
4435523|NCT00422383|7219139|FG001|Overall Study|Protocol Violation|1
4435524|NCT00422383|7219140|FG002|Overall Study|Protocol Violation|1
4435525|NCT00422383|7219141|FG003|Overall Study|Protocol Violation|0
4435526|NCT00422383|7219142|FG004|Overall Study|Protocol Violation|0
4435527|NCT00422383|7219138|FG000|Overall Study|Withdrawal by Subject|5
4435528|NCT00422383|7219139|FG001|Overall Study|Withdrawal by Subject|5
4435529|NCT00422383|7219140|FG002|Overall Study|Withdrawal by Subject|0
4435530|NCT00422383|7219141|FG003|Overall Study|Withdrawal by Subject|0
4435531|NCT00422383|7219142|FG004|Overall Study|Withdrawal by Subject|1
4435532|NCT00422422|7219160|FG000|Overall Study|Lack of Efficacy|1
4435533|NCT00422422|7219160|FG000|Overall Study|Protocol Violation|1
4435534|NCT00422422|7219160|FG000|Overall Study|Withdrawal by Subject|2
4435535|NCT00422422|7219160|FG000|Overall Study|SAE, non-fatal|1
4435536|NCT00422422|7219160|FG000|Overall Study|AE, non-serious non-fatal|5
4435537|NCT00422461|7219174|FG000|Overall Study|Adverse Event|1
4435538|NCT00422461|7219175|FG001|Overall Study|Adverse Event|2
4435539|NCT00422461|7219176|FG002|Overall Study|Adverse Event|1
4435540|NCT00422461|7219177|FG003|Overall Study|Adverse Event|1
4435541|NCT00422461|7219174|FG000|Overall Study|Other|0
4435542|NCT00422461|7219175|FG001|Overall Study|Other|0
4435543|NCT00422461|7219176|FG002|Overall Study|Other|0
4435544|NCT00422461|7219177|FG003|Overall Study|Other|2
4435545|NCT00422461|7219174|FG000|Overall Study|Participants no longer willing to participate in study|1
4435546|NCT00422461|7219175|FG001|Overall Study|Participants no longer willing to participate in study|0
4435547|NCT00422461|7219176|FG002|Overall Study|Participants no longer willing to participate in study|0
4435548|NCT00422461|7219177|FG003|Overall Study|Participants no longer willing to participate in study|0
4435549|NCT00422461|7219174|FG000|Overall Study|Randomized but not treated|1
4435550|NCT00422461|7219175|FG001|Overall Study|Randomized but not treated|1
4435551|NCT00422461|7219176|FG002|Overall Study|Randomized but not treated|0
4435552|NCT00422461|7219177|FG003|Overall Study|Randomized but not treated|0
4435553|NCT00422513|7219189|FG000|Overall Study|Lack of Efficacy|4
4435554|NCT00422513|7219190|FG001|Overall Study|Lack of Efficacy|5
4435555|NCT00422513|7219189|FG000|Overall Study|Protocol Violation|23
4435556|NCT00422513|7219190|FG001|Overall Study|Protocol Violation|7
4435557|NCT00422513|7219189|FG000|Overall Study|Refused Treatment|4
4435558|NCT00422513|7219190|FG001|Overall Study|Refused Treatment|2
4435559|NCT00422513|7219189|FG000|Overall Study|Withdrawal by Subject|2
4435560|NCT00422513|7219190|FG001|Overall Study|Withdrawal by Subject|1
4435561|NCT00422513|7219189|FG000|Overall Study|early termination of the study|67
4435562|NCT00422513|7219190|FG001|Overall Study|early termination of the study|80
4435563|NCT00422513|7219189|FG000|Overall Study|Adverse Event|4
4435564|NCT00422513|7219190|FG001|Overall Study|Adverse Event|4
4435565|NCT00422513|7219189|FG000|Overall Study|Death|3
4435566|NCT00422513|7219190|FG001|Overall Study|Death|7
4435567|NCT00422591|7219196|FG000|Overall Study|Physician Decision|4
4435568|NCT00422591|7219196|FG000|Overall Study|Withdrawal by Subject|2
4435569|NCT00422734|7219215|FG000|Overall Study|Physician Decision|1
4435570|NCT00422734|7219216|FG001|Overall Study|Physician Decision|1
4435571|NCT00422734|7219215|FG000|Overall Study|Protocol Violation|1
4435572|NCT00422734|7219216|FG001|Overall Study|Protocol Violation|6
4435573|NCT00422734|7219215|FG000|Overall Study|Withdrawal by Subject|12
4435574|NCT00422734|7219216|FG001|Overall Study|Withdrawal by Subject|8
4435575|NCT00422734|7219215|FG000|Overall Study|Adverse Event|0
4435576|NCT00422734|7219216|FG001|Overall Study|Adverse Event|3
4435577|NCT00422734|7219215|FG000|Overall Study|Partner Decision|0
4435578|NCT00422734|7219216|FG001|Overall Study|Partner Decision|3
4435579|NCT00422799|7219222|FG000|Overall Study|Withdrawal by Subject|6
4435580|NCT00422799|7219222|FG000|Overall Study|Adverse Event|7
4435581|NCT00422903|7219245|FG000|Overall Study|Disease Progression|3
4435582|NCT00422903|7219246|FG001|Overall Study|Disease Progression|1
4435583|NCT00422903|7219245|FG000|Overall Study|Adverse Event|0
4435584|NCT00422903|7219246|FG001|Overall Study|Adverse Event|2
4435585|NCT00422903|7219245|FG000|Overall Study|Informed Consent Withdrawn|1
4435586|NCT00422903|7219246|FG001|Overall Study|Informed Consent Withdrawn|2
4435587|NCT00423046|7219254|FG000|Overall Study|Other|340
4435588|NCT00423046|7219255|FG001|Overall Study|Other|345
4435589|NCT00423085|7219266|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21
4435590|NCT00423085|7219267|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38
4435591|NCT00423085|7219268|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34
4435592|NCT00423085|7219269|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0
4435593|NCT00423085|7219266|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8
4435594|NCT00423085|7219267|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16
4435595|NCT00423085|7219268|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11
4435596|NCT00423085|7219269|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0
4435597|NCT00423085|7219266|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7
4435598|NCT00423085|7219267|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6
4435599|NCT00423085|7219268|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7
4435600|NCT00423085|7219269|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
4435601|NCT00423085|7219266|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8
4435602|NCT00423085|7219267|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3
4435603|NCT00423085|7219268|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7
4435604|NCT00423085|7219269|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0
4435605|NCT00423085|7219266|FG000|24-Week Double-Blind Treatment Phase|Death|1
4435606|NCT00423085|7219267|FG001|24-Week Double-Blind Treatment Phase|Death|1
4435607|NCT00423085|7219268|FG002|24-Week Double-Blind Treatment Phase|Death|0
4435608|NCT00423085|7219269|FG003|24-Week Double-Blind Treatment Phase|Death|0
4435609|NCT00423085|7219266|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1
4435610|NCT00423085|7219267|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
4435611|NCT00423085|7219268|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
4435612|NCT00423085|7219269|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
4435613|NCT00423085|7219266|FG000|52-Week Open-Label Extension Phase|Adverse Event|0
4435614|NCT00423085|7219267|FG001|52-Week Open-Label Extension Phase|Adverse Event|0
4435615|NCT00423085|7219268|FG002|52-Week Open-Label Extension Phase|Adverse Event|0
4435616|NCT00423085|7219269|FG003|52-Week Open-Label Extension Phase|Adverse Event|97
4435617|NCT00423085|7219266|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
4435618|NCT00423085|7219267|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
4435619|NCT00423085|7219268|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
4435620|NCT00423085|7219269|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37
4435621|NCT00423085|7219266|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
4435622|NCT00423085|7219267|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
4435623|NCT00423085|7219268|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
4435624|NCT00423085|7219269|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18
4435625|NCT00423085|7219266|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0
4435626|NCT00423085|7219267|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0
4435627|NCT00423085|7219268|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0
4435628|NCT00423085|7219269|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9
4435629|NCT00423085|7219266|FG000|52-Week Open-Label Extension Phase|Death|0
4435630|NCT00423085|7219267|FG001|52-Week Open-Label Extension Phase|Death|0
4435631|NCT00423085|7219268|FG002|52-Week Open-Label Extension Phase|Death|0
4435632|NCT00423085|7219269|FG003|52-Week Open-Label Extension Phase|Death|2
4435633|NCT00423098|7219281|FG000|Overall Study|Adverse Event|1
4435634|NCT00423098|7219282|FG001|Overall Study|Adverse Event|2
4435635|NCT00423098|7219281|FG000|Overall Study|Unsatisfactory therapeutic effect|0
4435636|NCT00423098|7219282|FG001|Overall Study|Unsatisfactory therapeutic effect|1
4435637|NCT00423098|7219281|FG000|Overall Study|Administrative problems|0
4435638|NCT00423098|7219282|FG001|Overall Study|Administrative problems|1
4435639|NCT00423098|7219281|FG000|Overall Study|Death|2
4435640|NCT00423098|7219282|FG001|Overall Study|Death|0
4435641|NCT00423137|7219292|FG000|Overall Study|Lost to Follow-up|0
4435642|NCT00423137|7219293|FG001|Overall Study|Lost to Follow-up|0
4435643|NCT00423137|7219294|FG002|Overall Study|Lost to Follow-up|1
4435644|NCT00423137|7219295|FG003|Overall Study|Lost to Follow-up|0
4435645|NCT00423137|7219292|FG000|Overall Study|Protocol Violation|0
4435646|NCT00423137|7219293|FG001|Overall Study|Protocol Violation|0
4435647|NCT00423137|7219294|FG002|Overall Study|Protocol Violation|0
4435648|NCT00423137|7219295|FG003|Overall Study|Protocol Violation|1
4435649|NCT00423137|7219292|FG000|Overall Study|Adverse Event Study disease worse|1
4435650|NCT00423137|7219293|FG001|Overall Study|Adverse Event Study disease worse|0
4435651|NCT00423137|7219294|FG002|Overall Study|Adverse Event Study disease worse|3
4435652|NCT00423137|7219295|FG003|Overall Study|Adverse Event Study disease worse|1
4435653|NCT00423137|7219292|FG000|Overall Study|Adverse Event Other|0
4435654|NCT00423137|7219293|FG001|Overall Study|Adverse Event Other|0
4435655|NCT00423137|7219294|FG002|Overall Study|Adverse Event Other|2
4435656|NCT00423137|7219295|FG003|Overall Study|Adverse Event Other|0
4435657|NCT00423150|7219308|FG000|Overall Study|Adverse Event|11
4435658|NCT00423150|7219308|FG000|Overall Study|Progression of disease being studied|69
4435659|NCT00423150|7219308|FG000|Overall Study|Withdrawal by Subject|1
4435660|NCT00423150|7219308|FG000|Overall Study|Non-compliance with protocol|1
4435661|NCT00423150|7219308|FG000|Overall Study|Administrative|4
4435662|NCT00423189|7219315|FG000|Overall Study|Death|0
4435663|NCT00423189|7219316|FG001|Overall Study|Death|1
4435664|NCT00423189|7219317|FG002|Overall Study|Death|0
4435665|NCT00423267|7219332|FG000|Period A|Withdrawal by Subject|0
4435666|NCT00423267|7219333|FG001|Period A|Withdrawal by Subject|1
4435667|NCT00423267|7219332|FG000|Period A|Non-compliance with protocol|1
4435668|NCT00423267|7219333|FG001|Period A|Non-compliance with protocol|0
4435669|NCT00423267|7219332|FG000|Period A|Administrative|1
4435670|NCT00423267|7219333|FG001|Period A|Administrative|0
4435671|NCT00423293|7219341|FG000|Overall Study|Ineligible / No protocol treatment|11
4435672|NCT00423319|7219347|FG000|Overall Study|Death|2
4435673|NCT00423319|7219348|FG001|Overall Study|Death|0
4435674|NCT00423319|7219347|FG000|Overall Study|Adverse Event|93
4435675|NCT00423319|7219348|FG001|Overall Study|Adverse Event|112
4435676|NCT00423319|7219347|FG000|Overall Study|Withdrawal by Subject|86
4435677|NCT00423319|7219348|FG001|Overall Study|Withdrawal by Subject|99
4435678|NCT00423319|7219347|FG000|Overall Study|Lost to Follow-up|4
4435679|NCT00423319|7219348|FG001|Overall Study|Lost to Follow-up|3
4435680|NCT00423319|7219347|FG000|Overall Study|Poor compliance or noncompliance|1
4435681|NCT00423319|7219348|FG001|Overall Study|Poor compliance or noncompliance|1
4435682|NCT00423319|7219347|FG000|Overall Study|No longer meets study criteria|15
4435683|NCT00423319|7219348|FG001|Overall Study|No longer meets study criteria|15
4435684|NCT00423319|7219347|FG000|Overall Study|Other|23
4435685|NCT00423319|7219348|FG001|Overall Study|Other|22
4435686|NCT00423332|7219357|FG000|Overall Study|Adverse Event|6
4435687|NCT00423332|7219358|FG001|Overall Study|Adverse Event|2
4435688|NCT00423332|7219357|FG000|Overall Study|Withdrawal by Subject|1
4435689|NCT00423332|7219358|FG001|Overall Study|Withdrawal by Subject|0
4435690|NCT00423332|7219357|FG000|Overall Study|Condition under investigation worsened|1
4435691|NCT00423332|7219358|FG001|Overall Study|Condition under investigation worsened|1
4435692|NCT00423332|7219357|FG000|Overall Study|Progressive at Week 6|0
4435693|NCT00423332|7219358|FG001|Overall Study|Progressive at Week 6|1
4435694|NCT00423332|7219357|FG000|Overall Study|Unblinded before 12 weeks|1
4435695|NCT00423332|7219358|FG001|Overall Study|Unblinded before 12 weeks|3
4435696|NCT00423449|7219383|FG000|Overall Study|Clinical Adverse Event|1
4435697|NCT00423449|7219384|FG001|Overall Study|Clinical Adverse Event|0
4435698|NCT00423449|7219385|FG002|Overall Study|Clinical Adverse Event|1
4435699|NCT00423449|7219386|FG003|Overall Study|Clinical Adverse Event|8
4435700|NCT00423449|7219387|FG004|Overall Study|Clinical Adverse Event|2
4435701|NCT00423449|7219383|FG000|Overall Study|Death|1
4435702|NCT00423449|7219384|FG001|Overall Study|Death|0
4435703|NCT00423449|7219385|FG002|Overall Study|Death|2
4435704|NCT00423449|7219386|FG003|Overall Study|Death|1
4435705|NCT00423449|7219387|FG004|Overall Study|Death|1
4435706|NCT00423449|7219383|FG000|Overall Study|Progressive Disease|1
4435707|NCT00423449|7219384|FG001|Overall Study|Progressive Disease|3
4435708|NCT00423449|7219385|FG002|Overall Study|Progressive Disease|8
4435709|NCT00423449|7219386|FG003|Overall Study|Progressive Disease|11
4435710|NCT00423449|7219387|FG004|Overall Study|Progressive Disease|4
4435711|NCT00423449|7219383|FG000|Overall Study|Laboratory Adverse Event|0
4435712|NCT00423449|7219384|FG001|Overall Study|Laboratory Adverse Event|1
4435713|NCT00423449|7219385|FG002|Overall Study|Laboratory Adverse Event|2
4435714|NCT00423449|7219386|FG003|Overall Study|Laboratory Adverse Event|0
4435715|NCT00423449|7219387|FG004|Overall Study|Laboratory Adverse Event|0
4435716|NCT00423449|7219383|FG000|Overall Study|Other|0
4435717|NCT00423449|7219384|FG001|Overall Study|Other|0
4435718|NCT00423449|7219385|FG002|Overall Study|Other|0
4435719|NCT00423449|7219386|FG003|Overall Study|Other|1
4435720|NCT00423449|7219387|FG004|Overall Study|Other|0
4435721|NCT00423449|7219383|FG000|Overall Study|Protocol Violation|0
4435722|NCT00423449|7219384|FG001|Overall Study|Protocol Violation|0
4435723|NCT00423449|7219385|FG002|Overall Study|Protocol Violation|2
4435724|NCT00423449|7219386|FG003|Overall Study|Protocol Violation|1
4435725|NCT00423449|7219387|FG004|Overall Study|Protocol Violation|0
4435726|NCT00423592|7219400|FG000|Overall Study|Adverse Event (through Week 12)|2
4435727|NCT00423592|7219400|FG000|Overall Study|Adverse Event (post Week 12)|5
4435728|NCT00423605|7219404|FG000|Overall Study|Adverse Event|129
4435729|NCT00423605|7219404|FG000|Overall Study|Withdrawal by Subject|36
4435730|NCT00423605|7219404|FG000|Overall Study|Lost to Follow-up|15
4435731|NCT00423605|7219404|FG000|Overall Study|Lack of Efficacy|38
4435732|NCT00423605|7219404|FG000|Overall Study|Sponsor Decision|3
4435733|NCT00423605|7219404|FG000|Overall Study|Physician Decision|8
4435734|NCT00423605|7219404|FG000|Overall Study|Protocol Violation|7
4435735|NCT00423605|7219404|FG000|Overall Study|Not one of the pre-specified options|5
4435736|NCT00423657|7219410|FG000|Overall Study|Withdrew consent|10
4435737|NCT00423657|7219411|FG001|Overall Study|Withdrew consent|8
4435738|NCT00423657|7219410|FG000|Overall Study|Non-compliance|0
4435739|NCT00423657|7219411|FG001|Overall Study|Non-compliance|1
4435740|NCT00423657|7219410|FG000|Overall Study|Other|15
4435741|NCT00423657|7219411|FG001|Overall Study|Other|16
4435742|NCT00423657|7219410|FG000|Overall Study|Request of sponsor/investigator|1
4435743|NCT00423657|7219411|FG001|Overall Study|Request of sponsor/investigator|0
4435744|NCT00423670|7219424|FG000|Treatment Period|Switched to Arm 8 at TW 24|36
4435745|NCT00423670|7219425|FG001|Treatment Period|Switched to Arm 8 at TW 24|0
4435746|NCT00423670|7219426|FG002|Treatment Period|Switched to Arm 8 at TW 24|0
4435747|NCT00423670|7219427|FG003|Treatment Period|Switched to Arm 8 at TW 24|0
4435748|NCT00423670|7219428|FG004|Treatment Period|Switched to Arm 8 at TW 24|0
4435749|NCT00423670|7219429|FG005|Treatment Period|Switched to Arm 8 at TW 24|0
4435750|NCT00423670|7219430|FG006|Treatment Period|Switched to Arm 8 at TW 24|0
4435751|NCT00423670|7219431|FG007|Treatment Period|Switched to Arm 8 at TW 24|0
4435752|NCT00423670|7219424|FG000|Treatment Period|Adverse Event|8
4435753|NCT00423670|7219425|FG001|Treatment Period|Adverse Event|12
4435754|NCT00423670|7219426|FG002|Treatment Period|Adverse Event|15
4435755|NCT00423670|7219427|FG003|Treatment Period|Adverse Event|20
4435756|NCT00423670|7219428|FG004|Treatment Period|Adverse Event|9
4435757|NCT00423670|7219429|FG005|Treatment Period|Adverse Event|4
4435758|NCT00423670|7219430|FG006|Treatment Period|Adverse Event|7
4435759|NCT00423670|7219431|FG007|Treatment Period|Adverse Event|2
4435760|NCT00423670|7219424|FG000|Treatment Period|Protocol-defined clinical event|0
4435761|NCT00423670|7219425|FG001|Treatment Period|Protocol-defined clinical event|7
4435762|NCT00423670|7219426|FG002|Treatment Period|Protocol-defined clinical event|4
4435763|NCT00423670|7219427|FG003|Treatment Period|Protocol-defined clinical event|12
4435764|NCT00423670|7219428|FG004|Treatment Period|Protocol-defined clinical event|5
4435765|NCT00423670|7219429|FG005|Treatment Period|Protocol-defined clinical event|4
4435766|NCT00423670|7219430|FG006|Treatment Period|Protocol-defined clinical event|16
4435767|NCT00423670|7219431|FG007|Treatment Period|Protocol-defined clinical event|15
4435768|NCT00423670|7219424|FG000|Treatment Period|Lost to Follow-up|2
4435769|NCT00423670|7219425|FG001|Treatment Period|Lost to Follow-up|1
4435770|NCT00423670|7219426|FG002|Treatment Period|Lost to Follow-up|3
4435771|NCT00423670|7219427|FG003|Treatment Period|Lost to Follow-up|1
4435772|NCT00423670|7219428|FG004|Treatment Period|Lost to Follow-up|6
4435773|NCT00423670|7219429|FG005|Treatment Period|Lost to Follow-up|0
4435774|NCT00423670|7219430|FG006|Treatment Period|Lost to Follow-up|3
4435775|NCT00423670|7219431|FG007|Treatment Period|Lost to Follow-up|1
4435776|NCT00423670|7219424|FG000|Treatment Period|Subject withdrew (not treatment related)|3
4435777|NCT00423670|7219425|FG001|Treatment Period|Subject withdrew (not treatment related)|9
4435778|NCT00423670|7219426|FG002|Treatment Period|Subject withdrew (not treatment related)|4
4435779|NCT00423670|7219427|FG003|Treatment Period|Subject withdrew (not treatment related)|4
4435780|NCT00423670|7219428|FG004|Treatment Period|Subject withdrew (not treatment related)|5
4435781|NCT00423670|7219429|FG005|Treatment Period|Subject withdrew (not treatment related)|0
4435782|NCT00423670|7219430|FG006|Treatment Period|Subject withdrew (not treatment related)|3
4435783|NCT00423670|7219431|FG007|Treatment Period|Subject withdrew (not treatment related)|0
4435784|NCT00423670|7219424|FG000|Treatment Period|Investigator decision|0
4435785|NCT00423670|7219425|FG001|Treatment Period|Investigator decision|0
4435786|NCT00423670|7219426|FG002|Treatment Period|Investigator decision|0
4435787|NCT00423670|7219427|FG003|Treatment Period|Investigator decision|0
4435788|NCT00423670|7219428|FG004|Treatment Period|Investigator decision|0
4435789|NCT00423670|7219429|FG005|Treatment Period|Investigator decision|0
4435790|NCT00423670|7219430|FG006|Treatment Period|Investigator decision|0
4435791|NCT00423670|7219431|FG007|Treatment Period|Investigator decision|1
4435792|NCT00423670|7219424|FG000|Treatment Period|Non-compliance with protocol|3
4435793|NCT00423670|7219425|FG001|Treatment Period|Non-compliance with protocol|1
4435794|NCT00423670|7219426|FG002|Treatment Period|Non-compliance with protocol|1
4435795|NCT00423670|7219427|FG003|Treatment Period|Non-compliance with protocol|3
4435796|NCT00423670|7219428|FG004|Treatment Period|Non-compliance with protocol|2
4435797|NCT00423670|7219429|FG005|Treatment Period|Non-compliance with protocol|0
4435798|NCT00423670|7219430|FG006|Treatment Period|Non-compliance with protocol|2
4435799|NCT00423670|7219431|FG007|Treatment Period|Non-compliance with protocol|2
4435800|NCT00423670|7219424|FG000|Follow-up Period|Lost to Follow-up|0
4435801|NCT00423670|7219425|FG001|Follow-up Period|Lost to Follow-up|12
4435802|NCT00423670|7219426|FG002|Follow-up Period|Lost to Follow-up|8
4435803|NCT00423670|7219427|FG003|Follow-up Period|Lost to Follow-up|3
4435804|NCT00423670|7219428|FG004|Follow-up Period|Lost to Follow-up|1
4435805|NCT00423670|7219429|FG005|Follow-up Period|Lost to Follow-up|0
4435806|NCT00423670|7219430|FG006|Follow-up Period|Lost to Follow-up|5
4435807|NCT00423670|7219431|FG007|Follow-up Period|Lost to Follow-up|0
4435808|NCT00423670|7219424|FG000|Follow-up Period|Subject withdrew (not treatment related)|1
4435809|NCT00423670|7219425|FG001|Follow-up Period|Subject withdrew (not treatment related)|4
4435810|NCT00423670|7219426|FG002|Follow-up Period|Subject withdrew (not treatment related)|2
4435811|NCT00423670|7219427|FG003|Follow-up Period|Subject withdrew (not treatment related)|1
4435812|NCT00423670|7219428|FG004|Follow-up Period|Subject withdrew (not treatment related)|1
4435813|NCT00423670|7219429|FG005|Follow-up Period|Subject withdrew (not treatment related)|0
4435814|NCT00423670|7219430|FG006|Follow-up Period|Subject withdrew (not treatment related)|1
4435815|NCT00423670|7219431|FG007|Follow-up Period|Subject withdrew (not treatment related)|1
4435816|NCT00423670|7219424|FG000|Follow-up Period|Non-compliance with protocol|2
4435817|NCT00423670|7219425|FG001|Follow-up Period|Non-compliance with protocol|0
4435818|NCT00423670|7219426|FG002|Follow-up Period|Non-compliance with protocol|1
4435819|NCT00423670|7219427|FG003|Follow-up Period|Non-compliance with protocol|1
4435820|NCT00423670|7219428|FG004|Follow-up Period|Non-compliance with protocol|0
4435821|NCT00423670|7219429|FG005|Follow-up Period|Non-compliance with protocol|0
4435822|NCT00423670|7219430|FG006|Follow-up Period|Non-compliance with protocol|3
4435823|NCT00423670|7219431|FG007|Follow-up Period|Non-compliance with protocol|2
4435824|NCT00423722|7219465|FG000|Overall Study|Death|4
4435825|NCT00423722|7219466|FG001|Overall Study|Death|4
4435826|NCT00423722|7219465|FG000|Overall Study|Declined to participate|2
4435827|NCT00423722|7219466|FG001|Overall Study|Declined to participate|3
4435828|NCT00423722|7219465|FG000|Overall Study|Unable to complete questionnaires|4
4435829|NCT00423722|7219466|FG001|Overall Study|Unable to complete questionnaires|4
4435830|NCT00423722|7219465|FG000|Overall Study|Withdrawal by Subject|4
4435831|NCT00423722|7219466|FG001|Overall Study|Withdrawal by Subject|2
4435832|NCT00423735|7219481|FG000|Overall Study|Ineligible / No protocol treatment|8
4435833|NCT00423735|7219482|FG001|Overall Study|Ineligible / No protocol treatment|6
4435834|NCT00423735|7219483|FG002|Overall Study|Ineligible / No protocol treatment|0
4435835|NCT00423800|7219495|FG000|Overall Study|Protocol Violation|0
4435836|NCT00423800|7219496|FG001|Overall Study|Protocol Violation|1
4435837|NCT00423813|7219506|FG000|Overall Study|Adverse Event|11
4435838|NCT00423813|7219507|FG001|Overall Study|Adverse Event|30
4435839|NCT00423813|7219508|FG002|Overall Study|Adverse Event|40
4435840|NCT00423813|7219506|FG000|Overall Study|Withdrawal by Subject|6
4435841|NCT00423813|7219507|FG001|Overall Study|Withdrawal by Subject|8
4435842|NCT00423813|7219508|FG002|Overall Study|Withdrawal by Subject|5
4435843|NCT00423813|7219506|FG000|Overall Study|Lost to Follow-up|5
4435844|NCT00423813|7219507|FG001|Overall Study|Lost to Follow-up|4
4435845|NCT00423813|7219508|FG002|Overall Study|Lost to Follow-up|4
4435846|NCT00423813|7219506|FG000|Overall Study|Lack of Efficacy|23
4435847|NCT00423813|7219507|FG001|Overall Study|Lack of Efficacy|18
4435848|NCT00423813|7219508|FG002|Overall Study|Lack of Efficacy|19
4435849|NCT00423813|7219506|FG000|Overall Study|Physician Decision|2
4435850|NCT00423813|7219507|FG001|Overall Study|Physician Decision|0
4435851|NCT00423813|7219508|FG002|Overall Study|Physician Decision|0
4435852|NCT00423813|7219506|FG000|Overall Study|Sponsor Decision|0
4435853|NCT00423813|7219507|FG001|Overall Study|Sponsor Decision|1
4435854|NCT00423813|7219508|FG002|Overall Study|Sponsor Decision|0
4435855|NCT00423813|7219506|FG000|Overall Study|Protocol Violation|9
4435856|NCT00423813|7219507|FG001|Overall Study|Protocol Violation|4
4435857|NCT00423813|7219508|FG002|Overall Study|Protocol Violation|4
4435858|NCT00423813|7219506|FG000|Overall Study|Pregnancy|0
4435859|NCT00423813|7219507|FG001|Overall Study|Pregnancy|0
4435860|NCT00423813|7219508|FG002|Overall Study|Pregnancy|1
4435861|NCT00423813|7219506|FG000|Overall Study|Subject started night shift work|1
4435862|NCT00423813|7219507|FG001|Overall Study|Subject started night shift work|0
4435863|NCT00423813|7219508|FG002|Overall Study|Subject started night shift work|0
4435864|NCT00423813|7219506|FG000|Overall Study|Will start exclusionary medications|0
4435865|NCT00423813|7219507|FG001|Overall Study|Will start exclusionary medications|1
4435866|NCT00423813|7219508|FG002|Overall Study|Will start exclusionary medications|0
4435867|NCT00423813|7219506|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0
4435868|NCT00423813|7219507|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0
4435869|NCT00423813|7219508|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1
4435870|NCT00423852|7219516|FG000|Overall Study|Removed pior to the high-dose portion|3
4435871|NCT00423891|7219532|FG000|Enrolled|Withdrawal by Subject|0
4435872|NCT00423891|7219533|FG001|Enrolled|Withdrawal by Subject|0
4435873|NCT00423891|7219534|FG002|Enrolled|Withdrawal by Subject|1
4435874|NCT00423891|7219532|FG000|Enrolled|Lost to Follow-up|0
4435875|NCT00423891|7219533|FG001|Enrolled|Lost to Follow-up|0
4435876|NCT00423891|7219534|FG002|Enrolled|Lost to Follow-up|1
4435877|NCT00423891|7219532|FG000|Enrolled|No longer met criteria|11
4435878|NCT00423891|7219533|FG001|Enrolled|No longer met criteria|2
4435879|NCT00423891|7219534|FG002|Enrolled|No longer met criteria|1
4435880|NCT00423891|7219532|FG000|Treatment|Withdrawal by Subject|1
4435881|NCT00423891|7219533|FG001|Treatment|Withdrawal by Subject|0
4435882|NCT00423891|7219534|FG002|Treatment|Withdrawal by Subject|0
4435883|NCT00423891|7219532|FG000|Treatment|Lost to Follow-up|1
4435884|NCT00423891|7219533|FG001|Treatment|Lost to Follow-up|0
4435885|NCT00423891|7219534|FG002|Treatment|Lost to Follow-up|0
4435886|NCT00423891|7219532|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0
4435887|NCT00423891|7219533|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3
4435888|NCT00423891|7219534|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2
4435889|NCT00423891|7219532|FG000|Post-Dosing Follow Up|Lost to Follow-up|2
4435890|NCT00423891|7219533|FG001|Post-Dosing Follow Up|Lost to Follow-up|0
4435891|NCT00423891|7219534|FG002|Post-Dosing Follow Up|Lost to Follow-up|0
4435892|NCT00423917|7219544|FG000|Overall Study|Cancel|2
4435893|NCT00423917|7219544|FG000|Overall Study|Ineligible|1
4435894|NCT00423930|7219548|FG000|Overall Study|Withdrawal by Subject|2
4435895|NCT00423943|7219554|FG000|Overall Study|Withdrawal by Subject|3
4435896|NCT00423943|7219555|FG001|Overall Study|Withdrawal by Subject|1
4435897|NCT00424021|7219565|FG000|NCT00046319 Study Period|Adverse Event|1
4435898|NCT00424021|7219566|FG001|NCT00046319 Study Period|Adverse Event|0
4435899|NCT00424021|7219567|FG002|NCT00046319 Study Period|Adverse Event|1
4435900|NCT00424021|7219568|FG003|NCT00046319 Study Period|Adverse Event|1
4435901|NCT00424021|7219565|FG000|NCT00046319 Study Period|Withdrawal by Subject|0
4435902|NCT00424021|7219566|FG001|NCT00046319 Study Period|Withdrawal by Subject|1
4435903|NCT00424021|7219567|FG002|NCT00046319 Study Period|Withdrawal by Subject|0
4435904|NCT00424021|7219568|FG003|NCT00046319 Study Period|Withdrawal by Subject|0
4435905|NCT00424021|7219565|FG000|NCT00046319 Study Period|Sponsor discretion|0
4435906|NCT00424021|7219566|FG001|NCT00046319 Study Period|Sponsor discretion|1
4435907|NCT00424021|7219567|FG002|NCT00046319 Study Period|Sponsor discretion|0
4435908|NCT00424021|7219568|FG003|NCT00046319 Study Period|Sponsor discretion|0
4435909|NCT00424021|7219565|FG000|NCT00046319 Study Period|Lost to Follow-up|0
4435910|NCT00424021|7219566|FG001|NCT00046319 Study Period|Lost to Follow-up|1
4435911|NCT00424021|7219567|FG002|NCT00046319 Study Period|Lost to Follow-up|0
4435912|NCT00424021|7219568|FG003|NCT00046319 Study Period|Lost to Follow-up|0
4435913|NCT00424021|7219565|FG000|AMB-220-E Study Period|Adverse Event|1
4435914|NCT00424021|7219566|FG001|AMB-220-E Study Period|Adverse Event|1
4435915|NCT00424021|7219567|FG002|AMB-220-E Study Period|Adverse Event|3
4435916|NCT00424021|7219568|FG003|AMB-220-E Study Period|Adverse Event|7
4435917|NCT00424021|7219565|FG000|AMB-220-E Study Period|Death|0
4435918|NCT00424021|7219566|FG001|AMB-220-E Study Period|Death|0
4435919|NCT00424021|7219567|FG002|AMB-220-E Study Period|Death|1
4435920|NCT00424021|7219568|FG003|AMB-220-E Study Period|Death|1
4435921|NCT00424021|7219565|FG000|AMB-220-E Study Period|Lost to Follow-up|0
4435922|NCT00424021|7219566|FG001|AMB-220-E Study Period|Lost to Follow-up|1
4435923|NCT00424021|7219567|FG002|AMB-220-E Study Period|Lost to Follow-up|1
4435924|NCT00424021|7219568|FG003|AMB-220-E Study Period|Lost to Follow-up|1
4435925|NCT00424021|7219565|FG000|AMB-220-E Study Period|Physician Decision|0
4435926|NCT00424021|7219566|FG001|AMB-220-E Study Period|Physician Decision|0
4435927|NCT00424021|7219567|FG002|AMB-220-E Study Period|Physician Decision|0
4435928|NCT00424021|7219568|FG003|AMB-220-E Study Period|Physician Decision|1
4435929|NCT00424047|7219587|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18
4435930|NCT00424047|7219588|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12
4435931|NCT00424047|7219587|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67
4435932|NCT00424047|7219588|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122
4435933|NCT00424047|7219587|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1
4435934|NCT00424047|7219588|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3
4435935|NCT00424047|7219587|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23
4435936|NCT00424047|7219588|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8
4435937|NCT00424047|7219587|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11
4435938|NCT00424047|7219588|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10
4435939|NCT00424047|7219587|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2
4435940|NCT00424047|7219588|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1
4435941|NCT00424047|7219587|FG000|On Study at Time of Unblinding|Adverse Event|22
4435942|NCT00424047|7219588|FG001|On Study at Time of Unblinding|Adverse Event|12
4435943|NCT00424047|7219587|FG000|On Study at Time of Unblinding|Progression of disease|92
4435944|NCT00424047|7219588|FG001|On Study at Time of Unblinding|Progression of disease|128
4435945|NCT00424047|7219587|FG000|On Study at Time of Unblinding|Lack of Efficacy|1
4435946|NCT00424047|7219588|FG001|On Study at Time of Unblinding|Lack of Efficacy|3
4435947|NCT00424047|7219587|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24
4435948|NCT00424047|7219588|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9
4435949|NCT00424047|7219587|FG000|On Study at Time of Unblinding|Death|11
4435950|NCT00424047|7219588|FG001|On Study at Time of Unblinding|Death|11
4435951|NCT00424047|7219587|FG000|On Study at Time of Unblinding|Other|5
4435952|NCT00424047|7219588|FG001|On Study at Time of Unblinding|Other|4
4435953|NCT00424047|7219587|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1
4435954|NCT00424047|7219588|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0
4435955|NCT00424047|7219587|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0
4435956|NCT00424047|7219588|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1
4435957|NCT00424047|7219587|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12
4435958|NCT00424047|7219588|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4
4435959|NCT00424047|7219587|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7
4435960|NCT00424047|7219588|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3
4435961|NCT00424047|7219587|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1
4435962|NCT00424047|7219588|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0
4435963|NCT00424177|7219599|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8
4435964|NCT00424177|7219599|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1
4435965|NCT00424177|7219599|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1
4435966|NCT00424177|7219599|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1
4435967|NCT00424177|7219599|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2
4435968|NCT00424177|7219599|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1
4435969|NCT00424177|7219599|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1
4435970|NCT00424177|7219599|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1
4435971|NCT00424177|7219599|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1
4435972|NCT00424177|7219599|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1
4435973|NCT00424190|7219613|FG000|Overall Study|Withdrew consent|3
4435974|NCT00424190|7219614|FG001|Overall Study|Withdrew consent|4
4435975|NCT00424190|7219613|FG000|Overall Study|Death|3
4435976|NCT00424190|7219614|FG001|Overall Study|Death|0
4435977|NCT00424190|7219613|FG000|Overall Study|Noncompliance|1
4435978|NCT00424190|7219614|FG001|Overall Study|Noncompliance|2
4435979|NCT00424190|7219613|FG000|Overall Study|Request of sponsor or investigator|0
4435980|NCT00424190|7219614|FG001|Overall Study|Request of sponsor or investigator|2
4435981|NCT00424190|7219613|FG000|Overall Study|Diagnosis of osteomyelitis|0
4435982|NCT00424190|7219614|FG001|Overall Study|Diagnosis of osteomyelitis|1
4435983|NCT00424190|7219613|FG000|Overall Study|Other|15
4435984|NCT00424190|7219614|FG001|Overall Study|Other|21
4435985|NCT00424255|7219622|FG000|Overall Study|Death|115
4435986|NCT00424255|7219623|FG001|Overall Study|Death|111
4435987|NCT00424255|7219622|FG000|Overall Study|Lost to Follow-up|26
4435988|NCT00424255|7219623|FG001|Overall Study|Lost to Follow-up|20
4435989|NCT00424255|7219622|FG000|Overall Study|Protocol Violation|0
4435990|NCT00424255|7219623|FG001|Overall Study|Protocol Violation|1
4630220|NCT02362503|7498806|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1
4630221|NCT02362503|7498807|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0
4630222|NCT02362503|7498805|FG000|Open Label Period-Up to 96 Weeks|Other|0
4630223|NCT02362503|7498806|FG001|Open Label Period-Up to 96 Weeks|Other|1
4630224|NCT02362503|7498807|FG002|Open Label Period-Up to 96 Weeks|Other|1
4630225|NCT02362503|7498805|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0
4630226|NCT02362503|7498806|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4
4630227|NCT02362503|7498807|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4
4630228|NCT02362503|7498805|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0
4630229|NCT02362503|7498806|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1
4716297|NCT02990000|7645588|FG001|Overall Study|Failed to provide data beyond baseline|34
4716298|NCT02990910|7645596|FG000|Overall Study|Lack of Efficacy|6
4716299|NCT02990910|7645597|FG001|Overall Study|Lack of Efficacy|10
4716300|NCT02991040|7645603|FG000|Overall Study|Withdrawal by Subject|2
4716301|NCT02991040|7645603|FG000|Overall Study|Lost to Follow-up|2
4716302|NCT02991118|7645611|FG000|Overall Study|Death|3
4716303|NCT02991118|7645612|FG001|Overall Study|Death|8
4716304|NCT02991118|7645611|FG000|Overall Study|Protocol Violation|0
4716305|NCT02991118|7645612|FG001|Overall Study|Protocol Violation|3
4716306|NCT02991118|7645611|FG000|Overall Study|Physician Decision|0
4716307|NCT02991118|7645612|FG001|Overall Study|Physician Decision|1
4435991|NCT00424255|7219622|FG000|Overall Study|Withdrawal by Subject|34
4435992|NCT00424255|7219623|FG001|Overall Study|Withdrawal by Subject|38
4435993|NCT00424255|7219622|FG000|Overall Study|Physician Decision|3
4435994|NCT00424255|7219623|FG001|Overall Study|Physician Decision|7
4435995|NCT00424255|7219622|FG000|Overall Study|Cognitive Disturbance|1
4435996|NCT00424255|7219623|FG001|Overall Study|Cognitive Disturbance|0
4435997|NCT00424255|7219622|FG000|Overall Study|Non-compliance by Participants|1
4435998|NCT00424255|7219623|FG001|Overall Study|Non-compliance by Participants|0
4435999|NCT00424255|7219622|FG000|Overall Study|Fatigue|1
4436000|NCT00424255|7219623|FG001|Overall Study|Fatigue|0
4436001|NCT00424255|7219622|FG000|Overall Study|Disease Progression|0
4436002|NCT00424255|7219623|FG001|Overall Study|Disease Progression|2
4436003|NCT00424255|7219622|FG000|Overall Study|Sponsor Terminated Study|161
4436004|NCT00424255|7219623|FG001|Overall Study|Sponsor Terminated Study|167
4436005|NCT00424294|7219640|FG000|Overall Study|Adverse Event|4
4436006|NCT00424294|7219641|FG001|Overall Study|Adverse Event|10
4436007|NCT00424294|7219640|FG000|Overall Study|Lack of Efficacy|2
4436008|NCT00424294|7219641|FG001|Overall Study|Lack of Efficacy|1
4436009|NCT00424294|7219640|FG000|Overall Study|Withdrawal by Subject|1
4436010|NCT00424294|7219641|FG001|Overall Study|Withdrawal by Subject|2
4436011|NCT00424294|7219640|FG000|Overall Study|Other|0
4436012|NCT00424294|7219641|FG001|Overall Study|Other|2
4436013|NCT00424294|7219640|FG000|Overall Study|Randomized but not Treated|1
4436014|NCT00424294|7219641|FG001|Overall Study|Randomized but not Treated|0
4436015|NCT00424346|7219651|FG000|Core Study|Adverse Event|5
4436016|NCT00424346|7219652|FG001|Core Study|Adverse Event|3
4436017|NCT00424346|7219653|FG002|Core Study|Adverse Event|1
4436018|NCT00424346|7219654|FG003|Core Study|Adverse Event|1
4436019|NCT00424346|7219651|FG000|Core Study|Abnormal Laboratory Values|0
4436020|NCT00424346|7219652|FG001|Core Study|Abnormal Laboratory Values|1
4436021|NCT00424346|7219653|FG002|Core Study|Abnormal Laboratory Values|0
4436022|NCT00424346|7219654|FG003|Core Study|Abnormal Laboratory Values|0
4436023|NCT00424346|7219651|FG000|Core Study|Lack of Efficacy|1
4436024|NCT00424346|7219652|FG001|Core Study|Lack of Efficacy|3
4436025|NCT00424346|7219653|FG002|Core Study|Lack of Efficacy|0
4436026|NCT00424346|7219654|FG003|Core Study|Lack of Efficacy|4
4436027|NCT00424346|7219651|FG000|Core Study|Withdrawal by Subject|1
4436028|NCT00424346|7219652|FG001|Core Study|Withdrawal by Subject|0
4436029|NCT00424346|7219653|FG002|Core Study|Withdrawal by Subject|0
4436030|NCT00424346|7219654|FG003|Core Study|Withdrawal by Subject|2
4436031|NCT00424346|7219651|FG000|Core Study|Lost to Follow-up|1
4436032|NCT00424346|7219652|FG001|Core Study|Lost to Follow-up|1
4436033|NCT00424346|7219653|FG002|Core Study|Lost to Follow-up|0
4436034|NCT00424346|7219654|FG003|Core Study|Lost to Follow-up|0
4436035|NCT00424346|7219651|FG000|Core Study|Administrative Problems|1
4436036|NCT00424346|7219652|FG001|Core Study|Administrative Problems|0
4436037|NCT00424346|7219653|FG002|Core Study|Administrative Problems|1
4436038|NCT00424346|7219654|FG003|Core Study|Administrative Problems|0
4436039|NCT00424346|7219651|FG000|Core Study|Protocol Violation|0
4436040|NCT00424346|7219652|FG001|Core Study|Protocol Violation|0
4436041|NCT00424346|7219653|FG002|Core Study|Protocol Violation|2
4436042|NCT00424346|7219654|FG003|Core Study|Protocol Violation|0
4436043|NCT00424346|7219651|FG000|Extension Phase|Adverse Event|0
4436044|NCT00424346|7219652|FG001|Extension Phase|Adverse Event|9
4436045|NCT00424346|7219653|FG002|Extension Phase|Adverse Event|5
4436046|NCT00424346|7219654|FG003|Extension Phase|Adverse Event|4
4436047|NCT00424346|7219651|FG000|Extension Phase|Lack of Efficacy|0
4436048|NCT00424346|7219652|FG001|Extension Phase|Lack of Efficacy|16
4436049|NCT00424346|7219653|FG002|Extension Phase|Lack of Efficacy|14
4436050|NCT00424346|7219654|FG003|Extension Phase|Lack of Efficacy|11
4436051|NCT00424346|7219651|FG000|Extension Phase|Withdrawal by Subject|0
4436052|NCT00424346|7219652|FG001|Extension Phase|Withdrawal by Subject|5
4436053|NCT00424346|7219653|FG002|Extension Phase|Withdrawal by Subject|3
4436054|NCT00424346|7219654|FG003|Extension Phase|Withdrawal by Subject|4
4436055|NCT00424346|7219651|FG000|Extension Phase|Lost to Follow-up|0
4436056|NCT00424346|7219652|FG001|Extension Phase|Lost to Follow-up|2
4436057|NCT00424346|7219653|FG002|Extension Phase|Lost to Follow-up|0
4436058|NCT00424346|7219654|FG003|Extension Phase|Lost to Follow-up|0
4436059|NCT00424346|7219651|FG000|Extension Phase|Administrative Problems|0
4436060|NCT00424346|7219652|FG001|Extension Phase|Administrative Problems|69
4436061|NCT00424346|7219653|FG002|Extension Phase|Administrative Problems|32
4436062|NCT00424346|7219654|FG003|Extension Phase|Administrative Problems|35
4436063|NCT00424346|7219651|FG000|Extension Phase|Death|0
4436064|NCT00424346|7219652|FG001|Extension Phase|Death|0
4436065|NCT00424346|7219653|FG002|Extension Phase|Death|0
4436066|NCT00424346|7219654|FG003|Extension Phase|Death|1
4436067|NCT00424346|7219651|FG000|Extension Phase|Protocol Violation|0
4436068|NCT00424346|7219652|FG001|Extension Phase|Protocol Violation|1
4436069|NCT00424346|7219653|FG002|Extension Phase|Protocol Violation|1
4436070|NCT00424346|7219654|FG003|Extension Phase|Protocol Violation|0
4436071|NCT00424372|7219667|FG000|Overall Study|Death|1
4436072|NCT00424372|7219667|FG000|Overall Study|Adverse Event|18
4436073|NCT00424372|7219667|FG000|Overall Study|Lack of Efficacy|6
4436074|NCT00424372|7219667|FG000|Overall Study|Withdrawal by Subject|4
4436075|NCT00424372|7219667|FG000|Overall Study|Protocol Violation|1
4436076|NCT00424372|7219667|FG000|Overall Study|Health deterioration|1
4436077|NCT00424385|7219671|FG000|Cohort 0|Withdrawal by Subject|5
4436078|NCT00424385|7219671|FG000|Cohort 0|Physician Decision|1
4436079|NCT00424385|7219671|FG000|Cohort 1|Withdrawal by Subject|1
4436080|NCT00424398|7219680|FG000|Overall Study|Withdrawal by Subject|2
4436081|NCT00424398|7219681|FG001|Overall Study|Withdrawal by Subject|1
4436082|NCT00424398|7219682|FG002|Overall Study|Withdrawal by Subject|0
4436083|NCT00424398|7219680|FG000|Overall Study|Subject met exclusion criteria|1
4436084|NCT00424398|7219681|FG001|Overall Study|Subject met exclusion criteria|0
4436085|NCT00424398|7219682|FG002|Overall Study|Subject met exclusion criteria|0
4436086|NCT00424463|7219693|FG000|Overall Study|Adverse Event|2
4436087|NCT00424463|7219694|FG001|Overall Study|Adverse Event|3
4436088|NCT00424463|7219695|FG002|Overall Study|Adverse Event|2
4436089|NCT00424463|7219693|FG000|Overall Study|Physician Decision|0
4436090|NCT00424463|7219694|FG001|Overall Study|Physician Decision|2
4436091|NCT00424463|7219695|FG002|Overall Study|Physician Decision|2
4436092|NCT00424463|7219693|FG000|Overall Study|Withdrawal by Subject|4
4436093|NCT00424463|7219694|FG001|Overall Study|Withdrawal by Subject|2
4436094|NCT00424463|7219695|FG002|Overall Study|Withdrawal by Subject|5
4436095|NCT00424463|7219693|FG000|Overall Study|Tracheotomy due to worsening of ALS|1
4436096|NCT00424463|7219694|FG001|Overall Study|Tracheotomy due to worsening of ALS|7
4436097|NCT00424463|7219695|FG002|Overall Study|Tracheotomy due to worsening of ALS|6
4436098|NCT00424463|7219693|FG000|Overall Study|Patient's convenience|0
4436099|NCT00424463|7219694|FG001|Overall Study|Patient's convenience|0
4436100|NCT00424463|7219695|FG002|Overall Study|Patient's convenience|1
4436101|NCT00424476|7219706|FG000|Overall Study|Withdrawal by Subject|7
4436102|NCT00424476|7219707|FG001|Overall Study|Withdrawal by Subject|6
4436103|NCT00424476|7219708|FG002|Overall Study|Withdrawal by Subject|3
4436104|NCT00424476|7219706|FG000|Overall Study|Adverse Event|19
4436105|NCT00424476|7219707|FG001|Overall Study|Adverse Event|16
4436106|NCT00424476|7219708|FG002|Overall Study|Adverse Event|15
4436107|NCT00424476|7219706|FG000|Overall Study|Lack of Efficacy|16
4436108|NCT00424476|7219707|FG001|Overall Study|Lack of Efficacy|12
4436109|NCT00424476|7219708|FG002|Overall Study|Lack of Efficacy|12
4436110|NCT00424476|7219706|FG000|Overall Study|Lack of Compliance|1
4436111|NCT00424476|7219707|FG001|Overall Study|Lack of Compliance|1
4436112|NCT00424476|7219708|FG002|Overall Study|Lack of Compliance|1
4436113|NCT00424476|7219706|FG000|Overall Study|Lost to Follow-up|4
4436114|NCT00424476|7219707|FG001|Overall Study|Lost to Follow-up|6
4436115|NCT00424476|7219708|FG002|Overall Study|Lost to Follow-up|3
4436116|NCT00424476|7219706|FG000|Overall Study|Protocol Violation|7
4436117|NCT00424476|7219707|FG001|Overall Study|Protocol Violation|2
4436118|NCT00424476|7219708|FG002|Overall Study|Protocol Violation|3
4630230|NCT02362503|7498807|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0
4630231|NCT02362503|7498805|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3
4630232|NCT02362503|7498806|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8
4630233|NCT02362503|7498807|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6
4436119|NCT00424476|7219706|FG000|Overall Study|Physician Decision|3
4436120|NCT00424476|7219707|FG001|Overall Study|Physician Decision|2
4436121|NCT00424476|7219708|FG002|Overall Study|Physician Decision|3
4436122|NCT00424476|7219706|FG000|Overall Study|Other|4
4436123|NCT00424476|7219707|FG001|Overall Study|Other|3
4436124|NCT00424476|7219708|FG002|Overall Study|Other|9
4436125|NCT00424489|7219716|FG000|Overall Study|Death|3
4436126|NCT00424515|7219726|FG000|Overall Study|Progressive Disease|10
4436127|NCT00424515|7219727|FG001|Overall Study|Progressive Disease|11
4436128|NCT00424515|7219726|FG000|Overall Study|Adverse Event|0
4436129|NCT00424515|7219727|FG001|Overall Study|Adverse Event|1
4436130|NCT00424515|7219726|FG000|Overall Study|Intercurrent Illness|0
4590475|NCT01521923|7436510|FG000|Overall Study|Protocol Violation|0
4436131|NCT00424515|7219727|FG001|Overall Study|Intercurrent Illness|1
4436132|NCT00424515|7219726|FG000|Overall Study|Withdrawal by Subject|1
4436133|NCT00424515|7219727|FG001|Overall Study|Withdrawal by Subject|0
4590476|NCT01521923|7436511|FG001|Overall Study|Protocol Violation|0
4590477|NCT01521923|7436512|FG002|Overall Study|Protocol Violation|1
4590478|NCT01521923|7436513|FG003|Overall Study|Protocol Violation|0
4590479|NCT01521923|7436510|FG000|Overall Study|Lost to Follow-up|1
4590480|NCT01521923|7436511|FG001|Overall Study|Lost to Follow-up|0
4590481|NCT01521923|7436512|FG002|Overall Study|Lost to Follow-up|2
4590482|NCT01521923|7436513|FG003|Overall Study|Lost to Follow-up|1
4590483|NCT01521923|7436510|FG000|Overall Study|Withdrawal by Subject|1
4590484|NCT01521923|7436511|FG001|Overall Study|Withdrawal by Subject|1
4590485|NCT01521923|7436512|FG002|Overall Study|Withdrawal by Subject|1
4590486|NCT01521923|7436513|FG003|Overall Study|Withdrawal by Subject|2
4590487|NCT01521923|7436510|FG000|Overall Study|Other|2
4436134|NCT00424528|7219736|FG000|Overall Study|Adverse Event|2
4436135|NCT00424528|7219737|FG001|Overall Study|Adverse Event|1
4436136|NCT00424528|7219738|FG002|Overall Study|Adverse Event|2
4436137|NCT00424528|7219736|FG000|Overall Study|Protocol Violation|1
4436138|NCT00424528|7219737|FG001|Overall Study|Protocol Violation|1
4590488|NCT01521923|7436511|FG001|Overall Study|Other|1
4590489|NCT01521923|7436512|FG002|Overall Study|Other|3
4436139|NCT00424528|7219738|FG002|Overall Study|Protocol Violation|0
4436140|NCT00424528|7219736|FG000|Overall Study|Lost to Follow-up|0
4436141|NCT00424528|7219737|FG001|Overall Study|Lost to Follow-up|1
4436142|NCT00424528|7219738|FG002|Overall Study|Lost to Follow-up|0
4436143|NCT00424528|7219736|FG000|Overall Study|noncompliance with study requirements|2
4436144|NCT00424528|7219737|FG001|Overall Study|noncompliance with study requirements|1
4436145|NCT00424528|7219738|FG002|Overall Study|noncompliance with study requirements|2
4436146|NCT00424593|7219757|FG000|Acute Double-Blind Period|Adverse Event|16
4436147|NCT00424593|7219758|FG001|Acute Double-Blind Period|Adverse Event|7
4436148|NCT00424593|7219757|FG000|Acute Double-Blind Period|Withdrawal by Subject|11
4436149|NCT00424593|7219758|FG001|Acute Double-Blind Period|Withdrawal by Subject|10
4436150|NCT00424593|7219757|FG000|Acute Double-Blind Period|Protocol Violation|2
4436151|NCT00424593|7219758|FG001|Acute Double-Blind Period|Protocol Violation|2
4436152|NCT00424593|7219757|FG000|Acute Double-Blind Period|Physician Decision|1
4436153|NCT00424593|7219758|FG001|Acute Double-Blind Period|Physician Decision|2
4436154|NCT00424593|7219757|FG000|Acute Double-Blind Period|Lost to Follow-up|1
4436155|NCT00424593|7219758|FG001|Acute Double-Blind Period|Lost to Follow-up|1
4436156|NCT00424593|7219757|FG000|Acute Double-Blind Period|Lack of Efficacy|0
4436157|NCT00424593|7219758|FG001|Acute Double-Blind Period|Lack of Efficacy|1
4436158|NCT00424593|7219757|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19
4436159|NCT00424593|7219758|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0
4436160|NCT00424593|7219757|FG000|Dose-Blind Extension Period|Adverse Event|18
4436161|NCT00424593|7219758|FG001|Dose-Blind Extension Period|Adverse Event|0
4630234|NCT02362503|7498805|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4
4630235|NCT02362503|7498806|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3
4436162|NCT00424593|7219757|FG000|Dose-Blind Extension Period|Lack of Efficacy|9
4436163|NCT00424593|7219758|FG001|Dose-Blind Extension Period|Lack of Efficacy|0
4436164|NCT00424593|7219757|FG000|Dose-Blind Extension Period|Protocol Violation|9
4436165|NCT00424593|7219758|FG001|Dose-Blind Extension Period|Protocol Violation|0
4436166|NCT00424593|7219757|FG000|Dose-Blind Extension Period|Lost to Follow-up|6
4436167|NCT00424593|7219758|FG001|Dose-Blind Extension Period|Lost to Follow-up|0
4436168|NCT00424593|7219757|FG000|Dose-Blind Extension Period|Physician Decision|3
4436169|NCT00424593|7219758|FG001|Dose-Blind Extension Period|Physician Decision|0
4436170|NCT00424632|7219779|FG000|Overall Study|Death|0
4436171|NCT00424632|7219780|FG001|Overall Study|Death|0
4436172|NCT00424632|7219781|FG002|Overall Study|Death|0
4436173|NCT00424632|7219782|FG003|Overall Study|Death|0
4436174|NCT00424632|7219783|FG004|Overall Study|Death|0
4436175|NCT00424632|7219784|FG005|Overall Study|Death|2
4436176|NCT00424632|7219785|FG006|Overall Study|Death|0
4436177|NCT00424632|7219786|FG007|Overall Study|Death|0
4436178|NCT00424632|7219787|FG008|Overall Study|Death|0
4436179|NCT00424632|7219788|FG009|Overall Study|Death|0
4436180|NCT00424632|7219779|FG000|Overall Study|Adverse Event|0
4436181|NCT00424632|7219780|FG001|Overall Study|Adverse Event|0
4436182|NCT00424632|7219781|FG002|Overall Study|Adverse Event|0
4436183|NCT00424632|7219782|FG003|Overall Study|Adverse Event|0
4436184|NCT00424632|7219783|FG004|Overall Study|Adverse Event|0
4436185|NCT00424632|7219784|FG005|Overall Study|Adverse Event|0
4436186|NCT00424632|7219785|FG006|Overall Study|Adverse Event|0
4436187|NCT00424632|7219786|FG007|Overall Study|Adverse Event|0
4436188|NCT00424632|7219787|FG008|Overall Study|Adverse Event|3
4436189|NCT00424632|7219788|FG009|Overall Study|Adverse Event|2
4436190|NCT00424632|7219779|FG000|Overall Study|Global deterioration of health status|0
4436191|NCT00424632|7219780|FG001|Overall Study|Global deterioration of health status|0
4436192|NCT00424632|7219781|FG002|Overall Study|Global deterioration of health status|0
4436193|NCT00424632|7219782|FG003|Overall Study|Global deterioration of health status|1
4436194|NCT00424632|7219783|FG004|Overall Study|Global deterioration of health status|1
4436195|NCT00424632|7219784|FG005|Overall Study|Global deterioration of health status|0
4436196|NCT00424632|7219785|FG006|Overall Study|Global deterioration of health status|0
4436197|NCT00424632|7219786|FG007|Overall Study|Global deterioration of health status|0
4436198|NCT00424632|7219787|FG008|Overall Study|Global deterioration of health status|0
4436199|NCT00424632|7219788|FG009|Overall Study|Global deterioration of health status|0
4436200|NCT00424632|7219779|FG000|Overall Study|Objective progression or relapse|1
4436201|NCT00424632|7219780|FG001|Overall Study|Objective progression or relapse|1
4436202|NCT00424632|7219781|FG002|Overall Study|Objective progression or relapse|1
4436203|NCT00424632|7219782|FG003|Overall Study|Objective progression or relapse|2
4436204|NCT00424632|7219783|FG004|Overall Study|Objective progression or relapse|2
4436205|NCT00424632|7219784|FG005|Overall Study|Objective progression or relapse|13
4436206|NCT00424632|7219785|FG006|Overall Study|Objective progression or relapse|7
4630236|NCT02362503|7498807|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1
4630237|NCT02362503|7498805|FG000|Open Label Period-Up to 96 Weeks|Death|1
4436207|NCT00424632|7219786|FG007|Overall Study|Objective progression or relapse|3
4436208|NCT00424632|7219787|FG008|Overall Study|Objective progression or relapse|12
4436209|NCT00424632|7219788|FG009|Overall Study|Objective progression or relapse|4
4436210|NCT00424632|7219779|FG000|Overall Study|Other|0
4436211|NCT00424632|7219780|FG001|Overall Study|Other|0
4436212|NCT00424632|7219781|FG002|Overall Study|Other|0
4436213|NCT00424632|7219782|FG003|Overall Study|Other|1
4436214|NCT00424632|7219783|FG004|Overall Study|Other|0
4436215|NCT00424632|7219784|FG005|Overall Study|Other|0
4436216|NCT00424632|7219785|FG006|Overall Study|Other|0
4436217|NCT00424632|7219786|FG007|Overall Study|Other|0
4436218|NCT00424632|7219787|FG008|Overall Study|Other|1
4436219|NCT00424632|7219788|FG009|Overall Study|Other|0
4436220|NCT00424749|7219819|FG000|Overall Study|Withdrawal by Subject|1
4436221|NCT00424762|7219825|FG000|Overall Study|Withdrawal by Subject|18
4436222|NCT00424762|7219826|FG001|Overall Study|Withdrawal by Subject|19
4436223|NCT00424762|7219825|FG000|Overall Study|Lost to Follow-up|2
4436224|NCT00424762|7219826|FG001|Overall Study|Lost to Follow-up|3
4436225|NCT00424775|7219832|FG000|Overall Study|Adverse Event|2
4436226|NCT00424775|7219833|FG001|Overall Study|Adverse Event|0
4436227|NCT00424775|7219832|FG000|Overall Study|Lack of Efficacy|1
4436228|NCT00424775|7219833|FG001|Overall Study|Lack of Efficacy|0
4436229|NCT00424827|7219837|FG000|Overall Study|Adverse Event|1
4436230|NCT00425061|7219857|FG000|Overall Study|Adverse Event|1
4436231|NCT00425061|7219858|FG001|Overall Study|Adverse Event|0
4436232|NCT00425061|7219859|FG002|Overall Study|Adverse Event|0
4436233|NCT00425061|7219860|FG003|Overall Study|Adverse Event|2
4436234|NCT00425061|7219861|FG004|Overall Study|Adverse Event|2
4436235|NCT00425061|7219862|FG005|Overall Study|Adverse Event|0
4436236|NCT00425061|7219863|FG006|Overall Study|Adverse Event|0
4436237|NCT00425061|7219857|FG000|Overall Study|Lost to Follow-up|0
4436238|NCT00425061|7219858|FG001|Overall Study|Lost to Follow-up|1
4436239|NCT00425061|7219859|FG002|Overall Study|Lost to Follow-up|0
4436240|NCT00425061|7219860|FG003|Overall Study|Lost to Follow-up|0
4436241|NCT00425061|7219861|FG004|Overall Study|Lost to Follow-up|0
4436242|NCT00425061|7219862|FG005|Overall Study|Lost to Follow-up|0
4436243|NCT00425061|7219863|FG006|Overall Study|Lost to Follow-up|0
4436244|NCT00425061|7219857|FG000|Overall Study|Protocol Violation|1
4436245|NCT00425061|7219858|FG001|Overall Study|Protocol Violation|0
4436246|NCT00425061|7219859|FG002|Overall Study|Protocol Violation|0
4436247|NCT00425061|7219860|FG003|Overall Study|Protocol Violation|0
4436248|NCT00425061|7219861|FG004|Overall Study|Protocol Violation|0
4436249|NCT00425061|7219862|FG005|Overall Study|Protocol Violation|0
4436250|NCT00425061|7219863|FG006|Overall Study|Protocol Violation|0
4436251|NCT00425061|7219857|FG000|Overall Study|Withdrawal by Subject|0
4436252|NCT00425061|7219858|FG001|Overall Study|Withdrawal by Subject|1
4436253|NCT00425061|7219859|FG002|Overall Study|Withdrawal by Subject|0
4436254|NCT00425061|7219860|FG003|Overall Study|Withdrawal by Subject|0
4436255|NCT00425061|7219861|FG004|Overall Study|Withdrawal by Subject|1
4436256|NCT00425061|7219862|FG005|Overall Study|Withdrawal by Subject|0
4436257|NCT00425061|7219863|FG006|Overall Study|Withdrawal by Subject|3
4436258|NCT00425061|7219857|FG000|Overall Study|Sponsor's request|0
4436259|NCT00425061|7219858|FG001|Overall Study|Sponsor's request|0
4436260|NCT00425061|7219859|FG002|Overall Study|Sponsor's request|0
4436261|NCT00425061|7219860|FG003|Overall Study|Sponsor's request|0
4436262|NCT00425061|7219861|FG004|Overall Study|Sponsor's request|19
4436263|NCT00425061|7219862|FG005|Overall Study|Sponsor's request|4
4436264|NCT00425061|7219863|FG006|Overall Study|Sponsor's request|15
4436265|NCT00425061|7219857|FG000|Overall Study|Physician Decision|0
4436266|NCT00425061|7219858|FG001|Overall Study|Physician Decision|0
4436267|NCT00425061|7219859|FG002|Overall Study|Physician Decision|0
4436268|NCT00425061|7219860|FG003|Overall Study|Physician Decision|0
4436269|NCT00425061|7219861|FG004|Overall Study|Physician Decision|1
4436270|NCT00425061|7219862|FG005|Overall Study|Physician Decision|0
4436271|NCT00425061|7219863|FG006|Overall Study|Physician Decision|0
4436272|NCT00425061|7219857|FG000|Overall Study|Other|0
4436273|NCT00425061|7219858|FG001|Overall Study|Other|0
4436274|NCT00425061|7219859|FG002|Overall Study|Other|0
4436275|NCT00425061|7219860|FG003|Overall Study|Other|0
4436276|NCT00425061|7219861|FG004|Overall Study|Other|3
4436277|NCT00425061|7219862|FG005|Overall Study|Other|0
4436278|NCT00425061|7219863|FG006|Overall Study|Other|1
4436279|NCT00425113|7219883|FG000|Overall Study|uncontrolled diabetes mellitus|1
4436280|NCT00425113|7219884|FG001|Overall Study|uncontrolled diabetes mellitus|0
4436281|NCT00425113|7219883|FG000|Overall Study|diagnosis of abdominal TB|0
4436282|NCT00425113|7219884|FG001|Overall Study|diagnosis of abdominal TB|1
4436283|NCT00425113|7219883|FG000|Overall Study|missing study drug more than 14 days|0
4436284|NCT00425113|7219884|FG001|Overall Study|missing study drug more than 14 days|1
4436285|NCT00425113|7219883|FG000|Overall Study|Withdrawal by Subject|1
4436286|NCT00425113|7219884|FG001|Overall Study|Withdrawal by Subject|0
4436287|NCT00425269|7219893|FG000|Overall Study|Pregnancy|5
4436288|NCT00425269|7219894|FG001|Overall Study|Pregnancy|7
4436289|NCT00425269|7219893|FG000|Overall Study|Lost to Follow-up|9
4436290|NCT00425269|7219894|FG001|Overall Study|Lost to Follow-up|9
4436291|NCT00425269|7219893|FG000|Overall Study|moved or medical reason|5
4436292|NCT00425269|7219894|FG001|Overall Study|moved or medical reason|4
4436293|NCT00425308|7219902|FG000|Overall Study|Adverse Event|2
4436294|NCT00425308|7219903|FG001|Overall Study|Adverse Event|1
4436295|NCT00425308|7219902|FG000|Overall Study|Withdrawal by Subject|1
4436296|NCT00425308|7219903|FG001|Overall Study|Withdrawal by Subject|0
4436297|NCT00425308|7219902|FG000|Overall Study|Death|1
4436298|NCT00425308|7219903|FG001|Overall Study|Death|0
4436299|NCT00425373|7219918|FG000|Overall Study|Adverse Event|2
4436300|NCT00425373|7219919|FG001|Overall Study|Adverse Event|2
4436301|NCT00425373|7219920|FG002|Overall Study|Adverse Event|0
4436302|NCT00425373|7219921|FG003|Overall Study|Adverse Event|1
4436303|NCT00425373|7219922|FG004|Overall Study|Adverse Event|4
4436304|NCT00425373|7219923|FG005|Overall Study|Adverse Event|6
4436305|NCT00425373|7219924|FG006|Overall Study|Adverse Event|2
4436306|NCT00425373|7219925|FG007|Overall Study|Adverse Event|3
4436307|NCT00425373|7219926|FG008|Overall Study|Adverse Event|8
4436308|NCT00425373|7219918|FG000|Overall Study|Lost to Follow-up|0
4436309|NCT00425373|7219919|FG001|Overall Study|Lost to Follow-up|1
4436310|NCT00425373|7219920|FG002|Overall Study|Lost to Follow-up|0
4436311|NCT00425373|7219921|FG003|Overall Study|Lost to Follow-up|0
4436312|NCT00425373|7219922|FG004|Overall Study|Lost to Follow-up|1
4436313|NCT00425373|7219923|FG005|Overall Study|Lost to Follow-up|0
4436314|NCT00425373|7219924|FG006|Overall Study|Lost to Follow-up|0
4436315|NCT00425373|7219925|FG007|Overall Study|Lost to Follow-up|0
4436316|NCT00425373|7219926|FG008|Overall Study|Lost to Follow-up|0
4436317|NCT00425373|7219918|FG000|Overall Study|Protocol Violation|1
4436318|NCT00425373|7219919|FG001|Overall Study|Protocol Violation|0
4436319|NCT00425373|7219920|FG002|Overall Study|Protocol Violation|1
4436320|NCT00425373|7219921|FG003|Overall Study|Protocol Violation|0
4436321|NCT00425373|7219922|FG004|Overall Study|Protocol Violation|0
4436322|NCT00425373|7219923|FG005|Overall Study|Protocol Violation|0
4436323|NCT00425373|7219924|FG006|Overall Study|Protocol Violation|0
4436324|NCT00425373|7219925|FG007|Overall Study|Protocol Violation|5
4436325|NCT00425373|7219926|FG008|Overall Study|Protocol Violation|3
4436326|NCT00425373|7219918|FG000|Overall Study|Withdrawal by Subject|2
4436327|NCT00425373|7219919|FG001|Overall Study|Withdrawal by Subject|0
4436328|NCT00425373|7219920|FG002|Overall Study|Withdrawal by Subject|2
4436329|NCT00425373|7219921|FG003|Overall Study|Withdrawal by Subject|1
4436330|NCT00425373|7219922|FG004|Overall Study|Withdrawal by Subject|4
4436331|NCT00425373|7219923|FG005|Overall Study|Withdrawal by Subject|0
4436332|NCT00425373|7219924|FG006|Overall Study|Withdrawal by Subject|2
4436333|NCT00425373|7219925|FG007|Overall Study|Withdrawal by Subject|2
4436334|NCT00425373|7219926|FG008|Overall Study|Withdrawal by Subject|2
4436335|NCT00425373|7219918|FG000|Overall Study|Lack of Efficacy|0
4436336|NCT00425373|7219919|FG001|Overall Study|Lack of Efficacy|0
4436337|NCT00425373|7219920|FG002|Overall Study|Lack of Efficacy|0
4436338|NCT00425373|7219921|FG003|Overall Study|Lack of Efficacy|0
4436339|NCT00425373|7219922|FG004|Overall Study|Lack of Efficacy|1
4436340|NCT00425373|7219923|FG005|Overall Study|Lack of Efficacy|3
4436341|NCT00425373|7219924|FG006|Overall Study|Lack of Efficacy|3
4436342|NCT00425373|7219925|FG007|Overall Study|Lack of Efficacy|0
4436343|NCT00425373|7219926|FG008|Overall Study|Lack of Efficacy|5
4512760|NCT00937521|7322822|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
4512761|NCT00937521|7322823|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
4512762|NCT00937521|7322824|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1
4512763|NCT00937521|7322825|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1
4512764|NCT00937521|7322826|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
4512765|NCT00937521|7322827|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
4512766|NCT00937521|7322828|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
4512767|NCT00937521|7322829|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
4512768|NCT00937521|7322822|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
4512769|NCT00937521|7322823|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4
4512770|NCT00937521|7322824|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
4512771|NCT00937521|7322825|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
4512772|NCT00937521|7322826|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2
4512773|NCT00937521|7322827|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1
4512774|NCT00937521|7322828|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1
4512775|NCT00937521|7322829|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
4512776|NCT00937521|7322822|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1
4512777|NCT00937521|7322823|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0
4512778|NCT00937521|7322824|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0
4512779|NCT00937521|7322825|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0
4512780|NCT00937521|7322826|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0
4512781|NCT00937521|7322827|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0
4512782|NCT00937521|7322828|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1
4512783|NCT00937521|7322829|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0
4512784|NCT00937521|7322822|FG000|Booster Phase|Adverse Event|0
4512785|NCT00937521|7322823|FG001|Booster Phase|Adverse Event|0
4512786|NCT00937521|7322824|FG002|Booster Phase|Adverse Event|0
4512787|NCT00937521|7322825|FG003|Booster Phase|Adverse Event|0
4512788|NCT00937521|7322826|FG004|Booster Phase|Adverse Event|0
4512789|NCT00937521|7322827|FG005|Booster Phase|Adverse Event|0
4512790|NCT00937521|7322828|FG006|Booster Phase|Adverse Event|1
4512791|NCT00937521|7322829|FG007|Booster Phase|Adverse Event|0
4512792|NCT00937521|7322822|FG000|Booster Phase|Withdrawal by Subject|1
4512793|NCT00937521|7322823|FG001|Booster Phase|Withdrawal by Subject|0
4512794|NCT00937521|7322824|FG002|Booster Phase|Withdrawal by Subject|0
4512795|NCT00937521|7322825|FG003|Booster Phase|Withdrawal by Subject|1
4512796|NCT00937521|7322826|FG004|Booster Phase|Withdrawal by Subject|0
4512797|NCT00937521|7322827|FG005|Booster Phase|Withdrawal by Subject|0
4512798|NCT00937521|7322828|FG006|Booster Phase|Withdrawal by Subject|0
4512799|NCT00937521|7322829|FG007|Booster Phase|Withdrawal by Subject|2
4436344|NCT00425503|7219954|FG000|Overall Study|Adverse Event|2
4436345|NCT00425503|7219954|FG000|Overall Study|Protocol Violation|1
4436346|NCT00425555|7219960|FG000|Overall Study|Withdrawal by Subject|11
4436347|NCT00425555|7219961|FG001|Overall Study|Withdrawal by Subject|8
4436348|NCT00425555|7219960|FG000|Overall Study|Lost to Follow-up|0
4436349|NCT00425555|7219961|FG001|Overall Study|Lost to Follow-up|1
4436350|NCT00425555|7219960|FG000|Overall Study|Administrative problems|3
4436351|NCT00425555|7219961|FG001|Overall Study|Administrative problems|0
4436352|NCT00425555|7219960|FG000|Overall Study|Death|1
4436353|NCT00425555|7219961|FG001|Overall Study|Death|2
4436354|NCT00425555|7219960|FG000|Overall Study|New cancer therapy|2
4436355|NCT00425555|7219961|FG001|Overall Study|New cancer therapy|1
4436356|NCT00425555|7219960|FG000|Overall Study|Disease progression|36
4436357|NCT00425555|7219961|FG001|Overall Study|Disease progression|33
4436358|NCT00425555|7219960|FG000|Overall Study|Adverse Event|25
4436359|NCT00425555|7219961|FG001|Overall Study|Adverse Event|15
4436360|NCT00425555|7219960|FG000|Overall Study|Protocol Violation|1
4436361|NCT00425555|7219961|FG001|Overall Study|Protocol Violation|0
4436362|NCT00425607|7219970|FG000|Overall Study|Death|1
4436363|NCT00425607|7219970|FG000|Overall Study|Withdrawal by Subject|1
4436364|NCT00425698|7219980|FG000|Overall Study|Adverse Event|3
4436365|NCT00425698|7219981|FG001|Overall Study|Adverse Event|1
4436366|NCT00425698|7219980|FG000|Overall Study|Withdrawal by Subject|0
4436367|NCT00425698|7219981|FG001|Overall Study|Withdrawal by Subject|1
4436368|NCT00425750|7219987|FG000|Overall Study|Death|1
4436369|NCT00425750|7219987|FG000|Overall Study|Withdrawal by Subject|3
4436370|NCT00425750|7219987|FG000|Overall Study|Adverse Event|3
4436371|NCT00425750|7219987|FG000|Overall Study|Progression of disease|18
4436372|NCT00425854|7219997|FG000|Overall Study|Progressive Disease|19
4436373|NCT00425854|7219998|FG001|Overall Study|Progressive Disease|12
4436374|NCT00425854|7219997|FG000|Overall Study|Dose reduction toxicity AE|8
4436375|NCT00425854|7219998|FG001|Overall Study|Dose reduction toxicity AE|7
4436376|NCT00425854|7219997|FG000|Overall Study|Other Adverse Event|2
4436377|NCT00425854|7219998|FG001|Overall Study|Other Adverse Event|2
4436378|NCT00425945|7220007|FG000|Overall Study|Concern about Supplement|2
4436379|NCT00425945|7220008|FG001|Overall Study|Concern about Supplement|0
4436380|NCT00425945|7220007|FG000|Overall Study|Inconvenience|0
4436381|NCT00425945|7220008|FG001|Overall Study|Inconvenience|2
4436382|NCT00425945|7220007|FG000|Overall Study|Lost to Follow-up|0
4436383|NCT00425945|7220008|FG001|Overall Study|Lost to Follow-up|2
4436384|NCT00425945|7220007|FG000|Overall Study|Began hypertension medication|1
4436385|NCT00425945|7220008|FG001|Overall Study|Began hypertension medication|0
4436386|NCT00425945|7220007|FG000|Overall Study|Began cancer treatments|1
4436387|NCT00425945|7220008|FG001|Overall Study|Began cancer treatments|0
4436388|NCT00425945|7220007|FG000|Overall Study|Moved from area|0
4436389|NCT00425945|7220008|FG001|Overall Study|Moved from area|1
4436390|NCT00426127|7220016|FG000|Overall Study|Adverse Event|1
4436391|NCT00426127|7220016|FG000|Overall Study|Removed due to disease progression|1
4436392|NCT00426231|7220031|FG000|Overall Study|Withdrawal by Subject|9
4436393|NCT00426231|7220032|FG001|Overall Study|Withdrawal by Subject|12
4436394|NCT00426270|7220038|FG000|Overall Study|Incorrectly Enrolled in the Study|1
4436395|NCT00426270|7220038|FG000|Overall Study|Adverse Event|5
4436396|NCT00426361|7220058|FG000|Overall Study|Lost to Follow-up|3
4436397|NCT00426361|7220059|FG001|Overall Study|Lost to Follow-up|2
4436398|NCT00426361|7220060|FG002|Overall Study|Lost to Follow-up|5
4436399|NCT00426361|7220058|FG000|Overall Study|Withdrawal by Subject|1
4436400|NCT00426361|7220059|FG001|Overall Study|Withdrawal by Subject|3
4436401|NCT00426361|7220060|FG002|Overall Study|Withdrawal by Subject|0
4436402|NCT00426556|7220089|FG000|Phase I - Core Phase|Disease Progression|0
4436403|NCT00426556|7220090|FG001|Phase I - Core Phase|Disease Progression|6
4436404|NCT00426556|7220091|FG002|Phase I - Core Phase|Disease Progression|2
4436405|NCT00426556|7220092|FG003|Phase I - Core Phase|Disease Progression|0
4436406|NCT00426556|7220089|FG000|Phase I - Core Phase|Adverse Event|1
4436407|NCT00426556|7220090|FG001|Phase I - Core Phase|Adverse Event|3
4436408|NCT00426556|7220091|FG002|Phase I - Core Phase|Adverse Event|1
4436409|NCT00426556|7220092|FG003|Phase I - Core Phase|Adverse Event|0
4436410|NCT00426556|7220089|FG000|Phase I - Core Phase|Death|0
4436411|NCT00426556|7220090|FG001|Phase I - Core Phase|Death|1
4436412|NCT00426556|7220091|FG002|Phase I - Core Phase|Death|0
4436413|NCT00426556|7220092|FG003|Phase I - Core Phase|Death|0
4436414|NCT00426556|7220089|FG000|Phase I - Extension Phase|Adverse Event|0
4436415|NCT00426556|7220090|FG001|Phase I - Extension Phase|Adverse Event|1
4436416|NCT00426556|7220091|FG002|Phase I - Extension Phase|Adverse Event|1
4436417|NCT00426556|7220092|FG003|Phase I - Extension Phase|Adverse Event|0
4436418|NCT00426556|7220089|FG000|Phase I - Extension Phase|Disease Progression|5
4436419|NCT00426556|7220090|FG001|Phase I - Extension Phase|Disease Progression|5
4436420|NCT00426556|7220091|FG002|Phase I - Extension Phase|Disease Progression|6
4436421|NCT00426556|7220092|FG003|Phase I - Extension Phase|Disease Progression|0
4436422|NCT00426556|7220089|FG000|Phase II - Core Phase|Withdrawal by Subject|0
4436423|NCT00426556|7220090|FG001|Phase II - Core Phase|Withdrawal by Subject|0
4436424|NCT00426556|7220091|FG002|Phase II - Core Phase|Withdrawal by Subject|0
4436425|NCT00426556|7220092|FG003|Phase II - Core Phase|Withdrawal by Subject|3
4436426|NCT00426556|7220089|FG000|Phase II - Core Phase|Disease Progression|0
4436427|NCT00426556|7220090|FG001|Phase II - Core Phase|Disease Progression|0
4436428|NCT00426556|7220091|FG002|Phase II - Core Phase|Disease Progression|0
4436429|NCT00426556|7220092|FG003|Phase II - Core Phase|Disease Progression|16
4436430|NCT00426556|7220089|FG000|Phase II - Core Phase|Adverse Event|0
4436431|NCT00426556|7220090|FG001|Phase II - Core Phase|Adverse Event|0
4436432|NCT00426556|7220091|FG002|Phase II - Core Phase|Adverse Event|0
4436433|NCT00426556|7220092|FG003|Phase II - Core Phase|Adverse Event|8
4436434|NCT00426556|7220089|FG000|Phase II - Extension Phase|Disease Progression|0
4436435|NCT00426556|7220090|FG001|Phase II - Extension Phase|Disease Progression|0
4436436|NCT00426556|7220091|FG002|Phase II - Extension Phase|Disease Progression|0
4436437|NCT00426556|7220092|FG003|Phase II - Extension Phase|Disease Progression|21
4436438|NCT00426556|7220089|FG000|Phase II - Extension Phase|Adverse Event|0
4436439|NCT00426556|7220090|FG001|Phase II - Extension Phase|Adverse Event|0
4436440|NCT00426556|7220091|FG002|Phase II - Extension Phase|Adverse Event|0
4436441|NCT00426556|7220092|FG003|Phase II - Extension Phase|Adverse Event|2
4436442|NCT00426660|7220102|FG000|Overall Study|Death|14
4436443|NCT00426660|7220102|FG000|Overall Study|Adverse Event|23
4436444|NCT00426660|7220102|FG000|Overall Study|Insufficient Clinical Response|22
4436445|NCT00426660|7220102|FG000|Overall Study|Lost to Follow-up|15
4436446|NCT00426660|7220102|FG000|Overall Study|Other|23
4436447|NCT00426660|7220102|FG000|Overall Study|Withdrawal by Subject|18
4436448|NCT00426660|7220102|FG000|Overall Study|Protocol Violation|1
4436449|NCT00426660|7220102|FG000|Overall Study|Enrolled Not Treated|15
4436450|NCT00426751|7220108|FG000|Overall Study|Adverse Event|8
4436451|NCT00426751|7220109|FG001|Overall Study|Adverse Event|1
4436452|NCT00426751|7220108|FG000|Overall Study|Lost to Follow-up|7
4436453|NCT00426751|7220109|FG001|Overall Study|Lost to Follow-up|6
4436454|NCT00426751|7220108|FG000|Overall Study|Consent Withdrawn|0
4436455|NCT00426751|7220109|FG001|Overall Study|Consent Withdrawn|1
4436456|NCT00426751|7220108|FG000|Overall Study|Other Reasons|7
4436457|NCT00426751|7220109|FG001|Overall Study|Other Reasons|12
4436458|NCT00426764|7220115|FG000|Overall Study|Protocol Violation|1
4436459|NCT00426764|7220115|FG000|Overall Study|Withdrawal by Subject|4
4436460|NCT00426764|7220115|FG000|Overall Study|Physician Decision|6
4436461|NCT00426764|7220115|FG000|Overall Study|Compassionate Use|1
4436462|NCT00426764|7220115|FG000|Overall Study|Progressive Disease|83
4436463|NCT00426764|7220115|FG000|Overall Study|Adverse Event|24
4436464|NCT00426764|7220115|FG000|Overall Study|Other|1
4436465|NCT00426764|7220115|FG000|Overall Study|Death|1
4436466|NCT00426764|7220115|FG000|Overall Study|Other Reasons (Miscellaneous)|10
4436467|NCT00426842|7220125|FG000|Overall Study|Lost to Follow-up|1
4436468|NCT00427011|7220135|FG000|Overall Study|Adverse Event|10
4436469|NCT00427011|7220135|FG000|Overall Study|Withdrawal by Subject|1
4436470|NCT00427011|7220135|FG000|Overall Study|Lack of Efficacy|2
4436471|NCT00427011|7220135|FG000|Overall Study|Other|12
4436472|NCT00427349|7220164|FG000|Overall Study|Lack of Efficacy|23
4436473|NCT00427349|7220164|FG000|Overall Study|Adverse Event|14
4436474|NCT00427349|7220164|FG000|Overall Study|Death|1
4436475|NCT00427349|7220164|FG000|Overall Study|Withdrawal by Subject|3
4436476|NCT00427349|7220164|FG000|Overall Study|Alternative therapy|1
4436477|NCT00427349|7220164|FG000|Overall Study|Other|2
4436478|NCT00427349|7220164|FG000|Overall Study|Ineligible|1
4436479|NCT00427349|7220164|FG000|Overall Study|Never started therapy|1
4436480|NCT00427635|7220174|FG000|Treatment Phase|Withdrawal by Subject|1
4436481|NCT00427635|7220175|FG001|Treatment Phase|Withdrawal by Subject|0
4436482|NCT00427635|7220174|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0
4436483|NCT00427635|7220175|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1
4436484|NCT00427648|7220183|FG000|Overall Study|Protocol Violation|1
4436485|NCT00427648|7220184|FG001|Overall Study|Protocol Violation|2
4436486|NCT00427648|7220183|FG000|Overall Study|Adverse Event|0
4436487|NCT00427648|7220184|FG001|Overall Study|Adverse Event|1
4436488|NCT00427700|7220199|FG000|Overall Study|Lost to Follow-up|2
4436489|NCT00427700|7220200|FG001|Overall Study|Lost to Follow-up|5
4436490|NCT00427700|7220199|FG000|Overall Study|no induction of menses|1
4436491|NCT00427700|7220200|FG001|Overall Study|no induction of menses|4
4436492|NCT00427700|7220199|FG000|Overall Study|Pregnancy|0
4436493|NCT00427700|7220200|FG001|Overall Study|Pregnancy|2
4436494|NCT00427778|7220211|FG000|First Intervention (4 Weeks)|no longer interested|1
4436495|NCT00427778|7220212|FG001|First Intervention (4 Weeks)|no longer interested|0
4436496|NCT00427778|7220211|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2
4436497|NCT00427778|7220212|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0
4436498|NCT00427778|7220211|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0
4436499|NCT00427778|7220212|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1
4436500|NCT00427778|7220211|FG000|First Intervention (4 Weeks)|anxious about using ring|1
4436501|NCT00427778|7220212|FG001|First Intervention (4 Weeks)|anxious about using ring|0
4436502|NCT00427895|7220253|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
4436503|NCT00427895|7220254|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
4436504|NCT00427895|7220255|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
4436505|NCT00427895|7220256|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352
4436506|NCT00427895|7220257|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
4436507|NCT00427895|7220258|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
4436508|NCT00427895|7220259|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
4436509|NCT00427895|7220260|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
4436510|NCT00427895|7220253|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0
4436511|NCT00427895|7220254|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0
4436512|NCT00427895|7220255|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0
4436513|NCT00427895|7220256|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0
4436514|NCT00427895|7220257|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0
4436515|NCT00427895|7220258|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0
4436516|NCT00427895|7220259|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0
4436517|NCT00427895|7220260|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1
4436518|NCT00427895|7220253|FG000|Vax 2/Year 3 to 4|Protocol Violation|0
4436519|NCT00427895|7220254|FG001|Vax 2/Year 3 to 4|Protocol Violation|0
4436520|NCT00427895|7220255|FG002|Vax 2/Year 3 to 4|Protocol Violation|0
4436521|NCT00427895|7220256|FG003|Vax 2/Year 3 to 4|Protocol Violation|0
4436522|NCT00427895|7220257|FG004|Vax 2/Year 3 to 4|Protocol Violation|0
4436523|NCT00427895|7220258|FG005|Vax 2/Year 3 to 4|Protocol Violation|0
4436524|NCT00427895|7220259|FG006|Vax 2/Year 3 to 4|Protocol Violation|0
4436525|NCT00427895|7220260|FG007|Vax 2/Year 3 to 4|Protocol Violation|1
4436526|NCT00427895|7220253|FG000|Vax 2/Year 3 to 4|Failed to Return|0
4436527|NCT00427895|7220254|FG001|Vax 2/Year 3 to 4|Failed to Return|0
4436528|NCT00427895|7220255|FG002|Vax 2/Year 3 to 4|Failed to Return|0
4436529|NCT00427895|7220256|FG003|Vax 2/Year 3 to 4|Failed to Return|0
4436530|NCT00427895|7220257|FG004|Vax 2/Year 3 to 4|Failed to Return|1
4436531|NCT00427895|7220258|FG005|Vax 2/Year 3 to 4|Failed to Return|0
4436532|NCT00427895|7220259|FG006|Vax 2/Year 3 to 4|Failed to Return|0
4436533|NCT00427895|7220260|FG007|Vax 2/Year 3 to 4|Failed to Return|0
4436534|NCT00427895|7220253|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
4436535|NCT00427895|7220254|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1
4436536|NCT00427895|7220255|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4
4436537|NCT00427895|7220256|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32
4436538|NCT00427895|7220257|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
4436539|NCT00427895|7220258|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
4436540|NCT00427895|7220259|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
4436541|NCT00427895|7220260|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
4436542|NCT00427895|7220253|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4
4436543|NCT00427895|7220254|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
4436544|NCT00427895|7220255|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3
4436545|NCT00427895|7220256|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2
4436546|NCT00427895|7220257|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
4436547|NCT00427895|7220258|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
4436548|NCT00427895|7220259|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
4436549|NCT00427895|7220260|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
4436550|NCT00427895|7220253|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1
4436551|NCT00427895|7220254|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1
4436552|NCT00427895|7220255|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
4436553|NCT00427895|7220256|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
4436554|NCT00427895|7220257|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
4436555|NCT00427895|7220258|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
4436556|NCT00427895|7220259|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
4436557|NCT00427895|7220260|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
4436558|NCT00427895|7220253|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1
4436559|NCT00427895|7220254|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1
4436560|NCT00427895|7220255|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4
4436561|NCT00427895|7220256|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7
4436562|NCT00427895|7220257|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
4436563|NCT00427895|7220258|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
4436564|NCT00427895|7220259|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
4436565|NCT00427895|7220260|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
4436566|NCT00427895|7220253|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
4436567|NCT00427895|7220254|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
4436568|NCT00427895|7220255|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
4436569|NCT00427895|7220256|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2
4436570|NCT00427895|7220257|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
4436571|NCT00427895|7220258|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
4436572|NCT00427895|7220259|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
4436573|NCT00427895|7220260|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
4436574|NCT00427895|7220253|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1
4436575|NCT00427895|7220254|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3
4436576|NCT00427895|7220255|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2
4436577|NCT00427895|7220256|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1
4436578|NCT00427895|7220257|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
4436579|NCT00427895|7220258|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
4512800|NCT00937521|7322822|FG000|Booster Phase|Lost to Follow-up|2
4436580|NCT00427895|7220259|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
4436581|NCT00427895|7220260|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
4436582|NCT00427895|7220253|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0
4436583|NCT00427895|7220254|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0
4436584|NCT00427895|7220255|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1
4436585|NCT00427895|7220256|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2
4436586|NCT00427895|7220257|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0
4436587|NCT00427895|7220258|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0
4436588|NCT00427895|7220259|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0
4436589|NCT00427895|7220260|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0
4436590|NCT00427895|7220253|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
4436591|NCT00427895|7220254|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5
4436592|NCT00427895|7220255|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2
4436593|NCT00427895|7220256|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21
4436594|NCT00427895|7220257|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
4436595|NCT00427895|7220258|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
4436596|NCT00427895|7220259|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
4436597|NCT00427895|7220260|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
4436598|NCT00427895|7220253|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3
4630238|NCT02362503|7498806|FG001|Open Label Period-Up to 96 Weeks|Death|7
4630239|NCT02362503|7498807|FG002|Open Label Period-Up to 96 Weeks|Death|15
4630240|NCT02362503|7498805|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0
4630241|NCT02362503|7498806|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5
4436599|NCT00427895|7220254|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3
4436600|NCT00427895|7220255|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0
4436601|NCT00427895|7220256|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1
4436602|NCT00427895|7220257|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0
4436603|NCT00427895|7220258|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0
4436604|NCT00427895|7220259|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0
4436605|NCT00427895|7220260|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0
4436606|NCT00427895|7220253|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3
4436607|NCT00427895|7220254|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6
4630242|NCT02362503|7498807|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1
4630243|NCT02362503|7498805|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3
4630244|NCT02362503|7498806|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2
4630245|NCT02362503|7498807|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4
4630246|NCT02362503|7498805|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3
4630247|NCT02362503|7498806|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9
4630248|NCT02362503|7498807|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6
4630249|NCT02362503|7498805|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54
4630250|NCT02362503|7498806|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159
4630251|NCT02362503|7498807|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61
4630252|NCT02288247|7498818|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Adverse Event|52
4630253|NCT02288247|7498819|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Adverse Event|0
4630254|NCT02288247|7498818|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Death|35
4630255|NCT02288247|7498819|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Death|0
4630256|NCT02288247|7498818|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Lost to Follow-up|1
4630257|NCT02288247|7498819|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Lost to Follow-up|0
4630258|NCT02288247|7498818|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Progressive Disease|392
4630259|NCT02288247|7498819|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Progressive Disease|0
4630260|NCT02288247|7498818|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Protocol Violation|9
4630261|NCT02288247|7498819|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Protocol Violation|0
4630262|NCT02288247|7498818|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Withdrawal by Subject|52
4630263|NCT02288247|7498819|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Withdrawal by Subject|0
4630264|NCT02288247|7498818|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Other|106
4630265|NCT02288247|7498819|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Other|0
4630266|NCT02288247|7498818|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10
4630267|NCT02288247|7498819|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8
4630268|NCT02288247|7498818|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8
4630269|NCT02288247|7498819|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4
4630270|NCT02288247|7498818|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1
4630271|NCT02288247|7498819|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0
4633313|NCT01910298|7503381|FG001|Overall Study|Withdrawal by Subject|7
4436608|NCT00427895|7220255|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5
4436609|NCT00427895|7220256|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4
4436610|NCT00427895|7220257|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
4436611|NCT00427895|7220258|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
4436612|NCT00427895|7220259|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
4436613|NCT00427895|7220260|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
4436614|NCT00427895|7220253|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0
4436615|NCT00427895|7220254|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1
4436616|NCT00427895|7220255|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0
4436617|NCT00427895|7220256|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0
4436618|NCT00427895|7220257|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0
4436619|NCT00427895|7220258|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0
4436620|NCT00427895|7220259|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0
4436621|NCT00427895|7220260|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0
4436622|NCT00427895|7220253|FG000|Vax 1/Year 1 Follow-up|Death|1
4436623|NCT00427895|7220254|FG001|Vax 1/Year 1 Follow-up|Death|0
4436624|NCT00427895|7220255|FG002|Vax 1/Year 1 Follow-up|Death|0
4436625|NCT00427895|7220256|FG003|Vax 1/Year 1 Follow-up|Death|0
4436626|NCT00427895|7220257|FG004|Vax 1/Year 1 Follow-up|Death|0
4436627|NCT00427895|7220258|FG005|Vax 1/Year 1 Follow-up|Death|0
4436628|NCT00427895|7220259|FG006|Vax 1/Year 1 Follow-up|Death|0
4436629|NCT00427895|7220260|FG007|Vax 1/Year 1 Follow-up|Death|0
4436630|NCT00427895|7220253|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0
4436631|NCT00427895|7220254|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0
4436632|NCT00427895|7220255|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12
4436633|NCT00427895|7220256|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5
4436634|NCT00427895|7220257|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0
4436635|NCT00427895|7220258|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0
4436636|NCT00427895|7220259|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0
4436637|NCT00427895|7220260|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0
4436638|NCT00427895|7220253|FG000|Vax 1/Year 1 Follow-up|Other|0
4436639|NCT00427895|7220254|FG001|Vax 1/Year 1 Follow-up|Other|0
4436640|NCT00427895|7220255|FG002|Vax 1/Year 1 Follow-up|Other|0
4436641|NCT00427895|7220256|FG003|Vax 1/Year 1 Follow-up|Other|2
4436642|NCT00427895|7220257|FG004|Vax 1/Year 1 Follow-up|Other|0
4436643|NCT00427895|7220258|FG005|Vax 1/Year 1 Follow-up|Other|0
4436644|NCT00427895|7220259|FG006|Vax 1/Year 1 Follow-up|Other|0
4436645|NCT00427895|7220260|FG007|Vax 1/Year 1 Follow-up|Other|0
4436646|NCT00427895|7220253|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188
4436647|NCT00427895|7220254|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207
4436648|NCT00427895|7220255|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159
4436649|NCT00427895|7220256|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469
4436650|NCT00427895|7220257|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
4436651|NCT00427895|7220258|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
4436652|NCT00427895|7220259|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
4436653|NCT00427895|7220260|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
4436654|NCT00427908|7220303|FG000|Primary Phase|Lost to Follow-up|4
4436655|NCT00427908|7220304|FG001|Primary Phase|Lost to Follow-up|0
4436656|NCT00427908|7220305|FG002|Primary Phase|Lost to Follow-up|2
4436657|NCT00427908|7220306|FG003|Primary Phase|Lost to Follow-up|0
4436658|NCT00427908|7220303|FG000|Primary Phase|Withdrawal by Subject|1
4436659|NCT00427908|7220304|FG001|Primary Phase|Withdrawal by Subject|2
4436660|NCT00427908|7220305|FG002|Primary Phase|Withdrawal by Subject|1
4436661|NCT00427908|7220306|FG003|Primary Phase|Withdrawal by Subject|0
4436662|NCT00427908|7220303|FG000|Primary Phase|Adverse Event|0
4436663|NCT00427908|7220304|FG001|Primary Phase|Adverse Event|1
4436664|NCT00427908|7220305|FG002|Primary Phase|Adverse Event|0
4436665|NCT00427908|7220306|FG003|Primary Phase|Adverse Event|0
4436666|NCT00427921|7220341|FG000|Overall Study|Adverse Event|26
4436667|NCT00427921|7220341|FG000|Overall Study|Withdrawal by Subject|4
4436668|NCT00427921|7220341|FG000|Overall Study|Lost to Follow-up|2
4436669|NCT00427921|7220341|FG000|Overall Study|Other reason not specified|10
4436670|NCT00427921|7220341|FG000|Overall Study|Adverse Event + Hospitalization|1
4436671|NCT00427921|7220341|FG000|Overall Study|Adverse Event + Withdrew Consent|1
4436672|NCT00427921|7220341|FG000|Overall Study|Adverse Event + No Response|1
4436673|NCT00427921|7220341|FG000|Overall Study|Adverse Event + Worsening of CD|1
4436674|NCT00427921|7220341|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1
4436675|NCT00427921|7220341|FG000|Overall Study|Adverse Event + Lost Response|1
4436676|NCT00427921|7220341|FG000|Overall Study|Adverse Event + Withdrawn from Study|1
4436677|NCT00427921|7220341|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1
4436678|NCT00427934|7220349|FG000|Overall Study|Adverse Event|1
4436679|NCT00427934|7220350|FG001|Overall Study|Adverse Event|0
4436680|NCT00427934|7220351|FG002|Overall Study|Adverse Event|5
4436681|NCT00427934|7220352|FG003|Overall Study|Adverse Event|4
4436682|NCT00427934|7220349|FG000|Overall Study|Lack of Efficacy|0
4436683|NCT00427934|7220350|FG001|Overall Study|Lack of Efficacy|0
4436684|NCT00427934|7220351|FG002|Overall Study|Lack of Efficacy|5
4436685|NCT00427934|7220352|FG003|Overall Study|Lack of Efficacy|2
4436686|NCT00427934|7220349|FG000|Overall Study|Randomized But Did Not Receive Treatment|0
4436687|NCT00427934|7220350|FG001|Overall Study|Randomized But Did Not Receive Treatment|0
4436688|NCT00427934|7220351|FG002|Overall Study|Randomized But Did Not Receive Treatment|1
4436689|NCT00427934|7220352|FG003|Overall Study|Randomized But Did Not Receive Treatment|1
4436690|NCT00427934|7220349|FG000|Overall Study|Other|0
4436691|NCT00427934|7220350|FG001|Overall Study|Other|0
4436692|NCT00427934|7220351|FG002|Overall Study|Other|11
4436693|NCT00427934|7220352|FG003|Overall Study|Other|5
4436694|NCT00427934|7220349|FG000|Overall Study|Withdrawal by Subject|0
4436695|NCT00427934|7220350|FG001|Overall Study|Withdrawal by Subject|0
4436696|NCT00427934|7220351|FG002|Overall Study|Withdrawal by Subject|1
4436697|NCT00427934|7220352|FG003|Overall Study|Withdrawal by Subject|3
4436698|NCT00427960|7220366|FG000|Overall Study|Adverse Event|2
4436699|NCT00427960|7220367|FG001|Overall Study|Adverse Event|0
4436700|NCT00427960|7220366|FG000|Overall Study|Withdrawal by Subject|0
4436701|NCT00427960|7220367|FG001|Overall Study|Withdrawal by Subject|3
4436702|NCT00427960|7220366|FG000|Overall Study|Other|0
4436703|NCT00427960|7220367|FG001|Overall Study|Other|1
4436704|NCT00427999|7220377|FG000|Overall Study|Adverse Event|6
4436705|NCT00427999|7220377|FG000|Overall Study|Abnormal laboratory values|1
4436706|NCT00427999|7220377|FG000|Overall Study|Unsatisfactory therapeutic effect|13
4436707|NCT00427999|7220377|FG000|Overall Study|Protocol Violation|2
4436708|NCT00427999|7220377|FG000|Overall Study|Withdrawal by Subject|9
4436709|NCT00427999|7220377|FG000|Overall Study|Death|1
4436710|NCT00428090|7220390|FG000|Overall Study|Adverse Event|10
4436711|NCT00428090|7220391|FG001|Overall Study|Adverse Event|8
4436712|NCT00428090|7220392|FG002|Overall Study|Adverse Event|10
4436713|NCT00428090|7220393|FG003|Overall Study|Adverse Event|11
4436714|NCT00428090|7220390|FG000|Overall Study|Lost to Follow-up|3
4436715|NCT00428090|7220391|FG001|Overall Study|Lost to Follow-up|6
4436716|NCT00428090|7220392|FG002|Overall Study|Lost to Follow-up|1
4436717|NCT00428090|7220393|FG003|Overall Study|Lost to Follow-up|4
4436718|NCT00428090|7220390|FG000|Overall Study|Protocol Violation|3
4436719|NCT00428090|7220391|FG001|Overall Study|Protocol Violation|1
4436720|NCT00428090|7220392|FG002|Overall Study|Protocol Violation|3
4436721|NCT00428090|7220393|FG003|Overall Study|Protocol Violation|3
4436722|NCT00428090|7220390|FG000|Overall Study|Withdrawal by Subject|10
4436723|NCT00428090|7220391|FG001|Overall Study|Withdrawal by Subject|12
4436724|NCT00428090|7220392|FG002|Overall Study|Withdrawal by Subject|15
4436725|NCT00428090|7220393|FG003|Overall Study|Withdrawal by Subject|5
4436726|NCT00428090|7220390|FG000|Overall Study|Sponsor terminated study|0
4436727|NCT00428090|7220391|FG001|Overall Study|Sponsor terminated study|1
4436728|NCT00428090|7220392|FG002|Overall Study|Sponsor terminated study|0
4436729|NCT00428090|7220393|FG003|Overall Study|Sponsor terminated study|0
4436730|NCT00428090|7220390|FG000|Overall Study|Non-compliance|4
4436731|NCT00428090|7220391|FG001|Overall Study|Non-compliance|0
4436732|NCT00428090|7220392|FG002|Overall Study|Non-compliance|1
4436733|NCT00428090|7220393|FG003|Overall Study|Non-compliance|3
4436734|NCT00428090|7220390|FG000|Overall Study|Par. did not returned to visit|1
4436735|NCT00428090|7220391|FG001|Overall Study|Par. did not returned to visit|0
4436736|NCT00428090|7220392|FG002|Overall Study|Par. did not returned to visit|0
4436737|NCT00428090|7220393|FG003|Overall Study|Par. did not returned to visit|1
4436738|NCT00428090|7220390|FG000|Overall Study|Follow-Up visit not possible|1
4436739|NCT00428090|7220391|FG001|Overall Study|Follow-Up visit not possible|0
4436740|NCT00428090|7220392|FG002|Overall Study|Follow-Up visit not possible|0
4436741|NCT00428090|7220393|FG003|Overall Study|Follow-Up visit not possible|0
4436742|NCT00428090|7220390|FG000|Overall Study|Prohibited medication used for SAE|1
4436743|NCT00428090|7220391|FG001|Overall Study|Prohibited medication used for SAE|0
4436744|NCT00428090|7220392|FG002|Overall Study|Prohibited medication used for SAE|0
4436745|NCT00428090|7220393|FG003|Overall Study|Prohibited medication used for SAE|0
4436746|NCT00428090|7220390|FG000|Overall Study|Death of par.|1
4436747|NCT00428090|7220391|FG001|Overall Study|Death of par.|0
4436748|NCT00428090|7220392|FG002|Overall Study|Death of par.|1
4436749|NCT00428090|7220393|FG003|Overall Study|Death of par.|0
4436750|NCT00428090|7220390|FG000|Overall Study|Visit 7 exceed the visit window|0
4436751|NCT00428090|7220391|FG001|Overall Study|Visit 7 exceed the visit window|1
4436752|NCT00428090|7220392|FG002|Overall Study|Visit 7 exceed the visit window|0
4436753|NCT00428090|7220393|FG003|Overall Study|Visit 7 exceed the visit window|0
4436754|NCT00428090|7220390|FG000|Overall Study|Medical monitor terminated par.|0
4436755|NCT00428090|7220391|FG001|Overall Study|Medical monitor terminated par.|1
4436756|NCT00428090|7220392|FG002|Overall Study|Medical monitor terminated par.|0
4436757|NCT00428090|7220393|FG003|Overall Study|Medical monitor terminated par.|0
4436758|NCT00428090|7220390|FG000|Overall Study|Mental status of par. was|0
4436759|NCT00428090|7220391|FG001|Overall Study|Mental status of par. was|1
4436760|NCT00428090|7220392|FG002|Overall Study|Mental status of par. was|0
4436761|NCT00428090|7220393|FG003|Overall Study|Mental status of par. was|0
4436762|NCT00428090|7220390|FG000|Overall Study|Worsening of AD|0
4436763|NCT00428090|7220391|FG001|Overall Study|Worsening of AD|0
4436764|NCT00428090|7220392|FG002|Overall Study|Worsening of AD|1
4436765|NCT00428090|7220393|FG003|Overall Study|Worsening of AD|0
4436766|NCT00428090|7220390|FG000|Overall Study|Excluded for concerning QTc value|0
4436767|NCT00428090|7220391|FG001|Overall Study|Excluded for concerning QTc value|0
4436768|NCT00428090|7220392|FG002|Overall Study|Excluded for concerning QTc value|1
4436769|NCT00428090|7220393|FG003|Overall Study|Excluded for concerning QTc value|0
4436770|NCT00428090|7220390|FG000|Overall Study|Insufficient AD documentation|0
4436771|NCT00428090|7220391|FG001|Overall Study|Insufficient AD documentation|0
4436772|NCT00428090|7220392|FG002|Overall Study|Insufficient AD documentation|1
4436773|NCT00428090|7220393|FG003|Overall Study|Insufficient AD documentation|0
4436774|NCT00428090|7220390|FG000|Overall Study|High MMSE scores|0
4436775|NCT00428090|7220391|FG001|Overall Study|High MMSE scores|0
4436776|NCT00428090|7220392|FG002|Overall Study|High MMSE scores|1
4436777|NCT00428090|7220393|FG003|Overall Study|High MMSE scores|0
4436778|NCT00428090|7220390|FG000|Overall Study|Deterioration of cognitive status|0
4436779|NCT00428090|7220391|FG001|Overall Study|Deterioration of cognitive status|0
4436780|NCT00428090|7220392|FG002|Overall Study|Deterioration of cognitive status|1
4436781|NCT00428090|7220393|FG003|Overall Study|Deterioration of cognitive status|0
4436782|NCT00428090|7220390|FG000|Overall Study|Serious adverse event|0
4436783|NCT00428090|7220391|FG001|Overall Study|Serious adverse event|0
4436784|NCT00428090|7220392|FG002|Overall Study|Serious adverse event|1
4436785|NCT00428090|7220393|FG003|Overall Study|Serious adverse event|0
4436786|NCT00428090|7220390|FG000|Overall Study|Excluded for heart insufficiency|0
4436787|NCT00428090|7220391|FG001|Overall Study|Excluded for heart insufficiency|0
4436788|NCT00428090|7220392|FG002|Overall Study|Excluded for heart insufficiency|1
4436789|NCT00428090|7220393|FG003|Overall Study|Excluded for heart insufficiency|0
4436790|NCT00428090|7220390|FG000|Overall Study|Raised Creatinine Value|0
4436791|NCT00428090|7220391|FG001|Overall Study|Raised Creatinine Value|0
4436792|NCT00428090|7220392|FG002|Overall Study|Raised Creatinine Value|0
4436793|NCT00428090|7220393|FG003|Overall Study|Raised Creatinine Value|1
4436794|NCT00428116|7220413|FG000|Overall Study|Death|1
4436795|NCT00428116|7220414|FG001|Overall Study|Death|0
4436796|NCT00428116|7220413|FG000|Overall Study|Withdrawal by Subject|1
4436797|NCT00428116|7220414|FG001|Overall Study|Withdrawal by Subject|0
4436798|NCT00428116|7220413|FG000|Overall Study|Lost to Follow-up|1
4436799|NCT00428116|7220414|FG001|Overall Study|Lost to Follow-up|0
4436800|NCT00428220|7220421|FG000|Overall Study|Participant died|8
4436801|NCT00428220|7220421|FG000|Overall Study|Global deterioration of health status|7
4436802|NCT00428220|7220421|FG000|Overall Study|Lost to Follow-up|4
4436803|NCT00428220|7220421|FG000|Overall Study|Objective progression or relapse|123
4436804|NCT00428220|7220421|FG000|Overall Study|Participant refused continued treatment|7
4436805|NCT00428220|7220421|FG000|Overall Study|Adverse Event|51
4436806|NCT00428220|7220421|FG000|Overall Study|Other|23
4436807|NCT00428246|7220439|FG000|Overall Study|Withdrawal by Subject|0
4436808|NCT00428246|7220440|FG001|Overall Study|Withdrawal by Subject|0
4436809|NCT00428246|7220441|FG002|Overall Study|Withdrawal by Subject|1
4436810|NCT00428246|7220439|FG000|Overall Study|Adverse Event|1
4436811|NCT00428246|7220440|FG001|Overall Study|Adverse Event|0
4436812|NCT00428246|7220441|FG002|Overall Study|Adverse Event|0
4436813|NCT00428389|7220462|FG000|Core Phase|Adverse Event|6
4436814|NCT00428389|7220463|FG001|Core Phase|Adverse Event|4
4436815|NCT00428389|7220462|FG000|Core Phase|Lack of Efficacy|2
4436816|NCT00428389|7220463|FG001|Core Phase|Lack of Efficacy|0
4436817|NCT00428389|7220462|FG000|Core Phase|Abnormal test procedure result(s)|0
4436818|NCT00428389|7220463|FG001|Core Phase|Abnormal test procedure result(s)|1
4436819|NCT00428389|7220462|FG000|Core Phase|Withdrawal by Subject|3
4436820|NCT00428389|7220463|FG001|Core Phase|Withdrawal by Subject|4
4436821|NCT00428389|7220462|FG000|Core Phase|Protocol deviation|0
4436822|NCT00428389|7220463|FG001|Core Phase|Protocol deviation|2
4436823|NCT00428389|7220462|FG000|Extension Phase|Adverse Event|17
4436824|NCT00428389|7220463|FG001|Extension Phase|Adverse Event|11
4436825|NCT00428389|7220462|FG000|Extension Phase|Lack of Efficacy|4
4436826|NCT00428389|7220463|FG001|Extension Phase|Lack of Efficacy|3
4436827|NCT00428389|7220462|FG000|Extension Phase|Withdrawal by Subject|6
4436828|NCT00428389|7220463|FG001|Extension Phase|Withdrawal by Subject|6
4436829|NCT00428389|7220462|FG000|Extension Phase|Lost to Follow-up|0
4436830|NCT00428389|7220463|FG001|Extension Phase|Lost to Follow-up|3
4436831|NCT00428389|7220462|FG000|Extension Phase|Death|1
4436832|NCT00428389|7220463|FG001|Extension Phase|Death|0
4436833|NCT00428389|7220462|FG000|Extension Phase|Protocol Violation|3
4436834|NCT00428389|7220463|FG001|Extension Phase|Protocol Violation|2
4436835|NCT00428389|7220462|FG000|Extension Phase|Administrative problems|1
4436836|NCT00428389|7220463|FG001|Extension Phase|Administrative problems|1
4436837|NCT00428441|7220469|FG000|Overall Study|Lost to Follow-up|1
4436838|NCT00428597|7220488|FG000|Overall Study|Randomized but not treated|3
4436839|NCT00428597|7220489|FG001|Overall Study|Randomized but not treated|3
4436840|NCT00428597|7220488|FG000|Overall Study|Objective Progression or Relapse|19
4436841|NCT00428597|7220489|FG001|Overall Study|Objective Progression or Relapse|47
4436842|NCT00428597|7220488|FG000|Overall Study|Study Terminated by Sponsor|41
4436843|NCT00428597|7220489|FG001|Overall Study|Study Terminated by Sponsor|16
4436844|NCT00428597|7220488|FG000|Overall Study|Adverse Event|15
4436845|NCT00428597|7220489|FG001|Overall Study|Adverse Event|7
4436846|NCT00428597|7220488|FG000|Overall Study|Global Deterioration of Health Status|1
4436847|NCT00428597|7220489|FG001|Overall Study|Global Deterioration of Health Status|5
4436848|NCT00428597|7220488|FG000|Overall Study|Protocol Violation|2
4436849|NCT00428597|7220489|FG001|Overall Study|Protocol Violation|1
4436850|NCT00428597|7220488|FG000|Overall Study|Withdrawal by Subject|2
4436851|NCT00428597|7220489|FG001|Overall Study|Withdrawal by Subject|1
4436852|NCT00428597|7220488|FG000|Overall Study|Other|1
4436853|NCT00428597|7220489|FG001|Overall Study|Other|1
4436854|NCT00428597|7220488|FG000|Overall Study|Lost to Follow-up|0
4436855|NCT00428597|7220489|FG001|Overall Study|Lost to Follow-up|1
4436856|NCT00428597|7220488|FG000|Overall Study|Pregnancy|1
4436857|NCT00428597|7220489|FG001|Overall Study|Pregnancy|0
4436858|NCT00428597|7220488|FG000|Overall Study|Death|1
4436859|NCT00428597|7220489|FG001|Overall Study|Death|3
4436860|NCT00428610|7220498|FG000|Overall Study|Death Due to Adverse Event|3
4436861|NCT00428610|7220499|FG001|Overall Study|Death Due to Adverse Event|0
4436862|NCT00428610|7220500|FG002|Overall Study|Death Due to Adverse Event|5
4436863|NCT00428610|7220498|FG000|Overall Study|Death Due to Progressive Disease|0
4436864|NCT00428610|7220499|FG001|Overall Study|Death Due to Progressive Disease|0
4436865|NCT00428610|7220500|FG002|Overall Study|Death Due to Progressive Disease|2
4436866|NCT00428610|7220498|FG000|Overall Study|Adverse Event|2
4436867|NCT00428610|7220499|FG001|Overall Study|Adverse Event|3
4436868|NCT00428610|7220500|FG002|Overall Study|Adverse Event|2
4436869|NCT00428610|7220498|FG000|Overall Study|Investigator Decision|2
4436870|NCT00428610|7220499|FG001|Overall Study|Investigator Decision|1
4436871|NCT00428610|7220500|FG002|Overall Study|Investigator Decision|1
4436872|NCT00428610|7220498|FG000|Overall Study|Progressive Disease|42
4436873|NCT00428610|7220499|FG001|Overall Study|Progressive Disease|14
4436874|NCT00428610|7220500|FG002|Overall Study|Progressive Disease|22
4436875|NCT00428610|7220498|FG000|Overall Study|Withdrawal by Subject|4
4436876|NCT00428610|7220499|FG001|Overall Study|Withdrawal by Subject|0
4436877|NCT00428610|7220500|FG002|Overall Study|Withdrawal by Subject|0
4436878|NCT00428714|7220510|FG000|Overall Study|Progressive Disease|28
4436879|NCT00428714|7220511|FG001|Overall Study|Progressive Disease|36
4436880|NCT00428714|7220510|FG000|Overall Study|Withdrawal by Subject|0
4436881|NCT00428714|7220511|FG001|Overall Study|Withdrawal by Subject|3
4436882|NCT00428714|7220510|FG000|Overall Study|Adverse Event|0
4436883|NCT00428714|7220511|FG001|Overall Study|Adverse Event|2
4436884|NCT00428714|7220510|FG000|Overall Study|Physician Decision|1
4436885|NCT00428714|7220511|FG001|Overall Study|Physician Decision|1
4436886|NCT00428714|7220510|FG000|Overall Study|Death due to Progressive Disease (PD)|1
4436887|NCT00428714|7220511|FG001|Overall Study|Death due to Progressive Disease (PD)|0
4436888|NCT00428714|7220510|FG000|Overall Study|Death due to other then PD|1
4436889|NCT00428714|7220511|FG001|Overall Study|Death due to other then PD|0
4436890|NCT00428792|7220520|FG000|Overall Study|Lack of Efficacy|1
4436891|NCT00428792|7220521|FG001|Overall Study|Lack of Efficacy|3
4436892|NCT00428792|7220520|FG000|Overall Study|Lost to Follow-up|0
4436893|NCT00428792|7220521|FG001|Overall Study|Lost to Follow-up|1
4436894|NCT00428844|7220530|FG000|Completed Study Drug Treatment|Adverse Event|2
4436895|NCT00428844|7220531|FG001|Completed Study Drug Treatment|Adverse Event|4
4436896|NCT00428844|7220532|FG002|Completed Study Drug Treatment|Adverse Event|4
4436897|NCT00428844|7220530|FG000|Completed Study Drug Treatment|Protocol Violation|0
4436898|NCT00428844|7220531|FG001|Completed Study Drug Treatment|Protocol Violation|1
4436899|NCT00428844|7220532|FG002|Completed Study Drug Treatment|Protocol Violation|1
4436900|NCT00428844|7220530|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0
4436901|NCT00428844|7220531|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1
4436902|NCT00428844|7220532|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1
4436903|NCT00428844|7220530|FG000|Completed Study Drug Treatment|Randomized Not Treated|0
4436904|NCT00428844|7220531|FG001|Completed Study Drug Treatment|Randomized Not Treated|0
4436905|NCT00428844|7220532|FG002|Completed Study Drug Treatment|Randomized Not Treated|1
4436906|NCT00428844|7220530|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0
4436907|NCT00428844|7220531|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1
4436908|NCT00428844|7220532|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1
4436909|NCT00428844|7220530|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0
4436910|NCT00428844|7220531|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0
4436911|NCT00428844|7220532|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1
4436912|NCT00428844|7220530|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1
4436913|NCT00428844|7220531|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0
4436914|NCT00428844|7220532|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0
4436915|NCT00428844|7220530|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2
4436916|NCT00428844|7220531|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0
4436917|NCT00428844|7220532|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0
4436918|NCT00428844|7220530|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0
4436919|NCT00428844|7220531|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1
4436920|NCT00428844|7220532|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0
4436921|NCT00428948|7220546|FG000|Overall Study|Lost to Follow-up|15
4436922|NCT00428948|7220547|FG001|Overall Study|Lost to Follow-up|8
4436923|NCT00428948|7220546|FG000|Overall Study|Adverse Event|148
4436924|NCT00428948|7220547|FG001|Overall Study|Adverse Event|24
4436925|NCT00428948|7220546|FG000|Overall Study|Subject Met Withdrawal Criteria|4
4436926|NCT00428948|7220547|FG001|Overall Study|Subject Met Withdrawal Criteria|0
4436927|NCT00428948|7220546|FG000|Overall Study|Investigator Withdrew Subject|3
4436928|NCT00428948|7220547|FG001|Overall Study|Investigator Withdrew Subject|4
4436929|NCT00428948|7220546|FG000|Overall Study|Subject Withdrew Consent|50
4436930|NCT00428948|7220547|FG001|Overall Study|Subject Withdrew Consent|30
4436931|NCT00428948|7220546|FG000|Overall Study|Protocol Deviation|1
4436932|NCT00428948|7220547|FG001|Overall Study|Protocol Deviation|1
4436933|NCT00429104|7220571|FG000|Overall Study|Protocol Violation|1
4436934|NCT00429169|7220581|FG000|Overall Study|Lost to Follow-up|0
4436935|NCT00429169|7220582|FG001|Overall Study|Lost to Follow-up|1
4436936|NCT00429169|7220581|FG000|Overall Study|Ineligibility discovered after entry|2
4436937|NCT00429169|7220582|FG001|Overall Study|Ineligibility discovered after entry|1
4436938|NCT00429182|7220590|FG000|Overall Study|Not evaluable, Disease Progression|2
4436939|NCT00429182|7220590|FG000|Overall Study|Not eligible|5
4436940|NCT00429273|7220597|FG000|Overall Study|Lost to Follow-up|1
4436941|NCT00429273|7220598|FG001|Overall Study|Lost to Follow-up|2
4436942|NCT00429273|7220599|FG002|Overall Study|Lost to Follow-up|2
4436943|NCT00429273|7220597|FG000|Overall Study|Physician Decision|6
4436944|NCT00429273|7220598|FG001|Overall Study|Physician Decision|5
4436945|NCT00429273|7220599|FG002|Overall Study|Physician Decision|5
4436946|NCT00429273|7220597|FG000|Overall Study|Adverse Event|1
4436947|NCT00429273|7220598|FG001|Overall Study|Adverse Event|1
4436948|NCT00429273|7220599|FG002|Overall Study|Adverse Event|2
4436949|NCT00429299|7220610|FG000|Overall Study|Disease Progression|1
4436950|NCT00429299|7220611|FG001|Overall Study|Disease Progression|1
4436951|NCT00429299|7220612|FG002|Overall Study|Disease Progression|0
4436952|NCT00429299|7220610|FG000|Overall Study|Adverse Event|2
4436953|NCT00429299|7220611|FG001|Overall Study|Adverse Event|5
4436954|NCT00429299|7220612|FG002|Overall Study|Adverse Event|1
4436955|NCT00429299|7220610|FG000|Overall Study|Protocol Violation|1
4436956|NCT00429299|7220611|FG001|Overall Study|Protocol Violation|0
4436957|NCT00429299|7220612|FG002|Overall Study|Protocol Violation|0
4436958|NCT00429299|7220610|FG000|Overall Study|Withdrawal by Subject|0
4436959|NCT00429299|7220611|FG001|Overall Study|Withdrawal by Subject|1
4436960|NCT00429299|7220612|FG002|Overall Study|Withdrawal by Subject|3
4436961|NCT00429364|7220622|FG000|Overall Study|Withdrawal by Subject|11
4436962|NCT00429364|7220623|FG001|Overall Study|Withdrawal by Subject|5
4436963|NCT00429364|7220622|FG000|Overall Study|Physician Decision|4
4436964|NCT00429364|7220623|FG001|Overall Study|Physician Decision|2
4436965|NCT00429364|7220622|FG000|Overall Study|Lost to Follow-up|7
4436966|NCT00429364|7220623|FG001|Overall Study|Lost to Follow-up|6
4436967|NCT00429364|7220622|FG000|Overall Study|Death|0
4436968|NCT00429364|7220623|FG001|Overall Study|Death|1
4436969|NCT00429364|7220622|FG000|Overall Study|Underwent aortic root surgery|10
4436970|NCT00429364|7220623|FG001|Overall Study|Underwent aortic root surgery|18
4436971|NCT00429364|7220622|FG000|Overall Study|Pregnancy|0
4436972|NCT00429364|7220623|FG001|Overall Study|Pregnancy|1
4436973|NCT00429416|7220638|FG000|Overall Study|Death|1
4436974|NCT00429494|7220642|FG000|Overall Study|Withdrawal by Subject|9
4436975|NCT00429494|7220642|FG000|Overall Study|Death|6
4436976|NCT00429572|7220650|FG000|Overall Study|Disease progression|1
4436977|NCT00429585|7220656|FG000|Overall Study|Death|1
4436978|NCT00429585|7220657|FG001|Overall Study|Death|0
4436979|NCT00429585|7220656|FG000|Overall Study|Lost to Follow-up|27
4436980|NCT00429585|7220657|FG001|Overall Study|Lost to Follow-up|20
4590490|NCT01521923|7436513|FG003|Overall Study|Other|6
4590491|NCT01521923|7436510|FG000|Overall Study|AE, captured in Period 1|0
4590492|NCT01521923|7436511|FG001|Overall Study|AE, captured in Period 1|1
4590493|NCT01521923|7436512|FG002|Overall Study|AE, captured in Period 1|0
4590494|NCT01521923|7436513|FG003|Overall Study|AE, captured in Period 1|1
4590495|NCT01522235|7436541|FG000|Overall Study|Physician Decision|1
4590496|NCT01522235|7436542|FG001|Overall Study|Physician Decision|1
4590497|NCT01522248|7436554|FG000|Overall Study|Lost to Follow-up|1
4590498|NCT01522248|7436555|FG001|Overall Study|Lost to Follow-up|0
4590499|NCT01522404|7436582|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1
4590500|NCT01522404|7436583|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0
4590501|NCT01522404|7436582|FG000|First Intervention (up to Week 29)|Adverse Event|1
4590502|NCT01522404|7436583|FG001|First Intervention (up to Week 29)|Adverse Event|0
4590503|NCT01522404|7436582|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1
4590504|NCT01522404|7436583|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0
4590505|NCT01522443|7436612|FG000|Overall Study|No longer receiving clinical benefit|36
4590506|NCT01522443|7436613|FG001|Overall Study|No longer receiving clinical benefit|28
4590507|NCT01522443|7436612|FG000|Overall Study|Adverse Event|10
4590508|NCT01522443|7436613|FG001|Overall Study|Adverse Event|15
4590509|NCT01522443|7436612|FG000|Overall Study|Withdrawal by Subject|5
4590510|NCT01522443|7436613|FG001|Overall Study|Withdrawal by Subject|8
4590511|NCT01522443|7436612|FG000|Overall Study|No study treatment given|1
4590512|NCT01522443|7436613|FG001|Overall Study|No study treatment given|1
4590513|NCT01522443|7436612|FG000|Overall Study|Other|1
4590514|NCT01522443|7436613|FG001|Overall Study|Other|3
4590515|NCT01522456|7436619|FG000|Overall Study|Adverse Event|2
4590516|NCT01522456|7436619|FG000|Overall Study|Lost to Follow-up|2
4590517|NCT01522456|7436619|FG000|Overall Study|Withdrawal by Subject|2
4590518|NCT01522456|7436619|FG000|Overall Study|Pregnancy|1
4590519|NCT01522456|7436619|FG000|Overall Study|Tolerability Assessment|1
4590520|NCT01522651|7436635|FG000|Overall Study|Adverse Event|3
4590521|NCT01522651|7436636|FG001|Overall Study|Adverse Event|4
4590522|NCT01522651|7436637|FG002|Overall Study|Adverse Event|4
4590523|NCT01522651|7436638|FG003|Overall Study|Adverse Event|5
4436981|NCT00429585|7220656|FG000|Overall Study|Physician Decision|2
4436982|NCT00429585|7220657|FG001|Overall Study|Physician Decision|0
4436983|NCT00429663|7220665|FG000|Overall Study|Lost to Follow-up|24
4436984|NCT00429663|7220666|FG001|Overall Study|Lost to Follow-up|31
4436985|NCT00429663|7220665|FG000|Overall Study|Physician Decision|6
4436986|NCT00429663|7220666|FG001|Overall Study|Physician Decision|3
4436987|NCT00429663|7220665|FG000|Overall Study|Withdrawal by Subject|2
4436988|NCT00429663|7220666|FG001|Overall Study|Withdrawal by Subject|5
4436989|NCT00429663|7220665|FG000|Overall Study|Death|4
4436990|NCT00429663|7220666|FG001|Overall Study|Death|0
4436991|NCT00429793|7220681|FG000|Overall Study|Improper pre-protocol treatment|3
4436992|NCT00429793|7220681|FG000|Overall Study|Required test not done|1
4590524|NCT01522651|7436639|FG004|Overall Study|Adverse Event|4
4436993|NCT00429793|7220681|FG000|Overall Study|Never treated|1
4436994|NCT00429793|7220681|FG000|Overall Study|Non-measurable|1
4436995|NCT00430248|7220708|FG000|Overall Study|Adverse Event|49
4436996|NCT00430248|7220709|FG001|Overall Study|Adverse Event|61
4436997|NCT00430248|7220710|FG002|Overall Study|Adverse Event|64
4436998|NCT00430248|7220708|FG000|Overall Study|Protocol Violation|10
4436999|NCT00430248|7220709|FG001|Overall Study|Protocol Violation|2
4437000|NCT00430248|7220710|FG002|Overall Study|Protocol Violation|4
4437001|NCT00430248|7220708|FG000|Overall Study|Personal Reasons|12
4437002|NCT00430248|7220709|FG001|Overall Study|Personal Reasons|24
4437003|NCT00430248|7220710|FG002|Overall Study|Personal Reasons|9
4437004|NCT00430248|7220708|FG000|Overall Study|Lost to Follow-up|28
4437005|NCT00430248|7220709|FG001|Overall Study|Lost to Follow-up|33
4437006|NCT00430248|7220710|FG002|Overall Study|Lost to Follow-up|28
4437007|NCT00430248|7220708|FG000|Overall Study|Therapeutic Failure|1
4437008|NCT00430248|7220709|FG001|Overall Study|Therapeutic Failure|1
4437009|NCT00430248|7220710|FG002|Overall Study|Therapeutic Failure|1
4437010|NCT00430248|7220708|FG000|Overall Study|Withdrawal by Subject|14
4437011|NCT00430248|7220709|FG001|Overall Study|Withdrawal by Subject|20
4437012|NCT00430248|7220710|FG002|Overall Study|Withdrawal by Subject|16
4437013|NCT00430248|7220708|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0
4437014|NCT00430248|7220709|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2
4437015|NCT00430248|7220710|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0
4437016|NCT00430248|7220708|FG000|Overall Study|Gout Flare|3
4437017|NCT00430248|7220709|FG001|Overall Study|Gout Flare|7
4437018|NCT00430248|7220710|FG002|Overall Study|Gout Flare|2
4437019|NCT00430248|7220708|FG000|Overall Study|Reason Not Specified|8
4437020|NCT00430248|7220709|FG001|Overall Study|Reason Not Specified|8
4437021|NCT00430248|7220710|FG002|Overall Study|Reason Not Specified|11
4437022|NCT00430300|7220722|FG000|Overall Study|Adverse Event|0
4437023|NCT00430300|7220723|FG001|Overall Study|Adverse Event|2
4437024|NCT00430300|7220724|FG002|Overall Study|Adverse Event|1
4437025|NCT00430300|7220725|FG003|Overall Study|Adverse Event|1
4437026|NCT00430300|7220722|FG000|Overall Study|Withdrawal by Subject|1
4437027|NCT00430300|7220723|FG001|Overall Study|Withdrawal by Subject|0
4437028|NCT00430300|7220724|FG002|Overall Study|Withdrawal by Subject|5
4437029|NCT00430300|7220725|FG003|Overall Study|Withdrawal by Subject|0
4437030|NCT00430300|7220722|FG000|Overall Study|Laboratory abnormality|1
4437031|NCT00430300|7220723|FG001|Overall Study|Laboratory abnormality|0
4437032|NCT00430300|7220724|FG002|Overall Study|Laboratory abnormality|0
4437033|NCT00430300|7220725|FG003|Overall Study|Laboratory abnormality|0
4437034|NCT00430300|7220722|FG000|Overall Study|Other|0
4437035|NCT00430300|7220723|FG001|Overall Study|Other|0
4437036|NCT00430300|7220724|FG002|Overall Study|Other|0
4437037|NCT00430300|7220725|FG003|Overall Study|Other|1
4437038|NCT00430352|7220735|FG000|Overall Study|Disease progression|58
4437039|NCT00430352|7220735|FG000|Overall Study|Withdrawal by Subject|11
4437040|NCT00430352|7220735|FG000|Overall Study|Adverse Event|16
4437041|NCT00430352|7220735|FG000|Overall Study|Death|5
4437042|NCT00430352|7220735|FG000|Overall Study|Other|48
4437043|NCT00430482|7220741|FG000|Completed Treatment|Insufficient Treatment|7
4437044|NCT00430482|7220742|FG001|Completed Treatment|Insufficient Treatment|11
4437045|NCT00430495|7220752|FG000|Overall Study|Adverse Event|2
4437046|NCT00430495|7220753|FG001|Overall Study|Adverse Event|3
4437047|NCT00430495|7220754|FG002|Overall Study|Adverse Event|2
4437048|NCT00430495|7220755|FG003|Overall Study|Adverse Event|0
4437049|NCT00430495|7220752|FG000|Overall Study|Death|0
4437050|NCT00430495|7220753|FG001|Overall Study|Death|0
4437051|NCT00430495|7220754|FG002|Overall Study|Death|1
4437052|NCT00430495|7220755|FG003|Overall Study|Death|0
4437053|NCT00430495|7220752|FG000|Overall Study|Lost to Follow-up|0
4437054|NCT00430495|7220753|FG001|Overall Study|Lost to Follow-up|1
4437055|NCT00430495|7220754|FG002|Overall Study|Lost to Follow-up|4
4437056|NCT00430495|7220755|FG003|Overall Study|Lost to Follow-up|0
4437057|NCT00430495|7220752|FG000|Overall Study|Protocol Violation|1
4437058|NCT00430495|7220753|FG001|Overall Study|Protocol Violation|0
4437059|NCT00430495|7220754|FG002|Overall Study|Protocol Violation|1
4437060|NCT00430495|7220755|FG003|Overall Study|Protocol Violation|0
4437061|NCT00430495|7220752|FG000|Overall Study|Disease Progression|1
4437062|NCT00430495|7220753|FG001|Overall Study|Disease Progression|1
4437063|NCT00430495|7220754|FG002|Overall Study|Disease Progression|0
4437064|NCT00430495|7220755|FG003|Overall Study|Disease Progression|0
4437065|NCT00430495|7220752|FG000|Overall Study|Other|8
4437066|NCT00430495|7220753|FG001|Overall Study|Other|2
4437067|NCT00430495|7220754|FG002|Overall Study|Other|5
4437068|NCT00430495|7220755|FG003|Overall Study|Other|4
4437069|NCT00430495|7220752|FG000|Overall Study|Randomized but not Treated|2
4437070|NCT00430495|7220753|FG001|Overall Study|Randomized but not Treated|0
4437071|NCT00430495|7220754|FG002|Overall Study|Randomized but not Treated|0
4437072|NCT00430495|7220755|FG003|Overall Study|Randomized but not Treated|0
4437073|NCT00430521|7220773|FG000|Overall Study|Adverse Event|0
4437074|NCT00430521|7220774|FG001|Overall Study|Adverse Event|0
4437075|NCT00430521|7220775|FG002|Overall Study|Adverse Event|0
4437076|NCT00430521|7220776|FG003|Overall Study|Adverse Event|0
4437077|NCT00430521|7220777|FG004|Overall Study|Adverse Event|0
4437078|NCT00430521|7220778|FG005|Overall Study|Adverse Event|2
4437079|NCT00430521|7220779|FG006|Overall Study|Adverse Event|1
4437080|NCT00430521|7220780|FG007|Overall Study|Adverse Event|0
4437081|NCT00430521|7220773|FG000|Overall Study|Lost to Follow-up|7
4437082|NCT00430521|7220774|FG001|Overall Study|Lost to Follow-up|8
4437083|NCT00430521|7220775|FG002|Overall Study|Lost to Follow-up|3
4437084|NCT00430521|7220776|FG003|Overall Study|Lost to Follow-up|5
4437085|NCT00430521|7220777|FG004|Overall Study|Lost to Follow-up|5
4437086|NCT00430521|7220778|FG005|Overall Study|Lost to Follow-up|2
4437087|NCT00430521|7220779|FG006|Overall Study|Lost to Follow-up|8
4437088|NCT00430521|7220780|FG007|Overall Study|Lost to Follow-up|10
4437089|NCT00430521|7220773|FG000|Overall Study|Pregnancy|0
4437090|NCT00430521|7220774|FG001|Overall Study|Pregnancy|0
4437091|NCT00430521|7220775|FG002|Overall Study|Pregnancy|0
4437092|NCT00430521|7220776|FG003|Overall Study|Pregnancy|0
4437093|NCT00430521|7220777|FG004|Overall Study|Pregnancy|0
4437094|NCT00430521|7220778|FG005|Overall Study|Pregnancy|0
4437095|NCT00430521|7220779|FG006|Overall Study|Pregnancy|1
4437096|NCT00430521|7220780|FG007|Overall Study|Pregnancy|0
4437097|NCT00430521|7220773|FG000|Overall Study|Vaccine Expired|0
4437098|NCT00430521|7220774|FG001|Overall Study|Vaccine Expired|0
4437099|NCT00430521|7220775|FG002|Overall Study|Vaccine Expired|0
4437100|NCT00430521|7220776|FG003|Overall Study|Vaccine Expired|0
4437101|NCT00430521|7220777|FG004|Overall Study|Vaccine Expired|0
4437102|NCT00430521|7220778|FG005|Overall Study|Vaccine Expired|1
4437103|NCT00430521|7220779|FG006|Overall Study|Vaccine Expired|0
4437104|NCT00430521|7220780|FG007|Overall Study|Vaccine Expired|0
4437105|NCT00430521|7220773|FG000|Overall Study|Protocol Violation|1
4437106|NCT00430521|7220774|FG001|Overall Study|Protocol Violation|0
4437107|NCT00430521|7220775|FG002|Overall Study|Protocol Violation|0
4437108|NCT00430521|7220776|FG003|Overall Study|Protocol Violation|0
4437109|NCT00430521|7220777|FG004|Overall Study|Protocol Violation|0
4437110|NCT00430521|7220778|FG005|Overall Study|Protocol Violation|0
4437111|NCT00430521|7220779|FG006|Overall Study|Protocol Violation|0
4437112|NCT00430521|7220780|FG007|Overall Study|Protocol Violation|0
4437113|NCT00430521|7220773|FG000|Overall Study|Withdrawal by Subject|3
4437114|NCT00430521|7220774|FG001|Overall Study|Withdrawal by Subject|1
4437115|NCT00430521|7220775|FG002|Overall Study|Withdrawal by Subject|0
4437116|NCT00430521|7220776|FG003|Overall Study|Withdrawal by Subject|3
4437117|NCT00430521|7220777|FG004|Overall Study|Withdrawal by Subject|0
4437118|NCT00430521|7220778|FG005|Overall Study|Withdrawal by Subject|0
4437119|NCT00430521|7220779|FG006|Overall Study|Withdrawal by Subject|0
4437120|NCT00430521|7220780|FG007|Overall Study|Withdrawal by Subject|2
4437121|NCT00430573|7220811|FG000|Overall Study|Withdrawal by Subject|5
4437122|NCT00430638|7220828|FG000|Overall Study|Adverse Event|15
4437123|NCT00430638|7220829|FG001|Overall Study|Adverse Event|15
4437124|NCT00430638|7220828|FG000|Overall Study|Uncontrolled blood pressure|48
4437125|NCT00430638|7220829|FG001|Overall Study|Uncontrolled blood pressure|13
4437126|NCT00430638|7220828|FG000|Overall Study|Lost to Follow-up|1
4437127|NCT00430638|7220829|FG001|Overall Study|Lost to Follow-up|7
4437128|NCT00430638|7220828|FG000|Overall Study|Protocol Violation|6
4437129|NCT00430638|7220829|FG001|Overall Study|Protocol Violation|4
4437130|NCT00430638|7220828|FG000|Overall Study|Withdrawal by Subject|4
4437131|NCT00430638|7220829|FG001|Overall Study|Withdrawal by Subject|6
4437132|NCT00430638|7220828|FG000|Overall Study|Non-compliant|2
4437133|NCT00430638|7220829|FG001|Overall Study|Non-compliant|1
4437134|NCT00430638|7220828|FG000|Overall Study|Other|2
4437135|NCT00430638|7220829|FG001|Overall Study|Other|2
4437136|NCT00430677|7220842|FG000|Short-term Period|Death|1
4437137|NCT00430677|7220843|FG001|Short-term Period|Death|1
4437138|NCT00430677|7220844|FG002|Short-term Period|Death|5
4437139|NCT00430677|7220842|FG000|Short-term Period|Adverse Event|15
4437140|NCT00430677|7220843|FG001|Short-term Period|Adverse Event|13
4437141|NCT00430677|7220844|FG002|Short-term Period|Adverse Event|9
4437142|NCT00430677|7220842|FG000|Short-term Period|Lack of Efficacy|5
4437143|NCT00430677|7220843|FG001|Short-term Period|Lack of Efficacy|6
4437144|NCT00430677|7220844|FG002|Short-term Period|Lack of Efficacy|4
4437145|NCT00430677|7220842|FG000|Short-term Period|Withdrawal by Subject|1
4437146|NCT00430677|7220843|FG001|Short-term Period|Withdrawal by Subject|1
4437147|NCT00430677|7220844|FG002|Short-term Period|Withdrawal by Subject|2
4437148|NCT00430677|7220842|FG000|Short-term Period|Participant no longer met study criteria|1
4437149|NCT00430677|7220843|FG001|Short-term Period|Participant no longer met study criteria|1
4437150|NCT00430677|7220844|FG002|Short-term Period|Participant no longer met study criteria|2
4437151|NCT00430677|7220842|FG000|Short-term Period|Poor compliance/ noncompliance|0
4437152|NCT00430677|7220843|FG001|Short-term Period|Poor compliance/ noncompliance|1
4437153|NCT00430677|7220844|FG002|Short-term Period|Poor compliance/ noncompliance|0
4437154|NCT00430677|7220842|FG000|Short-term Period|Pregnancy|0
4437155|NCT00430677|7220843|FG001|Short-term Period|Pregnancy|2
4437156|NCT00430677|7220844|FG002|Short-term Period|Pregnancy|0
4437157|NCT00430677|7220842|FG000|Long-term Extension Period|Death|1
4437158|NCT00430677|7220843|FG001|Long-term Extension Period|Death|0
4437159|NCT00430677|7220844|FG002|Long-term Extension Period|Death|0
4437160|NCT00430677|7220842|FG000|Long-term Extension Period|Adverse Event|3
4437161|NCT00430677|7220843|FG001|Long-term Extension Period|Adverse Event|2
4437162|NCT00430677|7220844|FG002|Long-term Extension Period|Adverse Event|5
4437163|NCT00430677|7220842|FG000|Long-term Extension Period|Lack of Efficacy|5
4437164|NCT00430677|7220843|FG001|Long-term Extension Period|Lack of Efficacy|3
4437165|NCT00430677|7220844|FG002|Long-term Extension Period|Lack of Efficacy|8
4437166|NCT00430677|7220842|FG000|Long-term Extension Period|Lost to Follow-up|1
4437167|NCT00430677|7220843|FG001|Long-term Extension Period|Lost to Follow-up|1
4437168|NCT00430677|7220844|FG002|Long-term Extension Period|Lost to Follow-up|1
4437169|NCT00430677|7220842|FG000|Long-term Extension Period|Withdrawal by Subject|5
4437170|NCT00430677|7220843|FG001|Long-term Extension Period|Withdrawal by Subject|1
4437171|NCT00430677|7220844|FG002|Long-term Extension Period|Withdrawal by Subject|2
4437172|NCT00430677|7220842|FG000|Long-term Extension Period|Pregnancy|1
4437173|NCT00430677|7220843|FG001|Long-term Extension Period|Pregnancy|1
4437174|NCT00430677|7220844|FG002|Long-term Extension Period|Pregnancy|0
4437175|NCT00430677|7220842|FG000|Long-term Extension Period|Administrative reason by sponsor|41
4437176|NCT00430677|7220843|FG001|Long-term Extension Period|Administrative reason by sponsor|49
4437177|NCT00430677|7220844|FG002|Long-term Extension Period|Administrative reason by sponsor|46
4437178|NCT00430677|7220842|FG000|Long-term Extension Period|Other|2
4437179|NCT00430677|7220843|FG001|Long-term Extension Period|Other|1
4437180|NCT00430677|7220844|FG002|Long-term Extension Period|Other|1
4437181|NCT00430677|7220842|FG000|Long-term Extension Period|Poor compliance/noncompliance|1
4437182|NCT00430677|7220843|FG001|Long-term Extension Period|Poor compliance/noncompliance|0
4437183|NCT00430677|7220844|FG002|Long-term Extension Period|Poor compliance/noncompliance|0
4437184|NCT00430716|7220873|FG000|Double Blind Phase|Death|1
4437185|NCT00430716|7220874|FG001|Double Blind Phase|Death|0
4437186|NCT00430716|7220875|FG002|Double Blind Phase|Death|0
4437187|NCT00430716|7220873|FG000|Double Blind Phase|No longer willing to participate|2
4437188|NCT00430716|7220874|FG001|Double Blind Phase|No longer willing to participate|1
4437189|NCT00430716|7220875|FG002|Double Blind Phase|No longer willing to participate|1
4437190|NCT00430716|7220873|FG000|Double Blind Phase|Other|0
4437191|NCT00430716|7220874|FG001|Double Blind Phase|Other|2
4437192|NCT00430716|7220875|FG002|Double Blind Phase|Other|0
4437193|NCT00430716|7220873|FG000|Double Blind Phase|Study terminated by sponsor|1
4437194|NCT00430716|7220874|FG001|Double Blind Phase|Study terminated by sponsor|1
4437195|NCT00430716|7220875|FG002|Double Blind Phase|Study terminated by sponsor|2
4437196|NCT00430716|7220873|FG000|Double Blind Phase|Adverse Event|1
4437197|NCT00430716|7220874|FG001|Double Blind Phase|Adverse Event|1
4437198|NCT00430716|7220875|FG002|Double Blind Phase|Adverse Event|3
4437199|NCT00430716|7220873|FG000|Double Blind Phase|Not treated|1
4437200|NCT00430716|7220874|FG001|Double Blind Phase|Not treated|0
4437201|NCT00430716|7220875|FG002|Double Blind Phase|Not treated|0
4437202|NCT00430716|7220873|FG000|Open Label Phase|Lost to Follow-up|1
4437203|NCT00430716|7220874|FG001|Open Label Phase|Lost to Follow-up|0
4437204|NCT00430716|7220875|FG002|Open Label Phase|Lost to Follow-up|1
4437205|NCT00430716|7220873|FG000|Open Label Phase|No longer willing to participate|0
4437206|NCT00430716|7220874|FG001|Open Label Phase|No longer willing to participate|1
4437207|NCT00430716|7220875|FG002|Open Label Phase|No longer willing to participate|1
4437208|NCT00430716|7220873|FG000|Open Label Phase|Other|3
4437209|NCT00430716|7220874|FG001|Open Label Phase|Other|1
4437210|NCT00430716|7220875|FG002|Open Label Phase|Other|1
4437211|NCT00430716|7220873|FG000|Open Label Phase|Protocol Violation|1
4437212|NCT00430716|7220874|FG001|Open Label Phase|Protocol Violation|0
4437213|NCT00430716|7220875|FG002|Open Label Phase|Protocol Violation|0
4437214|NCT00430716|7220873|FG000|Open Label Phase|Study terminated by sponsor|4
4437215|NCT00430716|7220874|FG001|Open Label Phase|Study terminated by sponsor|5
4437216|NCT00430716|7220875|FG002|Open Label Phase|Study terminated by sponsor|4
4437217|NCT00430755|7220883|FG000|Overall Study|Withdrawal by Subject|53
4437218|NCT00430781|7220909|FG000|Interim Analysis; 11 February 2008|Adverse Event|10
4437219|NCT00430781|7220910|FG001|Interim Analysis; 11 February 2008|Adverse Event|3
4437220|NCT00430781|7220911|FG002|Interim Analysis; 11 February 2008|Adverse Event|7
4437221|NCT00430781|7220909|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1
4437222|NCT00430781|7220910|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0
4437223|NCT00430781|7220911|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1
4437224|NCT00430781|7220909|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0
4437225|NCT00430781|7220910|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1
4437226|NCT00430781|7220911|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0
4437227|NCT00430781|7220909|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4
4437228|NCT00430781|7220910|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0
4437229|NCT00430781|7220911|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2
4437230|NCT00430781|7220909|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1
4437231|NCT00430781|7220910|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0
4437232|NCT00430781|7220911|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0
4437233|NCT00430781|7220909|FG000|Interim Analysis; 11 February 2008|Disease Progression|16
4437234|NCT00430781|7220910|FG001|Interim Analysis; 11 February 2008|Disease Progression|30
4437235|NCT00430781|7220911|FG002|Interim Analysis; 11 February 2008|Disease Progression|22
4437236|NCT00430781|7220909|FG000|Interim Analysis; 11 February 2008|Death|0
4437237|NCT00430781|7220910|FG001|Interim Analysis; 11 February 2008|Death|1
4437238|NCT00430781|7220911|FG002|Interim Analysis; 11 February 2008|Death|0
4437239|NCT00430781|7220909|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2
4437240|NCT00430781|7220910|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0
4437241|NCT00430781|7220911|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0
4437242|NCT00430781|7220909|FG000|Interim Analysis; 11 February 2008|Physician Decision|2
4437243|NCT00430781|7220910|FG001|Interim Analysis; 11 February 2008|Physician Decision|3
4437244|NCT00430781|7220911|FG002|Interim Analysis; 11 February 2008|Physician Decision|3
4437245|NCT00430781|7220909|FG000|Interim Analysis; 11 February 2008|Ongoing|23
4437246|NCT00430781|7220910|FG001|Interim Analysis; 11 February 2008|Ongoing|20
4437247|NCT00430781|7220911|FG002|Interim Analysis; 11 February 2008|Ongoing|25
4437248|NCT00430781|7220909|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0
4437249|NCT00430781|7220910|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0
4437250|NCT00430781|7220911|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3
4437251|NCT00430781|7220909|FG000|Final Analysis; 31 July 2008|Protocol Violation|0
4437252|NCT00430781|7220910|FG001|Final Analysis; 31 July 2008|Protocol Violation|1
4437253|NCT00430781|7220911|FG002|Final Analysis; 31 July 2008|Protocol Violation|0
4437254|NCT00430781|7220909|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0
4437255|NCT00430781|7220910|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2
4437256|NCT00430781|7220911|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7
4437257|NCT00430781|7220909|FG000|Final Analysis; 31 July 2008|Physician Decision|0
4437258|NCT00430781|7220910|FG001|Final Analysis; 31 July 2008|Physician Decision|6
4437259|NCT00430781|7220911|FG002|Final Analysis; 31 July 2008|Physician Decision|6
4437260|NCT00430781|7220909|FG000|Final Analysis; 31 July 2008|Other|0
4437261|NCT00430781|7220910|FG001|Final Analysis; 31 July 2008|Other|1
4437262|NCT00430781|7220911|FG002|Final Analysis; 31 July 2008|Other|0
4437263|NCT00430781|7220909|FG000|Final Analysis; 31 July 2008|Ongoing|0
4437264|NCT00430781|7220910|FG001|Final Analysis; 31 July 2008|Ongoing|29
4437265|NCT00430781|7220911|FG002|Final Analysis; 31 July 2008|Ongoing|32
4437266|NCT00430781|7220909|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5
4437267|NCT00430781|7220910|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3
4437268|NCT00430781|7220911|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3
4437269|NCT00430781|7220909|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0
4437270|NCT00430781|7220910|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1
4437271|NCT00430781|7220911|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0
4437272|NCT00430781|7220909|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7
4437273|NCT00430781|7220910|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2
4437274|NCT00430781|7220911|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7
4437275|NCT00430781|7220909|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4
4437276|NCT00430781|7220910|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5
4437277|NCT00430781|7220911|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4
4437278|NCT00430781|7220909|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4
4437279|NCT00430781|7220910|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6
4437280|NCT00430781|7220911|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6
4437281|NCT00430781|7220909|FG000|End-of-Study Analysis; 28 July 2011|Other|4
4437282|NCT00430781|7220910|FG001|End-of-Study Analysis; 28 July 2011|Other|1
4437283|NCT00430781|7220911|FG002|End-of-Study Analysis; 28 July 2011|Other|0
4437284|NCT00430937|7220924|FG000|Overall Study|Adverse Event|3
4437285|NCT00430937|7220925|FG001|Overall Study|Adverse Event|8
4437286|NCT00430937|7220924|FG000|Overall Study|Death|0
4437287|NCT00430937|7220925|FG001|Overall Study|Death|1
4437288|NCT00430937|7220924|FG000|Overall Study|Lost to Follow-up|6
4437289|NCT00430937|7220925|FG001|Overall Study|Lost to Follow-up|6
4437290|NCT00430937|7220924|FG000|Overall Study|Withdrawal by Subject|5
4437291|NCT00430937|7220925|FG001|Overall Study|Withdrawal by Subject|2
4437292|NCT00430937|7220924|FG000|Overall Study|Protocol Violation|3
4437293|NCT00430937|7220925|FG001|Overall Study|Protocol Violation|2
4437294|NCT00430937|7220924|FG000|Overall Study|Lack of Efficacy|6
4437295|NCT00430937|7220925|FG001|Overall Study|Lack of Efficacy|5
4437296|NCT00430937|7220924|FG000|Overall Study|Inappropriate enrollment|2
4437297|NCT00430937|7220925|FG001|Overall Study|Inappropriate enrollment|1
4437298|NCT00430937|7220924|FG000|Overall Study|Administrative reasons|1
4437299|NCT00430937|7220925|FG001|Overall Study|Administrative reasons|0
4437300|NCT00430937|7220924|FG000|Overall Study|Protocol discontinuation criteria met|1
4437301|NCT00430937|7220925|FG001|Overall Study|Protocol discontinuation criteria met|2
4437302|NCT00430937|7220924|FG000|Overall Study|Unable to classify|0
4437303|NCT00430937|7220925|FG001|Overall Study|Unable to classify|1
4437304|NCT00430989|7220933|FG000|Overall Study|Lost to Follow-up|2
4437305|NCT00430989|7220934|FG001|Overall Study|Lost to Follow-up|3
4437306|NCT00430989|7220933|FG000|Overall Study|Withdrawal by Subject|15
4437307|NCT00430989|7220934|FG001|Overall Study|Withdrawal by Subject|14
4437308|NCT00430989|7220933|FG000|Overall Study|Protocol Violation|30
4437309|NCT00430989|7220934|FG001|Overall Study|Protocol Violation|37
4437310|NCT00430989|7220933|FG000|Overall Study|Not eligible|13
4437311|NCT00430989|7220934|FG001|Overall Study|Not eligible|6
4437312|NCT00431067|7220951|FG000|Overall Study|Other Adverse Event|9
4437313|NCT00431067|7220951|FG000|Overall Study|Progressive disease|30
4437314|NCT00431067|7220951|FG000|Overall Study|Non-compliance,lost to follow-up|2
4512801|NCT00937521|7322823|FG001|Booster Phase|Lost to Follow-up|2
4512802|NCT00937521|7322824|FG002|Booster Phase|Lost to Follow-up|4
4512803|NCT00937521|7322825|FG003|Booster Phase|Lost to Follow-up|2
4512804|NCT00937521|7322826|FG004|Booster Phase|Lost to Follow-up|4
4437315|NCT00431444|7220972|FG000|Overall Study|Protocol Violation|1
4437316|NCT00431444|7220973|FG001|Overall Study|Protocol Violation|4
4437317|NCT00431444|7220972|FG000|Overall Study|Adverse Event|2
4437318|NCT00431444|7220973|FG001|Overall Study|Adverse Event|1
4437319|NCT00431444|7220972|FG000|Overall Study|Withdrawal by Subject|1
4437320|NCT00431444|7220973|FG001|Overall Study|Withdrawal by Subject|1
4437321|NCT00431444|7220972|FG000|Overall Study|Lost to Follow-up|1
4437322|NCT00431444|7220973|FG001|Overall Study|Lost to Follow-up|0
4437323|NCT00431444|7220972|FG000|Overall Study|Administrative Problems|0
4437324|NCT00431444|7220973|FG001|Overall Study|Administrative Problems|1
4437325|NCT00431496|7220979|FG000|Overall Study|Adverse Event|3
4437326|NCT00431496|7220979|FG000|Overall Study|Lost to Follow-up|1
4437327|NCT00431496|7220979|FG000|Overall Study|Withdrawal by Subject|2
4437328|NCT00431496|7220979|FG000|Overall Study|Protocol-specified criteria|5
4437329|NCT00431834|7220992|FG000|Overall Study|Withdrawal by Subject|7
4437330|NCT00431834|7220992|FG000|Overall Study|Death|3
4437331|NCT00431834|7220992|FG000|Overall Study|Missed Endpoint Visit|2
4437332|NCT00431834|7220992|FG000|Overall Study|Lost to Follow-up|1
4437333|NCT00431847|7221003|FG000|Overall Study|completion of less than two study visits|6
4437334|NCT00431847|7221004|FG001|Overall Study|completion of less than two study visits|3
4437335|NCT00431847|7221005|FG002|Overall Study|completion of less than two study visits|4
4437336|NCT00431847|7221006|FG003|Overall Study|completion of less than two study visits|14
4437337|NCT00431847|7221007|FG004|Overall Study|completion of less than two study visits|0
4437338|NCT00431847|7221003|FG000|Overall Study|Protocol Violation|0
4437339|NCT00431847|7221004|FG001|Overall Study|Protocol Violation|0
4437340|NCT00431847|7221005|FG002|Overall Study|Protocol Violation|0
4437341|NCT00431847|7221006|FG003|Overall Study|Protocol Violation|0
4437342|NCT00431847|7221007|FG004|Overall Study|Protocol Violation|1
4437343|NCT00431951|7221021|FG000|Overall Study|Inability to follow study procedures|1
4437344|NCT00431951|7221022|FG001|Overall Study|Inability to follow study procedures|0
4437345|NCT00431951|7221023|FG002|Overall Study|Inability to follow study procedures|1
4437346|NCT00431951|7221024|FG003|Overall Study|Inability to follow study procedures|2
4437347|NCT00431951|7221021|FG000|Overall Study|Lost to Follow-up|0
4437348|NCT00431951|7221022|FG001|Overall Study|Lost to Follow-up|1
4437349|NCT00431951|7221023|FG002|Overall Study|Lost to Follow-up|0
4437350|NCT00431951|7221024|FG003|Overall Study|Lost to Follow-up|0
4437351|NCT00431951|7221021|FG000|Overall Study|Withdrawal by Subject|0
4437352|NCT00431951|7221022|FG001|Overall Study|Withdrawal by Subject|1
4437353|NCT00431951|7221023|FG002|Overall Study|Withdrawal by Subject|0
4437354|NCT00431951|7221024|FG003|Overall Study|Withdrawal by Subject|0
4437355|NCT00431951|7221021|FG000|Overall Study|Adverse Event|0
4437356|NCT00431951|7221022|FG001|Overall Study|Adverse Event|0
4437357|NCT00431951|7221023|FG002|Overall Study|Adverse Event|1
4437358|NCT00431951|7221024|FG003|Overall Study|Adverse Event|0
4437359|NCT00431964|7221040|FG000|Overall Study|Adverse Event|1
4437360|NCT00431964|7221041|FG001|Overall Study|Adverse Event|0
4437361|NCT00431964|7221040|FG000|Overall Study|Lost to Follow-up|1
4437362|NCT00431964|7221041|FG001|Overall Study|Lost to Follow-up|2
4437363|NCT00431964|7221040|FG000|Overall Study|Physician Decision|2
4437364|NCT00431964|7221041|FG001|Overall Study|Physician Decision|2
4437365|NCT00431964|7221040|FG000|Overall Study|Withdrawal by Subject|2
4437366|NCT00431964|7221041|FG001|Overall Study|Withdrawal by Subject|1
4437367|NCT00431964|7221040|FG000|Overall Study|Parental Consent Withdrawn|0
4437368|NCT00431964|7221041|FG001|Overall Study|Parental Consent Withdrawn|2
4437369|NCT00431964|7221040|FG000|Overall Study|Due to Unstable Health|0
4437370|NCT00431964|7221041|FG001|Overall Study|Due to Unstable Health|1
4437371|NCT00432042|7221050|FG000|Overall Study|Protocol Violation|2
4437372|NCT00432042|7221051|FG001|Overall Study|Protocol Violation|0
4437373|NCT00432042|7221052|FG002|Overall Study|Protocol Violation|0
4437374|NCT00432042|7221050|FG000|Overall Study|Withdrawal by Subject|0
4437375|NCT00432042|7221051|FG001|Overall Study|Withdrawal by Subject|0
4437376|NCT00432042|7221052|FG002|Overall Study|Withdrawal by Subject|2
4437377|NCT00432042|7221050|FG000|Overall Study|Lost to Follow-up|5
4437378|NCT00432042|7221051|FG001|Overall Study|Lost to Follow-up|1
4437379|NCT00432042|7221052|FG002|Overall Study|Lost to Follow-up|0
4437380|NCT00432159|7221065|FG000|Overall Study|Death|0
4437381|NCT00432159|7221066|FG001|Overall Study|Death|1
4437382|NCT00432159|7221067|FG002|Overall Study|Death|0
4437383|NCT00432159|7221068|FG003|Overall Study|Death|0
4437384|NCT00432159|7221069|FG004|Overall Study|Death|0
4437385|NCT00432159|7221065|FG000|Overall Study|Failure|9
4437386|NCT00432159|7221066|FG001|Overall Study|Failure|5
4437387|NCT00432159|7221067|FG002|Overall Study|Failure|3
4437388|NCT00432159|7221068|FG003|Overall Study|Failure|2
4437389|NCT00432159|7221069|FG004|Overall Study|Failure|3
4437390|NCT00432159|7221065|FG000|Overall Study|Missing NDI and/or neuro. assessment|13
4437391|NCT00432159|7221066|FG001|Overall Study|Missing NDI and/or neuro. assessment|24
4437392|NCT00432159|7221067|FG002|Overall Study|Missing NDI and/or neuro. assessment|1
4437393|NCT00432159|7221068|FG003|Overall Study|Missing NDI and/or neuro. assessment|3
4437394|NCT00432159|7221069|FG004|Overall Study|Missing NDI and/or neuro. assessment|7
4437395|NCT00432172|7221085|FG000|Overall Study|Physician Decision|0
4437396|NCT00432172|7221086|FG001|Overall Study|Physician Decision|0
4437397|NCT00432172|7221087|FG002|Overall Study|Physician Decision|2
4437398|NCT00432172|7221088|FG003|Overall Study|Physician Decision|0
4437399|NCT00432172|7221085|FG000|Overall Study|Adverse Event|4
4437400|NCT00432172|7221086|FG001|Overall Study|Adverse Event|2
4437401|NCT00432172|7221087|FG002|Overall Study|Adverse Event|4
4437402|NCT00432172|7221088|FG003|Overall Study|Adverse Event|3
4437403|NCT00432172|7221085|FG000|Overall Study|Disease progression|0
4437404|NCT00432172|7221086|FG001|Overall Study|Disease progression|2
4437405|NCT00432172|7221087|FG002|Overall Study|Disease progression|5
4437406|NCT00432172|7221088|FG003|Overall Study|Disease progression|1
4437407|NCT00432172|7221085|FG000|Overall Study|Withdrawal by Subject|0
4437408|NCT00432172|7221086|FG001|Overall Study|Withdrawal by Subject|1
4437409|NCT00432172|7221087|FG002|Overall Study|Withdrawal by Subject|0
4437410|NCT00432172|7221088|FG003|Overall Study|Withdrawal by Subject|2
4437411|NCT00432172|7221085|FG000|Overall Study|No treatment received|2
4437412|NCT00432172|7221086|FG001|Overall Study|No treatment received|2
4437413|NCT00432172|7221087|FG002|Overall Study|No treatment received|0
4437414|NCT00432172|7221088|FG003|Overall Study|No treatment received|1
4437415|NCT00432237|7221104|FG000|Overall Study|Adverse Event|0
4437416|NCT00432237|7221105|FG001|Overall Study|Adverse Event|0
4437417|NCT00432237|7221106|FG002|Overall Study|Adverse Event|0
4437418|NCT00432237|7221107|FG003|Overall Study|Adverse Event|1
4437419|NCT00432237|7221104|FG000|Overall Study|Lack of Efficacy|0
4437420|NCT00432237|7221105|FG001|Overall Study|Lack of Efficacy|0
4437421|NCT00432237|7221106|FG002|Overall Study|Lack of Efficacy|0
4437422|NCT00432237|7221107|FG003|Overall Study|Lack of Efficacy|1
4437423|NCT00432237|7221104|FG000|Overall Study|Lost to Follow-up|10
4437424|NCT00432237|7221105|FG001|Overall Study|Lost to Follow-up|10
4437425|NCT00432237|7221106|FG002|Overall Study|Lost to Follow-up|18
4437426|NCT00432237|7221107|FG003|Overall Study|Lost to Follow-up|18
4437427|NCT00432237|7221104|FG000|Overall Study|Physician Decision|1
4437428|NCT00432237|7221105|FG001|Overall Study|Physician Decision|3
4437429|NCT00432237|7221106|FG002|Overall Study|Physician Decision|2
4437430|NCT00432237|7221107|FG003|Overall Study|Physician Decision|1
4437431|NCT00432237|7221104|FG000|Overall Study|Pregnancy|0
4437432|NCT00432237|7221105|FG001|Overall Study|Pregnancy|1
4437433|NCT00432237|7221106|FG002|Overall Study|Pregnancy|0
4437434|NCT00432237|7221107|FG003|Overall Study|Pregnancy|0
4437435|NCT00432237|7221104|FG000|Overall Study|Protocol Violation|13
4437436|NCT00432237|7221105|FG001|Overall Study|Protocol Violation|10
4437437|NCT00432237|7221106|FG002|Overall Study|Protocol Violation|11
4437438|NCT00432237|7221107|FG003|Overall Study|Protocol Violation|8
4437439|NCT00432237|7221104|FG000|Overall Study|Withdrawal by Subject|5
4437440|NCT00432237|7221105|FG001|Overall Study|Withdrawal by Subject|6
4437441|NCT00432237|7221106|FG002|Overall Study|Withdrawal by Subject|9
4437442|NCT00432237|7221107|FG003|Overall Study|Withdrawal by Subject|11
4437443|NCT00432237|7221104|FG000|Overall Study|Lack of Qualifying Event|38
4437444|NCT00432237|7221105|FG001|Overall Study|Lack of Qualifying Event|71
4437445|NCT00432237|7221106|FG002|Overall Study|Lack of Qualifying Event|69
4437446|NCT00432237|7221107|FG003|Overall Study|Lack of Qualifying Event|84
4437447|NCT00432276|7221119|FG000|Overall Study|Hyperglycemic Rescue|44
4437448|NCT00432276|7221120|FG001|Overall Study|Hyperglycemic Rescue|87
4437449|NCT00432276|7221119|FG000|Overall Study|Adverse Event|13
4437450|NCT00432276|7221120|FG001|Overall Study|Adverse Event|16
4437451|NCT00432276|7221119|FG000|Overall Study|Protocol Violation|25
4437452|NCT00432276|7221120|FG001|Overall Study|Protocol Violation|20
4437453|NCT00432276|7221119|FG000|Overall Study|Lost to Follow-up|6
4437454|NCT00432276|7221120|FG001|Overall Study|Lost to Follow-up|2
4437455|NCT00432276|7221119|FG000|Overall Study|Withdrawal by Subject|25
4437456|NCT00432276|7221120|FG001|Overall Study|Withdrawal by Subject|20
4437457|NCT00432276|7221119|FG000|Overall Study|Physician Decision|6
4437458|NCT00432276|7221120|FG001|Overall Study|Physician Decision|8
4437459|NCT00432276|7221119|FG000|Overall Study|Other|2
4437460|NCT00432276|7221120|FG001|Overall Study|Other|3
4437461|NCT00432380|7221138|FG000|Overall Study|Migrated/moved from study area|3
4437462|NCT00432380|7221139|FG001|Overall Study|Migrated/moved from study area|4
4437463|NCT00432380|7221140|FG002|Overall Study|Migrated/moved from study area|1
4437464|NCT00432380|7221138|FG000|Overall Study|Adverse Event|1
4437465|NCT00432380|7221139|FG001|Overall Study|Adverse Event|0
4437466|NCT00432380|7221140|FG002|Overall Study|Adverse Event|0
4437467|NCT00432562|7221160|FG000|Overall Study|Death|3
4437468|NCT00432562|7221161|FG001|Overall Study|Death|0
4437469|NCT00432666|7221178|FG000|Main Period|Adverse Event|1
4437470|NCT00432666|7221179|FG001|Main Period|Adverse Event|1
4437471|NCT00432666|7221178|FG000|Main Period|Consent Withdrawn|1
4437472|NCT00432666|7221179|FG001|Main Period|Consent Withdrawn|0
4437473|NCT00432666|7221178|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1
4437474|NCT00432666|7221179|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0
4437475|NCT00432666|7221178|FG000|Open-Label Extension Period|Lack of Efficacy|6
4437476|NCT00432666|7221179|FG001|Open-Label Extension Period|Lack of Efficacy|0
4437477|NCT00432666|7221178|FG000|Open-Label Extension Period|Adverse Event|5
4437478|NCT00432666|7221179|FG001|Open-Label Extension Period|Adverse Event|0
4437479|NCT00432666|7221178|FG000|Open-Label Extension Period|Consent withdrawn|10
4437480|NCT00432666|7221179|FG001|Open-Label Extension Period|Consent withdrawn|0
4437481|NCT00432666|7221178|FG000|Open-Label Extension Period|Physician Decision|3
4437482|NCT00432666|7221179|FG001|Open-Label Extension Period|Physician Decision|0
4437483|NCT00432679|7221187|FG000|Overall Study|Adverse Event|2
4437484|NCT00432679|7221188|FG001|Overall Study|Adverse Event|1
4437485|NCT00432679|7221187|FG000|Overall Study|Withdrawal by Subject|3
4437486|NCT00432679|7221188|FG001|Overall Study|Withdrawal by Subject|2
4437487|NCT00432744|7221196|FG000|Months 0-6|Withdrawal by Subject|4
4437488|NCT00432744|7221197|FG001|Months 0-6|Withdrawal by Subject|4
4437489|NCT00432744|7221196|FG000|Months 0-6|Too disabled to score|1
4437490|NCT00432744|7221197|FG001|Months 0-6|Too disabled to score|0
4437491|NCT00432744|7221196|FG000|Months 7 - 12|Withdrawal by Subject|1
4437492|NCT00432744|7221197|FG001|Months 7 - 12|Withdrawal by Subject|0
4437493|NCT00432744|7221196|FG000|Months 7 - 12|Too disabled to score|0
4437494|NCT00432744|7221197|FG001|Months 7 - 12|Too disabled to score|1
4437495|NCT00432809|7221206|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2
4437496|NCT00432809|7221207|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0
4437497|NCT00432809|7221208|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0
4437498|NCT00432809|7221206|FG000|1 Year Follow-up|Withdrawal by Subject|7
4437499|NCT00432809|7221207|FG001|1 Year Follow-up|Withdrawal by Subject|0
4437500|NCT00432809|7221208|FG002|1 Year Follow-up|Withdrawal by Subject|1
4437501|NCT00432835|7221218|FG000|Overall Study|Adverse event: lead dislodgement.|6
4437502|NCT00432835|7221219|FG001|Overall Study|Adverse event: lead dislodgement.|7
4437503|NCT00432965|7221227|FG000|Overall Study|Lost to Follow-up|22
4437504|NCT00432965|7221228|FG001|Overall Study|Lost to Follow-up|19
4437505|NCT00432965|7221227|FG000|Overall Study|Withdrawal by Subject|13
4437506|NCT00432965|7221228|FG001|Overall Study|Withdrawal by Subject|13
4437507|NCT00432965|7221227|FG000|Overall Study|Physician Decision|14
4437508|NCT00432965|7221228|FG001|Overall Study|Physician Decision|13
4437509|NCT00432965|7221227|FG000|Overall Study|Lack of Efficacy|8
4437510|NCT00432965|7221228|FG001|Overall Study|Lack of Efficacy|13
4437511|NCT00432965|7221227|FG000|Overall Study|Non-compliance|7
4437512|NCT00432965|7221228|FG001|Overall Study|Non-compliance|0
4437513|NCT00432965|7221227|FG000|Overall Study|Adverse Event|22
4437514|NCT00432965|7221228|FG001|Overall Study|Adverse Event|19
4437515|NCT00432965|7221227|FG000|Overall Study|Death|3
4437516|NCT00432965|7221228|FG001|Overall Study|Death|4
4437517|NCT00432965|7221227|FG000|Overall Study|Exclusionary Methods|1
4437518|NCT00432965|7221228|FG001|Overall Study|Exclusionary Methods|2
4437519|NCT00432965|7221227|FG000|Overall Study|Incomplete Data|4
4437520|NCT00432965|7221228|FG001|Overall Study|Incomplete Data|3
4437521|NCT00432991|7221236|FG000|Overall Study|Protocol Violation|7
4437522|NCT00432991|7221237|FG001|Overall Study|Protocol Violation|12
4437523|NCT00433004|7221245|FG000|Overall Study|Lost to Follow-up|5
4437524|NCT00433004|7221246|FG001|Overall Study|Lost to Follow-up|7
4437525|NCT00433017|7221254|FG000|Overall Study|Adverse Event|5
4437526|NCT00433017|7221255|FG001|Overall Study|Adverse Event|3
4437527|NCT00433017|7221254|FG000|Overall Study|Withdrawal by Subject|4
4437528|NCT00433017|7221255|FG001|Overall Study|Withdrawal by Subject|5
4437529|NCT00433017|7221254|FG000|Overall Study|Lost to Follow-up|3
4437530|NCT00433017|7221255|FG001|Overall Study|Lost to Follow-up|4
4437531|NCT00433017|7221254|FG000|Overall Study|Administrative problems|80
4437532|NCT00433017|7221255|FG001|Overall Study|Administrative problems|86
4437533|NCT00433017|7221254|FG000|Overall Study|Protocol Violation|1
4437534|NCT00433017|7221255|FG001|Overall Study|Protocol Violation|0
4437535|NCT00433017|7221254|FG000|Overall Study|Death|2
4437536|NCT00433017|7221255|FG001|Overall Study|Death|2
4437537|NCT00433017|7221254|FG000|Overall Study|Subject no longer requires study drug|1
4437538|NCT00433017|7221255|FG001|Overall Study|Subject no longer requires study drug|1
4437539|NCT00433147|7221265|FG000|Overall Study|Adverse Event|0
4437540|NCT00433147|7221266|FG001|Overall Study|Adverse Event|1
4437541|NCT00433147|7221267|FG002|Overall Study|Adverse Event|0
4437542|NCT00433147|7221268|FG003|Overall Study|Adverse Event|0
4437543|NCT00433160|7221280|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6
4437544|NCT00433160|7221281|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2
4437545|NCT00433160|7221280|FG000|52-Week Double-Blind (DB) Period|Death|0
4437546|NCT00433160|7221281|FG001|52-Week Double-Blind (DB) Period|Death|0
4437547|NCT00433160|7221280|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
4437548|NCT00433160|7221281|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
4437549|NCT00433160|7221280|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0
4437550|NCT00433160|7221281|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1
4437551|NCT00433160|7221280|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0
4437552|NCT00433160|7221281|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2
4437553|NCT00433160|7221280|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6
4437554|NCT00433160|7221281|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1
4437555|NCT00433160|7221280|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4
4437556|NCT00433160|7221281|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2
4437557|NCT00433160|7221280|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0
4437558|NCT00433160|7221281|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0
4437559|NCT00433160|7221280|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1
4437560|NCT00433160|7221281|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2
4437561|NCT00433160|7221280|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3
4437562|NCT00433160|7221281|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1
4437563|NCT00433160|7221280|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1
4437564|NCT00433160|7221281|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2
4437565|NCT00433160|7221280|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2
4437566|NCT00433160|7221281|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0
4437567|NCT00433160|7221280|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0
4437568|NCT00433160|7221281|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1
4437569|NCT00433160|7221280|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2
4437570|NCT00433160|7221281|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0
4437571|NCT00433160|7221280|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8
4437572|NCT00433160|7221281|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2
4437573|NCT00433160|7221280|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0
4437574|NCT00433160|7221281|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1
4437575|NCT00433199|7221293|FG000|Double-Blind Period|Adverse Event|0
4437576|NCT00433199|7221294|FG001|Double-Blind Period|Adverse Event|25
4437577|NCT00433199|7221293|FG000|Double-Blind Period|Lack of Efficacy|0
4437578|NCT00433199|7221294|FG001|Double-Blind Period|Lack of Efficacy|2
4437579|NCT00433199|7221293|FG000|Double-Blind Period|Lost to Follow-up|2
4437580|NCT00433199|7221294|FG001|Double-Blind Period|Lost to Follow-up|5
4437581|NCT00433199|7221293|FG000|Double-Blind Period|Withdrawal by Subject|8
4437582|NCT00433199|7221294|FG001|Double-Blind Period|Withdrawal by Subject|19
4437583|NCT00433199|7221293|FG000|Double-Blind Period|Protocol Violation|1
4437584|NCT00433199|7221294|FG001|Double-Blind Period|Protocol Violation|10
4437585|NCT00433199|7221293|FG000|Double-Blind Period|Administrative|1
4437586|NCT00433199|7221294|FG001|Double-Blind Period|Administrative|5
4437587|NCT00433199|7221293|FG000|Open-Label Period|Adverse Event|0
4437588|NCT00433199|7221294|FG001|Open-Label Period|Adverse Event|19
4437589|NCT00433199|7221293|FG000|Open-Label Period|Lack of Efficacy|0
4437590|NCT00433199|7221294|FG001|Open-Label Period|Lack of Efficacy|2
4437591|NCT00433199|7221293|FG000|Open-Label Period|Lost to Follow-up|0
4437592|NCT00433199|7221294|FG001|Open-Label Period|Lost to Follow-up|3
4437593|NCT00433199|7221293|FG000|Open-Label Period|Withdrawal by Subject|0
4437594|NCT00433199|7221294|FG001|Open-Label Period|Withdrawal by Subject|7
4437595|NCT00433199|7221293|FG000|Open-Label Period|Protocol Violation|0
4437596|NCT00433199|7221294|FG001|Open-Label Period|Protocol Violation|2
4437597|NCT00433199|7221293|FG000|Open-Label Period|Administrative|0
4437598|NCT00433199|7221294|FG001|Open-Label Period|Administrative|1
4437599|NCT00433290|7221307|FG000|Overall Study|Adverse Event|24
4437600|NCT00433290|7221308|FG001|Overall Study|Adverse Event|7
4437601|NCT00433290|7221307|FG000|Overall Study|Lack of Efficacy|1
4437602|NCT00433290|7221308|FG001|Overall Study|Lack of Efficacy|5
4437603|NCT00433290|7221307|FG000|Overall Study|Withdrawal by Subject|4
4437604|NCT00433290|7221308|FG001|Overall Study|Withdrawal by Subject|2
4437605|NCT00433290|7221307|FG000|Overall Study|Protocol Violation|3
4437606|NCT00433290|7221308|FG001|Overall Study|Protocol Violation|2
4437607|NCT00433290|7221307|FG000|Overall Study|Physician Decision|2
4437608|NCT00433290|7221308|FG001|Overall Study|Physician Decision|0
4437609|NCT00433290|7221307|FG000|Overall Study|Entry Criteria Not Met|0
4437610|NCT00433290|7221308|FG001|Overall Study|Entry Criteria Not Met|1
4437611|NCT00433290|7221307|FG000|Overall Study|Lost to Follow-up|1
4437612|NCT00433290|7221308|FG001|Overall Study|Lost to Follow-up|0
4437613|NCT00433329|7221314|FG000|Overall Study|Adverse Event|9
4437614|NCT00433329|7221314|FG000|Overall Study|Death|4
4437615|NCT00433329|7221314|FG000|Overall Study|Withdrew consent|3
4437616|NCT00433329|7221314|FG000|Overall Study|Discontinued sildenafil|2
4437617|NCT00433329|7221314|FG000|Overall Study|Moved out of state|1
4437618|NCT00433329|7221314|FG000|Overall Study|Lost to Follow-up|1
4437619|NCT00433329|7221314|FG000|Overall Study|Physician Decision|1
4437620|NCT00433381|7221320|FG000|Overall Study|Ineligible / no protocol treatment|3
4437621|NCT00433381|7221321|FG001|Overall Study|Ineligible / no protocol treatment|3
4437622|NCT00433446|7221335|FG000|Overall Study|Adverse Event|4
4437623|NCT00433446|7221335|FG000|Overall Study|Refusal Unrelated to Adverse Event|1
4437624|NCT00433446|7221335|FG000|Overall Study|Progression|44
4437625|NCT00433446|7221335|FG000|Overall Study|Other - Not Protocol specified|3
4437626|NCT00433446|7221335|FG000|Overall Study|Ineligible|9
4437627|NCT00433537|7221339|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1
4437628|NCT00433537|7221340|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0
4437629|NCT00433537|7221341|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1
4437630|NCT00433537|7221339|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0
4437631|NCT00433537|7221340|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0
4437632|NCT00433537|7221341|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2
4437633|NCT00433537|7221339|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0
4437634|NCT00433537|7221340|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0
4437635|NCT00433537|7221341|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4
4437636|NCT00433537|7221339|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0
4437637|NCT00433537|7221340|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0
4437638|NCT00433537|7221341|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2
4437639|NCT00433537|7221339|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1
4437640|NCT00433537|7221340|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0
4437641|NCT00433537|7221341|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0
4437642|NCT00433537|7221339|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8
4437643|NCT00433537|7221340|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0
4437644|NCT00433537|7221341|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0
4437645|NCT00433537|7221339|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2
4437646|NCT00433537|7221340|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0
4437647|NCT00433537|7221341|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0
4437648|NCT00433537|7221339|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4
4437649|NCT00433537|7221340|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0
4437650|NCT00433537|7221341|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0
4437651|NCT00433537|7221339|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1
4437652|NCT00433537|7221340|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0
4437653|NCT00433537|7221341|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0
4437654|NCT00433654|7221363|FG000|Overall Study|Death|4
4437655|NCT00433654|7221364|FG001|Overall Study|Death|0
4437656|NCT00433654|7221363|FG000|Overall Study|Missed visit|6
4437657|NCT00433654|7221364|FG001|Overall Study|Missed visit|3
4437658|NCT00433654|7221363|FG000|Overall Study|Subject not yet due for visit|4
4437659|NCT00433654|7221364|FG001|Overall Study|Subject not yet due for visit|0
4437660|NCT00433654|7221363|FG000|Overall Study|Withdrawal by Subject|1
4437661|NCT00433654|7221364|FG001|Overall Study|Withdrawal by Subject|2
4437662|NCT00433771|7221381|FG000|Overall Study|screen fail|14
4437663|NCT00433771|7221381|FG000|Overall Study|Treated and later found to be ineligible|2
4437664|NCT00433771|7221381|FG000|Overall Study|Death|2
4437665|NCT00433771|7221381|FG000|Overall Study|Failure to deploy stent|1
4437666|NCT00433836|7221387|FG000|Overall Study|Adverse Event|7
4437667|NCT00433836|7221388|FG001|Overall Study|Adverse Event|0
4437668|NCT00433836|7221387|FG000|Overall Study|Lost to Follow-up|3
4437669|NCT00433836|7221388|FG001|Overall Study|Lost to Follow-up|0
4437670|NCT00433836|7221387|FG000|Overall Study|Withdrawal by Subject|2
4437671|NCT00433836|7221388|FG001|Overall Study|Withdrawal by Subject|1
4437672|NCT00433836|7221387|FG000|Overall Study|Unsatisfactory therapeutic effect|1
4437673|NCT00433836|7221388|FG001|Overall Study|Unsatisfactory therapeutic effect|1
4437674|NCT00433836|7221387|FG000|Overall Study|Protocol Violation|0
4437675|NCT00433836|7221388|FG001|Overall Study|Protocol Violation|2
4437676|NCT00433836|7221387|FG000|Overall Study|Condition no longer requires study drug|0
4437677|NCT00433836|7221388|FG001|Overall Study|Condition no longer requires study drug|1
4437678|NCT00433836|7221387|FG000|Overall Study|Abnormal laboratory values|0
4437679|NCT00433836|7221388|FG001|Overall Study|Abnormal laboratory values|1
4437680|NCT00433914|7221396|FG000|Overall Study|Withdrawal by Subject|0
4437681|NCT00433914|7221397|FG001|Overall Study|Withdrawal by Subject|2
4437682|NCT00433914|7221396|FG000|Overall Study|Lost to Follow-up|0
4437683|NCT00433914|7221397|FG001|Overall Study|Lost to Follow-up|1
4437684|NCT00433966|7221405|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40
4437685|NCT00433966|7221406|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43
4437686|NCT00433966|7221407|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0
4437687|NCT00433966|7221408|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0
4437688|NCT00433966|7221405|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97
4437689|NCT00433966|7221406|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103
4437690|NCT00433966|7221407|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0
4437691|NCT00433966|7221408|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0
4437692|NCT00433966|7221405|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29
4437693|NCT00433966|7221406|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28
4437694|NCT00433966|7221407|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0
4437695|NCT00433966|7221408|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0
4437696|NCT00433966|7221405|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0
4437697|NCT00433966|7221406|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0
4437698|NCT00433966|7221407|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41
4437699|NCT00433966|7221408|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15
4437700|NCT00433966|7221405|FG000|Stent Intervention/Randomization|Lost to Follow-up|0
4437701|NCT00433966|7221406|FG001|Stent Intervention/Randomization|Lost to Follow-up|0
4437702|NCT00433966|7221407|FG002|Stent Intervention/Randomization|Lost to Follow-up|113
4437703|NCT00433966|7221408|FG003|Stent Intervention/Randomization|Lost to Follow-up|47
4437704|NCT00434057|7221441|FG000|Overall Study|Withdrawal by Subject|1
4437705|NCT00434109|7221445|FG000|Overall Study|Physician Decision|9
4437706|NCT00434109|7221445|FG000|Overall Study|Adverse Event|5
4437707|NCT00434109|7221445|FG000|Overall Study|Protocol Violation|1
4437708|NCT00434109|7221445|FG000|Overall Study|had embolism, did not receive sunitinib|3
4437709|NCT00434122|7221451|FG000|Overall Study|Non-compliance with protocol|0
4437710|NCT00434122|7221452|FG001|Overall Study|Non-compliance with protocol|1
4437711|NCT00434122|7221451|FG000|Overall Study|loss of subject contact|1
4437712|NCT00434122|7221452|FG001|Overall Study|loss of subject contact|1
4437713|NCT00434122|7221451|FG000|Overall Study|Personal reasons|1
4437714|NCT00434122|7221452|FG001|Overall Study|Personal reasons|1
4437715|NCT00434122|7221451|FG000|Overall Study|Large follicle size|2
4437716|NCT00434122|7221452|FG001|Overall Study|Large follicle size|2
4437717|NCT00434122|7221451|FG000|Overall Study|Low follicular response.|1
4437718|NCT00434122|7221452|FG001|Overall Study|Low follicular response.|2
4437719|NCT00434122|7221451|FG000|Overall Study|Travelling of subject.|1
4437720|NCT00434122|7221452|FG001|Overall Study|Travelling of subject.|0
4437721|NCT00434148|7221462|FG000|Overall Study|Adverse Event|18
4437722|NCT00434148|7221463|FG001|Overall Study|Adverse Event|18
4437723|NCT00434148|7221462|FG000|Overall Study|Lack of Efficacy|25
4437724|NCT00434148|7221463|FG001|Overall Study|Lack of Efficacy|28
4437725|NCT00434148|7221462|FG000|Overall Study|Withdrawal by Subject|15
4437726|NCT00434148|7221463|FG001|Overall Study|Withdrawal by Subject|15
4437727|NCT00434148|7221462|FG000|Overall Study|Protocol Violation|4
4437728|NCT00434148|7221463|FG001|Overall Study|Protocol Violation|0
4437729|NCT00434148|7221462|FG000|Overall Study|Administrative problems|6
4437730|NCT00434148|7221463|FG001|Overall Study|Administrative problems|10
4437731|NCT00434148|7221462|FG000|Overall Study|Lost to Follow-up|0
4437732|NCT00434148|7221463|FG001|Overall Study|Lost to Follow-up|1
4437733|NCT00434148|7221462|FG000|Overall Study|Condition no longer requires study drug|1
4437734|NCT00434148|7221463|FG001|Overall Study|Condition no longer requires study drug|0
4437735|NCT00434148|7221462|FG000|Overall Study|Abnormal test procedure result|0
4437736|NCT00434148|7221463|FG001|Overall Study|Abnormal test procedure result|1
4437737|NCT00434161|7221472|FG000|Overall Study|Adverse Event|5
4437738|NCT00434161|7221473|FG001|Overall Study|Adverse Event|1
4437739|NCT00434161|7221474|FG002|Overall Study|Adverse Event|4
4437740|NCT00434161|7221472|FG000|Overall Study|Lost to Follow-up|0
4437741|NCT00434161|7221473|FG001|Overall Study|Lost to Follow-up|1
4437742|NCT00434161|7221474|FG002|Overall Study|Lost to Follow-up|0
4437743|NCT00434161|7221472|FG000|Overall Study|Death|1
4437744|NCT00434161|7221473|FG001|Overall Study|Death|0
4437745|NCT00434161|7221474|FG002|Overall Study|Death|1
4437746|NCT00434161|7221472|FG000|Overall Study|Non-Compliance|1
4437747|NCT00434161|7221473|FG001|Overall Study|Non-Compliance|1
4437748|NCT00434161|7221474|FG002|Overall Study|Non-Compliance|0
4437749|NCT00434161|7221472|FG000|Overall Study|Withdrawal by Subject|2
4437750|NCT00434161|7221473|FG001|Overall Study|Withdrawal by Subject|0
4437751|NCT00434161|7221474|FG002|Overall Study|Withdrawal by Subject|3
4437752|NCT00434161|7221472|FG000|Overall Study|Logistical error study assessments|1
4437753|NCT00434161|7221473|FG001|Overall Study|Logistical error study assessments|0
4437754|NCT00434161|7221474|FG002|Overall Study|Logistical error study assessments|3
4437755|NCT00434213|7221489|FG000|Overall Study|Adverse Event|12
4437756|NCT00434213|7221489|FG000|Overall Study|Lack of Efficacy|9
4437757|NCT00434213|7221489|FG000|Overall Study|Lost to Follow-up|14
4437758|NCT00434213|7221489|FG000|Overall Study|Withdrawal by Subject|7
4437759|NCT00434213|7221489|FG000|Overall Study|Protocol Violation|3
4437760|NCT00434213|7221489|FG000|Overall Study|Unable to comply with study visit window|2
4437761|NCT00434213|7221489|FG000|Overall Study|Application site reaction|1
4437762|NCT00434213|7221489|FG000|Overall Study|Non-compliant to study schedule|1
4437763|NCT00434252|7221495|FG000|Overall Study|Lack of Efficacy|50
4437764|NCT00434252|7221496|FG001|Overall Study|Lack of Efficacy|100
4437765|NCT00434252|7221495|FG000|Overall Study|Adverse Event|6
4437766|NCT00434252|7221496|FG001|Overall Study|Adverse Event|13
4437767|NCT00434252|7221495|FG000|Overall Study|Death|1
4437768|NCT00434252|7221496|FG001|Overall Study|Death|2
4437769|NCT00434252|7221495|FG000|Overall Study|Lost to Follow-up|0
4437770|NCT00434252|7221496|FG001|Overall Study|Lost to Follow-up|1
4437771|NCT00434252|7221495|FG000|Overall Study|Physician Decision|4
4437772|NCT00434252|7221496|FG001|Overall Study|Physician Decision|8
4437773|NCT00434252|7221495|FG000|Overall Study|Withdrawal by Subject|3
4437774|NCT00434252|7221496|FG001|Overall Study|Withdrawal by Subject|7
4437775|NCT00434304|7221511|FG000|Overall Study|Adverse Event|14
4437776|NCT00434304|7221511|FG000|Overall Study|Lack of Efficacy|2
4437777|NCT00434304|7221511|FG000|Overall Study|Withdrawal by Subject|4
4437778|NCT00434330|7221522|FG000|Overall Study|Adverse Event|0
4437779|NCT00434330|7221523|FG001|Overall Study|Adverse Event|0
4437780|NCT00434330|7221524|FG002|Overall Study|Adverse Event|1
4437781|NCT00434330|7221525|FG003|Overall Study|Adverse Event|0
4437782|NCT00434330|7221526|FG004|Overall Study|Adverse Event|0
4437783|NCT00434330|7221527|FG005|Overall Study|Adverse Event|0
4437784|NCT00434330|7221522|FG000|Overall Study|Death|1
4437785|NCT00434330|7221523|FG001|Overall Study|Death|0
4437786|NCT00434330|7221524|FG002|Overall Study|Death|0
4437787|NCT00434330|7221525|FG003|Overall Study|Death|0
4437788|NCT00434330|7221526|FG004|Overall Study|Death|1
4437789|NCT00434330|7221527|FG005|Overall Study|Death|1
4437790|NCT00434330|7221522|FG000|Overall Study|Withdrawal by Subject|0
4437791|NCT00434330|7221523|FG001|Overall Study|Withdrawal by Subject|0
4437792|NCT00434330|7221524|FG002|Overall Study|Withdrawal by Subject|1
4437793|NCT00434330|7221525|FG003|Overall Study|Withdrawal by Subject|1
4437794|NCT00434330|7221526|FG004|Overall Study|Withdrawal by Subject|0
4437795|NCT00434330|7221527|FG005|Overall Study|Withdrawal by Subject|0
4437796|NCT00434330|7221522|FG000|Overall Study|Renal transplant|0
4437797|NCT00434330|7221523|FG001|Overall Study|Renal transplant|0
4437798|NCT00434330|7221524|FG002|Overall Study|Renal transplant|0
4437799|NCT00434330|7221525|FG003|Overall Study|Renal transplant|1
4437800|NCT00434330|7221526|FG004|Overall Study|Renal transplant|0
4437801|NCT00434330|7221527|FG005|Overall Study|Renal transplant|0
4437802|NCT00434330|7221522|FG000|Overall Study|Subject Not Compliant With Study|0
4437803|NCT00434330|7221523|FG001|Overall Study|Subject Not Compliant With Study|0
4437804|NCT00434330|7221524|FG002|Overall Study|Subject Not Compliant With Study|1
4437805|NCT00434330|7221525|FG003|Overall Study|Subject Not Compliant With Study|0
4437806|NCT00434330|7221526|FG004|Overall Study|Subject Not Compliant With Study|0
4437807|NCT00434330|7221527|FG005|Overall Study|Subject Not Compliant With Study|0
4437808|NCT00434421|7221550|FG000|Overall Study|Withdrawal by Subject|1
4437809|NCT00434421|7221550|FG000|Overall Study|Non-compliance with study treatment|1
4437810|NCT00434512|7221573|FG000|Overall Study|Migrated/moved from study area|0
4437811|NCT00434512|7221574|FG001|Overall Study|Migrated/moved from study area|0
4437812|NCT00434512|7221575|FG002|Overall Study|Migrated/moved from study area|0
4437813|NCT00434512|7221576|FG003|Overall Study|Migrated/moved from study area|1
4437814|NCT00434512|7221577|FG004|Overall Study|Migrated/moved from study area|1
4437815|NCT00434512|7221578|FG005|Overall Study|Migrated/moved from study area|1
4437816|NCT00434512|7221573|FG000|Overall Study|Other|0
4437817|NCT00434512|7221574|FG001|Overall Study|Other|1
4437818|NCT00434512|7221575|FG002|Overall Study|Other|0
4437819|NCT00434512|7221576|FG003|Overall Study|Other|0
4437820|NCT00434512|7221577|FG004|Overall Study|Other|0
4437821|NCT00434512|7221578|FG005|Overall Study|Other|0
4437822|NCT00434577|7221601|FG000|Months 0-3|Serious Adverse Event|0
4437823|NCT00434577|7221602|FG001|Months 0-3|Serious Adverse Event|0
4437824|NCT00434577|7221603|FG002|Months 0-3|Serious Adverse Event|1
4437825|NCT00434577|7221604|FG003|Months 0-3|Serious Adverse Event|0
4437826|NCT00434577|7221605|FG004|Months 0-3|Serious Adverse Event|0
4437827|NCT00434577|7221601|FG000|Months 0-3|Adverse Event|0
4437828|NCT00434577|7221602|FG001|Months 0-3|Adverse Event|1
4437829|NCT00434577|7221603|FG002|Months 0-3|Adverse Event|1
4437830|NCT00434577|7221604|FG003|Months 0-3|Adverse Event|0
4437831|NCT00434577|7221605|FG004|Months 0-3|Adverse Event|0
4437832|NCT00434577|7221601|FG000|Months 0-3|Lost to Follow-up|0
4437833|NCT00434577|7221602|FG001|Months 0-3|Lost to Follow-up|0
4437834|NCT00434577|7221603|FG002|Months 0-3|Lost to Follow-up|0
4437835|NCT00434577|7221604|FG003|Months 0-3|Lost to Follow-up|0
4437836|NCT00434577|7221605|FG004|Months 0-3|Lost to Follow-up|2
4437837|NCT00434577|7221601|FG000|Months 0-3|Protocol Violation|1
4437838|NCT00434577|7221602|FG001|Months 0-3|Protocol Violation|0
4437839|NCT00434577|7221603|FG002|Months 0-3|Protocol Violation|1
4437840|NCT00434577|7221604|FG003|Months 0-3|Protocol Violation|0
4437841|NCT00434577|7221605|FG004|Months 0-3|Protocol Violation|0
4437842|NCT00434577|7221601|FG000|Months 0-3|Withdrawal by Subject|2
4437843|NCT00434577|7221602|FG001|Months 0-3|Withdrawal by Subject|1
4437844|NCT00434577|7221603|FG002|Months 0-3|Withdrawal by Subject|1
4437845|NCT00434577|7221604|FG003|Months 0-3|Withdrawal by Subject|1
4437846|NCT00434577|7221605|FG004|Months 0-3|Withdrawal by Subject|1
4437847|NCT00434642|7221619|FG000|Blinded Treatment Phase|Adverse Event|12
4437848|NCT00434642|7221620|FG001|Blinded Treatment Phase|Adverse Event|58
4437849|NCT00434642|7221619|FG000|Blinded Treatment Phase|Clinical Disease Progression|4
4437850|NCT00434642|7221620|FG001|Blinded Treatment Phase|Clinical Disease Progression|5
4437851|NCT00434642|7221619|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168
4437852|NCT00434642|7221620|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109
4437853|NCT00434642|7221619|FG000|Blinded Treatment Phase|Physician Decision|19
4437854|NCT00434642|7221620|FG001|Blinded Treatment Phase|Physician Decision|27
4437855|NCT00434642|7221619|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3
4437856|NCT00434642|7221620|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0
4437857|NCT00434642|7221619|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32
4437858|NCT00434642|7221620|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29
4437859|NCT00434642|7221619|FG000|Blinded Treatment Phase|Did not Receive Treatment|4
4437860|NCT00434642|7221620|FG001|Blinded Treatment Phase|Did not Receive Treatment|1
4437861|NCT00434642|7221619|FG000|Open-label Treatment Phase|Adverse Event|0
4437862|NCT00434642|7221620|FG001|Open-label Treatment Phase|Adverse Event|5
4437863|NCT00434642|7221619|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0
4437864|NCT00434642|7221620|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6
4437865|NCT00434759|7221628|FG000|Overall Study|Lack of Efficacy|5
4437866|NCT00434759|7221629|FG001|Overall Study|Lack of Efficacy|4
4437867|NCT00434759|7221628|FG000|Overall Study|Withdrawal by Subject|17
4437868|NCT00434759|7221629|FG001|Overall Study|Withdrawal by Subject|1
4437869|NCT00434759|7221628|FG000|Overall Study|family affairs|2
4437870|NCT00434759|7221629|FG001|Overall Study|family affairs|0
4437871|NCT00434876|7221639|FG000|Overall Study|Lost to Follow-up|1
4437872|NCT00434876|7221640|FG001|Overall Study|Lost to Follow-up|1
4437873|NCT00434954|7221648|FG000|Overall Study|Adverse Event|17
4437874|NCT00434954|7221649|FG001|Overall Study|Adverse Event|2
4437875|NCT00434954|7221648|FG000|Overall Study|Entry criteria not met|14
4437876|NCT00434954|7221649|FG001|Overall Study|Entry criteria not met|16
4437877|NCT00434954|7221648|FG000|Overall Study|Lost to Follow-up|0
4437878|NCT00434954|7221649|FG001|Overall Study|Lost to Follow-up|1
4437879|NCT00434954|7221648|FG000|Overall Study|Physician Decision|6
4437880|NCT00434954|7221649|FG001|Overall Study|Physician Decision|3
4437881|NCT00434954|7221648|FG000|Overall Study|Protocol Violation|36
4437882|NCT00434954|7221649|FG001|Overall Study|Protocol Violation|27
4437883|NCT00434954|7221648|FG000|Overall Study|Sponsor decision|1
4437884|NCT00434954|7221649|FG001|Overall Study|Sponsor decision|0
4437885|NCT00434954|7221648|FG000|Overall Study|Subject decision|8
4437886|NCT00434954|7221649|FG001|Overall Study|Subject decision|22
4437887|NCT00434967|7221659|FG000|Overall Study|Adverse Event|2
4437888|NCT00434967|7221660|FG001|Overall Study|Adverse Event|4
4437889|NCT00434967|7221661|FG002|Overall Study|Adverse Event|3
4437890|NCT00434967|7221662|FG003|Overall Study|Adverse Event|3
4437891|NCT00434967|7221659|FG000|Overall Study|Lost to Follow-up|0
4437892|NCT00434967|7221660|FG001|Overall Study|Lost to Follow-up|0
4437893|NCT00434967|7221661|FG002|Overall Study|Lost to Follow-up|1
4437894|NCT00434967|7221662|FG003|Overall Study|Lost to Follow-up|0
4437895|NCT00434967|7221659|FG000|Overall Study|Withdrawal by Subject|2
4437896|NCT00434967|7221660|FG001|Overall Study|Withdrawal by Subject|2
4437897|NCT00434967|7221661|FG002|Overall Study|Withdrawal by Subject|4
4437898|NCT00434967|7221662|FG003|Overall Study|Withdrawal by Subject|6
4437899|NCT00434967|7221659|FG000|Overall Study|Randomized in error|0
4437900|NCT00434967|7221660|FG001|Overall Study|Randomized in error|0
4437901|NCT00434967|7221661|FG002|Overall Study|Randomized in error|0
4437902|NCT00434967|7221662|FG003|Overall Study|Randomized in error|1
4437903|NCT00434967|7221659|FG000|Overall Study|Protocol Violation|0
4437904|NCT00434967|7221660|FG001|Overall Study|Protocol Violation|1
4437905|NCT00434967|7221661|FG002|Overall Study|Protocol Violation|0
4437906|NCT00434967|7221662|FG003|Overall Study|Protocol Violation|1
4437907|NCT00434967|7221659|FG000|Overall Study|Physician Decision|1
4437908|NCT00434967|7221660|FG001|Overall Study|Physician Decision|1
4437909|NCT00434967|7221661|FG002|Overall Study|Physician Decision|1
4437910|NCT00434967|7221662|FG003|Overall Study|Physician Decision|0
4437911|NCT00434967|7221659|FG000|Overall Study|Patient Disposition Challenges|2
4437912|NCT00434967|7221660|FG001|Overall Study|Patient Disposition Challenges|0
4437913|NCT00434967|7221661|FG002|Overall Study|Patient Disposition Challenges|0
4437914|NCT00434967|7221662|FG003|Overall Study|Patient Disposition Challenges|3
4437915|NCT00435019|7221683|FG000|Overall Study|Adverse Event|1
4437916|NCT00435019|7221684|FG001|Overall Study|Adverse Event|0
4437917|NCT00435019|7221683|FG000|Overall Study|Lack of Efficacy|1
4437918|NCT00435019|7221684|FG001|Overall Study|Lack of Efficacy|2
4437919|NCT00435019|7221683|FG000|Overall Study|Protocol Violation|3
4437920|NCT00435019|7221684|FG001|Overall Study|Protocol Violation|1
4437921|NCT00435019|7221683|FG000|Overall Study|Personal reasons for withdrawal|8
4437922|NCT00435019|7221684|FG001|Overall Study|Personal reasons for withdrawal|7
4437923|NCT00435045|7221692|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1
4437924|NCT00435045|7221693|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1
4437925|NCT00435045|7221692|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1
4437926|NCT00435045|7221693|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1
4437927|NCT00435045|7221692|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2
4437928|NCT00435045|7221693|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1
4437929|NCT00435045|7221692|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1
4437930|NCT00435045|7221693|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0
4437931|NCT00435045|7221692|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0
4437932|NCT00435045|7221693|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1
4437933|NCT00435045|7221692|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4
4437934|NCT00435045|7221693|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3
4437935|NCT00435045|7221692|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1
4437936|NCT00435045|7221693|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1
4437937|NCT00435045|7221692|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0
4437938|NCT00435045|7221693|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1
4437939|NCT00435045|7221692|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3
4437940|NCT00435045|7221693|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2
4437941|NCT00435045|7221692|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1
4437942|NCT00435045|7221693|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0
4437943|NCT00435045|7221692|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1
4437944|NCT00435045|7221693|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0
4437945|NCT00435162|7221702|FG000|Period 2 (2 Weeks)|Adverse Event|0
4437946|NCT00435162|7221703|FG001|Period 2 (2 Weeks)|Adverse Event|1
4437947|NCT00435162|7221704|FG002|Period 2 (2 Weeks)|Adverse Event|0
4437948|NCT00435162|7221705|FG003|Period 2 (2 Weeks)|Adverse Event|0
4437949|NCT00435162|7221706|FG004|Period 2 (2 Weeks)|Adverse Event|0
4437950|NCT00435162|7221707|FG005|Period 2 (2 Weeks)|Adverse Event|0
4437951|NCT00435188|7221722|FG000|Overall Study|Death|1
4437952|NCT00435188|7221723|FG001|Overall Study|Death|6
4437953|NCT00435188|7221722|FG000|Overall Study|Withdrawal by Subject|16
4437954|NCT00435188|7221723|FG001|Overall Study|Withdrawal by Subject|11
4437955|NCT00435188|7221722|FG000|Overall Study|Lost to Follow-up|5
4437956|NCT00435188|7221723|FG001|Overall Study|Lost to Follow-up|6
4437957|NCT00435370|7221733|FG000|Overall Study|Adverse Event|8
4437958|NCT00435370|7221734|FG001|Overall Study|Adverse Event|8
4437959|NCT00435370|7221733|FG000|Overall Study|Withdrawal by Subject|10
4437960|NCT00435370|7221734|FG001|Overall Study|Withdrawal by Subject|10
4437961|NCT00435370|7221733|FG000|Overall Study|Antipsychotic medication changed|4
4437962|NCT00435370|7221734|FG001|Overall Study|Antipsychotic medication changed|2
4437963|NCT00435409|7221742|FG000|Overall Study|Protocol Violation|1
4437964|NCT00435409|7221743|FG001|Overall Study|Protocol Violation|2
4437965|NCT00435409|7221744|FG002|Overall Study|Protocol Violation|0
4437966|NCT00435409|7221742|FG000|Overall Study|Lost to Follow-up|1
4437967|NCT00435409|7221743|FG001|Overall Study|Lost to Follow-up|2
4437968|NCT00435409|7221744|FG002|Overall Study|Lost to Follow-up|0
4437969|NCT00435409|7221742|FG000|Overall Study|Death|8
4437970|NCT00435409|7221743|FG001|Overall Study|Death|6
4437971|NCT00435409|7221744|FG002|Overall Study|Death|6
4437972|NCT00435409|7221742|FG000|Overall Study|Objective progression or relapse|158
4437973|NCT00435409|7221743|FG001|Overall Study|Objective progression or relapse|93
4437974|NCT00435409|7221744|FG002|Overall Study|Objective progression or relapse|58
4437975|NCT00435409|7221742|FG000|Overall Study|Global deterioration of health status|0
4437976|NCT00435409|7221743|FG001|Overall Study|Global deterioration of health status|0
4437977|NCT00435409|7221744|FG002|Overall Study|Global deterioration of health status|4
4437978|NCT00435409|7221742|FG000|Overall Study|Withdrawal by Subject|8
4437979|NCT00435409|7221743|FG001|Overall Study|Withdrawal by Subject|7
4437980|NCT00435409|7221744|FG002|Overall Study|Withdrawal by Subject|1
4437981|NCT00435409|7221742|FG000|Overall Study|Other|45
4437982|NCT00435409|7221743|FG001|Overall Study|Other|30
4437983|NCT00435409|7221744|FG002|Overall Study|Other|1
4437984|NCT00435409|7221742|FG000|Overall Study|Adverse Event|0
4437985|NCT00435409|7221743|FG001|Overall Study|Adverse Event|0
4437986|NCT00435409|7221744|FG002|Overall Study|Adverse Event|8
4437987|NCT00435409|7221742|FG000|Overall Study|Sponsor decision|0
4437988|NCT00435409|7221743|FG001|Overall Study|Sponsor decision|3
4437989|NCT00435409|7221744|FG002|Overall Study|Sponsor decision|0
4437990|NCT00435461|7221753|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1
4437991|NCT00435461|7221754|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0
4437992|NCT00435461|7221755|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0
4437993|NCT00435461|7221753|FG000|Overall Study|Protocol Violation|6
4437994|NCT00435461|7221754|FG001|Overall Study|Protocol Violation|9
4437995|NCT00435461|7221755|FG002|Overall Study|Protocol Violation|10
4437996|NCT00435461|7221753|FG000|Overall Study|Participant randomized(inadequate score)|1
4437997|NCT00435461|7221754|FG001|Overall Study|Participant randomized(inadequate score)|0
4437998|NCT00435461|7221755|FG002|Overall Study|Participant randomized(inadequate score)|0
4437999|NCT00435461|7221753|FG000|Overall Study|Compliance less than 80 percent|1
4438000|NCT00435461|7221754|FG001|Overall Study|Compliance less than 80 percent|0
4512805|NCT00937521|7322827|FG005|Booster Phase|Lost to Follow-up|4
4512806|NCT00937521|7322828|FG006|Booster Phase|Lost to Follow-up|3
4512807|NCT00937521|7322829|FG007|Booster Phase|Lost to Follow-up|0
4512808|NCT00937521|7322822|FG000|Booster Phase|Administrative Reason|0
4512809|NCT00937521|7322823|FG001|Booster Phase|Administrative Reason|0
4512810|NCT00937521|7322824|FG002|Booster Phase|Administrative Reason|1
4512811|NCT00937521|7322825|FG003|Booster Phase|Administrative Reason|0
4512812|NCT00937521|7322826|FG004|Booster Phase|Administrative Reason|1
4512813|NCT00937521|7322827|FG005|Booster Phase|Administrative Reason|1
4512814|NCT00937521|7322828|FG006|Booster Phase|Administrative Reason|0
4512815|NCT00937521|7322829|FG007|Booster Phase|Administrative Reason|0
4512816|NCT00937521|7322822|FG000|Booster Phase|Protocol Deviation|0
4512817|NCT00937521|7322823|FG001|Booster Phase|Protocol Deviation|0
4512818|NCT00937521|7322824|FG002|Booster Phase|Protocol Deviation|0
4512819|NCT00937521|7322825|FG003|Booster Phase|Protocol Deviation|0
4512820|NCT00937521|7322826|FG004|Booster Phase|Protocol Deviation|0
4512821|NCT00937521|7322827|FG005|Booster Phase|Protocol Deviation|0
4512822|NCT00937521|7322828|FG006|Booster Phase|Protocol Deviation|1
4512823|NCT00937521|7322829|FG007|Booster Phase|Protocol Deviation|0
4512824|NCT00937547|7322865|FG000|Overall Study|misdiagnosis|1
4512825|NCT00937547|7322866|FG001|Overall Study|misdiagnosis|6
4512826|NCT00937547|7322867|FG002|Overall Study|misdiagnosis|7
4512827|NCT00937560|7322875|FG000|Initial Treatment|Death|6
4438001|NCT00435461|7221755|FG002|Overall Study|Compliance less than 80 percent|0
4438002|NCT00435461|7221753|FG000|Overall Study|In error, two study medications switched|1
4438003|NCT00435461|7221754|FG001|Overall Study|In error, two study medications switched|0
4438004|NCT00435461|7221755|FG002|Overall Study|In error, two study medications switched|0
4438005|NCT00435461|7221753|FG000|Overall Study|Lack of Efficacy|2
4438006|NCT00435461|7221754|FG001|Overall Study|Lack of Efficacy|1
4438007|NCT00435461|7221755|FG002|Overall Study|Lack of Efficacy|0
4438008|NCT00435461|7221753|FG000|Overall Study|Withdrawal by Subject|1
4438009|NCT00435461|7221754|FG001|Overall Study|Withdrawal by Subject|0
4438010|NCT00435461|7221755|FG002|Overall Study|Withdrawal by Subject|2
4438011|NCT00435461|7221753|FG000|Overall Study|Randomized in error|1
4438012|NCT00435461|7221754|FG001|Overall Study|Randomized in error|0
4438013|NCT00435461|7221755|FG002|Overall Study|Randomized in error|0
4438014|NCT00435461|7221753|FG000|Overall Study|Participant could not tolerate symptoms|0
4438015|NCT00435461|7221754|FG001|Overall Study|Participant could not tolerate symptoms|0
4438016|NCT00435461|7221755|FG002|Overall Study|Participant could not tolerate symptoms|1
4512828|NCT00937560|7322875|FG000|Initial Treatment|Withdraw consent|3
4512829|NCT00937560|7322875|FG000|Initial Treatment|Adverse Event|1
4512830|NCT00937560|7322875|FG000|Initial Treatment|Lost to Follow-up|1
4512831|NCT00937560|7322875|FG000|Initial Treatment|No end of study page|10
4438017|NCT00435461|7221753|FG000|Overall Study|Participant could not swallow capsule|0
4438018|NCT00435461|7221754|FG001|Overall Study|Participant could not swallow capsule|0
4438019|NCT00435461|7221755|FG002|Overall Study|Participant could not swallow capsule|1
4438020|NCT00435461|7221753|FG000|Overall Study|Pregnancy|2
4438021|NCT00435461|7221754|FG001|Overall Study|Pregnancy|0
4438022|NCT00435461|7221755|FG002|Overall Study|Pregnancy|0
4438023|NCT00435461|7221753|FG000|Overall Study|Participant moved eDiary,studymedication|1
4438024|NCT00435461|7221754|FG001|Overall Study|Participant moved eDiary,studymedication|0
4438025|NCT00435461|7221755|FG002|Overall Study|Participant moved eDiary,studymedication|0
4438026|NCT00435461|7221753|FG000|Overall Study|Participant ended study one day early|1
4438027|NCT00435461|7221754|FG001|Overall Study|Participant ended study one day early|0
4438028|NCT00435461|7221755|FG002|Overall Study|Participant ended study one day early|0
4438029|NCT00435461|7221753|FG000|Overall Study|Noncompliance with study requirements|1
4438030|NCT00435461|7221754|FG001|Overall Study|Noncompliance with study requirements|1
4438031|NCT00435461|7221755|FG002|Overall Study|Noncompliance with study requirements|1
4438032|NCT00435461|7221753|FG000|Overall Study|Adverse Event|1
4438033|NCT00435461|7221754|FG001|Overall Study|Adverse Event|2
4438034|NCT00435461|7221755|FG002|Overall Study|Adverse Event|6
4438035|NCT00435461|7221753|FG000|Overall Study|Non-Compliance of diary|2
4438036|NCT00435461|7221754|FG001|Overall Study|Non-Compliance of diary|0
4438037|NCT00435461|7221755|FG002|Overall Study|Non-Compliance of diary|1
4438038|NCT00435461|7221753|FG000|Overall Study|Lost to Follow-up|1
4438039|NCT00435461|7221754|FG001|Overall Study|Lost to Follow-up|1
4438040|NCT00435461|7221755|FG002|Overall Study|Lost to Follow-up|2
4438041|NCT00435487|7221765|FG000|Overall Study|Death|3
4438042|NCT00435487|7221766|FG001|Overall Study|Death|4
4438043|NCT00435487|7221765|FG000|Overall Study|Adverse Event|0
4438044|NCT00435487|7221766|FG001|Overall Study|Adverse Event|3
4438045|NCT00435487|7221765|FG000|Overall Study|Lost to Follow-up|2
4438046|NCT00435487|7221766|FG001|Overall Study|Lost to Follow-up|2
4438047|NCT00435487|7221765|FG000|Overall Study|Other|5
4438048|NCT00435487|7221766|FG001|Overall Study|Other|2
4438049|NCT00435487|7221765|FG000|Overall Study|Withdrawal by Subject|2
4438050|NCT00435487|7221766|FG001|Overall Study|Withdrawal by Subject|1
4438051|NCT00435487|7221765|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0
4438052|NCT00435487|7221766|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2
4438053|NCT00435487|7221765|FG000|Overall Study|Received Drug in Other Treatment Group|0
4438054|NCT00435487|7221766|FG001|Overall Study|Received Drug in Other Treatment Group|1
4438055|NCT00435825|7221825|FG000|Overall Study|Abnormality of Laboratory Test|0
4438056|NCT00435825|7221826|FG001|Overall Study|Abnormality of Laboratory Test|1
4438057|NCT00435825|7221827|FG002|Overall Study|Abnormality of Laboratory Test|0
4438058|NCT00435825|7221828|FG003|Overall Study|Abnormality of Laboratory Test|0
4438059|NCT00435825|7221825|FG000|Overall Study|Insufficient Therapeutic Response|3
4438060|NCT00435825|7221826|FG001|Overall Study|Insufficient Therapeutic Response|1
4438061|NCT00435825|7221827|FG002|Overall Study|Insufficient Therapeutic Response|0
4438062|NCT00435825|7221828|FG003|Overall Study|Insufficient Therapeutic Response|3
4438063|NCT00435825|7221825|FG000|Overall Study|Other Protocol Violation|1
4438064|NCT00435825|7221826|FG001|Overall Study|Other Protocol Violation|0
4438065|NCT00435825|7221827|FG002|Overall Study|Other Protocol Violation|0
4438066|NCT00435825|7221828|FG003|Overall Study|Other Protocol Violation|0
4438067|NCT00435825|7221825|FG000|Overall Study|Refused treatment|2
4438068|NCT00435825|7221826|FG001|Overall Study|Refused treatment|0
4438069|NCT00435825|7221827|FG002|Overall Study|Refused treatment|0
4438070|NCT00435825|7221828|FG003|Overall Study|Refused treatment|5
4438071|NCT00435825|7221825|FG000|Overall Study|Failure to return|5
4438072|NCT00435825|7221826|FG001|Overall Study|Failure to return|0
4438073|NCT00435825|7221827|FG002|Overall Study|Failure to return|4
4438074|NCT00435825|7221828|FG003|Overall Study|Failure to return|0
4438075|NCT00435825|7221825|FG000|Overall Study|Did not receive study drug|1
4438076|NCT00435825|7221826|FG001|Overall Study|Did not receive study drug|0
4438077|NCT00435825|7221827|FG002|Overall Study|Did not receive study drug|2
4438078|NCT00435825|7221828|FG003|Overall Study|Did not receive study drug|0
4438079|NCT00435825|7221825|FG000|Overall Study|Did not enter follow-up|0
4438080|NCT00435825|7221826|FG001|Overall Study|Did not enter follow-up|4
4438081|NCT00435825|7221827|FG002|Overall Study|Did not enter follow-up|1
4438082|NCT00435825|7221828|FG003|Overall Study|Did not enter follow-up|3
4438083|NCT00435825|7221825|FG000|Overall Study|Did not complete full follow-up period|6
4438084|NCT00435825|7221826|FG001|Overall Study|Did not complete full follow-up period|6
4438085|NCT00435825|7221827|FG002|Overall Study|Did not complete full follow-up period|4
4438086|NCT00435825|7221828|FG003|Overall Study|Did not complete full follow-up period|5
4438087|NCT00435942|7221849|FG000|Overall Study|Death|17
4438088|NCT00435942|7221850|FG001|Overall Study|Death|10
4438089|NCT00435942|7221849|FG000|Overall Study|Withdrawal by Subject|2
4438090|NCT00435942|7221850|FG001|Overall Study|Withdrawal by Subject|0
4438091|NCT00435942|7221849|FG000|Overall Study|Lost to Follow-up|0
4438092|NCT00435942|7221850|FG001|Overall Study|Lost to Follow-up|16
4716308|NCT02991118|7645611|FG000|Overall Study|Moved out of the country|0
4716309|NCT02991118|7645612|FG001|Overall Study|Moved out of the country|1
4716310|NCT02991118|7645611|FG000|Overall Study|Adverse Event|2
4716311|NCT02991118|7645612|FG001|Overall Study|Adverse Event|2
4716312|NCT02991118|7645611|FG000|Overall Study|Withdrawal by Subject|1
4438093|NCT00435942|7221849|FG000|Overall Study|Conversion to Open Repair|1
4438094|NCT00435942|7221850|FG001|Overall Study|Conversion to Open Repair|0
4438095|NCT00435942|7221849|FG000|Overall Study|Technical Failure|3
4438096|NCT00435942|7221850|FG001|Overall Study|Technical Failure|0
4438097|NCT00435942|7221849|FG000|Overall Study|Other|0
4438098|NCT00435942|7221850|FG001|Overall Study|Other|1
4438099|NCT00435994|7221859|FG000|Overall Study|Lost to Follow-up|7
4438100|NCT00435994|7221860|FG001|Overall Study|Lost to Follow-up|0
4438101|NCT00435994|7221861|FG002|Overall Study|Lost to Follow-up|0
4438102|NCT00436007|7221873|FG000|Overall Study|Withdrawal by Subject|5
4438103|NCT00436007|7221874|FG001|Overall Study|Withdrawal by Subject|3
4438104|NCT00436007|7221875|FG002|Overall Study|Withdrawal by Subject|4
4438105|NCT00436007|7221873|FG000|Overall Study|Lost to Follow-up|14
4438106|NCT00436007|7221874|FG001|Overall Study|Lost to Follow-up|10
4438107|NCT00436007|7221875|FG002|Overall Study|Lost to Follow-up|13
4438108|NCT00436007|7221873|FG000|Overall Study|Physician Decision|0
4438109|NCT00436007|7221874|FG001|Overall Study|Physician Decision|0
4438110|NCT00436007|7221875|FG002|Overall Study|Physician Decision|2
4438111|NCT00436007|7221873|FG000|Overall Study|Death|0
4438112|NCT00436007|7221874|FG001|Overall Study|Death|1
4438113|NCT00436007|7221875|FG002|Overall Study|Death|3
4438114|NCT00436007|7221873|FG000|Overall Study|Other|0
4438115|NCT00436007|7221874|FG001|Overall Study|Other|0
4438116|NCT00436007|7221875|FG002|Overall Study|Other|1
4438117|NCT00436163|7221901|FG000|Overall Study|Lost to Follow-up|2
4438118|NCT00436163|7221901|FG000|Overall Study|Adverse Event|1
4438119|NCT00436215|7221906|FG000|Overall Study|Refused further treatment|3
4438120|NCT00436215|7221906|FG000|Overall Study|Small bowel obstruction|1
4438121|NCT00436280|7221910|FG000|Period 1: Induction|Adverse Event|8
4438122|NCT00436280|7221910|FG000|Period 1: Induction|Progressive Disease|12
4438123|NCT00436280|7221910|FG000|Period 1: Induction|Stable Disease|6
4438124|NCT00436280|7221910|FG000|Period 1: Induction|Withdrawal by Subject|1
4438125|NCT00436280|7221910|FG000|Period 1: Induction|Death|1
4438126|NCT00436280|7221910|FG000|Period 2: Consolidation|Adverse Event|1
4438127|NCT00436280|7221910|FG000|Period 2: Consolidation|Progressive Disease|10
4438128|NCT00436280|7221910|FG000|Period 2: Consolidation|Stable Disease|1
4438129|NCT00436280|7221910|FG000|Period 2: Consolidation|Physician Decision|2
4438130|NCT00436280|7221910|FG000|Period 2: Consolidation|Withdrawal by Subject|2
4438131|NCT00436280|7221910|FG000|Period 2: Consolidation|Death|1
4438132|NCT00436280|7221910|FG000|Period 3: Maintenance|Adverse Event|6
4438133|NCT00436280|7221910|FG000|Period 3: Maintenance|Progressive Disease|12
4438134|NCT00436332|7221914|FG000|Overall Study|Adverse Event|9
4438135|NCT00436332|7221914|FG000|Overall Study|Withdrawal by Subject|2
4438136|NCT00436332|7221914|FG000|Overall Study|Progression|59
4438137|NCT00436332|7221914|FG000|Overall Study|Death|2
4438138|NCT00436332|7221914|FG000|Overall Study|Not Protocol Specified|6
4438139|NCT00436332|7221914|FG000|Overall Study|Ineligible|2
4438140|NCT00436332|7221914|FG000|Overall Study|Never Received Treatment|3
4438141|NCT00436345|7221920|FG000|Overall Study|ICU resident beyond follow-up period|3
4630272|NCT02288247|7498818|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87
4438142|NCT00436345|7221921|FG001|Overall Study|ICU resident beyond follow-up period|0
4438143|NCT00436436|7221928|FG000|Overall Study|Progression|4
4438144|NCT00436436|7221928|FG000|Overall Study|Adverse Event|2
4438145|NCT00436436|7221928|FG000|Overall Study|Death|6
4438146|NCT00436501|7221951|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0
4438147|NCT00436501|7221952|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2
4438148|NCT00436501|7221951|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0
4438149|NCT00436501|7221952|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1
4438150|NCT00436553|7221962|FG000|Overall Study|Adverse Event|4
4438151|NCT00436553|7221963|FG001|Overall Study|Adverse Event|3
4438152|NCT00436553|7221964|FG002|Overall Study|Adverse Event|4
4438153|NCT00436553|7221962|FG000|Overall Study|Death|3
4438154|NCT00436553|7221963|FG001|Overall Study|Death|1
4438155|NCT00436553|7221964|FG002|Overall Study|Death|3
4438156|NCT00436553|7221962|FG000|Overall Study|Lost to Follow-up|0
4438157|NCT00436553|7221963|FG001|Overall Study|Lost to Follow-up|2
4438158|NCT00436553|7221964|FG002|Overall Study|Lost to Follow-up|0
4438159|NCT00436553|7221962|FG000|Overall Study|Protocol Violation|1
4438160|NCT00436553|7221963|FG001|Overall Study|Protocol Violation|0
4438161|NCT00436553|7221964|FG002|Overall Study|Protocol Violation|0
4438162|NCT00436553|7221962|FG000|Overall Study|Withdrawal by Subject|5
4438163|NCT00436553|7221963|FG001|Overall Study|Withdrawal by Subject|6
4438164|NCT00436553|7221964|FG002|Overall Study|Withdrawal by Subject|3
4438165|NCT00436566|7221972|FG000|Overall Study|Withdrawal by Subject|2
4438166|NCT00436566|7221972|FG000|Overall Study|Protocol Violation|1
4438167|NCT00436605|7221976|FG000|Overall Study|Protocol Violation|3
4438168|NCT00436618|7221983|FG000|Overall Study|Withdrawal by Subject|5
4438169|NCT00436618|7221984|FG001|Overall Study|Withdrawal by Subject|8
4438170|NCT00436618|7221985|FG002|Overall Study|Withdrawal by Subject|11
4438171|NCT00436618|7221983|FG000|Overall Study|Adverse Event|8
4438172|NCT00436618|7221984|FG001|Overall Study|Adverse Event|8
4512832|NCT00937560|7322875|FG000|Maintenance Treatment|Death|12
4438173|NCT00436618|7221985|FG002|Overall Study|Adverse Event|9
4438174|NCT00436618|7221983|FG000|Overall Study|Alternate Treatment|3
4438175|NCT00436618|7221984|FG001|Overall Study|Alternate Treatment|4
4438176|NCT00436618|7221985|FG002|Overall Study|Alternate Treatment|12
4438177|NCT00436618|7221983|FG000|Overall Study|Other Medical Problems|3
4438178|NCT00436618|7221984|FG001|Overall Study|Other Medical Problems|1
4438179|NCT00436618|7221985|FG002|Overall Study|Other Medical Problems|7
4438180|NCT00436618|7221983|FG000|Overall Study|Death|4
4438181|NCT00436618|7221984|FG001|Overall Study|Death|2
4438182|NCT00436618|7221985|FG002|Overall Study|Death|3
4438183|NCT00436618|7221983|FG000|Overall Study|New Primary or Other Reasons|6
4438184|NCT00436618|7221984|FG001|Overall Study|New Primary or Other Reasons|2
4438185|NCT00436618|7221985|FG002|Overall Study|New Primary or Other Reasons|12
4438186|NCT00436618|7221983|FG000|Overall Study|Still on treatment|1
4438187|NCT00436618|7221984|FG001|Overall Study|Still on treatment|2
4438188|NCT00436618|7221985|FG002|Overall Study|Still on treatment|7
4438189|NCT00436644|7221993|FG000|Overall Study|Adverse Event|2
4438190|NCT00436644|7221993|FG000|Overall Study|Death|1
4438191|NCT00436748|7221999|FG000|Overall Study|Ineligibility Determined|1
4438192|NCT00436748|7222000|FG001|Overall Study|Ineligibility Determined|1
4438193|NCT00436748|7221999|FG000|Overall Study|Adverse Event|0
4438194|NCT00436748|7222000|FG001|Overall Study|Adverse Event|2
4438195|NCT00436748|7221999|FG000|Overall Study|Consent Withdrawn|1
4438196|NCT00436748|7222000|FG001|Overall Study|Consent Withdrawn|4
4438197|NCT00436748|7221999|FG000|Overall Study|Administrative Decision|1
4438198|NCT00436748|7222000|FG001|Overall Study|Administrative Decision|0
4438199|NCT00436748|7221999|FG000|Overall Study|Lost to Follow-up|0
4438200|NCT00436748|7222000|FG001|Overall Study|Lost to Follow-up|1
4438201|NCT00436748|7221999|FG000|Overall Study|Protocol-specified Criteria|5
4438202|NCT00436748|7222000|FG001|Overall Study|Protocol-specified Criteria|4
4438203|NCT00436748|7221999|FG000|Overall Study|Other|3
4438204|NCT00436748|7222000|FG001|Overall Study|Other|0
4438205|NCT00436852|7222008|FG000|Overall Study|Death|23
4438206|NCT00436852|7222009|FG001|Overall Study|Death|34
4438207|NCT00436852|7222008|FG000|Overall Study|Lack of Efficacy|9
4438208|NCT00436852|7222009|FG001|Overall Study|Lack of Efficacy|7
4438209|NCT00436852|7222008|FG000|Overall Study|Withdrawal by Subject|2
4438210|NCT00436852|7222009|FG001|Overall Study|Withdrawal by Subject|4
4438211|NCT00436852|7222008|FG000|Overall Study|Ineligible|1
4438212|NCT00436852|7222009|FG001|Overall Study|Ineligible|0
4438213|NCT00436917|7222022|FG000|Overall Study|Withdrawal by Subject|13
4438214|NCT00436917|7222022|FG000|Overall Study|Adverse Event|2
4438215|NCT00436917|7222022|FG000|Overall Study|Physician Decision|1
4438216|NCT00436917|7222022|FG000|Overall Study|Death|1
4438217|NCT00436917|7222022|FG000|Overall Study|Lost to Follow-up|1
4438218|NCT00436917|7222022|FG000|Overall Study|Treatment for polymyalgia rheumatic|1
4438219|NCT00436917|7222022|FG000|Overall Study|Increased creatinine|1
4438220|NCT00436917|7222022|FG000|Overall Study|Personal conflicts of patient|1
4438221|NCT00436956|7222026|FG000|Overall Study|Not evaluable|1
4438222|NCT00436956|7222027|FG001|Overall Study|Not evaluable|0
4512833|NCT00937560|7322875|FG000|Maintenance Treatment|Withdraw consent|5
4512834|NCT00937560|7322875|FG000|Maintenance Treatment|According to protocol|1
4518477|NCT00974311|7330646|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16
4518478|NCT00974311|7330647|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7
4518479|NCT00974311|7330646|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108
4518480|NCT00974311|7330647|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42
4518481|NCT00974311|7330646|FG000|DB Phase (up to 24 Months)|Other|1
4518482|NCT00974311|7330647|FG001|DB Phase (up to 24 Months)|Other|0
4518483|NCT00974311|7330646|FG000|OLE Phase (up to 77 Months)|Death|14
4518484|NCT00974311|7330647|FG001|OLE Phase (up to 77 Months)|Death|21
4518485|NCT00974311|7330646|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78
4518486|NCT00974311|7330647|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26
4518487|NCT00974311|7330646|FG000|OLE Phase (up to 77 Months)|Other|15
4518488|NCT00974311|7330647|FG001|OLE Phase (up to 77 Months)|Other|2
4518489|NCT00974311|7330646|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2
4518490|NCT00974311|7330647|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1
4518491|NCT00974675|7330720|FG000|Overall Study|Adverse Event|2
4518492|NCT00974675|7330721|FG001|Overall Study|Adverse Event|1
4518493|NCT00974675|7330722|FG002|Overall Study|Adverse Event|1
4518494|NCT00974675|7330723|FG003|Overall Study|Adverse Event|1
4518495|NCT00974675|7330720|FG000|Overall Study|Physician Decision|0
4518496|NCT00974675|7330721|FG001|Overall Study|Physician Decision|0
4518497|NCT00974675|7330722|FG002|Overall Study|Physician Decision|1
4518498|NCT00974675|7330723|FG003|Overall Study|Physician Decision|0
4518499|NCT00974675|7330720|FG000|Overall Study|Participant on holiday; unable to attend|0
4518500|NCT00974675|7330721|FG001|Overall Study|Participant on holiday; unable to attend|0
4518501|NCT00974675|7330722|FG002|Overall Study|Participant on holiday; unable to attend|0
4518502|NCT00974675|7330723|FG003|Overall Study|Participant on holiday; unable to attend|1
4518503|NCT00974974|7330744|FG000|IR CD-LD Dose Adjustment|Adverse Event|0
4518504|NCT00974974|7330745|FG001|IR CD-LD Dose Adjustment|Adverse Event|3
4518505|NCT00974974|7330744|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0
4518506|NCT00974974|7330745|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1
4518507|NCT00974974|7330744|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0
4518508|NCT00974974|7330745|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1
4518509|NCT00974974|7330744|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0
4518510|NCT00974974|7330745|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7
4518511|NCT00974974|7330744|FG000|IR CD-LD Dose Adjustment|Various|0
4518512|NCT00974974|7330745|FG001|IR CD-LD Dose Adjustment|Various|9
4518513|NCT00974974|7330744|FG000|IPX066 Dose Conversion|Adverse Event|23
4518514|NCT00974974|7330745|FG001|IPX066 Dose Conversion|Adverse Event|0
4518515|NCT00974974|7330744|FG000|IPX066 Dose Conversion|Death|2
4716313|NCT02991118|7645612|FG001|Overall Study|Withdrawal by Subject|7
4716314|NCT02991118|7645611|FG000|Overall Study|Could not attend study visits|0
4716315|NCT02991118|7645612|FG001|Overall Study|Could not attend study visits|1
4716316|NCT02991118|7645611|FG000|Overall Study|Lost to Follow-up|1
4716317|NCT02991118|7645612|FG001|Overall Study|Lost to Follow-up|9
4438223|NCT00436982|7222045|FG000|Overall Study|Withdrawal by Subject|3
4438224|NCT00436982|7222046|FG001|Overall Study|Withdrawal by Subject|1
4438225|NCT00436982|7222045|FG000|Overall Study|Did not receive allocated intervention|0
4438226|NCT00436982|7222046|FG001|Overall Study|Did not receive allocated intervention|1
4438227|NCT00436982|7222045|FG000|Overall Study|no RSA data|1
4438228|NCT00436982|7222046|FG001|Overall Study|no RSA data|2
4438229|NCT00437034|7222056|FG000|Overall Study|Adverse Event|1
4438230|NCT00437034|7222056|FG000|Overall Study|Disease progression during treatment|5
4438231|NCT00437073|7222062|FG000|Overall Study|Sponsor Terminated Study|1
4438232|NCT00437073|7222063|FG001|Overall Study|Sponsor Terminated Study|0
4438233|NCT00437073|7222062|FG000|Overall Study|Physician Decision|0
4438234|NCT00437073|7222063|FG001|Overall Study|Physician Decision|1
4438235|NCT00437125|7222069|FG000|Overall Study|Adverse Event|12
4438236|NCT00437125|7222069|FG000|Overall Study|Death|1
4438237|NCT00437125|7222069|FG000|Overall Study|Clinical Relapse|1
4438238|NCT00437125|7222069|FG000|Overall Study|Lack of Efficacy|1
4438239|NCT00437125|7222069|FG000|Overall Study|Lost to Follow-up|1
4438240|NCT00437125|7222069|FG000|Overall Study|Withdrawal by Subject|13
4438241|NCT00437125|7222069|FG000|Overall Study|Withdrawal by Caregiver|2
4438242|NCT00437125|7222069|FG000|Overall Study|Physician Decision|1
4438243|NCT00437203|7222083|FG000|Overall Study|Death|0
4438244|NCT00437203|7222084|FG001|Overall Study|Death|0
4438245|NCT00437203|7222085|FG002|Overall Study|Death|1
4438246|NCT00437203|7222086|FG003|Overall Study|Death|0
4438247|NCT00437203|7222087|FG004|Overall Study|Death|0
4438248|NCT00437203|7222088|FG005|Overall Study|Death|0
4438249|NCT00437203|7222089|FG006|Overall Study|Death|0
4438250|NCT00437203|7222090|FG007|Overall Study|Death|1
4438251|NCT00437203|7222091|FG008|Overall Study|Death|0
4438252|NCT00437203|7222092|FG009|Overall Study|Death|1
4438253|NCT00437203|7222083|FG000|Overall Study|Adverse Event|1
4438254|NCT00437203|7222084|FG001|Overall Study|Adverse Event|1
4438255|NCT00437203|7222085|FG002|Overall Study|Adverse Event|0
4438256|NCT00437203|7222086|FG003|Overall Study|Adverse Event|0
4438257|NCT00437203|7222087|FG004|Overall Study|Adverse Event|0
4438258|NCT00437203|7222088|FG005|Overall Study|Adverse Event|0
4438259|NCT00437203|7222089|FG006|Overall Study|Adverse Event|0
4438260|NCT00437203|7222090|FG007|Overall Study|Adverse Event|1
4438261|NCT00437203|7222091|FG008|Overall Study|Adverse Event|0
4438262|NCT00437203|7222092|FG009|Overall Study|Adverse Event|1
4438263|NCT00437203|7222083|FG000|Overall Study|Study terminated by sponsor|0
4438264|NCT00437203|7222084|FG001|Overall Study|Study terminated by sponsor|0
4438265|NCT00437203|7222085|FG002|Overall Study|Study terminated by sponsor|0
4438266|NCT00437203|7222086|FG003|Overall Study|Study terminated by sponsor|0
4438267|NCT00437203|7222087|FG004|Overall Study|Study terminated by sponsor|0
4438268|NCT00437203|7222088|FG005|Overall Study|Study terminated by sponsor|0
4438269|NCT00437203|7222089|FG006|Overall Study|Study terminated by sponsor|0
4438270|NCT00437203|7222090|FG007|Overall Study|Study terminated by sponsor|0
4438271|NCT00437203|7222091|FG008|Overall Study|Study terminated by sponsor|1
4438272|NCT00437203|7222092|FG009|Overall Study|Study terminated by sponsor|0
4438273|NCT00437203|7222083|FG000|Overall Study|Objective progression or relapse|5
4438274|NCT00437203|7222084|FG001|Overall Study|Objective progression or relapse|6
4438275|NCT00437203|7222085|FG002|Overall Study|Objective progression or relapse|2
4438276|NCT00437203|7222086|FG003|Overall Study|Objective progression or relapse|3
4438277|NCT00437203|7222087|FG004|Overall Study|Objective progression or relapse|3
4438278|NCT00437203|7222088|FG005|Overall Study|Objective progression or relapse|3
4438279|NCT00437203|7222089|FG006|Overall Study|Objective progression or relapse|6
4438280|NCT00437203|7222090|FG007|Overall Study|Objective progression or relapse|1
4438281|NCT00437203|7222091|FG008|Overall Study|Objective progression or relapse|2
4438282|NCT00437203|7222092|FG009|Overall Study|Objective progression or relapse|2
4438283|NCT00437203|7222083|FG000|Overall Study|Other|0
4438284|NCT00437203|7222084|FG001|Overall Study|Other|1
4438285|NCT00437203|7222085|FG002|Overall Study|Other|0
4438286|NCT00437203|7222086|FG003|Overall Study|Other|0
4438287|NCT00437203|7222087|FG004|Overall Study|Other|0
4438288|NCT00437203|7222088|FG005|Overall Study|Other|0
4438289|NCT00437203|7222089|FG006|Overall Study|Other|1
4438290|NCT00437203|7222090|FG007|Overall Study|Other|0
4438291|NCT00437203|7222091|FG008|Overall Study|Other|0
4438292|NCT00437203|7222092|FG009|Overall Study|Other|0
4438293|NCT00437268|7222125|FG000|Overall Study|Adverse Event|1
4438294|NCT00437268|7222126|FG001|Overall Study|Adverse Event|1
4438295|NCT00437268|7222125|FG000|Overall Study|Withdrawal by Subject|2
4438296|NCT00437268|7222126|FG001|Overall Study|Withdrawal by Subject|2
4771723|NCT00261807|7748574|FG000|Overall Study|Death|1
4438297|NCT00437268|7222125|FG000|Overall Study|Progressive disease|9
4438298|NCT00437268|7222126|FG001|Overall Study|Progressive disease|9
4438299|NCT00437268|7222125|FG000|Overall Study|Physician Decision|1
4438300|NCT00437268|7222126|FG001|Overall Study|Physician Decision|0
4438301|NCT00437268|7222125|FG000|Overall Study|Death|0
4438302|NCT00437268|7222126|FG001|Overall Study|Death|1
4438303|NCT00437281|7222154|FG000|Overall Study|Adverse Event|0
4438304|NCT00437281|7222155|FG001|Overall Study|Adverse Event|0
4438305|NCT00437281|7222156|FG002|Overall Study|Adverse Event|0
4438306|NCT00437281|7222157|FG003|Overall Study|Adverse Event|1
4438307|NCT00437281|7222158|FG004|Overall Study|Adverse Event|0
4438308|NCT00437281|7222159|FG005|Overall Study|Adverse Event|1
4438309|NCT00437281|7222160|FG006|Overall Study|Adverse Event|0
4438310|NCT00437281|7222161|FG007|Overall Study|Adverse Event|0
4438311|NCT00437281|7222162|FG008|Overall Study|Adverse Event|0
4438312|NCT00437281|7222163|FG009|Overall Study|Adverse Event|1
4438313|NCT00437281|7222164|FG010|Overall Study|Adverse Event|0
4438314|NCT00437281|7222165|FG011|Overall Study|Adverse Event|0
4438315|NCT00437281|7222166|FG012|Overall Study|Adverse Event|0
4438316|NCT00437281|7222167|FG013|Overall Study|Adverse Event|1
4438317|NCT00437281|7222168|FG014|Overall Study|Adverse Event|1
4438318|NCT00437281|7222169|FG015|Overall Study|Adverse Event|0
4438319|NCT00437281|7222170|FG016|Overall Study|Adverse Event|0
4438320|NCT00437281|7222171|FG017|Overall Study|Adverse Event|0
4438321|NCT00437281|7222172|FG018|Overall Study|Adverse Event|1
4438322|NCT00437281|7222173|FG019|Overall Study|Adverse Event|0
4438323|NCT00437281|7222154|FG000|Overall Study|Lost to Follow-up|0
4438324|NCT00437281|7222155|FG001|Overall Study|Lost to Follow-up|0
4438325|NCT00437281|7222156|FG002|Overall Study|Lost to Follow-up|0
4438326|NCT00437281|7222157|FG003|Overall Study|Lost to Follow-up|0
4438327|NCT00437281|7222158|FG004|Overall Study|Lost to Follow-up|0
4438328|NCT00437281|7222159|FG005|Overall Study|Lost to Follow-up|0
4438329|NCT00437281|7222160|FG006|Overall Study|Lost to Follow-up|0
4438330|NCT00437281|7222161|FG007|Overall Study|Lost to Follow-up|0
4438331|NCT00437281|7222162|FG008|Overall Study|Lost to Follow-up|0
4438332|NCT00437281|7222163|FG009|Overall Study|Lost to Follow-up|0
4438333|NCT00437281|7222164|FG010|Overall Study|Lost to Follow-up|0
4438334|NCT00437281|7222165|FG011|Overall Study|Lost to Follow-up|0
4438335|NCT00437281|7222166|FG012|Overall Study|Lost to Follow-up|0
4438336|NCT00437281|7222167|FG013|Overall Study|Lost to Follow-up|0
4438337|NCT00437281|7222168|FG014|Overall Study|Lost to Follow-up|0
4438338|NCT00437281|7222169|FG015|Overall Study|Lost to Follow-up|0
4438339|NCT00437281|7222170|FG016|Overall Study|Lost to Follow-up|0
4438340|NCT00437281|7222171|FG017|Overall Study|Lost to Follow-up|0
4438341|NCT00437281|7222172|FG018|Overall Study|Lost to Follow-up|0
4438342|NCT00437281|7222173|FG019|Overall Study|Lost to Follow-up|1
4438343|NCT00437294|7222247|FG000|Overall Study|Adverse Event|5
4438344|NCT00437294|7222248|FG001|Overall Study|Adverse Event|4
4438345|NCT00437294|7222247|FG000|Overall Study|Death|5
4438346|NCT00437294|7222248|FG001|Overall Study|Death|2
4438347|NCT00437294|7222247|FG000|Overall Study|Physician Decision|0
4438348|NCT00437294|7222248|FG001|Overall Study|Physician Decision|3
4438349|NCT00437294|7222247|FG000|Overall Study|Withdrawal by Subject|5
4438350|NCT00437294|7222248|FG001|Overall Study|Withdrawal by Subject|0
4438351|NCT00437294|7222247|FG000|Overall Study|Progressive Disease|19
4438352|NCT00437294|7222248|FG001|Overall Study|Progressive Disease|23
4438353|NCT00437294|7222247|FG000|Overall Study|Sponsor Decision|8
4438354|NCT00437294|7222248|FG001|Overall Study|Sponsor Decision|9
4438355|NCT00437294|7222247|FG000|Overall Study|Protocol Violation|0
4438356|NCT00437294|7222248|FG001|Overall Study|Protocol Violation|1
4438357|NCT00437294|7222247|FG000|Overall Study|Entry criteria not met|1
4438358|NCT00437294|7222248|FG001|Overall Study|Entry criteria not met|1
4438359|NCT00437489|7222262|FG000|Overall Study|Study terminated by sponsor|23
4438360|NCT00437489|7222263|FG001|Overall Study|Study terminated by sponsor|21
4438361|NCT00437489|7222262|FG000|Overall Study|Lost to Follow-up|0
4438362|NCT00437489|7222263|FG001|Overall Study|Lost to Follow-up|1
4438363|NCT00437645|7222271|FG000|Overall Study|Adverse Event|15
4438364|NCT00437645|7222272|FG001|Overall Study|Adverse Event|84
4438365|NCT00437645|7222271|FG000|Overall Study|Withdrawal by Subject|10
4438366|NCT00437645|7222272|FG001|Overall Study|Withdrawal by Subject|22
4438367|NCT00437645|7222271|FG000|Overall Study|Protocol Violation|3
4438368|NCT00437645|7222272|FG001|Overall Study|Protocol Violation|3
4438369|NCT00437645|7222271|FG000|Overall Study|Lost to Follow-up|2
4438370|NCT00437645|7222272|FG001|Overall Study|Lost to Follow-up|3
4438371|NCT00437645|7222271|FG000|Overall Study|Administrative problems|2
4438372|NCT00437645|7222272|FG001|Overall Study|Administrative problems|1
4438373|NCT00437645|7222271|FG000|Overall Study|Lack of Efficacy|2
4438374|NCT00437645|7222272|FG001|Overall Study|Lack of Efficacy|1
4438375|NCT00437645|7222271|FG000|Overall Study|Condition no longer requires study drug|1
4438376|NCT00437645|7222272|FG001|Overall Study|Condition no longer requires study drug|1
4438377|NCT00437658|7222281|FG000|Treatment Period (24 Weeks)|Adverse Event|4
4438378|NCT00437658|7222282|FG001|Treatment Period (24 Weeks)|Adverse Event|7
4438379|NCT00437658|7222283|FG002|Treatment Period (24 Weeks)|Adverse Event|14
4438380|NCT00437658|7222281|FG000|Treatment Period (24 Weeks)|Non-compliance|1
4438381|NCT00437658|7222282|FG001|Treatment Period (24 Weeks)|Non-compliance|1
4438382|NCT00437658|7222283|FG002|Treatment Period (24 Weeks)|Non-compliance|4
4438383|NCT00437658|7222281|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9
4438384|NCT00437658|7222282|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7
4438385|NCT00437658|7222283|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7
4438386|NCT00437658|7222281|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4
4438387|NCT00437658|7222282|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2
4438388|NCT00437658|7222283|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3
4438389|NCT00437658|7222281|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5
4438390|NCT00437658|7222282|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4
4438391|NCT00437658|7222283|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5
4438392|NCT00437658|7222281|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5
4438393|NCT00437658|7222282|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1
4438394|NCT00437658|7222283|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0
4438395|NCT00437658|7222281|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1
4438396|NCT00437658|7222282|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0
4438397|NCT00437658|7222283|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1
4438398|NCT00437658|7222281|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3
4438399|NCT00437658|7222282|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0
4438400|NCT00437658|7222283|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1
4438401|NCT00437658|7222281|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12
4630273|NCT02288247|7498819|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94
4630274|NCT02288247|7498818|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2
4438402|NCT00437658|7222282|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6
4438403|NCT00437658|7222283|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8
4438404|NCT00437658|7222281|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0
4438405|NCT00437658|7222282|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2
4438406|NCT00437658|7222283|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2
4438407|NCT00437658|7222281|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5
4438408|NCT00437658|7222282|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0
4438409|NCT00437658|7222283|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1
4438410|NCT00437658|7222281|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3
4438411|NCT00437658|7222282|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0
4438412|NCT00437658|7222283|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1
4438413|NCT00437983|7222293|FG000|Overall Study|Adverse Event|6
4438414|NCT00437983|7222294|FG001|Overall Study|Adverse Event|6
4438415|NCT00437983|7222293|FG000|Overall Study|Protocol Violation|2
4438416|NCT00437983|7222294|FG001|Overall Study|Protocol Violation|1
4438417|NCT00437983|7222293|FG000|Overall Study|Withdrawal by Subject|5
4438418|NCT00437983|7222294|FG001|Overall Study|Withdrawal by Subject|6
4438419|NCT00438256|7222323|FG000|Overall Study|Ineligible for Resection|2
4438420|NCT00438256|7222324|FG001|Overall Study|Ineligible for Resection|1
4438421|NCT00438256|7222325|FG002|Overall Study|Ineligible for Resection|1
4438422|NCT00438256|7222326|FG003|Overall Study|Ineligible for Resection|7
4438423|NCT00438256|7222323|FG000|Overall Study|Excluded final Diagnosis|0
4438424|NCT00438256|7222324|FG001|Overall Study|Excluded final Diagnosis|0
4438425|NCT00438256|7222325|FG002|Overall Study|Excluded final Diagnosis|0
4438426|NCT00438256|7222326|FG003|Overall Study|Excluded final Diagnosis|2
4438427|NCT00438360|7222341|FG000|Overall Study|Adverse Event|6
4438428|NCT00438360|7222342|FG001|Overall Study|Adverse Event|1
4438429|NCT00438360|7222341|FG000|Overall Study|Lack of Efficacy|42
4438430|NCT00438360|7222342|FG001|Overall Study|Lack of Efficacy|27
4438431|NCT00438360|7222341|FG000|Overall Study|Other|24
4438432|NCT00438360|7222342|FG001|Overall Study|Other|15
4438433|NCT00438399|7222351|FG000|Overall Study|Lost to Follow-up|2
4438434|NCT00438399|7222352|FG001|Overall Study|Lost to Follow-up|2
4438435|NCT00438399|7222353|FG002|Overall Study|Lost to Follow-up|1
4438436|NCT00438399|7222354|FG003|Overall Study|Lost to Follow-up|1
4438437|NCT00438399|7222355|FG004|Overall Study|Lost to Follow-up|1
4438438|NCT00438399|7222356|FG005|Overall Study|Lost to Follow-up|1
4438439|NCT00438399|7222351|FG000|Overall Study|Adverse Event|0
4438440|NCT00438399|7222352|FG001|Overall Study|Adverse Event|0
4438441|NCT00438399|7222353|FG002|Overall Study|Adverse Event|1
4438442|NCT00438399|7222354|FG003|Overall Study|Adverse Event|1
4438443|NCT00438399|7222355|FG004|Overall Study|Adverse Event|0
4438444|NCT00438399|7222356|FG005|Overall Study|Adverse Event|1
4438445|NCT00438399|7222351|FG000|Overall Study|Withdrawal by Subject|5
4438446|NCT00438399|7222352|FG001|Overall Study|Withdrawal by Subject|6
4438447|NCT00438399|7222353|FG002|Overall Study|Withdrawal by Subject|3
4438448|NCT00438399|7222354|FG003|Overall Study|Withdrawal by Subject|2
4438449|NCT00438399|7222355|FG004|Overall Study|Withdrawal by Subject|2
4438450|NCT00438399|7222356|FG005|Overall Study|Withdrawal by Subject|2
4438451|NCT00438399|7222351|FG000|Overall Study|Protocol Violation|0
4438452|NCT00438399|7222352|FG001|Overall Study|Protocol Violation|0
4438453|NCT00438399|7222353|FG002|Overall Study|Protocol Violation|1
4438454|NCT00438399|7222354|FG003|Overall Study|Protocol Violation|0
4438455|NCT00438399|7222355|FG004|Overall Study|Protocol Violation|0
4438456|NCT00438399|7222356|FG005|Overall Study|Protocol Violation|1
4438457|NCT00438399|7222351|FG000|Overall Study|Subje stopped study|0
4438458|NCT00438399|7222352|FG001|Overall Study|Subje stopped study|0
4438459|NCT00438399|7222353|FG002|Overall Study|Subje stopped study|1
4438460|NCT00438399|7222354|FG003|Overall Study|Subje stopped study|0
4438461|NCT00438399|7222355|FG004|Overall Study|Subje stopped study|0
4438462|NCT00438399|7222356|FG005|Overall Study|Subje stopped study|0
4633314|NCT01910298|7503380|FG000|Overall Study|Protocol Deviation|0
4438463|NCT00438399|7222351|FG000|Overall Study|Pregnancy|0
4438464|NCT00438399|7222352|FG001|Overall Study|Pregnancy|0
4438465|NCT00438399|7222353|FG002|Overall Study|Pregnancy|0
4438466|NCT00438399|7222354|FG003|Overall Study|Pregnancy|0
4438467|NCT00438399|7222355|FG004|Overall Study|Pregnancy|0
4438468|NCT00438399|7222356|FG005|Overall Study|Pregnancy|1
4438469|NCT00438399|7222351|FG000|Overall Study|Patien stopped study at visit 4 by error|1
4438470|NCT00438399|7222352|FG001|Overall Study|Patien stopped study at visit 4 by error|0
4438471|NCT00438399|7222353|FG002|Overall Study|Patien stopped study at visit 4 by error|0
4438472|NCT00438399|7222354|FG003|Overall Study|Patien stopped study at visit 4 by error|0
4438473|NCT00438399|7222355|FG004|Overall Study|Patien stopped study at visit 4 by error|0
4438474|NCT00438399|7222356|FG005|Overall Study|Patien stopped study at visit 4 by error|0
4438475|NCT00438464|7222380|FG000|Overall Study|Terminated Early|14
4438476|NCT00438464|7222381|FG001|Overall Study|Terminated Early|5
4438477|NCT00438464|7222380|FG000|Overall Study|Incomplete data submission|0
4438478|NCT00438464|7222381|FG001|Overall Study|Incomplete data submission|2
4438479|NCT00438633|7222414|FG000|Overall Study|Withdrawal by Subject|1
4438480|NCT00438633|7222415|FG001|Overall Study|Withdrawal by Subject|0
4438481|NCT00438633|7222414|FG000|Overall Study|Lost to Follow-up|15
4438482|NCT00438633|7222415|FG001|Overall Study|Lost to Follow-up|17
4438483|NCT00438659|7222423|FG000|Overall Study|Discontinued Mometasone/Placebo|1
4438484|NCT00438659|7222424|FG001|Overall Study|Discontinued Mometasone/Placebo|2
4438485|NCT00438659|7222423|FG000|Overall Study|Cancel|5
4438486|NCT00438659|7222424|FG001|Overall Study|Cancel|2
4438487|NCT00438672|7222433|FG000|Overall Study|Lost to Follow-up|7
4438488|NCT00438672|7222434|FG001|Overall Study|Lost to Follow-up|9
4438489|NCT00438815|7222464|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30
4438490|NCT00438815|7222464|FG000|Overall Study|3-month follow-up no longer required|12
4438491|NCT00438815|7222464|FG000|Overall Study|Noncompliance with protocol requirements|9
4438492|NCT00438815|7222464|FG000|Overall Study|Transitioned to commercial C1INH-nf|6
4438493|NCT00438815|7222464|FG000|Overall Study|Lost to Follow-up|6
4438494|NCT00438815|7222464|FG000|Overall Study|Withdrawal by Subject|6
4438495|NCT00438815|7222464|FG000|Overall Study|Death|1
4438496|NCT00439140|7222506|FG000|Treatment Cycle 1|Lost to Follow-up|1
4438497|NCT00439140|7222507|FG001|Treatment Cycle 1|Lost to Follow-up|1
4438498|NCT00439140|7222508|FG002|Treatment Cycle 1|Lost to Follow-up|1
4438499|NCT00439140|7222506|FG000|Treatment Cycle 1|Personal reasons|0
4438500|NCT00439140|7222507|FG001|Treatment Cycle 1|Personal reasons|2
4438501|NCT00439140|7222508|FG002|Treatment Cycle 1|Personal reasons|0
4438502|NCT00439140|7222506|FG000|Treatment Cycle 1|Withdrawal by Subject|0
4438503|NCT00439140|7222507|FG001|Treatment Cycle 1|Withdrawal by Subject|1
4438504|NCT00439140|7222508|FG002|Treatment Cycle 1|Withdrawal by Subject|0
4438505|NCT00439140|7222506|FG000|Treatment Cycle 2|Withdrawal by Subject|1
4438506|NCT00439140|7222507|FG001|Treatment Cycle 2|Withdrawal by Subject|0
4438507|NCT00439140|7222508|FG002|Treatment Cycle 2|Withdrawal by Subject|0
4438508|NCT00439140|7222506|FG000|Treatment Cycle 2|Lost to Follow-up|1
4438509|NCT00439140|7222507|FG001|Treatment Cycle 2|Lost to Follow-up|1
4438510|NCT00439140|7222508|FG002|Treatment Cycle 2|Lost to Follow-up|0
4438511|NCT00439179|7222520|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0
4438512|NCT00439179|7222521|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2
4438513|NCT00439179|7222522|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0
4438514|NCT00439179|7222523|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0
4438515|NCT00439218|7222536|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1
4438516|NCT00439231|7222540|FG000|Overall Study|Lack of Efficacy|28
4438517|NCT00439244|7222547|FG000|Overall Study|Adverse Event|5
4438518|NCT00439244|7222548|FG001|Overall Study|Adverse Event|2
4438519|NCT00439244|7222549|FG002|Overall Study|Adverse Event|3
4438520|NCT00439244|7222547|FG000|Overall Study|Withdrawal by Subject|3
4438521|NCT00439244|7222548|FG001|Overall Study|Withdrawal by Subject|1
4438522|NCT00439244|7222549|FG002|Overall Study|Withdrawal by Subject|2
4438523|NCT00439244|7222547|FG000|Overall Study|Lost to Follow-up|2
4438524|NCT00439244|7222548|FG001|Overall Study|Lost to Follow-up|1
4438525|NCT00439244|7222549|FG002|Overall Study|Lost to Follow-up|2
4438526|NCT00439244|7222547|FG000|Overall Study|Death|0
4438527|NCT00439244|7222548|FG001|Overall Study|Death|1
4438528|NCT00439244|7222549|FG002|Overall Study|Death|0
4438529|NCT00439244|7222547|FG000|Overall Study|Protocol Violation|0
4438530|NCT00439244|7222548|FG001|Overall Study|Protocol Violation|1
4438531|NCT00439244|7222549|FG002|Overall Study|Protocol Violation|0
4438532|NCT00439244|7222547|FG000|Overall Study|Administrative problems|1
4438533|NCT00439244|7222548|FG001|Overall Study|Administrative problems|0
4438534|NCT00439244|7222549|FG002|Overall Study|Administrative problems|0
4438535|NCT00439270|7222562|FG000|Phase 1 (18.1 Months)|Disease progression|3
4438536|NCT00439270|7222563|FG001|Phase 1 (18.1 Months)|Disease progression|2
4438537|NCT00439270|7222564|FG002|Phase 1 (18.1 Months)|Disease progression|3
4438538|NCT00439270|7222565|FG003|Phase 1 (18.1 Months)|Disease progression|0
4438539|NCT00439270|7222566|FG004|Phase 1 (18.1 Months)|Disease progression|3
4438540|NCT00439270|7222562|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0
4438541|NCT00439270|7222563|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1
4438542|NCT00439270|7222564|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0
4438543|NCT00439270|7222565|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0
4438544|NCT00439270|7222566|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0
4438545|NCT00439270|7222562|FG000|Phase 2 (51.6 Months)|Disease progression|0
4438546|NCT00439270|7222563|FG001|Phase 2 (51.6 Months)|Disease progression|0
4438547|NCT00439270|7222564|FG002|Phase 2 (51.6 Months)|Disease progression|0
4438548|NCT00439270|7222565|FG003|Phase 2 (51.6 Months)|Disease progression|18
4438549|NCT00439270|7222566|FG004|Phase 2 (51.6 Months)|Disease progression|0
4438550|NCT00439270|7222562|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
4438551|NCT00439270|7222563|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
4438552|NCT00439270|7222564|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
4438553|NCT00439270|7222565|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1
4438554|NCT00439270|7222566|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
4438555|NCT00439270|7222562|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0
4438556|NCT00439270|7222563|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0
4438557|NCT00439270|7222564|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0
4438558|NCT00439270|7222565|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6
4438559|NCT00439270|7222566|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0
4438560|NCT00439270|7222562|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0
4438561|NCT00439270|7222563|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0
4438562|NCT00439270|7222564|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0
4438563|NCT00439270|7222565|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3
4438564|NCT00439270|7222566|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0
4438565|NCT00439270|7222562|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0
4438566|NCT00439270|7222563|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0
4438567|NCT00439270|7222564|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0
4438568|NCT00439270|7222565|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1
4438569|NCT00439270|7222566|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0
4438570|NCT00439270|7222562|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0
4438571|NCT00439270|7222563|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0
4438572|NCT00439270|7222564|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0
4438573|NCT00439270|7222565|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2
4438574|NCT00439270|7222566|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0
4438575|NCT00439270|7222562|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
4438576|NCT00439270|7222563|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
4438577|NCT00439270|7222564|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
4438578|NCT00439270|7222565|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2
4438579|NCT00439270|7222566|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
4438580|NCT00439270|7222562|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
4438581|NCT00439270|7222563|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
4438582|NCT00439270|7222564|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
4438583|NCT00439270|7222565|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1
4438584|NCT00439270|7222566|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
4438585|NCT00439309|7222596|FG000|Follow-Up|Death|1
4438586|NCT00439309|7222597|FG001|Follow-Up|Death|0
4438587|NCT00439309|7222596|FG000|Follow-Up|Lost to Follow-up|2
4438588|NCT00439309|7222597|FG001|Follow-Up|Lost to Follow-up|0
4438589|NCT00439309|7222596|FG000|Follow-Up|Withdrawal by Subject|0
4438590|NCT00439309|7222597|FG001|Follow-Up|Withdrawal by Subject|1
4438591|NCT00439309|7222596|FG000|Follow-Up|Late response by subject|0
4438592|NCT00439309|7222597|FG001|Follow-Up|Late response by subject|1
4438593|NCT00439517|7222641|FG000|Overall Study|Subject on treatment|1
4438594|NCT00439517|7222642|FG001|Overall Study|Subject on treatment|0
4438595|NCT00439517|7222641|FG000|Overall Study|Subject in survival follow-up|1
4438596|NCT00439517|7222642|FG001|Overall Study|Subject in survival follow-up|0
4438597|NCT00439556|7222651|FG000|Overall Study|Patient was taken off study for non-comp|0
4438598|NCT00439556|7222652|FG001|Overall Study|Patient was taken off study for non-comp|1
4438599|NCT00439556|7222653|FG002|Overall Study|Patient was taken off study for non-comp|0
4438600|NCT00439647|7222668|FG000|Overall Study|Withdrawal by Subject|25
4438601|NCT00439647|7222669|FG001|Overall Study|Withdrawal by Subject|22
4438602|NCT00439647|7222668|FG000|Overall Study|Death|15
4438603|NCT00439647|7222669|FG001|Overall Study|Death|18
4438604|NCT00439647|7222668|FG000|Overall Study|Adverse Event|11
4438605|NCT00439647|7222669|FG001|Overall Study|Adverse Event|11
4438606|NCT00439647|7222668|FG000|Overall Study|Lost to Follow-up|4
4438607|NCT00439647|7222669|FG001|Overall Study|Lost to Follow-up|12
4438608|NCT00439647|7222668|FG000|Overall Study|Protocol Violation|3
4438609|NCT00439647|7222669|FG001|Overall Study|Protocol Violation|4
4438610|NCT00439647|7222668|FG000|Overall Study|Lack of Efficacy|0
4438611|NCT00439647|7222669|FG001|Overall Study|Lack of Efficacy|4
4438612|NCT00439725|7222681|FG000|Treatment Period|Withdrawal by Subject|22
4438613|NCT00439725|7222682|FG001|Treatment Period|Withdrawal by Subject|19
4438614|NCT00439725|7222681|FG000|Treatment Period|Study terminated by sponsor|156
4438615|NCT00439725|7222682|FG001|Treatment Period|Study terminated by sponsor|148
4438616|NCT00439725|7222681|FG000|Treatment Period|Site closed by investigator|1
4438617|NCT00439725|7222682|FG001|Treatment Period|Site closed by investigator|2
4438618|NCT00439725|7222681|FG000|Treatment Period|Adverse Event|39
4438619|NCT00439725|7222682|FG001|Treatment Period|Adverse Event|18
4438620|NCT00439725|7222681|FG000|Treatment Period|Physician Decision|1
4438621|NCT00439725|7222682|FG001|Treatment Period|Physician Decision|1
4438622|NCT00439725|7222681|FG000|Treatment Period|Protocol Violation|2
4438623|NCT00439725|7222682|FG001|Treatment Period|Protocol Violation|1
4438624|NCT00439725|7222681|FG000|Treatment Period|Clinical endpoint reached|6
4438625|NCT00439725|7222682|FG001|Treatment Period|Clinical endpoint reached|50
4438626|NCT00439725|7222681|FG000|Treatment Period|Technical problems|1
4438627|NCT00439725|7222682|FG001|Treatment Period|Technical problems|0
4438628|NCT00439725|7222681|FG000|Treatment Period|Lost to Follow-up|1
4438629|NCT00439725|7222682|FG001|Treatment Period|Lost to Follow-up|1
4438630|NCT00439725|7222681|FG000|Treatment Period|Participant convenience|1
4438631|NCT00439725|7222682|FG001|Treatment Period|Participant convenience|0
4438632|NCT00439725|7222681|FG000|Treatment Period|Protocol driven decision point|1
4438633|NCT00439725|7222682|FG001|Treatment Period|Protocol driven decision point|1
4438634|NCT00439725|7222681|FG000|Treatment Period|Death|1
4438635|NCT00439725|7222682|FG001|Treatment Period|Death|1
4438636|NCT00439725|7222681|FG000|Treatment Period|Participant did not receive treatment|4
4438637|NCT00439725|7222682|FG001|Treatment Period|Participant did not receive treatment|4
4438638|NCT00439725|7222681|FG000|Observational Period|Withdrawal by Subject|2
4438639|NCT00439725|7222682|FG001|Observational Period|Withdrawal by Subject|2
4438640|NCT00439725|7222681|FG000|Observational Period|Lost to Follow-up|0
4438641|NCT00439725|7222682|FG001|Observational Period|Lost to Follow-up|1
4438642|NCT00439725|7222681|FG000|Observational Period|Death|0
4438643|NCT00439725|7222682|FG001|Observational Period|Death|2
4438644|NCT00439725|7222681|FG000|Observational Period|Study termination by sponsor|1
4438645|NCT00439725|7222682|FG001|Observational Period|Study termination by sponsor|1
4438646|NCT00439725|7222681|FG000|Observational Period|Clinical endpoint reached|3
4438647|NCT00439725|7222682|FG001|Observational Period|Clinical endpoint reached|1
4438648|NCT00439725|7222681|FG000|Observational Period|Technical problems|1
4438649|NCT00439725|7222682|FG001|Observational Period|Technical problems|0
4438650|NCT00439725|7222681|FG000|Observational Period|Participant convenience|1
4438651|NCT00439725|7222682|FG001|Observational Period|Participant convenience|0
4438652|NCT00439777|7222690|FG000|Treatment Period|Death|29
4438653|NCT00439777|7222691|FG001|Treatment Period|Death|21
4438654|NCT00439777|7222690|FG000|Treatment Period|Study terminated by sponsor|125
4438655|NCT00439777|7222691|FG001|Treatment Period|Study terminated by sponsor|132
4438656|NCT00439777|7222690|FG000|Treatment Period|Site closed by investigator|0
4438657|NCT00439777|7222691|FG001|Treatment Period|Site closed by investigator|1
4438658|NCT00439777|7222690|FG000|Treatment Period|Did not take study treatment|7
4438659|NCT00439777|7222691|FG001|Treatment Period|Did not take study treatment|8
4438660|NCT00439777|7222690|FG000|Treatment Period|Adverse Event|111
4438661|NCT00439777|7222691|FG001|Treatment Period|Adverse Event|92
4438662|NCT00439777|7222690|FG000|Treatment Period|Protocol Violation|23
4438663|NCT00439777|7222691|FG001|Treatment Period|Protocol Violation|30
4438664|NCT00439777|7222690|FG000|Treatment Period|Withdrawal by Subject|66
4438665|NCT00439777|7222691|FG001|Treatment Period|Withdrawal by Subject|118
4438666|NCT00439777|7222690|FG000|Treatment Period|Lack of Efficacy|1
4438667|NCT00439777|7222691|FG001|Treatment Period|Lack of Efficacy|4
4438668|NCT00439777|7222690|FG000|Treatment Period|Lost to Follow-up|8
4438669|NCT00439777|7222691|FG001|Treatment Period|Lost to Follow-up|10
4438670|NCT00439777|7222690|FG000|Treatment Period|Protocol driven decision point|1
4438671|NCT00439777|7222691|FG001|Treatment Period|Protocol driven decision point|3
4438672|NCT00439777|7222690|FG000|Treatment Period|Physician Decision|7
4438673|NCT00439777|7222691|FG001|Treatment Period|Physician Decision|18
4438674|NCT00439777|7222690|FG000|Treatment Period|Clinical endpoint reached|26
4438675|NCT00439777|7222691|FG001|Treatment Period|Clinical endpoint reached|13
4438676|NCT00439777|7222690|FG000|Treatment Period|Technical problems|3
4438677|NCT00439777|7222691|FG001|Treatment Period|Technical problems|1
4438678|NCT00439777|7222690|FG000|Treatment Period|Participant convenience|12
4438679|NCT00439777|7222691|FG001|Treatment Period|Participant convenience|8
4438680|NCT00439777|7222690|FG000|Observational Period|Protocol Violation|0
4438681|NCT00439777|7222691|FG001|Observational Period|Protocol Violation|2
4438682|NCT00439777|7222690|FG000|Observational Period|Withdrawal by Subject|9
4438683|NCT00439777|7222691|FG001|Observational Period|Withdrawal by Subject|5
4438684|NCT00439777|7222690|FG000|Observational Period|Lost to Follow-up|1
4438685|NCT00439777|7222691|FG001|Observational Period|Lost to Follow-up|11
4438686|NCT00439777|7222690|FG000|Observational Period|Death|27
4438687|NCT00439777|7222691|FG001|Observational Period|Death|20
4438688|NCT00439777|7222690|FG000|Observational Period|Study terminated by sponsor|3
4438689|NCT00439777|7222691|FG001|Observational Period|Study terminated by sponsor|1
4438690|NCT00439777|7222690|FG000|Observational Period|Protocol driven decision point|0
4438691|NCT00439777|7222691|FG001|Observational Period|Protocol driven decision point|1
4438692|NCT00439777|7222690|FG000|Observational Period|Lack of Efficacy|1
4438693|NCT00439777|7222691|FG001|Observational Period|Lack of Efficacy|0
4438694|NCT00439777|7222690|FG000|Observational Period|Technical problems|0
4438695|NCT00439777|7222691|FG001|Observational Period|Technical problems|1
4438696|NCT00440011|7222703|FG000|Overall Study|Adverse Event|2
4438697|NCT00440011|7222704|FG001|Overall Study|Adverse Event|0
4438698|NCT00440011|7222703|FG000|Overall Study|Lost to Follow-up|0
4438699|NCT00440011|7222704|FG001|Overall Study|Lost to Follow-up|2
4438700|NCT00440011|7222703|FG000|Overall Study|Protocol Violation|1
4438701|NCT00440011|7222704|FG001|Overall Study|Protocol Violation|1
4438702|NCT00440011|7222703|FG000|Overall Study|Withdrawal by Subject|1
4438703|NCT00440011|7222704|FG001|Overall Study|Withdrawal by Subject|0
4438704|NCT00440037|7222710|FG000|Overall Study|Withdrawal by Subject|6
4438705|NCT00440037|7222710|FG000|Overall Study|Administrative decision|3
4438706|NCT00440115|7222726|FG000|Overall Study|Death|7
4438707|NCT00440115|7222727|FG001|Overall Study|Death|9
4438708|NCT00440115|7222728|FG002|Overall Study|Death|5
4438709|NCT00440115|7222726|FG000|Overall Study|Incarceration|0
4438710|NCT00440115|7222727|FG001|Overall Study|Incarceration|2
4438711|NCT00440115|7222728|FG002|Overall Study|Incarceration|1
4438712|NCT00440193|7222747|FG000|Treatment Period|Adverse Event|74
4438713|NCT00440193|7222748|FG001|Treatment Period|Adverse Event|67
4438714|NCT00440193|7222747|FG000|Treatment Period|Death|19
4438715|NCT00440193|7222748|FG001|Treatment Period|Death|22
4438716|NCT00440193|7222747|FG000|Treatment Period|Lack of Efficacy|0
4438717|NCT00440193|7222748|FG001|Treatment Period|Lack of Efficacy|1
4438718|NCT00440193|7222747|FG000|Treatment Period|Lost to Follow-up|12
4438719|NCT00440193|7222748|FG001|Treatment Period|Lost to Follow-up|18
4438720|NCT00440193|7222747|FG000|Treatment Period|Physician Decision|3
4438721|NCT00440193|7222748|FG001|Treatment Period|Physician Decision|6
4438722|NCT00440193|7222747|FG000|Treatment Period|Protocol Violation|16
4438723|NCT00440193|7222748|FG001|Treatment Period|Protocol Violation|19
4438724|NCT00440193|7222747|FG000|Treatment Period|Withdrawal by Subject|36
4438725|NCT00440193|7222748|FG001|Treatment Period|Withdrawal by Subject|77
4438726|NCT00440193|7222747|FG000|Treatment Period|Clinical endpoint reached|28
4438727|NCT00440193|7222748|FG001|Treatment Period|Clinical endpoint reached|25
4438728|NCT00440193|7222747|FG000|Treatment Period|Study terminated by sponsor|102
4438729|NCT00440193|7222748|FG001|Treatment Period|Study terminated by sponsor|94
4438730|NCT00440193|7222747|FG000|Treatment Period|Protocol driven decision point|2
4438731|NCT00440193|7222748|FG001|Treatment Period|Protocol driven decision point|2
4438732|NCT00440193|7222747|FG000|Treatment Period|Switch to commercial drug|0
4438733|NCT00440193|7222748|FG001|Treatment Period|Switch to commercial drug|2
4438734|NCT00440193|7222747|FG000|Treatment Period|Technical problems|1
4438735|NCT00440193|7222748|FG001|Treatment Period|Technical problems|1
4438736|NCT00440193|7222747|FG000|Treatment Period|Participant convenience|5
4438737|NCT00440193|7222748|FG001|Treatment Period|Participant convenience|2
4438738|NCT00440193|7222747|FG000|Treatment Period|Participant did not receive treatment|7
4438739|NCT00440193|7222748|FG001|Treatment Period|Participant did not receive treatment|13
4438740|NCT00440193|7222747|FG000|Treatment Period|Site closed by investigator|0
4438741|NCT00440193|7222748|FG001|Treatment Period|Site closed by investigator|2
4438742|NCT00440193|7222747|FG000|Observational Period|Adverse Event|2
4438743|NCT00440193|7222748|FG001|Observational Period|Adverse Event|2
4438744|NCT00440193|7222747|FG000|Observational Period|Death|15
4438745|NCT00440193|7222748|FG001|Observational Period|Death|20
4438746|NCT00440193|7222747|FG000|Observational Period|Lost to Follow-up|12
4438747|NCT00440193|7222748|FG001|Observational Period|Lost to Follow-up|8
4438748|NCT00440193|7222747|FG000|Observational Period|Protocol Violation|1
4438749|NCT00440193|7222748|FG001|Observational Period|Protocol Violation|0
4438750|NCT00440193|7222747|FG000|Observational Period|Withdrawal by Subject|11
4438751|NCT00440193|7222748|FG001|Observational Period|Withdrawal by Subject|8
4438752|NCT00440193|7222747|FG000|Observational Period|Physician Decision|1
4438753|NCT00440193|7222748|FG001|Observational Period|Physician Decision|0
4438754|NCT00440193|7222747|FG000|Observational Period|Clinical endpoint reached|1
4438755|NCT00440193|7222748|FG001|Observational Period|Clinical endpoint reached|0
4438756|NCT00440193|7222747|FG000|Observational Period|Participant convenience|2
4438757|NCT00440193|7222748|FG001|Observational Period|Participant convenience|0
4438758|NCT00440232|7222756|FG000|Overall Study|Lost to Follow-up|1
4438759|NCT00440232|7222757|FG001|Overall Study|Lost to Follow-up|1
4438760|NCT00440232|7222756|FG000|Overall Study|Unable to treat within allowed time|0
4438761|NCT00440232|7222757|FG001|Overall Study|Unable to treat within allowed time|1
4438762|NCT00440232|7222756|FG000|Overall Study|Onset of headache within 4 hours of fast|2
4438763|NCT00440232|7222757|FG001|Overall Study|Onset of headache within 4 hours of fast|2
4438764|NCT00440297|7222765|FG000|Overall Study|Adverse Event|8
4438765|NCT00440297|7222766|FG001|Overall Study|Adverse Event|5
4438766|NCT00440297|7222765|FG000|Overall Study|Lost to Follow-up|1
4438767|NCT00440297|7222766|FG001|Overall Study|Lost to Follow-up|0
4438768|NCT00440297|7222765|FG000|Overall Study|Physician Decision|1
4438769|NCT00440297|7222766|FG001|Overall Study|Physician Decision|0
4438770|NCT00440297|7222765|FG000|Overall Study|Protocol Violation|11
4438771|NCT00440297|7222766|FG001|Overall Study|Protocol Violation|7
4438772|NCT00440297|7222765|FG000|Overall Study|Withdrawal by Subject|1
4438773|NCT00440297|7222766|FG001|Overall Study|Withdrawal by Subject|6
4438774|NCT00440297|7222765|FG000|Overall Study|Randomized by mistake|1
4438775|NCT00440297|7222766|FG001|Overall Study|Randomized by mistake|0
4438776|NCT00440310|7222774|FG000|Overall Study|Lost to Follow-up|4
4438777|NCT00440310|7222775|FG001|Overall Study|Lost to Follow-up|5
4438778|NCT00440310|7222774|FG000|Overall Study|Protocol Violation|0
4438779|NCT00440310|7222775|FG001|Overall Study|Protocol Violation|1
4438780|NCT00440310|7222774|FG000|Overall Study|Withdrawal by Subject|15
4438781|NCT00440310|7222775|FG001|Overall Study|Withdrawal by Subject|14
4438782|NCT00440310|7222774|FG000|Overall Study|No Reply at EOS|7
4438783|NCT00440310|7222775|FG001|Overall Study|No Reply at EOS|7
4438784|NCT00440310|7222774|FG000|Overall Study|Other|1
4438785|NCT00440310|7222775|FG001|Overall Study|Other|0
4716318|NCT02991859|7645657|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
4716319|NCT02991859|7645658|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1
4438786|NCT00440310|7222774|FG000|Overall Study|Status Unknown|1
4438787|NCT00440310|7222775|FG001|Overall Study|Status Unknown|3
4438788|NCT00440401|7222783|FG000|Overall Study|Adverse Event|2
4438789|NCT00440401|7222784|FG001|Overall Study|Adverse Event|1
4438790|NCT00440401|7222783|FG000|Overall Study|Other|2
4438791|NCT00440401|7222784|FG001|Overall Study|Other|5
4438792|NCT00440466|7222793|FG000|Overall Study|Death|3
4438793|NCT00440466|7222794|FG001|Overall Study|Death|2
4438794|NCT00440466|7222795|FG002|Overall Study|Death|9
4438795|NCT00440466|7222793|FG000|Overall Study|Adverse Event|3
4438796|NCT00440466|7222794|FG001|Overall Study|Adverse Event|4
4438797|NCT00440466|7222795|FG002|Overall Study|Adverse Event|11
4438798|NCT00440466|7222793|FG000|Overall Study|Lost to Follow-up|1
4438799|NCT00440466|7222794|FG001|Overall Study|Lost to Follow-up|0
4438800|NCT00440466|7222795|FG002|Overall Study|Lost to Follow-up|2
4438801|NCT00440466|7222793|FG000|Overall Study|Physician Decision|2
4438802|NCT00440466|7222794|FG001|Overall Study|Physician Decision|0
4438803|NCT00440466|7222795|FG002|Overall Study|Physician Decision|1
4438804|NCT00440466|7222793|FG000|Overall Study|Protocol Violation|2
4438805|NCT00440466|7222794|FG001|Overall Study|Protocol Violation|0
4438806|NCT00440466|7222795|FG002|Overall Study|Protocol Violation|4
4438807|NCT00440466|7222793|FG000|Overall Study|Withdrawal by Subject|2
4438808|NCT00440466|7222794|FG001|Overall Study|Withdrawal by Subject|5
4438809|NCT00440466|7222795|FG002|Overall Study|Withdrawal by Subject|9
4438810|NCT00440466|7222793|FG000|Overall Study|Began Dialysis|0
4438811|NCT00440466|7222794|FG001|Overall Study|Began Dialysis|0
4438812|NCT00440466|7222795|FG002|Overall Study|Began Dialysis|1
4438813|NCT00440466|7222793|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0
4438814|NCT00440466|7222794|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4
4438815|NCT00440466|7222795|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4
4438816|NCT00440518|7222819|FG000|Randomized /Titration Period|Lack of Efficacy|1
4438817|NCT00440518|7222820|FG001|Randomized /Titration Period|Lack of Efficacy|0
4438818|NCT00440518|7222821|FG002|Randomized /Titration Period|Lack of Efficacy|1
4438819|NCT00440518|7222819|FG000|Randomized /Titration Period|Subject Withdrew Consent|4
4438820|NCT00440518|7222820|FG001|Randomized /Titration Period|Subject Withdrew Consent|1
4438821|NCT00440518|7222821|FG002|Randomized /Titration Period|Subject Withdrew Consent|0
4438822|NCT00440518|7222819|FG000|Randomized /Titration Period|Protocol Deviation|1
4438823|NCT00440518|7222820|FG001|Randomized /Titration Period|Protocol Deviation|0
4438824|NCT00440518|7222821|FG002|Randomized /Titration Period|Protocol Deviation|0
4438825|NCT00440518|7222819|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2
4438826|NCT00440518|7222820|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3
4438827|NCT00440518|7222821|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2
4438828|NCT00440518|7222819|FG000|Randomized /Titration Period|Other|1
4438829|NCT00440518|7222820|FG001|Randomized /Titration Period|Other|0
4438830|NCT00440518|7222821|FG002|Randomized /Titration Period|Other|0
4438831|NCT00440518|7222819|FG000|Randomized /Titration Period|Lost to Follow-up|2
4438832|NCT00440518|7222820|FG001|Randomized /Titration Period|Lost to Follow-up|2
4438833|NCT00440518|7222821|FG002|Randomized /Titration Period|Lost to Follow-up|1
4438834|NCT00440518|7222819|FG000|Randomized /Titration Period|Adverse Event|2
4438835|NCT00440518|7222820|FG001|Randomized /Titration Period|Adverse Event|3
4438836|NCT00440518|7222821|FG002|Randomized /Titration Period|Adverse Event|0
4438837|NCT00440518|7222819|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3
4438838|NCT00440518|7222820|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4
4438839|NCT00440518|7222821|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2
4438840|NCT00440518|7222819|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0
4438841|NCT00440518|7222820|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1
4438842|NCT00440518|7222821|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1
4438843|NCT00440518|7222819|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3
4438844|NCT00440518|7222820|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2
4438845|NCT00440518|7222821|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4
4438846|NCT00440518|7222819|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0
4438847|NCT00440518|7222820|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3
4438848|NCT00440518|7222821|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6
4438849|NCT00440518|7222819|FG000|Maintenance and Safety Follow-up Periods|Other|0
4438850|NCT00440518|7222820|FG001|Maintenance and Safety Follow-up Periods|Other|0
4438851|NCT00440518|7222821|FG002|Maintenance and Safety Follow-up Periods|Other|2
4438852|NCT00440518|7222819|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1
4438853|NCT00440518|7222820|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2
4438854|NCT00440518|7222821|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0
4438855|NCT00440557|7222832|FG000|Overall Study|Withdrawal by Subject|10
4438856|NCT00440557|7222833|FG001|Overall Study|Withdrawal by Subject|5
4438857|NCT00440557|7222834|FG002|Overall Study|Withdrawal by Subject|11
4438858|NCT00440557|7222832|FG000|Overall Study|Lost to Follow-up|1
4438859|NCT00440557|7222833|FG001|Overall Study|Lost to Follow-up|2
4438860|NCT00440557|7222834|FG002|Overall Study|Lost to Follow-up|6
4438861|NCT00440557|7222832|FG000|Overall Study|Adverse Event|3
4438862|NCT00440557|7222833|FG001|Overall Study|Adverse Event|3
4438863|NCT00440557|7222834|FG002|Overall Study|Adverse Event|5
4438864|NCT00440557|7222832|FG000|Overall Study|Death|2
4438865|NCT00440557|7222833|FG001|Overall Study|Death|6
4438866|NCT00440557|7222834|FG002|Overall Study|Death|3
4438867|NCT00440557|7222832|FG000|Overall Study|Began Dialysis|4
4438868|NCT00440557|7222833|FG001|Overall Study|Began Dialysis|1
4438869|NCT00440557|7222834|FG002|Overall Study|Began Dialysis|4
4438870|NCT00440557|7222832|FG000|Overall Study|Principal Investigator decision|0
4438871|NCT00440557|7222833|FG001|Overall Study|Principal Investigator decision|3
4438872|NCT00440557|7222834|FG002|Overall Study|Principal Investigator decision|1
4438873|NCT00440557|7222832|FG000|Overall Study|Patient moved|1
4438874|NCT00440557|7222833|FG001|Overall Study|Patient moved|2
4438875|NCT00440557|7222834|FG002|Overall Study|Patient moved|1
4438876|NCT00440557|7222832|FG000|Overall Study|Principal Investigator's office closed|3
4438877|NCT00440557|7222833|FG001|Overall Study|Principal Investigator's office closed|6
4438878|NCT00440557|7222834|FG002|Overall Study|Principal Investigator's office closed|4
4438879|NCT00440557|7222832|FG000|Overall Study|Patient transferred to nursing home|0
4438880|NCT00440557|7222833|FG001|Overall Study|Patient transferred to nursing home|1
4438881|NCT00440557|7222834|FG002|Overall Study|Patient transferred to nursing home|0
4438882|NCT00440557|7222832|FG000|Overall Study|Patient had surgery|1
4438883|NCT00440557|7222833|FG001|Overall Study|Patient had surgery|0
4438884|NCT00440557|7222834|FG002|Overall Study|Patient had surgery|0
4438885|NCT00440700|7222856|FG000|Overall Study|Withdrawal by Subject|8
4438886|NCT00440700|7222857|FG001|Overall Study|Withdrawal by Subject|8
4438887|NCT00440700|7222858|FG002|Overall Study|Withdrawal by Subject|4
4438888|NCT00440726|7222869|FG000|Phase 1|Dose-Limiting Toxicity|0
4438889|NCT00440726|7222870|FG001|Phase 1|Dose-Limiting Toxicity|1
4438890|NCT00440726|7222871|FG002|Phase 1|Dose-Limiting Toxicity|0
4438891|NCT00440726|7222869|FG000|Phase 1|Physician Decision|1
4438892|NCT00440726|7222870|FG001|Phase 1|Physician Decision|0
4438893|NCT00440726|7222871|FG002|Phase 1|Physician Decision|0
4438894|NCT00440726|7222869|FG000|Phase 2|Death|0
4438895|NCT00440726|7222870|FG001|Phase 2|Death|0
4438896|NCT00440726|7222871|FG002|Phase 2|Death|1
4438897|NCT00440726|7222869|FG000|Phase 2|Adverse Event|0
4438898|NCT00440726|7222870|FG001|Phase 2|Adverse Event|0
4438899|NCT00440726|7222871|FG002|Phase 2|Adverse Event|1
4438900|NCT00440947|7222903|FG000|36-Week Induction Phase|Adverse Event|16
4438901|NCT00440947|7222904|FG001|36-Week Induction Phase|Adverse Event|0
4438902|NCT00440947|7222905|FG002|36-Week Induction Phase|Adverse Event|0
4438903|NCT00440947|7222906|FG003|36-Week Induction Phase|Adverse Event|0
4438904|NCT00440947|7222907|FG004|36-Week Induction Phase|Adverse Event|0
4438905|NCT00440947|7222903|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11
4438906|NCT00440947|7222904|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0
4438907|NCT00440947|7222905|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0
4438908|NCT00440947|7222906|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0
4438909|NCT00440947|7222907|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0
4438910|NCT00440947|7222903|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5
4438911|NCT00440947|7222904|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0
4438912|NCT00440947|7222905|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0
4438913|NCT00440947|7222906|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0
4438914|NCT00440947|7222907|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0
4438915|NCT00440947|7222903|FG000|36-Week Induction Phase|Non-compliance|10
4438916|NCT00440947|7222904|FG001|36-Week Induction Phase|Non-compliance|0
4438917|NCT00440947|7222905|FG002|36-Week Induction Phase|Non-compliance|0
4438918|NCT00440947|7222906|FG003|36-Week Induction Phase|Non-compliance|0
4438919|NCT00440947|7222907|FG004|36-Week Induction Phase|Non-compliance|0
4438920|NCT00440947|7222903|FG000|36-Week Induction Phase|Lost to Follow-up|16
4438921|NCT00440947|7222904|FG001|36-Week Induction Phase|Lost to Follow-up|0
4438922|NCT00440947|7222905|FG002|36-Week Induction Phase|Lost to Follow-up|0
4438923|NCT00440947|7222906|FG003|36-Week Induction Phase|Lost to Follow-up|0
4438924|NCT00440947|7222907|FG004|36-Week Induction Phase|Lost to Follow-up|0
4438925|NCT00440947|7222903|FG000|36-Week Induction Phase|Withdrawal by Subject|7
4438926|NCT00440947|7222904|FG001|36-Week Induction Phase|Withdrawal by Subject|0
4438927|NCT00440947|7222905|FG002|36-Week Induction Phase|Withdrawal by Subject|0
4438928|NCT00440947|7222906|FG003|36-Week Induction Phase|Withdrawal by Subject|0
4438929|NCT00440947|7222907|FG004|36-Week Induction Phase|Withdrawal by Subject|0
4438930|NCT00440947|7222903|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1
4438931|NCT00440947|7222904|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
4438932|NCT00440947|7222905|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
4438933|NCT00440947|7222906|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
4438934|NCT00440947|7222907|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
4438935|NCT00440947|7222903|FG000|36-Week Induction Phase|Took Exclusionary Medications|1
4438936|NCT00440947|7222904|FG001|36-Week Induction Phase|Took Exclusionary Medications|0
4438937|NCT00440947|7222905|FG002|36-Week Induction Phase|Took Exclusionary Medications|0
4438938|NCT00440947|7222906|FG003|36-Week Induction Phase|Took Exclusionary Medications|0
4512835|NCT00937768|7322881|FG000|Overall Study|Refused Further Treatment|3
4438939|NCT00440947|7222907|FG004|36-Week Induction Phase|Took Exclusionary Medications|0
4438940|NCT00440947|7222903|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1
4438941|NCT00440947|7222904|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
4438942|NCT00440947|7222905|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
4438943|NCT00440947|7222906|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
4438944|NCT00440947|7222907|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
4438945|NCT00440947|7222903|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1
4438946|NCT00440947|7222904|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
4438947|NCT00440947|7222905|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
4438948|NCT00440947|7222906|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
4438949|NCT00440947|7222907|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
4438950|NCT00440947|7222903|FG000|36-Week Induction Phase|Incarceration|3
4438951|NCT00440947|7222904|FG001|36-Week Induction Phase|Incarceration|0
4438952|NCT00440947|7222905|FG002|36-Week Induction Phase|Incarceration|0
4438953|NCT00440947|7222906|FG003|36-Week Induction Phase|Incarceration|0
4438954|NCT00440947|7222907|FG004|36-Week Induction Phase|Incarceration|0
4438955|NCT00440947|7222903|FG000|36-Week Induction Phase|Pregnancy|1
4438956|NCT00440947|7222904|FG001|36-Week Induction Phase|Pregnancy|0
4438957|NCT00440947|7222905|FG002|36-Week Induction Phase|Pregnancy|0
4438958|NCT00440947|7222906|FG003|36-Week Induction Phase|Pregnancy|0
4438959|NCT00440947|7222907|FG004|36-Week Induction Phase|Pregnancy|0
4438960|NCT00440947|7222903|FG000|48-Week Randomization Phase|Adverse Event|0
4438961|NCT00440947|7222904|FG001|48-Week Randomization Phase|Adverse Event|2
4438962|NCT00440947|7222905|FG002|48-Week Randomization Phase|Adverse Event|5
4438963|NCT00440947|7222906|FG003|48-Week Randomization Phase|Adverse Event|0
4438964|NCT00440947|7222907|FG004|48-Week Randomization Phase|Adverse Event|0
4438965|NCT00440947|7222903|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
4438966|NCT00440947|7222904|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1
4438967|NCT00440947|7222905|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1
4438968|NCT00440947|7222906|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
4438969|NCT00440947|7222907|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
4438970|NCT00440947|7222903|FG000|48-Week Randomization Phase|Non-compliance|0
4438971|NCT00440947|7222904|FG001|48-Week Randomization Phase|Non-compliance|3
4438972|NCT00440947|7222905|FG002|48-Week Randomization Phase|Non-compliance|4
4438973|NCT00440947|7222906|FG003|48-Week Randomization Phase|Non-compliance|0
4438974|NCT00440947|7222907|FG004|48-Week Randomization Phase|Non-compliance|0
4438975|NCT00440947|7222903|FG000|48-Week Randomization Phase|Lost to Follow-up|0
4438976|NCT00440947|7222904|FG001|48-Week Randomization Phase|Lost to Follow-up|2
4438977|NCT00440947|7222905|FG002|48-Week Randomization Phase|Lost to Follow-up|8
4438978|NCT00440947|7222906|FG003|48-Week Randomization Phase|Lost to Follow-up|0
4438979|NCT00440947|7222907|FG004|48-Week Randomization Phase|Lost to Follow-up|0
4438980|NCT00440947|7222903|FG000|48-Week Randomization Phase|Protocol Violation|0
4438981|NCT00440947|7222904|FG001|48-Week Randomization Phase|Protocol Violation|0
4438982|NCT00440947|7222905|FG002|48-Week Randomization Phase|Protocol Violation|1
4438983|NCT00440947|7222906|FG003|48-Week Randomization Phase|Protocol Violation|0
4438984|NCT00440947|7222907|FG004|48-Week Randomization Phase|Protocol Violation|0
4438985|NCT00440947|7222903|FG000|48-Week Randomization Phase|Withdrawal by Subject|0
4438986|NCT00440947|7222904|FG001|48-Week Randomization Phase|Withdrawal by Subject|2
4438987|NCT00440947|7222905|FG002|48-Week Randomization Phase|Withdrawal by Subject|4
4438988|NCT00440947|7222906|FG003|48-Week Randomization Phase|Withdrawal by Subject|0
4438989|NCT00440947|7222907|FG004|48-Week Randomization Phase|Withdrawal by Subject|0
4438990|NCT00440947|7222903|FG000|48-Week Randomization Phase|Pregnancy|0
4438991|NCT00440947|7222904|FG001|48-Week Randomization Phase|Pregnancy|0
4438992|NCT00440947|7222905|FG002|48-Week Randomization Phase|Pregnancy|1
4438993|NCT00440947|7222906|FG003|48-Week Randomization Phase|Pregnancy|0
4438994|NCT00440947|7222907|FG004|48-Week Randomization Phase|Pregnancy|0
4438995|NCT00440947|7222903|FG000|48-Week Randomization Phase|Incarceration|0
4438996|NCT00440947|7222904|FG001|48-Week Randomization Phase|Incarceration|3
4438997|NCT00440947|7222905|FG002|48-Week Randomization Phase|Incarceration|0
4438998|NCT00440947|7222906|FG003|48-Week Randomization Phase|Incarceration|0
4438999|NCT00440947|7222907|FG004|48-Week Randomization Phase|Incarceration|0
4439000|NCT00440947|7222903|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0
4439001|NCT00440947|7222904|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1
4439002|NCT00440947|7222905|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0
4439003|NCT00440947|7222906|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0
4439004|NCT00440947|7222907|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0
4439005|NCT00440947|7222903|FG000|48-Week Randomization Phase|Physician Decision|0
4439006|NCT00440947|7222904|FG001|48-Week Randomization Phase|Physician Decision|2
4439007|NCT00440947|7222905|FG002|48-Week Randomization Phase|Physician Decision|0
4439008|NCT00440947|7222906|FG003|48-Week Randomization Phase|Physician Decision|0
4439009|NCT00440947|7222907|FG004|48-Week Randomization Phase|Physician Decision|0
4439010|NCT00440947|7222903|FG000|Optional 60-Week Extension Phase|Adverse Event|0
4439011|NCT00440947|7222904|FG001|Optional 60-Week Extension Phase|Adverse Event|0
4439012|NCT00440947|7222905|FG002|Optional 60-Week Extension Phase|Adverse Event|0
4439013|NCT00440947|7222906|FG003|Optional 60-Week Extension Phase|Adverse Event|1
4439014|NCT00440947|7222907|FG004|Optional 60-Week Extension Phase|Adverse Event|3
4439015|NCT00440947|7222903|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
4439016|NCT00440947|7222904|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
4439017|NCT00440947|7222905|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
4439018|NCT00440947|7222906|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1
4439019|NCT00440947|7222907|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1
4439020|NCT00440947|7222903|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
4439021|NCT00440947|7222904|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
4439022|NCT00440947|7222905|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
4439023|NCT00440947|7222906|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3
4439024|NCT00440947|7222907|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2
4439025|NCT00440947|7222903|FG000|Optional 60-Week Extension Phase|Non-compliance|0
4439026|NCT00440947|7222904|FG001|Optional 60-Week Extension Phase|Non-compliance|0
4439027|NCT00440947|7222905|FG002|Optional 60-Week Extension Phase|Non-compliance|0
4439028|NCT00440947|7222906|FG003|Optional 60-Week Extension Phase|Non-compliance|1
4439029|NCT00440947|7222907|FG004|Optional 60-Week Extension Phase|Non-compliance|1
4439030|NCT00440947|7222903|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0
4439031|NCT00440947|7222904|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0
4439032|NCT00440947|7222905|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0
4439033|NCT00440947|7222906|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9
4439034|NCT00440947|7222907|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9
4439035|NCT00440947|7222903|FG000|Optional 60-Week Extension Phase|Protocol Violation|0
4439036|NCT00440947|7222904|FG001|Optional 60-Week Extension Phase|Protocol Violation|0
4439037|NCT00440947|7222905|FG002|Optional 60-Week Extension Phase|Protocol Violation|0
4439038|NCT00440947|7222906|FG003|Optional 60-Week Extension Phase|Protocol Violation|1
4439039|NCT00440947|7222907|FG004|Optional 60-Week Extension Phase|Protocol Violation|0
4439040|NCT00440947|7222903|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0
4439041|NCT00440947|7222904|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0
4439042|NCT00440947|7222905|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0
4439043|NCT00440947|7222906|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4
4439044|NCT00440947|7222907|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3
4439045|NCT00440947|7222903|FG000|Optional 60-Week Extension Phase|Pregnancy|0
4439046|NCT00440947|7222904|FG001|Optional 60-Week Extension Phase|Pregnancy|0
4439047|NCT00440947|7222905|FG002|Optional 60-Week Extension Phase|Pregnancy|0
4439048|NCT00440947|7222906|FG003|Optional 60-Week Extension Phase|Pregnancy|3
4439049|NCT00440947|7222907|FG004|Optional 60-Week Extension Phase|Pregnancy|0
4439050|NCT00440947|7222903|FG000|Optional 60-Week Extension Phase|Participant Moved|0
4439051|NCT00440947|7222904|FG001|Optional 60-Week Extension Phase|Participant Moved|0
4439052|NCT00440947|7222905|FG002|Optional 60-Week Extension Phase|Participant Moved|0
4439053|NCT00440947|7222906|FG003|Optional 60-Week Extension Phase|Participant Moved|1
4439054|NCT00440947|7222907|FG004|Optional 60-Week Extension Phase|Participant Moved|1
4439055|NCT00440947|7222903|FG000|Optional 60-Week Extension Phase|Sponsor Request|0
4439056|NCT00440947|7222904|FG001|Optional 60-Week Extension Phase|Sponsor Request|0
4439057|NCT00440947|7222905|FG002|Optional 60-Week Extension Phase|Sponsor Request|0
4439058|NCT00440947|7222906|FG003|Optional 60-Week Extension Phase|Sponsor Request|1
4439059|NCT00440947|7222907|FG004|Optional 60-Week Extension Phase|Sponsor Request|1
4439060|NCT00440947|7222903|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
4439061|NCT00440947|7222904|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
4439062|NCT00440947|7222905|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
4439063|NCT00440947|7222906|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3
4439064|NCT00440947|7222907|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3
4439065|NCT00440947|7222903|FG000|Optional 60-Week Extension Phase|Other|0
4439066|NCT00440947|7222904|FG001|Optional 60-Week Extension Phase|Other|0
4439067|NCT00440947|7222905|FG002|Optional 60-Week Extension Phase|Other|0
4439068|NCT00440947|7222906|FG003|Optional 60-Week Extension Phase|Other|1
4439069|NCT00440947|7222907|FG004|Optional 60-Week Extension Phase|Other|0
4439070|NCT00440947|7222903|FG000|Optional 60-Week Extension Phase|Physician Decision|0
4439071|NCT00440947|7222904|FG001|Optional 60-Week Extension Phase|Physician Decision|0
4439072|NCT00440947|7222905|FG002|Optional 60-Week Extension Phase|Physician Decision|0
4439073|NCT00440947|7222906|FG003|Optional 60-Week Extension Phase|Physician Decision|0
4439074|NCT00440947|7222907|FG004|Optional 60-Week Extension Phase|Physician Decision|1
4439075|NCT00440947|7222903|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
4439076|NCT00440947|7222904|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
4439077|NCT00440947|7222905|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
4439078|NCT00440947|7222906|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
4439079|NCT00440947|7222907|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1
4439080|NCT00440999|7222921|FG000|Overall Study|Adverse Event|0
4439081|NCT00440999|7222922|FG001|Overall Study|Adverse Event|2
4439082|NCT00440999|7222921|FG000|Overall Study|Lack of Efficacy|6
4439083|NCT00440999|7222922|FG001|Overall Study|Lack of Efficacy|7
4439084|NCT00440999|7222921|FG000|Overall Study|Lost to Follow-up|19
4439085|NCT00440999|7222922|FG001|Overall Study|Lost to Follow-up|12
4439086|NCT00440999|7222921|FG000|Overall Study|Protocol Violation|1
4439087|NCT00440999|7222922|FG001|Overall Study|Protocol Violation|0
4439088|NCT00440999|7222921|FG000|Overall Study|Withdrawal by Subject|2
4439089|NCT00440999|7222922|FG001|Overall Study|Withdrawal by Subject|5
4439090|NCT00440999|7222921|FG000|Overall Study|Subjets missed the visit|1
4439091|NCT00440999|7222922|FG001|Overall Study|Subjets missed the visit|0
4439092|NCT00440999|7222921|FG000|Overall Study|Mixed infection at entry|1
4439093|NCT00440999|7222922|FG001|Overall Study|Mixed infection at entry|0
4439094|NCT00440999|7222921|FG000|Overall Study|P. falciparum malaria|5
4439095|NCT00440999|7222922|FG001|Overall Study|P. falciparum malaria|14
4439096|NCT00440999|7222921|FG000|Overall Study|Subj left hosp without inform staff|0
4439097|NCT00440999|7222922|FG001|Overall Study|Subj left hosp without inform staff|1
4439098|NCT00441012|7222932|FG000|Overall Study|Adverse Event|0
4439099|NCT00441012|7222933|FG001|Overall Study|Adverse Event|1
4439100|NCT00441012|7222932|FG000|Overall Study|Lost to Follow-up|3
4439101|NCT00441012|7222933|FG001|Overall Study|Lost to Follow-up|3
4439102|NCT00441012|7222932|FG000|Overall Study|Protocol Violation|10
4439103|NCT00441012|7222933|FG001|Overall Study|Protocol Violation|9
4439104|NCT00441012|7222932|FG000|Overall Study|Withdrawal by Subject|4
4439105|NCT00441012|7222933|FG001|Overall Study|Withdrawal by Subject|0
4439106|NCT00441012|7222932|FG000|Overall Study|Subject Randomized but Not Vaccinated|1
4439107|NCT00441012|7222933|FG001|Overall Study|Subject Randomized but Not Vaccinated|0
4439108|NCT00441064|7222941|FG000|Overall Study|Adverse Event|1
4439109|NCT00441064|7222942|FG001|Overall Study|Adverse Event|0
4439110|NCT00441064|7222941|FG000|Overall Study|Abnormal laboratory values|0
4439111|NCT00441064|7222942|FG001|Overall Study|Abnormal laboratory values|2
4439112|NCT00441064|7222941|FG000|Overall Study|Abnormal test procedure results|0
4439113|NCT00441064|7222942|FG001|Overall Study|Abnormal test procedure results|1
4439114|NCT00441064|7222941|FG000|Overall Study|Unsatisfactory therapeutic effect|1
4439115|NCT00441064|7222942|FG001|Overall Study|Unsatisfactory therapeutic effect|0
4439116|NCT00441064|7222941|FG000|Overall Study|Protocol Deviation|3
4439117|NCT00441064|7222942|FG001|Overall Study|Protocol Deviation|2
4439118|NCT00441064|7222941|FG000|Overall Study|Patient withdrew consent|5
4439119|NCT00441064|7222942|FG001|Overall Study|Patient withdrew consent|2
4439120|NCT00441090|7222953|FG000|Overall Study|Adverse Event|0
4439121|NCT00441090|7222954|FG001|Overall Study|Adverse Event|1
4439122|NCT00441090|7222955|FG002|Overall Study|Adverse Event|1
4439123|NCT00441090|7222956|FG003|Overall Study|Adverse Event|0
4439124|NCT00441090|7222957|FG004|Overall Study|Adverse Event|0
4439125|NCT00441090|7222953|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0
4439126|NCT00441090|7222954|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0
4439127|NCT00441090|7222955|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0
4439128|NCT00441090|7222956|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2
4439129|NCT00441090|7222957|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0
4439130|NCT00441090|7222953|FG000|Overall Study|Withdrawal by Subject|1
4439131|NCT00441090|7222954|FG001|Overall Study|Withdrawal by Subject|0
4439132|NCT00441090|7222955|FG002|Overall Study|Withdrawal by Subject|1
4439133|NCT00441090|7222956|FG003|Overall Study|Withdrawal by Subject|0
4439134|NCT00441090|7222957|FG004|Overall Study|Withdrawal by Subject|0
4439135|NCT00441090|7222953|FG000|Overall Study|Lack of Efficacy|1
4439136|NCT00441090|7222954|FG001|Overall Study|Lack of Efficacy|0
4439137|NCT00441090|7222955|FG002|Overall Study|Lack of Efficacy|0
4439138|NCT00441090|7222956|FG003|Overall Study|Lack of Efficacy|0
4439139|NCT00441090|7222957|FG004|Overall Study|Lack of Efficacy|0
4439140|NCT00441103|7222971|FG000|Overall Study|Adverse Event|2
4439141|NCT00441103|7222972|FG001|Overall Study|Adverse Event|1
4439142|NCT00441103|7222971|FG000|Overall Study|Death|1
4439143|NCT00441103|7222972|FG001|Overall Study|Death|0
4439144|NCT00441103|7222971|FG000|Overall Study|Disease Progression|2
4439145|NCT00441103|7222972|FG001|Overall Study|Disease Progression|0
4439146|NCT00441103|7222971|FG000|Overall Study|Lost to Follow-up|1
4439147|NCT00441103|7222972|FG001|Overall Study|Lost to Follow-up|0
4439148|NCT00441103|7222971|FG000|Overall Study|Protocol Violation|1
4439149|NCT00441103|7222972|FG001|Overall Study|Protocol Violation|0
4439150|NCT00441103|7222971|FG000|Overall Study|Participant unable to use Rebiject II|1
4439151|NCT00441103|7222972|FG001|Overall Study|Participant unable to use Rebiject II|0
4439152|NCT00441103|7222971|FG000|Overall Study|Participant refused MRI|1
4439153|NCT00441103|7222972|FG001|Overall Study|Participant refused MRI|0
4439154|NCT00441103|7222971|FG000|Overall Study|Inclusion criteria absent|1
4439155|NCT00441103|7222972|FG001|Overall Study|Inclusion criteria absent|0
4439156|NCT00441103|7222971|FG000|Overall Study|Non-compliant|0
4439157|NCT00441103|7222972|FG001|Overall Study|Non-compliant|1
4439158|NCT00441103|7222971|FG000|Overall Study|Participant decided to withdraw|1
4439159|NCT00441103|7222972|FG001|Overall Study|Participant decided to withdraw|0
4439160|NCT00441103|7222971|FG000|Overall Study|Participant's reason|0
4439161|NCT00441103|7222972|FG001|Overall Study|Participant's reason|1
4439162|NCT00441103|7222971|FG000|Overall Study|Participant decided to stop|0
4439163|NCT00441103|7222972|FG001|Overall Study|Participant decided to stop|1
4439164|NCT00441116|7222981|FG000|Overall Study|Adverse Event|1
4439165|NCT00441116|7222982|FG001|Overall Study|Adverse Event|1
4439166|NCT00441116|7222981|FG000|Overall Study|Withdrawal by Subject|1
4439167|NCT00441116|7222982|FG001|Overall Study|Withdrawal by Subject|0
4439168|NCT00441116|7222981|FG000|Overall Study|Did not meet Eligibility Criteria|1
4439169|NCT00441116|7222982|FG001|Overall Study|Did not meet Eligibility Criteria|1
4439170|NCT00441129|7222990|FG000|Overall Study|Withdrawal by Subject|6
4439171|NCT00441129|7222991|FG001|Overall Study|Withdrawal by Subject|14
4439172|NCT00441142|7223001|FG000|Overall Study|Adverse Event|2
4439173|NCT00441142|7223002|FG001|Overall Study|Adverse Event|3
4439174|NCT00441142|7223003|FG002|Overall Study|Adverse Event|3
4439175|NCT00441142|7223004|FG003|Overall Study|Adverse Event|22
4439176|NCT00441142|7223001|FG000|Overall Study|Lack of Efficacy|3
4439177|NCT00441142|7223002|FG001|Overall Study|Lack of Efficacy|3
4439178|NCT00441142|7223003|FG002|Overall Study|Lack of Efficacy|17
4439179|NCT00441142|7223004|FG003|Overall Study|Lack of Efficacy|32
4439180|NCT00441142|7223001|FG000|Overall Study|Withdrawal by Subject|0
4439181|NCT00441142|7223002|FG001|Overall Study|Withdrawal by Subject|0
4439182|NCT00441142|7223003|FG002|Overall Study|Withdrawal by Subject|2
4439183|NCT00441142|7223004|FG003|Overall Study|Withdrawal by Subject|10
4439184|NCT00441142|7223001|FG000|Overall Study|Patient still receiving active study tx|1
4439185|NCT00441142|7223002|FG001|Overall Study|Patient still receiving active study tx|0
4439186|NCT00441142|7223003|FG002|Overall Study|Patient still receiving active study tx|0
4439187|NCT00441142|7223004|FG003|Overall Study|Patient still receiving active study tx|2
4439188|NCT00441142|7223001|FG000|Overall Study|Physician Decision|0
4439189|NCT00441142|7223002|FG001|Overall Study|Physician Decision|1
4439190|NCT00441142|7223003|FG002|Overall Study|Physician Decision|0
4439191|NCT00441142|7223004|FG003|Overall Study|Physician Decision|1
4439192|NCT00441142|7223001|FG000|Overall Study|Death|0
4439193|NCT00441142|7223002|FG001|Overall Study|Death|0
4630275|NCT02288247|7498819|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1
4630276|NCT02288247|7498818|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7
4630277|NCT02288247|7498819|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7
4630278|NCT02288247|7498818|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|20
4439194|NCT00441142|7223003|FG002|Overall Study|Death|0
4439195|NCT00441142|7223004|FG003|Overall Study|Death|1
4439196|NCT00441168|7223018|FG000|Treatment Period|Death|3
4439197|NCT00441168|7223019|FG001|Treatment Period|Death|0
4439198|NCT00441168|7223018|FG000|Treatment Period|Adverse Event|1
4439199|NCT00441168|7223019|FG001|Treatment Period|Adverse Event|2
4439200|NCT00441168|7223018|FG000|Treatment Period|Progressive Disease|0
4439201|NCT00441168|7223019|FG001|Treatment Period|Progressive Disease|2
4716320|NCT02991859|7645659|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
4716321|NCT02991859|7645660|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
4716322|NCT02991859|7645661|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1
4716323|NCT02991859|7645662|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
4716324|NCT02991859|7645663|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
4439202|NCT00441168|7223018|FG000|Treatment Period|Protocol Violation|0
4439203|NCT00441168|7223019|FG001|Treatment Period|Protocol Violation|1
4439204|NCT00441168|7223018|FG000|Treatment Period|Lost to Follow-up|0
4439205|NCT00441168|7223019|FG001|Treatment Period|Lost to Follow-up|1
4439206|NCT00441168|7223018|FG000|Treatment Period|Withdrawal by Subject|3
4439207|NCT00441168|7223019|FG001|Treatment Period|Withdrawal by Subject|0
4439208|NCT00441168|7223018|FG000|Treatment Period|qualified for stem-cell transplantation|3
4439209|NCT00441168|7223019|FG001|Treatment Period|qualified for stem-cell transplantation|0
4439210|NCT00441168|7223018|FG000|Treatment Period|refractory disease|1
4439211|NCT00441168|7223019|FG001|Treatment Period|refractory disease|0
4439212|NCT00441168|7223018|FG000|Follow-up Period|Death|3
4439213|NCT00441168|7223019|FG001|Follow-up Period|Death|0
4439214|NCT00441168|7223018|FG000|Follow-up Period|Lost to Follow-up|5
4439215|NCT00441168|7223019|FG001|Follow-up Period|Lost to Follow-up|6
4439216|NCT00441168|7223018|FG000|Follow-up Period|Withdrawal by Subject|3
4439217|NCT00441168|7223019|FG001|Follow-up Period|Withdrawal by Subject|0
4439218|NCT00441168|7223018|FG000|Follow-up Period|Other|1
4439219|NCT00441168|7223019|FG001|Follow-up Period|Other|3
4439220|NCT00441337|7223059|FG000|Overall Study|Disease Progression|6
4439221|NCT00441337|7223060|FG001|Overall Study|Disease Progression|6
4439222|NCT00441337|7223061|FG002|Overall Study|Disease Progression|4
4439223|NCT00441337|7223062|FG003|Overall Study|Disease Progression|18
4439224|NCT00441337|7223059|FG000|Overall Study|Lost to Follow-up|0
4439225|NCT00441337|7223060|FG001|Overall Study|Lost to Follow-up|0
4439226|NCT00441337|7223061|FG002|Overall Study|Lost to Follow-up|0
4439227|NCT00441337|7223062|FG003|Overall Study|Lost to Follow-up|1
4439228|NCT00441337|7223059|FG000|Overall Study|Sponsor Decision|0
4439229|NCT00441337|7223060|FG001|Overall Study|Sponsor Decision|0
4439230|NCT00441337|7223061|FG002|Overall Study|Sponsor Decision|1
4439231|NCT00441337|7223062|FG003|Overall Study|Sponsor Decision|2
4439232|NCT00441337|7223059|FG000|Overall Study|Did not meet inclusion criteria|0
4439233|NCT00441337|7223060|FG001|Overall Study|Did not meet inclusion criteria|0
4439234|NCT00441337|7223061|FG002|Overall Study|Did not meet inclusion criteria|1
4439235|NCT00441337|7223062|FG003|Overall Study|Did not meet inclusion criteria|0
4439236|NCT00441363|7223103|FG000|Overall Study|Adverse Event|4
4439237|NCT00441363|7223104|FG001|Overall Study|Adverse Event|2
4439238|NCT00441363|7223103|FG000|Overall Study|Withdrawal by Subject|3
4439239|NCT00441363|7223104|FG001|Overall Study|Withdrawal by Subject|4
4439240|NCT00441363|7223103|FG000|Overall Study|Physician Decision|6
4439241|NCT00441363|7223104|FG001|Overall Study|Physician Decision|7
4439242|NCT00441363|7223103|FG000|Overall Study|Lost to Follow-up|2
4439243|NCT00441363|7223104|FG001|Overall Study|Lost to Follow-up|2
4439244|NCT00441363|7223103|FG000|Overall Study|Other|2
4439245|NCT00441363|7223104|FG001|Overall Study|Other|0
4439246|NCT00441441|7223112|FG000|Overall Study|Adverse Event|2
4439247|NCT00441441|7223113|FG001|Overall Study|Adverse Event|1
4439248|NCT00441441|7223112|FG000|Overall Study|Protocol Violation|4
4439249|NCT00441441|7223113|FG001|Overall Study|Protocol Violation|6
4439250|NCT00441441|7223112|FG000|Overall Study|Exacerbation of asthma|1
4439251|NCT00441441|7223113|FG001|Overall Study|Exacerbation of asthma|2
4439252|NCT00441441|7223112|FG000|Overall Study|Withdrawal by Subject|1
4439253|NCT00441441|7223113|FG001|Overall Study|Withdrawal by Subject|2
4630279|NCT02288247|7498819|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21
4630280|NCT02288247|7498818|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1
4630281|NCT02288247|7498819|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0
4633315|NCT01910298|7503381|FG001|Overall Study|Protocol Deviation|5
4633316|NCT01910298|7503380|FG000|Overall Study|Lost to Follow-up|1
4633317|NCT01910298|7503381|FG001|Overall Study|Lost to Follow-up|1
4633318|NCT01910298|7503380|FG000|Overall Study|Study Terminated by Sponsor|1
4633319|NCT01910298|7503381|FG001|Overall Study|Study Terminated by Sponsor|17
4633320|NCT01910298|7503380|FG000|Overall Study|Other Miscellaneous Reasons|0
4633321|NCT01910298|7503381|FG001|Overall Study|Other Miscellaneous Reasons|2
4633322|NCT01910519|7503397|FG000|Overall Study|Withdrawal by Subject|2
4633323|NCT01910519|7503398|FG001|Overall Study|Withdrawal by Subject|0
4590525|NCT01522651|7436635|FG000|Overall Study|Cardioversion|1
4590526|NCT01522651|7436636|FG001|Overall Study|Cardioversion|0
4590527|NCT01522651|7436637|FG002|Overall Study|Cardioversion|0
4590528|NCT01522651|7436638|FG003|Overall Study|Cardioversion|0
4590529|NCT01522651|7436639|FG004|Overall Study|Cardioversion|0
4590530|NCT01522651|7436635|FG000|Overall Study|Device Malfunction|0
4590531|NCT01522651|7436636|FG001|Overall Study|Device Malfunction|1
4590532|NCT01522651|7436637|FG002|Overall Study|Device Malfunction|0
4590533|NCT01522651|7436638|FG003|Overall Study|Device Malfunction|0
4439254|NCT00441441|7223112|FG000|Overall Study|Other|3
4439255|NCT00441441|7223113|FG001|Overall Study|Other|3
4439256|NCT00441467|7223133|FG000|Overall Study|Adverse Event|6
4439257|NCT00441467|7223133|FG000|Overall Study|Withdrawal by Subject|3
4439258|NCT00441467|7223133|FG000|Overall Study|Progressive disease|9
4439259|NCT00441480|7223139|FG000|Overall Study|Protocol Violation|1
4439260|NCT00441480|7223140|FG001|Overall Study|Protocol Violation|1
4439261|NCT00441480|7223139|FG000|Overall Study|Withdrawal by Subject|2
4439262|NCT00441480|7223140|FG001|Overall Study|Withdrawal by Subject|3
4439263|NCT00441545|7223146|FG000|First Intervention|Adverse Event|6
4439264|NCT00441545|7223147|FG001|First Intervention|Adverse Event|5
4439265|NCT00441545|7223146|FG000|First Intervention|Protocol Violation|2
4439266|NCT00441545|7223147|FG001|First Intervention|Protocol Violation|2
4439267|NCT00441545|7223146|FG000|First Intervention|Withdrawal by Subject|3
4439268|NCT00441545|7223147|FG001|First Intervention|Withdrawal by Subject|3
4439269|NCT00441545|7223146|FG000|First Intervention|Kidney transplant|1
4439270|NCT00441545|7223147|FG001|First Intervention|Kidney transplant|1
4439271|NCT00441545|7223146|FG000|First Intervention|Lack of Efficacy|2
4439272|NCT00441545|7223147|FG001|First Intervention|Lack of Efficacy|0
4439273|NCT00441545|7223146|FG000|First Intervention|Subject exceeded safety criteria|0
4439274|NCT00441545|7223147|FG001|First Intervention|Subject exceeded safety criteria|1
4439275|NCT00441545|7223146|FG000|First Intervention|Subject met an exclusionary criteria|1
4439276|NCT00441545|7223147|FG001|First Intervention|Subject met an exclusionary criteria|0
4439277|NCT00441545|7223146|FG000|First Intervention|Extended hospitalization|1
4439278|NCT00441545|7223147|FG001|First Intervention|Extended hospitalization|0
4439279|NCT00441545|7223146|FG000|First Intervention|Site error|1
4439280|NCT00441545|7223147|FG001|First Intervention|Site error|0
4439281|NCT00441545|7223146|FG000|First Intervention|Sponsor's request|1
4439282|NCT00441545|7223147|FG001|First Intervention|Sponsor's request|0
4439283|NCT00441545|7223146|FG000|Second Intervention|Adverse Event|5
4439284|NCT00441545|7223147|FG001|Second Intervention|Adverse Event|2
4439285|NCT00441545|7223146|FG000|Second Intervention|Protocol Violation|4
4439286|NCT00441545|7223147|FG001|Second Intervention|Protocol Violation|1
4439287|NCT00441545|7223146|FG000|Second Intervention|Withdrawal by Subject|1
4439288|NCT00441545|7223147|FG001|Second Intervention|Withdrawal by Subject|1
4439289|NCT00441545|7223146|FG000|Second Intervention|Kidney Transplant|1
4439290|NCT00441545|7223147|FG001|Second Intervention|Kidney Transplant|1
4439291|NCT00441545|7223146|FG000|Second Intervention|Lack of Efficacy|0
4439292|NCT00441545|7223147|FG001|Second Intervention|Lack of Efficacy|1
4512836|NCT00937768|7322882|FG001|Overall Study|Refused Further Treatment|2
4512837|NCT00937768|7322881|FG000|Overall Study|Disease Progression|1
4512838|NCT00937768|7322882|FG001|Overall Study|Disease Progression|1
4512839|NCT00937768|7322881|FG000|Overall Study|Alternate Treatment|0
4512840|NCT00937768|7322882|FG001|Overall Study|Alternate Treatment|1
4512841|NCT00937768|7322881|FG000|Overall Study|No Further Funding|4
4439293|NCT00441545|7223146|FG000|Second Intervention|Subject exceeded safety criteria|1
4439294|NCT00441545|7223147|FG001|Second Intervention|Subject exceeded safety criteria|0
4439295|NCT00441545|7223146|FG000|Second Intervention|Subject moved|0
4439296|NCT00441545|7223147|FG001|Second Intervention|Subject moved|1
4439297|NCT00441584|7223157|FG000|Overall Study|Lack of Efficacy|79
4439298|NCT00441584|7223157|FG000|Overall Study|Withdrawal by Subject|8
4439299|NCT00441584|7223157|FG000|Overall Study|Adverse Event|6
4439300|NCT00441584|7223157|FG000|Overall Study|Protocol Violation|5
4439301|NCT00441584|7223157|FG000|Overall Study|Lost to Follow-up|4
4439302|NCT00441584|7223157|FG000|Overall Study|Failure to meet eligibility criteria|3
4439303|NCT00441701|7223171|FG000|Overall Study|Adverse Event|3
4439304|NCT00441701|7223172|FG001|Overall Study|Adverse Event|2
4439305|NCT00441701|7223173|FG002|Overall Study|Adverse Event|1
4439306|NCT00441701|7223174|FG003|Overall Study|Adverse Event|0
4439307|NCT00441701|7223175|FG004|Overall Study|Adverse Event|2
4439308|NCT00441701|7223176|FG005|Overall Study|Adverse Event|2
4439309|NCT00441701|7223177|FG006|Overall Study|Adverse Event|0
4439310|NCT00441701|7223178|FG007|Overall Study|Adverse Event|0
4439311|NCT00441701|7223179|FG008|Overall Study|Adverse Event|0
4439312|NCT00441701|7223180|FG009|Overall Study|Adverse Event|0
4439313|NCT00441701|7223171|FG000|Overall Study|Lack of Efficacy|2
4439314|NCT00441701|7223172|FG001|Overall Study|Lack of Efficacy|0
4439315|NCT00441701|7223173|FG002|Overall Study|Lack of Efficacy|2
4439316|NCT00441701|7223174|FG003|Overall Study|Lack of Efficacy|2
4439317|NCT00441701|7223175|FG004|Overall Study|Lack of Efficacy|0
4439318|NCT00441701|7223176|FG005|Overall Study|Lack of Efficacy|1
4439319|NCT00441701|7223177|FG006|Overall Study|Lack of Efficacy|0
4439320|NCT00441701|7223178|FG007|Overall Study|Lack of Efficacy|0
4439321|NCT00441701|7223179|FG008|Overall Study|Lack of Efficacy|0
4439322|NCT00441701|7223180|FG009|Overall Study|Lack of Efficacy|0
4439323|NCT00441701|7223171|FG000|Overall Study|Withdrawal by Subject|0
4439324|NCT00441701|7223172|FG001|Overall Study|Withdrawal by Subject|2
4439325|NCT00441701|7223173|FG002|Overall Study|Withdrawal by Subject|1
4439326|NCT00441701|7223174|FG003|Overall Study|Withdrawal by Subject|1
4439327|NCT00441701|7223175|FG004|Overall Study|Withdrawal by Subject|0
4439328|NCT00441701|7223176|FG005|Overall Study|Withdrawal by Subject|0
4439329|NCT00441701|7223177|FG006|Overall Study|Withdrawal by Subject|0
4439330|NCT00441701|7223178|FG007|Overall Study|Withdrawal by Subject|0
4439331|NCT00441701|7223179|FG008|Overall Study|Withdrawal by Subject|0
4439332|NCT00441701|7223180|FG009|Overall Study|Withdrawal by Subject|0
4439333|NCT00441727|7223201|FG000|Overall Study|Protocol Violation|19
4439334|NCT00441727|7223202|FG001|Overall Study|Protocol Violation|28
4439335|NCT00441727|7223203|FG002|Overall Study|Protocol Violation|32
4439336|NCT00441727|7223201|FG000|Overall Study|Adverse Event|26
4439337|NCT00441727|7223202|FG001|Overall Study|Adverse Event|33
4439338|NCT00441727|7223203|FG002|Overall Study|Adverse Event|28
4439339|NCT00441727|7223201|FG000|Overall Study|Lack of Efficacy|7
4439340|NCT00441727|7223202|FG001|Overall Study|Lack of Efficacy|8
4439341|NCT00441727|7223203|FG002|Overall Study|Lack of Efficacy|48
4439342|NCT00441727|7223201|FG000|Overall Study|Withdrawal by Subject|40
4439343|NCT00441727|7223202|FG001|Overall Study|Withdrawal by Subject|34
4439344|NCT00441727|7223203|FG002|Overall Study|Withdrawal by Subject|47
4439345|NCT00441727|7223201|FG000|Overall Study|Lost to Follow-up|5
4439346|NCT00441727|7223202|FG001|Overall Study|Lost to Follow-up|6
4439347|NCT00441727|7223203|FG002|Overall Study|Lost to Follow-up|5
4439348|NCT00441727|7223201|FG000|Overall Study|Safety Reasons|3
4439349|NCT00441727|7223202|FG001|Overall Study|Safety Reasons|1
4439350|NCT00441727|7223203|FG002|Overall Study|Safety Reasons|3
4439351|NCT00441727|7223201|FG000|Overall Study|Various reason specified|6
4439352|NCT00441727|7223202|FG001|Overall Study|Various reason specified|8
4439353|NCT00441727|7223203|FG002|Overall Study|Various reason specified|5
4439354|NCT00441792|7223235|FG000|Overall Study|Lost to Follow-up|0
4439355|NCT00441792|7223236|FG001|Overall Study|Lost to Follow-up|2
4439356|NCT00441974|7223263|FG000|Overall Study|Adverse Event|6
4439357|NCT00441974|7223263|FG000|Overall Study|Consent Withdrawn|35
4439358|NCT00441974|7223263|FG000|Overall Study|Lost to Follow-up|80
4439359|NCT00441974|7223263|FG000|Overall Study|Protocol Violation|7
4439360|NCT00442286|7223308|FG000|Overall Study|Death|2
4439361|NCT00442286|7223309|FG001|Overall Study|Death|2
4439362|NCT00442286|7223308|FG000|Overall Study|Lost to Follow-up|1
4439363|NCT00442286|7223309|FG001|Overall Study|Lost to Follow-up|0
4439364|NCT00442286|7223308|FG000|Overall Study|Withdrawal by Subject|2
4439365|NCT00442286|7223309|FG001|Overall Study|Withdrawal by Subject|0
4439366|NCT00442286|7223308|FG000|Overall Study|System explanted|1
4439367|NCT00442286|7223309|FG001|Overall Study|System explanted|0
4439368|NCT00442286|7223308|FG000|Overall Study|Patient Injury|1
4439369|NCT00442286|7223309|FG001|Overall Study|Patient Injury|0
4512842|NCT00937768|7322882|FG001|Overall Study|No Further Funding|4
4512843|NCT00937833|7322894|FG000|Overall Study|Protocol Violation|1
4512844|NCT00937833|7322895|FG001|Overall Study|Protocol Violation|2
4512845|NCT00937833|7322894|FG000|Overall Study|Procedure delayed; enrollment closed|0
4512846|NCT00937833|7322895|FG001|Overall Study|Procedure delayed; enrollment closed|1
4512847|NCT00937833|7322894|FG000|Overall Study|Lost to Follow-up|10
4512848|NCT00937833|7322895|FG001|Overall Study|Lost to Follow-up|8
4512849|NCT00937833|7322894|FG000|Overall Study|Withdrawal by Subject|4
4439370|NCT00442416|7223323|FG000|Overall Study|Adverse Event|4
4439371|NCT00442416|7223324|FG001|Overall Study|Adverse Event|1
4439372|NCT00442416|7223323|FG000|Overall Study|Death|1
4439373|NCT00442416|7223324|FG001|Overall Study|Death|0
4439374|NCT00442416|7223323|FG000|Overall Study|Lack of Efficacy|2
4439375|NCT00442416|7223324|FG001|Overall Study|Lack of Efficacy|0
4439376|NCT00442416|7223323|FG000|Overall Study|Protocol Violation|2
4439377|NCT00442416|7223324|FG001|Overall Study|Protocol Violation|3
4439378|NCT00442416|7223323|FG000|Overall Study|Withdrew consent|1
4439379|NCT00442416|7223324|FG001|Overall Study|Withdrew consent|2
4439380|NCT00442416|7223323|FG000|Overall Study|Administrative/Other|27
4439381|NCT00442416|7223324|FG001|Overall Study|Administrative/Other|33
4439382|NCT00442468|7223330|FG000|Overall Study|Adverse Event|4
4439383|NCT00442468|7223330|FG000|Overall Study|Withdrawal by Subject|91
4439384|NCT00442468|7223330|FG000|Overall Study|Did not complete all study procedures|88
4439385|NCT00442572|7223340|FG000|Overall Study|Relapse|8
4439386|NCT00442572|7223341|FG001|Overall Study|Relapse|1
4439387|NCT00442572|7223340|FG000|Overall Study|Lost to Follow-up|0
4439388|NCT00442572|7223341|FG001|Overall Study|Lost to Follow-up|1
4439389|NCT00442572|7223340|FG000|Overall Study|Withdrawal by Subject|0
4439390|NCT00442572|7223341|FG001|Overall Study|Withdrawal by Subject|1
4439391|NCT00442598|7223351|FG000|Overall Study|Adverse Event|1
4439392|NCT00442598|7223352|FG001|Overall Study|Adverse Event|0
4439393|NCT00442598|7223353|FG002|Overall Study|Adverse Event|0
4439394|NCT00442598|7223351|FG000|Overall Study|Tumor progression|3
4439395|NCT00442598|7223352|FG001|Overall Study|Tumor progression|4
4439396|NCT00442598|7223353|FG002|Overall Study|Tumor progression|0
4439397|NCT00442598|7223351|FG000|Overall Study|Clinical deterioration|1
4439398|NCT00442598|7223352|FG001|Overall Study|Clinical deterioration|2
4439399|NCT00442598|7223353|FG002|Overall Study|Clinical deterioration|0
4439400|NCT00442598|7223351|FG000|Overall Study|CA125 progression|0
4439401|NCT00442598|7223352|FG001|Overall Study|CA125 progression|1
4439402|NCT00442598|7223353|FG002|Overall Study|CA125 progression|0
4439403|NCT00442598|7223351|FG000|Overall Study|Reduced creatinine clearance|1
4439404|NCT00442598|7223352|FG001|Overall Study|Reduced creatinine clearance|0
4439405|NCT00442598|7223353|FG002|Overall Study|Reduced creatinine clearance|0
4439406|NCT00442598|7223351|FG000|Overall Study|Death|0
4439407|NCT00442598|7223352|FG001|Overall Study|Death|1
4439408|NCT00442598|7223353|FG002|Overall Study|Death|0
4439409|NCT00442702|7223384|FG000|Titration Period|Adverse Event|2
4439410|NCT00442702|7223385|FG001|Titration Period|Adverse Event|0
4439411|NCT00442702|7223384|FG000|Titration Period|Death|3
4439412|NCT00442702|7223385|FG001|Titration Period|Death|2
4439413|NCT00442702|7223384|FG000|Titration Period|Insufficient Therapeutic Response|1
4439414|NCT00442702|7223385|FG001|Titration Period|Insufficient Therapeutic Response|0
4439415|NCT00442702|7223384|FG000|Titration Period|Refused Treatment|4
4439416|NCT00442702|7223385|FG001|Titration Period|Refused Treatment|1
4439417|NCT00442702|7223384|FG000|Titration Period|Failure to return|1
4439418|NCT00442702|7223385|FG001|Titration Period|Failure to return|0
4439419|NCT00442702|7223384|FG000|Titration Period|Hospitalized in another hospital|1
4439420|NCT00442702|7223385|FG001|Titration Period|Hospitalized in another hospital|0
4439421|NCT00442702|7223384|FG000|Evaluation Period|Adverse Event|1
4439422|NCT00442702|7223385|FG001|Evaluation Period|Adverse Event|0
4439423|NCT00442702|7223384|FG000|Evaluation Period|Death|1
4439424|NCT00442702|7223385|FG001|Evaluation Period|Death|1
4439425|NCT00442702|7223384|FG000|Evaluation Period|Insufficient Therapeutic Response|1
4439426|NCT00442702|7223385|FG001|Evaluation Period|Insufficient Therapeutic Response|0
4439427|NCT00442702|7223384|FG000|Evaluation Period|Refused treatment|1
4439428|NCT00442702|7223385|FG001|Evaluation Period|Refused treatment|1
4439429|NCT00442702|7223384|FG000|Evaluation Period|Renal transplant|0
4439430|NCT00442702|7223385|FG001|Evaluation Period|Renal transplant|1
4439431|NCT00442702|7223384|FG000|Evaluation Period|Failure to return|1
4439432|NCT00442702|7223385|FG001|Evaluation Period|Failure to return|0
4439433|NCT00442702|7223384|FG000|Evaluation Period|Site closure|0
4439434|NCT00442702|7223385|FG001|Evaluation Period|Site closure|1
4439435|NCT00442936|7223401|FG000|Overall Study|Protocol Violation|1
4439436|NCT00442936|7223402|FG001|Overall Study|Protocol Violation|0
4439437|NCT00442936|7223403|FG002|Overall Study|Protocol Violation|1
4439438|NCT00442936|7223404|FG003|Overall Study|Protocol Violation|1
4439439|NCT00442962|7223414|FG000|Overall Study|Pregnancy|1
4439440|NCT00442962|7223414|FG000|Overall Study|Lost to Follow-up|7
4439441|NCT00443053|7223420|FG000|Overall Study|Adverse Event|2
4439442|NCT00443053|7223421|FG001|Overall Study|Adverse Event|1
4439443|NCT00443053|7223420|FG000|Overall Study|Withdrawal by Subject|9
4439444|NCT00443053|7223421|FG001|Overall Study|Withdrawal by Subject|18
4439445|NCT00443053|7223420|FG000|Overall Study|Lost to Follow-up|4
4439446|NCT00443053|7223421|FG001|Overall Study|Lost to Follow-up|5
4439447|NCT00443053|7223420|FG000|Overall Study|Did Not Meet Eligibility Criteria|1
4439448|NCT00443053|7223421|FG001|Overall Study|Did Not Meet Eligibility Criteria|0
4439449|NCT00443053|7223420|FG000|Overall Study|Noncompliance|2
4439450|NCT00443053|7223421|FG001|Overall Study|Noncompliance|1
4439451|NCT00443053|7223420|FG000|Overall Study|Other|3
4439452|NCT00443053|7223421|FG001|Overall Study|Other|4
4439453|NCT00443053|7223420|FG000|Overall Study|Physician Decision|0
4439454|NCT00443053|7223421|FG001|Overall Study|Physician Decision|4
4439455|NCT00443079|7223429|FG000|Overall Study|Lost to Follow-up|0
4439456|NCT00443079|7223430|FG001|Overall Study|Lost to Follow-up|1
4439457|NCT00443118|7223441|FG000|Overall Study|unknown primary outcome|3
4439458|NCT00443118|7223442|FG001|Overall Study|unknown primary outcome|1
4439459|NCT00443118|7223443|FG002|Overall Study|unknown primary outcome|0
4439460|NCT00443118|7223441|FG000|Overall Study|Withdrawal by Subject|1
4439461|NCT00443118|7223442|FG001|Overall Study|Withdrawal by Subject|0
4439462|NCT00443118|7223443|FG002|Overall Study|Withdrawal by Subject|0
4439463|NCT00443209|7223471|FG000|Months 1 to 12 Treatment Period|Adverse Event|22
4439464|NCT00443209|7223472|FG001|Months 1 to 12 Treatment Period|Adverse Event|11
4439465|NCT00443209|7223471|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14
4439466|NCT00443209|7223472|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7
4439467|NCT00443209|7223471|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50
4439468|NCT00443209|7223472|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11
4439469|NCT00443209|7223471|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1
4439470|NCT00443209|7223472|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1
4439471|NCT00443209|7223471|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36
4439472|NCT00443209|7223472|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15
4439473|NCT00443209|7223471|FG000|Months 1 to 12 Treatment Period|Physician Decision|8
4439474|NCT00443209|7223472|FG001|Months 1 to 12 Treatment Period|Physician Decision|4
4439475|NCT00443209|7223471|FG000|Months 1 to 12 Treatment Period|Pregnancy|3
4439476|NCT00443209|7223472|FG001|Months 1 to 12 Treatment Period|Pregnancy|4
4439477|NCT00443209|7223471|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43
4439478|NCT00443209|7223472|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23
4439479|NCT00443209|7223471|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95
4439480|NCT00443209|7223472|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34
4439481|NCT00443209|7223471|FG000|Months 1 to 12 Treatment Period|Missing|2
4439482|NCT00443209|7223472|FG001|Months 1 to 12 Treatment Period|Missing|1
4439483|NCT00443209|7223471|FG000|Months 1 to 12 Treatment Period|Not Treated|71
4439484|NCT00443209|7223472|FG001|Months 1 to 12 Treatment Period|Not Treated|43
4439485|NCT00443209|7223471|FG000|Months 13 to 18 Treatment Period|Adverse Event|1
4439486|NCT00443209|7223472|FG001|Months 13 to 18 Treatment Period|Adverse Event|0
4439487|NCT00443209|7223471|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1
4439488|NCT00443209|7223472|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0
4439489|NCT00443209|7223471|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1
4439490|NCT00443209|7223472|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0
4439491|NCT00443209|7223471|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2
4439492|NCT00443209|7223472|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2
4439493|NCT00443209|7223471|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87
4439494|NCT00443209|7223472|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43
4439495|NCT00443209|7223471|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7
4439496|NCT00443209|7223472|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2
4439497|NCT00443261|7223478|FG000|Overall Study|Death|1
4439498|NCT00443430|7223488|FG000|Overall Study|Lack of Efficacy|3
4439499|NCT00443430|7223489|FG001|Overall Study|Lack of Efficacy|3
4439500|NCT00443430|7223488|FG000|Overall Study|Adverse Event|1
4439501|NCT00443430|7223489|FG001|Overall Study|Adverse Event|1
4439502|NCT00443456|7223495|FG000|Overall Study|Adverse Event|16
4630282|NCT01492361|7498842|FG000|Overall Study|Withdrawal by Subject|281
4439503|NCT00443456|7223495|FG000|Overall Study|Move|1
4439504|NCT00443456|7223495|FG000|Overall Study|Withdrawal by Subject|1
4439505|NCT00443534|7223503|FG000|Overall Study|Lack of Efficacy|67
4439506|NCT00443534|7223503|FG000|Overall Study|Adverse Event|16
4439507|NCT00443534|7223503|FG000|Overall Study|Death|9
4439508|NCT00443534|7223503|FG000|Overall Study|Withdrawal by Subject|8
4439509|NCT00443534|7223503|FG000|Overall Study|Study Terminated by Sponsor|12
4439510|NCT00443534|7223503|FG000|Overall Study|Other|10
4439511|NCT00443534|7223503|FG000|Overall Study|Enrolled, Not Treated|1
4439512|NCT00443560|7223526|FG000|Overall Study|No intrathecal dose|58
4439513|NCT00443560|7223527|FG001|Overall Study|No intrathecal dose|26
4439514|NCT00443560|7223526|FG000|Overall Study|Multiple pregnancies or fetal demise|2
4439515|NCT00443560|7223527|FG001|Overall Study|Multiple pregnancies or fetal demise|4
4439516|NCT00443599|7223535|FG000|Overall Study|Physician Decision|2
4439517|NCT00443599|7223536|FG001|Overall Study|Physician Decision|1
4439518|NCT00443599|7223535|FG000|Overall Study|Death|1
4439519|NCT00443599|7223536|FG001|Overall Study|Death|1
4439520|NCT00443599|7223535|FG000|Overall Study|Cardiopulmonary bypass canceled|3
4439521|NCT00443599|7223536|FG001|Overall Study|Cardiopulmonary bypass canceled|1
4439522|NCT00443651|7223544|FG000|Overall Study|Death|1
4439523|NCT00443651|7223545|FG001|Overall Study|Death|5
4439524|NCT00443651|7223544|FG000|Overall Study|Adverse Event|5
4439525|NCT00443651|7223545|FG001|Overall Study|Adverse Event|6
4439526|NCT00443651|7223544|FG000|Overall Study|Lost to Follow-up|18
4439527|NCT00443651|7223545|FG001|Overall Study|Lost to Follow-up|12
4439528|NCT00443651|7223544|FG000|Overall Study|Patient's/Guardian's Decision|58
4439529|NCT00443651|7223545|FG001|Overall Study|Patient's/Guardian's Decision|30
4439530|NCT00443651|7223544|FG000|Overall Study|Physician Decision|13
4439531|NCT00443651|7223545|FG001|Overall Study|Physician Decision|4
4439532|NCT00443651|7223544|FG000|Overall Study|Pregnancy|0
4439533|NCT00443651|7223545|FG001|Overall Study|Pregnancy|1
4439534|NCT00443703|7223553|FG000|Overall Study|Never Treated|3
4439535|NCT00443703|7223554|FG001|Overall Study|Never Treated|1
4439536|NCT00443703|7223553|FG000|Overall Study|Adverse Event|7
4439537|NCT00443703|7223554|FG001|Overall Study|Adverse Event|3
4439538|NCT00443703|7223553|FG000|Overall Study|Lack of Efficacy|3
4439539|NCT00443703|7223554|FG001|Overall Study|Lack of Efficacy|1
4439540|NCT00443703|7223553|FG000|Overall Study|Lost to Follow-up|0
4439541|NCT00443703|7223554|FG001|Overall Study|Lost to Follow-up|4
4439542|NCT00443703|7223553|FG000|Overall Study|Physician Decision|4
4439543|NCT00443703|7223554|FG001|Overall Study|Physician Decision|2
4439544|NCT00443703|7223553|FG000|Overall Study|Protocol Violation|1
4439545|NCT00443703|7223554|FG001|Overall Study|Protocol Violation|1
4439546|NCT00443703|7223553|FG000|Overall Study|Withdrawal by Subject|9
4439547|NCT00443703|7223554|FG001|Overall Study|Withdrawal by Subject|6
4439548|NCT00443703|7223553|FG000|Overall Study|Progressive Disease|1
4439549|NCT00443703|7223554|FG001|Overall Study|Progressive Disease|0
4439550|NCT00443729|7223562|FG000|Overall Study|Never Treated|0
4439551|NCT00443729|7223563|FG001|Overall Study|Never Treated|1
4439552|NCT00443729|7223562|FG000|Overall Study|Lack of Efficacy|4
4439553|NCT00443729|7223563|FG001|Overall Study|Lack of Efficacy|2
4439554|NCT00443729|7223562|FG000|Overall Study|Lost to Follow-up|0
4439555|NCT00443729|7223563|FG001|Overall Study|Lost to Follow-up|1
4439556|NCT00443729|7223562|FG000|Overall Study|Physician Decision|2
4439557|NCT00443729|7223563|FG001|Overall Study|Physician Decision|1
4439558|NCT00443729|7223562|FG000|Overall Study|Protocol Violation|1
4439559|NCT00443729|7223563|FG001|Overall Study|Protocol Violation|1
4439560|NCT00443729|7223562|FG000|Overall Study|Withdrawal by Subject|3
4439561|NCT00443729|7223563|FG001|Overall Study|Withdrawal by Subject|1
4439562|NCT00443755|7223571|FG000|Overall Study|Withdrawal by Subject|2
4439563|NCT00443755|7223572|FG001|Overall Study|Withdrawal by Subject|1
4439564|NCT00443781|7223578|FG000|Overall Study|Lost to Follow-up|10
4439565|NCT00443781|7223578|FG000|Overall Study|Physician Decision|2
4439566|NCT00443781|7223578|FG000|Overall Study|Protocol Violation|1
4439567|NCT00443781|7223578|FG000|Overall Study|Withdrawal by Subject|6
4439568|NCT00443781|7223578|FG000|Overall Study|Unable to comply with study follow up|2
4439569|NCT00443781|7223578|FG000|Overall Study|Investigator terminated participation|1
4439570|NCT00443781|7223578|FG000|Overall Study|Insurance not covered|2
4439571|NCT00443781|7223578|FG000|Overall Study|PD/FAD not done|1
4439572|NCT00443820|7223586|FG000|Overall Study|Adverse Event|1
4439573|NCT00443820|7223587|FG001|Overall Study|Adverse Event|1
4439574|NCT00443820|7223588|FG002|Overall Study|Adverse Event|0
4439575|NCT00443820|7223589|FG003|Overall Study|Adverse Event|0
4439576|NCT00443820|7223586|FG000|Overall Study|Lack of Efficacy|3
4439577|NCT00443820|7223587|FG001|Overall Study|Lack of Efficacy|2
4439578|NCT00443820|7223588|FG002|Overall Study|Lack of Efficacy|1
4439579|NCT00443820|7223589|FG003|Overall Study|Lack of Efficacy|1
4439580|NCT00443820|7223586|FG000|Overall Study|Protocol Violation|2
4439581|NCT00443820|7223587|FG001|Overall Study|Protocol Violation|1
4439582|NCT00443820|7223588|FG002|Overall Study|Protocol Violation|2
4439583|NCT00443820|7223589|FG003|Overall Study|Protocol Violation|1
4439584|NCT00443820|7223586|FG000|Overall Study|Withdrawal by Subject|6
4439585|NCT00443820|7223587|FG001|Overall Study|Withdrawal by Subject|7
4439586|NCT00443820|7223588|FG002|Overall Study|Withdrawal by Subject|8
4439587|NCT00443820|7223589|FG003|Overall Study|Withdrawal by Subject|9
4439588|NCT00443820|7223586|FG000|Overall Study|Lost to Follow-up|9
4439589|NCT00443820|7223587|FG001|Overall Study|Lost to Follow-up|8
4439590|NCT00443820|7223588|FG002|Overall Study|Lost to Follow-up|6
4716325|NCT02991859|7645664|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
4716326|NCT02991859|7645665|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
4716327|NCT02991859|7645666|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
4716328|NCT02991859|7645667|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
4716329|NCT02991859|7645668|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
4716330|NCT02991859|7645669|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
4716331|NCT02991859|7645670|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
4716332|NCT02991859|7645671|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
4716333|NCT02991859|7645672|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
4716334|NCT02991859|7645673|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
4716335|NCT02991859|7645657|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
4716336|NCT02991859|7645658|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
4716337|NCT02991859|7645659|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
4716338|NCT02991859|7645660|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
4716339|NCT02991859|7645661|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
4716340|NCT02991859|7645662|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
4716341|NCT02991859|7645663|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
4716342|NCT02991859|7645664|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
4716343|NCT02991859|7645665|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
4716344|NCT02991859|7645666|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
4439591|NCT00443820|7223589|FG003|Overall Study|Lost to Follow-up|5
4439592|NCT00443820|7223586|FG000|Overall Study|Administrative problems|0
4439593|NCT00443820|7223587|FG001|Overall Study|Administrative problems|0
4439594|NCT00443820|7223588|FG002|Overall Study|Administrative problems|0
4439595|NCT00443820|7223589|FG003|Overall Study|Administrative problems|1
4439596|NCT00443820|7223586|FG000|Overall Study|Death|0
4439597|NCT00443820|7223587|FG001|Overall Study|Death|0
4439598|NCT00443820|7223588|FG002|Overall Study|Death|1
4439599|NCT00443820|7223589|FG003|Overall Study|Death|0
4439600|NCT00443846|7223601|FG000|Overall Study|Withdrawn due to intercurrent disease|1
4439601|NCT00443846|7223602|FG001|Overall Study|Withdrawn due to intercurrent disease|0
4439602|NCT00443846|7223601|FG000|Overall Study|Not vaccinated, no blood sample drawn|1
4439603|NCT00443846|7223602|FG001|Overall Study|Not vaccinated, no blood sample drawn|0
4439604|NCT00443846|7223601|FG000|Overall Study|Adverse Event|0
4439605|NCT00443846|7223602|FG001|Overall Study|Adverse Event|1
4439606|NCT00443846|7223601|FG000|Overall Study|Personal reason|8
4439607|NCT00443846|7223602|FG001|Overall Study|Personal reason|3
4439608|NCT00443846|7223601|FG000|Overall Study|Lost to Follow-up|1
4439609|NCT00443846|7223602|FG001|Overall Study|Lost to Follow-up|2
4439610|NCT00443872|7223608|FG000|Overall Study|Protocol Violation|7
4439611|NCT00443872|7223608|FG000|Overall Study|Lost to Follow-up|2
4439612|NCT00443872|7223608|FG000|Overall Study|Adverse Event|8
4439613|NCT00443898|7223625|FG000|Overall Study|Adverse Event|0
4439614|NCT00443898|7223626|FG001|Overall Study|Adverse Event|0
4439615|NCT00443898|7223627|FG002|Overall Study|Adverse Event|1
4439616|NCT00443898|7223628|FG003|Overall Study|Adverse Event|1
4439617|NCT00443898|7223625|FG000|Overall Study|Lack of Efficacy|2
4439618|NCT00443898|7223626|FG001|Overall Study|Lack of Efficacy|3
4439619|NCT00443898|7223627|FG002|Overall Study|Lack of Efficacy|3
4439620|NCT00443898|7223628|FG003|Overall Study|Lack of Efficacy|1
4439621|NCT00443898|7223625|FG000|Overall Study|Protocol Violation|1
4439622|NCT00443898|7223626|FG001|Overall Study|Protocol Violation|1
4439623|NCT00443898|7223627|FG002|Overall Study|Protocol Violation|1
4439624|NCT00443898|7223628|FG003|Overall Study|Protocol Violation|0
4439625|NCT00443898|7223625|FG000|Overall Study|Withdrawal by Subject|11
4439626|NCT00443898|7223626|FG001|Overall Study|Withdrawal by Subject|10
4439627|NCT00443898|7223627|FG002|Overall Study|Withdrawal by Subject|10
4439628|NCT00443898|7223628|FG003|Overall Study|Withdrawal by Subject|6
4439629|NCT00443898|7223625|FG000|Overall Study|Lost to Follow-up|10
4439630|NCT00443898|7223626|FG001|Overall Study|Lost to Follow-up|10
4439631|NCT00443898|7223627|FG002|Overall Study|Lost to Follow-up|14
4439632|NCT00443898|7223628|FG003|Overall Study|Lost to Follow-up|10
4439633|NCT00443898|7223625|FG000|Overall Study|Death|0
4439634|NCT00443898|7223626|FG001|Overall Study|Death|1
4439635|NCT00443898|7223627|FG002|Overall Study|Death|0
4439636|NCT00443898|7223628|FG003|Overall Study|Death|0
4439637|NCT00444067|7223664|FG000|Overall Study|Lost to Follow-up|0
4439638|NCT00444067|7223665|FG001|Overall Study|Lost to Follow-up|1
4439639|NCT00444106|7223686|FG000|Overall Study|Lost to Follow-up|2
4439640|NCT00444106|7223687|FG001|Overall Study|Lost to Follow-up|1
4439641|NCT00444106|7223688|FG002|Overall Study|Lost to Follow-up|0
4439642|NCT00444106|7223686|FG000|Overall Study|Abnormal Test Procedure Results|0
4439643|NCT00444106|7223687|FG001|Overall Study|Abnormal Test Procedure Results|0
4439644|NCT00444106|7223688|FG002|Overall Study|Abnormal Test Procedure Results|1
4439645|NCT00444145|7223699|FG000|Overall Study|Withdrawal by Subject|2
4439646|NCT00444145|7223699|FG000|Overall Study|Lost to Follow-up|1
4439647|NCT00444145|7223699|FG000|Overall Study|non-compliant|11
4439648|NCT00444145|7223699|FG000|Overall Study|Screen Failures|5
4439649|NCT00444275|7223706|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0
4439650|NCT00444275|7223707|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0
4439651|NCT00444275|7223708|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22
4439652|NCT00444275|7223709|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17
4439653|NCT00444275|7223710|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29
4439654|NCT00444275|7223706|FG000|Maintenance Treatment Phase|Lost to Follow-up|0
4439655|NCT00444275|7223707|FG001|Maintenance Treatment Phase|Lost to Follow-up|0
4439656|NCT00444275|7223708|FG002|Maintenance Treatment Phase|Lost to Follow-up|8
4439657|NCT00444275|7223709|FG003|Maintenance Treatment Phase|Lost to Follow-up|14
4439658|NCT00444275|7223710|FG004|Maintenance Treatment Phase|Lost to Follow-up|10
4439659|NCT00444275|7223706|FG000|Maintenance Treatment Phase|Adverse Event|0
4439660|NCT00444275|7223707|FG001|Maintenance Treatment Phase|Adverse Event|0
4439661|NCT00444275|7223708|FG002|Maintenance Treatment Phase|Adverse Event|3
4439662|NCT00444275|7223709|FG003|Maintenance Treatment Phase|Adverse Event|2
4439663|NCT00444275|7223710|FG004|Maintenance Treatment Phase|Adverse Event|13
4439664|NCT00444275|7223706|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0
4439665|NCT00444275|7223707|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0
4439666|NCT00444275|7223708|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1
4439667|NCT00444275|7223709|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0
4439668|NCT00444275|7223710|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6
4439669|NCT00444275|7223706|FG000|Maintenance Treatment Phase|Patient's wish|0
4439670|NCT00444275|7223707|FG001|Maintenance Treatment Phase|Patient's wish|0
4439671|NCT00444275|7223708|FG002|Maintenance Treatment Phase|Patient's wish|19
4439672|NCT00444275|7223709|FG003|Maintenance Treatment Phase|Patient's wish|9
4439673|NCT00444275|7223710|FG004|Maintenance Treatment Phase|Patient's wish|20
4439674|NCT00444275|7223706|FG000|Maintenance Treatment Phase|Protocol Violation|0
4439675|NCT00444275|7223707|FG001|Maintenance Treatment Phase|Protocol Violation|0
4439676|NCT00444275|7223708|FG002|Maintenance Treatment Phase|Protocol Violation|103
4439677|NCT00444275|7223709|FG003|Maintenance Treatment Phase|Protocol Violation|88
4439678|NCT00444275|7223710|FG004|Maintenance Treatment Phase|Protocol Violation|87
4439679|NCT00444275|7223706|FG000|Maintenance Treatment Phase|Ineffectiveness|0
4439680|NCT00444275|7223707|FG001|Maintenance Treatment Phase|Ineffectiveness|0
4439681|NCT00444275|7223708|FG002|Maintenance Treatment Phase|Ineffectiveness|5
4439682|NCT00444275|7223709|FG003|Maintenance Treatment Phase|Ineffectiveness|3
4439683|NCT00444275|7223710|FG004|Maintenance Treatment Phase|Ineffectiveness|14
4439684|NCT00444457|7223729|FG000|Infant Series|Other|0
4439685|NCT00444457|7223730|FG001|Infant Series|Other|1
4439686|NCT00444457|7223731|FG002|Infant Series|Other|0
4439687|NCT00444457|7223732|FG003|Infant Series|Other|0
4439688|NCT00444457|7223729|FG000|Infant Series|Parent or legal guardian request|18
4439689|NCT00444457|7223730|FG001|Infant Series|Parent or legal guardian request|29
4439690|NCT00444457|7223731|FG002|Infant Series|Parent or legal guardian request|34
4439691|NCT00444457|7223732|FG003|Infant Series|Parent or legal guardian request|14
4439692|NCT00444457|7223729|FG000|Infant Series|Lost to Follow-up|10
4439693|NCT00444457|7223730|FG001|Infant Series|Lost to Follow-up|11
4439694|NCT00444457|7223731|FG002|Infant Series|Lost to Follow-up|7
4439695|NCT00444457|7223732|FG003|Infant Series|Lost to Follow-up|6
4439696|NCT00444457|7223729|FG000|Infant Series|Protocol Violation|16
4439697|NCT00444457|7223730|FG001|Infant Series|Protocol Violation|8
4439698|NCT00444457|7223731|FG002|Infant Series|Protocol Violation|6
4439699|NCT00444457|7223732|FG003|Infant Series|Protocol Violation|3
4439700|NCT00444457|7223729|FG000|Infant Series|Failed to return|5
4439701|NCT00444457|7223730|FG001|Infant Series|Failed to return|4
4439702|NCT00444457|7223731|FG002|Infant Series|Failed to return|4
4439703|NCT00444457|7223732|FG003|Infant Series|Failed to return|2
4439704|NCT00444457|7223729|FG000|Infant Series|Investigator request|4
4439705|NCT00444457|7223730|FG001|Infant Series|Investigator request|3
4439706|NCT00444457|7223731|FG002|Infant Series|Investigator request|3
4439707|NCT00444457|7223732|FG003|Infant Series|Investigator request|2
4439708|NCT00444457|7223729|FG000|Infant Series|Other|0
4439709|NCT00444457|7223730|FG001|Infant Series|Other|2
4439710|NCT00444457|7223731|FG002|Infant Series|Other|4
4439711|NCT00444457|7223732|FG003|Infant Series|Other|0
4439712|NCT00444457|7223729|FG000|Infant Series|Adverse Event|1
4439713|NCT00444457|7223730|FG001|Infant Series|Adverse Event|2
4439714|NCT00444457|7223731|FG002|Infant Series|Adverse Event|2
4439715|NCT00444457|7223732|FG003|Infant Series|Adverse Event|0
4439716|NCT00444457|7223729|FG000|Infant Series|Death|0
4439717|NCT00444457|7223730|FG001|Infant Series|Death|1
4439718|NCT00444457|7223731|FG002|Infant Series|Death|1
4439719|NCT00444457|7223732|FG003|Infant Series|Death|1
4439720|NCT00444457|7223729|FG000|After Infant Series|Other|0
4439721|NCT00444457|7223730|FG001|After Infant Series|Other|1
4439722|NCT00444457|7223731|FG002|After Infant Series|Other|1
4439723|NCT00444457|7223732|FG003|After Infant Series|Other|1
4439724|NCT00444457|7223729|FG000|After Infant Series|Parent or legal guardian request|4
4439725|NCT00444457|7223730|FG001|After Infant Series|Parent or legal guardian request|11
4439726|NCT00444457|7223731|FG002|After Infant Series|Parent or legal guardian request|6
4439727|NCT00444457|7223732|FG003|After Infant Series|Parent or legal guardian request|3
4439728|NCT00444457|7223729|FG000|After Infant Series|Failed to return|7
4439729|NCT00444457|7223730|FG001|After Infant Series|Failed to return|6
4439730|NCT00444457|7223731|FG002|After Infant Series|Failed to return|5
4439731|NCT00444457|7223732|FG003|After Infant Series|Failed to return|1
4439732|NCT00444457|7223729|FG000|After Infant Series|Lost to Follow-up|5
4439733|NCT00444457|7223730|FG001|After Infant Series|Lost to Follow-up|5
4439734|NCT00444457|7223731|FG002|After Infant Series|Lost to Follow-up|5
4439735|NCT00444457|7223732|FG003|After Infant Series|Lost to Follow-up|2
4439736|NCT00444457|7223729|FG000|After Infant Series|Protocol Violation|2
4439737|NCT00444457|7223730|FG001|After Infant Series|Protocol Violation|4
4439738|NCT00444457|7223731|FG002|After Infant Series|Protocol Violation|2
4439739|NCT00444457|7223732|FG003|After Infant Series|Protocol Violation|2
4439740|NCT00444457|7223729|FG000|After Infant Series|Adverse Event|2
4439741|NCT00444457|7223730|FG001|After Infant Series|Adverse Event|2
4439742|NCT00444457|7223731|FG002|After Infant Series|Adverse Event|0
4439743|NCT00444457|7223732|FG003|After Infant Series|Adverse Event|0
4439744|NCT00444457|7223729|FG000|After Infant Series|Investigator request|0
4439745|NCT00444457|7223730|FG001|After Infant Series|Investigator request|0
4439746|NCT00444457|7223731|FG002|After Infant Series|Investigator request|0
4439747|NCT00444457|7223732|FG003|After Infant Series|Investigator request|1
4439748|NCT00444457|7223729|FG000|After Infant Series|Other|0
4439749|NCT00444457|7223730|FG001|After Infant Series|Other|1
4439750|NCT00444457|7223731|FG002|After Infant Series|Other|0
4439751|NCT00444457|7223732|FG003|After Infant Series|Other|0
4439752|NCT00444457|7223729|FG000|Toddler Dose|Lost to Follow-up|4
4439753|NCT00444457|7223730|FG001|Toddler Dose|Lost to Follow-up|1
4439754|NCT00444457|7223731|FG002|Toddler Dose|Lost to Follow-up|1
4439755|NCT00444457|7223732|FG003|Toddler Dose|Lost to Follow-up|3
4439756|NCT00444457|7223729|FG000|Toddler Dose|Failed to return|2
4439757|NCT00444457|7223730|FG001|Toddler Dose|Failed to return|2
4439758|NCT00444457|7223731|FG002|Toddler Dose|Failed to return|1
4439759|NCT00444457|7223732|FG003|Toddler Dose|Failed to return|3
4439760|NCT00444457|7223729|FG000|Toddler Dose|Parent or legal guardian request|0
4439761|NCT00444457|7223730|FG001|Toddler Dose|Parent or legal guardian request|3
4439762|NCT00444457|7223731|FG002|Toddler Dose|Parent or legal guardian request|2
4439763|NCT00444457|7223732|FG003|Toddler Dose|Parent or legal guardian request|1
4439764|NCT00444457|7223729|FG000|Toddler Dose|Protocol Violation|1
4439765|NCT00444457|7223730|FG001|Toddler Dose|Protocol Violation|0
4439766|NCT00444457|7223731|FG002|Toddler Dose|Protocol Violation|0
4439767|NCT00444457|7223732|FG003|Toddler Dose|Protocol Violation|1
4439768|NCT00444535|7223753|FG000|Overall Study|Withdrawal by Subject|5
4439769|NCT00444535|7223753|FG000|Overall Study|Physician Decision|5
4439770|NCT00444535|7223753|FG000|Overall Study|progressive disease|1
4439771|NCT00444535|7223753|FG000|Overall Study|Adverse Event|2
4439772|NCT00444587|7223759|FG000|Overall Study|Death|2
4439773|NCT00444587|7223760|FG001|Overall Study|Death|1
4439774|NCT00444587|7223759|FG000|Overall Study|Progression of the disease|73
4439775|NCT00444587|7223760|FG001|Overall Study|Progression of the disease|8
4439776|NCT00444587|7223759|FG000|Overall Study|Refused treatment/did not cooperate|4
4439777|NCT00444587|7223760|FG001|Overall Study|Refused treatment/did not cooperate|1
4439778|NCT00444587|7223759|FG000|Overall Study|Investigator decision|3
4439779|NCT00444587|7223760|FG001|Overall Study|Investigator decision|0
4439780|NCT00444587|7223759|FG000|Overall Study|Protocol Violation|1
4439781|NCT00444587|7223760|FG001|Overall Study|Protocol Violation|0
4439782|NCT00444587|7223759|FG000|Overall Study|Missing|0
4439783|NCT00444587|7223760|FG001|Overall Study|Missing|5
4439784|NCT00444600|7223772|FG000|Overall Study|Death|7
4439785|NCT00444600|7223773|FG001|Overall Study|Death|5
4439786|NCT00444600|7223774|FG002|Overall Study|Death|3
4439787|NCT00444600|7223775|FG003|Overall Study|Death|2
4439788|NCT00444600|7223772|FG000|Overall Study|Dropped|11
4439789|NCT00444600|7223773|FG001|Overall Study|Dropped|11
4439790|NCT00444600|7223774|FG002|Overall Study|Dropped|7
4439791|NCT00444600|7223775|FG003|Overall Study|Dropped|7
4439792|NCT00444600|7223772|FG000|Overall Study|Missed visit|1
4439793|NCT00444600|7223773|FG001|Overall Study|Missed visit|0
4439794|NCT00444600|7223774|FG002|Overall Study|Missed visit|0
4439795|NCT00444600|7223775|FG003|Overall Study|Missed visit|1
4439796|NCT00444626|7223791|FG000|Initial Treatment Period|Withdrawal by Subject|2
4439797|NCT00444626|7223791|FG000|Initial Treatment Period|Adverse Event|1
4439798|NCT00444626|7223791|FG000|Initial Treatment Period|Lost to Follow-up|9
4439799|NCT00444678|7223804|FG000|Overall Study|Toxicity|11
4439800|NCT00444678|7223804|FG000|Overall Study|Disease Progression|12
4439801|NCT00444678|7223804|FG000|Overall Study|Death|3
4439802|NCT00444678|7223804|FG000|Overall Study|Physician Decision|3
4439803|NCT00444678|7223804|FG000|Overall Study|Withdrawal by Subject|2
4439804|NCT00444795|7223808|FG000|Overall Study|Not Treated|1
4439805|NCT00444795|7223808|FG000|Overall Study|Treated Prior to the Contract Date|2
4439806|NCT00444912|7223823|FG000|Overall Study|Death|1
4439807|NCT00444912|7223824|FG001|Overall Study|Death|2
4439808|NCT00444912|7223823|FG000|Overall Study|Lost to Follow-up|1
4439809|NCT00444912|7223824|FG001|Overall Study|Lost to Follow-up|0
4439810|NCT00444912|7223823|FG000|Overall Study|Participant Failed Mobilization|1
4439811|NCT00444912|7223824|FG001|Overall Study|Participant Failed Mobilization|0
4439812|NCT00444925|7223833|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3
4439813|NCT00444925|7223834|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6
4439814|NCT00444925|7223835|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6
4439815|NCT00444925|7223833|FG000|Double-blind Treatment Period|Death|2
4439816|NCT00444925|7223834|FG001|Double-blind Treatment Period|Death|0
4439817|NCT00444925|7223835|FG002|Double-blind Treatment Period|Death|0
4439818|NCT00444925|7223833|FG000|Double-blind Treatment Period|Adverse Event|6
4439819|NCT00444925|7223834|FG001|Double-blind Treatment Period|Adverse Event|28
4439820|NCT00444925|7223835|FG002|Double-blind Treatment Period|Adverse Event|44
4439821|NCT00444925|7223833|FG000|Double-blind Treatment Period|Lack of Efficacy|5
4439822|NCT00444925|7223834|FG001|Double-blind Treatment Period|Lack of Efficacy|5
4439823|NCT00444925|7223835|FG002|Double-blind Treatment Period|Lack of Efficacy|13
4439824|NCT00444925|7223833|FG000|Double-blind Treatment Period|Lost to Follow-up|4
4439825|NCT00444925|7223834|FG001|Double-blind Treatment Period|Lost to Follow-up|8
4716345|NCT02991859|7645667|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
4716346|NCT02991859|7645668|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
4716347|NCT02991859|7645669|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1
4716348|NCT02991859|7645670|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1
4716349|NCT02991859|7645671|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
4716350|NCT02991859|7645672|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
4716351|NCT02991859|7645673|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
4716352|NCT02991859|7645657|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0
4439826|NCT00444925|7223835|FG002|Double-blind Treatment Period|Lost to Follow-up|5
4439827|NCT00444925|7223833|FG000|Double-blind Treatment Period|Withdrawal by Subject|6
4439828|NCT00444925|7223834|FG001|Double-blind Treatment Period|Withdrawal by Subject|8
4439829|NCT00444925|7223835|FG002|Double-blind Treatment Period|Withdrawal by Subject|7
4439830|NCT00444925|7223833|FG000|Double-blind Treatment Period|Other|7
4716353|NCT02991859|7645658|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0
4716354|NCT02991859|7645659|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0
4716355|NCT02991859|7645660|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0
4439831|NCT00444925|7223834|FG001|Double-blind Treatment Period|Other|7
4439832|NCT00444925|7223835|FG002|Double-blind Treatment Period|Other|12
4439833|NCT00444951|7223846|FG000|Overall Study|Lost to Follow-up|1
4439834|NCT00444951|7223847|FG001|Overall Study|Lost to Follow-up|1
4439835|NCT00444951|7223848|FG002|Overall Study|Lost to Follow-up|0
4439836|NCT00444951|7223846|FG000|Overall Study|Withdrawal by Subject|4
4439837|NCT00444951|7223847|FG001|Overall Study|Withdrawal by Subject|5
4439838|NCT00444951|7223848|FG002|Overall Study|Withdrawal by Subject|3
4439839|NCT00445003|7223863|FG000|Overall Study|Death|1
4439840|NCT00445003|7223864|FG001|Overall Study|Death|2
4439841|NCT00445003|7223865|FG002|Overall Study|Death|1
4439842|NCT00445003|7223863|FG000|Overall Study|Missed Visit|3
4439843|NCT00445003|7223864|FG001|Overall Study|Missed Visit|5
4439844|NCT00445003|7223865|FG002|Overall Study|Missed Visit|1
4439845|NCT00445003|7223863|FG000|Overall Study|Dropped|1
4439846|NCT00445003|7223864|FG001|Overall Study|Dropped|3
4439847|NCT00445003|7223865|FG002|Overall Study|Dropped|2
4439848|NCT00445068|7223873|FG000|Overall Study|Disease progression|26
4439849|NCT00445068|7223873|FG000|Overall Study|Adverse Event|5
4439850|NCT00445068|7223873|FG000|Overall Study|Abnormal laboratory value|2
4439851|NCT00445068|7223873|FG000|Overall Study|Withdrawal by Subject|2
4439852|NCT00445068|7223873|FG000|Overall Study|Death|1
4439853|NCT00445146|7223877|FG000|Overall Study|Withdrew Consent|29
4439854|NCT00445146|7223877|FG000|Overall Study|Lack of Efficacy|28
4439855|NCT00445146|7223877|FG000|Overall Study|Investigator's Discretion|22
4439856|NCT00445146|7223877|FG000|Overall Study|Adverse Event|13
4439857|NCT00445146|7223877|FG000|Overall Study|Lost to Follow-up|13
4439858|NCT00445146|7223877|FG000|Overall Study|Death|9
4439859|NCT00445146|7223877|FG000|Overall Study|Protocol Violation|4
4439860|NCT00445146|7223877|FG000|Overall Study|Pregnancy|1
4439861|NCT00445224|7223892|FG000|Specific Exercises|Withdrawal by Subject|3
4439862|NCT00445224|7223893|FG001|Specific Exercises|Withdrawal by Subject|3
4439863|NCT00445224|7223892|FG000|Specific Exercises|Withdrawal by Subject|1
4439864|NCT00445224|7223893|FG001|Specific Exercises|Withdrawal by Subject|0
4439865|NCT00445328|7223949|FG000|Overall Study|Death|0
4439866|NCT00445328|7223950|FG001|Overall Study|Death|1
4439867|NCT00445328|7223949|FG000|Overall Study|Adverse Event|0
4439868|NCT00445328|7223950|FG001|Overall Study|Adverse Event|3
4439869|NCT00445328|7223949|FG000|Overall Study|Other|0
4439870|NCT00445328|7223950|FG001|Overall Study|Other|2
4439871|NCT00445328|7223949|FG000|Overall Study|Withdrawal by Subject|2
4439872|NCT00445328|7223950|FG001|Overall Study|Withdrawal by Subject|0
4439873|NCT00445328|7223949|FG000|Overall Study|Protocol Violation|1
4439874|NCT00445328|7223950|FG001|Overall Study|Protocol Violation|0
4439875|NCT00445341|7223956|FG000|Overall Study|refused further treatment|1
4439876|NCT00445341|7223956|FG000|Overall Study|taken off treatment too early|1
4439877|NCT00445432|7223963|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1
4439878|NCT00445432|7223964|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2
4439879|NCT00445432|7223965|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7
4439880|NCT00445432|7223966|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0
4439881|NCT00445432|7223963|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
4439882|NCT00445432|7223964|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
4439883|NCT00445432|7223965|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2
4439884|NCT00445432|7223966|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
4439885|NCT00445432|7223963|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14
4439886|NCT00445432|7223964|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20
4439887|NCT00445432|7223965|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0
4439888|NCT00445432|7223966|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0
4439889|NCT00445432|7223963|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0
4439890|NCT00445432|7223964|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1
4439891|NCT00445432|7223965|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2
4439892|NCT00445432|7223966|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0
4439893|NCT00445432|7223963|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0
4439894|NCT00445432|7223964|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0
4439895|NCT00445432|7223965|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0
4439896|NCT00445432|7223966|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32
4439897|NCT00445432|7223963|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
4439898|NCT00445432|7223964|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
4439899|NCT00445432|7223965|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
4439900|NCT00445432|7223966|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3
4439901|NCT00445432|7223963|FG000|148 Weeks of Adalimumab Treatment|Other|0
4439902|NCT00445432|7223964|FG001|148 Weeks of Adalimumab Treatment|Other|0
4439903|NCT00445432|7223965|FG002|148 Weeks of Adalimumab Treatment|Other|0
4439904|NCT00445432|7223966|FG003|148 Weeks of Adalimumab Treatment|Other|9
4439905|NCT00445458|7223981|FG000|Overall Study|Disease Progression|3
4439906|NCT00445458|7223982|FG001|Overall Study|Disease Progression|4
4439907|NCT00445458|7223983|FG002|Overall Study|Disease Progression|54
4439908|NCT00445458|7223984|FG003|Overall Study|Disease Progression|27
4439909|NCT00445458|7223981|FG000|Overall Study|Withdrawal by Subject|0
4439910|NCT00445458|7223982|FG001|Overall Study|Withdrawal by Subject|0
4439911|NCT00445458|7223983|FG002|Overall Study|Withdrawal by Subject|7
4439912|NCT00445458|7223984|FG003|Overall Study|Withdrawal by Subject|0
4439913|NCT00445458|7223981|FG000|Overall Study|Adverse Event|0
4439914|NCT00445458|7223982|FG001|Overall Study|Adverse Event|0
4439915|NCT00445458|7223983|FG002|Overall Study|Adverse Event|3
4439916|NCT00445458|7223984|FG003|Overall Study|Adverse Event|0
4439917|NCT00445458|7223981|FG000|Overall Study|Death|0
4439918|NCT00445458|7223982|FG001|Overall Study|Death|1
4439919|NCT00445458|7223983|FG002|Overall Study|Death|2
4439920|NCT00445458|7223984|FG003|Overall Study|Death|0
4439921|NCT00445458|7223981|FG000|Overall Study|Physician Decision|0
4439922|NCT00445458|7223982|FG001|Overall Study|Physician Decision|0
4439923|NCT00445458|7223983|FG002|Overall Study|Physician Decision|1
4439924|NCT00445458|7223984|FG003|Overall Study|Physician Decision|1
4439925|NCT00445458|7223981|FG000|Overall Study|Surgery|0
4439926|NCT00445458|7223982|FG001|Overall Study|Surgery|0
4439927|NCT00445458|7223983|FG002|Overall Study|Surgery|1
4439928|NCT00445458|7223984|FG003|Overall Study|Surgery|0
4439929|NCT00445549|7224006|FG000|Overall Study|progressive disease|12
4439930|NCT00445601|7224017|FG000|Overall Study|Withdrawal by Subject|11
4439931|NCT00445601|7224018|FG001|Overall Study|Withdrawal by Subject|11
4439932|NCT00445601|7224017|FG000|Overall Study|TURBT Complication|12
4439933|NCT00445601|7224018|FG001|Overall Study|TURBT Complication|8
4439934|NCT00445601|7224017|FG000|Overall Study|Incorrect Disease Status|6
4439935|NCT00445601|7224018|FG001|Overall Study|Incorrect Disease Status|6
4439936|NCT00445601|7224017|FG000|Overall Study|Drug Delivery Issue|2
4439937|NCT00445601|7224018|FG001|Overall Study|Drug Delivery Issue|2
4439938|NCT00445601|7224017|FG000|Overall Study|Adverse Event|2
4439939|NCT00445601|7224018|FG001|Overall Study|Adverse Event|0
4439940|NCT00445601|7224017|FG000|Overall Study|Death prior to TURBT|0
4439941|NCT00445601|7224018|FG001|Overall Study|Death prior to TURBT|1
4439942|NCT00445679|7224032|FG000|Overall Study|Adverse Event|22
4439943|NCT00445679|7224033|FG001|Overall Study|Adverse Event|12
4439944|NCT00445679|7224034|FG002|Overall Study|Adverse Event|30
4439945|NCT00445679|7224035|FG003|Overall Study|Adverse Event|19
4439946|NCT00445679|7224032|FG000|Overall Study|Failed to return|1
4439947|NCT00445679|7224033|FG001|Overall Study|Failed to return|3
4439948|NCT00445679|7224034|FG002|Overall Study|Failed to return|2
4439949|NCT00445679|7224035|FG003|Overall Study|Failed to return|2
4439950|NCT00445679|7224032|FG000|Overall Study|Physician Decision|0
4439951|NCT00445679|7224033|FG001|Overall Study|Physician Decision|0
4439952|NCT00445679|7224034|FG002|Overall Study|Physician Decision|1
4439953|NCT00445679|7224035|FG003|Overall Study|Physician Decision|0
4439954|NCT00445679|7224032|FG000|Overall Study|Lost to Follow-up|10
4439955|NCT00445679|7224033|FG001|Overall Study|Lost to Follow-up|6
4439956|NCT00445679|7224034|FG002|Overall Study|Lost to Follow-up|6
4439957|NCT00445679|7224035|FG003|Overall Study|Lost to Follow-up|5
4439958|NCT00445679|7224032|FG000|Overall Study|Compliance|3
4439959|NCT00445679|7224033|FG001|Overall Study|Compliance|2
4439960|NCT00445679|7224034|FG002|Overall Study|Compliance|1
4439961|NCT00445679|7224035|FG003|Overall Study|Compliance|2
4439962|NCT00445679|7224032|FG000|Overall Study|Withdrawal of Informed Consent|0
4439963|NCT00445679|7224033|FG001|Overall Study|Withdrawal of Informed Consent|0
4439964|NCT00445679|7224034|FG002|Overall Study|Withdrawal of Informed Consent|1
4439965|NCT00445679|7224035|FG003|Overall Study|Withdrawal of Informed Consent|0
4439966|NCT00445679|7224032|FG000|Overall Study|Protocol Violation|2
4439967|NCT00445679|7224033|FG001|Overall Study|Protocol Violation|3
4439968|NCT00445679|7224034|FG002|Overall Study|Protocol Violation|3
4439969|NCT00445679|7224035|FG003|Overall Study|Protocol Violation|1
4439970|NCT00445679|7224032|FG000|Overall Study|Withdrawal by Subject|8
4439971|NCT00445679|7224033|FG001|Overall Study|Withdrawal by Subject|14
4439972|NCT00445679|7224034|FG002|Overall Study|Withdrawal by Subject|20
4439973|NCT00445679|7224035|FG003|Overall Study|Withdrawal by Subject|18
4439974|NCT00445679|7224032|FG000|Overall Study|Lack of Efficacy|2
4439975|NCT00445679|7224033|FG001|Overall Study|Lack of Efficacy|6
4439976|NCT00445679|7224034|FG002|Overall Study|Lack of Efficacy|2
4439977|NCT00445679|7224035|FG003|Overall Study|Lack of Efficacy|0
4439978|NCT00445692|7224045|FG000|Overall Study|Adverse Event|11
4439979|NCT00445692|7224045|FG000|Overall Study|Lack of Efficacy|5
4439980|NCT00445770|7224075|FG000|Overall Study|Adverse Event|9
4439981|NCT00445770|7224076|FG001|Overall Study|Adverse Event|15
4439982|NCT00445770|7224077|FG002|Overall Study|Adverse Event|19
4439983|NCT00445770|7224075|FG000|Overall Study|Lack of Efficacy|38
4439984|NCT00445770|7224076|FG001|Overall Study|Lack of Efficacy|13
4439985|NCT00445770|7224077|FG002|Overall Study|Lack of Efficacy|6
4439986|NCT00445770|7224075|FG000|Overall Study|Lost to Follow-up|0
4439987|NCT00445770|7224076|FG001|Overall Study|Lost to Follow-up|2
4439988|NCT00445770|7224077|FG002|Overall Study|Lost to Follow-up|0
4439989|NCT00445770|7224075|FG000|Overall Study|Other|6
4439990|NCT00445770|7224076|FG001|Overall Study|Other|5
4439991|NCT00445770|7224077|FG002|Overall Study|Other|6
4439992|NCT00445848|7224087|FG000|Overall Study|Adverse Event|14
4439993|NCT00445848|7224087|FG000|Overall Study|Withdrawal by Subject|4
4439994|NCT00445848|7224087|FG000|Overall Study|Progression|62
4439995|NCT00445848|7224087|FG000|Overall Study|Other-Not protocol specified|5
4439996|NCT00445939|7224113|FG000|Period A - Week 0 - Week 4|Adverse Event|1
4439997|NCT00445939|7224114|FG001|Period A - Week 0 - Week 4|Adverse Event|2
4439998|NCT00445939|7224115|FG002|Period A - Week 0 - Week 4|Adverse Event|0
4439999|NCT00445939|7224116|FG003|Period A - Week 0 - Week 4|Adverse Event|0
4440000|NCT00445939|7224113|FG000|Period B - Week 4 - Week 8|Adverse Event|2
4440001|NCT00445939|7224114|FG001|Period B - Week 4 - Week 8|Adverse Event|0
4440002|NCT00445939|7224115|FG002|Period B - Week 4 - Week 8|Adverse Event|0
4440003|NCT00445939|7224116|FG003|Period B - Week 4 - Week 8|Adverse Event|1
4440004|NCT00445978|7224136|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1
4440005|NCT00445978|7224136|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1
4440006|NCT00445978|7224136|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1
4440007|NCT00445978|7224136|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1
4440008|NCT00445978|7224136|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1
4440009|NCT00445978|7224136|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1
4440010|NCT00445978|7224136|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1
4440011|NCT00445978|7224136|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1
4440012|NCT00445978|7224136|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1
4440013|NCT00446030|7224149|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29
4440014|NCT00446030|7224150|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8
4440015|NCT00446030|7224149|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9
4440016|NCT00446030|7224150|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1
4440017|NCT00446030|7224149|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1
4440018|NCT00446030|7224150|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0
4440019|NCT00446030|7224149|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1
4440020|NCT00446030|7224150|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0
4440021|NCT00446030|7224149|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1
4440022|NCT00446030|7224150|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0
4440023|NCT00446030|7224149|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1
4440024|NCT00446030|7224150|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0
4440025|NCT00446030|7224149|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1
4440026|NCT00446030|7224150|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0
4440027|NCT00446030|7224149|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1
4440028|NCT00446030|7224150|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0
4440029|NCT00446030|7224149|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9
4440030|NCT00446030|7224150|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4
4440031|NCT00446030|7224149|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5
4440032|NCT00446030|7224150|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0
4440033|NCT00446030|7224149|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4
4440034|NCT00446030|7224150|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0
4440035|NCT00446030|7224149|FG000|FOLLOW-UP (up to 2-years)|Death|2
4630283|NCT01492361|7498843|FG001|Overall Study|Withdrawal by Subject|297
4630284|NCT01492361|7498842|FG000|Overall Study|Physician Decision|12
4630285|NCT01492361|7498843|FG001|Overall Study|Physician Decision|12
4630286|NCT01492361|7498842|FG000|Overall Study|Lost to Follow-up|6
4630287|NCT01492361|7498843|FG001|Overall Study|Lost to Follow-up|13
4630288|NCT01492361|7498842|FG000|Overall Study|Other than specified above|106
4440036|NCT00446030|7224150|FG001|FOLLOW-UP (up to 2-years)|Death|2
4440037|NCT00446030|7224149|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3
4440038|NCT00446030|7224150|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2
4440039|NCT00446030|7224149|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2
4440040|NCT00446030|7224150|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0
4440041|NCT00446030|7224149|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2
4440042|NCT00446030|7224150|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0
4440043|NCT00446030|7224149|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1
4440044|NCT00446030|7224150|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0
4440045|NCT00446030|7224149|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1
4440046|NCT00446030|7224150|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0
4440047|NCT00446030|7224149|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1
4440048|NCT00446030|7224150|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0
4440049|NCT00446030|7224149|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0
4440050|NCT00446030|7224150|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1
4440051|NCT00446095|7224161|FG000|Phase II (8 Weeks)|Lost to Follow-up|1
4440052|NCT00446095|7224162|FG001|Phase II (8 Weeks)|Lost to Follow-up|0
4440053|NCT00446095|7224163|FG002|Phase II (8 Weeks)|Lost to Follow-up|0
4440054|NCT00446095|7224164|FG003|Phase II (8 Weeks)|Lost to Follow-up|0
4440055|NCT00446095|7224165|FG004|Phase II (8 Weeks)|Lost to Follow-up|0
4440056|NCT00446095|7224161|FG000|Phase II (8 Weeks)|Adverse Event|0
4440057|NCT00446095|7224162|FG001|Phase II (8 Weeks)|Adverse Event|1
4630289|NCT01492361|7498843|FG001|Overall Study|Other than specified above|138
4630290|NCT01296711|7498857|FG000|Overall Study|Adverse Event|3
4630291|NCT01296711|7498858|FG001|Overall Study|Adverse Event|1
4630292|NCT01296711|7498859|FG002|Overall Study|Adverse Event|4
4630293|NCT01296711|7498860|FG003|Overall Study|Adverse Event|3
4440058|NCT00446095|7224163|FG002|Phase II (8 Weeks)|Adverse Event|1
4630294|NCT01296711|7498861|FG004|Overall Study|Adverse Event|1
4630295|NCT01296711|7498862|FG005|Overall Study|Adverse Event|6
4630296|NCT01296711|7498863|FG006|Overall Study|Adverse Event|11
4440059|NCT00446095|7224164|FG003|Phase II (8 Weeks)|Adverse Event|0
4440060|NCT00446095|7224165|FG004|Phase II (8 Weeks)|Adverse Event|0
4440061|NCT00446095|7224161|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1
4440062|NCT00446095|7224162|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0
4440063|NCT00446095|7224163|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0
4440064|NCT00446095|7224164|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0
4440065|NCT00446095|7224165|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0
4440066|NCT00446095|7224161|FG000|Phase II (8 Weeks)|Physician Decision|1
4440067|NCT00446095|7224162|FG001|Phase II (8 Weeks)|Physician Decision|0
4440068|NCT00446095|7224163|FG002|Phase II (8 Weeks)|Physician Decision|0
4440069|NCT00446095|7224164|FG003|Phase II (8 Weeks)|Physician Decision|0
4440070|NCT00446095|7224165|FG004|Phase II (8 Weeks)|Physician Decision|0
4440071|NCT00446095|7224161|FG000|Phase II (8 Weeks)|Lack of Efficacy|9
4440072|NCT00446095|7224162|FG001|Phase II (8 Weeks)|Lack of Efficacy|2
4440073|NCT00446095|7224163|FG002|Phase II (8 Weeks)|Lack of Efficacy|1
4440074|NCT00446095|7224164|FG003|Phase II (8 Weeks)|Lack of Efficacy|0
4440075|NCT00446095|7224165|FG004|Phase II (8 Weeks)|Lack of Efficacy|0
4440076|NCT00446095|7224161|FG000|Phase II (8 Weeks)|Ongoing|0
4440077|NCT00446095|7224162|FG001|Phase II (8 Weeks)|Ongoing|0
4440078|NCT00446095|7224163|FG002|Phase II (8 Weeks)|Ongoing|1
4440079|NCT00446095|7224164|FG003|Phase II (8 Weeks)|Ongoing|0
4440080|NCT00446095|7224165|FG004|Phase II (8 Weeks)|Ongoing|0
4440081|NCT00446095|7224161|FG000|Phase I (28 Days)|Adverse Event|0
4440082|NCT00446095|7224162|FG001|Phase I (28 Days)|Adverse Event|0
4440083|NCT00446095|7224163|FG002|Phase I (28 Days)|Adverse Event|0
4440084|NCT00446095|7224164|FG003|Phase I (28 Days)|Adverse Event|1
4440085|NCT00446095|7224165|FG004|Phase I (28 Days)|Adverse Event|0
4440086|NCT00446095|7224161|FG000|Phase I (28 Days)|Lack of Efficacy|0
4440087|NCT00446095|7224162|FG001|Phase I (28 Days)|Lack of Efficacy|0
4440088|NCT00446095|7224163|FG002|Phase I (28 Days)|Lack of Efficacy|0
4440089|NCT00446095|7224164|FG003|Phase I (28 Days)|Lack of Efficacy|0
4440090|NCT00446095|7224165|FG004|Phase I (28 Days)|Lack of Efficacy|3
4440091|NCT00446134|7224180|FG000|Overall Study|Adverse Event|7
4440092|NCT00446134|7224181|FG001|Overall Study|Adverse Event|17
4440093|NCT00446134|7224182|FG002|Overall Study|Adverse Event|13
4440094|NCT00446134|7224183|FG003|Overall Study|Adverse Event|18
4440095|NCT00446134|7224180|FG000|Overall Study|Lack of Efficacy|19
4440096|NCT00446134|7224181|FG001|Overall Study|Lack of Efficacy|19
4440097|NCT00446134|7224182|FG002|Overall Study|Lack of Efficacy|24
4440098|NCT00446134|7224183|FG003|Overall Study|Lack of Efficacy|19
4440099|NCT00446134|7224180|FG000|Overall Study|Protocol Violation|0
4440100|NCT00446134|7224181|FG001|Overall Study|Protocol Violation|2
4440101|NCT00446134|7224182|FG002|Overall Study|Protocol Violation|1
4440102|NCT00446134|7224183|FG003|Overall Study|Protocol Violation|0
4440103|NCT00446134|7224180|FG000|Overall Study|Lost to Follow-up|1
4440104|NCT00446134|7224181|FG001|Overall Study|Lost to Follow-up|3
4440105|NCT00446134|7224182|FG002|Overall Study|Lost to Follow-up|1
4440106|NCT00446134|7224183|FG003|Overall Study|Lost to Follow-up|1
4440107|NCT00446134|7224180|FG000|Overall Study|Withdrawal by Subject|3
4440108|NCT00446134|7224181|FG001|Overall Study|Withdrawal by Subject|3
4440109|NCT00446134|7224182|FG002|Overall Study|Withdrawal by Subject|1
4440110|NCT00446134|7224183|FG003|Overall Study|Withdrawal by Subject|3
4440111|NCT00446134|7224180|FG000|Overall Study|Physician Decision|0
4440112|NCT00446134|7224181|FG001|Overall Study|Physician Decision|0
4440113|NCT00446134|7224182|FG002|Overall Study|Physician Decision|0
4440114|NCT00446134|7224183|FG003|Overall Study|Physician Decision|2
4440115|NCT00446134|7224180|FG000|Overall Study|Adverse Event-Diarrhea|1
4440116|NCT00446134|7224181|FG001|Overall Study|Adverse Event-Diarrhea|1
4440117|NCT00446134|7224182|FG002|Overall Study|Adverse Event-Diarrhea|2
4440118|NCT00446134|7224183|FG003|Overall Study|Adverse Event-Diarrhea|0
4440119|NCT00446134|7224180|FG000|Overall Study|Reason Not Completed|3
4440120|NCT00446134|7224181|FG001|Overall Study|Reason Not Completed|0
4440121|NCT00446134|7224182|FG002|Overall Study|Reason Not Completed|1
4440122|NCT00446134|7224183|FG003|Overall Study|Reason Not Completed|2
4440123|NCT00446199|7224206|FG000|Overall Study|Adverse Event|7
4440124|NCT00446199|7224207|FG001|Overall Study|Adverse Event|4
4440125|NCT00446199|7224208|FG002|Overall Study|Adverse Event|6
4440126|NCT00446199|7224209|FG003|Overall Study|Adverse Event|4
4440127|NCT00446199|7224206|FG000|Overall Study|Lost to Follow-up|4
4440128|NCT00446199|7224207|FG001|Overall Study|Lost to Follow-up|5
4440129|NCT00446199|7224208|FG002|Overall Study|Lost to Follow-up|2
4440130|NCT00446199|7224209|FG003|Overall Study|Lost to Follow-up|6
4440131|NCT00446199|7224206|FG000|Overall Study|Protocol Violation|1
4440132|NCT00446199|7224207|FG001|Overall Study|Protocol Violation|2
4440133|NCT00446199|7224208|FG002|Overall Study|Protocol Violation|1
4440134|NCT00446199|7224209|FG003|Overall Study|Protocol Violation|3
4440135|NCT00446199|7224206|FG000|Overall Study|Withdrawal by Subject|2
4440136|NCT00446199|7224207|FG001|Overall Study|Withdrawal by Subject|5
4440137|NCT00446199|7224208|FG002|Overall Study|Withdrawal by Subject|9
4440138|NCT00446199|7224209|FG003|Overall Study|Withdrawal by Subject|10
4440139|NCT00446199|7224206|FG000|Overall Study|Site termination|2
4440140|NCT00446199|7224207|FG001|Overall Study|Site termination|0
4440141|NCT00446199|7224208|FG002|Overall Study|Site termination|0
4440142|NCT00446199|7224209|FG003|Overall Study|Site termination|1
4440143|NCT00446199|7224206|FG000|Overall Study|Randomization in Error|2
4440144|NCT00446199|7224207|FG001|Overall Study|Randomization in Error|0
4440145|NCT00446199|7224208|FG002|Overall Study|Randomization in Error|1
4440146|NCT00446199|7224209|FG003|Overall Study|Randomization in Error|1
4440147|NCT00446199|7224206|FG000|Overall Study|Lack of Efficacy|1
4440148|NCT00446199|7224207|FG001|Overall Study|Lack of Efficacy|0
4440149|NCT00446199|7224208|FG002|Overall Study|Lack of Efficacy|0
4440150|NCT00446199|7224209|FG003|Overall Study|Lack of Efficacy|1
4440151|NCT00446199|7224206|FG000|Overall Study|Non-compliant with study drug|1
4440152|NCT00446199|7224207|FG001|Overall Study|Non-compliant with study drug|0
4440153|NCT00446199|7224208|FG002|Overall Study|Non-compliant with study drug|5
4440154|NCT00446199|7224209|FG003|Overall Study|Non-compliant with study drug|0
4440155|NCT00446199|7224206|FG000|Overall Study|Non-compliant with visit schedule|1
4440156|NCT00446199|7224207|FG001|Overall Study|Non-compliant with visit schedule|1
4440157|NCT00446199|7224208|FG002|Overall Study|Non-compliant with visit schedule|1
4440158|NCT00446199|7224209|FG003|Overall Study|Non-compliant with visit schedule|2
4440159|NCT00446199|7224206|FG000|Overall Study|Hormone fear|0
4440160|NCT00446199|7224207|FG001|Overall Study|Hormone fear|0
4440161|NCT00446199|7224208|FG002|Overall Study|Hormone fear|0
4440162|NCT00446199|7224209|FG003|Overall Study|Hormone fear|1
4440163|NCT00446199|7224206|FG000|Overall Study|Lost interest in study participation|0
4440164|NCT00446199|7224207|FG001|Overall Study|Lost interest in study participation|1
4440165|NCT00446199|7224208|FG002|Overall Study|Lost interest in study participation|0
4440166|NCT00446199|7224209|FG003|Overall Study|Lost interest in study participation|0
4440167|NCT00446199|7224206|FG000|Overall Study|In-/Exclusion criterion violated|2
4440168|NCT00446199|7224207|FG001|Overall Study|In-/Exclusion criterion violated|1
4716356|NCT02991859|7645661|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0
4716357|NCT02991859|7645662|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1
4440169|NCT00446199|7224208|FG002|Overall Study|In-/Exclusion criterion violated|2
4440170|NCT00446199|7224209|FG003|Overall Study|In-/Exclusion criterion violated|1
4440171|NCT00446199|7224206|FG000|Overall Study|Move|0
4440172|NCT00446199|7224207|FG001|Overall Study|Move|1
4440173|NCT00446199|7224208|FG002|Overall Study|Move|0
4440174|NCT00446199|7224209|FG003|Overall Study|Move|0
4440175|NCT00446251|7224219|FG000|Overall Study|On-study Transplants|2
4440176|NCT00446251|7224219|FG000|Overall Study|Rituximab Infusion Reaction|2
4440177|NCT00446251|7224219|FG000|Overall Study|Lost to Follow-up|1
4440178|NCT00446446|7224231|FG000|Overall Study|Death|10
4440179|NCT00446446|7224231|FG000|Overall Study|Withdrawal by Subject|6
4440180|NCT00446446|7224231|FG000|Overall Study|Other|4
4440181|NCT00446446|7224231|FG000|Overall Study|Disease Progession|2
4440182|NCT00446446|7224231|FG000|Overall Study|Adverse Event|1
4440183|NCT00446446|7224231|FG000|Overall Study|On Treatment at Time of Data Cut-off|1
4440184|NCT00446459|7224235|FG000|8 Months|Protocol Violation|12
4440185|NCT00446459|7224235|FG000|12 Months|Protocol Violation|4
4440186|NCT00446459|7224235|FG000|12 Months|14 subjects to MMF + Rituximab Study|14
4440187|NCT00446511|7224243|FG000|Overall Study|Adverse Event|7
4440188|NCT00446511|7224244|FG001|Overall Study|Adverse Event|2
4440189|NCT00446511|7224245|FG002|Overall Study|Adverse Event|3
4440190|NCT00446511|7224246|FG003|Overall Study|Adverse Event|1
4440191|NCT00446511|7224243|FG000|Overall Study|Protocol Violation|0
4440192|NCT00446511|7224244|FG001|Overall Study|Protocol Violation|0
4440193|NCT00446511|7224245|FG002|Overall Study|Protocol Violation|0
4440194|NCT00446511|7224246|FG003|Overall Study|Protocol Violation|1
4440195|NCT00446511|7224243|FG000|Overall Study|Withdrawal by Subject|0
4440196|NCT00446511|7224244|FG001|Overall Study|Withdrawal by Subject|0
4440197|NCT00446511|7224245|FG002|Overall Study|Withdrawal by Subject|0
4440198|NCT00446511|7224246|FG003|Overall Study|Withdrawal by Subject|3
4440199|NCT00446511|7224243|FG000|Overall Study|Administrative Problems|3
4440200|NCT00446511|7224244|FG001|Overall Study|Administrative Problems|0
4440201|NCT00446511|7224245|FG002|Overall Study|Administrative Problems|4
4440202|NCT00446511|7224246|FG003|Overall Study|Administrative Problems|1
4440203|NCT00446550|7224260|FG000|Overall Study|Adverse Event|1
4440204|NCT00446550|7224261|FG001|Overall Study|Adverse Event|0
4440205|NCT00446563|7224270|FG000|Overall Study|Adverse Event|4
4440206|NCT00446563|7224271|FG001|Overall Study|Adverse Event|3
4440207|NCT00446563|7224270|FG000|Overall Study|Abnormal laboratory value(s)|0
4440208|NCT00446563|7224271|FG001|Overall Study|Abnormal laboratory value(s)|1
4440209|NCT00446563|7224270|FG000|Overall Study|Abnormal test procedure result(s)|1
4440210|NCT00446563|7224271|FG001|Overall Study|Abnormal test procedure result(s)|0
4440211|NCT00446563|7224270|FG000|Overall Study|Unsatisfactory therapeutic effect|0
4440212|NCT00446563|7224271|FG001|Overall Study|Unsatisfactory therapeutic effect|3
4440213|NCT00446563|7224270|FG000|Overall Study|Withdrawal by Subject|2
4440214|NCT00446563|7224271|FG001|Overall Study|Withdrawal by Subject|1
4440215|NCT00446563|7224270|FG000|Overall Study|Administrative problems|0
4440216|NCT00446563|7224271|FG001|Overall Study|Administrative problems|1
4716358|NCT02991859|7645663|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0
4440217|NCT00446641|7224279|FG000|Overall Study|Withdrawal by Subject|8
4440218|NCT00446641|7224280|FG001|Overall Study|Withdrawal by Subject|3
4440219|NCT00446641|7224279|FG000|Overall Study|poor compliance|8
4440220|NCT00446641|7224280|FG001|Overall Study|poor compliance|6
4440221|NCT00446641|7224279|FG000|Overall Study|Lost to Follow-up|1
4440222|NCT00446641|7224280|FG001|Overall Study|Lost to Follow-up|1
4440223|NCT00446654|7224288|FG000|Overall Study|Withdrawal by Subject|1
4440224|NCT00446654|7224289|FG001|Overall Study|Withdrawal by Subject|0
4440225|NCT00446654|7224288|FG000|Overall Study|Adverse Event|1
4440226|NCT00446654|7224289|FG001|Overall Study|Adverse Event|0
4440227|NCT00446797|7224297|FG000|Overall Study|Lack of Efficacy|0
4440228|NCT00446797|7224298|FG001|Overall Study|Lack of Efficacy|2
4440229|NCT00446797|7224297|FG000|Overall Study|Lost to Follow-up|5
4440230|NCT00446797|7224298|FG001|Overall Study|Lost to Follow-up|3
4440231|NCT00446797|7224297|FG000|Overall Study|Withdrawal by Subject|2
4440232|NCT00446797|7224298|FG001|Overall Study|Withdrawal by Subject|2
4440233|NCT00446797|7224297|FG000|Overall Study|Protocol Violation|1
4440234|NCT00446797|7224298|FG001|Overall Study|Protocol Violation|3
4440235|NCT00446797|7224297|FG000|Overall Study|subject entered at another site|0
4440236|NCT00446797|7224298|FG001|Overall Study|subject entered at another site|1
4440237|NCT00446797|7224297|FG000|Overall Study|did not meet entrance criteria|0
4440238|NCT00446797|7224298|FG001|Overall Study|did not meet entrance criteria|1
4440239|NCT00446849|7224304|FG000|Acute Phase|Lack of Efficacy|64
4630297|NCT01296711|7498864|FG007|Overall Study|Adverse Event|3
4630298|NCT01296711|7498857|FG000|Overall Study|Lack of Efficacy|1
4630299|NCT01296711|7498858|FG001|Overall Study|Lack of Efficacy|4
4630300|NCT01296711|7498859|FG002|Overall Study|Lack of Efficacy|1
4630301|NCT01296711|7498860|FG003|Overall Study|Lack of Efficacy|1
4630302|NCT01296711|7498861|FG004|Overall Study|Lack of Efficacy|1
4630303|NCT01296711|7498862|FG005|Overall Study|Lack of Efficacy|0
4630304|NCT01296711|7498863|FG006|Overall Study|Lack of Efficacy|2
4630305|NCT01296711|7498864|FG007|Overall Study|Lack of Efficacy|3
4630306|NCT01296711|7498857|FG000|Overall Study|Lost to Follow-up|0
4630307|NCT01296711|7498858|FG001|Overall Study|Lost to Follow-up|0
4630308|NCT01296711|7498859|FG002|Overall Study|Lost to Follow-up|1
4630309|NCT01296711|7498860|FG003|Overall Study|Lost to Follow-up|1
4630310|NCT01296711|7498861|FG004|Overall Study|Lost to Follow-up|2
4630311|NCT01296711|7498862|FG005|Overall Study|Lost to Follow-up|0
4630312|NCT01296711|7498863|FG006|Overall Study|Lost to Follow-up|4
4630313|NCT01296711|7498864|FG007|Overall Study|Lost to Follow-up|2
4630314|NCT01296711|7498857|FG000|Overall Study|Protocol Violation|0
4630315|NCT01296711|7498858|FG001|Overall Study|Protocol Violation|0
4630316|NCT01296711|7498859|FG002|Overall Study|Protocol Violation|0
4630317|NCT01296711|7498860|FG003|Overall Study|Protocol Violation|1
4630318|NCT01296711|7498861|FG004|Overall Study|Protocol Violation|1
4630319|NCT01296711|7498862|FG005|Overall Study|Protocol Violation|0
4630320|NCT01296711|7498863|FG006|Overall Study|Protocol Violation|0
4440240|NCT00446849|7224304|FG000|Acute Phase|Protocol Violation|10
4440241|NCT00446849|7224304|FG000|Acute Phase|Consent withdrawn|4
4440242|NCT00446849|7224304|FG000|Acute Phase|Lost to Follow-up|2
4440243|NCT00446849|7224304|FG000|Acute Phase|Physician Decision|1
4440244|NCT00446849|7224304|FG000|Acute Phase|noncompliance|1
4440245|NCT00446849|7224304|FG000|Maintenance Phase|Lack of Efficacy|40
4440246|NCT00446849|7224304|FG000|Maintenance Phase|Protocol Violation|7
4440247|NCT00446849|7224304|FG000|Maintenance Phase|Adverse Event|6
4440248|NCT00446849|7224304|FG000|Maintenance Phase|Consent withdrawn|5
4440249|NCT00446849|7224304|FG000|Maintenance Phase|Lost to Follow-up|3
4440250|NCT00446849|7224304|FG000|Maintenance Phase|Pregnancy|1
4440251|NCT00446849|7224304|FG000|Maintenance Phase|noncompliance|2
4440252|NCT00446849|7224304|FG000|Maintenance Phase|prohibited medication use|2
4440253|NCT00446849|7224304|FG000|Maintenance Phase|antibiotic use|1
4440254|NCT00446849|7224304|FG000|Maintenance Phase|study closure|1
4440255|NCT00446849|7224304|FG000|Maintenance Phase|hydrocodone use|1
4440256|NCT00446849|7224304|FG000|Maintenance Phase|concomitant medication use|1
4440257|NCT00446966|7224311|FG000|Overall Study|Lost to Follow-up|10
4440258|NCT00446966|7224312|FG001|Overall Study|Lost to Follow-up|7
4440259|NCT00446992|7224318|FG000|Overall Study|Adverse Event|11
4440260|NCT00446992|7224318|FG000|Overall Study|Lost to Follow-up|5
4440261|NCT00447005|7224322|FG000|Overall Study|Adverse Event|1
4440262|NCT00447005|7224322|FG000|Overall Study|Lack of Efficacy|11
4440263|NCT00447057|7224330|FG000|Overall Study|Adverse Event|4
4440264|NCT00447057|7224331|FG001|Overall Study|Adverse Event|10
4440265|NCT00447057|7224332|FG002|Overall Study|Adverse Event|0
4440266|NCT00447057|7224333|FG003|Overall Study|Adverse Event|3
4440267|NCT00447057|7224330|FG000|Overall Study|Death due to study disease|6
4440268|NCT00447057|7224331|FG001|Overall Study|Death due to study disease|4
4630321|NCT01296711|7498864|FG007|Overall Study|Protocol Violation|0
4630322|NCT01296711|7498857|FG000|Overall Study|Withdrawal by Subject|4
4630323|NCT01296711|7498858|FG001|Overall Study|Withdrawal by Subject|2
4630324|NCT01296711|7498859|FG002|Overall Study|Withdrawal by Subject|2
4440269|NCT00447057|7224332|FG002|Overall Study|Death due to study disease|1
4440270|NCT00447057|7224333|FG003|Overall Study|Death due to study disease|1
4440271|NCT00447057|7224330|FG000|Overall Study|Lost to Follow-up|0
4440272|NCT00447057|7224331|FG001|Overall Study|Lost to Follow-up|1
4440273|NCT00447057|7224332|FG002|Overall Study|Lost to Follow-up|0
4440274|NCT00447057|7224333|FG003|Overall Study|Lost to Follow-up|0
4440275|NCT00447057|7224330|FG000|Overall Study|Entry criteria not met|1
4440276|NCT00447057|7224331|FG001|Overall Study|Entry criteria not met|1
4440277|NCT00447057|7224332|FG002|Overall Study|Entry criteria not met|0
4440278|NCT00447057|7224333|FG003|Overall Study|Entry criteria not met|0
4440279|NCT00447057|7224330|FG000|Overall Study|Protocol Violation|0
4440280|NCT00447057|7224331|FG001|Overall Study|Protocol Violation|1
4440281|NCT00447057|7224332|FG002|Overall Study|Protocol Violation|0
4440282|NCT00447057|7224333|FG003|Overall Study|Protocol Violation|0
4440283|NCT00447057|7224330|FG000|Overall Study|Withdrawal by Subject|4
4440284|NCT00447057|7224331|FG001|Overall Study|Withdrawal by Subject|5
4440285|NCT00447057|7224332|FG002|Overall Study|Withdrawal by Subject|1
4440286|NCT00447057|7224333|FG003|Overall Study|Withdrawal by Subject|1
4440287|NCT00447057|7224330|FG000|Overall Study|Physician Decision|9
4440288|NCT00447057|7224331|FG001|Overall Study|Physician Decision|6
4440289|NCT00447057|7224332|FG002|Overall Study|Physician Decision|3
4440290|NCT00447057|7224333|FG003|Overall Study|Physician Decision|1
4440291|NCT00447057|7224330|FG000|Overall Study|Sponsor decision|1
4440292|NCT00447057|7224331|FG001|Overall Study|Sponsor decision|1
4440293|NCT00447057|7224332|FG002|Overall Study|Sponsor decision|0
4440294|NCT00447057|7224333|FG003|Overall Study|Sponsor decision|0
4440295|NCT00447057|7224330|FG000|Overall Study|Progressive disease|58
4440296|NCT00447057|7224331|FG001|Overall Study|Progressive disease|43
4440297|NCT00447057|7224332|FG002|Overall Study|Progressive disease|13
4440298|NCT00447057|7224333|FG003|Overall Study|Progressive disease|18
4440299|NCT00447057|7224330|FG000|Overall Study|Death due to adverse event|0
4440300|NCT00447057|7224331|FG001|Overall Study|Death due to adverse event|0
4440301|NCT00447057|7224332|FG002|Overall Study|Death due to adverse event|1
4440302|NCT00447057|7224333|FG003|Overall Study|Death due to adverse event|2
4440303|NCT00447057|7224330|FG000|Overall Study|Death, study drug related|0
4440304|NCT00447057|7224331|FG001|Overall Study|Death, study drug related|1
4440305|NCT00447057|7224332|FG002|Overall Study|Death, study drug related|0
4440306|NCT00447057|7224333|FG003|Overall Study|Death, study drug related|0
4440307|NCT00447226|7224354|FG000|12-Week Open-label Phase|Adverse Event|0
4440308|NCT00447226|7224355|FG001|12-Week Open-label Phase|Adverse Event|3
4440309|NCT00447226|7224354|FG000|12-Week Open-label Phase|Protocol Violation|0
4440310|NCT00447226|7224355|FG001|12-Week Open-label Phase|Protocol Violation|1
4440311|NCT00447226|7224354|FG000|12-Week Open-label Phase|Disease Progression|0
4440312|NCT00447226|7224355|FG001|12-Week Open-label Phase|Disease Progression|20
4440313|NCT00447226|7224354|FG000|12-Week Open-label Phase|Physician Decision|0
4440314|NCT00447226|7224355|FG001|12-Week Open-label Phase|Physician Decision|1
4440315|NCT00447226|7224354|FG000|Double-blind Phase|Disease Progression|4
4440316|NCT00447226|7224355|FG001|Double-blind Phase|Disease Progression|3
4440317|NCT00447265|7224370|FG000|Overall Study|Physician Decision|1
4440318|NCT00447265|7224371|FG001|Overall Study|Physician Decision|0
4440319|NCT00447278|7224377|FG000|Period II (6 Month Open-Label)|Adverse Event|7
4440320|NCT00447278|7224378|FG001|Period II (6 Month Open-Label)|Adverse Event|3
4440321|NCT00447278|7224377|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0
4440322|NCT00447278|7224378|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4
4440323|NCT00447278|7224377|FG000|Period II (6 Month Open-Label)|Protocol Violation|10
4440324|NCT00447278|7224378|FG001|Period II (6 Month Open-Label)|Protocol Violation|7
4440325|NCT00447278|7224377|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1
4440326|NCT00447278|7224378|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3
4440327|NCT00447278|7224377|FG000|Period II (6 Month Open-Label)|Physician Decision|4
4440328|NCT00447278|7224378|FG001|Period II (6 Month Open-Label)|Physician Decision|1
4440329|NCT00447278|7224377|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11
4440330|NCT00447278|7224378|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1
4440331|NCT00447278|7224377|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9
4440332|NCT00447278|7224378|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10
4440333|NCT00447278|7224377|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2
4440334|NCT00447278|7224378|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2
4440335|NCT00447278|7224377|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2
4440336|NCT00447278|7224378|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2
4440337|NCT00447278|7224377|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6
4440338|NCT00447278|7224378|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1
4440339|NCT00447278|7224377|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4
4440340|NCT00447278|7224378|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1
4440341|NCT00447278|7224377|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1
4440342|NCT00447278|7224378|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1
4440343|NCT00447278|7224377|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4
4440344|NCT00447278|7224378|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0
4440345|NCT00447278|7224377|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11
4440346|NCT00447278|7224378|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8
4512850|NCT00937833|7322895|FG001|Overall Study|Withdrawal by Subject|6
4512851|NCT00937950|7322910|FG000|Overall Study|Withdrawal by Subject|23
4512852|NCT00937950|7322910|FG000|Overall Study|Migrated/moved from study area|27
4512853|NCT00937950|7322910|FG000|Overall Study|Lost to Follow-up|144
4512854|NCT00937950|7322910|FG000|Overall Study|Missing confirmed|4
4512855|NCT00937950|7322910|FG000|Overall Study|Other|18
4512856|NCT00938015|7322914|FG000|Overall Study|Death|2
4512857|NCT00938015|7322914|FG000|Overall Study|Lost to Follow-up|32
4512858|NCT00938015|7322914|FG000|Overall Study|Adverse Event|32
4512859|NCT00938015|7322914|FG000|Overall Study|Non-responder|52
4440347|NCT00447382|7224392|FG000|Overall Study|Adverse Event|1
4440348|NCT00447382|7224393|FG001|Overall Study|Adverse Event|1
4440349|NCT00447382|7224392|FG000|Overall Study|Lack of Efficacy|1
4440350|NCT00447382|7224393|FG001|Overall Study|Lack of Efficacy|0
4440351|NCT00447382|7224392|FG000|Overall Study|Protocol Violation|2
4440352|NCT00447382|7224393|FG001|Overall Study|Protocol Violation|0
4440353|NCT00447382|7224392|FG000|Overall Study|Unclassified|2
4440354|NCT00447382|7224393|FG001|Overall Study|Unclassified|5
4440355|NCT00447499|7224399|FG000|Overall Study|Adverse Event|1
4440356|NCT00447499|7224399|FG000|Overall Study|Patient Decision|4
4440357|NCT00447499|7224399|FG000|Overall Study|Sponsor Decision|1
4440358|NCT00447499|7224399|FG000|Overall Study|Physician Decision|1
4440359|NCT00447590|7224405|FG000|Overall Study|Withdrawal by Subject|26
4440360|NCT00447590|7224405|FG000|Overall Study|Lost to Follow-up|24
4440361|NCT00447590|7224405|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10
4440362|NCT00447694|7224409|FG000|Overall Study|Adverse Event|2
4440363|NCT00447694|7224409|FG000|Overall Study|Abnormal laboratory value|1
4440364|NCT00447694|7224409|FG000|Overall Study|Abnormal test procedure result|1
4440365|NCT00447694|7224409|FG000|Overall Study|Withdrawal by Subject|2
4440366|NCT00447772|7224413|FG000|Overall Study|Lack of Efficacy|3
4440367|NCT00447772|7224413|FG000|Overall Study|Insufficient compliance|6
4440368|NCT00447772|7224413|FG000|Overall Study|Discontinuation of drug therapy|1
4440369|NCT00447772|7224413|FG000|Overall Study|Lost to Follow-up|9
4440370|NCT00447772|7224413|FG000|Overall Study|Withdrawal by Subject|1
4440371|NCT00447772|7224413|FG000|Overall Study|Unable to attend all study visits|2
4440372|NCT00447772|7224413|FG000|Overall Study|Adverse Event|1
4440373|NCT00447772|7224413|FG000|Overall Study|Patient relocated|1
4440374|NCT00447772|7224413|FG000|Overall Study|Incomplete documentation at visit 1|1
4440375|NCT00447772|7224413|FG000|Overall Study|Chemotherapy for lung cancer|1
4440376|NCT00447772|7224413|FG000|Overall Study|Premature re-injection required|1
4440377|NCT00447876|7224422|FG000|Overall Study|Withdrawal by Subject|1
4440378|NCT00447876|7224423|FG001|Overall Study|Withdrawal by Subject|4
4440379|NCT00447876|7224422|FG000|Overall Study|Lost to Follow-up|1
4440380|NCT00447876|7224423|FG001|Overall Study|Lost to Follow-up|0
4440381|NCT00447876|7224422|FG000|Overall Study|Deterioration of symptomology|1
4440382|NCT00447876|7224423|FG001|Overall Study|Deterioration of symptomology|0
4440383|NCT00447902|7224431|FG000|Overall Study|Adverse Event|0
4440384|NCT00447902|7224432|FG001|Overall Study|Adverse Event|3
4440385|NCT00447902|7224431|FG000|Overall Study|Protocol Violation|1
4440386|NCT00447902|7224432|FG001|Overall Study|Protocol Violation|0
4440387|NCT00447902|7224431|FG000|Overall Study|Withdrawal by Subject|0
4440388|NCT00447902|7224432|FG001|Overall Study|Withdrawal by Subject|1
4440389|NCT00447902|7224431|FG000|Overall Study|included patients who discontinued|1
4440390|NCT00447902|7224432|FG001|Overall Study|included patients who discontinued|1
4440391|NCT00447902|7224431|FG000|Overall Study|Lack of Efficacy|2
4440392|NCT00447902|7224432|FG001|Overall Study|Lack of Efficacy|1
4440393|NCT00448019|7224438|FG000|Overall Study|Withdrawal by Subject|3
4440394|NCT00448019|7224438|FG000|Overall Study|Disease progression|1
4440395|NCT00448019|7224438|FG000|Overall Study|Death|2
4440396|NCT00448019|7224438|FG000|Overall Study|Insurance Issues|1
4440397|NCT00448123|7224444|FG000|Overall Study|Lost to Follow-up|9
4440398|NCT00448123|7224445|FG001|Overall Study|Lost to Follow-up|6
4440399|NCT00448123|7224444|FG000|Overall Study|Physician Decision|6
4440400|NCT00448123|7224445|FG001|Overall Study|Physician Decision|6
4440401|NCT00448136|7224456|FG000|Overall Study|Death|3
4440402|NCT00448136|7224457|FG001|Overall Study|Death|8
4440403|NCT00448136|7224456|FG000|Overall Study|Investigator's decision (progression)|1
4440404|NCT00448136|7224457|FG001|Overall Study|Investigator's decision (progression)|0
4440405|NCT00448279|7224487|FG000|Overall Study|Lost to Follow-up|2
4440406|NCT00448279|7224488|FG001|Overall Study|Lost to Follow-up|2
4440407|NCT00448279|7224487|FG000|Overall Study|Adverse Event|1
4440408|NCT00448279|7224488|FG001|Overall Study|Adverse Event|1
4440409|NCT00448279|7224487|FG000|Overall Study|Disease progression|16
4440410|NCT00448279|7224488|FG001|Overall Study|Disease progression|18
4440411|NCT00448279|7224487|FG000|Overall Study|Withdrawal by Subject|4
4440412|NCT00448279|7224488|FG001|Overall Study|Withdrawal by Subject|3
4440413|NCT00448279|7224487|FG000|Overall Study|Other|6
4440414|NCT00448279|7224488|FG001|Overall Study|Other|4
4440415|NCT00448279|7224487|FG000|Overall Study|Protocol Violation|0
4440416|NCT00448279|7224488|FG001|Overall Study|Protocol Violation|1
4440417|NCT00448344|7224496|FG000|Overall Study|Lost to Follow-up|20
4630325|NCT01296711|7498860|FG003|Overall Study|Withdrawal by Subject|1
4630326|NCT01296711|7498861|FG004|Overall Study|Withdrawal by Subject|1
4630327|NCT01296711|7498862|FG005|Overall Study|Withdrawal by Subject|1
4630328|NCT01296711|7498863|FG006|Overall Study|Withdrawal by Subject|2
4630329|NCT01296711|7498864|FG007|Overall Study|Withdrawal by Subject|1
4630330|NCT01296711|7498857|FG000|Overall Study|Study termination|8
4630331|NCT01296711|7498858|FG001|Overall Study|Study termination|1
4440418|NCT00448344|7224497|FG001|Overall Study|Lost to Follow-up|22
4440419|NCT00448344|7224496|FG000|Overall Study|Withdrawal by Subject|6
4440420|NCT00448344|7224497|FG001|Overall Study|Withdrawal by Subject|8
4440421|NCT00448344|7224496|FG000|Overall Study|Death|3
4630332|NCT01296711|7498859|FG002|Overall Study|Study termination|5
4440422|NCT00448344|7224497|FG001|Overall Study|Death|4
4440423|NCT00448344|7224496|FG000|Overall Study|Physician Decision|1
4630333|NCT01296711|7498860|FG003|Overall Study|Study termination|4
4630334|NCT01296711|7498861|FG004|Overall Study|Study termination|4
4630335|NCT01296711|7498862|FG005|Overall Study|Study termination|4
4630336|NCT01296711|7498863|FG006|Overall Study|Study termination|8
4440424|NCT00448344|7224497|FG001|Overall Study|Physician Decision|2
4440425|NCT00448435|7224519|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1
4440426|NCT00448435|7224520|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0
4440427|NCT00448448|7224531|FG000|Overall Study|Withdrawal by Subject|13
4440428|NCT00448448|7224532|FG001|Overall Study|Withdrawal by Subject|2
4440429|NCT00448448|7224531|FG000|Overall Study|On protocol when study ended|83
4440430|NCT00448448|7224532|FG001|Overall Study|On protocol when study ended|36
4440431|NCT00448448|7224531|FG000|Overall Study|Lost to Follow-up|2
4440432|NCT00448448|7224532|FG001|Overall Study|Lost to Follow-up|1
4440433|NCT00448448|7224531|FG000|Overall Study|Wrong diagnosis (n=3) or other|2
4440434|NCT00448448|7224532|FG001|Overall Study|Wrong diagnosis (n=3) or other|1
4440435|NCT00448448|7224531|FG000|Overall Study|Signed consent lost|0
4440436|NCT00448448|7224532|FG001|Overall Study|Signed consent lost|1
4440437|NCT00448539|7224540|FG000|Overall Study|Medication non-compliance|4
4440438|NCT00448539|7224541|FG001|Overall Study|Medication non-compliance|1
4440439|NCT00448539|7224540|FG000|Overall Study|Protocol Violation|1
4440440|NCT00448539|7224541|FG001|Overall Study|Protocol Violation|0
4440441|NCT00448539|7224540|FG000|Overall Study|Request of the investigator or sponsor|67
4440442|NCT00448539|7224541|FG001|Overall Study|Request of the investigator or sponsor|54
4440443|NCT00448539|7224540|FG000|Overall Study|Withdrawal by Subject|20
4440444|NCT00448539|7224541|FG001|Overall Study|Withdrawal by Subject|24
4440445|NCT00448539|7224540|FG000|Overall Study|Diary non-compliance|1
4440446|NCT00448539|7224541|FG001|Overall Study|Diary non-compliance|0
4440447|NCT00448539|7224540|FG000|Overall Study|Adverse Event|9
4440448|NCT00448539|7224541|FG001|Overall Study|Adverse Event|26
4440449|NCT00448539|7224540|FG000|Overall Study|Lack of Efficacy|27
4440450|NCT00448539|7224541|FG001|Overall Study|Lack of Efficacy|40
4440451|NCT00448539|7224540|FG000|Overall Study|Miscellaneous|2
4440452|NCT00448539|7224541|FG001|Overall Study|Miscellaneous|1
4440453|NCT00448539|7224540|FG000|Overall Study|Change of meds|2
4440454|NCT00448539|7224541|FG001|Overall Study|Change of meds|3
4440455|NCT00448539|7224540|FG000|Overall Study|Lost to Follow-up|1
4440456|NCT00448539|7224541|FG001|Overall Study|Lost to Follow-up|3
4440457|NCT00448591|7224547|FG000|Overall Study|Withdrawal by Subject|178
4440458|NCT00448591|7224547|FG000|Overall Study|Progressive Disease|1382
4440459|NCT00448591|7224547|FG000|Overall Study|Adverse Event|382
4440460|NCT00448591|7224547|FG000|Overall Study|Protocol Violation|41
4440461|NCT00448591|7224547|FG000|Overall Study|Lost to Follow-up|19
4440462|NCT00448591|7224547|FG000|Overall Study|Treatment Regimen Completed|70
4440463|NCT00448591|7224547|FG000|Overall Study|Other|154
4440464|NCT00448591|7224547|FG000|Overall Study|Termination of Study|70
4440465|NCT00448669|7224572|FG000|Overall Study|Lost to Follow-up|52
4440466|NCT00448669|7224573|FG001|Overall Study|Lost to Follow-up|63
4440467|NCT00448669|7224572|FG000|Overall Study|Withdrawal by Subject|90
4440468|NCT00448669|7224573|FG001|Overall Study|Withdrawal by Subject|74
4440469|NCT00448669|7224572|FG000|Overall Study|Relocated|49
4440470|NCT00448669|7224573|FG001|Overall Study|Relocated|36
4440471|NCT00448669|7224572|FG000|Overall Study|Were withdrawn by investigator|10
4440472|NCT00448669|7224573|FG001|Overall Study|Were withdrawn by investigator|6
4440473|NCT00448669|7224572|FG000|Overall Study|Death|2
4440474|NCT00448669|7224573|FG001|Overall Study|Death|4
4440475|NCT00448669|7224572|FG000|Overall Study|Had other reasons|5
4440476|NCT00448669|7224573|FG001|Overall Study|Had other reasons|6
4440477|NCT00448669|7224572|FG000|Overall Study|HIV-infected at enrollment|1
4440478|NCT00448669|7224573|FG001|Overall Study|HIV-infected at enrollment|2
4440479|NCT00448669|7224572|FG000|Overall Study|Never started drug|9
4440480|NCT00448669|7224573|FG001|Overall Study|Never started drug|7
4440481|NCT00448708|7224583|FG000|Overall Study|Death|21
4440482|NCT00448708|7224584|FG001|Overall Study|Death|17
4440483|NCT00448708|7224583|FG000|Overall Study|Withdrawal by Subject|8
4440484|NCT00448708|7224584|FG001|Overall Study|Withdrawal by Subject|4
4440485|NCT00448708|7224583|FG000|Overall Study|Lost to Follow-up|6
4440486|NCT00448708|7224584|FG001|Overall Study|Lost to Follow-up|8
4440487|NCT00448708|7224583|FG000|Overall Study|not listed|0
4440488|NCT00448708|7224584|FG001|Overall Study|not listed|2
4440489|NCT00448747|7224592|FG000|Overall Study|collapsed veins|1
4440490|NCT00448747|7224593|FG001|Overall Study|collapsed veins|0
4440491|NCT00448760|7224609|FG000|Overall Study|Death|3
4440492|NCT00448812|7224615|FG000|Year 2|Missed visit but remained in study|4
4440493|NCT00448812|7224616|FG001|Year 2|Missed visit but remained in study|1
4440494|NCT00448812|7224615|FG000|Year 3|Withdrawal by Subject|1
4440495|NCT00448812|7224616|FG001|Year 3|Withdrawal by Subject|3
4440496|NCT00448812|7224615|FG000|Year 3|Lost to Follow-up|1
4440497|NCT00448812|7224616|FG001|Year 3|Lost to Follow-up|0
4440498|NCT00448812|7224615|FG000|Year 3|Missed visit but remained in study|2
4440499|NCT00448812|7224616|FG001|Year 3|Missed visit but remained in study|0
4440500|NCT00448812|7224615|FG000|Year 5|Missed visit but remained in study|1
4630337|NCT01296711|7498864|FG007|Overall Study|Study termination|10
4440501|NCT00448812|7224616|FG001|Year 5|Missed visit but remained in study|0
4440502|NCT00448864|7224637|FG000|Overall Study|Death|1
4440503|NCT00448864|7224638|FG001|Overall Study|Death|0
4440504|NCT00448864|7224639|FG002|Overall Study|Death|0
4440505|NCT00448864|7224637|FG000|Overall Study|Lost to Follow-up|3
4440506|NCT00448864|7224638|FG001|Overall Study|Lost to Follow-up|1
4440507|NCT00448864|7224639|FG002|Overall Study|Lost to Follow-up|0
4440508|NCT00448864|7224637|FG000|Overall Study|Physician Decision|1
4440509|NCT00448864|7224638|FG001|Overall Study|Physician Decision|0
4440510|NCT00448864|7224639|FG002|Overall Study|Physician Decision|1
4440511|NCT00448864|7224637|FG000|Overall Study|Withdrawal by Subject|0
4440512|NCT00448864|7224638|FG001|Overall Study|Withdrawal by Subject|2
4440513|NCT00448864|7224639|FG002|Overall Study|Withdrawal by Subject|0
4440514|NCT00448864|7224637|FG000|Overall Study|Protocol Violation|0
4440515|NCT00448864|7224638|FG001|Overall Study|Protocol Violation|2
4440516|NCT00448864|7224639|FG002|Overall Study|Protocol Violation|0
4440517|NCT00448916|7224653|FG000|Overall Study|Adverse Event|2
4440518|NCT00448916|7224654|FG001|Overall Study|Adverse Event|2
4440519|NCT00448916|7224655|FG002|Overall Study|Adverse Event|3
4440520|NCT00448916|7224656|FG003|Overall Study|Adverse Event|2
4440521|NCT00448916|7224653|FG000|Overall Study|Lack of Efficacy|1
4440522|NCT00448916|7224654|FG001|Overall Study|Lack of Efficacy|0
4440523|NCT00448916|7224655|FG002|Overall Study|Lack of Efficacy|2
4440524|NCT00448916|7224656|FG003|Overall Study|Lack of Efficacy|1
4440525|NCT00448916|7224653|FG000|Overall Study|Withdrawal by Subject|3
4440526|NCT00448916|7224654|FG001|Overall Study|Withdrawal by Subject|3
4440527|NCT00448916|7224655|FG002|Overall Study|Withdrawal by Subject|1
4440528|NCT00448916|7224656|FG003|Overall Study|Withdrawal by Subject|1
4440529|NCT00448916|7224653|FG000|Overall Study|Other|1
4440530|NCT00448916|7224654|FG001|Overall Study|Other|0
4440531|NCT00448916|7224655|FG002|Overall Study|Other|0
4440532|NCT00448916|7224656|FG003|Overall Study|Other|0
4440533|NCT00448916|7224653|FG000|Overall Study|Lost to Follow-up|0
4440534|NCT00448916|7224654|FG001|Overall Study|Lost to Follow-up|1
4440535|NCT00448916|7224655|FG002|Overall Study|Lost to Follow-up|0
4440536|NCT00448916|7224656|FG003|Overall Study|Lost to Follow-up|1
4440537|NCT00448916|7224653|FG000|Overall Study|Protocol Violation|0
4440538|NCT00448916|7224654|FG001|Overall Study|Protocol Violation|0
4440539|NCT00448916|7224655|FG002|Overall Study|Protocol Violation|0
4440540|NCT00448916|7224656|FG003|Overall Study|Protocol Violation|1
4440541|NCT00449033|7224681|FG000|Treatment Period|Adverse Event|117
4440542|NCT00449033|7224682|FG001|Treatment Period|Adverse Event|83
4440543|NCT00449033|7224681|FG000|Treatment Period|Death|21
4440544|NCT00449033|7224682|FG001|Treatment Period|Death|12
4440545|NCT00449033|7224681|FG000|Treatment Period|Lost to Follow-up|0
4440546|NCT00449033|7224682|FG001|Treatment Period|Lost to Follow-up|2
4440547|NCT00449033|7224681|FG000|Treatment Period|Physician Decision|4
4440548|NCT00449033|7224682|FG001|Treatment Period|Physician Decision|5
4440549|NCT00449033|7224681|FG000|Treatment Period|Protocol Violation|8
4440550|NCT00449033|7224682|FG001|Treatment Period|Protocol Violation|7
4440551|NCT00449033|7224681|FG000|Treatment Period|Disease Progression|231
4440552|NCT00449033|7224682|FG001|Treatment Period|Disease Progression|288
4440553|NCT00449033|7224681|FG000|Treatment Period|Consent Withdrawn|36
4440554|NCT00449033|7224682|FG001|Treatment Period|Consent Withdrawn|20
4440555|NCT00449033|7224681|FG000|Treatment Period|Amended Protocol Criteria|22
4440556|NCT00449033|7224682|FG001|Treatment Period|Amended Protocol Criteria|18
4440557|NCT00449033|7224681|FG000|Treatment Period|Non-compliance|7
4440558|NCT00449033|7224682|FG001|Treatment Period|Non-compliance|8
4440559|NCT00449033|7224681|FG000|Treatment Period|Second Malignancy|0
4440560|NCT00449033|7224682|FG001|Treatment Period|Second Malignancy|1
4440561|NCT00449033|7224681|FG000|Treatment Period|Reason Missing|0
4440562|NCT00449033|7224682|FG001|Treatment Period|Reason Missing|4
4440563|NCT00449033|7224681|FG000|Treatment Period|Treatment Ongoing|6
4440564|NCT00449033|7224682|FG001|Treatment Period|Treatment Ongoing|4
4440565|NCT00449033|7224681|FG000|Follow-up Period|Death|299
4440566|NCT00449033|7224682|FG001|Follow-up Period|Death|311
4440567|NCT00449033|7224681|FG000|Follow-up Period|Lost to Follow-up|6
4440568|NCT00449033|7224682|FG001|Follow-up Period|Lost to Follow-up|10
4440569|NCT00449033|7224681|FG000|Follow-up Period|Reason Missing|120
4440570|NCT00449033|7224682|FG001|Follow-up Period|Reason Missing|113
4440571|NCT00449072|7224694|FG000|Overall Study|Adverse Event|3
4440572|NCT00449072|7224695|FG001|Overall Study|Adverse Event|1
4440573|NCT00449072|7224694|FG000|Overall Study|Protocol Violation|14
4440574|NCT00449072|7224695|FG001|Overall Study|Protocol Violation|12
4440575|NCT00449072|7224694|FG000|Overall Study|Lost to Follow-up|5
4440576|NCT00449072|7224695|FG001|Overall Study|Lost to Follow-up|7
4440577|NCT00449072|7224694|FG000|Overall Study|Withdrawal by Subject|11
4440578|NCT00449072|7224695|FG001|Overall Study|Withdrawal by Subject|8
4440579|NCT00449072|7224694|FG000|Overall Study|Lack of Efficacy|1
4440580|NCT00449072|7224695|FG001|Overall Study|Lack of Efficacy|1
4440581|NCT00449072|7224694|FG000|Overall Study|Physician Decision|1
4440582|NCT00449072|7224695|FG001|Overall Study|Physician Decision|0
4440583|NCT00449072|7224694|FG000|Overall Study|Not treated|0
4440584|NCT00449072|7224695|FG001|Overall Study|Not treated|1
4440585|NCT00449072|7224694|FG000|Overall Study|Excluded medication|0
4440586|NCT00449072|7224695|FG001|Overall Study|Excluded medication|2
4440587|NCT00449072|7224694|FG000|Overall Study|Non-compliance|2
4440588|NCT00449072|7224695|FG001|Overall Study|Non-compliance|5
4440589|NCT00449072|7224694|FG000|Overall Study|Sponsor decision|1
4440590|NCT00449072|7224695|FG001|Overall Study|Sponsor decision|3
4440591|NCT00449072|7224694|FG000|Overall Study|Relocation|3
4440592|NCT00449072|7224695|FG001|Overall Study|Relocation|2
4440593|NCT00449150|7224704|FG000|Overall Study|Adverse Event|11
4440594|NCT00449150|7224705|FG001|Overall Study|Adverse Event|18
4440595|NCT00449150|7224706|FG002|Overall Study|Adverse Event|9
4440596|NCT00449150|7224704|FG000|Overall Study|Lack of Efficacy|1
4440597|NCT00449150|7224705|FG001|Overall Study|Lack of Efficacy|2
4440598|NCT00449150|7224706|FG002|Overall Study|Lack of Efficacy|2
4440599|NCT00449150|7224704|FG000|Overall Study|Other|16
4440600|NCT00449150|7224705|FG001|Overall Study|Other|13
4440601|NCT00449150|7224706|FG002|Overall Study|Other|14
4440602|NCT00449150|7224704|FG000|Overall Study|Withdrawal by Subject|17
4440603|NCT00449150|7224705|FG001|Overall Study|Withdrawal by Subject|18
4440604|NCT00449150|7224706|FG002|Overall Study|Withdrawal by Subject|21
4440605|NCT00449150|7224704|FG000|Overall Study|Protocol Violation|1
4440606|NCT00449150|7224705|FG001|Overall Study|Protocol Violation|2
4440607|NCT00449150|7224706|FG002|Overall Study|Protocol Violation|1
4440608|NCT00449163|7224717|FG000|Overall Study|Physician Decision|3
4440609|NCT00449176|7224724|FG000|Overall Study|Withdrawal by Subject|39
4440610|NCT00449176|7224725|FG001|Overall Study|Withdrawal by Subject|43
4440611|NCT00449176|7224726|FG002|Overall Study|Withdrawal by Subject|59
4440612|NCT00449176|7224724|FG000|Overall Study|Lost to Follow-up|13
4440613|NCT00449176|7224725|FG001|Overall Study|Lost to Follow-up|8
4440614|NCT00449176|7224726|FG002|Overall Study|Lost to Follow-up|12
4440615|NCT00449176|7224724|FG000|Overall Study|Adverse Event|51
4440616|NCT00449176|7224725|FG001|Overall Study|Adverse Event|107
4440617|NCT00449176|7224726|FG002|Overall Study|Adverse Event|15
4440618|NCT00449176|7224724|FG000|Overall Study|Lack of Efficacy|13
4440619|NCT00449176|7224725|FG001|Overall Study|Lack of Efficacy|7
4440620|NCT00449176|7224726|FG002|Overall Study|Lack of Efficacy|50
4440621|NCT00449176|7224724|FG000|Overall Study|Study drug non-compliant|14
4440622|NCT00449176|7224725|FG001|Overall Study|Study drug non-compliant|11
4440623|NCT00449176|7224726|FG002|Overall Study|Study drug non-compliant|11
4440624|NCT00449176|7224724|FG000|Overall Study|all other|22
4440625|NCT00449176|7224725|FG001|Overall Study|all other|19
4440626|NCT00449176|7224726|FG002|Overall Study|all other|20
4440627|NCT00449540|7224736|FG000|Pretreatment Phase|No migraine experienced|66
4440628|NCT00449540|7224737|FG001|Pretreatment Phase|No migraine experienced|0
4440629|NCT00449540|7224738|FG002|Pretreatment Phase|No migraine experienced|0
4440630|NCT00449540|7224736|FG000|Treatment Phase|did not experience or treat migraine|0
4440631|NCT00449540|7224737|FG001|Treatment Phase|did not experience or treat migraine|20
4440632|NCT00449540|7224738|FG002|Treatment Phase|did not experience or treat migraine|17
4440633|NCT00449644|7224750|FG000|Overall Study|Adverse Event|0
4440634|NCT00449644|7224751|FG001|Overall Study|Adverse Event|0
4440635|NCT00449644|7224752|FG002|Overall Study|Adverse Event|3
4440636|NCT00449644|7224753|FG003|Overall Study|Adverse Event|5
4440637|NCT00449644|7224750|FG000|Overall Study|Death|1
4440638|NCT00449644|7224751|FG001|Overall Study|Death|0
4440639|NCT00449644|7224752|FG002|Overall Study|Death|6
4440640|NCT00449644|7224753|FG003|Overall Study|Death|1
4440641|NCT00449644|7224750|FG000|Overall Study|Lost to Follow-up|1
4440642|NCT00449644|7224751|FG001|Overall Study|Lost to Follow-up|1
4440643|NCT00449644|7224752|FG002|Overall Study|Lost to Follow-up|5
4440644|NCT00449644|7224753|FG003|Overall Study|Lost to Follow-up|3
4440645|NCT00449644|7224750|FG000|Overall Study|Pregnancy|0
4440646|NCT00449644|7224751|FG001|Overall Study|Pregnancy|0
4440647|NCT00449644|7224752|FG002|Overall Study|Pregnancy|3
4440648|NCT00449644|7224753|FG003|Overall Study|Pregnancy|2
4440649|NCT00449644|7224750|FG000|Overall Study|Protocol Violation|4
4440650|NCT00449644|7224751|FG001|Overall Study|Protocol Violation|4
4440651|NCT00449644|7224752|FG002|Overall Study|Protocol Violation|3
4440652|NCT00449644|7224753|FG003|Overall Study|Protocol Violation|7
4440653|NCT00449644|7224750|FG000|Overall Study|Withdrawal by Subject|3
4440654|NCT00449644|7224751|FG001|Overall Study|Withdrawal by Subject|4
4440655|NCT00449644|7224752|FG002|Overall Study|Withdrawal by Subject|6
4440656|NCT00449644|7224753|FG003|Overall Study|Withdrawal by Subject|7
4440657|NCT00449644|7224750|FG000|Overall Study|Inclusion/exclusion criteria not met|0
4440658|NCT00449644|7224751|FG001|Overall Study|Inclusion/exclusion criteria not met|0
4440659|NCT00449644|7224752|FG002|Overall Study|Inclusion/exclusion criteria not met|2
4440660|NCT00449644|7224753|FG003|Overall Study|Inclusion/exclusion criteria not met|6
4440661|NCT00449644|7224750|FG000|Overall Study|Other|1
4440662|NCT00449644|7224751|FG001|Overall Study|Other|4
4440663|NCT00449644|7224752|FG002|Overall Study|Other|1
4440664|NCT00449644|7224753|FG003|Overall Study|Other|0
4440665|NCT00449644|7224750|FG000|Overall Study|Rolled-over to treatment with TMC207|0
4440666|NCT00449644|7224751|FG001|Overall Study|Rolled-over to treatment with TMC207|0
4440667|NCT00449644|7224752|FG002|Overall Study|Rolled-over to treatment with TMC207|0
4440668|NCT00449644|7224753|FG003|Overall Study|Rolled-over to treatment with TMC207|1
4440669|NCT00449670|7224768|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1
4440670|NCT00449670|7224769|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0
4440671|NCT00449670|7224768|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4
4440672|NCT00449670|7224769|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0
4440673|NCT00449670|7224768|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4
4440674|NCT00449670|7224769|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1
4440675|NCT00449670|7224768|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5
4440676|NCT00449670|7224769|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1
4440677|NCT00449670|7224768|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0
4440678|NCT00449670|7224769|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1
4440679|NCT00449670|7224768|FG000|Booster Phase (Study no.109873)|Other|0
4440680|NCT00449670|7224769|FG001|Booster Phase (Study no.109873)|Other|2
4440681|NCT00449696|7224784|FG000|Overall Study|Other Treatment Required|6
4440682|NCT00449696|7224785|FG001|Overall Study|Other Treatment Required|1
4440683|NCT00449696|7224784|FG000|Overall Study|Withdrawal by Subject|5
4440684|NCT00449696|7224785|FG001|Overall Study|Withdrawal by Subject|5
4440685|NCT00449696|7224784|FG000|Overall Study|Lost to Follow-up|2
4440686|NCT00449696|7224785|FG001|Overall Study|Lost to Follow-up|3
4440687|NCT00449696|7224784|FG000|Overall Study|Others|7
4440688|NCT00449696|7224785|FG001|Overall Study|Others|0
4440689|NCT00449761|7224795|FG000|Overall Study|Disease progression|12
4440690|NCT00449761|7224795|FG000|Overall Study|Death|5
4440691|NCT00449761|7224795|FG000|Overall Study|New cancer therapy|1
4440692|NCT00449787|7224802|FG000|Overall Study|Lost to Follow-up|10
4440693|NCT00449787|7224803|FG001|Overall Study|Lost to Follow-up|8
4440694|NCT00449787|7224802|FG000|Overall Study|Did not require medication|95
4440695|NCT00449787|7224803|FG001|Overall Study|Did not require medication|92
4440696|NCT00449865|7224813|FG000|Overall Study|Withdrawal by Subject|110
4440697|NCT00449865|7224814|FG001|Overall Study|Withdrawal by Subject|110
4440698|NCT00449865|7224813|FG000|Overall Study|Lost to Follow-up|36
4440699|NCT00449865|7224814|FG001|Overall Study|Lost to Follow-up|37
4440700|NCT00449865|7224813|FG000|Overall Study|Physician Decision|13
4440701|NCT00449865|7224814|FG001|Overall Study|Physician Decision|12
4440702|NCT00449865|7224813|FG000|Overall Study|Death|31
4440703|NCT00449865|7224814|FG001|Overall Study|Death|40
4440704|NCT00449865|7224813|FG000|Overall Study|Protocol Violation|8
4440705|NCT00449865|7224814|FG001|Overall Study|Protocol Violation|7
4440706|NCT00449865|7224813|FG000|Overall Study|Study was stopped|324
4440707|NCT00449865|7224814|FG001|Overall Study|Study was stopped|328
4440708|NCT00449930|7224822|FG000|Overall Study|Adverse Event|9
4440709|NCT00449930|7224823|FG001|Overall Study|Adverse Event|19
4440710|NCT00449930|7224822|FG000|Overall Study|Trial Terminated ( Site Closed)|1
4440711|NCT00449930|7224823|FG001|Overall Study|Trial Terminated ( Site Closed)|0
4440712|NCT00449930|7224822|FG000|Overall Study|Lack of Efficacy|10
4440713|NCT00449930|7224823|FG001|Overall Study|Lack of Efficacy|1
4440714|NCT00449930|7224822|FG000|Overall Study|Lost to Follow-up|9
4440715|NCT00449930|7224823|FG001|Overall Study|Lost to Follow-up|14
4440716|NCT00449930|7224822|FG000|Overall Study|Physician Decision|1
4440717|NCT00449930|7224823|FG001|Overall Study|Physician Decision|2
4440718|NCT00449930|7224822|FG000|Overall Study|Protocol Violation|14
4440719|NCT00449930|7224823|FG001|Overall Study|Protocol Violation|15
4440720|NCT00449930|7224822|FG000|Overall Study|Withdrawal by Subject|16
4440721|NCT00449930|7224823|FG001|Overall Study|Withdrawal by Subject|23
4440722|NCT00449930|7224822|FG000|Overall Study|Glycemic discontinuation criteria|1
4440723|NCT00449930|7224823|FG001|Overall Study|Glycemic discontinuation criteria|1
4440724|NCT00449956|7224832|FG000|Overall Study|Adverse Event|7
4440725|NCT00449956|7224833|FG001|Overall Study|Adverse Event|1
4440726|NCT00449956|7224834|FG002|Overall Study|Adverse Event|6
4440727|NCT00449956|7224832|FG000|Overall Study|Lack of Efficacy|0
4440728|NCT00449956|7224833|FG001|Overall Study|Lack of Efficacy|0
4440729|NCT00449956|7224834|FG002|Overall Study|Lack of Efficacy|1
4440730|NCT00449956|7224832|FG000|Overall Study|Protocol Violation|1
4440731|NCT00449956|7224833|FG001|Overall Study|Protocol Violation|1
4440732|NCT00449956|7224834|FG002|Overall Study|Protocol Violation|1
4440733|NCT00449956|7224832|FG000|Overall Study|Withdrawal by Subject|0
4440734|NCT00449956|7224833|FG001|Overall Study|Withdrawal by Subject|1
4440735|NCT00449956|7224834|FG002|Overall Study|Withdrawal by Subject|0
4440736|NCT00449956|7224832|FG000|Overall Study|Physician Decision|2
4440737|NCT00449956|7224833|FG001|Overall Study|Physician Decision|1
4440738|NCT00449956|7224834|FG002|Overall Study|Physician Decision|1
4440739|NCT00450112|7224857|FG000|Overall Study|Other Treatment Required|5
4440740|NCT00450112|7224858|FG001|Overall Study|Other Treatment Required|1
4440741|NCT00450112|7224857|FG000|Overall Study|Withdrawal by Subject|4
4440742|NCT00450112|7224858|FG001|Overall Study|Withdrawal by Subject|1
4440743|NCT00450112|7224857|FG000|Overall Study|Lost to Follow-up|2
4440744|NCT00450112|7224858|FG001|Overall Study|Lost to Follow-up|1
4440745|NCT00450112|7224857|FG000|Overall Study|Others|2
4440746|NCT00450112|7224858|FG001|Overall Study|Others|3
4440747|NCT00450177|7224866|FG000|Overall Study|Adverse Event|7
4440748|NCT00450177|7224867|FG001|Overall Study|Adverse Event|4
4440749|NCT00450177|7224866|FG000|Overall Study|Withdrawal by Subject|1
4440750|NCT00450177|7224867|FG001|Overall Study|Withdrawal by Subject|6
4440751|NCT00450177|7224866|FG000|Overall Study|Withdrawal by Primary Team|1
4440752|NCT00450177|7224867|FG001|Overall Study|Withdrawal by Primary Team|1
4440753|NCT00450190|7224873|FG000|Overall Study|Withdrawal by Subject|2
4440754|NCT00450216|7224879|FG000|Overall Study|Adverse Event|38
4440755|NCT00450216|7224880|FG001|Overall Study|Adverse Event|23
4440756|NCT00450216|7224879|FG000|Overall Study|Withdrawal by Subject|48
4440757|NCT00450216|7224880|FG001|Overall Study|Withdrawal by Subject|26
4440758|NCT00450216|7224879|FG000|Overall Study|Lost to Follow-up|16
4440759|NCT00450216|7224880|FG001|Overall Study|Lost to Follow-up|9
4440760|NCT00450216|7224879|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51
4440761|NCT00450216|7224880|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51
4440762|NCT00450216|7224879|FG000|Overall Study|misc|21
4440763|NCT00450216|7224880|FG001|Overall Study|misc|20
4440764|NCT00450255|7224897|FG000|Overall Study|Prior RFA ablation of liver|1
4440765|NCT00450372|7224907|FG000|Overall Study|Physician Decision|1
4440766|NCT00450385|7224914|FG000|Overall Study|Death|3
4440767|NCT00450385|7224914|FG000|Overall Study|Protocol Violation|1
4440768|NCT00450385|7224914|FG000|Overall Study|Withdrawal by Subject|2
4440769|NCT00450385|7224914|FG000|Overall Study|Lack of Efficacy|2
4440770|NCT00450385|7224914|FG000|Overall Study|Adverse Event|1
4440771|NCT00450385|7224914|FG000|Overall Study|Physician Decision|1
4440772|NCT00450385|7224914|FG000|Overall Study|Other|3
4440773|NCT00450411|7224919|FG000|Overall Study|Protocol Violation|6
4440774|NCT00450411|7224919|FG000|Overall Study|No protocol treatment|2
4440775|NCT00450437|7224934|FG000|Overall Study|Withdrawal by Subject|10
4440776|NCT00450437|7224935|FG001|Overall Study|Withdrawal by Subject|2
4440777|NCT00450437|7224936|FG002|Overall Study|Withdrawal by Subject|0
4440778|NCT00450437|7224937|FG003|Overall Study|Withdrawal by Subject|1
4440779|NCT00450437|7224934|FG000|Overall Study|Lost to Follow-up|31
4440780|NCT00450437|7224935|FG001|Overall Study|Lost to Follow-up|12
4440781|NCT00450437|7224936|FG002|Overall Study|Lost to Follow-up|19
4440782|NCT00450437|7224937|FG003|Overall Study|Lost to Follow-up|9
4440783|NCT00450437|7224934|FG000|Overall Study|Protocol Violation|0
4440784|NCT00450437|7224935|FG001|Overall Study|Protocol Violation|1
4440785|NCT00450437|7224936|FG002|Overall Study|Protocol Violation|0
4440786|NCT00450437|7224937|FG003|Overall Study|Protocol Violation|1
4440787|NCT00450437|7224934|FG000|Overall Study|Inappropriate enrollment|4
4440788|NCT00450437|7224935|FG001|Overall Study|Inappropriate enrollment|1
4440789|NCT00450437|7224936|FG002|Overall Study|Inappropriate enrollment|3
4440790|NCT00450437|7224937|FG003|Overall Study|Inappropriate enrollment|0
4440791|NCT00450437|7224934|FG000|Overall Study|Administrative reason|0
4440792|NCT00450437|7224935|FG001|Overall Study|Administrative reason|0
4440793|NCT00450437|7224936|FG002|Overall Study|Administrative reason|1
4440794|NCT00450437|7224937|FG003|Overall Study|Administrative reason|0
4440795|NCT00450437|7224934|FG000|Overall Study|Unable to Classify|1
4440796|NCT00450437|7224935|FG001|Overall Study|Unable to Classify|0
4440797|NCT00450437|7224936|FG002|Overall Study|Unable to Classify|1
4440798|NCT00450437|7224937|FG003|Overall Study|Unable to Classify|0
4771724|NCT00261807|7748574|FG000|Overall Study|Protocol Violation|2
4440805|NCT00450580|7224974|FG000|Overall Study|Adverse Event|5
4440806|NCT00450580|7224975|FG001|Overall Study|Adverse Event|7
4440807|NCT00450580|7224974|FG000|Overall Study|Lost to Follow-up|4
4440808|NCT00450580|7224975|FG001|Overall Study|Lost to Follow-up|5
4440809|NCT00450580|7224974|FG000|Overall Study|Withdrawal by Subject|2
4440810|NCT00450580|7224975|FG001|Overall Study|Withdrawal by Subject|2
4440811|NCT00450580|7224974|FG000|Overall Study|Protocol Violation|1
4440812|NCT00450580|7224975|FG001|Overall Study|Protocol Violation|1
4440813|NCT00450580|7224974|FG000|Overall Study|Protocol-defined virologic failure|1
4440814|NCT00450580|7224975|FG001|Overall Study|Protocol-defined virologic failure|0
4440815|NCT00450580|7224974|FG000|Overall Study|Could not comply with scheduled visits|1
4440816|NCT00450580|7224975|FG001|Overall Study|Could not comply with scheduled visits|0
4440817|NCT00450580|7224974|FG000|Overall Study|Patient went to Brazil|1
4440818|NCT00450580|7224975|FG001|Overall Study|Patient went to Brazil|0
4440819|NCT00450580|7224974|FG000|Overall Study|Patient could not swallow Norvir|1
4440820|NCT00450580|7224975|FG001|Overall Study|Patient could not swallow Norvir|0
4440821|NCT00450580|7224974|FG000|Overall Study|Withdrawal due to pregnancy|0
4440822|NCT00450580|7224975|FG001|Overall Study|Withdrawal due to pregnancy|1
4440823|NCT00450619|7224983|FG000|Overall Study|refused treatment after randomization|2
4440824|NCT00450619|7224984|FG001|Overall Study|refused treatment after randomization|0
4440825|NCT00450619|7224983|FG000|Overall Study|did not progress; refused further trmt|1
4440826|NCT00450619|7224984|FG001|Overall Study|did not progress; refused further trmt|1
4440827|NCT00450619|7224983|FG000|Overall Study|Adverse Event|1
4440828|NCT00450619|7224984|FG001|Overall Study|Adverse Event|0
4440829|NCT00450658|7224993|FG000|Overall Study|Adverse Event|24
4440830|NCT00450658|7224994|FG001|Overall Study|Adverse Event|15
4440831|NCT00450658|7224993|FG000|Overall Study|Withdrawal by Subject|43
4440832|NCT00450658|7224994|FG001|Overall Study|Withdrawal by Subject|26
4440833|NCT00450658|7224993|FG000|Overall Study|Lost to Follow-up|22
4440834|NCT00450658|7224994|FG001|Overall Study|Lost to Follow-up|5
4440835|NCT00450658|7224993|FG000|Overall Study|UGI ulcer|33
4440836|NCT00450658|7224994|FG001|Overall Study|UGI ulcer|34
4440837|NCT00450658|7224993|FG000|Overall Study|misc|21
4440838|NCT00450658|7224994|FG001|Overall Study|misc|10
4440839|NCT00450723|7225000|FG000|Overall Study|Physician Decision|5
4440840|NCT00450749|7225008|FG000|Overall Study|Withdrawal by Subject|0
4440841|NCT00450749|7225009|FG001|Overall Study|Withdrawal by Subject|0
4440842|NCT00450749|7225010|FG002|Overall Study|Withdrawal by Subject|2
4440843|NCT00450749|7225008|FG000|Overall Study|Noncompliant|0
4440844|NCT00450749|7225009|FG001|Overall Study|Noncompliant|1
4440845|NCT00450749|7225010|FG002|Overall Study|Noncompliant|0
4440846|NCT00450801|7225018|FG000|Overall Study|Death|1
4440847|NCT00450814|7225037|FG000|Overall Study|Failed to complete the initial therapy|0
4440848|NCT00450814|7225038|FG001|Overall Study|Failed to complete the initial therapy|0
4440849|NCT00450814|7225039|FG002|Overall Study|Failed to complete the initial therapy|0
4440850|NCT00450814|7225040|FG003|Overall Study|Failed to complete the initial therapy|1
4440851|NCT00450814|7225041|FG004|Overall Study|Failed to complete the initial therapy|1
4440852|NCT00450814|7225042|FG005|Overall Study|Failed to complete the initial therapy|1
4440853|NCT00450814|7225043|FG006|Overall Study|Failed to complete the initial therapy|0
4440854|NCT00450814|7225044|FG007|Overall Study|Failed to complete the initial therapy|0
4440855|NCT00450814|7225045|FG008|Overall Study|Failed to complete the initial therapy|0
4440856|NCT00450814|7225046|FG009|Overall Study|Failed to complete the initial therapy|0
4440857|NCT00450814|7225047|FG010|Overall Study|Failed to complete the initial therapy|0
4440858|NCT00450814|7225037|FG000|Overall Study|Patient withdrawal prior to treatment|0
4440859|NCT00450814|7225038|FG001|Overall Study|Patient withdrawal prior to treatment|0
4440860|NCT00450814|7225039|FG002|Overall Study|Patient withdrawal prior to treatment|0
4440861|NCT00450814|7225040|FG003|Overall Study|Patient withdrawal prior to treatment|0
4440862|NCT00450814|7225041|FG004|Overall Study|Patient withdrawal prior to treatment|0
4440863|NCT00450814|7225042|FG005|Overall Study|Patient withdrawal prior to treatment|0
4440864|NCT00450814|7225043|FG006|Overall Study|Patient withdrawal prior to treatment|0
4440865|NCT00450814|7225044|FG007|Overall Study|Patient withdrawal prior to treatment|0
4440866|NCT00450814|7225045|FG008|Overall Study|Patient withdrawal prior to treatment|0
4440867|NCT00450814|7225046|FG009|Overall Study|Patient withdrawal prior to treatment|1
4440868|NCT00450814|7225047|FG010|Overall Study|Patient withdrawal prior to treatment|0
4440869|NCT00450866|7225072|FG000|Overall Study|Adverse Event|0
4440870|NCT00450866|7225073|FG001|Overall Study|Adverse Event|1
4440871|NCT00450866|7225072|FG000|Overall Study|Withdrawal by Subject|5
4440872|NCT00450866|7225073|FG001|Overall Study|Withdrawal by Subject|2
4440873|NCT00450866|7225072|FG000|Overall Study|Death|1
4440874|NCT00450866|7225073|FG001|Overall Study|Death|0
4440875|NCT00450866|7225072|FG000|Overall Study|Physician Decision|1
4440876|NCT00450866|7225073|FG001|Overall Study|Physician Decision|0
4440877|NCT00451035|7225083|FG000|Overall Study|Disease progression|11
4440878|NCT00451035|7225083|FG000|Overall Study|Death|3
4440879|NCT00451035|7225083|FG000|Overall Study|New anti-neoplastic therapy|3
4440880|NCT00451178|7225094|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6
4440881|NCT00451178|7225095|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6
4440882|NCT00451178|7225094|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4
4440883|NCT00451178|7225095|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3
4440884|NCT00451178|7225094|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2
4440885|NCT00451178|7225095|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1
4440886|NCT00451178|7225094|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1
4440887|NCT00451178|7225095|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2
4440888|NCT00451178|7225094|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4
4440889|NCT00451178|7225095|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3
4440890|NCT00451178|7225094|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1
4440891|NCT00451178|7225095|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2
4440892|NCT00451178|7225094|FG000|Prior to Maintenance Therapy|Physician Decision|2
4440893|NCT00451178|7225095|FG001|Prior to Maintenance Therapy|Physician Decision|0
4440894|NCT00451178|7225094|FG000|Prior to Maintenance Therapy|PD|2
4440895|NCT00451178|7225095|FG001|Prior to Maintenance Therapy|PD|0
4440896|NCT00451178|7225094|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4
4440897|NCT00451178|7225095|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0
4440898|NCT00451178|7225094|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5
4440899|NCT00451178|7225095|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0
4440900|NCT00451178|7225094|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1
4440901|NCT00451178|7225095|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0
4440902|NCT00451178|7225094|FG000|Maintenance Therapy (up to 3 Years)|Death|1
4440903|NCT00451178|7225095|FG001|Maintenance Therapy (up to 3 Years)|Death|0
4440904|NCT00451178|7225094|FG000|Maintenance Therapy (up to 3 Years)|PD|10
4440905|NCT00451178|7225095|FG001|Maintenance Therapy (up to 3 Years)|PD|0
4440906|NCT00451178|7225094|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9
4440907|NCT00451178|7225095|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0
4440908|NCT00451178|7225094|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6
4440909|NCT00451178|7225095|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26
4440910|NCT00451191|7225107|FG000|Overall Study|withdrawal or received alternate tx|15
4440911|NCT00451191|7225108|FG001|Overall Study|withdrawal or received alternate tx|11
4440912|NCT00451204|7225116|FG000|Overall Study|Adverse Event|4
4440913|NCT00451204|7225117|FG001|Overall Study|Adverse Event|6
4440914|NCT00451204|7225116|FG000|Overall Study|Lack of Efficacy|4
4440915|NCT00451204|7225117|FG001|Overall Study|Lack of Efficacy|4
4440916|NCT00451204|7225116|FG000|Overall Study|Lost to Follow-up|4
4440917|NCT00451204|7225117|FG001|Overall Study|Lost to Follow-up|4
4440918|NCT00451204|7225116|FG000|Overall Study|Protocol Violation|1
4440919|NCT00451204|7225117|FG001|Overall Study|Protocol Violation|0
4440920|NCT00451204|7225116|FG000|Overall Study|Patient refusal|8
4440921|NCT00451204|7225117|FG001|Overall Study|Patient refusal|4
4440922|NCT00451204|7225116|FG000|Overall Study|Other|1
4440923|NCT00451204|7225117|FG001|Overall Study|Other|2
4440924|NCT00451217|7225130|FG000|Overall Study|Lost to Follow-up|0
4440925|NCT00451217|7225131|FG001|Overall Study|Lost to Follow-up|1
4440926|NCT00451217|7225132|FG002|Overall Study|Lost to Follow-up|1
4440927|NCT00451217|7225133|FG003|Overall Study|Lost to Follow-up|1
4440928|NCT00451217|7225130|FG000|Overall Study|Withdrawal by Subject|1
4440929|NCT00451217|7225131|FG001|Overall Study|Withdrawal by Subject|0
4440930|NCT00451217|7225132|FG002|Overall Study|Withdrawal by Subject|0
4440931|NCT00451217|7225133|FG003|Overall Study|Withdrawal by Subject|0
4440932|NCT00451217|7225130|FG000|Overall Study|Not Treated|1
4440933|NCT00451217|7225131|FG001|Overall Study|Not Treated|1
4440934|NCT00451217|7225132|FG002|Overall Study|Not Treated|3
4440935|NCT00451217|7225133|FG003|Overall Study|Not Treated|4
4440936|NCT00451282|7225145|FG000|Overall Study|Lost to Follow-up|6
4440937|NCT00451282|7225146|FG001|Overall Study|Lost to Follow-up|5
4440938|NCT00451321|7225160|FG000|Overall Study|Lost to Follow-up|3
4440939|NCT00451321|7225161|FG001|Overall Study|Lost to Follow-up|3
4440940|NCT00451321|7225162|FG002|Overall Study|Lost to Follow-up|1
4440941|NCT00451321|7225163|FG003|Overall Study|Lost to Follow-up|3
4440942|NCT00451321|7225164|FG004|Overall Study|Lost to Follow-up|0
4440943|NCT00451321|7225165|FG005|Overall Study|Lost to Follow-up|1
4440944|NCT00451321|7225166|FG006|Overall Study|Lost to Follow-up|0
4440945|NCT00451321|7225167|FG007|Overall Study|Lost to Follow-up|0
4440946|NCT00451321|7225160|FG000|Overall Study|Withdrawal by Subject|3
4440947|NCT00451321|7225161|FG001|Overall Study|Withdrawal by Subject|1
4440948|NCT00451321|7225162|FG002|Overall Study|Withdrawal by Subject|0
4440949|NCT00451321|7225163|FG003|Overall Study|Withdrawal by Subject|4
4440950|NCT00451321|7225164|FG004|Overall Study|Withdrawal by Subject|0
4440951|NCT00451321|7225165|FG005|Overall Study|Withdrawal by Subject|0
4440952|NCT00451321|7225166|FG006|Overall Study|Withdrawal by Subject|0
4440953|NCT00451321|7225167|FG007|Overall Study|Withdrawal by Subject|0
4440954|NCT00451321|7225160|FG000|Overall Study|Study closed/terminated|1
4440955|NCT00451321|7225161|FG001|Overall Study|Study closed/terminated|1
4440956|NCT00451321|7225162|FG002|Overall Study|Study closed/terminated|17
4440957|NCT00451321|7225163|FG003|Overall Study|Study closed/terminated|5
4440958|NCT00451321|7225164|FG004|Overall Study|Study closed/terminated|7
4440959|NCT00451321|7225165|FG005|Overall Study|Study closed/terminated|7
4440960|NCT00451321|7225166|FG006|Overall Study|Study closed/terminated|5
4440961|NCT00451321|7225167|FG007|Overall Study|Study closed/terminated|3
4440962|NCT00451321|7225160|FG000|Overall Study|Sponsor decision to amend protocol|0
4440963|NCT00451321|7225161|FG001|Overall Study|Sponsor decision to amend protocol|0
4440964|NCT00451321|7225162|FG002|Overall Study|Sponsor decision to amend protocol|0
4440965|NCT00451321|7225163|FG003|Overall Study|Sponsor decision to amend protocol|0
4440966|NCT00451321|7225164|FG004|Overall Study|Sponsor decision to amend protocol|0
4440967|NCT00451321|7225165|FG005|Overall Study|Sponsor decision to amend protocol|1
4440968|NCT00451321|7225166|FG006|Overall Study|Sponsor decision to amend protocol|1
4440969|NCT00451321|7225167|FG007|Overall Study|Sponsor decision to amend protocol|3
4440970|NCT00451451|7225189|FG000|Overall Study|Adverse Event|11
4440971|NCT00451451|7225190|FG001|Overall Study|Adverse Event|21
4440972|NCT00451451|7225191|FG002|Overall Study|Adverse Event|26
4440973|NCT00451451|7225192|FG003|Overall Study|Adverse Event|10
4440974|NCT00451451|7225189|FG000|Overall Study|Lost to Follow-up|11
4440975|NCT00451451|7225190|FG001|Overall Study|Lost to Follow-up|9
4440976|NCT00451451|7225191|FG002|Overall Study|Lost to Follow-up|8
4440977|NCT00451451|7225192|FG003|Overall Study|Lost to Follow-up|11
4440978|NCT00451451|7225189|FG000|Overall Study|Consent Withdrawn|14
4440979|NCT00451451|7225190|FG001|Overall Study|Consent Withdrawn|9
4440980|NCT00451451|7225191|FG002|Overall Study|Consent Withdrawn|17
4440981|NCT00451451|7225192|FG003|Overall Study|Consent Withdrawn|17
4440982|NCT00451451|7225189|FG000|Overall Study|Investigator Decision|6
4440983|NCT00451451|7225190|FG001|Overall Study|Investigator Decision|2
4440984|NCT00451451|7225191|FG002|Overall Study|Investigator Decision|1
4440985|NCT00451451|7225192|FG003|Overall Study|Investigator Decision|2
4440986|NCT00451451|7225189|FG000|Overall Study|Subject Non-Compliance|8
4440987|NCT00451451|7225190|FG001|Overall Study|Subject Non-Compliance|4
4440988|NCT00451451|7225191|FG002|Overall Study|Subject Non-Compliance|3
4440989|NCT00451451|7225192|FG003|Overall Study|Subject Non-Compliance|3
4440990|NCT00451451|7225189|FG000|Overall Study|Death|1
4440991|NCT00451451|7225190|FG001|Overall Study|Death|0
4440992|NCT00451451|7225191|FG002|Overall Study|Death|0
4440993|NCT00451451|7225192|FG003|Overall Study|Death|1
4440994|NCT00451451|7225189|FG000|Overall Study|Other Reasons for Not Completing Study|34
4440995|NCT00451451|7225190|FG001|Overall Study|Other Reasons for Not Completing Study|30
4440996|NCT00451451|7225191|FG002|Overall Study|Other Reasons for Not Completing Study|17
4440997|NCT00451451|7225192|FG003|Overall Study|Other Reasons for Not Completing Study|14
4440998|NCT00451555|7225207|FG000|Overall Study|Protocol Violation|2
4440999|NCT00451555|7225208|FG001|Overall Study|Protocol Violation|2
4441000|NCT00451555|7225207|FG000|Overall Study|Adverse Event|3
4441001|NCT00451555|7225208|FG001|Overall Study|Adverse Event|1
4441002|NCT00451555|7225207|FG000|Overall Study|Withdrawal by Subject|6
4441003|NCT00451555|7225208|FG001|Overall Study|Withdrawal by Subject|0
4441004|NCT00451555|7225207|FG000|Overall Study|Physician Decision|2
4441005|NCT00451555|7225208|FG001|Overall Study|Physician Decision|1
4441006|NCT00451906|7225234|FG000|Overall Study|Adverse Event|515
4441007|NCT00451906|7225234|FG000|Overall Study|Lost to Follow-up|31
4441008|NCT00451906|7225234|FG000|Overall Study|Withdrawal by Subject|111
4441009|NCT00451906|7225234|FG000|Overall Study|Protocol Violation|21
4441010|NCT00451906|7225234|FG000|Overall Study|Progressive disease|1328
4441011|NCT00451906|7225234|FG000|Overall Study|Termination of the study|108
4441012|NCT00451906|7225234|FG000|Overall Study|Other Reasons|121
4441013|NCT00451906|7225234|FG000|Overall Study|Did not complete final visit|4
4441014|NCT00451958|7225242|FG000|CS21A (NCT00451958)|Adverse Event|21
4441015|NCT00451958|7225243|FG001|CS21A (NCT00451958)|Adverse Event|34
4441016|NCT00451958|7225244|FG002|CS21A (NCT00451958)|Adverse Event|14
4441017|NCT00451958|7225245|FG003|CS21A (NCT00451958)|Adverse Event|17
4441018|NCT00451958|7225246|FG004|CS21A (NCT00451958)|Adverse Event|0
4441019|NCT00451958|7225242|FG000|CS21A (NCT00451958)|Lost to Follow-up|6
4441020|NCT00451958|7225243|FG001|CS21A (NCT00451958)|Lost to Follow-up|5
4441021|NCT00451958|7225244|FG002|CS21A (NCT00451958)|Lost to Follow-up|1
4441022|NCT00451958|7225245|FG003|CS21A (NCT00451958)|Lost to Follow-up|1
4441023|NCT00451958|7225246|FG004|CS21A (NCT00451958)|Lost to Follow-up|0
4441024|NCT00451958|7225242|FG000|CS21A (NCT00451958)|Protocol Violation|1
4441025|NCT00451958|7225243|FG001|CS21A (NCT00451958)|Protocol Violation|3
4441026|NCT00451958|7225244|FG002|CS21A (NCT00451958)|Protocol Violation|2
4441027|NCT00451958|7225245|FG003|CS21A (NCT00451958)|Protocol Violation|0
4441028|NCT00451958|7225246|FG004|CS21A (NCT00451958)|Protocol Violation|0
4441029|NCT00451958|7225242|FG000|CS21A (NCT00451958)|Physician Decision|2
4441030|NCT00451958|7225243|FG001|CS21A (NCT00451958)|Physician Decision|4
4441031|NCT00451958|7225244|FG002|CS21A (NCT00451958)|Physician Decision|4
4441032|NCT00451958|7225245|FG003|CS21A (NCT00451958)|Physician Decision|4
4441033|NCT00451958|7225246|FG004|CS21A (NCT00451958)|Physician Decision|0
4441034|NCT00451958|7225242|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7
4441035|NCT00451958|7225243|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4
4441036|NCT00451958|7225244|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4
4441037|NCT00451958|7225245|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3
4441038|NCT00451958|7225246|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0
4441039|NCT00451958|7225242|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28
4441040|NCT00451958|7225243|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27
4441041|NCT00451958|7225244|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17
4441042|NCT00451958|7225245|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14
4441043|NCT00451958|7225246|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0
4441044|NCT00452114|7225262|FG000|Overall Study|Physician Decision|3
4441045|NCT00452114|7225263|FG001|Overall Study|Physician Decision|3
4441046|NCT00452348|7225287|FG000|Overall Study|Adverse Event|6
4441047|NCT00452348|7225288|FG001|Overall Study|Adverse Event|9
4441048|NCT00452348|7225287|FG000|Overall Study|Lack of Efficacy|10
4441049|NCT00452348|7225288|FG001|Overall Study|Lack of Efficacy|9
4441050|NCT00452348|7225287|FG000|Overall Study|Lost to Follow-up|14
4441051|NCT00452348|7225288|FG001|Overall Study|Lost to Follow-up|8
4441052|NCT00452348|7225287|FG000|Overall Study|Protocol Violation|22
4441053|NCT00452348|7225288|FG001|Overall Study|Protocol Violation|28
4441054|NCT00452348|7225287|FG000|Overall Study|Withdrawal by Subject|18
4441055|NCT00452348|7225288|FG001|Overall Study|Withdrawal by Subject|21
4441056|NCT00452348|7225287|FG000|Overall Study|Other|9
4441057|NCT00452348|7225288|FG001|Overall Study|Other|9
4441058|NCT00452400|7225309|FG000|Overall Study|Adverse Event|1
4441059|NCT00452400|7225310|FG001|Overall Study|Adverse Event|1
4441060|NCT00452400|7225311|FG002|Overall Study|Adverse Event|5
4441061|NCT00452400|7225312|FG003|Overall Study|Adverse Event|0
4441062|NCT00452400|7225313|FG004|Overall Study|Adverse Event|2
4441063|NCT00452400|7225309|FG000|Overall Study|Protocol Violation|0
4441064|NCT00452400|7225310|FG001|Overall Study|Protocol Violation|0
4441065|NCT00452400|7225311|FG002|Overall Study|Protocol Violation|1
4441066|NCT00452400|7225312|FG003|Overall Study|Protocol Violation|0
4630338|NCT01296711|7498857|FG000|Overall Study|Continued elevated liver enzymes|0
4630339|NCT01296711|7498858|FG001|Overall Study|Continued elevated liver enzymes|0
4630340|NCT01296711|7498859|FG002|Overall Study|Continued elevated liver enzymes|0
4630341|NCT01296711|7498860|FG003|Overall Study|Continued elevated liver enzymes|1
4630342|NCT01296711|7498861|FG004|Overall Study|Continued elevated liver enzymes|0
4630343|NCT01296711|7498862|FG005|Overall Study|Continued elevated liver enzymes|0
4630344|NCT01296711|7498863|FG006|Overall Study|Continued elevated liver enzymes|0
4630345|NCT01296711|7498864|FG007|Overall Study|Continued elevated liver enzymes|0
4441067|NCT00452400|7225313|FG004|Overall Study|Protocol Violation|0
4441068|NCT00452400|7225309|FG000|Overall Study|Lost to Follow-up|1
4441069|NCT00452400|7225310|FG001|Overall Study|Lost to Follow-up|0
4441070|NCT00452400|7225311|FG002|Overall Study|Lost to Follow-up|0
4441071|NCT00452400|7225312|FG003|Overall Study|Lost to Follow-up|0
4716359|NCT02991859|7645664|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0
4441072|NCT00452400|7225313|FG004|Overall Study|Lost to Follow-up|0
4441073|NCT00452400|7225309|FG000|Overall Study|Withdrawal by Subject|1
4441074|NCT00452400|7225310|FG001|Overall Study|Withdrawal by Subject|0
4441075|NCT00452400|7225311|FG002|Overall Study|Withdrawal by Subject|1
4441076|NCT00452400|7225312|FG003|Overall Study|Withdrawal by Subject|0
4716360|NCT02991859|7645665|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0
4716361|NCT02991859|7645666|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0
4716362|NCT02991859|7645667|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0
4716363|NCT02991859|7645668|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0
4716364|NCT02991859|7645669|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0
4716365|NCT02991859|7645670|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0
4716366|NCT02991859|7645671|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0
4716367|NCT02991859|7645672|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0
4716368|NCT02991859|7645673|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0
4716369|NCT02991859|7645657|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0
4716370|NCT02991859|7645658|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0
4716371|NCT02991859|7645659|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0
4716372|NCT02991859|7645660|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0
4716373|NCT02991859|7645661|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0
4716374|NCT02991859|7645662|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0
4716375|NCT02991859|7645663|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0
4716376|NCT02991859|7645664|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0
4716377|NCT02991859|7645665|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0
4716378|NCT02991859|7645666|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1
4716379|NCT02991859|7645667|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0
4716380|NCT02991859|7645668|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0
4716381|NCT02991859|7645669|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0
4716382|NCT02991859|7645670|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0
4716383|NCT02991859|7645671|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0
4716384|NCT02991859|7645672|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0
4716385|NCT02991859|7645673|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0
4716386|NCT02991859|7645657|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
4716387|NCT02991859|7645658|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
4716388|NCT02991859|7645659|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
4716389|NCT02991859|7645660|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
4716390|NCT02991859|7645661|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
4441077|NCT00452400|7225313|FG004|Overall Study|Withdrawal by Subject|0
4441078|NCT00452400|7225309|FG000|Overall Study|Lack of Efficacy|2
4441079|NCT00452400|7225310|FG001|Overall Study|Lack of Efficacy|0
4441080|NCT00452400|7225311|FG002|Overall Study|Lack of Efficacy|0
4441081|NCT00452400|7225312|FG003|Overall Study|Lack of Efficacy|0
4441082|NCT00452400|7225313|FG004|Overall Study|Lack of Efficacy|0
4441083|NCT00452400|7225309|FG000|Overall Study|Other reasons not listed above|0
4441084|NCT00452400|7225310|FG001|Overall Study|Other reasons not listed above|0
4441085|NCT00452400|7225311|FG002|Overall Study|Other reasons not listed above|0
4441086|NCT00452400|7225312|FG003|Overall Study|Other reasons not listed above|1
4441087|NCT00452400|7225313|FG004|Overall Study|Other reasons not listed above|1
4441088|NCT00452413|7225328|FG000|Overall Study|Progressive Disease|4
4441089|NCT00452413|7225329|FG001|Overall Study|Progressive Disease|11
4441090|NCT00452413|7225330|FG002|Overall Study|Progressive Disease|30
4441091|NCT00452413|7225328|FG000|Overall Study|Withdrawal by Subject|0
4441092|NCT00452413|7225329|FG001|Overall Study|Withdrawal by Subject|1
4441093|NCT00452413|7225330|FG002|Overall Study|Withdrawal by Subject|4
4441094|NCT00452413|7225328|FG000|Overall Study|Adverse Event|0
4441095|NCT00452413|7225329|FG001|Overall Study|Adverse Event|0
4441096|NCT00452413|7225330|FG002|Overall Study|Adverse Event|5
4441097|NCT00452413|7225328|FG000|Overall Study|Physician Decision|0
4441098|NCT00452413|7225329|FG001|Overall Study|Physician Decision|0
4441099|NCT00452413|7225330|FG002|Overall Study|Physician Decision|4
4441100|NCT00452413|7225328|FG000|Overall Study|Death due to study disease|0
4441101|NCT00452413|7225329|FG001|Overall Study|Death due to study disease|0
4441102|NCT00452413|7225330|FG002|Overall Study|Death due to study disease|2
4441103|NCT00452413|7225328|FG000|Overall Study|Death due to adverse event (AE)|0
4441104|NCT00452413|7225329|FG001|Overall Study|Death due to adverse event (AE)|0
4441105|NCT00452413|7225330|FG002|Overall Study|Death due to adverse event (AE)|1
4441106|NCT00452413|7225328|FG000|Overall Study|On treatment|0
4441107|NCT00452413|7225329|FG001|Overall Study|On treatment|0
4441108|NCT00452413|7225330|FG002|Overall Study|On treatment|3
4441109|NCT00452439|7225350|FG000|Overall Study|Lost to Follow-up|1
4441110|NCT00452439|7225351|FG001|Overall Study|Lost to Follow-up|1
4441111|NCT00452439|7225350|FG000|Overall Study|Refused Treatment|4
4441112|NCT00452439|7225351|FG001|Overall Study|Refused Treatment|3
4441113|NCT00452439|7225350|FG000|Overall Study|Death|3
4441114|NCT00452439|7225351|FG001|Overall Study|Death|1
4441115|NCT00452439|7225350|FG000|Overall Study|Bone Marrow Transplant|0
4441116|NCT00452439|7225351|FG001|Overall Study|Bone Marrow Transplant|1
4441117|NCT00452439|7225350|FG000|Overall Study|Too Ill to Continue|0
4441118|NCT00452439|7225351|FG001|Overall Study|Too Ill to Continue|1
4441119|NCT00452439|7225350|FG000|Overall Study|Failed to achieve complete response|2
4441120|NCT00452439|7225351|FG001|Overall Study|Failed to achieve complete response|0
4441121|NCT00452439|7225350|FG000|Overall Study|Relapse|3
4716391|NCT02991859|7645662|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
4441122|NCT00452439|7225351|FG001|Overall Study|Relapse|0
4441123|NCT00452439|7225350|FG000|Overall Study|Fracture|1
4441124|NCT00452439|7225351|FG001|Overall Study|Fracture|0
4441125|NCT00452452|7225360|FG000|Overall Study|Protocol Violation|0
4441126|NCT00452452|7225361|FG001|Overall Study|Protocol Violation|0
4441127|NCT00452452|7225362|FG002|Overall Study|Protocol Violation|1
4441128|NCT00452452|7225360|FG000|Overall Study|Withdrawal by Subject|1
4441129|NCT00452452|7225361|FG001|Overall Study|Withdrawal by Subject|0
4441130|NCT00452452|7225362|FG002|Overall Study|Withdrawal by Subject|0
4441131|NCT00452452|7225360|FG000|Overall Study|Lost to Follow-up|1
4441132|NCT00452452|7225361|FG001|Overall Study|Lost to Follow-up|0
4441133|NCT00452452|7225362|FG002|Overall Study|Lost to Follow-up|0
4441134|NCT00452530|7225378|FG000|Overall Study|Death|1
4441135|NCT00452530|7225379|FG001|Overall Study|Death|0
4441136|NCT00452530|7225378|FG000|Overall Study|Adverse Event|40
4441137|NCT00452530|7225379|FG001|Overall Study|Adverse Event|44
4441138|NCT00452530|7225378|FG000|Overall Study|Withdrawal by Subject|68
4441139|NCT00452530|7225379|FG001|Overall Study|Withdrawal by Subject|57
4441140|NCT00452530|7225378|FG000|Overall Study|Lost to Follow-up|1
4441141|NCT00452530|7225379|FG001|Overall Study|Lost to Follow-up|0
4441142|NCT00452530|7225378|FG000|Overall Study|Poor compliance/noncompliance|1
4441143|NCT00452530|7225379|FG001|Overall Study|Poor compliance/noncompliance|2
4441144|NCT00452530|7225378|FG000|Overall Study|No longer met study criteria|18
4441145|NCT00452530|7225379|FG001|Overall Study|No longer met study criteria|22
4441146|NCT00452530|7225378|FG000|Overall Study|Other|7
4441147|NCT00452530|7225379|FG001|Overall Study|Other|11
4441148|NCT00452673|7225402|FG000|Dose Escalation Period|Disease Progression|6
4441149|NCT00452673|7225403|FG001|Dose Escalation Period|Disease Progression|6
4441150|NCT00452673|7225404|FG002|Dose Escalation Period|Disease Progression|2
4441151|NCT00452673|7225405|FG003|Dose Escalation Period|Disease Progression|6
4441152|NCT00452673|7225406|FG004|Dose Escalation Period|Disease Progression|0
4441153|NCT00452673|7225402|FG000|Dose Escalation Period|study drug toxicity|1
4441154|NCT00452673|7225403|FG001|Dose Escalation Period|study drug toxicity|3
4441155|NCT00452673|7225404|FG002|Dose Escalation Period|study drug toxicity|3
4441156|NCT00452673|7225405|FG003|Dose Escalation Period|study drug toxicity|1
4441157|NCT00452673|7225406|FG004|Dose Escalation Period|study drug toxicity|0
4441158|NCT00452673|7225402|FG000|Dose Escalation Period|Other|0
4441159|NCT00452673|7225403|FG001|Dose Escalation Period|Other|0
4441160|NCT00452673|7225404|FG002|Dose Escalation Period|Other|1
4441161|NCT00452673|7225405|FG003|Dose Escalation Period|Other|0
4441162|NCT00452673|7225406|FG004|Dose Escalation Period|Other|0
4441163|NCT00452673|7225402|FG000|Dose Escalation Period|Adverse Event|0
4441164|NCT00452673|7225403|FG001|Dose Escalation Period|Adverse Event|0
4441165|NCT00452673|7225404|FG002|Dose Escalation Period|Adverse Event|0
4441166|NCT00452673|7225405|FG003|Dose Escalation Period|Adverse Event|1
4441167|NCT00452673|7225406|FG004|Dose Escalation Period|Adverse Event|0
4441168|NCT00452673|7225402|FG000|Dose Escalation Period|Withdrawal by Subject|0
4441169|NCT00452673|7225403|FG001|Dose Escalation Period|Withdrawal by Subject|0
4441170|NCT00452673|7225404|FG002|Dose Escalation Period|Withdrawal by Subject|0
4441171|NCT00452673|7225405|FG003|Dose Escalation Period|Withdrawal by Subject|1
4441172|NCT00452673|7225406|FG004|Dose Escalation Period|Withdrawal by Subject|0
4441173|NCT00452673|7225402|FG000|Dose Expansion Period|Disease Progression|0
4441174|NCT00452673|7225403|FG001|Dose Expansion Period|Disease Progression|0
4441175|NCT00452673|7225404|FG002|Dose Expansion Period|Disease Progression|0
4441176|NCT00452673|7225405|FG003|Dose Expansion Period|Disease Progression|0
4441177|NCT00452673|7225406|FG004|Dose Expansion Period|Disease Progression|19
4441178|NCT00452673|7225402|FG000|Dose Expansion Period|Other|0
4441179|NCT00452673|7225403|FG001|Dose Expansion Period|Other|0
4441180|NCT00452673|7225404|FG002|Dose Expansion Period|Other|0
4441181|NCT00452673|7225405|FG003|Dose Expansion Period|Other|0
4441182|NCT00452673|7225406|FG004|Dose Expansion Period|Other|2
4441183|NCT00452699|7225419|FG000|Overall Study|Adverse Event|10
4441184|NCT00452699|7225420|FG001|Overall Study|Adverse Event|3
4441185|NCT00452699|7225419|FG000|Overall Study|Lack of Efficacy|6
4441186|NCT00452699|7225420|FG001|Overall Study|Lack of Efficacy|4
4441187|NCT00452699|7225419|FG000|Overall Study|Lost to Follow-up|6
4441188|NCT00452699|7225420|FG001|Overall Study|Lost to Follow-up|9
4441189|NCT00452699|7225419|FG000|Overall Study|Protocol Violation|21
4441190|NCT00452699|7225420|FG001|Overall Study|Protocol Violation|25
4441191|NCT00452699|7225419|FG000|Overall Study|Withdrawal by Subject|26
4630346|NCT01296711|7498857|FG000|Overall Study|Methotrexate discontinued|0
4630347|NCT01296711|7498858|FG001|Overall Study|Methotrexate discontinued|0
4630348|NCT01296711|7498859|FG002|Overall Study|Methotrexate discontinued|0
4630349|NCT01296711|7498860|FG003|Overall Study|Methotrexate discontinued|1
4441192|NCT00452699|7225420|FG001|Overall Study|Withdrawal by Subject|25
4441193|NCT00452699|7225419|FG000|Overall Study|Other|12
4441194|NCT00452699|7225420|FG001|Overall Study|Other|7
4441195|NCT00452790|7225428|FG000|Infant Series|Clinical hold - consent withdrawn|118
4441196|NCT00452790|7225429|FG001|Infant Series|Clinical hold - consent withdrawn|123
4441197|NCT00452790|7225428|FG000|Infant Series|Parent/legal guardian request|8
4441198|NCT00452790|7225429|FG001|Infant Series|Parent/legal guardian request|6
4441199|NCT00452790|7225428|FG000|Infant Series|Failed to return|4
4441200|NCT00452790|7225429|FG001|Infant Series|Failed to return|1
4441201|NCT00452790|7225428|FG000|Infant Series|Protocol Violation|1
4441202|NCT00452790|7225429|FG001|Infant Series|Protocol Violation|3
4441203|NCT00452790|7225428|FG000|Infant Series|Lost to Follow-up|2
4441204|NCT00452790|7225429|FG001|Infant Series|Lost to Follow-up|2
4441205|NCT00452790|7225428|FG000|Infant Series|Adverse Event|1
4441206|NCT00452790|7225429|FG001|Infant Series|Adverse Event|2
4441207|NCT00452790|7225428|FG000|Infant Series|Other reasons|1
4441208|NCT00452790|7225429|FG001|Infant Series|Other reasons|2
4441209|NCT00452790|7225428|FG000|Infant Series|Investigator request|0
4441210|NCT00452790|7225429|FG001|Infant Series|Investigator request|1
4441211|NCT00452790|7225428|FG000|Infant Series|Death|0
4441212|NCT00452790|7225429|FG001|Infant Series|Death|1
4441213|NCT00452790|7225428|FG000|After Infant Series|Investigator request|10
4441214|NCT00452790|7225429|FG001|After Infant Series|Investigator request|10
4441215|NCT00452790|7225428|FG000|After Infant Series|Adverse Event|4
4441216|NCT00452790|7225429|FG001|After Infant Series|Adverse Event|1
4441217|NCT00452790|7225428|FG000|After Infant Series|Parent/legal guardian request|1
4441218|NCT00452790|7225429|FG001|After Infant Series|Parent/legal guardian request|3
4441219|NCT00452790|7225428|FG000|After Infant Series|Lost to Follow-up|4
4441220|NCT00452790|7225429|FG001|After Infant Series|Lost to Follow-up|0
4441221|NCT00452790|7225428|FG000|After Infant Series|Failed to return|1
4441222|NCT00452790|7225429|FG001|After Infant Series|Failed to return|0
4441223|NCT00452790|7225428|FG000|After Infant Series|Other reasons|1
4441224|NCT00452790|7225429|FG001|After Infant Series|Other reasons|0
4441225|NCT00452790|7225428|FG000|Toddler Dose|Failed to return|0
4441226|NCT00452790|7225429|FG001|Toddler Dose|Failed to return|1
4441227|NCT00452790|7225428|FG000|Toddler Dose|Parent/legal guardian request|0
4441228|NCT00452790|7225429|FG001|Toddler Dose|Parent/legal guardian request|1
4441229|NCT00453102|7225443|FG000|Overall Study|Withdrawal by Subject|2
4512860|NCT00938015|7322914|FG000|Overall Study|Reason not related to Etanercept|29
4512861|NCT00938041|7322918|FG000|Overall Study|Lost to Follow-up|6
4512862|NCT00938041|7322918|FG000|Overall Study|Received Alternative Therapy|1
4512863|NCT00938041|7322918|FG000|Overall Study|Progressive Disease|5
4512864|NCT00938041|7322918|FG000|Overall Study|Death|12
4512865|NCT00938041|7322918|FG000|Overall Study|Adrenal Insufficiency|3
4512866|NCT00938327|7322939|FG000|Overall Study|Adverse Event|2
4512867|NCT00938327|7322939|FG000|Overall Study|Protocol Violation|1
4512868|NCT00938327|7322939|FG000|Overall Study|Withdrawal by Subject|4
4512869|NCT00938327|7322939|FG000|Overall Study|Lost to Follow-up|37
4512870|NCT00938327|7322939|FG000|Overall Study|2nd dose received outside of the study|7
4512871|NCT00938327|7322939|FG000|Overall Study|Vaccine not received as out of stock|9
4512872|NCT00938340|7322943|FG000|Overall Study|Withdrawal by Subject|3
4512873|NCT00938340|7322943|FG000|Overall Study|Protocol Violation|1
4512874|NCT00938340|7322943|FG000|Overall Study|Adverse Event|1
4512875|NCT00938366|7322991|FG000|Overall Study|Withdrawal by Subject|1
4512876|NCT00938366|7322992|FG001|Overall Study|Withdrawal by Subject|0
4512877|NCT00938392|7323000|FG000|Overall Study|Adverse Event|0
4512878|NCT00938392|7323001|FG001|Overall Study|Adverse Event|1
4512879|NCT00938392|7323000|FG000|Overall Study|Withdrawal by Subject|0
4512880|NCT00938392|7323001|FG001|Overall Study|Withdrawal by Subject|1
4512881|NCT00938392|7323000|FG000|Overall Study|Lost to Follow-up|2
4512882|NCT00938392|7323001|FG001|Overall Study|Lost to Follow-up|2
4512883|NCT00938431|7323010|FG000|Overall Study|Adverse Event|5
4512884|NCT00938431|7323011|FG001|Overall Study|Adverse Event|8
4512885|NCT00938431|7323012|FG002|Overall Study|Adverse Event|6
4512886|NCT00938431|7323010|FG000|Overall Study|Lack of Efficacy|0
4512887|NCT00938431|7323011|FG001|Overall Study|Lack of Efficacy|1
4512888|NCT00938431|7323012|FG002|Overall Study|Lack of Efficacy|0
4512889|NCT00938431|7323010|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1
4512890|NCT00938431|7323011|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0
4512891|NCT00938431|7323012|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0
4512892|NCT00938431|7323010|FG000|Overall Study|Dosing compliance issue|0
4512893|NCT00938431|7323011|FG001|Overall Study|Dosing compliance issue|0
4512894|NCT00938431|7323012|FG002|Overall Study|Dosing compliance issue|1
4512895|NCT00938431|7323010|FG000|Overall Study|Reached maximum dose early|0
4512896|NCT00938431|7323011|FG001|Overall Study|Reached maximum dose early|0
4512897|NCT00938431|7323012|FG002|Overall Study|Reached maximum dose early|1
4512898|NCT00938470|7323030|FG000|Overall Study|Disease Progression|3
4512899|NCT00938470|7323031|FG001|Overall Study|Disease Progression|0
4512900|NCT00938470|7323030|FG000|Overall Study|Alternate Treatment|1
4512901|NCT00938470|7323031|FG001|Overall Study|Alternate Treatment|0
4512902|NCT00938470|7323030|FG000|Overall Study|Death|3
4512903|NCT00938470|7323031|FG001|Overall Study|Death|2
4512904|NCT00938470|7323030|FG000|Overall Study|Other Reason|0
4512905|NCT00938470|7323031|FG001|Overall Study|Other Reason|1
4512906|NCT00938639|7323048|FG000|Overall Study|Moved away from study area|0
4512907|NCT00938639|7323049|FG001|Overall Study|Moved away from study area|1
4512908|NCT00938639|7323048|FG000|Overall Study|Lost to Follow-up|1
4512909|NCT00938639|7323049|FG001|Overall Study|Lost to Follow-up|2
4512910|NCT00938639|7323048|FG000|Overall Study|Family issues|1
4512911|NCT00938639|7323049|FG001|Overall Study|Family issues|1
4512912|NCT00938639|7323048|FG000|Overall Study|Participant noncompliance|1
4512913|NCT00938639|7323049|FG001|Overall Study|Participant noncompliance|0
4512914|NCT00938717|7323070|FG000|Overall Study|Adverse Event|10
4512915|NCT00938717|7323071|FG001|Overall Study|Adverse Event|41
4512916|NCT00938717|7323070|FG000|Overall Study|Protocol Violation|11
4512917|NCT00938717|7323071|FG001|Overall Study|Protocol Violation|8
4441230|NCT00453154|7225450|FG000|Double BIind Maintenance|Adverse Event|0
4441231|NCT00453154|7225451|FG001|Double BIind Maintenance|Adverse Event|0
4441232|NCT00453154|7225452|FG002|Double BIind Maintenance|Adverse Event|3
4441233|NCT00453154|7225453|FG003|Double BIind Maintenance|Adverse Event|12
4441234|NCT00453154|7225450|FG000|Double BIind Maintenance|Death|0
4441235|NCT00453154|7225451|FG001|Double BIind Maintenance|Death|0
4441236|NCT00453154|7225452|FG002|Double BIind Maintenance|Death|2
4441237|NCT00453154|7225453|FG003|Double BIind Maintenance|Death|1
4441238|NCT00453154|7225450|FG000|Double BIind Maintenance|Withdrawal by Subject|0
4441239|NCT00453154|7225451|FG001|Double BIind Maintenance|Withdrawal by Subject|0
4441240|NCT00453154|7225452|FG002|Double BIind Maintenance|Withdrawal by Subject|4
4441241|NCT00453154|7225453|FG003|Double BIind Maintenance|Withdrawal by Subject|4
4441242|NCT00453154|7225450|FG000|Double BIind Maintenance|Progression|0
4441243|NCT00453154|7225451|FG001|Double BIind Maintenance|Progression|0
4441244|NCT00453154|7225452|FG002|Double BIind Maintenance|Progression|29
4441245|NCT00453154|7225453|FG003|Double BIind Maintenance|Progression|26
4441246|NCT00453154|7225450|FG000|Double BIind Maintenance|Medical Issues|0
4441247|NCT00453154|7225451|FG001|Double BIind Maintenance|Medical Issues|0
4441248|NCT00453154|7225452|FG002|Double BIind Maintenance|Medical Issues|3
4441249|NCT00453154|7225453|FG003|Double BIind Maintenance|Medical Issues|1
4441250|NCT00453154|7225450|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0
4441251|NCT00453154|7225451|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0
4441252|NCT00453154|7225452|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5
4441253|NCT00453154|7225453|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5
4441254|NCT00453180|7225464|FG000|Overall Study|Lost to Follow-up|2
4441255|NCT00453180|7225465|FG001|Overall Study|Lost to Follow-up|1
4441256|NCT00453180|7225464|FG000|Overall Study|Adverse Event|1
4441257|NCT00453180|7225465|FG001|Overall Study|Adverse Event|2
4441258|NCT00453206|7225475|FG000|Overall Study|Death|1
4441259|NCT00453310|7225479|FG000|Overall Study|Progression of Disease|10
4441260|NCT00453349|7225489|FG000|Randomized|Adverse Event|12
4441261|NCT00453349|7225490|FG001|Randomized|Adverse Event|11
4441262|NCT00453349|7225489|FG000|Randomized|Lack of Efficacy|2
4441263|NCT00453349|7225490|FG001|Randomized|Lack of Efficacy|1
4441264|NCT00453349|7225489|FG000|Randomized|Lost to Follow-up|7
4441265|NCT00453349|7225490|FG001|Randomized|Lost to Follow-up|5
4441266|NCT00453349|7225489|FG000|Randomized|Protocol Violation|1
4441267|NCT00453349|7225490|FG001|Randomized|Protocol Violation|1
4441268|NCT00453349|7225489|FG000|Randomized|Withdrawal by Subject|3
4441269|NCT00453349|7225490|FG001|Randomized|Withdrawal by Subject|5
4441270|NCT00453349|7225489|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10
4441271|NCT00453349|7225490|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11
4441272|NCT00453349|7225489|FG000|Completed Study|Adverse Event|12
4441273|NCT00453349|7225490|FG001|Completed Study|Adverse Event|11
4441274|NCT00453349|7225489|FG000|Completed Study|Lack of Efficacy|2
4441275|NCT00453349|7225490|FG001|Completed Study|Lack of Efficacy|1
4441276|NCT00453349|7225489|FG000|Completed Study|Lost to Follow-up|7
4441277|NCT00453349|7225490|FG001|Completed Study|Lost to Follow-up|5
4441278|NCT00453349|7225489|FG000|Completed Study|Protocol Violation|1
4441279|NCT00453349|7225490|FG001|Completed Study|Protocol Violation|1
4441280|NCT00453349|7225489|FG000|Completed Study|Withdrawal by Subject|3
4441281|NCT00453349|7225490|FG001|Completed Study|Withdrawal by Subject|5
4441282|NCT00453349|7225489|FG000|Completed Study|Lost to follow up after study treatment|2
4441283|NCT00453349|7225490|FG001|Completed Study|Lost to follow up after study treatment|11
4441284|NCT00453362|7225496|FG000|Overall Study|Adverse Event|5
4441285|NCT00453362|7225496|FG000|Overall Study|Death|7
4441286|NCT00453362|7225496|FG000|Overall Study|Physician Decision|2
4441287|NCT00453362|7225496|FG000|Overall Study|Withdrawal by Subject|3
4441288|NCT00453362|7225496|FG000|Overall Study|Progression of disease|56
4441289|NCT00453362|7225496|FG000|Overall Study|Screening Failure|14
4441290|NCT00453921|7225552|FG000|Overall Study|Withdrawal by Subject|1
4441291|NCT00453921|7225553|FG001|Overall Study|Withdrawal by Subject|1
4441292|NCT00453921|7225554|FG002|Overall Study|Withdrawal by Subject|1
4441293|NCT00453921|7225555|FG003|Overall Study|Withdrawal by Subject|1
4441294|NCT00453921|7225552|FG000|Overall Study|Lost to Follow-up|0
4441295|NCT00453921|7225553|FG001|Overall Study|Lost to Follow-up|0
4441296|NCT00453921|7225554|FG002|Overall Study|Lost to Follow-up|1
4441297|NCT00453921|7225555|FG003|Overall Study|Lost to Follow-up|0
4441298|NCT00453973|7225571|FG000|Overall Study|Adverse Event|4
4441299|NCT00453973|7225572|FG001|Overall Study|Adverse Event|9
4441300|NCT00453973|7225571|FG000|Overall Study|Withdrawal by Subject|7
4441301|NCT00453973|7225572|FG001|Overall Study|Withdrawal by Subject|6
4441302|NCT00453973|7225571|FG000|Overall Study|PI Decision|0
4441303|NCT00453973|7225572|FG001|Overall Study|PI Decision|2
4441304|NCT00453973|7225571|FG000|Overall Study|Relocation|1
4441305|NCT00453973|7225572|FG001|Overall Study|Relocation|0
4441306|NCT00453973|7225571|FG000|Overall Study|Renal transplant|1
4441307|NCT00453973|7225572|FG001|Overall Study|Renal transplant|1
4441308|NCT00453973|7225571|FG000|Overall Study|Site closed by sponsor|3
4441309|NCT00453973|7225572|FG001|Overall Study|Site closed by sponsor|0
4441310|NCT00453973|7225571|FG000|Overall Study|Sponsor Decision to Terminate Study|35
4441311|NCT00453973|7225572|FG001|Overall Study|Sponsor Decision to Terminate Study|30
4441312|NCT00453986|7225583|FG000|Overall Study|Lost to Follow-up|6
4441313|NCT00453986|7225584|FG001|Overall Study|Lost to Follow-up|5
4441314|NCT00453986|7225585|FG002|Overall Study|Lost to Follow-up|6
4441315|NCT00453986|7225586|FG003|Overall Study|Lost to Follow-up|2
4441316|NCT00453986|7225587|FG004|Overall Study|Lost to Follow-up|0
4441317|NCT00453999|7225606|FG000|Overall Study|Adverse Event|1
4441318|NCT00453999|7225607|FG001|Overall Study|Adverse Event|2
4441319|NCT00453999|7225608|FG002|Overall Study|Adverse Event|1
4441320|NCT00453999|7225606|FG000|Overall Study|Lost to Follow-up|0
4441321|NCT00453999|7225607|FG001|Overall Study|Lost to Follow-up|1
4441322|NCT00453999|7225608|FG002|Overall Study|Lost to Follow-up|1
4441323|NCT00453999|7225606|FG000|Overall Study|Withdrawal by Subject|2
4441324|NCT00453999|7225607|FG001|Overall Study|Withdrawal by Subject|1
4441325|NCT00453999|7225608|FG002|Overall Study|Withdrawal by Subject|1
4441326|NCT00453999|7225606|FG000|Overall Study|Subject Request|2
4441327|NCT00453999|7225607|FG001|Overall Study|Subject Request|1
4441328|NCT00453999|7225608|FG002|Overall Study|Subject Request|0
4441329|NCT00454051|7225619|FG000|Overall Study|Adverse Event|1
4441330|NCT00454051|7225620|FG001|Overall Study|Adverse Event|2
4441331|NCT00454051|7225619|FG000|Overall Study|Withdrawal by Subject|1
4441332|NCT00454051|7225620|FG001|Overall Study|Withdrawal by Subject|0
4441333|NCT00454051|7225619|FG000|Overall Study|Protocol Violation|1
4441334|NCT00454051|7225620|FG001|Overall Study|Protocol Violation|1
4441335|NCT00454116|7225629|FG000|Overall Study|Adverse Event|5
4441336|NCT00454116|7225630|FG001|Overall Study|Adverse Event|11
4441337|NCT00454116|7225631|FG002|Overall Study|Adverse Event|9
4441338|NCT00454116|7225629|FG000|Overall Study|Condition under investigation worsened|17
4441339|NCT00454116|7225630|FG001|Overall Study|Condition under investigation worsened|13
4441340|NCT00454116|7225631|FG002|Overall Study|Condition under investigation worsened|18
4441341|NCT00454116|7225629|FG000|Overall Study|Withdrawal by Subject|3
4441342|NCT00454116|7225630|FG001|Overall Study|Withdrawal by Subject|3
4441343|NCT00454116|7225631|FG002|Overall Study|Withdrawal by Subject|1
4441344|NCT00454116|7225629|FG000|Overall Study|Other|2
4441345|NCT00454116|7225630|FG001|Overall Study|Other|2
4441346|NCT00454116|7225631|FG002|Overall Study|Other|0
4441347|NCT00454142|7225639|FG000|Overall Study|Withdrawal by Subject|1
4441348|NCT00454181|7225647|FG000|Overall Study|Adverse Event|1
4441349|NCT00454181|7225648|FG001|Overall Study|Adverse Event|1
4441350|NCT00454181|7225647|FG000|Overall Study|Lost to Follow-up|11
4441351|NCT00454181|7225648|FG001|Overall Study|Lost to Follow-up|1
4441352|NCT00454181|7225647|FG000|Overall Study|Protocol Violation|1
4441353|NCT00454181|7225648|FG001|Overall Study|Protocol Violation|1
4441354|NCT00454181|7225647|FG000|Overall Study|Withdrawal by Subject|2
4441355|NCT00454181|7225648|FG001|Overall Study|Withdrawal by Subject|0
4441356|NCT00454194|7225656|FG000|Overall Study|Adverse Event|7
4441357|NCT00454194|7225657|FG001|Overall Study|Adverse Event|2
4441358|NCT00454194|7225656|FG000|Overall Study|Withdrawal by Subject|12
4441359|NCT00454194|7225657|FG001|Overall Study|Withdrawal by Subject|8
4441360|NCT00454194|7225656|FG000|Overall Study|Other Medical Problems|1
4441361|NCT00454194|7225657|FG001|Overall Study|Other Medical Problems|2
4441362|NCT00454194|7225656|FG000|Overall Study|Other Unspecified Reason|2
4441363|NCT00454194|7225657|FG001|Overall Study|Other Unspecified Reason|2
4441364|NCT00454207|7225665|FG000|Overall Study|Adverse Event|3
4441365|NCT00454207|7225666|FG001|Overall Study|Adverse Event|1
4441366|NCT00454207|7225665|FG000|Overall Study|Lack of Efficacy|1
4441367|NCT00454207|7225666|FG001|Overall Study|Lack of Efficacy|0
4441368|NCT00454207|7225665|FG000|Overall Study|Protocol Violation|0
4441369|NCT00454207|7225666|FG001|Overall Study|Protocol Violation|1
4441370|NCT00454246|7225687|FG000|Overall Study|Adverse Event|2
4441371|NCT00454246|7225688|FG001|Overall Study|Adverse Event|2
4441372|NCT00454246|7225689|FG002|Overall Study|Adverse Event|0
4441373|NCT00454246|7225687|FG000|Overall Study|Violation of selection criteria at entry|6
4441374|NCT00454246|7225688|FG001|Overall Study|Violation of selection criteria at entry|0
4441375|NCT00454246|7225689|FG002|Overall Study|Violation of selection criteria at entry|0
4441376|NCT00454246|7225687|FG000|Overall Study|Protocol Violation|1
4441377|NCT00454246|7225688|FG001|Overall Study|Protocol Violation|0
4441378|NCT00454246|7225689|FG002|Overall Study|Protocol Violation|0
4441379|NCT00454246|7225687|FG000|Overall Study|Refused Treatment|1
4441380|NCT00454246|7225688|FG001|Overall Study|Refused Treatment|1
4441381|NCT00454246|7225689|FG002|Overall Study|Refused Treatment|0
4441382|NCT00454246|7225687|FG000|Overall Study|Failure to return|1
4441383|NCT00454246|7225688|FG001|Overall Study|Failure to return|0
4441384|NCT00454246|7225689|FG002|Overall Study|Failure to return|0
4441385|NCT00454246|7225687|FG000|Overall Study|Early termination of study|62
4441386|NCT00454246|7225688|FG001|Overall Study|Early termination of study|26
4441387|NCT00454246|7225689|FG002|Overall Study|Early termination of study|9
4441388|NCT00454363|7225708|FG000|Overall Study|Adverse Event|1
4441389|NCT00454363|7225709|FG001|Overall Study|Adverse Event|2
4441390|NCT00454363|7225708|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4
4441391|NCT00454363|7225709|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0
4441392|NCT00454584|7225734|FG000|Controlled Period|Adverse Event|5
4441393|NCT00454584|7225735|FG001|Controlled Period|Adverse Event|2
4441394|NCT00454584|7225736|FG002|Controlled Period|Adverse Event|1
4441395|NCT00454584|7225737|FG003|Controlled Period|Adverse Event|0
4441396|NCT00454584|7225738|FG004|Controlled Period|Adverse Event|0
4441397|NCT00454584|7225739|FG005|Controlled Period|Adverse Event|0
4441398|NCT00454584|7225734|FG000|Controlled Period|Lost to Follow-up|1
4441399|NCT00454584|7225735|FG001|Controlled Period|Lost to Follow-up|2
4441400|NCT00454584|7225736|FG002|Controlled Period|Lost to Follow-up|2
4441401|NCT00454584|7225737|FG003|Controlled Period|Lost to Follow-up|0
4441402|NCT00454584|7225738|FG004|Controlled Period|Lost to Follow-up|0
4441403|NCT00454584|7225739|FG005|Controlled Period|Lost to Follow-up|0
4441404|NCT00454584|7225734|FG000|Controlled Period|Other|5
4441405|NCT00454584|7225735|FG001|Controlled Period|Other|4
4441406|NCT00454584|7225736|FG002|Controlled Period|Other|2
4441407|NCT00454584|7225737|FG003|Controlled Period|Other|0
4441408|NCT00454584|7225738|FG004|Controlled Period|Other|0
4441409|NCT00454584|7225739|FG005|Controlled Period|Other|0
4441410|NCT00454584|7225734|FG000|After Controlled Period|Adverse Event|0
4441411|NCT00454584|7225735|FG001|After Controlled Period|Adverse Event|0
4441412|NCT00454584|7225736|FG002|After Controlled Period|Adverse Event|0
4441413|NCT00454584|7225737|FG003|After Controlled Period|Adverse Event|9
4441414|NCT00454584|7225738|FG004|After Controlled Period|Adverse Event|3
4441415|NCT00454584|7225739|FG005|After Controlled Period|Adverse Event|9
4441416|NCT00454584|7225734|FG000|After Controlled Period|Lack of Efficacy|0
4441417|NCT00454584|7225735|FG001|After Controlled Period|Lack of Efficacy|0
4441418|NCT00454584|7225736|FG002|After Controlled Period|Lack of Efficacy|0
4441419|NCT00454584|7225737|FG003|After Controlled Period|Lack of Efficacy|1
4441420|NCT00454584|7225738|FG004|After Controlled Period|Lack of Efficacy|0
4441421|NCT00454584|7225739|FG005|After Controlled Period|Lack of Efficacy|0
4441422|NCT00454584|7225734|FG000|After Controlled Period|Lost to Follow-up|0
4441423|NCT00454584|7225735|FG001|After Controlled Period|Lost to Follow-up|0
4441424|NCT00454584|7225736|FG002|After Controlled Period|Lost to Follow-up|0
4441425|NCT00454584|7225737|FG003|After Controlled Period|Lost to Follow-up|2
4441426|NCT00454584|7225738|FG004|After Controlled Period|Lost to Follow-up|4
4441427|NCT00454584|7225739|FG005|After Controlled Period|Lost to Follow-up|6
4441428|NCT00454584|7225734|FG000|After Controlled Period|Other|0
4441429|NCT00454584|7225735|FG001|After Controlled Period|Other|0
4441430|NCT00454584|7225736|FG002|After Controlled Period|Other|0
4441431|NCT00454584|7225737|FG003|After Controlled Period|Other|1
4630350|NCT01296711|7498861|FG004|Overall Study|Methotrexate discontinued|0
4441432|NCT00454584|7225738|FG004|After Controlled Period|Other|0
4441433|NCT00454584|7225739|FG005|After Controlled Period|Other|0
4441434|NCT00454584|7225734|FG000|After Controlled Period|Other|0
4716392|NCT02991859|7645663|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
4716393|NCT02991859|7645664|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
4716394|NCT02991859|7645665|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1
4716395|NCT02991859|7645666|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
4716396|NCT02991859|7645667|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
4716397|NCT02991859|7645668|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
4716398|NCT02991859|7645669|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
4716399|NCT02991859|7645670|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
4716400|NCT02991859|7645671|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
4716401|NCT02991859|7645672|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
4716402|NCT02991859|7645673|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
4716403|NCT02992132|7645759|FG000|Overall Study|Adverse Event|4
4716404|NCT02992132|7645760|FG001|Overall Study|Adverse Event|1
4716405|NCT02992132|7645761|FG002|Overall Study|Adverse Event|3
4716406|NCT02992132|7645759|FG000|Overall Study|Lack of Efficacy|2
4716407|NCT02992132|7645760|FG001|Overall Study|Lack of Efficacy|0
4716408|NCT02992132|7645761|FG002|Overall Study|Lack of Efficacy|0
4716409|NCT02992132|7645759|FG000|Overall Study|Non-compliance with study drug|2
4716410|NCT02992132|7645760|FG001|Overall Study|Non-compliance with study drug|0
4716411|NCT02992132|7645761|FG002|Overall Study|Non-compliance with study drug|0
4716412|NCT02992132|7645759|FG000|Overall Study|Progressive disease|1
4441435|NCT00454584|7225735|FG001|After Controlled Period|Other|0
4441436|NCT00454584|7225736|FG002|After Controlled Period|Other|0
4441437|NCT00454584|7225737|FG003|After Controlled Period|Other|13
4441438|NCT00454584|7225738|FG004|After Controlled Period|Other|5
4441439|NCT00454584|7225739|FG005|After Controlled Period|Other|17
4441440|NCT00454636|7225757|FG000|Overall Study|Adverse Event|10
4441441|NCT00454636|7225758|FG001|Overall Study|Adverse Event|6
4441442|NCT00454636|7225759|FG002|Overall Study|Adverse Event|9
4441443|NCT00454636|7225760|FG003|Overall Study|Adverse Event|15
4441444|NCT00454636|7225757|FG000|Overall Study|Disease Progression|11
4441445|NCT00454636|7225758|FG001|Overall Study|Disease Progression|12
4441446|NCT00454636|7225759|FG002|Overall Study|Disease Progression|4
4441447|NCT00454636|7225760|FG003|Overall Study|Disease Progression|11
4441448|NCT00454636|7225757|FG000|Overall Study|Protocol Violation|3
4441449|NCT00454636|7225758|FG001|Overall Study|Protocol Violation|2
4441450|NCT00454636|7225759|FG002|Overall Study|Protocol Violation|3
4441451|NCT00454636|7225760|FG003|Overall Study|Protocol Violation|3
4441452|NCT00454636|7225757|FG000|Overall Study|Death|6
4441453|NCT00454636|7225758|FG001|Overall Study|Death|1
4441454|NCT00454636|7225759|FG002|Overall Study|Death|1
4441455|NCT00454636|7225760|FG003|Overall Study|Death|1
4441456|NCT00454636|7225757|FG000|Overall Study|Patient refusal|1
4441457|NCT00454636|7225758|FG001|Overall Study|Patient refusal|1
4716413|NCT02992132|7645760|FG001|Overall Study|Progressive disease|0
4716414|NCT02992132|7645761|FG002|Overall Study|Progressive disease|0
4716415|NCT02992132|7645759|FG000|Overall Study|Protocol Violation|2
4716416|NCT02992132|7645760|FG001|Overall Study|Protocol Violation|2
4716417|NCT02992132|7645761|FG002|Overall Study|Protocol Violation|0
4716418|NCT02992132|7645759|FG000|Overall Study|Caregiver withdrew consent|2
4716419|NCT02992132|7645760|FG001|Overall Study|Caregiver withdrew consent|3
4716420|NCT02992132|7645761|FG002|Overall Study|Caregiver withdrew consent|2
4716421|NCT02992132|7645759|FG000|Overall Study|Withdrawal by Subject|0
4716422|NCT02992132|7645760|FG001|Overall Study|Withdrawal by Subject|2
4716423|NCT02992132|7645761|FG002|Overall Study|Withdrawal by Subject|1
4716424|NCT02992132|7645759|FG000|Overall Study|Physician Decision|0
4716425|NCT02992132|7645760|FG001|Overall Study|Physician Decision|0
4716426|NCT02992132|7645761|FG002|Overall Study|Physician Decision|1
4716427|NCT02992288|7645795|FG000|Overall Study|Adverse Event|8
4716428|NCT02992288|7645796|FG001|Overall Study|Adverse Event|2
4716429|NCT02992288|7645797|FG002|Overall Study|Adverse Event|2
4716430|NCT02992288|7645798|FG003|Overall Study|Adverse Event|2
4716431|NCT02992288|7645799|FG004|Overall Study|Adverse Event|2
4716432|NCT02992288|7645800|FG005|Overall Study|Adverse Event|7
4716433|NCT02992288|7645795|FG000|Overall Study|Non-compliance with study drug|0
4716434|NCT02992288|7645796|FG001|Overall Study|Non-compliance with study drug|1
4716435|NCT02992288|7645797|FG002|Overall Study|Non-compliance with study drug|1
4716436|NCT02992288|7645798|FG003|Overall Study|Non-compliance with study drug|0
4716437|NCT02992288|7645799|FG004|Overall Study|Non-compliance with study drug|1
4716438|NCT02992288|7645800|FG005|Overall Study|Non-compliance with study drug|0
4716439|NCT02992288|7645795|FG000|Overall Study|Physician Decision|3
4716440|NCT02992288|7645796|FG001|Overall Study|Physician Decision|0
4716441|NCT02992288|7645797|FG002|Overall Study|Physician Decision|1
4716442|NCT02992288|7645798|FG003|Overall Study|Physician Decision|0
4716443|NCT02992288|7645799|FG004|Overall Study|Physician Decision|0
4716444|NCT02992288|7645800|FG005|Overall Study|Physician Decision|1
4716445|NCT02992288|7645795|FG000|Overall Study|Death|2
4441458|NCT00454636|7225759|FG002|Overall Study|Patient refusal|3
4441459|NCT00454636|7225760|FG003|Overall Study|Patient refusal|2
4441460|NCT00454636|7225757|FG000|Overall Study|Lost to Follow-up|0
4441461|NCT00454636|7225758|FG001|Overall Study|Lost to Follow-up|1
4441462|NCT00454636|7225759|FG002|Overall Study|Lost to Follow-up|0
4441463|NCT00454636|7225760|FG003|Overall Study|Lost to Follow-up|0
4441464|NCT00454649|7225780|FG000|Overall Study|Lack of Efficacy|2
4441465|NCT00454649|7225781|FG001|Overall Study|Lack of Efficacy|2
4441466|NCT00454649|7225782|FG002|Overall Study|Lack of Efficacy|10
4441467|NCT00454649|7225783|FG003|Overall Study|Lack of Efficacy|3
4441468|NCT00454649|7225784|FG004|Overall Study|Lack of Efficacy|0
4441469|NCT00454649|7225785|FG005|Overall Study|Lack of Efficacy|4
4441470|NCT00454649|7225786|FG006|Overall Study|Lack of Efficacy|5
4441471|NCT00454649|7225787|FG007|Overall Study|Lack of Efficacy|13
4441472|NCT00454649|7225788|FG008|Overall Study|Lack of Efficacy|10
4441473|NCT00454649|7225789|FG009|Overall Study|Lack of Efficacy|2
4441474|NCT00454649|7225780|FG000|Overall Study|Adverse Event|0
4441475|NCT00454649|7225781|FG001|Overall Study|Adverse Event|1
4441476|NCT00454649|7225782|FG002|Overall Study|Adverse Event|3
4441477|NCT00454649|7225783|FG003|Overall Study|Adverse Event|0
4441478|NCT00454649|7225784|FG004|Overall Study|Adverse Event|1
4441479|NCT00454649|7225785|FG005|Overall Study|Adverse Event|2
4441480|NCT00454649|7225786|FG006|Overall Study|Adverse Event|3
4441481|NCT00454649|7225787|FG007|Overall Study|Adverse Event|4
4441482|NCT00454649|7225788|FG008|Overall Study|Adverse Event|6
4441483|NCT00454649|7225789|FG009|Overall Study|Adverse Event|2
4441484|NCT00454649|7225780|FG000|Overall Study|Lost to Follow-up|0
4441485|NCT00454649|7225781|FG001|Overall Study|Lost to Follow-up|0
4441486|NCT00454649|7225782|FG002|Overall Study|Lost to Follow-up|1
4441487|NCT00454649|7225783|FG003|Overall Study|Lost to Follow-up|0
4441488|NCT00454649|7225784|FG004|Overall Study|Lost to Follow-up|0
4441489|NCT00454649|7225785|FG005|Overall Study|Lost to Follow-up|0
4441490|NCT00454649|7225786|FG006|Overall Study|Lost to Follow-up|1
4441491|NCT00454649|7225787|FG007|Overall Study|Lost to Follow-up|0
4441492|NCT00454649|7225788|FG008|Overall Study|Lost to Follow-up|0
4441493|NCT00454649|7225789|FG009|Overall Study|Lost to Follow-up|0
4441494|NCT00454649|7225780|FG000|Overall Study|Other|1
4441495|NCT00454649|7225781|FG001|Overall Study|Other|1
4441496|NCT00454649|7225782|FG002|Overall Study|Other|5
4441497|NCT00454649|7225783|FG003|Overall Study|Other|3
4441498|NCT00454649|7225784|FG004|Overall Study|Other|0
4441499|NCT00454649|7225785|FG005|Overall Study|Other|0
4441500|NCT00454649|7225786|FG006|Overall Study|Other|0
4441501|NCT00454649|7225787|FG007|Overall Study|Other|0
4441502|NCT00454649|7225788|FG008|Overall Study|Other|3
4716446|NCT02992288|7645796|FG001|Overall Study|Death|0
4716447|NCT02992288|7645797|FG002|Overall Study|Death|2
4716448|NCT02992288|7645798|FG003|Overall Study|Death|1
4716449|NCT02992288|7645799|FG004|Overall Study|Death|2
4716450|NCT02992288|7645800|FG005|Overall Study|Death|0
4716451|NCT02992288|7645795|FG000|Overall Study|Lost to Follow-up|0
4716452|NCT02992288|7645796|FG001|Overall Study|Lost to Follow-up|0
4716453|NCT02992288|7645797|FG002|Overall Study|Lost to Follow-up|0
4716454|NCT02992288|7645798|FG003|Overall Study|Lost to Follow-up|1
4716455|NCT02992288|7645799|FG004|Overall Study|Lost to Follow-up|0
4441503|NCT00454649|7225789|FG009|Overall Study|Other|1
4441504|NCT00454649|7225780|FG000|Overall Study|Withdrawal by Subject|0
4441505|NCT00454649|7225781|FG001|Overall Study|Withdrawal by Subject|0
4441506|NCT00454649|7225782|FG002|Overall Study|Withdrawal by Subject|0
4441507|NCT00454649|7225783|FG003|Overall Study|Withdrawal by Subject|0
4441508|NCT00454649|7225784|FG004|Overall Study|Withdrawal by Subject|0
4441509|NCT00454649|7225785|FG005|Overall Study|Withdrawal by Subject|1
4441510|NCT00454649|7225786|FG006|Overall Study|Withdrawal by Subject|0
4441511|NCT00454649|7225787|FG007|Overall Study|Withdrawal by Subject|2
4441512|NCT00454649|7225788|FG008|Overall Study|Withdrawal by Subject|1
4441513|NCT00454649|7225789|FG009|Overall Study|Withdrawal by Subject|0
4441514|NCT00454779|7225832|FG000|First-line Treatment Phase|Lack of Efficacy|0
4441515|NCT00454779|7225833|FG001|First-line Treatment Phase|Lack of Efficacy|2
4441516|NCT00454779|7225832|FG000|First-line Treatment Phase|Withdrawal by Subject|2
4441517|NCT00454779|7225833|FG001|First-line Treatment Phase|Withdrawal by Subject|4
4441518|NCT00454779|7225832|FG000|First-line Treatment Phase|Lost to Follow-up|1
4441519|NCT00454779|7225833|FG001|First-line Treatment Phase|Lost to Follow-up|0
4441520|NCT00454779|7225832|FG000|First-line Treatment Phase|Protocol Violation|0
4441521|NCT00454779|7225833|FG001|First-line Treatment Phase|Protocol Violation|1
4441522|NCT00454779|7225832|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1
4441523|NCT00454779|7225833|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1
4441524|NCT00454779|7225832|FG000|First-line Treatment Phase|Ongoing|1
4441525|NCT00454779|7225833|FG001|First-line Treatment Phase|Ongoing|0
4441526|NCT00454779|7225832|FG000|Second-line Treatment Phase|Withdrawal by Subject|0
4441527|NCT00454779|7225833|FG001|Second-line Treatment Phase|Withdrawal by Subject|1
4441528|NCT00454779|7225832|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0
4441529|NCT00454779|7225833|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1
4441530|NCT00454779|7225832|FG000|Second-line Treatment Phase|Ongoing|0
4441531|NCT00454779|7225833|FG001|Second-line Treatment Phase|Ongoing|1
4441532|NCT00454805|7225841|FG000|Overall Study|Withdrawal by Subject|9
4441533|NCT00454805|7225842|FG001|Overall Study|Withdrawal by Subject|2
4441534|NCT00454805|7225841|FG000|Overall Study|Death|0
4441535|NCT00454805|7225842|FG001|Overall Study|Death|2
4441536|NCT00454805|7225841|FG000|Overall Study|Disease progression|16
4441537|NCT00454805|7225842|FG001|Overall Study|Disease progression|19
4441538|NCT00454805|7225841|FG000|Overall Study|In order to begin radiotherapy|1
4441539|NCT00454805|7225842|FG001|Overall Study|In order to begin radiotherapy|0
4441540|NCT00454818|7225856|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1
4441541|NCT00454818|7225857|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0
4441542|NCT00454818|7225858|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0
4441543|NCT00454818|7225859|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0
4441544|NCT00454818|7225860|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0
4441545|NCT00454818|7225856|FG000|Phase I: Open-label Dose-escalation|Death|0
4441546|NCT00454818|7225857|FG001|Phase I: Open-label Dose-escalation|Death|1
4441547|NCT00454818|7225858|FG002|Phase I: Open-label Dose-escalation|Death|0
4441548|NCT00454818|7225859|FG003|Phase I: Open-label Dose-escalation|Death|0
4441549|NCT00454818|7225860|FG004|Phase I: Open-label Dose-escalation|Death|0
4441550|NCT00454818|7225856|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
4441551|NCT00454818|7225857|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
4441552|NCT00454818|7225858|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1
4441553|NCT00454818|7225859|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1
4441554|NCT00454818|7225860|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
4441555|NCT00454818|7225856|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
4441556|NCT00454818|7225857|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1
4441557|NCT00454818|7225858|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
4441558|NCT00454818|7225859|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1
4441559|NCT00454818|7225860|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
4441560|NCT00454818|7225856|FG000|Phase 2: Randomized Double-blind|Death|0
4441561|NCT00454818|7225857|FG001|Phase 2: Randomized Double-blind|Death|1
4441562|NCT00454818|7225858|FG002|Phase 2: Randomized Double-blind|Death|0
4441563|NCT00454818|7225859|FG003|Phase 2: Randomized Double-blind|Death|0
4441564|NCT00454818|7225860|FG004|Phase 2: Randomized Double-blind|Death|1
4441565|NCT00454818|7225856|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0
4441566|NCT00454818|7225857|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0
4441567|NCT00454818|7225858|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2
4441568|NCT00454818|7225859|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0
4441569|NCT00454818|7225860|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1
4441570|NCT00454818|7225856|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
4441571|NCT00454818|7225857|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
4441572|NCT00454818|7225858|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1
4441573|NCT00454818|7225859|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
4441574|NCT00454818|7225860|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2
4441575|NCT00454857|7225877|FG000|Overall Study|Withdrawal by Subject|15
4441576|NCT00454857|7225877|FG000|Overall Study|Lost to Follow-up|16
4441577|NCT00454857|7225877|FG000|Overall Study|Noncompliance|6
4441578|NCT00454857|7225877|FG000|Overall Study|Death|5
4441579|NCT00454857|7225877|FG000|Overall Study|Other|11
4441580|NCT00454857|7225877|FG000|Overall Study|Reason unknown|1
4441581|NCT00454909|7225884|FG000|Overall Study|Withdrawal by Subject|1
4441582|NCT00454909|7225885|FG001|Overall Study|Withdrawal by Subject|0
4441583|NCT00454909|7225886|FG002|Overall Study|Withdrawal by Subject|0
4441584|NCT00454909|7225884|FG000|Overall Study|Migrated/moved from study area|0
4441585|NCT00454909|7225885|FG001|Overall Study|Migrated/moved from study area|0
4441586|NCT00454909|7225886|FG002|Overall Study|Migrated/moved from study area|1
4441587|NCT00454909|7225884|FG000|Overall Study|Lost to follow-up (complete vaccination)|5
4441588|NCT00454909|7225885|FG001|Overall Study|Lost to follow-up (complete vaccination)|3
4441589|NCT00454909|7225886|FG002|Overall Study|Lost to follow-up (complete vaccination)|1
4441590|NCT00454909|7225884|FG000|Overall Study|Others|1
4441591|NCT00454909|7225885|FG001|Overall Study|Others|0
4441592|NCT00454909|7225886|FG002|Overall Study|Others|0
4441593|NCT00454987|7225898|FG000|Booster Period (NCT00258700)|Adverse Event|1
4441594|NCT00454987|7225899|FG001|Booster Period (NCT00258700)|Adverse Event|0
4441595|NCT00454987|7225900|FG002|Booster Period (NCT00258700)|Adverse Event|0
4441596|NCT00454987|7225898|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0
4441597|NCT00454987|7225899|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1
4441598|NCT00454987|7225900|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0
4441599|NCT00454987|7225898|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1
4441600|NCT00454987|7225899|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0
4441601|NCT00454987|7225900|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0
4441602|NCT00455013|7225912|FG000|Short Term Period|Adverse Event|2
4441603|NCT00455013|7225913|FG001|Short Term Period|Adverse Event|5
4441604|NCT00455013|7225914|FG002|Short Term Period|Adverse Event|0
4441605|NCT00455013|7225912|FG000|Short Term Period|Withdrawal by Subject|0
4441606|NCT00455013|7225913|FG001|Short Term Period|Withdrawal by Subject|0
4441607|NCT00455013|7225914|FG002|Short Term Period|Withdrawal by Subject|1
4441608|NCT00455013|7225912|FG000|Short Term Period|Lack of Efficacy|4
4441609|NCT00455013|7225913|FG001|Short Term Period|Lack of Efficacy|0
4441610|NCT00455013|7225914|FG002|Short Term Period|Lack of Efficacy|0
4441611|NCT00455013|7225912|FG000|Short Term Period|Other|0
4441612|NCT00455013|7225913|FG001|Short Term Period|Other|0
4441613|NCT00455013|7225914|FG002|Short Term Period|Other|1
4441614|NCT00455013|7225912|FG000|Long Term Extension (LTE)|Adverse Event|0
4441615|NCT00455013|7225913|FG001|Long Term Extension (LTE)|Adverse Event|1
4441616|NCT00455013|7225914|FG002|Long Term Extension (LTE)|Adverse Event|1
4441617|NCT00455013|7225912|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1
4441618|NCT00455013|7225913|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0
4441619|NCT00455013|7225914|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1
4441620|NCT00455013|7225912|FG000|Long Term Extension (LTE)|Death|1
4441621|NCT00455013|7225913|FG001|Long Term Extension (LTE)|Death|1
4441622|NCT00455013|7225914|FG002|Long Term Extension (LTE)|Death|0
4441623|NCT00455013|7225912|FG000|Long Term Extension (LTE)|No longer met criteria|0
4441624|NCT00455013|7225913|FG001|Long Term Extension (LTE)|No longer met criteria|0
4441625|NCT00455013|7225914|FG002|Long Term Extension (LTE)|No longer met criteria|1
4441626|NCT00455013|7225912|FG000|Long Term Extension (LTE)|Subject Request or refused|0
4441627|NCT00455013|7225913|FG001|Long Term Extension (LTE)|Subject Request or refused|0
4441628|NCT00455013|7225914|FG002|Long Term Extension (LTE)|Subject Request or refused|3
4441629|NCT00455013|7225912|FG000|Long Term Extension (LTE)|Poor non-compliance|0
4441630|NCT00455013|7225913|FG001|Long Term Extension (LTE)|Poor non-compliance|1
4441631|NCT00455013|7225914|FG002|Long Term Extension (LTE)|Poor non-compliance|0
4441632|NCT00455013|7225912|FG000|Long Term Extension (LTE)|non-specified|0
4441633|NCT00455013|7225913|FG001|Long Term Extension (LTE)|non-specified|0
4441634|NCT00455013|7225914|FG002|Long Term Extension (LTE)|non-specified|1
4441635|NCT00455195|7225924|FG000|Double-blind Study AGLU02704|Adverse Event|2
4441636|NCT00455195|7225925|FG001|Double-blind Study AGLU02704|Adverse Event|1
4441637|NCT00455195|7225924|FG000|Double-blind Study AGLU02704|Death|1
4441638|NCT00455195|7225925|FG001|Double-blind Study AGLU02704|Death|0
4441639|NCT00455195|7225924|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2
4441640|NCT00455195|7225925|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2
4441641|NCT00455195|7225924|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0
4441642|NCT00455195|7225925|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1
4441643|NCT00455312|7225933|FG000|Overall Study|Death|0
4441644|NCT00455312|7225934|FG001|Overall Study|Death|1
4441645|NCT00455429|7225944|FG000|Overall Study|Study Terminated by Sponsor|0
4441646|NCT00455429|7225945|FG001|Overall Study|Study Terminated by Sponsor|0
4441647|NCT00455429|7225946|FG002|Overall Study|Study Terminated by Sponsor|0
4441648|NCT00455429|7225947|FG003|Overall Study|Study Terminated by Sponsor|3
4441649|NCT00455429|7225944|FG000|Overall Study|Lost to Follow-up|1
4441650|NCT00455429|7225945|FG001|Overall Study|Lost to Follow-up|0
4441651|NCT00455429|7225946|FG002|Overall Study|Lost to Follow-up|0
4441652|NCT00455429|7225947|FG003|Overall Study|Lost to Follow-up|3
4441653|NCT00455429|7225944|FG000|Overall Study|Withdrawal by Subject|0
4441654|NCT00455429|7225945|FG001|Overall Study|Withdrawal by Subject|1
4441655|NCT00455429|7225946|FG002|Overall Study|Withdrawal by Subject|1
4441656|NCT00455429|7225947|FG003|Overall Study|Withdrawal by Subject|0
4441657|NCT00455429|7225944|FG000|Overall Study|Lack of Efficacy|0
4441658|NCT00455429|7225945|FG001|Overall Study|Lack of Efficacy|1
4441659|NCT00455429|7225946|FG002|Overall Study|Lack of Efficacy|0
4441660|NCT00455429|7225947|FG003|Overall Study|Lack of Efficacy|1
4441661|NCT00455429|7225944|FG000|Overall Study|Adverse Event|0
4441662|NCT00455429|7225945|FG001|Overall Study|Adverse Event|1
4441663|NCT00455429|7225946|FG002|Overall Study|Adverse Event|0
4441664|NCT00455429|7225947|FG003|Overall Study|Adverse Event|3
4441665|NCT00455429|7225944|FG000|Overall Study|Randomly assigned but not treated|0
4441666|NCT00455429|7225945|FG001|Overall Study|Randomly assigned but not treated|0
4441667|NCT00455429|7225946|FG002|Overall Study|Randomly assigned but not treated|0
4441668|NCT00455429|7225947|FG003|Overall Study|Randomly assigned but not treated|2
4441669|NCT00455429|7225944|FG000|Overall Study|Personal Reason|1
4441670|NCT00455429|7225945|FG001|Overall Study|Personal Reason|0
4441671|NCT00455429|7225946|FG002|Overall Study|Personal Reason|0
4441672|NCT00455429|7225947|FG003|Overall Study|Personal Reason|0
4441673|NCT00455429|7225944|FG000|Overall Study|Non-compliance|0
4441674|NCT00455429|7225945|FG001|Overall Study|Non-compliance|0
4441675|NCT00455429|7225946|FG002|Overall Study|Non-compliance|0
4441676|NCT00455429|7225947|FG003|Overall Study|Non-compliance|1
4441677|NCT00455429|7225944|FG000|Overall Study|Other|0
4441678|NCT00455429|7225945|FG001|Overall Study|Other|2
4441679|NCT00455429|7225946|FG002|Overall Study|Other|0
4441680|NCT00455429|7225947|FG003|Overall Study|Other|1
4441681|NCT00455455|7225960|FG000|Washout|Withdrawal by Subject|0
4441682|NCT00455455|7225961|FG001|Washout|Withdrawal by Subject|1
4441683|NCT00455455|7225960|FG000|Washout|Withdrawal by Subject|1
4441684|NCT00455455|7225961|FG001|Washout|Withdrawal by Subject|0
4441685|NCT00455520|7225972|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24
4441686|NCT00455520|7225973|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0
4441687|NCT00455520|7225972|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3
4441688|NCT00455520|7225973|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0
4441689|NCT00455520|7225972|FG000|Open Label Tapentadol Extended Release|Adverse Event|100
4441690|NCT00455520|7225973|FG001|Open Label Tapentadol Extended Release|Adverse Event|0
4441691|NCT00455520|7225972|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23
4441692|NCT00455520|7225973|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0
4441693|NCT00455520|7225972|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13
4441694|NCT00455520|7225973|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0
4441695|NCT00455520|7225972|FG000|Open Label Tapentadol Extended Release|All other|33
4441696|NCT00455520|7225973|FG001|Open Label Tapentadol Extended Release|All other|0
4441697|NCT00455520|7225972|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29
4441698|NCT00455520|7225973|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15
4441699|NCT00455520|7225972|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8
4441700|NCT00455520|7225973|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29
4441701|NCT00455520|7225972|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15
4441702|NCT00455520|7225973|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7
4441703|NCT00455520|7225972|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3
4441704|NCT00455520|7225973|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3
4441705|NCT00455520|7225972|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4
4441706|NCT00455520|7225973|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2
4441707|NCT00455520|7225972|FG000|Double Blind Tapentadol ER vs Placebo|All other|4
4441708|NCT00455520|7225973|FG001|Double Blind Tapentadol ER vs Placebo|All other|6
4441709|NCT00455533|7225981|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1
4441710|NCT00455533|7225982|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0
4441711|NCT00455533|7225983|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0
4441712|NCT00455533|7225981|FG000|Period One: Initial Chemotherapy|Disease Progression|5
4441713|NCT00455533|7225982|FG001|Period One: Initial Chemotherapy|Disease Progression|0
4441714|NCT00455533|7225983|FG002|Period One: Initial Chemotherapy|Disease Progression|0
4441715|NCT00455533|7225981|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2
4441716|NCT00455533|7225982|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0
4441717|NCT00455533|7225983|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0
4441718|NCT00455533|7225981|FG000|Period One: Initial Chemotherapy|Not Reported|1
4441719|NCT00455533|7225982|FG001|Period One: Initial Chemotherapy|Not Reported|0
4441720|NCT00455533|7225983|FG002|Period One: Initial Chemotherapy|Not Reported|0
4441721|NCT00455533|7225981|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2
4441722|NCT00455533|7225982|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0
4441723|NCT00455533|7225983|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0
4441724|NCT00455533|7225981|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2
4441725|NCT00455533|7225982|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0
4441726|NCT00455533|7225983|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0
4441727|NCT00455533|7225981|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1
4441728|NCT00455533|7225982|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0
4512918|NCT00938717|7323070|FG000|Overall Study|Withdrawal by Subject|26
4441729|NCT00455533|7225983|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0
4441730|NCT00455533|7225981|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2
4441731|NCT00455533|7225982|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0
4441732|NCT00455533|7225983|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0
4441733|NCT00455533|7225981|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2
4441734|NCT00455533|7225982|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0
4441735|NCT00455533|7225983|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0
4441736|NCT00455533|7225981|FG000|Period Two: Randomized Period|Death|0
4441737|NCT00455533|7225982|FG001|Period Two: Randomized Period|Death|0
4441738|NCT00455533|7225983|FG002|Period Two: Randomized Period|Death|3
4441739|NCT00455533|7225981|FG000|Period Two: Randomized Period|Disease Progression|0
4441740|NCT00455533|7225982|FG001|Period Two: Randomized Period|Disease Progression|1
4441741|NCT00455533|7225983|FG002|Period Two: Randomized Period|Disease Progression|1
4441742|NCT00455533|7225981|FG000|Period Two: Randomized Period|Lost to Follow-up|0
4441743|NCT00455533|7225982|FG001|Period Two: Randomized Period|Lost to Follow-up|0
4441744|NCT00455533|7225983|FG002|Period Two: Randomized Period|Lost to Follow-up|1
4441745|NCT00455533|7225981|FG000|Period Two: Randomized Period|Other - need reasons|0
4441746|NCT00455533|7225982|FG001|Period Two: Randomized Period|Other - need reasons|1
4441747|NCT00455533|7225983|FG002|Period Two: Randomized Period|Other - need reasons|0
4441748|NCT00455533|7225981|FG000|Period Two: Randomized Period|Study Drug Toxicity|0
4441749|NCT00455533|7225982|FG001|Period Two: Randomized Period|Study Drug Toxicity|2
4441750|NCT00455533|7225983|FG002|Period Two: Randomized Period|Study Drug Toxicity|0
4441751|NCT00455533|7225981|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0
4441752|NCT00455533|7225982|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2
4441753|NCT00455533|7225983|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1
4441754|NCT00455741|7226046|FG000|Overall Study|Physician Decision|0
4441755|NCT00455741|7226047|FG001|Overall Study|Physician Decision|1
4441756|NCT00455858|7226063|FG000|Overall Study|Lost to Follow-up|2
4441757|NCT00455858|7226063|FG000|Overall Study|Protocol Violation|1
4441758|NCT00455858|7226063|FG000|Overall Study|Lack of Efficacy|1
4441759|NCT00455858|7226063|FG000|Overall Study|Well controlled FPG without insulin|1
4441760|NCT00455858|7226063|FG000|Overall Study|Withdrawal|1
4441761|NCT00455923|7226069|FG000|Overall Study|Pregnancy|0
4441762|NCT00455923|7226070|FG001|Overall Study|Pregnancy|2
4441763|NCT00455923|7226069|FG000|Overall Study|Other|3
4441764|NCT00455923|7226070|FG001|Overall Study|Other|1
4441765|NCT00456092|7226103|FG000|Extension Phase|Grade 2 or Greater AE|2
4441766|NCT00456092|7226104|FG001|Extension Phase|Grade 2 or Greater AE|2
4441767|NCT00456092|7226105|FG002|Extension Phase|Grade 2 or Greater AE|0
4441768|NCT00456092|7226106|FG003|Extension Phase|Grade 2 or Greater AE|0
4441769|NCT00456092|7226107|FG004|Extension Phase|Grade 2 or Greater AE|2
4441770|NCT00456092|7226103|FG000|Extension Phase|Flare of Psoriatic Arthritis|1
4441771|NCT00456092|7226104|FG001|Extension Phase|Flare of Psoriatic Arthritis|0
4441772|NCT00456092|7226105|FG002|Extension Phase|Flare of Psoriatic Arthritis|0
4441773|NCT00456092|7226106|FG003|Extension Phase|Flare of Psoriatic Arthritis|0
4441774|NCT00456092|7226107|FG004|Extension Phase|Flare of Psoriatic Arthritis|1
4441775|NCT00456092|7226103|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3
4441776|NCT00456092|7226104|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1
4441777|NCT00456092|7226105|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0
4441778|NCT00456092|7226106|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0
4441779|NCT00456092|7226107|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2
4441780|NCT00456092|7226103|FG000|Extension Phase|Withdrew Consent|2
4441781|NCT00456092|7226104|FG001|Extension Phase|Withdrew Consent|0
4441782|NCT00456092|7226105|FG002|Extension Phase|Withdrew Consent|0
4441783|NCT00456092|7226106|FG003|Extension Phase|Withdrew Consent|0
4441784|NCT00456092|7226107|FG004|Extension Phase|Withdrew Consent|0
4441785|NCT00456092|7226103|FG000|Extension Phase|Lost to Follow-up|1
4441786|NCT00456092|7226104|FG001|Extension Phase|Lost to Follow-up|1
4441787|NCT00456092|7226105|FG002|Extension Phase|Lost to Follow-up|0
4441788|NCT00456092|7226106|FG003|Extension Phase|Lost to Follow-up|0
4441789|NCT00456092|7226107|FG004|Extension Phase|Lost to Follow-up|1
4441790|NCT00456092|7226103|FG000|Extension Phase|Other|2
4441791|NCT00456092|7226104|FG001|Extension Phase|Other|0
4441792|NCT00456092|7226105|FG002|Extension Phase|Other|0
4441793|NCT00456092|7226106|FG003|Extension Phase|Other|1
4441794|NCT00456092|7226107|FG004|Extension Phase|Other|1
4441795|NCT00456092|7226103|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3
4441796|NCT00456092|7226104|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4
4441797|NCT00456092|7226105|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2
4441798|NCT00456092|7226106|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0
4441799|NCT00456092|7226107|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0
4441800|NCT00456092|7226103|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1
4441801|NCT00456092|7226104|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2
4441802|NCT00456092|7226105|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0
4441803|NCT00456092|7226106|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0
4441804|NCT00456092|7226107|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0
4512919|NCT00938717|7323071|FG001|Overall Study|Withdrawal by Subject|24
4441805|NCT00456092|7226103|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2
4441806|NCT00456092|7226104|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
4441807|NCT00456092|7226105|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
4441808|NCT00456092|7226106|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
4441809|NCT00456092|7226107|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
4441810|NCT00456092|7226103|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0
4441811|NCT00456092|7226104|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1
4441812|NCT00456092|7226105|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2
4441813|NCT00456092|7226106|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0
4441814|NCT00456092|7226107|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0
4441815|NCT00456092|7226103|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0
4441816|NCT00456092|7226104|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3
4441817|NCT00456092|7226105|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3
4441818|NCT00456092|7226106|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0
4441819|NCT00456092|7226107|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0
4441820|NCT00456092|7226103|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0
4441821|NCT00456092|7226104|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2
4441822|NCT00456092|7226105|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7
4441823|NCT00456092|7226106|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0
4441824|NCT00456092|7226107|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0
4441825|NCT00456092|7226103|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0
4441826|NCT00456092|7226104|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1
4441827|NCT00456092|7226105|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2
4441828|NCT00456092|7226106|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0
4441829|NCT00456092|7226107|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0
4441830|NCT00456092|7226103|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0
4441831|NCT00456092|7226104|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1
4441832|NCT00456092|7226105|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1
4441833|NCT00456092|7226106|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0
4441834|NCT00456092|7226107|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0
4441835|NCT00456092|7226103|FG000|Treatment Phase (12 Weeks)|Other|1
4441836|NCT00456092|7226104|FG001|Treatment Phase (12 Weeks)|Other|0
4441837|NCT00456092|7226105|FG002|Treatment Phase (12 Weeks)|Other|1
4441838|NCT00456092|7226106|FG003|Treatment Phase (12 Weeks)|Other|0
4441839|NCT00456092|7226107|FG004|Treatment Phase (12 Weeks)|Other|0
4441840|NCT00456300|7226130|FG000|Overall Study|Adverse Event|1
4441841|NCT00456300|7226131|FG001|Overall Study|Adverse Event|0
4441842|NCT00456365|7226141|FG000|Overall Study|Lost to Follow-up|1
4441843|NCT00456365|7226142|FG001|Overall Study|Lost to Follow-up|3
4441844|NCT00456365|7226141|FG000|Overall Study|Withdrawal by Subject|4
4441845|NCT00456365|7226142|FG001|Overall Study|Withdrawal by Subject|7
4441846|NCT00456365|7226141|FG000|Overall Study|Pregnancy|1
4441847|NCT00456365|7226142|FG001|Overall Study|Pregnancy|1
4441848|NCT00456365|7226141|FG000|Overall Study|oncologic diagnosis|1
4441849|NCT00456365|7226142|FG001|Overall Study|oncologic diagnosis|1
4441850|NCT00456495|7226150|FG000|Overall Study|Physician Decision|2
4441851|NCT00456521|7226161|FG000|Overall Study|Adverse Event|150
4441852|NCT00456521|7226162|FG001|Overall Study|Adverse Event|25
4441853|NCT00456521|7226161|FG000|Overall Study|Withdrawal by Subject|43
4441854|NCT00456521|7226162|FG001|Overall Study|Withdrawal by Subject|24
4441855|NCT00456521|7226161|FG000|Overall Study|Lost to Follow-up|22
4441856|NCT00456521|7226162|FG001|Overall Study|Lost to Follow-up|17
4441857|NCT00456521|7226161|FG000|Overall Study|Lack of Efficacy|3
4441858|NCT00456521|7226162|FG001|Overall Study|Lack of Efficacy|6
4441859|NCT00456521|7226161|FG000|Overall Study|Protocol Violation|4
4441860|NCT00456521|7226162|FG001|Overall Study|Protocol Violation|0
4441861|NCT00456521|7226161|FG000|Overall Study|Pregnancy|1
4441862|NCT00456521|7226162|FG001|Overall Study|Pregnancy|1
4441863|NCT00456521|7226161|FG000|Overall Study|Drug non-compliance, moved, other|26
4441864|NCT00456521|7226162|FG001|Overall Study|Drug non-compliance, moved, other|11
4441865|NCT00456599|7226178|FG000|Overall Study|Non-compliance|1
4441866|NCT00456599|7226178|FG000|Overall Study|Withdrawal by Subject|2
4441867|NCT00456755|7226188|FG000|Overall Study|Lost to Follow-up|2
4441868|NCT00456755|7226189|FG001|Overall Study|Lost to Follow-up|1
4441869|NCT00456846|7226206|FG000|Overall Study|Adverse Event|2
4441870|NCT00456846|7226207|FG001|Overall Study|Adverse Event|15
4441871|NCT00456846|7226206|FG000|Overall Study|Physician Decision|11
4441872|NCT00456846|7226207|FG001|Overall Study|Physician Decision|6
4441873|NCT00456846|7226206|FG000|Overall Study|Protocol Deviation|2
4441874|NCT00456846|7226207|FG001|Overall Study|Protocol Deviation|0
4441875|NCT00456846|7226206|FG000|Overall Study|Participant Discretion|1
4441876|NCT00456846|7226207|FG001|Overall Study|Participant Discretion|5
4441877|NCT00456846|7226206|FG000|Overall Study|Other|0
4441878|NCT00456846|7226207|FG001|Overall Study|Other|2
4441879|NCT00457002|7226221|FG000|Overall Study|Death|40
4441880|NCT00457002|7226222|FG001|Overall Study|Death|47
4441881|NCT00457002|7226221|FG000|Overall Study|Adverse Event|284
4441882|NCT00457002|7226222|FG001|Overall Study|Adverse Event|260
4441883|NCT00457002|7226221|FG000|Overall Study|Withdrawal by Subject|299
4441884|NCT00457002|7226222|FG001|Overall Study|Withdrawal by Subject|271
4441885|NCT00457002|7226221|FG000|Overall Study|Lost to Follow-up|72
4441886|NCT00457002|7226222|FG001|Overall Study|Lost to Follow-up|71
4441887|NCT00457002|7226221|FG000|Overall Study|Poor/Non-compliance|46
4441888|NCT00457002|7226222|FG001|Overall Study|Poor/Non-compliance|33
4441889|NCT00457002|7226221|FG000|Overall Study|No longer met criteria|41
4441890|NCT00457002|7226222|FG001|Overall Study|No longer met criteria|37
4441891|NCT00457002|7226221|FG000|Overall Study|Administrative reason by Sponsor|1
4441892|NCT00457002|7226222|FG001|Overall Study|Administrative reason by Sponsor|0
4441893|NCT00457002|7226221|FG000|Overall Study|non-specified|29
4441894|NCT00457002|7226222|FG001|Overall Study|non-specified|38
4441895|NCT00457002|7226221|FG000|Overall Study|treated for 1 day; missing status/reason|1
4441896|NCT00457002|7226222|FG001|Overall Study|treated for 1 day; missing status/reason|0
4441897|NCT00457015|7226230|FG000|Overall Study|Left study site against medical advice|0
4441898|NCT00457015|7226231|FG001|Overall Study|Left study site against medical advice|1
4441899|NCT00457249|7226248|FG000|Overall Study|Lost to Follow-up|3
4441900|NCT00457249|7226249|FG001|Overall Study|Lost to Follow-up|0
4441901|NCT00457249|7226248|FG000|Overall Study|Protocol Violation|4
4441902|NCT00457249|7226249|FG001|Overall Study|Protocol Violation|1
4441903|NCT00457249|7226248|FG000|Overall Study|Withdrawal by Subject|3
4441904|NCT00457249|7226249|FG001|Overall Study|Withdrawal by Subject|1
4441905|NCT00457249|7226248|FG000|Overall Study|Serious Adverse Events|2
4441906|NCT00457249|7226249|FG001|Overall Study|Serious Adverse Events|0
4441907|NCT00457301|7226259|FG000|Overall Study|Withdrawal by Subject|3
4441908|NCT00457301|7226260|FG001|Overall Study|Withdrawal by Subject|3
4441909|NCT00457301|7226259|FG000|Overall Study|Censored out of the study|15
4441910|NCT00457301|7226260|FG001|Overall Study|Censored out of the study|14
4441911|NCT00457301|7226259|FG000|Overall Study|Death|5
4441912|NCT00457301|7226260|FG001|Overall Study|Death|7
4441913|NCT00457392|7226277|FG000|Overall Study|Objective Progression or Relapse|229
4441914|NCT00457392|7226278|FG001|Overall Study|Objective Progression or Relapse|296
4441915|NCT00457392|7226277|FG000|Overall Study|Death|106
4441916|NCT00457392|7226278|FG001|Overall Study|Death|106
4441917|NCT00457392|7226277|FG000|Overall Study|Adverse Event|84
4441918|NCT00457392|7226278|FG001|Overall Study|Adverse Event|41
4441919|NCT00457392|7226277|FG000|Overall Study|Global Deterioration of Health Status|22
4441920|NCT00457392|7226278|FG001|Overall Study|Global Deterioration of Health Status|8
4441921|NCT00457392|7226277|FG000|Overall Study|Withdrawal by Subject|14
4441922|NCT00457392|7226278|FG001|Overall Study|Withdrawal by Subject|8
4441923|NCT00457392|7226277|FG000|Overall Study|Lost to Follow-up|6
4441924|NCT00457392|7226278|FG001|Overall Study|Lost to Follow-up|7
4441925|NCT00457392|7226277|FG000|Overall Study|Protocol Violation|4
4441926|NCT00457392|7226278|FG001|Overall Study|Protocol Violation|3
4441927|NCT00457392|7226277|FG000|Overall Study|Other|7
4441928|NCT00457392|7226278|FG001|Overall Study|Other|4
4441929|NCT00457392|7226277|FG000|Overall Study|Study Terminated by Sponsor|1
4441930|NCT00457392|7226278|FG001|Overall Study|Study Terminated by Sponsor|4
4441931|NCT00457392|7226277|FG000|Overall Study|Randomized, Not Treated|7
4441932|NCT00457392|7226278|FG001|Overall Study|Randomized, Not Treated|3
4441933|NCT00457418|7226284|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2
4441934|NCT00457418|7226284|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1
4441935|NCT00457418|7226284|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2
4441936|NCT00457418|7226284|FG000|Post PK Maintenance|Adverse Event|10
4441937|NCT00457418|7226284|FG000|Post PK Maintenance|Progression of Disease|6
4441938|NCT00457418|7226284|FG000|Post PK Maintenance|Withdrawal by Subject|11
4630351|NCT01296711|7498862|FG005|Overall Study|Methotrexate discontinued|0
4441939|NCT00457418|7226284|FG000|Post PK Maintenance|Lost to Follow-up|1
4441940|NCT00457626|7226288|FG000|Overall Study|Adverse Event|3
4441941|NCT00457626|7226288|FG000|Overall Study|Administrative Problems|2
4441942|NCT00457626|7226288|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1
4441943|NCT00457639|7226292|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3
4441944|NCT00457639|7226293|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0
4441945|NCT00457639|7226292|FG000|Intervention 1 (6 Months)|unrelated illness|0
4441946|NCT00457639|7226293|FG001|Intervention 1 (6 Months)|unrelated illness|2
4441947|NCT00457639|7226292|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0
4441948|NCT00457639|7226293|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1
4441949|NCT00457665|7226301|FG000|12 Months|Drug allergy|1
4441950|NCT00457665|7226302|FG001|12 Months|Drug allergy|1
4441951|NCT00457665|7226301|FG000|12 Months|High HIV viral load|5
4441952|NCT00457665|7226302|FG001|12 Months|High HIV viral load|1
4441953|NCT00457665|7226301|FG000|12 Months|Lipodystrophy|2
4441954|NCT00457665|7226302|FG001|12 Months|Lipodystrophy|0
4441955|NCT00457665|7226301|FG000|12 Months|Withdrawal by Subject|0
4441956|NCT00457665|7226302|FG001|12 Months|Withdrawal by Subject|2
4630352|NCT01296711|7498863|FG006|Overall Study|Methotrexate discontinued|0
4630353|NCT01296711|7498864|FG007|Overall Study|Methotrexate discontinued|0
4630354|NCT01296711|7498857|FG000|Overall Study|Investigator discretion|0
4630355|NCT01296711|7498858|FG001|Overall Study|Investigator discretion|0
4441957|NCT00457665|7226301|FG000|12 Months|Abnormal Liver function tests|0
4441958|NCT00457665|7226302|FG001|12 Months|Abnormal Liver function tests|5
4441959|NCT00457665|7226301|FG000|24 Months|Withdrawal by Subject|3
4441960|NCT00457665|7226302|FG001|24 Months|Withdrawal by Subject|2
4441961|NCT00457665|7226301|FG000|24 Months|Lipodystrophy|1
4441962|NCT00457665|7226302|FG001|24 Months|Lipodystrophy|1
4441963|NCT00457665|7226301|FG000|24 Months|Abnormal liver function tests|1
4441964|NCT00457665|7226302|FG001|24 Months|Abnormal liver function tests|5
4441965|NCT00457691|7226310|FG000|Overall Study|Adverse Event|4
4441966|NCT00457691|7226311|FG001|Overall Study|Adverse Event|1
4441967|NCT00457691|7226310|FG000|Overall Study|Death|163
4441968|NCT00457691|7226311|FG001|Overall Study|Death|148
4441969|NCT00457691|7226310|FG000|Overall Study|Protocol Violation|1
4441970|NCT00457691|7226311|FG001|Overall Study|Protocol Violation|3
4441971|NCT00457691|7226310|FG000|Overall Study|Lost to Follow-up|23
4441972|NCT00457691|7226311|FG001|Overall Study|Lost to Follow-up|14
4441973|NCT00457691|7226310|FG000|Overall Study|Study terminated by Sponsor|1
4441974|NCT00457691|7226311|FG001|Overall Study|Study terminated by Sponsor|1
4441975|NCT00457691|7226310|FG000|Overall Study|Subject refused (reason other than AE)|14
4441976|NCT00457691|7226311|FG001|Overall Study|Subject refused (reason other than AE)|19
4441977|NCT00457691|7226310|FG000|Overall Study|Disease progression, study terminated|180
4441978|NCT00457691|7226311|FG001|Overall Study|Disease progression, study terminated|196
4441979|NCT00457743|7226333|FG000|Overall Study|Adverse Event|0
4441980|NCT00457743|7226334|FG001|Overall Study|Adverse Event|4
4441981|NCT00457743|7226335|FG002|Overall Study|Adverse Event|0
4441982|NCT00457743|7226333|FG000|Overall Study|Lack of Efficacy|3
4441983|NCT00457743|7226334|FG001|Overall Study|Lack of Efficacy|23
4441984|NCT00457743|7226335|FG002|Overall Study|Lack of Efficacy|3
4441985|NCT00457821|7226356|FG000|Part 2|Withdrawal by Subject|0
4441986|NCT00457821|7226357|FG001|Part 2|Withdrawal by Subject|0
4441987|NCT00457821|7226358|FG002|Part 2|Withdrawal by Subject|0
4441988|NCT00457821|7226359|FG003|Part 2|Withdrawal by Subject|0
4441989|NCT00457821|7226360|FG004|Part 2|Withdrawal by Subject|0
4441990|NCT00457821|7226361|FG005|Part 2|Withdrawal by Subject|0
4441991|NCT00457821|7226362|FG006|Part 2|Withdrawal by Subject|0
4441992|NCT00457821|7226363|FG007|Part 2|Withdrawal by Subject|1
4441993|NCT00458211|7226389|FG000|Overall Study|Lack of Efficacy|12
4441994|NCT00458211|7226389|FG000|Overall Study|Withdrawal by Subject|2
4441995|NCT00458211|7226389|FG000|Overall Study|Protocol Violation|2
4441996|NCT00458302|7226413|FG000|Overall Study|Adverse Event|4
4441997|NCT00458302|7226414|FG001|Overall Study|Adverse Event|14
4441998|NCT00458302|7226413|FG000|Overall Study|Pregnancy|2
4441999|NCT00458302|7226414|FG001|Overall Study|Pregnancy|1
4442000|NCT00458302|7226413|FG000|Overall Study|Protocol Violation|0
4442001|NCT00458302|7226414|FG001|Overall Study|Protocol Violation|2
4442002|NCT00458302|7226413|FG000|Overall Study|Withdrawal by Subject|6
4442003|NCT00458302|7226414|FG001|Overall Study|Withdrawal by Subject|4
4442004|NCT00458302|7226413|FG000|Overall Study|Inc/Exc Criteria Not Met|1
4442005|NCT00458302|7226414|FG001|Overall Study|Inc/Exc Criteria Not Met|1
4442006|NCT00458302|7226413|FG000|Overall Study|Study Termination By Sponsor|1
4442007|NCT00458302|7226414|FG001|Overall Study|Study Termination By Sponsor|0
4442008|NCT00458302|7226413|FG000|Overall Study|Lost to Follow-up|2
4442009|NCT00458302|7226414|FG001|Overall Study|Lost to Follow-up|0
4442010|NCT00458302|7226413|FG000|Overall Study|Other|4
4442011|NCT00458302|7226414|FG001|Overall Study|Other|2
4442012|NCT00458341|7226423|FG000|Cycle 1|Adverse Event|1
4442013|NCT00458341|7226424|FG001|Cycle 1|Adverse Event|0
4442014|NCT00458393|7226432|FG000|Overall Study|Withdrawal by Subject|67
4442015|NCT00458393|7226433|FG001|Overall Study|Withdrawal by Subject|80
4442016|NCT00458393|7226432|FG000|Overall Study|Physician Decision|31
4442017|NCT00458393|7226433|FG001|Overall Study|Physician Decision|22
4442018|NCT00458393|7226432|FG000|Overall Study|Relocated|77
4442019|NCT00458393|7226433|FG001|Overall Study|Relocated|81
4442020|NCT00458393|7226432|FG000|Overall Study|Lost to Follow-up|115
4442021|NCT00458393|7226433|FG001|Overall Study|Lost to Follow-up|92
4442022|NCT00458393|7226432|FG000|Overall Study|Sites marked other on the form.|19
4442023|NCT00458393|7226433|FG001|Overall Study|Sites marked other on the form.|20
4442024|NCT00458484|7226464|FG000|Overall Study|Not eligible b/c prior radiation history|0
4442025|NCT00458484|7226465|FG001|Overall Study|Not eligible b/c prior radiation history|0
4442026|NCT00458484|7226466|FG002|Overall Study|Not eligible b/c prior radiation history|0
4442027|NCT00458484|7226467|FG003|Overall Study|Not eligible b/c prior radiation history|0
4442028|NCT00458484|7226468|FG004|Overall Study|Not eligible b/c prior radiation history|0
4442029|NCT00458484|7226469|FG005|Overall Study|Not eligible b/c prior radiation history|1
4442030|NCT00458484|7226470|FG006|Overall Study|Not eligible b/c prior radiation history|0
4442031|NCT00458705|7226495|FG000|Overall Study|Adverse Event|4
4442032|NCT00458705|7226495|FG000|Overall Study|Not Treated|1
4442033|NCT00458783|7226501|FG000|Overall Study|Protocol Violation|1228
4442034|NCT00458783|7226502|FG001|Overall Study|Protocol Violation|1220
4442035|NCT00459043|7226525|FG000|Overall Study|Withdrawal by Subject|1
4442036|NCT00459043|7226526|FG001|Overall Study|Withdrawal by Subject|0
4442037|NCT00459056|7226534|FG000|First Intervention (First Three Months)|Lost to Follow-up|1
4442038|NCT00459056|7226535|FG001|First Intervention (First Three Months)|Lost to Follow-up|1
4442039|NCT00459108|7226541|FG000|Overall Study|Withdrawal by Subject|5
4442040|NCT00459108|7226541|FG000|Overall Study|Adverse Event|3
4442041|NCT00459108|7226541|FG000|Overall Study|Death|2
4442042|NCT00459108|7226541|FG000|Overall Study|Progression|1
4442043|NCT00459134|7226548|FG000|Overall Study|Physician Decision|1
4442044|NCT00459134|7226549|FG001|Overall Study|Physician Decision|1
4442045|NCT00459134|7226548|FG000|Overall Study|Withdrawal by Subject|8
4442046|NCT00459134|7226549|FG001|Overall Study|Withdrawal by Subject|7
4442047|NCT00459134|7226548|FG000|Overall Study|Lost to Follow-up|6
4442048|NCT00459134|7226549|FG001|Overall Study|Lost to Follow-up|7
4442049|NCT00459134|7226548|FG000|Overall Study|Surgery|1
4442050|NCT00459134|7226549|FG001|Overall Study|Surgery|2
4442051|NCT00459134|7226548|FG000|Overall Study|Toxicity|4
4442052|NCT00459134|7226549|FG001|Overall Study|Toxicity|5
4442053|NCT00459134|7226548|FG000|Overall Study|Progression|1
4442054|NCT00459134|7226549|FG001|Overall Study|Progression|0
4442055|NCT00459134|7226548|FG000|Overall Study|Multiple Reasons|2
4442056|NCT00459134|7226549|FG001|Overall Study|Multiple Reasons|3
4442057|NCT00459186|7226555|FG000|Single Agent RAD001|Withdrawal by Subject|1
4442058|NCT00459186|7226555|FG000|PET Imaging and Assessment|Adverse Event|3
4442059|NCT00459290|7226559|FG000|Overall Study|Adverse Event|3
4442060|NCT00459290|7226559|FG000|Overall Study|Ineligible|2
4512920|NCT00938717|7323070|FG000|Overall Study|Lost to Follow-up|13
4512921|NCT00938717|7323071|FG001|Overall Study|Lost to Follow-up|18
4512922|NCT00938717|7323070|FG000|Overall Study|Lack of Efficacy|33
4512923|NCT00938717|7323071|FG001|Overall Study|Lack of Efficacy|15
4512924|NCT00938717|7323070|FG000|Overall Study|Other reason|5
4512925|NCT00938717|7323071|FG001|Overall Study|Other reason|2
4512926|NCT00938860|7323088|FG000|Overall Study|Adverse Event|2
4512927|NCT00938860|7323089|FG001|Overall Study|Adverse Event|1
4512928|NCT00938860|7323088|FG000|Overall Study|Abnormal laboratory values|2
4512929|NCT00938860|7323089|FG001|Overall Study|Abnormal laboratory values|2
4512930|NCT00938860|7323088|FG000|Overall Study|Withdrawal by Subject|11
4512931|NCT00938860|7323089|FG001|Overall Study|Withdrawal by Subject|8
4512932|NCT00938860|7323088|FG000|Overall Study|Lost to Follow-up|4
4512933|NCT00938860|7323089|FG001|Overall Study|Lost to Follow-up|4
4512934|NCT00938860|7323088|FG000|Overall Study|Administration problems|2
4512935|NCT00938860|7323089|FG001|Overall Study|Administration problems|0
4512936|NCT00938860|7323088|FG000|Overall Study|Death|1
4512937|NCT00938860|7323089|FG001|Overall Study|Death|1
4512938|NCT00938860|7323088|FG000|Overall Study|Protocol Violation|3
4512939|NCT00938860|7323089|FG001|Overall Study|Protocol Violation|1
4512940|NCT00938886|7323097|FG000|Overall Study|Death|0
4512941|NCT00938886|7323098|FG001|Overall Study|Death|1
4512942|NCT00938886|7323097|FG000|Overall Study|Withdrawal by Subject|4
4512943|NCT00938886|7323098|FG001|Overall Study|Withdrawal by Subject|7
4512944|NCT00938886|7323097|FG000|Overall Study|Lost to Follow-up|3
4512945|NCT00938886|7323098|FG001|Overall Study|Lost to Follow-up|2
4512946|NCT00938964|7323106|FG000|Overall Study|Death|3
4512947|NCT00938964|7323107|FG001|Overall Study|Death|3
4512948|NCT00938964|7323106|FG000|Overall Study|Lost to Follow-up|2
4512949|NCT00938964|7323107|FG001|Overall Study|Lost to Follow-up|3
4512950|NCT00938964|7323106|FG000|Overall Study|Withdrawal by Subject|22
4512951|NCT00938964|7323107|FG001|Overall Study|Withdrawal by Subject|18
4512952|NCT00938964|7323106|FG000|Overall Study|Found to Meet Exclusion Criteria|3
4512953|NCT00938964|7323107|FG001|Overall Study|Found to Meet Exclusion Criteria|4
4512954|NCT00939003|7323115|FG000|Double-blind Treatment Period|Adverse Event|1
4512955|NCT00939003|7323116|FG001|Double-blind Treatment Period|Adverse Event|1
4512956|NCT00939003|7323115|FG000|Double-blind Treatment Period|Lack of Efficacy|0
4512957|NCT00939003|7323116|FG001|Double-blind Treatment Period|Lack of Efficacy|1
4512958|NCT00939003|7323115|FG000|Double-blind Treatment Period|Pregnancy|0
4512959|NCT00939003|7323116|FG001|Double-blind Treatment Period|Pregnancy|1
4512960|NCT00939003|7323115|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1
4512961|NCT00939003|7323116|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1
4512962|NCT00939003|7323115|FG000|Open-label Treatment Period|Adverse Event|4
4512963|NCT00939003|7323116|FG001|Open-label Treatment Period|Adverse Event|8
4512964|NCT00939003|7323115|FG000|Open-label Treatment Period|Withdrawal by Subject|14
4512965|NCT00939003|7323116|FG001|Open-label Treatment Period|Withdrawal by Subject|7
4512966|NCT00939003|7323115|FG000|Open-label Treatment Period|Lack of Efficacy|6
4512967|NCT00939003|7323116|FG001|Open-label Treatment Period|Lack of Efficacy|9
4512968|NCT00939003|7323115|FG000|Open-label Treatment Period|Pregnancy|1
4512969|NCT00939003|7323116|FG001|Open-label Treatment Period|Pregnancy|1
4512970|NCT00939003|7323115|FG000|Open-label Treatment Period|Exclusion Criteria|1
4512971|NCT00939003|7323116|FG001|Open-label Treatment Period|Exclusion Criteria|0
4512972|NCT00939003|7323115|FG000|Open-label Treatment Period|Site Closure|3
4512973|NCT00939003|7323116|FG001|Open-label Treatment Period|Site Closure|4
4512974|NCT00939029|7323127|FG000|Overall Study|Withdrawal by Subject|3
4512975|NCT00939029|7323128|FG001|Overall Study|Withdrawal by Subject|7
4512976|NCT00939029|7323127|FG000|Overall Study|Lost to Follow-up|3
4512977|NCT00939029|7323128|FG001|Overall Study|Lost to Follow-up|4
4512978|NCT00939029|7323127|FG000|Overall Study|Adverse Event|0
4512979|NCT00939029|7323128|FG001|Overall Study|Adverse Event|1
4512980|NCT00939055|7323136|FG000|Overall Study|Discontinuation prior to procedure|4
4512981|NCT00939055|7323137|FG001|Overall Study|Discontinuation prior to procedure|0
4512982|NCT00939094|7323146|FG000|Overall Study|Adverse Event|9
4512983|NCT00939094|7323147|FG001|Overall Study|Adverse Event|0
4512984|NCT00939094|7323146|FG000|Overall Study|Withdrawal by Subject|1
4512985|NCT00939094|7323147|FG001|Overall Study|Withdrawal by Subject|6
4512986|NCT00939094|7323146|FG000|Overall Study|Lost to Follow-up|1
4512987|NCT00939094|7323147|FG001|Overall Study|Lost to Follow-up|1
4442061|NCT00459316|7226582|FG000|Steps 1 & 2|Other eligibility failure|1
4442062|NCT00459316|7226583|FG001|Steps 1 & 2|Other eligibility failure|1
4442063|NCT00459316|7226584|FG002|Steps 1 & 2|Other eligibility failure|0
4442064|NCT00459316|7226582|FG000|Steps 1 & 2|Death|1
4442065|NCT00459316|7226583|FG001|Steps 1 & 2|Death|1
4442066|NCT00459316|7226584|FG002|Steps 1 & 2|Death|0
4442067|NCT00459316|7226582|FG000|Steps 1 & 2|Not able to get to clinic|7
4442068|NCT00459316|7226583|FG001|Steps 1 & 2|Not able to get to clinic|4
4442069|NCT00459316|7226584|FG002|Steps 1 & 2|Not able to get to clinic|0
4442070|NCT00459316|7226582|FG000|Steps 1 & 2|Withdrawal by Subject|6
4442071|NCT00459316|7226583|FG001|Steps 1 & 2|Withdrawal by Subject|1
4442072|NCT00459316|7226584|FG002|Steps 1 & 2|Withdrawal by Subject|0
4442073|NCT00459316|7226582|FG000|Steps 1 & 2|Not willing to adhere to regulations|1
4442074|NCT00459316|7226583|FG001|Steps 1 & 2|Not willing to adhere to regulations|0
4442075|NCT00459316|7226584|FG002|Steps 1 & 2|Not willing to adhere to regulations|0
4442076|NCT00459316|7226582|FG000|Steps 1 & 2|Lost to Follow-up|5
4442077|NCT00459316|7226583|FG001|Steps 1 & 2|Lost to Follow-up|0
4442078|NCT00459316|7226584|FG002|Steps 1 & 2|Lost to Follow-up|2
4442079|NCT00459316|7226582|FG000|Step 3|Withdrawal by Subject|3
4442080|NCT00459316|7226583|FG001|Step 3|Withdrawal by Subject|0
4442081|NCT00459316|7226584|FG002|Step 3|Withdrawal by Subject|1
4442082|NCT00459342|7226607|FG000|Overall Study|Not eligible|1
4442083|NCT00459355|7226613|FG000|Overall Study|Subject no longer met inc criteria|20
4442084|NCT00459355|7226614|FG001|Overall Study|Subject no longer met inc criteria|18
4442085|NCT00459537|7226639|FG000|Overall Study|Adverse Event|1
4442086|NCT00459537|7226640|FG001|Overall Study|Adverse Event|6
4442087|NCT00459537|7226639|FG000|Overall Study|Lack of Efficacy|10
4442088|NCT00459537|7226640|FG001|Overall Study|Lack of Efficacy|11
4442089|NCT00459537|7226639|FG000|Overall Study|Withdrawal by Subject|20
4442090|NCT00459537|7226640|FG001|Overall Study|Withdrawal by Subject|26
4442091|NCT00459537|7226639|FG000|Overall Study|Lost to Follow-up|27
4442092|NCT00459537|7226640|FG001|Overall Study|Lost to Follow-up|30
4442093|NCT00459537|7226639|FG000|Overall Study|Administrative problems|3
4442094|NCT00459537|7226640|FG001|Overall Study|Administrative problems|0
4442095|NCT00459537|7226639|FG000|Overall Study|Protocol Violation|4
4442096|NCT00459537|7226640|FG001|Overall Study|Protocol Violation|3
4442097|NCT00459537|7226639|FG000|Overall Study|Missing|1
4442098|NCT00459537|7226640|FG001|Overall Study|Missing|0
4442099|NCT00459667|7226649|FG000|Overall Study|Adverse Event|9
4442100|NCT00459667|7226650|FG001|Overall Study|Adverse Event|12
4442101|NCT00459667|7226651|FG002|Overall Study|Adverse Event|8
4442102|NCT00459667|7226649|FG000|Overall Study|Lost to Follow-up|5
4442103|NCT00459667|7226650|FG001|Overall Study|Lost to Follow-up|9
4442104|NCT00459667|7226651|FG002|Overall Study|Lost to Follow-up|3
4442105|NCT00459667|7226649|FG000|Overall Study|Pregnancy|1
4442106|NCT00459667|7226650|FG001|Overall Study|Pregnancy|1
4442107|NCT00459667|7226651|FG002|Overall Study|Pregnancy|1
4442108|NCT00459667|7226649|FG000|Overall Study|Protocol Violation|1
4442109|NCT00459667|7226650|FG001|Overall Study|Protocol Violation|0
4442110|NCT00459667|7226651|FG002|Overall Study|Protocol Violation|0
4442111|NCT00459667|7226649|FG000|Overall Study|Withdrawal by Subject|3
4442112|NCT00459667|7226650|FG001|Overall Study|Withdrawal by Subject|5
4442113|NCT00459667|7226651|FG002|Overall Study|Withdrawal by Subject|5
4442114|NCT00459667|7226649|FG000|Overall Study|Other disease modifying treatment|1
4442115|NCT00459667|7226650|FG001|Overall Study|Other disease modifying treatment|2
4442116|NCT00459667|7226651|FG002|Overall Study|Other disease modifying treatment|1
4442117|NCT00459667|7226649|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12
4442118|NCT00459667|7226650|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15
4442119|NCT00459667|7226651|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1
4442120|NCT00459667|7226649|FG000|Overall Study|No treatment administered|6
4442121|NCT00459667|7226650|FG001|Overall Study|No treatment administered|3
4442122|NCT00459667|7226651|FG002|Overall Study|No treatment administered|1
4442123|NCT00459706|7226661|FG000|Overall Study|Adverse Event|19
4442124|NCT00459706|7226662|FG001|Overall Study|Adverse Event|13
4442125|NCT00459706|7226661|FG000|Overall Study|Withdrawal by Subject|1
4442126|NCT00459706|7226662|FG001|Overall Study|Withdrawal by Subject|6
4442127|NCT00459706|7226661|FG000|Overall Study|Physician Decision|2
4442128|NCT00459706|7226662|FG001|Overall Study|Physician Decision|0
4442129|NCT00459706|7226661|FG000|Overall Study|Discontinuation of Study by Sponsor|1
4442130|NCT00459706|7226662|FG001|Overall Study|Discontinuation of Study by Sponsor|0
4442131|NCT00459706|7226661|FG000|Overall Study|Protocol Violation|2
4442132|NCT00459706|7226662|FG001|Overall Study|Protocol Violation|1
4442133|NCT00459706|7226661|FG000|Overall Study|Failed to Return|1
4442134|NCT00459706|7226662|FG001|Overall Study|Failed to Return|0
4442135|NCT00459706|7226661|FG000|Overall Study|Other|0
4442136|NCT00459706|7226662|FG001|Overall Study|Other|1
4442137|NCT00459875|7226685|FG000|Overall Study|Ineligible participant|1
4442138|NCT00459875|7226685|FG000|Overall Study|Adverse Event|2
4442139|NCT00459953|7226691|FG000|Overall Study|not analyzed-household member in study|1
4442140|NCT00459953|7226692|FG001|Overall Study|not analyzed-household member in study|1
4442141|NCT00459979|7226698|FG000|Overall Study|Withdrawal by Subject|1
4442142|NCT00459979|7226698|FG000|Overall Study|Protocol Violation|1
4442143|NCT00460031|7226702|FG000|Overall Study|Adverse Event|5
4442144|NCT00460031|7226702|FG000|Overall Study|Withdrawal by Subject|5
4442145|NCT00460031|7226702|FG000|Overall Study|Death|1
4442146|NCT00460109|7226706|FG000|Overall Study|Death|1
4442147|NCT00460239|7226710|FG000|Overall Study|Physician Decision|0
4442148|NCT00460239|7226711|FG001|Overall Study|Physician Decision|1
4442149|NCT00460239|7226712|FG002|Overall Study|Physician Decision|0
4442150|NCT00460239|7226713|FG003|Overall Study|Physician Decision|0
4442151|NCT00460239|7226714|FG004|Overall Study|Physician Decision|0
4442152|NCT00460239|7226715|FG005|Overall Study|Physician Decision|2
4442153|NCT00460239|7226716|FG006|Overall Study|Physician Decision|0
4442154|NCT00460239|7226717|FG007|Overall Study|Physician Decision|0
4442155|NCT00460239|7226718|FG008|Overall Study|Physician Decision|0
4442156|NCT00460239|7226710|FG000|Overall Study|Withdrawal by Subject|0
4442157|NCT00460239|7226711|FG001|Overall Study|Withdrawal by Subject|0
4442158|NCT00460239|7226712|FG002|Overall Study|Withdrawal by Subject|0
4442159|NCT00460239|7226713|FG003|Overall Study|Withdrawal by Subject|0
4442160|NCT00460239|7226714|FG004|Overall Study|Withdrawal by Subject|0
4442161|NCT00460239|7226715|FG005|Overall Study|Withdrawal by Subject|1
4442162|NCT00460239|7226716|FG006|Overall Study|Withdrawal by Subject|0
4442163|NCT00460239|7226717|FG007|Overall Study|Withdrawal by Subject|0
4442164|NCT00460239|7226718|FG008|Overall Study|Withdrawal by Subject|0
4442165|NCT00460265|7226733|FG000|Overall Study|Lost to Follow-up|14
4442166|NCT00460265|7226734|FG001|Overall Study|Lost to Follow-up|15
4442167|NCT00460265|7226733|FG000|Overall Study|Physician Decision|1
4442168|NCT00460265|7226734|FG001|Overall Study|Physician Decision|2
4442169|NCT00460265|7226733|FG000|Overall Study|Withdrawal by Subject|10
4442170|NCT00460265|7226734|FG001|Overall Study|Withdrawal by Subject|25
4442171|NCT00460265|7226733|FG000|Overall Study|Ongoing|60
4442172|NCT00460265|7226734|FG001|Overall Study|Ongoing|47
4442173|NCT00460408|7226744|FG000|Overall Study|Adverse Event|1
4442174|NCT00460408|7226745|FG001|Overall Study|Adverse Event|0
4442175|NCT00460408|7226746|FG002|Overall Study|Adverse Event|0
4442176|NCT00460408|7226747|FG003|Overall Study|Adverse Event|0
4442177|NCT00460408|7226744|FG000|Overall Study|Death|7
4442178|NCT00460408|7226745|FG001|Overall Study|Death|0
4442179|NCT00460408|7226746|FG002|Overall Study|Death|0
4442180|NCT00460408|7226747|FG003|Overall Study|Death|0
4442181|NCT00460408|7226744|FG000|Overall Study|Lost to Follow-up|11
4442182|NCT00460408|7226745|FG001|Overall Study|Lost to Follow-up|0
4442183|NCT00460408|7226746|FG002|Overall Study|Lost to Follow-up|1
4442184|NCT00460408|7226747|FG003|Overall Study|Lost to Follow-up|0
4442185|NCT00460408|7226744|FG000|Overall Study|Withdrawal by Subject|31
4442186|NCT00460408|7226745|FG001|Overall Study|Withdrawal by Subject|0
4442187|NCT00460408|7226746|FG002|Overall Study|Withdrawal by Subject|0
4442188|NCT00460408|7226747|FG003|Overall Study|Withdrawal by Subject|0
4442189|NCT00460408|7226744|FG000|Overall Study|Insufficient clinical response|5
4442190|NCT00460408|7226745|FG001|Overall Study|Insufficient clinical response|1
4442191|NCT00460408|7226746|FG002|Overall Study|Insufficient clinical response|5
4442192|NCT00460408|7226747|FG003|Overall Study|Insufficient clinical response|0
4442193|NCT00460408|7226744|FG000|Overall Study|Other|12
4442194|NCT00460408|7226745|FG001|Overall Study|Other|2
4442195|NCT00460408|7226746|FG002|Overall Study|Other|0
4442196|NCT00460408|7226747|FG003|Overall Study|Other|0
4442197|NCT00460434|7226771|FG000|Overall Study|Lost to Follow-up|3
4442198|NCT00460434|7226772|FG001|Overall Study|Lost to Follow-up|7
4442199|NCT00460564|7226795|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3
4442200|NCT00460564|7226796|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1
4442201|NCT00460564|7226797|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0
4442202|NCT00460564|7226798|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0
4442203|NCT00460564|7226799|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0
4442204|NCT00460564|7226800|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0
4442205|NCT00460564|7226801|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0
4442206|NCT00460564|7226802|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0
4442207|NCT00460564|7226795|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1
4442208|NCT00460564|7226796|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
4442209|NCT00460564|7226797|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
4442210|NCT00460564|7226798|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
4442211|NCT00460564|7226799|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
4442212|NCT00460564|7226800|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
4442213|NCT00460564|7226801|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
4442214|NCT00460564|7226802|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
4442215|NCT00460564|7226795|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0
4442216|NCT00460564|7226796|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0
4442217|NCT00460564|7226797|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0
4442218|NCT00460564|7226798|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0
4442219|NCT00460564|7226799|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3
4442220|NCT00460564|7226800|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5
4442221|NCT00460564|7226801|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2
4442222|NCT00460564|7226802|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0
4442223|NCT00460564|7226795|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
4442224|NCT00460564|7226796|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
4442225|NCT00460564|7226797|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
4442226|NCT00460564|7226798|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
4442227|NCT00460564|7226799|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5
4442228|NCT00460564|7226800|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1
4442229|NCT00460564|7226801|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
4442230|NCT00460564|7226802|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
4442231|NCT00460564|7226795|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
4442232|NCT00460564|7226796|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
4442233|NCT00460564|7226797|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
4442234|NCT00460564|7226798|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
4442235|NCT00460564|7226799|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1
4442236|NCT00460564|7226800|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
4442237|NCT00460564|7226801|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
4442238|NCT00460564|7226802|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
4442239|NCT00460577|7226824|FG000|Overall Study|Protocol Violation|2
4442240|NCT00460577|7226825|FG001|Overall Study|Protocol Violation|6
4442241|NCT00460603|7226843|FG000|Phase 1|Death|1
4442242|NCT00460603|7226844|FG001|Phase 1|Death|0
4442243|NCT00460603|7226845|FG002|Phase 1|Death|0
4442244|NCT00460603|7226846|FG003|Phase 1|Death|2
4442245|NCT00460603|7226847|FG004|Phase 1|Death|0
4442246|NCT00460603|7226848|FG005|Phase 1|Death|0
4442247|NCT00460603|7226849|FG006|Phase 1|Death|0
4442248|NCT00460603|7226850|FG007|Phase 1|Death|0
4442249|NCT00460603|7226851|FG008|Phase 1|Death|1
4442250|NCT00460603|7226852|FG009|Phase 1|Death|0
4442251|NCT00460603|7226853|FG010|Phase 1|Death|0
4442252|NCT00460603|7226854|FG011|Phase 1|Death|0
4442253|NCT00460603|7226843|FG000|Phase 1|Adverse Event|3
4442254|NCT00460603|7226844|FG001|Phase 1|Adverse Event|1
4442255|NCT00460603|7226845|FG002|Phase 1|Adverse Event|1
4442256|NCT00460603|7226846|FG003|Phase 1|Adverse Event|2
4442257|NCT00460603|7226847|FG004|Phase 1|Adverse Event|0
4442258|NCT00460603|7226848|FG005|Phase 1|Adverse Event|0
4442259|NCT00460603|7226849|FG006|Phase 1|Adverse Event|3
4442260|NCT00460603|7226850|FG007|Phase 1|Adverse Event|0
4442261|NCT00460603|7226851|FG008|Phase 1|Adverse Event|4
4442262|NCT00460603|7226852|FG009|Phase 1|Adverse Event|0
4442263|NCT00460603|7226853|FG010|Phase 1|Adverse Event|0
4442264|NCT00460603|7226854|FG011|Phase 1|Adverse Event|0
4442265|NCT00460603|7226843|FG000|Phase 1|Lack of Efficacy|1
4442266|NCT00460603|7226844|FG001|Phase 1|Lack of Efficacy|0
4442267|NCT00460603|7226845|FG002|Phase 1|Lack of Efficacy|1
4442268|NCT00460603|7226846|FG003|Phase 1|Lack of Efficacy|2
4442269|NCT00460603|7226847|FG004|Phase 1|Lack of Efficacy|2
4442270|NCT00460603|7226848|FG005|Phase 1|Lack of Efficacy|2
4442271|NCT00460603|7226849|FG006|Phase 1|Lack of Efficacy|2
4442272|NCT00460603|7226850|FG007|Phase 1|Lack of Efficacy|2
4442273|NCT00460603|7226851|FG008|Phase 1|Lack of Efficacy|11
4442274|NCT00460603|7226852|FG009|Phase 1|Lack of Efficacy|0
4442275|NCT00460603|7226853|FG010|Phase 1|Lack of Efficacy|0
4442276|NCT00460603|7226854|FG011|Phase 1|Lack of Efficacy|0
4442277|NCT00460603|7226843|FG000|Phase 1|Withdrawal by Subject|1
4442278|NCT00460603|7226844|FG001|Phase 1|Withdrawal by Subject|2
4442279|NCT00460603|7226845|FG002|Phase 1|Withdrawal by Subject|1
4442280|NCT00460603|7226846|FG003|Phase 1|Withdrawal by Subject|1
4442281|NCT00460603|7226847|FG004|Phase 1|Withdrawal by Subject|3
4442282|NCT00460603|7226848|FG005|Phase 1|Withdrawal by Subject|0
4442283|NCT00460603|7226849|FG006|Phase 1|Withdrawal by Subject|1
4442284|NCT00460603|7226850|FG007|Phase 1|Withdrawal by Subject|0
4442285|NCT00460603|7226851|FG008|Phase 1|Withdrawal by Subject|2
4442286|NCT00460603|7226852|FG009|Phase 1|Withdrawal by Subject|0
4442287|NCT00460603|7226853|FG010|Phase 1|Withdrawal by Subject|0
4442288|NCT00460603|7226854|FG011|Phase 1|Withdrawal by Subject|0
4442289|NCT00460603|7226843|FG000|Phase 1|Other|0
4442290|NCT00460603|7226844|FG001|Phase 1|Other|3
4442291|NCT00460603|7226845|FG002|Phase 1|Other|1
4442292|NCT00460603|7226846|FG003|Phase 1|Other|1
4442293|NCT00460603|7226847|FG004|Phase 1|Other|1
4442294|NCT00460603|7226848|FG005|Phase 1|Other|2
4442295|NCT00460603|7226849|FG006|Phase 1|Other|0
4442296|NCT00460603|7226850|FG007|Phase 1|Other|1
4442297|NCT00460603|7226851|FG008|Phase 1|Other|0
4442298|NCT00460603|7226852|FG009|Phase 1|Other|0
4442299|NCT00460603|7226853|FG010|Phase 1|Other|0
4442300|NCT00460603|7226854|FG011|Phase 1|Other|0
4442301|NCT00460603|7226843|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
4442302|NCT00460603|7226844|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
4442303|NCT00460603|7226845|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
4442304|NCT00460603|7226846|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
4442305|NCT00460603|7226847|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
4442306|NCT00460603|7226848|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
4442307|NCT00460603|7226849|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
4442308|NCT00460603|7226850|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
4442309|NCT00460603|7226851|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
4442310|NCT00460603|7226852|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1
4442311|NCT00460603|7226853|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
4442312|NCT00460603|7226854|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
4442313|NCT00460603|7226843|FG000|Phase 2|Adverse Event|0
4442314|NCT00460603|7226844|FG001|Phase 2|Adverse Event|0
4442315|NCT00460603|7226845|FG002|Phase 2|Adverse Event|0
4442316|NCT00460603|7226846|FG003|Phase 2|Adverse Event|0
4442317|NCT00460603|7226847|FG004|Phase 2|Adverse Event|0
4442318|NCT00460603|7226848|FG005|Phase 2|Adverse Event|0
4442319|NCT00460603|7226849|FG006|Phase 2|Adverse Event|0
4442320|NCT00460603|7226850|FG007|Phase 2|Adverse Event|0
4442321|NCT00460603|7226851|FG008|Phase 2|Adverse Event|0
4442322|NCT00460603|7226852|FG009|Phase 2|Adverse Event|12
4442323|NCT00460603|7226853|FG010|Phase 2|Adverse Event|9
4442324|NCT00460603|7226854|FG011|Phase 2|Adverse Event|10
4442325|NCT00460603|7226843|FG000|Phase 2|Death|0
4442326|NCT00460603|7226844|FG001|Phase 2|Death|0
4442327|NCT00460603|7226845|FG002|Phase 2|Death|0
4442328|NCT00460603|7226846|FG003|Phase 2|Death|0
4442329|NCT00460603|7226847|FG004|Phase 2|Death|0
4442330|NCT00460603|7226848|FG005|Phase 2|Death|0
4442331|NCT00460603|7226849|FG006|Phase 2|Death|0
4442332|NCT00460603|7226850|FG007|Phase 2|Death|0
4442333|NCT00460603|7226851|FG008|Phase 2|Death|0
4442334|NCT00460603|7226852|FG009|Phase 2|Death|4
4442335|NCT00460603|7226853|FG010|Phase 2|Death|2
4442336|NCT00460603|7226854|FG011|Phase 2|Death|2
4442337|NCT00460603|7226843|FG000|Phase 2|Protocol Violation|0
4442338|NCT00460603|7226844|FG001|Phase 2|Protocol Violation|0
4442339|NCT00460603|7226845|FG002|Phase 2|Protocol Violation|0
4442340|NCT00460603|7226846|FG003|Phase 2|Protocol Violation|0
4442341|NCT00460603|7226847|FG004|Phase 2|Protocol Violation|0
4442342|NCT00460603|7226848|FG005|Phase 2|Protocol Violation|0
4442343|NCT00460603|7226849|FG006|Phase 2|Protocol Violation|0
4442344|NCT00460603|7226850|FG007|Phase 2|Protocol Violation|0
4442345|NCT00460603|7226851|FG008|Phase 2|Protocol Violation|0
4442346|NCT00460603|7226852|FG009|Phase 2|Protocol Violation|1
4442347|NCT00460603|7226853|FG010|Phase 2|Protocol Violation|1
4442348|NCT00460603|7226854|FG011|Phase 2|Protocol Violation|0
4442349|NCT00460603|7226843|FG000|Phase 2|Lost to Follow-up|0
4442350|NCT00460603|7226844|FG001|Phase 2|Lost to Follow-up|0
4442351|NCT00460603|7226845|FG002|Phase 2|Lost to Follow-up|0
4442352|NCT00460603|7226846|FG003|Phase 2|Lost to Follow-up|0
4442353|NCT00460603|7226847|FG004|Phase 2|Lost to Follow-up|0
4442354|NCT00460603|7226848|FG005|Phase 2|Lost to Follow-up|0
4442355|NCT00460603|7226849|FG006|Phase 2|Lost to Follow-up|0
4442356|NCT00460603|7226850|FG007|Phase 2|Lost to Follow-up|0
4442357|NCT00460603|7226851|FG008|Phase 2|Lost to Follow-up|0
4442358|NCT00460603|7226852|FG009|Phase 2|Lost to Follow-up|1
4442359|NCT00460603|7226853|FG010|Phase 2|Lost to Follow-up|0
4442360|NCT00460603|7226854|FG011|Phase 2|Lost to Follow-up|0
4442361|NCT00460603|7226843|FG000|Phase 2|Other|0
4442362|NCT00460603|7226844|FG001|Phase 2|Other|0
4442363|NCT00460603|7226845|FG002|Phase 2|Other|0
4442364|NCT00460603|7226846|FG003|Phase 2|Other|0
4442365|NCT00460603|7226847|FG004|Phase 2|Other|0
4442366|NCT00460603|7226848|FG005|Phase 2|Other|0
4442367|NCT00460603|7226849|FG006|Phase 2|Other|0
4442368|NCT00460603|7226850|FG007|Phase 2|Other|0
4442369|NCT00460603|7226851|FG008|Phase 2|Other|0
4442370|NCT00460603|7226852|FG009|Phase 2|Other|6
4442371|NCT00460603|7226853|FG010|Phase 2|Other|16
4442372|NCT00460603|7226854|FG011|Phase 2|Other|7
4442373|NCT00460603|7226843|FG000|Phase 2|Objective Progression or Relapse|0
4442374|NCT00460603|7226844|FG001|Phase 2|Objective Progression or Relapse|0
4442375|NCT00460603|7226845|FG002|Phase 2|Objective Progression or Relapse|0
4442376|NCT00460603|7226846|FG003|Phase 2|Objective Progression or Relapse|0
4442377|NCT00460603|7226847|FG004|Phase 2|Objective Progression or Relapse|0
4442378|NCT00460603|7226848|FG005|Phase 2|Objective Progression or Relapse|0
4442379|NCT00460603|7226849|FG006|Phase 2|Objective Progression or Relapse|0
4442380|NCT00460603|7226850|FG007|Phase 2|Objective Progression or Relapse|0
4442381|NCT00460603|7226851|FG008|Phase 2|Objective Progression or Relapse|0
4442382|NCT00460603|7226852|FG009|Phase 2|Objective Progression or Relapse|9
4442383|NCT00460603|7226853|FG010|Phase 2|Objective Progression or Relapse|10
4442384|NCT00460603|7226854|FG011|Phase 2|Objective Progression or Relapse|17
4442385|NCT00460603|7226843|FG000|Phase 2|Global Deterioration of Health Status|0
4442386|NCT00460603|7226844|FG001|Phase 2|Global Deterioration of Health Status|0
4442387|NCT00460603|7226845|FG002|Phase 2|Global Deterioration of Health Status|0
4442388|NCT00460603|7226846|FG003|Phase 2|Global Deterioration of Health Status|0
4442389|NCT00460603|7226847|FG004|Phase 2|Global Deterioration of Health Status|0
4442390|NCT00460603|7226848|FG005|Phase 2|Global Deterioration of Health Status|0
4442391|NCT00460603|7226849|FG006|Phase 2|Global Deterioration of Health Status|0
4442392|NCT00460603|7226850|FG007|Phase 2|Global Deterioration of Health Status|0
4442393|NCT00460603|7226851|FG008|Phase 2|Global Deterioration of Health Status|0
4442394|NCT00460603|7226852|FG009|Phase 2|Global Deterioration of Health Status|0
4442395|NCT00460603|7226853|FG010|Phase 2|Global Deterioration of Health Status|1
4442396|NCT00460603|7226854|FG011|Phase 2|Global Deterioration of Health Status|0
4442397|NCT00460603|7226843|FG000|Phase 2|Withdrawal by Subject|0
4442398|NCT00460603|7226844|FG001|Phase 2|Withdrawal by Subject|0
4442399|NCT00460603|7226845|FG002|Phase 2|Withdrawal by Subject|0
4442400|NCT00460603|7226846|FG003|Phase 2|Withdrawal by Subject|0
4442401|NCT00460603|7226847|FG004|Phase 2|Withdrawal by Subject|0
4442402|NCT00460603|7226848|FG005|Phase 2|Withdrawal by Subject|0
4442403|NCT00460603|7226849|FG006|Phase 2|Withdrawal by Subject|0
4442404|NCT00460603|7226850|FG007|Phase 2|Withdrawal by Subject|0
4442405|NCT00460603|7226851|FG008|Phase 2|Withdrawal by Subject|0
4442406|NCT00460603|7226852|FG009|Phase 2|Withdrawal by Subject|5
4442407|NCT00460603|7226853|FG010|Phase 2|Withdrawal by Subject|4
4442408|NCT00460603|7226854|FG011|Phase 2|Withdrawal by Subject|5
4442409|NCT00460603|7226843|FG000|Phase 2|Randomized, but not treated|0
4442410|NCT00460603|7226844|FG001|Phase 2|Randomized, but not treated|0
4442411|NCT00460603|7226845|FG002|Phase 2|Randomized, but not treated|0
4442412|NCT00460603|7226846|FG003|Phase 2|Randomized, but not treated|0
4442413|NCT00460603|7226847|FG004|Phase 2|Randomized, but not treated|0
4442414|NCT00460603|7226848|FG005|Phase 2|Randomized, but not treated|0
4442415|NCT00460603|7226849|FG006|Phase 2|Randomized, but not treated|0
4442416|NCT00460603|7226850|FG007|Phase 2|Randomized, but not treated|0
4442417|NCT00460603|7226851|FG008|Phase 2|Randomized, but not treated|0
4442418|NCT00460603|7226852|FG009|Phase 2|Randomized, but not treated|3
4442419|NCT00460603|7226853|FG010|Phase 2|Randomized, but not treated|0
4442420|NCT00460603|7226854|FG011|Phase 2|Randomized, but not treated|0
4442421|NCT00460655|7226882|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3
4442422|NCT00460655|7226883|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0
4442423|NCT00460655|7226884|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0
4442424|NCT00460655|7226885|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0
4442425|NCT00460655|7226882|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3
4442426|NCT00460655|7226883|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
4442427|NCT00460655|7226884|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
4442428|NCT00460655|7226885|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
4442429|NCT00460655|7226882|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0
4442430|NCT00460655|7226883|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1
4442431|NCT00460655|7226884|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0
4442432|NCT00460655|7226885|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0
4442433|NCT00460655|7226882|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0
4442434|NCT00460655|7226883|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0
4442435|NCT00460655|7226884|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1
4442436|NCT00460655|7226885|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6
4442437|NCT00460655|7226882|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
4442438|NCT00460655|7226883|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
4442439|NCT00460655|7226884|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6
4442440|NCT00460655|7226885|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2
4442441|NCT00460655|7226882|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
4442442|NCT00460655|7226883|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
4442443|NCT00460655|7226884|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
4442444|NCT00460655|7226885|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1
4442445|NCT00460746|7226895|FG000|Overall Study|Adverse Event|1
4442446|NCT00460746|7226895|FG000|Overall Study|Lost to Follow-up|1
4442447|NCT00460798|7226899|FG000|Overall Study|Death|59
4442448|NCT00460798|7226899|FG000|Overall Study|Adverse Event|27
4442449|NCT00460798|7226899|FG000|Overall Study|Lost to Follow-up|19
4442450|NCT00460798|7226899|FG000|Overall Study|Progressive Disease|99
4442451|NCT00460798|7226899|FG000|Overall Study|Other|27
4442452|NCT00460798|7226899|FG000|Overall Study|Ongoing at Date of Cut-Off|82
4442453|NCT00460798|7226899|FG000|Overall Study|Missing/Incomplete Dosing Information|27
4442454|NCT00460811|7226908|FG000|Overall Study|Adverse Event|4
4442455|NCT00460811|7226909|FG001|Overall Study|Adverse Event|6
4442456|NCT00460811|7226910|FG002|Overall Study|Adverse Event|3
4442457|NCT00460811|7226911|FG003|Overall Study|Adverse Event|10
4442458|NCT00460811|7226912|FG004|Overall Study|Adverse Event|2
4442459|NCT00460811|7226908|FG000|Overall Study|Noncompliance|1
4442460|NCT00460811|7226909|FG001|Overall Study|Noncompliance|0
4442461|NCT00460811|7226910|FG002|Overall Study|Noncompliance|0
4442462|NCT00460811|7226911|FG003|Overall Study|Noncompliance|2
4442463|NCT00460811|7226912|FG004|Overall Study|Noncompliance|1
4442464|NCT00460811|7226908|FG000|Overall Study|Withdrawal by Subject|7
4442465|NCT00460811|7226909|FG001|Overall Study|Withdrawal by Subject|7
4442466|NCT00460811|7226910|FG002|Overall Study|Withdrawal by Subject|6
4442467|NCT00460811|7226911|FG003|Overall Study|Withdrawal by Subject|3
4442468|NCT00460811|7226912|FG004|Overall Study|Withdrawal by Subject|11
4442469|NCT00460811|7226908|FG000|Overall Study|Physician Decision|1
4442470|NCT00460811|7226909|FG001|Overall Study|Physician Decision|0
4442471|NCT00460811|7226910|FG002|Overall Study|Physician Decision|0
4442472|NCT00460811|7226911|FG003|Overall Study|Physician Decision|0
4442473|NCT00460811|7226912|FG004|Overall Study|Physician Decision|0
4442474|NCT00460811|7226908|FG000|Overall Study|Lost to Follow-up|3
4442475|NCT00460811|7226909|FG001|Overall Study|Lost to Follow-up|2
4442476|NCT00460811|7226910|FG002|Overall Study|Lost to Follow-up|5
4442477|NCT00460811|7226911|FG003|Overall Study|Lost to Follow-up|3
4442478|NCT00460811|7226912|FG004|Overall Study|Lost to Follow-up|6
4442479|NCT00461123|7226954|FG000|Overall Study|Adverse Event|1
4442480|NCT00461123|7226955|FG001|Overall Study|Adverse Event|0
4442481|NCT00461123|7226954|FG000|Overall Study|Lost to Follow-up|1
4442482|NCT00461123|7226955|FG001|Overall Study|Lost to Follow-up|1
4442483|NCT00461123|7226954|FG000|Overall Study|Protocol Violation|3
4442484|NCT00461123|7226955|FG001|Overall Study|Protocol Violation|2
4442485|NCT00461123|7226954|FG000|Overall Study|Withdrawal by Subject|1
4442486|NCT00461123|7226955|FG001|Overall Study|Withdrawal by Subject|3
4442487|NCT00461175|7226963|FG000|Overall Study|Protocol Violation|522
4442488|NCT00461175|7226964|FG001|Overall Study|Protocol Violation|365
4442489|NCT00461253|7226972|FG000|Overall Study|Death|985
4442490|NCT00461253|7226973|FG001|Overall Study|Death|0
4442491|NCT00461253|7226972|FG000|Overall Study|Protocol Violation|613
4442492|NCT00461253|7226973|FG001|Overall Study|Protocol Violation|236
4442493|NCT00461253|7226972|FG000|Overall Study|no response|2609
4442494|NCT00461253|7226973|FG001|Overall Study|no response|11789
4442495|NCT00461253|7226972|FG000|Overall Study|administrative|773
4442496|NCT00461253|7226973|FG001|Overall Study|administrative|7773
4442497|NCT00461305|7226994|FG000|Treatment|Adverse Event|26
4442498|NCT00461305|7226995|FG001|Treatment|Adverse Event|3
4442499|NCT00461305|7226994|FG000|Treatment|Lost to Follow-up|4
4442500|NCT00461305|7226995|FG001|Treatment|Lost to Follow-up|2
4442501|NCT00461305|7226994|FG000|Treatment|Protocol Violation|13
4442502|NCT00461305|7226995|FG001|Treatment|Protocol Violation|2
4442503|NCT00461305|7226994|FG000|Treatment|Withdrawal by Subject|48
4442504|NCT00461305|7226995|FG001|Treatment|Withdrawal by Subject|2
4442505|NCT00461305|7226994|FG000|Treatment|Never dispensed|5
4442506|NCT00461305|7226995|FG001|Treatment|Never dispensed|0
4442507|NCT00461305|7226994|FG000|Treatment|Study drug not taken|1
4442508|NCT00461305|7226995|FG001|Treatment|Study drug not taken|0
4442509|NCT00461305|7226994|FG000|Treatment|Partially missing diary|2
4442510|NCT00461305|7226995|FG001|Treatment|Partially missing diary|0
4442511|NCT00461305|7226994|FG000|Treatment|Other (missing drug etc)|2
4442512|NCT00461305|7226995|FG001|Treatment|Other (missing drug etc)|0
4442513|NCT00461305|7226994|FG000|Continued Treatment|Adverse Event|26
4442514|NCT00461305|7226995|FG001|Continued Treatment|Adverse Event|0
4442515|NCT00461305|7226994|FG000|Continued Treatment|Lost to Follow-up|4
4442516|NCT00461305|7226995|FG001|Continued Treatment|Lost to Follow-up|0
4442517|NCT00461305|7226994|FG000|Continued Treatment|Protocol Violation|13
4442518|NCT00461305|7226995|FG001|Continued Treatment|Protocol Violation|0
4442519|NCT00461305|7226994|FG000|Continued Treatment|Withdrawal by Subject|48
4442520|NCT00461305|7226995|FG001|Continued Treatment|Withdrawal by Subject|0
4442521|NCT00461305|7226994|FG000|Continued Treatment|Partially missing diary|2
4442522|NCT00461305|7226995|FG001|Continued Treatment|Partially missing diary|0
4442523|NCT00461305|7226994|FG000|Continued Treatment|Other (missing drug etc)|2
4442524|NCT00461305|7226995|FG001|Continued Treatment|Other (missing drug etc)|0
4442525|NCT00461500|7227012|FG000|Overall Study|Adverse Event|1
4442526|NCT00461500|7227013|FG001|Overall Study|Adverse Event|0
4442527|NCT00461500|7227012|FG000|Overall Study|Lack of Efficacy|0
4442528|NCT00461500|7227013|FG001|Overall Study|Lack of Efficacy|1
4442529|NCT00461500|7227012|FG000|Overall Study|Expired Drug Treatment|1
4442530|NCT00461500|7227013|FG001|Overall Study|Expired Drug Treatment|1
4442531|NCT00461500|7227012|FG000|Overall Study|Study Stopped|1
4442532|NCT00461500|7227013|FG001|Overall Study|Study Stopped|2
4442533|NCT00461500|7227012|FG000|Overall Study|Drug Treatment Misuse|1
4442534|NCT00461500|7227013|FG001|Overall Study|Drug Treatment Misuse|0
4442535|NCT00461500|7227012|FG000|Overall Study|No Longer Willing to Take Part in Study|1
4442536|NCT00461500|7227013|FG001|Overall Study|No Longer Willing to Take Part in Study|0
4442537|NCT00461500|7227012|FG000|Overall Study|Lost to Follow-up|2
4442538|NCT00461500|7227013|FG001|Overall Study|Lost to Follow-up|2
4442539|NCT00461552|7227034|FG000|Overall Study|Drug Dispensing error|0
4442540|NCT00461552|7227035|FG001|Overall Study|Drug Dispensing error|2
4442541|NCT00461630|7227052|FG000|Overall Study|Death|798
4442542|NCT00461630|7227053|FG001|Overall Study|Death|732
4442543|NCT00461630|7227052|FG000|Overall Study|Lost to Follow-up|108
4442544|NCT00461630|7227053|FG001|Overall Study|Lost to Follow-up|95
4442545|NCT00461708|7227061|FG000|Overall Study|Adverse Event|17
4442546|NCT00461708|7227062|FG001|Overall Study|Adverse Event|7
4442547|NCT00461708|7227061|FG000|Overall Study|Lack of Efficacy|68
4442548|NCT00461708|7227062|FG001|Overall Study|Lack of Efficacy|20
4442549|NCT00461708|7227061|FG000|Overall Study|Physician Decision|10
4442550|NCT00461708|7227062|FG001|Overall Study|Physician Decision|4
4442551|NCT00461708|7227061|FG000|Overall Study|Withdrawal by Subject|8
4442552|NCT00461708|7227062|FG001|Overall Study|Withdrawal by Subject|2
4442553|NCT00461708|7227061|FG000|Overall Study|Other|4
4442554|NCT00461708|7227062|FG001|Overall Study|Other|4
4442555|NCT00461708|7227061|FG000|Overall Study|Death|8
4442556|NCT00461708|7227062|FG001|Overall Study|Death|1
4442557|NCT00461786|7227094|FG000|Overall Study|Entry Criteria Not Met|2
4442558|NCT00461786|7227094|FG000|Overall Study|Inevaluable (Never Treated)|1
4442559|NCT00461981|7227104|FG000|Overall Study|Lost to Follow-up|9
4442560|NCT00461981|7227105|FG001|Overall Study|Lost to Follow-up|6
4442561|NCT00461981|7227104|FG000|Overall Study|Withdrawal by Subject|2
4442562|NCT00461981|7227105|FG001|Overall Study|Withdrawal by Subject|3
4442563|NCT00462306|7227170|FG000|Overall Study|insufficient data|0
4442564|NCT00462306|7227171|FG001|Overall Study|insufficient data|13
4442565|NCT00462345|7227190|FG000|Overall Study|Withdrawal by Subject|2
4442566|NCT00462345|7227190|FG000|Overall Study|Did not complete second course|1
4442567|NCT00462384|7227194|FG000|Overall Study|Adverse Event|2
4442568|NCT00462384|7227194|FG000|Overall Study|Death|2
4442569|NCT00462384|7227194|FG000|Overall Study|Withdrawal by Subject|1
4442570|NCT00462384|7227194|FG000|Overall Study|Other|4
4442571|NCT00462462|7227214|FG000|Overall Study|Physician Decision|0
4442572|NCT00462462|7227215|FG001|Overall Study|Physician Decision|1
4442573|NCT00462488|7227225|FG000|Overall Study|Protocol Violation|1
4442574|NCT00462488|7227226|FG001|Overall Study|Protocol Violation|0
4442575|NCT00462488|7227225|FG000|Overall Study|Lack of Efficacy|19
4442576|NCT00462488|7227226|FG001|Overall Study|Lack of Efficacy|17
4442577|NCT00462501|7227232|FG000|Overall Study|Not treated|3
4442578|NCT00462501|7227232|FG000|Overall Study|Adverse Event|2
4442579|NCT00462670|7227251|FG000|Overall Study|Adverse Event|3
4442580|NCT00462670|7227252|FG001|Overall Study|Adverse Event|5
4442581|NCT00462670|7227251|FG000|Overall Study|Lack of Efficacy|1
4442582|NCT00462670|7227252|FG001|Overall Study|Lack of Efficacy|0
4442583|NCT00462670|7227251|FG000|Overall Study|Protocol Violation|1
4442584|NCT00462670|7227252|FG001|Overall Study|Protocol Violation|0
4442585|NCT00462670|7227251|FG000|Overall Study|Resolution of signs and symptoms|0
4442586|NCT00462670|7227252|FG001|Overall Study|Resolution of signs and symptoms|2
4442587|NCT00462709|7227258|FG000|Overall Study|Transitioned to commercial C1INH-nf|40
4442588|NCT00462709|7227258|FG000|Overall Study|Lost to Follow-up|10
4442589|NCT00462709|7227258|FG000|Overall Study|Withdrawal by Subject|8
4442590|NCT00462709|7227258|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3
4442591|NCT00462709|7227258|FG000|Overall Study|Death|2
4442592|NCT00462709|7227258|FG000|Overall Study|Logistical reasons|2
4442593|NCT00462709|7227258|FG000|Overall Study|Physician Decision|1
4442594|NCT00462709|7227258|FG000|Overall Study|Withdrew to start treatment with Cetor|1
4442595|NCT00462761|7227280|FG000|Overall Study|Adverse Event|6
4442596|NCT00462761|7227280|FG000|Overall Study|Withdrawal by Subject|9
4442597|NCT00462761|7227280|FG000|Overall Study|Physician Decision|5
4442598|NCT00462761|7227280|FG000|Overall Study|Disease progression|43
4442599|NCT00462761|7227280|FG000|Overall Study|Death|12
4442600|NCT00462761|7227280|FG000|Overall Study|Other|1
4442601|NCT00462826|7227312|FG000|Overall Study|Ineligible - second primary|1
4442602|NCT00462826|7227312|FG000|Overall Study|Ineligible - wrong cell type|1
4442603|NCT00462826|7227312|FG000|Overall Study|Ineligible - wrong primary|2
4442604|NCT00462826|7227312|FG000|Overall Study|Never treated|1
4442605|NCT00462865|7227331|FG000|Overall Study|Adverse Event|1
4442606|NCT00462982|7227352|FG000|Overall Study|Adverse Event|1
4442607|NCT00462982|7227352|FG000|Overall Study|Patient Not Treated|2
4442608|NCT00463047|7227356|FG000|Titration Period 1|Adverse Event|10
4442609|NCT00463047|7227357|FG001|Titration Period 1|Adverse Event|8
4442610|NCT00463047|7227356|FG000|Titration Period 1|Lack of Efficacy|10
4442611|NCT00463047|7227357|FG001|Titration Period 1|Lack of Efficacy|4
4442612|NCT00463047|7227356|FG000|Titration Period 1|Lost to Follow-up|2
4442613|NCT00463047|7227357|FG001|Titration Period 1|Lost to Follow-up|0
4442614|NCT00463047|7227356|FG000|Titration Period 1|Non-compliance with study medication|3
4442615|NCT00463047|7227357|FG001|Titration Period 1|Non-compliance with study medication|5
4442616|NCT00463047|7227356|FG000|Titration Period 1|Protocol Violation|5
4442617|NCT00463047|7227357|FG001|Titration Period 1|Protocol Violation|5
4442618|NCT00463047|7227356|FG000|Titration Period 1|Withdrawal by Subject|3
4442619|NCT00463047|7227357|FG001|Titration Period 1|Withdrawal by Subject|5
4442620|NCT00463047|7227356|FG000|Titration Period 1|Non-compliance procedures|4
4442621|NCT00463047|7227357|FG001|Titration Period 1|Non-compliance procedures|10
4442622|NCT00463047|7227356|FG000|Titration Period 1|Other|0
4442623|NCT00463047|7227357|FG001|Titration Period 1|Other|2
4442624|NCT00463047|7227356|FG000|Titration Period 2|Adverse Event|9
4442625|NCT00463047|7227357|FG001|Titration Period 2|Adverse Event|9
4442626|NCT00463047|7227356|FG000|Titration Period 2|Lack of Efficacy|6
4442627|NCT00463047|7227357|FG001|Titration Period 2|Lack of Efficacy|4
4442628|NCT00463047|7227356|FG000|Titration Period 2|Withdrawal by Subject|1
4442629|NCT00463047|7227357|FG001|Titration Period 2|Withdrawal by Subject|0
4442630|NCT00463047|7227356|FG000|Titration Period 2|Protocol Violation|2
4442631|NCT00463047|7227357|FG001|Titration Period 2|Protocol Violation|3
4442632|NCT00463047|7227356|FG000|Titration Period 2|Lost to Follow-up|1
4442633|NCT00463047|7227357|FG001|Titration Period 2|Lost to Follow-up|2
4442634|NCT00463047|7227356|FG000|Titration Period 2|Non-compliance study medication|4
4442635|NCT00463047|7227357|FG001|Titration Period 2|Non-compliance study medication|2
4442636|NCT00463047|7227356|FG000|Titration Period 2|Non-compliance procedures|4
4442637|NCT00463047|7227357|FG001|Titration Period 2|Non-compliance procedures|1
4442638|NCT00463047|7227356|FG000|Titration Period 2|Other|3
4442639|NCT00463047|7227357|FG001|Titration Period 2|Other|2
4442640|NCT00463047|7227356|FG000|Double-Blind Treatment Period 1|Adverse Event|0
4442641|NCT00463047|7227357|FG001|Double-Blind Treatment Period 1|Adverse Event|2
4442642|NCT00463047|7227356|FG000|Double-Blind Treatment Period 1|Protocol Violation|1
4442643|NCT00463047|7227357|FG001|Double-Blind Treatment Period 1|Protocol Violation|2
4442644|NCT00463047|7227356|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1
4442645|NCT00463047|7227357|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0
4442646|NCT00463047|7227356|FG000|Double-Blind Treatment Period 1|Other|1
4442647|NCT00463047|7227357|FG001|Double-Blind Treatment Period 1|Other|0
4442648|NCT00463047|7227356|FG000|Double-Blind Treatment Period 2|Adverse Event|0
4442649|NCT00463047|7227357|FG001|Double-Blind Treatment Period 2|Adverse Event|1
4442650|NCT00463047|7227356|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0
4442651|NCT00463047|7227357|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1
4442652|NCT00463047|7227356|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1
4442653|NCT00463047|7227357|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0
4518516|NCT00974974|7330745|FG001|IPX066 Dose Conversion|Death|0
4442654|NCT00463060|7227366|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5
4442655|NCT00463060|7227366|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1
4442656|NCT00463151|7227379|FG000|Overall Study|Adverse Event|0
4442657|NCT00463151|7227380|FG001|Overall Study|Adverse Event|0
4442658|NCT00463151|7227381|FG002|Overall Study|Adverse Event|1
4442659|NCT00463151|7227382|FG003|Overall Study|Adverse Event|0
4442660|NCT00463151|7227379|FG000|Overall Study|Lack of Efficacy|2
4442661|NCT00463151|7227380|FG001|Overall Study|Lack of Efficacy|5
4442662|NCT00463151|7227381|FG002|Overall Study|Lack of Efficacy|2
4442663|NCT00463151|7227382|FG003|Overall Study|Lack of Efficacy|5
4442664|NCT00463151|7227379|FG000|Overall Study|Protocol Violation|0
4442665|NCT00463151|7227380|FG001|Overall Study|Protocol Violation|0
4442666|NCT00463151|7227381|FG002|Overall Study|Protocol Violation|0
4442667|NCT00463151|7227382|FG003|Overall Study|Protocol Violation|1
4442668|NCT00463151|7227379|FG000|Overall Study|Withdrawal by Subject|0
4442669|NCT00463151|7227380|FG001|Overall Study|Withdrawal by Subject|0
4442670|NCT00463151|7227381|FG002|Overall Study|Withdrawal by Subject|0
4442671|NCT00463151|7227382|FG003|Overall Study|Withdrawal by Subject|1
4442672|NCT00463229|7227394|FG000|Overall Study|Lost to Follow-up|5
4442673|NCT00463229|7227395|FG001|Overall Study|Lost to Follow-up|7
4442674|NCT00463229|7227394|FG000|Overall Study|Death|4
4442675|NCT00463229|7227395|FG001|Overall Study|Death|3
4442676|NCT00463346|7227404|FG000|Overall Study|Withdrawal by Subject|3
4442677|NCT00463346|7227405|FG001|Overall Study|Withdrawal by Subject|3
4442678|NCT00463385|7227417|FG000|Overall Study|Other|4
4442679|NCT00463385|7227418|FG001|Overall Study|Other|3
4442680|NCT00463385|7227419|FG002|Overall Study|Other|6
4442681|NCT00463385|7227420|FG003|Overall Study|Other|4
4442682|NCT00463385|7227417|FG000|Overall Study|Adverse Event|5
4442683|NCT00463385|7227418|FG001|Overall Study|Adverse Event|8
4442684|NCT00463385|7227419|FG002|Overall Study|Adverse Event|4
4442685|NCT00463385|7227420|FG003|Overall Study|Adverse Event|2
4442686|NCT00463385|7227417|FG000|Overall Study|Lack of Efficacy|6
4442687|NCT00463385|7227418|FG001|Overall Study|Lack of Efficacy|6
4442688|NCT00463385|7227419|FG002|Overall Study|Lack of Efficacy|7
4442689|NCT00463385|7227420|FG003|Overall Study|Lack of Efficacy|9
4442690|NCT00463385|7227417|FG000|Overall Study|Withdrawal by Subject|3
4442691|NCT00463385|7227418|FG001|Overall Study|Withdrawal by Subject|3
4442692|NCT00463385|7227419|FG002|Overall Study|Withdrawal by Subject|3
4442693|NCT00463385|7227420|FG003|Overall Study|Withdrawal by Subject|4
4442694|NCT00463385|7227417|FG000|Overall Study|Lost to Follow-up|0
4442695|NCT00463385|7227418|FG001|Overall Study|Lost to Follow-up|0
4442696|NCT00463385|7227419|FG002|Overall Study|Lost to Follow-up|0
4442697|NCT00463385|7227420|FG003|Overall Study|Lost to Follow-up|1
4442698|NCT00463385|7227417|FG000|Overall Study|Death|2
4442699|NCT00463385|7227418|FG001|Overall Study|Death|1
4442700|NCT00463385|7227419|FG002|Overall Study|Death|2
4442701|NCT00463385|7227420|FG003|Overall Study|Death|0
4442702|NCT00463385|7227417|FG000|Overall Study|Missing|2
4442703|NCT00463385|7227418|FG001|Overall Study|Missing|0
4442704|NCT00463385|7227419|FG002|Overall Study|Missing|0
4442705|NCT00463385|7227420|FG003|Overall Study|Missing|2
4442706|NCT00463385|7227417|FG000|Overall Study|1 participant received commercial drug|0
4442707|NCT00463385|7227418|FG001|Overall Study|1 participant received commercial drug|1
4590534|NCT01522651|7436639|FG004|Overall Study|Device Malfunction|0
4590535|NCT01522651|7436635|FG000|Overall Study|Investigator's Discretion|0
4590536|NCT01522651|7436636|FG001|Overall Study|Investigator's Discretion|1
4590537|NCT01522651|7436637|FG002|Overall Study|Investigator's Discretion|0
4442708|NCT00463385|7227419|FG002|Overall Study|1 participant received commercial drug|0
4442709|NCT00463385|7227420|FG003|Overall Study|1 participant received commercial drug|0
4442710|NCT00463476|7227457|FG000|Overall Study|Withdrawal by Subject|1
4442711|NCT00463476|7227458|FG001|Overall Study|Withdrawal by Subject|2
4442712|NCT00463476|7227457|FG000|Overall Study|Lost to Follow-up|1
4442713|NCT00463476|7227458|FG001|Overall Study|Lost to Follow-up|1
4442714|NCT00463567|7227471|FG000|Overall Study|Adverse Event|29
4442715|NCT00463567|7227472|FG001|Overall Study|Adverse Event|26
4442716|NCT00463567|7227473|FG002|Overall Study|Adverse Event|17
4442717|NCT00463567|7227474|FG003|Overall Study|Adverse Event|46
4442718|NCT00463567|7227475|FG004|Overall Study|Adverse Event|10
4442719|NCT00463567|7227476|FG005|Overall Study|Adverse Event|10
4442720|NCT00463567|7227477|FG006|Overall Study|Adverse Event|4
4442721|NCT00463567|7227471|FG000|Overall Study|Withdrawal by Subject|29
4442722|NCT00463567|7227472|FG001|Overall Study|Withdrawal by Subject|22
4442723|NCT00463567|7227473|FG002|Overall Study|Withdrawal by Subject|20
4442724|NCT00463567|7227474|FG003|Overall Study|Withdrawal by Subject|37
4442725|NCT00463567|7227475|FG004|Overall Study|Withdrawal by Subject|6
4442726|NCT00463567|7227476|FG005|Overall Study|Withdrawal by Subject|5
4442727|NCT00463567|7227477|FG006|Overall Study|Withdrawal by Subject|1
4442728|NCT00463567|7227471|FG000|Overall Study|Protocol Deviation|13
4590538|NCT01522651|7436638|FG003|Overall Study|Investigator's Discretion|0
4442729|NCT00463567|7227472|FG001|Overall Study|Protocol Deviation|9
4442730|NCT00463567|7227473|FG002|Overall Study|Protocol Deviation|14
4442731|NCT00463567|7227474|FG003|Overall Study|Protocol Deviation|11
4442732|NCT00463567|7227475|FG004|Overall Study|Protocol Deviation|1
4442733|NCT00463567|7227476|FG005|Overall Study|Protocol Deviation|1
4442734|NCT00463567|7227477|FG006|Overall Study|Protocol Deviation|2
4442735|NCT00463567|7227471|FG000|Overall Study|Lost to Follow-up|12
4442736|NCT00463567|7227472|FG001|Overall Study|Lost to Follow-up|6
4442737|NCT00463567|7227473|FG002|Overall Study|Lost to Follow-up|13
4442738|NCT00463567|7227474|FG003|Overall Study|Lost to Follow-up|8
4442739|NCT00463567|7227475|FG004|Overall Study|Lost to Follow-up|1
4442740|NCT00463567|7227476|FG005|Overall Study|Lost to Follow-up|1
4442741|NCT00463567|7227477|FG006|Overall Study|Lost to Follow-up|1
4442742|NCT00463567|7227471|FG000|Overall Study|Administrative problems|5
4442743|NCT00463567|7227472|FG001|Overall Study|Administrative problems|3
4442744|NCT00463567|7227473|FG002|Overall Study|Administrative problems|6
4442745|NCT00463567|7227474|FG003|Overall Study|Administrative problems|9
4442746|NCT00463567|7227475|FG004|Overall Study|Administrative problems|3
4442747|NCT00463567|7227476|FG005|Overall Study|Administrative problems|2
4442748|NCT00463567|7227477|FG006|Overall Study|Administrative problems|2
4442749|NCT00463567|7227471|FG000|Overall Study|Lack of Efficacy|4
4442750|NCT00463567|7227472|FG001|Overall Study|Lack of Efficacy|9
4442751|NCT00463567|7227473|FG002|Overall Study|Lack of Efficacy|9
4442752|NCT00463567|7227474|FG003|Overall Study|Lack of Efficacy|17
4442753|NCT00463567|7227475|FG004|Overall Study|Lack of Efficacy|1
4442754|NCT00463567|7227476|FG005|Overall Study|Lack of Efficacy|0
4442755|NCT00463567|7227477|FG006|Overall Study|Lack of Efficacy|1
4442756|NCT00463567|7227471|FG000|Overall Study|Abnormal lab value(s)|1
4442757|NCT00463567|7227472|FG001|Overall Study|Abnormal lab value(s)|1
4442758|NCT00463567|7227473|FG002|Overall Study|Abnormal lab value(s)|2
4442759|NCT00463567|7227474|FG003|Overall Study|Abnormal lab value(s)|1
4442760|NCT00463567|7227475|FG004|Overall Study|Abnormal lab value(s)|1
4442761|NCT00463567|7227476|FG005|Overall Study|Abnormal lab value(s)|0
4442762|NCT00463567|7227477|FG006|Overall Study|Abnormal lab value(s)|0
4442763|NCT00463567|7227471|FG000|Overall Study|Abnormal test procedure result(s)|1
4442764|NCT00463567|7227472|FG001|Overall Study|Abnormal test procedure result(s)|1
4442765|NCT00463567|7227473|FG002|Overall Study|Abnormal test procedure result(s)|6
4442766|NCT00463567|7227474|FG003|Overall Study|Abnormal test procedure result(s)|2
4442767|NCT00463567|7227475|FG004|Overall Study|Abnormal test procedure result(s)|0
4442768|NCT00463567|7227476|FG005|Overall Study|Abnormal test procedure result(s)|2
4442769|NCT00463567|7227477|FG006|Overall Study|Abnormal test procedure result(s)|0
4442770|NCT00463567|7227471|FG000|Overall Study|Death|1
4442771|NCT00463567|7227472|FG001|Overall Study|Death|0
4442772|NCT00463567|7227473|FG002|Overall Study|Death|2
4442773|NCT00463567|7227474|FG003|Overall Study|Death|0
4442774|NCT00463567|7227475|FG004|Overall Study|Death|0
4442775|NCT00463567|7227476|FG005|Overall Study|Death|0
4442776|NCT00463567|7227477|FG006|Overall Study|Death|0
4442777|NCT00463580|7227501|FG000|Overall Study|Lost to Follow-up|1
4442778|NCT00463580|7227502|FG001|Overall Study|Lost to Follow-up|0
4442779|NCT00463580|7227501|FG000|Overall Study|Schedule conflict|2
4442780|NCT00463580|7227502|FG001|Overall Study|Schedule conflict|0
4442781|NCT00463580|7227501|FG000|Overall Study|Medical/psychiatric complications|0
4442782|NCT00463580|7227502|FG001|Overall Study|Medical/psychiatric complications|2
4442783|NCT00463606|7227517|FG000|Overall Study|Adverse Event|21
4442784|NCT00463606|7227518|FG001|Overall Study|Adverse Event|18
4442785|NCT00463606|7227519|FG002|Overall Study|Adverse Event|11
4442786|NCT00463606|7227517|FG000|Overall Study|Withdrawal by Subject|11
4442787|NCT00463606|7227518|FG001|Overall Study|Withdrawal by Subject|11
4442788|NCT00463606|7227519|FG002|Overall Study|Withdrawal by Subject|5
4442789|NCT00463606|7227517|FG000|Overall Study|Lost to Follow-up|2
4442790|NCT00463606|7227518|FG001|Overall Study|Lost to Follow-up|2
4442791|NCT00463606|7227519|FG002|Overall Study|Lost to Follow-up|3
4442792|NCT00463606|7227517|FG000|Overall Study|Subject noncompliance|1
4442793|NCT00463606|7227518|FG001|Overall Study|Subject noncompliance|1
4442794|NCT00463606|7227519|FG002|Overall Study|Subject noncompliance|0
4442795|NCT00463606|7227517|FG000|Overall Study|Subject moved out of town|1
4442796|NCT00463606|7227518|FG001|Overall Study|Subject moved out of town|0
4442797|NCT00463606|7227519|FG002|Overall Study|Subject moved out of town|0
4442798|NCT00463606|7227517|FG000|Overall Study|Physician Decision|0
4442799|NCT00463606|7227518|FG001|Overall Study|Physician Decision|1
4442800|NCT00463606|7227519|FG002|Overall Study|Physician Decision|0
4442801|NCT00463606|7227517|FG000|Overall Study|Sponsor request|0
4442802|NCT00463606|7227518|FG001|Overall Study|Sponsor request|1
4442803|NCT00463606|7227519|FG002|Overall Study|Sponsor request|0
4442804|NCT00463606|7227517|FG000|Overall Study|Exclusion criteria violation|2
4442805|NCT00463606|7227518|FG001|Overall Study|Exclusion criteria violation|0
4442806|NCT00463606|7227519|FG002|Overall Study|Exclusion criteria violation|0
4442807|NCT00463606|7227517|FG000|Overall Study|Coordinator error|1
4442808|NCT00463606|7227518|FG001|Overall Study|Coordinator error|0
4442809|NCT00463606|7227519|FG002|Overall Study|Coordinator error|0
4442810|NCT00463606|7227517|FG000|Overall Study|Patient randomized in error|1
4442811|NCT00463606|7227518|FG001|Overall Study|Patient randomized in error|0
4442812|NCT00463606|7227519|FG002|Overall Study|Patient randomized in error|0
4442813|NCT00463606|7227517|FG000|Overall Study|Participation in another ABT-335 trial|1
4442814|NCT00463606|7227518|FG001|Overall Study|Participation in another ABT-335 trial|0
4442815|NCT00463606|7227519|FG002|Overall Study|Participation in another ABT-335 trial|0
4442816|NCT00463606|7227517|FG000|Overall Study|Protocol Violation|0
4442817|NCT00463606|7227518|FG001|Overall Study|Protocol Violation|0
4442818|NCT00463606|7227519|FG002|Overall Study|Protocol Violation|1
4442819|NCT00463684|7227527|FG000|Overall Study|Withdrawal by Subject|1
4442820|NCT00463684|7227527|FG000|Overall Study|Lost to Follow-up|3
4442821|NCT00463788|7227533|FG000|Overall Study|Progressive Disease|86
4442822|NCT00463788|7227534|FG001|Overall Study|Progressive Disease|42
4442823|NCT00463788|7227533|FG000|Overall Study|Adverse Event|6
4442824|NCT00463788|7227534|FG001|Overall Study|Adverse Event|2
4442825|NCT00463788|7227533|FG000|Overall Study|Withdrawal by Subject|6
4442826|NCT00463788|7227534|FG001|Overall Study|Withdrawal by Subject|2
4442827|NCT00463788|7227533|FG000|Overall Study|Death|4
4442828|NCT00463788|7227534|FG001|Overall Study|Death|3
4442829|NCT00463788|7227533|FG000|Overall Study|Symptomatic Deterioration|2
4442830|NCT00463788|7227534|FG001|Overall Study|Symptomatic Deterioration|3
4442831|NCT00463788|7227533|FG000|Overall Study|Lost to Follow-up|1
4442832|NCT00463788|7227534|FG001|Overall Study|Lost to Follow-up|0
4442833|NCT00463788|7227533|FG000|Overall Study|Protocol Violation|0
4442834|NCT00463788|7227534|FG001|Overall Study|Protocol Violation|1
4442835|NCT00463788|7227533|FG000|Overall Study|Other|3
4442836|NCT00463788|7227534|FG001|Overall Study|Other|0
4442837|NCT00463788|7227533|FG000|Overall Study|Randomized but not treated|1
4442838|NCT00463788|7227534|FG001|Overall Study|Randomized but not treated|1
4442839|NCT00463801|7227541|FG000|Overall Study|Protocol Violation|1
4442840|NCT00463801|7227541|FG000|Overall Study|Lack of Efficacy|2
4442841|NCT00463801|7227541|FG000|Overall Study|Adverse Event|4
4442842|NCT00463801|7227541|FG000|Overall Study|Lost to Follow-up|5
4442843|NCT00463801|7227541|FG000|Overall Study|No longer require therapy|1
4442844|NCT00463840|7227545|FG000|Overall Study|Disease progression|7
4442845|NCT00463840|7227545|FG000|Overall Study|Withdrawal by Subject|2
4442846|NCT00463840|7227545|FG000|Overall Study|Adverse Event|3
4442847|NCT00463866|7227551|FG000|Overall Study|Adverse Event|70
4442848|NCT00463866|7227552|FG001|Overall Study|Adverse Event|93
4442849|NCT00463866|7227551|FG000|Overall Study|Withdrawal by Subject|81
4442850|NCT00463866|7227552|FG001|Overall Study|Withdrawal by Subject|79
4442851|NCT00463866|7227551|FG000|Overall Study|Lost to Follow-up|46
4442852|NCT00463866|7227552|FG001|Overall Study|Lost to Follow-up|55
4442853|NCT00463866|7227551|FG000|Overall Study|Incorrect Enrolment|64
4442854|NCT00463866|7227552|FG001|Overall Study|Incorrect Enrolment|66
4442855|NCT00463866|7227551|FG000|Overall Study|Severe Non-Compliance to Protocol|25
4442856|NCT00463866|7227552|FG001|Overall Study|Severe Non-Compliance to Protocol|21
4442857|NCT00463866|7227551|FG000|Overall Study|Safety Reason|1
4442858|NCT00463866|7227552|FG001|Overall Study|Safety Reason|3
4442859|NCT00463866|7227551|FG000|Overall Study|Mis-Randomization of subject|0
4442860|NCT00463866|7227552|FG001|Overall Study|Mis-Randomization of subject|1
4442861|NCT00463866|7227551|FG000|Overall Study|Other|22
4442862|NCT00463866|7227552|FG001|Overall Study|Other|22
4442863|NCT00464087|7227561|FG000|Overall Study|No PCI per inclusion criteria|0
4442864|NCT00464087|7227562|FG001|Overall Study|No PCI per inclusion criteria|0
4442865|NCT00464087|7227563|FG002|Overall Study|No PCI per inclusion criteria|29
4442866|NCT00464269|7227586|FG000|Overall Study|Lack of Efficacy|1
4442867|NCT00464269|7227587|FG001|Overall Study|Lack of Efficacy|0
4442868|NCT00464269|7227588|FG002|Overall Study|Lack of Efficacy|0
4442869|NCT00464269|7227589|FG003|Overall Study|Lack of Efficacy|0
4442870|NCT00464269|7227586|FG000|Overall Study|Lost to Follow-up|0
4442871|NCT00464269|7227587|FG001|Overall Study|Lost to Follow-up|4
4442872|NCT00464269|7227588|FG002|Overall Study|Lost to Follow-up|0
4442873|NCT00464269|7227589|FG003|Overall Study|Lost to Follow-up|1
4442874|NCT00464269|7227586|FG000|Overall Study|Withdrawal by Subject|0
4442875|NCT00464269|7227587|FG001|Overall Study|Withdrawal by Subject|2
4442876|NCT00464269|7227588|FG002|Overall Study|Withdrawal by Subject|1
4442877|NCT00464269|7227589|FG003|Overall Study|Withdrawal by Subject|1
4442878|NCT00464269|7227586|FG000|Overall Study|Other reason|3
4442879|NCT00464269|7227587|FG001|Overall Study|Other reason|3
4442880|NCT00464269|7227588|FG002|Overall Study|Other reason|1
4442881|NCT00464269|7227589|FG003|Overall Study|Other reason|1
4442882|NCT00464269|7227586|FG000|Overall Study|AE, serious fatal|0
4442883|NCT00464269|7227587|FG001|Overall Study|AE, serious fatal|0
4442884|NCT00464269|7227588|FG002|Overall Study|AE, serious fatal|1
4442885|NCT00464269|7227589|FG003|Overall Study|AE, serious fatal|1
4442886|NCT00464269|7227586|FG000|Overall Study|SAE, non-fatal|0
4442887|NCT00464269|7227587|FG001|Overall Study|SAE, non-fatal|0
4442888|NCT00464269|7227588|FG002|Overall Study|SAE, non-fatal|0
4442889|NCT00464269|7227589|FG003|Overall Study|SAE, non-fatal|1
4442890|NCT00464269|7227586|FG000|Overall Study|AE, non-serious non-fatal|2
4442891|NCT00464269|7227587|FG001|Overall Study|AE, non-serious non-fatal|8
4442892|NCT00464269|7227588|FG002|Overall Study|AE, non-serious non-fatal|3
4442893|NCT00464269|7227589|FG003|Overall Study|AE, non-serious non-fatal|4
4442894|NCT00464269|7227586|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
4442895|NCT00464269|7227587|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
4442896|NCT00464269|7227588|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
4442897|NCT00464269|7227589|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
4442898|NCT00464308|7227604|FG000|Overall Study|Adverse Event|22
4442899|NCT00464308|7227605|FG001|Overall Study|Adverse Event|27
4442900|NCT00464308|7227606|FG002|Overall Study|Adverse Event|16
4442901|NCT00464308|7227604|FG000|Overall Study|Lost to Follow-up|29
4442902|NCT00464308|7227605|FG001|Overall Study|Lost to Follow-up|19
4442903|NCT00464308|7227606|FG002|Overall Study|Lost to Follow-up|20
4442904|NCT00464308|7227604|FG000|Overall Study|Patient discontinued and other reasons|17
4442905|NCT00464308|7227605|FG001|Overall Study|Patient discontinued and other reasons|17
4442906|NCT00464308|7227606|FG002|Overall Study|Patient discontinued and other reasons|23
4630356|NCT01296711|7498859|FG002|Overall Study|Investigator discretion|0
4630357|NCT01296711|7498860|FG003|Overall Study|Investigator discretion|0
4630358|NCT01296711|7498861|FG004|Overall Study|Investigator discretion|0
4630359|NCT01296711|7498862|FG005|Overall Study|Investigator discretion|0
4442907|NCT00464308|7227604|FG000|Overall Study|Physician Decision|1
4442908|NCT00464308|7227605|FG001|Overall Study|Physician Decision|0
4442909|NCT00464308|7227606|FG002|Overall Study|Physician Decision|0
4442910|NCT00464334|7227625|FG000|Overall Study|Adverse Event|0
4442911|NCT00464334|7227626|FG001|Overall Study|Adverse Event|0
4442912|NCT00464334|7227627|FG002|Overall Study|Adverse Event|0
4442913|NCT00464334|7227628|FG003|Overall Study|Adverse Event|1
4442914|NCT00464334|7227629|FG004|Overall Study|Adverse Event|1
4442915|NCT00464334|7227630|FG005|Overall Study|Adverse Event|1
4442916|NCT00464334|7227631|FG006|Overall Study|Adverse Event|0
4442917|NCT00464334|7227632|FG007|Overall Study|Adverse Event|0
4442918|NCT00464334|7227633|FG008|Overall Study|Adverse Event|2
4442919|NCT00464334|7227634|FG009|Overall Study|Adverse Event|1
4442920|NCT00464334|7227635|FG010|Overall Study|Adverse Event|2
4442921|NCT00464334|7227625|FG000|Overall Study|Lack of Efficacy|0
4442922|NCT00464334|7227626|FG001|Overall Study|Lack of Efficacy|1
4442923|NCT00464334|7227627|FG002|Overall Study|Lack of Efficacy|0
4442924|NCT00464334|7227628|FG003|Overall Study|Lack of Efficacy|0
4442925|NCT00464334|7227629|FG004|Overall Study|Lack of Efficacy|0
4442926|NCT00464334|7227630|FG005|Overall Study|Lack of Efficacy|0
4442927|NCT00464334|7227631|FG006|Overall Study|Lack of Efficacy|0
4442928|NCT00464334|7227632|FG007|Overall Study|Lack of Efficacy|0
4442929|NCT00464334|7227633|FG008|Overall Study|Lack of Efficacy|0
4442930|NCT00464334|7227634|FG009|Overall Study|Lack of Efficacy|0
4442931|NCT00464334|7227635|FG010|Overall Study|Lack of Efficacy|0
4442932|NCT00464334|7227625|FG000|Overall Study|Lost to Follow-up|0
4442933|NCT00464334|7227626|FG001|Overall Study|Lost to Follow-up|0
4442934|NCT00464334|7227627|FG002|Overall Study|Lost to Follow-up|1
4442935|NCT00464334|7227628|FG003|Overall Study|Lost to Follow-up|0
4442936|NCT00464334|7227629|FG004|Overall Study|Lost to Follow-up|1
4442937|NCT00464334|7227630|FG005|Overall Study|Lost to Follow-up|0
4442938|NCT00464334|7227631|FG006|Overall Study|Lost to Follow-up|1
4442939|NCT00464334|7227632|FG007|Overall Study|Lost to Follow-up|0
4442940|NCT00464334|7227633|FG008|Overall Study|Lost to Follow-up|0
4442941|NCT00464334|7227634|FG009|Overall Study|Lost to Follow-up|0
4442942|NCT00464334|7227635|FG010|Overall Study|Lost to Follow-up|2
4442943|NCT00464334|7227625|FG000|Overall Study|Progressive Disease|0
4442944|NCT00464334|7227626|FG001|Overall Study|Progressive Disease|0
4442945|NCT00464334|7227627|FG002|Overall Study|Progressive Disease|0
4442946|NCT00464334|7227628|FG003|Overall Study|Progressive Disease|0
4442947|NCT00464334|7227629|FG004|Overall Study|Progressive Disease|0
4442948|NCT00464334|7227630|FG005|Overall Study|Progressive Disease|1
4442949|NCT00464334|7227631|FG006|Overall Study|Progressive Disease|0
4442950|NCT00464334|7227632|FG007|Overall Study|Progressive Disease|0
4442951|NCT00464334|7227633|FG008|Overall Study|Progressive Disease|1
4442952|NCT00464334|7227634|FG009|Overall Study|Progressive Disease|0
4442953|NCT00464334|7227635|FG010|Overall Study|Progressive Disease|0
4442954|NCT00464334|7227625|FG000|Overall Study|Study Terminated by Sponsor|0
4442955|NCT00464334|7227626|FG001|Overall Study|Study Terminated by Sponsor|0
4442956|NCT00464334|7227627|FG002|Overall Study|Study Terminated by Sponsor|0
4442957|NCT00464334|7227628|FG003|Overall Study|Study Terminated by Sponsor|1
4442958|NCT00464334|7227629|FG004|Overall Study|Study Terminated by Sponsor|0
4442959|NCT00464334|7227630|FG005|Overall Study|Study Terminated by Sponsor|0
4442960|NCT00464334|7227631|FG006|Overall Study|Study Terminated by Sponsor|0
4442961|NCT00464334|7227632|FG007|Overall Study|Study Terminated by Sponsor|0
4442962|NCT00464334|7227633|FG008|Overall Study|Study Terminated by Sponsor|0
4442963|NCT00464334|7227634|FG009|Overall Study|Study Terminated by Sponsor|0
4442964|NCT00464334|7227635|FG010|Overall Study|Study Terminated by Sponsor|0
4442965|NCT00464334|7227625|FG000|Overall Study|Withdrawal by Subject|1
4442966|NCT00464334|7227626|FG001|Overall Study|Withdrawal by Subject|7
4442967|NCT00464334|7227627|FG002|Overall Study|Withdrawal by Subject|4
4442968|NCT00464334|7227628|FG003|Overall Study|Withdrawal by Subject|2
4442969|NCT00464334|7227629|FG004|Overall Study|Withdrawal by Subject|2
4442970|NCT00464334|7227630|FG005|Overall Study|Withdrawal by Subject|2
4442971|NCT00464334|7227631|FG006|Overall Study|Withdrawal by Subject|2
4442972|NCT00464334|7227632|FG007|Overall Study|Withdrawal by Subject|1
4442973|NCT00464334|7227633|FG008|Overall Study|Withdrawal by Subject|3
4442974|NCT00464334|7227634|FG009|Overall Study|Withdrawal by Subject|0
4442975|NCT00464334|7227635|FG010|Overall Study|Withdrawal by Subject|0
4512988|NCT00939094|7323146|FG000|Overall Study|Eligibility criteria not fulfilled|2
4512989|NCT00939094|7323147|FG001|Overall Study|Eligibility criteria not fulfilled|0
4512990|NCT00939094|7323146|FG000|Overall Study|Severe non-compliance to protocol|0
4512991|NCT00939094|7323147|FG001|Overall Study|Severe non-compliance to protocol|1
4512992|NCT00939094|7323146|FG000|Overall Study|Study stopped by sponsor|0
4512993|NCT00939094|7323147|FG001|Overall Study|Study stopped by sponsor|2
4512994|NCT00939094|7323146|FG000|Overall Study|Abnormal ECG findings|1
4630360|NCT01296711|7498863|FG006|Overall Study|Investigator discretion|1
4442976|NCT00464490|7227690|FG000|Overall Study|Physician Decision|11
4442977|NCT00464490|7227691|FG001|Overall Study|Physician Decision|11
4442978|NCT00464542|7227697|FG000|Pre-treatment|Withdrawal by Subject|2
4442979|NCT00464568|7227701|FG000|Overall Study|Adverse Event|2
4442980|NCT00464620|7227718|FG000|Overall Study|Physician Decision|1
4442981|NCT00464620|7227719|FG001|Overall Study|Physician Decision|0
4442982|NCT00464620|7227720|FG002|Overall Study|Physician Decision|0
4442983|NCT00464620|7227718|FG000|Overall Study|Withdrawal by Subject|1
4442984|NCT00464620|7227719|FG001|Overall Study|Withdrawal by Subject|0
4442985|NCT00464620|7227720|FG002|Overall Study|Withdrawal by Subject|3
4442986|NCT00464620|7227718|FG000|Overall Study|Ineligible sarcoma subtype|0
4442987|NCT00464620|7227719|FG001|Overall Study|Ineligible sarcoma subtype|2
4442988|NCT00464620|7227720|FG002|Overall Study|Ineligible sarcoma subtype|2
4442989|NCT00464620|7227718|FG000|Overall Study|Use of prohibited concomitant medication|0
4442990|NCT00464620|7227719|FG001|Overall Study|Use of prohibited concomitant medication|0
4442991|NCT00464620|7227720|FG002|Overall Study|Use of prohibited concomitant medication|2
4442992|NCT00464672|7227745|FG000|Overall Study|withdrawal of consent|0
4442993|NCT00464672|7227746|FG001|Overall Study|withdrawal of consent|0
4442994|NCT00464672|7227747|FG002|Overall Study|withdrawal of consent|0
4442995|NCT00464672|7227748|FG003|Overall Study|withdrawal of consent|1
4442996|NCT00464672|7227749|FG004|Overall Study|withdrawal of consent|9
4442997|NCT00464672|7227750|FG005|Overall Study|withdrawal of consent|4
4442998|NCT00464672|7227745|FG000|Overall Study|Lost to Follow-up|25
4442999|NCT00464672|7227746|FG001|Overall Study|Lost to Follow-up|10
4443000|NCT00464672|7227747|FG002|Overall Study|Lost to Follow-up|0
4443001|NCT00464672|7227748|FG003|Overall Study|Lost to Follow-up|0
4443002|NCT00464672|7227749|FG004|Overall Study|Lost to Follow-up|1
4443003|NCT00464672|7227750|FG005|Overall Study|Lost to Follow-up|0
4443004|NCT00464737|7227800|FG000|Overall Study|Adverse Event|12
4443005|NCT00464737|7227801|FG001|Overall Study|Adverse Event|17
4443006|NCT00464737|7227802|FG002|Overall Study|Adverse Event|33
4443007|NCT00464737|7227800|FG000|Overall Study|Lack of Efficacy|7
4443008|NCT00464737|7227801|FG001|Overall Study|Lack of Efficacy|7
4443009|NCT00464737|7227802|FG002|Overall Study|Lack of Efficacy|4
4443010|NCT00464737|7227800|FG000|Overall Study|Withdrawal by Subject|5
4443011|NCT00464737|7227801|FG001|Overall Study|Withdrawal by Subject|3
4443012|NCT00464737|7227802|FG002|Overall Study|Withdrawal by Subject|5
4443013|NCT00464737|7227800|FG000|Overall Study|Protocol Violation|1
4443014|NCT00464737|7227801|FG001|Overall Study|Protocol Violation|1
4443015|NCT00464737|7227802|FG002|Overall Study|Protocol Violation|5
4443016|NCT00464737|7227800|FG000|Overall Study|Non-compliance|0
4443017|NCT00464737|7227801|FG001|Overall Study|Non-compliance|1
4443018|NCT00464737|7227802|FG002|Overall Study|Non-compliance|1
4443019|NCT00464737|7227800|FG000|Overall Study|Lost to Follow-up|5
4443020|NCT00464737|7227801|FG001|Overall Study|Lost to Follow-up|2
4443021|NCT00464737|7227802|FG002|Overall Study|Lost to Follow-up|5
4443022|NCT00464737|7227800|FG000|Overall Study|Other: Subject's schedule doesn't permit|1
4443023|NCT00464737|7227801|FG001|Overall Study|Other: Subject's schedule doesn't permit|0
4443024|NCT00464737|7227802|FG002|Overall Study|Other: Subject's schedule doesn't permit|0
4443025|NCT00464737|7227800|FG000|Overall Study|Other: Subject left town; family illness|1
4443026|NCT00464737|7227801|FG001|Overall Study|Other: Subject left town; family illness|0
4443027|NCT00464737|7227802|FG002|Overall Study|Other: Subject left town; family illness|0
4443028|NCT00464737|7227800|FG000|Overall Study|Other: Study demands too great|0
4443029|NCT00464737|7227801|FG001|Overall Study|Other: Study demands too great|1
4443030|NCT00464737|7227802|FG002|Overall Study|Other: Study demands too great|0
4443031|NCT00464737|7227800|FG000|Overall Study|Other: Personal family reasons|0
4443032|NCT00464737|7227801|FG001|Overall Study|Other: Personal family reasons|0
4443033|NCT00464737|7227802|FG002|Overall Study|Other: Personal family reasons|1
4443034|NCT00464737|7227800|FG000|Overall Study|Other: Subject's disability per sponsor|0
4443035|NCT00464737|7227801|FG001|Overall Study|Other: Subject's disability per sponsor|0
4443036|NCT00464737|7227802|FG002|Overall Study|Other: Subject's disability per sponsor|1
4443037|NCT00464815|7227812|FG000|Overall Study|Withdrawal by Subject|6
4443038|NCT00464815|7227813|FG001|Overall Study|Withdrawal by Subject|3
4443039|NCT00464945|7227821|FG000|Infant Series|Withdrawal by parent/guardian request|2
4443040|NCT00464945|7227822|FG001|Infant Series|Withdrawal by parent/guardian request|1
4443041|NCT00464945|7227821|FG000|Infant Series|Protocol Violation|1
4443042|NCT00464945|7227822|FG001|Infant Series|Protocol Violation|0
4443043|NCT00464945|7227821|FG000|Infant Series|Lost to Follow-up|1
4443044|NCT00464945|7227822|FG001|Infant Series|Lost to Follow-up|0
4443045|NCT00464945|7227821|FG000|After Infant Series|Withdrawal by Subject|0
4443046|NCT00464945|7227822|FG001|After Infant Series|Withdrawal by Subject|2
4443047|NCT00464945|7227821|FG000|Toddler Dose|Lost to Follow-up|0
4443048|NCT00464945|7227822|FG001|Toddler Dose|Lost to Follow-up|1
4443049|NCT00465101|7227853|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3
4443050|NCT00465101|7227853|FG000|Overall Study|Change in health precluded follow up|4
4443051|NCT00465101|7227853|FG000|Overall Study|Did not meet study criteria|4
4443052|NCT00465101|7227853|FG000|Overall Study|Lost to Follow-up|5
4443053|NCT00465101|7227853|FG000|Overall Study|Other|6
4443054|NCT00465101|7227853|FG000|Overall Study|Pt. Insurance not accepted at center|2
4443055|NCT00465101|7227853|FG000|Overall Study|Patient postponed procedure|1
4443056|NCT00465101|7227853|FG000|Overall Study|Site closed due to IRB expiration|1
4443057|NCT00465101|7227853|FG000|Overall Study|Unable to obtain IRB approval|1
4443058|NCT00465101|7227853|FG000|Overall Study|Death|3
4443059|NCT00465101|7227853|FG000|Overall Study|Withdrawal by Subject|25
4443060|NCT00465101|7227853|FG000|Overall Study|Physician Decision|1
4443061|NCT00465101|7227853|FG000|Overall Study|Withdrew consent prior to procedure|3
4443062|NCT00465179|7227879|FG000|Overall Study|Adverse Event|4
4630361|NCT01296711|7498864|FG007|Overall Study|Investigator discretion|0
4630362|NCT01296711|7498857|FG000|Overall Study|Other|0
4630363|NCT01296711|7498858|FG001|Overall Study|Other|0
4630364|NCT01296711|7498859|FG002|Overall Study|Other|0
4630365|NCT01296711|7498860|FG003|Overall Study|Other|0
4443063|NCT00465179|7227879|FG000|Overall Study|Withdrawal by Subject|2
4443064|NCT00465179|7227879|FG000|Overall Study|Progression of Disease|47
4443065|NCT00465270|7227885|FG000|Overall Study|Death|7
4443066|NCT00465270|7227886|FG001|Overall Study|Death|11
4443067|NCT00465270|7227885|FG000|Overall Study|Withdrawal by Subject|34
4443068|NCT00465270|7227886|FG001|Overall Study|Withdrawal by Subject|78
4443069|NCT00465270|7227885|FG000|Overall Study|Lost to Follow-up|60
4443070|NCT00465270|7227886|FG001|Overall Study|Lost to Follow-up|67
4443071|NCT00465270|7227885|FG000|Overall Study|Investigator request|3
4443072|NCT00465270|7227886|FG001|Overall Study|Investigator request|4
4443073|NCT00465361|7227892|FG000|Baseline Assessment|Personal Issues/Scheduling|4
4443074|NCT00465569|7227907|FG000|Overall Study|persistent eczema during dose escalation|1
4443075|NCT00465569|7227908|FG001|Overall Study|persistent eczema during dose escalation|0
4443076|NCT00465647|7227933|FG000|Overall Study|Administrative|2
4443077|NCT00465647|7227934|FG001|Overall Study|Administrative|2
4443078|NCT00465647|7227935|FG002|Overall Study|Administrative|3
4443079|NCT00465647|7227936|FG003|Overall Study|Administrative|2
4443080|NCT00465647|7227933|FG000|Overall Study|Adverse Event|2
4443081|NCT00465647|7227934|FG001|Overall Study|Adverse Event|0
4443082|NCT00465647|7227935|FG002|Overall Study|Adverse Event|3
4443083|NCT00465647|7227936|FG003|Overall Study|Adverse Event|2
4443084|NCT00465647|7227933|FG000|Overall Study|Withdrawal by Subject|1
4443085|NCT00465647|7227934|FG001|Overall Study|Withdrawal by Subject|2
4443086|NCT00465647|7227935|FG002|Overall Study|Withdrawal by Subject|2
4443087|NCT00465647|7227936|FG003|Overall Study|Withdrawal by Subject|7
4443088|NCT00465647|7227933|FG000|Overall Study|"The other reasons included loss of IV"|8
4443089|NCT00465647|7227934|FG001|Overall Study|"The other reasons included loss of IV"|4
4443090|NCT00465647|7227935|FG002|Overall Study|"The other reasons included loss of IV"|3
4443091|NCT00465647|7227936|FG003|Overall Study|"The other reasons included loss of IV"|2
4443092|NCT00465738|7227958|FG000|Overall Study|Lost to Follow-up|2
4443093|NCT00465738|7227959|FG001|Overall Study|Lost to Follow-up|0
4443094|NCT00465738|7227958|FG000|Overall Study|Adverse Event|0
4443095|NCT00465738|7227959|FG001|Overall Study|Adverse Event|1
4443096|NCT00465738|7227958|FG000|Overall Study|Withdrawal by Subject|2
4443097|NCT00465738|7227959|FG001|Overall Study|Withdrawal by Subject|0
4443098|NCT00465738|7227958|FG000|Overall Study|Other|2
4443099|NCT00465738|7227959|FG001|Overall Study|Other|5
4443100|NCT00465816|7227968|FG000|Overall Study|Lost to Follow-up|0
4443101|NCT00465816|7227969|FG001|Overall Study|Lost to Follow-up|0
4443102|NCT00465816|7227970|FG002|Overall Study|Lost to Follow-up|2
4443103|NCT00465894|7227981|FG000|Treatment For 12 Weeks|Lost to Follow-up|4
4443104|NCT00465894|7227982|FG001|Treatment For 12 Weeks|Lost to Follow-up|1
4443105|NCT00465894|7227981|FG000|Treatment For 12 Weeks|Family Issues|1
4443106|NCT00465894|7227982|FG001|Treatment For 12 Weeks|Family Issues|1
4443107|NCT00465894|7227981|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0
4443108|NCT00465894|7227982|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1
4443109|NCT00465972|7228006|FG000|Overall Study|Withdrawal by Subject|2
4443110|NCT00465972|7228007|FG001|Overall Study|Withdrawal by Subject|1
4443111|NCT00465985|7228015|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4
4443112|NCT00465985|7228016|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0
4443113|NCT00465985|7228015|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0
4443114|NCT00465985|7228016|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12
4443115|NCT00465985|7228015|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1
4443116|NCT00465985|7228016|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0
4443117|NCT00465985|7228015|FG000|Part III - Open-label Treatment Period|Adverse Event|1
4443118|NCT00465985|7228016|FG001|Part III - Open-label Treatment Period|Adverse Event|0
4443119|NCT00466167|7228033|FG000|Overall Study|Adverse Event|8
4443120|NCT00466167|7228034|FG001|Overall Study|Adverse Event|8
4443121|NCT00466167|7228035|FG002|Overall Study|Adverse Event|7
4443122|NCT00466167|7228033|FG000|Overall Study|Lack of Efficacy|2
4630366|NCT01296711|7498861|FG004|Overall Study|Other|0
4630367|NCT01296711|7498862|FG005|Overall Study|Other|0
4443123|NCT00466167|7228034|FG001|Overall Study|Lack of Efficacy|0
4443124|NCT00466167|7228035|FG002|Overall Study|Lack of Efficacy|3
4443125|NCT00466167|7228033|FG000|Overall Study|Protocol Violation|1
4443126|NCT00466167|7228034|FG001|Overall Study|Protocol Violation|1
4443127|NCT00466167|7228035|FG002|Overall Study|Protocol Violation|2
4443128|NCT00466167|7228033|FG000|Overall Study|Lost to Follow-up|3
4443129|NCT00466167|7228034|FG001|Overall Study|Lost to Follow-up|2
4630368|NCT01296711|7498863|FG006|Overall Study|Other|1
4443130|NCT00466167|7228035|FG002|Overall Study|Lost to Follow-up|2
4443131|NCT00466167|7228033|FG000|Overall Study|Withdrawal by Subject|4
4443132|NCT00466167|7228034|FG001|Overall Study|Withdrawal by Subject|1
4443133|NCT00466167|7228035|FG002|Overall Study|Withdrawal by Subject|6
4443134|NCT00466167|7228033|FG000|Overall Study|patient did not meet inclusion criteria|1
4443135|NCT00466167|7228034|FG001|Overall Study|patient did not meet inclusion criteria|0
4443136|NCT00466167|7228035|FG002|Overall Study|patient did not meet inclusion criteria|1
4443137|NCT00466167|7228033|FG000|Overall Study|Not treated|1
4443138|NCT00466167|7228034|FG001|Overall Study|Not treated|0
4443139|NCT00466167|7228035|FG002|Overall Study|Not treated|0
4443140|NCT00466193|7228045|FG000|Overall Study|Adverse Event|0
4443141|NCT00466193|7228046|FG001|Overall Study|Adverse Event|1
4443142|NCT00466193|7228045|FG000|Overall Study|Lost to Follow-up|2
4443143|NCT00466193|7228046|FG001|Overall Study|Lost to Follow-up|4
4443144|NCT00466193|7228045|FG000|Overall Study|Physician Decision|1
4443145|NCT00466193|7228046|FG001|Overall Study|Physician Decision|0
4443146|NCT00466193|7228045|FG000|Overall Study|Protocol Violation|1
4443147|NCT00466193|7228046|FG001|Overall Study|Protocol Violation|1
4443148|NCT00466193|7228045|FG000|Overall Study|Withdrawal by Subject|7
4443149|NCT00466193|7228046|FG001|Overall Study|Withdrawal by Subject|2
4443150|NCT00466193|7228045|FG000|Overall Study|Patient refused Visit 4 procedures|1
4443151|NCT00466193|7228046|FG001|Overall Study|Patient refused Visit 4 procedures|0
4443152|NCT00466440|7228084|FG000|Overall Study|Adverse Event|0
4443153|NCT00466440|7228085|FG001|Overall Study|Adverse Event|3
4443154|NCT00466440|7228086|FG002|Overall Study|Adverse Event|1
4443155|NCT00466440|7228084|FG000|Overall Study|Death|1
4443156|NCT00466440|7228085|FG001|Overall Study|Death|1
4443157|NCT00466440|7228086|FG002|Overall Study|Death|0
4443158|NCT00466440|7228084|FG000|Overall Study|Progressive disease|13
4443159|NCT00466440|7228085|FG001|Overall Study|Progressive disease|5
4443160|NCT00466440|7228086|FG002|Overall Study|Progressive disease|4
4443161|NCT00466440|7228084|FG000|Overall Study|Lost to Follow-up|0
4443162|NCT00466440|7228085|FG001|Overall Study|Lost to Follow-up|1
4443163|NCT00466440|7228086|FG002|Overall Study|Lost to Follow-up|0
4443164|NCT00466440|7228084|FG000|Overall Study|Physician Decision|0
4443165|NCT00466440|7228085|FG001|Overall Study|Physician Decision|1
4443166|NCT00466440|7228086|FG002|Overall Study|Physician Decision|2
4443167|NCT00466440|7228084|FG000|Overall Study|Protocol entry criteria not met|0
4443168|NCT00466440|7228085|FG001|Overall Study|Protocol entry criteria not met|0
4443169|NCT00466440|7228086|FG002|Overall Study|Protocol entry criteria not met|4
4443170|NCT00466440|7228084|FG000|Overall Study|Withdrawal by Subject|0
4443171|NCT00466440|7228085|FG001|Overall Study|Withdrawal by Subject|1
4443172|NCT00466440|7228086|FG002|Overall Study|Withdrawal by Subject|0
4443173|NCT00466440|7228084|FG000|Overall Study|Sponsor decision|0
4443174|NCT00466440|7228085|FG001|Overall Study|Sponsor decision|0
4443175|NCT00466440|7228086|FG002|Overall Study|Sponsor decision|1
4443176|NCT00466505|7228103|FG000|Overall Study|disease progression|13
4443177|NCT00466505|7228103|FG000|Overall Study|Adverse Event|4
4443178|NCT00466687|7228116|FG000|Overall Study|Adverse Event|1
4443179|NCT00466687|7228116|FG000|Overall Study|Other complicating illness|3
4443180|NCT00466687|7228116|FG000|Overall Study|Withdrawal by Subject|1
4443181|NCT00466687|7228116|FG000|Overall Study|Disease progression|29
4443182|NCT00466726|7228122|FG000|Overall Study|Not evaluable for response|14
4443183|NCT00466921|7228153|FG000|First 3 Cycles of Treatment|Adverse Event|2
4443184|NCT00466921|7228153|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5
4443185|NCT00466921|7228153|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2
4443186|NCT00466921|7228153|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2
4443187|NCT00466921|7228153|FG000|Completed 4 Cycles/Reached 1st Response|Other|1
4443188|NCT00466921|7228153|FG000|Follow up for a Minimum of 1 Year|Death|6
4443189|NCT00466947|7228159|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875
4443190|NCT00466947|7228160|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863
4443191|NCT00466947|7228159|FG000|Study End Analysis Period|Adverse Event|35
4443192|NCT00466947|7228160|FG001|Study End Analysis Period|Adverse Event|43
4443193|NCT00466947|7228159|FG000|Study End Analysis Period|Lost to Follow-up|1137
4443194|NCT00466947|7228160|FG001|Study End Analysis Period|Lost to Follow-up|1167
4443195|NCT00466947|7228159|FG000|Study End Analysis Period|Physician Decision|29
4443196|NCT00466947|7228160|FG001|Study End Analysis Period|Physician Decision|29
4443197|NCT00466947|7228159|FG000|Study End Analysis Period|Protocol Violation|9
4443198|NCT00466947|7228160|FG001|Study End Analysis Period|Protocol Violation|17
4443199|NCT00466947|7228159|FG000|Study End Analysis Period|Withdrawal by Subject|1264
4443200|NCT00466947|7228160|FG001|Study End Analysis Period|Withdrawal by Subject|1267
4443201|NCT00466947|7228159|FG000|Study End Analysis Period|Other - Forbidden vaccination|21
4443202|NCT00466947|7228160|FG001|Study End Analysis Period|Other - Forbidden vaccination|10
4443203|NCT00466947|7228159|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1
4443204|NCT00466947|7228160|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0
4443205|NCT00466947|7228159|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0
4443206|NCT00466947|7228160|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1
4443207|NCT00467051|7228181|FG000|Overall Study|Adverse Event|2
4443208|NCT00467259|7228192|FG000|Overall Study|Adverse Event|24
4443209|NCT00467259|7228193|FG001|Overall Study|Adverse Event|90
4443210|NCT00467259|7228192|FG000|Overall Study|Protocol Violation|1
4443211|NCT00467259|7228193|FG001|Overall Study|Protocol Violation|7
4443212|NCT00467259|7228192|FG000|Overall Study|Withdrawal by Subject|34
4443213|NCT00467259|7228193|FG001|Overall Study|Withdrawal by Subject|108
4443214|NCT00467259|7228192|FG000|Overall Study|Physician Decision|0
4443215|NCT00467259|7228193|FG001|Overall Study|Physician Decision|2
4443216|NCT00467259|7228192|FG000|Overall Study|Lost to Follow-up|14
4443217|NCT00467259|7228193|FG001|Overall Study|Lost to Follow-up|34
4443218|NCT00467259|7228192|FG000|Overall Study|Site Closed|2
4443219|NCT00467259|7228193|FG001|Overall Study|Site Closed|1
4443220|NCT00467272|7228199|FG000|Overall Study|Pneumonia|2
4443221|NCT00467272|7228199|FG000|Overall Study|Thrombophlebitis|1
4443222|NCT00467285|7228205|FG000|Overall Study|Lost to Follow-up|4
4443223|NCT00467285|7228206|FG001|Overall Study|Lost to Follow-up|4
4443224|NCT00467363|7228234|FG000|Overall Study|Lost to Follow-up|80
4443225|NCT00467363|7228235|FG001|Overall Study|Lost to Follow-up|70
4443226|NCT00467519|7228250|FG000|Overall Study|Protocol Violation|8
4443227|NCT00467519|7228251|FG001|Overall Study|Protocol Violation|4
4443228|NCT00467519|7228250|FG000|Overall Study|Lost to Follow-up|2
4443229|NCT00467519|7228251|FG001|Overall Study|Lost to Follow-up|9
4443230|NCT00467519|7228250|FG000|Overall Study|Withdrawal by Subject|4
4443231|NCT00467519|7228251|FG001|Overall Study|Withdrawal by Subject|10
4443232|NCT00467558|7228259|FG000|Overall Study|Lost to Follow-up|2
4443233|NCT00467558|7228260|FG001|Overall Study|Lost to Follow-up|0
4443234|NCT00467584|7228269|FG000|Overall Study|Withdrawal by Subject|4
4443235|NCT00467584|7228270|FG001|Overall Study|Withdrawal by Subject|5
4443236|NCT00467584|7228271|FG002|Overall Study|Withdrawal by Subject|1
4443237|NCT00467597|7228283|FG000|Overall Study|Withdrawal by Subject|2
4443238|NCT00467597|7228284|FG001|Overall Study|Withdrawal by Subject|0
4443239|NCT00467610|7228294|FG000|Overall Study|Withdrawal by Subject|1
4443240|NCT00467649|7228300|FG000|Phase 1 (Randomized Population)|Adverse Event|2
4443241|NCT00467649|7228301|FG001|Phase 1 (Randomized Population)|Adverse Event|0
4443242|NCT00467649|7228302|FG002|Phase 1 (Randomized Population)|Adverse Event|0
4443243|NCT00467649|7228303|FG003|Phase 1 (Randomized Population)|Adverse Event|0
4443244|NCT00467649|7228304|FG004|Phase 1 (Randomized Population)|Adverse Event|0
4443245|NCT00467649|7228305|FG005|Phase 1 (Randomized Population)|Adverse Event|0
4443246|NCT00467649|7228300|FG000|Phase 1 (Randomized Population)|Investigator Decision|1
4443247|NCT00467649|7228301|FG001|Phase 1 (Randomized Population)|Investigator Decision|0
4443248|NCT00467649|7228302|FG002|Phase 1 (Randomized Population)|Investigator Decision|0
4443249|NCT00467649|7228303|FG003|Phase 1 (Randomized Population)|Investigator Decision|0
4443250|NCT00467649|7228304|FG004|Phase 1 (Randomized Population)|Investigator Decision|0
4443251|NCT00467649|7228305|FG005|Phase 1 (Randomized Population)|Investigator Decision|0
4443252|NCT00467649|7228300|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2
4443253|NCT00467649|7228301|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4
4443254|NCT00467649|7228302|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0
4443255|NCT00467649|7228303|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0
4443256|NCT00467649|7228304|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0
4443257|NCT00467649|7228305|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0
4443258|NCT00467649|7228300|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4
4443259|NCT00467649|7228301|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2
4443260|NCT00467649|7228302|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0
4443261|NCT00467649|7228303|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0
4443262|NCT00467649|7228304|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0
4443263|NCT00467649|7228305|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0
4443264|NCT00467649|7228300|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
4443265|NCT00467649|7228301|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
4443266|NCT00467649|7228302|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
4443267|NCT00467649|7228303|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1
4443268|NCT00467649|7228304|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
4443269|NCT00467649|7228305|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
4443270|NCT00467649|7228300|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
4443271|NCT00467649|7228301|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
4443272|NCT00467649|7228302|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
4443273|NCT00467649|7228303|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1
4443274|NCT00467649|7228304|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
4443275|NCT00467649|7228305|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
4443276|NCT00467649|7228300|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
4443277|NCT00467649|7228301|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
4443278|NCT00467649|7228302|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
4443279|NCT00467649|7228303|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
4630369|NCT01296711|7498864|FG007|Overall Study|Other|0
4630370|NCT01296711|7498857|FG000|Overall Study|Required restricted steroid injections|0
4443280|NCT00467649|7228304|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
4443281|NCT00467649|7228305|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1
4443282|NCT00467740|7228328|FG000|Overall Study|Adverse Event|0
4443283|NCT00467740|7228329|FG001|Overall Study|Adverse Event|0
4443284|NCT00467740|7228330|FG002|Overall Study|Adverse Event|1
4443285|NCT00467740|7228331|FG003|Overall Study|Adverse Event|0
4443286|NCT00467740|7228332|FG004|Overall Study|Adverse Event|0
4443287|NCT00467740|7228328|FG000|Overall Study|Protocol Violation|0
4443288|NCT00467740|7228329|FG001|Overall Study|Protocol Violation|0
4443289|NCT00467740|7228330|FG002|Overall Study|Protocol Violation|1
4443290|NCT00467740|7228331|FG003|Overall Study|Protocol Violation|0
4443291|NCT00467740|7228332|FG004|Overall Study|Protocol Violation|0
4443292|NCT00467740|7228328|FG000|Overall Study|Lost to Follow-up|0
4443293|NCT00467740|7228329|FG001|Overall Study|Lost to Follow-up|1
4443294|NCT00467740|7228330|FG002|Overall Study|Lost to Follow-up|0
4443295|NCT00467740|7228331|FG003|Overall Study|Lost to Follow-up|0
4443296|NCT00467740|7228332|FG004|Overall Study|Lost to Follow-up|0
4443297|NCT00467740|7228328|FG000|Overall Study|Withdrawal by Subject|1
4443298|NCT00467740|7228329|FG001|Overall Study|Withdrawal by Subject|1
4443299|NCT00467740|7228330|FG002|Overall Study|Withdrawal by Subject|0
4443300|NCT00467740|7228331|FG003|Overall Study|Withdrawal by Subject|1
4443301|NCT00467740|7228332|FG004|Overall Study|Withdrawal by Subject|0
4443302|NCT00467740|7228328|FG000|Overall Study|Lack of Efficacy|0
4443303|NCT00467740|7228329|FG001|Overall Study|Lack of Efficacy|1
4443304|NCT00467740|7228330|FG002|Overall Study|Lack of Efficacy|0
4443305|NCT00467740|7228331|FG003|Overall Study|Lack of Efficacy|0
4443306|NCT00467740|7228332|FG004|Overall Study|Lack of Efficacy|0
4443307|NCT00467779|7228359|FG000|Stage 1|Adverse Event|1
4443308|NCT00467779|7228360|FG001|Stage 1|Adverse Event|0
4443309|NCT00467779|7228361|FG002|Stage 1|Adverse Event|0
4443310|NCT00467779|7228362|FG003|Stage 1|Adverse Event|0
4443311|NCT00467779|7228363|FG004|Stage 1|Adverse Event|0
4443312|NCT00467779|7228364|FG005|Stage 1|Adverse Event|1
4443313|NCT00467779|7228365|FG006|Stage 1|Adverse Event|2
4443314|NCT00467779|7228366|FG007|Stage 1|Adverse Event|1
4443315|NCT00467779|7228367|FG008|Stage 1|Adverse Event|0
4443316|NCT00467779|7228368|FG009|Stage 1|Adverse Event|0
4443317|NCT00467779|7228369|FG010|Stage 1|Adverse Event|0
4443318|NCT00467779|7228370|FG011|Stage 1|Adverse Event|0
4443319|NCT00467779|7228371|FG012|Stage 1|Adverse Event|0
4443320|NCT00467779|7228372|FG013|Stage 1|Adverse Event|0
4443321|NCT00467779|7228373|FG014|Stage 1|Adverse Event|0
4443322|NCT00467779|7228359|FG000|Stage 1|Disease Progression|2
4443323|NCT00467779|7228360|FG001|Stage 1|Disease Progression|2
4443324|NCT00467779|7228361|FG002|Stage 1|Disease Progression|2
4443325|NCT00467779|7228362|FG003|Stage 1|Disease Progression|3
4443326|NCT00467779|7228363|FG004|Stage 1|Disease Progression|2
4443327|NCT00467779|7228364|FG005|Stage 1|Disease Progression|2
4443328|NCT00467779|7228365|FG006|Stage 1|Disease Progression|4
4443329|NCT00467779|7228366|FG007|Stage 1|Disease Progression|5
4443330|NCT00467779|7228367|FG008|Stage 1|Disease Progression|0
4443331|NCT00467779|7228368|FG009|Stage 1|Disease Progression|0
4443332|NCT00467779|7228369|FG010|Stage 1|Disease Progression|0
4443333|NCT00467779|7228370|FG011|Stage 1|Disease Progression|0
4443334|NCT00467779|7228371|FG012|Stage 1|Disease Progression|0
4443335|NCT00467779|7228372|FG013|Stage 1|Disease Progression|0
4443336|NCT00467779|7228373|FG014|Stage 1|Disease Progression|0
4443337|NCT00467779|7228359|FG000|Stage 1|Unspecified Reason|1
4443338|NCT00467779|7228360|FG001|Stage 1|Unspecified Reason|0
4443339|NCT00467779|7228361|FG002|Stage 1|Unspecified Reason|1
4443340|NCT00467779|7228362|FG003|Stage 1|Unspecified Reason|0
4443341|NCT00467779|7228363|FG004|Stage 1|Unspecified Reason|1
4443342|NCT00467779|7228364|FG005|Stage 1|Unspecified Reason|2
4443343|NCT00467779|7228365|FG006|Stage 1|Unspecified Reason|0
4443344|NCT00467779|7228366|FG007|Stage 1|Unspecified Reason|0
4443345|NCT00467779|7228367|FG008|Stage 1|Unspecified Reason|0
4443346|NCT00467779|7228368|FG009|Stage 1|Unspecified Reason|0
4443347|NCT00467779|7228369|FG010|Stage 1|Unspecified Reason|0
4443348|NCT00467779|7228370|FG011|Stage 1|Unspecified Reason|0
4443349|NCT00467779|7228371|FG012|Stage 1|Unspecified Reason|0
4443350|NCT00467779|7228372|FG013|Stage 1|Unspecified Reason|0
4443351|NCT00467779|7228373|FG014|Stage 1|Unspecified Reason|0
4443352|NCT00467779|7228359|FG000|Stage 1|Physician Decision|0
4443353|NCT00467779|7228360|FG001|Stage 1|Physician Decision|1
4443354|NCT00467779|7228361|FG002|Stage 1|Physician Decision|0
4443355|NCT00467779|7228362|FG003|Stage 1|Physician Decision|0
4443356|NCT00467779|7228363|FG004|Stage 1|Physician Decision|0
4443357|NCT00467779|7228364|FG005|Stage 1|Physician Decision|0
4443358|NCT00467779|7228365|FG006|Stage 1|Physician Decision|0
4443359|NCT00467779|7228366|FG007|Stage 1|Physician Decision|0
4443360|NCT00467779|7228367|FG008|Stage 1|Physician Decision|0
4443361|NCT00467779|7228368|FG009|Stage 1|Physician Decision|0
4443362|NCT00467779|7228369|FG010|Stage 1|Physician Decision|0
4443363|NCT00467779|7228370|FG011|Stage 1|Physician Decision|0
4443364|NCT00467779|7228371|FG012|Stage 1|Physician Decision|0
4443365|NCT00467779|7228372|FG013|Stage 1|Physician Decision|0
4443366|NCT00467779|7228373|FG014|Stage 1|Physician Decision|0
4443367|NCT00467779|7228359|FG000|Stage 1|Withdrawal by Subject|0
4443368|NCT00467779|7228360|FG001|Stage 1|Withdrawal by Subject|0
4443369|NCT00467779|7228361|FG002|Stage 1|Withdrawal by Subject|0
4443370|NCT00467779|7228362|FG003|Stage 1|Withdrawal by Subject|0
4443371|NCT00467779|7228363|FG004|Stage 1|Withdrawal by Subject|0
4443372|NCT00467779|7228364|FG005|Stage 1|Withdrawal by Subject|0
4443373|NCT00467779|7228365|FG006|Stage 1|Withdrawal by Subject|1
4443374|NCT00467779|7228366|FG007|Stage 1|Withdrawal by Subject|1
4443375|NCT00467779|7228367|FG008|Stage 1|Withdrawal by Subject|0
4443376|NCT00467779|7228368|FG009|Stage 1|Withdrawal by Subject|0
4443377|NCT00467779|7228369|FG010|Stage 1|Withdrawal by Subject|0
4443378|NCT00467779|7228370|FG011|Stage 1|Withdrawal by Subject|0
4443379|NCT00467779|7228371|FG012|Stage 1|Withdrawal by Subject|0
4443380|NCT00467779|7228372|FG013|Stage 1|Withdrawal by Subject|0
4443381|NCT00467779|7228373|FG014|Stage 1|Withdrawal by Subject|0
4443382|NCT00467779|7228359|FG000|Stage 1A|Adverse Event|0
4443383|NCT00467779|7228360|FG001|Stage 1A|Adverse Event|0
4443384|NCT00467779|7228361|FG002|Stage 1A|Adverse Event|0
4443385|NCT00467779|7228362|FG003|Stage 1A|Adverse Event|0
4443386|NCT00467779|7228363|FG004|Stage 1A|Adverse Event|0
4443387|NCT00467779|7228364|FG005|Stage 1A|Adverse Event|0
4443388|NCT00467779|7228365|FG006|Stage 1A|Adverse Event|0
4443389|NCT00467779|7228366|FG007|Stage 1A|Adverse Event|0
4443390|NCT00467779|7228367|FG008|Stage 1A|Adverse Event|0
4443391|NCT00467779|7228368|FG009|Stage 1A|Adverse Event|0
4443392|NCT00467779|7228369|FG010|Stage 1A|Adverse Event|0
4443393|NCT00467779|7228370|FG011|Stage 1A|Adverse Event|0
4443394|NCT00467779|7228371|FG012|Stage 1A|Adverse Event|1
4443395|NCT00467779|7228372|FG013|Stage 1A|Adverse Event|0
4443396|NCT00467779|7228373|FG014|Stage 1A|Adverse Event|0
4443397|NCT00467779|7228359|FG000|Stage 1A|Death|0
4443398|NCT00467779|7228360|FG001|Stage 1A|Death|0
4443399|NCT00467779|7228361|FG002|Stage 1A|Death|0
4443400|NCT00467779|7228362|FG003|Stage 1A|Death|0
4443401|NCT00467779|7228363|FG004|Stage 1A|Death|0
4443402|NCT00467779|7228364|FG005|Stage 1A|Death|0
4443403|NCT00467779|7228365|FG006|Stage 1A|Death|0
4443404|NCT00467779|7228366|FG007|Stage 1A|Death|0
4443405|NCT00467779|7228367|FG008|Stage 1A|Death|0
4443406|NCT00467779|7228368|FG009|Stage 1A|Death|0
4443407|NCT00467779|7228369|FG010|Stage 1A|Death|0
4443408|NCT00467779|7228370|FG011|Stage 1A|Death|1
4443409|NCT00467779|7228371|FG012|Stage 1A|Death|1
4443410|NCT00467779|7228372|FG013|Stage 1A|Death|0
4443411|NCT00467779|7228373|FG014|Stage 1A|Death|0
4443412|NCT00467779|7228359|FG000|Stage 1A|Disease Progression|0
4443413|NCT00467779|7228360|FG001|Stage 1A|Disease Progression|0
4443414|NCT00467779|7228361|FG002|Stage 1A|Disease Progression|0
4716456|NCT02992288|7645800|FG005|Overall Study|Lost to Follow-up|0
4716457|NCT02992288|7645795|FG000|Overall Study|Protocol Violation|0
4716458|NCT02992288|7645796|FG001|Overall Study|Protocol Violation|0
4716459|NCT02992288|7645797|FG002|Overall Study|Protocol Violation|0
4716460|NCT02992288|7645798|FG003|Overall Study|Protocol Violation|0
4716461|NCT02992288|7645799|FG004|Overall Study|Protocol Violation|0
4716462|NCT02992288|7645800|FG005|Overall Study|Protocol Violation|1
4716463|NCT02992288|7645795|FG000|Overall Study|Withdrawal by Subject|4
4716464|NCT02992288|7645796|FG001|Overall Study|Withdrawal by Subject|2
4716465|NCT02992288|7645797|FG002|Overall Study|Withdrawal by Subject|1
4716466|NCT02992288|7645798|FG003|Overall Study|Withdrawal by Subject|5
4716467|NCT02992288|7645799|FG004|Overall Study|Withdrawal by Subject|3
4716468|NCT02992288|7645800|FG005|Overall Study|Withdrawal by Subject|4
4716469|NCT02992691|7645814|FG000|Overall Study|Adverse Event|2
4443415|NCT00467779|7228362|FG003|Stage 1A|Disease Progression|0
4443416|NCT00467779|7228363|FG004|Stage 1A|Disease Progression|0
4443417|NCT00467779|7228364|FG005|Stage 1A|Disease Progression|0
4443418|NCT00467779|7228365|FG006|Stage 1A|Disease Progression|0
4443419|NCT00467779|7228366|FG007|Stage 1A|Disease Progression|0
4443420|NCT00467779|7228367|FG008|Stage 1A|Disease Progression|0
4443421|NCT00467779|7228368|FG009|Stage 1A|Disease Progression|2
4443422|NCT00467779|7228369|FG010|Stage 1A|Disease Progression|2
4443423|NCT00467779|7228370|FG011|Stage 1A|Disease Progression|5
4443424|NCT00467779|7228371|FG012|Stage 1A|Disease Progression|2
4443425|NCT00467779|7228372|FG013|Stage 1A|Disease Progression|0
4443426|NCT00467779|7228373|FG014|Stage 1A|Disease Progression|0
4443427|NCT00467779|7228359|FG000|Stage 1A|Physician Decision|0
4443428|NCT00467779|7228360|FG001|Stage 1A|Physician Decision|0
4443429|NCT00467779|7228361|FG002|Stage 1A|Physician Decision|0
4443430|NCT00467779|7228362|FG003|Stage 1A|Physician Decision|0
4443431|NCT00467779|7228363|FG004|Stage 1A|Physician Decision|0
4443432|NCT00467779|7228364|FG005|Stage 1A|Physician Decision|0
4443433|NCT00467779|7228365|FG006|Stage 1A|Physician Decision|0
4443434|NCT00467779|7228366|FG007|Stage 1A|Physician Decision|0
4443435|NCT00467779|7228367|FG008|Stage 1A|Physician Decision|0
4443436|NCT00467779|7228368|FG009|Stage 1A|Physician Decision|1
4443437|NCT00467779|7228369|FG010|Stage 1A|Physician Decision|0
4443438|NCT00467779|7228370|FG011|Stage 1A|Physician Decision|0
4443439|NCT00467779|7228371|FG012|Stage 1A|Physician Decision|0
4443440|NCT00467779|7228372|FG013|Stage 1A|Physician Decision|0
4443441|NCT00467779|7228373|FG014|Stage 1A|Physician Decision|0
4443442|NCT00467779|7228359|FG000|Stage 1A|Withdrawal by Subject|0
4443443|NCT00467779|7228360|FG001|Stage 1A|Withdrawal by Subject|0
4443444|NCT00467779|7228361|FG002|Stage 1A|Withdrawal by Subject|0
4443445|NCT00467779|7228362|FG003|Stage 1A|Withdrawal by Subject|0
4443446|NCT00467779|7228363|FG004|Stage 1A|Withdrawal by Subject|0
4716470|NCT02992691|7645814|FG000|Overall Study|Withdrawal by Subject|1
4716471|NCT02992899|7645831|FG000|Overall Study|Withdrawal by Subject|1
4716472|NCT02992899|7645832|FG001|Overall Study|Withdrawal by Subject|0
4716473|NCT02992899|7645831|FG000|Overall Study|Lost to Follow-up|1
4443447|NCT00467779|7228364|FG005|Stage 1A|Withdrawal by Subject|0
4443448|NCT00467779|7228365|FG006|Stage 1A|Withdrawal by Subject|0
4443449|NCT00467779|7228366|FG007|Stage 1A|Withdrawal by Subject|0
4443450|NCT00467779|7228367|FG008|Stage 1A|Withdrawal by Subject|0
4443451|NCT00467779|7228368|FG009|Stage 1A|Withdrawal by Subject|0
4443452|NCT00467779|7228369|FG010|Stage 1A|Withdrawal by Subject|1
4443453|NCT00467779|7228370|FG011|Stage 1A|Withdrawal by Subject|1
4443454|NCT00467779|7228371|FG012|Stage 1A|Withdrawal by Subject|1
4443455|NCT00467779|7228372|FG013|Stage 1A|Withdrawal by Subject|0
4443456|NCT00467779|7228373|FG014|Stage 1A|Withdrawal by Subject|0
4443457|NCT00467779|7228359|FG000|Stage 1A|Unspecified Reason|0
4443458|NCT00467779|7228360|FG001|Stage 1A|Unspecified Reason|0
4443459|NCT00467779|7228361|FG002|Stage 1A|Unspecified Reason|0
4443460|NCT00467779|7228362|FG003|Stage 1A|Unspecified Reason|0
4443461|NCT00467779|7228363|FG004|Stage 1A|Unspecified Reason|0
4443462|NCT00467779|7228364|FG005|Stage 1A|Unspecified Reason|0
4443463|NCT00467779|7228365|FG006|Stage 1A|Unspecified Reason|0
4443464|NCT00467779|7228366|FG007|Stage 1A|Unspecified Reason|0
4443465|NCT00467779|7228367|FG008|Stage 1A|Unspecified Reason|0
4443466|NCT00467779|7228368|FG009|Stage 1A|Unspecified Reason|0
4443467|NCT00467779|7228369|FG010|Stage 1A|Unspecified Reason|0
4443468|NCT00467779|7228370|FG011|Stage 1A|Unspecified Reason|1
4443469|NCT00467779|7228371|FG012|Stage 1A|Unspecified Reason|1
4443470|NCT00467779|7228372|FG013|Stage 1A|Unspecified Reason|0
4443471|NCT00467779|7228373|FG014|Stage 1A|Unspecified Reason|0
4443472|NCT00467779|7228359|FG000|Stage 2|Adverse Event|0
4443473|NCT00467779|7228360|FG001|Stage 2|Adverse Event|0
4443474|NCT00467779|7228361|FG002|Stage 2|Adverse Event|0
4443475|NCT00467779|7228362|FG003|Stage 2|Adverse Event|0
4443476|NCT00467779|7228363|FG004|Stage 2|Adverse Event|0
4443477|NCT00467779|7228364|FG005|Stage 2|Adverse Event|0
4443478|NCT00467779|7228365|FG006|Stage 2|Adverse Event|0
4443479|NCT00467779|7228366|FG007|Stage 2|Adverse Event|0
4443480|NCT00467779|7228367|FG008|Stage 2|Adverse Event|1
4443481|NCT00467779|7228368|FG009|Stage 2|Adverse Event|0
4443482|NCT00467779|7228369|FG010|Stage 2|Adverse Event|0
4443483|NCT00467779|7228370|FG011|Stage 2|Adverse Event|0
4443484|NCT00467779|7228371|FG012|Stage 2|Adverse Event|0
4443485|NCT00467779|7228372|FG013|Stage 2|Adverse Event|0
4443486|NCT00467779|7228373|FG014|Stage 2|Adverse Event|0
4443487|NCT00467779|7228359|FG000|Stage 2|Death|0
4443488|NCT00467779|7228360|FG001|Stage 2|Death|0
4443489|NCT00467779|7228361|FG002|Stage 2|Death|0
4443490|NCT00467779|7228362|FG003|Stage 2|Death|0
4443491|NCT00467779|7228363|FG004|Stage 2|Death|0
4443492|NCT00467779|7228364|FG005|Stage 2|Death|0
4443493|NCT00467779|7228365|FG006|Stage 2|Death|0
4630371|NCT01296711|7498858|FG001|Overall Study|Required restricted steroid injections|0
4630372|NCT01296711|7498859|FG002|Overall Study|Required restricted steroid injections|0
4630373|NCT01296711|7498860|FG003|Overall Study|Required restricted steroid injections|0
4630374|NCT01296711|7498861|FG004|Overall Study|Required restricted steroid injections|0
4630375|NCT01296711|7498862|FG005|Overall Study|Required restricted steroid injections|0
4630376|NCT01296711|7498863|FG006|Overall Study|Required restricted steroid injections|1
4630377|NCT01296711|7498864|FG007|Overall Study|Required restricted steroid injections|0
4630378|NCT01296711|7498857|FG000|Overall Study|Ongoing missed appointments|0
4630379|NCT01296711|7498858|FG001|Overall Study|Ongoing missed appointments|0
4630380|NCT01296711|7498859|FG002|Overall Study|Ongoing missed appointments|0
4630381|NCT01296711|7498860|FG003|Overall Study|Ongoing missed appointments|0
4630382|NCT01296711|7498861|FG004|Overall Study|Ongoing missed appointments|0
4630383|NCT01296711|7498862|FG005|Overall Study|Ongoing missed appointments|0
4630384|NCT01296711|7498863|FG006|Overall Study|Ongoing missed appointments|1
4630385|NCT01296711|7498864|FG007|Overall Study|Ongoing missed appointments|0
4630386|NCT01296711|7498857|FG000|Overall Study|Failure to comply with visits|0
4630387|NCT01296711|7498858|FG001|Overall Study|Failure to comply with visits|0
4630388|NCT01296711|7498859|FG002|Overall Study|Failure to comply with visits|0
4630389|NCT01296711|7498860|FG003|Overall Study|Failure to comply with visits|0
4630390|NCT01296711|7498861|FG004|Overall Study|Failure to comply with visits|0
4630391|NCT01296711|7498862|FG005|Overall Study|Failure to comply with visits|0
4630392|NCT01296711|7498863|FG006|Overall Study|Failure to comply with visits|0
4630393|NCT01296711|7498864|FG007|Overall Study|Failure to comply with visits|1
4630394|NCT01296711|7498857|FG000|Overall Study|Patient decision due to transport|0
4630395|NCT01296711|7498858|FG001|Overall Study|Patient decision due to transport|0
4630396|NCT01296711|7498859|FG002|Overall Study|Patient decision due to transport|0
4630397|NCT01296711|7498860|FG003|Overall Study|Patient decision due to transport|0
4630398|NCT01296711|7498861|FG004|Overall Study|Patient decision due to transport|0
4443494|NCT00467779|7228366|FG007|Stage 2|Death|0
4443495|NCT00467779|7228367|FG008|Stage 2|Death|1
4443496|NCT00467779|7228368|FG009|Stage 2|Death|0
4443497|NCT00467779|7228369|FG010|Stage 2|Death|0
4443498|NCT00467779|7228370|FG011|Stage 2|Death|0
4443499|NCT00467779|7228371|FG012|Stage 2|Death|0
4443500|NCT00467779|7228372|FG013|Stage 2|Death|0
4443501|NCT00467779|7228373|FG014|Stage 2|Death|0
4443502|NCT00467779|7228359|FG000|Stage 2|Disease Progression|0
4443503|NCT00467779|7228360|FG001|Stage 2|Disease Progression|0
4443504|NCT00467779|7228361|FG002|Stage 2|Disease Progression|0
4443505|NCT00467779|7228362|FG003|Stage 2|Disease Progression|0
4443506|NCT00467779|7228363|FG004|Stage 2|Disease Progression|0
4443507|NCT00467779|7228364|FG005|Stage 2|Disease Progression|0
4443508|NCT00467779|7228365|FG006|Stage 2|Disease Progression|0
4443509|NCT00467779|7228366|FG007|Stage 2|Disease Progression|0
4443510|NCT00467779|7228367|FG008|Stage 2|Disease Progression|16
4443511|NCT00467779|7228368|FG009|Stage 2|Disease Progression|0
4443512|NCT00467779|7228369|FG010|Stage 2|Disease Progression|0
4443513|NCT00467779|7228370|FG011|Stage 2|Disease Progression|0
4443514|NCT00467779|7228371|FG012|Stage 2|Disease Progression|0
4443515|NCT00467779|7228372|FG013|Stage 2|Disease Progression|0
4443516|NCT00467779|7228373|FG014|Stage 2|Disease Progression|0
4443517|NCT00467779|7228359|FG000|Stage 2|Unspecified Reason|0
4443518|NCT00467779|7228360|FG001|Stage 2|Unspecified Reason|0
4443519|NCT00467779|7228361|FG002|Stage 2|Unspecified Reason|0
4443520|NCT00467779|7228362|FG003|Stage 2|Unspecified Reason|0
4443521|NCT00467779|7228363|FG004|Stage 2|Unspecified Reason|0
4443522|NCT00467779|7228364|FG005|Stage 2|Unspecified Reason|0
4443523|NCT00467779|7228365|FG006|Stage 2|Unspecified Reason|0
4443524|NCT00467779|7228366|FG007|Stage 2|Unspecified Reason|0
4443525|NCT00467779|7228367|FG008|Stage 2|Unspecified Reason|3
4443526|NCT00467779|7228368|FG009|Stage 2|Unspecified Reason|0
4443527|NCT00467779|7228369|FG010|Stage 2|Unspecified Reason|0
4443528|NCT00467779|7228370|FG011|Stage 2|Unspecified Reason|0
4443529|NCT00467779|7228371|FG012|Stage 2|Unspecified Reason|0
4443530|NCT00467779|7228372|FG013|Stage 2|Unspecified Reason|0
4443531|NCT00467779|7228373|FG014|Stage 2|Unspecified Reason|0
4443532|NCT00467779|7228359|FG000|Stage 2A|Adverse Event|0
4443533|NCT00467779|7228360|FG001|Stage 2A|Adverse Event|0
4443534|NCT00467779|7228361|FG002|Stage 2A|Adverse Event|0
4443535|NCT00467779|7228362|FG003|Stage 2A|Adverse Event|0
4443536|NCT00467779|7228363|FG004|Stage 2A|Adverse Event|0
4443537|NCT00467779|7228364|FG005|Stage 2A|Adverse Event|0
4443538|NCT00467779|7228365|FG006|Stage 2A|Adverse Event|0
4443539|NCT00467779|7228366|FG007|Stage 2A|Adverse Event|0
4443540|NCT00467779|7228367|FG008|Stage 2A|Adverse Event|0
4443541|NCT00467779|7228368|FG009|Stage 2A|Adverse Event|0
4443542|NCT00467779|7228369|FG010|Stage 2A|Adverse Event|0
4443543|NCT00467779|7228370|FG011|Stage 2A|Adverse Event|0
4443544|NCT00467779|7228371|FG012|Stage 2A|Adverse Event|0
4443545|NCT00467779|7228372|FG013|Stage 2A|Adverse Event|2
4443546|NCT00467779|7228373|FG014|Stage 2A|Adverse Event|0
4443547|NCT00467779|7228359|FG000|Stage 2A|Death|0
4443548|NCT00467779|7228360|FG001|Stage 2A|Death|0
4443549|NCT00467779|7228361|FG002|Stage 2A|Death|0
4443550|NCT00467779|7228362|FG003|Stage 2A|Death|0
4443551|NCT00467779|7228363|FG004|Stage 2A|Death|0
4443552|NCT00467779|7228364|FG005|Stage 2A|Death|0
4443553|NCT00467779|7228365|FG006|Stage 2A|Death|0
4443554|NCT00467779|7228366|FG007|Stage 2A|Death|0
4443555|NCT00467779|7228367|FG008|Stage 2A|Death|0
4443556|NCT00467779|7228368|FG009|Stage 2A|Death|0
4443557|NCT00467779|7228369|FG010|Stage 2A|Death|0
4443558|NCT00467779|7228370|FG011|Stage 2A|Death|0
4443559|NCT00467779|7228371|FG012|Stage 2A|Death|0
4443560|NCT00467779|7228372|FG013|Stage 2A|Death|1
4443561|NCT00467779|7228373|FG014|Stage 2A|Death|0
4443562|NCT00467779|7228359|FG000|Stage 2A|Disease Progression|0
4443563|NCT00467779|7228360|FG001|Stage 2A|Disease Progression|0
4443564|NCT00467779|7228361|FG002|Stage 2A|Disease Progression|0
4443565|NCT00467779|7228362|FG003|Stage 2A|Disease Progression|0
4443566|NCT00467779|7228363|FG004|Stage 2A|Disease Progression|0
4443567|NCT00467779|7228364|FG005|Stage 2A|Disease Progression|0
4443568|NCT00467779|7228365|FG006|Stage 2A|Disease Progression|0
4443569|NCT00467779|7228366|FG007|Stage 2A|Disease Progression|0
4443570|NCT00467779|7228367|FG008|Stage 2A|Disease Progression|0
4443571|NCT00467779|7228368|FG009|Stage 2A|Disease Progression|0
4443572|NCT00467779|7228369|FG010|Stage 2A|Disease Progression|0
4443573|NCT00467779|7228370|FG011|Stage 2A|Disease Progression|0
4443574|NCT00467779|7228371|FG012|Stage 2A|Disease Progression|0
4443575|NCT00467779|7228372|FG013|Stage 2A|Disease Progression|10
4443576|NCT00467779|7228373|FG014|Stage 2A|Disease Progression|0
4443577|NCT00467779|7228359|FG000|Stage 2A|Unspecified Reason|0
4443578|NCT00467779|7228360|FG001|Stage 2A|Unspecified Reason|0
4443579|NCT00467779|7228361|FG002|Stage 2A|Unspecified Reason|0
4443580|NCT00467779|7228362|FG003|Stage 2A|Unspecified Reason|0
4443581|NCT00467779|7228363|FG004|Stage 2A|Unspecified Reason|0
4443582|NCT00467779|7228364|FG005|Stage 2A|Unspecified Reason|0
4443583|NCT00467779|7228365|FG006|Stage 2A|Unspecified Reason|0
4443584|NCT00467779|7228366|FG007|Stage 2A|Unspecified Reason|0
4443585|NCT00467779|7228367|FG008|Stage 2A|Unspecified Reason|0
4443586|NCT00467779|7228368|FG009|Stage 2A|Unspecified Reason|0
4443587|NCT00467779|7228369|FG010|Stage 2A|Unspecified Reason|0
4443588|NCT00467779|7228370|FG011|Stage 2A|Unspecified Reason|0
4443589|NCT00467779|7228371|FG012|Stage 2A|Unspecified Reason|0
4443590|NCT00467779|7228372|FG013|Stage 2A|Unspecified Reason|7
4443591|NCT00467779|7228373|FG014|Stage 2A|Unspecified Reason|0
4443592|NCT00467779|7228359|FG000|Stage 2A|Withdrawal by Subject|0
4443593|NCT00467779|7228360|FG001|Stage 2A|Withdrawal by Subject|0
4443594|NCT00467779|7228361|FG002|Stage 2A|Withdrawal by Subject|0
4443595|NCT00467779|7228362|FG003|Stage 2A|Withdrawal by Subject|0
4443596|NCT00467779|7228363|FG004|Stage 2A|Withdrawal by Subject|0
4443597|NCT00467779|7228364|FG005|Stage 2A|Withdrawal by Subject|0
4443598|NCT00467779|7228365|FG006|Stage 2A|Withdrawal by Subject|0
4443599|NCT00467779|7228366|FG007|Stage 2A|Withdrawal by Subject|0
4443600|NCT00467779|7228367|FG008|Stage 2A|Withdrawal by Subject|0
4443601|NCT00467779|7228368|FG009|Stage 2A|Withdrawal by Subject|0
4443602|NCT00467779|7228369|FG010|Stage 2A|Withdrawal by Subject|0
4443603|NCT00467779|7228370|FG011|Stage 2A|Withdrawal by Subject|0
4443604|NCT00467779|7228371|FG012|Stage 2A|Withdrawal by Subject|0
4443605|NCT00467779|7228372|FG013|Stage 2A|Withdrawal by Subject|1
4443606|NCT00467779|7228373|FG014|Stage 2A|Withdrawal by Subject|0
4443607|NCT00467779|7228359|FG000|Stage 3|Adverse Event|0
4443608|NCT00467779|7228360|FG001|Stage 3|Adverse Event|0
4443609|NCT00467779|7228361|FG002|Stage 3|Adverse Event|0
4443610|NCT00467779|7228362|FG003|Stage 3|Adverse Event|0
4443611|NCT00467779|7228363|FG004|Stage 3|Adverse Event|0
4443612|NCT00467779|7228364|FG005|Stage 3|Adverse Event|0
4443613|NCT00467779|7228365|FG006|Stage 3|Adverse Event|0
4443614|NCT00467779|7228366|FG007|Stage 3|Adverse Event|0
4443615|NCT00467779|7228367|FG008|Stage 3|Adverse Event|0
4443616|NCT00467779|7228368|FG009|Stage 3|Adverse Event|0
4443617|NCT00467779|7228369|FG010|Stage 3|Adverse Event|0
4443618|NCT00467779|7228370|FG011|Stage 3|Adverse Event|0
4443619|NCT00467779|7228371|FG012|Stage 3|Adverse Event|0
4443620|NCT00467779|7228372|FG013|Stage 3|Adverse Event|0
4443621|NCT00467779|7228373|FG014|Stage 3|Adverse Event|2
4443622|NCT00467779|7228359|FG000|Stage 3|Death|0
4443623|NCT00467779|7228360|FG001|Stage 3|Death|0
4443624|NCT00467779|7228361|FG002|Stage 3|Death|0
4443625|NCT00467779|7228362|FG003|Stage 3|Death|0
4443626|NCT00467779|7228363|FG004|Stage 3|Death|0
4443627|NCT00467779|7228364|FG005|Stage 3|Death|0
4443628|NCT00467779|7228365|FG006|Stage 3|Death|0
4443629|NCT00467779|7228366|FG007|Stage 3|Death|0
4443630|NCT00467779|7228367|FG008|Stage 3|Death|0
4443631|NCT00467779|7228368|FG009|Stage 3|Death|0
4443632|NCT00467779|7228369|FG010|Stage 3|Death|0
4443633|NCT00467779|7228370|FG011|Stage 3|Death|0
4443634|NCT00467779|7228371|FG012|Stage 3|Death|0
4443635|NCT00467779|7228372|FG013|Stage 3|Death|0
4443636|NCT00467779|7228373|FG014|Stage 3|Death|1
4443637|NCT00467779|7228359|FG000|Stage 3|Disease Progression|0
4443638|NCT00467779|7228360|FG001|Stage 3|Disease Progression|0
4443639|NCT00467779|7228361|FG002|Stage 3|Disease Progression|0
4443640|NCT00467779|7228362|FG003|Stage 3|Disease Progression|0
4443641|NCT00467779|7228363|FG004|Stage 3|Disease Progression|0
4443642|NCT00467779|7228364|FG005|Stage 3|Disease Progression|0
4443643|NCT00467779|7228365|FG006|Stage 3|Disease Progression|0
4443644|NCT00467779|7228366|FG007|Stage 3|Disease Progression|0
4443645|NCT00467779|7228367|FG008|Stage 3|Disease Progression|0
4443646|NCT00467779|7228368|FG009|Stage 3|Disease Progression|0
4443647|NCT00467779|7228369|FG010|Stage 3|Disease Progression|0
4443648|NCT00467779|7228370|FG011|Stage 3|Disease Progression|0
4443649|NCT00467779|7228371|FG012|Stage 3|Disease Progression|0
4443650|NCT00467779|7228372|FG013|Stage 3|Disease Progression|0
4443651|NCT00467779|7228373|FG014|Stage 3|Disease Progression|9
4443652|NCT00467779|7228359|FG000|Stage 3|Unspecified Reason|0
4443653|NCT00467779|7228360|FG001|Stage 3|Unspecified Reason|0
4443654|NCT00467779|7228361|FG002|Stage 3|Unspecified Reason|0
4443655|NCT00467779|7228362|FG003|Stage 3|Unspecified Reason|0
4443656|NCT00467779|7228363|FG004|Stage 3|Unspecified Reason|0
4443657|NCT00467779|7228364|FG005|Stage 3|Unspecified Reason|0
4443658|NCT00467779|7228365|FG006|Stage 3|Unspecified Reason|0
4443659|NCT00467779|7228366|FG007|Stage 3|Unspecified Reason|0
4443660|NCT00467779|7228367|FG008|Stage 3|Unspecified Reason|0
4443661|NCT00467779|7228368|FG009|Stage 3|Unspecified Reason|0
4443662|NCT00467779|7228369|FG010|Stage 3|Unspecified Reason|0
4443663|NCT00467779|7228370|FG011|Stage 3|Unspecified Reason|0
4443664|NCT00467779|7228371|FG012|Stage 3|Unspecified Reason|0
4443665|NCT00467779|7228372|FG013|Stage 3|Unspecified Reason|0
4443666|NCT00467779|7228373|FG014|Stage 3|Unspecified Reason|5
4443667|NCT00467818|7228413|FG000|Overall Study|Adverse Event|1
4443668|NCT00467818|7228414|FG001|Overall Study|Adverse Event|0
4443669|NCT00467818|7228413|FG000|Overall Study|Lost to Follow-up|2
4443670|NCT00467818|7228414|FG001|Overall Study|Lost to Follow-up|2
4443671|NCT00467831|7228422|FG000|Overall Study|Death|2
4443672|NCT00467831|7228422|FG000|Overall Study|Withdrawal by Subject|1
4443673|NCT00467857|7228444|FG000|Overall Study|Adverse Event|1
4443674|NCT00467857|7228445|FG001|Overall Study|Adverse Event|0
4443675|NCT00467857|7228444|FG000|Overall Study|Withdrew consent|2
4443676|NCT00467857|7228445|FG001|Overall Study|Withdrew consent|0
4443677|NCT00467857|7228444|FG000|Overall Study|Death|0
4443678|NCT00467857|7228445|FG001|Overall Study|Death|1
4443679|NCT00467857|7228444|FG000|Overall Study|Discharged from court service|0
4443680|NCT00467857|7228445|FG001|Overall Study|Discharged from court service|1
4443681|NCT00467857|7228444|FG000|Overall Study|Emergency care required|0
4443682|NCT00467857|7228445|FG001|Overall Study|Emergency care required|1
4443683|NCT00467857|7228444|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0
4443684|NCT00467857|7228445|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2
4443685|NCT00467857|7228444|FG000|Overall Study|Discontinuation reason missing|0
4443686|NCT00467857|7228445|FG001|Overall Study|Discontinuation reason missing|3
4443687|NCT00467870|7228457|FG000|Overall Study|Adverse Event|13
4443688|NCT00467870|7228458|FG001|Overall Study|Adverse Event|9
4443689|NCT00467870|7228459|FG002|Overall Study|Adverse Event|1
4443690|NCT00467870|7228460|FG003|Overall Study|Adverse Event|15
4443691|NCT00467870|7228461|FG004|Overall Study|Adverse Event|15
4443692|NCT00467870|7228462|FG005|Overall Study|Adverse Event|1
4443693|NCT00467870|7228457|FG000|Overall Study|Protocol Violation|2
4443694|NCT00467870|7228458|FG001|Overall Study|Protocol Violation|1
4443695|NCT00467870|7228459|FG002|Overall Study|Protocol Violation|1
4443696|NCT00467870|7228460|FG003|Overall Study|Protocol Violation|2
4443697|NCT00467870|7228461|FG004|Overall Study|Protocol Violation|0
4443698|NCT00467870|7228462|FG005|Overall Study|Protocol Violation|0
4443699|NCT00467870|7228457|FG000|Overall Study|Withdrawal by Subject|14
4443700|NCT00467870|7228458|FG001|Overall Study|Withdrawal by Subject|21
4443701|NCT00467870|7228459|FG002|Overall Study|Withdrawal by Subject|0
4443702|NCT00467870|7228460|FG003|Overall Study|Withdrawal by Subject|9
4443703|NCT00467870|7228461|FG004|Overall Study|Withdrawal by Subject|10
4443704|NCT00467870|7228462|FG005|Overall Study|Withdrawal by Subject|1
4443705|NCT00467870|7228457|FG000|Overall Study|Lost to Follow-up|5
4443706|NCT00467870|7228458|FG001|Overall Study|Lost to Follow-up|3
4443707|NCT00467870|7228459|FG002|Overall Study|Lost to Follow-up|1
4443708|NCT00467870|7228460|FG003|Overall Study|Lost to Follow-up|1
4443709|NCT00467870|7228461|FG004|Overall Study|Lost to Follow-up|3
4443710|NCT00467870|7228462|FG005|Overall Study|Lost to Follow-up|0
4443711|NCT00467870|7228457|FG000|Overall Study|Subject Non-compliance|3
4443712|NCT00467870|7228458|FG001|Overall Study|Subject Non-compliance|4
4443713|NCT00467870|7228459|FG002|Overall Study|Subject Non-compliance|0
4443714|NCT00467870|7228460|FG003|Overall Study|Subject Non-compliance|1
4443715|NCT00467870|7228461|FG004|Overall Study|Subject Non-compliance|5
4443716|NCT00467870|7228462|FG005|Overall Study|Subject Non-compliance|0
4443717|NCT00467870|7228457|FG000|Overall Study|Other/Unknown|8
4512995|NCT00939094|7323147|FG001|Overall Study|Abnormal ECG findings|0
4512996|NCT00939107|7323155|FG000|Overall Study|Lost to Follow-up|14
4443718|NCT00467870|7228458|FG001|Overall Study|Other/Unknown|5
4443719|NCT00467870|7228459|FG002|Overall Study|Other/Unknown|1
4443720|NCT00467870|7228460|FG003|Overall Study|Other/Unknown|5
4443721|NCT00467870|7228461|FG004|Overall Study|Other/Unknown|4
4443722|NCT00467870|7228462|FG005|Overall Study|Other/Unknown|0
4443723|NCT00467896|7228472|FG000|Overall Study|Consent Withdrawal|18
4443724|NCT00467896|7228472|FG000|Overall Study|Adverse Event|7
4443725|NCT00467896|7228472|FG000|Overall Study|Serious Adverse Event|13
4443726|NCT00467896|7228472|FG000|Overall Study|Non-compliance|3
4443727|NCT00467896|7228472|FG000|Overall Study|Changed therapy|2
4443728|NCT00467896|7228472|FG000|Overall Study|Patient received transplant|2
4443729|NCT00467896|7228472|FG000|Overall Study|Patient had atrial septostomy|1
4443730|NCT00467896|7228472|FG000|Overall Study|Patient weaned off iloprost|1
4443731|NCT00467896|7228472|FG000|Overall Study|Mainly used Prodose not I-neb® device|1
4443732|NCT00467896|7228472|FG000|Overall Study|Started intravenous prostacyclin|1
4443733|NCT00467896|7228472|FG000|Overall Study|Started inhaled Remodulin|1
4443734|NCT00467896|7228472|FG000|Overall Study|Patient had no improvement|1
4443735|NCT00467961|7228478|FG000|Overall Study|Technical Failures|5
4443736|NCT00467961|7228478|FG000|Overall Study|Disease Progression|2
4443737|NCT00468052|7228484|FG000|Overall Study|Protocol Violation|7
4443738|NCT00468052|7228485|FG001|Overall Study|Protocol Violation|8
4443739|NCT00468104|7228493|FG000|First Intervention|Protocol Violation|2
4443740|NCT00468104|7228494|FG001|First Intervention|Protocol Violation|1
4443741|NCT00468104|7228493|FG000|First Intervention|bleeding at chest tube site--first dose|1
4443742|NCT00468104|7228494|FG001|First Intervention|bleeding at chest tube site--first dose|0
4443743|NCT00468104|7228493|FG000|First Intervention|died within 3 weeks|1
4443744|NCT00468104|7228494|FG001|First Intervention|died within 3 weeks|0
4443745|NCT00468104|7228493|FG000|First Intervention|malposition/blocked chest tube tube|2
4443746|NCT00468104|7228494|FG001|First Intervention|malposition/blocked chest tube tube|0
4443747|NCT00468104|7228493|FG000|First Intervention|large lung mass with minimal effusion|1
4443748|NCT00468104|7228494|FG001|First Intervention|large lung mass with minimal effusion|0
4443749|NCT00468104|7228493|FG000|First Intervention|associated prolonged pneumothorax|1
4443750|NCT00468104|7228494|FG001|First Intervention|associated prolonged pneumothorax|0
4443751|NCT00468104|7228493|FG000|First Intervention|trapped lung|1
4443752|NCT00468104|7228494|FG001|First Intervention|trapped lung|0
4443753|NCT00468104|7228493|FG000|Second Intervention|Withdrawal by Subject|5
4443754|NCT00468104|7228494|FG001|Second Intervention|Withdrawal by Subject|2
4443755|NCT00468104|7228493|FG000|Second Intervention|discarded for malposition of chest tube|0
4443756|NCT00468104|7228494|FG001|Second Intervention|discarded for malposition of chest tube|2
4630399|NCT01296711|7498862|FG005|Overall Study|Patient decision due to transport|0
4443757|NCT00468143|7228503|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3
4443758|NCT00468143|7228504|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4
4443759|NCT00468143|7228503|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3
4443760|NCT00468143|7228504|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3
4443761|NCT00468169|7228512|FG000|Overall Study|Withdrawal by Subject|1
4443762|NCT00468169|7228513|FG001|Overall Study|Withdrawal by Subject|0
4443763|NCT00468286|7228527|FG000|Overall Study|Adverse Event|1
4443764|NCT00468286|7228528|FG001|Overall Study|Adverse Event|6
4443765|NCT00468286|7228527|FG000|Overall Study|Protocol Violation|2
4630400|NCT01296711|7498863|FG006|Overall Study|Patient decision due to transport|0
4443766|NCT00468286|7228528|FG001|Overall Study|Protocol Violation|2
4443767|NCT00468286|7228527|FG000|Overall Study|Withdrawal by Subject|4
4443768|NCT00468286|7228528|FG001|Overall Study|Withdrawal by Subject|3
4443769|NCT00468286|7228527|FG000|Overall Study|Physician Decision|0
4443770|NCT00468286|7228528|FG001|Overall Study|Physician Decision|1
4443771|NCT00468299|7228536|FG000|Overall Study|Withdrawal by Subject|0
4443772|NCT00468299|7228537|FG001|Overall Study|Withdrawal by Subject|1
4443773|NCT00468481|7228547|FG000|Overall Study|Adverse Event|13
4443774|NCT00468481|7228548|FG001|Overall Study|Adverse Event|3
4443775|NCT00468481|7228547|FG000|Overall Study|Lost to Follow-up|25
4443776|NCT00468481|7228548|FG001|Overall Study|Lost to Follow-up|8
4443777|NCT00468481|7228547|FG000|Overall Study|Pregnancy|2
4443778|NCT00468481|7228548|FG001|Overall Study|Pregnancy|0
4443779|NCT00468481|7228547|FG000|Overall Study|Protocol Violation|18
4443780|NCT00468481|7228548|FG001|Overall Study|Protocol Violation|8
4443781|NCT00468481|7228547|FG000|Overall Study|Withdrawal by Subject|12
4443782|NCT00468481|7228548|FG001|Overall Study|Withdrawal by Subject|3
4443783|NCT00468481|7228547|FG000|Overall Study|susp/diag malignant/premalignant disease|1
4443784|NCT00468481|7228548|FG001|Overall Study|susp/diag malignant/premalignant disease|0
4443785|NCT00468481|7228547|FG000|Overall Study|Prohibited Medication|1
4443786|NCT00468481|7228548|FG001|Overall Study|Prohibited Medication|1
4443787|NCT00468481|7228547|FG000|Overall Study|Egg Donor|1
4443788|NCT00468481|7228548|FG001|Overall Study|Egg Donor|0
4443789|NCT00468481|7228547|FG000|Overall Study|Moved out of area|4
4443790|NCT00468481|7228548|FG001|Overall Study|Moved out of area|1
4443791|NCT00468481|7228547|FG000|Overall Study|Non-Compliance|5
4443792|NCT00468481|7228548|FG001|Overall Study|Non-Compliance|0
4443793|NCT00468481|7228547|FG000|Overall Study|Other|6
4443794|NCT00468481|7228548|FG001|Overall Study|Other|0
4443795|NCT00468546|7228556|FG000|Week 24 Analysis|Lack of Efficacy|83
4443796|NCT00468546|7228557|FG001|Week 24 Analysis|Lack of Efficacy|37
4443797|NCT00468546|7228556|FG000|Week 24 Analysis|Refused treatment|5
4443798|NCT00468546|7228557|FG001|Week 24 Analysis|Refused treatment|5
4443799|NCT00468546|7228556|FG000|Week 24 Analysis|Adverse Event|1
4443800|NCT00468546|7228557|FG001|Week 24 Analysis|Adverse Event|8
4443801|NCT00468546|7228556|FG000|Week 24 Analysis|Failure to return|3
4443802|NCT00468546|7228557|FG001|Week 24 Analysis|Failure to return|4
4443803|NCT00468546|7228556|FG000|Week 24 Analysis|Rescue therapy|2
4443804|NCT00468546|7228557|FG001|Week 24 Analysis|Rescue therapy|0
4443805|NCT00468546|7228556|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0
4443806|NCT00468546|7228557|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1
4443807|NCT00468546|7228556|FG000|Week 24 Analysis|Due to clinical hold|1
4443808|NCT00468546|7228557|FG001|Week 24 Analysis|Due to clinical hold|0
4443809|NCT00468546|7228556|FG000|Week 24 Analysis|Went onto rescue therapy|1
4443810|NCT00468546|7228557|FG001|Week 24 Analysis|Went onto rescue therapy|0
4443811|NCT00468546|7228556|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1
4443812|NCT00468546|7228557|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0
4443813|NCT00468546|7228556|FG000|Week 24 to Week 104 Analysis|Adverse Event|2
4443814|NCT00468546|7228557|FG001|Week 24 to Week 104 Analysis|Adverse Event|5
4630401|NCT01296711|7498864|FG007|Overall Study|Patient decision due to transport|1
4630402|NCT00084656|7498885|FG000|Overall Study|Other reasons|0
4630403|NCT00084656|7498886|FG001|Overall Study|Other reasons|12
4443815|NCT00468546|7228556|FG000|Week 24 to Week 104 Analysis|Death|1
4443816|NCT00468546|7228557|FG001|Week 24 to Week 104 Analysis|Death|0
4443817|NCT00468546|7228556|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3
4443818|NCT00468546|7228557|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12
4443819|NCT00468546|7228556|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0
4443820|NCT00468546|7228557|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2
4443821|NCT00468546|7228556|FG000|Week 24 to Week 104 Analysis|Refused treatment|4
4443822|NCT00468546|7228557|FG001|Week 24 to Week 104 Analysis|Refused treatment|7
4443823|NCT00468546|7228556|FG000|Week 24 to Week 104 Analysis|Failure to return|1
4443824|NCT00468546|7228557|FG001|Week 24 to Week 104 Analysis|Failure to return|2
4443825|NCT00468546|7228556|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77
4443826|NCT00468546|7228557|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183
4443827|NCT00468546|7228556|FG000|Week 24 to Week 104 Analysis|Other|17
4630404|NCT00084656|7498887|FG002|Overall Study|Other reasons|11
4630405|NCT00084656|7498885|FG000|Overall Study|Withdrawal by Subject|15
4630406|NCT00084656|7498886|FG001|Overall Study|Withdrawal by Subject|4
4443828|NCT00468546|7228557|FG001|Week 24 to Week 104 Analysis|Other|14
4443829|NCT00468559|7228565|FG000|Open-label Treatment Phase|Adverse Event|5
4443830|NCT00468559|7228566|FG001|Open-label Treatment Phase|Adverse Event|0
4443831|NCT00468559|7228567|FG002|Open-label Treatment Phase|Adverse Event|0
4443832|NCT00468559|7228565|FG000|Open-label Treatment Phase|Lack of Efficacy|9
4443833|NCT00468559|7228566|FG001|Open-label Treatment Phase|Lack of Efficacy|0
4443834|NCT00468559|7228567|FG002|Open-label Treatment Phase|Lack of Efficacy|0
4443835|NCT00468559|7228565|FG000|Open-label Treatment Phase|Withdrawal by Subject|4
4443836|NCT00468559|7228566|FG001|Open-label Treatment Phase|Withdrawal by Subject|0
4512997|NCT00939107|7323156|FG001|Overall Study|Lost to Follow-up|12
4630407|NCT00084656|7498887|FG002|Overall Study|Withdrawal by Subject|4
4443837|NCT00468559|7228567|FG002|Open-label Treatment Phase|Withdrawal by Subject|0
4443838|NCT00468559|7228565|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0
4443839|NCT00468559|7228566|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8
4443840|NCT00468559|7228567|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17
4443841|NCT00468559|7228565|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0
4443842|NCT00468559|7228566|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2
4443843|NCT00468559|7228567|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0
4443844|NCT00468585|7228579|FG000|Overall Study|Patient not treated|1
4443845|NCT00468585|7228580|FG001|Overall Study|Patient not treated|0
4443846|NCT00468585|7228581|FG002|Overall Study|Patient not treated|1
4443847|NCT00468585|7228582|FG003|Overall Study|Patient not treated|0
4443848|NCT00468585|7228579|FG000|Overall Study|Patient found to be ineligible|0
4443849|NCT00468585|7228580|FG001|Overall Study|Patient found to be ineligible|0
4443850|NCT00468585|7228581|FG002|Overall Study|Patient found to be ineligible|1
4443851|NCT00468585|7228582|FG003|Overall Study|Patient found to be ineligible|0
4443852|NCT00468585|7228579|FG000|Overall Study|Adverse Event|0
4443853|NCT00468585|7228580|FG001|Overall Study|Adverse Event|0
4443854|NCT00468585|7228581|FG002|Overall Study|Adverse Event|1
4443855|NCT00468585|7228582|FG003|Overall Study|Adverse Event|0
4443856|NCT00468585|7228579|FG000|Overall Study|Withdrawal by Subject|0
4443857|NCT00468585|7228580|FG001|Overall Study|Withdrawal by Subject|0
4443858|NCT00468585|7228581|FG002|Overall Study|Withdrawal by Subject|2
4443859|NCT00468585|7228582|FG003|Overall Study|Withdrawal by Subject|1
4443860|NCT00468650|7228592|FG000|Overall Study|Lost to Follow-up|4
4443861|NCT00468650|7228592|FG000|Overall Study|Withdrawal by Subject|2
4443862|NCT00468650|7228592|FG000|Overall Study|Protocol Violation|1
4443863|NCT00468676|7228599|FG000|Overall Study|Lost to Follow-up|14
4443864|NCT00468676|7228600|FG001|Overall Study|Lost to Follow-up|11
4443865|NCT00468676|7228599|FG000|Overall Study|Death|2
4443866|NCT00468676|7228600|FG001|Overall Study|Death|1
4443867|NCT00468728|7228610|FG000|Treatment|criteria for mITT population|4
4443868|NCT00468728|7228611|FG001|Treatment|criteria for mITT population|11
4443869|NCT00468728|7228610|FG000|Follow-up|mITT failure|34
4443870|NCT00468728|7228611|FG001|Follow-up|mITT failure|31
4443871|NCT00468819|7228622|FG000|Overall Study|Withdrawal by Subject|4
4443872|NCT00468819|7228623|FG001|Overall Study|Withdrawal by Subject|0
4443873|NCT00468819|7228624|FG002|Overall Study|Withdrawal by Subject|1
4443874|NCT00468819|7228622|FG000|Overall Study|Lost to Follow-up|0
4443875|NCT00468819|7228623|FG001|Overall Study|Lost to Follow-up|0
4443876|NCT00468819|7228624|FG002|Overall Study|Lost to Follow-up|1
4443877|NCT00468819|7228622|FG000|Overall Study|Drop-outs (Treatment never received)|2
4443878|NCT00468819|7228623|FG001|Overall Study|Drop-outs (Treatment never received)|0
4443879|NCT00468819|7228624|FG002|Overall Study|Drop-outs (Treatment never received)|0
4443880|NCT00468845|7228637|FG000|Overall Study|Adverse Event|9
4443881|NCT00468845|7228638|FG001|Overall Study|Adverse Event|14
4443882|NCT00468845|7228639|FG002|Overall Study|Adverse Event|11
4443883|NCT00468845|7228637|FG000|Overall Study|Lost to Follow-up|2
4443884|NCT00468845|7228638|FG001|Overall Study|Lost to Follow-up|1
4443885|NCT00468845|7228639|FG002|Overall Study|Lost to Follow-up|2
4443886|NCT00468845|7228637|FG000|Overall Study|Other|4
4443887|NCT00468845|7228638|FG001|Overall Study|Other|9
4443888|NCT00468845|7228639|FG002|Overall Study|Other|5
4443889|NCT00468845|7228637|FG000|Overall Study|No longer willing to participate|5
4443890|NCT00468845|7228638|FG001|Overall Study|No longer willing to participate|6
4443891|NCT00468845|7228639|FG002|Overall Study|No longer willing to participate|10
4443892|NCT00468845|7228637|FG000|Overall Study|Randomized, not treated|1
4443893|NCT00468845|7228638|FG001|Overall Study|Randomized, not treated|4
4443894|NCT00468845|7228639|FG002|Overall Study|Randomized, not treated|2
4443895|NCT00468858|7228650|FG000|Overall Study|Adverse Event|0
4443896|NCT00468858|7228651|FG001|Overall Study|Adverse Event|1
4443897|NCT00468858|7228652|FG002|Overall Study|Adverse Event|0
4443898|NCT00468858|7228650|FG000|Overall Study|Withdrawal by Subject|7
4443899|NCT00468858|7228651|FG001|Overall Study|Withdrawal by Subject|4
4443900|NCT00468858|7228652|FG002|Overall Study|Withdrawal by Subject|5
4443901|NCT00468858|7228650|FG000|Overall Study|Relocation|1
4443902|NCT00468858|7228651|FG001|Overall Study|Relocation|3
4443903|NCT00468858|7228652|FG002|Overall Study|Relocation|3
4443904|NCT00468858|7228650|FG000|Overall Study|Lost to Follow-up|1
4443905|NCT00468858|7228651|FG001|Overall Study|Lost to Follow-up|2
4443906|NCT00468858|7228652|FG002|Overall Study|Lost to Follow-up|5
4443907|NCT00468858|7228650|FG000|Overall Study|Other|0
4443908|NCT00468858|7228651|FG001|Overall Study|Other|0
4443909|NCT00468858|7228652|FG002|Overall Study|Other|1
4443910|NCT00468910|7228716|FG000|Overall Study|Lost to Follow-up|2
4443911|NCT00468910|7228717|FG001|Overall Study|Lost to Follow-up|1
4443912|NCT00468910|7228716|FG000|Overall Study|Withdrawal by Subject|2
4443913|NCT00468910|7228717|FG001|Overall Study|Withdrawal by Subject|1
4443914|NCT00468910|7228716|FG000|Overall Study|Medical Contraindication|0
4443915|NCT00468910|7228717|FG001|Overall Study|Medical Contraindication|1
4443916|NCT00469014|7228728|FG000|Initial Phase Randomization|Disease Progression|0
4443917|NCT00469014|7228729|FG001|Initial Phase Randomization|Disease Progression|1
4443918|NCT00469014|7228730|FG002|Initial Phase Randomization|Disease Progression|1
4443919|NCT00469014|7228731|FG003|Initial Phase Randomization|Disease Progression|0
4443920|NCT00469014|7228728|FG000|Initial Phase Randomization|No Response|1
4443921|NCT00469014|7228729|FG001|Initial Phase Randomization|No Response|0
4443922|NCT00469014|7228730|FG002|Initial Phase Randomization|No Response|0
4443923|NCT00469014|7228731|FG003|Initial Phase Randomization|No Response|1
4443924|NCT00469014|7228728|FG000|Adaptive Randomization|Not Evaluable|1
4443925|NCT00469014|7228729|FG001|Adaptive Randomization|Not Evaluable|0
4443926|NCT00469014|7228730|FG002|Adaptive Randomization|Not Evaluable|0
4443927|NCT00469014|7228731|FG003|Adaptive Randomization|Not Evaluable|1
4443928|NCT00469014|7228728|FG000|Adaptive Randomization|No Response|0
4443929|NCT00469014|7228729|FG001|Adaptive Randomization|No Response|1
4443930|NCT00469014|7228730|FG002|Adaptive Randomization|No Response|0
4443931|NCT00469014|7228731|FG003|Adaptive Randomization|No Response|0
4443932|NCT00469014|7228728|FG000|Adaptive Randomization|Death|0
4443933|NCT00469014|7228729|FG001|Adaptive Randomization|Death|0
4443934|NCT00469014|7228730|FG002|Adaptive Randomization|Death|1
4443935|NCT00469014|7228731|FG003|Adaptive Randomization|Death|0
4443936|NCT00469079|7228744|FG000|Overall Study|Lack of Efficacy|3
4443937|NCT00469079|7228745|FG001|Overall Study|Lack of Efficacy|8
4443938|NCT00469079|7228746|FG002|Overall Study|Lack of Efficacy|5
4443939|NCT00469079|7228744|FG000|Overall Study|Adverse Event|1
4443940|NCT00469079|7228745|FG001|Overall Study|Adverse Event|3
4443941|NCT00469079|7228746|FG002|Overall Study|Adverse Event|2
4443942|NCT00469079|7228744|FG000|Overall Study|Lost to Follow-up|4
4443943|NCT00469079|7228745|FG001|Overall Study|Lost to Follow-up|8
4443944|NCT00469079|7228746|FG002|Overall Study|Lost to Follow-up|10
4443945|NCT00469079|7228744|FG000|Overall Study|Withdrawal by Subject|1
4443946|NCT00469079|7228745|FG001|Overall Study|Withdrawal by Subject|2
4443947|NCT00469079|7228746|FG002|Overall Study|Withdrawal by Subject|2
4443948|NCT00469079|7228744|FG000|Overall Study|Ineligible|0
4443949|NCT00469079|7228745|FG001|Overall Study|Ineligible|1
4443950|NCT00469079|7228746|FG002|Overall Study|Ineligible|0
4443951|NCT00469092|7228762|FG000|Overall Study|Adverse Event|5
4443952|NCT00469092|7228763|FG001|Overall Study|Adverse Event|4
4443953|NCT00469092|7228762|FG000|Overall Study|Lack of Efficacy|1
4443954|NCT00469092|7228763|FG001|Overall Study|Lack of Efficacy|0
4443955|NCT00469092|7228762|FG000|Overall Study|Lost to Follow-up|1
4443956|NCT00469092|7228763|FG001|Overall Study|Lost to Follow-up|2
4443957|NCT00469092|7228762|FG000|Overall Study|Protocol Violation|3
4443958|NCT00469092|7228763|FG001|Overall Study|Protocol Violation|3
4443959|NCT00469092|7228762|FG000|Overall Study|Withdrawal by Subject|4
4443960|NCT00469092|7228763|FG001|Overall Study|Withdrawal by Subject|4
4443961|NCT00469092|7228762|FG000|Overall Study|Withdrawal Criteria|3
4443962|NCT00469092|7228763|FG001|Overall Study|Withdrawal Criteria|4
4443963|NCT00469092|7228762|FG000|Overall Study|Incorrectly Randomised|4
4443964|NCT00469092|7228763|FG001|Overall Study|Incorrectly Randomised|3
4443965|NCT00469092|7228762|FG000|Overall Study|Contraindication metformin/glimepiride|1
4443966|NCT00469092|7228763|FG001|Overall Study|Contraindication metformin/glimepiride|0
4443967|NCT00469092|7228762|FG000|Overall Study|Use of lipid lowering drug|1
4443968|NCT00469092|7228763|FG001|Overall Study|Use of lipid lowering drug|0
4443969|NCT00469092|7228762|FG000|Overall Study|Hypoglycaemic Episodes|1
4443970|NCT00469092|7228763|FG001|Overall Study|Hypoglycaemic Episodes|1
4443971|NCT00469092|7228762|FG000|Overall Study|Abnormal lab value|1
4443972|NCT00469092|7228763|FG001|Overall Study|Abnormal lab value|0
4443973|NCT00469092|7228762|FG000|Overall Study|Use of Corticosteroid|1
4443974|NCT00469092|7228763|FG001|Overall Study|Use of Corticosteroid|0
4443975|NCT00469144|7228771|FG000|Overall Study|Death|0
4443976|NCT00469144|7228772|FG001|Overall Study|Death|1
4443977|NCT00469144|7228771|FG000|Overall Study|No Response|5
4443978|NCT00469144|7228772|FG001|Overall Study|No Response|5
4443979|NCT00469144|7228771|FG000|Overall Study|Progressive Disease|1
4443980|NCT00469144|7228772|FG001|Overall Study|Progressive Disease|0
4443981|NCT00469209|7228785|FG000|Overall Study|Adverse Event|1
4443982|NCT00469209|7228786|FG001|Overall Study|Adverse Event|0
4443983|NCT00469209|7228787|FG002|Overall Study|Adverse Event|1
4443984|NCT00469456|7228815|FG000|Overall Study|Adverse Event|4
4443985|NCT00469456|7228816|FG001|Overall Study|Adverse Event|3
4443986|NCT00469456|7228815|FG000|Overall Study|Protocol Violation|1
4443987|NCT00469456|7228816|FG001|Overall Study|Protocol Violation|0
4443988|NCT00469456|7228815|FG000|Overall Study|Withdrawal by Subject|4
4443989|NCT00469456|7228816|FG001|Overall Study|Withdrawal by Subject|1
4443990|NCT00469833|7228831|FG000|Overall Study|No IV access|2
4443991|NCT00469859|7228843|FG000|Overall Study|Inevaluable|0
4443992|NCT00469859|7228844|FG001|Overall Study|Inevaluable|2
4443993|NCT00469898|7228850|FG000|Overall Study|Adverse Event|7
4443994|NCT00469898|7228850|FG000|Overall Study|Withdrawal by Subject|4
4443995|NCT00469898|7228850|FG000|Overall Study|Death|4
4443996|NCT00469898|7228850|FG000|Overall Study|Disease progression|9
4443997|NCT00469898|7228850|FG000|Overall Study|Decreased performance status|1
4443998|NCT00470054|7228862|FG000|Overall Study|Ineligible|1
4443999|NCT00470093|7228866|FG000|Overall Study|Adverse Event|2
4512998|NCT00939185|7323175|FG000|Overall Study|Adverse Event|3
4512999|NCT00939185|7323175|FG000|Overall Study|Lack of Efficacy|1
4513000|NCT00939185|7323175|FG000|Overall Study|Lost to Follow-up|6
4513001|NCT00939185|7323175|FG000|Overall Study|Other|3
4513002|NCT00939185|7323175|FG000|Overall Study|Withdrawal by Subject|2
4513003|NCT00939185|7323175|FG000|Overall Study|Randomized But Did Not Receive Treatment|10
4513004|NCT00939341|7323196|FG000|Overall Study|Adverse Event|15
4513005|NCT00939341|7323196|FG000|Overall Study|Pregnancy|1
4444000|NCT00470158|7228896|FG000|Overall Study|Death|0
4444001|NCT00470158|7228897|FG001|Overall Study|Death|0
4444002|NCT00470158|7228898|FG002|Overall Study|Death|0
4444003|NCT00470158|7228899|FG003|Overall Study|Death|0
4444004|NCT00470158|7228900|FG004|Overall Study|Death|2
4444005|NCT00470158|7228896|FG000|Overall Study|Lost to Follow-up|7
4444006|NCT00470158|7228897|FG001|Overall Study|Lost to Follow-up|8
4444007|NCT00470158|7228898|FG002|Overall Study|Lost to Follow-up|8
4444008|NCT00470158|7228899|FG003|Overall Study|Lost to Follow-up|5
4444009|NCT00470158|7228900|FG004|Overall Study|Lost to Follow-up|4
4444010|NCT00470158|7228896|FG000|Overall Study|Protocol Violation|1
4444011|NCT00470158|7228897|FG001|Overall Study|Protocol Violation|0
4444012|NCT00470158|7228898|FG002|Overall Study|Protocol Violation|0
4444013|NCT00470158|7228899|FG003|Overall Study|Protocol Violation|0
4444014|NCT00470158|7228900|FG004|Overall Study|Protocol Violation|0
4444015|NCT00470184|7228912|FG000|Overall Study|Not Treated(became ineligible)|4
4444016|NCT00470184|7228912|FG000|Overall Study|Not treated (other)|1
4444017|NCT00470184|7228912|FG000|Overall Study|disease Progression|4
4444018|NCT00470184|7228912|FG000|Overall Study|Adverse Event|3
4444019|NCT00470184|7228912|FG000|Overall Study|Withdrawal by Subject|4
4444020|NCT00470184|7228912|FG000|Overall Study|other|5
4444021|NCT00470184|7228912|FG000|Overall Study|recurrence|1
4444022|NCT00470262|7228919|FG000|Overall Study|Withdrawal by Subject|2
4630408|NCT00084656|7498885|FG000|Overall Study|Disease relapse|0
4630409|NCT00084656|7498886|FG001|Overall Study|Disease relapse|9
4630410|NCT00084656|7498887|FG002|Overall Study|Disease relapse|10
4444023|NCT00470262|7228920|FG001|Overall Study|Withdrawal by Subject|0
4444024|NCT00470275|7228927|FG000|Overall Study|Death|1
4444025|NCT00470275|7228927|FG000|Overall Study|Lack of Efficacy|7
4444026|NCT00470275|7228927|FG000|Overall Study|Withdrawal by Subject|2
4444027|NCT00470366|7228936|FG000|Overall Study|Adverse Event|3
4444028|NCT00470366|7228936|FG000|Overall Study|Poor compliance|1
4716474|NCT02992899|7645832|FG001|Overall Study|Lost to Follow-up|3
4716475|NCT02993224|7645838|FG000|Core Phase - Period 1|Adverse Event|4
4444029|NCT00470418|7228952|FG000|Overall Study|Withdrawal by Subject|1
4444030|NCT00470418|7228953|FG001|Overall Study|Withdrawal by Subject|0
4444031|NCT00470470|7228959|FG000|Overall Study|Adverse Event|2
4444032|NCT00470470|7228959|FG000|Overall Study|Death|2
4444033|NCT00470470|7228959|FG000|Overall Study|Not treated|1
4444034|NCT00470535|7228963|FG000|Overall Study|Disease Progression|13
4444035|NCT00470535|7228963|FG000|Overall Study|Withdrawal by Subject|1
4444036|NCT00470535|7228963|FG000|Overall Study|Adverse Event|1
4444037|NCT00470535|7228963|FG000|Overall Study|Death|1
4444038|NCT00470535|7228963|FG000|Overall Study|Other|2
4444039|NCT00470626|7228991|FG000|Overall Study|Lost to Follow-up|10
4444040|NCT00470626|7228991|FG000|Overall Study|Withdrawal by Subject|7
4444041|NCT00470834|7229001|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16
4444042|NCT00470834|7229002|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14
4444043|NCT00470834|7229001|FG000|Treatment Period (18 Months)|Adverse Event|7
4444044|NCT00470834|7229002|FG001|Treatment Period (18 Months)|Adverse Event|6
4444045|NCT00470834|7229001|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4
4444046|NCT00470834|7229002|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5
4444047|NCT00470834|7229001|FG000|Treatment Period (18 Months)|Physician Decision|4
4444048|NCT00470834|7229002|FG001|Treatment Period (18 Months)|Physician Decision|4
4444049|NCT00470834|7229001|FG000|Treatment Period (18 Months)|Protocol Violation|3
4444050|NCT00470834|7229002|FG001|Treatment Period (18 Months)|Protocol Violation|1
4444051|NCT00470834|7229001|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1
4444052|NCT00470834|7229002|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1
4444053|NCT00470834|7229001|FG000|Treatment Period (18 Months)|Lost to Follow-up|1
4444054|NCT00470834|7229002|FG001|Treatment Period (18 Months)|Lost to Follow-up|0
4444055|NCT00470834|7229001|FG000|Treatment Period (18 Months)|Non-compliance|1
4444056|NCT00470834|7229002|FG001|Treatment Period (18 Months)|Non-compliance|0
4444057|NCT00470834|7229001|FG000|Treatment Period (18 Months)|Lack of Efficacy|1
4444058|NCT00470834|7229002|FG001|Treatment Period (18 Months)|Lack of Efficacy|0
4444059|NCT00470834|7229001|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6
4444060|NCT00470834|7229002|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7
4444061|NCT00470834|7229001|FG000|Extension Period (24 Months)|Adverse Event|3
4444062|NCT00470834|7229002|FG001|Extension Period (24 Months)|Adverse Event|4
4444063|NCT00470834|7229001|FG000|Extension Period (24 Months)|Withdrawal by Subject|2
4444064|NCT00470834|7229002|FG001|Extension Period (24 Months)|Withdrawal by Subject|5
4444065|NCT00470834|7229001|FG000|Extension Period (24 Months)|Physician Decision|4
4444066|NCT00470834|7229002|FG001|Extension Period (24 Months)|Physician Decision|3
4444067|NCT00470834|7229001|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0
4444068|NCT00470834|7229002|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1
4444069|NCT00470834|7229001|FG000|Extension Period (24 Months)|Lost to Follow-up|0
4444070|NCT00470834|7229002|FG001|Extension Period (24 Months)|Lost to Follow-up|1
4630411|NCT00084656|7498885|FG000|Overall Study|Disease progression|9
4630412|NCT00084656|7498886|FG001|Overall Study|Disease progression|0
4444071|NCT00470834|7229001|FG000|Extension Period (24 Months)|Non-compliance|0
4444072|NCT00470834|7229002|FG001|Extension Period (24 Months)|Non-compliance|1
4444073|NCT00470834|7229001|FG000|Extension Period (24 Months)|Disease Progression|0
4444074|NCT00470834|7229002|FG001|Extension Period (24 Months)|Disease Progression|1
4444075|NCT00470847|7229008|FG000|Overall Study|Pt still receiving treatment|1
4444076|NCT00471081|7229025|FG000|Active Phase|Protocol Violation|1
4444077|NCT00471081|7229026|FG001|Active Phase|Protocol Violation|1
4444078|NCT00471081|7229025|FG000|Active Phase|Withdrawal by Subject|0
4444079|NCT00471081|7229026|FG001|Active Phase|Withdrawal by Subject|3
4444080|NCT00471081|7229025|FG000|Active Phase|Lost to Follow-up|0
4444081|NCT00471081|7229026|FG001|Active Phase|Lost to Follow-up|1
4630413|NCT00084656|7498887|FG002|Overall Study|Disease progression|0
4630414|NCT00084656|7498885|FG000|Overall Study|Lost to Follow-up|1
4630415|NCT00084656|7498886|FG001|Overall Study|Lost to Follow-up|0
4630416|NCT00084656|7498887|FG002|Overall Study|Lost to Follow-up|1
4630417|NCT01879852|7498926|FG000|Overall Study|Withdrawal by Subject|2
4630418|NCT01879852|7498927|FG001|Overall Study|Withdrawal by Subject|0
4630419|NCT01880086|7498963|FG000|Overall Study|Lost to Follow-up|1
4630420|NCT01880086|7498964|FG001|Overall Study|Lost to Follow-up|1
4630421|NCT01880424|7498998|FG000|Overall Study|Adverse Event|7
4630422|NCT01880424|7498999|FG001|Overall Study|Adverse Event|6
4630423|NCT01880424|7498998|FG000|Overall Study|Lack of Efficacy|1
4630424|NCT01880424|7498999|FG001|Overall Study|Lack of Efficacy|4
4444082|NCT00471081|7229025|FG000|Active Phase|Lost health plan/insurance|1
4444083|NCT00471081|7229026|FG001|Active Phase|Lost health plan/insurance|8
4444084|NCT00471081|7229025|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1
4444085|NCT00471081|7229026|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4
4444086|NCT00471081|7229025|FG000|Extended Safety Follow-Up|Lost to Follow-up|1
4444087|NCT00471081|7229026|FG001|Extended Safety Follow-Up|Lost to Follow-up|8
4444088|NCT00471081|7229025|FG000|Extended Safety Follow-Up|Missing confirmed|0
4444089|NCT00471081|7229026|FG001|Extended Safety Follow-Up|Missing confirmed|1
4444090|NCT00471107|7229036|FG000|Overall Study|Technical problems/data loss|3
4444091|NCT00471107|7229037|FG001|Overall Study|Technical problems/data loss|1
4444092|NCT00471107|7229038|FG002|Overall Study|Technical problems/data loss|3
4444093|NCT00471146|7229048|FG000|Overall Study|Adverse Event|32
4444094|NCT00471146|7229049|FG001|Overall Study|Adverse Event|33
4444095|NCT00471146|7229048|FG000|Overall Study|Withdrawal by Subject|14
4444096|NCT00471146|7229049|FG001|Overall Study|Withdrawal by Subject|11
4444097|NCT00471146|7229048|FG000|Overall Study|Death|11
4444098|NCT00471146|7229049|FG001|Overall Study|Death|12
4444099|NCT00471146|7229048|FG000|Overall Study|Lost to Follow-up|4
4444100|NCT00471146|7229049|FG001|Overall Study|Lost to Follow-up|2
4444101|NCT00471146|7229048|FG000|Overall Study|Protocol Violation|2
4444102|NCT00471146|7229049|FG001|Overall Study|Protocol Violation|2
4444103|NCT00471146|7229048|FG000|Overall Study|Objective progression or relapse|84
4444104|NCT00471146|7229049|FG001|Overall Study|Objective progression or relapse|87
4444105|NCT00471146|7229048|FG000|Overall Study|Global deterioration of health status|12
4444106|NCT00471146|7229049|FG001|Overall Study|Global deterioration of health status|14
4444107|NCT00471146|7229048|FG000|Overall Study|Randomized but not treated|9
4444108|NCT00471146|7229049|FG001|Overall Study|Randomized but not treated|8
4444109|NCT00471146|7229048|FG000|Overall Study|Other|4
4444110|NCT00471146|7229049|FG001|Overall Study|Other|5
4444111|NCT00471237|7229062|FG000|Overall Study|Adverse Event|6
4444112|NCT00471237|7229063|FG001|Overall Study|Adverse Event|5
4444113|NCT00471237|7229064|FG002|Overall Study|Adverse Event|4
4444114|NCT00471237|7229065|FG003|Overall Study|Adverse Event|8
4444115|NCT00471237|7229066|FG004|Overall Study|Adverse Event|7
4444116|NCT00471237|7229067|FG005|Overall Study|Adverse Event|5
4444117|NCT00471237|7229068|FG006|Overall Study|Adverse Event|0
4444118|NCT00471237|7229062|FG000|Overall Study|Lost to Follow-up|1
4444119|NCT00471237|7229063|FG001|Overall Study|Lost to Follow-up|1
4444120|NCT00471237|7229064|FG002|Overall Study|Lost to Follow-up|0
4444121|NCT00471237|7229065|FG003|Overall Study|Lost to Follow-up|2
4444122|NCT00471237|7229066|FG004|Overall Study|Lost to Follow-up|3
4444123|NCT00471237|7229067|FG005|Overall Study|Lost to Follow-up|0
4444124|NCT00471237|7229068|FG006|Overall Study|Lost to Follow-up|0
4444125|NCT00471237|7229062|FG000|Overall Study|Protocol Violation|3
4444126|NCT00471237|7229063|FG001|Overall Study|Protocol Violation|6
4444127|NCT00471237|7229064|FG002|Overall Study|Protocol Violation|3
4444128|NCT00471237|7229065|FG003|Overall Study|Protocol Violation|2
4444129|NCT00471237|7229066|FG004|Overall Study|Protocol Violation|2
4444130|NCT00471237|7229067|FG005|Overall Study|Protocol Violation|4
4444131|NCT00471237|7229068|FG006|Overall Study|Protocol Violation|1
4444132|NCT00471237|7229062|FG000|Overall Study|Withdrawal by Subject|8
4444133|NCT00471237|7229063|FG001|Overall Study|Withdrawal by Subject|6
4444134|NCT00471237|7229064|FG002|Overall Study|Withdrawal by Subject|5
4444135|NCT00471237|7229065|FG003|Overall Study|Withdrawal by Subject|8
4513006|NCT00939341|7323196|FG000|Overall Study|Lost to Follow-up|23
4630425|NCT01880424|7498998|FG000|Overall Study|Lost to Follow-up|3
4444136|NCT00471237|7229066|FG004|Overall Study|Withdrawal by Subject|7
4444137|NCT00471237|7229067|FG005|Overall Study|Withdrawal by Subject|4
4444138|NCT00471237|7229068|FG006|Overall Study|Withdrawal by Subject|2
4444139|NCT00471237|7229062|FG000|Overall Study|Sponsor terminated study|20
4444140|NCT00471237|7229063|FG001|Overall Study|Sponsor terminated study|23
4444141|NCT00471237|7229064|FG002|Overall Study|Sponsor terminated study|19
4444142|NCT00471237|7229065|FG003|Overall Study|Sponsor terminated study|22
4630426|NCT01880424|7498999|FG001|Overall Study|Lost to Follow-up|2
4444143|NCT00471237|7229066|FG004|Overall Study|Sponsor terminated study|18
4444144|NCT00471237|7229067|FG005|Overall Study|Sponsor terminated study|24
4444145|NCT00471237|7229068|FG006|Overall Study|Sponsor terminated study|0
4444146|NCT00471237|7229062|FG000|Overall Study|Non-compliance|0
4444147|NCT00471237|7229063|FG001|Overall Study|Non-compliance|1
4444148|NCT00471237|7229064|FG002|Overall Study|Non-compliance|0
4444149|NCT00471237|7229065|FG003|Overall Study|Non-compliance|1
4444150|NCT00471237|7229066|FG004|Overall Study|Non-compliance|0
4444151|NCT00471237|7229067|FG005|Overall Study|Non-compliance|0
4444152|NCT00471237|7229068|FG006|Overall Study|Non-compliance|0
4444153|NCT00471237|7229062|FG000|Overall Study|Met serum creatinine withdrawal criteria|1
4444154|NCT00471237|7229063|FG001|Overall Study|Met serum creatinine withdrawal criteria|0
4444155|NCT00471237|7229064|FG002|Overall Study|Met serum creatinine withdrawal criteria|2
4444156|NCT00471237|7229065|FG003|Overall Study|Met serum creatinine withdrawal criteria|2
4444157|NCT00471237|7229066|FG004|Overall Study|Met serum creatinine withdrawal criteria|0
4444158|NCT00471237|7229067|FG005|Overall Study|Met serum creatinine withdrawal criteria|0
4444159|NCT00471237|7229068|FG006|Overall Study|Met serum creatinine withdrawal criteria|0
4444160|NCT00471237|7229062|FG000|Overall Study|Early stopping due to non-efficacy|1
4444161|NCT00471237|7229063|FG001|Overall Study|Early stopping due to non-efficacy|0
4444162|NCT00471237|7229064|FG002|Overall Study|Early stopping due to non-efficacy|0
4444163|NCT00471237|7229065|FG003|Overall Study|Early stopping due to non-efficacy|0
4444164|NCT00471237|7229066|FG004|Overall Study|Early stopping due to non-efficacy|1
4444165|NCT00471237|7229067|FG005|Overall Study|Early stopping due to non-efficacy|0
4444166|NCT00471237|7229068|FG006|Overall Study|Early stopping due to non-efficacy|0
4444167|NCT00471237|7229062|FG000|Overall Study|Participant planned to travel to abraod|1
4444168|NCT00471237|7229063|FG001|Overall Study|Participant planned to travel to abraod|0
4444169|NCT00471237|7229064|FG002|Overall Study|Participant planned to travel to abraod|0
4444170|NCT00471237|7229065|FG003|Overall Study|Participant planned to travel to abraod|0
4444171|NCT00471237|7229066|FG004|Overall Study|Participant planned to travel to abraod|0
4444172|NCT00471237|7229067|FG005|Overall Study|Participant planned to travel to abraod|1
4444173|NCT00471237|7229068|FG006|Overall Study|Participant planned to travel to abraod|0
4444174|NCT00471237|7229062|FG000|Overall Study|High parathyroid hormone|0
4444175|NCT00471237|7229063|FG001|Overall Study|High parathyroid hormone|0
4444176|NCT00471237|7229064|FG002|Overall Study|High parathyroid hormone|1
4444177|NCT00471237|7229065|FG003|Overall Study|High parathyroid hormone|0
4444178|NCT00471237|7229066|FG004|Overall Study|High parathyroid hormone|0
4444179|NCT00471237|7229067|FG005|Overall Study|High parathyroid hormone|0
4444180|NCT00471237|7229068|FG006|Overall Study|High parathyroid hormone|0
4444181|NCT00471237|7229062|FG000|Overall Study|Participant lost medication|0
4444182|NCT00471237|7229063|FG001|Overall Study|Participant lost medication|0
4444183|NCT00471237|7229064|FG002|Overall Study|Participant lost medication|0
4444184|NCT00471237|7229065|FG003|Overall Study|Participant lost medication|0
4444185|NCT00471237|7229066|FG004|Overall Study|Participant lost medication|1
4444186|NCT00471237|7229067|FG005|Overall Study|Participant lost medication|0
4444187|NCT00471237|7229068|FG006|Overall Study|Participant lost medication|0
4444188|NCT00471237|7229062|FG000|Overall Study|Administration of prohibited medicine|0
4444189|NCT00471237|7229063|FG001|Overall Study|Administration of prohibited medicine|0
4444190|NCT00471237|7229064|FG002|Overall Study|Administration of prohibited medicine|0
4444191|NCT00471237|7229065|FG003|Overall Study|Administration of prohibited medicine|0
4444192|NCT00471237|7229066|FG004|Overall Study|Administration of prohibited medicine|1
4444193|NCT00471237|7229067|FG005|Overall Study|Administration of prohibited medicine|0
4444194|NCT00471237|7229068|FG006|Overall Study|Administration of prohibited medicine|0
4444195|NCT00471237|7229062|FG000|Overall Study|Participant shifted residence|0
4444196|NCT00471237|7229063|FG001|Overall Study|Participant shifted residence|0
4444197|NCT00471237|7229064|FG002|Overall Study|Participant shifted residence|0
4444198|NCT00471237|7229065|FG003|Overall Study|Participant shifted residence|0
4444199|NCT00471237|7229066|FG004|Overall Study|Participant shifted residence|1
4444200|NCT00471237|7229067|FG005|Overall Study|Participant shifted residence|0
4444201|NCT00471237|7229068|FG006|Overall Study|Participant shifted residence|0
4444202|NCT00471237|7229062|FG000|Overall Study|Participant's decision|0
4444203|NCT00471237|7229063|FG001|Overall Study|Participant's decision|0
4444204|NCT00471237|7229064|FG002|Overall Study|Participant's decision|0
4444205|NCT00471237|7229065|FG003|Overall Study|Participant's decision|0
4444206|NCT00471237|7229066|FG004|Overall Study|Participant's decision|0
4444207|NCT00471237|7229067|FG005|Overall Study|Participant's decision|1
4444208|NCT00471237|7229068|FG006|Overall Study|Participant's decision|0
4444209|NCT00471276|7229088|FG000|Overall Study|Death|2
4444210|NCT00471276|7229088|FG000|Overall Study|Adverse Event|16
4444211|NCT00471276|7229088|FG000|Overall Study|Protocol Violation|1
4444212|NCT00471276|7229088|FG000|Overall Study|Objective progression or relapse|54
4444213|NCT00471276|7229088|FG000|Overall Study|Global deterioration of health status|1
4444214|NCT00471276|7229088|FG000|Overall Study|Other|3
4444215|NCT00471276|7229088|FG000|Overall Study|Refused treatment|6
4444216|NCT00471315|7229092|FG000|Overall Study|Adverse Event|7
4444217|NCT00471315|7229092|FG000|Overall Study|Withdrawal by Subject|1
4444218|NCT00471328|7229098|FG000|Core Phase|Adverse Event|18
4444219|NCT00471328|7229099|FG001|Core Phase|Adverse Event|6
4444220|NCT00471328|7229098|FG000|Core Phase|Death|8
4444221|NCT00471328|7229099|FG001|Core Phase|Death|4
4444222|NCT00471328|7229098|FG000|Core Phase|Withdrawal by Subject|2
4444223|NCT00471328|7229099|FG001|Core Phase|Withdrawal by Subject|2
4444224|NCT00471328|7229098|FG000|Core Phase|Abnormal laboratory value|1
4444225|NCT00471328|7229099|FG001|Core Phase|Abnormal laboratory value|0
4444226|NCT00471328|7229098|FG000|Core Phase|Disease Progression|78
4444227|NCT00471328|7229099|FG001|Core Phase|Disease Progression|53
4444228|NCT00471328|7229098|FG000|Core Phase|Administrative Problem|0
4444229|NCT00471328|7229099|FG001|Core Phase|Administrative Problem|1
4444230|NCT00471328|7229098|FG000|Core Phase|Protocol Deviation|0
4444231|NCT00471328|7229099|FG001|Core Phase|Protocol Deviation|1
4444232|NCT00471328|7229098|FG000|Extension Phase|Adverse Event|3
4444233|NCT00471328|7229099|FG001|Extension Phase|Adverse Event|12
4444234|NCT00471328|7229098|FG000|Extension Phase|Withdrawal by Subject|0
4444235|NCT00471328|7229099|FG001|Extension Phase|Withdrawal by Subject|2
4444236|NCT00471328|7229098|FG000|Extension Phase|Death|1
4444237|NCT00471328|7229099|FG001|Extension Phase|Death|7
4444238|NCT00471328|7229098|FG000|Extension Phase|Protocol Deviation|3
4444239|NCT00471328|7229099|FG001|Extension Phase|Protocol Deviation|1
4444240|NCT00471328|7229098|FG000|Extension Phase|Treatment duration as per protocol|0
4444241|NCT00471328|7229099|FG001|Extension Phase|Treatment duration as per protocol|1
4444242|NCT00471328|7229098|FG000|Extension Phase|Disease Progression|32
4444243|NCT00471328|7229099|FG001|Extension Phase|Disease Progression|44
4444244|NCT00471328|7229098|FG000|Extension Phase|New cancer Therapy|1
4444245|NCT00471328|7229099|FG001|Extension Phase|New cancer Therapy|0
4444246|NCT00471328|7229098|FG000|Extension Phase|Administrative Problem|1
4444247|NCT00471328|7229099|FG001|Extension Phase|Administrative Problem|0
4444248|NCT00471354|7229107|FG000|Overall Study|Protocol Entry Criteria Not Met|1
4444249|NCT00471354|7229107|FG000|Overall Study|Adverse Event|13
4444250|NCT00471354|7229107|FG000|Overall Study|Protocol Violation|12
4444251|NCT00471354|7229107|FG000|Overall Study|Withdrawal by Subject|1
4444252|NCT00471354|7229107|FG000|Overall Study|Physician Decision|4
4444253|NCT00471354|7229107|FG000|Overall Study|Sponsor Decision|1
4444254|NCT00471354|7229107|FG000|Overall Study|Lost to Follow-up|3
4444255|NCT00471354|7229107|FG000|Overall Study|Lack of Efficacy|5
4444256|NCT00471354|7229107|FG000|Overall Study|Patient/Caregiver Decision|12
4444257|NCT00471445|7229120|FG000|Overall Study|Withdrawal by Subject|1
4444258|NCT00471445|7229121|FG001|Overall Study|Withdrawal by Subject|1
4444259|NCT00471445|7229120|FG000|Overall Study|Ineligible|1
4444260|NCT00471445|7229121|FG001|Overall Study|Ineligible|0
4444261|NCT00471445|7229120|FG000|Overall Study|Protocol Violation|0
4444262|NCT00471445|7229121|FG001|Overall Study|Protocol Violation|1
4444263|NCT00471497|7229130|FG000|Core Treatment Phase|Abnormal Laboratory Values|3
4444264|NCT00471497|7229131|FG001|Core Treatment Phase|Abnormal Laboratory Values|9
4444265|NCT00471497|7229132|FG002|Core Treatment Phase|Abnormal Laboratory Values|9
4444266|NCT00471497|7229130|FG000|Core Treatment Phase|Abnormal Test Procedures|1
4444267|NCT00471497|7229131|FG001|Core Treatment Phase|Abnormal Test Procedures|0
4444268|NCT00471497|7229132|FG002|Core Treatment Phase|Abnormal Test Procedures|1
4444269|NCT00471497|7229130|FG000|Core Treatment Phase|Condition no longer requires study drug|0
4444270|NCT00471497|7229131|FG001|Core Treatment Phase|Condition no longer requires study drug|1
4444271|NCT00471497|7229132|FG002|Core Treatment Phase|Condition no longer requires study drug|0
4444272|NCT00471497|7229130|FG000|Core Treatment Phase|Withdrawal by Subject|31
4444273|NCT00471497|7229131|FG001|Core Treatment Phase|Withdrawal by Subject|29
4444274|NCT00471497|7229132|FG002|Core Treatment Phase|Withdrawal by Subject|34
4444275|NCT00471497|7229130|FG000|Core Treatment Phase|Lost to Follow-up|6
4444276|NCT00471497|7229131|FG001|Core Treatment Phase|Lost to Follow-up|6
4444277|NCT00471497|7229132|FG002|Core Treatment Phase|Lost to Follow-up|3
4444278|NCT00471497|7229130|FG000|Core Treatment Phase|Death|3
4444279|NCT00471497|7229131|FG001|Core Treatment Phase|Death|9
4444280|NCT00471497|7229132|FG002|Core Treatment Phase|Death|3
4444281|NCT00471497|7229130|FG000|Core Treatment Phase|Disease Progression|10
4444282|NCT00471497|7229131|FG001|Core Treatment Phase|Disease Progression|2
4444283|NCT00471497|7229132|FG002|Core Treatment Phase|Disease Progression|4
4444284|NCT00471497|7229130|FG000|Core Treatment Phase|Protocol Violation|6
4444285|NCT00471497|7229131|FG001|Core Treatment Phase|Protocol Violation|15
4444286|NCT00471497|7229132|FG002|Core Treatment Phase|Protocol Violation|11
4444287|NCT00471497|7229130|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19
4444288|NCT00471497|7229131|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11
4444289|NCT00471497|7229132|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13
4444290|NCT00471497|7229130|FG000|Core Treatment Phase|Administrative problems|14
4444291|NCT00471497|7229131|FG001|Core Treatment Phase|Administrative problems|14
4444292|NCT00471497|7229132|FG002|Core Treatment Phase|Administrative problems|12
4444293|NCT00471497|7229130|FG000|Core Treatment Phase|Adverse Event|43
4444294|NCT00471497|7229131|FG001|Core Treatment Phase|Adverse Event|53
4590539|NCT01522651|7436639|FG004|Overall Study|Investigator's Discretion|0
4630427|NCT01880424|7498998|FG000|Overall Study|Protocol Violation|11
4590540|NCT01522651|7436635|FG000|Overall Study|Protocol Violation|3
4444295|NCT00471497|7229132|FG002|Core Treatment Phase|Adverse Event|89
4444296|NCT00471497|7229130|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2
4444297|NCT00471497|7229131|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0
4444298|NCT00471497|7229132|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0
4444299|NCT00471497|7229130|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46
4444300|NCT00471497|7229131|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26
4444301|NCT00471497|7229132|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3
4444302|NCT00471497|7229130|FG000|Extension Phase|Adverse Event|9
4444303|NCT00471497|7229131|FG001|Extension Phase|Adverse Event|5
4444304|NCT00471497|7229132|FG002|Extension Phase|Adverse Event|1
4444305|NCT00471497|7229130|FG000|Extension Phase|Unsatisfactory therapeutic effect|8
4444306|NCT00471497|7229131|FG001|Extension Phase|Unsatisfactory therapeutic effect|6
4444307|NCT00471497|7229132|FG002|Extension Phase|Unsatisfactory therapeutic effect|0
4444308|NCT00471497|7229130|FG000|Extension Phase|Withdrawal by Subject|3
4444309|NCT00471497|7229131|FG001|Extension Phase|Withdrawal by Subject|1
4444310|NCT00471497|7229132|FG002|Extension Phase|Withdrawal by Subject|0
4444311|NCT00471497|7229130|FG000|Extension Phase|Lost to Follow-up|2
4444312|NCT00471497|7229131|FG001|Extension Phase|Lost to Follow-up|0
4444313|NCT00471497|7229132|FG002|Extension Phase|Lost to Follow-up|0
4444314|NCT00471497|7229130|FG000|Extension Phase|Death|1
4444315|NCT00471497|7229131|FG001|Extension Phase|Death|0
4444316|NCT00471497|7229132|FG002|Extension Phase|Death|0
4444317|NCT00471497|7229130|FG000|Extension Phase|Disease progression|2
4444318|NCT00471497|7229131|FG001|Extension Phase|Disease progression|0
4444319|NCT00471497|7229132|FG002|Extension Phase|Disease progression|0
4444320|NCT00471497|7229130|FG000|Extension Phase|Protocol Violation|2
4444321|NCT00471497|7229131|FG001|Extension Phase|Protocol Violation|2
4444322|NCT00471497|7229132|FG002|Extension Phase|Protocol Violation|0
4444323|NCT00471536|7229143|FG000|Overall Study|Withdrawal by Subject|1
4444324|NCT00471718|7229160|FG000|Overall Study|Adverse Event|3
4444325|NCT00471718|7229160|FG000|Overall Study|other complicating disease|1
4444326|NCT00471718|7229160|FG000|Overall Study|disease progression|22
4444327|NCT00471718|7229160|FG000|Overall Study|Withdrawal by Subject|1
4444328|NCT00471822|7229168|FG000|Overall Study|Protocol Violation|2
4444329|NCT00471887|7229176|FG000|Overall Study|Adverse Event|9
4444330|NCT00472030|7229182|FG000|Overall Study|Physician Decision|1
4444331|NCT00472030|7229183|FG001|Overall Study|Physician Decision|0
4444332|NCT00472199|7229210|FG000|Overall Study|Adverse Event|19
4444333|NCT00472199|7229211|FG001|Overall Study|Adverse Event|23
4444334|NCT00472199|7229210|FG000|Overall Study|Lack of Efficacy|4
4444335|NCT00472199|7229211|FG001|Overall Study|Lack of Efficacy|25
4444336|NCT00472199|7229210|FG000|Overall Study|Lost to Follow-up|2
4444337|NCT00472199|7229211|FG001|Overall Study|Lost to Follow-up|4
4444338|NCT00472199|7229210|FG000|Overall Study|Protocol Violation|3
4444339|NCT00472199|7229211|FG001|Overall Study|Protocol Violation|2
4444340|NCT00472199|7229210|FG000|Overall Study|Withdrawal by Subject|6
4444341|NCT00472199|7229211|FG001|Overall Study|Withdrawal by Subject|5
4444342|NCT00472199|7229210|FG000|Overall Study|personal reason|0
4444343|NCT00472199|7229211|FG001|Overall Study|personal reason|1
4444344|NCT00472199|7229210|FG000|Overall Study|patient was asymptomatic|1
4444345|NCT00472199|7229211|FG001|Overall Study|patient was asymptomatic|0
4444346|NCT00472290|7229217|FG000|Overall Study|Progression of Therapy-Related MDS|1
4444347|NCT00472290|7229217|FG000|Overall Study|Protocol Specified Criteria|7
4444348|NCT00472290|7229217|FG000|Overall Study|Administrative Decision|37
4444349|NCT00472290|7229217|FG000|Overall Study|Death|3
4444350|NCT00472290|7229217|FG000|Overall Study|Lost to Follow-up|1
4444351|NCT00472290|7229217|FG000|Overall Study|Lack of Efficacy|1
4444352|NCT00472290|7229217|FG000|Overall Study|Disease Progression|4
4444353|NCT00472290|7229217|FG000|Overall Study|Withdrawal by Subject|5
4444354|NCT00472290|7229217|FG000|Overall Study|Adverse Event|6
4444355|NCT00472290|7229217|FG000|Overall Study|Requirement for alternative therapy|7
4444356|NCT00472303|7229223|FG000|Titration Phase|Adverse Event|22
4444357|NCT00472303|7229224|FG001|Titration Phase|Adverse Event|12
4444358|NCT00472303|7229225|FG002|Titration Phase|Adverse Event|0
4630428|NCT01880424|7498999|FG001|Overall Study|Protocol Violation|13
4630429|NCT01880424|7498998|FG000|Overall Study|Withdrawal by Subject|10
4630430|NCT01880424|7498999|FG001|Overall Study|Withdrawal by Subject|30
4630431|NCT01880424|7498998|FG000|Overall Study|Other|1
4630432|NCT01880424|7498999|FG001|Overall Study|Other|0
4630433|NCT01880437|7499008|FG000|Overall Study|Death|12
4630434|NCT01880437|7499009|FG001|Overall Study|Death|4
4630435|NCT01880437|7499010|FG002|Overall Study|Death|17
4630436|NCT01880437|7499008|FG000|Overall Study|Study terminated by Sponsor|3
4630437|NCT01880437|7499009|FG001|Overall Study|Study terminated by Sponsor|0
4630438|NCT01880437|7499010|FG002|Overall Study|Study terminated by Sponsor|2
4630439|NCT01880515|7499022|FG000|Overall Study|Lost to Follow-up|3
4630440|NCT01880515|7499023|FG001|Overall Study|Lost to Follow-up|2
4630441|NCT01880515|7499022|FG000|Overall Study|Disease Progression|5
4630442|NCT01880515|7499023|FG001|Overall Study|Disease Progression|7
4630443|NCT01880528|7499032|FG000|Overall Study|Other|1
4630444|NCT01880528|7499033|FG001|Overall Study|Other|1
4630445|NCT01880554|7499039|FG000|Overall Study|Protocol Violation|14
4630446|NCT01880554|7499039|FG000|Overall Study|Simon's design requirements|2
4630447|NCT01880593|7499046|FG000|Overall Study|Adverse Event|1
4444359|NCT00472303|7229223|FG000|Titration Phase|Death|4
4444360|NCT00472303|7229224|FG001|Titration Phase|Death|2
4630448|NCT01880593|7499047|FG001|Overall Study|Adverse Event|0
4630449|NCT01880593|7499046|FG000|Overall Study|Lack of Efficacy|1
4630450|NCT01880593|7499047|FG001|Overall Study|Lack of Efficacy|5
4630451|NCT01880593|7499046|FG000|Overall Study|Withdrawal by Subject|6
4630452|NCT01880593|7499047|FG001|Overall Study|Withdrawal by Subject|1
4630453|NCT01880736|7499075|FG000|Overall Study|Adverse Event|0
4630454|NCT01880736|7499076|FG001|Overall Study|Adverse Event|0
4630455|NCT01880736|7499077|FG002|Overall Study|Adverse Event|0
4630456|NCT01880736|7499078|FG003|Overall Study|Adverse Event|1
4630457|NCT01880736|7499075|FG000|Overall Study|Withdrawal Criteria|1
4630458|NCT01880736|7499076|FG001|Overall Study|Withdrawal Criteria|2
4630459|NCT01880736|7499077|FG002|Overall Study|Withdrawal Criteria|1
4630460|NCT01880736|7499078|FG003|Overall Study|Withdrawal Criteria|5
4630461|NCT01881009|7499099|FG000|Summer Camp Session (6 Days)|Unable to wear device|0
4630462|NCT01881009|7499100|FG001|Summer Camp Session (6 Days)|Unable to wear device|1
4630463|NCT01881126|7499131|FG000|Overall Study|Non-compliance|1
4630464|NCT01881126|7499132|FG001|Overall Study|Non-compliance|1
4630465|NCT01881126|7499131|FG000|Overall Study|Adverse Event|0
4630466|NCT01881126|7499132|FG001|Overall Study|Adverse Event|1
4630467|NCT01881230|7499141|FG000|Overall Study|Death|2
4630468|NCT01881230|7499142|FG001|Overall Study|Death|0
4444361|NCT00472303|7229225|FG002|Titration Phase|Death|0
4444362|NCT00472303|7229223|FG000|Titration Phase|Lack of Efficacy|10
4444363|NCT00472303|7229224|FG001|Titration Phase|Lack of Efficacy|0
4444364|NCT00472303|7229225|FG002|Titration Phase|Lack of Efficacy|0
4444365|NCT00472303|7229223|FG000|Titration Phase|Withdrawal by Subject|16
4444366|NCT00472303|7229224|FG001|Titration Phase|Withdrawal by Subject|13
4444367|NCT00472303|7229225|FG002|Titration Phase|Withdrawal by Subject|0
4444368|NCT00472303|7229223|FG000|Titration Phase|Trial Medication non-compliant|4
4444369|NCT00472303|7229224|FG001|Titration Phase|Trial Medication non-compliant|1
4444370|NCT00472303|7229225|FG002|Titration Phase|Trial Medication non-compliant|0
4444371|NCT00472303|7229223|FG000|Titration Phase|Other|3
4444372|NCT00472303|7229224|FG001|Titration Phase|Other|1
4444373|NCT00472303|7229225|FG002|Titration Phase|Other|0
4444374|NCT00472303|7229223|FG000|Discontinuations After Titration Phase|Adverse Event|6
4444375|NCT00472303|7229224|FG001|Discontinuations After Titration Phase|Adverse Event|0
4444376|NCT00472303|7229225|FG002|Discontinuations After Titration Phase|Adverse Event|0
4444377|NCT00472303|7229223|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48
4444378|NCT00472303|7229224|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17
4444379|NCT00472303|7229225|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0
4444380|NCT00472303|7229223|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2
4444381|NCT00472303|7229224|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2
4444382|NCT00472303|7229225|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0
4444383|NCT00472303|7229223|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0
4444384|NCT00472303|7229224|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1
4444385|NCT00472303|7229225|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0
4444386|NCT00472303|7229223|FG000|Discontinuations After Titration Phase|Other|5
4444387|NCT00472303|7229224|FG001|Discontinuations After Titration Phase|Other|0
4444388|NCT00472303|7229225|FG002|Discontinuations After Titration Phase|Other|0
4444389|NCT00472303|7229223|FG000|Maintenance Phase|Adverse Event|5
4444390|NCT00472303|7229224|FG001|Maintenance Phase|Adverse Event|6
4444391|NCT00472303|7229225|FG002|Maintenance Phase|Adverse Event|6
4444392|NCT00472303|7229223|FG000|Maintenance Phase|Death|3
4444393|NCT00472303|7229224|FG001|Maintenance Phase|Death|0
4444394|NCT00472303|7229225|FG002|Maintenance Phase|Death|2
4444395|NCT00472303|7229223|FG000|Maintenance Phase|Lack of Efficacy|2
4444396|NCT00472303|7229224|FG001|Maintenance Phase|Lack of Efficacy|2
4444397|NCT00472303|7229225|FG002|Maintenance Phase|Lack of Efficacy|4
4444398|NCT00472303|7229223|FG000|Maintenance Phase|Withdrawal by Subject|6
4444399|NCT00472303|7229224|FG001|Maintenance Phase|Withdrawal by Subject|7
4444400|NCT00472303|7229225|FG002|Maintenance Phase|Withdrawal by Subject|3
4444401|NCT00472303|7229223|FG000|Maintenance Phase|Trial medication non-compliant|0
4444402|NCT00472303|7229224|FG001|Maintenance Phase|Trial medication non-compliant|0
4444403|NCT00472303|7229225|FG002|Maintenance Phase|Trial medication non-compliant|1
4444404|NCT00472303|7229223|FG000|Maintenance Phase|Resolution of pain|0
4444405|NCT00472303|7229224|FG001|Maintenance Phase|Resolution of pain|0
4444406|NCT00472303|7229225|FG002|Maintenance Phase|Resolution of pain|1
4444407|NCT00472303|7229223|FG000|Maintenance Phase|Other|1
4444408|NCT00472303|7229224|FG001|Maintenance Phase|Other|1
4444409|NCT00472303|7229225|FG002|Maintenance Phase|Other|0
4444410|NCT00472420|7229253|FG000|Induction Treatment Period|Physician Decision|9
4444411|NCT00472420|7229253|FG000|Induction Treatment Period|Adverse Event|3
4444412|NCT00472420|7229253|FG000|Induction Treatment Period|Non-compliance|1
4444413|NCT00472420|7229253|FG000|Induction Treatment Period|Death|3
4444414|NCT00472420|7229253|FG000|Follow-up Period|Death|5
4444415|NCT00472420|7229253|FG000|Follow-up Period|Physician Decision|9
4630469|NCT01881230|7499143|FG002|Overall Study|Death|1
4444416|NCT00472420|7229253|FG000|Follow-up Period|Lost to Follow-up|2
4444417|NCT00472420|7229253|FG000|Follow-up Period|Protocol Violation|1
4444418|NCT00472446|7229261|FG000|Overall Study|Protocol Violation|0
4444419|NCT00472446|7229262|FG001|Overall Study|Protocol Violation|0
4630470|NCT01881230|7499141|FG000|Overall Study|Adverse Event|9
4630471|NCT01881230|7499142|FG001|Overall Study|Adverse Event|13
4444420|NCT00472446|7229263|FG002|Overall Study|Protocol Violation|0
4444421|NCT00472446|7229264|FG003|Overall Study|Protocol Violation|1
4444422|NCT00472446|7229261|FG000|Overall Study|Reintervention|0
4444423|NCT00472446|7229262|FG001|Overall Study|Reintervention|0
4444424|NCT00472446|7229263|FG002|Overall Study|Reintervention|1
4444425|NCT00472446|7229264|FG003|Overall Study|Reintervention|1
4444426|NCT00472446|7229261|FG000|Overall Study|Questionnaires not returned|5
4444427|NCT00472446|7229262|FG001|Overall Study|Questionnaires not returned|6
4444428|NCT00472446|7229263|FG002|Overall Study|Questionnaires not returned|6
4444429|NCT00472446|7229264|FG003|Overall Study|Questionnaires not returned|4
4444430|NCT00472641|7229283|FG000|Overall Study|Lack of Efficacy|3
4444431|NCT00472641|7229283|FG000|Overall Study|Adverse Event|3
4444432|NCT00472641|7229283|FG000|Overall Study|Lost to Follow-up|1
4444433|NCT00473083|7229320|FG000|Overall Study|Adverse Event|1
4444434|NCT00473083|7229321|FG001|Overall Study|Adverse Event|0
4444435|NCT00473083|7229322|FG002|Overall Study|Adverse Event|0
4444436|NCT00473265|7229333|FG000|Overall Study|Unrelated adverse event|5
4444437|NCT00473265|7229333|FG000|Overall Study|Off treatment early|15
4444438|NCT00473330|7229340|FG000|Core Study|Adverse Event|4
4444439|NCT00473330|7229341|FG001|Core Study|Adverse Event|4
4630472|NCT01881230|7499143|FG002|Overall Study|Adverse Event|12
4630473|NCT01881230|7499141|FG000|Overall Study|Progressive Disease|31
4630474|NCT01881230|7499142|FG001|Overall Study|Progressive Disease|35
4630475|NCT01881230|7499143|FG002|Overall Study|Progressive Disease|36
4630476|NCT01881230|7499141|FG000|Overall Study|Symptomatic Deterioration|3
4630477|NCT01881230|7499142|FG001|Overall Study|Symptomatic Deterioration|3
4630478|NCT01881230|7499143|FG002|Overall Study|Symptomatic Deterioration|1
4630479|NCT01881230|7499141|FG000|Overall Study|Withdrawal by Subject|6
4630480|NCT01881230|7499142|FG001|Overall Study|Withdrawal by Subject|4
4630481|NCT01881230|7499143|FG002|Overall Study|Withdrawal by Subject|6
4444440|NCT00473330|7229342|FG002|Core Study|Adverse Event|1
4444441|NCT00473330|7229340|FG000|Core Study|Death|6
4444442|NCT00473330|7229341|FG001|Core Study|Death|4
4444443|NCT00473330|7229342|FG002|Core Study|Death|4
4444444|NCT00473330|7229340|FG000|Core Study|Lost to Follow-up|5
4444445|NCT00473330|7229341|FG001|Core Study|Lost to Follow-up|5
4444446|NCT00473330|7229342|FG002|Core Study|Lost to Follow-up|10
4444447|NCT00473330|7229340|FG000|Core Study|Physician Decision|2
4444448|NCT00473330|7229341|FG001|Core Study|Physician Decision|1
4444449|NCT00473330|7229342|FG002|Core Study|Physician Decision|3
4444450|NCT00473330|7229340|FG000|Core Study|Subject Non-compliance|1
4444451|NCT00473330|7229341|FG001|Core Study|Subject Non-compliance|2
4444452|NCT00473330|7229342|FG002|Core Study|Subject Non-compliance|1
4444453|NCT00473330|7229340|FG000|Core Study|Subject Required Other Therapy|0
4444454|NCT00473330|7229341|FG001|Core Study|Subject Required Other Therapy|1
4444455|NCT00473330|7229342|FG002|Core Study|Subject Required Other Therapy|3
4444456|NCT00473330|7229340|FG000|Core Study|Subject's Decision|9
4444457|NCT00473330|7229341|FG001|Core Study|Subject's Decision|8
4444458|NCT00473330|7229342|FG002|Core Study|Subject's Decision|19
4444459|NCT00473330|7229340|FG000|Open-label Extension Through Month 48|Adverse Event|0
4444460|NCT00473330|7229341|FG001|Open-label Extension Through Month 48|Adverse Event|0
4444461|NCT00473330|7229342|FG002|Open-label Extension Through Month 48|Adverse Event|2
4444462|NCT00473330|7229340|FG000|Open-label Extension Through Month 48|Death|2
4444463|NCT00473330|7229341|FG001|Open-label Extension Through Month 48|Death|0
4444464|NCT00473330|7229342|FG002|Open-label Extension Through Month 48|Death|0
4444465|NCT00473330|7229340|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1
4444466|NCT00473330|7229341|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0
4444467|NCT00473330|7229342|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2
4444468|NCT00473330|7229340|FG000|Open-label Extension Through Month 48|Physician's Decision|2
4444469|NCT00473330|7229341|FG001|Open-label Extension Through Month 48|Physician's Decision|1
4444470|NCT00473330|7229342|FG002|Open-label Extension Through Month 48|Physician's Decision|3
4444471|NCT00473330|7229340|FG000|Open-label Extension Through Month 48|Subject's Decision|1
4444472|NCT00473330|7229341|FG001|Open-label Extension Through Month 48|Subject's Decision|3
4444473|NCT00473330|7229342|FG002|Open-label Extension Through Month 48|Subject's Decision|3
4444474|NCT00473330|7229340|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18
4444475|NCT00473330|7229341|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15
4444476|NCT00473330|7229342|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16
4444477|NCT00473330|7229340|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2
4444478|NCT00473330|7229341|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1
4444479|NCT00473330|7229342|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0
4444480|NCT00473330|7229340|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0
4444481|NCT00473330|7229341|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0
4444482|NCT00473330|7229342|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1
4630482|NCT01881230|7499141|FG000|Overall Study|Physician Decision|4
4630483|NCT01881230|7499142|FG001|Overall Study|Physician Decision|3
4630484|NCT01881230|7499143|FG002|Overall Study|Physician Decision|6
4444483|NCT00473330|7229340|FG000|Open-label Extension Through Month 60|Adverse Event|0
4444484|NCT00473330|7229341|FG001|Open-label Extension Through Month 60|Adverse Event|0
4444485|NCT00473330|7229342|FG002|Open-label Extension Through Month 60|Adverse Event|2
4444486|NCT00473330|7229340|FG000|Open-label Extension Through Month 60|Death|2
4444487|NCT00473330|7229341|FG001|Open-label Extension Through Month 60|Death|2
4444488|NCT00473330|7229342|FG002|Open-label Extension Through Month 60|Death|1
4444489|NCT00473330|7229340|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3
4444490|NCT00473330|7229341|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0
4444491|NCT00473330|7229342|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4
4444492|NCT00473330|7229340|FG000|Open-label Extension Through Month 60|Physician's Decision|2
4444493|NCT00473330|7229341|FG001|Open-label Extension Through Month 60|Physician's Decision|1
4444494|NCT00473330|7229342|FG002|Open-label Extension Through Month 60|Physician's Decision|3
4444495|NCT00473330|7229340|FG000|Open-label Extension Through Month 60|Subject's Decision|1
4444496|NCT00473330|7229341|FG001|Open-label Extension Through Month 60|Subject's Decision|3
4444497|NCT00473330|7229342|FG002|Open-label Extension Through Month 60|Subject's Decision|4
4444498|NCT00473330|7229340|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77
4444499|NCT00473330|7229341|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71
4444500|NCT00473330|7229342|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62
4444501|NCT00473330|7229340|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2
4444502|NCT00473330|7229341|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1
4444503|NCT00473330|7229342|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0
4444504|NCT00473330|7229340|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1
4444505|NCT00473330|7229341|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0
4444506|NCT00473330|7229342|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1
4444507|NCT00473382|7229373|FG000|Core Study|Adverse Event|3
4444508|NCT00473382|7229374|FG001|Core Study|Adverse Event|1
4444509|NCT00473382|7229375|FG002|Core Study|Adverse Event|1
4444510|NCT00473382|7229373|FG000|Core Study|Death|3
4444511|NCT00473382|7229374|FG001|Core Study|Death|5
4444512|NCT00473382|7229375|FG002|Core Study|Death|10
4444513|NCT00473382|7229373|FG000|Core Study|Lost to Follow-up|3
4444514|NCT00473382|7229374|FG001|Core Study|Lost to Follow-up|3
4444515|NCT00473382|7229375|FG002|Core Study|Lost to Follow-up|3
4444516|NCT00473382|7229373|FG000|Core Study|Physician Decision|1
4444517|NCT00473382|7229374|FG001|Core Study|Physician Decision|2
4444518|NCT00473382|7229375|FG002|Core Study|Physician Decision|2
4444519|NCT00473382|7229373|FG000|Core Study|Subject non-compliance|5
4444520|NCT00473382|7229374|FG001|Core Study|Subject non-compliance|2
4444521|NCT00473382|7229375|FG002|Core Study|Subject non-compliance|1
4444522|NCT00473382|7229373|FG000|Core Study|Subject needed other treatment|1
4444523|NCT00473382|7229374|FG001|Core Study|Subject needed other treatment|3
4444524|NCT00473382|7229375|FG002|Core Study|Subject needed other treatment|2
4444525|NCT00473382|7229373|FG000|Core Study|Subject's decision|12
4444526|NCT00473382|7229374|FG001|Core Study|Subject's decision|11
4444527|NCT00473382|7229375|FG002|Core Study|Subject's decision|10
4444528|NCT00473382|7229373|FG000|Open-label Extension Through Month 48|Adverse Event|0
4444529|NCT00473382|7229374|FG001|Open-label Extension Through Month 48|Adverse Event|0
4444530|NCT00473382|7229375|FG002|Open-label Extension Through Month 48|Adverse Event|1
4444531|NCT00473382|7229373|FG000|Open-label Extension Through Month 48|Death|1
4444532|NCT00473382|7229374|FG001|Open-label Extension Through Month 48|Death|3
4444533|NCT00473382|7229375|FG002|Open-label Extension Through Month 48|Death|3
4444534|NCT00473382|7229373|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1
4444535|NCT00473382|7229374|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2
4444536|NCT00473382|7229375|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1
4444537|NCT00473382|7229373|FG000|Open-label Extension Through Month 48|Subject's Decision|5
4444538|NCT00473382|7229374|FG001|Open-label Extension Through Month 48|Subject's Decision|1
4444539|NCT00473382|7229375|FG002|Open-label Extension Through Month 48|Subject's Decision|6
4444540|NCT00473382|7229373|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41
4444541|NCT00473382|7229374|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34
4444542|NCT00473382|7229375|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36
4444543|NCT00473382|7229373|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2
4444544|NCT00473382|7229374|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1
4444545|NCT00473382|7229375|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0
4444546|NCT00473382|7229373|FG000|Open-label Extension Through Month 60|Adverse Event|0
4444547|NCT00473382|7229374|FG001|Open-label Extension Through Month 60|Adverse Event|0
4444548|NCT00473382|7229375|FG002|Open-label Extension Through Month 60|Adverse Event|2
4444549|NCT00473382|7229373|FG000|Open-label Extension Through Month 60|Death|1
4444550|NCT00473382|7229374|FG001|Open-label Extension Through Month 60|Death|7
4444551|NCT00473382|7229375|FG002|Open-label Extension Through Month 60|Death|4
4444552|NCT00473382|7229373|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1
4444553|NCT00473382|7229374|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3
4444554|NCT00473382|7229375|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1
4444555|NCT00473382|7229373|FG000|Open-label Extension Through Month 60|Subject's Decision|7
4444556|NCT00473382|7229374|FG001|Open-label Extension Through Month 60|Subject's Decision|1
4444557|NCT00473382|7229375|FG002|Open-label Extension Through Month 60|Subject's Decision|6
4444558|NCT00473382|7229373|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75
4444559|NCT00473382|7229374|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70
4444560|NCT00473382|7229375|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69
4444561|NCT00473382|7229373|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2
4444562|NCT00473382|7229374|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1
4444563|NCT00473382|7229375|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0
4444564|NCT00473434|7229401|FG000|Overall Study|Physician Decision|3
4444565|NCT00473434|7229401|FG000|Overall Study|Withdrawal by Subject|9
4444566|NCT00473434|7229401|FG000|Overall Study|Compliance|3
4444567|NCT00473434|7229401|FG000|Overall Study|Lack of Efficacy|3
4444568|NCT00473434|7229401|FG000|Overall Study|Adverse Event|3
4444569|NCT00473434|7229401|FG000|Overall Study|Patient was selling medication to others|1
4444570|NCT00473434|7229401|FG000|Overall Study|Safety evaluation|1
4444571|NCT00473434|7229401|FG000|Overall Study|Reason not specified|6
4630485|NCT01881230|7499141|FG000|Overall Study|Non-Compliance with Study Drug|1
4630486|NCT01881230|7499142|FG001|Overall Study|Non-Compliance with Study Drug|2
4630487|NCT01881230|7499143|FG002|Overall Study|Non-Compliance with Study Drug|0
4630488|NCT01881230|7499141|FG000|Overall Study|Given Commercially Available Drug|0
4630489|NCT01881230|7499142|FG001|Overall Study|Given Commercially Available Drug|0
4630490|NCT01881230|7499143|FG002|Overall Study|Given Commercially Available Drug|2
4630491|NCT01881230|7499141|FG000|Overall Study|Protocol Violation|1
4630492|NCT01881230|7499142|FG001|Overall Study|Protocol Violation|1
4630493|NCT01881230|7499143|FG002|Overall Study|Protocol Violation|0
4630494|NCT01881230|7499141|FG000|Overall Study|Miscellaneous|3
4630495|NCT01881230|7499142|FG001|Overall Study|Miscellaneous|3
4630496|NCT01881230|7499143|FG002|Overall Study|Miscellaneous|0
4630497|NCT01881230|7499141|FG000|Overall Study|Untreated: Other|0
4630498|NCT01881230|7499142|FG001|Overall Study|Untreated: Other|0
4630499|NCT01881230|7499143|FG002|Overall Study|Untreated: Other|1
4630500|NCT01881230|7499141|FG000|Overall Study|Untreated: Death|0
4630501|NCT01881230|7499142|FG001|Overall Study|Untreated: Death|0
4630502|NCT01881230|7499143|FG002|Overall Study|Untreated: Death|1
4630503|NCT01881230|7499141|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1
4630504|NCT01881230|7499142|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0
4630505|NCT01881230|7499143|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0
4630506|NCT01881620|7499177|FG000|Overall Study|Protocol Violation|4
4444572|NCT00473434|7229401|FG000|Overall Study|Ceased in favor of Paliperidone|1
4444573|NCT00473434|7229401|FG000|Overall Study|Switching to trial medication|1
4444574|NCT00473434|7229401|FG000|Overall Study|No longer required|1
4444575|NCT00473512|7229423|FG000|Period 1 (Phase 1)|Adverse Event|0
4444576|NCT00473512|7229424|FG001|Period 1 (Phase 1)|Adverse Event|0
4444577|NCT00473512|7229425|FG002|Period 1 (Phase 1)|Adverse Event|0
4444578|NCT00473512|7229426|FG003|Period 1 (Phase 1)|Adverse Event|5
4444579|NCT00473512|7229427|FG004|Period 1 (Phase 1)|Adverse Event|0
4444580|NCT00473512|7229423|FG000|Period 1 (Phase 1)|Death|0
4444581|NCT00473512|7229424|FG001|Period 1 (Phase 1)|Death|0
4444582|NCT00473512|7229425|FG002|Period 1 (Phase 1)|Death|0
4444583|NCT00473512|7229426|FG003|Period 1 (Phase 1)|Death|1
4444584|NCT00473512|7229427|FG004|Period 1 (Phase 1)|Death|0
4444585|NCT00473512|7229423|FG000|Period 1 (Phase 1)|Disease Progression|1
4444586|NCT00473512|7229424|FG001|Period 1 (Phase 1)|Disease Progression|1
4444587|NCT00473512|7229425|FG002|Period 1 (Phase 1)|Disease Progression|0
4444588|NCT00473512|7229426|FG003|Period 1 (Phase 1)|Disease Progression|10
4444589|NCT00473512|7229427|FG004|Period 1 (Phase 1)|Disease Progression|1
4444590|NCT00473512|7229423|FG000|Period 1 (Phase 1)|Other|0
4444591|NCT00473512|7229424|FG001|Period 1 (Phase 1)|Other|0
4444592|NCT00473512|7229425|FG002|Period 1 (Phase 1)|Other|0
4444593|NCT00473512|7229426|FG003|Period 1 (Phase 1)|Other|1
4444594|NCT00473512|7229427|FG004|Period 1 (Phase 1)|Other|0
4444595|NCT00473512|7229423|FG000|Period 2 (Phase 2)|Adverse Event|0
4444596|NCT00473512|7229424|FG001|Period 2 (Phase 2)|Adverse Event|0
4444597|NCT00473512|7229425|FG002|Period 2 (Phase 2)|Adverse Event|0
4444598|NCT00473512|7229426|FG003|Period 2 (Phase 2)|Adverse Event|1
4444599|NCT00473512|7229427|FG004|Period 2 (Phase 2)|Adverse Event|0
4444600|NCT00473512|7229423|FG000|Period 2 (Phase 2)|Death|0
4444601|NCT00473512|7229424|FG001|Period 2 (Phase 2)|Death|0
4444602|NCT00473512|7229425|FG002|Period 2 (Phase 2)|Death|0
4444603|NCT00473512|7229426|FG003|Period 2 (Phase 2)|Death|1
4444604|NCT00473512|7229427|FG004|Period 2 (Phase 2)|Death|1
4444605|NCT00473512|7229423|FG000|Period 2 (Phase 2)|Disease Progression|0
4444606|NCT00473512|7229424|FG001|Period 2 (Phase 2)|Disease Progression|2
4444607|NCT00473512|7229425|FG002|Period 2 (Phase 2)|Disease Progression|2
4444608|NCT00473512|7229426|FG003|Period 2 (Phase 2)|Disease Progression|17
4444609|NCT00473512|7229427|FG004|Period 2 (Phase 2)|Disease Progression|1
4444610|NCT00473512|7229423|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0
4444611|NCT00473512|7229424|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0
4444612|NCT00473512|7229425|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0
4630507|NCT01881737|7499181|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3
4630508|NCT01881737|7499181|FG000|Overall Study|Withdrawal by Subject|1
4630509|NCT01881737|7499181|FG000|Overall Study|Worsening of baseline behavior|1
4444613|NCT00473512|7229426|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1
4444614|NCT00473512|7229427|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0
4444615|NCT00473512|7229423|FG000|Period 2 (Phase 2)|Other|1
4444616|NCT00473512|7229424|FG001|Period 2 (Phase 2)|Other|0
4444617|NCT00473512|7229425|FG002|Period 2 (Phase 2)|Other|0
4444618|NCT00473512|7229426|FG003|Period 2 (Phase 2)|Other|3
4444619|NCT00473512|7229427|FG004|Period 2 (Phase 2)|Other|0
4444620|NCT00473564|7229447|FG000|Overall Study|robot surgery aborted in OR|23
4444621|NCT00473590|7229453|FG000|Overall Study|Adverse Event|3
4444622|NCT00473590|7229454|FG001|Overall Study|Adverse Event|3
4444623|NCT00473590|7229453|FG000|Overall Study|Death|4
4444624|NCT00473590|7229454|FG001|Overall Study|Death|2
4444625|NCT00473590|7229453|FG000|Overall Study|Progression not resulting in death|24
4444626|NCT00473590|7229454|FG001|Overall Study|Progression not resulting in death|20
4444627|NCT00473590|7229453|FG000|Overall Study|Non-protocol-specified therapy|7
4444628|NCT00473590|7229454|FG001|Overall Study|Non-protocol-specified therapy|5
4444629|NCT00473590|7229453|FG000|Overall Study|Physician Decision|2
4444630|NCT00473590|7229454|FG001|Overall Study|Physician Decision|4
4444631|NCT00473590|7229453|FG000|Overall Study|Withdrawal by Subject|5
4444632|NCT00473590|7229454|FG001|Overall Study|Withdrawal by Subject|3
4444633|NCT00473590|7229453|FG000|Overall Study|Other|0
4444634|NCT00473590|7229454|FG001|Overall Study|Other|1
4444635|NCT00473655|7229479|FG000|Overall Study|Lost to Follow-up|9
4444636|NCT00473655|7229480|FG001|Overall Study|Lost to Follow-up|5
4444637|NCT00473655|7229481|FG002|Overall Study|Lost to Follow-up|8
4444638|NCT00473668|7229492|FG000|Overall Study|Withdrawal by Subject|0
4444639|NCT00473668|7229493|FG001|Overall Study|Withdrawal by Subject|2
4444640|NCT00473668|7229494|FG002|Overall Study|Withdrawal by Subject|0
4444641|NCT00473668|7229492|FG000|Overall Study|Migrated/moved from study area|3
4444642|NCT00473668|7229493|FG001|Overall Study|Migrated/moved from study area|2
4444643|NCT00473668|7229494|FG002|Overall Study|Migrated/moved from study area|0
4444644|NCT00473668|7229492|FG000|Overall Study|Lost to Follow-up|0
4444645|NCT00473668|7229493|FG001|Overall Study|Lost to Follow-up|4
4444646|NCT00473668|7229494|FG002|Overall Study|Lost to Follow-up|6
4444647|NCT00473668|7229492|FG000|Overall Study|Other|2
4444648|NCT00473668|7229493|FG001|Overall Study|Other|3
4444649|NCT00473668|7229494|FG002|Overall Study|Other|4
4444650|NCT00473694|7229506|FG000|Overall Study|Adverse Event|0
4444651|NCT00473694|7229507|FG001|Overall Study|Adverse Event|1
4444652|NCT00473694|7229508|FG002|Overall Study|Adverse Event|0
4444653|NCT00473694|7229509|FG003|Overall Study|Adverse Event|0
4444654|NCT00473694|7229506|FG000|Overall Study|Participants did not receive treatment|11
4444655|NCT00473694|7229507|FG001|Overall Study|Participants did not receive treatment|3
4444656|NCT00473694|7229508|FG002|Overall Study|Participants did not receive treatment|5
4444657|NCT00473694|7229509|FG003|Overall Study|Participants did not receive treatment|6
4444658|NCT00473694|7229506|FG000|Overall Study|Lost to Follow-up|0
4444659|NCT00473694|7229507|FG001|Overall Study|Lost to Follow-up|0
4444660|NCT00473694|7229508|FG002|Overall Study|Lost to Follow-up|0
4444661|NCT00473694|7229509|FG003|Overall Study|Lost to Follow-up|1
4444662|NCT00473746|7229527|FG000|Period 1 (Phase 1)|Adverse Event|1
4444663|NCT00473746|7229528|FG001|Period 1 (Phase 1)|Adverse Event|0
4444664|NCT00473746|7229529|FG002|Period 1 (Phase 1)|Adverse Event|0
4444665|NCT00473746|7229530|FG003|Period 1 (Phase 1)|Adverse Event|0
4444666|NCT00473746|7229531|FG004|Period 1 (Phase 1)|Adverse Event|0
4444667|NCT00473746|7229527|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0
4444668|NCT00473746|7229528|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1
4444669|NCT00473746|7229529|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0
4444670|NCT00473746|7229530|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0
4444671|NCT00473746|7229531|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0
4444672|NCT00473746|7229527|FG000|Period 1 (Phase 1)|Progressive Disease|5
4444673|NCT00473746|7229528|FG001|Period 1 (Phase 1)|Progressive Disease|6
4444674|NCT00473746|7229529|FG002|Period 1 (Phase 1)|Progressive Disease|6
4444675|NCT00473746|7229530|FG003|Period 1 (Phase 1)|Progressive Disease|10
4444676|NCT00473746|7229531|FG004|Period 1 (Phase 1)|Progressive Disease|0
4444677|NCT00473746|7229527|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0
4444678|NCT00473746|7229528|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1
4444679|NCT00473746|7229529|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0
4444680|NCT00473746|7229530|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0
4444681|NCT00473746|7229531|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0
4444682|NCT00473746|7229527|FG000|Period 1 (Phase 1)|Reason not specified|0
4444683|NCT00473746|7229528|FG001|Period 1 (Phase 1)|Reason not specified|1
4444684|NCT00473746|7229529|FG002|Period 1 (Phase 1)|Reason not specified|0
4444685|NCT00473746|7229530|FG003|Period 1 (Phase 1)|Reason not specified|0
4444686|NCT00473746|7229531|FG004|Period 1 (Phase 1)|Reason not specified|0
4444687|NCT00473746|7229527|FG000|Period 2 (Phase 2)|Adverse Event|0
4444688|NCT00473746|7229528|FG001|Period 2 (Phase 2)|Adverse Event|0
4444689|NCT00473746|7229529|FG002|Period 2 (Phase 2)|Adverse Event|0
4444690|NCT00473746|7229530|FG003|Period 2 (Phase 2)|Adverse Event|0
4444691|NCT00473746|7229531|FG004|Period 2 (Phase 2)|Adverse Event|3
4444692|NCT00473746|7229527|FG000|Period 2 (Phase 2)|Death|0
4444693|NCT00473746|7229528|FG001|Period 2 (Phase 2)|Death|0
4444694|NCT00473746|7229529|FG002|Period 2 (Phase 2)|Death|0
4444695|NCT00473746|7229530|FG003|Period 2 (Phase 2)|Death|0
4444696|NCT00473746|7229531|FG004|Period 2 (Phase 2)|Death|1
4444697|NCT00473746|7229527|FG000|Period 2 (Phase 2)|Progressive Disease|0
4444698|NCT00473746|7229528|FG001|Period 2 (Phase 2)|Progressive Disease|0
4444699|NCT00473746|7229529|FG002|Period 2 (Phase 2)|Progressive Disease|0
4444700|NCT00473746|7229530|FG003|Period 2 (Phase 2)|Progressive Disease|0
4444701|NCT00473746|7229531|FG004|Period 2 (Phase 2)|Progressive Disease|20
4444702|NCT00473746|7229527|FG000|Period 2 (Phase 2)|Reason not specified|0
4444703|NCT00473746|7229528|FG001|Period 2 (Phase 2)|Reason not specified|0
4444704|NCT00473746|7229529|FG002|Period 2 (Phase 2)|Reason not specified|0
4444705|NCT00473746|7229530|FG003|Period 2 (Phase 2)|Reason not specified|0
4444706|NCT00473746|7229531|FG004|Period 2 (Phase 2)|Reason not specified|3
4444707|NCT00473824|7229547|FG000|Overall Study|Virologic Breakthrough|1
4444708|NCT00473824|7229548|FG001|Overall Study|Virologic Breakthrough|0
4444709|NCT00473824|7229547|FG000|Overall Study|Adverse Event|1
4444710|NCT00473824|7229548|FG001|Overall Study|Adverse Event|0
4444711|NCT00473824|7229547|FG000|Overall Study|Death|1
4444712|NCT00473824|7229548|FG001|Overall Study|Death|0
4444713|NCT00473824|7229547|FG000|Overall Study|Lost to Follow-up|1
4444714|NCT00473824|7229548|FG001|Overall Study|Lost to Follow-up|0
4444715|NCT00473824|7229547|FG000|Overall Study|Withdrawal by physician|1
4444716|NCT00473824|7229548|FG001|Overall Study|Withdrawal by physician|0
4444717|NCT00473876|7229565|FG000|Overall Study|Lost to Follow-up|3
4444718|NCT00473876|7229566|FG001|Overall Study|Lost to Follow-up|1
4444719|NCT00473889|7229576|FG000|Overall Study|Did not receive study medication|1
4444720|NCT00473889|7229577|FG001|Overall Study|Did not receive study medication|4
4444721|NCT00473889|7229576|FG000|Overall Study|Adverse Event|30
4444722|NCT00473889|7229577|FG001|Overall Study|Adverse Event|17
4444723|NCT00473889|7229576|FG000|Overall Study|Protocol Violation|4
4444724|NCT00473889|7229577|FG001|Overall Study|Protocol Violation|2
4444725|NCT00473889|7229576|FG000|Overall Study|Lack of Efficacy|28
4444726|NCT00473889|7229577|FG001|Overall Study|Lack of Efficacy|29
4444727|NCT00473889|7229576|FG000|Overall Study|Lost to Follow-up|2
4444728|NCT00473889|7229577|FG001|Overall Study|Lost to Follow-up|1
4444729|NCT00473889|7229576|FG000|Overall Study|Physician Decision|10
4444730|NCT00473889|7229577|FG001|Overall Study|Physician Decision|5
4444731|NCT00473889|7229576|FG000|Overall Study|Trial Terminated|3
4444732|NCT00473889|7229577|FG001|Overall Study|Trial Terminated|6
4444733|NCT00473889|7229576|FG000|Overall Study|Withdrawal by Subject|5
4444734|NCT00473889|7229577|FG001|Overall Study|Withdrawal by Subject|0
4444735|NCT00474045|7229585|FG000|Overall Study|Adverse Event|18
4444736|NCT00474045|7229586|FG001|Overall Study|Adverse Event|8
4444737|NCT00474045|7229585|FG000|Overall Study|Unclassified|1
4444738|NCT00474045|7229586|FG001|Overall Study|Unclassified|3
4444739|NCT00474045|7229585|FG000|Overall Study|Lack of Efficacy|0
4444740|NCT00474045|7229586|FG001|Overall Study|Lack of Efficacy|9
4444741|NCT00474045|7229585|FG000|Overall Study|Lost to Follow-up|1
4444742|NCT00474045|7229586|FG001|Overall Study|Lost to Follow-up|1
4444743|NCT00474045|7229585|FG000|Overall Study|Protocol Violation|10
4444744|NCT00474045|7229586|FG001|Overall Study|Protocol Violation|12
4444745|NCT00474045|7229585|FG000|Overall Study|Withdrawal by Subject|16
4444746|NCT00474045|7229586|FG001|Overall Study|Withdrawal by Subject|18
4444747|NCT00474045|7229585|FG000|Overall Study|Withdrawal criteria|60
4444748|NCT00474045|7229586|FG001|Overall Study|Withdrawal criteria|50
4444749|NCT00474058|7229594|FG000|Overall Study|Adverse Event|11
4444750|NCT00474058|7229595|FG001|Overall Study|Adverse Event|6
4444751|NCT00474058|7229594|FG000|Overall Study|Lack of Efficacy|0
4444752|NCT00474058|7229595|FG001|Overall Study|Lack of Efficacy|4
4444753|NCT00474058|7229594|FG000|Overall Study|Withdrawal by Subject|11
4444754|NCT00474058|7229595|FG001|Overall Study|Withdrawal by Subject|7
4444755|NCT00474058|7229594|FG000|Overall Study|Other|2
4444756|NCT00474058|7229595|FG001|Overall Study|Other|0
4444757|NCT00474175|7229613|FG000|Overall Study|Lack of Efficacy|0
4444758|NCT00474175|7229614|FG001|Overall Study|Lack of Efficacy|0
4444759|NCT00474175|7229615|FG002|Overall Study|Lack of Efficacy|1
4444760|NCT00474175|7229613|FG000|Overall Study|Withdrawal by Subject|0
4444761|NCT00474175|7229614|FG001|Overall Study|Withdrawal by Subject|1
4444762|NCT00474175|7229615|FG002|Overall Study|Withdrawal by Subject|1
4444763|NCT00474175|7229613|FG000|Overall Study|Ineligible|1
4444764|NCT00474175|7229614|FG001|Overall Study|Ineligible|3
4444765|NCT00474175|7229615|FG002|Overall Study|Ineligible|1
4444766|NCT00474175|7229613|FG000|Overall Study|Protocol Violation|0
4444767|NCT00474175|7229614|FG001|Overall Study|Protocol Violation|2
4444768|NCT00474175|7229615|FG002|Overall Study|Protocol Violation|1
4444769|NCT00474175|7229613|FG000|Overall Study|Administrative|0
4444770|NCT00474175|7229614|FG001|Overall Study|Administrative|1
4444771|NCT00474175|7229615|FG002|Overall Study|Administrative|0
4444772|NCT00474240|7229634|FG000|Overall Study|Withdrawal by Subject|1
4444773|NCT00474240|7229635|FG001|Overall Study|Withdrawal by Subject|1
4444774|NCT00474240|7229636|FG002|Overall Study|Withdrawal by Subject|0
4444775|NCT00474240|7229637|FG003|Overall Study|Withdrawal by Subject|2
4444776|NCT00474240|7229638|FG004|Overall Study|Withdrawal by Subject|3
4444777|NCT00474240|7229639|FG005|Overall Study|Withdrawal by Subject|1
4444778|NCT00474240|7229634|FG000|Overall Study|Adverse Event|0
4444779|NCT00474240|7229635|FG001|Overall Study|Adverse Event|0
4444780|NCT00474240|7229636|FG002|Overall Study|Adverse Event|9
4444781|NCT00474240|7229637|FG003|Overall Study|Adverse Event|14
4444782|NCT00474240|7229638|FG004|Overall Study|Adverse Event|5
4444783|NCT00474240|7229639|FG005|Overall Study|Adverse Event|16
4444784|NCT00474240|7229634|FG000|Overall Study|Removed due to lab value|0
4444785|NCT00474240|7229635|FG001|Overall Study|Removed due to lab value|0
4444786|NCT00474240|7229636|FG002|Overall Study|Removed due to lab value|0
4444787|NCT00474240|7229637|FG003|Overall Study|Removed due to lab value|0
4444788|NCT00474240|7229638|FG004|Overall Study|Removed due to lab value|0
4444789|NCT00474240|7229639|FG005|Overall Study|Removed due to lab value|1
4444790|NCT00474253|7229655|FG000|Overall Study|Withdrew consent|2
4444791|NCT00474253|7229656|FG001|Overall Study|Withdrew consent|0
4444792|NCT00474253|7229655|FG000|Overall Study|Withdrew due to surgery-related issues|0
4444793|NCT00474253|7229656|FG001|Overall Study|Withdrew due to surgery-related issues|3
4444794|NCT00474253|7229655|FG000|Overall Study|Lost to Follow-up|1
4444795|NCT00474253|7229656|FG001|Overall Study|Lost to Follow-up|0
4444796|NCT00474253|7229655|FG000|Overall Study|Discharged prior to study completion|0
4444797|NCT00474253|7229656|FG001|Overall Study|Discharged prior to study completion|1
4444798|NCT00474266|7229666|FG000|Overall Study|Withdrawal by Subject|7
4444799|NCT00474266|7229667|FG001|Overall Study|Withdrawal by Subject|20
4444800|NCT00474266|7229668|FG002|Overall Study|Withdrawal by Subject|4
4444801|NCT00474266|7229669|FG003|Overall Study|Withdrawal by Subject|7
4444802|NCT00474383|7229682|FG000|Main Study|Adverse Event|11
4444803|NCT00474383|7229683|FG001|Main Study|Adverse Event|0
4444804|NCT00474383|7229682|FG000|Main Study|Symptomatic Deterioration|1
4444805|NCT00474383|7229683|FG001|Main Study|Symptomatic Deterioration|0
4444806|NCT00474383|7229682|FG000|Main Study|Progressive Disease|23
4444807|NCT00474383|7229683|FG001|Main Study|Progressive Disease|0
4444808|NCT00474383|7229682|FG000|Main Study|Other|1
4444809|NCT00474383|7229683|FG001|Main Study|Other|0
4444810|NCT00474383|7229682|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6
4444811|NCT00474383|7229683|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0
4444812|NCT00474383|7229682|FG000|Extension|Progressive Disease|0
4444813|NCT00474383|7229683|FG001|Extension|Progressive Disease|5
4444814|NCT00474487|7229691|FG000|Overall Study|Withdrawal by Subject|6
4444815|NCT00474487|7229692|FG001|Overall Study|Withdrawal by Subject|0
4444816|NCT00474487|7229693|FG002|Overall Study|Withdrawal by Subject|0
4444817|NCT00474487|7229694|FG003|Overall Study|Withdrawal by Subject|0
4444818|NCT00474487|7229691|FG000|Overall Study|Lost to Follow-up|20
4444819|NCT00474487|7229692|FG001|Overall Study|Lost to Follow-up|1
4444820|NCT00474487|7229693|FG002|Overall Study|Lost to Follow-up|7
4444821|NCT00474487|7229694|FG003|Overall Study|Lost to Follow-up|0
4444822|NCT00474487|7229691|FG000|Overall Study|Inappropriate enrollment|4
4444823|NCT00474487|7229692|FG001|Overall Study|Inappropriate enrollment|0
4444824|NCT00474487|7229693|FG002|Overall Study|Inappropriate enrollment|7
4444825|NCT00474487|7229694|FG003|Overall Study|Inappropriate enrollment|0
4444826|NCT00474487|7229691|FG000|Overall Study|Death|0
4444827|NCT00474487|7229692|FG001|Overall Study|Death|1
4444828|NCT00474487|7229693|FG002|Overall Study|Death|0
4444829|NCT00474487|7229694|FG003|Overall Study|Death|0
4444830|NCT00474526|7229721|FG000|Overall Study|ADMINISTRATIVE REASON|11
4444831|NCT00474526|7229722|FG001|Overall Study|ADMINISTRATIVE REASON|9
4444832|NCT00474526|7229723|FG002|Overall Study|ADMINISTRATIVE REASON|9
4444833|NCT00474526|7229724|FG003|Overall Study|ADMINISTRATIVE REASON|20
4444834|NCT00474526|7229725|FG004|Overall Study|ADMINISTRATIVE REASON|9
4444835|NCT00474526|7229726|FG005|Overall Study|ADMINISTRATIVE REASON|1
4444836|NCT00474526|7229727|FG006|Overall Study|ADMINISTRATIVE REASON|1
4444837|NCT00474526|7229728|FG007|Overall Study|ADMINISTRATIVE REASON|0
4444838|NCT00474526|7229729|FG008|Overall Study|ADMINISTRATIVE REASON|2
4444839|NCT00474526|7229730|FG009|Overall Study|ADMINISTRATIVE REASON|1
4444840|NCT00474526|7229731|FG010|Overall Study|ADMINISTRATIVE REASON|1
4444841|NCT00474526|7229732|FG011|Overall Study|ADMINISTRATIVE REASON|1
4444842|NCT00474526|7229733|FG012|Overall Study|ADMINISTRATIVE REASON|1
4444843|NCT00474526|7229734|FG013|Overall Study|ADMINISTRATIVE REASON|1
4444844|NCT00474526|7229735|FG014|Overall Study|ADMINISTRATIVE REASON|2
4444845|NCT00474526|7229736|FG015|Overall Study|ADMINISTRATIVE REASON|0
4444846|NCT00474526|7229737|FG016|Overall Study|ADMINISTRATIVE REASON|0
4444847|NCT00474526|7229721|FG000|Overall Study|Adverse Event|2
4444848|NCT00474526|7229722|FG001|Overall Study|Adverse Event|0
4444849|NCT00474526|7229723|FG002|Overall Study|Adverse Event|2
4444850|NCT00474526|7229724|FG003|Overall Study|Adverse Event|4
4444851|NCT00474526|7229725|FG004|Overall Study|Adverse Event|2
4444852|NCT00474526|7229726|FG005|Overall Study|Adverse Event|1
4444853|NCT00474526|7229727|FG006|Overall Study|Adverse Event|1
4444854|NCT00474526|7229728|FG007|Overall Study|Adverse Event|0
4444855|NCT00474526|7229729|FG008|Overall Study|Adverse Event|0
4444856|NCT00474526|7229730|FG009|Overall Study|Adverse Event|0
4444857|NCT00474526|7229731|FG010|Overall Study|Adverse Event|0
4444858|NCT00474526|7229732|FG011|Overall Study|Adverse Event|0
4444859|NCT00474526|7229733|FG012|Overall Study|Adverse Event|0
4444860|NCT00474526|7229734|FG013|Overall Study|Adverse Event|0
4444861|NCT00474526|7229735|FG014|Overall Study|Adverse Event|1
4444862|NCT00474526|7229736|FG015|Overall Study|Adverse Event|1
4633324|NCT01910519|7503397|FG000|Overall Study|Adverse Event|2
4444863|NCT00474526|7229737|FG016|Overall Study|Adverse Event|0
4444864|NCT00474526|7229721|FG000|Overall Study|Death|0
4444865|NCT00474526|7229722|FG001|Overall Study|Death|0
4444866|NCT00474526|7229723|FG002|Overall Study|Death|0
4444867|NCT00474526|7229724|FG003|Overall Study|Death|0
4444868|NCT00474526|7229725|FG004|Overall Study|Death|0
4444869|NCT00474526|7229726|FG005|Overall Study|Death|0
4444870|NCT00474526|7229727|FG006|Overall Study|Death|0
4444871|NCT00474526|7229728|FG007|Overall Study|Death|0
4444872|NCT00474526|7229729|FG008|Overall Study|Death|0
4444873|NCT00474526|7229730|FG009|Overall Study|Death|0
4444874|NCT00474526|7229731|FG010|Overall Study|Death|0
4444875|NCT00474526|7229732|FG011|Overall Study|Death|0
4444876|NCT00474526|7229733|FG012|Overall Study|Death|0
4444877|NCT00474526|7229734|FG013|Overall Study|Death|3
4444878|NCT00474526|7229735|FG014|Overall Study|Death|0
4444879|NCT00474526|7229736|FG015|Overall Study|Death|0
4444880|NCT00474526|7229737|FG016|Overall Study|Death|0
4444881|NCT00474526|7229721|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0
4444882|NCT00474526|7229722|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1
4444883|NCT00474526|7229723|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0
4444884|NCT00474526|7229724|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1
4444885|NCT00474526|7229725|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2
4444886|NCT00474526|7229726|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0
4444887|NCT00474526|7229727|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0
4444888|NCT00474526|7229728|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0
4444889|NCT00474526|7229729|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0
4444890|NCT00474526|7229730|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0
4444891|NCT00474526|7229731|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0
4444892|NCT00474526|7229732|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0
4444893|NCT00474526|7229733|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0
4444894|NCT00474526|7229734|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2
4444895|NCT00474526|7229735|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2
4444896|NCT00474526|7229736|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0
4444897|NCT00474526|7229737|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0
4444898|NCT00474526|7229721|FG000|Overall Study|Lost to Follow-up|8
4444899|NCT00474526|7229722|FG001|Overall Study|Lost to Follow-up|6
4444900|NCT00474526|7229723|FG002|Overall Study|Lost to Follow-up|13
4444901|NCT00474526|7229724|FG003|Overall Study|Lost to Follow-up|29
4444902|NCT00474526|7229725|FG004|Overall Study|Lost to Follow-up|11
4444903|NCT00474526|7229726|FG005|Overall Study|Lost to Follow-up|5
4444904|NCT00474526|7229727|FG006|Overall Study|Lost to Follow-up|8
4444905|NCT00474526|7229728|FG007|Overall Study|Lost to Follow-up|1
4444906|NCT00474526|7229729|FG008|Overall Study|Lost to Follow-up|0
4444907|NCT00474526|7229730|FG009|Overall Study|Lost to Follow-up|6
4444908|NCT00474526|7229731|FG010|Overall Study|Lost to Follow-up|2
4444909|NCT00474526|7229732|FG011|Overall Study|Lost to Follow-up|4
4444910|NCT00474526|7229733|FG012|Overall Study|Lost to Follow-up|6
4444911|NCT00474526|7229734|FG013|Overall Study|Lost to Follow-up|74
4444912|NCT00474526|7229735|FG014|Overall Study|Lost to Follow-up|29
4444913|NCT00474526|7229736|FG015|Overall Study|Lost to Follow-up|4
4444914|NCT00474526|7229737|FG016|Overall Study|Lost to Follow-up|5
4444915|NCT00474526|7229721|FG000|Overall Study|Protocol Violation|2
4444916|NCT00474526|7229722|FG001|Overall Study|Protocol Violation|6
4444917|NCT00474526|7229723|FG002|Overall Study|Protocol Violation|4
4444918|NCT00474526|7229724|FG003|Overall Study|Protocol Violation|12
4444919|NCT00474526|7229725|FG004|Overall Study|Protocol Violation|3
4444920|NCT00474526|7229726|FG005|Overall Study|Protocol Violation|1
4444921|NCT00474526|7229727|FG006|Overall Study|Protocol Violation|3
4444922|NCT00474526|7229728|FG007|Overall Study|Protocol Violation|0
4444923|NCT00474526|7229729|FG008|Overall Study|Protocol Violation|0
4444924|NCT00474526|7229730|FG009|Overall Study|Protocol Violation|4
4444925|NCT00474526|7229731|FG010|Overall Study|Protocol Violation|2
4444926|NCT00474526|7229732|FG011|Overall Study|Protocol Violation|2
4444927|NCT00474526|7229733|FG012|Overall Study|Protocol Violation|4
4444928|NCT00474526|7229734|FG013|Overall Study|Protocol Violation|19
4444929|NCT00474526|7229735|FG014|Overall Study|Protocol Violation|9
4444930|NCT00474526|7229736|FG015|Overall Study|Protocol Violation|6
4444931|NCT00474526|7229737|FG016|Overall Study|Protocol Violation|2
4444932|NCT00474526|7229721|FG000|Overall Study|UNABLE TO CLASSIFY|1
4444933|NCT00474526|7229722|FG001|Overall Study|UNABLE TO CLASSIFY|0
4444934|NCT00474526|7229723|FG002|Overall Study|UNABLE TO CLASSIFY|0
4444935|NCT00474526|7229724|FG003|Overall Study|UNABLE TO CLASSIFY|1
4444936|NCT00474526|7229725|FG004|Overall Study|UNABLE TO CLASSIFY|3
4444937|NCT00474526|7229726|FG005|Overall Study|UNABLE TO CLASSIFY|2
4444938|NCT00474526|7229727|FG006|Overall Study|UNABLE TO CLASSIFY|0
4444939|NCT00474526|7229728|FG007|Overall Study|UNABLE TO CLASSIFY|1
4444940|NCT00474526|7229729|FG008|Overall Study|UNABLE TO CLASSIFY|0
4444941|NCT00474526|7229730|FG009|Overall Study|UNABLE TO CLASSIFY|3
4444942|NCT00474526|7229731|FG010|Overall Study|UNABLE TO CLASSIFY|0
4444943|NCT00474526|7229732|FG011|Overall Study|UNABLE TO CLASSIFY|0
4444944|NCT00474526|7229733|FG012|Overall Study|UNABLE TO CLASSIFY|0
4444945|NCT00474526|7229734|FG013|Overall Study|UNABLE TO CLASSIFY|20
4444946|NCT00474526|7229735|FG014|Overall Study|UNABLE TO CLASSIFY|12
4444947|NCT00474526|7229736|FG015|Overall Study|UNABLE TO CLASSIFY|6
4444948|NCT00474526|7229737|FG016|Overall Study|UNABLE TO CLASSIFY|1
4444949|NCT00474526|7229721|FG000|Overall Study|Withdrawal by Subject|9
4444950|NCT00474526|7229722|FG001|Overall Study|Withdrawal by Subject|24
4444951|NCT00474526|7229723|FG002|Overall Study|Withdrawal by Subject|21
4444952|NCT00474526|7229724|FG003|Overall Study|Withdrawal by Subject|52
4444953|NCT00474526|7229725|FG004|Overall Study|Withdrawal by Subject|38
4444954|NCT00474526|7229726|FG005|Overall Study|Withdrawal by Subject|6
4444955|NCT00474526|7229727|FG006|Overall Study|Withdrawal by Subject|12
4444956|NCT00474526|7229728|FG007|Overall Study|Withdrawal by Subject|4
4444957|NCT00474526|7229729|FG008|Overall Study|Withdrawal by Subject|4
4444958|NCT00474526|7229730|FG009|Overall Study|Withdrawal by Subject|13
4444959|NCT00474526|7229731|FG010|Overall Study|Withdrawal by Subject|5
4444960|NCT00474526|7229732|FG011|Overall Study|Withdrawal by Subject|4
4444961|NCT00474526|7229733|FG012|Overall Study|Withdrawal by Subject|4
4444962|NCT00474526|7229734|FG013|Overall Study|Withdrawal by Subject|37
4444963|NCT00474526|7229735|FG014|Overall Study|Withdrawal by Subject|22
4444964|NCT00474526|7229736|FG015|Overall Study|Withdrawal by Subject|1
4444965|NCT00474526|7229737|FG016|Overall Study|Withdrawal by Subject|1
4444966|NCT00474539|7229825|FG000|Infant Series|Withdrawal by Subject|3
4444967|NCT00474539|7229826|FG001|Infant Series|Withdrawal by Subject|4
4444968|NCT00474539|7229825|FG000|Infant Series|Randomization error|5
4444969|NCT00474539|7229826|FG001|Infant Series|Randomization error|0
4444970|NCT00474539|7229825|FG000|Infant Series|Lost to Follow-up|2
4444971|NCT00474539|7229826|FG001|Infant Series|Lost to Follow-up|1
4444972|NCT00474539|7229825|FG000|Infant Series|Protocol Violation|0
4444973|NCT00474539|7229826|FG001|Infant Series|Protocol Violation|1
4444974|NCT00474539|7229825|FG000|After Infant Series|Lost to Follow-up|3
4444975|NCT00474539|7229826|FG001|After Infant Series|Lost to Follow-up|0
4444976|NCT00474539|7229825|FG000|After Infant Series|Withdrawal by Subject|1
4444977|NCT00474539|7229826|FG001|After Infant Series|Withdrawal by Subject|0
4444978|NCT00474539|7229825|FG000|Toddler Dose|Protocol Violation|1
4444979|NCT00474539|7229826|FG001|Toddler Dose|Protocol Violation|0
4444980|NCT00474630|7229872|FG000|Overall Study|Adverse Event|98
4444981|NCT00474630|7229873|FG001|Overall Study|Adverse Event|26
4444982|NCT00474630|7229872|FG000|Overall Study|Lost to Follow-up|22
4444983|NCT00474630|7229873|FG001|Overall Study|Lost to Follow-up|15
4444984|NCT00474630|7229872|FG000|Overall Study|Withdrawal by Subject|21
4444985|NCT00474630|7229873|FG001|Overall Study|Withdrawal by Subject|15
4444986|NCT00474630|7229872|FG000|Overall Study|Protocol Violation|3
4444987|NCT00474630|7229873|FG001|Overall Study|Protocol Violation|4
4444988|NCT00474630|7229872|FG000|Overall Study|Lack of Efficacy|5
4444989|NCT00474630|7229873|FG001|Overall Study|Lack of Efficacy|6
4444990|NCT00474630|7229872|FG000|Overall Study|Drug noncompliance, other|11
4444991|NCT00474630|7229873|FG001|Overall Study|Drug noncompliance, other|4
4444992|NCT00474708|7229882|FG000|Overall Study|Lack of Efficacy|11
4444993|NCT00474708|7229883|FG001|Overall Study|Lack of Efficacy|5
4444994|NCT00474708|7229882|FG000|Overall Study|Suicide ideation/behavior|0
4444995|NCT00474708|7229883|FG001|Overall Study|Suicide ideation/behavior|1
4444996|NCT00474708|7229882|FG000|Overall Study|Withdrawal by Subject|7
4444997|NCT00474708|7229883|FG001|Overall Study|Withdrawal by Subject|0
4444998|NCT00474708|7229882|FG000|Overall Study|Lack of compliance|12
4444999|NCT00474708|7229883|FG001|Overall Study|Lack of compliance|4
4445000|NCT00474708|7229882|FG000|Overall Study|Lost to Follow-up|18
4445001|NCT00474708|7229883|FG001|Overall Study|Lost to Follow-up|9
4445002|NCT00474708|7229882|FG000|Overall Study|Physician Decision|9
4445003|NCT00474708|7229883|FG001|Overall Study|Physician Decision|6
4445004|NCT00474760|7229896|FG000|Overall Study|Death|0
4445005|NCT00474760|7229897|FG001|Overall Study|Death|0
4445006|NCT00474760|7229898|FG002|Overall Study|Death|0
4445007|NCT00474760|7229899|FG003|Overall Study|Death|0
4445008|NCT00474760|7229900|FG004|Overall Study|Death|2
4445009|NCT00474760|7229901|FG005|Overall Study|Death|0
4445010|NCT00474760|7229902|FG006|Overall Study|Death|0
4445011|NCT00474760|7229896|FG000|Overall Study|Adverse Event|0
4445012|NCT00474760|7229897|FG001|Overall Study|Adverse Event|0
4445013|NCT00474760|7229898|FG002|Overall Study|Adverse Event|0
4445014|NCT00474760|7229899|FG003|Overall Study|Adverse Event|0
4445015|NCT00474760|7229900|FG004|Overall Study|Adverse Event|1
4445016|NCT00474760|7229901|FG005|Overall Study|Adverse Event|7
4445017|NCT00474760|7229902|FG006|Overall Study|Adverse Event|0
4445018|NCT00474760|7229896|FG000|Overall Study|Laboratory abnormality|0
4445019|NCT00474760|7229897|FG001|Overall Study|Laboratory abnormality|0
4445020|NCT00474760|7229898|FG002|Overall Study|Laboratory abnormality|0
4445021|NCT00474760|7229899|FG003|Overall Study|Laboratory abnormality|0
4445022|NCT00474760|7229900|FG004|Overall Study|Laboratory abnormality|0
4445023|NCT00474760|7229901|FG005|Overall Study|Laboratory abnormality|1
4445024|NCT00474760|7229902|FG006|Overall Study|Laboratory abnormality|0
4445025|NCT00474760|7229896|FG000|Overall Study|Withdrawal by Subject|0
4445026|NCT00474760|7229897|FG001|Overall Study|Withdrawal by Subject|0
4445027|NCT00474760|7229898|FG002|Overall Study|Withdrawal by Subject|0
4445028|NCT00474760|7229899|FG003|Overall Study|Withdrawal by Subject|1
4445029|NCT00474760|7229900|FG004|Overall Study|Withdrawal by Subject|0
4445030|NCT00474760|7229901|FG005|Overall Study|Withdrawal by Subject|1
4445031|NCT00474760|7229902|FG006|Overall Study|Withdrawal by Subject|1
4445032|NCT00474760|7229896|FG000|Overall Study|Other|0
4445033|NCT00474760|7229897|FG001|Overall Study|Other|1
4445034|NCT00474760|7229898|FG002|Overall Study|Other|0
4445035|NCT00474760|7229899|FG003|Overall Study|Other|0
4445036|NCT00474760|7229900|FG004|Overall Study|Other|1
4445037|NCT00474760|7229901|FG005|Overall Study|Other|0
4513007|NCT00939341|7323196|FG000|Overall Study|Withdrawal by Subject|13
4445038|NCT00474760|7229902|FG006|Overall Study|Other|0
4445039|NCT00474760|7229896|FG000|Overall Study|Progressive disease|3
4445040|NCT00474760|7229897|FG001|Overall Study|Progressive disease|2
4445041|NCT00474760|7229898|FG002|Overall Study|Progressive disease|3
4445042|NCT00474760|7229899|FG003|Overall Study|Progressive disease|2
4445043|NCT00474760|7229900|FG004|Overall Study|Progressive disease|8
4445044|NCT00474760|7229901|FG005|Overall Study|Progressive disease|20
4445045|NCT00474760|7229902|FG006|Overall Study|Progressive disease|7
4445046|NCT00474760|7229896|FG000|Overall Study|Terminated by sponsor|0
4445047|NCT00474760|7229897|FG001|Overall Study|Terminated by sponsor|0
4445048|NCT00474760|7229898|FG002|Overall Study|Terminated by sponsor|0
4445049|NCT00474760|7229899|FG003|Overall Study|Terminated by sponsor|0
4445050|NCT00474760|7229900|FG004|Overall Study|Terminated by sponsor|0
4445051|NCT00474760|7229901|FG005|Overall Study|Terminated by sponsor|0
4445052|NCT00474760|7229902|FG006|Overall Study|Terminated by sponsor|2
4445053|NCT00474786|7229927|FG000|Overall Study|Not Meeting Study Criteria|0
4445054|NCT00474786|7229928|FG001|Overall Study|Not Meeting Study Criteria|1
4445055|NCT00474786|7229927|FG000|Overall Study|Investigator Request|2
4445056|NCT00474786|7229928|FG001|Overall Study|Investigator Request|1
4445057|NCT00474786|7229927|FG000|Overall Study|Death|189
4445058|NCT00474786|7229928|FG001|Overall Study|Death|170
4445059|NCT00474786|7229927|FG000|Overall Study|Discontinuation of Study by Sponsor|42
4445060|NCT00474786|7229928|FG001|Overall Study|Discontinuation of Study by Sponsor|59
4445061|NCT00474786|7229927|FG000|Overall Study|Lost to Follow-up|4
4445062|NCT00474786|7229928|FG001|Overall Study|Lost to Follow-up|7
4445063|NCT00474786|7229927|FG000|Overall Study|Protocol Violation|2
4445064|NCT00474786|7229928|FG001|Overall Study|Protocol Violation|0
4445065|NCT00474786|7229927|FG000|Overall Study|Withdrawal by Subject|15
4445066|NCT00474786|7229928|FG001|Overall Study|Withdrawal by Subject|15
4445067|NCT00474786|7229927|FG000|Overall Study|Other|5
4445068|NCT00474786|7229928|FG001|Overall Study|Other|0
4445069|NCT00474812|7229934|FG000|Overall Study|Withdrawal by Subject|5
4445070|NCT00474812|7229934|FG000|Overall Study|No Initiation of treatment|2
4445071|NCT00474903|7229951|FG000|Overall Study|Protocol Violation|1
4445072|NCT00474903|7229952|FG001|Overall Study|Protocol Violation|5
4445073|NCT00474903|7229953|FG002|Overall Study|Protocol Violation|2
4445074|NCT00474929|7229966|FG000|Overall Study|Withdrawal by Subject|0
4445075|NCT00474929|7229967|FG001|Overall Study|Withdrawal by Subject|1
4445076|NCT00474929|7229968|FG002|Overall Study|Withdrawal by Subject|0
4445077|NCT00474929|7229969|FG003|Overall Study|Withdrawal by Subject|0
4445078|NCT00474929|7229970|FG004|Overall Study|Withdrawal by Subject|0
4445079|NCT00474929|7229966|FG000|Overall Study|Unrelated medical condition|0
4445080|NCT00474929|7229967|FG001|Overall Study|Unrelated medical condition|0
4445081|NCT00474929|7229968|FG002|Overall Study|Unrelated medical condition|1
4445082|NCT00474929|7229969|FG003|Overall Study|Unrelated medical condition|0
4445083|NCT00474929|7229970|FG004|Overall Study|Unrelated medical condition|0
4445084|NCT00474929|7229966|FG000|Overall Study|Physician Decision|0
4445085|NCT00474929|7229967|FG001|Overall Study|Physician Decision|0
4445086|NCT00474929|7229968|FG002|Overall Study|Physician Decision|1
4445087|NCT00474929|7229969|FG003|Overall Study|Physician Decision|2
4445088|NCT00474929|7229970|FG004|Overall Study|Physician Decision|0
4445089|NCT00474955|7229983|FG000|Overall Study|Adverse Event|2
4445090|NCT00474955|7229983|FG000|Overall Study|Drug unavailability|1
4445091|NCT00474955|7229983|FG000|Overall Study|Personal reasons|5
4445092|NCT00474968|7229989|FG000|Overall Study|Withdrawal by Subject|8
4445093|NCT00474968|7229990|FG001|Overall Study|Withdrawal by Subject|7
4445094|NCT00474968|7229989|FG000|Overall Study|Protocol Violation|9
4445095|NCT00474968|7229990|FG001|Overall Study|Protocol Violation|8
4445096|NCT00474968|7229989|FG000|Overall Study|Sample not collected|1
4445097|NCT00474968|7229990|FG001|Overall Study|Sample not collected|1
4445098|NCT00474994|7229996|FG000|Overall Study|Patient Not treated|1
4445099|NCT00474994|7229996|FG000|Overall Study|Patient evaluable for toxicity only|3
4445100|NCT00474994|7229996|FG000|Overall Study|Patient found to be ineligible|1
4445101|NCT00475020|7230000|FG000|Overall Study|Physician Decision|3
4445102|NCT00475020|7230000|FG000|Overall Study|Insurance Denial|1
4445103|NCT00475020|7230000|FG000|Overall Study|Donor not able to donate the last minute|1
4445104|NCT00475033|7230006|FG000|Infant Series|Failed to return|3
4445105|NCT00475033|7230007|FG001|Infant Series|Failed to return|4
4445106|NCT00475033|7230006|FG000|Infant Series|Parent or legal guardian request|1
4445107|NCT00475033|7230007|FG001|Infant Series|Parent or legal guardian request|5
4445108|NCT00475033|7230006|FG000|Infant Series|Protocol Violation|1
4445109|NCT00475033|7230007|FG001|Infant Series|Protocol Violation|2
4445110|NCT00475033|7230006|FG000|Infant Series|Lost to Follow-up|2
4445111|NCT00475033|7230007|FG001|Infant Series|Lost to Follow-up|0
4445112|NCT00475033|7230006|FG000|Infant Series|Adverse Event|0
4445113|NCT00475033|7230007|FG001|Infant Series|Adverse Event|2
4445114|NCT00475033|7230006|FG000|After the Infant Series|Adverse Event|0
4445115|NCT00475033|7230007|FG001|After the Infant Series|Adverse Event|4
4445116|NCT00475033|7230006|FG000|After the Infant Series|Parent or legal guardian request|2
4445117|NCT00475033|7230007|FG001|After the Infant Series|Parent or legal guardian request|2
4445118|NCT00475033|7230006|FG000|After the Infant Series|Failed to return|2
4445119|NCT00475033|7230007|FG001|After the Infant Series|Failed to return|1
4445120|NCT00475033|7230006|FG000|After the Infant Series|Protocol Violation|1
4445121|NCT00475033|7230007|FG001|After the Infant Series|Protocol Violation|0
4445122|NCT00475033|7230006|FG000|After the Infant Series|Lost to Follow-up|1
4445123|NCT00475033|7230007|FG001|After the Infant Series|Lost to Follow-up|0
4445124|NCT00475033|7230006|FG000|After the Infant Series|Other|0
4445125|NCT00475033|7230007|FG001|After the Infant Series|Other|1
4445126|NCT00475033|7230006|FG000|Toddler Dose|Parent or legal guardian request|2
4445127|NCT00475033|7230007|FG001|Toddler Dose|Parent or legal guardian request|0
4445128|NCT00475033|7230006|FG000|Toddler Dose|Failed to return|1
4445129|NCT00475033|7230007|FG001|Toddler Dose|Failed to return|0
4445130|NCT00475033|7230006|FG000|Toddler Dose|Lost to Follow-up|1
4445131|NCT00475033|7230007|FG001|Toddler Dose|Lost to Follow-up|0
4445132|NCT00475176|7230045|FG000|Overall Study|Adverse Event|2
4445133|NCT00475176|7230045|FG000|Overall Study|Withdrawal by Subject|1
4445134|NCT00475176|7230045|FG000|Overall Study|Protocol Violation|1
4445135|NCT00475228|7230060|FG000|Overall Study|Lost to Follow-up|17
4445136|NCT00475228|7230061|FG001|Overall Study|Lost to Follow-up|17
4445137|NCT00475306|7230085|FG000|Overall Study|Protocol Violation|1
4445138|NCT00475306|7230086|FG001|Overall Study|Protocol Violation|1
4445139|NCT00475306|7230087|FG002|Overall Study|Protocol Violation|0
4445140|NCT00475306|7230088|FG003|Overall Study|Protocol Violation|1
4445141|NCT00475423|7230114|FG000|Overall Study|Protocol Violation|5
4445142|NCT00475423|7230114|FG000|Overall Study|Adverse Event|4
4445143|NCT00475423|7230114|FG000|Overall Study|Withdrawal by Subject|6
4445144|NCT00475423|7230114|FG000|Overall Study|Lack of Efficacy|8
4445145|NCT00475423|7230114|FG000|Overall Study|Death|1
4445146|NCT00475423|7230114|FG000|Overall Study|Reason not specified|1
4445147|NCT00475423|7230114|FG000|Overall Study|Lost to Follow-up|7
4513008|NCT00939341|7323196|FG000|Overall Study|Protocol Violation|6
4513009|NCT00939341|7323196|FG000|Overall Study|Incorrect enrolment|8
4513010|NCT00939393|7323209|FG000|Overall Study|Withdrawal by Subject|1
4513011|NCT00939393|7323210|FG001|Overall Study|Withdrawal by Subject|0
4513012|NCT00939393|7323209|FG000|Overall Study|Lost to Follow-up|3
4513013|NCT00939393|7323210|FG001|Overall Study|Lost to Follow-up|0
4513014|NCT00939484|7323225|FG000|Overall Study|Progression/Relapse|8
4513015|NCT00939484|7323226|FG001|Overall Study|Progression/Relapse|20
4513016|NCT00939484|7323227|FG002|Overall Study|Progression/Relapse|3
4513017|NCT00939510|7323237|FG000|Overall Study|Withdrawal by Subject|1
4513018|NCT00939523|7323241|FG000|Overall Study|Lack of Efficacy|1
4513019|NCT00939523|7323241|FG000|Overall Study|Physician Decision|2
4513020|NCT00939627|7323263|FG000|Overall Study|Disease Progression|16
4513021|NCT00939627|7323264|FG001|Overall Study|Disease Progression|12
4513022|NCT00939627|7323265|FG002|Overall Study|Disease Progression|0
4513023|NCT00939627|7323263|FG000|Overall Study|Adverse Event|6
4513024|NCT00939627|7323264|FG001|Overall Study|Adverse Event|7
4513025|NCT00939627|7323265|FG002|Overall Study|Adverse Event|0
4513026|NCT00939627|7323263|FG000|Overall Study|Death|0
4513027|NCT00939627|7323264|FG001|Overall Study|Death|2
4513028|NCT00939627|7323265|FG002|Overall Study|Death|0
4513029|NCT00939627|7323263|FG000|Overall Study|Withdrawal by Subject|2
4513030|NCT00939627|7323264|FG001|Overall Study|Withdrawal by Subject|4
4513031|NCT00939627|7323265|FG002|Overall Study|Withdrawal by Subject|0
4513032|NCT00939627|7323263|FG000|Overall Study|Other complicating disease|1
4513033|NCT00939627|7323264|FG001|Overall Study|Other complicating disease|1
4513034|NCT00939627|7323265|FG002|Overall Study|Other complicating disease|0
4513035|NCT00939627|7323263|FG000|Overall Study|Not compliant|2
4513036|NCT00939627|7323264|FG001|Overall Study|Not compliant|0
4513037|NCT00939627|7323265|FG002|Overall Study|Not compliant|0
4513038|NCT00939627|7323263|FG000|Overall Study|No off-tx reason given|0
4716476|NCT02993224|7645838|FG000|Core Phase - Period 1|Withdrawal by Subject|1
4716477|NCT02993224|7645838|FG000|Core Phase - Period 1|Lost to Follow-up|3
4716478|NCT02993224|7645838|FG000|Core Phase- Period 2|Adverse Event|1
4716479|NCT02993224|7645838|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2
4716480|NCT02993224|7645838|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1
4716481|NCT02993224|7645838|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1
4716482|NCT02993224|7645838|FG000|Extension Phase|Adverse Event|3
4716483|NCT02993224|7645838|FG000|Extension Phase|Withdrawal by Subject|3
4716484|NCT02993224|7645838|FG000|Extension Phase|Lost to Follow-up|2
4716485|NCT02993224|7645838|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27
4716486|NCT02993250|7645846|FG000|Overall Study|Lost to Follow-up|0
4716487|NCT02993250|7645847|FG001|Overall Study|Lost to Follow-up|1
4736203|NCT03560518|7685156|FG000|Double Blind Treatment Period|Lost to Follow-up|5
4736204|NCT03560518|7685157|FG001|Double Blind Treatment Period|Lost to Follow-up|6
4736205|NCT03560518|7685158|FG002|Double Blind Treatment Period|Lost to Follow-up|6
4513039|NCT00939627|7323264|FG001|Overall Study|No off-tx reason given|2
4513040|NCT00939627|7323265|FG002|Overall Study|No off-tx reason given|0
4513041|NCT00939640|7323271|FG000|Overall Study|Physician Decision|1
4513042|NCT00939692|7323287|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1
4513043|NCT00939692|7323288|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0
4513044|NCT00939692|7323287|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0
4513045|NCT00939692|7323288|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1
4513046|NCT00939770|7323318|FG000|Overall Study|Adverse Event|1
4513047|NCT00939770|7323319|FG001|Overall Study|Adverse Event|1
4513048|NCT00939770|7323320|FG002|Overall Study|Adverse Event|0
4513049|NCT00939770|7323321|FG003|Overall Study|Adverse Event|0
4513050|NCT00939770|7323322|FG004|Overall Study|Adverse Event|6
4445148|NCT00475644|7230167|FG000|Overall Study|Protocol Violation|13
4445149|NCT00475670|7230173|FG000|Overall Study|Death|0
4445150|NCT00475670|7230174|FG001|Overall Study|Death|1
4445151|NCT00475670|7230173|FG000|Overall Study|Lack of Efficacy|3
4445152|NCT00475670|7230174|FG001|Overall Study|Lack of Efficacy|34
4445153|NCT00475670|7230173|FG000|Overall Study|Refused treatment|0
4445154|NCT00475670|7230174|FG001|Overall Study|Refused treatment|2
4445155|NCT00475670|7230173|FG000|Overall Study|Failure to Return|0
4445156|NCT00475670|7230174|FG001|Overall Study|Failure to Return|1
4445157|NCT00475670|7230173|FG000|Overall Study|Other|0
4445158|NCT00475670|7230174|FG001|Overall Study|Other|3
4445159|NCT00475709|7230180|FG000|Overall Study|Did not meet eligibility criteria|8
4445160|NCT00475709|7230180|FG000|Overall Study|Death|41
4445161|NCT00475709|7230180|FG000|Overall Study|Device Explant|6
4445162|NCT00475709|7230180|FG000|Overall Study|Lost to Follow-up|21
4445163|NCT00475722|7230186|FG000|Overall Study|Withdrawal by Subject|12
4445164|NCT00475722|7230187|FG001|Overall Study|Withdrawal by Subject|12
4445165|NCT00475722|7230186|FG000|Overall Study|Protocol Violation|3
4445166|NCT00475722|7230187|FG001|Overall Study|Protocol Violation|0
4445167|NCT00475735|7230199|FG000|Treatment Period 1|Adverse Event|2
4445168|NCT00475735|7230200|FG001|Treatment Period 1|Adverse Event|0
4445169|NCT00475735|7230201|FG002|Treatment Period 1|Adverse Event|0
4445170|NCT00475735|7230202|FG003|Treatment Period 1|Adverse Event|0
4445171|NCT00475735|7230203|FG004|Treatment Period 1|Adverse Event|0
4445172|NCT00475735|7230204|FG005|Treatment Period 1|Adverse Event|0
4445173|NCT00475735|7230199|FG000|Treatment Period 1|Lack of Efficacy|1
4445174|NCT00475735|7230200|FG001|Treatment Period 1|Lack of Efficacy|0
4445175|NCT00475735|7230201|FG002|Treatment Period 1|Lack of Efficacy|0
4445176|NCT00475735|7230202|FG003|Treatment Period 1|Lack of Efficacy|0
4445177|NCT00475735|7230203|FG004|Treatment Period 1|Lack of Efficacy|0
4445178|NCT00475735|7230204|FG005|Treatment Period 1|Lack of Efficacy|0
4445179|NCT00475735|7230199|FG000|Treatment Period 1|Lost to Follow-up|0
4445180|NCT00475735|7230200|FG001|Treatment Period 1|Lost to Follow-up|0
4445181|NCT00475735|7230201|FG002|Treatment Period 1|Lost to Follow-up|0
4445182|NCT00475735|7230202|FG003|Treatment Period 1|Lost to Follow-up|0
4445183|NCT00475735|7230203|FG004|Treatment Period 1|Lost to Follow-up|0
4445184|NCT00475735|7230204|FG005|Treatment Period 1|Lost to Follow-up|1
4445185|NCT00475735|7230199|FG000|Treatment Period 1|Protocol Violation|0
4445186|NCT00475735|7230200|FG001|Treatment Period 1|Protocol Violation|0
4445187|NCT00475735|7230201|FG002|Treatment Period 1|Protocol Violation|0
4445188|NCT00475735|7230202|FG003|Treatment Period 1|Protocol Violation|1
4445189|NCT00475735|7230203|FG004|Treatment Period 1|Protocol Violation|0
4445190|NCT00475735|7230204|FG005|Treatment Period 1|Protocol Violation|0
4445191|NCT00475735|7230199|FG000|Treatment Period 1|Withdrawal by Subject|1
4445192|NCT00475735|7230200|FG001|Treatment Period 1|Withdrawal by Subject|1
4445193|NCT00475735|7230201|FG002|Treatment Period 1|Withdrawal by Subject|0
4445194|NCT00475735|7230202|FG003|Treatment Period 1|Withdrawal by Subject|0
4445195|NCT00475735|7230203|FG004|Treatment Period 1|Withdrawal by Subject|0
4445196|NCT00475735|7230204|FG005|Treatment Period 1|Withdrawal by Subject|0
4445197|NCT00475735|7230199|FG000|Treatment Period 1|DC due to AE but continuing|0
4445198|NCT00475735|7230200|FG001|Treatment Period 1|DC due to AE but continuing|0
4445199|NCT00475735|7230201|FG002|Treatment Period 1|DC due to AE but continuing|0
4445200|NCT00475735|7230202|FG003|Treatment Period 1|DC due to AE but continuing|1
4445201|NCT00475735|7230203|FG004|Treatment Period 1|DC due to AE but continuing|2
4445202|NCT00475735|7230204|FG005|Treatment Period 1|DC due to AE but continuing|2
4445203|NCT00475735|7230199|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0
4445204|NCT00475735|7230200|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1
4445205|NCT00475735|7230201|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0
4445206|NCT00475735|7230202|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0
4445207|NCT00475735|7230203|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0
4445208|NCT00475735|7230204|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0
4445209|NCT00475735|7230199|FG000|Treatment Washout|Lost to Follow-up|0
4445210|NCT00475735|7230200|FG001|Treatment Washout|Lost to Follow-up|1
4445211|NCT00475735|7230201|FG002|Treatment Washout|Lost to Follow-up|0
4445212|NCT00475735|7230202|FG003|Treatment Washout|Lost to Follow-up|0
4445213|NCT00475735|7230203|FG004|Treatment Washout|Lost to Follow-up|0
4445214|NCT00475735|7230204|FG005|Treatment Washout|Lost to Follow-up|0
4445215|NCT00475735|7230199|FG000|Treatment Washout|Protocol Violation|0
4445216|NCT00475735|7230200|FG001|Treatment Washout|Protocol Violation|1
4445217|NCT00475735|7230201|FG002|Treatment Washout|Protocol Violation|0
4445218|NCT00475735|7230202|FG003|Treatment Washout|Protocol Violation|0
4445219|NCT00475735|7230203|FG004|Treatment Washout|Protocol Violation|0
4445220|NCT00475735|7230204|FG005|Treatment Washout|Protocol Violation|0
4445221|NCT00475735|7230199|FG000|Treatment Period 2|Adverse Event|0
4445222|NCT00475735|7230200|FG001|Treatment Period 2|Adverse Event|1
4445223|NCT00475735|7230201|FG002|Treatment Period 2|Adverse Event|0
4445224|NCT00475735|7230202|FG003|Treatment Period 2|Adverse Event|2
4445225|NCT00475735|7230203|FG004|Treatment Period 2|Adverse Event|0
4445226|NCT00475735|7230204|FG005|Treatment Period 2|Adverse Event|0
4445227|NCT00475735|7230199|FG000|Treatment Period 2|Lack of Efficacy|0
4445228|NCT00475735|7230200|FG001|Treatment Period 2|Lack of Efficacy|0
4445229|NCT00475735|7230201|FG002|Treatment Period 2|Lack of Efficacy|0
4445230|NCT00475735|7230202|FG003|Treatment Period 2|Lack of Efficacy|0
4445231|NCT00475735|7230203|FG004|Treatment Period 2|Lack of Efficacy|0
4445232|NCT00475735|7230204|FG005|Treatment Period 2|Lack of Efficacy|1
4445233|NCT00475735|7230199|FG000|Treatment Period 2|Withdrawal by Subject|0
4445234|NCT00475735|7230200|FG001|Treatment Period 2|Withdrawal by Subject|0
4445235|NCT00475735|7230201|FG002|Treatment Period 2|Withdrawal by Subject|0
4445236|NCT00475735|7230202|FG003|Treatment Period 2|Withdrawal by Subject|0
4445237|NCT00475735|7230203|FG004|Treatment Period 2|Withdrawal by Subject|1
4445238|NCT00475735|7230204|FG005|Treatment Period 2|Withdrawal by Subject|0
4445239|NCT00475852|7230225|FG000|Overall Study|Death|444
4445240|NCT00475852|7230226|FG001|Overall Study|Death|456
4445241|NCT00475852|7230225|FG000|Overall Study|Withdrawal by Subject|19
4445242|NCT00475852|7230226|FG001|Overall Study|Withdrawal by Subject|24
4445243|NCT00475852|7230225|FG000|Overall Study|Lost to Follow-up|54
4445244|NCT00475852|7230226|FG001|Overall Study|Lost to Follow-up|68
4445245|NCT00475865|7230235|FG000|Overall Study|Adverse Event|0
4445246|NCT00475865|7230236|FG001|Overall Study|Adverse Event|3
4445247|NCT00475865|7230237|FG002|Overall Study|Adverse Event|4
4445248|NCT00475865|7230235|FG000|Overall Study|Lack of Efficacy|1
4445249|NCT00475865|7230236|FG001|Overall Study|Lack of Efficacy|0
4445250|NCT00475865|7230237|FG002|Overall Study|Lack of Efficacy|0
4445251|NCT00475865|7230235|FG000|Overall Study|Progressive disease|0
4445252|NCT00475865|7230236|FG001|Overall Study|Progressive disease|1
4445253|NCT00475865|7230237|FG002|Overall Study|Progressive disease|2
4445254|NCT00475865|7230235|FG000|Overall Study|Participant did not wish to continue|1
4445255|NCT00475865|7230236|FG001|Overall Study|Participant did not wish to continue|0
4445256|NCT00475865|7230237|FG002|Overall Study|Participant did not wish to continue|0
4445257|NCT00475865|7230235|FG000|Overall Study|Other than above|0
4445258|NCT00475865|7230236|FG001|Overall Study|Other than above|1
4445259|NCT00475865|7230237|FG002|Overall Study|Other than above|0
4445260|NCT00475982|7230273|FG000|Overall Study|surgery rescheduled|7
4445261|NCT00475982|7230274|FG001|Overall Study|surgery rescheduled|3
4445262|NCT00476008|7230282|FG000|Overall Study|Adverse Event|4
4445263|NCT00476008|7230283|FG001|Overall Study|Adverse Event|4
4445264|NCT00476008|7230282|FG000|Overall Study|Placebo concerns|2
4445265|NCT00476008|7230283|FG001|Overall Study|Placebo concerns|2
4445266|NCT00476008|7230282|FG000|Overall Study|Physician Decision: Medication Noncompli|2
4445267|NCT00476008|7230283|FG001|Overall Study|Physician Decision: Medication Noncompli|1
4445268|NCT00476008|7230282|FG000|Overall Study|Withdrawal by Subject|0
4445269|NCT00476008|7230283|FG001|Overall Study|Withdrawal by Subject|1
4445270|NCT00476008|7230282|FG000|Overall Study|Death|1
4445271|NCT00476008|7230283|FG001|Overall Study|Death|0
4445272|NCT00476047|7230308|FG000|Overall Study|Lost to Follow-up|1
4445273|NCT00476086|7230314|FG000|Overall Study|Alternative therapy|1
4445274|NCT00476086|7230314|FG000|Overall Study|Progressive Disease|4
4445275|NCT00476151|7230322|FG000|Overall Study|Adverse Event|0
4445276|NCT00476151|7230323|FG001|Overall Study|Adverse Event|2
4445277|NCT00476151|7230322|FG000|Overall Study|Protocol Violation|1
4445278|NCT00476151|7230323|FG001|Overall Study|Protocol Violation|3
4445279|NCT00476151|7230322|FG000|Overall Study|Withdrawal by Subject|2
4445280|NCT00476151|7230323|FG001|Overall Study|Withdrawal by Subject|0
4445281|NCT00476151|7230322|FG000|Overall Study|Physician Decision|0
4445282|NCT00476151|7230323|FG001|Overall Study|Physician Decision|2
4445283|NCT00476229|7230329|FG000|Overall Study|Progressive shortness of breath|1
4445284|NCT00476476|7230346|FG000|Overall Study|Adverse Event|2
4445285|NCT00476476|7230347|FG001|Overall Study|Adverse Event|7
4445286|NCT00476476|7230346|FG000|Overall Study|Progressive Disease|0
4445287|NCT00476476|7230347|FG001|Overall Study|Progressive Disease|17
4445288|NCT00476593|7230356|FG000|Overall Study|Lost to Follow-up|10
4445289|NCT00476593|7230357|FG001|Overall Study|Lost to Follow-up|2
4445290|NCT00476593|7230358|FG002|Overall Study|Lost to Follow-up|8
4445291|NCT00476593|7230359|FG003|Overall Study|Lost to Follow-up|22
4445292|NCT00476957|7230379|FG000|Overall Study|Lost to Follow-up|176
4445293|NCT00476957|7230380|FG001|Overall Study|Lost to Follow-up|193
4445294|NCT00476996|7230389|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12
4445295|NCT00476996|7230390|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7
4445296|NCT00476996|7230391|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7
4445297|NCT00476996|7230392|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0
4445298|NCT00476996|7230389|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1
4445299|NCT00476996|7230390|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3
4445300|NCT00476996|7230391|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0
4445301|NCT00476996|7230392|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0
4445302|NCT00476996|7230389|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24
4445303|NCT00476996|7230390|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20
4445304|NCT00476996|7230391|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21
4445305|NCT00476996|7230392|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0
4445306|NCT00476996|7230389|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0
4445307|NCT00476996|7230390|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2
4445308|NCT00476996|7230391|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0
4513051|NCT00939770|7323323|FG005|Overall Study|Adverse Event|2
4445309|NCT00476996|7230392|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0
4445310|NCT00476996|7230389|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0
4445311|NCT00476996|7230390|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4
4445312|NCT00476996|7230391|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3
4445313|NCT00476996|7230392|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0
4445314|NCT00476996|7230389|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22
4445315|NCT00476996|7230390|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5
4445316|NCT00476996|7230391|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6
4445317|NCT00476996|7230392|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0
4445318|NCT00476996|7230389|FG000|Blinded Treatment Phase (up to Week 48)|Death|2
4445319|NCT00476996|7230390|FG001|Blinded Treatment Phase (up to Week 48)|Death|1
4445320|NCT00476996|7230391|FG002|Blinded Treatment Phase (up to Week 48)|Death|1
4445321|NCT00476996|7230392|FG003|Blinded Treatment Phase (up to Week 48)|Death|0
4445322|NCT00476996|7230389|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11
4445323|NCT00476996|7230390|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13
4445324|NCT00476996|7230391|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7
4445325|NCT00476996|7230392|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0
4445326|NCT00476996|7230389|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0
4445327|NCT00476996|7230390|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0
4445328|NCT00476996|7230391|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0
4445329|NCT00476996|7230392|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50
4445330|NCT00476996|7230389|FG000|OLE Phase (From Week 48)|Adverse Event|0
4445331|NCT00476996|7230390|FG001|OLE Phase (From Week 48)|Adverse Event|0
4445332|NCT00476996|7230391|FG002|OLE Phase (From Week 48)|Adverse Event|0
4445333|NCT00476996|7230392|FG003|OLE Phase (From Week 48)|Adverse Event|8
4445334|NCT00476996|7230389|FG000|OLE Phase (From Week 48)|Death|0
4445335|NCT00476996|7230390|FG001|OLE Phase (From Week 48)|Death|0
4445336|NCT00476996|7230391|FG002|OLE Phase (From Week 48)|Death|0
4445337|NCT00476996|7230392|FG003|OLE Phase (From Week 48)|Death|7
4445338|NCT00476996|7230389|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0
4445339|NCT00476996|7230390|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0
4445340|NCT00476996|7230391|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0
4445341|NCT00476996|7230392|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13
4445342|NCT00476996|7230389|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0
4445343|NCT00476996|7230390|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0
4445344|NCT00476996|7230391|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0
4445345|NCT00476996|7230392|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4
4445346|NCT00476996|7230389|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0
4445347|NCT00476996|7230390|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0
4445348|NCT00476996|7230391|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0
4445349|NCT00476996|7230392|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4
4445350|NCT00476996|7230389|FG000|OLE Phase (From Week 48)|Early termination of the study|0
4445351|NCT00476996|7230390|FG001|OLE Phase (From Week 48)|Early termination of the study|0
4445352|NCT00476996|7230391|FG002|OLE Phase (From Week 48)|Early termination of the study|0
4445353|NCT00476996|7230392|FG003|OLE Phase (From Week 48)|Early termination of the study|578
4445354|NCT00477152|7230405|FG000|Overall Study|Parent withdrew consent|2
4445355|NCT00477152|7230405|FG000|Overall Study|Adverse Event|1
4445356|NCT00477165|7230411|FG000|Overall Study|Adverse Event|7
4445357|NCT00477165|7230412|FG001|Overall Study|Adverse Event|2
4445358|NCT00477269|7230433|FG000|Core Study|Adverse Event|6
4445359|NCT00477269|7230434|FG001|Core Study|Adverse Event|4
4445360|NCT00477269|7230435|FG002|Core Study|Adverse Event|0
4445361|NCT00477269|7230433|FG000|Core Study|Death|3
4445362|NCT00477269|7230434|FG001|Core Study|Death|3
4716488|NCT02993471|7645871|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1
4716489|NCT02993471|7645871|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1
4716490|NCT02993783|7645895|FG000|Overall Study|Reason not Specified|6
4716491|NCT02993783|7645896|FG001|Overall Study|Reason not Specified|9
4716492|NCT02994056|7645902|FG000|Overall Study|Death|8
4716493|NCT02994056|7645902|FG000|Overall Study|Withdrew Consent|1
4716494|NCT02994108|7645917|FG000|Intervention Messages|Withdrawal by Subject|2
4716495|NCT02994108|7645918|FG001|Intervention Messages|Withdrawal by Subject|0
4716496|NCT02994108|7645917|FG000|Phase 1 Assessment|Lost to Follow-up|5
4445363|NCT00477269|7230435|FG002|Core Study|Death|0
4445364|NCT00477269|7230433|FG000|Core Study|Withdrawn Consent|0
4445365|NCT00477269|7230434|FG001|Core Study|Withdrawn Consent|1
4445366|NCT00477269|7230435|FG002|Core Study|Withdrawn Consent|0
4445367|NCT00477269|7230433|FG000|Open Label Extension|Adverse Event|0
4716497|NCT02994108|7645918|FG001|Phase 1 Assessment|Lost to Follow-up|3
4716498|NCT02994108|7645917|FG000|Phase 2 Assessment|Lost to Follow-up|8
4716499|NCT02994108|7645918|FG001|Phase 2 Assessment|Lost to Follow-up|7
4716500|NCT02994108|7645917|FG000|Phase 2 Assessment|Withdrawal by Subject|1
4716501|NCT02994108|7645918|FG001|Phase 2 Assessment|Withdrawal by Subject|0
4716502|NCT02994394|7645936|FG000|Period 1 (Days 1 to 3)|Adverse Event|0
4445368|NCT00477269|7230434|FG001|Open Label Extension|Adverse Event|0
4445369|NCT00477269|7230435|FG002|Open Label Extension|Adverse Event|4
4716503|NCT02994394|7645937|FG001|Period 1 (Days 1 to 3)|Adverse Event|0
4716504|NCT02994394|7645938|FG002|Period 1 (Days 1 to 3)|Adverse Event|1
4445370|NCT00477269|7230433|FG000|Open Label Extension|Abnormal laboratory values|0
4445371|NCT00477269|7230434|FG001|Open Label Extension|Abnormal laboratory values|0
4445372|NCT00477269|7230435|FG002|Open Label Extension|Abnormal laboratory values|1
4445373|NCT00477269|7230433|FG000|Open Label Extension|unsatisfactory therapeutic effects|0
4445374|NCT00477269|7230434|FG001|Open Label Extension|unsatisfactory therapeutic effects|0
4445375|NCT00477269|7230435|FG002|Open Label Extension|unsatisfactory therapeutic effects|2
4445376|NCT00477269|7230433|FG000|Open Label Extension|Adminiatrative problems|0
4445377|NCT00477269|7230434|FG001|Open Label Extension|Adminiatrative problems|0
4445378|NCT00477269|7230435|FG002|Open Label Extension|Adminiatrative problems|2
4445379|NCT00477269|7230433|FG000|Open Label Extension|Death|0
4445380|NCT00477269|7230434|FG001|Open Label Extension|Death|0
4445381|NCT00477269|7230435|FG002|Open Label Extension|Death|4
4445382|NCT00477295|7230445|FG000|Overall Study|Adverse Event|31
4445383|NCT00477295|7230446|FG001|Overall Study|Adverse Event|35
4445384|NCT00477295|7230445|FG000|Overall Study|Withdrawal by Subject|35
4445385|NCT00477295|7230446|FG001|Overall Study|Withdrawal by Subject|24
4445386|NCT00477295|7230445|FG000|Overall Study|Lack of Efficacy|23
4445387|NCT00477295|7230446|FG001|Overall Study|Lack of Efficacy|23
4445388|NCT00477295|7230445|FG000|Overall Study|Protocol Violation|3
4445389|NCT00477295|7230446|FG001|Overall Study|Protocol Violation|8
4445390|NCT00477295|7230445|FG000|Overall Study|Physician Decision|4
4445391|NCT00477295|7230446|FG001|Overall Study|Physician Decision|5
4445392|NCT00477295|7230445|FG000|Overall Study|Lost to Follow-up|21
4445393|NCT00477295|7230446|FG001|Overall Study|Lost to Follow-up|11
4445394|NCT00477295|7230445|FG000|Overall Study|Other|4
4445395|NCT00477295|7230446|FG001|Overall Study|Other|3
4445396|NCT00477334|7230456|FG000|Overall Study|Discontinued prior to taking study drug|106
4445397|NCT00477334|7230457|FG001|Overall Study|Discontinued prior to taking study drug|53
4716505|NCT02994394|7645939|FG003|Period 1 (Days 1 to 3)|Adverse Event|0
4716506|NCT02994394|7645940|FG004|Period 1 (Days 1 to 3)|Adverse Event|0
4716507|NCT02994394|7645941|FG005|Period 1 (Days 1 to 3)|Adverse Event|0
4716508|NCT02994394|7645936|FG000|Period 2 (Days 4 to 6)|Adverse Event|0
4445398|NCT00477334|7230456|FG000|Overall Study|Adverse Event|1
4445399|NCT00477334|7230457|FG001|Overall Study|Adverse Event|2
4445400|NCT00477334|7230456|FG000|Overall Study|Withdrawal by Subject|2
4445401|NCT00477334|7230457|FG001|Overall Study|Withdrawal by Subject|1
4445402|NCT00477334|7230456|FG000|Overall Study|Lost to Follow-up|15
4445403|NCT00477334|7230457|FG001|Overall Study|Lost to Follow-up|4
4445404|NCT00477334|7230456|FG000|Overall Study|Administrative Problems|39
4445405|NCT00477334|7230457|FG001|Overall Study|Administrative Problems|15
4445406|NCT00477334|7230456|FG000|Overall Study|Protocol Violation|7
4445407|NCT00477334|7230457|FG001|Overall Study|Protocol Violation|1
4445408|NCT00477386|7230469|FG000|Overall Study|Adverse Event|4
4445409|NCT00477386|7230470|FG001|Overall Study|Adverse Event|8
4513052|NCT00939770|7323324|FG006|Overall Study|Adverse Event|1
4630510|NCT01881750|7499189|FG000|Overall Study|Changes in concomitant therapies|2
4630511|NCT01881750|7499190|FG001|Overall Study|Changes in concomitant therapies|3
4630512|NCT01881750|7499189|FG000|Overall Study|Lost to Follow-up|0
4630513|NCT01881750|7499190|FG001|Overall Study|Lost to Follow-up|1
4630514|NCT01881776|7499201|FG000|Overall Study|Lost to Follow-up|1
4630515|NCT01881776|7499202|FG001|Overall Study|Lost to Follow-up|2
4630516|NCT01881776|7499203|FG002|Overall Study|Lost to Follow-up|1
4630517|NCT01881776|7499201|FG000|Overall Study|Protocol Violation|0
4630518|NCT01881776|7499202|FG001|Overall Study|Protocol Violation|2
4630519|NCT01881776|7499203|FG002|Overall Study|Protocol Violation|1
4633325|NCT01910519|7503398|FG001|Overall Study|Adverse Event|0
4716509|NCT02994394|7645937|FG001|Period 2 (Days 4 to 6)|Adverse Event|1
4716510|NCT02994394|7645938|FG002|Period 2 (Days 4 to 6)|Adverse Event|0
4716511|NCT02994394|7645939|FG003|Period 2 (Days 4 to 6)|Adverse Event|0
4716512|NCT02994394|7645940|FG004|Period 2 (Days 4 to 6)|Adverse Event|1
4716513|NCT02994394|7645941|FG005|Period 2 (Days 4 to 6)|Adverse Event|0
4716514|NCT02994654|7645955|FG000|Overall Study|Lost to Follow-up|1
4716515|NCT02994940|7645967|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6
4445410|NCT00477386|7230469|FG000|Overall Study|Disease progression, relapse|3
4445411|NCT00477386|7230470|FG001|Overall Study|Disease progression, relapse|4
4633326|NCT01911260|7503457|FG000|Supplementation Period|transference or evasion of school|7
4633327|NCT01911260|7503458|FG001|Supplementation Period|transference or evasion of school|9
4633328|NCT01911260|7503459|FG002|Supplementation Period|transference or evasion of school|7
4445412|NCT00477386|7230469|FG000|Overall Study|Disease progression, refractory|1
4633329|NCT01911260|7503460|FG003|Supplementation Period|transference or evasion of school|6
4633330|NCT01911260|7503457|FG000|Supplementation Period|Adverse Event|2
4633331|NCT01911260|7503458|FG001|Supplementation Period|Adverse Event|0
4633332|NCT01911260|7503459|FG002|Supplementation Period|Adverse Event|1
4445413|NCT00477386|7230470|FG001|Overall Study|Disease progression, refractory|3
4445414|NCT00477386|7230469|FG000|Overall Study|Other|1
4445415|NCT00477386|7230470|FG001|Overall Study|Other|2
4445416|NCT00477386|7230469|FG000|Overall Study|Physician Decision|1
4445417|NCT00477386|7230470|FG001|Overall Study|Physician Decision|0
4445418|NCT00477386|7230469|FG000|Overall Study|Withdrawal by Subject|1
4445419|NCT00477386|7230470|FG001|Overall Study|Withdrawal by Subject|0
4445420|NCT00477464|7230491|FG000|Overall Study|Lost to Follow-up|1
4445421|NCT00477464|7230491|FG000|Overall Study|Death|36
4445422|NCT00477464|7230491|FG000|Overall Study|Completion of protocol-defined follow-up|14
4445423|NCT00477490|7230502|FG000|Part I: 4 Week Efficacy|Adverse Event|1
4445424|NCT00477490|7230503|FG001|Part I: 4 Week Efficacy|Adverse Event|4
4445425|NCT00477490|7230504|FG002|Part I: 4 Week Efficacy|Adverse Event|0
4445426|NCT00477490|7230505|FG003|Part I: 4 Week Efficacy|Adverse Event|5
4445427|NCT00477490|7230506|FG004|Part I: 4 Week Efficacy|Adverse Event|6
4445428|NCT00477490|7230507|FG005|Part I: 4 Week Efficacy|Adverse Event|0
4445429|NCT00477490|7230508|FG006|Part I: 4 Week Efficacy|Adverse Event|0
4445430|NCT00477490|7230509|FG007|Part I: 4 Week Efficacy|Adverse Event|0
4445431|NCT00477490|7230510|FG008|Part I: 4 Week Efficacy|Adverse Event|0
4445432|NCT00477490|7230502|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1
4445433|NCT00477490|7230503|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
4445434|NCT00477490|7230504|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
4445435|NCT00477490|7230505|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5
4445436|NCT00477490|7230506|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4
4445437|NCT00477490|7230507|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
4445438|NCT00477490|7230508|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
4445439|NCT00477490|7230509|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
4445440|NCT00477490|7230510|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
4445441|NCT00477490|7230502|FG000|Part I: 4 Week Efficacy|Protocol Violation|2
4445442|NCT00477490|7230503|FG001|Part I: 4 Week Efficacy|Protocol Violation|0
4445443|NCT00477490|7230504|FG002|Part I: 4 Week Efficacy|Protocol Violation|0
4445444|NCT00477490|7230505|FG003|Part I: 4 Week Efficacy|Protocol Violation|0
4445445|NCT00477490|7230506|FG004|Part I: 4 Week Efficacy|Protocol Violation|1
4445446|NCT00477490|7230507|FG005|Part I: 4 Week Efficacy|Protocol Violation|0
4445447|NCT00477490|7230508|FG006|Part I: 4 Week Efficacy|Protocol Violation|0
4445448|NCT00477490|7230509|FG007|Part I: 4 Week Efficacy|Protocol Violation|0
4445449|NCT00477490|7230510|FG008|Part I: 4 Week Efficacy|Protocol Violation|0
4445450|NCT00477490|7230502|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6
4445451|NCT00477490|7230503|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5
4445452|NCT00477490|7230504|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6
4445453|NCT00477490|7230505|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4
4445454|NCT00477490|7230506|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9
4445455|NCT00477490|7230507|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0
4445456|NCT00477490|7230508|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0
4445457|NCT00477490|7230509|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0
4445458|NCT00477490|7230510|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0
4445459|NCT00477490|7230502|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2
4445460|NCT00477490|7230503|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4
4445461|NCT00477490|7230504|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1
4445462|NCT00477490|7230505|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5
4445463|NCT00477490|7230506|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3
4445464|NCT00477490|7230507|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0
4445465|NCT00477490|7230508|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0
4445466|NCT00477490|7230509|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0
4445467|NCT00477490|7230510|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0
4445468|NCT00477490|7230502|FG000|Part I: 4 Week Efficacy|Other, not specified|2
4445469|NCT00477490|7230503|FG001|Part I: 4 Week Efficacy|Other, not specified|4
4445470|NCT00477490|7230504|FG002|Part I: 4 Week Efficacy|Other, not specified|0
4445471|NCT00477490|7230505|FG003|Part I: 4 Week Efficacy|Other, not specified|1
4445472|NCT00477490|7230506|FG004|Part I: 4 Week Efficacy|Other, not specified|1
4445473|NCT00477490|7230507|FG005|Part I: 4 Week Efficacy|Other, not specified|0
4445474|NCT00477490|7230508|FG006|Part I: 4 Week Efficacy|Other, not specified|0
4445475|NCT00477490|7230509|FG007|Part I: 4 Week Efficacy|Other, not specified|0
4445476|NCT00477490|7230510|FG008|Part I: 4 Week Efficacy|Other, not specified|0
4445477|NCT00477490|7230502|FG000|Part I: 4 Week Efficacy|Not Reported|1
4445478|NCT00477490|7230503|FG001|Part I: 4 Week Efficacy|Not Reported|2
4445479|NCT00477490|7230504|FG002|Part I: 4 Week Efficacy|Not Reported|3
4445480|NCT00477490|7230505|FG003|Part I: 4 Week Efficacy|Not Reported|0
4445481|NCT00477490|7230506|FG004|Part I: 4 Week Efficacy|Not Reported|1
4445482|NCT00477490|7230507|FG005|Part I: 4 Week Efficacy|Not Reported|0
4445483|NCT00477490|7230508|FG006|Part I: 4 Week Efficacy|Not Reported|0
4445484|NCT00477490|7230509|FG007|Part I: 4 Week Efficacy|Not Reported|0
4445485|NCT00477490|7230510|FG008|Part I: 4 Week Efficacy|Not Reported|0
4445486|NCT00477490|7230502|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0
4445487|NCT00477490|7230503|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15
4445488|NCT00477490|7230504|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7
4445489|NCT00477490|7230505|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7
4445490|NCT00477490|7230506|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10
4445491|NCT00477490|7230507|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4
4445492|NCT00477490|7230508|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2
4445493|NCT00477490|7230509|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3
4445494|NCT00477490|7230510|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2
4445495|NCT00477490|7230502|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0
4445496|NCT00477490|7230503|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2
4445497|NCT00477490|7230504|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3
4445498|NCT00477490|7230505|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1
4445499|NCT00477490|7230506|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1
4445500|NCT00477490|7230507|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1
4445501|NCT00477490|7230508|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1
4445502|NCT00477490|7230509|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1
4445503|NCT00477490|7230510|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4
4445504|NCT00477490|7230502|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
4445505|NCT00477490|7230503|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3
4445506|NCT00477490|7230504|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2
4445507|NCT00477490|7230505|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
4445508|NCT00477490|7230506|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5
4445509|NCT00477490|7230507|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
4445510|NCT00477490|7230508|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1
4445511|NCT00477490|7230509|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
4445512|NCT00477490|7230510|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
4445513|NCT00477490|7230502|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
4445514|NCT00477490|7230503|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
4445515|NCT00477490|7230504|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
4445516|NCT00477490|7230505|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
4445517|NCT00477490|7230506|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
4445518|NCT00477490|7230507|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
4445519|NCT00477490|7230508|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
4445520|NCT00477490|7230509|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
4445521|NCT00477490|7230510|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
4445522|NCT00477490|7230502|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0
4445523|NCT00477490|7230503|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1
4445524|NCT00477490|7230504|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0
4445525|NCT00477490|7230505|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0
4445526|NCT00477490|7230506|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0
4445527|NCT00477490|7230507|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0
4445528|NCT00477490|7230508|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0
4445529|NCT00477490|7230509|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0
4445530|NCT00477490|7230510|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0
4445531|NCT00477490|7230502|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0
4445532|NCT00477490|7230503|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4
4445533|NCT00477490|7230504|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2
4445534|NCT00477490|7230505|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4
4445535|NCT00477490|7230506|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2
4445536|NCT00477490|7230507|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1
4445537|NCT00477490|7230508|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1
4445538|NCT00477490|7230509|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0
4445539|NCT00477490|7230510|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1
4445540|NCT00477490|7230502|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0
4445541|NCT00477490|7230503|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3
4445542|NCT00477490|7230504|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1
4445543|NCT00477490|7230505|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0
4445544|NCT00477490|7230506|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1
4445545|NCT00477490|7230507|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0
4445546|NCT00477490|7230508|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0
4445547|NCT00477490|7230509|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0
4445548|NCT00477490|7230510|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0
4445549|NCT00477594|7230540|FG000|Year 1 and Year 2|Adverse Event|4
4445550|NCT00477594|7230541|FG001|Year 1 and Year 2|Adverse Event|2
4445551|NCT00477594|7230540|FG000|Year 1 and Year 2|Physician Decision|2
4445552|NCT00477594|7230541|FG001|Year 1 and Year 2|Physician Decision|1
4445553|NCT00477594|7230540|FG000|Year 1 and Year 2|Withdrawal by Subject|2
4445554|NCT00477594|7230541|FG001|Year 1 and Year 2|Withdrawal by Subject|1
4445555|NCT00477594|7230540|FG000|Year 1 and Year 2|Other|1
4445556|NCT00477594|7230541|FG001|Year 1 and Year 2|Other|0
4445557|NCT00477594|7230540|FG000|Year 3|Adverse Event|1
4445558|NCT00477594|7230541|FG001|Year 3|Adverse Event|0
4445559|NCT00477594|7230540|FG000|Year 3|Withdrawal by Subject|1
4445560|NCT00477594|7230541|FG001|Year 3|Withdrawal by Subject|0
4445561|NCT00477594|7230540|FG000|Follow-up Period|Withdrawal by Subject|2
4445562|NCT00477594|7230541|FG001|Follow-up Period|Withdrawal by Subject|1
4445563|NCT00477594|7230540|FG000|Follow-up Period|Other|1
4445564|NCT00477594|7230541|FG001|Follow-up Period|Other|0
4445565|NCT00477607|7230549|FG000|Overall Study|Lost to Follow-up|7
4445566|NCT00477607|7230550|FG001|Overall Study|Lost to Follow-up|7
4445567|NCT00477633|7230556|FG000|Overall Study|Did not receive treatment|23
4445568|NCT00477633|7230556|FG000|Overall Study|Adverse Event|143
4445569|NCT00477633|7230556|FG000|Overall Study|Pregnancy|23
4445570|NCT00477633|7230556|FG000|Overall Study|Lost to Follow-up|271
4445571|NCT00477633|7230556|FG000|Overall Study|Withdrawal by Subject|149
4445572|NCT00477633|7230556|FG000|Overall Study|Protocol Violation|25
4445573|NCT00477633|7230556|FG000|Overall Study|Various (Moving, Enrollment closed)|75
4445574|NCT00477672|7230567|FG000|Overall Study|Adverse Event|3
4445575|NCT00477672|7230568|FG001|Overall Study|Adverse Event|5
4445576|NCT00477672|7230569|FG002|Overall Study|Adverse Event|6
4445577|NCT00477672|7230567|FG000|Overall Study|Death|0
4445578|NCT00477672|7230568|FG001|Overall Study|Death|1
4445579|NCT00477672|7230569|FG002|Overall Study|Death|0
4445580|NCT00477672|7230567|FG000|Overall Study|Disease progression|0
4445581|NCT00477672|7230568|FG001|Overall Study|Disease progression|1
4445582|NCT00477672|7230569|FG002|Overall Study|Disease progression|0
4445583|NCT00477672|7230567|FG000|Overall Study|Physician Decision|1
4445584|NCT00477672|7230568|FG001|Overall Study|Physician Decision|0
4445585|NCT00477672|7230569|FG002|Overall Study|Physician Decision|0
4445586|NCT00477672|7230567|FG000|Overall Study|Protocol noncompliance|0
4445587|NCT00477672|7230568|FG001|Overall Study|Protocol noncompliance|2
4445588|NCT00477672|7230569|FG002|Overall Study|Protocol noncompliance|0
4445589|NCT00477672|7230567|FG000|Overall Study|Consent withdrawn|2
4445590|NCT00477672|7230568|FG001|Overall Study|Consent withdrawn|5
4445591|NCT00477672|7230569|FG002|Overall Study|Consent withdrawn|10
4445592|NCT00477672|7230567|FG000|Overall Study|Discretion of Sponsor|1
4445593|NCT00477672|7230568|FG001|Overall Study|Discretion of Sponsor|2
4445594|NCT00477672|7230569|FG002|Overall Study|Discretion of Sponsor|0
4445595|NCT00477750|7230581|FG000|Overall Study|Currently Receiving Treatment|11
4445596|NCT00477971|7230589|FG000|Overall Study|Disease progression|6
4445597|NCT00477971|7230590|FG001|Overall Study|Disease progression|0
4445598|NCT00477971|7230589|FG000|Overall Study|Withdrawal by Subject|3
4445599|NCT00477971|7230590|FG001|Overall Study|Withdrawal by Subject|1
4445600|NCT00477971|7230589|FG000|Overall Study|Adverse Event|3
4445601|NCT00477971|7230590|FG001|Overall Study|Adverse Event|0
4445602|NCT00477971|7230589|FG000|Overall Study|Death|2
4445603|NCT00477971|7230590|FG001|Overall Study|Death|4
4445604|NCT00477971|7230589|FG000|Overall Study|Alternative treatment|3
4445605|NCT00477971|7230590|FG001|Overall Study|Alternative treatment|1
4445606|NCT00478023|7230601|FG000|Overall Study|Adverse Event|11
4445607|NCT00478023|7230602|FG001|Overall Study|Adverse Event|7
4445608|NCT00478023|7230603|FG002|Overall Study|Adverse Event|8
4445609|NCT00478023|7230604|FG003|Overall Study|Adverse Event|14
4445610|NCT00478023|7230605|FG004|Overall Study|Adverse Event|6
4445611|NCT00478023|7230601|FG000|Overall Study|Death|1
4445612|NCT00478023|7230602|FG001|Overall Study|Death|0
4445613|NCT00478023|7230603|FG002|Overall Study|Death|0
4445614|NCT00478023|7230604|FG003|Overall Study|Death|0
4445615|NCT00478023|7230605|FG004|Overall Study|Death|0
4445616|NCT00478023|7230601|FG000|Overall Study|Lack of Efficacy|11
4445617|NCT00478023|7230602|FG001|Overall Study|Lack of Efficacy|10
4445618|NCT00478023|7230603|FG002|Overall Study|Lack of Efficacy|4
4445619|NCT00478023|7230604|FG003|Overall Study|Lack of Efficacy|5
4445620|NCT00478023|7230605|FG004|Overall Study|Lack of Efficacy|41
4445621|NCT00478023|7230601|FG000|Overall Study|Lost to Follow-up|3
4445622|NCT00478023|7230602|FG001|Overall Study|Lost to Follow-up|1
4445623|NCT00478023|7230603|FG002|Overall Study|Lost to Follow-up|1
4445624|NCT00478023|7230604|FG003|Overall Study|Lost to Follow-up|1
4445625|NCT00478023|7230605|FG004|Overall Study|Lost to Follow-up|0
4445626|NCT00478023|7230601|FG000|Overall Study|Withdrawal by Subject|2
4445627|NCT00478023|7230602|FG001|Overall Study|Withdrawal by Subject|3
4445628|NCT00478023|7230603|FG002|Overall Study|Withdrawal by Subject|2
4445629|NCT00478023|7230604|FG003|Overall Study|Withdrawal by Subject|4
4445630|NCT00478023|7230605|FG004|Overall Study|Withdrawal by Subject|5
4445631|NCT00478023|7230601|FG000|Overall Study|Lack of pain, Technical difficulties|7
4445632|NCT00478023|7230602|FG001|Overall Study|Lack of pain, Technical difficulties|3
4445633|NCT00478023|7230603|FG002|Overall Study|Lack of pain, Technical difficulties|5
4445634|NCT00478023|7230604|FG003|Overall Study|Lack of pain, Technical difficulties|6
4445635|NCT00478023|7230605|FG004|Overall Study|Lack of pain, Technical difficulties|3
4445636|NCT00478140|7230630|FG000|Overall Study|Clinical Disease Progression|1
4445637|NCT00478205|7230650|FG000|Overall Study|Adverse Event|182
4445638|NCT00478205|7230651|FG001|Overall Study|Adverse Event|39
4445639|NCT00478205|7230650|FG000|Overall Study|Medication Non-compliance|9
4445640|NCT00478205|7230651|FG001|Overall Study|Medication Non-compliance|4
4445641|NCT00478205|7230650|FG000|Overall Study|Protocol Violation|15
4445642|NCT00478205|7230651|FG001|Overall Study|Protocol Violation|5
4445643|NCT00478205|7230650|FG000|Overall Study|Request of Investigator or Sponsor|4
4445644|NCT00478205|7230651|FG001|Overall Study|Request of Investigator or Sponsor|5
4445645|NCT00478205|7230650|FG000|Overall Study|Withdrawal by Subject|61
4445646|NCT00478205|7230651|FG001|Overall Study|Withdrawal by Subject|22
4445647|NCT00478205|7230650|FG000|Overall Study|Lack of Efficacy|1
4445648|NCT00478205|7230651|FG001|Overall Study|Lack of Efficacy|0
4445649|NCT00478205|7230650|FG000|Overall Study|Other|24
4445650|NCT00478205|7230651|FG001|Overall Study|Other|12
4445651|NCT00478231|7230666|FG000|Overall Study|Death|7
4445652|NCT00478231|7230666|FG000|Overall Study|Lack of Efficacy|47
4445653|NCT00478231|7230666|FG000|Overall Study|Lost to Follow-up|7
4445654|NCT00478231|7230666|FG000|Overall Study|Withdrawal by Subject|6
4445655|NCT00478231|7230666|FG000|Overall Study|Other|9
4445656|NCT00478231|7230666|FG000|Overall Study|Adverse Event|5
4445657|NCT00478231|7230666|FG000|Overall Study|Randomized, not treated|3
4445658|NCT00478244|7230670|FG000|Overall Study|Did not receive transplant|1
4445659|NCT00478257|7230676|FG000|Overall Study|Withdrawal by Subject|8
4445660|NCT00478257|7230677|FG001|Overall Study|Withdrawal by Subject|3
4445661|NCT00478426|7230696|FG000|Overall Study|Withdrawal by Subject|1
4445662|NCT00478608|7230721|FG000|Overall Study|Adverse Event|1
4445663|NCT00478608|7230721|FG000|Overall Study|Serious Adverse Event|14
4445664|NCT00478608|7230721|FG000|Overall Study|Withdrawal by Subject|2
4445665|NCT00478608|7230721|FG000|Overall Study|Protocol Violation|3
4445666|NCT00478647|7230725|FG000|Overall Study|Adverse Event|1
4445667|NCT00478647|7230725|FG000|Overall Study|Withdrawal by Subject|1
4445668|NCT00478673|7230729|FG000|30-Days Post-Procedure|Death|2
4445669|NCT00478673|7230729|FG000|30-Days Post-Procedure|Withdrawal by Subject|1
4445670|NCT00478673|7230729|FG000|30-Days Post-Procedure|Missed Visit|7
4445671|NCT00478673|7230729|FG000|12-Months Post-Procedure|Death|23
4445672|NCT00478673|7230729|FG000|12-Months Post-Procedure|Lost to Follow-up|4
4445673|NCT00478673|7230729|FG000|12-Months Post-Procedure|Withdrawal by Subject|6
4445674|NCT00478673|7230729|FG000|12-Months Post-Procedure|Missed Visit|25
4445675|NCT00478673|7230729|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6
4445676|NCT00478777|7230733|FG000|Overall Study|Adverse Event|29
4445677|NCT00478777|7230733|FG000|Overall Study|Lack of Efficacy|23
4445678|NCT00478777|7230733|FG000|Overall Study|Withdrawal by Subject|4
4445679|NCT00478777|7230733|FG000|Overall Study|Death|3
4445680|NCT00478777|7230733|FG000|Overall Study|Protocol Violation|3
4445681|NCT00478777|7230733|FG000|Overall Study|Lost to Follow-up|3
4445682|NCT00478777|7230733|FG000|Overall Study|Physician Decision|1
4445683|NCT00478777|7230733|FG000|Overall Study|Intolerance of therapy|1
4445684|NCT00478777|7230733|FG000|Overall Study|Lack of compliance|1
4445685|NCT00478777|7230733|FG000|Overall Study|Lymphocytes infusion|1
4445686|NCT00478777|7230733|FG000|Overall Study|End of therapy|2
4445687|NCT00478777|7230733|FG000|Overall Study|Not treated with lenalidomide|6
4445688|NCT00478881|7230739|FG000|Overall Study|Adverse Event|31
4445689|NCT00478881|7230740|FG001|Overall Study|Adverse Event|12
4445690|NCT00478881|7230739|FG000|Overall Study|Lack of Efficacy|0
4445691|NCT00478881|7230740|FG001|Overall Study|Lack of Efficacy|3
4445692|NCT00478881|7230739|FG000|Overall Study|Lost to Follow-up|0
4445693|NCT00478881|7230740|FG001|Overall Study|Lost to Follow-up|1
4445694|NCT00478881|7230739|FG000|Overall Study|Protocol Violation|2
4445695|NCT00478881|7230740|FG001|Overall Study|Protocol Violation|2
4445696|NCT00478881|7230739|FG000|Overall Study|Withdrawal by Subject|6
4445697|NCT00478881|7230740|FG001|Overall Study|Withdrawal by Subject|2
4445698|NCT00478881|7230739|FG000|Overall Study|Non-Compliance with Study Medication|0
4445699|NCT00478881|7230740|FG001|Overall Study|Non-Compliance with Study Medication|2
4445700|NCT00478933|7230746|FG000|Overall Study|Protocol Violation|22
4445701|NCT00478933|7230746|FG000|Overall Study|Informed consent not verified|3
4445702|NCT00478933|7230746|FG000|Overall Study|Inadequate data available|53
4445703|NCT00479232|7230803|FG000|Overall Study|Adverse Event|0
4445704|NCT00479232|7230804|FG001|Overall Study|Adverse Event|0
4445705|NCT00479232|7230805|FG002|Overall Study|Adverse Event|5
4445706|NCT00479232|7230806|FG003|Overall Study|Adverse Event|0
4445707|NCT00479232|7230807|FG004|Overall Study|Adverse Event|0
4445708|NCT00479232|7230808|FG005|Overall Study|Adverse Event|10
4445709|NCT00479232|7230803|FG000|Overall Study|Deviation from Protocol|0
4445710|NCT00479232|7230804|FG001|Overall Study|Deviation from Protocol|0
4445711|NCT00479232|7230805|FG002|Overall Study|Deviation from Protocol|1
4445712|NCT00479232|7230806|FG003|Overall Study|Deviation from Protocol|0
4445713|NCT00479232|7230807|FG004|Overall Study|Deviation from Protocol|0
4445714|NCT00479232|7230808|FG005|Overall Study|Deviation from Protocol|0
4445715|NCT00479232|7230803|FG000|Overall Study|Lack of Efficacy|0
4445716|NCT00479232|7230804|FG001|Overall Study|Lack of Efficacy|0
4445717|NCT00479232|7230805|FG002|Overall Study|Lack of Efficacy|2
4445718|NCT00479232|7230806|FG003|Overall Study|Lack of Efficacy|0
4445719|NCT00479232|7230807|FG004|Overall Study|Lack of Efficacy|0
4445720|NCT00479232|7230808|FG005|Overall Study|Lack of Efficacy|4
4445721|NCT00479232|7230803|FG000|Overall Study|Physician Decision|0
4445722|NCT00479232|7230804|FG001|Overall Study|Physician Decision|0
4445723|NCT00479232|7230805|FG002|Overall Study|Physician Decision|2
4445724|NCT00479232|7230806|FG003|Overall Study|Physician Decision|0
4445725|NCT00479232|7230807|FG004|Overall Study|Physician Decision|0
4445726|NCT00479232|7230808|FG005|Overall Study|Physician Decision|1
4445727|NCT00479232|7230803|FG000|Overall Study|Progressive Disease|3
4445728|NCT00479232|7230804|FG001|Overall Study|Progressive Disease|1
4445729|NCT00479232|7230805|FG002|Overall Study|Progressive Disease|12
4445730|NCT00479232|7230806|FG003|Overall Study|Progressive Disease|3
4445731|NCT00479232|7230807|FG004|Overall Study|Progressive Disease|3
4445732|NCT00479232|7230808|FG005|Overall Study|Progressive Disease|12
4445733|NCT00479232|7230803|FG000|Overall Study|Withdrew Consent|0
4445734|NCT00479232|7230804|FG001|Overall Study|Withdrew Consent|2
4445735|NCT00479232|7230805|FG002|Overall Study|Withdrew Consent|6
4445736|NCT00479232|7230806|FG003|Overall Study|Withdrew Consent|0
4445737|NCT00479232|7230807|FG004|Overall Study|Withdrew Consent|1
4445738|NCT00479232|7230808|FG005|Overall Study|Withdrew Consent|3
4445739|NCT00479336|7230830|FG000|Overall Study|Adverse Event|1
4445740|NCT00479336|7230831|FG001|Overall Study|Adverse Event|1
4445741|NCT00479336|7230832|FG002|Overall Study|Adverse Event|1
4445742|NCT00479336|7230833|FG003|Overall Study|Adverse Event|3
4445743|NCT00479336|7230830|FG000|Overall Study|Lack of Efficacy|1
4445744|NCT00479336|7230831|FG001|Overall Study|Lack of Efficacy|0
4445745|NCT00479336|7230832|FG002|Overall Study|Lack of Efficacy|0
4445746|NCT00479336|7230833|FG003|Overall Study|Lack of Efficacy|0
4445747|NCT00479336|7230830|FG000|Overall Study|Protocol Violation|0
4445748|NCT00479336|7230831|FG001|Overall Study|Protocol Violation|1
4445749|NCT00479336|7230832|FG002|Overall Study|Protocol Violation|0
4445750|NCT00479336|7230833|FG003|Overall Study|Protocol Violation|0
4445751|NCT00479336|7230830|FG000|Overall Study|Withdrawal by Subject|1
4445752|NCT00479336|7230831|FG001|Overall Study|Withdrawal by Subject|2
4445753|NCT00479336|7230832|FG002|Overall Study|Withdrawal by Subject|0
4445754|NCT00479336|7230833|FG003|Overall Study|Withdrawal by Subject|0
4445755|NCT00479336|7230830|FG000|Overall Study|Physician Decision|0
4445756|NCT00479336|7230831|FG001|Overall Study|Physician Decision|1
4445757|NCT00479336|7230832|FG002|Overall Study|Physician Decision|0
4445758|NCT00479336|7230833|FG003|Overall Study|Physician Decision|2
4445759|NCT00479336|7230830|FG000|Overall Study|Resolution of all hepatic edema findings|1
4445760|NCT00479336|7230831|FG001|Overall Study|Resolution of all hepatic edema findings|1
4445761|NCT00479336|7230832|FG002|Overall Study|Resolution of all hepatic edema findings|0
4445762|NCT00479336|7230833|FG003|Overall Study|Resolution of all hepatic edema findings|0
4445763|NCT00479388|7230845|FG000|Overall Study|Adverse Event|90
4445764|NCT00479388|7230846|FG001|Overall Study|Adverse Event|45
4445765|NCT00479388|7230845|FG000|Overall Study|Lost to Follow-up|0
4445766|NCT00479388|7230846|FG001|Overall Study|Lost to Follow-up|2
4445767|NCT00479388|7230845|FG000|Overall Study|Protocol Violation|10
4445768|NCT00479388|7230846|FG001|Overall Study|Protocol Violation|9
4445769|NCT00479388|7230845|FG000|Overall Study|Withdrawal by Subject|32
4445770|NCT00479388|7230846|FG001|Overall Study|Withdrawal by Subject|17
4445771|NCT00479401|7230855|FG000|Overall Study|Adverse Event|24
4445772|NCT00479401|7230856|FG001|Overall Study|Adverse Event|20
4445773|NCT00479401|7230857|FG002|Overall Study|Adverse Event|4
4445774|NCT00479401|7230855|FG000|Overall Study|Lack of Efficacy|2
4445775|NCT00479401|7230856|FG001|Overall Study|Lack of Efficacy|2
4445776|NCT00479401|7230857|FG002|Overall Study|Lack of Efficacy|4
4445777|NCT00479401|7230855|FG000|Overall Study|Protocol Violation|2
4445778|NCT00479401|7230856|FG001|Overall Study|Protocol Violation|1
4445779|NCT00479401|7230857|FG002|Overall Study|Protocol Violation|1
4445780|NCT00479401|7230855|FG000|Overall Study|Lost to Follow-up|1
4445781|NCT00479401|7230856|FG001|Overall Study|Lost to Follow-up|1
4445782|NCT00479401|7230857|FG002|Overall Study|Lost to Follow-up|1
4445783|NCT00479401|7230855|FG000|Overall Study|Withdrawal by Subject|16
4445784|NCT00479401|7230856|FG001|Overall Study|Withdrawal by Subject|10
4445785|NCT00479401|7230857|FG002|Overall Study|Withdrawal by Subject|2
4445786|NCT00479401|7230855|FG000|Overall Study|Exclusion criteria, relocation|4
4445787|NCT00479401|7230856|FG001|Overall Study|Exclusion criteria, relocation|3
4445788|NCT00479401|7230857|FG002|Overall Study|Exclusion criteria, relocation|0
4445789|NCT00479466|7230871|FG000|Overall Study|Adverse Event|5
4445790|NCT00479466|7230872|FG001|Overall Study|Adverse Event|1
4445791|NCT00479466|7230873|FG002|Overall Study|Adverse Event|0
4445792|NCT00479466|7230874|FG003|Overall Study|Adverse Event|1
4445793|NCT00479466|7230875|FG004|Overall Study|Adverse Event|2
4445794|NCT00479466|7230876|FG005|Overall Study|Adverse Event|0
4445795|NCT00479466|7230871|FG000|Overall Study|Hyperglycemia|0
4445796|NCT00479466|7230872|FG001|Overall Study|Hyperglycemia|0
4445797|NCT00479466|7230873|FG002|Overall Study|Hyperglycemia|0
4445798|NCT00479466|7230874|FG003|Overall Study|Hyperglycemia|0
4445799|NCT00479466|7230875|FG004|Overall Study|Hyperglycemia|0
4445800|NCT00479466|7230876|FG005|Overall Study|Hyperglycemia|1
4445801|NCT00479466|7230871|FG000|Overall Study|Lack of Efficacy|2
4445802|NCT00479466|7230872|FG001|Overall Study|Lack of Efficacy|0
4445803|NCT00479466|7230873|FG002|Overall Study|Lack of Efficacy|1
4445804|NCT00479466|7230874|FG003|Overall Study|Lack of Efficacy|0
4445805|NCT00479466|7230875|FG004|Overall Study|Lack of Efficacy|0
4445806|NCT00479466|7230876|FG005|Overall Study|Lack of Efficacy|0
4445807|NCT00479466|7230871|FG000|Overall Study|Lost to Follow-up|0
4445808|NCT00479466|7230872|FG001|Overall Study|Lost to Follow-up|1
4445809|NCT00479466|7230873|FG002|Overall Study|Lost to Follow-up|1
4445810|NCT00479466|7230874|FG003|Overall Study|Lost to Follow-up|0
4445811|NCT00479466|7230875|FG004|Overall Study|Lost to Follow-up|2
4445812|NCT00479466|7230876|FG005|Overall Study|Lost to Follow-up|2
4445813|NCT00479466|7230871|FG000|Overall Study|Physician Decision|2
4445814|NCT00479466|7230872|FG001|Overall Study|Physician Decision|1
4445815|NCT00479466|7230873|FG002|Overall Study|Physician Decision|1
4445816|NCT00479466|7230874|FG003|Overall Study|Physician Decision|0
4445817|NCT00479466|7230875|FG004|Overall Study|Physician Decision|0
4445818|NCT00479466|7230876|FG005|Overall Study|Physician Decision|0
4445819|NCT00479466|7230871|FG000|Overall Study|Pregnancy|0
4445820|NCT00479466|7230872|FG001|Overall Study|Pregnancy|0
4445821|NCT00479466|7230873|FG002|Overall Study|Pregnancy|0
4445822|NCT00479466|7230874|FG003|Overall Study|Pregnancy|0
4445823|NCT00479466|7230875|FG004|Overall Study|Pregnancy|1
4445824|NCT00479466|7230876|FG005|Overall Study|Pregnancy|0
4445825|NCT00479466|7230871|FG000|Overall Study|Protocol Violation|1
4445826|NCT00479466|7230872|FG001|Overall Study|Protocol Violation|0
4445827|NCT00479466|7230873|FG002|Overall Study|Protocol Violation|0
4445828|NCT00479466|7230874|FG003|Overall Study|Protocol Violation|0
4445829|NCT00479466|7230875|FG004|Overall Study|Protocol Violation|0
4445830|NCT00479466|7230876|FG005|Overall Study|Protocol Violation|0
4445831|NCT00479466|7230871|FG000|Overall Study|Withdrawal by Subject|3
4445832|NCT00479466|7230872|FG001|Overall Study|Withdrawal by Subject|5
4445833|NCT00479466|7230873|FG002|Overall Study|Withdrawal by Subject|0
4445834|NCT00479466|7230874|FG003|Overall Study|Withdrawal by Subject|2
4445835|NCT00479466|7230875|FG004|Overall Study|Withdrawal by Subject|3
4445836|NCT00479466|7230876|FG005|Overall Study|Withdrawal by Subject|1
4445837|NCT00479557|7230897|FG000|Overall Study|Death|0
4445838|NCT00479557|7230898|FG001|Overall Study|Death|0
4445839|NCT00479557|7230899|FG002|Overall Study|Death|0
4445840|NCT00479557|7230900|FG003|Overall Study|Death|0
4445841|NCT00479557|7230901|FG004|Overall Study|Death|0
4445842|NCT00479557|7230902|FG005|Overall Study|Death|1
4445843|NCT00479557|7230903|FG006|Overall Study|Death|0
4445844|NCT00479557|7230897|FG000|Overall Study|Lack of Efficacy|1
4445845|NCT00479557|7230898|FG001|Overall Study|Lack of Efficacy|0
4445846|NCT00479557|7230899|FG002|Overall Study|Lack of Efficacy|0
4445847|NCT00479557|7230900|FG003|Overall Study|Lack of Efficacy|0
4445848|NCT00479557|7230901|FG004|Overall Study|Lack of Efficacy|0
4445849|NCT00479557|7230902|FG005|Overall Study|Lack of Efficacy|0
4445850|NCT00479557|7230903|FG006|Overall Study|Lack of Efficacy|0
4445851|NCT00479557|7230897|FG000|Overall Study|Lost to Follow-up|0
4445852|NCT00479557|7230898|FG001|Overall Study|Lost to Follow-up|2
4445853|NCT00479557|7230899|FG002|Overall Study|Lost to Follow-up|0
4445854|NCT00479557|7230900|FG003|Overall Study|Lost to Follow-up|2
4445855|NCT00479557|7230901|FG004|Overall Study|Lost to Follow-up|0
4445856|NCT00479557|7230902|FG005|Overall Study|Lost to Follow-up|0
4445857|NCT00479557|7230903|FG006|Overall Study|Lost to Follow-up|0
4445858|NCT00479557|7230897|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1
4445859|NCT00479557|7230898|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0
4445860|NCT00479557|7230899|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3
4445861|NCT00479557|7230900|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2
4445862|NCT00479557|7230901|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0
4445863|NCT00479557|7230902|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1
4445864|NCT00479557|7230903|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0
4445865|NCT00479557|7230897|FG000|Overall Study|AE not related to Study Drug|1
4445866|NCT00479557|7230898|FG001|Overall Study|AE not related to Study Drug|3
4445867|NCT00479557|7230899|FG002|Overall Study|AE not related to Study Drug|0
4445868|NCT00479557|7230900|FG003|Overall Study|AE not related to Study Drug|0
4445869|NCT00479557|7230901|FG004|Overall Study|AE not related to Study Drug|2
4445870|NCT00479557|7230902|FG005|Overall Study|AE not related to Study Drug|2
4445871|NCT00479557|7230903|FG006|Overall Study|AE not related to Study Drug|1
4445872|NCT00479557|7230897|FG000|Overall Study|Caregiver Request|2
4445873|NCT00479557|7230898|FG001|Overall Study|Caregiver Request|2
4445874|NCT00479557|7230899|FG002|Overall Study|Caregiver Request|2
4445875|NCT00479557|7230900|FG003|Overall Study|Caregiver Request|0
4445876|NCT00479557|7230901|FG004|Overall Study|Caregiver Request|1
4445877|NCT00479557|7230902|FG005|Overall Study|Caregiver Request|2
4445878|NCT00479557|7230903|FG006|Overall Study|Caregiver Request|0
4445879|NCT00479557|7230897|FG000|Overall Study|Investigator Request|0
4445880|NCT00479557|7230898|FG001|Overall Study|Investigator Request|0
4445881|NCT00479557|7230899|FG002|Overall Study|Investigator Request|1
4445882|NCT00479557|7230900|FG003|Overall Study|Investigator Request|0
4445883|NCT00479557|7230901|FG004|Overall Study|Investigator Request|0
4445884|NCT00479557|7230902|FG005|Overall Study|Investigator Request|0
4445885|NCT00479557|7230903|FG006|Overall Study|Investigator Request|0
4445886|NCT00479557|7230897|FG000|Overall Study|Subject Request|3
4445887|NCT00479557|7230898|FG001|Overall Study|Subject Request|0
4445888|NCT00479557|7230899|FG002|Overall Study|Subject Request|1
4445889|NCT00479557|7230900|FG003|Overall Study|Subject Request|1
4445890|NCT00479557|7230901|FG004|Overall Study|Subject Request|1
4445891|NCT00479557|7230902|FG005|Overall Study|Subject Request|4
4445892|NCT00479557|7230903|FG006|Overall Study|Subject Request|1
4445893|NCT00479557|7230897|FG000|Overall Study|Other|2
4445894|NCT00479557|7230898|FG001|Overall Study|Other|3
4445895|NCT00479557|7230899|FG002|Overall Study|Other|1
4445896|NCT00479557|7230900|FG003|Overall Study|Other|0
4445897|NCT00479557|7230901|FG004|Overall Study|Other|0
4445898|NCT00479557|7230902|FG005|Overall Study|Other|3
4445899|NCT00479557|7230903|FG006|Overall Study|Other|0
4445900|NCT00479674|7230925|FG000|Overall Study|Adverse Event|18
4445901|NCT00479674|7230925|FG000|Overall Study|Withdrawal by Subject|6
4445902|NCT00479674|7230925|FG000|Overall Study|Physician Decision|14
4445903|NCT00479674|7230925|FG000|Overall Study|none provided|3
4445904|NCT00479687|7230931|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0
4445905|NCT00479687|7230932|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2
4445906|NCT00479687|7230933|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0
4445907|NCT00479687|7230931|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0
4445908|NCT00479687|7230932|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1
4445909|NCT00479687|7230933|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0
4445910|NCT00479687|7230931|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4
4445911|NCT00479687|7230932|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5
4445912|NCT00479687|7230933|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0
4445913|NCT00479687|7230931|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2
4445914|NCT00479687|7230932|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0
4445915|NCT00479687|7230933|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0
4445916|NCT00479687|7230931|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19
4445917|NCT00479687|7230932|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11
4445918|NCT00479687|7230933|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0
4445919|NCT00479687|7230931|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0
4445920|NCT00479687|7230932|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0
4445921|NCT00479687|7230933|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4
4445922|NCT00479687|7230931|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0
4445923|NCT00479687|7230932|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0
4445924|NCT00479687|7230933|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3
4445925|NCT00479687|7230931|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0
4445926|NCT00479687|7230932|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0
4445927|NCT00479687|7230933|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1
4445928|NCT00479687|7230931|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0
4445929|NCT00479687|7230932|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0
4445930|NCT00479687|7230933|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1
4445931|NCT00479765|7230940|FG000|Overall Study|study terminated|4
4445932|NCT00479856|7230944|FG000|Overall Study|Adverse Event|1
4445933|NCT00479856|7230944|FG000|Overall Study|Withdrawal by Subject|1
4445934|NCT00479856|7230944|FG000|Overall Study|Physician Decision|1
4445935|NCT00479882|7230952|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96
4445936|NCT00479882|7230953|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99
4445937|NCT00479882|7230954|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98
4445938|NCT00479882|7230955|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87
4445939|NCT00479882|7230952|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0
4445940|NCT00479882|7230953|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
4445941|NCT00479882|7230954|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
4445942|NCT00479882|7230955|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
4445943|NCT00479882|7230952|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12
4445944|NCT00479882|7230953|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9
4445945|NCT00479882|7230954|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9
4445946|NCT00479882|7230955|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11
4445947|NCT00479882|7230952|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4
4630520|NCT01881789|7499217|FG000|Overall Study|Withdrawal by Subject|0
4630521|NCT01881789|7499218|FG001|Overall Study|Withdrawal by Subject|2
4630522|NCT01881789|7499219|FG002|Overall Study|Withdrawal by Subject|1
4630523|NCT01881789|7499220|FG003|Overall Study|Withdrawal by Subject|0
4630524|NCT01881789|7499221|FG004|Overall Study|Withdrawal by Subject|1
4630525|NCT01881789|7499222|FG005|Overall Study|Withdrawal by Subject|1
4630526|NCT01881789|7499217|FG000|Overall Study|Study Terminated by Sponsor|0
4445948|NCT00479882|7230953|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6
4445949|NCT00479882|7230954|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9
4445950|NCT00479882|7230955|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5
4445951|NCT00479882|7230952|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0
4445952|NCT00479882|7230953|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4
4445953|NCT00479882|7230954|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2
4445954|NCT00479882|7230955|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1
4445955|NCT00479882|7230952|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24
4445956|NCT00479882|7230953|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33
4445957|NCT00479882|7230954|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30
4445958|NCT00479882|7230955|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25
4445959|NCT00479882|7230952|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2
4445960|NCT00479882|7230953|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7
4445961|NCT00479882|7230954|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5
4445962|NCT00479882|7230955|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7
4445963|NCT00479882|7230952|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12
4445964|NCT00479882|7230953|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13
4445965|NCT00479882|7230954|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12
4445966|NCT00479882|7230955|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10
4445967|NCT00479882|7230952|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3
4445968|NCT00479882|7230953|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1
4445969|NCT00479882|7230954|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2
4513053|NCT00939770|7323325|FG007|Overall Study|Adverse Event|1
4630527|NCT01881789|7499218|FG001|Overall Study|Study Terminated by Sponsor|0
4445970|NCT00479882|7230955|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2
4445971|NCT00479882|7230952|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
4445972|NCT00479882|7230953|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2
4445973|NCT00479882|7230954|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
4445974|NCT00479882|7230955|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
4445975|NCT00479882|7230952|FG000|Crossover: Period III (Weeks 13-20)|Other|5
4445976|NCT00479882|7230953|FG001|Crossover: Period III (Weeks 13-20)|Other|0
4445977|NCT00479882|7230954|FG002|Crossover: Period III (Weeks 13-20)|Other|2
4445978|NCT00479882|7230955|FG003|Crossover: Period III (Weeks 13-20)|Other|2
4445979|NCT00479882|7230952|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1
4445980|NCT00479882|7230953|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2
4445981|NCT00479882|7230954|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1
4445982|NCT00479882|7230955|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0
4445983|NCT00479882|7230952|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
4445984|NCT00479882|7230953|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
4445985|NCT00479882|7230954|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1
4445986|NCT00479882|7230955|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
4445987|NCT00479882|7230952|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
4445988|NCT00479882|7230953|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
4445989|NCT00479882|7230954|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1
4445990|NCT00479882|7230955|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
4445991|NCT00480025|7230983|FG000|Overall Study|Protocol Violation|12
4445992|NCT00480025|7230984|FG001|Overall Study|Protocol Violation|7
4445993|NCT00480025|7230983|FG000|Overall Study|Patients remaining ongoing at Data Lock|101
4445994|NCT00480025|7230984|FG001|Overall Study|Patients remaining ongoing at Data Lock|55
4445995|NCT00480025|7230983|FG000|Overall Study|Disease Progression / Recurrence|449
4445996|NCT00480025|7230984|FG001|Overall Study|Disease Progression / Recurrence|224
4445997|NCT00480025|7230983|FG000|Overall Study|Adverse Event|44
4445998|NCT00480025|7230984|FG001|Overall Study|Adverse Event|12
4445999|NCT00480025|7230983|FG000|Overall Study|Other|70
4446000|NCT00480025|7230984|FG001|Overall Study|Other|29
4446001|NCT00480025|7230983|FG000|Overall Study|SAE including intercurrent illness|76
4446002|NCT00480025|7230984|FG001|Overall Study|SAE including intercurrent illness|42
4446003|NCT00480077|7230998|FG000|Overall Study|Death|19
4446004|NCT00480077|7230999|FG001|Overall Study|Death|15
4446005|NCT00480077|7230998|FG000|Overall Study|early exit|12
4446006|NCT00480077|7230999|FG001|Overall Study|early exit|11
4446007|NCT00480324|7231007|FG000|Overall Study|Adverse Event|1
4446008|NCT00480324|7231008|FG001|Overall Study|Adverse Event|1
4446009|NCT00480324|7231007|FG000|Overall Study|Protocol Violation|0
4446010|NCT00480324|7231008|FG001|Overall Study|Protocol Violation|1
4446011|NCT00480324|7231007|FG000|Overall Study|Withdrawal by Subject|14
4446012|NCT00480324|7231008|FG001|Overall Study|Withdrawal by Subject|5
4446013|NCT00480324|7231007|FG000|Overall Study|Lost to Follow-up|17
4446014|NCT00480324|7231008|FG001|Overall Study|Lost to Follow-up|8
4446015|NCT00480324|7231007|FG000|Overall Study|Subject's mother pregnant|0
4446016|NCT00480324|7231008|FG001|Overall Study|Subject's mother pregnant|1
4446017|NCT00480441|7231016|FG000|Screening|Not Eligible|37
4446018|NCT00480441|7231017|FG001|Screening|Not Eligible|0
4446019|NCT00480441|7231018|FG002|Screening|Not Eligible|0
4446020|NCT00480441|7231016|FG000|Baseline Functional MRI|Functional MRI data not usable|4
4446021|NCT00480441|7231017|FG001|Baseline Functional MRI|Functional MRI data not usable|0
4446022|NCT00480441|7231018|FG002|Baseline Functional MRI|Functional MRI data not usable|0
4446023|NCT00480441|7231016|FG000|Baseline Functional MRI|Lost to Follow-up|4
4446024|NCT00480441|7231017|FG001|Baseline Functional MRI|Lost to Follow-up|0
4446025|NCT00480441|7231018|FG002|Baseline Functional MRI|Lost to Follow-up|0
4446026|NCT00480441|7231016|FG000|Baseline Functional MRI|physical contraindication|4
4446027|NCT00480441|7231017|FG001|Baseline Functional MRI|physical contraindication|0
4446028|NCT00480441|7231018|FG002|Baseline Functional MRI|physical contraindication|0
4446029|NCT00480441|7231016|FG000|Randomization|Lost to Follow-up|0
4446030|NCT00480441|7231017|FG001|Randomization|Lost to Follow-up|7
4446031|NCT00480441|7231018|FG002|Randomization|Lost to Follow-up|2
4446032|NCT00480493|7231027|FG000|Overall Study|moved|2
4446033|NCT00480493|7231028|FG001|Overall Study|moved|7
4446034|NCT00480532|7231040|FG000|Overall Study|Withdrawal by Subject|2
4446035|NCT00480532|7231041|FG001|Overall Study|Withdrawal by Subject|4
4446036|NCT00480532|7231042|FG002|Overall Study|Withdrawal by Subject|3
4446037|NCT00480532|7231043|FG003|Overall Study|Withdrawal by Subject|1
4446038|NCT00480532|7231040|FG000|Overall Study|Protocol Violation|0
4446039|NCT00480532|7231041|FG001|Overall Study|Protocol Violation|0
4446040|NCT00480532|7231042|FG002|Overall Study|Protocol Violation|1
4446041|NCT00480532|7231043|FG003|Overall Study|Protocol Violation|0
4446042|NCT00480636|7231053|FG000|Overall Study|Death|12
4446043|NCT00480636|7231053|FG000|Overall Study|Lost to Follow-up|4
4446044|NCT00480636|7231053|FG000|Overall Study|Other|2
4446045|NCT00480636|7231053|FG000|Overall Study|Lost to follow-up; subsequently died|1
4446046|NCT00480779|7231072|FG000|Overall Study|Other|2
4446047|NCT00480779|7231073|FG001|Overall Study|Other|0
4446048|NCT00480779|7231072|FG000|Overall Study|Job and Health-related|0
4446049|NCT00480779|7231073|FG001|Overall Study|Job and Health-related|3
4446050|NCT00480857|7231079|FG000|Overall Study|Lack of Efficacy|2
4446051|NCT00481065|7231095|FG000|Overall Study|Adverse event or death|1
4446052|NCT00481065|7231096|FG001|Overall Study|Adverse event or death|1
4446053|NCT00481065|7231097|FG002|Overall Study|Adverse event or death|3
4446054|NCT00481065|7231098|FG003|Overall Study|Adverse event or death|0
4446055|NCT00481065|7231099|FG004|Overall Study|Adverse event or death|2
4446056|NCT00481065|7231100|FG005|Overall Study|Adverse event or death|0
4446057|NCT00481065|7231101|FG006|Overall Study|Adverse event or death|1
4446058|NCT00481065|7231102|FG007|Overall Study|Adverse event or death|1
4446059|NCT00481065|7231095|FG000|Overall Study|Withdrawal by Subject|11
4446060|NCT00481065|7231096|FG001|Overall Study|Withdrawal by Subject|12
4446061|NCT00481065|7231097|FG002|Overall Study|Withdrawal by Subject|7
4446062|NCT00481065|7231098|FG003|Overall Study|Withdrawal by Subject|11
4446063|NCT00481065|7231099|FG004|Overall Study|Withdrawal by Subject|13
4446064|NCT00481065|7231100|FG005|Overall Study|Withdrawal by Subject|12
4446065|NCT00481065|7231101|FG006|Overall Study|Withdrawal by Subject|9
4446066|NCT00481065|7231102|FG007|Overall Study|Withdrawal by Subject|10
4446067|NCT00481065|7231095|FG000|Overall Study|Lost to Follow-up|4
4446068|NCT00481065|7231096|FG001|Overall Study|Lost to Follow-up|2
4446069|NCT00481065|7231097|FG002|Overall Study|Lost to Follow-up|4
4446070|NCT00481065|7231098|FG003|Overall Study|Lost to Follow-up|3
4446071|NCT00481065|7231099|FG004|Overall Study|Lost to Follow-up|3
4446072|NCT00481065|7231100|FG005|Overall Study|Lost to Follow-up|3
4446073|NCT00481065|7231101|FG006|Overall Study|Lost to Follow-up|2
4446074|NCT00481065|7231102|FG007|Overall Study|Lost to Follow-up|5
4446075|NCT00481065|7231095|FG000|Overall Study|Inappropriate enrollment|4
4446076|NCT00481065|7231096|FG001|Overall Study|Inappropriate enrollment|0
4446077|NCT00481065|7231097|FG002|Overall Study|Inappropriate enrollment|2
4446078|NCT00481065|7231098|FG003|Overall Study|Inappropriate enrollment|0
4446079|NCT00481065|7231099|FG004|Overall Study|Inappropriate enrollment|2
4446080|NCT00481065|7231100|FG005|Overall Study|Inappropriate enrollment|1
4446081|NCT00481065|7231101|FG006|Overall Study|Inappropriate enrollment|0
4446082|NCT00481065|7231102|FG007|Overall Study|Inappropriate enrollment|1
4446083|NCT00481065|7231095|FG000|Overall Study|Administrative reason|0
4513054|NCT00939770|7323318|FG000|Overall Study|Lack of Efficacy|4
4513055|NCT00939770|7323319|FG001|Overall Study|Lack of Efficacy|6
4513056|NCT00939770|7323320|FG002|Overall Study|Lack of Efficacy|13
4513057|NCT00939770|7323321|FG003|Overall Study|Lack of Efficacy|9
4513058|NCT00939770|7323322|FG004|Overall Study|Lack of Efficacy|16
4513059|NCT00939770|7323323|FG005|Overall Study|Lack of Efficacy|8
4513060|NCT00939770|7323324|FG006|Overall Study|Lack of Efficacy|11
4513061|NCT00939770|7323325|FG007|Overall Study|Lack of Efficacy|1
4513062|NCT00939770|7323318|FG000|Overall Study|Lost to Follow-up|0
4513063|NCT00939770|7323319|FG001|Overall Study|Lost to Follow-up|0
4513064|NCT00939770|7323320|FG002|Overall Study|Lost to Follow-up|0
4513065|NCT00939770|7323321|FG003|Overall Study|Lost to Follow-up|0
4513066|NCT00939770|7323322|FG004|Overall Study|Lost to Follow-up|1
4513067|NCT00939770|7323323|FG005|Overall Study|Lost to Follow-up|0
4513068|NCT00939770|7323324|FG006|Overall Study|Lost to Follow-up|0
4513069|NCT00939770|7323325|FG007|Overall Study|Lost to Follow-up|0
4513070|NCT00939770|7323318|FG000|Overall Study|Physician Decision|0
4513071|NCT00939770|7323319|FG001|Overall Study|Physician Decision|0
4513072|NCT00939770|7323320|FG002|Overall Study|Physician Decision|2
4513073|NCT00939770|7323321|FG003|Overall Study|Physician Decision|0
4513074|NCT00939770|7323322|FG004|Overall Study|Physician Decision|7
4513075|NCT00939770|7323323|FG005|Overall Study|Physician Decision|1
4513076|NCT00939770|7323324|FG006|Overall Study|Physician Decision|0
4513077|NCT00939770|7323325|FG007|Overall Study|Physician Decision|6
4513078|NCT00939770|7323318|FG000|Overall Study|Protocol Violation|0
4513079|NCT00939770|7323319|FG001|Overall Study|Protocol Violation|0
4513080|NCT00939770|7323320|FG002|Overall Study|Protocol Violation|0
4513081|NCT00939770|7323321|FG003|Overall Study|Protocol Violation|0
4513082|NCT00939770|7323322|FG004|Overall Study|Protocol Violation|1
4513083|NCT00939770|7323323|FG005|Overall Study|Protocol Violation|0
4513084|NCT00939770|7323324|FG006|Overall Study|Protocol Violation|0
4513085|NCT00939770|7323325|FG007|Overall Study|Protocol Violation|0
4513086|NCT00939770|7323318|FG000|Overall Study|Withdrawal by Subject|0
4513087|NCT00939770|7323319|FG001|Overall Study|Withdrawal by Subject|1
4513088|NCT00939770|7323320|FG002|Overall Study|Withdrawal by Subject|5
4513089|NCT00939770|7323321|FG003|Overall Study|Withdrawal by Subject|2
4513090|NCT00939770|7323322|FG004|Overall Study|Withdrawal by Subject|6
4513091|NCT00939770|7323323|FG005|Overall Study|Withdrawal by Subject|0
4513092|NCT00939770|7323324|FG006|Overall Study|Withdrawal by Subject|2
4513093|NCT00939770|7323325|FG007|Overall Study|Withdrawal by Subject|2
4513094|NCT00939783|7323356|FG000|Overall Study|Death|6
4513095|NCT00939783|7323356|FG000|Overall Study|Adverse Event|39
4513096|NCT00939783|7323356|FG000|Overall Study|Study Terminated by Sponsor|498
4513097|NCT00939783|7323356|FG000|Overall Study|Withdrawal by Subject|78
4513098|NCT00939783|7323356|FG000|Overall Study|Other|16
4446084|NCT00481065|7231096|FG001|Overall Study|Administrative reason|0
4446085|NCT00481065|7231097|FG002|Overall Study|Administrative reason|0
4446086|NCT00481065|7231098|FG003|Overall Study|Administrative reason|0
4513099|NCT00939783|7323356|FG000|Overall Study|Lost to Follow-up|8
4513100|NCT00939783|7323356|FG000|Overall Study|Protocol Violation|3
4513101|NCT00939783|7323356|FG000|Overall Study|Enrolled but not treated|1
4513102|NCT00939809|7323364|FG000|Overall Study|Adverse Event|2
4513103|NCT00939809|7323364|FG000|Overall Study|Death|1
4513104|NCT00939822|7323370|FG000|Overall Study|Lost to Follow-up|1
4513105|NCT00939822|7323371|FG001|Overall Study|Lost to Follow-up|0
4513106|NCT00939822|7323370|FG000|Overall Study|withdrew from study due to busy schedule|1
4513107|NCT00939822|7323371|FG001|Overall Study|withdrew from study due to busy schedule|1
4513108|NCT00939822|7323370|FG000|Overall Study|Mental health issues|0
4513109|NCT00939822|7323371|FG001|Overall Study|Mental health issues|2
4513110|NCT00940017|7323403|FG000|Overall Study|did not meet entrance criteria|3
4513111|NCT00940017|7323403|FG000|Overall Study|Adverse Event|1
4513112|NCT00940108|7323411|FG000|Overall Study|Adverse Event|2
4513113|NCT00940108|7323412|FG001|Overall Study|Adverse Event|4
4513114|NCT00940108|7323413|FG002|Overall Study|Adverse Event|0
4513115|NCT00940108|7323414|FG003|Overall Study|Adverse Event|2
4513116|NCT00940108|7323411|FG000|Overall Study|Withdrew Consent|2
4513117|NCT00940108|7323412|FG001|Overall Study|Withdrew Consent|1
4513118|NCT00940108|7323413|FG002|Overall Study|Withdrew Consent|0
4513119|NCT00940108|7323414|FG003|Overall Study|Withdrew Consent|1
4513120|NCT00940108|7323411|FG000|Overall Study|Dose 2 contraindicated|1
4513121|NCT00940108|7323412|FG001|Overall Study|Dose 2 contraindicated|1
4513122|NCT00940108|7323413|FG002|Overall Study|Dose 2 contraindicated|0
4513123|NCT00940108|7323414|FG003|Overall Study|Dose 2 contraindicated|1
4513124|NCT00940108|7323411|FG000|Overall Study|Declined further vaccination|0
4513125|NCT00940108|7323412|FG001|Overall Study|Declined further vaccination|1
4513126|NCT00940108|7323413|FG002|Overall Study|Declined further vaccination|3
4513127|NCT00940108|7323414|FG003|Overall Study|Declined further vaccination|0
4513128|NCT00940108|7323411|FG000|Overall Study|Refused - pyrexia after Dose 1|0
4513129|NCT00940108|7323412|FG001|Overall Study|Refused - pyrexia after Dose 1|1
4513130|NCT00940108|7323413|FG002|Overall Study|Refused - pyrexia after Dose 1|0
4513131|NCT00940108|7323414|FG003|Overall Study|Refused - pyrexia after Dose 1|0
4513132|NCT00940108|7323411|FG000|Overall Study|Viral illness after Dose 1|0
4513133|NCT00940108|7323412|FG001|Overall Study|Viral illness after Dose 1|1
4513134|NCT00940108|7323413|FG002|Overall Study|Viral illness after Dose 1|0
4513135|NCT00940108|7323414|FG003|Overall Study|Viral illness after Dose 1|0
4513136|NCT00940108|7323411|FG000|Overall Study|Diagnosed with H1N1|0
4513137|NCT00940108|7323412|FG001|Overall Study|Diagnosed with H1N1|0
4513138|NCT00940108|7323413|FG002|Overall Study|Diagnosed with H1N1|0
4513139|NCT00940108|7323414|FG003|Overall Study|Diagnosed with H1N1|1
4513140|NCT00940316|7323444|FG000|Reached First Response at 8 Weeks|Adverse Event|2
4513141|NCT00940316|7323445|FG001|Reached First Response at 8 Weeks|Adverse Event|1
4513142|NCT00940316|7323446|FG002|Reached First Response at 8 Weeks|Adverse Event|0
4513143|NCT00940316|7323444|FG000|Reached First Response at 8 Weeks|Progressive disease|1
4513144|NCT00940316|7323445|FG001|Reached First Response at 8 Weeks|Progressive disease|3
4513145|NCT00940316|7323446|FG002|Reached First Response at 8 Weeks|Progressive disease|0
4513146|NCT00940316|7323444|FG000|Moved on to be Treated Cycle 5|Adverse Event|2
4513147|NCT00940316|7323445|FG001|Moved on to be Treated Cycle 5|Adverse Event|0
4513148|NCT00940316|7323446|FG002|Moved on to be Treated Cycle 5|Adverse Event|0
4513149|NCT00940316|7323444|FG000|Treated After Cycle 5|Adverse Event|0
4513150|NCT00940316|7323445|FG001|Treated After Cycle 5|Adverse Event|0
4513151|NCT00940316|7323446|FG002|Treated After Cycle 5|Adverse Event|1
4630528|NCT01881789|7499219|FG002|Overall Study|Study Terminated by Sponsor|0
4513152|NCT00940316|7323444|FG000|Treated After Cycle 5|Progressive disease|0
4513153|NCT00940316|7323445|FG001|Treated After Cycle 5|Progressive disease|1
4513154|NCT00940316|7323446|FG002|Treated After Cycle 5|Progressive disease|0
4513155|NCT00940342|7323465|FG000|Overall Study|Adverse Event|0
4513156|NCT00940342|7323466|FG001|Overall Study|Adverse Event|2
4630529|NCT01881789|7499220|FG003|Overall Study|Study Terminated by Sponsor|0
4630530|NCT01881789|7499221|FG004|Overall Study|Study Terminated by Sponsor|0
4630531|NCT01881789|7499222|FG005|Overall Study|Study Terminated by Sponsor|1
4630532|NCT01881789|7499217|FG000|Overall Study|Other|3
4630533|NCT01881789|7499218|FG001|Overall Study|Other|5
4630534|NCT01881789|7499219|FG002|Overall Study|Other|2
4630535|NCT01881789|7499220|FG003|Overall Study|Other|3
4630536|NCT01881789|7499221|FG004|Overall Study|Other|1
4630537|NCT01881789|7499222|FG005|Overall Study|Other|1
4630538|NCT01882088|7499261|FG000|Overall Study|Intolerance of esophageal manometry|1
4630539|NCT01882088|7499261|FG000|Overall Study|no possibility to place the catheter|1
4630540|NCT01882088|7499261|FG000|Overall Study|Protocol Violation|1
4513157|NCT00940342|7323467|FG002|Overall Study|Adverse Event|1
4513158|NCT00940485|7323488|FG000|Overall Study|HBeAb positive at Baseline|3
4513159|NCT00940485|7323489|FG001|Overall Study|HBeAb positive at Baseline|2
4513160|NCT00940485|7323488|FG000|Overall Study|Lost to Follow-up|2
4513161|NCT00940485|7323489|FG001|Overall Study|Lost to Follow-up|3
4513162|NCT00940485|7323488|FG000|Overall Study|Adverse Event|8
4513163|NCT00940485|7323489|FG001|Overall Study|Adverse Event|0
4513164|NCT00940485|7323488|FG000|Overall Study|Withdrawal by Subject|1
4513165|NCT00940485|7323489|FG001|Overall Study|Withdrawal by Subject|1
4630541|NCT01882088|7499261|FG000|Overall Study|inadequate pH-impedance tracings|2
4630542|NCT01882257|7499268|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0
4630543|NCT01882257|7499269|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2
4630544|NCT01882257|7499270|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1
4513166|NCT00940485|7323488|FG000|Overall Study|Others|1
4513167|NCT00940485|7323489|FG001|Overall Study|Others|1
4513168|NCT00940602|7323524|FG000|Overall Study|Administrative problems|1
4513169|NCT00940602|7323525|FG001|Overall Study|Administrative problems|1
4513170|NCT00940602|7323524|FG000|Overall Study|Patient/guardian decision|13
4513171|NCT00940602|7323525|FG001|Overall Study|Patient/guardian decision|28
4513172|NCT00940602|7323524|FG000|Overall Study|Physician Decision|8
4513173|NCT00940602|7323525|FG001|Overall Study|Physician Decision|5
4513174|NCT00940602|7323524|FG000|Overall Study|Pregnancy|1
4513175|NCT00940602|7323525|FG001|Overall Study|Pregnancy|0
4513176|NCT00940602|7323524|FG000|Overall Study|Protocol Deviation (untreated)|1
4513177|NCT00940602|7323525|FG001|Overall Study|Protocol Deviation (untreated)|0
4513178|NCT00940602|7323524|FG000|Overall Study|Disease progression|8
4513179|NCT00940602|7323525|FG001|Overall Study|Disease progression|2
4513180|NCT00940602|7323524|FG000|Overall Study|Death|38
4513181|NCT00940602|7323525|FG001|Overall Study|Death|19
4513182|NCT00940602|7323524|FG000|Overall Study|Lost to Follow-up|3
4513183|NCT00940602|7323525|FG001|Overall Study|Lost to Follow-up|1
4513184|NCT00940602|7323524|FG000|Overall Study|Patient withdrew consent|26
4513185|NCT00940602|7323525|FG001|Overall Study|Patient withdrew consent|13
4513186|NCT00940602|7323524|FG000|Overall Study|Adverse Event|7
4513187|NCT00940602|7323525|FG001|Overall Study|Adverse Event|2
4513188|NCT00940602|7323524|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43
4513189|NCT00940602|7323525|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5
4513190|NCT00940823|7323538|FG000|Overall Study|Death|8
4513191|NCT00940823|7323539|FG001|Overall Study|Death|12
4513192|NCT00940823|7323538|FG000|Overall Study|Lost to Follow-up|27
4513193|NCT00940823|7323539|FG001|Overall Study|Lost to Follow-up|20
4513194|NCT00940875|7323549|FG000|Treatment Phase|Adverse Event|9
4513195|NCT00940875|7323550|FG001|Treatment Phase|Adverse Event|3
4513196|NCT00940875|7323549|FG000|Treatment Phase|Death|3
4513197|NCT00940875|7323550|FG001|Treatment Phase|Death|5
4513198|NCT00940875|7323549|FG000|Treatment Phase|Lack of Efficacy|1
4513199|NCT00940875|7323550|FG001|Treatment Phase|Lack of Efficacy|0
4513200|NCT00940875|7323549|FG000|Treatment Phase|Withdrawal by Subject|3
4513201|NCT00940875|7323550|FG001|Treatment Phase|Withdrawal by Subject|0
4513202|NCT00940875|7323549|FG000|Treatment Phase|Disease progression|9
4513203|NCT00940875|7323550|FG001|Treatment Phase|Disease progression|11
4513204|NCT00940875|7323549|FG000|Treatment Phase|Physician Decision|1
4513205|NCT00940875|7323550|FG001|Treatment Phase|Physician Decision|0
4513206|NCT00940875|7323549|FG000|Post-Study Treatment|Death|0
4513207|NCT00940875|7323550|FG001|Post-Study Treatment|Death|1
4513208|NCT00940875|7323549|FG000|Post-Study Treatment|Disease Progression|0
4513209|NCT00940875|7323550|FG001|Post-Study Treatment|Disease Progression|2
4513210|NCT00940888|7323557|FG000|Overall Study|Unsuccessful Implant|4
4513211|NCT00940888|7323557|FG000|Overall Study|Death|461
4513212|NCT00940888|7323557|FG000|Overall Study|Withdrawn - Non-Death|364
4513213|NCT00940888|7323557|FG000|Overall Study|Lost to Follow-up|6
4513214|NCT00940992|7323579|FG000|Overall Study|Adverse Event|2
4513215|NCT00940992|7323580|FG001|Overall Study|Adverse Event|0
4513216|NCT00940992|7323581|FG002|Overall Study|Adverse Event|1
4513217|NCT00940992|7323579|FG000|Overall Study|subject request|2
4513218|NCT00940992|7323580|FG001|Overall Study|subject request|1
4513219|NCT00940992|7323581|FG002|Overall Study|subject request|0
4513220|NCT00940992|7323579|FG000|Overall Study|Lost to Follow-up|0
4513221|NCT00940992|7323580|FG001|Overall Study|Lost to Follow-up|1
4513222|NCT00940992|7323581|FG002|Overall Study|Lost to Follow-up|1
4513223|NCT00941031|7323604|FG000|Induction Period|Lack of Efficacy|2
4513224|NCT00941031|7323605|FG001|Induction Period|Lack of Efficacy|1
4513225|NCT00941031|7323606|FG002|Induction Period|Lack of Efficacy|0
4513226|NCT00941031|7323607|FG003|Induction Period|Lack of Efficacy|5
4513227|NCT00941031|7323608|FG004|Induction Period|Lack of Efficacy|0
4513228|NCT00941031|7323609|FG005|Induction Period|Lack of Efficacy|0
4513229|NCT00941031|7323610|FG006|Induction Period|Lack of Efficacy|0
4513230|NCT00941031|7323604|FG000|Induction Period|Withdrawal by Subject|1
4513231|NCT00941031|7323605|FG001|Induction Period|Withdrawal by Subject|2
4513232|NCT00941031|7323606|FG002|Induction Period|Withdrawal by Subject|2
4513233|NCT00941031|7323607|FG003|Induction Period|Withdrawal by Subject|2
4513234|NCT00941031|7323608|FG004|Induction Period|Withdrawal by Subject|0
4513235|NCT00941031|7323609|FG005|Induction Period|Withdrawal by Subject|0
4513236|NCT00941031|7323610|FG006|Induction Period|Withdrawal by Subject|0
4513237|NCT00941031|7323604|FG000|Induction Period|Adminstative Problems|1
4513238|NCT00941031|7323605|FG001|Induction Period|Adminstative Problems|1
4513239|NCT00941031|7323606|FG002|Induction Period|Adminstative Problems|1
4513240|NCT00941031|7323607|FG003|Induction Period|Adminstative Problems|0
4513241|NCT00941031|7323608|FG004|Induction Period|Adminstative Problems|0
4513242|NCT00941031|7323609|FG005|Induction Period|Adminstative Problems|0
4513243|NCT00941031|7323610|FG006|Induction Period|Adminstative Problems|0
4513244|NCT00941031|7323604|FG000|Induction Period|Adverse Event|1
4513245|NCT00941031|7323605|FG001|Induction Period|Adverse Event|0
4513246|NCT00941031|7323606|FG002|Induction Period|Adverse Event|3
4513247|NCT00941031|7323607|FG003|Induction Period|Adverse Event|2
4513248|NCT00941031|7323608|FG004|Induction Period|Adverse Event|0
4513249|NCT00941031|7323609|FG005|Induction Period|Adverse Event|0
4513250|NCT00941031|7323610|FG006|Induction Period|Adverse Event|0
4513251|NCT00941031|7323604|FG000|Maintenance Period|Withdrawal by Subject|0
4513252|NCT00941031|7323605|FG001|Maintenance Period|Withdrawal by Subject|0
4513253|NCT00941031|7323606|FG002|Maintenance Period|Withdrawal by Subject|0
4513254|NCT00941031|7323607|FG003|Maintenance Period|Withdrawal by Subject|0
4513255|NCT00941031|7323608|FG004|Maintenance Period|Withdrawal by Subject|6
4513256|NCT00941031|7323609|FG005|Maintenance Period|Withdrawal by Subject|2
4513257|NCT00941031|7323610|FG006|Maintenance Period|Withdrawal by Subject|13
4513258|NCT00941031|7323604|FG000|Maintenance Period|Administrative Problems|0
4513259|NCT00941031|7323605|FG001|Maintenance Period|Administrative Problems|0
4513260|NCT00941031|7323606|FG002|Maintenance Period|Administrative Problems|0
4513261|NCT00941031|7323607|FG003|Maintenance Period|Administrative Problems|0
4513262|NCT00941031|7323608|FG004|Maintenance Period|Administrative Problems|1
4513263|NCT00941031|7323609|FG005|Maintenance Period|Administrative Problems|0
4513264|NCT00941031|7323610|FG006|Maintenance Period|Administrative Problems|1
4513265|NCT00941031|7323604|FG000|Maintenance Period|Protocol Violation|0
4513266|NCT00941031|7323605|FG001|Maintenance Period|Protocol Violation|0
4513267|NCT00941031|7323606|FG002|Maintenance Period|Protocol Violation|0
4513268|NCT00941031|7323607|FG003|Maintenance Period|Protocol Violation|0
4513269|NCT00941031|7323608|FG004|Maintenance Period|Protocol Violation|0
4513270|NCT00941031|7323609|FG005|Maintenance Period|Protocol Violation|0
4513271|NCT00941031|7323610|FG006|Maintenance Period|Protocol Violation|1
4513272|NCT00941031|7323604|FG000|Maintenance Period|Adverse Event|0
4513273|NCT00941031|7323605|FG001|Maintenance Period|Adverse Event|0
4513274|NCT00941031|7323606|FG002|Maintenance Period|Adverse Event|0
4513275|NCT00941031|7323607|FG003|Maintenance Period|Adverse Event|0
4513276|NCT00941031|7323608|FG004|Maintenance Period|Adverse Event|0
4513277|NCT00941031|7323609|FG005|Maintenance Period|Adverse Event|2
4513278|NCT00941031|7323610|FG006|Maintenance Period|Adverse Event|8
4513279|NCT00941031|7323604|FG000|Maintenance Period|Lost to Follow-up|0
4513280|NCT00941031|7323605|FG001|Maintenance Period|Lost to Follow-up|0
4513281|NCT00941031|7323606|FG002|Maintenance Period|Lost to Follow-up|0
4513282|NCT00941031|7323607|FG003|Maintenance Period|Lost to Follow-up|0
4513283|NCT00941031|7323608|FG004|Maintenance Period|Lost to Follow-up|2
4513284|NCT00941031|7323609|FG005|Maintenance Period|Lost to Follow-up|2
4513285|NCT00941031|7323610|FG006|Maintenance Period|Lost to Follow-up|7
4513286|NCT00941031|7323604|FG000|Maintenance Period|Lack of Efficacy|0
4513287|NCT00941031|7323605|FG001|Maintenance Period|Lack of Efficacy|0
4513288|NCT00941031|7323606|FG002|Maintenance Period|Lack of Efficacy|0
4513289|NCT00941031|7323607|FG003|Maintenance Period|Lack of Efficacy|0
4513290|NCT00941031|7323608|FG004|Maintenance Period|Lack of Efficacy|0
4513291|NCT00941031|7323609|FG005|Maintenance Period|Lack of Efficacy|0
4513292|NCT00941031|7323610|FG006|Maintenance Period|Lack of Efficacy|13
4513293|NCT00941070|7323629|FG000|Overall Study|Patient non-compliant|1
4513294|NCT00941304|7323640|FG000|Overall Study|Lost to Follow-up|1
4513295|NCT00941304|7323641|FG001|Overall Study|Lost to Follow-up|0
4513296|NCT00941304|7323642|FG002|Overall Study|Lost to Follow-up|0
4513297|NCT00941304|7323643|FG003|Overall Study|Lost to Follow-up|0
4513298|NCT00941304|7323644|FG004|Overall Study|Lost to Follow-up|0
4630545|NCT01882257|7499268|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0
4630546|NCT01882257|7499269|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11
4630547|NCT01882257|7499270|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4
4630548|NCT01882439|7499285|FG000|Overall Study|Adverse event related to study drug|3
4630549|NCT01882439|7499286|FG001|Overall Study|Adverse event related to study drug|8
4630550|NCT01882439|7499287|FG002|Overall Study|Adverse event related to study drug|1
4630551|NCT01882439|7499288|FG003|Overall Study|Adverse event related to study drug|2
4630552|NCT01882439|7499285|FG000|Overall Study|Pregnancy|0
4630553|NCT01882439|7499286|FG001|Overall Study|Pregnancy|1
4630554|NCT01882439|7499287|FG002|Overall Study|Pregnancy|0
4630555|NCT01882439|7499288|FG003|Overall Study|Pregnancy|0
4630556|NCT01882439|7499285|FG000|Overall Study|Protocol Violation|2
4630557|NCT01882439|7499286|FG001|Overall Study|Protocol Violation|2
4630558|NCT01882439|7499287|FG002|Overall Study|Protocol Violation|0
4630559|NCT01882439|7499288|FG003|Overall Study|Protocol Violation|1
4630560|NCT01882439|7499285|FG000|Overall Study|No longer willing to participate|1
4630561|NCT01882439|7499286|FG001|Overall Study|No longer willing to participate|4
4630562|NCT01882439|7499287|FG002|Overall Study|No longer willing to participate|2
4630563|NCT01882439|7499288|FG003|Overall Study|No longer willing to participate|3
4630564|NCT01882439|7499285|FG000|Overall Study|Medication error with no associated AE|0
4630565|NCT01882439|7499286|FG001|Overall Study|Medication error with no associated AE|0
4630566|NCT01882439|7499287|FG002|Overall Study|Medication error with no associated AE|2
4630567|NCT01882439|7499288|FG003|Overall Study|Medication error with no associated AE|0
4630568|NCT01882439|7499285|FG000|Overall Study|Insufficient clinical response|1
4630569|NCT01882439|7499286|FG001|Overall Study|Insufficient clinical response|4
4630570|NCT01882439|7499287|FG002|Overall Study|Insufficient clinical response|4
4630571|NCT01882439|7499288|FG003|Overall Study|Insufficient clinical response|2
4630572|NCT01882439|7499285|FG000|Overall Study|Adverse event unrelated to study drug|2
4513299|NCT00941330|7323658|FG000|Overall Study|Other|1
4513300|NCT00941330|7323659|FG001|Overall Study|Other|0
4513301|NCT00941330|7323658|FG000|Overall Study|Physician Decision|0
4513302|NCT00941330|7323659|FG001|Overall Study|Physician Decision|2
4513303|NCT00941603|7323671|FG000|Overall Study|Adverse Event|10
4513304|NCT00941603|7323672|FG001|Overall Study|Adverse Event|15
4513305|NCT00941603|7323673|FG002|Overall Study|Adverse Event|5
4513306|NCT00941603|7323674|FG003|Overall Study|Adverse Event|1
4513307|NCT00941603|7323675|FG004|Overall Study|Adverse Event|4
4513308|NCT00941603|7323676|FG005|Overall Study|Adverse Event|0
4513309|NCT00941603|7323671|FG000|Overall Study|Lost to Follow-up|0
4513310|NCT00941603|7323672|FG001|Overall Study|Lost to Follow-up|0
4513311|NCT00941603|7323673|FG002|Overall Study|Lost to Follow-up|0
4513312|NCT00941603|7323674|FG003|Overall Study|Lost to Follow-up|1
4513313|NCT00941603|7323675|FG004|Overall Study|Lost to Follow-up|0
4513314|NCT00941603|7323676|FG005|Overall Study|Lost to Follow-up|2
4513315|NCT00941603|7323671|FG000|Overall Study|Withdrawal by Subject|0
4513316|NCT00941603|7323672|FG001|Overall Study|Withdrawal by Subject|0
4513317|NCT00941603|7323673|FG002|Overall Study|Withdrawal by Subject|0
4513318|NCT00941603|7323674|FG003|Overall Study|Withdrawal by Subject|2
4513319|NCT00941603|7323675|FG004|Overall Study|Withdrawal by Subject|0
4513320|NCT00941603|7323676|FG005|Overall Study|Withdrawal by Subject|1
4513321|NCT00941603|7323671|FG000|Overall Study|Protocol Violation|0
4513322|NCT00941603|7323672|FG001|Overall Study|Protocol Violation|1
4513323|NCT00941603|7323673|FG002|Overall Study|Protocol Violation|0
4513324|NCT00941603|7323674|FG003|Overall Study|Protocol Violation|0
4513325|NCT00941603|7323675|FG004|Overall Study|Protocol Violation|0
4513326|NCT00941603|7323676|FG005|Overall Study|Protocol Violation|0
4513327|NCT00941603|7323671|FG000|Overall Study|Did not meet protocol eligibility|1
4513328|NCT00941603|7323672|FG001|Overall Study|Did not meet protocol eligibility|0
4513329|NCT00941603|7323673|FG002|Overall Study|Did not meet protocol eligibility|0
4513330|NCT00941603|7323674|FG003|Overall Study|Did not meet protocol eligibility|0
4513331|NCT00941603|7323675|FG004|Overall Study|Did not meet protocol eligibility|0
4513332|NCT00941603|7323676|FG005|Overall Study|Did not meet protocol eligibility|0
4513333|NCT00941655|7323692|FG000|Overall Study|received some chemo, 4 and 9 cycles|1
4513334|NCT00941655|7323693|FG001|Overall Study|received some chemo, 4 and 9 cycles|0
4513335|NCT00941655|7323692|FG000|Overall Study|not meet criteria for chemo foll surgery|4
4513336|NCT00941655|7323693|FG001|Overall Study|not meet criteria for chemo foll surgery|0
4513337|NCT00941655|7323692|FG000|Overall Study|progressed while on chemo|0
4513338|NCT00941655|7323693|FG001|Overall Study|progressed while on chemo|2
4513339|NCT00941655|7323692|FG000|Overall Study|refused further treatment|0
4513340|NCT00941655|7323693|FG001|Overall Study|refused further treatment|1
4513341|NCT00941655|7323692|FG000|Overall Study|withdrew consent|0
4513342|NCT00941655|7323693|FG001|Overall Study|withdrew consent|1
4513343|NCT00941655|7323692|FG000|Overall Study|non-compliant|0
4513344|NCT00941655|7323693|FG001|Overall Study|non-compliant|1
4513345|NCT00941720|7323722|FG000|Overall Study|Withdrawal by Subject|1
4513346|NCT00941720|7323722|FG000|Overall Study|Insurance denied participation|11
4513347|NCT00941720|7323722|FG000|Overall Study|ineligible|2
4513348|NCT00941733|7323728|FG000|Overall Study|Death|24
4513349|NCT00941733|7323729|FG001|Overall Study|Death|10
4513350|NCT00941733|7323728|FG000|Overall Study|Withdrawal by Subject|14
4513351|NCT00941733|7323729|FG001|Overall Study|Withdrawal by Subject|6
4513352|NCT00941733|7323728|FG000|Overall Study|Adverse Event|20
4630573|NCT01882439|7499286|FG001|Overall Study|Adverse event unrelated to study drug|2
4630574|NCT01882439|7499287|FG002|Overall Study|Adverse event unrelated to study drug|1
4630575|NCT01882439|7499288|FG003|Overall Study|Adverse event unrelated to study drug|1
4630576|NCT01882465|7499303|FG000|Period 1|Lens Discomfort|0
4630577|NCT01882465|7499304|FG001|Period 1|Lens Discomfort|0
4630578|NCT01882465|7499305|FG002|Period 1|Lens Discomfort|0
4630579|NCT01882465|7499306|FG003|Period 1|Lens Discomfort|1
4630580|NCT01882465|7499307|FG004|Period 1|Lens Discomfort|0
4513353|NCT00941733|7323729|FG001|Overall Study|Adverse Event|4
4513354|NCT00941733|7323728|FG000|Overall Study|Lost to Follow-up|1
4513355|NCT00941733|7323729|FG001|Overall Study|Lost to Follow-up|2
4513356|NCT00941733|7323728|FG000|Overall Study|Protocol Violation|15
4513357|NCT00941733|7323729|FG001|Overall Study|Protocol Violation|6
4513358|NCT00941798|7323737|FG000|Overall Study|Withdrawal by Subject|72
4513359|NCT00941798|7323738|FG001|Overall Study|Withdrawal by Subject|74
4513360|NCT00941798|7323737|FG000|Overall Study|Adverse Event|43
4513361|NCT00941798|7323738|FG001|Overall Study|Adverse Event|23
4513362|NCT00941798|7323737|FG000|Overall Study|Lost to Follow-up|29
4513363|NCT00941798|7323738|FG001|Overall Study|Lost to Follow-up|23
4513364|NCT00941798|7323737|FG000|Overall Study|Protocol Violation|17
4513365|NCT00941798|7323738|FG001|Overall Study|Protocol Violation|20
4513366|NCT00941798|7323737|FG000|Overall Study|Administrative problems|13
4513367|NCT00941798|7323738|FG001|Overall Study|Administrative problems|23
4513368|NCT00941798|7323737|FG000|Overall Study|Lack of Efficacy|10
4513369|NCT00941798|7323738|FG001|Overall Study|Lack of Efficacy|17
4513370|NCT00941798|7323737|FG000|Overall Study|Patient's inability to use device|6
4513371|NCT00941798|7323738|FG001|Overall Study|Patient's inability to use device|1
4513372|NCT00941798|7323737|FG000|Overall Study|Abnormal test procedure results|3
4630581|NCT01882465|7499308|FG005|Period 1|Lens Discomfort|0
4630582|NCT01882465|7499309|FG006|Period 1|Lens Discomfort|0
4513373|NCT00941798|7323738|FG001|Overall Study|Abnormal test procedure results|1
4513374|NCT00941798|7323737|FG000|Overall Study|Abnormal laboratory values|1
4513375|NCT00941798|7323738|FG001|Overall Study|Abnormal laboratory values|2
4513376|NCT00941798|7323737|FG000|Overall Study|Death|0
4513377|NCT00941798|7323738|FG001|Overall Study|Death|1
4513378|NCT00941863|7323749|FG000|Until Primary Completion Date (PCD)|Adverse Event|1
4513379|NCT00941863|7323750|FG001|Until Primary Completion Date (PCD)|Adverse Event|2
4513380|NCT00941863|7323751|FG002|Until Primary Completion Date (PCD)|Adverse Event|2
4513381|NCT00941863|7323752|FG003|Until Primary Completion Date (PCD)|Adverse Event|1
4513382|NCT00941863|7323753|FG004|Until Primary Completion Date (PCD)|Adverse Event|5
4513383|NCT00941863|7323749|FG000|Until Primary Completion Date (PCD)|Physician Decision|0
4513384|NCT00941863|7323750|FG001|Until Primary Completion Date (PCD)|Physician Decision|0
4513385|NCT00941863|7323751|FG002|Until Primary Completion Date (PCD)|Physician Decision|0
4513386|NCT00941863|7323752|FG003|Until Primary Completion Date (PCD)|Physician Decision|0
4513387|NCT00941863|7323753|FG004|Until Primary Completion Date (PCD)|Physician Decision|1
4513388|NCT00941863|7323749|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
4513389|NCT00941863|7323750|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
4513390|NCT00941863|7323751|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1
4513391|NCT00941863|7323752|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
4513392|NCT00941863|7323753|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8
4513393|NCT00941863|7323749|FG000|Until Primary Completion Date (PCD)|Death|0
4513394|NCT00941863|7323750|FG001|Until Primary Completion Date (PCD)|Death|0
4513395|NCT00941863|7323751|FG002|Until Primary Completion Date (PCD)|Death|1
4513396|NCT00941863|7323752|FG003|Until Primary Completion Date (PCD)|Death|2
4513397|NCT00941863|7323753|FG004|Until Primary Completion Date (PCD)|Death|7
4513398|NCT00941863|7323749|FG000|Until Primary Completion Date (PCD)|Disease progression|6
4513399|NCT00941863|7323750|FG001|Until Primary Completion Date (PCD)|Disease progression|1
4513400|NCT00941863|7323751|FG002|Until Primary Completion Date (PCD)|Disease progression|8
4513401|NCT00941863|7323752|FG003|Until Primary Completion Date (PCD)|Disease progression|14
4513402|NCT00941863|7323753|FG004|Until Primary Completion Date (PCD)|Disease progression|73
4513403|NCT00941863|7323749|FG000|Continued After PCD|Withdrawal by Subject|0
4513404|NCT00941863|7323750|FG001|Continued After PCD|Withdrawal by Subject|0
4513405|NCT00941863|7323751|FG002|Continued After PCD|Withdrawal by Subject|0
4513406|NCT00941863|7323752|FG003|Continued After PCD|Withdrawal by Subject|0
4513407|NCT00941863|7323753|FG004|Continued After PCD|Withdrawal by Subject|1
4513408|NCT00941863|7323749|FG000|Continued After PCD|Disease progression, recurrence, relapse|0
4513409|NCT00941863|7323750|FG001|Continued After PCD|Disease progression, recurrence, relapse|0
4513410|NCT00941863|7323751|FG002|Continued After PCD|Disease progression, recurrence, relapse|0
4513411|NCT00941863|7323752|FG003|Continued After PCD|Disease progression, recurrence, relapse|0
4513412|NCT00941863|7323753|FG004|Continued After PCD|Disease progression, recurrence, relapse|18
4513413|NCT00942084|7323783|FG000|Overall Study|Death|2
4513414|NCT00942162|7323794|FG000|Overall Study|Death|45
4513415|NCT00942162|7323795|FG001|Overall Study|Death|35
4513416|NCT00942162|7323796|FG002|Overall Study|Death|0
4513417|NCT00942162|7323794|FG000|Overall Study|Withdrawal by Subject|7
4513418|NCT00942162|7323795|FG001|Overall Study|Withdrawal by Subject|2
4513419|NCT00942162|7323796|FG002|Overall Study|Withdrawal by Subject|0
4513420|NCT00942162|7323794|FG000|Overall Study|Lost to Follow-up|4
4513421|NCT00942162|7323795|FG001|Overall Study|Lost to Follow-up|0
4513422|NCT00942162|7323796|FG002|Overall Study|Lost to Follow-up|0
4513423|NCT00942162|7323794|FG000|Overall Study|Other|14
4513424|NCT00942162|7323795|FG001|Overall Study|Other|13
4513425|NCT00942162|7323796|FG002|Overall Study|Other|2
4513426|NCT00942175|7323810|FG000|Overall Study|Adverse Event|2
4513427|NCT00942175|7323811|FG001|Overall Study|Adverse Event|1
4513428|NCT00942175|7323812|FG002|Overall Study|Adverse Event|0
4513429|NCT00942175|7323813|FG003|Overall Study|Adverse Event|0
4513430|NCT00942175|7323810|FG000|Overall Study|Protocol Violation|0
4513431|NCT00942175|7323811|FG001|Overall Study|Protocol Violation|1
4513432|NCT00942175|7323812|FG002|Overall Study|Protocol Violation|2
4513433|NCT00942175|7323813|FG003|Overall Study|Protocol Violation|0
4513434|NCT00942175|7323810|FG000|Overall Study|Pregnancy|0
4513435|NCT00942175|7323811|FG001|Overall Study|Pregnancy|0
4513436|NCT00942175|7323812|FG002|Overall Study|Pregnancy|0
4513437|NCT00942175|7323813|FG003|Overall Study|Pregnancy|1
4513438|NCT00942175|7323810|FG000|Overall Study|Elevated Alanine Amino Transferase|0
4513439|NCT00942175|7323811|FG001|Overall Study|Elevated Alanine Amino Transferase|0
4513440|NCT00942175|7323812|FG002|Overall Study|Elevated Alanine Amino Transferase|0
4513441|NCT00942175|7323813|FG003|Overall Study|Elevated Alanine Amino Transferase|1
4513442|NCT00942175|7323810|FG000|Overall Study|Low Platelet Count|0
4513443|NCT00942175|7323811|FG001|Overall Study|Low Platelet Count|2
4513444|NCT00942175|7323812|FG002|Overall Study|Low Platelet Count|0
4513445|NCT00942175|7323813|FG003|Overall Study|Low Platelet Count|0
4513446|NCT00942188|7323835|FG000|Overall Study|Adverse Event|0
4513447|NCT00942188|7323836|FG001|Overall Study|Adverse Event|3
4513448|NCT00942188|7323837|FG002|Overall Study|Adverse Event|2
4513449|NCT00942188|7323838|FG003|Overall Study|Adverse Event|0
4513450|NCT00942188|7323835|FG000|Overall Study|Lack of Efficacy|0
4513451|NCT00942188|7323836|FG001|Overall Study|Lack of Efficacy|0
4513452|NCT00942188|7323837|FG002|Overall Study|Lack of Efficacy|0
4513453|NCT00942188|7323838|FG003|Overall Study|Lack of Efficacy|1
4513454|NCT00942188|7323835|FG000|Overall Study|Protocol Violation|1
4513455|NCT00942188|7323836|FG001|Overall Study|Protocol Violation|1
4513456|NCT00942188|7323837|FG002|Overall Study|Protocol Violation|0
4513457|NCT00942188|7323838|FG003|Overall Study|Protocol Violation|0
4513458|NCT00942188|7323835|FG000|Overall Study|Lost to Follow-up|2
4513459|NCT00942188|7323836|FG001|Overall Study|Lost to Follow-up|1
4513460|NCT00942188|7323837|FG002|Overall Study|Lost to Follow-up|2
4513461|NCT00942188|7323838|FG003|Overall Study|Lost to Follow-up|0
4513462|NCT00942188|7323835|FG000|Overall Study|Withdrawal by Subject|1
4513463|NCT00942188|7323836|FG001|Overall Study|Withdrawal by Subject|3
4513464|NCT00942188|7323837|FG002|Overall Study|Withdrawal by Subject|4
4513465|NCT00942188|7323838|FG003|Overall Study|Withdrawal by Subject|2
4513466|NCT00942188|7323835|FG000|Overall Study|Physician Decision|0
4513467|NCT00942188|7323836|FG001|Overall Study|Physician Decision|0
4513468|NCT00942188|7323837|FG002|Overall Study|Physician Decision|1
4513469|NCT00942188|7323838|FG003|Overall Study|Physician Decision|0
4513470|NCT00942188|7323835|FG000|Overall Study|Sponsor Decision|0
4513471|NCT00942188|7323836|FG001|Overall Study|Sponsor Decision|2
4513472|NCT00942188|7323837|FG002|Overall Study|Sponsor Decision|0
4513473|NCT00942188|7323838|FG003|Overall Study|Sponsor Decision|1
4513474|NCT00942266|7323850|FG000|Overall Study|Withdrawal by Subject|1
4513475|NCT00942266|7323851|FG001|Overall Study|Withdrawal by Subject|0
4513476|NCT00942266|7323850|FG000|Overall Study|Adverse Event|2
4513477|NCT00942266|7323851|FG001|Overall Study|Adverse Event|1
4513478|NCT00942266|7323850|FG000|Overall Study|Disease Progression|38
4513479|NCT00942266|7323851|FG001|Overall Study|Disease Progression|11
4513480|NCT00942266|7323850|FG000|Overall Study|Failure to thrive and pt withdrawal|0
4513481|NCT00942266|7323851|FG001|Overall Study|Failure to thrive and pt withdrawal|1
4513482|NCT00942266|7323850|FG000|Overall Study|Intercurrent illness|0
4513483|NCT00942266|7323851|FG001|Overall Study|Intercurrent illness|1
4513484|NCT00942266|7323850|FG000|Overall Study|Physician Decision|2
4513485|NCT00942266|7323851|FG001|Overall Study|Physician Decision|0
4513486|NCT00942266|7323850|FG000|Overall Study|medical deterioration (pneumonia)|0
4513487|NCT00942266|7323851|FG001|Overall Study|medical deterioration (pneumonia)|1
4513488|NCT00942357|7323900|FG000|Overall Study|Ineligible|37
4513489|NCT00942357|7323901|FG001|Overall Study|Ineligible|40
4513490|NCT00942422|7323907|FG000|Overall Study|Withdrawal by Subject|1
4513491|NCT00942422|7323907|FG000|Overall Study|Death|1
4513492|NCT00942422|7323907|FG000|Overall Study|Progressive diease|1
4518517|NCT00974974|7330744|FG000|IPX066 Dose Conversion|Lack of Efficacy|13
4518518|NCT00974974|7330745|FG001|IPX066 Dose Conversion|Lack of Efficacy|0
4518519|NCT00974974|7330744|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12
4518520|NCT00974974|7330745|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0
4518521|NCT00974974|7330744|FG000|IPX066 Dose Conversion|Various|3
4518522|NCT00974974|7330745|FG001|IPX066 Dose Conversion|Various|0
4518523|NCT00974974|7330744|FG000|IPX066 Dose Conversion|Protocol Violation|4
4518524|NCT00974974|7330745|FG001|IPX066 Dose Conversion|Protocol Violation|0
4518525|NCT00974974|7330744|FG000|Maintenance - Double Blind Treatment|Adverse Event|3
4518526|NCT00974974|7330745|FG001|Maintenance - Double Blind Treatment|Adverse Event|3
4518527|NCT00974974|7330744|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1
4518528|NCT00974974|7330745|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1
4518529|NCT00974974|7330744|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0
4518530|NCT00974974|7330745|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1
4518531|NCT00974974|7330744|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2
4518532|NCT00974974|7330745|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2
4518533|NCT00974974|7330744|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0
4518534|NCT00974974|7330745|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1
4518535|NCT00974974|7330744|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5
4518536|NCT00974974|7330745|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2
4518537|NCT00974974|7330744|FG000|Maintenance - Double Blind Treatment|Various|4
4518538|NCT00974974|7330745|FG001|Maintenance - Double Blind Treatment|Various|0
4518539|NCT00975000|7330753|FG000|Overall Study|Other|1
4518540|NCT00975000|7330754|FG001|Overall Study|Other|0
4518541|NCT00975000|7330753|FG000|Overall Study|Adverse Event|1
4518542|NCT00975000|7330754|FG001|Overall Study|Adverse Event|1
4518543|NCT00975000|7330753|FG000|Overall Study|Withdrawal by Subject|2
4518544|NCT00975000|7330754|FG001|Overall Study|Withdrawal by Subject|2
4518545|NCT00975000|7330753|FG000|Overall Study|Lost to Follow-up|0
4518546|NCT00975000|7330754|FG001|Overall Study|Lost to Follow-up|1
4518547|NCT00975000|7330753|FG000|Overall Study|Protocol-specified Criteria|1
4518548|NCT00975000|7330754|FG001|Overall Study|Protocol-specified Criteria|0
4518549|NCT00975000|7330753|FG000|Overall Study|Non-compliance|0
4518550|NCT00975000|7330754|FG001|Overall Study|Non-compliance|1
4518551|NCT00975130|7330760|FG000|Study Part 1|Adverse Event|150
4518552|NCT00975130|7330761|FG001|Study Part 1|Adverse Event|0
4518553|NCT00975130|7330762|FG002|Study Part 1|Adverse Event|0
4518554|NCT00975130|7330760|FG000|Study Part 1|Lost to Follow-up|19
4518555|NCT00975130|7330761|FG001|Study Part 1|Lost to Follow-up|0
4518556|NCT00975130|7330762|FG002|Study Part 1|Lost to Follow-up|0
4518557|NCT00975130|7330760|FG000|Study Part 1|Withdrawal by Subject|61
4518558|NCT00975130|7330761|FG001|Study Part 1|Withdrawal by Subject|0
4518559|NCT00975130|7330762|FG002|Study Part 1|Withdrawal by Subject|0
4518560|NCT00975130|7330760|FG000|Study Part 1|Protocol Violation|13
4518561|NCT00975130|7330761|FG001|Study Part 1|Protocol Violation|0
4518562|NCT00975130|7330762|FG002|Study Part 1|Protocol Violation|0
4513493|NCT00942604|7323952|FG000|Overall Study|Protocol Violation|1
4513494|NCT00942604|7323953|FG001|Overall Study|Protocol Violation|1
4513495|NCT00942604|7323952|FG000|Overall Study|Adverse Event|0
4513496|NCT00942604|7323953|FG001|Overall Study|Adverse Event|1
4513497|NCT00942604|7323952|FG000|Overall Study|Withdrawal by Subject|0
4513498|NCT00942604|7323953|FG001|Overall Study|Withdrawal by Subject|1
4513499|NCT00942604|7323952|FG000|Overall Study|Patient relocation|1
4513500|NCT00942604|7323953|FG001|Overall Study|Patient relocation|1
4513501|NCT00942708|7323959|FG000|Overall Study|Withdrawal by Subject|1
4513502|NCT00942734|7323964|FG000|Overall Study|Adverse Event|2
4513503|NCT00942734|7323964|FG000|Overall Study|Protocol Violation|3
4513504|NCT00942734|7323964|FG000|Overall Study|Disease Progression|2
4513505|NCT00942734|7323964|FG000|Overall Study|Physician Decision|1
4513506|NCT00942968|7324011|FG000|Overall Study|Adverse Event|60
4513507|NCT00942968|7324011|FG000|Overall Study|Death|76
4513508|NCT00942968|7324011|FG000|Overall Study|Protocol Violation|9
4513509|NCT00942968|7324011|FG000|Overall Study|Lost to Follow-up|4
4513510|NCT00942968|7324011|FG000|Overall Study|Withdrawal by Subject|44
4513511|NCT00942968|7324011|FG000|Overall Study|Sponsor request|5
4513512|NCT00942968|7324011|FG000|Overall Study|Physician Decision|11
4513513|NCT00942968|7324011|FG000|Overall Study|Progression of disease|12
4513514|NCT00942968|7324011|FG000|Overall Study|Inferior vena cava filter placement|4
4513515|NCT00942968|7324011|FG000|Overall Study|Pulmonary embolism (PE)|1
4513516|NCT00942968|7324011|FG000|Overall Study|Participant required pancreatic biopsy|1
4513517|NCT00942968|7324011|FG000|Overall Study|Deep vein thrombosis (DVT)|2
4513518|NCT00942994|7324017|FG000|Overall Study|Adverse Event|7
4513519|NCT00942994|7324018|FG001|Overall Study|Adverse Event|4
4513520|NCT00942994|7324017|FG000|Overall Study|Abnormal laboratory value(s)|1
4513521|NCT00942994|7324018|FG001|Overall Study|Abnormal laboratory value(s)|0
4513522|NCT00942994|7324017|FG000|Overall Study|Unsatisfactory therapeutic effect|1
4513523|NCT00942994|7324018|FG001|Overall Study|Unsatisfactory therapeutic effect|1
4513524|NCT00942994|7324017|FG000|Overall Study|Patient withdrew consent|5
4513525|NCT00942994|7324018|FG001|Overall Study|Patient withdrew consent|8
4513526|NCT00942994|7324017|FG000|Overall Study|Lost to Follow-up|1
4513527|NCT00942994|7324018|FG001|Overall Study|Lost to Follow-up|4
4513528|NCT00942994|7324017|FG000|Overall Study|Protocol deviation|1
4513529|NCT00942994|7324018|FG001|Overall Study|Protocol deviation|2
4513530|NCT00943072|7324026|FG000|Overall Study|Adverse Event|0
4513531|NCT00943072|7324027|FG001|Overall Study|Adverse Event|3
4513532|NCT00943072|7324026|FG000|Overall Study|Death|0
4513533|NCT00943072|7324027|FG001|Overall Study|Death|2
4513534|NCT00943072|7324026|FG000|Overall Study|Withdrawal by Subject|3
4513535|NCT00943072|7324027|FG001|Overall Study|Withdrawal by Subject|1
4513536|NCT00943072|7324026|FG000|Overall Study|Protocol Violation|0
4513537|NCT00943072|7324027|FG001|Overall Study|Protocol Violation|1
4513538|NCT00943072|7324026|FG000|Overall Study|Lost to Follow-up|1
4513539|NCT00943072|7324027|FG001|Overall Study|Lost to Follow-up|2
4513540|NCT00943072|7324026|FG000|Overall Study|Lack of Efficacy|0
4513541|NCT00943072|7324027|FG001|Overall Study|Lack of Efficacy|4
4590541|NCT01522651|7436636|FG001|Overall Study|Protocol Violation|0
4590542|NCT01522651|7436637|FG002|Overall Study|Protocol Violation|0
4590543|NCT01522651|7436638|FG003|Overall Study|Protocol Violation|0
4590544|NCT01522651|7436639|FG004|Overall Study|Protocol Violation|0
4630583|NCT01882465|7499303|FG000|Period 1|Withdrawal by Subject|0
4630584|NCT01882465|7499304|FG001|Period 1|Withdrawal by Subject|0
4630585|NCT01882465|7499305|FG002|Period 1|Withdrawal by Subject|0
4630586|NCT01882465|7499306|FG003|Period 1|Withdrawal by Subject|0
4630587|NCT01882465|7499307|FG004|Period 1|Withdrawal by Subject|0
4630588|NCT01882465|7499308|FG005|Period 1|Withdrawal by Subject|0
4630589|NCT01882465|7499309|FG006|Period 1|Withdrawal by Subject|1
4630590|NCT01882465|7499303|FG000|Period 2|Protocol Violation|0
4630591|NCT01882465|7499304|FG001|Period 2|Protocol Violation|0
4630592|NCT01882465|7499305|FG002|Period 2|Protocol Violation|0
4590545|NCT01522651|7436635|FG000|Overall Study|Reason Not Specified|0
4590546|NCT01522651|7436636|FG001|Overall Study|Reason Not Specified|0
4716516|NCT02994940|7645968|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0
4716517|NCT02994940|7645967|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1
4716518|NCT02994940|7645968|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0
4771725|NCT04620798|7748597|FG000|Overall Study|Lost to Follow-up|126
4590547|NCT01522651|7436637|FG002|Overall Study|Reason Not Specified|0
4630593|NCT01882465|7499306|FG003|Period 2|Protocol Violation|0
4630594|NCT01882465|7499307|FG004|Period 2|Protocol Violation|1
4630595|NCT01882465|7499308|FG005|Period 2|Protocol Violation|0
4630596|NCT01882465|7499309|FG006|Period 2|Protocol Violation|0
4630597|NCT01882647|7499329|FG000|Overall Study|Lost to Follow-up|2
4630598|NCT01882647|7499330|FG001|Overall Study|Lost to Follow-up|2
4590548|NCT01522651|7436638|FG003|Overall Study|Reason Not Specified|1
4590549|NCT01522651|7436639|FG004|Overall Study|Reason Not Specified|0
4513542|NCT00943072|7324026|FG000|Overall Study|Other|1
4513543|NCT00943072|7324027|FG001|Overall Study|Other|1
4513544|NCT00943111|7324046|FG000|52-Weeks Primary Analysis Period|Adverse Event|2
4513545|NCT00943111|7324047|FG001|52-Weeks Primary Analysis Period|Adverse Event|1
4513546|NCT00943111|7324048|FG002|52-Weeks Primary Analysis Period|Adverse Event|0
4630599|NCT01882647|7499329|FG000|Overall Study|Withdrawal by Subject|0
4513547|NCT00943111|7324046|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0
4513548|NCT00943111|7324047|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1
4513549|NCT00943111|7324048|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0
4513550|NCT00943111|7324046|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0
4513551|NCT00943111|7324047|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0
4513552|NCT00943111|7324048|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51
4513553|NCT00943111|7324046|FG000|5 Years Long-term Treatment Period|Adverse Event|0
4513554|NCT00943111|7324047|FG001|5 Years Long-term Treatment Period|Adverse Event|0
4513555|NCT00943111|7324048|FG002|5 Years Long-term Treatment Period|Adverse Event|9
4513556|NCT00943111|7324046|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0
4513557|NCT00943111|7324047|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0
4513558|NCT00943111|7324048|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8
4513559|NCT00943111|7324046|FG000|5 Years Long-term Treatment Period|Pregnancy|0
4513560|NCT00943111|7324047|FG001|5 Years Long-term Treatment Period|Pregnancy|0
4513561|NCT00943111|7324048|FG002|5 Years Long-term Treatment Period|Pregnancy|4
4513562|NCT00943111|7324046|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0
4513563|NCT00943111|7324047|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0
4513564|NCT00943111|7324048|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1
4513565|NCT00943111|7324046|FG000|5 Years Long-term Treatment Period|Other than specified above|0
4513566|NCT00943111|7324047|FG001|5 Years Long-term Treatment Period|Other than specified above|0
4513567|NCT00943111|7324048|FG002|5 Years Long-term Treatment Period|Other than specified above|2
4513568|NCT00943124|7324055|FG000|Period 1|Withdrawal by Subject|1
4513569|NCT00943124|7324056|FG001|Period 1|Withdrawal by Subject|1
4513570|NCT00943124|7324055|FG000|Period 1|Did Not Follow Study Procedures|1
4513571|NCT00943124|7324056|FG001|Period 1|Did Not Follow Study Procedures|0
4513572|NCT00943124|7324055|FG000|Period 1|Personal Reasons|0
4513573|NCT00943124|7324056|FG001|Period 1|Personal Reasons|1
4513574|NCT00943306|7324093|FG000|Overall Study|Physician Decision|1
4513575|NCT00943306|7324093|FG000|Overall Study|Death|1
4513576|NCT00943306|7324093|FG000|Overall Study|Sponsor decision due to non-compliance|1
4513577|NCT00943319|7324097|FG000|Overall Study|Death|1
4513578|NCT00943384|7324101|FG000|Overall Study|Dispositioned prior to treatment|23
4513579|NCT00943384|7324101|FG000|Overall Study|Treated off protocol-protocol violation|5
4513580|NCT00943384|7324101|FG000|Overall Study|Lost to Follow-up|16
4513581|NCT00943384|7324101|FG000|Overall Study|Withdrawal by Subject|5
4513582|NCT00943579|7324125|FG000|Overall Study|Adverse Event|4
4513583|NCT00943579|7324126|FG001|Overall Study|Adverse Event|3
4513584|NCT00943579|7324125|FG000|Overall Study|Lack of Efficacy|2
4513585|NCT00943579|7324126|FG001|Overall Study|Lack of Efficacy|2
4513586|NCT00943592|7324135|FG000|Overall Study|Death|3
4513587|NCT00943670|7324148|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2
4513588|NCT00943670|7324148|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3
4513589|NCT00943670|7324148|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15
4513590|NCT00943670|7324148|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2
4513591|NCT00943670|7324148|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20
4513592|NCT00943670|7324148|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1
4513593|NCT00943670|7324148|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4
4513594|NCT00943670|7324148|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6
4513595|NCT00943670|7324148|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2
4513596|NCT00943670|7324148|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5
4513597|NCT00943722|7324168|FG000|Overall Study|Adverse Event|0
4513598|NCT00943722|7324169|FG001|Overall Study|Adverse Event|0
4513599|NCT00943722|7324170|FG002|Overall Study|Adverse Event|0
4513600|NCT00943722|7324171|FG003|Overall Study|Adverse Event|1
4513601|NCT00943722|7324172|FG004|Overall Study|Adverse Event|0
4513602|NCT00943722|7324168|FG000|Overall Study|Lost to Follow-up|12
4513603|NCT00943722|7324169|FG001|Overall Study|Lost to Follow-up|8
4513604|NCT00943722|7324170|FG002|Overall Study|Lost to Follow-up|10
4513605|NCT00943722|7324171|FG003|Overall Study|Lost to Follow-up|8
4513606|NCT00943722|7324172|FG004|Overall Study|Lost to Follow-up|11
4513607|NCT00943722|7324168|FG000|Overall Study|Physician Decision|1
4513608|NCT00943722|7324169|FG001|Overall Study|Physician Decision|0
4513609|NCT00943722|7324170|FG002|Overall Study|Physician Decision|0
4513610|NCT00943722|7324171|FG003|Overall Study|Physician Decision|0
4513611|NCT00943722|7324172|FG004|Overall Study|Physician Decision|1
4513612|NCT00943722|7324168|FG000|Overall Study|Pregnancy|0
4513613|NCT00943722|7324169|FG001|Overall Study|Pregnancy|0
4513614|NCT00943722|7324170|FG002|Overall Study|Pregnancy|1
4513615|NCT00943722|7324171|FG003|Overall Study|Pregnancy|0
4513616|NCT00943722|7324172|FG004|Overall Study|Pregnancy|0
4513617|NCT00943722|7324168|FG000|Overall Study|Protocol Violation|0
4513618|NCT00943722|7324169|FG001|Overall Study|Protocol Violation|1
4513619|NCT00943722|7324170|FG002|Overall Study|Protocol Violation|0
4513620|NCT00943722|7324171|FG003|Overall Study|Protocol Violation|0
4513621|NCT00943722|7324172|FG004|Overall Study|Protocol Violation|2
4513622|NCT00943722|7324168|FG000|Overall Study|Withdrawal by Subject|12
4513623|NCT00943722|7324169|FG001|Overall Study|Withdrawal by Subject|13
4513624|NCT00943722|7324170|FG002|Overall Study|Withdrawal by Subject|2
4513625|NCT00943722|7324171|FG003|Overall Study|Withdrawal by Subject|13
4513626|NCT00943722|7324172|FG004|Overall Study|Withdrawal by Subject|8
4513627|NCT00943735|7324186|FG000|Overall Study|Adverse Event|12
4513628|NCT00943735|7324186|FG000|Overall Study|Withdrawal by Subject|8
4513629|NCT00943735|7324186|FG000|Overall Study|Death|1
4513630|NCT00943735|7324186|FG000|Overall Study|Other|8
4513631|NCT00943735|7324186|FG000|Overall Study|Other|3
4513632|NCT00943761|7324192|FG000|Overall Study|Lost to Follow-up|2
4513633|NCT00943761|7324193|FG001|Overall Study|Lost to Follow-up|0
4513634|NCT00943761|7324192|FG000|Overall Study|Withdrawal by Subject|2
4513635|NCT00943761|7324193|FG001|Overall Study|Withdrawal by Subject|1
4513636|NCT00943787|7324199|FG000|Overall Study|Physician Decision|4
4513637|NCT00943787|7324199|FG000|Overall Study|Withdrawal by Subject|3
4513638|NCT00943826|7324209|FG000|Concurrent Phase|Adverse Event|50
4513639|NCT00943826|7324210|FG001|Concurrent Phase|Adverse Event|27
4513640|NCT00943826|7324209|FG000|Concurrent Phase|Withdrew consent|3
4513641|NCT00943826|7324210|FG001|Concurrent Phase|Withdrew consent|7
4513642|NCT00943826|7324209|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5
4513643|NCT00943826|7324210|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7
4513644|NCT00943826|7324209|FG000|Concurrent Phase|Administrative reasons|2
4513645|NCT00943826|7324210|FG001|Concurrent Phase|Administrative reasons|1
4513646|NCT00943826|7324209|FG000|Concurrent Phase|Protocol Violation|1
4513647|NCT00943826|7324210|FG001|Concurrent Phase|Protocol Violation|0
4513648|NCT00943826|7324209|FG000|Maintenance Phase|Adverse Event|31
4513649|NCT00943826|7324210|FG001|Maintenance Phase|Adverse Event|30
4513650|NCT00943826|7324209|FG000|Maintenance Phase|Withdrew consent|2
4513651|NCT00943826|7324210|FG001|Maintenance Phase|Withdrew consent|4
4513652|NCT00943826|7324209|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6
4513653|NCT00943826|7324210|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3
4513654|NCT00943826|7324209|FG000|Maintenance Phase|Administrative reasons|4
4513655|NCT00943826|7324210|FG001|Maintenance Phase|Administrative reasons|1
4513656|NCT00943826|7324209|FG000|Maintenance Phase|Failure to return|0
4513657|NCT00943826|7324210|FG001|Maintenance Phase|Failure to return|1
4513658|NCT00943826|7324209|FG000|Monotherapy Phase|Adverse Event|42
4513659|NCT00943826|7324210|FG001|Monotherapy Phase|Adverse Event|5
4513660|NCT00943826|7324209|FG000|Monotherapy Phase|Administrative reasons|11
4513661|NCT00943826|7324210|FG001|Monotherapy Phase|Administrative reasons|5
4513662|NCT00943826|7324209|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8
4513663|NCT00943826|7324210|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2
4513664|NCT00943826|7324209|FG000|Monotherapy Phase|Withdrew Consent|2
4630600|NCT01882647|7499330|FG001|Overall Study|Withdrawal by Subject|4
4630601|NCT01882803|7499349|FG000|Overall Study|Disease Progression|53
4630602|NCT01882803|7499349|FG000|Overall Study|Adverse Event|22
4630603|NCT01882803|7499349|FG000|Overall Study|Death|7
4630604|NCT01882803|7499349|FG000|Overall Study|Physician Decision|7
4630605|NCT01882803|7499349|FG000|Overall Study|Protocol Violation|1
4630606|NCT01882803|7499349|FG000|Overall Study|Withdrawal by Subject|4
4630607|NCT01882829|7499354|FG000|Overall Study|Adverse Event|4
4630608|NCT01882829|7499354|FG000|Overall Study|Protocol Violation|1
4630609|NCT01882829|7499354|FG000|Overall Study|Withdrawal by Subject|1
4630610|NCT01882907|7499364|FG000|Overall Study|Adverse Event|3
4630611|NCT01882907|7499365|FG001|Overall Study|Adverse Event|1
4630612|NCT01882907|7499364|FG000|Overall Study|Lack of Efficacy|0
4630613|NCT01882907|7499365|FG001|Overall Study|Lack of Efficacy|3
4630614|NCT01882907|7499364|FG000|Overall Study|Lost to Follow-up|1
4630615|NCT01882907|7499365|FG001|Overall Study|Lost to Follow-up|4
4630616|NCT01882907|7499364|FG000|Overall Study|Protocol Violation|10
4630617|NCT01882907|7499365|FG001|Overall Study|Protocol Violation|14
4630618|NCT01882907|7499364|FG000|Overall Study|Withdrawal by Subject|0
4630619|NCT01882907|7499365|FG001|Overall Study|Withdrawal by Subject|6
4630620|NCT01882985|7499373|FG000|Overall Study|Lost to Follow-up|1
4630621|NCT01882985|7499373|FG000|Overall Study|Withdrawal by Subject|1
4630622|NCT01883362|7499383|FG000|Treatment|Adverse Event|1
4716519|NCT02994940|7645967|FG000|Overall Study|Did not receive study medications: red dye allergy|0
4716520|NCT02994940|7645968|FG001|Overall Study|Did not receive study medications: red dye allergy|1
4716521|NCT02995980|7645992|FG000|Overall Study|Lost to Follow-up|14
4716522|NCT02996097|7645997|FG000|Overall Study|Lost to Follow-up|11
4716523|NCT02996097|7645998|FG001|Overall Study|Lost to Follow-up|11
4716524|NCT02996448|7646003|FG000|Overall Study|Study terminated due to adverse effects|3
4716525|NCT02996474|7646008|FG000|Overall Study|Physician Decision|5
4716526|NCT02996500|7646018|FG000|Overall Study|Adverse Event|1
4716527|NCT02996500|7646019|FG001|Overall Study|Adverse Event|1
4716528|NCT02996500|7646020|FG002|Overall Study|Adverse Event|4
4716529|NCT02996500|7646021|FG003|Overall Study|Adverse Event|3
4716530|NCT02996500|7646022|FG004|Overall Study|Adverse Event|1
4716531|NCT02996500|7646023|FG005|Overall Study|Adverse Event|2
4716532|NCT02996500|7646018|FG000|Overall Study|Lack of Efficacy|0
4630623|NCT01883362|7499384|FG001|Treatment|Adverse Event|8
4513665|NCT00943826|7324210|FG001|Monotherapy Phase|Withdrew Consent|3
4513666|NCT00943826|7324209|FG000|Monotherapy Phase|Failure to return|2
4630624|NCT01883362|7499383|FG000|Treatment|Withdrawal by Subject|6
4630625|NCT01883362|7499384|FG001|Treatment|Withdrawal by Subject|2
4630626|NCT01883362|7499383|FG000|Treatment|Administrative problems|4
4513667|NCT00943826|7324210|FG001|Monotherapy Phase|Failure to return|1
4513668|NCT00943826|7324209|FG000|After Primary Overall Survival Analysis|Adverse Event|11
4513669|NCT00943826|7324210|FG001|After Primary Overall Survival Analysis|Adverse Event|0
4513670|NCT00943826|7324209|FG000|After Primary Overall Survival Analysis|Administrative reasons|10
4513671|NCT00943826|7324210|FG001|After Primary Overall Survival Analysis|Administrative reasons|16
4513672|NCT00943826|7324209|FG000|After Primary Overall Survival Analysis|Progression of Disease|2
4513673|NCT00943826|7324210|FG001|After Primary Overall Survival Analysis|Progression of Disease|4
4513674|NCT00943826|7324209|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4
4513675|NCT00943826|7324210|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0
4513676|NCT00943917|7324253|FG000|Stage I|Adverse Event|1
4513677|NCT00943917|7324254|FG001|Stage I|Adverse Event|2
4513678|NCT00943917|7324255|FG002|Stage I|Adverse Event|2
4513679|NCT00943917|7324256|FG003|Stage I|Adverse Event|0
4513680|NCT00943917|7324257|FG004|Stage I|Adverse Event|0
4513681|NCT00943917|7324258|FG005|Stage I|Adverse Event|0
4513682|NCT00943917|7324259|FG006|Stage I|Adverse Event|0
4513683|NCT00943917|7324260|FG007|Stage I|Adverse Event|0
4513684|NCT00943917|7324261|FG008|Stage I|Adverse Event|0
4513685|NCT00943917|7324262|FG009|Stage I|Adverse Event|0
4513686|NCT00943917|7324263|FG010|Stage I|Adverse Event|0
4513687|NCT00943917|7324264|FG011|Stage I|Adverse Event|0
4513688|NCT00943917|7324265|FG012|Stage I|Adverse Event|0
4513689|NCT00943917|7324266|FG013|Stage I|Adverse Event|0
4513690|NCT00943917|7324267|FG014|Stage I|Adverse Event|0
4513691|NCT00943917|7324253|FG000|Stage I|Lost to Follow-up|0
4513692|NCT00943917|7324254|FG001|Stage I|Lost to Follow-up|0
4513693|NCT00943917|7324255|FG002|Stage I|Lost to Follow-up|1
4513694|NCT00943917|7324256|FG003|Stage I|Lost to Follow-up|0
4513695|NCT00943917|7324257|FG004|Stage I|Lost to Follow-up|0
4513696|NCT00943917|7324258|FG005|Stage I|Lost to Follow-up|0
4513697|NCT00943917|7324259|FG006|Stage I|Lost to Follow-up|0
4513698|NCT00943917|7324260|FG007|Stage I|Lost to Follow-up|0
4513699|NCT00943917|7324261|FG008|Stage I|Lost to Follow-up|0
4513700|NCT00943917|7324262|FG009|Stage I|Lost to Follow-up|0
4513701|NCT00943917|7324263|FG010|Stage I|Lost to Follow-up|0
4513702|NCT00943917|7324264|FG011|Stage I|Lost to Follow-up|0
4513703|NCT00943917|7324265|FG012|Stage I|Lost to Follow-up|0
4513704|NCT00943917|7324266|FG013|Stage I|Lost to Follow-up|0
4513705|NCT00943917|7324267|FG014|Stage I|Lost to Follow-up|0
4513706|NCT00943917|7324253|FG000|Stage I|hyperglycemia|0
4513707|NCT00943917|7324254|FG001|Stage I|hyperglycemia|0
4513708|NCT00943917|7324255|FG002|Stage I|hyperglycemia|1
4513709|NCT00943917|7324256|FG003|Stage I|hyperglycemia|0
4513710|NCT00943917|7324257|FG004|Stage I|hyperglycemia|0
4513711|NCT00943917|7324258|FG005|Stage I|hyperglycemia|0
4513712|NCT00943917|7324259|FG006|Stage I|hyperglycemia|0
4513713|NCT00943917|7324260|FG007|Stage I|hyperglycemia|0
4513714|NCT00943917|7324261|FG008|Stage I|hyperglycemia|0
4513715|NCT00943917|7324262|FG009|Stage I|hyperglycemia|0
4513716|NCT00943917|7324263|FG010|Stage I|hyperglycemia|0
4513717|NCT00943917|7324264|FG011|Stage I|hyperglycemia|0
4630627|NCT01883362|7499384|FG001|Treatment|Administrative problems|1
4630628|NCT01883362|7499383|FG000|Treatment|Relapse|4
4716533|NCT02996500|7646019|FG001|Overall Study|Lack of Efficacy|0
4716534|NCT02996500|7646020|FG002|Overall Study|Lack of Efficacy|0
4716535|NCT02996500|7646021|FG003|Overall Study|Lack of Efficacy|0
4716536|NCT02996500|7646022|FG004|Overall Study|Lack of Efficacy|2
4716537|NCT02996500|7646023|FG005|Overall Study|Lack of Efficacy|0
4716538|NCT02996500|7646018|FG000|Overall Study|Lost to Follow-up|1
4716539|NCT02996500|7646019|FG001|Overall Study|Lost to Follow-up|0
4716540|NCT02996500|7646020|FG002|Overall Study|Lost to Follow-up|0
4716541|NCT02996500|7646021|FG003|Overall Study|Lost to Follow-up|0
4716542|NCT02996500|7646022|FG004|Overall Study|Lost to Follow-up|0
4716543|NCT02996500|7646023|FG005|Overall Study|Lost to Follow-up|1
4716544|NCT02996500|7646018|FG000|Overall Study|No Longer Meets Eligibility Criteria|0
4716545|NCT02996500|7646019|FG001|Overall Study|No Longer Meets Eligibility Criteria|0
4716546|NCT02996500|7646020|FG002|Overall Study|No Longer Meets Eligibility Criteria|1
4716547|NCT02996500|7646021|FG003|Overall Study|No Longer Meets Eligibility Criteria|0
4716548|NCT02996500|7646022|FG004|Overall Study|No Longer Meets Eligibility Criteria|0
4716549|NCT02996500|7646023|FG005|Overall Study|No Longer Meets Eligibility Criteria|0
4716550|NCT02996500|7646018|FG000|Overall Study|Non-Compliance With Study Drug|0
4716551|NCT02996500|7646019|FG001|Overall Study|Non-Compliance With Study Drug|0
4716552|NCT02996500|7646020|FG002|Overall Study|Non-Compliance With Study Drug|0
4513718|NCT00943917|7324265|FG012|Stage I|hyperglycemia|0
4513719|NCT00943917|7324266|FG013|Stage I|hyperglycemia|0
4513720|NCT00943917|7324267|FG014|Stage I|hyperglycemia|0
4513721|NCT00943917|7324253|FG000|Stage I|A1C elevation|1
4513722|NCT00943917|7324254|FG001|Stage I|A1C elevation|0
4513723|NCT00943917|7324255|FG002|Stage I|A1C elevation|0
4513724|NCT00943917|7324256|FG003|Stage I|A1C elevation|0
4630629|NCT01883362|7499384|FG001|Treatment|Relapse|2
4716553|NCT02996500|7646021|FG003|Overall Study|Non-Compliance With Study Drug|0
4513725|NCT00943917|7324257|FG004|Stage I|A1C elevation|0
4513726|NCT00943917|7324258|FG005|Stage I|A1C elevation|0
4513727|NCT00943917|7324259|FG006|Stage I|A1C elevation|0
4513728|NCT00943917|7324260|FG007|Stage I|A1C elevation|0
4513729|NCT00943917|7324261|FG008|Stage I|A1C elevation|0
4513730|NCT00943917|7324262|FG009|Stage I|A1C elevation|0
4771726|NCT04620798|7748598|FG001|Overall Study|Lost to Follow-up|138
4513731|NCT00943917|7324263|FG010|Stage I|A1C elevation|0
4513732|NCT00943917|7324264|FG011|Stage I|A1C elevation|0
4513733|NCT00943917|7324265|FG012|Stage I|A1C elevation|0
4513734|NCT00943917|7324266|FG013|Stage I|A1C elevation|0
4513735|NCT00943917|7324267|FG014|Stage I|A1C elevation|0
4513736|NCT00943917|7324253|FG000|Stage I|Withdrawal by Subject|2
4513737|NCT00943917|7324254|FG001|Stage I|Withdrawal by Subject|1
4513738|NCT00943917|7324255|FG002|Stage I|Withdrawal by Subject|2
4513739|NCT00943917|7324256|FG003|Stage I|Withdrawal by Subject|0
4513740|NCT00943917|7324257|FG004|Stage I|Withdrawal by Subject|0
4513741|NCT00943917|7324258|FG005|Stage I|Withdrawal by Subject|0
4513742|NCT00943917|7324259|FG006|Stage I|Withdrawal by Subject|0
4513743|NCT00943917|7324260|FG007|Stage I|Withdrawal by Subject|0
4513744|NCT00943917|7324261|FG008|Stage I|Withdrawal by Subject|0
4513745|NCT00943917|7324262|FG009|Stage I|Withdrawal by Subject|0
4513746|NCT00943917|7324263|FG010|Stage I|Withdrawal by Subject|0
4513747|NCT00943917|7324264|FG011|Stage I|Withdrawal by Subject|0
4513748|NCT00943917|7324265|FG012|Stage I|Withdrawal by Subject|0
4513749|NCT00943917|7324266|FG013|Stage I|Withdrawal by Subject|0
4513750|NCT00943917|7324267|FG014|Stage I|Withdrawal by Subject|0
4630630|NCT01883362|7499383|FG000|Treatment|Randomized, not treated|1
4630631|NCT01883362|7499384|FG001|Treatment|Randomized, not treated|1
4630632|NCT01883362|7499383|FG000|Post Treatment Follow-up|Protocol Violation|0
4630633|NCT01883362|7499384|FG001|Post Treatment Follow-up|Protocol Violation|1
4630634|NCT01883362|7499383|FG000|Post Treatment Follow-up|Withdrawal by Subject|4
4630635|NCT01883362|7499384|FG001|Post Treatment Follow-up|Withdrawal by Subject|3
4630636|NCT01883362|7499383|FG000|Post Treatment Follow-up|Lost to Follow-up|1
4716554|NCT02996500|7646022|FG004|Overall Study|Non-Compliance With Study Drug|0
4716555|NCT02996500|7646023|FG005|Overall Study|Non-Compliance With Study Drug|1
4716556|NCT02996500|7646018|FG000|Overall Study|Progressive Disease|1
4716557|NCT02996500|7646019|FG001|Overall Study|Progressive Disease|0
4716558|NCT02996500|7646020|FG002|Overall Study|Progressive Disease|0
4716559|NCT02996500|7646021|FG003|Overall Study|Progressive Disease|0
4716560|NCT02996500|7646022|FG004|Overall Study|Progressive Disease|0
4716561|NCT02996500|7646023|FG005|Overall Study|Progressive Disease|0
4716562|NCT02996500|7646018|FG000|Overall Study|Other|2
4716563|NCT02996500|7646019|FG001|Overall Study|Other|0
4716564|NCT02996500|7646020|FG002|Overall Study|Other|2
4716565|NCT02996500|7646021|FG003|Overall Study|Other|0
4716566|NCT02996500|7646022|FG004|Overall Study|Other|0
4513751|NCT00943917|7324253|FG000|Stage II|Adverse Event|0
4513752|NCT00943917|7324254|FG001|Stage II|Adverse Event|0
4513753|NCT00943917|7324255|FG002|Stage II|Adverse Event|0
4513754|NCT00943917|7324256|FG003|Stage II|Adverse Event|0
4513755|NCT00943917|7324257|FG004|Stage II|Adverse Event|0
4513756|NCT00943917|7324258|FG005|Stage II|Adverse Event|1
4513757|NCT00943917|7324259|FG006|Stage II|Adverse Event|3
4513758|NCT00943917|7324260|FG007|Stage II|Adverse Event|0
4513759|NCT00943917|7324261|FG008|Stage II|Adverse Event|1
4513760|NCT00943917|7324262|FG009|Stage II|Adverse Event|0
4513761|NCT00943917|7324263|FG010|Stage II|Adverse Event|0
4513762|NCT00943917|7324264|FG011|Stage II|Adverse Event|0
4513763|NCT00943917|7324265|FG012|Stage II|Adverse Event|0
4513764|NCT00943917|7324266|FG013|Stage II|Adverse Event|0
4513765|NCT00943917|7324267|FG014|Stage II|Adverse Event|0
4513766|NCT00943917|7324253|FG000|Stage II|Withdrawal by Subject|0
4513767|NCT00943917|7324254|FG001|Stage II|Withdrawal by Subject|0
4513768|NCT00943917|7324255|FG002|Stage II|Withdrawal by Subject|0
4513769|NCT00943917|7324256|FG003|Stage II|Withdrawal by Subject|0
4513770|NCT00943917|7324257|FG004|Stage II|Withdrawal by Subject|0
4513771|NCT00943917|7324258|FG005|Stage II|Withdrawal by Subject|1
4513772|NCT00943917|7324259|FG006|Stage II|Withdrawal by Subject|0
4513773|NCT00943917|7324260|FG007|Stage II|Withdrawal by Subject|0
4716567|NCT02996500|7646023|FG005|Overall Study|Other|0
4716568|NCT02996500|7646018|FG000|Overall Study|Protocol Violation|0
4716569|NCT02996500|7646019|FG001|Overall Study|Protocol Violation|0
4716570|NCT02996500|7646020|FG002|Overall Study|Protocol Violation|0
4716571|NCT02996500|7646021|FG003|Overall Study|Protocol Violation|1
4716572|NCT02996500|7646022|FG004|Overall Study|Protocol Violation|0
4716573|NCT02996500|7646023|FG005|Overall Study|Protocol Violation|0
4716574|NCT02996500|7646018|FG000|Overall Study|Withdrawal by Subject|3
4716575|NCT02996500|7646019|FG001|Overall Study|Withdrawal by Subject|0
4716576|NCT02996500|7646020|FG002|Overall Study|Withdrawal by Subject|3
4716577|NCT02996500|7646021|FG003|Overall Study|Withdrawal by Subject|0
4716578|NCT02996500|7646022|FG004|Overall Study|Withdrawal by Subject|2
4513774|NCT00943917|7324261|FG008|Stage II|Withdrawal by Subject|0
4513775|NCT00943917|7324262|FG009|Stage II|Withdrawal by Subject|0
4513776|NCT00943917|7324263|FG010|Stage II|Withdrawal by Subject|0
4513777|NCT00943917|7324264|FG011|Stage II|Withdrawal by Subject|0
4513778|NCT00943917|7324265|FG012|Stage II|Withdrawal by Subject|0
4513779|NCT00943917|7324266|FG013|Stage II|Withdrawal by Subject|0
4513780|NCT00943917|7324267|FG014|Stage II|Withdrawal by Subject|0
4513781|NCT00943917|7324253|FG000|Stage II|Pregnancy|0
4513782|NCT00943917|7324254|FG001|Stage II|Pregnancy|0
4513783|NCT00943917|7324255|FG002|Stage II|Pregnancy|0
4513784|NCT00943917|7324256|FG003|Stage II|Pregnancy|0
4513785|NCT00943917|7324257|FG004|Stage II|Pregnancy|0
4716579|NCT02996500|7646023|FG005|Overall Study|Withdrawal by Subject|0
4716580|NCT02996682|7646052|FG000|Overall Study|Death|0
4513786|NCT00943917|7324258|FG005|Stage II|Pregnancy|1
4513787|NCT00943917|7324259|FG006|Stage II|Pregnancy|0
4513788|NCT00943917|7324260|FG007|Stage II|Pregnancy|0
4513789|NCT00943917|7324261|FG008|Stage II|Pregnancy|0
4513790|NCT00943917|7324262|FG009|Stage II|Pregnancy|0
4513791|NCT00943917|7324263|FG010|Stage II|Pregnancy|0
4513792|NCT00943917|7324264|FG011|Stage II|Pregnancy|0
4513793|NCT00943917|7324265|FG012|Stage II|Pregnancy|0
4513794|NCT00943917|7324266|FG013|Stage II|Pregnancy|0
4513795|NCT00943917|7324267|FG014|Stage II|Pregnancy|0
4513796|NCT00943917|7324253|FG000|Stage II Continuation|Adverse Event|0
4513797|NCT00943917|7324254|FG001|Stage II Continuation|Adverse Event|0
4513798|NCT00943917|7324255|FG002|Stage II Continuation|Adverse Event|0
4513799|NCT00943917|7324256|FG003|Stage II Continuation|Adverse Event|0
4513800|NCT00943917|7324257|FG004|Stage II Continuation|Adverse Event|0
4513801|NCT00943917|7324258|FG005|Stage II Continuation|Adverse Event|0
4513802|NCT00943917|7324259|FG006|Stage II Continuation|Adverse Event|0
4513803|NCT00943917|7324260|FG007|Stage II Continuation|Adverse Event|0
4513804|NCT00943917|7324261|FG008|Stage II Continuation|Adverse Event|0
4513805|NCT00943917|7324262|FG009|Stage II Continuation|Adverse Event|0
4716581|NCT02996682|7646053|FG001|Overall Study|Death|3
4716582|NCT02996968|7646070|FG000|Overall Study|Withdrawal by Subject|1
4716583|NCT02996968|7646071|FG001|Overall Study|Withdrawal by Subject|0
4716584|NCT02997163|7646093|FG000|Overall Study|Adverse Event|1
4716585|NCT02997163|7646094|FG001|Overall Study|Adverse Event|0
4716586|NCT02997163|7646095|FG002|Overall Study|Adverse Event|0
4716587|NCT02997163|7646096|FG003|Overall Study|Adverse Event|1
4716588|NCT02997176|7646110|FG000|Overall Study|Adverse Event|0
4716589|NCT02997176|7646111|FG001|Overall Study|Adverse Event|0
4716590|NCT02997176|7646112|FG002|Overall Study|Adverse Event|0
4716591|NCT02997176|7646113|FG003|Overall Study|Adverse Event|8
4716592|NCT02997176|7646110|FG000|Overall Study|Progressive Disease|1
4716593|NCT02997176|7646111|FG001|Overall Study|Progressive Disease|0
4716594|NCT02997176|7646112|FG002|Overall Study|Progressive Disease|1
4446087|NCT00481065|7231099|FG004|Overall Study|Administrative reason|0
4446088|NCT00481065|7231100|FG005|Overall Study|Administrative reason|2
4446089|NCT00481065|7231101|FG006|Overall Study|Administrative reason|1
4446090|NCT00481065|7231102|FG007|Overall Study|Administrative reason|0
4446091|NCT00481065|7231095|FG000|Overall Study|Protocol Violation|2
4446092|NCT00481065|7231096|FG001|Overall Study|Protocol Violation|1
4446093|NCT00481065|7231097|FG002|Overall Study|Protocol Violation|1
4446094|NCT00481065|7231098|FG003|Overall Study|Protocol Violation|1
4446095|NCT00481065|7231099|FG004|Overall Study|Protocol Violation|2
4446096|NCT00481065|7231100|FG005|Overall Study|Protocol Violation|6
4446097|NCT00481065|7231101|FG006|Overall Study|Protocol Violation|3
4446098|NCT00481065|7231102|FG007|Overall Study|Protocol Violation|2
4446099|NCT00481065|7231095|FG000|Overall Study|Unable to classify|0
4446100|NCT00481065|7231096|FG001|Overall Study|Unable to classify|1
4446101|NCT00481065|7231097|FG002|Overall Study|Unable to classify|2
4446102|NCT00481065|7231098|FG003|Overall Study|Unable to classify|0
4446103|NCT00481065|7231099|FG004|Overall Study|Unable to classify|1
4446104|NCT00481065|7231100|FG005|Overall Study|Unable to classify|0
4446105|NCT00481065|7231101|FG006|Overall Study|Unable to classify|0
4446106|NCT00481065|7231102|FG007|Overall Study|Unable to classify|0
4446107|NCT00481078|7231124|FG000|Overall Study|Progression of disease|11
4446108|NCT00481078|7231125|FG001|Overall Study|Progression of disease|11
4446109|NCT00481078|7231124|FG000|Overall Study|Adverse Event|15
4446110|NCT00481078|7231125|FG001|Overall Study|Adverse Event|3
4446111|NCT00481078|7231124|FG000|Overall Study|Death|5
4446112|NCT00481078|7231125|FG001|Overall Study|Death|3
4446113|NCT00481078|7231124|FG000|Overall Study|Intercurrent illness|1
4446114|NCT00481078|7231125|FG001|Overall Study|Intercurrent illness|0
4446115|NCT00481078|7231124|FG000|Overall Study|Withdrawal by Subject|7
4446116|NCT00481078|7231125|FG001|Overall Study|Withdrawal by Subject|1
4446117|NCT00481078|7231124|FG000|Overall Study|Information not available|1
4446118|NCT00481078|7231125|FG001|Overall Study|Information not available|0
4446119|NCT00481078|7231124|FG000|Overall Study|Received other treatment|2
4446120|NCT00481078|7231125|FG001|Overall Study|Received other treatment|1
4446121|NCT00481078|7231124|FG000|Overall Study|Brain metastasis|0
4446122|NCT00481078|7231125|FG001|Overall Study|Brain metastasis|1
4446123|NCT00481195|7231133|FG000|Overall Study|Adverse Event|16
4446124|NCT00481195|7231134|FG001|Overall Study|Adverse Event|11
4446125|NCT00481195|7231133|FG000|Overall Study|Lack of Efficacy|1
4446126|NCT00481195|7231134|FG001|Overall Study|Lack of Efficacy|3
4446127|NCT00481195|7231133|FG000|Overall Study|Lost to Follow-up|4
4446128|NCT00481195|7231134|FG001|Overall Study|Lost to Follow-up|6
4446129|NCT00481195|7231133|FG000|Overall Study|Physician Decision|3
4446130|NCT00481195|7231134|FG001|Overall Study|Physician Decision|1
4446131|NCT00481195|7231133|FG000|Overall Study|Protocol Violation|10
4446132|NCT00481195|7231134|FG001|Overall Study|Protocol Violation|7
4446133|NCT00481195|7231133|FG000|Overall Study|Withdrawal by Subject|3
4446134|NCT00481195|7231134|FG001|Overall Study|Withdrawal by Subject|9
4446135|NCT00481195|7231133|FG000|Overall Study|Miscellaneous|2
4446136|NCT00481195|7231134|FG001|Overall Study|Miscellaneous|2
4446137|NCT00481247|7231142|FG000|Overall Study|Death|0
4513806|NCT00943917|7324263|FG010|Stage II Continuation|Adverse Event|0
4513807|NCT00943917|7324264|FG011|Stage II Continuation|Adverse Event|1
4513808|NCT00943917|7324265|FG012|Stage II Continuation|Adverse Event|2
4513809|NCT00943917|7324266|FG013|Stage II Continuation|Adverse Event|1
4513810|NCT00943917|7324267|FG014|Stage II Continuation|Adverse Event|1
4513811|NCT00943917|7324253|FG000|Stage II Continuation|Withdrawal by Subject|0
4513812|NCT00943917|7324254|FG001|Stage II Continuation|Withdrawal by Subject|0
4513813|NCT00943917|7324255|FG002|Stage II Continuation|Withdrawal by Subject|0
4513814|NCT00943917|7324256|FG003|Stage II Continuation|Withdrawal by Subject|0
4513815|NCT00943917|7324257|FG004|Stage II Continuation|Withdrawal by Subject|0
4513816|NCT00943917|7324258|FG005|Stage II Continuation|Withdrawal by Subject|0
4513817|NCT00943917|7324259|FG006|Stage II Continuation|Withdrawal by Subject|0
4513818|NCT00943917|7324260|FG007|Stage II Continuation|Withdrawal by Subject|0
4513819|NCT00943917|7324261|FG008|Stage II Continuation|Withdrawal by Subject|0
4513820|NCT00943917|7324262|FG009|Stage II Continuation|Withdrawal by Subject|0
4513821|NCT00943917|7324263|FG010|Stage II Continuation|Withdrawal by Subject|0
4513822|NCT00943917|7324264|FG011|Stage II Continuation|Withdrawal by Subject|0
4513823|NCT00943917|7324265|FG012|Stage II Continuation|Withdrawal by Subject|0
4513824|NCT00943917|7324266|FG013|Stage II Continuation|Withdrawal by Subject|1
4513825|NCT00943917|7324267|FG014|Stage II Continuation|Withdrawal by Subject|3
4716595|NCT02997176|7646113|FG003|Overall Study|Progressive Disease|1
4716596|NCT02997176|7646110|FG000|Overall Study|Death|0
4716597|NCT02997176|7646111|FG001|Overall Study|Death|0
4716598|NCT02997176|7646112|FG002|Overall Study|Death|1
4513826|NCT00943917|7324253|FG000|Stage II Continuation|Protocol Violation|0
4513827|NCT00943917|7324254|FG001|Stage II Continuation|Protocol Violation|0
4513828|NCT00943917|7324255|FG002|Stage II Continuation|Protocol Violation|0
4513829|NCT00943917|7324256|FG003|Stage II Continuation|Protocol Violation|0
4513830|NCT00943917|7324257|FG004|Stage II Continuation|Protocol Violation|0
4513831|NCT00943917|7324258|FG005|Stage II Continuation|Protocol Violation|0
4513832|NCT00943917|7324259|FG006|Stage II Continuation|Protocol Violation|0
4513833|NCT00943917|7324260|FG007|Stage II Continuation|Protocol Violation|0
4513834|NCT00943917|7324261|FG008|Stage II Continuation|Protocol Violation|0
4513835|NCT00943917|7324262|FG009|Stage II Continuation|Protocol Violation|1
4513836|NCT00943917|7324263|FG010|Stage II Continuation|Protocol Violation|0
4513837|NCT00943917|7324264|FG011|Stage II Continuation|Protocol Violation|1
4513838|NCT00943917|7324265|FG012|Stage II Continuation|Protocol Violation|0
4513839|NCT00943917|7324266|FG013|Stage II Continuation|Protocol Violation|0
4513840|NCT00943917|7324267|FG014|Stage II Continuation|Protocol Violation|0
4513841|NCT00943917|7324253|FG000|Stage II Continuation|hypoglycemia|0
4513842|NCT00943917|7324254|FG001|Stage II Continuation|hypoglycemia|0
4513843|NCT00943917|7324255|FG002|Stage II Continuation|hypoglycemia|0
4513844|NCT00943917|7324256|FG003|Stage II Continuation|hypoglycemia|0
4513845|NCT00943917|7324257|FG004|Stage II Continuation|hypoglycemia|0
4513846|NCT00943917|7324258|FG005|Stage II Continuation|hypoglycemia|0
4513847|NCT00943917|7324259|FG006|Stage II Continuation|hypoglycemia|0
4513848|NCT00943917|7324260|FG007|Stage II Continuation|hypoglycemia|0
4513849|NCT00943917|7324261|FG008|Stage II Continuation|hypoglycemia|0
4513850|NCT00943917|7324262|FG009|Stage II Continuation|hypoglycemia|0
4513851|NCT00943917|7324263|FG010|Stage II Continuation|hypoglycemia|0
4513852|NCT00943917|7324264|FG011|Stage II Continuation|hypoglycemia|0
4513853|NCT00943917|7324265|FG012|Stage II Continuation|hypoglycemia|1
4513854|NCT00943917|7324266|FG013|Stage II Continuation|hypoglycemia|0
4513855|NCT00943917|7324267|FG014|Stage II Continuation|hypoglycemia|0
4513856|NCT00943917|7324253|FG000|Stage II Continuation|A1C elevation|0
4513857|NCT00943917|7324254|FG001|Stage II Continuation|A1C elevation|0
4513858|NCT00943917|7324255|FG002|Stage II Continuation|A1C elevation|0
4716599|NCT02997176|7646113|FG003|Overall Study|Death|1
4716600|NCT02997176|7646110|FG000|Overall Study|Withdrawal by Subject|0
4716601|NCT02997176|7646111|FG001|Overall Study|Withdrawal by Subject|2
4716602|NCT02997176|7646112|FG002|Overall Study|Withdrawal by Subject|0
4716603|NCT02997176|7646113|FG003|Overall Study|Withdrawal by Subject|1
4716604|NCT02998021|7646156|FG000|Overall Study|Withdrawal by Subject|3
4716605|NCT02998021|7646157|FG001|Overall Study|Withdrawal by Subject|1
4716606|NCT02998021|7646156|FG000|Overall Study|unsafe home|0
4716607|NCT02998021|7646157|FG001|Overall Study|unsafe home|1
4716608|NCT02998151|7646163|FG000|Overall Study|Withdrawal by Subject|3
4716609|NCT02998151|7646163|FG000|Overall Study|Participant declined to re-enroll for baclofen|8
4716610|NCT02998151|7646163|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13
4716611|NCT02998541|7646178|FG000|Overall Study|Adverse Event|4
4716612|NCT02998541|7646179|FG001|Overall Study|Adverse Event|5
4716613|NCT02998541|7646180|FG002|Overall Study|Adverse Event|1
4716614|NCT02998541|7646178|FG000|Overall Study|Protocol Violation|1
4716615|NCT02998541|7646179|FG001|Overall Study|Protocol Violation|0
4716616|NCT02998541|7646180|FG002|Overall Study|Protocol Violation|0
4716617|NCT02998541|7646178|FG000|Overall Study|Withdrawal by Subject|3
4716618|NCT02998541|7646179|FG001|Overall Study|Withdrawal by Subject|1
4513859|NCT00943917|7324256|FG003|Stage II Continuation|A1C elevation|0
4513860|NCT00943917|7324257|FG004|Stage II Continuation|A1C elevation|0
4513861|NCT00943917|7324258|FG005|Stage II Continuation|A1C elevation|0
4513862|NCT00943917|7324259|FG006|Stage II Continuation|A1C elevation|0
4513863|NCT00943917|7324260|FG007|Stage II Continuation|A1C elevation|0
4513864|NCT00943917|7324261|FG008|Stage II Continuation|A1C elevation|0
4513865|NCT00943917|7324262|FG009|Stage II Continuation|A1C elevation|0
4513866|NCT00943917|7324263|FG010|Stage II Continuation|A1C elevation|0
4513867|NCT00943917|7324264|FG011|Stage II Continuation|A1C elevation|0
4513868|NCT00943917|7324265|FG012|Stage II Continuation|A1C elevation|0
4513869|NCT00943917|7324266|FG013|Stage II Continuation|A1C elevation|1
4513870|NCT00943917|7324267|FG014|Stage II Continuation|A1C elevation|0
4513871|NCT00944034|7324333|FG000|Overall Study|Inappropriate enrollment|0
4513872|NCT00944034|7324334|FG001|Overall Study|Inappropriate enrollment|1
4513873|NCT00944034|7324335|FG002|Overall Study|Inappropriate enrollment|0
4513874|NCT00944034|7324336|FG003|Overall Study|Inappropriate enrollment|1
4513875|NCT00944034|7324337|FG004|Overall Study|Inappropriate enrollment|2
4513876|NCT00944034|7324338|FG005|Overall Study|Inappropriate enrollment|1
4513877|NCT00944034|7324339|FG006|Overall Study|Inappropriate enrollment|0
4513878|NCT00944034|7324340|FG007|Overall Study|Inappropriate enrollment|0
4513879|NCT00944034|7324341|FG008|Overall Study|Inappropriate enrollment|1
4513880|NCT00944034|7324342|FG009|Overall Study|Inappropriate enrollment|1
4513881|NCT00944034|7324343|FG010|Overall Study|Inappropriate enrollment|0
4513882|NCT00944034|7324344|FG011|Overall Study|Inappropriate enrollment|0
4513883|NCT00944034|7324333|FG000|Overall Study|Withdrawal by Subject|3
4513884|NCT00944034|7324334|FG001|Overall Study|Withdrawal by Subject|2
4513885|NCT00944034|7324335|FG002|Overall Study|Withdrawal by Subject|6
4513886|NCT00944034|7324336|FG003|Overall Study|Withdrawal by Subject|2
4716619|NCT02998541|7646180|FG002|Overall Study|Withdrawal by Subject|0
4716620|NCT02998541|7646178|FG000|Overall Study|Lost to Follow-up|0
4716621|NCT02998541|7646179|FG001|Overall Study|Lost to Follow-up|3
4716622|NCT02998541|7646180|FG002|Overall Study|Lost to Follow-up|1
4716623|NCT02998541|7646178|FG000|Overall Study|Physician Decision|0
4716624|NCT02998541|7646179|FG001|Overall Study|Physician Decision|0
4716625|NCT02998541|7646180|FG002|Overall Study|Physician Decision|3
4716626|NCT02998541|7646178|FG000|Overall Study|Withdrawal by Parent/Guardian|0
4716627|NCT02998541|7646179|FG001|Overall Study|Withdrawal by Parent/Guardian|0
4716628|NCT02998541|7646180|FG002|Overall Study|Withdrawal by Parent/Guardian|1
4716629|NCT02998554|7646190|FG000|Overall Study|Adverse Event|8
4716630|NCT02998554|7646191|FG001|Overall Study|Adverse Event|3
4716631|NCT02998554|7646190|FG000|Overall Study|Protocol deviation|1
4716632|NCT02998554|7646191|FG001|Overall Study|Protocol deviation|0
4716633|NCT02998554|7646190|FG000|Overall Study|Withdrawal by Subject|2
4716634|NCT02998554|7646191|FG001|Overall Study|Withdrawal by Subject|6
4716635|NCT02998554|7646190|FG000|Overall Study|Lost to Follow-up|0
4716636|NCT02998554|7646191|FG001|Overall Study|Lost to Follow-up|1
4716637|NCT02998554|7646190|FG000|Overall Study|Lack of Efficacy|0
4716638|NCT02998554|7646191|FG001|Overall Study|Lack of Efficacy|1
4716639|NCT02998671|7646204|FG000|Period 1|Study Terminated By Sponsor|2
4716640|NCT02998671|7646205|FG001|Period 1|Study Terminated By Sponsor|1
4716641|NCT02998671|7646206|FG002|Period 1|Study Terminated By Sponsor|0
4716642|NCT02998671|7646207|FG003|Period 1|Study Terminated By Sponsor|0
4716643|NCT02998671|7646208|FG004|Period 1|Study Terminated By Sponsor|1
4716644|NCT02998671|7646204|FG000|Period 1|Withdrawal by Subject|1
4716645|NCT02998671|7646205|FG001|Period 1|Withdrawal by Subject|2
4716646|NCT02998671|7646206|FG002|Period 1|Withdrawal by Subject|0
4716647|NCT02998671|7646207|FG003|Period 1|Withdrawal by Subject|0
4716648|NCT02998671|7646208|FG004|Period 1|Withdrawal by Subject|2
4716649|NCT02998671|7646204|FG000|Period 1|Pregnancy|1
4716650|NCT02998671|7646205|FG001|Period 1|Pregnancy|0
4716651|NCT02998671|7646206|FG002|Period 1|Pregnancy|0
4716652|NCT02998671|7646207|FG003|Period 1|Pregnancy|0
4716653|NCT02998671|7646208|FG004|Period 1|Pregnancy|0
4716654|NCT02998671|7646204|FG000|Period 1|Adverse Event|0
4716655|NCT02998671|7646205|FG001|Period 1|Adverse Event|0
4716656|NCT02998671|7646206|FG002|Period 1|Adverse Event|0
4716657|NCT02998671|7646207|FG003|Period 1|Adverse Event|0
4716658|NCT02998671|7646208|FG004|Period 1|Adverse Event|1
4716659|NCT02998671|7646204|FG000|Period 2|Adverse Event|0
4716660|NCT02998671|7646205|FG001|Period 2|Adverse Event|1
4716661|NCT02998671|7646206|FG002|Period 2|Adverse Event|0
4716662|NCT02998671|7646207|FG003|Period 2|Adverse Event|0
4716663|NCT02998671|7646208|FG004|Period 2|Adverse Event|0
4716664|NCT02998671|7646204|FG000|Period 2|Study Terminated By Sponsor|3
4716665|NCT02998671|7646205|FG001|Period 2|Study Terminated By Sponsor|5
4716666|NCT02998671|7646206|FG002|Period 2|Study Terminated By Sponsor|1
4716667|NCT02998671|7646207|FG003|Period 2|Study Terminated By Sponsor|3
4716668|NCT02998671|7646208|FG004|Period 2|Study Terminated By Sponsor|0
4716669|NCT02998671|7646204|FG000|Period 2|Withdrawal by Subject|0
4513887|NCT00944034|7324337|FG004|Overall Study|Withdrawal by Subject|5
4513888|NCT00944034|7324338|FG005|Overall Study|Withdrawal by Subject|8
4513889|NCT00944034|7324339|FG006|Overall Study|Withdrawal by Subject|2
4513890|NCT00944034|7324340|FG007|Overall Study|Withdrawal by Subject|2
4513891|NCT00944034|7324341|FG008|Overall Study|Withdrawal by Subject|3
4513892|NCT00944034|7324342|FG009|Overall Study|Withdrawal by Subject|4
4513893|NCT00944034|7324343|FG010|Overall Study|Withdrawal by Subject|0
4716670|NCT02998671|7646205|FG001|Period 2|Withdrawal by Subject|1
4716671|NCT02998671|7646206|FG002|Period 2|Withdrawal by Subject|0
4513894|NCT00944034|7324344|FG011|Overall Study|Withdrawal by Subject|4
4513895|NCT00944034|7324333|FG000|Overall Study|Lost to Follow-up|0
4513896|NCT00944034|7324334|FG001|Overall Study|Lost to Follow-up|4
4513897|NCT00944034|7324335|FG002|Overall Study|Lost to Follow-up|2
4513898|NCT00944034|7324336|FG003|Overall Study|Lost to Follow-up|0
4513899|NCT00944034|7324337|FG004|Overall Study|Lost to Follow-up|5
4513900|NCT00944034|7324338|FG005|Overall Study|Lost to Follow-up|7
4513901|NCT00944034|7324339|FG006|Overall Study|Lost to Follow-up|0
4513902|NCT00944034|7324340|FG007|Overall Study|Lost to Follow-up|1
4513903|NCT00944034|7324341|FG008|Overall Study|Lost to Follow-up|5
4513904|NCT00944034|7324342|FG009|Overall Study|Lost to Follow-up|1
4513905|NCT00944034|7324343|FG010|Overall Study|Lost to Follow-up|1
4513906|NCT00944034|7324344|FG011|Overall Study|Lost to Follow-up|0
4513907|NCT00944034|7324333|FG000|Overall Study|Death|0
4513908|NCT00944034|7324334|FG001|Overall Study|Death|0
4513909|NCT00944034|7324335|FG002|Overall Study|Death|1
4513910|NCT00944034|7324336|FG003|Overall Study|Death|0
4513911|NCT00944034|7324337|FG004|Overall Study|Death|0
4513912|NCT00944034|7324338|FG005|Overall Study|Death|0
4513913|NCT00944034|7324339|FG006|Overall Study|Death|0
4513914|NCT00944034|7324340|FG007|Overall Study|Death|0
4513915|NCT00944034|7324341|FG008|Overall Study|Death|0
4513916|NCT00944034|7324342|FG009|Overall Study|Death|0
4513917|NCT00944034|7324343|FG010|Overall Study|Death|0
4513918|NCT00944034|7324344|FG011|Overall Study|Death|0
4513919|NCT00944034|7324333|FG000|Overall Study|Protocol Violation|2
4513920|NCT00944034|7324334|FG001|Overall Study|Protocol Violation|0
4513921|NCT00944034|7324335|FG002|Overall Study|Protocol Violation|0
4513922|NCT00944034|7324336|FG003|Overall Study|Protocol Violation|1
4513923|NCT00944034|7324337|FG004|Overall Study|Protocol Violation|2
4513924|NCT00944034|7324338|FG005|Overall Study|Protocol Violation|3
4513925|NCT00944034|7324339|FG006|Overall Study|Protocol Violation|0
4513926|NCT00944034|7324340|FG007|Overall Study|Protocol Violation|1
4513927|NCT00944034|7324341|FG008|Overall Study|Protocol Violation|1
4513928|NCT00944034|7324342|FG009|Overall Study|Protocol Violation|4
4513929|NCT00944034|7324343|FG010|Overall Study|Protocol Violation|0
4513930|NCT00944034|7324344|FG011|Overall Study|Protocol Violation|0
4513931|NCT00944034|7324333|FG000|Overall Study|Unable to classify|0
4513932|NCT00944034|7324334|FG001|Overall Study|Unable to classify|0
4513933|NCT00944034|7324335|FG002|Overall Study|Unable to classify|0
4513934|NCT00944034|7324336|FG003|Overall Study|Unable to classify|0
4513935|NCT00944034|7324337|FG004|Overall Study|Unable to classify|0
4513936|NCT00944034|7324338|FG005|Overall Study|Unable to classify|1
4513937|NCT00944034|7324339|FG006|Overall Study|Unable to classify|1
4513938|NCT00944034|7324340|FG007|Overall Study|Unable to classify|1
4513939|NCT00944034|7324341|FG008|Overall Study|Unable to classify|0
4513940|NCT00944034|7324342|FG009|Overall Study|Unable to classify|0
4513941|NCT00944034|7324343|FG010|Overall Study|Unable to classify|0
4513942|NCT00944034|7324344|FG011|Overall Study|Unable to classify|0
4513943|NCT00944034|7324333|FG000|Overall Study|Administrative reason|0
4513944|NCT00944034|7324334|FG001|Overall Study|Administrative reason|0
4513945|NCT00944034|7324335|FG002|Overall Study|Administrative reason|0
4513946|NCT00944034|7324336|FG003|Overall Study|Administrative reason|0
4513947|NCT00944034|7324337|FG004|Overall Study|Administrative reason|0
4513948|NCT00944034|7324338|FG005|Overall Study|Administrative reason|0
4513949|NCT00944034|7324339|FG006|Overall Study|Administrative reason|1
4513950|NCT00944034|7324340|FG007|Overall Study|Administrative reason|0
4513951|NCT00944034|7324341|FG008|Overall Study|Administrative reason|0
4513952|NCT00944034|7324342|FG009|Overall Study|Administrative reason|0
4513953|NCT00944034|7324343|FG010|Overall Study|Administrative reason|0
4513954|NCT00944034|7324344|FG011|Overall Study|Administrative reason|0
4513955|NCT00944125|7324400|FG000|3 to 6 Months|Withdrawal by Subject|0
4513956|NCT00944125|7324401|FG001|3 to 6 Months|Withdrawal by Subject|2
4513957|NCT00944125|7324400|FG000|6 Months to Study Completion|Withdrawal by Subject|0
4513958|NCT00944125|7324401|FG001|6 Months to Study Completion|Withdrawal by Subject|2
4513959|NCT00944645|7324423|FG000|Period 2|Adverse Event|1
4513960|NCT00944645|7324424|FG001|Period 2|Adverse Event|0
4513961|NCT00944645|7324423|FG000|Period 2|Lost to Follow-up|0
4513962|NCT00944645|7324424|FG001|Period 2|Lost to Follow-up|3
4513963|NCT00944645|7324423|FG000|Period 2|Withdrawal by Subject|7
4513964|NCT00944645|7324424|FG001|Period 2|Withdrawal by Subject|6
4513965|NCT00944658|7324432|FG000|Treatment 12 Weeks|Adverse Event|0
4513966|NCT00944658|7324433|FG001|Treatment 12 Weeks|Adverse Event|2
4513967|NCT00944697|7324460|FG000|Overall Study|Withdrawal by Subject|1
4513968|NCT00944697|7324461|FG001|Overall Study|Withdrawal by Subject|1
4513969|NCT00944697|7324460|FG000|Overall Study|Adverse Event|0
4513970|NCT00944697|7324461|FG001|Overall Study|Adverse Event|3
4513971|NCT00944697|7324460|FG000|Overall Study|Administrative|1
4513972|NCT00944697|7324461|FG001|Overall Study|Administrative|1
4513973|NCT00945191|7324512|FG000|Overall Study|Did not achieve a complete response|18
4513974|NCT00945191|7324512|FG000|Overall Study|Participant relocated to another state|1
4513975|NCT00945191|7324512|FG000|Overall Study|Disease progression|3
4513976|NCT00945191|7324512|FG000|Overall Study|Serious adverse event or adverse event|1
4513977|NCT00945191|7324512|FG000|Overall Study|Investigator's discretion|1
4513978|NCT00945243|7324516|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3
4513979|NCT00945321|7324567|FG000|Period 1|Adverse Event|0
4513980|NCT00945321|7324568|FG001|Period 1|Adverse Event|0
4513981|NCT00945321|7324569|FG002|Period 1|Adverse Event|0
4513982|NCT00945321|7324570|FG003|Period 1|Adverse Event|0
4513983|NCT00945321|7324571|FG004|Period 1|Adverse Event|1
4513984|NCT00945321|7324572|FG005|Period 1|Adverse Event|0
4513985|NCT00945321|7324567|FG000|Period 4|Lost to Follow-up|0
4513986|NCT00945321|7324568|FG001|Period 4|Lost to Follow-up|0
4513987|NCT00945321|7324569|FG002|Period 4|Lost to Follow-up|0
4513988|NCT00945321|7324570|FG003|Period 4|Lost to Follow-up|0
4513989|NCT00945321|7324571|FG004|Period 4|Lost to Follow-up|0
4513990|NCT00945321|7324572|FG005|Period 4|Lost to Follow-up|1
4513991|NCT00945477|7324599|FG000|Overall Study|Adverse Event|3
4513992|NCT00945477|7324599|FG000|Overall Study|Lack of Efficacy|2
4513993|NCT00945477|7324599|FG000|Overall Study|Withdrawal by Subject|1
4513994|NCT00945555|7324604|FG000|Overall Study|Referred to another hospital|5
4513995|NCT00945555|7324604|FG000|Overall Study|Worsening condition, intensive care unit|1
4513996|NCT00945555|7324604|FG000|Overall Study|Withdrawal by Subject|2
4716672|NCT02998671|7646207|FG003|Period 2|Withdrawal by Subject|0
4716673|NCT02998671|7646208|FG004|Period 2|Withdrawal by Subject|0
4716674|NCT02998671|7646204|FG000|Period 2|Lost to Follow-up|0
4716675|NCT02998671|7646205|FG001|Period 2|Lost to Follow-up|0
4716676|NCT02998671|7646206|FG002|Period 2|Lost to Follow-up|0
4716677|NCT02998671|7646207|FG003|Period 2|Lost to Follow-up|1
4716678|NCT02998671|7646208|FG004|Period 2|Lost to Follow-up|0
4716679|NCT02998996|7646243|FG000|Overall Study|Lost to Follow-up|0
4716680|NCT02998996|7646244|FG001|Overall Study|Lost to Follow-up|0
4716681|NCT02998996|7646245|FG002|Overall Study|Lost to Follow-up|1
4716682|NCT02998996|7646246|FG003|Overall Study|Lost to Follow-up|0
4716683|NCT02998996|7646247|FG004|Overall Study|Lost to Follow-up|0
4716684|NCT02998996|7646248|FG005|Overall Study|Lost to Follow-up|0
4716685|NCT02998996|7646243|FG000|Overall Study|Pregnancy|0
4716686|NCT02998996|7646244|FG001|Overall Study|Pregnancy|1
4716687|NCT02998996|7646245|FG002|Overall Study|Pregnancy|0
4716688|NCT02998996|7646246|FG003|Overall Study|Pregnancy|0
4716689|NCT02998996|7646247|FG004|Overall Study|Pregnancy|0
4716690|NCT02998996|7646248|FG005|Overall Study|Pregnancy|0
4716691|NCT02998996|7646243|FG000|Overall Study|Family reasons|0
4446138|NCT00481247|7231143|FG001|Overall Study|Death|1
4446139|NCT00481247|7231142|FG000|Overall Study|Disease progression|18
4446140|NCT00481247|7231143|FG001|Overall Study|Disease progression|22
4446141|NCT00481247|7231142|FG000|Overall Study|Intolerance|42
4446142|NCT00481247|7231143|FG001|Overall Study|Intolerance|17
4446143|NCT00481247|7231142|FG000|Overall Study|Treatment failure|10
4716692|NCT02998996|7646244|FG001|Overall Study|Family reasons|0
4716693|NCT02998996|7646245|FG002|Overall Study|Family reasons|0
4716694|NCT02998996|7646246|FG003|Overall Study|Family reasons|0
4716695|NCT02998996|7646247|FG004|Overall Study|Family reasons|1
4716696|NCT02998996|7646248|FG005|Overall Study|Family reasons|0
4716697|NCT02999100|7646268|FG000|Part 1 (up to 15 Days)|Adverse Event|0
4716698|NCT02999100|7646269|FG001|Part 1 (up to 15 Days)|Adverse Event|1
4716699|NCT02999100|7646270|FG002|Part 1 (up to 15 Days)|Adverse Event|0
4716700|NCT02999100|7646271|FG003|Part 1 (up to 15 Days)|Adverse Event|0
4716701|NCT02999100|7646272|FG004|Part 1 (up to 15 Days)|Adverse Event|0
4716702|NCT02999100|7646273|FG005|Part 1 (up to 15 Days)|Adverse Event|0
4716703|NCT02999100|7646268|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
4716704|NCT02999100|7646269|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
4716705|NCT02999100|7646270|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
4716706|NCT02999100|7646271|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
4716707|NCT02999100|7646272|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
4716708|NCT02999100|7646273|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1
4716709|NCT02999100|7646268|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
4716710|NCT02999100|7646269|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
4716711|NCT02999100|7646270|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1
4716712|NCT02999100|7646271|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
4716713|NCT02999100|7646272|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
4716714|NCT02999100|7646273|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
4716715|NCT02999178|7646297|FG000|Overall Study|Adverse Event|85
4716716|NCT02999178|7646298|FG001|Overall Study|Adverse Event|62
4716717|NCT02999178|7646297|FG000|Overall Study|Protocol Violation|1
4716718|NCT02999178|7646298|FG001|Overall Study|Protocol Violation|2
4716719|NCT02999178|7646297|FG000|Overall Study|Lost to Follow-up|0
4716720|NCT02999178|7646298|FG001|Overall Study|Lost to Follow-up|2
4716721|NCT02999178|7646297|FG000|Overall Study|Withdrawal by Subject|21
4716722|NCT02999178|7646298|FG001|Overall Study|Withdrawal by Subject|21
4716723|NCT02999178|7646297|FG000|Overall Study|Other reason not defined above|7
4716724|NCT02999178|7646298|FG001|Overall Study|Other reason not defined above|13
4716725|NCT02999191|7646307|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0
4716726|NCT02999191|7646308|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1
4716727|NCT02999191|7646309|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0
4716728|NCT02999672|7646319|FG000|Overall Study|Death|0
4446144|NCT00481247|7231143|FG001|Overall Study|Treatment failure|14
4446145|NCT00481247|7231142|FG000|Overall Study|AE unrelated to study drug|13
4446146|NCT00481247|7231143|FG001|Overall Study|AE unrelated to study drug|4
4446147|NCT00481247|7231142|FG000|Overall Study|Withdrawal by Subject|8
4446148|NCT00481247|7231143|FG001|Overall Study|Withdrawal by Subject|13
4513997|NCT00945555|7324604|FG000|Overall Study|Participant continued treatment at home|1
4513998|NCT00945555|7324604|FG000|Overall Study|Death|18
4513999|NCT00945555|7324604|FG000|Overall Study|Other|1
4514000|NCT00945659|7324622|FG000|Overall Study|Lost to Follow-up|7
4514001|NCT00945659|7324623|FG001|Overall Study|Lost to Follow-up|20
4514002|NCT00945659|7324624|FG002|Overall Study|Lost to Follow-up|17
4514003|NCT00945815|7324651|FG000|Overall Study|Death|3
4514004|NCT00945815|7324651|FG000|Overall Study|Not protocol specified|1
4514005|NCT00945815|7324651|FG000|Overall Study|Ineligible|3
4514006|NCT00945815|7324651|FG000|Overall Study|Did not begin protocol therapy|1
4514007|NCT00945893|7324666|FG000|Overall Study|Lost to Follow-up|2
4514008|NCT00945893|7324667|FG001|Overall Study|Lost to Follow-up|8
4514009|NCT00945893|7324666|FG000|Overall Study|Withdrawal of consent|1
4514010|NCT00945893|7324667|FG001|Overall Study|Withdrawal of consent|2
4514011|NCT00945906|7324677|FG000|Overall Study|Withdrawal by Subject|1
4514012|NCT00945906|7324677|FG000|Overall Study|Did not want to return for last visit|2
4514013|NCT00945906|7324677|FG000|Overall Study|Unable to return for last visit|2
4514014|NCT00945906|7324677|FG000|Overall Study|Moved to another country|2
4514015|NCT00945945|7324683|FG000|Overall Study|Adverse Event|15
4514016|NCT00945945|7324684|FG001|Overall Study|Adverse Event|35
4514017|NCT00945945|7324683|FG000|Overall Study|Withdrawal by Subject|7
4514018|NCT00945945|7324684|FG001|Overall Study|Withdrawal by Subject|10
4514019|NCT00945945|7324683|FG000|Overall Study|Lost to Follow-up|4
4514020|NCT00945945|7324684|FG001|Overall Study|Lost to Follow-up|5
4514021|NCT00945945|7324683|FG000|Overall Study|Lack of Efficacy|6
4514022|NCT00945945|7324684|FG001|Overall Study|Lack of Efficacy|2
4514023|NCT00945945|7324683|FG000|Overall Study|Protocol Violation|4
4514024|NCT00945945|7324684|FG001|Overall Study|Protocol Violation|2
4514025|NCT00945945|7324683|FG000|Overall Study|Entry Criteria Not Met|0
4514026|NCT00945945|7324684|FG001|Overall Study|Entry Criteria Not Met|1
4514027|NCT00946088|7324701|FG000|Overall Study|Withdrawal by Subject|0
4514028|NCT00946088|7324702|FG001|Overall Study|Withdrawal by Subject|1
4514029|NCT00946101|7324712|FG000|Overall Study|Lost to Follow-up|2
4514030|NCT00946101|7324713|FG001|Overall Study|Lost to Follow-up|1
4514031|NCT00946101|7324712|FG000|Overall Study|Withdrawal of consent|2
4514032|NCT00946101|7324713|FG001|Overall Study|Withdrawal of consent|0
4514033|NCT00946101|7324712|FG000|Overall Study|Physician Decision|0
4514034|NCT00946101|7324713|FG001|Overall Study|Physician Decision|1
4514035|NCT00946114|7324725|FG000|Overall Study|Death|5
4514036|NCT00946114|7324726|FG001|Overall Study|Death|2
4514037|NCT00946114|7324725|FG000|Overall Study|Other|1
4514038|NCT00946114|7324726|FG001|Overall Study|Other|0
4514039|NCT00946114|7324725|FG000|Overall Study|Withdrawal by Subject|2
4514040|NCT00946114|7324726|FG001|Overall Study|Withdrawal by Subject|0
4514041|NCT00946153|7324737|FG000|Phase 2|Adverse Event|0
4514042|NCT00946153|7324738|FG001|Phase 2|Adverse Event|0
4514043|NCT00946153|7324739|FG002|Phase 2|Adverse Event|0
4514044|NCT00946153|7324740|FG003|Phase 2|Adverse Event|0
4514045|NCT00946153|7324741|FG004|Phase 2|Adverse Event|6
4514046|NCT00946153|7324737|FG000|Phase 2|Need more reduction of dose|0
4514047|NCT00946153|7324738|FG001|Phase 2|Need more reduction of dose|0
4514048|NCT00946153|7324739|FG002|Phase 2|Need more reduction of dose|0
4514049|NCT00946153|7324740|FG003|Phase 2|Need more reduction of dose|0
4514050|NCT00946153|7324741|FG004|Phase 2|Need more reduction of dose|2
4514051|NCT00946153|7324737|FG000|Phase 2|Physician Decision|0
4514052|NCT00946153|7324738|FG001|Phase 2|Physician Decision|0
4514053|NCT00946153|7324739|FG002|Phase 2|Physician Decision|0
4514054|NCT00946153|7324740|FG003|Phase 2|Physician Decision|0
4514055|NCT00946153|7324741|FG004|Phase 2|Physician Decision|1
4514056|NCT00946153|7324737|FG000|Phase 2|14 days washout for recovery due to AE|0
4514057|NCT00946153|7324738|FG001|Phase 2|14 days washout for recovery due to AE|0
4514058|NCT00946153|7324739|FG002|Phase 2|14 days washout for recovery due to AE|0
4514059|NCT00946153|7324740|FG003|Phase 2|14 days washout for recovery due to AE|0
4514060|NCT00946153|7324741|FG004|Phase 2|14 days washout for recovery due to AE|4
4514061|NCT00946192|7324761|FG000|Overall Study|Lost to Follow-up|6
4514062|NCT00946192|7324762|FG001|Overall Study|Lost to Follow-up|11
4514063|NCT00946192|7324763|FG002|Overall Study|Lost to Follow-up|9
4514064|NCT00946192|7324761|FG000|Overall Study|Withdrawal by Subject|10
4514065|NCT00946192|7324762|FG001|Overall Study|Withdrawal by Subject|7
4716729|NCT02999672|7646320|FG001|Overall Study|Death|1
4716730|NCT02999672|7646319|FG000|Overall Study|Study Terminated by Sponsor|0
4716731|NCT02999672|7646320|FG001|Overall Study|Study Terminated by Sponsor|1
4716732|NCT02999672|7646319|FG000|Overall Study|Progressive Disease|9
4716733|NCT02999672|7646320|FG001|Overall Study|Progressive Disease|5
4514066|NCT00946192|7324763|FG002|Overall Study|Withdrawal by Subject|3
4514067|NCT00946192|7324761|FG000|Overall Study|Did not start medication|2
4514068|NCT00946192|7324762|FG001|Overall Study|Did not start medication|0
4514069|NCT00946192|7324763|FG002|Overall Study|Did not start medication|0
4514070|NCT00946296|7324786|FG000|Overall Study|Physician Decision|3
4514071|NCT00946296|7324787|FG001|Overall Study|Physician Decision|0
4514072|NCT00946309|7324795|FG000|Overall Study|Protocol Violation|1
4514073|NCT00946309|7324796|FG001|Overall Study|Protocol Violation|0
4514074|NCT00946309|7324795|FG000|Overall Study|Lost to Follow-up|0
4514075|NCT00946309|7324796|FG001|Overall Study|Lost to Follow-up|1
4514076|NCT00946309|7324795|FG000|Overall Study|Procedure cancelled/discontinued|0
4514077|NCT00946309|7324796|FG001|Overall Study|Procedure cancelled/discontinued|3
4514078|NCT00946322|7324803|FG000|Pre-treatment|participant failure to follow up|1
4514079|NCT00946322|7324803|FG000|Post-treatment|participant failure to follow up|2
4514080|NCT00946530|7324829|FG000|Overall Study|Withdrawal by Subject|0
4514081|NCT00946530|7324830|FG001|Overall Study|Withdrawal by Subject|3
4514082|NCT00946530|7324831|FG002|Overall Study|Withdrawal by Subject|0
4514083|NCT00946530|7324832|FG003|Overall Study|Withdrawal by Subject|3
4514084|NCT00946530|7324829|FG000|Overall Study|Physician Decision|1
4514085|NCT00946530|7324830|FG001|Overall Study|Physician Decision|1
4514086|NCT00946530|7324831|FG002|Overall Study|Physician Decision|1
4514087|NCT00946530|7324832|FG003|Overall Study|Physician Decision|1
4514088|NCT00946647|7324851|FG000|Phase 1 Part|Adverse Event|2
4514089|NCT00946647|7324852|FG001|Phase 1 Part|Adverse Event|5
4514090|NCT00946647|7324853|FG002|Phase 1 Part|Adverse Event|3
4514091|NCT00946647|7324854|FG003|Phase 1 Part|Adverse Event|0
4514092|NCT00946647|7324855|FG004|Phase 1 Part|Adverse Event|0
4514093|NCT00946647|7324851|FG000|Phase 1 Part|Disease progression|3
4514094|NCT00946647|7324852|FG001|Phase 1 Part|Disease progression|6
4514095|NCT00946647|7324853|FG002|Phase 1 Part|Disease progression|1
4514096|NCT00946647|7324854|FG003|Phase 1 Part|Disease progression|0
4514097|NCT00946647|7324855|FG004|Phase 1 Part|Disease progression|0
4514098|NCT00946647|7324851|FG000|Phase 1 Part|Withdrawal by Subject|1
4514099|NCT00946647|7324852|FG001|Phase 1 Part|Withdrawal by Subject|4
4514100|NCT00946647|7324853|FG002|Phase 1 Part|Withdrawal by Subject|3
4514101|NCT00946647|7324854|FG003|Phase 1 Part|Withdrawal by Subject|0
4514102|NCT00946647|7324855|FG004|Phase 1 Part|Withdrawal by Subject|0
4514103|NCT00946647|7324851|FG000|Phase 1 Part|Abnormal values|0
4514104|NCT00946647|7324852|FG001|Phase 1 Part|Abnormal values|2
4514105|NCT00946647|7324853|FG002|Phase 1 Part|Abnormal values|0
4514106|NCT00946647|7324854|FG003|Phase 1 Part|Abnormal values|0
4514107|NCT00946647|7324855|FG004|Phase 1 Part|Abnormal values|0
4514108|NCT00946647|7324851|FG000|Phase 1 Part|Reason missing|0
4514109|NCT00946647|7324852|FG001|Phase 1 Part|Reason missing|1
4514110|NCT00946647|7324853|FG002|Phase 1 Part|Reason missing|0
4514111|NCT00946647|7324854|FG003|Phase 1 Part|Reason missing|0
4514112|NCT00946647|7324855|FG004|Phase 1 Part|Reason missing|0
4514113|NCT00946647|7324851|FG000|Phase ll Part|Untreated|0
4514114|NCT00946647|7324852|FG001|Phase ll Part|Untreated|0
4514115|NCT00946647|7324853|FG002|Phase ll Part|Untreated|0
4514116|NCT00946647|7324854|FG003|Phase ll Part|Untreated|0
4514117|NCT00946647|7324855|FG004|Phase ll Part|Untreated|2
4514118|NCT00946647|7324851|FG000|Phase ll Part|Adverse Event|0
4514119|NCT00946647|7324852|FG001|Phase ll Part|Adverse Event|0
4514120|NCT00946647|7324853|FG002|Phase ll Part|Adverse Event|0
4514121|NCT00946647|7324854|FG003|Phase ll Part|Adverse Event|10
4514122|NCT00946647|7324855|FG004|Phase ll Part|Adverse Event|6
4514123|NCT00946647|7324851|FG000|Phase ll Part|Withdrawal by Subject|0
4514124|NCT00946647|7324852|FG001|Phase ll Part|Withdrawal by Subject|0
4514125|NCT00946647|7324853|FG002|Phase ll Part|Withdrawal by Subject|0
4514126|NCT00946647|7324854|FG003|Phase ll Part|Withdrawal by Subject|8
4514127|NCT00946647|7324855|FG004|Phase ll Part|Withdrawal by Subject|6
4514128|NCT00946647|7324851|FG000|Phase ll Part|Administrative problems|0
4514129|NCT00946647|7324852|FG001|Phase ll Part|Administrative problems|0
4514130|NCT00946647|7324853|FG002|Phase ll Part|Administrative problems|0
4514131|NCT00946647|7324854|FG003|Phase ll Part|Administrative problems|3
4514132|NCT00946647|7324855|FG004|Phase ll Part|Administrative problems|8
4514133|NCT00946647|7324851|FG000|Phase ll Part|Death|0
4514134|NCT00946647|7324852|FG001|Phase ll Part|Death|0
4514135|NCT00946647|7324853|FG002|Phase ll Part|Death|0
4514136|NCT00946647|7324854|FG003|Phase ll Part|Death|7
4514137|NCT00946647|7324855|FG004|Phase ll Part|Death|4
4514138|NCT00946647|7324851|FG000|Phase ll Part|Disease progression|0
4514139|NCT00946647|7324852|FG001|Phase ll Part|Disease progression|0
4514140|NCT00946647|7324853|FG002|Phase ll Part|Disease progression|0
4514141|NCT00946647|7324854|FG003|Phase ll Part|Disease progression|6
4514142|NCT00946647|7324855|FG004|Phase ll Part|Disease progression|14
4514143|NCT00946647|7324851|FG000|Phase ll Part|Protocol Violation|0
4514144|NCT00946647|7324852|FG001|Phase ll Part|Protocol Violation|0
4514145|NCT00946647|7324853|FG002|Phase ll Part|Protocol Violation|0
4514146|NCT00946647|7324854|FG003|Phase ll Part|Protocol Violation|4
4514147|NCT00946647|7324855|FG004|Phase ll Part|Protocol Violation|2
4514148|NCT00946647|7324851|FG000|Phase ll Part|Subj cond no longer required study drug|0
4514149|NCT00946647|7324852|FG001|Phase ll Part|Subj cond no longer required study drug|0
4514150|NCT00946647|7324853|FG002|Phase ll Part|Subj cond no longer required study drug|0
4514151|NCT00946647|7324854|FG003|Phase ll Part|Subj cond no longer required study drug|2
4514152|NCT00946647|7324855|FG004|Phase ll Part|Subj cond no longer required study drug|0
4514153|NCT00946712|7324870|FG000|Overall Study|Adverse Event|118
4514154|NCT00946712|7324871|FG001|Overall Study|Adverse Event|124
4514155|NCT00946712|7324870|FG000|Overall Study|Disease progression|308
4514156|NCT00946712|7324871|FG001|Overall Study|Disease progression|404
4514157|NCT00946712|7324870|FG000|Overall Study|Death|21
4514158|NCT00946712|7324871|FG001|Overall Study|Death|22
4514159|NCT00946712|7324870|FG000|Overall Study|No treatment given|25
4514160|NCT00946712|7324871|FG001|Overall Study|No treatment given|29
4514161|NCT00946712|7324870|FG000|Overall Study|Other reasons|61
4514162|NCT00946712|7324871|FG001|Overall Study|Other reasons|73
4514163|NCT00946712|7324870|FG000|Overall Study|On Treatment|0
4514164|NCT00946712|7324871|FG001|Overall Study|On Treatment|4
4514165|NCT00946712|7324870|FG000|Overall Study|Ineligible|14
4514166|NCT00946712|7324871|FG001|Overall Study|Ineligible|6
4514167|NCT00946881|7324878|FG000|First Treatment|Withdrawal by Subject|1
4514168|NCT00946881|7324878|FG000|First Treatment|Patient relocated to another state|1
4514169|NCT00946881|7324878|FG000|Retreatment|Withdrawal by Subject|1
4514170|NCT00946920|7324905|FG000|Overall Study|Withdrawal by Subject|28
4514171|NCT00946920|7324906|FG001|Overall Study|Withdrawal by Subject|15
4514172|NCT00946920|7324905|FG000|Overall Study|Lost to Follow-up|2
4514173|NCT00946920|7324906|FG001|Overall Study|Lost to Follow-up|2
4514174|NCT00946920|7324905|FG000|Overall Study|Physician Decision|5
4514175|NCT00946920|7324906|FG001|Overall Study|Physician Decision|2
4514176|NCT00946920|7324905|FG000|Overall Study|Adverse Event|41
4514177|NCT00946920|7324906|FG001|Overall Study|Adverse Event|14
4514178|NCT00946920|7324905|FG000|Overall Study|Protocol Violation|16
4514179|NCT00946920|7324906|FG001|Overall Study|Protocol Violation|8
4514180|NCT00946920|7324905|FG000|Overall Study|Miscellaneous reasons|18
4514181|NCT00946920|7324906|FG001|Overall Study|Miscellaneous reasons|3
4514182|NCT00946998|7324914|FG000|Overall Study|Exited prior to first outcome assessment|5
4514183|NCT00946998|7324915|FG001|Overall Study|Exited prior to first outcome assessment|3
4514184|NCT00947115|7324924|FG000|Overall Study|Missed reporting interval|3
4514185|NCT00947115|7324925|FG001|Overall Study|Missed reporting interval|4
4514186|NCT00947115|7324926|FG002|Overall Study|Missed reporting interval|2
4514187|NCT00947115|7324924|FG000|Overall Study|Physician Decision|0
4514188|NCT00947115|7324925|FG001|Overall Study|Physician Decision|2
4514189|NCT00947115|7324926|FG002|Overall Study|Physician Decision|0
4514190|NCT00947115|7324924|FG000|Overall Study|Death|0
4514191|NCT00947115|7324925|FG001|Overall Study|Death|1
4514192|NCT00947115|7324926|FG002|Overall Study|Death|1
4514193|NCT00947115|7324924|FG000|Overall Study|Migrated from study area|2
4514194|NCT00947115|7324925|FG001|Overall Study|Migrated from study area|0
4514195|NCT00947115|7324926|FG002|Overall Study|Migrated from study area|0
4514196|NCT00947115|7324924|FG000|Overall Study|Withdrawal by Subject|1
4514197|NCT00947115|7324925|FG001|Overall Study|Withdrawal by Subject|3
4514198|NCT00947115|7324926|FG002|Overall Study|Withdrawal by Subject|4
4514199|NCT00947115|7324924|FG000|Overall Study|Lost to Follow-up|11
4514200|NCT00947115|7324925|FG001|Overall Study|Lost to Follow-up|12
4514201|NCT00947115|7324926|FG002|Overall Study|Lost to Follow-up|8
4514202|NCT00947154|7324934|FG000|Overall Study|Lost to Follow-up|1
4514203|NCT00947193|7324943|FG000|Overall Study|Lost to Follow-up|1
4514204|NCT00947193|7324944|FG001|Overall Study|Lost to Follow-up|0
4514205|NCT00947193|7324943|FG000|Overall Study|Withdrawal by Subject|1
4514206|NCT00947193|7324944|FG001|Overall Study|Withdrawal by Subject|0
4514207|NCT00947193|7324943|FG000|Overall Study|Factor VIII >1%|1
4514208|NCT00947193|7324944|FG001|Overall Study|Factor VIII >1%|0
4514209|NCT00947349|7325001|FG000|Triple Treatment Combination Period|Adverse Event|0
4514210|NCT00947349|7325002|FG001|Triple Treatment Combination Period|Adverse Event|1
4514211|NCT00947349|7325003|FG002|Triple Treatment Combination Period|Adverse Event|0
4514212|NCT00947349|7325004|FG003|Triple Treatment Combination Period|Adverse Event|0
4514213|NCT00947349|7325001|FG000|Overall Study Standard of Care|Lack of Efficacy|0
4514214|NCT00947349|7325002|FG001|Overall Study Standard of Care|Lack of Efficacy|0
4514215|NCT00947349|7325003|FG002|Overall Study Standard of Care|Lack of Efficacy|1
4514216|NCT00947349|7325004|FG003|Overall Study Standard of Care|Lack of Efficacy|1
4514217|NCT00947349|7325001|FG000|Overall Study Standard of Care|Withdrawal by Subject|0
4514218|NCT00947349|7325002|FG001|Overall Study Standard of Care|Withdrawal by Subject|0
4514219|NCT00947349|7325003|FG002|Overall Study Standard of Care|Withdrawal by Subject|1
4514220|NCT00947349|7325004|FG003|Overall Study Standard of Care|Withdrawal by Subject|0
4514221|NCT00947349|7325001|FG000|Overall Study Standard of Care|Other|0
4514222|NCT00947349|7325002|FG001|Overall Study Standard of Care|Other|0
4514223|NCT00947349|7325003|FG002|Overall Study Standard of Care|Other|0
4514224|NCT00947349|7325004|FG003|Overall Study Standard of Care|Other|1
4514225|NCT00947427|7325034|FG000|Overall Study|Withdrawal by Subject|1
4514226|NCT00947427|7325035|FG001|Overall Study|Withdrawal by Subject|3
4514227|NCT00947427|7325034|FG000|Overall Study|Protocol Violation|0
4514228|NCT00947427|7325035|FG001|Overall Study|Protocol Violation|1
4514229|NCT00947531|7325052|FG000|Overall Study|Withdrawal by Subject|10
4514230|NCT00947531|7325053|FG001|Overall Study|Withdrawal by Subject|7
4514231|NCT00947531|7325052|FG000|Overall Study|Administrative Reason|0
4514232|NCT00947531|7325053|FG001|Overall Study|Administrative Reason|1
4514233|NCT00947531|7325052|FG000|Overall Study|Adverse Event|2
4514234|NCT00947531|7325053|FG001|Overall Study|Adverse Event|2
4514235|NCT00947531|7325052|FG000|Overall Study|Lack of Efficacy|1
4514236|NCT00947531|7325053|FG001|Overall Study|Lack of Efficacy|0
4514237|NCT00947531|7325052|FG000|Overall Study|Other|1
4514238|NCT00947531|7325053|FG001|Overall Study|Other|1
4514239|NCT00947544|7325059|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1
4514240|NCT00947544|7325060|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0
4518563|NCT00975130|7330760|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9
4518564|NCT00975130|7330761|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0
4518565|NCT00975130|7330762|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0
4518566|NCT00975130|7330760|FG000|Study Part 1|Administrative|4
4514241|NCT00947856|7325099|FG000|Treatment Period|Progressive Disease|33
4514242|NCT00947856|7325100|FG001|Treatment Period|Progressive Disease|12
4514243|NCT00947856|7325099|FG000|Treatment Period|Adverse Event|15
4514244|NCT00947856|7325100|FG001|Treatment Period|Adverse Event|9
4514245|NCT00947856|7325099|FG000|Treatment Period|Physician Decision|14
4514246|NCT00947856|7325100|FG001|Treatment Period|Physician Decision|6
4514247|NCT00947856|7325099|FG000|Treatment Period|Study Stopped by Sponsor|4
4514248|NCT00947856|7325100|FG001|Treatment Period|Study Stopped by Sponsor|4
4514249|NCT00947856|7325099|FG000|Treatment Period|Withdrawal by Subject|12
4514250|NCT00947856|7325100|FG001|Treatment Period|Withdrawal by Subject|1
4514251|NCT00947856|7325099|FG000|Follow-up Period|Study Stopped by Sponsor|40
4514252|NCT00947856|7325100|FG001|Follow-up Period|Study Stopped by Sponsor|20
4514253|NCT00947856|7325099|FG000|Follow-up Period|Re-enrolled for Retreatment|2
4514254|NCT00947856|7325100|FG001|Follow-up Period|Re-enrolled for Retreatment|3
4514255|NCT00947856|7325099|FG000|Follow-up Period|Lost to Follow-up|7
4514256|NCT00947856|7325100|FG001|Follow-up Period|Lost to Follow-up|0
4514257|NCT00947856|7325099|FG000|Follow-up Period|Patient unavailable for site visits|1
4514258|NCT00947856|7325100|FG001|Follow-up Period|Patient unavailable for site visits|0
4514259|NCT00947856|7325099|FG000|Follow-up Period|Withdrawal by Subject|1
4514260|NCT00947856|7325100|FG001|Follow-up Period|Withdrawal by Subject|0
4514261|NCT00947882|7325119|FG000|Overall Study|Adverse Event|0
4514262|NCT00947882|7325120|FG001|Overall Study|Adverse Event|1
4514263|NCT00947882|7325121|FG002|Overall Study|Adverse Event|4
4514264|NCT00947882|7325122|FG003|Overall Study|Adverse Event|4
4514265|NCT00947882|7325119|FG000|Overall Study|Withdrawal by Subject|2
4514266|NCT00947882|7325120|FG001|Overall Study|Withdrawal by Subject|0
4514267|NCT00947882|7325121|FG002|Overall Study|Withdrawal by Subject|8
4514268|NCT00947882|7325122|FG003|Overall Study|Withdrawal by Subject|2
4514269|NCT00947882|7325119|FG000|Overall Study|Protocol Violation|0
4514270|NCT00947882|7325120|FG001|Overall Study|Protocol Violation|0
4514271|NCT00947882|7325121|FG002|Overall Study|Protocol Violation|1
4514272|NCT00947882|7325122|FG003|Overall Study|Protocol Violation|0
4514273|NCT00947882|7325119|FG000|Overall Study|Lost to Follow-up|0
4716734|NCT02999672|7646319|FG000|Overall Study|Adverse Event|4
4716735|NCT02999672|7646320|FG001|Overall Study|Adverse Event|0
4716736|NCT03000075|7646342|FG000|Part A|Adverse Event|4
4716737|NCT03000075|7646343|FG001|Part A|Adverse Event|0
4716738|NCT03000075|7646344|FG002|Part A|Adverse Event|0
4716739|NCT03000075|7646345|FG003|Part A|Adverse Event|0
4716740|NCT03000075|7646346|FG004|Part A|Adverse Event|0
4716741|NCT03000075|7646347|FG005|Part A|Adverse Event|0
4716742|NCT03000075|7646348|FG006|Part A|Adverse Event|0
4716743|NCT03000075|7646342|FG000|Part B|Not dosed due to AE|0
4716744|NCT03000075|7646343|FG001|Part B|Not dosed due to AE|0
4716745|NCT03000075|7646344|FG002|Part B|Not dosed due to AE|0
4716746|NCT03000075|7646345|FG003|Part B|Not dosed due to AE|0
4716747|NCT03000075|7646346|FG004|Part B|Not dosed due to AE|0
4716748|NCT03000075|7646347|FG005|Part B|Not dosed due to AE|2
4716749|NCT03000075|7646348|FG006|Part B|Not dosed due to AE|1
4716750|NCT03000075|7646342|FG000|Part B|Adverse Event|0
4716751|NCT03000075|7646343|FG001|Part B|Adverse Event|0
4716752|NCT03000075|7646344|FG002|Part B|Adverse Event|0
4716753|NCT03000075|7646345|FG003|Part B|Adverse Event|0
4716754|NCT03000075|7646346|FG004|Part B|Adverse Event|1
4716755|NCT03000075|7646347|FG005|Part B|Adverse Event|0
4716756|NCT03000075|7646348|FG006|Part B|Adverse Event|0
4716757|NCT03000348|7646397|FG000|Overall Study|Adverse Event|1
4716758|NCT03000348|7646398|FG001|Overall Study|Adverse Event|1
4716759|NCT03000348|7646399|FG002|Overall Study|Adverse Event|1
4716760|NCT03000348|7646400|FG003|Overall Study|Adverse Event|1
4716761|NCT03000348|7646401|FG004|Overall Study|Adverse Event|1
4716762|NCT03000348|7646402|FG005|Overall Study|Adverse Event|1
4716763|NCT03000348|7646397|FG000|Overall Study|Lost to Follow-up|0
4716764|NCT03000348|7646398|FG001|Overall Study|Lost to Follow-up|0
4716765|NCT03000348|7646399|FG002|Overall Study|Lost to Follow-up|1
4716766|NCT03000348|7646400|FG003|Overall Study|Lost to Follow-up|0
4716767|NCT03000348|7646401|FG004|Overall Study|Lost to Follow-up|0
4716768|NCT03000348|7646402|FG005|Overall Study|Lost to Follow-up|0
4716769|NCT03000348|7646397|FG000|Overall Study|Withdrawal by Subject|0
4716770|NCT03000348|7646398|FG001|Overall Study|Withdrawal by Subject|1
4716771|NCT03000348|7646399|FG002|Overall Study|Withdrawal by Subject|0
4514274|NCT00947882|7325120|FG001|Overall Study|Lost to Follow-up|2
4514275|NCT00947882|7325121|FG002|Overall Study|Lost to Follow-up|1
4514276|NCT00947882|7325122|FG003|Overall Study|Lost to Follow-up|0
4514277|NCT00947882|7325119|FG000|Overall Study|Other/Unknown|10
4514278|NCT00947882|7325120|FG001|Overall Study|Other/Unknown|13
4514279|NCT00947882|7325121|FG002|Overall Study|Other/Unknown|3
4514280|NCT00947882|7325122|FG003|Overall Study|Other/Unknown|6
4514281|NCT00947882|7325119|FG000|Overall Study|Trial Terminated by Sponsor|62
4514282|NCT00947882|7325120|FG001|Overall Study|Trial Terminated by Sponsor|61
4514283|NCT00947882|7325121|FG002|Overall Study|Trial Terminated by Sponsor|62
4514284|NCT00947882|7325122|FG003|Overall Study|Trial Terminated by Sponsor|70
4514285|NCT00948025|7325135|FG000|Phase 1 (Pilot Phase)|Adverse Event|1
4514286|NCT00948025|7325136|FG001|Phase 1 (Pilot Phase)|Adverse Event|1
4514287|NCT00948025|7325135|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7
4716772|NCT03000348|7646400|FG003|Overall Study|Withdrawal by Subject|0
4514288|NCT00948025|7325136|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1
4514289|NCT00948025|7325135|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1
4716773|NCT03000348|7646401|FG004|Overall Study|Withdrawal by Subject|0
4716774|NCT03000348|7646402|FG005|Overall Study|Withdrawal by Subject|0
4716775|NCT03000348|7646397|FG000|Overall Study|Consent|0
4716776|NCT03000348|7646398|FG001|Overall Study|Consent|0
4716777|NCT03000348|7646399|FG002|Overall Study|Consent|0
4716778|NCT03000348|7646400|FG003|Overall Study|Consent|0
4716779|NCT03000348|7646401|FG004|Overall Study|Consent|1
4630637|NCT01883362|7499384|FG001|Post Treatment Follow-up|Lost to Follow-up|4
4630638|NCT01883362|7499383|FG000|Post Treatment Follow-up|Administrative problems|2
4630639|NCT01883362|7499384|FG001|Post Treatment Follow-up|Administrative problems|0
4716780|NCT03000348|7646402|FG005|Overall Study|Consent|0
4716781|NCT03000348|7646397|FG000|Overall Study|Failure to expectorate sputum|1
4716782|NCT03000348|7646398|FG001|Overall Study|Failure to expectorate sputum|0
4716783|NCT03000348|7646399|FG002|Overall Study|Failure to expectorate sputum|1
4716784|NCT03000348|7646400|FG003|Overall Study|Failure to expectorate sputum|0
4716785|NCT03000348|7646401|FG004|Overall Study|Failure to expectorate sputum|1
4716786|NCT03000348|7646402|FG005|Overall Study|Failure to expectorate sputum|0
4716787|NCT03000348|7646397|FG000|Overall Study|No gram negative|1
4716788|NCT03000348|7646398|FG001|Overall Study|No gram negative|2
4716789|NCT03000348|7646399|FG002|Overall Study|No gram negative|1
4716790|NCT03000348|7646400|FG003|Overall Study|No gram negative|1
4716791|NCT03000348|7646401|FG004|Overall Study|No gram negative|1
4716792|NCT03000348|7646402|FG005|Overall Study|No gram negative|1
4716793|NCT03000348|7646397|FG000|Overall Study|Patient had no transport|0
4716794|NCT03000348|7646398|FG001|Overall Study|Patient had no transport|0
4716795|NCT03000348|7646399|FG002|Overall Study|Patient had no transport|0
4716796|NCT03000348|7646400|FG003|Overall Study|Patient had no transport|1
4716797|NCT03000348|7646401|FG004|Overall Study|Patient had no transport|0
4716798|NCT03000348|7646402|FG005|Overall Study|Patient had no transport|0
4716799|NCT03000348|7646397|FG000|Overall Study|Dosing|0
4716800|NCT03000348|7646398|FG001|Overall Study|Dosing|0
4716801|NCT03000348|7646399|FG002|Overall Study|Dosing|0
4716802|NCT03000348|7646400|FG003|Overall Study|Dosing|0
4716803|NCT03000348|7646401|FG004|Overall Study|Dosing|1
4716804|NCT03000348|7646402|FG005|Overall Study|Dosing|0
4716805|NCT03000452|7646419|FG000|Treatment Period|Death|1
4716806|NCT03000452|7646419|FG000|Treatment Period|Progressive Disease (PD)|14
4716807|NCT03000452|7646419|FG000|Treatment Period|Physician Decision|1
4716808|NCT03000452|7646419|FG000|Treatment Period|Miscellaneous|2
4716809|NCT03000452|7646419|FG000|Follow-Up Period|Study Terminated by Sponsor|1
4716810|NCT03000452|7646419|FG000|Follow-Up Period|Death|3
4716811|NCT03000452|7646419|FG000|Follow-Up Period|Withdrawal by Subject|3
4716812|NCT03000673|7646436|FG000|Overall Study|Withdrawal by Subject|1
4716813|NCT03000673|7646437|FG001|Overall Study|Withdrawal by Subject|0
4716814|NCT03000673|7646438|FG002|Overall Study|Withdrawal by Subject|0
4716815|NCT03000673|7646439|FG003|Overall Study|Withdrawal by Subject|0
4716816|NCT03000686|7646452|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0
4716817|NCT03000686|7646453|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1
4716818|NCT03000686|7646454|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0
4716819|NCT03000686|7646455|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0
4716820|NCT03001076|7646469|FG000|Overall Study|Withdrawal by patient|2
4716821|NCT03001076|7646470|FG001|Overall Study|Withdrawal by patient|0
4716822|NCT03001076|7646469|FG000|Overall Study|Other|1
4716823|NCT03001076|7646470|FG001|Overall Study|Other|0
4716824|NCT03001076|7646469|FG000|Overall Study|Adverse Event|3
4716825|NCT03001076|7646470|FG001|Overall Study|Adverse Event|3
4716826|NCT03001076|7646469|FG000|Overall Study|Sponsor decision|1
4716827|NCT03001076|7646470|FG001|Overall Study|Sponsor decision|0
4716828|NCT03001076|7646469|FG000|Overall Study|Lost to Follow-up|0
4716829|NCT03001076|7646470|FG001|Overall Study|Lost to Follow-up|2
4716830|NCT03001219|7646478|FG000|Proof of Concept|Study Termination by Sponsor|0
4716831|NCT03001219|7646479|FG001|Proof of Concept|Study Termination by Sponsor|1
4716832|NCT03001219|7646478|FG000|Proof of Concept|Withdrawal by Subject|0
4716833|NCT03001219|7646479|FG001|Proof of Concept|Withdrawal by Subject|4
4716834|NCT03001219|7646478|FG000|Proof of Concept|Protocol Deviation|0
4716835|NCT03001219|7646479|FG001|Proof of Concept|Protocol Deviation|1
4716836|NCT03001219|7646478|FG000|Proof of Concept|Adverse Event|1
4716837|NCT03001219|7646479|FG001|Proof of Concept|Adverse Event|1
4716838|NCT03001219|7646478|FG000|Proof of Concept|Physician Decision|1
4716839|NCT03001219|7646479|FG001|Proof of Concept|Physician Decision|0
4716840|NCT03001219|7646478|FG000|Extension Period Analysis|Study Termination by Sponsor|0
4716841|NCT03001219|7646479|FG001|Extension Period Analysis|Study Termination by Sponsor|36
4716842|NCT03001219|7646478|FG000|Extension Period Analysis|Participant Non-Compliance|0
4716843|NCT03001219|7646479|FG001|Extension Period Analysis|Participant Non-Compliance|1
4716844|NCT03001219|7646478|FG000|Extension Period Analysis|Physician Decision|0
4716845|NCT03001219|7646479|FG001|Extension Period Analysis|Physician Decision|1
4716846|NCT03001219|7646478|FG000|Extension Period Analysis|Adverse Event|1
4716847|NCT03001219|7646479|FG001|Extension Period Analysis|Adverse Event|1
4716848|NCT03001219|7646478|FG000|Extension Period Analysis|Protocol Deviation|0
4518567|NCT00975130|7330761|FG001|Study Part 1|Administrative|0
4514290|NCT00948025|7325136|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1
4514291|NCT00948064|7325146|FG000|Phase I|No treatment received|1
4514292|NCT00948064|7325147|FG001|Phase I|No treatment received|0
4514293|NCT00948064|7325148|FG002|Phase I|No treatment received|0
4514294|NCT00948064|7325146|FG000|Phase II|Physician Decision|0
4514295|NCT00948064|7325147|FG001|Phase II|Physician Decision|0
4514296|NCT00948064|7325148|FG002|Phase II|Physician Decision|1
4514297|NCT00948064|7325146|FG000|Phase II|Withdrawal by Subject|0
4514298|NCT00948064|7325147|FG001|Phase II|Withdrawal by Subject|1
4514299|NCT00948064|7325148|FG002|Phase II|Withdrawal by Subject|0
4514300|NCT00948155|7325172|FG000|First Intervention 21 Days|Lost to Follow-up|2
4514301|NCT00948155|7325173|FG001|First Intervention 21 Days|Lost to Follow-up|2
4514302|NCT00948155|7325172|FG000|Washout 14 Days|Lost to Follow-up|1
4514303|NCT00948155|7325173|FG001|Washout 14 Days|Lost to Follow-up|2
4514304|NCT00948246|7325181|FG000|Overall Study|Lost to Follow-up|11
4514305|NCT00948246|7325181|FG000|Overall Study|Adverse Event|11
4514306|NCT00948246|7325181|FG000|Overall Study|Death|1
4514307|NCT00948246|7325181|FG000|Overall Study|Withdrawal by Subject|1
4514308|NCT00948389|7325199|FG000|Overall Study|Disease Progression/Relapse/Death|3
4514309|NCT00948389|7325200|FG001|Overall Study|Disease Progression/Relapse/Death|3
4514310|NCT00948389|7325201|FG002|Overall Study|Disease Progression/Relapse/Death|7
4514311|NCT00948389|7325202|FG003|Overall Study|Disease Progression/Relapse/Death|8
4514312|NCT00948389|7325203|FG004|Overall Study|Disease Progression/Relapse/Death|1
4514313|NCT00948389|7325199|FG000|Overall Study|Thrombocytopenia, Grade 4|2
4514314|NCT00948389|7325200|FG001|Overall Study|Thrombocytopenia, Grade 4|0
4514315|NCT00948389|7325201|FG002|Overall Study|Thrombocytopenia, Grade 4|0
4514316|NCT00948389|7325202|FG003|Overall Study|Thrombocytopenia, Grade 4|1
4514317|NCT00948389|7325203|FG004|Overall Study|Thrombocytopenia, Grade 4|0
4514318|NCT00948389|7325199|FG000|Overall Study|Both Progression and Toxicity|1
4514319|NCT00948389|7325200|FG001|Overall Study|Both Progression and Toxicity|0
4514320|NCT00948389|7325201|FG002|Overall Study|Both Progression and Toxicity|0
4514321|NCT00948389|7325202|FG003|Overall Study|Both Progression and Toxicity|0
4514322|NCT00948389|7325203|FG004|Overall Study|Both Progression and Toxicity|0
4514323|NCT00948428|7325220|FG000|Overall Study|Withdrawal by Subject|6
4514324|NCT00948428|7325221|FG001|Overall Study|Withdrawal by Subject|12
4514325|NCT00948428|7325222|FG002|Overall Study|Withdrawal by Subject|7
4514326|NCT00948428|7325220|FG000|Overall Study|Adverse Event|6
4514327|NCT00948428|7325221|FG001|Overall Study|Adverse Event|3
4514328|NCT00948428|7325222|FG002|Overall Study|Adverse Event|0
4514329|NCT00948428|7325220|FG000|Overall Study|Lost to Follow-up|2
4514330|NCT00948428|7325221|FG001|Overall Study|Lost to Follow-up|1
4514331|NCT00948428|7325222|FG002|Overall Study|Lost to Follow-up|1
4514332|NCT00948428|7325220|FG000|Overall Study|Death|2
4514333|NCT00948428|7325221|FG001|Overall Study|Death|0
4514334|NCT00948428|7325222|FG002|Overall Study|Death|0
4514335|NCT00948428|7325220|FG000|Overall Study|Intercurrent Illness|1
4514336|NCT00948428|7325221|FG001|Overall Study|Intercurrent Illness|0
4514337|NCT00948428|7325222|FG002|Overall Study|Intercurrent Illness|0
4514338|NCT00948428|7325220|FG000|Overall Study|Non-compliance|1
4514339|NCT00948428|7325221|FG001|Overall Study|Non-compliance|2
4514340|NCT00948428|7325222|FG002|Overall Study|Non-compliance|0
4514341|NCT00948441|7325232|FG000|Overall Study|no longer meet inclusion criteria|1
4514342|NCT00948441|7325233|FG001|Overall Study|no longer meet inclusion criteria|4
4514343|NCT00948506|7325243|FG000|Overall Study|Withdrawal by Subject|3
4514344|NCT00948506|7325244|FG001|Overall Study|Withdrawal by Subject|1
4716849|NCT03001219|7646479|FG001|Extension Period Analysis|Protocol Deviation|1
4716850|NCT03001219|7646478|FG000|Extension Period Analysis|Withdrawal by Subject|4
4716851|NCT03001219|7646479|FG001|Extension Period Analysis|Withdrawal by Subject|5
4716852|NCT03001557|7646517|FG000|Core Phase|Randomized but not treated|0
4716853|NCT03001557|7646518|FG001|Core Phase|Randomized but not treated|0
4716854|NCT03001557|7646519|FG002|Core Phase|Randomized but not treated|1
4716855|NCT03001557|7646520|FG003|Core Phase|Randomized but not treated|0
4716856|NCT03001557|7646521|FG004|Core Phase|Randomized but not treated|0
4716857|NCT03001557|7646522|FG005|Core Phase|Randomized but not treated|0
4716858|NCT03001557|7646523|FG006|Core Phase|Randomized but not treated|0
4716859|NCT03001557|7646524|FG007|Core Phase|Randomized but not treated|0
4716860|NCT03001557|7646517|FG000|Extension Phase|Adverse Event|0
4716861|NCT03001557|7646518|FG001|Extension Phase|Adverse Event|0
4716862|NCT03001557|7646519|FG002|Extension Phase|Adverse Event|0
4716863|NCT03001557|7646520|FG003|Extension Phase|Adverse Event|0
4716864|NCT03001557|7646521|FG004|Extension Phase|Adverse Event|0
4716865|NCT03001557|7646522|FG005|Extension Phase|Adverse Event|2
4716866|NCT03001557|7646523|FG006|Extension Phase|Adverse Event|0
4716867|NCT03001557|7646524|FG007|Extension Phase|Adverse Event|0
4514345|NCT00948675|7325264|FG000|Overall Study|Lost to Follow-up|1
4514346|NCT00948675|7325265|FG001|Overall Study|Lost to Follow-up|0
4514347|NCT00948688|7325271|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1
4514348|NCT00948688|7325272|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0
4514349|NCT00948688|7325271|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1
4514350|NCT00948688|7325272|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0
4514351|NCT00948688|7325271|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0
4716868|NCT03001557|7646517|FG000|Extension Phase|Withdrawal by Subject|0
4716869|NCT03001557|7646518|FG001|Extension Phase|Withdrawal by Subject|0
4514352|NCT00948688|7325272|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1
4514353|NCT00948766|7325281|FG000|Core Study|Adverse Event|73
4514354|NCT00948766|7325282|FG001|Core Study|Adverse Event|51
4514355|NCT00948766|7325281|FG000|Core Study|Unsatisfactory Therapeutic Effect|13
4514356|NCT00948766|7325282|FG001|Core Study|Unsatisfactory Therapeutic Effect|14
4514357|NCT00948766|7325281|FG000|Core Study|Patient Withdrew Consent|27
4514358|NCT00948766|7325282|FG001|Core Study|Patient Withdrew Consent|46
4514359|NCT00948766|7325281|FG000|Core Study|Lost to Follow-up|3
4514360|NCT00948766|7325282|FG001|Core Study|Lost to Follow-up|2
4514361|NCT00948766|7325281|FG000|Core Study|Administrative Problems|2
4514362|NCT00948766|7325282|FG001|Core Study|Administrative Problems|2
4514363|NCT00948766|7325281|FG000|Core Study|Death|1
4514364|NCT00948766|7325282|FG001|Core Study|Death|1
4514365|NCT00948766|7325281|FG000|Core Study|Protocol Deviation|8
4514366|NCT00948766|7325282|FG001|Core Study|Protocol Deviation|10
4514367|NCT00948766|7325281|FG000|Extension Study|Adverse Event|43
4514368|NCT00948766|7325282|FG001|Extension Study|Adverse Event|0
4514369|NCT00948766|7325281|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2
4514370|NCT00948766|7325282|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0
4514371|NCT00948766|7325281|FG000|Extension Study|Study Drug No Longer Required|1
4514372|NCT00948766|7325282|FG001|Extension Study|Study Drug No Longer Required|0
4514373|NCT00948766|7325281|FG000|Extension Study|Patient Withdrew Consent|32
4514374|NCT00948766|7325282|FG001|Extension Study|Patient Withdrew Consent|0
4514375|NCT00948766|7325281|FG000|Extension Study|Lost to Follow-up|8
4514376|NCT00948766|7325282|FG001|Extension Study|Lost to Follow-up|0
4514377|NCT00948766|7325281|FG000|Extension Study|Administrative Problems|1
4514378|NCT00948766|7325282|FG001|Extension Study|Administrative Problems|0
4716870|NCT03001557|7646519|FG002|Extension Phase|Withdrawal by Subject|0
4716871|NCT03001557|7646520|FG003|Extension Phase|Withdrawal by Subject|0
4716872|NCT03001557|7646521|FG004|Extension Phase|Withdrawal by Subject|0
4716873|NCT03001557|7646522|FG005|Extension Phase|Withdrawal by Subject|1
4716874|NCT03001557|7646523|FG006|Extension Phase|Withdrawal by Subject|5
4716875|NCT03001557|7646524|FG007|Extension Phase|Withdrawal by Subject|2
4716876|NCT03001557|7646517|FG000|Extension Phase|Lost to Follow-up|0
4716877|NCT03001557|7646518|FG001|Extension Phase|Lost to Follow-up|0
4716878|NCT03001557|7646519|FG002|Extension Phase|Lost to Follow-up|0
4716879|NCT03001557|7646520|FG003|Extension Phase|Lost to Follow-up|0
4716880|NCT03001557|7646521|FG004|Extension Phase|Lost to Follow-up|0
4716881|NCT03001557|7646522|FG005|Extension Phase|Lost to Follow-up|0
4716882|NCT03001557|7646523|FG006|Extension Phase|Lost to Follow-up|2
4716883|NCT03001557|7646524|FG007|Extension Phase|Lost to Follow-up|1
4716884|NCT03001557|7646517|FG000|Extension Phase|Administrative Reason|0
4716885|NCT03001557|7646518|FG001|Extension Phase|Administrative Reason|0
4716886|NCT03001557|7646519|FG002|Extension Phase|Administrative Reason|0
4716887|NCT03001557|7646520|FG003|Extension Phase|Administrative Reason|0
4716888|NCT03001557|7646521|FG004|Extension Phase|Administrative Reason|0
4716889|NCT03001557|7646522|FG005|Extension Phase|Administrative Reason|1
4716890|NCT03001557|7646523|FG006|Extension Phase|Administrative Reason|3
4716891|NCT03001557|7646524|FG007|Extension Phase|Administrative Reason|3
4716892|NCT03001557|7646517|FG000|Extension Phase|Loss of caregiver|0
4716893|NCT03001557|7646518|FG001|Extension Phase|Loss of caregiver|0
4716894|NCT03001557|7646519|FG002|Extension Phase|Loss of caregiver|0
4716895|NCT03001557|7646520|FG003|Extension Phase|Loss of caregiver|0
4716896|NCT03001557|7646521|FG004|Extension Phase|Loss of caregiver|0
4716897|NCT03001557|7646522|FG005|Extension Phase|Loss of caregiver|0
4716898|NCT03001557|7646523|FG006|Extension Phase|Loss of caregiver|1
4716899|NCT03001557|7646524|FG007|Extension Phase|Loss of caregiver|0
4716900|NCT03001557|7646517|FG000|Extension Phase|Others|0
4716901|NCT03001557|7646518|FG001|Extension Phase|Others|0
4716902|NCT03001557|7646519|FG002|Extension Phase|Others|0
4716903|NCT03001557|7646520|FG003|Extension Phase|Others|0
4716904|NCT03001557|7646521|FG004|Extension Phase|Others|0
4716905|NCT03001557|7646522|FG005|Extension Phase|Others|1
4716906|NCT03001557|7646523|FG006|Extension Phase|Others|3
4716907|NCT03001557|7646524|FG007|Extension Phase|Others|0
4716908|NCT03002038|7646584|FG000|Overall Study|Adverse Event|3
4716909|NCT03002038|7646585|FG001|Overall Study|Adverse Event|1
4716910|NCT03002038|7646584|FG000|Overall Study|Withdrawal by Subject|8
4716911|NCT03002038|7646585|FG001|Overall Study|Withdrawal by Subject|4
4716912|NCT03002038|7646584|FG000|Overall Study|Immigration to another region|0
4716913|NCT03002038|7646585|FG001|Overall Study|Immigration to another region|2
4716914|NCT03002077|7646591|FG000|Overall Study|Non-compliance with Study Drug|4
4716915|NCT03002077|7646591|FG000|Overall Study|Non-compliance w/Background ADT|1
4716916|NCT03002077|7646591|FG000|Overall Study|Study Terminated by Sponsor|257
4716917|NCT03002077|7646591|FG000|Overall Study|Site Terminated by Sponsor|5
4716918|NCT03002077|7646591|FG000|Overall Study|Miscellaneous Reasons|10
4716919|NCT03002077|7646591|FG000|Overall Study|Adverse Event|23
4716920|NCT03002077|7646591|FG000|Overall Study|Lack of Efficacy|20
4716921|NCT03002077|7646591|FG000|Overall Study|Withdrawal by Subject|72
4716922|NCT03002077|7646591|FG000|Overall Study|Lost to Follow-up|21
4716923|NCT03002077|7646591|FG000|Overall Study|Pregnancy|4
4514379|NCT00948766|7325281|FG000|Extension Study|Death|4
4716924|NCT03002077|7646591|FG000|Overall Study|Protocol Violation|21
4716925|NCT03002194|7646595|FG000|Overall Study|Lost to Follow-up|6
4716926|NCT03002194|7646595|FG000|Overall Study|Adverse Event|1
4514380|NCT00948766|7325282|FG001|Extension Study|Death|0
4514381|NCT00948818|7325297|FG000|Overall Study|Adverse Event|10
4514382|NCT00948818|7325298|FG001|Overall Study|Adverse Event|32
4514383|NCT00948818|7325297|FG000|Overall Study|Protocol Violation|9
4514384|NCT00948818|7325298|FG001|Overall Study|Protocol Violation|10
4630640|NCT01883362|7499383|FG000|Post Treatment Follow-up|Death|8
4514385|NCT00948818|7325297|FG000|Overall Study|Withdrawal by Subject|25
4514386|NCT00948818|7325298|FG001|Overall Study|Withdrawal by Subject|25
4514387|NCT00948818|7325297|FG000|Overall Study|Lost to Follow-up|10
4514388|NCT00948818|7325298|FG001|Overall Study|Lost to Follow-up|17
4716927|NCT03002194|7646595|FG000|Overall Study|Lack of Efficacy|1
4716928|NCT03002194|7646595|FG000|Overall Study|Withdrawal by Subject|2
4716929|NCT03002311|7646601|FG000|Overall Study|Lost to Follow-up|13
4716930|NCT03002311|7646602|FG001|Overall Study|Lost to Follow-up|26
4716931|NCT03002311|7646601|FG000|Overall Study|Referral provider called to schedule app|3
4716932|NCT03002311|7646602|FG001|Overall Study|Referral provider called to schedule app|3
4716933|NCT03002311|7646601|FG000|Overall Study|Physician Decision|3
4716934|NCT03002311|7646602|FG001|Overall Study|Physician Decision|1
4716935|NCT03002610|7646620|FG000|Overall Study|Withdrawal by Subject|6
4716936|NCT03002610|7646621|FG001|Overall Study|Withdrawal by Subject|25
4716937|NCT03002610|7646622|FG002|Overall Study|Withdrawal by Subject|13
4716938|NCT03002623|7646632|FG000|Overall Study|Lost to Follow-up|1
4716939|NCT03002623|7646633|FG001|Overall Study|Lost to Follow-up|0
4716940|NCT03002623|7646632|FG000|Overall Study|Physician Decision|1
4716941|NCT03002623|7646633|FG001|Overall Study|Physician Decision|1
4716942|NCT03002818|7646653|FG000|Overall Study|Decision of the investigator|1
4716943|NCT03003000|7646673|FG000|Overall Study|Adverse Event|1
4716944|NCT03003000|7646674|FG001|Overall Study|Adverse Event|2
4716945|NCT03003000|7646675|FG002|Overall Study|Adverse Event|3
4716946|NCT03003000|7646673|FG000|Overall Study|Lack of Efficacy|1
4716947|NCT03003000|7646674|FG001|Overall Study|Lack of Efficacy|0
4716948|NCT03003000|7646675|FG002|Overall Study|Lack of Efficacy|0
4716949|NCT03003000|7646673|FG000|Overall Study|Non-compliant with protocol|0
4716950|NCT03003000|7646674|FG001|Overall Study|Non-compliant with protocol|1
4716951|NCT03003000|7646675|FG002|Overall Study|Non-compliant with protocol|1
4716952|NCT03003000|7646673|FG000|Overall Study|Refused to continue medication|2
4716953|NCT03003000|7646674|FG001|Overall Study|Refused to continue medication|0
4716954|NCT03003000|7646675|FG002|Overall Study|Refused to continue medication|0
4716955|NCT03003000|7646673|FG000|Overall Study|Other than listed|1
4716956|NCT03003000|7646674|FG001|Overall Study|Other than listed|1
4716957|NCT03003000|7646675|FG002|Overall Study|Other than listed|1
4716958|NCT03003390|7646694|FG000|Overall Study|Physician Decision|2
4716959|NCT03003390|7646695|FG001|Overall Study|Physician Decision|0
4716960|NCT03003390|7646694|FG000|Overall Study|Parent refused intervention|2
4716961|NCT03003390|7646695|FG001|Overall Study|Parent refused intervention|0
4716962|NCT03003494|7646706|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28
4716963|NCT03003676|7646712|FG000|Overall Study|Lack of Efficacy|5
4716964|NCT03003676|7646713|FG001|Overall Study|Lack of Efficacy|7
4716965|NCT03003676|7646712|FG000|Overall Study|Withdrawal by Subject|0
4716966|NCT03003676|7646713|FG001|Overall Study|Withdrawal by Subject|1
4716967|NCT03003676|7646712|FG000|Overall Study|Hepatitis B infection|1
4716968|NCT03003676|7646713|FG001|Overall Study|Hepatitis B infection|0
4716969|NCT03004469|7646742|FG000|Overall Study|Adverse Event|6
4716970|NCT03004469|7646743|FG001|Overall Study|Adverse Event|4
4716971|NCT03004469|7646744|FG002|Overall Study|Adverse Event|6
4716972|NCT03004469|7646742|FG000|Overall Study|Lack of Efficacy|1
4716973|NCT03004469|7646743|FG001|Overall Study|Lack of Efficacy|0
4716974|NCT03004469|7646744|FG002|Overall Study|Lack of Efficacy|1
4716975|NCT03004469|7646742|FG000|Overall Study|Lost to Follow-up|23
4716976|NCT03004469|7646743|FG001|Overall Study|Lost to Follow-up|14
4716977|NCT03004469|7646744|FG002|Overall Study|Lost to Follow-up|6
4716978|NCT03004469|7646742|FG000|Overall Study|Non-Compliance with Study Drug|2
4716979|NCT03004469|7646743|FG001|Overall Study|Non-Compliance with Study Drug|0
4716980|NCT03004469|7646744|FG002|Overall Study|Non-Compliance with Study Drug|0
4716981|NCT03004469|7646742|FG000|Overall Study|Protocol Violation|0
4716982|NCT03004469|7646743|FG001|Overall Study|Protocol Violation|0
4716983|NCT03004469|7646744|FG002|Overall Study|Protocol Violation|1
4716984|NCT03004469|7646742|FG000|Overall Study|Withdrawal by Subject|29
4716985|NCT03004469|7646743|FG001|Overall Study|Withdrawal by Subject|27
4716986|NCT03004469|7646744|FG002|Overall Study|Withdrawal by Subject|10
4716987|NCT03004469|7646742|FG000|Overall Study|Other unspecified reason|0
4716988|NCT03004469|7646743|FG001|Overall Study|Other unspecified reason|4
4716989|NCT03004469|7646744|FG002|Overall Study|Other unspecified reason|1
4716990|NCT03004924|7646812|FG000|Overall Study|Adverse Event|6
4716991|NCT03004924|7646813|FG001|Overall Study|Adverse Event|5
4716992|NCT03004924|7646814|FG002|Overall Study|Adverse Event|10
4716993|NCT03004924|7646812|FG000|Overall Study|Protocol Violation|4
4716994|NCT03004924|7646813|FG001|Overall Study|Protocol Violation|0
4716995|NCT03004924|7646814|FG002|Overall Study|Protocol Violation|1
4716996|NCT03004924|7646812|FG000|Overall Study|Withdrawal by Subject|5
4716997|NCT03004924|7646813|FG001|Overall Study|Withdrawal by Subject|3
4716998|NCT03004924|7646814|FG002|Overall Study|Withdrawal by Subject|5
4716999|NCT03004924|7646812|FG000|Overall Study|Lost to Follow-up|6
4630641|NCT01883362|7499384|FG001|Post Treatment Follow-up|Death|4
4514389|NCT00948818|7325297|FG000|Overall Study|Lack of Efficacy|4
4514390|NCT00948818|7325298|FG001|Overall Study|Lack of Efficacy|5
4514391|NCT00948818|7325297|FG000|Overall Study|Other Reason|4
4514392|NCT00948818|7325298|FG001|Overall Study|Other Reason|5
4514393|NCT00948857|7325309|FG000|Overall Study|Lost to Follow-up|1
4514394|NCT00948857|7325310|FG001|Overall Study|Lost to Follow-up|0
4514395|NCT00948896|7325324|FG000|Randomization to 24 Months of Age|Death|1
4514396|NCT00948896|7325325|FG001|Randomization to 24 Months of Age|Death|0
4514397|NCT00948896|7325326|FG002|Randomization to 24 Months of Age|Death|0
4514398|NCT00948896|7325327|FG003|Randomization to 24 Months of Age|Death|0
4514399|NCT00948896|7325328|FG004|Randomization to 24 Months of Age|Death|2
4514400|NCT00948896|7325329|FG005|Randomization to 24 Months of Age|Death|1
4514401|NCT00948896|7325330|FG006|Randomization to 24 Months of Age|Death|2
4514402|NCT00948896|7325331|FG007|Randomization to 24 Months of Age|Death|1
4514403|NCT00948896|7325324|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3
4514404|NCT00948896|7325325|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5
4514405|NCT00948896|7325326|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4
4514406|NCT00948896|7325327|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4
4514407|NCT00948896|7325328|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0
4514408|NCT00948896|7325329|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1
4514409|NCT00948896|7325330|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0
4514410|NCT00948896|7325331|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0
4514411|NCT00948896|7325324|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4
4514412|NCT00948896|7325325|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4
4514413|NCT00948896|7325326|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2
4514414|NCT00948896|7325327|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5
4514415|NCT00948896|7325328|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0
4514416|NCT00948896|7325329|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0
4514417|NCT00948896|7325330|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1
4514418|NCT00948896|7325331|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0
4514419|NCT00948896|7325324|FG000|Randomization to 24 Months of Age|Protocol Violation|0
4514420|NCT00948896|7325325|FG001|Randomization to 24 Months of Age|Protocol Violation|1
4514421|NCT00948896|7325326|FG002|Randomization to 24 Months of Age|Protocol Violation|0
4514422|NCT00948896|7325327|FG003|Randomization to 24 Months of Age|Protocol Violation|1
4514423|NCT00948896|7325328|FG004|Randomization to 24 Months of Age|Protocol Violation|0
4514424|NCT00948896|7325329|FG005|Randomization to 24 Months of Age|Protocol Violation|0
4514425|NCT00948896|7325330|FG006|Randomization to 24 Months of Age|Protocol Violation|1
4514426|NCT00948896|7325331|FG007|Randomization to 24 Months of Age|Protocol Violation|1
4514427|NCT00948896|7325324|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0
4514428|NCT00948896|7325325|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3
4514429|NCT00948896|7325326|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3
4514430|NCT00948896|7325327|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1
4514431|NCT00948896|7325328|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0
4514432|NCT00948896|7325329|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2
4514433|NCT00948896|7325330|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0
4514434|NCT00948896|7325331|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0
4514435|NCT00948896|7325324|FG000|24 Months of Age to 36 Months of Age|Death|0
4514436|NCT00948896|7325325|FG001|24 Months of Age to 36 Months of Age|Death|2
4514437|NCT00948896|7325326|FG002|24 Months of Age to 36 Months of Age|Death|2
4514438|NCT00948896|7325327|FG003|24 Months of Age to 36 Months of Age|Death|0
4514439|NCT00948896|7325328|FG004|24 Months of Age to 36 Months of Age|Death|0
4514440|NCT00948896|7325329|FG005|24 Months of Age to 36 Months of Age|Death|1
4514441|NCT00948896|7325330|FG006|24 Months of Age to 36 Months of Age|Death|0
4514442|NCT00948896|7325331|FG007|24 Months of Age to 36 Months of Age|Death|0
4514443|NCT00948896|7325324|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
4514444|NCT00948896|7325325|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
4514445|NCT00948896|7325326|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
4514446|NCT00948896|7325327|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
4514447|NCT00948896|7325328|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
4514448|NCT00948896|7325329|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
4514449|NCT00948896|7325330|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
4514450|NCT00948896|7325331|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
4514451|NCT00948896|7325324|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2
4514452|NCT00948896|7325325|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
4514453|NCT00948896|7325326|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1
4514454|NCT00948896|7325327|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
4514455|NCT00948896|7325328|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1
4514456|NCT00948896|7325329|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
4514457|NCT00948896|7325330|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
4514458|NCT00948896|7325331|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
4514459|NCT00948896|7325324|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0
4514460|NCT00948896|7325325|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0
4514461|NCT00948896|7325326|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1
4514462|NCT00948896|7325327|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0
4514463|NCT00948896|7325328|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0
4514464|NCT00948896|7325329|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1
4514465|NCT00948896|7325330|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0
4514466|NCT00948896|7325331|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0
4514467|NCT00948896|7325324|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
4514468|NCT00948896|7325325|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
4514469|NCT00948896|7325326|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
4514470|NCT00948896|7325327|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1
4514471|NCT00948896|7325328|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
4514472|NCT00948896|7325329|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
4514473|NCT00948896|7325330|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
4514474|NCT00948896|7325331|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
4514475|NCT00948922|7325356|FG000|Overall Study|Did not start study treatment|2
4514476|NCT00948922|7325357|FG001|Overall Study|Did not start study treatment|5
4514477|NCT00948922|7325358|FG002|Overall Study|Did not start study treatment|0
4514478|NCT00948922|7325356|FG000|Overall Study|Withdrawal by Subject|0
4514479|NCT00948922|7325357|FG001|Overall Study|Withdrawal by Subject|2
4514480|NCT00948922|7325358|FG002|Overall Study|Withdrawal by Subject|1
4514481|NCT00948922|7325356|FG000|Overall Study|Death|3
4514482|NCT00948922|7325357|FG001|Overall Study|Death|0
4514483|NCT00948922|7325358|FG002|Overall Study|Death|0
4514484|NCT00948922|7325356|FG000|Overall Study|Disease progression|0
4514485|NCT00948922|7325357|FG001|Overall Study|Disease progression|1
4514486|NCT00948922|7325358|FG002|Overall Study|Disease progression|0
4514487|NCT00948922|7325356|FG000|Overall Study|Insurance issues|1
4514488|NCT00948922|7325357|FG001|Overall Study|Insurance issues|0
4514489|NCT00948922|7325358|FG002|Overall Study|Insurance issues|0
4514490|NCT00948922|7325356|FG000|Overall Study|Transplant eligibility issues|2
4514491|NCT00948922|7325357|FG001|Overall Study|Transplant eligibility issues|3
4514492|NCT00948922|7325358|FG002|Overall Study|Transplant eligibility issues|0
4514493|NCT00948922|7325356|FG000|Overall Study|Not evaluable at time of analysis|0
4514494|NCT00948922|7325357|FG001|Overall Study|Not evaluable at time of analysis|3
4514495|NCT00948922|7325358|FG002|Overall Study|Not evaluable at time of analysis|0
4514496|NCT00948974|7325376|FG000|Overall Study|Lost to Follow-up|23
4514497|NCT00948974|7325377|FG001|Overall Study|Lost to Follow-up|20
4514498|NCT00949117|7325394|FG000|Overall Study|Lack of Efficacy|2
4514499|NCT00949117|7325395|FG001|Overall Study|Lack of Efficacy|3
4514500|NCT00949117|7325394|FG000|Overall Study|Protocol Violation|1
4514501|NCT00949117|7325395|FG001|Overall Study|Protocol Violation|1
4514502|NCT00949117|7325394|FG000|Overall Study|Adverse Event|0
4514503|NCT00949117|7325395|FG001|Overall Study|Adverse Event|1
4514504|NCT00949325|7325407|FG000|Overall Study|Adverse Event|0
4514505|NCT00949325|7325408|FG001|Overall Study|Adverse Event|2
4514506|NCT00949325|7325409|FG002|Overall Study|Adverse Event|0
4514507|NCT00949533|7325427|FG000|Overall Study|Lost to Follow-up|0
4717000|NCT03004924|7646813|FG001|Overall Study|Lost to Follow-up|1
4717001|NCT03004924|7646814|FG002|Overall Study|Lost to Follow-up|4
4717002|NCT03004924|7646812|FG000|Overall Study|Lack of Efficacy|2
4717003|NCT03004924|7646813|FG001|Overall Study|Lack of Efficacy|4
4717004|NCT03004924|7646814|FG002|Overall Study|Lack of Efficacy|2
4717005|NCT03004924|7646812|FG000|Overall Study|Physician Decision|1
4717006|NCT03004924|7646813|FG001|Overall Study|Physician Decision|0
4717007|NCT03004924|7646814|FG002|Overall Study|Physician Decision|1
4717008|NCT03004924|7646812|FG000|Overall Study|Withdrawal by parent/guardian|1
4717009|NCT03004924|7646813|FG001|Overall Study|Withdrawal by parent/guardian|0
4717010|NCT03004924|7646814|FG002|Overall Study|Withdrawal by parent/guardian|2
4717011|NCT03004924|7646812|FG000|Overall Study|Screen Failure|1
4717012|NCT03004924|7646813|FG001|Overall Study|Screen Failure|0
4717013|NCT03004924|7646814|FG002|Overall Study|Screen Failure|0
4717014|NCT03004924|7646812|FG000|Overall Study|Pregnancy|0
4717015|NCT03004924|7646813|FG001|Overall Study|Pregnancy|1
4717016|NCT03004924|7646814|FG002|Overall Study|Pregnancy|0
4514508|NCT00949533|7325428|FG001|Overall Study|Lost to Follow-up|1
4514509|NCT00949650|7325436|FG000|Overall Study|Progressive disease|188
4514510|NCT00949650|7325437|FG001|Overall Study|Progressive disease|19
4514511|NCT00949650|7325436|FG000|Overall Study|Completed 6 courses of chemotherapy|0
4717017|NCT03004924|7646812|FG000|Overall Study|Terminated by Sponsor|0
4717018|NCT03004924|7646813|FG001|Overall Study|Terminated by Sponsor|0
4717019|NCT03004924|7646814|FG002|Overall Study|Terminated by Sponsor|1
4717020|NCT03004924|7646812|FG000|Overall Study|Missed Study Visit|0
4717021|NCT03004924|7646813|FG001|Overall Study|Missed Study Visit|0
4717022|NCT03004924|7646814|FG002|Overall Study|Missed Study Visit|2
4717023|NCT03004924|7646812|FG000|Overall Study|HSV1 Positive|1
4717024|NCT03004924|7646813|FG001|Overall Study|HSV1 Positive|0
4717025|NCT03004924|7646814|FG002|Overall Study|HSV1 Positive|0
4717026|NCT03005067|7646836|FG000|Overall Study|Withdrawal by Subject|3
4717027|NCT03005067|7646837|FG001|Overall Study|Withdrawal by Subject|2
4717028|NCT03005067|7646836|FG000|Overall Study|Adverse Event|4
4717029|NCT03005067|7646837|FG001|Overall Study|Adverse Event|3
4514512|NCT00949650|7325437|FG001|Overall Study|Completed 6 courses of chemotherapy|60
4514513|NCT00949650|7325436|FG000|Overall Study|Other Adverse Event (AE)|28
4514514|NCT00949650|7325437|FG001|Overall Study|Other Adverse Event (AE)|17
4514515|NCT00949650|7325436|FG000|Overall Study|Protocol Violation|1
4514516|NCT00949650|7325437|FG001|Overall Study|Protocol Violation|4
4514517|NCT00949650|7325436|FG000|Overall Study|Refusal to continue medication|7
4514518|NCT00949650|7325437|FG001|Overall Study|Refusal to continue medication|11
4514519|NCT00949650|7325436|FG000|Overall Study|Not treated|1
4514520|NCT00949650|7325437|FG001|Overall Study|Not treated|4
4514521|NCT00949650|7325436|FG000|Overall Study|Other not specified above|5
4514522|NCT00949650|7325437|FG001|Overall Study|Other not specified above|0
4514523|NCT00949702|7325447|FG000|Overall Study|Death|40
4514524|NCT00949702|7325447|FG000|Overall Study|Disease progression|7
4514525|NCT00949702|7325447|FG000|Overall Study|Withdrawal of consent|1
4514526|NCT00949715|7325453|FG000|Overall Study|Physician Decision|1
4514527|NCT00949715|7325454|FG001|Overall Study|Physician Decision|0
4514528|NCT00949715|7325453|FG000|Overall Study|Lost to Follow-up|1
4514529|NCT00949715|7325454|FG001|Overall Study|Lost to Follow-up|0
4514530|NCT00949715|7325453|FG000|Overall Study|Missing 24 month LVEF measurement|2
4514531|NCT00949715|7325454|FG001|Overall Study|Missing 24 month LVEF measurement|0
4514532|NCT00949884|7325462|FG000|Overall Study|Adverse Event|14
4514533|NCT00949884|7325463|FG001|Overall Study|Adverse Event|3
4514534|NCT00949884|7325464|FG002|Overall Study|Adverse Event|12
4514535|NCT00949884|7325462|FG000|Overall Study|Did not meet inclusion/exclusion|2
4514536|NCT00949884|7325463|FG001|Overall Study|Did not meet inclusion/exclusion|1
4514537|NCT00949884|7325464|FG002|Overall Study|Did not meet inclusion/exclusion|3
4514538|NCT00949884|7325462|FG000|Overall Study|Lost to Follow-up|7
4514539|NCT00949884|7325463|FG001|Overall Study|Lost to Follow-up|5
4514540|NCT00949884|7325464|FG002|Overall Study|Lost to Follow-up|5
4514541|NCT00949884|7325462|FG000|Overall Study|Physician Decision|5
4514542|NCT00949884|7325463|FG001|Overall Study|Physician Decision|0
4514543|NCT00949884|7325464|FG002|Overall Study|Physician Decision|6
4514544|NCT00949884|7325462|FG000|Overall Study|Treatment non-compliance|5
4514545|NCT00949884|7325463|FG001|Overall Study|Treatment non-compliance|0
4514546|NCT00949884|7325464|FG002|Overall Study|Treatment non-compliance|8
4514547|NCT00949884|7325462|FG000|Overall Study|Withdrawal by Subject|13
4514548|NCT00949884|7325463|FG001|Overall Study|Withdrawal by Subject|4
4514549|NCT00949884|7325464|FG002|Overall Study|Withdrawal by Subject|16
4514550|NCT00949884|7325462|FG000|Overall Study|Lack of Efficacy|4
4514551|NCT00949884|7325463|FG001|Overall Study|Lack of Efficacy|2
4514552|NCT00949884|7325464|FG002|Overall Study|Lack of Efficacy|7
4514553|NCT00949884|7325462|FG000|Overall Study|Study terminated by sponsor|0
4590550|NCT01522651|7436635|FG000|Overall Study|Participant Non-Compliance|1
4717030|NCT03005067|7646836|FG000|Overall Study|Other (reason not specified)|3
4717031|NCT03005067|7646837|FG001|Overall Study|Other (reason not specified)|1
4717032|NCT03005067|7646836|FG000|Overall Study|Protocol Violation|0
4717033|NCT03005067|7646837|FG001|Overall Study|Protocol Violation|1
4717034|NCT03005106|7646843|FG000|Overall Study|Lost to Follow-up|16
4717035|NCT03005106|7646843|FG000|Overall Study|Adverse Event|1
4717036|NCT03005106|7646843|FG000|Overall Study|Physician Decision|1
4717037|NCT03005106|7646843|FG000|Overall Study|Death|2
4717038|NCT03005288|7646849|FG000|Overall Study|Withdrawal by Subject|7
4717039|NCT03005288|7646850|FG001|Overall Study|Withdrawal by Subject|5
4717040|NCT03005288|7646849|FG000|Overall Study|Lost to Follow-up|0
4717041|NCT03005288|7646850|FG001|Overall Study|Lost to Follow-up|1
4717042|NCT03005288|7646849|FG000|Overall Study|Adverse Event|5
4717043|NCT03005288|7646850|FG001|Overall Study|Adverse Event|0
4717044|NCT03005288|7646849|FG000|Overall Study|Protocol deviation|0
4717045|NCT03005288|7646850|FG001|Overall Study|Protocol deviation|1
4717046|NCT03005288|7646849|FG000|Overall Study|Physician Decision|0
4717047|NCT03005288|7646850|FG001|Overall Study|Physician Decision|1
4717048|NCT03006341|7646860|FG000|Overall Study|Not linked in the EMR|25069
4717049|NCT03006341|7646861|FG001|Overall Study|Not linked in the EMR|67505
4717050|NCT03006341|7646862|FG002|Overall Study|Not linked in the EMR|30993
4717051|NCT03006341|7646863|FG003|Overall Study|Not linked in the EMR|10685
4717052|NCT03006393|7646873|FG000|Overall Study|Withdrawal by Subject|1
4717053|NCT03006393|7646874|FG001|Overall Study|Withdrawal by Subject|1
4717054|NCT03006393|7646873|FG000|Overall Study|Pregnancy|0
4717055|NCT03006393|7646874|FG001|Overall Study|Pregnancy|1
4514554|NCT00949884|7325463|FG001|Overall Study|Study terminated by sponsor|0
4514555|NCT00949884|7325464|FG002|Overall Study|Study terminated by sponsor|1
4514556|NCT00949910|7325473|FG000|Overall Study|Progressive Disease|3750
4514557|NCT00949910|7325473|FG000|Overall Study|Symptomatic Deterioration|1088
4514558|NCT00949910|7325473|FG000|Overall Study|Lost to Follow-up|100
4514559|NCT00949910|7325473|FG000|Overall Study|Study Drug-Related Adverse Event|315
4590551|NCT01522651|7436636|FG001|Overall Study|Participant Non-Compliance|0
4717056|NCT03006393|7646873|FG000|Overall Study|Lost to Follow-up|0
4717057|NCT03006393|7646874|FG001|Overall Study|Lost to Follow-up|1
4717058|NCT03006458|7646880|FG000|First Intervention|Unsatisfied Vision|0
4717059|NCT03006458|7646881|FG001|First Intervention|Unsatisfied Vision|3
4717060|NCT03006562|7646898|FG000|Overall Study|Lost to Follow-up|0
4717061|NCT03006562|7646899|FG001|Overall Study|Lost to Follow-up|1
4717062|NCT03006848|7646905|FG000|Overall Study|Adverse Event|1
4717063|NCT03006848|7646905|FG000|Overall Study|Physician Decision|1
4514560|NCT00949910|7325473|FG000|Overall Study|Participant Refusal|390
4514561|NCT00949910|7325473|FG000|Overall Study|Death Due to Malignant Disease|456
4514562|NCT00949910|7325473|FG000|Overall Study|Death Due to Progression/Deterioration|4
4514563|NCT00949910|7325473|FG000|Overall Study|Death Due to Adverse Event|115
4514564|NCT00949910|7325473|FG000|Overall Study|Death Due to Toxicity|3
4514565|NCT00949910|7325473|FG000|Overall Study|Death from Unknown Cause|5
4514566|NCT00949910|7325473|FG000|Overall Study|Unspecified Progression/Deterioration|13
4514567|NCT00949910|7325473|FG000|Overall Study|Switched to Compassionate/Other Use|174
4514568|NCT00949910|7325473|FG000|Overall Study|Switched to Commercial Treatment|4
4514569|NCT00949910|7325473|FG000|Overall Study|Violation of Eligibility|23
4514570|NCT00949910|7325473|FG000|Overall Study|Logistical Reasons|13
4514571|NCT00949910|7325473|FG000|Overall Study|Non-Compliance|10
4514572|NCT00949910|7325473|FG000|Overall Study|Prolonged Dosing Interruption|4
4514573|NCT00949910|7325473|FG000|Overall Study|Adverse Event|83
4514574|NCT00949910|7325473|FG000|Overall Study|Serious Adverse Event|6
4514575|NCT00949910|7325473|FG000|Overall Study|Physician/Participant Decision|7
4514576|NCT00949910|7325473|FG000|Overall Study|Other|4
4514577|NCT00949910|7325473|FG000|Overall Study|No Data|9
4514578|NCT00949975|7325481|FG000|Overall Study|Voluntary discontinuation|6
4514579|NCT00949975|7325482|FG001|Overall Study|Voluntary discontinuation|5
4514580|NCT00949975|7325483|FG002|Overall Study|Voluntary discontinuation|3
4514581|NCT00949975|7325484|FG003|Overall Study|Voluntary discontinuation|6
4514582|NCT00949975|7325481|FG000|Overall Study|Adverse Event|11
4514583|NCT00949975|7325482|FG001|Overall Study|Adverse Event|11
4514584|NCT00949975|7325483|FG002|Overall Study|Adverse Event|10
4514585|NCT00949975|7325484|FG003|Overall Study|Adverse Event|10
4514586|NCT00949975|7325481|FG000|Overall Study|Safety reason|0
4514587|NCT00949975|7325482|FG001|Overall Study|Safety reason|1
4514588|NCT00949975|7325483|FG002|Overall Study|Safety reason|0
4514589|NCT00949975|7325484|FG003|Overall Study|Safety reason|0
4514590|NCT00949975|7325481|FG000|Overall Study|Study-specific criteria|0
4514591|NCT00949975|7325482|FG001|Overall Study|Study-specific criteria|1
4514592|NCT00949975|7325483|FG002|Overall Study|Study-specific criteria|1
4514593|NCT00949975|7325484|FG003|Overall Study|Study-specific criteria|0
4514594|NCT00949975|7325481|FG000|Overall Study|Incorrect enrolment|5
4514595|NCT00949975|7325482|FG001|Overall Study|Incorrect enrolment|10
4514596|NCT00949975|7325483|FG002|Overall Study|Incorrect enrolment|4
4514597|NCT00949975|7325484|FG003|Overall Study|Incorrect enrolment|7
4514598|NCT00949975|7325481|FG000|Overall Study|Severe non-compliance|3
4514599|NCT00949975|7325482|FG001|Overall Study|Severe non-compliance|1
4514600|NCT00949975|7325483|FG002|Overall Study|Severe non-compliance|0
4514601|NCT00949975|7325484|FG003|Overall Study|Severe non-compliance|2
4514602|NCT00949975|7325481|FG000|Overall Study|Lost to Follow-up|1
4514603|NCT00949975|7325482|FG001|Overall Study|Lost to Follow-up|0
4514604|NCT00949975|7325483|FG002|Overall Study|Lost to Follow-up|1
4514605|NCT00949975|7325484|FG003|Overall Study|Lost to Follow-up|3
4514606|NCT00949975|7325481|FG000|Overall Study|Other|1
4514607|NCT00949975|7325482|FG001|Overall Study|Other|0
4514608|NCT00949975|7325483|FG002|Overall Study|Other|0
4514609|NCT00949975|7325484|FG003|Overall Study|Other|0
4514610|NCT00950170|7325494|FG000|Overall Study|Parent/Legal Guardian Request|1
4514611|NCT00950170|7325494|FG000|Overall Study|Adverse Event|2
4514612|NCT00950170|7325494|FG000|Overall Study|Discontinuation of Study by Sponsor|1
4514613|NCT00950248|7325527|FG000|Year 1: Baseline|Withdrawal by Subject|6
4514614|NCT00950248|7325528|FG001|Year 1: Baseline|Withdrawal by Subject|0
4514615|NCT00950248|7325529|FG002|Year 1: Baseline|Withdrawal by Subject|0
4514616|NCT00950248|7325527|FG000|Year 1: Baseline|worsening of symptoms|2
4514617|NCT00950248|7325528|FG001|Year 1: Baseline|worsening of symptoms|0
4514618|NCT00950248|7325529|FG002|Year 1: Baseline|worsening of symptoms|0
4514619|NCT00950248|7325527|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0
4514620|NCT00950248|7325528|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2
4514621|NCT00950248|7325529|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4
4717064|NCT03006848|7646905|FG000|Overall Study|Lack of Efficacy|16
4717065|NCT03006887|7646916|FG000|Overall Study|Adverse Event|1
4717066|NCT03007472|7646938|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2
4717067|NCT03007472|7646938|FG000|Overall Study|Death|2
4717068|NCT03007472|7646938|FG000|Overall Study|Loss to Follow Up|1
4717069|NCT03007953|7646944|FG000|Overall Study|Withdrawal by Subject|5
4717070|NCT03007953|7646945|FG001|Overall Study|Withdrawal by Subject|2
4717071|NCT03007953|7646944|FG000|Overall Study|Death|5
4717072|NCT03007953|7646945|FG001|Overall Study|Death|7
4717073|NCT03007953|7646944|FG000|Overall Study|Lost to Follow-up|3
4717074|NCT03007953|7646945|FG001|Overall Study|Lost to Follow-up|2
4717075|NCT03007953|7646944|FG000|Overall Study|Enrolled in Hospice|3
4717076|NCT03007953|7646945|FG001|Overall Study|Enrolled in Hospice|2
4717077|NCT03007966|7646953|FG000|Overall Study|Did not meeting inclusion/exclusion|1
4717078|NCT03007966|7646954|FG001|Overall Study|Did not meeting inclusion/exclusion|0
4514622|NCT00950248|7325527|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0
4590552|NCT01522651|7436637|FG002|Overall Study|Participant Non-Compliance|0
4590553|NCT01522651|7436638|FG003|Overall Study|Participant Non-Compliance|0
4717079|NCT03008070|7646964|FG000|Overall Study|Adverse Event|3
4717080|NCT03008070|7646965|FG001|Overall Study|Adverse Event|3
4717081|NCT03008070|7646966|FG002|Overall Study|Adverse Event|3
4514623|NCT00950248|7325528|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3
4514624|NCT00950248|7325529|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0
4514625|NCT00950248|7325527|FG000|Year 2&3 Treatment Randomization|Death|0
4514626|NCT00950248|7325528|FG001|Year 2&3 Treatment Randomization|Death|0
4514627|NCT00950248|7325529|FG002|Year 2&3 Treatment Randomization|Death|1
4514628|NCT00950248|7325527|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0
4514629|NCT00950248|7325528|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1
4514630|NCT00950248|7325529|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0
4514631|NCT00950300|7325538|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6
4514632|NCT00950300|7325539|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15
4514633|NCT00950300|7325538|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1
4514634|NCT00950300|7325539|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3
4514635|NCT00950300|7325538|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3
4717082|NCT03008070|7646964|FG000|Overall Study|Lost to Follow-up|1
4717083|NCT03008070|7646965|FG001|Overall Study|Lost to Follow-up|1
4717084|NCT03008070|7646966|FG002|Overall Study|Lost to Follow-up|0
4717085|NCT03008070|7646964|FG000|Overall Study|Non compliance|0
4717086|NCT03008070|7646965|FG001|Overall Study|Non compliance|1
4717087|NCT03008070|7646966|FG002|Overall Study|Non compliance|1
4717088|NCT03008070|7646964|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0
4717089|NCT03008070|7646965|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1
4717090|NCT03008070|7646966|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0
4717091|NCT03008070|7646964|FG000|Overall Study|Withdrawal by Subject|2
4717092|NCT03008070|7646965|FG001|Overall Study|Withdrawal by Subject|0
4717093|NCT03008070|7646966|FG002|Overall Study|Withdrawal by Subject|1
4717094|NCT03008070|7646964|FG000|Overall Study|Use of prohibited drug|0
4717095|NCT03008070|7646965|FG001|Overall Study|Use of prohibited drug|0
4717096|NCT03008070|7646966|FG002|Overall Study|Use of prohibited drug|2
4736206|NCT03560518|7685156|FG000|Double Blind Treatment Period|Withdrawal by Subject|10
4736207|NCT03560518|7685157|FG001|Double Blind Treatment Period|Withdrawal by Subject|6
4736208|NCT03560518|7685158|FG002|Double Blind Treatment Period|Withdrawal by Subject|5
4736209|NCT03560518|7685156|FG000|Double Blind Treatment Period|Lack of Efficacy|2
4736210|NCT03560518|7685157|FG001|Double Blind Treatment Period|Lack of Efficacy|1
4736211|NCT03560518|7685158|FG002|Double Blind Treatment Period|Lack of Efficacy|1
4736212|NCT03560518|7685156|FG000|Double Blind Treatment Period|Adverse Event|0
4736213|NCT03560518|7685157|FG001|Double Blind Treatment Period|Adverse Event|3
4736214|NCT03560518|7685158|FG002|Double Blind Treatment Period|Adverse Event|1
4736215|NCT03560739|7685170|FG000|Overall Study|Adverse Event|0
4736216|NCT03560739|7685171|FG001|Overall Study|Adverse Event|1
4736217|NCT03560739|7685172|FG002|Overall Study|Adverse Event|0
4736218|NCT03560739|7685173|FG003|Overall Study|Adverse Event|0
4736219|NCT03560869|7685183|FG000|Overall Study|Withdrawal by Subject|3
4736220|NCT03560869|7685184|FG001|Overall Study|Withdrawal by Subject|4
4736221|NCT03560869|7685183|FG000|Overall Study|Screening failure|4
4736222|NCT03560869|7685184|FG001|Overall Study|Screening failure|4
4736223|NCT03560869|7685183|FG000|Overall Study|Withdrawal by PI|0
4736224|NCT03560869|7685184|FG001|Overall Study|Withdrawal by PI|1
4736225|NCT03560986|7685192|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3
4736226|NCT03560986|7685193|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1
4736227|NCT03560986|7685192|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1
4736228|NCT03560986|7685193|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1
4736229|NCT03560986|7685192|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0
4736230|NCT03560986|7685193|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1
4736231|NCT03560986|7685192|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32
4736232|NCT03560986|7685193|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35
4736233|NCT03560986|7685192|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1
4736234|NCT03560986|7685193|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0
4736235|NCT03560986|7685192|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0
4736236|NCT03560986|7685193|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1
4736237|NCT03560986|7685192|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7
4736238|NCT03560986|7685193|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7
4736239|NCT03561090|7685207|FG000|Overall Study|Adverse Event|11
4736240|NCT03561090|7685208|FG001|Overall Study|Adverse Event|7
4771727|NCT04256629|7748623|FG000|Overall Study|Adverse Event|0
4736241|NCT03561090|7685207|FG000|Overall Study|Non-Compliance With Study Drug|2
4736242|NCT03561090|7685208|FG001|Overall Study|Non-Compliance With Study Drug|0
4736243|NCT03561090|7685207|FG000|Overall Study|Protocol Violation|2
4736244|NCT03561090|7685208|FG001|Overall Study|Protocol Violation|2
4736245|NCT03561090|7685207|FG000|Overall Study|Withdrawal by Subject|7
4736246|NCT03561090|7685208|FG001|Overall Study|Withdrawal by Subject|7
4736247|NCT03561090|7685207|FG000|Overall Study|Lost to Follow-up|7
4736248|NCT03561090|7685208|FG001|Overall Study|Lost to Follow-up|2
4736249|NCT03561090|7685207|FG000|Overall Study|Study Terminated by Sponsor|10
4736250|NCT03561090|7685208|FG001|Overall Study|Study Terminated by Sponsor|15
4736251|NCT03561090|7685207|FG000|Overall Study|Randomized by Mistake|1
4514636|NCT00950300|7325539|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0
4514637|NCT00950300|7325538|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2
4514638|NCT00950300|7325539|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1
4514639|NCT00950300|7325538|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1
4514640|NCT00950300|7325539|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0
4514641|NCT00950300|7325538|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4
4514642|NCT00950300|7325539|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5
4514643|NCT00950300|7325538|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2
4514644|NCT00950300|7325539|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1
4514645|NCT00950300|7325538|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12
4514646|NCT00950300|7325539|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11
4514647|NCT00950300|7325538|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10
4514648|NCT00950300|7325539|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5
4514649|NCT00950300|7325538|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1
4514650|NCT00950300|7325539|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1
4514651|NCT00950300|7325538|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3
4514652|NCT00950300|7325539|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4
4514653|NCT00950300|7325538|FG000|TFFU Period|Death|4
4514654|NCT00950300|7325539|FG001|TFFU Period|Death|1
4514655|NCT00950300|7325538|FG000|TFFU Period|Refused Treatment|10
4514656|NCT00950300|7325539|FG001|TFFU Period|Refused Treatment|11
4514657|NCT00950300|7325538|FG000|TFFU Period|Failure to Return|16
4514658|NCT00950300|7325539|FG001|TFFU Period|Failure to Return|16
4514659|NCT00950300|7325538|FG000|TFFU Period|Recurrence of Disease|63
4514660|NCT00950300|7325539|FG001|TFFU Period|Recurrence of Disease|72
4514661|NCT00950300|7325538|FG000|TFFU Period|Other|4
4514662|NCT00950300|7325539|FG001|TFFU Period|Other|3
4514663|NCT00950300|7325538|FG000|SFU Period|Death|44
4514664|NCT00950300|7325539|FG001|SFU Period|Death|42
4514665|NCT00950300|7325538|FG000|SFU Period|Lost to Follow-up|30
4514666|NCT00950300|7325539|FG001|SFU Period|Lost to Follow-up|28
4514667|NCT00950300|7325538|FG000|SFU Period|Withdrawal by Subject|4
4514668|NCT00950300|7325539|FG001|SFU Period|Withdrawal by Subject|8
4514669|NCT00950599|7325572|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0
4514670|NCT00950599|7325573|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0
4514671|NCT00950599|7325574|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0
4514672|NCT00950599|7325575|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1
4514673|NCT00950599|7325576|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0
4514674|NCT00950599|7325577|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0
4514675|NCT00950599|7325578|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0
4514676|NCT00950599|7325579|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0
4514677|NCT00950599|7325580|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0
4514678|NCT00950599|7325581|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0
4514679|NCT00950599|7325572|FG000|Double-Blind Treatment Period|Adverse Event|0
4514680|NCT00950599|7325573|FG001|Double-Blind Treatment Period|Adverse Event|1
4514681|NCT00950599|7325574|FG002|Double-Blind Treatment Period|Adverse Event|1
4514682|NCT00950599|7325575|FG003|Double-Blind Treatment Period|Adverse Event|1
4514683|NCT00950599|7325576|FG004|Double-Blind Treatment Period|Adverse Event|1
4514684|NCT00950599|7325577|FG005|Double-Blind Treatment Period|Adverse Event|1
4514685|NCT00950599|7325578|FG006|Double-Blind Treatment Period|Adverse Event|0
4514686|NCT00950599|7325579|FG007|Double-Blind Treatment Period|Adverse Event|0
4514687|NCT00950599|7325580|FG008|Double-Blind Treatment Period|Adverse Event|0
4514688|NCT00950599|7325581|FG009|Double-Blind Treatment Period|Adverse Event|0
4514689|NCT00950599|7325572|FG000|Double-Blind Treatment Period|Lack of Efficacy|2
4514690|NCT00950599|7325573|FG001|Double-Blind Treatment Period|Lack of Efficacy|5
4514691|NCT00950599|7325574|FG002|Double-Blind Treatment Period|Lack of Efficacy|5
4514692|NCT00950599|7325575|FG003|Double-Blind Treatment Period|Lack of Efficacy|7
4514693|NCT00950599|7325576|FG004|Double-Blind Treatment Period|Lack of Efficacy|3
4514694|NCT00950599|7325577|FG005|Double-Blind Treatment Period|Lack of Efficacy|6
4514695|NCT00950599|7325578|FG006|Double-Blind Treatment Period|Lack of Efficacy|0
4514696|NCT00950599|7325579|FG007|Double-Blind Treatment Period|Lack of Efficacy|1
4514697|NCT00950599|7325580|FG008|Double-Blind Treatment Period|Lack of Efficacy|0
4514698|NCT00950599|7325581|FG009|Double-Blind Treatment Period|Lack of Efficacy|0
4514699|NCT00950599|7325572|FG000|Double-Blind Treatment Period|Lost to Follow-up|0
4514700|NCT00950599|7325573|FG001|Double-Blind Treatment Period|Lost to Follow-up|0
4514701|NCT00950599|7325574|FG002|Double-Blind Treatment Period|Lost to Follow-up|0
4514702|NCT00950599|7325575|FG003|Double-Blind Treatment Period|Lost to Follow-up|1
4514703|NCT00950599|7325576|FG004|Double-Blind Treatment Period|Lost to Follow-up|1
4514704|NCT00950599|7325577|FG005|Double-Blind Treatment Period|Lost to Follow-up|2
4514705|NCT00950599|7325578|FG006|Double-Blind Treatment Period|Lost to Follow-up|0
4514706|NCT00950599|7325579|FG007|Double-Blind Treatment Period|Lost to Follow-up|1
4514707|NCT00950599|7325580|FG008|Double-Blind Treatment Period|Lost to Follow-up|0
4514708|NCT00950599|7325581|FG009|Double-Blind Treatment Period|Lost to Follow-up|0
4514709|NCT00950599|7325572|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1
4514710|NCT00950599|7325573|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1
4514711|NCT00950599|7325574|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0
4514712|NCT00950599|7325575|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0
4514713|NCT00950599|7325576|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0
4514714|NCT00950599|7325577|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0
4514715|NCT00950599|7325578|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0
4514716|NCT00950599|7325579|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1
4514717|NCT00950599|7325580|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0
4514718|NCT00950599|7325581|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0
4514719|NCT00950599|7325572|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0
4514720|NCT00950599|7325573|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0
4514721|NCT00950599|7325574|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0
4514722|NCT00950599|7325575|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0
4514723|NCT00950599|7325576|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1
4514724|NCT00950599|7325577|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1
4514725|NCT00950599|7325578|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0
4514726|NCT00950599|7325579|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0
4514727|NCT00950599|7325580|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0
4514728|NCT00950599|7325581|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0
4514729|NCT00950599|7325572|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4
4514730|NCT00950599|7325573|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3
4514731|NCT00950599|7325574|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3
4514732|NCT00950599|7325575|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1
4514733|NCT00950599|7325576|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1
4514734|NCT00950599|7325577|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2
4514735|NCT00950599|7325578|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0
4514736|NCT00950599|7325579|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3
4514737|NCT00950599|7325580|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0
4514738|NCT00950599|7325581|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0
4514739|NCT00950599|7325572|FG000|Follow-Up Period|Adverse Event|0
4514740|NCT00950599|7325573|FG001|Follow-Up Period|Adverse Event|0
4514741|NCT00950599|7325574|FG002|Follow-Up Period|Adverse Event|0
4514742|NCT00950599|7325575|FG003|Follow-Up Period|Adverse Event|0
4514743|NCT00950599|7325576|FG004|Follow-Up Period|Adverse Event|0
4514744|NCT00950599|7325577|FG005|Follow-Up Period|Adverse Event|0
4514745|NCT00950599|7325578|FG006|Follow-Up Period|Adverse Event|0
4514746|NCT00950599|7325579|FG007|Follow-Up Period|Adverse Event|0
4514747|NCT00950599|7325580|FG008|Follow-Up Period|Adverse Event|1
4514748|NCT00950599|7325581|FG009|Follow-Up Period|Adverse Event|0
4717097|NCT03008460|7646991|FG000|Overall Study|Protocol deviation|0
4717098|NCT03008460|7646992|FG001|Overall Study|Protocol deviation|2
4717099|NCT03008460|7646991|FG000|Overall Study|Study drug not dispensed|0
4717100|NCT03008460|7646992|FG001|Overall Study|Study drug not dispensed|1
4717101|NCT03008460|7646991|FG000|Overall Study|Adverse Event|0
4717102|NCT03008460|7646992|FG001|Overall Study|Adverse Event|1
4717103|NCT03008460|7646991|FG000|Overall Study|Withdrawal by Subject|5
4717104|NCT03008460|7646992|FG001|Overall Study|Withdrawal by Subject|6
4717105|NCT03008460|7646991|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1
4717106|NCT03008460|7646992|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0
4717107|NCT03008460|7646991|FG000|Overall Study|End of study visit outside permitted time window|0
4717108|NCT03008460|7646992|FG001|Overall Study|End of study visit outside permitted time window|1
4717109|NCT03008460|7646991|FG000|Overall Study|Lost to Follow-up|1
4717110|NCT03008460|7646992|FG001|Overall Study|Lost to Follow-up|3
4717111|NCT03008915|7647038|FG000|Treatment 1|Withdrawal by Subject|0
4717112|NCT03008915|7647039|FG001|Treatment 1|Withdrawal by Subject|1
4717113|NCT03010254|7647074|FG000|Overall Study|Adverse Event|0
4717114|NCT03010254|7647075|FG001|Overall Study|Adverse Event|1
4717115|NCT03010254|7647074|FG000|Overall Study|Lost to Follow-up|4
4717116|NCT03010254|7647075|FG001|Overall Study|Lost to Follow-up|0
4717117|NCT03010254|7647074|FG000|Overall Study|Withdrawal by Subject|1
4717118|NCT03010254|7647075|FG001|Overall Study|Withdrawal by Subject|1
4717119|NCT03010254|7647074|FG000|Overall Study|Other|2
4717120|NCT03010254|7647075|FG001|Overall Study|Other|3
4717121|NCT03010462|7647090|FG000|Overall Study|Withdrawal by Subject|3
4717122|NCT03010462|7647091|FG001|Overall Study|Withdrawal by Subject|1
4717123|NCT03010501|7647106|FG000|Study Week 1|Withdrawal by Subject|2
4717124|NCT03010501|7647107|FG001|Study Week 1|Withdrawal by Subject|1
4717125|NCT03010501|7647108|FG002|Study Week 1|Withdrawal by Subject|0
4717126|NCT03010501|7647109|FG003|Study Week 1|Withdrawal by Subject|2
4717127|NCT03010501|7647110|FG004|Study Week 1|Withdrawal by Subject|0
4514749|NCT00950599|7325572|FG000|Follow-Up Period|Lack of Efficacy|0
4717128|NCT03010501|7647111|FG005|Study Week 1|Withdrawal by Subject|0
4717129|NCT03010501|7647106|FG000|Study Week 3|Withdrawal by Subject|0
4717130|NCT03010501|7647107|FG001|Study Week 3|Withdrawal by Subject|0
4717131|NCT03010501|7647108|FG002|Study Week 3|Withdrawal by Subject|0
4717132|NCT03010501|7647109|FG003|Study Week 3|Withdrawal by Subject|1
4717133|NCT03010501|7647110|FG004|Study Week 3|Withdrawal by Subject|0
4514750|NCT00950599|7325573|FG001|Follow-Up Period|Lack of Efficacy|0
4514751|NCT00950599|7325574|FG002|Follow-Up Period|Lack of Efficacy|0
4514752|NCT00950599|7325575|FG003|Follow-Up Period|Lack of Efficacy|0
4514753|NCT00950599|7325576|FG004|Follow-Up Period|Lack of Efficacy|0
4514754|NCT00950599|7325577|FG005|Follow-Up Period|Lack of Efficacy|0
4514755|NCT00950599|7325578|FG006|Follow-Up Period|Lack of Efficacy|0
4514756|NCT00950599|7325579|FG007|Follow-Up Period|Lack of Efficacy|0
4514757|NCT00950599|7325580|FG008|Follow-Up Period|Lack of Efficacy|3
4514758|NCT00950599|7325581|FG009|Follow-Up Period|Lack of Efficacy|0
4717134|NCT03010501|7647111|FG005|Study Week 3|Withdrawal by Subject|0
4717135|NCT03010527|7647122|FG000|Overall Study|Death|0
4717136|NCT03010527|7647123|FG001|Overall Study|Death|0
4717137|NCT03010527|7647124|FG002|Overall Study|Death|1
4717138|NCT03010527|7647122|FG000|Overall Study|Adverse Event|0
4717139|NCT03010527|7647123|FG001|Overall Study|Adverse Event|4
4717140|NCT03010527|7647124|FG002|Overall Study|Adverse Event|2
4717141|NCT03010527|7647122|FG000|Overall Study|Protocol Violation|0
4717142|NCT03010527|7647123|FG001|Overall Study|Protocol Violation|1
4717143|NCT03010527|7647124|FG002|Overall Study|Protocol Violation|0
4717144|NCT03010527|7647122|FG000|Overall Study|Lost to Follow-up|0
4717145|NCT03010527|7647123|FG001|Overall Study|Lost to Follow-up|2
4717146|NCT03010527|7647124|FG002|Overall Study|Lost to Follow-up|1
4717147|NCT03010527|7647122|FG000|Overall Study|Withdrawal by Subject|0
4717148|NCT03010527|7647123|FG001|Overall Study|Withdrawal by Subject|3
4717149|NCT03010527|7647124|FG002|Overall Study|Withdrawal by Subject|4
4717150|NCT03010527|7647122|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0
4717151|NCT03010527|7647123|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4
4717152|NCT03010527|7647124|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6
4717153|NCT03010527|7647122|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0
4717154|NCT03010527|7647123|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4
4717155|NCT03010527|7647124|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2
4717156|NCT03010527|7647122|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0
4717157|NCT03010527|7647123|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1
4717158|NCT03010527|7647124|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0
4717159|NCT03011099|7647182|FG000|Overall Study|Withdrawal by Subject|0
4717160|NCT03011099|7647183|FG001|Overall Study|Withdrawal by Subject|2
4717161|NCT03011333|7647198|FG000|Overall Study|Lost to Follow-up|0
4717162|NCT03011333|7647199|FG001|Overall Study|Lost to Follow-up|1
4717163|NCT03011333|7647200|FG002|Overall Study|Lost to Follow-up|0
4717164|NCT03011333|7647201|FG003|Overall Study|Lost to Follow-up|1
4717165|NCT03011333|7647202|FG004|Overall Study|Lost to Follow-up|4
4717166|NCT03011333|7647203|FG005|Overall Study|Lost to Follow-up|4
4717167|NCT03011333|7647204|FG006|Overall Study|Lost to Follow-up|5
4717168|NCT03011840|7647222|FG000|Overall Study|Not received PIL in post PIL phase|0
4717169|NCT03011840|7647223|FG001|Overall Study|Not received PIL in post PIL phase|21
4717170|NCT03011892|7647235|FG000|Double Blind (DB) Period|Adverse Event|0
4717171|NCT03011892|7647236|FG001|Double Blind (DB) Period|Adverse Event|1
4717172|NCT03011892|7647237|FG002|Double Blind (DB) Period|Adverse Event|1
4717173|NCT03011892|7647238|FG003|Double Blind (DB) Period|Adverse Event|0
4717174|NCT03011892|7647239|FG004|Double Blind (DB) Period|Adverse Event|0
4717175|NCT03011892|7647240|FG005|Double Blind (DB) Period|Adverse Event|0
4717176|NCT03011892|7647241|FG006|Double Blind (DB) Period|Adverse Event|0
4717177|NCT03011892|7647242|FG007|Double Blind (DB) Period|Adverse Event|0
4717178|NCT03011892|7647243|FG008|Double Blind (DB) Period|Adverse Event|0
4717179|NCT03011892|7647244|FG009|Double Blind (DB) Period|Adverse Event|0
4717180|NCT03011892|7647245|FG010|Double Blind (DB) Period|Adverse Event|0
4717181|NCT03011892|7647246|FG011|Double Blind (DB) Period|Adverse Event|0
4717182|NCT03011892|7647235|FG000|Double Blind (DB) Period|Lack of Efficacy|1
4717183|NCT03011892|7647236|FG001|Double Blind (DB) Period|Lack of Efficacy|0
4717184|NCT03011892|7647237|FG002|Double Blind (DB) Period|Lack of Efficacy|0
4717185|NCT03011892|7647238|FG003|Double Blind (DB) Period|Lack of Efficacy|0
4717186|NCT03011892|7647239|FG004|Double Blind (DB) Period|Lack of Efficacy|0
4717187|NCT03011892|7647240|FG005|Double Blind (DB) Period|Lack of Efficacy|0
4717188|NCT03011892|7647241|FG006|Double Blind (DB) Period|Lack of Efficacy|0
4717189|NCT03011892|7647242|FG007|Double Blind (DB) Period|Lack of Efficacy|0
4717190|NCT03011892|7647243|FG008|Double Blind (DB) Period|Lack of Efficacy|0
4717191|NCT03011892|7647244|FG009|Double Blind (DB) Period|Lack of Efficacy|0
4717192|NCT03011892|7647245|FG010|Double Blind (DB) Period|Lack of Efficacy|0
4717193|NCT03011892|7647246|FG011|Double Blind (DB) Period|Lack of Efficacy|0
4717194|NCT03011892|7647235|FG000|Double Blind (DB) Period|Lost to Follow-up|0
4717195|NCT03011892|7647236|FG001|Double Blind (DB) Period|Lost to Follow-up|3
4717196|NCT03011892|7647237|FG002|Double Blind (DB) Period|Lost to Follow-up|2
4717197|NCT03011892|7647238|FG003|Double Blind (DB) Period|Lost to Follow-up|5
4717198|NCT03011892|7647239|FG004|Double Blind (DB) Period|Lost to Follow-up|0
4717199|NCT03011892|7647240|FG005|Double Blind (DB) Period|Lost to Follow-up|2
4717200|NCT03011892|7647241|FG006|Double Blind (DB) Period|Lost to Follow-up|0
4717201|NCT03011892|7647242|FG007|Double Blind (DB) Period|Lost to Follow-up|0
4717202|NCT03011892|7647243|FG008|Double Blind (DB) Period|Lost to Follow-up|0
4717203|NCT03011892|7647244|FG009|Double Blind (DB) Period|Lost to Follow-up|0
4717204|NCT03011892|7647245|FG010|Double Blind (DB) Period|Lost to Follow-up|0
4514759|NCT00950599|7325572|FG000|Follow-Up Period|Lost to Follow-up|0
4514760|NCT00950599|7325573|FG001|Follow-Up Period|Lost to Follow-up|0
4514761|NCT00950599|7325574|FG002|Follow-Up Period|Lost to Follow-up|0
4514762|NCT00950599|7325575|FG003|Follow-Up Period|Lost to Follow-up|0
4514763|NCT00950599|7325576|FG004|Follow-Up Period|Lost to Follow-up|0
4514764|NCT00950599|7325577|FG005|Follow-Up Period|Lost to Follow-up|0
4514765|NCT00950599|7325578|FG006|Follow-Up Period|Lost to Follow-up|0
4514766|NCT00950599|7325579|FG007|Follow-Up Period|Lost to Follow-up|0
4514767|NCT00950599|7325580|FG008|Follow-Up Period|Lost to Follow-up|5
4717205|NCT03011892|7647246|FG011|Double Blind (DB) Period|Lost to Follow-up|0
4717206|NCT03011892|7647235|FG000|Double Blind (DB) Period|Other|1
4717207|NCT03011892|7647236|FG001|Double Blind (DB) Period|Other|1
4717208|NCT03011892|7647237|FG002|Double Blind (DB) Period|Other|1
4717209|NCT03011892|7647238|FG003|Double Blind (DB) Period|Other|0
4717210|NCT03011892|7647239|FG004|Double Blind (DB) Period|Other|1
4717211|NCT03011892|7647240|FG005|Double Blind (DB) Period|Other|0
4717212|NCT03011892|7647241|FG006|Double Blind (DB) Period|Other|0
4717213|NCT03011892|7647242|FG007|Double Blind (DB) Period|Other|0
4717214|NCT03011892|7647243|FG008|Double Blind (DB) Period|Other|0
4717215|NCT03011892|7647244|FG009|Double Blind (DB) Period|Other|0
4717216|NCT03011892|7647245|FG010|Double Blind (DB) Period|Other|0
4717217|NCT03011892|7647246|FG011|Double Blind (DB) Period|Other|0
4717218|NCT03011892|7647235|FG000|Double Blind (DB) Period|Physician Decision|1
4717219|NCT03011892|7647236|FG001|Double Blind (DB) Period|Physician Decision|0
4717220|NCT03011892|7647237|FG002|Double Blind (DB) Period|Physician Decision|1
4717221|NCT03011892|7647238|FG003|Double Blind (DB) Period|Physician Decision|0
4717222|NCT03011892|7647239|FG004|Double Blind (DB) Period|Physician Decision|0
4717223|NCT03011892|7647240|FG005|Double Blind (DB) Period|Physician Decision|0
4717224|NCT03011892|7647241|FG006|Double Blind (DB) Period|Physician Decision|0
4717225|NCT03011892|7647242|FG007|Double Blind (DB) Period|Physician Decision|0
4717226|NCT03011892|7647243|FG008|Double Blind (DB) Period|Physician Decision|0
4717227|NCT03011892|7647244|FG009|Double Blind (DB) Period|Physician Decision|0
4717228|NCT03011892|7647245|FG010|Double Blind (DB) Period|Physician Decision|0
4717229|NCT03011892|7647246|FG011|Double Blind (DB) Period|Physician Decision|0
4717230|NCT03011892|7647235|FG000|Double Blind (DB) Period|Pregnancy|0
4717231|NCT03011892|7647236|FG001|Double Blind (DB) Period|Pregnancy|0
4717232|NCT03011892|7647237|FG002|Double Blind (DB) Period|Pregnancy|0
4717233|NCT03011892|7647238|FG003|Double Blind (DB) Period|Pregnancy|0
4717234|NCT03011892|7647239|FG004|Double Blind (DB) Period|Pregnancy|1
4717235|NCT03011892|7647240|FG005|Double Blind (DB) Period|Pregnancy|0
4717236|NCT03011892|7647241|FG006|Double Blind (DB) Period|Pregnancy|0
4717237|NCT03011892|7647242|FG007|Double Blind (DB) Period|Pregnancy|0
4717238|NCT03011892|7647243|FG008|Double Blind (DB) Period|Pregnancy|0
4717239|NCT03011892|7647244|FG009|Double Blind (DB) Period|Pregnancy|0
4717240|NCT03011892|7647245|FG010|Double Blind (DB) Period|Pregnancy|0
4717241|NCT03011892|7647246|FG011|Double Blind (DB) Period|Pregnancy|0
4717242|NCT03011892|7647235|FG000|Double Blind (DB) Period|Protocol Violation|1
4717243|NCT03011892|7647236|FG001|Double Blind (DB) Period|Protocol Violation|0
4717244|NCT03011892|7647237|FG002|Double Blind (DB) Period|Protocol Violation|0
4717245|NCT03011892|7647238|FG003|Double Blind (DB) Period|Protocol Violation|0
4717246|NCT03011892|7647239|FG004|Double Blind (DB) Period|Protocol Violation|0
4717247|NCT03011892|7647240|FG005|Double Blind (DB) Period|Protocol Violation|0
4717248|NCT03011892|7647241|FG006|Double Blind (DB) Period|Protocol Violation|0
4717249|NCT03011892|7647242|FG007|Double Blind (DB) Period|Protocol Violation|0
4717250|NCT03011892|7647243|FG008|Double Blind (DB) Period|Protocol Violation|0
4717251|NCT03011892|7647244|FG009|Double Blind (DB) Period|Protocol Violation|0
4717252|NCT03011892|7647245|FG010|Double Blind (DB) Period|Protocol Violation|0
4717253|NCT03011892|7647246|FG011|Double Blind (DB) Period|Protocol Violation|0
4717254|NCT03011892|7647235|FG000|Double Blind (DB) Period|Withdrawal by Subject|7
4717255|NCT03011892|7647236|FG001|Double Blind (DB) Period|Withdrawal by Subject|5
4717256|NCT03011892|7647237|FG002|Double Blind (DB) Period|Withdrawal by Subject|1
4717257|NCT03011892|7647238|FG003|Double Blind (DB) Period|Withdrawal by Subject|2
4717258|NCT03011892|7647239|FG004|Double Blind (DB) Period|Withdrawal by Subject|4
4717259|NCT03011892|7647240|FG005|Double Blind (DB) Period|Withdrawal by Subject|3
4717260|NCT03011892|7647241|FG006|Double Blind (DB) Period|Withdrawal by Subject|0
4717261|NCT03011892|7647242|FG007|Double Blind (DB) Period|Withdrawal by Subject|0
4717262|NCT03011892|7647243|FG008|Double Blind (DB) Period|Withdrawal by Subject|0
4717263|NCT03011892|7647244|FG009|Double Blind (DB) Period|Withdrawal by Subject|0
4717264|NCT03011892|7647245|FG010|Double Blind (DB) Period|Withdrawal by Subject|0
4717265|NCT03011892|7647246|FG011|Double Blind (DB) Period|Withdrawal by Subject|0
4717266|NCT03011892|7647235|FG000|Double Blind (DB) Period|Randomized but not treated|0
4717267|NCT03011892|7647236|FG001|Double Blind (DB) Period|Randomized but not treated|0
4717268|NCT03011892|7647237|FG002|Double Blind (DB) Period|Randomized but not treated|0
4717269|NCT03011892|7647238|FG003|Double Blind (DB) Period|Randomized but not treated|0
4717270|NCT03011892|7647239|FG004|Double Blind (DB) Period|Randomized but not treated|1
4717271|NCT03011892|7647240|FG005|Double Blind (DB) Period|Randomized but not treated|0
4717272|NCT03011892|7647241|FG006|Double Blind (DB) Period|Randomized but not treated|0
4717273|NCT03011892|7647242|FG007|Double Blind (DB) Period|Randomized but not treated|0
4717274|NCT03011892|7647243|FG008|Double Blind (DB) Period|Randomized but not treated|0
4514768|NCT00950599|7325581|FG009|Follow-Up Period|Lost to Follow-up|1
4514769|NCT00950599|7325572|FG000|Follow-Up Period|Physician Decision|0
4514770|NCT00950599|7325573|FG001|Follow-Up Period|Physician Decision|0
4514771|NCT00950599|7325574|FG002|Follow-Up Period|Physician Decision|0
4514772|NCT00950599|7325575|FG003|Follow-Up Period|Physician Decision|0
4514773|NCT00950599|7325576|FG004|Follow-Up Period|Physician Decision|0
4514774|NCT00950599|7325577|FG005|Follow-Up Period|Physician Decision|0
4514775|NCT00950599|7325578|FG006|Follow-Up Period|Physician Decision|0
4514776|NCT00950599|7325579|FG007|Follow-Up Period|Physician Decision|0
4514777|NCT00950599|7325580|FG008|Follow-Up Period|Physician Decision|1
4514778|NCT00950599|7325581|FG009|Follow-Up Period|Physician Decision|0
4514779|NCT00950599|7325572|FG000|Follow-Up Period|Poor/Noncompliance|0
4514780|NCT00950599|7325573|FG001|Follow-Up Period|Poor/Noncompliance|0
4514781|NCT00950599|7325574|FG002|Follow-Up Period|Poor/Noncompliance|0
4514782|NCT00950599|7325575|FG003|Follow-Up Period|Poor/Noncompliance|0
4514783|NCT00950599|7325576|FG004|Follow-Up Period|Poor/Noncompliance|0
4514784|NCT00950599|7325577|FG005|Follow-Up Period|Poor/Noncompliance|0
4514785|NCT00950599|7325578|FG006|Follow-Up Period|Poor/Noncompliance|0
4514786|NCT00950599|7325579|FG007|Follow-Up Period|Poor/Noncompliance|0
4514787|NCT00950599|7325580|FG008|Follow-Up Period|Poor/Noncompliance|1
4514788|NCT00950599|7325581|FG009|Follow-Up Period|Poor/Noncompliance|0
4514789|NCT00950599|7325572|FG000|Follow-Up Period|Subject withdrew Consent|0
4514790|NCT00950599|7325573|FG001|Follow-Up Period|Subject withdrew Consent|0
4514791|NCT00950599|7325574|FG002|Follow-Up Period|Subject withdrew Consent|0
4514792|NCT00950599|7325575|FG003|Follow-Up Period|Subject withdrew Consent|0
4514793|NCT00950599|7325576|FG004|Follow-Up Period|Subject withdrew Consent|0
4630642|NCT01883362|7499383|FG000|Post Treatment Follow-up|Relapse|1
4630643|NCT01883362|7499384|FG001|Post Treatment Follow-up|Relapse|2
4630644|NCT01883453|7499415|FG000|Overall Study|No episode of common cold|25
4630645|NCT01883453|7499416|FG001|Overall Study|No episode of common cold|23
4717275|NCT03011892|7647244|FG009|Double Blind (DB) Period|Randomized but not treated|0
4717276|NCT03011892|7647245|FG010|Double Blind (DB) Period|Randomized but not treated|0
4717277|NCT03011892|7647246|FG011|Double Blind (DB) Period|Randomized but not treated|0
4717278|NCT03011892|7647235|FG000|Open Label (OL) Period|Lost to Follow-up|0
4717279|NCT03011892|7647236|FG001|Open Label (OL) Period|Lost to Follow-up|0
4717280|NCT03011892|7647237|FG002|Open Label (OL) Period|Lost to Follow-up|0
4717281|NCT03011892|7647238|FG003|Open Label (OL) Period|Lost to Follow-up|0
4717282|NCT03011892|7647239|FG004|Open Label (OL) Period|Lost to Follow-up|0
4717283|NCT03011892|7647240|FG005|Open Label (OL) Period|Lost to Follow-up|0
4717284|NCT03011892|7647241|FG006|Open Label (OL) Period|Lost to Follow-up|4
4717285|NCT03011892|7647242|FG007|Open Label (OL) Period|Lost to Follow-up|2
4717286|NCT03011892|7647243|FG008|Open Label (OL) Period|Lost to Follow-up|1
4717287|NCT03011892|7647244|FG009|Open Label (OL) Period|Lost to Follow-up|0
4717288|NCT03011892|7647245|FG010|Open Label (OL) Period|Lost to Follow-up|1
4717289|NCT03011892|7647246|FG011|Open Label (OL) Period|Lost to Follow-up|1
4717290|NCT03011892|7647235|FG000|Open Label (OL) Period|Withdrawal by Subject|0
4717291|NCT03011892|7647236|FG001|Open Label (OL) Period|Withdrawal by Subject|0
4717292|NCT03011892|7647237|FG002|Open Label (OL) Period|Withdrawal by Subject|0
4717293|NCT03011892|7647238|FG003|Open Label (OL) Period|Withdrawal by Subject|0
4717294|NCT03011892|7647239|FG004|Open Label (OL) Period|Withdrawal by Subject|0
4717295|NCT03011892|7647240|FG005|Open Label (OL) Period|Withdrawal by Subject|0
4717296|NCT03011892|7647241|FG006|Open Label (OL) Period|Withdrawal by Subject|3
4717297|NCT03011892|7647242|FG007|Open Label (OL) Period|Withdrawal by Subject|0
4717298|NCT03011892|7647243|FG008|Open Label (OL) Period|Withdrawal by Subject|1
4717299|NCT03011892|7647244|FG009|Open Label (OL) Period|Withdrawal by Subject|0
4717300|NCT03011892|7647245|FG010|Open Label (OL) Period|Withdrawal by Subject|1
4717301|NCT03011892|7647246|FG011|Open Label (OL) Period|Withdrawal by Subject|2
4717302|NCT03011892|7647235|FG000|Open Label (OL) Period|Reason not specified|0
4717303|NCT03011892|7647236|FG001|Open Label (OL) Period|Reason not specified|0
4717304|NCT03011892|7647237|FG002|Open Label (OL) Period|Reason not specified|0
4717305|NCT03011892|7647238|FG003|Open Label (OL) Period|Reason not specified|0
4717306|NCT03011892|7647239|FG004|Open Label (OL) Period|Reason not specified|0
4717307|NCT03011892|7647240|FG005|Open Label (OL) Period|Reason not specified|0
4717308|NCT03011892|7647241|FG006|Open Label (OL) Period|Reason not specified|0
4717309|NCT03011892|7647242|FG007|Open Label (OL) Period|Reason not specified|1
4717310|NCT03011892|7647243|FG008|Open Label (OL) Period|Reason not specified|0
4717311|NCT03011892|7647244|FG009|Open Label (OL) Period|Reason not specified|0
4717312|NCT03011892|7647245|FG010|Open Label (OL) Period|Reason not specified|0
4717313|NCT03011892|7647246|FG011|Open Label (OL) Period|Reason not specified|0
4717314|NCT03012061|7647276|FG000|Overall Study|Withdrawal by Subject|1
4717315|NCT03012061|7647277|FG001|Overall Study|Withdrawal by Subject|5
4717316|NCT03012061|7647278|FG002|Overall Study|Withdrawal by Subject|4
4717317|NCT03012061|7647276|FG000|Overall Study|Investigator Site Closed|1
4717318|NCT03012061|7647277|FG001|Overall Study|Investigator Site Closed|2
4717319|NCT03012061|7647278|FG002|Overall Study|Investigator Site Closed|0
4717320|NCT03012061|7647276|FG000|Overall Study|Lost to Follow-up|2
4514794|NCT00950599|7325577|FG005|Follow-Up Period|Subject withdrew Consent|0
4514795|NCT00950599|7325578|FG006|Follow-Up Period|Subject withdrew Consent|0
4630646|NCT01883492|7499424|FG000|Overall Study|Lost to Follow-up|3
4514796|NCT00950599|7325579|FG007|Follow-Up Period|Subject withdrew Consent|0
4514797|NCT00950599|7325580|FG008|Follow-Up Period|Subject withdrew Consent|2
4514798|NCT00950599|7325581|FG009|Follow-Up Period|Subject withdrew Consent|1
4514799|NCT00950651|7325615|FG000|Overall Study|Adverse Event|17
4514800|NCT00950651|7325616|FG001|Overall Study|Adverse Event|20
4514801|NCT00950651|7325615|FG000|Overall Study|Death|1
4514802|NCT00950651|7325616|FG001|Overall Study|Death|0
4514803|NCT00950651|7325615|FG000|Overall Study|Lack of Efficacy|2
4514804|NCT00950651|7325616|FG001|Overall Study|Lack of Efficacy|2
4514805|NCT00950651|7325615|FG000|Overall Study|Protocol Violation|3
4717321|NCT03012061|7647277|FG001|Overall Study|Lost to Follow-up|1
4717322|NCT03012061|7647278|FG002|Overall Study|Lost to Follow-up|0
4717323|NCT03012061|7647276|FG000|Overall Study|Study closed/ Terminated|0
4717324|NCT03012061|7647277|FG001|Overall Study|Study closed/ Terminated|0
4717325|NCT03012061|7647278|FG002|Overall Study|Study closed/ Terminated|1
4717326|NCT03012061|7647276|FG000|Overall Study|Met Protocol Withdrawal Criterion|0
4717327|NCT03012061|7647277|FG001|Overall Study|Met Protocol Withdrawal Criterion|0
4717328|NCT03012061|7647278|FG002|Overall Study|Met Protocol Withdrawal Criterion|1
4717329|NCT03012061|7647276|FG000|Overall Study|Protocol Violation|0
4717330|NCT03012061|7647277|FG001|Overall Study|Protocol Violation|0
4717331|NCT03012061|7647278|FG002|Overall Study|Protocol Violation|2
4717332|NCT03012061|7647276|FG000|Overall Study|Lack of Efficacy|0
4717333|NCT03012061|7647277|FG001|Overall Study|Lack of Efficacy|1
4717334|NCT03012061|7647278|FG002|Overall Study|Lack of Efficacy|0
4717335|NCT03012061|7647276|FG000|Overall Study|Adverse Event|2
4717336|NCT03012061|7647277|FG001|Overall Study|Adverse Event|0
4717337|NCT03012061|7647278|FG002|Overall Study|Adverse Event|0
4717338|NCT03012334|7647310|FG000|Period 1|Withdrawal by Subject|0
4717339|NCT03012334|7647311|FG001|Period 1|Withdrawal by Subject|0
4717340|NCT03012334|7647312|FG002|Period 1|Withdrawal by Subject|0
4717341|NCT03012334|7647313|FG003|Period 1|Withdrawal by Subject|0
4717342|NCT03012334|7647314|FG004|Period 1|Withdrawal by Subject|0
4717343|NCT03012334|7647315|FG005|Period 1|Withdrawal by Subject|0
4717344|NCT03012334|7647316|FG006|Period 1|Withdrawal by Subject|0
4717345|NCT03012334|7647317|FG007|Period 1|Withdrawal by Subject|0
4717346|NCT03012334|7647318|FG008|Period 1|Withdrawal by Subject|0
4717347|NCT03012334|7647319|FG009|Period 1|Withdrawal by Subject|1
4717348|NCT03012334|7647310|FG000|Period 2|Withdrawal by Subject|0
4514806|NCT00950651|7325616|FG001|Overall Study|Protocol Violation|4
4717349|NCT03012334|7647311|FG001|Period 2|Withdrawal by Subject|1
4717350|NCT03012334|7647312|FG002|Period 2|Withdrawal by Subject|0
4717351|NCT03012334|7647313|FG003|Period 2|Withdrawal by Subject|0
4717352|NCT03012334|7647314|FG004|Period 2|Withdrawal by Subject|0
4717353|NCT03012334|7647315|FG005|Period 2|Withdrawal by Subject|0
4717354|NCT03012334|7647316|FG006|Period 2|Withdrawal by Subject|0
4717355|NCT03012334|7647317|FG007|Period 2|Withdrawal by Subject|0
4717356|NCT03012334|7647318|FG008|Period 2|Withdrawal by Subject|0
4717357|NCT03012334|7647319|FG009|Period 2|Withdrawal by Subject|0
4717358|NCT03012334|7647310|FG000|Period 2|Protocol Violation|0
4717359|NCT03012334|7647311|FG001|Period 2|Protocol Violation|0
4717360|NCT03012334|7647312|FG002|Period 2|Protocol Violation|1
4717361|NCT03012334|7647313|FG003|Period 2|Protocol Violation|0
4717362|NCT03012334|7647314|FG004|Period 2|Protocol Violation|0
4717363|NCT03012334|7647315|FG005|Period 2|Protocol Violation|0
4717364|NCT03012334|7647316|FG006|Period 2|Protocol Violation|0
4717365|NCT03012334|7647317|FG007|Period 2|Protocol Violation|1
4717366|NCT03012334|7647318|FG008|Period 2|Protocol Violation|0
4717367|NCT03012334|7647319|FG009|Period 2|Protocol Violation|0
4717368|NCT03012334|7647310|FG000|Period 4|Non-Compliance|0
4717369|NCT03012334|7647311|FG001|Period 4|Non-Compliance|0
4717370|NCT03012334|7647312|FG002|Period 4|Non-Compliance|0
4717371|NCT03012334|7647313|FG003|Period 4|Non-Compliance|0
4717372|NCT03012334|7647314|FG004|Period 4|Non-Compliance|0
4717373|NCT03012334|7647315|FG005|Period 4|Non-Compliance|0
4717374|NCT03012334|7647316|FG006|Period 4|Non-Compliance|1
4717375|NCT03012334|7647317|FG007|Period 4|Non-Compliance|0
4717376|NCT03012334|7647318|FG008|Period 4|Non-Compliance|0
4717377|NCT03012334|7647319|FG009|Period 4|Non-Compliance|0
4717378|NCT03012334|7647310|FG000|Period 4|Adverse Event|0
4717379|NCT03012334|7647311|FG001|Period 4|Adverse Event|0
4717380|NCT03012334|7647312|FG002|Period 4|Adverse Event|0
4717381|NCT03012334|7647313|FG003|Period 4|Adverse Event|0
4717382|NCT03012334|7647314|FG004|Period 4|Adverse Event|0
4717383|NCT03012334|7647315|FG005|Period 4|Adverse Event|0
4717384|NCT03012334|7647316|FG006|Period 4|Adverse Event|0
4717385|NCT03012334|7647317|FG007|Period 4|Adverse Event|0
4717386|NCT03012334|7647318|FG008|Period 4|Adverse Event|1
4717387|NCT03012334|7647319|FG009|Period 4|Adverse Event|0
4717388|NCT03012828|7647346|FG000|Overall Study|Lost to Follow-up|1
4717389|NCT03012828|7647347|FG001|Overall Study|Lost to Follow-up|0
4717390|NCT03012828|7647348|FG002|Overall Study|Lost to Follow-up|1
4717391|NCT03012828|7647349|FG003|Overall Study|Lost to Follow-up|0
4717392|NCT03012828|7647350|FG004|Overall Study|Lost to Follow-up|1
4717393|NCT03012828|7647351|FG005|Overall Study|Lost to Follow-up|0
4717394|NCT03012828|7647346|FG000|Overall Study|Withdrawal by Subject|0
4717395|NCT03012828|7647347|FG001|Overall Study|Withdrawal by Subject|0
4717396|NCT03012828|7647348|FG002|Overall Study|Withdrawal by Subject|1
4514807|NCT00950651|7325615|FG000|Overall Study|Withdrawal by Subject|8
4514808|NCT00950651|7325616|FG001|Overall Study|Withdrawal by Subject|9
4514809|NCT00950664|7325624|FG000|First Intervention|Lost to Follow-up|1
4514810|NCT00950664|7325625|FG001|First Intervention|Lost to Follow-up|3
4514811|NCT00950664|7325624|FG000|First Intervention|Withdrawal by Subject|2
4514812|NCT00950664|7325625|FG001|First Intervention|Withdrawal by Subject|2
4514813|NCT00950742|7325637|FG000|Overall Study|Other Adverse Event|1
4514814|NCT00950742|7325638|FG001|Overall Study|Other Adverse Event|0
4514815|NCT00950742|7325637|FG000|Overall Study|Withdrawal by Subject|3
4514816|NCT00950742|7325638|FG001|Overall Study|Withdrawal by Subject|0
4514817|NCT00950742|7325637|FG000|Overall Study|Progressive Disease|6
4514818|NCT00950742|7325638|FG001|Overall Study|Progressive Disease|2
4514819|NCT00950742|7325637|FG000|Overall Study|Dose limiting toxicity|6
4514820|NCT00950742|7325638|FG001|Overall Study|Dose limiting toxicity|0
4514821|NCT00950755|7325648|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3
4514822|NCT00950755|7325648|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1
4514823|NCT00950755|7325648|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27
4514824|NCT00950755|7325648|FG000|Dosimetric and Therapeutic Treatment|Death|1
4514825|NCT00950755|7325648|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1
4514826|NCT00950755|7325648|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1
4514827|NCT00950755|7325648|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6
4514828|NCT00950755|7325648|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1
4514829|NCT00950755|7325648|FG000|Long-Term Follow-Up|Lost to Follow-up|1
4514830|NCT00950755|7325648|FG000|Long-Term Follow-Up|Death|8
4514831|NCT00950807|7325652|FG000|Treatment Period 1|Lack of Efficacy|1
4514832|NCT00950807|7325653|FG001|Treatment Period 1|Lack of Efficacy|0
4514833|NCT00950807|7325654|FG002|Treatment Period 1|Lack of Efficacy|0
4514834|NCT00950807|7325655|FG003|Treatment Period 1|Lack of Efficacy|0
4514835|NCT00950807|7325656|FG004|Treatment Period 1|Lack of Efficacy|0
4514836|NCT00950807|7325657|FG005|Treatment Period 1|Lack of Efficacy|1
4514837|NCT00950807|7325658|FG006|Treatment Period 1|Lack of Efficacy|0
4514838|NCT00950807|7325659|FG007|Treatment Period 1|Lack of Efficacy|0
4514839|NCT00950807|7325660|FG008|Treatment Period 1|Lack of Efficacy|0
4514840|NCT00950807|7325661|FG009|Treatment Period 1|Lack of Efficacy|0
4514841|NCT00950807|7325652|FG000|Treatment Period 1|Protocol Violation|1
4514842|NCT00950807|7325653|FG001|Treatment Period 1|Protocol Violation|0
4514843|NCT00950807|7325654|FG002|Treatment Period 1|Protocol Violation|0
4514844|NCT00950807|7325655|FG003|Treatment Period 1|Protocol Violation|0
4514845|NCT00950807|7325656|FG004|Treatment Period 1|Protocol Violation|0
4514846|NCT00950807|7325657|FG005|Treatment Period 1|Protocol Violation|0
4514847|NCT00950807|7325658|FG006|Treatment Period 1|Protocol Violation|0
4514848|NCT00950807|7325659|FG007|Treatment Period 1|Protocol Violation|0
4514849|NCT00950807|7325660|FG008|Treatment Period 1|Protocol Violation|0
4514850|NCT00950807|7325661|FG009|Treatment Period 1|Protocol Violation|0
4514851|NCT00950807|7325652|FG000|Treatment Period 1|Lost to Follow-up|0
4514852|NCT00950807|7325653|FG001|Treatment Period 1|Lost to Follow-up|0
4514853|NCT00950807|7325654|FG002|Treatment Period 1|Lost to Follow-up|1
4514854|NCT00950807|7325655|FG003|Treatment Period 1|Lost to Follow-up|0
4514855|NCT00950807|7325656|FG004|Treatment Period 1|Lost to Follow-up|0
4514856|NCT00950807|7325657|FG005|Treatment Period 1|Lost to Follow-up|0
4514857|NCT00950807|7325658|FG006|Treatment Period 1|Lost to Follow-up|0
4514858|NCT00950807|7325659|FG007|Treatment Period 1|Lost to Follow-up|0
4514859|NCT00950807|7325660|FG008|Treatment Period 1|Lost to Follow-up|0
4514860|NCT00950807|7325661|FG009|Treatment Period 1|Lost to Follow-up|0
4514861|NCT00950807|7325652|FG000|Treatment Period 1|Withdrawal by Subject|1
4514862|NCT00950807|7325653|FG001|Treatment Period 1|Withdrawal by Subject|0
4514863|NCT00950807|7325654|FG002|Treatment Period 1|Withdrawal by Subject|0
4514864|NCT00950807|7325655|FG003|Treatment Period 1|Withdrawal by Subject|0
4514865|NCT00950807|7325656|FG004|Treatment Period 1|Withdrawal by Subject|1
4514866|NCT00950807|7325657|FG005|Treatment Period 1|Withdrawal by Subject|0
4514867|NCT00950807|7325658|FG006|Treatment Period 1|Withdrawal by Subject|0
4514868|NCT00950807|7325659|FG007|Treatment Period 1|Withdrawal by Subject|0
4514869|NCT00950807|7325660|FG008|Treatment Period 1|Withdrawal by Subject|1
4514870|NCT00950807|7325661|FG009|Treatment Period 1|Withdrawal by Subject|0
4514871|NCT00950807|7325652|FG000|Treatment Period 1|Adverse Event|0
4514872|NCT00950807|7325653|FG001|Treatment Period 1|Adverse Event|0
4514873|NCT00950807|7325654|FG002|Treatment Period 1|Adverse Event|0
4514874|NCT00950807|7325655|FG003|Treatment Period 1|Adverse Event|0
4514875|NCT00950807|7325656|FG004|Treatment Period 1|Adverse Event|0
4514876|NCT00950807|7325657|FG005|Treatment Period 1|Adverse Event|1
4514877|NCT00950807|7325658|FG006|Treatment Period 1|Adverse Event|0
4514878|NCT00950807|7325659|FG007|Treatment Period 1|Adverse Event|0
4514879|NCT00950807|7325660|FG008|Treatment Period 1|Adverse Event|0
4514880|NCT00950807|7325661|FG009|Treatment Period 1|Adverse Event|0
4514881|NCT00950807|7325652|FG000|Washout Period 1|Lack of Efficacy|0
4514882|NCT00950807|7325653|FG001|Washout Period 1|Lack of Efficacy|0
4514883|NCT00950807|7325654|FG002|Washout Period 1|Lack of Efficacy|0
4514884|NCT00950807|7325655|FG003|Washout Period 1|Lack of Efficacy|0
4514885|NCT00950807|7325656|FG004|Washout Period 1|Lack of Efficacy|0
4514886|NCT00950807|7325657|FG005|Washout Period 1|Lack of Efficacy|0
4514887|NCT00950807|7325658|FG006|Washout Period 1|Lack of Efficacy|1
4514888|NCT00950807|7325659|FG007|Washout Period 1|Lack of Efficacy|0
4514889|NCT00950807|7325660|FG008|Washout Period 1|Lack of Efficacy|0
4514890|NCT00950807|7325661|FG009|Washout Period 1|Lack of Efficacy|0
4514891|NCT00950807|7325652|FG000|Washout Period 1|Withdrawal by Subject|0
4514892|NCT00950807|7325653|FG001|Washout Period 1|Withdrawal by Subject|0
4514893|NCT00950807|7325654|FG002|Washout Period 1|Withdrawal by Subject|0
4514894|NCT00950807|7325655|FG003|Washout Period 1|Withdrawal by Subject|0
4514895|NCT00950807|7325656|FG004|Washout Period 1|Withdrawal by Subject|0
4514896|NCT00950807|7325657|FG005|Washout Period 1|Withdrawal by Subject|0
4514897|NCT00950807|7325658|FG006|Washout Period 1|Withdrawal by Subject|0
4514898|NCT00950807|7325659|FG007|Washout Period 1|Withdrawal by Subject|0
4514899|NCT00950807|7325660|FG008|Washout Period 1|Withdrawal by Subject|1
4514900|NCT00950807|7325661|FG009|Washout Period 1|Withdrawal by Subject|0
4717397|NCT03012828|7647349|FG003|Overall Study|Withdrawal by Subject|0
4717398|NCT03012828|7647350|FG004|Overall Study|Withdrawal by Subject|0
4717399|NCT03012828|7647351|FG005|Overall Study|Withdrawal by Subject|1
4717400|NCT03012828|7647346|FG000|Overall Study|Non-compliance with protocol|0
4717401|NCT03012828|7647347|FG001|Overall Study|Non-compliance with protocol|0
4717402|NCT03012828|7647348|FG002|Overall Study|Non-compliance with protocol|0
4717403|NCT03012828|7647349|FG003|Overall Study|Non-compliance with protocol|0
4717404|NCT03012828|7647350|FG004|Overall Study|Non-compliance with protocol|1
4717405|NCT03012828|7647351|FG005|Overall Study|Non-compliance with protocol|0
4717406|NCT03012828|7647346|FG000|Overall Study|Delay to last visit would delay DBL|0
4717407|NCT03012828|7647347|FG001|Overall Study|Delay to last visit would delay DBL|0
4717408|NCT03012828|7647348|FG002|Overall Study|Delay to last visit would delay DBL|0
4717409|NCT03012828|7647349|FG003|Overall Study|Delay to last visit would delay DBL|0
4717410|NCT03012828|7647350|FG004|Overall Study|Delay to last visit would delay DBL|0
4717411|NCT03012828|7647351|FG005|Overall Study|Delay to last visit would delay DBL|1
4717412|NCT03012841|7647367|FG000|Overall Study|Protocol Violation|0
4717413|NCT03012841|7647368|FG001|Overall Study|Protocol Violation|10
4717414|NCT03012841|7647367|FG000|Overall Study|Lost to Follow-up|6
4717415|NCT03012841|7647368|FG001|Overall Study|Lost to Follow-up|1
4717416|NCT03012841|7647367|FG000|Overall Study|Withdrawal by Subject|6
4717417|NCT03012841|7647368|FG001|Overall Study|Withdrawal by Subject|0
4717418|NCT03012841|7647367|FG000|Overall Study|Unable to complete 12 month visit|6
4717419|NCT03012841|7647368|FG001|Overall Study|Unable to complete 12 month visit|0
4717420|NCT03012841|7647367|FG000|Overall Study|Subject relocation|1
4717421|NCT03012841|7647368|FG001|Overall Study|Subject relocation|0
4717422|NCT03012841|7647367|FG000|Overall Study|Seasonal winter travel|1
4717423|NCT03012841|7647368|FG001|Overall Study|Seasonal winter travel|0
4717424|NCT03012841|7647367|FG000|Overall Study|Physician Decision|0
4717425|NCT03012841|7647368|FG001|Overall Study|Physician Decision|2
4717426|NCT03012841|7647367|FG000|Overall Study|No ablation performed|0
4717427|NCT03012841|7647368|FG001|Overall Study|No ablation performed|2
4717428|NCT03012841|7647367|FG000|Overall Study|Study reached n=165 treated subject cap|0
4717429|NCT03012841|7647368|FG001|Overall Study|Study reached n=165 treated subject cap|5
4717430|NCT03012841|7647367|FG000|Overall Study|Insurance change|0
4717431|NCT03012841|7647368|FG001|Overall Study|Insurance change|1
4717432|NCT03013985|7647375|FG000|Overall Study|Protocol Violation|2
4717433|NCT03013985|7647376|FG001|Overall Study|Protocol Violation|2
4717434|NCT03013985|7647375|FG000|Overall Study|Withdrawal by Subject|14
4717435|NCT03013985|7647376|FG001|Overall Study|Withdrawal by Subject|17
4717436|NCT03014011|7647382|FG000|First Intervention|Withdrawal by Subject|1
4717437|NCT03014011|7647383|FG001|First Intervention|Withdrawal by Subject|0
4717438|NCT03014011|7647382|FG000|Washout|Withdrawal by Subject|1
4717439|NCT03014011|7647383|FG001|Washout|Withdrawal by Subject|0
4717440|NCT03014180|7647389|FG000|Overall Study|Protocol Violation|2
4717441|NCT03014206|7647397|FG000|Overall Study|Registration Violation|12
4717442|NCT03014453|7647401|FG000|Overall Study|Lost to Follow-up|12
4717443|NCT03014453|7647401|FG000|Overall Study|Discontinued GER|3
4717444|NCT03014453|7647401|FG000|Overall Study|Excluded|19
4717445|NCT03014453|7647401|FG000|Overall Study|Refused to take part in|37
4717446|NCT03014479|7647407|FG000|Overall Study|Adverse Event|0
4717447|NCT03014479|7647408|FG001|Overall Study|Adverse Event|1
4717448|NCT03014479|7647407|FG000|Overall Study|Voluntary Withdrawal|0
4717449|NCT03014479|7647408|FG001|Overall Study|Voluntary Withdrawal|2
4717450|NCT03014479|7647407|FG000|Overall Study|Unacceptable Inability of Site Visit|0
4717451|NCT03014479|7647408|FG001|Overall Study|Unacceptable Inability of Site Visit|1
4717452|NCT03014674|7647426|FG000|Overall Study|Withdrawal by Subject|1
4717453|NCT03014674|7647427|FG001|Overall Study|Withdrawal by Subject|0
4717454|NCT03014674|7647428|FG002|Overall Study|Withdrawal by Subject|0
4717455|NCT03015116|7647448|FG000|Overall Study|Lost to Follow-up|3
4717456|NCT03015116|7647449|FG001|Overall Study|Lost to Follow-up|0
4717457|NCT03015116|7647450|FG002|Overall Study|Lost to Follow-up|2
4717458|NCT03015116|7647448|FG000|Overall Study|Withdrawal by Subject|3
4717459|NCT03015116|7647449|FG001|Overall Study|Withdrawal by Subject|1
4514901|NCT00950807|7325652|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3
4514902|NCT00950807|7325653|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0
4717460|NCT03015116|7647450|FG002|Overall Study|Withdrawal by Subject|0
4736252|NCT03561090|7685208|FG001|Overall Study|Randomized by Mistake|1
4514903|NCT00950807|7325654|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0
4514904|NCT00950807|7325655|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0
4717461|NCT03015116|7647448|FG000|Overall Study|Subject has New Medical Status|1
4717462|NCT03015116|7647449|FG001|Overall Study|Subject has New Medical Status|0
4717463|NCT03015116|7647450|FG002|Overall Study|Subject has New Medical Status|0
4717464|NCT03015116|7647448|FG000|Overall Study|Physician Decision|0
4717465|NCT03015116|7647449|FG001|Overall Study|Physician Decision|1
4717466|NCT03015116|7647450|FG002|Overall Study|Physician Decision|0
4717467|NCT03015181|7647467|FG000|Overall Study|Enrolled, but product never administered|1
4717468|NCT03015181|7647468|FG001|Overall Study|Enrolled, but product never administered|0
4717469|NCT03015181|7647469|FG002|Overall Study|Enrolled, but product never administered|0
4717470|NCT03015181|7647470|FG003|Overall Study|Enrolled, but product never administered|0
4717471|NCT03015181|7647471|FG004|Overall Study|Enrolled, but product never administered|0
4717472|NCT03015181|7647472|FG005|Overall Study|Enrolled, but product never administered|0
4717473|NCT03015181|7647473|FG006|Overall Study|Enrolled, but product never administered|0
4717474|NCT03015181|7647467|FG000|Overall Study|Withdrawal by Subject|0
4717475|NCT03015181|7647468|FG001|Overall Study|Withdrawal by Subject|0
4717476|NCT03015181|7647469|FG002|Overall Study|Withdrawal by Subject|0
4717477|NCT03015181|7647470|FG003|Overall Study|Withdrawal by Subject|0
4717478|NCT03015181|7647471|FG004|Overall Study|Withdrawal by Subject|0
4717479|NCT03015181|7647472|FG005|Overall Study|Withdrawal by Subject|1
4717480|NCT03015181|7647473|FG006|Overall Study|Withdrawal by Subject|0
4717481|NCT03015181|7647467|FG000|Overall Study|Physician Decision|0
4717482|NCT03015181|7647468|FG001|Overall Study|Physician Decision|0
4717483|NCT03015181|7647469|FG002|Overall Study|Physician Decision|0
4717484|NCT03015181|7647470|FG003|Overall Study|Physician Decision|0
4717485|NCT03015181|7647471|FG004|Overall Study|Physician Decision|0
4717486|NCT03015181|7647472|FG005|Overall Study|Physician Decision|0
4717487|NCT03015181|7647473|FG006|Overall Study|Physician Decision|1
4717488|NCT03015220|7647513|FG000|Overall Study|Withdrawal by Subject|3
4717489|NCT03015220|7647514|FG001|Overall Study|Withdrawal by Subject|2
4717490|NCT03015220|7647515|FG002|Overall Study|Withdrawal by Subject|2
4717491|NCT03015220|7647516|FG003|Overall Study|Withdrawal by Subject|2
4717492|NCT03015220|7647513|FG000|Overall Study|Lost to Follow-up|0
4717493|NCT03015220|7647514|FG001|Overall Study|Lost to Follow-up|0
4717494|NCT03015220|7647515|FG002|Overall Study|Lost to Follow-up|1
4717495|NCT03015220|7647516|FG003|Overall Study|Lost to Follow-up|0
4717496|NCT03015363|7647526|FG000|Overall Study|Physician Decision|14
4717497|NCT03015363|7647526|FG000|Overall Study|Withdrawal by Subject|3
4717498|NCT03015532|7647538|FG000|Overall Study|Adverse Event|0
4717499|NCT03015532|7647539|FG001|Overall Study|Adverse Event|0
4717500|NCT03015532|7647540|FG002|Overall Study|Adverse Event|0
4717501|NCT03015532|7647541|FG003|Overall Study|Adverse Event|0
4717502|NCT03015532|7647542|FG004|Overall Study|Adverse Event|0
4717503|NCT03015532|7647543|FG005|Overall Study|Adverse Event|2
4717504|NCT03015532|7647544|FG006|Overall Study|Adverse Event|1
4717505|NCT03015532|7647545|FG007|Overall Study|Adverse Event|0
4717506|NCT03015532|7647538|FG000|Overall Study|Withdrawal by Subject|0
4717507|NCT03015532|7647539|FG001|Overall Study|Withdrawal by Subject|0
4717508|NCT03015532|7647540|FG002|Overall Study|Withdrawal by Subject|0
4717509|NCT03015532|7647541|FG003|Overall Study|Withdrawal by Subject|0
4717510|NCT03015532|7647542|FG004|Overall Study|Withdrawal by Subject|0
4717511|NCT03015532|7647543|FG005|Overall Study|Withdrawal by Subject|0
4717512|NCT03015532|7647544|FG006|Overall Study|Withdrawal by Subject|1
4717513|NCT03015532|7647545|FG007|Overall Study|Withdrawal by Subject|0
4717514|NCT03016078|7647578|FG000|Overall Study|Protocol Violation|1
4717515|NCT03016078|7647578|FG000|Overall Study|Protocol Violation|1
4717516|NCT03016325|7647590|FG000|Treatment Period|Participant withdrew consent|0
4717517|NCT03016325|7647591|FG001|Treatment Period|Participant withdrew consent|1
4717518|NCT03016325|7647592|FG002|Treatment Period|Participant withdrew consent|0
4717519|NCT03016325|7647593|FG003|Treatment Period|Participant withdrew consent|0
4717520|NCT03016325|7647594|FG004|Treatment Period|Participant withdrew consent|0
4717521|NCT03016325|7647595|FG005|Treatment Period|Participant withdrew consent|0
4717522|NCT03016325|7647596|FG006|Treatment Period|Participant withdrew consent|0
4717523|NCT03016325|7647597|FG007|Treatment Period|Participant withdrew consent|0
4717524|NCT03016325|7647590|FG000|Treatment Period|Death|0
4717525|NCT03016325|7647591|FG001|Treatment Period|Death|0
4717526|NCT03016325|7647592|FG002|Treatment Period|Death|0
4717527|NCT03016325|7647593|FG003|Treatment Period|Death|0
4717528|NCT03016325|7647594|FG004|Treatment Period|Death|2
4717529|NCT03016325|7647595|FG005|Treatment Period|Death|0
4717530|NCT03016325|7647596|FG006|Treatment Period|Death|0
4514905|NCT00950807|7325656|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0
4717531|NCT03016325|7647597|FG007|Treatment Period|Death|0
4717532|NCT03016325|7647590|FG000|Treatment Period|Participant refuses assessments|0
4717533|NCT03016325|7647591|FG001|Treatment Period|Participant refuses assessments|0
4717534|NCT03016325|7647592|FG002|Treatment Period|Participant refuses assessments|1
4717535|NCT03016325|7647593|FG003|Treatment Period|Participant refuses assessments|0
4717536|NCT03016325|7647594|FG004|Treatment Period|Participant refuses assessments|0
4717537|NCT03016325|7647595|FG005|Treatment Period|Participant refuses assessments|0
4717538|NCT03016325|7647596|FG006|Treatment Period|Participant refuses assessments|0
4717539|NCT03016325|7647597|FG007|Treatment Period|Participant refuses assessments|0
4717540|NCT03016325|7647590|FG000|32-Day Follow-Up Period|Death|2
4717541|NCT03016325|7647591|FG001|32-Day Follow-Up Period|Death|0
4717542|NCT03016325|7647592|FG002|32-Day Follow-Up Period|Death|5
4717543|NCT03016325|7647593|FG003|32-Day Follow-Up Period|Death|6
4717544|NCT03016325|7647594|FG004|32-Day Follow-Up Period|Death|3
4717545|NCT03016325|7647595|FG005|32-Day Follow-Up Period|Death|0
4717546|NCT03016325|7647596|FG006|32-Day Follow-Up Period|Death|0
4717547|NCT03016325|7647597|FG007|32-Day Follow-Up Period|Death|0
4717548|NCT03016325|7647590|FG000|32-Day Follow-Up Period|Lost to Follow-up|1
4717549|NCT03016325|7647591|FG001|32-Day Follow-Up Period|Lost to Follow-up|0
4717550|NCT03016325|7647592|FG002|32-Day Follow-Up Period|Lost to Follow-up|1
4717551|NCT03016325|7647593|FG003|32-Day Follow-Up Period|Lost to Follow-up|1
4717552|NCT03016325|7647594|FG004|32-Day Follow-Up Period|Lost to Follow-up|0
4717553|NCT03016325|7647595|FG005|32-Day Follow-Up Period|Lost to Follow-up|0
4717554|NCT03016325|7647596|FG006|32-Day Follow-Up Period|Lost to Follow-up|0
4717555|NCT03016325|7647597|FG007|32-Day Follow-Up Period|Lost to Follow-up|0
4717556|NCT03016325|7647590|FG000|32-Day Follow-Up Period|Poor/non-compliance|1
4717557|NCT03016325|7647591|FG001|32-Day Follow-Up Period|Poor/non-compliance|0
4717558|NCT03016325|7647592|FG002|32-Day Follow-Up Period|Poor/non-compliance|0
4717559|NCT03016325|7647593|FG003|32-Day Follow-Up Period|Poor/non-compliance|1
4717560|NCT03016325|7647594|FG004|32-Day Follow-Up Period|Poor/non-compliance|1
4717561|NCT03016325|7647595|FG005|32-Day Follow-Up Period|Poor/non-compliance|0
4717562|NCT03016325|7647596|FG006|32-Day Follow-Up Period|Poor/non-compliance|0
4717563|NCT03016325|7647597|FG007|32-Day Follow-Up Period|Poor/non-compliance|0
4717564|NCT03016325|7647590|FG000|32-Day Follow-Up Period|Participant refused to visit|0
4717565|NCT03016325|7647591|FG001|32-Day Follow-Up Period|Participant refused to visit|1
4717566|NCT03016325|7647592|FG002|32-Day Follow-Up Period|Participant refused to visit|2
4717567|NCT03016325|7647593|FG003|32-Day Follow-Up Period|Participant refused to visit|0
4717568|NCT03016325|7647594|FG004|32-Day Follow-Up Period|Participant refused to visit|2
4717569|NCT03016325|7647595|FG005|32-Day Follow-Up Period|Participant refused to visit|0
4717570|NCT03016325|7647596|FG006|32-Day Follow-Up Period|Participant refused to visit|0
4717571|NCT03016325|7647597|FG007|32-Day Follow-Up Period|Participant refused to visit|0
4717572|NCT03016325|7647590|FG000|32-Day Follow-Up Period|Participant withdrew consent|0
4717573|NCT03016325|7647591|FG001|32-Day Follow-Up Period|Participant withdrew consent|0
4717574|NCT03016325|7647592|FG002|32-Day Follow-Up Period|Participant withdrew consent|0
4717575|NCT03016325|7647593|FG003|32-Day Follow-Up Period|Participant withdrew consent|0
4717576|NCT03016325|7647594|FG004|32-Day Follow-Up Period|Participant withdrew consent|2
4717577|NCT03016325|7647595|FG005|32-Day Follow-Up Period|Participant withdrew consent|0
4717578|NCT03016325|7647596|FG006|32-Day Follow-Up Period|Participant withdrew consent|1
4717579|NCT03016325|7647597|FG007|32-Day Follow-Up Period|Participant withdrew consent|0
4717580|NCT03016325|7647590|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
4717581|NCT03016325|7647591|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
4717582|NCT03016325|7647592|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1
4717583|NCT03016325|7647593|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
4717584|NCT03016325|7647594|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
4717585|NCT03016325|7647595|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
4717586|NCT03016325|7647596|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
4717587|NCT03016325|7647597|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
4717588|NCT03016325|7647590|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
4717589|NCT03016325|7647591|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1
4717590|NCT03016325|7647592|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
4717591|NCT03016325|7647593|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
4717592|NCT03016325|7647594|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
4717593|NCT03016325|7647595|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
4717594|NCT03016325|7647596|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
4717595|NCT03016325|7647597|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
4717596|NCT03016325|7647590|FG000|182-Day Follow-Up Period|Death|3
4717597|NCT03016325|7647591|FG001|182-Day Follow-Up Period|Death|3
4717598|NCT03016325|7647592|FG002|182-Day Follow-Up Period|Death|11
4717599|NCT03016325|7647593|FG003|182-Day Follow-Up Period|Death|12
4717600|NCT03016325|7647594|FG004|182-Day Follow-Up Period|Death|9
4717601|NCT03016325|7647595|FG005|182-Day Follow-Up Period|Death|0
4717602|NCT03016325|7647596|FG006|182-Day Follow-Up Period|Death|0
4717603|NCT03016325|7647597|FG007|182-Day Follow-Up Period|Death|1
4717604|NCT03016325|7647590|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1
4717605|NCT03016325|7647591|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0
4717606|NCT03016325|7647592|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0
4717607|NCT03016325|7647593|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0
4717608|NCT03016325|7647594|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0
4717609|NCT03016325|7647595|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0
4717610|NCT03016325|7647596|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0
4717611|NCT03016325|7647597|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0
4514906|NCT00950807|7325657|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0
4514907|NCT00950807|7325658|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1
4514908|NCT00950807|7325659|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1
4514909|NCT00950807|7325660|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0
4514910|NCT00950807|7325661|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0
4514911|NCT00950807|7325652|FG000|Washout Period 1|Adverse Event|2
4514912|NCT00950807|7325653|FG001|Washout Period 1|Adverse Event|0
4514913|NCT00950807|7325654|FG002|Washout Period 1|Adverse Event|0
4514914|NCT00950807|7325655|FG003|Washout Period 1|Adverse Event|1
4514915|NCT00950807|7325656|FG004|Washout Period 1|Adverse Event|1
4514916|NCT00950807|7325657|FG005|Washout Period 1|Adverse Event|0
4514917|NCT00950807|7325658|FG006|Washout Period 1|Adverse Event|0
4514918|NCT00950807|7325659|FG007|Washout Period 1|Adverse Event|0
4514919|NCT00950807|7325660|FG008|Washout Period 1|Adverse Event|0
4514920|NCT00950807|7325661|FG009|Washout Period 1|Adverse Event|0
4514921|NCT00950807|7325652|FG000|Treatment Period 2|Lack of Efficacy|1
4717612|NCT03016325|7647590|FG000|182-Day Follow-Up Period|Participant withdrew consent|0
4717613|NCT03016325|7647591|FG001|182-Day Follow-Up Period|Participant withdrew consent|0
4717614|NCT03016325|7647592|FG002|182-Day Follow-Up Period|Participant withdrew consent|0
4717615|NCT03016325|7647593|FG003|182-Day Follow-Up Period|Participant withdrew consent|0
4717616|NCT03016325|7647594|FG004|182-Day Follow-Up Period|Participant withdrew consent|1
4717617|NCT03016325|7647595|FG005|182-Day Follow-Up Period|Participant withdrew consent|0
4717618|NCT03016325|7647596|FG006|182-Day Follow-Up Period|Participant withdrew consent|1
4717619|NCT03016325|7647597|FG007|182-Day Follow-Up Period|Participant withdrew consent|0
4717620|NCT03016325|7647590|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0
4717621|NCT03016325|7647591|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0
4717622|NCT03016325|7647592|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0
4717623|NCT03016325|7647593|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0
4717624|NCT03016325|7647594|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1
4717625|NCT03016325|7647595|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0
4717626|NCT03016325|7647596|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0
4717627|NCT03016325|7647597|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0
4717628|NCT03016325|7647590|FG000|182-Day Follow-Up Period|Alive, per civil unit|0
4717629|NCT03016325|7647591|FG001|182-Day Follow-Up Period|Alive, per civil unit|0
4717630|NCT03016325|7647592|FG002|182-Day Follow-Up Period|Alive, per civil unit|0
4717631|NCT03016325|7647593|FG003|182-Day Follow-Up Period|Alive, per civil unit|0
4717632|NCT03016325|7647594|FG004|182-Day Follow-Up Period|Alive, per civil unit|1
4717633|NCT03016325|7647595|FG005|182-Day Follow-Up Period|Alive, per civil unit|0
4717634|NCT03016325|7647596|FG006|182-Day Follow-Up Period|Alive, per civil unit|0
4717635|NCT03016325|7647597|FG007|182-Day Follow-Up Period|Alive, per civil unit|0
4717636|NCT03016325|7647590|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0
4717637|NCT03016325|7647591|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0
4717638|NCT03016325|7647592|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0
4717639|NCT03016325|7647593|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1
4717640|NCT03016325|7647594|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0
4717641|NCT03016325|7647595|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0
4717642|NCT03016325|7647596|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0
4717643|NCT03016325|7647597|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0
4717644|NCT03016325|7647590|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
4717645|NCT03016325|7647591|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1
4717646|NCT03016325|7647592|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
4717647|NCT03016325|7647593|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
4717648|NCT03016325|7647594|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
4717649|NCT03016325|7647595|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
4717650|NCT03016325|7647596|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
4717651|NCT03016325|7647597|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
4717652|NCT03016325|7647590|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0
4717653|NCT03016325|7647591|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0
4717654|NCT03016325|7647592|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0
4717655|NCT03016325|7647593|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0
4717656|NCT03016325|7647594|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0
4717657|NCT03016325|7647595|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5
4717658|NCT03016325|7647596|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3
4717659|NCT03016325|7647597|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4
4717660|NCT03016403|7647622|FG000|Baseline|Death|5
4717661|NCT03016403|7647623|FG001|Baseline|Death|8
4717662|NCT03016403|7647624|FG002|Baseline|Death|1
4717663|NCT03016403|7647625|FG003|Baseline|Death|0
4717664|NCT03016403|7647622|FG000|Baseline|Withdrawal by Subject|2
4717665|NCT03016403|7647623|FG001|Baseline|Withdrawal by Subject|8
4717666|NCT03016403|7647624|FG002|Baseline|Withdrawal by Subject|4
4514922|NCT00950807|7325653|FG001|Treatment Period 2|Lack of Efficacy|0
4514923|NCT00950807|7325654|FG002|Treatment Period 2|Lack of Efficacy|0
4514924|NCT00950807|7325655|FG003|Treatment Period 2|Lack of Efficacy|0
4514925|NCT00950807|7325656|FG004|Treatment Period 2|Lack of Efficacy|0
4514926|NCT00950807|7325657|FG005|Treatment Period 2|Lack of Efficacy|0
4514927|NCT00950807|7325658|FG006|Treatment Period 2|Lack of Efficacy|0
4514928|NCT00950807|7325659|FG007|Treatment Period 2|Lack of Efficacy|0
4514929|NCT00950807|7325660|FG008|Treatment Period 2|Lack of Efficacy|0
4514930|NCT00950807|7325661|FG009|Treatment Period 2|Lack of Efficacy|0
4514931|NCT00950807|7325652|FG000|Treatment Period 2|Withdrawal by Subject|0
4514932|NCT00950807|7325653|FG001|Treatment Period 2|Withdrawal by Subject|0
4717667|NCT03016403|7647625|FG003|Baseline|Withdrawal by Subject|10
4717668|NCT03016403|7647622|FG000|Baseline|Lost to Follow-up|9
4717669|NCT03016403|7647623|FG001|Baseline|Lost to Follow-up|11
4717670|NCT03016403|7647624|FG002|Baseline|Lost to Follow-up|6
4717671|NCT03016403|7647625|FG003|Baseline|Lost to Follow-up|24
4717672|NCT03016403|7647622|FG000|6-week Follow-up|Death|1
4717673|NCT03016403|7647623|FG001|6-week Follow-up|Death|4
4717674|NCT03016403|7647624|FG002|6-week Follow-up|Death|0
4717675|NCT03016403|7647625|FG003|6-week Follow-up|Death|0
4717676|NCT03016403|7647622|FG000|6-week Follow-up|Lost to Follow-up|2
4717677|NCT03016403|7647623|FG001|6-week Follow-up|Lost to Follow-up|7
4717678|NCT03016403|7647624|FG002|6-week Follow-up|Lost to Follow-up|4
4717679|NCT03016403|7647625|FG003|6-week Follow-up|Lost to Follow-up|8
4717680|NCT03016403|7647622|FG000|6-week Follow-up|Withdrawal by Subject|0
4717681|NCT03016403|7647623|FG001|6-week Follow-up|Withdrawal by Subject|2
4717682|NCT03016403|7647624|FG002|6-week Follow-up|Withdrawal by Subject|0
4717683|NCT03016403|7647625|FG003|6-week Follow-up|Withdrawal by Subject|1
4717684|NCT03016403|7647622|FG000|3-month Follow-up and 6-month Follow-up|Death|6
4717685|NCT03016403|7647623|FG001|3-month Follow-up and 6-month Follow-up|Death|4
4717686|NCT03016403|7647624|FG002|3-month Follow-up and 6-month Follow-up|Death|0
4717687|NCT03016403|7647625|FG003|3-month Follow-up and 6-month Follow-up|Death|0
4717688|NCT03016403|7647622|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6
4717689|NCT03016403|7647623|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7
4717690|NCT03016403|7647624|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8
4717691|NCT03016403|7647625|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6
4717692|NCT03016403|7647622|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0
4717693|NCT03016403|7647623|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0
4717694|NCT03016403|7647624|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0
4717695|NCT03016403|7647625|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1
4514933|NCT00950807|7325654|FG002|Treatment Period 2|Withdrawal by Subject|0
4514934|NCT00950807|7325655|FG003|Treatment Period 2|Withdrawal by Subject|0
4514935|NCT00950807|7325656|FG004|Treatment Period 2|Withdrawal by Subject|0
4514936|NCT00950807|7325657|FG005|Treatment Period 2|Withdrawal by Subject|0
4514937|NCT00950807|7325658|FG006|Treatment Period 2|Withdrawal by Subject|1
4514938|NCT00950807|7325659|FG007|Treatment Period 2|Withdrawal by Subject|2
4514939|NCT00950807|7325660|FG008|Treatment Period 2|Withdrawal by Subject|0
4514940|NCT00950807|7325661|FG009|Treatment Period 2|Withdrawal by Subject|0
4514941|NCT00950807|7325652|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1
4514942|NCT00950807|7325653|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0
4514943|NCT00950807|7325654|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0
4514944|NCT00950807|7325655|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0
4514945|NCT00950807|7325656|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0
4514946|NCT00950807|7325657|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0
4514947|NCT00950807|7325658|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0
4514948|NCT00950807|7325659|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0
4514949|NCT00950807|7325660|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0
4514950|NCT00950807|7325661|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0
4514951|NCT00950807|7325652|FG000|Treatment Period 2|Adverse Event|0
4514952|NCT00950807|7325653|FG001|Treatment Period 2|Adverse Event|1
4514953|NCT00950807|7325654|FG002|Treatment Period 2|Adverse Event|0
4514954|NCT00950807|7325655|FG003|Treatment Period 2|Adverse Event|1
4514955|NCT00950807|7325656|FG004|Treatment Period 2|Adverse Event|0
4514956|NCT00950807|7325657|FG005|Treatment Period 2|Adverse Event|1
4514957|NCT00950807|7325658|FG006|Treatment Period 2|Adverse Event|0
4514958|NCT00950807|7325659|FG007|Treatment Period 2|Adverse Event|1
4514959|NCT00950807|7325660|FG008|Treatment Period 2|Adverse Event|0
4514960|NCT00950807|7325661|FG009|Treatment Period 2|Adverse Event|0
4514961|NCT00950807|7325652|FG000|Washout Period 2|Lack of Efficacy|1
4514962|NCT00950807|7325653|FG001|Washout Period 2|Lack of Efficacy|0
4514963|NCT00950807|7325654|FG002|Washout Period 2|Lack of Efficacy|0
4514964|NCT00950807|7325655|FG003|Washout Period 2|Lack of Efficacy|0
4514965|NCT00950807|7325656|FG004|Washout Period 2|Lack of Efficacy|0
4514966|NCT00950807|7325657|FG005|Washout Period 2|Lack of Efficacy|0
4514967|NCT00950807|7325658|FG006|Washout Period 2|Lack of Efficacy|0
4514968|NCT00950807|7325659|FG007|Washout Period 2|Lack of Efficacy|0
4514969|NCT00950807|7325660|FG008|Washout Period 2|Lack of Efficacy|0
4514970|NCT00950807|7325661|FG009|Washout Period 2|Lack of Efficacy|0
4514971|NCT00950807|7325652|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0
4590554|NCT01522651|7436639|FG004|Overall Study|Participant Non-Compliance|0
4514972|NCT00950807|7325653|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1
4514973|NCT00950807|7325654|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0
4514974|NCT00950807|7325655|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0
4514975|NCT00950807|7325656|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1
4514976|NCT00950807|7325657|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0
4514977|NCT00950807|7325658|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1
4514978|NCT00950807|7325659|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1
4514979|NCT00950807|7325660|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0
4514980|NCT00950807|7325661|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0
4514981|NCT00950807|7325652|FG000|Washout Period 2|Adverse Event|3
4514982|NCT00950807|7325653|FG001|Washout Period 2|Adverse Event|0
4514983|NCT00950807|7325654|FG002|Washout Period 2|Adverse Event|0
4514984|NCT00950807|7325655|FG003|Washout Period 2|Adverse Event|1
4514985|NCT00950807|7325656|FG004|Washout Period 2|Adverse Event|0
4514986|NCT00950807|7325657|FG005|Washout Period 2|Adverse Event|0
4514987|NCT00950807|7325658|FG006|Washout Period 2|Adverse Event|0
4514988|NCT00950807|7325659|FG007|Washout Period 2|Adverse Event|0
4514989|NCT00950807|7325660|FG008|Washout Period 2|Adverse Event|0
4514990|NCT00950807|7325661|FG009|Washout Period 2|Adverse Event|0
4514991|NCT00950807|7325652|FG000|Treatment Period 3|Withdrawal by Subject|0
4514992|NCT00950807|7325653|FG001|Treatment Period 3|Withdrawal by Subject|0
4514993|NCT00950807|7325654|FG002|Treatment Period 3|Withdrawal by Subject|0
4514994|NCT00950807|7325655|FG003|Treatment Period 3|Withdrawal by Subject|0
4514995|NCT00950807|7325656|FG004|Treatment Period 3|Withdrawal by Subject|0
4514996|NCT00950807|7325657|FG005|Treatment Period 3|Withdrawal by Subject|0
4514997|NCT00950807|7325658|FG006|Treatment Period 3|Withdrawal by Subject|0
4514998|NCT00950807|7325659|FG007|Treatment Period 3|Withdrawal by Subject|0
4514999|NCT00950807|7325660|FG008|Treatment Period 3|Withdrawal by Subject|0
4515000|NCT00950807|7325661|FG009|Treatment Period 3|Withdrawal by Subject|1
4515001|NCT00950807|7325652|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1
4515002|NCT00950807|7325653|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0
4515003|NCT00950807|7325654|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0
4515004|NCT00950807|7325655|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0
4515005|NCT00950807|7325656|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0
4515006|NCT00950807|7325657|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0
4515007|NCT00950807|7325658|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0
4515008|NCT00950807|7325659|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1
4515009|NCT00950807|7325660|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0
4515010|NCT00950807|7325661|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0
4515011|NCT00950807|7325652|FG000|Treatment Period 3|Adverse Event|0
4515012|NCT00950807|7325653|FG001|Treatment Period 3|Adverse Event|0
4515013|NCT00950807|7325654|FG002|Treatment Period 3|Adverse Event|0
4515014|NCT00950807|7325655|FG003|Treatment Period 3|Adverse Event|0
4515015|NCT00950807|7325656|FG004|Treatment Period 3|Adverse Event|0
4515016|NCT00950807|7325657|FG005|Treatment Period 3|Adverse Event|0
4515017|NCT00950807|7325658|FG006|Treatment Period 3|Adverse Event|1
4515018|NCT00950807|7325659|FG007|Treatment Period 3|Adverse Event|0
4515019|NCT00950807|7325660|FG008|Treatment Period 3|Adverse Event|0
4515020|NCT00950807|7325661|FG009|Treatment Period 3|Adverse Event|0
4515021|NCT00950859|7325700|FG000|Overall Study|Adverse Event|3
4515022|NCT00950859|7325701|FG001|Overall Study|Adverse Event|3
4515023|NCT00950859|7325700|FG000|Overall Study|Insufficient Viral Load Response|12
4515024|NCT00950859|7325701|FG001|Overall Study|Insufficient Viral Load Response|3
4515025|NCT00950859|7325700|FG000|Overall Study|Protocol Violation|1
4515026|NCT00950859|7325701|FG001|Overall Study|Protocol Violation|1
4515027|NCT00950859|7325700|FG000|Overall Study|Lost to Follow-up|0
4515028|NCT00950859|7325701|FG001|Overall Study|Lost to Follow-up|3
4515029|NCT00950872|7325707|FG000|Overall Study|Withdrawal by Subject|1
4515030|NCT00950872|7325707|FG000|Overall Study|Did not have surgery|2
4515031|NCT00950911|7325713|FG000|Overall Study|Adverse Event|0
4515032|NCT00950911|7325714|FG001|Overall Study|Adverse Event|2
4515033|NCT00950911|7325713|FG000|Overall Study|Death|4
4515034|NCT00950911|7325714|FG001|Overall Study|Death|6
4515035|NCT00950911|7325713|FG000|Overall Study|Disease progression|2
4515036|NCT00950911|7325714|FG001|Overall Study|Disease progression|2
4515037|NCT00950911|7325713|FG000|Overall Study|Consent withdrawn|1
4515038|NCT00950911|7325714|FG001|Overall Study|Consent withdrawn|3
4515039|NCT00950911|7325713|FG000|Overall Study|Administrative decision|3
4515040|NCT00950911|7325714|FG001|Overall Study|Administrative decision|1
4515041|NCT00950911|7325713|FG000|Overall Study|Ineligibility determined|1
4515042|NCT00950911|7325714|FG001|Overall Study|Ineligibility determined|0
4590555|NCT01522651|7436635|FG000|Overall Study|Withdrew Consent|1
4515043|NCT00950911|7325713|FG000|Overall Study|Noncompliance|1
4515044|NCT00950911|7325714|FG001|Overall Study|Noncompliance|0
4515045|NCT00950911|7325713|FG000|Overall Study|Poor performance status|0
4515046|NCT00950911|7325714|FG001|Overall Study|Poor performance status|1
4515047|NCT00950950|7325722|FG000|Overall Study|Adverse Event|1
4515048|NCT00950950|7325723|FG001|Overall Study|Adverse Event|0
4515049|NCT00950950|7325722|FG000|Overall Study|Withdrawal by Subject|0
4515050|NCT00950950|7325723|FG001|Overall Study|Withdrawal by Subject|1
4515051|NCT00950963|7325732|FG000|Overall Study|Lost to Follow-up|29
4515052|NCT00950963|7325733|FG001|Overall Study|Lost to Follow-up|24
4515053|NCT00951015|7325743|FG000|Randomization Phase 96 Week|Adverse Event|1
4515054|NCT00951015|7325744|FG001|Randomization Phase 96 Week|Adverse Event|1
4515055|NCT00951015|7325745|FG002|Randomization Phase 96 Week|Adverse Event|2
4515056|NCT00951015|7325746|FG003|Randomization Phase 96 Week|Adverse Event|5
4515057|NCT00951015|7325747|FG004|Randomization Phase 96 Week|Adverse Event|0
4515058|NCT00951015|7325743|FG000|Randomization Phase 96 Week|Lack of Efficacy|1
4515059|NCT00951015|7325744|FG001|Randomization Phase 96 Week|Lack of Efficacy|1
4515060|NCT00951015|7325745|FG002|Randomization Phase 96 Week|Lack of Efficacy|0
4515061|NCT00951015|7325746|FG003|Randomization Phase 96 Week|Lack of Efficacy|0
4515062|NCT00951015|7325747|FG004|Randomization Phase 96 Week|Lack of Efficacy|0
4515063|NCT00951015|7325743|FG000|Randomization Phase 96 Week|Protocol Violation|1
4515064|NCT00951015|7325744|FG001|Randomization Phase 96 Week|Protocol Violation|1
4515065|NCT00951015|7325745|FG002|Randomization Phase 96 Week|Protocol Violation|1
4515066|NCT00951015|7325746|FG003|Randomization Phase 96 Week|Protocol Violation|0
4515067|NCT00951015|7325747|FG004|Randomization Phase 96 Week|Protocol Violation|0
4515068|NCT00951015|7325743|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
4515069|NCT00951015|7325744|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
4515070|NCT00951015|7325745|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
4515071|NCT00951015|7325746|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1
4515072|NCT00951015|7325747|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
4515073|NCT00951015|7325743|FG000|Randomization Phase 96 Week|Lost to Follow-up|0
4515074|NCT00951015|7325744|FG001|Randomization Phase 96 Week|Lost to Follow-up|3
4515075|NCT00951015|7325745|FG002|Randomization Phase 96 Week|Lost to Follow-up|1
4515076|NCT00951015|7325746|FG003|Randomization Phase 96 Week|Lost to Follow-up|2
4515077|NCT00951015|7325747|FG004|Randomization Phase 96 Week|Lost to Follow-up|0
4515078|NCT00951015|7325743|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2
4515079|NCT00951015|7325744|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1
4515080|NCT00951015|7325745|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1
4515081|NCT00951015|7325746|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2
4515082|NCT00951015|7325747|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0
4515083|NCT00951015|7325743|FG000|Open-label Phase|Adverse Event|0
4515084|NCT00951015|7325744|FG001|Open-label Phase|Adverse Event|0
4515085|NCT00951015|7325745|FG002|Open-label Phase|Adverse Event|0
4515086|NCT00951015|7325746|FG003|Open-label Phase|Adverse Event|0
4515087|NCT00951015|7325747|FG004|Open-label Phase|Adverse Event|3
4515088|NCT00951015|7325743|FG000|Open-label Phase|Lack of Efficacy|0
4515089|NCT00951015|7325744|FG001|Open-label Phase|Lack of Efficacy|0
4515090|NCT00951015|7325745|FG002|Open-label Phase|Lack of Efficacy|0
4515091|NCT00951015|7325746|FG003|Open-label Phase|Lack of Efficacy|0
4515092|NCT00951015|7325747|FG004|Open-label Phase|Lack of Efficacy|1
4515093|NCT00951015|7325743|FG000|Open-label Phase|Protocol Violation|0
4515094|NCT00951015|7325744|FG001|Open-label Phase|Protocol Violation|0
4515095|NCT00951015|7325745|FG002|Open-label Phase|Protocol Violation|0
4515096|NCT00951015|7325746|FG003|Open-label Phase|Protocol Violation|0
4515097|NCT00951015|7325747|FG004|Open-label Phase|Protocol Violation|12
4515098|NCT00951015|7325743|FG000|Open-label Phase|Lost to Follow-up|0
4515099|NCT00951015|7325744|FG001|Open-label Phase|Lost to Follow-up|0
4515100|NCT00951015|7325745|FG002|Open-label Phase|Lost to Follow-up|0
4515101|NCT00951015|7325746|FG003|Open-label Phase|Lost to Follow-up|0
4515102|NCT00951015|7325747|FG004|Open-label Phase|Lost to Follow-up|12
4515103|NCT00951015|7325743|FG000|Open-label Phase|Withdrawal by Subject|0
4515104|NCT00951015|7325744|FG001|Open-label Phase|Withdrawal by Subject|0
4515105|NCT00951015|7325745|FG002|Open-label Phase|Withdrawal by Subject|0
4515106|NCT00951015|7325746|FG003|Open-label Phase|Withdrawal by Subject|0
4515107|NCT00951015|7325747|FG004|Open-label Phase|Withdrawal by Subject|14
4515108|NCT00951015|7325743|FG000|Open-label Phase|Physician Decision|0
4515109|NCT00951015|7325744|FG001|Open-label Phase|Physician Decision|0
4515110|NCT00951015|7325745|FG002|Open-label Phase|Physician Decision|0
4515111|NCT00951015|7325746|FG003|Open-label Phase|Physician Decision|0
4515112|NCT00951015|7325747|FG004|Open-label Phase|Physician Decision|8
4515113|NCT00951041|7325772|FG000|Overall Study|Withdrawal by Subject|1
4515114|NCT00951041|7325773|FG001|Overall Study|Withdrawal by Subject|1
4515115|NCT00951041|7325772|FG000|Overall Study|Lost to Follow-up|1
4515116|NCT00951041|7325773|FG001|Overall Study|Lost to Follow-up|0
4515117|NCT00951041|7325772|FG000|Overall Study|Other|3
4515118|NCT00951041|7325773|FG001|Overall Study|Other|0
4515119|NCT00951080|7325782|FG000|Overall Study|Adverse Event|3
4515120|NCT00951080|7325783|FG001|Overall Study|Adverse Event|3
4515121|NCT00951080|7325782|FG000|Overall Study|Lost to Follow-up|0
4515122|NCT00951080|7325783|FG001|Overall Study|Lost to Follow-up|1
4515123|NCT00951080|7325782|FG000|Overall Study|Physician Decision|4
4515124|NCT00951080|7325783|FG001|Overall Study|Physician Decision|1
4515125|NCT00951080|7325782|FG000|Overall Study|Other|19
4515126|NCT00951080|7325783|FG001|Overall Study|Other|22
4515127|NCT00951171|7325797|FG000|Overall Study|Adverse Event|2
4515128|NCT00951171|7325798|FG001|Overall Study|Adverse Event|0
4515129|NCT00951275|7325804|FG000|Overall Study|Administrative Reason|1
4515130|NCT00951275|7325804|FG000|Overall Study|Adverse Event|7
4515131|NCT00951275|7325804|FG000|Overall Study|Withdrawal by Subject|4
4515132|NCT00951275|7325804|FG000|Overall Study|Protocol Violation|1
4515133|NCT00951379|7325810|FG000|Overall Study|Adverse Event|4
4515134|NCT00951379|7325811|FG001|Overall Study|Adverse Event|1
4515135|NCT00951379|7325810|FG000|Overall Study|Withdrawal by Subject|1
4515136|NCT00951379|7325811|FG001|Overall Study|Withdrawal by Subject|0
4515137|NCT00951379|7325810|FG000|Overall Study|Noncompliance|1
4515138|NCT00951379|7325811|FG001|Overall Study|Noncompliance|0
4515139|NCT00951379|7325810|FG000|Overall Study|Disease Progression|0
4515140|NCT00951379|7325811|FG001|Overall Study|Disease Progression|1
4515141|NCT00951483|7325827|FG000|Overall Study|Physician Decision|4
4515142|NCT00951483|7325828|FG001|Overall Study|Physician Decision|0
4515143|NCT00951483|7325827|FG000|Overall Study|Withdrawal by Subject|15
4515144|NCT00951483|7325828|FG001|Overall Study|Withdrawal by Subject|0
4515145|NCT00951496|7325839|FG000|Overall Study|Did not initiate study treatment|10
4515146|NCT00951496|7325840|FG001|Overall Study|Did not initiate study treatment|8
4515147|NCT00951496|7325841|FG002|Overall Study|Did not initiate study treatment|13
4515148|NCT00951509|7325852|FG000|Overall Study|Withdrawal by Subject|2
4515149|NCT00951665|7325874|FG000|Phase 1b|Adverse Event|2
4515150|NCT00951665|7325875|FG001|Phase 1b|Adverse Event|1
4515151|NCT00951665|7325876|FG002|Phase 1b|Adverse Event|0
4515152|NCT00951665|7325877|FG003|Phase 1b|Adverse Event|1
4515153|NCT00951665|7325878|FG004|Phase 1b|Adverse Event|0
4515154|NCT00951665|7325879|FG005|Phase 1b|Adverse Event|0
4515155|NCT00951665|7325874|FG000|Phase 1b|Death|1
4515156|NCT00951665|7325875|FG001|Phase 1b|Death|0
4515157|NCT00951665|7325876|FG002|Phase 1b|Death|2
4515158|NCT00951665|7325877|FG003|Phase 1b|Death|0
4515159|NCT00951665|7325878|FG004|Phase 1b|Death|0
4515160|NCT00951665|7325879|FG005|Phase 1b|Death|0
4515161|NCT00951665|7325874|FG000|Phase 1b|Physician Decision|4
4515162|NCT00951665|7325875|FG001|Phase 1b|Physician Decision|0
4515163|NCT00951665|7325876|FG002|Phase 1b|Physician Decision|1
4515164|NCT00951665|7325877|FG003|Phase 1b|Physician Decision|0
4515165|NCT00951665|7325878|FG004|Phase 1b|Physician Decision|0
4515166|NCT00951665|7325879|FG005|Phase 1b|Physician Decision|0
4515167|NCT00951665|7325874|FG000|Phase 1b|Withdrawal by Subject|0
4515168|NCT00951665|7325875|FG001|Phase 1b|Withdrawal by Subject|1
4515169|NCT00951665|7325876|FG002|Phase 1b|Withdrawal by Subject|0
4515170|NCT00951665|7325877|FG003|Phase 1b|Withdrawal by Subject|0
4515171|NCT00951665|7325878|FG004|Phase 1b|Withdrawal by Subject|0
4515172|NCT00951665|7325879|FG005|Phase 1b|Withdrawal by Subject|0
4515173|NCT00951665|7325874|FG000|Phase 1b|Disease Progression|13
4515174|NCT00951665|7325875|FG001|Phase 1b|Disease Progression|2
4515175|NCT00951665|7325876|FG002|Phase 1b|Disease Progression|14
4515176|NCT00951665|7325877|FG003|Phase 1b|Disease Progression|0
4515177|NCT00951665|7325878|FG004|Phase 1b|Disease Progression|0
4515178|NCT00951665|7325879|FG005|Phase 1b|Disease Progression|0
4515179|NCT00951665|7325874|FG000|Phase 1b|Protocol Violation|2
4515180|NCT00951665|7325875|FG001|Phase 1b|Protocol Violation|0
4515181|NCT00951665|7325876|FG002|Phase 1b|Protocol Violation|0
4515182|NCT00951665|7325877|FG003|Phase 1b|Protocol Violation|0
4515183|NCT00951665|7325878|FG004|Phase 1b|Protocol Violation|0
4515184|NCT00951665|7325879|FG005|Phase 1b|Protocol Violation|0
4515185|NCT00951665|7325874|FG000|Phase 2a|Adverse Event|0
4515186|NCT00951665|7325875|FG001|Phase 2a|Adverse Event|0
4515187|NCT00951665|7325876|FG002|Phase 2a|Adverse Event|0
4515188|NCT00951665|7325877|FG003|Phase 2a|Adverse Event|0
4515189|NCT00951665|7325878|FG004|Phase 2a|Adverse Event|2
4515190|NCT00951665|7325879|FG005|Phase 2a|Adverse Event|0
4515191|NCT00951665|7325874|FG000|Phase 2a|Death|0
4515192|NCT00951665|7325875|FG001|Phase 2a|Death|0
4515193|NCT00951665|7325876|FG002|Phase 2a|Death|0
4515194|NCT00951665|7325877|FG003|Phase 2a|Death|0
4515195|NCT00951665|7325878|FG004|Phase 2a|Death|1
4515196|NCT00951665|7325879|FG005|Phase 2a|Death|1
4515197|NCT00951665|7325874|FG000|Phase 2a|Lost to Follow-up|0
4515198|NCT00951665|7325875|FG001|Phase 2a|Lost to Follow-up|0
4515199|NCT00951665|7325876|FG002|Phase 2a|Lost to Follow-up|0
4515200|NCT00951665|7325877|FG003|Phase 2a|Lost to Follow-up|0
4515201|NCT00951665|7325878|FG004|Phase 2a|Lost to Follow-up|1
4515202|NCT00951665|7325879|FG005|Phase 2a|Lost to Follow-up|0
4515203|NCT00951665|7325874|FG000|Phase 2a|Physician Decision|0
4515204|NCT00951665|7325875|FG001|Phase 2a|Physician Decision|0
4590556|NCT01522651|7436636|FG001|Overall Study|Withdrew Consent|1
4515205|NCT00951665|7325876|FG002|Phase 2a|Physician Decision|0
4515206|NCT00951665|7325877|FG003|Phase 2a|Physician Decision|0
4515207|NCT00951665|7325878|FG004|Phase 2a|Physician Decision|0
4515208|NCT00951665|7325879|FG005|Phase 2a|Physician Decision|1
4515209|NCT00951665|7325874|FG000|Phase 2a|Withdrawal by Subject|0
4515210|NCT00951665|7325875|FG001|Phase 2a|Withdrawal by Subject|0
4515211|NCT00951665|7325876|FG002|Phase 2a|Withdrawal by Subject|0
4515212|NCT00951665|7325877|FG003|Phase 2a|Withdrawal by Subject|0
4515213|NCT00951665|7325878|FG004|Phase 2a|Withdrawal by Subject|2
4515214|NCT00951665|7325879|FG005|Phase 2a|Withdrawal by Subject|0
4515215|NCT00951665|7325874|FG000|Phase 2a|Disease Progression|0
4515216|NCT00951665|7325875|FG001|Phase 2a|Disease Progression|0
4515217|NCT00951665|7325876|FG002|Phase 2a|Disease Progression|0
4515218|NCT00951665|7325877|FG003|Phase 2a|Disease Progression|0
4515219|NCT00951665|7325878|FG004|Phase 2a|Disease Progression|6
4515220|NCT00951665|7325879|FG005|Phase 2a|Disease Progression|5
4515221|NCT00951912|7325942|FG000|Overall Study|Lack of Efficacy|1
4515222|NCT00951912|7325943|FG001|Overall Study|Lack of Efficacy|0
4515223|NCT00951912|7325944|FG002|Overall Study|Lack of Efficacy|0
4515224|NCT00951912|7325942|FG000|Overall Study|Adverse Event|0
4590557|NCT01522651|7436637|FG002|Overall Study|Withdrew Consent|0
4515225|NCT00951912|7325943|FG001|Overall Study|Adverse Event|1
4515226|NCT00951912|7325944|FG002|Overall Study|Adverse Event|1
4515227|NCT00951912|7325942|FG000|Overall Study|Lost to Follow-up|2
4515228|NCT00951912|7325943|FG001|Overall Study|Lost to Follow-up|2
4515229|NCT00951912|7325944|FG002|Overall Study|Lost to Follow-up|0
4515230|NCT00951912|7325942|FG000|Overall Study|Physician Decision|1
4717696|NCT03016598|7647639|FG000|Overall Study|Lost to Follow-up|0
4717697|NCT03016598|7647640|FG001|Overall Study|Lost to Follow-up|2
4717698|NCT03017079|7647648|FG000|Overall Study|Physician Decision|1
4717699|NCT03017079|7647649|FG001|Overall Study|Physician Decision|1
4717700|NCT03017079|7647648|FG000|Overall Study|Death|3
4717701|NCT03017079|7647649|FG001|Overall Study|Death|2
4717702|NCT03017079|7647648|FG000|Overall Study|Lack of Efficacy|2
4717703|NCT03017079|7647649|FG001|Overall Study|Lack of Efficacy|2
4717704|NCT03017079|7647648|FG000|Overall Study|Protocol Violation|0
4717705|NCT03017079|7647649|FG001|Overall Study|Protocol Violation|1
4717706|NCT03017235|7647664|FG000|Overall Study|Withdrawal by Subject|4
4717707|NCT03017235|7647665|FG001|Overall Study|Withdrawal by Subject|3
4717708|NCT03017235|7647664|FG000|Overall Study|Lost to Follow-up|2
4717709|NCT03017235|7647665|FG001|Overall Study|Lost to Follow-up|7
4717710|NCT03017235|7647664|FG000|Overall Study|Adverse Event|0
4717711|NCT03017235|7647665|FG001|Overall Study|Adverse Event|1
4717712|NCT03017235|7647664|FG000|Overall Study|Protocol Violation|2
4717713|NCT03017235|7647665|FG001|Overall Study|Protocol Violation|1
4717714|NCT03017235|7647664|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4
4717715|NCT03017235|7647665|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2
4717716|NCT03017612|7647684|FG000|Overall Study|Adverse Event|2
4717717|NCT03017846|7647688|FG000|Overall Study|Lost to Follow-up|3
4717718|NCT03017846|7647688|FG000|Overall Study|Adverse Event|2
4717719|NCT03018028|7647715|FG000|Overall Study|Withdrawal by Subject|3
4717720|NCT03018028|7647716|FG001|Overall Study|Withdrawal by Subject|0
4717721|NCT03018028|7647717|FG002|Overall Study|Withdrawal by Subject|1
4717722|NCT03018028|7647718|FG003|Overall Study|Withdrawal by Subject|2
4717723|NCT03018028|7647719|FG004|Overall Study|Withdrawal by Subject|0
4717724|NCT03018106|7647733|FG000|Overall Study|Lost to Follow-up|0
4717725|NCT03018106|7647734|FG001|Overall Study|Lost to Follow-up|1
4717726|NCT03018249|7647744|FG000|Overall Study|Withdrawal by Subject|2
4717727|NCT03018249|7647745|FG001|Overall Study|Withdrawal by Subject|2
4717728|NCT03018340|7647753|FG000|Overall Study|Adverse Event|1
4717729|NCT03018340|7647754|FG001|Overall Study|Adverse Event|2
4717730|NCT03018340|7647753|FG000|Overall Study|Withdrawal by Subject|0
4717731|NCT03018340|7647754|FG001|Overall Study|Withdrawal by Subject|8
4717732|NCT03018340|7647753|FG000|Overall Study|Lack of Efficacy|0
4717733|NCT03018340|7647754|FG001|Overall Study|Lack of Efficacy|1
4717734|NCT03018340|7647753|FG000|Overall Study|Non-compliance with study drug/procedure|3
4717735|NCT03018340|7647754|FG001|Overall Study|Non-compliance with study drug/procedure|4
4717736|NCT03018340|7647753|FG000|Overall Study|Lost to Follow-up|1
4717737|NCT03018340|7647754|FG001|Overall Study|Lost to Follow-up|7
4717738|NCT03018340|7647753|FG000|Overall Study|Protocol Violation|3
4717739|NCT03018340|7647754|FG001|Overall Study|Protocol Violation|7
4717740|NCT03018340|7647753|FG000|Overall Study|Not further specified|0
4717741|NCT03018340|7647754|FG001|Overall Study|Not further specified|1
4717742|NCT03018691|7647767|FG000|Overall Study|Adverse Event|1
4717743|NCT03018691|7647768|FG001|Overall Study|Adverse Event|1
4717744|NCT03018691|7647769|FG002|Overall Study|Adverse Event|4
4717745|NCT03018691|7647767|FG000|Overall Study|Lack of Efficacy|0
4717746|NCT03018691|7647768|FG001|Overall Study|Lack of Efficacy|0
4717747|NCT03018691|7647769|FG002|Overall Study|Lack of Efficacy|1
4717748|NCT03018691|7647767|FG000|Overall Study|Withdrawal by Subject|0
4717749|NCT03018691|7647768|FG001|Overall Study|Withdrawal by Subject|0
4717750|NCT03018691|7647769|FG002|Overall Study|Withdrawal by Subject|1
4717751|NCT03018691|7647767|FG000|Overall Study|Withdrawal by parent/guardian|1
4717752|NCT03018691|7647768|FG001|Overall Study|Withdrawal by parent/guardian|0
4717753|NCT03018691|7647769|FG002|Overall Study|Withdrawal by parent/guardian|1
4717754|NCT03018938|7647806|FG000|Overall Study|Death|0
4717755|NCT03018938|7647807|FG001|Overall Study|Death|1
4446149|NCT00481247|7231142|FG000|Overall Study|Pregnancy|2
4446150|NCT00481247|7231143|FG001|Overall Study|Pregnancy|1
4446151|NCT00481247|7231142|FG000|Overall Study|Lost to Follow-up|1
4446152|NCT00481247|7231143|FG001|Overall Study|Lost to Follow-up|2
4446153|NCT00481247|7231142|FG000|Overall Study|Poor compliance/noncompliance|1
4446154|NCT00481247|7231143|FG001|Overall Study|Poor compliance/noncompliance|7
4446155|NCT00481247|7231142|FG000|Overall Study|Administrative reason by sponsor|157
4446156|NCT00481247|7231143|FG001|Overall Study|Administrative reason by sponsor|162
4717756|NCT03018938|7647806|FG000|Overall Study|Lost to Follow-up|21
4717757|NCT03018938|7647807|FG001|Overall Study|Lost to Follow-up|32
4717758|NCT03018938|7647806|FG000|Overall Study|Withdrawal by Subject|38
4717759|NCT03018938|7647807|FG001|Overall Study|Withdrawal by Subject|45
4717760|NCT03018938|7647806|FG000|Overall Study|Physician Decision|3
4717761|NCT03018938|7647807|FG001|Overall Study|Physician Decision|2
4717762|NCT03018938|7647806|FG000|Overall Study|Sponsor Decision|0
4717763|NCT03018938|7647807|FG001|Overall Study|Sponsor Decision|1
4717764|NCT03018938|7647806|FG000|Overall Study|Screen failure-After randomization|4
4717765|NCT03018938|7647807|FG001|Overall Study|Screen failure-After randomization|2
4717766|NCT03018938|7647806|FG000|Overall Study|Not recorded|0
4717767|NCT03018938|7647807|FG001|Overall Study|Not recorded|2
4717768|NCT03019289|7647848|FG000|Overall Study|Adverse Event|1
4717769|NCT03019289|7647849|FG001|Overall Study|Adverse Event|0
4717770|NCT03019289|7647850|FG002|Overall Study|Adverse Event|0
4717771|NCT03019289|7647851|FG003|Overall Study|Adverse Event|0
4717772|NCT03019289|7647852|FG004|Overall Study|Adverse Event|0
4717773|NCT03019289|7647853|FG005|Overall Study|Adverse Event|0
4717774|NCT03019289|7647854|FG006|Overall Study|Adverse Event|0
4717775|NCT03019289|7647855|FG007|Overall Study|Adverse Event|0
4717776|NCT03019289|7647856|FG008|Overall Study|Adverse Event|1
4717777|NCT03019289|7647848|FG000|Overall Study|Other|1
4717778|NCT03019289|7647849|FG001|Overall Study|Other|0
4717779|NCT03019289|7647850|FG002|Overall Study|Other|0
4717780|NCT03019289|7647851|FG003|Overall Study|Other|0
4717781|NCT03019289|7647852|FG004|Overall Study|Other|0
4717782|NCT03019289|7647853|FG005|Overall Study|Other|0
4717783|NCT03019289|7647854|FG006|Overall Study|Other|0
4717784|NCT03019289|7647855|FG007|Overall Study|Other|0
4717785|NCT03019289|7647856|FG008|Overall Study|Other|0
4717786|NCT03019406|7647881|FG000|ETP: Ongoing From Week 26|Ongoing|6
4717787|NCT03019406|7647882|FG001|ETP: Ongoing From Week 26|Ongoing|5
4717788|NCT03019406|7647883|FG002|ETP: Ongoing From Week 26|Ongoing|5
4717789|NCT03019406|7647884|FG003|ETP: Ongoing From Week 26|Ongoing|3
4717790|NCT03019458|7647899|FG000|Overall Study|Death|0
4717791|NCT03019458|7647900|FG001|Overall Study|Death|1
4717792|NCT03019549|7647908|FG000|Washout|DId not meet genotype criteria|11
4717793|NCT03019549|7647908|FG000|Period 2|Adverse Event|2
4717794|NCT03019549|7647908|FG000|Period 2|Physician Decision|2
4717795|NCT03019549|7647908|FG000|Period 2|Withdrawal by Subject|1
4717796|NCT03019627|7647919|FG000|Overall Study|Adverse Event|8
4446157|NCT00481247|7231142|FG000|Overall Study|Varied|6
4446158|NCT00481247|7231143|FG001|Overall Study|Varied|15
4446159|NCT00481247|7231142|FG000|Overall Study|Did not receive treatment|1
4446160|NCT00481247|7231143|FG001|Overall Study|Did not receive treatment|2
4446161|NCT00481676|7231169|FG000|Overall Study|Adverse Event|0
4446162|NCT00481676|7231170|FG001|Overall Study|Adverse Event|1
4446163|NCT00481676|7231169|FG000|Overall Study|Unsatisfactory therapeutic effect|1
4446164|NCT00481676|7231170|FG001|Overall Study|Unsatisfactory therapeutic effect|4
4446165|NCT00481676|7231169|FG000|Overall Study|Administrative problem|1
4446166|NCT00481676|7231170|FG001|Overall Study|Administrative problem|0
4446167|NCT00481767|7231178|FG000|Overall Study|Withdrawal by Subject|16
4446168|NCT00481767|7231179|FG001|Overall Study|Withdrawal by Subject|11
4446169|NCT00481767|7231178|FG000|Overall Study|Lost to Follow-up|16
4446170|NCT00481767|7231179|FG001|Overall Study|Lost to Follow-up|10
4446171|NCT00481832|7231185|FG000|Enrollment|Physician Decision|8
4446172|NCT00481832|7231185|FG000|Enrollment|Unable to collect enough stem cells|2
4446173|NCT00481832|7231185|FG000|Inter-transplant Period|Adverse Event|4
4446174|NCT00481832|7231185|FG000|Inter-transplant Period|Death|3
4446175|NCT00481832|7231185|FG000|Inter-transplant Period|Physician Decision|4
4446176|NCT00481832|7231185|FG000|Inter-transplant Period|Disease relapse|11
4446177|NCT00481832|7231185|FG000|Inter-transplant Period|Lack of allogeneic donor|5
4515231|NCT00951912|7325943|FG001|Overall Study|Physician Decision|0
4515232|NCT00951912|7325944|FG002|Overall Study|Physician Decision|1
4515233|NCT00951912|7325942|FG000|Overall Study|Withdrawal by Subject|1
4515234|NCT00951912|7325943|FG001|Overall Study|Withdrawal by Subject|1
4515235|NCT00951912|7325944|FG002|Overall Study|Withdrawal by Subject|0
4717797|NCT03019627|7647920|FG001|Overall Study|Adverse Event|0
4717798|NCT03019627|7647919|FG000|Overall Study|Unrelated to adverse event|1
4717799|NCT03019627|7647920|FG001|Overall Study|Unrelated to adverse event|3
4717800|NCT03019627|7647919|FG000|Overall Study|Lost to Follow-up|2
4717801|NCT03019627|7647920|FG001|Overall Study|Lost to Follow-up|1
4717802|NCT03019627|7647919|FG000|Overall Study|not compliance|2
4717803|NCT03019627|7647920|FG001|Overall Study|not compliance|2
4717804|NCT03019627|7647919|FG000|Overall Study|Other|2
4717805|NCT03019627|7647920|FG001|Overall Study|Other|2
4717806|NCT03019965|7647962|FG000|Overall Study|Withdrawal by Subject|1
4717807|NCT03019965|7647963|FG001|Overall Study|Withdrawal by Subject|0
4717808|NCT03019965|7647962|FG000|Overall Study|Protocol Violation|1
4717809|NCT03019965|7647963|FG001|Overall Study|Protocol Violation|3
4717810|NCT03019965|7647962|FG000|Overall Study|viral or fungal infection|3
4717811|NCT03019965|7647963|FG001|Overall Study|viral or fungal infection|4
4717812|NCT03019965|7647962|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4
4717813|NCT03019965|7647963|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5
4717814|NCT03019965|7647962|FG000|Overall Study|Physician Decision|1
4717815|NCT03019965|7647963|FG001|Overall Study|Physician Decision|1
4717816|NCT03020069|7647975|FG000|Overall Study|Lost to Follow-up|0
4717817|NCT03020069|7647976|FG001|Overall Study|Lost to Follow-up|1
4717818|NCT03020407|7647992|FG000|Overall Study|Withdrawal by Subject|2
4717819|NCT03020407|7647993|FG001|Overall Study|Withdrawal by Subject|1
4515236|NCT00951912|7325942|FG000|Overall Study|Other:Depression|1
4717820|NCT03020407|7647992|FG000|Overall Study|Lost to Follow-up|2
4717821|NCT03020407|7647993|FG001|Overall Study|Lost to Follow-up|3
4717822|NCT03020407|7647992|FG000|Overall Study|Protocol Violation|0
4717823|NCT03020407|7647993|FG001|Overall Study|Protocol Violation|1
4717824|NCT03020576|7648049|FG000|Overall Study|Withdrawal by Subject|1
4717825|NCT03020576|7648050|FG001|Overall Study|Withdrawal by Subject|2
4717826|NCT03020615|7648059|FG000|Overall Study|Physician Decision|3
4717827|NCT03020615|7648060|FG001|Overall Study|Physician Decision|1
4717828|NCT03020615|7648061|FG002|Overall Study|Physician Decision|2
4717829|NCT03020615|7648059|FG000|Overall Study|Parent/guardian/patient choice|3
4717830|NCT03020615|7648060|FG001|Overall Study|Parent/guardian/patient choice|0
4717831|NCT03020615|7648061|FG002|Overall Study|Parent/guardian/patient choice|4
4717832|NCT03020615|7648059|FG000|Overall Study|Screen failure|0
4717833|NCT03020615|7648060|FG001|Overall Study|Screen failure|0
4717834|NCT03020615|7648061|FG002|Overall Study|Screen failure|1
4717835|NCT03020615|7648059|FG000|Overall Study|Death|1
4717836|NCT03020615|7648060|FG001|Overall Study|Death|0
4717837|NCT03020615|7648061|FG002|Overall Study|Death|0
4717838|NCT03020615|7648059|FG000|Overall Study|Lost to Follow-up|0
4717839|NCT03020615|7648060|FG001|Overall Study|Lost to Follow-up|1
4717840|NCT03020615|7648061|FG002|Overall Study|Lost to Follow-up|0
4717841|NCT03020641|7648074|FG000|Overall Study|Lost to Follow-up|0
4717842|NCT03020641|7648075|FG001|Overall Study|Lost to Follow-up|1
4717843|NCT03020641|7648074|FG000|Overall Study|Converted to open surgery|2
4717844|NCT03020641|7648075|FG001|Overall Study|Converted to open surgery|1
4717845|NCT03020641|7648074|FG000|Overall Study|for surgery not performed|0
4717846|NCT03020641|7648075|FG001|Overall Study|for surgery not performed|1
4717847|NCT03020745|7648101|FG000|Part 2 (Up to 169 Days)|Adverse Event|0
4717848|NCT03020745|7648102|FG001|Part 2 (Up to 169 Days)|Adverse Event|0
4717849|NCT03020745|7648103|FG002|Part 2 (Up to 169 Days)|Adverse Event|0
4717850|NCT03020745|7648104|FG003|Part 2 (Up to 169 Days)|Adverse Event|0
4717851|NCT03020745|7648105|FG004|Part 2 (Up to 169 Days)|Adverse Event|0
4717852|NCT03020745|7648106|FG005|Part 2 (Up to 169 Days)|Adverse Event|0
4717853|NCT03020745|7648107|FG006|Part 2 (Up to 169 Days)|Adverse Event|0
4717854|NCT03020745|7648108|FG007|Part 2 (Up to 169 Days)|Adverse Event|0
4717855|NCT03020745|7648109|FG008|Part 2 (Up to 169 Days)|Adverse Event|1
4717856|NCT03020745|7648110|FG009|Part 2 (Up to 169 Days)|Adverse Event|0
4717857|NCT03020745|7648101|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
4717858|NCT03020745|7648102|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
4717859|NCT03020745|7648103|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
4717860|NCT03020745|7648104|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
4717861|NCT03020745|7648105|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
4717862|NCT03020745|7648106|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
4717863|NCT03020745|7648107|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
4717864|NCT03020745|7648108|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1
4717865|NCT03020745|7648109|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
4717866|NCT03020745|7648110|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
4717867|NCT03020745|7648101|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
4717868|NCT03020745|7648102|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
4717869|NCT03020745|7648103|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
4717870|NCT03020745|7648104|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
4717871|NCT03020745|7648105|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
4717872|NCT03020745|7648106|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1
4717873|NCT03020745|7648107|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
4717874|NCT03020745|7648108|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
4717875|NCT03020745|7648109|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1
4717876|NCT03020745|7648110|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
4717877|NCT03020745|7648101|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
4717878|NCT03020745|7648102|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
4717879|NCT03020745|7648103|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
4717880|NCT03020745|7648104|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
4717881|NCT03020745|7648105|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
4717882|NCT03020745|7648106|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
4717883|NCT03020745|7648107|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
4717884|NCT03020745|7648108|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
4717885|NCT03020745|7648109|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2
4717886|NCT03020745|7648110|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
4717887|NCT03020888|7648134|FG000|Overall Study|Physician Decision|4
4717888|NCT03020888|7648134|FG000|Overall Study|Withdrawal by Subject|6
4717889|NCT03020888|7648134|FG000|Overall Study|Insurance coverage|2
4717890|NCT03020888|7648134|FG000|Overall Study|Lost to Follow-up|1
4717891|NCT03020966|7648140|FG000|Overall Study|Withdrawal by Subject|2
4717892|NCT03020966|7648141|FG001|Overall Study|Withdrawal by Subject|0
4717893|NCT03020992|7648147|FG000|Overall Study|Adverse Event|5
4717894|NCT03020992|7648147|FG000|Overall Study|Withdrawal by Subject|1
4717895|NCT03021005|7648154|FG000|Overall Study|Lost to Follow-up|39
4717896|NCT03021005|7648155|FG001|Overall Study|Lost to Follow-up|26
4717897|NCT03021018|7648164|FG000|Overall Study|Adverse Event|1
4717898|NCT03021018|7648165|FG001|Overall Study|Adverse Event|0
4717899|NCT03021018|7648166|FG002|Overall Study|Adverse Event|0
4717900|NCT03021018|7648164|FG000|Overall Study|Fall with subsequent nasal fracture|1
4717901|NCT03021018|7648165|FG001|Overall Study|Fall with subsequent nasal fracture|0
4717902|NCT03021018|7648166|FG002|Overall Study|Fall with subsequent nasal fracture|0
4717903|NCT03021187|7648178|FG000|Overall Study|Death|0
4717904|NCT03021187|7648179|FG001|Overall Study|Death|0
4717905|NCT03021187|7648180|FG002|Overall Study|Death|3
4717906|NCT03021187|7648181|FG003|Overall Study|Death|0
4717907|NCT03021187|7648178|FG000|Overall Study|Withdrawal by Subject|0
4717908|NCT03021187|7648179|FG001|Overall Study|Withdrawal by Subject|6
4717909|NCT03021187|7648180|FG002|Overall Study|Withdrawal by Subject|2
4717910|NCT03021187|7648181|FG003|Overall Study|Withdrawal by Subject|5
4717911|NCT03021187|7648178|FG000|Overall Study|Lost to Follow-up|10
4717912|NCT03021187|7648179|FG001|Overall Study|Lost to Follow-up|3
4717913|NCT03021187|7648180|FG002|Overall Study|Lost to Follow-up|1
4717914|NCT03021187|7648181|FG003|Overall Study|Lost to Follow-up|4
4736253|NCT03561090|7685207|FG000|Overall Study|Other Not Specified|0
4736254|NCT03561090|7685208|FG001|Overall Study|Other Not Specified|2
4736255|NCT03561883|7685218|FG000|Overall Study|Adverse Event|10
4736256|NCT03561883|7685219|FG001|Overall Study|Adverse Event|13
4736257|NCT03561883|7685218|FG000|Overall Study|Non-Compliance With Study Drug|1
4736258|NCT03561883|7685219|FG001|Overall Study|Non-Compliance With Study Drug|2
4736259|NCT03561883|7685218|FG000|Overall Study|Protocol Violation|2
4736260|NCT03561883|7685219|FG001|Overall Study|Protocol Violation|3
4736261|NCT03561883|7685218|FG000|Overall Study|Withdrawal by Subject|14
4736262|NCT03561883|7685219|FG001|Overall Study|Withdrawal by Subject|6
4736263|NCT03561883|7685218|FG000|Overall Study|Lost to Follow-up|2
4736264|NCT03561883|7685219|FG001|Overall Study|Lost to Follow-up|6
4736265|NCT03561883|7685218|FG000|Overall Study|Study Terminated by Sponsor|12
4736266|NCT03561883|7685219|FG001|Overall Study|Study Terminated by Sponsor|11
4736267|NCT03561883|7685218|FG000|Overall Study|Physician Decision|1
4736268|NCT03561883|7685219|FG001|Overall Study|Physician Decision|0
4736269|NCT03561883|7685218|FG000|Overall Study|Randomized by Mistake|1
4736270|NCT03561883|7685219|FG001|Overall Study|Randomized by Mistake|0
4736271|NCT03561883|7685218|FG000|Overall Study|Other, Not Specified|3
4736272|NCT03561883|7685219|FG001|Overall Study|Other, Not Specified|2
4736273|NCT03562117|7685228|FG000|Part 1, Up to 3 Days|Adverse Event|1
4736274|NCT03562117|7685229|FG001|Part 1, Up to 3 Days|Adverse Event|0
4736275|NCT03562117|7685230|FG002|Part 1, Up to 3 Days|Adverse Event|0
4737583|NCT03614156|7687814|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6
4737584|NCT03614156|7687815|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0
4737585|NCT03614156|7687816|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0
4737586|NCT03614156|7687817|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0
4737587|NCT03614156|7687814|FG000|Open-Label Treatment Period|Adverse Event|7
4737588|NCT03614156|7687815|FG001|Open-Label Treatment Period|Adverse Event|0
4737589|NCT03614156|7687816|FG002|Open-Label Treatment Period|Adverse Event|0
4737590|NCT03614156|7687817|FG003|Open-Label Treatment Period|Adverse Event|0
4737591|NCT03614156|7687814|FG000|Open-Label Treatment Period|Lack of Efficacy|18
4737592|NCT03614156|7687815|FG001|Open-Label Treatment Period|Lack of Efficacy|0
4737593|NCT03614156|7687816|FG002|Open-Label Treatment Period|Lack of Efficacy|0
4737594|NCT03614156|7687817|FG003|Open-Label Treatment Period|Lack of Efficacy|0
4737595|NCT03614156|7687814|FG000|Open-Label Treatment Period|Withdrawal by Subject|36
4737596|NCT03614156|7687815|FG001|Open-Label Treatment Period|Withdrawal by Subject|0
4737597|NCT03614156|7687816|FG002|Open-Label Treatment Period|Withdrawal by Subject|0
4737598|NCT03614156|7687817|FG003|Open-Label Treatment Period|Withdrawal by Subject|0
4737599|NCT03614156|7687814|FG000|Open-Label Treatment Period|Lost to Follow-up|10
4737600|NCT03614156|7687815|FG001|Open-Label Treatment Period|Lost to Follow-up|0
4737601|NCT03614156|7687816|FG002|Open-Label Treatment Period|Lost to Follow-up|0
4737602|NCT03614156|7687817|FG003|Open-Label Treatment Period|Lost to Follow-up|0
4737603|NCT03614156|7687814|FG000|Open-Label Treatment Period|Protocol Violation|2
4737604|NCT03614156|7687815|FG001|Open-Label Treatment Period|Protocol Violation|0
4737605|NCT03614156|7687816|FG002|Open-Label Treatment Period|Protocol Violation|0
4737606|NCT03614156|7687817|FG003|Open-Label Treatment Period|Protocol Violation|0
4737607|NCT03614156|7687814|FG000|Open-Label Treatment Period|Non-compliance with study drug|1
4737608|NCT03614156|7687815|FG001|Open-Label Treatment Period|Non-compliance with study drug|0
4737609|NCT03614156|7687816|FG002|Open-Label Treatment Period|Non-compliance with study drug|0
4737610|NCT03614156|7687817|FG003|Open-Label Treatment Period|Non-compliance with study drug|0
4737611|NCT03614156|7687814|FG000|Open-Label Treatment Period|Study terminated by sponsor|74
4737612|NCT03614156|7687815|FG001|Open-Label Treatment Period|Study terminated by sponsor|0
4737613|NCT03614156|7687816|FG002|Open-Label Treatment Period|Study terminated by sponsor|0
4737614|NCT03614156|7687817|FG003|Open-Label Treatment Period|Study terminated by sponsor|0
4737615|NCT03614156|7687814|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0
4737616|NCT03614156|7687815|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2
4737617|NCT03614156|7687816|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0
4737618|NCT03614156|7687817|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1
4737619|NCT03614156|7687814|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0
4737620|NCT03614156|7687815|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4
4737621|NCT03614156|7687816|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1
4737622|NCT03614156|7687817|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1
4737623|NCT03614156|7687814|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0
4737624|NCT03614156|7687815|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0
4717915|NCT03021265|7648191|FG000|Overall Study|Adverse Event|29
4717916|NCT03021265|7648191|FG000|Overall Study|Lack of Efficacy|3
4717917|NCT03021265|7648191|FG000|Overall Study|Improved|17
4717918|NCT03021265|7648191|FG000|Overall Study|Lost to Follow-up|67
4717919|NCT03021265|7648191|FG000|Overall Study|No reason given|2
4717920|NCT03021265|7648191|FG000|Overall Study|No visit since the first visit|4
4717921|NCT03021304|7648195|FG000|Overall Study|Lack of Efficacy|1
4717922|NCT03021499|7648210|FG000|Overall Study|Adverse Event|1
4717923|NCT03021499|7648211|FG001|Overall Study|Adverse Event|0
4717924|NCT03021499|7648210|FG000|Overall Study|Death|1
4717925|NCT03021499|7648211|FG001|Overall Study|Death|5
4717926|NCT03021499|7648210|FG000|Overall Study|Lack of Efficacy|0
4717927|NCT03021499|7648211|FG001|Overall Study|Lack of Efficacy|1
4717928|NCT03021499|7648210|FG000|Overall Study|Lost to Follow-up|1
4717929|NCT03021499|7648211|FG001|Overall Study|Lost to Follow-up|3
4717930|NCT03021499|7648210|FG000|Overall Study|Physician Decision|2
4717931|NCT03021499|7648211|FG001|Overall Study|Physician Decision|3
4717932|NCT03021499|7648210|FG000|Overall Study|Pregnancy|1
4717933|NCT03021499|7648211|FG001|Overall Study|Pregnancy|0
4717934|NCT03021499|7648210|FG000|Overall Study|Withdrawal by Subject|7
4717935|NCT03021499|7648211|FG001|Overall Study|Withdrawal by Subject|14
4717936|NCT03021499|7648210|FG000|Overall Study|Prohibited medication required|1
4717937|NCT03021499|7648211|FG001|Overall Study|Prohibited medication required|0
4717938|NCT03021499|7648210|FG000|Overall Study|Protocol non-compliance|1
4717939|NCT03021499|7648211|FG001|Overall Study|Protocol non-compliance|1
4717940|NCT03021499|7648210|FG000|Overall Study|None of the above|0
4717941|NCT03021499|7648211|FG001|Overall Study|None of the above|4
4717942|NCT03021499|7648210|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1
4717943|NCT03021499|7648211|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0
4717944|NCT03021564|7648230|FG000|Overall Study|Death|84
4717945|NCT03021564|7648231|FG001|Overall Study|Death|466
4717946|NCT03021564|7648230|FG000|Overall Study|Lost to Follow-up|0
4717947|NCT03021564|7648231|FG001|Overall Study|Lost to Follow-up|2
4717948|NCT03021642|7648241|FG000|Washout Period (21 Days)|Adverse Event|1
4717949|NCT03021642|7648242|FG001|Washout Period (21 Days)|Adverse Event|1
4717950|NCT03021668|7648250|FG000|Overall Study|Physician Decision|0
4717951|NCT03021668|7648251|FG001|Overall Study|Physician Decision|1
4717952|NCT03022045|7648272|FG000|Overall Study|Adverse Event|0
4717953|NCT03022045|7648273|FG001|Overall Study|Adverse Event|1
4717954|NCT03022045|7648272|FG000|Overall Study|Withdrawal by Subject|1
4717955|NCT03022045|7648273|FG001|Overall Study|Withdrawal by Subject|1
4717956|NCT03022084|7648285|FG000|Overall Study|Lost to Follow-up|2
4717957|NCT03022084|7648286|FG001|Overall Study|Lost to Follow-up|3
4717958|NCT03022370|7648296|FG000|Overall Study|Death|6
4717959|NCT03022370|7648297|FG001|Overall Study|Death|12
4717960|NCT03022370|7648296|FG000|Overall Study|Lost to Follow-up|174
4717961|NCT03022370|7648297|FG001|Overall Study|Lost to Follow-up|109
4717962|NCT03022422|7648338|FG000|Overall Study|3 subjects consented but not vaccinated|0
4717963|NCT03022422|7648339|FG001|Overall Study|3 subjects consented but not vaccinated|0
4717964|NCT03022422|7648340|FG002|Overall Study|3 subjects consented but not vaccinated|3
4717965|NCT03022422|7648341|FG003|Overall Study|3 subjects consented but not vaccinated|0
4717966|NCT03022422|7648342|FG004|Overall Study|3 subjects consented but not vaccinated|0
4717967|NCT03022422|7648343|FG005|Overall Study|3 subjects consented but not vaccinated|0
4717968|NCT03022630|7648398|FG000|Overall Study|Death|9
4717969|NCT03022630|7648399|FG001|Overall Study|Death|7
4717970|NCT03022630|7648398|FG000|Overall Study|Withdrawal by Subject|0
4717971|NCT03022630|7648399|FG001|Overall Study|Withdrawal by Subject|5
4717972|NCT03022799|7648423|FG000|Overall Study|Adverse Event|0
4717973|NCT03022799|7648424|FG001|Overall Study|Adverse Event|0
4717974|NCT03022799|7648425|FG002|Overall Study|Adverse Event|0
4717975|NCT03022799|7648426|FG003|Overall Study|Adverse Event|0
4717976|NCT03022799|7648427|FG004|Overall Study|Adverse Event|0
4717977|NCT03022799|7648428|FG005|Overall Study|Adverse Event|0
4717978|NCT03022799|7648429|FG006|Overall Study|Adverse Event|0
4717979|NCT03022799|7648430|FG007|Overall Study|Adverse Event|0
4717980|NCT03022799|7648431|FG008|Overall Study|Adverse Event|0
4717981|NCT03022799|7648432|FG009|Overall Study|Adverse Event|1
4717982|NCT03022799|7648433|FG010|Overall Study|Adverse Event|1
4717983|NCT03022799|7648434|FG011|Overall Study|Adverse Event|0
4717984|NCT03022799|7648435|FG012|Overall Study|Adverse Event|0
4717985|NCT03022981|7648493|FG000|Overall Study|Adverse Event|0
4717986|NCT03022981|7648494|FG001|Overall Study|Adverse Event|1
4717987|NCT03022981|7648495|FG002|Overall Study|Adverse Event|0
4717988|NCT03022981|7648493|FG000|Overall Study|Investigator's Discretion|0
4717989|NCT03022981|7648494|FG001|Overall Study|Investigator's Discretion|1
4717990|NCT03022981|7648495|FG002|Overall Study|Investigator's Discretion|2
4717991|NCT03022981|7648493|FG000|Overall Study|Lost to Follow-up|6
4717992|NCT03022981|7648494|FG001|Overall Study|Lost to Follow-up|2
4717993|NCT03022981|7648495|FG002|Overall Study|Lost to Follow-up|1
4717994|NCT03022981|7648493|FG000|Overall Study|Non-Compliance With Study Drug|0
4717995|NCT03022981|7648494|FG001|Overall Study|Non-Compliance With Study Drug|0
4717996|NCT03022981|7648495|FG002|Overall Study|Non-Compliance With Study Drug|2
4717997|NCT03022981|7648493|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0
4717998|NCT03022981|7648494|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0
4717999|NCT03022981|7648495|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1
4718000|NCT03023137|7648515|FG000|Overall Study|Multiple pregnancy|2
4718001|NCT03023137|7648516|FG001|Overall Study|Multiple pregnancy|4
4718002|NCT03023137|7648515|FG000|Overall Study|Lost to Follow-up|1
4718003|NCT03023137|7648516|FG001|Overall Study|Lost to Follow-up|1
4718004|NCT03023137|7648515|FG000|Overall Study|Protocol Violation|0
4718005|NCT03023137|7648516|FG001|Overall Study|Protocol Violation|4
4718006|NCT03023137|7648515|FG000|Overall Study|Lost the baby in a car accident|1
4718007|NCT03023137|7648516|FG001|Overall Study|Lost the baby in a car accident|0
4718008|NCT03023397|7648530|FG000|Run-In|Failed screening allergen challenge|1
4718009|NCT03023397|7648531|FG001|Run-In|Failed screening allergen challenge|0
4718010|NCT03023397|7648532|FG002|Run-In|Failed screening allergen challenge|0
4718011|NCT03023397|7648530|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1
4718012|NCT03023397|7648531|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0
4718013|NCT03023397|7648532|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0
4718014|NCT03023423|7648544|FG000|Overall Study|Death|5
4718015|NCT03023423|7648545|FG001|Overall Study|Death|12
4718016|NCT03023423|7648546|FG002|Overall Study|Death|20
4718017|NCT03023423|7648544|FG000|Overall Study|Other|0
4718018|NCT03023423|7648545|FG001|Overall Study|Other|2
4718019|NCT03023423|7648546|FG002|Overall Study|Other|2
4718020|NCT03023423|7648544|FG000|Overall Study|Ongoing|2
4718021|NCT03023423|7648545|FG001|Overall Study|Ongoing|32
4718022|NCT03023423|7648546|FG002|Overall Study|Ongoing|24
4718023|NCT03023722|7648597|FG000|Overall Study|No follow-up assessment|4
4515237|NCT00951912|7325943|FG001|Overall Study|Other:Depression|0
4718024|NCT03023826|7648601|FG000|Period 1|Withdrawal by Subject|0
4718025|NCT03023826|7648602|FG001|Period 1|Withdrawal by Subject|0
4718026|NCT03023826|7648603|FG002|Period 1|Withdrawal by Subject|0
4718027|NCT03023826|7648604|FG003|Period 1|Withdrawal by Subject|0
4718028|NCT03023826|7648605|FG004|Period 1|Withdrawal by Subject|1
4718029|NCT03023826|7648606|FG005|Period 1|Withdrawal by Subject|0
4718030|NCT03023878|7648614|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11
4718031|NCT03023878|7648614|FG000|Pre-Study Run-In Period|Death|1
4718032|NCT03023878|7648614|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5
4718033|NCT03023878|7648614|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2
4718034|NCT03023878|7648614|FG000|Treatment Period|Disease Progression|1
4718035|NCT03023878|7648614|FG000|Treatment Period|Withdrawal by Subject|1
4718036|NCT03023878|7648614|FG000|Treatment Period|Adverse Event|1
4718037|NCT03023878|7648614|FG000|Long Term Follow-Up Period|Death|2
4718038|NCT03024606|7648633|FG000|Overall Study|Withdrawal by Subject|9
4718039|NCT03024606|7648634|FG001|Overall Study|Withdrawal by Subject|10
4718040|NCT03024970|7648640|FG000|First Intervention|Adverse Event|1
4718041|NCT03024970|7648641|FG001|First Intervention|Adverse Event|0
4718042|NCT03024970|7648640|FG000|Second Intervention|Lost to Follow-up|1
4718043|NCT03024970|7648641|FG001|Second Intervention|Lost to Follow-up|0
4718044|NCT03025217|7648647|FG000|Overall Study|Pregnancy|1
4718045|NCT03025217|7648647|FG000|Overall Study|Lost to Follow-up|1
4718046|NCT03025217|7648647|FG000|Overall Study|Not eligible, poor English|2
4718047|NCT03026075|7648660|FG000|Overall Study|Physician Decision|1
4718048|NCT03026088|7648664|FG000|Overall Study|Study termination|20
4718049|NCT03026166|7648670|FG000|Overall Study|Death|22
4718050|NCT03026166|7648671|FG001|Overall Study|Death|7
4718051|NCT03026166|7648670|FG000|Overall Study|Physician Decision|2
4718052|NCT03026166|7648671|FG001|Overall Study|Physician Decision|0
4718053|NCT03026166|7648670|FG000|Overall Study|Withdrawal by Subject|1
4718054|NCT03026166|7648671|FG001|Overall Study|Withdrawal by Subject|2
4718055|NCT03026166|7648670|FG000|Overall Study|Lost to Follow-up|1
4718056|NCT03026166|7648671|FG001|Overall Study|Lost to Follow-up|0
4718057|NCT03026166|7648670|FG000|Overall Study|Study Terminated by Sponsor|3
4718058|NCT03026166|7648671|FG001|Overall Study|Study Terminated by Sponsor|3
4718059|NCT03026166|7648670|FG000|Overall Study|Other|1
4718060|NCT03026166|7648671|FG001|Overall Study|Other|0
4718061|NCT03026257|7648683|FG000|Overall Study|Adverse Event|3
4718062|NCT03026257|7648684|FG001|Overall Study|Adverse Event|0
4718063|NCT03026257|7648685|FG002|Overall Study|Adverse Event|0
4718064|NCT03026257|7648686|FG003|Overall Study|Adverse Event|0
4718065|NCT03026257|7648687|FG004|Overall Study|Adverse Event|0
4718066|NCT03026257|7648688|FG005|Overall Study|Adverse Event|0
4718067|NCT03026257|7648683|FG000|Overall Study|Lost to Follow-up|1
4718068|NCT03026257|7648684|FG001|Overall Study|Lost to Follow-up|0
4718069|NCT03026257|7648685|FG002|Overall Study|Lost to Follow-up|0
4718070|NCT03026257|7648686|FG003|Overall Study|Lost to Follow-up|0
4718071|NCT03026257|7648687|FG004|Overall Study|Lost to Follow-up|0
4718072|NCT03026257|7648688|FG005|Overall Study|Lost to Follow-up|0
4718073|NCT03026257|7648683|FG000|Overall Study|Protocol Violation|1
4718074|NCT03026257|7648684|FG001|Overall Study|Protocol Violation|0
4718075|NCT03026257|7648685|FG002|Overall Study|Protocol Violation|0
4718076|NCT03026257|7648686|FG003|Overall Study|Protocol Violation|1
4718077|NCT03026257|7648687|FG004|Overall Study|Protocol Violation|1
4718078|NCT03026257|7648688|FG005|Overall Study|Protocol Violation|0
4718079|NCT03026257|7648683|FG000|Overall Study|Withdrawal by Subject|1
4718080|NCT03026257|7648684|FG001|Overall Study|Withdrawal by Subject|1
4718081|NCT03026257|7648685|FG002|Overall Study|Withdrawal by Subject|0
4718082|NCT03026257|7648686|FG003|Overall Study|Withdrawal by Subject|0
4718083|NCT03026257|7648687|FG004|Overall Study|Withdrawal by Subject|0
4718084|NCT03026257|7648688|FG005|Overall Study|Withdrawal by Subject|0
4718085|NCT03026283|7648702|FG000|CCTA Diagnosis|CCTA not performed as planned|9
4718086|NCT03026283|7648703|FG001|CCTA Diagnosis|CCTA not performed as planned|0
4718087|NCT03026283|7648704|FG002|CCTA Diagnosis|CCTA not performed as planned|0
4718088|NCT03026283|7648705|FG003|CCTA Diagnosis|CCTA not performed as planned|0
4718089|NCT03026283|7648706|FG004|CCTA Diagnosis|CCTA not performed as planned|0
4718090|NCT03026283|7648707|FG005|CCTA Diagnosis|CCTA not performed as planned|0
4718091|NCT03026283|7648708|FG006|CCTA Diagnosis|CCTA not performed as planned|0
4718092|NCT03026283|7648709|FG007|CCTA Diagnosis|CCTA not performed as planned|0
4718093|NCT03026283|7648702|FG000|CCTA Diagnosis|Withdrawal by Subject|5
4718094|NCT03026283|7648703|FG001|CCTA Diagnosis|Withdrawal by Subject|0
4718095|NCT03026283|7648704|FG002|CCTA Diagnosis|Withdrawal by Subject|0
4718096|NCT03026283|7648705|FG003|CCTA Diagnosis|Withdrawal by Subject|0
4718097|NCT03026283|7648706|FG004|CCTA Diagnosis|Withdrawal by Subject|0
4718098|NCT03026283|7648707|FG005|CCTA Diagnosis|Withdrawal by Subject|0
4718099|NCT03026283|7648708|FG006|CCTA Diagnosis|Withdrawal by Subject|0
4718100|NCT03026283|7648709|FG007|CCTA Diagnosis|Withdrawal by Subject|0
4718101|NCT03026283|7648702|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
4718102|NCT03026283|7648703|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3
4718103|NCT03026283|7648704|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
4718104|NCT03026283|7648705|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
4718105|NCT03026283|7648706|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
4718106|NCT03026283|7648707|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
4718107|NCT03026283|7648708|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
4718108|NCT03026283|7648709|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
4718109|NCT03026283|7648702|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
4718110|NCT03026283|7648703|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
4718111|NCT03026283|7648704|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15
4718112|NCT03026283|7648705|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
4718113|NCT03026283|7648706|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
4718114|NCT03026283|7648707|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
4718115|NCT03026283|7648708|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
4718116|NCT03026283|7648709|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
4718117|NCT03026283|7648702|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
4718118|NCT03026283|7648703|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
4771728|NCT04256629|7748624|FG001|Overall Study|Adverse Event|0
4771729|NCT04256629|7748625|FG002|Overall Study|Adverse Event|0
4771730|NCT04256629|7748626|FG003|Overall Study|Adverse Event|0
4771731|NCT04256629|7748627|FG004|Overall Study|Adverse Event|0
4771732|NCT04256629|7748628|FG005|Overall Study|Adverse Event|1
4771733|NCT04256629|7748623|FG000|Overall Study|Protocol Violation|0
4771734|NCT04256629|7748624|FG001|Overall Study|Protocol Violation|1
4771735|NCT04256629|7748625|FG002|Overall Study|Protocol Violation|0
4771736|NCT04256629|7748626|FG003|Overall Study|Protocol Violation|0
4771737|NCT04256629|7748627|FG004|Overall Study|Protocol Violation|0
4771738|NCT04256629|7748628|FG005|Overall Study|Protocol Violation|0
4771739|NCT04014075|7748640|FG000|Overall Study|Progressive Disease|39
4771740|NCT04014075|7748640|FG000|Overall Study|Adverse Event|9
4771741|NCT04014075|7748640|FG000|Overall Study|Clinical Progression|2
4771742|NCT04014075|7748640|FG000|Overall Study|Death|2
4771743|NCT04014075|7748640|FG000|Overall Study|Withdrawal by Subject|2
4771744|NCT04014075|7748640|FG000|Overall Study|Miscellaneous|1
4771745|NCT04014075|7748640|FG000|Overall Study|Physician Decision|1
4718119|NCT03026283|7648704|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
4718120|NCT03026283|7648705|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8
4718121|NCT03026283|7648706|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11
4718122|NCT03026283|7648707|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
4718123|NCT03026283|7648708|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
4718124|NCT03026283|7648709|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
4718125|NCT03026283|7648702|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0
4718126|NCT03026283|7648703|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0
4718127|NCT03026283|7648704|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0
4718128|NCT03026283|7648705|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9
4718129|NCT03026283|7648706|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2
4718130|NCT03026283|7648707|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2
4718131|NCT03026283|7648708|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0
4718132|NCT03026283|7648709|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0
4718133|NCT03026283|7648702|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
4718134|NCT03026283|7648703|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
4718135|NCT03026283|7648704|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
4718136|NCT03026283|7648705|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2
4718137|NCT03026283|7648706|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
4718138|NCT03026283|7648707|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7
4718139|NCT03026283|7648708|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
4718140|NCT03026283|7648709|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
4718141|NCT03026283|7648702|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
4718142|NCT03026283|7648703|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
4718143|NCT03026283|7648704|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
4718144|NCT03026283|7648705|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1
4718145|NCT03026283|7648706|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
4718146|NCT03026283|7648707|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
4718147|NCT03026283|7648708|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
4718148|NCT03026283|7648709|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
4718149|NCT03026283|7648702|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
4718150|NCT03026283|7648703|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
4718151|NCT03026283|7648704|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
4718152|NCT03026283|7648705|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
4718153|NCT03026283|7648706|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25
4718154|NCT03026283|7648707|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19
4718155|NCT03026283|7648708|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
4718156|NCT03026283|7648709|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
4718157|NCT03026530|7648724|FG000|Overall Study|Lost to Follow-up|19
4718158|NCT03026530|7648725|FG001|Overall Study|Lost to Follow-up|24
4718159|NCT03026530|7648724|FG000|Overall Study|Protocol Violation|2
4718160|NCT03026530|7648725|FG001|Overall Study|Protocol Violation|5
4718161|NCT03027466|7648762|FG000|Overall Study|Opting out of the app|1869
4718162|NCT03027466|7648763|FG001|Overall Study|Opting out of the app|1819
4718163|NCT03027466|7648764|FG002|Overall Study|Opting out of the app|1743
4718164|NCT03027466|7648765|FG003|Overall Study|Opting out of the app|1821
4718165|NCT03027557|7648778|FG000|Overall Study|Adverse Event|1
4718166|NCT03027557|7648779|FG001|Overall Study|Adverse Event|0
4718167|NCT03027557|7648780|FG002|Overall Study|Adverse Event|0
4718168|NCT03028012|7648800|FG000|Overall Study|Lost to Follow-up|2
4718169|NCT03028012|7648801|FG001|Overall Study|Lost to Follow-up|3
4718170|NCT03028012|7648802|FG002|Overall Study|Lost to Follow-up|3
4718171|NCT03028129|7648835|FG000|Overall Study|Adverse Event|13
4718172|NCT03028129|7648836|FG001|Overall Study|Adverse Event|2
4718173|NCT03028129|7648835|FG000|Overall Study|Lost to Follow-up|50
4718174|NCT03028129|7648836|FG001|Overall Study|Lost to Follow-up|38
4718175|NCT03028129|7648835|FG000|Overall Study|Physician Decision|0
4718176|NCT03028129|7648836|FG001|Overall Study|Physician Decision|1
4718177|NCT03028129|7648835|FG000|Overall Study|Protocol Violation|1
4718178|NCT03028129|7648836|FG001|Overall Study|Protocol Violation|1
4718179|NCT03028129|7648835|FG000|Overall Study|Withdrawal by Subject|62
4718180|NCT03028129|7648836|FG001|Overall Study|Withdrawal by Subject|45
4718181|NCT03028142|7648842|FG000|Overall Study|Adverse Event|1
4718182|NCT03028142|7648843|FG001|Overall Study|Adverse Event|1
4718183|NCT03028142|7648844|FG002|Overall Study|Adverse Event|0
4718184|NCT03028142|7648845|FG003|Overall Study|Adverse Event|0
4718185|NCT03028142|7648846|FG004|Overall Study|Adverse Event|0
4718186|NCT03028142|7648847|FG005|Overall Study|Adverse Event|1
4718187|NCT03028142|7648842|FG000|Overall Study|Withdrawal by Subject|0
4718188|NCT03028142|7648843|FG001|Overall Study|Withdrawal by Subject|0
4718189|NCT03028142|7648844|FG002|Overall Study|Withdrawal by Subject|0
4718190|NCT03028142|7648845|FG003|Overall Study|Withdrawal by Subject|0
4718191|NCT03028142|7648846|FG004|Overall Study|Withdrawal by Subject|1
4718192|NCT03028142|7648847|FG005|Overall Study|Withdrawal by Subject|0
4718193|NCT03028415|7648880|FG000|Overall Study|Lost to Follow-up|6
4718194|NCT03028415|7648881|FG001|Overall Study|Lost to Follow-up|3
4718195|NCT03028415|7648880|FG000|Overall Study|Withdrawal by Subject|1
4718196|NCT03028415|7648881|FG001|Overall Study|Withdrawal by Subject|0
4718197|NCT03028415|7648880|FG000|Overall Study|Discontinued due to COVID-19|1
4718198|NCT03028415|7648881|FG001|Overall Study|Discontinued due to COVID-19|0
4630647|NCT01883492|7499425|FG001|Overall Study|Lost to Follow-up|4
4630648|NCT01883492|7499424|FG000|Overall Study|Surgery on contra-lateral hip|0
4630649|NCT01883492|7499425|FG001|Overall Study|Surgery on contra-lateral hip|1
4630650|NCT01883492|7499424|FG000|Overall Study|Poor X-ray quality|7
4630651|NCT01883492|7499425|FG001|Overall Study|Poor X-ray quality|4
4630652|NCT01883492|7499424|FG000|Overall Study|Withdrawal by Subject|1
4630653|NCT01883492|7499425|FG001|Overall Study|Withdrawal by Subject|0
4630654|NCT01883492|7499424|FG000|Overall Study|inappropriate implant used|1
4630655|NCT01883492|7499425|FG001|Overall Study|inappropriate implant used|1
4630656|NCT01883492|7499424|FG000|Overall Study|bone anatomy did not meet study criteria|1
4630657|NCT01883492|7499425|FG001|Overall Study|bone anatomy did not meet study criteria|1
4630658|NCT01883635|7499433|FG000|Overall Study|Withdrawal by Subject|4
4630659|NCT01883635|7499434|FG001|Overall Study|Withdrawal by Subject|0
4630660|NCT01883895|7499451|FG000|Overall Study|Lost to Follow-up|2
4718199|NCT03028870|7648921|FG000|Overall Study|Adverse Event|7
4718200|NCT03028870|7648922|FG001|Overall Study|Adverse Event|4
4718201|NCT03028870|7648923|FG002|Overall Study|Adverse Event|3
4718202|NCT03028870|7648924|FG003|Overall Study|Adverse Event|3
4718203|NCT03028870|7648921|FG000|Overall Study|Withdrawal by Subject|1
4718204|NCT03028870|7648922|FG001|Overall Study|Withdrawal by Subject|1
4718205|NCT03028870|7648923|FG002|Overall Study|Withdrawal by Subject|1
4718206|NCT03028870|7648924|FG003|Overall Study|Withdrawal by Subject|2
4718207|NCT03028870|7648921|FG000|Overall Study|Lost to Follow-up|1
4718208|NCT03028870|7648922|FG001|Overall Study|Lost to Follow-up|0
4718209|NCT03028870|7648923|FG002|Overall Study|Lost to Follow-up|0
4718210|NCT03028870|7648924|FG003|Overall Study|Lost to Follow-up|0
4718211|NCT03028870|7648921|FG000|Overall Study|Lack of Efficacy|3
4718212|NCT03028870|7648922|FG001|Overall Study|Lack of Efficacy|0
4718213|NCT03028870|7648923|FG002|Overall Study|Lack of Efficacy|0
4718214|NCT03028870|7648924|FG003|Overall Study|Lack of Efficacy|0
4718215|NCT03028870|7648921|FG000|Overall Study|Administrative|5
4718216|NCT03028870|7648922|FG001|Overall Study|Administrative|5
4718217|NCT03028870|7648923|FG002|Overall Study|Administrative|12
4718218|NCT03028870|7648924|FG003|Overall Study|Administrative|4
4718219|NCT03029143|7648978|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8
4718220|NCT03029143|7648979|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0
4718221|NCT03029143|7648980|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0
4718222|NCT03029143|7648978|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12
4718223|NCT03029143|7648979|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0
4718224|NCT03029143|7648980|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0
4718225|NCT03029143|7648978|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1
4718226|NCT03029143|7648979|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0
4718227|NCT03029143|7648980|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0
4718228|NCT03029143|7648978|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6
4718229|NCT03029143|7648979|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0
4718230|NCT03029143|7648980|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0
4718231|NCT03029143|7648978|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142
4718232|NCT03029143|7648979|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0
4718233|NCT03029143|7648980|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0
4718234|NCT03029143|7648978|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0
4718235|NCT03029143|7648979|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3
4718236|NCT03029143|7648980|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9
4718237|NCT03029143|7648978|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0
4718238|NCT03029143|7648979|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1
4718239|NCT03029143|7648980|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3
4718240|NCT03029143|7648978|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0
4718241|NCT03029143|7648979|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1
4718242|NCT03029143|7648980|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3
4718243|NCT03029143|7648978|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0
4718244|NCT03029143|7648979|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10
4718245|NCT03029143|7648980|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1
4718246|NCT03029143|7648978|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0
4718247|NCT03029143|7648979|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6
4718248|NCT03029143|7648980|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7
4718249|NCT03029143|7648978|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0
4718250|NCT03029143|7648979|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2
4718251|NCT03029143|7648980|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1
4718252|NCT03029208|7648991|FG000|Overall Study|Withdrawal by Subject|2
4630661|NCT01884025|7499470|FG000|Overall Study|Lost to Follow-up|3
4630662|NCT01884025|7499471|FG001|Overall Study|Lost to Follow-up|4
4630663|NCT01884311|7499486|FG000|Overall Study|Withdrawal by Subject|3
4718253|NCT03029208|7648992|FG001|Overall Study|Withdrawal by Subject|3
4718254|NCT03029208|7648991|FG000|Overall Study|Lost to Follow-up|0
4718255|NCT03029208|7648992|FG001|Overall Study|Lost to Follow-up|1
4718256|NCT03029247|7649009|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3
4718257|NCT03029247|7649010|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0
4718258|NCT03029247|7649009|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1
4718259|NCT03029247|7649010|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1
4718260|NCT03029247|7649009|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7
4718261|NCT03029247|7649010|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4
4718262|NCT03029247|7649009|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2
4718263|NCT03029247|7649010|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2
4718264|NCT03029585|7649018|FG000|Overall Study|Death|1
4718265|NCT03029585|7649019|FG001|Overall Study|Death|1
4718266|NCT03029585|7649018|FG000|Overall Study|Withdrawal by Subject|1
4718267|NCT03029585|7649019|FG001|Overall Study|Withdrawal by Subject|0
4718268|NCT03029624|7649025|FG000|Overall Study|Adverse Event|1
4718269|NCT03029624|7649025|FG000|Overall Study|Withdrawal by Subject|1
4718270|NCT03029624|7649025|FG000|Overall Study|Lack of Efficacy|1
4718271|NCT03029624|7649025|FG000|Overall Study|MRI need|2
4718272|NCT03029650|7649031|FG000|Washout (1 Week)|Withdrawal by Subject|1
4718273|NCT03029650|7649032|FG001|Washout (1 Week)|Withdrawal by Subject|1
4718274|NCT03029650|7649031|FG000|Washout (1 Week)|Physician Decision|0
4718275|NCT03029650|7649032|FG001|Washout (1 Week)|Physician Decision|1
4718276|NCT03029780|7649053|FG000|Overall Study|Disease Progression|1
4718277|NCT03029780|7649054|FG001|Overall Study|Disease Progression|3
4718278|NCT03029780|7649053|FG000|Overall Study|Study Drug Toxicity|5
4718279|NCT03029780|7649054|FG001|Overall Study|Study Drug Toxicity|5
4718280|NCT03029780|7649053|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0
4718281|NCT03029780|7649054|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3
4718282|NCT03029819|7649062|FG000|Overall Study|Lost to Follow-up|3
4718283|NCT03029819|7649063|FG001|Overall Study|Lost to Follow-up|5
4718284|NCT03029819|7649062|FG000|Overall Study|Removed due to disruptive behavior|0
4718285|NCT03029819|7649063|FG001|Overall Study|Removed due to disruptive behavior|1
4718286|NCT03030599|7649081|FG000|Open Label Treatment and Titration|Protocol deviation|8
4718287|NCT03030599|7649082|FG001|Open Label Treatment and Titration|Protocol deviation|0
4718288|NCT03030599|7649083|FG002|Open Label Treatment and Titration|Protocol deviation|0
4718289|NCT03030599|7649081|FG000|Open Label Treatment and Titration|Other|1
4718290|NCT03030599|7649082|FG001|Open Label Treatment and Titration|Other|0
4718291|NCT03030599|7649083|FG002|Open Label Treatment and Titration|Other|0
4718292|NCT03030599|7649081|FG000|Open Label Treatment and Titration|Physician Decision|3
4718293|NCT03030599|7649082|FG001|Open Label Treatment and Titration|Physician Decision|0
4718294|NCT03030599|7649083|FG002|Open Label Treatment and Titration|Physician Decision|0
4718295|NCT03030599|7649081|FG000|Open Label Treatment and Titration|Lack of Efficacy|1
4718296|NCT03030599|7649082|FG001|Open Label Treatment and Titration|Lack of Efficacy|0
4718297|NCT03030599|7649083|FG002|Open Label Treatment and Titration|Lack of Efficacy|0
4718298|NCT03030599|7649081|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4
4718299|NCT03030599|7649082|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0
4718300|NCT03030599|7649083|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0
4718301|NCT03030599|7649081|FG000|Open Label Treatment and Titration|Adverse Event|18
4718302|NCT03030599|7649082|FG001|Open Label Treatment and Titration|Adverse Event|0
4718303|NCT03030599|7649083|FG002|Open Label Treatment and Titration|Adverse Event|0
4718304|NCT03030599|7649081|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6
4718305|NCT03030599|7649082|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0
4718306|NCT03030599|7649083|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0
4718307|NCT03030599|7649081|FG000|Open Label Treatment and Titration|Sponsor decision|2
4718308|NCT03030599|7649082|FG001|Open Label Treatment and Titration|Sponsor decision|0
4718309|NCT03030599|7649083|FG002|Open Label Treatment and Titration|Sponsor decision|0
4718310|NCT03030599|7649081|FG000|Open Label Treatment and Titration|Lost to Follow-up|3
4718311|NCT03030599|7649082|FG001|Open Label Treatment and Titration|Lost to Follow-up|0
4718312|NCT03030599|7649083|FG002|Open Label Treatment and Titration|Lost to Follow-up|0
4718313|NCT03030599|7649081|FG000|Stable Dose|Protocol deviation|3
4718314|NCT03030599|7649082|FG001|Stable Dose|Protocol deviation|0
4718315|NCT03030599|7649083|FG002|Stable Dose|Protocol deviation|0
4718316|NCT03030599|7649081|FG000|Stable Dose|Adverse Event|1
4718317|NCT03030599|7649082|FG001|Stable Dose|Adverse Event|0
4718318|NCT03030599|7649083|FG002|Stable Dose|Adverse Event|0
4718319|NCT03030599|7649081|FG000|Stable Dose|Lost to Follow-up|1
4718320|NCT03030599|7649082|FG001|Stable Dose|Lost to Follow-up|0
4718321|NCT03030599|7649083|FG002|Stable Dose|Lost to Follow-up|0
4718322|NCT03030599|7649081|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0
4515238|NCT00951912|7325944|FG002|Overall Study|Other:Depression|0
4718323|NCT03030599|7649082|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0
4718324|NCT03030599|7649083|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2
4718325|NCT03030599|7649081|FG000|Double Blind Randomized Withdrawal|Adverse Event|0
4718326|NCT03030599|7649082|FG001|Double Blind Randomized Withdrawal|Adverse Event|0
4718327|NCT03030599|7649083|FG002|Double Blind Randomized Withdrawal|Adverse Event|3
4736276|NCT03562481|7685249|FG000|First Intervention|Lost to Follow-up|1
4718328|NCT03030599|7649081|FG000|Double Blind Randomized Withdrawal|Randomized in error|0
4718329|NCT03030599|7649082|FG001|Double Blind Randomized Withdrawal|Randomized in error|0
4718330|NCT03030599|7649083|FG002|Double Blind Randomized Withdrawal|Randomized in error|2
4718331|NCT03030599|7649081|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0
4718332|NCT03030599|7649082|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0
4718333|NCT03030599|7649083|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1
4718334|NCT03030599|7649081|FG000|Open-label Extension|Adverse Event|3
4718335|NCT03030599|7649082|FG001|Open-label Extension|Adverse Event|0
4718336|NCT03030599|7649083|FG002|Open-label Extension|Adverse Event|0
4718337|NCT03030599|7649081|FG000|Open-label Extension|Lost to Follow-up|2
4718338|NCT03030599|7649082|FG001|Open-label Extension|Lost to Follow-up|0
4718339|NCT03030599|7649083|FG002|Open-label Extension|Lost to Follow-up|0
4718340|NCT03030599|7649081|FG000|Open-label Extension|Lack of Efficacy|1
4718341|NCT03030599|7649082|FG001|Open-label Extension|Lack of Efficacy|0
4718342|NCT03030599|7649083|FG002|Open-label Extension|Lack of Efficacy|0
4718343|NCT03030599|7649081|FG000|Open-label Extension|Other Reason|1
4718344|NCT03030599|7649082|FG001|Open-label Extension|Other Reason|0
4718345|NCT03030599|7649083|FG002|Open-label Extension|Other Reason|0
4718346|NCT03030989|7649126|FG000|Overall Study|Fever|2
4718347|NCT03030989|7649127|FG001|Overall Study|Fever|2
4718348|NCT03030989|7649126|FG000|Overall Study|Rash|2
4718349|NCT03030989|7649127|FG001|Overall Study|Rash|1
4718350|NCT03030989|7649126|FG000|Overall Study|Fatigue/Overwhelmed|1
4718351|NCT03030989|7649127|FG001|Overall Study|Fatigue/Overwhelmed|5
4718352|NCT03030989|7649126|FG000|Overall Study|Positive Blood Cultures|2
4718353|NCT03030989|7649127|FG001|Overall Study|Positive Blood Cultures|1
4718354|NCT03030989|7649126|FG000|Overall Study|Line Removed|0
4718355|NCT03030989|7649127|FG001|Overall Study|Line Removed|2
4718356|NCT03030989|7649126|FG000|Overall Study|No longer interested|5
4718357|NCT03030989|7649127|FG001|Overall Study|No longer interested|3
4718358|NCT03031431|7649133|FG000|Overall Study|Infant removed by maternal request|1
4718359|NCT03031496|7649137|FG000|Period 1|Adverse Event|2
4718360|NCT03031496|7649138|FG001|Period 1|Adverse Event|0
4718361|NCT03031496|7649137|FG000|Period 1|Withdrawal by Subject|0
4718362|NCT03031496|7649138|FG001|Period 1|Withdrawal by Subject|2
4718363|NCT03031678|7649144|FG000|Overall Study|Study closed prior to completion|1
4718364|NCT03031899|7649161|FG000|Overall Study|Protocol Violation|1
4718365|NCT03031899|7649161|FG000|Overall Study|lesion disappeared after stopping habit|1
4718366|NCT03031938|7649171|FG000|Overall Study|Death|1
4718367|NCT03031938|7649172|FG001|Overall Study|Death|0
4718368|NCT03032380|7649189|FG000|Overall Study|Adverse Event|0
4718369|NCT03032380|7649190|FG001|Overall Study|Adverse Event|1
4718370|NCT03032380|7649189|FG000|Overall Study|Lack of Efficacy|1
4718371|NCT03032380|7649190|FG001|Overall Study|Lack of Efficacy|0
4718372|NCT03032380|7649189|FG000|Overall Study|Withdrawal by Subject|2
4718373|NCT03032380|7649190|FG001|Overall Study|Withdrawal by Subject|3
4718374|NCT03032380|7649189|FG000|Overall Study|Recovery|0
4718375|NCT03032380|7649190|FG001|Overall Study|Recovery|1
4718376|NCT03032380|7649189|FG000|Overall Study|Death|39
4718377|NCT03032380|7649190|FG001|Overall Study|Death|34
4718378|NCT03032380|7649189|FG000|Overall Study|Other - Miscellaneous|0
4718379|NCT03032380|7649190|FG001|Overall Study|Other - Miscellaneous|1
4718380|NCT03032523|7649207|FG000|Overall Study|Withdrawal by Subject|2
4718381|NCT03032523|7649208|FG001|Overall Study|Withdrawal by Subject|2
4718382|NCT03032523|7649207|FG000|Overall Study|Physician Decision|1
4718383|NCT03032523|7649208|FG001|Overall Study|Physician Decision|0
4718384|NCT03033394|7649248|FG000|Completed Pharmacokinetic Analysis|Missing data|1
4718385|NCT03033394|7649248|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3
4718386|NCT03033394|7649248|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1
4718387|NCT03033394|7649248|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1
4718388|NCT03033394|7649248|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1
4718389|NCT03033745|7649269|FG000|Overall Study|Protocol Violation|0
4718390|NCT03033745|7649270|FG001|Overall Study|Protocol Violation|0
4718391|NCT03033745|7649271|FG002|Overall Study|Protocol Violation|1
4718392|NCT03033745|7649269|FG000|Overall Study|Adverse Event|1
4718393|NCT03033745|7649270|FG001|Overall Study|Adverse Event|0
4718394|NCT03033745|7649271|FG002|Overall Study|Adverse Event|1
4718395|NCT03033745|7649269|FG000|Overall Study|Withdrawal by Subject|0
4718396|NCT03033745|7649270|FG001|Overall Study|Withdrawal by Subject|1
4718397|NCT03033745|7649271|FG002|Overall Study|Withdrawal by Subject|0
4718398|NCT03033784|7649288|FG000|Overall Study|Anxiety related to MRI scanner|0
4718399|NCT03033784|7649289|FG001|Overall Study|Anxiety related to MRI scanner|1
4718400|NCT03033784|7649290|FG002|Overall Study|Anxiety related to MRI scanner|0
4718401|NCT03033784|7649291|FG003|Overall Study|Anxiety related to MRI scanner|0
4718402|NCT03033784|7649292|FG004|Overall Study|Anxiety related to MRI scanner|0
4718403|NCT03033784|7649293|FG005|Overall Study|Anxiety related to MRI scanner|0
4718404|NCT03033784|7649294|FG006|Overall Study|Anxiety related to MRI scanner|0
4718405|NCT03033784|7649295|FG007|Overall Study|Anxiety related to MRI scanner|0
4718406|NCT03033784|7649296|FG008|Overall Study|Anxiety related to MRI scanner|0
4718407|NCT03033784|7649297|FG009|Overall Study|Anxiety related to MRI scanner|0
4718408|NCT03033784|7649298|FG010|Overall Study|Anxiety related to MRI scanner|0
4718409|NCT03033784|7649299|FG011|Overall Study|Anxiety related to MRI scanner|0
4718410|NCT03033784|7649300|FG012|Overall Study|Anxiety related to MRI scanner|0
4718411|NCT03033784|7649288|FG000|Overall Study|Withdrawal by Subject|0
4718412|NCT03033784|7649289|FG001|Overall Study|Withdrawal by Subject|0
4718413|NCT03033784|7649290|FG002|Overall Study|Withdrawal by Subject|0
4718414|NCT03033784|7649291|FG003|Overall Study|Withdrawal by Subject|0
4718415|NCT03033784|7649292|FG004|Overall Study|Withdrawal by Subject|0
4718416|NCT03033784|7649293|FG005|Overall Study|Withdrawal by Subject|0
4718417|NCT03033784|7649294|FG006|Overall Study|Withdrawal by Subject|0
4718418|NCT03033784|7649295|FG007|Overall Study|Withdrawal by Subject|0
4718419|NCT03033784|7649296|FG008|Overall Study|Withdrawal by Subject|0
4718420|NCT03033784|7649297|FG009|Overall Study|Withdrawal by Subject|0
4718421|NCT03033784|7649298|FG010|Overall Study|Withdrawal by Subject|0
4718422|NCT03033784|7649299|FG011|Overall Study|Withdrawal by Subject|0
4718423|NCT03033784|7649300|FG012|Overall Study|Withdrawal by Subject|2
4718424|NCT03034044|7649311|FG000|Overall Study|Enrolled, but not received Xyntha|1
4446178|NCT00481871|7231203|FG000|Overall Study|Progressive Disease - pt withdrew|0
4446179|NCT00481871|7231204|FG001|Overall Study|Progressive Disease - pt withdrew|0
4718425|NCT03034057|7649315|FG000|Overall Study|Withdrawal by Subject|10
4718426|NCT03034057|7649315|FG000|Overall Study|Protocol Violation|1
4718427|NCT03034057|7649315|FG000|Overall Study|Not defined|2
4718428|NCT03034057|7649315|FG000|Overall Study|Lost to Follow-up|19
4718429|NCT03034057|7649315|FG000|Overall Study|Adverse Event|22
4718430|NCT03034057|7649315|FG000|Overall Study|Medication error without associated AE|1
4718431|NCT03034135|7649319|FG000|Overall Study|Withdrawal by Subject|2
4718432|NCT03034460|7649325|FG000|Overall Study|Adverse Event|0
4718433|NCT03034460|7649326|FG001|Overall Study|Adverse Event|1
4718434|NCT03034460|7649325|FG000|Overall Study|Withdrawal by Subject|2
4718435|NCT03034460|7649326|FG001|Overall Study|Withdrawal by Subject|2
4718436|NCT03034460|7649325|FG000|Overall Study|Personal Reasons|1
4718437|NCT03034460|7649326|FG001|Overall Study|Personal Reasons|0
4736277|NCT03562481|7685250|FG001|First Intervention|Lost to Follow-up|0
4736278|NCT03565068|7685364|FG000|Overall Study|Protocol Violation|0
4736279|NCT03565068|7685365|FG001|Overall Study|Protocol Violation|0
4736280|NCT03565068|7685366|FG002|Overall Study|Protocol Violation|0
4736281|NCT03565068|7685367|FG003|Overall Study|Protocol Violation|0
4736282|NCT03565068|7685368|FG004|Overall Study|Protocol Violation|1
4736283|NCT03565068|7685369|FG005|Overall Study|Protocol Violation|0
4736284|NCT03565068|7685370|FG006|Overall Study|Protocol Violation|0
4736285|NCT03565068|7685371|FG007|Overall Study|Protocol Violation|1
4736286|NCT03565068|7685372|FG008|Overall Study|Protocol Violation|0
4736287|NCT03565068|7685364|FG000|Overall Study|Sponsor decision|0
4736288|NCT03565068|7685365|FG001|Overall Study|Sponsor decision|0
4736289|NCT03565068|7685366|FG002|Overall Study|Sponsor decision|0
4736290|NCT03565068|7685367|FG003|Overall Study|Sponsor decision|0
4736291|NCT03565068|7685368|FG004|Overall Study|Sponsor decision|1
4736292|NCT03565068|7685369|FG005|Overall Study|Sponsor decision|1
4736293|NCT03565068|7685370|FG006|Overall Study|Sponsor decision|0
4736294|NCT03565068|7685371|FG007|Overall Study|Sponsor decision|0
4736295|NCT03565068|7685372|FG008|Overall Study|Sponsor decision|0
4736296|NCT03565068|7685364|FG000|Overall Study|Withdrawal by Subject|0
4736297|NCT03565068|7685365|FG001|Overall Study|Withdrawal by Subject|0
4736298|NCT03565068|7685366|FG002|Overall Study|Withdrawal by Subject|1
4736299|NCT03565068|7685367|FG003|Overall Study|Withdrawal by Subject|0
4736300|NCT03565068|7685368|FG004|Overall Study|Withdrawal by Subject|2
4736301|NCT03565068|7685369|FG005|Overall Study|Withdrawal by Subject|0
4736302|NCT03565068|7685370|FG006|Overall Study|Withdrawal by Subject|1
4736303|NCT03565068|7685371|FG007|Overall Study|Withdrawal by Subject|5
4736304|NCT03565068|7685372|FG008|Overall Study|Withdrawal by Subject|1
4736305|NCT03565068|7685364|FG000|Overall Study|Physician Decision|0
4736306|NCT03565068|7685365|FG001|Overall Study|Physician Decision|0
4736307|NCT03565068|7685366|FG002|Overall Study|Physician Decision|0
4736308|NCT03565068|7685367|FG003|Overall Study|Physician Decision|0
4736309|NCT03565068|7685368|FG004|Overall Study|Physician Decision|0
4736310|NCT03565068|7685369|FG005|Overall Study|Physician Decision|0
4736311|NCT03565068|7685370|FG006|Overall Study|Physician Decision|0
4736312|NCT03565068|7685371|FG007|Overall Study|Physician Decision|1
4736313|NCT03565068|7685372|FG008|Overall Study|Physician Decision|0
4736314|NCT03565068|7685364|FG000|Overall Study|Lost to Follow-up|0
4736315|NCT03565068|7685365|FG001|Overall Study|Lost to Follow-up|0
4736316|NCT03565068|7685366|FG002|Overall Study|Lost to Follow-up|0
4736317|NCT03565068|7685367|FG003|Overall Study|Lost to Follow-up|0
4736318|NCT03565068|7685368|FG004|Overall Study|Lost to Follow-up|0
4736319|NCT03565068|7685369|FG005|Overall Study|Lost to Follow-up|0
4736320|NCT03565068|7685370|FG006|Overall Study|Lost to Follow-up|0
4736321|NCT03565068|7685371|FG007|Overall Study|Lost to Follow-up|1
4736322|NCT03565068|7685372|FG008|Overall Study|Lost to Follow-up|0
4736323|NCT03565211|7685429|FG000|Overall Study|Withdrawal by Subject|2
4736324|NCT03565211|7685429|FG000|Overall Study|Lost to Follow-up|1
4736325|NCT03565211|7685429|FG000|Overall Study|Adverse Event|44
4736326|NCT03565211|7685429|FG000|Overall Study|Personal issues|1
4736327|NCT03565315|7685437|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0
4736328|NCT03565315|7685438|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0
4718438|NCT03034577|7649338|FG000|Overall Study|Withdrawal by Subject|6
4718439|NCT03034577|7649339|FG001|Overall Study|Withdrawal by Subject|9
4718440|NCT03034577|7649338|FG000|Overall Study|Lost to Follow-up|25
4718441|NCT03034577|7649339|FG001|Overall Study|Lost to Follow-up|26
4718442|NCT03034772|7649349|FG000|Overall Study|Adverse Event|0
4718443|NCT03034772|7649350|FG001|Overall Study|Adverse Event|1
4718444|NCT03034772|7649349|FG000|Overall Study|Withdrawal by Subject|0
4718445|NCT03034772|7649350|FG001|Overall Study|Withdrawal by Subject|1
4718446|NCT03034915|7649359|FG000|Overall Study|Adverse Event|29
4718447|NCT03034915|7649360|FG001|Overall Study|Adverse Event|32
4718448|NCT03034915|7649361|FG002|Overall Study|Adverse Event|22
4718449|NCT03034915|7649359|FG000|Overall Study|Lost to Follow-up|5
4718450|NCT03034915|7649360|FG001|Overall Study|Lost to Follow-up|13
4718451|NCT03034915|7649361|FG002|Overall Study|Lost to Follow-up|3
4718452|NCT03034915|7649359|FG000|Overall Study|Withdrawal by Subject|29
4718453|NCT03034915|7649360|FG001|Overall Study|Withdrawal by Subject|46
4718454|NCT03034915|7649361|FG002|Overall Study|Withdrawal by Subject|41
4718455|NCT03034915|7649359|FG000|Overall Study|Protocol Deviation|2
4718456|NCT03034915|7649360|FG001|Overall Study|Protocol Deviation|14
4718457|NCT03034915|7649361|FG002|Overall Study|Protocol Deviation|7
4718458|NCT03034915|7649359|FG000|Overall Study|Lack of Efficacy|8
4718459|NCT03034915|7649360|FG001|Overall Study|Lack of Efficacy|16
4718460|NCT03034915|7649361|FG002|Overall Study|Lack of Efficacy|18
4718461|NCT03034915|7649359|FG000|Overall Study|Site closed|2
4718462|NCT03034915|7649360|FG001|Overall Study|Site closed|2
4718463|NCT03034915|7649361|FG002|Overall Study|Site closed|4
4718464|NCT03034915|7649359|FG000|Overall Study|Protocol-defined withdrawal criteria met|19
4718465|NCT03034915|7649360|FG001|Overall Study|Protocol-defined withdrawal criteria met|26
4718466|NCT03034915|7649361|FG002|Overall Study|Protocol-defined withdrawal criteria met|29
4718467|NCT03034915|7649359|FG000|Overall Study|Physician Decision|1
4718468|NCT03034915|7649360|FG001|Overall Study|Physician Decision|5
4718469|NCT03034915|7649361|FG002|Overall Study|Physician Decision|2
4718470|NCT03034954|7649383|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1
4718471|NCT03034954|7649384|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0
4718472|NCT03034967|7649396|FG000|Overall Study|Withdrawal by Subject|9
4718473|NCT03034967|7649397|FG001|Overall Study|Withdrawal by Subject|2
4718474|NCT03034967|7649398|FG002|Overall Study|Withdrawal by Subject|6
4718475|NCT03034967|7649399|FG003|Overall Study|Withdrawal by Subject|6
4718476|NCT03034967|7649400|FG004|Overall Study|Withdrawal by Subject|9
4718477|NCT03034967|7649401|FG005|Overall Study|Withdrawal by Subject|2
4718478|NCT03034967|7649396|FG000|Overall Study|Physician Decision|1
4718479|NCT03034967|7649397|FG001|Overall Study|Physician Decision|0
4718480|NCT03034967|7649398|FG002|Overall Study|Physician Decision|1
4718481|NCT03034967|7649399|FG003|Overall Study|Physician Decision|1
4718482|NCT03034967|7649400|FG004|Overall Study|Physician Decision|1
4718483|NCT03034967|7649401|FG005|Overall Study|Physician Decision|0
4718484|NCT03034967|7649396|FG000|Overall Study|Lost to Follow-up|0
4718485|NCT03034967|7649397|FG001|Overall Study|Lost to Follow-up|0
4718486|NCT03034967|7649398|FG002|Overall Study|Lost to Follow-up|0
4718487|NCT03034967|7649399|FG003|Overall Study|Lost to Follow-up|1
4718488|NCT03034967|7649400|FG004|Overall Study|Lost to Follow-up|0
4718489|NCT03034967|7649401|FG005|Overall Study|Lost to Follow-up|2
4718490|NCT03034967|7649396|FG000|Overall Study|Liver function test abnormality|0
4718491|NCT03034967|7649397|FG001|Overall Study|Liver function test abnormality|0
4718492|NCT03034967|7649398|FG002|Overall Study|Liver function test abnormality|1
4718493|NCT03034967|7649399|FG003|Overall Study|Liver function test abnormality|0
4718494|NCT03034967|7649400|FG004|Overall Study|Liver function test abnormality|0
4718495|NCT03034967|7649401|FG005|Overall Study|Liver function test abnormality|0
4718496|NCT03034967|7649396|FG000|Overall Study|Protocol Violation|1
4718497|NCT03034967|7649397|FG001|Overall Study|Protocol Violation|0
4718498|NCT03034967|7649398|FG002|Overall Study|Protocol Violation|0
4718499|NCT03034967|7649399|FG003|Overall Study|Protocol Violation|0
4718500|NCT03034967|7649400|FG004|Overall Study|Protocol Violation|0
4718501|NCT03034967|7649401|FG005|Overall Study|Protocol Violation|2
4718502|NCT03034967|7649396|FG000|Overall Study|Lack of Efficacy|0
4718503|NCT03034967|7649397|FG001|Overall Study|Lack of Efficacy|1
4718504|NCT03034967|7649398|FG002|Overall Study|Lack of Efficacy|2
4718505|NCT03034967|7649399|FG003|Overall Study|Lack of Efficacy|1
4718506|NCT03034967|7649400|FG004|Overall Study|Lack of Efficacy|1
4718507|NCT03034967|7649401|FG005|Overall Study|Lack of Efficacy|0
4718508|NCT03034967|7649396|FG000|Overall Study|Adverse Event, non-fatal|3
4718509|NCT03034967|7649397|FG001|Overall Study|Adverse Event, non-fatal|1
4718510|NCT03034967|7649398|FG002|Overall Study|Adverse Event, non-fatal|2
4718511|NCT03034967|7649399|FG003|Overall Study|Adverse Event, non-fatal|0
4718512|NCT03034967|7649400|FG004|Overall Study|Adverse Event, non-fatal|2
4718513|NCT03034967|7649401|FG005|Overall Study|Adverse Event, non-fatal|8
4718514|NCT03034967|7649396|FG000|Overall Study|Adverse Event, Serious Fatal|0
4718515|NCT03034967|7649397|FG001|Overall Study|Adverse Event, Serious Fatal|1
4718516|NCT03034967|7649398|FG002|Overall Study|Adverse Event, Serious Fatal|1
4718517|NCT03034967|7649399|FG003|Overall Study|Adverse Event, Serious Fatal|2
4446180|NCT00481871|7231205|FG002|Overall Study|Progressive Disease - pt withdrew|1
4718518|NCT03034967|7649400|FG004|Overall Study|Adverse Event, Serious Fatal|1
4718519|NCT03034967|7649401|FG005|Overall Study|Adverse Event, Serious Fatal|1
4718520|NCT03035032|7649420|FG000|Overall Study|Adverse Event|2
4718521|NCT03035032|7649420|FG000|Overall Study|Death|9
4718522|NCT03035032|7649420|FG000|Overall Study|Lost to Follow-up|1
4718523|NCT03035032|7649420|FG000|Overall Study|Progressive Disease|22
4718524|NCT03035032|7649420|FG000|Overall Study|Protocol Violation|2
4718525|NCT03035032|7649420|FG000|Overall Study|Withdrawal by Subject|2
4718526|NCT03035032|7649420|FG000|Overall Study|Physician Decision|5
4718527|NCT03035864|7649484|FG000|Treatment Period|Adverse Event|1
4718528|NCT03035864|7649485|FG001|Treatment Period|Adverse Event|0
4718529|NCT03035864|7649484|FG000|Treatment Period|Other|3
4718530|NCT03035864|7649485|FG001|Treatment Period|Other|1
4718531|NCT03035864|7649484|FG000|Follow-up Period|Adverse Event|1
4718532|NCT03035864|7649485|FG001|Follow-up Period|Adverse Event|0
4718533|NCT03035864|7649484|FG000|Follow-up Period|Lost to Follow-up|6
4718534|NCT03035864|7649485|FG001|Follow-up Period|Lost to Follow-up|2
4718535|NCT03035864|7649484|FG000|Follow-up Period|Physician Decision|1
4718536|NCT03035864|7649485|FG001|Follow-up Period|Physician Decision|0
4718537|NCT03035864|7649484|FG000|Follow-up Period|Other|3
4718538|NCT03035864|7649485|FG001|Follow-up Period|Other|2
4718539|NCT03035916|7649494|FG000|Overall Study|Puncture failed|0
4718540|NCT03035916|7649495|FG001|Overall Study|Puncture failed|2
4718541|NCT03035916|7649496|FG002|Overall Study|Puncture failed|0
4718542|NCT03035942|7649512|FG000|Overall Study|Adverse Event|8
4718543|NCT03035942|7649513|FG001|Overall Study|Adverse Event|4
4718544|NCT03035942|7649514|FG002|Overall Study|Adverse Event|5
4718545|NCT03036072|7649535|FG000|Overall Study|Death|0
4718546|NCT03036072|7649536|FG001|Overall Study|Death|1
4718547|NCT03036072|7649535|FG000|Overall Study|Withdrawal by Subject|0
4718548|NCT03036072|7649536|FG001|Overall Study|Withdrawal by Subject|1
4718549|NCT03036072|7649535|FG000|Overall Study|Physician Decision|0
4718550|NCT03036072|7649536|FG001|Overall Study|Physician Decision|1
4718551|NCT03036124|7649544|FG000|Overall Study|Lost to Follow-up|0
4718552|NCT03036124|7649545|FG001|Overall Study|Lost to Follow-up|2
4718553|NCT03036124|7649544|FG000|Overall Study|Withdrawal by Subject|5
4718554|NCT03036124|7649545|FG001|Overall Study|Withdrawal by Subject|4
4718555|NCT03036150|7649553|FG000|Overall Study|Withdrawal by Subject|8
4718556|NCT03036150|7649554|FG001|Overall Study|Withdrawal by Subject|3
4718557|NCT03036150|7649553|FG000|Overall Study|Lost to Follow-up|2
4718558|NCT03036150|7649554|FG001|Overall Study|Lost to Follow-up|2
4718559|NCT03036813|7649650|FG000|Overall Study|Adverse Event|6
4718560|NCT03036813|7649651|FG001|Overall Study|Adverse Event|11
4718561|NCT03036813|7649652|FG002|Overall Study|Adverse Event|6
4718562|NCT03036813|7649650|FG000|Overall Study|Withdrawal by Subject|12
4718563|NCT03036813|7649651|FG001|Overall Study|Withdrawal by Subject|6
4718564|NCT03036813|7649652|FG002|Overall Study|Withdrawal by Subject|10
4718565|NCT03036813|7649650|FG000|Overall Study|Lost to Follow-up|1
4718566|NCT03036813|7649651|FG001|Overall Study|Lost to Follow-up|1
4718567|NCT03036813|7649652|FG002|Overall Study|Lost to Follow-up|0
4718568|NCT03036813|7649650|FG000|Overall Study|Physician Decision|2
4718569|NCT03036813|7649651|FG001|Overall Study|Physician Decision|1
4718570|NCT03036813|7649652|FG002|Overall Study|Physician Decision|1
4718571|NCT03036813|7649650|FG000|Overall Study|Non-Compliance|1
4718572|NCT03036813|7649651|FG001|Overall Study|Non-Compliance|5
4718573|NCT03036813|7649652|FG002|Overall Study|Non-Compliance|3
4718574|NCT03036813|7649650|FG000|Overall Study|Pregnancy|0
4718575|NCT03036813|7649651|FG001|Overall Study|Pregnancy|0
4718576|NCT03036813|7649652|FG002|Overall Study|Pregnancy|1
4718577|NCT03036813|7649650|FG000|Overall Study|Other|0
4718578|NCT03036813|7649651|FG001|Overall Study|Other|3
4718579|NCT03036813|7649652|FG002|Overall Study|Other|5
4718580|NCT03036839|7649666|FG000|Overall Study|Adverse Event|0
4718581|NCT03036839|7649667|FG001|Overall Study|Adverse Event|0
4718582|NCT03036839|7649668|FG002|Overall Study|Adverse Event|1
4718583|NCT03036839|7649666|FG000|Overall Study|Death|3
4718584|NCT03036839|7649667|FG001|Overall Study|Death|0
4718585|NCT03036839|7649668|FG002|Overall Study|Death|3
4718586|NCT03036839|7649666|FG000|Overall Study|Withdrew Consent|0
4718587|NCT03036839|7649667|FG001|Overall Study|Withdrew Consent|0
4718588|NCT03036839|7649668|FG002|Overall Study|Withdrew Consent|1
4718589|NCT03036852|7649682|FG000|Overall Study|Death|2
4718590|NCT03036852|7649682|FG000|Overall Study|Lack of Efficacy|2
4718591|NCT03036852|7649682|FG000|Overall Study|Adverse Event|1
4718592|NCT03036852|7649682|FG000|Overall Study|Lost to Follow-up|1
4718593|NCT03037307|7649730|FG000|Period 1|Did Not Meet Study Criteria|0
4718594|NCT03037307|7649731|FG001|Period 1|Did Not Meet Study Criteria|0
4718595|NCT03037307|7649732|FG002|Period 1|Did Not Meet Study Criteria|0
4718596|NCT03037307|7649733|FG003|Period 1|Did Not Meet Study Criteria|1
4718597|NCT03037307|7649734|FG004|Period 1|Did Not Meet Study Criteria|0
4718598|NCT03037307|7649735|FG005|Period 1|Did Not Meet Study Criteria|0
4718599|NCT03037489|7649746|FG000|Overall Study|Adverse Event|4
4718600|NCT03037489|7649747|FG001|Overall Study|Adverse Event|0
4718601|NCT03037489|7649746|FG000|Overall Study|Withdrawal by Subject|3
4718602|NCT03037489|7649747|FG001|Overall Study|Withdrawal by Subject|0
4718603|NCT03037580|7649764|FG000|Overall Study|Withdrawal by Subject|3
4718604|NCT03037580|7649765|FG001|Overall Study|Withdrawal by Subject|0
4718605|NCT03037580|7649764|FG000|Overall Study|Adverse Event|1
4718606|NCT03037580|7649765|FG001|Overall Study|Adverse Event|0
4718607|NCT03037580|7649764|FG000|Overall Study|Study Terminated by Sponsor|12
4718608|NCT03037580|7649765|FG001|Overall Study|Study Terminated by Sponsor|15
4718609|NCT03037580|7649764|FG000|Overall Study|Death|0
4718610|NCT03037580|7649765|FG001|Overall Study|Death|1
4718611|NCT03037619|7649773|FG000|Overall Study|Lost to Follow-up|0
4718612|NCT03037619|7649774|FG001|Overall Study|Lost to Follow-up|1
4718613|NCT03038113|7649814|FG000|Overall Study|Withdrawal by Subject|0
4718614|NCT03038113|7649815|FG001|Overall Study|Withdrawal by Subject|0
4718615|NCT03038113|7649816|FG002|Overall Study|Withdrawal by Subject|1
4718616|NCT03038113|7649817|FG003|Overall Study|Withdrawal by Subject|0
4718617|NCT03038113|7649818|FG004|Overall Study|Withdrawal by Subject|0
4718618|NCT03038113|7649819|FG005|Overall Study|Withdrawal by Subject|0
4718619|NCT03038113|7649820|FG006|Overall Study|Withdrawal by Subject|0
4718620|NCT03038113|7649821|FG007|Overall Study|Withdrawal by Subject|0
4718621|NCT03038113|7649822|FG008|Overall Study|Withdrawal by Subject|0
4718622|NCT03038113|7649823|FG009|Overall Study|Withdrawal by Subject|0
4718623|NCT03038113|7649824|FG010|Overall Study|Withdrawal by Subject|0
4718624|NCT03038113|7649825|FG011|Overall Study|Withdrawal by Subject|0
4718625|NCT03038113|7649826|FG012|Overall Study|Withdrawal by Subject|0
4718626|NCT03038113|7649827|FG013|Overall Study|Withdrawal by Subject|1
4718627|NCT03038113|7649814|FG000|Overall Study|Lost to Follow-up|0
4718628|NCT03038113|7649815|FG001|Overall Study|Lost to Follow-up|0
4718629|NCT03038113|7649816|FG002|Overall Study|Lost to Follow-up|0
4718630|NCT03038113|7649817|FG003|Overall Study|Lost to Follow-up|0
4718631|NCT03038113|7649818|FG004|Overall Study|Lost to Follow-up|0
4718632|NCT03038113|7649819|FG005|Overall Study|Lost to Follow-up|0
4718633|NCT03038113|7649820|FG006|Overall Study|Lost to Follow-up|1
4718634|NCT03038113|7649821|FG007|Overall Study|Lost to Follow-up|0
4718635|NCT03038113|7649822|FG008|Overall Study|Lost to Follow-up|0
4718636|NCT03038113|7649823|FG009|Overall Study|Lost to Follow-up|0
4718637|NCT03038113|7649824|FG010|Overall Study|Lost to Follow-up|0
4718638|NCT03038113|7649825|FG011|Overall Study|Lost to Follow-up|0
4718639|NCT03038113|7649826|FG012|Overall Study|Lost to Follow-up|0
4718640|NCT03038113|7649827|FG013|Overall Study|Lost to Follow-up|0
4718641|NCT03038126|7649876|FG000|Overall Study|Death|1
4718642|NCT03038126|7649877|FG001|Overall Study|Death|1
4718643|NCT03038126|7649876|FG000|Overall Study|Withdrawal by Subject|5
4718644|NCT03038126|7649877|FG001|Overall Study|Withdrawal by Subject|0
4718645|NCT03038126|7649876|FG000|Overall Study|Lost to Follow-up|0
4718646|NCT03038126|7649877|FG001|Overall Study|Lost to Follow-up|1
4718647|NCT03038126|7649876|FG000|Overall Study|Long Term Hospitalization|2
4718648|NCT03038126|7649877|FG001|Overall Study|Long Term Hospitalization|0
4718649|NCT03038126|7649876|FG000|Overall Study|Too Ill to Participate|1
4718650|NCT03038126|7649877|FG001|Overall Study|Too Ill to Participate|2
4718651|NCT03038620|7649908|FG000|Overall Study|Lost to Follow-up|18
4718652|NCT03038620|7649909|FG001|Overall Study|Lost to Follow-up|23
4718653|NCT03038620|7649908|FG000|Overall Study|Withdrawal by Subject|0
4718654|NCT03038620|7649909|FG001|Overall Study|Withdrawal by Subject|15
4718655|NCT03038620|7649908|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1
4718656|NCT03038620|7649909|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0
4718657|NCT03038880|7649937|FG000|Overall Study|Death|1
4718658|NCT03038880|7649938|FG001|Overall Study|Death|2
4718659|NCT03038880|7649939|FG002|Overall Study|Death|0
4718660|NCT03038880|7649937|FG000|Overall Study|Physician Decision|2
4718661|NCT03038880|7649938|FG001|Overall Study|Physician Decision|1
4718662|NCT03038880|7649939|FG002|Overall Study|Physician Decision|0
4718663|NCT03039023|7649952|FG000|Overall Study|Withdrawal by Subject|1
4718664|NCT03039023|7649953|FG001|Overall Study|Withdrawal by Subject|0
4718665|NCT03039023|7649954|FG002|Overall Study|Withdrawal by Subject|1
4718666|NCT03039023|7649955|FG003|Overall Study|Withdrawal by Subject|1
4718667|NCT03039023|7649956|FG004|Overall Study|Withdrawal by Subject|0
4718668|NCT03039023|7649952|FG000|Overall Study|Physician Decision|0
4718669|NCT03039023|7649953|FG001|Overall Study|Physician Decision|0
4718670|NCT03039023|7649954|FG002|Overall Study|Physician Decision|0
4718671|NCT03039023|7649955|FG003|Overall Study|Physician Decision|1
4718672|NCT03039023|7649956|FG004|Overall Study|Physician Decision|0
4718673|NCT03039192|7649988|FG000|Overall Study|Lost to Follow-up|4
4718674|NCT03039192|7649989|FG001|Overall Study|Lost to Follow-up|4
4718675|NCT03039192|7649988|FG000|Overall Study|Adverse event, serious fatal|0
4718676|NCT03039192|7649989|FG001|Overall Study|Adverse event, serious fatal|1
4718677|NCT03039192|7649988|FG000|Overall Study|Adverse event, non-fatal|0
4718678|NCT03039192|7649989|FG001|Overall Study|Adverse event, non-fatal|2
4718679|NCT03039192|7649988|FG000|Overall Study|Withdrawal by Subject|6
4718680|NCT03039192|7649989|FG001|Overall Study|Withdrawal by Subject|9
4718681|NCT03039192|7649988|FG000|Overall Study|Discontinued from treatment phase|19
4718682|NCT03039192|7649989|FG001|Overall Study|Discontinued from treatment phase|12
4718683|NCT03039192|7649988|FG000|Overall Study|Other|3
4718684|NCT03039192|7649989|FG001|Overall Study|Other|2
4718685|NCT03039283|7649995|FG000|Overall Study|Protocol Violation|2
4718686|NCT03039569|7650010|FG000|Overall Study|Lost to Follow-up|5
4718687|NCT03039569|7650011|FG001|Overall Study|Lost to Follow-up|4
4718688|NCT03039621|7650020|FG000|Overall Study|Violation of inclusion criteria|3
4718689|NCT03039621|7650021|FG001|Overall Study|Violation of inclusion criteria|2
4718690|NCT03039621|7650020|FG000|Overall Study|Non-compliance with protocol requirement|4
4718691|NCT03039621|7650021|FG001|Overall Study|Non-compliance with protocol requirement|5
4718692|NCT03039621|7650020|FG000|Overall Study|Necessity to use drugs forbidden by pro|4
4718693|NCT03039621|7650021|FG001|Overall Study|Necessity to use drugs forbidden by pro|7
4718694|NCT03039621|7650020|FG000|Overall Study|Violation of non-inclusion criteria|1
4718695|NCT03039621|7650021|FG001|Overall Study|Violation of non-inclusion criteria|2
4718696|NCT03039686|7650030|FG000|Double-blind Period|Administrative Reason by Sponsor|24
4718697|NCT03039686|7650031|FG001|Double-blind Period|Administrative Reason by Sponsor|25
4718698|NCT03039686|7650032|FG002|Double-blind Period|Administrative Reason by Sponsor|21
4718699|NCT03039686|7650030|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1
4718700|NCT03039686|7650031|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2
4718701|NCT03039686|7650032|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0
4718702|NCT03039686|7650030|FG000|Double-blind Period|Withdrawal by Subject|2
4718703|NCT03039686|7650031|FG001|Double-blind Period|Withdrawal by Subject|2
4718704|NCT03039686|7650032|FG002|Double-blind Period|Withdrawal by Subject|1
4590558|NCT01522651|7436638|FG003|Overall Study|Withdrew Consent|1
4590559|NCT01522651|7436639|FG004|Overall Study|Withdrew Consent|1
4718705|NCT03039686|7650030|FG000|Double-blind Period|Death|0
4718706|NCT03039686|7650031|FG001|Double-blind Period|Death|0
4718707|NCT03039686|7650032|FG002|Double-blind Period|Death|1
4718708|NCT03039686|7650030|FG000|Open Label Period|Administrative Reason by Sponsor|0
4718709|NCT03039686|7650031|FG001|Open Label Period|Administrative Reason by Sponsor|34
4718710|NCT03039686|7650032|FG002|Open Label Period|Administrative Reason by Sponsor|41
4718711|NCT03039686|7650030|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0
4718712|NCT03039686|7650031|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1
4718713|NCT03039686|7650032|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0
4718714|NCT03039686|7650030|FG000|Open Label Period|Withdrawal by Subject|0
4718715|NCT03039686|7650031|FG001|Open Label Period|Withdrawal by Subject|3
4718716|NCT03039686|7650032|FG002|Open Label Period|Withdrawal by Subject|1
4718717|NCT03039699|7650052|FG000|Overall Study|Incorrect inclusion|5
4718718|NCT03039699|7650053|FG001|Overall Study|Incorrect inclusion|4
4718719|NCT03039699|7650052|FG000|Overall Study|Lack of data to assess study endpoint|5
4718720|NCT03039699|7650053|FG001|Overall Study|Lack of data to assess study endpoint|3
4718721|NCT03039699|7650052|FG000|Overall Study|Bacterial infection|12
4718722|NCT03039699|7650053|FG001|Overall Study|Bacterial infection|28
4718723|NCT03039738|7650061|FG000|Overall Study|Incomplete data sets|54
4718724|NCT03039738|7650062|FG001|Overall Study|Incomplete data sets|0
4718725|NCT03040024|7650084|FG000|Overall Study|Adverse Event|0
4718726|NCT03040024|7650085|FG001|Overall Study|Adverse Event|1
4718727|NCT03040024|7650086|FG002|Overall Study|Adverse Event|0
4718728|NCT03040024|7650084|FG000|Overall Study|Death|0
4718729|NCT03040024|7650085|FG001|Overall Study|Death|1
4718730|NCT03040024|7650086|FG002|Overall Study|Death|0
4718731|NCT03040024|7650084|FG000|Overall Study|Physician Decision|0
4718732|NCT03040024|7650085|FG001|Overall Study|Physician Decision|0
4718733|NCT03040024|7650086|FG002|Overall Study|Physician Decision|1
4718734|NCT03040336|7650105|FG000|Overall Study|Death|1
4718735|NCT03040336|7650106|FG001|Overall Study|Death|0
4718736|NCT03040336|7650105|FG000|Overall Study|Withdrawal by Subject|2
4718737|NCT03040336|7650106|FG001|Overall Study|Withdrawal by Subject|3
4718738|NCT03040674|7650163|FG000|Overall Study|Lost to Follow-up|225
4718739|NCT03040674|7650163|FG000|Overall Study|Death|23
4718740|NCT03040687|7650171|FG000|Overall Study|Withdrawal by Subject|1
4718741|NCT03040687|7650172|FG001|Overall Study|Withdrawal by Subject|0
4718742|NCT03040687|7650173|FG002|Overall Study|Withdrawal by Subject|0
4718743|NCT03040713|7650181|FG000|Overall Study|Positive amyloid scan|3
4718744|NCT03040986|7650191|FG000|Overall Study|Hospice|1
4718745|NCT03040986|7650192|FG001|Overall Study|Hospice|0
4718746|NCT03040986|7650191|FG000|Overall Study|Adverse Event|2
4718747|NCT03040986|7650192|FG001|Overall Study|Adverse Event|1
4718748|NCT03040986|7650191|FG000|Overall Study|Disease progression on study|3
4718749|NCT03040986|7650192|FG001|Overall Study|Disease progression on study|1
4718750|NCT03041025|7650203|FG000|Overall Study|Adverse Event|0
4718751|NCT03041025|7650204|FG001|Overall Study|Adverse Event|0
4718752|NCT03041025|7650205|FG002|Overall Study|Adverse Event|1
4718753|NCT03041025|7650203|FG000|Overall Study|Lost to Follow-up|1
4718754|NCT03041025|7650204|FG001|Overall Study|Lost to Follow-up|0
4718755|NCT03041025|7650205|FG002|Overall Study|Lost to Follow-up|0
4718756|NCT03041025|7650203|FG000|Overall Study|Withdrawal by Subject|0
4718757|NCT03041025|7650204|FG001|Overall Study|Withdrawal by Subject|0
4718758|NCT03041025|7650205|FG002|Overall Study|Withdrawal by Subject|1
4718759|NCT03041038|7650218|FG000|Overall Study|Withdrawal by Subject|4
4718760|NCT03041038|7650219|FG001|Overall Study|Withdrawal by Subject|0
4590560|NCT01522651|7436635|FG000|Overall Study|Randomized but Never Treated|0
4590561|NCT01522651|7436636|FG001|Overall Study|Randomized but Never Treated|1
4630664|NCT01884311|7499486|FG000|Overall Study|withdrew consent due to AEs|1
4718761|NCT03041038|7650218|FG000|Overall Study|Lost to Follow-up|1
4718762|NCT03041038|7650219|FG001|Overall Study|Lost to Follow-up|1
4718763|NCT03041038|7650218|FG000|Overall Study|Protocol Violation|1
4718764|NCT03041038|7650219|FG001|Overall Study|Protocol Violation|1
4718765|NCT03041090|7650229|FG000|Overall Study|technical error|0
4718766|NCT03041090|7650230|FG001|Overall Study|technical error|3
4590562|NCT01522651|7436637|FG002|Overall Study|Randomized but Never Treated|0
4718767|NCT03041116|7650238|FG000|Double-blind|Death|0
4718768|NCT03041116|7650239|FG001|Double-blind|Death|2
4718769|NCT03041116|7650238|FG000|Double-blind|Withdrawal by Subject|0
4718770|NCT03041116|7650239|FG001|Double-blind|Withdrawal by Subject|4
4718771|NCT03041116|7650238|FG000|Open-label|Death|1
4718772|NCT03041116|7650239|FG001|Open-label|Death|0
4718773|NCT03041116|7650238|FG000|Open-label|Termination of the study by Sponsor|39
4718774|NCT03041116|7650239|FG001|Open-label|Termination of the study by Sponsor|37
4718775|NCT03041116|7650238|FG000|Open-label|Withdrawal by Subject|1
4718776|NCT03041116|7650239|FG001|Open-label|Withdrawal by Subject|0
4718777|NCT03041181|7650251|FG000|Overall Study|Disease Progression|1
4718778|NCT03041181|7650252|FG001|Overall Study|Disease Progression|2
4718779|NCT03041792|7650284|FG000|Overall Study|Adverse Event|4
4718780|NCT03041792|7650285|FG001|Overall Study|Adverse Event|0
4718781|NCT03041792|7650284|FG000|Overall Study|Death in the family|0
4718782|NCT03041792|7650285|FG001|Overall Study|Death in the family|2
4718783|NCT03041792|7650284|FG000|Overall Study|Randomized but not treated|0
4718784|NCT03041792|7650285|FG001|Overall Study|Randomized but not treated|1
4718785|NCT03042312|7650336|FG000|Overall Study|Administrative Reason|1
4718786|NCT03042312|7650337|FG001|Overall Study|Administrative Reason|1
4718787|NCT03042312|7650336|FG000|Overall Study|Adverse Event|0
4718788|NCT03042312|7650337|FG001|Overall Study|Adverse Event|1
4718789|NCT03042312|7650336|FG000|Overall Study|Lost to Follow-up|1
4718790|NCT03042312|7650337|FG001|Overall Study|Lost to Follow-up|3
4718791|NCT03042312|7650336|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4
4718792|NCT03042312|7650337|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2
4718793|NCT03042312|7650336|FG000|Overall Study|Withdrawal by Subject|4
4718794|NCT03042312|7650337|FG001|Overall Study|Withdrawal by Subject|5
4718795|NCT03042559|7650345|FG000|Overall Study|drop out|1
4718796|NCT03042559|7650346|FG001|Overall Study|drop out|1
4718797|NCT03042767|7650363|FG000|Overall Study|Lost to Follow-up|1
4718798|NCT03042767|7650364|FG001|Overall Study|Lost to Follow-up|2
4718799|NCT03042910|7650370|FG000|Overall Study|Adverse Event|1
4718800|NCT03042910|7650370|FG000|Overall Study|Disease Progression|2
4718801|NCT03042910|7650370|FG000|Overall Study|Withdrawal by Subject|3
4718802|NCT03042910|7650370|FG000|Overall Study|Enrolled but not treated|1
4718803|NCT03043365|7650403|FG000|Weeks 0 to Week 8|Adverse Event|1
4718804|NCT03043365|7650404|FG001|Weeks 0 to Week 8|Adverse Event|3
4718805|NCT03043365|7650403|FG000|Weeks 0 to Week 8|Lost to Follow-up|2
4718806|NCT03043365|7650404|FG001|Weeks 0 to Week 8|Lost to Follow-up|0
4718807|NCT03043365|7650403|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1
4718808|NCT03043365|7650404|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0
4718809|NCT03043560|7650423|FG000|Overall Study|Discontinued Intervention|1
4718810|NCT03043560|7650424|FG001|Overall Study|Discontinued Intervention|2
4718811|NCT03043560|7650423|FG000|Overall Study|Lost to Follow-up|0
4718812|NCT03043560|7650424|FG001|Overall Study|Lost to Follow-up|1
4718813|NCT03043651|7650430|FG000|Overall Study|Death|1
4718814|NCT03043651|7650430|FG000|Overall Study|Progressive Disease|2
4718815|NCT03043651|7650430|FG000|Overall Study|Adverse Event|2
4718816|NCT03043651|7650430|FG000|Overall Study|Withdrawal by Subject|4
4718817|NCT03043651|7650430|FG000|Overall Study|Study Terminated by Sponsor|39
4718818|NCT03044106|7650465|FG000|Washout (1 Week)|Withdrawal by Subject|0
4718819|NCT03044106|7650466|FG001|Washout (1 Week)|Withdrawal by Subject|2
4718820|NCT03044197|7650481|FG000|Overall Study|Withdrawal by Subject|3
4718821|NCT03044197|7650482|FG001|Overall Study|Withdrawal by Subject|1
4718822|NCT03044249|7650490|FG000|Overall Study|Adverse Event|4
4718823|NCT03044249|7650491|FG001|Overall Study|Adverse Event|9
4718824|NCT03044249|7650490|FG000|Overall Study|Lost to Follow-up|1
4718825|NCT03044249|7650491|FG001|Overall Study|Lost to Follow-up|0
4718826|NCT03044249|7650490|FG000|Overall Study|Non-compliance with Study Drug|1
4718827|NCT03044249|7650491|FG001|Overall Study|Non-compliance with Study Drug|0
4718828|NCT03044249|7650490|FG000|Overall Study|Study Terminated by Sponsor|2
4718829|NCT03044249|7650491|FG001|Overall Study|Study Terminated by Sponsor|0
4718830|NCT03044249|7650490|FG000|Overall Study|Withdrawal by Subject|2
4718831|NCT03044249|7650491|FG001|Overall Study|Withdrawal by Subject|5
4718832|NCT03044353|7650505|FG000|Overall Study|Adverse Event|0
4718833|NCT03044353|7650506|FG001|Overall Study|Adverse Event|1
4718834|NCT03044353|7650507|FG002|Overall Study|Adverse Event|0
4736329|NCT03565315|7685439|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0
4736330|NCT03565315|7685440|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1
4736331|NCT03565887|7685489|FG000|Overall Study|Adverse Event|1
4736332|NCT03565887|7685490|FG001|Overall Study|Adverse Event|0
4736333|NCT03565887|7685489|FG000|Overall Study|Withdrawal by Subject|0
4736334|NCT03565887|7685490|FG001|Overall Study|Withdrawal by Subject|2
4736335|NCT03566238|7685499|FG000|Overall Study|Adverse Event|0
4736336|NCT03566238|7685500|FG001|Overall Study|Adverse Event|1
4736337|NCT03566238|7685501|FG002|Overall Study|Adverse Event|0
4736338|NCT03566238|7685499|FG000|Overall Study|Lack of Efficacy|4
4736339|NCT03566238|7685500|FG001|Overall Study|Lack of Efficacy|2
4736340|NCT03566238|7685501|FG002|Overall Study|Lack of Efficacy|5
4736341|NCT03566238|7685499|FG000|Overall Study|Other|1
4736342|NCT03566238|7685500|FG001|Overall Study|Other|0
4736343|NCT03566238|7685501|FG002|Overall Study|Other|0
4736344|NCT03566485|7685511|FG000|Overall Study|Disease progression|5
4718835|NCT03044431|7650518|FG000|Overall Study|Lost to Follow-up|59
4718836|NCT03044574|7650524|FG000|Overall Study|Lost to Follow-up|37
4718837|NCT03044574|7650525|FG001|Overall Study|Lost to Follow-up|45
4718838|NCT03044730|7650540|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1
4718839|NCT03044730|7650540|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1
4718840|NCT03044730|7650540|FG000|3 Cycles of Pembro + Capecitab|Death|1
4718841|NCT03044730|7650540|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1
4718842|NCT03044730|7650540|FG000|Cycles 4 and Beyond|Progressive Disease|9
4718843|NCT03044730|7650540|FG000|Cycles 4 and Beyond|Adverse Event|1
4718844|NCT03044730|7650540|FG000|On Follow-up for 2 Years|Still in follow-up|7
4718845|NCT03044730|7650540|FG000|On Follow-up for 2 Years|Lost to Follow-up|1
4718846|NCT03044730|7650540|FG000|On Follow-up for 2 Years|Death|17
4718847|NCT03044886|7650548|FG000|Overall Study|Lost to Follow-up|15
4718848|NCT03044886|7650549|FG001|Overall Study|Lost to Follow-up|10
4718849|NCT03044886|7650550|FG002|Overall Study|Lost to Follow-up|12
4718850|NCT03045081|7650560|FG000|Overall Study|Withdrawal by Subject|6
4718851|NCT03045081|7650561|FG001|Overall Study|Withdrawal by Subject|11
4718852|NCT03045302|7650567|FG000|Overall Study|Pre-treatment adverse event|1
4718853|NCT03045328|7650571|FG000|Overall Study|Withdrawal by Subject|2
4718854|NCT03045887|7650609|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3
4718855|NCT03045887|7650610|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
4718856|NCT03045887|7650611|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
4718857|NCT03045887|7650612|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
4718858|NCT03045887|7650613|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
4718859|NCT03045887|7650614|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
4718860|NCT03045887|7650615|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
4718861|NCT03045887|7650616|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
4718862|NCT03045887|7650617|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
4718863|NCT03045887|7650618|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
4718864|NCT03045887|7650609|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
4718865|NCT03045887|7650610|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
4718866|NCT03045887|7650611|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
4718867|NCT03045887|7650612|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1
4718868|NCT03045887|7650613|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
4718869|NCT03045887|7650614|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
4718870|NCT03045887|7650615|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
4718871|NCT03045887|7650616|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
4718872|NCT03045887|7650617|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
4718873|NCT03045887|7650618|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
4718874|NCT03045887|7650609|FG000|Part A, Period 2 (1 Day)|Adverse Event|1
4718875|NCT03045887|7650610|FG001|Part A, Period 2 (1 Day)|Adverse Event|0
4718876|NCT03045887|7650611|FG002|Part A, Period 2 (1 Day)|Adverse Event|0
4718877|NCT03045887|7650612|FG003|Part A, Period 2 (1 Day)|Adverse Event|0
4718878|NCT03045887|7650613|FG004|Part A, Period 2 (1 Day)|Adverse Event|0
4718879|NCT03045887|7650614|FG005|Part A, Period 2 (1 Day)|Adverse Event|0
4718880|NCT03045887|7650615|FG006|Part A, Period 2 (1 Day)|Adverse Event|0
4718881|NCT03045887|7650616|FG007|Part A, Period 2 (1 Day)|Adverse Event|0
4718882|NCT03045887|7650617|FG008|Part A, Period 2 (1 Day)|Adverse Event|0
4718883|NCT03045887|7650618|FG009|Part A, Period 2 (1 Day)|Adverse Event|0
4718884|NCT03045887|7650609|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
4718885|NCT03045887|7650610|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
4718886|NCT03045887|7650611|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1
4718887|NCT03045887|7650612|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1
4718888|NCT03045887|7650613|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
4718889|NCT03045887|7650614|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
4718890|NCT03045887|7650615|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
4718891|NCT03045887|7650616|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
4718892|NCT03045887|7650617|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
4718893|NCT03045887|7650618|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
4718894|NCT03045887|7650609|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
4718895|NCT03045887|7650610|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
4718896|NCT03045887|7650611|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
4718897|NCT03045887|7650612|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1
4718898|NCT03045887|7650613|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
4718899|NCT03045887|7650614|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
4718900|NCT03045887|7650615|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
4718901|NCT03045887|7650616|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
4718902|NCT03045887|7650617|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
4718903|NCT03045887|7650618|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
4718904|NCT03046056|7650652|FG000|Overall Study|Non-responder at Week 10|6
4718905|NCT03046056|7650653|FG001|Overall Study|Non-responder at Week 10|6
4718906|NCT03046056|7650654|FG002|Overall Study|Non-responder at Week 10|4
4718907|NCT03046056|7650652|FG000|Overall Study|Protocol-specified Disease Worsening|3
4718908|NCT03046056|7650653|FG001|Overall Study|Protocol-specified Disease Worsening|3
4718909|NCT03046056|7650654|FG002|Overall Study|Protocol-specified Disease Worsening|1
4718910|NCT03046056|7650652|FG000|Overall Study|Adverse Event|1
4718911|NCT03046056|7650653|FG001|Overall Study|Adverse Event|5
4718912|NCT03046056|7650654|FG002|Overall Study|Adverse Event|0
4718913|NCT03046056|7650652|FG000|Overall Study|Non-compliance With Study Drug|0
4718914|NCT03046056|7650653|FG001|Overall Study|Non-compliance With Study Drug|0
4718915|NCT03046056|7650654|FG002|Overall Study|Non-compliance With Study Drug|2
4718916|NCT03046056|7650652|FG000|Overall Study|Protocol Violation|1
4718917|NCT03046056|7650653|FG001|Overall Study|Protocol Violation|1
4718918|NCT03046056|7650654|FG002|Overall Study|Protocol Violation|0
4718919|NCT03046056|7650652|FG000|Overall Study|Investigator's Discretion|0
4718920|NCT03046056|7650653|FG001|Overall Study|Investigator's Discretion|1
4718921|NCT03046056|7650654|FG002|Overall Study|Investigator's Discretion|0
4718922|NCT03046056|7650652|FG000|Overall Study|Withdrew Consent|1
4718923|NCT03046056|7650653|FG001|Overall Study|Withdrew Consent|0
4718924|NCT03046056|7650654|FG002|Overall Study|Withdrew Consent|0
4718925|NCT03046446|7650680|FG000|Overall Study|Lack of Efficacy|7
4718926|NCT03046446|7650680|FG000|Overall Study|Adverse Event|6
4718927|NCT03046446|7650680|FG000|Overall Study|Lost to Follow-up|3
4718928|NCT03046446|7650680|FG000|Overall Study|Withdrawal by Subject|14
4718929|NCT03046446|7650680|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3
4718930|NCT03046446|7650680|FG000|Overall Study|Disease Progression (see caveats)|25
4718931|NCT03046446|7650680|FG000|Overall Study|Non OA related knee surgery|1
4718932|NCT03047551|7650743|FG000|Overall Study|Did not receive TAS|1
4718933|NCT03047551|7650744|FG001|Overall Study|Did not receive TAS|0
4718934|NCT03047551|7650743|FG000|Overall Study|Physician Decision|1
4718935|NCT03047551|7650744|FG001|Overall Study|Physician Decision|0
4718936|NCT03047551|7650743|FG000|Overall Study|Withdrawal by Subject|0
4718937|NCT03047551|7650744|FG001|Overall Study|Withdrawal by Subject|1
4718938|NCT03047551|7650743|FG000|Overall Study|Probe malfunction|0
4718939|NCT03047551|7650744|FG001|Overall Study|Probe malfunction|1
4718940|NCT03047551|7650743|FG000|Overall Study|Ineligible|0
4718941|NCT03047551|7650744|FG001|Overall Study|Ineligible|1
4718942|NCT03047720|7650752|FG000|First Intervention (6weeks)|Participant data entry insufficient|7
4718943|NCT03047720|7650753|FG001|First Intervention (6weeks)|Participant data entry insufficient|0
4718944|NCT03047980|7650759|FG000|Overall Study|Adverse Event|1
4718945|NCT03048058|7650769|FG000|Overall Study|Lost to Follow-up|4
4718946|NCT03048058|7650770|FG001|Overall Study|Lost to Follow-up|0
4718947|NCT03048058|7650769|FG000|Overall Study|Withdrawal by Subject|0
4718948|NCT03048058|7650770|FG001|Overall Study|Withdrawal by Subject|4
4718949|NCT03048500|7650789|FG000|2 Cycles of Treatment|Withdrawal by Subject|1
4718950|NCT03048500|7650789|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4
4718951|NCT03048500|7650789|FG000|Reached 1st Response/Continued Treatment|Death|1
4718952|NCT03048500|7650789|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1
4718953|NCT03048500|7650789|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1
4718954|NCT03048500|7650789|FG000|Follow up for 3 Years|Currently in Follow-up|4
4718955|NCT03048500|7650789|FG000|Follow up for 3 Years|Death|12
4718956|NCT03048747|7650793|FG000|Overall Study|Adverse Event|2
4718957|NCT03048747|7650793|FG000|Overall Study|Participant Met Withdrawal Criteria|2
4718958|NCT03048747|7650793|FG000|Overall Study|Physician Decision|1
4718959|NCT03049280|7650807|FG000|Overall Study|Physician Decision|1
4718960|NCT03049488|7650819|FG000|Overall Study|Lost to Follow-up|1
4718961|NCT03049488|7650820|FG001|Overall Study|Lost to Follow-up|1
4718962|NCT03049488|7650821|FG002|Overall Study|Lost to Follow-up|0
4718963|NCT03049488|7650822|FG003|Overall Study|Lost to Follow-up|0
4718964|NCT03049488|7650823|FG004|Overall Study|Lost to Follow-up|0
4718965|NCT03049488|7650824|FG005|Overall Study|Lost to Follow-up|0
4718966|NCT03049488|7650819|FG000|Overall Study|Moved from Area|1
4718967|NCT03049488|7650820|FG001|Overall Study|Moved from Area|0
4718968|NCT03049488|7650821|FG002|Overall Study|Moved from Area|0
4718969|NCT03049488|7650822|FG003|Overall Study|Moved from Area|1
4718970|NCT03049488|7650823|FG004|Overall Study|Moved from Area|1
4718971|NCT03049488|7650824|FG005|Overall Study|Moved from Area|0
4718972|NCT03049488|7650819|FG000|Overall Study|Physician Decision|0
4718973|NCT03049488|7650820|FG001|Overall Study|Physician Decision|1
4718974|NCT03049488|7650821|FG002|Overall Study|Physician Decision|0
4718975|NCT03049488|7650822|FG003|Overall Study|Physician Decision|0
4718976|NCT03049488|7650823|FG004|Overall Study|Physician Decision|0
4718977|NCT03049488|7650824|FG005|Overall Study|Physician Decision|0
4718978|NCT03049488|7650819|FG000|Overall Study|Withdrawal by Subject|0
4718979|NCT03049488|7650820|FG001|Overall Study|Withdrawal by Subject|0
4718980|NCT03049488|7650821|FG002|Overall Study|Withdrawal by Subject|0
4718981|NCT03049488|7650822|FG003|Overall Study|Withdrawal by Subject|1
4718982|NCT03049488|7650823|FG004|Overall Study|Withdrawal by Subject|1
4718983|NCT03049488|7650824|FG005|Overall Study|Withdrawal by Subject|0
4718984|NCT03049748|7650850|FG000|Overall Study|Lost to Follow-up|1
4718985|NCT03049748|7650851|FG001|Overall Study|Lost to Follow-up|0
4718986|NCT03049748|7650850|FG000|Overall Study|Death|3
4718987|NCT03049748|7650851|FG001|Overall Study|Death|0
4718988|NCT03049748|7650850|FG000|Overall Study|Withdrawal by Subject|0
4718989|NCT03049748|7650851|FG001|Overall Study|Withdrawal by Subject|3
4718990|NCT03049748|7650850|FG000|Overall Study|Protocol Violation|0
4718991|NCT03049748|7650851|FG001|Overall Study|Protocol Violation|2
4718992|NCT03049748|7650850|FG000|Overall Study|Moved out of state (relocation)|0
4718993|NCT03049748|7650851|FG001|Overall Study|Moved out of state (relocation)|1
4718994|NCT03049852|7650860|FG000|Overall Study|Lost to Follow-up|0
4718995|NCT03049852|7650861|FG001|Overall Study|Lost to Follow-up|1
4718996|NCT03049852|7650862|FG002|Overall Study|Lost to Follow-up|0
4718997|NCT03050307|7650947|FG000|Overall Study|Adverse Event|4
4718998|NCT03050307|7650948|FG001|Overall Study|Adverse Event|2
4718999|NCT03050307|7650947|FG000|Overall Study|Significant Protocol Deviation|0
4719000|NCT03050307|7650948|FG001|Overall Study|Significant Protocol Deviation|1
4719001|NCT03050307|7650947|FG000|Overall Study|Lost to Follow-up|0
4719002|NCT03050307|7650948|FG001|Overall Study|Lost to Follow-up|1
4719003|NCT03050307|7650947|FG000|Overall Study|Voluntary Withdrawal|3
4719004|NCT03050307|7650948|FG001|Overall Study|Voluntary Withdrawal|4
4719005|NCT03050307|7650947|FG000|Overall Study|Reason not Specified|1
4719006|NCT03050307|7650948|FG001|Overall Study|Reason not Specified|1
4719007|NCT03050359|7650967|FG000|Overall Study|Randomized But Not Treated|2
4719008|NCT03050359|7650968|FG001|Overall Study|Randomized But Not Treated|0
4719009|NCT03050359|7650967|FG000|Overall Study|Pretreatment Event/Adverse Event|5
4719010|NCT03050359|7650968|FG001|Overall Study|Pretreatment Event/Adverse Event|10
4719011|NCT03050359|7650967|FG000|Overall Study|Significant Protocol Deviation|2
4719012|NCT03050359|7650968|FG001|Overall Study|Significant Protocol Deviation|3
4719013|NCT03050359|7650967|FG000|Overall Study|Lost to Follow-up|2
4630665|NCT01884311|7499486|FG000|Overall Study|Precautionary measure|1
4630666|NCT01884337|7499495|FG000|Treatment|Adverse Event|2
4719014|NCT03050359|7650968|FG001|Overall Study|Lost to Follow-up|1
4719015|NCT03050359|7650967|FG000|Overall Study|Voluntary Withdrawal|4
4719016|NCT03050359|7650968|FG001|Overall Study|Voluntary Withdrawal|6
4719017|NCT03050359|7650967|FG000|Overall Study|Pregnancy|1
4719018|NCT03050359|7650968|FG001|Overall Study|Pregnancy|0
4719019|NCT03050359|7650967|FG000|Overall Study|Reason Not Specified|1
4719020|NCT03050359|7650968|FG001|Overall Study|Reason Not Specified|0
4719021|NCT03050372|7650976|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1
4719022|NCT03050372|7650977|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0
4719023|NCT03050372|7650976|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0
4719024|NCT03050372|7650977|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1
4719025|NCT03050450|7650987|FG000|Overall Study|Physician Decision|1
4719026|NCT03050450|7650988|FG001|Overall Study|Physician Decision|0
4719027|NCT03050450|7650989|FG002|Overall Study|Physician Decision|0
4719028|NCT03050450|7650990|FG003|Overall Study|Physician Decision|0
4719029|NCT03050450|7650991|FG004|Overall Study|Physician Decision|0
4719030|NCT03050801|7651072|FG000|Experiment 1|Lost to Follow-up|0
4719031|NCT03050801|7651073|FG001|Experiment 1|Lost to Follow-up|1
4719032|NCT03050801|7651074|FG002|Experiment 1|Lost to Follow-up|0
4719033|NCT03050801|7651075|FG003|Experiment 1|Lost to Follow-up|0
4719034|NCT03050801|7651076|FG004|Experiment 1|Lost to Follow-up|0
4719035|NCT03050801|7651077|FG005|Experiment 1|Lost to Follow-up|0
4719036|NCT03050801|7651072|FG000|Experiment 1|Physician Decision|0
4719037|NCT03050801|7651073|FG001|Experiment 1|Physician Decision|3
4719038|NCT03050801|7651074|FG002|Experiment 1|Physician Decision|0
4719039|NCT03050801|7651075|FG003|Experiment 1|Physician Decision|0
4719040|NCT03050801|7651076|FG004|Experiment 1|Physician Decision|0
4719041|NCT03050801|7651077|FG005|Experiment 1|Physician Decision|0
4719042|NCT03050801|7651072|FG000|Experiment 1|Change of experimental design|0
4719043|NCT03050801|7651073|FG001|Experiment 1|Change of experimental design|3
4719044|NCT03050801|7651074|FG002|Experiment 1|Change of experimental design|0
4719045|NCT03050801|7651075|FG003|Experiment 1|Change of experimental design|0
4719046|NCT03050801|7651076|FG004|Experiment 1|Change of experimental design|0
4719047|NCT03050801|7651077|FG005|Experiment 1|Change of experimental design|0
4719048|NCT03050801|7651072|FG000|Experiment 1|Unable to obtain critical rTMS measure|0
4719049|NCT03050801|7651073|FG001|Experiment 1|Unable to obtain critical rTMS measure|0
4719050|NCT03050801|7651074|FG002|Experiment 1|Unable to obtain critical rTMS measure|2
4719051|NCT03050801|7651075|FG003|Experiment 1|Unable to obtain critical rTMS measure|0
4719052|NCT03050801|7651076|FG004|Experiment 1|Unable to obtain critical rTMS measure|0
4719053|NCT03050801|7651077|FG005|Experiment 1|Unable to obtain critical rTMS measure|0
4719054|NCT03050801|7651072|FG000|Experiment 2|Lost to Follow-up|0
4719055|NCT03050801|7651073|FG001|Experiment 2|Lost to Follow-up|0
4719056|NCT03050801|7651074|FG002|Experiment 2|Lost to Follow-up|0
4719057|NCT03050801|7651075|FG003|Experiment 2|Lost to Follow-up|1
4719058|NCT03050801|7651076|FG004|Experiment 2|Lost to Follow-up|1
4719059|NCT03050801|7651077|FG005|Experiment 2|Lost to Follow-up|0
4719060|NCT03050801|7651072|FG000|Experiment 2|Physician Decision|0
4719061|NCT03050801|7651073|FG001|Experiment 2|Physician Decision|0
4719062|NCT03050801|7651074|FG002|Experiment 2|Physician Decision|0
4719063|NCT03050801|7651075|FG003|Experiment 2|Physician Decision|0
4719064|NCT03050801|7651076|FG004|Experiment 2|Physician Decision|1
4719065|NCT03050801|7651077|FG005|Experiment 2|Physician Decision|0
4719066|NCT03050801|7651072|FG000|Experiment 2|Pregnancy|0
4719067|NCT03050801|7651073|FG001|Experiment 2|Pregnancy|0
4719068|NCT03050801|7651074|FG002|Experiment 2|Pregnancy|0
4719069|NCT03050801|7651075|FG003|Experiment 2|Pregnancy|0
4630667|NCT01884337|7499496|FG001|Treatment|Adverse Event|2
4719070|NCT03050801|7651076|FG004|Experiment 2|Pregnancy|1
4719071|NCT03050801|7651077|FG005|Experiment 2|Pregnancy|0
4719072|NCT03050801|7651072|FG000|Experiment 2|Withdrawal by Subject|0
4719073|NCT03050801|7651073|FG001|Experiment 2|Withdrawal by Subject|0
4719074|NCT03050801|7651074|FG002|Experiment 2|Withdrawal by Subject|0
4719075|NCT03050801|7651075|FG003|Experiment 2|Withdrawal by Subject|1
4719076|NCT03050801|7651076|FG004|Experiment 2|Withdrawal by Subject|0
4719077|NCT03050801|7651077|FG005|Experiment 2|Withdrawal by Subject|0
4719078|NCT03050801|7651072|FG000|Experiment 2|Poor data quality|0
4719079|NCT03050801|7651073|FG001|Experiment 2|Poor data quality|0
4719080|NCT03050801|7651074|FG002|Experiment 2|Poor data quality|0
4719081|NCT03050801|7651075|FG003|Experiment 2|Poor data quality|4
4719082|NCT03050801|7651076|FG004|Experiment 2|Poor data quality|1
4719083|NCT03050801|7651077|FG005|Experiment 2|Poor data quality|0
4719084|NCT03050801|7651072|FG000|Experiment 2|Discomfort during stimulation|0
4719085|NCT03050801|7651073|FG001|Experiment 2|Discomfort during stimulation|0
4719086|NCT03050801|7651074|FG002|Experiment 2|Discomfort during stimulation|0
4719087|NCT03050801|7651075|FG003|Experiment 2|Discomfort during stimulation|0
4719088|NCT03050801|7651076|FG004|Experiment 2|Discomfort during stimulation|0
4719089|NCT03050801|7651077|FG005|Experiment 2|Discomfort during stimulation|2
4719090|NCT03051100|7651105|FG000|Overall Study|Withdrawal by Subject|1
4719091|NCT03051100|7651106|FG001|Overall Study|Withdrawal by Subject|0
4719092|NCT03051165|7651112|FG000|Overall Study|Withdrawal by Subject|1
4719093|NCT03051165|7651112|FG000|Overall Study|Early termination of study|12
4719094|NCT03051607|7651130|FG000|Overall Study|Adverse Event|66
4719095|NCT03051620|7651134|FG000|Overall Study|Lost to Follow-up|6
4719096|NCT03051620|7651134|FG000|Overall Study|n=124 enrolled in extension (all completed)|12
4719097|NCT03052322|7651174|FG000|Overall Study|Other un-specified|1
4719098|NCT03052322|7651175|FG001|Overall Study|Other un-specified|2
4719099|NCT03052322|7651174|FG000|Overall Study|Withdrawal by Subject|10
4719100|NCT03052322|7651175|FG001|Overall Study|Withdrawal by Subject|9
4719101|NCT03052322|7651174|FG000|Overall Study|Death|0
4719102|NCT03052322|7651175|FG001|Overall Study|Death|2
4719103|NCT03052322|7651174|FG000|Overall Study|Lack of Efficacy|1
4719104|NCT03052322|7651175|FG001|Overall Study|Lack of Efficacy|2
4719105|NCT03052322|7651174|FG000|Overall Study|Protocol Violation|1
4719106|NCT03052322|7651175|FG001|Overall Study|Protocol Violation|0
4719107|NCT03052322|7651174|FG000|Overall Study|Lost to Follow-up|2
4719108|NCT03052322|7651175|FG001|Overall Study|Lost to Follow-up|4
4719109|NCT03052322|7651174|FG000|Overall Study|Adverse Event|6
4719110|NCT03052322|7651175|FG001|Overall Study|Adverse Event|13
4719111|NCT03052426|7651184|FG000|Overall Study|Withdrawal by Subject|0
4719112|NCT03052426|7651185|FG001|Overall Study|Withdrawal by Subject|1
4719113|NCT03052426|7651186|FG002|Overall Study|Withdrawal by Subject|0
4719114|NCT03052426|7651184|FG000|Overall Study|Lost to Follow-up|2
4719115|NCT03052426|7651185|FG001|Overall Study|Lost to Follow-up|0
4719116|NCT03052426|7651186|FG002|Overall Study|Lost to Follow-up|1
4719117|NCT03052517|7651202|FG000|Overall Study|Study Terminated By Sponsor|928
4719118|NCT03052517|7651203|FG001|Overall Study|Study Terminated By Sponsor|938
4719119|NCT03052517|7651204|FG002|Overall Study|Study Terminated By Sponsor|296
4719120|NCT03052517|7651202|FG000|Overall Study|Subject/Guardian Decision|50
4719121|NCT03052517|7651203|FG001|Overall Study|Subject/Guardian Decision|45
4719122|NCT03052517|7651204|FG002|Overall Study|Subject/Guardian Decision|22
4719123|NCT03052517|7651202|FG000|Overall Study|Lack of Efficacy|23
4719124|NCT03052517|7651203|FG001|Overall Study|Lack of Efficacy|14
4719125|NCT03052517|7651204|FG002|Overall Study|Lack of Efficacy|7
4719126|NCT03052517|7651202|FG000|Overall Study|Adverse Event|6
4719127|NCT03052517|7651203|FG001|Overall Study|Adverse Event|5
4719128|NCT03052517|7651204|FG002|Overall Study|Adverse Event|0
4719129|NCT03052517|7651202|FG000|Overall Study|Physician Decision|4
4719130|NCT03052517|7651203|FG001|Overall Study|Physician Decision|5
4719131|NCT03052517|7651204|FG002|Overall Study|Physician Decision|1
4719132|NCT03052517|7651202|FG000|Overall Study|Death|3
4719133|NCT03052517|7651203|FG001|Overall Study|Death|0
4719134|NCT03052517|7651204|FG002|Overall Study|Death|1
4719135|NCT03052517|7651202|FG000|Overall Study|Lost to Follow-up|2
4719136|NCT03052517|7651203|FG001|Overall Study|Lost to Follow-up|4
4719137|NCT03052517|7651204|FG002|Overall Study|Lost to Follow-up|0
4719138|NCT03052517|7651202|FG000|Overall Study|Pregnancy|1
4719139|NCT03052517|7651203|FG001|Overall Study|Pregnancy|0
4719140|NCT03052517|7651204|FG002|Overall Study|Pregnancy|1
4719141|NCT03052517|7651202|FG000|Overall Study|Non-Compliance With Study Treatment|0
4719142|NCT03052517|7651203|FG001|Overall Study|Non-Compliance With Study Treatment|2
4719143|NCT03052517|7651204|FG002|Overall Study|Non-Compliance With Study Treatment|0
4719144|NCT03052517|7651202|FG000|Overall Study|Technical Problems|0
4719145|NCT03052517|7651203|FG001|Overall Study|Technical Problems|1
4719146|NCT03052517|7651204|FG002|Overall Study|Technical Problems|0
4719147|NCT03052725|7651218|FG000|Overall Study|Adverse Event|2
4719148|NCT03052725|7651219|FG001|Overall Study|Adverse Event|0
4719149|NCT03052725|7651218|FG000|Overall Study|Withdrawal by Subject|3
4719150|NCT03052725|7651219|FG001|Overall Study|Withdrawal by Subject|4
4719151|NCT03052725|7651218|FG000|Overall Study|Pregnancy|0
4719152|NCT03052725|7651219|FG001|Overall Study|Pregnancy|1
4719153|NCT03052725|7651218|FG000|Overall Study|Site closure|0
4719154|NCT03052725|7651219|FG001|Overall Study|Site closure|1
4719155|NCT03052725|7651218|FG000|Overall Study|Study terminated by sponsor|143
4719156|NCT03052725|7651219|FG001|Overall Study|Study terminated by sponsor|144
4719157|NCT03052751|7651226|FG000|Dosing Period 1|Adverse Event|0
4719158|NCT03052751|7651227|FG001|Dosing Period 1|Adverse Event|1
4719159|NCT03052751|7651228|FG002|Dosing Period 1|Adverse Event|0
4719160|NCT03052751|7651229|FG003|Dosing Period 1|Adverse Event|0
4719161|NCT03052751|7651230|FG004|Dosing Period 1|Adverse Event|0
4719162|NCT03052751|7651231|FG005|Dosing Period 1|Adverse Event|0
4719163|NCT03052751|7651226|FG000|Dosing Period 2|Adverse Event|0
4719164|NCT03052751|7651227|FG001|Dosing Period 2|Adverse Event|0
4719165|NCT03052751|7651228|FG002|Dosing Period 2|Adverse Event|3
4719166|NCT03052751|7651229|FG003|Dosing Period 2|Adverse Event|0
4719167|NCT03052751|7651230|FG004|Dosing Period 2|Adverse Event|0
4719168|NCT03052751|7651231|FG005|Dosing Period 2|Adverse Event|0
4719169|NCT03052751|7651226|FG000|Observation Period|Adverse Event|0
4719170|NCT03052751|7651227|FG001|Observation Period|Adverse Event|0
4719171|NCT03052751|7651228|FG002|Observation Period|Adverse Event|0
4630668|NCT01884337|7499495|FG000|Treatment|Subj. request to discont. treatment|2
4630669|NCT01884337|7499496|FG001|Treatment|Subj. request to discont. treatment|0
4719172|NCT03052751|7651229|FG003|Observation Period|Adverse Event|0
4719173|NCT03052751|7651230|FG004|Observation Period|Adverse Event|1
4719174|NCT03052751|7651231|FG005|Observation Period|Adverse Event|0
4719175|NCT03052764|7651243|FG000|Double-Blind Treatment Period|Adverse Event|2
4719176|NCT03052764|7651244|FG001|Double-Blind Treatment Period|Adverse Event|0
4719177|NCT03052764|7651243|FG000|Double-Blind Treatment Period|Lack of Efficacy|1
4719178|NCT03052764|7651244|FG001|Double-Blind Treatment Period|Lack of Efficacy|0
4719179|NCT03052764|7651243|FG000|Double-Blind Treatment Period|Protocol Violation|2
4719180|NCT03052764|7651244|FG001|Double-Blind Treatment Period|Protocol Violation|1
4719181|NCT03052764|7651243|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3
4719182|NCT03052764|7651244|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1
4719183|NCT03052764|7651243|FG000|Double-Blind Treatment Period|Reason not Specified|2
4719184|NCT03052764|7651244|FG001|Double-Blind Treatment Period|Reason not Specified|1
4719185|NCT03052816|7651254|FG000|Overall Study|Withdrawal by Subject|1
4719186|NCT03052816|7651255|FG001|Overall Study|Withdrawal by Subject|0
4719187|NCT03052816|7651254|FG000|Overall Study|Desired opioids|2
4719188|NCT03052816|7651255|FG001|Overall Study|Desired opioids|0
4719189|NCT03052959|7651265|FG000|Overall Study|Lost to Follow-up|4
4719190|NCT03052959|7651266|FG001|Overall Study|Lost to Follow-up|5
4719191|NCT03053050|7651286|FG000|Randomized Phase|Study Terminated by Sponsor|259
4719192|NCT03053050|7651287|FG001|Randomized Phase|Study Terminated by Sponsor|260
4719193|NCT03053050|7651288|FG002|Randomized Phase|Study Terminated by Sponsor|128
4719194|NCT03053050|7651289|FG003|Randomized Phase|Study Terminated by Sponsor|0
4719195|NCT03053050|7651286|FG000|Randomized Phase|Withdrew Consent|16
4719196|NCT03053050|7651287|FG001|Randomized Phase|Withdrew Consent|8
4719197|NCT03053050|7651288|FG002|Randomized Phase|Withdrew Consent|9
4719198|NCT03053050|7651289|FG003|Randomized Phase|Withdrew Consent|0
4719199|NCT03053050|7651286|FG000|Randomized Phase|Investigator's Discretion|6
4719200|NCT03053050|7651287|FG001|Randomized Phase|Investigator's Discretion|6
4719201|NCT03053050|7651288|FG002|Randomized Phase|Investigator's Discretion|3
4719202|NCT03053050|7651289|FG003|Randomized Phase|Investigator's Discretion|0
4719203|NCT03053050|7651286|FG000|Randomized Phase|Lost to Follow-up|5
4719204|NCT03053050|7651287|FG001|Randomized Phase|Lost to Follow-up|1
4719205|NCT03053050|7651288|FG002|Randomized Phase|Lost to Follow-up|1
4719206|NCT03053050|7651289|FG003|Randomized Phase|Lost to Follow-up|0
4719207|NCT03053050|7651286|FG000|Randomized Phase|Adverse Event|0
4719208|NCT03053050|7651287|FG001|Randomized Phase|Adverse Event|1
4719209|NCT03053050|7651288|FG002|Randomized Phase|Adverse Event|0
4719210|NCT03053050|7651289|FG003|Randomized Phase|Adverse Event|0
4719211|NCT03053050|7651286|FG000|Randomized Phase|Randomized but Never Treated|2
4719212|NCT03053050|7651287|FG001|Randomized Phase|Randomized but Never Treated|2
4719213|NCT03053050|7651288|FG002|Randomized Phase|Randomized but Never Treated|2
4719214|NCT03053050|7651289|FG003|Randomized Phase|Randomized but Never Treated|0
4719215|NCT03053050|7651286|FG000|Randomized Phase|Entered the Open-Label Phase|36
4719216|NCT03053050|7651287|FG001|Randomized Phase|Entered the Open-Label Phase|45
4719217|NCT03053050|7651288|FG002|Randomized Phase|Entered the Open-Label Phase|18
4719218|NCT03053050|7651289|FG003|Randomized Phase|Entered the Open-Label Phase|0
4719219|NCT03053050|7651286|FG000|Open-label Phase|Study Terminated by Sponsor|0
4719220|NCT03053050|7651287|FG001|Open-label Phase|Study Terminated by Sponsor|0
4719221|NCT03053050|7651288|FG002|Open-label Phase|Study Terminated by Sponsor|0
4719222|NCT03053050|7651289|FG003|Open-label Phase|Study Terminated by Sponsor|89
4630670|NCT01884337|7499495|FG000|Follow-up Period|Lost to Follow-up|1
4630671|NCT01884337|7499496|FG001|Follow-up Period|Lost to Follow-up|1
4633333|NCT01911260|7503460|FG003|Supplementation Period|Adverse Event|0
4633334|NCT01911260|7503457|FG000|Supplementation Period|refused to receive supplement|1
4633335|NCT01911260|7503458|FG001|Supplementation Period|refused to receive supplement|0
4633336|NCT01911260|7503459|FG002|Supplementation Period|refused to receive supplement|1
4633337|NCT01911260|7503460|FG003|Supplementation Period|refused to receive supplement|0
4633338|NCT01911260|7503457|FG000|Supplementation Period|less than 12 weeks supplementation|0
4633339|NCT01911260|7503458|FG001|Supplementation Period|less than 12 weeks supplementation|3
4633340|NCT01911260|7503459|FG002|Supplementation Period|less than 12 weeks supplementation|1
4633341|NCT01911260|7503460|FG003|Supplementation Period|less than 12 weeks supplementation|2
4719223|NCT03053050|7651286|FG000|Open-label Phase|Withdrew Consent|0
4719224|NCT03053050|7651287|FG001|Open-label Phase|Withdrew Consent|0
4719225|NCT03053050|7651288|FG002|Open-label Phase|Withdrew Consent|0
4719226|NCT03053050|7651289|FG003|Open-label Phase|Withdrew Consent|6
4719227|NCT03053050|7651286|FG000|Open-label Phase|Investigator's Discretion|0
4719228|NCT03053050|7651287|FG001|Open-label Phase|Investigator's Discretion|0
4719229|NCT03053050|7651288|FG002|Open-label Phase|Investigator's Discretion|0
4719230|NCT03053050|7651289|FG003|Open-label Phase|Investigator's Discretion|4
4719231|NCT03053063|7651301|FG000|Randomized Phase|Study Terminated by Sponsor|326
4719232|NCT03053063|7651302|FG001|Randomized Phase|Study Terminated by Sponsor|317
4719233|NCT03053063|7651303|FG002|Randomized Phase|Study Terminated by Sponsor|161
4719234|NCT03053063|7651304|FG003|Randomized Phase|Study Terminated by Sponsor|0
4719235|NCT03053063|7651301|FG000|Randomized Phase|Withdrew consent|8
4719236|NCT03053063|7651302|FG001|Randomized Phase|Withdrew consent|11
4719237|NCT03053063|7651303|FG002|Randomized Phase|Withdrew consent|5
4719238|NCT03053063|7651304|FG003|Randomized Phase|Withdrew consent|0
4719239|NCT03053063|7651301|FG000|Randomized Phase|Investigator's Discretion|8
4719240|NCT03053063|7651302|FG001|Randomized Phase|Investigator's Discretion|6
4719241|NCT03053063|7651303|FG002|Randomized Phase|Investigator's Discretion|2
4719242|NCT03053063|7651304|FG003|Randomized Phase|Investigator's Discretion|0
4719243|NCT03053063|7651301|FG000|Randomized Phase|Lost to Follow-up|3
4719244|NCT03053063|7651302|FG001|Randomized Phase|Lost to Follow-up|5
4719245|NCT03053063|7651303|FG002|Randomized Phase|Lost to Follow-up|1
4719246|NCT03053063|7651304|FG003|Randomized Phase|Lost to Follow-up|0
4719247|NCT03053063|7651301|FG000|Randomized Phase|Adverse Event|0
4719248|NCT03053063|7651302|FG001|Randomized Phase|Adverse Event|1
4719249|NCT03053063|7651303|FG002|Randomized Phase|Adverse Event|0
4719250|NCT03053063|7651304|FG003|Randomized Phase|Adverse Event|0
4719251|NCT03053063|7651301|FG000|Randomized Phase|Randomized but Never Treated|1
4719252|NCT03053063|7651302|FG001|Randomized Phase|Randomized but Never Treated|3
4719253|NCT03053063|7651303|FG002|Randomized Phase|Randomized but Never Treated|2
4719254|NCT03053063|7651304|FG003|Randomized Phase|Randomized but Never Treated|0
4719255|NCT03053063|7651301|FG000|Randomized Phase|Entered the Open-Label Phase|9
4719256|NCT03053063|7651302|FG001|Randomized Phase|Entered the Open-Label Phase|11
4719257|NCT03053063|7651303|FG002|Randomized Phase|Entered the Open-Label Phase|3
4719258|NCT03053063|7651304|FG003|Randomized Phase|Entered the Open-Label Phase|0
4719259|NCT03053063|7651301|FG000|Open-Label Phase|Study Terminated by Sponsor|0
4719260|NCT03053063|7651302|FG001|Open-Label Phase|Study Terminated by Sponsor|0
4719261|NCT03053063|7651303|FG002|Open-Label Phase|Study Terminated by Sponsor|0
4719262|NCT03053063|7651304|FG003|Open-Label Phase|Study Terminated by Sponsor|19
4719263|NCT03053063|7651301|FG000|Open-Label Phase|Death|0
4719264|NCT03053063|7651302|FG001|Open-Label Phase|Death|0
4719265|NCT03053063|7651303|FG002|Open-Label Phase|Death|0
4719266|NCT03053063|7651304|FG003|Open-Label Phase|Death|2
4719267|NCT03053063|7651301|FG000|Open-Label Phase|Investigator's discretion|0
4719268|NCT03053063|7651302|FG001|Open-Label Phase|Investigator's discretion|0
4719269|NCT03053063|7651303|FG002|Open-Label Phase|Investigator's discretion|0
4719270|NCT03053063|7651304|FG003|Open-Label Phase|Investigator's discretion|2
4719271|NCT03053102|7651313|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1
4719272|NCT03053102|7651313|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1
4719273|NCT03053180|7651318|FG000|Overall Study|Failure to Return|1
4719274|NCT03053271|7651322|FG000|Overall Study|Did not meet randomization criteria|3
4719275|NCT03053271|7651322|FG000|Overall Study|Withdrawal by Subject|1
4719276|NCT03053427|7651338|FG000|Overall Study|Adverse Event|4
4719277|NCT03053427|7651339|FG001|Overall Study|Adverse Event|4
4719278|NCT03053427|7651338|FG000|Overall Study|Lack of Efficacy|1
4719279|NCT03053427|7651339|FG001|Overall Study|Lack of Efficacy|3
4719280|NCT03053427|7651338|FG000|Overall Study|Lost to Follow-up|2
4719281|NCT03053427|7651339|FG001|Overall Study|Lost to Follow-up|2
4719282|NCT03053427|7651338|FG000|Overall Study|Worsening of the target disease|0
4719283|NCT03053427|7651339|FG001|Overall Study|Worsening of the target disease|1
4719284|NCT03053427|7651338|FG000|Overall Study|Protocol Deviation|3
4719285|NCT03053427|7651339|FG001|Overall Study|Protocol Deviation|3
4719286|NCT03053427|7651338|FG000|Overall Study|Withdrawal by Subject|3
4719287|NCT03053427|7651339|FG001|Overall Study|Withdrawal by Subject|2
4719288|NCT03053427|7651338|FG000|Overall Study|Miscellaneous|0
4719289|NCT03053427|7651339|FG001|Overall Study|Miscellaneous|1
4719290|NCT03053492|7651347|FG000|Overall Study|Adverse Event|1
4719291|NCT03053492|7651348|FG001|Overall Study|Adverse Event|1
4719292|NCT03053492|7651347|FG000|Overall Study|Withdrawal by Subject|7
4719293|NCT03053492|7651348|FG001|Overall Study|Withdrawal by Subject|5
4719294|NCT03054064|7651365|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1
4719295|NCT03054064|7651365|FG000|Overall Study|Investigator Decision|2
4719296|NCT03054064|7651365|FG000|Overall Study|Bladder Issue|1
4719297|NCT03054064|7651365|FG000|Overall Study|High Blood Pressure|1
4719298|NCT03054064|7651365|FG000|Overall Study|Change in Status|1
4719299|NCT03054337|7651397|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1
4719300|NCT03054337|7651398|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2
4719301|NCT03054337|7651399|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1
4719302|NCT03054337|7651400|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0
4719303|NCT03054337|7651401|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0
4719304|NCT03054337|7651402|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1
4719305|NCT03054350|7651435|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4
4719306|NCT03054350|7651436|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2
4719307|NCT03054350|7651437|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1
4719308|NCT03054350|7651438|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2
4719309|NCT03054350|7651439|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4
4719310|NCT03054350|7651440|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3
4719311|NCT03054350|7651435|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0
4719312|NCT03054350|7651436|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0
4719313|NCT03054350|7651437|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1
4719314|NCT03054350|7651438|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0
4719315|NCT03054350|7651439|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0
4719316|NCT03054350|7651440|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0
4719317|NCT03054350|7651435|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1
4719318|NCT03054350|7651436|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0
4719319|NCT03054350|7651437|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0
4719320|NCT03054350|7651438|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1
4719321|NCT03054350|7651439|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0
4719322|NCT03054350|7651440|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0
4719323|NCT03054350|7651435|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0
4719324|NCT03054350|7651436|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0
4719325|NCT03054350|7651437|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1
4719326|NCT03054350|7651438|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0
4719327|NCT03054350|7651439|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0
4719328|NCT03054350|7651440|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0
4719329|NCT03054428|7651474|FG000|Overall Study|Physician Decision|0
4719330|NCT03054428|7651475|FG001|Overall Study|Physician Decision|1
4719331|NCT03054428|7651476|FG002|Overall Study|Physician Decision|1
4719332|NCT03054428|7651474|FG000|Overall Study|Lack of Efficacy|3
4719333|NCT03054428|7651475|FG001|Overall Study|Lack of Efficacy|1
4719334|NCT03054428|7651476|FG002|Overall Study|Lack of Efficacy|0
4719335|NCT03054428|7651474|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0
4719336|NCT03054428|7651475|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0
4719337|NCT03054428|7651476|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1
4719338|NCT03054428|7651474|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1
4719339|NCT03054428|7651475|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0
4719340|NCT03054428|7651476|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0
4719341|NCT03054428|7651474|FG000|Overall Study|Transitioned to OLE study|76
4719342|NCT03054428|7651475|FG001|Overall Study|Transitioned to OLE study|76
4719343|NCT03054428|7651476|FG002|Overall Study|Transitioned to OLE study|73
4719344|NCT03054428|7651474|FG000|Overall Study|Withdrawal by Subject|3
4719345|NCT03054428|7651475|FG001|Overall Study|Withdrawal by Subject|2
4719346|NCT03054428|7651476|FG002|Overall Study|Withdrawal by Subject|3
4719347|NCT03054428|7651474|FG000|Overall Study|Lost to Follow-up|0
4719348|NCT03054428|7651475|FG001|Overall Study|Lost to Follow-up|0
4719349|NCT03054428|7651476|FG002|Overall Study|Lost to Follow-up|1
4719350|NCT03054870|7651571|FG000|Day of Ventilation Imaging|Protocol Violation|4
4719351|NCT03054870|7651571|FG000|Day of Ventilation Imaging|Lost to Follow-up|1
4719352|NCT03055195|7651623|FG000|Overall Study|Lack of Efficacy|1
4719353|NCT03055195|7651624|FG001|Overall Study|Lack of Efficacy|0
4719354|NCT03055195|7651623|FG000|Overall Study|Withdrawal by Subject|6
4719355|NCT03055195|7651624|FG001|Overall Study|Withdrawal by Subject|7
4719356|NCT03055195|7651623|FG000|Overall Study|Study Terminated by Sponsor|2
4719357|NCT03055195|7651624|FG001|Overall Study|Study Terminated by Sponsor|6
4719358|NCT03055195|7651623|FG000|Overall Study|Protocol Violation|2
4719359|NCT03055195|7651624|FG001|Overall Study|Protocol Violation|1
4719360|NCT03055195|7651623|FG000|Overall Study|Physician Decision|1
4719361|NCT03055195|7651624|FG001|Overall Study|Physician Decision|0
4719362|NCT03055221|7651630|FG000|Overall Study|Adverse Event|2
4719363|NCT03055221|7651630|FG000|Overall Study|Withdrawal by Subject|4
4719364|NCT03055221|7651630|FG000|Overall Study|Death|6
4719365|NCT03055221|7651630|FG000|Overall Study|Physician Decision|1
4719366|NCT03055221|7651630|FG000|Overall Study|Study terminated by Sponsor|3
4719367|NCT03055260|7651636|FG000|Overall Study|Withdrawal by Subject|1
4719368|NCT03055260|7651637|FG001|Overall Study|Withdrawal by Subject|0
4719369|NCT03055338|7651646|FG000|Overall Study|Lost to Follow-up|9
4719370|NCT03055338|7651647|FG001|Overall Study|Lost to Follow-up|2
4719371|NCT03055338|7651648|FG002|Overall Study|Lost to Follow-up|3
4719372|NCT03055338|7651646|FG000|Overall Study|No Post-treatment Protocol Contact|0
4719373|NCT03055338|7651647|FG001|Overall Study|No Post-treatment Protocol Contact|1
4719374|NCT03055338|7651648|FG002|Overall Study|No Post-treatment Protocol Contact|0
4719375|NCT03055338|7651646|FG000|Overall Study|Physician Decision|0
4719376|NCT03055338|7651647|FG001|Overall Study|Physician Decision|0
4719377|NCT03055338|7651648|FG002|Overall Study|Physician Decision|2
4630672|NCT01884350|7499504|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17
4719378|NCT03055338|7651646|FG000|Overall Study|Withdrawal by Subject|9
4719379|NCT03055338|7651647|FG001|Overall Study|Withdrawal by Subject|8
4719380|NCT03055338|7651648|FG002|Overall Study|Withdrawal by Subject|7
4719381|NCT03055494|7651658|FG000|Overall Study|Lost to Follow-up|6
4719382|NCT03055494|7651659|FG001|Overall Study|Lost to Follow-up|0
4719383|NCT03055494|7651658|FG000|Overall Study|Physician Decision|2
4719384|NCT03055494|7651659|FG001|Overall Study|Physician Decision|0
4719385|NCT03055494|7651658|FG000|Overall Study|Withdrawal by Subject|1
4719386|NCT03055494|7651659|FG001|Overall Study|Withdrawal by Subject|0
4719387|NCT03055494|7651658|FG000|Overall Study|Adverse Event|0
4719388|NCT03055494|7651659|FG001|Overall Study|Adverse Event|1
4719389|NCT03055494|7651658|FG000|Overall Study|Non-compliance with study treatment|1
4719390|NCT03055494|7651659|FG001|Overall Study|Non-compliance with study treatment|0
4719391|NCT03055624|7651666|FG000|Overall Study|Study closed|9
4736345|NCT03566485|7685512|FG001|Overall Study|Disease progression|4
4736346|NCT03566485|7685511|FG000|Overall Study|Clinical progression|0
4736347|NCT03566485|7685512|FG001|Overall Study|Clinical progression|1
4736348|NCT03566485|7685511|FG000|Overall Study|Toxicity|0
4736349|NCT03566485|7685512|FG001|Overall Study|Toxicity|2
4736350|NCT03566550|7685520|FG000|Overall Study|Withdrawal by Subject|0
4736351|NCT03566550|7685521|FG001|Overall Study|Withdrawal by Subject|1
4736352|NCT03566680|7685527|FG000|Overall Study|Pregnancy|1
4736353|NCT03566680|7685527|FG000|Overall Study|Lost to Follow-up|13
4736354|NCT03566680|7685527|FG000|Overall Study|Withdrawal by Subject|3
4736355|NCT03566810|7685535|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0
4736356|NCT03566810|7685536|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1
4736357|NCT03566810|7685537|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0
4736358|NCT03566810|7685538|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0
4736359|NCT03566823|7685551|FG000|Overall Study|Lack of Efficacy|0
4736360|NCT03566823|7685552|FG001|Overall Study|Lack of Efficacy|1
4736361|NCT03566823|7685553|FG002|Overall Study|Lack of Efficacy|0
4736362|NCT03566823|7685551|FG000|Overall Study|Withdrawal by Subject|1
4736363|NCT03566823|7685552|FG001|Overall Study|Withdrawal by Subject|2
4736364|NCT03566823|7685553|FG002|Overall Study|Withdrawal by Subject|0
4736365|NCT03566823|7685551|FG000|Overall Study|Adverse Event|1
4736366|NCT03566823|7685552|FG001|Overall Study|Adverse Event|0
4736367|NCT03566823|7685553|FG002|Overall Study|Adverse Event|2
4736368|NCT03566979|7685565|FG000|Overall Study|Withdrawal by Subject|2
4736369|NCT03566979|7685566|FG001|Overall Study|Withdrawal by Subject|0
4736370|NCT03566979|7685567|FG002|Overall Study|Withdrawal by Subject|1
4736371|NCT03566979|7685568|FG003|Overall Study|Withdrawal by Subject|1
4736372|NCT03566979|7685565|FG000|Overall Study|Lost to Follow-up|2
4736373|NCT03566979|7685566|FG001|Overall Study|Lost to Follow-up|7
4736374|NCT03566979|7685567|FG002|Overall Study|Lost to Follow-up|9
4736375|NCT03566979|7685568|FG003|Overall Study|Lost to Follow-up|5
4736376|NCT03566979|7685565|FG000|Overall Study|Adverse Event|1
4736377|NCT03566979|7685566|FG001|Overall Study|Adverse Event|0
4736378|NCT03566979|7685567|FG002|Overall Study|Adverse Event|0
4736379|NCT03566979|7685568|FG003|Overall Study|Adverse Event|0
4736380|NCT03567291|7685594|FG000|Period I|Adverse Event|14
4736381|NCT03567291|7685595|FG001|Period I|Adverse Event|0
4736382|NCT03567291|7685596|FG002|Period I|Adverse Event|0
4736383|NCT03567291|7685597|FG003|Period I|Adverse Event|0
4736384|NCT03567291|7685594|FG000|Period I|Protocol Violation|1
4736385|NCT03567291|7685595|FG001|Period I|Protocol Violation|0
4736386|NCT03567291|7685596|FG002|Period I|Protocol Violation|0
4736387|NCT03567291|7685597|FG003|Period I|Protocol Violation|0
4736388|NCT03567291|7685594|FG000|Period I|Withdrawal by Subject|23
4736389|NCT03567291|7685595|FG001|Period I|Withdrawal by Subject|0
4736390|NCT03567291|7685596|FG002|Period I|Withdrawal by Subject|0
4736391|NCT03567291|7685597|FG003|Period I|Withdrawal by Subject|0
4736392|NCT03567291|7685594|FG000|Period I|Lost to Follow-up|2
4736393|NCT03567291|7685595|FG001|Period I|Lost to Follow-up|0
4736394|NCT03567291|7685596|FG002|Period I|Lost to Follow-up|0
4736395|NCT03567291|7685597|FG003|Period I|Lost to Follow-up|0
4736396|NCT03567291|7685594|FG000|Period I|Terminated by sponsor|44
4736397|NCT03567291|7685595|FG001|Period I|Terminated by sponsor|0
4736398|NCT03567291|7685596|FG002|Period I|Terminated by sponsor|0
4736399|NCT03567291|7685597|FG003|Period I|Terminated by sponsor|0
4736400|NCT03567291|7685594|FG000|Period I|Missing or unknown|7
4736401|NCT03567291|7685595|FG001|Period I|Missing or unknown|0
4736402|NCT03567291|7685596|FG002|Period I|Missing or unknown|0
4736403|NCT03567291|7685597|FG003|Period I|Missing or unknown|0
4736404|NCT03567291|7685594|FG000|Period II|Adverse Event|0
4736405|NCT03567291|7685595|FG001|Period II|Adverse Event|1
4736406|NCT03567291|7685596|FG002|Period II|Adverse Event|0
4736407|NCT03567291|7685597|FG003|Period II|Adverse Event|0
4736408|NCT03567291|7685594|FG000|Period II|Missing or unknown|0
4736409|NCT03567291|7685595|FG001|Period II|Missing or unknown|2
4736410|NCT03567291|7685596|FG002|Period II|Missing or unknown|1
4736411|NCT03567291|7685597|FG003|Period II|Missing or unknown|0
4736412|NCT03567291|7685594|FG000|Period III|Adverse Event|0
4736413|NCT03567291|7685595|FG001|Period III|Adverse Event|0
4736414|NCT03567291|7685596|FG002|Period III|Adverse Event|0
4736415|NCT03567291|7685597|FG003|Period III|Adverse Event|4
4719392|NCT03055806|7651678|FG000|Overall Study|Adverse Event|0
4719393|NCT03055806|7651679|FG001|Overall Study|Adverse Event|0
4719394|NCT03055806|7651680|FG002|Overall Study|Adverse Event|1
4719395|NCT03055806|7651681|FG003|Overall Study|Adverse Event|1
4719396|NCT03055806|7651678|FG000|Overall Study|Lost to Follow-up|0
4719397|NCT03055806|7651679|FG001|Overall Study|Lost to Follow-up|3
4719398|NCT03055806|7651680|FG002|Overall Study|Lost to Follow-up|6
4719399|NCT03055806|7651681|FG003|Overall Study|Lost to Follow-up|7
4719400|NCT03055806|7651678|FG000|Overall Study|Physician Decision|1
4719401|NCT03055806|7651679|FG001|Overall Study|Physician Decision|0
4719402|NCT03055806|7651680|FG002|Overall Study|Physician Decision|0
4719403|NCT03055806|7651681|FG003|Overall Study|Physician Decision|1
4719404|NCT03055806|7651678|FG000|Overall Study|Protocol Violation|1
4719405|NCT03055806|7651679|FG001|Overall Study|Protocol Violation|0
4719406|NCT03055806|7651680|FG002|Overall Study|Protocol Violation|0
4719407|NCT03055806|7651681|FG003|Overall Study|Protocol Violation|0
4719408|NCT03055806|7651678|FG000|Overall Study|Withdrawal of consent to continue drug|1
4719409|NCT03055806|7651679|FG001|Overall Study|Withdrawal of consent to continue drug|1
4719410|NCT03055806|7651680|FG002|Overall Study|Withdrawal of consent to continue drug|2
4719411|NCT03055806|7651681|FG003|Overall Study|Withdrawal of consent to continue drug|0
4719412|NCT03055806|7651678|FG000|Overall Study|Withdrawal of consent to continue study|2
4719413|NCT03055806|7651679|FG001|Overall Study|Withdrawal of consent to continue study|3
4719414|NCT03055806|7651680|FG002|Overall Study|Withdrawal of consent to continue study|4
4719415|NCT03055806|7651681|FG003|Overall Study|Withdrawal of consent to continue study|6
4719416|NCT03055806|7651678|FG000|Overall Study|Partner not willing to try intercourse|1
4719417|NCT03055806|7651679|FG001|Overall Study|Partner not willing to try intercourse|0
4719418|NCT03055806|7651680|FG002|Overall Study|Partner not willing to try intercourse|0
4719419|NCT03055806|7651681|FG003|Overall Study|Partner not willing to try intercourse|0
4719420|NCT03055832|7651693|FG000|Week 2|Withdrawal by Subject|1
4719421|NCT03055832|7651694|FG001|Week 2|Withdrawal by Subject|0
4719422|NCT03055858|7651714|FG000|Overall Study|Death|5
4719423|NCT03055858|7651714|FG000|Overall Study|Adverse Event|1
4719424|NCT03055936|7651726|FG000|Overall Study|Adverse Event|0
4719425|NCT03055936|7651727|FG001|Overall Study|Adverse Event|1
4719426|NCT03055936|7651728|FG002|Overall Study|Adverse Event|1
4719427|NCT03055936|7651729|FG003|Overall Study|Adverse Event|1
4719428|NCT03055936|7651726|FG000|Overall Study|Personal reason|2
4719429|NCT03055936|7651727|FG001|Overall Study|Personal reason|0
4719430|NCT03055936|7651728|FG002|Overall Study|Personal reason|1
4719431|NCT03055936|7651729|FG003|Overall Study|Personal reason|0
4719432|NCT03055988|7651763|FG000|Period 1|Adverse Event|0
4719433|NCT03055988|7651764|FG001|Period 1|Adverse Event|1
4719434|NCT03055988|7651763|FG000|Period 1|Lost to Follow-up|1
4719435|NCT03055988|7651764|FG001|Period 1|Lost to Follow-up|0
4719436|NCT03055988|7651763|FG000|Period 1|Withdrawal by Subject|0
4719437|NCT03055988|7651764|FG001|Period 1|Withdrawal by Subject|4
4719438|NCT03055988|7651763|FG000|Period 2|Adverse Event|0
4719439|NCT03055988|7651764|FG001|Period 2|Adverse Event|1
4719440|NCT03055988|7651763|FG000|Period 2|Other than listed|1
4719441|NCT03055988|7651764|FG001|Period 2|Other than listed|1
4719442|NCT03056040|7651772|FG000|Primary Evaluation Period|Withdrawal by Subject|1
4719443|NCT03056040|7651773|FG001|Primary Evaluation Period|Withdrawal by Subject|1
4719444|NCT03056040|7651772|FG000|Primary Evaluation Period|Lack of Efficacy|0
4719445|NCT03056040|7651773|FG001|Primary Evaluation Period|Lack of Efficacy|1
4719446|NCT03056040|7651772|FG000|Primary Evaluation Period|Pregnancy|0
4719447|NCT03056040|7651773|FG001|Primary Evaluation Period|Pregnancy|1
4719448|NCT03056300|7651783|FG000|Overall Study|Surgical reason per study protocol|3
4719449|NCT03056352|7651787|FG000|Overall Study|Lost to Follow-up|1
4719450|NCT03056573|7651809|FG000|Overall Study|Death|2
4719451|NCT03056573|7651810|FG001|Overall Study|Death|4
4719452|NCT03056573|7651809|FG000|Overall Study|Withdrawal by Subject|2
4719453|NCT03056573|7651810|FG001|Overall Study|Withdrawal by Subject|0
4719454|NCT03056573|7651809|FG000|Overall Study|Lost to Follow-up|1
4719455|NCT03056573|7651810|FG001|Overall Study|Lost to Follow-up|1
4719456|NCT03056690|7651818|FG000|Overall Study|Adverse Event|3
4719457|NCT03056690|7651819|FG001|Overall Study|Adverse Event|2
4719458|NCT03056690|7651818|FG000|Overall Study|Lack of Efficacy|1
4719459|NCT03056690|7651819|FG001|Overall Study|Lack of Efficacy|2
4719460|NCT03056690|7651818|FG000|Overall Study|Lost to Follow-up|3
4719461|NCT03056690|7651819|FG001|Overall Study|Lost to Follow-up|2
4719462|NCT03056690|7651818|FG000|Overall Study|Protocol Violation|2
4719463|NCT03056690|7651819|FG001|Overall Study|Protocol Violation|2
4719464|NCT03056690|7651818|FG000|Overall Study|Withdrawal by Subject|3
4719465|NCT03056690|7651819|FG001|Overall Study|Withdrawal by Subject|6
4719466|NCT03056690|7651818|FG000|Overall Study|Non-compliance with Study Drug|1
4719467|NCT03056690|7651819|FG001|Overall Study|Non-compliance with Study Drug|0
4719468|NCT03056690|7651818|FG000|Overall Study|Miscellaneous|1
4719469|NCT03056690|7651819|FG001|Overall Study|Miscellaneous|2
4719470|NCT03057496|7651842|FG000|Overall Study|Withdrawal by Subject|8
4719471|NCT03057496|7651842|FG000|Overall Study|Lost to Follow-up|5
4719472|NCT03057496|7651842|FG000|Overall Study|Did not use device during home trial|3
4719473|NCT03057496|7651842|FG000|Overall Study|Device failure|2
4719474|NCT03057977|7651863|FG000|Discontinuation From Treatment|Withdrawal by Subject|124
4719475|NCT03057977|7651864|FG001|Discontinuation From Treatment|Withdrawal by Subject|92
4719476|NCT03057977|7651863|FG000|Discontinuation From Treatment|Lost to Follow-up|11
4719477|NCT03057977|7651864|FG001|Discontinuation From Treatment|Lost to Follow-up|17
4719478|NCT03057977|7651863|FG000|Discontinuation From Treatment|Protocol Violation|6
4719479|NCT03057977|7651864|FG001|Discontinuation From Treatment|Protocol Violation|5
4719480|NCT03057977|7651863|FG000|Discontinuation From Treatment|Not treated|4
4719481|NCT03057977|7651864|FG001|Discontinuation From Treatment|Not treated|0
4719482|NCT03057977|7651863|FG000|Discontinuation From Treatment|Adverse Event|343
4719483|NCT03057977|7651864|FG001|Discontinuation From Treatment|Adverse Event|337
4719484|NCT03057977|7651863|FG000|Discontinuation From Treatment|Reason Unknown|0
4719485|NCT03057977|7651864|FG001|Discontinuation From Treatment|Reason Unknown|1
4719486|NCT03057977|7651863|FG000|Discontinuation From Treatment|Personal Reasons|1
4719487|NCT03057977|7651864|FG001|Discontinuation From Treatment|Personal Reasons|1
4719488|NCT03057977|7651863|FG000|Discontinuation From Treatment|Unblinded medication|1
4719489|NCT03057977|7651864|FG001|Discontinuation From Treatment|Unblinded medication|0
4719490|NCT03057977|7651863|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1
4719491|NCT03057977|7651864|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1
4719492|NCT03057977|7651863|FG000|Discontinuation From Treatment|Principle Investigator Decision|2
4719493|NCT03057977|7651864|FG001|Discontinuation From Treatment|Principle Investigator Decision|0
4719494|NCT03057977|7651863|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2
4719495|NCT03057977|7651864|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4
4719496|NCT03057977|7651863|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4
4719497|NCT03057977|7651864|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3
4719498|NCT03057977|7651863|FG000|Discontinuation From Treatment|Unable to continue treatment|4
4719499|NCT03057977|7651864|FG001|Discontinuation From Treatment|Unable to continue treatment|1
4719500|NCT03057977|7651863|FG000|Discontinuation From Treatment|Not attending study visit|3
4719501|NCT03057977|7651864|FG001|Discontinuation From Treatment|Not attending study visit|10
4719502|NCT03057977|7651863|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1
4719503|NCT03057977|7651864|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4
4719504|NCT03057977|7651863|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8
4719505|NCT03057977|7651864|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6
4719506|NCT03057977|7651863|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9
4719507|NCT03057977|7651864|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9
4719508|NCT03057977|7651863|FG000|Discontinuation From Trial|Limited follow-up agreed|2
4719509|NCT03057977|7651864|FG001|Discontinuation From Trial|Limited follow-up agreed|2
4719510|NCT03057977|7651863|FG000|Discontinuation From Trial|Withdrawal by Subject|9
4719511|NCT03057977|7651864|FG001|Discontinuation From Trial|Withdrawal by Subject|11
4719512|NCT03058679|7651872|FG000|Baseline to Week 6|Lost to Follow-up|3
4719513|NCT03058679|7651873|FG001|Baseline to Week 6|Lost to Follow-up|2
4719514|NCT03058679|7651872|FG000|Baseline to Week 6|Change in Crohn's disease medication|4
4719515|NCT03058679|7651873|FG001|Baseline to Week 6|Change in Crohn's disease medication|2
4719516|NCT03058679|7651872|FG000|Baseline to Week 6|Adverse Event|6
4719517|NCT03058679|7651873|FG001|Baseline to Week 6|Adverse Event|6
4719518|NCT03058679|7651872|FG000|Baseline to Week 6|Withdrawal by Subject|4
4719519|NCT03058679|7651873|FG001|Baseline to Week 6|Withdrawal by Subject|3
4719520|NCT03058679|7651872|FG000|Baseline to Week 6|Difficulty following the diet|0
4719521|NCT03058679|7651873|FG001|Baseline to Week 6|Difficulty following the diet|2
4719522|NCT03058679|7651872|FG000|Baseline to Week 6|Physician Decision|1
4719523|NCT03058679|7651873|FG001|Baseline to Week 6|Physician Decision|0
4719524|NCT03058679|7651872|FG000|Week 6 to Week 12|Change in medication|5
4719525|NCT03058679|7651873|FG001|Week 6 to Week 12|Change in medication|7
4719526|NCT03058679|7651872|FG000|Week 6 to Week 12|Adverse Event|4
4719527|NCT03058679|7651873|FG001|Week 6 to Week 12|Adverse Event|3
4719528|NCT03058679|7651872|FG000|Week 6 to Week 12|Withdrawal by Subject|9
4719529|NCT03058679|7651873|FG001|Week 6 to Week 12|Withdrawal by Subject|4
4719530|NCT03058679|7651872|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2
4719531|NCT03058679|7651873|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3
4719532|NCT03058692|7651881|FG000|Overall Study|Lost to Follow-up|2
4719533|NCT03058692|7651882|FG001|Overall Study|Lost to Follow-up|1
4719534|NCT03058692|7651881|FG000|Overall Study|Withdrawal by Subject|1
4719535|NCT03058692|7651882|FG001|Overall Study|Withdrawal by Subject|1
4719536|NCT03058991|7651892|FG000|Overall Study|Lost to Follow-up|17
4719537|NCT03058991|7651893|FG001|Overall Study|Lost to Follow-up|12
4719538|NCT03058991|7651894|FG002|Overall Study|Lost to Follow-up|12
4719539|NCT03058991|7651892|FG000|Overall Study|Withdrawal by Subject|1
4719540|NCT03058991|7651893|FG001|Overall Study|Withdrawal by Subject|0
4719541|NCT03058991|7651894|FG002|Overall Study|Withdrawal by Subject|0
4719542|NCT03060447|7651917|FG000|Overall Study|Withdrawal by Subject|2
4719543|NCT03060447|7651918|FG001|Overall Study|Withdrawal by Subject|0
4719544|NCT03060512|7651936|FG000|Overall Study|Adverse Event|4
4719545|NCT03060512|7651937|FG001|Overall Study|Adverse Event|6
4719546|NCT03060512|7651936|FG000|Overall Study|Lost to Follow-up|1
4719547|NCT03060512|7651937|FG001|Overall Study|Lost to Follow-up|1
4719548|NCT03060512|7651936|FG000|Overall Study|Withdrawal by Subject|1
4719549|NCT03060512|7651937|FG001|Overall Study|Withdrawal by Subject|0
4719550|NCT03060512|7651936|FG000|Overall Study|Non-compliance with study medication|1
4719551|NCT03060512|7651937|FG001|Overall Study|Non-compliance with study medication|2
4719552|NCT03060551|7651948|FG000|Overall Study|Withdrawal by Subject|1
4719553|NCT03060551|7651948|FG000|Overall Study|Adverse Event|1
4719554|NCT03061097|7651963|FG000|Overall Study|Withdrawal by Subject|0
4719555|NCT03061097|7651964|FG001|Overall Study|Withdrawal by Subject|3
4719556|NCT03061175|7651972|FG000|Baseline|Participant was deemed ineligible|1
4719557|NCT03061175|7651973|FG001|Baseline|Participant was deemed ineligible|0
4719558|NCT03061175|7651972|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6
4719559|NCT03061175|7651973|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2
4719560|NCT03061175|7651972|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0
4719561|NCT03061175|7651973|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1
4719562|NCT03061175|7651972|FG000|Followup 2 at 6 Months|Lost to Follow-up|4
4719563|NCT03061175|7651973|FG001|Followup 2 at 6 Months|Lost to Follow-up|7
4719564|NCT03061188|7651983|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0
4719565|NCT03061188|7651984|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0
4719566|NCT03061188|7651985|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1
4719567|NCT03061188|7651986|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1
4719568|NCT03061188|7651983|FG000|On Follow-up for 3 Years|Death|0
4719569|NCT03061188|7651984|FG001|On Follow-up for 3 Years|Death|3
4719570|NCT03061188|7651985|FG002|On Follow-up for 3 Years|Death|5
4719571|NCT03061188|7651986|FG003|On Follow-up for 3 Years|Death|2
4719572|NCT03061188|7651983|FG000|On Follow-up for 3 Years|Still in follow-up|0
4719573|NCT03061188|7651984|FG001|On Follow-up for 3 Years|Still in follow-up|0
4719574|NCT03061188|7651985|FG002|On Follow-up for 3 Years|Still in follow-up|0
4719575|NCT03061188|7651986|FG003|On Follow-up for 3 Years|Still in follow-up|3
4719576|NCT03061214|7652004|FG000|Overall Study|Withdrawal by Subject|21
4719577|NCT03061214|7652005|FG001|Overall Study|Withdrawal by Subject|26
4719578|NCT03061214|7652006|FG002|Overall Study|Withdrawal by Subject|9
4719579|NCT03061214|7652004|FG000|Overall Study|Lost to Follow-up|3
4719580|NCT03061214|7652005|FG001|Overall Study|Lost to Follow-up|1
4719581|NCT03061214|7652006|FG002|Overall Study|Lost to Follow-up|1
4719582|NCT03061214|7652004|FG000|Overall Study|Death|1
4719583|NCT03061214|7652005|FG001|Overall Study|Death|1
4719584|NCT03061214|7652006|FG002|Overall Study|Death|0
4719585|NCT03061331|7652016|FG000|Washout Period (8 Weeks)|Adverse Event|2
4719586|NCT03061331|7652017|FG001|Washout Period (8 Weeks)|Adverse Event|1
4719587|NCT03062891|7652078|FG000|Overall Study|Withdrawal by Subject|2
4719588|NCT03062891|7652079|FG001|Overall Study|Withdrawal by Subject|0
4719589|NCT03062891|7652078|FG000|Overall Study|Lost to Follow-up|50
4719590|NCT03062891|7652079|FG001|Overall Study|Lost to Follow-up|38
4719591|NCT03063086|7652106|FG000|Overall Study|technical problems|1
4719592|NCT03063086|7652107|FG001|Overall Study|technical problems|0
4719593|NCT03063086|7652108|FG002|Overall Study|technical problems|0
4719594|NCT03063086|7652109|FG003|Overall Study|technical problems|0
4719595|NCT03063086|7652110|FG004|Overall Study|technical problems|0
4719596|NCT03063086|7652111|FG005|Overall Study|technical problems|0
4719597|NCT03063086|7652106|FG000|Overall Study|Adverse Event|1
4719598|NCT03063086|7652107|FG001|Overall Study|Adverse Event|1
4719599|NCT03063086|7652108|FG002|Overall Study|Adverse Event|1
4719600|NCT03063086|7652109|FG003|Overall Study|Adverse Event|1
4719601|NCT03063086|7652110|FG004|Overall Study|Adverse Event|0
4719602|NCT03063086|7652111|FG005|Overall Study|Adverse Event|0
4719603|NCT03063086|7652106|FG000|Overall Study|subject/guardian decision|1
4719604|NCT03063086|7652107|FG001|Overall Study|subject/guardian decision|0
4719605|NCT03063086|7652108|FG002|Overall Study|subject/guardian decision|0
4719606|NCT03063086|7652109|FG003|Overall Study|subject/guardian decision|0
4719607|NCT03063086|7652110|FG004|Overall Study|subject/guardian decision|0
4719608|NCT03063086|7652111|FG005|Overall Study|subject/guardian decision|0
4719609|NCT03063086|7652106|FG000|Overall Study|Non-compliance with study treatment|0
4719610|NCT03063086|7652107|FG001|Overall Study|Non-compliance with study treatment|0
4719611|NCT03063086|7652108|FG002|Overall Study|Non-compliance with study treatment|0
4719612|NCT03063086|7652109|FG003|Overall Study|Non-compliance with study treatment|1
4719613|NCT03063086|7652110|FG004|Overall Study|Non-compliance with study treatment|0
4719614|NCT03063086|7652111|FG005|Overall Study|Non-compliance with study treatment|1
4719615|NCT03063086|7652106|FG000|Overall Study|Physician Decision|0
4719616|NCT03063086|7652107|FG001|Overall Study|Physician Decision|0
4719617|NCT03063086|7652108|FG002|Overall Study|Physician Decision|0
4719618|NCT03063086|7652109|FG003|Overall Study|Physician Decision|1
4719619|NCT03063086|7652110|FG004|Overall Study|Physician Decision|0
4719620|NCT03063086|7652111|FG005|Overall Study|Physician Decision|0
4719621|NCT03064438|7652175|FG000|Overall Study|Lost to Follow-up|1
4719622|NCT03064438|7652176|FG001|Overall Study|Lost to Follow-up|0
4719623|NCT03064438|7652175|FG000|Overall Study|Withdrawal by Subject|0
4719624|NCT03064438|7652176|FG001|Overall Study|Withdrawal by Subject|1
4719625|NCT03064451|7652182|FG000|Overall Study|Lost to Follow-up|1
4719626|NCT03064451|7652182|FG000|Overall Study|Mapping Failure|4
4719627|NCT03064451|7652182|FG000|Overall Study|Exited prior to procedure|8
4719628|NCT03064451|7652182|FG000|Overall Study|Withdrew consent: 3-month FU visit|1
4719629|NCT03064841|7652186|FG000|Overall Study|Inclusion/exclusion criteria violation|4
4719630|NCT03064841|7652186|FG000|Overall Study|No glycated haemoglobinA1c measurement|11
4719631|NCT03064841|7652186|FG000|Overall Study|Screen failure|2
4719632|NCT03065023|7652194|FG000|Overall Study|Progressive Disease|0
4719633|NCT03065023|7652195|FG001|Overall Study|Progressive Disease|1
4719634|NCT03065023|7652196|FG002|Overall Study|Progressive Disease|0
4719635|NCT03065023|7652197|FG003|Overall Study|Progressive Disease|0
4719636|NCT03065023|7652198|FG004|Overall Study|Progressive Disease|0
4719637|NCT03065023|7652194|FG000|Overall Study|Death|2
4719638|NCT03065023|7652195|FG001|Overall Study|Death|0
4719639|NCT03065023|7652196|FG002|Overall Study|Death|1
4719640|NCT03065023|7652197|FG003|Overall Study|Death|1
4719641|NCT03065023|7652198|FG004|Overall Study|Death|0
4719642|NCT03065023|7652194|FG000|Overall Study|Lost to Follow-up|0
4719643|NCT03065023|7652195|FG001|Overall Study|Lost to Follow-up|1
4719644|NCT03065023|7652196|FG002|Overall Study|Lost to Follow-up|0
4719645|NCT03065023|7652197|FG003|Overall Study|Lost to Follow-up|0
4719646|NCT03065023|7652198|FG004|Overall Study|Lost to Follow-up|0
4719647|NCT03065023|7652194|FG000|Overall Study|Participant Decision|0
4719648|NCT03065023|7652195|FG001|Overall Study|Participant Decision|0
4719649|NCT03065023|7652196|FG002|Overall Study|Participant Decision|0
4719650|NCT03065023|7652197|FG003|Overall Study|Participant Decision|1
4719651|NCT03065023|7652198|FG004|Overall Study|Participant Decision|0
4719652|NCT03065023|7652194|FG000|Overall Study|Withdrawal by Subject|0
4719653|NCT03065023|7652195|FG001|Overall Study|Withdrawal by Subject|0
4719654|NCT03065023|7652196|FG002|Overall Study|Withdrawal by Subject|0
4719655|NCT03065023|7652197|FG003|Overall Study|Withdrawal by Subject|1
4719656|NCT03065023|7652198|FG004|Overall Study|Withdrawal by Subject|0
4719657|NCT03065400|7652235|FG000|Overall Study|Adverse Event|1
4719658|NCT03065400|7652235|FG000|Overall Study|Physician Decision|3
4719659|NCT03065400|7652235|FG000|Overall Study|Withdrawal by Subject|1
4719660|NCT03065400|7652235|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5
4719661|NCT03065530|7652243|FG000|Overall Study|Lack of Efficacy|1
4719662|NCT03065530|7652244|FG001|Overall Study|Lack of Efficacy|1
4719663|NCT03065530|7652245|FG002|Overall Study|Lack of Efficacy|0
4719664|NCT03065530|7652246|FG003|Overall Study|Lack of Efficacy|1
4719665|NCT03065530|7652243|FG000|Overall Study|Protocol Violation|1
4719666|NCT03065530|7652244|FG001|Overall Study|Protocol Violation|0
4719667|NCT03065530|7652245|FG002|Overall Study|Protocol Violation|1
4719668|NCT03065530|7652246|FG003|Overall Study|Protocol Violation|1
4719669|NCT03066193|7652277|FG000|Overall Study|Withdrawal by Subject|1
4719670|NCT03066609|7652284|FG000|INDUCTION|Pregnancy|0
4719671|NCT03066609|7652285|FG001|INDUCTION|Pregnancy|0
4719672|NCT03066609|7652286|FG002|INDUCTION|Pregnancy|1
4719673|NCT03066609|7652287|FG003|INDUCTION|Pregnancy|0
4719674|NCT03066609|7652284|FG000|INDUCTION|Lack of Efficacy|0
4719675|NCT03066609|7652285|FG001|INDUCTION|Lack of Efficacy|0
4719676|NCT03066609|7652286|FG002|INDUCTION|Lack of Efficacy|1
4719677|NCT03066609|7652287|FG003|INDUCTION|Lack of Efficacy|0
4719678|NCT03066609|7652284|FG000|INDUCTION|Adverse Event|2
4719679|NCT03066609|7652285|FG001|INDUCTION|Adverse Event|2
4719680|NCT03066609|7652286|FG002|INDUCTION|Adverse Event|0
4719681|NCT03066609|7652287|FG003|INDUCTION|Adverse Event|0
4719682|NCT03066609|7652284|FG000|MAINTENANCE|Adverse Event|0
4719683|NCT03066609|7652285|FG001|MAINTENANCE|Adverse Event|0
4719684|NCT03066609|7652286|FG002|MAINTENANCE|Adverse Event|0
4719685|NCT03066609|7652287|FG003|MAINTENANCE|Adverse Event|1
4719686|NCT03066609|7652284|FG000|MAINTENANCE|Withdrawal by Subject|4
4719687|NCT03066609|7652285|FG001|MAINTENANCE|Withdrawal by Subject|2
4719688|NCT03066609|7652286|FG002|MAINTENANCE|Withdrawal by Subject|1
4719689|NCT03066609|7652287|FG003|MAINTENANCE|Withdrawal by Subject|1
4719690|NCT03066609|7652284|FG000|MAINTENANCE|Lost to Follow-up|0
4719691|NCT03066609|7652285|FG001|MAINTENANCE|Lost to Follow-up|1
4719692|NCT03066609|7652286|FG002|MAINTENANCE|Lost to Follow-up|1
4719693|NCT03066609|7652287|FG003|MAINTENANCE|Lost to Follow-up|0
4719694|NCT03066609|7652284|FG000|MAINTENANCE|Pregnancy|1
4719695|NCT03066609|7652285|FG001|MAINTENANCE|Pregnancy|0
4719696|NCT03066609|7652286|FG002|MAINTENANCE|Pregnancy|0
4719697|NCT03066609|7652287|FG003|MAINTENANCE|Pregnancy|0
4719698|NCT03066609|7652284|FG000|MAINTENANCE|Lack of Efficacy|2
4719699|NCT03066609|7652285|FG001|MAINTENANCE|Lack of Efficacy|1
4719700|NCT03066609|7652286|FG002|MAINTENANCE|Lack of Efficacy|0
4719701|NCT03066609|7652287|FG003|MAINTENANCE|Lack of Efficacy|1
4719702|NCT03066609|7652284|FG000|OVERALL STUDY|Adverse Event|2
4719703|NCT03066609|7652285|FG001|OVERALL STUDY|Adverse Event|2
4719704|NCT03066609|7652286|FG002|OVERALL STUDY|Adverse Event|0
4719705|NCT03066609|7652287|FG003|OVERALL STUDY|Adverse Event|1
4719706|NCT03066609|7652284|FG000|OVERALL STUDY|Withdrawal by Subject|4
4719707|NCT03066609|7652285|FG001|OVERALL STUDY|Withdrawal by Subject|2
4719708|NCT03066609|7652286|FG002|OVERALL STUDY|Withdrawal by Subject|1
4719709|NCT03066609|7652287|FG003|OVERALL STUDY|Withdrawal by Subject|2
4719710|NCT03066609|7652284|FG000|OVERALL STUDY|Lost to Follow-up|1
4719711|NCT03066609|7652285|FG001|OVERALL STUDY|Lost to Follow-up|1
4719712|NCT03066609|7652286|FG002|OVERALL STUDY|Lost to Follow-up|1
4719713|NCT03066609|7652287|FG003|OVERALL STUDY|Lost to Follow-up|1
4719714|NCT03066609|7652284|FG000|OVERALL STUDY|Pregnancy|1
4719715|NCT03066609|7652285|FG001|OVERALL STUDY|Pregnancy|0
4719716|NCT03066609|7652286|FG002|OVERALL STUDY|Pregnancy|1
4719717|NCT03066609|7652287|FG003|OVERALL STUDY|Pregnancy|0
4719718|NCT03066609|7652284|FG000|OVERALL STUDY|Lack of Efficacy|2
4719719|NCT03066609|7652285|FG001|OVERALL STUDY|Lack of Efficacy|1
4719720|NCT03066609|7652286|FG002|OVERALL STUDY|Lack of Efficacy|1
4719721|NCT03066609|7652287|FG003|OVERALL STUDY|Lack of Efficacy|1
4719722|NCT03066609|7652284|FG000|OVERALL STUDY|discontinued follow up|0
4719723|NCT03066609|7652285|FG001|OVERALL STUDY|discontinued follow up|2
4719724|NCT03066609|7652286|FG002|OVERALL STUDY|discontinued follow up|0
4719725|NCT03066609|7652287|FG003|OVERALL STUDY|discontinued follow up|0
4719726|NCT03066778|7652300|FG000|Overall Study|Death|167
4719727|NCT03066778|7652301|FG001|Overall Study|Death|183
4719728|NCT03066778|7652300|FG000|Overall Study|Withdrawal by Subject|4
4719729|NCT03066778|7652301|FG001|Overall Study|Withdrawal by Subject|5
4719730|NCT03066778|7652300|FG000|Overall Study|Ongoing in Study|57
4719731|NCT03066778|7652301|FG001|Overall Study|Ongoing in Study|37
4719732|NCT03066804|7652309|FG000|Overall Study|Physician Decision|0
4719733|NCT03066804|7652310|FG001|Overall Study|Physician Decision|4
4719734|NCT03066804|7652309|FG000|Overall Study|Death|23
4719735|NCT03066804|7652310|FG001|Overall Study|Death|17
4719736|NCT03066804|7652309|FG000|Overall Study|Withdrawal by Subject|19
4719737|NCT03066804|7652310|FG001|Overall Study|Withdrawal by Subject|25
4719738|NCT03066804|7652309|FG000|Overall Study|Lost to Follow-up|2
4719739|NCT03066804|7652310|FG001|Overall Study|Lost to Follow-up|0
4719740|NCT03066804|7652309|FG000|Overall Study|Adverse Event|2
4719741|NCT03066804|7652310|FG001|Overall Study|Adverse Event|3
4719742|NCT03066804|7652309|FG000|Overall Study|Technical problems|5
4719743|NCT03066804|7652310|FG001|Overall Study|Technical problems|1
4719744|NCT03066830|7652319|FG000|Overall Study|At the Participant's own Request|16
4719745|NCT03066830|7652320|FG001|Overall Study|At the Participant's own Request|17
4719746|NCT03066830|7652319|FG000|Overall Study|Other|3
4719747|NCT03066830|7652320|FG001|Overall Study|Other|0
4719748|NCT03066830|7652319|FG000|Overall Study|Poor Compliance to Protocol|1
4719749|NCT03066830|7652320|FG001|Overall Study|Poor Compliance to Protocol|0
4719750|NCT03066830|7652319|FG000|Overall Study|Adverse Event|2
4719751|NCT03066830|7652320|FG001|Overall Study|Adverse Event|2
4719752|NCT03066830|7652319|FG000|Overall Study|Lost to Follow-up|11
4719753|NCT03066830|7652320|FG001|Overall Study|Lost to Follow-up|3
4719754|NCT03066999|7652334|FG000|Overall Study|abnormal urethraBladder neck contracture|0
4719755|NCT03066999|7652335|FG001|Overall Study|abnormal urethraBladder neck contracture|2
4719756|NCT03067129|7652346|FG000|Overall Study|Ongoing|45
4719757|NCT03067129|7652347|FG001|Overall Study|Ongoing|28
4719758|NCT03067129|7652348|FG002|Overall Study|Ongoing|27
4719759|NCT03067129|7652349|FG003|Overall Study|Ongoing|23
4719760|NCT03067129|7652346|FG000|Overall Study|Partially dosed; refused to swallow entire dose|0
4719761|NCT03067129|7652347|FG001|Overall Study|Partially dosed; refused to swallow entire dose|0
4719762|NCT03067129|7652348|FG002|Overall Study|Partially dosed; refused to swallow entire dose|0
4719763|NCT03067129|7652349|FG003|Overall Study|Partially dosed; refused to swallow entire dose|1
4719764|NCT03067311|7652369|FG000|Overall Study|Lost to Follow-up|1
4719765|NCT03067311|7652370|FG001|Overall Study|Lost to Follow-up|1
4719766|NCT03067311|7652369|FG000|Overall Study|Moved away|1
4719767|NCT03067311|7652370|FG001|Overall Study|Moved away|1
4719768|NCT03067441|7652378|FG000|Overall Study|Withdrawal by Subject|16
4719769|NCT03067441|7652379|FG001|Overall Study|Withdrawal by Subject|34
4719770|NCT03067441|7652378|FG000|Overall Study|Lost to Follow-up|7
4719771|NCT03067441|7652379|FG001|Overall Study|Lost to Follow-up|5
4719772|NCT03067441|7652378|FG000|Overall Study|Adverse Event|7
4719773|NCT03067441|7652379|FG001|Overall Study|Adverse Event|14
4719774|NCT03067441|7652378|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1
4719775|NCT03067441|7652379|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0
4719776|NCT03067441|7652378|FG000|Overall Study|Physician Decision|1
4633404|NCT01911819|7503581|FG001|Overall Study|Withdrawal by Subject|1
4719777|NCT03067441|7652379|FG001|Overall Study|Physician Decision|3
4719778|NCT03067441|7652378|FG000|Overall Study|Other|1
4719779|NCT03067441|7652379|FG001|Overall Study|Other|1
4719780|NCT03067987|7652398|FG000|Overall Study|Lost to Follow-up|7
4719781|NCT03067987|7652399|FG001|Overall Study|Lost to Follow-up|10
4719782|NCT03067987|7652398|FG000|Overall Study|Protocol Violation|1
4719783|NCT03067987|7652399|FG001|Overall Study|Protocol Violation|2
4719784|NCT03067987|7652398|FG000|Overall Study|Withdrawal by Subject|2
4719785|NCT03067987|7652399|FG001|Overall Study|Withdrawal by Subject|1
4719786|NCT03068455|7652421|FG000|Pre-treatment Period|Disease progression|0
4719787|NCT03068455|7652422|FG001|Pre-treatment Period|Disease progression|1
4719788|NCT03068455|7652421|FG000|Pre-treatment Period|Participant withdrew consent|1
4719789|NCT03068455|7652422|FG001|Pre-treatment Period|Participant withdrew consent|1
4719790|NCT03068455|7652421|FG000|Pre-treatment Period|Poor/non-compliance|0
4719791|NCT03068455|7652422|FG001|Pre-treatment Period|Poor/non-compliance|1
4719792|NCT03068455|7652421|FG000|Pre-treatment Period|Participant no longer meets study criteria|1
4719793|NCT03068455|7652422|FG001|Pre-treatment Period|Participant no longer meets study criteria|3
4719794|NCT03068455|7652421|FG000|Pre-treatment Period|Not reported|2
4719795|NCT03068455|7652422|FG001|Pre-treatment Period|Not reported|1
4719796|NCT03068455|7652421|FG000|Treatment Period|Disease progression|166
4719797|NCT03068455|7652422|FG001|Treatment Period|Disease progression|208
4719798|NCT03068455|7652421|FG000|Treatment Period|Study drug toxicity|317
4719799|NCT03068455|7652422|FG001|Treatment Period|Study drug toxicity|104
4719800|NCT03068455|7652421|FG000|Treatment Period|Adverse Event unrelated to study drug|15
4719801|NCT03068455|7652422|FG001|Treatment Period|Adverse Event unrelated to study drug|7
4719802|NCT03068455|7652421|FG000|Treatment Period|Participant request to stop therapy|33
4719803|NCT03068455|7652422|FG001|Treatment Period|Participant request to stop therapy|20
4719804|NCT03068455|7652421|FG000|Treatment Period|Participant withdrew consent|5
4719805|NCT03068455|7652422|FG001|Treatment Period|Participant withdrew consent|10
4719806|NCT03068455|7652421|FG000|Treatment Period|Poor/non-compliance|3
4719807|NCT03068455|7652422|FG001|Treatment Period|Poor/non-compliance|0
4719808|NCT03068455|7652421|FG000|Treatment Period|Participant no longer meets study criteria|1
4719809|NCT03068455|7652422|FG001|Treatment Period|Participant no longer meets study criteria|3
4719810|NCT03068455|7652421|FG000|Treatment Period|Other reasons|12
4719811|NCT03068455|7652422|FG001|Treatment Period|Other reasons|4
4719812|NCT03068468|7652430|FG000|Placebo-Controlled Period|Randomized but not Treated|1
4719813|NCT03068468|7652431|FG001|Placebo-Controlled Period|Randomized but not Treated|3
4719814|NCT03068468|7652432|FG002|Placebo-Controlled Period|Randomized but not Treated|0
4719815|NCT03068468|7652433|FG003|Placebo-Controlled Period|Randomized but not Treated|0
4719816|NCT03068468|7652430|FG000|Placebo-Controlled Period|Lack of Efficacy|0
4719817|NCT03068468|7652431|FG001|Placebo-Controlled Period|Lack of Efficacy|1
4719818|NCT03068468|7652432|FG002|Placebo-Controlled Period|Lack of Efficacy|0
4719819|NCT03068468|7652433|FG003|Placebo-Controlled Period|Lack of Efficacy|0
4719820|NCT03068468|7652430|FG000|Placebo-Controlled Period|Adverse Event|16
4719821|NCT03068468|7652431|FG001|Placebo-Controlled Period|Adverse Event|21
4719822|NCT03068468|7652432|FG002|Placebo-Controlled Period|Adverse Event|0
4719823|NCT03068468|7652433|FG003|Placebo-Controlled Period|Adverse Event|0
4719824|NCT03068468|7652430|FG000|Placebo-Controlled Period|Withdrawal by Subject|3
4719825|NCT03068468|7652431|FG001|Placebo-Controlled Period|Withdrawal by Subject|11
4719826|NCT03068468|7652432|FG002|Placebo-Controlled Period|Withdrawal by Subject|0
4719827|NCT03068468|7652433|FG003|Placebo-Controlled Period|Withdrawal by Subject|0
4719828|NCT03068468|7652430|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1
4719829|NCT03068468|7652431|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2
4719830|NCT03068468|7652432|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
4719831|NCT03068468|7652433|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
4719832|NCT03068468|7652430|FG000|Placebo-Controlled Period|Reason Not Specified|1
4719833|NCT03068468|7652431|FG001|Placebo-Controlled Period|Reason Not Specified|6
4719834|NCT03068468|7652432|FG002|Placebo-Controlled Period|Reason Not Specified|0
4719835|NCT03068468|7652433|FG003|Placebo-Controlled Period|Reason Not Specified|0
4719836|NCT03068468|7652430|FG000|Placebo-Controlled Period|Death|0
4719837|NCT03068468|7652431|FG001|Placebo-Controlled Period|Death|1
4719838|NCT03068468|7652432|FG002|Placebo-Controlled Period|Death|0
4719839|NCT03068468|7652433|FG003|Placebo-Controlled Period|Death|0
4719840|NCT03068468|7652430|FG000|Open-Label Extension Period|Lack of Efficacy|0
4719841|NCT03068468|7652431|FG001|Open-Label Extension Period|Lack of Efficacy|0
4719842|NCT03068468|7652432|FG002|Open-Label Extension Period|Lack of Efficacy|1
4719843|NCT03068468|7652433|FG003|Open-Label Extension Period|Lack of Efficacy|2
4719844|NCT03068468|7652430|FG000|Open-Label Extension Period|Adverse Event|0
4719845|NCT03068468|7652431|FG001|Open-Label Extension Period|Adverse Event|0
4719846|NCT03068468|7652432|FG002|Open-Label Extension Period|Adverse Event|13
4719847|NCT03068468|7652433|FG003|Open-Label Extension Period|Adverse Event|17
4719848|NCT03068468|7652430|FG000|Open-Label Extension Period|Withdrawal by Subject|0
4719849|NCT03068468|7652431|FG001|Open-Label Extension Period|Withdrawal by Subject|0
4719850|NCT03068468|7652432|FG002|Open-Label Extension Period|Withdrawal by Subject|7
4719851|NCT03068468|7652433|FG003|Open-Label Extension Period|Withdrawal by Subject|20
4719852|NCT03068468|7652430|FG000|Open-Label Extension Period|Death|0
4719853|NCT03068468|7652431|FG001|Open-Label Extension Period|Death|0
4719854|NCT03068468|7652432|FG002|Open-Label Extension Period|Death|0
4719855|NCT03068468|7652433|FG003|Open-Label Extension Period|Death|1
4719856|NCT03068468|7652430|FG000|Open-Label Extension Period|Lost to Follow-up|0
4719857|NCT03068468|7652431|FG001|Open-Label Extension Period|Lost to Follow-up|0
4719858|NCT03068468|7652432|FG002|Open-Label Extension Period|Lost to Follow-up|1
4719859|NCT03068468|7652433|FG003|Open-Label Extension Period|Lost to Follow-up|0
4719860|NCT03068468|7652430|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0
4719861|NCT03068468|7652431|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0
4719862|NCT03068468|7652432|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2
4719863|NCT03068468|7652433|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0
4719864|NCT03068468|7652430|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0
4719865|NCT03068468|7652431|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0
4719866|NCT03068468|7652432|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115
4719867|NCT03068468|7652433|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228
4719868|NCT03068468|7652430|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0
4719869|NCT03068468|7652431|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0
4719870|NCT03068468|7652432|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0
4719871|NCT03068468|7652433|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4
4719872|NCT03068468|7652430|FG000|Open-Label Extension Period|Reason not Specified|0
4719873|NCT03068468|7652431|FG001|Open-Label Extension Period|Reason not Specified|0
4736416|NCT03567291|7685594|FG000|Period III|Withdrawal by Subject|0
4719874|NCT03068468|7652432|FG002|Open-Label Extension Period|Reason not Specified|1
4719875|NCT03068468|7652433|FG003|Open-Label Extension Period|Reason not Specified|4
4719876|NCT03068715|7652452|FG000|Overall Study|No longer met inclusion criteria|1
4719877|NCT03068715|7652453|FG001|Overall Study|No longer met inclusion criteria|0
4719878|NCT03068754|7652463|FG000|Randomized Treatment Period (RTP)|Adverse Event|1
4719879|NCT03068754|7652464|FG001|Randomized Treatment Period (RTP)|Adverse Event|3
4719880|NCT03068754|7652465|FG002|Randomized Treatment Period (RTP)|Adverse Event|0
4719881|NCT03068754|7652466|FG003|Randomized Treatment Period (RTP)|Adverse Event|0
4719882|NCT03068754|7652463|FG000|Randomized Treatment Period (RTP)|Death|2
4719883|NCT03068754|7652464|FG001|Randomized Treatment Period (RTP)|Death|2
4719884|NCT03068754|7652465|FG002|Randomized Treatment Period (RTP)|Death|0
4719885|NCT03068754|7652466|FG003|Randomized Treatment Period (RTP)|Death|0
4719886|NCT03068754|7652463|FG000|Randomized Treatment Period (RTP)|Disease progression|1
4719887|NCT03068754|7652464|FG001|Randomized Treatment Period (RTP)|Disease progression|2
4719888|NCT03068754|7652465|FG002|Randomized Treatment Period (RTP)|Disease progression|0
4719889|NCT03068754|7652466|FG003|Randomized Treatment Period (RTP)|Disease progression|0
4719890|NCT03068754|7652463|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1
4719891|NCT03068754|7652464|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0
4719892|NCT03068754|7652465|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0
4719893|NCT03068754|7652466|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0
4719894|NCT03068754|7652463|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6
4719895|NCT03068754|7652464|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2
4719896|NCT03068754|7652465|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0
4719897|NCT03068754|7652466|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0
4719898|NCT03068754|7652463|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1
4719899|NCT03068754|7652464|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0
4719900|NCT03068754|7652465|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0
4719901|NCT03068754|7652466|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0
4719902|NCT03068754|7652463|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0
4719903|NCT03068754|7652464|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1
4719904|NCT03068754|7652465|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0
4719905|NCT03068754|7652466|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0
4719906|NCT03068754|7652463|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55
4719907|NCT03068754|7652464|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29
4719908|NCT03068754|7652465|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0
4719909|NCT03068754|7652466|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0
4719910|NCT03068754|7652463|FG000|Open Label Extension Period (OLE)|Adverse Event|0
4719911|NCT03068754|7652464|FG001|Open Label Extension Period (OLE)|Adverse Event|0
4719912|NCT03068754|7652465|FG002|Open Label Extension Period (OLE)|Adverse Event|0
4719913|NCT03068754|7652466|FG003|Open Label Extension Period (OLE)|Adverse Event|1
4719914|NCT03068754|7652463|FG000|Open Label Extension Period (OLE)|Death|0
4719915|NCT03068754|7652464|FG001|Open Label Extension Period (OLE)|Death|0
4719916|NCT03068754|7652465|FG002|Open Label Extension Period (OLE)|Death|0
4719917|NCT03068754|7652466|FG003|Open Label Extension Period (OLE)|Death|1
4719918|NCT03068754|7652463|FG000|Open Label Extension Period (OLE)|Disease progression|0
4719919|NCT03068754|7652464|FG001|Open Label Extension Period (OLE)|Disease progression|0
4719920|NCT03068754|7652465|FG002|Open Label Extension Period (OLE)|Disease progression|3
4719921|NCT03068754|7652466|FG003|Open Label Extension Period (OLE)|Disease progression|1
4719922|NCT03068754|7652463|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0
4719923|NCT03068754|7652464|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0
4719924|NCT03068754|7652465|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5
4719925|NCT03068754|7652466|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0
4719926|NCT03068754|7652463|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0
4719927|NCT03068754|7652464|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0
4719928|NCT03068754|7652465|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1
4719929|NCT03068754|7652466|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0
4719930|NCT03068754|7652463|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0
4719931|NCT03068754|7652464|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0
4719932|NCT03068754|7652465|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12
4719933|NCT03068754|7652466|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3
4719934|NCT03068767|7652478|FG000|Overall Study|Lost to Follow-up|7
4719935|NCT03068767|7652479|FG001|Overall Study|Lost to Follow-up|3
4719936|NCT03068767|7652478|FG000|Overall Study|Protocol Violation|3
4719937|NCT03068767|7652479|FG001|Overall Study|Protocol Violation|0
4719938|NCT03069313|7652519|FG000|Overall Study|Adverse Event|5
4719939|NCT03069352|7652525|FG000|Overall Study|Ongoing|12
4719940|NCT03069352|7652526|FG001|Overall Study|Ongoing|40
4719941|NCT03069365|7652532|FG000|Overall Study|Adverse Event|1
4719942|NCT03069482|7652538|FG000|Overall Study|Lost to Follow-up|0
4719943|NCT03069482|7652539|FG001|Overall Study|Lost to Follow-up|1
4719944|NCT03069482|7652538|FG000|Overall Study|Physician Decision|1
4719945|NCT03069482|7652539|FG001|Overall Study|Physician Decision|0
4719946|NCT03069716|7652559|FG000|Run-in Period (2 Weeks)|Adverse Event|1
4719947|NCT03069716|7652560|FG001|Run-in Period (2 Weeks)|Adverse Event|0
4719948|NCT03069716|7652561|FG002|Run-in Period (2 Weeks)|Adverse Event|0
4719949|NCT03069716|7652559|FG000|Run-in Period (2 Weeks)|Protocol Violation|1
4719950|NCT03069716|7652560|FG001|Run-in Period (2 Weeks)|Protocol Violation|0
4719951|NCT03069716|7652561|FG002|Run-in Period (2 Weeks)|Protocol Violation|0
4719952|NCT03069716|7652559|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5
4719953|NCT03069716|7652560|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0
4719954|NCT03069716|7652561|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0
4719955|NCT03069716|7652559|FG000|Randomized Treatment|Withdrawal by Subject|0
4719956|NCT03069716|7652560|FG001|Randomized Treatment|Withdrawal by Subject|2
4719957|NCT03069716|7652561|FG002|Randomized Treatment|Withdrawal by Subject|0
4719958|NCT03069989|7652570|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1
4719959|NCT03069989|7652571|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0
4719960|NCT03070171|7652580|FG000|Treatment Period 2 + Washout|Other Adverse Event|0
4719961|NCT03070171|7652581|FG001|Treatment Period 2 + Washout|Other Adverse Event|1
4719962|NCT03070171|7652580|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0
4719963|NCT03070171|7652581|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1
4719964|NCT03070431|7652594|FG000|Overall Study|Withdrawal by Subject|2
4719965|NCT03070431|7652594|FG000|Overall Study|Lost to Follow-up|2
4719966|NCT03070483|7652630|FG000|Overall Study|Lost to Follow-up|2
4736417|NCT03567291|7685595|FG001|Period III|Withdrawal by Subject|0
4736418|NCT03567291|7685596|FG002|Period III|Withdrawal by Subject|0
4736419|NCT03567291|7685597|FG003|Period III|Withdrawal by Subject|4
4736420|NCT03567291|7685594|FG000|Period III|Lost to Follow-up|0
4736421|NCT03567291|7685595|FG001|Period III|Lost to Follow-up|0
4736422|NCT03567291|7685596|FG002|Period III|Lost to Follow-up|0
4736423|NCT03567291|7685597|FG003|Period III|Lost to Follow-up|1
4736424|NCT03567291|7685594|FG000|Period III|Terminated by sponsor|0
4736425|NCT03567291|7685595|FG001|Period III|Terminated by sponsor|0
4736426|NCT03567291|7685596|FG002|Period III|Terminated by sponsor|0
4736427|NCT03567291|7685597|FG003|Period III|Terminated by sponsor|68
4736428|NCT03567291|7685594|FG000|Period III|Missing or unknown|0
4736429|NCT03567291|7685595|FG001|Period III|Missing or unknown|0
4736430|NCT03567291|7685596|FG002|Period III|Missing or unknown|0
4736431|NCT03567291|7685597|FG003|Period III|Missing or unknown|8
4736432|NCT03567382|7685605|FG000|Overall Study|Lost to Follow-up|1
4736433|NCT03567382|7685606|FG001|Overall Study|Lost to Follow-up|21
4736434|NCT03567382|7685607|FG002|Overall Study|Lost to Follow-up|1
4736435|NCT03567382|7685608|FG003|Overall Study|Lost to Follow-up|21
4736436|NCT03567382|7685605|FG000|Overall Study|Withdrawal by Subject|2
4736437|NCT03567382|7685606|FG001|Overall Study|Withdrawal by Subject|14
4736438|NCT03567382|7685607|FG002|Overall Study|Withdrawal by Subject|1
4736439|NCT03567382|7685608|FG003|Overall Study|Withdrawal by Subject|12
4736440|NCT03567616|7685621|FG000|Overall Study|Disease progression|4
4736441|NCT03567616|7685621|FG000|Overall Study|Withdrawal by Subject|1
4736442|NCT03567616|7685621|FG000|Overall Study|Physician Decision|1
4736443|NCT03567616|7685621|FG000|Overall Study|Death|1
4736444|NCT03567616|7685621|FG000|Overall Study|Adverse Event|1
4736445|NCT03567980|7685628|FG000|Overall Study|Adverse Event|1
4736446|NCT03568500|7685635|FG000|Overall Study|Lost to Follow-up|1
4736447|NCT03568500|7685636|FG001|Overall Study|Lost to Follow-up|1
4736448|NCT03568500|7685637|FG002|Overall Study|Lost to Follow-up|2
4736449|NCT03568500|7685635|FG000|Overall Study|Adverse Event|1
4736450|NCT03568500|7685636|FG001|Overall Study|Adverse Event|1
4736451|NCT03568500|7685637|FG002|Overall Study|Adverse Event|2
4736452|NCT03568500|7685635|FG000|Overall Study|Physician Decision|1
4736453|NCT03568500|7685636|FG001|Overall Study|Physician Decision|0
4736454|NCT03568500|7685637|FG002|Overall Study|Physician Decision|0
4736455|NCT03568500|7685635|FG000|Overall Study|Withdrawal by Subject|4
4736456|NCT03568500|7685636|FG001|Overall Study|Withdrawal by Subject|2
4736457|NCT03568500|7685637|FG002|Overall Study|Withdrawal by Subject|0
4736458|NCT03568500|7685635|FG000|Overall Study|Technical Problems|2
4736459|NCT03568500|7685636|FG001|Overall Study|Technical Problems|1
4736460|NCT03568500|7685637|FG002|Overall Study|Technical Problems|0
4736461|NCT03568500|7685635|FG000|Overall Study|Participant Noncompliance|1
4736462|NCT03568500|7685636|FG001|Overall Study|Participant Noncompliance|1
4736463|NCT03568500|7685637|FG002|Overall Study|Participant Noncompliance|0
4736464|NCT03568942|7685660|FG000|Overall Study|Family emergency|1
4736465|NCT03568942|7685660|FG000|Overall Study|Lost to Follow-up|1
4736466|NCT03569098|7685689|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5
4736467|NCT03569098|7685690|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2
4736468|NCT03569098|7685691|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5
4736469|NCT03569098|7685689|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0
4736470|NCT03569098|7685690|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6
4736471|NCT03569098|7685691|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3
4736472|NCT03569098|7685689|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1
4736473|NCT03569098|7685690|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1
4736474|NCT03569098|7685691|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0
4736475|NCT03569098|7685689|FG000|Double-Blind Treatment Cycle 1|Technical problems|0
4736476|NCT03569098|7685690|FG001|Double-Blind Treatment Cycle 1|Technical problems|0
4719967|NCT03070782|7652658|FG000|Overall Study|Adverse Event|3
4719968|NCT03070782|7652659|FG001|Overall Study|Adverse Event|0
4719969|NCT03070782|7652660|FG002|Overall Study|Adverse Event|3
4719970|NCT03070782|7652661|FG003|Overall Study|Adverse Event|1
4719971|NCT03070782|7652662|FG004|Overall Study|Adverse Event|6
4719972|NCT03070782|7652663|FG005|Overall Study|Adverse Event|2
4719973|NCT03070782|7652658|FG000|Overall Study|Withdrawal by Subject|2
4719974|NCT03070782|7652659|FG001|Overall Study|Withdrawal by Subject|1
4719975|NCT03070782|7652660|FG002|Overall Study|Withdrawal by Subject|1
4719976|NCT03070782|7652661|FG003|Overall Study|Withdrawal by Subject|0
4719977|NCT03070782|7652662|FG004|Overall Study|Withdrawal by Subject|4
4719978|NCT03070782|7652663|FG005|Overall Study|Withdrawal by Subject|3
4719979|NCT03070782|7652658|FG000|Overall Study|Reason Not Specified|2
4719980|NCT03070782|7652659|FG001|Overall Study|Reason Not Specified|0
4719981|NCT03070782|7652660|FG002|Overall Study|Reason Not Specified|0
4719982|NCT03070782|7652661|FG003|Overall Study|Reason Not Specified|1
4719983|NCT03070782|7652662|FG004|Overall Study|Reason Not Specified|2
4719984|NCT03070782|7652663|FG005|Overall Study|Reason Not Specified|1
4719985|NCT03070782|7652658|FG000|Overall Study|Ineligibility|0
4719986|NCT03070782|7652659|FG001|Overall Study|Ineligibility|0
4719987|NCT03070782|7652660|FG002|Overall Study|Ineligibility|0
4719988|NCT03070782|7652661|FG003|Overall Study|Ineligibility|1
4719989|NCT03070782|7652662|FG004|Overall Study|Ineligibility|0
4719990|NCT03070782|7652663|FG005|Overall Study|Ineligibility|1
4719991|NCT03070782|7652658|FG000|Overall Study|Pregnancy|0
4719992|NCT03070782|7652659|FG001|Overall Study|Pregnancy|0
4719993|NCT03070782|7652660|FG002|Overall Study|Pregnancy|0
4719994|NCT03070782|7652661|FG003|Overall Study|Pregnancy|1
4719995|NCT03070782|7652662|FG004|Overall Study|Pregnancy|0
4719996|NCT03070782|7652663|FG005|Overall Study|Pregnancy|0
4719997|NCT03070782|7652658|FG000|Overall Study|Investigator Judgement|0
4719998|NCT03070782|7652659|FG001|Overall Study|Investigator Judgement|0
4719999|NCT03070782|7652660|FG002|Overall Study|Investigator Judgement|0
4720000|NCT03070782|7652661|FG003|Overall Study|Investigator Judgement|1
4720001|NCT03070782|7652662|FG004|Overall Study|Investigator Judgement|0
4720002|NCT03070782|7652663|FG005|Overall Study|Investigator Judgement|0
4720003|NCT03070964|7652677|FG000|Overall Study|Progressive disease|8
4720004|NCT03070964|7652677|FG000|Overall Study|Treatment-unrelated adverse event|2
4720005|NCT03070964|7652677|FG000|Overall Study|Never treated|1
4720006|NCT03070964|7652677|FG000|Overall Study|Physician Decision|1
4720007|NCT03070964|7652677|FG000|Overall Study|Withdrawal by Subject|1
4720008|NCT03070964|7652677|FG000|Overall Study|Adverse Event|1
4720009|NCT03071094|7652683|FG000|Overall Study|Death|1
4720010|NCT03071094|7652684|FG001|Overall Study|Death|1
4720011|NCT03071094|7652683|FG000|Overall Study|Adverse Event|1
4720012|NCT03071094|7652684|FG001|Overall Study|Adverse Event|0
4720013|NCT03071263|7652692|FG000|Overall Study|Adverse Event|1
4720014|NCT03071263|7652693|FG001|Overall Study|Adverse Event|3
4720015|NCT03071263|7652692|FG000|Overall Study|Withdrawal by Subject|1
4720016|NCT03071263|7652693|FG001|Overall Study|Withdrawal by Subject|3
4720017|NCT03071263|7652692|FG000|Overall Study|Physician Decision|1
4720018|NCT03071263|7652693|FG001|Overall Study|Physician Decision|0
4720019|NCT03071263|7652692|FG000|Overall Study|Participant moved to another city|0
4720020|NCT03071263|7652693|FG001|Overall Study|Participant moved to another city|1
4720021|NCT03071276|7652699|FG000|Overall Study|Adverse Event|1
4720022|NCT03071276|7652699|FG000|Overall Study|Lack of Efficacy|14
4720023|NCT03072160|7652713|FG000|Overall Study|Adverse Event|3
4720024|NCT03072160|7652714|FG001|Overall Study|Adverse Event|1
4720025|NCT03072160|7652713|FG000|Overall Study|Refused further treatment|6
4720026|NCT03072160|7652714|FG001|Overall Study|Refused further treatment|1
4720027|NCT03072160|7652713|FG000|Overall Study|Physician Decision|1
4720028|NCT03072160|7652714|FG001|Overall Study|Physician Decision|0
4720029|NCT03072160|7652713|FG000|Overall Study|Disease progression on study|1
4720030|NCT03072160|7652714|FG001|Overall Study|Disease progression on study|1
4720031|NCT03072160|7652713|FG000|Overall Study|No contact|0
4720032|NCT03072160|7652714|FG001|Overall Study|No contact|1
4720033|NCT03072719|7652771|FG000|Overall Study|Adverse Event|1
4720034|NCT03072719|7652772|FG001|Overall Study|Adverse Event|1
4720035|NCT03072875|7652787|FG000|Overall Study|Lost to Follow-up|1
4720036|NCT03073005|7652800|FG000|Overall Study|Death|6
4720037|NCT03073005|7652801|FG001|Overall Study|Death|0
4720038|NCT03073005|7652802|FG002|Overall Study|Death|7
4720039|NCT03073005|7652803|FG003|Overall Study|Death|0
4720040|NCT03073005|7652800|FG000|Overall Study|caregiver withdrew bc of pt death|0
4720041|NCT03073005|7652801|FG001|Overall Study|caregiver withdrew bc of pt death|6
4720042|NCT03073005|7652802|FG002|Overall Study|caregiver withdrew bc of pt death|0
4720043|NCT03073005|7652803|FG003|Overall Study|caregiver withdrew bc of pt death|7
4720044|NCT03073005|7652800|FG000|Overall Study|Lost to Follow-up|2
4720045|NCT03073005|7652801|FG001|Overall Study|Lost to Follow-up|2
4720046|NCT03073005|7652802|FG002|Overall Study|Lost to Follow-up|1
4720047|NCT03073005|7652803|FG003|Overall Study|Lost to Follow-up|2
4720048|NCT03073005|7652800|FG000|Overall Study|Withdrawal by Subject|0
4720049|NCT03073005|7652801|FG001|Overall Study|Withdrawal by Subject|4
4720050|NCT03073005|7652802|FG002|Overall Study|Withdrawal by Subject|4
4720051|NCT03073005|7652803|FG003|Overall Study|Withdrawal by Subject|4
4720052|NCT03073109|7652818|FG000|Overall Study|Adverse Event|0
4720053|NCT03073109|7652819|FG001|Overall Study|Adverse Event|1
4720054|NCT03073109|7652818|FG000|Overall Study|Other|2
4720055|NCT03073109|7652819|FG001|Overall Study|Other|0
4720056|NCT03073109|7652818|FG000|Overall Study|Lost to Follow-up|8
4720057|NCT03073109|7652819|FG001|Overall Study|Lost to Follow-up|1
4720058|NCT03073200|7652854|FG000|Double Blind Treatment Period|Protocol Violation|1
4720059|NCT03073200|7652855|FG001|Double Blind Treatment Period|Protocol Violation|0
4720060|NCT03073200|7652856|FG002|Double Blind Treatment Period|Protocol Violation|0
4720061|NCT03073200|7652857|FG003|Double Blind Treatment Period|Protocol Violation|0
4720062|NCT03073200|7652858|FG004|Double Blind Treatment Period|Protocol Violation|0
4720063|NCT03073200|7652859|FG005|Double Blind Treatment Period|Protocol Violation|0
4720064|NCT03073200|7652860|FG006|Double Blind Treatment Period|Protocol Violation|0
4720065|NCT03073200|7652861|FG007|Double Blind Treatment Period|Protocol Violation|0
4720066|NCT03073200|7652862|FG008|Double Blind Treatment Period|Protocol Violation|0
4720067|NCT03073200|7652863|FG009|Double Blind Treatment Period|Protocol Violation|0
4720068|NCT03073200|7652864|FG010|Double Blind Treatment Period|Protocol Violation|0
4720069|NCT03073200|7652865|FG011|Double Blind Treatment Period|Protocol Violation|0
4720070|NCT03073200|7652866|FG012|Double Blind Treatment Period|Protocol Violation|0
4720071|NCT03073200|7652867|FG013|Double Blind Treatment Period|Protocol Violation|0
4720072|NCT03073200|7652868|FG014|Double Blind Treatment Period|Protocol Violation|0
4720073|NCT03073200|7652854|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
4720074|NCT03073200|7652855|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1
4720075|NCT03073200|7652856|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
4720076|NCT03073200|7652857|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
4720077|NCT03073200|7652858|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
4720078|NCT03073200|7652859|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
4720079|NCT03073200|7652860|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
4720080|NCT03073200|7652861|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
4720081|NCT03073200|7652862|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
4720082|NCT03073200|7652863|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
4720083|NCT03073200|7652864|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
4720084|NCT03073200|7652865|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
4720085|NCT03073200|7652866|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
4720086|NCT03073200|7652867|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
4720087|NCT03073200|7652868|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0
4720088|NCT03073200|7652854|FG000|Double Blind Treatment Period|Withdrawal by Subject|1
4720089|NCT03073200|7652855|FG001|Double Blind Treatment Period|Withdrawal by Subject|0
4630673|NCT01884350|7499505|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20
4630674|NCT01884350|7499506|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0
4630675|NCT01884350|7499504|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6
4630676|NCT01884350|7499505|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4
4630677|NCT01884350|7499506|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0
4630678|NCT01884350|7499504|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0
4630679|NCT01884350|7499505|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1
4630680|NCT01884350|7499506|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0
4633405|NCT01911819|7503582|FG002|Overall Study|Withdrawal by Subject|0
4720090|NCT03073200|7652856|FG002|Double Blind Treatment Period|Withdrawal by Subject|0
4720091|NCT03073200|7652857|FG003|Double Blind Treatment Period|Withdrawal by Subject|0
4720092|NCT03073200|7652858|FG004|Double Blind Treatment Period|Withdrawal by Subject|0
4720093|NCT03073200|7652859|FG005|Double Blind Treatment Period|Withdrawal by Subject|0
4720094|NCT03073200|7652860|FG006|Double Blind Treatment Period|Withdrawal by Subject|0
4720095|NCT03073200|7652861|FG007|Double Blind Treatment Period|Withdrawal by Subject|0
4720096|NCT03073200|7652862|FG008|Double Blind Treatment Period|Withdrawal by Subject|0
4720097|NCT03073200|7652863|FG009|Double Blind Treatment Period|Withdrawal by Subject|0
4720098|NCT03073200|7652864|FG010|Double Blind Treatment Period|Withdrawal by Subject|0
4720099|NCT03073200|7652865|FG011|Double Blind Treatment Period|Withdrawal by Subject|0
4720100|NCT03073200|7652866|FG012|Double Blind Treatment Period|Withdrawal by Subject|0
4720101|NCT03073200|7652867|FG013|Double Blind Treatment Period|Withdrawal by Subject|0
4720102|NCT03073200|7652868|FG014|Double Blind Treatment Period|Withdrawal by Subject|0
4720103|NCT03073200|7652854|FG000|Open-Label Maintenance Period|Lost to Follow-up|0
4720104|NCT03073200|7652855|FG001|Open-Label Maintenance Period|Lost to Follow-up|0
4720105|NCT03073200|7652856|FG002|Open-Label Maintenance Period|Lost to Follow-up|0
4720106|NCT03073200|7652857|FG003|Open-Label Maintenance Period|Lost to Follow-up|1
4720107|NCT03073200|7652858|FG004|Open-Label Maintenance Period|Lost to Follow-up|2
4720108|NCT03073200|7652859|FG005|Open-Label Maintenance Period|Lost to Follow-up|0
4720109|NCT03073200|7652860|FG006|Open-Label Maintenance Period|Lost to Follow-up|0
4720110|NCT03073200|7652861|FG007|Open-Label Maintenance Period|Lost to Follow-up|0
4720111|NCT03073200|7652862|FG008|Open-Label Maintenance Period|Lost to Follow-up|0
4720112|NCT03073200|7652863|FG009|Open-Label Maintenance Period|Lost to Follow-up|0
4720113|NCT03073200|7652864|FG010|Open-Label Maintenance Period|Lost to Follow-up|0
4771746|NCT03284853|7748654|FG000|Overall Study|Adverse Event|40
4720114|NCT03073200|7652865|FG011|Open-Label Maintenance Period|Lost to Follow-up|0
4720115|NCT03073200|7652866|FG012|Open-Label Maintenance Period|Lost to Follow-up|0
4720116|NCT03073200|7652867|FG013|Open-Label Maintenance Period|Lost to Follow-up|0
4720117|NCT03073200|7652868|FG014|Open-Label Maintenance Period|Lost to Follow-up|0
4720118|NCT03073200|7652854|FG000|Open-Label Maintenance Period|Participant moved to another city|0
4720119|NCT03073200|7652855|FG001|Open-Label Maintenance Period|Participant moved to another city|0
4720120|NCT03073200|7652856|FG002|Open-Label Maintenance Period|Participant moved to another city|0
4720121|NCT03073200|7652857|FG003|Open-Label Maintenance Period|Participant moved to another city|1
4720122|NCT03073200|7652858|FG004|Open-Label Maintenance Period|Participant moved to another city|0
4720123|NCT03073200|7652859|FG005|Open-Label Maintenance Period|Participant moved to another city|0
4720124|NCT03073200|7652860|FG006|Open-Label Maintenance Period|Participant moved to another city|0
4720125|NCT03073200|7652861|FG007|Open-Label Maintenance Period|Participant moved to another city|0
4720126|NCT03073200|7652862|FG008|Open-Label Maintenance Period|Participant moved to another city|0
4720127|NCT03073200|7652863|FG009|Open-Label Maintenance Period|Participant moved to another city|0
4720128|NCT03073200|7652864|FG010|Open-Label Maintenance Period|Participant moved to another city|0
4720129|NCT03073200|7652865|FG011|Open-Label Maintenance Period|Participant moved to another city|0
4720130|NCT03073200|7652866|FG012|Open-Label Maintenance Period|Participant moved to another city|0
4720131|NCT03073200|7652867|FG013|Open-Label Maintenance Period|Participant moved to another city|0
4720132|NCT03073200|7652868|FG014|Open-Label Maintenance Period|Participant moved to another city|0
4720133|NCT03073200|7652854|FG000|Open-Label Maintenance Period|Lack of Efficacy|0
4720134|NCT03073200|7652855|FG001|Open-Label Maintenance Period|Lack of Efficacy|0
4720135|NCT03073200|7652856|FG002|Open-Label Maintenance Period|Lack of Efficacy|0
4720136|NCT03073200|7652857|FG003|Open-Label Maintenance Period|Lack of Efficacy|0
4720137|NCT03073200|7652858|FG004|Open-Label Maintenance Period|Lack of Efficacy|1
4720138|NCT03073200|7652859|FG005|Open-Label Maintenance Period|Lack of Efficacy|0
4720139|NCT03073200|7652860|FG006|Open-Label Maintenance Period|Lack of Efficacy|0
4720140|NCT03073200|7652861|FG007|Open-Label Maintenance Period|Lack of Efficacy|0
4720141|NCT03073200|7652862|FG008|Open-Label Maintenance Period|Lack of Efficacy|0
4720142|NCT03073200|7652863|FG009|Open-Label Maintenance Period|Lack of Efficacy|0
4720143|NCT03073200|7652864|FG010|Open-Label Maintenance Period|Lack of Efficacy|0
4720144|NCT03073200|7652865|FG011|Open-Label Maintenance Period|Lack of Efficacy|0
4720145|NCT03073200|7652866|FG012|Open-Label Maintenance Period|Lack of Efficacy|0
4720146|NCT03073200|7652867|FG013|Open-Label Maintenance Period|Lack of Efficacy|0
4720147|NCT03073200|7652868|FG014|Open-Label Maintenance Period|Lack of Efficacy|0
4720148|NCT03073200|7652854|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0
4720149|NCT03073200|7652855|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0
4720150|NCT03073200|7652856|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0
4720151|NCT03073200|7652857|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2
4720152|NCT03073200|7652858|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1
4720153|NCT03073200|7652859|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0
4720154|NCT03073200|7652860|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0
4720155|NCT03073200|7652861|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0
4720156|NCT03073200|7652862|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0
4720157|NCT03073200|7652863|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0
4720158|NCT03073200|7652864|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0
4720159|NCT03073200|7652865|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0
4720160|NCT03073200|7652866|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0
4720161|NCT03073200|7652867|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0
4720162|NCT03073200|7652868|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0
4720163|NCT03073200|7652854|FG000|Extension Period|Lost to Follow-up|0
4720164|NCT03073200|7652855|FG001|Extension Period|Lost to Follow-up|0
4720165|NCT03073200|7652856|FG002|Extension Period|Lost to Follow-up|0
4720166|NCT03073200|7652857|FG003|Extension Period|Lost to Follow-up|0
4720167|NCT03073200|7652858|FG004|Extension Period|Lost to Follow-up|0
4720168|NCT03073200|7652859|FG005|Extension Period|Lost to Follow-up|0
4720169|NCT03073200|7652860|FG006|Extension Period|Lost to Follow-up|1
4720170|NCT03073200|7652861|FG007|Extension Period|Lost to Follow-up|1
4720171|NCT03073200|7652862|FG008|Extension Period|Lost to Follow-up|0
4720172|NCT03073200|7652863|FG009|Extension Period|Lost to Follow-up|0
4720173|NCT03073200|7652864|FG010|Extension Period|Lost to Follow-up|0
4720174|NCT03073200|7652865|FG011|Extension Period|Lost to Follow-up|0
4720175|NCT03073200|7652866|FG012|Extension Period|Lost to Follow-up|0
4720176|NCT03073200|7652867|FG013|Extension Period|Lost to Follow-up|0
4720177|NCT03073200|7652868|FG014|Extension Period|Lost to Follow-up|0
4720178|NCT03073200|7652854|FG000|Extension Period|Sponsor Decision|0
4720179|NCT03073200|7652855|FG001|Extension Period|Sponsor Decision|0
4720180|NCT03073200|7652856|FG002|Extension Period|Sponsor Decision|0
4720181|NCT03073200|7652857|FG003|Extension Period|Sponsor Decision|0
4720182|NCT03073200|7652858|FG004|Extension Period|Sponsor Decision|0
4720183|NCT03073200|7652859|FG005|Extension Period|Sponsor Decision|0
4720184|NCT03073200|7652860|FG006|Extension Period|Sponsor Decision|0
4720185|NCT03073200|7652861|FG007|Extension Period|Sponsor Decision|0
4720186|NCT03073200|7652862|FG008|Extension Period|Sponsor Decision|1
4720187|NCT03073200|7652863|FG009|Extension Period|Sponsor Decision|0
4720188|NCT03073200|7652864|FG010|Extension Period|Sponsor Decision|0
4720189|NCT03073200|7652865|FG011|Extension Period|Sponsor Decision|0
4720190|NCT03073200|7652866|FG012|Extension Period|Sponsor Decision|0
4720191|NCT03073200|7652867|FG013|Extension Period|Sponsor Decision|0
4720192|NCT03073200|7652868|FG014|Extension Period|Sponsor Decision|0
4720193|NCT03073200|7652854|FG000|Extension Period|Withdrawal by Parent/Guardian|0
4630681|NCT01884350|7499504|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7
4630682|NCT01884350|7499505|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6
4630683|NCT01884350|7499506|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0
4630684|NCT01884350|7499504|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15
4630685|NCT01884350|7499505|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11
4630686|NCT01884350|7499506|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0
4630687|NCT01884350|7499504|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0
4630688|NCT01884350|7499505|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2
4630689|NCT01884350|7499506|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0
4630690|NCT01884350|7499504|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2
4630691|NCT01884350|7499505|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5
4630692|NCT01884350|7499506|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0
4630693|NCT01884350|7499504|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2
4630694|NCT01884350|7499505|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0
4630695|NCT01884350|7499506|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0
4630696|NCT01884350|7499504|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1
4630697|NCT01884350|7499505|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1
4630698|NCT01884350|7499506|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0
4630699|NCT01884350|7499504|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1
4630700|NCT01884350|7499505|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1
4633406|NCT01911845|7503590|FG000|Overall Study|Adverse Event|2
4720194|NCT03073200|7652855|FG001|Extension Period|Withdrawal by Parent/Guardian|0
4720195|NCT03073200|7652856|FG002|Extension Period|Withdrawal by Parent/Guardian|0
4720196|NCT03073200|7652857|FG003|Extension Period|Withdrawal by Parent/Guardian|0
4720197|NCT03073200|7652858|FG004|Extension Period|Withdrawal by Parent/Guardian|0
4720198|NCT03073200|7652859|FG005|Extension Period|Withdrawal by Parent/Guardian|0
4720199|NCT03073200|7652860|FG006|Extension Period|Withdrawal by Parent/Guardian|1
4720200|NCT03073200|7652861|FG007|Extension Period|Withdrawal by Parent/Guardian|3
4720201|NCT03073200|7652862|FG008|Extension Period|Withdrawal by Parent/Guardian|1
4720202|NCT03073200|7652863|FG009|Extension Period|Withdrawal by Parent/Guardian|0
4720203|NCT03073200|7652864|FG010|Extension Period|Withdrawal by Parent/Guardian|0
4720204|NCT03073200|7652865|FG011|Extension Period|Withdrawal by Parent/Guardian|0
4720205|NCT03073200|7652866|FG012|Extension Period|Withdrawal by Parent/Guardian|0
4720206|NCT03073200|7652867|FG013|Extension Period|Withdrawal by Parent/Guardian|0
4720207|NCT03073200|7652868|FG014|Extension Period|Withdrawal by Parent/Guardian|0
4720208|NCT03073200|7652854|FG000|Extension Period|Withdrawal by Subject|0
4720209|NCT03073200|7652855|FG001|Extension Period|Withdrawal by Subject|0
4720210|NCT03073200|7652856|FG002|Extension Period|Withdrawal by Subject|0
4720211|NCT03073200|7652857|FG003|Extension Period|Withdrawal by Subject|0
4720212|NCT03073200|7652858|FG004|Extension Period|Withdrawal by Subject|0
4720213|NCT03073200|7652859|FG005|Extension Period|Withdrawal by Subject|0
4720214|NCT03073200|7652860|FG006|Extension Period|Withdrawal by Subject|1
4720215|NCT03073200|7652861|FG007|Extension Period|Withdrawal by Subject|2
4720216|NCT03073200|7652862|FG008|Extension Period|Withdrawal by Subject|0
4720217|NCT03073200|7652863|FG009|Extension Period|Withdrawal by Subject|0
4720218|NCT03073200|7652864|FG010|Extension Period|Withdrawal by Subject|0
4720219|NCT03073200|7652865|FG011|Extension Period|Withdrawal by Subject|0
4720220|NCT03073200|7652866|FG012|Extension Period|Withdrawal by Subject|0
4720221|NCT03073200|7652867|FG013|Extension Period|Withdrawal by Subject|0
4720222|NCT03073200|7652868|FG014|Extension Period|Withdrawal by Subject|0
4720223|NCT03073200|7652854|FG000|Randomized Withdrawal Period|Lost to Follow-up|0
4720224|NCT03073200|7652855|FG001|Randomized Withdrawal Period|Lost to Follow-up|0
4720225|NCT03073200|7652856|FG002|Randomized Withdrawal Period|Lost to Follow-up|0
4720226|NCT03073200|7652857|FG003|Randomized Withdrawal Period|Lost to Follow-up|0
4720227|NCT03073200|7652858|FG004|Randomized Withdrawal Period|Lost to Follow-up|0
4720228|NCT03073200|7652859|FG005|Randomized Withdrawal Period|Lost to Follow-up|0
4720229|NCT03073200|7652860|FG006|Randomized Withdrawal Period|Lost to Follow-up|0
4720230|NCT03073200|7652861|FG007|Randomized Withdrawal Period|Lost to Follow-up|0
4720231|NCT03073200|7652862|FG008|Randomized Withdrawal Period|Lost to Follow-up|0
4720232|NCT03073200|7652863|FG009|Randomized Withdrawal Period|Lost to Follow-up|0
4720233|NCT03073200|7652864|FG010|Randomized Withdrawal Period|Lost to Follow-up|0
4720234|NCT03073200|7652865|FG011|Randomized Withdrawal Period|Lost to Follow-up|1
4720235|NCT03073200|7652866|FG012|Randomized Withdrawal Period|Lost to Follow-up|0
4720236|NCT03073200|7652867|FG013|Randomized Withdrawal Period|Lost to Follow-up|0
4720237|NCT03073200|7652868|FG014|Randomized Withdrawal Period|Lost to Follow-up|0
4720238|NCT03073200|7652854|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
4771747|NCT03284853|7748655|FG001|Overall Study|Adverse Event|4
4720239|NCT03073200|7652855|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
4720240|NCT03073200|7652856|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
4720241|NCT03073200|7652857|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
4720242|NCT03073200|7652858|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
4720243|NCT03073200|7652859|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
4720244|NCT03073200|7652860|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
4720245|NCT03073200|7652861|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
4720246|NCT03073200|7652862|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
4720247|NCT03073200|7652863|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
4720248|NCT03073200|7652864|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
4720249|NCT03073200|7652865|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1
4720250|NCT03073200|7652866|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
4720251|NCT03073200|7652867|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
4720252|NCT03073200|7652868|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0
4720253|NCT03073200|7652854|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0
4720254|NCT03073200|7652855|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0
4720255|NCT03073200|7652856|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0
4720256|NCT03073200|7652857|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0
4720257|NCT03073200|7652858|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0
4720258|NCT03073200|7652859|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0
4720259|NCT03073200|7652860|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0
4720260|NCT03073200|7652861|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0
4720261|NCT03073200|7652862|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0
4720262|NCT03073200|7652863|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0
4720263|NCT03073200|7652864|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1
4720264|NCT03073200|7652865|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1
4720265|NCT03073200|7652866|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0
4720266|NCT03073200|7652867|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0
4720267|NCT03073200|7652868|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0
4720268|NCT03073200|7652854|FG000|Randomized Withdrawal Period|Adverse Event|0
4720269|NCT03073200|7652855|FG001|Randomized Withdrawal Period|Adverse Event|0
4720270|NCT03073200|7652856|FG002|Randomized Withdrawal Period|Adverse Event|0
4720271|NCT03073200|7652857|FG003|Randomized Withdrawal Period|Adverse Event|0
4720272|NCT03073200|7652858|FG004|Randomized Withdrawal Period|Adverse Event|0
4720273|NCT03073200|7652859|FG005|Randomized Withdrawal Period|Adverse Event|0
4720274|NCT03073200|7652860|FG006|Randomized Withdrawal Period|Adverse Event|0
4720275|NCT03073200|7652861|FG007|Randomized Withdrawal Period|Adverse Event|0
4720276|NCT03073200|7652862|FG008|Randomized Withdrawal Period|Adverse Event|0
4720277|NCT03073200|7652863|FG009|Randomized Withdrawal Period|Adverse Event|0
4720278|NCT03073200|7652864|FG010|Randomized Withdrawal Period|Adverse Event|1
4720279|NCT03073200|7652865|FG011|Randomized Withdrawal Period|Adverse Event|0
4720280|NCT03073200|7652866|FG012|Randomized Withdrawal Period|Adverse Event|0
4720281|NCT03073200|7652867|FG013|Randomized Withdrawal Period|Adverse Event|0
4720282|NCT03073200|7652868|FG014|Randomized Withdrawal Period|Adverse Event|0
4720283|NCT03073200|7652854|FG000|Post-Treatment Follow-Up Period|Adverse Event|0
4720284|NCT03073200|7652855|FG001|Post-Treatment Follow-Up Period|Adverse Event|0
4720285|NCT03073200|7652856|FG002|Post-Treatment Follow-Up Period|Adverse Event|0
4720286|NCT03073200|7652857|FG003|Post-Treatment Follow-Up Period|Adverse Event|0
4720287|NCT03073200|7652858|FG004|Post-Treatment Follow-Up Period|Adverse Event|0
4720288|NCT03073200|7652859|FG005|Post-Treatment Follow-Up Period|Adverse Event|0
4720289|NCT03073200|7652860|FG006|Post-Treatment Follow-Up Period|Adverse Event|0
4720290|NCT03073200|7652861|FG007|Post-Treatment Follow-Up Period|Adverse Event|0
4720291|NCT03073200|7652862|FG008|Post-Treatment Follow-Up Period|Adverse Event|0
4720292|NCT03073200|7652863|FG009|Post-Treatment Follow-Up Period|Adverse Event|0
4720293|NCT03073200|7652864|FG010|Post-Treatment Follow-Up Period|Adverse Event|0
4720294|NCT03073200|7652865|FG011|Post-Treatment Follow-Up Period|Adverse Event|0
4720295|NCT03073200|7652866|FG012|Post-Treatment Follow-Up Period|Adverse Event|0
4720296|NCT03073200|7652867|FG013|Post-Treatment Follow-Up Period|Adverse Event|2
4720297|NCT03073200|7652868|FG014|Post-Treatment Follow-Up Period|Adverse Event|0
4720298|NCT03073200|7652854|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0
4720299|NCT03073200|7652855|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0
4720300|NCT03073200|7652856|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0
4720301|NCT03073200|7652857|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0
4720302|NCT03073200|7652858|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0
4720303|NCT03073200|7652859|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0
4720304|NCT03073200|7652860|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0
4720305|NCT03073200|7652861|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0
4720306|NCT03073200|7652862|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0
4720307|NCT03073200|7652863|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0
4720308|NCT03073200|7652864|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0
4720309|NCT03073200|7652865|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0
4720310|NCT03073200|7652866|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0
4720311|NCT03073200|7652867|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1
4720312|NCT03073200|7652868|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0
4720313|NCT03073200|7652854|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0
4720314|NCT03073200|7652855|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0
4720315|NCT03073200|7652856|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0
4720316|NCT03073200|7652857|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0
4720317|NCT03073200|7652858|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0
4720318|NCT03073200|7652859|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0
4720319|NCT03073200|7652860|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0
4720320|NCT03073200|7652861|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0
4720321|NCT03073200|7652862|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0
4720322|NCT03073200|7652863|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0
4720323|NCT03073200|7652864|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0
4720324|NCT03073200|7652865|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0
4720325|NCT03073200|7652866|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0
4720326|NCT03073200|7652867|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1
4720327|NCT03073200|7652868|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0
4720328|NCT03073200|7652854|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0
4720329|NCT03073200|7652855|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0
4720330|NCT03073200|7652856|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0
4720331|NCT03073200|7652857|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0
4720332|NCT03073200|7652858|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0
4720333|NCT03073200|7652859|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0
4720334|NCT03073200|7652860|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0
4720335|NCT03073200|7652861|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0
4720336|NCT03073200|7652862|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0
4720337|NCT03073200|7652863|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0
4720338|NCT03073200|7652864|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0
4720339|NCT03073200|7652865|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0
4720340|NCT03073200|7652866|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0
4720341|NCT03073200|7652867|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1
4720342|NCT03073200|7652868|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0
4720343|NCT03073200|7652854|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
4720344|NCT03073200|7652855|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
4720345|NCT03073200|7652856|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
4720346|NCT03073200|7652857|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
4720347|NCT03073200|7652858|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
4720348|NCT03073200|7652859|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
4720349|NCT03073200|7652860|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
4720350|NCT03073200|7652861|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
4720351|NCT03073200|7652862|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
4720352|NCT03073200|7652863|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
4720353|NCT03073200|7652864|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
4720354|NCT03073200|7652865|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
4720355|NCT03073200|7652866|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
4720356|NCT03073200|7652867|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0
4720357|NCT03073200|7652868|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1
4720358|NCT03073200|7652854|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
4720359|NCT03073200|7652855|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
4720360|NCT03073200|7652856|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
4720361|NCT03073200|7652857|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
4720362|NCT03073200|7652858|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
4720363|NCT03073200|7652859|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
4720364|NCT03073200|7652860|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
4720365|NCT03073200|7652861|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
4720366|NCT03073200|7652862|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
4720367|NCT03073200|7652863|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
4720368|NCT03073200|7652864|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
4720369|NCT03073200|7652865|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
4720370|NCT03073200|7652866|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
4720371|NCT03073200|7652867|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11
4720372|NCT03073200|7652868|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0
4720373|NCT03073200|7652854|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
4720374|NCT03073200|7652855|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
4771748|NCT03284853|7748654|FG000|Overall Study|Withdrawal by Subject|5
4771749|NCT03284853|7748655|FG001|Overall Study|Withdrawal by Subject|1
4720375|NCT03073200|7652856|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
4720376|NCT03073200|7652857|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
4720377|NCT03073200|7652858|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
4720378|NCT03073200|7652859|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
4720379|NCT03073200|7652860|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
4720380|NCT03073200|7652861|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
4720381|NCT03073200|7652862|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
4720382|NCT03073200|7652863|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
4720383|NCT03073200|7652864|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
4720384|NCT03073200|7652865|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
4720385|NCT03073200|7652866|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
4630701|NCT01884350|7499506|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0
4720386|NCT03073200|7652867|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9
4720387|NCT03073200|7652868|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
4720388|NCT03073200|7652854|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
4720389|NCT03073200|7652855|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
4720390|NCT03073200|7652856|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
4720391|NCT03073200|7652857|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
4720392|NCT03073200|7652858|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
4720393|NCT03073200|7652859|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
4720394|NCT03073200|7652860|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
4720395|NCT03073200|7652861|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
4720396|NCT03073200|7652862|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
4720397|NCT03073200|7652863|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
4720398|NCT03073200|7652864|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
4720399|NCT03073200|7652865|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
4720400|NCT03073200|7652866|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
4720401|NCT03073200|7652867|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2
4720402|NCT03073200|7652868|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0
4720403|NCT03073213|7652893|FG000|Multiple Dose Period|Protocol Violation|0
4720404|NCT03073213|7652894|FG001|Multiple Dose Period|Protocol Violation|0
4720405|NCT03073213|7652895|FG002|Multiple Dose Period|Protocol Violation|1
4720406|NCT03073798|7652923|FG000|Overall Study|Adverse Event|1
4720407|NCT03073798|7652923|FG000|Overall Study|Withdrawal by Subject|1
4720408|NCT03074162|7652948|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0
4720409|NCT03074162|7652949|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0
4720410|NCT03074162|7652950|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1
4720411|NCT03074162|7652951|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0
4720412|NCT03074162|7652952|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0
4720413|NCT03074162|7652953|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0
4720414|NCT03074162|7652948|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0
4720415|NCT03074162|7652949|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0
4720416|NCT03074162|7652950|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1
4720417|NCT03074162|7652951|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0
4720418|NCT03074162|7652952|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0
4720419|NCT03074162|7652953|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1
4720420|NCT03074162|7652948|FG000|Period 3|Withdrawal by Subject|1
4720421|NCT03074162|7652949|FG001|Period 3|Withdrawal by Subject|0
4720422|NCT03074162|7652950|FG002|Period 3|Withdrawal by Subject|0
4720423|NCT03074162|7652951|FG003|Period 3|Withdrawal by Subject|0
4720424|NCT03074162|7652952|FG004|Period 3|Withdrawal by Subject|1
4720425|NCT03074162|7652953|FG005|Period 3|Withdrawal by Subject|0
4720426|NCT03074331|7652961|FG000|Overall Study|Enrolled but Not Treated|1
4720427|NCT03074331|7652961|FG000|Overall Study|Lost to Follow-up|5
4720428|NCT03074331|7652961|FG000|Overall Study|Withdrew Consent|1
4720429|NCT03074500|7652977|FG000|Overall Study|Lost to Follow-up|1
4720430|NCT03074500|7652978|FG001|Overall Study|Lost to Follow-up|0
4720431|NCT03074500|7652979|FG002|Overall Study|Lost to Follow-up|0
4720432|NCT03074500|7652977|FG000|Overall Study|Lack of Efficacy|0
4720433|NCT03074500|7652978|FG001|Overall Study|Lack of Efficacy|1
4720434|NCT03074500|7652979|FG002|Overall Study|Lack of Efficacy|0
4720435|NCT03074500|7652977|FG000|Overall Study|Adverse Event|0
4720436|NCT03074500|7652978|FG001|Overall Study|Adverse Event|0
4720437|NCT03074500|7652979|FG002|Overall Study|Adverse Event|1
4720438|NCT03075163|7653018|FG000|Overall Study|not eligible for treatment limb|138
4720439|NCT03075163|7653019|FG001|Overall Study|not eligible for treatment limb|138
4720440|NCT03075267|7653028|FG000|Overall Study|Protocol Violation|1
4720441|NCT03075267|7653029|FG001|Overall Study|Protocol Violation|0
4720442|NCT03075267|7653030|FG002|Overall Study|Protocol Violation|0
4720443|NCT03075410|7653047|FG000|Part A-Period 2 (14 Days)|Personal reasons|1
4630702|NCT01884350|7499504|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3
4720444|NCT03075410|7653048|FG001|Part A-Period 2 (14 Days)|Personal reasons|0
4720445|NCT03075410|7653049|FG002|Part A-Period 2 (14 Days)|Personal reasons|1
4720446|NCT03075410|7653050|FG003|Part A-Period 2 (14 Days)|Personal reasons|0
4720447|NCT03075410|7653051|FG004|Part A-Period 2 (14 Days)|Personal reasons|0
4720448|NCT03075410|7653052|FG005|Part A-Period 2 (14 Days)|Personal reasons|0
4720449|NCT03075410|7653053|FG006|Part A-Period 2 (14 Days)|Personal reasons|0
4720450|NCT03075410|7653054|FG007|Part A-Period 2 (14 Days)|Personal reasons|0
4720451|NCT03075410|7653055|FG008|Part A-Period 2 (14 Days)|Personal reasons|0
4720452|NCT03075410|7653047|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1
4720453|NCT03075410|7653048|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
4720454|NCT03075410|7653049|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
4720455|NCT03075410|7653050|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
4720456|NCT03075410|7653051|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
4720457|NCT03075410|7653052|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
4720458|NCT03075410|7653053|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
4720459|NCT03075410|7653054|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
4720460|NCT03075410|7653055|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
4720461|NCT03075501|7653085|FG000|Overall Study|Scheduling difficulties|15
4720462|NCT03075501|7653086|FG001|Overall Study|Scheduling difficulties|9
4720463|NCT03075644|7653099|FG000|Overall Study|Withdrawal by Subject|1
4720464|NCT03075644|7653100|FG001|Overall Study|Withdrawal by Subject|1
4720465|NCT03075761|7653109|FG000|Overall Study|Lost to Follow-up|1
4720466|NCT03075761|7653110|FG001|Overall Study|Lost to Follow-up|6
4720467|NCT03075839|7653121|FG000|Overall Study|Lost to Follow-up|4
4720468|NCT03075878|7653125|FG000|Overall Study|Physician Decision|1
4720469|NCT03075891|7653131|FG000|Overall Study|Withdrawal by Subject|3
4720470|NCT03075891|7653132|FG001|Overall Study|Withdrawal by Subject|6
4720471|NCT03075891|7653131|FG000|Overall Study|Lost to Follow-up|1
4720472|NCT03075891|7653132|FG001|Overall Study|Lost to Follow-up|0
4720473|NCT03075891|7653131|FG000|Overall Study|Pregnancy|3
4720474|NCT03075891|7653132|FG001|Overall Study|Pregnancy|1
4720475|NCT03075891|7653131|FG000|Overall Study|visits not performed (no time)|1
4720476|NCT03075891|7653132|FG001|Overall Study|visits not performed (no time)|0
4720477|NCT03075891|7653131|FG000|Overall Study|Drug abuse relapse issue|0
4720478|NCT03075891|7653132|FG001|Overall Study|Drug abuse relapse issue|1
4720479|NCT03075891|7653131|FG000|Overall Study|Participant requiring study withdrawal|0
4720480|NCT03075891|7653132|FG001|Overall Study|Participant requiring study withdrawal|1
4720481|NCT03075891|7653131|FG000|Overall Study|Adverse event, non-fatal|1
4720482|NCT03075891|7653132|FG001|Overall Study|Adverse event, non-fatal|4
4720483|NCT03075904|7653140|FG000|Overall Study|Physician Decision|3
4720484|NCT03075904|7653140|FG000|Overall Study|Need for Medication not Permitted|1
4720485|NCT03076190|7653146|FG000|Overall Study|Lost to Follow-up|9
4720486|NCT03076190|7653147|FG001|Overall Study|Lost to Follow-up|34
4720487|NCT03076190|7653146|FG000|Overall Study|Excluded from Analysis (zero duration ev|9
4720488|NCT03076190|7653147|FG001|Overall Study|Excluded from Analysis (zero duration ev|7
4720489|NCT03076515|7653173|FG000|Overall Study|DMC decision based on interim analysis|25
4720490|NCT03076515|7653174|FG001|Overall Study|DMC decision based on interim analysis|29
4720491|NCT03076970|7653180|FG000|Washout Period 2|Adverse Event|0
4720492|NCT03076970|7653181|FG001|Washout Period 2|Adverse Event|0
4720493|NCT03076970|7653182|FG002|Washout Period 2|Adverse Event|0
4720494|NCT03076970|7653183|FG003|Washout Period 2|Adverse Event|0
4720495|NCT03076970|7653184|FG004|Washout Period 2|Adverse Event|1
4720496|NCT03076970|7653185|FG005|Washout Period 2|Adverse Event|0
4720497|NCT03076970|7653180|FG000|Period 3|Withdrawal by Subject|0
4720498|NCT03076970|7653181|FG001|Period 3|Withdrawal by Subject|0
4720499|NCT03076970|7653182|FG002|Period 3|Withdrawal by Subject|0
4720500|NCT03076970|7653183|FG003|Period 3|Withdrawal by Subject|0
4720501|NCT03076970|7653184|FG004|Period 3|Withdrawal by Subject|0
4720502|NCT03076970|7653185|FG005|Period 3|Withdrawal by Subject|1
4720503|NCT03076970|7653180|FG000|Period 3|Failure to meet I/E criteria|0
4720504|NCT03076970|7653181|FG001|Period 3|Failure to meet I/E criteria|0
4720505|NCT03076970|7653182|FG002|Period 3|Failure to meet I/E criteria|0
4720506|NCT03076970|7653183|FG003|Period 3|Failure to meet I/E criteria|0
4630703|NCT01884350|7499505|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3
4630704|NCT01884350|7499506|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0
4630705|NCT01884350|7499504|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21
4720507|NCT03076970|7653184|FG004|Period 3|Failure to meet I/E criteria|1
4720508|NCT03076970|7653185|FG005|Period 3|Failure to meet I/E criteria|0
4720509|NCT03076996|7653205|FG000|Overall Study|Withdrawal by Subject|2
4720510|NCT03076996|7653205|FG000|Overall Study|Lost to Follow-up|3
4720511|NCT03076996|7653205|FG000|Overall Study|Literacy precluded participation|1
4720512|NCT03077607|7653236|FG000|Period 1 (15 Days)|Adverse Event|1
4720513|NCT03077607|7653237|FG001|Period 1 (15 Days)|Adverse Event|0
4720514|NCT03077607|7653236|FG000|Period 1 (15 Days)|Death|1
4720515|NCT03077607|7653237|FG001|Period 1 (15 Days)|Death|0
4720516|NCT03077607|7653236|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1
4720517|NCT03077607|7653237|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0
4720518|NCT03077607|7653236|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2
4720519|NCT03077607|7653237|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2
4720520|NCT03077646|7653257|FG000|Overall Study|Lost to Follow-up|29
4720521|NCT03077646|7653258|FG001|Overall Study|Lost to Follow-up|30
4720522|NCT03077646|7653259|FG002|Overall Study|Lost to Follow-up|31
4720523|NCT03077659|7653270|FG000|Overall Study|Withdrawal by Subject|0
4720524|NCT03077659|7653271|FG001|Overall Study|Withdrawal by Subject|0
4720525|NCT03077659|7653272|FG002|Overall Study|Withdrawal by Subject|1
4720526|NCT03077711|7653285|FG000|Overall Study|Lost to Follow-up|2
4720527|NCT03077711|7653286|FG001|Overall Study|Lost to Follow-up|2
4720528|NCT03077711|7653285|FG000|Overall Study|noncompliant taking medication|2
4720529|NCT03077711|7653286|FG001|Overall Study|noncompliant taking medication|0
4720530|NCT03077724|7653296|FG000|Overall Study|Lost to Follow-up|5
4720531|NCT03077724|7653297|FG001|Overall Study|Lost to Follow-up|1
4720532|NCT03077724|7653296|FG000|Overall Study|Withdrawal by Subject|3
4720533|NCT03077724|7653297|FG001|Overall Study|Withdrawal by Subject|1
4720534|NCT03077919|7653315|FG000|Overall Study|Lost to Follow-up|4
4720535|NCT03077919|7653316|FG001|Overall Study|Lost to Follow-up|1
4720536|NCT03078556|7653373|FG000|Treatment Period 1 (4 Days)|Adverse Event|0
4720537|NCT03078556|7653374|FG001|Treatment Period 1 (4 Days)|Adverse Event|1
4720538|NCT03078556|7653375|FG002|Treatment Period 1 (4 Days)|Adverse Event|0
4720539|NCT03078556|7653376|FG003|Treatment Period 1 (4 Days)|Adverse Event|0
4720540|NCT03078556|7653373|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2
4720541|NCT03078556|7653374|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0
4720542|NCT03078556|7653375|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1
4720543|NCT03078556|7653376|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0
4720544|NCT03078556|7653373|FG000|Washout Period 1 (7 Days)|Adverse Event|0
4720545|NCT03078556|7653374|FG001|Washout Period 1 (7 Days)|Adverse Event|1
4720546|NCT03078556|7653375|FG002|Washout Period 1 (7 Days)|Adverse Event|0
4720547|NCT03078556|7653376|FG003|Washout Period 1 (7 Days)|Adverse Event|1
4720548|NCT03078556|7653373|FG000|Washout Period 1 (7 Days)|Physician Decision|0
4720549|NCT03078556|7653374|FG001|Washout Period 1 (7 Days)|Physician Decision|1
4720550|NCT03078556|7653375|FG002|Washout Period 1 (7 Days)|Physician Decision|0
4720551|NCT03078556|7653376|FG003|Washout Period 1 (7 Days)|Physician Decision|0
4720552|NCT03078582|7653403|FG000|Overall Study|Adverse Event|0
4720553|NCT03078582|7653404|FG001|Overall Study|Adverse Event|8
4720554|NCT03078751|7653434|FG000|Overall Study|Adverse Event|4
4720555|NCT03078751|7653435|FG001|Overall Study|Adverse Event|0
4720556|NCT03078751|7653434|FG000|Overall Study|Physician Decision|1
4720557|NCT03078751|7653435|FG001|Overall Study|Physician Decision|0
4720558|NCT03078751|7653434|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0
4720559|NCT03078751|7653435|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23
4720560|NCT03078751|7653434|FG000|Overall Study|Subject/guardian decision|8
4720561|NCT03078751|7653435|FG001|Overall Study|Subject/guardian decision|1
4720562|NCT03078751|7653434|FG000|Overall Study|Untreated|0
4720563|NCT03078751|7653435|FG001|Overall Study|Untreated|4
4720564|NCT03078816|7653441|FG000|Overall Study|Withdrawal by Subject|1
4720565|NCT03078907|7653447|FG000|Overall Study|Adverse Event|2
4720566|NCT03078907|7653448|FG001|Overall Study|Adverse Event|0
4720567|NCT03078907|7653447|FG000|Overall Study|Other|1
4720568|NCT03078907|7653448|FG001|Overall Study|Other|0
4720569|NCT03078907|7653447|FG000|Overall Study|Protocol Violation|0
4720570|NCT03078907|7653448|FG001|Overall Study|Protocol Violation|1
4720571|NCT03080454|7653493|FG000|Baseline|Adverse Event|2
4720572|NCT03080454|7653493|FG000|Anodal Doublestim (5 Days)|Adverse Event|1
4720573|NCT03080454|7653493|FG000|Anodal FU (7 Days)|Lost to Follow-up|4
4720574|NCT03080493|7653502|FG000|Overall Study|Did not provide NRS pain results|1
4720575|NCT03080493|7653503|FG001|Overall Study|Did not provide NRS pain results|0
4720576|NCT03080493|7653502|FG000|Overall Study|Adverse Event|0
4720577|NCT03080493|7653503|FG001|Overall Study|Adverse Event|1
4720578|NCT03080493|7653502|FG000|Overall Study|Randomization error (parity group)|0
4720579|NCT03080493|7653503|FG001|Overall Study|Randomization error (parity group)|1
4720580|NCT03080961|7653509|FG000|Overall Study|Withdrawal by Subject|3
4720581|NCT03081884|7653527|FG000|Overall Study|deferred prostate cancer treatment|1
4720582|NCT03081884|7653527|FG000|Overall Study|metastasis managed with systemic therapy|3
4720583|NCT03082261|7653541|FG000|Overall Study|Death|4
4720584|NCT03082261|7653541|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1
4720585|NCT03082261|7653541|FG000|Overall Study|Insurance denial|1
4720586|NCT03082261|7653541|FG000|Overall Study|Peripheral lead added|1
4720587|NCT03082261|7653541|FG000|Overall Study|Withdrawal by Subject|40
4720588|NCT03082261|7653541|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2
4720589|NCT03082261|7653541|FG000|Overall Study|Subject implanted with device other than study device|1
4720590|NCT03082261|7653541|FG000|Overall Study|Lost to Follow-up|14
4720591|NCT03082261|7653541|FG000|Overall Study|Subject moved to a different state|1
4720592|NCT03082261|7653541|FG000|Overall Study|Subject non-compliance|2
4720593|NCT03082261|7653541|FG000|Overall Study|Subject participation terminated by investigator|9
4720594|NCT03082261|7653541|FG000|Overall Study|Subject participation terminated by sponsor|4
4720595|NCT03082261|7653541|FG000|Overall Study|System explant|19
4720596|NCT03082261|7653541|FG000|Overall Study|Unable to place lead(s)|2
4720597|NCT03082261|7653541|FG000|Overall Study|Unsuccessful trial evaluation period|19
4720598|NCT03082599|7653578|FG000|Overall Study|Lost to Follow-up|1
4720599|NCT03082599|7653579|FG001|Overall Study|Lost to Follow-up|0
4720600|NCT03083132|7653596|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0
4720601|NCT03083132|7653597|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2
4720602|NCT03083132|7653596|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1
4720603|NCT03083132|7653597|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0
4720604|NCT03083132|7653596|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0
4720605|NCT03083132|7653597|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1
4720606|NCT03083470|7653617|FG000|Overall Study|Lost to Follow-up|0
4720607|NCT03083470|7653618|FG001|Overall Study|Lost to Follow-up|0
4720608|NCT03083470|7653619|FG002|Overall Study|Lost to Follow-up|0
4720609|NCT03083470|7653620|FG003|Overall Study|Lost to Follow-up|0
4720610|NCT03083470|7653621|FG004|Overall Study|Lost to Follow-up|1
4720611|NCT03083470|7653617|FG000|Overall Study|Withdrawal by Subject|0
4720612|NCT03083470|7653618|FG001|Overall Study|Withdrawal by Subject|0
4720613|NCT03083470|7653619|FG002|Overall Study|Withdrawal by Subject|0
4720614|NCT03083470|7653620|FG003|Overall Study|Withdrawal by Subject|0
4720615|NCT03083470|7653621|FG004|Overall Study|Withdrawal by Subject|1
4720616|NCT03083483|7653636|FG000|Overall Study|Adverse Event|1
4720617|NCT03083483|7653637|FG001|Overall Study|Adverse Event|1
4720618|NCT03083483|7653638|FG002|Overall Study|Adverse Event|1
4720619|NCT03083483|7653636|FG000|Overall Study|Lost to Follow-up|2
4720620|NCT03083483|7653637|FG001|Overall Study|Lost to Follow-up|1
4720621|NCT03083483|7653638|FG002|Overall Study|Lost to Follow-up|1
4720622|NCT03083483|7653636|FG000|Overall Study|technological issues|1
4720623|NCT03083483|7653637|FG001|Overall Study|technological issues|0
4720624|NCT03083483|7653638|FG002|Overall Study|technological issues|1
4720625|NCT03083639|7653648|FG000|Washout Period (at Least 6 Days)|Pregnancy|0
4720626|NCT03083639|7653649|FG001|Washout Period (at Least 6 Days)|Pregnancy|1
4720627|NCT03083639|7653648|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1
4720628|NCT03083639|7653649|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0
4720629|NCT03083847|7653674|FG000|Main|Physician Decision|0
4720630|NCT03083847|7653675|FG001|Main|Physician Decision|0
4720631|NCT03083847|7653676|FG002|Main|Physician Decision|0
4720632|NCT03083847|7653677|FG003|Main|Physician Decision|0
4720633|NCT03083847|7653678|FG004|Main|Physician Decision|0
4720634|NCT03083847|7653679|FG005|Main|Physician Decision|1
4720635|NCT03083847|7653680|FG006|Main|Physician Decision|0
4720636|NCT03083847|7653681|FG007|Main|Physician Decision|0
4720637|NCT03083847|7653682|FG008|Main|Physician Decision|0
4720638|NCT03083847|7653683|FG009|Main|Physician Decision|0
4720639|NCT03083847|7653674|FG000|Main|Pregnancy|0
4720640|NCT03083847|7653675|FG001|Main|Pregnancy|0
4720641|NCT03083847|7653676|FG002|Main|Pregnancy|0
4720642|NCT03083847|7653677|FG003|Main|Pregnancy|0
4720643|NCT03083847|7653678|FG004|Main|Pregnancy|0
4720644|NCT03083847|7653679|FG005|Main|Pregnancy|0
4720645|NCT03083847|7653680|FG006|Main|Pregnancy|0
4720646|NCT03083847|7653681|FG007|Main|Pregnancy|1
4720647|NCT03083847|7653682|FG008|Main|Pregnancy|0
4720648|NCT03083847|7653683|FG009|Main|Pregnancy|0
4720649|NCT03083847|7653674|FG000|Main|Adverse Event|0
4720650|NCT03083847|7653675|FG001|Main|Adverse Event|0
4720651|NCT03083847|7653676|FG002|Main|Adverse Event|0
4720652|NCT03083847|7653677|FG003|Main|Adverse Event|0
4720653|NCT03083847|7653678|FG004|Main|Adverse Event|0
4720654|NCT03083847|7653679|FG005|Main|Adverse Event|0
4720655|NCT03083847|7653680|FG006|Main|Adverse Event|0
4720656|NCT03083847|7653681|FG007|Main|Adverse Event|2
4720657|NCT03083847|7653682|FG008|Main|Adverse Event|0
4720658|NCT03083847|7653683|FG009|Main|Adverse Event|0
4720659|NCT03083847|7653674|FG000|Main|Withdrawal by Subject|0
4720660|NCT03083847|7653675|FG001|Main|Withdrawal by Subject|0
4720661|NCT03083847|7653676|FG002|Main|Withdrawal by Subject|0
4720662|NCT03083847|7653677|FG003|Main|Withdrawal by Subject|0
4720663|NCT03083847|7653678|FG004|Main|Withdrawal by Subject|0
4720664|NCT03083847|7653679|FG005|Main|Withdrawal by Subject|0
4720665|NCT03083847|7653680|FG006|Main|Withdrawal by Subject|1
4720666|NCT03083847|7653681|FG007|Main|Withdrawal by Subject|1
4720667|NCT03083847|7653682|FG008|Main|Withdrawal by Subject|0
4720668|NCT03083847|7653683|FG009|Main|Withdrawal by Subject|0
4720669|NCT03083990|7653713|FG000|Overall Study|Adverse Event|1
4720670|NCT03083990|7653714|FG001|Overall Study|Adverse Event|0
4720671|NCT03084302|7653720|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9
4720672|NCT03084302|7653720|FG000|Overall Study|No valid objective monitor data|6
4720673|NCT03084315|7653727|FG000|Overall Study|Lost to Follow-up|8
4720674|NCT03084315|7653728|FG001|Overall Study|Lost to Follow-up|7
4720675|NCT03084315|7653727|FG000|Overall Study|Withdrawal by Subject|2
4720676|NCT03084315|7653728|FG001|Overall Study|Withdrawal by Subject|2
4720677|NCT03084796|7653740|FG000|Overall Study|Adverse Event|4
4720678|NCT03084796|7653741|FG001|Overall Study|Adverse Event|5
4720679|NCT03084796|7653742|FG002|Overall Study|Adverse Event|6
4720680|NCT03084796|7653743|FG003|Overall Study|Adverse Event|2
4720681|NCT03084796|7653744|FG004|Overall Study|Adverse Event|3
4720682|NCT03084796|7653745|FG005|Overall Study|Adverse Event|5
4720683|NCT03084796|7653740|FG000|Overall Study|Withdrawal by Subject|3
4720684|NCT03084796|7653741|FG001|Overall Study|Withdrawal by Subject|5
4720685|NCT03084796|7653742|FG002|Overall Study|Withdrawal by Subject|2
4720686|NCT03084796|7653743|FG003|Overall Study|Withdrawal by Subject|1
4720687|NCT03084796|7653744|FG004|Overall Study|Withdrawal by Subject|3
4720688|NCT03084796|7653745|FG005|Overall Study|Withdrawal by Subject|0
4720689|NCT03084796|7653740|FG000|Overall Study|Protocol Violation|0
4720690|NCT03084796|7653741|FG001|Overall Study|Protocol Violation|0
4720691|NCT03084796|7653742|FG002|Overall Study|Protocol Violation|1
4720692|NCT03084796|7653743|FG003|Overall Study|Protocol Violation|0
4720693|NCT03084796|7653744|FG004|Overall Study|Protocol Violation|1
4720694|NCT03084796|7653745|FG005|Overall Study|Protocol Violation|1
4720695|NCT03084796|7653740|FG000|Overall Study|Lack of Efficacy|0
4720696|NCT03084796|7653741|FG001|Overall Study|Lack of Efficacy|0
4720697|NCT03084796|7653742|FG002|Overall Study|Lack of Efficacy|1
4720698|NCT03084796|7653743|FG003|Overall Study|Lack of Efficacy|0
4720699|NCT03084796|7653744|FG004|Overall Study|Lack of Efficacy|1
4720700|NCT03084796|7653745|FG005|Overall Study|Lack of Efficacy|0
4720701|NCT03084796|7653740|FG000|Overall Study|Lost to Follow-up|0
4720702|NCT03084796|7653741|FG001|Overall Study|Lost to Follow-up|0
4720703|NCT03084796|7653742|FG002|Overall Study|Lost to Follow-up|1
4720704|NCT03084796|7653743|FG003|Overall Study|Lost to Follow-up|1
4720705|NCT03084796|7653744|FG004|Overall Study|Lost to Follow-up|3
4720706|NCT03084796|7653745|FG005|Overall Study|Lost to Follow-up|1
4720707|NCT03084796|7653740|FG000|Overall Study|Randomization error|0
4720708|NCT03084796|7653741|FG001|Overall Study|Randomization error|0
4720709|NCT03084796|7653742|FG002|Overall Study|Randomization error|1
4720710|NCT03084796|7653743|FG003|Overall Study|Randomization error|0
4720711|NCT03084796|7653744|FG004|Overall Study|Randomization error|0
4720712|NCT03084796|7653745|FG005|Overall Study|Randomization error|0
4720713|NCT03085017|7653761|FG000|Overall Study|Death|0
4720714|NCT03085017|7653762|FG001|Overall Study|Death|3
4720715|NCT03085238|7653768|FG000|Overall Study|Adverse Event|2
4720716|NCT03085238|7653768|FG000|Overall Study|Death|2
4720717|NCT03085758|7653784|FG000|Overall Study|Death|26
4720718|NCT03085758|7653785|FG001|Overall Study|Death|24
4720719|NCT03085758|7653786|FG002|Overall Study|Death|53
4720720|NCT03085758|7653784|FG000|Overall Study|Lost to Follow-up|1
4720721|NCT03085758|7653785|FG001|Overall Study|Lost to Follow-up|1
4720722|NCT03085758|7653786|FG002|Overall Study|Lost to Follow-up|1
4720723|NCT03085758|7653784|FG000|Overall Study|Withdrawal by Subject|2
4720724|NCT03085758|7653785|FG001|Overall Study|Withdrawal by Subject|2
4720725|NCT03085758|7653786|FG002|Overall Study|Withdrawal by Subject|1
4720726|NCT03085758|7653784|FG000|Overall Study|Refusal to recall it up to day 90|0
4720727|NCT03085758|7653785|FG001|Overall Study|Refusal to recall it up to day 90|0
4720728|NCT03085758|7653786|FG002|Overall Study|Refusal to recall it up to day 90|1
4720729|NCT03085758|7653784|FG000|Overall Study|Pt seen by doctor in digestive surgery|0
4720730|NCT03085758|7653785|FG001|Overall Study|Pt seen by doctor in digestive surgery|1
4720731|NCT03085758|7653786|FG002|Overall Study|Pt seen by doctor in digestive surgery|0
4720732|NCT03085797|7653800|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1
4720733|NCT03085797|7653801|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0
4720734|NCT03085797|7653800|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16
4720735|NCT03085797|7653801|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17
4630706|NCT01884350|7499505|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0
4630707|NCT01884350|7499506|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2
4720736|NCT03085797|7653800|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0
4720737|NCT03085797|7653801|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1
4720738|NCT03085914|7653829|FG000|Overall Study|Death|6
4720739|NCT03085914|7653830|FG001|Overall Study|Death|6
4720740|NCT03085914|7653831|FG002|Overall Study|Death|4
4720741|NCT03085914|7653832|FG003|Overall Study|Death|1
4720742|NCT03085914|7653833|FG004|Overall Study|Death|5
4720743|NCT03085914|7653834|FG005|Overall Study|Death|2
4720744|NCT03085914|7653835|FG006|Overall Study|Death|2
4720745|NCT03085914|7653829|FG000|Overall Study|Withdrawal by Subject|1
4720746|NCT03085914|7653830|FG001|Overall Study|Withdrawal by Subject|1
4720747|NCT03085914|7653831|FG002|Overall Study|Withdrawal by Subject|2
4720748|NCT03085914|7653832|FG003|Overall Study|Withdrawal by Subject|2
4720749|NCT03085914|7653833|FG004|Overall Study|Withdrawal by Subject|2
4720750|NCT03085914|7653834|FG005|Overall Study|Withdrawal by Subject|0
4720751|NCT03085914|7653835|FG006|Overall Study|Withdrawal by Subject|1
4720752|NCT03085914|7653829|FG000|Overall Study|Lost to Follow-up|0
4720753|NCT03085914|7653830|FG001|Overall Study|Lost to Follow-up|0
4720754|NCT03085914|7653831|FG002|Overall Study|Lost to Follow-up|1
4720755|NCT03085914|7653832|FG003|Overall Study|Lost to Follow-up|0
4720756|NCT03085914|7653833|FG004|Overall Study|Lost to Follow-up|0
4720757|NCT03085914|7653834|FG005|Overall Study|Lost to Follow-up|1
4720758|NCT03085914|7653835|FG006|Overall Study|Lost to Follow-up|1
4720759|NCT03085914|7653829|FG000|Overall Study|Reason was not specified,|2
4720760|NCT03085914|7653830|FG001|Overall Study|Reason was not specified,|2
4720761|NCT03085914|7653831|FG002|Overall Study|Reason was not specified,|2
4720762|NCT03085914|7653832|FG003|Overall Study|Reason was not specified,|3
4720763|NCT03085914|7653833|FG004|Overall Study|Reason was not specified,|3
4720764|NCT03085914|7653834|FG005|Overall Study|Reason was not specified,|3
4720765|NCT03085914|7653835|FG006|Overall Study|Reason was not specified,|6
4720766|NCT03085914|7653829|FG000|Overall Study|Progressive Disease|0
4720767|NCT03085914|7653830|FG001|Overall Study|Progressive Disease|0
4720768|NCT03085914|7653831|FG002|Overall Study|Progressive Disease|2
4720769|NCT03085914|7653832|FG003|Overall Study|Progressive Disease|2
4720770|NCT03085914|7653833|FG004|Overall Study|Progressive Disease|1
4720771|NCT03085914|7653834|FG005|Overall Study|Progressive Disease|1
4720772|NCT03085914|7653835|FG006|Overall Study|Progressive Disease|1
4720773|NCT03085914|7653829|FG000|Overall Study|Study Terminated by the Sponsor|0
4720774|NCT03085914|7653830|FG001|Overall Study|Study Terminated by the Sponsor|0
4720775|NCT03085914|7653831|FG002|Overall Study|Study Terminated by the Sponsor|0
4720776|NCT03085914|7653832|FG003|Overall Study|Study Terminated by the Sponsor|1
4720777|NCT03085914|7653833|FG004|Overall Study|Study Terminated by the Sponsor|2
4720778|NCT03085914|7653834|FG005|Overall Study|Study Terminated by the Sponsor|1
4720779|NCT03085914|7653835|FG006|Overall Study|Study Terminated by the Sponsor|0
4720780|NCT03085927|7653856|FG000|Overall Study|Withdrawal by Subject|1
4720781|NCT03085927|7653857|FG001|Overall Study|Withdrawal by Subject|4
4720782|NCT03085927|7653856|FG000|Overall Study|Lost to Follow-up|3
4720783|NCT03085927|7653857|FG001|Overall Study|Lost to Follow-up|1
4720784|NCT03085927|7653856|FG000|Overall Study|Death|1
4720785|NCT03085927|7653857|FG001|Overall Study|Death|0
4720786|NCT03085927|7653856|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1
4720787|NCT03085927|7653857|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0
4720788|NCT03085927|7653856|FG000|Overall Study|Dyad Became Ineligible|0
4720789|NCT03085927|7653857|FG001|Overall Study|Dyad Became Ineligible|1
4736477|NCT03569098|7685691|FG002|Double-Blind Treatment Cycle 1|Technical problems|2
4736478|NCT03569098|7685689|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1
4736479|NCT03569098|7685690|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0
4736480|NCT03569098|7685691|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0
4736481|NCT03569098|7685689|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0
4736482|NCT03569098|7685690|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1
4736483|NCT03569098|7685691|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0
4736484|NCT03569098|7685689|FG000|Double-Blind Treatment Cycle 1|Other|1
4736485|NCT03569098|7685690|FG001|Double-Blind Treatment Cycle 1|Other|0
4736486|NCT03569098|7685691|FG002|Double-Blind Treatment Cycle 1|Other|1
4736487|NCT03569098|7685689|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0
4736488|NCT03569098|7685690|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21
4736489|NCT03569098|7685691|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0
4736490|NCT03569098|7685689|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0
4736491|NCT03569098|7685690|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11
4736492|NCT03569098|7685691|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0
4736493|NCT03569098|7685689|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0
4736494|NCT03569098|7685690|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3
4736495|NCT03569098|7685691|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0
4736496|NCT03569098|7685689|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0
4736497|NCT03569098|7685690|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0
4736498|NCT03569098|7685691|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4
4736499|NCT03569098|7685689|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0
4736500|NCT03569098|7685690|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1
4736501|NCT03569098|7685691|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1
4736502|NCT03569098|7685689|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0
4736503|NCT03569098|7685690|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0
4736504|NCT03569098|7685691|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1
4736505|NCT03569202|7685704|FG000|Part 3|Physician Decision|1
4736506|NCT03569202|7685705|FG001|Part 3|Physician Decision|0
4736507|NCT03569202|7685704|FG000|Part 3|Other|1
4736508|NCT03569202|7685705|FG001|Part 3|Other|1
4736509|NCT03569371|7685711|FG000|Overall Study|Lack of Efficacy|1
4736510|NCT03569371|7685711|FG000|Overall Study|Lost to Follow-up|1
4736511|NCT03569371|7685711|FG000|Overall Study|Adverse Event|1
4736512|NCT03570554|7685782|FG000|Overall Study|Non-compliance with study drug|0
4736513|NCT03570554|7685783|FG001|Overall Study|Non-compliance with study drug|0
4736514|NCT03570554|7685784|FG002|Overall Study|Non-compliance with study drug|1
4736515|NCT03570554|7685785|FG003|Overall Study|Non-compliance with study drug|0
4736516|NCT03570554|7685782|FG000|Overall Study|Adverse Event|0
4630708|NCT01884350|7499504|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7
4736517|NCT03570554|7685783|FG001|Overall Study|Adverse Event|0
4736518|NCT03570554|7685784|FG002|Overall Study|Adverse Event|0
4736519|NCT03570554|7685785|FG003|Overall Study|Adverse Event|1
4736520|NCT03570697|7685828|FG000|Overall Study|Lost to Follow-up|0
4736521|NCT03570697|7685829|FG001|Overall Study|Lost to Follow-up|1
4736522|NCT03570697|7685828|FG000|Overall Study|Death|2
4736523|NCT03570697|7685829|FG001|Overall Study|Death|0
4736524|NCT03570697|7685828|FG000|Overall Study|Withdrawal by Subject|4
4736525|NCT03570697|7685829|FG001|Overall Study|Withdrawal by Subject|2
4736526|NCT03571256|7685838|FG000|Overall Study|Adverse Event|3
4736527|NCT03571256|7685839|FG001|Overall Study|Adverse Event|0
4736528|NCT03571256|7685840|FG002|Overall Study|Adverse Event|1
4736529|NCT03571256|7685838|FG000|Overall Study|Withdrawal by Subject|3
4736530|NCT03571256|7685839|FG001|Overall Study|Withdrawal by Subject|1
4736531|NCT03571256|7685840|FG002|Overall Study|Withdrawal by Subject|1
4736532|NCT03571256|7685838|FG000|Overall Study|Other than specified|0
4736533|NCT03571256|7685839|FG001|Overall Study|Other than specified|1
4736534|NCT03571256|7685840|FG002|Overall Study|Other than specified|1
4736535|NCT03571256|7685838|FG000|Overall Study|Protocol Violation|0
4736536|NCT03571256|7685839|FG001|Overall Study|Protocol Violation|1
4720790|NCT03086018|7653865|FG000|Final Testing for End of Trial|Adverse Event|1
4720791|NCT03086018|7653865|FG000|Final Testing for End of Trial|Withdrawal by Subject|1
4720792|NCT03086057|7653875|FG000|Stage 1: PrEP Uptake|Incarcerated|3
4720793|NCT03086057|7653876|FG001|Stage 1: PrEP Uptake|Incarcerated|1
4720794|NCT03086057|7653877|FG002|Stage 1: PrEP Uptake|Incarcerated|0
4720795|NCT03086057|7653878|FG003|Stage 1: PrEP Uptake|Incarcerated|0
4720796|NCT03086057|7653875|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1
4720797|NCT03086057|7653876|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4
4720798|NCT03086057|7653877|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0
4720799|NCT03086057|7653878|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0
4720800|NCT03086057|7653875|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6
4720801|NCT03086057|7653876|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5
4720802|NCT03086057|7653877|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0
4720803|NCT03086057|7653878|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0
4720804|NCT03086057|7653875|FG000|Stage 1: PrEP Uptake|Death|1
4720805|NCT03086057|7653876|FG001|Stage 1: PrEP Uptake|Death|0
4720806|NCT03086057|7653877|FG002|Stage 1: PrEP Uptake|Death|0
4720807|NCT03086057|7653878|FG003|Stage 1: PrEP Uptake|Death|0
4720808|NCT03086057|7653875|FG000|Stage 2: PrEP Adherence|Incarcerated|0
4720809|NCT03086057|7653876|FG001|Stage 2: PrEP Adherence|Incarcerated|0
4720810|NCT03086057|7653877|FG002|Stage 2: PrEP Adherence|Incarcerated|2
4720811|NCT03086057|7653878|FG003|Stage 2: PrEP Adherence|Incarcerated|0
4720812|NCT03086057|7653875|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0
4720813|NCT03086057|7653876|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0
4720814|NCT03086057|7653877|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1
4720815|NCT03086057|7653878|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0
4720816|NCT03086057|7653875|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0
4720817|NCT03086057|7653876|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0
4720818|NCT03086057|7653877|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3
4720819|NCT03086057|7653878|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2
4720820|NCT03086135|7653888|FG000|Overall Study|Adverse Event|1
4720821|NCT03086135|7653888|FG000|Overall Study|Lost to Follow-up|2
4720822|NCT03086330|7653910|FG000|Overall Study|Withdrawal by Subject|3
4720823|NCT03086330|7653911|FG001|Overall Study|Withdrawal by Subject|2
4720824|NCT03086330|7653910|FG000|Overall Study|Lost to Follow-up|1
4720825|NCT03086330|7653911|FG001|Overall Study|Lost to Follow-up|2
4720826|NCT03086343|7653919|FG000|Overall Study|Adverse Event|7
4720827|NCT03086343|7653920|FG001|Overall Study|Adverse Event|7
4720828|NCT03086343|7653919|FG000|Overall Study|Withdrawal by Subject|10
4720829|NCT03086343|7653920|FG001|Overall Study|Withdrawal by Subject|6
4720830|NCT03086343|7653919|FG000|Overall Study|Lost to Follow-up|3
4720831|NCT03086343|7653920|FG001|Overall Study|Lost to Follow-up|1
4720832|NCT03086343|7653919|FG000|Overall Study|Lack of Efficacy|4
4720833|NCT03086343|7653920|FG001|Overall Study|Lack of Efficacy|6
4720834|NCT03086343|7653919|FG000|Overall Study|Other, not specified|8
4720835|NCT03086343|7653920|FG001|Overall Study|Other, not specified|4
4720836|NCT03086343|7653919|FG000|Overall Study|Missing|0
4720837|NCT03086343|7653920|FG001|Overall Study|Missing|1
4720838|NCT03086447|7653941|FG000|Overall Study|No Longer Meets Eligibility Criteria|0
4720839|NCT03086447|7653942|FG001|Overall Study|No Longer Meets Eligibility Criteria|1
4720840|NCT03086447|7653941|FG000|Overall Study|Lost Lens|2
4720841|NCT03086447|7653942|FG001|Overall Study|Lost Lens|5
4720842|NCT03086447|7653941|FG000|Overall Study|Product quality complaint|0
4720843|NCT03086447|7653942|FG001|Overall Study|Product quality complaint|1
4720844|NCT03086447|7653941|FG000|Overall Study|Lens Damage|1
4720845|NCT03086447|7653942|FG001|Overall Study|Lens Damage|6
4720846|NCT03086447|7653941|FG000|Overall Study|Unsatisfactory Lens Fitting|0
4720847|NCT03086447|7653942|FG001|Overall Study|Unsatisfactory Lens Fitting|1
4720848|NCT03086447|7653941|FG000|Overall Study|Test Article No Longer Available|1
4720849|NCT03086447|7653942|FG001|Overall Study|Test Article No Longer Available|0
4720850|NCT03086447|7653941|FG000|Overall Study|Protocol Violation|2
4720851|NCT03086447|7653942|FG001|Overall Study|Protocol Violation|4
4720852|NCT03086447|7653941|FG000|Overall Study|Lost to Follow-up|0
4720853|NCT03086447|7653942|FG001|Overall Study|Lost to Follow-up|1
4720854|NCT03086447|7653941|FG000|Overall Study|Adverse Event|3
4720855|NCT03086447|7653942|FG001|Overall Study|Adverse Event|0
4720856|NCT03086447|7653941|FG000|Overall Study|Lens Discomfort|2
4720857|NCT03086447|7653942|FG001|Overall Study|Lens Discomfort|1
4720858|NCT03086460|7653948|FG000|Study Participants|Lost to Follow-up|2
4720859|NCT03086460|7653948|FG000|Study Participants|Protocol Violation|1
4720860|NCT03086460|7653948|FG000|Study Participants|Withdrawal by Subject|6
4720861|NCT03086460|7653948|FG000|Treatment A|Lost to Follow-up|1
4720862|NCT03086460|7653948|FG000|Treatment A|Protocol Violation|1
4720863|NCT03086460|7653948|FG000|Treatment A|Withdrawal by Subject|2
4720864|NCT03086460|7653948|FG000|Treatment C|Withdrawal by Subject|2
4720865|NCT03086460|7653948|FG000|Treatment E|Lost to Follow-up|1
4720866|NCT03086460|7653948|FG000|Treatment E|Withdrawal by Subject|3
4720867|NCT03086551|7653965|FG000|First Intervention|Failure to meet inclusion criterion|1
4720868|NCT03086551|7653966|FG001|First Intervention|Failure to meet inclusion criterion|0
4720869|NCT03086551|7653965|FG000|First Intervention|Lost to Follow-up|0
4720870|NCT03086551|7653966|FG001|First Intervention|Lost to Follow-up|1
4720871|NCT03086551|7653965|FG000|Washout|Lost to Follow-up|1
4720872|NCT03086551|7653966|FG001|Washout|Lost to Follow-up|2
4720873|NCT03086551|7653965|FG000|Washout|Withdrawal by Subject|2
4720874|NCT03086551|7653966|FG001|Washout|Withdrawal by Subject|1
4720875|NCT03087513|7653992|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2
4720876|NCT03087643|7654016|FG000|Overall Study|Withdrawal by Subject|2
4720877|NCT03087643|7654017|FG001|Overall Study|Withdrawal by Subject|4
4720878|NCT03087643|7654016|FG000|Overall Study|Death|2
4720879|NCT03087643|7654017|FG001|Overall Study|Death|2
4720880|NCT03087786|7654025|FG000|Overall Study|Withdrawal by Subject|2
4720881|NCT03087786|7654026|FG001|Overall Study|Withdrawal by Subject|0
4720882|NCT03087851|7654035|FG000|Overall Study|Withdraw on medical grounds|0
4720883|NCT03087851|7654036|FG001|Overall Study|Withdraw on medical grounds|1
4720884|NCT03087851|7654037|FG002|Overall Study|Withdraw on medical grounds|2
4720885|NCT03088917|7654084|FG000|Overall Study|In care/cured elsewhere|15
4720886|NCT03088917|7654084|FG000|Overall Study|Refuse re-evaluation|13
4720887|NCT03088917|7654084|FG000|Overall Study|Contact not established|13
4720888|NCT03088917|7654084|FG000|Overall Study|Severe comorbidity/short life expectancy|5
4720889|NCT03088917|7654084|FG000|Overall Study|Moved outside study region|50
4720890|NCT03089047|7654092|FG000|Overall Study|Lost to Follow-up|1
4720891|NCT03089047|7654093|FG001|Overall Study|Lost to Follow-up|0
4720892|NCT03089216|7654103|FG000|Overall Study|Adverse Event|0
4720893|NCT03089216|7654104|FG001|Overall Study|Adverse Event|0
4720894|NCT03089216|7654105|FG002|Overall Study|Adverse Event|0
4720895|NCT03089216|7654106|FG003|Overall Study|Adverse Event|1
4720896|NCT03089580|7654120|FG000|Overall Study|Lost to Follow-up|2
4720897|NCT03089697|7654128|FG000|Overall Study|Adverse Event|1
4720898|NCT03089697|7654129|FG001|Overall Study|Adverse Event|2
4720899|NCT03089697|7654128|FG000|Overall Study|Withdrawal by Subject|1
4720900|NCT03089697|7654129|FG001|Overall Study|Withdrawal by Subject|0
4720901|NCT03089944|7654149|FG000|Overall Study|Lost to Follow-up|8
4720902|NCT03089944|7654149|FG000|Overall Study|Withdrew Consent|2
4771750|NCT03284853|7748654|FG000|Overall Study|Lost to Follow-up|1
4771751|NCT03284853|7748655|FG001|Overall Study|Lost to Follow-up|0
4771752|NCT03284853|7748654|FG000|Overall Study|Lack of Efficacy|1
4771753|NCT03284853|7748655|FG001|Overall Study|Lack of Efficacy|0
4771754|NCT03284853|7748654|FG000|Overall Study|Disallowed Concurrent Medication|1
4771755|NCT03284853|7748655|FG001|Overall Study|Disallowed Concurrent Medication|1
4771756|NCT03284853|7748654|FG000|Overall Study|Protocol Violation|3
4771757|NCT03284853|7748655|FG001|Overall Study|Protocol Violation|3
4771758|NCT03284853|7748654|FG000|Overall Study|Death|0
4771759|NCT03284853|7748655|FG001|Overall Study|Death|1
4771760|NCT03284853|7748654|FG000|Overall Study|Other - Reason not reported in CSR|4
4771761|NCT03284853|7748655|FG001|Overall Study|Other - Reason not reported in CSR|3
4771762|NCT02774889|7748678|FG000|Overall Study|Lost to Follow-up|2
4771763|NCT02774889|7748679|FG001|Overall Study|Lost to Follow-up|1
4771764|NCT02297438|7748699|FG000|Overall Study|Death|79
4771765|NCT02297438|7748700|FG001|Overall Study|Death|86
4771766|NCT02297438|7748699|FG000|Overall Study|Lost to Follow-up|9
4771767|NCT02297438|7748700|FG001|Overall Study|Lost to Follow-up|7
4771768|NCT02297438|7748699|FG000|Overall Study|Withdrawal by Subject|7
4771769|NCT02297438|7748700|FG001|Overall Study|Withdrawal by Subject|0
4771770|NCT02297438|7748699|FG000|Overall Study|Other|9
4771771|NCT02297438|7748700|FG001|Overall Study|Other|5
4771772|NCT02297438|7748699|FG000|Overall Study|Ongoing|65
4771773|NCT02297438|7748700|FG001|Overall Study|Ongoing|73
4771774|NCT02297412|7748708|FG000|Overall Study|Canceled|1
4771775|NCT02297412|7748709|FG001|Overall Study|Canceled|1
4771776|NCT02250326|7748727|FG000|Treatment Period|Death|1
4771777|NCT02250326|7748728|FG001|Treatment Period|Death|12
4771778|NCT02250326|7748729|FG002|Treatment Period|Death|2
4771779|NCT02250326|7748727|FG000|Treatment Period|Adverse Event|8
4771780|NCT02250326|7748728|FG001|Treatment Period|Adverse Event|4
4771781|NCT02250326|7748729|FG002|Treatment Period|Adverse Event|8
4771782|NCT02250326|7748727|FG000|Treatment Period|Progressive Disease|42
4630709|NCT01884350|7499505|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3
4771783|NCT02250326|7748728|FG001|Treatment Period|Progressive Disease|36
4771784|NCT02250326|7748729|FG002|Treatment Period|Progressive Disease|45
4771785|NCT02250326|7748727|FG000|Treatment Period|Symptomatic Deterioration|9
4771786|NCT02250326|7748728|FG001|Treatment Period|Symptomatic Deterioration|4
4771787|NCT02250326|7748729|FG002|Treatment Period|Symptomatic Deterioration|10
4771788|NCT02250326|7748727|FG000|Treatment Period|Withdrawal by Subject|11
4771789|NCT02250326|7748728|FG001|Treatment Period|Withdrawal by Subject|5
4771790|NCT02250326|7748729|FG002|Treatment Period|Withdrawal by Subject|4
4771791|NCT02250326|7748727|FG000|Treatment Period|Miscellaneous|8
4771792|NCT02250326|7748728|FG001|Treatment Period|Miscellaneous|2
4771793|NCT02250326|7748729|FG002|Treatment Period|Miscellaneous|7
4630710|NCT01884350|7499506|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3
4720903|NCT03089944|7654149|FG000|Overall Study|Adverse Event|1
4720904|NCT03089944|7654149|FG000|Overall Study|Other|1
4771794|NCT02250326|7748727|FG000|Treatment Period|Randomized or assigned; not treated|2
4771795|NCT02250326|7748728|FG001|Treatment Period|Randomized or assigned; not treated|1
4771796|NCT02250326|7748729|FG002|Treatment Period|Randomized or assigned; not treated|1
4771797|NCT02250326|7748727|FG000|Follow-Up Period|Death|46
4771798|NCT02250326|7748728|FG001|Follow-Up Period|Death|26
4771799|NCT02250326|7748729|FG002|Follow-Up Period|Death|32
4771800|NCT02250326|7748727|FG000|Follow-Up Period|Unknown or Missing|2
4720905|NCT03090100|7654155|FG000|Overall Study|Adverse Event|9
4720906|NCT03090100|7654156|FG001|Overall Study|Adverse Event|11
4720907|NCT03090100|7654155|FG000|Overall Study|Pregnancy|1
4720908|NCT03090100|7654156|FG001|Overall Study|Pregnancy|1
4720909|NCT03090100|7654155|FG000|Overall Study|Lack of Efficacy|2
4720910|NCT03090100|7654156|FG001|Overall Study|Lack of Efficacy|7
4720911|NCT03090100|7654155|FG000|Overall Study|Lost to Follow-up|2
4720912|NCT03090100|7654156|FG001|Overall Study|Lost to Follow-up|2
4720913|NCT03090100|7654155|FG000|Overall Study|Withdrawal by Subject|7
4720914|NCT03090100|7654156|FG001|Overall Study|Withdrawal by Subject|19
4720915|NCT03090100|7654155|FG000|Overall Study|Protocol Violation|2
4720916|NCT03090100|7654156|FG001|Overall Study|Protocol Violation|6
4720917|NCT03090100|7654155|FG000|Overall Study|Non-compliance|2
4720918|NCT03090100|7654156|FG001|Overall Study|Non-compliance|0
4720919|NCT03090100|7654155|FG000|Overall Study|Other|2
4720920|NCT03090100|7654156|FG001|Overall Study|Other|2
4720921|NCT03091348|7654191|FG000|Overall Study|Lost to Follow-up|2
4720922|NCT03091348|7654192|FG001|Overall Study|Lost to Follow-up|1
4720923|NCT03091400|7654205|FG000|Washout - 2 Weeks|Withdrawal by Subject|1
4720924|NCT03091400|7654206|FG001|Washout - 2 Weeks|Withdrawal by Subject|0
4720925|NCT03091439|7654214|FG000|Overall Study|Study Terminated by the Sponsor|1
4720926|NCT03091439|7654215|FG001|Overall Study|Study Terminated by the Sponsor|0
4720927|NCT03091738|7654240|FG000|Overall Study|Adverse Event|1
4720928|NCT03091738|7654240|FG000|Overall Study|Lost to Follow-up|1
4720929|NCT03091777|7654251|FG000|Overall Study|Pregnancy|2
4720930|NCT03091777|7654252|FG001|Overall Study|Pregnancy|1
4720931|NCT03091777|7654253|FG002|Overall Study|Pregnancy|0
4720932|NCT03091777|7654251|FG000|Overall Study|Adverse Event|2
4720933|NCT03091777|7654252|FG001|Overall Study|Adverse Event|1
4720934|NCT03091777|7654253|FG002|Overall Study|Adverse Event|4
4720935|NCT03091777|7654251|FG000|Overall Study|Withdrawal by Subject|4
4720936|NCT03091777|7654252|FG001|Overall Study|Withdrawal by Subject|2
4720937|NCT03091777|7654253|FG002|Overall Study|Withdrawal by Subject|6
4720938|NCT03091777|7654251|FG000|Overall Study|Protocol Violation|2
4720939|NCT03091777|7654252|FG001|Overall Study|Protocol Violation|1
4720940|NCT03091777|7654253|FG002|Overall Study|Protocol Violation|1
4720941|NCT03091777|7654251|FG000|Overall Study|Lost to Follow-up|12
4720942|NCT03091777|7654252|FG001|Overall Study|Lost to Follow-up|14
4720943|NCT03091777|7654253|FG002|Overall Study|Lost to Follow-up|7
4720944|NCT03091777|7654251|FG000|Overall Study|Lack of Efficacy|0
4720945|NCT03091777|7654252|FG001|Overall Study|Lack of Efficacy|0
4720946|NCT03091777|7654253|FG002|Overall Study|Lack of Efficacy|5
4720947|NCT03091777|7654251|FG000|Overall Study|Noncompliance with study drug|2
4720948|NCT03091777|7654252|FG001|Overall Study|Noncompliance with study drug|3
4720949|NCT03091777|7654253|FG002|Overall Study|Noncompliance with study drug|1
4720950|NCT03091777|7654251|FG000|Overall Study|Physician Decision|1
4720951|NCT03091777|7654252|FG001|Overall Study|Physician Decision|0
4720952|NCT03091777|7654253|FG002|Overall Study|Physician Decision|1
4720953|NCT03091777|7654251|FG000|Overall Study|Abnormal Laboratory Value|7
4720954|NCT03091777|7654252|FG001|Overall Study|Abnormal Laboratory Value|11
4720955|NCT03091777|7654253|FG002|Overall Study|Abnormal Laboratory Value|12
4720956|NCT03091920|7654264|FG000|Overall Study|Adverse Event|0
4720957|NCT03091920|7654265|FG001|Overall Study|Adverse Event|1
4720958|NCT03091920|7654266|FG002|Overall Study|Adverse Event|0
4720959|NCT03092375|7654297|FG000|Overall Study|Lack of Efficacy|0
4720960|NCT03092375|7654298|FG001|Overall Study|Lack of Efficacy|1
4720961|NCT03092375|7654299|FG002|Overall Study|Lack of Efficacy|1
4720962|NCT03092375|7654300|FG003|Overall Study|Lack of Efficacy|0
4720963|NCT03092479|7654319|FG000|Overall Study|Lost to Follow-up|3
4720964|NCT03092479|7654320|FG001|Overall Study|Lost to Follow-up|2
4720965|NCT03092479|7654319|FG000|Overall Study|Withdrawal by Subject|4
4720966|NCT03092479|7654320|FG001|Overall Study|Withdrawal by Subject|0
4720967|NCT03092726|7654328|FG000|Overall Study|Adverse Event|3
4720968|NCT03092726|7654329|FG001|Overall Study|Adverse Event|10
4720969|NCT03092726|7654328|FG000|Overall Study|Lack of Efficacy|0
4720970|NCT03092726|7654329|FG001|Overall Study|Lack of Efficacy|1
4720971|NCT03092726|7654328|FG000|Overall Study|Lost to Follow-up|1
4720972|NCT03092726|7654329|FG001|Overall Study|Lost to Follow-up|0
4720973|NCT03092726|7654328|FG000|Overall Study|Withdrawal by Subject|5
4720974|NCT03092726|7654329|FG001|Overall Study|Withdrawal by Subject|3
4720975|NCT03092752|7654335|FG000|Overall Study|Aged <40 years|14209
4720976|NCT03092752|7654335|FG000|Overall Study|At least one claim with T2DM|61299
4720977|NCT03092752|7654335|FG000|Overall Study|Having no claim of study drugs|29282
4720978|NCT03092752|7654335|FG000|Overall Study|Average hospital visit interval >92 days|10779
4720979|NCT03092752|7654335|FG000|Overall Study|<6 month history|245900
4720980|NCT03092791|7654364|FG000|Overall Study|Lost to Follow-up|0
4720981|NCT03092791|7654365|FG001|Overall Study|Lost to Follow-up|0
4720982|NCT03092791|7654366|FG002|Overall Study|Lost to Follow-up|0
4720983|NCT03092791|7654367|FG003|Overall Study|Lost to Follow-up|0
4720984|NCT03092791|7654368|FG004|Overall Study|Lost to Follow-up|0
4720985|NCT03092791|7654369|FG005|Overall Study|Lost to Follow-up|0
4720986|NCT03092791|7654370|FG006|Overall Study|Lost to Follow-up|1
4720987|NCT03092791|7654371|FG007|Overall Study|Lost to Follow-up|0
4720988|NCT03092791|7654364|FG000|Overall Study|Withdrawal of Consent|0
4720989|NCT03092791|7654365|FG001|Overall Study|Withdrawal of Consent|0
4720990|NCT03092791|7654366|FG002|Overall Study|Withdrawal of Consent|0
4720991|NCT03092791|7654367|FG003|Overall Study|Withdrawal of Consent|0
4720992|NCT03092791|7654368|FG004|Overall Study|Withdrawal of Consent|4
4720993|NCT03092791|7654369|FG005|Overall Study|Withdrawal of Consent|12
4720994|NCT03092791|7654370|FG006|Overall Study|Withdrawal of Consent|6
4720995|NCT03092791|7654371|FG007|Overall Study|Withdrawal of Consent|4
4720996|NCT03092791|7654364|FG000|Overall Study|Study Termination|0
4720997|NCT03092791|7654365|FG001|Overall Study|Study Termination|0
4720998|NCT03092791|7654366|FG002|Overall Study|Study Termination|0
4720999|NCT03092791|7654367|FG003|Overall Study|Study Termination|0
4721000|NCT03092791|7654368|FG004|Overall Study|Study Termination|55
4721001|NCT03092791|7654369|FG005|Overall Study|Study Termination|46
4721002|NCT03092791|7654370|FG006|Overall Study|Study Termination|53
4721003|NCT03092791|7654371|FG007|Overall Study|Study Termination|55
4721004|NCT03092791|7654364|FG000|Overall Study|Death|0
4721005|NCT03092791|7654365|FG001|Overall Study|Death|0
4721006|NCT03092791|7654366|FG002|Overall Study|Death|0
4721007|NCT03092791|7654367|FG003|Overall Study|Death|0
4721008|NCT03092791|7654368|FG004|Overall Study|Death|0
4721009|NCT03092791|7654369|FG005|Overall Study|Death|1
4721010|NCT03092791|7654370|FG006|Overall Study|Death|0
4630711|NCT01884350|7499504|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1
4630712|NCT01884350|7499505|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0
4630713|NCT01884350|7499506|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1
4630714|NCT01884350|7499504|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17
4630715|NCT01884350|7499505|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6
4630716|NCT01884350|7499506|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3
4721011|NCT03092791|7654371|FG007|Overall Study|Death|1
4721012|NCT03092791|7654364|FG000|Overall Study|Reason Not Specified|0
4721013|NCT03092791|7654365|FG001|Overall Study|Reason Not Specified|0
4721014|NCT03092791|7654366|FG002|Overall Study|Reason Not Specified|0
4721015|NCT03092791|7654367|FG003|Overall Study|Reason Not Specified|0
4721016|NCT03092791|7654368|FG004|Overall Study|Reason Not Specified|1
4721017|NCT03092791|7654369|FG005|Overall Study|Reason Not Specified|1
4721018|NCT03092791|7654370|FG006|Overall Study|Reason Not Specified|0
4721019|NCT03092791|7654371|FG007|Overall Study|Reason Not Specified|0
4721020|NCT03093181|7654431|FG000|Overall Study|Withdrawal by Subject|2
4721021|NCT03093181|7654432|FG001|Overall Study|Withdrawal by Subject|1
4721022|NCT03093181|7654433|FG002|Overall Study|Withdrawal by Subject|2
4721023|NCT03093181|7654431|FG000|Overall Study|Other (Not specified)|1
4721024|NCT03093181|7654432|FG001|Overall Study|Other (Not specified)|0
4721025|NCT03093181|7654433|FG002|Overall Study|Other (Not specified)|0
4721026|NCT03093181|7654431|FG000|Overall Study|Adverse Event|0
4721027|NCT03093181|7654432|FG001|Overall Study|Adverse Event|1
4721028|NCT03093181|7654433|FG002|Overall Study|Adverse Event|0
4721029|NCT03093181|7654431|FG000|Overall Study|Other (Protocol violation)|0
4721030|NCT03093181|7654432|FG001|Overall Study|Other (Protocol violation)|0
4721031|NCT03093181|7654433|FG002|Overall Study|Other (Protocol violation)|1
4721032|NCT03093324|7654456|FG000|Overall Study|Adverse Event|4
4721033|NCT03093324|7654457|FG001|Overall Study|Adverse Event|15
4721034|NCT03093324|7654456|FG000|Overall Study|Lost to Follow-up|1
4721035|NCT03093324|7654457|FG001|Overall Study|Lost to Follow-up|0
4721036|NCT03093324|7654456|FG000|Overall Study|Protocol Deviation|2
4721037|NCT03093324|7654457|FG001|Overall Study|Protocol Deviation|2
4721038|NCT03093324|7654456|FG000|Overall Study|Withdrawal by Subject|2
4721039|NCT03093324|7654457|FG001|Overall Study|Withdrawal by Subject|2
4721040|NCT03093350|7654463|FG000|Overall Study|Death|1
4721041|NCT03093350|7654463|FG000|Overall Study|Signed consent, never began treartment|1
4721042|NCT03093415|7654470|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17
4721043|NCT03093415|7654471|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36
4721044|NCT03093415|7654472|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0
4721045|NCT03093415|7654470|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40
4721046|NCT03093415|7654471|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0
4721047|NCT03093415|7654472|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0
4721048|NCT03093415|7654470|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28
4721049|NCT03093415|7654471|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6
4721050|NCT03093415|7654472|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0
4721051|NCT03093415|7654470|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0
4721052|NCT03093415|7654471|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12
4721053|NCT03093415|7654472|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0
4721054|NCT03093415|7654470|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18
4721055|NCT03093415|7654471|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12
4721056|NCT03093415|7654472|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0
4721057|NCT03093415|7654470|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4
4721058|NCT03093415|7654471|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4
4721059|NCT03093415|7654472|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0
4736537|NCT03571256|7685840|FG002|Overall Study|Protocol Violation|1
4721060|NCT03093415|7654470|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15
4721061|NCT03093415|7654471|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32
4721062|NCT03093415|7654472|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0
4721063|NCT03093415|7654470|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5
4721064|NCT03093415|7654471|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3
4721065|NCT03093415|7654472|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0
4721066|NCT03093415|7654470|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4
4721067|NCT03093415|7654471|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2
4721068|NCT03093415|7654472|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0
4721069|NCT03093415|7654470|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9
4721070|NCT03093415|7654471|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3
4721071|NCT03093415|7654472|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0
4721072|NCT03093415|7654470|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1
4721073|NCT03093415|7654471|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8
4721074|NCT03093415|7654472|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3
4721075|NCT03093454|7654482|FG000|Overall Study|Withdrawal by Subject|1
4721076|NCT03093454|7654483|FG001|Overall Study|Withdrawal by Subject|1
4721077|NCT03093454|7654482|FG000|Overall Study|Scheduling conflict|3
4721078|NCT03093454|7654483|FG001|Overall Study|Scheduling conflict|1
4721079|NCT03093454|7654482|FG000|Overall Study|Physician Decision|2
4721080|NCT03093454|7654483|FG001|Overall Study|Physician Decision|1
4721081|NCT03093870|7654501|FG000|Overall Study|Withdrawal by Subject|2
4721082|NCT03093870|7654502|FG001|Overall Study|Withdrawal by Subject|6
4721083|NCT03093870|7654503|FG002|Overall Study|Withdrawal by Subject|5
4721084|NCT03093870|7654501|FG000|Overall Study|Death|1
4721085|NCT03093870|7654502|FG001|Overall Study|Death|35
4721086|NCT03093870|7654503|FG002|Overall Study|Death|35
4721087|NCT03093870|7654501|FG000|Overall Study|Radiographic disease progression|10
4721088|NCT03093870|7654502|FG001|Overall Study|Radiographic disease progression|0
4721089|NCT03093870|7654503|FG002|Overall Study|Radiographic disease progression|0
4721090|NCT03093870|7654501|FG000|Overall Study|Clinical disease progression|1
4721091|NCT03093870|7654502|FG001|Overall Study|Clinical disease progression|0
4721092|NCT03093870|7654503|FG002|Overall Study|Clinical disease progression|0
4721093|NCT03093870|7654501|FG000|Overall Study|Physician Decision|2
4721094|NCT03093870|7654502|FG001|Overall Study|Physician Decision|0
4721095|NCT03093870|7654503|FG002|Overall Study|Physician Decision|0
4721096|NCT03093870|7654501|FG000|Overall Study|Adverse Event|7
4721097|NCT03093870|7654502|FG001|Overall Study|Adverse Event|0
4721098|NCT03093870|7654503|FG002|Overall Study|Adverse Event|0
4721099|NCT03093870|7654501|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1
4721100|NCT03093870|7654502|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0
4721101|NCT03093870|7654503|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0
4721102|NCT03093870|7654501|FG000|Overall Study|Lost to Follow-up|0
4721103|NCT03093870|7654502|FG001|Overall Study|Lost to Follow-up|0
4721104|NCT03093870|7654503|FG002|Overall Study|Lost to Follow-up|1
4721105|NCT03094195|7654514|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12
4721106|NCT03094195|7654515|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10
4721107|NCT03094195|7654516|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11
4721108|NCT03094195|7654517|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
4721109|NCT03094195|7654518|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
4721110|NCT03094195|7654519|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
4721111|NCT03094195|7654520|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
4721112|NCT03094195|7654521|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
4721113|NCT03094195|7654514|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3
4721114|NCT03094195|7654515|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2
4721115|NCT03094195|7654516|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1
4721116|NCT03094195|7654517|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0
4721117|NCT03094195|7654518|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0
4721118|NCT03094195|7654519|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0
4721119|NCT03094195|7654520|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0
4721120|NCT03094195|7654521|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0
4721121|NCT03094195|7654514|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0
4721122|NCT03094195|7654515|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0
4721123|NCT03094195|7654516|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1
4721124|NCT03094195|7654517|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0
4721125|NCT03094195|7654518|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0
4721126|NCT03094195|7654519|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0
4721127|NCT03094195|7654520|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0
4721128|NCT03094195|7654521|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0
4721129|NCT03094195|7654514|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
4721130|NCT03094195|7654515|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1
4721131|NCT03094195|7654516|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1
4721132|NCT03094195|7654517|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
4721133|NCT03094195|7654518|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
4721134|NCT03094195|7654519|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
4721135|NCT03094195|7654520|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
4721136|NCT03094195|7654521|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
4721137|NCT03094611|7654545|FG000|Overall Study|Lack of Efficacy|1
4721138|NCT03094611|7654545|FG000|Overall Study|Stem Cell Transplant|1
4721139|NCT03095027|7654568|FG000|Period 2, Second Week of Wear|Adverse Event|1
4721140|NCT03095027|7654569|FG001|Period 2, Second Week of Wear|Adverse Event|0
4721141|NCT03095118|7654584|FG000|Overall Study|Adverse Event|1
4721142|NCT03095118|7654584|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1
4721143|NCT03095508|7654590|FG000|Overall Study|Adverse Event|0
4721144|NCT03095508|7654591|FG001|Overall Study|Adverse Event|1
4721145|NCT03095521|7654599|FG000|Overall Study|Withdrawal by Subject|0
4721146|NCT03095521|7654600|FG001|Overall Study|Withdrawal by Subject|1
4721147|NCT03095521|7654599|FG000|Overall Study|Lost to Follow-up|0
4721148|NCT03095521|7654600|FG001|Overall Study|Lost to Follow-up|1
4721149|NCT03095599|7654608|FG000|Overall Study|Withdrawal by Subject|1
4721150|NCT03095599|7654609|FG001|Overall Study|Withdrawal by Subject|0
4721151|NCT03095599|7654608|FG000|Overall Study|Lost to Follow-up|1
4721152|NCT03095599|7654609|FG001|Overall Study|Lost to Follow-up|0
4721153|NCT03095599|7654608|FG000|Overall Study|Withdrawal prior to vaccination|1
4721154|NCT03095599|7654609|FG001|Overall Study|Withdrawal prior to vaccination|0
4721155|NCT03095651|7654654|FG000|Overall Study|Lost to Follow-up|1
4721156|NCT03095651|7654655|FG001|Overall Study|Lost to Follow-up|1
4721157|NCT03095651|7654656|FG002|Overall Study|Lost to Follow-up|0
4721158|NCT03095651|7654657|FG003|Overall Study|Lost to Follow-up|1
4721159|NCT03095651|7654658|FG004|Overall Study|Lost to Follow-up|0
4721160|NCT03095651|7654659|FG005|Overall Study|Lost to Follow-up|0
4721161|NCT03095651|7654660|FG006|Overall Study|Lost to Follow-up|0
4721162|NCT03095651|7654661|FG007|Overall Study|Lost to Follow-up|0
4721163|NCT03095651|7654654|FG000|Overall Study|Withdrawal by Subject|0
4721164|NCT03095651|7654655|FG001|Overall Study|Withdrawal by Subject|0
4721165|NCT03095651|7654656|FG002|Overall Study|Withdrawal by Subject|0
4721166|NCT03095651|7654657|FG003|Overall Study|Withdrawal by Subject|0
4721167|NCT03095651|7654658|FG004|Overall Study|Withdrawal by Subject|0
4721168|NCT03095651|7654659|FG005|Overall Study|Withdrawal by Subject|1
4721169|NCT03095651|7654660|FG006|Overall Study|Withdrawal by Subject|0
4721170|NCT03095651|7654661|FG007|Overall Study|Withdrawal by Subject|0
4721171|NCT03096314|7654689|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9
4721172|NCT03096314|7654690|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12
4721173|NCT03096483|7654717|FG000|Overall Study|Withdrawal by site|1
4721174|NCT03096847|7654745|FG000|Overall Study|Other|2
4721175|NCT03096847|7654746|FG001|Overall Study|Other|1
4721176|NCT03096847|7654747|FG002|Overall Study|Other|2
4721177|NCT03096847|7654745|FG000|Overall Study|Lost to Follow-up|1
4721178|NCT03096847|7654746|FG001|Overall Study|Lost to Follow-up|0
4721179|NCT03096847|7654747|FG002|Overall Study|Lost to Follow-up|1
4721180|NCT03096847|7654745|FG000|Overall Study|Death|6
4721181|NCT03096847|7654746|FG001|Overall Study|Death|0
4721182|NCT03096847|7654747|FG002|Overall Study|Death|2
4721183|NCT03096847|7654745|FG000|Overall Study|Protocol Violation|3
4721184|NCT03096847|7654746|FG001|Overall Study|Protocol Violation|0
4721185|NCT03096847|7654747|FG002|Overall Study|Protocol Violation|6
4721186|NCT03096847|7654745|FG000|Overall Study|Physician Decision|12
4721187|NCT03096847|7654746|FG001|Overall Study|Physician Decision|2
4721188|NCT03096847|7654747|FG002|Overall Study|Physician Decision|8
4721189|NCT03096847|7654745|FG000|Overall Study|Withdrawal by Subject|24
4721190|NCT03096847|7654746|FG001|Overall Study|Withdrawal by Subject|1
4721191|NCT03096847|7654747|FG002|Overall Study|Withdrawal by Subject|12
4721192|NCT03096847|7654745|FG000|Overall Study|Adverse Event|72
4721193|NCT03096847|7654746|FG001|Overall Study|Adverse Event|6
4721194|NCT03096847|7654747|FG002|Overall Study|Adverse Event|28
4721195|NCT03096847|7654745|FG000|Overall Study|Progressive disease|97
4721196|NCT03096847|7654746|FG001|Overall Study|Progressive disease|10
4721197|NCT03096847|7654747|FG002|Overall Study|Progressive disease|78
4721198|NCT03096847|7654745|FG000|Overall Study|Non-compliance with study medication|1
4721199|NCT03096847|7654746|FG001|Overall Study|Non-compliance with study medication|0
4721200|NCT03096847|7654747|FG002|Overall Study|Non-compliance with study medication|0
4721201|NCT03096847|7654745|FG000|Overall Study|New therapy for study indication|1
4721202|NCT03096847|7654746|FG001|Overall Study|New therapy for study indication|0
4721203|NCT03096847|7654747|FG002|Overall Study|New therapy for study indication|1
4721204|NCT03097029|7654774|FG000|Overall Study|Withdrawal by Subject|1
4721205|NCT03097133|7654780|FG000|Overall Study|Lost to Follow-up|3
4721206|NCT03097133|7654781|FG001|Overall Study|Lost to Follow-up|2
4721207|NCT03097133|7654780|FG000|Overall Study|Withdrawal by Subject|2
4721208|NCT03097133|7654781|FG001|Overall Study|Withdrawal by Subject|5
4721209|NCT03097133|7654780|FG000|Overall Study|Discontinued DB, not entered FU Phase|21
4721210|NCT03097133|7654781|FG001|Overall Study|Discontinued DB, not entered FU Phase|25
4721211|NCT03097133|7654780|FG000|Overall Study|Other|3
4721212|NCT03097133|7654781|FG001|Overall Study|Other|2
4721213|NCT03097133|7654780|FG000|Overall Study|Adverse Event|1
4721214|NCT03097133|7654781|FG001|Overall Study|Adverse Event|0
4721215|NCT03097289|7654787|FG000|Overall Study|Adverse Event|1
4721216|NCT03097289|7654787|FG000|Overall Study|Equipment failure|2
4721217|NCT03097289|7654787|FG000|Overall Study|Collected platelet product unusable|3
4721218|NCT03097315|7654792|FG000|Overall Study|Withdrawal by Subject|1
4721219|NCT03097588|7654826|FG000|Overall Study|Adverse Event|1
4721220|NCT03097614|7654830|FG000|Overall Study|Adverse Event|3
4446181|NCT00481871|7231206|FG003|Overall Study|Progressive Disease - pt withdrew|0
4446182|NCT00481871|7231207|FG004|Overall Study|Progressive Disease - pt withdrew|0
4446183|NCT00481988|7231217|FG000|Overall Study|Withdrawal by Subject|1
4446184|NCT00481988|7231218|FG001|Overall Study|Withdrawal by Subject|1
4446185|NCT00482001|7231226|FG000|Overall Study|Protocol Violation|1
4446186|NCT00482001|7231227|FG001|Overall Study|Protocol Violation|1
4446187|NCT00482014|7231239|FG000|Overall Study|Withdrawal by Subject|1
4446188|NCT00482014|7231240|FG001|Overall Study|Withdrawal by Subject|2
4446189|NCT00482014|7231241|FG002|Overall Study|Withdrawal by Subject|3
4446190|NCT00482014|7231242|FG003|Overall Study|Withdrawal by Subject|4
4446191|NCT00482014|7231239|FG000|Overall Study|Adverse Event|3
4446192|NCT00482014|7231240|FG001|Overall Study|Adverse Event|0
4446193|NCT00482014|7231241|FG002|Overall Study|Adverse Event|2
4446194|NCT00482014|7231242|FG003|Overall Study|Adverse Event|8
4446195|NCT00482014|7231239|FG000|Overall Study|Death|1
4446196|NCT00482014|7231240|FG001|Overall Study|Death|2
4446197|NCT00482014|7231241|FG002|Overall Study|Death|1
4446198|NCT00482014|7231242|FG003|Overall Study|Death|4
4446199|NCT00482014|7231239|FG000|Overall Study|Lack of Efficacy|1
4446200|NCT00482014|7231240|FG001|Overall Study|Lack of Efficacy|0
4446201|NCT00482014|7231241|FG002|Overall Study|Lack of Efficacy|4
4446202|NCT00482014|7231242|FG003|Overall Study|Lack of Efficacy|6
4446203|NCT00482014|7231239|FG000|Overall Study|Sponsor Decision|1
4446204|NCT00482014|7231240|FG001|Overall Study|Sponsor Decision|2
4446205|NCT00482014|7231241|FG002|Overall Study|Sponsor Decision|1
4446206|NCT00482014|7231242|FG003|Overall Study|Sponsor Decision|1
4446207|NCT00482053|7231254|FG000|Inter-treatment Period|Disease progression|1
4446208|NCT00482170|7231260|FG000|Overall Study|Adverse Event|5
4446209|NCT00482170|7231261|FG001|Overall Study|Adverse Event|14
4446210|NCT00482170|7231260|FG000|Overall Study|Withdrawal by Subject|6
4446211|NCT00482170|7231261|FG001|Overall Study|Withdrawal by Subject|1
4446212|NCT00482170|7231260|FG000|Overall Study|Protocol Violation|2
4446213|NCT00482170|7231261|FG001|Overall Study|Protocol Violation|3
4446214|NCT00482170|7231260|FG000|Overall Study|Lost to Follow-up|2
4446215|NCT00482170|7231261|FG001|Overall Study|Lost to Follow-up|0
4446216|NCT00482170|7231260|FG000|Overall Study|Unspecified reason|0
4446217|NCT00482170|7231261|FG001|Overall Study|Unspecified reason|2
4446218|NCT00482274|7231267|FG000|Overall Study|Adverse Event|1
4446219|NCT00482391|7231271|FG000|Overall Study|Withdrawal by Subject|1
4446220|NCT00482391|7231271|FG000|Overall Study|Adverse Event|1
4446221|NCT00482391|7231271|FG000|Overall Study|Death|1
4446222|NCT00482612|7231289|FG000|In-treatment Period|No study medication administered|0
4446223|NCT00482612|7231290|FG001|In-treatment Period|No study medication administered|0
4446224|NCT00482612|7231291|FG002|In-treatment Period|No study medication administered|1
4446225|NCT00482612|7231292|FG003|In-treatment Period|No study medication administered|0
4446226|NCT00482612|7231289|FG000|Follow-up Period|Other|4
4446227|NCT00482612|7231290|FG001|Follow-up Period|Other|2
4446228|NCT00482612|7231291|FG002|Follow-up Period|Other|1
4446229|NCT00482612|7231292|FG003|Follow-up Period|Other|2
4446230|NCT00482612|7231289|FG000|Follow-up Period|Lack of compliance|0
4446231|NCT00482612|7231290|FG001|Follow-up Period|Lack of compliance|0
4446232|NCT00482612|7231291|FG002|Follow-up Period|Lack of compliance|1
4446233|NCT00482612|7231292|FG003|Follow-up Period|Lack of compliance|0
4446234|NCT00482612|7231289|FG000|Follow-up Period|Lost to Follow-up|0
4446235|NCT00482612|7231290|FG001|Follow-up Period|Lost to Follow-up|4
4446236|NCT00482612|7231291|FG002|Follow-up Period|Lost to Follow-up|2
4446237|NCT00482612|7231292|FG003|Follow-up Period|Lost to Follow-up|1
4446238|NCT00482612|7231289|FG000|Follow-up Period|Adverse Event|4
4446239|NCT00482612|7231290|FG001|Follow-up Period|Adverse Event|7
4446240|NCT00482612|7231291|FG002|Follow-up Period|Adverse Event|9
4446241|NCT00482612|7231292|FG003|Follow-up Period|Adverse Event|0
4446242|NCT00482612|7231289|FG000|Follow-up Period|Lack of Efficacy|2
4446243|NCT00482612|7231290|FG001|Follow-up Period|Lack of Efficacy|0
4446244|NCT00482612|7231291|FG002|Follow-up Period|Lack of Efficacy|1
4446245|NCT00482612|7231292|FG003|Follow-up Period|Lack of Efficacy|0
4446246|NCT00482612|7231289|FG000|Follow-up Period|Withdrawal by Subject|3
4446247|NCT00482612|7231290|FG001|Follow-up Period|Withdrawal by Subject|5
4446248|NCT00482612|7231291|FG002|Follow-up Period|Withdrawal by Subject|7
4446249|NCT00482612|7231292|FG003|Follow-up Period|Withdrawal by Subject|2
4721221|NCT03097861|7654855|FG000|Overall Study|Adverse Event|3
4446250|NCT00482612|7231289|FG000|Follow-up Period|Reasons not related to trial|1
4446251|NCT00482612|7231290|FG001|Follow-up Period|Reasons not related to trial|0
4446252|NCT00482612|7231291|FG002|Follow-up Period|Reasons not related to trial|1
4446253|NCT00482612|7231292|FG003|Follow-up Period|Reasons not related to trial|3
4446254|NCT00482703|7231321|FG000|Overall Study|Poor compliance|1
4721222|NCT03097861|7654856|FG001|Overall Study|Adverse Event|8
4721223|NCT03097861|7654857|FG002|Overall Study|Adverse Event|4
4446255|NCT00482703|7231322|FG001|Overall Study|Poor compliance|0
4446256|NCT00482729|7231337|FG000|Overall Study|Adverse Event|29
4446257|NCT00482729|7231338|FG001|Overall Study|Adverse Event|33
4446258|NCT00482729|7231337|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0
4446259|NCT00482729|7231338|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2
4446260|NCT00482729|7231337|FG000|Overall Study|Hyperglycemia Criteria|7
4446261|NCT00482729|7231338|FG001|Overall Study|Hyperglycemia Criteria|5
4446262|NCT00482729|7231337|FG000|Overall Study|Lack of Efficacy|4
4446263|NCT00482729|7231338|FG001|Overall Study|Lack of Efficacy|16
4446264|NCT00482729|7231337|FG000|Overall Study|Lost to Follow-up|86
4446265|NCT00482729|7231338|FG001|Overall Study|Lost to Follow-up|66
4446266|NCT00482729|7231337|FG000|Overall Study|Physician Decision|10
4446267|NCT00482729|7231338|FG001|Overall Study|Physician Decision|7
4446268|NCT00482729|7231337|FG000|Overall Study|Pregnancy|4
4446269|NCT00482729|7231338|FG001|Overall Study|Pregnancy|2
4446270|NCT00482729|7231337|FG000|Overall Study|Protocol Violation|10
4446271|NCT00482729|7231338|FG001|Overall Study|Protocol Violation|18
4446272|NCT00482729|7231337|FG000|Overall Study|Withdrawal by Subject|67
4446273|NCT00482729|7231338|FG001|Overall Study|Withdrawal by Subject|69
4446274|NCT00483002|7231353|FG000|Overall Study|Adverse Event|68
4446275|NCT00483002|7231353|FG000|Overall Study|Lack of Efficacy|555
4446276|NCT00483002|7231353|FG000|Overall Study|Lost to Follow-up|962
4446277|NCT00483002|7231353|FG000|Overall Study|Other|2
4446278|NCT00483002|7231353|FG000|Overall Study|Other|967
4446279|NCT00483041|7231359|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0
4446280|NCT00483041|7231360|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1
4446281|NCT00483184|7231369|FG000|Overall Study|Withdrawal by Subject|2
4446282|NCT00483184|7231370|FG001|Overall Study|Withdrawal by Subject|2
4446283|NCT00483184|7231371|FG002|Overall Study|Withdrawal by Subject|0
4446284|NCT00483184|7231369|FG000|Overall Study|Lost to Follow-up|1
4446285|NCT00483184|7231370|FG001|Overall Study|Lost to Follow-up|0
4446286|NCT00483184|7231371|FG002|Overall Study|Lost to Follow-up|0
4446287|NCT00483184|7231369|FG000|Overall Study|Adverse Event|1
4446288|NCT00483184|7231370|FG001|Overall Study|Adverse Event|2
4630717|NCT01884350|7499504|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17
4630718|NCT01884350|7499505|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3
4630719|NCT01884350|7499506|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0
4630720|NCT01884350|7499504|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3
4630721|NCT01884350|7499505|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0
4630722|NCT01884350|7499506|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2
4721224|NCT03097861|7654855|FG000|Overall Study|Investigator Decision|0
4446289|NCT00483184|7231371|FG002|Overall Study|Adverse Event|2
4446290|NCT00483184|7231369|FG000|Overall Study|Protocol Violation|1
4446291|NCT00483184|7231370|FG001|Overall Study|Protocol Violation|0
4446292|NCT00483184|7231371|FG002|Overall Study|Protocol Violation|1
4446293|NCT00483327|7231396|FG000|Overall Study|Adverse Event|1
4446294|NCT00483327|7231396|FG000|Overall Study|Withdrawal by Subject|3
4446295|NCT00483327|7231396|FG000|Overall Study|Lost to Follow-up|4
4446296|NCT00483327|7231396|FG000|Overall Study|Patient Non Compliance|2
4446297|NCT00483379|7231404|FG000|Treatment Period|Adverse Event|1
4446298|NCT00483379|7231405|FG001|Treatment Period|Adverse Event|0
4446299|NCT00483379|7231404|FG000|Treatment Period|Withdrawal by Subject|1
4446300|NCT00483379|7231405|FG001|Treatment Period|Withdrawal by Subject|0
4446301|NCT00483405|7231413|FG000|Overall Study|Adverse Event|8
4721225|NCT03097861|7654856|FG001|Overall Study|Investigator Decision|1
4721226|NCT03097861|7654857|FG002|Overall Study|Investigator Decision|0
4721227|NCT03097861|7654855|FG000|Overall Study|Lost to Follow-up|0
4721228|NCT03097861|7654856|FG001|Overall Study|Lost to Follow-up|7
4721229|NCT03097861|7654857|FG002|Overall Study|Lost to Follow-up|1
4721230|NCT03097861|7654855|FG000|Overall Study|Withdrawal by Subject|1
4721231|NCT03097861|7654856|FG001|Overall Study|Withdrawal by Subject|5
4721232|NCT03097861|7654857|FG002|Overall Study|Withdrawal by Subject|3
4721233|NCT03097861|7654855|FG000|Overall Study|Reason not provided|3
4721234|NCT03097861|7654856|FG001|Overall Study|Reason not provided|1
4721235|NCT03097861|7654857|FG002|Overall Study|Reason not provided|1
4721236|NCT03098030|7654871|FG000|Overall Study|Death|10
4721237|NCT03098030|7654872|FG001|Overall Study|Death|156
4721238|NCT03098030|7654873|FG002|Overall Study|Death|156
4721239|NCT03098030|7654874|FG003|Overall Study|Death|82
4721240|NCT03098030|7654871|FG000|Overall Study|Withdrawal by Subject|0
4721241|NCT03098030|7654872|FG001|Overall Study|Withdrawal by Subject|7
4721242|NCT03098030|7654873|FG002|Overall Study|Withdrawal by Subject|8
4721243|NCT03098030|7654874|FG003|Overall Study|Withdrawal by Subject|2
4446302|NCT00483405|7231413|FG000|Overall Study|Lack of Efficacy|14
4446303|NCT00483405|7231413|FG000|Overall Study|Death|3
4446304|NCT00483405|7231413|FG000|Overall Study|Withdrawal by Subject|2
4446305|NCT00483405|7231413|FG000|Overall Study|Other complicating disease|1
4446306|NCT00483548|7231435|FG000|Overall Study|Randomized; not treated with study drug|1
4446307|NCT00483548|7231436|FG001|Overall Study|Randomized; not treated with study drug|3
4446308|NCT00483548|7231435|FG000|Overall Study|Adverse Event|25
4446309|NCT00483548|7231436|FG001|Overall Study|Adverse Event|14
4446310|NCT00483548|7231435|FG000|Overall Study|Laboratory abnormality|1
4446311|NCT00483548|7231436|FG001|Overall Study|Laboratory abnormality|2
4446312|NCT00483548|7231435|FG000|Overall Study|Lack of Efficacy|4
4446313|NCT00483548|7231436|FG001|Overall Study|Lack of Efficacy|8
4446314|NCT00483548|7231435|FG000|Overall Study|Protocol Violation|11
4446315|NCT00483548|7231436|FG001|Overall Study|Protocol Violation|7
4446316|NCT00483548|7231435|FG000|Overall Study|Pregnancy|1
4446317|NCT00483548|7231436|FG001|Overall Study|Pregnancy|0
4446318|NCT00483548|7231435|FG000|Overall Study|Protocol required discontinuation|6
4446319|NCT00483548|7231436|FG001|Overall Study|Protocol required discontinuation|6
4446320|NCT00483548|7231435|FG000|Overall Study|Unable to comply with protocol schedule|1
4446321|NCT00483548|7231436|FG001|Overall Study|Unable to comply with protocol schedule|0
4446322|NCT00483548|7231435|FG000|Overall Study|Non-compliance with medication|2
4446323|NCT00483548|7231436|FG001|Overall Study|Non-compliance with medication|0
4446324|NCT00483548|7231435|FG000|Overall Study|Lost to Follow-up|3
4446325|NCT00483548|7231436|FG001|Overall Study|Lost to Follow-up|4
4446326|NCT00483548|7231435|FG000|Overall Study|Withdrawal by Subject|5
4446327|NCT00483548|7231436|FG001|Overall Study|Withdrawal by Subject|2
4446328|NCT00483574|7231448|FG000|Overall Study|Adverse Event|6
4446329|NCT00483574|7231449|FG001|Overall Study|Adverse Event|0
4446330|NCT00483574|7231448|FG000|Overall Study|Protocol Violation|28
4446331|NCT00483574|7231449|FG001|Overall Study|Protocol Violation|9
4446332|NCT00483574|7231448|FG000|Overall Study|Lost to Follow-up|16
4446333|NCT00483574|7231449|FG001|Overall Study|Lost to Follow-up|4
4446334|NCT00483574|7231448|FG000|Overall Study|Withdrawal by Subject|52
4446335|NCT00483574|7231449|FG001|Overall Study|Withdrawal by Subject|0
4446336|NCT00483652|7231459|FG000|Double-blind Treatment Period|Protocol Violation|2
4446337|NCT00483652|7231460|FG001|Double-blind Treatment Period|Protocol Violation|1
4446338|NCT00483652|7231459|FG000|Double-blind Treatment Period|Adverse Event|3
4446339|NCT00483652|7231460|FG001|Double-blind Treatment Period|Adverse Event|4
4446340|NCT00483652|7231459|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1
4446341|NCT00483652|7231460|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0
4446342|NCT00483652|7231459|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1
4446343|NCT00483652|7231460|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0
4446344|NCT00483704|7231469|FG000|Randomization|Withdrawal by Subject|19
4446345|NCT00483704|7231470|FG001|Randomization|Withdrawal by Subject|28
4446346|NCT00483704|7231471|FG002|Randomization|Withdrawal by Subject|18
4446347|NCT00483704|7231469|FG000|Randomization|Protocol Violation|14
4446348|NCT00483704|7231470|FG001|Randomization|Protocol Violation|25
4446349|NCT00483704|7231471|FG002|Randomization|Protocol Violation|22
4446350|NCT00483704|7231469|FG000|Randomization|Lost to Follow-up|14
4446351|NCT00483704|7231470|FG001|Randomization|Lost to Follow-up|14
4446352|NCT00483704|7231471|FG002|Randomization|Lost to Follow-up|19
4446353|NCT00483704|7231469|FG000|Randomization|Pregnancy|1
4446354|NCT00483704|7231470|FG001|Randomization|Pregnancy|0
4446355|NCT00483704|7231471|FG002|Randomization|Pregnancy|0
4446356|NCT00483704|7231469|FG000|Randomization|Physician Decision|2
4446357|NCT00483704|7231470|FG001|Randomization|Physician Decision|4
4446358|NCT00483704|7231471|FG002|Randomization|Physician Decision|0
4446359|NCT00483704|7231469|FG000|Randomization|Progressive disease|0
4446360|NCT00483704|7231470|FG001|Randomization|Progressive disease|0
4446361|NCT00483704|7231471|FG002|Randomization|Progressive disease|1
4446362|NCT00483704|7231469|FG000|Randomization|Lack of qualifying migraines|21
4446363|NCT00483704|7231470|FG001|Randomization|Lack of qualifying migraines|25
4446364|NCT00483704|7231471|FG002|Randomization|Lack of qualifying migraines|31
4446365|NCT00483704|7231469|FG000|Treatment|Lack of qualifying migraines|101
4446366|NCT00483704|7231470|FG001|Treatment|Lack of qualifying migraines|99
4446367|NCT00483704|7231471|FG002|Treatment|Lack of qualifying migraines|116
4446368|NCT00483704|7231469|FG000|Treatment|Adverse Event|3
4446369|NCT00483704|7231470|FG001|Treatment|Adverse Event|5
4446370|NCT00483704|7231471|FG002|Treatment|Adverse Event|4
4446371|NCT00483704|7231469|FG000|Treatment|Withdrawal by Subject|16
4446372|NCT00483704|7231470|FG001|Treatment|Withdrawal by Subject|12
4446373|NCT00483704|7231471|FG002|Treatment|Withdrawal by Subject|21
4446374|NCT00483704|7231469|FG000|Treatment|Protocol Violation|6
4446375|NCT00483704|7231470|FG001|Treatment|Protocol Violation|3
4446376|NCT00483704|7231471|FG002|Treatment|Protocol Violation|5
4446377|NCT00483704|7231469|FG000|Treatment|Lost to Follow-up|2
4446378|NCT00483704|7231470|FG001|Treatment|Lost to Follow-up|7
4446379|NCT00483704|7231471|FG002|Treatment|Lost to Follow-up|5
4446380|NCT00483704|7231469|FG000|Treatment|Lack of Efficacy|1
4446381|NCT00483704|7231470|FG001|Treatment|Lack of Efficacy|1
4446382|NCT00483704|7231471|FG002|Treatment|Lack of Efficacy|1
4446383|NCT00483704|7231469|FG000|Treatment|Pregnancy|0
4446384|NCT00483704|7231470|FG001|Treatment|Pregnancy|1
4446385|NCT00483704|7231471|FG002|Treatment|Pregnancy|0
4446386|NCT00483704|7231469|FG000|Treatment|Physician Decision|0
4446387|NCT00483704|7231470|FG001|Treatment|Physician Decision|1
4446388|NCT00483704|7231471|FG002|Treatment|Physician Decision|4
4446389|NCT00483717|7231484|FG000|Overall Study|Protocol Violation|5
4446390|NCT00483717|7231485|FG001|Overall Study|Protocol Violation|7
4446391|NCT00483717|7231484|FG000|Overall Study|Time of dosing missing|1
4446392|NCT00483717|7231485|FG001|Overall Study|Time of dosing missing|1
4446393|NCT00483717|7231484|FG000|Overall Study|No treatment for migraine|16
4446394|NCT00483717|7231485|FG001|Overall Study|No treatment for migraine|13
4446395|NCT00483717|7231484|FG000|Overall Study|Lost to Follow-up|1
4446396|NCT00483717|7231485|FG001|Overall Study|Lost to Follow-up|0
4446397|NCT00483717|7231484|FG000|Overall Study|Withdrawal by Subject|1
4446398|NCT00483717|7231485|FG001|Overall Study|Withdrawal by Subject|0
4721244|NCT03098030|7654871|FG000|Overall Study|Lost to Follow-up|0
4721245|NCT03098030|7654872|FG001|Overall Study|Lost to Follow-up|0
4721246|NCT03098030|7654873|FG002|Overall Study|Lost to Follow-up|2
4721247|NCT03098030|7654874|FG003|Overall Study|Lost to Follow-up|1
4736538|NCT03571516|7685852|FG000|Overall Study|Severe diarrhea|1
4630723|NCT01884350|7499504|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4
4630724|NCT01884350|7499505|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0
4446399|NCT00483756|7231494|FG000|Overall Study|Death|2
4446400|NCT00483756|7231495|FG001|Overall Study|Death|0
4446401|NCT00483756|7231496|FG002|Overall Study|Death|1
4736539|NCT03571516|7685853|FG001|Overall Study|Severe diarrhea|0
4736540|NCT03571516|7685852|FG000|Overall Study|Withdrawal by Subject|0
4736541|NCT03571516|7685853|FG001|Overall Study|Withdrawal by Subject|1
4736542|NCT03572062|7685923|FG000|Overall Study|Adverse Event|0
4736543|NCT03572062|7685924|FG001|Overall Study|Adverse Event|0
4736544|NCT03572062|7685925|FG002|Overall Study|Adverse Event|0
4736545|NCT03572062|7685926|FG003|Overall Study|Adverse Event|0
4736546|NCT03572062|7685927|FG004|Overall Study|Adverse Event|0
4736547|NCT03572062|7685928|FG005|Overall Study|Adverse Event|0
4736548|NCT03572062|7685929|FG006|Overall Study|Adverse Event|0
4736549|NCT03572062|7685930|FG007|Overall Study|Adverse Event|0
4736550|NCT03572062|7685931|FG008|Overall Study|Adverse Event|1
4736551|NCT03572062|7685932|FG009|Overall Study|Adverse Event|3
4736552|NCT03572062|7685923|FG000|Overall Study|Death|0
4736553|NCT03572062|7685924|FG001|Overall Study|Death|0
4736554|NCT03572062|7685925|FG002|Overall Study|Death|0
4736555|NCT03572062|7685926|FG003|Overall Study|Death|0
4736556|NCT03572062|7685927|FG004|Overall Study|Death|0
4736557|NCT03572062|7685928|FG005|Overall Study|Death|1
4736558|NCT03572062|7685929|FG006|Overall Study|Death|0
4736559|NCT03572062|7685930|FG007|Overall Study|Death|0
4736560|NCT03572062|7685931|FG008|Overall Study|Death|0
4736561|NCT03572062|7685932|FG009|Overall Study|Death|0
4736562|NCT03572062|7685923|FG000|Overall Study|Lost to Follow-up|0
4736563|NCT03572062|7685924|FG001|Overall Study|Lost to Follow-up|0
4736564|NCT03572062|7685925|FG002|Overall Study|Lost to Follow-up|0
4736565|NCT03572062|7685926|FG003|Overall Study|Lost to Follow-up|0
4736566|NCT03572062|7685927|FG004|Overall Study|Lost to Follow-up|0
4736567|NCT03572062|7685928|FG005|Overall Study|Lost to Follow-up|1
4736568|NCT03572062|7685929|FG006|Overall Study|Lost to Follow-up|1
4736569|NCT03572062|7685930|FG007|Overall Study|Lost to Follow-up|0
4736570|NCT03572062|7685931|FG008|Overall Study|Lost to Follow-up|0
4736571|NCT03572062|7685932|FG009|Overall Study|Lost to Follow-up|0
4736572|NCT03572062|7685923|FG000|Overall Study|No Longer Meets Eligibility Criteria|0
4736573|NCT03572062|7685924|FG001|Overall Study|No Longer Meets Eligibility Criteria|0
4736574|NCT03572062|7685925|FG002|Overall Study|No Longer Meets Eligibility Criteria|0
4736575|NCT03572062|7685926|FG003|Overall Study|No Longer Meets Eligibility Criteria|0
4736576|NCT03572062|7685927|FG004|Overall Study|No Longer Meets Eligibility Criteria|0
4736577|NCT03572062|7685928|FG005|Overall Study|No Longer Meets Eligibility Criteria|0
4736578|NCT03572062|7685929|FG006|Overall Study|No Longer Meets Eligibility Criteria|0
4736579|NCT03572062|7685930|FG007|Overall Study|No Longer Meets Eligibility Criteria|0
4736580|NCT03572062|7685931|FG008|Overall Study|No Longer Meets Eligibility Criteria|1
4736581|NCT03572062|7685932|FG009|Overall Study|No Longer Meets Eligibility Criteria|0
4736582|NCT03572062|7685923|FG000|Overall Study|Study Terminated By Sponsor|0
4736583|NCT03572062|7685924|FG001|Overall Study|Study Terminated By Sponsor|0
4736584|NCT03572062|7685925|FG002|Overall Study|Study Terminated By Sponsor|0
4736585|NCT03572062|7685926|FG003|Overall Study|Study Terminated By Sponsor|0
4736586|NCT03572062|7685927|FG004|Overall Study|Study Terminated By Sponsor|0
4736587|NCT03572062|7685928|FG005|Overall Study|Study Terminated By Sponsor|0
4736588|NCT03572062|7685929|FG006|Overall Study|Study Terminated By Sponsor|0
4736589|NCT03572062|7685930|FG007|Overall Study|Study Terminated By Sponsor|0
4736590|NCT03572062|7685931|FG008|Overall Study|Study Terminated By Sponsor|29
4736591|NCT03572062|7685932|FG009|Overall Study|Study Terminated By Sponsor|27
4736592|NCT03572062|7685923|FG000|Overall Study|Physician Decision|0
4736593|NCT03572062|7685924|FG001|Overall Study|Physician Decision|0
4736594|NCT03572062|7685925|FG002|Overall Study|Physician Decision|0
4736595|NCT03572062|7685926|FG003|Overall Study|Physician Decision|0
4736596|NCT03572062|7685927|FG004|Overall Study|Physician Decision|0
4736597|NCT03572062|7685928|FG005|Overall Study|Physician Decision|0
4736598|NCT03572062|7685929|FG006|Overall Study|Physician Decision|0
4736599|NCT03572062|7685930|FG007|Overall Study|Physician Decision|0
4736600|NCT03572062|7685931|FG008|Overall Study|Physician Decision|1
4736601|NCT03572062|7685932|FG009|Overall Study|Physician Decision|0
4446402|NCT00483756|7231494|FG000|Overall Study|Adverse Event|19
4736602|NCT03572062|7685923|FG000|Overall Study|Withdrawal by Subject|0
4736603|NCT03572062|7685924|FG001|Overall Study|Withdrawal by Subject|0
4736604|NCT03572062|7685925|FG002|Overall Study|Withdrawal by Subject|0
4721248|NCT03098433|7654907|FG000|Overall Study|Withdrawal by Subject|10
4721249|NCT03098550|7654915|FG000|Overall Study|Disease Progression|30
4721250|NCT03098550|7654916|FG001|Overall Study|Disease Progression|19
4721251|NCT03098550|7654917|FG002|Overall Study|Disease Progression|41
4721252|NCT03098550|7654915|FG000|Overall Study|Study Drug Toxicity|2
4721253|NCT03098550|7654916|FG001|Overall Study|Study Drug Toxicity|1
4721254|NCT03098550|7654917|FG002|Overall Study|Study Drug Toxicity|0
4721255|NCT03098550|7654915|FG000|Overall Study|Death|1
4721256|NCT03098550|7654916|FG001|Overall Study|Death|0
4721257|NCT03098550|7654917|FG002|Overall Study|Death|0
4721258|NCT03098550|7654915|FG000|Overall Study|Adverse Event unrelated to Study Drug|6
4721259|NCT03098550|7654916|FG001|Overall Study|Adverse Event unrelated to Study Drug|0
4721260|NCT03098550|7654917|FG002|Overall Study|Adverse Event unrelated to Study Drug|1
4721261|NCT03098550|7654915|FG000|Overall Study|Administrative reason by sponsor|0
4721262|NCT03098550|7654916|FG001|Overall Study|Administrative reason by sponsor|0
4721263|NCT03098550|7654917|FG002|Overall Study|Administrative reason by sponsor|1
4721264|NCT03098550|7654915|FG000|Overall Study|Other reasons|2
4721265|NCT03098550|7654916|FG001|Overall Study|Other reasons|0
4721266|NCT03098550|7654917|FG002|Overall Study|Other reasons|0
4721267|NCT03098979|7654962|FG000|Overall Study|Adverse Event|1
4721268|NCT03098979|7654963|FG001|Overall Study|Adverse Event|0
4721269|NCT03098979|7654964|FG002|Overall Study|Adverse Event|1
4721270|NCT03098979|7654965|FG003|Overall Study|Adverse Event|4
4721271|NCT03098979|7654966|FG004|Overall Study|Adverse Event|6
4721272|NCT03098979|7654967|FG005|Overall Study|Adverse Event|1
4721273|NCT03098979|7654962|FG000|Overall Study|Withdrawal by Subject|2
4721274|NCT03098979|7654963|FG001|Overall Study|Withdrawal by Subject|1
4721275|NCT03098979|7654964|FG002|Overall Study|Withdrawal by Subject|1
4721276|NCT03098979|7654965|FG003|Overall Study|Withdrawal by Subject|1
4721277|NCT03098979|7654966|FG004|Overall Study|Withdrawal by Subject|2
4721278|NCT03098979|7654967|FG005|Overall Study|Withdrawal by Subject|1
4721279|NCT03098979|7654962|FG000|Overall Study|Death|1
4721280|NCT03098979|7654963|FG001|Overall Study|Death|0
4721281|NCT03098979|7654964|FG002|Overall Study|Death|2
4721282|NCT03098979|7654965|FG003|Overall Study|Death|0
4721283|NCT03098979|7654966|FG004|Overall Study|Death|1
4721284|NCT03098979|7654967|FG005|Overall Study|Death|0
4721285|NCT03098979|7654962|FG000|Overall Study|Physician Decision|2
4721286|NCT03098979|7654963|FG001|Overall Study|Physician Decision|1
4721287|NCT03098979|7654964|FG002|Overall Study|Physician Decision|0
4721288|NCT03098979|7654965|FG003|Overall Study|Physician Decision|0
4721289|NCT03098979|7654966|FG004|Overall Study|Physician Decision|0
4721290|NCT03098979|7654967|FG005|Overall Study|Physician Decision|0
4721291|NCT03098979|7654962|FG000|Overall Study|Non-compliance|0
4721292|NCT03098979|7654963|FG001|Overall Study|Non-compliance|0
4721293|NCT03098979|7654964|FG002|Overall Study|Non-compliance|0
4721294|NCT03098979|7654965|FG003|Overall Study|Non-compliance|0
4721295|NCT03098979|7654966|FG004|Overall Study|Non-compliance|0
4721296|NCT03098979|7654967|FG005|Overall Study|Non-compliance|1
4721297|NCT03098979|7654962|FG000|Overall Study|Protocol Violation|0
4721298|NCT03098979|7654963|FG001|Overall Study|Protocol Violation|0
4721299|NCT03098979|7654964|FG002|Overall Study|Protocol Violation|0
4721300|NCT03098979|7654965|FG003|Overall Study|Protocol Violation|0
4721301|NCT03098979|7654966|FG004|Overall Study|Protocol Violation|0
4721302|NCT03098979|7654967|FG005|Overall Study|Protocol Violation|1
4721303|NCT03099096|7654981|FG000|Overall Study|Adverse Event|1
4721304|NCT03099096|7654981|FG000|Overall Study|Physician Decision|1
4721305|NCT03099161|7654988|FG000|Overall Study|Adverse Event|0
4721306|NCT03099161|7654989|FG001|Overall Study|Adverse Event|0
4721307|NCT03099161|7654990|FG002|Overall Study|Adverse Event|2
4721308|NCT03099161|7654988|FG000|Overall Study|Physician Decision|2
4721309|NCT03099161|7654989|FG001|Overall Study|Physician Decision|0
4721310|NCT03099161|7654990|FG002|Overall Study|Physician Decision|0
4721311|NCT03099161|7654988|FG000|Overall Study|Progressive Disease|1
4721312|NCT03099161|7654989|FG001|Overall Study|Progressive Disease|4
4721313|NCT03099161|7654990|FG002|Overall Study|Progressive Disease|1
4721314|NCT03099187|7655000|FG000|Double-blind Treatment|Adverse Event|19
4721315|NCT03099187|7655001|FG001|Double-blind Treatment|Adverse Event|1
4721316|NCT03099187|7655002|FG002|Double-blind Treatment|Adverse Event|0
4721317|NCT03099187|7655003|FG003|Double-blind Treatment|Adverse Event|0
4721318|NCT03099187|7655000|FG000|Double-blind Treatment|Death|1
4721319|NCT03099187|7655001|FG001|Double-blind Treatment|Death|3
4721320|NCT03099187|7655002|FG002|Double-blind Treatment|Death|0
4721321|NCT03099187|7655003|FG003|Double-blind Treatment|Death|0
4721322|NCT03099187|7655000|FG000|Double-blind Treatment|Lack of Efficacy|1
4721323|NCT03099187|7655001|FG001|Double-blind Treatment|Lack of Efficacy|0
4721324|NCT03099187|7655002|FG002|Double-blind Treatment|Lack of Efficacy|0
4721325|NCT03099187|7655003|FG003|Double-blind Treatment|Lack of Efficacy|0
4721326|NCT03099187|7655000|FG000|Double-blind Treatment|Physician Decision|2
4721327|NCT03099187|7655001|FG001|Double-blind Treatment|Physician Decision|1
4721328|NCT03099187|7655002|FG002|Double-blind Treatment|Physician Decision|0
4721329|NCT03099187|7655003|FG003|Double-blind Treatment|Physician Decision|0
4721330|NCT03099187|7655000|FG000|Double-blind Treatment|Withdrawal by Subject|9
4721331|NCT03099187|7655001|FG001|Double-blind Treatment|Withdrawal by Subject|4
4721332|NCT03099187|7655002|FG002|Double-blind Treatment|Withdrawal by Subject|0
4721333|NCT03099187|7655003|FG003|Double-blind Treatment|Withdrawal by Subject|0
4721334|NCT03099187|7655000|FG000|Double-blind Treatment|Lung transplantation|0
4721335|NCT03099187|7655001|FG001|Double-blind Treatment|Lung transplantation|1
4721336|NCT03099187|7655002|FG002|Double-blind Treatment|Lung transplantation|0
4721337|NCT03099187|7655003|FG003|Double-blind Treatment|Lung transplantation|0
4721338|NCT03099187|7655000|FG000|Double-blind Treatment|Non-compliance with study drug|0
4721339|NCT03099187|7655001|FG001|Double-blind Treatment|Non-compliance with study drug|2
4721340|NCT03099187|7655002|FG002|Double-blind Treatment|Non-compliance with study drug|0
4721341|NCT03099187|7655003|FG003|Double-blind Treatment|Non-compliance with study drug|0
4721342|NCT03099187|7655000|FG000|Double-blind Treatment|Disease progression|0
4721343|NCT03099187|7655001|FG001|Double-blind Treatment|Disease progression|1
4721344|NCT03099187|7655002|FG002|Double-blind Treatment|Disease progression|0
4721345|NCT03099187|7655003|FG003|Double-blind Treatment|Disease progression|0
4721346|NCT03099187|7655000|FG000|Double-blind Treatment|Randomization error|0
4721347|NCT03099187|7655001|FG001|Double-blind Treatment|Randomization error|2
4721348|NCT03099187|7655002|FG002|Double-blind Treatment|Randomization error|0
4721349|NCT03099187|7655003|FG003|Double-blind Treatment|Randomization error|0
4721350|NCT03099187|7655000|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1
4721351|NCT03099187|7655001|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1
4721352|NCT03099187|7655002|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0
4721353|NCT03099187|7655003|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0
4721354|NCT03099187|7655000|FG000|12-month Safety Follow-up|Adverse Event|0
4721355|NCT03099187|7655001|FG001|12-month Safety Follow-up|Adverse Event|0
4721356|NCT03099187|7655002|FG002|12-month Safety Follow-up|Adverse Event|5
4721357|NCT03099187|7655003|FG003|12-month Safety Follow-up|Adverse Event|12
4721358|NCT03099187|7655000|FG000|12-month Safety Follow-up|Death|0
4721359|NCT03099187|7655001|FG001|12-month Safety Follow-up|Death|0
4721360|NCT03099187|7655002|FG002|12-month Safety Follow-up|Death|7
4721361|NCT03099187|7655003|FG003|12-month Safety Follow-up|Death|9
4721362|NCT03099187|7655000|FG000|12-month Safety Follow-up|Lung transplantation|0
4721363|NCT03099187|7655001|FG001|12-month Safety Follow-up|Lung transplantation|0
4721364|NCT03099187|7655002|FG002|12-month Safety Follow-up|Lung transplantation|2
4721365|NCT03099187|7655003|FG003|12-month Safety Follow-up|Lung transplantation|1
4721366|NCT03099187|7655000|FG000|12-month Safety Follow-up|Lost to Follow-up|0
4721367|NCT03099187|7655001|FG001|12-month Safety Follow-up|Lost to Follow-up|0
4721368|NCT03099187|7655002|FG002|12-month Safety Follow-up|Lost to Follow-up|1
4721369|NCT03099187|7655003|FG003|12-month Safety Follow-up|Lost to Follow-up|0
4721370|NCT03099187|7655000|FG000|12-month Safety Follow-up|Symptomatic deterioration|0
4721371|NCT03099187|7655001|FG001|12-month Safety Follow-up|Symptomatic deterioration|0
4721372|NCT03099187|7655002|FG002|12-month Safety Follow-up|Symptomatic deterioration|1
4721373|NCT03099187|7655003|FG003|12-month Safety Follow-up|Symptomatic deterioration|1
4721374|NCT03099187|7655000|FG000|12-month Safety Follow-up|Withdrawal by Subject|0
4721375|NCT03099187|7655001|FG001|12-month Safety Follow-up|Withdrawal by Subject|0
4721376|NCT03099187|7655002|FG002|12-month Safety Follow-up|Withdrawal by Subject|3
4721377|NCT03099187|7655003|FG003|12-month Safety Follow-up|Withdrawal by Subject|2
4721378|NCT03099187|7655000|FG000|12-month Safety Follow-up|Due to hospitalization|0
4721379|NCT03099187|7655001|FG001|12-month Safety Follow-up|Due to hospitalization|0
4721380|NCT03099187|7655002|FG002|12-month Safety Follow-up|Due to hospitalization|0
4721381|NCT03099187|7655003|FG003|12-month Safety Follow-up|Due to hospitalization|1
4721382|NCT03099538|7655023|FG000|Overall Study|Lack of Efficacy|3
4721383|NCT03099694|7655036|FG000|Overall Study|Withdrawal by Subject|11
4721384|NCT03099694|7655037|FG001|Overall Study|Withdrawal by Subject|13
4721385|NCT03099694|7655036|FG000|Overall Study|Lost to Follow-up|9
4721386|NCT03099694|7655037|FG001|Overall Study|Lost to Follow-up|5
4721387|NCT03100058|7655053|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
4721388|NCT03100058|7655054|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
4721389|NCT03100058|7655055|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4
4721390|NCT03100058|7655056|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8
4721391|NCT03100058|7655057|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1
4721392|NCT03100058|7655058|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
4721393|NCT03100058|7655059|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3
4721394|NCT03100058|7655060|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11
4721395|NCT03100058|7655061|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2
4721396|NCT03100058|7655062|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
4721397|NCT03100058|7655063|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
4721398|NCT03100058|7655064|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
4721399|NCT03100058|7655065|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
4721400|NCT03100058|7655053|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2
4721401|NCT03100058|7655054|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4
4721402|NCT03100058|7655055|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3
4721403|NCT03100058|7655056|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4
4721404|NCT03100058|7655057|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1
4721405|NCT03100058|7655058|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1
4721406|NCT03100058|7655059|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1
4736605|NCT03572062|7685926|FG003|Overall Study|Withdrawal by Subject|0
4446403|NCT00483756|7231495|FG001|Overall Study|Adverse Event|38
4446404|NCT00483756|7231496|FG002|Overall Study|Adverse Event|40
4446405|NCT00483756|7231494|FG000|Overall Study|Lack of Efficacy|1
4446406|NCT00483756|7231495|FG001|Overall Study|Lack of Efficacy|0
4446407|NCT00483756|7231496|FG002|Overall Study|Lack of Efficacy|0
4446408|NCT00483756|7231494|FG000|Overall Study|Lost to Follow-up|3
4446409|NCT00483756|7231495|FG001|Overall Study|Lost to Follow-up|1
4446410|NCT00483756|7231496|FG002|Overall Study|Lost to Follow-up|0
4446411|NCT00483756|7231494|FG000|Overall Study|Withdrawal by Subject|5
4446412|NCT00483756|7231495|FG001|Overall Study|Withdrawal by Subject|3
4446413|NCT00483756|7231496|FG002|Overall Study|Withdrawal by Subject|4
4446414|NCT00483756|7231494|FG000|Overall Study|Other|2
4446415|NCT00483756|7231495|FG001|Overall Study|Other|4
4446416|NCT00483756|7231496|FG002|Overall Study|Other|3
4446417|NCT00483756|7231494|FG000|Overall Study|Randomized, Not Treated|1
4446418|NCT00483756|7231495|FG001|Overall Study|Randomized, Not Treated|4
4446419|NCT00483756|7231496|FG002|Overall Study|Randomized, Not Treated|4
4446420|NCT00483938|7231511|FG000|Overall Study|Protocol Violation|0
4446421|NCT00483938|7231512|FG001|Overall Study|Protocol Violation|0
4446422|NCT00483938|7231513|FG002|Overall Study|Protocol Violation|0
4446423|NCT00483938|7231514|FG003|Overall Study|Protocol Violation|0
4446424|NCT00483938|7231515|FG004|Overall Study|Protocol Violation|0
4446425|NCT00483938|7231516|FG005|Overall Study|Protocol Violation|0
4446426|NCT00483938|7231517|FG006|Overall Study|Protocol Violation|3
4446427|NCT00483938|7231511|FG000|Overall Study|Withdrawal by Subject|1
4446428|NCT00483938|7231512|FG001|Overall Study|Withdrawal by Subject|6
4446429|NCT00483938|7231513|FG002|Overall Study|Withdrawal by Subject|0
4446430|NCT00483938|7231514|FG003|Overall Study|Withdrawal by Subject|0
4446431|NCT00483938|7231515|FG004|Overall Study|Withdrawal by Subject|1
4446432|NCT00483938|7231516|FG005|Overall Study|Withdrawal by Subject|3
4446433|NCT00483938|7231517|FG006|Overall Study|Withdrawal by Subject|2
4446434|NCT00483938|7231511|FG000|Overall Study|Lost to Follow-up|1
4446435|NCT00483938|7231512|FG001|Overall Study|Lost to Follow-up|2
4446436|NCT00483938|7231513|FG002|Overall Study|Lost to Follow-up|0
4446437|NCT00483938|7231514|FG003|Overall Study|Lost to Follow-up|2
4446438|NCT00483938|7231515|FG004|Overall Study|Lost to Follow-up|1
4446439|NCT00483938|7231516|FG005|Overall Study|Lost to Follow-up|1
4446440|NCT00483938|7231517|FG006|Overall Study|Lost to Follow-up|3
4446441|NCT00483938|7231511|FG000|Overall Study|Death|0
4446442|NCT00483938|7231512|FG001|Overall Study|Death|2
4446443|NCT00483938|7231513|FG002|Overall Study|Death|0
4446444|NCT00483938|7231514|FG003|Overall Study|Death|0
4446445|NCT00483938|7231515|FG004|Overall Study|Death|0
4446446|NCT00483938|7231516|FG005|Overall Study|Death|0
4446447|NCT00483938|7231517|FG006|Overall Study|Death|0
4446448|NCT00483938|7231511|FG000|Overall Study|Other|3
4446449|NCT00483938|7231512|FG001|Overall Study|Other|9
4446450|NCT00483938|7231513|FG002|Overall Study|Other|0
4446451|NCT00483938|7231514|FG003|Overall Study|Other|4
4446452|NCT00483938|7231515|FG004|Overall Study|Other|0
4446453|NCT00483938|7231516|FG005|Overall Study|Other|4
4446454|NCT00483938|7231517|FG006|Overall Study|Other|32
4446455|NCT00484094|7231536|FG000|Overall Study|Discontinued|39
4446456|NCT00484094|7231536|FG000|Overall Study|Other|3
4446457|NCT00484159|7231543|FG000|Overall Study|Lost to Follow-up|1
4446458|NCT00484159|7231544|FG001|Overall Study|Lost to Follow-up|1
4446459|NCT00484159|7231545|FG002|Overall Study|Lost to Follow-up|0
4446460|NCT00484185|7231553|FG000|Overall Study|Lost to Follow-up|44
4446461|NCT00484185|7231553|FG000|Overall Study|Other|20
4446462|NCT00484185|7231553|FG000|Overall Study|Randomized but not treated|5
4446463|NCT00484185|7231553|FG000|Overall Study|Death|2
4446464|NCT00484198|7231561|FG000|Overall Study|Participant Withdrew Consent|12
4446465|NCT00484198|7231562|FG001|Overall Study|Participant Withdrew Consent|21
4446466|NCT00484198|7231563|FG002|Overall Study|Participant Withdrew Consent|47
4446467|NCT00484198|7231564|FG003|Overall Study|Participant Withdrew Consent|59
4446468|NCT00484198|7231561|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16
4630725|NCT01884350|7499506|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0
4630726|NCT01884350|7499504|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3
4446469|NCT00484198|7231562|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17
4446470|NCT00484198|7231563|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29
4446471|NCT00484198|7231564|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38
4446472|NCT00484198|7231561|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3
4446473|NCT00484198|7231562|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2
4446474|NCT00484198|7231563|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6
4446475|NCT00484198|7231564|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8
4446476|NCT00484198|7231561|FG000|Overall Study|Adverse Event|3
4446477|NCT00484198|7231562|FG001|Overall Study|Adverse Event|11
4446478|NCT00484198|7231563|FG002|Overall Study|Adverse Event|32
4446479|NCT00484198|7231564|FG003|Overall Study|Adverse Event|31
4446480|NCT00484198|7231561|FG000|Overall Study|Protocol Violation|0
4446481|NCT00484198|7231562|FG001|Overall Study|Protocol Violation|5
4721407|NCT03100058|7655060|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4
4721408|NCT03100058|7655061|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2
4721409|NCT03100058|7655062|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0
4721410|NCT03100058|7655063|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0
4721411|NCT03100058|7655064|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0
4721412|NCT03100058|7655065|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0
4721413|NCT03100058|7655053|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
4721414|NCT03100058|7655054|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1
4721415|NCT03100058|7655055|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1
4721416|NCT03100058|7655056|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
4721417|NCT03100058|7655057|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
4721418|NCT03100058|7655058|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1
4721419|NCT03100058|7655059|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1
4721420|NCT03100058|7655060|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
4721421|NCT03100058|7655061|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
4721422|NCT03100058|7655062|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
4721423|NCT03100058|7655063|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
4721424|NCT03100058|7655064|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
4721425|NCT03100058|7655065|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
4721426|NCT03100058|7655053|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
4721427|NCT03100058|7655054|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1
4721428|NCT03100058|7655055|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1
4721429|NCT03100058|7655056|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
4721430|NCT03100058|7655057|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
4721431|NCT03100058|7655058|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
4721432|NCT03100058|7655059|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1
4721433|NCT03100058|7655060|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
4721434|NCT03100058|7655061|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1
4721435|NCT03100058|7655062|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
4721436|NCT03100058|7655063|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
4721437|NCT03100058|7655064|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
4721438|NCT03100058|7655065|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
4721439|NCT03100058|7655053|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
4721440|NCT03100058|7655054|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
4721441|NCT03100058|7655055|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
4721442|NCT03100058|7655056|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1
4721443|NCT03100058|7655057|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
4721444|NCT03100058|7655058|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
4721445|NCT03100058|7655059|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
4721446|NCT03100058|7655060|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1
4721447|NCT03100058|7655061|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
4721448|NCT03100058|7655062|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
4721449|NCT03100058|7655063|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
4721450|NCT03100058|7655064|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
4721451|NCT03100058|7655065|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
4721452|NCT03100058|7655053|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
4721453|NCT03100058|7655054|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
4721454|NCT03100058|7655055|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
4721455|NCT03100058|7655056|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1
4721456|NCT03100058|7655057|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
4721457|NCT03100058|7655058|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
4721458|NCT03100058|7655059|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1
4721459|NCT03100058|7655060|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
4721460|NCT03100058|7655061|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
4721461|NCT03100058|7655062|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
4721462|NCT03100058|7655063|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
4721463|NCT03100058|7655064|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
4721464|NCT03100058|7655065|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
4721465|NCT03100058|7655053|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0
4721466|NCT03100058|7655054|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1
4721467|NCT03100058|7655055|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0
4721468|NCT03100058|7655056|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0
4721469|NCT03100058|7655057|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0
4721470|NCT03100058|7655058|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0
4721471|NCT03100058|7655059|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0
4721472|NCT03100058|7655060|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0
4721473|NCT03100058|7655061|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0
4721474|NCT03100058|7655062|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0
4721475|NCT03100058|7655063|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0
4721476|NCT03100058|7655064|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0
4721477|NCT03100058|7655065|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0
4721478|NCT03100058|7655053|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1
4721479|NCT03100058|7655054|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
4721480|NCT03100058|7655055|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
4721481|NCT03100058|7655056|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
4721482|NCT03100058|7655057|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
4721483|NCT03100058|7655058|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
4721484|NCT03100058|7655059|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
4721485|NCT03100058|7655060|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
4721486|NCT03100058|7655061|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
4721487|NCT03100058|7655062|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
4771801|NCT02250326|7748728|FG001|Follow-Up Period|Unknown or Missing|3
4771802|NCT02250326|7748729|FG002|Follow-Up Period|Unknown or Missing|3
4771803|NCT02250326|7748727|FG000|Follow-Up Period|Lost to Follow-up|1
4771804|NCT02250326|7748728|FG001|Follow-Up Period|Lost to Follow-up|1
4771805|NCT02250326|7748729|FG002|Follow-Up Period|Lost to Follow-up|3
4771806|NCT01503515|7748751|FG000|Overall Study|Adverse Event|4
4771807|NCT01503515|7748752|FG001|Overall Study|Adverse Event|5
4771808|NCT01503515|7748751|FG000|Overall Study|Death|0
4771809|NCT01503515|7748752|FG001|Overall Study|Death|1
4771810|NCT01503515|7748751|FG000|Overall Study|Physician Decision|14
4771811|NCT01503515|7748752|FG001|Overall Study|Physician Decision|23
4771812|NCT01503515|7748751|FG000|Overall Study|Withdrawal by Subject|0
4771813|NCT01503515|7748752|FG001|Overall Study|Withdrawal by Subject|1
4771814|NCT01503515|7748751|FG000|Overall Study|Institutional dx of proven/probable IFI|2
4771815|NCT01503515|7748752|FG001|Overall Study|Institutional dx of proven/probable IFI|4
4771816|NCT01503515|7748751|FG000|Overall Study|Ineligible|1
4771817|NCT01503515|7748752|FG001|Overall Study|Ineligible|1
4771818|NCT00245960|7748785|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6
4771819|NCT00245960|7748786|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7
4771820|NCT00245960|7748785|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0
4771821|NCT00245960|7748786|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1
4771822|NCT00245960|7748785|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2
4771823|NCT00245960|7748786|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0
4771824|NCT00245960|7748785|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2
4771825|NCT00245960|7748786|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1
4771826|NCT00245960|7748785|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3
4771827|NCT00245960|7748786|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0
4771828|NCT00245960|7748785|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2
4771829|NCT00245960|7748786|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2
4771830|NCT00245960|7748785|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8
4771831|NCT00245960|7748786|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4
4771832|NCT00245960|7748785|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2
4771833|NCT00245960|7748786|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2
4771834|NCT00245960|7748785|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2
4771835|NCT00245960|7748786|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5
4771836|NCT00245960|7748785|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1
4771837|NCT00245960|7748786|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3
4771838|NCT00245960|7748785|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1
4771839|NCT00245960|7748786|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3
4771840|NCT00245960|7748785|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0
4771841|NCT00245960|7748786|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1
4721488|NCT03100058|7655063|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
4721489|NCT03100058|7655064|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
4721490|NCT03100058|7655065|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
4721491|NCT03100058|7655053|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
4721492|NCT03100058|7655054|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
4721493|NCT03100058|7655055|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
4721494|NCT03100058|7655056|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
4721495|NCT03100058|7655057|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
4721496|NCT03100058|7655058|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
4721497|NCT03100058|7655059|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1
4721498|NCT03100058|7655060|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
4721499|NCT03100058|7655061|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
4721500|NCT03100058|7655062|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
4721501|NCT03100058|7655063|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
4721502|NCT03100058|7655064|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
4721503|NCT03100058|7655065|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
4721504|NCT03100058|7655053|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
4721505|NCT03100058|7655054|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
4721506|NCT03100058|7655055|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
4721507|NCT03100058|7655056|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
4721508|NCT03100058|7655057|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
4721509|NCT03100058|7655058|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
4721510|NCT03100058|7655059|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
4721511|NCT03100058|7655060|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
4721512|NCT03100058|7655061|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
4721513|NCT03100058|7655062|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
4721514|NCT03100058|7655063|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4
4721515|NCT03100058|7655064|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2
4721516|NCT03100058|7655065|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1
4721517|NCT03100058|7655053|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
4721518|NCT03100058|7655054|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
4721519|NCT03100058|7655055|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
4721520|NCT03100058|7655056|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
4721521|NCT03100058|7655057|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
4721522|NCT03100058|7655058|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
4630727|NCT01884350|7499505|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0
4630728|NCT01884350|7499506|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0
4721523|NCT03100058|7655059|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
4721524|NCT03100058|7655060|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
4721525|NCT03100058|7655061|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
4721526|NCT03100058|7655062|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
4721527|NCT03100058|7655063|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3
4721528|NCT03100058|7655064|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1
4721529|NCT03100058|7655065|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
4721530|NCT03100058|7655053|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
4721531|NCT03100058|7655054|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
4721532|NCT03100058|7655055|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
4721533|NCT03100058|7655056|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
4721534|NCT03100058|7655057|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
4721535|NCT03100058|7655058|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
4721536|NCT03100058|7655059|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
4721537|NCT03100058|7655060|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
4721538|NCT03100058|7655061|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
4721539|NCT03100058|7655062|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4
4721540|NCT03100058|7655063|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7
4721541|NCT03100058|7655064|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
4721542|NCT03100058|7655065|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2
4721543|NCT03100058|7655053|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0
4721544|NCT03100058|7655054|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0
4721545|NCT03100058|7655055|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0
4721546|NCT03100058|7655056|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0
4721547|NCT03100058|7655057|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0
4721548|NCT03100058|7655058|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0
4721549|NCT03100058|7655059|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0
4721550|NCT03100058|7655060|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0
4721551|NCT03100058|7655061|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0
4721552|NCT03100058|7655062|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0
4721553|NCT03100058|7655063|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1
4721554|NCT03100058|7655064|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0
4633407|NCT01911845|7503590|FG000|Overall Study|Lost to Follow-up|1
4721555|NCT03100058|7655065|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0
4721556|NCT03100058|7655053|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
4721557|NCT03100058|7655054|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
4721558|NCT03100058|7655055|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
4721559|NCT03100058|7655056|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
4721560|NCT03100058|7655057|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
4721561|NCT03100058|7655058|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
4721562|NCT03100058|7655059|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
4721563|NCT03100058|7655060|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
4721564|NCT03100058|7655061|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
4721565|NCT03100058|7655062|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
4721566|NCT03100058|7655063|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
4721567|NCT03100058|7655064|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
4721568|NCT03100058|7655065|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1
4721569|NCT03100058|7655053|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
4721570|NCT03100058|7655054|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
4721571|NCT03100058|7655055|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
4721572|NCT03100058|7655056|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
4721573|NCT03100058|7655057|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
4721574|NCT03100058|7655058|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
4721575|NCT03100058|7655059|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
4721576|NCT03100058|7655060|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
4721577|NCT03100058|7655061|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
4721578|NCT03100058|7655062|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1
4721579|NCT03100058|7655063|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
4721580|NCT03100058|7655064|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
4721581|NCT03100058|7655065|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
4721582|NCT03100344|7655112|FG000|Overall Study|Adverse Event|0
4721583|NCT03100344|7655113|FG001|Overall Study|Adverse Event|3
4721584|NCT03100344|7655114|FG002|Overall Study|Adverse Event|2
4721585|NCT03100344|7655115|FG003|Overall Study|Adverse Event|3
4721586|NCT03100344|7655112|FG000|Overall Study|Lack of Efficacy|2
4721587|NCT03100344|7655113|FG001|Overall Study|Lack of Efficacy|0
4721588|NCT03100344|7655114|FG002|Overall Study|Lack of Efficacy|0
4721589|NCT03100344|7655115|FG003|Overall Study|Lack of Efficacy|0
4721590|NCT03100344|7655112|FG000|Overall Study|Protocol Violation|1
4721591|NCT03100344|7655113|FG001|Overall Study|Protocol Violation|0
4721592|NCT03100344|7655114|FG002|Overall Study|Protocol Violation|0
4721593|NCT03100344|7655115|FG003|Overall Study|Protocol Violation|0
4721594|NCT03100344|7655112|FG000|Overall Study|Withdrawal by Subject|10
4721595|NCT03100344|7655113|FG001|Overall Study|Withdrawal by Subject|7
4721596|NCT03100344|7655114|FG002|Overall Study|Withdrawal by Subject|4
4721597|NCT03100344|7655115|FG003|Overall Study|Withdrawal by Subject|8
4721598|NCT03100344|7655112|FG000|Overall Study|Lost to Follow-up|1
4721599|NCT03100344|7655113|FG001|Overall Study|Lost to Follow-up|1
4721600|NCT03100344|7655114|FG002|Overall Study|Lost to Follow-up|1
4721601|NCT03100344|7655115|FG003|Overall Study|Lost to Follow-up|1
4721602|NCT03100825|7655130|FG000|Overall Study|Participant/Guardian Decision|7
4721603|NCT03100825|7655130|FG000|Overall Study|Physician Decision|1
4721604|NCT03100838|7655134|FG000|Overall Study|Adverse Event|1
4721605|NCT03100838|7655135|FG001|Overall Study|Adverse Event|0
4721606|NCT03100838|7655136|FG002|Overall Study|Adverse Event|0
4721607|NCT03100838|7655137|FG003|Overall Study|Adverse Event|0
4721608|NCT03100838|7655134|FG000|Overall Study|Physician Decision|1
4721609|NCT03100838|7655135|FG001|Overall Study|Physician Decision|1
4721610|NCT03100838|7655136|FG002|Overall Study|Physician Decision|1
4721611|NCT03100838|7655137|FG003|Overall Study|Physician Decision|1
4721612|NCT03100838|7655134|FG000|Overall Study|Pregnancy|0
4721613|NCT03100838|7655135|FG001|Overall Study|Pregnancy|1
4721614|NCT03100838|7655136|FG002|Overall Study|Pregnancy|0
4721615|NCT03100838|7655137|FG003|Overall Study|Pregnancy|0
4721616|NCT03100838|7655134|FG000|Overall Study|Lost to Follow-up|0
4721617|NCT03100838|7655135|FG001|Overall Study|Lost to Follow-up|0
4721618|NCT03100838|7655136|FG002|Overall Study|Lost to Follow-up|1
4721619|NCT03100838|7655137|FG003|Overall Study|Lost to Follow-up|0
4721620|NCT03100942|7655155|FG000|Randomized Treatment Period|Withdrew Consent|4
4721621|NCT03100942|7655156|FG001|Randomized Treatment Period|Withdrew Consent|5
4721622|NCT03100942|7655157|FG002|Randomized Treatment Period|Withdrew Consent|3
4721623|NCT03100942|7655158|FG003|Randomized Treatment Period|Withdrew Consent|3
4721624|NCT03100942|7655159|FG004|Randomized Treatment Period|Withdrew Consent|0
4721625|NCT03100942|7655160|FG005|Randomized Treatment Period|Withdrew Consent|0
4721626|NCT03100942|7655161|FG006|Randomized Treatment Period|Withdrew Consent|0
4721627|NCT03100942|7655155|FG000|Randomized Treatment Period|Adverse Event|5
4721628|NCT03100942|7655156|FG001|Randomized Treatment Period|Adverse Event|2
4721629|NCT03100942|7655157|FG002|Randomized Treatment Period|Adverse Event|1
4721630|NCT03100942|7655158|FG003|Randomized Treatment Period|Adverse Event|0
4721631|NCT03100942|7655159|FG004|Randomized Treatment Period|Adverse Event|0
4721632|NCT03100942|7655160|FG005|Randomized Treatment Period|Adverse Event|0
4721633|NCT03100942|7655161|FG006|Randomized Treatment Period|Adverse Event|0
4721634|NCT03100942|7655155|FG000|Randomized Treatment Period|Investigator's Discretion|2
4721635|NCT03100942|7655156|FG001|Randomized Treatment Period|Investigator's Discretion|1
4721636|NCT03100942|7655157|FG002|Randomized Treatment Period|Investigator's Discretion|0
4721637|NCT03100942|7655158|FG003|Randomized Treatment Period|Investigator's Discretion|0
4721638|NCT03100942|7655159|FG004|Randomized Treatment Period|Investigator's Discretion|0
4721639|NCT03100942|7655160|FG005|Randomized Treatment Period|Investigator's Discretion|0
4721640|NCT03100942|7655161|FG006|Randomized Treatment Period|Investigator's Discretion|0
4721641|NCT03100942|7655155|FG000|Randomized Treatment Period|Protocol Violation|0
4721642|NCT03100942|7655156|FG001|Randomized Treatment Period|Protocol Violation|1
4721643|NCT03100942|7655157|FG002|Randomized Treatment Period|Protocol Violation|1
4721644|NCT03100942|7655158|FG003|Randomized Treatment Period|Protocol Violation|1
4721645|NCT03100942|7655159|FG004|Randomized Treatment Period|Protocol Violation|0
4721646|NCT03100942|7655160|FG005|Randomized Treatment Period|Protocol Violation|0
4630729|NCT01884350|7499504|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4
4721647|NCT03100942|7655161|FG006|Randomized Treatment Period|Protocol Violation|0
4721648|NCT03100942|7655155|FG000|Randomized Treatment Period|Lost to Follow-up|0
4721649|NCT03100942|7655156|FG001|Randomized Treatment Period|Lost to Follow-up|0
4721650|NCT03100942|7655157|FG002|Randomized Treatment Period|Lost to Follow-up|1
4721651|NCT03100942|7655158|FG003|Randomized Treatment Period|Lost to Follow-up|0
4721652|NCT03100942|7655159|FG004|Randomized Treatment Period|Lost to Follow-up|0
4721653|NCT03100942|7655160|FG005|Randomized Treatment Period|Lost to Follow-up|0
4721654|NCT03100942|7655161|FG006|Randomized Treatment Period|Lost to Follow-up|0
4721655|NCT03100942|7655155|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1
4721656|NCT03100942|7655156|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0
4721657|NCT03100942|7655157|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0
4630730|NCT01884350|7499505|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1
4630731|NCT01884350|7499506|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0
4721658|NCT03100942|7655158|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1
4721659|NCT03100942|7655159|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0
4721660|NCT03100942|7655160|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0
4721661|NCT03100942|7655161|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0
4721662|NCT03100942|7655155|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0
4721663|NCT03100942|7655156|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0
4721664|NCT03100942|7655157|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0
4721665|NCT03100942|7655158|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0
4721666|NCT03100942|7655159|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0
4721667|NCT03100942|7655160|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0
4721668|NCT03100942|7655161|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1
4721669|NCT03101020|7655185|FG000|Overall Study|Lack of time to participate|1
4721670|NCT03101020|7655186|FG001|Overall Study|Lack of time to participate|0
4721671|NCT03101020|7655185|FG000|Overall Study|Ran over by a car|0
4721672|NCT03101020|7655186|FG001|Overall Study|Ran over by a car|1
4721673|NCT03101020|7655185|FG000|Overall Study|Withdrawal by Subject|0
4721674|NCT03101020|7655186|FG001|Overall Study|Withdrawal by Subject|2
4721675|NCT03101150|7655216|FG000|Overall Study|Lost to Follow-up|2
4721676|NCT03101150|7655217|FG001|Overall Study|Lost to Follow-up|4
4721677|NCT03101150|7655216|FG000|Overall Study|Miscarriage|3
4721678|NCT03101150|7655217|FG001|Overall Study|Miscarriage|6
4721679|NCT03101241|7655225|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4
4721680|NCT03101241|7655226|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2
4721681|NCT03101241|7655225|FG000|Overall Study|Participant withdrew consent|3
4721682|NCT03101241|7655226|FG001|Overall Study|Participant withdrew consent|1
4721683|NCT03101241|7655225|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2
4721684|NCT03101241|7655226|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0
4721685|NCT03101241|7655225|FG000|Overall Study|Lost to Follow-up|2
4721686|NCT03101241|7655226|FG001|Overall Study|Lost to Follow-up|0
4721687|NCT03101241|7655225|FG000|Overall Study|Lack of Efficacy|0
4721688|NCT03101241|7655226|FG001|Overall Study|Lack of Efficacy|1
4721689|NCT03101241|7655225|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0
4721690|NCT03101241|7655226|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1
4721691|NCT03101267|7655235|FG000|Primary Study Period|Withdrawal by Subject|1
4721692|NCT03101267|7655236|FG001|Primary Study Period|Withdrawal by Subject|2
4721693|NCT03101267|7655237|FG002|Primary Study Period|Withdrawal by Subject|3
4721694|NCT03101267|7655235|FG000|Primary Study Period|Miscellaneous|2
4721695|NCT03101267|7655236|FG001|Primary Study Period|Miscellaneous|0
4721696|NCT03101267|7655237|FG002|Primary Study Period|Miscellaneous|0
4721697|NCT03101293|7655247|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1
4721698|NCT03101293|7655248|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0
4721699|NCT03101358|7655258|FG000|Overall Study|Non-compliance with study schedule|1
4721700|NCT03101358|7655259|FG001|Overall Study|Non-compliance with study schedule|0
4721701|NCT03101358|7655260|FG002|Overall Study|Non-compliance with study schedule|0
4721702|NCT03101358|7655261|FG003|Overall Study|Non-compliance with study schedule|1
4721703|NCT03101358|7655258|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0
4721704|NCT03101358|7655259|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0
4721705|NCT03101358|7655260|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1
4721706|NCT03101358|7655261|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0
4721707|NCT03101358|7655258|FG000|Overall Study|Physician Decision|1
4721708|NCT03101358|7655259|FG001|Overall Study|Physician Decision|0
4721709|NCT03101358|7655260|FG002|Overall Study|Physician Decision|0
4721710|NCT03101358|7655261|FG003|Overall Study|Physician Decision|3
4721711|NCT03101358|7655258|FG000|Overall Study|Adverse Event|0
4721712|NCT03101358|7655259|FG001|Overall Study|Adverse Event|0
4721713|NCT03101358|7655260|FG002|Overall Study|Adverse Event|1
4721714|NCT03101358|7655261|FG003|Overall Study|Adverse Event|0
4721715|NCT03101358|7655258|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0
4721716|NCT03101358|7655259|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0
4721717|NCT03101358|7655260|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0
4721718|NCT03101358|7655261|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1
4721719|NCT03101358|7655258|FG000|Overall Study|Lost to Follow-up|1
4721720|NCT03101358|7655259|FG001|Overall Study|Lost to Follow-up|0
4721721|NCT03101358|7655260|FG002|Overall Study|Lost to Follow-up|0
4721722|NCT03101358|7655261|FG003|Overall Study|Lost to Follow-up|1
4721723|NCT03101371|7655274|FG000|Overall Study|Physician Decision|0
4721724|NCT03101371|7655275|FG001|Overall Study|Physician Decision|1
4721725|NCT03101371|7655274|FG000|Overall Study|Lost to Follow-up|1
4721726|NCT03101371|7655275|FG001|Overall Study|Lost to Follow-up|4
4721727|NCT03101371|7655274|FG000|Overall Study|Did not meet eligibility criteria|2
4721728|NCT03101371|7655275|FG001|Overall Study|Did not meet eligibility criteria|1
4721729|NCT03101462|7655283|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1
4721730|NCT03101462|7655284|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1
4721731|NCT03101514|7655290|FG000|Overall Study|Withdrawal by Subject|4
4721732|NCT03101514|7655290|FG000|Overall Study|Protocol Violation|2
4721733|NCT03101514|7655290|FG000|Overall Study|patient's information was incomplete|1
4721734|NCT03101592|7655297|FG000|Overall Study|participant files could not be located|111
4721735|NCT03101592|7655298|FG001|Overall Study|participant files could not be located|170
4721736|NCT03101592|7655299|FG002|Overall Study|participant files could not be located|118
4721737|NCT03102710|7655344|FG000|Overall Study|Dental metal affected MRI scan quality|1
4721738|NCT03102710|7655345|FG001|Overall Study|Dental metal affected MRI scan quality|0
4721739|NCT03102710|7655346|FG002|Overall Study|Dental metal affected MRI scan quality|0
4721740|NCT03102710|7655344|FG000|Overall Study|Technical issues during final MRI scan|0
4721741|NCT03102710|7655345|FG001|Overall Study|Technical issues during final MRI scan|1
4721742|NCT03102710|7655346|FG002|Overall Study|Technical issues during final MRI scan|0
4721743|NCT03102710|7655344|FG000|Overall Study|Nausea during MRI scan|0
4721744|NCT03102710|7655345|FG001|Overall Study|Nausea during MRI scan|1
4721745|NCT03102710|7655346|FG002|Overall Study|Nausea during MRI scan|0
4630732|NCT01884350|7499504|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1
4630733|NCT01884350|7499505|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0
4630734|NCT01884350|7499506|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0
4630735|NCT01884350|7499504|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2
4630736|NCT01884350|7499505|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0
4630737|NCT01884350|7499506|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0
4630738|NCT01884545|7499537|FG000|Overall Study|Lost to Follow-up|6
4630739|NCT01884545|7499538|FG001|Overall Study|Lost to Follow-up|4
4630740|NCT01884545|7499539|FG002|Overall Study|Lost to Follow-up|9
4630741|NCT01884545|7499540|FG003|Overall Study|Lost to Follow-up|4
4630742|NCT01884545|7499537|FG000|Overall Study|Patient withdrawn|7
4630743|NCT01884545|7499538|FG001|Overall Study|Patient withdrawn|12
4630744|NCT01884545|7499539|FG002|Overall Study|Patient withdrawn|5
4630745|NCT01884545|7499540|FG003|Overall Study|Patient withdrawn|5
4630746|NCT01884545|7499537|FG000|Overall Study|Non-adherence|0
4630747|NCT01884545|7499538|FG001|Overall Study|Non-adherence|2
4630748|NCT01884545|7499539|FG002|Overall Study|Non-adherence|0
4630749|NCT01884545|7499540|FG003|Overall Study|Non-adherence|0
4630750|NCT01884571|7499550|FG000|Overall Study|Adverse Event|1
4630751|NCT01884571|7499550|FG000|Overall Study|Death|2
4630752|NCT01884571|7499550|FG000|Overall Study|Withdrawal by Subject|2
4630753|NCT01884571|7499550|FG000|Overall Study|Disease progression|3
4630754|NCT01884597|7499557|FG000|Overall Study|Adverse Event|0
4630755|NCT01884597|7499558|FG001|Overall Study|Adverse Event|0
4630756|NCT01884597|7499559|FG002|Overall Study|Adverse Event|1
4630757|NCT01884597|7499557|FG000|Overall Study|Lack of Efficacy|1
4630758|NCT01884597|7499558|FG001|Overall Study|Lack of Efficacy|0
4721746|NCT03102710|7655344|FG000|Overall Study|Subject unable to attend final session|0
4721747|NCT03102710|7655345|FG001|Overall Study|Subject unable to attend final session|1
4630759|NCT01884597|7499559|FG002|Overall Study|Lack of Efficacy|0
4630760|NCT01884597|7499557|FG000|Overall Study|Death|0
4721748|NCT03102710|7655346|FG002|Overall Study|Subject unable to attend final session|0
4721749|NCT03102762|7655365|FG000|Overall Study|Lost to Follow-up|1
4721750|NCT03102762|7655366|FG001|Overall Study|Lost to Follow-up|0
4721751|NCT03102918|7655388|FG000|Overall Study|Protocol Violation|1
4721752|NCT03102918|7655389|FG001|Overall Study|Protocol Violation|0
4721753|NCT03103100|7655402|FG000|Overall Study|Adverse Event|1
4721754|NCT03103100|7655403|FG001|Overall Study|Adverse Event|0
4721755|NCT03103100|7655404|FG002|Overall Study|Adverse Event|0
4721756|NCT03103100|7655402|FG000|Overall Study|Physician Decision|1
4721757|NCT03103100|7655403|FG001|Overall Study|Physician Decision|0
4721758|NCT03103100|7655404|FG002|Overall Study|Physician Decision|2
4721759|NCT03103503|7655445|FG000|Overall Study|Death|64
4721760|NCT03103503|7655445|FG000|Overall Study|Physician Decision|57
4721761|NCT03103503|7655445|FG000|Overall Study|Withdrawal by Subject|10
4721762|NCT03103503|7655445|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10
4721763|NCT03103503|7655445|FG000|Overall Study|Lost to Follow-up|3
4721764|NCT03103503|7655445|FG000|Overall Study|Study Closure|757
4721765|NCT03103763|7655452|FG000|Overall Study|Death|15
4721766|NCT03103763|7655453|FG001|Overall Study|Death|5
4721767|NCT03103763|7655454|FG002|Overall Study|Death|5
4721768|NCT03103763|7655452|FG000|Overall Study|Withdrawal by Subject|0
4721769|NCT03103763|7655453|FG001|Overall Study|Withdrawal by Subject|3
4721770|NCT03103763|7655454|FG002|Overall Study|Withdrawal by Subject|2
4721771|NCT03103906|7655464|FG000|Overall Study|Adverse Event|2
4721772|NCT03103906|7655465|FG001|Overall Study|Adverse Event|3
4721773|NCT03103906|7655464|FG000|Overall Study|Other|2
4721774|NCT03103906|7655465|FG001|Overall Study|Other|0
4721775|NCT03103919|7655473|FG000|Overall Study|Adverse Event|2
4721776|NCT03103919|7655474|FG001|Overall Study|Adverse Event|2
4721777|NCT03104816|7655534|FG000|Overall Study|Lack of Efficacy|0
4721778|NCT03104816|7655535|FG001|Overall Study|Lack of Efficacy|2
4721779|NCT03104816|7655536|FG002|Overall Study|Lack of Efficacy|0
4721780|NCT03104816|7655534|FG000|Overall Study|Protocol Violation|2
4721781|NCT03104816|7655535|FG001|Overall Study|Protocol Violation|0
4721782|NCT03104816|7655536|FG002|Overall Study|Protocol Violation|2
4721783|NCT03105297|7655553|FG000|Baseline Phase (Day 1)|Other|21
4721784|NCT03105297|7655553|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1
4721785|NCT03105297|7655553|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7
4721786|NCT03105362|7655564|FG000|Overall Study|Withdrawal by Subject|1
4721787|NCT03105362|7655564|FG000|Overall Study|Lost to Follow-up|1
4721788|NCT03106077|7655588|FG000|Overall Study|Screen Failure|94
4721789|NCT03106077|7655589|FG001|Overall Study|Screen Failure|0
4721790|NCT03106753|7655610|FG000|Overall Study|Withdrawal by Subject|0
4721791|NCT03106753|7655611|FG001|Overall Study|Withdrawal by Subject|1
4721792|NCT03107026|7655635|FG000|Overall Study|Adverse Event|2
4721793|NCT03107026|7655636|FG001|Overall Study|Adverse Event|14
4721794|NCT03107026|7655637|FG002|Overall Study|Adverse Event|23
4721795|NCT03107026|7655635|FG000|Overall Study|Lost to Follow-up|12
4721796|NCT03107026|7655636|FG001|Overall Study|Lost to Follow-up|12
4721797|NCT03107026|7655637|FG002|Overall Study|Lost to Follow-up|13
4721798|NCT03107026|7655635|FG000|Overall Study|Protocol Violation|1
4721799|NCT03107026|7655636|FG001|Overall Study|Protocol Violation|2
4721800|NCT03107026|7655637|FG002|Overall Study|Protocol Violation|0
4721801|NCT03107026|7655635|FG000|Overall Study|Pregnancy|1
4721802|NCT03107026|7655636|FG001|Overall Study|Pregnancy|0
4721803|NCT03107026|7655637|FG002|Overall Study|Pregnancy|0
4721804|NCT03107026|7655635|FG000|Overall Study|Withdrawal by Subject|13
4721805|NCT03107026|7655636|FG001|Overall Study|Withdrawal by Subject|5
4721806|NCT03107026|7655637|FG002|Overall Study|Withdrawal by Subject|17
4721807|NCT03107026|7655635|FG000|Overall Study|non compliance with study visits|1
4721808|NCT03107026|7655636|FG001|Overall Study|non compliance with study visits|2
4721809|NCT03107026|7655637|FG002|Overall Study|non compliance with study visits|0
4721810|NCT03107026|7655635|FG000|Overall Study|non-compliance with study drug|2
4721811|NCT03107026|7655636|FG001|Overall Study|non-compliance with study drug|2
4721812|NCT03107026|7655637|FG002|Overall Study|non-compliance with study drug|3
4721813|NCT03107026|7655635|FG000|Overall Study|Physician Decision|0
4721814|NCT03107026|7655636|FG001|Overall Study|Physician Decision|1
4721815|NCT03107026|7655637|FG002|Overall Study|Physician Decision|0
4721816|NCT03107052|7655648|FG000|Overall Study|Adverse Event|6
4721817|NCT03107052|7655649|FG001|Overall Study|Adverse Event|1
4721818|NCT03107052|7655650|FG002|Overall Study|Adverse Event|2
4721819|NCT03107052|7655648|FG000|Overall Study|Withdrawal by Subject|9
4721820|NCT03107052|7655649|FG001|Overall Study|Withdrawal by Subject|5
4721821|NCT03107052|7655650|FG002|Overall Study|Withdrawal by Subject|8
4721822|NCT03107052|7655648|FG000|Overall Study|Protocol Violation|6
4721823|NCT03107052|7655649|FG001|Overall Study|Protocol Violation|0
4721824|NCT03107052|7655650|FG002|Overall Study|Protocol Violation|3
4721825|NCT03107052|7655648|FG000|Overall Study|Lost to Follow-up|4
4721826|NCT03107052|7655649|FG001|Overall Study|Lost to Follow-up|0
4721827|NCT03107052|7655650|FG002|Overall Study|Lost to Follow-up|1
4721828|NCT03107052|7655648|FG000|Overall Study|Lack of Efficacy|23
4721829|NCT03107052|7655649|FG001|Overall Study|Lack of Efficacy|7
4721830|NCT03107052|7655650|FG002|Overall Study|Lack of Efficacy|4
4721831|NCT03107052|7655648|FG000|Overall Study|Other than specified|4
4721832|NCT03107052|7655649|FG001|Overall Study|Other than specified|2
4721833|NCT03107052|7655650|FG002|Overall Study|Other than specified|0
4721834|NCT03107052|7655648|FG000|Overall Study|Study terminated due to futility|67
4721835|NCT03107052|7655649|FG001|Overall Study|Study terminated due to futility|31
4721836|NCT03107052|7655650|FG002|Overall Study|Study terminated due to futility|23
4721837|NCT03107091|7655658|FG000|Overall Study|Physician Decision|1
4721838|NCT03107377|7655665|FG000|Overall Study|Adverse Event|3
4721839|NCT03107377|7655666|FG001|Overall Study|Adverse Event|3
4721840|NCT03107377|7655665|FG000|Overall Study|Protocol Violation|9
4721841|NCT03107377|7655666|FG001|Overall Study|Protocol Violation|12
4721842|NCT03107377|7655665|FG000|Overall Study|Physician Decision|3
4721843|NCT03107377|7655666|FG001|Overall Study|Physician Decision|6
4721844|NCT03107377|7655665|FG000|Overall Study|Pregnancy|7
4721845|NCT03107377|7655666|FG001|Overall Study|Pregnancy|7
4721846|NCT03107377|7655665|FG000|Overall Study|Withdrawal by Subject|16
4721847|NCT03107377|7655666|FG001|Overall Study|Withdrawal by Subject|22
4721848|NCT03107377|7655665|FG000|Overall Study|Lost to Follow-up|37
4721849|NCT03107377|7655666|FG001|Overall Study|Lost to Follow-up|34
4721850|NCT03107377|7655665|FG000|Overall Study|Other reason not specified|16
4721851|NCT03107377|7655666|FG001|Overall Study|Other reason not specified|15
4721852|NCT03107715|7655674|FG000|Overall Study|did not deliver at the home hospital|4
4721853|NCT03107715|7655675|FG001|Overall Study|did not deliver at the home hospital|6
4721854|NCT03107715|7655674|FG000|Overall Study|infant stillborn|0
4721855|NCT03107715|7655675|FG001|Overall Study|infant stillborn|1
4721856|NCT03107793|7655690|FG000|Induction Period (16 Weeks)|Adverse Event|5
4721857|NCT03107793|7655691|FG001|Induction Period (16 Weeks)|Adverse Event|0
4721858|NCT03107793|7655692|FG002|Induction Period (16 Weeks)|Adverse Event|0
4721859|NCT03107793|7655690|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3
4721860|NCT03107793|7655691|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0
4721861|NCT03107793|7655692|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0
4721862|NCT03107793|7655690|FG000|Induction Period (16 Weeks)|Physician Decision|1
4721863|NCT03107793|7655691|FG001|Induction Period (16 Weeks)|Physician Decision|0
4721864|NCT03107793|7655692|FG002|Induction Period (16 Weeks)|Physician Decision|0
4721865|NCT03107793|7655690|FG000|Induction Period (16 Weeks)|Progressive Disease|1
4721866|NCT03107793|7655691|FG001|Induction Period (16 Weeks)|Progressive Disease|0
4721867|NCT03107793|7655692|FG002|Induction Period (16 Weeks)|Progressive Disease|0
4721868|NCT03107793|7655690|FG000|Maintenance Period (16-48 Week)|Adverse Event|0
4721869|NCT03107793|7655691|FG001|Maintenance Period (16-48 Week)|Adverse Event|6
4721870|NCT03107793|7655692|FG002|Maintenance Period (16-48 Week)|Adverse Event|10
4721871|NCT03107793|7655690|FG000|Maintenance Period (16-48 Week)|Death|0
4721872|NCT03107793|7655691|FG001|Maintenance Period (16-48 Week)|Death|2
4721873|NCT03107793|7655692|FG002|Maintenance Period (16-48 Week)|Death|0
4721874|NCT03107793|7655690|FG000|Maintenance Period (16-48 Week)|Lack of Efficacy|0
4721875|NCT03107793|7655691|FG001|Maintenance Period (16-48 Week)|Lack of Efficacy|21
4721876|NCT03107793|7655692|FG002|Maintenance Period (16-48 Week)|Lack of Efficacy|8
4721877|NCT03107793|7655690|FG000|Maintenance Period (16-48 Week)|Lost to Follow-up|0
4721878|NCT03107793|7655691|FG001|Maintenance Period (16-48 Week)|Lost to Follow-up|1
4721879|NCT03107793|7655692|FG002|Maintenance Period (16-48 Week)|Lost to Follow-up|0
4721880|NCT03107793|7655690|FG000|Maintenance Period (16-48 Week)|Withdrawal by Subject|0
4721881|NCT03107793|7655691|FG001|Maintenance Period (16-48 Week)|Withdrawal by Subject|12
4721882|NCT03107793|7655692|FG002|Maintenance Period (16-48 Week)|Withdrawal by Subject|4
4721883|NCT03107793|7655690|FG000|Maintenance Period (16-48 Week)|Physician Decision|0
4721884|NCT03107793|7655691|FG001|Maintenance Period (16-48 Week)|Physician Decision|1
4721885|NCT03107793|7655692|FG002|Maintenance Period (16-48 Week)|Physician Decision|2
4721886|NCT03107793|7655690|FG000|Maintenance Period (16-48 Week)|Pregnancy|0
4721887|NCT03107793|7655691|FG001|Maintenance Period (16-48 Week)|Pregnancy|1
4721888|NCT03107793|7655692|FG002|Maintenance Period (16-48 Week)|Pregnancy|1
4721889|NCT03107793|7655690|FG000|Maintenance Period (16-48 Week)|Disease Relapse|0
4721890|NCT03107793|7655691|FG001|Maintenance Period (16-48 Week)|Disease Relapse|2
4721891|NCT03107793|7655692|FG002|Maintenance Period (16-48 Week)|Disease Relapse|1
4721892|NCT03107793|7655690|FG000|Maintenance Period (16-48 Week)|Progressive Disease|0
4721893|NCT03107793|7655691|FG001|Maintenance Period (16-48 Week)|Progressive Disease|0
4721894|NCT03107793|7655692|FG002|Maintenance Period (16-48 Week)|Progressive Disease|1
4721895|NCT03107793|7655690|FG000|Maintenance Period (16-48 Week)|Received A Disallowed Concomitant Treatment|0
4721896|NCT03107793|7655691|FG001|Maintenance Period (16-48 Week)|Received A Disallowed Concomitant Treatment|0
4721897|NCT03107793|7655692|FG002|Maintenance Period (16-48 Week)|Received A Disallowed Concomitant Treatment|1
4721898|NCT03108027|7655699|FG000|Period 1|Subject/Guardian Decision|0
4721899|NCT03108027|7655700|FG001|Period 1|Subject/Guardian Decision|0
4721900|NCT03108027|7655701|FG002|Period 1|Subject/Guardian Decision|0
4721901|NCT03108027|7655702|FG003|Period 1|Subject/Guardian Decision|2
4721902|NCT03108027|7655703|FG004|Period 1|Subject/Guardian Decision|0
4721903|NCT03108027|7655704|FG005|Period 1|Subject/Guardian Decision|0
4721904|NCT03108027|7655699|FG000|Period 3|Adverse Event|0
4721905|NCT03108027|7655700|FG001|Period 3|Adverse Event|1
4721906|NCT03108027|7655701|FG002|Period 3|Adverse Event|0
4721907|NCT03108027|7655702|FG003|Period 3|Adverse Event|0
4721908|NCT03108027|7655703|FG004|Period 3|Adverse Event|0
4721909|NCT03108027|7655704|FG005|Period 3|Adverse Event|0
4721910|NCT03108157|7655714|FG000|Overall Study|Protocol Violation|15
4721911|NCT03108157|7655715|FG001|Overall Study|Protocol Violation|4
4721912|NCT03108521|7655750|FG000|Overall Study|Lost to Follow-up|3
4721913|NCT03108521|7655751|FG001|Overall Study|Lost to Follow-up|0
4721914|NCT03108521|7655750|FG000|Overall Study|Lack of Efficacy|2
4721915|NCT03108521|7655751|FG001|Overall Study|Lack of Efficacy|0
4721916|NCT03108521|7655750|FG000|Overall Study|Physician Decision|4
4721917|NCT03108521|7655751|FG001|Overall Study|Physician Decision|0
4721918|NCT03108521|7655750|FG000|Overall Study|Adverse Event|3
4721919|NCT03108521|7655751|FG001|Overall Study|Adverse Event|0
4721920|NCT03109184|7655798|FG000|Overall Study|Lost to Follow-up|6
4721921|NCT03109184|7655799|FG001|Overall Study|Lost to Follow-up|6
4721922|NCT03109184|7655798|FG000|Overall Study|Withdrawal by Subject|1
4721923|NCT03109184|7655799|FG001|Overall Study|Withdrawal by Subject|1
4721924|NCT03110029|7655829|FG000|Overall Study|Withdrawal by Subject|1
4721925|NCT03110029|7655830|FG001|Overall Study|Withdrawal by Subject|1
4721926|NCT03110185|7655838|FG000|Overall Study|Death|0
4721927|NCT03110185|7655839|FG001|Overall Study|Death|1
4721928|NCT03110185|7655838|FG000|Overall Study|Withdrawal by Subject|2
4721929|NCT03110185|7655839|FG001|Overall Study|Withdrawal by Subject|7
4721930|NCT03110185|7655838|FG000|Overall Study|Time Constraints|0
4721931|NCT03110185|7655839|FG001|Overall Study|Time Constraints|6
4721932|NCT03110185|7655838|FG000|Overall Study|Conflict with care|5
4721933|NCT03110185|7655839|FG001|Overall Study|Conflict with care|12
4721934|NCT03110185|7655838|FG000|Overall Study|Protocol Violation|1
4721935|NCT03110185|7655839|FG001|Overall Study|Protocol Violation|4
4721936|NCT03110185|7655838|FG000|Overall Study|MRI Incompatible|2
4721937|NCT03110185|7655839|FG001|Overall Study|MRI Incompatible|0
4721938|NCT03110185|7655838|FG000|Overall Study|Patient Refusal|0
4721939|NCT03110185|7655839|FG001|Overall Study|Patient Refusal|1
4721940|NCT03110562|7655870|FG000|Overall Study|Withdrawal by Subject|37
4721941|NCT03110562|7655871|FG001|Overall Study|Withdrawal by Subject|35
4721942|NCT03110562|7655870|FG000|Overall Study|Death|47
4721943|NCT03110562|7655871|FG001|Overall Study|Death|61
4721944|NCT03110562|7655870|FG000|Overall Study|Lost to Follow-up|7
4721945|NCT03110562|7655871|FG001|Overall Study|Lost to Follow-up|6
4721946|NCT03110562|7655870|FG000|Overall Study|Other|2
4721947|NCT03110562|7655871|FG001|Overall Study|Other|1
4721948|NCT03110562|7655870|FG000|Overall Study|Randomized but never treated|0
4721949|NCT03110562|7655871|FG001|Overall Study|Randomized but never treated|3
4721950|NCT03110562|7655870|FG000|Overall Study|Ongoing|102
4721951|NCT03110562|7655871|FG001|Overall Study|Ongoing|101
4721952|NCT03110770|7655898|FG000|Overall Study|Death|1
4721953|NCT03110770|7655899|FG001|Overall Study|Death|0
4721954|NCT03110770|7655900|FG002|Overall Study|Death|0
4721955|NCT03110770|7655901|FG003|Overall Study|Death|1
4721956|NCT03110770|7655902|FG004|Overall Study|Death|0
4721957|NCT03110770|7655898|FG000|Overall Study|Enrolled but did not receive product|0
4721958|NCT03110770|7655899|FG001|Overall Study|Enrolled but did not receive product|0
4721959|NCT03110770|7655900|FG002|Overall Study|Enrolled but did not receive product|0
4721960|NCT03110770|7655901|FG003|Overall Study|Enrolled but did not receive product|8
4721961|NCT03110770|7655902|FG004|Overall Study|Enrolled but did not receive product|7
4721962|NCT03110770|7655898|FG000|Overall Study|Lost to Follow-up|0
4721963|NCT03110770|7655899|FG001|Overall Study|Lost to Follow-up|0
4721964|NCT03110770|7655900|FG002|Overall Study|Lost to Follow-up|0
4721965|NCT03110770|7655901|FG003|Overall Study|Lost to Follow-up|53
4721966|NCT03110770|7655902|FG004|Overall Study|Lost to Follow-up|45
4721967|NCT03110770|7655898|FG000|Overall Study|Investigator Decision|0
4721968|NCT03110770|7655899|FG001|Overall Study|Investigator Decision|0
4721969|NCT03110770|7655900|FG002|Overall Study|Investigator Decision|0
4721970|NCT03110770|7655901|FG003|Overall Study|Investigator Decision|5
4721971|NCT03110770|7655902|FG004|Overall Study|Investigator Decision|3
4721972|NCT03110770|7655898|FG000|Overall Study|Withdrawal by Subject|0
4630761|NCT01884597|7499558|FG001|Overall Study|Death|1
4630762|NCT01884597|7499559|FG002|Overall Study|Death|0
4446482|NCT00484198|7231563|FG002|Overall Study|Protocol Violation|6
4446483|NCT00484198|7231564|FG003|Overall Study|Protocol Violation|8
4446484|NCT00484198|7231561|FG000|Overall Study|Other|7
4446485|NCT00484198|7231562|FG001|Overall Study|Other|10
4446486|NCT00484198|7231563|FG002|Overall Study|Other|31
4446487|NCT00484198|7231564|FG003|Overall Study|Other|28
4446488|NCT00484289|7231582|FG000|Long Term Phase|Adverse Event|1
4446489|NCT00484289|7231583|FG001|Long Term Phase|Adverse Event|17
4446490|NCT00484289|7231584|FG002|Long Term Phase|Adverse Event|5
4446491|NCT00484289|7231582|FG000|Long Term Phase|Withdrawal by Subject|0
4446492|NCT00484289|7231583|FG001|Long Term Phase|Withdrawal by Subject|7
4721973|NCT03110770|7655899|FG001|Overall Study|Withdrawal by Subject|0
4721974|NCT03110770|7655900|FG002|Overall Study|Withdrawal by Subject|0
4721975|NCT03110770|7655901|FG003|Overall Study|Withdrawal by Subject|24
4446493|NCT00484289|7231584|FG002|Long Term Phase|Withdrawal by Subject|6
4446494|NCT00484289|7231582|FG000|Long Term Phase|Inadequate response|2
4721976|NCT03110770|7655902|FG004|Overall Study|Withdrawal by Subject|24
4721977|NCT03110770|7655898|FG000|Overall Study|Moved from area|5
4630763|NCT01884675|7499575|FG000|Overall Study|Study closed/terminated|3
4721978|NCT03110770|7655899|FG001|Overall Study|Moved from area|0
4721979|NCT03110770|7655900|FG002|Overall Study|Moved from area|2
4721980|NCT03110770|7655901|FG003|Overall Study|Moved from area|42
4721981|NCT03110770|7655902|FG004|Overall Study|Moved from area|43
4721982|NCT03110770|7655898|FG000|Overall Study|Illness/Injury unrelated to product|0
4721983|NCT03110770|7655899|FG001|Overall Study|Illness/Injury unrelated to product|0
4721984|NCT03110770|7655900|FG002|Overall Study|Illness/Injury unrelated to product|0
4721985|NCT03110770|7655901|FG003|Overall Study|Illness/Injury unrelated to product|0
4721986|NCT03110770|7655902|FG004|Overall Study|Illness/Injury unrelated to product|1
4721987|NCT03111108|7655918|FG000|Overall Study|Death|0
4721988|NCT03111108|7655919|FG001|Overall Study|Death|1
4721989|NCT03111108|7655918|FG000|Overall Study|Withdrawal by Subject|1
4721990|NCT03111108|7655919|FG001|Overall Study|Withdrawal by Subject|0
4736606|NCT03572062|7685927|FG004|Overall Study|Withdrawal by Subject|0
4736607|NCT03572062|7685928|FG005|Overall Study|Withdrawal by Subject|0
4736608|NCT03572062|7685929|FG006|Overall Study|Withdrawal by Subject|0
4736609|NCT03572062|7685930|FG007|Overall Study|Withdrawal by Subject|0
4736610|NCT03572062|7685931|FG008|Overall Study|Withdrawal by Subject|0
4736611|NCT03572062|7685932|FG009|Overall Study|Withdrawal by Subject|1
4736612|NCT03572062|7685923|FG000|Overall Study|Randomized But Not Treated|0
4736613|NCT03572062|7685924|FG001|Overall Study|Randomized But Not Treated|0
4736614|NCT03572062|7685925|FG002|Overall Study|Randomized But Not Treated|0
4736615|NCT03572062|7685926|FG003|Overall Study|Randomized But Not Treated|0
4736616|NCT03572062|7685927|FG004|Overall Study|Randomized But Not Treated|1
4736617|NCT03572062|7685928|FG005|Overall Study|Randomized But Not Treated|2
4736618|NCT03572062|7685929|FG006|Overall Study|Randomized But Not Treated|0
4736619|NCT03572062|7685930|FG007|Overall Study|Randomized But Not Treated|1
4736620|NCT03572062|7685931|FG008|Overall Study|Randomized But Not Treated|0
4736621|NCT03572062|7685932|FG009|Overall Study|Randomized But Not Treated|0
4736622|NCT03572218|7685954|FG000|Overall Study|Lost to Follow-up|3
4736623|NCT03572218|7685955|FG001|Overall Study|Lost to Follow-up|2
4736624|NCT03572218|7685954|FG000|Overall Study|No longer available for study visits|2
4736625|NCT03572218|7685955|FG001|Overall Study|No longer available for study visits|1
4736626|NCT03572218|7685954|FG000|Overall Study|No longer interested|1
4736627|NCT03572218|7685955|FG001|Overall Study|No longer interested|2
4736628|NCT03573323|7686000|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1
4736629|NCT03573323|7686001|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1
4736630|NCT03573323|7686000|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15
4736631|NCT03573323|7686001|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8
4736632|NCT03573323|7686000|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3
4736633|NCT03573323|7686001|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8
4736634|NCT03573323|7686000|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17
4736635|NCT03573323|7686001|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9
4736636|NCT03573323|7686000|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2
4736637|NCT03573323|7686001|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3
4736638|NCT03573323|7686000|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1
4736639|NCT03573323|7686001|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2
4736640|NCT03573323|7686000|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1
4736641|NCT03573323|7686001|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0
4736642|NCT03573323|7686000|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14
4736643|NCT03573323|7686001|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13
4736644|NCT03573323|7686000|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0
4736645|NCT03573323|7686001|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1
4736646|NCT03573323|7686000|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0
4736647|NCT03573323|7686001|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1
4736648|NCT03573323|7686000|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1
4736649|NCT03573323|7686001|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2
4736650|NCT03573323|7686000|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22
4736651|NCT03573323|7686001|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12
4736652|NCT03573323|7686000|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8
4736653|NCT03573323|7686001|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19
4736654|NCT03573323|7686000|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4
4736655|NCT03573323|7686001|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3
4736656|NCT03573323|7686000|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3
4736657|NCT03573323|7686001|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2
4736658|NCT03573323|7686000|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14
4736659|NCT03573323|7686001|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8
4736660|NCT03573323|7686000|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8
4736661|NCT03573323|7686001|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11
4736662|NCT03573323|7686000|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0
4736663|NCT03573323|7686001|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1
4736664|NCT03573323|7686000|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0
4736665|NCT03573323|7686001|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1
4736666|NCT03573505|7686013|FG000|Overall Study|Adverse Event|1
4721991|NCT03113916|7656030|FG000|Overall Study|Withdrawal by Subject|9
4721992|NCT03113916|7656031|FG001|Overall Study|Withdrawal by Subject|7
4721993|NCT03113916|7656030|FG000|Overall Study|Pregnancy|1
4721994|NCT03113916|7656031|FG001|Overall Study|Pregnancy|3
4721995|NCT03113916|7656030|FG000|Overall Study|Lost to Follow-up|1
4721996|NCT03113916|7656031|FG001|Overall Study|Lost to Follow-up|2
4721997|NCT03114488|7656051|FG000|Time Period 2|Withdrawal by Subject|1
4721998|NCT03114488|7656052|FG001|Time Period 2|Withdrawal by Subject|3
4721999|NCT03114657|7656064|FG000|Overall Study|Adverse Event|9
4722000|NCT03114657|7656065|FG001|Overall Study|Adverse Event|6
4722001|NCT03114657|7656064|FG000|Overall Study|Death|4
4722002|NCT03114657|7656065|FG001|Overall Study|Death|0
4722003|NCT03114657|7656064|FG000|Overall Study|Multiple Reasons|1
4722004|NCT03114657|7656065|FG001|Overall Study|Multiple Reasons|2
4722005|NCT03114657|7656064|FG000|Overall Study|Physician Decision|2
4722006|NCT03114657|7656065|FG001|Overall Study|Physician Decision|2
4722007|NCT03114657|7656064|FG000|Overall Study|Study Terminated By Sponsor|355
4722008|NCT03114657|7656065|FG001|Overall Study|Study Terminated By Sponsor|374
4722009|NCT03114657|7656064|FG000|Overall Study|Symptomatic Deterioration|0
4722010|NCT03114657|7656065|FG001|Overall Study|Symptomatic Deterioration|1
4722011|NCT03114657|7656064|FG000|Overall Study|Withdrawal by Subject|28
4722012|NCT03114657|7656065|FG001|Overall Study|Withdrawal by Subject|22
4722013|NCT03114969|7656085|FG000|Overall Study|Lost to Follow-up|0
4722014|NCT03114969|7656086|FG001|Overall Study|Lost to Follow-up|0
4722015|NCT03114969|7656087|FG002|Overall Study|Lost to Follow-up|3
4722016|NCT03114969|7656088|FG003|Overall Study|Lost to Follow-up|2
4722017|NCT03114969|7656089|FG004|Overall Study|Lost to Follow-up|0
4722018|NCT03114969|7656090|FG005|Overall Study|Lost to Follow-up|0
4722019|NCT03114969|7656091|FG006|Overall Study|Lost to Follow-up|0
4722020|NCT03114969|7656092|FG007|Overall Study|Lost to Follow-up|0
4722021|NCT03114969|7656093|FG008|Overall Study|Lost to Follow-up|0
4722022|NCT03114969|7656085|FG000|Overall Study|Adverse Event|0
4722023|NCT03114969|7656086|FG001|Overall Study|Adverse Event|0
4722024|NCT03114969|7656087|FG002|Overall Study|Adverse Event|1
4722025|NCT03114969|7656088|FG003|Overall Study|Adverse Event|0
4722026|NCT03114969|7656089|FG004|Overall Study|Adverse Event|0
4722027|NCT03114969|7656090|FG005|Overall Study|Adverse Event|1
4722028|NCT03114969|7656091|FG006|Overall Study|Adverse Event|1
4722029|NCT03114969|7656092|FG007|Overall Study|Adverse Event|0
4722030|NCT03114969|7656093|FG008|Overall Study|Adverse Event|2
4722031|NCT03115112|7656135|FG000|Overall Study|Adverse Event|5
4722032|NCT03115112|7656136|FG001|Overall Study|Adverse Event|1
4722033|NCT03115112|7656135|FG000|Overall Study|Withdrawal by Subject|4
4722034|NCT03115112|7656136|FG001|Overall Study|Withdrawal by Subject|2
4722035|NCT03115112|7656135|FG000|Overall Study|Lost to Follow-up|0
4722036|NCT03115112|7656136|FG001|Overall Study|Lost to Follow-up|1
4722037|NCT03115112|7656135|FG000|Overall Study|Death|1
4722038|NCT03115112|7656136|FG001|Overall Study|Death|0
4722039|NCT03115112|7656135|FG000|Overall Study|Pregnancy|1
4722040|NCT03115112|7656136|FG001|Overall Study|Pregnancy|0
4722041|NCT03115112|7656135|FG000|Overall Study|Site closure|1
4722042|NCT03115112|7656136|FG001|Overall Study|Site closure|1
4722043|NCT03115476|7656160|FG000|LP0084-1369|Death|1
4722044|NCT03115476|7656161|FG001|LP0084-1369|Death|0
4722045|NCT03115476|7656162|FG002|LP0084-1369|Death|2
4722046|NCT03115476|7656160|FG000|LP0084-1369|Trial terminated by Sponsor|190
4722047|NCT03115476|7656161|FG001|LP0084-1369|Trial terminated by Sponsor|210
4722048|NCT03115476|7656162|FG002|LP0084-1369|Trial terminated by Sponsor|160
4722049|NCT03116152|7656194|FG000|Overall Study|Disease Progression|49
4722050|NCT03116152|7656195|FG001|Overall Study|Disease Progression|47
4722051|NCT03116152|7656194|FG000|Overall Study|Death|5
4722052|NCT03116152|7656195|FG001|Overall Study|Death|2
4722053|NCT03116152|7656194|FG000|Overall Study|Adverse Event|21
4722054|NCT03116152|7656195|FG001|Overall Study|Adverse Event|7
4722055|NCT03116152|7656194|FG000|Overall Study|Protocol Violation|2
4722056|NCT03116152|7656195|FG001|Overall Study|Protocol Violation|2
4722057|NCT03116152|7656194|FG000|Overall Study|Withdrawal by Subject|0
4722058|NCT03116152|7656195|FG001|Overall Study|Withdrawal by Subject|1
4722059|NCT03116152|7656194|FG000|Overall Study|Physician Decision|3
4722060|NCT03116152|7656195|FG001|Overall Study|Physician Decision|2
4722061|NCT03116152|7656194|FG000|Overall Study|other|11
4722062|NCT03116152|7656195|FG001|Overall Study|other|34
4722063|NCT03116698|7656214|FG000|Overall Study|Adverse Event|1
4722064|NCT03116698|7656215|FG001|Overall Study|Adverse Event|1
4722065|NCT03116698|7656216|FG002|Overall Study|Adverse Event|1
4722066|NCT03116698|7656217|FG003|Overall Study|Adverse Event|0
4722067|NCT03116698|7656214|FG000|Overall Study|Withdrawal by Subject|1
4722068|NCT03116698|7656215|FG001|Overall Study|Withdrawal by Subject|4
4722069|NCT03116698|7656216|FG002|Overall Study|Withdrawal by Subject|5
4722070|NCT03116698|7656217|FG003|Overall Study|Withdrawal by Subject|2
4722071|NCT03116698|7656214|FG000|Overall Study|Lost to Follow-up|2
4722072|NCT03116698|7656215|FG001|Overall Study|Lost to Follow-up|0
4722073|NCT03116698|7656216|FG002|Overall Study|Lost to Follow-up|0
4722074|NCT03116698|7656217|FG003|Overall Study|Lost to Follow-up|0
4722075|NCT03116698|7656214|FG000|Overall Study|Physician Decision|1
4722076|NCT03116698|7656215|FG001|Overall Study|Physician Decision|1
4722077|NCT03116698|7656216|FG002|Overall Study|Physician Decision|0
4722078|NCT03116698|7656217|FG003|Overall Study|Physician Decision|0
4722079|NCT03116698|7656214|FG000|Overall Study|Protocol Violation|1
4722080|NCT03116698|7656215|FG001|Overall Study|Protocol Violation|0
4722081|NCT03116698|7656216|FG002|Overall Study|Protocol Violation|0
4722082|NCT03116698|7656217|FG003|Overall Study|Protocol Violation|0
4722083|NCT03116698|7656214|FG000|Overall Study|Death|0
4722084|NCT03116698|7656215|FG001|Overall Study|Death|0
4722085|NCT03116698|7656216|FG002|Overall Study|Death|2
4722086|NCT03116698|7656217|FG003|Overall Study|Death|0
4722087|NCT03116828|7656229|FG000|Overall Study|Adverse Event|1
4722088|NCT03116828|7656230|FG001|Overall Study|Adverse Event|10
4722089|NCT03116828|7656229|FG000|Overall Study|Withdrawal by Subject|4
4722090|NCT03116828|7656230|FG001|Overall Study|Withdrawal by Subject|8
4722091|NCT03116828|7656229|FG000|Overall Study|OTHER|3
4722092|NCT03116828|7656230|FG001|Overall Study|OTHER|3
4722093|NCT03117361|7656260|FG000|Overall Study|Progressive disease|5
4722094|NCT03117361|7656260|FG000|Overall Study|Death|1
4722095|NCT03117361|7656260|FG000|Overall Study|Physician Decision|2
4722096|NCT03117361|7656260|FG000|Overall Study|On study treatment at the end of study|1
4722097|NCT03117361|7656260|FG000|Overall Study|Treatment-related adverse event|1
4722098|NCT03117738|7656301|FG000|Overall Study|Withdrawal by Subject|3
4722099|NCT03117738|7656302|FG001|Overall Study|Withdrawal by Subject|1
4722100|NCT03117738|7656301|FG000|Overall Study|Lost to Follow-up|1
4722101|NCT03117738|7656302|FG001|Overall Study|Lost to Follow-up|4
4722102|NCT03118297|7656310|FG000|Overall Study|Lost to Follow-up|0
4722103|NCT03118297|7656311|FG001|Overall Study|Lost to Follow-up|2
4722104|NCT03118518|7656323|FG000|Overall Study|Early Exit after treatment|2
4722105|NCT03118518|7656324|FG001|Overall Study|Early Exit after treatment|8
4722106|NCT03118518|7656323|FG000|Overall Study|Early Exit after randomization but prior to treatment|4
4722107|NCT03118518|7656324|FG001|Overall Study|Early Exit after randomization but prior to treatment|3
4722108|NCT03118739|7656341|FG000|Overall Study|Physician Decision|0
4722109|NCT03118739|7656342|FG001|Overall Study|Physician Decision|1
4722110|NCT03118739|7656341|FG000|Overall Study|Withdrawal by Subject|5
4722111|NCT03118739|7656342|FG001|Overall Study|Withdrawal by Subject|3
4771842|NCT04015336|7748873|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1
4771843|NCT03920280|7748952|FG000|Overall Study|Adverse Event|2
4771844|NCT03920280|7748953|FG001|Overall Study|Adverse Event|3
4771845|NCT03920280|7748952|FG000|Overall Study|Lost to Follow-up|0
4771846|NCT03920280|7748953|FG001|Overall Study|Lost to Follow-up|1
4771847|NCT03920280|7748952|FG000|Overall Study|Withdrawal by Subject|1
4771848|NCT03920280|7748953|FG001|Overall Study|Withdrawal by Subject|1
4771849|NCT03920280|7748952|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0
4771850|NCT03920280|7748953|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1
4771851|NCT03913091|7748964|FG000|Overall Study|Lost to Follow-up|18
4771852|NCT03913091|7748965|FG001|Overall Study|Lost to Follow-up|11
4771853|NCT03913091|7748964|FG000|Overall Study|Required additional meds/surgery|1
4771854|NCT03913091|7748965|FG001|Overall Study|Required additional meds/surgery|2
4771855|NCT03913091|7748964|FG000|Overall Study|Chronic pain/history of substance abuse|1
4771856|NCT03913091|7748965|FG001|Overall Study|Chronic pain/history of substance abuse|1
4771857|NCT03802565|7748976|FG000|Overall Study|Adverse Event|0
4771858|NCT03802565|7748977|FG001|Overall Study|Adverse Event|1
4771859|NCT03802565|7748978|FG002|Overall Study|Adverse Event|2
4771860|NCT03802565|7748979|FG003|Overall Study|Adverse Event|1
4771861|NCT03802565|7748980|FG004|Overall Study|Adverse Event|1
4771862|NCT03802565|7748976|FG000|Overall Study|Withdrawal by Subject|2
4771863|NCT03802565|7748977|FG001|Overall Study|Withdrawal by Subject|2
4771864|NCT03802565|7748978|FG002|Overall Study|Withdrawal by Subject|2
4771865|NCT03802565|7748979|FG003|Overall Study|Withdrawal by Subject|0
4771866|NCT03802565|7748980|FG004|Overall Study|Withdrawal by Subject|1
4771867|NCT03802565|7748976|FG000|Overall Study|Protocol Violation|2
4771868|NCT03802565|7748977|FG001|Overall Study|Protocol Violation|1
4771869|NCT03802565|7748978|FG002|Overall Study|Protocol Violation|4
4771870|NCT03802565|7748979|FG003|Overall Study|Protocol Violation|5
4771871|NCT03802565|7748980|FG004|Overall Study|Protocol Violation|1
4771872|NCT03802565|7748976|FG000|Overall Study|Lost to Follow-up|0
4771873|NCT03802565|7748977|FG001|Overall Study|Lost to Follow-up|0
4771874|NCT03802565|7748978|FG002|Overall Study|Lost to Follow-up|1
4771875|NCT03802565|7748979|FG003|Overall Study|Lost to Follow-up|0
4771876|NCT03802565|7748980|FG004|Overall Study|Lost to Follow-up|0
4771877|NCT03802565|7748976|FG000|Overall Study|Subjects Related to Each Other|1
4771878|NCT03802565|7748977|FG001|Overall Study|Subjects Related to Each Other|0
4771879|NCT03802565|7748978|FG002|Overall Study|Subjects Related to Each Other|0
4771880|NCT03802565|7748979|FG003|Overall Study|Subjects Related to Each Other|2
4771881|NCT03802565|7748980|FG004|Overall Study|Subjects Related to Each Other|1
4771882|NCT03802565|7748976|FG000|Overall Study|Elevated Enzymes|0
4771883|NCT03802565|7748977|FG001|Overall Study|Elevated Enzymes|0
4771884|NCT03802565|7748978|FG002|Overall Study|Elevated Enzymes|0
4771885|NCT03802565|7748979|FG003|Overall Study|Elevated Enzymes|0
4771886|NCT03802565|7748980|FG004|Overall Study|Elevated Enzymes|2
4771887|NCT03769194|7748996|FG000|Overall Study|Withdrawal by Subject|0
4771888|NCT03769194|7748997|FG001|Overall Study|Withdrawal by Subject|7
4771889|NCT03769194|7748998|FG002|Overall Study|Withdrawal by Subject|4
4771890|NCT03769194|7748999|FG003|Overall Study|Withdrawal by Subject|1
4771891|NCT03769194|7748996|FG000|Overall Study|moved from study area|0
4722112|NCT03118739|7656341|FG000|Overall Study|Lost to Follow-up|2
4722113|NCT03118739|7656342|FG001|Overall Study|Lost to Follow-up|0
4722114|NCT03118765|7656353|FG000|Overall Study|Withdrawal by Subject|0
4722115|NCT03118765|7656354|FG001|Overall Study|Withdrawal by Subject|0
4722116|NCT03118765|7656355|FG002|Overall Study|Withdrawal by Subject|1
4722117|NCT03118765|7656356|FG003|Overall Study|Withdrawal by Subject|0
4722118|NCT03118765|7656357|FG004|Overall Study|Withdrawal by Subject|0
4722119|NCT03118765|7656353|FG000|Overall Study|Adverse Event|1
4722120|NCT03118765|7656354|FG001|Overall Study|Adverse Event|1
4722121|NCT03118765|7656355|FG002|Overall Study|Adverse Event|1
4722122|NCT03118765|7656356|FG003|Overall Study|Adverse Event|1
4722123|NCT03118765|7656357|FG004|Overall Study|Adverse Event|1
4722124|NCT03118765|7656353|FG000|Overall Study|Non compliance with Study Procedures|0
4722125|NCT03118765|7656354|FG001|Overall Study|Non compliance with Study Procedures|0
4722126|NCT03118765|7656355|FG002|Overall Study|Non compliance with Study Procedures|0
4722127|NCT03118765|7656356|FG003|Overall Study|Non compliance with Study Procedures|1
4722128|NCT03118765|7656357|FG004|Overall Study|Non compliance with Study Procedures|0
4722129|NCT03118765|7656353|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0
4722130|NCT03118765|7656354|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1
4722131|NCT03118765|7656355|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1
4722132|NCT03118765|7656356|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0
4722133|NCT03118765|7656357|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0
4722134|NCT03118765|7656353|FG000|Overall Study|COPD Exacerbation|1
4722135|NCT03118765|7656354|FG001|Overall Study|COPD Exacerbation|0
4722136|NCT03118765|7656355|FG002|Overall Study|COPD Exacerbation|0
4722137|NCT03118765|7656356|FG003|Overall Study|COPD Exacerbation|1
4722138|NCT03118765|7656357|FG004|Overall Study|COPD Exacerbation|0
4722139|NCT03118765|7656353|FG000|Overall Study|Lost to Follow-up|1
4722140|NCT03118765|7656354|FG001|Overall Study|Lost to Follow-up|0
4722141|NCT03118765|7656355|FG002|Overall Study|Lost to Follow-up|1
4722142|NCT03118765|7656356|FG003|Overall Study|Lost to Follow-up|0
4722143|NCT03118765|7656357|FG004|Overall Study|Lost to Follow-up|0
4722144|NCT03118765|7656353|FG000|Overall Study|Sponsor Decision|1
4722145|NCT03118765|7656354|FG001|Overall Study|Sponsor Decision|0
4722146|NCT03118765|7656355|FG002|Overall Study|Sponsor Decision|1
4722147|NCT03118765|7656356|FG003|Overall Study|Sponsor Decision|0
4722148|NCT03118765|7656357|FG004|Overall Study|Sponsor Decision|1
4722149|NCT03118934|7656377|FG000|Overall Study|Adverse Event|0
4722150|NCT03118934|7656378|FG001|Overall Study|Adverse Event|0
4722151|NCT03118934|7656379|FG002|Overall Study|Adverse Event|0
4722152|NCT03118934|7656380|FG003|Overall Study|Adverse Event|0
4722153|NCT03118934|7656381|FG004|Overall Study|Adverse Event|0
4722154|NCT03118934|7656382|FG005|Overall Study|Adverse Event|1
4722155|NCT03118934|7656377|FG000|Overall Study|Physician Decision|0
4722156|NCT03118934|7656378|FG001|Overall Study|Physician Decision|0
4722157|NCT03118934|7656379|FG002|Overall Study|Physician Decision|0
4722158|NCT03118934|7656380|FG003|Overall Study|Physician Decision|0
4722159|NCT03118934|7656381|FG004|Overall Study|Physician Decision|0
4722160|NCT03118934|7656382|FG005|Overall Study|Physician Decision|1
4722161|NCT03118934|7656377|FG000|Overall Study|Discontinued prior to exposure|0
4722162|NCT03118934|7656378|FG001|Overall Study|Discontinued prior to exposure|1
4722163|NCT03118934|7656379|FG002|Overall Study|Discontinued prior to exposure|1
4722164|NCT03118934|7656380|FG003|Overall Study|Discontinued prior to exposure|1
4722165|NCT03118934|7656381|FG004|Overall Study|Discontinued prior to exposure|2
4722166|NCT03118934|7656382|FG005|Overall Study|Discontinued prior to exposure|0
4722167|NCT03118947|7656392|FG000|Overall Study|Adverse Event|7
4722168|NCT03118947|7656392|FG000|Overall Study|Death|3
4722169|NCT03118947|7656392|FG000|Overall Study|Lack of Efficacy|4
4722170|NCT03118947|7656392|FG000|Overall Study|Non-compliance with study drug|1
4722171|NCT03118947|7656392|FG000|Overall Study|Protocol Violation|2
4722172|NCT03118947|7656392|FG000|Overall Study|Withdrawal by Subject|3
4722173|NCT03118947|7656392|FG000|Overall Study|Withdrawal by caregiver|3
4722174|NCT03118947|7656392|FG000|Overall Study|Change in patient's living situation|4
4722175|NCT03118947|7656392|FG000|Overall Study|Lost to Follow-up|2
4722176|NCT03119610|7656442|FG000|Overall Study|Adverse Event|1
4722177|NCT03119610|7656443|FG001|Overall Study|Adverse Event|0
4722178|NCT03119610|7656442|FG000|Overall Study|Lost to Follow-up|0
4722179|NCT03119610|7656443|FG001|Overall Study|Lost to Follow-up|1
4722180|NCT03119688|7656474|FG000|Overall Study|Adverse Event|4
4722181|NCT03119701|7656493|FG000|6-day Dosing|Death|4
4722182|NCT03119701|7656494|FG001|6-day Dosing|Death|1
4722183|NCT03119701|7656493|FG000|6-day Dosing|Adverse Event|3
4722184|NCT03119701|7656494|FG001|6-day Dosing|Adverse Event|0
4722185|NCT03119701|7656493|FG000|6-day Dosing|Physician Decision|0
4722186|NCT03119701|7656494|FG001|6-day Dosing|Physician Decision|1
4722187|NCT03119701|7656493|FG000|6-day Dosing|Withdrawal by Subject|0
4722188|NCT03119701|7656494|FG001|6-day Dosing|Withdrawal by Subject|1
4722189|NCT03119701|7656493|FG000|Mid-term (Final) Follow-up at D90|Death|3
4722190|NCT03119701|7656494|FG001|Mid-term (Final) Follow-up at D90|Death|1
4722191|NCT03120013|7656516|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0
4722192|NCT03120013|7656517|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1
4722193|NCT03120351|7656525|FG000|Overall Study|Physician Decision|1
4722194|NCT03120351|7656526|FG001|Overall Study|Physician Decision|1
4722195|NCT03120520|7656536|FG000|Overall Study|Lost to Follow-up|1
4722196|NCT03120520|7656537|FG001|Overall Study|Lost to Follow-up|1
4722197|NCT03120520|7656538|FG002|Overall Study|Lost to Follow-up|1
4722198|NCT03120520|7656539|FG003|Overall Study|Lost to Follow-up|1
4722199|NCT03120520|7656536|FG000|Overall Study|Withdrawal by Subject|3
4722200|NCT03120520|7656537|FG001|Overall Study|Withdrawal by Subject|2
4722201|NCT03120520|7656538|FG002|Overall Study|Withdrawal by Subject|3
4722202|NCT03120520|7656539|FG003|Overall Study|Withdrawal by Subject|2
4722203|NCT03120520|7656536|FG000|Overall Study|Other|0
4722204|NCT03120520|7656537|FG001|Overall Study|Other|1
4722205|NCT03120520|7656538|FG002|Overall Study|Other|0
4722206|NCT03120520|7656539|FG003|Overall Study|Other|0
4722207|NCT03121950|7656599|FG000|Overall Study|Withdrawal by Subject|11
4722208|NCT03121950|7656600|FG001|Overall Study|Withdrawal by Subject|2
4722209|NCT03122145|7656610|FG000|Overall Study|Concurrent respiratory disease|3
4722210|NCT03122145|7656611|FG001|Overall Study|Concurrent respiratory disease|0
4722211|NCT03122171|7656617|FG000|Overall Study|Withdrawal by Subject|1
4722212|NCT03122184|7656623|FG000|Overall Study|Lost to Follow-up|4
4722213|NCT03122184|7656624|FG001|Overall Study|Lost to Follow-up|6
4722214|NCT03122184|7656623|FG000|Overall Study|Withdrawal by Subject|3
4722215|NCT03122184|7656624|FG001|Overall Study|Withdrawal by Subject|0
4722216|NCT03122184|7656623|FG000|Overall Study|Terminated due to cognitive problem|1
4722217|NCT03122184|7656624|FG001|Overall Study|Terminated due to cognitive problem|0
4722218|NCT03122223|7656634|FG000|Overall Study|Withdrawal by Subject|2
4722219|NCT03122223|7656635|FG001|Overall Study|Withdrawal by Subject|2
4722220|NCT03122223|7656636|FG002|Overall Study|Withdrawal by Subject|1
4722221|NCT03122223|7656637|FG003|Overall Study|Withdrawal by Subject|0
4722222|NCT03122223|7656634|FG000|Overall Study|Lost to Follow-up|0
4722223|NCT03122223|7656635|FG001|Overall Study|Lost to Follow-up|2
4722224|NCT03122223|7656636|FG002|Overall Study|Lost to Follow-up|2
4722225|NCT03122223|7656637|FG003|Overall Study|Lost to Follow-up|0
4722226|NCT03122223|7656634|FG000|Overall Study|Participant unable to adhere|1
4722227|NCT03122223|7656635|FG001|Overall Study|Participant unable to adhere|1
4722228|NCT03122223|7656636|FG002|Overall Study|Participant unable to adhere|1
4722229|NCT03122223|7656637|FG003|Overall Study|Participant unable to adhere|0
4722230|NCT03122457|7656647|FG000|Overall Study|Withdrawal by Subject|6
4722231|NCT03122535|7656651|FG000|Overall Study|Lost to Follow-up|68
4722232|NCT03122535|7656652|FG001|Overall Study|Lost to Follow-up|68
4722233|NCT03122535|7656651|FG000|Overall Study|Physician Decision|3
4722234|NCT03122535|7656652|FG001|Overall Study|Physician Decision|3
4722235|NCT03122535|7656651|FG000|Overall Study|Withdrawal by Subject|2
4722236|NCT03122535|7656652|FG001|Overall Study|Withdrawal by Subject|2
4722237|NCT03122548|7656658|FG000|Overall Study|Death|2
4722238|NCT03122548|7656658|FG000|Overall Study|Progression - subject went into hospice|1
4722239|NCT03122548|7656658|FG000|Overall Study|Study Terminated by Sponsor|2
4722240|NCT03122860|7656681|FG000|Overall Study|Discontinued Before Treatment|1
4722241|NCT03122860|7656682|FG001|Overall Study|Discontinued Before Treatment|1
4722242|NCT03122860|7656683|FG002|Overall Study|Discontinued Before Treatment|2
4722243|NCT03122860|7656684|FG003|Overall Study|Discontinued Before Treatment|0
4722244|NCT03122860|7656685|FG004|Overall Study|Discontinued Before Treatment|1
4722245|NCT03122860|7656686|FG005|Overall Study|Discontinued Before Treatment|0
4722246|NCT03122860|7656681|FG000|Overall Study|Adverse Event|1
4722247|NCT03122860|7656682|FG001|Overall Study|Adverse Event|0
4722248|NCT03122860|7656683|FG002|Overall Study|Adverse Event|1
4722249|NCT03122860|7656684|FG003|Overall Study|Adverse Event|1
4722250|NCT03122860|7656685|FG004|Overall Study|Adverse Event|0
4722251|NCT03122860|7656686|FG005|Overall Study|Adverse Event|0
4722252|NCT03122860|7656681|FG000|Overall Study|Lost to Follow-up|5
4722253|NCT03122860|7656682|FG001|Overall Study|Lost to Follow-up|2
4722254|NCT03122860|7656683|FG002|Overall Study|Lost to Follow-up|3
4722255|NCT03122860|7656684|FG003|Overall Study|Lost to Follow-up|3
4722256|NCT03122860|7656685|FG004|Overall Study|Lost to Follow-up|5
4722257|NCT03122860|7656686|FG005|Overall Study|Lost to Follow-up|4
4722258|NCT03122860|7656681|FG000|Overall Study|Subject Non-Compliance|0
4722259|NCT03122860|7656682|FG001|Overall Study|Subject Non-Compliance|0
4722260|NCT03122860|7656683|FG002|Overall Study|Subject Non-Compliance|1
4722261|NCT03122860|7656684|FG003|Overall Study|Subject Non-Compliance|0
4722262|NCT03122860|7656685|FG004|Overall Study|Subject Non-Compliance|0
4722263|NCT03122860|7656686|FG005|Overall Study|Subject Non-Compliance|0
4722264|NCT03122860|7656681|FG000|Overall Study|Withdrawal by Subject|3
4722265|NCT03122860|7656682|FG001|Overall Study|Withdrawal by Subject|2
4722266|NCT03122860|7656683|FG002|Overall Study|Withdrawal by Subject|5
4722267|NCT03122860|7656684|FG003|Overall Study|Withdrawal by Subject|7
4722268|NCT03122860|7656685|FG004|Overall Study|Withdrawal by Subject|9
4722269|NCT03122860|7656686|FG005|Overall Study|Withdrawal by Subject|8
4722270|NCT03122886|7656703|FG000|Overall Study|Withdrawal by Subject|1
4722271|NCT03122886|7656704|FG001|Overall Study|Withdrawal by Subject|2
4722272|NCT03123120|7656726|FG000|Overall Study|Lost to Follow-up|0
4722273|NCT03123120|7656727|FG001|Overall Study|Lost to Follow-up|1
4722274|NCT03123120|7656726|FG000|Overall Study|Withdrawal by Subject|0
4722275|NCT03123120|7656727|FG001|Overall Study|Withdrawal by Subject|1
4722276|NCT03123354|7656742|FG000|Overall Study|Physician Decision|6
4722277|NCT03123471|7656748|FG000|Placebo-controlled Phase|Adverse Event|3
4722278|NCT03123471|7656749|FG001|Placebo-controlled Phase|Adverse Event|8
4722279|NCT03123471|7656748|FG000|Placebo-controlled Phase|Lack of Efficacy|3
4722280|NCT03123471|7656749|FG001|Placebo-controlled Phase|Lack of Efficacy|4
4722281|NCT03123471|7656748|FG000|Placebo-controlled Phase|Withdrawal by Subject|6
4722282|NCT03123471|7656749|FG001|Placebo-controlled Phase|Withdrawal by Subject|16
4722283|NCT03123471|7656748|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3
4722284|NCT03123471|7656749|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0
4722285|NCT03123471|7656748|FG000|Placebo-controlled Phase|Lost to Follow-up|1
4722286|NCT03123471|7656749|FG001|Placebo-controlled Phase|Lost to Follow-up|3
4722287|NCT03123471|7656748|FG000|Placebo-controlled Phase|Protocol Deviation|2
4722288|NCT03123471|7656749|FG001|Placebo-controlled Phase|Protocol Deviation|1
4722289|NCT03123471|7656748|FG000|Placebo-controlled Phase|Miscellaneous|0
4722290|NCT03123471|7656749|FG001|Placebo-controlled Phase|Miscellaneous|1
4722291|NCT03123471|7656748|FG000|Apremilast Extension Phase|Lost to Follow-up|2
4722292|NCT03123471|7656749|FG001|Apremilast Extension Phase|Lost to Follow-up|5
4722293|NCT03123471|7656748|FG000|Apremilast Extension Phase|Adverse Event|1
4722294|NCT03123471|7656749|FG001|Apremilast Extension Phase|Adverse Event|5
4722295|NCT03123471|7656748|FG000|Apremilast Extension Phase|Lack of Efficacy|2
4722296|NCT03123471|7656749|FG001|Apremilast Extension Phase|Lack of Efficacy|8
4722297|NCT03123471|7656748|FG000|Apremilast Extension Phase|Withdrawal by Subject|3
4722298|NCT03123471|7656749|FG001|Apremilast Extension Phase|Withdrawal by Subject|7
4722299|NCT03123588|7656763|FG000|Overall Study|Study Terminated by Sponsor|2
4722300|NCT03123588|7656764|FG001|Overall Study|Study Terminated by Sponsor|5
4722301|NCT03123588|7656763|FG000|Overall Study|Withdrawal by Subject|1
4722302|NCT03123588|7656764|FG001|Overall Study|Withdrawal by Subject|0
4722303|NCT03123588|7656763|FG000|Overall Study|Adverse Event|1
4722304|NCT03123588|7656764|FG001|Overall Study|Adverse Event|0
4722305|NCT03123588|7656763|FG000|Overall Study|Physician Decision|2
4722306|NCT03123588|7656764|FG001|Overall Study|Physician Decision|1
4722307|NCT03123861|7656788|FG000|Overall Study|Protocol Violation|1
4722308|NCT03123861|7656789|FG001|Overall Study|Protocol Violation|1
4722309|NCT03123861|7656788|FG000|Overall Study|Withdrawal by Subject|2
4722310|NCT03123861|7656789|FG001|Overall Study|Withdrawal by Subject|2
4722311|NCT03123939|7656808|FG000|Overall Study|Lack of Efficacy|6
4722312|NCT03123939|7656808|FG000|Overall Study|Death|5
4722313|NCT03123939|7656808|FG000|Overall Study|Physician Decision|2
4722314|NCT03123939|7656808|FG000|Overall Study|Subject/guardian decision|2
4722315|NCT03123939|7656808|FG000|Overall Study|Lost to Follow-up|1
4722316|NCT03123939|7656808|FG000|Overall Study|New therapy for study indication|1
4722317|NCT03123939|7656808|FG000|Overall Study|Protocol deviation|1
4722318|NCT03123939|7656808|FG000|Overall Study|Progressive disease|18
4722319|NCT03123939|7656808|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4
4722320|NCT03123939|7656808|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1
4722321|NCT03124108|7656821|FG000|Overall Study|Adverse Event|0
4722322|NCT03124108|7656822|FG001|Overall Study|Adverse Event|1
4722323|NCT03124108|7656823|FG002|Overall Study|Adverse Event|0
4722324|NCT03124199|7656844|FG000|Overall Study|Lost to Follow-up|4
4722325|NCT03124381|7656874|FG000|Overall Study|Lost to Follow-up|1
4722326|NCT03124381|7656875|FG001|Overall Study|Lost to Follow-up|1
4722327|NCT03124381|7656874|FG000|Overall Study|Withdrawal by Subject|6
4722328|NCT03124381|7656875|FG001|Overall Study|Withdrawal by Subject|3
4722329|NCT03124381|7656874|FG000|Overall Study|Protocol Violation|0
4722330|NCT03124381|7656875|FG001|Overall Study|Protocol Violation|1
4722331|NCT03124381|7656874|FG000|Overall Study|Adverse Event|1
4722332|NCT03124381|7656875|FG001|Overall Study|Adverse Event|1
4722333|NCT03124381|7656874|FG000|Overall Study|Non-Compliance with Study Treatment|1
4722334|NCT03124381|7656875|FG001|Overall Study|Non-Compliance with Study Treatment|0
4722335|NCT03124407|7656885|FG000|Overall Study|Lost to Follow-up|1
4722336|NCT03124407|7656886|FG001|Overall Study|Lost to Follow-up|0
4722337|NCT03124407|7656887|FG002|Overall Study|Lost to Follow-up|0
4722338|NCT03124407|7656888|FG003|Overall Study|Lost to Follow-up|0
4722339|NCT03124407|7656885|FG000|Overall Study|Adverse Event|0
4722340|NCT03124407|7656886|FG001|Overall Study|Adverse Event|0
4722341|NCT03124407|7656887|FG002|Overall Study|Adverse Event|1
4446495|NCT00484289|7231583|FG001|Long Term Phase|Inadequate response|7
4446496|NCT00484289|7231584|FG002|Long Term Phase|Inadequate response|4
4722342|NCT03124407|7656888|FG003|Overall Study|Adverse Event|0
4722343|NCT03124459|7656908|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0
4722344|NCT03124459|7656909|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0
4722345|NCT03124459|7656910|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0
4722346|NCT03124459|7656911|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0
4722347|NCT03124459|7656912|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2
4722348|NCT03124459|7656913|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0
4722349|NCT03124459|7656908|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0
4722350|NCT03124459|7656909|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0
4722351|NCT03124459|7656910|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0
4722352|NCT03124459|7656911|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0
4722353|NCT03124459|7656912|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1
4722354|NCT03124459|7656913|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0
4736667|NCT03573505|7686014|FG001|Overall Study|Adverse Event|1
4722355|NCT03124459|7656908|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0
4722356|NCT03124459|7656909|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0
4722357|NCT03124459|7656910|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0
4722358|NCT03124459|7656911|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11
4722359|NCT03124459|7656912|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12
4722360|NCT03124459|7656913|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0
4722361|NCT03124459|7656908|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0
4722362|NCT03124459|7656909|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0
4722363|NCT03124459|7656910|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0
4722364|NCT03124459|7656911|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1
4722365|NCT03124459|7656912|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4
4722366|NCT03124459|7656913|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0
4722367|NCT03124459|7656908|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0
4722368|NCT03124459|7656909|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0
4722369|NCT03124459|7656910|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0
4722370|NCT03124459|7656911|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0
4722371|NCT03124459|7656912|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0
4722372|NCT03124459|7656913|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22
4722373|NCT03124459|7656908|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0
4722374|NCT03124459|7656909|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0
4722375|NCT03124459|7656910|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0
4722376|NCT03124459|7656911|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0
4722377|NCT03124459|7656912|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0
4722378|NCT03124459|7656913|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1
4722379|NCT03124537|7656928|FG000|Overall Study|Lost to Follow-up|3
4722380|NCT03124537|7656929|FG001|Overall Study|Lost to Follow-up|5
4722381|NCT03124537|7656928|FG000|Overall Study|App Crash, Incomplete Data|7
4722382|NCT03124537|7656929|FG001|Overall Study|App Crash, Incomplete Data|8
4722383|NCT03124563|7656941|FG000|Overall Study|Lost to Follow-up|1
4722384|NCT03124563|7656942|FG001|Overall Study|Lost to Follow-up|1
4722385|NCT03124563|7656941|FG000|Overall Study|Withdrawal by Subject|1
4722386|NCT03124563|7656942|FG001|Overall Study|Withdrawal by Subject|1
4722387|NCT03124784|7656964|FG000|Overall Study|Adverse Event|1
4722388|NCT03124784|7656964|FG000|Overall Study|Computer/Equip Malfunction|1
4736668|NCT03573505|7686013|FG000|Overall Study|Consent withdrawn|0
4736669|NCT03573505|7686014|FG001|Overall Study|Consent withdrawn|1
4446497|NCT00484289|7231582|FG000|Long Term Phase|Other Reason|0
4446498|NCT00484289|7231583|FG001|Long Term Phase|Other Reason|5
4446499|NCT00484289|7231584|FG002|Long Term Phase|Other Reason|1
4446500|NCT00484289|7231582|FG000|Post Marketing Phase|Adverse Event|0
4446501|NCT00484289|7231583|FG001|Post Marketing Phase|Adverse Event|1
4446502|NCT00484289|7231584|FG002|Post Marketing Phase|Adverse Event|0
4446503|NCT00484315|7231595|FG000|12-Month Clinical Follow-up|Death|6
4446504|NCT00484315|7231596|FG001|12-Month Clinical Follow-up|Death|2
4630764|NCT01884675|7499576|FG001|Overall Study|Study closed/terminated|2
4630765|NCT01884688|7499584|FG000|Overall Study|Screen Failure|2
4630766|NCT01885000|7499599|FG000|Overall Study|Adverse Event|1
4630767|NCT01885000|7499600|FG001|Overall Study|Adverse Event|0
4630768|NCT01885000|7499599|FG000|Overall Study|Withdrawal by Subject|1
4630769|NCT01885000|7499600|FG001|Overall Study|Withdrawal by Subject|1
4630770|NCT01885000|7499599|FG000|Overall Study|Protocol Violation|0
4630771|NCT01885000|7499600|FG001|Overall Study|Protocol Violation|1
4446505|NCT00484315|7231595|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4
4446506|NCT00484315|7231596|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0
4446507|NCT00484315|7231595|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2
4446508|NCT00484315|7231596|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1
4446509|NCT00484315|7231595|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13
4446510|NCT00484315|7231596|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4
4446511|NCT00484315|7231595|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3
4446512|NCT00484315|7231596|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2
4446513|NCT00484315|7231595|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25
4446514|NCT00484315|7231596|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11
4446515|NCT00484315|7231595|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3
4446516|NCT00484315|7231596|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2
4446517|NCT00484679|7231620|FG000|Overall Study|Withdrawal by Subject|3
4446518|NCT00484939|7231633|FG000|Overall Study|Death|9
4446519|NCT00484939|7231634|FG001|Overall Study|Death|13
4446520|NCT00484939|7231633|FG000|Overall Study|Adverse Event|22
4446521|NCT00484939|7231634|FG001|Overall Study|Adverse Event|12
4446522|NCT00484939|7231633|FG000|Overall Study|Patient Withdrew Consent|19
4446523|NCT00484939|7231634|FG001|Overall Study|Patient Withdrew Consent|10
4446524|NCT00484939|7231633|FG000|Overall Study|Protocol Violation|3
4446525|NCT00484939|7231634|FG001|Overall Study|Protocol Violation|3
4446526|NCT00484939|7231633|FG000|Overall Study|Lost to Follow-up|0
4446527|NCT00484939|7231634|FG001|Overall Study|Lost to Follow-up|3
4630772|NCT01885104|7499608|FG000|Overall Study|Withdrawal of Consent|1
4630773|NCT01885104|7499609|FG001|Overall Study|Withdrawal of Consent|0
4515239|NCT00951912|7325942|FG000|Overall Study|Other: Colon cancer|1
4722389|NCT03125200|7657017|FG000|Overall Study|Study Termination|0
4722390|NCT03125200|7657018|FG001|Overall Study|Study Termination|0
4722391|NCT03125200|7657019|FG002|Overall Study|Study Termination|0
4722392|NCT03125200|7657020|FG003|Overall Study|Study Termination|1
4722393|NCT03125200|7657021|FG004|Overall Study|Study Termination|1
4722394|NCT03125200|7657022|FG005|Overall Study|Study Termination|2
4722395|NCT03125200|7657023|FG006|Overall Study|Study Termination|1
4722396|NCT03125200|7657017|FG000|Overall Study|Clinical Progression|0
4722397|NCT03125200|7657018|FG001|Overall Study|Clinical Progression|0
4722398|NCT03125200|7657019|FG002|Overall Study|Clinical Progression|0
4722399|NCT03125200|7657020|FG003|Overall Study|Clinical Progression|1
4722400|NCT03125200|7657021|FG004|Overall Study|Clinical Progression|0
4722401|NCT03125200|7657022|FG005|Overall Study|Clinical Progression|1
4722402|NCT03125200|7657023|FG006|Overall Study|Clinical Progression|0
4722403|NCT03125200|7657017|FG000|Overall Study|Progressive Disease|2
4722404|NCT03125200|7657018|FG001|Overall Study|Progressive Disease|1
4722405|NCT03125200|7657019|FG002|Overall Study|Progressive Disease|2
4722406|NCT03125200|7657020|FG003|Overall Study|Progressive Disease|1
4722407|NCT03125200|7657021|FG004|Overall Study|Progressive Disease|2
4722408|NCT03125200|7657022|FG005|Overall Study|Progressive Disease|0
4722409|NCT03125200|7657023|FG006|Overall Study|Progressive Disease|1
4722410|NCT03125200|7657017|FG000|Overall Study|Lack of Efficacy|0
4722411|NCT03125200|7657018|FG001|Overall Study|Lack of Efficacy|0
4722412|NCT03125200|7657019|FG002|Overall Study|Lack of Efficacy|0
4722413|NCT03125200|7657020|FG003|Overall Study|Lack of Efficacy|1
4722414|NCT03125200|7657021|FG004|Overall Study|Lack of Efficacy|0
4722415|NCT03125200|7657022|FG005|Overall Study|Lack of Efficacy|0
4722416|NCT03125200|7657023|FG006|Overall Study|Lack of Efficacy|0
4722417|NCT03125200|7657017|FG000|Overall Study|Toxicity|0
4722418|NCT03125200|7657018|FG001|Overall Study|Toxicity|0
4722419|NCT03125200|7657019|FG002|Overall Study|Toxicity|0
4722420|NCT03125200|7657020|FG003|Overall Study|Toxicity|1
4722421|NCT03125200|7657021|FG004|Overall Study|Toxicity|0
4722422|NCT03125200|7657022|FG005|Overall Study|Toxicity|0
4722423|NCT03125200|7657023|FG006|Overall Study|Toxicity|0
4722424|NCT03125200|7657017|FG000|Overall Study|Consent Withdrawn by Subject|0
4722425|NCT03125200|7657018|FG001|Overall Study|Consent Withdrawn by Subject|1
4722426|NCT03125200|7657019|FG002|Overall Study|Consent Withdrawn by Subject|0
4722427|NCT03125200|7657020|FG003|Overall Study|Consent Withdrawn by Subject|0
4722428|NCT03125200|7657021|FG004|Overall Study|Consent Withdrawn by Subject|1
4722429|NCT03125200|7657022|FG005|Overall Study|Consent Withdrawn by Subject|0
4722430|NCT03125200|7657023|FG006|Overall Study|Consent Withdrawn by Subject|1
4722431|NCT03125395|7657046|FG000|Overall Study|Adverse Event|2
4722432|NCT03125395|7657046|FG000|Overall Study|Withdrawal of consent (not due to AE)|1
4722433|NCT03125395|7657046|FG000|Overall Study|Physician Decision|2
4722434|NCT03125395|7657046|FG000|Overall Study|Commercial drug is available|5
4722435|NCT03125629|7657050|FG000|Overall Study|Withdrawal by Subject|2
4722436|NCT03125629|7657050|FG000|Overall Study|Equipment malfunction|1
4722437|NCT03125915|7657066|FG000|1 Month Follow up|Lost to Follow-up|3
4722438|NCT03125915|7657067|FG001|1 Month Follow up|Lost to Follow-up|3
4722439|NCT03125915|7657068|FG002|1 Month Follow up|Lost to Follow-up|2
4722440|NCT03125915|7657069|FG003|1 Month Follow up|Lost to Follow-up|3
4722441|NCT03125915|7657066|FG000|3 Month Follow-up|Lost to Follow-up|6
4722442|NCT03125915|7657067|FG001|3 Month Follow-up|Lost to Follow-up|4
4722443|NCT03125915|7657068|FG002|3 Month Follow-up|Lost to Follow-up|4
4722444|NCT03125915|7657069|FG003|3 Month Follow-up|Lost to Follow-up|2
4722445|NCT03125915|7657066|FG000|6 Month Follow-up|Lost to Follow-up|7
4722446|NCT03125915|7657067|FG001|6 Month Follow-up|Lost to Follow-up|3
4722447|NCT03125915|7657068|FG002|6 Month Follow-up|Lost to Follow-up|6
4722448|NCT03125915|7657069|FG003|6 Month Follow-up|Lost to Follow-up|3
4722449|NCT03125941|7657081|FG000|Overall Study|did not receive intervention|1
4722450|NCT03125941|7657082|FG001|Overall Study|did not receive intervention|2
4722451|NCT03126227|7657090|FG000|Overall Study|Adverse Event|43
4722452|NCT03126227|7657091|FG001|Overall Study|Adverse Event|4
4722453|NCT03126227|7657090|FG000|Overall Study|Death|0
4722454|NCT03126227|7657091|FG001|Overall Study|Death|1
4722455|NCT03126227|7657090|FG000|Overall Study|Lost to Follow-up|0
4722456|NCT03126227|7657091|FG001|Overall Study|Lost to Follow-up|1
4722457|NCT03126227|7657090|FG000|Overall Study|Physician Decision|2
4722458|NCT03126227|7657091|FG001|Overall Study|Physician Decision|0
4722459|NCT03126227|7657090|FG000|Overall Study|Protocol Violation|1
4722460|NCT03126227|7657091|FG001|Overall Study|Protocol Violation|0
4722461|NCT03126227|7657090|FG000|Overall Study|Withdrawal by Subject|19
4722462|NCT03126227|7657091|FG001|Overall Study|Withdrawal by Subject|3
4722463|NCT03126227|7657090|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8
4722464|NCT03126227|7657091|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1
4722465|NCT03126227|7657090|FG000|Overall Study|Lack of dosing compliance|2
4722466|NCT03126227|7657091|FG001|Overall Study|Lack of dosing compliance|0
4722467|NCT03126227|7657090|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2
4722468|NCT03126227|7657091|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0
4722469|NCT03126227|7657090|FG000|Overall Study|Scheduling conflict|1
4722470|NCT03126227|7657091|FG001|Overall Study|Scheduling conflict|0
4722471|NCT03126344|7657100|FG000|Overall Study|Lost to Follow-up|0
4722472|NCT03126344|7657101|FG001|Overall Study|Lost to Follow-up|0
4722473|NCT03126344|7657102|FG002|Overall Study|Lost to Follow-up|5
4722474|NCT03126539|7657133|FG000|Overall Study|Lost to Follow-up|1
4722475|NCT03126539|7657134|FG001|Overall Study|Lost to Follow-up|1
4722476|NCT03126539|7657135|FG002|Overall Study|Lost to Follow-up|1
4722477|NCT03126539|7657136|FG003|Overall Study|Lost to Follow-up|0
4722478|NCT03126539|7657137|FG004|Overall Study|Lost to Follow-up|0
4722479|NCT03126786|7657170|FG000|Overall Study|Adverse Event|3
4722480|NCT03126786|7657171|FG001|Overall Study|Adverse Event|0
4722481|NCT03126786|7657170|FG000|Overall Study|Lost to Follow-up|0
4722482|NCT03126786|7657171|FG001|Overall Study|Lost to Follow-up|1
4722483|NCT03126786|7657170|FG000|Overall Study|Withdrawal by Subject|3
4722484|NCT03126786|7657171|FG001|Overall Study|Withdrawal by Subject|1
4722485|NCT03127384|7657205|FG000|Overall Study|Lost to Follow-up|4
4722486|NCT03127384|7657205|FG000|Overall Study|Subject request|2
4722487|NCT03127644|7657223|FG000|Overall Study|Study-specific withdrawal criteria|0
4722488|NCT03127644|7657224|FG001|Overall Study|Study-specific withdrawal criteria|0
4722489|NCT03127644|7657225|FG002|Overall Study|Study-specific withdrawal criteria|2
4722490|NCT03128099|7657263|FG000|Overall Study|High dose task was too long|0
4722491|NCT03128099|7657264|FG001|Overall Study|High dose task was too long|4
4722492|NCT03128099|7657265|FG002|Overall Study|High dose task was too long|0
4722493|NCT03128099|7657263|FG000|Overall Study|Participant got a full time job.|1
4722494|NCT03128099|7657264|FG001|Overall Study|Participant got a full time job.|0
4722495|NCT03128099|7657265|FG002|Overall Study|Participant got a full time job.|0
4722496|NCT03128099|7657263|FG000|Overall Study|Became homeless and lost contact|1
4722497|NCT03128099|7657264|FG001|Overall Study|Became homeless and lost contact|0
4722498|NCT03128099|7657265|FG002|Overall Study|Became homeless and lost contact|0
4722499|NCT03128099|7657263|FG000|Overall Study|Did not complete all the assessments|0
4722500|NCT03128099|7657264|FG001|Overall Study|Did not complete all the assessments|0
4722501|NCT03128099|7657265|FG002|Overall Study|Did not complete all the assessments|1
4722502|NCT03128307|7657271|FG000|Overall Study|Lost to Follow-up|29
4722503|NCT03128307|7657271|FG000|Overall Study|Withdrawal by Subject|5
4722504|NCT03128723|7657279|FG000|Overall Study|Withdrawal by Subject|2
4722505|NCT03128892|7657283|FG000|Overall Study|Withdrawal by Subject|2
4722506|NCT03128892|7657283|FG000|Overall Study|Physician Decision|1
4722507|NCT03129100|7657292|FG000|Lead-In Period (Period 1)|Adverse Event|2
4722508|NCT03129100|7657293|FG001|Lead-In Period (Period 1)|Adverse Event|6
4722509|NCT03129100|7657294|FG002|Lead-In Period (Period 1)|Adverse Event|0
4722510|NCT03129100|7657295|FG003|Lead-In Period (Period 1)|Adverse Event|0
4722511|NCT03129100|7657296|FG004|Lead-In Period (Period 1)|Adverse Event|0
4722512|NCT03129100|7657297|FG005|Lead-In Period (Period 1)|Adverse Event|0
4722513|NCT03129100|7657298|FG006|Lead-In Period (Period 1)|Adverse Event|0
4722514|NCT03129100|7657299|FG007|Lead-In Period (Period 1)|Adverse Event|0
4722515|NCT03129100|7657300|FG008|Lead-In Period (Period 1)|Adverse Event|0
4722516|NCT03129100|7657301|FG009|Lead-In Period (Period 1)|Adverse Event|0
4722517|NCT03129100|7657302|FG010|Lead-In Period (Period 1)|Adverse Event|0
4722518|NCT03129100|7657292|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2
4722519|NCT03129100|7657293|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0
4722520|NCT03129100|7657294|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0
4722521|NCT03129100|7657295|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0
4722522|NCT03129100|7657296|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0
4722523|NCT03129100|7657297|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0
4722524|NCT03129100|7657298|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0
4722525|NCT03129100|7657299|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0
4722526|NCT03129100|7657300|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0
4722527|NCT03129100|7657301|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0
4722528|NCT03129100|7657302|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0
4722529|NCT03129100|7657292|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8
4722530|NCT03129100|7657293|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8
4722531|NCT03129100|7657294|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0
4722532|NCT03129100|7657295|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0
4722533|NCT03129100|7657296|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0
4722534|NCT03129100|7657297|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0
4722535|NCT03129100|7657298|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0
4722536|NCT03129100|7657299|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0
4722537|NCT03129100|7657300|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0
4722538|NCT03129100|7657301|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0
4722539|NCT03129100|7657302|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0
4722540|NCT03129100|7657292|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3
4722541|NCT03129100|7657293|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2
4722542|NCT03129100|7657294|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0
4722543|NCT03129100|7657295|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0
4722544|NCT03129100|7657296|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0
4722545|NCT03129100|7657297|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0
4722546|NCT03129100|7657298|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0
4722547|NCT03129100|7657299|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0
4722548|NCT03129100|7657300|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0
4722549|NCT03129100|7657301|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0
4722550|NCT03129100|7657302|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0
4722551|NCT03129100|7657292|FG000|Lead-In Period (Period 1)|Surgery Programmed|0
4722552|NCT03129100|7657293|FG001|Lead-In Period (Period 1)|Surgery Programmed|1
4722553|NCT03129100|7657294|FG002|Lead-In Period (Period 1)|Surgery Programmed|0
4722554|NCT03129100|7657295|FG003|Lead-In Period (Period 1)|Surgery Programmed|0
4722555|NCT03129100|7657296|FG004|Lead-In Period (Period 1)|Surgery Programmed|0
4722556|NCT03129100|7657297|FG005|Lead-In Period (Period 1)|Surgery Programmed|0
4722557|NCT03129100|7657298|FG006|Lead-In Period (Period 1)|Surgery Programmed|0
4722558|NCT03129100|7657299|FG007|Lead-In Period (Period 1)|Surgery Programmed|0
4722559|NCT03129100|7657300|FG008|Lead-In Period (Period 1)|Surgery Programmed|0
4722560|NCT03129100|7657301|FG009|Lead-In Period (Period 1)|Surgery Programmed|0
4722561|NCT03129100|7657302|FG010|Lead-In Period (Period 1)|Surgery Programmed|0
4722562|NCT03129100|7657292|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0
4722563|NCT03129100|7657293|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0
4722564|NCT03129100|7657294|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2
4722565|NCT03129100|7657295|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1
4722566|NCT03129100|7657296|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0
4722567|NCT03129100|7657297|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2
4722568|NCT03129100|7657298|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0
4722569|NCT03129100|7657299|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0
4722570|NCT03129100|7657300|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0
4722571|NCT03129100|7657301|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0
4722572|NCT03129100|7657302|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0
4722573|NCT03129100|7657292|FG000|Period2 Extension Period (Group A and B)|Death|0
4722574|NCT03129100|7657293|FG001|Period2 Extension Period (Group A and B)|Death|0
4722575|NCT03129100|7657294|FG002|Period2 Extension Period (Group A and B)|Death|1
4722576|NCT03129100|7657295|FG003|Period2 Extension Period (Group A and B)|Death|0
4722577|NCT03129100|7657296|FG004|Period2 Extension Period (Group A and B)|Death|0
4722578|NCT03129100|7657297|FG005|Period2 Extension Period (Group A and B)|Death|0
4722579|NCT03129100|7657298|FG006|Period2 Extension Period (Group A and B)|Death|0
4722580|NCT03129100|7657299|FG007|Period2 Extension Period (Group A and B)|Death|0
4722581|NCT03129100|7657300|FG008|Period2 Extension Period (Group A and B)|Death|0
4722582|NCT03129100|7657301|FG009|Period2 Extension Period (Group A and B)|Death|0
4722583|NCT03129100|7657302|FG010|Period2 Extension Period (Group A and B)|Death|0
4722584|NCT03129100|7657292|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
4722585|NCT03129100|7657293|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
4722586|NCT03129100|7657294|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13
4722587|NCT03129100|7657295|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5
4722588|NCT03129100|7657296|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1
4722589|NCT03129100|7657297|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1
4722590|NCT03129100|7657298|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2
4722591|NCT03129100|7657299|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
4722592|NCT03129100|7657300|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
4722593|NCT03129100|7657301|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
4722594|NCT03129100|7657302|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0
4722595|NCT03129100|7657292|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0
4722596|NCT03129100|7657293|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0
4722597|NCT03129100|7657294|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1
4722598|NCT03129100|7657295|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0
4722599|NCT03129100|7657296|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0
4722600|NCT03129100|7657297|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0
4722601|NCT03129100|7657298|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0
4722602|NCT03129100|7657299|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0
4722603|NCT03129100|7657300|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0
4722604|NCT03129100|7657301|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0
4722605|NCT03129100|7657302|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0
4722606|NCT03129100|7657292|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
4722607|NCT03129100|7657293|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
4722608|NCT03129100|7657294|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2
4722609|NCT03129100|7657295|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
4722610|NCT03129100|7657296|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
4771892|NCT03769194|7748997|FG001|Overall Study|moved from study area|2
4771893|NCT03769194|7748998|FG002|Overall Study|moved from study area|1
4771894|NCT03769194|7748999|FG003|Overall Study|moved from study area|1
4771895|NCT03769194|7748996|FG000|Overall Study|Lost to Follow-up|3
4771896|NCT03769194|7748997|FG001|Overall Study|Lost to Follow-up|6
4771897|NCT03769194|7748998|FG002|Overall Study|Lost to Follow-up|3
4771898|NCT03769194|7748999|FG003|Overall Study|Lost to Follow-up|6
4771899|NCT03769194|7748996|FG000|Overall Study|other|1
4771900|NCT03769194|7748997|FG001|Overall Study|other|3
4771901|NCT03769194|7748998|FG002|Overall Study|other|0
4722611|NCT03129100|7657297|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
4722612|NCT03129100|7657298|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
4722613|NCT03129100|7657299|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
4722614|NCT03129100|7657300|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
4722615|NCT03129100|7657301|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
4722616|NCT03129100|7657302|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0
4722617|NCT03129100|7657292|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
4722618|NCT03129100|7657293|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
4722619|NCT03129100|7657294|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2
4722620|NCT03129100|7657295|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
4722621|NCT03129100|7657296|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
4722622|NCT03129100|7657297|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
4722623|NCT03129100|7657298|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
4722624|NCT03129100|7657299|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
4722625|NCT03129100|7657300|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
4722626|NCT03129100|7657301|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
4722627|NCT03129100|7657302|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0
4722628|NCT03129100|7657292|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0
4722629|NCT03129100|7657293|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0
4722630|NCT03129100|7657294|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0
4722631|NCT03129100|7657295|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0
4722632|NCT03129100|7657296|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5
4722633|NCT03129100|7657297|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6
4722634|NCT03129100|7657298|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19
4722635|NCT03129100|7657299|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0
4722636|NCT03129100|7657300|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0
4722637|NCT03129100|7657301|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0
4722638|NCT03129100|7657302|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0
4722639|NCT03129100|7657292|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
4722640|NCT03129100|7657293|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
4722641|NCT03129100|7657294|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
4722642|NCT03129100|7657295|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
4722643|NCT03129100|7657296|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
4722644|NCT03129100|7657297|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
4722645|NCT03129100|7657298|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
4722646|NCT03129100|7657299|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
4722647|NCT03129100|7657300|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
4722648|NCT03129100|7657301|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1
4722649|NCT03129100|7657302|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0
4722650|NCT03130257|7657350|FG000|Overall Study|Withdrawal by Subject|1
4722651|NCT03130257|7657351|FG001|Overall Study|Withdrawal by Subject|0
4722652|NCT03130257|7657352|FG002|Overall Study|Withdrawal by Subject|2
4722653|NCT03131167|7657386|FG000|Overall Study|Other (Unspecified)|0
4722654|NCT03131167|7657387|FG001|Overall Study|Other (Unspecified)|0
4722655|NCT03131167|7657388|FG002|Overall Study|Other (Unspecified)|0
4722656|NCT03131167|7657389|FG003|Overall Study|Other (Unspecified)|0
4722657|NCT03131167|7657390|FG004|Overall Study|Other (Unspecified)|0
4722658|NCT03131167|7657391|FG005|Overall Study|Other (Unspecified)|1
4722659|NCT03131167|7657392|FG006|Overall Study|Other (Unspecified)|0
4722660|NCT03131167|7657393|FG007|Overall Study|Other (Unspecified)|0
4515240|NCT00951912|7325943|FG001|Overall Study|Other: Colon cancer|0
4515241|NCT00951912|7325944|FG002|Overall Study|Other: Colon cancer|0
4515242|NCT00951912|7325942|FG000|Overall Study|Other: Stroke|0
4515243|NCT00951912|7325943|FG001|Overall Study|Other: Stroke|1
4515244|NCT00951912|7325944|FG002|Overall Study|Other: Stroke|0
4515245|NCT00952068|7325952|FG000|Overall Study|Adverse Event|3
4722661|NCT03131167|7657394|FG008|Overall Study|Other (Unspecified)|0
4722662|NCT03131167|7657395|FG009|Overall Study|Other (Unspecified)|0
4722663|NCT03131167|7657396|FG010|Overall Study|Other (Unspecified)|0
4722664|NCT03131167|7657397|FG011|Overall Study|Other (Unspecified)|0
4722665|NCT03131167|7657398|FG012|Overall Study|Other (Unspecified)|0
4722666|NCT03131453|7657451|FG000|Overall Study|Study terminated by Sponsor|424
4722667|NCT03131453|7657452|FG001|Overall Study|Study terminated by Sponsor|222
4722668|NCT03131453|7657453|FG002|Overall Study|Study terminated by Sponsor|438
4722669|NCT03131453|7657451|FG000|Overall Study|Withdrawal by Subject|18
4722670|NCT03131453|7657452|FG001|Overall Study|Withdrawal by Subject|7
4722671|NCT03131453|7657453|FG002|Overall Study|Withdrawal by Subject|13
4722672|NCT03131453|7657451|FG000|Overall Study|Adverse Event|10
4722673|NCT03131453|7657452|FG001|Overall Study|Adverse Event|3
4722674|NCT03131453|7657453|FG002|Overall Study|Adverse Event|3
4722675|NCT03131453|7657451|FG000|Overall Study|Lost to Follow-up|1
4515246|NCT00952068|7325952|FG000|Overall Study|Withdrawal by Subject|4
4515247|NCT00952276|7325996|FG000|Overall Study|Withdrawal by Subject|1
4515248|NCT00952276|7325997|FG001|Overall Study|Withdrawal by Subject|0
4722676|NCT03131453|7657452|FG001|Overall Study|Lost to Follow-up|0
4722677|NCT03131453|7657453|FG002|Overall Study|Lost to Follow-up|1
4722678|NCT03131453|7657451|FG000|Overall Study|Physician Decision|1
4722679|NCT03131453|7657452|FG001|Overall Study|Physician Decision|0
4722680|NCT03131453|7657453|FG002|Overall Study|Physician Decision|1
4722681|NCT03131453|7657451|FG000|Overall Study|Non-compliance with study treatment|1
4722682|NCT03131453|7657452|FG001|Overall Study|Non-compliance with study treatment|0
4722683|NCT03131453|7657453|FG002|Overall Study|Non-compliance with study treatment|0
4722684|NCT03131453|7657451|FG000|Overall Study|Technical problems|1
4722685|NCT03131453|7657452|FG001|Overall Study|Technical problems|0
4722686|NCT03131453|7657453|FG002|Overall Study|Technical problems|0
4722687|NCT03131453|7657451|FG000|Overall Study|Protocol deviation|0
4722688|NCT03131453|7657452|FG001|Overall Study|Protocol deviation|1
4722689|NCT03131453|7657453|FG002|Overall Study|Protocol deviation|0
4722690|NCT03131479|7657466|FG000|Overall Study|Adverse Event|0
4722691|NCT03131479|7657467|FG001|Overall Study|Adverse Event|0
4722692|NCT03131479|7657468|FG002|Overall Study|Adverse Event|1
4722693|NCT03131479|7657469|FG003|Overall Study|Adverse Event|1
4722694|NCT03131479|7657470|FG004|Overall Study|Adverse Event|0
4722695|NCT03131479|7657466|FG000|Overall Study|Subject/Guardian Decision|0
4722696|NCT03131479|7657467|FG001|Overall Study|Subject/Guardian Decision|0
4722697|NCT03131479|7657468|FG002|Overall Study|Subject/Guardian Decision|0
4722698|NCT03131479|7657469|FG003|Overall Study|Subject/Guardian Decision|1
4722699|NCT03131479|7657470|FG004|Overall Study|Subject/Guardian Decision|0
4722700|NCT03131570|7657484|FG000|Overall Study|Adverse Event|1
4722701|NCT03131570|7657485|FG001|Overall Study|Adverse Event|0
4722702|NCT03131596|7657493|FG000|Overall Study|Protocol Violation|3
4722703|NCT03131596|7657494|FG001|Overall Study|Protocol Violation|3
4722704|NCT03131596|7657493|FG000|Overall Study|Lost to Follow-up|3
4722705|NCT03131596|7657494|FG001|Overall Study|Lost to Follow-up|0
4722706|NCT03131648|7657502|FG000|Initial Treatment Period|Not dosed|2
4722707|NCT03131648|7657503|FG001|Initial Treatment Period|Not dosed|2
4722708|NCT03131648|7657504|FG002|Initial Treatment Period|Not dosed|0
4722709|NCT03131648|7657505|FG003|Initial Treatment Period|Not dosed|0
4722710|NCT03131648|7657506|FG004|Initial Treatment Period|Not dosed|0
4722711|NCT03131648|7657507|FG005|Initial Treatment Period|Not dosed|0
4722712|NCT03131648|7657508|FG006|Initial Treatment Period|Not dosed|0
4722713|NCT03131648|7657509|FG007|Initial Treatment Period|Not dosed|0
4722714|NCT03131648|7657502|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51
4722715|NCT03131648|7657503|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18
4722716|NCT03131648|7657504|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0
4722717|NCT03131648|7657505|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0
4722718|NCT03131648|7657506|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0
4722719|NCT03131648|7657507|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0
4722720|NCT03131648|7657508|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0
4722721|NCT03131648|7657509|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0
4722722|NCT03131648|7657502|FG000|Open-label Treatment|Discontinued IMP|0
4722723|NCT03131648|7657503|FG001|Open-label Treatment|Discontinued IMP|0
4722724|NCT03131648|7657504|FG002|Open-label Treatment|Discontinued IMP|0
4722725|NCT03131648|7657505|FG003|Open-label Treatment|Discontinued IMP|0
4722726|NCT03131648|7657506|FG004|Open-label Treatment|Discontinued IMP|0
4722727|NCT03131648|7657507|FG005|Open-label Treatment|Discontinued IMP|0
4722728|NCT03131648|7657508|FG006|Open-label Treatment|Discontinued IMP|112
4722729|NCT03131648|7657509|FG007|Open-label Treatment|Discontinued IMP|0
4722730|NCT03131648|7657502|FG000|Open-label Treatment|Completed Week 50|0
4722731|NCT03131648|7657503|FG001|Open-label Treatment|Completed Week 50|0
4722732|NCT03131648|7657504|FG002|Open-label Treatment|Completed Week 50|0
4722733|NCT03131648|7657505|FG003|Open-label Treatment|Completed Week 50|0
4722734|NCT03131648|7657506|FG004|Open-label Treatment|Completed Week 50|0
4722735|NCT03131648|7657507|FG005|Open-label Treatment|Completed Week 50|0
4722736|NCT03131648|7657508|FG006|Open-label Treatment|Completed Week 50|6
4722737|NCT03131648|7657509|FG007|Open-label Treatment|Completed Week 50|0
4722738|NCT03131648|7657502|FG000|Maintenance Treatment Period|Not dosed|0
4722739|NCT03131648|7657503|FG001|Maintenance Treatment Period|Not dosed|0
4722740|NCT03131648|7657504|FG002|Maintenance Treatment Period|Not dosed|3
4722741|NCT03131648|7657505|FG003|Maintenance Treatment Period|Not dosed|2
4722742|NCT03131648|7657506|FG004|Maintenance Treatment Period|Not dosed|1
4722743|NCT03131648|7657507|FG005|Maintenance Treatment Period|Not dosed|0
4722744|NCT03131648|7657508|FG006|Maintenance Treatment Period|Not dosed|0
4722745|NCT03131648|7657509|FG007|Maintenance Treatment Period|Not dosed|0
4722746|NCT03131648|7657502|FG000|Maintenance Treatment Period|Discontinued IMP|0
4722747|NCT03131648|7657503|FG001|Maintenance Treatment Period|Discontinued IMP|0
4722748|NCT03131648|7657504|FG002|Maintenance Treatment Period|Discontinued IMP|3
4722749|NCT03131648|7657505|FG003|Maintenance Treatment Period|Discontinued IMP|5
4722750|NCT03131648|7657506|FG004|Maintenance Treatment Period|Discontinued IMP|4
4722751|NCT03131648|7657507|FG005|Maintenance Treatment Period|Discontinued IMP|4
4722752|NCT03131648|7657508|FG006|Maintenance Treatment Period|Discontinued IMP|0
4722753|NCT03131648|7657509|FG007|Maintenance Treatment Period|Discontinued IMP|0
4722754|NCT03131648|7657502|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0
4722755|NCT03131648|7657503|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0
4722756|NCT03131648|7657504|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21
4722757|NCT03131648|7657505|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18
4722758|NCT03131648|7657506|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9
4722759|NCT03131648|7657507|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10
4722760|NCT03131648|7657508|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0
4722761|NCT03131648|7657509|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0
4722762|NCT03131648|7657502|FG000|Maintenance Treatment Period|Completed Week 50|0
4722763|NCT03131648|7657503|FG001|Maintenance Treatment Period|Completed Week 50|0
4722764|NCT03131648|7657504|FG002|Maintenance Treatment Period|Completed Week 50|0
4722765|NCT03131648|7657505|FG003|Maintenance Treatment Period|Completed Week 50|0
4722766|NCT03131648|7657506|FG004|Maintenance Treatment Period|Completed Week 50|1
4722767|NCT03131648|7657507|FG005|Maintenance Treatment Period|Completed Week 50|0
4722768|NCT03131648|7657508|FG006|Maintenance Treatment Period|Completed Week 50|0
4722769|NCT03131648|7657509|FG007|Maintenance Treatment Period|Completed Week 50|0
4722770|NCT03131648|7657502|FG000|Open-label (Short Term Extension)|Discontinued IMP|0
4722771|NCT03131648|7657503|FG001|Open-label (Short Term Extension)|Discontinued IMP|0
4722772|NCT03131648|7657504|FG002|Open-label (Short Term Extension)|Discontinued IMP|0
4722773|NCT03131648|7657505|FG003|Open-label (Short Term Extension)|Discontinued IMP|0
4722774|NCT03131648|7657506|FG004|Open-label (Short Term Extension)|Discontinued IMP|0
4722775|NCT03131648|7657507|FG005|Open-label (Short Term Extension)|Discontinued IMP|0
4722776|NCT03131648|7657508|FG006|Open-label (Short Term Extension)|Discontinued IMP|0
4722777|NCT03131648|7657509|FG007|Open-label (Short Term Extension)|Discontinued IMP|3
4722778|NCT03131687|7657532|FG000|Overall Study|Adverse Event|0
4722779|NCT03131687|7657533|FG001|Overall Study|Adverse Event|1
4722780|NCT03131687|7657534|FG002|Overall Study|Adverse Event|0
4722781|NCT03131687|7657535|FG003|Overall Study|Adverse Event|1
4722782|NCT03131687|7657536|FG004|Overall Study|Adverse Event|2
4722783|NCT03131687|7657537|FG005|Overall Study|Adverse Event|2
4722784|NCT03131687|7657532|FG000|Overall Study|Death|1
4722785|NCT03131687|7657533|FG001|Overall Study|Death|0
4722786|NCT03131687|7657534|FG002|Overall Study|Death|0
4722787|NCT03131687|7657535|FG003|Overall Study|Death|0
4722788|NCT03131687|7657536|FG004|Overall Study|Death|0
4722789|NCT03131687|7657537|FG005|Overall Study|Death|0
4722790|NCT03131687|7657532|FG000|Overall Study|Withdrawal by Subject|3
4722791|NCT03131687|7657533|FG001|Overall Study|Withdrawal by Subject|3
4722792|NCT03131687|7657534|FG002|Overall Study|Withdrawal by Subject|3
4722793|NCT03131687|7657535|FG003|Overall Study|Withdrawal by Subject|1
4722794|NCT03131687|7657536|FG004|Overall Study|Withdrawal by Subject|2
4722795|NCT03131687|7657537|FG005|Overall Study|Withdrawal by Subject|1
4722796|NCT03131687|7657532|FG000|Overall Study|Lost to Follow-up|1
4722797|NCT03131687|7657533|FG001|Overall Study|Lost to Follow-up|4
4722798|NCT03131687|7657534|FG002|Overall Study|Lost to Follow-up|0
4722799|NCT03131687|7657535|FG003|Overall Study|Lost to Follow-up|1
4722800|NCT03131687|7657536|FG004|Overall Study|Lost to Follow-up|4
4722801|NCT03131687|7657537|FG005|Overall Study|Lost to Follow-up|2
4722802|NCT03131687|7657532|FG000|Overall Study|Participant Started New Diabetic Drug|1
4722803|NCT03131687|7657533|FG001|Overall Study|Participant Started New Diabetic Drug|0
4722804|NCT03131687|7657534|FG002|Overall Study|Participant Started New Diabetic Drug|0
4722805|NCT03131687|7657535|FG003|Overall Study|Participant Started New Diabetic Drug|0
4722806|NCT03131687|7657536|FG004|Overall Study|Participant Started New Diabetic Drug|0
4722807|NCT03131687|7657537|FG005|Overall Study|Participant Started New Diabetic Drug|0
4722808|NCT03131687|7657532|FG000|Overall Study|Principle Investigator Decision|0
4722809|NCT03131687|7657533|FG001|Overall Study|Principle Investigator Decision|1
4722810|NCT03131687|7657534|FG002|Overall Study|Principle Investigator Decision|0
4722811|NCT03131687|7657535|FG003|Overall Study|Principle Investigator Decision|0
4722812|NCT03131687|7657536|FG004|Overall Study|Principle Investigator Decision|0
4722813|NCT03131687|7657537|FG005|Overall Study|Principle Investigator Decision|0
4722814|NCT03131687|7657532|FG000|Overall Study|Inadvertent Enrollment|0
4722815|NCT03131687|7657533|FG001|Overall Study|Inadvertent Enrollment|0
4722816|NCT03131687|7657534|FG002|Overall Study|Inadvertent Enrollment|0
4722817|NCT03131687|7657535|FG003|Overall Study|Inadvertent Enrollment|1
4722818|NCT03131687|7657536|FG004|Overall Study|Inadvertent Enrollment|0
4722819|NCT03131687|7657537|FG005|Overall Study|Inadvertent Enrollment|0
4722820|NCT03131713|7657566|FG000|Overall Study|Lost to Follow-up|5
4722821|NCT03131713|7657567|FG001|Overall Study|Lost to Follow-up|0
4722822|NCT03131895|7657577|FG000|Washout Period (at Least 5 Days)|Adverse Event|1
4722823|NCT03131895|7657578|FG001|Washout Period (at Least 5 Days)|Adverse Event|0
4722824|NCT03131895|7657579|FG002|Washout Period (at Least 5 Days)|Adverse Event|0
4722825|NCT03131895|7657580|FG003|Washout Period (at Least 5 Days)|Adverse Event|1
4722826|NCT03131895|7657577|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0
4722827|NCT03131895|7657578|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3
4722828|NCT03131895|7657579|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2
4722829|NCT03131895|7657580|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3
4722830|NCT03131895|7657577|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
4722831|NCT03131895|7657578|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2
4736670|NCT03573505|7686013|FG000|Overall Study|Disease progression|0
4722832|NCT03131895|7657579|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
4722833|NCT03131895|7657580|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1
4722834|NCT03131895|7657577|FG000|Washout Period (at Least 5 Days)|Other|0
4722835|NCT03131895|7657578|FG001|Washout Period (at Least 5 Days)|Other|0
4722836|NCT03131895|7657579|FG002|Washout Period (at Least 5 Days)|Other|2
4722837|NCT03131895|7657580|FG003|Washout Period (at Least 5 Days)|Other|0
4722838|NCT03131895|7657577|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0
4722839|NCT03131895|7657578|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1
4722840|NCT03131895|7657579|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0
4722841|NCT03131895|7657580|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0
4722842|NCT03131895|7657577|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1
4722843|NCT03131895|7657578|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0
4722844|NCT03131895|7657579|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0
4722845|NCT03131895|7657580|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0
4722846|NCT03131999|7657592|FG000|Overall Study|Withdrawal by Subject|0
4722847|NCT03131999|7657593|FG001|Overall Study|Withdrawal by Subject|1
4722848|NCT03132220|7657601|FG000|Overall Study|Lost to Follow-up|17
4722849|NCT03132220|7657602|FG001|Overall Study|Lost to Follow-up|8
4722850|NCT03132220|7657601|FG000|Overall Study|Withdrawal by Subject|1
4722851|NCT03132220|7657602|FG001|Overall Study|Withdrawal by Subject|4
4722852|NCT03133481|7657637|FG000|Overall Study|FC Catheter fell out post operative day1|0
4722853|NCT03133481|7657638|FG001|Overall Study|FC Catheter fell out post operative day1|4
4722854|NCT03133767|7657690|FG000|Overall Study|Lost to Follow-up|38
4722855|NCT03133767|7657691|FG001|Overall Study|Lost to Follow-up|24
4722856|NCT03133767|7657690|FG000|Overall Study|Protocol Violation|0
4722857|NCT03133767|7657691|FG001|Overall Study|Protocol Violation|1
4722858|NCT03134183|7657730|FG000|Overall Study|Withdrawal by Subject|1
4722859|NCT03134183|7657731|FG001|Overall Study|Withdrawal by Subject|1
4722860|NCT03134222|7657753|FG000|Treatment Period (Up to Week 12)|Adverse Event|4
4722861|NCT03134222|7657754|FG001|Treatment Period (Up to Week 12)|Adverse Event|1
4722862|NCT03134222|7657755|FG002|Treatment Period (Up to Week 12)|Adverse Event|0
4722863|NCT03134222|7657756|FG003|Treatment Period (Up to Week 12)|Adverse Event|0
4722864|NCT03134222|7657757|FG004|Treatment Period (Up to Week 12)|Adverse Event|0
4722865|NCT03134222|7657753|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1
4722866|NCT03134222|7657754|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1
4722867|NCT03134222|7657755|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1
4722868|NCT03134222|7657756|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0
4722869|NCT03134222|7657757|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0
4722870|NCT03134222|7657753|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0
4722871|NCT03134222|7657754|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1
4722872|NCT03134222|7657755|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0
4722873|NCT03134222|7657756|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0
4722874|NCT03134222|7657757|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0
4722875|NCT03134222|7657753|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0
4722876|NCT03134222|7657754|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1
4722877|NCT03134222|7657755|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1
4722878|NCT03134222|7657756|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0
4722879|NCT03134222|7657757|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0
4722880|NCT03134222|7657753|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0
4722881|NCT03134222|7657754|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2
4722882|NCT03134222|7657755|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0
4722883|NCT03134222|7657756|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0
4722884|NCT03134222|7657757|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1
4722885|NCT03134222|7657753|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2
4722886|NCT03134222|7657754|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0
4722887|NCT03134222|7657755|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0
4722888|NCT03134222|7657756|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0
4722889|NCT03134222|7657757|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0
4722890|NCT03134222|7657753|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0
4722891|NCT03134222|7657754|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0
4722892|NCT03134222|7657755|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0
4722893|NCT03134222|7657756|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1
4722894|NCT03134222|7657757|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0
4722895|NCT03134222|7657753|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0
4722896|NCT03134222|7657754|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1
4722897|NCT03134222|7657755|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0
4722898|NCT03134222|7657756|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0
4722899|NCT03134222|7657757|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0
4722900|NCT03134599|7657790|FG000|Week 1|Lost to Follow-up|0
4722901|NCT03134599|7657791|FG001|Week 1|Lost to Follow-up|0
4722902|NCT03134599|7657792|FG002|Week 1|Lost to Follow-up|0
4722903|NCT03134599|7657793|FG003|Week 1|Lost to Follow-up|0
4722904|NCT03134599|7657794|FG004|Week 1|Lost to Follow-up|1
4722905|NCT03134599|7657795|FG005|Week 1|Lost to Follow-up|0
4722906|NCT03134599|7657790|FG000|Week 2|Lost to Follow-up|1
4722907|NCT03134599|7657791|FG001|Week 2|Lost to Follow-up|0
4722908|NCT03134599|7657792|FG002|Week 2|Lost to Follow-up|0
4722909|NCT03134599|7657793|FG003|Week 2|Lost to Follow-up|1
4722910|NCT03134599|7657794|FG004|Week 2|Lost to Follow-up|1
4722911|NCT03134599|7657795|FG005|Week 2|Lost to Follow-up|0
4722912|NCT03134599|7657790|FG000|Week 3|Lost to Follow-up|0
4722913|NCT03134599|7657791|FG001|Week 3|Lost to Follow-up|0
4722914|NCT03134599|7657792|FG002|Week 3|Lost to Follow-up|0
4722915|NCT03134599|7657793|FG003|Week 3|Lost to Follow-up|1
4722916|NCT03134599|7657794|FG004|Week 3|Lost to Follow-up|0
4722917|NCT03134599|7657795|FG005|Week 3|Lost to Follow-up|1
4722918|NCT03134911|7657818|FG000|Overall Study|Screen failure|31
4722919|NCT03134911|7657818|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3
4722920|NCT03135028|7657901|FG000|Overall Study|Death|6
4722921|NCT03135028|7657901|FG000|Overall Study|Study Terminated by Sponsor|2
4722922|NCT03135028|7657901|FG000|Overall Study|Withdrew Consent|1
4722923|NCT03135210|7657907|FG000|Overall Study|Death|0
4722924|NCT03135210|7657908|FG001|Overall Study|Death|1
4722925|NCT03135431|7657925|FG000|Overall Study|Study Surgeon not available|2
4722926|NCT03135431|7657926|FG001|Overall Study|Study Surgeon not available|0
4722927|NCT03135522|7657934|FG000|Overall Study|Adverse Event|1
4722928|NCT03135522|7657935|FG001|Overall Study|Adverse Event|0
4722929|NCT03135548|7657948|FG000|Overall Study|Lost to Follow-up|3
4722930|NCT03135548|7657949|FG001|Overall Study|Lost to Follow-up|0
4722931|NCT03135548|7657950|FG002|Overall Study|Lost to Follow-up|0
4722932|NCT03135548|7657948|FG000|Overall Study|Withdrawal by Subject|2
4722933|NCT03135548|7657949|FG001|Overall Study|Withdrawal by Subject|2
4446528|NCT00484939|7231633|FG000|Overall Study|Discretion of Investigator or Sponsor|7
4446529|NCT00484939|7231634|FG001|Overall Study|Discretion of Investigator or Sponsor|3
4446530|NCT00484939|7231633|FG000|Overall Study|Disease progression|67
4446531|NCT00484939|7231634|FG001|Overall Study|Disease progression|88
4446532|NCT00484939|7231633|FG000|Overall Study|Screen Failure|2
4446533|NCT00484939|7231634|FG001|Overall Study|Screen Failure|2
4446534|NCT00484939|7231633|FG000|Overall Study|Reason Not Specified|11
4446535|NCT00484939|7231634|FG001|Overall Study|Reason Not Specified|6
4446536|NCT00485069|7231642|FG000|Overall Study|Adverse Event|10
4446537|NCT00485069|7231643|FG001|Overall Study|Adverse Event|4
4446538|NCT00485069|7231642|FG000|Overall Study|Lack of Efficacy|2
4446539|NCT00485069|7231643|FG001|Overall Study|Lack of Efficacy|1
4722934|NCT03135548|7657950|FG002|Overall Study|Withdrawal by Subject|1
4722935|NCT03135548|7657948|FG000|Overall Study|Other than listed|0
4722936|NCT03135548|7657949|FG001|Overall Study|Other than listed|2
4722937|NCT03135548|7657950|FG002|Overall Study|Other than listed|2
4722938|NCT03135899|7657966|FG000|Overall Study|Failed spirometry,unable to repeat visit|0
4722939|NCT03135899|7657967|FG001|Overall Study|Failed spirometry,unable to repeat visit|0
4722940|NCT03135899|7657968|FG002|Overall Study|Failed spirometry,unable to repeat visit|0
4722941|NCT03135899|7657969|FG003|Overall Study|Failed spirometry,unable to repeat visit|0
4722942|NCT03135899|7657970|FG004|Overall Study|Failed spirometry,unable to repeat visit|0
4722943|NCT03135899|7657971|FG005|Overall Study|Failed spirometry,unable to repeat visit|0
4722944|NCT03135899|7657972|FG006|Overall Study|Failed spirometry,unable to repeat visit|1
4722945|NCT03135899|7657973|FG007|Overall Study|Failed spirometry,unable to repeat visit|0
4722946|NCT03135899|7657966|FG000|Overall Study|Withdrawal by Subject|0
4722947|NCT03135899|7657967|FG001|Overall Study|Withdrawal by Subject|0
4722948|NCT03135899|7657968|FG002|Overall Study|Withdrawal by Subject|0
4722949|NCT03135899|7657969|FG003|Overall Study|Withdrawal by Subject|0
4722950|NCT03135899|7657970|FG004|Overall Study|Withdrawal by Subject|0
4722951|NCT03135899|7657971|FG005|Overall Study|Withdrawal by Subject|2
4722952|NCT03135899|7657972|FG006|Overall Study|Withdrawal by Subject|0
4722953|NCT03135899|7657973|FG007|Overall Study|Withdrawal by Subject|0
4722954|NCT03136068|7657989|FG000|Overall Study|Lost to Follow-up|1
4722955|NCT03136068|7657990|FG001|Overall Study|Lost to Follow-up|1
4722956|NCT03136068|7657989|FG000|Overall Study|Protocol Violation|1
4722957|NCT03136068|7657990|FG001|Overall Study|Protocol Violation|0
4722958|NCT03136107|7657996|FG000|Overall Study|Other (Not specified)|1
4722959|NCT03136159|7658006|FG000|Overall Study|chorioamnionitis|2
4722960|NCT03136159|7658007|FG001|Overall Study|chorioamnionitis|0
4722961|NCT03136159|7658006|FG000|Overall Study|vertical skin incision|1
4722962|NCT03136159|7658007|FG001|Overall Study|vertical skin incision|0
4722963|NCT03136159|7658006|FG000|Overall Study|additional dressing|1
4722964|NCT03136159|7658007|FG001|Overall Study|additional dressing|0
4722965|NCT03136159|7658006|FG000|Overall Study|never got dressing placed|1
4722966|NCT03136159|7658007|FG001|Overall Study|never got dressing placed|0
4722967|NCT03136198|7658015|FG000|Overall Study|Withdrawal by Subject|0
4722968|NCT03136198|7658016|FG001|Overall Study|Withdrawal by Subject|1
4722969|NCT03136367|7658030|FG000|T1 Consultation|discontinued mistakenly included|2
4722970|NCT03136367|7658031|FG001|T1 Consultation|discontinued mistakenly included|6
4722971|NCT03136367|7658032|FG002|T1 Consultation|discontinued mistakenly included|1
4722972|NCT03136367|7658030|FG000|T1 Consultation|Discontinued other|0
4722973|NCT03136367|7658031|FG001|T1 Consultation|Discontinued other|1
4722974|NCT03136367|7658032|FG002|T1 Consultation|Discontinued other|0
4722975|NCT03136367|7658030|FG000|T2 Post-consultation|Withdrawal by Subject|1
4736671|NCT03573505|7686014|FG001|Overall Study|Disease progression|1
4722976|NCT03136367|7658031|FG001|T2 Post-consultation|Withdrawal by Subject|1
4722977|NCT03136367|7658032|FG002|T2 Post-consultation|Withdrawal by Subject|5
4722978|NCT03136367|7658030|FG000|T2 Post-consultation|discontinued mistakenly included|2
4722979|NCT03136367|7658031|FG001|T2 Post-consultation|discontinued mistakenly included|2
4722980|NCT03136367|7658032|FG002|T2 Post-consultation|discontinued mistakenly included|17
4722981|NCT03136367|7658030|FG000|T2 Post-consultation|Discontinued other|0
4722982|NCT03136367|7658031|FG001|T2 Post-consultation|Discontinued other|2
4722983|NCT03136367|7658032|FG002|T2 Post-consultation|Discontinued other|6
4722984|NCT03136367|7658030|FG000|T2 Post-consultation|Discontinued transferred care|0
4722985|NCT03136367|7658031|FG001|T2 Post-consultation|Discontinued transferred care|0
4722986|NCT03136367|7658032|FG002|T2 Post-consultation|Discontinued transferred care|3
4722987|NCT03136367|7658030|FG000|T2 Post-consultation|Discontinued lost contact|0
4722988|NCT03136367|7658031|FG001|T2 Post-consultation|Discontinued lost contact|1
4722989|NCT03136367|7658032|FG002|T2 Post-consultation|Discontinued lost contact|0
4722990|NCT03136367|7658030|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5
4722991|NCT03136367|7658031|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9
4722992|NCT03136367|7658032|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8
4722993|NCT03136367|7658030|FG000|T3 1 Week After Surgery|Discontinued transferred care|2
4722994|NCT03136367|7658031|FG001|T3 1 Week After Surgery|Discontinued transferred care|11
4722995|NCT03136367|7658032|FG002|T3 1 Week After Surgery|Discontinued transferred care|14
4722996|NCT03136367|7658030|FG000|T3 1 Week After Surgery|other discontinued|2
4722997|NCT03136367|7658031|FG001|T3 1 Week After Surgery|other discontinued|4
4722998|NCT03136367|7658032|FG002|T3 1 Week After Surgery|other discontinued|3
4722999|NCT03136367|7658030|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0
4723000|NCT03136367|7658031|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6
4723001|NCT03136367|7658032|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2
4723002|NCT03136367|7658030|FG000|T3 1 Week After Surgery|Discontinued lost contact|1
4723003|NCT03136367|7658031|FG001|T3 1 Week After Surgery|Discontinued lost contact|2
4446540|NCT00485069|7231642|FG000|Overall Study|Protocol Violation|0
4446541|NCT00485069|7231643|FG001|Overall Study|Protocol Violation|1
4446542|NCT00485069|7231642|FG000|Overall Study|Withdrawal by Subject|6
4446543|NCT00485069|7231643|FG001|Overall Study|Withdrawal by Subject|6
4446544|NCT00485134|7231664|FG000|Overall Study|Lost to Follow-up|1
4446545|NCT00485134|7231665|FG001|Overall Study|Lost to Follow-up|0
4446546|NCT00485134|7231666|FG002|Overall Study|Lost to Follow-up|0
4446547|NCT00485134|7231667|FG003|Overall Study|Lost to Follow-up|0
4723004|NCT03136367|7658032|FG002|T3 1 Week After Surgery|Discontinued lost contact|4
4723005|NCT03136367|7658030|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1
4723006|NCT03136367|7658031|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3
4723007|NCT03136367|7658032|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0
4723008|NCT03136367|7658030|FG000|T4 12 Weeks After Surgery|Death|0
4723009|NCT03136367|7658031|FG001|T4 12 Weeks After Surgery|Death|1
4723010|NCT03136367|7658032|FG002|T4 12 Weeks After Surgery|Death|3
4723011|NCT03136367|7658030|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1
4723012|NCT03136367|7658031|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0
4723013|NCT03136367|7658032|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0
4723014|NCT03136367|7658030|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0
4723015|NCT03136367|7658031|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1
4723016|NCT03136367|7658032|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5
4723017|NCT03136367|7658030|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0
4723018|NCT03136367|7658031|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0
4723019|NCT03136367|7658032|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1
4723020|NCT03136367|7658030|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1
4723021|NCT03136367|7658031|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1
4723022|NCT03136367|7658032|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1
4723023|NCT03136367|7658030|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1
4723024|NCT03136367|7658031|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0
4723025|NCT03136367|7658032|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0
4723026|NCT03136367|7658030|FG000|T5 1 Year After Surgery|Death|0
4723027|NCT03136367|7658031|FG001|T5 1 Year After Surgery|Death|0
4723028|NCT03136367|7658032|FG002|T5 1 Year After Surgery|Death|1
4723029|NCT03136367|7658030|FG000|T5 1 Year After Surgery|Discontinued lost contact|1
4723030|NCT03136367|7658031|FG001|T5 1 Year After Surgery|Discontinued lost contact|6
4723031|NCT03136367|7658032|FG002|T5 1 Year After Surgery|Discontinued lost contact|0
4723032|NCT03136367|7658030|FG000|T5 1 Year After Surgery|Lost to Follow-up|2
4723033|NCT03136367|7658031|FG001|T5 1 Year After Surgery|Lost to Follow-up|22
4723034|NCT03136367|7658032|FG002|T5 1 Year After Surgery|Lost to Follow-up|15
4723035|NCT03136367|7658030|FG000|T5 1 Year After Surgery|study ended before due|31
4723036|NCT03136367|7658031|FG001|T5 1 Year After Surgery|study ended before due|103
4723037|NCT03136367|7658032|FG002|T5 1 Year After Surgery|study ended before due|110
4723038|NCT03136367|7658030|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0
4723039|NCT03136367|7658031|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4
4723040|NCT03136367|7658032|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2
4515249|NCT00952276|7325998|FG002|Overall Study|Withdrawal by Subject|0
4515250|NCT00952276|7325999|FG003|Overall Study|Withdrawal by Subject|1
4723041|NCT03136380|7658045|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
4723042|NCT03136380|7658046|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1
4723043|NCT03136380|7658047|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
4723044|NCT03136380|7658048|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
4723045|NCT03136380|7658049|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
4723046|NCT03136484|7658069|FG000|Overall Study|Withdrawal by Subject|19
4723047|NCT03136484|7658070|FG001|Overall Study|Withdrawal by Subject|14
4723048|NCT03136484|7658069|FG000|Overall Study|Lost to Follow-up|7
4723049|NCT03136484|7658070|FG001|Overall Study|Lost to Follow-up|8
4723050|NCT03136484|7658069|FG000|Overall Study|Death|1
4723051|NCT03136484|7658070|FG001|Overall Study|Death|0
4723052|NCT03136861|7658083|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3
4723053|NCT03136861|7658084|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2
4723054|NCT03136861|7658085|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
4723055|NCT03136861|7658086|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
4723056|NCT03136861|7658087|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
4723057|NCT03136861|7658088|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
4723058|NCT03136861|7658089|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
4723059|NCT03136861|7658083|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1
4723060|NCT03136861|7658084|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1
4723061|NCT03136861|7658085|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
4723062|NCT03136861|7658086|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
4723063|NCT03136861|7658087|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
4723064|NCT03136861|7658088|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
4723065|NCT03136861|7658089|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
4723066|NCT03136861|7658083|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2
4723067|NCT03136861|7658084|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1
4723068|NCT03136861|7658085|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
4723069|NCT03136861|7658086|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
4630774|NCT01885104|7499608|FG000|Overall Study|Lost to Follow-up|0
4630775|NCT01885104|7499609|FG001|Overall Study|Lost to Follow-up|1
4723070|NCT03136861|7658087|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
4723071|NCT03136861|7658088|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
4723072|NCT03136861|7658089|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
4723073|NCT03136861|7658083|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
4723074|NCT03136861|7658084|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1
4723075|NCT03136861|7658085|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
4723076|NCT03136861|7658086|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
4723077|NCT03136861|7658087|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
4723078|NCT03136861|7658088|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
4723079|NCT03136861|7658089|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
4723080|NCT03136861|7658083|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1
4723081|NCT03136861|7658084|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1
4723082|NCT03136861|7658085|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
4723083|NCT03136861|7658086|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
4723084|NCT03136861|7658087|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
4723085|NCT03136861|7658088|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
4723086|NCT03136861|7658089|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
4723087|NCT03136861|7658083|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0
4723088|NCT03136861|7658084|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0
4723089|NCT03136861|7658085|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0
4723090|NCT03136861|7658086|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1
4723091|NCT03136861|7658087|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2
4723092|NCT03136861|7658088|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0
4723093|NCT03136861|7658089|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1
4723094|NCT03136861|7658083|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
4723095|NCT03136861|7658084|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
4723096|NCT03136861|7658085|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1
4723097|NCT03136861|7658086|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
4723098|NCT03136861|7658087|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
4723099|NCT03136861|7658088|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
4723100|NCT03136861|7658089|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
4723101|NCT03136861|7658083|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
4723102|NCT03136861|7658084|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
4723103|NCT03136861|7658085|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1
4723104|NCT03136861|7658086|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
4723105|NCT03136861|7658087|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
4723106|NCT03136861|7658088|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
4723107|NCT03136861|7658089|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
4723108|NCT03137069|7658113|FG000|Overall Study|Withdrawal by Subject|1
4723109|NCT03137069|7658114|FG001|Overall Study|Withdrawal by Subject|2
4723110|NCT03137069|7658115|FG002|Overall Study|Withdrawal by Subject|2
4723111|NCT03137069|7658116|FG003|Overall Study|Withdrawal by Subject|2
4723112|NCT03137069|7658117|FG004|Overall Study|Withdrawal by Subject|0
4446548|NCT00485134|7231668|FG004|Overall Study|Lost to Follow-up|0
4446549|NCT00485134|7231669|FG005|Overall Study|Lost to Follow-up|0
4446550|NCT00485134|7231670|FG006|Overall Study|Lost to Follow-up|0
4446551|NCT00485134|7231671|FG007|Overall Study|Lost to Follow-up|0
4446552|NCT00485134|7231664|FG000|Overall Study|Withdrawal by Subject|0
4446553|NCT00485134|7231665|FG001|Overall Study|Withdrawal by Subject|1
4446554|NCT00485134|7231666|FG002|Overall Study|Withdrawal by Subject|0
4446555|NCT00485134|7231667|FG003|Overall Study|Withdrawal by Subject|0
4446556|NCT00485134|7231668|FG004|Overall Study|Withdrawal by Subject|0
4446557|NCT00485134|7231669|FG005|Overall Study|Withdrawal by Subject|0
4446558|NCT00485134|7231670|FG006|Overall Study|Withdrawal by Subject|0
4446559|NCT00485134|7231671|FG007|Overall Study|Withdrawal by Subject|0
4723113|NCT03137069|7658118|FG005|Overall Study|Withdrawal by Subject|0
4723114|NCT03137069|7658113|FG000|Overall Study|Adverse Event|0
4723115|NCT03137069|7658114|FG001|Overall Study|Adverse Event|3
4723116|NCT03137069|7658115|FG002|Overall Study|Adverse Event|1
4723117|NCT03137069|7658116|FG003|Overall Study|Adverse Event|1
4723118|NCT03137069|7658117|FG004|Overall Study|Adverse Event|0
4723119|NCT03137069|7658118|FG005|Overall Study|Adverse Event|1
4723120|NCT03137069|7658113|FG000|Overall Study|Protocol Violation|0
4723121|NCT03137069|7658114|FG001|Overall Study|Protocol Violation|1
4723122|NCT03137069|7658115|FG002|Overall Study|Protocol Violation|0
4723123|NCT03137069|7658116|FG003|Overall Study|Protocol Violation|1
4723124|NCT03137069|7658117|FG004|Overall Study|Protocol Violation|1
4723125|NCT03137069|7658118|FG005|Overall Study|Protocol Violation|1
4723126|NCT03137069|7658113|FG000|Overall Study|Physician Decision|0
4723127|NCT03137069|7658114|FG001|Overall Study|Physician Decision|0
4723128|NCT03137069|7658115|FG002|Overall Study|Physician Decision|0
4723129|NCT03137069|7658116|FG003|Overall Study|Physician Decision|1
4723130|NCT03137069|7658117|FG004|Overall Study|Physician Decision|0
4723131|NCT03137069|7658118|FG005|Overall Study|Physician Decision|0
4723132|NCT03137069|7658113|FG000|Overall Study|Study Terminated by Sponsor|0
4723133|NCT03137069|7658114|FG001|Overall Study|Study Terminated by Sponsor|0
4723134|NCT03137069|7658115|FG002|Overall Study|Study Terminated by Sponsor|0
4723135|NCT03137069|7658116|FG003|Overall Study|Study Terminated by Sponsor|0
4723136|NCT03137069|7658117|FG004|Overall Study|Study Terminated by Sponsor|1
4723137|NCT03137069|7658118|FG005|Overall Study|Study Terminated by Sponsor|0
4723138|NCT03137069|7658113|FG000|Overall Study|Data Entry Error|0
4723139|NCT03137069|7658114|FG001|Overall Study|Data Entry Error|0
4723140|NCT03137069|7658115|FG002|Overall Study|Data Entry Error|0
4723141|NCT03137069|7658116|FG003|Overall Study|Data Entry Error|1
4723142|NCT03137069|7658117|FG004|Overall Study|Data Entry Error|0
4723143|NCT03137069|7658118|FG005|Overall Study|Data Entry Error|0
4723144|NCT03137121|7658138|FG000|Overall Study|Withdrawal by Subject|0
4723145|NCT03137121|7658139|FG001|Overall Study|Withdrawal by Subject|1
4723146|NCT03137303|7658147|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1
4723147|NCT03137303|7658148|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4
4723148|NCT03137303|7658147|FG000|T1: 3-month Follow-up|Lost to Follow-up|5
4723149|NCT03137303|7658148|FG001|T1: 3-month Follow-up|Lost to Follow-up|6
4723150|NCT03137303|7658147|FG000|T2: 6-month Follow-up|Lost to Follow-up|5
4723151|NCT03137303|7658148|FG001|T2: 6-month Follow-up|Lost to Follow-up|5
4723152|NCT03137303|7658147|FG000|T3: 9-month Follow-up|Death|1
4723153|NCT03137303|7658148|FG001|T3: 9-month Follow-up|Death|0
4723154|NCT03137303|7658147|FG000|T3: 9-month Follow-up|Lost to Follow-up|4
4723155|NCT03137303|7658148|FG001|T3: 9-month Follow-up|Lost to Follow-up|4
4723156|NCT03137303|7658147|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0
4723157|NCT03137303|7658148|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1
4723158|NCT03137303|7658147|FG000|T4: 12-month Follow-up|Lost to Follow-up|7
4723159|NCT03137303|7658148|FG001|T4: 12-month Follow-up|Lost to Follow-up|4
4723160|NCT03137459|7658156|FG000|2-month Assessment|Withdrawal by Subject|13
4723161|NCT03137459|7658157|FG001|2-month Assessment|Withdrawal by Subject|3
4723162|NCT03137459|7658156|FG000|2-month Assessment|Unable to reach|42
4723163|NCT03137459|7658157|FG001|2-month Assessment|Unable to reach|32
4723164|NCT03137459|7658156|FG000|2-month Assessment|Refused assessment|7
4723165|NCT03137459|7658157|FG001|2-month Assessment|Refused assessment|5
4723166|NCT03137459|7658156|FG000|2-month Assessment|Acutely ill|6
4723167|NCT03137459|7658157|FG001|2-month Assessment|Acutely ill|2
4723168|NCT03137459|7658156|FG000|4-month Assessment|Death|4
4723169|NCT03137459|7658157|FG001|4-month Assessment|Death|2
4723170|NCT03137459|7658156|FG000|4-month Assessment|Withdrawal by Subject|4
4723171|NCT03137459|7658157|FG001|4-month Assessment|Withdrawal by Subject|2
4723172|NCT03137459|7658156|FG000|4-month Assessment|Unable to reach|44
4446560|NCT00485134|7231664|FG000|Overall Study|Change in health status|0
4446561|NCT00485134|7231665|FG001|Overall Study|Change in health status|1
4723173|NCT03137459|7658157|FG001|4-month Assessment|Unable to reach|29
4723174|NCT03137459|7658156|FG000|4-month Assessment|Refused assessment|24
4723175|NCT03137459|7658157|FG001|4-month Assessment|Refused assessment|10
4723176|NCT03137459|7658156|FG000|4-month Assessment|Acutely ill|2
4723177|NCT03137459|7658157|FG001|4-month Assessment|Acutely ill|3
4723178|NCT03137459|7658156|FG000|6-months|Lost to Follow-up|14
4723179|NCT03137459|7658157|FG001|6-months|Lost to Follow-up|11
4723180|NCT03137459|7658156|FG000|6-months|Death|0
4723181|NCT03137459|7658157|FG001|6-months|Death|2
4723182|NCT03137459|7658156|FG000|6-months|Refused assessment|6
4723183|NCT03137459|7658157|FG001|6-months|Refused assessment|3
4723184|NCT03137459|7658156|FG000|6-months|Acutely ill|1
4723185|NCT03137459|7658157|FG001|6-months|Acutely ill|1
4723186|NCT03137784|7658168|FG000|Overall Study|Adverse Event|1
4723187|NCT03137784|7658169|FG001|Overall Study|Adverse Event|1
4723188|NCT03137784|7658170|FG002|Overall Study|Adverse Event|0
4723189|NCT03137784|7658171|FG003|Overall Study|Adverse Event|0
4723190|NCT03137784|7658172|FG004|Overall Study|Adverse Event|0
4723191|NCT03137784|7658173|FG005|Overall Study|Adverse Event|0
4723192|NCT03137784|7658168|FG000|Overall Study|Subject/guardian decision|1
4723193|NCT03137784|7658169|FG001|Overall Study|Subject/guardian decision|0
4723194|NCT03137784|7658170|FG002|Overall Study|Subject/guardian decision|0
4723195|NCT03137784|7658171|FG003|Overall Study|Subject/guardian decision|0
4723196|NCT03137784|7658172|FG004|Overall Study|Subject/guardian decision|0
4723197|NCT03137784|7658173|FG005|Overall Study|Subject/guardian decision|0
4723198|NCT03137784|7658168|FG000|Overall Study|Non-compliance with study treatment|0
4723199|NCT03137784|7658169|FG001|Overall Study|Non-compliance with study treatment|0
4723200|NCT03137784|7658170|FG002|Overall Study|Non-compliance with study treatment|0
4723201|NCT03137784|7658171|FG003|Overall Study|Non-compliance with study treatment|0
4723202|NCT03137784|7658172|FG004|Overall Study|Non-compliance with study treatment|1
4723203|NCT03137784|7658173|FG005|Overall Study|Non-compliance with study treatment|0
4723204|NCT03137992|7658181|FG000|Washout Period 1|Adverse Event|1
4723205|NCT03137992|7658182|FG001|Washout Period 1|Adverse Event|1
4723206|NCT03137992|7658183|FG002|Washout Period 1|Adverse Event|0
4723207|NCT03137992|7658184|FG003|Washout Period 1|Adverse Event|0
4723208|NCT03137992|7658185|FG004|Washout Period 1|Adverse Event|0
4723209|NCT03137992|7658186|FG005|Washout Period 1|Adverse Event|1
4723210|NCT03137992|7658181|FG000|Washout Period 1|Withdrawal by Subject|0
4723211|NCT03137992|7658182|FG001|Washout Period 1|Withdrawal by Subject|1
4723212|NCT03137992|7658183|FG002|Washout Period 1|Withdrawal by Subject|1
4723213|NCT03137992|7658184|FG003|Washout Period 1|Withdrawal by Subject|0
4723214|NCT03137992|7658185|FG004|Washout Period 1|Withdrawal by Subject|0
4723215|NCT03137992|7658186|FG005|Washout Period 1|Withdrawal by Subject|0
4723216|NCT03137992|7658181|FG000|Washout Period 1|Principal Investigator Discretion|0
4723217|NCT03137992|7658182|FG001|Washout Period 1|Principal Investigator Discretion|1
4723218|NCT03137992|7658183|FG002|Washout Period 1|Principal Investigator Discretion|0
4723219|NCT03137992|7658184|FG003|Washout Period 1|Principal Investigator Discretion|0
4723220|NCT03137992|7658185|FG004|Washout Period 1|Principal Investigator Discretion|0
4723221|NCT03137992|7658186|FG005|Washout Period 1|Principal Investigator Discretion|0
4723222|NCT03137992|7658181|FG000|Washout Period 1|COPD Exacerbation|1
4723223|NCT03137992|7658182|FG001|Washout Period 1|COPD Exacerbation|1
4723224|NCT03137992|7658183|FG002|Washout Period 1|COPD Exacerbation|1
4723225|NCT03137992|7658184|FG003|Washout Period 1|COPD Exacerbation|0
4723226|NCT03137992|7658185|FG004|Washout Period 1|COPD Exacerbation|1
4723227|NCT03137992|7658186|FG005|Washout Period 1|COPD Exacerbation|1
4723228|NCT03137992|7658181|FG000|Washout Period 1|Subject Noncompliance|1
4723229|NCT03137992|7658182|FG001|Washout Period 1|Subject Noncompliance|0
4723230|NCT03137992|7658183|FG002|Washout Period 1|Subject Noncompliance|0
4723231|NCT03137992|7658184|FG003|Washout Period 1|Subject Noncompliance|0
4723232|NCT03137992|7658185|FG004|Washout Period 1|Subject Noncompliance|1
4723233|NCT03137992|7658186|FG005|Washout Period 1|Subject Noncompliance|0
4723234|NCT03137992|7658181|FG000|Period 2 (Visit 3)|COPD Exacerbation|1
4723235|NCT03137992|7658182|FG001|Period 2 (Visit 3)|COPD Exacerbation|1
4723236|NCT03137992|7658183|FG002|Period 2 (Visit 3)|COPD Exacerbation|0
4723237|NCT03137992|7658184|FG003|Period 2 (Visit 3)|COPD Exacerbation|0
4723238|NCT03137992|7658185|FG004|Period 2 (Visit 3)|COPD Exacerbation|0
4723239|NCT03137992|7658186|FG005|Period 2 (Visit 3)|COPD Exacerbation|1
4723240|NCT03137992|7658181|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2
4723241|NCT03137992|7658182|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3
4723242|NCT03137992|7658183|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3
4723243|NCT03137992|7658184|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4
4723244|NCT03137992|7658185|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3
4723245|NCT03137992|7658186|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7
4723246|NCT03137992|7658181|FG000|Period 2 (Visit 3)|Adverse Event|0
4723247|NCT03137992|7658182|FG001|Period 2 (Visit 3)|Adverse Event|1
4723248|NCT03137992|7658183|FG002|Period 2 (Visit 3)|Adverse Event|0
4723249|NCT03137992|7658184|FG003|Period 2 (Visit 3)|Adverse Event|0
4723250|NCT03137992|7658185|FG004|Period 2 (Visit 3)|Adverse Event|0
4723251|NCT03137992|7658186|FG005|Period 2 (Visit 3)|Adverse Event|0
4723252|NCT03137992|7658181|FG000|Period 2 (Visit 3)|Lost to Follow-up|0
4723253|NCT03137992|7658182|FG001|Period 2 (Visit 3)|Lost to Follow-up|0
4723254|NCT03137992|7658183|FG002|Period 2 (Visit 3)|Lost to Follow-up|0
4723255|NCT03137992|7658184|FG003|Period 2 (Visit 3)|Lost to Follow-up|1
4723256|NCT03137992|7658185|FG004|Period 2 (Visit 3)|Lost to Follow-up|0
4723257|NCT03137992|7658186|FG005|Period 2 (Visit 3)|Lost to Follow-up|0
4723258|NCT03137992|7658181|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0
4723259|NCT03137992|7658182|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2
4723260|NCT03137992|7658183|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0
4723261|NCT03137992|7658184|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0
4723262|NCT03137992|7658185|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1
4723263|NCT03137992|7658186|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0
4723264|NCT03137992|7658181|FG000|Washout Period 2|COPD Exacerbation|1
4723265|NCT03137992|7658182|FG001|Washout Period 2|COPD Exacerbation|1
4723266|NCT03137992|7658183|FG002|Washout Period 2|COPD Exacerbation|0
4723267|NCT03137992|7658184|FG003|Washout Period 2|COPD Exacerbation|0
4723268|NCT03137992|7658185|FG004|Washout Period 2|COPD Exacerbation|1
4723269|NCT03137992|7658186|FG005|Washout Period 2|COPD Exacerbation|0
4723270|NCT03137992|7658181|FG000|Washout Period 2|Subject Non-compliance|0
4723271|NCT03137992|7658182|FG001|Washout Period 2|Subject Non-compliance|1
4723272|NCT03137992|7658183|FG002|Washout Period 2|Subject Non-compliance|0
4723273|NCT03137992|7658184|FG003|Washout Period 2|Subject Non-compliance|0
4723274|NCT03137992|7658185|FG004|Washout Period 2|Subject Non-compliance|0
4723275|NCT03137992|7658186|FG005|Washout Period 2|Subject Non-compliance|0
4723276|NCT03137992|7658181|FG000|Washout Period 2|Adverse Event|0
4723277|NCT03137992|7658182|FG001|Washout Period 2|Adverse Event|0
4723278|NCT03137992|7658183|FG002|Washout Period 2|Adverse Event|0
4723279|NCT03137992|7658184|FG003|Washout Period 2|Adverse Event|1
4723280|NCT03137992|7658185|FG004|Washout Period 2|Adverse Event|1
4723281|NCT03137992|7658186|FG005|Washout Period 2|Adverse Event|0
4723282|NCT03137992|7658181|FG000|Washout Period 2|Withdrawal by Subject|1
4723283|NCT03137992|7658182|FG001|Washout Period 2|Withdrawal by Subject|0
4723284|NCT03137992|7658183|FG002|Washout Period 2|Withdrawal by Subject|0
4723285|NCT03137992|7658184|FG003|Washout Period 2|Withdrawal by Subject|0
4723286|NCT03137992|7658185|FG004|Washout Period 2|Withdrawal by Subject|1
4723287|NCT03137992|7658186|FG005|Washout Period 2|Withdrawal by Subject|0
4723288|NCT03137992|7658181|FG000|Washout Period 2|Sponsor Decision|0
4723289|NCT03137992|7658182|FG001|Washout Period 2|Sponsor Decision|0
4723290|NCT03137992|7658183|FG002|Washout Period 2|Sponsor Decision|0
4723291|NCT03137992|7658184|FG003|Washout Period 2|Sponsor Decision|0
4723292|NCT03137992|7658185|FG004|Washout Period 2|Sponsor Decision|0
4723293|NCT03137992|7658186|FG005|Washout Period 2|Sponsor Decision|1
4723294|NCT03137992|7658181|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6
4723295|NCT03137992|7658182|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0
4723296|NCT03137992|7658183|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2
4723297|NCT03137992|7658184|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0
4630776|NCT01885104|7499608|FG000|Overall Study|Physician Decision|1
4630777|NCT01885104|7499609|FG001|Overall Study|Physician Decision|0
4630778|NCT01885182|7499626|FG000|Overall Study|Adverse Event|11
4630779|NCT01885182|7499627|FG001|Overall Study|Adverse Event|13
4630780|NCT01885182|7499626|FG000|Overall Study|Withdrawal by Subject|13
4723298|NCT03137992|7658185|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2
4723299|NCT03137992|7658186|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3
4723300|NCT03137992|7658181|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0
4723301|NCT03137992|7658182|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2
4723302|NCT03137992|7658183|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1
4723303|NCT03137992|7658184|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0
4723304|NCT03137992|7658185|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1
4723305|NCT03137992|7658186|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0
4630781|NCT01885182|7499627|FG001|Overall Study|Withdrawal by Subject|6
4723306|NCT03137992|7658181|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1
4723307|NCT03137992|7658182|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0
4723308|NCT03137992|7658183|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1
4723309|NCT03137992|7658184|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0
4723310|NCT03137992|7658185|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0
4723311|NCT03137992|7658186|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0
4723312|NCT03137992|7658181|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0
4630782|NCT01885182|7499626|FG000|Overall Study|Lost to Follow-up|2
4723313|NCT03137992|7658182|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0
4723314|NCT03137992|7658183|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0
4723315|NCT03137992|7658184|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1
4723316|NCT03137992|7658185|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0
4723317|NCT03137992|7658186|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0
4723318|NCT03137992|7658181|FG000|Part 2 (Open-label Extension)|Per study team|1
4723319|NCT03137992|7658182|FG001|Part 2 (Open-label Extension)|Per study team|0
4723320|NCT03137992|7658183|FG002|Part 2 (Open-label Extension)|Per study team|0
4723321|NCT03137992|7658184|FG003|Part 2 (Open-label Extension)|Per study team|0
4723322|NCT03137992|7658185|FG004|Part 2 (Open-label Extension)|Per study team|0
4723323|NCT03137992|7658186|FG005|Part 2 (Open-label Extension)|Per study team|0
4723324|NCT03137992|7658181|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0
4630783|NCT01885182|7499627|FG001|Overall Study|Lost to Follow-up|2
4723325|NCT03137992|7658182|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0
4723326|NCT03137992|7658183|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0
4723327|NCT03137992|7658184|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0
4723328|NCT03137992|7658185|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0
4723329|NCT03137992|7658186|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1
4736672|NCT03573505|7686013|FG000|Overall Study|Site Terminated by Sponsor|1
4736673|NCT03573505|7686014|FG001|Overall Study|Site Terminated by Sponsor|1
4736674|NCT03573505|7686013|FG000|Overall Study|Study terminated by sponsor|50
4736675|NCT03573505|7686014|FG001|Overall Study|Study terminated by sponsor|45
4736676|NCT03573505|7686013|FG000|Overall Study|Reason not specified|0
4736677|NCT03573505|7686014|FG001|Overall Study|Reason not specified|1
4736678|NCT03573505|7686013|FG000|Overall Study|Death|0
4736679|NCT03573505|7686014|FG001|Overall Study|Death|4
4736680|NCT03573804|7686021|FG000|Overall Study|claustrophobia or MRI table problems|10
4736681|NCT03573830|7686033|FG000|Overall Study|Dropped without completing treatment|0
4736682|NCT03573830|7686034|FG001|Overall Study|Dropped without completing treatment|7
4736683|NCT03573830|7686033|FG000|Overall Study|Lost to Follow-up|4
4736684|NCT03573830|7686034|FG001|Overall Study|Lost to Follow-up|0
4736685|NCT03573908|7686041|FG000|Treatment Period|Adverse Event|4
4736686|NCT03573908|7686042|FG001|Treatment Period|Adverse Event|9
4736687|NCT03573908|7686043|FG002|Treatment Period|Adverse Event|0
4736688|NCT03573908|7686044|FG003|Treatment Period|Adverse Event|0
4736689|NCT03573908|7686045|FG004|Treatment Period|Adverse Event|0
4736690|NCT03573908|7686041|FG000|Treatment Period|Protocol Violation|1
4736691|NCT03573908|7686042|FG001|Treatment Period|Protocol Violation|0
4736692|NCT03573908|7686043|FG002|Treatment Period|Protocol Violation|0
4736693|NCT03573908|7686044|FG003|Treatment Period|Protocol Violation|0
4736694|NCT03573908|7686045|FG004|Treatment Period|Protocol Violation|0
4736695|NCT03573908|7686041|FG000|Treatment Period|Withdrawal by Subject|7
4736696|NCT03573908|7686042|FG001|Treatment Period|Withdrawal by Subject|5
4736697|NCT03573908|7686043|FG002|Treatment Period|Withdrawal by Subject|0
4736698|NCT03573908|7686044|FG003|Treatment Period|Withdrawal by Subject|0
4736699|NCT03573908|7686045|FG004|Treatment Period|Withdrawal by Subject|0
4736700|NCT03573908|7686041|FG000|Treatment Period|Lost to Follow-up|7
4736701|NCT03573908|7686042|FG001|Treatment Period|Lost to Follow-up|6
4736702|NCT03573908|7686043|FG002|Treatment Period|Lost to Follow-up|0
4736703|NCT03573908|7686044|FG003|Treatment Period|Lost to Follow-up|0
4736704|NCT03573908|7686045|FG004|Treatment Period|Lost to Follow-up|0
4736705|NCT03573908|7686041|FG000|Treatment Period|Pregnancy|1
4736706|NCT03573908|7686042|FG001|Treatment Period|Pregnancy|0
4736707|NCT03573908|7686043|FG002|Treatment Period|Pregnancy|0
4736708|NCT03573908|7686044|FG003|Treatment Period|Pregnancy|0
4736709|NCT03573908|7686045|FG004|Treatment Period|Pregnancy|0
4736710|NCT03573908|7686041|FG000|Treatment Period|Other, Not Specified|4
4736711|NCT03573908|7686042|FG001|Treatment Period|Other, Not Specified|6
4771902|NCT03769194|7748999|FG003|Overall Study|other|1
4771903|NCT03738332|7749009|FG000|Overall Study|Withdrawal by Subject|1
4771904|NCT03416179|7749022|FG000|Overall Study|Death|67
4771905|NCT03416179|7749023|FG001|Overall Study|Death|60
4771906|NCT03416179|7749024|FG002|Overall Study|Death|96
4771907|NCT03416179|7749025|FG003|Overall Study|Death|88
4771908|NCT03416179|7749022|FG000|Overall Study|Withdrawal by Subject|13
4771909|NCT03416179|7749023|FG001|Overall Study|Withdrawal by Subject|19
4771910|NCT03416179|7749024|FG002|Overall Study|Withdrawal by Subject|5
4771911|NCT03416179|7749025|FG003|Overall Study|Withdrawal by Subject|6
4771912|NCT03416179|7749022|FG000|Overall Study|Ongoing|121
4446562|NCT00485134|7231666|FG002|Overall Study|Change in health status|2
4446563|NCT00485134|7231667|FG003|Overall Study|Change in health status|1
4446564|NCT00485134|7231668|FG004|Overall Study|Change in health status|0
4446565|NCT00485134|7231669|FG005|Overall Study|Change in health status|1
4771913|NCT03416179|7749023|FG001|Overall Study|Ongoing|123
4771914|NCT03416179|7749024|FG002|Overall Study|Ongoing|62
4771915|NCT03416179|7749025|FG003|Overall Study|Ongoing|66
4736712|NCT03573908|7686043|FG002|Treatment Period|Other, Not Specified|0
4736713|NCT03573908|7686044|FG003|Treatment Period|Other, Not Specified|0
4736714|NCT03573908|7686045|FG004|Treatment Period|Other, Not Specified|0
4736715|NCT03573908|7686041|FG000|Randomized Withdrawal Period|Adverse Event|0
4736716|NCT03573908|7686042|FG001|Randomized Withdrawal Period|Adverse Event|0
4736717|NCT03573908|7686043|FG002|Randomized Withdrawal Period|Adverse Event|3
4736718|NCT03573908|7686044|FG003|Randomized Withdrawal Period|Adverse Event|0
4736719|NCT03573908|7686045|FG004|Randomized Withdrawal Period|Adverse Event|0
4736720|NCT03573908|7686041|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0
4736721|NCT03573908|7686042|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0
4771916|NCT03416179|7749022|FG000|Overall Study|Lost to Follow-up|0
4771917|NCT03416179|7749023|FG001|Overall Study|Lost to Follow-up|0
4771918|NCT03416179|7749024|FG002|Overall Study|Lost to Follow-up|0
4771919|NCT03416179|7749025|FG003|Overall Study|Lost to Follow-up|2
4771920|NCT03416179|7749022|FG000|Overall Study|Other|0
4771921|NCT03416179|7749023|FG001|Overall Study|Other|1
4771922|NCT03416179|7749024|FG002|Overall Study|Other|0
4771923|NCT03416179|7749025|FG003|Overall Study|Other|0
4771924|NCT03353922|7749035|FG000|Overall Study|Withdrawal by Subject|1
4771925|NCT03353922|7749036|FG001|Overall Study|Withdrawal by Subject|0
4771926|NCT03353922|7749037|FG002|Overall Study|Withdrawal by Subject|1
4771927|NCT03353922|7749038|FG003|Overall Study|Withdrawal by Subject|1
4771928|NCT03353922|7749039|FG004|Overall Study|Withdrawal by Subject|0
4723330|NCT03138655|7658246|FG000|Overall Study|Adverse Event|2
4723331|NCT03138655|7658247|FG001|Overall Study|Adverse Event|1
4446566|NCT00485134|7231670|FG006|Overall Study|Change in health status|0
4446567|NCT00485134|7231671|FG007|Overall Study|Change in health status|0
4723332|NCT03138655|7658248|FG002|Overall Study|Adverse Event|2
4723333|NCT03138655|7658249|FG003|Overall Study|Adverse Event|1
4723334|NCT03138655|7658250|FG004|Overall Study|Adverse Event|1
4723335|NCT03138655|7658251|FG005|Overall Study|Adverse Event|4
4723336|NCT03138655|7658252|FG006|Overall Study|Adverse Event|2
4723337|NCT03138655|7658253|FG007|Overall Study|Adverse Event|2
4723338|NCT03138655|7658246|FG000|Overall Study|Withdrawal by Subject|0
4723339|NCT03138655|7658247|FG001|Overall Study|Withdrawal by Subject|1
4723340|NCT03138655|7658248|FG002|Overall Study|Withdrawal by Subject|0
4723341|NCT03138655|7658249|FG003|Overall Study|Withdrawal by Subject|0
4723342|NCT03138655|7658250|FG004|Overall Study|Withdrawal by Subject|0
4723343|NCT03138655|7658251|FG005|Overall Study|Withdrawal by Subject|0
4723344|NCT03138655|7658252|FG006|Overall Study|Withdrawal by Subject|1
4723345|NCT03138655|7658253|FG007|Overall Study|Withdrawal by Subject|0
4723346|NCT03138655|7658246|FG000|Overall Study|Reason not Specified|1
4723347|NCT03138655|7658247|FG001|Overall Study|Reason not Specified|0
4723348|NCT03138655|7658248|FG002|Overall Study|Reason not Specified|0
4723349|NCT03138655|7658249|FG003|Overall Study|Reason not Specified|2
4723350|NCT03138655|7658250|FG004|Overall Study|Reason not Specified|1
4723351|NCT03138655|7658251|FG005|Overall Study|Reason not Specified|1
4723352|NCT03138655|7658252|FG006|Overall Study|Reason not Specified|0
4723353|NCT03138655|7658253|FG007|Overall Study|Reason not Specified|0
4723354|NCT03138967|7658291|FG000|Overall Study|Death|0
4723355|NCT03138967|7658292|FG001|Overall Study|Death|1
4723356|NCT03138967|7658291|FG000|Overall Study|Physician Decision|1
4723357|NCT03138967|7658292|FG001|Overall Study|Physician Decision|3
4723358|NCT03139240|7658307|FG000|Overall Study|Lost to Follow-up|0
4723359|NCT03139240|7658308|FG001|Overall Study|Lost to Follow-up|1
4723360|NCT03139240|7658309|FG002|Overall Study|Lost to Follow-up|1
4723361|NCT03139240|7658310|FG003|Overall Study|Lost to Follow-up|0
4723362|NCT03139279|7658320|FG000|Overall Study|Physician Decision|2
4723363|NCT03139279|7658321|FG001|Overall Study|Physician Decision|0
4723364|NCT03139279|7658320|FG000|Overall Study|Protocol Violation|5
4723365|NCT03139279|7658321|FG001|Overall Study|Protocol Violation|4
4723366|NCT03139279|7658320|FG000|Overall Study|Withdrawal by Subject|0
4723367|NCT03139279|7658321|FG001|Overall Study|Withdrawal by Subject|2
4723368|NCT03139448|7658329|FG000|Overall Study|Lack of Efficacy|6
4723369|NCT03139448|7658330|FG001|Overall Study|Lack of Efficacy|7
4723370|NCT03139448|7658329|FG000|Overall Study|Location of procedure changed|2
4723371|NCT03139448|7658330|FG001|Overall Study|Location of procedure changed|8
4723372|NCT03139448|7658329|FG000|Overall Study|Withdrawal by Subject|3
4723373|NCT03139448|7658330|FG001|Overall Study|Withdrawal by Subject|6
4723374|NCT03139448|7658329|FG000|Overall Study|Screen fail|1
4723375|NCT03139448|7658330|FG001|Overall Study|Screen fail|3
4723376|NCT03139448|7658329|FG000|Overall Study|Physician Decision|0
4723377|NCT03139448|7658330|FG001|Overall Study|Physician Decision|2
4723378|NCT03139552|7658336|FG000|Overall Study|unable to attend tasting due to schedule|3
4723379|NCT03139604|7658362|FG000|Overall Study|Other|7
4723380|NCT03139604|7658363|FG001|Overall Study|Other|3
4723381|NCT03139604|7658362|FG000|Overall Study|Withdrawal by Subject|16
4723382|NCT03139604|7658363|FG001|Overall Study|Withdrawal by Subject|17
4723383|NCT03139604|7658362|FG000|Overall Study|Physician Decision|1
4723384|NCT03139604|7658363|FG001|Overall Study|Physician Decision|2
4723385|NCT03139604|7658362|FG000|Overall Study|Lost to Follow-up|3
4723386|NCT03139604|7658363|FG001|Overall Study|Lost to Follow-up|1
4723387|NCT03139604|7658362|FG000|Overall Study|Death|65
4723388|NCT03139604|7658363|FG001|Overall Study|Death|67
4723389|NCT03139604|7658362|FG000|Overall Study|Study Terminated by Sponsor|122
4723390|NCT03139604|7658363|FG001|Overall Study|Study Terminated by Sponsor|127
4723391|NCT03139604|7658362|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5
4723392|NCT03139604|7658363|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3
4723393|NCT03141086|7658397|FG000|Overall Study|Study Terminated By Sponsor|1
4723394|NCT03141086|7658398|FG001|Overall Study|Study Terminated By Sponsor|1
4723395|NCT03141086|7658397|FG000|Overall Study|Withdrawal by Subject|0
4723396|NCT03141086|7658398|FG001|Overall Study|Withdrawal by Subject|1
4723397|NCT03141086|7658397|FG000|Overall Study|Protocol Violation|0
4723398|NCT03141086|7658398|FG001|Overall Study|Protocol Violation|1
4723399|NCT03141086|7658397|FG000|Overall Study|Adverse Event|0
4723400|NCT03141086|7658398|FG001|Overall Study|Adverse Event|2
4723401|NCT03141151|7658406|FG000|Overall Study|Lost to Follow-up|3
4723402|NCT03141151|7658407|FG001|Overall Study|Lost to Follow-up|2
4723403|NCT03141151|7658406|FG000|Overall Study|Withdrawal by Subject|3
4723404|NCT03141151|7658407|FG001|Overall Study|Withdrawal by Subject|2
4723405|NCT03141307|7658442|FG000|In-Hospital|Withdrawal by Subject|0
4723406|NCT03141307|7658443|FG001|In-Hospital|Withdrawal by Subject|2
4723407|NCT03141307|7658442|FG000|In-Hospital|Protocol Violation|4
4723408|NCT03141307|7658443|FG001|In-Hospital|Protocol Violation|0
4723409|NCT03141307|7658442|FG000|Follow-Up|Lost to Follow-up|97
4723410|NCT03141307|7658443|FG001|Follow-Up|Lost to Follow-up|54
4723411|NCT03141788|7658469|FG000|Overall Study|Lost to Follow-up|1
4723412|NCT03141788|7658469|FG000|Overall Study|Protocol Violation|3
4723413|NCT03141788|7658469|FG000|Overall Study|Withdrawal by Subject|4
4723414|NCT03141905|7658478|FG000|Overall Study|Death|3
4723415|NCT03141905|7658479|FG001|Overall Study|Death|2
4723416|NCT03141905|7658478|FG000|Overall Study|Withdrawal by Subject|1
4723417|NCT03141905|7658479|FG001|Overall Study|Withdrawal by Subject|0
4723418|NCT03141905|7658478|FG000|Overall Study|Lost to Follow-up|3
4723419|NCT03141905|7658479|FG001|Overall Study|Lost to Follow-up|7
4723420|NCT03141905|7658478|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17
4723421|NCT03141905|7658479|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10
4723422|NCT03142451|7658501|FG000|Overall Study|Adverse Event|5
4723423|NCT03142451|7658502|FG001|Overall Study|Adverse Event|2
4723424|NCT03142451|7658501|FG000|Overall Study|Lost to Follow-up|25
4723425|NCT03142451|7658502|FG001|Overall Study|Lost to Follow-up|8
4723426|NCT03142451|7658501|FG000|Overall Study|Participant request|24
4723427|NCT03142451|7658502|FG001|Overall Study|Participant request|12
4723428|NCT03142451|7658501|FG000|Overall Study|Protocol Violation|3
4723429|NCT03142451|7658502|FG001|Overall Study|Protocol Violation|1
4723430|NCT03142451|7658501|FG000|Overall Study|Other|1
4723431|NCT03142451|7658502|FG001|Overall Study|Other|1
4723432|NCT03142750|7658510|FG000|Overall Study|Lost to Follow-up|4
4723433|NCT03142750|7658511|FG001|Overall Study|Lost to Follow-up|1
4723434|NCT03142932|7658523|FG000|Overall Study|Lost to Follow-up|2
4723435|NCT03142932|7658524|FG001|Overall Study|Lost to Follow-up|11
4723436|NCT03143101|7658533|FG000|Overall Study|Withdrawal by Subject|0
4723437|NCT03143101|7658534|FG001|Overall Study|Withdrawal by Subject|1
4723438|NCT03143101|7658535|FG002|Overall Study|Withdrawal by Subject|0
4723439|NCT03143101|7658533|FG000|Overall Study|Lost to Follow-up|2
4723440|NCT03143101|7658534|FG001|Overall Study|Lost to Follow-up|2
4723441|NCT03143101|7658535|FG002|Overall Study|Lost to Follow-up|0
4723442|NCT03143166|7658543|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1
4723443|NCT03143855|7658562|FG000|Overall Study|Withdrawal by Subject|4
4723444|NCT03143855|7658563|FG001|Overall Study|Withdrawal by Subject|3
4723445|NCT03143855|7658562|FG000|Overall Study|Protocol Violation|1
4723446|NCT03143855|7658563|FG001|Overall Study|Protocol Violation|0
4723447|NCT03143855|7658562|FG000|Overall Study|Participant experienced withdrawal|0
4723448|NCT03143855|7658563|FG001|Overall Study|Participant experienced withdrawal|1
4723449|NCT03144180|7658593|FG000|Overall Study|STAT Delivery|1
4723450|NCT03144180|7658594|FG001|Overall Study|STAT Delivery|1
4723451|NCT03144180|7658593|FG000|Overall Study|Provider forgot to fill out forms|1
4723452|NCT03144180|7658594|FG001|Overall Study|Provider forgot to fill out forms|3
4723453|NCT03144180|7658593|FG000|Overall Study|Provider forgot to use the Q-cup|0
4723454|NCT03144180|7658594|FG001|Overall Study|Provider forgot to use the Q-cup|1
4723455|NCT03144180|7658593|FG000|Overall Study|Scrub tech removed tube cap|0
4723456|NCT03144180|7658594|FG001|Overall Study|Scrub tech removed tube cap|1
4723457|NCT03144687|7658620|FG000|Overall Study|Adverse Event|1
4723458|NCT03144687|7658621|FG001|Overall Study|Adverse Event|0
4723459|NCT03144687|7658620|FG000|Overall Study|Progressive disease|3
4723460|NCT03144687|7658621|FG001|Overall Study|Progressive disease|0
4723461|NCT03144687|7658620|FG000|Overall Study|Death|0
4515251|NCT00952276|7326000|FG004|Overall Study|Withdrawal by Subject|0
4515252|NCT00952289|7326014|FG000|All Participants|Death|9
4515253|NCT00952289|7326015|FG001|All Participants|Death|9
4723462|NCT03144687|7658621|FG001|Overall Study|Death|2
4723463|NCT03144687|7658620|FG000|Overall Study|Lost to Follow-up|0
4723464|NCT03144687|7658621|FG001|Overall Study|Lost to Follow-up|1
4723465|NCT03144687|7658620|FG000|Overall Study|Physician Decision|5
4723466|NCT03144687|7658621|FG001|Overall Study|Physician Decision|2
4723467|NCT03144687|7658620|FG000|Overall Study|Withdrawal by Subject|1
4723468|NCT03144687|7658621|FG001|Overall Study|Withdrawal by Subject|3
4723469|NCT03144687|7658620|FG000|Overall Study|Participants With Ongoing Treatment|3
4723470|NCT03144687|7658621|FG001|Overall Study|Participants With Ongoing Treatment|2
4723471|NCT03144804|7658631|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4
4723472|NCT03145064|7658635|FG000|Overall Study|Death|24
4723473|NCT03145064|7658635|FG000|Overall Study|Lost to Follow-up|3
4723474|NCT03145064|7658635|FG000|Overall Study|Withdrawal by Subject|6
4723475|NCT03145064|7658635|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4
4723476|NCT03145064|7658635|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4
4723477|NCT03145207|7658640|FG000|Overall Study|volunteer started taking allergy shots|1
4723478|NCT03145207|7658640|FG000|Overall Study|baseline blood pressure high|1
4723479|NCT03146403|7658679|FG000|Overall Study|Withdrawal by Subject|0
4723480|NCT03146403|7658680|FG001|Overall Study|Withdrawal by Subject|3
4723481|NCT03146403|7658679|FG000|Overall Study|Lost to Follow-up|2
4723482|NCT03146403|7658680|FG001|Overall Study|Lost to Follow-up|0
4723483|NCT03146663|7658701|FG000|Overall Study|Did not receive study treatment|1
4723484|NCT03146663|7658702|FG001|Overall Study|Did not receive study treatment|1
4723485|NCT03146741|7658709|FG000|Overall Study|Txp with non-HCV+ heart|4
4723486|NCT03146741|7658709|FG000|Overall Study|Listeted for MOT|2
4723487|NCT03146741|7658709|FG000|Overall Study|Physician Decision|2
4723488|NCT03146741|7658709|FG000|Overall Study|Awaiting txp|2
4446568|NCT00485134|7231664|FG000|Overall Study|Withdrew for adverse event|0
4446569|NCT00485134|7231665|FG001|Overall Study|Withdrew for adverse event|0
4446570|NCT00485134|7231666|FG002|Overall Study|Withdrew for adverse event|1
4446571|NCT00485134|7231667|FG003|Overall Study|Withdrew for adverse event|0
4446572|NCT00485134|7231668|FG004|Overall Study|Withdrew for adverse event|0
4446573|NCT00485134|7231669|FG005|Overall Study|Withdrew for adverse event|0
4446574|NCT00485134|7231670|FG006|Overall Study|Withdrew for adverse event|0
4446575|NCT00485134|7231671|FG007|Overall Study|Withdrew for adverse event|0
4446576|NCT00485134|7231664|FG000|Overall Study|Positive drug test|0
4446577|NCT00485134|7231665|FG001|Overall Study|Positive drug test|0
4446578|NCT00485134|7231666|FG002|Overall Study|Positive drug test|0
4446579|NCT00485134|7231667|FG003|Overall Study|Positive drug test|0
4446580|NCT00485134|7231668|FG004|Overall Study|Positive drug test|2
4446581|NCT00485134|7231669|FG005|Overall Study|Positive drug test|1
4446582|NCT00485134|7231670|FG006|Overall Study|Positive drug test|0
4446583|NCT00485134|7231671|FG007|Overall Study|Positive drug test|0
4446584|NCT00485134|7231664|FG000|Overall Study|Non-compliance|0
4446585|NCT00485134|7231665|FG001|Overall Study|Non-compliance|0
4446586|NCT00485134|7231666|FG002|Overall Study|Non-compliance|0
4446587|NCT00485134|7231667|FG003|Overall Study|Non-compliance|0
4446588|NCT00485134|7231668|FG004|Overall Study|Non-compliance|1
4446589|NCT00485134|7231669|FG005|Overall Study|Non-compliance|2
4446590|NCT00485134|7231670|FG006|Overall Study|Non-compliance|2
4446591|NCT00485134|7231671|FG007|Overall Study|Non-compliance|0
4446592|NCT00485134|7231664|FG000|Overall Study|Unable to comply with study schedule|0
4446593|NCT00485134|7231665|FG001|Overall Study|Unable to comply with study schedule|0
4446594|NCT00485134|7231666|FG002|Overall Study|Unable to comply with study schedule|0
4446595|NCT00485134|7231667|FG003|Overall Study|Unable to comply with study schedule|0
4446596|NCT00485134|7231668|FG004|Overall Study|Unable to comply with study schedule|0
4446597|NCT00485134|7231669|FG005|Overall Study|Unable to comply with study schedule|0
4446598|NCT00485134|7231670|FG006|Overall Study|Unable to comply with study schedule|0
4723489|NCT03147248|7658735|FG000|Overall Study|Adverse Event|0
4723490|NCT03147248|7658736|FG001|Overall Study|Adverse Event|2
4723491|NCT03147248|7658737|FG002|Overall Study|Adverse Event|2
4723492|NCT03147248|7658738|FG003|Overall Study|Adverse Event|2
4723493|NCT03147248|7658739|FG004|Overall Study|Adverse Event|6
4723494|NCT03147248|7658740|FG005|Overall Study|Adverse Event|11
4723495|NCT03147248|7658735|FG000|Overall Study|Disease progression|1
4723496|NCT03147248|7658736|FG001|Overall Study|Disease progression|0
4723497|NCT03147248|7658737|FG002|Overall Study|Disease progression|0
4723498|NCT03147248|7658738|FG003|Overall Study|Disease progression|0
4723499|NCT03147248|7658739|FG004|Overall Study|Disease progression|0
4723500|NCT03147248|7658740|FG005|Overall Study|Disease progression|2
4723501|NCT03147248|7658735|FG000|Overall Study|Withdrawal by Subject|0
4723502|NCT03147248|7658736|FG001|Overall Study|Withdrawal by Subject|0
4723503|NCT03147248|7658737|FG002|Overall Study|Withdrawal by Subject|0
4723504|NCT03147248|7658738|FG003|Overall Study|Withdrawal by Subject|0
4723505|NCT03147248|7658739|FG004|Overall Study|Withdrawal by Subject|12
4723506|NCT03147248|7658740|FG005|Overall Study|Withdrawal by Subject|9
4723507|NCT03147248|7658735|FG000|Overall Study|Protocol Violation|0
4723508|NCT03147248|7658736|FG001|Overall Study|Protocol Violation|0
4723509|NCT03147248|7658737|FG002|Overall Study|Protocol Violation|0
4723510|NCT03147248|7658738|FG003|Overall Study|Protocol Violation|0
4723511|NCT03147248|7658739|FG004|Overall Study|Protocol Violation|2
4723512|NCT03147248|7658740|FG005|Overall Study|Protocol Violation|0
4723513|NCT03147248|7658735|FG000|Overall Study|Lost to Follow-up|0
4723514|NCT03147248|7658736|FG001|Overall Study|Lost to Follow-up|0
4723515|NCT03147248|7658737|FG002|Overall Study|Lost to Follow-up|0
4723516|NCT03147248|7658738|FG003|Overall Study|Lost to Follow-up|0
4723517|NCT03147248|7658739|FG004|Overall Study|Lost to Follow-up|2
4723518|NCT03147248|7658740|FG005|Overall Study|Lost to Follow-up|0
4723519|NCT03147248|7658735|FG000|Overall Study|Pregnancy|0
4723520|NCT03147248|7658736|FG001|Overall Study|Pregnancy|0
4723521|NCT03147248|7658737|FG002|Overall Study|Pregnancy|0
4723522|NCT03147248|7658738|FG003|Overall Study|Pregnancy|0
4723523|NCT03147248|7658739|FG004|Overall Study|Pregnancy|1
4723524|NCT03147248|7658740|FG005|Overall Study|Pregnancy|0
4723525|NCT03147248|7658735|FG000|Overall Study|Death|0
4723526|NCT03147248|7658736|FG001|Overall Study|Death|0
4723527|NCT03147248|7658737|FG002|Overall Study|Death|0
4723528|NCT03147248|7658738|FG003|Overall Study|Death|0
4723529|NCT03147248|7658739|FG004|Overall Study|Death|0
4723530|NCT03147248|7658740|FG005|Overall Study|Death|4
4723531|NCT03147248|7658735|FG000|Overall Study|Physician Decision|0
4723532|NCT03147248|7658736|FG001|Overall Study|Physician Decision|0
4723533|NCT03147248|7658737|FG002|Overall Study|Physician Decision|0
4723534|NCT03147248|7658738|FG003|Overall Study|Physician Decision|0
4723535|NCT03147248|7658739|FG004|Overall Study|Physician Decision|2
4446599|NCT00485134|7231671|FG007|Overall Study|Unable to comply with study schedule|1
4446600|NCT00485134|7231664|FG000|Overall Study|Pregnancy|0
4446601|NCT00485134|7231665|FG001|Overall Study|Pregnancy|0
4723536|NCT03147248|7658740|FG005|Overall Study|Physician Decision|4
4446602|NCT00485134|7231666|FG002|Overall Study|Pregnancy|0
4723537|NCT03147248|7658735|FG000|Overall Study|Prolonged Dosing Interval|0
4723538|NCT03147248|7658736|FG001|Overall Study|Prolonged Dosing Interval|0
4723539|NCT03147248|7658737|FG002|Overall Study|Prolonged Dosing Interval|0
4723540|NCT03147248|7658738|FG003|Overall Study|Prolonged Dosing Interval|0
4723541|NCT03147248|7658739|FG004|Overall Study|Prolonged Dosing Interval|1
4723542|NCT03147248|7658740|FG005|Overall Study|Prolonged Dosing Interval|1
4723543|NCT03147495|7658756|FG000|Overall Study|Physician Decision|0
4723544|NCT03147495|7658757|FG001|Overall Study|Physician Decision|6
4723545|NCT03148067|7658780|FG000|Overall Study|Lost to Follow-up|3
4723546|NCT03148067|7658780|FG000|Overall Study|Death|1
4723547|NCT03148691|7658823|FG000|Overall Study|Protocol Violation|1
4723548|NCT03148691|7658824|FG001|Overall Study|Protocol Violation|2
4723549|NCT03148691|7658825|FG002|Overall Study|Protocol Violation|7
4723550|NCT03148691|7658823|FG000|Overall Study|Lost to Follow-up|0
4723551|NCT03148691|7658824|FG001|Overall Study|Lost to Follow-up|0
4723552|NCT03148691|7658825|FG002|Overall Study|Lost to Follow-up|1
4723553|NCT03148691|7658823|FG000|Overall Study|Other|1
4723554|NCT03148691|7658824|FG001|Overall Study|Other|0
4723555|NCT03148691|7658825|FG002|Overall Study|Other|0
4723556|NCT03148691|7658823|FG000|Overall Study|Withdrawal by Subject|1
4723557|NCT03148691|7658824|FG001|Overall Study|Withdrawal by Subject|0
4723558|NCT03148691|7658825|FG002|Overall Study|Withdrawal by Subject|0
4723559|NCT03149042|7658833|FG000|Overall Study|Invasive FFR not performed|21
4723560|NCT03149042|7658833|FG000|Overall Study|Poor CT Image Quality|1
4723561|NCT03149042|7658833|FG000|Overall Study|Invasive FFR Measurement cancelled|1
4723562|NCT03149055|7658838|FG000|Overall Study|Not treated|4
4723563|NCT03149328|7658857|FG000|Overall Study|Withdrawal by Subject|30
4723564|NCT03149328|7658858|FG001|Overall Study|Withdrawal by Subject|26
4723565|NCT03149328|7658857|FG000|Overall Study|Changed Dialysis Modality|18
4723566|NCT03149328|7658858|FG001|Overall Study|Changed Dialysis Modality|1
4723567|NCT03149328|7658857|FG000|Overall Study|Transplant|9
4723568|NCT03149328|7658858|FG001|Overall Study|Transplant|1
4723569|NCT03149328|7658857|FG000|Overall Study|Lost to Follow-up|25
4723570|NCT03149328|7658858|FG001|Overall Study|Lost to Follow-up|16
4723571|NCT03149328|7658857|FG000|Overall Study|Left Study Site|1
4723572|NCT03149328|7658858|FG001|Overall Study|Left Study Site|2
4723573|NCT03149328|7658857|FG000|Overall Study|Language Barrier|1
4723574|NCT03149328|7658858|FG001|Overall Study|Language Barrier|0
4723575|NCT03149848|7658864|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1
4723576|NCT03149848|7658864|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2
4723577|NCT03150056|7658900|FG000|Overall Study|Withdrawal by Subject|0
4723578|NCT03150056|7658901|FG001|Overall Study|Withdrawal by Subject|0
4723579|NCT03150056|7658902|FG002|Overall Study|Withdrawal by Subject|0
4723580|NCT03150056|7658903|FG003|Overall Study|Withdrawal by Subject|0
4723581|NCT03150056|7658904|FG004|Overall Study|Withdrawal by Subject|0
4723582|NCT03150056|7658905|FG005|Overall Study|Withdrawal by Subject|2
4723583|NCT03150056|7658900|FG000|Overall Study|Study terminated by Sponsor|1
4723584|NCT03150056|7658901|FG001|Overall Study|Study terminated by Sponsor|3
4723585|NCT03150056|7658902|FG002|Overall Study|Study terminated by Sponsor|1
4723586|NCT03150056|7658903|FG003|Overall Study|Study terminated by Sponsor|1
4723587|NCT03150056|7658904|FG004|Overall Study|Study terminated by Sponsor|5
4723588|NCT03150056|7658905|FG005|Overall Study|Study terminated by Sponsor|6
4723589|NCT03150056|7658900|FG000|Overall Study|Death|9
4723590|NCT03150056|7658901|FG001|Overall Study|Death|2
4723591|NCT03150056|7658902|FG002|Overall Study|Death|2
4723592|NCT03150056|7658903|FG003|Overall Study|Death|7
4723593|NCT03150056|7658904|FG004|Overall Study|Death|8
4723594|NCT03150056|7658905|FG005|Overall Study|Death|10
4723595|NCT03150056|7658900|FG000|Overall Study|Ongoing in the study|0
4723596|NCT03150056|7658901|FG001|Overall Study|Ongoing in the study|0
4723597|NCT03150056|7658902|FG002|Overall Study|Ongoing in the study|1
4723598|NCT03150056|7658903|FG003|Overall Study|Ongoing in the study|1
4723599|NCT03150056|7658904|FG004|Overall Study|Ongoing in the study|3
4723600|NCT03150056|7658905|FG005|Overall Study|Ongoing in the study|0
4723601|NCT03150082|7658922|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1
4723602|NCT03150082|7658923|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0
4723603|NCT03150485|7658959|FG000|Overall Study|Unsatisfactory Lens Fitting|0
4723604|NCT03150485|7658960|FG001|Overall Study|Unsatisfactory Lens Fitting|1
4723605|NCT03150485|7658961|FG002|Overall Study|Unsatisfactory Lens Fitting|0
4723606|NCT03150485|7658962|FG003|Overall Study|Unsatisfactory Lens Fitting|0
4723607|NCT03150485|7658963|FG004|Overall Study|Unsatisfactory Lens Fitting|0
4723608|NCT03150485|7658964|FG005|Overall Study|Unsatisfactory Lens Fitting|0
4723609|NCT03150589|7658971|FG000|Overall Study|Withdrawal by Subject|16
4723610|NCT03150589|7658972|FG001|Overall Study|Withdrawal by Subject|9
4723611|NCT03150589|7658971|FG000|Overall Study|Adverse Event|7
4723612|NCT03150589|7658972|FG001|Overall Study|Adverse Event|6
4723613|NCT03150589|7658971|FG000|Overall Study|Protocol Violation|4
4723614|NCT03150589|7658972|FG001|Overall Study|Protocol Violation|3
4723615|NCT03150589|7658971|FG000|Overall Study|Lost to Follow-up|3
4723616|NCT03150589|7658972|FG001|Overall Study|Lost to Follow-up|3
4723617|NCT03150589|7658971|FG000|Overall Study|Death|2
4723618|NCT03150589|7658972|FG001|Overall Study|Death|3
4723619|NCT03150589|7658971|FG000|Overall Study|IP non-compliance and other reasons|12
4723620|NCT03150589|7658972|FG001|Overall Study|IP non-compliance and other reasons|3
4723621|NCT03150719|7658980|FG000|Overall Study|Adverse Event|0
4723622|NCT03150719|7658981|FG001|Overall Study|Adverse Event|1
4723623|NCT03150719|7658980|FG000|Overall Study|Death|0
4723624|NCT03150719|7658981|FG001|Overall Study|Death|1
4723625|NCT03150719|7658980|FG000|Overall Study|Other|1
4723626|NCT03150719|7658981|FG001|Overall Study|Other|0
4723627|NCT03151148|7659002|FG000|Overall Study|Lost to Follow-up|1
4723628|NCT03151148|7659003|FG001|Overall Study|Lost to Follow-up|0
4723629|NCT03151148|7659002|FG000|Overall Study|Withdrawal by Subject|1
4723630|NCT03151148|7659003|FG001|Overall Study|Withdrawal by Subject|0
4723631|NCT03151395|7659019|FG000|Overall Study|Adverse Event|2
4723632|NCT03151395|7659019|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6
4723633|NCT03151395|7659019|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3
4723634|NCT03151395|7659019|FG000|Overall Study|Unspecified reason|4
4723635|NCT03151551|7659041|FG000|Open-Label Treatment Period|Adverse Event|0
4723636|NCT03151551|7659042|FG001|Open-Label Treatment Period|Adverse Event|2
4723637|NCT03151551|7659041|FG000|Open-Label Treatment Period|Lost to Follow-up|1
4723638|NCT03151551|7659042|FG001|Open-Label Treatment Period|Lost to Follow-up|1
4723639|NCT03151551|7659041|FG000|Open-Label Treatment Period|Withdrawal by Subject|12
4723640|NCT03151551|7659042|FG001|Open-Label Treatment Period|Withdrawal by Subject|18
4723641|NCT03151551|7659041|FG000|Open-Label Treatment Period|Lack of Efficacy|1
4723642|NCT03151551|7659042|FG001|Open-Label Treatment Period|Lack of Efficacy|1
4723643|NCT03151551|7659041|FG000|Open-Label Treatment Period|Physician Decision|3
4723644|NCT03151551|7659042|FG001|Open-Label Treatment Period|Physician Decision|0
4723645|NCT03151551|7659041|FG000|Open-Label Treatment Period|Protocol Deviation|1
4723646|NCT03151551|7659042|FG001|Open-Label Treatment Period|Protocol Deviation|2
4723647|NCT03151551|7659041|FG000|Post-Treatment Follow-Up Period|Adverse Event|1
4723648|NCT03151551|7659042|FG001|Post-Treatment Follow-Up Period|Adverse Event|3
4723649|NCT03151551|7659041|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4
4723650|NCT03151551|7659042|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2
4723651|NCT03151551|7659041|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20
4723652|NCT03151551|7659042|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22
4723653|NCT03151551|7659041|FG000|Post-Treatment Follow-Up Period|Physician Decision|0
4723654|NCT03151551|7659042|FG001|Post-Treatment Follow-Up Period|Physician Decision|1
4723655|NCT03152019|7659052|FG000|Overall Study|Adverse Event|0
4723656|NCT03152019|7659053|FG001|Overall Study|Adverse Event|1
4723657|NCT03152110|7659068|FG000|Overall Study|Withdrawal by Subject|3
4723658|NCT03152552|7659090|FG000|Treatment Period 1 (12 Weeks)|Death|0
4723659|NCT03152552|7659091|FG001|Treatment Period 1 (12 Weeks)|Death|1
4723660|NCT03152552|7659092|FG002|Treatment Period 1 (12 Weeks)|Death|0
4723661|NCT03152552|7659093|FG003|Treatment Period 1 (12 Weeks)|Death|0
4723662|NCT03152552|7659094|FG004|Treatment Period 1 (12 Weeks)|Death|1
4723663|NCT03152552|7659090|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0
4723664|NCT03152552|7659091|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1
4723665|NCT03152552|7659092|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0
4723666|NCT03152552|7659093|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0
4723667|NCT03152552|7659094|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0
4723668|NCT03152552|7659090|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8
4723669|NCT03152552|7659091|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9
4723670|NCT03152552|7659092|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19
4723671|NCT03152552|7659093|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19
4723672|NCT03152552|7659094|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20
4723673|NCT03152552|7659090|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
4723674|NCT03152552|7659091|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
4723675|NCT03152552|7659092|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
4723676|NCT03152552|7659093|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
4723677|NCT03152552|7659094|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
4723678|NCT03152552|7659090|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0
4723679|NCT03152552|7659091|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0
4723680|NCT03152552|7659092|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1
4723681|NCT03152552|7659093|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0
4723682|NCT03152552|7659094|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0
4723683|NCT03152552|7659090|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0
4723684|NCT03152552|7659091|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0
4723685|NCT03152552|7659092|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0
4723686|NCT03152552|7659093|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1
4723687|NCT03152552|7659094|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0
4723688|NCT03152552|7659090|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6
4630784|NCT01885182|7499626|FG000|Overall Study|Lack of Efficacy|8
4630785|NCT01885182|7499627|FG001|Overall Study|Lack of Efficacy|1
4723689|NCT03152552|7659091|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5
4723690|NCT03152552|7659092|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9
4723691|NCT03152552|7659093|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9
4723692|NCT03152552|7659094|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11
4630786|NCT01885195|7499635|FG000|Overall Study|Adverse Event|29
4723693|NCT03154047|7659125|FG000|Overall Study|Death|1
4723694|NCT03154047|7659125|FG000|Overall Study|Study terminated by sponsor|76
4723695|NCT03154047|7659125|FG000|Overall Study|Withdrawal by Subject|3
4723696|NCT03154086|7659144|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
4723697|NCT03154086|7659145|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
4723698|NCT03154086|7659146|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
4723699|NCT03154086|7659147|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1
4723700|NCT03154086|7659148|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
4723701|NCT03154086|7659149|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
4723702|NCT03154086|7659150|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
4723703|NCT03154086|7659151|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
4723704|NCT03154086|7659152|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
4723705|NCT03154086|7659153|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
4723706|NCT03154086|7659154|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
4723707|NCT03154086|7659155|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
4723708|NCT03154086|7659156|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
4723709|NCT03154086|7659157|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
4723710|NCT03154086|7659158|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
4723711|NCT03154086|7659144|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
4723712|NCT03154086|7659145|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1
4723713|NCT03154086|7659146|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
4723714|NCT03154086|7659147|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
4723715|NCT03154086|7659148|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
4723716|NCT03154086|7659149|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
4723717|NCT03154086|7659150|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
4723718|NCT03154086|7659151|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
4723719|NCT03154086|7659152|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
4723720|NCT03154086|7659153|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
4723721|NCT03154086|7659154|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
4723722|NCT03154086|7659155|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
4723723|NCT03154086|7659156|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
4723724|NCT03154086|7659157|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
4723725|NCT03154086|7659158|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
4723726|NCT03154086|7659144|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
4723727|NCT03154086|7659145|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
4723728|NCT03154086|7659146|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1
4723729|NCT03154086|7659147|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
4723730|NCT03154086|7659148|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
4723731|NCT03154086|7659149|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
4723732|NCT03154086|7659150|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
4723733|NCT03154086|7659151|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
4723734|NCT03154086|7659152|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
4723735|NCT03154086|7659153|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
4723736|NCT03154086|7659154|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
4723737|NCT03154086|7659155|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
4723738|NCT03154086|7659156|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
4723739|NCT03154086|7659157|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
4723740|NCT03154086|7659158|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
4723741|NCT03154086|7659144|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1
4723742|NCT03154086|7659145|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
4723743|NCT03154086|7659146|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
4723744|NCT03154086|7659147|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
4723745|NCT03154086|7659148|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
4723746|NCT03154086|7659149|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
4723747|NCT03154086|7659150|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
4723748|NCT03154086|7659151|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
4723749|NCT03154086|7659152|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
4723750|NCT03154086|7659153|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
4723751|NCT03154086|7659154|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
4723752|NCT03154086|7659155|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
4723753|NCT03154086|7659156|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
4723754|NCT03154086|7659157|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
4723755|NCT03154086|7659158|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
4723756|NCT03154086|7659144|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
4723757|NCT03154086|7659145|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
4630787|NCT01885195|7499635|FG000|Overall Study|Death|1
4630788|NCT01885195|7499635|FG000|Overall Study|Disease Progression|67
4630789|NCT01885195|7499635|FG000|Overall Study|Protocol Deviation|2
4630790|NCT01885195|7499635|FG000|Overall Study|Physician Decision|3
4630791|NCT01885195|7499635|FG000|Overall Study|Patient/guardian decision|8
4630792|NCT01885208|7499641|FG000|Overall Study|Unclassified|32
4723758|NCT03154086|7659146|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
4771929|NCT03353922|7749040|FG005|Overall Study|Withdrawal by Subject|0
4630793|NCT01885208|7499642|FG001|Overall Study|Unclassified|38
4723759|NCT03154086|7659147|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
4723760|NCT03154086|7659148|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
4723761|NCT03154086|7659149|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
4723762|NCT03154086|7659150|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
4723763|NCT03154086|7659151|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
4723764|NCT03154086|7659152|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1
4723765|NCT03154086|7659153|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
4723766|NCT03154086|7659154|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
4723767|NCT03154086|7659155|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
4723768|NCT03154086|7659156|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
4723769|NCT03154086|7659157|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
4723770|NCT03154086|7659158|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
4723771|NCT03154086|7659144|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
4723772|NCT03154086|7659145|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
4723773|NCT03154086|7659146|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
4723774|NCT03154086|7659147|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
4723775|NCT03154086|7659148|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
4723776|NCT03154086|7659149|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
4723777|NCT03154086|7659150|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
4723778|NCT03154086|7659151|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1
4723779|NCT03154086|7659152|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
4723780|NCT03154086|7659153|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
4723781|NCT03154086|7659154|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
4723782|NCT03154086|7659155|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
4723783|NCT03154086|7659156|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
4723784|NCT03154086|7659157|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
4723785|NCT03154086|7659158|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
4723786|NCT03154086|7659144|FG000|Part B (Up to 25 Days)|Adverse Event|0
4723787|NCT03154086|7659145|FG001|Part B (Up to 25 Days)|Adverse Event|0
4723788|NCT03154086|7659146|FG002|Part B (Up to 25 Days)|Adverse Event|0
4723789|NCT03154086|7659147|FG003|Part B (Up to 25 Days)|Adverse Event|0
4723790|NCT03154086|7659148|FG004|Part B (Up to 25 Days)|Adverse Event|0
4723791|NCT03154086|7659149|FG005|Part B (Up to 25 Days)|Adverse Event|0
4723792|NCT03154086|7659150|FG006|Part B (Up to 25 Days)|Adverse Event|0
4723793|NCT03154086|7659151|FG007|Part B (Up to 25 Days)|Adverse Event|0
4723794|NCT03154086|7659152|FG008|Part B (Up to 25 Days)|Adverse Event|0
4723795|NCT03154086|7659153|FG009|Part B (Up to 25 Days)|Adverse Event|0
4723796|NCT03154086|7659154|FG010|Part B (Up to 25 Days)|Adverse Event|1
4723797|NCT03154086|7659155|FG011|Part B (Up to 25 Days)|Adverse Event|0
4723798|NCT03154086|7659156|FG012|Part B (Up to 25 Days)|Adverse Event|0
4723799|NCT03154086|7659157|FG013|Part B (Up to 25 Days)|Adverse Event|0
4723800|NCT03154086|7659158|FG014|Part B (Up to 25 Days)|Adverse Event|0
4723801|NCT03154476|7659226|FG000|Overall Study|Lost to Follow-up|4
4723802|NCT03154476|7659227|FG001|Overall Study|Lost to Follow-up|4
4723803|NCT03155178|7659255|FG000|Overall Study|Did not meet treatment day baseline|7
4723804|NCT03155178|7659256|FG001|Overall Study|Did not meet treatment day baseline|7
4723805|NCT03155178|7659257|FG002|Overall Study|Did not meet treatment day baseline|7
4723806|NCT03155178|7659258|FG003|Overall Study|Did not meet treatment day baseline|7
4723807|NCT03155269|7659274|FG000|Overall Study|Withdrawal by Subject|4
4723808|NCT03155269|7659275|FG001|Overall Study|Withdrawal by Subject|5
4723809|NCT03155269|7659274|FG000|Overall Study|Lost to Follow-up|1
4723810|NCT03155269|7659275|FG001|Overall Study|Lost to Follow-up|2
4723811|NCT03155724|7659281|FG000|Overall Study|Death|3
4723812|NCT03155724|7659281|FG000|Overall Study|Physician Decision|1
4723813|NCT03155724|7659281|FG000|Overall Study|Study closure|7
4723814|NCT03155945|7659287|FG000|Overall Study|Lost to Follow-up|0
4723815|NCT03155945|7659288|FG001|Overall Study|Lost to Follow-up|1
4723816|NCT03155945|7659287|FG000|Overall Study|Withdrawal by Subject|0
4723817|NCT03155945|7659288|FG001|Overall Study|Withdrawal by Subject|1
4723818|NCT03155945|7659287|FG000|Overall Study|Other Reason|0
4723819|NCT03155945|7659288|FG001|Overall Study|Other Reason|1
4723820|NCT03156270|7659294|FG000|Overall Study|Failed pre-treatment screening|1
4723821|NCT03156270|7659294|FG000|Overall Study|Lost to Follow-up|1
4723822|NCT03156543|7659302|FG000|Overall Study|Withdrawal by Subject|1
4723823|NCT03156543|7659303|FG001|Overall Study|Withdrawal by Subject|0
4723824|NCT03156621|7659311|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0
4723825|NCT03156621|7659312|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2
4723826|NCT03156621|7659311|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0
4723827|NCT03156621|7659312|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1
4736722|NCT03573908|7686043|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0
4736723|NCT03573908|7686044|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0
4736724|NCT03573908|7686045|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2
4736725|NCT03573908|7686041|FG000|Randomized Withdrawal Period|Lost to Follow-up|0
4736726|NCT03573908|7686042|FG001|Randomized Withdrawal Period|Lost to Follow-up|0
4736727|NCT03573908|7686043|FG002|Randomized Withdrawal Period|Lost to Follow-up|1
4723828|NCT03157089|7659323|FG000|Overall Study|Treated only with pembrolizumab|1
4723829|NCT03157089|7659324|FG001|Overall Study|Treated only with pembrolizumab|0
4723830|NCT03157089|7659323|FG000|Overall Study|Adverse Event|5
4723831|NCT03157089|7659324|FG001|Overall Study|Adverse Event|4
4723832|NCT03157089|7659323|FG000|Overall Study|Progressive disease|6
4723833|NCT03157089|7659324|FG001|Overall Study|Progressive disease|8
4723834|NCT03157531|7659335|FG000|Overall Study|Death|2
4723835|NCT03157531|7659335|FG000|Overall Study|Lost to Follow-up|4
4723836|NCT03157583|7659339|FG000|Overall Study|Other (did not meet study criteria)|1
4723837|NCT03158012|7659359|FG000|Overall Study|Withdrawal by Subject|0
4723838|NCT03158012|7659360|FG001|Overall Study|Withdrawal by Subject|1
4723839|NCT03158220|7659381|FG000|Overall Study|Screen Failure|0
4723840|NCT03158220|7659382|FG001|Overall Study|Screen Failure|1
4723841|NCT03158220|7659381|FG000|Overall Study|Withdrawal by Subject|8
4723842|NCT03158220|7659382|FG001|Overall Study|Withdrawal by Subject|9
4723843|NCT03158220|7659381|FG000|Overall Study|Status unknown|0
4723844|NCT03158220|7659382|FG001|Overall Study|Status unknown|1
4723845|NCT03158220|7659381|FG000|Overall Study|Lost to Follow-up|8
4723846|NCT03158220|7659382|FG001|Overall Study|Lost to Follow-up|5
4723847|NCT03158220|7659381|FG000|Overall Study|Physician Decision|1
4723848|NCT03158220|7659382|FG001|Overall Study|Physician Decision|0
4723849|NCT03158272|7659392|FG000|Overall Study|Disease progression|3
4723850|NCT03158272|7659393|FG001|Overall Study|Disease progression|3
4723851|NCT03158272|7659394|FG002|Overall Study|Disease progression|4
4723852|NCT03158272|7659395|FG003|Overall Study|Disease progression|6
4723853|NCT03158272|7659392|FG000|Overall Study|Death|0
4723854|NCT03158272|7659393|FG001|Overall Study|Death|0
4723855|NCT03158272|7659394|FG002|Overall Study|Death|1
4723856|NCT03158272|7659395|FG003|Overall Study|Death|0
4723857|NCT03158272|7659392|FG000|Overall Study|Other reasons|0
4723858|NCT03158272|7659393|FG001|Overall Study|Other reasons|0
4723859|NCT03158272|7659394|FG002|Overall Study|Other reasons|1
4723860|NCT03158272|7659395|FG003|Overall Study|Other reasons|0
4723861|NCT03158272|7659392|FG000|Overall Study|Adverse event unrelated to the drug|0
4723862|NCT03158272|7659393|FG001|Overall Study|Adverse event unrelated to the drug|1
4723863|NCT03158272|7659394|FG002|Overall Study|Adverse event unrelated to the drug|0
4723864|NCT03158272|7659395|FG003|Overall Study|Adverse event unrelated to the drug|0
4723865|NCT03158311|7659410|FG000|Overall Study|Subject/Guardian Decision|10
4723866|NCT03158311|7659411|FG001|Overall Study|Subject/Guardian Decision|6
4723867|NCT03158311|7659412|FG002|Overall Study|Subject/Guardian Decision|11
4515254|NCT00952289|7326014|FG000|All Participants|Adverse Event|8
4515255|NCT00952289|7326015|FG001|All Participants|Adverse Event|8
4515256|NCT00952289|7326014|FG000|All Participants|Disease progression|3
4515257|NCT00952289|7326015|FG001|All Participants|Disease progression|12
4515258|NCT00952289|7326014|FG000|All Participants|Withdrawal by Subject|1
4515259|NCT00952289|7326015|FG001|All Participants|Withdrawal by Subject|10
4515260|NCT00952289|7326014|FG000|All Participants|Data lost during site relocation|0
4515261|NCT00952289|7326015|FG001|All Participants|Data lost during site relocation|1
4515262|NCT00952289|7326014|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0
4723868|NCT03158311|7659410|FG000|Overall Study|Adverse Event|5
4723869|NCT03158311|7659411|FG001|Overall Study|Adverse Event|3
4723870|NCT03158311|7659412|FG002|Overall Study|Adverse Event|3
4723871|NCT03158311|7659410|FG000|Overall Study|Techinical Problems|3
4723872|NCT03158311|7659411|FG001|Overall Study|Techinical Problems|1
4723873|NCT03158311|7659412|FG002|Overall Study|Techinical Problems|5
4723874|NCT03158311|7659410|FG000|Overall Study|Physician Decision|2
4723875|NCT03158311|7659411|FG001|Overall Study|Physician Decision|3
4723876|NCT03158311|7659412|FG002|Overall Study|Physician Decision|7
4723877|NCT03158311|7659410|FG000|Overall Study|Lost to Follow-up|1
4723878|NCT03158311|7659411|FG001|Overall Study|Lost to Follow-up|1
4723879|NCT03158311|7659412|FG002|Overall Study|Lost to Follow-up|1
4723880|NCT03158311|7659410|FG000|Overall Study|Sponsor decision|1
4723881|NCT03158311|7659411|FG001|Overall Study|Sponsor decision|0
4723882|NCT03158311|7659412|FG002|Overall Study|Sponsor decision|0
4723883|NCT03158311|7659410|FG000|Overall Study|Pregnancy|0
4723884|NCT03158311|7659411|FG001|Overall Study|Pregnancy|2
4723885|NCT03158311|7659412|FG002|Overall Study|Pregnancy|0
4723886|NCT03158311|7659410|FG000|Overall Study|Randomized in error|0
4723887|NCT03158311|7659411|FG001|Overall Study|Randomized in error|0
4723888|NCT03158311|7659412|FG002|Overall Study|Randomized in error|1
4723889|NCT03159091|7659435|FG000|Overall Study|Incorrect inclusion ineligible patient|5
4723890|NCT03159091|7659436|FG001|Overall Study|Incorrect inclusion ineligible patient|3
4723891|NCT03159091|7659435|FG000|Overall Study|Patient has taken no dose of study drug|0
4723892|NCT03159091|7659436|FG001|Overall Study|Patient has taken no dose of study drug|1
4723893|NCT03159455|7659479|FG000|Overall Study|Adverse Event|0
4723894|NCT03159455|7659480|FG001|Overall Study|Adverse Event|0
4723895|NCT03159455|7659481|FG002|Overall Study|Adverse Event|0
4723896|NCT03159455|7659482|FG003|Overall Study|Adverse Event|0
4723897|NCT03159455|7659483|FG004|Overall Study|Adverse Event|0
4723898|NCT03159455|7659484|FG005|Overall Study|Adverse Event|1
4723899|NCT03159468|7659508|FG000|Overall Study|Withdrawal by Subject|0
4723900|NCT03159468|7659509|FG001|Overall Study|Withdrawal by Subject|0
4723901|NCT03159468|7659510|FG002|Overall Study|Withdrawal by Subject|3
4723902|NCT03159468|7659511|FG003|Overall Study|Withdrawal by Subject|0
4723903|NCT03159468|7659512|FG004|Overall Study|Withdrawal by Subject|0
4723904|NCT03159468|7659513|FG005|Overall Study|Withdrawal by Subject|0
4723905|NCT03159611|7659529|FG000|Overall Study|Did Not Meet Inclusion Criteria|9
4723906|NCT03159611|7659530|FG001|Overall Study|Did Not Meet Inclusion Criteria|5
4723907|NCT03159611|7659529|FG000|Overall Study|Did Not Meet Exclusion Criteria|1
4630794|NCT01885559|7499650|FG000|Overall Study|Lost to Follow-up|15
4630795|NCT01885559|7499651|FG001|Overall Study|Lost to Follow-up|16
4630796|NCT01885559|7499650|FG000|Overall Study|Less than full participation|9
4630797|NCT01885559|7499651|FG001|Overall Study|Less than full participation|19
4630798|NCT01885559|7499650|FG000|Overall Study|Protocol Violation|0
4630799|NCT01885559|7499651|FG001|Overall Study|Protocol Violation|1
4630800|NCT01885936|7499694|FG000|Overall Study|Withdrawal by Subject|1
4630801|NCT01885936|7499695|FG001|Overall Study|Withdrawal by Subject|0
4630802|NCT01886105|7499701|FG000|Overall Study|Lack of Efficacy|3
4630803|NCT01886287|7499710|FG000|Overall Study|Radiographic disease progression|1
4630804|NCT01886287|7499710|FG000|Overall Study|Clinical progression due to disease|1
4630805|NCT01886300|7499714|FG000|Overall Study|Trial terminated by sponsor|16
4633342|NCT01911260|7503457|FG000|Follow-up Period|transference or evasion of school|13
4633343|NCT01911260|7503458|FG001|Follow-up Period|transference or evasion of school|20
4633344|NCT01911260|7503459|FG002|Follow-up Period|transference or evasion of school|15
4633345|NCT01911260|7503460|FG003|Follow-up Period|transference or evasion of school|12
4633346|NCT01911273|7503472|FG000|Overall Study|Progression of Disease|1
4633347|NCT01911273|7503473|FG001|Overall Study|Progression of Disease|0
4633348|NCT01911273|7503472|FG000|Overall Study|Withdrawal by Subject|0
4633349|NCT01911273|7503473|FG001|Overall Study|Withdrawal by Subject|2
4633350|NCT01911429|7503517|FG000|Overall Study|Adverse Event|5
4633351|NCT01911429|7503518|FG001|Overall Study|Adverse Event|3
4633352|NCT01911429|7503519|FG002|Overall Study|Adverse Event|9
4633353|NCT01911429|7503517|FG000|Overall Study|Lack of Efficacy|1
4633354|NCT01911429|7503518|FG001|Overall Study|Lack of Efficacy|2
4633355|NCT01911429|7503519|FG002|Overall Study|Lack of Efficacy|4
4633356|NCT01911429|7503517|FG000|Overall Study|Lost to Follow-up|0
4633357|NCT01911429|7503518|FG001|Overall Study|Lost to Follow-up|0
4633358|NCT01911429|7503519|FG002|Overall Study|Lost to Follow-up|1
4633359|NCT01911429|7503517|FG000|Overall Study|Protocol Violation|0
4633360|NCT01911429|7503518|FG001|Overall Study|Protocol Violation|0
4633361|NCT01911429|7503519|FG002|Overall Study|Protocol Violation|1
4633362|NCT01911429|7503517|FG000|Overall Study|Withdrawal by Subject|5
4633363|NCT01911429|7503518|FG001|Overall Study|Withdrawal by Subject|5
4633364|NCT01911429|7503519|FG002|Overall Study|Withdrawal by Subject|4
4633365|NCT01911429|7503517|FG000|Overall Study|Accidental randomization|0
4633366|NCT01911429|7503518|FG001|Overall Study|Accidental randomization|0
4633367|NCT01911429|7503519|FG002|Overall Study|Accidental randomization|1
4633368|NCT01911429|7503517|FG000|Overall Study|subject left study|1
4633369|NCT01911429|7503518|FG001|Overall Study|subject left study|0
4633370|NCT01911429|7503519|FG002|Overall Study|subject left study|0
4633371|NCT01911442|7503530|FG000|Overall Study|Adverse Event|2
4633372|NCT01911442|7503531|FG001|Overall Study|Adverse Event|2
4633373|NCT01911442|7503532|FG002|Overall Study|Adverse Event|4
4633374|NCT01911442|7503530|FG000|Overall Study|Lack of Efficacy|1
4633375|NCT01911442|7503531|FG001|Overall Study|Lack of Efficacy|1
4723908|NCT03159611|7659530|FG001|Overall Study|Did Not Meet Exclusion Criteria|3
4723909|NCT03159611|7659529|FG000|Overall Study|Protocol Violation|7
4723910|NCT03159611|7659530|FG001|Overall Study|Protocol Violation|4
4723911|NCT03159611|7659529|FG000|Overall Study|Adverse Event|1
4723912|NCT03159611|7659530|FG001|Overall Study|Adverse Event|0
4723913|NCT03159611|7659529|FG000|Overall Study|Withdrawal by Subject|1
4723914|NCT03159611|7659530|FG001|Overall Study|Withdrawal by Subject|1
4723915|NCT03159611|7659529|FG000|Overall Study|Non-compliance with protocol requirement|3
4723916|NCT03159611|7659530|FG001|Overall Study|Non-compliance with protocol requirement|2
4723917|NCT03159611|7659529|FG000|Overall Study|Inability to perform procedures|1
4723918|NCT03159611|7659530|FG001|Overall Study|Inability to perform procedures|0
4723919|NCT03160560|7659580|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2
4723920|NCT03160560|7659581|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1
4723921|NCT03160560|7659582|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1
4723922|NCT03160560|7659583|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0
4723923|NCT03160560|7659580|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1
4723924|NCT03160560|7659581|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0
4723925|NCT03160560|7659582|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0
4723926|NCT03160560|7659583|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0
4723927|NCT03160573|7659597|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1
4723928|NCT03160573|7659598|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3
4723929|NCT03160573|7659599|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2
4723930|NCT03160573|7659600|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2
4633376|NCT01911442|7503532|FG002|Overall Study|Lack of Efficacy|1
4633377|NCT01911442|7503530|FG000|Overall Study|Lost to Follow-up|2
4633378|NCT01911442|7503531|FG001|Overall Study|Lost to Follow-up|0
4633379|NCT01911442|7503532|FG002|Overall Study|Lost to Follow-up|1
4723931|NCT03160703|7659614|FG000|Overall Study|Withdrawal by Subject|0
4723932|NCT03160703|7659615|FG001|Overall Study|Withdrawal by Subject|0
4723933|NCT03160703|7659616|FG002|Overall Study|Withdrawal by Subject|0
4630806|NCT01886313|7499720|FG000|Overall Study|Adverse Event|1
4630807|NCT01886313|7499721|FG001|Overall Study|Adverse Event|1
4630808|NCT01886378|7499727|FG000|Overall Study|Adverse Event|1
4630809|NCT01886378|7499727|FG000|Overall Study|Withdrawal by Subject|4
4630810|NCT01886690|7499733|FG000|Overall Study|Protocol Violation|0
4630811|NCT01886690|7499734|FG001|Overall Study|Protocol Violation|1
4630812|NCT01886690|7499733|FG000|Overall Study|Personal Reasons|0
4630813|NCT01886690|7499734|FG001|Overall Study|Personal Reasons|1
4630814|NCT01886716|7499744|FG000|Week 1|Lost to Follow-up|0
4630815|NCT01886716|7499745|FG001|Week 1|Lost to Follow-up|0
4630816|NCT01886716|7499746|FG002|Week 1|Lost to Follow-up|2
4630817|NCT01886716|7499747|FG003|Week 1|Lost to Follow-up|2
4630818|NCT01886716|7499744|FG000|Week 2|Lost to Follow-up|3
4630819|NCT01886716|7499745|FG001|Week 2|Lost to Follow-up|2
4630820|NCT01886716|7499746|FG002|Week 2|Lost to Follow-up|1
4630821|NCT01886716|7499747|FG003|Week 2|Lost to Follow-up|3
4630822|NCT01886716|7499744|FG000|Week 3|Lost to Follow-up|1
4630823|NCT01886716|7499745|FG001|Week 3|Lost to Follow-up|1
4630824|NCT01886716|7499746|FG002|Week 3|Lost to Follow-up|0
4630825|NCT01886716|7499747|FG003|Week 3|Lost to Follow-up|1
4630826|NCT01886781|7499759|FG000|Overall Study|Protocol Violation|5
4630827|NCT01886781|7499760|FG001|Overall Study|Protocol Violation|0
4630828|NCT01886781|7499759|FG000|Overall Study|Adverse Event|1
4630829|NCT01886781|7499760|FG001|Overall Study|Adverse Event|0
4630830|NCT01886781|7499759|FG000|Overall Study|Lost to Follow-up|5
4630831|NCT01886781|7499760|FG001|Overall Study|Lost to Follow-up|0
4630832|NCT01886781|7499759|FG000|Overall Study|Withdrawal by Subject|2
4630833|NCT01886781|7499760|FG001|Overall Study|Withdrawal by Subject|1
4630834|NCT01886781|7499759|FG000|Overall Study|Worsening of symptoms|1
4630835|NCT01886781|7499760|FG001|Overall Study|Worsening of symptoms|1
4630836|NCT01886833|7499782|FG000|Overall Study|IgA not available from both periods|204
4630837|NCT01887210|7499813|FG000|Overall Study|Withdrawal by Subject|1
4630838|NCT01887210|7499814|FG001|Overall Study|Withdrawal by Subject|3
4630839|NCT01887210|7499813|FG000|Overall Study|Lost to Follow-up|0
4630840|NCT01887210|7499814|FG001|Overall Study|Lost to Follow-up|1
4630841|NCT01887353|7499836|FG000|Overall Study|Study stopped early|4
4723934|NCT03160703|7659617|FG003|Overall Study|Withdrawal by Subject|1
4723935|NCT03160716|7659627|FG000|Overall Study|Lost to Follow-up|1
4723936|NCT03160885|7659633|FG000|Initial Treatment Period|Not dosed|2
4723937|NCT03160885|7659634|FG001|Initial Treatment Period|Not dosed|0
4723938|NCT03160885|7659635|FG002|Initial Treatment Period|Not dosed|0
4723939|NCT03160885|7659636|FG003|Initial Treatment Period|Not dosed|0
4723940|NCT03160885|7659637|FG004|Initial Treatment Period|Not dosed|0
4723941|NCT03160885|7659638|FG005|Initial Treatment Period|Not dosed|0
4723942|NCT03160885|7659639|FG006|Initial Treatment Period|Not dosed|0
4723943|NCT03160885|7659633|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33
4723944|NCT03160885|7659634|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22
4723945|NCT03160885|7659635|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0
4723946|NCT03160885|7659636|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0
4723947|NCT03160885|7659637|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0
4723948|NCT03160885|7659638|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0
4723949|NCT03160885|7659639|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0
4723950|NCT03160885|7659633|FG000|Open-label Treatment|Not dosed|0
4723951|NCT03160885|7659634|FG001|Open-label Treatment|Not dosed|0
4723952|NCT03160885|7659635|FG002|Open-label Treatment|Not dosed|0
4723953|NCT03160885|7659636|FG003|Open-label Treatment|Not dosed|0
4723954|NCT03160885|7659637|FG004|Open-label Treatment|Not dosed|0
4723955|NCT03160885|7659638|FG005|Open-label Treatment|Not dosed|0
4723956|NCT03160885|7659639|FG006|Open-label Treatment|Not dosed|2
4723957|NCT03160885|7659633|FG000|Open-label Treatment|Discontinued IMP|0
4723958|NCT03160885|7659634|FG001|Open-label Treatment|Discontinued IMP|0
4723959|NCT03160885|7659635|FG002|Open-label Treatment|Discontinued IMP|0
4723960|NCT03160885|7659636|FG003|Open-label Treatment|Discontinued IMP|0
4723961|NCT03160885|7659637|FG004|Open-label Treatment|Discontinued IMP|0
4723962|NCT03160885|7659638|FG005|Open-label Treatment|Discontinued IMP|0
4723963|NCT03160885|7659639|FG006|Open-label Treatment|Discontinued IMP|131
4723964|NCT03160885|7659633|FG000|Open-label Treatment|Completed Week 50|0
4723965|NCT03160885|7659634|FG001|Open-label Treatment|Completed Week 50|0
4723966|NCT03160885|7659635|FG002|Open-label Treatment|Completed Week 50|0
4723967|NCT03160885|7659636|FG003|Open-label Treatment|Completed Week 50|0
4723968|NCT03160885|7659637|FG004|Open-label Treatment|Completed Week 50|0
4723969|NCT03160885|7659638|FG005|Open-label Treatment|Completed Week 50|0
4723970|NCT03160885|7659639|FG006|Open-label Treatment|Completed Week 50|4
4723971|NCT03160885|7659633|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0
4723972|NCT03160885|7659634|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0
4723973|NCT03160885|7659635|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0
4630842|NCT01887353|7499837|FG001|Overall Study|Study stopped early|3
4630843|NCT01887418|7499846|FG000|Overall Study|Travelling difficulties|0
4630844|NCT01887418|7499847|FG001|Overall Study|Travelling difficulties|0
4630845|NCT01887418|7499848|FG002|Overall Study|Travelling difficulties|1
4630846|NCT01887600|7499880|FG000|Overall Study|Death|39
4630847|NCT01887600|7499881|FG001|Overall Study|Death|16
4630848|NCT01887600|7499880|FG000|Overall Study|Lack of Efficacy|3
4630849|NCT01887600|7499881|FG001|Overall Study|Lack of Efficacy|26
4630850|NCT01887600|7499880|FG000|Overall Study|Lost to Follow-up|5
4723974|NCT03160885|7659636|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1
4723975|NCT03160885|7659637|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0
4723976|NCT03160885|7659638|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0
4723977|NCT03160885|7659639|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0
4630851|NCT01887600|7499881|FG001|Overall Study|Lost to Follow-up|1
4630852|NCT01887600|7499880|FG000|Overall Study|Physician Decision|7
4630853|NCT01887600|7499881|FG001|Overall Study|Physician Decision|8
4630854|NCT01887600|7499880|FG000|Overall Study|Protocol Deviation|3
4630855|NCT01887600|7499881|FG001|Overall Study|Protocol Deviation|0
4723978|NCT03160885|7659633|FG000|Maintenance Treatment Period|Discontinued IMP|0
4723979|NCT03160885|7659634|FG001|Maintenance Treatment Period|Discontinued IMP|0
4723980|NCT03160885|7659635|FG002|Maintenance Treatment Period|Discontinued IMP|9
4723981|NCT03160885|7659636|FG003|Maintenance Treatment Period|Discontinued IMP|13
4723982|NCT03160885|7659637|FG004|Maintenance Treatment Period|Discontinued IMP|5
4723983|NCT03160885|7659638|FG005|Maintenance Treatment Period|Discontinued IMP|7
4723984|NCT03160885|7659639|FG006|Maintenance Treatment Period|Discontinued IMP|0
4723985|NCT03160885|7659633|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0
4723986|NCT03160885|7659634|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0
4723987|NCT03160885|7659635|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29
4723988|NCT03160885|7659636|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26
4723989|NCT03160885|7659637|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26
4723990|NCT03160885|7659638|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8
4723991|NCT03160885|7659639|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0
4723992|NCT03160885|7659633|FG000|Maintenance Treatment Period|Completed Week 50|0
4723993|NCT03160885|7659634|FG001|Maintenance Treatment Period|Completed Week 50|0
4723994|NCT03160885|7659635|FG002|Maintenance Treatment Period|Completed Week 50|1
4723995|NCT03160885|7659636|FG003|Maintenance Treatment Period|Completed Week 50|0
4723996|NCT03160885|7659637|FG004|Maintenance Treatment Period|Completed Week 50|0
4723997|NCT03160885|7659638|FG005|Maintenance Treatment Period|Completed Week 50|0
4723998|NCT03160885|7659639|FG006|Maintenance Treatment Period|Completed Week 50|0
4723999|NCT03160898|7659660|FG000|Overall Study|Adverse Event|4
4724000|NCT03160898|7659661|FG001|Overall Study|Adverse Event|8
4724001|NCT03160898|7659662|FG002|Overall Study|Adverse Event|7
4724002|NCT03160898|7659663|FG003|Overall Study|Adverse Event|10
4724003|NCT03160898|7659660|FG000|Overall Study|Death|1
4724004|NCT03160898|7659661|FG001|Overall Study|Death|0
4724005|NCT03160898|7659662|FG002|Overall Study|Death|0
4724006|NCT03160898|7659663|FG003|Overall Study|Death|1
4724007|NCT03160898|7659660|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3
4724008|NCT03160898|7659661|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0
4724009|NCT03160898|7659662|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0
4724010|NCT03160898|7659663|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1
4724011|NCT03160898|7659660|FG000|Overall Study|Lost to Follow-up|1
4724012|NCT03160898|7659661|FG001|Overall Study|Lost to Follow-up|1
4724013|NCT03160898|7659662|FG002|Overall Study|Lost to Follow-up|1
4724014|NCT03160898|7659663|FG003|Overall Study|Lost to Follow-up|2
4724015|NCT03160898|7659660|FG000|Overall Study|Physician Decision|1
4724016|NCT03160898|7659661|FG001|Overall Study|Physician Decision|0
4724017|NCT03160898|7659662|FG002|Overall Study|Physician Decision|0
4724018|NCT03160898|7659663|FG003|Overall Study|Physician Decision|1
4724019|NCT03160898|7659660|FG000|Overall Study|Progressive Disease|4
4724020|NCT03160898|7659661|FG001|Overall Study|Progressive Disease|1
4724021|NCT03160898|7659662|FG002|Overall Study|Progressive Disease|2
4724022|NCT03160898|7659663|FG003|Overall Study|Progressive Disease|1
4724023|NCT03160898|7659660|FG000|Overall Study|Protocol Violation|1
4724024|NCT03160898|7659661|FG001|Overall Study|Protocol Violation|0
4724025|NCT03160898|7659662|FG002|Overall Study|Protocol Violation|2
4724026|NCT03160898|7659663|FG003|Overall Study|Protocol Violation|0
4724027|NCT03160898|7659660|FG000|Overall Study|Sponsor Discretion|2
4724028|NCT03160898|7659661|FG001|Overall Study|Sponsor Discretion|0
4724029|NCT03160898|7659662|FG002|Overall Study|Sponsor Discretion|0
4724030|NCT03160898|7659663|FG003|Overall Study|Sponsor Discretion|0
4724031|NCT03160898|7659660|FG000|Overall Study|Withdrawal by Subject|1
4724032|NCT03160898|7659661|FG001|Overall Study|Withdrawal by Subject|3
4724033|NCT03160898|7659662|FG002|Overall Study|Withdrawal by Subject|2
4724034|NCT03160898|7659663|FG003|Overall Study|Withdrawal by Subject|1
4724035|NCT03160898|7659660|FG000|Overall Study|Other|2
4724036|NCT03160898|7659661|FG001|Overall Study|Other|0
4724037|NCT03160898|7659662|FG002|Overall Study|Other|2
4724038|NCT03160898|7659663|FG003|Overall Study|Other|2
4724039|NCT03161405|7659688|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1
4724040|NCT03161483|7659699|FG000|Overall Study|Death|1
4724041|NCT03161483|7659700|FG001|Overall Study|Death|0
4724042|NCT03161483|7659701|FG002|Overall Study|Death|0
4630856|NCT01887600|7499880|FG000|Overall Study|Withdrawal by Subject|58
4724043|NCT03161483|7659702|FG003|Overall Study|Death|0
4724044|NCT03161483|7659699|FG000|Overall Study|Adverse Event|5
4630857|NCT01887600|7499881|FG001|Overall Study|Withdrawal by Subject|52
4724045|NCT03161483|7659700|FG001|Overall Study|Adverse Event|1
4724046|NCT03161483|7659701|FG002|Overall Study|Adverse Event|11
4724047|NCT03161483|7659702|FG003|Overall Study|Adverse Event|2
4724048|NCT03161483|7659699|FG000|Overall Study|Pregnancy|1
4724049|NCT03161483|7659700|FG001|Overall Study|Pregnancy|0
4724050|NCT03161483|7659701|FG002|Overall Study|Pregnancy|0
4724051|NCT03161483|7659702|FG003|Overall Study|Pregnancy|0
4724052|NCT03161483|7659699|FG000|Overall Study|Lack of Efficacy|0
4724053|NCT03161483|7659700|FG001|Overall Study|Lack of Efficacy|0
4724054|NCT03161483|7659701|FG002|Overall Study|Lack of Efficacy|1
4724055|NCT03161483|7659702|FG003|Overall Study|Lack of Efficacy|0
4724056|NCT03161483|7659699|FG000|Overall Study|Withdrawal by Subject|2
4724057|NCT03161483|7659700|FG001|Overall Study|Withdrawal by Subject|2
4724058|NCT03161483|7659701|FG002|Overall Study|Withdrawal by Subject|6
4724059|NCT03161483|7659702|FG003|Overall Study|Withdrawal by Subject|5
4724060|NCT03161483|7659699|FG000|Overall Study|Lost to Follow-up|0
4724061|NCT03161483|7659700|FG001|Overall Study|Lost to Follow-up|0
4724062|NCT03161483|7659701|FG002|Overall Study|Lost to Follow-up|1
4724063|NCT03161483|7659702|FG003|Overall Study|Lost to Follow-up|0
4724064|NCT03161483|7659699|FG000|Overall Study|Protocol Violation|0
4724065|NCT03161483|7659700|FG001|Overall Study|Protocol Violation|0
4724066|NCT03161483|7659701|FG002|Overall Study|Protocol Violation|1
4724067|NCT03161483|7659702|FG003|Overall Study|Protocol Violation|0
4724068|NCT03161483|7659699|FG000|Overall Study|Other reasons|1
4724069|NCT03161483|7659700|FG001|Overall Study|Other reasons|0
4724070|NCT03161483|7659701|FG002|Overall Study|Other reasons|0
4724071|NCT03161483|7659702|FG003|Overall Study|Other reasons|1
4724072|NCT03162055|7659723|FG000|Overall Study|Adverse Event|6
4724073|NCT03162055|7659724|FG001|Overall Study|Adverse Event|5
4724074|NCT03162055|7659723|FG000|Overall Study|Death|3
4724075|NCT03162055|7659724|FG001|Overall Study|Death|3
4724076|NCT03162055|7659723|FG000|Overall Study|Lost to Follow-up|0
4724077|NCT03162055|7659724|FG001|Overall Study|Lost to Follow-up|1
4724078|NCT03162055|7659723|FG000|Overall Study|Study-specific withdrawal criteria|22
4724079|NCT03162055|7659724|FG001|Overall Study|Study-specific withdrawal criteria|14
4724080|NCT03162055|7659723|FG000|Overall Study|Withdrawal by Subject|17
4724081|NCT03162055|7659724|FG001|Overall Study|Withdrawal by Subject|2
4724082|NCT03162055|7659723|FG000|Overall Study|Did not receive treatment|2
4724083|NCT03162055|7659724|FG001|Overall Study|Did not receive treatment|0
4724084|NCT03162055|7659723|FG000|Overall Study|Incorrect randomization|4
4724085|NCT03162055|7659724|FG001|Overall Study|Incorrect randomization|3
4724086|NCT03162055|7659723|FG000|Overall Study|Other|8
4724087|NCT03162055|7659724|FG001|Overall Study|Other|15
4724088|NCT03162328|7659730|FG000|Screening Period|Did not meet inclusion/exclusion|21
4724089|NCT03162328|7659731|FG001|Screening Period|Did not meet inclusion/exclusion|0
4724090|NCT03162328|7659732|FG002|Screening Period|Did not meet inclusion/exclusion|0
4724091|NCT03162328|7659730|FG000|Screening Period|Withdrawal by Subject|1
4724092|NCT03162328|7659731|FG001|Screening Period|Withdrawal by Subject|0
4724093|NCT03162328|7659732|FG002|Screening Period|Withdrawal by Subject|0
4724094|NCT03162328|7659730|FG000|Study Period|Withdrawal by Subject|0
4771930|NCT03353922|7749035|FG000|Overall Study|Adverse Event|0
4771931|NCT03353922|7749036|FG001|Overall Study|Adverse Event|1
4771932|NCT03353922|7749037|FG002|Overall Study|Adverse Event|0
4771933|NCT03353922|7749038|FG003|Overall Study|Adverse Event|0
4771934|NCT03353922|7749039|FG004|Overall Study|Adverse Event|0
4771935|NCT03353922|7749040|FG005|Overall Study|Adverse Event|0
4724095|NCT03162328|7659731|FG001|Study Period|Withdrawal by Subject|0
4724096|NCT03162328|7659732|FG002|Study Period|Withdrawal by Subject|1
4724097|NCT03162614|7659772|FG000|Overall Study|Lost to Follow-up|2
4724098|NCT03162614|7659773|FG001|Overall Study|Lost to Follow-up|1
4724099|NCT03162614|7659774|FG002|Overall Study|Lost to Follow-up|1
4724100|NCT03162614|7659775|FG003|Overall Study|Lost to Follow-up|1
4724101|NCT03162614|7659776|FG004|Overall Study|Lost to Follow-up|2
4724102|NCT03162614|7659777|FG005|Overall Study|Lost to Follow-up|0
4724103|NCT03162614|7659772|FG000|Overall Study|Protocol Violation|0
4724104|NCT03162614|7659773|FG001|Overall Study|Protocol Violation|1
4724105|NCT03162614|7659774|FG002|Overall Study|Protocol Violation|0
4724106|NCT03162614|7659775|FG003|Overall Study|Protocol Violation|1
4724107|NCT03162614|7659776|FG004|Overall Study|Protocol Violation|0
4724108|NCT03162614|7659777|FG005|Overall Study|Protocol Violation|0
4724109|NCT03162614|7659772|FG000|Overall Study|Withdrawal by Subject|2
4724110|NCT03162614|7659773|FG001|Overall Study|Withdrawal by Subject|1
4724111|NCT03162614|7659774|FG002|Overall Study|Withdrawal by Subject|1
4724112|NCT03162614|7659775|FG003|Overall Study|Withdrawal by Subject|1
4724113|NCT03162614|7659776|FG004|Overall Study|Withdrawal by Subject|0
4724114|NCT03162614|7659777|FG005|Overall Study|Withdrawal by Subject|0
4724115|NCT03162614|7659772|FG000|Overall Study|Missed vaccination, exclusion criteria|2
4724116|NCT03162614|7659773|FG001|Overall Study|Missed vaccination, exclusion criteria|2
4724117|NCT03162614|7659774|FG002|Overall Study|Missed vaccination, exclusion criteria|2
4724118|NCT03162614|7659775|FG003|Overall Study|Missed vaccination, exclusion criteria|4
4724119|NCT03162614|7659776|FG004|Overall Study|Missed vaccination, exclusion criteria|3
4724120|NCT03162614|7659777|FG005|Overall Study|Missed vaccination, exclusion criteria|0
4724121|NCT03162796|7659794|FG000|Placebo Controlled Period: Week 0 - 24|Other|0
4724122|NCT03162796|7659795|FG001|Placebo Controlled Period: Week 0 - 24|Other|1
4724123|NCT03162796|7659796|FG002|Placebo Controlled Period: Week 0 - 24|Other|1
4724124|NCT03162796|7659794|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1
4724125|NCT03162796|7659795|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0
4724126|NCT03162796|7659796|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0
4724127|NCT03162796|7659794|FG000|Placebo Controlled Period: Week 0 - 24|Death|1
4724128|NCT03162796|7659795|FG001|Placebo Controlled Period: Week 0 - 24|Death|0
4724129|NCT03162796|7659796|FG002|Placebo Controlled Period: Week 0 - 24|Death|0
4724130|NCT03162796|7659794|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1
4724131|NCT03162796|7659795|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0
4724132|NCT03162796|7659796|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0
4724133|NCT03162796|7659794|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3
4724134|NCT03162796|7659795|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0
4724135|NCT03162796|7659796|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1
4724136|NCT03162796|7659794|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4
4724137|NCT03162796|7659795|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0
4724138|NCT03162796|7659796|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0
4724139|NCT03162796|7659794|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2
4724140|NCT03162796|7659795|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3
4724141|NCT03162796|7659796|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1
4724142|NCT03162796|7659794|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0
4724143|NCT03162796|7659795|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2
4724144|NCT03162796|7659796|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0
4724145|NCT03162796|7659794|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4
4724146|NCT03162796|7659795|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3
4724147|NCT03162796|7659796|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1
4724148|NCT03162796|7659794|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3
4724149|NCT03162796|7659795|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2
4724150|NCT03162796|7659796|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0
4724151|NCT03162796|7659794|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1
4724152|NCT03162796|7659795|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2
4724153|NCT03162796|7659796|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1
4724154|NCT03163446|7659837|FG000|Overall Study|Unable to return for Day 180 visit|2
4724155|NCT03163446|7659838|FG001|Overall Study|Unable to return for Day 180 visit|0
4724156|NCT03163446|7659837|FG000|Overall Study|Withdrawal by Subject|2
4724157|NCT03163446|7659838|FG001|Overall Study|Withdrawal by Subject|6
4724158|NCT03163446|7659837|FG000|Overall Study|Death|16
4724159|NCT03163446|7659838|FG001|Overall Study|Death|5
4724160|NCT03163446|7659837|FG000|Overall Study|Lost to Follow-up|6
4724161|NCT03163446|7659838|FG001|Overall Study|Lost to Follow-up|5
4724162|NCT03163446|7659837|FG000|Overall Study|Physician Decision|1
4724163|NCT03163446|7659838|FG001|Overall Study|Physician Decision|1
4724164|NCT03163446|7659837|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1
4724165|NCT03163446|7659838|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0
4724166|NCT03164551|7659881|FG000|Overall Study|Imaging discontinued prior completion|8
4724167|NCT03164551|7659882|FG001|Overall Study|Imaging discontinued prior completion|0
4724168|NCT03164551|7659881|FG000|Overall Study|Participant was non-compliant|1
4724169|NCT03164551|7659882|FG001|Overall Study|Participant was non-compliant|0
4724170|NCT03164551|7659881|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12
4724171|NCT03164551|7659882|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14
4724172|NCT03164551|7659881|FG000|Overall Study|Other|8
4724173|NCT03164551|7659882|FG001|Overall Study|Other|2
4724174|NCT03165045|7659897|FG000|Visit 1|No registration after visit 1|9
4724175|NCT03165045|7659897|FG000|Visit 1|No treatment documented|10
4724176|NCT03165045|7659897|FG000|Visit 1|No visit 1|10
4724177|NCT03165045|7659897|FG000|Visit 2|Available CCQ score at visit 1 only|109
4724178|NCT03165045|7659897|FG000|Visit 2|No available total CCQ score at all|29
4724179|NCT03165045|7659897|FG000|Visit 2|Available total CCQ score at vist 2 only|44
4724180|NCT03165110|7659912|FG000|Overall Study|Anroid phone software incompatibility|1
4724181|NCT03166124|7659963|FG000|Treatment Period 1|Adverse Event|0
4724182|NCT03166124|7659964|FG001|Treatment Period 1|Adverse Event|0
4724183|NCT03166124|7659965|FG002|Treatment Period 1|Adverse Event|1
4724184|NCT03166124|7659966|FG003|Treatment Period 1|Adverse Event|0
4724185|NCT03166124|7659963|FG000|Wash-out Period|Withdrawal by Subject|0
4724186|NCT03166124|7659964|FG001|Wash-out Period|Withdrawal by Subject|1
4724187|NCT03166124|7659965|FG002|Wash-out Period|Withdrawal by Subject|0
4724188|NCT03166124|7659966|FG003|Wash-out Period|Withdrawal by Subject|1
4724189|NCT03166124|7659963|FG000|Wash-out Period|Adverse Event|0
4724190|NCT03166124|7659964|FG001|Wash-out Period|Adverse Event|1
4724191|NCT03166124|7659965|FG002|Wash-out Period|Adverse Event|1
4724192|NCT03166124|7659966|FG003|Wash-out Period|Adverse Event|0
4724193|NCT03166215|7659979|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0
4724194|NCT03166215|7659980|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2
4724195|NCT03166215|7659981|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0
4724196|NCT03166215|7659979|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0
4724197|NCT03166215|7659980|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0
4724198|NCT03166215|7659981|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2
4724199|NCT03166735|7659997|FG000|Overall Study|Not Treated|1
4724200|NCT03166735|7659998|FG001|Overall Study|Not Treated|0
4724201|NCT03166735|7659999|FG002|Overall Study|Not Treated|0
4724202|NCT03166735|7660000|FG003|Overall Study|Not Treated|0
4724203|NCT03166735|7660001|FG004|Overall Study|Not Treated|0
4724204|NCT03166735|7659997|FG000|Overall Study|follow-up not completed as planned|0
4724205|NCT03166735|7659998|FG001|Overall Study|follow-up not completed as planned|1
4630858|NCT01887600|7499880|FG000|Overall Study|Adverse Event|21
4630859|NCT01887600|7499881|FG001|Overall Study|Adverse Event|9
4630860|NCT01887600|7499880|FG000|Overall Study|Non-compliance with study drug|3
4630861|NCT01887600|7499881|FG001|Overall Study|Non-compliance with study drug|0
4724206|NCT03166735|7659999|FG002|Overall Study|follow-up not completed as planned|1
4724207|NCT03166735|7660000|FG003|Overall Study|follow-up not completed as planned|0
4724208|NCT03166735|7660001|FG004|Overall Study|follow-up not completed as planned|1
4724209|NCT03166735|7659997|FG000|Overall Study|Withdrawal by Subject|0
4724210|NCT03166735|7659998|FG001|Overall Study|Withdrawal by Subject|0
4724211|NCT03166735|7659999|FG002|Overall Study|Withdrawal by Subject|1
4724212|NCT03166735|7660000|FG003|Overall Study|Withdrawal by Subject|1
4724213|NCT03166735|7660001|FG004|Overall Study|Withdrawal by Subject|2
4724214|NCT03166735|7659997|FG000|Overall Study|Lost to Follow-up|0
4724215|NCT03166735|7659998|FG001|Overall Study|Lost to Follow-up|2
4724216|NCT03166735|7659999|FG002|Overall Study|Lost to Follow-up|1
4724217|NCT03166735|7660000|FG003|Overall Study|Lost to Follow-up|0
4724218|NCT03166735|7660001|FG004|Overall Study|Lost to Follow-up|1
4724219|NCT03167073|7660016|FG000|Overall Study|Stillbirth|1
4724220|NCT03167073|7660017|FG001|Overall Study|Stillbirth|0
4724221|NCT03167151|7660026|FG000|Overall Study|Withdrawal by Subject|1
4724222|NCT03167151|7660027|FG001|Overall Study|Withdrawal by Subject|0
4724223|NCT03167151|7660028|FG002|Overall Study|Withdrawal by Subject|0
4724224|NCT03167151|7660026|FG000|Overall Study|No evidence of tumour at surgery|0
4724225|NCT03167151|7660027|FG001|Overall Study|No evidence of tumour at surgery|1
4724226|NCT03167151|7660028|FG002|Overall Study|No evidence of tumour at surgery|1
4724227|NCT03167359|7660036|FG000|Overall Study|Physician Decision|1
4724228|NCT03167359|7660036|FG000|Overall Study|Lost to Follow-up|1
4724229|NCT03167411|7660042|FG000|Overall Study|Adverse Event|0
4724230|NCT03167411|7660043|FG001|Overall Study|Adverse Event|1
4724231|NCT03168425|7660113|FG000|Overall Study|Lost to Follow-up|5
4724232|NCT03168425|7660114|FG001|Overall Study|Lost to Follow-up|8
4724233|NCT03168425|7660113|FG000|Overall Study|unable to confirm post op opioids|2
4724234|NCT03168425|7660114|FG001|Overall Study|unable to confirm post op opioids|3
4724235|NCT03168711|7660130|FG000|Overall Study|Adverse Event|2
4724236|NCT03168711|7660131|FG001|Overall Study|Adverse Event|0
4724237|NCT03168711|7660130|FG000|Overall Study|Withdrawal by Subject|0
4724238|NCT03168711|7660131|FG001|Overall Study|Withdrawal by Subject|1
4724239|NCT03168711|7660130|FG000|Overall Study|Death|0
4724240|NCT03168711|7660131|FG001|Overall Study|Death|1
4724241|NCT03168919|7660141|FG000|Overall Study|Withdrawal by Subject|2
4724242|NCT03169153|7660153|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1
4724243|NCT03169153|7660154|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1
4724244|NCT03169153|7660153|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2
4724245|NCT03169153|7660154|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3
4724246|NCT03169153|7660153|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1
4630862|NCT01887600|7499880|FG000|Overall Study|Miscellaneous|6
4630863|NCT01887600|7499881|FG001|Overall Study|Miscellaneous|2
4630864|NCT01887600|7499880|FG000|Overall Study|Progressive Disease|1
4630865|NCT01887600|7499881|FG001|Overall Study|Progressive Disease|0
4630866|NCT01887678|7499890|FG000|Overall Study|Adverse Event|4
4630867|NCT01887678|7499891|FG001|Overall Study|Adverse Event|6
4630868|NCT01887678|7499890|FG000|Overall Study|Exceeded rescue medication dosage|4
4630869|NCT01887678|7499891|FG001|Overall Study|Exceeded rescue medication dosage|5
4630870|NCT01887678|7499890|FG000|Overall Study|Withdrawal of consent|3
4630871|NCT01887678|7499891|FG001|Overall Study|Withdrawal of consent|4
4630872|NCT01887678|7499890|FG000|Overall Study|Lost to Follow-up|4
4630873|NCT01887678|7499891|FG001|Overall Study|Lost to Follow-up|2
4630874|NCT01887678|7499890|FG000|Overall Study|Deterioration of clinical condition|0
4630875|NCT01887678|7499891|FG001|Overall Study|Deterioration of clinical condition|4
4630876|NCT01887678|7499890|FG000|Overall Study|Lack of Efficacy|1
4630877|NCT01887678|7499891|FG001|Overall Study|Lack of Efficacy|2
4630878|NCT01887678|7499890|FG000|Overall Study|Non-compliance|0
4630879|NCT01887678|7499891|FG001|Overall Study|Non-compliance|3
4630880|NCT01887678|7499890|FG000|Overall Study|Specified|1
4630881|NCT01887678|7499891|FG001|Overall Study|Specified|2
4630882|NCT01887717|7499899|FG000|Overall Study|Withdrawal by Subject|1
4630883|NCT01887717|7499900|FG001|Overall Study|Withdrawal by Subject|7
4630884|NCT01887717|7499899|FG000|Overall Study|Physician Decision|0
4630885|NCT01887717|7499900|FG001|Overall Study|Physician Decision|2
4630886|NCT01887717|7499899|FG000|Overall Study|Administrative reasons|5
4630887|NCT01887717|7499900|FG001|Overall Study|Administrative reasons|2
4630888|NCT01888003|7499928|FG000|Overall Study|Study Terminated|5
4630889|NCT01888003|7499929|FG001|Overall Study|Study Terminated|6
4630890|NCT01888003|7499930|FG002|Overall Study|Study Terminated|40
4630891|NCT01888367|7499941|FG000|Overall Study|Physician Decision|3
4630892|NCT01888367|7499942|FG001|Overall Study|Physician Decision|4
4630893|NCT01888367|7499943|FG002|Overall Study|Physician Decision|2
4630894|NCT01888367|7499941|FG000|Overall Study|Death|2
4630895|NCT01888367|7499942|FG001|Overall Study|Death|0
4724247|NCT03169153|7660154|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2
4724248|NCT03169153|7660153|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1
4724249|NCT03169153|7660154|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0
4724250|NCT03169244|7660162|FG000|Overall Study|Lost to Follow-up|1
4724251|NCT03169244|7660163|FG001|Overall Study|Lost to Follow-up|2
4724252|NCT03169244|7660162|FG000|Overall Study|Adverse Event|1
4724253|NCT03169244|7660163|FG001|Overall Study|Adverse Event|0
4724254|NCT03169244|7660162|FG000|Overall Study|Withdrawal by Subject|2
4724255|NCT03169244|7660163|FG001|Overall Study|Withdrawal by Subject|2
4724256|NCT03169244|7660162|FG000|Overall Study|Physician Decision|1
4724257|NCT03169244|7660163|FG001|Overall Study|Physician Decision|0
4724258|NCT03170154|7660178|FG000|Overall Study|Lost to Follow-up|4
4724259|NCT03170154|7660178|FG000|Overall Study|Death|2
4724260|NCT03170154|7660178|FG000|Overall Study|Withdrawal by Subject|2
4724261|NCT03170193|7660194|FG000|Overall Study|Withdrawal by Subject|0
4724262|NCT03170193|7660195|FG001|Overall Study|Withdrawal by Subject|0
4724263|NCT03170193|7660196|FG002|Overall Study|Withdrawal by Subject|0
4724264|NCT03170193|7660197|FG003|Overall Study|Withdrawal by Subject|1
4724265|NCT03170193|7660198|FG004|Overall Study|Withdrawal by Subject|0
4724266|NCT03170193|7660199|FG005|Overall Study|Withdrawal by Subject|0
4724267|NCT03170193|7660200|FG006|Overall Study|Withdrawal by Subject|0
4724268|NCT03170193|7660194|FG000|Overall Study|Lost to Follow-up|1
4724269|NCT03170193|7660195|FG001|Overall Study|Lost to Follow-up|1
4724270|NCT03170193|7660196|FG002|Overall Study|Lost to Follow-up|0
4724271|NCT03170193|7660197|FG003|Overall Study|Lost to Follow-up|0
4724272|NCT03170193|7660198|FG004|Overall Study|Lost to Follow-up|0
4724273|NCT03170193|7660199|FG005|Overall Study|Lost to Follow-up|0
4724274|NCT03170193|7660200|FG006|Overall Study|Lost to Follow-up|0
4724275|NCT03170232|7660233|FG000|Overall Study|Adverse Event|0
4724276|NCT03170232|7660234|FG001|Overall Study|Adverse Event|1
4724277|NCT03170232|7660233|FG000|Overall Study|Protocol Violation|0
4724278|NCT03170232|7660234|FG001|Overall Study|Protocol Violation|1
4724279|NCT03170232|7660233|FG000|Overall Study|Lack of Efficacy|0
4724280|NCT03170232|7660234|FG001|Overall Study|Lack of Efficacy|1
4724281|NCT03170232|7660233|FG000|Overall Study|Study closed/terminated|26
4724282|NCT03170232|7660234|FG001|Overall Study|Study closed/terminated|23
4724283|NCT03170232|7660233|FG000|Overall Study|Lost to Follow-up|1
4724284|NCT03170232|7660234|FG001|Overall Study|Lost to Follow-up|0
4724285|NCT03170232|7660233|FG000|Overall Study|Withdrawal by Subject|0
4724286|NCT03170232|7660234|FG001|Overall Study|Withdrawal by Subject|1
4630896|NCT01888367|7499943|FG002|Overall Study|Death|1
4630897|NCT01888367|7499941|FG000|Overall Study|Withdrawal by Subject|1
4630898|NCT01888367|7499942|FG001|Overall Study|Withdrawal by Subject|0
4630899|NCT01888367|7499943|FG002|Overall Study|Withdrawal by Subject|1
4630900|NCT01888367|7499941|FG000|Overall Study|Lost to Follow-up|1
4630901|NCT01888367|7499942|FG001|Overall Study|Lost to Follow-up|1
4630902|NCT01888367|7499943|FG002|Overall Study|Lost to Follow-up|0
4724287|NCT03170271|7660242|FG000|Overall Study|Adverse Event|7
4724288|NCT03170271|7660243|FG001|Overall Study|Adverse Event|2
4724289|NCT03170271|7660242|FG000|Overall Study|Lost to Follow-up|0
4724290|NCT03170271|7660243|FG001|Overall Study|Lost to Follow-up|1
4724291|NCT03170271|7660242|FG000|Overall Study|Physician Decision|1
4724292|NCT03170271|7660243|FG001|Overall Study|Physician Decision|0
4724293|NCT03170271|7660242|FG000|Overall Study|Protocol-specified withdrawal criterion|2
4724294|NCT03170271|7660243|FG001|Overall Study|Protocol-specified withdrawal criterion|1
4724295|NCT03170271|7660242|FG000|Overall Study|Withdrawal by Subject|17
4724296|NCT03170271|7660243|FG001|Overall Study|Withdrawal by Subject|5
4724297|NCT03170271|7660242|FG000|Overall Study|Other|2
4724298|NCT03170271|7660243|FG001|Overall Study|Other|2
4724299|NCT03170271|7660242|FG000|Overall Study|Randomized in error|4
4724300|NCT03170271|7660243|FG001|Overall Study|Randomized in error|0
4724301|NCT03170544|7660282|FG000|Part 1|Lost to Follow-up|1
4724302|NCT03170544|7660283|FG001|Part 1|Lost to Follow-up|0
4724303|NCT03170544|7660284|FG002|Part 1|Lost to Follow-up|0
4724304|NCT03170544|7660285|FG003|Part 1|Lost to Follow-up|0
4724305|NCT03170544|7660286|FG004|Part 1|Lost to Follow-up|0
4724306|NCT03170544|7660287|FG005|Part 1|Lost to Follow-up|0
4724307|NCT03170544|7660288|FG006|Part 1|Lost to Follow-up|0
4724308|NCT03170544|7660289|FG007|Part 1|Lost to Follow-up|0
4724309|NCT03170544|7660290|FG008|Part 1|Lost to Follow-up|0
4724310|NCT03170544|7660291|FG009|Part 1|Lost to Follow-up|0
4724311|NCT03170544|7660292|FG010|Part 1|Lost to Follow-up|0
4724312|NCT03170544|7660293|FG011|Part 1|Lost to Follow-up|0
4724313|NCT03170544|7660282|FG000|Part 1|Not treated|0
4724314|NCT03170544|7660283|FG001|Part 1|Not treated|0
4724315|NCT03170544|7660284|FG002|Part 1|Not treated|0
4724316|NCT03170544|7660285|FG003|Part 1|Not treated|1
4724317|NCT03170544|7660286|FG004|Part 1|Not treated|0
4724318|NCT03170544|7660287|FG005|Part 1|Not treated|0
4724319|NCT03170544|7660288|FG006|Part 1|Not treated|0
4724320|NCT03170544|7660289|FG007|Part 1|Not treated|0
4724321|NCT03170544|7660290|FG008|Part 1|Not treated|0
4724322|NCT03170544|7660291|FG009|Part 1|Not treated|0
4724323|NCT03170544|7660292|FG010|Part 1|Not treated|0
4724324|NCT03170544|7660293|FG011|Part 1|Not treated|0
4724325|NCT03170609|7660383|FG000|Overall Study|Death|0
4724326|NCT03170609|7660384|FG001|Overall Study|Death|0
4724327|NCT03170609|7660385|FG002|Overall Study|Death|1
4724328|NCT03170609|7660386|FG003|Overall Study|Death|0
4724329|NCT03170609|7660387|FG004|Overall Study|Death|0
4724330|NCT03170609|7660388|FG005|Overall Study|Death|0
4724331|NCT03170609|7660389|FG006|Overall Study|Death|0
4724332|NCT03170609|7660383|FG000|Overall Study|Withdrawal by Subject|1
4724333|NCT03170609|7660384|FG001|Overall Study|Withdrawal by Subject|2
4724334|NCT03170609|7660385|FG002|Overall Study|Withdrawal by Subject|0
4724335|NCT03170609|7660386|FG003|Overall Study|Withdrawal by Subject|0
4724336|NCT03170609|7660387|FG004|Overall Study|Withdrawal by Subject|0
4724337|NCT03170609|7660388|FG005|Overall Study|Withdrawal by Subject|0
4724338|NCT03170609|7660389|FG006|Overall Study|Withdrawal by Subject|1
4724339|NCT03170609|7660383|FG000|Overall Study|Lost to Follow-up|1
4724340|NCT03170609|7660384|FG001|Overall Study|Lost to Follow-up|0
4724341|NCT03170609|7660385|FG002|Overall Study|Lost to Follow-up|5
4724342|NCT03170609|7660386|FG003|Overall Study|Lost to Follow-up|2
4724343|NCT03170609|7660387|FG004|Overall Study|Lost to Follow-up|1
4724344|NCT03170609|7660388|FG005|Overall Study|Lost to Follow-up|1
4724345|NCT03170609|7660389|FG006|Overall Study|Lost to Follow-up|0
4724346|NCT03170609|7660383|FG000|Overall Study|Other|1
4724347|NCT03170609|7660384|FG001|Overall Study|Other|0
4724348|NCT03170609|7660385|FG002|Overall Study|Other|0
4724349|NCT03170609|7660386|FG003|Overall Study|Other|0
4724350|NCT03170609|7660387|FG004|Overall Study|Other|0
4724351|NCT03170609|7660388|FG005|Overall Study|Other|1
4724352|NCT03170609|7660389|FG006|Overall Study|Other|0
4724353|NCT03171415|7660426|FG000|Overall Study|Lost to Follow-up|0
4724354|NCT03171415|7660427|FG001|Overall Study|Lost to Follow-up|0
4724355|NCT03171415|7660428|FG002|Overall Study|Lost to Follow-up|0
4724356|NCT03171415|7660429|FG003|Overall Study|Lost to Follow-up|0
4724357|NCT03171415|7660430|FG004|Overall Study|Lost to Follow-up|2
4724358|NCT03172130|7660455|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3
4724359|NCT03172130|7660456|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1
4724360|NCT03172325|7660464|FG000|Overall Study|Adverse Event|2
4724361|NCT03172325|7660465|FG001|Overall Study|Adverse Event|3
4724362|NCT03172325|7660464|FG000|Overall Study|Positive PPD|1
4724363|NCT03172325|7660465|FG001|Overall Study|Positive PPD|0
4724364|NCT03172325|7660464|FG000|Overall Study|Poor Compliance|1
4724365|NCT03172325|7660465|FG001|Overall Study|Poor Compliance|1
4724366|NCT03172364|7660473|FG000|Overall Study|Adverse Event|1
4724367|NCT03172364|7660474|FG001|Overall Study|Adverse Event|1
4724368|NCT03172364|7660473|FG000|Overall Study|Protocol Violation|1
4724369|NCT03172364|7660474|FG001|Overall Study|Protocol Violation|0
4724370|NCT03172481|7660482|FG000|Double-blind|Withdrawal by Subject|1
4724371|NCT03172481|7660483|FG001|Double-blind|Withdrawal by Subject|0
4724372|NCT03172494|7660492|FG000|Overall Study|Adverse Event|5
4724373|NCT03172494|7660493|FG001|Overall Study|Adverse Event|1
4724374|NCT03172494|7660494|FG002|Overall Study|Adverse Event|15
4724375|NCT03172494|7660492|FG000|Overall Study|Protocol Violation|3
4724376|NCT03172494|7660493|FG001|Overall Study|Protocol Violation|2
4724377|NCT03172494|7660494|FG002|Overall Study|Protocol Violation|1
4724378|NCT03172494|7660492|FG000|Overall Study|Lack of Efficacy|0
4724379|NCT03172494|7660493|FG001|Overall Study|Lack of Efficacy|0
4724380|NCT03172494|7660494|FG002|Overall Study|Lack of Efficacy|4
4724381|NCT03172494|7660492|FG000|Overall Study|Pregnancy|0
4724382|NCT03172494|7660493|FG001|Overall Study|Pregnancy|1
4724383|NCT03172494|7660494|FG002|Overall Study|Pregnancy|0
4724384|NCT03172494|7660492|FG000|Overall Study|Withdrawal by Subject|10
4724385|NCT03172494|7660493|FG001|Overall Study|Withdrawal by Subject|8
4724386|NCT03172494|7660494|FG002|Overall Study|Withdrawal by Subject|8
4724387|NCT03172494|7660492|FG000|Overall Study|Severe hypoglycaemic episode|0
4724388|NCT03172494|7660493|FG001|Overall Study|Severe hypoglycaemic episode|0
4724389|NCT03172494|7660494|FG002|Overall Study|Severe hypoglycaemic episode|1
4724390|NCT03172494|7660492|FG000|Overall Study|Non-compliance towards treatment|2
4724391|NCT03172494|7660493|FG001|Overall Study|Non-compliance towards treatment|0
4724392|NCT03172494|7660494|FG002|Overall Study|Non-compliance towards treatment|0
4724393|NCT03172702|7660503|FG000|Overall Study|Adverse Event|9
4724394|NCT03172702|7660503|FG000|Overall Study|Death|2
4724395|NCT03172702|7660503|FG000|Overall Study|Study-specific Withdrawal Criteria|10
4724396|NCT03172702|7660503|FG000|Overall Study|Withdrawal by Subject|5
4724397|NCT03172702|7660503|FG000|Overall Study|Other|2
4724398|NCT03173313|7660535|FG000|Overall Study|Lost to Follow-up|2
4724399|NCT03173313|7660536|FG001|Overall Study|Lost to Follow-up|3
4724400|NCT03173313|7660535|FG000|Overall Study|Withdrawal by Subject|0
4724401|NCT03173313|7660536|FG001|Overall Study|Withdrawal by Subject|1
4724402|NCT03173313|7660535|FG000|Overall Study|Death|5
4724403|NCT03173313|7660536|FG001|Overall Study|Death|0
4724404|NCT03173313|7660535|FG000|Overall Study|Physician Decision|1
4724405|NCT03173313|7660536|FG001|Overall Study|Physician Decision|0
4724406|NCT03173313|7660535|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0
4724407|NCT03173313|7660536|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1
4724408|NCT03173313|7660535|FG000|Overall Study|Bone Fracture|1
4724409|NCT03173313|7660536|FG001|Overall Study|Bone Fracture|0
4724410|NCT03173547|7660544|FG000|Overall Study|Adverse Event|2
4724411|NCT03173547|7660545|FG001|Overall Study|Adverse Event|0
4724412|NCT03173547|7660544|FG000|Overall Study|Withdrawal by Subject|2
4724413|NCT03173547|7660545|FG001|Overall Study|Withdrawal by Subject|2
4724414|NCT03173560|7660553|FG000|Overall Study|Ongoing on Treatment|38
4724415|NCT03173560|7660554|FG001|Overall Study|Ongoing on Treatment|50
4724416|NCT03173560|7660553|FG000|Overall Study|Ongoing Survival Follow-up|56
4724417|NCT03173560|7660554|FG001|Overall Study|Ongoing Survival Follow-up|57
4724418|NCT03173560|7660553|FG000|Overall Study|Lost to Follow-up|1
4724419|NCT03173560|7660554|FG001|Overall Study|Lost to Follow-up|4
4724420|NCT03173560|7660553|FG000|Overall Study|Withdrawal by Subject|10
4724421|NCT03173560|7660554|FG001|Overall Study|Withdrawal by Subject|5
4724422|NCT03173560|7660553|FG000|Overall Study|Other|0
4724423|NCT03173560|7660554|FG001|Overall Study|Other|1
4736728|NCT03573908|7686044|FG003|Randomized Withdrawal Period|Lost to Follow-up|0
4736729|NCT03573908|7686045|FG004|Randomized Withdrawal Period|Lost to Follow-up|0
4736730|NCT03573908|7686041|FG000|Randomized Withdrawal Period|Other, Not Specified|0
4736731|NCT03573908|7686042|FG001|Randomized Withdrawal Period|Other, Not Specified|0
4736732|NCT03573908|7686043|FG002|Randomized Withdrawal Period|Other, Not Specified|4
4736733|NCT03573908|7686044|FG003|Randomized Withdrawal Period|Other, Not Specified|2
4736734|NCT03573908|7686045|FG004|Randomized Withdrawal Period|Other, Not Specified|0
4736735|NCT03574753|7686071|FG000|Overall Study|Adverse Event|3
4736736|NCT03574753|7686071|FG000|Overall Study|Progression/relapse|19
4736737|NCT03574753|7686071|FG000|Overall Study|Death|1
4736738|NCT03575702|7686082|FG000|Overall Study|Withdrawal by Subject|1
4736739|NCT03575702|7686083|FG001|Overall Study|Withdrawal by Subject|1
4736740|NCT03575702|7686082|FG000|Overall Study|Lost to Follow-up|1
4736741|NCT03575702|7686083|FG001|Overall Study|Lost to Follow-up|2
4736742|NCT03575702|7686082|FG000|Overall Study|Protocol Violation|0
4736743|NCT03575702|7686083|FG001|Overall Study|Protocol Violation|1
4736744|NCT03575702|7686082|FG000|Overall Study|Patient non compliance|4
4736745|NCT03575702|7686083|FG001|Overall Study|Patient non compliance|0
4736746|NCT03575806|7686100|FG000|Overall Study|Withdrawal by Subject|0
4736747|NCT03575806|7686101|FG001|Overall Study|Withdrawal by Subject|2
4736748|NCT03575806|7686100|FG000|Overall Study|Protocol Violation|0
4736749|NCT03575806|7686101|FG001|Overall Study|Protocol Violation|2
4736750|NCT03575871|7686110|FG000|Overall Study|Adverse Event|5
4736751|NCT03575871|7686111|FG001|Overall Study|Adverse Event|5
4736752|NCT03575871|7686112|FG002|Overall Study|Adverse Event|8
4736753|NCT03575871|7686110|FG000|Overall Study|Death|1
4736754|NCT03575871|7686111|FG001|Overall Study|Death|0
4736755|NCT03575871|7686112|FG002|Overall Study|Death|0
4736756|NCT03575871|7686110|FG000|Overall Study|Lack of Efficacy|5
4736757|NCT03575871|7686111|FG001|Overall Study|Lack of Efficacy|4
4736758|NCT03575871|7686112|FG002|Overall Study|Lack of Efficacy|7
4736759|NCT03575871|7686110|FG000|Overall Study|Lost to Follow-up|1
4736760|NCT03575871|7686111|FG001|Overall Study|Lost to Follow-up|1
4736761|NCT03575871|7686112|FG002|Overall Study|Lost to Follow-up|1
4736762|NCT03575871|7686110|FG000|Overall Study|Protocol Deviation|1
4736763|NCT03575871|7686111|FG001|Overall Study|Protocol Deviation|1
4736764|NCT03575871|7686112|FG002|Overall Study|Protocol Deviation|1
4736765|NCT03575871|7686110|FG000|Overall Study|Withdrawal by Subject|6
4736766|NCT03575871|7686111|FG001|Overall Study|Withdrawal by Subject|1
4736767|NCT03575871|7686112|FG002|Overall Study|Withdrawal by Subject|9
4736768|NCT03575871|7686110|FG000|Overall Study|Other than specified|2
4630903|NCT01888367|7499941|FG000|Overall Study|Protocol Violation|0
4630904|NCT01888367|7499942|FG001|Overall Study|Protocol Violation|0
4724424|NCT03174925|7660593|FG000|Overall Study|Elastographic images not retrievable|2
4724425|NCT03174925|7660593|FG000|Overall Study|Elastography image not interpretable|1
4724426|NCT03175120|7660599|FG000|Overall Study|Adverse Event|2
4724427|NCT03175120|7660600|FG001|Overall Study|Adverse Event|2
4724428|NCT03175120|7660599|FG000|Overall Study|Protocol Violation|5
4724429|NCT03175120|7660600|FG001|Overall Study|Protocol Violation|2
4724430|NCT03175120|7660599|FG000|Overall Study|Lost to Follow-up|1
4724431|NCT03175120|7660600|FG001|Overall Study|Lost to Follow-up|0
4724432|NCT03175120|7660599|FG000|Overall Study|Withdrawal by Subject|2
4724433|NCT03175120|7660600|FG001|Overall Study|Withdrawal by Subject|5
4724434|NCT03175120|7660599|FG000|Overall Study|Other|2
4724435|NCT03175120|7660600|FG001|Overall Study|Other|3
4724436|NCT03175172|7660606|FG000|Overall Study|Death|3
4724437|NCT03175172|7660606|FG000|Overall Study|Withdrawal by Subject|3
4724438|NCT03175172|7660606|FG000|Overall Study|Lost to Follow-up|1
4724439|NCT03175172|7660606|FG000|Overall Study|Study Terminated by Sponsor|3
4724440|NCT03175562|7660610|FG000|Overall Study|Adverse Event|1
4724441|NCT03175562|7660610|FG000|Overall Study|Lost to Follow-up|3
4724442|NCT03175562|7660610|FG000|Overall Study|Withdrawal by Subject|7
4724443|NCT03175562|7660610|FG000|Overall Study|Other (Not Specified)|5
4724444|NCT03176238|7660628|FG000|Overall Study|Unacceptable AEs|15
4724445|NCT03176238|7660629|FG001|Overall Study|Unacceptable AEs|8
4724446|NCT03176238|7660628|FG000|Overall Study|Abnormal lab value(s)|2
4724447|NCT03176238|7660629|FG001|Overall Study|Abnormal lab value(s)|0
4724448|NCT03176238|7660628|FG000|Overall Study|Inter-current illness|0
4724449|NCT03176238|7660629|FG001|Overall Study|Inter-current illness|1
4724450|NCT03176238|7660628|FG000|Overall Study|Consent withdrawal|14
4724451|NCT03176238|7660629|FG001|Overall Study|Consent withdrawal|2
4724452|NCT03176238|7660628|FG000|Overall Study|Lost to Follow-up|3
4724453|NCT03176238|7660629|FG001|Overall Study|Lost to Follow-up|0
4724454|NCT03176238|7660628|FG000|Overall Study|Administrative problems|1
4724455|NCT03176238|7660629|FG001|Overall Study|Administrative problems|0
4724456|NCT03176238|7660628|FG000|Overall Study|Death|3
4724457|NCT03176238|7660629|FG001|Overall Study|Death|0
4724458|NCT03176238|7660628|FG000|Overall Study|Disease Progression|133
4724459|NCT03176238|7660629|FG001|Overall Study|Disease Progression|22
4724460|NCT03176238|7660628|FG000|Overall Study|Tx duration completed per EAP|0
4724461|NCT03176238|7660629|FG001|Overall Study|Tx duration completed per EAP|1
4724462|NCT03176238|7660628|FG000|Overall Study|Patient is switched to commercial drug|16
4724463|NCT03176238|7660629|FG001|Overall Study|Patient is switched to commercial drug|1
4724464|NCT03176238|7660628|FG000|Overall Study|Protocol Violation|1
4724465|NCT03176238|7660629|FG001|Overall Study|Protocol Violation|0
4771936|NCT03173456|7749075|FG000|Baseline|Medication dispensing system malfunction'|0
4771937|NCT03173456|7749076|FG001|Baseline|Medication dispensing system malfunction'|1
4771938|NCT03173456|7749077|FG002|Baseline|Medication dispensing system malfunction'|0
4771939|NCT03173456|7749078|FG003|Baseline|Medication dispensing system malfunction'|0
4771940|NCT03173456|7749079|FG004|Baseline|Medication dispensing system malfunction'|2
4771941|NCT03173456|7749075|FG000|2 Hour Follow-up|Withdrawal by Subject|0
4771942|NCT03173456|7749076|FG001|2 Hour Follow-up|Withdrawal by Subject|1
4771943|NCT03173456|7749077|FG002|2 Hour Follow-up|Withdrawal by Subject|1
4771944|NCT03173456|7749078|FG003|2 Hour Follow-up|Withdrawal by Subject|1
4771945|NCT03173456|7749079|FG004|2 Hour Follow-up|Withdrawal by Subject|2
4771946|NCT03020160|7749102|FG000|Overall Study|Continuing to receive emicizumab|7
4771947|NCT03020160|7749103|FG001|Overall Study|Continuing to receive emicizumab|41
4771948|NCT03003520|7749112|FG000|Induction|Ongoing|1
4771949|NCT03003520|7749113|FG001|Induction|Ongoing|0
4771950|NCT03003520|7749112|FG000|Induction|Adverse Event|4
4630905|NCT01888367|7499943|FG002|Overall Study|Protocol Violation|1
4630906|NCT01888367|7499941|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1
4630907|NCT01888367|7499942|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0
4630908|NCT01888367|7499943|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0
4630909|NCT01888432|7499953|FG000|12-month Analysis (FAS)|Lost to Follow-up|0
4630910|NCT01888432|7499954|FG001|12-month Analysis (FAS)|Lost to Follow-up|2
4630911|NCT01888432|7499953|FG000|12-month Analysis (FAS)|Physician Decision|1
4630912|NCT01888432|7499954|FG001|12-month Analysis (FAS)|Physician Decision|1
4630913|NCT01888432|7499953|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6
4771951|NCT03003520|7749113|FG001|Induction|Adverse Event|0
4771952|NCT03003520|7749112|FG000|Induction|Death|1
4771953|NCT03003520|7749113|FG001|Induction|Death|0
4771954|NCT03003520|7749112|FG000|Induction|Palliative care|1
4771955|NCT03003520|7749113|FG001|Induction|Palliative care|0
4771956|NCT03003520|7749112|FG000|Induction|Physician Decision|2
4771957|NCT03003520|7749113|FG001|Induction|Physician Decision|0
4771958|NCT03003520|7749112|FG000|Induction|Withdrawal by Subject|3
4771959|NCT03003520|7749113|FG001|Induction|Withdrawal by Subject|0
4771960|NCT03003520|7749112|FG000|Induction|Progressive disease|1
4771961|NCT03003520|7749113|FG001|Induction|Progressive disease|0
4771962|NCT03003520|7749112|FG000|Consolidation|Ongoing|18
4771963|NCT03003520|7749113|FG001|Consolidation|Ongoing|0
4771964|NCT03003520|7749112|FG000|Consolidation|Adverse Event|2
4771965|NCT03003520|7749113|FG001|Consolidation|Adverse Event|0
4771966|NCT03003520|7749112|FG000|Consolidation|Progressive disease|3
4724466|NCT03176238|7660628|FG000|Overall Study|Changes in the patient's condition|2
4724467|NCT03176238|7660629|FG001|Overall Study|Changes in the patient's condition|1
4724468|NCT03176238|7660628|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9
4724469|NCT03176238|7660629|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0
4724470|NCT03176407|7660639|FG000|Overall Study|Protocol Violation|1
4724471|NCT03176407|7660639|FG000|Overall Study|human failure|1
4724472|NCT03176407|7660639|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1
4724473|NCT03176459|7660647|FG000|Overall Study|Lost to Follow-up|5
4724474|NCT03176459|7660648|FG001|Overall Study|Lost to Follow-up|7
4724475|NCT03176784|7660667|FG000|Overall Study|Lost to Follow-up|77
4724476|NCT03176784|7660668|FG001|Overall Study|Lost to Follow-up|79
4724477|NCT03176784|7660669|FG002|Overall Study|Lost to Follow-up|79
4724478|NCT03176784|7660670|FG003|Overall Study|Lost to Follow-up|49
4724479|NCT03176784|7660667|FG000|Overall Study|Withdrawal by Subject|28
4724480|NCT03176784|7660668|FG001|Overall Study|Withdrawal by Subject|34
4724481|NCT03176784|7660669|FG002|Overall Study|Withdrawal by Subject|34
4724482|NCT03176784|7660670|FG003|Overall Study|Withdrawal by Subject|21
4724483|NCT03178266|7660738|FG000|Overall Study|Death|0
4724484|NCT03178266|7660739|FG001|Overall Study|Death|1
4724485|NCT03178266|7660738|FG000|Overall Study|Disont. Early|0
4724486|NCT03178266|7660739|FG001|Overall Study|Disont. Early|1
4724487|NCT03178266|7660738|FG000|Overall Study|Withdrawal by Subject|0
4724488|NCT03178266|7660739|FG001|Overall Study|Withdrawal by Subject|2
4724489|NCT03178669|7660757|FG000|Overall Study|Adverse Event|4
4724490|NCT03178669|7660758|FG001|Overall Study|Adverse Event|1
4724491|NCT03178669|7660759|FG002|Overall Study|Adverse Event|4
4724492|NCT03178669|7660760|FG003|Overall Study|Adverse Event|2
4724493|NCT03178669|7660761|FG004|Overall Study|Adverse Event|2
4724494|NCT03178669|7660757|FG000|Overall Study|Lack of Efficacy|0
4724495|NCT03178669|7660758|FG001|Overall Study|Lack of Efficacy|0
4724496|NCT03178669|7660759|FG002|Overall Study|Lack of Efficacy|2
4724497|NCT03178669|7660760|FG003|Overall Study|Lack of Efficacy|0
4724498|NCT03178669|7660761|FG004|Overall Study|Lack of Efficacy|1
4724499|NCT03178669|7660757|FG000|Overall Study|Physician Decision|0
4724500|NCT03178669|7660758|FG001|Overall Study|Physician Decision|0
4724501|NCT03178669|7660759|FG002|Overall Study|Physician Decision|0
4724502|NCT03178669|7660760|FG003|Overall Study|Physician Decision|0
4724503|NCT03178669|7660761|FG004|Overall Study|Physician Decision|1
4724504|NCT03178669|7660757|FG000|Overall Study|Withdrawal by Subject|1
4724505|NCT03178669|7660758|FG001|Overall Study|Withdrawal by Subject|0
4724506|NCT03178669|7660759|FG002|Overall Study|Withdrawal by Subject|1
4724507|NCT03178669|7660760|FG003|Overall Study|Withdrawal by Subject|1
4724508|NCT03178669|7660761|FG004|Overall Study|Withdrawal by Subject|0
4724509|NCT03178669|7660757|FG000|Overall Study|Lost to Follow-up|0
4724510|NCT03178669|7660758|FG001|Overall Study|Lost to Follow-up|0
4724511|NCT03178669|7660759|FG002|Overall Study|Lost to Follow-up|0
4724512|NCT03178669|7660760|FG003|Overall Study|Lost to Follow-up|1
4724513|NCT03178669|7660761|FG004|Overall Study|Lost to Follow-up|0
4724514|NCT03178773|7660775|FG000|Overall Study|Death|0
4724515|NCT03178773|7660776|FG001|Overall Study|Death|1
4724516|NCT03178773|7660775|FG000|Overall Study|Lost to Follow-up|29
4724517|NCT03178773|7660776|FG001|Overall Study|Lost to Follow-up|25
4724518|NCT03178773|7660775|FG000|Overall Study|Withdrawal by Subject|10
4724519|NCT03178773|7660776|FG001|Overall Study|Withdrawal by Subject|14
4724520|NCT03178851|7660786|FG000|Overall Study|Death|48
4724521|NCT03178851|7660787|FG001|Overall Study|Death|2
4724522|NCT03178851|7660788|FG002|Overall Study|Death|25
4724523|NCT03178851|7660786|FG000|Overall Study|Withdrawal by Subject|8
4724524|NCT03178851|7660787|FG001|Overall Study|Withdrawal by Subject|0
4724525|NCT03178851|7660788|FG002|Overall Study|Withdrawal by Subject|0
4724526|NCT03178851|7660786|FG000|Overall Study|Lost to Follow-up|5
4724527|NCT03178851|7660787|FG001|Overall Study|Lost to Follow-up|2
4724528|NCT03178851|7660788|FG002|Overall Study|Lost to Follow-up|0
4724529|NCT03178851|7660786|FG000|Overall Study|Adverse Event|0
4724530|NCT03178851|7660787|FG001|Overall Study|Adverse Event|0
4724531|NCT03178851|7660788|FG002|Overall Study|Adverse Event|1
4724532|NCT03178851|7660786|FG000|Overall Study|Study Termination by Sponsor|31
4724533|NCT03178851|7660787|FG001|Overall Study|Study Termination by Sponsor|7
4724534|NCT03178851|7660788|FG002|Overall Study|Study Termination by Sponsor|26
4724535|NCT03178942|7660799|FG000|Overall Study|Withdrawal by Subject|2
4724536|NCT03178942|7660800|FG001|Overall Study|Withdrawal by Subject|0
4724537|NCT03178942|7660799|FG000|Overall Study|Lost to Follow-up|1
4724538|NCT03178942|7660800|FG001|Overall Study|Lost to Follow-up|2
4724539|NCT03179319|7660808|FG000|Overall Study|Lost to Follow-up|6
4724540|NCT03179319|7660809|FG001|Overall Study|Lost to Follow-up|0
4724541|NCT03179787|7660842|FG000|Overall Study|Lost to Follow-up|15
4724542|NCT03179787|7660842|FG000|Overall Study|Case report failures|2
4724543|NCT03179787|7660842|FG000|Overall Study|Treatment not administered|1
4724544|NCT03179891|7660846|FG000|First Intervention|Withdrawal by Subject|1
4724545|NCT03179891|7660847|FG001|First Intervention|Withdrawal by Subject|1
4724546|NCT03179891|7660846|FG000|First Intervention|Unspecified reason|1
4724547|NCT03179891|7660847|FG001|First Intervention|Unspecified reason|0
4724548|NCT03179891|7660846|FG000|First Intervention|Protocol Violation|0
4724549|NCT03179891|7660847|FG001|First Intervention|Protocol Violation|1
4724550|NCT03180138|7660859|FG000|Overall Study|Mobile-phone could not be verified|2
4724551|NCT03180138|7660860|FG001|Overall Study|Mobile-phone could not be verified|13
4724552|NCT03180138|7660861|FG002|Overall Study|Mobile-phone could not be verified|15
4724553|NCT03180138|7660859|FG000|Overall Study|No prior immunization records|17
4724554|NCT03180138|7660860|FG001|Overall Study|No prior immunization records|0
4724555|NCT03180138|7660861|FG002|Overall Study|No prior immunization records|6
4724556|NCT03180138|7660859|FG000|Overall Study|Found to be >24 mon after randomization|3
4724557|NCT03180138|7660860|FG001|Overall Study|Found to be >24 mon after randomization|0
4724558|NCT03180138|7660861|FG002|Overall Study|Found to be >24 mon after randomization|3
4724559|NCT03180528|7660903|FG000|Overall Study|Adverse Event|1
4724560|NCT03180528|7660903|FG000|Overall Study|Withdrawal by Subject|1
4724561|NCT03180528|7660903|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1
4724562|NCT03180619|7660910|FG000|Overall Study|Withdrew Consent|5
4724563|NCT03180619|7660911|FG001|Overall Study|Withdrew Consent|0
4724564|NCT03180619|7660912|FG002|Overall Study|Withdrew Consent|2
4724565|NCT03180619|7660910|FG000|Overall Study|Death|2
4724566|NCT03180619|7660911|FG001|Overall Study|Death|1
4724567|NCT03180619|7660912|FG002|Overall Study|Death|2
4724568|NCT03180619|7660910|FG000|Overall Study|Adverse Event|2
4724569|NCT03180619|7660911|FG001|Overall Study|Adverse Event|0
4724570|NCT03180619|7660912|FG002|Overall Study|Adverse Event|1
4724571|NCT03180619|7660910|FG000|Overall Study|Investigator's discretion|2
4724572|NCT03180619|7660911|FG001|Overall Study|Investigator's discretion|0
4724573|NCT03180619|7660912|FG002|Overall Study|Investigator's discretion|1
4724574|NCT03180645|7660930|FG000|Overall Study|Adverse Event|0
4724575|NCT03180645|7660931|FG001|Overall Study|Adverse Event|1
4724576|NCT03180645|7660932|FG002|Overall Study|Adverse Event|2
4724577|NCT03180801|7660947|FG000|Overall Study|Physician Decision|3
4724578|NCT03180801|7660948|FG001|Overall Study|Physician Decision|3
4724579|NCT03180801|7660949|FG002|Overall Study|Physician Decision|1
4724580|NCT03180801|7660947|FG000|Overall Study|Non-compliance|1
4724581|NCT03180801|7660948|FG001|Overall Study|Non-compliance|4
4724582|NCT03180801|7660949|FG002|Overall Study|Non-compliance|0
4724583|NCT03180801|7660947|FG000|Overall Study|Inoculation Target Reached|1
4724584|NCT03180801|7660948|FG001|Overall Study|Inoculation Target Reached|1
4724585|NCT03180801|7660949|FG002|Overall Study|Inoculation Target Reached|3
4724586|NCT03180801|7660947|FG000|Overall Study|Adverse Event|1
4724587|NCT03180801|7660948|FG001|Overall Study|Adverse Event|0
4724588|NCT03180801|7660949|FG002|Overall Study|Adverse Event|2
4724589|NCT03180801|7660947|FG000|Overall Study|Withdrawal by Subject|2
4724590|NCT03180801|7660948|FG001|Overall Study|Withdrawal by Subject|2
4724591|NCT03180801|7660949|FG002|Overall Study|Withdrawal by Subject|1
4724592|NCT03180801|7660947|FG000|Overall Study|Lost to Follow-up|0
4724593|NCT03180801|7660948|FG001|Overall Study|Lost to Follow-up|2
4724594|NCT03180801|7660949|FG002|Overall Study|Lost to Follow-up|3
4724595|NCT03181451|7660981|FG000|Overall Study|Adverse Event|0
4724596|NCT03181451|7660982|FG001|Overall Study|Adverse Event|1
4724597|NCT03181451|7660983|FG002|Overall Study|Adverse Event|0
4724598|NCT03181451|7660981|FG000|Overall Study|Withdrawal by Subject|0
4724599|NCT03181451|7660982|FG001|Overall Study|Withdrawal by Subject|1
4724600|NCT03181451|7660983|FG002|Overall Study|Withdrawal by Subject|0
4724601|NCT03181503|7660995|FG000|Overall Study|Adverse Event|2
4724602|NCT03181503|7660996|FG001|Overall Study|Adverse Event|2
4724603|NCT03181503|7660995|FG000|Overall Study|Protocol Violation|1
4724604|NCT03181503|7660996|FG001|Overall Study|Protocol Violation|0
4724605|NCT03181503|7660995|FG000|Overall Study|Withdrawal by Subject|3
4724606|NCT03181503|7660996|FG001|Overall Study|Withdrawal by Subject|0
4724607|NCT03181503|7660995|FG000|Overall Study|Lost to Follow-up|1
4590563|NCT01522651|7436638|FG003|Overall Study|Randomized but Never Treated|1
4590564|NCT01522651|7436639|FG004|Overall Study|Randomized but Never Treated|1
4590565|NCT01522950|7436681|FG000|Overall Study|Withdrawal by Subject|3
4590566|NCT01522950|7436682|FG001|Overall Study|Withdrawal by Subject|2
4590567|NCT01522950|7436683|FG002|Overall Study|Withdrawal by Subject|1
4590568|NCT01522950|7436681|FG000|Overall Study|Adverse Event|3
4630914|NCT01888432|7499954|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3
4630915|NCT01888432|7499953|FG000|12-month Analysis (FAS)|Death|4
4590569|NCT01522950|7436682|FG001|Overall Study|Adverse Event|1
4590570|NCT01522950|7436683|FG002|Overall Study|Adverse Event|1
4590571|NCT01522950|7436681|FG000|Overall Study|Protocol Violation|0
4590572|NCT01522950|7436682|FG001|Overall Study|Protocol Violation|0
4590573|NCT01522950|7436683|FG002|Overall Study|Protocol Violation|2
4590574|NCT01522950|7436681|FG000|Overall Study|Death|0
4590575|NCT01522950|7436682|FG001|Overall Study|Death|1
4630916|NCT01888432|7499954|FG001|12-month Analysis (FAS)|Death|3
4724608|NCT03181503|7660996|FG001|Overall Study|Lost to Follow-up|1
4724609|NCT03181594|7661005|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4
4724610|NCT03181594|7661005|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3
4724611|NCT03181594|7661005|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1
4724612|NCT03181594|7661005|FG000|Initial Study Protocol (12-month FU)|Death|1
4590576|NCT01522950|7436683|FG002|Overall Study|Death|1
4590577|NCT01522950|7436681|FG000|Overall Study|Study Medication Sensitivity|0
4590578|NCT01522950|7436682|FG001|Overall Study|Study Medication Sensitivity|1
4590579|NCT01522950|7436683|FG002|Overall Study|Study Medication Sensitivity|0
4630917|NCT01888432|7499953|FG000|24-month Analysis (FAS)|Graft loss|0
4724613|NCT03181594|7661005|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3
4724614|NCT03181594|7661005|FG000|Long-term Extension (15-24 Month FU)|Death|2
4724615|NCT03181932|7661020|FG000|Period 1 (Double-blind Period)|Adverse Event|5
4724616|NCT03181932|7661021|FG001|Period 1 (Double-blind Period)|Adverse Event|1
4724617|NCT03181932|7661020|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0
4724618|NCT03181932|7661021|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1
4724619|NCT03181932|7661020|FG000|Period 1 (Double-blind Period)|Protocol Violation|1
4724620|NCT03181932|7661021|FG001|Period 1 (Double-blind Period)|Protocol Violation|2
4724621|NCT03181932|7661020|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5
4724622|NCT03181932|7661021|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9
4724623|NCT03181932|7661020|FG000|Period 2 (Open-label Period)|Adverse Event|1
4724624|NCT03181932|7661021|FG001|Period 2 (Open-label Period)|Adverse Event|6
4724625|NCT03181932|7661020|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0
4724626|NCT03181932|7661021|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1
4724627|NCT03181932|7661020|FG000|Period 2 (Open-label Period)|Protocol Violation|3
4724628|NCT03181932|7661021|FG001|Period 2 (Open-label Period)|Protocol Violation|1
4724629|NCT03181932|7661020|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2
4724630|NCT03181932|7661021|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5
4724631|NCT03181932|7661020|FG000|Period 2 (Open-label Period)|Reason missing|2
4724632|NCT03181932|7661021|FG001|Period 2 (Open-label Period)|Reason missing|0
4724633|NCT03181958|7661031|FG000|Overall Study|Lost to Follow-up|17
4724634|NCT03181958|7661032|FG001|Overall Study|Lost to Follow-up|21
4724635|NCT03181958|7661033|FG002|Overall Study|Lost to Follow-up|15
4724636|NCT03182738|7661064|FG000|Overall Study|Lost to Follow-up|9
4724637|NCT03182738|7661065|FG001|Overall Study|Lost to Follow-up|3
4724638|NCT03182738|7661064|FG000|Overall Study|Pregnancy|0
4724639|NCT03182738|7661065|FG001|Overall Study|Pregnancy|1
4724640|NCT03182738|7661064|FG000|Overall Study|Withdrawal by Subject|0
4724641|NCT03182738|7661065|FG001|Overall Study|Withdrawal by Subject|1
4724642|NCT03182868|7661076|FG000|Overall Study|Protocol Violation|3
4724643|NCT03182868|7661077|FG001|Overall Study|Protocol Violation|0
4724644|NCT03182868|7661078|FG002|Overall Study|Protocol Violation|4
4724645|NCT03182868|7661079|FG003|Overall Study|Protocol Violation|1
4724646|NCT03182868|7661080|FG004|Overall Study|Protocol Violation|8
4724647|NCT03183063|7661114|FG000|Overall Study|Withdrawal by Subject|2
4724648|NCT03183063|7661115|FG001|Overall Study|Withdrawal by Subject|0
4724649|NCT03183063|7661116|FG002|Overall Study|Withdrawal by Subject|0
4724650|NCT03183063|7661114|FG000|Overall Study|Physician Decision|3
4724651|NCT03183063|7661115|FG001|Overall Study|Physician Decision|4
4724652|NCT03183063|7661116|FG002|Overall Study|Physician Decision|4
4724653|NCT03183518|7661130|FG000|Overall Study|Other (Not specified)|2
4724654|NCT03183518|7661130|FG000|Overall Study|Other (Withdrawal of consent)|1
4724655|NCT03183908|7661146|FG000|Overall Study|Missing Symptom Diary Data|0
4724656|NCT03183908|7661147|FG001|Overall Study|Missing Symptom Diary Data|2
4724657|NCT03184077|7661159|FG000|Overall Study|Lost to Follow-up|21
4724658|NCT03184077|7661160|FG001|Overall Study|Lost to Follow-up|21
4724659|NCT03184441|7661182|FG000|Overall Study|Withdrawal by Subject|1
4724660|NCT03184519|7661189|FG000|Overall Study|Lost to Follow-up|6
4724661|NCT03184519|7661189|FG000|Overall Study|Physician Decision|21
4724662|NCT03184558|7661193|FG000|Overall Study|Withdrawal by Subject|2
4724663|NCT03184558|7661193|FG000|Overall Study|Death|16
4724664|NCT03184558|7661193|FG000|Overall Study|Lost to Follow-up|2
4724665|NCT03184558|7661193|FG000|Overall Study|Other|9
4724666|NCT03184701|7661197|FG000|Overall Study|Death|3
4724667|NCT03184701|7661197|FG000|Overall Study|Physician Decision|3
4724668|NCT03184701|7661197|FG000|Overall Study|Withdrawal by Subject|6
4724669|NCT03184701|7661197|FG000|Overall Study|Lost to Follow-up|5
4724670|NCT03184987|7661204|FG000|Overall Study|Withdrawal by Subject|0
4724671|NCT03184987|7661205|FG001|Overall Study|Withdrawal by Subject|1
4724672|NCT03184987|7661206|FG002|Overall Study|Withdrawal by Subject|2
4724673|NCT03184987|7661204|FG000|Overall Study|Physician Decision|0
4724674|NCT03184987|7661205|FG001|Overall Study|Physician Decision|0
4724675|NCT03184987|7661206|FG002|Overall Study|Physician Decision|1
4724676|NCT03184987|7661204|FG000|Overall Study|Adverse Event|1
4724677|NCT03184987|7661205|FG001|Overall Study|Adverse Event|0
4724678|NCT03184987|7661206|FG002|Overall Study|Adverse Event|1
4724679|NCT03185481|7661246|FG000|Overall Study|Adverse Event|1
4724680|NCT03185481|7661246|FG000|Overall Study|Study Terminated by Sponsor|4
4724681|NCT03186378|7661295|FG000|Overall Study|Lost to Follow-up|1
4724682|NCT03186378|7661296|FG001|Overall Study|Lost to Follow-up|0
4724683|NCT03186781|7661329|FG000|Overall Study|Lost to Follow-up|0
4724684|NCT03186781|7661330|FG001|Overall Study|Lost to Follow-up|0
4724685|NCT03186781|7661331|FG002|Overall Study|Lost to Follow-up|1
4724686|NCT03186781|7661332|FG003|Overall Study|Lost to Follow-up|0
4724687|NCT03186781|7661333|FG004|Overall Study|Lost to Follow-up|1
4724688|NCT03186781|7661334|FG005|Overall Study|Lost to Follow-up|0
4724689|NCT03186781|7661329|FG000|Overall Study|Moved from Area|0
4724690|NCT03186781|7661330|FG001|Overall Study|Moved from Area|0
4724691|NCT03186781|7661331|FG002|Overall Study|Moved from Area|0
4724692|NCT03186781|7661332|FG003|Overall Study|Moved from Area|0
4724693|NCT03186781|7661333|FG004|Overall Study|Moved from Area|1
4724694|NCT03186781|7661334|FG005|Overall Study|Moved from Area|0
4724695|NCT03186781|7661329|FG000|Overall Study|Withdrawal by Subject|0
4724696|NCT03186781|7661330|FG001|Overall Study|Withdrawal by Subject|0
4724697|NCT03186781|7661331|FG002|Overall Study|Withdrawal by Subject|0
4724698|NCT03186781|7661332|FG003|Overall Study|Withdrawal by Subject|0
4724699|NCT03186781|7661333|FG004|Overall Study|Withdrawal by Subject|1
4724700|NCT03186781|7661334|FG005|Overall Study|Withdrawal by Subject|0
4724701|NCT03187132|7661372|FG000|Inpatient Trauma Only|Lost to Follow-up|3
4724702|NCT03187132|7661373|FG001|Inpatient Trauma Only|Lost to Follow-up|12
4724703|NCT03187132|7661372|FG000|Inpatient Trauma Only|socioeconomic burden|1
4724704|NCT03187132|7661373|FG001|Inpatient Trauma Only|socioeconomic burden|0
4724705|NCT03187132|7661372|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0
4724706|NCT03187132|7661373|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5
4724707|NCT03187132|7661372|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1
4724708|NCT03187132|7661373|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0
4724709|NCT03187132|7661372|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2
4724710|NCT03187132|7661373|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5
4724711|NCT03187132|7661372|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1
4724712|NCT03187132|7661373|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0
4724713|NCT03187132|7661372|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0
4724714|NCT03187132|7661373|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2
4724715|NCT03187132|7661372|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27
4724716|NCT03187132|7661373|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47
4724717|NCT03187132|7661372|FG000|Pain Clinic Only, Fully Remote|Disease burden|6
4724718|NCT03187132|7661373|FG001|Pain Clinic Only, Fully Remote|Disease burden|5
4724719|NCT03187132|7661372|FG000|Pain Clinic Only, Fully Remote|Language barrier|0
4724720|NCT03187132|7661373|FG001|Pain Clinic Only, Fully Remote|Language barrier|1
4724721|NCT03187132|7661372|FG000|Pain Clinic Only, Fully Remote|EMR|0
4724722|NCT03187132|7661373|FG001|Pain Clinic Only, Fully Remote|EMR|1
4724723|NCT03187197|7661382|FG000|Overall Study|Stopped Pradaxa®/VKA|11
4724724|NCT03187197|7661383|FG001|Overall Study|Stopped Pradaxa®/VKA|65
4724725|NCT03187197|7661384|FG002|Overall Study|Stopped Pradaxa®/VKA|4
4724726|NCT03187197|7661382|FG000|Overall Study|Withdrawal by Subject|8
4724727|NCT03187197|7661383|FG001|Overall Study|Withdrawal by Subject|63
4724728|NCT03187197|7661384|FG002|Overall Study|Withdrawal by Subject|4
4724729|NCT03187197|7661382|FG000|Overall Study|Lost to Follow-up|1
4724730|NCT03187197|7661383|FG001|Overall Study|Lost to Follow-up|60
4724731|NCT03187197|7661384|FG002|Overall Study|Lost to Follow-up|7
4724732|NCT03187197|7661382|FG000|Overall Study|Adverse Event|6
4724733|NCT03187197|7661383|FG001|Overall Study|Adverse Event|29
4724734|NCT03187197|7661384|FG002|Overall Study|Adverse Event|0
4724735|NCT03187197|7661382|FG000|Overall Study|Death|0
4724736|NCT03187197|7661383|FG001|Overall Study|Death|11
4724737|NCT03187197|7661384|FG002|Overall Study|Death|0
4724738|NCT03187197|7661382|FG000|Overall Study|Administrative problem|1
4724739|NCT03187197|7661383|FG001|Overall Study|Administrative problem|1
4724740|NCT03187197|7661384|FG002|Overall Study|Administrative problem|0
4724741|NCT03187197|7661382|FG000|Overall Study|Reason not listed|2
4724742|NCT03187197|7661383|FG001|Overall Study|Reason not listed|54
4724743|NCT03187197|7661384|FG002|Overall Study|Reason not listed|1
4724744|NCT03187197|7661382|FG000|Overall Study|Missing|1
4724745|NCT03187197|7661383|FG001|Overall Study|Missing|32
4724746|NCT03187197|7661384|FG002|Overall Study|Missing|3
4724747|NCT03187197|7661382|FG000|Overall Study|Status missing|2
4724748|NCT03187197|7661383|FG001|Overall Study|Status missing|33
4724749|NCT03187197|7661384|FG002|Overall Study|Status missing|3
4724750|NCT03187197|7661382|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14
4724751|NCT03187197|7661383|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45
4724752|NCT03187197|7661384|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1
4771967|NCT03003520|7749113|FG001|Consolidation|Progressive disease|1
4771968|NCT03003520|7749112|FG000|Consolidation|Withdrawal by Subject|1
4771969|NCT03003520|7749113|FG001|Consolidation|Withdrawal by Subject|0
4724756|NCT03187301|7661396|FG000|Titration Period|Adverse Event|0
4724757|NCT03187301|7661397|FG001|Titration Period|Adverse Event|0
4724758|NCT03187301|7661398|FG002|Titration Period|Adverse Event|0
4724759|NCT03187301|7661399|FG003|Titration Period|Adverse Event|0
4724760|NCT03187301|7661400|FG004|Titration Period|Adverse Event|0
4724761|NCT03187301|7661401|FG005|Titration Period|Adverse Event|0
4724762|NCT03187301|7661402|FG006|Titration Period|Adverse Event|5
4724763|NCT03187301|7661396|FG000|Titration Period|Withdrawal by Subject|0
4724764|NCT03187301|7661397|FG001|Titration Period|Withdrawal by Subject|0
4724765|NCT03187301|7661398|FG002|Titration Period|Withdrawal by Subject|0
4724766|NCT03187301|7661399|FG003|Titration Period|Withdrawal by Subject|0
4630918|NCT01888432|7499954|FG001|24-month Analysis (FAS)|Graft loss|1
4724767|NCT03187301|7661400|FG004|Titration Period|Withdrawal by Subject|0
4724768|NCT03187301|7661401|FG005|Titration Period|Withdrawal by Subject|0
4724769|NCT03187301|7661402|FG006|Titration Period|Withdrawal by Subject|1
4724770|NCT03187301|7661396|FG000|Titration Period|Exclusion Criteria Met|0
4724771|NCT03187301|7661397|FG001|Titration Period|Exclusion Criteria Met|0
4724772|NCT03187301|7661398|FG002|Titration Period|Exclusion Criteria Met|0
4724773|NCT03187301|7661399|FG003|Titration Period|Exclusion Criteria Met|0
4724774|NCT03187301|7661400|FG004|Titration Period|Exclusion Criteria Met|0
4724775|NCT03187301|7661401|FG005|Titration Period|Exclusion Criteria Met|0
4724776|NCT03187301|7661402|FG006|Titration Period|Exclusion Criteria Met|1
4724777|NCT03187301|7661396|FG000|Pre-Intervention|Withdrawal by Subject|1
4724778|NCT03187301|7661397|FG001|Pre-Intervention|Withdrawal by Subject|0
4724779|NCT03187301|7661398|FG002|Pre-Intervention|Withdrawal by Subject|0
4724780|NCT03187301|7661399|FG003|Pre-Intervention|Withdrawal by Subject|0
4724781|NCT03187301|7661400|FG004|Pre-Intervention|Withdrawal by Subject|0
4724782|NCT03187301|7661401|FG005|Pre-Intervention|Withdrawal by Subject|0
4724783|NCT03187301|7661402|FG006|Pre-Intervention|Withdrawal by Subject|0
4724784|NCT03187756|7661440|FG000|Overall Study|Termination of study|4
4724785|NCT03188055|7661446|FG000|Overall Study|Unavailable for training|0
4724786|NCT03188055|7661447|FG001|Overall Study|Unavailable for training|0
4724787|NCT03188055|7661448|FG002|Overall Study|Unavailable for training|19
4724788|NCT03188055|7661449|FG003|Overall Study|Unavailable for training|0
4724789|NCT03188055|7661450|FG004|Overall Study|Unavailable for training|0
4724790|NCT03188055|7661451|FG005|Overall Study|Unavailable for training|
4724791|NCT03188055|7661446|FG000|Overall Study|Lost to Follow-up|0
4724792|NCT03188055|7661447|FG001|Overall Study|Lost to Follow-up|18
4724793|NCT03188055|7661448|FG002|Overall Study|Lost to Follow-up|0
4724794|NCT03188055|7661449|FG003|Overall Study|Lost to Follow-up|11
4724795|NCT03188055|7661450|FG004|Overall Study|Lost to Follow-up|0
4724796|NCT03188055|7661451|FG005|Overall Study|Lost to Follow-up|
4724797|NCT03188055|7661446|FG000|Overall Study|Withdrawal by Subject|0
4724798|NCT03188055|7661447|FG001|Overall Study|Withdrawal by Subject|1
4724799|NCT03188055|7661448|FG002|Overall Study|Withdrawal by Subject|0
4724800|NCT03188055|7661449|FG003|Overall Study|Withdrawal by Subject|1
4724801|NCT03188055|7661450|FG004|Overall Study|Withdrawal by Subject|0
4724802|NCT03188055|7661451|FG005|Overall Study|Withdrawal by Subject|
4724803|NCT03188120|7661462|FG000|Overall Study|Adverse Event|4
4724804|NCT03188120|7661462|FG000|Overall Study|Insufficient Effectiveness|8
4724805|NCT03188120|7661462|FG000|Overall Study|Improved|12
4724806|NCT03188120|7661462|FG000|Overall Study|Lost to Follow-up|7
4724807|NCT03188120|7661462|FG000|Overall Study|Other than specified|3
4724808|NCT03188120|7661462|FG000|Overall Study|No visit after the first visit|13
4724809|NCT03188185|7661468|FG000|Stage 1|Adverse Event|4
4724810|NCT03188185|7661469|FG001|Stage 1|Adverse Event|12
4724811|NCT03188185|7661470|FG002|Stage 1|Adverse Event|0
4724812|NCT03188185|7661471|FG003|Stage 1|Adverse Event|0
4724813|NCT03188185|7661468|FG000|Stage 1|Lack of Efficacy|0
4724814|NCT03188185|7661469|FG001|Stage 1|Lack of Efficacy|2
4724815|NCT03188185|7661470|FG002|Stage 1|Lack of Efficacy|0
4724816|NCT03188185|7661471|FG003|Stage 1|Lack of Efficacy|0
4724817|NCT03188185|7661468|FG000|Stage 1|Lost to Follow-up|6
4724818|NCT03188185|7661469|FG001|Stage 1|Lost to Follow-up|1
4724819|NCT03188185|7661470|FG002|Stage 1|Lost to Follow-up|0
4724820|NCT03188185|7661471|FG003|Stage 1|Lost to Follow-up|0
4724821|NCT03188185|7661468|FG000|Stage 1|Withdrawal by Subject|9
4724822|NCT03188185|7661469|FG001|Stage 1|Withdrawal by Subject|0
4724823|NCT03188185|7661470|FG002|Stage 1|Withdrawal by Subject|0
4724824|NCT03188185|7661471|FG003|Stage 1|Withdrawal by Subject|0
4724825|NCT03188185|7661468|FG000|Stage 1|Identified as a professional patient|0
4724826|NCT03188185|7661469|FG001|Stage 1|Identified as a professional patient|1
4724827|NCT03188185|7661470|FG002|Stage 1|Identified as a professional patient|0
4724828|NCT03188185|7661471|FG003|Stage 1|Identified as a professional patient|0
4724829|NCT03188185|7661468|FG000|Stage 2|Adverse Event|0
4724830|NCT03188185|7661469|FG001|Stage 2|Adverse Event|0
4724831|NCT03188185|7661470|FG002|Stage 2|Adverse Event|2
4724832|NCT03188185|7661471|FG003|Stage 2|Adverse Event|4
4724833|NCT03188185|7661468|FG000|Stage 2|Lack of Efficacy|0
4724834|NCT03188185|7661469|FG001|Stage 2|Lack of Efficacy|0
4724835|NCT03188185|7661470|FG002|Stage 2|Lack of Efficacy|3
4724836|NCT03188185|7661471|FG003|Stage 2|Lack of Efficacy|0
4724837|NCT03188185|7661468|FG000|Stage 2|Lost to Follow-up|0
4724838|NCT03188185|7661469|FG001|Stage 2|Lost to Follow-up|0
4724839|NCT03188185|7661470|FG002|Stage 2|Lost to Follow-up|1
4724840|NCT03188185|7661471|FG003|Stage 2|Lost to Follow-up|0
4724841|NCT03188185|7661468|FG000|Stage 2|Physician Decision|0
4724842|NCT03188185|7661469|FG001|Stage 2|Physician Decision|0
4724843|NCT03188185|7661470|FG002|Stage 2|Physician Decision|0
4724844|NCT03188185|7661471|FG003|Stage 2|Physician Decision|1
4724845|NCT03188185|7661468|FG000|Stage 2|Withdrawal by Subject|0
4724846|NCT03188185|7661469|FG001|Stage 2|Withdrawal by Subject|0
4724847|NCT03188185|7661470|FG002|Stage 2|Withdrawal by Subject|3
4724848|NCT03188185|7661471|FG003|Stage 2|Withdrawal by Subject|1
4724849|NCT03188263|7661483|FG000|Overall Study|Withdrawal by Subject|3
4724850|NCT03188263|7661484|FG001|Overall Study|Withdrawal by Subject|0
4724851|NCT03188263|7661483|FG000|Overall Study|Physician Decision|1
4724852|NCT03188263|7661484|FG001|Overall Study|Physician Decision|0
4724853|NCT03188536|7661501|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5
4724854|NCT03188536|7661501|FG000|Overall Study|Not participated/met inclusion criteria|1
4724855|NCT03188718|7661505|FG000|Overall Study|Participant noncompliance|4
4724856|NCT03188718|7661505|FG000|Overall Study|Withdrawal by Subject|1
4724857|NCT03188718|7661505|FG000|Overall Study|Device failure|3
4724858|NCT03188991|7661513|FG000|Overall Study|Withdrawal by Subject|0
4724859|NCT03188991|7661514|FG001|Overall Study|Withdrawal by Subject|0
4724860|NCT03188991|7661515|FG002|Overall Study|Withdrawal by Subject|0
4724861|NCT03188991|7661516|FG003|Overall Study|Withdrawal by Subject|1
4724862|NCT03189446|7661530|FG000|Overall Study|Adverse Event|2
4724863|NCT03189446|7661530|FG000|Overall Study|Withdrawal by Subject|2
4724864|NCT03189446|7661530|FG000|Overall Study|Physician Decision|1
4724865|NCT03189524|7661537|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7
4724866|NCT03189524|7661538|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5
4724867|NCT03189524|7661539|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11
4724868|NCT03189524|7661537|FG000|Overall Study|Death|2
4724869|NCT03189524|7661538|FG001|Overall Study|Death|2
4724870|NCT03189524|7661539|FG002|Overall Study|Death|1
4724871|NCT03189524|7661537|FG000|Overall Study|Lost to Follow-up|1
4724872|NCT03189524|7661538|FG001|Overall Study|Lost to Follow-up|0
4724873|NCT03189524|7661539|FG002|Overall Study|Lost to Follow-up|8
4724874|NCT03189524|7661537|FG000|Overall Study|Withdrawal by Subject|1
4724875|NCT03189524|7661538|FG001|Overall Study|Withdrawal by Subject|1
4724876|NCT03189524|7661539|FG002|Overall Study|Withdrawal by Subject|3
4724877|NCT03189524|7661537|FG000|Overall Study|Progressive Disease|0
4724878|NCT03189524|7661538|FG001|Overall Study|Progressive Disease|2
4724879|NCT03189524|7661539|FG002|Overall Study|Progressive Disease|0
4724880|NCT03189745|7661562|FG000|Overall Study|Conflict in work schedule of participant|1
4724881|NCT03189745|7661563|FG001|Overall Study|Conflict in work schedule of participant|1
4724882|NCT03191396|7661626|FG000|Overall Study|Lost to Follow-up|0
4724883|NCT03191396|7661627|FG001|Overall Study|Lost to Follow-up|3
4724884|NCT03191396|7661626|FG000|Overall Study|Withdrawal by Subject|3
4724885|NCT03191396|7661627|FG001|Overall Study|Withdrawal by Subject|2
4724886|NCT03191552|7661636|FG000|Overall Study|Lost to Follow-up|1
4724887|NCT03191552|7661637|FG001|Overall Study|Lost to Follow-up|0
4724888|NCT03191552|7661638|FG002|Overall Study|Lost to Follow-up|0
4724889|NCT03191552|7661636|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0
4724890|NCT03191552|7661637|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1
4724891|NCT03191552|7661638|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0
4736769|NCT03575871|7686111|FG001|Overall Study|Other than specified|2
4736770|NCT03575871|7686112|FG002|Overall Study|Other than specified|0
4736771|NCT03575975|7686130|FG000|Overall Study|Lost to Follow-up|1
4736772|NCT03575975|7686131|FG001|Overall Study|Lost to Follow-up|0
4736773|NCT03575975|7686132|FG002|Overall Study|Lost to Follow-up|0
4736774|NCT03576066|7686140|FG000|Overall Study|Noncompliance with study drug|0
4736775|NCT03576066|7686141|FG001|Overall Study|Noncompliance with study drug|1
4736776|NCT03576716|7686171|FG000|Overall Study|Withdrawal by Subject|0
4736777|NCT03576716|7686172|FG001|Overall Study|Withdrawal by Subject|1
4736778|NCT03576768|7686182|FG000|Overall Study|Lost to Follow-up|3
4736779|NCT03576768|7686183|FG001|Overall Study|Lost to Follow-up|3
4736780|NCT03576768|7686184|FG002|Overall Study|Lost to Follow-up|0
4736781|NCT03576768|7686185|FG003|Overall Study|Lost to Follow-up|0
4736782|NCT03577730|7686220|FG000|Overall Study|Physician Decision|3
4736783|NCT03577730|7686221|FG001|Overall Study|Physician Decision|1
4736784|NCT03577730|7686220|FG000|Overall Study|Did not receive allocated intervention|1
4736785|NCT03577730|7686221|FG001|Overall Study|Did not receive allocated intervention|0
4736786|NCT03578146|7686233|FG000|Overall Study|Did Not Receive Treatment|1
4736787|NCT03578146|7686234|FG001|Overall Study|Did Not Receive Treatment|0
4736788|NCT03578146|7686235|FG002|Overall Study|Did Not Receive Treatment|0
4736789|NCT03578146|7686236|FG003|Overall Study|Did Not Receive Treatment|0
4736790|NCT03578146|7686237|FG004|Overall Study|Did Not Receive Treatment|0
4736791|NCT03578146|7686238|FG005|Overall Study|Did Not Receive Treatment|2
4736792|NCT03578146|7686233|FG000|Overall Study|Lost to Follow-up|0
4736793|NCT03578146|7686234|FG001|Overall Study|Lost to Follow-up|1
4736794|NCT03578146|7686235|FG002|Overall Study|Lost to Follow-up|1
4736795|NCT03578146|7686236|FG003|Overall Study|Lost to Follow-up|0
4736796|NCT03578146|7686237|FG004|Overall Study|Lost to Follow-up|0
4736797|NCT03578146|7686238|FG005|Overall Study|Lost to Follow-up|1
4736798|NCT03579290|7686265|FG000|Overall Study|Lost to Follow-up|9
4736799|NCT03579719|7686277|FG000|Overall Study|Protocol deviation, pre-existent disease|1
4736800|NCT03579940|7686292|FG000|Period 2|Withdrawal by Subject|0
4736801|NCT03579940|7686293|FG001|Period 2|Withdrawal by Subject|0
4736802|NCT03579940|7686294|FG002|Period 2|Withdrawal by Subject|1
4736803|NCT03579940|7686295|FG003|Period 2|Withdrawal by Subject|0
4736804|NCT03579940|7686296|FG004|Period 2|Withdrawal by Subject|0
4736805|NCT03579940|7686297|FG005|Period 2|Withdrawal by Subject|0
4736806|NCT03579940|7686298|FG006|Period 2|Withdrawal by Subject|0
4736807|NCT03579940|7686299|FG007|Period 2|Withdrawal by Subject|0
4736808|NCT03579940|7686300|FG008|Period 2|Withdrawal by Subject|0
4736809|NCT03579940|7686301|FG009|Period 2|Withdrawal by Subject|0
4736810|NCT03579940|7686302|FG010|Period 2|Withdrawal by Subject|0
4736811|NCT03581825|7686357|FG000|Period 1|Lens Discomfort|1
4736812|NCT03581825|7686358|FG001|Period 1|Lens Discomfort|0
4736813|NCT03581825|7686357|FG000|Period 2|Unsatisfactory Vision to Test|0
4736814|NCT03581825|7686358|FG001|Period 2|Unsatisfactory Vision to Test|1
4736815|NCT03582215|7686372|FG000|Overall Study|Adverse Event|1
4736816|NCT03582215|7686373|FG001|Overall Study|Adverse Event|0
4736817|NCT03582215|7686374|FG002|Overall Study|Adverse Event|0
4736818|NCT03582215|7686375|FG003|Overall Study|Adverse Event|0
4736819|NCT03582215|7686376|FG004|Overall Study|Adverse Event|0
4724892|NCT03191630|7661652|FG000|Overall Study|Lost to Follow-up|7
4724893|NCT03191630|7661653|FG001|Overall Study|Lost to Follow-up|7
4724894|NCT03191799|7661661|FG000|Overall Study|Withdrawal by Subject|4
4724895|NCT03191799|7661661|FG000|Overall Study|Physician Decision|2
4724896|NCT03191799|7661661|FG000|Overall Study|Lost to Follow-up|1
4724897|NCT03191799|7661661|FG000|Overall Study|Death|2
4724898|NCT03192137|7661667|FG000|Overall Study|Adverse Event|10
4724899|NCT03192137|7661668|FG001|Overall Study|Adverse Event|11
4724900|NCT03192137|7661667|FG000|Overall Study|Physician Decision|1
4724901|NCT03192137|7661668|FG001|Overall Study|Physician Decision|0
4724902|NCT03192137|7661667|FG000|Overall Study|Lack of Efficacy|20
4724903|NCT03192137|7661668|FG001|Overall Study|Lack of Efficacy|37
4724904|NCT03192137|7661667|FG000|Overall Study|Withdrawal by Subject|3
4724905|NCT03192137|7661668|FG001|Overall Study|Withdrawal by Subject|3
4724906|NCT03192137|7661667|FG000|Overall Study|Protocol Violation|4
4724907|NCT03192137|7661668|FG001|Overall Study|Protocol Violation|3
4724908|NCT03192137|7661667|FG000|Overall Study|Surgery Cancelled|4
4724909|NCT03192137|7661668|FG001|Overall Study|Surgery Cancelled|1
4724910|NCT03192137|7661667|FG000|Overall Study|Other - Various Administrative Reasons|8
4724911|NCT03192137|7661668|FG001|Overall Study|Other - Various Administrative Reasons|3
4724912|NCT03192150|7661676|FG000|Overall Study|Adverse Event|14
4724913|NCT03192150|7661677|FG001|Overall Study|Adverse Event|12
4724914|NCT03192150|7661676|FG000|Overall Study|Lack of Efficacy|23
4724915|NCT03192150|7661677|FG001|Overall Study|Lack of Efficacy|30
4724916|NCT03192150|7661676|FG000|Overall Study|Lost to Follow-up|1
4724917|NCT03192150|7661677|FG001|Overall Study|Lost to Follow-up|1
4724918|NCT03192150|7661676|FG000|Overall Study|Withdrawal by Subject|4
4724919|NCT03192150|7661677|FG001|Overall Study|Withdrawal by Subject|2
4724920|NCT03192150|7661676|FG000|Overall Study|Protocol Violation|5
4724921|NCT03192150|7661677|FG001|Overall Study|Protocol Violation|2
4724922|NCT03192150|7661676|FG000|Overall Study|Surgery Canceled|6
4724923|NCT03192150|7661677|FG001|Overall Study|Surgery Canceled|2
4724924|NCT03192150|7661676|FG000|Overall Study|Other-Various Administrative Reasons|2
4724925|NCT03192150|7661677|FG001|Overall Study|Other-Various Administrative Reasons|5
4724926|NCT03192176|7661691|FG000|Overall Study|Adverse Event|1
4724927|NCT03192176|7661692|FG001|Overall Study|Adverse Event|0
4724928|NCT03192176|7661693|FG002|Overall Study|Adverse Event|4
4724929|NCT03192176|7661694|FG003|Overall Study|Adverse Event|5
4724930|NCT03192176|7661695|FG004|Overall Study|Adverse Event|3
4724931|NCT03192176|7661696|FG005|Overall Study|Adverse Event|2
4724932|NCT03192176|7661697|FG006|Overall Study|Adverse Event|3
4724933|NCT03192176|7661698|FG007|Overall Study|Adverse Event|3
4724934|NCT03192176|7661691|FG000|Overall Study|Lost to Follow-up|0
4724935|NCT03192176|7661692|FG001|Overall Study|Lost to Follow-up|0
4724936|NCT03192176|7661693|FG002|Overall Study|Lost to Follow-up|1
4724937|NCT03192176|7661694|FG003|Overall Study|Lost to Follow-up|2
4724938|NCT03192176|7661695|FG004|Overall Study|Lost to Follow-up|3
4724939|NCT03192176|7661696|FG005|Overall Study|Lost to Follow-up|1
4724940|NCT03192176|7661697|FG006|Overall Study|Lost to Follow-up|1
4724941|NCT03192176|7661698|FG007|Overall Study|Lost to Follow-up|1
4630919|NCT01888432|7499953|FG000|24-month Analysis (FAS)|Lost to Follow-up|0
4724942|NCT03192176|7661691|FG000|Overall Study|Physician Decision|1
4724943|NCT03192176|7661692|FG001|Overall Study|Physician Decision|0
4724944|NCT03192176|7661693|FG002|Overall Study|Physician Decision|0
4724945|NCT03192176|7661694|FG003|Overall Study|Physician Decision|0
4724946|NCT03192176|7661695|FG004|Overall Study|Physician Decision|0
4724947|NCT03192176|7661696|FG005|Overall Study|Physician Decision|2
4724948|NCT03192176|7661697|FG006|Overall Study|Physician Decision|1
4724949|NCT03192176|7661698|FG007|Overall Study|Physician Decision|0
4724950|NCT03192176|7661691|FG000|Overall Study|Protocol Deviation|1
4724951|NCT03192176|7661692|FG001|Overall Study|Protocol Deviation|1
4724952|NCT03192176|7661693|FG002|Overall Study|Protocol Deviation|0
4724953|NCT03192176|7661694|FG003|Overall Study|Protocol Deviation|0
4724954|NCT03192176|7661695|FG004|Overall Study|Protocol Deviation|2
4724955|NCT03192176|7661696|FG005|Overall Study|Protocol Deviation|0
4724956|NCT03192176|7661697|FG006|Overall Study|Protocol Deviation|0
4724957|NCT03192176|7661698|FG007|Overall Study|Protocol Deviation|0
4724958|NCT03192176|7661691|FG000|Overall Study|Withdrawal by Subject|3
4724959|NCT03192176|7661692|FG001|Overall Study|Withdrawal by Subject|4
4724960|NCT03192176|7661693|FG002|Overall Study|Withdrawal by Subject|0
4724961|NCT03192176|7661694|FG003|Overall Study|Withdrawal by Subject|4
4724962|NCT03192176|7661695|FG004|Overall Study|Withdrawal by Subject|3
4724963|NCT03192176|7661696|FG005|Overall Study|Withdrawal by Subject|4
4724964|NCT03192176|7661697|FG006|Overall Study|Withdrawal by Subject|4
4771970|NCT03003520|7749112|FG000|Follow-up|Death|1
4724965|NCT03192176|7661698|FG007|Overall Study|Withdrawal by Subject|2
4724966|NCT03192176|7661691|FG000|Overall Study|Miscellaneous|1
4724967|NCT03192176|7661692|FG001|Overall Study|Miscellaneous|0
4724968|NCT03192176|7661693|FG002|Overall Study|Miscellaneous|1
4724969|NCT03192176|7661694|FG003|Overall Study|Miscellaneous|1
4724970|NCT03192176|7661695|FG004|Overall Study|Miscellaneous|1
4724971|NCT03192176|7661696|FG005|Overall Study|Miscellaneous|2
4724972|NCT03192176|7661697|FG006|Overall Study|Miscellaneous|0
4724973|NCT03192176|7661698|FG007|Overall Study|Miscellaneous|1
4724974|NCT03192306|7661719|FG000|Overall Study|Did not treat cold sore during study|149
4736820|NCT03582215|7686377|FG005|Overall Study|Adverse Event|0
4724975|NCT03192306|7661720|FG001|Overall Study|Did not treat cold sore during study|143
4724976|NCT03192306|7661719|FG000|Overall Study|Withdrawal by Subject|1
4724977|NCT03192306|7661720|FG001|Overall Study|Withdrawal by Subject|1
4724978|NCT03192306|7661719|FG000|Overall Study|Lost to Follow-up|1
4724979|NCT03192306|7661720|FG001|Overall Study|Lost to Follow-up|0
4724980|NCT03192306|7661719|FG000|Overall Study|Protocol Violation|1
4724981|NCT03192306|7661720|FG001|Overall Study|Protocol Violation|1
4724982|NCT03192475|7661728|FG000|Overall Study|Death|0
4724983|NCT03192475|7661729|FG001|Overall Study|Death|1
4724984|NCT03192475|7661728|FG000|Overall Study|Lost to Follow-up|13
4724985|NCT03192475|7661729|FG001|Overall Study|Lost to Follow-up|8
4724986|NCT03192488|7661736|FG000|First Washout (>6d)|Withdrawal by Subject|0
4724987|NCT03192488|7661737|FG001|First Washout (>6d)|Withdrawal by Subject|0
4724988|NCT03192488|7661738|FG002|First Washout (>6d)|Withdrawal by Subject|1
4724989|NCT03192488|7661739|FG003|First Washout (>6d)|Withdrawal by Subject|0
4724990|NCT03192488|7661740|FG004|First Washout (>6d)|Withdrawal by Subject|0
4724991|NCT03192488|7661741|FG005|First Washout (>6d)|Withdrawal by Subject|1
4724992|NCT03192488|7661736|FG000|Third Intervention (d1)|Adverse Event|0
4724993|NCT03192488|7661737|FG001|Third Intervention (d1)|Adverse Event|0
4724994|NCT03192488|7661738|FG002|Third Intervention (d1)|Adverse Event|0
4724995|NCT03192488|7661739|FG003|Third Intervention (d1)|Adverse Event|0
4724996|NCT03192488|7661740|FG004|Third Intervention (d1)|Adverse Event|1
4724997|NCT03192488|7661741|FG005|Third Intervention (d1)|Adverse Event|0
4724998|NCT03192904|7661770|FG000|Overall Study|Physician Decision|3
4724999|NCT03192904|7661771|FG001|Overall Study|Physician Decision|1
4725000|NCT03192904|7661770|FG000|Overall Study|Lost to Follow-up|0
4725001|NCT03192904|7661771|FG001|Overall Study|Lost to Follow-up|1
4725002|NCT03193021|7661779|FG000|Overall Study|Lost to Follow-up|1
4725003|NCT03193021|7661780|FG001|Overall Study|Lost to Follow-up|1
4725004|NCT03193047|7661788|FG000|Overall Study|Physician Decision|1
4725005|NCT03193047|7661789|FG001|Overall Study|Physician Decision|0
4725006|NCT03193047|7661788|FG000|Overall Study|Participant Left State|1
4725007|NCT03193047|7661789|FG001|Overall Study|Participant Left State|0
4725008|NCT03193736|7661835|FG000|Overall Study|Death|2
4725009|NCT03193736|7661835|FG000|Overall Study|Withdrawal by Subject|1
4725010|NCT03193736|7661835|FG000|Overall Study|Lost to Follow-up|1
4725011|NCT03193736|7661835|FG000|Overall Study|implant not received|1
4725012|NCT03194217|7661843|FG000|Overall Study|Adverse Event|0
4725013|NCT03194217|7661844|FG001|Overall Study|Adverse Event|2
4725014|NCT03194217|7661845|FG002|Overall Study|Adverse Event|3
4725015|NCT03194217|7661846|FG003|Overall Study|Adverse Event|3
4725016|NCT03194217|7661843|FG000|Overall Study|Failure to meet randomisation criteria|0
4725017|NCT03194217|7661844|FG001|Overall Study|Failure to meet randomisation criteria|0
4725018|NCT03194217|7661845|FG002|Overall Study|Failure to meet randomisation criteria|0
4725019|NCT03194217|7661846|FG003|Overall Study|Failure to meet randomisation criteria|1
4725020|NCT03194217|7661843|FG000|Overall Study|Other|0
4725021|NCT03194217|7661844|FG001|Overall Study|Other|1
4725022|NCT03194217|7661845|FG002|Overall Study|Other|1
4725023|NCT03194217|7661846|FG003|Overall Study|Other|0
4725024|NCT03194464|7661874|FG000|Overall Study|data not usable|2
4725025|NCT03194490|7661882|FG000|Overall Study|Lost to Follow-up|1
4725026|NCT03194490|7661883|FG001|Overall Study|Lost to Follow-up|3
4725027|NCT03194490|7661882|FG000|Overall Study|participant developed specific neck pain|1
4725028|NCT03194490|7661883|FG001|Overall Study|participant developed specific neck pain|0
4725029|NCT03196193|7661963|FG000|Overall Study|Adverse Event|1
4725030|NCT03196193|7661964|FG001|Overall Study|Adverse Event|0
4725031|NCT03196193|7661963|FG000|Overall Study|Computed Tomography (CT) data missing|2
4725032|NCT03196193|7661964|FG001|Overall Study|Computed Tomography (CT) data missing|0
4725033|NCT03196284|7661976|FG000|Main Part|Withdrawal by Subject|0
4725034|NCT03196284|7661977|FG001|Main Part|Withdrawal by Subject|1
4725035|NCT03196284|7661978|FG002|Main Part|Withdrawal by Subject|0
4725036|NCT03196284|7661976|FG000|Extension Part|Lack of Efficacy|0
4725037|NCT03196284|7661977|FG001|Extension Part|Lack of Efficacy|0
4725038|NCT03196284|7661978|FG002|Extension Part|Lack of Efficacy|1
4725039|NCT03196284|7661976|FG000|Extension Part|Withdrawal by Subject|0
4725040|NCT03196284|7661977|FG001|Extension Part|Withdrawal by Subject|0
4725041|NCT03196284|7661978|FG002|Extension Part|Withdrawal by Subject|1
4725042|NCT03196284|7661976|FG000|Extension Part|Physician Decision|0
4725043|NCT03196284|7661977|FG001|Extension Part|Physician Decision|0
4725044|NCT03196284|7661978|FG002|Extension Part|Physician Decision|1
4725045|NCT03196297|7661998|FG000|Main Period|Withdrawal by Subject|4
4725046|NCT03196297|7661998|FG000|Extension Period|Withdrawal by Subject|1
4725047|NCT03196297|7661998|FG000|Extension Period|Lack of Efficacy|2
4725048|NCT03196349|7662017|FG000|Overall Study|Did not receive study drug|0
4725049|NCT03196349|7662018|FG001|Overall Study|Did not receive study drug|1
4725050|NCT03196349|7662019|FG002|Overall Study|Did not receive study drug|2
4725051|NCT03196349|7662017|FG000|Overall Study|No data entered|2
4725052|NCT03196349|7662018|FG001|Overall Study|No data entered|4
4725053|NCT03196349|7662019|FG002|Overall Study|No data entered|0
4725054|NCT03196349|7662017|FG000|Overall Study|Study Terminated early|15
4725055|NCT03196349|7662018|FG001|Overall Study|Study Terminated early|9
4725056|NCT03196349|7662019|FG002|Overall Study|Study Terminated early|11
4725057|NCT03196505|7662029|FG000|Overall Study|Physician Decision|26
4725058|NCT03196505|7662030|FG001|Overall Study|Physician Decision|26
4725059|NCT03196635|7662036|FG000|Overall Study|Withdrawal by Subject|1
4725060|NCT03196791|7662056|FG000|Overall Study|Protocol Violation|7
4725061|NCT03196791|7662057|FG001|Overall Study|Protocol Violation|3
4725062|NCT03196791|7662056|FG000|Overall Study|Withdrawal by Subject|3
4725063|NCT03196791|7662057|FG001|Overall Study|Withdrawal by Subject|2
4725064|NCT03196973|7662066|FG000|Overall Study|Adverse Event|1
4725065|NCT03196973|7662067|FG001|Overall Study|Adverse Event|1
4725066|NCT03196973|7662068|FG002|Overall Study|Adverse Event|2
4725067|NCT03196973|7662066|FG000|Overall Study|Lack of Efficacy|2
4725068|NCT03196973|7662067|FG001|Overall Study|Lack of Efficacy|6
4725069|NCT03196973|7662068|FG002|Overall Study|Lack of Efficacy|1
4725070|NCT03196973|7662066|FG000|Overall Study|Lost to Follow-up|4
4725071|NCT03196973|7662067|FG001|Overall Study|Lost to Follow-up|3
4725072|NCT03196973|7662068|FG002|Overall Study|Lost to Follow-up|2
4725073|NCT03196973|7662066|FG000|Overall Study|Consent withdrawn|2
4725074|NCT03196973|7662067|FG001|Overall Study|Consent withdrawn|1
4725075|NCT03196973|7662068|FG002|Overall Study|Consent withdrawn|0
4725076|NCT03196973|7662066|FG000|Overall Study|Administration of a wrong kit of study medication|0
4725077|NCT03196973|7662067|FG001|Overall Study|Administration of a wrong kit of study medication|1
4725078|NCT03196973|7662068|FG002|Overall Study|Administration of a wrong kit of study medication|0
4725079|NCT03197129|7662091|FG000|Overall Study|did not answer the VPT: shyness|4
4725080|NCT03197129|7662092|FG001|Overall Study|did not answer the VPT: shyness|5
4725081|NCT03197324|7662100|FG000|Overall Study|Adverse Event|0
4725082|NCT03197324|7662101|FG001|Overall Study|Adverse Event|1
4725083|NCT03197376|7662111|FG000|Primary and Booster Phase|Adverse Event|0
4725084|NCT03197376|7662112|FG001|Primary and Booster Phase|Adverse Event|0
4725085|NCT03197376|7662113|FG002|Primary and Booster Phase|Adverse Event|0
4725086|NCT03197376|7662114|FG003|Primary and Booster Phase|Adverse Event|1
4725087|NCT03197376|7662111|FG000|Primary and Booster Phase|Death|1
4725088|NCT03197376|7662112|FG001|Primary and Booster Phase|Death|0
4725089|NCT03197376|7662113|FG002|Primary and Booster Phase|Death|0
4725090|NCT03197376|7662114|FG003|Primary and Booster Phase|Death|2
4725091|NCT03197376|7662111|FG000|Primary and Booster Phase|Lost to Follow-up|0
4725092|NCT03197376|7662112|FG001|Primary and Booster Phase|Lost to Follow-up|0
4725093|NCT03197376|7662113|FG002|Primary and Booster Phase|Lost to Follow-up|1
4725094|NCT03197376|7662114|FG003|Primary and Booster Phase|Lost to Follow-up|0
4725095|NCT03197376|7662111|FG000|Primary and Booster Phase|Physician Decision|1
4725096|NCT03197376|7662112|FG001|Primary and Booster Phase|Physician Decision|0
4725097|NCT03197376|7662113|FG002|Primary and Booster Phase|Physician Decision|1
4725098|NCT03197376|7662114|FG003|Primary and Booster Phase|Physician Decision|3
4725099|NCT03197376|7662111|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11
4725100|NCT03197376|7662112|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10
4725101|NCT03197376|7662113|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14
4725102|NCT03197376|7662114|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11
4725103|NCT03197376|7662111|FG000|Primary and Booster Phase|Ineligibility criteria|1
4725104|NCT03197376|7662112|FG001|Primary and Booster Phase|Ineligibility criteria|1
4725105|NCT03197376|7662113|FG002|Primary and Booster Phase|Ineligibility criteria|4
4725106|NCT03197376|7662114|FG003|Primary and Booster Phase|Ineligibility criteria|2
4725107|NCT03197376|7662111|FG000|Primary and Booster Phase|Not vaccine related|1
4725108|NCT03197376|7662112|FG001|Primary and Booster Phase|Not vaccine related|2
4725109|NCT03197376|7662113|FG002|Primary and Booster Phase|Not vaccine related|0
4725110|NCT03197376|7662114|FG003|Primary and Booster Phase|Not vaccine related|6
4725111|NCT03197376|7662111|FG000|Immune Persistence Phase|Lost to Follow-up|0
4725112|NCT03197376|7662112|FG001|Immune Persistence Phase|Lost to Follow-up|0
4725113|NCT03197376|7662113|FG002|Immune Persistence Phase|Lost to Follow-up|2
4725114|NCT03197376|7662114|FG003|Immune Persistence Phase|Lost to Follow-up|1
4725115|NCT03197376|7662111|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4
4725116|NCT03197376|7662112|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4
4725117|NCT03197376|7662113|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2
4725118|NCT03197376|7662114|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3
4725119|NCT03197376|7662111|FG000|Immune Persistence Phase|Not vaccine related|1
4725120|NCT03197376|7662112|FG001|Immune Persistence Phase|Not vaccine related|0
4725121|NCT03197376|7662113|FG002|Immune Persistence Phase|Not vaccine related|1
4725122|NCT03197376|7662114|FG003|Immune Persistence Phase|Not vaccine related|1
4725123|NCT03197558|7662172|FG000|Overall Study|Tubes not placed|1
4725124|NCT03197883|7662178|FG000|Overall Study|Adverse Event|1
4725125|NCT03197883|7662179|FG001|Overall Study|Adverse Event|1
4725126|NCT03197883|7662178|FG000|Overall Study|Lost to Follow-up|1
4725127|NCT03197883|7662179|FG001|Overall Study|Lost to Follow-up|0
4725128|NCT03197883|7662178|FG000|Overall Study|Protocol Violation|1
4725129|NCT03197883|7662179|FG001|Overall Study|Protocol Violation|0
4725130|NCT03197883|7662178|FG000|Overall Study|Other (Not Specified)|0
4725131|NCT03197883|7662179|FG001|Overall Study|Other (Not Specified)|5
4725132|NCT03198507|7662217|FG000|Overall Study|Withdrawal by Subject|1
4725133|NCT03198507|7662218|FG001|Overall Study|Withdrawal by Subject|0
4725134|NCT03198520|7662224|FG000|Overall Study|Physician Decision|2
4725135|NCT03198520|7662224|FG000|Overall Study|Protocol Violation|2
4725136|NCT03198520|7662224|FG000|Overall Study|Withdrawal by Subject|1
4725137|NCT03198520|7662224|FG000|Overall Study|Study Ended|1
4725138|NCT03198715|7662241|FG000|Overall Study|Death|0
4725139|NCT03198715|7662242|FG001|Overall Study|Death|0
4725140|NCT03198715|7662243|FG002|Overall Study|Death|1
4725141|NCT03198715|7662244|FG003|Overall Study|Death|0
4725142|NCT03198715|7662245|FG004|Overall Study|Death|2
4725143|NCT03198715|7662241|FG000|Overall Study|Other|0
4725144|NCT03198715|7662242|FG001|Overall Study|Other|1
4725145|NCT03198715|7662243|FG002|Overall Study|Other|1
4725146|NCT03198715|7662244|FG003|Overall Study|Other|0
4725147|NCT03198715|7662245|FG004|Overall Study|Other|0
4725148|NCT03198754|7662259|FG000|Overall Study|Withdrawal by Subject|5
4725149|NCT03198754|7662260|FG001|Overall Study|Withdrawal by Subject|4
4725150|NCT03198754|7662259|FG000|Overall Study|Lost to Follow-up|4
4725151|NCT03198754|7662260|FG001|Overall Study|Lost to Follow-up|3
4725152|NCT03198754|7662259|FG000|Overall Study|Ineligible|2
4725153|NCT03198754|7662260|FG001|Overall Study|Ineligible|1
4725154|NCT03198767|7662273|FG000|Overall Study|Protocol Violation|0
4725155|NCT03198767|7662274|FG001|Overall Study|Protocol Violation|0
4725156|NCT03198767|7662275|FG002|Overall Study|Protocol Violation|0
4725157|NCT03198767|7662276|FG003|Overall Study|Protocol Violation|6
4725158|NCT03198767|7662277|FG004|Overall Study|Protocol Violation|0
4725159|NCT03198767|7662278|FG005|Overall Study|Protocol Violation|0
4725160|NCT03198767|7662279|FG006|Overall Study|Protocol Violation|0
4771971|NCT03003520|7749113|FG001|Follow-up|Death|1
4771972|NCT03003520|7749112|FG000|Follow-up|Ongoing|12
4771973|NCT03003520|7749113|FG001|Follow-up|Ongoing|2
4771974|NCT03003520|7749112|FG000|Follow-up|Withdrawal by Subject|1
4771975|NCT03003520|7749113|FG001|Follow-up|Withdrawal by Subject|0
4771976|NCT02862457|7749134|FG000|Overall Study|Death|1
4771977|NCT02862457|7749135|FG001|Overall Study|Death|3
4771978|NCT02862457|7749136|FG002|Overall Study|Death|2
4771979|NCT02862457|7749137|FG003|Overall Study|Death|3
4771980|NCT02862457|7749138|FG004|Overall Study|Death|0
4771981|NCT02862457|7749139|FG005|Overall Study|Death|2
4771982|NCT02862457|7749140|FG006|Overall Study|Death|1
4771983|NCT02862457|7749134|FG000|Overall Study|Lost to Follow-up|1
4771984|NCT02862457|7749135|FG001|Overall Study|Lost to Follow-up|0
4771985|NCT02862457|7749136|FG002|Overall Study|Lost to Follow-up|0
4771986|NCT02862457|7749137|FG003|Overall Study|Lost to Follow-up|1
4771987|NCT02862457|7749138|FG004|Overall Study|Lost to Follow-up|0
4771988|NCT02862457|7749139|FG005|Overall Study|Lost to Follow-up|0
4771989|NCT02862457|7749140|FG006|Overall Study|Lost to Follow-up|0
4771990|NCT02862457|7749134|FG000|Overall Study|Withdrawal by Subject|0
4771991|NCT02862457|7749135|FG001|Overall Study|Withdrawal by Subject|0
4771992|NCT02862457|7749136|FG002|Overall Study|Withdrawal by Subject|1
4771993|NCT02862457|7749137|FG003|Overall Study|Withdrawal by Subject|0
4771994|NCT02862457|7749138|FG004|Overall Study|Withdrawal by Subject|0
4771995|NCT02862457|7749139|FG005|Overall Study|Withdrawal by Subject|1
4771996|NCT02862457|7749140|FG006|Overall Study|Withdrawal by Subject|0
4771997|NCT02820753|7749166|FG000|2 Month|Withdrawal by Subject|3
4771998|NCT02820753|7749167|FG001|2 Month|Withdrawal by Subject|3
4771999|NCT02820753|7749166|FG000|2 Month|Lost to Follow-up|24
4772000|NCT02820753|7749167|FG001|2 Month|Lost to Follow-up|26
4772001|NCT02820753|7749166|FG000|2 Month|Stopped per NIH Hold|51
4772002|NCT02820753|7749167|FG001|2 Month|Stopped per NIH Hold|13
4772003|NCT02820753|7749166|FG000|6 Month|Withdrawal by Subject|2
4772004|NCT02820753|7749167|FG001|6 Month|Withdrawal by Subject|2
4772005|NCT02820753|7749166|FG000|6 Month|Lost to Follow-up|20
4772006|NCT02820753|7749167|FG001|6 Month|Lost to Follow-up|27
4772007|NCT02820753|7749166|FG000|6 Month|Stopped per NIH Hold|81
4772008|NCT02820753|7749167|FG001|6 Month|Stopped per NIH Hold|81
4772009|NCT02820753|7749166|FG000|6 Month|Death|0
4772010|NCT02820753|7749167|FG001|6 Month|Death|1
4772011|NCT02733042|7749192|FG000|Treatment Period|Adverse Event|1
4772012|NCT02733042|7749193|FG001|Treatment Period|Adverse Event|0
4772013|NCT02733042|7749194|FG002|Treatment Period|Adverse Event|1
4772014|NCT02733042|7749195|FG003|Treatment Period|Adverse Event|1
4772015|NCT02733042|7749196|FG004|Treatment Period|Adverse Event|0
4772016|NCT02733042|7749197|FG005|Treatment Period|Adverse Event|0
4772017|NCT02733042|7749198|FG006|Treatment Period|Adverse Event|0
4772018|NCT02733042|7749199|FG007|Treatment Period|Adverse Event|0
4772019|NCT02733042|7749200|FG008|Treatment Period|Adverse Event|0
4772020|NCT02733042|7749201|FG009|Treatment Period|Adverse Event|0
4772021|NCT02733042|7749202|FG010|Treatment Period|Adverse Event|2
4772022|NCT02733042|7749203|FG011|Treatment Period|Adverse Event|2
4772023|NCT02733042|7749204|FG012|Treatment Period|Adverse Event|0
4772024|NCT02733042|7749205|FG013|Treatment Period|Adverse Event|2
4772025|NCT02733042|7749206|FG014|Treatment Period|Adverse Event|0
4772026|NCT02733042|7749207|FG015|Treatment Period|Adverse Event|0
4725161|NCT03199911|7662346|FG000|Overall Study|Lost to Follow-up|5
4725162|NCT03199911|7662347|FG001|Overall Study|Lost to Follow-up|5
4772027|NCT02733042|7749208|FG016|Treatment Period|Adverse Event|0
4772028|NCT02733042|7749209|FG017|Treatment Period|Adverse Event|1
4772029|NCT02733042|7749210|FG018|Treatment Period|Adverse Event|0
4772030|NCT02733042|7749192|FG000|Treatment Period|Progressive Disease|2
4772031|NCT02733042|7749193|FG001|Treatment Period|Progressive Disease|1
4772032|NCT02733042|7749194|FG002|Treatment Period|Progressive Disease|3
4772033|NCT02733042|7749195|FG003|Treatment Period|Progressive Disease|1
4772034|NCT02733042|7749196|FG004|Treatment Period|Progressive Disease|1
4772035|NCT02733042|7749197|FG005|Treatment Period|Progressive Disease|3
4725163|NCT03199911|7662346|FG000|Overall Study|Did not proceed with surgery|2
4725164|NCT03199911|7662347|FG001|Overall Study|Did not proceed with surgery|1
4725165|NCT03199963|7662355|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5
4725166|NCT03199963|7662356|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5
4725167|NCT03199963|7662355|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9
4725168|NCT03199963|7662356|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2
4725169|NCT03199963|7662355|FG000|Blinded Phase - Overall Study|Adverse Event|10
4725170|NCT03199963|7662356|FG001|Blinded Phase - Overall Study|Adverse Event|5
4725171|NCT03199963|7662355|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109
4725172|NCT03199963|7662356|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54
4725173|NCT03199963|7662355|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7
4725174|NCT03199963|7662356|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5
4725175|NCT03199963|7662355|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0
4725176|NCT03199963|7662356|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1
4725177|NCT03200366|7662367|FG000|Patient Navigation Intervention Given|Death|0
4725178|NCT03200366|7662368|FG001|Patient Navigation Intervention Given|Death|2
4725179|NCT03200366|7662369|FG002|Patient Navigation Intervention Given|Death|0
4725180|NCT03200366|7662367|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0
4725181|NCT03200366|7662368|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25
4725182|NCT03200366|7662369|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0
4725183|NCT03200366|7662367|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0
4725184|NCT03200366|7662368|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1
4725185|NCT03200366|7662369|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0
4725186|NCT03200366|7662367|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0
4725187|NCT03200366|7662368|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2
4725188|NCT03200366|7662369|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0
4725189|NCT03200366|7662367|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0
4725190|NCT03200366|7662368|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1
4725191|NCT03200366|7662369|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0
4725192|NCT03200366|7662367|FG000|6 Month Post-Baseline Interview|Death|1
4725193|NCT03200366|7662368|FG001|6 Month Post-Baseline Interview|Death|1
4725194|NCT03200366|7662369|FG002|6 Month Post-Baseline Interview|Death|1
4725195|NCT03200366|7662367|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27
4725196|NCT03200366|7662368|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21
4725197|NCT03200366|7662369|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17
4725198|NCT03200366|7662367|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1
4725199|NCT03200366|7662368|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1
4725200|NCT03200366|7662369|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0
4725201|NCT03200366|7662367|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1
4725202|NCT03200366|7662368|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0
4725203|NCT03200366|7662369|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0
4725204|NCT03200366|7662367|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0
4725205|NCT03200366|7662368|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0
4725206|NCT03200366|7662369|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1
4725207|NCT03200366|7662367|FG000|9 Month Post-Baseline Interview|Death|1
4725208|NCT03200366|7662368|FG001|9 Month Post-Baseline Interview|Death|1
4725209|NCT03200366|7662369|FG002|9 Month Post-Baseline Interview|Death|1
4725210|NCT03200366|7662367|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23
4725211|NCT03200366|7662368|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18
4725212|NCT03200366|7662369|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9
4725213|NCT03200366|7662367|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0
4725214|NCT03200366|7662368|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0
4725215|NCT03200366|7662369|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1
4725216|NCT03200366|7662367|FG000|9 Month Post-Baseline Interview|Refused interview|0
4725217|NCT03200366|7662368|FG001|9 Month Post-Baseline Interview|Refused interview|2
4725218|NCT03200366|7662369|FG002|9 Month Post-Baseline Interview|Refused interview|0
4725219|NCT03200860|7662398|FG000|Overall Study|Withdrawal by Subject|1
4725220|NCT03200860|7662399|FG001|Overall Study|Withdrawal by Subject|0
4725221|NCT03200912|7662408|FG000|Overall Study|Adverse Event|3
4725222|NCT03200912|7662409|FG001|Overall Study|Adverse Event|0
4725223|NCT03200912|7662410|FG002|Overall Study|Adverse Event|0
4725224|NCT03200912|7662408|FG000|Overall Study|Withdrawal by Subject|1
4725225|NCT03200912|7662409|FG001|Overall Study|Withdrawal by Subject|2
4725226|NCT03200912|7662410|FG002|Overall Study|Withdrawal by Subject|4
4725227|NCT03200912|7662408|FG000|Overall Study|Non-compliance with study drug|0
4725228|NCT03200912|7662409|FG001|Overall Study|Non-compliance with study drug|1
4725229|NCT03200912|7662410|FG002|Overall Study|Non-compliance with study drug|0
4725230|NCT03201003|7662429|FG000|Overall Study|Adverse Event|14
4725231|NCT03201003|7662430|FG001|Overall Study|Adverse Event|1
4725232|NCT03201003|7662429|FG000|Overall Study|Other reasons|5
4725233|NCT03201003|7662430|FG001|Overall Study|Other reasons|1
4725234|NCT03201003|7662429|FG000|Overall Study|Withdrawal by Subject|4
4725235|NCT03201003|7662430|FG001|Overall Study|Withdrawal by Subject|1
4725236|NCT03201003|7662429|FG000|Overall Study|Lost to Follow-up|2
4725237|NCT03201003|7662430|FG001|Overall Study|Lost to Follow-up|0
4725238|NCT03201003|7662429|FG000|Overall Study|Protocol Violation|1
4725239|NCT03201003|7662430|FG001|Overall Study|Protocol Violation|0
4725240|NCT03201211|7662439|FG000|Overall Study|Adverse Event|1
4725241|NCT03201211|7662440|FG001|Overall Study|Adverse Event|0
4725242|NCT03201211|7662441|FG002|Overall Study|Adverse Event|0
4725243|NCT03201211|7662439|FG000|Overall Study|Protocol Violation|1
4725244|NCT03201211|7662440|FG001|Overall Study|Protocol Violation|0
4725245|NCT03201211|7662441|FG002|Overall Study|Protocol Violation|0
4725246|NCT03201211|7662439|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
4725247|NCT03201211|7662440|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
4725248|NCT03201211|7662441|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1
4725249|NCT03201211|7662439|FG000|Overall Study|OTHER unknown reasons|0
4725250|NCT03201211|7662440|FG001|Overall Study|OTHER unknown reasons|1
4725251|NCT03201211|7662441|FG002|Overall Study|OTHER unknown reasons|0
4725252|NCT03201562|7662452|FG000|Overall Study|Physician Decision|0
4725253|NCT03201562|7662453|FG001|Overall Study|Physician Decision|0
4725254|NCT03201562|7662454|FG002|Overall Study|Physician Decision|1
4725255|NCT03201562|7662452|FG000|Overall Study|Adverse Event|0
4725256|NCT03201562|7662453|FG001|Overall Study|Adverse Event|0
4725257|NCT03201562|7662454|FG002|Overall Study|Adverse Event|1
4725258|NCT03201562|7662452|FG000|Overall Study|Lost to Follow-up|0
4725259|NCT03201562|7662453|FG001|Overall Study|Lost to Follow-up|1
4725260|NCT03201562|7662454|FG002|Overall Study|Lost to Follow-up|2
4725261|NCT03201809|7662464|FG000|Overall Study|Lost to Follow-up|2
4725262|NCT03201809|7662465|FG001|Overall Study|Lost to Follow-up|0
4725263|NCT03201900|7662471|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9
4725264|NCT03201900|7662471|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1
4725265|NCT03201900|7662471|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6
4725266|NCT03201900|7662471|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2
4725267|NCT03201900|7662471|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6
4725268|NCT03201900|7662471|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11
4725269|NCT03201900|7662471|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2
4725270|NCT03201900|7662471|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1
4725271|NCT03201900|7662471|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1
4725272|NCT03201900|7662471|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1
4725273|NCT03201900|7662471|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1
4725274|NCT03201900|7662471|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3
4725275|NCT03201900|7662471|FG000|Extension Phase (From Week 63 to 156)|Other|1
4725276|NCT03202511|7662494|FG000|Overall Study|Withdrawal by Subject|1
4725277|NCT03202511|7662495|FG001|Overall Study|Withdrawal by Subject|0
4725278|NCT03203291|7662510|FG000|Overall Study|Withdrawal by Subject|1
4725279|NCT03203447|7662516|FG000|Overall Study|Withdrawal by Subject|2
4725280|NCT03203447|7662517|FG001|Overall Study|Withdrawal by Subject|1
4725281|NCT03203447|7662516|FG000|Overall Study|Lost to Follow-up|1
4725282|NCT03203447|7662517|FG001|Overall Study|Lost to Follow-up|10
4725283|NCT03203447|7662516|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159
4725284|NCT03203447|7662517|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152
4725285|NCT03204279|7662546|FG000|Overall Study|Withdrawal by Subject|0
4725286|NCT03204279|7662547|FG001|Overall Study|Withdrawal by Subject|1
4725287|NCT03204981|7662576|FG000|Overall Study|Physician Decision|2
4725288|NCT03204981|7662576|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4
4725289|NCT03205046|7662584|FG000|Overall Study|Death|10
4725290|NCT03205046|7662585|FG001|Overall Study|Death|6
4725291|NCT03205046|7662584|FG000|Overall Study|Withdrawal by Subject|1
4725292|NCT03205046|7662585|FG001|Overall Study|Withdrawal by Subject|2
4725293|NCT03205046|7662584|FG000|Overall Study|Lost to Follow-up|0
4725294|NCT03205046|7662585|FG001|Overall Study|Lost to Follow-up|1
4725295|NCT03205046|7662584|FG000|Overall Study|Study terminated by sponsor|2
4725296|NCT03205046|7662585|FG001|Overall Study|Study terminated by sponsor|1
4725297|NCT03205150|7662594|FG000|Overall Study|Protocol deviation|1
4725298|NCT03205150|7662595|FG001|Overall Study|Protocol deviation|3
4725299|NCT03205150|7662596|FG002|Overall Study|Protocol deviation|0
4725300|NCT03205150|7662594|FG000|Overall Study|Patient/guardian decision|0
4725301|NCT03205150|7662595|FG001|Overall Study|Patient/guardian decision|3
4725302|NCT03205150|7662596|FG002|Overall Study|Patient/guardian decision|0
4725303|NCT03205150|7662594|FG000|Overall Study|Adverse Event|1
4725304|NCT03205150|7662595|FG001|Overall Study|Adverse Event|1
4725305|NCT03205150|7662596|FG002|Overall Study|Adverse Event|1
4725306|NCT03205150|7662594|FG000|Overall Study|Lost to Follow-up|0
4725307|NCT03205150|7662595|FG001|Overall Study|Lost to Follow-up|0
4725308|NCT03205150|7662596|FG002|Overall Study|Lost to Follow-up|1
4725309|NCT03205488|7662608|FG000|Overall Study|Adverse Event|1
4725310|NCT03205488|7662609|FG001|Overall Study|Adverse Event|2
4725311|NCT03205488|7662610|FG002|Overall Study|Adverse Event|4
4725312|NCT03205488|7662608|FG000|Overall Study|Protocol Violation|0
4725313|NCT03205488|7662609|FG001|Overall Study|Protocol Violation|0
4725314|NCT03205488|7662610|FG002|Overall Study|Protocol Violation|1
4725315|NCT03205566|7662624|FG000|Phase 1|Protocol Violation|1
4725316|NCT03205566|7662625|FG001|Phase 1|Protocol Violation|1
4725317|NCT03206749|7662638|FG000|Overall Study|Withdrawal of consent|5
4725318|NCT03206749|7662639|FG001|Overall Study|Withdrawal of consent|3
4725319|NCT03206749|7662640|FG002|Overall Study|Withdrawal of consent|6
4725320|NCT03206749|7662638|FG000|Overall Study|Lost to Follow-up|0
4725321|NCT03206749|7662639|FG001|Overall Study|Lost to Follow-up|0
4725322|NCT03206749|7662640|FG002|Overall Study|Lost to Follow-up|1
4725323|NCT03206788|7662651|FG000|Overall Study|Withdrawal by Subject|0
4725324|NCT03206788|7662652|FG001|Overall Study|Withdrawal by Subject|1
4725325|NCT03206788|7662651|FG000|Overall Study|Adverse Event|0
4725326|NCT03206788|7662652|FG001|Overall Study|Adverse Event|1
4725327|NCT03206788|7662651|FG000|Overall Study|Physician Decision|0
4725328|NCT03206788|7662652|FG001|Overall Study|Physician Decision|1
4725329|NCT03206918|7662658|FG000|Overall Study|Death|11
4725330|NCT03206918|7662658|FG000|Overall Study|Withdrawal by Subject|5
4725331|NCT03206918|7662658|FG000|Overall Study|Study terminated by sponsor|12
4725332|NCT03206918|7662658|FG000|Overall Study|Lost to Follow-up|3
4725333|NCT03206918|7662658|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60
4725334|NCT03206970|7662663|FG000|Overall Study|Death|21
4725335|NCT03206970|7662663|FG000|Overall Study|Withdrawal by Subject|13
4725336|NCT03206970|7662663|FG000|Overall Study|Lost to Follow-up|3
4725337|NCT03206970|7662663|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49
4725338|NCT03207243|7662691|FG000|Overall Study|Adverse Event|2
4725339|NCT03207243|7662692|FG001|Overall Study|Adverse Event|2
4725340|NCT03207243|7662691|FG000|Overall Study|Loss of Asthma Control|47
4725341|NCT03207243|7662692|FG001|Overall Study|Loss of Asthma Control|31
4725342|NCT03207243|7662691|FG000|Overall Study|Withdrawal by Subject|2
4725343|NCT03207243|7662692|FG001|Overall Study|Withdrawal by Subject|4
4725344|NCT03207243|7662691|FG000|Overall Study|Physician Decision|1
4725345|NCT03207243|7662692|FG001|Overall Study|Physician Decision|1
4725346|NCT03207243|7662691|FG000|Overall Study|Lost to Follow-up|0
4725347|NCT03207243|7662692|FG001|Overall Study|Lost to Follow-up|1
4725348|NCT03207243|7662691|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7
4725349|NCT03207243|7662692|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2
4725350|NCT03207243|7662691|FG000|Overall Study|Protocol Violation|0
4725351|NCT03207243|7662692|FG001|Overall Study|Protocol Violation|3
4725352|NCT03207750|7662732|FG000|Overall Study|Adverse Event|3
4725353|NCT03207750|7662733|FG001|Overall Study|Adverse Event|2
4725354|NCT03207750|7662732|FG000|Overall Study|Lost to Follow-up|21
4725355|NCT03207750|7662733|FG001|Overall Study|Lost to Follow-up|29
4446603|NCT00485134|7231667|FG003|Overall Study|Pregnancy|0
4446604|NCT00485134|7231668|FG004|Overall Study|Pregnancy|0
4446605|NCT00485134|7231669|FG005|Overall Study|Pregnancy|0
4725356|NCT03207750|7662732|FG000|Overall Study|Protocol Violation|0
4725357|NCT03207750|7662733|FG001|Overall Study|Protocol Violation|1
4725358|NCT03207750|7662732|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11
4725359|NCT03207750|7662733|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13
4725360|NCT03207750|7662732|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7
4725361|NCT03207750|7662733|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10
4725362|NCT03207750|7662732|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10
4725363|NCT03207750|7662733|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5
4725364|NCT03207750|7662732|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1
4725365|NCT03207750|7662733|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2
4725366|NCT03207750|7662732|FG000|Overall Study|OTHER, NOT SPECIFIED|5
4725367|NCT03207750|7662733|FG001|Overall Study|OTHER, NOT SPECIFIED|4
4725368|NCT03207763|7662741|FG000|Overall Study|Lost to Follow-up|1
4725369|NCT03207763|7662742|FG001|Overall Study|Lost to Follow-up|0
4725370|NCT03208088|7662757|FG000|Period 2|Withdrawal by Subject|0
4725371|NCT03208088|7662758|FG001|Period 2|Withdrawal by Subject|0
4725372|NCT03208088|7662759|FG002|Period 2|Withdrawal by Subject|0
4725373|NCT03208088|7662760|FG003|Period 2|Withdrawal by Subject|0
4725374|NCT03208088|7662761|FG004|Period 2|Withdrawal by Subject|0
4725375|NCT03208088|7662762|FG005|Period 2|Withdrawal by Subject|0
4725376|NCT03208088|7662763|FG006|Period 2|Withdrawal by Subject|0
4725377|NCT03208088|7662764|FG007|Period 2|Withdrawal by Subject|0
4725378|NCT03208088|7662765|FG008|Period 2|Withdrawal by Subject|1
4725379|NCT03208088|7662766|FG009|Period 2|Withdrawal by Subject|0
4725380|NCT03208088|7662757|FG000|Period 3|Unsatisfactory Test Article|0
4725381|NCT03208088|7662758|FG001|Period 3|Unsatisfactory Test Article|0
4725382|NCT03208088|7662759|FG002|Period 3|Unsatisfactory Test Article|0
4725383|NCT03208088|7662760|FG003|Period 3|Unsatisfactory Test Article|1
4725384|NCT03208088|7662761|FG004|Period 3|Unsatisfactory Test Article|0
4725385|NCT03208088|7662762|FG005|Period 3|Unsatisfactory Test Article|0
4725386|NCT03208088|7662763|FG006|Period 3|Unsatisfactory Test Article|0
4725387|NCT03208088|7662764|FG007|Period 3|Unsatisfactory Test Article|0
4725388|NCT03208088|7662765|FG008|Period 3|Unsatisfactory Test Article|0
4725389|NCT03208088|7662766|FG009|Period 3|Unsatisfactory Test Article|0
4725390|NCT03208088|7662757|FG000|Period 4|Unsatisfactory Test Article|0
4725391|NCT03208088|7662758|FG001|Period 4|Unsatisfactory Test Article|0
4725392|NCT03208088|7662759|FG002|Period 4|Unsatisfactory Test Article|0
4725393|NCT03208088|7662760|FG003|Period 4|Unsatisfactory Test Article|1
4725394|NCT03208088|7662761|FG004|Period 4|Unsatisfactory Test Article|0
4725395|NCT03208088|7662762|FG005|Period 4|Unsatisfactory Test Article|0
4725396|NCT03208088|7662763|FG006|Period 4|Unsatisfactory Test Article|0
4725397|NCT03208088|7662764|FG007|Period 4|Unsatisfactory Test Article|0
4725398|NCT03208088|7662765|FG008|Period 4|Unsatisfactory Test Article|0
4725399|NCT03208088|7662766|FG009|Period 4|Unsatisfactory Test Article|0
4736821|NCT03582215|7686378|FG006|Overall Study|Adverse Event|2
4736822|NCT03582215|7686379|FG007|Overall Study|Adverse Event|2
4736823|NCT03582813|7686439|FG000|Overall Study|Lost to Follow-up|18
4736824|NCT03582813|7686440|FG001|Overall Study|Lost to Follow-up|21
4736825|NCT03582813|7686439|FG000|Overall Study|Withdrawal by Subject|1
4736826|NCT03582813|7686440|FG001|Overall Study|Withdrawal by Subject|0
4736827|NCT03582826|7686448|FG000|Overall Study|Lost to Follow-up|39
4736828|NCT03582826|7686449|FG001|Overall Study|Lost to Follow-up|0
4736829|NCT03582826|7686448|FG000|Overall Study|Withdrawal by Subject|2
4736830|NCT03582826|7686449|FG001|Overall Study|Withdrawal by Subject|0
4736831|NCT03582943|7686466|FG000|Allocated to Groups|Withdrawal by Subject|1
4736832|NCT03582943|7686467|FG001|Allocated to Groups|Withdrawal by Subject|1
4736833|NCT03582943|7686466|FG000|Intervention and Follow up|Withdrawal by Subject|4
4736834|NCT03582943|7686467|FG001|Intervention and Follow up|Withdrawal by Subject|2
4736835|NCT03582943|7686466|FG000|Analyzed|Protocol Violation|4
4736836|NCT03582943|7686467|FG001|Analyzed|Protocol Violation|1
4736837|NCT03583372|7686477|FG000|Overall Study|Withdrawal by Subject|6
4736838|NCT03583372|7686478|FG001|Overall Study|Withdrawal by Subject|11
4736839|NCT03583372|7686479|FG002|Overall Study|Withdrawal by Subject|7
4736840|NCT03583372|7686480|FG003|Overall Study|Withdrawal by Subject|8
4736841|NCT03583372|7686477|FG000|Overall Study|Lost to Follow-up|4
4736842|NCT03583372|7686478|FG001|Overall Study|Lost to Follow-up|6
4736843|NCT03583372|7686479|FG002|Overall Study|Lost to Follow-up|3
4736844|NCT03583372|7686480|FG003|Overall Study|Lost to Follow-up|2
4736845|NCT03583372|7686477|FG000|Overall Study|Adverse Event|1
4736846|NCT03583372|7686478|FG001|Overall Study|Adverse Event|3
4736847|NCT03583372|7686479|FG002|Overall Study|Adverse Event|4
4736848|NCT03583372|7686480|FG003|Overall Study|Adverse Event|4
4736849|NCT03583372|7686477|FG000|Overall Study|Physician Decision|0
4736850|NCT03583372|7686478|FG001|Overall Study|Physician Decision|1
4736851|NCT03583372|7686479|FG002|Overall Study|Physician Decision|1
4736852|NCT03583372|7686480|FG003|Overall Study|Physician Decision|1
4736853|NCT03583372|7686477|FG000|Overall Study|Lack of Efficacy|0
4736854|NCT03583372|7686478|FG001|Overall Study|Lack of Efficacy|1
4736855|NCT03583372|7686479|FG002|Overall Study|Lack of Efficacy|0
4736856|NCT03583372|7686480|FG003|Overall Study|Lack of Efficacy|1
4736857|NCT03583372|7686477|FG000|Overall Study|Death|1
4736858|NCT03583372|7686478|FG001|Overall Study|Death|0
4736859|NCT03583372|7686479|FG002|Overall Study|Death|0
4736860|NCT03583372|7686480|FG003|Overall Study|Death|0
4736861|NCT03583372|7686477|FG000|Overall Study|Protocol Violation|0
4736862|NCT03583372|7686478|FG001|Overall Study|Protocol Violation|1
4736863|NCT03583372|7686479|FG002|Overall Study|Protocol Violation|0
4736864|NCT03583372|7686480|FG003|Overall Study|Protocol Violation|0
4736865|NCT03583372|7686477|FG000|Overall Study|Subject Withdrawn due to Sponsor|0
4736866|NCT03583372|7686478|FG001|Overall Study|Subject Withdrawn due to Sponsor|0
4736867|NCT03583372|7686479|FG002|Overall Study|Subject Withdrawn due to Sponsor|0
4736868|NCT03583372|7686480|FG003|Overall Study|Subject Withdrawn due to Sponsor|1
4736869|NCT03583372|7686477|FG000|Overall Study|Did Not Receive Study Drug|0
4736870|NCT03583372|7686478|FG001|Overall Study|Did Not Receive Study Drug|1
4736871|NCT03583372|7686479|FG002|Overall Study|Did Not Receive Study Drug|0
4736872|NCT03583372|7686480|FG003|Overall Study|Did Not Receive Study Drug|0
4736873|NCT03583372|7686477|FG000|Overall Study|Captured as Other in the Database|1
4736874|NCT03583372|7686478|FG001|Overall Study|Captured as Other in the Database|2
4736875|NCT03583372|7686479|FG002|Overall Study|Captured as Other in the Database|4
4736876|NCT03583372|7686480|FG003|Overall Study|Captured as Other in the Database|1
4736877|NCT03583385|7686490|FG000|Treatment Period 1|Withdrawal by Subject|1
4736878|NCT03583385|7686491|FG001|Treatment Period 1|Withdrawal by Subject|1
4736879|NCT03583385|7686490|FG000|Treatment Period 2|Adverse Event|1
4736880|NCT03583385|7686491|FG001|Treatment Period 2|Adverse Event|0
4737625|NCT03614156|7687816|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3
4737626|NCT03614156|7687817|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4
4737627|NCT03614156|7687814|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0
4737628|NCT03614156|7687815|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1
4737629|NCT03614156|7687816|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1
4737630|NCT03614156|7687817|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1
4737631|NCT03614156|7687814|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0
4737632|NCT03614156|7687815|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22
4737633|NCT03614156|7687816|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26
4737634|NCT03614156|7687817|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38
4737635|NCT03614156|7687814|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0
4737636|NCT03614156|7687815|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1
4737637|NCT03614156|7687816|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0
4725400|NCT03208933|7662802|FG000|Overall Study|Death|3
4725401|NCT03208933|7662802|FG000|Overall Study|Withdrawal by Subject|3
4725402|NCT03208933|7662802|FG000|Overall Study|Adverse Event|1
4725403|NCT03208933|7662802|FG000|Overall Study|Lost to Follow-up|2
4725404|NCT03208933|7662802|FG000|Overall Study|Physician Decision|3
4725405|NCT03208933|7662802|FG000|Overall Study|Protocol Violation|1
4725406|NCT03209362|7662813|FG000|Overall Study|Adverse Event|0
4725407|NCT03209362|7662814|FG001|Overall Study|Adverse Event|1
4725408|NCT03209362|7662813|FG000|Overall Study|Lost to Follow-up|0
4725409|NCT03209362|7662814|FG001|Overall Study|Lost to Follow-up|1
4725410|NCT03209362|7662813|FG000|Overall Study|Withdrawal by Subject|2
4725411|NCT03209362|7662814|FG001|Overall Study|Withdrawal by Subject|0
4725412|NCT03209362|7662813|FG000|Overall Study|Other|0
4725413|NCT03209362|7662814|FG001|Overall Study|Other|1
4725414|NCT03209492|7662820|FG000|Overall Study|Case Report Forms Uncollected|5
4725415|NCT03209518|7662831|FG000|Overall Study|Case Report Forms Uncollected|1
4725416|NCT03209518|7662831|FG000|Overall Study|Protocol Deviation|1
4725417|NCT03209570|7662837|FG000|Overall Study|Death|1
4725418|NCT03209570|7662838|FG001|Overall Study|Death|0
4725419|NCT03209570|7662837|FG000|Overall Study|Incomplete Data|8
4725420|NCT03209570|7662838|FG001|Overall Study|Incomplete Data|10
4725421|NCT03209570|7662837|FG000|Overall Study|Protocol Violation|1
4725422|NCT03209570|7662838|FG001|Overall Study|Protocol Violation|0
4725423|NCT03209570|7662837|FG000|Overall Study|Withdrawal by Subject|0
4725424|NCT03209570|7662838|FG001|Overall Study|Withdrawal by Subject|3
4725425|NCT03209973|7662855|FG000|Overall Study|Withdrawal by Subject|7
4725426|NCT03209973|7662855|FG000|Overall Study|Lost to Follow-up|2
4725427|NCT03209973|7662855|FG000|Overall Study|Death|8
4725428|NCT03209973|7662855|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32
4725429|NCT03209973|7662855|FG000|Overall Study|Sponsor Decision|18
4725430|NCT03209973|7662855|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1
4725431|NCT03209973|7662855|FG000|Overall Study|Participant Refused to Return to Treatment|2
4725432|NCT03210220|7662872|FG000|Overall Study|Physician Decision|1
4725433|NCT03210220|7662873|FG001|Overall Study|Physician Decision|0
4725434|NCT03210259|7662881|FG000|12-Week Run-in Period|Adverse Event|1
4725435|NCT03210259|7662882|FG001|12-Week Run-in Period|Adverse Event|0
4725436|NCT03210259|7662883|FG002|12-Week Run-in Period|Adverse Event|0
4725437|NCT03210259|7662881|FG000|12-Week Run-in Period|Death|1
4725438|NCT03210259|7662882|FG001|12-Week Run-in Period|Death|0
4725439|NCT03210259|7662883|FG002|12-Week Run-in Period|Death|0
4725440|NCT03210259|7662881|FG000|12-Week Run-in Period|Withdrawal by Subject|9
4725441|NCT03210259|7662882|FG001|12-Week Run-in Period|Withdrawal by Subject|0
4725442|NCT03210259|7662883|FG002|12-Week Run-in Period|Withdrawal by Subject|0
4725443|NCT03210259|7662881|FG000|12-Week Run-in Period|Lost to Follow-up|4
4725444|NCT03210259|7662882|FG001|12-Week Run-in Period|Lost to Follow-up|0
4725445|NCT03210259|7662883|FG002|12-Week Run-in Period|Lost to Follow-up|0
4725446|NCT03210259|7662881|FG000|12-Week Run-in Period|Lack of Efficacy|6
4725447|NCT03210259|7662882|FG001|12-Week Run-in Period|Lack of Efficacy|0
4725448|NCT03210259|7662883|FG002|12-Week Run-in Period|Lack of Efficacy|0
4725449|NCT03210259|7662881|FG000|48-Week Randomized Responder Period|Missed study visit|0
4725450|NCT03210259|7662882|FG001|48-Week Randomized Responder Period|Missed study visit|1
4725451|NCT03210259|7662883|FG002|48-Week Randomized Responder Period|Missed study visit|2
4725452|NCT03210259|7662881|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0
4725453|NCT03210259|7662882|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3
4725454|NCT03210259|7662883|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8
4725455|NCT03210259|7662881|FG000|48-Week Randomized Responder Period|Pregnancy|0
4725456|NCT03210259|7662882|FG001|48-Week Randomized Responder Period|Pregnancy|1
4725457|NCT03210259|7662883|FG002|48-Week Randomized Responder Period|Pregnancy|0
4725458|NCT03210259|7662881|FG000|48-Week Randomized Responder Period|Physician Decision|0
4725459|NCT03210259|7662882|FG001|48-Week Randomized Responder Period|Physician Decision|0
4725460|NCT03210259|7662883|FG002|48-Week Randomized Responder Period|Physician Decision|1
4725461|NCT03210259|7662881|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0
4725462|NCT03210259|7662882|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5
4725463|NCT03210259|7662883|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17
4725464|NCT03210259|7662881|FG000|48-Week Randomized Responder Period|Adverse Event|0
4725465|NCT03210259|7662882|FG001|48-Week Randomized Responder Period|Adverse Event|1
4725466|NCT03210259|7662883|FG002|48-Week Randomized Responder Period|Adverse Event|1
4725467|NCT03210519|7662910|FG000|Overall Study|Adverse Event|2
4725468|NCT03210519|7662911|FG001|Overall Study|Adverse Event|0
4725469|NCT03210961|7662936|FG000|Overall Study|Adverse Event|0
4725470|NCT03210961|7662937|FG001|Overall Study|Adverse Event|0
4725471|NCT03210961|7662938|FG002|Overall Study|Adverse Event|0
4725472|NCT03210961|7662939|FG003|Overall Study|Adverse Event|0
4725473|NCT03210961|7662940|FG004|Overall Study|Adverse Event|0
4725474|NCT03210961|7662941|FG005|Overall Study|Adverse Event|0
4725475|NCT03210961|7662942|FG006|Overall Study|Adverse Event|0
4725476|NCT03210961|7662943|FG007|Overall Study|Adverse Event|0
4725477|NCT03210961|7662944|FG008|Overall Study|Adverse Event|0
4725478|NCT03210961|7662945|FG009|Overall Study|Adverse Event|0
4725479|NCT03210961|7662946|FG010|Overall Study|Adverse Event|0
4725480|NCT03210961|7662947|FG011|Overall Study|Adverse Event|0
4725481|NCT03210961|7662948|FG012|Overall Study|Adverse Event|0
4725482|NCT03210961|7662949|FG013|Overall Study|Adverse Event|1
4725483|NCT03210961|7662950|FG014|Overall Study|Adverse Event|0
4725484|NCT03210961|7662936|FG000|Overall Study|Lost to Follow-up|0
4725485|NCT03210961|7662937|FG001|Overall Study|Lost to Follow-up|0
4725486|NCT03210961|7662938|FG002|Overall Study|Lost to Follow-up|0
4725487|NCT03210961|7662939|FG003|Overall Study|Lost to Follow-up|0
4725488|NCT03210961|7662940|FG004|Overall Study|Lost to Follow-up|0
4725489|NCT03210961|7662941|FG005|Overall Study|Lost to Follow-up|0
4725490|NCT03210961|7662942|FG006|Overall Study|Lost to Follow-up|0
4725491|NCT03210961|7662943|FG007|Overall Study|Lost to Follow-up|0
4725492|NCT03210961|7662944|FG008|Overall Study|Lost to Follow-up|0
4725493|NCT03210961|7662945|FG009|Overall Study|Lost to Follow-up|0
4725494|NCT03210961|7662946|FG010|Overall Study|Lost to Follow-up|0
4725495|NCT03210961|7662947|FG011|Overall Study|Lost to Follow-up|0
4725496|NCT03210961|7662948|FG012|Overall Study|Lost to Follow-up|0
4725497|NCT03210961|7662949|FG013|Overall Study|Lost to Follow-up|0
4725498|NCT03210961|7662950|FG014|Overall Study|Lost to Follow-up|1
4725499|NCT03210961|7662936|FG000|Overall Study|Withdrawal by Subject|0
4725500|NCT03210961|7662937|FG001|Overall Study|Withdrawal by Subject|0
4725501|NCT03210961|7662938|FG002|Overall Study|Withdrawal by Subject|0
4725502|NCT03210961|7662939|FG003|Overall Study|Withdrawal by Subject|0
4725503|NCT03210961|7662940|FG004|Overall Study|Withdrawal by Subject|0
4725504|NCT03210961|7662941|FG005|Overall Study|Withdrawal by Subject|0
4725505|NCT03210961|7662942|FG006|Overall Study|Withdrawal by Subject|0
4725506|NCT03210961|7662943|FG007|Overall Study|Withdrawal by Subject|0
4725507|NCT03210961|7662944|FG008|Overall Study|Withdrawal by Subject|0
4725508|NCT03210961|7662945|FG009|Overall Study|Withdrawal by Subject|0
4725509|NCT03210961|7662946|FG010|Overall Study|Withdrawal by Subject|0
4725510|NCT03210961|7662947|FG011|Overall Study|Withdrawal by Subject|0
4725511|NCT03210961|7662948|FG012|Overall Study|Withdrawal by Subject|0
4725512|NCT03210961|7662949|FG013|Overall Study|Withdrawal by Subject|0
4725513|NCT03210961|7662950|FG014|Overall Study|Withdrawal by Subject|1
4725514|NCT03210961|7662936|FG000|Overall Study|No Longer Meets Eligibility Criteria|0
4725515|NCT03210961|7662937|FG001|Overall Study|No Longer Meets Eligibility Criteria|0
4725516|NCT03210961|7662938|FG002|Overall Study|No Longer Meets Eligibility Criteria|0
4725517|NCT03210961|7662939|FG003|Overall Study|No Longer Meets Eligibility Criteria|0
4725518|NCT03210961|7662940|FG004|Overall Study|No Longer Meets Eligibility Criteria|0
4725519|NCT03210961|7662941|FG005|Overall Study|No Longer Meets Eligibility Criteria|0
4725520|NCT03210961|7662942|FG006|Overall Study|No Longer Meets Eligibility Criteria|0
4725521|NCT03210961|7662943|FG007|Overall Study|No Longer Meets Eligibility Criteria|0
4725522|NCT03210961|7662944|FG008|Overall Study|No Longer Meets Eligibility Criteria|0
4725523|NCT03210961|7662945|FG009|Overall Study|No Longer Meets Eligibility Criteria|0
4725524|NCT03210961|7662946|FG010|Overall Study|No Longer Meets Eligibility Criteria|0
4725525|NCT03210961|7662947|FG011|Overall Study|No Longer Meets Eligibility Criteria|0
4725526|NCT03210961|7662948|FG012|Overall Study|No Longer Meets Eligibility Criteria|0
4725527|NCT03210961|7662949|FG013|Overall Study|No Longer Meets Eligibility Criteria|1
4725528|NCT03210961|7662950|FG014|Overall Study|No Longer Meets Eligibility Criteria|0
4725529|NCT03210961|7662936|FG000|Overall Study|Other|0
4725530|NCT03210961|7662937|FG001|Overall Study|Other|0
4725531|NCT03210961|7662938|FG002|Overall Study|Other|0
4725532|NCT03210961|7662939|FG003|Overall Study|Other|1
4725533|NCT03210961|7662940|FG004|Overall Study|Other|0
4725534|NCT03210961|7662941|FG005|Overall Study|Other|0
4725535|NCT03210961|7662942|FG006|Overall Study|Other|1
4725536|NCT03210961|7662943|FG007|Overall Study|Other|0
4725537|NCT03210961|7662944|FG008|Overall Study|Other|0
4725538|NCT03210961|7662945|FG009|Overall Study|Other|0
4725539|NCT03210961|7662946|FG010|Overall Study|Other|1
4725540|NCT03210961|7662947|FG011|Overall Study|Other|0
4725541|NCT03210961|7662948|FG012|Overall Study|Other|2
4725542|NCT03210961|7662949|FG013|Overall Study|Other|2
4725543|NCT03210961|7662950|FG014|Overall Study|Other|0
4725544|NCT03211156|7663010|FG000|Overall Study|Withdrawal by Subject|0
4725545|NCT03211156|7663011|FG001|Overall Study|Withdrawal by Subject|2
4725546|NCT03211156|7663010|FG000|Overall Study|Lost to Follow-up|1
4725547|NCT03211156|7663011|FG001|Overall Study|Lost to Follow-up|1
4725548|NCT03211156|7663010|FG000|Overall Study|Adverse Event|1
4725549|NCT03211156|7663011|FG001|Overall Study|Adverse Event|0
4725550|NCT03212261|7663030|FG000|Overall Study|Became ineligible d/t tech|2
4725551|NCT03212261|7663030|FG000|Overall Study|Tech Trouble- No first study visit|1
4725552|NCT03212261|7663030|FG000|Overall Study|Lost to Follow-up|7
4725553|NCT03212261|7663030|FG000|Overall Study|Family Emergency|1
4725554|NCT03212261|7663030|FG000|Overall Study|Too busy/ No time|5
4725555|NCT03212326|7663035|FG000|Overall Study|Physician Decision|4
4725556|NCT03212365|7663041|FG000|Overall Study|Discharged prior to Xa level|12
4725557|NCT03212365|7663042|FG001|Overall Study|Discharged prior to Xa level|8
4725558|NCT03212365|7663041|FG000|Overall Study|Bled requiring enoxaparin cessation|4
4725559|NCT03212365|7663042|FG001|Overall Study|Bled requiring enoxaparin cessation|2
4725560|NCT03212365|7663041|FG000|Overall Study|Refused study medication|3
4725561|NCT03212365|7663042|FG001|Overall Study|Refused study medication|0
4725562|NCT03212365|7663041|FG000|Overall Study|Initiated heparin infusion on floor|1
4772036|NCT02733042|7749198|FG006|Treatment Period|Progressive Disease|0
4725563|NCT03212365|7663042|FG001|Overall Study|Initiated heparin infusion on floor|1
4725564|NCT03212365|7663041|FG000|Overall Study|Unexpected return to OR|1
4725565|NCT03212365|7663042|FG001|Overall Study|Unexpected return to OR|1
4725566|NCT03212365|7663041|FG000|Overall Study|Medication distribution error|1
4725567|NCT03212365|7663042|FG001|Overall Study|Medication distribution error|0
4725568|NCT03212365|7663041|FG000|Overall Study|Required epidural placement|1
4725569|NCT03212365|7663042|FG001|Overall Study|Required epidural placement|0
4725570|NCT03212365|7663041|FG000|Overall Study|Withdrawal by Subject|0
4725571|NCT03212365|7663042|FG001|Overall Study|Withdrawal by Subject|1
4725572|NCT03212365|7663041|FG000|Overall Study|developed acute renal failure|0
4725573|NCT03212365|7663042|FG001|Overall Study|developed acute renal failure|1
4725574|NCT03212521|7663048|FG000|Overall Study|Adverse Event|1
4725575|NCT03212521|7663048|FG000|Overall Study|Lost to Follow-up|4
4725576|NCT03212521|7663048|FG000|Overall Study|Withdrawal by Subject|1
4725577|NCT03212521|7663048|FG000|Overall Study|Other|1
4725578|NCT03212690|7663070|FG000|Overall Study|Protocol Violation|1
4725579|NCT03213210|7663074|FG000|Overall Study|Lost to Follow-up|2
4725580|NCT03213210|7663074|FG000|Overall Study|Study termination|3
4725581|NCT03213366|7663080|FG000|Overall Study|Lost to Follow-up|9
4725582|NCT03213366|7663081|FG001|Overall Study|Lost to Follow-up|4
4725583|NCT03213509|7663106|FG000|Overall Study|Did not consent for verbal autopsy|4
4725584|NCT03213509|7663107|FG001|Overall Study|Did not consent for verbal autopsy|5
4725585|NCT03213626|7663114|FG000|Overall Study|Adverse Event|1
4725586|NCT03213626|7663114|FG000|Overall Study|Progressive Disease|6
4725587|NCT03213938|7663120|FG000|Overall Study|Lost to Follow-up|4
4725588|NCT03213938|7663121|FG001|Overall Study|Lost to Follow-up|3
4725589|NCT03213938|7663120|FG000|Overall Study|Lack of Efficacy|1
4725590|NCT03213938|7663121|FG001|Overall Study|Lack of Efficacy|0
4725591|NCT03213938|7663120|FG000|Overall Study|Decline to participate|5
4725592|NCT03213938|7663121|FG001|Overall Study|Decline to participate|4
4725593|NCT03213938|7663120|FG000|Overall Study|Without reason|4
4725594|NCT03213938|7663121|FG001|Overall Study|Without reason|5
4725595|NCT03214081|7663127|FG000|Overall Study|Case Report Forms Uncollected|9
4725596|NCT03214081|7663127|FG000|Overall Study|Protocol Deviation|54
4725597|NCT03214094|7663131|FG000|Overall Study|Case Report Forms Uncollected|14
4725598|NCT03214094|7663131|FG000|Overall Study|Protocol Deviation|46
4725599|NCT03214198|7663135|FG000|Overall Study|Case Report Forms Uncollected|18
4725600|NCT03214198|7663135|FG000|Overall Study|Protocol Deviation|18
4725601|NCT03214224|7663139|FG000|Overall Study|Protocol Violation|1
4725602|NCT03214224|7663139|FG000|Overall Study|Withdrawal by Subject|2
4725603|NCT03214224|7663139|FG000|Overall Study|Practice controls or therapists|6
4725604|NCT03214367|7663149|FG000|Lead-in Period|Withdrawal by Subject|50
4725605|NCT03214367|7663150|FG001|Lead-in Period|Withdrawal by Subject|0
4725606|NCT03214367|7663151|FG002|Lead-in Period|Withdrawal by Subject|0
4725607|NCT03214367|7663152|FG003|Lead-in Period|Withdrawal by Subject|0
4725608|NCT03214367|7663153|FG004|Lead-in Period|Withdrawal by Subject|2
4725609|NCT03214367|7663154|FG005|Lead-in Period|Withdrawal by Subject|0
4725610|NCT03214367|7663155|FG006|Lead-in Period|Withdrawal by Subject|0
4725611|NCT03214367|7663156|FG007|Lead-in Period|Withdrawal by Subject|0
4725612|NCT03214367|7663149|FG000|Lead-in Period|Adverse Event|3
4725613|NCT03214367|7663150|FG001|Lead-in Period|Adverse Event|0
4725614|NCT03214367|7663151|FG002|Lead-in Period|Adverse Event|0
4725615|NCT03214367|7663152|FG003|Lead-in Period|Adverse Event|0
4725616|NCT03214367|7663153|FG004|Lead-in Period|Adverse Event|0
4725617|NCT03214367|7663154|FG005|Lead-in Period|Adverse Event|0
4725618|NCT03214367|7663155|FG006|Lead-in Period|Adverse Event|0
4725619|NCT03214367|7663156|FG007|Lead-in Period|Adverse Event|0
4725620|NCT03214367|7663149|FG000|Lead-in Period|Lost to Follow-up|12
4725621|NCT03214367|7663150|FG001|Lead-in Period|Lost to Follow-up|0
4725622|NCT03214367|7663151|FG002|Lead-in Period|Lost to Follow-up|0
4725623|NCT03214367|7663152|FG003|Lead-in Period|Lost to Follow-up|0
4725624|NCT03214367|7663153|FG004|Lead-in Period|Lost to Follow-up|0
4725625|NCT03214367|7663154|FG005|Lead-in Period|Lost to Follow-up|0
4725626|NCT03214367|7663155|FG006|Lead-in Period|Lost to Follow-up|0
4725627|NCT03214367|7663156|FG007|Lead-in Period|Lost to Follow-up|0
4725628|NCT03214367|7663149|FG000|Lead-in Period|Sponsor Decision|11
4725629|NCT03214367|7663150|FG001|Lead-in Period|Sponsor Decision|0
4725630|NCT03214367|7663151|FG002|Lead-in Period|Sponsor Decision|0
4725631|NCT03214367|7663152|FG003|Lead-in Period|Sponsor Decision|0
4725632|NCT03214367|7663153|FG004|Lead-in Period|Sponsor Decision|0
4725633|NCT03214367|7663154|FG005|Lead-in Period|Sponsor Decision|0
4725634|NCT03214367|7663155|FG006|Lead-in Period|Sponsor Decision|0
4725635|NCT03214367|7663156|FG007|Lead-in Period|Sponsor Decision|0
4725636|NCT03214367|7663149|FG000|Lead-in Period|Physician Decision|12
4725637|NCT03214367|7663150|FG001|Lead-in Period|Physician Decision|0
4725638|NCT03214367|7663151|FG002|Lead-in Period|Physician Decision|0
4725639|NCT03214367|7663152|FG003|Lead-in Period|Physician Decision|0
4725640|NCT03214367|7663153|FG004|Lead-in Period|Physician Decision|0
4725641|NCT03214367|7663154|FG005|Lead-in Period|Physician Decision|0
4725642|NCT03214367|7663155|FG006|Lead-in Period|Physician Decision|0
4725643|NCT03214367|7663156|FG007|Lead-in Period|Physician Decision|0
4725644|NCT03214367|7663149|FG000|Lead-in Period|Protocol Violation|5
4725645|NCT03214367|7663150|FG001|Lead-in Period|Protocol Violation|0
4725646|NCT03214367|7663151|FG002|Lead-in Period|Protocol Violation|0
4725647|NCT03214367|7663152|FG003|Lead-in Period|Protocol Violation|0
4725648|NCT03214367|7663153|FG004|Lead-in Period|Protocol Violation|0
4725649|NCT03214367|7663154|FG005|Lead-in Period|Protocol Violation|0
4725650|NCT03214367|7663155|FG006|Lead-in Period|Protocol Violation|0
4725651|NCT03214367|7663156|FG007|Lead-in Period|Protocol Violation|0
4725652|NCT03214367|7663149|FG000|Lead-in Period|Treatment Interruption|1
4725653|NCT03214367|7663150|FG001|Lead-in Period|Treatment Interruption|0
4725654|NCT03214367|7663151|FG002|Lead-in Period|Treatment Interruption|0
4725655|NCT03214367|7663152|FG003|Lead-in Period|Treatment Interruption|0
4725656|NCT03214367|7663153|FG004|Lead-in Period|Treatment Interruption|0
4725657|NCT03214367|7663154|FG005|Lead-in Period|Treatment Interruption|0
4725658|NCT03214367|7663155|FG006|Lead-in Period|Treatment Interruption|0
4725659|NCT03214367|7663156|FG007|Lead-in Period|Treatment Interruption|0
4725660|NCT03214367|7663149|FG000|Treatment Period|Adverse Event|0
4725661|NCT03214367|7663150|FG001|Treatment Period|Adverse Event|1
4725662|NCT03214367|7663151|FG002|Treatment Period|Adverse Event|4
4725663|NCT03214367|7663152|FG003|Treatment Period|Adverse Event|2
4725664|NCT03214367|7663153|FG004|Treatment Period|Adverse Event|0
4725665|NCT03214367|7663154|FG005|Treatment Period|Adverse Event|0
4725666|NCT03214367|7663155|FG006|Treatment Period|Adverse Event|0
4725667|NCT03214367|7663156|FG007|Treatment Period|Adverse Event|0
4725668|NCT03214367|7663149|FG000|Treatment Period|Death|0
4725669|NCT03214367|7663150|FG001|Treatment Period|Death|1
4725670|NCT03214367|7663151|FG002|Treatment Period|Death|1
4725671|NCT03214367|7663152|FG003|Treatment Period|Death|1
4725672|NCT03214367|7663153|FG004|Treatment Period|Death|0
4725673|NCT03214367|7663154|FG005|Treatment Period|Death|0
4725674|NCT03214367|7663155|FG006|Treatment Period|Death|0
4725675|NCT03214367|7663156|FG007|Treatment Period|Death|0
4725676|NCT03214367|7663149|FG000|Treatment Period|Lost to Follow-up|0
4725677|NCT03214367|7663150|FG001|Treatment Period|Lost to Follow-up|5
4725678|NCT03214367|7663151|FG002|Treatment Period|Lost to Follow-up|3
4725679|NCT03214367|7663152|FG003|Treatment Period|Lost to Follow-up|2
4725680|NCT03214367|7663153|FG004|Treatment Period|Lost to Follow-up|0
4725681|NCT03214367|7663154|FG005|Treatment Period|Lost to Follow-up|2
4725682|NCT03214367|7663155|FG006|Treatment Period|Lost to Follow-up|1
4725683|NCT03214367|7663156|FG007|Treatment Period|Lost to Follow-up|0
4725684|NCT03214367|7663149|FG000|Treatment Period|Sponsor Decision|0
4725685|NCT03214367|7663150|FG001|Treatment Period|Sponsor Decision|3
4725686|NCT03214367|7663151|FG002|Treatment Period|Sponsor Decision|0
4725687|NCT03214367|7663152|FG003|Treatment Period|Sponsor Decision|0
4725688|NCT03214367|7663153|FG004|Treatment Period|Sponsor Decision|0
4725689|NCT03214367|7663154|FG005|Treatment Period|Sponsor Decision|0
4630920|NCT01888432|7499954|FG001|24-month Analysis (FAS)|Lost to Follow-up|2
4630921|NCT01888432|7499953|FG000|24-month Analysis (FAS)|Physician Decision|2
4630922|NCT01888432|7499954|FG001|24-month Analysis (FAS)|Physician Decision|4
4725690|NCT03214367|7663155|FG006|Treatment Period|Sponsor Decision|0
4725691|NCT03214367|7663156|FG007|Treatment Period|Sponsor Decision|0
4725692|NCT03214367|7663149|FG000|Treatment Period|Physician Decision|0
4725693|NCT03214367|7663150|FG001|Treatment Period|Physician Decision|1
4725694|NCT03214367|7663151|FG002|Treatment Period|Physician Decision|2
4725695|NCT03214367|7663152|FG003|Treatment Period|Physician Decision|0
4725696|NCT03214367|7663153|FG004|Treatment Period|Physician Decision|0
4725697|NCT03214367|7663154|FG005|Treatment Period|Physician Decision|0
4725698|NCT03214367|7663155|FG006|Treatment Period|Physician Decision|0
4725699|NCT03214367|7663156|FG007|Treatment Period|Physician Decision|0
4725700|NCT03214367|7663149|FG000|Treatment Period|Protocol Violation|0
4772037|NCT02733042|7749199|FG007|Treatment Period|Progressive Disease|3
4772038|NCT02733042|7749200|FG008|Treatment Period|Progressive Disease|3
4772039|NCT02733042|7749201|FG009|Treatment Period|Progressive Disease|0
4772040|NCT02733042|7749202|FG010|Treatment Period|Progressive Disease|2
4772041|NCT02733042|7749203|FG011|Treatment Period|Progressive Disease|2
4772042|NCT02733042|7749204|FG012|Treatment Period|Progressive Disease|8
4772043|NCT02733042|7749205|FG013|Treatment Period|Progressive Disease|1
4772044|NCT02733042|7749206|FG014|Treatment Period|Progressive Disease|4
4772045|NCT02733042|7749207|FG015|Treatment Period|Progressive Disease|7
4772046|NCT02733042|7749208|FG016|Treatment Period|Progressive Disease|2
4772047|NCT02733042|7749209|FG017|Treatment Period|Progressive Disease|3
4772048|NCT02733042|7749210|FG018|Treatment Period|Progressive Disease|4
4772049|NCT02733042|7749192|FG000|Treatment Period|Withdrawal by Subject|0
4772050|NCT02733042|7749193|FG001|Treatment Period|Withdrawal by Subject|1
4772051|NCT02733042|7749194|FG002|Treatment Period|Withdrawal by Subject|2
4772052|NCT02733042|7749195|FG003|Treatment Period|Withdrawal by Subject|1
4772053|NCT02733042|7749196|FG004|Treatment Period|Withdrawal by Subject|0
4772054|NCT02733042|7749197|FG005|Treatment Period|Withdrawal by Subject|0
4772055|NCT02733042|7749198|FG006|Treatment Period|Withdrawal by Subject|0
4772056|NCT02733042|7749199|FG007|Treatment Period|Withdrawal by Subject|0
4772057|NCT02733042|7749200|FG008|Treatment Period|Withdrawal by Subject|1
4772058|NCT02733042|7749201|FG009|Treatment Period|Withdrawal by Subject|1
4772059|NCT02733042|7749202|FG010|Treatment Period|Withdrawal by Subject|0
4772060|NCT02733042|7749203|FG011|Treatment Period|Withdrawal by Subject|2
4772061|NCT02733042|7749204|FG012|Treatment Period|Withdrawal by Subject|1
4772062|NCT02733042|7749205|FG013|Treatment Period|Withdrawal by Subject|1
4772063|NCT02733042|7749206|FG014|Treatment Period|Withdrawal by Subject|0
4725701|NCT03214367|7663150|FG001|Treatment Period|Protocol Violation|3
4725702|NCT03214367|7663151|FG002|Treatment Period|Protocol Violation|0
4725703|NCT03214367|7663152|FG003|Treatment Period|Protocol Violation|0
4725704|NCT03214367|7663153|FG004|Treatment Period|Protocol Violation|0
4725705|NCT03214367|7663154|FG005|Treatment Period|Protocol Violation|0
4725706|NCT03214367|7663155|FG006|Treatment Period|Protocol Violation|0
4725707|NCT03214367|7663156|FG007|Treatment Period|Protocol Violation|0
4725708|NCT03214367|7663149|FG000|Treatment Period|Withdrawal by Subject|0
4725709|NCT03214367|7663150|FG001|Treatment Period|Withdrawal by Subject|20
4725710|NCT03214367|7663151|FG002|Treatment Period|Withdrawal by Subject|23
4725711|NCT03214367|7663152|FG003|Treatment Period|Withdrawal by Subject|14
4725712|NCT03214367|7663153|FG004|Treatment Period|Withdrawal by Subject|0
4725713|NCT03214367|7663154|FG005|Treatment Period|Withdrawal by Subject|1
4725714|NCT03214367|7663155|FG006|Treatment Period|Withdrawal by Subject|1
4725715|NCT03214367|7663156|FG007|Treatment Period|Withdrawal by Subject|1
4725716|NCT03214380|7663174|FG000|Lead-in|Adverse Event|3
4725717|NCT03214380|7663175|FG001|Lead-in|Adverse Event|0
4725718|NCT03214380|7663176|FG002|Lead-in|Adverse Event|0
4725719|NCT03214380|7663177|FG003|Lead-in|Adverse Event|1
4725720|NCT03214380|7663178|FG004|Lead-in|Adverse Event|0
4725721|NCT03214380|7663179|FG005|Lead-in|Adverse Event|0
4725722|NCT03214380|7663174|FG000|Lead-in|Lost to Follow-up|4
4725723|NCT03214380|7663175|FG001|Lead-in|Lost to Follow-up|0
4725724|NCT03214380|7663176|FG002|Lead-in|Lost to Follow-up|0
4725725|NCT03214380|7663177|FG003|Lead-in|Lost to Follow-up|1
4725726|NCT03214380|7663178|FG004|Lead-in|Lost to Follow-up|0
4725727|NCT03214380|7663179|FG005|Lead-in|Lost to Follow-up|0
4725728|NCT03214380|7663174|FG000|Lead-in|Eligibility Criteria|3
4725729|NCT03214380|7663175|FG001|Lead-in|Eligibility Criteria|0
4725730|NCT03214380|7663176|FG002|Lead-in|Eligibility Criteria|0
4725731|NCT03214380|7663177|FG003|Lead-in|Eligibility Criteria|0
4725732|NCT03214380|7663178|FG004|Lead-in|Eligibility Criteria|0
4725733|NCT03214380|7663179|FG005|Lead-in|Eligibility Criteria|0
4725734|NCT03214380|7663174|FG000|Lead-in|Physician Decision|6
4725735|NCT03214380|7663175|FG001|Lead-in|Physician Decision|0
4725736|NCT03214380|7663176|FG002|Lead-in|Physician Decision|0
4725737|NCT03214380|7663177|FG003|Lead-in|Physician Decision|0
4725738|NCT03214380|7663178|FG004|Lead-in|Physician Decision|0
4725739|NCT03214380|7663179|FG005|Lead-in|Physician Decision|0
4725740|NCT03214380|7663174|FG000|Lead-in|Protocol Deviation|7
4725741|NCT03214380|7663175|FG001|Lead-in|Protocol Deviation|0
4725742|NCT03214380|7663176|FG002|Lead-in|Protocol Deviation|0
4725743|NCT03214380|7663177|FG003|Lead-in|Protocol Deviation|3
4725744|NCT03214380|7663178|FG004|Lead-in|Protocol Deviation|0
4725745|NCT03214380|7663179|FG005|Lead-in|Protocol Deviation|0
4725746|NCT03214380|7663174|FG000|Lead-in|Withdrawal by Subject|41
4725747|NCT03214380|7663175|FG001|Lead-in|Withdrawal by Subject|0
4725748|NCT03214380|7663176|FG002|Lead-in|Withdrawal by Subject|0
4725749|NCT03214380|7663177|FG003|Lead-in|Withdrawal by Subject|14
4725750|NCT03214380|7663178|FG004|Lead-in|Withdrawal by Subject|0
4725751|NCT03214380|7663179|FG005|Lead-in|Withdrawal by Subject|0
4725752|NCT03214380|7663174|FG000|Lead-in|Family Emergency|1
4725753|NCT03214380|7663175|FG001|Lead-in|Family Emergency|0
4725754|NCT03214380|7663176|FG002|Lead-in|Family Emergency|0
4725755|NCT03214380|7663177|FG003|Lead-in|Family Emergency|0
4725756|NCT03214380|7663178|FG004|Lead-in|Family Emergency|0
4725757|NCT03214380|7663179|FG005|Lead-in|Family Emergency|0
4725758|NCT03214380|7663174|FG000|Lead-in|Natural Disaster|9
4725759|NCT03214380|7663175|FG001|Lead-in|Natural Disaster|0
4725760|NCT03214380|7663176|FG002|Lead-in|Natural Disaster|0
4725761|NCT03214380|7663177|FG003|Lead-in|Natural Disaster|0
4725762|NCT03214380|7663178|FG004|Lead-in|Natural Disaster|0
4725763|NCT03214380|7663179|FG005|Lead-in|Natural Disaster|0
4725764|NCT03214380|7663174|FG000|Lead-in|Non Compliance|1
4725765|NCT03214380|7663175|FG001|Lead-in|Non Compliance|0
4725766|NCT03214380|7663176|FG002|Lead-in|Non Compliance|0
4725767|NCT03214380|7663177|FG003|Lead-in|Non Compliance|0
4725768|NCT03214380|7663178|FG004|Lead-in|Non Compliance|0
4725769|NCT03214380|7663179|FG005|Lead-in|Non Compliance|0
4725770|NCT03214380|7663174|FG000|Lead-in|Participant Schedule|2
4725771|NCT03214380|7663175|FG001|Lead-in|Participant Schedule|0
4725772|NCT03214380|7663176|FG002|Lead-in|Participant Schedule|0
4725773|NCT03214380|7663177|FG003|Lead-in|Participant Schedule|0
4725774|NCT03214380|7663178|FG004|Lead-in|Participant Schedule|0
4725775|NCT03214380|7663179|FG005|Lead-in|Participant Schedule|0
4725776|NCT03214380|7663174|FG000|Treatment Period|Adverse Event|0
4725777|NCT03214380|7663175|FG001|Treatment Period|Adverse Event|1
4725778|NCT03214380|7663176|FG002|Treatment Period|Adverse Event|1
4725779|NCT03214380|7663177|FG003|Treatment Period|Adverse Event|0
4725780|NCT03214380|7663178|FG004|Treatment Period|Adverse Event|1
4725781|NCT03214380|7663179|FG005|Treatment Period|Adverse Event|0
4725782|NCT03214380|7663174|FG000|Treatment Period|Non-Compliance with Study Drug|0
4725783|NCT03214380|7663175|FG001|Treatment Period|Non-Compliance with Study Drug|0
4725784|NCT03214380|7663176|FG002|Treatment Period|Non-Compliance with Study Drug|0
4725785|NCT03214380|7663177|FG003|Treatment Period|Non-Compliance with Study Drug|0
4725786|NCT03214380|7663178|FG004|Treatment Period|Non-Compliance with Study Drug|1
4725787|NCT03214380|7663179|FG005|Treatment Period|Non-Compliance with Study Drug|0
4725788|NCT03214380|7663174|FG000|Treatment Period|Withdrawal by Subject|0
4725789|NCT03214380|7663175|FG001|Treatment Period|Withdrawal by Subject|10
4725790|NCT03214380|7663176|FG002|Treatment Period|Withdrawal by Subject|8
4725791|NCT03214380|7663177|FG003|Treatment Period|Withdrawal by Subject|0
4725792|NCT03214380|7663178|FG004|Treatment Period|Withdrawal by Subject|7
4725793|NCT03214380|7663179|FG005|Treatment Period|Withdrawal by Subject|11
4725794|NCT03214380|7663174|FG000|Treatment Period|Death|0
4725795|NCT03214380|7663175|FG001|Treatment Period|Death|1
4725796|NCT03214380|7663176|FG002|Treatment Period|Death|2
4725797|NCT03214380|7663177|FG003|Treatment Period|Death|0
4725798|NCT03214380|7663178|FG004|Treatment Period|Death|0
4725799|NCT03214380|7663179|FG005|Treatment Period|Death|0
4725800|NCT03214380|7663174|FG000|Treatment Period|Lost to Follow-up|0
4725801|NCT03214380|7663175|FG001|Treatment Period|Lost to Follow-up|6
4725802|NCT03214380|7663176|FG002|Treatment Period|Lost to Follow-up|3
4725803|NCT03214380|7663177|FG003|Treatment Period|Lost to Follow-up|0
4725804|NCT03214380|7663178|FG004|Treatment Period|Lost to Follow-up|0
4725805|NCT03214380|7663179|FG005|Treatment Period|Lost to Follow-up|0
4725806|NCT03214380|7663174|FG000|Treatment Period|Participant schedule|0
4725807|NCT03214380|7663175|FG001|Treatment Period|Participant schedule|0
4725808|NCT03214380|7663176|FG002|Treatment Period|Participant schedule|1
4725809|NCT03214380|7663177|FG003|Treatment Period|Participant schedule|0
4725810|NCT03214380|7663178|FG004|Treatment Period|Participant schedule|0
4725811|NCT03214380|7663179|FG005|Treatment Period|Participant schedule|0
4725812|NCT03214380|7663174|FG000|Treatment Period|Treatment Interruption|0
4725813|NCT03214380|7663175|FG001|Treatment Period|Treatment Interruption|0
4725814|NCT03214380|7663176|FG002|Treatment Period|Treatment Interruption|1
4725815|NCT03214380|7663177|FG003|Treatment Period|Treatment Interruption|0
4725816|NCT03214380|7663178|FG004|Treatment Period|Treatment Interruption|0
4725817|NCT03214380|7663179|FG005|Treatment Period|Treatment Interruption|0
4725818|NCT03214406|7663193|FG000|Overall Study|did not meet enrollment criteria|9
4725819|NCT03214406|7663194|FG001|Overall Study|did not meet enrollment criteria|13
4725820|NCT03214406|7663193|FG000|Overall Study|Withdrawal by Subject|1
4725821|NCT03214406|7663194|FG001|Overall Study|Withdrawal by Subject|0
4725822|NCT03214406|7663193|FG000|Overall Study|Lost to Follow-up|0
4725823|NCT03214406|7663194|FG001|Overall Study|Lost to Follow-up|2
4725824|NCT03214588|7663203|FG000|Overall Study|Adverse Event|1
4725825|NCT03214588|7663204|FG001|Overall Study|Adverse Event|0
4725826|NCT03214588|7663205|FG002|Overall Study|Adverse Event|2
4725827|NCT03214588|7663203|FG000|Overall Study|Reason Not Specified|0
4725828|NCT03214588|7663204|FG001|Overall Study|Reason Not Specified|1
4725829|NCT03214588|7663205|FG002|Overall Study|Reason Not Specified|0
4725830|NCT03214640|7663217|FG000|Overall Study|Protocol Violation|1
4725831|NCT03214640|7663218|FG001|Overall Study|Protocol Violation|2
4725832|NCT03214640|7663219|FG002|Overall Study|Protocol Violation|1
4725833|NCT03214640|7663220|FG003|Overall Study|Protocol Violation|4
4725834|NCT03214952|7663230|FG000|Overall Study|Protocol Deviation|45
4725835|NCT03214952|7663230|FG000|Overall Study|Case Report Forms Uncollected|13
4725836|NCT03215667|7663234|FG000|Overall Study|Physician Decision|4
4725837|NCT03215706|7663240|FG000|Randomization|Adverse Event unrelated to study drug|1
4725838|NCT03215706|7663241|FG001|Randomization|Adverse Event unrelated to study drug|0
4725839|NCT03215706|7663240|FG000|Randomization|participant withdrew consent|1
4725840|NCT03215706|7663241|FG001|Randomization|participant withdrew consent|3
4725841|NCT03215706|7663240|FG000|Randomization|no longer meets study criteria|1
4725842|NCT03215706|7663241|FG001|Randomization|no longer meets study criteria|4
4725843|NCT03215706|7663240|FG000|Randomization|other reasons|0
4725844|NCT03215706|7663241|FG001|Randomization|other reasons|2
4725845|NCT03215706|7663240|FG000|Treatment Period|Disease Progression|150
4725846|NCT03215706|7663241|FG001|Treatment Period|Disease Progression|142
4725847|NCT03215706|7663240|FG000|Treatment Period|Study Drug Toxicity|53
4725848|NCT03215706|7663241|FG001|Treatment Period|Study Drug Toxicity|21
4725849|NCT03215706|7663240|FG000|Treatment Period|Death|2
4725850|NCT03215706|7663241|FG001|Treatment Period|Death|1
4725851|NCT03215706|7663240|FG000|Treatment Period|Adverse event unrelated to study drug|24
4725852|NCT03215706|7663241|FG001|Treatment Period|Adverse event unrelated to study drug|23
4725853|NCT03215706|7663240|FG000|Treatment Period|Request to D/C treatment|1
4725854|NCT03215706|7663241|FG001|Treatment Period|Request to D/C treatment|6
4725855|NCT03215706|7663240|FG000|Treatment Period|Participant withdrew consent|3
4725856|NCT03215706|7663241|FG001|Treatment Period|Participant withdrew consent|4
4725857|NCT03215706|7663240|FG000|Treatment Period|Lost to Follow-up|0
4725858|NCT03215706|7663241|FG001|Treatment Period|Lost to Follow-up|1
4725859|NCT03215706|7663240|FG000|Treatment Period|Other Reasons|4
4725860|NCT03215706|7663241|FG001|Treatment Period|Other Reasons|5
4725861|NCT03215706|7663240|FG000|Treatment Period|Ongoing in the treatment period|105
4725862|NCT03215706|7663241|FG001|Treatment Period|Ongoing in the treatment period|43
4725863|NCT03215758|7663249|FG000|Overall Study|Technical Problems|1
4725864|NCT03215758|7663250|FG001|Overall Study|Technical Problems|0
4725865|NCT03215758|7663249|FG000|Overall Study|Protocol deviation|0
4725866|NCT03215758|7663250|FG001|Overall Study|Protocol deviation|1
4725867|NCT03215758|7663249|FG000|Overall Study|Physician Decision|0
4725868|NCT03215758|7663250|FG001|Overall Study|Physician Decision|1
4725869|NCT03215758|7663249|FG000|Overall Study|Death|0
4725870|NCT03215758|7663250|FG001|Overall Study|Death|1
4725871|NCT03215758|7663249|FG000|Overall Study|Adverse Event|1
4725872|NCT03215758|7663250|FG001|Overall Study|Adverse Event|2
4725873|NCT03215758|7663249|FG000|Overall Study|Subject/Guardian Decision|3
4725874|NCT03215758|7663250|FG001|Overall Study|Subject/Guardian Decision|3
4725875|NCT03215771|7663256|FG000|Overall Study|Withdrawal by Subject|2
4725876|NCT03215771|7663256|FG000|Overall Study|Physician Decision|1
4725877|NCT03216226|7663280|FG000|Overall Study|Adverse Event|3
4725878|NCT03216226|7663281|FG001|Overall Study|Adverse Event|0
4725879|NCT03216226|7663280|FG000|Overall Study|Protocol Violation|1
4725880|NCT03216226|7663281|FG001|Overall Study|Protocol Violation|3
4725881|NCT03216226|7663280|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1
4725882|NCT03216226|7663281|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0
4725883|NCT03216226|7663280|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0
4725884|NCT03216226|7663281|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1
4725885|NCT03216226|7663280|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0
4725886|NCT03216226|7663281|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1
4725887|NCT03216265|7663290|FG000|Overall Study|Adverse Event|2
4725888|NCT03216265|7663291|FG001|Overall Study|Adverse Event|0
4725889|NCT03216265|7663292|FG002|Overall Study|Adverse Event|2
4725890|NCT03216265|7663290|FG000|Overall Study|Lost to Follow-up|0
4725891|NCT03216265|7663291|FG001|Overall Study|Lost to Follow-up|1
4725892|NCT03216265|7663292|FG002|Overall Study|Lost to Follow-up|0
4725893|NCT03216265|7663290|FG000|Overall Study|Withdrawal by Subject|0
4725894|NCT03216265|7663291|FG001|Overall Study|Withdrawal by Subject|0
4725895|NCT03216265|7663292|FG002|Overall Study|Withdrawal by Subject|1
4725896|NCT03216746|7663331|FG000|Overall Study|Lost to Follow-up|6
4725897|NCT03216746|7663332|FG001|Overall Study|Lost to Follow-up|8
4725898|NCT03216746|7663333|FG002|Overall Study|Lost to Follow-up|5
4725899|NCT03216746|7663334|FG003|Overall Study|Lost to Follow-up|6
4725900|NCT03216850|7663344|FG000|Overall Study|Pre-analytical error|6
4725901|NCT03216954|7663381|FG000|Overall Study|Adverse Event|0
4725902|NCT03216954|7663382|FG001|Overall Study|Adverse Event|0
4725903|NCT03216954|7663383|FG002|Overall Study|Adverse Event|1
4725904|NCT03216954|7663384|FG003|Overall Study|Adverse Event|0
4725905|NCT03216954|7663385|FG004|Overall Study|Adverse Event|1
4725906|NCT03216954|7663381|FG000|Overall Study|Withdrawal by Subject|2
4725907|NCT03216954|7663382|FG001|Overall Study|Withdrawal by Subject|0
4725908|NCT03216954|7663383|FG002|Overall Study|Withdrawal by Subject|0
4725909|NCT03216954|7663384|FG003|Overall Study|Withdrawal by Subject|0
4725910|NCT03216954|7663385|FG004|Overall Study|Withdrawal by Subject|0
4725911|NCT03216954|7663381|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0
4725912|NCT03216954|7663382|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1
4725913|NCT03216954|7663383|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0
4725914|NCT03216954|7663384|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0
4725915|NCT03216954|7663385|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0
4725916|NCT03217968|7663393|FG000|Overall Study|Withdrawal by Subject|4
4725917|NCT03217968|7663393|FG000|Overall Study|Lost to Follow-up|1
4725918|NCT03217968|7663393|FG000|Overall Study|Protocol Violation|6
4725919|NCT03218397|7663399|FG000|Overall Study|Prior positive blood culture|8
4725920|NCT03218397|7663400|FG001|Overall Study|Prior positive blood culture|13
4725921|NCT03218397|7663399|FG000|Overall Study|Comfort care|8
4725922|NCT03218397|7663400|FG001|Overall Study|Comfort care|5
4725923|NCT03218397|7663399|FG000|Overall Study|Comfort care and positive blood culture|1
4725924|NCT03218397|7663400|FG001|Overall Study|Comfort care and positive blood culture|0
4725925|NCT03218397|7663399|FG000|Overall Study|Comfort care and mixed culture|0
4725926|NCT03218397|7663400|FG001|Overall Study|Comfort care and mixed culture|1
4725927|NCT03218397|7663399|FG000|Overall Study|Mixed culture|2
4725928|NCT03218397|7663400|FG001|Overall Study|Mixed culture|2
4725929|NCT03218397|7663399|FG000|Overall Study|Inaccessible hospital records|2
4725930|NCT03218397|7663400|FG001|Overall Study|Inaccessible hospital records|5
4725931|NCT03218397|7663399|FG000|Overall Study|No gram-negative bacilli (GNB)|0
4725932|NCT03218397|7663400|FG001|Overall Study|No gram-negative bacilli (GNB)|2
4725933|NCT03218397|7663399|FG000|Overall Study|Randomized during laboratory off hours|2
4725934|NCT03218397|7663400|FG001|Overall Study|Randomized during laboratory off hours|1
4725935|NCT03218787|7663428|FG000|Overall Study|Lost to Follow-up|12
4725936|NCT03218787|7663428|FG000|Overall Study|Withdrawal by Subject|72
4725937|NCT03218787|7663428|FG000|Overall Study|Physician Decision|11
4725938|NCT03218787|7663428|FG000|Overall Study|Death|111
4725939|NCT03219216|7663434|FG000|Overall Study|Lost to Follow-up|0
4725940|NCT03219216|7663435|FG001|Overall Study|Lost to Follow-up|1
4725941|NCT03219723|7663466|FG000|Overall Study|Case Report Forms Uncollected|6
4725942|NCT03219723|7663466|FG000|Overall Study|Protocol Deviation|4
4725943|NCT03220217|7663532|FG000|Overall Study|Withdrawal by Subject|0
4725944|NCT03220217|7663533|FG001|Overall Study|Withdrawal by Subject|1
4725945|NCT03220217|7663534|FG002|Overall Study|Withdrawal by Subject|0
4725946|NCT03220217|7663532|FG000|Overall Study|Subject Missed Procedure|0
4725947|NCT03220217|7663533|FG001|Overall Study|Subject Missed Procedure|0
4725948|NCT03220217|7663534|FG002|Overall Study|Subject Missed Procedure|1
4725949|NCT03220737|7663585|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4
4725950|NCT03220737|7663586|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1
4725951|NCT03220737|7663587|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4
4725952|NCT03220737|7663588|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1
4725953|NCT03220737|7663589|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4
4725954|NCT03220737|7663590|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0
4725955|NCT03220737|7663591|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0
4725956|NCT03220737|7663585|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2
4725957|NCT03220737|7663586|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1
4725958|NCT03220737|7663587|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6
4725959|NCT03220737|7663588|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1
4725960|NCT03220737|7663589|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13
4725961|NCT03220737|7663590|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1
4725962|NCT03220737|7663591|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0
4725963|NCT03220737|7663585|FG000|Main Study (Day 1 - 181)|Protocol Violation|0
4725964|NCT03220737|7663586|FG001|Main Study (Day 1 - 181)|Protocol Violation|0
4725965|NCT03220737|7663587|FG002|Main Study (Day 1 - 181)|Protocol Violation|1
4725966|NCT03220737|7663588|FG003|Main Study (Day 1 - 181)|Protocol Violation|1
4725967|NCT03220737|7663589|FG004|Main Study (Day 1 - 181)|Protocol Violation|3
4725968|NCT03220737|7663590|FG005|Main Study (Day 1 - 181)|Protocol Violation|0
4725969|NCT03220737|7663591|FG006|Main Study (Day 1 - 181)|Protocol Violation|1
4725970|NCT03220737|7663585|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
4725971|NCT03220737|7663586|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
4725972|NCT03220737|7663587|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1
4725973|NCT03220737|7663588|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
4725974|NCT03220737|7663589|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
4725975|NCT03220737|7663590|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
4725976|NCT03220737|7663591|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0
4725977|NCT03220737|7663585|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
4725978|NCT03220737|7663586|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
4725979|NCT03220737|7663587|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
4725980|NCT03220737|7663588|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
4725981|NCT03220737|7663589|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2
4725982|NCT03220737|7663590|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
4725983|NCT03220737|7663591|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0
4725984|NCT03220737|7663585|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1
4725985|NCT03220737|7663586|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
4725986|NCT03220737|7663587|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
4725987|NCT03220737|7663588|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
4725988|NCT03220737|7663589|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
4725989|NCT03220737|7663590|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
4725990|NCT03220737|7663591|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0
4725991|NCT03220737|7663585|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9
4725992|NCT03220737|7663586|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
4725993|NCT03220737|7663587|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
4725994|NCT03220737|7663588|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
4725995|NCT03220737|7663589|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
4725996|NCT03220737|7663590|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
4725997|NCT03220737|7663591|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0
4725998|NCT03220737|7663585|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1
4725999|NCT03220737|7663586|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
4726000|NCT03220737|7663587|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
4726001|NCT03220737|7663588|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
4726002|NCT03220737|7663589|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
4726003|NCT03220737|7663590|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
4726004|NCT03220737|7663591|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0
4726005|NCT03221387|7663626|FG000|Overall Study|Lost to Follow-up|1
4726006|NCT03221387|7663626|FG000|Overall Study|Lung transplant|1
4726007|NCT03222141|7663654|FG000|Overall Study|Death|15
4726008|NCT03222141|7663654|FG000|Overall Study|Lost to Follow-up|3
4726009|NCT03222349|7663659|FG000|Overall Study|Treatment B not done|5
4726010|NCT03222349|7663660|FG001|Overall Study|Treatment B not done|0
4726011|NCT03222349|7663659|FG000|Overall Study|Lost to Follow-up|1
4726012|NCT03222349|7663660|FG001|Overall Study|Lost to Follow-up|2
4726013|NCT03222349|7663659|FG000|Overall Study|Withdrawal by Subject|1
4726014|NCT03222349|7663660|FG001|Overall Study|Withdrawal by Subject|0
4726015|NCT03222349|7663659|FG000|Overall Study|Treatment A not done|0
4726016|NCT03222349|7663660|FG001|Overall Study|Treatment A not done|5
4726017|NCT03222349|7663659|FG000|Overall Study|Study terminated by sponsor|1
4726018|NCT03222349|7663660|FG001|Overall Study|Study terminated by sponsor|0
4726019|NCT03222583|7663699|FG000|Overall Study|Withdrawal by Subject|3
4726020|NCT03222583|7663700|FG001|Overall Study|Withdrawal by Subject|3
4726021|NCT03222583|7663699|FG000|Overall Study|Lost to Follow-up|1
4726022|NCT03222583|7663700|FG001|Overall Study|Lost to Follow-up|0
4726023|NCT03222583|7663699|FG000|Overall Study|Other|1
4726024|NCT03222583|7663700|FG001|Overall Study|Other|3
4726025|NCT03223909|7663748|FG000|Overall Study|Protocol Violation|48
4726026|NCT03223909|7663749|FG001|Overall Study|Protocol Violation|45
4726027|NCT03223909|7663750|FG002|Overall Study|Protocol Violation|16
4726028|NCT03224130|7663760|FG000|Overall Study|consent issue|0
4726029|NCT03224130|7663761|FG001|Overall Study|consent issue|1
4726030|NCT03224182|7663769|FG000|Overall Study|Study Drug Not Instilled|6
4726031|NCT03224182|7663770|FG001|Overall Study|Study Drug Not Instilled|1
4726032|NCT03224182|7663769|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22
4726033|NCT03224182|7663770|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11
4726034|NCT03224182|7663769|FG000|Overall Study|Withdrew of Consent|4
4726035|NCT03224182|7663770|FG001|Overall Study|Withdrew of Consent|2
4726036|NCT03224182|7663769|FG000|Overall Study|Investigator Decision|3
4726037|NCT03224182|7663770|FG001|Overall Study|Investigator Decision|1
4726038|NCT03224182|7663769|FG000|Overall Study|Sponsor Decision|26
4726039|NCT03224182|7663770|FG001|Overall Study|Sponsor Decision|12
4726040|NCT03224182|7663769|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4
4726041|NCT03224182|7663770|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0
4726042|NCT03224182|7663769|FG000|Overall Study|Lost to Follow-up|1
4726043|NCT03224182|7663770|FG001|Overall Study|Lost to Follow-up|0
4726044|NCT03224182|7663769|FG000|Overall Study|Participant Had Recurrence|11
4726045|NCT03224182|7663770|FG001|Overall Study|Participant Had Recurrence|5
4726046|NCT03224182|7663769|FG000|Overall Study|Death|0
4726047|NCT03224182|7663770|FG001|Overall Study|Death|1
4726048|NCT03224182|7663769|FG000|Overall Study|Reason not Specified|3
4726049|NCT03224182|7663770|FG001|Overall Study|Reason not Specified|3
4726050|NCT03224182|7663769|FG000|Overall Study|Other|1
4726051|NCT03224182|7663770|FG001|Overall Study|Other|0
4726052|NCT03224234|7663780|FG000|Main Study|Lost to Follow-up|5
4726053|NCT03224234|7663781|FG001|Main Study|Lost to Follow-up|5
4726054|NCT03224325|7663815|FG000|Overall Study|Adverse Event|1
4726055|NCT03224325|7663816|FG001|Overall Study|Adverse Event|0
4726056|NCT03224325|7663817|FG002|Overall Study|Adverse Event|0
4726057|NCT03224325|7663818|FG003|Overall Study|Adverse Event|0
4726058|NCT03224325|7663819|FG004|Overall Study|Adverse Event|0
4726059|NCT03224325|7663820|FG005|Overall Study|Adverse Event|0
4726060|NCT03224325|7663821|FG006|Overall Study|Adverse Event|1
4726061|NCT03224325|7663815|FG000|Overall Study|Withdrawal by Subject|0
4726062|NCT03224325|7663816|FG001|Overall Study|Withdrawal by Subject|0
4726063|NCT03224325|7663817|FG002|Overall Study|Withdrawal by Subject|0
4726064|NCT03224325|7663818|FG003|Overall Study|Withdrawal by Subject|1
4726065|NCT03224325|7663819|FG004|Overall Study|Withdrawal by Subject|0
4726066|NCT03224325|7663820|FG005|Overall Study|Withdrawal by Subject|0
4726067|NCT03224325|7663821|FG006|Overall Study|Withdrawal by Subject|0
4736881|NCT03583450|7686499|FG000|Overall Study|hardware malfunction (battery depletion)|1
4736882|NCT03583450|7686500|FG001|Overall Study|hardware malfunction (battery depletion)|0
4736883|NCT03583606|7686511|FG000|Overall Study|Lost to Follow-up|0
4736884|NCT03583606|7686512|FG001|Overall Study|Lost to Follow-up|1
4736885|NCT03583606|7686513|FG002|Overall Study|Lost to Follow-up|0
4736886|NCT03583606|7686511|FG000|Overall Study|Ineligible at baseline|1
4736887|NCT03583606|7686512|FG001|Overall Study|Ineligible at baseline|0
4736888|NCT03583606|7686513|FG002|Overall Study|Ineligible at baseline|0
4736889|NCT03584009|7686524|FG000|Overall Study|Death|18
4736890|NCT03584009|7686525|FG001|Overall Study|Death|9
4736891|NCT03584009|7686524|FG000|Overall Study|Lost to Follow-up|0
4736892|NCT03584009|7686525|FG001|Overall Study|Lost to Follow-up|1
4736893|NCT03584009|7686524|FG000|Overall Study|Physician Decision|1
4736894|NCT03584009|7686525|FG001|Overall Study|Physician Decision|1
4736895|NCT03584009|7686524|FG000|Overall Study|Withdrawal by Subject|3
4736896|NCT03584009|7686525|FG001|Overall Study|Withdrawal by Subject|1
4736897|NCT03584009|7686524|FG000|Overall Study|Ongoing in study|29
4736898|NCT03584009|7686525|FG001|Overall Study|Ongoing in study|40
4736899|NCT03585244|7686538|FG000|Overall Study|Withdrawal by Subject|15
4736900|NCT03585296|7686542|FG000|Overall Study|Adverse Event|1
4736901|NCT03585296|7686542|FG000|Overall Study|Lost to Follow-up|2
4736902|NCT03585296|7686542|FG000|Overall Study|Withdrawal by Subject|2
4736903|NCT03585504|7686548|FG000|Overall Study|Lost to Follow-up|26
4736904|NCT03585504|7686549|FG001|Overall Study|Lost to Follow-up|29
4736905|NCT03585712|7686560|FG000|Treatment Period 1|Protocol Violation|1
4736906|NCT03585712|7686561|FG001|Treatment Period 1|Protocol Violation|0
4736907|NCT03585712|7686562|FG002|Treatment Period 1|Protocol Violation|0
4736908|NCT03585712|7686560|FG000|Treatment Periods 2 and 3|Protocol Violation|0
4736909|NCT03585712|7686561|FG001|Treatment Periods 2 and 3|Protocol Violation|1
4736910|NCT03585712|7686562|FG002|Treatment Periods 2 and 3|Protocol Violation|1
4736911|NCT03585712|7686560|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0
4736912|NCT03585712|7686561|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2
4736913|NCT03585712|7686562|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0
4736914|NCT03585712|7686560|FG000|Treatment Periods 2 and 3|Physician Decision|0
4736915|NCT03585712|7686561|FG001|Treatment Periods 2 and 3|Physician Decision|0
4736916|NCT03585712|7686562|FG002|Treatment Periods 2 and 3|Physician Decision|2
4736917|NCT03585959|7686589|FG000|Overall Study|Physician Decision|1
4726068|NCT03224598|7663940|FG000|Overall Study|Lost to Follow-up|0
4726069|NCT03224598|7663941|FG001|Overall Study|Lost to Follow-up|2
4726070|NCT03224598|7663942|FG002|Overall Study|Lost to Follow-up|0
4726071|NCT03224598|7663940|FG000|Overall Study|Other|0
4726072|NCT03224598|7663941|FG001|Overall Study|Other|1
4726073|NCT03224598|7663942|FG002|Overall Study|Other|0
4726074|NCT03226249|7663990|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1
4726075|NCT03226249|7663990|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29
4726076|NCT03226249|7663990|FG000|Survival Follow-up|Patients still in follow-up.|30
4726077|NCT03226275|7663998|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0
4726078|NCT03226275|7663999|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0
4726079|NCT03226275|7664000|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1
4726080|NCT03226275|7664001|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0
4726081|NCT03226275|7663998|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0
4726082|NCT03226275|7663999|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0
4726083|NCT03226275|7664000|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0
4726084|NCT03226275|7664001|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1
4726085|NCT03226353|7664011|FG000|Overall Study|Withdrawal by Subject|1
4726086|NCT03226353|7664011|FG000|Overall Study|Screen Failure|5
4726087|NCT03226392|7664037|FG000|Overall Study|Protocol Deviation|1
4726088|NCT03226392|7664038|FG001|Overall Study|Protocol Deviation|0
4726089|NCT03226392|7664037|FG000|Overall Study|Physician Decision|1
4726090|NCT03226392|7664038|FG001|Overall Study|Physician Decision|0
4726091|NCT03226392|7664037|FG000|Overall Study|Lost to Follow-up|1
4726092|NCT03226392|7664038|FG001|Overall Study|Lost to Follow-up|0
4726093|NCT03226392|7664037|FG000|Overall Study|Adverse Event|1
4726094|NCT03226392|7664038|FG001|Overall Study|Adverse Event|0
4726095|NCT03226392|7664037|FG000|Overall Study|Technical Problems|0
4726096|NCT03226392|7664038|FG001|Overall Study|Technical Problems|2
4726097|NCT03226392|7664037|FG000|Overall Study|Subject/Guardian Decision|7
4726098|NCT03226392|7664038|FG001|Overall Study|Subject/Guardian Decision|6
4726099|NCT03226769|7664061|FG000|Overall Study|Withdrawal by Subject|0
4726100|NCT03226769|7664062|FG001|Overall Study|Withdrawal by Subject|1
4726101|NCT03227445|7664077|FG000|Period 1 (28 Days)|Adverse Event|1
4726102|NCT03227445|7664078|FG001|Period 1 (28 Days)|Adverse Event|2
4726103|NCT03227445|7664079|FG002|Period 1 (28 Days)|Adverse Event|0
4726104|NCT03227445|7664080|FG003|Period 1 (28 Days)|Adverse Event|1
4726105|NCT03227445|7664077|FG000|Period 1 (28 Days)|Protocol Violation|1
4726106|NCT03227445|7664078|FG001|Period 1 (28 Days)|Protocol Violation|0
4726107|NCT03227445|7664079|FG002|Period 1 (28 Days)|Protocol Violation|0
4726108|NCT03227445|7664080|FG003|Period 1 (28 Days)|Protocol Violation|0
4726109|NCT03227445|7664077|FG000|Period 1 (28 Days)|Withdrawal by Subject|0
4726110|NCT03227445|7664078|FG001|Period 1 (28 Days)|Withdrawal by Subject|0
4726111|NCT03227445|7664079|FG002|Period 1 (28 Days)|Withdrawal by Subject|1
4726112|NCT03227445|7664080|FG003|Period 1 (28 Days)|Withdrawal by Subject|1
4726113|NCT03227445|7664077|FG000|Period 2 (28 Days)|Adverse Event|1
4726114|NCT03227445|7664078|FG001|Period 2 (28 Days)|Adverse Event|0
4726115|NCT03227445|7664079|FG002|Period 2 (28 Days)|Adverse Event|2
4726116|NCT03227445|7664080|FG003|Period 2 (28 Days)|Adverse Event|1
4726117|NCT03227445|7664077|FG000|Period 2 (28 Days)|Protocol Violation|0
4726118|NCT03227445|7664078|FG001|Period 2 (28 Days)|Protocol Violation|0
4726119|NCT03227445|7664079|FG002|Period 2 (28 Days)|Protocol Violation|0
4726120|NCT03227445|7664080|FG003|Period 2 (28 Days)|Protocol Violation|1
4726121|NCT03227445|7664077|FG000|Period 2 (28 Days)|Withdrawal by Subject|0
4726122|NCT03227445|7664078|FG001|Period 2 (28 Days)|Withdrawal by Subject|1
4726123|NCT03227445|7664079|FG002|Period 2 (28 Days)|Withdrawal by Subject|0
4726124|NCT03227445|7664080|FG003|Period 2 (28 Days)|Withdrawal by Subject|1
4726125|NCT03227692|7664091|FG000|Overall Study|Protocol Violation|1
4726126|NCT03227692|7664092|FG001|Overall Study|Protocol Violation|1
4726127|NCT03227692|7664091|FG000|Overall Study|Lost to Follow-up|4
4726128|NCT03227692|7664092|FG001|Overall Study|Lost to Follow-up|2
4726129|NCT03227692|7664091|FG000|Overall Study|Adverse Event|0
4726130|NCT03227692|7664092|FG001|Overall Study|Adverse Event|2
4726131|NCT03227861|7664098|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4
4726132|NCT03227861|7664098|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1
4726133|NCT03227861|7664098|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1
4726134|NCT03227861|7664098|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1
4726135|NCT03227861|7664098|FG000|Main Study Period (Week 0 to Week 48)|Other|5
4726136|NCT03227861|7664098|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55
4726137|NCT03227861|7664098|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16
4726138|NCT03227861|7664098|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6
4726139|NCT03227861|7664098|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1
4726140|NCT03227861|7664098|FG000|Extension Period (Week 48 to Week 96)|Other|2
4726141|NCT03228212|7664113|FG000|Period 1|Adverse Event|1
4726142|NCT03228212|7664114|FG001|Period 1|Adverse Event|0
4726143|NCT03228212|7664113|FG000|Period 1|no longer meets eligibility criteria|0
4726144|NCT03228212|7664114|FG001|Period 1|no longer meets eligibility criteria|1
4726145|NCT03228212|7664113|FG000|Period 2|Lost to Follow-up|1
4726146|NCT03228212|7664114|FG001|Period 2|Lost to Follow-up|0
4726147|NCT03228420|7664122|FG000|Overall Study|Lost to Follow-up|5
4726148|NCT03228420|7664123|FG001|Overall Study|Lost to Follow-up|3
4726149|NCT03228420|7664122|FG000|Overall Study|Withdrawal by Subject|10
4726150|NCT03228420|7664123|FG001|Overall Study|Withdrawal by Subject|0
4726151|NCT03228420|7664122|FG000|Overall Study|Adverse Event|5
4726152|NCT03228420|7664123|FG001|Overall Study|Adverse Event|2
4726153|NCT03228433|7664135|FG000|Overall Study|Lost to Follow-up|1
4726154|NCT03228433|7664136|FG001|Overall Study|Lost to Follow-up|0
4726155|NCT03228433|7664137|FG002|Overall Study|Lost to Follow-up|0
4726156|NCT03228433|7664138|FG003|Overall Study|Lost to Follow-up|0
4726157|NCT03228433|7664139|FG004|Overall Study|Lost to Follow-up|0
4726158|NCT03228433|7664140|FG005|Overall Study|Lost to Follow-up|0
4726159|NCT03228433|7664135|FG000|Overall Study|Positive alcohol test|0
4726160|NCT03228433|7664136|FG001|Overall Study|Positive alcohol test|0
4726161|NCT03228433|7664137|FG002|Overall Study|Positive alcohol test|0
4726162|NCT03228433|7664138|FG003|Overall Study|Positive alcohol test|1
4726163|NCT03228433|7664139|FG004|Overall Study|Positive alcohol test|0
4726164|NCT03228433|7664140|FG005|Overall Study|Positive alcohol test|0
4726165|NCT03228836|7664162|FG000|Overall Study|Adverse Event|3
4726166|NCT03228836|7664162|FG000|Overall Study|Withdrawal by Subject|1
4726167|NCT03228836|7664162|FG000|Overall Study|Death|1
4726168|NCT03228836|7664162|FG000|Overall Study|Physician Decision|1
4726169|NCT03228836|7664162|FG000|Overall Study|Disease Progression|7
4726170|NCT03228836|7664162|FG000|Overall Study|Other|4
4726171|NCT03229109|7664177|FG000|Overall Study|Withdrawal by Subject|0
4726172|NCT03229109|7664178|FG001|Overall Study|Withdrawal by Subject|0
4726173|NCT03229109|7664179|FG002|Overall Study|Withdrawal by Subject|0
4726174|NCT03229109|7664180|FG003|Overall Study|Withdrawal by Subject|1
4726175|NCT03229486|7664205|FG000|Overall Study|Protocol Violation|0
4726176|NCT03229486|7664206|FG001|Overall Study|Protocol Violation|1
4726177|NCT03229759|7664212|FG000|Overall Study|Screen Failure|30
4726178|NCT03230864|7664225|FG000|Prospective Confirmation (PC) Period|Adverse Event|3
4726179|NCT03230864|7664226|FG001|Prospective Confirmation (PC) Period|Adverse Event|0
4726180|NCT03230864|7664227|FG002|Prospective Confirmation (PC) Period|Adverse Event|0
4726181|NCT03230864|7664228|FG003|Prospective Confirmation (PC) Period|Adverse Event|0
4726182|NCT03230864|7664225|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0
4726183|NCT03230864|7664226|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2
4726184|NCT03230864|7664227|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0
4726185|NCT03230864|7664228|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0
4726186|NCT03230864|7664225|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1
4726187|NCT03230864|7664226|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2
4726188|NCT03230864|7664227|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0
4726189|NCT03230864|7664228|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0
4726190|NCT03230864|7664225|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4
4726191|NCT03230864|7664226|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1
4726192|NCT03230864|7664227|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
4726193|NCT03230864|7664228|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
4726194|NCT03230864|7664225|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14
4726195|NCT03230864|7664226|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5
4726196|NCT03230864|7664227|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0
4726197|NCT03230864|7664228|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0
4726198|NCT03230864|7664225|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9
4726199|NCT03230864|7664226|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9
4726200|NCT03230864|7664227|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0
4726201|NCT03230864|7664228|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0
4726202|NCT03230864|7664225|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1
4726203|NCT03230864|7664226|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0
4726204|NCT03230864|7664227|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0
4726205|NCT03230864|7664228|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0
4726206|NCT03230864|7664225|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0
4726207|NCT03230864|7664226|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0
4726208|NCT03230864|7664227|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5
4726209|NCT03230864|7664228|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1
4726210|NCT03230864|7664225|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0
4726211|NCT03230864|7664226|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0
4726212|NCT03230864|7664227|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1
4726213|NCT03230864|7664228|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1
4726214|NCT03230864|7664225|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0
4726215|NCT03230864|7664226|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0
4726216|NCT03230864|7664227|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2
4726217|NCT03230864|7664228|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0
4726218|NCT03231228|7664240|FG000|Overall Study|Lost to Follow-up|2
4630923|NCT01888432|7499953|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7
4630924|NCT01888432|7499954|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6
4726219|NCT03231228|7664241|FG001|Overall Study|Lost to Follow-up|0
4726220|NCT03231228|7664240|FG000|Overall Study|Physician Decision|1
4726221|NCT03231228|7664241|FG001|Overall Study|Physician Decision|0
4726222|NCT03231371|7664251|FG000|Overall Study|Withdrawal by Subject|1
4726223|NCT03231371|7664251|FG000|Overall Study|chose or were ineligible to have MRI|12
4726224|NCT03231709|7664257|FG000|Treatment Period 1|Reason not Specified|0
4726225|NCT03231709|7664258|FG001|Treatment Period 1|Reason not Specified|1
4726226|NCT03231709|7664257|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0
4726227|NCT03231709|7664258|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1
4726228|NCT03231800|7664270|FG000|Overall Study|Lost to Follow-up|0
4726229|NCT03231800|7664271|FG001|Overall Study|Lost to Follow-up|2
4726230|NCT03231800|7664270|FG000|Overall Study|Protocol Violation|1
4726231|NCT03231800|7664271|FG001|Overall Study|Protocol Violation|1
4726232|NCT03231800|7664270|FG000|Overall Study|reason not provided|2
4726233|NCT03231800|7664271|FG001|Overall Study|reason not provided|0
4726234|NCT03231943|7664293|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0
4726235|NCT03231943|7664294|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1
4726236|NCT03231943|7664295|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1
4726237|NCT03231943|7664296|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0
4726238|NCT03231943|7664297|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0
4726239|NCT03231943|7664298|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0
4726240|NCT03231943|7664299|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0
4726241|NCT03231943|7664300|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0
4726242|NCT03231943|7664301|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0
4726243|NCT03231943|7664302|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0
4726244|NCT03231943|7664303|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0
4726245|NCT03231943|7664304|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0
4726246|NCT03231943|7664305|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0
4726247|NCT03231943|7664293|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
4726248|NCT03231943|7664294|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1
4726249|NCT03231943|7664295|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
4726250|NCT03231943|7664296|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
4726251|NCT03231943|7664297|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
4726252|NCT03231943|7664298|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
4726253|NCT03231943|7664299|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
4726254|NCT03231943|7664300|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
4726255|NCT03231943|7664301|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
4726256|NCT03231943|7664302|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
4726257|NCT03231943|7664303|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
4726258|NCT03231943|7664304|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
4726259|NCT03231943|7664305|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
4726260|NCT03231943|7664293|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1
4726261|NCT03231943|7664294|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0
4726262|NCT03231943|7664295|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0
4726263|NCT03231943|7664296|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0
4726264|NCT03231943|7664297|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0
4726265|NCT03231943|7664298|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0
4726266|NCT03231943|7664299|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0
4726267|NCT03231943|7664300|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0
4726268|NCT03231943|7664301|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0
4726269|NCT03231943|7664302|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0
4726270|NCT03231943|7664303|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0
4726271|NCT03231943|7664304|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0
4726272|NCT03231943|7664305|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0
4726273|NCT03231943|7664293|FG000|Part 2|Adverse Event|0
4726274|NCT03231943|7664294|FG001|Part 2|Adverse Event|0
4726275|NCT03231943|7664295|FG002|Part 2|Adverse Event|0
4726276|NCT03231943|7664296|FG003|Part 2|Adverse Event|0
4726277|NCT03231943|7664297|FG004|Part 2|Adverse Event|0
4726278|NCT03231943|7664298|FG005|Part 2|Adverse Event|0
4726279|NCT03231943|7664299|FG006|Part 2|Adverse Event|0
4726280|NCT03231943|7664300|FG007|Part 2|Adverse Event|0
4726281|NCT03231943|7664301|FG008|Part 2|Adverse Event|0
4726282|NCT03231943|7664302|FG009|Part 2|Adverse Event|0
4726283|NCT03231943|7664303|FG010|Part 2|Adverse Event|1
4726284|NCT03231943|7664304|FG011|Part 2|Adverse Event|0
4726285|NCT03231943|7664305|FG012|Part 2|Adverse Event|0
4726286|NCT03231943|7664293|FG000|Part 2|Withdrawal by Subject|0
4726287|NCT03231943|7664294|FG001|Part 2|Withdrawal by Subject|0
4726288|NCT03231943|7664295|FG002|Part 2|Withdrawal by Subject|0
4726289|NCT03231943|7664296|FG003|Part 2|Withdrawal by Subject|0
4726290|NCT03231943|7664297|FG004|Part 2|Withdrawal by Subject|0
4726291|NCT03231943|7664298|FG005|Part 2|Withdrawal by Subject|0
4726292|NCT03231943|7664299|FG006|Part 2|Withdrawal by Subject|0
4726293|NCT03231943|7664300|FG007|Part 2|Withdrawal by Subject|0
4726294|NCT03231943|7664301|FG008|Part 2|Withdrawal by Subject|0
4726295|NCT03231943|7664302|FG009|Part 2|Withdrawal by Subject|0
4726296|NCT03231943|7664303|FG010|Part 2|Withdrawal by Subject|0
4726297|NCT03231943|7664304|FG011|Part 2|Withdrawal by Subject|1
4726298|NCT03231943|7664305|FG012|Part 2|Withdrawal by Subject|0
4726299|NCT03232281|7664354|FG000|Overall Study|Adverse Event|1
4726300|NCT03232281|7664355|FG001|Overall Study|Adverse Event|1
4726301|NCT03232281|7664354|FG000|Overall Study|Withdrawal by Subject|5
4726302|NCT03232281|7664355|FG001|Overall Study|Withdrawal by Subject|4
4726303|NCT03232281|7664354|FG000|Overall Study|Protocol Deviation|1
4726304|NCT03232281|7664355|FG001|Overall Study|Protocol Deviation|1
4726305|NCT03232333|7664361|FG000|Overall Study|Infection or Osteomyelitis|9
4726306|NCT03232333|7664361|FG000|Overall Study|Lost to Follow-up|4
4726307|NCT03232333|7664361|FG000|Overall Study|Withdrawal by Subject|2
4726308|NCT03232567|7664369|FG000|Overall Study|Withdrawal by Subject|0
4726309|NCT03232567|7664370|FG001|Overall Study|Withdrawal by Subject|1
4726310|NCT03232567|7664371|FG002|Overall Study|Withdrawal by Subject|0
4726311|NCT03232567|7664372|FG003|Overall Study|Withdrawal by Subject|0
4726312|NCT03232983|7664405|FG000|Period 1|Physician Decision|0
4726313|NCT03232983|7664406|FG001|Period 1|Physician Decision|0
4726314|NCT03232983|7664407|FG002|Period 1|Physician Decision|1
4726315|NCT03232983|7664408|FG003|Period 1|Physician Decision|0
4726316|NCT03232983|7664405|FG000|Washout Period 2|Physician Decision|0
4726317|NCT03232983|7664406|FG001|Washout Period 2|Physician Decision|0
4726318|NCT03232983|7664407|FG002|Washout Period 2|Physician Decision|1
4726319|NCT03232983|7664408|FG003|Washout Period 2|Physician Decision|0
4726320|NCT03232983|7664405|FG000|Washout Period 2|Withdrawal by Subject|0
4726321|NCT03232983|7664406|FG001|Washout Period 2|Withdrawal by Subject|0
4726322|NCT03232983|7664407|FG002|Washout Period 2|Withdrawal by Subject|0
4726323|NCT03232983|7664408|FG003|Washout Period 2|Withdrawal by Subject|1
4726324|NCT03232983|7664405|FG000|Period 4|Withdrawal by Subject|1
4726325|NCT03232983|7664406|FG001|Period 4|Withdrawal by Subject|0
4726326|NCT03232983|7664407|FG002|Period 4|Withdrawal by Subject|0
4726327|NCT03232983|7664408|FG003|Period 4|Withdrawal by Subject|0
4726328|NCT03233009|7664420|FG000|Overall Study|Lost to Follow-up|1
4726329|NCT03233230|7664437|FG000|Overall Study|Adverse Event|6
4726330|NCT03233230|7664438|FG001|Overall Study|Adverse Event|3
4726331|NCT03233230|7664439|FG002|Overall Study|Adverse Event|6
4726332|NCT03233230|7664440|FG003|Overall Study|Adverse Event|3
4726333|NCT03233230|7664437|FG000|Overall Study|Protocol Violation|1
4726334|NCT03233230|7664438|FG001|Overall Study|Protocol Violation|2
4726335|NCT03233230|7664439|FG002|Overall Study|Protocol Violation|1
4726336|NCT03233230|7664440|FG003|Overall Study|Protocol Violation|1
4726337|NCT03233230|7664437|FG000|Overall Study|Lack of Efficacy|1
4726338|NCT03233230|7664438|FG001|Overall Study|Lack of Efficacy|0
4726339|NCT03233230|7664439|FG002|Overall Study|Lack of Efficacy|0
4726340|NCT03233230|7664440|FG003|Overall Study|Lack of Efficacy|0
4726341|NCT03233230|7664437|FG000|Overall Study|Other|5
4726342|NCT03233230|7664438|FG001|Overall Study|Other|5
4726343|NCT03233230|7664439|FG002|Overall Study|Other|5
4726344|NCT03233230|7664440|FG003|Overall Study|Other|3
4726345|NCT03233230|7664437|FG000|Overall Study|Withdrawal by Subject|2
4726346|NCT03233230|7664438|FG001|Overall Study|Withdrawal by Subject|2
4726347|NCT03233230|7664439|FG002|Overall Study|Withdrawal by Subject|0
4726348|NCT03233230|7664440|FG003|Overall Study|Withdrawal by Subject|1
4726349|NCT03233230|7664437|FG000|Overall Study|Lost to Follow-up|0
4726350|NCT03233230|7664438|FG001|Overall Study|Lost to Follow-up|3
4726351|NCT03233230|7664439|FG002|Overall Study|Lost to Follow-up|0
4772064|NCT02733042|7749207|FG015|Treatment Period|Withdrawal by Subject|0
4772065|NCT02733042|7749208|FG016|Treatment Period|Withdrawal by Subject|0
4772066|NCT02733042|7749209|FG017|Treatment Period|Withdrawal by Subject|0
4772067|NCT02733042|7749210|FG018|Treatment Period|Withdrawal by Subject|0
4772068|NCT02733042|7749192|FG000|Treatment Period|Other|0
4772069|NCT02733042|7749193|FG001|Treatment Period|Other|0
4772070|NCT02733042|7749194|FG002|Treatment Period|Other|1
4772071|NCT02733042|7749195|FG003|Treatment Period|Other|0
4772072|NCT02733042|7749196|FG004|Treatment Period|Other|0
4772073|NCT02733042|7749197|FG005|Treatment Period|Other|0
4772074|NCT02733042|7749198|FG006|Treatment Period|Other|0
4772075|NCT02733042|7749199|FG007|Treatment Period|Other|0
4772076|NCT02733042|7749200|FG008|Treatment Period|Other|0
4772077|NCT02733042|7749201|FG009|Treatment Period|Other|1
4772078|NCT02733042|7749202|FG010|Treatment Period|Other|1
4772079|NCT02733042|7749203|FG011|Treatment Period|Other|0
4772080|NCT02733042|7749204|FG012|Treatment Period|Other|0
4772081|NCT02733042|7749205|FG013|Treatment Period|Other|0
4772082|NCT02733042|7749206|FG014|Treatment Period|Other|0
4772083|NCT02733042|7749207|FG015|Treatment Period|Other|1
4772084|NCT02733042|7749208|FG016|Treatment Period|Other|0
4772085|NCT02733042|7749209|FG017|Treatment Period|Other|1
4772086|NCT02733042|7749210|FG018|Treatment Period|Other|0
4772087|NCT02733042|7749192|FG000|Treatment Period|Ongoing on Assigned Treatment|0
4772088|NCT02733042|7749193|FG001|Treatment Period|Ongoing on Assigned Treatment|0
4772089|NCT02733042|7749194|FG002|Treatment Period|Ongoing on Assigned Treatment|0
4772090|NCT02733042|7749195|FG003|Treatment Period|Ongoing on Assigned Treatment|0
4772091|NCT02733042|7749196|FG004|Treatment Period|Ongoing on Assigned Treatment|3
4726352|NCT03233230|7664440|FG003|Overall Study|Lost to Follow-up|0
4726353|NCT03233308|7664450|FG000|Overall Study|Adverse Event|1
4726354|NCT03233308|7664450|FG000|Overall Study|Protocol Violation|1
4726355|NCT03233438|7664463|FG000|Overall Study|Lost to Follow-up|4
4726356|NCT03233438|7664464|FG001|Overall Study|Lost to Follow-up|9
4772092|NCT02733042|7749197|FG005|Treatment Period|Ongoing on Assigned Treatment|0
4772093|NCT02733042|7749198|FG006|Treatment Period|Ongoing on Assigned Treatment|0
4726357|NCT03233438|7664463|FG000|Overall Study|Withdrawal by Subject|2
4726358|NCT03233438|7664464|FG001|Overall Study|Withdrawal by Subject|1
4726359|NCT03233438|7664463|FG000|Overall Study|No recording of dalbavancin|0
4726360|NCT03233438|7664464|FG001|Overall Study|No recording of dalbavancin|1
4726361|NCT03233529|7664470|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1
4726362|NCT03233529|7664470|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1
4726363|NCT03234036|7664503|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1
4726364|NCT03234036|7664504|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1
4726365|NCT03234036|7664505|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0
4726366|NCT03234036|7664506|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0
4726367|NCT03234465|7664533|FG000|Overall Study|Adverse Event|4
4726368|NCT03234465|7664534|FG001|Overall Study|Adverse Event|2
4726369|NCT03234465|7664533|FG000|Overall Study|Death|0
4726370|NCT03234465|7664534|FG001|Overall Study|Death|1
4726371|NCT03234465|7664533|FG000|Overall Study|Lost to Follow-up|1
4726372|NCT03234465|7664534|FG001|Overall Study|Lost to Follow-up|1
4726373|NCT03234465|7664533|FG000|Overall Study|Withdrawal by Subject|12
4726374|NCT03234465|7664534|FG001|Overall Study|Withdrawal by Subject|27
4726375|NCT03234465|7664533|FG000|Overall Study|Symptomatic deterioration|0
4726376|NCT03234465|7664534|FG001|Overall Study|Symptomatic deterioration|1
4726377|NCT03234465|7664533|FG000|Overall Study|Non-compliance|2
4726378|NCT03234465|7664534|FG001|Overall Study|Non-compliance|0
4726379|NCT03234465|7664533|FG000|Overall Study|Other|14
4726380|NCT03234465|7664534|FG001|Overall Study|Other|8
4726381|NCT03234608|7664542|FG000|Overall Study|Lost to Follow-up|23
4726382|NCT03234608|7664543|FG001|Overall Study|Lost to Follow-up|21
4726383|NCT03235050|7664554|FG000|Overall Study|Adverse Event|0
4726384|NCT03235050|7664555|FG001|Overall Study|Adverse Event|0
4726385|NCT03235050|7664556|FG002|Overall Study|Adverse Event|1
4726386|NCT03235050|7664557|FG003|Overall Study|Adverse Event|4
4726387|NCT03235050|7664558|FG004|Overall Study|Adverse Event|1
4726388|NCT03235050|7664554|FG000|Overall Study|Death|0
4726389|NCT03235050|7664555|FG001|Overall Study|Death|0
4726390|NCT03235050|7664556|FG002|Overall Study|Death|0
4726391|NCT03235050|7664557|FG003|Overall Study|Death|2
4726392|NCT03235050|7664558|FG004|Overall Study|Death|1
4726393|NCT03235050|7664554|FG000|Overall Study|Lost to Follow-up|1
4726394|NCT03235050|7664555|FG001|Overall Study|Lost to Follow-up|2
4726395|NCT03235050|7664556|FG002|Overall Study|Lost to Follow-up|1
4726396|NCT03235050|7664557|FG003|Overall Study|Lost to Follow-up|2
4726397|NCT03235050|7664558|FG004|Overall Study|Lost to Follow-up|0
4726398|NCT03235050|7664554|FG000|Overall Study|Withdrawal by Subject|3
4726399|NCT03235050|7664555|FG001|Overall Study|Withdrawal by Subject|2
4726400|NCT03235050|7664556|FG002|Overall Study|Withdrawal by Subject|2
4726401|NCT03235050|7664557|FG003|Overall Study|Withdrawal by Subject|5
4726402|NCT03235050|7664558|FG004|Overall Study|Withdrawal by Subject|7
4726403|NCT03235050|7664554|FG000|Overall Study|Other reasons|0
4726404|NCT03235050|7664555|FG001|Overall Study|Other reasons|1
4726405|NCT03235050|7664556|FG002|Overall Study|Other reasons|0
4726406|NCT03235050|7664557|FG003|Overall Study|Other reasons|1
4726407|NCT03235050|7664558|FG004|Overall Study|Other reasons|2
4726408|NCT03235089|7664570|FG000|Overall Study|Lost to Follow-up|1
4726409|NCT03235089|7664571|FG001|Overall Study|Lost to Follow-up|1
4726410|NCT03235089|7664570|FG000|Overall Study|Physician Decision|2
4726411|NCT03235089|7664571|FG001|Overall Study|Physician Decision|2
4726412|NCT03235115|7664578|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
4726413|NCT03235115|7664579|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
4726414|NCT03235115|7664580|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
4726415|NCT03235115|7664581|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
4726416|NCT03235115|7664582|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
4726417|NCT03235115|7664583|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1
4726418|NCT03235154|7664591|FG000|Overall Study|Withdrawal by Subject|1
4726419|NCT03235154|7664591|FG000|Overall Study|Adverse Event|1
4726420|NCT03235154|7664591|FG000|Overall Study|Lost to Follow-up|2
4726421|NCT03235284|7664604|FG000|Overall Study|Adverse Event|1
4726422|NCT03235284|7664605|FG001|Overall Study|Adverse Event|2
4726423|NCT03235284|7664606|FG002|Overall Study|Adverse Event|1
4726424|NCT03235349|7664614|FG000|Overall Study|Adverse Event|1
4726425|NCT03235349|7664614|FG000|Overall Study|Other|1
4726426|NCT03235479|7664624|FG000|Overall Study|Lost to Follow-up|8
4726427|NCT03235479|7664625|FG001|Overall Study|Lost to Follow-up|11
4726428|NCT03235479|7664624|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23
4726429|NCT03235479|7664625|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17
4726430|NCT03235479|7664624|FG000|Overall Study|Pregnancy|1
4726431|NCT03235479|7664625|FG001|Overall Study|Pregnancy|0
4726432|NCT03235479|7664624|FG000|Overall Study|Protocol Deviation|1
4726433|NCT03235479|7664625|FG001|Overall Study|Protocol Deviation|3
4726434|NCT03235479|7664624|FG000|Overall Study|Technical Problems|3
4726435|NCT03235479|7664625|FG001|Overall Study|Technical Problems|2
4726436|NCT03235479|7664624|FG000|Overall Study|Withdrawal by Subject|2
4726437|NCT03235479|7664625|FG001|Overall Study|Withdrawal by Subject|2
4726438|NCT03235479|7664624|FG000|Overall Study|Other Reasons|3
4726439|NCT03235479|7664625|FG001|Overall Study|Other Reasons|5
4726440|NCT03235726|7664639|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
4590580|NCT01523275|7436708|FG000|Overall Study|Lost to Follow-up|1
4590581|NCT01523275|7436709|FG001|Overall Study|Lost to Follow-up|2
4590582|NCT01523275|7436708|FG000|Overall Study|Withdrawal by Subject|1
4590583|NCT01523275|7436709|FG001|Overall Study|Withdrawal by Subject|0
4590584|NCT01523301|7436717|FG000|Overall Study|Adverse Event|25
4590585|NCT01523301|7436718|FG001|Overall Study|Adverse Event|16
4726441|NCT03235726|7664640|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
4726442|NCT03235726|7664641|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
4726443|NCT03235726|7664642|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
4726444|NCT03235726|7664643|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1
4726445|NCT03235726|7664644|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
4726446|NCT03235726|7664645|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
4726447|NCT03235726|7664646|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
4726448|NCT03235726|7664647|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
4726449|NCT03235726|7664648|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
4726450|NCT03235726|7664639|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
4726451|NCT03235726|7664640|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
4726452|NCT03235726|7664641|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
4726453|NCT03235726|7664642|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
4726454|NCT03235726|7664643|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1
4726455|NCT03235726|7664644|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
4726456|NCT03235726|7664645|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
4726457|NCT03235726|7664646|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
4726458|NCT03235726|7664647|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
4726459|NCT03235726|7664648|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
4726460|NCT03236246|7664689|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8
4726461|NCT03236246|7664690|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7
4726462|NCT03236246|7664689|FG000|24-Week Dose Titration Period|Lost to Follow-up|0
4726463|NCT03236246|7664690|FG001|24-Week Dose Titration Period|Lost to Follow-up|2
4726464|NCT03236246|7664689|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3
4726465|NCT03236246|7664690|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2
4726466|NCT03236246|7664689|FG000|24-Week Dose Titration Period|Investigator Judgement|1
4726467|NCT03236246|7664690|FG001|24-Week Dose Titration Period|Investigator Judgement|1
4726468|NCT03236246|7664689|FG000|24-Week Dose Titration Period|Prohibited Therapy|1
4726469|NCT03236246|7664690|FG001|24-Week Dose Titration Period|Prohibited Therapy|1
4726470|NCT03236246|7664689|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0
4726471|NCT03236246|7664690|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1
4726472|NCT03236246|7664689|FG000|24-Week Dose Titration Period|Death|3
4726473|NCT03236246|7664690|FG001|24-Week Dose Titration Period|Death|1
4726474|NCT03236246|7664689|FG000|24-Week Dose Titration Period|Protocol Violation|0
4726475|NCT03236246|7664690|FG001|24-Week Dose Titration Period|Protocol Violation|2
4726476|NCT03236246|7664689|FG000|24-Week Dose Titration Period|Adverse Event|7
4726477|NCT03236246|7664690|FG001|24-Week Dose Titration Period|Adverse Event|8
4726478|NCT03236246|7664689|FG000|24-Week Dose Titration Period|Captured as Other|1
4726479|NCT03236246|7664690|FG001|24-Week Dose Titration Period|Captured as Other|2
4726480|NCT03236246|7664689|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1
4726481|NCT03236246|7664690|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3
4726482|NCT03236246|7664689|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1
4726483|NCT03236246|7664690|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1
4726484|NCT03236246|7664689|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1
4726485|NCT03236246|7664690|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0
4726486|NCT03236246|7664689|FG000|24-Week Dose Maintenance Period|Death|0
4726487|NCT03236246|7664690|FG001|24-Week Dose Maintenance Period|Death|1
4726488|NCT03236246|7664689|FG000|24-Week Dose Maintenance Period|Adverse Event|0
4726489|NCT03236246|7664690|FG001|24-Week Dose Maintenance Period|Adverse Event|1
4726490|NCT03236506|7664699|FG000|Overall Study|Death|1
4726491|NCT03236506|7664700|FG001|Overall Study|Death|1
4726492|NCT03236506|7664701|FG002|Overall Study|Death|1
4726493|NCT03236506|7664699|FG000|Overall Study|Withdrawal by Subject|3
4726494|NCT03236506|7664700|FG001|Overall Study|Withdrawal by Subject|3
4726495|NCT03236506|7664701|FG002|Overall Study|Withdrawal by Subject|4
4726496|NCT03236506|7664699|FG000|Overall Study|Did not initiate treatment|2
4726497|NCT03236506|7664700|FG001|Overall Study|Did not initiate treatment|1
4726498|NCT03236506|7664701|FG002|Overall Study|Did not initiate treatment|2
4726499|NCT03236779|7664711|FG000|Overall Study|Lost to Follow-up|13
4726500|NCT03236779|7664712|FG001|Overall Study|Lost to Follow-up|21
4726501|NCT03237013|7664723|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43
4726502|NCT03237013|7664724|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30
4726503|NCT03237013|7664725|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37
4726504|NCT03237065|7664735|FG000|Overall Study|Adverse Event|0
4726505|NCT03237065|7664736|FG001|Overall Study|Adverse Event|2
4726506|NCT03237065|7664735|FG000|Overall Study|Protocol Violation|0
4590586|NCT01523301|7436717|FG000|Overall Study|Lack of Efficacy|0
4726507|NCT03237065|7664736|FG001|Overall Study|Protocol Violation|1
4630925|NCT01888432|7499953|FG000|24-month Analysis (FAS)|Death|8
4630926|NCT01888432|7499954|FG001|24-month Analysis (FAS)|Death|4
4726508|NCT03237065|7664735|FG000|Overall Study|Withdrawal by Subject|3
4726509|NCT03237065|7664736|FG001|Overall Study|Withdrawal by Subject|0
4726510|NCT03237065|7664735|FG000|Overall Study|Lost to Follow-up|1
4726511|NCT03237065|7664736|FG001|Overall Study|Lost to Follow-up|0
4726512|NCT03237065|7664735|FG000|Overall Study|Unable to obtain venous access|0
4726513|NCT03237065|7664736|FG001|Overall Study|Unable to obtain venous access|1
4726514|NCT03237481|7664765|FG000|Overall Study|Lost to Follow-up|1
4726515|NCT03237481|7664766|FG001|Overall Study|Lost to Follow-up|0
4515263|NCT00952289|7326015|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19
4515264|NCT00952289|7326014|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0
4515265|NCT00952289|7326015|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15
4630927|NCT01888432|7499953|FG000|36-month Analysis (Extension)|Death|1
4726516|NCT03237481|7664767|FG002|Overall Study|Lost to Follow-up|0
4726517|NCT03237481|7664765|FG000|Overall Study|Protocol Violation|1
4726518|NCT03237481|7664766|FG001|Overall Study|Protocol Violation|0
4726519|NCT03237481|7664767|FG002|Overall Study|Protocol Violation|0
4726520|NCT03237481|7664765|FG000|Overall Study|Withdrawal by Subject|3
4726521|NCT03237481|7664766|FG001|Overall Study|Withdrawal by Subject|2
4726522|NCT03237481|7664767|FG002|Overall Study|Withdrawal by Subject|1
4726523|NCT03237845|7664777|FG000|Overall Study|Adverse Event|0
4726524|NCT03237845|7664778|FG001|Overall Study|Adverse Event|1
4726525|NCT03237845|7664777|FG000|Overall Study|Lost to Follow-up|13
4726526|NCT03237845|7664778|FG001|Overall Study|Lost to Follow-up|10
4726527|NCT03237845|7664777|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26
4726528|NCT03237845|7664778|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31
4726529|NCT03237845|7664777|FG000|Overall Study|Non-Compliance With Study Treatment|0
4726530|NCT03237845|7664778|FG001|Overall Study|Non-Compliance With Study Treatment|1
4726531|NCT03237845|7664777|FG000|Overall Study|Physician Decision|1
4726532|NCT03237845|7664778|FG001|Overall Study|Physician Decision|2
4726533|NCT03237845|7664777|FG000|Overall Study|Pregnancy|1
4726534|NCT03237845|7664778|FG001|Overall Study|Pregnancy|0
4726535|NCT03237845|7664777|FG000|Overall Study|Protocol Deviation|0
4726536|NCT03237845|7664778|FG001|Overall Study|Protocol Deviation|1
4726537|NCT03237845|7664777|FG000|Overall Study|Technical Problems|8
4726538|NCT03237845|7664778|FG001|Overall Study|Technical Problems|1
4726539|NCT03237845|7664777|FG000|Overall Study|Withdrawal by Subject|3
4726540|NCT03237845|7664778|FG001|Overall Study|Withdrawal by Subject|3
4726541|NCT03237845|7664777|FG000|Overall Study|Other Reasons|4
4726542|NCT03237845|7664778|FG001|Overall Study|Other Reasons|0
4630928|NCT01888432|7499954|FG001|36-month Analysis (Extension)|Death|0
4726543|NCT03238001|7664788|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2
4726544|NCT03238001|7664788|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2
4726545|NCT03238001|7664788|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16
4726546|NCT03238001|7664788|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2
4726547|NCT03238001|7664788|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3
4726548|NCT03238001|7664788|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3
4726549|NCT03238001|7664788|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1
4726550|NCT03238001|7664788|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4
4726551|NCT03238352|7664803|FG000|Overall Study|Lost to Follow-up|0
4726552|NCT03238352|7664804|FG001|Overall Study|Lost to Follow-up|2
4726553|NCT03238352|7664805|FG002|Overall Study|Lost to Follow-up|1
4726554|NCT03238352|7664803|FG000|Overall Study|Withdrawal by Subject|0
4726555|NCT03238352|7664804|FG001|Overall Study|Withdrawal by Subject|1
4726556|NCT03238352|7664805|FG002|Overall Study|Withdrawal by Subject|0
4726557|NCT03238417|7664815|FG000|Overall|non-response|955
4726558|NCT03238417|7664816|FG001|Overall|non-response|1920
4726559|NCT03238417|7664815|FG000|Overall|partial completion|48
4726560|NCT03238417|7664816|FG001|Overall|partial completion|68
4726561|NCT03238417|7664815|FG000|Baseline|Partial completion|17
4630929|NCT01888497|7499970|FG000|Washout Period 1|Withdrawal by Subject|0
4726562|NCT03238417|7664816|FG001|Baseline|Partial completion|48
4726563|NCT03238417|7664815|FG000|Baseline|non-response|372
4726564|NCT03238417|7664816|FG001|Baseline|non-response|669
4726565|NCT03238417|7664815|FG000|12-month|non-response|296
4726566|NCT03238417|7664816|FG001|12-month|non-response|669
4726567|NCT03238417|7664815|FG000|12-month|partial completion|23
4726568|NCT03238417|7664816|FG001|12-month|partial completion|37
4726569|NCT03238417|7664815|FG000|24-month|non-response|287
4726570|NCT03238417|7664816|FG001|24-month|non-response|594
4726571|NCT03238417|7664815|FG000|24-month|partial completion|8
4726572|NCT03238417|7664816|FG001|24-month|partial completion|31
4726573|NCT03238651|7664827|FG000|Overall Study|Other|0
4726574|NCT03238651|7664828|FG001|Overall Study|Other|0
4726575|NCT03238651|7664829|FG002|Overall Study|Other|0
4726576|NCT03238651|7664830|FG003|Overall Study|Other|0
4726577|NCT03238651|7664831|FG004|Overall Study|Other|1
4726578|NCT03238651|7664827|FG000|Overall Study|Progressive Disease|2
4726579|NCT03238651|7664828|FG001|Overall Study|Progressive Disease|2
4726580|NCT03238651|7664829|FG002|Overall Study|Progressive Disease|2
4726581|NCT03238651|7664830|FG003|Overall Study|Progressive Disease|2
4726582|NCT03238651|7664831|FG004|Overall Study|Progressive Disease|0
4726583|NCT03238651|7664827|FG000|Overall Study|Withdrawal by Subject|0
4726584|NCT03238651|7664828|FG001|Overall Study|Withdrawal by Subject|1
4726585|NCT03238651|7664829|FG002|Overall Study|Withdrawal by Subject|0
4726586|NCT03238651|7664830|FG003|Overall Study|Withdrawal by Subject|1
4726587|NCT03238651|7664831|FG004|Overall Study|Withdrawal by Subject|0
4726588|NCT03238651|7664827|FG000|Overall Study|Adverse Event|1
4726589|NCT03238651|7664828|FG001|Overall Study|Adverse Event|3
4726590|NCT03238651|7664829|FG002|Overall Study|Adverse Event|2
4726591|NCT03238651|7664830|FG003|Overall Study|Adverse Event|0
4726592|NCT03238651|7664831|FG004|Overall Study|Adverse Event|0
4726593|NCT03238781|7664847|FG000|Overall Study|Adverse Event|1
4726594|NCT03238781|7664848|FG001|Overall Study|Adverse Event|1
4726595|NCT03238781|7664849|FG002|Overall Study|Adverse Event|2
4726596|NCT03238781|7664847|FG000|Overall Study|Lost to Follow-up|2
4772094|NCT02733042|7749199|FG007|Treatment Period|Ongoing on Assigned Treatment|0
4772095|NCT02733042|7749200|FG008|Treatment Period|Ongoing on Assigned Treatment|0
4772096|NCT02733042|7749201|FG009|Treatment Period|Ongoing on Assigned Treatment|8
4772097|NCT02733042|7749202|FG010|Treatment Period|Ongoing on Assigned Treatment|4
4772098|NCT02733042|7749203|FG011|Treatment Period|Ongoing on Assigned Treatment|0
4772099|NCT02733042|7749204|FG012|Treatment Period|Ongoing on Assigned Treatment|0
4772100|NCT02733042|7749205|FG013|Treatment Period|Ongoing on Assigned Treatment|0
4772101|NCT02733042|7749206|FG014|Treatment Period|Ongoing on Assigned Treatment|0
4772102|NCT02733042|7749207|FG015|Treatment Period|Ongoing on Assigned Treatment|0
4772103|NCT02733042|7749208|FG016|Treatment Period|Ongoing on Assigned Treatment|0
4772104|NCT02733042|7749209|FG017|Treatment Period|Ongoing on Assigned Treatment|0
4772105|NCT02733042|7749210|FG018|Treatment Period|Ongoing on Assigned Treatment|1
4772106|NCT02733042|7749192|FG000|Treatment Period|Death|0
4772107|NCT02733042|7749193|FG001|Treatment Period|Death|0
4772108|NCT02733042|7749194|FG002|Treatment Period|Death|0
4772109|NCT02733042|7749195|FG003|Treatment Period|Death|0
4772110|NCT02733042|7749196|FG004|Treatment Period|Death|0
4772111|NCT02733042|7749197|FG005|Treatment Period|Death|0
4772112|NCT02733042|7749198|FG006|Treatment Period|Death|1
4772113|NCT02733042|7749199|FG007|Treatment Period|Death|0
4772114|NCT02733042|7749200|FG008|Treatment Period|Death|1
4772115|NCT02733042|7749201|FG009|Treatment Period|Death|0
4772116|NCT02733042|7749202|FG010|Treatment Period|Death|1
4772117|NCT02733042|7749203|FG011|Treatment Period|Death|0
4772118|NCT02733042|7749204|FG012|Treatment Period|Death|0
4772119|NCT02733042|7749205|FG013|Treatment Period|Death|0
4772120|NCT02733042|7749206|FG014|Treatment Period|Death|1
4772121|NCT02733042|7749207|FG015|Treatment Period|Death|2
4772122|NCT02733042|7749208|FG016|Treatment Period|Death|0
4772123|NCT02733042|7749209|FG017|Treatment Period|Death|0
4772124|NCT02733042|7749210|FG018|Treatment Period|Death|0
4772125|NCT02733042|7749192|FG000|Follow-up Period|Ongoing on Follow-up|2
4772126|NCT02733042|7749193|FG001|Follow-up Period|Ongoing on Follow-up|2
4772127|NCT02733042|7749194|FG002|Follow-up Period|Ongoing on Follow-up|4
4772128|NCT02733042|7749195|FG003|Follow-up Period|Ongoing on Follow-up|2
4772129|NCT02733042|7749196|FG004|Follow-up Period|Ongoing on Follow-up|0
4772130|NCT02733042|7749197|FG005|Follow-up Period|Ongoing on Follow-up|0
4772131|NCT02733042|7749198|FG006|Follow-up Period|Ongoing on Follow-up|0
4772132|NCT02733042|7749199|FG007|Follow-up Period|Ongoing on Follow-up|1
4772133|NCT02733042|7749200|FG008|Follow-up Period|Ongoing on Follow-up|0
4772134|NCT02733042|7749201|FG009|Follow-up Period|Ongoing on Follow-up|2
4772135|NCT02733042|7749202|FG010|Follow-up Period|Ongoing on Follow-up|4
4772136|NCT02733042|7749203|FG011|Follow-up Period|Ongoing on Follow-up|9
4772137|NCT02733042|7749204|FG012|Follow-up Period|Ongoing on Follow-up|1
4772138|NCT02733042|7749205|FG013|Follow-up Period|Ongoing on Follow-up|3
4772139|NCT02733042|7749206|FG014|Follow-up Period|Ongoing on Follow-up|0
4772140|NCT02733042|7749207|FG015|Follow-up Period|Ongoing on Follow-up|0
4772141|NCT02733042|7749208|FG016|Follow-up Period|Ongoing on Follow-up|0
4772142|NCT02733042|7749209|FG017|Follow-up Period|Ongoing on Follow-up|1
4772143|NCT02733042|7749210|FG018|Follow-up Period|Ongoing on Follow-up|0
4772144|NCT02733042|7749192|FG000|Follow-up Period|Death|1
4772145|NCT02733042|7749193|FG001|Follow-up Period|Death|1
4772146|NCT02733042|7749194|FG002|Follow-up Period|Death|2
4772147|NCT02733042|7749195|FG003|Follow-up Period|Death|0
4772148|NCT02733042|7749196|FG004|Follow-up Period|Death|1
4772149|NCT02733042|7749197|FG005|Follow-up Period|Death|2
4772150|NCT02733042|7749198|FG006|Follow-up Period|Death|0
4772151|NCT02733042|7749199|FG007|Follow-up Period|Death|3
4772152|NCT02733042|7749200|FG008|Follow-up Period|Death|3
4772153|NCT02733042|7749201|FG009|Follow-up Period|Death|0
4772154|NCT02733042|7749202|FG010|Follow-up Period|Death|0
4772155|NCT02733042|7749203|FG011|Follow-up Period|Death|0
4772156|NCT02733042|7749204|FG012|Follow-up Period|Death|8
4772157|NCT02733042|7749205|FG013|Follow-up Period|Death|1
4772158|NCT02733042|7749206|FG014|Follow-up Period|Death|1
4772159|NCT02733042|7749207|FG015|Follow-up Period|Death|4
4772160|NCT02733042|7749208|FG016|Follow-up Period|Death|0
4772161|NCT02733042|7749209|FG017|Follow-up Period|Death|1
4772162|NCT02733042|7749210|FG018|Follow-up Period|Death|2
4772163|NCT02733042|7749192|FG000|Follow-up Period|Other|0
4772164|NCT02733042|7749193|FG001|Follow-up Period|Other|0
4772165|NCT02733042|7749194|FG002|Follow-up Period|Other|0
4772166|NCT02733042|7749195|FG003|Follow-up Period|Other|1
4726597|NCT03238781|7664848|FG001|Overall Study|Lost to Follow-up|1
4726598|NCT03238781|7664849|FG002|Overall Study|Lost to Follow-up|2
4726599|NCT03238781|7664847|FG000|Overall Study|Withdrawal by Subject|23
4726600|NCT03238781|7664848|FG001|Overall Study|Withdrawal by Subject|14
4726601|NCT03238781|7664849|FG002|Overall Study|Withdrawal by Subject|16
4726602|NCT03238781|7664847|FG000|Overall Study|Decision by sponsor|0
4726603|NCT03238781|7664848|FG001|Overall Study|Decision by sponsor|1
4726604|NCT03238781|7664849|FG002|Overall Study|Decision by sponsor|0
4726605|NCT03238911|7664859|FG000|Overall Study|Withdrawal by Subject|1
4726606|NCT03238911|7664860|FG001|Overall Study|Withdrawal by Subject|2
4726607|NCT03238911|7664859|FG000|Overall Study|Lost to Follow-up|2
4726608|NCT03238911|7664860|FG001|Overall Study|Lost to Follow-up|1
4726609|NCT03238924|7664869|FG000|Overall Study|Withdrawal by Subject|2
4726610|NCT03238924|7664870|FG001|Overall Study|Withdrawal by Subject|2
4726611|NCT03238963|7664878|FG000|Overall Study|Prohibited medication given due to hospital stay|1
4726612|NCT03238963|7664879|FG001|Overall Study|Prohibited medication given due to hospital stay|0
4726613|NCT03238963|7664878|FG000|Overall Study|Withdrawal by Subject|1
4726614|NCT03238963|7664879|FG001|Overall Study|Withdrawal by Subject|1
4726615|NCT03238963|7664878|FG000|Overall Study|Lost to Follow-up|1
4726616|NCT03238963|7664879|FG001|Overall Study|Lost to Follow-up|0
4726617|NCT03238963|7664878|FG000|Overall Study|Protocol Violation|1
4726618|NCT03238963|7664879|FG001|Overall Study|Protocol Violation|1
4726619|NCT03238963|7664878|FG000|Overall Study|Adverse Event|1
4726620|NCT03238963|7664879|FG001|Overall Study|Adverse Event|0
4726621|NCT03239470|7664890|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1
4726622|NCT03239470|7664891|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0
4726623|NCT03239483|7664897|FG000|Overall Study|Lost to Follow-up|1
4726624|NCT03239483|7664898|FG001|Overall Study|Lost to Follow-up|0
4726625|NCT03239483|7664897|FG000|Overall Study|Withdrawal by Subject|1
4726626|NCT03239483|7664898|FG001|Overall Study|Withdrawal by Subject|0
4726627|NCT03239873|7664951|FG000|Overall Study|Lost to Follow-up|15
4726628|NCT03239873|7664952|FG001|Overall Study|Lost to Follow-up|16
4726629|NCT03239873|7664951|FG000|Overall Study|Physician Decision|1
4726630|NCT03239873|7664952|FG001|Overall Study|Physician Decision|0
4726631|NCT03239873|7664951|FG000|Overall Study|Withdrawal by Parent/Guardian|12
4726632|NCT03239873|7664952|FG001|Overall Study|Withdrawal by Parent/Guardian|11
4726633|NCT03239873|7664951|FG000|Overall Study|Withdrawal by Subject|2
4726634|NCT03239873|7664952|FG001|Overall Study|Withdrawal by Subject|0
4726635|NCT03239873|7664951|FG000|Overall Study|Contraindication to study medication|1
4726636|NCT03239873|7664952|FG001|Overall Study|Contraindication to study medication|0
4726637|NCT03239873|7664951|FG000|Overall Study|Protocol Violation|1
4726638|NCT03239873|7664952|FG001|Overall Study|Protocol Violation|0
4726639|NCT03240081|7664960|FG000|Overall Study|Withdrawal by Subject|0
4726640|NCT03240081|7664961|FG001|Overall Study|Withdrawal by Subject|2
4726641|NCT03240081|7664960|FG000|Overall Study|Lost to Follow-up|0
4726642|NCT03240081|7664961|FG001|Overall Study|Lost to Follow-up|1
4726643|NCT03240133|7664970|FG000|Overall Study|Withdrawal by Subject|0
4726644|NCT03240133|7664971|FG001|Overall Study|Withdrawal by Subject|1
4726645|NCT03240133|7664972|FG002|Overall Study|Withdrawal by Subject|0
4726646|NCT03240133|7664970|FG000|Overall Study|Adverse Event|1
4726647|NCT03240133|7664971|FG001|Overall Study|Adverse Event|1
4726648|NCT03240133|7664972|FG002|Overall Study|Adverse Event|0
4726649|NCT03240133|7664970|FG000|Overall Study|Rash|1
4726650|NCT03240133|7664971|FG001|Overall Study|Rash|0
4726651|NCT03240133|7664972|FG002|Overall Study|Rash|0
4726652|NCT03240133|7664970|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1
4726653|NCT03240133|7664971|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0
4726654|NCT03240133|7664972|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0
4726655|NCT03240133|7664970|FG000|Overall Study|Intercurrent illness.|0
4726656|NCT03240133|7664971|FG001|Overall Study|Intercurrent illness.|1
4726657|NCT03240133|7664972|FG002|Overall Study|Intercurrent illness.|0
4726658|NCT03240133|7664970|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0
4726659|NCT03240133|7664971|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0
4726660|NCT03240133|7664972|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1
4736918|NCT03585959|7686589|FG000|Overall Study|Unsuccessful Procedure|2
4736919|NCT03586167|7686597|FG000|Overall Study|Other|1
4736920|NCT03586167|7686598|FG001|Overall Study|Other|0
4736921|NCT03586544|7686606|FG000|First Intervention|Adverse Event|0
4736922|NCT03586544|7686607|FG001|First Intervention|Adverse Event|1
4736923|NCT03586544|7686606|FG000|Second Intervention|Withdrawal by Subject|0
4736924|NCT03586544|7686607|FG001|Second Intervention|Withdrawal by Subject|1
4736925|NCT03586648|7686618|FG000|Period 1|Withdrawal by Subject|0
4736926|NCT03586648|7686619|FG001|Period 1|Withdrawal by Subject|1
4736927|NCT03586648|7686618|FG000|Period 1|Lost to Follow-up|1
4736928|NCT03586648|7686619|FG001|Period 1|Lost to Follow-up|1
4736929|NCT03586648|7686618|FG000|Period 1|Adverse Event|1
4736930|NCT03586648|7686619|FG001|Period 1|Adverse Event|0
4736931|NCT03586648|7686618|FG000|Period 1|Study related symptoms or complaints|2
4736932|NCT03586648|7686619|FG001|Period 1|Study related symptoms or complaints|1
4736933|NCT03586648|7686618|FG000|Period 1|Physician Decision|0
4736934|NCT03586648|7686619|FG001|Period 1|Physician Decision|1
4726661|NCT03240575|7665000|FG000|Overall Study|Adverse Event|0
4726662|NCT03240575|7665001|FG001|Overall Study|Adverse Event|2
4726663|NCT03240575|7665002|FG002|Overall Study|Adverse Event|0
4726664|NCT03240575|7665003|FG003|Overall Study|Adverse Event|1
4726665|NCT03240575|7665000|FG000|Overall Study|Withdrawal by Subject|2
4726666|NCT03240575|7665001|FG001|Overall Study|Withdrawal by Subject|11
4726667|NCT03240575|7665002|FG002|Overall Study|Withdrawal by Subject|0
4726668|NCT03240575|7665003|FG003|Overall Study|Withdrawal by Subject|1
4726669|NCT03240575|7665000|FG000|Overall Study|Other|0
4726670|NCT03240575|7665001|FG001|Overall Study|Other|1
4726671|NCT03240575|7665002|FG002|Overall Study|Other|0
4726672|NCT03240575|7665003|FG003|Overall Study|Other|0
4726673|NCT03241342|7665023|FG000|Overall Study|Adverse Event|5
4726674|NCT03241342|7665024|FG001|Overall Study|Adverse Event|8
4726675|NCT03241342|7665025|FG002|Overall Study|Adverse Event|4
4726676|NCT03241342|7665023|FG000|Overall Study|Lack of Efficacy|0
4726677|NCT03241342|7665024|FG001|Overall Study|Lack of Efficacy|0
4726678|NCT03241342|7665025|FG002|Overall Study|Lack of Efficacy|1
4726679|NCT03241342|7665023|FG000|Overall Study|noncompliance with study drug|2
4726680|NCT03241342|7665024|FG001|Overall Study|noncompliance with study drug|1
4726681|NCT03241342|7665025|FG002|Overall Study|noncompliance with study drug|1
4726682|NCT03241342|7665023|FG000|Overall Study|sponsor decision|0
4726683|NCT03241342|7665024|FG001|Overall Study|sponsor decision|1
4726684|NCT03241342|7665025|FG002|Overall Study|sponsor decision|2
4726685|NCT03241342|7665023|FG000|Overall Study|not reported|15
4726686|NCT03241342|7665024|FG001|Overall Study|not reported|21
4726687|NCT03241342|7665025|FG002|Overall Study|not reported|19
4726688|NCT03241368|7665033|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25
4726689|NCT03241368|7665033|FG000|Overall Study|Lost to Follow-up|1
4726690|NCT03241368|7665033|FG000|Overall Study|Physician Decision|6
4726691|NCT03241368|7665033|FG000|Overall Study|Withdrawal by Subject|6
4726692|NCT03241368|7665033|FG000|Overall Study|Protocol Violation|1
4726693|NCT03241927|7665065|FG000|Overall Study|study terminated|1
4726694|NCT03241927|7665066|FG001|Overall Study|study terminated|0
4726695|NCT03242018|7665075|FG000|Overall Study|Adverse Event|7
4726696|NCT03242018|7665076|FG001|Overall Study|Adverse Event|7
4726697|NCT03242018|7665077|FG002|Overall Study|Adverse Event|6
4726698|NCT03242018|7665075|FG000|Overall Study|Lost to Follow-up|2
4726699|NCT03242018|7665076|FG001|Overall Study|Lost to Follow-up|2
4726700|NCT03242018|7665077|FG002|Overall Study|Lost to Follow-up|2
4726701|NCT03242018|7665075|FG000|Overall Study|At the Participant's Own Request|5
4726702|NCT03242018|7665076|FG001|Overall Study|At the Participant's Own Request|1
4726703|NCT03242018|7665077|FG002|Overall Study|At the Participant's Own Request|4
4726704|NCT03242018|7665075|FG000|Overall Study|Reason Not Specified|3
4726705|NCT03242018|7665076|FG001|Overall Study|Reason Not Specified|4
4726706|NCT03242018|7665077|FG002|Overall Study|Reason Not Specified|1
4726707|NCT03242018|7665075|FG000|Overall Study|Study Terminated by Sponsor|1
4726708|NCT03242018|7665076|FG001|Overall Study|Study Terminated by Sponsor|0
4726709|NCT03242018|7665077|FG002|Overall Study|Study Terminated by Sponsor|1
4726710|NCT03242252|7665093|FG000|Overall Study|At the Participant's own Request|18
4726711|NCT03242252|7665094|FG001|Overall Study|At the Participant's own Request|10
4726712|NCT03242252|7665095|FG002|Overall Study|At the Participant's own Request|15
4726713|NCT03242252|7665093|FG000|Overall Study|Adverse Event|8
4726714|NCT03242252|7665094|FG001|Overall Study|Adverse Event|6
4726715|NCT03242252|7665095|FG002|Overall Study|Adverse Event|9
4726716|NCT03242252|7665093|FG000|Overall Study|Poor Compliance to Protocol|0
4726717|NCT03242252|7665094|FG001|Overall Study|Poor Compliance to Protocol|2
4726718|NCT03242252|7665095|FG002|Overall Study|Poor Compliance to Protocol|3
4726719|NCT03242252|7665093|FG000|Overall Study|Study Terminated by Sponsor|1
4726720|NCT03242252|7665094|FG001|Overall Study|Study Terminated by Sponsor|0
4726721|NCT03242252|7665095|FG002|Overall Study|Study Terminated by Sponsor|0
4726722|NCT03242252|7665093|FG000|Overall Study|Reason not Specified|4
4726723|NCT03242252|7665094|FG001|Overall Study|Reason not Specified|4
4726724|NCT03242252|7665095|FG002|Overall Study|Reason not Specified|1
4726725|NCT03242252|7665093|FG000|Overall Study|Lost to Follow-up|5
4726726|NCT03242252|7665094|FG001|Overall Study|Lost to Follow-up|1
4726727|NCT03242252|7665095|FG002|Overall Study|Lost to Follow-up|4
4726728|NCT03242434|7665115|FG000|Overall Study|Death|0
4726729|NCT03242434|7665116|FG001|Overall Study|Death|2
4726730|NCT03242759|7665129|FG000|Overall Study|Adverse Event|5
4726731|NCT03242759|7665130|FG001|Overall Study|Adverse Event|1
4630930|NCT01888497|7499971|FG001|Washout Period 1|Withdrawal by Subject|0
4630931|NCT01888497|7499972|FG002|Washout Period 1|Withdrawal by Subject|1
4726732|NCT03242759|7665129|FG000|Overall Study|Withdrawal by Subject|4
4726733|NCT03242759|7665130|FG001|Overall Study|Withdrawal by Subject|3
4726734|NCT03242759|7665129|FG000|Overall Study|Lost to Follow-up|3
4726735|NCT03242759|7665130|FG001|Overall Study|Lost to Follow-up|1
4726736|NCT03242759|7665129|FG000|Overall Study|Administrative problems|1
4726737|NCT03242759|7665130|FG001|Overall Study|Administrative problems|1
4726738|NCT03242759|7665129|FG000|Overall Study|Death|22
4726739|NCT03242759|7665130|FG001|Overall Study|Death|0
4726740|NCT03242759|7665129|FG000|Overall Study|Change visit schedule|0
4726741|NCT03242759|7665130|FG001|Overall Study|Change visit schedule|1
4772167|NCT02733042|7749196|FG004|Follow-up Period|Other|0
4772168|NCT02733042|7749197|FG005|Follow-up Period|Other|0
4726742|NCT03242863|7665136|FG000|Study Week 1|Withdrawal by Subject|0
4726743|NCT03242863|7665137|FG001|Study Week 1|Withdrawal by Subject|1
4726744|NCT03242863|7665138|FG002|Study Week 1|Withdrawal by Subject|0
4726745|NCT03242863|7665139|FG003|Study Week 1|Withdrawal by Subject|0
4726746|NCT03242863|7665140|FG004|Study Week 1|Withdrawal by Subject|3
4726747|NCT03242863|7665141|FG005|Study Week 1|Withdrawal by Subject|0
4726748|NCT03242928|7665151|FG000|Overall Study|Adverse Event|2
4726749|NCT03242928|7665152|FG001|Overall Study|Adverse Event|1
4726750|NCT03242928|7665151|FG000|Overall Study|Lost to Follow-up|2
4726751|NCT03242928|7665152|FG001|Overall Study|Lost to Follow-up|0
4726752|NCT03242928|7665151|FG000|Overall Study|Physician Decision|0
4726753|NCT03242928|7665152|FG001|Overall Study|Physician Decision|1
4726754|NCT03242928|7665151|FG000|Overall Study|Withdrawal by Subject|5
4726755|NCT03242928|7665152|FG001|Overall Study|Withdrawal by Subject|3
4726756|NCT03243084|7665182|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1
4726757|NCT03243084|7665183|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0
4726758|NCT03243305|7665190|FG000|Overall Study|Lost to Follow-up|250
4726759|NCT03243305|7665190|FG000|Overall Study|Withdrawal by Subject|170
4726760|NCT03243305|7665190|FG000|Overall Study|Pregnancy|104
4726761|NCT03243305|7665190|FG000|Overall Study|Non-Compliance with Study Drug|38
4726762|NCT03243305|7665190|FG000|Overall Study|Adverse Event|23
4726763|NCT03243305|7665190|FG000|Overall Study|No sexually active|26
4726764|NCT03243305|7665190|FG000|Overall Study|Physician Decision|22
4726765|NCT03243305|7665190|FG000|Overall Study|Protocol Violation|22
4726766|NCT03243305|7665190|FG000|Overall Study|Study method no longer primary method|12
4726767|NCT03243305|7665190|FG000|Overall Study|Study Terminated by Sponsor|1
4726768|NCT03243305|7665190|FG000|Overall Study|Early terminations|267
4726769|NCT03243630|7665194|FG000|Overall Study|Protocol Violation|1
4726770|NCT03243630|7665194|FG000|Overall Study|Physician Decision|1
4726771|NCT03244618|7665213|FG000|Overall Study|Lost to Follow-up|3
4726772|NCT03244618|7665214|FG001|Overall Study|Lost to Follow-up|4
4726773|NCT03244618|7665213|FG000|Overall Study|Protocol Violation|4
4726774|NCT03244618|7665214|FG001|Overall Study|Protocol Violation|3
4726775|NCT03244618|7665213|FG000|Overall Study|Withdrawal by Subject|0
4726776|NCT03244618|7665214|FG001|Overall Study|Withdrawal by Subject|2
4726777|NCT03244800|7665224|FG000|Overall Study|Adverse Event|0
4726778|NCT03244800|7665225|FG001|Overall Study|Adverse Event|1
4726779|NCT03244800|7665226|FG002|Overall Study|Adverse Event|0
4726780|NCT03244800|7665227|FG003|Overall Study|Adverse Event|1
4726781|NCT03244800|7665224|FG000|Overall Study|Withdrew treatment|0
4726782|NCT03244800|7665225|FG001|Overall Study|Withdrew treatment|0
4726783|NCT03244800|7665226|FG002|Overall Study|Withdrew treatment|0
4726784|NCT03244800|7665227|FG003|Overall Study|Withdrew treatment|1
4726785|NCT03244917|7665246|FG000|Overall Study|Lost to Follow-up|2
4726786|NCT03244917|7665247|FG001|Overall Study|Lost to Follow-up|2
4726787|NCT03245398|7665264|FG000|Overall Study|Travelled to another island|1
4726788|NCT03245398|7665265|FG001|Overall Study|Travelled to another island|0
4726789|NCT03245619|7665299|FG000|Part A (Up to Day 22)|Physician Decision|4
4726790|NCT03245619|7665300|FG001|Part A (Up to Day 22)|Physician Decision|6
4726791|NCT03245619|7665301|FG002|Part A (Up to Day 22)|Physician Decision|6
4726792|NCT03245619|7665302|FG003|Part A (Up to Day 22)|Physician Decision|0
4726793|NCT03245619|7665303|FG004|Part A (Up to Day 22)|Physician Decision|0
4726794|NCT03245619|7665304|FG005|Part A (Up to Day 22)|Physician Decision|0
4726795|NCT03245619|7665305|FG006|Part A (Up to Day 22)|Physician Decision|0
4726796|NCT03245619|7665306|FG007|Part A (Up to Day 22)|Physician Decision|0
4726797|NCT03245619|7665307|FG008|Part A (Up to Day 22)|Physician Decision|0
4726798|NCT03245619|7665308|FG009|Part A (Up to Day 22)|Physician Decision|0
4726799|NCT03245619|7665309|FG010|Part A (Up to Day 22)|Physician Decision|0
4726800|NCT03245619|7665310|FG011|Part A (Up to Day 22)|Physician Decision|0
4726801|NCT03245619|7665311|FG012|Part A (Up to Day 22)|Physician Decision|0
4726802|NCT03245619|7665312|FG013|Part A (Up to Day 22)|Physician Decision|0
4726803|NCT03245619|7665313|FG014|Part A (Up to Day 22)|Physician Decision|0
4726804|NCT03245619|7665314|FG015|Part A (Up to Day 22)|Physician Decision|0
4726805|NCT03245619|7665315|FG016|Part A (Up to Day 22)|Physician Decision|0
4726806|NCT03245723|7665376|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1
4726807|NCT03245723|7665377|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0
4726808|NCT03245723|7665376|FG000|Overall Study|Claustrophobia from wearing the mask|1
4726809|NCT03245723|7665377|FG001|Overall Study|Claustrophobia from wearing the mask|0
4726810|NCT03245723|7665376|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2
4726811|NCT03245723|7665377|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0
4726812|NCT03245723|7665376|FG000|Overall Study|Image acquisition/reconstruction failure|1
4726813|NCT03245723|7665377|FG001|Overall Study|Image acquisition/reconstruction failure|1
4726814|NCT03245736|7665383|FG000|Overall Study|Adverse Event|1
4726815|NCT03245736|7665383|FG000|Overall Study|Progressive Disease|4
4726816|NCT03246061|7665398|FG000|Overall Study|Still in follow-up|15
4726817|NCT03246061|7665399|FG001|Overall Study|Still in follow-up|21
4726818|NCT03246152|7665407|FG000|Overall Study|Lost to Follow-up|2
4726819|NCT03246152|7665407|FG000|Overall Study|Protocol Violation|1
4726820|NCT03246646|7665413|FG000|Overall Study|deemed ineligible and administratively withdrawn|1
4726821|NCT03246646|7665414|FG001|Overall Study|deemed ineligible and administratively withdrawn|0
4726822|NCT03246646|7665413|FG000|Overall Study|Withdrawal by Subject|3
4446606|NCT00485134|7231670|FG006|Overall Study|Pregnancy|1
4446607|NCT00485134|7231671|FG007|Overall Study|Pregnancy|0
4726823|NCT03246646|7665414|FG001|Overall Study|Withdrawal by Subject|0
4726824|NCT03246646|7665413|FG000|Overall Study|Lost to Follow-up|7
4726825|NCT03246646|7665414|FG001|Overall Study|Lost to Follow-up|0
4726826|NCT03246672|7665420|FG000|Overall Study|Lost to Follow-up|2
4726827|NCT03246724|7665428|FG000|Overall Study|Withdrawal by Subject|5
4726828|NCT03246724|7665429|FG001|Overall Study|Withdrawal by Subject|2
4726829|NCT03246724|7665430|FG002|Overall Study|Withdrawal by Subject|4
4726830|NCT03246724|7665431|FG003|Overall Study|Withdrawal by Subject|2
4726831|NCT03246724|7665428|FG000|Overall Study|Ineligible on day of surgery|7
4726832|NCT03246724|7665429|FG001|Overall Study|Ineligible on day of surgery|2
4726833|NCT03246724|7665430|FG002|Overall Study|Ineligible on day of surgery|0
4726834|NCT03246724|7665431|FG003|Overall Study|Ineligible on day of surgery|3
4726835|NCT03246724|7665428|FG000|Overall Study|Study completed before surgical date|2
4726836|NCT03246724|7665429|FG001|Overall Study|Study completed before surgical date|1
4726837|NCT03246724|7665430|FG002|Overall Study|Study completed before surgical date|8
4726838|NCT03246724|7665431|FG003|Overall Study|Study completed before surgical date|1
4726839|NCT03246724|7665428|FG000|Overall Study|Transferred to other arm|0
4726840|NCT03246724|7665429|FG001|Overall Study|Transferred to other arm|0
4726841|NCT03246724|7665430|FG002|Overall Study|Transferred to other arm|1
4726842|NCT03246724|7665431|FG003|Overall Study|Transferred to other arm|0
4726843|NCT03246724|7665428|FG000|Overall Study|Unable to obtain medication timely|0
4726844|NCT03246724|7665429|FG001|Overall Study|Unable to obtain medication timely|2
4726845|NCT03246724|7665430|FG002|Overall Study|Unable to obtain medication timely|2
4726846|NCT03246724|7665431|FG003|Overall Study|Unable to obtain medication timely|1
4726847|NCT03246724|7665428|FG000|Overall Study|Re-consented to participate|0
4726848|NCT03246724|7665429|FG001|Overall Study|Re-consented to participate|0
4726849|NCT03246724|7665430|FG002|Overall Study|Re-consented to participate|0
4726850|NCT03246724|7665431|FG003|Overall Study|Re-consented to participate|1
4726851|NCT03247517|7665455|FG000|Overall Study|Adverse Event|0
4726852|NCT03247517|7665456|FG001|Overall Study|Adverse Event|4
4726853|NCT03247517|7665457|FG002|Overall Study|Adverse Event|2
4726854|NCT03247517|7665455|FG000|Overall Study|Lost to Follow-up|2
4726855|NCT03247517|7665456|FG001|Overall Study|Lost to Follow-up|6
4726856|NCT03247517|7665457|FG002|Overall Study|Lost to Follow-up|4
4726857|NCT03247517|7665455|FG000|Overall Study|Consent withdrawn by caregiver|1
4726858|NCT03247517|7665456|FG001|Overall Study|Consent withdrawn by caregiver|4
4726859|NCT03247517|7665457|FG002|Overall Study|Consent withdrawn by caregiver|7
4726860|NCT03247517|7665455|FG000|Overall Study|Assent/consent withdrawn by subject|2
4726861|NCT03247517|7665456|FG001|Overall Study|Assent/consent withdrawn by subject|3
4726862|NCT03247517|7665457|FG002|Overall Study|Assent/consent withdrawn by subject|1
4726863|NCT03247517|7665455|FG000|Overall Study|Protocol Violation|0
4726864|NCT03247517|7665456|FG001|Overall Study|Protocol Violation|2
4726865|NCT03247517|7665457|FG002|Overall Study|Protocol Violation|0
4726866|NCT03247517|7665455|FG000|Overall Study|Multiple reasons|3
4726867|NCT03247517|7665456|FG001|Overall Study|Multiple reasons|1
4726868|NCT03247517|7665457|FG002|Overall Study|Multiple reasons|0
4726869|NCT03247530|7665468|FG000|Overall Study|Withdrawal by caregiver|19
4726870|NCT03247530|7665469|FG001|Overall Study|Withdrawal by caregiver|8
4726871|NCT03247530|7665470|FG002|Overall Study|Withdrawal by caregiver|10
4726872|NCT03247530|7665468|FG000|Overall Study|Lost to Follow-up|3
4726873|NCT03247530|7665469|FG001|Overall Study|Lost to Follow-up|9
4726874|NCT03247530|7665470|FG002|Overall Study|Lost to Follow-up|6
4726875|NCT03247530|7665468|FG000|Overall Study|Adverse Event|2
4726876|NCT03247530|7665469|FG001|Overall Study|Adverse Event|5
4726877|NCT03247530|7665470|FG002|Overall Study|Adverse Event|2
4726878|NCT03247530|7665468|FG000|Overall Study|Failure to follow procedure|1
4726879|NCT03247530|7665469|FG001|Overall Study|Failure to follow procedure|1
4726880|NCT03247530|7665470|FG002|Overall Study|Failure to follow procedure|1
4726881|NCT03247530|7665468|FG000|Overall Study|Withdrawal by Subject|1
4726882|NCT03247530|7665469|FG001|Overall Study|Withdrawal by Subject|1
4726883|NCT03247530|7665470|FG002|Overall Study|Withdrawal by Subject|0
4726884|NCT03247530|7665468|FG000|Overall Study|Study medication misuse|0
4726885|NCT03247530|7665469|FG001|Overall Study|Study medication misuse|1
4726886|NCT03247530|7665470|FG002|Overall Study|Study medication misuse|0
4726887|NCT03247530|7665468|FG000|Overall Study|Other, multiple categories|1
4726888|NCT03247530|7665469|FG001|Overall Study|Other, multiple categories|3
4726889|NCT03247530|7665470|FG002|Overall Study|Other, multiple categories|1
4726890|NCT03247543|7665484|FG000|Overall Study|Adverse Event|3
4726891|NCT03247543|7665485|FG001|Overall Study|Adverse Event|6
4726892|NCT03247543|7665486|FG002|Overall Study|Adverse Event|4
4726893|NCT03247543|7665484|FG000|Overall Study|Lost to Follow-up|10
4726894|NCT03247543|7665485|FG001|Overall Study|Lost to Follow-up|7
4726895|NCT03247543|7665486|FG002|Overall Study|Lost to Follow-up|8
4726896|NCT03247543|7665484|FG000|Overall Study|Consent withdrawn by caregiver|2
4726897|NCT03247543|7665485|FG001|Overall Study|Consent withdrawn by caregiver|2
4726898|NCT03247543|7665486|FG002|Overall Study|Consent withdrawn by caregiver|9
4726899|NCT03247543|7665484|FG000|Overall Study|Withdrawal by Subject|0
4726900|NCT03247543|7665485|FG001|Overall Study|Withdrawal by Subject|0
4726901|NCT03247543|7665486|FG002|Overall Study|Withdrawal by Subject|1
4726902|NCT03247543|7665484|FG000|Overall Study|Failure to Follow study procedures|1
4726903|NCT03247543|7665485|FG001|Overall Study|Failure to Follow study procedures|3
4726904|NCT03247543|7665486|FG002|Overall Study|Failure to Follow study procedures|1
4726905|NCT03247543|7665484|FG000|Overall Study|Lack of Efficacy|1
4726906|NCT03247543|7665485|FG001|Overall Study|Lack of Efficacy|0
4726907|NCT03247543|7665486|FG002|Overall Study|Lack of Efficacy|0
4726908|NCT03247543|7665484|FG000|Overall Study|Non-compliance with study visits|0
4726909|NCT03247543|7665485|FG001|Overall Study|Non-compliance with study visits|1
4726910|NCT03247543|7665486|FG002|Overall Study|Non-compliance with study visits|0
4726911|NCT03247556|7665499|FG000|Overall Study|Adverse Event|1
4726912|NCT03247556|7665500|FG001|Overall Study|Adverse Event|4
4726913|NCT03247556|7665501|FG002|Overall Study|Adverse Event|5
4726914|NCT03247556|7665499|FG000|Overall Study|Lost to Follow-up|5
4726915|NCT03247556|7665500|FG001|Overall Study|Lost to Follow-up|5
4726916|NCT03247556|7665501|FG002|Overall Study|Lost to Follow-up|4
4726917|NCT03247556|7665499|FG000|Overall Study|Consent Withdrawn by Caregiver|4
4726918|NCT03247556|7665500|FG001|Overall Study|Consent Withdrawn by Caregiver|1
4726919|NCT03247556|7665501|FG002|Overall Study|Consent Withdrawn by Caregiver|5
4726920|NCT03247556|7665499|FG000|Overall Study|Assent/consent Withdrawn by Subject|0
4726921|NCT03247556|7665500|FG001|Overall Study|Assent/consent Withdrawn by Subject|2
4726922|NCT03247556|7665501|FG002|Overall Study|Assent/consent Withdrawn by Subject|2
4726923|NCT03247556|7665499|FG000|Overall Study|Protocol Violation|2
4726924|NCT03247556|7665500|FG001|Overall Study|Protocol Violation|0
4726925|NCT03247556|7665501|FG002|Overall Study|Protocol Violation|1
4726926|NCT03247556|7665499|FG000|Overall Study|Subject did not meet inclusion criteria|0
4726927|NCT03247556|7665500|FG001|Overall Study|Subject did not meet inclusion criteria|0
4726928|NCT03247556|7665501|FG002|Overall Study|Subject did not meet inclusion criteria|1
4726929|NCT03247673|7665512|FG000|Overall Study|Withdrawal by Subject|1
4726930|NCT03247673|7665513|FG001|Overall Study|Withdrawal by Subject|0
4726931|NCT03247673|7665514|FG002|Overall Study|Withdrawal by Subject|3
4726932|NCT03247673|7665512|FG000|Overall Study|Lost to Follow-up|0
4726933|NCT03247673|7665513|FG001|Overall Study|Lost to Follow-up|0
4726934|NCT03247673|7665514|FG002|Overall Study|Lost to Follow-up|1
4726935|NCT03247686|7665524|FG000|Overall Study|Withdrawal by Subject|1
4726936|NCT03247686|7665525|FG001|Overall Study|Withdrawal by Subject|2
4726937|NCT03247816|7665549|FG000|Overall Study|Adverse Event|12
4726938|NCT03247816|7665549|FG000|Overall Study|Physician Decision|3
4726939|NCT03247816|7665549|FG000|Overall Study|Lack of Efficacy|1
4726940|NCT03247816|7665549|FG000|Overall Study|Lost to Follow-up|10
4726941|NCT03247816|7665549|FG000|Overall Study|Missing Feraccru stop date|3
4726942|NCT03248037|7665566|FG000|Overall Study|Withdrawal by Subject|6
4726943|NCT03248037|7665567|FG001|Overall Study|Withdrawal by Subject|9
4726944|NCT03248037|7665566|FG000|Overall Study|Adverse Event|15
4726945|NCT03248037|7665567|FG001|Overall Study|Adverse Event|0
4726946|NCT03248492|7665587|FG000|Overall Study|Ongoing|23
4726947|NCT03248492|7665588|FG001|Overall Study|Ongoing|26
4726948|NCT03248492|7665589|FG002|Overall Study|Ongoing|3
4726949|NCT03248492|7665590|FG003|Overall Study|Ongoing|85
4726950|NCT03248492|7665591|FG004|Overall Study|Ongoing|2
4726951|NCT03248492|7665587|FG000|Overall Study|Progressive disease per RECIST v1.1|16
4726952|NCT03248492|7665588|FG001|Overall Study|Progressive disease per RECIST v1.1|12
4726953|NCT03248492|7665589|FG002|Overall Study|Progressive disease per RECIST v1.1|9
4726954|NCT03248492|7665590|FG003|Overall Study|Progressive disease per RECIST v1.1|22
4726955|NCT03248492|7665591|FG004|Overall Study|Progressive disease per RECIST v1.1|0
4726956|NCT03248492|7665587|FG000|Overall Study|Adverse Event|6
4726957|NCT03248492|7665588|FG001|Overall Study|Adverse Event|6
4726958|NCT03248492|7665589|FG002|Overall Study|Adverse Event|8
4726959|NCT03248492|7665590|FG003|Overall Study|Adverse Event|8
4726960|NCT03248492|7665591|FG004|Overall Study|Adverse Event|1
4726961|NCT03248492|7665587|FG000|Overall Study|Withdrawal by Subject|3
4726962|NCT03248492|7665588|FG001|Overall Study|Withdrawal by Subject|3
4726963|NCT03248492|7665589|FG002|Overall Study|Withdrawal by Subject|0
4726964|NCT03248492|7665590|FG003|Overall Study|Withdrawal by Subject|3
4726965|NCT03248492|7665591|FG004|Overall Study|Withdrawal by Subject|1
4726966|NCT03248492|7665587|FG000|Overall Study|Physician Decision|1
4726967|NCT03248492|7665588|FG001|Overall Study|Physician Decision|0
4726968|NCT03248492|7665589|FG002|Overall Study|Physician Decision|1
4726969|NCT03248492|7665590|FG003|Overall Study|Physician Decision|2
4726970|NCT03248492|7665591|FG004|Overall Study|Physician Decision|0
4726971|NCT03248492|7665587|FG000|Overall Study|Death|1
4726972|NCT03248492|7665588|FG001|Overall Study|Death|0
4726973|NCT03248492|7665589|FG002|Overall Study|Death|0
4726974|NCT03248492|7665590|FG003|Overall Study|Death|6
4726975|NCT03248492|7665591|FG004|Overall Study|Death|0
4726976|NCT03248492|7665587|FG000|Overall Study|Other|0
4726977|NCT03248492|7665588|FG001|Overall Study|Other|1
4726978|NCT03248492|7665589|FG002|Overall Study|Other|0
4726979|NCT03248492|7665590|FG003|Overall Study|Other|4
4726980|NCT03248492|7665591|FG004|Overall Study|Other|0
4726981|NCT03248882|7665616|FG000|Overall Study|Adverse Event|3
4726982|NCT03248882|7665617|FG001|Overall Study|Adverse Event|3
4726983|NCT03248882|7665618|FG002|Overall Study|Adverse Event|2
4726984|NCT03248882|7665619|FG003|Overall Study|Adverse Event|6
4726985|NCT03248882|7665620|FG004|Overall Study|Adverse Event|9
4726986|NCT03248882|7665616|FG000|Overall Study|Lost to Follow-up|0
4726987|NCT03248882|7665617|FG001|Overall Study|Lost to Follow-up|0
4726988|NCT03248882|7665618|FG002|Overall Study|Lost to Follow-up|0
4726989|NCT03248882|7665619|FG003|Overall Study|Lost to Follow-up|0
4726990|NCT03248882|7665620|FG004|Overall Study|Lost to Follow-up|1
4726991|NCT03248882|7665616|FG000|Overall Study|Protocol Violation|2
4726992|NCT03248882|7665617|FG001|Overall Study|Protocol Violation|0
4726993|NCT03248882|7665618|FG002|Overall Study|Protocol Violation|2
4726994|NCT03248882|7665619|FG003|Overall Study|Protocol Violation|0
4726995|NCT03248882|7665620|FG004|Overall Study|Protocol Violation|1
4726996|NCT03248882|7665616|FG000|Overall Study|Withdrawal by Subject|2
4726997|NCT03248882|7665617|FG001|Overall Study|Withdrawal by Subject|2
4726998|NCT03248882|7665618|FG002|Overall Study|Withdrawal by Subject|3
4726999|NCT03248882|7665619|FG003|Overall Study|Withdrawal by Subject|4
4727000|NCT03248882|7665620|FG004|Overall Study|Withdrawal by Subject|2
4727001|NCT03249454|7665679|FG000|Overall Study|Withdrawal by Subject|0
4727002|NCT03249454|7665680|FG001|Overall Study|Withdrawal by Subject|0
4727003|NCT03249454|7665681|FG002|Overall Study|Withdrawal by Subject|0
4727004|NCT03249454|7665682|FG003|Overall Study|Withdrawal by Subject|0
4727005|NCT03249454|7665683|FG004|Overall Study|Withdrawal by Subject|0
4727006|NCT03249454|7665684|FG005|Overall Study|Withdrawal by Subject|0
4727007|NCT03249454|7665685|FG006|Overall Study|Withdrawal by Subject|0
4727008|NCT03249454|7665686|FG007|Overall Study|Withdrawal by Subject|0
4727009|NCT03249454|7665687|FG008|Overall Study|Withdrawal by Subject|0
4727010|NCT03249454|7665688|FG009|Overall Study|Withdrawal by Subject|1
4727011|NCT03249454|7665689|FG010|Overall Study|Withdrawal by Subject|1
4727012|NCT03249909|7665715|FG000|Overall Study|Withdrawal by Subject|3
4727013|NCT03249909|7665716|FG001|Overall Study|Withdrawal by Subject|0
4727014|NCT03249909|7665717|FG002|Overall Study|Withdrawal by Subject|0
4727015|NCT03249909|7665715|FG000|Overall Study|Adverse Event|3
4727016|NCT03249909|7665716|FG001|Overall Study|Adverse Event|0
4727017|NCT03249909|7665717|FG002|Overall Study|Adverse Event|0
4727018|NCT03249909|7665715|FG000|Overall Study|Lost to Follow-up|0
4727019|NCT03249909|7665716|FG001|Overall Study|Lost to Follow-up|1
4727020|NCT03249909|7665717|FG002|Overall Study|Lost to Follow-up|0
4727021|NCT03249935|7665728|FG000|Overall Study|Discharged from facility early|36
4727022|NCT03249935|7665728|FG000|Overall Study|Negative for chlamydia at enrollment|4
4727023|NCT03249935|7665728|FG000|Overall Study|Protocol Violation|5
4727024|NCT03250182|7665734|FG000|Overall Study|Withdrawal by Subject|1
4727025|NCT03251482|7665768|FG000|Overall Study|Withdrawal by Subject|0
4727026|NCT03251482|7665769|FG001|Overall Study|Withdrawal by Subject|1
4727027|NCT03251482|7665770|FG002|Overall Study|Withdrawal by Subject|0
4727028|NCT03251482|7665771|FG003|Overall Study|Withdrawal by Subject|0
4727029|NCT03251482|7665772|FG004|Overall Study|Withdrawal by Subject|0
4727030|NCT03251963|7665790|FG000|Overall Study|inappropriate Xa level timing|6
4727031|NCT03251963|7665791|FG001|Overall Study|inappropriate Xa level timing|3
4727032|NCT03251963|7665790|FG000|Overall Study|no peak Xa level drawn|2
4727033|NCT03251963|7665791|FG001|Overall Study|no peak Xa level drawn|0
4727034|NCT03251963|7665790|FG000|Overall Study|bled prior to Xa level|1
4727035|NCT03251963|7665791|FG001|Overall Study|bled prior to Xa level|2
4727036|NCT03252015|7665801|FG000|Overall Study|Withdrawal by Subject|0
4727037|NCT03252015|7665802|FG001|Overall Study|Withdrawal by Subject|1
4727038|NCT03252015|7665803|FG002|Overall Study|Withdrawal by Subject|1
4727039|NCT03252015|7665804|FG003|Overall Study|Withdrawal by Subject|0
4727040|NCT03252015|7665801|FG000|Overall Study|Adverse Event|1
4727041|NCT03252015|7665802|FG001|Overall Study|Adverse Event|0
4727042|NCT03252015|7665803|FG002|Overall Study|Adverse Event|0
4727043|NCT03252015|7665804|FG003|Overall Study|Adverse Event|1
4727044|NCT03252145|7665830|FG000|Overall Study|Withdrawal by Subject|1
4727045|NCT03252145|7665831|FG001|Overall Study|Withdrawal by Subject|0
4727046|NCT03252145|7665830|FG000|Overall Study|Complicating Disease|1
4727047|NCT03252145|7665831|FG001|Overall Study|Complicating Disease|2
4727048|NCT03253094|7665868|FG000|Overall Study|Adverse Event|2
4727049|NCT03253094|7665869|FG001|Overall Study|Adverse Event|0
4727050|NCT03253094|7665870|FG002|Overall Study|Adverse Event|0
4727051|NCT03253094|7665871|FG003|Overall Study|Adverse Event|0
4727052|NCT03253094|7665872|FG004|Overall Study|Adverse Event|0
4727053|NCT03253094|7665873|FG005|Overall Study|Adverse Event|0
4727054|NCT03253094|7665868|FG000|Overall Study|Lack of Efficacy|0
4727055|NCT03253094|7665869|FG001|Overall Study|Lack of Efficacy|0
4727056|NCT03253094|7665870|FG002|Overall Study|Lack of Efficacy|2
4727057|NCT03253094|7665871|FG003|Overall Study|Lack of Efficacy|1
4727058|NCT03253094|7665872|FG004|Overall Study|Lack of Efficacy|2
4727059|NCT03253094|7665873|FG005|Overall Study|Lack of Efficacy|1
4727060|NCT03253094|7665868|FG000|Overall Study|Lost to Follow-up|0
4727061|NCT03253094|7665869|FG001|Overall Study|Lost to Follow-up|0
4727062|NCT03253094|7665870|FG002|Overall Study|Lost to Follow-up|1
4727063|NCT03253094|7665871|FG003|Overall Study|Lost to Follow-up|1
4727064|NCT03253094|7665872|FG004|Overall Study|Lost to Follow-up|0
4727065|NCT03253094|7665873|FG005|Overall Study|Lost to Follow-up|1
4727066|NCT03253094|7665868|FG000|Overall Study|Physician Decision|1
4727067|NCT03253094|7665869|FG001|Overall Study|Physician Decision|0
4727068|NCT03253094|7665870|FG002|Overall Study|Physician Decision|0
4727069|NCT03253094|7665871|FG003|Overall Study|Physician Decision|1
4727070|NCT03253094|7665872|FG004|Overall Study|Physician Decision|0
4727071|NCT03253094|7665873|FG005|Overall Study|Physician Decision|2
4727072|NCT03253094|7665868|FG000|Overall Study|Withdrawal by Subject|1
4727073|NCT03253094|7665869|FG001|Overall Study|Withdrawal by Subject|2
4727074|NCT03253094|7665870|FG002|Overall Study|Withdrawal by Subject|1
4727075|NCT03253094|7665871|FG003|Overall Study|Withdrawal by Subject|0
4727076|NCT03253094|7665872|FG004|Overall Study|Withdrawal by Subject|3
4727077|NCT03253094|7665873|FG005|Overall Study|Withdrawal by Subject|0
4727078|NCT03253094|7665868|FG000|Overall Study|Other|0
4727079|NCT03253094|7665869|FG001|Overall Study|Other|1
4727080|NCT03253094|7665870|FG002|Overall Study|Other|2
4727081|NCT03253094|7665871|FG003|Overall Study|Other|1
4727082|NCT03253094|7665872|FG004|Overall Study|Other|0
4727083|NCT03253094|7665873|FG005|Overall Study|Other|0
4727084|NCT03254108|7665892|FG000|Overall Study|Adverse Event|0
4727085|NCT03254108|7665893|FG001|Overall Study|Adverse Event|2
4727086|NCT03254108|7665894|FG002|Overall Study|Adverse Event|0
4727087|NCT03254108|7665895|FG003|Overall Study|Adverse Event|1
4727088|NCT03254108|7665896|FG004|Overall Study|Adverse Event|1
4727089|NCT03254108|7665892|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0
4727090|NCT03254108|7665893|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0
4727091|NCT03254108|7665894|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0
4727092|NCT03254108|7665895|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0
4727093|NCT03254108|7665896|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2
4727094|NCT03254134|7665910|FG000|Overall Study|Not eligible patients|599
4727095|NCT03254134|7665911|FG001|Overall Study|Not eligible patients|3630
4727096|NCT03254459|7665923|FG000|Overall Study|Adverse Event|7
4727097|NCT03254459|7665924|FG001|Overall Study|Adverse Event|20
4727098|NCT03254459|7665923|FG000|Overall Study|Withdrawal by Subject Consent|3
4727099|NCT03254459|7665924|FG001|Overall Study|Withdrawal by Subject Consent|1
4727100|NCT03254459|7665923|FG000|Overall Study|Lost to Follow-up|0
4727101|NCT03254459|7665924|FG001|Overall Study|Lost to Follow-up|1
4727102|NCT03254459|7665923|FG000|Overall Study|Miscellaneous|0
4727103|NCT03254459|7665924|FG001|Overall Study|Miscellaneous|1
4727104|NCT03254602|7665930|FG000|Overall Study|Lost to Follow-up|4
4727105|NCT03255187|7665940|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1
4727106|NCT03255187|7665941|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3
4727107|NCT03255187|7665940|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0
4727108|NCT03255187|7665941|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1
4727109|NCT03255291|7665953|FG000|Overall Study|Determined to be ineligible|10
4727110|NCT03255291|7665954|FG001|Overall Study|Determined to be ineligible|12
4727111|NCT03255291|7665955|FG002|Overall Study|Determined to be ineligible|6
4727112|NCT03255291|7665956|FG003|Overall Study|Determined to be ineligible|6
4727113|NCT03255291|7665957|FG004|Overall Study|Determined to be ineligible|5
4727114|NCT03255291|7665958|FG005|Overall Study|Determined to be ineligible|10
4727115|NCT03255291|7665953|FG000|Overall Study|Baseline data collection issues|3
4727116|NCT03255291|7665954|FG001|Overall Study|Baseline data collection issues|0
4727117|NCT03255291|7665955|FG002|Overall Study|Baseline data collection issues|0
4727118|NCT03255291|7665956|FG003|Overall Study|Baseline data collection issues|0
4727119|NCT03255291|7665957|FG004|Overall Study|Baseline data collection issues|2
4727120|NCT03255291|7665958|FG005|Overall Study|Baseline data collection issues|0
4727121|NCT03255382|7665978|FG000|Overall Study|Adverse Event|3
4727122|NCT03255382|7665979|FG001|Overall Study|Adverse Event|0
4727123|NCT03255382|7665978|FG000|Overall Study|Lost to Follow-up|2
4727124|NCT03255382|7665979|FG001|Overall Study|Lost to Follow-up|0
4727125|NCT03255382|7665978|FG000|Overall Study|Withdrawal by Subject|2
4727126|NCT03255382|7665979|FG001|Overall Study|Withdrawal by Subject|0
4727127|NCT03255382|7665978|FG000|Overall Study|Other|6
4727128|NCT03255382|7665979|FG001|Overall Study|Other|0
4727129|NCT03255655|7665988|FG000|Overall Study|Lost to Follow-up|7
4727130|NCT03255655|7665989|FG001|Overall Study|Lost to Follow-up|4
4727131|NCT03255733|7665995|FG000|Overall Study|Lost to Follow-up|4
4727132|NCT03255824|7666001|FG000|Overall Study|Under-sedation|2
4727133|NCT03255824|7666002|FG001|Overall Study|Under-sedation|1
4727134|NCT03255941|7666016|FG000|Overall Study|Not eligible or refused injection|37
4727135|NCT03255941|7666017|FG001|Overall Study|Not eligible or refused injection|44
4727136|NCT03255941|7666018|FG002|Overall Study|Not eligible or refused injection|5
4727137|NCT03255941|7666019|FG003|Overall Study|Not eligible or refused injection|6
4727138|NCT03255941|7666016|FG000|Overall Study|Did not complete exit interview|1
4727139|NCT03255941|7666017|FG001|Overall Study|Did not complete exit interview|2
4727140|NCT03255941|7666018|FG002|Overall Study|Did not complete exit interview|0
4727141|NCT03255941|7666019|FG003|Overall Study|Did not complete exit interview|0
4727142|NCT03255980|7666045|FG000|Overall Study|Grade =>3 Skin Toxicity|1
4727143|NCT03255980|7666046|FG001|Overall Study|Grade =>3 Skin Toxicity|4
4727144|NCT03255980|7666047|FG002|Overall Study|Grade =>3 Skin Toxicity|6
4727145|NCT03255980|7666048|FG003|Overall Study|Grade =>3 Skin Toxicity|5
4727146|NCT03255980|7666045|FG000|Overall Study|Adverse Event|1
4727147|NCT03255980|7666046|FG001|Overall Study|Adverse Event|1
4727148|NCT03255980|7666047|FG002|Overall Study|Adverse Event|0
4727149|NCT03255980|7666048|FG003|Overall Study|Adverse Event|1
4736935|NCT03586648|7686618|FG000|Period 2|Adverse Event|1
4727150|NCT03255980|7666045|FG000|Overall Study|Lack of compliance to study or assessmen|0
4727151|NCT03255980|7666046|FG001|Overall Study|Lack of compliance to study or assessmen|1
4727152|NCT03255980|7666047|FG002|Overall Study|Lack of compliance to study or assessmen|0
4727153|NCT03255980|7666048|FG003|Overall Study|Lack of compliance to study or assessmen|0
4727154|NCT03255980|7666045|FG000|Overall Study|Lost to Follow-up|1
4727155|NCT03255980|7666046|FG001|Overall Study|Lost to Follow-up|1
4727156|NCT03255980|7666047|FG002|Overall Study|Lost to Follow-up|0
4727157|NCT03255980|7666048|FG003|Overall Study|Lost to Follow-up|3
4727158|NCT03255980|7666045|FG000|Overall Study|Withdrawal by Subject|0
4727159|NCT03255980|7666046|FG001|Overall Study|Withdrawal by Subject|1
4727160|NCT03255980|7666047|FG002|Overall Study|Withdrawal by Subject|0
4727161|NCT03255980|7666048|FG003|Overall Study|Withdrawal by Subject|3
4727162|NCT03256526|7666091|FG000|Overall Study|Adverse Event|1
4727163|NCT03256526|7666092|FG001|Overall Study|Adverse Event|0
4727164|NCT03256526|7666093|FG002|Overall Study|Adverse Event|1
4727165|NCT03256526|7666091|FG000|Overall Study|Lost to Follow-up|1
4727166|NCT03256526|7666092|FG001|Overall Study|Lost to Follow-up|0
4727167|NCT03256526|7666093|FG002|Overall Study|Lost to Follow-up|2
4727168|NCT03256552|7666101|FG000|Overall Study|Protocol Violation|1
4727169|NCT03256552|7666101|FG000|Overall Study|Physician Decision|1
4727170|NCT03256552|7666101|FG000|Overall Study|Adverse Event|1
4727171|NCT03256552|7666101|FG000|Overall Study|Withdrawal by Subject|2
4727172|NCT03256578|7666113|FG000|Overall Study|Excluded Post Randomization|66
4727173|NCT03256578|7666114|FG001|Overall Study|Excluded Post Randomization|56
4727174|NCT03256695|7666120|FG000|Overall Study|Adverse Event|8
4727175|NCT03256695|7666120|FG000|Overall Study|Death|2
4727176|NCT03256695|7666120|FG000|Overall Study|Withdrawal by Subject|14
4727177|NCT03256695|7666120|FG000|Overall Study|Non-compliance with study drug|1
4727178|NCT03256695|7666120|FG000|Overall Study|Lost to Follow-up|3
4727179|NCT03256695|7666120|FG000|Overall Study|Lack of Efficacy|3
4727180|NCT03256695|7666120|FG000|Overall Study|Protocol Violation|5
4727181|NCT03256695|7666120|FG000|Overall Study|Other than specified|3
4727182|NCT03256851|7666130|FG000|Overall Study|Withdrawal by Subject|1
4727183|NCT03256851|7666131|FG001|Overall Study|Withdrawal by Subject|0
4736936|NCT03586648|7686619|FG001|Period 2|Adverse Event|0
4736937|NCT03586726|7686625|FG000|Overall Study|Withdrawal by Subject|1
4736938|NCT03586830|7686633|FG000|Overall Study|Site terminated by Sponsor|1
4736939|NCT03586830|7686634|FG001|Overall Study|Site terminated by Sponsor|4
4736940|NCT03586830|7686635|FG002|Overall Study|Site terminated by Sponsor|3
4736941|NCT03586830|7686636|FG003|Overall Study|Site terminated by Sponsor|3
4736942|NCT03586830|7686633|FG000|Overall Study|Lost to Follow-up|0
4736943|NCT03586830|7686634|FG001|Overall Study|Lost to Follow-up|2
4736944|NCT03586830|7686635|FG002|Overall Study|Lost to Follow-up|2
4736945|NCT03586830|7686636|FG003|Overall Study|Lost to Follow-up|1
4736946|NCT03586830|7686633|FG000|Overall Study|Withdrawal by Subject|1
4736947|NCT03586830|7686634|FG001|Overall Study|Withdrawal by Subject|0
4736948|NCT03586830|7686635|FG002|Overall Study|Withdrawal by Subject|3
4736949|NCT03586830|7686636|FG003|Overall Study|Withdrawal by Subject|1
4772169|NCT02733042|7749198|FG006|Follow-up Period|Other|0
4772170|NCT02733042|7749199|FG007|Follow-up Period|Other|0
4772171|NCT02733042|7749200|FG008|Follow-up Period|Other|0
4772172|NCT02733042|7749201|FG009|Follow-up Period|Other|0
4772173|NCT02733042|7749202|FG010|Follow-up Period|Other|0
4772174|NCT02733042|7749203|FG011|Follow-up Period|Other|0
4630932|NCT01888497|7499973|FG003|Washout Period 1|Withdrawal by Subject|1
4772175|NCT02733042|7749204|FG012|Follow-up Period|Other|0
4772176|NCT02733042|7749205|FG013|Follow-up Period|Other|0
4772177|NCT02733042|7749206|FG014|Follow-up Period|Other|0
4772178|NCT02733042|7749207|FG015|Follow-up Period|Other|0
4772179|NCT02733042|7749208|FG016|Follow-up Period|Other|0
4772180|NCT02733042|7749209|FG017|Follow-up Period|Other|0
4772181|NCT02733042|7749210|FG018|Follow-up Period|Other|0
4772182|NCT02733042|7749192|FG000|Follow-up Period|Withdrawal by Subject|0
4772183|NCT02733042|7749193|FG001|Follow-up Period|Withdrawal by Subject|0
4772184|NCT02733042|7749194|FG002|Follow-up Period|Withdrawal by Subject|0
4772185|NCT02733042|7749195|FG003|Follow-up Period|Withdrawal by Subject|0
4772186|NCT02733042|7749196|FG004|Follow-up Period|Withdrawal by Subject|0
4772187|NCT02733042|7749197|FG005|Follow-up Period|Withdrawal by Subject|0
4772188|NCT02733042|7749198|FG006|Follow-up Period|Withdrawal by Subject|0
4772189|NCT02733042|7749199|FG007|Follow-up Period|Withdrawal by Subject|0
4772190|NCT02733042|7749200|FG008|Follow-up Period|Withdrawal by Subject|1
4772191|NCT02733042|7749201|FG009|Follow-up Period|Withdrawal by Subject|0
4772192|NCT02733042|7749202|FG010|Follow-up Period|Withdrawal by Subject|1
4772193|NCT02733042|7749203|FG011|Follow-up Period|Withdrawal by Subject|0
4772194|NCT02733042|7749204|FG012|Follow-up Period|Withdrawal by Subject|0
4736950|NCT03587974|7686682|FG000|Overall Study|caregiver demented, care recipient died|3
4736951|NCT03587974|7686683|FG001|Overall Study|caregiver demented, care recipient died|3
4736952|NCT03587974|7686682|FG000|Overall Study|Withdrawal by Subject|2
4736953|NCT03587974|7686683|FG001|Overall Study|Withdrawal by Subject|1
4736954|NCT03588572|7686691|FG000|Visitation 1|Lack of Efficacy|1
4736955|NCT03588572|7686692|FG001|Visitation 1|Lack of Efficacy|1
4736956|NCT03588572|7686691|FG000|Visitation 2|Lost to Follow-up|1
4736957|NCT03588572|7686692|FG001|Visitation 2|Lost to Follow-up|1
4736958|NCT03588572|7686691|FG000|Visitation 2|Lack of Efficacy|0
4772195|NCT02733042|7749205|FG013|Follow-up Period|Withdrawal by Subject|0
4727184|NCT03257358|7666157|FG000|Overall Study|Adverse Event|25
4727185|NCT03257358|7666158|FG001|Overall Study|Adverse Event|12
4727186|NCT03257358|7666157|FG000|Overall Study|Lack of Efficacy|1
4727187|NCT03257358|7666158|FG001|Overall Study|Lack of Efficacy|1
4727188|NCT03257358|7666157|FG000|Overall Study|Lost to Follow-up|12
4727189|NCT03257358|7666158|FG001|Overall Study|Lost to Follow-up|4
4727190|NCT03257358|7666157|FG000|Overall Study|Non-compliance with fingolimod treatment|4
4727191|NCT03257358|7666158|FG001|Overall Study|Non-compliance with fingolimod treatment|2
4727192|NCT03257358|7666157|FG000|Overall Study|Physician Decision|2
4727193|NCT03257358|7666158|FG001|Overall Study|Physician Decision|2
4727194|NCT03257358|7666157|FG000|Overall Study|Protocol Violation|5
4727195|NCT03257358|7666158|FG001|Overall Study|Protocol Violation|3
4727196|NCT03257358|7666157|FG000|Overall Study|Technical problems|4
4727197|NCT03257358|7666158|FG001|Overall Study|Technical problems|1
4727198|NCT03257358|7666157|FG000|Overall Study|Withdrawal by Subject|8
4727199|NCT03257358|7666158|FG001|Overall Study|Withdrawal by Subject|3
4727200|NCT03257358|7666157|FG000|Overall Study|Withdrawal of informed consent|9
4727201|NCT03257358|7666158|FG001|Overall Study|Withdrawal of informed consent|5
4727202|NCT03257358|7666157|FG000|Overall Study|New therapy for study indication|1
4727203|NCT03257358|7666158|FG001|Overall Study|New therapy for study indication|0
4727204|NCT03257358|7666157|FG000|Overall Study|No longer requires treatment|0
4727205|NCT03257358|7666158|FG001|Overall Study|No longer requires treatment|1
4727206|NCT03257371|7666164|FG000|Overall Study|Lost to Follow-up|1
4727207|NCT03257410|7666170|FG000|Overall Study|Adverse Event|2
4727208|NCT03257410|7666171|FG001|Overall Study|Adverse Event|3
4727209|NCT03257410|7666170|FG000|Overall Study|Protocol Violation|1
4727210|NCT03257410|7666171|FG001|Overall Study|Protocol Violation|2
4727211|NCT03257410|7666170|FG000|Overall Study|Lost to Follow-up|1
4727212|NCT03257410|7666171|FG001|Overall Study|Lost to Follow-up|0
4727213|NCT03257410|7666170|FG000|Overall Study|Withdrawal by Subject|1
4727214|NCT03257410|7666171|FG001|Overall Study|Withdrawal by Subject|2
4727215|NCT03257410|7666170|FG000|Overall Study|Physician Decision|1
4727216|NCT03257410|7666171|FG001|Overall Study|Physician Decision|1
4727217|NCT03257410|7666170|FG000|Overall Study|Renal transplantation|2
4727218|NCT03257410|7666171|FG001|Overall Study|Renal transplantation|0
4727219|NCT03257410|7666170|FG000|Overall Study|Switch to peritoneal dialysis|1
4727220|NCT03257410|7666171|FG001|Overall Study|Switch to peritoneal dialysis|0
4727221|NCT03257410|7666170|FG000|Overall Study|Death|3
4727222|NCT03257410|7666171|FG001|Overall Study|Death|2
4727223|NCT03257410|7666170|FG000|Overall Study|Change to another dialysis center|2
4727224|NCT03257410|7666171|FG001|Overall Study|Change to another dialysis center|2
4727225|NCT03257410|7666170|FG000|Overall Study|Missing 3 consecutive study treatments|5
4727226|NCT03257410|7666171|FG001|Overall Study|Missing 3 consecutive study treatments|6
4727227|NCT03257410|7666170|FG000|Overall Study|Miscellaneous|2
4727228|NCT03257410|7666171|FG001|Overall Study|Miscellaneous|2
4727229|NCT03257410|7666170|FG000|Overall Study|Other|0
4727230|NCT03257410|7666171|FG001|Overall Study|Other|1
4727231|NCT03257631|7666181|FG000|Overall Study|Death|8
4727232|NCT03257631|7666182|FG001|Overall Study|Death|5
4727233|NCT03257631|7666183|FG002|Overall Study|Death|13
4727234|NCT03257631|7666184|FG003|Overall Study|Death|5
4727235|NCT03257631|7666181|FG000|Overall Study|Progressive Disease|0
4727236|NCT03257631|7666182|FG001|Overall Study|Progressive Disease|0
4727237|NCT03257631|7666183|FG002|Overall Study|Progressive Disease|1
4727238|NCT03257631|7666184|FG003|Overall Study|Progressive Disease|0
4727239|NCT03257631|7666181|FG000|Overall Study|Withdrawal by Parent/Guardian|0
4727240|NCT03257631|7666182|FG001|Overall Study|Withdrawal by Parent/Guardian|2
4727241|NCT03257631|7666183|FG002|Overall Study|Withdrawal by Parent/Guardian|4
4727242|NCT03257631|7666184|FG003|Overall Study|Withdrawal by Parent/Guardian|1
4727243|NCT03257631|7666181|FG000|Overall Study|Lost to Follow-up|0
4727244|NCT03257631|7666182|FG001|Overall Study|Lost to Follow-up|0
4727245|NCT03257631|7666183|FG002|Overall Study|Lost to Follow-up|1
4727246|NCT03257631|7666184|FG003|Overall Study|Lost to Follow-up|0
4727247|NCT03257631|7666181|FG000|Overall Study|Still on Study|3
4727248|NCT03257631|7666182|FG001|Overall Study|Still on Study|2
4727249|NCT03257631|7666183|FG002|Overall Study|Still on Study|4
4727250|NCT03257631|7666184|FG003|Overall Study|Still on Study|4
4727251|NCT03257657|7666196|FG000|Overall Study|Lost to Follow-up|0
4727252|NCT03257657|7666197|FG001|Overall Study|Lost to Follow-up|3
4727253|NCT03257657|7666196|FG000|Overall Study|Withdrawn|0
4727254|NCT03257657|7666197|FG001|Overall Study|Withdrawn|1
4727255|NCT03257657|7666196|FG000|Overall Study|Noted not eligible right after enrolled|0
4727256|NCT03257657|7666197|FG001|Overall Study|Noted not eligible right after enrolled|1
4727257|NCT03257813|7666206|FG000|Overall Study|Protocol Violation|6
4727258|NCT03257813|7666207|FG001|Overall Study|Protocol Violation|3
4727259|NCT03257865|7666218|FG000|Overall Study|Adverse Event|4
4727260|NCT03257865|7666219|FG001|Overall Study|Adverse Event|8
4727261|NCT03257865|7666218|FG000|Overall Study|Lack of Efficacy|1
4727262|NCT03257865|7666219|FG001|Overall Study|Lack of Efficacy|2
4727263|NCT03257865|7666218|FG000|Overall Study|Non-compliance with Study Drug|0
4727264|NCT03257865|7666219|FG001|Overall Study|Non-compliance with Study Drug|2
4727265|NCT03257865|7666218|FG000|Overall Study|Withdrawal by Subject|23
4727266|NCT03257865|7666219|FG001|Overall Study|Withdrawal by Subject|17
4727267|NCT03257865|7666218|FG000|Overall Study|Physician Decision|3
4727268|NCT03257865|7666219|FG001|Overall Study|Physician Decision|1
4727269|NCT03257865|7666218|FG000|Overall Study|Other|0
4727270|NCT03257865|7666219|FG001|Overall Study|Other|1
4727271|NCT03257865|7666218|FG000|Overall Study|Lost to Follow-up|4
4727272|NCT03257865|7666219|FG001|Overall Study|Lost to Follow-up|4
4727273|NCT03257995|7666225|FG000|Overall Study|Adverse Event|0
4727274|NCT03257995|7666226|FG001|Overall Study|Adverse Event|1
4727275|NCT03257995|7666227|FG002|Overall Study|Adverse Event|0
4727276|NCT03257995|7666228|FG003|Overall Study|Adverse Event|0
4727277|NCT03257995|7666229|FG004|Overall Study|Adverse Event|0
4727278|NCT03257995|7666230|FG005|Overall Study|Adverse Event|0
4727279|NCT03257995|7666225|FG000|Overall Study|Protocol deviation|0
4727280|NCT03257995|7666226|FG001|Overall Study|Protocol deviation|0
4727281|NCT03257995|7666227|FG002|Overall Study|Protocol deviation|0
4727282|NCT03257995|7666228|FG003|Overall Study|Protocol deviation|0
4727283|NCT03257995|7666229|FG004|Overall Study|Protocol deviation|0
4727284|NCT03257995|7666230|FG005|Overall Study|Protocol deviation|2
4727285|NCT03258710|7666252|FG000|Overall Study|Adverse Event|1
4727286|NCT03258710|7666252|FG000|Overall Study|Protocol-defined stopping criteria|1
4727287|NCT03258710|7666252|FG000|Overall Study|Physician Decision|1
4727288|NCT03258762|7666258|FG000|Overall Study|Lost to Follow-up|0
4727289|NCT03258762|7666259|FG001|Overall Study|Lost to Follow-up|1
4727290|NCT03258814|7666268|FG000|Overall Study|Early Termination|4
4727291|NCT03258814|7666269|FG001|Overall Study|Early Termination|3
4727292|NCT03258814|7666270|FG002|Overall Study|Early Termination|10
4727293|NCT03259087|7666282|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0
4727294|NCT03259087|7666283|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0
4727295|NCT03259087|7666284|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0
4727296|NCT03259087|7666285|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0
4727297|NCT03259087|7666286|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1
4727298|NCT03259087|7666282|FG000|Period 2 of Part 2|Adverse Event|0
4727299|NCT03259087|7666283|FG001|Period 2 of Part 2|Adverse Event|0
4727300|NCT03259087|7666284|FG002|Period 2 of Part 2|Adverse Event|0
4727301|NCT03259087|7666285|FG003|Period 2 of Part 2|Adverse Event|0
4727302|NCT03259087|7666286|FG004|Period 2 of Part 2|Adverse Event|1
4727303|NCT03259308|7666339|FG000|Overall Study|Adverse Event|5
4727304|NCT03259308|7666340|FG001|Overall Study|Adverse Event|4
4727305|NCT03259308|7666341|FG002|Overall Study|Adverse Event|1
4727306|NCT03259308|7666339|FG000|Overall Study|Withdrawal by Subject|2
4727307|NCT03259308|7666340|FG001|Overall Study|Withdrawal by Subject|1
4727308|NCT03259308|7666341|FG002|Overall Study|Withdrawal by Subject|3
4727309|NCT03259308|7666339|FG000|Overall Study|Lost to Follow-up|0
4727310|NCT03259308|7666340|FG001|Overall Study|Lost to Follow-up|0
4727311|NCT03259308|7666341|FG002|Overall Study|Lost to Follow-up|1
4727312|NCT03259308|7666339|FG000|Overall Study|Pregnancy|0
4727313|NCT03259308|7666340|FG001|Overall Study|Pregnancy|0
4727314|NCT03259308|7666341|FG002|Overall Study|Pregnancy|1
4727315|NCT03259308|7666339|FG000|Overall Study|Protocol Deviation|0
4727316|NCT03259308|7666340|FG001|Overall Study|Protocol Deviation|3
4727317|NCT03259308|7666341|FG002|Overall Study|Protocol Deviation|0
4727318|NCT03259308|7666339|FG000|Overall Study|Lack of Efficacy|0
4727319|NCT03259308|7666340|FG001|Overall Study|Lack of Efficacy|0
4727320|NCT03259308|7666341|FG002|Overall Study|Lack of Efficacy|1
4727321|NCT03259334|7666352|FG000|Overall Study|Adverse Event|3
4727322|NCT03259334|7666353|FG001|Overall Study|Adverse Event|8
4727323|NCT03259334|7666354|FG002|Overall Study|Adverse Event|5
4727324|NCT03259334|7666352|FG000|Overall Study|Withdrawal by Subject|4
4727325|NCT03259334|7666353|FG001|Overall Study|Withdrawal by Subject|2
4727326|NCT03259334|7666354|FG002|Overall Study|Withdrawal by Subject|4
4727327|NCT03259334|7666352|FG000|Overall Study|Physician Decision|1
4727328|NCT03259334|7666353|FG001|Overall Study|Physician Decision|0
4727329|NCT03259334|7666354|FG002|Overall Study|Physician Decision|0
4727330|NCT03259334|7666352|FG000|Overall Study|Lost to Follow-up|0
4727331|NCT03259334|7666353|FG001|Overall Study|Lost to Follow-up|2
4727332|NCT03259334|7666354|FG002|Overall Study|Lost to Follow-up|1
4727333|NCT03259334|7666352|FG000|Overall Study|Protocol Deviation|0
4727334|NCT03259334|7666353|FG001|Overall Study|Protocol Deviation|3
4727335|NCT03259334|7666354|FG002|Overall Study|Protocol Deviation|2
4727336|NCT03259334|7666352|FG000|Overall Study|Lack of Efficacy|2
4727337|NCT03259334|7666353|FG001|Overall Study|Lack of Efficacy|0
4727338|NCT03259334|7666354|FG002|Overall Study|Lack of Efficacy|1
4727339|NCT03259334|7666352|FG000|Overall Study|Randomized but never treated|0
4727340|NCT03259334|7666353|FG001|Overall Study|Randomized but never treated|2
4727341|NCT03259334|7666354|FG002|Overall Study|Randomized but never treated|0
4727342|NCT03259425|7666362|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1
4727343|NCT03259490|7666368|FG000|Period 1|Withdrawal by Subject|0
4727344|NCT03259490|7666369|FG001|Period 1|Withdrawal by Subject|1
4727345|NCT03259490|7666368|FG000|Period 2|Protocol Violation|1
4727346|NCT03259490|7666369|FG001|Period 2|Protocol Violation|0
4727347|NCT03259555|7666377|FG000|Overall Study|Adverse Event|6
4727348|NCT03259555|7666378|FG001|Overall Study|Adverse Event|4
4727349|NCT03259555|7666377|FG000|Overall Study|Lack of Efficacy|6
4727350|NCT03259555|7666378|FG001|Overall Study|Lack of Efficacy|4
4727351|NCT03259555|7666377|FG000|Overall Study|Lost to Follow-up|0
4727352|NCT03259555|7666378|FG001|Overall Study|Lost to Follow-up|2
4727353|NCT03259555|7666377|FG000|Overall Study|Non-Compliance With Study Drug|1
4727354|NCT03259555|7666378|FG001|Overall Study|Non-Compliance With Study Drug|0
4727355|NCT03259555|7666377|FG000|Overall Study|Progressive Disease|0
4727356|NCT03259555|7666378|FG001|Overall Study|Progressive Disease|2
4727357|NCT03259555|7666377|FG000|Overall Study|Withdrawal by Subject|19
4727358|NCT03259555|7666378|FG001|Overall Study|Withdrawal by Subject|16
4727359|NCT03259555|7666377|FG000|Overall Study|Physician Decision|1
4727360|NCT03259555|7666378|FG001|Overall Study|Physician Decision|2
4727361|NCT03259555|7666377|FG000|Overall Study|Other|1
4727362|NCT03259555|7666378|FG001|Overall Study|Other|0
4727363|NCT03259789|7666387|FG000|Overall Study|Adverse Event|3
4727364|NCT03259789|7666388|FG001|Overall Study|Adverse Event|2
4727365|NCT03259789|7666389|FG002|Overall Study|Adverse Event|1
4727366|NCT03259789|7666387|FG000|Overall Study|Withdrawal by Subject|9
4446608|NCT00485173|7231685|FG000|Overall Study|Death|4
4446609|NCT00485173|7231686|FG001|Overall Study|Death|3
4446610|NCT00485173|7231685|FG000|Overall Study|Lost to Follow-up|32
4446611|NCT00485173|7231686|FG001|Overall Study|Lost to Follow-up|61
4446612|NCT00485264|7231698|FG000|Overall Study|Enrolled But Not Given Treatment|0
4446613|NCT00485264|7231699|FG001|Overall Study|Enrolled But Not Given Treatment|0
4727367|NCT03259789|7666388|FG001|Overall Study|Withdrawal by Subject|5
4727368|NCT03259789|7666389|FG002|Overall Study|Withdrawal by Subject|1
4727369|NCT03259789|7666387|FG000|Overall Study|Lost to Follow-up|5
4727370|NCT03259789|7666388|FG001|Overall Study|Lost to Follow-up|9
4727371|NCT03259789|7666389|FG002|Overall Study|Lost to Follow-up|4
4727372|NCT03259789|7666387|FG000|Overall Study|Physician Decision|0
4727373|NCT03259789|7666388|FG001|Overall Study|Physician Decision|1
4727374|NCT03259789|7666389|FG002|Overall Study|Physician Decision|0
4727375|NCT03260205|7666403|FG000|Overall Study|Adverse Event|2
4727376|NCT03260205|7666404|FG001|Overall Study|Adverse Event|0
4727377|NCT03260205|7666405|FG002|Overall Study|Adverse Event|2
4727378|NCT03260205|7666406|FG003|Overall Study|Adverse Event|2
4727379|NCT03260205|7666407|FG004|Overall Study|Adverse Event|4
4727380|NCT03260205|7666403|FG000|Overall Study|Lost to Follow-up|2
4727381|NCT03260205|7666404|FG001|Overall Study|Lost to Follow-up|2
4727382|NCT03260205|7666405|FG002|Overall Study|Lost to Follow-up|1
4727383|NCT03260205|7666406|FG003|Overall Study|Lost to Follow-up|1
4727384|NCT03260205|7666407|FG004|Overall Study|Lost to Follow-up|5
4727385|NCT03260205|7666403|FG000|Overall Study|Protocol Violation|0
4727386|NCT03260205|7666404|FG001|Overall Study|Protocol Violation|0
4727387|NCT03260205|7666405|FG002|Overall Study|Protocol Violation|2
4727388|NCT03260205|7666406|FG003|Overall Study|Protocol Violation|0
4727389|NCT03260205|7666407|FG004|Overall Study|Protocol Violation|1
4727390|NCT03260205|7666403|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4
4727391|NCT03260205|7666404|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5
4727392|NCT03260205|7666405|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1
4727393|NCT03260205|7666406|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0
4727394|NCT03260205|7666407|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2
4727395|NCT03260205|7666403|FG000|Overall Study|Other: Unspecified|0
4727396|NCT03260205|7666404|FG001|Overall Study|Other: Unspecified|0
4727397|NCT03260205|7666405|FG002|Overall Study|Other: Unspecified|3
4727398|NCT03260205|7666406|FG003|Overall Study|Other: Unspecified|1
4727399|NCT03260205|7666407|FG004|Overall Study|Other: Unspecified|1
4727400|NCT03260205|7666403|FG000|Overall Study|Participant Who Did Not Received AnyDose|1
4727401|NCT03260205|7666404|FG001|Overall Study|Participant Who Did Not Received AnyDose|1
4727402|NCT03260205|7666405|FG002|Overall Study|Participant Who Did Not Received AnyDose|2
4727403|NCT03260205|7666406|FG003|Overall Study|Participant Who Did Not Received AnyDose|3
4727404|NCT03260205|7666407|FG004|Overall Study|Participant Who Did Not Received AnyDose|1
4727405|NCT03261037|7666468|FG000|Overall Study|Withdrawal by Subject|2
4727406|NCT03261037|7666469|FG001|Overall Study|Withdrawal by Subject|13
4727407|NCT03261037|7666470|FG002|Overall Study|Withdrawal by Subject|0
4727408|NCT03261037|7666471|FG003|Overall Study|Withdrawal by Subject|18
4727409|NCT03261037|7666468|FG000|Overall Study|Non-compliance with study procedures|0
4727410|NCT03261037|7666469|FG001|Overall Study|Non-compliance with study procedures|2
4727411|NCT03261037|7666470|FG002|Overall Study|Non-compliance with study procedures|0
4727412|NCT03261037|7666471|FG003|Overall Study|Non-compliance with study procedures|6
4727413|NCT03261037|7666468|FG000|Overall Study|Participant moving away and can no longer be in study|0
4727414|NCT03261037|7666469|FG001|Overall Study|Participant moving away and can no longer be in study|1
4727415|NCT03261037|7666470|FG002|Overall Study|Participant moving away and can no longer be in study|0
4727416|NCT03261037|7666471|FG003|Overall Study|Participant moving away and can no longer be in study|0
4727417|NCT03261037|7666468|FG000|Overall Study|Participant came out of study due to investigator discretion|0
4727418|NCT03261037|7666469|FG001|Overall Study|Participant came out of study due to investigator discretion|2
4727419|NCT03261037|7666470|FG002|Overall Study|Participant came out of study due to investigator discretion|0
4727420|NCT03261037|7666471|FG003|Overall Study|Participant came out of study due to investigator discretion|0
4727421|NCT03261037|7666468|FG000|Overall Study|Diagnosed but protocol deviation|1
4727422|NCT03261037|7666469|FG001|Overall Study|Diagnosed but protocol deviation|0
4446614|NCT00485264|7231700|FG002|Overall Study|Enrolled But Not Given Treatment|0
4727423|NCT03261037|7666470|FG002|Overall Study|Diagnosed but protocol deviation|0
4727424|NCT03261037|7666471|FG003|Overall Study|Diagnosed but protocol deviation|0
4727425|NCT03261037|7666468|FG000|Overall Study|Participant did not want to continue the study|0
4727426|NCT03261037|7666469|FG001|Overall Study|Participant did not want to continue the study|1
4727427|NCT03261037|7666470|FG002|Overall Study|Participant did not want to continue the study|0
4727428|NCT03261037|7666471|FG003|Overall Study|Participant did not want to continue the study|0
4727429|NCT03261037|7666468|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0
4727430|NCT03261037|7666469|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0
4727431|NCT03261037|7666470|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0
4727432|NCT03261037|7666471|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1
4727433|NCT03261037|7666468|FG000|Overall Study|Participant presented clinical improvement|0
4727434|NCT03261037|7666469|FG001|Overall Study|Participant presented clinical improvement|2
4727435|NCT03261037|7666470|FG002|Overall Study|Participant presented clinical improvement|0
4727436|NCT03261037|7666471|FG003|Overall Study|Participant presented clinical improvement|0
4727437|NCT03261037|7666468|FG000|Overall Study|Technical difficulties|0
4727438|NCT03261037|7666469|FG001|Overall Study|Technical difficulties|0
4727439|NCT03261037|7666470|FG002|Overall Study|Technical difficulties|0
4727440|NCT03261037|7666471|FG003|Overall Study|Technical difficulties|1
4727441|NCT03261037|7666468|FG000|Overall Study|Equipment failed to work|0
4727442|NCT03261037|7666469|FG001|Overall Study|Equipment failed to work|0
4727443|NCT03261037|7666470|FG002|Overall Study|Equipment failed to work|0
4727444|NCT03261037|7666471|FG003|Overall Study|Equipment failed to work|1
4727445|NCT03261037|7666468|FG000|Overall Study|End of study for participant and no follow up|0
4727446|NCT03261037|7666469|FG001|Overall Study|End of study for participant and no follow up|0
4727447|NCT03261037|7666470|FG002|Overall Study|End of study for participant and no follow up|0
4727448|NCT03261037|7666471|FG003|Overall Study|End of study for participant and no follow up|1
4727449|NCT03261037|7666468|FG000|Overall Study|Participant was too weak to continue in study|1
4727450|NCT03261037|7666469|FG001|Overall Study|Participant was too weak to continue in study|0
4727451|NCT03261037|7666470|FG002|Overall Study|Participant was too weak to continue in study|0
4727452|NCT03261037|7666471|FG003|Overall Study|Participant was too weak to continue in study|0
4727453|NCT03261167|7666484|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0
4727454|NCT03261167|7666485|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3
4727455|NCT03261167|7666484|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3
4727456|NCT03261167|7666485|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1
4727457|NCT03261167|7666484|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1
4727458|NCT03261167|7666485|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0
4727459|NCT03261167|7666484|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1
4727460|NCT03261167|7666485|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0
4727461|NCT03261167|7666484|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1
4727462|NCT03261167|7666485|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1
4727463|NCT03261336|7666497|FG000|Overall Study|Adverse Event|1
4727464|NCT03261947|7666506|FG000|Overall Study|Death|10
4727465|NCT03261947|7666507|FG001|Overall Study|Death|13
4727466|NCT03261947|7666508|FG002|Overall Study|Death|17
4727467|NCT03261947|7666509|FG003|Overall Study|Death|12
4727468|NCT03261947|7666510|FG004|Overall Study|Death|8
4727469|NCT03261947|7666506|FG000|Overall Study|Lost to Follow-up|0
4727470|NCT03261947|7666507|FG001|Overall Study|Lost to Follow-up|0
4727471|NCT03261947|7666508|FG002|Overall Study|Lost to Follow-up|2
4727472|NCT03261947|7666509|FG003|Overall Study|Lost to Follow-up|1
4727473|NCT03261947|7666510|FG004|Overall Study|Lost to Follow-up|0
4727474|NCT03261947|7666506|FG000|Overall Study|Withdrawal by Subject|0
4727475|NCT03261947|7666507|FG001|Overall Study|Withdrawal by Subject|0
4727476|NCT03261947|7666508|FG002|Overall Study|Withdrawal by Subject|3
4727477|NCT03261947|7666509|FG003|Overall Study|Withdrawal by Subject|0
4727478|NCT03261947|7666510|FG004|Overall Study|Withdrawal by Subject|1
4727479|NCT03261947|7666506|FG000|Overall Study|Site Terminated by Sponsor|0
4727480|NCT03261947|7666507|FG001|Overall Study|Site Terminated by Sponsor|0
4727481|NCT03261947|7666508|FG002|Overall Study|Site Terminated by Sponsor|4
4727482|NCT03261947|7666509|FG003|Overall Study|Site Terminated by Sponsor|7
4727483|NCT03261947|7666510|FG004|Overall Study|Site Terminated by Sponsor|5
4727484|NCT03261947|7666506|FG000|Overall Study|Reason not Specified|2
4727485|NCT03261947|7666507|FG001|Overall Study|Reason not Specified|0
4727486|NCT03261947|7666508|FG002|Overall Study|Reason not Specified|4
4727487|NCT03261947|7666509|FG003|Overall Study|Reason not Specified|1
4727488|NCT03261947|7666510|FG004|Overall Study|Reason not Specified|3
4727489|NCT03262012|7666547|FG000|Overall Study|Withdrawal by Subject|15
4727490|NCT03262012|7666548|FG001|Overall Study|Withdrawal by Subject|13
4727491|NCT03262012|7666549|FG002|Overall Study|Withdrawal by Subject|8
4727492|NCT03262012|7666550|FG003|Overall Study|Withdrawal by Subject|7
4727493|NCT03262012|7666547|FG000|Overall Study|Adverse Event|10
4727494|NCT03262012|7666548|FG001|Overall Study|Adverse Event|12
4727495|NCT03262012|7666549|FG002|Overall Study|Adverse Event|4
4727496|NCT03262012|7666550|FG003|Overall Study|Adverse Event|6
4727497|NCT03262012|7666547|FG000|Overall Study|Physician Decision|2
4727498|NCT03262012|7666548|FG001|Overall Study|Physician Decision|5
4727499|NCT03262012|7666549|FG002|Overall Study|Physician Decision|1
4727500|NCT03262012|7666550|FG003|Overall Study|Physician Decision|0
4727501|NCT03262012|7666547|FG000|Overall Study|Lack of Efficacy|0
4727502|NCT03262012|7666548|FG001|Overall Study|Lack of Efficacy|5
4727503|NCT03262012|7666549|FG002|Overall Study|Lack of Efficacy|1
4727504|NCT03262012|7666550|FG003|Overall Study|Lack of Efficacy|2
4727505|NCT03262012|7666547|FG000|Overall Study|Protocol Discontinuation Criteria|0
4727506|NCT03262012|7666548|FG001|Overall Study|Protocol Discontinuation Criteria|1
4727507|NCT03262012|7666549|FG002|Overall Study|Protocol Discontinuation Criteria|0
4727508|NCT03262012|7666550|FG003|Overall Study|Protocol Discontinuation Criteria|0
4727509|NCT03262038|7666562|FG000|Overall Study|Withdrawal by Subject|0
4727510|NCT03262038|7666563|FG001|Overall Study|Withdrawal by Subject|1
4727511|NCT03262233|7666573|FG000|Overall Study|Withdrawal by Subject|12
4727512|NCT03262233|7666574|FG001|Overall Study|Withdrawal by Subject|8
4727513|NCT03262233|7666575|FG002|Overall Study|Withdrawal by Subject|21
4727514|NCT03262233|7666576|FG003|Overall Study|Withdrawal by Subject|13
4727515|NCT03262233|7666573|FG000|Overall Study|Declined due to shock|1
4727516|NCT03262233|7666574|FG001|Overall Study|Declined due to shock|2
4727517|NCT03262233|7666575|FG002|Overall Study|Declined due to shock|2
4727518|NCT03262233|7666576|FG003|Overall Study|Declined due to shock|3
4727519|NCT03262233|7666573|FG000|Overall Study|Protocol Violation|5
4727520|NCT03262233|7666574|FG001|Overall Study|Protocol Violation|10
4727521|NCT03262233|7666575|FG002|Overall Study|Protocol Violation|2
4727522|NCT03262233|7666576|FG003|Overall Study|Protocol Violation|13
4727523|NCT03262233|7666573|FG000|Overall Study|data collection artifact|0
4727524|NCT03262233|7666574|FG001|Overall Study|data collection artifact|1
4727525|NCT03262233|7666575|FG002|Overall Study|data collection artifact|0
4727526|NCT03262233|7666576|FG003|Overall Study|data collection artifact|0
4727527|NCT03262389|7666587|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1
4727528|NCT03262389|7666587|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1
4727529|NCT03262389|7666587|FG000|Overall Study|opted out of PET/MR|1
4727530|NCT03262441|7666591|FG000|Overall Study|Withdrawal by Subject|1
4727531|NCT03263442|7666597|FG000|Inpatient Phase|Death|1
4727532|NCT03263442|7666598|FG001|Inpatient Phase|Death|0
4727533|NCT03263442|7666597|FG000|Inpatient Phase|Withdrawal by Subject|1
4727534|NCT03263442|7666598|FG001|Inpatient Phase|Withdrawal by Subject|0
4727535|NCT03263442|7666597|FG000|Inpatient Phase|Inadequate Drug Exposure|0
4727536|NCT03263442|7666598|FG001|Inpatient Phase|Inadequate Drug Exposure|1
4727537|NCT03263442|7666597|FG000|1-month Follow-Up|Lost to Follow-up|1
4727538|NCT03263442|7666598|FG001|1-month Follow-Up|Lost to Follow-up|0
4727539|NCT03263442|7666597|FG000|3-month Follow-Up|Lost to Follow-up|1
4727540|NCT03263442|7666598|FG001|3-month Follow-Up|Lost to Follow-up|3
4727541|NCT03263442|7666597|FG000|6-month Follow-Up|Lost to Follow-up|2
4727542|NCT03263442|7666598|FG001|6-month Follow-Up|Lost to Follow-up|2
4727543|NCT03263702|7666608|FG000|Overall Study|Lost to Follow-up|2
4727544|NCT03263702|7666609|FG001|Overall Study|Lost to Follow-up|2
4727545|NCT03263702|7666608|FG000|Overall Study|Withdrawal by Subject|1
4727546|NCT03263702|7666609|FG001|Overall Study|Withdrawal by Subject|2
4727547|NCT03263780|7666615|FG000|Overall Study|Withdrawal by Subject|3
4727548|NCT03263780|7666615|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7
4727549|NCT03264066|7666625|FG000|Overall Study|Adverse Event|1
4727550|NCT03264066|7666626|FG001|Overall Study|Adverse Event|1
4727551|NCT03264066|7666627|FG002|Overall Study|Adverse Event|0
4727552|NCT03264066|7666628|FG003|Overall Study|Adverse Event|0
4727553|NCT03264066|7666629|FG004|Overall Study|Adverse Event|0
4727554|NCT03264066|7666630|FG005|Overall Study|Adverse Event|0
4727555|NCT03264066|7666625|FG000|Overall Study|Death|12
4727556|NCT03264066|7666626|FG001|Overall Study|Death|12
4727557|NCT03264066|7666627|FG002|Overall Study|Death|8
4727558|NCT03264066|7666628|FG003|Overall Study|Death|10
4727559|NCT03264066|7666629|FG004|Overall Study|Death|6
4727560|NCT03264066|7666630|FG005|Overall Study|Death|1
4727561|NCT03264066|7666625|FG000|Overall Study|Lost to Follow-up|1
4727562|NCT03264066|7666626|FG001|Overall Study|Lost to Follow-up|0
4727563|NCT03264066|7666627|FG002|Overall Study|Lost to Follow-up|0
4727564|NCT03264066|7666628|FG003|Overall Study|Lost to Follow-up|0
4727565|NCT03264066|7666629|FG004|Overall Study|Lost to Follow-up|0
4727566|NCT03264066|7666630|FG005|Overall Study|Lost to Follow-up|0
4727567|NCT03264066|7666625|FG000|Overall Study|Progressive Disease|0
4727568|NCT03264066|7666626|FG001|Overall Study|Progressive Disease|2
4727569|NCT03264066|7666627|FG002|Overall Study|Progressive Disease|1
4727570|NCT03264066|7666628|FG003|Overall Study|Progressive Disease|0
4727571|NCT03264066|7666629|FG004|Overall Study|Progressive Disease|0
4727572|NCT03264066|7666630|FG005|Overall Study|Progressive Disease|0
4772196|NCT02733042|7749206|FG014|Follow-up Period|Withdrawal by Subject|0
4727573|NCT03264066|7666625|FG000|Overall Study|Study Terminated by Sponsor|5
4727574|NCT03264066|7666626|FG001|Overall Study|Study Terminated by Sponsor|5
4727575|NCT03264066|7666627|FG002|Overall Study|Study Terminated by Sponsor|8
4727576|NCT03264066|7666628|FG003|Overall Study|Study Terminated by Sponsor|5
4727577|NCT03264066|7666629|FG004|Overall Study|Study Terminated by Sponsor|1
4727578|NCT03264066|7666630|FG005|Overall Study|Study Terminated by Sponsor|2
4727579|NCT03264066|7666625|FG000|Overall Study|Withdrawal by Subject|1
4727580|NCT03264066|7666626|FG001|Overall Study|Withdrawal by Subject|0
4727581|NCT03264066|7666627|FG002|Overall Study|Withdrawal by Subject|0
4727582|NCT03264066|7666628|FG003|Overall Study|Withdrawal by Subject|5
4727583|NCT03264066|7666629|FG004|Overall Study|Withdrawal by Subject|0
4727584|NCT03264066|7666630|FG005|Overall Study|Withdrawal by Subject|0
4727585|NCT03264456|7666679|FG000|Overall Study|Withdrawal by Subject|3
4727586|NCT03264456|7666679|FG000|Overall Study|Lost to Follow-up|1
4727587|NCT03265119|7666685|FG000|Overall Study|Adverse Event|2
4727588|NCT03265119|7666686|FG001|Overall Study|Adverse Event|1
4727589|NCT03265119|7666685|FG000|Overall Study|Lack of Efficacy|3
4727590|NCT03265119|7666686|FG001|Overall Study|Lack of Efficacy|0
4727591|NCT03265119|7666685|FG000|Overall Study|Protocol Violation|1
4727592|NCT03265119|7666686|FG001|Overall Study|Protocol Violation|2
4727593|NCT03265119|7666685|FG000|Overall Study|Withdrawal by Subject|2
4727594|NCT03265119|7666686|FG001|Overall Study|Withdrawal by Subject|4
4727595|NCT03265119|7666685|FG000|Overall Study|Lost to Follow-up|1
4727596|NCT03265119|7666686|FG001|Overall Study|Lost to Follow-up|0
4727597|NCT03265119|7666685|FG000|Overall Study|Lack of Compliance|1
4727598|NCT03265119|7666686|FG001|Overall Study|Lack of Compliance|0
4727599|NCT03265132|7666694|FG000|Overall Study|Adverse Event|0
4727600|NCT03265132|7666695|FG001|Overall Study|Adverse Event|1
4727601|NCT03265132|7666694|FG000|Overall Study|Lack of Efficacy|0
4727602|NCT03265132|7666695|FG001|Overall Study|Lack of Efficacy|2
4727603|NCT03265132|7666694|FG000|Overall Study|Progressive disease|0
4727604|NCT03265132|7666695|FG001|Overall Study|Progressive disease|2
4727605|NCT03265132|7666694|FG000|Overall Study|Withdrawal by Subject|0
4727606|NCT03265132|7666695|FG001|Overall Study|Withdrawal by Subject|1
4727607|NCT03265600|7666705|FG000|Overall Study|Lost to Follow-up|17
4727608|NCT03265600|7666706|FG001|Overall Study|Lost to Follow-up|5
4727609|NCT03265600|7666705|FG000|Overall Study|Withdrawal by Subject|4
4727610|NCT03265600|7666706|FG001|Overall Study|Withdrawal by Subject|2
4727611|NCT03265600|7666705|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3
4727612|NCT03265600|7666706|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5
4727613|NCT03265938|7666712|FG000|Overall Study|Withdrawal by Subject|1
4727614|NCT03265938|7666712|FG000|Overall Study|Physician Decision|1
4727615|NCT03265938|7666712|FG000|Overall Study|friable mass|6
4727616|NCT03266094|7666717|FG000|Overall Study|Lost to Follow-up|1
4727617|NCT03266094|7666717|FG000|Overall Study|Withdrawal by Subject|1
4727618|NCT03266107|7666723|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1
4727619|NCT03266107|7666723|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2
4727620|NCT03266107|7666723|FG000|3-Month Follow-up Visit|Lost to Follow-up|1
4727621|NCT03266107|7666723|FG000|12-Month Follow-up Visit|Lost to Follow-up|1
4727622|NCT03266172|7666732|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1
4727623|NCT03266172|7666733|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0
4727624|NCT03266172|7666734|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0
4727625|NCT03266172|7666732|FG000|Part A: Washout Period (7 Days)|Adverse Event|1
4727626|NCT03266172|7666733|FG001|Part A: Washout Period (7 Days)|Adverse Event|0
4727627|NCT03266172|7666734|FG002|Part A: Washout Period (7 Days)|Adverse Event|0
4727628|NCT03266172|7666732|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1
4727629|NCT03266172|7666733|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0
4727630|NCT03266172|7666734|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0
4727631|NCT03266172|7666732|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0
4727632|NCT03266172|7666733|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2
4727633|NCT03266172|7666734|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0
4727634|NCT03266172|7666732|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0
4727635|NCT03266172|7666733|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0
4727636|NCT03266172|7666734|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1
4727637|NCT03266172|7666732|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0
4727638|NCT03266172|7666733|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0
4727639|NCT03266172|7666734|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1
4727640|NCT03266588|7666796|FG000|Observational Period|Screen Failure: Eligibility Criteria|439
4727641|NCT03266588|7666797|FG001|Observational Period|Screen Failure: Eligibility Criteria|228
4727642|NCT03266588|7666798|FG002|Observational Period|Screen Failure: Eligibility Criteria|140
4727643|NCT03266588|7666796|FG000|Observational Period|Withdrawal by Subject|44
4727644|NCT03266588|7666797|FG001|Observational Period|Withdrawal by Subject|22
4727645|NCT03266588|7666798|FG002|Observational Period|Withdrawal by Subject|13
4727646|NCT03266588|7666796|FG000|Observational Period|Non-compliance|18
4727647|NCT03266588|7666797|FG001|Observational Period|Non-compliance|12
4727648|NCT03266588|7666798|FG002|Observational Period|Non-compliance|10
4727649|NCT03266588|7666796|FG000|Observational Period|Lost to Follow-up|8
4727650|NCT03266588|7666797|FG001|Observational Period|Lost to Follow-up|12
4727651|NCT03266588|7666798|FG002|Observational Period|Lost to Follow-up|4
4727652|NCT03266588|7666796|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3
4727653|NCT03266588|7666797|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1
4727654|NCT03266588|7666798|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0
4727655|NCT03266588|7666796|FG000|Observational Period|Protocol Deviation|1
4727656|NCT03266588|7666797|FG001|Observational Period|Protocol Deviation|0
4727657|NCT03266588|7666798|FG002|Observational Period|Protocol Deviation|0
4727658|NCT03266588|7666796|FG000|Observational Period|Other Reasons|3
4727659|NCT03266588|7666797|FG001|Observational Period|Other Reasons|0
4727660|NCT03266588|7666798|FG002|Observational Period|Other Reasons|1
4727661|NCT03266588|7666796|FG000|Long-term Treatment Period|Adverse Event|33
4727662|NCT03266588|7666797|FG001|Long-term Treatment Period|Adverse Event|17
4727663|NCT03266588|7666798|FG002|Long-term Treatment Period|Adverse Event|8
4727664|NCT03266588|7666796|FG000|Long-term Treatment Period|Lack of Efficacy|41
4727665|NCT03266588|7666797|FG001|Long-term Treatment Period|Lack of Efficacy|31
4727666|NCT03266588|7666798|FG002|Long-term Treatment Period|Lack of Efficacy|5
4727667|NCT03266588|7666796|FG000|Long-term Treatment Period|Lost to Follow-up|39
4727668|NCT03266588|7666797|FG001|Long-term Treatment Period|Lost to Follow-up|37
4727669|NCT03266588|7666798|FG002|Long-term Treatment Period|Lost to Follow-up|8
4727670|NCT03266588|7666796|FG000|Long-term Treatment Period|Non-Compliance|126
4727671|NCT03266588|7666797|FG001|Long-term Treatment Period|Non-Compliance|57
4727672|NCT03266588|7666798|FG002|Long-term Treatment Period|Non-Compliance|7
4727673|NCT03266588|7666796|FG000|Long-term Treatment Period|Pregnancy|11
4727674|NCT03266588|7666797|FG001|Long-term Treatment Period|Pregnancy|5
4727675|NCT03266588|7666798|FG002|Long-term Treatment Period|Pregnancy|0
4727676|NCT03266588|7666796|FG000|Long-term Treatment Period|Protocol Deviation|17
4727677|NCT03266588|7666797|FG001|Long-term Treatment Period|Protocol Deviation|10
4727678|NCT03266588|7666798|FG002|Long-term Treatment Period|Protocol Deviation|4
4727679|NCT03266588|7666796|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33
4727680|NCT03266588|7666797|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17
4727681|NCT03266588|7666798|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17
4727682|NCT03266588|7666796|FG000|Long-term Treatment Period|Withdrawal by Subject|100
4727683|NCT03266588|7666797|FG001|Long-term Treatment Period|Withdrawal by Subject|63
4727684|NCT03266588|7666798|FG002|Long-term Treatment Period|Withdrawal by Subject|16
4727685|NCT03266588|7666796|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1
4727686|NCT03266588|7666797|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2
4727687|NCT03266588|7666798|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0
4727688|NCT03266588|7666796|FG000|Long-term Treatment Period|Other Reasons|5
4727689|NCT03266588|7666797|FG001|Long-term Treatment Period|Other Reasons|0
4727690|NCT03266588|7666798|FG002|Long-term Treatment Period|Other Reasons|0
4727691|NCT03266588|7666796|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0
4727692|NCT03266588|7666797|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1
4727693|NCT03266588|7666798|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0
4727694|NCT03267212|7666806|FG000|First Intervention|Lost to Follow-up|0
4727695|NCT03267212|7666807|FG001|First Intervention|Lost to Follow-up|2
4727696|NCT03267212|7666806|FG000|First Intervention|Withdrawal by Subject|1
4727697|NCT03267212|7666807|FG001|First Intervention|Withdrawal by Subject|1
4727698|NCT03267212|7666806|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1
4727699|NCT03267212|7666807|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0
4727700|NCT03267264|7666817|FG000|Overall Study|Withdrawal by Subject|1
4727701|NCT03267264|7666818|FG001|Overall Study|Withdrawal by Subject|0
4727702|NCT03267264|7666819|FG002|Overall Study|Withdrawal by Subject|2
4727703|NCT03267264|7666820|FG003|Overall Study|Withdrawal by Subject|4
4727704|NCT03267511|7666837|FG000|Overall Study|Lost to Follow-up|0
4727705|NCT03267511|7666838|FG001|Overall Study|Lost to Follow-up|0
4727706|NCT03267511|7666839|FG002|Overall Study|Lost to Follow-up|0
4727707|NCT03267511|7666840|FG003|Overall Study|Lost to Follow-up|1
4727708|NCT03267576|7666854|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0
4727709|NCT03267576|7666855|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1
4727710|NCT03267576|7666854|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1
4727711|NCT03267576|7666855|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1
4727712|NCT03267940|7666867|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1
4727713|NCT03267940|7666868|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2
4727714|NCT03267940|7666869|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0
4727715|NCT03267940|7666870|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0
4727716|NCT03267940|7666871|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0
4727717|NCT03267940|7666872|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0
4727718|NCT03267940|7666867|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
4727719|NCT03267940|7666868|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1
4727720|NCT03267940|7666869|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
4727721|NCT03267940|7666870|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
4727722|NCT03267940|7666871|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
4727723|NCT03267940|7666872|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
4727724|NCT03267940|7666867|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
4727725|NCT03267940|7666868|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1
4727726|NCT03267940|7666869|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
4727727|NCT03267940|7666870|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
4727728|NCT03267940|7666871|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
4727729|NCT03267940|7666872|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
4727730|NCT03267940|7666867|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7
4727731|NCT03267940|7666868|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3
4727732|NCT03267940|7666869|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0
4772197|NCT02733042|7749207|FG015|Follow-up Period|Withdrawal by Subject|1
4727733|NCT03267940|7666870|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0
4727734|NCT03267940|7666871|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0
4727735|NCT03267940|7666872|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0
4727736|NCT03267940|7666867|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0
4727737|NCT03267940|7666868|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0
4727738|NCT03267940|7666869|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0
4727739|NCT03267940|7666870|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3
4727740|NCT03267940|7666871|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2
4727741|NCT03267940|7666872|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0
4727742|NCT03267940|7666867|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0
4727743|NCT03267940|7666868|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0
4727744|NCT03267940|7666869|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2
4727745|NCT03267940|7666870|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1
4727746|NCT03267940|7666871|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2
4727747|NCT03267940|7666872|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0
4727748|NCT03267940|7666867|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0
4727749|NCT03267940|7666868|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0
4727750|NCT03267940|7666869|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2
4727751|NCT03267940|7666870|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1
4727752|NCT03267940|7666871|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1
4727753|NCT03267940|7666872|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1
4727754|NCT03267940|7666867|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0
4727755|NCT03267940|7666868|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0
4727756|NCT03267940|7666869|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7
4727757|NCT03267940|7666870|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4
4727758|NCT03267940|7666871|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5
4727759|NCT03267940|7666872|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3
4727760|NCT03267940|7666867|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0
4727761|NCT03267940|7666868|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0
4727762|NCT03267940|7666869|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10
4727763|NCT03267940|7666870|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13
4727764|NCT03267940|7666871|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0
4727765|NCT03267940|7666872|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6
4727766|NCT03268590|7666898|FG000|Overall Study|Previously unknown exclusion criteria|1
4727767|NCT03268746|7666905|FG000|Overall Study|Withdrawal by Subject|1
4727768|NCT03268941|7666920|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
4727769|NCT03268941|7666921|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
4727770|NCT03268941|7666922|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
4727771|NCT03268941|7666923|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1
4727772|NCT03268941|7666924|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
4727773|NCT03268941|7666925|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
4727774|NCT03268941|7666926|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
4727775|NCT03268941|7666920|FG000|Part 1 (Days 1 to 9)|Adverse Event|0
4727776|NCT03268941|7666921|FG001|Part 1 (Days 1 to 9)|Adverse Event|0
4727777|NCT03268941|7666922|FG002|Part 1 (Days 1 to 9)|Adverse Event|0
4727778|NCT03268941|7666923|FG003|Part 1 (Days 1 to 9)|Adverse Event|1
4727779|NCT03268941|7666924|FG004|Part 1 (Days 1 to 9)|Adverse Event|0
4727780|NCT03268941|7666925|FG005|Part 1 (Days 1 to 9)|Adverse Event|0
4727781|NCT03268941|7666926|FG006|Part 1 (Days 1 to 9)|Adverse Event|0
4727782|NCT03268941|7666920|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1
4727783|NCT03268941|7666921|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0
4727784|NCT03268941|7666922|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0
4727785|NCT03268941|7666923|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0
4727786|NCT03268941|7666924|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0
4727787|NCT03268941|7666925|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0
4727788|NCT03268941|7666926|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0
4727789|NCT03268941|7666920|FG000|Part 2: Days 17 to 25|Reason not specified|0
4727790|NCT03268941|7666921|FG001|Part 2: Days 17 to 25|Reason not specified|0
4727791|NCT03268941|7666922|FG002|Part 2: Days 17 to 25|Reason not specified|0
4727792|NCT03268941|7666923|FG003|Part 2: Days 17 to 25|Reason not specified|0
4727793|NCT03268941|7666924|FG004|Part 2: Days 17 to 25|Reason not specified|0
4727794|NCT03268941|7666925|FG005|Part 2: Days 17 to 25|Reason not specified|0
4727795|NCT03268941|7666926|FG006|Part 2: Days 17 to 25|Reason not specified|1
4727796|NCT03268941|7666920|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0
4727797|NCT03268941|7666921|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0
4727798|NCT03268941|7666922|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0
4727799|NCT03268941|7666923|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0
4727800|NCT03268941|7666924|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0
4727801|NCT03268941|7666925|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0
4727802|NCT03268941|7666926|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1
4727803|NCT03269552|7666954|FG000|Overall Study|Adverse Event|2
4727804|NCT03270085|7666961|FG000|Overall Study|Withdrawal by Subject|1
4727805|NCT03270085|7666962|FG001|Overall Study|Withdrawal by Subject|0
4727806|NCT03270644|7666997|FG000|Day 1 Lasmiditan Reference|Physician Decision|1
4727807|NCT03270644|7666997|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1
4727808|NCT03270657|7667008|FG000|Overall Study|Withdrawal by Subject|1
4727809|NCT03271307|7667026|FG000|Overall Study|Lost to Follow-up|0
4727810|NCT03271307|7667027|FG001|Overall Study|Lost to Follow-up|0
4727811|NCT03271307|7667028|FG002|Overall Study|Lost to Follow-up|0
4727812|NCT03271307|7667029|FG003|Overall Study|Lost to Follow-up|28
4727813|NCT03271307|7667030|FG004|Overall Study|Lost to Follow-up|91
4727814|NCT03271528|7667062|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1
4727815|NCT03271528|7667063|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0
4727816|NCT03271528|7667062|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1
4727817|NCT03271528|7667063|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0
4727818|NCT03271528|7667062|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0
4727819|NCT03271528|7667063|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1
4727820|NCT03271528|7667062|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0
4727821|NCT03271528|7667063|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1
4727822|NCT03271528|7667062|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1
4727823|NCT03271528|7667063|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1
4727824|NCT03271528|7667062|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1
4727825|NCT03271528|7667063|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0
4727826|NCT03271528|7667062|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1
4727827|NCT03271528|7667063|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0
4727828|NCT03273153|7667080|FG000|Overall Study|Remain on Study|161
4727829|NCT03273153|7667081|FG001|Overall Study|Remain on Study|159
4727830|NCT03273153|7667080|FG000|Overall Study|Death|41
4727831|NCT03273153|7667081|FG001|Overall Study|Death|45
4727832|NCT03273153|7667080|FG000|Overall Study|Lost to Follow-up|3
4727833|NCT03273153|7667081|FG001|Overall Study|Lost to Follow-up|3
4727834|NCT03273153|7667080|FG000|Overall Study|Protocol Violation|3
4727835|NCT03273153|7667081|FG001|Overall Study|Protocol Violation|0
4727836|NCT03273153|7667080|FG000|Overall Study|Withdrawal by Subject|16
4727837|NCT03273153|7667081|FG001|Overall Study|Withdrawal by Subject|13
4727838|NCT03273153|7667080|FG000|Overall Study|Symptomatic Deterioration|0
4727839|NCT03273153|7667081|FG001|Overall Study|Symptomatic Deterioration|1
4727840|NCT03273153|7667080|FG000|Overall Study|Other|0
4727841|NCT03273153|7667081|FG001|Overall Study|Other|1
4727842|NCT03273166|7667087|FG000|Overall Study|Withdrawn prior to Completion|31
4727843|NCT03273257|7667094|FG000|Overall Study|Death|0
4727844|NCT03273257|7667095|FG001|Overall Study|Death|1
4727845|NCT03273257|7667094|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1
4727846|NCT03273257|7667095|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1
4727847|NCT03273257|7667094|FG000|Overall Study|Study terminated|3
4727848|NCT03273257|7667095|FG001|Overall Study|Study terminated|2
4727849|NCT03273387|7667121|FG000|Overall Study|Death|2
4727850|NCT03273387|7667122|FG001|Overall Study|Death|2
4727851|NCT03273387|7667121|FG000|Overall Study|Withdrawal by Subject|1
4727852|NCT03273387|7667122|FG001|Overall Study|Withdrawal by Subject|1
4727853|NCT03273946|7667156|FG000|Overall Study|Withdrawal by Subject|5
4727854|NCT03273946|7667156|FG000|Overall Study|Unwillingness of the guardian|1
4727855|NCT03273946|7667156|FG000|Overall Study|Participant refused to use the drug|2
4727856|NCT03273946|7667156|FG000|Overall Study|Participant relative refused to use drug|1
4727857|NCT03274076|7667162|FG000|24 Weeks Double Blind|Withdrawal by Subject|0
4727858|NCT03274076|7667163|FG001|24 Weeks Double Blind|Withdrawal by Subject|1
4727859|NCT03274076|7667164|FG002|24 Weeks Double Blind|Withdrawal by Subject|0
4727860|NCT03274076|7667165|FG003|24 Weeks Double Blind|Withdrawal by Subject|0
4727861|NCT03274076|7667162|FG000|24 Weeks Open Label|Adverse Event|0
4727862|NCT03274076|7667163|FG001|24 Weeks Open Label|Adverse Event|0
4727863|NCT03274076|7667164|FG002|24 Weeks Open Label|Adverse Event|2
4727864|NCT03274076|7667165|FG003|24 Weeks Open Label|Adverse Event|0
4727865|NCT03274076|7667162|FG000|24 Weeks Open Label|Withdrawal by Subject|0
4727866|NCT03274076|7667163|FG001|24 Weeks Open Label|Withdrawal by Subject|0
4727867|NCT03274076|7667164|FG002|24 Weeks Open Label|Withdrawal by Subject|0
4727868|NCT03274076|7667165|FG003|24 Weeks Open Label|Withdrawal by Subject|1
4727869|NCT03274440|7667184|FG000|Overall Study|Time commitment too great|1
4727870|NCT03274440|7667185|FG001|Overall Study|Time commitment too great|0
4727871|NCT03274440|7667186|FG002|Overall Study|Time commitment too great|0
4727872|NCT03274440|7667187|FG003|Overall Study|Time commitment too great|1
4727873|NCT03274440|7667188|FG004|Overall Study|Time commitment too great|0
4727874|NCT03274440|7667189|FG005|Overall Study|Time commitment too great|0
4727875|NCT03274453|7667201|FG000|Overall Study|Lost to Follow-up|2
4727876|NCT03274453|7667202|FG001|Overall Study|Lost to Follow-up|5
4727877|NCT03274453|7667203|FG002|Overall Study|Lost to Follow-up|4
4727878|NCT03274453|7667204|FG003|Overall Study|Lost to Follow-up|1
4727879|NCT03274453|7667201|FG000|Overall Study|Physician Decision|2
4727880|NCT03274453|7667202|FG001|Overall Study|Physician Decision|0
4727881|NCT03274453|7667203|FG002|Overall Study|Physician Decision|0
4727882|NCT03274453|7667204|FG003|Overall Study|Physician Decision|3
4727883|NCT03274453|7667201|FG000|Overall Study|Surgery Cancelled|0
4727884|NCT03274453|7667202|FG001|Overall Study|Surgery Cancelled|1
4727885|NCT03274453|7667203|FG002|Overall Study|Surgery Cancelled|0
4727886|NCT03274453|7667204|FG003|Overall Study|Surgery Cancelled|0
4727887|NCT03274466|7667216|FG000|Overall Study|Withdrawal by Subject|7
4727888|NCT03274466|7667217|FG001|Overall Study|Withdrawal by Subject|3
4727889|NCT03274466|7667216|FG000|Overall Study|Protocol Specified Withdrawal|5
4727890|NCT03274466|7667217|FG001|Overall Study|Protocol Specified Withdrawal|11
4727891|NCT03274466|7667216|FG000|Overall Study|Lost to Follow-up|5
4727892|NCT03274466|7667217|FG001|Overall Study|Lost to Follow-up|7
4727893|NCT03274466|7667216|FG000|Overall Study|Subject Non-compliance|0
4727894|NCT03274466|7667217|FG001|Overall Study|Subject Non-compliance|1
4727895|NCT03274466|7667216|FG000|Overall Study|Adverse Event|3
4727896|NCT03274466|7667217|FG001|Overall Study|Adverse Event|3
4727897|NCT03274466|7667216|FG000|Overall Study|Physician Decision|0
4727898|NCT03274466|7667217|FG001|Overall Study|Physician Decision|1
4727899|NCT03274466|7667216|FG000|Overall Study|Protocol Violation|3
4727900|NCT03274466|7667217|FG001|Overall Study|Protocol Violation|3
4727901|NCT03274986|7667250|FG000|Overall Study|Withdrawal by Subject|0
4727902|NCT03274986|7667251|FG001|Overall Study|Withdrawal by Subject|1
4727903|NCT03274986|7667250|FG000|Overall Study|Lost to Follow-up|0
4727904|NCT03274986|7667251|FG001|Overall Study|Lost to Follow-up|1
4727905|NCT03275246|7667271|FG000|Overall Study|Protocol Violation|5
4727906|NCT03275246|7667271|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1
4727907|NCT03275389|7667285|FG000|Overall Study|Lost to Follow-up|10
4727908|NCT03275389|7667286|FG001|Overall Study|Lost to Follow-up|10
4727909|NCT03275389|7667287|FG002|Overall Study|Lost to Follow-up|19
4727910|NCT03275389|7667288|FG003|Overall Study|Lost to Follow-up|12
4727911|NCT03275389|7667289|FG004|Overall Study|Lost to Follow-up|11
4727912|NCT03275389|7667290|FG005|Overall Study|Lost to Follow-up|12
4727913|NCT03275389|7667291|FG006|Overall Study|Lost to Follow-up|21
4727914|NCT03275389|7667292|FG007|Overall Study|Lost to Follow-up|15
4727915|NCT03275389|7667293|FG008|Overall Study|Lost to Follow-up|12
4727916|NCT03275389|7667294|FG009|Overall Study|Lost to Follow-up|14
4727917|NCT03275389|7667285|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0
4727918|NCT03275389|7667286|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0
4727919|NCT03275389|7667287|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0
4727920|NCT03275389|7667288|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0
4727921|NCT03275389|7667289|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0
4727922|NCT03275389|7667290|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1
4727923|NCT03275389|7667291|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0
4727924|NCT03275389|7667292|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0
4727925|NCT03275389|7667293|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0
4727926|NCT03275389|7667294|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1
4727927|NCT03275389|7667285|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1
4727928|NCT03275389|7667286|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
4727929|NCT03275389|7667287|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0
4727930|NCT03275389|7667288|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5
4727931|NCT03275389|7667289|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3
4727932|NCT03275389|7667290|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3
4727933|NCT03275389|7667291|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3
4727934|NCT03275389|7667292|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3
4727935|NCT03275389|7667293|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2
4727936|NCT03275389|7667294|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2
4727937|NCT03275389|7667285|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
4727938|NCT03275389|7667286|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2
4727939|NCT03275389|7667287|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
4727940|NCT03275389|7667288|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3
4727941|NCT03275389|7667289|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
4727942|NCT03275389|7667290|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
4727943|NCT03275389|7667291|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1
4727944|NCT03275389|7667292|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
4727945|NCT03275389|7667293|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
4727946|NCT03275389|7667294|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
4727947|NCT03275389|7667285|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
4727948|NCT03275389|7667286|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
4727949|NCT03275389|7667287|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1
4727950|NCT03275389|7667288|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
4727951|NCT03275389|7667289|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
4727952|NCT03275389|7667290|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
4727953|NCT03275389|7667291|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
4727954|NCT03275389|7667292|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
4727955|NCT03275389|7667293|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
4727956|NCT03275389|7667294|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1
4727957|NCT03275389|7667285|FG000|Overall Study|Other|0
4727958|NCT03275389|7667286|FG001|Overall Study|Other|4
4727959|NCT03275389|7667287|FG002|Overall Study|Other|3
4727960|NCT03275389|7667288|FG003|Overall Study|Other|2
4727961|NCT03275389|7667289|FG004|Overall Study|Other|2
4727962|NCT03275389|7667290|FG005|Overall Study|Other|2
4727963|NCT03275389|7667291|FG006|Overall Study|Other|0
4727964|NCT03275389|7667292|FG007|Overall Study|Other|0
4727965|NCT03275389|7667293|FG008|Overall Study|Other|1
4727966|NCT03275389|7667294|FG009|Overall Study|Other|0
4736959|NCT03588572|7686692|FG001|Visitation 2|Lack of Efficacy|1
4736960|NCT03588572|7686691|FG000|Visitation 2|Withdrawal by Subject|1
4736961|NCT03588572|7686692|FG001|Visitation 2|Withdrawal by Subject|0
4736962|NCT03588572|7686691|FG000|Visitation 3|Lost to Follow-up|1
4736963|NCT03588572|7686692|FG001|Visitation 3|Lost to Follow-up|1
4736964|NCT03588572|7686691|FG000|Visitation 3|Physician Decision|1
4736965|NCT03588572|7686692|FG001|Visitation 3|Physician Decision|1
4772198|NCT02733042|7749208|FG016|Follow-up Period|Withdrawal by Subject|0
4772199|NCT02733042|7749209|FG017|Follow-up Period|Withdrawal by Subject|0
4772200|NCT02733042|7749210|FG018|Follow-up Period|Withdrawal by Subject|0
4772201|NCT02574286|7749271|FG000|Overall Study|Adverse Event|3
4772202|NCT02574286|7749271|FG000|Overall Study|Withdrawal by Subject|2
4772203|NCT02471144|7749279|FG000|Induction Period (Up to Week 12)|Adverse Event|0
4772204|NCT02471144|7749280|FG001|Induction Period (Up to Week 12)|Adverse Event|1
4772205|NCT02471144|7749281|FG002|Induction Period (Up to Week 12)|Adverse Event|1
4772206|NCT02471144|7749282|FG003|Induction Period (Up to Week 12)|Adverse Event|0
4772207|NCT02471144|7749283|FG004|Induction Period (Up to Week 12)|Adverse Event|0
4772208|NCT02471144|7749284|FG005|Induction Period (Up to Week 12)|Adverse Event|0
4772209|NCT02471144|7749285|FG006|Induction Period (Up to Week 12)|Adverse Event|0
4772210|NCT02471144|7749286|FG007|Induction Period (Up to Week 12)|Adverse Event|0
4772211|NCT02471144|7749287|FG008|Induction Period (Up to Week 12)|Adverse Event|0
4772212|NCT02471144|7749288|FG009|Induction Period (Up to Week 12)|Adverse Event|0
4772213|NCT02471144|7749289|FG010|Induction Period (Up to Week 12)|Adverse Event|0
4772214|NCT02471144|7749279|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0
4772215|NCT02471144|7749280|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0
4772216|NCT02471144|7749281|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0
4772217|NCT02471144|7749282|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1
4772218|NCT02471144|7749283|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0
4772219|NCT02471144|7749284|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0
4772220|NCT02471144|7749285|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0
4772221|NCT02471144|7749286|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0
4772222|NCT02471144|7749287|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0
4772223|NCT02471144|7749288|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0
4772224|NCT02471144|7749289|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0
4772225|NCT02471144|7749279|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0
4772226|NCT02471144|7749280|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0
4772227|NCT02471144|7749281|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1
4772228|NCT02471144|7749282|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0
4772229|NCT02471144|7749283|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0
4772230|NCT02471144|7749284|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0
4772231|NCT02471144|7749285|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0
4772232|NCT02471144|7749286|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0
4772233|NCT02471144|7749287|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0
4772234|NCT02471144|7749288|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0
4772235|NCT02471144|7749289|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0
4772236|NCT02471144|7749279|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1
4772237|NCT02471144|7749280|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1
4772238|NCT02471144|7749281|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
4772239|NCT02471144|7749282|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
4772240|NCT02471144|7749283|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
4772241|NCT02471144|7749284|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
4772242|NCT02471144|7749285|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
4772243|NCT02471144|7749286|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
4772244|NCT02471144|7749287|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
4772245|NCT02471144|7749288|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
4772246|NCT02471144|7749289|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0
4772247|NCT02471144|7749279|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0
4772248|NCT02471144|7749280|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0
4772249|NCT02471144|7749281|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0
4736966|NCT03588572|7686691|FG000|Visitation 3|Withdrawal by Subject|1
4736967|NCT03588572|7686692|FG001|Visitation 3|Withdrawal by Subject|0
4736968|NCT03588741|7686698|FG000|Overall Study|Withdrawal by Subject|1
4736969|NCT03588910|7686708|FG000|Overall Study|Withdrawal by Subject|1
4736970|NCT03588910|7686709|FG001|Overall Study|Withdrawal by Subject|0
4736971|NCT03588910|7686708|FG000|Overall Study|Allergy|2
4736972|NCT03588910|7686709|FG001|Overall Study|Allergy|0
4736973|NCT03588910|7686708|FG000|Overall Study|Protocol Violation|0
4736974|NCT03588910|7686709|FG001|Overall Study|Protocol Violation|3
4736975|NCT03588910|7686708|FG000|Overall Study|Did not complete Day 1 Survey|5
4727967|NCT03276026|7667348|FG000|Overall Study|Protocol Violation|1
4727968|NCT03276026|7667349|FG001|Overall Study|Protocol Violation|0
4727969|NCT03276078|7667355|FG000|Overall Study|Adverse Event|1
4727970|NCT03276975|7667379|FG000|Overall Study|Withdrawal by Subject|1
4727971|NCT03276975|7667380|FG001|Overall Study|Withdrawal by Subject|0
4727972|NCT03277352|7667399|FG000|Overall Study|Study Terminated By Sponsor|2
4727973|NCT03277352|7667399|FG000|Overall Study|Withdrawal by Subject|4
4727974|NCT03277352|7667399|FG000|Overall Study|Death|4
4727975|NCT03277794|7667419|FG000|Overall Study|Lost to Follow-up|2
4727976|NCT03277794|7667420|FG001|Overall Study|Lost to Follow-up|4
4727977|NCT03277794|7667419|FG000|Overall Study|Withdrew due to high acuity|1
4727978|NCT03277794|7667420|FG001|Overall Study|Withdrew due to high acuity|0
4727979|NCT03277846|7667429|FG000|Overall Study|Inpatient stay too brief|12
4727980|NCT03277846|7667430|FG001|Overall Study|Inpatient stay too brief|11
4727981|NCT03278028|7667438|FG000|Overall Study|Lost to Follow-up|1
4727982|NCT03278028|7667439|FG001|Overall Study|Lost to Follow-up|0
4727983|NCT03278028|7667438|FG000|Overall Study|Withdrawal by Subject|3
4727984|NCT03278028|7667439|FG001|Overall Study|Withdrawal by Subject|1
4727985|NCT03278028|7667438|FG000|Overall Study|Pregnancy|0
4727986|NCT03278028|7667439|FG001|Overall Study|Pregnancy|1
4727987|NCT03278106|7667463|FG000|Overall Study|No protocol treatment|1
4727988|NCT03278613|7667478|FG000|Overall Study|Lost to Follow-up|3
4727989|NCT03278613|7667479|FG001|Overall Study|Lost to Follow-up|1
4727990|NCT03280108|7667517|FG000|Overall Study|Lost to Follow-up|2
4727991|NCT03280108|7667518|FG001|Overall Study|Lost to Follow-up|0
4727992|NCT03280121|7667529|FG000|Overall Study|Physician Decision|1
4727993|NCT03280121|7667529|FG000|Overall Study|Lost to Follow-up|1
4727994|NCT03280121|7667529|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4
4727995|NCT03280264|7667533|FG000|Overall Study|Adverse Event|1
4727996|NCT03280264|7667533|FG000|Overall Study|Physician Decision|1
4727997|NCT03280264|7667533|FG000|Overall Study|Withdrawal by Subject|1
4727998|NCT03280381|7667540|FG000|Overall Study|Physician Decision|0
4727999|NCT03280381|7667541|FG001|Overall Study|Physician Decision|2
4728000|NCT03280537|7667550|FG000|Overall Study|Withdrawal by Subject|2
4728001|NCT03280537|7667551|FG001|Overall Study|Withdrawal by Subject|4
4728002|NCT03280550|7667559|FG000|Overall Study|Withdrawal by Subject|2
4728003|NCT03280550|7667560|FG001|Overall Study|Withdrawal by Subject|2
4728004|NCT03280550|7667559|FG000|Overall Study|Physician Decision|0
4728005|NCT03280550|7667560|FG001|Overall Study|Physician Decision|1
4728006|NCT03280615|7667568|FG000|Overall Study|Lost to Follow-up|1
4728007|NCT03280615|7667569|FG001|Overall Study|Lost to Follow-up|2
4728008|NCT03280615|7667568|FG000|Overall Study|Adverse Event|1
4728009|NCT03280615|7667569|FG001|Overall Study|Adverse Event|1
4728010|NCT03280615|7667568|FG000|Overall Study|Withdrawal by Subject|2
4728011|NCT03280615|7667569|FG001|Overall Study|Withdrawal by Subject|2
4728012|NCT03281304|7667581|FG000|Overall Study|Adverse Event|5
4728013|NCT03281304|7667582|FG001|Overall Study|Adverse Event|2
4728014|NCT03281304|7667581|FG000|Overall Study|Lack of Efficacy|2
4728015|NCT03281304|7667582|FG001|Overall Study|Lack of Efficacy|0
4728016|NCT03281304|7667581|FG000|Overall Study|Pregnancy|1
4728017|NCT03281304|7667582|FG001|Overall Study|Pregnancy|0
4728018|NCT03281304|7667581|FG000|Overall Study|Withdrawal by Subject|5
4728019|NCT03281304|7667582|FG001|Overall Study|Withdrawal by Subject|10
4728020|NCT03281577|7667596|FG000|Overall Study|Adverse Event|0
4728021|NCT03281577|7667597|FG001|Overall Study|Adverse Event|0
4728022|NCT03281577|7667598|FG002|Overall Study|Adverse Event|0
4728023|NCT03281577|7667599|FG003|Overall Study|Adverse Event|1
4728024|NCT03281577|7667596|FG000|Overall Study|Withdrawal by Subject|1
4728025|NCT03281577|7667597|FG001|Overall Study|Withdrawal by Subject|0
4728026|NCT03281577|7667598|FG002|Overall Study|Withdrawal by Subject|0
4728027|NCT03281577|7667599|FG003|Overall Study|Withdrawal by Subject|0
4728028|NCT03281668|7667612|FG000|Overall Study|Physician Decision|1
4728029|NCT03281668|7667612|FG000|Overall Study|scheduling conflict, family circumstance|2
4728030|NCT03281668|7667612|FG000|Overall Study|Withdrawal by Subject|4
4728031|NCT03281668|7667612|FG000|Overall Study|Lost to Follow-up|1
4728032|NCT03281876|7667618|FG000|Overall Study|Adverse Event|4
4728033|NCT03281876|7667619|FG001|Overall Study|Adverse Event|15
4728034|NCT03281876|7667618|FG000|Overall Study|Lost to Follow-up|1
4728035|NCT03281876|7667619|FG001|Overall Study|Lost to Follow-up|4
4728036|NCT03281876|7667618|FG000|Overall Study|Withdrawal by Subject|11
4728037|NCT03281876|7667619|FG001|Overall Study|Withdrawal by Subject|15
4728038|NCT03281876|7667618|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2
4728039|NCT03281876|7667619|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
4728040|NCT03281876|7667618|FG000|Overall Study|OTHER|5
4728041|NCT03281876|7667619|FG001|Overall Study|OTHER|5
4728042|NCT03282227|7667636|FG000|Overall Study|Exposure Goals Achieved|60
4728043|NCT03282227|7667636|FG000|Overall Study|Non-compliance w/ protocol requirements|79
4728044|NCT03282227|7667636|FG000|Overall Study|Adverse Event|15
4728045|NCT03282227|7667636|FG000|Overall Study|Lost to Follow-up|21
4728046|NCT03282227|7667636|FG000|Overall Study|Withdrawal by Subject|20
4728047|NCT03282227|7667636|FG000|Overall Study|Lack of Efficacy|12
4728048|NCT03282227|7667636|FG000|Overall Study|Sponsor decision|3
4728049|NCT03282227|7667636|FG000|Overall Study|Physician Decision|2
4728050|NCT03282227|7667636|FG000|Overall Study|Pregnancy|2
4728051|NCT03282227|7667636|FG000|Overall Study|Other|1
4728052|NCT03282357|7667640|FG000|Overall Study|Lost to Follow-up|3
4728053|NCT03282357|7667640|FG000|Overall Study|Withdrawal by Subject|4
4728054|NCT03282357|7667640|FG000|Overall Study|Adverse Event|1
4728055|NCT03282357|7667640|FG000|Overall Study|Other|9
4728056|NCT03283098|7667670|FG000|Overall Study|Withdrawal by Subject|0
4728057|NCT03283098|7667671|FG001|Overall Study|Withdrawal by Subject|1
4728058|NCT03283319|7667683|FG000|Overall Study|Lost to Follow-up|5
4728059|NCT03283319|7667684|FG001|Overall Study|Lost to Follow-up|4
4728060|NCT03283319|7667685|FG002|Overall Study|Lost to Follow-up|5
4728061|NCT03283319|7667686|FG003|Overall Study|Lost to Follow-up|5
4728062|NCT03283319|7667687|FG004|Overall Study|Lost to Follow-up|4
4728063|NCT03283319|7667688|FG005|Overall Study|Lost to Follow-up|3
4728064|NCT03283319|7667683|FG000|Overall Study|Withdrawal by Subject|2
4728065|NCT03283319|7667684|FG001|Overall Study|Withdrawal by Subject|2
4728066|NCT03283319|7667685|FG002|Overall Study|Withdrawal by Subject|2
4728067|NCT03283319|7667686|FG003|Overall Study|Withdrawal by Subject|1
4728068|NCT03283319|7667687|FG004|Overall Study|Withdrawal by Subject|0
4728069|NCT03283319|7667688|FG005|Overall Study|Withdrawal by Subject|1
4728070|NCT03283319|7667683|FG000|Overall Study|BARDA regulatory agency or IRB decision|0
4728071|NCT03283319|7667684|FG001|Overall Study|BARDA regulatory agency or IRB decision|0
4728072|NCT03283319|7667685|FG002|Overall Study|BARDA regulatory agency or IRB decision|0
4728073|NCT03283319|7667686|FG003|Overall Study|BARDA regulatory agency or IRB decision|1
4728074|NCT03283319|7667687|FG004|Overall Study|BARDA regulatory agency or IRB decision|0
4728075|NCT03283319|7667688|FG005|Overall Study|BARDA regulatory agency or IRB decision|0
4728076|NCT03283553|7667713|FG000|Patient Participant Flow|Death|5
4728077|NCT03283553|7667714|FG001|Patient Participant Flow|Death|10
4728078|NCT03283553|7667713|FG000|Patient Participant Flow|Withdrawal by Subject|4
4728079|NCT03283553|7667714|FG001|Patient Participant Flow|Withdrawal by Subject|2
4728080|NCT03283553|7667713|FG000|Patient Participant Flow|Lost to Follow-up|1
4728081|NCT03283553|7667714|FG001|Patient Participant Flow|Lost to Follow-up|1
4728082|NCT03283553|7667713|FG000|Care Partner Participant Flow|Withdrawal by Subject|4
4728083|NCT03283553|7667714|FG001|Care Partner Participant Flow|Withdrawal by Subject|3
4728084|NCT03283553|7667713|FG000|Care Partner Participant Flow|Lost to Follow-up|1
4728085|NCT03283553|7667714|FG001|Care Partner Participant Flow|Lost to Follow-up|1
4728086|NCT03283553|7667713|FG000|Care Partner Participant Flow|Discontinued because patient death|5
4728087|NCT03283553|7667714|FG001|Care Partner Participant Flow|Discontinued because patient death|11
4728088|NCT03283696|7667724|FG000|Overall Study|Physician Decision|5
4728089|NCT03283696|7667725|FG001|Overall Study|Physician Decision|6
4728090|NCT03283696|7667724|FG000|Overall Study|Withdrawal by Subject|2
4728091|NCT03283696|7667725|FG001|Overall Study|Withdrawal by Subject|0
4728092|NCT03284229|7667747|FG000|Overall Study|Lost to Follow-up|3
4728093|NCT03284424|7667783|FG000|Overall Study|Death|56
4728094|NCT03284424|7667784|FG001|Overall Study|Death|13
4728095|NCT03284424|7667783|FG000|Overall Study|Lost to Follow-up|1
4728096|NCT03284424|7667784|FG001|Overall Study|Lost to Follow-up|0
4728097|NCT03284424|7667783|FG000|Overall Study|Physician Decision|1
4728098|NCT03284424|7667784|FG001|Overall Study|Physician Decision|0
4728099|NCT03284424|7667783|FG000|Overall Study|Withdrawal by Subject|3
4728100|NCT03284424|7667784|FG001|Overall Study|Withdrawal by Subject|2
4728101|NCT03284424|7667783|FG000|Overall Study|Ongoing in study|44
4728102|NCT03284424|7667784|FG001|Overall Study|Ongoing in study|39
4728103|NCT03284710|7667793|FG000|Overall Study|Withdrawal by Subject|1
4728104|NCT03284710|7667794|FG001|Overall Study|Withdrawal by Subject|0
4728105|NCT03284710|7667795|FG002|Overall Study|Withdrawal by Subject|1
4728106|NCT03284710|7667796|FG003|Overall Study|Withdrawal by Subject|6
4728107|NCT03284710|7667793|FG000|Overall Study|Lost to Follow-up|3
4728108|NCT03284710|7667794|FG001|Overall Study|Lost to Follow-up|3
4728109|NCT03284710|7667795|FG002|Overall Study|Lost to Follow-up|1
4728110|NCT03284710|7667796|FG003|Overall Study|Lost to Follow-up|0
4728111|NCT03284710|7667793|FG000|Overall Study|Physician Decision|1
4728112|NCT03284710|7667794|FG001|Overall Study|Physician Decision|0
4728113|NCT03284710|7667795|FG002|Overall Study|Physician Decision|0
4728114|NCT03284710|7667796|FG003|Overall Study|Physician Decision|0
4728115|NCT03284710|7667793|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1
4728116|NCT03284710|7667794|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0
4728117|NCT03284710|7667795|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0
4728118|NCT03284710|7667796|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1
4728119|NCT03284710|7667793|FG000|Overall Study|HIV Infection|0
4728120|NCT03284710|7667794|FG001|Overall Study|HIV Infection|2
4728121|NCT03284710|7667795|FG002|Overall Study|HIV Infection|2
4728122|NCT03284710|7667796|FG003|Overall Study|HIV Infection|1
4728123|NCT03285113|7667820|FG000|Overall Study|Unable to implant leads|2
4728124|NCT03285295|7667829|FG000|Alinity s HBsAg|Protocol Violation|11
4728125|NCT03285295|7667830|FG001|Alinity s HBsAg|Protocol Violation|0
4728126|NCT03285295|7667831|FG002|Alinity s HBsAg|Protocol Violation|0
4728127|NCT03285295|7667832|FG003|Alinity s HBsAg|Protocol Violation|0
4728128|NCT03285295|7667833|FG004|Alinity s HBsAg|Protocol Violation|0
4728129|NCT03285295|7667829|FG000|Alinity s HBsAg|No Result on Comparator Assay|17
4728130|NCT03285295|7667830|FG001|Alinity s HBsAg|No Result on Comparator Assay|0
4728131|NCT03285295|7667831|FG002|Alinity s HBsAg|No Result on Comparator Assay|0
4728132|NCT03285295|7667832|FG003|Alinity s HBsAg|No Result on Comparator Assay|0
4728133|NCT03285295|7667833|FG004|Alinity s HBsAg|No Result on Comparator Assay|0
4728134|NCT03285295|7667829|FG000|Alinity s HBsAg|No Results Generated|74
4728135|NCT03285295|7667830|FG001|Alinity s HBsAg|No Results Generated|6
4728136|NCT03285295|7667831|FG002|Alinity s HBsAg|No Results Generated|0
4728137|NCT03285295|7667832|FG003|Alinity s HBsAg|No Results Generated|0
4728138|NCT03285295|7667833|FG004|Alinity s HBsAg|No Results Generated|0
4728139|NCT03285295|7667829|FG000|Alinity s HTLV I/II|Protocol Violation|6
4728140|NCT03285295|7667830|FG001|Alinity s HTLV I/II|Protocol Violation|0
4728141|NCT03285295|7667831|FG002|Alinity s HTLV I/II|Protocol Violation|0
4728142|NCT03285295|7667832|FG003|Alinity s HTLV I/II|Protocol Violation|0
4728143|NCT03285295|7667833|FG004|Alinity s HTLV I/II|Protocol Violation|0
4728144|NCT03285295|7667829|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15
4728145|NCT03285295|7667830|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0
4728146|NCT03285295|7667831|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0
4728147|NCT03285295|7667832|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0
4728148|NCT03285295|7667833|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0
4728149|NCT03285295|7667829|FG000|Alinity s HTLV I/II|No Results Generated|70
4728150|NCT03285295|7667830|FG001|Alinity s HTLV I/II|No Results Generated|0
4728151|NCT03285295|7667831|FG002|Alinity s HTLV I/II|No Results Generated|0
4728152|NCT03285295|7667832|FG003|Alinity s HTLV I/II|No Results Generated|0
4728153|NCT03285295|7667833|FG004|Alinity s HTLV I/II|No Results Generated|0
4728154|NCT03285295|7667829|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4
4728155|NCT03285295|7667830|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
4728156|NCT03285295|7667831|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
4728157|NCT03285295|7667832|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
4728158|NCT03285295|7667833|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
4728159|NCT03285295|7667829|FG000|Alinity s Anti-HCV|Protocol Violation|12
4728160|NCT03285295|7667830|FG001|Alinity s Anti-HCV|Protocol Violation|0
4728161|NCT03285295|7667831|FG002|Alinity s Anti-HCV|Protocol Violation|0
4728162|NCT03285295|7667832|FG003|Alinity s Anti-HCV|Protocol Violation|0
4728163|NCT03285295|7667833|FG004|Alinity s Anti-HCV|Protocol Violation|0
4728164|NCT03285295|7667829|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13
4728165|NCT03285295|7667830|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0
4728166|NCT03285295|7667831|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0
4728167|NCT03285295|7667832|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0
4728168|NCT03285295|7667833|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0
4728169|NCT03285295|7667829|FG000|Alinity s Anti-HCV|No Results Generated|71
4728170|NCT03285295|7667830|FG001|Alinity s Anti-HCV|No Results Generated|0
4728171|NCT03285295|7667831|FG002|Alinity s Anti-HCV|No Results Generated|0
4728172|NCT03285295|7667832|FG003|Alinity s Anti-HCV|No Results Generated|0
4728173|NCT03285295|7667833|FG004|Alinity s Anti-HCV|No Results Generated|0
4728174|NCT03285295|7667829|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18
4728175|NCT03285295|7667830|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
4728176|NCT03285295|7667831|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
4728177|NCT03285295|7667832|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
4728178|NCT03285295|7667833|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
4728179|NCT03285295|7667829|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11
4728180|NCT03285295|7667830|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
4728181|NCT03285295|7667831|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
4728182|NCT03285295|7667832|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
4728183|NCT03285295|7667833|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
4728184|NCT03285295|7667829|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16
4728185|NCT03285295|7667830|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
4728186|NCT03285295|7667831|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
4728187|NCT03285295|7667832|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
4728188|NCT03285295|7667833|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
4728189|NCT03285295|7667829|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72
4728190|NCT03285295|7667830|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0
4728191|NCT03285295|7667831|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0
4728192|NCT03285295|7667832|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0
4728193|NCT03285295|7667833|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0
4728194|NCT03285295|7667829|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11
4728195|NCT03285295|7667830|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
4728196|NCT03285295|7667831|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
4728197|NCT03285295|7667832|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
4728198|NCT03285295|7667833|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
4728199|NCT03285295|7667829|FG000|Alinity s Anti-HBc|Protocol Violation|8
4728200|NCT03285295|7667830|FG001|Alinity s Anti-HBc|Protocol Violation|0
4630933|NCT01888497|7499970|FG000|Washout Period 2|Adverse Event|0
4630934|NCT01888497|7499971|FG001|Washout Period 2|Adverse Event|0
4630935|NCT01888497|7499972|FG002|Washout Period 2|Adverse Event|0
4728201|NCT03285295|7667831|FG002|Alinity s Anti-HBc|Protocol Violation|0
4728202|NCT03285295|7667832|FG003|Alinity s Anti-HBc|Protocol Violation|0
4728203|NCT03285295|7667833|FG004|Alinity s Anti-HBc|Protocol Violation|0
4728204|NCT03285295|7667829|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13
4728205|NCT03285295|7667830|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1
4728206|NCT03285295|7667831|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0
4728207|NCT03285295|7667832|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0
4728208|NCT03285295|7667833|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0
4728209|NCT03285295|7667829|FG000|Alinity s Anti-HBc|No Results Generated|70
4728210|NCT03285295|7667830|FG001|Alinity s Anti-HBc|No Results Generated|0
4728211|NCT03285295|7667831|FG002|Alinity s Anti-HBc|No Results Generated|0
4728212|NCT03285295|7667832|FG003|Alinity s Anti-HBc|No Results Generated|0
4728213|NCT03285295|7667833|FG004|Alinity s Anti-HBc|No Results Generated|0
4728214|NCT03285295|7667829|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14
4728215|NCT03285295|7667830|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
4728216|NCT03285295|7667831|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
4728217|NCT03285295|7667832|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
4728218|NCT03285295|7667833|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
4728219|NCT03285295|7667829|FG000|Alinity s Chagas|Protocol Violation|76
4728220|NCT03285295|7667830|FG001|Alinity s Chagas|Protocol Violation|0
4728221|NCT03285295|7667831|FG002|Alinity s Chagas|Protocol Violation|0
4728222|NCT03285295|7667832|FG003|Alinity s Chagas|Protocol Violation|0
4728223|NCT03285295|7667833|FG004|Alinity s Chagas|Protocol Violation|0
4728224|NCT03285295|7667829|FG000|Alinity s Chagas|No Results on Comparator Assay|38
4728225|NCT03285295|7667830|FG001|Alinity s Chagas|No Results on Comparator Assay|0
4728226|NCT03285295|7667831|FG002|Alinity s Chagas|No Results on Comparator Assay|0
4728227|NCT03285295|7667832|FG003|Alinity s Chagas|No Results on Comparator Assay|0
4728228|NCT03285295|7667833|FG004|Alinity s Chagas|No Results on Comparator Assay|0
4728229|NCT03285295|7667829|FG000|Alinity s Chagas|No Results Generated|105
4728230|NCT03285295|7667830|FG001|Alinity s Chagas|No Results Generated|0
4728231|NCT03285295|7667831|FG002|Alinity s Chagas|No Results Generated|0
4728232|NCT03285295|7667832|FG003|Alinity s Chagas|No Results Generated|0
4728233|NCT03285295|7667833|FG004|Alinity s Chagas|No Results Generated|0
4728234|NCT03285295|7667829|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13
4728235|NCT03285295|7667830|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0
4728236|NCT03285295|7667831|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0
4728237|NCT03285295|7667832|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0
4728238|NCT03285295|7667833|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0
4728239|NCT03285308|7667864|FG000|Overall Study|Adverse Event|3
4728240|NCT03285308|7667865|FG001|Overall Study|Adverse Event|7
4728241|NCT03285308|7667864|FG000|Overall Study|Withdrawal by Subject|8
4728242|NCT03285308|7667865|FG001|Overall Study|Withdrawal by Subject|9
4728243|NCT03285308|7667864|FG000|Overall Study|Lost to Follow-up|3
4728244|NCT03285308|7667865|FG001|Overall Study|Lost to Follow-up|1
4728245|NCT03285308|7667864|FG000|Overall Study|Protocol Deviation|6
4728246|NCT03285308|7667865|FG001|Overall Study|Protocol Deviation|5
4728247|NCT03285308|7667864|FG000|Overall Study|Reason not Specified|0
4728248|NCT03285308|7667865|FG001|Overall Study|Reason not Specified|1
4728249|NCT03285477|7667886|FG000|Treatment and Response Assessment Period|Death|1
4728250|NCT03285477|7667887|FG001|Treatment and Response Assessment Period|Death|0
4728251|NCT03285477|7667886|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1
4728252|NCT03285477|7667887|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0
4728253|NCT03285477|7667886|FG000|Recurrence Follow-up Period|Lost to Follow-up|0
4728254|NCT03285477|7667887|FG001|Recurrence Follow-up Period|Lost to Follow-up|1
4728255|NCT03285477|7667886|FG000|Recurrence Follow-up Period|Withdrawal of consent|1
4728256|NCT03285477|7667887|FG001|Recurrence Follow-up Period|Withdrawal of consent|3
4728257|NCT03285477|7667886|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5
4728258|NCT03285477|7667887|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51
4728259|NCT03285490|7667896|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0
4728260|NCT03285490|7667897|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1
4728261|NCT03285490|7667896|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18
4728262|NCT03285490|7667897|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60
4728263|NCT03285594|7667934|FG000|Overall Study|At the Participant's Own Request|10
4728264|NCT03285594|7667935|FG001|Overall Study|At the Participant's Own Request|5
4728265|NCT03285594|7667936|FG002|Overall Study|At the Participant's Own Request|21
4728266|NCT03285594|7667934|FG000|Overall Study|Adverse Event|2
4728267|NCT03285594|7667935|FG001|Overall Study|Adverse Event|2
4728268|NCT03285594|7667936|FG002|Overall Study|Adverse Event|6
4728269|NCT03285594|7667934|FG000|Overall Study|Poor Compliance to Protocol|0
4728270|NCT03285594|7667935|FG001|Overall Study|Poor Compliance to Protocol|0
4728271|NCT03285594|7667936|FG002|Overall Study|Poor Compliance to Protocol|1
4728272|NCT03285594|7667934|FG000|Overall Study|Lost to Follow-up|0
4728273|NCT03285594|7667935|FG001|Overall Study|Lost to Follow-up|0
4728274|NCT03285594|7667936|FG002|Overall Study|Lost to Follow-up|1
4728275|NCT03285594|7667934|FG000|Overall Study|Reason Not Specified|3
4728276|NCT03285594|7667935|FG001|Overall Study|Reason Not Specified|4
4728277|NCT03285594|7667936|FG002|Overall Study|Reason Not Specified|8
4728278|NCT03285646|7667947|FG000|Overall Study|Adverse Event|1
4728279|NCT03285646|7667948|FG001|Overall Study|Adverse Event|0
4728280|NCT03285646|7667947|FG000|Overall Study|Withdrawal by Subject|10
4728281|NCT03285646|7667948|FG001|Overall Study|Withdrawal by Subject|2
4772250|NCT02471144|7749282|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0
4728282|NCT03285646|7667947|FG000|Overall Study|Lost to Follow-up|2
4728283|NCT03285646|7667948|FG001|Overall Study|Lost to Follow-up|1
4728284|NCT03285646|7667947|FG000|Overall Study|Investigator/Sponsor Decision|0
4728285|NCT03285646|7667948|FG001|Overall Study|Investigator/Sponsor Decision|1
4728286|NCT03285711|7667957|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2
4728287|NCT03285711|7667958|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1
4728288|NCT03285711|7667959|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0
4728289|NCT03285711|7667960|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0
4728290|NCT03285711|7667957|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1
4728291|NCT03285711|7667958|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0
4728292|NCT03285711|7667959|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0
4728293|NCT03285711|7667960|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0
4728294|NCT03285711|7667957|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0
4728295|NCT03285711|7667958|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0
4728296|NCT03285711|7667959|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1
4728297|NCT03285711|7667960|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0
4728298|NCT03285711|7667957|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0
4728299|NCT03285711|7667958|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1
4728300|NCT03285711|7667959|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0
4728301|NCT03285711|7667960|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0
4728302|NCT03285958|7667976|FG000|Overall Study|Lost to Follow-up|1
4728303|NCT03285958|7667977|FG001|Overall Study|Lost to Follow-up|1
4728304|NCT03285958|7667976|FG000|Overall Study|Withdrawal by Subject|1
4728305|NCT03285958|7667977|FG001|Overall Study|Withdrawal by Subject|0
4728306|NCT03285958|7667976|FG000|Overall Study|Not able to attend required orientation|3
4728307|NCT03285958|7667977|FG001|Overall Study|Not able to attend required orientation|0
4728308|NCT03286218|7667996|FG000|Qualification Phase Period 1|Adverse Event|1
4728309|NCT03286218|7667997|FG001|Qualification Phase Period 1|Adverse Event|0
4728310|NCT03286218|7667998|FG002|Qualification Phase Period 1|Adverse Event|0
4728311|NCT03286218|7667999|FG003|Qualification Phase Period 1|Adverse Event|0
4728312|NCT03286218|7668000|FG004|Qualification Phase Period 1|Adverse Event|0
4728313|NCT03286218|7668001|FG005|Qualification Phase Period 1|Adverse Event|0
4728314|NCT03286218|7668002|FG006|Qualification Phase Period 1|Adverse Event|0
4728315|NCT03286218|7668003|FG007|Qualification Phase Period 1|Adverse Event|0
4728316|NCT03286218|7668004|FG008|Qualification Phase Period 1|Adverse Event|0
4728317|NCT03286218|7668005|FG009|Qualification Phase Period 1|Adverse Event|0
4728318|NCT03286218|7668006|FG010|Qualification Phase Period 1|Adverse Event|0
4728319|NCT03286218|7668007|FG011|Qualification Phase Period 1|Adverse Event|0
4728320|NCT03286218|7667996|FG000|Qualification Phase Period 1|Withdrawal by Subject|0
4728321|NCT03286218|7667997|FG001|Qualification Phase Period 1|Withdrawal by Subject|1
4728322|NCT03286218|7667998|FG002|Qualification Phase Period 1|Withdrawal by Subject|0
4728323|NCT03286218|7667999|FG003|Qualification Phase Period 1|Withdrawal by Subject|0
4728324|NCT03286218|7668000|FG004|Qualification Phase Period 1|Withdrawal by Subject|0
4728325|NCT03286218|7668001|FG005|Qualification Phase Period 1|Withdrawal by Subject|0
4728326|NCT03286218|7668002|FG006|Qualification Phase Period 1|Withdrawal by Subject|0
4728327|NCT03286218|7668003|FG007|Qualification Phase Period 1|Withdrawal by Subject|0
4728328|NCT03286218|7668004|FG008|Qualification Phase Period 1|Withdrawal by Subject|0
4728329|NCT03286218|7668005|FG009|Qualification Phase Period 1|Withdrawal by Subject|0
4728330|NCT03286218|7668006|FG010|Qualification Phase Period 1|Withdrawal by Subject|0
4728331|NCT03286218|7668007|FG011|Qualification Phase Period 1|Withdrawal by Subject|0
4728332|NCT03286218|7667996|FG000|Qualification Phase Period 2|Adverse Event|0
4728333|NCT03286218|7667997|FG001|Qualification Phase Period 2|Adverse Event|1
4728334|NCT03286218|7667998|FG002|Qualification Phase Period 2|Adverse Event|0
4728335|NCT03286218|7667999|FG003|Qualification Phase Period 2|Adverse Event|0
4728336|NCT03286218|7668000|FG004|Qualification Phase Period 2|Adverse Event|0
4728337|NCT03286218|7668001|FG005|Qualification Phase Period 2|Adverse Event|0
4728338|NCT03286218|7668002|FG006|Qualification Phase Period 2|Adverse Event|0
4728339|NCT03286218|7668003|FG007|Qualification Phase Period 2|Adverse Event|0
4728340|NCT03286218|7668004|FG008|Qualification Phase Period 2|Adverse Event|0
4728341|NCT03286218|7668005|FG009|Qualification Phase Period 2|Adverse Event|0
4728342|NCT03286218|7668006|FG010|Qualification Phase Period 2|Adverse Event|0
4728343|NCT03286218|7668007|FG011|Qualification Phase Period 2|Adverse Event|0
4728344|NCT03286218|7667996|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14
4728345|NCT03286218|7667997|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15
4728346|NCT03286218|7667998|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0
4728347|NCT03286218|7667999|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0
4728348|NCT03286218|7668000|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0
4728349|NCT03286218|7668001|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0
4728350|NCT03286218|7668002|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0
4728351|NCT03286218|7668003|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0
4728352|NCT03286218|7668004|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0
4515266|NCT00952289|7326014|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0
4728353|NCT03286218|7668005|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0
4728354|NCT03286218|7668006|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0
4728355|NCT03286218|7668007|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0
4728356|NCT03286218|7667996|FG000|Qualification Phase Period 2|Lost to Follow-up|0
4728357|NCT03286218|7667997|FG001|Qualification Phase Period 2|Lost to Follow-up|1
4728358|NCT03286218|7667998|FG002|Qualification Phase Period 2|Lost to Follow-up|0
4728359|NCT03286218|7667999|FG003|Qualification Phase Period 2|Lost to Follow-up|0
4728360|NCT03286218|7668000|FG004|Qualification Phase Period 2|Lost to Follow-up|0
4728361|NCT03286218|7668001|FG005|Qualification Phase Period 2|Lost to Follow-up|0
4728362|NCT03286218|7668002|FG006|Qualification Phase Period 2|Lost to Follow-up|0
4728363|NCT03286218|7668003|FG007|Qualification Phase Period 2|Lost to Follow-up|0
4728364|NCT03286218|7668004|FG008|Qualification Phase Period 2|Lost to Follow-up|0
4728365|NCT03286218|7668005|FG009|Qualification Phase Period 2|Lost to Follow-up|0
4728366|NCT03286218|7668006|FG010|Qualification Phase Period 2|Lost to Follow-up|0
4728367|NCT03286218|7668007|FG011|Qualification Phase Period 2|Lost to Follow-up|0
4728368|NCT03286218|7667996|FG000|Qualification Phase Period 2|Protocol Violation|2
4728369|NCT03286218|7667997|FG001|Qualification Phase Period 2|Protocol Violation|0
4728370|NCT03286218|7667998|FG002|Qualification Phase Period 2|Protocol Violation|0
4728371|NCT03286218|7667999|FG003|Qualification Phase Period 2|Protocol Violation|0
4728372|NCT03286218|7668000|FG004|Qualification Phase Period 2|Protocol Violation|0
4728373|NCT03286218|7668001|FG005|Qualification Phase Period 2|Protocol Violation|0
4728374|NCT03286218|7668002|FG006|Qualification Phase Period 2|Protocol Violation|0
4728375|NCT03286218|7668003|FG007|Qualification Phase Period 2|Protocol Violation|0
4728376|NCT03286218|7668004|FG008|Qualification Phase Period 2|Protocol Violation|0
4728377|NCT03286218|7668005|FG009|Qualification Phase Period 2|Protocol Violation|0
4728378|NCT03286218|7668006|FG010|Qualification Phase Period 2|Protocol Violation|0
4728379|NCT03286218|7668007|FG011|Qualification Phase Period 2|Protocol Violation|0
4728380|NCT03286218|7667996|FG000|Qualification Phase Period 2|Withdrawal by Subject|1
4728381|NCT03286218|7667997|FG001|Qualification Phase Period 2|Withdrawal by Subject|2
4728382|NCT03286218|7667998|FG002|Qualification Phase Period 2|Withdrawal by Subject|0
4728383|NCT03286218|7667999|FG003|Qualification Phase Period 2|Withdrawal by Subject|0
4728384|NCT03286218|7668000|FG004|Qualification Phase Period 2|Withdrawal by Subject|0
4728385|NCT03286218|7668001|FG005|Qualification Phase Period 2|Withdrawal by Subject|0
4728386|NCT03286218|7668002|FG006|Qualification Phase Period 2|Withdrawal by Subject|0
4728387|NCT03286218|7668003|FG007|Qualification Phase Period 2|Withdrawal by Subject|0
4728388|NCT03286218|7668004|FG008|Qualification Phase Period 2|Withdrawal by Subject|0
4728389|NCT03286218|7668005|FG009|Qualification Phase Period 2|Withdrawal by Subject|0
4728390|NCT03286218|7668006|FG010|Qualification Phase Period 2|Withdrawal by Subject|0
4728391|NCT03286218|7668007|FG011|Qualification Phase Period 2|Withdrawal by Subject|0
4728392|NCT03286218|7667996|FG000|Treatment Phase Period 1|Withdrawal by Subject|0
4728393|NCT03286218|7667997|FG001|Treatment Phase Period 1|Withdrawal by Subject|0
4728394|NCT03286218|7667998|FG002|Treatment Phase Period 1|Withdrawal by Subject|1
4728395|NCT03286218|7667999|FG003|Treatment Phase Period 1|Withdrawal by Subject|1
4728396|NCT03286218|7668000|FG004|Treatment Phase Period 1|Withdrawal by Subject|0
4728397|NCT03286218|7668001|FG005|Treatment Phase Period 1|Withdrawal by Subject|1
4728398|NCT03286218|7668002|FG006|Treatment Phase Period 1|Withdrawal by Subject|0
4728399|NCT03286218|7668003|FG007|Treatment Phase Period 1|Withdrawal by Subject|0
4728400|NCT03286218|7668004|FG008|Treatment Phase Period 1|Withdrawal by Subject|0
4728401|NCT03286218|7668005|FG009|Treatment Phase Period 1|Withdrawal by Subject|0
4728402|NCT03286218|7668006|FG010|Treatment Phase Period 1|Withdrawal by Subject|0
4728403|NCT03286218|7668007|FG011|Treatment Phase Period 1|Withdrawal by Subject|1
4728404|NCT03286218|7667996|FG000|Treatment Phase Period 4|Withdrawal by Subject|0
4728405|NCT03286218|7667997|FG001|Treatment Phase Period 4|Withdrawal by Subject|0
4728406|NCT03286218|7667998|FG002|Treatment Phase Period 4|Withdrawal by Subject|0
4728407|NCT03286218|7667999|FG003|Treatment Phase Period 4|Withdrawal by Subject|0
4728408|NCT03286218|7668000|FG004|Treatment Phase Period 4|Withdrawal by Subject|0
4728409|NCT03286218|7668001|FG005|Treatment Phase Period 4|Withdrawal by Subject|0
4728410|NCT03286218|7668002|FG006|Treatment Phase Period 4|Withdrawal by Subject|0
4728411|NCT03286218|7668003|FG007|Treatment Phase Period 4|Withdrawal by Subject|0
4728412|NCT03286218|7668004|FG008|Treatment Phase Period 4|Withdrawal by Subject|0
4728413|NCT03286218|7668005|FG009|Treatment Phase Period 4|Withdrawal by Subject|0
4728414|NCT03286218|7668006|FG010|Treatment Phase Period 4|Withdrawal by Subject|0
4728415|NCT03286218|7668007|FG011|Treatment Phase Period 4|Withdrawal by Subject|1
4728416|NCT03286400|7668038|FG000|Overall Study|Death|10
4728417|NCT03286400|7668038|FG000|Overall Study|Lost to Follow-up|10
4728418|NCT03286400|7668038|FG000|Overall Study|Physician Decision|1
4728419|NCT03286400|7668038|FG000|Overall Study|Scheduling difficulty|4
4728420|NCT03286543|7668053|FG000|Consented|Screen failure before randomization|2
4728421|NCT03286543|7668054|FG001|Consented|Screen failure before randomization|0
4728422|NCT03286543|7668055|FG002|Consented|Screen failure before randomization|0
4728423|NCT03286543|7668053|FG000|Consented|Screen failure before enrollment|4
4728424|NCT03286543|7668054|FG001|Consented|Screen failure before enrollment|0
4728425|NCT03286543|7668055|FG002|Consented|Screen failure before enrollment|0
4728426|NCT03286543|7668053|FG000|Consented|TKA cancelled after enrollment|1
4728427|NCT03286543|7668054|FG001|Consented|TKA cancelled after enrollment|0
4728428|NCT03286543|7668055|FG002|Consented|TKA cancelled after enrollment|0
4728429|NCT03286543|7668053|FG000|Consented|Withdrawn from study|12
4728430|NCT03286543|7668054|FG001|Consented|Withdrawn from study|0
4728431|NCT03286543|7668055|FG002|Consented|Withdrawn from study|0
4728432|NCT03286543|7668053|FG000|Study Enrollment|TKA cancelled after enrollment|0
4728433|NCT03286543|7668054|FG001|Study Enrollment|TKA cancelled after enrollment|0
4728434|NCT03286543|7668055|FG002|Study Enrollment|TKA cancelled after enrollment|1
4728435|NCT03286543|7668053|FG000|Study Enrollment|Withdrawn from study|0
4728436|NCT03286543|7668054|FG001|Study Enrollment|Withdrawn from study|6
4728437|NCT03286543|7668055|FG002|Study Enrollment|Withdrawn from study|6
4728438|NCT03286751|7668061|FG000|Washout Period 1|Withdrawal by Subject|0
4728439|NCT03286751|7668062|FG001|Washout Period 1|Withdrawal by Subject|0
4728440|NCT03286751|7668063|FG002|Washout Period 1|Withdrawal by Subject|0
4728441|NCT03286751|7668064|FG003|Washout Period 1|Withdrawal by Subject|0
4728442|NCT03286751|7668065|FG004|Washout Period 1|Withdrawal by Subject|1
4728443|NCT03286751|7668066|FG005|Washout Period 1|Withdrawal by Subject|0
4728444|NCT03286751|7668061|FG000|Washout Period 2|Personal Reasons|0
4728445|NCT03286751|7668062|FG001|Washout Period 2|Personal Reasons|1
4728446|NCT03286751|7668063|FG002|Washout Period 2|Personal Reasons|0
4728447|NCT03286751|7668064|FG003|Washout Period 2|Personal Reasons|0
4728448|NCT03286751|7668065|FG004|Washout Period 2|Personal Reasons|0
4728449|NCT03286751|7668066|FG005|Washout Period 2|Personal Reasons|0
4728450|NCT03286751|7668061|FG000|Washout Period 5|Adverse Event|0
4728451|NCT03286751|7668062|FG001|Washout Period 5|Adverse Event|0
4728452|NCT03286751|7668063|FG002|Washout Period 5|Adverse Event|0
4728453|NCT03286751|7668064|FG003|Washout Period 5|Adverse Event|0
4728454|NCT03286751|7668065|FG004|Washout Period 5|Adverse Event|1
4728455|NCT03286751|7668066|FG005|Washout Period 5|Adverse Event|0
4728456|NCT03287219|7668101|FG000|Overall Study|Protocol Violation|0
4728457|NCT03287219|7668102|FG001|Overall Study|Protocol Violation|2
4728458|NCT03287622|7668176|FG000|Overall Study|Withdrawal by Subject|1
4728459|NCT03287622|7668177|FG001|Overall Study|Withdrawal by Subject|0
4728460|NCT03287622|7668176|FG000|Overall Study|Lost to Follow-up|27
4728461|NCT03287622|7668177|FG001|Overall Study|Lost to Follow-up|15
4728462|NCT03287622|7668176|FG000|Overall Study|No prescripion after surgery|28
4728463|NCT03287622|7668177|FG001|Overall Study|No prescripion after surgery|31
4728464|NCT03287622|7668176|FG000|Overall Study|prolonged Length of stay|2
4728465|NCT03287622|7668177|FG001|Overall Study|prolonged Length of stay|0
4728466|NCT03287622|7668176|FG000|Overall Study|surgery related|0
4728467|NCT03287622|7668177|FG001|Overall Study|surgery related|2
4728468|NCT03287635|7668190|FG000|Overall Study|Lost to Follow-up|5
4728469|NCT03287635|7668190|FG000|Overall Study|Withdrawal by Subject|1
4728470|NCT03287635|7668190|FG000|Overall Study|Physician Decision|1
4728471|NCT03287791|7668202|FG000|Overall Study|Insufficient Therapeutic Response|0
4728472|NCT03287791|7668203|FG001|Overall Study|Insufficient Therapeutic Response|0
4728473|NCT03287791|7668204|FG002|Overall Study|Insufficient Therapeutic Response|1
4728474|NCT03287791|7668202|FG000|Overall Study|Adverse Event|0
4728475|NCT03287791|7668203|FG001|Overall Study|Adverse Event|4
4728476|NCT03287791|7668204|FG002|Overall Study|Adverse Event|3
4728477|NCT03287791|7668202|FG000|Overall Study|Withdrawal by Subject|12
4728478|NCT03287791|7668203|FG001|Overall Study|Withdrawal by Subject|12
4728479|NCT03287791|7668204|FG002|Overall Study|Withdrawal by Subject|17
4728480|NCT03287791|7668202|FG000|Overall Study|Missed more than 6 consecutive doses|3
4728481|NCT03287791|7668203|FG001|Overall Study|Missed more than 6 consecutive doses|2
4728482|NCT03287791|7668204|FG002|Overall Study|Missed more than 6 consecutive doses|2
4728483|NCT03287791|7668202|FG000|Overall Study|Lost to Follow-up|8
4728484|NCT03287791|7668203|FG001|Overall Study|Lost to Follow-up|14
4728485|NCT03287791|7668204|FG002|Overall Study|Lost to Follow-up|11
4728486|NCT03287791|7668202|FG000|Overall Study|Protocol Violation|7
4728487|NCT03287791|7668203|FG001|Overall Study|Protocol Violation|2
4728488|NCT03287791|7668204|FG002|Overall Study|Protocol Violation|1
4728489|NCT03287791|7668202|FG000|Overall Study|Participant was enrolled at 2 sites|1
4728490|NCT03287791|7668203|FG001|Overall Study|Participant was enrolled at 2 sites|0
4728491|NCT03287791|7668204|FG002|Overall Study|Participant was enrolled at 2 sites|1
4728492|NCT03287791|7668202|FG000|Overall Study|Too much time between 2 visits|0
4728493|NCT03287791|7668203|FG001|Overall Study|Too much time between 2 visits|1
4728494|NCT03287791|7668204|FG002|Overall Study|Too much time between 2 visits|0
4728495|NCT03287791|7668202|FG000|Overall Study|Non-compliance|0
4728496|NCT03287791|7668203|FG001|Overall Study|Non-compliance|1
4728497|NCT03287791|7668204|FG002|Overall Study|Non-compliance|0
4728498|NCT03287791|7668202|FG000|Overall Study|Did not meet inclusion criteria|1
4728499|NCT03287791|7668203|FG001|Overall Study|Did not meet inclusion criteria|0
4728500|NCT03287791|7668204|FG002|Overall Study|Did not meet inclusion criteria|0
4728501|NCT03287804|7668212|FG000|Overall Study|Death|1
4728502|NCT03287804|7668212|FG000|Overall Study|Physician Decision|2
4728503|NCT03287804|7668212|FG000|Overall Study|Progressive disease|8
4728504|NCT03287869|7668219|FG000|Overall Study|Adverse Event|14
4728505|NCT03287869|7668220|FG001|Overall Study|Adverse Event|12
4728506|NCT03287869|7668219|FG000|Overall Study|Lack of Efficacy|1
4728507|NCT03287869|7668220|FG001|Overall Study|Lack of Efficacy|0
4728508|NCT03287869|7668219|FG000|Overall Study|Lost to Follow-up|13
4728509|NCT03287869|7668220|FG001|Overall Study|Lost to Follow-up|19
4728510|NCT03287869|7668219|FG000|Overall Study|Non-Compliance With Study Drug|5
4728511|NCT03287869|7668220|FG001|Overall Study|Non-Compliance With Study Drug|9
4728512|NCT03287869|7668219|FG000|Overall Study|Progressive Disease|1
4728513|NCT03287869|7668220|FG001|Overall Study|Progressive Disease|0
4728514|NCT03287869|7668219|FG000|Overall Study|Protocol Deviation|2
4728515|NCT03287869|7668220|FG001|Overall Study|Protocol Deviation|1
4728516|NCT03287869|7668219|FG000|Overall Study|Withdrawal by Subject|36
4728517|NCT03287869|7668220|FG001|Overall Study|Withdrawal by Subject|43
4728518|NCT03287869|7668219|FG000|Overall Study|Early Closure of the Site|0
4728519|NCT03287869|7668220|FG001|Overall Study|Early Closure of the Site|1
4728520|NCT03287869|7668219|FG000|Overall Study|Physician Decision|5
4728521|NCT03287869|7668220|FG001|Overall Study|Physician Decision|5
4728522|NCT03287869|7668219|FG000|Overall Study|Reason not Specified|6
4728523|NCT03287869|7668220|FG001|Overall Study|Reason not Specified|3
4728524|NCT03288714|7668228|FG000|Overall Study|Lost to Follow-up|2
4728525|NCT03288714|7668229|FG001|Overall Study|Lost to Follow-up|1
4728526|NCT03288714|7668228|FG000|Overall Study|Non-compliance with study schedule|2
4728527|NCT03288714|7668229|FG001|Overall Study|Non-compliance with study schedule|0
4728528|NCT03288714|7668228|FG000|Overall Study|Withdrawal by Subject|3
4728529|NCT03288714|7668229|FG001|Overall Study|Withdrawal by Subject|1
4728530|NCT03288714|7668228|FG000|Overall Study|Clinical Worsening|2
4728531|NCT03288714|7668229|FG001|Overall Study|Clinical Worsening|1
4728532|NCT03288714|7668228|FG000|Overall Study|Adverse Event|1
4728533|NCT03288714|7668229|FG001|Overall Study|Adverse Event|0
4728534|NCT03288779|7668237|FG000|Overall Study|Withdrawal by Subject|3
4728535|NCT03288987|7668243|FG000|Overall Study|Protocol Violation|10
4728536|NCT03288987|7668244|FG001|Overall Study|Protocol Violation|4
4728537|NCT03289208|7668266|FG000|Overall Study|Adverse Event|1
4728538|NCT03289208|7668267|FG001|Overall Study|Adverse Event|0
4728539|NCT03289208|7668268|FG002|Overall Study|Adverse Event|0
4728540|NCT03289455|7668292|FG000|Overall Study|Death|1
4728541|NCT03289455|7668293|FG001|Overall Study|Death|0
4728542|NCT03289455|7668294|FG002|Overall Study|Death|0
4728543|NCT03289455|7668292|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0
4728544|NCT03289455|7668293|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1
4728545|NCT03289455|7668294|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0
4728546|NCT03289455|7668292|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0
4728547|NCT03289455|7668293|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0
4728548|NCT03289455|7668294|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1
4728549|NCT03289455|7668292|FG000|Overall Study|Progressive disease|3
4728550|NCT03289455|7668293|FG001|Overall Study|Progressive disease|4
4728551|NCT03289455|7668294|FG002|Overall Study|Progressive disease|5
4728552|NCT03289533|7668313|FG000|Overall Study|Death|12
4728553|NCT03289533|7668313|FG000|Overall Study|Terminated from study by sponsor|10
4728554|NCT03289676|7668319|FG000|Overall Study|Withdrawal by Subject|2
4772251|NCT02471144|7749283|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1
4772252|NCT02471144|7749284|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0
4772253|NCT02471144|7749285|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1
4772254|NCT02471144|7749286|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0
4772255|NCT02471144|7749287|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1
4772256|NCT02471144|7749288|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0
4772257|NCT02471144|7749289|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0
4772258|NCT02471144|7749279|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
4772259|NCT02471144|7749280|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
4772260|NCT02471144|7749281|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
4772261|NCT02471144|7749282|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
4772262|NCT02471144|7749283|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
4772263|NCT02471144|7749284|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1
4772264|NCT02471144|7749285|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
4772265|NCT02471144|7749286|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
4772266|NCT02471144|7749287|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3
4772267|NCT02471144|7749288|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
4772268|NCT02471144|7749289|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0
4772269|NCT02471144|7749279|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
4772270|NCT02471144|7749280|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
4772271|NCT02471144|7749281|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
4772272|NCT02471144|7749282|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
4772273|NCT02471144|7749283|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
4772274|NCT02471144|7749284|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
4772275|NCT02471144|7749285|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
4772276|NCT02471144|7749286|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
4772277|NCT02471144|7749287|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1
4772278|NCT02471144|7749288|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
4772279|NCT02471144|7749289|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0
4772280|NCT02471144|7749279|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
4772281|NCT02471144|7749280|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
4728555|NCT03289676|7668320|FG001|Overall Study|Withdrawal by Subject|0
4728556|NCT03289676|7668319|FG000|Overall Study|Protocol Violation|2
4728557|NCT03289676|7668320|FG001|Overall Study|Protocol Violation|0
4728558|NCT03289676|7668319|FG000|Overall Study|Lost to Follow-up|0
4728559|NCT03289676|7668320|FG001|Overall Study|Lost to Follow-up|1
4728560|NCT03290300|7668344|FG000|Overall Study|Lost to Follow-up|3
4736976|NCT03588910|7686709|FG001|Overall Study|Did not complete Day 1 Survey|10
4736977|NCT03588910|7686708|FG000|Overall Study|Did not complete Day 7 Survey|5
4736978|NCT03588910|7686709|FG001|Overall Study|Did not complete Day 7 Survey|2
4736979|NCT03589469|7686715|FG000|Overall Study|Ongoing in study|58
4736980|NCT03589469|7686715|FG000|Overall Study|Withdrawal by Subject|6
4736981|NCT03589469|7686715|FG000|Overall Study|Physician Decision|1
4736982|NCT03589469|7686715|FG000|Overall Study|Death|77
4736983|NCT03589469|7686715|FG000|Overall Study|Lost to Follow-up|3
4736984|NCT03589807|7686725|FG000|Overall Study|Lost to Follow-up|0
4736985|NCT03589807|7686726|FG001|Overall Study|Lost to Follow-up|2
4736986|NCT03589807|7686727|FG002|Overall Study|Lost to Follow-up|2
4736987|NCT03589807|7686728|FG003|Overall Study|Lost to Follow-up|3
4736988|NCT03589807|7686729|FG004|Overall Study|Lost to Follow-up|1
4736989|NCT03589807|7686730|FG005|Overall Study|Lost to Follow-up|1
4736990|NCT03589807|7686725|FG000|Overall Study|Withdrawal by Subject|0
4736991|NCT03589807|7686726|FG001|Overall Study|Withdrawal by Subject|5
4736992|NCT03589807|7686727|FG002|Overall Study|Withdrawal by Subject|0
4736993|NCT03589807|7686728|FG003|Overall Study|Withdrawal by Subject|0
4736994|NCT03589807|7686729|FG004|Overall Study|Withdrawal by Subject|0
4736995|NCT03589807|7686730|FG005|Overall Study|Withdrawal by Subject|0
4736996|NCT03589807|7686725|FG000|Overall Study|Protocol Violation|0
4736997|NCT03589807|7686726|FG001|Overall Study|Protocol Violation|0
4736998|NCT03589807|7686727|FG002|Overall Study|Protocol Violation|0
4736999|NCT03589807|7686728|FG003|Overall Study|Protocol Violation|1
4737000|NCT03589807|7686729|FG004|Overall Study|Protocol Violation|0
4737001|NCT03589807|7686730|FG005|Overall Study|Protocol Violation|0
4737002|NCT03589807|7686725|FG000|Overall Study|Enrolled but treatment not administered|0
4737003|NCT03589807|7686726|FG001|Overall Study|Enrolled but treatment not administered|0
4737004|NCT03589807|7686727|FG002|Overall Study|Enrolled but treatment not administered|0
4737005|NCT03589807|7686728|FG003|Overall Study|Enrolled but treatment not administered|0
4737006|NCT03589807|7686729|FG004|Overall Study|Enrolled but treatment not administered|1
4737007|NCT03589807|7686730|FG005|Overall Study|Enrolled but treatment not administered|0
4737008|NCT03589885|7686750|FG000|Treatment Period 1-Randomized Set|Adverse Event|0
4737009|NCT03589885|7686751|FG001|Treatment Period 1-Randomized Set|Adverse Event|1
4737010|NCT03589885|7686752|FG002|Treatment Period 1-Randomized Set|Adverse Event|0
4737011|NCT03589885|7686753|FG003|Treatment Period 1-Randomized Set|Adverse Event|0
4737012|NCT03589885|7686754|FG004|Treatment Period 1-Randomized Set|Adverse Event|0
4737013|NCT03589885|7686750|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0
4737014|NCT03589885|7686751|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0
4737015|NCT03589885|7686752|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2
4737016|NCT03589885|7686753|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0
4737017|NCT03589885|7686754|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0
4737018|NCT03589885|7686750|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0
4737019|NCT03589885|7686751|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1
4737020|NCT03589885|7686752|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0
4737021|NCT03589885|7686753|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0
4737022|NCT03589885|7686754|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0
4737023|NCT03589885|7686750|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0
4737024|NCT03589885|7686751|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0
4737025|NCT03589885|7686752|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1
4737026|NCT03589885|7686753|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0
4737027|NCT03589885|7686754|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0
4737028|NCT03589885|7686750|FG000|Treatment Period 2-Randomized Set|Adverse Event|0
4737029|NCT03589885|7686751|FG001|Treatment Period 2-Randomized Set|Adverse Event|1
4737030|NCT03589885|7686752|FG002|Treatment Period 2-Randomized Set|Adverse Event|0
4737031|NCT03589885|7686753|FG003|Treatment Period 2-Randomized Set|Adverse Event|0
4737032|NCT03589885|7686754|FG004|Treatment Period 2-Randomized Set|Adverse Event|0
4737033|NCT03589885|7686750|FG000|Treatment Period 2-Randomized Set|Pregnancy|1
4737034|NCT03589885|7686751|FG001|Treatment Period 2-Randomized Set|Pregnancy|0
4737035|NCT03589885|7686752|FG002|Treatment Period 2-Randomized Set|Pregnancy|0
4737036|NCT03589885|7686753|FG003|Treatment Period 2-Randomized Set|Pregnancy|0
4737037|NCT03589885|7686754|FG004|Treatment Period 2-Randomized Set|Pregnancy|0
4737038|NCT03589885|7686750|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0
4737039|NCT03589885|7686751|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3
4737040|NCT03589885|7686752|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1
4737041|NCT03589885|7686753|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0
4737042|NCT03589885|7686754|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1
4737043|NCT03589885|7686750|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0
4737044|NCT03589885|7686751|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1
4737045|NCT03589885|7686752|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0
4728561|NCT03291288|7668397|FG000|Drug-drug Interaction Phase|Adverse Event|2
4728562|NCT03291288|7668398|FG001|Drug-drug Interaction Phase|Adverse Event|0
4728563|NCT03291288|7668397|FG000|Drug-drug Interaction Phase|Disease progression|1
4728564|NCT03291288|7668398|FG001|Drug-drug Interaction Phase|Disease progression|0
4728565|NCT03291288|7668397|FG000|Drug-drug Interaction Phase|Other|3
4728566|NCT03291288|7668398|FG001|Drug-drug Interaction Phase|Other|0
4728567|NCT03291288|7668397|FG000|Pexidartinib Only|Ongoing|0
4728568|NCT03291288|7668398|FG001|Pexidartinib Only|Ongoing|2
4728569|NCT03292016|7668427|FG000|Second Washout|Adverse Event|0
4728570|NCT03292016|7668428|FG001|Second Washout|Adverse Event|1
4728571|NCT03292016|7668429|FG002|Second Washout|Adverse Event|0
4728572|NCT03292016|7668430|FG003|Second Washout|Adverse Event|0
4728573|NCT03292016|7668431|FG004|Second Washout|Adverse Event|0
4728574|NCT03292016|7668432|FG005|Second Washout|Adverse Event|0
4728575|NCT03292406|7668443|FG000|Overall Study|Progressive Disease|6
4728576|NCT03292406|7668444|FG001|Overall Study|Progressive Disease|3
4728577|NCT03292406|7668445|FG002|Overall Study|Progressive Disease|4
4728578|NCT03292406|7668443|FG000|Overall Study|Adverse Event|7
4728579|NCT03292406|7668444|FG001|Overall Study|Adverse Event|1
4728580|NCT03292406|7668445|FG002|Overall Study|Adverse Event|4
4728581|NCT03292406|7668443|FG000|Overall Study|Withdrawal by Subject|0
4728582|NCT03292406|7668444|FG001|Overall Study|Withdrawal by Subject|7
4728583|NCT03292406|7668445|FG002|Overall Study|Withdrawal by Subject|2
4728584|NCT03292406|7668443|FG000|Overall Study|Protocol Violation|0
4728585|NCT03292406|7668444|FG001|Overall Study|Protocol Violation|1
4728586|NCT03292406|7668445|FG002|Overall Study|Protocol Violation|1
4728587|NCT03292406|7668443|FG000|Overall Study|Other|0
4728588|NCT03292406|7668444|FG001|Overall Study|Other|1
4728589|NCT03292406|7668445|FG002|Overall Study|Other|2
4728590|NCT03292432|7668455|FG000|Overall Study|Lost to Follow-up|11
4728591|NCT03292432|7668456|FG001|Overall Study|Lost to Follow-up|8
4728592|NCT03292432|7668455|FG000|Overall Study|Death|2
4728593|NCT03292432|7668456|FG001|Overall Study|Death|1
4728594|NCT03292432|7668455|FG000|Overall Study|Withdrawal by Subject|1
4728595|NCT03292432|7668456|FG001|Overall Study|Withdrawal by Subject|2
4728596|NCT03292432|7668455|FG000|Overall Study|Site closed before any data collected|1
4728597|NCT03292432|7668456|FG001|Overall Study|Site closed before any data collected|0
4728598|NCT03292640|7668477|FG000|Overall Study|Withdrawal by Subject|17
4728599|NCT03292640|7668478|FG001|Overall Study|Withdrawal by Subject|16
4728600|NCT03292640|7668477|FG000|Overall Study|Adverse Event|20
4728601|NCT03292640|7668478|FG001|Overall Study|Adverse Event|2
4630936|NCT01888497|7499973|FG003|Washout Period 2|Adverse Event|1
4630937|NCT01888497|7499970|FG000|Washout Period 2|Withdrawal by Subject|0
4728602|NCT03292640|7668477|FG000|Overall Study|Lost to Follow-up|24
4728603|NCT03292640|7668478|FG001|Overall Study|Lost to Follow-up|24
4728604|NCT03292653|7668491|FG000|Overall Study|Adverse Event|0
4728605|NCT03292653|7668492|FG001|Overall Study|Adverse Event|0
4630938|NCT01888497|7499971|FG001|Washout Period 2|Withdrawal by Subject|0
4630939|NCT01888497|7499972|FG002|Washout Period 2|Withdrawal by Subject|0
4630940|NCT01888497|7499973|FG003|Washout Period 2|Withdrawal by Subject|1
4630941|NCT01888640|7499986|FG000|Overall Study|Lost to Follow-up|1
4630942|NCT01888640|7499987|FG001|Overall Study|Lost to Follow-up|2
4630943|NCT01888640|7499988|FG002|Overall Study|Lost to Follow-up|0
4630944|NCT01888640|7499986|FG000|Overall Study|Withdrawal by Subject|15
4630945|NCT01888640|7499987|FG001|Overall Study|Withdrawal by Subject|11
4630946|NCT01888640|7499988|FG002|Overall Study|Withdrawal by Subject|4
4630947|NCT01888640|7499986|FG000|Overall Study|Minimum dose not met|10
4630948|NCT01888640|7499987|FG001|Overall Study|Minimum dose not met|16
4728606|NCT03292653|7668493|FG002|Overall Study|Adverse Event|1
4728607|NCT03292653|7668491|FG000|Overall Study|Did not Receive Treatment|1
4728608|NCT03292653|7668492|FG001|Overall Study|Did not Receive Treatment|0
4728609|NCT03292653|7668493|FG002|Overall Study|Did not Receive Treatment|0
4728610|NCT03293394|7668552|FG000|Follow-up (6 Months)|Adverse Event|4
4728611|NCT03293394|7668553|FG001|Follow-up (6 Months)|Adverse Event|2
4728612|NCT03293485|7668559|FG000|Overall Study|Death|1
4728613|NCT03293485|7668559|FG000|Overall Study|Screen Failure|2
4728614|NCT03293485|7668559|FG000|Overall Study|Withdrawal by Subject|2
4630949|NCT01888640|7499988|FG002|Overall Study|Minimum dose not met|0
4630950|NCT01888640|7499986|FG000|Overall Study|Given wrong unit (placebo)|1
4728615|NCT03293654|7668568|FG000|Overall Study|Lost to Follow-up|0
4728616|NCT03293654|7668569|FG001|Overall Study|Lost to Follow-up|1
4728617|NCT03293654|7668570|FG002|Overall Study|Lost to Follow-up|0
4728618|NCT03294317|7668582|FG000|Overall Study|Physician Decision|1
4728619|NCT03294317|7668582|FG000|Overall Study|Withdrawal by Subject|6
4728620|NCT03294317|7668582|FG000|Overall Study|Lost to Follow-up|1
4728621|NCT03294317|7668582|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1
4728622|NCT03294317|7668582|FG000|Overall Study|Failed HB lead implant|8
4728623|NCT03294317|7668582|FG000|Overall Study|Received CRT instead|1
4728624|NCT03294317|7668582|FG000|Overall Study|Exited after lead revision|2
4728625|NCT03294538|7668589|FG000|Overall Study|Adverse Event|0
4728626|NCT03294538|7668590|FG001|Overall Study|Adverse Event|1
4728627|NCT03294538|7668591|FG002|Overall Study|Adverse Event|1
4728628|NCT03294538|7668589|FG000|Overall Study|Lost to Follow-up|1
4728629|NCT03294538|7668590|FG001|Overall Study|Lost to Follow-up|0
4728630|NCT03294538|7668591|FG002|Overall Study|Lost to Follow-up|0
4728631|NCT03294538|7668589|FG000|Overall Study|Outside of Visit Window|4
4728632|NCT03294538|7668590|FG001|Overall Study|Outside of Visit Window|4
4728633|NCT03294538|7668591|FG002|Overall Study|Outside of Visit Window|1
4728634|NCT03294681|7668608|FG000|Overall Study|Withdrawal by Subject|1
4728635|NCT03294941|7668623|FG000|Overall Study|Withdrawal by Subject|0
4728636|NCT03294941|7668624|FG001|Overall Study|Withdrawal by Subject|2
4728637|NCT03295201|7668633|FG000|Overall Study|Lost to Follow-up|1
4728638|NCT03295201|7668634|FG001|Overall Study|Lost to Follow-up|1
4728639|NCT03295201|7668633|FG000|Overall Study|Hospital admission|0
4728640|NCT03295201|7668634|FG001|Overall Study|Hospital admission|1
4728641|NCT03295318|7668652|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1
4728642|NCT03295318|7668653|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0
4728643|NCT03295318|7668654|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0
4728644|NCT03295318|7668652|FG000|Overall Study|Death|1
4728645|NCT03295318|7668653|FG001|Overall Study|Death|1
4728646|NCT03295318|7668654|FG002|Overall Study|Death|1
4728647|NCT03295318|7668652|FG000|Overall Study|Protocol Violation|4
4728648|NCT03295318|7668653|FG001|Overall Study|Protocol Violation|3
4728649|NCT03295318|7668654|FG002|Overall Study|Protocol Violation|3
4728650|NCT03295318|7668652|FG000|Overall Study|Withdrawal by Subject|0
4728651|NCT03295318|7668653|FG001|Overall Study|Withdrawal by Subject|0
4728652|NCT03295318|7668654|FG002|Overall Study|Withdrawal by Subject|1
4728653|NCT03295318|7668652|FG000|Overall Study|Subject discontinued due to travel|0
4728654|NCT03295318|7668653|FG001|Overall Study|Subject discontinued due to travel|1
4728655|NCT03295318|7668654|FG002|Overall Study|Subject discontinued due to travel|0
4728656|NCT03295721|7668688|FG000|Overall Study|Adverse Event|1
4728657|NCT03295721|7668689|FG001|Overall Study|Adverse Event|0
4728658|NCT03295721|7668690|FG002|Overall Study|Adverse Event|0
4728659|NCT03295721|7668688|FG000|Overall Study|Lost to Follow-up|1
4728660|NCT03295721|7668689|FG001|Overall Study|Lost to Follow-up|1
4728661|NCT03295721|7668690|FG002|Overall Study|Lost to Follow-up|1
4728662|NCT03295721|7668688|FG000|Overall Study|Withdrawal by Subject|1
4728663|NCT03295721|7668689|FG001|Overall Study|Withdrawal by Subject|0
4728664|NCT03295721|7668690|FG002|Overall Study|Withdrawal by Subject|1
4728665|NCT03295721|7668688|FG000|Overall Study|Death|0
4728666|NCT03295721|7668689|FG001|Overall Study|Death|0
4728667|NCT03295721|7668690|FG002|Overall Study|Death|1
4728668|NCT03296527|7668738|FG000|Overall Study|Adverse Event|15
4728669|NCT03296527|7668739|FG001|Overall Study|Adverse Event|33
4728670|NCT03296527|7668738|FG000|Overall Study|Protocol Deviation|4
4728671|NCT03296527|7668739|FG001|Overall Study|Protocol Deviation|0
4728672|NCT03296527|7668738|FG000|Overall Study|Subject withdrew consent|3
4728673|NCT03296527|7668739|FG001|Overall Study|Subject withdrew consent|1
4728674|NCT03296527|7668738|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9
4728675|NCT03296527|7668739|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14
4728676|NCT03296527|7668738|FG000|Overall Study|Discontinuations due to withdrawal from trial|2
4728677|NCT03296527|7668739|FG001|Overall Study|Discontinuations due to withdrawal from trial|3
4630951|NCT01888640|7499987|FG001|Overall Study|Given wrong unit (placebo)|0
4630952|NCT01888640|7499988|FG002|Overall Study|Given wrong unit (placebo)|0
4630953|NCT01888640|7499986|FG000|Overall Study|Excluded for prior TENS|0
4630954|NCT01888640|7499987|FG001|Overall Study|Excluded for prior TENS|1
4630955|NCT01888640|7499988|FG002|Overall Study|Excluded for prior TENS|0
4728678|NCT03296527|7668738|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0
4728679|NCT03296527|7668739|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2
4728680|NCT03296527|7668738|FG000|Overall Study|Discontinuation due to liquid in uterus|1
4728681|NCT03296527|7668739|FG001|Overall Study|Discontinuation due to liquid in uterus|0
4728682|NCT03296527|7668738|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1
4728683|NCT03296527|7668739|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0
4728684|NCT03296566|7668748|FG000|Overall Study|Lost to Follow-up|19
4728685|NCT03296566|7668749|FG001|Overall Study|Lost to Follow-up|46
4728686|NCT03296566|7668748|FG000|Overall Study|Withdrawal by Subject|0
4728687|NCT03296566|7668749|FG001|Overall Study|Withdrawal by Subject|3
4728688|NCT03297021|7668804|FG000|Overall Study|Incomplete/illegible data sheet|4
4728689|NCT03297021|7668805|FG001|Overall Study|Incomplete/illegible data sheet|2
4728690|NCT03297021|7668806|FG002|Overall Study|Incomplete/illegible data sheet|3
4728691|NCT03297021|7668804|FG000|Overall Study|Missing Post-Op Data|1
4728692|NCT03297021|7668805|FG001|Overall Study|Missing Post-Op Data|2
4728693|NCT03297021|7668806|FG002|Overall Study|Missing Post-Op Data|1
4728694|NCT03297216|7668820|FG000|Overall Study|Death|0
4728695|NCT03297216|7668821|FG001|Overall Study|Death|1
4728696|NCT03297216|7668820|FG000|Overall Study|Miscarriage|0
4728697|NCT03297216|7668821|FG001|Overall Study|Miscarriage|2
4728698|NCT03297216|7668820|FG000|Overall Study|Lost to Follow-up|3
4728699|NCT03297216|7668821|FG001|Overall Study|Lost to Follow-up|2
4728700|NCT03297294|7668836|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30
4728701|NCT03297294|7668837|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31
4728702|NCT03297294|7668838|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
4630956|NCT01888640|7499986|FG000|Overall Study|Researcher Termination of Participant|0
4728703|NCT03297294|7668839|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
4728704|NCT03297294|7668840|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
4728705|NCT03297294|7668836|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4
4728706|NCT03297294|7668837|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4
4728707|NCT03297294|7668838|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
4728708|NCT03297294|7668839|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
4728709|NCT03297294|7668840|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
4728710|NCT03297294|7668836|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3
4728711|NCT03297294|7668837|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1
4728712|NCT03297294|7668838|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0
4728713|NCT03297294|7668839|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0
4728714|NCT03297294|7668840|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0
4728715|NCT03297294|7668836|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1
4728716|NCT03297294|7668837|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1
4728717|NCT03297294|7668838|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0
4728718|NCT03297294|7668839|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0
4728719|NCT03297294|7668840|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0
4728720|NCT03297294|7668836|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0
4728721|NCT03297294|7668837|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0
4728722|NCT03297294|7668838|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0
4728723|NCT03297294|7668839|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1
4728724|NCT03297294|7668840|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0
4728725|NCT03297398|7668855|FG000|Overall Study|Sponsor's decision|6
4728726|NCT03297398|7668856|FG001|Overall Study|Sponsor's decision|9
4728727|NCT03297398|7668857|FG002|Overall Study|Sponsor's decision|7
4728728|NCT03297398|7668855|FG000|Overall Study|Adverse Event|1
4728729|NCT03297398|7668856|FG001|Overall Study|Adverse Event|4
4728730|NCT03297398|7668857|FG002|Overall Study|Adverse Event|4
4728731|NCT03297398|7668855|FG000|Overall Study|Withdrawal by Subject|1
4728732|NCT03297398|7668856|FG001|Overall Study|Withdrawal by Subject|2
4728733|NCT03297398|7668857|FG002|Overall Study|Withdrawal by Subject|2
4728734|NCT03297398|7668855|FG000|Overall Study|Protocol Violation|0
4728735|NCT03297398|7668856|FG001|Overall Study|Protocol Violation|2
4728736|NCT03297398|7668857|FG002|Overall Study|Protocol Violation|0
4728737|NCT03297398|7668855|FG000|Overall Study|Physician Decision|0
4728738|NCT03297398|7668856|FG001|Overall Study|Physician Decision|0
4728739|NCT03297398|7668857|FG002|Overall Study|Physician Decision|1
4728740|NCT03297398|7668855|FG000|Overall Study|Lost to Follow-up|0
4728741|NCT03297398|7668856|FG001|Overall Study|Lost to Follow-up|0
4728742|NCT03297398|7668857|FG002|Overall Study|Lost to Follow-up|1
4728743|NCT03298412|7668905|FG000|Run-in Period|Other, Not Specified|1
4728744|NCT03298412|7668905|FG000|Run-in Period|Disease Progression|1
4728745|NCT03298412|7668905|FG000|Run-in Period|Ineligibility Determined|1
4728746|NCT03298412|7668905|FG000|Run-in Period|Decision by Sponsor|6
4728747|NCT03299101|7668930|FG000|Overall Study|Lost to Follow-up|1
4728748|NCT03299101|7668930|FG000|Overall Study|Withdrawal by Subject|5
4728749|NCT03299101|7668930|FG000|Overall Study|Surgery was changed|3
4728750|NCT03299101|7668930|FG000|Overall Study|Not enough time to complete prehab|1
4728751|NCT03299244|7668936|FG000|Overall Study|Withdrawal by Subject|34
4728752|NCT03299244|7668937|FG001|Overall Study|Withdrawal by Subject|29
4728753|NCT03299244|7668936|FG000|Overall Study|Decision by Sponsor|4
4728754|NCT03299244|7668937|FG001|Overall Study|Decision by Sponsor|5
4728755|NCT03299244|7668936|FG000|Overall Study|Death|9
4728756|NCT03299244|7668937|FG001|Overall Study|Death|4
4728757|NCT03299686|7668946|FG000|Treatment Epoch|Subject/Guardian Decision|2
4728758|NCT03299686|7668947|FG001|Treatment Epoch|Subject/Guardian Decision|0
4728759|NCT03299686|7668946|FG000|Treatment Epoch|Physician Decision|1
4728760|NCT03299686|7668947|FG001|Treatment Epoch|Physician Decision|0
4728761|NCT03299686|7668946|FG000|Treatment Epoch|Adverse Event|8
4728762|NCT03299686|7668947|FG001|Treatment Epoch|Adverse Event|4
4728763|NCT03299686|7668946|FG000|Follow-up Epoch|Subject/Guardian Decision|0
4728764|NCT03299686|7668947|FG001|Follow-up Epoch|Subject/Guardian Decision|1
4728765|NCT03299881|7668955|FG000|Overall Study|Study Termination|17
4728766|NCT03299881|7668956|FG001|Overall Study|Study Termination|13
4728767|NCT03300050|7668967|FG000|Overall Study|Lost to Follow-up|2
4728768|NCT03300050|7668968|FG001|Overall Study|Lost to Follow-up|1
4728769|NCT03300050|7668969|FG002|Overall Study|Lost to Follow-up|0
4728770|NCT03300050|7668970|FG003|Overall Study|Lost to Follow-up|0
4728771|NCT03300050|7668971|FG004|Overall Study|Lost to Follow-up|1
4728772|NCT03300050|7668967|FG000|Overall Study|Withdrawal by Subject|1
4728773|NCT03300050|7668968|FG001|Overall Study|Withdrawal by Subject|1
4728774|NCT03300050|7668969|FG002|Overall Study|Withdrawal by Subject|1
4728775|NCT03300050|7668970|FG003|Overall Study|Withdrawal by Subject|0
4728776|NCT03300050|7668971|FG004|Overall Study|Withdrawal by Subject|0
4728777|NCT03300050|7668967|FG000|Overall Study|Death|0
4728778|NCT03300050|7668968|FG001|Overall Study|Death|0
4728779|NCT03300050|7668969|FG002|Overall Study|Death|1
4728780|NCT03300050|7668970|FG003|Overall Study|Death|0
4728781|NCT03300050|7668971|FG004|Overall Study|Death|0
4728782|NCT03300050|7668967|FG000|Overall Study|Not Eligible at Randomization|0
4728783|NCT03300050|7668968|FG001|Overall Study|Not Eligible at Randomization|0
4728784|NCT03300050|7668969|FG002|Overall Study|Not Eligible at Randomization|1
4728785|NCT03300050|7668970|FG003|Overall Study|Not Eligible at Randomization|1
4728786|NCT03300050|7668971|FG004|Overall Study|Not Eligible at Randomization|0
4728787|NCT03300570|7668994|FG000|Overall Study|Adverse Event|0
4728788|NCT03300570|7668995|FG001|Overall Study|Adverse Event|1
4728789|NCT03300570|7668994|FG000|Overall Study|Withdrawal by Subject|1
4728790|NCT03300570|7668995|FG001|Overall Study|Withdrawal by Subject|0
4728791|NCT03300570|7668994|FG000|Overall Study|Inadequate bowel prep|1
4630957|NCT01888640|7499987|FG001|Overall Study|Researcher Termination of Participant|1
4630958|NCT01888640|7499988|FG002|Overall Study|Researcher Termination of Participant|1
4630959|NCT01888874|7500006|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2
4630960|NCT01888874|7500007|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2
4630961|NCT01888874|7500008|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3
4630962|NCT01888874|7500009|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4
4630963|NCT01888874|7500010|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3
4630964|NCT01888874|7500011|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0
4728792|NCT03300570|7668995|FG001|Overall Study|Inadequate bowel prep|0
4728793|NCT03301155|7669026|FG000|Overall Study|Сompliance with exclusion criteria|8
4728794|NCT03301155|7669027|FG001|Overall Study|Сompliance with exclusion criteria|7
4728795|NCT03301623|7669074|FG000|Overall Study|Death|3
4728796|NCT03301623|7669075|FG001|Overall Study|Death|1
4728797|NCT03301623|7669074|FG000|Overall Study|Withdrawal by Subject|11
4728798|NCT03301623|7669075|FG001|Overall Study|Withdrawal by Subject|13
4728799|NCT03301623|7669074|FG000|Overall Study|Lost to Follow-up|3
4728800|NCT03301623|7669075|FG001|Overall Study|Lost to Follow-up|1
4728801|NCT03301649|7669084|FG000|Overall Study|Need alternate therapy due to live lice|17
4728802|NCT03301649|7669085|FG001|Overall Study|Need alternate therapy due to live lice|25
4728803|NCT03301649|7669086|FG002|Overall Study|Need alternate therapy due to live lice|81
4728804|NCT03301649|7669084|FG000|Overall Study|Lost to Follow-up|11
4728805|NCT03301649|7669085|FG001|Overall Study|Lost to Follow-up|11
4728806|NCT03301649|7669086|FG002|Overall Study|Lost to Follow-up|3
4728807|NCT03301649|7669084|FG000|Overall Study|Protocol Violation|0
4728808|NCT03301649|7669085|FG001|Overall Study|Protocol Violation|1
4728809|NCT03301649|7669086|FG002|Overall Study|Protocol Violation|1
4728810|NCT03301649|7669084|FG000|Overall Study|Withdrawal by Subject|10
4728811|NCT03301649|7669085|FG001|Overall Study|Withdrawal by Subject|4
4728812|NCT03301649|7669086|FG002|Overall Study|Withdrawal by Subject|0
4728813|NCT03301649|7669084|FG000|Overall Study|Other than specified|5
4728814|NCT03301649|7669085|FG001|Overall Study|Other than specified|3
4728815|NCT03301649|7669086|FG002|Overall Study|Other than specified|0
4728816|NCT03301714|7669097|FG000|Overall Study|Lost to Follow-up|10
4728817|NCT03301714|7669098|FG001|Overall Study|Lost to Follow-up|4
4728818|NCT03301714|7669099|FG002|Overall Study|Lost to Follow-up|4
4728819|NCT03301714|7669097|FG000|Overall Study|Did not receive allocated intervention|0
4728820|NCT03301714|7669098|FG001|Overall Study|Did not receive allocated intervention|2
4728821|NCT03301714|7669099|FG002|Overall Study|Did not receive allocated intervention|3
4728822|NCT03301740|7669112|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1
4728823|NCT03301740|7669113|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0
4728824|NCT03301740|7669112|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1
4728825|NCT03301740|7669113|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0
4728826|NCT03301831|7669128|FG000|Overall Study|Lost to Follow-up|5
4728827|NCT03301831|7669129|FG001|Overall Study|Lost to Follow-up|3
4728828|NCT03301831|7669128|FG000|Overall Study|Protocol Violation|4
4728829|NCT03301831|7669129|FG001|Overall Study|Protocol Violation|0
4728830|NCT03301831|7669128|FG000|Overall Study|Withdrawal by Subject|11
4728831|NCT03301831|7669129|FG001|Overall Study|Withdrawal by Subject|0
4728832|NCT03301844|7669137|FG000|Overall Study|suspected colon cancer|1
4728833|NCT03301844|7669138|FG001|Overall Study|suspected colon cancer|1
4728834|NCT03302559|7669157|FG000|Overall Study|Adverse Event|2
4728835|NCT03302559|7669157|FG000|Overall Study|Lost to Follow-up|1
4728836|NCT03302559|7669157|FG000|Overall Study|Withdrew Consent|3
4728837|NCT03302936|7669190|FG000|Overall Study|Protocol Violation|3
4728838|NCT03302936|7669191|FG001|Overall Study|Protocol Violation|4
4728839|NCT03302975|7669201|FG000|Overall Study|Lost to Follow-up|4
4728840|NCT03303079|7669208|FG000|Overall Study|Adverse Event|0
4728841|NCT03303079|7669209|FG001|Overall Study|Adverse Event|1
4630965|NCT01888874|7500012|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0
4630966|NCT01888874|7500006|FG000|Period 1 (Baseline up to Week 12)|Other|1
4630967|NCT01888874|7500007|FG001|Period 1 (Baseline up to Week 12)|Other|0
4630968|NCT01888874|7500008|FG002|Period 1 (Baseline up to Week 12)|Other|1
4728842|NCT03303079|7669210|FG002|Overall Study|Adverse Event|3
4728843|NCT03303079|7669208|FG000|Overall Study|Protocol Violation|5
4728844|NCT03303079|7669209|FG001|Overall Study|Protocol Violation|4
4728845|NCT03303079|7669210|FG002|Overall Study|Protocol Violation|7
4772282|NCT02471144|7749281|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
4728846|NCT03303079|7669208|FG000|Overall Study|Withdrawal by Subject|2
4728847|NCT03303079|7669209|FG001|Overall Study|Withdrawal by Subject|4
4728848|NCT03303079|7669210|FG002|Overall Study|Withdrawal by Subject|2
4728849|NCT03303079|7669208|FG000|Overall Study|Other than specified|0
4515267|NCT00952289|7326015|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11
4515268|NCT00952289|7326014|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0
4515269|NCT00952289|7326015|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2
4515270|NCT00952289|7326014|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0
4515271|NCT00952289|7326015|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7
4515272|NCT00952341|7326039|FG000|Cycle 1|Adverse Event|4
4515273|NCT00952341|7326040|FG001|Cycle 1|Adverse Event|1
4515274|NCT00952341|7326039|FG000|Cycle 1|Withdrawal by Subject|3
4728850|NCT03303079|7669209|FG001|Overall Study|Other than specified|2
4728851|NCT03303079|7669210|FG002|Overall Study|Other than specified|0
4728852|NCT03303092|7669221|FG000|Overall Study|Adverse Event|1
4728853|NCT03303092|7669222|FG001|Overall Study|Adverse Event|0
4728854|NCT03303092|7669223|FG002|Overall Study|Adverse Event|1
4728855|NCT03303092|7669221|FG000|Overall Study|Protocol Violation|1
4728856|NCT03303092|7669222|FG001|Overall Study|Protocol Violation|5
4728857|NCT03303092|7669223|FG002|Overall Study|Protocol Violation|1
4728858|NCT03303092|7669221|FG000|Overall Study|Withdrawal by Subject|1
4728859|NCT03303092|7669222|FG001|Overall Study|Withdrawal by Subject|1
4728860|NCT03303092|7669223|FG002|Overall Study|Withdrawal by Subject|3
4728861|NCT03303105|7669233|FG000|Overall Study|Adverse Event|0
4630969|NCT01888874|7500009|FG003|Period 1 (Baseline up to Week 12)|Other|1
4630970|NCT01888874|7500010|FG004|Period 1 (Baseline up to Week 12)|Other|3
4630971|NCT01888874|7500011|FG005|Period 1 (Baseline up to Week 12)|Other|3
4630972|NCT01888874|7500012|FG006|Period 1 (Baseline up to Week 12)|Other|0
4630973|NCT01888874|7500006|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0
4630974|NCT01888874|7500007|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0
4728862|NCT03303105|7669234|FG001|Overall Study|Adverse Event|2
4728863|NCT03303105|7669233|FG000|Overall Study|Lack of Efficacy|1
4728864|NCT03303105|7669234|FG001|Overall Study|Lack of Efficacy|0
4728865|NCT03303105|7669233|FG000|Overall Study|Protocol Violation|1
4728866|NCT03303105|7669234|FG001|Overall Study|Protocol Violation|0
4728867|NCT03303105|7669233|FG000|Overall Study|Withdrawal by Subject|0
4728868|NCT03303105|7669234|FG001|Overall Study|Withdrawal by Subject|2
4728869|NCT03303417|7669263|FG000|Overall Study|Withdrawal by Subject|1
4728870|NCT03303417|7669264|FG001|Overall Study|Withdrawal by Subject|1
4728871|NCT03303521|7669272|FG000|Overall Study|Withdrawal by Subject|2
4728872|NCT03303521|7669273|FG001|Overall Study|Withdrawal by Subject|0
4728873|NCT03303521|7669272|FG000|Overall Study|Death|1
4728874|NCT03303521|7669273|FG001|Overall Study|Death|0
4728875|NCT03303521|7669272|FG000|Overall Study|Kidney transplantation|0
4728876|NCT03303521|7669273|FG001|Overall Study|Kidney transplantation|1
4728877|NCT03303521|7669272|FG000|Overall Study|Investigational product discontinuation|0
4728878|NCT03303521|7669273|FG001|Overall Study|Investigational product discontinuation|1
4728879|NCT03303521|7669272|FG000|Overall Study|Transferred to non-study dialysis center|1
4728880|NCT03303521|7669273|FG001|Overall Study|Transferred to non-study dialysis center|0
4728881|NCT03303521|7669272|FG000|Overall Study|Non-comliance to study protocol|0
4728882|NCT03303521|7669273|FG001|Overall Study|Non-comliance to study protocol|1
4728883|NCT03303521|7669272|FG000|Overall Study|Adverse Event|1
4728884|NCT03303521|7669273|FG001|Overall Study|Adverse Event|0
4728885|NCT03304184|7669339|FG000|Overall Study|Withdrawal by Subject|1
4728886|NCT03304184|7669340|FG001|Overall Study|Withdrawal by Subject|2
4728887|NCT03304522|7669349|FG000|Overall Study|Adverse Event|0
4728888|NCT03304522|7669350|FG001|Overall Study|Adverse Event|4
4728889|NCT03304522|7669349|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1
4728890|NCT03304522|7669350|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1
4728891|NCT03304522|7669349|FG000|Overall Study|Withdrawal of consent (for other reason)|0
4728892|NCT03304522|7669350|FG001|Overall Study|Withdrawal of consent (for other reason)|2
4728893|NCT03304522|7669349|FG000|Overall Study|Other|0
4728894|NCT03304522|7669350|FG001|Overall Study|Other|1
4728895|NCT03304626|7669358|FG000|Overall Study|Adverse Event|1
4728896|NCT03304626|7669359|FG001|Overall Study|Adverse Event|0
4728897|NCT03304626|7669358|FG000|Overall Study|Lack of Efficacy|1
4515275|NCT00952341|7326040|FG001|Cycle 1|Withdrawal by Subject|8
4728898|NCT03304626|7669359|FG001|Overall Study|Lack of Efficacy|1
4728899|NCT03304873|7669368|FG000|Overall Study|Lost to Follow-up|1
4728900|NCT03304873|7669369|FG001|Overall Study|Lost to Follow-up|8
4728901|NCT03305081|7669377|FG000|Overall Study|Lost to Follow-up|10
4728902|NCT03305081|7669378|FG001|Overall Study|Lost to Follow-up|15
4728903|NCT03305419|7669401|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
4728904|NCT03305419|7669402|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1
4728905|NCT03305419|7669403|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
4728906|NCT03305419|7669404|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
4728907|NCT03305419|7669405|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
4728908|NCT03305419|7669406|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
4728909|NCT03305419|7669407|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
4728910|NCT03305419|7669408|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
4728911|NCT03305419|7669401|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1
4728912|NCT03305419|7669402|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
4728913|NCT03305419|7669403|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
4728914|NCT03305419|7669404|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
4728915|NCT03305419|7669405|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
4728916|NCT03305419|7669406|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
4728917|NCT03305419|7669407|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
4728918|NCT03305419|7669408|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
4728919|NCT03305419|7669401|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1
4728920|NCT03305419|7669402|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
4728921|NCT03305419|7669403|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
4728922|NCT03305419|7669404|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
4728923|NCT03305419|7669405|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
4728924|NCT03305419|7669406|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
4728925|NCT03305419|7669407|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
4728926|NCT03305419|7669408|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
4728927|NCT03305419|7669401|FG000|Part B (14 Days)|Adverse Event|0
4728928|NCT03305419|7669402|FG001|Part B (14 Days)|Adverse Event|0
4728929|NCT03305419|7669403|FG002|Part B (14 Days)|Adverse Event|0
4728930|NCT03305419|7669404|FG003|Part B (14 Days)|Adverse Event|0
4728931|NCT03305419|7669405|FG004|Part B (14 Days)|Adverse Event|1
4728932|NCT03305419|7669406|FG005|Part B (14 Days)|Adverse Event|2
4728933|NCT03305419|7669407|FG006|Part B (14 Days)|Adverse Event|4
4728934|NCT03305419|7669408|FG007|Part B (14 Days)|Adverse Event|0
4728935|NCT03305419|7669401|FG000|Part B (14 Days)|Physician Decision|0
4728936|NCT03305419|7669402|FG001|Part B (14 Days)|Physician Decision|0
4728937|NCT03305419|7669403|FG002|Part B (14 Days)|Physician Decision|0
4728938|NCT03305419|7669404|FG003|Part B (14 Days)|Physician Decision|0
4728939|NCT03305419|7669405|FG004|Part B (14 Days)|Physician Decision|2
4728940|NCT03305419|7669406|FG005|Part B (14 Days)|Physician Decision|8
4728941|NCT03305419|7669407|FG006|Part B (14 Days)|Physician Decision|1
4728942|NCT03305419|7669408|FG007|Part B (14 Days)|Physician Decision|0
4737046|NCT03589885|7686753|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0
4737047|NCT03589885|7686754|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0
4737048|NCT03590613|7686772|FG000|Period 2, 4 Days|Physician Decision|0
4737049|NCT03590613|7686773|FG001|Period 2, 4 Days|Physician Decision|0
4737050|NCT03590613|7686774|FG002|Period 2, 4 Days|Physician Decision|0
4737051|NCT03590613|7686775|FG003|Period 2, 4 Days|Physician Decision|1
4737052|NCT03591146|7686799|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0
4737053|NCT03591146|7686800|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0
4737054|NCT03591146|7686801|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0
4737055|NCT03591146|7686802|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0
4737056|NCT03591146|7686803|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1
4737057|NCT03591146|7686799|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0
4737058|NCT03591146|7686800|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1
4737059|NCT03591146|7686801|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0
4737060|NCT03591146|7686802|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0
4737061|NCT03591146|7686803|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0
4737062|NCT03591146|7686799|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0
4737063|NCT03591146|7686800|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0
4737064|NCT03591146|7686801|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0
4737065|NCT03591146|7686802|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0
4737066|NCT03591146|7686803|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1
4737067|NCT03591146|7686799|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0
4737068|NCT03591146|7686800|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0
4737069|NCT03591146|7686801|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1
4737070|NCT03591146|7686802|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0
4737071|NCT03591146|7686803|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1
4737072|NCT03591406|7686817|FG000|Overall Study|Adverse Event|5
4737073|NCT03591406|7686818|FG001|Overall Study|Adverse Event|3
4737074|NCT03591406|7686817|FG000|Overall Study|Protocol Violation|2
4737075|NCT03591406|7686818|FG001|Overall Study|Protocol Violation|1
4737076|NCT03591406|7686817|FG000|Overall Study|Withdrawal by Subject|0
4737077|NCT03591406|7686818|FG001|Overall Study|Withdrawal by Subject|5
4737078|NCT03592745|7686835|FG000|Overall Study|Adverse Event|0
4737079|NCT03592745|7686836|FG001|Overall Study|Adverse Event|2
4737080|NCT03592745|7686835|FG000|Overall Study|Lost to Follow-up|2
4737081|NCT03592745|7686836|FG001|Overall Study|Lost to Follow-up|0
4737082|NCT03592745|7686835|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1
4737083|NCT03592745|7686836|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1
4737084|NCT03593681|7686859|FG000|Overall Study|Inadequate sample collected|12
4737085|NCT03593681|7686859|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11
4737086|NCT03593681|7686859|FG000|Overall Study|Protocol Violation|3
4737087|NCT03593681|7686859|FG000|Overall Study|Withdrawal by Subject|3
4737088|NCT03593681|7686859|FG000|Overall Study|Procedure not attempted|3
4737089|NCT03593681|7686859|FG000|Overall Study|Adverse Event|2
4737090|NCT03593681|7686859|FG000|Overall Study|Physician Decision|1
4737091|NCT03593876|7686880|FG000|Overall Study|Withdrawal by Subject|1
4737092|NCT03593876|7686880|FG000|Overall Study|Discharged home before intervention completion|2
4728943|NCT03305575|7669433|FG000|Overall Study|Physician Decision|1
4728944|NCT03305575|7669434|FG001|Overall Study|Physician Decision|0
4728945|NCT03305666|7669446|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2
4728946|NCT03305666|7669447|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0
4728947|NCT03305731|7669453|FG000|Overall Study|Protocol Violation|1
4728948|NCT03305770|7669459|FG000|Overall Study|Physician Decision - prior to dispense|0
4728949|NCT03305770|7669460|FG001|Overall Study|Physician Decision - prior to dispense|1
4728950|NCT03305770|7669459|FG000|Overall Study|Subject moved|1
4728951|NCT03305770|7669460|FG001|Overall Study|Subject moved|0
4728952|NCT03305809|7669472|FG000|Overall Study|Adverse Event|2
4728953|NCT03305809|7669473|FG001|Overall Study|Adverse Event|2
4728954|NCT03305809|7669474|FG002|Overall Study|Adverse Event|6
4728955|NCT03305809|7669475|FG003|Overall Study|Adverse Event|6
4728956|NCT03305809|7669472|FG000|Overall Study|Death|0
4728957|NCT03305809|7669473|FG001|Overall Study|Death|0
4728958|NCT03305809|7669474|FG002|Overall Study|Death|1
4728959|NCT03305809|7669475|FG003|Overall Study|Death|1
4728960|NCT03305809|7669472|FG000|Overall Study|Lost to Follow-up|1
4728961|NCT03305809|7669473|FG001|Overall Study|Lost to Follow-up|2
4728962|NCT03305809|7669474|FG002|Overall Study|Lost to Follow-up|0
4728963|NCT03305809|7669475|FG003|Overall Study|Lost to Follow-up|0
4728964|NCT03305809|7669472|FG000|Overall Study|Sponsor Decision|1
4728965|NCT03305809|7669473|FG001|Overall Study|Sponsor Decision|0
4728966|NCT03305809|7669474|FG002|Overall Study|Sponsor Decision|1
4728967|NCT03305809|7669475|FG003|Overall Study|Sponsor Decision|8
4728968|NCT03305809|7669472|FG000|Overall Study|Physician Decision|0
4728969|NCT03305809|7669473|FG001|Overall Study|Physician Decision|0
4728970|NCT03305809|7669474|FG002|Overall Study|Physician Decision|2
4728971|NCT03305809|7669475|FG003|Overall Study|Physician Decision|4
4728972|NCT03305809|7669472|FG000|Overall Study|Progressive Disease|0
4728973|NCT03305809|7669473|FG001|Overall Study|Progressive Disease|0
4728974|NCT03305809|7669474|FG002|Overall Study|Progressive Disease|1
4728975|NCT03305809|7669475|FG003|Overall Study|Progressive Disease|0
4728976|NCT03305809|7669472|FG000|Overall Study|Protocol Violation|1
4728977|NCT03305809|7669473|FG001|Overall Study|Protocol Violation|0
4728978|NCT03305809|7669474|FG002|Overall Study|Protocol Violation|2
4728979|NCT03305809|7669475|FG003|Overall Study|Protocol Violation|3
4728980|NCT03305809|7669472|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0
4728981|NCT03305809|7669473|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0
4728982|NCT03305809|7669474|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0
4728983|NCT03305809|7669475|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2
4728984|NCT03305809|7669472|FG000|Overall Study|Withdrawal by Subject|2
4728985|NCT03305809|7669473|FG001|Overall Study|Withdrawal by Subject|4
4728986|NCT03305809|7669474|FG002|Overall Study|Withdrawal by Subject|5
4728987|NCT03305809|7669475|FG003|Overall Study|Withdrawal by Subject|2
4728988|NCT03305809|7669472|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0
4728989|NCT03305809|7669473|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0
4728990|NCT03305809|7669474|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1
4728991|NCT03305809|7669475|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1
4728992|NCT03306043|7669504|FG000|Overall Study|Adverse Event|1
4728993|NCT03306043|7669504|FG000|Overall Study|Lost to Follow-up|1
4728994|NCT03306043|7669504|FG000|Overall Study|Withdrawal by Subject|2
4728995|NCT03306277|7669512|FG000|Overall Study|Death|1
4728996|NCT03306277|7669512|FG000|Overall Study|Adverse Event|1
4728997|NCT03306277|7669512|FG000|Overall Study|Withdrawal by Subject|1
4728998|NCT03306433|7669537|FG000|Overall Study|Lost to Follow-up|3
4728999|NCT03306433|7669537|FG000|Overall Study|Patient did not have teeth extracted|1
4729000|NCT03306433|7669537|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3
4729001|NCT03307174|7669592|FG000|Overall Study|Unplanned ICU Administrion|5
4729002|NCT03307174|7669593|FG001|Overall Study|Unplanned ICU Administrion|3
4729003|NCT03307174|7669592|FG000|Overall Study|Aborted Surgery|1
4729004|NCT03307174|7669593|FG001|Overall Study|Aborted Surgery|2
4729005|NCT03307174|7669592|FG000|Overall Study|Hypotension|6
4729006|NCT03307174|7669593|FG001|Overall Study|Hypotension|0
4729007|NCT03307174|7669592|FG000|Overall Study|Nonfunctional epidural|1
4729008|NCT03307174|7669593|FG001|Overall Study|Nonfunctional epidural|1
4729009|NCT03307174|7669592|FG000|Overall Study|Planned epidural removal|1
4729010|NCT03307174|7669593|FG001|Overall Study|Planned epidural removal|0
4729011|NCT03307174|7669592|FG000|Overall Study|Intrathecal catheter placement|0
4729012|NCT03307174|7669593|FG001|Overall Study|Intrathecal catheter placement|1
4729013|NCT03307252|7669610|FG000|Part 2, Period 1|Treatment not received|0
4729014|NCT03307252|7669611|FG001|Part 2, Period 1|Treatment not received|0
4729015|NCT03307252|7669612|FG002|Part 2, Period 1|Treatment not received|0
4729016|NCT03307252|7669613|FG003|Part 2, Period 1|Treatment not received|0
4729017|NCT03307252|7669614|FG004|Part 2, Period 1|Treatment not received|0
4729018|NCT03307252|7669615|FG005|Part 2, Period 1|Treatment not received|1
4729019|NCT03307252|7669616|FG006|Part 2, Period 1|Treatment not received|0
4729020|NCT03307252|7669617|FG007|Part 2, Period 1|Treatment not received|0
4729021|NCT03307252|7669618|FG008|Part 2, Period 1|Treatment not received|0
4729022|NCT03307252|7669619|FG009|Part 2, Period 1|Treatment not received|0
4729023|NCT03307252|7669620|FG010|Part 2, Period 1|Treatment not received|0
4729024|NCT03307252|7669610|FG000|Part 2, Period 3|Other than listed|0
4729025|NCT03307252|7669611|FG001|Part 2, Period 3|Other than listed|0
4729026|NCT03307252|7669612|FG002|Part 2, Period 3|Other than listed|0
4729027|NCT03307252|7669613|FG003|Part 2, Period 3|Other than listed|0
4729028|NCT03307252|7669614|FG004|Part 2, Period 3|Other than listed|1
4729029|NCT03307252|7669615|FG005|Part 2, Period 3|Other than listed|0
4729030|NCT03307252|7669616|FG006|Part 2, Period 3|Other than listed|0
4729031|NCT03307252|7669617|FG007|Part 2, Period 3|Other than listed|0
4729032|NCT03307252|7669618|FG008|Part 2, Period 3|Other than listed|0
4729033|NCT03307252|7669619|FG009|Part 2, Period 3|Other than listed|0
4729034|NCT03307252|7669620|FG010|Part 2, Period 3|Other than listed|0
4729035|NCT03307252|7669610|FG000|Part 2, Period 4|Other than listed|0
4729036|NCT03307252|7669611|FG001|Part 2, Period 4|Other than listed|0
4729037|NCT03307252|7669612|FG002|Part 2, Period 4|Other than listed|0
4729038|NCT03307252|7669613|FG003|Part 2, Period 4|Other than listed|0
4729039|NCT03307252|7669614|FG004|Part 2, Period 4|Other than listed|0
4729040|NCT03307252|7669615|FG005|Part 2, Period 4|Other than listed|0
4729041|NCT03307252|7669616|FG006|Part 2, Period 4|Other than listed|1
4729042|NCT03307252|7669617|FG007|Part 2, Period 4|Other than listed|0
4729043|NCT03307252|7669618|FG008|Part 2, Period 4|Other than listed|0
4729044|NCT03307252|7669619|FG009|Part 2, Period 4|Other than listed|0
4729045|NCT03307252|7669620|FG010|Part 2, Period 4|Other than listed|0
4729046|NCT03307252|7669610|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
4729047|NCT03307252|7669611|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
4729048|NCT03307252|7669612|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
4729049|NCT03307252|7669613|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
4729050|NCT03307252|7669614|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
4729051|NCT03307252|7669615|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
4729052|NCT03307252|7669616|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
4729053|NCT03307252|7669617|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
4729054|NCT03307252|7669618|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
4729055|NCT03307252|7669619|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
4729056|NCT03307252|7669620|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1
4729057|NCT03307837|7669642|FG000|Overall Study|Withdrawal by Subject|0
4729058|NCT03307837|7669643|FG001|Overall Study|Withdrawal by Subject|0
4729059|NCT03307837|7669644|FG002|Overall Study|Withdrawal by Subject|1
4729060|NCT03307837|7669645|FG003|Overall Study|Withdrawal by Subject|0
4729061|NCT03307837|7669646|FG004|Overall Study|Withdrawal by Subject|0
4729062|NCT03307837|7669647|FG005|Overall Study|Withdrawal by Subject|1
4729063|NCT03307837|7669642|FG000|Overall Study|Lost to Follow-up|1
4729064|NCT03307837|7669643|FG001|Overall Study|Lost to Follow-up|1
4729065|NCT03307837|7669644|FG002|Overall Study|Lost to Follow-up|0
4729066|NCT03307837|7669645|FG003|Overall Study|Lost to Follow-up|0
4729067|NCT03307837|7669646|FG004|Overall Study|Lost to Follow-up|0
4729068|NCT03307837|7669647|FG005|Overall Study|Lost to Follow-up|1
4729069|NCT03308942|7669723|FG000|Stage 1 (up to a Maximum of 29 Months)|Withdrawal by Subject|2
4729070|NCT03308942|7669724|FG001|Stage 1 (up to a Maximum of 29 Months)|Withdrawal by Subject|2
4729071|NCT03308942|7669725|FG002|Stage 1 (up to a Maximum of 29 Months)|Withdrawal by Subject|2
4729072|NCT03308942|7669726|FG003|Stage 1 (up to a Maximum of 29 Months)|Withdrawal by Subject|0
4729073|NCT03308942|7669727|FG004|Stage 1 (up to a Maximum of 29 Months)|Withdrawal by Subject|0
4729074|NCT03308942|7669723|FG000|Stage 1 (up to a Maximum of 29 Months)|Death|8
4729075|NCT03308942|7669724|FG001|Stage 1 (up to a Maximum of 29 Months)|Death|15
4729076|NCT03308942|7669725|FG002|Stage 1 (up to a Maximum of 29 Months)|Death|1
4729077|NCT03308942|7669726|FG003|Stage 1 (up to a Maximum of 29 Months)|Death|0
4729078|NCT03308942|7669727|FG004|Stage 1 (up to a Maximum of 29 Months)|Death|0
4729079|NCT03308942|7669723|FG000|Stage 1 (up to a Maximum of 29 Months)|Ongoing at the time of analysis|7
4729080|NCT03308942|7669724|FG001|Stage 1 (up to a Maximum of 29 Months)|Ongoing at the time of analysis|4
4729081|NCT03308942|7669725|FG002|Stage 1 (up to a Maximum of 29 Months)|Ongoing at the time of analysis|0
4729082|NCT03308942|7669726|FG003|Stage 1 (up to a Maximum of 29 Months)|Ongoing at the time of analysis|0
4729083|NCT03308942|7669727|FG004|Stage 1 (up to a Maximum of 29 Months)|Ongoing at the time of analysis|0
4729084|NCT03308942|7669723|FG000|Stage 2 (up to a Maximum of 17 Months)|Withdrawal by Subject|0
4729085|NCT03308942|7669724|FG001|Stage 2 (up to a Maximum of 17 Months)|Withdrawal by Subject|0
4729086|NCT03308942|7669725|FG002|Stage 2 (up to a Maximum of 17 Months)|Withdrawal by Subject|0
4729087|NCT03308942|7669726|FG003|Stage 2 (up to a Maximum of 17 Months)|Withdrawal by Subject|3
4729088|NCT03308942|7669727|FG004|Stage 2 (up to a Maximum of 17 Months)|Withdrawal by Subject|0
4729089|NCT03308942|7669723|FG000|Stage 2 (up to a Maximum of 17 Months)|Death|0
4729090|NCT03308942|7669724|FG001|Stage 2 (up to a Maximum of 17 Months)|Death|0
4729091|NCT03308942|7669725|FG002|Stage 2 (up to a Maximum of 17 Months)|Death|0
4729092|NCT03308942|7669726|FG003|Stage 2 (up to a Maximum of 17 Months)|Death|4
4729093|NCT03308942|7669727|FG004|Stage 2 (up to a Maximum of 17 Months)|Death|0
4729094|NCT03308942|7669723|FG000|Stage 2 (up to a Maximum of 17 Months)|Ongoing at the time of analysis|0
4515276|NCT00952341|7326039|FG000|Cycle 1|Protocol Violation|2
4729095|NCT03308942|7669724|FG001|Stage 2 (up to a Maximum of 17 Months)|Ongoing at the time of analysis|0
4729096|NCT03308942|7669725|FG002|Stage 2 (up to a Maximum of 17 Months)|Ongoing at the time of analysis|0
4729097|NCT03308942|7669726|FG003|Stage 2 (up to a Maximum of 17 Months)|Ongoing at the time of analysis|5
4729098|NCT03308942|7669727|FG004|Stage 2 (up to a Maximum of 17 Months)|Ongoing at the time of analysis|0
4729099|NCT03308968|7669743|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3
4729100|NCT03308968|7669744|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1
4729101|NCT03308968|7669745|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4
4729102|NCT03308968|7669743|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2
4729103|NCT03308968|7669744|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2
4729104|NCT03308968|7669745|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3
4729105|NCT03308968|7669743|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6
4729106|NCT03308968|7669744|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0
4729107|NCT03308968|7669745|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2
4729108|NCT03308968|7669743|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1
4729109|NCT03308968|7669744|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1
4729110|NCT03308968|7669745|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0
4729111|NCT03308968|7669743|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1
4729112|NCT03308968|7669744|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0
4729113|NCT03308968|7669745|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0
4729114|NCT03308968|7669743|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1
4729115|NCT03308968|7669744|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1
4729116|NCT03308968|7669745|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0
4729117|NCT03308968|7669743|FG000|Double-Blind Period (12 Weeks)|Other than specified|1
4729118|NCT03308968|7669744|FG001|Double-Blind Period (12 Weeks)|Other than specified|0
4729119|NCT03308968|7669745|FG002|Double-Blind Period (12 Weeks)|Other than specified|2
4729120|NCT03308968|7669743|FG000|Open-Label Period (12 Weeks)|Other than specified|1
4729121|NCT03308968|7669744|FG001|Open-Label Period (12 Weeks)|Other than specified|2
4729122|NCT03308968|7669745|FG002|Open-Label Period (12 Weeks)|Other than specified|1
4729123|NCT03308968|7669743|FG000|Open-Label Period (12 Weeks)|Adverse Event|4
4729124|NCT03308968|7669744|FG001|Open-Label Period (12 Weeks)|Adverse Event|1
4729125|NCT03308968|7669745|FG002|Open-Label Period (12 Weeks)|Adverse Event|1
4729126|NCT03308968|7669743|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5
4729127|NCT03308968|7669744|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5
4729128|NCT03308968|7669745|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7
4729129|NCT03308968|7669743|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0
4729130|NCT03308968|7669744|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1
4729131|NCT03308968|7669745|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1
4729132|NCT03308968|7669743|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0
4729133|NCT03308968|7669744|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0
4729134|NCT03308968|7669745|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1
4729135|NCT03308968|7669743|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0
4729136|NCT03308968|7669744|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1
4729137|NCT03308968|7669745|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1
4729138|NCT03308968|7669743|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1
4729139|NCT03308968|7669744|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2
4729140|NCT03308968|7669745|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0
4729141|NCT03309020|7669758|FG000|Overall Study|Death|1
4729142|NCT03309020|7669759|FG001|Overall Study|Death|0
4729143|NCT03309020|7669758|FG000|Overall Study|Did not undergo surgery|2
4729144|NCT03309020|7669759|FG001|Overall Study|Did not undergo surgery|1
4729145|NCT03309202|7669771|FG000|Overall Study|Lost to Follow-up|1
4729146|NCT03309202|7669772|FG001|Overall Study|Lost to Follow-up|0
4729147|NCT03309202|7669773|FG002|Overall Study|Lost to Follow-up|0
4729148|NCT03309202|7669774|FG003|Overall Study|Lost to Follow-up|0
4729149|NCT03309605|7669805|FG000|Overall Study|Adverse Event|0
4729150|NCT03309605|7669806|FG001|Overall Study|Adverse Event|0
4729151|NCT03309605|7669807|FG002|Overall Study|Adverse Event|0
4729152|NCT03309605|7669808|FG003|Overall Study|Adverse Event|1
4729153|NCT03309605|7669809|FG004|Overall Study|Adverse Event|0
4729154|NCT03309605|7669810|FG005|Overall Study|Adverse Event|0
4729155|NCT03309605|7669811|FG006|Overall Study|Adverse Event|2
4729156|NCT03309605|7669812|FG007|Overall Study|Adverse Event|1
4729157|NCT03309605|7669805|FG000|Overall Study|Withdrawal by Subject|0
4729158|NCT03309605|7669806|FG001|Overall Study|Withdrawal by Subject|0
4729159|NCT03309605|7669807|FG002|Overall Study|Withdrawal by Subject|0
4729160|NCT03309605|7669808|FG003|Overall Study|Withdrawal by Subject|0
4729161|NCT03309605|7669809|FG004|Overall Study|Withdrawal by Subject|1
4729162|NCT03309605|7669810|FG005|Overall Study|Withdrawal by Subject|0
4729163|NCT03309605|7669811|FG006|Overall Study|Withdrawal by Subject|1
4729164|NCT03309605|7669812|FG007|Overall Study|Withdrawal by Subject|1
4729165|NCT03309696|7669832|FG000|Overall Study|Analysis of TEP data could not be completed|0
4729166|NCT03309696|7669833|FG001|Overall Study|Analysis of TEP data could not be completed|5
4729167|NCT03309696|7669834|FG002|Overall Study|Analysis of TEP data could not be completed|0
4729168|NCT03309696|7669835|FG003|Overall Study|Analysis of TEP data could not be completed|0
4729169|NCT03309943|7669864|FG000|Overall Study|Withdrawal by Subject|0
4729170|NCT03309943|7669865|FG001|Overall Study|Withdrawal by Subject|1
4729171|NCT03309943|7669864|FG000|Overall Study|Inappropriate behavior towards staff|0
4729172|NCT03309943|7669865|FG001|Overall Study|Inappropriate behavior towards staff|1
4729173|NCT03310021|7669891|FG000|Overall Study|Withdrawal by Subject|0
4729174|NCT03310021|7669892|FG001|Overall Study|Withdrawal by Subject|0
4729175|NCT03310021|7669893|FG002|Overall Study|Withdrawal by Subject|0
4729176|NCT03310021|7669894|FG003|Overall Study|Withdrawal by Subject|0
4729177|NCT03310021|7669895|FG004|Overall Study|Withdrawal by Subject|0
4729178|NCT03310021|7669896|FG005|Overall Study|Withdrawal by Subject|0
4729179|NCT03310021|7669897|FG006|Overall Study|Withdrawal by Subject|1
4729180|NCT03310021|7669898|FG007|Overall Study|Withdrawal by Subject|0
4729181|NCT03310021|7669899|FG008|Overall Study|Withdrawal by Subject|0
4729182|NCT03310021|7669900|FG009|Overall Study|Withdrawal by Subject|0
4729183|NCT03310021|7669901|FG010|Overall Study|Withdrawal by Subject|0
4729184|NCT03310021|7669902|FG011|Overall Study|Withdrawal by Subject|0
4729185|NCT03310021|7669903|FG012|Overall Study|Withdrawal by Subject|0
4729186|NCT03310021|7669904|FG013|Overall Study|Withdrawal by Subject|0
4729187|NCT03310021|7669905|FG014|Overall Study|Withdrawal by Subject|0
4729188|NCT03310021|7669906|FG015|Overall Study|Withdrawal by Subject|0
4729189|NCT03310021|7669907|FG016|Overall Study|Withdrawal by Subject|0
4729190|NCT03310021|7669908|FG017|Overall Study|Withdrawal by Subject|0
4729191|NCT03310021|7669909|FG018|Overall Study|Withdrawal by Subject|0
4729192|NCT03310021|7669910|FG019|Overall Study|Withdrawal by Subject|0
4729193|NCT03310021|7669891|FG000|Overall Study|Lost to Follow-up|0
4729194|NCT03310021|7669892|FG001|Overall Study|Lost to Follow-up|0
4729195|NCT03310021|7669893|FG002|Overall Study|Lost to Follow-up|0
4729196|NCT03310021|7669894|FG003|Overall Study|Lost to Follow-up|0
4729197|NCT03310021|7669895|FG004|Overall Study|Lost to Follow-up|0
4729198|NCT03310021|7669896|FG005|Overall Study|Lost to Follow-up|0
4729199|NCT03310021|7669897|FG006|Overall Study|Lost to Follow-up|0
4729200|NCT03310021|7669898|FG007|Overall Study|Lost to Follow-up|0
4729201|NCT03310021|7669899|FG008|Overall Study|Lost to Follow-up|0
4729202|NCT03310021|7669900|FG009|Overall Study|Lost to Follow-up|0
4729203|NCT03310021|7669901|FG010|Overall Study|Lost to Follow-up|1
4729204|NCT03310021|7669902|FG011|Overall Study|Lost to Follow-up|0
4729205|NCT03310021|7669903|FG012|Overall Study|Lost to Follow-up|0
4729206|NCT03310021|7669904|FG013|Overall Study|Lost to Follow-up|0
4729207|NCT03310021|7669905|FG014|Overall Study|Lost to Follow-up|0
4729208|NCT03310021|7669906|FG015|Overall Study|Lost to Follow-up|0
4729209|NCT03310021|7669907|FG016|Overall Study|Lost to Follow-up|0
4729210|NCT03310021|7669908|FG017|Overall Study|Lost to Follow-up|0
4729211|NCT03310021|7669909|FG018|Overall Study|Lost to Follow-up|0
4729212|NCT03310021|7669910|FG019|Overall Study|Lost to Follow-up|0
4729213|NCT03310268|7669955|FG000|Overall Study|(Not specified)|1
4729214|NCT03310268|7669956|FG001|Overall Study|(Not specified)|5
4729215|NCT03310268|7669957|FG002|Overall Study|(Not specified)|0
4729216|NCT03310411|7669965|FG000|Period 1|Adverse Event|0
4729217|NCT03310411|7669966|FG001|Period 1|Adverse Event|0
4729218|NCT03310411|7669967|FG002|Period 1|Adverse Event|0
4729219|NCT03310411|7669968|FG003|Period 1|Adverse Event|1
4729220|NCT03310580|7670003|FG000|Overall Study|Adverse Event|0
4729221|NCT03310580|7670004|FG001|Overall Study|Adverse Event|1
4729222|NCT03310580|7670005|FG002|Overall Study|Adverse Event|0
4729223|NCT03310723|7670016|FG000|Overall Study|Withdrawal by Subject|0
4729224|NCT03310723|7670017|FG001|Overall Study|Withdrawal by Subject|1
4729225|NCT03310723|7670016|FG000|Overall Study|Protocol Violation|0
4729226|NCT03310723|7670017|FG001|Overall Study|Protocol Violation|2
4729227|NCT03310775|7670025|FG000|Overall Study|Lost to Follow-up|2
4729228|NCT03310775|7670026|FG001|Overall Study|Lost to Follow-up|3
4729229|NCT03310775|7670025|FG000|Overall Study|aggravation of depression|0
4729230|NCT03310775|7670026|FG001|Overall Study|aggravation of depression|1
4729231|NCT03310970|7670032|FG000|Overall Study|Withdrawal by Subject|0
4729232|NCT03310970|7670033|FG001|Overall Study|Withdrawal by Subject|1
4729233|NCT03311230|7670044|FG000|Overall Study|Withdrawal by Subject|1
4729234|NCT03311230|7670045|FG001|Overall Study|Withdrawal by Subject|4
4729235|NCT03311230|7670046|FG002|Overall Study|Withdrawal by Subject|2
4729236|NCT03311230|7670047|FG003|Overall Study|Withdrawal by Subject|7
4729237|NCT03311230|7670044|FG000|Overall Study|Unrelated injury|0
4729238|NCT03311230|7670045|FG001|Overall Study|Unrelated injury|1
4729239|NCT03311230|7670046|FG002|Overall Study|Unrelated injury|0
4729240|NCT03311230|7670047|FG003|Overall Study|Unrelated injury|0
4729241|NCT03311373|7670057|FG000|Overall Study|Adverse Event|1
4729242|NCT03311373|7670057|FG000|Overall Study|Protocol Discontinuation Criteria|3
4729243|NCT03311373|7670057|FG000|Overall Study|Lost to Follow-up|1
4729244|NCT03311373|7670057|FG000|Overall Study|Physician Decision|1
4729245|NCT03311373|7670057|FG000|Overall Study|Withdrawal by Subject|3
4729246|NCT03311646|7670067|FG000|Overall Study|Physician Decision|1
4729247|NCT03311646|7670067|FG000|Overall Study|Withdrawal by Subject|5
4729248|NCT03311646|7670067|FG000|Overall Study|Lost to Follow-up|5
4729249|NCT03311646|7670067|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4
4729250|NCT03311659|7670072|FG000|Overall Study|Protocol Violation|1
4729251|NCT03311724|7670080|FG000|Overall Study|Physician Decision|0
4729252|NCT03311724|7670081|FG001|Overall Study|Physician Decision|0
4729253|NCT03311724|7670082|FG002|Overall Study|Physician Decision|0
4729254|NCT03311724|7670083|FG003|Overall Study|Physician Decision|1
4729255|NCT03311724|7670080|FG000|Overall Study|Protocol Violation|1
4729256|NCT03311724|7670081|FG001|Overall Study|Protocol Violation|0
4729257|NCT03311724|7670082|FG002|Overall Study|Protocol Violation|1
4729258|NCT03311724|7670083|FG003|Overall Study|Protocol Violation|0
4729259|NCT03311724|7670080|FG000|Overall Study|Withdrawal by Subject|1
4729260|NCT03311724|7670081|FG001|Overall Study|Withdrawal by Subject|1
4729261|NCT03311724|7670082|FG002|Overall Study|Withdrawal by Subject|0
4729262|NCT03311724|7670083|FG003|Overall Study|Withdrawal by Subject|0
4729263|NCT03311724|7670080|FG000|Overall Study|Lost to Follow-up|1
4729264|NCT03311724|7670081|FG001|Overall Study|Lost to Follow-up|0
4729265|NCT03311724|7670082|FG002|Overall Study|Lost to Follow-up|0
4729266|NCT03311724|7670083|FG003|Overall Study|Lost to Follow-up|0
4729267|NCT03311724|7670080|FG000|Overall Study|Sponsor Decision|0
4729268|NCT03311724|7670081|FG001|Overall Study|Sponsor Decision|0
4729269|NCT03311724|7670082|FG002|Overall Study|Sponsor Decision|1
4729270|NCT03311724|7670083|FG003|Overall Study|Sponsor Decision|0
4729271|NCT03311841|7670101|FG000|14-day Wash-out|Adverse Event|0
4729272|NCT03311841|7670102|FG001|14-day Wash-out|Adverse Event|1
4729273|NCT03311841|7670103|FG002|14-day Wash-out|Adverse Event|0
4729274|NCT03311841|7670104|FG003|14-day Wash-out|Adverse Event|0
4729275|NCT03311841|7670105|FG004|14-day Wash-out|Adverse Event|0
4729276|NCT03311841|7670101|FG000|14-day Wash-out|Non-Compliance With Study Drug|0
4729277|NCT03311841|7670102|FG001|14-day Wash-out|Non-Compliance With Study Drug|0
4729278|NCT03311841|7670103|FG002|14-day Wash-out|Non-Compliance With Study Drug|0
4729279|NCT03311841|7670104|FG003|14-day Wash-out|Non-Compliance With Study Drug|1
4729280|NCT03311841|7670105|FG004|14-day Wash-out|Non-Compliance With Study Drug|0
4729281|NCT03312114|7670144|FG000|Overall Study|All the five enrolled dropped out of the|5
4729282|NCT03312218|7670151|FG000|Overall Study|Never signed in to access the app|54
4729283|NCT03312218|7670152|FG001|Overall Study|Never signed in to access the app|58
4729284|NCT03312231|7670163|FG000|Overall Study|Lost to Follow-up|2
4729285|NCT03312231|7670164|FG001|Overall Study|Lost to Follow-up|6
4729286|NCT03312231|7670165|FG002|Overall Study|Lost to Follow-up|1
4729287|NCT03312231|7670166|FG003|Overall Study|Lost to Follow-up|3
4729288|NCT03312231|7670167|FG004|Overall Study|Lost to Follow-up|1
4729289|NCT03312231|7670163|FG000|Overall Study|Withdrawal by Subject|0
4729290|NCT03312231|7670164|FG001|Overall Study|Withdrawal by Subject|3
4729291|NCT03312231|7670165|FG002|Overall Study|Withdrawal by Subject|1
4729292|NCT03312231|7670166|FG003|Overall Study|Withdrawal by Subject|0
4729293|NCT03312231|7670167|FG004|Overall Study|Withdrawal by Subject|0
4729294|NCT03312231|7670163|FG000|Overall Study|Death|0
4729295|NCT03312231|7670164|FG001|Overall Study|Death|1
4729296|NCT03312231|7670165|FG002|Overall Study|Death|1
4729297|NCT03312231|7670166|FG003|Overall Study|Death|0
4729298|NCT03312231|7670167|FG004|Overall Study|Death|0
4729299|NCT03312231|7670163|FG000|Overall Study|Study Vaccination not Received|1
4729300|NCT03312231|7670164|FG001|Overall Study|Study Vaccination not Received|1
4729301|NCT03312231|7670165|FG002|Overall Study|Study Vaccination not Received|1
4729302|NCT03312231|7670166|FG003|Overall Study|Study Vaccination not Received|0
4729303|NCT03312231|7670167|FG004|Overall Study|Study Vaccination not Received|0
4729304|NCT03312543|7670198|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0
4729305|NCT03312543|7670199|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2
4729306|NCT03312543|7670198|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1
4729307|NCT03312543|7670199|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2
4729308|NCT03312543|7670198|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3
4729309|NCT03312543|7670199|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4
4729310|NCT03312543|7670198|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1
4729311|NCT03312543|7670199|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1
4729312|NCT03312543|7670198|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1
4729313|NCT03312543|7670199|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1
4729314|NCT03312543|7670198|FG000|Regression (Week 12 to Week 24)|Death|0
4729315|NCT03312543|7670199|FG001|Regression (Week 12 to Week 24)|Death|1
4729316|NCT03312933|7670209|FG000|Overall Study|Protocol Violation|15
4729317|NCT03312933|7670209|FG000|Overall Study|Lost to Follow-up|36
4729318|NCT03312933|7670209|FG000|Overall Study|Withdrawal by Subject|3
4729319|NCT03313037|7670215|FG000|Overall Study|Protocol Violation|4
4729320|NCT03313037|7670216|FG001|Overall Study|Protocol Violation|1
4729321|NCT03313037|7670215|FG000|Overall Study|Other|1
4729322|NCT03313037|7670216|FG001|Overall Study|Other|1
4729323|NCT03313037|7670215|FG000|Overall Study|Withdrawal by Subject|4
4729324|NCT03313037|7670216|FG001|Overall Study|Withdrawal by Subject|3
4729325|NCT03313037|7670215|FG000|Overall Study|No longer meets eligibility criteria|1
4729326|NCT03313037|7670216|FG001|Overall Study|No longer meets eligibility criteria|7
4729327|NCT03313037|7670215|FG000|Overall Study|Lost to Follow-up|9
4729328|NCT03313037|7670216|FG001|Overall Study|Lost to Follow-up|8
4729329|NCT03313037|7670215|FG000|Overall Study|Randomized but not treated|1
4729330|NCT03313037|7670216|FG001|Overall Study|Randomized but not treated|0
4729331|NCT03313050|7670226|FG000|Stage 2: 12 Months|Adverse Event|0
4729332|NCT03313050|7670227|FG001|Stage 2: 12 Months|Adverse Event|0
4729333|NCT03313050|7670228|FG002|Stage 2: 12 Months|Adverse Event|0
4729334|NCT03313050|7670229|FG003|Stage 2: 12 Months|Adverse Event|1
4729335|NCT03313050|7670226|FG000|Stage 2: 12 Months|Death|0
4729336|NCT03313050|7670227|FG001|Stage 2: 12 Months|Death|0
4729337|NCT03313050|7670228|FG002|Stage 2: 12 Months|Death|3
4729338|NCT03313050|7670229|FG003|Stage 2: 12 Months|Death|0
4729339|NCT03313050|7670226|FG000|Stage 2: 12 Months|Lost to Follow-up|0
4729340|NCT03313050|7670227|FG001|Stage 2: 12 Months|Lost to Follow-up|0
4729341|NCT03313050|7670228|FG002|Stage 2: 12 Months|Lost to Follow-up|1
4729342|NCT03313050|7670229|FG003|Stage 2: 12 Months|Lost to Follow-up|5
4729343|NCT03313050|7670226|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0
4729344|NCT03313050|7670227|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0
4729345|NCT03313050|7670228|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0
4729346|NCT03313050|7670229|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3
4729347|NCT03313050|7670226|FG000|Stage 2: 12 Months|Protocol deviation|0
4729348|NCT03313050|7670227|FG001|Stage 2: 12 Months|Protocol deviation|0
4729349|NCT03313050|7670228|FG002|Stage 2: 12 Months|Protocol deviation|7
4729350|NCT03313050|7670229|FG003|Stage 2: 12 Months|Protocol deviation|7
4729351|NCT03313050|7670226|FG000|Stage 2: 12 Months|Withdrawal by Subject|0
4729352|NCT03313050|7670227|FG001|Stage 2: 12 Months|Withdrawal by Subject|0
4729353|NCT03313050|7670228|FG002|Stage 2: 12 Months|Withdrawal by Subject|0
4729354|NCT03313050|7670229|FG003|Stage 2: 12 Months|Withdrawal by Subject|3
4729355|NCT03313050|7670226|FG000|Stage 2: 12 Months|Other|0
4729356|NCT03313050|7670227|FG001|Stage 2: 12 Months|Other|0
4729357|NCT03313050|7670228|FG002|Stage 2: 12 Months|Other|0
4729358|NCT03313050|7670229|FG003|Stage 2: 12 Months|Other|1
4729359|NCT03313076|7670243|FG000|Overall Study|Withdrawal by Subject|2
4729360|NCT03313076|7670244|FG001|Overall Study|Withdrawal by Subject|0
4729361|NCT03313076|7670245|FG002|Overall Study|Withdrawal by Subject|0
4729362|NCT03313076|7670246|FG003|Overall Study|Withdrawal by Subject|0
4729363|NCT03313076|7670243|FG000|Overall Study|Lost to Follow-up|0
4729364|NCT03313076|7670244|FG001|Overall Study|Lost to Follow-up|2
4729365|NCT03313076|7670245|FG002|Overall Study|Lost to Follow-up|2
4729366|NCT03313076|7670246|FG003|Overall Study|Lost to Follow-up|2
4729367|NCT03313310|7670264|FG000|Phase 2|Lost to Follow-up|4
4729368|NCT03313310|7670265|FG001|Phase 2|Lost to Follow-up|0
4729369|NCT03313310|7670264|FG000|Phase 3|Lost to Follow-up|0
4729370|NCT03313310|7670265|FG001|Phase 3|Lost to Follow-up|1
4729371|NCT03314233|7670271|FG000|Overall Study|No longer eligible at time of delivery|1
4729372|NCT03314519|7670277|FG000|Overall Study|Protocol Violation|3
4729373|NCT03314519|7670278|FG001|Overall Study|Protocol Violation|2
4729374|NCT03314662|7670287|FG000|Overall Study|Withdrawal by Subject|1
4729375|NCT03314662|7670288|FG001|Overall Study|Withdrawal by Subject|1
4729376|NCT03314662|7670289|FG002|Overall Study|Withdrawal by Subject|1
4729377|NCT03314662|7670287|FG000|Overall Study|Lost to Follow-up|5
4772283|NCT02471144|7749282|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
4772284|NCT02471144|7749283|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
4772285|NCT02471144|7749284|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
4772286|NCT02471144|7749285|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
4772287|NCT02471144|7749286|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2
4772288|NCT02471144|7749287|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1
4772289|NCT02471144|7749288|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
4772290|NCT02471144|7749289|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0
4772291|NCT02471144|7749279|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
4772292|NCT02471144|7749280|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
4772293|NCT02471144|7749281|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
4772294|NCT02471144|7749282|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
4772295|NCT02471144|7749283|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
4772296|NCT02471144|7749284|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
4772297|NCT02471144|7749285|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
4772298|NCT02471144|7749286|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
4772299|NCT02471144|7749287|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0
4772300|NCT02471144|7749288|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|5
4772301|NCT02471144|7749289|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|2
4772302|NCT02471144|7749279|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0
4772303|NCT02471144|7749280|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0
4772304|NCT02471144|7749281|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0
4772305|NCT02471144|7749282|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0
4772306|NCT02471144|7749283|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0
4772307|NCT02471144|7749284|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0
4772308|NCT02471144|7749285|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0
4772309|NCT02471144|7749286|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0
4772310|NCT02471144|7749287|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0
4772311|NCT02471144|7749288|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2
4772312|NCT02471144|7749289|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0
4772313|NCT02471144|7749279|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
4772314|NCT02471144|7749280|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
4515277|NCT00952341|7326040|FG001|Cycle 1|Protocol Violation|1
4729378|NCT03314662|7670288|FG001|Overall Study|Lost to Follow-up|4
4729379|NCT03314662|7670289|FG002|Overall Study|Lost to Follow-up|4
4729380|NCT03314662|7670287|FG000|Overall Study|Death|2
4729381|NCT03314662|7670288|FG001|Overall Study|Death|0
4729382|NCT03314662|7670289|FG002|Overall Study|Death|0
4729383|NCT03314857|7670314|FG000|Overall Study|Death|4
4729384|NCT03314857|7670314|FG000|Overall Study|Physician Decision|1
4729385|NCT03315208|7670333|FG000|Overall Study|Lost to Follow-up|11
4729386|NCT03315208|7670334|FG001|Overall Study|Lost to Follow-up|6
4729387|NCT03315208|7670333|FG000|Overall Study|Withdrawal by Subject|2
4729388|NCT03315208|7670334|FG001|Overall Study|Withdrawal by Subject|0
4729389|NCT03315286|7670343|FG000|Overall Study|Lost to Follow-up|0
4729390|NCT03315286|7670344|FG001|Overall Study|Lost to Follow-up|3
4729391|NCT03315286|7670343|FG000|Overall Study|Withdrawal by Subject|1
4729392|NCT03315286|7670344|FG001|Overall Study|Withdrawal by Subject|0
4729393|NCT03315286|7670343|FG000|Overall Study|Protocol Violation|0
4729394|NCT03315286|7670344|FG001|Overall Study|Protocol Violation|1
4729395|NCT03315689|7670369|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1
4729396|NCT03315689|7670370|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0
4729397|NCT03315689|7670369|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0
4729398|NCT03315689|7670370|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2
4729399|NCT03315689|7670369|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0
4729400|NCT03315689|7670370|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1
4729401|NCT03315793|7670392|FG000|Overall Study|Adverse Event|4
4729402|NCT03315793|7670393|FG001|Overall Study|Adverse Event|2
4729403|NCT03315793|7670392|FG000|Overall Study|Protocol Deviation|1
4729404|NCT03315793|7670393|FG001|Overall Study|Protocol Deviation|0
4729405|NCT03315793|7670392|FG000|Overall Study|Difficult for regular visit|0
4729406|NCT03315793|7670393|FG001|Overall Study|Difficult for regular visit|1
4729407|NCT03316131|7670410|FG000|Treatment Period 2|Protocol deviation|1
4729408|NCT03316131|7670411|FG001|Treatment Period 2|Protocol deviation|0
4729409|NCT03316170|7670419|FG000|Overall Study|Death|1
4729410|NCT03316170|7670420|FG001|Overall Study|Death|0
4729411|NCT03316170|7670419|FG000|Overall Study|Lost to Follow-up|6
4729412|NCT03316170|7670420|FG001|Overall Study|Lost to Follow-up|7
4729413|NCT03316547|7670439|FG000|Overall Study|Death|3
4729414|NCT03316547|7670440|FG001|Overall Study|Death|1
4729415|NCT03316547|7670439|FG000|Overall Study|Lost to Follow-up|6
4729416|NCT03316547|7670440|FG001|Overall Study|Lost to Follow-up|6
4729417|NCT03316547|7670439|FG000|Overall Study|Withdrawal by Subject|3
4729418|NCT03316547|7670440|FG001|Overall Study|Withdrawal by Subject|2
4729419|NCT03316547|7670439|FG000|Overall Study|Transfer to another hospital|6
4729420|NCT03316547|7670440|FG001|Overall Study|Transfer to another hospital|4
4729421|NCT03316911|7670450|FG000|Overall Study|Lost to Follow-up|33
4729422|NCT03316911|7670451|FG001|Overall Study|Lost to Follow-up|29
4729423|NCT03317379|7670500|FG000|Overall Study|Lost to Follow-up|0
4729424|NCT03317379|7670501|FG001|Overall Study|Lost to Follow-up|3
4729425|NCT03317379|7670502|FG002|Overall Study|Lost to Follow-up|2
4729426|NCT03318315|7670526|FG000|Overall Study|Lost to Follow-up|3
4729427|NCT03318315|7670527|FG001|Overall Study|Lost to Follow-up|2
4729428|NCT03318315|7670528|FG002|Overall Study|Lost to Follow-up|1
4729429|NCT03318315|7670526|FG000|Overall Study|Protocol Violation|1
4729430|NCT03318315|7670527|FG001|Overall Study|Protocol Violation|1
4729431|NCT03318315|7670528|FG002|Overall Study|Protocol Violation|1
4729432|NCT03318315|7670526|FG000|Overall Study|Withdrawal by Subject|0
4729433|NCT03318315|7670527|FG001|Overall Study|Withdrawal by Subject|0
4729434|NCT03318315|7670528|FG002|Overall Study|Withdrawal by Subject|2
4729435|NCT03318783|7670550|FG000|Overall Study|Withdrawal by Subject|0
4729436|NCT03318783|7670551|FG001|Overall Study|Withdrawal by Subject|1
4729437|NCT03318783|7670550|FG000|Overall Study|Death|0
4729438|NCT03318783|7670551|FG001|Overall Study|Death|1
4729439|NCT03319212|7670594|FG000|Overall Study|Discontinued as moving out of local area|0
4729440|NCT03319212|7670595|FG001|Overall Study|Discontinued as moving out of local area|1
4729441|NCT03319212|7670594|FG000|Overall Study|Adverse Event|2
4729442|NCT03319212|7670595|FG001|Overall Study|Adverse Event|2
4729443|NCT03319212|7670594|FG000|Overall Study|Withdrawal by Subject|0
4729444|NCT03319212|7670595|FG001|Overall Study|Withdrawal by Subject|1
4729445|NCT03319212|7670594|FG000|Overall Study|Lost to Follow-up|0
4729446|NCT03319212|7670595|FG001|Overall Study|Lost to Follow-up|1
4729447|NCT03319212|7670594|FG000|Overall Study|Physician Decision|1
4729448|NCT03319212|7670595|FG001|Overall Study|Physician Decision|0
4729449|NCT03319719|7670609|FG000|Overall Study|Lost to Follow-up|1
4729450|NCT03319953|7670623|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1
4729451|NCT03319953|7670624|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0
4729452|NCT03319953|7670625|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0
4729453|NCT03319953|7670626|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0
4729454|NCT03319953|7670623|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0
4729455|NCT03319953|7670624|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0
4729456|NCT03319953|7670625|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1
4729457|NCT03319953|7670626|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1
4729458|NCT03320057|7670634|FG000|Overall Study|Lost to Follow-up|4
4729459|NCT03320057|7670635|FG001|Overall Study|Lost to Follow-up|17
4729460|NCT03320057|7670634|FG000|Overall Study|Did not take mifepristone or misoprostol|2
4729461|NCT03320057|7670635|FG001|Overall Study|Did not take mifepristone or misoprostol|0
4729462|NCT03320369|7670645|FG000|Overall Study|Adverse Event|1
4729463|NCT03320369|7670645|FG000|Overall Study|Withdrawal by Subject|2
4737093|NCT03594071|7686897|FG000|Overall Study|Re-operation|3
4737094|NCT03594071|7686897|FG000|Overall Study|Missed visit|2
4737095|NCT03594227|7686905|FG000|Overall Study|Adverse Event|2
4737096|NCT03594227|7686906|FG001|Overall Study|Adverse Event|1
4737097|NCT03594227|7686907|FG002|Overall Study|Adverse Event|0
4737098|NCT03594227|7686908|FG003|Overall Study|Adverse Event|2
4737099|NCT03594227|7686905|FG000|Overall Study|Lost to Follow-up|1
4737100|NCT03594227|7686906|FG001|Overall Study|Lost to Follow-up|1
4737101|NCT03594227|7686907|FG002|Overall Study|Lost to Follow-up|1
4737102|NCT03594227|7686908|FG003|Overall Study|Lost to Follow-up|0
4737103|NCT03594227|7686905|FG000|Overall Study|Withdrawal by Subject|1
4737104|NCT03594227|7686906|FG001|Overall Study|Withdrawal by Subject|1
4737105|NCT03594227|7686907|FG002|Overall Study|Withdrawal by Subject|1
4737106|NCT03594227|7686908|FG003|Overall Study|Withdrawal by Subject|1
4737107|NCT03594227|7686905|FG000|Overall Study|Pregnancy|0
4737108|NCT03594227|7686906|FG001|Overall Study|Pregnancy|1
4737109|NCT03594227|7686907|FG002|Overall Study|Pregnancy|0
4737110|NCT03594227|7686908|FG003|Overall Study|Pregnancy|0
4737111|NCT03594227|7686905|FG000|Overall Study|Sponsor Decision|0
4737112|NCT03594227|7686906|FG001|Overall Study|Sponsor Decision|0
4737113|NCT03594227|7686907|FG002|Overall Study|Sponsor Decision|0
4737114|NCT03594227|7686908|FG003|Overall Study|Sponsor Decision|1
4737115|NCT03594227|7686905|FG000|Overall Study|Programmatic Analysis Non-completer|1
4737116|NCT03594227|7686906|FG001|Overall Study|Programmatic Analysis Non-completer|0
4737117|NCT03594227|7686907|FG002|Overall Study|Programmatic Analysis Non-completer|1
4737118|NCT03594227|7686908|FG003|Overall Study|Programmatic Analysis Non-completer|1
4737119|NCT03595176|7686943|FG000|Overall Study|Death|0
4737120|NCT03595176|7686944|FG001|Overall Study|Death|2
4737121|NCT03595176|7686943|FG000|Overall Study|Lost to Follow-up|0
4737122|NCT03595176|7686944|FG001|Overall Study|Lost to Follow-up|1
4737123|NCT03595280|7686956|FG000|Overall Study|Lost to Follow-up|6
4737124|NCT03595280|7686957|FG001|Overall Study|Lost to Follow-up|9
4737125|NCT03595280|7686958|FG002|Overall Study|Lost to Follow-up|15
4737126|NCT03595618|7686988|FG000|Overall Study|Adverse Event|16
4737127|NCT03595618|7686989|FG001|Overall Study|Adverse Event|17
4737128|NCT03595618|7686990|FG002|Overall Study|Adverse Event|20
4737129|NCT03595618|7686991|FG003|Overall Study|Adverse Event|8
4737130|NCT03595618|7686988|FG000|Overall Study|Withdrawal by Subject|12
4737131|NCT03595618|7686989|FG001|Overall Study|Withdrawal by Subject|14
4737132|NCT03595618|7686990|FG002|Overall Study|Withdrawal by Subject|14
4737133|NCT03595618|7686991|FG003|Overall Study|Withdrawal by Subject|10
4737134|NCT03595618|7686988|FG000|Overall Study|Lost to Follow-up|6
4737135|NCT03595618|7686989|FG001|Overall Study|Lost to Follow-up|4
4737136|NCT03595618|7686990|FG002|Overall Study|Lost to Follow-up|5
4737137|NCT03595618|7686991|FG003|Overall Study|Lost to Follow-up|6
4737138|NCT03595618|7686988|FG000|Overall Study|Protocol Violation|2
4737139|NCT03595618|7686989|FG001|Overall Study|Protocol Violation|0
4737140|NCT03595618|7686990|FG002|Overall Study|Protocol Violation|6
4737141|NCT03595618|7686991|FG003|Overall Study|Protocol Violation|2
4737142|NCT03595618|7686988|FG000|Overall Study|Physician Decision|0
4737143|NCT03595618|7686989|FG001|Overall Study|Physician Decision|0
4737144|NCT03595618|7686990|FG002|Overall Study|Physician Decision|1
4737145|NCT03595618|7686991|FG003|Overall Study|Physician Decision|2
4737146|NCT03595618|7686988|FG000|Overall Study|Miscellaneous|7
4737147|NCT03595618|7686989|FG001|Overall Study|Miscellaneous|5
4737148|NCT03595618|7686990|FG002|Overall Study|Miscellaneous|10
4737149|NCT03595618|7686991|FG003|Overall Study|Miscellaneous|6
4737150|NCT03595904|7687003|FG000|Overall Study|Protocol Violation|3
4737151|NCT03595904|7687004|FG001|Overall Study|Protocol Violation|1
4737152|NCT03595904|7687003|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4
4737153|NCT03595904|7687004|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3
4737154|NCT03595904|7687003|FG000|Overall Study|Insurance complications|1
4737155|NCT03595904|7687004|FG001|Overall Study|Insurance complications|0
4737156|NCT03595904|7687003|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2
4737157|NCT03595904|7687004|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1
4737158|NCT03596151|7687010|FG000|Overall Study|Withdrawal by Subject|1
4737159|NCT03596177|7687016|FG000|Single Blind Period|Withdrawal by Subject|1
4737160|NCT03596177|7687017|FG001|Single Blind Period|Withdrawal by Subject|1
4737161|NCT03596177|7687016|FG000|Single Blind Period|Other|1
4737162|NCT03596177|7687017|FG001|Single Blind Period|Other|0
4737163|NCT03596177|7687016|FG000|Double Blind Period|Withdrawal by Subject|0
4737164|NCT03596177|7687017|FG001|Double Blind Period|Withdrawal by Subject|1
4737165|NCT03596177|7687016|FG000|Double Blind Period|Other|0
4737166|NCT03596177|7687017|FG001|Double Blind Period|Other|4
4737167|NCT03596177|7687016|FG000|Double Blind Period|Death during safety follow-up|0
4737168|NCT03596177|7687017|FG001|Double Blind Period|Death during safety follow-up|1
4737169|NCT03597022|7687039|FG000|Overall Study|Premature termination of the study|7
4737170|NCT03597022|7687040|FG001|Overall Study|Premature termination of the study|7
4737171|NCT03597022|7687041|FG002|Overall Study|Premature termination of the study|8
4737172|NCT03597022|7687039|FG000|Overall Study|Serious adverse event|1
4737173|NCT03597022|7687040|FG001|Overall Study|Serious adverse event|1
4737174|NCT03597022|7687041|FG002|Overall Study|Serious adverse event|0
4737175|NCT03597061|7687051|FG000|Overall Study|Lost to Follow-up|1
4729464|NCT03320824|7670651|FG000|Overall Study|Withdrawal by Subject|8
4729465|NCT03320824|7670652|FG001|Overall Study|Withdrawal by Subject|1
4729466|NCT03320824|7670651|FG000|Overall Study|Lost to Follow-up|10
4729467|NCT03320824|7670652|FG001|Overall Study|Lost to Follow-up|1
4729468|NCT03320824|7670651|FG000|Overall Study|moved out of state|0
4729469|NCT03320824|7670652|FG001|Overall Study|moved out of state|1
4729470|NCT03320824|7670651|FG000|Overall Study|could not complete final visit|0
4729471|NCT03320824|7670652|FG001|Overall Study|could not complete final visit|1
4729472|NCT03320850|7670668|FG000|Overall Study|Lost to Follow-up|0
4729473|NCT03320850|7670669|FG001|Overall Study|Lost to Follow-up|0
4729474|NCT03320850|7670670|FG002|Overall Study|Lost to Follow-up|0
4729475|NCT03320850|7670671|FG003|Overall Study|Lost to Follow-up|0
4729476|NCT03320850|7670672|FG004|Overall Study|Lost to Follow-up|1
4590587|NCT01523301|7436718|FG001|Overall Study|Lack of Efficacy|2
4590588|NCT01523301|7436717|FG000|Overall Study|Protocol Violation|3
4590589|NCT01523301|7436718|FG001|Overall Study|Protocol Violation|4
4729477|NCT03320850|7670673|FG005|Overall Study|Lost to Follow-up|2
4729478|NCT03320850|7670674|FG006|Overall Study|Lost to Follow-up|2
4729479|NCT03320850|7670675|FG007|Overall Study|Lost to Follow-up|0
4729480|NCT03320850|7670676|FG008|Overall Study|Lost to Follow-up|6
4729481|NCT03320850|7670677|FG009|Overall Study|Lost to Follow-up|4
4729482|NCT03320850|7670668|FG000|Overall Study|Withdrawal by Subject|0
4729483|NCT03320850|7670669|FG001|Overall Study|Withdrawal by Subject|0
4729484|NCT03320850|7670670|FG002|Overall Study|Withdrawal by Subject|0
4729485|NCT03320850|7670671|FG003|Overall Study|Withdrawal by Subject|0
4729486|NCT03320850|7670672|FG004|Overall Study|Withdrawal by Subject|1
4729487|NCT03320850|7670673|FG005|Overall Study|Withdrawal by Subject|2
4729488|NCT03320850|7670674|FG006|Overall Study|Withdrawal by Subject|4
4729489|NCT03320850|7670675|FG007|Overall Study|Withdrawal by Subject|5
4729490|NCT03320850|7670676|FG008|Overall Study|Withdrawal by Subject|2
4729491|NCT03320850|7670677|FG009|Overall Study|Withdrawal by Subject|1
4729492|NCT03320850|7670668|FG000|Overall Study|Lack of Efficacy|0
4729493|NCT03320850|7670669|FG001|Overall Study|Lack of Efficacy|0
4729494|NCT03320850|7670670|FG002|Overall Study|Lack of Efficacy|0
4729495|NCT03320850|7670671|FG003|Overall Study|Lack of Efficacy|1
4729496|NCT03320850|7670672|FG004|Overall Study|Lack of Efficacy|0
4729497|NCT03320850|7670673|FG005|Overall Study|Lack of Efficacy|1
4729498|NCT03320850|7670674|FG006|Overall Study|Lack of Efficacy|0
4729499|NCT03320850|7670675|FG007|Overall Study|Lack of Efficacy|2
4729500|NCT03320850|7670676|FG008|Overall Study|Lack of Efficacy|0
4729501|NCT03320850|7670677|FG009|Overall Study|Lack of Efficacy|3
4729502|NCT03320850|7670668|FG000|Overall Study|Failure to Meet Randomization Criteria|0
4729503|NCT03320850|7670669|FG001|Overall Study|Failure to Meet Randomization Criteria|0
4729504|NCT03320850|7670670|FG002|Overall Study|Failure to Meet Randomization Criteria|0
4729505|NCT03320850|7670671|FG003|Overall Study|Failure to Meet Randomization Criteria|0
4729506|NCT03320850|7670672|FG004|Overall Study|Failure to Meet Randomization Criteria|0
4729507|NCT03320850|7670673|FG005|Overall Study|Failure to Meet Randomization Criteria|1
4729508|NCT03320850|7670674|FG006|Overall Study|Failure to Meet Randomization Criteria|0
4729509|NCT03320850|7670675|FG007|Overall Study|Failure to Meet Randomization Criteria|0
4729510|NCT03320850|7670676|FG008|Overall Study|Failure to Meet Randomization Criteria|0
4729511|NCT03320850|7670677|FG009|Overall Study|Failure to Meet Randomization Criteria|0
4729512|NCT03320850|7670668|FG000|Overall Study|Adverse Event|0
4729513|NCT03320850|7670669|FG001|Overall Study|Adverse Event|0
4729514|NCT03320850|7670670|FG002|Overall Study|Adverse Event|0
4729515|NCT03320850|7670671|FG003|Overall Study|Adverse Event|0
4729516|NCT03320850|7670672|FG004|Overall Study|Adverse Event|0
4729517|NCT03320850|7670673|FG005|Overall Study|Adverse Event|2
4729518|NCT03320850|7670674|FG006|Overall Study|Adverse Event|1
4729519|NCT03320850|7670675|FG007|Overall Study|Adverse Event|0
4729520|NCT03320850|7670676|FG008|Overall Study|Adverse Event|2
4729521|NCT03320850|7670677|FG009|Overall Study|Adverse Event|0
4729522|NCT03320850|7670668|FG000|Overall Study|Reason Not Specified|0
4729523|NCT03320850|7670669|FG001|Overall Study|Reason Not Specified|0
4729524|NCT03320850|7670670|FG002|Overall Study|Reason Not Specified|0
4729525|NCT03320850|7670671|FG003|Overall Study|Reason Not Specified|0
4729526|NCT03320850|7670672|FG004|Overall Study|Reason Not Specified|0
4729527|NCT03320850|7670673|FG005|Overall Study|Reason Not Specified|1
4729528|NCT03320850|7670674|FG006|Overall Study|Reason Not Specified|0
4729529|NCT03320850|7670675|FG007|Overall Study|Reason Not Specified|0
4729530|NCT03320850|7670676|FG008|Overall Study|Reason Not Specified|0
4729531|NCT03320850|7670677|FG009|Overall Study|Reason Not Specified|1
4729532|NCT03320941|7670709|FG000|Overall Study|subject/guardian decision|0
4729533|NCT03320941|7670710|FG001|Overall Study|subject/guardian decision|0
4729534|NCT03320941|7670711|FG002|Overall Study|subject/guardian decision|0
4729535|NCT03320941|7670712|FG003|Overall Study|subject/guardian decision|1
4729536|NCT03320941|7670713|FG004|Overall Study|subject/guardian decision|0
4729537|NCT03321006|7670727|FG000|Overall Study|Death|1
4729538|NCT03321006|7670728|FG001|Overall Study|Death|0
4729539|NCT03321006|7670727|FG000|Overall Study|Lack of Efficacy|1
4729540|NCT03321006|7670728|FG001|Overall Study|Lack of Efficacy|0
4729541|NCT03321396|7670747|FG000|Overall Study|Physician Decision|1
4729542|NCT03321721|7670754|FG000|Overall Study|Lost to Follow-up|4
4590590|NCT01523301|7436717|FG000|Overall Study|Lost to Follow-up|1
4729543|NCT03321721|7670755|FG001|Overall Study|Lost to Follow-up|8
4729544|NCT03321721|7670756|FG002|Overall Study|Lost to Follow-up|11
4729545|NCT03322423|7670765|FG000|Period 1|Subject no longer eligible|0
4729546|NCT03322423|7670766|FG001|Period 1|Subject no longer eligible|1
4729547|NCT03322423|7670765|FG000|Period 1|Withdrawal by Subject|0
4729548|NCT03322423|7670766|FG001|Period 1|Withdrawal by Subject|1
4729549|NCT03322423|7670765|FG000|Period 1|Incorrect Lens Dispensed|1
4729550|NCT03322423|7670766|FG001|Period 1|Incorrect Lens Dispensed|0
4729551|NCT03322423|7670765|FG000|Period 1|Unsatisfactory Lens Fitting|1
4729552|NCT03322423|7670766|FG001|Period 1|Unsatisfactory Lens Fitting|0
4729553|NCT03322423|7670765|FG000|Period 2|Dispensed incorrect lens in left eye|0
4729554|NCT03322423|7670766|FG001|Period 2|Dispensed incorrect lens in left eye|1
4729555|NCT03322423|7670765|FG000|Period 2|Protocol Violation|1
4729556|NCT03322423|7670766|FG001|Period 2|Protocol Violation|0
4729557|NCT03322423|7670765|FG000|Period 2|Subject not eligible for Pytergiumectomy|0
4729558|NCT03322423|7670766|FG001|Period 2|Subject not eligible for Pytergiumectomy|1
4729559|NCT03322462|7670772|FG000|Overall Study|Technical difficulties|2
4729560|NCT03322462|7670772|FG000|Overall Study|Other|1
4729561|NCT03322514|7670780|FG000|Overall Study|Withdrawal by Subject|1
4729562|NCT03322514|7670781|FG001|Overall Study|Withdrawal by Subject|1
4729563|NCT03323086|7670807|FG000|Overall Study|Lost to Follow-up|3
4729564|NCT03323086|7670808|FG001|Overall Study|Lost to Follow-up|2
4729565|NCT03323164|7670816|FG000|Overall Study|Poor quality imaging/scans|2
4729566|NCT03323164|7670817|FG001|Overall Study|Poor quality imaging/scans|2
4729567|NCT03323736|7670839|FG000|Overall Study|Screen Failure|14
4729568|NCT03323736|7670840|FG001|Overall Study|Screen Failure|9
4729569|NCT03323736|7670841|FG002|Overall Study|Screen Failure|1
4729570|NCT03323736|7670839|FG000|Overall Study|Withdrawal Before Treatment|3
4729571|NCT03323736|7670840|FG001|Overall Study|Withdrawal Before Treatment|1
4729572|NCT03323736|7670841|FG002|Overall Study|Withdrawal Before Treatment|1
4729573|NCT03323736|7670839|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2
4729574|NCT03323736|7670840|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2
4729575|NCT03323736|7670841|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0
4729576|NCT03324581|7670877|FG000|Overall Study|Adverse Event|18
4729577|NCT03324581|7670878|FG001|Overall Study|Adverse Event|11
4729578|NCT03324581|7670879|FG002|Overall Study|Adverse Event|7
4729579|NCT03324581|7670877|FG000|Overall Study|Lack of Efficacy|0
4729580|NCT03324581|7670878|FG001|Overall Study|Lack of Efficacy|1
4729581|NCT03324581|7670879|FG002|Overall Study|Lack of Efficacy|0
4729582|NCT03324581|7670877|FG000|Overall Study|Lost to Follow-up|5
4729583|NCT03324581|7670878|FG001|Overall Study|Lost to Follow-up|3
4729584|NCT03324581|7670879|FG002|Overall Study|Lost to Follow-up|6
4729585|NCT03324581|7670877|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2
4729586|NCT03324581|7670878|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2
4729587|NCT03324581|7670879|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0
4729588|NCT03324581|7670877|FG000|Overall Study|Physician Decision|0
4729589|NCT03324581|7670878|FG001|Overall Study|Physician Decision|1
4729590|NCT03324581|7670879|FG002|Overall Study|Physician Decision|2
4729591|NCT03324581|7670877|FG000|Overall Study|Protocol Deviation|8
4729592|NCT03324581|7670878|FG001|Overall Study|Protocol Deviation|9
4729593|NCT03324581|7670879|FG002|Overall Study|Protocol Deviation|4
4729594|NCT03324581|7670877|FG000|Overall Study|Withdrawal by Subject|6
4729595|NCT03324581|7670878|FG001|Overall Study|Withdrawal by Subject|8
4729596|NCT03324581|7670879|FG002|Overall Study|Withdrawal by Subject|6
4729597|NCT03324581|7670877|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0
4729598|NCT03324581|7670878|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1
4729599|NCT03324581|7670879|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0
4729600|NCT03325010|7670896|FG000|Overall Study|Adverse Event|3
4729601|NCT03325010|7670897|FG001|Overall Study|Adverse Event|8
4729602|NCT03325010|7670896|FG000|Overall Study|Protocol Violation|1
4729603|NCT03325010|7670897|FG001|Overall Study|Protocol Violation|8
4729604|NCT03325010|7670896|FG000|Overall Study|Withdrawal by Subject|1
4729605|NCT03325010|7670897|FG001|Overall Study|Withdrawal by Subject|3
4729606|NCT03325010|7670896|FG000|Overall Study|Lost to Follow-up|1
4729607|NCT03325010|7670897|FG001|Overall Study|Lost to Follow-up|0
4729608|NCT03325010|7670896|FG000|Overall Study|Physician Decision|1
4729609|NCT03325010|7670897|FG001|Overall Study|Physician Decision|1
4729610|NCT03325010|7670896|FG000|Overall Study|Lack of Efficacy|2
4729611|NCT03325010|7670897|FG001|Overall Study|Lack of Efficacy|0
4729612|NCT03325556|7670903|FG000|Open-label Period|Lack of Response in OL period|70
4729613|NCT03325556|7670904|FG001|Open-label Period|Lack of Response in OL period|0
4729614|NCT03325556|7670905|FG002|Open-label Period|Lack of Response in OL period|0
4729615|NCT03325556|7670903|FG000|Open-label Period|Adverse Event|27
4729616|NCT03325556|7670904|FG001|Open-label Period|Adverse Event|0
4729617|NCT03325556|7670905|FG002|Open-label Period|Adverse Event|0
4729618|NCT03325556|7670903|FG000|Open-label Period|Death|1
4729619|NCT03325556|7670904|FG001|Open-label Period|Death|0
4729620|NCT03325556|7670905|FG002|Open-label Period|Death|0
4729621|NCT03325556|7670903|FG000|Open-label Period|Lost to Follow-up|1
4729622|NCT03325556|7670904|FG001|Open-label Period|Lost to Follow-up|0
4729623|NCT03325556|7670905|FG002|Open-label Period|Lost to Follow-up|0
4729624|NCT03325556|7670903|FG000|Open-label Period|Non-compliance with study drug|5
4729625|NCT03325556|7670904|FG001|Open-label Period|Non-compliance with study drug|0
4729626|NCT03325556|7670905|FG002|Open-label Period|Non-compliance with study drug|0
4729627|NCT03325556|7670903|FG000|Open-label Period|Use of prohibited medication|1
4729628|NCT03325556|7670904|FG001|Open-label Period|Use of prohibited medication|0
4729629|NCT03325556|7670905|FG002|Open-label Period|Use of prohibited medication|0
4729630|NCT03325556|7670903|FG000|Open-label Period|Protocol Violation|4
4729631|NCT03325556|7670904|FG001|Open-label Period|Protocol Violation|0
4729632|NCT03325556|7670905|FG002|Open-label Period|Protocol Violation|0
4729633|NCT03325556|7670903|FG000|Open-label Period|Withdrawal by Subject|17
4729634|NCT03325556|7670904|FG001|Open-label Period|Withdrawal by Subject|0
4729635|NCT03325556|7670905|FG002|Open-label Period|Withdrawal by Subject|0
4729636|NCT03325556|7670903|FG000|Open-label Period|Not otherwise specified|8
4729637|NCT03325556|7670904|FG001|Open-label Period|Not otherwise specified|0
4729638|NCT03325556|7670905|FG002|Open-label Period|Not otherwise specified|0
4729639|NCT03325556|7670903|FG000|Open-label Period|Administrative discont. at study termination|41
4729640|NCT03325556|7670904|FG001|Open-label Period|Administrative discont. at study termination|0
4729641|NCT03325556|7670905|FG002|Open-label Period|Administrative discont. at study termination|0
4729642|NCT03325556|7670903|FG000|Double-blind Period|Relapse|0
4729643|NCT03325556|7670904|FG001|Double-blind Period|Relapse|15
4729644|NCT03325556|7670905|FG002|Double-blind Period|Relapse|34
4729645|NCT03325556|7670903|FG000|Double-blind Period|Adverse Event|0
4729646|NCT03325556|7670904|FG001|Double-blind Period|Adverse Event|3
4729647|NCT03325556|7670905|FG002|Double-blind Period|Adverse Event|1
4729648|NCT03325556|7670903|FG000|Double-blind Period|Noncompliance with study drug|0
4729649|NCT03325556|7670904|FG001|Double-blind Period|Noncompliance with study drug|0
4729650|NCT03325556|7670905|FG002|Double-blind Period|Noncompliance with study drug|1
4729651|NCT03325556|7670903|FG000|Double-blind Period|Use of prohibited medication|0
4729652|NCT03325556|7670904|FG001|Double-blind Period|Use of prohibited medication|1
4729653|NCT03325556|7670905|FG002|Double-blind Period|Use of prohibited medication|0
4729654|NCT03325556|7670903|FG000|Double-blind Period|Physician Decision|0
4729655|NCT03325556|7670904|FG001|Double-blind Period|Physician Decision|0
4729656|NCT03325556|7670905|FG002|Double-blind Period|Physician Decision|1
4729657|NCT03325556|7670903|FG000|Double-blind Period|Withdrawal by Subject|0
4729658|NCT03325556|7670904|FG001|Double-blind Period|Withdrawal by Subject|6
4729659|NCT03325556|7670905|FG002|Double-blind Period|Withdrawal by Subject|4
4729660|NCT03325556|7670903|FG000|Double-blind Period|Not otherwise specified|0
4729661|NCT03325556|7670904|FG001|Double-blind Period|Not otherwise specified|1
4729662|NCT03325556|7670905|FG002|Double-blind Period|Not otherwise specified|5
4729663|NCT03325556|7670903|FG000|Double-blind Period|Administrative discont. at study termination|0
4729664|NCT03325556|7670904|FG001|Double-blind Period|Administrative discont. at study termination|35
4729665|NCT03325556|7670905|FG002|Double-blind Period|Administrative discont. at study termination|31
4729666|NCT03325673|7670914|FG000|Overall Study|Adverse Event|4
4729667|NCT03325673|7670915|FG001|Overall Study|Adverse Event|0
4729668|NCT03325881|7670934|FG000|Overall Study|Protocol Violation|0
4729669|NCT03325881|7670935|FG001|Overall Study|Protocol Violation|1
4729670|NCT03325881|7670934|FG000|Overall Study|Withdrawal by Subject|0
4729671|NCT03325881|7670935|FG001|Overall Study|Withdrawal by Subject|2
4729672|NCT03325881|7670934|FG000|Overall Study|Lack of Efficacy|2
4729673|NCT03325881|7670935|FG001|Overall Study|Lack of Efficacy|0
4729674|NCT03325881|7670934|FG000|Overall Study|Not treated|1
4729675|NCT03325881|7670935|FG001|Overall Study|Not treated|0
4729676|NCT03325894|7670945|FG000|Overall Study|Adverse Event|2
4729677|NCT03325894|7670946|FG001|Overall Study|Adverse Event|3
4729678|NCT03325894|7670945|FG000|Overall Study|Protocol Violation|1
4729679|NCT03325894|7670946|FG001|Overall Study|Protocol Violation|2
4729680|NCT03325894|7670945|FG000|Overall Study|Withdrawal by Subject|10
4729681|NCT03325894|7670946|FG001|Overall Study|Withdrawal by Subject|6
4729682|NCT03325894|7670945|FG000|Overall Study|Lost to Follow-up|4
4729683|NCT03325894|7670946|FG001|Overall Study|Lost to Follow-up|9
4729684|NCT03325894|7670945|FG000|Overall Study|Lack of Efficacy|8
4729685|NCT03325894|7670946|FG001|Overall Study|Lack of Efficacy|14
4729686|NCT03325894|7670945|FG000|Overall Study|Study Terminated by Sponsor|38
4729687|NCT03325894|7670946|FG001|Overall Study|Study Terminated by Sponsor|43
4729688|NCT03325894|7670945|FG000|Overall Study|Other (Not received Treatment)|1
4729689|NCT03325894|7670946|FG001|Overall Study|Other (Not received Treatment)|0
4729690|NCT03326323|7670955|FG000|Overall Study|Unable to receive ANH protocol|3
4729691|NCT03326518|7670962|FG000|Overall Study|Protocol Violation|1
4729692|NCT03326518|7670963|FG001|Overall Study|Protocol Violation|0
4729693|NCT03326518|7670964|FG002|Overall Study|Protocol Violation|0
4729694|NCT03326518|7670962|FG000|Overall Study|Withdrawal by Subject|1
4729695|NCT03326518|7670963|FG001|Overall Study|Withdrawal by Subject|0
4729696|NCT03326518|7670964|FG002|Overall Study|Withdrawal by Subject|0
4729697|NCT03326518|7670962|FG000|Overall Study|Lost to Follow-up|1
4729698|NCT03326518|7670963|FG001|Overall Study|Lost to Follow-up|0
4729699|NCT03326518|7670964|FG002|Overall Study|Lost to Follow-up|1
4729700|NCT03327220|7671047|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1
4729701|NCT03327220|7671048|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2
4729702|NCT03327220|7671047|FG000|Overall Study|Investigator Decision|2
4729703|NCT03327220|7671048|FG001|Overall Study|Investigator Decision|0
4729704|NCT03327220|7671047|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0
4729705|NCT03327220|7671048|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1
4729706|NCT03327220|7671047|FG000|Overall Study|Fungal infection|1
4729707|NCT03327220|7671048|FG001|Overall Study|Fungal infection|0
4729708|NCT03327220|7671047|FG000|Overall Study|Discharged to Rehabilitation|0
4729709|NCT03327220|7671048|FG001|Overall Study|Discharged to Rehabilitation|1
4729710|NCT03327220|7671047|FG000|Overall Study|Missing|1
4729711|NCT03327220|7671048|FG001|Overall Study|Missing|0
4729712|NCT03327402|7671054|FG000|Overall Study|Withdrawal by Subject|1
4729713|NCT03327402|7671054|FG000|Overall Study|Other (Visit Out-Of-Window)|1
4729714|NCT03328182|7671068|FG000|Overall Study|Withdrawal by Subject|1
4729715|NCT03328182|7671068|FG000|Overall Study|Protocol Violation|2
4729716|NCT03328182|7671068|FG000|Overall Study|No Product Evaluated|1
4729717|NCT03328325|7671081|FG000|Overall Study|Lost to Follow-up|4
4729718|NCT03328325|7671081|FG000|Overall Study|Physician Decision|1
4729719|NCT03328325|7671081|FG000|Overall Study|Withdrawal by Subject|3
4729720|NCT03328325|7671081|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3
4729721|NCT03328832|7671091|FG000|Overall Study|Lost to Follow-up|0
4729722|NCT03328832|7671092|FG001|Overall Study|Lost to Follow-up|1
4729723|NCT03328897|7671101|FG000|Randomized-treatment Epoch|Adverse Event|4
4729724|NCT03328897|7671102|FG001|Randomized-treatment Epoch|Adverse Event|1
4729725|NCT03328897|7671103|FG002|Randomized-treatment Epoch|Adverse Event|1
4729726|NCT03328897|7671101|FG000|Randomized-treatment Epoch|Lost to Follow-up|0
4729727|NCT03328897|7671102|FG001|Randomized-treatment Epoch|Lost to Follow-up|1
4729728|NCT03328897|7671103|FG002|Randomized-treatment Epoch|Lost to Follow-up|0
4729729|NCT03328897|7671101|FG000|Randomized-treatment Epoch|Pregnancy|3
4729730|NCT03328897|7671102|FG001|Randomized-treatment Epoch|Pregnancy|0
4729731|NCT03328897|7671103|FG002|Randomized-treatment Epoch|Pregnancy|0
4729732|NCT03328897|7671101|FG000|Randomized-treatment Epoch|Patient/guardian decision|8
4446615|NCT00485264|7231701|FG003|Overall Study|Enrolled But Not Given Treatment|0
4446616|NCT00485264|7231702|FG004|Overall Study|Enrolled But Not Given Treatment|1
4446617|NCT00485264|7231703|FG005|Overall Study|Enrolled But Not Given Treatment|0
4446618|NCT00485264|7231698|FG000|Overall Study|Death|1
4446619|NCT00485264|7231699|FG001|Overall Study|Death|0
4446620|NCT00485264|7231700|FG002|Overall Study|Death|0
4729733|NCT03328897|7671102|FG001|Randomized-treatment Epoch|Patient/guardian decision|3
4729734|NCT03328897|7671103|FG002|Randomized-treatment Epoch|Patient/guardian decision|1
4729735|NCT03328897|7671101|FG000|Randomized-treatment Epoch|Lack of Efficacy|1
4729736|NCT03328897|7671102|FG001|Randomized-treatment Epoch|Lack of Efficacy|0
4729737|NCT03328897|7671103|FG002|Randomized-treatment Epoch|Lack of Efficacy|0
4729738|NCT03328897|7671101|FG000|Follow-up Epoch|Adverse Event|4
4729739|NCT03328897|7671102|FG001|Follow-up Epoch|Adverse Event|0
4729740|NCT03328897|7671103|FG002|Follow-up Epoch|Adverse Event|1
4729741|NCT03328897|7671101|FG000|Follow-up Epoch|Lack of Efficacy|1
4729742|NCT03328897|7671102|FG001|Follow-up Epoch|Lack of Efficacy|1
4729743|NCT03328897|7671103|FG002|Follow-up Epoch|Lack of Efficacy|1
4729744|NCT03328897|7671101|FG000|Follow-up Epoch|Lost to Follow-up|0
4729745|NCT03328897|7671102|FG001|Follow-up Epoch|Lost to Follow-up|1
4729746|NCT03328897|7671103|FG002|Follow-up Epoch|Lost to Follow-up|0
4729747|NCT03328897|7671101|FG000|Follow-up Epoch|Pregnancy|1
4729748|NCT03328897|7671102|FG001|Follow-up Epoch|Pregnancy|0
4729749|NCT03328897|7671103|FG002|Follow-up Epoch|Pregnancy|0
4729750|NCT03328897|7671101|FG000|Follow-up Epoch|Patient/guardian decision|2
4729751|NCT03328897|7671102|FG001|Follow-up Epoch|Patient/guardian decision|1
4729752|NCT03328897|7671103|FG002|Follow-up Epoch|Patient/guardian decision|0
4729753|NCT03329196|7671118|FG000|Overall Study|Adverse Event|10
4729754|NCT03329196|7671119|FG001|Overall Study|Adverse Event|5
4729755|NCT03329196|7671118|FG000|Overall Study|Physician Decision|2
4729756|NCT03329196|7671119|FG001|Overall Study|Physician Decision|2
4729757|NCT03329196|7671118|FG000|Overall Study|Withdrawal by Subject|11
4729758|NCT03329196|7671119|FG001|Overall Study|Withdrawal by Subject|3
4729759|NCT03329196|7671118|FG000|Overall Study|Hepatic function abnormalities|0
4729760|NCT03329196|7671119|FG001|Overall Study|Hepatic function abnormalities|1
4729761|NCT03329196|7671118|FG000|Overall Study|Conducting rescue therapy before Week 24|2
4729762|NCT03329196|7671119|FG001|Overall Study|Conducting rescue therapy before Week 24|1
4729763|NCT03329196|7671118|FG000|Overall Study|Difficult to control Hb|2
4729764|NCT03329196|7671119|FG001|Overall Study|Difficult to control Hb|3
4729765|NCT03329196|7671118|FG000|Overall Study|Dialysis or renal transplant|13
4729766|NCT03329196|7671119|FG001|Overall Study|Dialysis or renal transplant|15
4729767|NCT03329573|7671139|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0
4729768|NCT03329573|7671140|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1
4729769|NCT03329573|7671141|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0
4729770|NCT03329573|7671142|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0
4729771|NCT03329573|7671139|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1
4729772|NCT03329573|7671140|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2
4729773|NCT03329573|7671141|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0
4729774|NCT03329573|7671142|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0
4729775|NCT03329573|7671139|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1
4729776|NCT03329573|7671140|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0
4729777|NCT03329573|7671141|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0
4446621|NCT00485264|7231701|FG003|Overall Study|Death|0
4729778|NCT03329573|7671142|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0
4729779|NCT03329573|7671139|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0
4729780|NCT03329573|7671140|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1
4729781|NCT03329573|7671141|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0
4729782|NCT03329573|7671142|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0
4729783|NCT03329846|7671154|FG000|Overall Study|Disease progression|4
4729784|NCT03329846|7671155|FG001|Overall Study|Disease progression|6
4729785|NCT03329846|7671154|FG000|Overall Study|Study drug toxicity|1
4729786|NCT03329846|7671155|FG001|Overall Study|Study drug toxicity|0
4729787|NCT03329846|7671154|FG000|Overall Study|Participant request to discontinue treatment|0
4729788|NCT03329846|7671155|FG001|Overall Study|Participant request to discontinue treatment|1
4729789|NCT03329846|7671154|FG000|Overall Study|Participant withdrew consent|1
4729790|NCT03329846|7671155|FG001|Overall Study|Participant withdrew consent|0
4729791|NCT03329846|7671154|FG000|Overall Study|Other reasons|2
4729792|NCT03329846|7671155|FG001|Overall Study|Other reasons|2
4729793|NCT03329885|7671167|FG000|Overall Study|Sponsor discontinued the study early|0
4729794|NCT03329885|7671168|FG001|Overall Study|Sponsor discontinued the study early|0
4729795|NCT03329885|7671169|FG002|Overall Study|Sponsor discontinued the study early|0
4729796|NCT03329885|7671170|FG003|Overall Study|Sponsor discontinued the study early|0
4729797|NCT03329885|7671171|FG004|Overall Study|Sponsor discontinued the study early|0
4729798|NCT03329885|7671172|FG005|Overall Study|Sponsor discontinued the study early|0
4729799|NCT03329885|7671173|FG006|Overall Study|Sponsor discontinued the study early|1
4729800|NCT03329885|7671174|FG007|Overall Study|Sponsor discontinued the study early|1
4729801|NCT03329885|7671175|FG008|Overall Study|Sponsor discontinued the study early|0
4729802|NCT03329989|7671208|FG000|Overall Study|Withdrawal by Subject|9
4729803|NCT03329989|7671208|FG000|Overall Study|Lost to Follow-up|8
4729804|NCT03329989|7671208|FG000|Overall Study|Adverse Event|5
4729805|NCT03329989|7671208|FG000|Overall Study|Protocol Violation|1
4729806|NCT03330002|7671212|FG000|Overall Study|Lost to Follow-up|15
4729807|NCT03330002|7671212|FG000|Overall Study|Death|7
4729808|NCT03330119|7671224|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166
4729809|NCT03330119|7671225|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282
4729810|NCT03330236|7671233|FG000|Overall Study|Death|2
4729811|NCT03330236|7671234|FG001|Overall Study|Death|1
4729812|NCT03330236|7671233|FG000|Overall Study|Withdrawal by Subject|2
4729813|NCT03330236|7671234|FG001|Overall Study|Withdrawal by Subject|4
4729814|NCT03330236|7671233|FG000|Overall Study|Lost to Follow-up|0
4729815|NCT03330236|7671234|FG001|Overall Study|Lost to Follow-up|2
4729816|NCT03330236|7671233|FG000|Overall Study|Physician Decision|2
4729817|NCT03330236|7671234|FG001|Overall Study|Physician Decision|0
4729818|NCT03330236|7671233|FG000|Overall Study|Protocol Violation|4
4729819|NCT03330236|7671234|FG001|Overall Study|Protocol Violation|3
4729820|NCT03330236|7671233|FG000|Overall Study|SedLine malfunction/blinding|19
4729821|NCT03330236|7671234|FG001|Overall Study|SedLine malfunction/blinding|14
4729822|NCT03330236|7671233|FG000|Overall Study|Volatile anesthetics used|11
4729823|NCT03330236|7671234|FG001|Overall Study|Volatile anesthetics used|8
4729824|NCT03330236|7671233|FG000|Overall Study|Surgery aborted/converted to open|60
4729825|NCT03330236|7671234|FG001|Overall Study|Surgery aborted/converted to open|52
4729826|NCT03330288|7671271|FG000|Overall Study|Other reason|1
4729827|NCT03330288|7671272|FG001|Overall Study|Other reason|1
4729828|NCT03330288|7671271|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1
4729829|NCT03330288|7671272|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0
4729830|NCT03330288|7671271|FG000|Overall Study|Adverse Event|1
4729831|NCT03330288|7671272|FG001|Overall Study|Adverse Event|0
4729832|NCT03330288|7671271|FG000|Overall Study|Withdrawal by Subject|1
4729833|NCT03330288|7671272|FG001|Overall Study|Withdrawal by Subject|0
4729834|NCT03330288|7671271|FG000|Overall Study|Lost to Follow-up|26
4729835|NCT03330288|7671272|FG001|Overall Study|Lost to Follow-up|7
4729836|NCT03331042|7671303|FG000|Overall Study|Protocol Violation|1
4729837|NCT03331042|7671304|FG001|Overall Study|Protocol Violation|0
4729838|NCT03331042|7671305|FG002|Overall Study|Protocol Violation|0
4729839|NCT03331042|7671306|FG003|Overall Study|Protocol Violation|0
4729840|NCT03331042|7671303|FG000|Overall Study|Physician Decision|0
4729841|NCT03331042|7671304|FG001|Overall Study|Physician Decision|0
4729842|NCT03331042|7671305|FG002|Overall Study|Physician Decision|1
4729843|NCT03331042|7671306|FG003|Overall Study|Physician Decision|0
4729844|NCT03331042|7671303|FG000|Overall Study|Lost to Follow-up|0
4729845|NCT03331042|7671304|FG001|Overall Study|Lost to Follow-up|0
4729846|NCT03331042|7671305|FG002|Overall Study|Lost to Follow-up|0
4729847|NCT03331042|7671306|FG003|Overall Study|Lost to Follow-up|1
4729848|NCT03331315|7671333|FG000|Overall Study|Physician Decision|18
4729849|NCT03331315|7671334|FG001|Overall Study|Physician Decision|14
4729850|NCT03331666|7671344|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2
4729851|NCT03331666|7671345|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2
4729852|NCT03332160|7671371|FG000|Overall Study|Withdrawal by Subject|1
4729853|NCT03332160|7671372|FG001|Overall Study|Withdrawal by Subject|1
4729854|NCT03332160|7671371|FG000|Overall Study|Adverse Event|0
4729855|NCT03332160|7671372|FG001|Overall Study|Adverse Event|1
4729856|NCT03332160|7671371|FG000|Overall Study|Developed Exclusion Criteria|0
4729857|NCT03332160|7671372|FG001|Overall Study|Developed Exclusion Criteria|1
4729858|NCT03332160|7671371|FG000|Overall Study|Non-adherence to treatment|0
4729859|NCT03332160|7671372|FG001|Overall Study|Non-adherence to treatment|2
4729860|NCT03332212|7671383|FG000|Overall Study|Not treated|0
4729861|NCT03332212|7671384|FG001|Overall Study|Not treated|1
4729862|NCT03332212|7671385|FG002|Overall Study|Not treated|0
4729863|NCT03332212|7671386|FG003|Overall Study|Not treated|0
4729864|NCT03332212|7671383|FG000|Overall Study|Adverse Event|0
4729865|NCT03332212|7671384|FG001|Overall Study|Adverse Event|0
4729866|NCT03332212|7671385|FG002|Overall Study|Adverse Event|0
4729867|NCT03332212|7671386|FG003|Overall Study|Adverse Event|1
4729868|NCT03332212|7671383|FG000|Overall Study|worsening of disease under study|1
4729869|NCT03332212|7671384|FG001|Overall Study|worsening of disease under study|1
4729870|NCT03332212|7671385|FG002|Overall Study|worsening of disease under study|0
4729871|NCT03332212|7671386|FG003|Overall Study|worsening of disease under study|0
4729872|NCT03332628|7671407|FG000|Overall Study|Physician Decision|2
4729873|NCT03332771|7671416|FG000|Overall Study|Adverse Event|6
4729874|NCT03332771|7671417|FG001|Overall Study|Adverse Event|4
4729875|NCT03332771|7671418|FG002|Overall Study|Adverse Event|1
4729876|NCT03332771|7671419|FG003|Overall Study|Adverse Event|3
4729877|NCT03332771|7671416|FG000|Overall Study|Poor Compliance to Protocol|0
4729878|NCT03332771|7671417|FG001|Overall Study|Poor Compliance to Protocol|1
4729879|NCT03332771|7671418|FG002|Overall Study|Poor Compliance to Protocol|0
4729880|NCT03332771|7671419|FG003|Overall Study|Poor Compliance to Protocol|1
4729881|NCT03332771|7671416|FG000|Overall Study|Lost to Follow-up|2
4729882|NCT03332771|7671417|FG001|Overall Study|Lost to Follow-up|2
4729883|NCT03332771|7671418|FG002|Overall Study|Lost to Follow-up|1
4729884|NCT03332771|7671419|FG003|Overall Study|Lost to Follow-up|2
4729885|NCT03332771|7671416|FG000|Overall Study|At the Participant's own request|20
4729886|NCT03332771|7671417|FG001|Overall Study|At the Participant's own request|26
4729887|NCT03332771|7671418|FG002|Overall Study|At the Participant's own request|14
4729888|NCT03332771|7671419|FG003|Overall Study|At the Participant's own request|23
4729889|NCT03332771|7671416|FG000|Overall Study|Reason Not Specified|6
4729890|NCT03332771|7671417|FG001|Overall Study|Reason Not Specified|18
4729891|NCT03332771|7671418|FG002|Overall Study|Reason Not Specified|16
4729892|NCT03332771|7671419|FG003|Overall Study|Reason Not Specified|19
4729893|NCT03332784|7671449|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
4729894|NCT03332784|7671450|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1
4729895|NCT03332784|7671451|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
4729896|NCT03332784|7671452|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
4729897|NCT03332784|7671453|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
4729898|NCT03332784|7671454|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
4729899|NCT03332784|7671455|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
4729900|NCT03332784|7671456|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
4729901|NCT03332784|7671457|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
4729902|NCT03332784|7671458|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
4729903|NCT03332784|7671459|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
4729904|NCT03332784|7671460|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
4729905|NCT03332784|7671461|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
4729906|NCT03332784|7671462|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
4729907|NCT03332784|7671463|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1
4729908|NCT03332784|7671464|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
4729909|NCT03332784|7671465|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
4729910|NCT03332784|7671466|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
4729911|NCT03332784|7671467|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
4729912|NCT03332784|7671468|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0
4729913|NCT03333109|7671529|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0
4729914|NCT03333109|7671530|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0
4729915|NCT03333109|7671531|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2
4729916|NCT03333109|7671529|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0
4729917|NCT03333109|7671530|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0
4729918|NCT03333109|7671531|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1
4729919|NCT03333109|7671529|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4
4729920|NCT03333109|7671530|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0
4729921|NCT03333109|7671531|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1
4729922|NCT03333109|7671529|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1
4729923|NCT03333109|7671530|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0
4729924|NCT03333109|7671531|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0
4729925|NCT03333109|7671529|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9
4729926|NCT03333109|7671530|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6
4729927|NCT03333109|7671531|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5
4729928|NCT03333109|7671529|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3
4729929|NCT03333109|7671530|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0
4729930|NCT03333109|7671531|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3
4729931|NCT03333109|7671529|FG000|Safety Follow-up Period|Lost to Follow-up|6
4729932|NCT03333109|7671530|FG001|Safety Follow-up Period|Lost to Follow-up|2
4729933|NCT03333109|7671531|FG002|Safety Follow-up Period|Lost to Follow-up|1
4729934|NCT03333109|7671529|FG000|Safety Follow-up Period|Withdrawal by Subject|7
4729935|NCT03333109|7671530|FG001|Safety Follow-up Period|Withdrawal by Subject|2
4729936|NCT03333109|7671531|FG002|Safety Follow-up Period|Withdrawal by Subject|12
4729937|NCT03333876|7671560|FG000|Screening Period|Screen Failure|4
4729938|NCT03333876|7671560|FG000|Nasal Dilator|Bed Partner Lost to follow up|6
4772315|NCT02471144|7749281|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
4772316|NCT02471144|7749282|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
4772317|NCT02471144|7749283|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
4772318|NCT02471144|7749284|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
4772319|NCT02471144|7749285|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
4772320|NCT02471144|7749286|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
4772321|NCT02471144|7749287|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
4772322|NCT02471144|7749288|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0
4772323|NCT02471144|7749289|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2
4772324|NCT02440464|7749307|FG000|Overall Study|Withdrawal by Subject|3
4772325|NCT02440464|7749308|FG001|Overall Study|Withdrawal by Subject|2
4772326|NCT02366728|7749325|FG000|Overall Study|Death|0
4772327|NCT02366728|7749326|FG001|Overall Study|Death|0
4772328|NCT02366728|7749327|FG002|Overall Study|Death|1
4772329|NCT02366728|7749325|FG000|Overall Study|Adverse Event|1
4772330|NCT02366728|7749326|FG001|Overall Study|Adverse Event|0
4772331|NCT02366728|7749327|FG002|Overall Study|Adverse Event|0
4772332|NCT02366728|7749325|FG000|Overall Study|Screen Failure|2
4772333|NCT02366728|7749326|FG001|Overall Study|Screen Failure|1
4772334|NCT02366728|7749327|FG002|Overall Study|Screen Failure|0
4772335|NCT02366728|7749325|FG000|Overall Study|Only yielded 2 vaccines|1
4772336|NCT02366728|7749326|FG001|Overall Study|Only yielded 2 vaccines|0
4772337|NCT02366728|7749327|FG002|Overall Study|Only yielded 2 vaccines|0
4772338|NCT02236572|7749335|FG000|Overall Study|Withdrawal by Subject|1
4772339|NCT02236572|7749335|FG000|Overall Study|Protocol Violation|1
4772340|NCT02236572|7749335|FG000|Overall Study|Lost to Follow-up|1
4772341|NCT02083354|7749339|FG000|Overall Study|Withdrawal by Subject|9
4772342|NCT02083354|7749339|FG000|Overall Study|Lost to Follow-up|1
4772343|NCT02083354|7749339|FG000|Overall Study|Adverse Event|3
4772344|NCT02083354|7749339|FG000|Overall Study|Disease progression|46
4772345|NCT02083354|7749339|FG000|Overall Study|Study closed/terminated|5
4772346|NCT01446016|7749373|FG000|Overall Study|Lost to Follow-up|3
4772347|NCT01446016|7749373|FG000|Overall Study|Withdrawal by Subject|1
4772348|NCT01446016|7749373|FG000|Overall Study|Toxicity|3
4772349|NCT01434602|7749395|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0
4772350|NCT01434602|7749396|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1
4772351|NCT01434602|7749397|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0
4772352|NCT01434602|7749398|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0
4772353|NCT01434602|7749399|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0
4772354|NCT01434602|7749395|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0
4772355|NCT01434602|7749396|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0
4772356|NCT01434602|7749397|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0
4772357|NCT01434602|7749398|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1
4772358|NCT01434602|7749399|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0
4772359|NCT01434602|7749395|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0
4772360|NCT01434602|7749396|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0
4772361|NCT01434602|7749397|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0
4772362|NCT01434602|7749398|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1
4772363|NCT01434602|7749399|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0
4772364|NCT01434602|7749395|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0
4772365|NCT01434602|7749396|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0
4772366|NCT01434602|7749397|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0
4772367|NCT01434602|7749398|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1
4772368|NCT01434602|7749399|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0
4772369|NCT01434602|7749395|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0
4772370|NCT01434602|7749396|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0
4772371|NCT01434602|7749397|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0
4772372|NCT01434602|7749398|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1
4772373|NCT01434602|7749399|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0
4772374|NCT01434602|7749395|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0
4772375|NCT01434602|7749396|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0
4729939|NCT03333876|7671560|FG000|Mandibular Advancement|Adverse Event|2
4729940|NCT03333876|7671560|FG000|Mandibular Advancement|Product Damage|2
4729941|NCT03333941|7671573|FG000|Overall Study|Lost to Follow-up|10
4729942|NCT03333941|7671573|FG000|Overall Study|Death|2
4729943|NCT03333941|7671573|FG000|Overall Study|Adverse Event|1
4729944|NCT03334175|7671579|FG000|Overall Study|Lost to Follow-up|0
4729945|NCT03334175|7671580|FG001|Overall Study|Lost to Follow-up|1
4729946|NCT03334188|7671588|FG000|Overall Study|Withdrawal by Subject|0
4729947|NCT03334188|7671589|FG001|Overall Study|Withdrawal by Subject|1
4729948|NCT03334188|7671588|FG000|Overall Study|Death|1
4729949|NCT03334188|7671589|FG001|Overall Study|Death|0
4729950|NCT03334188|7671588|FG000|Overall Study|Never had qualifying clinic visit|7
4729951|NCT03334188|7671589|FG001|Overall Study|Never had qualifying clinic visit|7
4729952|NCT03334214|7671598|FG000|Overall Study|Adverse Event or Serious Adverse Event|0
4729953|NCT03334214|7671599|FG001|Overall Study|Adverse Event or Serious Adverse Event|1
4729954|NCT03334214|7671598|FG000|Overall Study|Withdrawal by Subject|0
4729955|NCT03334214|7671599|FG001|Overall Study|Withdrawal by Subject|1
4729956|NCT03334214|7671598|FG000|Overall Study|Other|1
4729957|NCT03334214|7671599|FG001|Overall Study|Other|0
4729958|NCT03334396|7671614|FG000|Overall Study|Adverse Event|1
4729959|NCT03334396|7671615|FG001|Overall Study|Adverse Event|0
4729960|NCT03334396|7671616|FG002|Overall Study|Adverse Event|1
4729961|NCT03334396|7671617|FG003|Overall Study|Adverse Event|0
4729962|NCT03334396|7671618|FG004|Overall Study|Adverse Event|0
4729963|NCT03334396|7671619|FG005|Overall Study|Adverse Event|0
4729964|NCT03334396|7671620|FG006|Overall Study|Adverse Event|0
4729965|NCT03334396|7671621|FG007|Overall Study|Adverse Event|0
4729966|NCT03334396|7671614|FG000|Overall Study|Lack of Efficacy|10
4729967|NCT03334396|7671615|FG001|Overall Study|Lack of Efficacy|4
4729968|NCT03334396|7671616|FG002|Overall Study|Lack of Efficacy|1
4729969|NCT03334396|7671617|FG003|Overall Study|Lack of Efficacy|3
4729970|NCT03334396|7671618|FG004|Overall Study|Lack of Efficacy|1
4729971|NCT03334396|7671619|FG005|Overall Study|Lack of Efficacy|0
4729972|NCT03334396|7671620|FG006|Overall Study|Lack of Efficacy|0
4729973|NCT03334396|7671621|FG007|Overall Study|Lack of Efficacy|1
4729974|NCT03334396|7671614|FG000|Overall Study|Lost to Follow-up|0
4729975|NCT03334396|7671615|FG001|Overall Study|Lost to Follow-up|0
4729976|NCT03334396|7671616|FG002|Overall Study|Lost to Follow-up|1
4729977|NCT03334396|7671617|FG003|Overall Study|Lost to Follow-up|0
4729978|NCT03334396|7671618|FG004|Overall Study|Lost to Follow-up|0
4729979|NCT03334396|7671619|FG005|Overall Study|Lost to Follow-up|0
4729980|NCT03334396|7671620|FG006|Overall Study|Lost to Follow-up|1
4729981|NCT03334396|7671621|FG007|Overall Study|Lost to Follow-up|0
4729982|NCT03334396|7671614|FG000|Overall Study|Physician Decision|1
4729983|NCT03334396|7671615|FG001|Overall Study|Physician Decision|0
4729984|NCT03334396|7671616|FG002|Overall Study|Physician Decision|0
4729985|NCT03334396|7671617|FG003|Overall Study|Physician Decision|0
4729986|NCT03334396|7671618|FG004|Overall Study|Physician Decision|0
4729987|NCT03334396|7671619|FG005|Overall Study|Physician Decision|0
4729988|NCT03334396|7671620|FG006|Overall Study|Physician Decision|0
4729989|NCT03334396|7671621|FG007|Overall Study|Physician Decision|0
4729990|NCT03334396|7671614|FG000|Overall Study|Withdrawal by Subject|10
4729991|NCT03334396|7671615|FG001|Overall Study|Withdrawal by Subject|5
4729992|NCT03334396|7671616|FG002|Overall Study|Withdrawal by Subject|7
4729993|NCT03334396|7671617|FG003|Overall Study|Withdrawal by Subject|2
4729994|NCT03334396|7671618|FG004|Overall Study|Withdrawal by Subject|2
4729995|NCT03334396|7671619|FG005|Overall Study|Withdrawal by Subject|1
4729996|NCT03334396|7671620|FG006|Overall Study|Withdrawal by Subject|2
4729997|NCT03334396|7671621|FG007|Overall Study|Withdrawal by Subject|0
4729998|NCT03334396|7671614|FG000|Overall Study|Pregnancy|0
4729999|NCT03334396|7671615|FG001|Overall Study|Pregnancy|1
4730000|NCT03334396|7671616|FG002|Overall Study|Pregnancy|0
4730001|NCT03334396|7671617|FG003|Overall Study|Pregnancy|0
4730002|NCT03334396|7671618|FG004|Overall Study|Pregnancy|0
4730003|NCT03334396|7671619|FG005|Overall Study|Pregnancy|0
4730004|NCT03334396|7671620|FG006|Overall Study|Pregnancy|0
4730005|NCT03334396|7671621|FG007|Overall Study|Pregnancy|0
4730006|NCT03334396|7671614|FG000|Overall Study|Ineligible|0
4730007|NCT03334396|7671615|FG001|Overall Study|Ineligible|1
4730008|NCT03334396|7671616|FG002|Overall Study|Ineligible|0
4730009|NCT03334396|7671617|FG003|Overall Study|Ineligible|0
4730010|NCT03334396|7671618|FG004|Overall Study|Ineligible|0
4730011|NCT03334396|7671619|FG005|Overall Study|Ineligible|0
4730012|NCT03334396|7671620|FG006|Overall Study|Ineligible|0
4730013|NCT03334396|7671621|FG007|Overall Study|Ineligible|0
4730014|NCT03334396|7671614|FG000|Overall Study|Started New Job|1
4730015|NCT03334396|7671615|FG001|Overall Study|Started New Job|0
4730016|NCT03334396|7671616|FG002|Overall Study|Started New Job|0
4730017|NCT03334396|7671617|FG003|Overall Study|Started New Job|0
4730018|NCT03334396|7671618|FG004|Overall Study|Started New Job|0
4730019|NCT03334396|7671619|FG005|Overall Study|Started New Job|0
4730020|NCT03334396|7671620|FG006|Overall Study|Started New Job|0
4730021|NCT03334396|7671621|FG007|Overall Study|Started New Job|0
4730022|NCT03334422|7671642|FG000|Overall Study|Adverse Event|1
4730023|NCT03334422|7671643|FG001|Overall Study|Adverse Event|3
4730024|NCT03334422|7671644|FG002|Overall Study|Adverse Event|2
4730025|NCT03334422|7671645|FG003|Overall Study|Adverse Event|2
4730026|NCT03334422|7671642|FG000|Overall Study|Lack of Efficacy|10
4730027|NCT03334422|7671643|FG001|Overall Study|Lack of Efficacy|2
4730028|NCT03334422|7671644|FG002|Overall Study|Lack of Efficacy|7
4730029|NCT03334422|7671645|FG003|Overall Study|Lack of Efficacy|3
4730030|NCT03334422|7671642|FG000|Overall Study|Withdrawal by Subject|8
4730031|NCT03334422|7671643|FG001|Overall Study|Withdrawal by Subject|3
4730032|NCT03334422|7671644|FG002|Overall Study|Withdrawal by Subject|1
4730033|NCT03334422|7671645|FG003|Overall Study|Withdrawal by Subject|0
4730034|NCT03334422|7671642|FG000|Overall Study|Lost to Follow-up|0
4730035|NCT03334422|7671643|FG001|Overall Study|Lost to Follow-up|0
4730036|NCT03334422|7671644|FG002|Overall Study|Lost to Follow-up|0
4730037|NCT03334422|7671645|FG003|Overall Study|Lost to Follow-up|1
4730038|NCT03334422|7671642|FG000|Overall Study|Inability to obtain laboratory samples|0
4730039|NCT03334422|7671643|FG001|Overall Study|Inability to obtain laboratory samples|1
4730040|NCT03334422|7671644|FG002|Overall Study|Inability to obtain laboratory samples|0
4730041|NCT03334422|7671645|FG003|Overall Study|Inability to obtain laboratory samples|0
4730042|NCT03334422|7671642|FG000|Overall Study|Pregnancy|0
4730043|NCT03334422|7671643|FG001|Overall Study|Pregnancy|1
4730044|NCT03334422|7671644|FG002|Overall Study|Pregnancy|0
4730045|NCT03334422|7671645|FG003|Overall Study|Pregnancy|0
4446622|NCT00485264|7231702|FG004|Overall Study|Death|1
4446623|NCT00485264|7231703|FG005|Overall Study|Death|0
4446624|NCT00485264|7231698|FG000|Overall Study|Adverse Event|1
4446625|NCT00485264|7231699|FG001|Overall Study|Adverse Event|0
4730046|NCT03334448|7671660|FG000|Washout|Personal Reason|0
4730047|NCT03334448|7671661|FG001|Washout|Personal Reason|1
4730048|NCT03334448|7671662|FG002|Washout|Personal Reason|0
4730049|NCT03334448|7671663|FG003|Washout|Personal Reason|0
4730050|NCT03334448|7671660|FG000|Washout|Protocol Violation|0
4730051|NCT03334448|7671661|FG001|Washout|Protocol Violation|0
4730052|NCT03334448|7671662|FG002|Washout|Protocol Violation|0
4730053|NCT03334448|7671663|FG003|Washout|Protocol Violation|1
4730054|NCT03334630|7671671|FG000|Overall Study|Withdrawal by Subject|7
4730055|NCT03334630|7671672|FG001|Overall Study|Withdrawal by Subject|7
4730056|NCT03334630|7671671|FG000|Overall Study|Lost to Follow-up|3
4730057|NCT03334630|7671672|FG001|Overall Study|Lost to Follow-up|1
4730058|NCT03334630|7671671|FG000|Overall Study|Adverse Event|0
4730059|NCT03334630|7671672|FG001|Overall Study|Adverse Event|1
4730060|NCT03334630|7671671|FG000|Overall Study|Physician Decision|1
4730061|NCT03334630|7671672|FG001|Overall Study|Physician Decision|1
4730062|NCT03334630|7671671|FG000|Overall Study|Enrollment closed|2
4730063|NCT03334630|7671672|FG001|Overall Study|Enrollment closed|1
4730064|NCT03334630|7671671|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0
4730065|NCT03334630|7671672|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1
4730066|NCT03334630|7671671|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1
4730067|NCT03334630|7671672|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1
4730068|NCT03334695|7671680|FG000|Overall Study|Lost to Follow-up|3
4730069|NCT03334695|7671681|FG001|Overall Study|Lost to Follow-up|3
4730070|NCT03334695|7671680|FG000|Overall Study|Physician Decision|1
4730071|NCT03334695|7671681|FG001|Overall Study|Physician Decision|2
4730072|NCT03334695|7671680|FG000|Overall Study|Protocol Violation|0
4730073|NCT03334695|7671681|FG001|Overall Study|Protocol Violation|1
4730074|NCT03334721|7671691|FG000|Overall Study|Withdrawal by Subject|1
4730075|NCT03334721|7671692|FG001|Overall Study|Withdrawal by Subject|0
4730076|NCT03334721|7671691|FG000|Overall Study|No longer met inclusion/exclusion criter|1
4730077|NCT03334721|7671692|FG001|Overall Study|No longer met inclusion/exclusion criter|0
4730078|NCT03334747|7671724|FG000|Treatment Phase|Technical problems|0
4730079|NCT03334747|7671725|FG001|Treatment Phase|Technical problems|0
4730080|NCT03334747|7671726|FG002|Treatment Phase|Technical problems|0
4730081|NCT03334747|7671727|FG003|Treatment Phase|Technical problems|0
4730082|NCT03334747|7671728|FG004|Treatment Phase|Technical problems|1
4730083|NCT03334747|7671729|FG005|Treatment Phase|Technical problems|0
4730084|NCT03334747|7671730|FG006|Treatment Phase|Technical problems|0
4730085|NCT03334747|7671731|FG007|Treatment Phase|Technical problems|0
4730086|NCT03334747|7671732|FG008|Treatment Phase|Technical problems|0
4730087|NCT03334747|7671724|FG000|Treatment Phase|Subject/guardian decision|1
4730088|NCT03334747|7671725|FG001|Treatment Phase|Subject/guardian decision|0
4730089|NCT03334747|7671726|FG002|Treatment Phase|Subject/guardian decision|0
4730090|NCT03334747|7671727|FG003|Treatment Phase|Subject/guardian decision|0
4730091|NCT03334747|7671728|FG004|Treatment Phase|Subject/guardian decision|0
4730092|NCT03334747|7671729|FG005|Treatment Phase|Subject/guardian decision|1
4730093|NCT03334747|7671730|FG006|Treatment Phase|Subject/guardian decision|0
4730094|NCT03334747|7671731|FG007|Treatment Phase|Subject/guardian decision|0
4730095|NCT03334747|7671732|FG008|Treatment Phase|Subject/guardian decision|0
4730096|NCT03334747|7671724|FG000|Follow-Up Phase|Subject/guardian decision|0
4730097|NCT03334747|7671725|FG001|Follow-Up Phase|Subject/guardian decision|0
4730098|NCT03334747|7671726|FG002|Follow-Up Phase|Subject/guardian decision|0
4730099|NCT03334747|7671727|FG003|Follow-Up Phase|Subject/guardian decision|0
4730100|NCT03334747|7671728|FG004|Follow-Up Phase|Subject/guardian decision|0
4730101|NCT03334747|7671729|FG005|Follow-Up Phase|Subject/guardian decision|0
4730102|NCT03334747|7671730|FG006|Follow-Up Phase|Subject/guardian decision|1
4730103|NCT03334747|7671731|FG007|Follow-Up Phase|Subject/guardian decision|0
4446626|NCT00485264|7231700|FG002|Overall Study|Adverse Event|2
4730104|NCT03334747|7671732|FG008|Follow-Up Phase|Subject/guardian decision|1
4730105|NCT03334903|7671774|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1
4730106|NCT03334903|7671775|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0
4730107|NCT03334903|7671774|FG000|Overall Study|Protocol Violation|1
4730108|NCT03334903|7671775|FG001|Overall Study|Protocol Violation|3
4730109|NCT03334903|7671774|FG000|Overall Study|Surgery postponed|1
4730110|NCT03334903|7671775|FG001|Overall Study|Surgery postponed|0
4730111|NCT03334903|7671774|FG000|Overall Study|Adverse Event|1
4730112|NCT03334903|7671775|FG001|Overall Study|Adverse Event|1
4730113|NCT03334903|7671774|FG000|Overall Study|Withdrawal by Subject|0
4730114|NCT03334903|7671775|FG001|Overall Study|Withdrawal by Subject|1
4730115|NCT03335150|7671783|FG000|Overall Study|Withdrawal by Subject|10
4730116|NCT03335150|7671784|FG001|Overall Study|Withdrawal by Subject|4
4730117|NCT03335150|7671783|FG000|Overall Study|Adverse Event|0
4730118|NCT03335150|7671784|FG001|Overall Study|Adverse Event|1
4730119|NCT03335566|7671860|FG000|Overall Study|Adverse Event|0
4730120|NCT03335566|7671861|FG001|Overall Study|Adverse Event|1
4730121|NCT03335566|7671860|FG000|Overall Study|Lost to Follow-up|1
4730122|NCT03335566|7671861|FG001|Overall Study|Lost to Follow-up|0
4730123|NCT03335566|7671860|FG000|Overall Study|Technical Problems|1
4730124|NCT03335566|7671861|FG001|Overall Study|Technical Problems|0
4730125|NCT03335566|7671860|FG000|Overall Study|Protocol Violation|1
4730126|NCT03335566|7671861|FG001|Overall Study|Protocol Violation|0
4730127|NCT03335566|7671860|FG000|Overall Study|Other than specified above|1
4730128|NCT03335566|7671861|FG001|Overall Study|Other than specified above|2
4737176|NCT03597061|7687052|FG001|Overall Study|Lost to Follow-up|0
4737177|NCT03597061|7687051|FG000|Overall Study|Protocol Violation|0
4737178|NCT03597061|7687052|FG001|Overall Study|Protocol Violation|1
4737179|NCT03597139|7687060|FG000|Overall Study|Adverse Event|3
4737180|NCT03597139|7687061|FG001|Overall Study|Adverse Event|0
4737181|NCT03597139|7687060|FG000|Overall Study|Protocol Non-compliance|1
4737182|NCT03597139|7687061|FG001|Overall Study|Protocol Non-compliance|0
4737183|NCT03597347|7687074|FG000|Overall Study|Withdrawal by Subject|1
4737184|NCT03597347|7687075|FG001|Overall Study|Withdrawal by Subject|1
4737185|NCT03597347|7687076|FG002|Overall Study|Withdrawal by Subject|0
4737186|NCT03597347|7687074|FG000|Overall Study|Withdrawal due to Covid-19|3
4737187|NCT03597347|7687075|FG001|Overall Study|Withdrawal due to Covid-19|0
4737188|NCT03597347|7687076|FG002|Overall Study|Withdrawal due to Covid-19|0
4737189|NCT03597347|7687074|FG000|Overall Study|Sponsor decision to terminate study|3
4737190|NCT03597347|7687075|FG001|Overall Study|Sponsor decision to terminate study|2
4737191|NCT03597347|7687076|FG002|Overall Study|Sponsor decision to terminate study|4
4737192|NCT03597529|7687086|FG000|Overall Study|Lost to Follow-up|10
4737193|NCT03597529|7687087|FG001|Overall Study|Lost to Follow-up|12
4737194|NCT03597529|7687086|FG000|Overall Study|Physician Decision|3
4737195|NCT03597529|7687087|FG001|Overall Study|Physician Decision|1
4737196|NCT03597529|7687086|FG000|Overall Study|Withdrawal by Subject|6
4737197|NCT03597529|7687087|FG001|Overall Study|Withdrawal by Subject|3
4737198|NCT03597529|7687086|FG000|Overall Study|Non-compliant with study activities|1
4737199|NCT03597529|7687087|FG001|Overall Study|Non-compliant with study activities|2
4737200|NCT03599089|7687116|FG000|Overall Study|Lost to Follow-up|1
4737201|NCT03599089|7687117|FG001|Overall Study|Lost to Follow-up|0
4737202|NCT03599089|7687118|FG002|Overall Study|Lost to Follow-up|0
4737203|NCT03599089|7687119|FG003|Overall Study|Lost to Follow-up|0
4737204|NCT03599089|7687116|FG000|Overall Study|Withdrawal by Subject|2
4737205|NCT03599089|7687117|FG001|Overall Study|Withdrawal by Subject|1
4737206|NCT03599089|7687118|FG002|Overall Study|Withdrawal by Subject|0
4737207|NCT03599089|7687119|FG003|Overall Study|Withdrawal by Subject|0
4737208|NCT03599089|7687116|FG000|Overall Study|Lack of Efficacy|0
4737209|NCT03599089|7687117|FG001|Overall Study|Lack of Efficacy|0
4737210|NCT03599089|7687118|FG002|Overall Study|Lack of Efficacy|1
4737211|NCT03599089|7687119|FG003|Overall Study|Lack of Efficacy|2
4737212|NCT03599193|7687131|FG000|Overall Study|Adverse Event|0
4737213|NCT03599193|7687132|FG001|Overall Study|Adverse Event|2
4737214|NCT03599193|7687131|FG000|Overall Study|Withdrawal by Subject|1
4737215|NCT03599193|7687132|FG001|Overall Study|Withdrawal by Subject|0
4737216|NCT03599193|7687131|FG000|Overall Study|Protocol Violation|1
4737217|NCT03599193|7687132|FG001|Overall Study|Protocol Violation|0
4737218|NCT03599193|7687131|FG000|Overall Study|Lost to Follow-up|0
4737219|NCT03599193|7687132|FG001|Overall Study|Lost to Follow-up|1
4737220|NCT03599349|7687150|FG000|Overall Study|Lost to Follow-up|1
4737221|NCT03599362|7687154|FG000|Overall Study|Screen Failure|3
4737222|NCT03600376|7687187|FG000|Overall Study|Adverse Event|1
4737223|NCT03600376|7687188|FG001|Overall Study|Adverse Event|1
4737224|NCT03600376|7687187|FG000|Overall Study|Transferred to other facility|1
4737225|NCT03600376|7687188|FG001|Overall Study|Transferred to other facility|0
4737226|NCT03600376|7687187|FG000|Overall Study|Investigator Decision|0
4737227|NCT03600376|7687188|FG001|Overall Study|Investigator Decision|4
4737228|NCT03600376|7687187|FG000|Overall Study|Determined to be ineligible for study|0
4737229|NCT03600376|7687188|FG001|Overall Study|Determined to be ineligible for study|1
4737230|NCT03600428|7687196|FG000|Overall Study|Not eligible|0
4737231|NCT03600428|7687197|FG001|Overall Study|Not eligible|1
4737232|NCT03600428|7687196|FG000|Overall Study|Lost to Follow-up|5
4737233|NCT03600428|7687197|FG001|Overall Study|Lost to Follow-up|4
4737234|NCT03601052|7687203|FG000|Overall Study|Lost to Follow-up|2
4730129|NCT03336502|7671890|FG000|Overall Study|Physician Decision|0
4730130|NCT03336502|7671891|FG001|Overall Study|Physician Decision|1
4730131|NCT03336502|7671890|FG000|Overall Study|Prohibited Drugs|1
4730132|NCT03336502|7671891|FG001|Overall Study|Prohibited Drugs|1
4730133|NCT03336502|7671890|FG000|Overall Study|Death|1
4730134|NCT03336502|7671891|FG001|Overall Study|Death|2
4730135|NCT03336502|7671890|FG000|Overall Study|Adverse Event|2
4730136|NCT03336502|7671891|FG001|Overall Study|Adverse Event|5
4730137|NCT03337139|7671912|FG000|Phase I|Withdrawal by Subject|10
4730138|NCT03337139|7671913|FG001|Phase I|Withdrawal by Subject|0
4730139|NCT03337152|7671921|FG000|Overall Study|Physician Decision|1
4730140|NCT03337152|7671922|FG001|Overall Study|Physician Decision|0
4730141|NCT03337152|7671921|FG000|Overall Study|Lost to Follow-up|1
4730142|NCT03337152|7671922|FG001|Overall Study|Lost to Follow-up|3
4730143|NCT03337152|7671921|FG000|Overall Study|Adverse Event|3
4730144|NCT03337152|7671922|FG001|Overall Study|Adverse Event|1
4730145|NCT03337152|7671921|FG000|Overall Study|Stopped drug dosing due to study halt|6
4730146|NCT03337152|7671922|FG001|Overall Study|Stopped drug dosing due to study halt|7
4730147|NCT03337308|7671934|FG000|Overall Study|Adverse Event|2
4730148|NCT03337308|7671935|FG001|Overall Study|Adverse Event|3
4730149|NCT03337308|7671936|FG002|Overall Study|Adverse Event|3
4730150|NCT03337308|7671937|FG003|Overall Study|Adverse Event|1
4730151|NCT03337308|7671934|FG000|Overall Study|Lost to Follow-up|1
4730152|NCT03337308|7671935|FG001|Overall Study|Lost to Follow-up|2
4730153|NCT03337308|7671936|FG002|Overall Study|Lost to Follow-up|0
4730154|NCT03337308|7671937|FG003|Overall Study|Lost to Follow-up|0
4730155|NCT03337308|7671934|FG000|Overall Study|Withdrawal by Subject|2
4730156|NCT03337308|7671935|FG001|Overall Study|Withdrawal by Subject|1
4730157|NCT03337308|7671936|FG002|Overall Study|Withdrawal by Subject|2
4730158|NCT03337308|7671937|FG003|Overall Study|Withdrawal by Subject|1
4730159|NCT03337308|7671934|FG000|Overall Study|Protocol Violation|0
4730160|NCT03337308|7671935|FG001|Overall Study|Protocol Violation|1
4730161|NCT03337308|7671936|FG002|Overall Study|Protocol Violation|0
4730162|NCT03337308|7671937|FG003|Overall Study|Protocol Violation|0
4730163|NCT03337477|7671949|FG000|Overall Study|not categorized into the listed ones|11
4730164|NCT03337477|7671950|FG001|Overall Study|not categorized into the listed ones|9
4730165|NCT03337477|7671949|FG000|Overall Study|Withdrawal by Subject|0
4730166|NCT03337477|7671950|FG001|Overall Study|Withdrawal by Subject|1
4730167|NCT03337477|7671949|FG000|Overall Study|Death|0
4730168|NCT03337477|7671950|FG001|Overall Study|Death|1
4730169|NCT03337477|7671949|FG000|Overall Study|Lost to Follow-up|0
4730170|NCT03337477|7671950|FG001|Overall Study|Lost to Follow-up|2
4730171|NCT03337490|7671961|FG000|Overall Study|Withdrawal by Subject|1
4730172|NCT03337490|7671962|FG001|Overall Study|Withdrawal by Subject|0
4730173|NCT03337490|7671963|FG002|Overall Study|Withdrawal by Subject|0
4730174|NCT03337490|7671961|FG000|Overall Study|Lack of Efficacy|10
4730175|NCT03337490|7671962|FG001|Overall Study|Lack of Efficacy|12
4730176|NCT03337490|7671963|FG002|Overall Study|Lack of Efficacy|35
4730177|NCT03337490|7671961|FG000|Overall Study|Physician Decision|0
4730178|NCT03337490|7671962|FG001|Overall Study|Physician Decision|1
4730179|NCT03337490|7671963|FG002|Overall Study|Physician Decision|0
4730180|NCT03337490|7671961|FG000|Overall Study|Lost to Follow-up|0
4730181|NCT03337490|7671962|FG001|Overall Study|Lost to Follow-up|1
4730182|NCT03337490|7671963|FG002|Overall Study|Lost to Follow-up|0
4730183|NCT03337542|7671971|FG000|Overall Study|Withdrew Consent|17
4730184|NCT03337542|7671971|FG000|Overall Study|Allergic Adverse Event|1
4730185|NCT03337542|7671971|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1
4730186|NCT03337542|7671971|FG000|Overall Study|Lost to Follow-up|1
4730187|NCT03337542|7671971|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1
4730188|NCT03338010|7671978|FG000|Overall Study|Withdrawal by Subject|14
4730189|NCT03338010|7671979|FG001|Overall Study|Withdrawal by Subject|8
4730190|NCT03338010|7671978|FG000|Overall Study|Lost to Follow-up|4
4730191|NCT03338010|7671979|FG001|Overall Study|Lost to Follow-up|2
4730192|NCT03338010|7671978|FG000|Overall Study|Adverse Event|3
4730193|NCT03338010|7671979|FG001|Overall Study|Adverse Event|2
4730194|NCT03338010|7671978|FG000|Overall Study|Physician Decision|2
4730195|NCT03338010|7671979|FG001|Overall Study|Physician Decision|2
4730196|NCT03338010|7671978|FG000|Overall Study|Non-Compliance with Study Drug|0
4730197|NCT03338010|7671979|FG001|Overall Study|Non-Compliance with Study Drug|3
4730198|NCT03338010|7671978|FG000|Overall Study|Protocol Violation|0
4730199|NCT03338010|7671979|FG001|Overall Study|Protocol Violation|1
4730200|NCT03338023|7671987|FG000|Overall Study|Withdrawal by Subject|3
4730201|NCT03338023|7671988|FG001|Overall Study|Withdrawal by Subject|4
4730202|NCT03338023|7671987|FG000|Overall Study|Protocol Violation|3
4730203|NCT03338023|7671988|FG001|Overall Study|Protocol Violation|3
4730204|NCT03338023|7671987|FG000|Overall Study|Lost to Follow-up|2
4730205|NCT03338023|7671988|FG001|Overall Study|Lost to Follow-up|1
4730206|NCT03338023|7671987|FG000|Overall Study|Physician Decision|1
4730207|NCT03338023|7671988|FG001|Overall Study|Physician Decision|2
4730208|NCT03338062|7672011|FG000|Overall Study|Alternative Therapy|1
4730209|NCT03338062|7672012|FG001|Overall Study|Alternative Therapy|0
4730210|NCT03338296|7672021|FG000|Overall Study|Adverse Event|0
4730211|NCT03338296|7672022|FG001|Overall Study|Adverse Event|1
4730212|NCT03338296|7672021|FG000|Overall Study|Withdrawal by Subject|14
4730213|NCT03338296|7672022|FG001|Overall Study|Withdrawal by Subject|13
4730214|NCT03338296|7672021|FG000|Overall Study|Lost to Follow-up|10
4730215|NCT03338296|7672022|FG001|Overall Study|Lost to Follow-up|10
4730216|NCT03338296|7672021|FG000|Overall Study|Study Terminated by Sponsor|77
4730217|NCT03338296|7672022|FG001|Overall Study|Study Terminated by Sponsor|76
4730218|NCT03338296|7672021|FG000|Overall Study|Other|2
4730219|NCT03338296|7672022|FG001|Overall Study|Other|7
4730220|NCT03338296|7672021|FG000|Overall Study|Missing|0
4730221|NCT03338296|7672022|FG001|Overall Study|Missing|1
4730222|NCT03338400|7672030|FG000|Overall Study|Lost to Follow-up|1
4730223|NCT03338400|7672031|FG001|Overall Study|Lost to Follow-up|2
4730224|NCT03338569|7672064|FG000|Overall Study|Physician Decision|8
4730225|NCT03338569|7672065|FG001|Overall Study|Physician Decision|3
4730226|NCT03338569|7672064|FG000|Overall Study|Withdrawal by Subject|0
4730227|NCT03338569|7672065|FG001|Overall Study|Withdrawal by Subject|1
4730228|NCT03338569|7672064|FG000|Overall Study|Lost to Follow-up|0
4730229|NCT03338569|7672065|FG001|Overall Study|Lost to Follow-up|1
4730230|NCT03338673|7672073|FG000|Overall Study|Lost to Follow-up|1
4730231|NCT03338673|7672074|FG001|Overall Study|Lost to Follow-up|1
4730232|NCT03338816|7672098|FG000|6-Month Double-blind Period|Adverse Event|0
4730233|NCT03338816|7672099|FG001|6-Month Double-blind Period|Adverse Event|1
4730234|NCT03338816|7672098|FG000|Open-Label Extension Period|Ongoing in Study|46
4730235|NCT03338816|7672099|FG001|Open-Label Extension Period|Ongoing in Study|47
4730236|NCT03338855|7672107|FG000|Overall Study|Withdrawn as birth control pill stopped|1
4730237|NCT03338855|7672108|FG001|Overall Study|Withdrawn as birth control pill stopped|0
4730238|NCT03338894|7672114|FG000|Overall Study|not able able to attend 9 or more classes|10
4730239|NCT03338998|7672120|FG000|Treatment Period|Withdrawal by Subject|1
4730240|NCT03338998|7672121|FG001|Treatment Period|Withdrawal by Subject|1
4730241|NCT03338998|7672120|FG000|Treatment Period|Adverse Event|0
4730242|NCT03338998|7672121|FG001|Treatment Period|Adverse Event|2
4730243|NCT03338998|7672120|FG000|Treatment Period|Protocol deviation|1
4730244|NCT03338998|7672121|FG001|Treatment Period|Protocol deviation|0
4730245|NCT03338998|7672120|FG000|Treatment Period|Physician Decision|2
4730246|NCT03338998|7672121|FG001|Treatment Period|Physician Decision|0
4730247|NCT03338998|7672120|FG000|Treatment Period|Subject failed swallow test|4
4730248|NCT03338998|7672121|FG001|Treatment Period|Subject failed swallow test|0
4730249|NCT03338998|7672120|FG000|Safety Follow-Up Period|Adverse Event|0
4730250|NCT03338998|7672121|FG001|Safety Follow-Up Period|Adverse Event|1
4730251|NCT03338998|7672120|FG000|Safety Follow-Up Period|Protocol deviation|1
4730252|NCT03338998|7672121|FG001|Safety Follow-Up Period|Protocol deviation|0
4730253|NCT03338998|7672120|FG000|Safety Follow-Up Period|Lost to Follow-up|1
4730254|NCT03338998|7672121|FG001|Safety Follow-Up Period|Lost to Follow-up|0
4730255|NCT03339219|7672141|FG000|Overall Study|Death|12
4730256|NCT03339219|7672141|FG000|Overall Study|Site Terminated by Sponsor|22
4730257|NCT03339219|7672141|FG000|Overall Study|Withdrawal by Subject|1
4730258|NCT03339297|7672147|FG000|Overall Study|Relapse of Hematologic Disease|1
4730259|NCT03339297|7672148|FG001|Overall Study|Relapse of Hematologic Disease|0
4730260|NCT03339297|7672147|FG000|Overall Study|Death|10
4730261|NCT03339297|7672148|FG001|Overall Study|Death|7
4730262|NCT03339297|7672147|FG000|Overall Study|Hepatic Candidosis|1
4730263|NCT03339297|7672148|FG001|Overall Study|Hepatic Candidosis|0
4730264|NCT03339297|7672147|FG000|Overall Study|Adverse Event, Serious Fatal|0
4730265|NCT03339297|7672148|FG001|Overall Study|Adverse Event, Serious Fatal|2
4730266|NCT03339297|7672147|FG000|Overall Study|Consent Withdrawn by Participant|3
4730267|NCT03339297|7672148|FG001|Overall Study|Consent Withdrawn by Participant|3
4730268|NCT03339297|7672147|FG000|Overall Study|Disease Relapse|2
4730269|NCT03339297|7672148|FG001|Overall Study|Disease Relapse|0
4730270|NCT03339297|7672147|FG000|Overall Study|Physician Decision|1
4730271|NCT03339297|7672148|FG001|Overall Study|Physician Decision|1
4730272|NCT03339297|7672147|FG000|Overall Study|Relapse of Disease New Transplant Performed|1
4730273|NCT03339297|7672148|FG001|Overall Study|Relapse of Disease New Transplant Performed|0
4730274|NCT03339297|7672147|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1
4730275|NCT03339297|7672148|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0
4730276|NCT03339297|7672147|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1
4730277|NCT03339297|7672148|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0
4730278|NCT03339297|7672147|FG000|Overall Study|Adverse Event, Non-fatal|1
4730279|NCT03339297|7672148|FG001|Overall Study|Adverse Event, Non-fatal|0
4730280|NCT03339297|7672147|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0
4730281|NCT03339297|7672148|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1
4730282|NCT03339297|7672147|FG000|Overall Study|Patient Was Not Eligible|1
4730283|NCT03339297|7672148|FG001|Overall Study|Patient Was Not Eligible|0
4730284|NCT03339453|7672156|FG000|First Visit of Glucagon Treatment|Adverse Event|0
4730285|NCT03339453|7672157|FG001|First Visit of Glucagon Treatment|Adverse Event|1
4730286|NCT03339583|7672178|FG000|First Intervention (14 Days)|Adverse Event|1
4730287|NCT03339583|7672179|FG001|First Intervention (14 Days)|Adverse Event|0
4730288|NCT03339583|7672178|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0
4730289|NCT03339583|7672179|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1
4730290|NCT03339583|7672178|FG000|Second Intervention (14 Days)|Adverse Event|0
4730291|NCT03339583|7672179|FG001|Second Intervention (14 Days)|Adverse Event|1
4730292|NCT03339583|7672178|FG000|Follow-up (14 Days)|Physician Decision|6
4730293|NCT03339583|7672179|FG001|Follow-up (14 Days)|Physician Decision|3
4730294|NCT03339713|7672189|FG000|Overall Study|Lost to Follow-up|2
4730295|NCT03339713|7672190|FG001|Overall Study|Lost to Follow-up|1
4730296|NCT03339713|7672189|FG000|Overall Study|Protocol Violation|1
4730297|NCT03339713|7672190|FG001|Overall Study|Protocol Violation|0
4730298|NCT03339713|7672189|FG000|Overall Study|Withdrawal by Subject|1
4730299|NCT03339713|7672190|FG001|Overall Study|Withdrawal by Subject|1
4730300|NCT03339726|7672201|FG000|Overall Study|Withdrawal by Subject|1
4730301|NCT03339726|7672202|FG001|Overall Study|Withdrawal by Subject|0
4730302|NCT03339726|7672203|FG002|Overall Study|Withdrawal by Subject|0
4730303|NCT03339726|7672201|FG000|Overall Study|Lost to Follow-up|0
4730304|NCT03339726|7672202|FG001|Overall Study|Lost to Follow-up|1
4730305|NCT03339726|7672203|FG002|Overall Study|Lost to Follow-up|0
4730306|NCT03339999|7672215|FG000|Overall Study|Adverse Event|1
4730307|NCT03339999|7672216|FG001|Overall Study|Adverse Event|2
4730308|NCT03339999|7672217|FG002|Overall Study|Adverse Event|2
4730309|NCT03339999|7672218|FG003|Overall Study|Adverse Event|1
4730310|NCT03339999|7672215|FG000|Overall Study|Lack of Efficacy|0
4730311|NCT03339999|7672216|FG001|Overall Study|Lack of Efficacy|1
4730312|NCT03339999|7672217|FG002|Overall Study|Lack of Efficacy|0
4730313|NCT03339999|7672218|FG003|Overall Study|Lack of Efficacy|0
4730314|NCT03339999|7672215|FG000|Overall Study|Lost to Follow-up|0
4730315|NCT03339999|7672216|FG001|Overall Study|Lost to Follow-up|0
4730316|NCT03339999|7672217|FG002|Overall Study|Lost to Follow-up|0
4730317|NCT03339999|7672218|FG003|Overall Study|Lost to Follow-up|1
4730318|NCT03339999|7672215|FG000|Overall Study|Study Terminated by Sponsor|6
4730319|NCT03339999|7672216|FG001|Overall Study|Study Terminated by Sponsor|3
4730320|NCT03339999|7672217|FG002|Overall Study|Study Terminated by Sponsor|4
4730321|NCT03339999|7672218|FG003|Overall Study|Study Terminated by Sponsor|3
4730322|NCT03340025|7672233|FG000|Overall Study|Lost to Follow-up|2
4730323|NCT03340025|7672234|FG001|Overall Study|Lost to Follow-up|2
4730324|NCT03340961|7672318|FG000|Overall Study|Adverse Event|1
4730325|NCT03340961|7672319|FG001|Overall Study|Adverse Event|3
4730326|NCT03340961|7672320|FG002|Overall Study|Adverse Event|2
4730327|NCT03340961|7672321|FG003|Overall Study|Adverse Event|4
4730328|NCT03340961|7672318|FG000|Overall Study|Lost to Follow-up|0
4730329|NCT03340961|7672319|FG001|Overall Study|Lost to Follow-up|1
4730330|NCT03340961|7672320|FG002|Overall Study|Lost to Follow-up|0
4730331|NCT03340961|7672321|FG003|Overall Study|Lost to Follow-up|1
4730332|NCT03340961|7672318|FG000|Overall Study|Withdrawal by Subject|3
4730333|NCT03340961|7672319|FG001|Overall Study|Withdrawal by Subject|2
4730334|NCT03340961|7672320|FG002|Overall Study|Withdrawal by Subject|4
4730335|NCT03340961|7672321|FG003|Overall Study|Withdrawal by Subject|7
4730336|NCT03340961|7672318|FG000|Overall Study|Use of prohibited treatment|0
4730337|NCT03340961|7672319|FG001|Overall Study|Use of prohibited treatment|3
4730338|NCT03340961|7672320|FG002|Overall Study|Use of prohibited treatment|2
4730339|NCT03340961|7672321|FG003|Overall Study|Use of prohibited treatment|4
4730340|NCT03340961|7672318|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0
4730341|NCT03340961|7672319|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1
4730342|NCT03340961|7672320|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0
4730343|NCT03340961|7672321|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1
4730344|NCT03340961|7672318|FG000|Overall Study|Subject developed an exclusion criterion|0
4730345|NCT03340961|7672319|FG001|Overall Study|Subject developed an exclusion criterion|1
4730346|NCT03340961|7672320|FG002|Overall Study|Subject developed an exclusion criterion|0
4730347|NCT03340961|7672321|FG003|Overall Study|Subject developed an exclusion criterion|0
4730348|NCT03340961|7672318|FG000|Overall Study|Protocol Violation|1
4730349|NCT03340961|7672319|FG001|Overall Study|Protocol Violation|0
4730350|NCT03340961|7672320|FG002|Overall Study|Protocol Violation|1
4730351|NCT03340961|7672321|FG003|Overall Study|Protocol Violation|0
4730352|NCT03340961|7672318|FG000|Overall Study|Adverse Event|1
4730353|NCT03340961|7672319|FG001|Overall Study|Adverse Event|1
4730354|NCT03340961|7672320|FG002|Overall Study|Adverse Event|0
4730355|NCT03340961|7672321|FG003|Overall Study|Adverse Event|0
4730356|NCT03340961|7672318|FG000|Overall Study|Lack of Efficacy|0
4730357|NCT03340961|7672319|FG001|Overall Study|Lack of Efficacy|0
4730358|NCT03340961|7672320|FG002|Overall Study|Lack of Efficacy|0
4730359|NCT03340961|7672321|FG003|Overall Study|Lack of Efficacy|1
4730360|NCT03341273|7672333|FG000|Overall Study|Lost to Follow-up|7
4730361|NCT03341273|7672334|FG001|Overall Study|Lost to Follow-up|7
4730362|NCT03341273|7672333|FG000|Overall Study|Withdrawal by Subject|4
4730363|NCT03341273|7672334|FG001|Overall Study|Withdrawal by Subject|2
4730364|NCT03341273|7672333|FG000|Overall Study|Physician Decision|1
4730365|NCT03341273|7672334|FG001|Overall Study|Physician Decision|0
4730366|NCT03341273|7672333|FG000|Overall Study|Protocol Violation|0
4730367|NCT03341273|7672334|FG001|Overall Study|Protocol Violation|1
4730368|NCT03341273|7672333|FG000|Overall Study|Enrolled but Treatment Not Administered|6
4730369|NCT03341273|7672334|FG001|Overall Study|Enrolled but Treatment Not Administered|1
4730370|NCT03341273|7672333|FG000|Overall Study|Became ineligible after enrollment|1
4730371|NCT03341273|7672334|FG001|Overall Study|Became ineligible after enrollment|0
4730372|NCT03341273|7672333|FG000|Overall Study|Not Eligible at Enrollment|0
4730373|NCT03341273|7672334|FG001|Overall Study|Not Eligible at Enrollment|1
4730374|NCT03341273|7672333|FG000|Overall Study|Participant incarcerated|1
4772376|NCT01434602|7749397|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0
4730375|NCT03341273|7672334|FG001|Overall Study|Participant incarcerated|0
4730376|NCT03341299|7672340|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0
4730377|NCT03341299|7672341|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0
4730378|NCT03341299|7672342|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1
4730379|NCT03341299|7672343|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0
4730380|NCT03341312|7672355|FG000|Period 1|Withdrawal by Subject|0
4730381|NCT03341312|7672356|FG001|Period 1|Withdrawal by Subject|1
4730382|NCT03341312|7672357|FG002|Period 1|Withdrawal by Subject|0
4730383|NCT03341312|7672358|FG003|Period 1|Withdrawal by Subject|0
4730384|NCT03341507|7672370|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34
4730385|NCT03341533|7672376|FG000|Overall Study|Withdrawal by Subject|1
4730386|NCT03341533|7672377|FG001|Overall Study|Withdrawal by Subject|1
4730387|NCT03341533|7672376|FG000|Overall Study|Not eligible after randomization|2
4730388|NCT03341533|7672377|FG001|Overall Study|Not eligible after randomization|1
4730389|NCT03341637|7672389|FG000|Overall Study|Lost to Follow-up|1
4730390|NCT03341637|7672390|FG001|Overall Study|Lost to Follow-up|0
4730391|NCT03341637|7672389|FG000|Overall Study|Withdrawal by Subject|3
4730392|NCT03341637|7672390|FG001|Overall Study|Withdrawal by Subject|3
4730393|NCT03341637|7672389|FG000|Overall Study|Reason not Specified|1
4730394|NCT03341637|7672390|FG001|Overall Study|Reason not Specified|1
4730395|NCT03341923|7672420|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0
4730396|NCT03341923|7672421|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1
4730397|NCT03342404|7672440|FG000|Overall Study|Withdrawal by Subject|9
4730398|NCT03342404|7672441|FG001|Overall Study|Withdrawal by Subject|10
4730399|NCT03342404|7672440|FG000|Overall Study|Lack of Efficacy|1
4730400|NCT03342404|7672441|FG001|Overall Study|Lack of Efficacy|17
4730401|NCT03342404|7672440|FG000|Overall Study|Adverse Event|3
4730402|NCT03342404|7672441|FG001|Overall Study|Adverse Event|4
4730403|NCT03342404|7672440|FG000|Overall Study|Noncompliance with study drug|1
4730404|NCT03342404|7672441|FG001|Overall Study|Noncompliance with study drug|0
4730405|NCT03342404|7672440|FG000|Overall Study|Other reasons|1
4730406|NCT03342404|7672441|FG001|Overall Study|Other reasons|0
4730407|NCT03342469|7672449|FG000|Overall Study|Withdrawal by Subject|0
4730408|NCT03342469|7672450|FG001|Overall Study|Withdrawal by Subject|1
4730409|NCT03342469|7672451|FG002|Overall Study|Withdrawal by Subject|0
4730410|NCT03342469|7672452|FG003|Overall Study|Withdrawal by Subject|0
4730411|NCT03342560|7672463|FG000|Overall Study|Lost to Follow-up|2
4730412|NCT03342690|7672471|FG000|Overall Study|Missing Information|9
4730413|NCT03342690|7672471|FG000|Overall Study|Protocol Violation|16
4730414|NCT03342898|7672478|FG000|Overall Study|Adverse Event|3
4730415|NCT03342898|7672479|FG001|Overall Study|Adverse Event|1
4730416|NCT03342898|7672480|FG002|Overall Study|Adverse Event|0
4730417|NCT03342898|7672478|FG000|Overall Study|Lost to Follow-up|44
4730418|NCT03342898|7672479|FG001|Overall Study|Lost to Follow-up|40
4730419|NCT03342898|7672480|FG002|Overall Study|Lost to Follow-up|42
4730420|NCT03342898|7672478|FG000|Overall Study|Withdrawal of Consent|5
4730421|NCT03342898|7672479|FG001|Overall Study|Withdrawal of Consent|9
4730422|NCT03342898|7672480|FG002|Overall Study|Withdrawal of Consent|11
4730423|NCT03342898|7672478|FG000|Overall Study|Death|0
4730424|NCT03342898|7672479|FG001|Overall Study|Death|1
4730425|NCT03342898|7672480|FG002|Overall Study|Death|1
4730426|NCT03342898|7672478|FG000|Overall Study|Reason not Specified|2
4730427|NCT03342898|7672479|FG001|Overall Study|Reason not Specified|2
4730428|NCT03342898|7672480|FG002|Overall Study|Reason not Specified|0
4730429|NCT03342963|7672492|FG000|Overall Study|Adverse Event|1
4730430|NCT03342963|7672493|FG001|Overall Study|Adverse Event|2
4730431|NCT03342963|7672494|FG002|Overall Study|Adverse Event|0
4730432|NCT03342963|7672495|FG003|Overall Study|Adverse Event|0
4730433|NCT03342963|7672492|FG000|Overall Study|Withdrawal by Subject|1
4730434|NCT03342963|7672493|FG001|Overall Study|Withdrawal by Subject|0
4730435|NCT03342963|7672494|FG002|Overall Study|Withdrawal by Subject|0
4730436|NCT03342963|7672495|FG003|Overall Study|Withdrawal by Subject|0
4730437|NCT03343067|7672508|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0
4730438|NCT03343067|7672509|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3
4730439|NCT03343067|7672510|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1
4730440|NCT03343639|7672529|FG000|Overall Study|Withdrawal by Subject|10
4730441|NCT03343639|7672530|FG001|Overall Study|Withdrawal by Subject|6
4730442|NCT03343639|7672529|FG000|Overall Study|Lost to Follow-up|4
4730443|NCT03343639|7672530|FG001|Overall Study|Lost to Follow-up|5
4730444|NCT03343639|7672529|FG000|Overall Study|Protocol Violation|0
4730445|NCT03343639|7672530|FG001|Overall Study|Protocol Violation|1
4730446|NCT03343704|7672538|FG000|Overall Study|Refused to complete follow up|0
4730447|NCT03343704|7672539|FG001|Overall Study|Refused to complete follow up|1
4730448|NCT03343704|7672538|FG000|Overall Study|Death|0
4730449|NCT03343704|7672539|FG001|Overall Study|Death|1
4730450|NCT03343704|7672538|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1
4730451|NCT03343704|7672539|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0
4730452|NCT03344172|7672549|FG000|Overall Study|Received <1 dose of treatment|1
4730453|NCT03344172|7672550|FG001|Overall Study|Received <1 dose of treatment|0
4730454|NCT03344640|7672566|FG000|Overall Study|Adverse Event|1
4730455|NCT03344640|7672567|FG001|Overall Study|Adverse Event|0
4730456|NCT03344640|7672566|FG000|Overall Study|Physician Decision|1
4730457|NCT03344640|7672567|FG001|Overall Study|Physician Decision|1
4730458|NCT03344640|7672566|FG000|Overall Study|Withdrawal by Subject|1
4730459|NCT03344640|7672567|FG001|Overall Study|Withdrawal by Subject|2
4730460|NCT03344640|7672566|FG000|Follow-up Epoch|Withdrawal by Subject|0
4730461|NCT03344640|7672567|FG001|Follow-up Epoch|Withdrawal by Subject|2
4730462|NCT03345407|7672610|FG000|Overall Study|Withdrawal by Subject|11
4730463|NCT03345407|7672611|FG001|Overall Study|Withdrawal by Subject|1
4730464|NCT03345407|7672612|FG002|Overall Study|Withdrawal by Subject|5
4730465|NCT03345407|7672613|FG003|Overall Study|Withdrawal by Subject|6
4730466|NCT03345407|7672614|FG004|Overall Study|Withdrawal by Subject|3
4730467|NCT03345407|7672615|FG005|Overall Study|Withdrawal by Subject|6
4730468|NCT03345407|7672616|FG006|Overall Study|Withdrawal by Subject|16
4730469|NCT03345407|7672610|FG000|Overall Study|Physician Decision|3
4730470|NCT03345407|7672611|FG001|Overall Study|Physician Decision|1
4730471|NCT03345407|7672612|FG002|Overall Study|Physician Decision|0
4730472|NCT03345407|7672613|FG003|Overall Study|Physician Decision|0
4730473|NCT03345407|7672614|FG004|Overall Study|Physician Decision|1
4730474|NCT03345407|7672615|FG005|Overall Study|Physician Decision|2
4730475|NCT03345407|7672616|FG006|Overall Study|Physician Decision|3
4730476|NCT03345407|7672610|FG000|Overall Study|Lost to Follow-up|2
4730477|NCT03345407|7672611|FG001|Overall Study|Lost to Follow-up|0
4730478|NCT03345407|7672612|FG002|Overall Study|Lost to Follow-up|1
4730479|NCT03345407|7672613|FG003|Overall Study|Lost to Follow-up|0
4730480|NCT03345407|7672614|FG004|Overall Study|Lost to Follow-up|1
4730481|NCT03345407|7672615|FG005|Overall Study|Lost to Follow-up|2
4730482|NCT03345407|7672616|FG006|Overall Study|Lost to Follow-up|3
4730483|NCT03345407|7672610|FG000|Overall Study|Protocol-defined stopping criteria|9
4730484|NCT03345407|7672611|FG001|Overall Study|Protocol-defined stopping criteria|0
4730485|NCT03345407|7672612|FG002|Overall Study|Protocol-defined stopping criteria|0
4730486|NCT03345407|7672613|FG003|Overall Study|Protocol-defined stopping criteria|0
4730487|NCT03345407|7672614|FG004|Overall Study|Protocol-defined stopping criteria|2
4730488|NCT03345407|7672615|FG005|Overall Study|Protocol-defined stopping criteria|1
4730489|NCT03345407|7672616|FG006|Overall Study|Protocol-defined stopping criteria|1
4730490|NCT03345407|7672610|FG000|Overall Study|Protocol Violation|2
4730491|NCT03345407|7672611|FG001|Overall Study|Protocol Violation|0
4730492|NCT03345407|7672612|FG002|Overall Study|Protocol Violation|0
4730493|NCT03345407|7672613|FG003|Overall Study|Protocol Violation|0
4730494|NCT03345407|7672614|FG004|Overall Study|Protocol Violation|1
4730495|NCT03345407|7672615|FG005|Overall Study|Protocol Violation|0
4730496|NCT03345407|7672616|FG006|Overall Study|Protocol Violation|3
4730497|NCT03345407|7672610|FG000|Overall Study|Lack of Efficacy|1
4730498|NCT03345407|7672611|FG001|Overall Study|Lack of Efficacy|1
4730499|NCT03345407|7672612|FG002|Overall Study|Lack of Efficacy|1
4730500|NCT03345407|7672613|FG003|Overall Study|Lack of Efficacy|1
4730501|NCT03345407|7672614|FG004|Overall Study|Lack of Efficacy|1
4730502|NCT03345407|7672615|FG005|Overall Study|Lack of Efficacy|0
4730503|NCT03345407|7672616|FG006|Overall Study|Lack of Efficacy|3
4730504|NCT03345407|7672610|FG000|Overall Study|Adverse Event|4
4730505|NCT03345407|7672611|FG001|Overall Study|Adverse Event|0
4730506|NCT03345407|7672612|FG002|Overall Study|Adverse Event|5
4730507|NCT03345407|7672613|FG003|Overall Study|Adverse Event|4
4730508|NCT03345407|7672614|FG004|Overall Study|Adverse Event|6
4730509|NCT03345407|7672615|FG005|Overall Study|Adverse Event|5
4730510|NCT03345407|7672616|FG006|Overall Study|Adverse Event|16
4730511|NCT03345472|7672638|FG000|Implant to 3 Months|Withdrawal by Subject|2
4730512|NCT03345472|7672638|FG000|Implant to 3 Months|Physician Decision|1
4730513|NCT03345472|7672638|FG000|Implant to 3 Months|Adverse Event|1
4730514|NCT03345472|7672638|FG000|3 Months to 12 Months|Physician Decision|3
4730515|NCT03345472|7672638|FG000|3 Months to 12 Months|Lost to Follow-up|2
4730516|NCT03345472|7672638|FG000|3 Months to 12 Months|Withdrawal by Subject|1
4730517|NCT03345472|7672638|FG000|3 Months to 12 Months|Adverse Event|1
4730518|NCT03345472|7672638|FG000|3 Months to 12 Months|Death|1
4730519|NCT03345914|7672645|FG000|Overall Study|Transition to another study at week 16|80
4730520|NCT03345914|7672646|FG001|Overall Study|Transition to another study at week 16|86
4730521|NCT03345914|7672647|FG002|Overall Study|Transition to another study at week 16|78
4730522|NCT03345914|7672645|FG000|Overall Study|Transition to OLE during follow-up|37
4730523|NCT03345914|7672646|FG001|Overall Study|Transition to OLE during follow-up|33
4730524|NCT03345914|7672647|FG002|Overall Study|Transition to OLE during follow-up|39
4730525|NCT03345914|7672645|FG000|Overall Study|Physician Decision|0
4730526|NCT03345914|7672646|FG001|Overall Study|Physician Decision|1
4730527|NCT03345914|7672647|FG002|Overall Study|Physician Decision|1
4730528|NCT03345914|7672645|FG000|Overall Study|Withdrawal by Subject|5
4730529|NCT03345914|7672646|FG001|Overall Study|Withdrawal by Subject|1
4730530|NCT03345914|7672647|FG002|Overall Study|Withdrawal by Subject|2
4730531|NCT03345914|7672645|FG000|Overall Study|Other|1
4730532|NCT03345914|7672646|FG001|Overall Study|Other|1
4730533|NCT03345914|7672647|FG002|Overall Study|Other|1
4730534|NCT03345914|7672645|FG000|Overall Study|Ongoing|0
4730535|NCT03345914|7672646|FG001|Overall Study|Ongoing|0
4730536|NCT03345914|7672647|FG002|Overall Study|Ongoing|1
4730537|NCT03345979|7672657|FG000|Overall Study|Withdrawal by Subject|20
4730538|NCT03345979|7672658|FG001|Overall Study|Withdrawal by Subject|31
4730539|NCT03345979|7672657|FG000|Overall Study|Adverse Event|10
4730540|NCT03345979|7672658|FG001|Overall Study|Adverse Event|11
4730541|NCT03345979|7672657|FG000|Overall Study|Lost to Follow-up|8
4730542|NCT03345979|7672658|FG001|Overall Study|Lost to Follow-up|9
4730543|NCT03345979|7672657|FG000|Overall Study|Lack of Efficacy|4
4730544|NCT03345979|7672658|FG001|Overall Study|Lack of Efficacy|2
4730545|NCT03345979|7672657|FG000|Overall Study|Protocol Violation|1
4730546|NCT03345979|7672658|FG001|Overall Study|Protocol Violation|3
4730547|NCT03345979|7672657|FG000|Overall Study|Physician Decision|0
4730548|NCT03345979|7672658|FG001|Overall Study|Physician Decision|2
4730549|NCT03346057|7672668|FG000|Overall Study|Death|1
4730550|NCT03346057|7672669|FG001|Overall Study|Death|2
4730551|NCT03346057|7672670|FG002|Overall Study|Death|0
4730552|NCT03346057|7672671|FG003|Overall Study|Death|0
4730553|NCT03346057|7672668|FG000|Overall Study|Lost to Follow-up|0
4730554|NCT03346057|7672669|FG001|Overall Study|Lost to Follow-up|2
4730555|NCT03346057|7672670|FG002|Overall Study|Lost to Follow-up|1
4730556|NCT03346057|7672671|FG003|Overall Study|Lost to Follow-up|0
4730557|NCT03346057|7672668|FG000|Overall Study|Ineligible For Study - Not Treated|0
4730558|NCT03346057|7672669|FG001|Overall Study|Ineligible For Study - Not Treated|1
4730559|NCT03346057|7672670|FG002|Overall Study|Ineligible For Study - Not Treated|0
4730560|NCT03346057|7672671|FG003|Overall Study|Ineligible For Study - Not Treated|0
4730561|NCT03346057|7672668|FG000|Overall Study|Renal Insufficiency - Not Treated|1
4730562|NCT03346057|7672669|FG001|Overall Study|Renal Insufficiency - Not Treated|0
4730563|NCT03346057|7672670|FG002|Overall Study|Renal Insufficiency - Not Treated|0
4730564|NCT03346057|7672671|FG003|Overall Study|Renal Insufficiency - Not Treated|0
4730565|NCT03346057|7672668|FG000|Overall Study|Physician Decision|3
4730566|NCT03346057|7672669|FG001|Overall Study|Physician Decision|2
4730567|NCT03346057|7672670|FG002|Overall Study|Physician Decision|0
4730568|NCT03346057|7672671|FG003|Overall Study|Physician Decision|2
4730569|NCT03346057|7672668|FG000|Overall Study|Randomization Mistake - Not Treated|1
4730570|NCT03346057|7672669|FG001|Overall Study|Randomization Mistake - Not Treated|1
4730571|NCT03346057|7672670|FG002|Overall Study|Randomization Mistake - Not Treated|0
4730572|NCT03346057|7672671|FG003|Overall Study|Randomization Mistake - Not Treated|0
4730573|NCT03346057|7672668|FG000|Overall Study|Withdrawal by Subject|1
4730574|NCT03346057|7672669|FG001|Overall Study|Withdrawal by Subject|0
4730575|NCT03346057|7672670|FG002|Overall Study|Withdrawal by Subject|0
4730576|NCT03346057|7672671|FG003|Overall Study|Withdrawal by Subject|0
4730577|NCT03346070|7672686|FG000|Overall Study|Death|0
4730578|NCT03346070|7672687|FG001|Overall Study|Death|0
4730579|NCT03346070|7672688|FG002|Overall Study|Death|0
4730580|NCT03346070|7672689|FG003|Overall Study|Death|0
4730581|NCT03346070|7672690|FG004|Overall Study|Death|1
4730582|NCT03346070|7672686|FG000|Overall Study|Lost to Follow-up|0
4730583|NCT03346070|7672687|FG001|Overall Study|Lost to Follow-up|1
4730584|NCT03346070|7672688|FG002|Overall Study|Lost to Follow-up|2
4730585|NCT03346070|7672689|FG003|Overall Study|Lost to Follow-up|0
4730586|NCT03346070|7672690|FG004|Overall Study|Lost to Follow-up|0
4730587|NCT03346070|7672686|FG000|Overall Study|Physician Decision|0
4730588|NCT03346070|7672687|FG001|Overall Study|Physician Decision|0
4730589|NCT03346070|7672688|FG002|Overall Study|Physician Decision|0
4730590|NCT03346070|7672689|FG003|Overall Study|Physician Decision|1
4730591|NCT03346070|7672690|FG004|Overall Study|Physician Decision|1
4730592|NCT03346070|7672686|FG000|Overall Study|Withdrawal by Subject|1
4730593|NCT03346070|7672687|FG001|Overall Study|Withdrawal by Subject|0
4730594|NCT03346070|7672688|FG002|Overall Study|Withdrawal by Subject|0
4730595|NCT03346070|7672689|FG003|Overall Study|Withdrawal by Subject|1
4730596|NCT03346070|7672690|FG004|Overall Study|Withdrawal by Subject|0
4730597|NCT03346070|7672686|FG000|Overall Study|Study medication not received as planned|2
4730598|NCT03346070|7672687|FG001|Overall Study|Study medication not received as planned|3
4730599|NCT03346070|7672688|FG002|Overall Study|Study medication not received as planned|2
4730600|NCT03346070|7672689|FG003|Overall Study|Study medication not received as planned|3
4730601|NCT03346070|7672690|FG004|Overall Study|Study medication not received as planned|2
4730602|NCT03346070|7672686|FG000|Overall Study|Screen Failure|0
4730603|NCT03346070|7672687|FG001|Overall Study|Screen Failure|0
4730604|NCT03346070|7672688|FG002|Overall Study|Screen Failure|0
4730605|NCT03346070|7672689|FG003|Overall Study|Screen Failure|1
4730606|NCT03346070|7672690|FG004|Overall Study|Screen Failure|1
4730607|NCT03346759|7672715|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2
4730608|NCT03346759|7672716|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3
4730609|NCT03346759|7672715|FG000|First Menstrual Cycle|Withdrawal by Subject|1
4730610|NCT03346759|7672716|FG001|First Menstrual Cycle|Withdrawal by Subject|0
4730611|NCT03346759|7672715|FG000|Second Menstrual Cycle|Lost to Follow-up|1
4730612|NCT03346759|7672716|FG001|Second Menstrual Cycle|Lost to Follow-up|0
4730613|NCT03347188|7672743|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2
4730614|NCT03347188|7672744|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2
4730615|NCT03347188|7672743|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4
4730616|NCT03347188|7672744|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8
4730617|NCT03347188|7672743|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7
4730618|NCT03347188|7672744|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4
4772377|NCT01434602|7749398|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1
4772378|NCT01434602|7749399|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0
4730619|NCT03347188|7672743|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1
4730620|NCT03347188|7672744|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1
4730621|NCT03347188|7672743|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1
4730622|NCT03347188|7672744|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2
4730623|NCT03347188|7672743|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26
4730624|NCT03347188|7672744|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28
4730625|NCT03347188|7672743|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1
4730626|NCT03347188|7672744|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0
4730627|NCT03347188|7672743|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0
4730628|NCT03347188|7672744|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1
4730629|NCT03347279|7672752|FG000|Overall Study|Withdrawal by Subject|8
4730630|NCT03347279|7672753|FG001|Overall Study|Withdrawal by Subject|15
4730631|NCT03347279|7672752|FG000|Overall Study|Death|0
4730632|NCT03347279|7672753|FG001|Overall Study|Death|2
4730633|NCT03347279|7672752|FG000|Overall Study|Lost to Follow-up|5
4730634|NCT03347279|7672753|FG001|Overall Study|Lost to Follow-up|2
4730635|NCT03347279|7672752|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3
4730636|NCT03347279|7672753|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4
4730637|NCT03347695|7672761|FG000|Overall Study|Death|0
4730638|NCT03347695|7672762|FG001|Overall Study|Death|4
4730639|NCT03347695|7672761|FG000|Overall Study|Lost to Follow-up|0
4730640|NCT03347695|7672762|FG001|Overall Study|Lost to Follow-up|1
4730641|NCT03349034|7672781|FG000|Overall Study|catheters dislodged during transport|2
4730642|NCT03349034|7672782|FG001|Overall Study|catheters dislodged during transport|0
4730643|NCT03349034|7672781|FG000|Overall Study|intubated for >48 hrs following surgery|1
4730644|NCT03349034|7672782|FG001|Overall Study|intubated for >48 hrs following surgery|1
4730645|NCT03349034|7672781|FG000|Overall Study|soft tissue flap used|1
4730646|NCT03349034|7672782|FG001|Overall Study|soft tissue flap used|0
4730647|NCT03349034|7672781|FG000|Overall Study|Other|0
4730648|NCT03349034|7672782|FG001|Overall Study|Other|1
4730649|NCT03349060|7672793|FG000|Overall Study|Adverse Event|9
4730650|NCT03349060|7672794|FG001|Overall Study|Adverse Event|9
4730651|NCT03349060|7672795|FG002|Overall Study|Adverse Event|7
4730652|NCT03349060|7672793|FG000|Overall Study|Lack of Efficacy|1
4730653|NCT03349060|7672794|FG001|Overall Study|Lack of Efficacy|0
4730654|NCT03349060|7672795|FG002|Overall Study|Lack of Efficacy|2
4730655|NCT03349060|7672793|FG000|Overall Study|Lost to Follow-up|2
4730656|NCT03349060|7672794|FG001|Overall Study|Lost to Follow-up|1
4730657|NCT03349060|7672795|FG002|Overall Study|Lost to Follow-up|1
4730658|NCT03349060|7672793|FG000|Overall Study|Protocol Violation|2
4730659|NCT03349060|7672794|FG001|Overall Study|Protocol Violation|2
4730660|NCT03349060|7672795|FG002|Overall Study|Protocol Violation|1
4730661|NCT03349060|7672793|FG000|Overall Study|Withdrawal by Subject|5
4730662|NCT03349060|7672794|FG001|Overall Study|Withdrawal by Subject|3
4730663|NCT03349060|7672795|FG002|Overall Study|Withdrawal by Subject|4
4730664|NCT03349060|7672793|FG000|Overall Study|Medication error,no linked adverse event|0
4730665|NCT03349060|7672794|FG001|Overall Study|Medication error,no linked adverse event|0
4730666|NCT03349060|7672795|FG002|Overall Study|Medication error,no linked adverse event|1
4730667|NCT03349060|7672793|FG000|Overall Study|Withdrawal By Parent/Guardian|0
4730668|NCT03349060|7672794|FG001|Overall Study|Withdrawal By Parent/Guardian|1
4730669|NCT03349060|7672795|FG002|Overall Study|Withdrawal By Parent/Guardian|0
4730670|NCT03349060|7672793|FG000|Overall Study|Other|2
4730671|NCT03349060|7672794|FG001|Overall Study|Other|1
4730672|NCT03349060|7672795|FG002|Overall Study|Other|0
4730673|NCT03349099|7672805|FG000|Overall Study|Physician Decision|3
4730674|NCT03349099|7672806|FG001|Overall Study|Physician Decision|4
4730675|NCT03349099|7672805|FG000|Overall Study|Stone migrated from the kidney|1
4730676|NCT03349099|7672806|FG001|Overall Study|Stone migrated from the kidney|0
4730677|NCT03349333|7672812|FG000|Overall Study|Progression of Disease|36
4730678|NCT03349333|7672812|FG000|Overall Study|Adverse Event|11
4730679|NCT03349333|7672812|FG000|Overall Study|Other|6
4730680|NCT03349333|7672812|FG000|Overall Study|Withdrawal by Subject|5
4730681|NCT03349333|7672812|FG000|Overall Study|Conditions interfere with participation|2
4730682|NCT03349333|7672812|FG000|Overall Study|Physician Decision|2
4730683|NCT03349333|7672812|FG000|Overall Study|3-week lapse between pralatrexate doses|1
4730684|NCT03349333|7672812|FG000|Overall Study|Patients in treatment less than 24 month|8
4730685|NCT03349437|7672816|FG000|Screening|Screen Fail|4
4730686|NCT03349437|7672817|FG001|Screening|Screen Fail|0
4730687|NCT03349437|7672818|FG002|Screening|Screen Fail|0
4730688|NCT03349437|7672816|FG000|Screening|Withdrawn|1
4730689|NCT03349437|7672817|FG001|Screening|Withdrawn|0
4730690|NCT03349437|7672818|FG002|Screening|Withdrawn|0
4730691|NCT03349515|7672827|FG000|Overall Study|Lack of Efficacy|2
4730692|NCT03349515|7672828|FG001|Overall Study|Lack of Efficacy|0
4730693|NCT03349515|7672827|FG000|Overall Study|Physician Decision|3
4730694|NCT03349515|7672828|FG001|Overall Study|Physician Decision|1
4730695|NCT03349710|7672870|FG000|Treatment Period|Death|0
4730696|NCT03349710|7672871|FG001|Treatment Period|Death|0
4730697|NCT03349710|7672872|FG002|Treatment Period|Death|1
4730698|NCT03349710|7672873|FG003|Treatment Period|Death|0
4730699|NCT03349710|7672870|FG000|Treatment Period|Disease Progression|0
4730700|NCT03349710|7672871|FG001|Treatment Period|Disease Progression|2
4730701|NCT03349710|7672872|FG002|Treatment Period|Disease Progression|0
4730702|NCT03349710|7672873|FG003|Treatment Period|Disease Progression|1
4730703|NCT03349710|7672870|FG000|Treatment Period|Study Drug Toxicity|1
4730704|NCT03349710|7672871|FG001|Treatment Period|Study Drug Toxicity|0
4730705|NCT03349710|7672872|FG002|Treatment Period|Study Drug Toxicity|1
4730706|NCT03349710|7672873|FG003|Treatment Period|Study Drug Toxicity|1
4730707|NCT03349710|7672870|FG000|Treatment Period|Adverse event unrelated to Study Drug|2
4730708|NCT03349710|7672871|FG001|Treatment Period|Adverse event unrelated to Study Drug|1
4730709|NCT03349710|7672872|FG002|Treatment Period|Adverse event unrelated to Study Drug|1
4730710|NCT03349710|7672873|FG003|Treatment Period|Adverse event unrelated to Study Drug|1
4730711|NCT03349710|7672870|FG000|Treatment Period|admin reason by sponsor|0
4730712|NCT03349710|7672871|FG001|Treatment Period|admin reason by sponsor|7
4730713|NCT03349710|7672872|FG002|Treatment Period|admin reason by sponsor|0
4730714|NCT03349710|7672873|FG003|Treatment Period|admin reason by sponsor|19
4730715|NCT03349710|7672870|FG000|Treatment Period|Other Reason|2
4730716|NCT03349710|7672871|FG001|Treatment Period|Other Reason|0
4730717|NCT03349710|7672872|FG002|Treatment Period|Other Reason|2
4730718|NCT03349710|7672873|FG003|Treatment Period|Other Reason|1
4730719|NCT03349710|7672870|FG000|Treatment Period|completed|6
4730720|NCT03349710|7672871|FG001|Treatment Period|completed|0
4730721|NCT03349710|7672872|FG002|Treatment Period|completed|18
4730722|NCT03349710|7672873|FG003|Treatment Period|completed|1
4730723|NCT03349710|7672870|FG000|Treatment Period|participant request to discontinue|0
4730724|NCT03349710|7672871|FG001|Treatment Period|participant request to discontinue|0
4730725|NCT03349710|7672872|FG002|Treatment Period|participant request to discontinue|4
4730726|NCT03349710|7672873|FG003|Treatment Period|participant request to discontinue|0
4730727|NCT03349710|7672870|FG000|Treatment Period|participant withdrew consent|1
4730728|NCT03349710|7672871|FG001|Treatment Period|participant withdrew consent|0
4730729|NCT03349710|7672872|FG002|Treatment Period|participant withdrew consent|0
4730730|NCT03349710|7672873|FG003|Treatment Period|participant withdrew consent|0
4730731|NCT03350256|7672896|FG000|Overall Study|Inclusion/exclusion violation|4
4730732|NCT03350256|7672896|FG000|Overall Study|Recommended for other therapies|2
4730733|NCT03350256|7672896|FG000|Overall Study|Protocol Violation|3
4730734|NCT03350256|7672896|FG000|Overall Study|Non compliance|2
4630975|NCT01888874|7500008|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0
4630976|NCT01888874|7500009|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0
4630977|NCT01888874|7500010|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0
4630978|NCT01888874|7500011|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0
4630979|NCT01888874|7500012|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1
4630980|NCT01888874|7500006|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0
4630981|NCT01888874|7500007|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2
4630982|NCT01888874|7500008|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3
4630983|NCT01888874|7500009|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1
4630984|NCT01888874|7500010|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2
4630985|NCT01888874|7500011|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1
4630986|NCT01888874|7500012|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0
4730735|NCT03350256|7672896|FG000|Overall Study|Denial by insurance|1
4730736|NCT03350256|7672896|FG000|Overall Study|Adverse Event|2
4730737|NCT03350256|7672896|FG000|Overall Study|Trial failure|12
4730738|NCT03350256|7672896|FG000|Overall Study|Did not proceed to permanent implant|3
4730739|NCT03350256|7672896|FG000|Overall Study|Withdrawal by Subject|3
4730740|NCT03350256|7672896|FG000|Overall Study|Subject moving out of state|1
4730741|NCT03350256|7672896|FG000|Overall Study|Lost to Follow-up|1
4730742|NCT03350256|7672896|FG000|Overall Study|Lack of Efficacy|2
4730743|NCT03350672|7672907|FG000|Overall Study|Withdrawal by Subject|7
4730744|NCT03350672|7672908|FG001|Overall Study|Withdrawal by Subject|0
4730745|NCT03350672|7672909|FG002|Overall Study|Withdrawal by Subject|0
4737235|NCT03601715|7687226|FG000|Second Intervention|Lost to Follow-up|1
4737236|NCT03601715|7687227|FG001|Second Intervention|Lost to Follow-up|1
4737237|NCT03601715|7687228|FG002|Second Intervention|Lost to Follow-up|0
4737238|NCT03602053|7687239|FG000|Overall Study|Withdrawal by Subject|7
4737239|NCT03602053|7687240|FG001|Overall Study|Withdrawal by Subject|9
4737240|NCT03602053|7687241|FG002|Overall Study|Withdrawal by Subject|7
4737241|NCT03602053|7687239|FG000|Overall Study|Lost to Follow-up|5
4737242|NCT03602053|7687240|FG001|Overall Study|Lost to Follow-up|6
4737243|NCT03602053|7687241|FG002|Overall Study|Lost to Follow-up|0
4737244|NCT03602053|7687239|FG000|Overall Study|Protocol Violation|3
4737245|NCT03602053|7687240|FG001|Overall Study|Protocol Violation|0
4737246|NCT03602053|7687241|FG002|Overall Study|Protocol Violation|4
4737247|NCT03602053|7687239|FG000|Overall Study|Physician Decision|1
4737248|NCT03602053|7687240|FG001|Overall Study|Physician Decision|0
4737249|NCT03602053|7687241|FG002|Overall Study|Physician Decision|0
4630987|NCT01888874|7500006|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
4737250|NCT03602053|7687239|FG000|Overall Study|migration|2
4737251|NCT03602053|7687240|FG001|Overall Study|migration|3
4737252|NCT03602053|7687241|FG002|Overall Study|migration|0
4737253|NCT03602053|7687239|FG000|Overall Study|Other|1
4737254|NCT03602053|7687240|FG001|Overall Study|Other|0
4737255|NCT03602053|7687241|FG002|Overall Study|Other|0
4730746|NCT03351114|7672946|FG000|Overall Study|Withdrawal by Subject|1
4730747|NCT03351231|7672950|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1
4730748|NCT03351231|7672950|FG000|Combination Therapy Period|Disease progression|2
4730749|NCT03351231|7672950|FG000|Combination Therapy Period|Study drug toxicity|1
4730750|NCT03351231|7672950|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1
4730751|NCT03351231|7672950|FG000|Safety Follow-Up Period|Participant withdrew consent|1
4730752|NCT03351231|7672950|FG000|Safety Follow-Up Period|Other reason|2
4730753|NCT03351335|7672957|FG000|Overall Study|Failure to maintain inclusion/exclusion|0
4730754|NCT03351335|7672958|FG001|Overall Study|Failure to maintain inclusion/exclusion|0
4730755|NCT03351335|7672959|FG002|Overall Study|Failure to maintain inclusion/exclusion|4
4730756|NCT03351478|7672970|FG000|Overall Study|At the subject's own request|11
4730757|NCT03351478|7672971|FG001|Overall Study|At the subject's own request|12
4730758|NCT03351478|7672972|FG002|Overall Study|At the subject's own request|5
4730759|NCT03351478|7672970|FG000|Overall Study|Adverse Event|1
4730760|NCT03351478|7672971|FG001|Overall Study|Adverse Event|2
4730761|NCT03351478|7672972|FG002|Overall Study|Adverse Event|1
4730762|NCT03351478|7672970|FG000|Overall Study|Poor compliance to protocol|1
4730763|NCT03351478|7672971|FG001|Overall Study|Poor compliance to protocol|0
4730764|NCT03351478|7672972|FG002|Overall Study|Poor compliance to protocol|0
4730765|NCT03351478|7672970|FG000|Overall Study|Reason not Specified|1
4730766|NCT03351478|7672971|FG001|Overall Study|Reason not Specified|3
4730767|NCT03351478|7672972|FG002|Overall Study|Reason not Specified|0
4730768|NCT03351478|7672970|FG000|Overall Study|Lost to Follow-up|0
4730769|NCT03351478|7672971|FG001|Overall Study|Lost to Follow-up|0
4730770|NCT03351478|7672972|FG002|Overall Study|Lost to Follow-up|1
4730771|NCT03351608|7672985|FG000|Overall Study|Lost to Follow-up|0
4730772|NCT03351608|7672986|FG001|Overall Study|Lost to Follow-up|1
4730773|NCT03351608|7672987|FG002|Overall Study|Lost to Follow-up|1
4730774|NCT03351608|7672988|FG003|Overall Study|Lost to Follow-up|1
4730775|NCT03351608|7672989|FG004|Overall Study|Lost to Follow-up|1
4730776|NCT03351608|7672985|FG000|Overall Study|Physician Decision|1
4730777|NCT03351608|7672986|FG001|Overall Study|Physician Decision|0
4730778|NCT03351608|7672987|FG002|Overall Study|Physician Decision|0
4730779|NCT03351608|7672988|FG003|Overall Study|Physician Decision|2
4730780|NCT03351608|7672989|FG004|Overall Study|Physician Decision|1
4730781|NCT03351608|7672985|FG000|Overall Study|Randomized by mistake, no treatment given|0
4730782|NCT03351608|7672986|FG001|Overall Study|Randomized by mistake, no treatment given|0
4730783|NCT03351608|7672987|FG002|Overall Study|Randomized by mistake, no treatment given|0
4730784|NCT03351608|7672988|FG003|Overall Study|Randomized by mistake, no treatment given|1
4730785|NCT03351608|7672989|FG004|Overall Study|Randomized by mistake, no treatment given|0
4730786|NCT03351608|7672985|FG000|Overall Study|Withdrawal by parent/guardian|0
4730787|NCT03351608|7672986|FG001|Overall Study|Withdrawal by parent/guardian|0
4730788|NCT03351608|7672987|FG002|Overall Study|Withdrawal by parent/guardian|1
4730789|NCT03351608|7672988|FG003|Overall Study|Withdrawal by parent/guardian|1
4730790|NCT03351608|7672989|FG004|Overall Study|Withdrawal by parent/guardian|0
4730791|NCT03351608|7672985|FG000|Overall Study|Other|0
4730792|NCT03351608|7672986|FG001|Overall Study|Other|1
4730793|NCT03351608|7672987|FG002|Overall Study|Other|1
4730794|NCT03351608|7672988|FG003|Overall Study|Other|3
4730795|NCT03351608|7672989|FG004|Overall Study|Other|0
4730796|NCT03351738|7673045|FG000|Overall Study|Withdrawal by Subject|0
4730797|NCT03351738|7673046|FG001|Overall Study|Withdrawal by Subject|1
4730798|NCT03351738|7673047|FG002|Overall Study|Withdrawal by Subject|0
4730799|NCT03351738|7673048|FG003|Overall Study|Withdrawal by Subject|1
4730800|NCT03351738|7673049|FG004|Overall Study|Withdrawal by Subject|0
4730801|NCT03351738|7673050|FG005|Overall Study|Withdrawal by Subject|0
4730802|NCT03352414|7673088|FG000|Overall Study|Ineligible by operative criteria|12
4730803|NCT03352414|7673089|FG001|Overall Study|Ineligible by operative criteria|10
4730804|NCT03352453|7673099|FG000|Overall Study|Miscellaneous Reasons|1
4730805|NCT03352453|7673100|FG001|Overall Study|Miscellaneous Reasons|2
4730806|NCT03352453|7673099|FG000|Overall Study|Lack of Efficacy|1
4730807|NCT03352453|7673100|FG001|Overall Study|Lack of Efficacy|0
4730808|NCT03352453|7673099|FG000|Overall Study|Withdrawal by Subject|8
4730809|NCT03352453|7673100|FG001|Overall Study|Withdrawal by Subject|14
4730810|NCT03352453|7673099|FG000|Overall Study|Study Terminated by Sponsor|2
4730811|NCT03352453|7673100|FG001|Overall Study|Study Terminated by Sponsor|1
4730812|NCT03352453|7673099|FG000|Overall Study|Protocol Deviation|1
4730813|NCT03352453|7673100|FG001|Overall Study|Protocol Deviation|0
4730814|NCT03352453|7673099|FG000|Overall Study|Lost to Follow-up|7
4730815|NCT03352453|7673100|FG001|Overall Study|Lost to Follow-up|6
4730816|NCT03352453|7673099|FG000|Overall Study|Adverse Event|2
4730817|NCT03352453|7673100|FG001|Overall Study|Adverse Event|9
4730818|NCT03352713|7673115|FG000|Overall Study|Lost to Follow-up|8
4730819|NCT03352713|7673115|FG000|Overall Study|Withdrawn by investigator|5
4730820|NCT03352713|7673115|FG000|Overall Study|Completed 0 EMAs|8
4730821|NCT03352713|7673115|FG000|Overall Study|Device incompatible/stolen|5
4730822|NCT03353220|7673119|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4
4730823|NCT03353220|7673120|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7
4730824|NCT03353740|7673130|FG000|Overall Study|Images for these participants not viable|52
4730825|NCT03354429|7673154|FG000|Overall Study|Withdrawal by Subject|8
4730826|NCT03354429|7673155|FG001|Overall Study|Withdrawal by Subject|7
4730827|NCT03354429|7673154|FG000|Overall Study|Lost to Follow-up|1
4730828|NCT03354429|7673155|FG001|Overall Study|Lost to Follow-up|0
4730829|NCT03354637|7673173|FG000|Double-blind Period|Protocol Violation|2
4730830|NCT03354637|7673174|FG001|Double-blind Period|Protocol Violation|0
4730831|NCT03354637|7673175|FG002|Double-blind Period|Protocol Violation|0
4730832|NCT03354637|7673173|FG000|Double-blind Period|Adverse Event|1
4730833|NCT03354637|7673174|FG001|Double-blind Period|Adverse Event|2
4730834|NCT03354637|7673175|FG002|Double-blind Period|Adverse Event|0
4730835|NCT03354637|7673173|FG000|Double-blind Period|Lost to Follow-up|3
4730836|NCT03354637|7673174|FG001|Double-blind Period|Lost to Follow-up|4
4730837|NCT03354637|7673175|FG002|Double-blind Period|Lost to Follow-up|3
4730838|NCT03354637|7673173|FG000|Double-blind Period|Withdrawal by Subject|10
4730839|NCT03354637|7673174|FG001|Double-blind Period|Withdrawal by Subject|6
4730840|NCT03354637|7673175|FG002|Double-blind Period|Withdrawal by Subject|4
4730841|NCT03354637|7673173|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1
4730842|NCT03354637|7673174|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1
4730843|NCT03354637|7673175|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0
4730844|NCT03354637|7673173|FG000|Open Label Extension|Adverse Event|0
4730845|NCT03354637|7673174|FG001|Open Label Extension|Adverse Event|0
4730846|NCT03354637|7673175|FG002|Open Label Extension|Adverse Event|1
4730847|NCT03354637|7673173|FG000|Open Label Extension|Lost to Follow-up|0
4730848|NCT03354637|7673174|FG001|Open Label Extension|Lost to Follow-up|0
4730849|NCT03354637|7673175|FG002|Open Label Extension|Lost to Follow-up|2
4730850|NCT03354637|7673173|FG000|Open Label Extension|Withdrawal by Subject|0
4730851|NCT03354637|7673174|FG001|Open Label Extension|Withdrawal by Subject|0
4730852|NCT03354637|7673175|FG002|Open Label Extension|Withdrawal by Subject|5
4730853|NCT03354637|7673173|FG000|Open Label Extension|Study Terminated by Sponsor|0
4730854|NCT03354637|7673174|FG001|Open Label Extension|Study Terminated by Sponsor|0
4730855|NCT03354637|7673175|FG002|Open Label Extension|Study Terminated by Sponsor|17
4730856|NCT03354637|7673173|FG000|Open Label Extension|Subject Noncompliance|0
4730857|NCT03354637|7673174|FG001|Open Label Extension|Subject Noncompliance|0
4730858|NCT03354637|7673175|FG002|Open Label Extension|Subject Noncompliance|1
4730859|NCT03354637|7673173|FG000|Open Label Extension|Lack of Efficacy|0
4730860|NCT03354637|7673174|FG001|Open Label Extension|Lack of Efficacy|0
4730861|NCT03354637|7673175|FG002|Open Label Extension|Lack of Efficacy|1
4730862|NCT03354637|7673173|FG000|Open Label Extension|Physician Decision|0
4730863|NCT03354637|7673174|FG001|Open Label Extension|Physician Decision|0
4730864|NCT03354637|7673175|FG002|Open Label Extension|Physician Decision|1
4730865|NCT03354663|7673184|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4
4730866|NCT03354663|7673184|FG000|Enrollment to Catheter Insertion|Adverse Event|1
4730867|NCT03354663|7673184|FG000|Completed 30-day Visit|Withdrawal by Subject|1
4730868|NCT03354663|7673184|FG000|Completed 30-day Visit|Missed Visit|1
4730869|NCT03355326|7673203|FG000|Overall Study|Protocol Violation|3
4730870|NCT03355326|7673204|FG001|Overall Study|Protocol Violation|3
4730871|NCT03355742|7673210|FG000|Overall Study|Lost to Follow-up|4
4730872|NCT03355742|7673210|FG000|Overall Study|Withdrawal by Subject|29
4730873|NCT03355742|7673210|FG000|Overall Study|Physician Decision|6
4730874|NCT03355742|7673210|FG000|Overall Study|Death|55
4730875|NCT03355742|7673210|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5
4730876|NCT03356145|7673220|FG000|Overall Study|Withdrawal by Subject|2
4730877|NCT03356145|7673221|FG001|Overall Study|Withdrawal by Subject|1
4730878|NCT03356145|7673220|FG000|Overall Study|Did not meet inclusion criteria|1
4730879|NCT03356145|7673221|FG001|Overall Study|Did not meet inclusion criteria|0
4730880|NCT03356977|7673227|FG000|Overall Study|Lost to Follow-up|3
4730881|NCT03356977|7673227|FG000|Overall Study|Withdrawal by parent/guardian|2
4730882|NCT03357341|7673233|FG000|Overall Study|Withdrawal by Subject|3
4730883|NCT03357341|7673234|FG001|Overall Study|Withdrawal by Subject|6
4730884|NCT03357341|7673233|FG000|Overall Study|Lost to Follow-up|4
4730885|NCT03357341|7673234|FG001|Overall Study|Lost to Follow-up|5
4730886|NCT03357341|7673233|FG000|Overall Study|Death|0
4730887|NCT03357341|7673234|FG001|Overall Study|Death|1
4730888|NCT03357471|7673256|FG000|Overall Study|Adverse Event|1
4730889|NCT03357471|7673257|FG001|Overall Study|Adverse Event|0
4730890|NCT03357471|7673256|FG000|Overall Study|Lost to Follow-up|1
4730891|NCT03357471|7673257|FG001|Overall Study|Lost to Follow-up|0
4730892|NCT03357731|7673272|FG000|Overall Study|Withdrew consent due to personal reasons|0
4730893|NCT03357731|7673273|FG001|Overall Study|Withdrew consent due to personal reasons|0
4730894|NCT03357731|7673274|FG002|Overall Study|Withdrew consent due to personal reasons|0
4730895|NCT03357731|7673275|FG003|Overall Study|Withdrew consent due to personal reasons|0
4730896|NCT03357731|7673276|FG004|Overall Study|Withdrew consent due to personal reasons|1
4730897|NCT03357731|7673277|FG005|Overall Study|Withdrew consent due to personal reasons|0
4730898|NCT03357731|7673272|FG000|Overall Study|Acute bradycardia and hypotension|0
4730899|NCT03357731|7673273|FG001|Overall Study|Acute bradycardia and hypotension|0
4730900|NCT03357731|7673274|FG002|Overall Study|Acute bradycardia and hypotension|0
4730901|NCT03357731|7673275|FG003|Overall Study|Acute bradycardia and hypotension|1
4730902|NCT03357731|7673276|FG004|Overall Study|Acute bradycardia and hypotension|0
4730903|NCT03357731|7673277|FG005|Overall Study|Acute bradycardia and hypotension|0
4730904|NCT03357731|7673272|FG000|Overall Study|Adverse Event|0
4730905|NCT03357731|7673273|FG001|Overall Study|Adverse Event|0
4730906|NCT03357731|7673274|FG002|Overall Study|Adverse Event|0
4730907|NCT03357731|7673275|FG003|Overall Study|Adverse Event|0
4730908|NCT03357731|7673276|FG004|Overall Study|Adverse Event|0
4730909|NCT03357731|7673277|FG005|Overall Study|Adverse Event|1
4730910|NCT03357731|7673272|FG000|Overall Study|Hypotension|0
4730911|NCT03357731|7673273|FG001|Overall Study|Hypotension|0
4730912|NCT03357731|7673274|FG002|Overall Study|Hypotension|1
4730913|NCT03357731|7673275|FG003|Overall Study|Hypotension|1
4730914|NCT03357731|7673276|FG004|Overall Study|Hypotension|0
4730915|NCT03357731|7673277|FG005|Overall Study|Hypotension|0
4730916|NCT03357731|7673272|FG000|Overall Study|Lost to Follow-up|0
4730917|NCT03357731|7673273|FG001|Overall Study|Lost to Follow-up|0
4730918|NCT03357731|7673274|FG002|Overall Study|Lost to Follow-up|0
4730919|NCT03357731|7673275|FG003|Overall Study|Lost to Follow-up|1
4730920|NCT03357731|7673276|FG004|Overall Study|Lost to Follow-up|0
4730921|NCT03357731|7673277|FG005|Overall Study|Lost to Follow-up|0
4730922|NCT03358147|7673290|FG000|Overall Study|Withdrawal by Subject|13
4730923|NCT03358147|7673291|FG001|Overall Study|Withdrawal by Subject|19
4730924|NCT03358147|7673292|FG002|Overall Study|Withdrawal by Subject|16
4730925|NCT03358147|7673293|FG003|Overall Study|Withdrawal by Subject|10
4730926|NCT03358147|7673294|FG004|Overall Study|Withdrawal by Subject|5
4730927|NCT03358147|7673290|FG000|Overall Study|Adverse Event|3
4730928|NCT03358147|7673291|FG001|Overall Study|Adverse Event|9
4730929|NCT03358147|7673292|FG002|Overall Study|Adverse Event|7
4730930|NCT03358147|7673293|FG003|Overall Study|Adverse Event|5
4730931|NCT03358147|7673294|FG004|Overall Study|Adverse Event|2
4730932|NCT03358147|7673290|FG000|Overall Study|Lost to Follow-up|4
4730933|NCT03358147|7673291|FG001|Overall Study|Lost to Follow-up|3
4730934|NCT03358147|7673292|FG002|Overall Study|Lost to Follow-up|7
4730935|NCT03358147|7673293|FG003|Overall Study|Lost to Follow-up|6
4730936|NCT03358147|7673294|FG004|Overall Study|Lost to Follow-up|4
4730937|NCT03358147|7673290|FG000|Overall Study|Major Protocol Deviation|11
4730938|NCT03358147|7673291|FG001|Overall Study|Major Protocol Deviation|3
4730939|NCT03358147|7673292|FG002|Overall Study|Major Protocol Deviation|2
4730940|NCT03358147|7673293|FG003|Overall Study|Major Protocol Deviation|3
4730941|NCT03358147|7673294|FG004|Overall Study|Major Protocol Deviation|1
4730942|NCT03358147|7673290|FG000|Overall Study|Protocol specified criteria|2
4772379|NCT01434602|7749395|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0
4772380|NCT01434602|7749396|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0
4772381|NCT01434602|7749397|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0
4772382|NCT01434602|7749398|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0
4772383|NCT01434602|7749399|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1
4772384|NCT01434602|7749395|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0
4772385|NCT01434602|7749396|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0
4772386|NCT01434602|7749397|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0
4772387|NCT01434602|7749398|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1
4772388|NCT01434602|7749399|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1
4772389|NCT01434602|7749395|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0
4772390|NCT01434602|7749396|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0
4772391|NCT01434602|7749397|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0
4772392|NCT01434602|7749398|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1
4772393|NCT01434602|7749399|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0
4772394|NCT01434602|7749395|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0
4772395|NCT01434602|7749396|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0
4772396|NCT01434602|7749397|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0
4772397|NCT01434602|7749398|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2
4772398|NCT01434602|7749399|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0
4772399|NCT01411332|7749420|FG000|Overall Study|Lost to Follow-up|1
4772400|NCT01411332|7749421|FG001|Overall Study|Lost to Follow-up|0
4772401|NCT01411332|7749420|FG000|Overall Study|Protocol Violation|1
4772402|NCT01411332|7749421|FG001|Overall Study|Protocol Violation|1
4772403|NCT01411332|7749420|FG000|Overall Study|Withdrawal by Subject|0
4772404|NCT01411332|7749421|FG001|Overall Study|Withdrawal by Subject|1
4772405|NCT01399918|7749427|FG000|Overall Study|Not eligible and not enrolled in the study|2
4772406|NCT01147653|7749437|FG000|Year 2|Withdrawal by Subject|2
4772407|NCT01147653|7749438|FG001|Year 2|Withdrawal by Subject|3
4772408|NCT01078454|7749458|FG000|Overall Study|Adverse Event|1
4772409|NCT01078454|7749459|FG001|Overall Study|Adverse Event|1
4772410|NCT01078454|7749458|FG000|Overall Study|Death|0
4772411|NCT01078454|7749459|FG001|Overall Study|Death|1
4772412|NCT00687596|7749467|FG000|Overall Study|Adverse Event (AE)|10
4730943|NCT03358147|7673291|FG001|Overall Study|Protocol specified criteria|3
4730944|NCT03358147|7673292|FG002|Overall Study|Protocol specified criteria|0
4730945|NCT03358147|7673293|FG003|Overall Study|Protocol specified criteria|3
4730946|NCT03358147|7673294|FG004|Overall Study|Protocol specified criteria|1
4730947|NCT03358147|7673290|FG000|Overall Study|Physician Decision|1
4730948|NCT03358147|7673291|FG001|Overall Study|Physician Decision|0
4730949|NCT03358147|7673292|FG002|Overall Study|Physician Decision|1
4772413|NCT00687596|7749468|FG001|Overall Study|Adverse Event (AE)|3
4772414|NCT00687596|7749467|FG000|Overall Study|Radiological Disease Progression|6
4772415|NCT00687596|7749468|FG001|Overall Study|Radiological Disease Progression|2
4772416|NCT00687596|7749467|FG000|Overall Study|Clinical Disease Progression|1
4772417|NCT00687596|7749468|FG001|Overall Study|Clinical Disease Progression|3
4772418|NCT00687596|7749467|FG000|Overall Study|Investigator Discretion|3
4772419|NCT00687596|7749468|FG001|Overall Study|Investigator Discretion|1
4772420|NCT00687596|7749467|FG000|Overall Study|Sponsor Terminated Study|6
4772421|NCT00687596|7749468|FG001|Overall Study|Sponsor Terminated Study|17
4772422|NCT00458536|7749474|FG000|Overall Study|Disease progression prior to treatment|7
4772423|NCT00458536|7749474|FG000|Overall Study|Unable to make vaccine|3
4772424|NCT00458536|7749474|FG000|Overall Study|No measurable disease after surgery|2
4772425|NCT00458536|7749474|FG000|Overall Study|Did not have renal cell carcinoma|2
4772426|NCT00458536|7749474|FG000|Overall Study|Patient did not have surgery|1
4772427|NCT00458536|7749474|FG000|Overall Study|Ineligible due to toxicity|1
4772428|NCT00458536|7749474|FG000|Overall Study|Withdrawal by Subject|1
4772429|NCT00458536|7749474|FG000|Overall Study|Progressive disease during treatment|2
4772430|NCT00112840|7749481|FG000|Overall Study|Physician Decision|1
4772431|NCT00112840|7749482|FG001|Overall Study|Physician Decision|0
4772432|NCT00112840|7749483|FG002|Overall Study|Physician Decision|0
4772433|NCT00112840|7749481|FG000|Overall Study|Withdrawal by Subject|1
4772434|NCT00112840|7749482|FG001|Overall Study|Withdrawal by Subject|0
4772435|NCT00112840|7749483|FG002|Overall Study|Withdrawal by Subject|1
4772436|NCT00112840|7749481|FG000|Overall Study|Protocol Violation|0
4772437|NCT00112840|7749482|FG001|Overall Study|Protocol Violation|0
4772438|NCT00112840|7749483|FG002|Overall Study|Protocol Violation|5
4772439|NCT04207749|7749512|FG000|Overall Study|Lost to Follow-up|0
4772440|NCT04207749|7749513|FG001|Overall Study|Lost to Follow-up|2
4772441|NCT04207749|7749512|FG000|Overall Study|Protocol Violation|0
4772442|NCT04207749|7749513|FG001|Overall Study|Protocol Violation|1
4772443|NCT04207749|7749512|FG000|Overall Study|Withdrawal by Subject|3
4772444|NCT04207749|7749513|FG001|Overall Study|Withdrawal by Subject|0
4772445|NCT04207749|7749512|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1
4772446|NCT04207749|7749513|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4
4772447|NCT04167345|7749527|FG000|Overall Study|Other|1
4772448|NCT04167345|7749528|FG001|Overall Study|Other|1
4772449|NCT04167345|7749529|FG002|Overall Study|Other|0
4772450|NCT04167345|7749530|FG003|Overall Study|Other|0
4772451|NCT04167345|7749531|FG004|Overall Study|Other|0
4772452|NCT04042077|7749549|FG000|Overall Study|Adverse Event|0
4772453|NCT04042077|7749550|FG001|Overall Study|Adverse Event|1
4772454|NCT04042077|7749549|FG000|Overall Study|Death|2
4772455|NCT04042077|7749550|FG001|Overall Study|Death|1
4772456|NCT04042077|7749549|FG000|Overall Study|Physician Decision|2
4772457|NCT04042077|7749550|FG001|Overall Study|Physician Decision|0
4772458|NCT04042077|7749549|FG000|Overall Study|Withdrawal by Subject|3
4772459|NCT04042077|7749550|FG001|Overall Study|Withdrawal by Subject|2
4772460|NCT04042077|7749549|FG000|Overall Study|Lack of Efficacy|0
4772461|NCT04042077|7749550|FG001|Overall Study|Lack of Efficacy|1
4772462|NCT04001803|7749562|FG000|Overall Study|Ongoing at the time of analysis|103
4772463|NCT04001803|7749562|FG000|Overall Study|Adverse Event|2
4772464|NCT04001803|7749562|FG000|Overall Study|Protocol Violation|2
4772465|NCT04001803|7749562|FG000|Overall Study|Lost to Follow-up|2
4772466|NCT04001803|7749562|FG000|Overall Study|Physician Decision|1
4772467|NCT04001803|7749562|FG000|Overall Study|Withdrawal by Subject|4
4772468|NCT03925324|7749578|FG000|Overall Study|Death|1
4772469|NCT03925324|7749579|FG001|Overall Study|Death|1
4772470|NCT03875092|7749587|FG000|Overall Study|Adverse Event|2
4772471|NCT03875092|7749588|FG001|Overall Study|Adverse Event|5
4772472|NCT03875092|7749587|FG000|Overall Study|Death|28
4772473|NCT03875092|7749588|FG001|Overall Study|Death|41
4772474|NCT03875092|7749587|FG000|Overall Study|Ongoing in Study|35
4772475|NCT03875092|7749588|FG001|Overall Study|Ongoing in Study|14
4772476|NCT03738397|7749600|FG000|Overall Study|Adverse Event|3
4772477|NCT03738397|7749601|FG001|Overall Study|Adverse Event|7
4772478|NCT03738397|7749600|FG000|Overall Study|Withdrawal by Subject|8
4772479|NCT03738397|7749601|FG001|Overall Study|Withdrawal by Subject|11
4772480|NCT03738397|7749600|FG000|Overall Study|Lost to Follow-up|8
4772481|NCT03738397|7749601|FG001|Overall Study|Lost to Follow-up|5
4772482|NCT03738397|7749600|FG000|Overall Study|COVID-19 Logistical Restrictions|1
4772483|NCT03738397|7749601|FG001|Overall Study|COVID-19 Logistical Restrictions|1
4772484|NCT03738397|7749600|FG000|Overall Study|Other|4
4772485|NCT03738397|7749601|FG001|Overall Study|Other|6
4772486|NCT03666624|7749609|FG000|Overall Study|participant grieving over recent death of parent|1
4772487|NCT03666624|7749610|FG001|Overall Study|participant grieving over recent death of parent|0
4772488|NCT03649217|7749616|FG000|Overall Study|subject had severe ataxia not initially found|1
4772489|NCT03649217|7749616|FG000|Overall Study|subject had cognitive issues not initially found|1
4772490|NCT03569293|7749635|FG000|Overall Study|Adverse Event|4
4772491|NCT03569293|7749636|FG001|Overall Study|Adverse Event|1
4772492|NCT03569293|7749637|FG002|Overall Study|Adverse Event|5
4772493|NCT03569293|7749638|FG003|Overall Study|Adverse Event|1
4772494|NCT03569293|7749639|FG004|Overall Study|Adverse Event|0
4772495|NCT03569293|7749640|FG005|Overall Study|Adverse Event|0
4772496|NCT03569293|7749635|FG000|Overall Study|Withdrawal by Subject|16
4772497|NCT03569293|7749636|FG001|Overall Study|Withdrawal by Subject|2
4772498|NCT03569293|7749637|FG002|Overall Study|Withdrawal by Subject|4
4772499|NCT03569293|7749638|FG003|Overall Study|Withdrawal by Subject|1
4772500|NCT03569293|7749639|FG004|Overall Study|Withdrawal by Subject|0
4772501|NCT03569293|7749640|FG005|Overall Study|Withdrawal by Subject|0
4772502|NCT03569293|7749635|FG000|Overall Study|Lost to Follow-up|1
4772503|NCT03569293|7749636|FG001|Overall Study|Lost to Follow-up|3
4772504|NCT03569293|7749637|FG002|Overall Study|Lost to Follow-up|1
4772505|NCT03569293|7749638|FG003|Overall Study|Lost to Follow-up|1
4772506|NCT03569293|7749639|FG004|Overall Study|Lost to Follow-up|0
4772507|NCT03569293|7749640|FG005|Overall Study|Lost to Follow-up|0
4772508|NCT03569293|7749635|FG000|Overall Study|Other|8
4772509|NCT03569293|7749636|FG001|Overall Study|Other|2
4772510|NCT03569293|7749637|FG002|Overall Study|Other|1
4772511|NCT03569293|7749638|FG003|Overall Study|Other|1
4772512|NCT03569293|7749639|FG004|Overall Study|Other|0
4772513|NCT03569293|7749640|FG005|Overall Study|Other|0
4772514|NCT03569293|7749635|FG000|Overall Study|Ongoing at Time of Analysis|8
4772515|NCT03569293|7749636|FG001|Overall Study|Ongoing at Time of Analysis|1
4772516|NCT03569293|7749637|FG002|Overall Study|Ongoing at Time of Analysis|3
4772517|NCT03569293|7749638|FG003|Overall Study|Ongoing at Time of Analysis|0
4772518|NCT03569293|7749639|FG004|Overall Study|Ongoing at Time of Analysis|0
4772519|NCT03569293|7749640|FG005|Overall Study|Ongoing at Time of Analysis|0
4772520|NCT03318003|7749725|FG000|Overall Study|Withdrawal by Subject|1
4772521|NCT03318003|7749726|FG001|Overall Study|Withdrawal by Subject|1
4772522|NCT03318003|7749725|FG000|Overall Study|fetal loss|0
4772523|NCT03318003|7749726|FG001|Overall Study|fetal loss|1
4772524|NCT03132753|7749756|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27
4772525|NCT03132753|7749757|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32
4772526|NCT03132753|7749756|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6
4772527|NCT03132753|7749757|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2
4772528|NCT03067077|7749772|FG000|Overall Study|Did not receive surgery|4
4772529|NCT03067077|7749773|FG001|Overall Study|Did not receive surgery|5
4772530|NCT03067077|7749772|FG000|Overall Study|Lost to Follow-up|3
4772531|NCT03067077|7749773|FG001|Overall Study|Lost to Follow-up|2
4772532|NCT03059446|7749779|FG000|Overall Study|Adverse Event|11
4772533|NCT03059446|7749779|FG000|Overall Study|Withdrawal of Consent|16
4772534|NCT03059446|7749779|FG000|Overall Study|Lost to Follow-up|3
4772535|NCT03059446|7749779|FG000|Overall Study|Protocol Violation|1
4772536|NCT03059446|7749779|FG000|Overall Study|Study Terminated by Sponsor|131
4772537|NCT03059446|7749779|FG000|Overall Study|Reason not Specified|5
4772538|NCT03035409|7749783|FG000|Overall Study|Adverse Event|5
4772539|NCT03035409|7749783|FG000|Overall Study|Death|2
4772540|NCT03035409|7749783|FG000|Overall Study|Withdrawal by Subject|2
4772541|NCT03035409|7749783|FG000|Overall Study|Non compliance|4
4772542|NCT03035409|7749783|FG000|Overall Study|Patient was jittery|1
4772543|NCT03035409|7749783|FG000|Overall Study|Did not like Questionnaire|1
4772544|NCT03035409|7749783|FG000|Overall Study|Aspartate Aminotransferase increased|1
4772545|NCT03035409|7749783|FG000|Overall Study|Did not like taking drugs|1
4772546|NCT03011034|7749793|FG000|Overall Study|Adverse Event|1
4772547|NCT03011034|7749794|FG001|Overall Study|Adverse Event|0
4772548|NCT02853331|7749824|FG000|Overall Study|Death|59
4772549|NCT02853331|7749825|FG001|Overall Study|Death|95
4772550|NCT02853331|7749824|FG000|Overall Study|Withdrawal by Subject|5
4772551|NCT02853331|7749825|FG001|Overall Study|Withdrawal by Subject|9
4772552|NCT02853331|7749824|FG000|Overall Study|Ongoing in study|368
4772553|NCT02853331|7749825|FG001|Overall Study|Ongoing in study|325
4772554|NCT02847637|7749835|FG000|Overall Study|Withdrew from treatment due to AE|0
4772555|NCT02847637|7749836|FG001|Overall Study|Withdrew from treatment due to AE|0
4772556|NCT02847637|7749837|FG002|Overall Study|Withdrew from treatment due to AE|1
4772557|NCT02847637|7749838|FG003|Overall Study|Withdrew from treatment due to AE|0
4772558|NCT02847637|7749835|FG000|Overall Study|Ongoing treatment with emicizumab|16
4772559|NCT02847637|7749836|FG001|Overall Study|Ongoing treatment with emicizumab|35
4772560|NCT02847637|7749837|FG002|Overall Study|Ongoing treatment with emicizumab|34
4772561|NCT02847637|7749838|FG003|Overall Study|Ongoing treatment with emicizumab|63
4772562|NCT02847637|7749835|FG000|Overall Study|First emicizumab dose delayed|1
4772563|NCT02847637|7749836|FG001|Overall Study|First emicizumab dose delayed|0
4772564|NCT02847637|7749837|FG002|Overall Study|First emicizumab dose delayed|0
4772565|NCT02847637|7749838|FG003|Overall Study|First emicizumab dose delayed|0
4772566|NCT02667587|7749873|FG000|Pre-Treatment|Not reported|1
4772567|NCT02667587|7749874|FG001|Pre-Treatment|Not reported|0
4772568|NCT02667587|7749873|FG000|Pre-Treatment|Participant no longer meets study criteria|2
4772569|NCT02667587|7749874|FG001|Pre-Treatment|Participant no longer meets study criteria|2
4772570|NCT02667587|7749873|FG000|Pre-Treatment|Participant withdrew consent|0
4772571|NCT02667587|7749874|FG001|Pre-Treatment|Participant withdrew consent|1
4772572|NCT02667587|7749873|FG000|Pre-Treatment|Adverse event unrelated to study drug|1
4772573|NCT02667587|7749874|FG001|Pre-Treatment|Adverse event unrelated to study drug|0
4772574|NCT02667587|7749873|FG000|End of Treatment|Other reasons|11
4772575|NCT02667587|7749874|FG001|End of Treatment|Other reasons|8
4772576|NCT02667587|7749873|FG000|End of Treatment|Participant no Longer Meets Study Criteria|1
4772577|NCT02667587|7749874|FG001|End of Treatment|Participant no Longer Meets Study Criteria|2
4772578|NCT02667587|7749873|FG000|End of Treatment|Poor/Non-Compliance|0
4772579|NCT02667587|7749874|FG001|End of Treatment|Poor/Non-Compliance|1
4772580|NCT02667587|7749873|FG000|End of Treatment|Maximum Clinical Benefit|3
4772581|NCT02667587|7749874|FG001|End of Treatment|Maximum Clinical Benefit|3
4772582|NCT02667587|7749873|FG000|End of Treatment|Participant Withdrew Consent|5
4772583|NCT02667587|7749874|FG001|End of Treatment|Participant Withdrew Consent|6
4772584|NCT02667587|7749873|FG000|End of Treatment|Participants Request to Discontinue Study Treatment|25
4772585|NCT02667587|7749874|FG001|End of Treatment|Participants Request to Discontinue Study Treatment|26
4772586|NCT02667587|7749873|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19
4772587|NCT02667587|7749874|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20
4772588|NCT02667587|7749873|FG000|End of Treatment|Death|2
4772589|NCT02667587|7749874|FG001|End of Treatment|Death|1
4772590|NCT02667587|7749873|FG000|End of Treatment|Study Drug Toxicity|74
4772591|NCT02667587|7749874|FG001|End of Treatment|Study Drug Toxicity|18
4772592|NCT02667587|7749873|FG000|End of Treatment|Disease progression|177
4772593|NCT02667587|7749874|FG001|End of Treatment|Disease progression|222
4772594|NCT02667587|7749873|FG000|End of Treatment|Lost to Follow-up|1
4772595|NCT02667587|7749874|FG001|End of Treatment|Lost to Follow-up|3
4772596|NCT02601014|7749891|FG000|Overall Study|Adverse Event|3
4772597|NCT02601014|7749892|FG001|Overall Study|Adverse Event|3
4772598|NCT02601014|7749891|FG000|Overall Study|Death|3
4772599|NCT02601014|7749892|FG001|Overall Study|Death|1
4772600|NCT02601014|7749891|FG000|Overall Study|Disease progression|4
4772601|NCT02601014|7749892|FG001|Overall Study|Disease progression|8
4772602|NCT02579096|7749900|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10
4772603|NCT02579096|7749901|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6
4772604|NCT02579096|7749900|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2
4772605|NCT02579096|7749901|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1
4772606|NCT02579096|7749900|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32
4772607|NCT02579096|7749901|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36
4772608|NCT02579096|7749900|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9
4772609|NCT02579096|7749901|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4
4772610|NCT02579096|7749900|FG000|Phase 1, Weeks 0 - 24|Other reasons|4
4772611|NCT02579096|7749901|FG001|Phase 1, Weeks 0 - 24|Other reasons|3
4772612|NCT02579096|7749900|FG000|Phase 2, Weeks 25 - 48|Death|2
4772613|NCT02579096|7749901|FG001|Phase 2, Weeks 25 - 48|Death|4
4772614|NCT02579096|7749900|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3
4772615|NCT02579096|7749901|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1
4772616|NCT02579096|7749900|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4
4772617|NCT02579096|7749901|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0
4772618|NCT02579096|7749900|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9
4772619|NCT02579096|7749901|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12
4772620|NCT02579096|7749900|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4
4772621|NCT02579096|7749901|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9
4772622|NCT02579096|7749900|FG000|Phase 2, Weeks 25 - 48|Other reasons|0
4772623|NCT02579096|7749901|FG001|Phase 2, Weeks 25 - 48|Other reasons|5
4772624|NCT02579096|7749900|FG000|Phase 3, Weeks 49 - 72|Death|3
4772625|NCT02579096|7749901|FG001|Phase 3, Weeks 49 - 72|Death|2
4772626|NCT02579096|7749900|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0
4772627|NCT02579096|7749901|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1
4772628|NCT02579096|7749900|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0
4772629|NCT02579096|7749901|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5
4772630|NCT02579096|7749900|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6
4772631|NCT02579096|7749901|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4
4772632|NCT02579096|7749900|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10
4772633|NCT02579096|7749901|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5
4772634|NCT02579096|7749900|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0
4772635|NCT02579096|7749901|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1
4772636|NCT02579096|7749900|FG000|Phase 3, Weeks 49 - 72|Other reasons|3
4772637|NCT02579096|7749901|FG001|Phase 3, Weeks 49 - 72|Other reasons|0
4772638|NCT02538666|7749910|FG000|Overall Study|Disease progression|1
4772639|NCT02538666|7749911|FG001|Overall Study|Disease progression|0
4772640|NCT02538666|7749912|FG002|Overall Study|Disease progression|0
4772641|NCT02538666|7749910|FG000|Overall Study|no longer meets study criteria|1
4772642|NCT02538666|7749911|FG001|Overall Study|no longer meets study criteria|0
4772643|NCT02538666|7749912|FG002|Overall Study|no longer meets study criteria|0
4772644|NCT02538666|7749910|FG000|Overall Study|Withdrew Consent|0
4772645|NCT02538666|7749911|FG001|Overall Study|Withdrew Consent|1
4772646|NCT02538666|7749912|FG002|Overall Study|Withdrew Consent|1
4772647|NCT02527200|7749925|FG000|Overall Study|Withdrawal by Subject|3
4772648|NCT02527200|7749926|FG001|Overall Study|Withdrawal by Subject|2
4730950|NCT03358147|7673293|FG003|Overall Study|Physician Decision|6
4730951|NCT03358147|7673294|FG004|Overall Study|Physician Decision|1
4730952|NCT03358147|7673290|FG000|Overall Study|Administrative reasons|0
4730953|NCT03358147|7673291|FG001|Overall Study|Administrative reasons|1
4730954|NCT03358147|7673292|FG002|Overall Study|Administrative reasons|0
4730955|NCT03358147|7673293|FG003|Overall Study|Administrative reasons|3
4730956|NCT03358147|7673294|FG004|Overall Study|Administrative reasons|0
4730957|NCT03358147|7673290|FG000|Overall Study|Lack of Efficacy|0
4730958|NCT03358147|7673291|FG001|Overall Study|Lack of Efficacy|1
4730959|NCT03358147|7673292|FG002|Overall Study|Lack of Efficacy|1
4772649|NCT02527200|7749927|FG002|Overall Study|Withdrawal by Subject|1
4772650|NCT02527200|7749928|FG003|Overall Study|Withdrawal by Subject|0
4772651|NCT02527200|7749925|FG000|Overall Study|Unclassified|0
4772652|NCT02527200|7749926|FG001|Overall Study|Unclassified|1
4772653|NCT02527200|7749927|FG002|Overall Study|Unclassified|0
4772654|NCT02527200|7749928|FG003|Overall Study|Unclassified|0
4772655|NCT02527200|7749925|FG000|Overall Study|Lost to Follow-up|0
4772656|NCT02527200|7749926|FG001|Overall Study|Lost to Follow-up|0
4772657|NCT02527200|7749927|FG002|Overall Study|Lost to Follow-up|1
4772658|NCT02527200|7749928|FG003|Overall Study|Lost to Follow-up|0
4772659|NCT02511106|7749944|FG000|Overall Study|Lost to Follow-up|1
4772660|NCT02511106|7749945|FG001|Overall Study|Lost to Follow-up|2
4772661|NCT02511106|7749944|FG000|Overall Study|Withdrawal by Subject|19
4772662|NCT02511106|7749945|FG001|Overall Study|Withdrawal by Subject|14
4772663|NCT02511106|7749944|FG000|Overall Study|Ongoing study at data cut-off|309
4772664|NCT02511106|7749945|FG001|Overall Study|Ongoing study at data cut-off|307
4772665|NCT02511106|7749944|FG000|Overall Study|Without specified reason|1
4772666|NCT02511106|7749945|FG001|Overall Study|Without specified reason|0
4772667|NCT02511106|7749944|FG000|Overall Study|Missing|1
4772668|NCT02511106|7749945|FG001|Overall Study|Missing|0
4772669|NCT02253316|7749985|FG000|Consolidation|Progression|4
4772670|NCT02253316|7749986|FG001|Consolidation|Progression|0
4772671|NCT02253316|7749987|FG002|Consolidation|Progression|0
4772672|NCT02253316|7749985|FG000|Consolidation|Non-Compliance|1
4772673|NCT02253316|7749986|FG001|Consolidation|Non-Compliance|0
4772674|NCT02253316|7749987|FG002|Consolidation|Non-Compliance|0
4772675|NCT02253316|7749985|FG000|Consolidation|Patient Withdrew Logistical Concerns|2
4772676|NCT02253316|7749986|FG001|Consolidation|Patient Withdrew Logistical Concerns|0
4772677|NCT02253316|7749987|FG002|Consolidation|Patient Withdrew Logistical Concerns|0
4772678|NCT02253316|7749985|FG000|Consolidation|Secondary Malignancy|2
4772679|NCT02253316|7749986|FG001|Consolidation|Secondary Malignancy|0
4772680|NCT02253316|7749987|FG002|Consolidation|Secondary Malignancy|0
4772681|NCT02253316|7749985|FG000|Consolidation|Adverse Event|7
4772682|NCT02253316|7749986|FG001|Consolidation|Adverse Event|0
4772683|NCT02253316|7749987|FG002|Consolidation|Adverse Event|0
4772684|NCT02253316|7749985|FG000|Maintenance|Patient Withdrew Logistical Concerns|0
4772685|NCT02253316|7749986|FG001|Maintenance|Patient Withdrew Logistical Concerns|6
4772686|NCT02253316|7749987|FG002|Maintenance|Patient Withdrew Logistical Concerns|6
4772687|NCT02253316|7749985|FG000|Maintenance|Physician Decision|0
4772688|NCT02253316|7749986|FG001|Maintenance|Physician Decision|5
4772689|NCT02253316|7749987|FG002|Maintenance|Physician Decision|16
4772690|NCT02253316|7749985|FG000|Maintenance|Non-Compliance|0
4772691|NCT02253316|7749986|FG001|Maintenance|Non-Compliance|1
4772692|NCT02253316|7749987|FG002|Maintenance|Non-Compliance|1
4772693|NCT02253316|7749985|FG000|Maintenance|Secondary Malignancy|0
4772694|NCT02253316|7749986|FG001|Maintenance|Secondary Malignancy|1
4772695|NCT02253316|7749987|FG002|Maintenance|Secondary Malignancy|5
4772696|NCT02253316|7749985|FG000|Maintenance|Adverse Event|0
4772697|NCT02253316|7749986|FG001|Maintenance|Adverse Event|8
4772698|NCT02253316|7749987|FG002|Maintenance|Adverse Event|12
4772699|NCT02253316|7749985|FG000|Maintenance|Still receiving active treatment|0
4772700|NCT02253316|7749986|FG001|Maintenance|Still receiving active treatment|25
4772701|NCT02253316|7749987|FG002|Maintenance|Still receiving active treatment|27
4772702|NCT02224573|7749997|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0
4730960|NCT03358147|7673293|FG003|Overall Study|Lack of Efficacy|0
4772703|NCT02224573|7749998|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1
4772704|NCT02224573|7749997|FG000|Treatment Phase|Started on Other IMP|1
4772705|NCT02224573|7749998|FG001|Treatment Phase|Started on Other IMP|0
4772706|NCT02224573|7749997|FG000|Treatment Phase|Participant Discontinued IMP|0
4772707|NCT02224573|7749998|FG001|Treatment Phase|Participant Discontinued IMP|1
4772708|NCT02224573|7749997|FG000|Treatment Phase|Lack of Efficacy|15
4772709|NCT02224573|7749998|FG001|Treatment Phase|Lack of Efficacy|8
4772710|NCT02224573|7749997|FG000|Treatment Phase|Began Commercial Product|1
4772711|NCT02224573|7749998|FG001|Treatment Phase|Began Commercial Product|0
4772712|NCT02224573|7749997|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3
4772713|NCT02224573|7749998|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3
4772714|NCT02224573|7749997|FG000|Treatment Phase|Met Withdrawal Criteria|5
4772715|NCT02224573|7749998|FG001|Treatment Phase|Met Withdrawal Criteria|7
4772716|NCT02224573|7749997|FG000|Treatment Phase|Participant Did Not Return for Visits|0
4772717|NCT02224573|7749998|FG001|Treatment Phase|Participant Did Not Return for Visits|1
4772718|NCT02224573|7749997|FG000|Treatment Phase|Continued Compassionate Use|1
4772719|NCT02224573|7749998|FG001|Treatment Phase|Continued Compassionate Use|0
4772720|NCT02224573|7749997|FG000|Treatment Phase|Lack of Efficiency|2
4772721|NCT02224573|7749998|FG001|Treatment Phase|Lack of Efficiency|1
4772722|NCT02224573|7749997|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0
4772723|NCT02224573|7749998|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1
4772724|NCT02224573|7749997|FG000|Treatment Phase|Participant Moved|2
4772725|NCT02224573|7749998|FG001|Treatment Phase|Participant Moved|0
4772726|NCT02224573|7749997|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62
4772727|NCT02224573|7749998|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48
4772728|NCT02224573|7749997|FG000|Treatment Phase|Refused Medication|1
4772729|NCT02224573|7749998|FG001|Treatment Phase|Refused Medication|1
4772730|NCT02224573|7749997|FG000|Treatment Phase|Adverse Event|26
4772731|NCT02224573|7749998|FG001|Treatment Phase|Adverse Event|38
4772732|NCT02224573|7749997|FG000|Treatment Phase|Placed in Group Home|0
4772733|NCT02224573|7749998|FG001|Treatment Phase|Placed in Group Home|1
4772734|NCT02224573|7749997|FG000|Treatment Phase|Pursued Other Trials|1
4772735|NCT02224573|7749998|FG001|Treatment Phase|Pursued Other Trials|0
4772736|NCT02224573|7749997|FG000|Treatment Phase|Withdrawn by the Investigator|23
4772737|NCT02224573|7749998|FG001|Treatment Phase|Withdrawn by the Investigator|11
4772738|NCT02224573|7749997|FG000|Treatment Phase|Lost to Follow-up|2
4772739|NCT02224573|7749998|FG001|Treatment Phase|Lost to Follow-up|1
4772740|NCT02224573|7749997|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1
4772741|NCT02224573|7749998|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0
4515278|NCT00952341|7326039|FG000|Cycle 1|Lost to Follow-up|11
4515279|NCT00952341|7326040|FG001|Cycle 1|Lost to Follow-up|2
4515280|NCT00952341|7326039|FG000|Cycle 1|Physician Decision|0
4515281|NCT00952341|7326040|FG001|Cycle 1|Physician Decision|1
4515282|NCT00952341|7326039|FG000|Cycle 2|Withdrawal by Subject|1
4515283|NCT00952341|7326040|FG001|Cycle 2|Withdrawal by Subject|1
4515284|NCT00952341|7326039|FG000|Cycle 2|Protocol Violation|1
4515285|NCT00952341|7326040|FG001|Cycle 2|Protocol Violation|0
4515286|NCT00952341|7326039|FG000|Cycle 2|Lost to Follow-up|6
4515287|NCT00952341|7326040|FG001|Cycle 2|Lost to Follow-up|9
4515288|NCT00952341|7326039|FG000|Cycle 2|Physician Decision|1
4515289|NCT00952341|7326040|FG001|Cycle 2|Physician Decision|1
4515290|NCT00952341|7326039|FG000|Cycle 2|Progressive Disease|0
4515291|NCT00952341|7326040|FG001|Cycle 2|Progressive Disease|1
4515292|NCT00952367|7326046|FG000|Overall Study|Withdrawal by Subject|2
4515293|NCT00952367|7326046|FG000|Overall Study|Noncoordination|1
4515294|NCT00952367|7326046|FG000|Overall Study|Protocol Violation|3
4515295|NCT00952380|7326055|FG000|Overall Study|Other|0
4515296|NCT00952380|7326056|FG001|Overall Study|Other|0
4515297|NCT00952380|7326057|FG002|Overall Study|Other|0
4515298|NCT00952380|7326058|FG003|Overall Study|Other|0
4515299|NCT00952380|7326059|FG004|Overall Study|Other|1
4515300|NCT00952380|7326055|FG000|Overall Study|Withdrawal by Subject|0
4515301|NCT00952380|7326056|FG001|Overall Study|Withdrawal by Subject|0
4515302|NCT00952380|7326057|FG002|Overall Study|Withdrawal by Subject|1
4515303|NCT00952380|7326058|FG003|Overall Study|Withdrawal by Subject|0
4515304|NCT00952380|7326059|FG004|Overall Study|Withdrawal by Subject|2
4515305|NCT00952380|7326055|FG000|Overall Study|Adverse Event|0
4515306|NCT00952380|7326056|FG001|Overall Study|Adverse Event|1
4515307|NCT00952380|7326057|FG002|Overall Study|Adverse Event|0
4515308|NCT00952380|7326058|FG003|Overall Study|Adverse Event|0
4515309|NCT00952380|7326059|FG004|Overall Study|Adverse Event|3
4515310|NCT00952380|7326055|FG000|Overall Study|Physician Decision|0
4515311|NCT00952380|7326056|FG001|Overall Study|Physician Decision|0
4515312|NCT00952380|7326057|FG002|Overall Study|Physician Decision|1
4515313|NCT00952380|7326058|FG003|Overall Study|Physician Decision|2
4515314|NCT00952380|7326059|FG004|Overall Study|Physician Decision|0
4515315|NCT00952380|7326055|FG000|Overall Study|Non-compliant to protocol|0
4515316|NCT00952380|7326056|FG001|Overall Study|Non-compliant to protocol|0
4515317|NCT00952380|7326057|FG002|Overall Study|Non-compliant to protocol|0
4515318|NCT00952380|7326058|FG003|Overall Study|Non-compliant to protocol|1
4515319|NCT00952380|7326059|FG004|Overall Study|Non-compliant to protocol|0
4515320|NCT00952419|7326083|FG000|Overall Study|Adverse Event|2
4515321|NCT00952419|7326084|FG001|Overall Study|Adverse Event|0
4515322|NCT00952419|7326085|FG002|Overall Study|Adverse Event|0
4515323|NCT00952419|7326083|FG000|Overall Study|Protocol Violation|3
4515324|NCT00952419|7326084|FG001|Overall Study|Protocol Violation|7
4515325|NCT00952419|7326085|FG002|Overall Study|Protocol Violation|0
4515326|NCT00952419|7326083|FG000|Overall Study|Withdrawal by Subject|1
4515327|NCT00952419|7326084|FG001|Overall Study|Withdrawal by Subject|3
4772742|NCT02224573|7749997|FG000|Taper Phase|Hospitalization/Dose Reduction|1
4772743|NCT02224573|7749998|FG001|Taper Phase|Hospitalization/Dose Reduction|0
4772744|NCT02224573|7749997|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0
4515328|NCT00952419|7326085|FG002|Overall Study|Withdrawal by Subject|0
4515329|NCT00952484|7326096|FG000|Overall Study|Withdrawal by Subject|0
4515330|NCT00952484|7326097|FG001|Overall Study|Withdrawal by Subject|1
4515331|NCT00952484|7326098|FG002|Overall Study|Withdrawal by Subject|0
4772745|NCT02224573|7749998|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3
4772746|NCT02224573|7749997|FG000|Taper Phase|Adverse Event|1
4772747|NCT02224573|7749998|FG001|Taper Phase|Adverse Event|1
4772748|NCT01991067|7750007|FG000|Overall Study|Lost to Follow-up|6
4772749|NCT01991067|7750008|FG001|Overall Study|Lost to Follow-up|5
4772750|NCT01966471|7750016|FG000|Overall Study|Death|33
4772751|NCT01966471|7750017|FG001|Overall Study|Death|44
4772752|NCT01966471|7750016|FG000|Overall Study|Lost to Follow-up|14
4772753|NCT01966471|7750017|FG001|Overall Study|Lost to Follow-up|16
4772754|NCT01966471|7750016|FG000|Overall Study|Other|3
4772755|NCT01966471|7750017|FG001|Overall Study|Other|5
4772756|NCT01966471|7750016|FG000|Overall Study|Physician Decision|5
4772757|NCT01966471|7750017|FG001|Overall Study|Physician Decision|5
4772758|NCT01966471|7750016|FG000|Overall Study|Withdrawal by Subject|48
4772759|NCT01966471|7750017|FG001|Overall Study|Withdrawal by Subject|43
4772760|NCT01774721|7750038|FG000|Overall Study|Death|76
4772761|NCT01774721|7750039|FG001|Overall Study|Death|91
4772762|NCT01774721|7750038|FG000|Overall Study|Withdrawal by Subject|14
4772763|NCT01774721|7750039|FG001|Overall Study|Withdrawal by Subject|10
4772764|NCT01774721|7750038|FG000|Overall Study|Lost to Follow-up|1
4772765|NCT01774721|7750039|FG001|Overall Study|Lost to Follow-up|1
4772766|NCT01774721|7750038|FG000|Overall Study|Did not meet eligibility criteria|0
4772767|NCT01774721|7750039|FG001|Overall Study|Did not meet eligibility criteria|3
4772768|NCT01774721|7750038|FG000|Overall Study|Ongoing in study|136
4772769|NCT01774721|7750039|FG001|Overall Study|Ongoing in study|120
4772770|NCT01709331|7750056|FG000|Overall Study|Adverse Event|1
4772771|NCT01656434|7750077|FG000|Overall Study|Adverse Event|199
4772772|NCT01656434|7750078|FG001|Overall Study|Adverse Event|63
4772773|NCT01656434|7750077|FG000|Overall Study|Enrollment terminated at trial site|2
4772774|NCT01656434|7750078|FG001|Overall Study|Enrollment terminated at trial site|0
4772775|NCT01656434|7750077|FG000|Overall Study|Lost to Follow-up|309
4772776|NCT01656434|7750078|FG001|Overall Study|Lost to Follow-up|76
4772777|NCT01656434|7750077|FG000|Overall Study|Site discontinued study participation|24
4772778|NCT01656434|7750078|FG001|Overall Study|Site discontinued study participation|9
4772779|NCT01656434|7750077|FG000|Overall Study|Screen failure|2
4772780|NCT01656434|7750078|FG001|Overall Study|Screen failure|0
4772781|NCT01656434|7750077|FG000|Overall Study|Protocol Violation|7
4772782|NCT01656434|7750078|FG001|Overall Study|Protocol Violation|0
4772783|NCT01656434|7750077|FG000|Overall Study|Pregnancy wish|18
4772784|NCT01656434|7750078|FG001|Overall Study|Pregnancy wish|6
4772785|NCT01656434|7750077|FG000|Overall Study|Pregnancy|45
4772786|NCT01656434|7750078|FG001|Overall Study|Pregnancy|10
4772787|NCT01656434|7750077|FG000|Overall Study|Physician Decision|7
4772788|NCT01656434|7750078|FG001|Overall Study|Physician Decision|2
4772789|NCT01656434|7750077|FG000|Overall Study|Non-compliance with study drug|48
4772790|NCT01656434|7750078|FG001|Overall Study|Non-compliance with study drug|9
4772791|NCT01656434|7750077|FG000|Overall Study|Study terminated by sponsor|1501
4772792|NCT01656434|7750078|FG001|Overall Study|Study terminated by sponsor|348
4772793|NCT01656434|7750077|FG000|Overall Study|Participant discontinued; drug related|13
4772794|NCT01656434|7750078|FG001|Overall Study|Participant discontinued; drug related|4
4772795|NCT01656434|7750077|FG000|Overall Study|Part. discontinued; unrelated to drug|55
4772796|NCT01656434|7750078|FG001|Overall Study|Part. discontinued; unrelated to drug|10
4772797|NCT01656434|7750077|FG000|Overall Study|Non-compliance with protocol|39
4772798|NCT01656434|7750078|FG001|Overall Study|Non-compliance with protocol|15
4772799|NCT01656434|7750077|FG000|Overall Study|Participant moved|40
4772800|NCT01656434|7750078|FG001|Overall Study|Participant moved|12
4772801|NCT01656434|7750077|FG000|Overall Study|Participant withdrew consent|28
4772802|NCT01656434|7750078|FG001|Overall Study|Participant withdrew consent|9
4772803|NCT01656434|7750077|FG000|Overall Study|Withdrawal by Subject|64
4772804|NCT01656434|7750078|FG001|Overall Study|Withdrawal by Subject|7
4772805|NCT01496118|7750107|FG000|Overall Study|Disease progression|3
4772806|NCT01496118|7750108|FG001|Overall Study|Disease progression|2
4772807|NCT01496118|7750109|FG002|Overall Study|Disease progression|3
4772808|NCT01496118|7750110|FG003|Overall Study|Disease progression|1
4772809|NCT01496118|7750111|FG004|Overall Study|Disease progression|2
4772810|NCT01496118|7750112|FG005|Overall Study|Disease progression|2
4772811|NCT01496118|7750113|FG006|Overall Study|Disease progression|14
4772812|NCT01496118|7750114|FG007|Overall Study|Disease progression|10
4772813|NCT01496118|7750107|FG000|Overall Study|Physician Decision|0
4772814|NCT01496118|7750108|FG001|Overall Study|Physician Decision|0
4772815|NCT01496118|7750109|FG002|Overall Study|Physician Decision|0
4772816|NCT01496118|7750110|FG003|Overall Study|Physician Decision|0
4772817|NCT01496118|7750111|FG004|Overall Study|Physician Decision|1
4772818|NCT01496118|7750112|FG005|Overall Study|Physician Decision|0
4772819|NCT01496118|7750113|FG006|Overall Study|Physician Decision|3
4772820|NCT01496118|7750114|FG007|Overall Study|Physician Decision|6
4772821|NCT01496118|7750107|FG000|Overall Study|Adverse Event|1
4772822|NCT01496118|7750108|FG001|Overall Study|Adverse Event|1
4772823|NCT01496118|7750109|FG002|Overall Study|Adverse Event|0
4772824|NCT01496118|7750110|FG003|Overall Study|Adverse Event|0
4772825|NCT01496118|7750111|FG004|Overall Study|Adverse Event|0
4772826|NCT01496118|7750112|FG005|Overall Study|Adverse Event|0
4772827|NCT01496118|7750113|FG006|Overall Study|Adverse Event|6
4772828|NCT01496118|7750114|FG007|Overall Study|Adverse Event|10
4772829|NCT01496118|7750107|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0
4772830|NCT01496118|7750108|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0
4772831|NCT01496118|7750109|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0
4772832|NCT01496118|7750110|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0
4772833|NCT01496118|7750111|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0
4772834|NCT01496118|7750112|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0
4772835|NCT01496118|7750113|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1
4772836|NCT01496118|7750114|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0
4772837|NCT01496118|7750107|FG000|Overall Study|Death|0
4772838|NCT01496118|7750108|FG001|Overall Study|Death|0
4772839|NCT01496118|7750109|FG002|Overall Study|Death|0
4772840|NCT01496118|7750110|FG003|Overall Study|Death|0
4772841|NCT01496118|7750111|FG004|Overall Study|Death|0
4772842|NCT01496118|7750112|FG005|Overall Study|Death|0
4772843|NCT01496118|7750113|FG006|Overall Study|Death|1
4772844|NCT01496118|7750114|FG007|Overall Study|Death|1
4772845|NCT01496118|7750107|FG000|Overall Study|Withdrawal by Subject|0
4772846|NCT01496118|7750108|FG001|Overall Study|Withdrawal by Subject|0
4772847|NCT01496118|7750109|FG002|Overall Study|Withdrawal by Subject|0
4772848|NCT01496118|7750110|FG003|Overall Study|Withdrawal by Subject|2
4772849|NCT01496118|7750111|FG004|Overall Study|Withdrawal by Subject|0
4772850|NCT01496118|7750112|FG005|Overall Study|Withdrawal by Subject|1
4772851|NCT01496118|7750113|FG006|Overall Study|Withdrawal by Subject|6
4772852|NCT01496118|7750114|FG007|Overall Study|Withdrawal by Subject|3
4772853|NCT01350934|7750134|FG000|Base Study|Adverse Event|6
4772854|NCT01350934|7750135|FG001|Base Study|Adverse Event|0
4772855|NCT01350934|7750134|FG000|Base Study|Lost to Follow-up|1
4772856|NCT01350934|7750135|FG001|Base Study|Lost to Follow-up|0
4772857|NCT01350934|7750134|FG000|Base Study|Protocol Violation|1
4772858|NCT01350934|7750135|FG001|Base Study|Protocol Violation|1
4772859|NCT01350934|7750134|FG000|Base Study|Withdrawal by Subject|1
4772860|NCT01350934|7750135|FG001|Base Study|Withdrawal by Subject|2
4772861|NCT01350934|7750134|FG000|Base Study|Non-Compliance With Study Drug|2
4772862|NCT01350934|7750135|FG001|Base Study|Non-Compliance With Study Drug|0
4772863|NCT01350934|7750134|FG000|Extension Study|Adverse Event|2
4772864|NCT01350934|7750135|FG001|Extension Study|Adverse Event|1
4772865|NCT01350934|7750134|FG000|Extension Study|Lost to Follow-up|2
4772866|NCT01350934|7750135|FG001|Extension Study|Lost to Follow-up|0
4772867|NCT01350934|7750134|FG000|Extension Study|Protocol Violation|1
4772868|NCT01350934|7750135|FG001|Extension Study|Protocol Violation|1
4772869|NCT01350934|7750134|FG000|Extension Study|Lack of Efficacy|0
4772870|NCT01350934|7750135|FG001|Extension Study|Lack of Efficacy|1
4772871|NCT01350934|7750134|FG000|Extension Study|Withdrawal by Subject|0
4772872|NCT01350934|7750135|FG001|Extension Study|Withdrawal by Subject|1
4772873|NCT01286207|7750144|FG000|Overall Study|Adverse Event|27
4772874|NCT01286207|7750145|FG001|Overall Study|Adverse Event|41
4772875|NCT01286207|7750146|FG002|Overall Study|Adverse Event|8
4772876|NCT01286207|7750144|FG000|Overall Study|Lost to Follow-up|49
4772877|NCT01286207|7750145|FG001|Overall Study|Lost to Follow-up|43
4772878|NCT01286207|7750146|FG002|Overall Study|Lost to Follow-up|20
4772879|NCT01286207|7750144|FG000|Overall Study|Withdrawal by Subject|93
4772880|NCT01286207|7750145|FG001|Overall Study|Withdrawal by Subject|79
4772881|NCT01286207|7750146|FG002|Overall Study|Withdrawal by Subject|41
4772882|NCT01286207|7750144|FG000|Overall Study|Lack of Response|92
4772883|NCT01286207|7750145|FG001|Overall Study|Lack of Response|38
4772884|NCT01286207|7750146|FG002|Overall Study|Lack of Response|8
4772885|NCT01286207|7750144|FG000|Overall Study|Other|37
4772886|NCT01286207|7750145|FG001|Overall Study|Other|47
4772887|NCT01286207|7750146|FG002|Overall Study|Other|13
4630988|NCT01888874|7500007|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
4633380|NCT01911442|7503530|FG000|Overall Study|Withdrawal by Subject|1
4730961|NCT03358147|7673294|FG004|Overall Study|Lack of Efficacy|0
4730962|NCT03358238|7673308|FG000|Overall Study|Withdrawal by Subject|0
4730963|NCT03358238|7673309|FG001|Overall Study|Withdrawal by Subject|1
4730964|NCT03358290|7673331|FG000|Overall Study|Study discontinued by Sponsor|0
4730965|NCT03358290|7673332|FG001|Overall Study|Study discontinued by Sponsor|1
4730966|NCT03358290|7673333|FG002|Overall Study|Study discontinued by Sponsor|1
4730967|NCT03358290|7673334|FG003|Overall Study|Study discontinued by Sponsor|0
4730968|NCT03358290|7673335|FG004|Overall Study|Study discontinued by Sponsor|0
4730969|NCT03358290|7673331|FG000|Overall Study|Adverse Event|0
4730970|NCT03358290|7673332|FG001|Overall Study|Adverse Event|0
4730971|NCT03358290|7673333|FG002|Overall Study|Adverse Event|1
4730972|NCT03358290|7673334|FG003|Overall Study|Adverse Event|2
4730973|NCT03358290|7673335|FG004|Overall Study|Adverse Event|0
4730974|NCT03358290|7673331|FG000|Overall Study|Withdrawal by Subject|0
4730975|NCT03358290|7673332|FG001|Overall Study|Withdrawal by Subject|0
4730976|NCT03358290|7673333|FG002|Overall Study|Withdrawal by Subject|0
4730977|NCT03358290|7673334|FG003|Overall Study|Withdrawal by Subject|0
4730978|NCT03358290|7673335|FG004|Overall Study|Withdrawal by Subject|1
4730979|NCT03358329|7673347|FG000|Overall Study|Lost to Follow-up|2
4730980|NCT03358329|7673347|FG000|Overall Study|Withdrawal by Subject|2
4730981|NCT03358407|7673372|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
4730982|NCT03358407|7673373|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
4730983|NCT03358407|7673374|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1
4730984|NCT03358407|7673375|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
4730985|NCT03358407|7673376|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
4730986|NCT03358407|7673377|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
4730987|NCT03358407|7673378|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
4730988|NCT03358407|7673379|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
4730989|NCT03358407|7673380|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
4730990|NCT03358407|7673381|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
4730991|NCT03358407|7673372|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
4730992|NCT03358407|7673373|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
4730993|NCT03358407|7673374|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
4730994|NCT03358407|7673375|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
4730995|NCT03358407|7673376|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1
4730996|NCT03358407|7673377|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
4730997|NCT03358407|7673378|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
4730998|NCT03358407|7673379|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
4730999|NCT03358407|7673380|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
4731000|NCT03358407|7673381|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
4731001|NCT03358407|7673372|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
4731002|NCT03358407|7673373|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
4731003|NCT03358407|7673374|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
4731004|NCT03358407|7673375|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
4731005|NCT03358407|7673376|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
4731006|NCT03358407|7673377|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1
4731007|NCT03358407|7673378|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
4731008|NCT03358407|7673379|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2
4731009|NCT03358407|7673380|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
4731010|NCT03358407|7673381|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
4731011|NCT03358407|7673372|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
4731012|NCT03358407|7673373|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
4731013|NCT03358407|7673374|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
4731014|NCT03358407|7673375|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
4731015|NCT03358407|7673376|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
4731016|NCT03358407|7673377|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1
4731017|NCT03358407|7673378|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
4731018|NCT03358407|7673379|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1
4731019|NCT03358407|7673380|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
4731020|NCT03358407|7673381|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
4731021|NCT03358407|7673372|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
4731022|NCT03358407|7673373|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
4731023|NCT03358407|7673374|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
4731024|NCT03358407|7673375|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
4731025|NCT03358407|7673376|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
4731026|NCT03358407|7673377|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1
4772888|NCT01263769|7750154|FG000|Overall Study|Non-Compliant with treatment|1
4772889|NCT01227187|7750162|FG000|Overall Study|Physician Decision|0
4772890|NCT01227187|7750163|FG001|Overall Study|Physician Decision|0
4772891|NCT01227187|7750164|FG002|Overall Study|Physician Decision|0
4772892|NCT01227187|7750165|FG003|Overall Study|Physician Decision|1
4772893|NCT01222247|7750177|FG000|Overall Study|Lost to Follow-up|2
4731027|NCT03358407|7673378|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1
4731028|NCT03358407|7673379|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
4731029|NCT03358407|7673380|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
4731030|NCT03358407|7673381|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
4731031|NCT03358407|7673372|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
4731032|NCT03358407|7673373|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
4731033|NCT03358407|7673374|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
4731034|NCT03358407|7673375|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
4731035|NCT03358407|7673376|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
4731036|NCT03358407|7673377|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3
4731037|NCT03358407|7673378|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3
4731038|NCT03358407|7673379|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6
4731039|NCT03358407|7673380|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
4731040|NCT03358407|7673381|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
4731041|NCT03358472|7673412|FG000|Overall Study|Death|6
4731042|NCT03358472|7673413|FG001|Overall Study|Death|3
4731043|NCT03358472|7673414|FG002|Overall Study|Death|10
4731044|NCT03358472|7673412|FG000|Overall Study|Physician Decision|0
4731045|NCT03358472|7673413|FG001|Overall Study|Physician Decision|1
4731046|NCT03358472|7673414|FG002|Overall Study|Physician Decision|0
4731047|NCT03358472|7673412|FG000|Overall Study|Withdrawal by Subject|0
4772894|NCT01222247|7750178|FG001|Overall Study|Lost to Follow-up|2
4772895|NCT01144416|7750214|FG000|Intervention Period|Adverse Event|5
4772896|NCT01144416|7750215|FG001|Intervention Period|Adverse Event|6
4772897|NCT01144416|7750214|FG000|Intervention Period|Insufficient ovarian response|11
4772898|NCT01144416|7750215|FG001|Intervention Period|Insufficient ovarian response|17
4772899|NCT01144416|7750214|FG000|Intervention Period|Risk of OHSS|0
4772900|NCT01144416|7750215|FG001|Intervention Period|Risk of OHSS|1
4772901|NCT01144416|7750214|FG000|Intervention Period|Too high ovarian response|4
4772902|NCT01144416|7750215|FG001|Intervention Period|Too high ovarian response|2
4772903|NCT01144416|7750214|FG000|Intervention Period|No/too few/bad oocytes|7
4772904|NCT01144416|7750215|FG001|Intervention Period|No/too few/bad oocytes|5
4772905|NCT01144416|7750214|FG000|Intervention Period|No or abnormal fertilization|25
4772906|NCT01144416|7750215|FG001|Intervention Period|No or abnormal fertilization|10
4772907|NCT01144416|7750214|FG000|Intervention Period|No/too few/bad quality embryos|3
4772908|NCT01144416|7750215|FG001|Intervention Period|No/too few/bad quality embryos|3
4772909|NCT01144416|7750214|FG000|Intervention Period|Other|7
4772910|NCT01144416|7750215|FG001|Intervention Period|Other|5
4772911|NCT01140048|7750225|FG000|Overall Study|Physician Decision|1
4772912|NCT01140048|7750225|FG000|Overall Study|Withdrawal by Subject|13
4772913|NCT01140048|7750225|FG000|Overall Study|Lost to Follow-up|31
4772914|NCT01065779|7750240|FG000|Overall Study|Duplicate Investigation|1
4772915|NCT01065779|7750240|FG000|Overall Study|Investigation Before Contract Date|37
4772916|NCT01065779|7750240|FG000|Overall Study|Non-enrollment Period Administration|10
4772917|NCT01065779|7750240|FG000|Overall Study|Not Administered With Study Drug|17
4772918|NCT01065779|7750240|FG000|Overall Study|Failed to Follow-up|10
4772919|NCT01065779|7750240|FG000|Overall Study|Inclusion Criteria Violation|7
4772920|NCT00974571|7750247|FG000|Overall Study|Adverse Event|31
4772921|NCT00974571|7750248|FG001|Overall Study|Adverse Event|4
4772922|NCT00974571|7750249|FG002|Overall Study|Adverse Event|27
4772923|NCT00974571|7750247|FG000|Overall Study|Lack of Efficacy|3
4772924|NCT00974571|7750248|FG001|Overall Study|Lack of Efficacy|2
4772925|NCT00974571|7750249|FG002|Overall Study|Lack of Efficacy|9
4772926|NCT00974571|7750247|FG000|Overall Study|Lost to Follow-up|2
4772927|NCT00974571|7750248|FG001|Overall Study|Lost to Follow-up|1
4772928|NCT00974571|7750249|FG002|Overall Study|Lost to Follow-up|2
4772929|NCT00974571|7750247|FG000|Overall Study|Protocol Violation|13
4772930|NCT00974571|7750248|FG001|Overall Study|Protocol Violation|4
4772931|NCT00974571|7750249|FG002|Overall Study|Protocol Violation|18
4772932|NCT00974571|7750247|FG000|Overall Study|Withdrawal by Subject|14
4772933|NCT00974571|7750248|FG001|Overall Study|Withdrawal by Subject|5
4772934|NCT00974571|7750249|FG002|Overall Study|Withdrawal by Subject|16
4772935|NCT00974571|7750247|FG000|Overall Study|Patient Moved|1
4772936|NCT00974571|7750248|FG001|Overall Study|Patient Moved|0
4772937|NCT00974571|7750249|FG002|Overall Study|Patient Moved|1
4772938|NCT00974571|7750247|FG000|Overall Study|Other|4
4772939|NCT00974571|7750248|FG001|Overall Study|Other|0
4772940|NCT00974571|7750249|FG002|Overall Study|Other|10
4772941|NCT00972738|7750260|FG000|Overall Study|Adverse Event|7
4772942|NCT00972738|7750261|FG001|Overall Study|Adverse Event|1
4772943|NCT00972738|7750262|FG002|Overall Study|Adverse Event|8
4772944|NCT00972738|7750260|FG000|Overall Study|Protocol Violation|2
4772945|NCT00972738|7750261|FG001|Overall Study|Protocol Violation|1
4772946|NCT00972738|7750262|FG002|Overall Study|Protocol Violation|3
4772947|NCT00972738|7750260|FG000|Overall Study|Lost to Follow-up|1
4772948|NCT00972738|7750261|FG001|Overall Study|Lost to Follow-up|0
4772949|NCT00972738|7750262|FG002|Overall Study|Lost to Follow-up|1
4772950|NCT00972738|7750260|FG000|Overall Study|Lack of Efficacy|5
4772951|NCT00972738|7750261|FG001|Overall Study|Lack of Efficacy|1
4772952|NCT00972738|7750262|FG002|Overall Study|Lack of Efficacy|11
4772953|NCT00972738|7750260|FG000|Overall Study|Withdrawal by Subject|5
4772954|NCT00972738|7750261|FG001|Overall Study|Withdrawal by Subject|1
4772955|NCT00972738|7750262|FG002|Overall Study|Withdrawal by Subject|4
4772956|NCT00972738|7750260|FG000|Overall Study|Moved|0
4772957|NCT00972738|7750261|FG001|Overall Study|Moved|0
4772958|NCT00972738|7750262|FG002|Overall Study|Moved|1
4772959|NCT00972738|7750260|FG000|Overall Study|Other|1
4772960|NCT00972738|7750261|FG001|Overall Study|Other|2
4772961|NCT00972738|7750262|FG002|Overall Study|Other|1
4772962|NCT00968201|7750272|FG000|Base Study - (Period II)|Adverse Event|8
4772963|NCT00968201|7750273|FG001|Base Study - (Period II)|Adverse Event|0
4772964|NCT00968201|7750274|FG002|Base Study - (Period II)|Adverse Event|16
4772965|NCT00968201|7750272|FG000|Base Study - (Period II)|Lack of Efficacy|0
4772966|NCT00968201|7750273|FG001|Base Study - (Period II)|Lack of Efficacy|0
4772967|NCT00968201|7750274|FG002|Base Study - (Period II)|Lack of Efficacy|1
4772968|NCT00968201|7750272|FG000|Base Study - (Period II)|Lost to Follow-up|2
4772969|NCT00968201|7750273|FG001|Base Study - (Period II)|Lost to Follow-up|0
4772970|NCT00968201|7750274|FG002|Base Study - (Period II)|Lost to Follow-up|7
4772971|NCT00968201|7750272|FG000|Base Study - (Period II)|Protocol Violation|12
4772972|NCT00968201|7750273|FG001|Base Study - (Period II)|Protocol Violation|0
4772973|NCT00968201|7750274|FG002|Base Study - (Period II)|Protocol Violation|12
4772974|NCT00968201|7750272|FG000|Base Study - (Period II)|Withdrawal by Subject|4
4772975|NCT00968201|7750273|FG001|Base Study - (Period II)|Withdrawal by Subject|0
4772976|NCT00968201|7750274|FG002|Base Study - (Period II)|Withdrawal by Subject|8
4772977|NCT00968201|7750272|FG000|Base Study - (Period II)|Site Error|0
4772978|NCT00968201|7750273|FG001|Base Study - (Period II)|Site Error|0
4772979|NCT00968201|7750274|FG002|Base Study - (Period II)|Site Error|1
4772980|NCT00968201|7750272|FG000|Extension Study - (Period III)|Adverse Event|0
4772981|NCT00968201|7750273|FG001|Extension Study - (Period III)|Adverse Event|5
4772982|NCT00968201|7750274|FG002|Extension Study - (Period III)|Adverse Event|22
4772983|NCT00968201|7750272|FG000|Extension Study - (Period III)|Lost to Follow-up|0
4772984|NCT00968201|7750273|FG001|Extension Study - (Period III)|Lost to Follow-up|7
4772985|NCT00968201|7750274|FG002|Extension Study - (Period III)|Lost to Follow-up|13
4772986|NCT00968201|7750272|FG000|Extension Study - (Period III)|Protocol Violation|0
4772987|NCT00968201|7750273|FG001|Extension Study - (Period III)|Protocol Violation|17
4772988|NCT00968201|7750274|FG002|Extension Study - (Period III)|Protocol Violation|14
4772989|NCT00968201|7750272|FG000|Extension Study - (Period III)|Withdrawal by Subject|0
4772990|NCT00968201|7750273|FG001|Extension Study - (Period III)|Withdrawal by Subject|20
4772991|NCT00968201|7750274|FG002|Extension Study - (Period III)|Withdrawal by Subject|40
4772992|NCT00968201|7750272|FG000|Extension Study - (Period III)|Patient Relocated|0
4772993|NCT00968201|7750273|FG001|Extension Study - (Period III)|Patient Relocated|1
4772994|NCT00968201|7750274|FG002|Extension Study - (Period III)|Patient Relocated|1
4772995|NCT00968201|7750272|FG000|Extension Study - (Period III)|Noncompliance|0
4772996|NCT00968201|7750273|FG001|Extension Study - (Period III)|Noncompliance|0
4772997|NCT00968201|7750274|FG002|Extension Study - (Period III)|Noncompliance|3
4772998|NCT00968201|7750272|FG000|Extension Study - (Period III)|Other|0
4772999|NCT00968201|7750273|FG001|Extension Study - (Period III)|Other|0
4773000|NCT00968201|7750274|FG002|Extension Study - (Period III)|Other|2
4773001|NCT00968201|7750272|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0
4773002|NCT00968201|7750273|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74
4773003|NCT00968201|7750274|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185
4773004|NCT00968149|7750285|FG000|Overall Study|Adverse Event|5
4773005|NCT00968149|7750286|FG001|Overall Study|Adverse Event|1
4773006|NCT00968149|7750285|FG000|Overall Study|Lack of Efficacy|0
4773007|NCT00968149|7750286|FG001|Overall Study|Lack of Efficacy|4
4773008|NCT00968149|7750285|FG000|Overall Study|Lost to Follow-up|0
4773009|NCT00968149|7750286|FG001|Overall Study|Lost to Follow-up|1
4773010|NCT00968149|7750285|FG000|Overall Study|Protocol Violation|4
4773011|NCT00968149|7750286|FG001|Overall Study|Protocol Violation|0
4773012|NCT00968149|7750285|FG000|Overall Study|Withdrawal by Subject|2
4773013|NCT00968149|7750286|FG001|Overall Study|Withdrawal by Subject|0
4773014|NCT00963469|7750295|FG000|Overall Study|Adverse Event|15
4773015|NCT00963469|7750296|FG001|Overall Study|Adverse Event|11
4773016|NCT00963469|7750297|FG002|Overall Study|Adverse Event|1
4773017|NCT00963469|7750295|FG000|Overall Study|Lack of Efficacy|10
4773018|NCT00963469|7750296|FG001|Overall Study|Lack of Efficacy|7
4773019|NCT00963469|7750297|FG002|Overall Study|Lack of Efficacy|2
4773020|NCT00963469|7750295|FG000|Overall Study|Lost to Follow-up|1
4773021|NCT00963469|7750296|FG001|Overall Study|Lost to Follow-up|1
4773022|NCT00963469|7750297|FG002|Overall Study|Lost to Follow-up|0
4773023|NCT00963469|7750295|FG000|Overall Study|Protocol Violation|5
4773024|NCT00963469|7750296|FG001|Overall Study|Protocol Violation|5
4773025|NCT00963469|7750297|FG002|Overall Study|Protocol Violation|3
4773026|NCT00963469|7750295|FG000|Overall Study|Withdrawal by Subject|4
4773027|NCT00963469|7750296|FG001|Overall Study|Withdrawal by Subject|1
4773028|NCT00963469|7750297|FG002|Overall Study|Withdrawal by Subject|1
4773029|NCT00963469|7750295|FG000|Overall Study|Pre-randomization Adverse Event|1
4773030|NCT00963469|7750296|FG001|Overall Study|Pre-randomization Adverse Event|2
4773031|NCT00963469|7750297|FG002|Overall Study|Pre-randomization Adverse Event|0
4773032|NCT00963469|7750295|FG000|Overall Study|Moved|1
4773033|NCT00963469|7750296|FG001|Overall Study|Moved|0
4773034|NCT00963469|7750297|FG002|Overall Study|Moved|0
4773035|NCT00963469|7750295|FG000|Overall Study|Site closed (local pollen Season ended)|4
4773036|NCT00963469|7750296|FG001|Overall Study|Site closed (local pollen Season ended)|1
4773037|NCT00963469|7750297|FG002|Overall Study|Site closed (local pollen Season ended)|3
4773038|NCT00960141|7750308|FG000|Overall Study|Adverse Event|4
4773039|NCT00960141|7750309|FG001|Overall Study|Adverse Event|8
4773040|NCT00960141|7750310|FG002|Overall Study|Adverse Event|2
4773041|NCT00960141|7750308|FG000|Overall Study|Lack of Efficacy|3
4773042|NCT00960141|7750309|FG001|Overall Study|Lack of Efficacy|4
4773043|NCT00960141|7750310|FG002|Overall Study|Lack of Efficacy|2
4773044|NCT00960141|7750308|FG000|Overall Study|Lost to Follow-up|1
4773045|NCT00960141|7750309|FG001|Overall Study|Lost to Follow-up|0
4773046|NCT00960141|7750310|FG002|Overall Study|Lost to Follow-up|0
4773047|NCT00960141|7750308|FG000|Overall Study|Protocol Violation|1
4773048|NCT00960141|7750309|FG001|Overall Study|Protocol Violation|3
4773049|NCT00960141|7750310|FG002|Overall Study|Protocol Violation|2
4773050|NCT00960141|7750308|FG000|Overall Study|Withdrawal by Subject|1
4773051|NCT00960141|7750309|FG001|Overall Study|Withdrawal by Subject|2
4773052|NCT00960141|7750310|FG002|Overall Study|Withdrawal by Subject|1
4773053|NCT00943683|7750320|FG000|Overall Study|Adverse Event|3
4773054|NCT00943683|7750321|FG001|Overall Study|Adverse Event|3
4773055|NCT00943683|7750320|FG000|Overall Study|Lost to Follow-up|1
4773056|NCT00943683|7750321|FG001|Overall Study|Lost to Follow-up|1
4773057|NCT00943683|7750320|FG000|Overall Study|Protocol Violation|1
4773058|NCT00943683|7750321|FG001|Overall Study|Protocol Violation|2
4773059|NCT00943683|7750320|FG000|Overall Study|Withdrawal by Subject|1
4773060|NCT00943683|7750321|FG001|Overall Study|Withdrawal by Subject|0
4773061|NCT00943683|7750320|FG000|Overall Study|Patient Moved|1
4773062|NCT00943683|7750321|FG001|Overall Study|Patient Moved|0
4773063|NCT00943397|7750329|FG000|Overall Study|Adverse Event|0
4773064|NCT00943397|7750330|FG001|Overall Study|Adverse Event|6
4773065|NCT00943397|7750329|FG000|Overall Study|Lost to Follow-up|0
4773066|NCT00943397|7750330|FG001|Overall Study|Lost to Follow-up|4
4773067|NCT00943397|7750329|FG000|Overall Study|Protocol Violation|2
4773068|NCT00943397|7750330|FG001|Overall Study|Protocol Violation|5
4773069|NCT00943397|7750329|FG000|Overall Study|Withdrawal by Subject|1
4773070|NCT00943397|7750330|FG001|Overall Study|Withdrawal by Subject|1
4773071|NCT00943397|7750329|FG000|Overall Study|Site terminated and other|12
4773072|NCT00943397|7750330|FG001|Overall Study|Site terminated and other|56
4773073|NCT00937937|7750336|FG000|Overall Study|Adverse Event|6
4773074|NCT00937937|7750336|FG000|Overall Study|Withdrawal by Subject|2
4773075|NCT00937937|7750336|FG000|Overall Study|Progression/relapse|61
4773076|NCT00937937|7750336|FG000|Overall Study|Death|1
4773077|NCT00937937|7750336|FG000|Overall Study|Other|2
4773078|NCT00911547|7750345|FG000|Overall Study|Adverse Event|8
4773079|NCT00911547|7750346|FG001|Overall Study|Adverse Event|27
4773080|NCT00911547|7750347|FG002|Overall Study|Adverse Event|11
4773081|NCT00911547|7750348|FG003|Overall Study|Adverse Event|6
4773082|NCT00911547|7750345|FG000|Overall Study|Lost to Follow-up|0
4773083|NCT00911547|7750346|FG001|Overall Study|Lost to Follow-up|0
4773084|NCT00911547|7750347|FG002|Overall Study|Lost to Follow-up|2
4773085|NCT00911547|7750348|FG003|Overall Study|Lost to Follow-up|1
4773086|NCT00911547|7750345|FG000|Overall Study|Protocol Violation|0
4773087|NCT00911547|7750346|FG001|Overall Study|Protocol Violation|5
4773088|NCT00911547|7750347|FG002|Overall Study|Protocol Violation|5
4773089|NCT00911547|7750348|FG003|Overall Study|Protocol Violation|1
4773090|NCT00911547|7750345|FG000|Overall Study|Withdrawal by Subject|3
4773091|NCT00911547|7750346|FG001|Overall Study|Withdrawal by Subject|10
4773092|NCT00911547|7750347|FG002|Overall Study|Withdrawal by Subject|4
4773093|NCT00911547|7750348|FG003|Overall Study|Withdrawal by Subject|8
4773094|NCT00899379|7750363|FG000|Overall Study|Adverse Event|2
4773095|NCT00899379|7750364|FG001|Overall Study|Adverse Event|2
4773096|NCT00899379|7750365|FG002|Overall Study|Adverse Event|1
4773097|NCT00899379|7750366|FG003|Overall Study|Adverse Event|1
4773098|NCT00899379|7750367|FG004|Overall Study|Adverse Event|2
4773099|NCT00899379|7750363|FG000|Overall Study|Lack of Efficacy|0
4773100|NCT00899379|7750364|FG001|Overall Study|Lack of Efficacy|4
4773101|NCT00899379|7750365|FG002|Overall Study|Lack of Efficacy|3
4773102|NCT00899379|7750366|FG003|Overall Study|Lack of Efficacy|0
4773103|NCT00899379|7750367|FG004|Overall Study|Lack of Efficacy|1
4773104|NCT00899379|7750363|FG000|Overall Study|Lost to Follow-up|9
4773105|NCT00899379|7750364|FG001|Overall Study|Lost to Follow-up|3
4773106|NCT00899379|7750365|FG002|Overall Study|Lost to Follow-up|0
4773107|NCT00899379|7750366|FG003|Overall Study|Lost to Follow-up|6
4773108|NCT00899379|7750367|FG004|Overall Study|Lost to Follow-up|2
4773109|NCT00899379|7750363|FG000|Overall Study|Protocol Violation|0
4773110|NCT00899379|7750364|FG001|Overall Study|Protocol Violation|0
4773111|NCT00899379|7750365|FG002|Overall Study|Protocol Violation|1
4773112|NCT00899379|7750366|FG003|Overall Study|Protocol Violation|1
4773113|NCT00899379|7750367|FG004|Overall Study|Protocol Violation|0
4773114|NCT00899379|7750363|FG000|Overall Study|Withdrawal by Subject|2
4773115|NCT00899379|7750364|FG001|Overall Study|Withdrawal by Subject|4
4773116|NCT00899379|7750365|FG002|Overall Study|Withdrawal by Subject|2
4773117|NCT00899379|7750366|FG003|Overall Study|Withdrawal by Subject|3
4773118|NCT00899379|7750367|FG004|Overall Study|Withdrawal by Subject|6
4773119|NCT00899379|7750363|FG000|Overall Study|Pregnancy|0
4773120|NCT00899379|7750364|FG001|Overall Study|Pregnancy|0
4773121|NCT00899379|7750365|FG002|Overall Study|Pregnancy|1
4773122|NCT00899379|7750366|FG003|Overall Study|Pregnancy|0
4773123|NCT00899379|7750367|FG004|Overall Study|Pregnancy|1
4773124|NCT00899379|7750363|FG000|Overall Study|Patient Uncooperative|0
4773125|NCT00899379|7750364|FG001|Overall Study|Patient Uncooperative|1
4773126|NCT00899379|7750365|FG002|Overall Study|Patient Uncooperative|0
4773127|NCT00899379|7750366|FG003|Overall Study|Patient Uncooperative|1
4773128|NCT00899379|7750367|FG004|Overall Study|Patient Uncooperative|2
4773129|NCT00899379|7750363|FG000|Overall Study|Abnormal Baseline ECG|0
4773130|NCT00899379|7750364|FG001|Overall Study|Abnormal Baseline ECG|0
4773131|NCT00899379|7750365|FG002|Overall Study|Abnormal Baseline ECG|0
4773132|NCT00899379|7750366|FG003|Overall Study|Abnormal Baseline ECG|1
4773133|NCT00899379|7750367|FG004|Overall Study|Abnormal Baseline ECG|0
4773134|NCT00899379|7750363|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1
4773135|NCT00899379|7750364|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1
4773136|NCT00899379|7750365|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1
4773137|NCT00899379|7750366|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0
4773138|NCT00899379|7750367|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0
4773139|NCT00899379|7750363|FG000|Overall Study|Not Completed/Entered Extn|5
4773140|NCT00899379|7750364|FG001|Overall Study|Not Completed/Entered Extn|1
4773141|NCT00899379|7750365|FG002|Overall Study|Not Completed/Entered Extn|6
4773142|NCT00899379|7750366|FG003|Overall Study|Not Completed/Entered Extn|4
4773143|NCT00899379|7750367|FG004|Overall Study|Not Completed/Entered Extn|3
4773144|NCT00899379|7750363|FG000|Overall Study|Study Terminated|3
4773145|NCT00899379|7750364|FG001|Overall Study|Study Terminated|0
4773146|NCT00899379|7750365|FG002|Overall Study|Study Terminated|3
4773147|NCT00899379|7750366|FG003|Overall Study|Study Terminated|3
4773148|NCT00899379|7750367|FG004|Overall Study|Study Terminated|1
4773149|NCT00899379|7750363|FG000|Overall Study|Lost to Follow-up|3
4773150|NCT00899379|7750364|FG001|Overall Study|Lost to Follow-up|1
4773151|NCT00899379|7750365|FG002|Overall Study|Lost to Follow-up|0
4773152|NCT00899379|7750366|FG003|Overall Study|Lost to Follow-up|2
4773153|NCT00899379|7750367|FG004|Overall Study|Lost to Follow-up|5
4773154|NCT00899379|7750363|FG000|Overall Study|Withdrawal by Subject|4
4773155|NCT00899379|7750364|FG001|Overall Study|Withdrawal by Subject|7
4773156|NCT00899379|7750365|FG002|Overall Study|Withdrawal by Subject|4
4773157|NCT00899379|7750366|FG003|Overall Study|Withdrawal by Subject|7
4773158|NCT00899379|7750367|FG004|Overall Study|Withdrawal by Subject|2
4630989|NCT01888874|7500008|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
4630990|NCT01888874|7500009|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
4630991|NCT01888874|7500010|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1
4630992|NCT01888874|7500011|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
4630993|NCT01888874|7500012|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
4630994|NCT01888874|7500006|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
4633381|NCT01911442|7503531|FG001|Overall Study|Withdrawal by Subject|0
4773159|NCT00899379|7750363|FG000|Overall Study|Pregnancy|1
4773160|NCT00899379|7750364|FG001|Overall Study|Pregnancy|0
4773161|NCT00899379|7750365|FG002|Overall Study|Pregnancy|0
4773162|NCT00899379|7750366|FG003|Overall Study|Pregnancy|0
4773163|NCT00899379|7750367|FG004|Overall Study|Pregnancy|0
4773164|NCT00899379|7750363|FG000|Overall Study|Patient Uncooperative|0
4773165|NCT00899379|7750364|FG001|Overall Study|Patient Uncooperative|0
4773166|NCT00899379|7750365|FG002|Overall Study|Patient Uncooperative|0
4773167|NCT00899379|7750366|FG003|Overall Study|Patient Uncooperative|1
4773168|NCT00899379|7750367|FG004|Overall Study|Patient Uncooperative|0
4773169|NCT00899379|7750363|FG000|Overall Study|Abnormal Prestudy Labs|0
4773170|NCT00899379|7750364|FG001|Overall Study|Abnormal Prestudy Labs|0
4773171|NCT00899379|7750365|FG002|Overall Study|Abnormal Prestudy Labs|0
4773172|NCT00899379|7750366|FG003|Overall Study|Abnormal Prestudy Labs|0
4773173|NCT00899379|7750367|FG004|Overall Study|Abnormal Prestudy Labs|2
4773174|NCT00899379|7750363|FG000|Overall Study|Abnormal Baseline ECG|0
4773175|NCT00899379|7750364|FG001|Overall Study|Abnormal Baseline ECG|0
4773176|NCT00899379|7750365|FG002|Overall Study|Abnormal Baseline ECG|1
4773177|NCT00899379|7750366|FG003|Overall Study|Abnormal Baseline ECG|1
4773178|NCT00899379|7750367|FG004|Overall Study|Abnormal Baseline ECG|0
4773179|NCT00899379|7750363|FG000|Overall Study|No Attack Pretreatment|3
4773180|NCT00899379|7750364|FG001|Overall Study|No Attack Pretreatment|5
4773181|NCT00899379|7750365|FG002|Overall Study|No Attack Pretreatment|5
4773182|NCT00899379|7750366|FG003|Overall Study|No Attack Pretreatment|6
4773183|NCT00899379|7750367|FG004|Overall Study|No Attack Pretreatment|4
4773184|NCT00899379|7750363|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1
4773185|NCT00899379|7750364|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0
4773186|NCT00899379|7750365|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0
4773187|NCT00899379|7750366|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0
4773188|NCT00899379|7750367|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0
4773189|NCT00899379|7750363|FG000|Overall Study|Inc/Exc Criteria Not Met|0
4773190|NCT00899379|7750364|FG001|Overall Study|Inc/Exc Criteria Not Met|0
4773191|NCT00899379|7750365|FG002|Overall Study|Inc/Exc Criteria Not Met|1
4773192|NCT00899379|7750366|FG003|Overall Study|Inc/Exc Criteria Not Met|0
4773193|NCT00899379|7750367|FG004|Overall Study|Inc/Exc Criteria Not Met|0
4773194|NCT00898677|7750377|FG000|Overall Study|Adverse Event|0
4773195|NCT00898677|7750378|FG001|Overall Study|Adverse Event|0
4773196|NCT00898677|7750379|FG002|Overall Study|Adverse Event|1
4773197|NCT00898677|7750380|FG003|Overall Study|Adverse Event|0
4773198|NCT00898677|7750377|FG000|Overall Study|Lost to Follow-up|0
4773199|NCT00898677|7750378|FG001|Overall Study|Lost to Follow-up|0
4773200|NCT00898677|7750379|FG002|Overall Study|Lost to Follow-up|2
4773201|NCT00898677|7750380|FG003|Overall Study|Lost to Follow-up|0
4773202|NCT00898677|7750377|FG000|Overall Study|Protocol Violation|1
4773203|NCT00898677|7750378|FG001|Overall Study|Protocol Violation|1
4773204|NCT00898677|7750379|FG002|Overall Study|Protocol Violation|2
4773205|NCT00898677|7750380|FG003|Overall Study|Protocol Violation|0
4773206|NCT00898677|7750377|FG000|Overall Study|Withdrawal by Subject|0
4773207|NCT00898677|7750378|FG001|Overall Study|Withdrawal by Subject|0
4773208|NCT00898677|7750379|FG002|Overall Study|Withdrawal by Subject|0
4773209|NCT00898677|7750380|FG003|Overall Study|Withdrawal by Subject|1
4773210|NCT00898677|7750377|FG000|Overall Study|Not Treated: Adverse Event|0
4773211|NCT00898677|7750378|FG001|Overall Study|Not Treated: Adverse Event|2
4773212|NCT00898677|7750379|FG002|Overall Study|Not Treated: Adverse Event|1
4773213|NCT00898677|7750380|FG003|Overall Study|Not Treated: Adverse Event|0
4773214|NCT00898677|7750377|FG000|Overall Study|Not Treated: Lost to Follow-Up|0
4773215|NCT00898677|7750378|FG001|Overall Study|Not Treated: Lost to Follow-Up|5
4773216|NCT00898677|7750379|FG002|Overall Study|Not Treated: Lost to Follow-Up|5
4773217|NCT00898677|7750380|FG003|Overall Study|Not Treated: Lost to Follow-Up|2
4773218|NCT00898677|7750377|FG000|Overall Study|Not Treated: Pregnancy|0
4773219|NCT00898677|7750378|FG001|Overall Study|Not Treated: Pregnancy|0
4773220|NCT00898677|7750379|FG002|Overall Study|Not Treated: Pregnancy|1
4773221|NCT00898677|7750380|FG003|Overall Study|Not Treated: Pregnancy|0
4773222|NCT00898677|7750377|FG000|Overall Study|Not Treated: Protocol Violation|2
4773223|NCT00898677|7750378|FG001|Overall Study|Not Treated: Protocol Violation|0
4773224|NCT00898677|7750379|FG002|Overall Study|Not Treated: Protocol Violation|2
4773225|NCT00898677|7750380|FG003|Overall Study|Not Treated: Protocol Violation|0
4731048|NCT03358472|7673413|FG001|Overall Study|Withdrawal by Subject|0
4731049|NCT03358472|7673414|FG002|Overall Study|Withdrawal by Subject|1
4731050|NCT03358472|7673412|FG000|Overall Study|On-going at clinical cut off date|9
4731051|NCT03358472|7673413|FG001|Overall Study|On-going at clinical cut off date|6
4731052|NCT03358472|7673414|FG002|Overall Study|On-going at clinical cut off date|5
4731053|NCT03359395|7673433|FG000|First Intervention A / B|Withdrawal by Subject|1
4731054|NCT03359395|7673434|FG001|First Intervention A / B|Withdrawal by Subject|0
4773226|NCT00898677|7750377|FG000|Overall Study|Not Treated: Withdraw by Subject|2
4773227|NCT00898677|7750378|FG001|Overall Study|Not Treated: Withdraw by Subject|16
4773228|NCT00898677|7750379|FG002|Overall Study|Not Treated: Withdraw by Subject|11
4773229|NCT00898677|7750380|FG003|Overall Study|Not Treated: Withdraw by Subject|3
4773230|NCT00898677|7750377|FG000|Overall Study|Not Treated: Patient uncooperative|2
4773231|NCT00898677|7750378|FG001|Overall Study|Not Treated: Patient uncooperative|3
4773232|NCT00898677|7750379|FG002|Overall Study|Not Treated: Patient uncooperative|1
4773233|NCT00898677|7750380|FG003|Overall Study|Not Treated: Patient uncooperative|0
4773234|NCT00898677|7750377|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0
4773235|NCT00898677|7750378|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0
4773236|NCT00898677|7750379|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0
4773237|NCT00898677|7750380|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1
4773238|NCT00898677|7750377|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1
4773239|NCT00898677|7750378|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0
4773240|NCT00898677|7750379|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0
4773241|NCT00898677|7750380|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0
4773242|NCT00898677|7750377|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0
4773243|NCT00898677|7750378|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3
4773244|NCT00898677|7750379|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1
4773245|NCT00898677|7750380|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0
4773246|NCT00898677|7750377|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9
4773247|NCT00898677|7750378|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39
4773248|NCT00898677|7750379|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43
4773249|NCT00898677|7750380|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12
4773250|NCT00898677|7750377|FG000|Overall Study|Not Treated: Other (Not Specified)|0
4773251|NCT00898677|7750378|FG001|Overall Study|Not Treated: Other (Not Specified)|0
4773252|NCT00898677|7750379|FG002|Overall Study|Not Treated: Other (Not Specified)|2
4773253|NCT00898677|7750380|FG003|Overall Study|Not Treated: Other (Not Specified)|0
4773254|NCT00897949|7750393|FG000|Overall Study|Adverse Event|1
4773255|NCT00897949|7750394|FG001|Overall Study|Adverse Event|1
4731055|NCT03359395|7673433|FG000|First Intervention A / B|Lost to Follow-up|2
4773256|NCT00897949|7750395|FG002|Overall Study|Adverse Event|0
4773257|NCT00897949|7750393|FG000|Overall Study|Lost to Follow-up|0
4773258|NCT00897949|7750394|FG001|Overall Study|Lost to Follow-up|2
4773259|NCT00897949|7750395|FG002|Overall Study|Lost to Follow-up|1
4773260|NCT00897949|7750393|FG000|Overall Study|Protocol Violation|6
4773261|NCT00897949|7750394|FG001|Overall Study|Protocol Violation|3
4773262|NCT00897949|7750395|FG002|Overall Study|Protocol Violation|1
4773263|NCT00897949|7750393|FG000|Overall Study|Withdrawal by Subject|1
4773264|NCT00897949|7750394|FG001|Overall Study|Withdrawal by Subject|2
4773265|NCT00897949|7750395|FG002|Overall Study|Withdrawal by Subject|0
4773266|NCT00897949|7750393|FG000|Overall Study|Patient Uncoorperative|0
4773267|NCT00897949|7750394|FG001|Overall Study|Patient Uncoorperative|2
4773268|NCT00897949|7750395|FG002|Overall Study|Patient Uncoorperative|1
4773269|NCT00897949|7750393|FG000|Overall Study|Lost to Follow-up|30
4773270|NCT00897949|7750394|FG001|Overall Study|Lost to Follow-up|23
4773271|NCT00897949|7750395|FG002|Overall Study|Lost to Follow-up|17
4773272|NCT00897949|7750393|FG000|Overall Study|Withdrawal by Subject|24
4773273|NCT00897949|7750394|FG001|Overall Study|Withdrawal by Subject|31
4773274|NCT00897949|7750395|FG002|Overall Study|Withdrawal by Subject|17
4773275|NCT00897949|7750393|FG000|Overall Study|Abnormal Prestudy Labs|2
4773276|NCT00897949|7750394|FG001|Overall Study|Abnormal Prestudy Labs|3
4773277|NCT00897949|7750395|FG002|Overall Study|Abnormal Prestudy Labs|4
4773278|NCT00897949|7750393|FG000|Overall Study|Abnormal Baseline ECG|2
4773279|NCT00897949|7750394|FG001|Overall Study|Abnormal Baseline ECG|2
4773280|NCT00897949|7750395|FG002|Overall Study|Abnormal Baseline ECG|4
4773281|NCT00897949|7750393|FG000|Overall Study|Need for Concom. Med.|0
4773282|NCT00897949|7750394|FG001|Overall Study|Need for Concom. Med.|1
4773283|NCT00897949|7750395|FG002|Overall Study|Need for Concom. Med.|1
4773284|NCT00897949|7750393|FG000|Overall Study|Lack of Migraine Attack|29
4773285|NCT00897949|7750394|FG001|Overall Study|Lack of Migraine Attack|30
4773286|NCT00897949|7750395|FG002|Overall Study|Lack of Migraine Attack|19
4773287|NCT00897949|7750393|FG000|Overall Study|Did not take study drug|9
4773288|NCT00897949|7750394|FG001|Overall Study|Did not take study drug|3
4773289|NCT00897949|7750395|FG002|Overall Study|Did not take study drug|4
4773290|NCT00897104|7750412|FG000|Overall Study|Lost to Follow-up|12
4773291|NCT00897104|7750413|FG001|Overall Study|Lost to Follow-up|17
4773292|NCT00897104|7750414|FG002|Overall Study|Lost to Follow-up|2
4773293|NCT00897104|7750412|FG000|Overall Study|Pregnancy|0
4773294|NCT00897104|7750413|FG001|Overall Study|Pregnancy|1
4773295|NCT00897104|7750414|FG002|Overall Study|Pregnancy|0
4773296|NCT00897104|7750412|FG000|Overall Study|Protocol Violation|0
4773297|NCT00897104|7750413|FG001|Overall Study|Protocol Violation|1
4773298|NCT00897104|7750414|FG002|Overall Study|Protocol Violation|0
4773299|NCT00897104|7750412|FG000|Overall Study|Withdrawal by Subject|23
4773300|NCT00897104|7750413|FG001|Overall Study|Withdrawal by Subject|27
4773301|NCT00897104|7750414|FG002|Overall Study|Withdrawal by Subject|3
4773302|NCT00897104|7750412|FG000|Overall Study|Abnormal Prestudy Labs|2
4773303|NCT00897104|7750413|FG001|Overall Study|Abnormal Prestudy Labs|0
4773304|NCT00897104|7750414|FG002|Overall Study|Abnormal Prestudy Labs|0
4773305|NCT00897104|7750412|FG000|Overall Study|Abnormal Baseline ECG|2
4773306|NCT00897104|7750413|FG001|Overall Study|Abnormal Baseline ECG|2
4773307|NCT00897104|7750414|FG002|Overall Study|Abnormal Baseline ECG|0
4773308|NCT00897104|7750412|FG000|Overall Study|Need for Concom. Med.|0
4773309|NCT00897104|7750413|FG001|Overall Study|Need for Concom. Med.|1
4773310|NCT00897104|7750414|FG002|Overall Study|Need for Concom. Med.|1
4773311|NCT00897104|7750412|FG000|Overall Study|Lack of Migraine Attack|20
4773312|NCT00897104|7750413|FG001|Overall Study|Lack of Migraine Attack|22
4773313|NCT00897104|7750414|FG002|Overall Study|Lack of Migraine Attack|1
4773314|NCT00897104|7750412|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1
4773315|NCT00897104|7750413|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0
4773316|NCT00897104|7750414|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0
4773317|NCT00897104|7750412|FG000|Overall Study|Other|3
4773318|NCT00897104|7750413|FG001|Overall Study|Other|0
4773319|NCT00897104|7750414|FG002|Overall Study|Other|0
4773320|NCT00897104|7750412|FG000|Overall Study|Protocol Violation|1
4773321|NCT00897104|7750413|FG001|Overall Study|Protocol Violation|0
4773322|NCT00897104|7750414|FG002|Overall Study|Protocol Violation|0
4773323|NCT00897104|7750412|FG000|Overall Study|Withdrawal by Subject|0
4773324|NCT00897104|7750413|FG001|Overall Study|Withdrawal by Subject|0
4773325|NCT00897104|7750414|FG002|Overall Study|Withdrawal by Subject|1
4773326|NCT00803790|7750424|FG000|Period 1|Adverse Event|0
4773327|NCT00803790|7750425|FG001|Period 1|Adverse Event|1
4773328|NCT00803790|7750426|FG002|Period 1|Adverse Event|0
4773329|NCT00803790|7750427|FG003|Period 1|Adverse Event|0
4773330|NCT00803790|7750424|FG000|Period 1|Lost to Follow-up|1
4773331|NCT00803790|7750425|FG001|Period 1|Lost to Follow-up|2
4773332|NCT00803790|7750426|FG002|Period 1|Lost to Follow-up|0
4773333|NCT00803790|7750427|FG003|Period 1|Lost to Follow-up|0
4773334|NCT00803790|7750424|FG000|Period 1|Withdrawal by Subject|8
4773335|NCT00803790|7750425|FG001|Period 1|Withdrawal by Subject|6
4773336|NCT00803790|7750426|FG002|Period 1|Withdrawal by Subject|0
4773337|NCT00803790|7750427|FG003|Period 1|Withdrawal by Subject|0
4773338|NCT00803790|7750424|FG000|Period 1|positive drug screen or personal reasons|0
4773339|NCT00803790|7750425|FG001|Period 1|positive drug screen or personal reasons|3
4773340|NCT00803790|7750426|FG002|Period 1|positive drug screen or personal reasons|0
4773341|NCT00803790|7750427|FG003|Period 1|positive drug screen or personal reasons|4
4773342|NCT00803790|7750424|FG000|Period 1|Protocol Violation|0
4773343|NCT00803790|7750425|FG001|Period 1|Protocol Violation|0
4773344|NCT00803790|7750426|FG002|Period 1|Protocol Violation|1
4773345|NCT00803790|7750427|FG003|Period 1|Protocol Violation|0
4773346|NCT00803790|7750424|FG000|Period 2|Adverse Event|0
4773347|NCT00803790|7750425|FG001|Period 2|Adverse Event|0
4773348|NCT00803790|7750426|FG002|Period 2|Adverse Event|1
4773349|NCT00803790|7750427|FG003|Period 2|Adverse Event|1
4773350|NCT00803790|7750424|FG000|Period 2|Withdrawal by Subject|1
4773351|NCT00803790|7750425|FG001|Period 2|Withdrawal by Subject|0
4773352|NCT00803790|7750426|FG002|Period 2|Withdrawal by Subject|0
4773353|NCT00803790|7750427|FG003|Period 2|Withdrawal by Subject|0
4773354|NCT00803790|7750424|FG000|Period 2|Positive Drug Screen or Personal Reasons|1
4773355|NCT00803790|7750425|FG001|Period 2|Positive Drug Screen or Personal Reasons|0
4773356|NCT00803790|7750426|FG002|Period 2|Positive Drug Screen or Personal Reasons|0
4773357|NCT00803790|7750427|FG003|Period 2|Positive Drug Screen or Personal Reasons|0
4773358|NCT00725491|7750440|FG000|Overall Study|Adverse Event|3
4773359|NCT00725491|7750441|FG001|Overall Study|Adverse Event|2
4773360|NCT00725491|7750440|FG000|Overall Study|Pregnancy|0
4773361|NCT00725491|7750441|FG001|Overall Study|Pregnancy|3
4773362|NCT00725491|7750440|FG000|Overall Study|Risk for hyperstimulation|2
4773363|NCT00725491|7750441|FG001|Overall Study|Risk for hyperstimulation|9
4773364|NCT00725491|7750440|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1
4773365|NCT00725491|7750441|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1
4773366|NCT00725491|7750440|FG000|Overall Study|Fertilization failure|0
4446627|NCT00485264|7231701|FG003|Overall Study|Adverse Event|3
4446628|NCT00485264|7231702|FG004|Overall Study|Adverse Event|1
4446629|NCT00485264|7231703|FG005|Overall Study|Adverse Event|3
4446630|NCT00485264|7231698|FG000|Overall Study|Pregnancy|4
4773367|NCT00725491|7750441|FG001|Overall Study|Fertilization failure|1
4773368|NCT00725491|7750440|FG000|Overall Study|No/too few embryos/ bad quality embryos|3
4773369|NCT00725491|7750441|FG001|Overall Study|No/too few embryos/ bad quality embryos|2
4773370|NCT00703014|7750449|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33
4773371|NCT00703014|7750450|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32
4773372|NCT00703014|7750451|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0
4773373|NCT00703014|7750452|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0
4773374|NCT00703014|7750449|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0
4773375|NCT00703014|7750450|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0
4773376|NCT00703014|7750451|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47
4773377|NCT00703014|7750452|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42
4773378|NCT00702845|7750464|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2
4773379|NCT00702845|7750465|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2
4773380|NCT00702845|7750464|FG000|Overall Study|Too high ovarian response|5
4773381|NCT00702845|7750465|FG001|Overall Study|Too high ovarian response|1
4773382|NCT00702845|7750464|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1
4773383|NCT00702845|7750465|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0
4773384|NCT00702845|7750464|FG000|Overall Study|Insufficient ovarian response|1
4773385|NCT00702845|7750465|FG001|Overall Study|Insufficient ovarian response|0
4773386|NCT00702845|7750464|FG000|Overall Study|No/too few/bad quality embryos retrieved|7
4773387|NCT00702845|7750465|FG001|Overall Study|No/too few/bad quality embryos retrieved|1
4773388|NCT00702845|7750464|FG000|Overall Study|No or abnormal fertilization|4
4773389|NCT00702845|7750465|FG001|Overall Study|No or abnormal fertilization|2
4773390|NCT00702845|7750464|FG000|Overall Study|Patient's decision|2
4773391|NCT00702845|7750465|FG001|Overall Study|Patient's decision|1
4773392|NCT00702845|7750464|FG000|Overall Study|Not randomized|0
4773393|NCT00702845|7750465|FG001|Overall Study|Not randomized|1
4773394|NCT00702520|7750500|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
4773395|NCT00702520|7750501|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1
4773396|NCT00702520|7750502|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
4773397|NCT00702520|7750503|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
4773398|NCT00702520|7750500|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3
4773399|NCT00702520|7750501|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6
4773400|NCT00702520|7750502|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0
4773401|NCT00702520|7750503|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0
4773402|NCT00702520|7750500|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15
4773403|NCT00702520|7750501|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10
4773404|NCT00702520|7750502|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0
4773405|NCT00702520|7750503|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0
4773406|NCT00697255|7750542|FG000|Stage 1a|Insufficient ovarian response|1
4773407|NCT00697255|7750543|FG001|Stage 1a|Insufficient ovarian response|0
4773408|NCT00697255|7750542|FG000|Stage 1a|Multifollicular growth|1
4773409|NCT00697255|7750543|FG001|Stage 1a|Multifollicular growth|0
4773410|NCT00697255|7750542|FG000|Stage 1a|Not growing of dominant follicle|1
4773411|NCT00697255|7750543|FG001|Stage 1a|Not growing of dominant follicle|0
4773412|NCT00697255|7750542|FG000|Stage 1b|Not growing of dominant follicle|0
4446631|NCT00485264|7231699|FG001|Overall Study|Pregnancy|0
4773413|NCT00697255|7750543|FG001|Stage 1b|Not growing of dominant follicle|1
4773414|NCT00697255|7750542|FG000|Stage 1b|Insufficient ovarian response|0
4773415|NCT00697255|7750543|FG001|Stage 1b|Insufficient ovarian response|1
4773416|NCT00696878|7750549|FG000|Overall Study|Adverse Event|8
4773417|NCT00696878|7750549|FG000|Overall Study|Withdrawal by Subject|87
4773418|NCT00696878|7750549|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18
4773419|NCT00696878|7750549|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304
4773420|NCT00696878|7750549|FG000|Overall Study|Trial stopped|32
4773421|NCT00696878|7750549|FG000|Overall Study|Other reason (not specified)|55
4773422|NCT00696800|7750555|FG000|Overall Study|Adverse Event|16
4773423|NCT00696800|7750556|FG001|Overall Study|Adverse Event|3
4773424|NCT00696800|7750555|FG000|Overall Study|Insufficient compliance with medication|2
4773425|NCT00696800|7750556|FG001|Overall Study|Insufficient compliance with medication|1
4773426|NCT00696800|7750555|FG000|Overall Study|Insufficient ovarian response on Day 8|4
4773427|NCT00696800|7750556|FG001|Overall Study|Insufficient ovarian response on Day 8|1
4773428|NCT00696800|7750555|FG000|Overall Study|Insufficient ovarian response|4
4773429|NCT00696800|7750556|FG001|Overall Study|Insufficient ovarian response|1
4773430|NCT00696800|7750555|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8
4773431|NCT00696800|7750556|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2
4773432|NCT00696800|7750555|FG000|Overall Study|Too high ovarian response|6
4773433|NCT00696800|7750556|FG001|Overall Study|Too high ovarian response|1
4773434|NCT00696800|7750555|FG000|Overall Study|No/too few/bad quality oocytes|4
4773435|NCT00696800|7750556|FG001|Overall Study|No/too few/bad quality oocytes|3
4773436|NCT00696800|7750555|FG000|Overall Study|No/abnormal fertilization|11
4773437|NCT00696800|7750556|FG001|Overall Study|No/abnormal fertilization|13
4773438|NCT00696800|7750555|FG000|Overall Study|No/too few/bad quality embryos|24
4773439|NCT00696800|7750556|FG001|Overall Study|No/too few/bad quality embryos|18
4773440|NCT00696800|7750555|FG000|Overall Study|Other Reasons|5
4773441|NCT00696800|7750556|FG001|Overall Study|Other Reasons|3
4773442|NCT00696800|7750555|FG000|Overall Study|Not treated|1
4773443|NCT00696800|7750556|FG001|Overall Study|Not treated|2
4773444|NCT00616967|7750564|FG000|Overall Study|Withdrawal by Subject|0
4773445|NCT00616967|7750565|FG001|Overall Study|Withdrawal by Subject|0
4773446|NCT00616967|7750566|FG002|Overall Study|Withdrawal by Subject|1
4773447|NCT00461032|7750586|FG000|Overall Study|Adverse Event|5
4773448|NCT00461032|7750587|FG001|Overall Study|Adverse Event|6
4773449|NCT00461032|7750586|FG000|Overall Study|Lack of Efficacy|5
4773450|NCT00461032|7750587|FG001|Overall Study|Lack of Efficacy|1
4773451|NCT00461032|7750586|FG000|Overall Study|Lost to Follow-up|7
4773452|NCT00461032|7750587|FG001|Overall Study|Lost to Follow-up|12
4773453|NCT00461032|7750586|FG000|Overall Study|Protocol Violation|4
4773454|NCT00461032|7750587|FG001|Overall Study|Protocol Violation|4
4773455|NCT00461032|7750586|FG000|Overall Study|Withdrawal by Subject|7
4773456|NCT00461032|7750587|FG001|Overall Study|Withdrawal by Subject|15
4773457|NCT00461032|7750586|FG000|Overall Study|Patient Moved or Relocated|2
4773458|NCT00461032|7750587|FG001|Overall Study|Patient Moved or Relocated|1
4773459|NCT00461032|7750586|FG000|Overall Study|Other|7
4773460|NCT00461032|7750587|FG001|Overall Study|Other|5
4773461|NCT00289874|7750608|FG000|Overall Study|Adverse Event|1
4773462|NCT00289874|7750609|FG001|Overall Study|Adverse Event|5
4773463|NCT00289874|7750608|FG000|Overall Study|Lost to Follow-up|1
4773464|NCT00289874|7750609|FG001|Overall Study|Lost to Follow-up|1
4773465|NCT00289874|7750608|FG000|Overall Study|Protocol Violation|3
4773466|NCT00289874|7750609|FG001|Overall Study|Protocol Violation|2
4773467|NCT00289874|7750608|FG000|Overall Study|Did not meet eligibility|1
4773468|NCT00289874|7750609|FG001|Overall Study|Did not meet eligibility|0
4773469|NCT00250458|7750617|FG000|Overall Study|Lost to Follow-up|4
4773470|NCT00250458|7750618|FG001|Overall Study|Lost to Follow-up|2
4773471|NCT00250458|7750617|FG000|Overall Study|Protocol Violation|0
4773472|NCT00250458|7750618|FG001|Overall Study|Protocol Violation|1
4773473|NCT00250458|7750617|FG000|Overall Study|Withdrawal by Subject|4
4773474|NCT00250458|7750618|FG001|Overall Study|Withdrawal by Subject|2
4773475|NCT00250458|7750617|FG000|Overall Study|Lack of Migraine Attack|20
4773476|NCT00250458|7750618|FG001|Overall Study|Lack of Migraine Attack|9
4773477|NCT00250458|7750617|FG000|Overall Study|Qualifying migraine but did not treat|3
4773478|NCT00250458|7750618|FG001|Overall Study|Qualifying migraine but did not treat|3
4773479|NCT00250458|7750617|FG000|Overall Study|Other|1
4773480|NCT00250458|7750618|FG001|Overall Study|Other|0
4773481|NCT00245570|7750624|FG000|Washout Between Periods III and IV|Adverse Event|0
4773482|NCT00245570|7750625|FG001|Washout Between Periods III and IV|Adverse Event|1
4773483|NCT00245570|7750626|FG002|Washout Between Periods III and IV|Adverse Event|0
4773484|NCT00245570|7750627|FG003|Washout Between Periods III and IV|Adverse Event|0
4773485|NCT00245570|7750628|FG004|Washout Between Periods III and IV|Adverse Event|0
4773486|NCT00245570|7750629|FG005|Washout Between Periods III and IV|Adverse Event|0
4773487|NCT00092131|7750653|FG000|Treatment Period I|Adverse Event|1
4773488|NCT00092131|7750654|FG001|Treatment Period I|Adverse Event|0
4773489|NCT00092131|7750653|FG000|Treatment Period II|Adverse Event|0
4773490|NCT00092131|7750654|FG001|Treatment Period II|Adverse Event|1
4773491|NCT00092118|7750662|FG000|Overall Study|Adverse Event|35
4773492|NCT00092118|7750663|FG001|Overall Study|Adverse Event|32
4773493|NCT00092118|7750662|FG000|Overall Study|Lack of Efficacy|12
4773494|NCT00092118|7750663|FG001|Overall Study|Lack of Efficacy|14
4773495|NCT00092118|7750662|FG000|Overall Study|Lost to Follow-up|4
4773496|NCT00092118|7750663|FG001|Overall Study|Lost to Follow-up|3
4773497|NCT00092118|7750662|FG000|Overall Study|Protocol Violation|23
4773498|NCT00092118|7750663|FG001|Overall Study|Protocol Violation|25
4773499|NCT00092118|7750662|FG000|Overall Study|Withdrawal by Subject|4
4773500|NCT00092118|7750663|FG001|Overall Study|Withdrawal by Subject|10
4773501|NCT00092118|7750662|FG000|Overall Study|Other|6
4773502|NCT00092118|7750663|FG001|Overall Study|Other|5
4773503|NCT00090142|7750669|FG000|Treatment Period I|Lost to Follow-up|1
4773504|NCT00090142|7750670|FG001|Treatment Period I|Lost to Follow-up|2
4773505|NCT00090142|7750669|FG000|Treatment Period I|Protocol Violation|2
4773506|NCT00090142|7750670|FG001|Treatment Period I|Protocol Violation|0
4773507|NCT00090142|7750669|FG000|Treatment Period I|Withdrawal by Subject|2
4773508|NCT00090142|7750670|FG001|Treatment Period I|Withdrawal by Subject|0
4773509|NCT00090142|7750669|FG000|Treatment Period I|Other|0
4773510|NCT00090142|7750670|FG001|Treatment Period I|Other|1
4773511|NCT00090142|7750669|FG000|Treatment Period II|Other|1
4773512|NCT00090142|7750670|FG001|Treatment Period II|Other|0
4773513|NCT04771013|7750682|FG000|Overall Study|Withdrawal by Subject|2
4773514|NCT04771013|7750683|FG001|Overall Study|Withdrawal by Subject|0
4773515|NCT04771013|7750682|FG000|Overall Study|Death|0
4630995|NCT01888874|7500007|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1
4630996|NCT01888874|7500008|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
4630997|NCT01888874|7500009|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
4630998|NCT01888874|7500010|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
4630999|NCT01888874|7500011|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
4631000|NCT01888874|7500012|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0
4631001|NCT01888874|7500006|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0
4631002|NCT01888874|7500007|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1
4631003|NCT01888874|7500008|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0
4631004|NCT01888874|7500009|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0
4631005|NCT01888874|7500010|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0
4631006|NCT01888874|7500011|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1
4631007|NCT01888874|7500012|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0
4631008|NCT01888874|7500006|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1
4631009|NCT01888874|7500007|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1
4631010|NCT01888874|7500008|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2
4631011|NCT01888874|7500009|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
4631012|NCT01888874|7500010|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1
4631013|NCT01888874|7500011|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
4773516|NCT04771013|7750683|FG001|Overall Study|Death|5
4773517|NCT04771013|7750682|FG000|Overall Study|Referred to another hospital before day 20|0
4773518|NCT04771013|7750683|FG001|Overall Study|Referred to another hospital before day 20|1
4773519|NCT04497987|7750691|FG000|Overall Study|Adverse Event|1
4773520|NCT04497987|7750692|FG001|Overall Study|Adverse Event|0
4773521|NCT04497987|7750691|FG000|Overall Study|Death|21
4773522|NCT04497987|7750692|FG001|Overall Study|Death|13
4773523|NCT04497987|7750691|FG000|Overall Study|Lost to Follow-up|19
4773524|NCT04497987|7750692|FG001|Overall Study|Lost to Follow-up|17
4773525|NCT04497987|7750691|FG000|Overall Study|Other - as reported by the investigator|22
4773526|NCT04497987|7750692|FG001|Overall Study|Other - as reported by the investigator|16
4773527|NCT04497987|7750691|FG000|Overall Study|Physician Decision|1
4773528|NCT04497987|7750692|FG001|Overall Study|Physician Decision|0
4773529|NCT04497987|7750691|FG000|Overall Study|Withdrawal by Subject|35
4773530|NCT04497987|7750692|FG001|Overall Study|Withdrawal by Subject|21
4773531|NCT03512210|7750748|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3
4773532|NCT03512210|7750748|FG000|Step 1: MINMON Intervention|Protocol Violation|1
4773533|NCT03512210|7750748|FG000|Step 2:Post-MINMON|Death|2
4773534|NCT03512210|7750748|FG000|Step 2:Post-MINMON|Lost to Follow-up|30
4773535|NCT03512210|7750748|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2
4773536|NCT03493854|7750763|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3
4773537|NCT03493854|7750764|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5
4773538|NCT03493854|7750763|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1
4773539|NCT03493854|7750764|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1
4773540|NCT03493854|7750763|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0
4773541|NCT03493854|7750764|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1
4773542|NCT03493854|7750763|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1
4773543|NCT03493854|7750764|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2
4773544|NCT03493854|7750763|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3
4773545|NCT03493854|7750764|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3
4773546|NCT03493854|7750763|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1
4773547|NCT03493854|7750764|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2
4773548|NCT03493854|7750763|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1
4773549|NCT03493854|7750764|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0
4773550|NCT03493854|7750763|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Ongoing Adjuvant Treatment|229
4773551|NCT03493854|7750764|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Ongoing Adjuvant Treatment|228
4773552|NCT03493854|7750763|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|2
4773553|NCT03493854|7750764|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|2
4773554|NCT03493854|7750763|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0
4773555|NCT03493854|7750764|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|1
4773556|NCT03493854|7750763|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|3
4773557|NCT03493854|7750764|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0
4773558|NCT03493854|7750763|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Protocol Violation|1
4773559|NCT03493854|7750764|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Protocol Violation|0
4773560|NCT03493854|7750763|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2
4773561|NCT03493854|7750764|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|0
4773562|NCT03493854|7750763|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|5
4773563|NCT03493854|7750764|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|3
4773564|NCT03493854|7750763|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|1
4773565|NCT03493854|7750764|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|1
4773566|NCT03493854|7750763|FG000|Treatment-Free Follow-Up (up to 3 Years)|Ongoing in Follow-Up|18
4773567|NCT03493854|7750764|FG001|Treatment-Free Follow-Up (up to 3 Years)|Ongoing in Follow-Up|16
4773568|NCT03180307|7750798|FG000|Overall Study|Lost to Follow-up|2
4773569|NCT03180307|7750799|FG001|Overall Study|Lost to Follow-up|0
4773570|NCT03180307|7750798|FG000|Overall Study|Death|1
4773571|NCT03180307|7750799|FG001|Overall Study|Death|0
4773572|NCT03180307|7750798|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3
4773573|NCT03180307|7750799|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0
4515332|NCT00952523|7326107|FG000|Overall Study|Withdrawal by Subject|7
4515333|NCT00952588|7326115|FG000|Overall Study|Death|28
4515334|NCT00952588|7326116|FG001|Overall Study|Death|13
4515335|NCT00952588|7326115|FG000|Overall Study|Withdrawal by Subject|2
4515336|NCT00952588|7326116|FG001|Overall Study|Withdrawal by Subject|5
4515337|NCT00952588|7326115|FG000|Overall Study|Adverse Event|2
4515338|NCT00952588|7326116|FG001|Overall Study|Adverse Event|3
4515339|NCT00952588|7326115|FG000|Overall Study|Lost to Follow-up|2
4515340|NCT00952588|7326116|FG001|Overall Study|Lost to Follow-up|0
4515341|NCT00952588|7326115|FG000|Overall Study|Physician Decision|0
4515342|NCT00952588|7326116|FG001|Overall Study|Physician Decision|1
4515343|NCT00952588|7326115|FG000|Overall Study|Lack of Efficacy|2
4515344|NCT00952588|7326116|FG001|Overall Study|Lack of Efficacy|2
4515345|NCT00952614|7326122|FG000|Overall Study|Death|3
4773574|NCT02668822|7750818|FG000|Overall Study|Protocol Violation|2
4773575|NCT02668822|7750819|FG001|Overall Study|Protocol Violation|0
4773576|NCT02668822|7750818|FG000|Overall Study|Study Terminated by Sponsor|7
4773577|NCT02668822|7750819|FG001|Overall Study|Study Terminated by Sponsor|9
4773578|NCT02668783|7750827|FG000|Overall Study|Pregnancy|0
4773579|NCT02668783|7750828|FG001|Overall Study|Pregnancy|1
4773580|NCT02668783|7750827|FG000|Overall Study|Protocol Violation|2
4773581|NCT02668783|7750828|FG001|Overall Study|Protocol Violation|1
4773582|NCT02668783|7750827|FG000|Overall Study|Study terminated by sponsor|9
4773583|NCT02668783|7750828|FG001|Overall Study|Study terminated by sponsor|10
4773584|NCT02668783|7750827|FG000|Overall Study|Subject moved|1
4773585|NCT02668783|7750828|FG001|Overall Study|Subject moved|0
4773586|NCT02668783|7750827|FG000|Overall Study|Withdrawal by Subject|1
4773587|NCT02668783|7750828|FG001|Overall Study|Withdrawal by Subject|0
4773588|NCT02616146|7750836|FG000|Overall Study|Adverse Event|64
4773589|NCT02616146|7750837|FG001|Overall Study|Adverse Event|24
4773590|NCT02616146|7750836|FG000|Overall Study|Lost to Follow-up|23
4773591|NCT02616146|7750837|FG001|Overall Study|Lost to Follow-up|13
4773592|NCT02616146|7750836|FG000|Overall Study|Non-compliance with study protocol|2
4773593|NCT02616146|7750837|FG001|Overall Study|Non-compliance with study protocol|0
4773594|NCT02616146|7750836|FG000|Overall Study|Non-compliance with study drug|4
4773595|NCT02616146|7750837|FG001|Overall Study|Non-compliance with study drug|2
4773596|NCT02616146|7750836|FG000|Overall Study|Pregnancy|2
4773597|NCT02616146|7750837|FG001|Overall Study|Pregnancy|2
4773598|NCT02616146|7750836|FG000|Overall Study|Pregnancy wish|3
4773599|NCT02616146|7750837|FG001|Overall Study|Pregnancy wish|0
4773600|NCT02616146|7750836|FG000|Overall Study|Protocol Violation|6
4773601|NCT02616146|7750837|FG001|Overall Study|Protocol Violation|3
4773602|NCT02616146|7750836|FG000|Overall Study|Study terminated by sponsor|1372
4773603|NCT02616146|7750837|FG001|Overall Study|Study terminated by sponsor|432
4773604|NCT02616146|7750836|FG000|Overall Study|Participant moved|4
4773605|NCT02616146|7750837|FG001|Overall Study|Participant moved|3
4773606|NCT02616146|7750836|FG000|Overall Study|Withdrawal by Subject|30
4773607|NCT02616146|7750837|FG001|Overall Study|Withdrawal by Subject|24
4773608|NCT02616146|7750836|FG000|Overall Study|Physician Decision|2
4773609|NCT02616146|7750837|FG001|Overall Study|Physician Decision|1
4773610|NCT02524288|7750856|FG000|Overall Study|Adverse Event|115
4773611|NCT02524288|7750856|FG000|Overall Study|Lost to Follow-up|216
4773612|NCT02524288|7750856|FG000|Overall Study|Non-Compliance With Protocol|32
4773613|NCT02524288|7750856|FG000|Overall Study|Non-Compliance With Study Drug|14
4773614|NCT02524288|7750856|FG000|Overall Study|Pregnancy Wish|6
4773615|NCT02524288|7750856|FG000|Overall Study|Protocol Violation|6
4773616|NCT02524288|7750856|FG000|Overall Study|Screen Failure|2
4773617|NCT02524288|7750856|FG000|Overall Study|Site Discontinued Study Participation|1
4773618|NCT02524288|7750856|FG000|Overall Study|Study Terminated By Sponsor|1417
4773619|NCT02524288|7750856|FG000|Overall Study|Subject Moved|32
4773620|NCT02524288|7750856|FG000|Overall Study|Withdrawal by Subject|76
4773621|NCT02524288|7750856|FG000|Overall Study|Pregnancy|22
4773622|NCT02524288|7750856|FG000|Overall Study|Physician Decision|2
4773623|NCT02489942|7750860|FG000|Overall Study|Request by patient|602
4773624|NCT02489942|7750860|FG000|Overall Study|Improvement/remission|157
4773625|NCT02489942|7750860|FG000|Overall Study|No change/Progressive disease|263
4773626|NCT02489942|7750860|FG000|Overall Study|Adverse Event|522
4773627|NCT02489942|7750860|FG000|Overall Study|Other personal reasons|1218
4773628|NCT02489942|7750860|FG000|Overall Study|Lost to Follow-up|456
4773629|NCT02489942|7750860|FG000|Overall Study|Not continuously investigated|7
4773630|NCT02489942|7750860|FG000|Overall Study|Patient started jardiance treatment out of registration period|1
4773631|NCT02489942|7750860|FG000|Overall Study|Multiple registration|1
4773632|NCT02489942|7750860|FG000|Overall Study|No patient visit after entry|100
4773633|NCT02489942|7750860|FG000|Overall Study|No treatment with Jardiance|2
4773634|NCT02489942|7750860|FG000|Overall Study|Patient received Jardiance before registration|1
4773635|NCT02489942|7750860|FG000|Overall Study|No CRF collected|86
4773636|NCT02409342|7750866|FG000|Overall Study|Death|181
4773637|NCT02409342|7750867|FG001|Overall Study|Death|174
4773638|NCT02409342|7750866|FG000|Overall Study|Withdrawal by Subject|24
4773639|NCT02409342|7750867|FG001|Overall Study|Withdrawal by Subject|16
4773640|NCT02409342|7750866|FG000|Overall Study|On-going in study|79
4773641|NCT02409342|7750867|FG001|Overall Study|On-going in study|92
4773642|NCT02409342|7750866|FG000|Overall Study|Lost to Follow-up|3
4773643|NCT02409342|7750867|FG001|Overall Study|Lost to Follow-up|3
4773644|NCT02275546|7750884|FG000|Treatment Period 2|Withdrawal by Subject|2
4773645|NCT02275546|7750885|FG001|Treatment Period 2|Withdrawal by Subject|1
4773646|NCT02275546|7750884|FG000|Treatment Period 2|Protocol Violation|0
4773647|NCT02275546|7750885|FG001|Treatment Period 2|Protocol Violation|1
4773648|NCT02077166|7750898|FG000|Overall Study|Death|6
4773649|NCT02077166|7750899|FG001|Overall Study|Death|7
4773650|NCT02077166|7750900|FG002|Overall Study|Death|5
4773651|NCT02077166|7750901|FG003|Overall Study|Death|6
4773652|NCT02077166|7750902|FG004|Overall Study|Death|4
4773653|NCT02077166|7750903|FG005|Overall Study|Death|32
4773654|NCT02077166|7750904|FG006|Overall Study|Death|22
4773655|NCT02077166|7750898|FG000|Overall Study|Study Closure by Sponsor|3
4773656|NCT02077166|7750899|FG001|Overall Study|Study Closure by Sponsor|0
4773657|NCT02077166|7750900|FG002|Overall Study|Study Closure by Sponsor|2
4773658|NCT02077166|7750901|FG003|Overall Study|Study Closure by Sponsor|2
4773659|NCT02077166|7750902|FG004|Overall Study|Study Closure by Sponsor|2
4773660|NCT02077166|7750903|FG005|Overall Study|Study Closure by Sponsor|12
4773661|NCT02077166|7750904|FG006|Overall Study|Study Closure by Sponsor|4
4773662|NCT02077166|7750898|FG000|Overall Study|Lost to Follow-up|0
4773663|NCT02077166|7750899|FG001|Overall Study|Lost to Follow-up|0
4773664|NCT02077166|7750900|FG002|Overall Study|Lost to Follow-up|0
4773665|NCT02077166|7750901|FG003|Overall Study|Lost to Follow-up|0
4773666|NCT02077166|7750902|FG004|Overall Study|Lost to Follow-up|0
4773667|NCT02077166|7750903|FG005|Overall Study|Lost to Follow-up|1
4773668|NCT02077166|7750904|FG006|Overall Study|Lost to Follow-up|0
4773669|NCT02077166|7750898|FG000|Overall Study|Withdrawal by Subject|3
4773670|NCT02077166|7750899|FG001|Overall Study|Withdrawal by Subject|0
4773671|NCT02077166|7750900|FG002|Overall Study|Withdrawal by Subject|1
4773672|NCT02077166|7750901|FG003|Overall Study|Withdrawal by Subject|1
4773673|NCT02077166|7750902|FG004|Overall Study|Withdrawal by Subject|1
4773674|NCT02077166|7750903|FG005|Overall Study|Withdrawal by Subject|3
4773675|NCT02077166|7750904|FG006|Overall Study|Withdrawal by Subject|0
4773676|NCT02077166|7750898|FG000|Overall Study|Other, Not Specified|0
4773677|NCT02077166|7750899|FG001|Overall Study|Other, Not Specified|0
4773678|NCT02077166|7750900|FG002|Overall Study|Other, Not Specified|1
4773679|NCT02077166|7750901|FG003|Overall Study|Other, Not Specified|0
4773680|NCT02077166|7750902|FG004|Overall Study|Other, Not Specified|1
4773681|NCT02077166|7750903|FG005|Overall Study|Other, Not Specified|7
4773682|NCT02077166|7750904|FG006|Overall Study|Other, Not Specified|8
4773683|NCT01891344|7750929|FG000|Overall Study|Ongoing|6
4773684|NCT01891344|7750930|FG001|Overall Study|Ongoing|2
4773685|NCT01891344|7750931|FG002|Overall Study|Ongoing|0
4773686|NCT01891344|7750932|FG003|Overall Study|Ongoing|1
4773687|NCT01891344|7750933|FG004|Overall Study|Ongoing|4
4773688|NCT01891344|7750934|FG005|Overall Study|Ongoing|1
4773689|NCT01891344|7750935|FG006|Overall Study|Ongoing|0
4773690|NCT01891344|7750936|FG007|Overall Study|Ongoing|0
4773691|NCT01847274|7750958|FG000|Overall Study|Adverse Event|17
4773692|NCT01847274|7750959|FG001|Overall Study|Adverse Event|1
4773693|NCT01847274|7750960|FG002|Overall Study|Adverse Event|33
4773694|NCT01847274|7750961|FG003|Overall Study|Adverse Event|2
4773695|NCT01847274|7750958|FG000|Overall Study|Withdrawal by Subject|8
4773696|NCT01847274|7750959|FG001|Overall Study|Withdrawal by Subject|8
4773697|NCT01847274|7750960|FG002|Overall Study|Withdrawal by Subject|11
4773698|NCT01847274|7750961|FG003|Overall Study|Withdrawal by Subject|1
4773699|NCT01847274|7750958|FG000|Overall Study|Disease Progression|63
4773700|NCT01847274|7750959|FG001|Overall Study|Disease Progression|49
4773701|NCT01847274|7750960|FG002|Overall Study|Disease Progression|129
4773702|NCT01847274|7750961|FG003|Overall Study|Disease Progression|98
4773703|NCT01847274|7750958|FG000|Overall Study|Treatment Associated Risk|0
4773704|NCT01847274|7750959|FG001|Overall Study|Treatment Associated Risk|2
4773705|NCT01847274|7750960|FG002|Overall Study|Treatment Associated Risk|2
4773706|NCT01847274|7750961|FG003|Overall Study|Treatment Associated Risk|0
4773707|NCT01847274|7750958|FG000|Overall Study|Other Reasons|3
4773708|NCT01847274|7750959|FG001|Overall Study|Other Reasons|1
4731056|NCT03359395|7673434|FG001|First Intervention A / B|Lost to Follow-up|3
4731057|NCT03359395|7673433|FG000|Second Intervention B/A|Exclusion criteria|0
4731058|NCT03359395|7673434|FG001|Second Intervention B/A|Exclusion criteria|1
4731059|NCT03359395|7673433|FG000|Second Intervention B/A|Lost to Follow-up|3
4731060|NCT03359395|7673434|FG001|Second Intervention B/A|Lost to Follow-up|2
4731061|NCT03359473|7673444|FG000|Overall Study|Adverse Event|0
4731062|NCT03359473|7673445|FG001|Overall Study|Adverse Event|2
4731063|NCT03359473|7673446|FG002|Overall Study|Adverse Event|5
4731064|NCT03359473|7673447|FG003|Overall Study|Adverse Event|3
4731065|NCT03359473|7673444|FG000|Overall Study|Lost to Follow-up|0
4773709|NCT01847274|7750960|FG002|Overall Study|Other Reasons|11
4773710|NCT01847274|7750961|FG003|Overall Study|Other Reasons|3
4773711|NCT01847274|7750958|FG000|Overall Study|Non Compliance|0
4773712|NCT01847274|7750959|FG001|Overall Study|Non Compliance|0
4773713|NCT01847274|7750960|FG002|Overall Study|Non Compliance|2
4773714|NCT01847274|7750961|FG003|Overall Study|Non Compliance|0
4773715|NCT01670656|7750976|FG000|Overall Study|Non-compliance with study drug|0
4773716|NCT01670656|7750977|FG001|Overall Study|Non-compliance with study drug|0
4773717|NCT01670656|7750978|FG002|Overall Study|Non-compliance with study drug|3
4773718|NCT01670656|7750979|FG003|Overall Study|Non-compliance with study drug|0
4773719|NCT01670656|7750980|FG004|Overall Study|Non-compliance with study drug|1
4773720|NCT01670656|7750976|FG000|Overall Study|Pregnancy|0
4773721|NCT01670656|7750977|FG001|Overall Study|Pregnancy|0
4773722|NCT01670656|7750978|FG002|Overall Study|Pregnancy|0
4773723|NCT01670656|7750979|FG003|Overall Study|Pregnancy|0
4773724|NCT01670656|7750980|FG004|Overall Study|Pregnancy|1
4773725|NCT01670656|7750976|FG000|Overall Study|Withdrawal by Subject|1
4773726|NCT01670656|7750977|FG001|Overall Study|Withdrawal by Subject|1
4773727|NCT01670656|7750978|FG002|Overall Study|Withdrawal by Subject|0
4773728|NCT01670656|7750979|FG003|Overall Study|Withdrawal by Subject|0
4773729|NCT01670656|7750980|FG004|Overall Study|Withdrawal by Subject|0
4773730|NCT01670656|7750976|FG000|Overall Study|Non-compliance with protocol|0
4731066|NCT03359473|7673445|FG001|Overall Study|Lost to Follow-up|1
4773731|NCT01670656|7750977|FG001|Overall Study|Non-compliance with protocol|3
4773732|NCT01670656|7750978|FG002|Overall Study|Non-compliance with protocol|1
4773733|NCT01670656|7750979|FG003|Overall Study|Non-compliance with protocol|1
4773734|NCT01670656|7750980|FG004|Overall Study|Non-compliance with protocol|2
4773735|NCT01670656|7750976|FG000|Overall Study|Adverse Event|2
4773736|NCT01670656|7750977|FG001|Overall Study|Adverse Event|2
4773737|NCT01670656|7750978|FG002|Overall Study|Adverse Event|2
4773738|NCT01670656|7750979|FG003|Overall Study|Adverse Event|3
4773739|NCT01670656|7750980|FG004|Overall Study|Adverse Event|3
4773740|NCT01670656|7750976|FG000|Overall Study|Subject withdrew consent|0
4773741|NCT01670656|7750977|FG001|Overall Study|Subject withdrew consent|1
4773742|NCT01670656|7750978|FG002|Overall Study|Subject withdrew consent|2
4773743|NCT01670656|7750979|FG003|Overall Study|Subject withdrew consent|1
4773744|NCT01670656|7750980|FG004|Overall Study|Subject withdrew consent|1
4773745|NCT01670656|7750976|FG000|Overall Study|Lost to Follow-up|0
4773746|NCT01670656|7750977|FG001|Overall Study|Lost to Follow-up|0
4773747|NCT01670656|7750978|FG002|Overall Study|Lost to Follow-up|0
4773748|NCT01670656|7750979|FG003|Overall Study|Lost to Follow-up|0
4773749|NCT01670656|7750980|FG004|Overall Study|Lost to Follow-up|3
4773750|NCT01670656|7750976|FG000|Overall Study|Subject moved|0
4773751|NCT01670656|7750977|FG001|Overall Study|Subject moved|0
4773752|NCT01670656|7750978|FG002|Overall Study|Subject moved|0
4773753|NCT01670656|7750979|FG003|Overall Study|Subject moved|1
4773754|NCT01670656|7750980|FG004|Overall Study|Subject moved|0
4773755|NCT01501955|7750994|FG000|Overall Study|Withdrawal by Subject|1
4773756|NCT01501955|7750995|FG001|Overall Study|Withdrawal by Subject|0
4773757|NCT01501955|7750994|FG000|Overall Study|Adverse Event|1
4773758|NCT01501955|7750995|FG001|Overall Study|Adverse Event|3
4773759|NCT01335399|7751003|FG000|Pre-treatment Period|No longer meeting study criteria|0
4773760|NCT01335399|7751004|FG001|Pre-treatment Period|No longer meeting study criteria|1
4773761|NCT01335399|7751003|FG000|Pre-treatment Period|Participant request to discontinue|0
4773762|NCT01335399|7751004|FG001|Pre-treatment Period|Participant request to discontinue|1
4773763|NCT01335399|7751003|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0
4773764|NCT01335399|7751004|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1
4773765|NCT01335399|7751003|FG000|Pre-treatment Period|Consent withdrawal|3
4773766|NCT01335399|7751004|FG001|Pre-treatment Period|Consent withdrawal|0
4773767|NCT01335399|7751003|FG000|Treatment Period|Disease progression|114
4773768|NCT01335399|7751004|FG001|Treatment Period|Disease progression|141
4773769|NCT01335399|7751003|FG000|Treatment Period|Adverse event unrelated to study drug|105
4773770|NCT01335399|7751004|FG001|Treatment Period|Adverse event unrelated to study drug|65
4773771|NCT01335399|7751003|FG000|Treatment Period|Study drug toxicity|51
4773772|NCT01335399|7751004|FG001|Treatment Period|Study drug toxicity|64
4773773|NCT01335399|7751003|FG000|Treatment Period|Participant request to discontinue|27
4731067|NCT03359473|7673446|FG002|Overall Study|Lost to Follow-up|0
4731068|NCT03359473|7673447|FG003|Overall Study|Lost to Follow-up|0
4731069|NCT03359473|7673444|FG000|Overall Study|Physician Decision|0
4731070|NCT03359473|7673445|FG001|Overall Study|Physician Decision|1
4731071|NCT03359473|7673446|FG002|Overall Study|Physician Decision|0
4731072|NCT03359473|7673447|FG003|Overall Study|Physician Decision|1
4731073|NCT03359473|7673444|FG000|Overall Study|Withdrawal by Subject|1
4731074|NCT03359473|7673445|FG001|Overall Study|Withdrawal by Subject|2
4731075|NCT03359473|7673446|FG002|Overall Study|Withdrawal by Subject|1
4731076|NCT03359473|7673447|FG003|Overall Study|Withdrawal by Subject|0
4731077|NCT03359473|7673444|FG000|Overall Study|Protocol-defined stopping criteria|1
4731078|NCT03359473|7673445|FG001|Overall Study|Protocol-defined stopping criteria|0
4731079|NCT03359473|7673446|FG002|Overall Study|Protocol-defined stopping criteria|0
4731080|NCT03359473|7673447|FG003|Overall Study|Protocol-defined stopping criteria|1
4731081|NCT03359590|7673460|FG000|First Intervention|Withdrawal by Subject|1
4731082|NCT03359590|7673461|FG001|First Intervention|Withdrawal by Subject|1
4731083|NCT03359590|7673460|FG000|First Intervention|Protocol Violation|0
4731084|NCT03359590|7673461|FG001|First Intervention|Protocol Violation|1
4731085|NCT03359850|7673478|FG000|PK Phase (Up to Day 8)|Physician Decision|0
4731086|NCT03359850|7673479|FG001|PK Phase (Up to Day 8)|Physician Decision|1
4731087|NCT03359850|7673478|FG000|PK Phase (Up to Day 8)|Adverse Event|1
4731088|NCT03359850|7673479|FG001|PK Phase (Up to Day 8)|Adverse Event|0
4731089|NCT03359850|7673478|FG000|Extension Phase (Up to 28 Months)|Death|2
4731090|NCT03359850|7673479|FG001|Extension Phase (Up to 28 Months)|Death|4
4731091|NCT03359850|7673478|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1
4773774|NCT01335399|7751004|FG001|Treatment Period|Participant request to discontinue|21
4773775|NCT01335399|7751003|FG000|Treatment Period|Other reasons|14
4773776|NCT01335399|7751004|FG001|Treatment Period|Other reasons|26
4773777|NCT01335399|7751003|FG000|Treatment Period|Consent withdrawal|10
4773778|NCT01335399|7751004|FG001|Treatment Period|Consent withdrawal|6
4773779|NCT01335399|7751003|FG000|Treatment Period|Death|7
4773780|NCT01335399|7751004|FG001|Treatment Period|Death|8
4773781|NCT01335399|7751003|FG000|Treatment Period|Poor/Non-compliance|3
4773782|NCT01335399|7751004|FG001|Treatment Period|Poor/Non-compliance|4
4773783|NCT01335399|7751003|FG000|Treatment Period|Lost to Follow-up|0
4773784|NCT01335399|7751004|FG001|Treatment Period|Lost to Follow-up|2
4773785|NCT01335399|7751003|FG000|Treatment Period|Maximum clinical benefit|1
4773786|NCT01335399|7751004|FG001|Treatment Period|Maximum clinical benefit|1
4773787|NCT01335399|7751003|FG000|Treatment Period|No longer meet study criteria|0
4773788|NCT01335399|7751004|FG001|Treatment Period|No longer meet study criteria|1
4773789|NCT01335399|7751003|FG000|Treatment Period|Not reported|1
4773790|NCT01335399|7751004|FG001|Treatment Period|Not reported|0
4773791|NCT01277211|7751012|FG000|Overall Study|Adverse Event|60
4773792|NCT01277211|7751013|FG001|Overall Study|Adverse Event|22
4773793|NCT01277211|7751012|FG000|Overall Study|Pregnancy|9
4773794|NCT01277211|7751013|FG001|Overall Study|Pregnancy|4
4773795|NCT01277211|7751012|FG000|Overall Study|Lost to Follow-up|14
4773796|NCT01277211|7751013|FG001|Overall Study|Lost to Follow-up|9
4773797|NCT01277211|7751012|FG000|Overall Study|Did not wish to continue|17
4773798|NCT01277211|7751013|FG001|Overall Study|Did not wish to continue|0
4773799|NCT01277211|7751012|FG000|Overall Study|Withdrew Consent|9
4773800|NCT01277211|7751013|FG001|Overall Study|Withdrew Consent|9
4773801|NCT01277211|7751012|FG000|Overall Study|Non-compliance with protocol|13
4773802|NCT01277211|7751013|FG001|Overall Study|Non-compliance with protocol|4
4773803|NCT01277211|7751012|FG000|Overall Study|Did not meet protocol eligibility|1
4773804|NCT01277211|7751013|FG001|Overall Study|Did not meet protocol eligibility|0
4773805|NCT01277211|7751012|FG000|Overall Study|Administrative|3
4773806|NCT01277211|7751013|FG001|Overall Study|Administrative|0
4773807|NCT01277211|7751012|FG000|Overall Study|Pregnancy wish|0
4773808|NCT01277211|7751013|FG001|Overall Study|Pregnancy wish|2
4773809|NCT01277211|7751012|FG000|Overall Study|Discontinued prior to treatment|24
4773810|NCT01277211|7751013|FG001|Overall Study|Discontinued prior to treatment|13
4773811|NCT01244828|7751023|FG000|Overall Study|Adverse Event|37
4773812|NCT01244828|7751023|FG000|Overall Study|Withdrawal by Subject|31
4773813|NCT01244828|7751023|FG000|Overall Study|Lack of Efficacy|7
4773814|NCT01244828|7751023|FG000|Overall Study|Lost to Follow-up|2
4773815|NCT01244828|7751023|FG000|Overall Study|Other reason (not specified)|1
4773816|NCT01207492|7751027|FG000|Overall Study|Still on study|1
4773817|NCT01207492|7751027|FG000|Overall Study|Withdrawal by Subject|9
4773818|NCT01207492|7751027|FG000|Overall Study|Physician Decision|1
4773819|NCT01207492|7751027|FG000|Overall Study|Progressive disease|3
4773820|NCT01207492|7751027|FG000|Overall Study|Toxicity|1
4773821|NCT01181778|7751031|FG000|Overall Study|Physician Decision|48
4773822|NCT01047540|7751042|FG000|Overall Study|Protocol Violation|1
4773823|NCT01047540|7751043|FG001|Overall Study|Protocol Violation|0
4773824|NCT01047540|7751044|FG002|Overall Study|Protocol Violation|0
4773825|NCT01047540|7751045|FG003|Overall Study|Protocol Violation|0
4773826|NCT01047540|7751046|FG004|Overall Study|Protocol Violation|0
4773827|NCT01047540|7751042|FG000|Overall Study|Lost to Follow-up|1
4773828|NCT01047540|7751043|FG001|Overall Study|Lost to Follow-up|0
4773829|NCT01047540|7751044|FG002|Overall Study|Lost to Follow-up|0
4773830|NCT01047540|7751045|FG003|Overall Study|Lost to Follow-up|0
4773831|NCT01047540|7751046|FG004|Overall Study|Lost to Follow-up|0
4773832|NCT01047540|7751042|FG000|Overall Study|Withdrawal by Subject|1
4773833|NCT01047540|7751043|FG001|Overall Study|Withdrawal by Subject|0
4773834|NCT01047540|7751044|FG002|Overall Study|Withdrawal by Subject|3
4773835|NCT01047540|7751045|FG003|Overall Study|Withdrawal by Subject|0
4773836|NCT01047540|7751046|FG004|Overall Study|Withdrawal by Subject|1
4773837|NCT01047540|7751042|FG000|Overall Study|Pregnancy|1
4773838|NCT01047540|7751043|FG001|Overall Study|Pregnancy|0
4773839|NCT01047540|7751044|FG002|Overall Study|Pregnancy|0
4773840|NCT01047540|7751045|FG003|Overall Study|Pregnancy|0
4773841|NCT01047540|7751046|FG004|Overall Study|Pregnancy|0
4773842|NCT01047540|7751042|FG000|Overall Study|Adverse Event|1
4773843|NCT01047540|7751043|FG001|Overall Study|Adverse Event|0
4773844|NCT01047540|7751044|FG002|Overall Study|Adverse Event|0
4773845|NCT01047540|7751045|FG003|Overall Study|Adverse Event|0
4773846|NCT01047540|7751046|FG004|Overall Study|Adverse Event|0
4773847|NCT00778999|7751091|FG000|Overall Study|Discontinuation: no embryo transfer|14
4773848|NCT00778999|7751092|FG001|Overall Study|Discontinuation: no embryo transfer|14
4773849|NCT00778999|7751091|FG000|Overall Study|Did not receive recFSH|14
4773850|NCT00778999|7751092|FG001|Overall Study|Did not receive recFSH|20
4773851|NCT00620464|7751100|FG000|Overall Study|Adverse Event|15
4773852|NCT00620464|7751101|FG001|Overall Study|Adverse Event|17
4446632|NCT00485264|7231700|FG002|Overall Study|Pregnancy|0
4446633|NCT00485264|7231701|FG003|Overall Study|Pregnancy|0
4446634|NCT00485264|7231702|FG004|Overall Study|Pregnancy|0
4446635|NCT00485264|7231703|FG005|Overall Study|Pregnancy|0
4446636|NCT00485264|7231698|FG000|Overall Study|Disallowed Medication|0
4446637|NCT00485264|7231699|FG001|Overall Study|Disallowed Medication|0
4446638|NCT00485264|7231700|FG002|Overall Study|Disallowed Medication|0
4446639|NCT00485264|7231701|FG003|Overall Study|Disallowed Medication|0
4446640|NCT00485264|7231702|FG004|Overall Study|Disallowed Medication|0
4446641|NCT00485264|7231703|FG005|Overall Study|Disallowed Medication|1
4446642|NCT00485264|7231698|FG000|Overall Study|Number/Volume/Timing of Study Meds|2
4446643|NCT00485264|7231699|FG001|Overall Study|Number/Volume/Timing of Study Meds|1
4446644|NCT00485264|7231700|FG002|Overall Study|Number/Volume/Timing of Study Meds|1
4773853|NCT00620464|7751100|FG000|Overall Study|Lost to Follow-up|1
4773854|NCT00620464|7751101|FG001|Overall Study|Lost to Follow-up|1
4773855|NCT00620464|7751100|FG000|Overall Study|Planning Pregnancy|1
4773856|NCT00620464|7751101|FG001|Overall Study|Planning Pregnancy|4
4773857|NCT00620464|7751100|FG000|Overall Study|Personal|2
4446645|NCT00485264|7231701|FG003|Overall Study|Number/Volume/Timing of Study Meds|0
4446646|NCT00485264|7231702|FG004|Overall Study|Number/Volume/Timing of Study Meds|0
4446647|NCT00485264|7231703|FG005|Overall Study|Number/Volume/Timing of Study Meds|0
4446648|NCT00485264|7231698|FG000|Overall Study|Lack of Efficacy|0
4446649|NCT00485264|7231699|FG001|Overall Study|Lack of Efficacy|1
4446650|NCT00485264|7231700|FG002|Overall Study|Lack of Efficacy|0
4773858|NCT00620464|7751101|FG001|Overall Study|Personal|2
4773859|NCT00620464|7751100|FG000|Overall Study|Used prohibited medication|1
4773860|NCT00620464|7751101|FG001|Overall Study|Used prohibited medication|0
4773861|NCT00620035|7751107|FG000|Overall Study|Adverse Event|106
4773862|NCT00620035|7751107|FG000|Overall Study|Withdrawal of Informed Consent|1
4773863|NCT00620035|7751107|FG000|Overall Study|Other Reason|38
4773864|NCT00210249|7751111|FG000|Overall Study|Lost to Follow-up|5
4773865|NCT00210249|7751111|FG000|Overall Study|Protocol Violation|11
4446651|NCT00485264|7231701|FG003|Overall Study|Lack of Efficacy|0
4515346|NCT00952614|7326122|FG000|Overall Study|Lost to Follow-up|3
4631014|NCT01888874|7500012|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
4631015|NCT01888874|7500006|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
4631016|NCT01888874|7500007|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
4631017|NCT01888874|7500008|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
4631018|NCT01888874|7500009|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
4631019|NCT01888874|7500010|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1
4631020|NCT01888874|7500011|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
4631021|NCT01888874|7500012|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0
4631022|NCT01888874|7500006|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0
4631023|NCT01888874|7500007|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0
4631024|NCT01888874|7500008|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2
4631025|NCT01888874|7500009|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0
4631026|NCT01888874|7500010|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0
4631027|NCT01888874|7500011|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1
4631028|NCT01888874|7500012|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0
4631029|NCT01888874|7500006|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0
4631030|NCT01888874|7500007|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0
4631031|NCT01888874|7500008|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1
4631032|NCT01888874|7500009|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0
4631033|NCT01888874|7500010|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0
4631034|NCT01888874|7500011|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0
4631035|NCT01888874|7500012|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0
4631036|NCT01888874|7500006|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2
4631037|NCT01888874|7500007|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0
4631038|NCT01888874|7500008|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3
4631039|NCT01888874|7500009|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2
4631040|NCT01888874|7500010|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1
4631041|NCT01888874|7500011|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1
4731092|NCT03359850|7673479|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2
4731093|NCT03359850|7673478|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5
4731094|NCT03359850|7673479|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0
4731095|NCT03360071|7673493|FG000|Overall Study|Lost to Follow-up|1
4731096|NCT03360071|7673494|FG001|Overall Study|Lost to Follow-up|0
4731097|NCT03360344|7673522|FG000|Overall Study|Withdrawal by Subject|0
4731098|NCT03360344|7673523|FG001|Overall Study|Withdrawal by Subject|1
4731099|NCT03360344|7673524|FG002|Overall Study|Withdrawal by Subject|1
4731100|NCT03360747|7673532|FG000|Overall Study|Voluntary Withdrawal|1
4731101|NCT03361137|7673541|FG000|Overall Study|Reason not specified|1
4731102|NCT03361137|7673542|FG001|Overall Study|Reason not specified|0
4631042|NCT01888874|7500012|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3
4631043|NCT01888874|7500006|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0
4731103|NCT03361137|7673543|FG002|Overall Study|Reason not specified|0
4731104|NCT03361137|7673544|FG003|Overall Study|Reason not specified|0
4731105|NCT03361137|7673545|FG004|Overall Study|Reason not specified|0
4731106|NCT03361176|7673561|FG000|Overall Study|Lost to Follow-up|1
4731107|NCT03361176|7673562|FG001|Overall Study|Lost to Follow-up|2
4731108|NCT03361176|7673561|FG000|Overall Study|Adverse Event|0
4731109|NCT03361176|7673562|FG001|Overall Study|Adverse Event|2
4731110|NCT03361176|7673561|FG000|Overall Study|Withdrawal by Subject|0
4731111|NCT03361176|7673562|FG001|Overall Study|Withdrawal by Subject|1
4731112|NCT03361293|7673570|FG000|Overall Study|Lost to Follow-up|0
4731113|NCT03361293|7673571|FG001|Overall Study|Lost to Follow-up|2
4731114|NCT03361293|7673570|FG000|Overall Study|Withdrawal by Subject|1
4731115|NCT03361293|7673571|FG001|Overall Study|Withdrawal by Subject|3
4731116|NCT03361423|7673579|FG000|Overall Study|Withdrawal by Subject|4
4631044|NCT01888874|7500007|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1
4631045|NCT01888874|7500008|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0
4631046|NCT01888874|7500009|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0
4631047|NCT01888874|7500010|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0
4631048|NCT01888874|7500011|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1
4631049|NCT01888874|7500012|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0
4631050|NCT01888900|7500031|FG000|Overall Study|failed treatment|0
4631051|NCT01888900|7500032|FG001|Overall Study|failed treatment|2
4631052|NCT01888965|7500044|FG000|Overall Study|Adverse Event|5
4631053|NCT01888965|7500044|FG000|Overall Study|Lack of Efficacy|4
4631054|NCT01889069|7500050|FG000|Overall Study|Death|18
4731117|NCT03361423|7673580|FG001|Overall Study|Withdrawal by Subject|3
4731118|NCT03361423|7673579|FG000|Overall Study|Did not treat|19
4731119|NCT03361423|7673580|FG001|Overall Study|Did not treat|18
4731120|NCT03361423|7673579|FG000|Overall Study|Started >60 minutes from migraine onset|0
4731121|NCT03361423|7673580|FG001|Overall Study|Started >60 minutes from migraine onset|1
4731122|NCT03361423|7673579|FG000|Overall Study|Missing data|4
4731123|NCT03361423|7673580|FG001|Overall Study|Missing data|1
4731124|NCT03361605|7673586|FG000|Overall Study|Analyzable data not available|3
4731125|NCT03363321|7673627|FG000|Overall Study|Withdrawal by Subject|0
4731126|NCT03363321|7673628|FG001|Overall Study|Withdrawal by Subject|1
4731127|NCT03363321|7673629|FG002|Overall Study|Withdrawal by Subject|0
4731128|NCT03363321|7673630|FG003|Overall Study|Withdrawal by Subject|1
4731129|NCT03363321|7673631|FG004|Overall Study|Withdrawal by Subject|0
4731130|NCT03363776|7673647|FG000|Overall Study|Progressive disease|2
4731131|NCT03363776|7673648|FG001|Overall Study|Progressive disease|3
4731132|NCT03363776|7673649|FG002|Overall Study|Progressive disease|1
4731133|NCT03363776|7673647|FG000|Overall Study|Study drug toxicity|0
4731134|NCT03363776|7673648|FG001|Overall Study|Study drug toxicity|0
4731135|NCT03363776|7673649|FG002|Overall Study|Study drug toxicity|1
4731136|NCT03363776|7673647|FG000|Overall Study|Death|1
4731137|NCT03363776|7673648|FG001|Overall Study|Death|0
4731138|NCT03363776|7673649|FG002|Overall Study|Death|0
4731139|NCT03363906|7673689|FG000|Period 1 (Reference or Test)|Adverse Event|1
4731140|NCT03363906|7673690|FG001|Period 1 (Reference or Test)|Adverse Event|2
4731141|NCT03363906|7673689|FG000|Period 2 (Test or Reference)|Adverse Event|2
4731142|NCT03363906|7673690|FG001|Period 2 (Test or Reference)|Adverse Event|0
4731143|NCT03363906|7673689|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1
4731144|NCT03363906|7673690|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1
4731145|NCT03363906|7673689|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1
4731146|NCT03363906|7673690|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0
4731147|NCT03364023|7673696|FG000|Overall Study|Lost to Follow-up|3
4731148|NCT03364023|7673696|FG000|Overall Study|Death|14
4731149|NCT03364049|7673704|FG000|Overall Study|Death|6
4731150|NCT03364049|7673705|FG001|Overall Study|Death|4
4731151|NCT03364049|7673706|FG002|Overall Study|Death|5
4731152|NCT03364049|7673707|FG003|Overall Study|Death|14
4731153|NCT03364049|7673704|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0
4731154|NCT03364049|7673705|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1
4731155|NCT03364049|7673706|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0
4731156|NCT03364049|7673707|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0
4731157|NCT03364049|7673704|FG000|Overall Study|Withdrawal by Subject|0
4731158|NCT03364049|7673705|FG001|Overall Study|Withdrawal by Subject|1
4731159|NCT03364049|7673706|FG002|Overall Study|Withdrawal by Subject|1
4731160|NCT03364049|7673707|FG003|Overall Study|Withdrawal by Subject|1
4731161|NCT03364192|7673717|FG000|Overall Study|Ineligible|10
4731162|NCT03364192|7673717|FG000|Overall Study|Withdrawal by Subject|5
4731163|NCT03364192|7673717|FG000|Overall Study|Lost to Follow-up|1
4731164|NCT03364309|7673725|FG000|Induction Period|Adverse Event|4
4731165|NCT03364309|7673726|FG001|Induction Period|Adverse Event|0
4731166|NCT03364309|7673727|FG002|Induction Period|Adverse Event|1
4731167|NCT03364309|7673728|FG003|Induction Period|Adverse Event|0
4731168|NCT03364309|7673729|FG004|Induction Period|Adverse Event|0
4731169|NCT03364309|7673730|FG005|Induction Period|Adverse Event|0
4731170|NCT03364309|7673731|FG006|Induction Period|Adverse Event|0
4731171|NCT03364309|7673732|FG007|Induction Period|Adverse Event|0
4731172|NCT03364309|7673733|FG008|Induction Period|Adverse Event|0
4731173|NCT03364309|7673734|FG009|Induction Period|Adverse Event|0
4731174|NCT03364309|7673735|FG010|Induction Period|Adverse Event|0
4731175|NCT03364309|7673736|FG011|Induction Period|Adverse Event|0
4731176|NCT03364309|7673737|FG012|Induction Period|Adverse Event|0
4731177|NCT03364309|7673738|FG013|Induction Period|Adverse Event|0
4731178|NCT03364309|7673739|FG014|Induction Period|Adverse Event|0
4731179|NCT03364309|7673740|FG015|Induction Period|Adverse Event|0
4731180|NCT03364309|7673741|FG016|Induction Period|Adverse Event|0
4731181|NCT03364309|7673742|FG017|Induction Period|Adverse Event|0
4731182|NCT03364309|7673743|FG018|Induction Period|Adverse Event|0
4731183|NCT03364309|7673725|FG000|Induction Period|Withdrawal by Subject|1
4731184|NCT03364309|7673726|FG001|Induction Period|Withdrawal by Subject|3
4631055|NCT01889069|7500050|FG000|Overall Study|Progression of Disease|14
4631056|NCT01889069|7500050|FG000|Overall Study|Lost to Follow-up|6
4631057|NCT01889069|7500050|FG000|Overall Study|Other|4
4731185|NCT03364309|7673727|FG002|Induction Period|Withdrawal by Subject|0
4731186|NCT03364309|7673728|FG003|Induction Period|Withdrawal by Subject|0
4731187|NCT03364309|7673729|FG004|Induction Period|Withdrawal by Subject|0
4731188|NCT03364309|7673730|FG005|Induction Period|Withdrawal by Subject|0
4731189|NCT03364309|7673731|FG006|Induction Period|Withdrawal by Subject|0
4731190|NCT03364309|7673732|FG007|Induction Period|Withdrawal by Subject|0
4731191|NCT03364309|7673733|FG008|Induction Period|Withdrawal by Subject|0
4731192|NCT03364309|7673734|FG009|Induction Period|Withdrawal by Subject|0
4731193|NCT03364309|7673735|FG010|Induction Period|Withdrawal by Subject|0
4731194|NCT03364309|7673736|FG011|Induction Period|Withdrawal by Subject|0
4731195|NCT03364309|7673737|FG012|Induction Period|Withdrawal by Subject|0
4731196|NCT03364309|7673738|FG013|Induction Period|Withdrawal by Subject|0
4731197|NCT03364309|7673739|FG014|Induction Period|Withdrawal by Subject|0
4731198|NCT03364309|7673740|FG015|Induction Period|Withdrawal by Subject|0
4731199|NCT03364309|7673741|FG016|Induction Period|Withdrawal by Subject|0
4731200|NCT03364309|7673742|FG017|Induction Period|Withdrawal by Subject|0
4731201|NCT03364309|7673743|FG018|Induction Period|Withdrawal by Subject|0
4731202|NCT03364309|7673725|FG000|Induction Period|Lost to Follow-up|1
4731203|NCT03364309|7673726|FG001|Induction Period|Lost to Follow-up|0
4731204|NCT03364309|7673727|FG002|Induction Period|Lost to Follow-up|0
4731205|NCT03364309|7673728|FG003|Induction Period|Lost to Follow-up|0
4731206|NCT03364309|7673729|FG004|Induction Period|Lost to Follow-up|0
4731207|NCT03364309|7673730|FG005|Induction Period|Lost to Follow-up|0
4731208|NCT03364309|7673731|FG006|Induction Period|Lost to Follow-up|0
4731209|NCT03364309|7673732|FG007|Induction Period|Lost to Follow-up|0
4731210|NCT03364309|7673733|FG008|Induction Period|Lost to Follow-up|0
4731211|NCT03364309|7673734|FG009|Induction Period|Lost to Follow-up|0
4731212|NCT03364309|7673735|FG010|Induction Period|Lost to Follow-up|0
4731213|NCT03364309|7673736|FG011|Induction Period|Lost to Follow-up|0
4731214|NCT03364309|7673737|FG012|Induction Period|Lost to Follow-up|0
4731215|NCT03364309|7673738|FG013|Induction Period|Lost to Follow-up|0
4731216|NCT03364309|7673739|FG014|Induction Period|Lost to Follow-up|0
4731217|NCT03364309|7673740|FG015|Induction Period|Lost to Follow-up|0
4731218|NCT03364309|7673741|FG016|Induction Period|Lost to Follow-up|0
4731219|NCT03364309|7673742|FG017|Induction Period|Lost to Follow-up|0
4731220|NCT03364309|7673743|FG018|Induction Period|Lost to Follow-up|0
4731221|NCT03364309|7673725|FG000|Induction Period|Physician Decision|0
4731222|NCT03364309|7673726|FG001|Induction Period|Physician Decision|1
4731223|NCT03364309|7673727|FG002|Induction Period|Physician Decision|0
4731224|NCT03364309|7673728|FG003|Induction Period|Physician Decision|0
4731225|NCT03364309|7673729|FG004|Induction Period|Physician Decision|0
4731226|NCT03364309|7673730|FG005|Induction Period|Physician Decision|0
4731227|NCT03364309|7673731|FG006|Induction Period|Physician Decision|0
4731228|NCT03364309|7673732|FG007|Induction Period|Physician Decision|0
4731229|NCT03364309|7673733|FG008|Induction Period|Physician Decision|0
4731230|NCT03364309|7673734|FG009|Induction Period|Physician Decision|0
4731231|NCT03364309|7673735|FG010|Induction Period|Physician Decision|0
4731232|NCT03364309|7673736|FG011|Induction Period|Physician Decision|0
4731233|NCT03364309|7673737|FG012|Induction Period|Physician Decision|0
4731234|NCT03364309|7673738|FG013|Induction Period|Physician Decision|0
4731235|NCT03364309|7673739|FG014|Induction Period|Physician Decision|0
4731236|NCT03364309|7673740|FG015|Induction Period|Physician Decision|0
4731237|NCT03364309|7673741|FG016|Induction Period|Physician Decision|0
4731238|NCT03364309|7673742|FG017|Induction Period|Physician Decision|0
4731239|NCT03364309|7673743|FG018|Induction Period|Physician Decision|0
4731240|NCT03364309|7673725|FG000|Maintenance Period|Withdrawal by Subject|0
4731241|NCT03364309|7673726|FG001|Maintenance Period|Withdrawal by Subject|0
4731242|NCT03364309|7673727|FG002|Maintenance Period|Withdrawal by Subject|0
4731243|NCT03364309|7673728|FG003|Maintenance Period|Withdrawal by Subject|1
4731244|NCT03364309|7673729|FG004|Maintenance Period|Withdrawal by Subject|3
4731245|NCT03364309|7673730|FG005|Maintenance Period|Withdrawal by Subject|1
4731246|NCT03364309|7673731|FG006|Maintenance Period|Withdrawal by Subject|3
4731247|NCT03364309|7673732|FG007|Maintenance Period|Withdrawal by Subject|0
4731248|NCT03364309|7673733|FG008|Maintenance Period|Withdrawal by Subject|1
4731249|NCT03364309|7673734|FG009|Maintenance Period|Withdrawal by Subject|1
4731250|NCT03364309|7673735|FG010|Maintenance Period|Withdrawal by Subject|2
4731251|NCT03364309|7673736|FG011|Maintenance Period|Withdrawal by Subject|0
4731252|NCT03364309|7673737|FG012|Maintenance Period|Withdrawal by Subject|0
4731253|NCT03364309|7673738|FG013|Maintenance Period|Withdrawal by Subject|0
4731254|NCT03364309|7673739|FG014|Maintenance Period|Withdrawal by Subject|0
4731255|NCT03364309|7673740|FG015|Maintenance Period|Withdrawal by Subject|0
4731256|NCT03364309|7673741|FG016|Maintenance Period|Withdrawal by Subject|0
4731257|NCT03364309|7673742|FG017|Maintenance Period|Withdrawal by Subject|0
4731258|NCT03364309|7673743|FG018|Maintenance Period|Withdrawal by Subject|0
4731259|NCT03364309|7673725|FG000|Maintenance Period|Adverse Event|0
4731260|NCT03364309|7673726|FG001|Maintenance Period|Adverse Event|0
4631058|NCT01889069|7500050|FG000|Overall Study|Consent Withdrawal|3
4631059|NCT01889238|7500060|FG000|Overall Study|Treatment ongoing|9
4631060|NCT01889251|7500066|FG000|Overall Study|Adverse Event|1
4631061|NCT01889251|7500067|FG001|Overall Study|Adverse Event|0
4631062|NCT01889602|7500089|FG000|First Intervention|Adverse Event|1
4631063|NCT01889602|7500090|FG001|First Intervention|Adverse Event|1
4631064|NCT01889602|7500091|FG002|First Intervention|Adverse Event|1
4631065|NCT01889602|7500089|FG000|First Intervention|Protocol Violation|0
4631066|NCT01889602|7500090|FG001|First Intervention|Protocol Violation|1
4631067|NCT01889602|7500091|FG002|First Intervention|Protocol Violation|1
4631068|NCT01889602|7500089|FG000|First Intervention|Study ending|0
4631069|NCT01889602|7500090|FG001|First Intervention|Study ending|1
4631070|NCT01889602|7500091|FG002|First Intervention|Study ending|0
4631071|NCT01889602|7500089|FG000|Second Intervention|Adverse Event|0
4631072|NCT01889602|7500090|FG001|Second Intervention|Adverse Event|0
4631073|NCT01889602|7500091|FG002|Second Intervention|Adverse Event|1
4631074|NCT01889602|7500089|FG000|Second Intervention|Study ending|1
4631075|NCT01889602|7500090|FG001|Second Intervention|Study ending|0
4631076|NCT01889602|7500091|FG002|Second Intervention|Study ending|0
4631077|NCT01889602|7500089|FG000|Second Intervention|Withdrawal by Subject|0
4631078|NCT01889602|7500090|FG001|Second Intervention|Withdrawal by Subject|0
4631079|NCT01889602|7500091|FG002|Second Intervention|Withdrawal by Subject|1
4631080|NCT01889602|7500089|FG000|Third Intervention|Protocol Violation|1
4631081|NCT01889602|7500090|FG001|Third Intervention|Protocol Violation|0
4631082|NCT01889602|7500091|FG002|Third Intervention|Protocol Violation|0
4631083|NCT01889602|7500089|FG000|Third Intervention|Withdrawal by Subject|2
4631084|NCT01889602|7500090|FG001|Third Intervention|Withdrawal by Subject|2
4631085|NCT01889602|7500091|FG002|Third Intervention|Withdrawal by Subject|0
4631086|NCT01889862|7500131|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4
4631087|NCT01889862|7500132|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0
4631088|NCT01889862|7500133|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0
4631089|NCT01889862|7500134|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0
4631090|NCT01889862|7500135|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0
4631091|NCT01889862|7500131|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2
4631092|NCT01889862|7500132|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0
4631093|NCT01889862|7500133|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0
4446652|NCT00485264|7231702|FG004|Overall Study|Lack of Efficacy|0
4446653|NCT00485264|7231703|FG005|Overall Study|Lack of Efficacy|0
4446654|NCT00485264|7231698|FG000|Overall Study|Guardian Consent Withdrawn|1
4446655|NCT00485264|7231699|FG001|Overall Study|Guardian Consent Withdrawn|0
4446656|NCT00485264|7231700|FG002|Overall Study|Guardian Consent Withdrawn|0
4446657|NCT00485264|7231701|FG003|Overall Study|Guardian Consent Withdrawn|0
4446658|NCT00485264|7231702|FG004|Overall Study|Guardian Consent Withdrawn|1
4446659|NCT00485264|7231703|FG005|Overall Study|Guardian Consent Withdrawn|0
4446660|NCT00485264|7231698|FG000|Overall Study|Physician Decision|0
4446661|NCT00485264|7231699|FG001|Overall Study|Physician Decision|2
4446662|NCT00485264|7231700|FG002|Overall Study|Physician Decision|0
4631094|NCT01889862|7500134|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0
4631095|NCT01889862|7500135|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0
4631096|NCT01889862|7500131|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4
4515347|NCT00952614|7326122|FG000|Overall Study|other reason|1
4515348|NCT00952705|7326137|FG000|Overall Study|Lost to Follow-up|24
4515349|NCT00952705|7326138|FG001|Overall Study|Lost to Follow-up|8
4515350|NCT00952705|7326139|FG002|Overall Study|Lost to Follow-up|9
4631097|NCT01889862|7500132|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0
4631098|NCT01889862|7500133|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0
4631099|NCT01889862|7500134|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0
4631100|NCT01889862|7500135|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0
4631101|NCT01889862|7500131|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2
4631102|NCT01889862|7500132|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0
4631103|NCT01889862|7500133|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0
4631104|NCT01889862|7500134|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0
4631105|NCT01889862|7500135|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0
4631106|NCT01889862|7500131|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0
4631107|NCT01889862|7500132|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0
4631108|NCT01889862|7500133|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1
4731261|NCT03364309|7673727|FG002|Maintenance Period|Adverse Event|0
4731262|NCT03364309|7673728|FG003|Maintenance Period|Adverse Event|0
4731263|NCT03364309|7673729|FG004|Maintenance Period|Adverse Event|2
4731264|NCT03364309|7673730|FG005|Maintenance Period|Adverse Event|0
4731265|NCT03364309|7673731|FG006|Maintenance Period|Adverse Event|3
4731266|NCT03364309|7673732|FG007|Maintenance Period|Adverse Event|0
4731267|NCT03364309|7673733|FG008|Maintenance Period|Adverse Event|1
4731268|NCT03364309|7673734|FG009|Maintenance Period|Adverse Event|0
4731269|NCT03364309|7673735|FG010|Maintenance Period|Adverse Event|2
4731270|NCT03364309|7673736|FG011|Maintenance Period|Adverse Event|0
4731271|NCT03364309|7673737|FG012|Maintenance Period|Adverse Event|0
4446663|NCT00485264|7231701|FG003|Overall Study|Physician Decision|0
4446664|NCT00485264|7231702|FG004|Overall Study|Physician Decision|0
4446665|NCT00485264|7231703|FG005|Overall Study|Physician Decision|0
4446666|NCT00485264|7231698|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0
4446667|NCT00485264|7231699|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0
4446668|NCT00485264|7231700|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1
4446669|NCT00485264|7231701|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0
4446670|NCT00485264|7231702|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0
4446671|NCT00485264|7231703|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0
4446672|NCT00485264|7231698|FG000|Overall Study|Not Able to Attend Clinic|5
4446673|NCT00485264|7231699|FG001|Overall Study|Not Able to Attend Clinic|0
4446674|NCT00485264|7231700|FG002|Overall Study|Not Able to Attend Clinic|0
4446675|NCT00485264|7231701|FG003|Overall Study|Not Able to Attend Clinic|1
4446676|NCT00485264|7231702|FG004|Overall Study|Not Able to Attend Clinic|1
4446677|NCT00485264|7231703|FG005|Overall Study|Not Able to Attend Clinic|2
4446678|NCT00485264|7231698|FG000|Overall Study|Non-Compliant|17
4731272|NCT03364309|7673738|FG013|Maintenance Period|Adverse Event|0
4731273|NCT03364309|7673739|FG014|Maintenance Period|Adverse Event|0
4731274|NCT03364309|7673740|FG015|Maintenance Period|Adverse Event|0
4731275|NCT03364309|7673741|FG016|Maintenance Period|Adverse Event|0
4731276|NCT03364309|7673742|FG017|Maintenance Period|Adverse Event|0
4731277|NCT03364309|7673743|FG018|Maintenance Period|Adverse Event|0
4731278|NCT03364309|7673725|FG000|Maintenance Period|Relapsed|0
4731279|NCT03364309|7673726|FG001|Maintenance Period|Relapsed|0
4731280|NCT03364309|7673727|FG002|Maintenance Period|Relapsed|0
4731281|NCT03364309|7673728|FG003|Maintenance Period|Relapsed|43
4731282|NCT03364309|7673729|FG004|Maintenance Period|Relapsed|7
4731283|NCT03364309|7673730|FG005|Maintenance Period|Relapsed|45
4731284|NCT03364309|7673731|FG006|Maintenance Period|Relapsed|10
4631109|NCT01889862|7500134|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0
4631110|NCT01889862|7500135|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0
4631111|NCT01889862|7500131|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0
4631112|NCT01889862|7500132|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0
4631113|NCT01889862|7500133|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0
4631114|NCT01889862|7500134|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0
4631115|NCT01889862|7500135|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5
4631116|NCT01889862|7500131|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0
4631117|NCT01889862|7500132|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0
4631118|NCT01889862|7500133|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0
4631119|NCT01889862|7500134|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0
4631120|NCT01889862|7500135|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14
4631121|NCT01889862|7500131|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0
4631122|NCT01889862|7500132|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0
4631123|NCT01889862|7500133|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0
4631124|NCT01889862|7500134|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0
4631125|NCT01889862|7500135|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4
4631126|NCT01889862|7500131|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0
4631127|NCT01889862|7500132|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0
4631128|NCT01889862|7500133|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0
4631129|NCT01889862|7500134|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0
4631130|NCT01889862|7500135|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5
4631131|NCT01889862|7500131|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0
4631132|NCT01889862|7500132|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0
4631133|NCT01889862|7500133|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0
4631134|NCT01889862|7500134|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0
4631135|NCT01889862|7500135|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2
4631136|NCT01890109|7500183|FG000|Overall Study|Withdrawal by Subject|0
4631137|NCT01890109|7500184|FG001|Overall Study|Withdrawal by Subject|3
4631138|NCT01890109|7500183|FG000|Overall Study|Lost to Follow-up|1
4631139|NCT01890109|7500184|FG001|Overall Study|Lost to Follow-up|2
4631140|NCT01890122|7500195|FG000|Overall Study|Adverse Event|1
4631141|NCT01890122|7500196|FG001|Overall Study|Adverse Event|1
4631142|NCT01890122|7500197|FG002|Overall Study|Adverse Event|1
4631143|NCT01890122|7500198|FG003|Overall Study|Adverse Event|2
4631144|NCT01890122|7500195|FG000|Overall Study|Major Protocol Deviation|3
4631145|NCT01890122|7500196|FG001|Overall Study|Major Protocol Deviation|1
4631146|NCT01890122|7500197|FG002|Overall Study|Major Protocol Deviation|0
4631147|NCT01890122|7500198|FG003|Overall Study|Major Protocol Deviation|1
4631148|NCT01890122|7500195|FG000|Overall Study|Lost to Follow-up|0
4631149|NCT01890122|7500196|FG001|Overall Study|Lost to Follow-up|1
4631150|NCT01890122|7500197|FG002|Overall Study|Lost to Follow-up|2
4631151|NCT01890122|7500198|FG003|Overall Study|Lost to Follow-up|2
4631152|NCT01890122|7500195|FG000|Overall Study|Voluntary Withdrawal|8
4631153|NCT01890122|7500196|FG001|Overall Study|Voluntary Withdrawal|8
4631154|NCT01890122|7500197|FG002|Overall Study|Voluntary Withdrawal|2
4631155|NCT01890122|7500198|FG003|Overall Study|Voluntary Withdrawal|11
4631156|NCT01890122|7500195|FG000|Overall Study|Lack of Efficacy|14
4631157|NCT01890122|7500196|FG001|Overall Study|Lack of Efficacy|24
4631158|NCT01890122|7500197|FG002|Overall Study|Lack of Efficacy|7
4631159|NCT01890122|7500198|FG003|Overall Study|Lack of Efficacy|41
4631160|NCT01890122|7500195|FG000|Overall Study|Reason not Specified|0
4631161|NCT01890122|7500196|FG001|Overall Study|Reason not Specified|1
4631162|NCT01890122|7500197|FG002|Overall Study|Reason not Specified|1
4631163|NCT01890122|7500198|FG003|Overall Study|Reason not Specified|2
4631164|NCT01890122|7500195|FG000|Overall Study|Randomized but not Treated|1
4631165|NCT01890122|7500196|FG001|Overall Study|Randomized but not Treated|1
4631166|NCT01890122|7500197|FG002|Overall Study|Randomized but not Treated|0
4631167|NCT01890122|7500198|FG003|Overall Study|Randomized but not Treated|0
4631168|NCT01890148|7500208|FG000|Overall Study|Adverse Event|1
4631169|NCT01890265|7500227|FG000|Overall Study|Other (Unspecified reason)|0
4631170|NCT01890265|7500228|FG001|Overall Study|Other (Unspecified reason)|1
4631171|NCT01890265|7500229|FG002|Overall Study|Other (Unspecified reason)|0
4631172|NCT01890265|7500230|FG003|Overall Study|Other (Unspecified reason)|0
4631173|NCT01890265|7500231|FG004|Overall Study|Other (Unspecified reason)|0
4631174|NCT01890265|7500232|FG005|Overall Study|Other (Unspecified reason)|0
4631175|NCT01890265|7500227|FG000|Overall Study|Progressive disease|6
4731285|NCT03364309|7673732|FG007|Maintenance Period|Relapsed|2
4731286|NCT03364309|7673733|FG008|Maintenance Period|Relapsed|0
4731287|NCT03364309|7673734|FG009|Maintenance Period|Relapsed|0
4731288|NCT03364309|7673735|FG010|Maintenance Period|Relapsed|0
4731289|NCT03364309|7673736|FG011|Maintenance Period|Relapsed|0
4731290|NCT03364309|7673737|FG012|Maintenance Period|Relapsed|0
4731291|NCT03364309|7673738|FG013|Maintenance Period|Relapsed|0
4731292|NCT03364309|7673739|FG014|Maintenance Period|Relapsed|0
4731293|NCT03364309|7673740|FG015|Maintenance Period|Relapsed|0
4731294|NCT03364309|7673741|FG016|Maintenance Period|Relapsed|0
4731295|NCT03364309|7673742|FG017|Maintenance Period|Relapsed|0
4731296|NCT03364309|7673743|FG018|Maintenance Period|Relapsed|0
4731297|NCT03364309|7673725|FG000|Maintenance Period|Lack of Efficacy|0
4731298|NCT03364309|7673726|FG001|Maintenance Period|Lack of Efficacy|0
4631176|NCT01890265|7500228|FG001|Overall Study|Progressive disease|6
4731299|NCT03364309|7673727|FG002|Maintenance Period|Lack of Efficacy|0
4731300|NCT03364309|7673728|FG003|Maintenance Period|Lack of Efficacy|0
4731301|NCT03364309|7673729|FG004|Maintenance Period|Lack of Efficacy|0
4631177|NCT01890265|7500229|FG002|Overall Study|Progressive disease|0
4631178|NCT01890265|7500230|FG003|Overall Study|Progressive disease|0
4631179|NCT01890265|7500231|FG004|Overall Study|Progressive disease|0
4631180|NCT01890265|7500232|FG005|Overall Study|Progressive disease|0
4731302|NCT03364309|7673730|FG005|Maintenance Period|Lack of Efficacy|0
4731303|NCT03364309|7673731|FG006|Maintenance Period|Lack of Efficacy|0
4631181|NCT01890265|7500227|FG000|Overall Study|Adverse Event|2
4631182|NCT01890265|7500228|FG001|Overall Study|Adverse Event|1
4631183|NCT01890265|7500229|FG002|Overall Study|Adverse Event|0
4631184|NCT01890265|7500230|FG003|Overall Study|Adverse Event|0
4631185|NCT01890265|7500231|FG004|Overall Study|Adverse Event|0
4631186|NCT01890265|7500232|FG005|Overall Study|Adverse Event|0
4631187|NCT01890265|7500227|FG000|Overall Study|Death|2
4631188|NCT01890265|7500228|FG001|Overall Study|Death|3
4446679|NCT00485264|7231699|FG001|Overall Study|Non-Compliant|2
4446680|NCT00485264|7231700|FG002|Overall Study|Non-Compliant|1
4446681|NCT00485264|7231701|FG003|Overall Study|Non-Compliant|0
4446682|NCT00485264|7231702|FG004|Overall Study|Non-Compliant|1
4446683|NCT00485264|7231703|FG005|Overall Study|Non-Compliant|0
4731304|NCT03364309|7673732|FG007|Maintenance Period|Lack of Efficacy|0
4731305|NCT03364309|7673733|FG008|Maintenance Period|Lack of Efficacy|1
4731306|NCT03364309|7673734|FG009|Maintenance Period|Lack of Efficacy|3
4731307|NCT03364309|7673735|FG010|Maintenance Period|Lack of Efficacy|2
4731308|NCT03364309|7673736|FG011|Maintenance Period|Lack of Efficacy|0
4731309|NCT03364309|7673737|FG012|Maintenance Period|Lack of Efficacy|0
4731310|NCT03364309|7673738|FG013|Maintenance Period|Lack of Efficacy|0
4731311|NCT03364309|7673739|FG014|Maintenance Period|Lack of Efficacy|0
4731312|NCT03364309|7673740|FG015|Maintenance Period|Lack of Efficacy|0
4731313|NCT03364309|7673741|FG016|Maintenance Period|Lack of Efficacy|0
4446684|NCT00485264|7231698|FG000|Overall Study|Lost to Follow-up|2
4446685|NCT00485264|7231699|FG001|Overall Study|Lost to Follow-up|1
4446686|NCT00485264|7231700|FG002|Overall Study|Lost to Follow-up|1
4446687|NCT00485264|7231701|FG003|Overall Study|Lost to Follow-up|0
4446688|NCT00485264|7231702|FG004|Overall Study|Lost to Follow-up|0
4446689|NCT00485264|7231703|FG005|Overall Study|Lost to Follow-up|1
4446690|NCT00485264|7231698|FG000|Overall Study|Other Reason|3
4446691|NCT00485264|7231699|FG001|Overall Study|Other Reason|0
4446692|NCT00485264|7231700|FG002|Overall Study|Other Reason|0
4446693|NCT00485264|7231701|FG003|Overall Study|Other Reason|0
4446694|NCT00485264|7231702|FG004|Overall Study|Other Reason|0
4446695|NCT00485264|7231703|FG005|Overall Study|Other Reason|0
4446696|NCT00485303|7231722|FG000|Overall Study|Adverse Event|5
4446697|NCT00485303|7231722|FG000|Overall Study|Progressive Disease|44
4446698|NCT00485303|7231722|FG000|Overall Study|Other|3
4446699|NCT00485303|7231722|FG000|Overall Study|Initiation of new anti-cancer treatment|2
4446700|NCT00485303|7231722|FG000|Overall Study|Treatment ongoing at cutoff date|2
4446701|NCT00485472|7231743|FG000|Overall Study|Adverse Event|8
4446702|NCT00485472|7231744|FG001|Overall Study|Adverse Event|5
4446703|NCT00485472|7231743|FG000|Overall Study|Lack of Efficacy|5
4446704|NCT00485472|7231744|FG001|Overall Study|Lack of Efficacy|4
4446705|NCT00485472|7231743|FG000|Overall Study|Withdrawal by Subject|1
4446706|NCT00485472|7231744|FG001|Overall Study|Withdrawal by Subject|0
4446707|NCT00485472|7231743|FG000|Overall Study|Protocol Violation|0
4446708|NCT00485472|7231744|FG001|Overall Study|Protocol Violation|1
4446709|NCT00485472|7231743|FG000|Overall Study|Other|2
4446710|NCT00485472|7231744|FG001|Overall Study|Other|1
4446711|NCT00485472|7231743|FG000|Overall Study|Lost to Follow-up|0
4446712|NCT00485472|7231744|FG001|Overall Study|Lost to Follow-up|1
4446713|NCT00485589|7231757|FG000|Overall Study|Death|2
4446714|NCT00485589|7231758|FG001|Overall Study|Death|2
4446715|NCT00485589|7231759|FG002|Overall Study|Death|0
4446716|NCT00485589|7231757|FG000|Overall Study|Failure to return|6
4446717|NCT00485589|7231758|FG001|Overall Study|Failure to return|5
4446718|NCT00485589|7231759|FG002|Overall Study|Failure to return|1
4446719|NCT00485589|7231757|FG000|Overall Study|Protocol Violation|1
4446720|NCT00485589|7231758|FG001|Overall Study|Protocol Violation|0
4446721|NCT00485589|7231759|FG002|Overall Study|Protocol Violation|0
4446722|NCT00485589|7231757|FG000|Overall Study|Violation of selection criteria at entry|0
4446723|NCT00485589|7231758|FG001|Overall Study|Violation of selection criteria at entry|3
4731314|NCT03364309|7673742|FG017|Maintenance Period|Lack of Efficacy|0
4731315|NCT03364309|7673743|FG018|Maintenance Period|Lack of Efficacy|0
4731316|NCT03364309|7673725|FG000|Maintenance Period|Death|0
4731317|NCT03364309|7673726|FG001|Maintenance Period|Death|0
4731318|NCT03364309|7673727|FG002|Maintenance Period|Death|0
4731319|NCT03364309|7673728|FG003|Maintenance Period|Death|0
4731320|NCT03364309|7673729|FG004|Maintenance Period|Death|0
4731321|NCT03364309|7673730|FG005|Maintenance Period|Death|0
4731322|NCT03364309|7673731|FG006|Maintenance Period|Death|0
4731323|NCT03364309|7673732|FG007|Maintenance Period|Death|0
4731324|NCT03364309|7673733|FG008|Maintenance Period|Death|1
4731325|NCT03364309|7673734|FG009|Maintenance Period|Death|0
4446724|NCT00485589|7231759|FG002|Overall Study|Violation of selection criteria at entry|1
4446725|NCT00485589|7231757|FG000|Overall Study|Administrative/Other|1
4446726|NCT00485589|7231758|FG001|Overall Study|Administrative/Other|2
4446727|NCT00485589|7231759|FG002|Overall Study|Administrative/Other|1
4446728|NCT00485589|7231757|FG000|Overall Study|Insufficient therapeutic response|10
4446729|NCT00485589|7231758|FG001|Overall Study|Insufficient therapeutic response|3
4446730|NCT00485589|7231759|FG002|Overall Study|Insufficient therapeutic response|1
4731326|NCT03364309|7673735|FG010|Maintenance Period|Death|0
4731327|NCT03364309|7673736|FG011|Maintenance Period|Death|0
4731328|NCT03364309|7673737|FG012|Maintenance Period|Death|0
4515351|NCT00952705|7326137|FG000|Overall Study|Withdrawal by Subject|2
4515352|NCT00952705|7326138|FG001|Overall Study|Withdrawal by Subject|1
4515353|NCT00952705|7326139|FG002|Overall Study|Withdrawal by Subject|1
4515354|NCT00952705|7326137|FG000|Overall Study|Death|2
4515355|NCT00952705|7326138|FG001|Overall Study|Death|0
4515356|NCT00952705|7326139|FG002|Overall Study|Death|0
4515357|NCT00952705|7326137|FG000|Overall Study|Incarcerated post dose|5
4515358|NCT00952705|7326138|FG001|Overall Study|Incarcerated post dose|0
4515359|NCT00952705|7326139|FG002|Overall Study|Incarcerated post dose|0
4515360|NCT00952705|7326137|FG000|Overall Study|Exclusion criteria not met pre dose|0
4515361|NCT00952705|7326138|FG001|Overall Study|Exclusion criteria not met pre dose|1
4515362|NCT00952705|7326139|FG002|Overall Study|Exclusion criteria not met pre dose|0
4515363|NCT00952731|7326164|FG000|Overall Study|Drug supply expired|1
4515364|NCT00952731|7326165|FG001|Overall Study|Drug supply expired|0
4515365|NCT00952822|7326171|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
4515366|NCT00952822|7326172|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1
4515367|NCT00952822|7326173|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
4731329|NCT03364309|7673738|FG013|Maintenance Period|Death|0
4731330|NCT03364309|7673739|FG014|Maintenance Period|Death|0
4515368|NCT00952822|7326174|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
4515369|NCT00952822|7326171|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
4515370|NCT00952822|7326172|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
4515371|NCT00952822|7326173|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1
4515372|NCT00952822|7326174|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
4515373|NCT00952848|7326185|FG000|Overall Study|Withdrawal by Subject|4
4515374|NCT00953017|7326193|FG000|Overall Study|DId not show up for colonoscopy|4
4515375|NCT00953017|7326194|FG001|Overall Study|DId not show up for colonoscopy|4
4515376|NCT00953017|7326195|FG002|Overall Study|DId not show up for colonoscopy|5
4515377|NCT00953017|7326196|FG003|Overall Study|DId not show up for colonoscopy|4
4515378|NCT00953017|7326193|FG000|Overall Study|Incomplete data|1
4515379|NCT00953017|7326194|FG001|Overall Study|Incomplete data|1
4515380|NCT00953017|7326195|FG002|Overall Study|Incomplete data|0
4515381|NCT00953017|7326196|FG003|Overall Study|Incomplete data|0
4515382|NCT00953017|7326193|FG000|Overall Study|Procedure incomplete due to pain/looping|0
4515383|NCT00953017|7326194|FG001|Overall Study|Procedure incomplete due to pain/looping|1
4515384|NCT00953017|7326195|FG002|Overall Study|Procedure incomplete due to pain/looping|0
4515385|NCT00953017|7326196|FG003|Overall Study|Procedure incomplete due to pain/looping|1
4515386|NCT00953017|7326193|FG000|Overall Study|Brown stool prior to procedure|0
4515387|NCT00953017|7326194|FG001|Overall Study|Brown stool prior to procedure|0
4515388|NCT00953017|7326195|FG002|Overall Study|Brown stool prior to procedure|1
4515389|NCT00953017|7326196|FG003|Overall Study|Brown stool prior to procedure|0
4515390|NCT00953043|7326208|FG000|Overall Study|Withdrawal by Subject|4
4515391|NCT00953043|7326209|FG001|Overall Study|Withdrawal by Subject|0
4515392|NCT00953043|7326208|FG000|Overall Study|Physician Decision|0
4515393|NCT00953043|7326209|FG001|Overall Study|Physician Decision|2
4515394|NCT00953056|7326221|FG000|Overall Study|Withdrew Consent|0
4515395|NCT00953056|7326222|FG001|Overall Study|Withdrew Consent|0
4515396|NCT00953056|7326223|FG002|Overall Study|Withdrew Consent|0
4515397|NCT00953056|7326224|FG003|Overall Study|Withdrew Consent|0
4515398|NCT00953056|7326225|FG004|Overall Study|Withdrew Consent|2
4731331|NCT03364309|7673740|FG015|Maintenance Period|Death|0
4731332|NCT03364309|7673741|FG016|Maintenance Period|Death|0
4731333|NCT03364309|7673742|FG017|Maintenance Period|Death|0
4731334|NCT03364309|7673743|FG018|Maintenance Period|Death|0
4731335|NCT03364309|7673725|FG000|Maintenance Period|Lost to Follow-up|0
4731336|NCT03364309|7673726|FG001|Maintenance Period|Lost to Follow-up|0
4731337|NCT03364309|7673727|FG002|Maintenance Period|Lost to Follow-up|0
4731338|NCT03364309|7673728|FG003|Maintenance Period|Lost to Follow-up|0
4731339|NCT03364309|7673729|FG004|Maintenance Period|Lost to Follow-up|0
4731340|NCT03364309|7673730|FG005|Maintenance Period|Lost to Follow-up|0
4731341|NCT03364309|7673731|FG006|Maintenance Period|Lost to Follow-up|0
4731342|NCT03364309|7673732|FG007|Maintenance Period|Lost to Follow-up|0
4731343|NCT03364309|7673733|FG008|Maintenance Period|Lost to Follow-up|1
4731344|NCT03364309|7673734|FG009|Maintenance Period|Lost to Follow-up|0
4731345|NCT03364309|7673735|FG010|Maintenance Period|Lost to Follow-up|0
4731346|NCT03364309|7673736|FG011|Maintenance Period|Lost to Follow-up|0
4515399|NCT00953056|7326226|FG005|Overall Study|Withdrew Consent|3
4515400|NCT00953056|7326221|FG000|Overall Study|Serious Adverse Event|0
4515401|NCT00953056|7326222|FG001|Overall Study|Serious Adverse Event|0
4515402|NCT00953056|7326223|FG002|Overall Study|Serious Adverse Event|0
4515403|NCT00953056|7326224|FG003|Overall Study|Serious Adverse Event|0
4515404|NCT00953056|7326225|FG004|Overall Study|Serious Adverse Event|0
4515405|NCT00953056|7326226|FG005|Overall Study|Serious Adverse Event|1
4518568|NCT00975130|7330762|FG002|Study Part 1|Administrative|0
4518569|NCT00975130|7330760|FG000|Study Part 1|Withdrew Consent|24
4518570|NCT00975130|7330761|FG001|Study Part 1|Withdrew Consent|0
4518571|NCT00975130|7330762|FG002|Study Part 1|Withdrew Consent|0
4518572|NCT00975130|7330760|FG000|Study Part 2|Adverse Event|0
4518573|NCT00975130|7330761|FG001|Study Part 2|Adverse Event|14
4518574|NCT00975130|7330762|FG002|Study Part 2|Adverse Event|7
4518575|NCT00975130|7330760|FG000|Study Part 2|Lost to Follow-up|0
4518576|NCT00975130|7330761|FG001|Study Part 2|Lost to Follow-up|0
4518577|NCT00975130|7330762|FG002|Study Part 2|Lost to Follow-up|1
4518578|NCT00975130|7330760|FG000|Study Part 2|Withdrawal by Subject|0
4518579|NCT00975130|7330761|FG001|Study Part 2|Withdrawal by Subject|13
4518580|NCT00975130|7330762|FG002|Study Part 2|Withdrawal by Subject|5
4518581|NCT00975130|7330760|FG000|Study Part 2|Withdrew Consent|0
4518582|NCT00975130|7330761|FG001|Study Part 2|Withdrew Consent|6
4518583|NCT00975130|7330762|FG002|Study Part 2|Withdrew Consent|2
4518584|NCT00975130|7330760|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0
4518585|NCT00975130|7330761|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4
4518586|NCT00975130|7330762|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1
4518587|NCT00975130|7330760|FG000|Study Part 2|Administrative|0
4518588|NCT00975130|7330761|FG001|Study Part 2|Administrative|1
4518589|NCT00975130|7330762|FG002|Study Part 2|Administrative|0
4518590|NCT00975130|7330760|FG000|Study Part 2|Protocol Violation|0
4518591|NCT00975130|7330761|FG001|Study Part 2|Protocol Violation|0
4518592|NCT00975130|7330762|FG002|Study Part 2|Protocol Violation|1
4518593|NCT00975143|7330777|FG000|Overall Study|Adverse Event|19
4518594|NCT00975143|7330778|FG001|Overall Study|Adverse Event|15
4518595|NCT00975143|7330777|FG000|Overall Study|Withdrawal by Subject|15
4518596|NCT00975143|7330778|FG001|Overall Study|Withdrawal by Subject|15
4518597|NCT00975143|7330777|FG000|Overall Study|Lost to Follow-up|20
4518598|NCT00975143|7330778|FG001|Overall Study|Lost to Follow-up|16
4518599|NCT00975143|7330777|FG000|Overall Study|Non-compliance|5
4518600|NCT00975143|7330778|FG001|Overall Study|Non-compliance|8
4518601|NCT00975143|7330777|FG000|Overall Study|Physician Decision|1
4518602|NCT00975143|7330778|FG001|Overall Study|Physician Decision|2
4518603|NCT00975143|7330777|FG000|Overall Study|Details not available|10
4518604|NCT00975143|7330778|FG001|Overall Study|Details not available|4
4518605|NCT00975156|7330786|FG000|Overall Study|Protocol Violation|0
4518606|NCT00975156|7330787|FG001|Overall Study|Protocol Violation|1
4518607|NCT00975195|7330799|FG000|Overall Study|Adverse Event|108
4518608|NCT00975195|7330800|FG001|Overall Study|Adverse Event|101
4518609|NCT00975195|7330799|FG000|Overall Study|Lack of Efficacy|6
4518610|NCT00975195|7330800|FG001|Overall Study|Lack of Efficacy|6
4631189|NCT01890265|7500229|FG002|Overall Study|Death|1
4631190|NCT01890265|7500230|FG003|Overall Study|Death|0
4631191|NCT01890265|7500231|FG004|Overall Study|Death|0
4631192|NCT01890265|7500232|FG005|Overall Study|Death|0
4631193|NCT01890265|7500227|FG000|Overall Study|Withdrawal by Subject|0
4631194|NCT01890265|7500228|FG001|Overall Study|Withdrawal by Subject|2
4631195|NCT01890265|7500229|FG002|Overall Study|Withdrawal by Subject|3
4631196|NCT01890265|7500230|FG003|Overall Study|Withdrawal by Subject|0
4631197|NCT01890265|7500231|FG004|Overall Study|Withdrawal by Subject|2
4631198|NCT01890265|7500232|FG005|Overall Study|Withdrawal by Subject|0
4631199|NCT01890421|7500255|FG000|Overall Study|Adverse Event|1
4631200|NCT01890421|7500255|FG000|Overall Study|Other reason|10
4631201|NCT01890434|7500259|FG000|Overall Study|Adverse Event|8
4731347|NCT03364309|7673737|FG012|Maintenance Period|Lost to Follow-up|0
4731348|NCT03364309|7673738|FG013|Maintenance Period|Lost to Follow-up|0
4731349|NCT03364309|7673739|FG014|Maintenance Period|Lost to Follow-up|0
4518611|NCT00975195|7330799|FG000|Overall Study|Protocol Violation|27
4731350|NCT03364309|7673740|FG015|Maintenance Period|Lost to Follow-up|0
4731351|NCT03364309|7673741|FG016|Maintenance Period|Lost to Follow-up|0
4731352|NCT03364309|7673742|FG017|Maintenance Period|Lost to Follow-up|0
4518612|NCT00975195|7330800|FG001|Overall Study|Protocol Violation|23
4518613|NCT00975195|7330799|FG000|Overall Study|Lost to Follow-up|9
4518614|NCT00975195|7330800|FG001|Overall Study|Lost to Follow-up|7
4518615|NCT00975195|7330799|FG000|Overall Study|Withdrawal by Subject|48
4518616|NCT00975195|7330800|FG001|Overall Study|Withdrawal by Subject|61
4518617|NCT00975195|7330799|FG000|Overall Study|Other reason not defined above|29
4518618|NCT00975195|7330800|FG001|Overall Study|Other reason not defined above|33
4518619|NCT00975195|7330799|FG000|Overall Study|Not treated|1
4518620|NCT00975195|7330800|FG001|Overall Study|Not treated|2
4518621|NCT00975221|7330808|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2
4518622|NCT00975221|7330809|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3
4631202|NCT01890434|7500259|FG000|Overall Study|PCI at external hospital|1
4631203|NCT01890434|7500259|FG000|Overall Study|Assessment discrepancy|1
4631204|NCT01890434|7500259|FG000|Overall Study|CRC didn't contact participant for FU|1
4515406|NCT00953147|7326258|FG000|Overall Study|Adverse Event|8
4515407|NCT00953147|7326259|FG001|Overall Study|Adverse Event|16
4515408|NCT00953147|7326260|FG002|Overall Study|Adverse Event|6
4515409|NCT00953147|7326258|FG000|Overall Study|Protocol Violation|2
4515410|NCT00953147|7326259|FG001|Overall Study|Protocol Violation|8
4515411|NCT00953147|7326260|FG002|Overall Study|Protocol Violation|4
4515412|NCT00953147|7326258|FG000|Overall Study|Withdrawal by Subject|13
4515413|NCT00953147|7326259|FG001|Overall Study|Withdrawal by Subject|15
4631205|NCT01890434|7500259|FG000|Overall Study|Could not get whole set of images|1
4631206|NCT01890434|7500259|FG000|Overall Study|Decline to return for GSPECT|1
4631207|NCT01890434|7500259|FG000|Overall Study|GSPECT at rest was not done|1
4515414|NCT00953147|7326260|FG002|Overall Study|Withdrawal by Subject|12
4515415|NCT00953147|7326258|FG000|Overall Study|Lost to Follow-up|8
4515416|NCT00953147|7326259|FG001|Overall Study|Lost to Follow-up|9
4515417|NCT00953147|7326260|FG002|Overall Study|Lost to Follow-up|4
4515418|NCT00953147|7326258|FG000|Overall Study|Physician Decision|2
4515419|NCT00953147|7326259|FG001|Overall Study|Physician Decision|7
4515420|NCT00953147|7326260|FG002|Overall Study|Physician Decision|3
4515421|NCT00953147|7326258|FG000|Overall Study|Other|4
4515422|NCT00953147|7326259|FG001|Overall Study|Other|11
4515423|NCT00953147|7326260|FG002|Overall Study|Other|13
4515424|NCT00953160|7326268|FG000|Overall Study|Lost to Follow-up|23
4515425|NCT00953160|7326268|FG000|Overall Study|Withdrawal by Subject|4
4515426|NCT00953225|7326310|FG000|Overall Study|Withdrawal by Subject|2
4515427|NCT00953225|7326311|FG001|Overall Study|Withdrawal by Subject|0
4515428|NCT00953407|7326329|FG000|Overall Study|Failed inclusion criteria|1
4515429|NCT00953407|7326330|FG001|Overall Study|Failed inclusion criteria|1
4515430|NCT00953407|7326331|FG002|Overall Study|Failed inclusion criteria|1
4515431|NCT00953407|7326332|FG003|Overall Study|Failed inclusion criteria|1
4515432|NCT00953407|7326333|FG004|Overall Study|Failed inclusion criteria|1
4515433|NCT00953407|7326329|FG000|Overall Study|Lost to Follow-up|0
4515434|NCT00953407|7326330|FG001|Overall Study|Lost to Follow-up|0
4515435|NCT00953407|7326331|FG002|Overall Study|Lost to Follow-up|0
4515436|NCT00953407|7326332|FG003|Overall Study|Lost to Follow-up|1
4515437|NCT00953407|7326333|FG004|Overall Study|Lost to Follow-up|0
4446731|NCT00485589|7231757|FG000|Overall Study|Refused treatment/did not cooperate|1
4446732|NCT00485589|7231758|FG001|Overall Study|Refused treatment/did not cooperate|0
4446733|NCT00485589|7231759|FG002|Overall Study|Refused treatment/did not cooperate|2
4446734|NCT00485589|7231757|FG000|Overall Study|Withdrawal by Subject|3
4446735|NCT00485589|7231758|FG001|Overall Study|Withdrawal by Subject|2
4446736|NCT00485589|7231759|FG002|Overall Study|Withdrawal by Subject|2
4446737|NCT00485589|7231757|FG000|Overall Study|Adverse Event|3
4446738|NCT00485589|7231758|FG001|Overall Study|Adverse Event|3
4446739|NCT00485589|7231759|FG002|Overall Study|Adverse Event|10
4446740|NCT00485732|7231790|FG000|Overall Study|Protocol Violation|1
4446741|NCT00485732|7231791|FG001|Overall Study|Protocol Violation|3
4446742|NCT00485732|7231790|FG000|Overall Study|Withdrawal by Subject|5
4446743|NCT00485732|7231791|FG001|Overall Study|Withdrawal by Subject|4
4446744|NCT00485732|7231790|FG000|Overall Study|Lost to Follow-up|2
4446745|NCT00485732|7231791|FG001|Overall Study|Lost to Follow-up|2
4446746|NCT00485758|7231799|FG000|Overall Study|Adverse Event|102
4446747|NCT00485758|7231800|FG001|Overall Study|Adverse Event|31
4446748|NCT00485758|7231799|FG000|Overall Study|Death|0
4446749|NCT00485758|7231800|FG001|Overall Study|Death|1
4446750|NCT00485758|7231799|FG000|Overall Study|Lost to Follow-up|5
4446751|NCT00485758|7231800|FG001|Overall Study|Lost to Follow-up|1
4446752|NCT00485758|7231799|FG000|Overall Study|Physician Decision|3
4515438|NCT00953524|7326349|FG000|Overall Study|Adverse Event|2
4515439|NCT00953524|7326350|FG001|Overall Study|Adverse Event|0
4446753|NCT00485758|7231800|FG001|Overall Study|Physician Decision|3
4515440|NCT00953524|7326351|FG002|Overall Study|Adverse Event|1
4515441|NCT00953524|7326352|FG003|Overall Study|Adverse Event|2
4515442|NCT00953524|7326349|FG000|Overall Study|Protocol Violation|18
4515443|NCT00953524|7326350|FG001|Overall Study|Protocol Violation|10
4446754|NCT00485758|7231799|FG000|Overall Study|Protocol Violation|11
4446755|NCT00485758|7231800|FG001|Overall Study|Protocol Violation|2
4446756|NCT00485758|7231799|FG000|Overall Study|Withdrawal by Subject|32
4446757|NCT00485758|7231800|FG001|Overall Study|Withdrawal by Subject|27
4446758|NCT00485758|7231799|FG000|Overall Study|Study Terminated by Sponsor|3
4446759|NCT00485758|7231800|FG001|Overall Study|Study Terminated by Sponsor|0
4446760|NCT00486044|7231850|FG000|Overall Study|Withdrawal by Subject|2
4446761|NCT00486044|7231851|FG001|Overall Study|Withdrawal by Subject|1
4446762|NCT00486044|7231850|FG000|Overall Study|Adverse Event|0
4446763|NCT00486044|7231851|FG001|Overall Study|Adverse Event|1
4446764|NCT00486044|7231850|FG000|Overall Study|Lost to Follow-up|0
4446765|NCT00486044|7231851|FG001|Overall Study|Lost to Follow-up|1
4446766|NCT00486226|7231857|FG000|Overall Study|Death|3
4446767|NCT00486226|7231857|FG000|Overall Study|Adverse Event|1
4446768|NCT00486226|7231857|FG000|Overall Study|Withdrawal by Subject|1
4446769|NCT00486226|7231857|FG000|Overall Study|Lost to Follow-up|8
4731353|NCT03364309|7673743|FG018|Maintenance Period|Lost to Follow-up|0
4731354|NCT03364309|7673725|FG000|Maintenance Period|Miscellaneous|0
4731355|NCT03364309|7673726|FG001|Maintenance Period|Miscellaneous|0
4731356|NCT03364309|7673727|FG002|Maintenance Period|Miscellaneous|0
4731357|NCT03364309|7673728|FG003|Maintenance Period|Miscellaneous|0
4731358|NCT03364309|7673729|FG004|Maintenance Period|Miscellaneous|0
4731359|NCT03364309|7673730|FG005|Maintenance Period|Miscellaneous|0
4731360|NCT03364309|7673731|FG006|Maintenance Period|Miscellaneous|0
4731361|NCT03364309|7673732|FG007|Maintenance Period|Miscellaneous|0
4731362|NCT03364309|7673733|FG008|Maintenance Period|Miscellaneous|1
4731363|NCT03364309|7673734|FG009|Maintenance Period|Miscellaneous|0
4446770|NCT00486252|7231864|FG000|Overall Study|Adverse Event|7
4446771|NCT00486252|7231864|FG000|Overall Study|Lack of Efficacy|9
4446772|NCT00486252|7231864|FG000|Overall Study|Lost to Follow-up|24
4631208|NCT01890434|7500259|FG000|Overall Study|Participant didn't complete MRI|1
4631209|NCT01890434|7500259|FG000|Overall Study|Uncontactable by phone|1
4446773|NCT00486252|7231864|FG000|Overall Study|Other|18
4446774|NCT00486265|7231870|FG000|Overall Study|Adverse Event|1
4446775|NCT00486265|7231870|FG000|Overall Study|Lack of Efficacy|8
4446776|NCT00486278|7231874|FG000|Overall Study|Adverse Event|5
4446777|NCT00486278|7231874|FG000|Overall Study|Withdrawal by Subject|2
4446778|NCT00486278|7231874|FG000|Overall Study|Physician Decision|2
4446779|NCT00486291|7231890|FG000|Overall Study|Adverse Event|3
4446780|NCT00486291|7231891|FG001|Overall Study|Adverse Event|4
4446781|NCT00486291|7231890|FG000|Overall Study|Lost to Follow-up|3
4446782|NCT00486291|7231891|FG001|Overall Study|Lost to Follow-up|7
4446783|NCT00486291|7231890|FG000|Overall Study|protocol non-compliance|10
4446784|NCT00486291|7231891|FG001|Overall Study|protocol non-compliance|15
4446785|NCT00486291|7231890|FG000|Overall Study|requirement for restricted medication|0
4446786|NCT00486291|7231891|FG001|Overall Study|requirement for restricted medication|3
4446787|NCT00486330|7231897|FG000|Overall Study|Adverse Event|2
4446788|NCT00486434|7231903|FG000|Overall Study|Withdrawal by Subject|34
4446789|NCT00486434|7231904|FG001|Overall Study|Withdrawal by Subject|39
4446790|NCT00486434|7231903|FG000|Overall Study|Adverse Event|118
4446791|NCT00486434|7231904|FG001|Overall Study|Adverse Event|44
4446792|NCT00486434|7231903|FG000|Overall Study|Protocol Violation|22
4446793|NCT00486434|7231904|FG001|Overall Study|Protocol Violation|21
4446794|NCT00486434|7231903|FG000|Overall Study|Lack of Efficacy|12
4446795|NCT00486434|7231904|FG001|Overall Study|Lack of Efficacy|19
4446796|NCT00486434|7231903|FG000|Overall Study|Lost to Follow-up|2
4446797|NCT00486434|7231904|FG001|Overall Study|Lost to Follow-up|3
4446798|NCT00486434|7231903|FG000|Overall Study|Death|1
4446799|NCT00486434|7231904|FG001|Overall Study|Death|2
4446800|NCT00486434|7231903|FG000|Overall Study|Personal reasons|5
4446801|NCT00486434|7231904|FG001|Overall Study|Personal reasons|6
4446802|NCT00486603|7231927|FG000|Overall Study|Withdrawal by Subject|1
4446803|NCT00486603|7231928|FG001|Overall Study|Withdrawal by Subject|0
4446804|NCT00486603|7231929|FG002|Overall Study|Withdrawal by Subject|0
4446805|NCT00486603|7231930|FG003|Overall Study|Withdrawal by Subject|0
4446806|NCT00486603|7231931|FG004|Overall Study|Withdrawal by Subject|0
4446807|NCT00486603|7231927|FG000|Overall Study|Physician Decision|0
4446808|NCT00486603|7231928|FG001|Overall Study|Physician Decision|1
4446809|NCT00486603|7231929|FG002|Overall Study|Physician Decision|0
4446810|NCT00486603|7231930|FG003|Overall Study|Physician Decision|0
4446811|NCT00486603|7231931|FG004|Overall Study|Physician Decision|0
4446812|NCT00486720|7231959|FG000|Overall Study|Adverse Event|1
4446813|NCT00486720|7231960|FG001|Overall Study|Adverse Event|2
4446814|NCT00486720|7231959|FG000|Overall Study|Lack of Efficacy|4
4446815|NCT00486720|7231960|FG001|Overall Study|Lack of Efficacy|6
4446816|NCT00486720|7231959|FG000|Overall Study|Physician Decision|1
4446817|NCT00486720|7231960|FG001|Overall Study|Physician Decision|2
4446818|NCT00486720|7231959|FG000|Overall Study|Protocol Violation|1
4446819|NCT00486720|7231960|FG001|Overall Study|Protocol Violation|0
4446820|NCT00486720|7231959|FG000|Overall Study|Withdrawal by Subject|3
4446821|NCT00486720|7231960|FG001|Overall Study|Withdrawal by Subject|1
4446822|NCT00486720|7231959|FG000|Overall Study|Progressive Disease|0
4446823|NCT00486720|7231960|FG001|Overall Study|Progressive Disease|1
4446824|NCT00486759|7231968|FG000|Treatment|Adverse event/intercurrent illness|86
4446825|NCT00486759|7231969|FG001|Treatment|Adverse event/intercurrent illness|39
4446826|NCT00486759|7231968|FG000|Treatment|Insufficient therapeutic response|37
4446827|NCT00486759|7231969|FG001|Treatment|Insufficient therapeutic response|39
4446828|NCT00486759|7231968|FG000|Treatment|Death|17
4446829|NCT00486759|7231969|FG001|Treatment|Death|10
4446830|NCT00486759|7231968|FG000|Treatment|Withdrew consent|15
4446831|NCT00486759|7231969|FG001|Treatment|Withdrew consent|12
4446832|NCT00486759|7231968|FG000|Treatment|Administrative/reason not specified|17
4446833|NCT00486759|7231969|FG001|Treatment|Administrative/reason not specified|21
4446834|NCT00486759|7231968|FG000|Treatment|Refused treatment|10
4446835|NCT00486759|7231969|FG001|Treatment|Refused treatment|7
4446836|NCT00486759|7231968|FG000|Treatment|Violation of selection criteria at entry|3
4446837|NCT00486759|7231969|FG001|Treatment|Violation of selection criteria at entry|3
4631210|NCT01890434|7500259|FG000|Overall Study|Moved out of position|1
4631211|NCT01890434|7500259|FG000|Overall Study|Unable to contact|1
4631212|NCT01890434|7500259|FG000|Overall Study|Withdrawal by PI for ICA not performed|2
4731364|NCT03364309|7673735|FG010|Maintenance Period|Miscellaneous|0
4731365|NCT03364309|7673736|FG011|Maintenance Period|Miscellaneous|0
4731366|NCT03364309|7673737|FG012|Maintenance Period|Miscellaneous|0
4731367|NCT03364309|7673738|FG013|Maintenance Period|Miscellaneous|0
4731368|NCT03364309|7673739|FG014|Maintenance Period|Miscellaneous|0
4731369|NCT03364309|7673740|FG015|Maintenance Period|Miscellaneous|0
4731370|NCT03364309|7673741|FG016|Maintenance Period|Miscellaneous|0
4731371|NCT03364309|7673742|FG017|Maintenance Period|Miscellaneous|0
4731372|NCT03364309|7673743|FG018|Maintenance Period|Miscellaneous|0
4731373|NCT03364309|7673725|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
4731374|NCT03364309|7673726|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
4731375|NCT03364309|7673727|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
4731376|NCT03364309|7673728|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
4731377|NCT03364309|7673729|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
4731378|NCT03364309|7673730|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
4731379|NCT03364309|7673731|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
4731380|NCT03364309|7673732|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
4731381|NCT03364309|7673733|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
4731382|NCT03364309|7673734|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
4731383|NCT03364309|7673735|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
4631213|NCT01890473|7500265|FG000|Overall Study|Lost to Follow-up|1
4631214|NCT01890473|7500266|FG001|Overall Study|Lost to Follow-up|0
4631215|NCT01890473|7500265|FG000|Overall Study|Poor/non-compliance|1
4631216|NCT01890473|7500266|FG001|Overall Study|Poor/non-compliance|0
4631217|NCT01890512|7500274|FG000|Overall Study|Physician Decision|1
4631218|NCT01890512|7500274|FG000|Overall Study|Withdrawal by Subject|1
4631219|NCT01890512|7500274|FG000|Overall Study|Protocol Violation|1
4631220|NCT01890707|7500293|FG000|Overall Study|Lost to Follow-up|1
4631221|NCT01890707|7500294|FG001|Overall Study|Lost to Follow-up|1
4631222|NCT01890746|7500302|FG000|Overall Study|Death|39
4631223|NCT01890746|7500303|FG001|Overall Study|Death|30
4631224|NCT01890746|7500302|FG000|Overall Study|Adverse Event|1
4631225|NCT01890746|7500303|FG001|Overall Study|Adverse Event|0
4631226|NCT01890746|7500302|FG000|Overall Study|Lost to Follow-up|4
4631227|NCT01890746|7500303|FG001|Overall Study|Lost to Follow-up|1
4631228|NCT01890746|7500302|FG000|Overall Study|Physician Decision|3
4631229|NCT01890746|7500303|FG001|Overall Study|Physician Decision|2
4631230|NCT01890746|7500302|FG000|Overall Study|Withdrawal by Subject|5
4631231|NCT01890746|7500303|FG001|Overall Study|Withdrawal by Subject|8
4631232|NCT01890785|7500315|FG000|Third Intervention|Withdrawal by Subject|0
4731384|NCT03364309|7673736|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
4731385|NCT03364309|7673737|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
4731386|NCT03364309|7673738|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1
4731387|NCT03364309|7673739|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1
4731388|NCT03364309|7673740|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1
4731389|NCT03364309|7673741|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
4731390|NCT03364309|7673742|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
4731391|NCT03364309|7673743|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0
4731392|NCT03364309|7673725|FG000|Re-treatment (Maintenance) Period|Adverse Event|0
4731393|NCT03364309|7673726|FG001|Re-treatment (Maintenance) Period|Adverse Event|0
4731394|NCT03364309|7673727|FG002|Re-treatment (Maintenance) Period|Adverse Event|0
4731395|NCT03364309|7673728|FG003|Re-treatment (Maintenance) Period|Adverse Event|0
4731396|NCT03364309|7673729|FG004|Re-treatment (Maintenance) Period|Adverse Event|0
4731397|NCT03364309|7673730|FG005|Re-treatment (Maintenance) Period|Adverse Event|0
4731398|NCT03364309|7673731|FG006|Re-treatment (Maintenance) Period|Adverse Event|0
4731399|NCT03364309|7673732|FG007|Re-treatment (Maintenance) Period|Adverse Event|0
4731400|NCT03364309|7673733|FG008|Re-treatment (Maintenance) Period|Adverse Event|0
4731401|NCT03364309|7673734|FG009|Re-treatment (Maintenance) Period|Adverse Event|0
4731402|NCT03364309|7673735|FG010|Re-treatment (Maintenance) Period|Adverse Event|0
4731403|NCT03364309|7673736|FG011|Re-treatment (Maintenance) Period|Adverse Event|0
4631233|NCT01890785|7500316|FG001|Third Intervention|Withdrawal by Subject|1
4631234|NCT01890785|7500317|FG002|Third Intervention|Withdrawal by Subject|0
4731404|NCT03364309|7673737|FG012|Re-treatment (Maintenance) Period|Adverse Event|0
4731405|NCT03364309|7673738|FG013|Re-treatment (Maintenance) Period|Adverse Event|0
4731406|NCT03364309|7673739|FG014|Re-treatment (Maintenance) Period|Adverse Event|1
4731407|NCT03364309|7673740|FG015|Re-treatment (Maintenance) Period|Adverse Event|0
4731408|NCT03364309|7673741|FG016|Re-treatment (Maintenance) Period|Adverse Event|0
4731409|NCT03364309|7673742|FG017|Re-treatment (Maintenance) Period|Adverse Event|0
4731410|NCT03364309|7673743|FG018|Re-treatment (Maintenance) Period|Adverse Event|0
4731411|NCT03364309|7673725|FG000|Re-treatment (Maintenance) Period|Relapse|0
4731412|NCT03364309|7673726|FG001|Re-treatment (Maintenance) Period|Relapse|0
4731413|NCT03364309|7673727|FG002|Re-treatment (Maintenance) Period|Relapse|0
4731414|NCT03364309|7673728|FG003|Re-treatment (Maintenance) Period|Relapse|0
4731415|NCT03364309|7673729|FG004|Re-treatment (Maintenance) Period|Relapse|0
4731416|NCT03364309|7673730|FG005|Re-treatment (Maintenance) Period|Relapse|0
4731417|NCT03364309|7673731|FG006|Re-treatment (Maintenance) Period|Relapse|0
4731418|NCT03364309|7673732|FG007|Re-treatment (Maintenance) Period|Relapse|0
4731419|NCT03364309|7673733|FG008|Re-treatment (Maintenance) Period|Relapse|0
4731420|NCT03364309|7673734|FG009|Re-treatment (Maintenance) Period|Relapse|0
4731421|NCT03364309|7673735|FG010|Re-treatment (Maintenance) Period|Relapse|0
4731422|NCT03364309|7673736|FG011|Re-treatment (Maintenance) Period|Relapse|0
4731423|NCT03364309|7673737|FG012|Re-treatment (Maintenance) Period|Relapse|1
4731424|NCT03364309|7673738|FG013|Re-treatment (Maintenance) Period|Relapse|0
4731425|NCT03364309|7673739|FG014|Re-treatment (Maintenance) Period|Relapse|0
4731426|NCT03364309|7673740|FG015|Re-treatment (Maintenance) Period|Relapse|1
4731427|NCT03364309|7673741|FG016|Re-treatment (Maintenance) Period|Relapse|0
4731428|NCT03364309|7673742|FG017|Re-treatment (Maintenance) Period|Relapse|0
4731429|NCT03364309|7673743|FG018|Re-treatment (Maintenance) Period|Relapse|0
4731430|NCT03364309|7673725|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0
4731431|NCT03364309|7673726|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0
4737256|NCT03602339|7687253|FG000|Overall Study|Withdrawal by Subject|9
4731432|NCT03364309|7673727|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0
4731433|NCT03364309|7673728|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0
4731434|NCT03364309|7673729|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0
4731435|NCT03364309|7673730|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0
4731436|NCT03364309|7673731|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0
4731437|NCT03364309|7673732|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0
4731438|NCT03364309|7673733|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0
4731439|NCT03364309|7673734|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0
4731440|NCT03364309|7673735|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0
4731441|NCT03364309|7673736|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0
4731442|NCT03364309|7673737|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0
4731443|NCT03364309|7673738|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0
4731444|NCT03364309|7673739|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0
4731445|NCT03364309|7673740|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0
4731446|NCT03364309|7673741|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3
4731447|NCT03364309|7673742|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19
4731448|NCT03364309|7673743|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1
4731449|NCT03364309|7673725|FG000|Post-Treatment Followup Period|Adverse Event|0
4731450|NCT03364309|7673726|FG001|Post-Treatment Followup Period|Adverse Event|0
4731451|NCT03364309|7673727|FG002|Post-Treatment Followup Period|Adverse Event|0
4731452|NCT03364309|7673728|FG003|Post-Treatment Followup Period|Adverse Event|0
4731453|NCT03364309|7673729|FG004|Post-Treatment Followup Period|Adverse Event|0
4731454|NCT03364309|7673730|FG005|Post-Treatment Followup Period|Adverse Event|0
4731455|NCT03364309|7673731|FG006|Post-Treatment Followup Period|Adverse Event|0
4731456|NCT03364309|7673732|FG007|Post-Treatment Followup Period|Adverse Event|0
4731457|NCT03364309|7673733|FG008|Post-Treatment Followup Period|Adverse Event|0
4737257|NCT03602339|7687253|FG000|Overall Study|Physician Decision|2
4737258|NCT03602339|7687253|FG000|Overall Study|Other reason|4
4737259|NCT03602482|7687262|FG000|Overall Study|Withdrawal by Subject|6
4737260|NCT03602482|7687263|FG001|Overall Study|Withdrawal by Subject|7
4737261|NCT03602482|7687264|FG002|Overall Study|Withdrawal by Subject|0
4737262|NCT03602482|7687265|FG003|Overall Study|Withdrawal by Subject|0
4737263|NCT03603028|7687278|FG000|Overall Study|Withdrawal by Subject|1
4737264|NCT03603652|7687336|FG000|Overall Study|Death|2
4737265|NCT03604341|7687346|FG000|Overall Study|Withdrawal by Subject|1
4737266|NCT03604341|7687347|FG001|Overall Study|Withdrawal by Subject|1
4737267|NCT03604341|7687346|FG000|Overall Study|Adverse Event|1
4737268|NCT03604341|7687347|FG001|Overall Study|Adverse Event|0
4737269|NCT03604341|7687346|FG000|Overall Study|Protocol Violation|0
4737270|NCT03604341|7687347|FG001|Overall Study|Protocol Violation|1
4737271|NCT03604497|7687353|FG000|Overall Study|Protocol Violation|52
4737272|NCT03604523|7687363|FG000|Overall Study|Physician Decision|1
4737273|NCT03604523|7687364|FG001|Overall Study|Physician Decision|0
4737274|NCT03605212|7687387|FG000|Treatment Period|Adverse Event|1
4737275|NCT03605212|7687388|FG001|Treatment Period|Adverse Event|0
4737276|NCT03605212|7687389|FG002|Treatment Period|Adverse Event|0
4737277|NCT03605212|7687390|FG003|Treatment Period|Adverse Event|0
4737278|NCT03605212|7687391|FG004|Treatment Period|Adverse Event|0
4737279|NCT03605212|7687387|FG000|Treatment Period|Physician Decision|0
4737280|NCT03605212|7687388|FG001|Treatment Period|Physician Decision|0
4737281|NCT03605212|7687389|FG002|Treatment Period|Physician Decision|0
4737282|NCT03605212|7687390|FG003|Treatment Period|Physician Decision|0
4737283|NCT03605212|7687391|FG004|Treatment Period|Physician Decision|1
4737284|NCT03605693|7687406|FG000|Overall Study|Lost to Follow-up|4
4737285|NCT03605693|7687407|FG001|Overall Study|Lost to Follow-up|0
4737286|NCT03605693|7687406|FG000|Overall Study|Physician Decision|1
4737287|NCT03605693|7687407|FG001|Overall Study|Physician Decision|0
4590591|NCT01523301|7436718|FG001|Overall Study|Lost to Follow-up|0
4590592|NCT01523301|7436717|FG000|Overall Study|Withdrawal by Subject|6
4590593|NCT01523301|7436718|FG001|Overall Study|Withdrawal by Subject|8
4590594|NCT01523301|7436717|FG000|Overall Study|Other Reason|0
4590595|NCT01523301|7436718|FG001|Overall Study|Other Reason|2
4590596|NCT01523366|7436726|FG000|Treatment Period 1|Withdrawal by Subject|1
4590597|NCT01523366|7436727|FG001|Treatment Period 1|Withdrawal by Subject|0
4590598|NCT01523366|7436726|FG000|Treatment Period 2|Not completed at least 7 days treatment|1
4590599|NCT01523366|7436727|FG001|Treatment Period 2|Not completed at least 7 days treatment|0
4590600|NCT01523392|7436737|FG000|Treatment Period 1|Withdrawal by Subject|2
4590601|NCT01523392|7436738|FG001|Treatment Period 1|Withdrawal by Subject|0
4590602|NCT01523392|7436737|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1
4590603|NCT01523392|7436738|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0
4590604|NCT01523392|7436737|FG000|Washout Period - 10 to 14 Days|Adverse Event|1
4590605|NCT01523392|7436738|FG001|Washout Period - 10 to 14 Days|Adverse Event|0
4590606|NCT01523457|7436748|FG000|Overall Study|Withdrawal by Subject|7
4590607|NCT01523457|7436749|FG001|Overall Study|Withdrawal by Subject|2
4590608|NCT01523587|7436778|FG000|Overall Study|Other than listed|5
4590609|NCT01523587|7436779|FG001|Overall Study|Other than listed|5
4590610|NCT01523587|7436778|FG000|Overall Study|Worsening of underlying cancer disease|19
4731458|NCT03364309|7673734|FG009|Post-Treatment Followup Period|Adverse Event|0
4731459|NCT03364309|7673735|FG010|Post-Treatment Followup Period|Adverse Event|0
4731460|NCT03364309|7673736|FG011|Post-Treatment Followup Period|Adverse Event|0
4731461|NCT03364309|7673737|FG012|Post-Treatment Followup Period|Adverse Event|0
4731462|NCT03364309|7673738|FG013|Post-Treatment Followup Period|Adverse Event|0
4731463|NCT03364309|7673739|FG014|Post-Treatment Followup Period|Adverse Event|0
4731464|NCT03364309|7673740|FG015|Post-Treatment Followup Period|Adverse Event|0
4731465|NCT03364309|7673741|FG016|Post-Treatment Followup Period|Adverse Event|2
4731466|NCT03364309|7673742|FG017|Post-Treatment Followup Period|Adverse Event|6
4731467|NCT03364309|7673743|FG018|Post-Treatment Followup Period|Adverse Event|1
4731468|NCT03364309|7673725|FG000|Post-Treatment Followup Period|Lost to Follow-up|0
4731469|NCT03364309|7673726|FG001|Post-Treatment Followup Period|Lost to Follow-up|0
4731470|NCT03364309|7673727|FG002|Post-Treatment Followup Period|Lost to Follow-up|0
4731471|NCT03364309|7673728|FG003|Post-Treatment Followup Period|Lost to Follow-up|0
4731472|NCT03364309|7673729|FG004|Post-Treatment Followup Period|Lost to Follow-up|0
4731473|NCT03364309|7673730|FG005|Post-Treatment Followup Period|Lost to Follow-up|0
4731474|NCT03364309|7673731|FG006|Post-Treatment Followup Period|Lost to Follow-up|0
4731475|NCT03364309|7673732|FG007|Post-Treatment Followup Period|Lost to Follow-up|0
4731476|NCT03364309|7673733|FG008|Post-Treatment Followup Period|Lost to Follow-up|0
4731477|NCT03364309|7673734|FG009|Post-Treatment Followup Period|Lost to Follow-up|0
4731478|NCT03364309|7673735|FG010|Post-Treatment Followup Period|Lost to Follow-up|0
4731479|NCT03364309|7673736|FG011|Post-Treatment Followup Period|Lost to Follow-up|0
4731480|NCT03364309|7673737|FG012|Post-Treatment Followup Period|Lost to Follow-up|0
4731481|NCT03364309|7673738|FG013|Post-Treatment Followup Period|Lost to Follow-up|0
4731482|NCT03364309|7673739|FG014|Post-Treatment Followup Period|Lost to Follow-up|0
4731483|NCT03364309|7673740|FG015|Post-Treatment Followup Period|Lost to Follow-up|0
4731484|NCT03364309|7673741|FG016|Post-Treatment Followup Period|Lost to Follow-up|0
4731485|NCT03364309|7673742|FG017|Post-Treatment Followup Period|Lost to Follow-up|2
4731486|NCT03364309|7673743|FG018|Post-Treatment Followup Period|Lost to Follow-up|0
4731487|NCT03364309|7673725|FG000|Post-Treatment Followup Period|Miscellaneous|0
4731488|NCT03364309|7673726|FG001|Post-Treatment Followup Period|Miscellaneous|0
4731489|NCT03364309|7673727|FG002|Post-Treatment Followup Period|Miscellaneous|0
4731490|NCT03364309|7673728|FG003|Post-Treatment Followup Period|Miscellaneous|0
4731491|NCT03364309|7673729|FG004|Post-Treatment Followup Period|Miscellaneous|0
4731492|NCT03364309|7673730|FG005|Post-Treatment Followup Period|Miscellaneous|0
4731493|NCT03364309|7673731|FG006|Post-Treatment Followup Period|Miscellaneous|0
4731494|NCT03364309|7673732|FG007|Post-Treatment Followup Period|Miscellaneous|0
4731495|NCT03364309|7673733|FG008|Post-Treatment Followup Period|Miscellaneous|0
4731496|NCT03364309|7673734|FG009|Post-Treatment Followup Period|Miscellaneous|0
4731497|NCT03364309|7673735|FG010|Post-Treatment Followup Period|Miscellaneous|0
4731498|NCT03364309|7673736|FG011|Post-Treatment Followup Period|Miscellaneous|0
4731499|NCT03364309|7673737|FG012|Post-Treatment Followup Period|Miscellaneous|0
4731500|NCT03364309|7673738|FG013|Post-Treatment Followup Period|Miscellaneous|0
4731501|NCT03364309|7673739|FG014|Post-Treatment Followup Period|Miscellaneous|0
4731502|NCT03364309|7673740|FG015|Post-Treatment Followup Period|Miscellaneous|0
4731503|NCT03364309|7673741|FG016|Post-Treatment Followup Period|Miscellaneous|0
4731504|NCT03364309|7673742|FG017|Post-Treatment Followup Period|Miscellaneous|4
4731505|NCT03364309|7673743|FG018|Post-Treatment Followup Period|Miscellaneous|0
4731506|NCT03364335|7673772|FG000|Overall Study|Adverse Event|3
4731507|NCT03364335|7673773|FG001|Overall Study|Adverse Event|4
4731508|NCT03364335|7673774|FG002|Overall Study|Adverse Event|1
4731509|NCT03364335|7673775|FG003|Overall Study|Adverse Event|2
4731510|NCT03364335|7673776|FG004|Overall Study|Adverse Event|0
4731511|NCT03364335|7673772|FG000|Overall Study|Lost to Follow-up|7
4731512|NCT03364335|7673773|FG001|Overall Study|Lost to Follow-up|7
4731513|NCT03364335|7673774|FG002|Overall Study|Lost to Follow-up|10
4731514|NCT03364335|7673775|FG003|Overall Study|Lost to Follow-up|11
4731515|NCT03364335|7673776|FG004|Overall Study|Lost to Follow-up|11
4731516|NCT03364608|7673788|FG000|Overall Study|Withdrawal by Subject|4
4731517|NCT03364608|7673788|FG000|Overall Study|Protocol Violation|2
4731518|NCT03364608|7673788|FG000|Overall Study|Lost to Follow-up|2
4731519|NCT03364673|7673800|FG000|Overall Study|Withdrawal by Subject|2
4731520|NCT03364673|7673800|FG000|Overall Study|Injury unrelated to study|3
4731521|NCT03364738|7673804|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6
4731522|NCT03364738|7673804|FG000|Overall Study|Withdrawal by Subject|1
4731523|NCT03364738|7673804|FG000|Overall Study|Adverse Event|1
4731524|NCT03364751|7673813|FG000|Overall Study|Withdrawal by Subject|1
4731525|NCT03364751|7673814|FG001|Overall Study|Withdrawal by Subject|0
4731526|NCT03364751|7673815|FG002|Overall Study|Withdrawal by Subject|0
4731527|NCT03364751|7673816|FG003|Overall Study|Withdrawal by Subject|0
4731528|NCT03364751|7673813|FG000|Overall Study|Lost to Follow-up|0
4731529|NCT03364751|7673814|FG001|Overall Study|Lost to Follow-up|1
4731530|NCT03364751|7673815|FG002|Overall Study|Lost to Follow-up|0
4731531|NCT03364751|7673816|FG003|Overall Study|Lost to Follow-up|0
4731532|NCT03365011|7673832|FG000|Overall Study|Withdrawal by Subject|1
4731533|NCT03365011|7673833|FG001|Overall Study|Withdrawal by Subject|2
4731534|NCT03365934|7673856|FG000|Overall Study|Adverse Event|1
4731535|NCT03365934|7673856|FG000|Overall Study|Withdrawal by Subject|1
4731536|NCT03367793|7673886|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0
4731537|NCT03367793|7673887|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0
4731538|NCT03367793|7673888|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1
4731539|NCT03367793|7673889|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0
4731540|NCT03367793|7673890|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0
4731541|NCT03367793|7673891|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0
4731542|NCT03368807|7673915|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3
4731543|NCT03368807|7673915|FG000|Period 1 (Blinded CGM)|Protocol Violation|1
4731544|NCT03368807|7673915|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1
4731545|NCT03368807|7673915|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1
4731546|NCT03368859|7673923|FG000|Overall Study|Withdrew Consent|5
4731547|NCT03368859|7673924|FG001|Overall Study|Withdrew Consent|4
4731548|NCT03368859|7673923|FG000|Overall Study|Death|12
4731549|NCT03368859|7673924|FG001|Overall Study|Death|6
4731550|NCT03368859|7673923|FG000|Overall Study|Study terminated by Sponsor|18
4731551|NCT03368859|7673924|FG001|Overall Study|Study terminated by Sponsor|23
4731552|NCT03368859|7673923|FG000|Overall Study|Other|1
4731553|NCT03368859|7673924|FG001|Overall Study|Other|1
4731554|NCT03369236|7673958|FG000|Double-blind Treatment Period|Accidental unblinding|0
4731555|NCT03369236|7673959|FG001|Double-blind Treatment Period|Accidental unblinding|1
4731556|NCT03369236|7673958|FG000|Open-label Extension Period|Lack of Efficacy|2
4731557|NCT03369236|7673959|FG001|Open-label Extension Period|Lack of Efficacy|1
4631235|NCT01890785|7500318|FG003|Third Intervention|Withdrawal by Subject|0
4631236|NCT01890785|7500319|FG004|Third Intervention|Withdrawal by Subject|0
4631237|NCT01890785|7500320|FG005|Third Intervention|Withdrawal by Subject|0
4631238|NCT01890915|7500331|FG000|Overall Study|Adverse Event|1
4631239|NCT01890915|7500332|FG001|Overall Study|Adverse Event|0
4631240|NCT01890915|7500331|FG000|Overall Study|Protocol Violation|2
4631241|NCT01890915|7500332|FG001|Overall Study|Protocol Violation|0
4631242|NCT01890915|7500331|FG000|Overall Study|Equipment Malfunction|0
4631243|NCT01890915|7500332|FG001|Overall Study|Equipment Malfunction|1
4631244|NCT01890967|7500353|FG000|Overall Study|Adverse Event|3
4631245|NCT01890967|7500354|FG001|Overall Study|Adverse Event|3
4631246|NCT01890967|7500355|FG002|Overall Study|Adverse Event|3
4631247|NCT01890967|7500356|FG003|Overall Study|Adverse Event|2
4631248|NCT01890967|7500357|FG004|Overall Study|Adverse Event|1
4631249|NCT01890967|7500358|FG005|Overall Study|Adverse Event|7
4631250|NCT01890967|7500353|FG000|Overall Study|Death|1
4631251|NCT01890967|7500354|FG001|Overall Study|Death|0
4631252|NCT01890967|7500355|FG002|Overall Study|Death|0
4631253|NCT01890967|7500356|FG003|Overall Study|Death|0
4631254|NCT01890967|7500357|FG004|Overall Study|Death|0
4631255|NCT01890967|7500358|FG005|Overall Study|Death|0
4631256|NCT01890967|7500353|FG000|Overall Study|Lost to Follow-up|1
4631257|NCT01890967|7500354|FG001|Overall Study|Lost to Follow-up|1
4631258|NCT01890967|7500355|FG002|Overall Study|Lost to Follow-up|1
4631259|NCT01890967|7500356|FG003|Overall Study|Lost to Follow-up|1
4631260|NCT01890967|7500357|FG004|Overall Study|Lost to Follow-up|0
4631261|NCT01890967|7500358|FG005|Overall Study|Lost to Follow-up|1
4631262|NCT01890967|7500353|FG000|Overall Study|Protocol Violation|0
4631263|NCT01890967|7500354|FG001|Overall Study|Protocol Violation|3
4631264|NCT01890967|7500355|FG002|Overall Study|Protocol Violation|3
4631265|NCT01890967|7500356|FG003|Overall Study|Protocol Violation|2
4631266|NCT01890967|7500357|FG004|Overall Study|Protocol Violation|4
4631267|NCT01890967|7500358|FG005|Overall Study|Protocol Violation|1
4631268|NCT01890967|7500353|FG000|Overall Study|Sponsor Decision|2
4631269|NCT01890967|7500354|FG001|Overall Study|Sponsor Decision|0
4631270|NCT01890967|7500355|FG002|Overall Study|Sponsor Decision|1
4631271|NCT01890967|7500356|FG003|Overall Study|Sponsor Decision|3
4631272|NCT01890967|7500357|FG004|Overall Study|Sponsor Decision|2
4631273|NCT01890967|7500358|FG005|Overall Study|Sponsor Decision|3
4631274|NCT01890967|7500353|FG000|Overall Study|Withdrawal by Subject|3
4631275|NCT01890967|7500354|FG001|Overall Study|Withdrawal by Subject|4
4631276|NCT01890967|7500355|FG002|Overall Study|Withdrawal by Subject|2
4631277|NCT01890967|7500356|FG003|Overall Study|Withdrawal by Subject|3
4631278|NCT01890967|7500357|FG004|Overall Study|Withdrawal by Subject|3
4631279|NCT01890967|7500358|FG005|Overall Study|Withdrawal by Subject|1
4631280|NCT01891357|7500411|FG000|Overall Study|Protocol Violation|3
4631281|NCT01891669|7500425|FG000|Overall Study|Death|0
4631282|NCT01891669|7500426|FG001|Overall Study|Death|0
4631283|NCT01891669|7500427|FG002|Overall Study|Death|0
4631284|NCT01891669|7500428|FG003|Overall Study|Death|0
4631285|NCT01891669|7500429|FG004|Overall Study|Death|0
4631286|NCT01891669|7500430|FG005|Overall Study|Death|0
4446838|NCT00486759|7231968|FG000|Treatment|Other protocol violation|1
4446839|NCT00486759|7231969|FG001|Treatment|Other protocol violation|5
4446840|NCT00486759|7231968|FG000|Treatment|Failure to return|1
4446841|NCT00486759|7231969|FG001|Treatment|Failure to return|1
4446842|NCT00486759|7231968|FG000|Safety Follow-up|Insufficient therapeutic response|40
4446843|NCT00486759|7231969|FG001|Safety Follow-up|Insufficient therapeutic response|50
4446844|NCT00486759|7231968|FG000|Safety Follow-up|Death|40
4446845|NCT00486759|7231969|FG001|Safety Follow-up|Death|29
4446846|NCT00486759|7231968|FG000|Safety Follow-up|Withdrew consent|32
4446847|NCT00486759|7231969|FG001|Safety Follow-up|Withdrew consent|23
4446848|NCT00486759|7231968|FG000|Safety Follow-up|Failure to return|9
4446849|NCT00486759|7231969|FG001|Safety Follow-up|Failure to return|6
4731558|NCT03369236|7673958|FG000|Open-label Extension Period|Adverse Event|0
4731559|NCT03369236|7673959|FG001|Open-label Extension Period|Adverse Event|1
4731560|NCT03369236|7673958|FG000|Open-label Extension Period|Sponsor decision to close study|3
4731561|NCT03369236|7673959|FG001|Open-label Extension Period|Sponsor decision to close study|4
4731562|NCT03369418|7673988|FG000|Overall Study|Withdrawal by Subject|3
4731563|NCT03369418|7673989|FG001|Overall Study|Withdrawal by Subject|3
4731564|NCT03369704|7673997|FG000|Treatment Epoch|technical problems|1
4731565|NCT03369704|7673998|FG001|Treatment Epoch|technical problems|0
4731566|NCT03369704|7673997|FG000|Treatment Epoch|Protocol Violation|1
4731567|NCT03369704|7673998|FG001|Treatment Epoch|Protocol Violation|0
4731568|NCT03369704|7673997|FG000|Treatment Epoch|Lost to Follow-up|0
4731569|NCT03369704|7673998|FG001|Treatment Epoch|Lost to Follow-up|1
4731570|NCT03369704|7673997|FG000|Treatment Epoch|Lack of Efficacy|0
4731571|NCT03369704|7673998|FG001|Treatment Epoch|Lack of Efficacy|2
4731572|NCT03369704|7673997|FG000|Treatment Epoch|Adverse Event|2
4731573|NCT03369704|7673998|FG001|Treatment Epoch|Adverse Event|0
4731574|NCT03369704|7673997|FG000|Follow-up Epoch|Lost to Follow-up|1
4731575|NCT03369704|7673998|FG001|Follow-up Epoch|Lost to Follow-up|0
4731576|NCT03369951|7674008|FG000|Overall Study|Withdrawal by Subject|3
4731577|NCT03369951|7674008|FG000|Overall Study|Death|1
4731578|NCT03369951|7674008|FG000|Overall Study|Lost to Follow-up|1
4731579|NCT03369951|7674008|FG000|Overall Study|Protocol Violation|1
4731580|NCT03370289|7674025|FG000|Overall Study|Screen Failure|1
4731581|NCT03370289|7674025|FG000|Overall Study|Sample Size Sufficient|4
4737288|NCT03605745|7687413|FG000|Overall Study|Study was terminated for business reasons|47
4737289|NCT03605836|7687421|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2
4737290|NCT03605836|7687422|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0
4737291|NCT03605836|7687423|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0
4737292|NCT03605836|7687424|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0
4737293|NCT03605836|7687421|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2
4737294|NCT03605836|7687422|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0
4737295|NCT03605836|7687423|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0
4737296|NCT03605836|7687424|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0
4737297|NCT03605836|7687421|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8
4737298|NCT03605836|7687422|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0
4737299|NCT03605836|7687423|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0
4737300|NCT03605836|7687424|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0
4737301|NCT03605836|7687421|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4
4737302|NCT03605836|7687422|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0
4737303|NCT03605836|7687423|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0
4737304|NCT03605836|7687424|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0
4737305|NCT03605836|7687421|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4
4737306|NCT03605836|7687422|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0
4737307|NCT03605836|7687423|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0
4737308|NCT03605836|7687424|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0
4737309|NCT03605836|7687421|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17
4737310|NCT03605836|7687422|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0
4737311|NCT03605836|7687423|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0
4737312|NCT03605836|7687424|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0
4737313|NCT03605836|7687421|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5
4737314|NCT03605836|7687422|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0
4737315|NCT03605836|7687423|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0
4737316|NCT03605836|7687424|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0
4737317|NCT03605836|7687421|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7
4737318|NCT03605836|7687422|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0
4731582|NCT03370302|7674035|FG000|Dose Escalation Phase|Other|0
4731583|NCT03370302|7674036|FG001|Dose Escalation Phase|Other|1
4731584|NCT03370302|7674037|FG002|Dose Escalation Phase|Other|1
4731585|NCT03370302|7674038|FG003|Dose Escalation Phase|Other|0
4731586|NCT03370302|7674039|FG004|Dose Escalation Phase|Other|0
4731587|NCT03370302|7674040|FG005|Dose Escalation Phase|Other|0
4731588|NCT03370302|7674035|FG000|Dose Escalation Phase|Withdrawal by Subject|0
4731589|NCT03370302|7674036|FG001|Dose Escalation Phase|Withdrawal by Subject|1
4731590|NCT03370302|7674037|FG002|Dose Escalation Phase|Withdrawal by Subject|2
4731591|NCT03370302|7674038|FG003|Dose Escalation Phase|Withdrawal by Subject|0
4731592|NCT03370302|7674039|FG004|Dose Escalation Phase|Withdrawal by Subject|0
4731593|NCT03370302|7674040|FG005|Dose Escalation Phase|Withdrawal by Subject|2
4731594|NCT03370302|7674035|FG000|Dose Escalation Phase|Adverse Event|1
4731595|NCT03370302|7674036|FG001|Dose Escalation Phase|Adverse Event|0
4731596|NCT03370302|7674037|FG002|Dose Escalation Phase|Adverse Event|2
4731597|NCT03370302|7674038|FG003|Dose Escalation Phase|Adverse Event|0
4731598|NCT03370302|7674039|FG004|Dose Escalation Phase|Adverse Event|0
4731599|NCT03370302|7674040|FG005|Dose Escalation Phase|Adverse Event|0
4731600|NCT03370302|7674035|FG000|Dose Escalation Phase|Progressive Disease|2
4731601|NCT03370302|7674036|FG001|Dose Escalation Phase|Progressive Disease|4
4731602|NCT03370302|7674037|FG002|Dose Escalation Phase|Progressive Disease|2
4731603|NCT03370302|7674038|FG003|Dose Escalation Phase|Progressive Disease|0
4731604|NCT03370302|7674039|FG004|Dose Escalation Phase|Progressive Disease|3
4731605|NCT03370302|7674040|FG005|Dose Escalation Phase|Progressive Disease|1
4731606|NCT03370302|7674035|FG000|Dose Expansion Phase|Progressive Disease|0
4731607|NCT03370302|7674036|FG001|Dose Expansion Phase|Progressive Disease|0
4731608|NCT03370302|7674037|FG002|Dose Expansion Phase|Progressive Disease|0
4731609|NCT03370302|7674038|FG003|Dose Expansion Phase|Progressive Disease|6
4631287|NCT01891669|7500431|FG006|Overall Study|Death|0
4731610|NCT03370302|7674039|FG004|Dose Expansion Phase|Progressive Disease|0
4731611|NCT03370302|7674040|FG005|Dose Expansion Phase|Progressive Disease|0
4731612|NCT03370419|7674058|FG000|Overall Study|Lost to Follow-up|16
4731613|NCT03370471|7674064|FG000|Overall Study|Withdrawal by Subject|6
4731614|NCT03370471|7674065|FG001|Overall Study|Withdrawal by Subject|1
4731615|NCT03370471|7674064|FG000|Overall Study|Unable to access veins for blood draw|0
4731616|NCT03370471|7674065|FG001|Overall Study|Unable to access veins for blood draw|1
4731617|NCT03370471|7674064|FG000|Overall Study|Screen fail|1
4731618|NCT03370471|7674065|FG001|Overall Study|Screen fail|0
4731619|NCT03370770|7674073|FG000|Overall Study|Patient was followed in another hospital center|1
4731620|NCT03370770|7674073|FG000|Overall Study|Progressive Disease|98
4731621|NCT03370770|7674073|FG000|Overall Study|Adverse Event|2
4731622|NCT03370770|7674073|FG000|Overall Study|Death|5
4731623|NCT03371355|7674081|FG000|Overall Study|Investigator judgment|0
4731624|NCT03371355|7674082|FG001|Overall Study|Investigator judgment|0
4731625|NCT03371355|7674083|FG002|Overall Study|Investigator judgment|1
4731626|NCT03371355|7674084|FG003|Overall Study|Investigator judgment|1
4731627|NCT03371355|7674081|FG000|Overall Study|Voluntary withdrawal|1
4731628|NCT03371355|7674082|FG001|Overall Study|Voluntary withdrawal|0
4731629|NCT03371355|7674083|FG002|Overall Study|Voluntary withdrawal|1
4731630|NCT03371355|7674084|FG003|Overall Study|Voluntary withdrawal|2
4731631|NCT03371355|7674081|FG000|Overall Study|Adverse Event|0
4731632|NCT03371355|7674082|FG001|Overall Study|Adverse Event|1
4731633|NCT03371355|7674083|FG002|Overall Study|Adverse Event|2
4731634|NCT03371355|7674084|FG003|Overall Study|Adverse Event|3
4731635|NCT03371355|7674081|FG000|Overall Study|Reason not Specified|0
4731636|NCT03371355|7674082|FG001|Overall Study|Reason not Specified|1
4731637|NCT03371355|7674083|FG002|Overall Study|Reason not Specified|0
4731638|NCT03371355|7674084|FG003|Overall Study|Reason not Specified|1
4731639|NCT03371381|7674098|FG000|Overall Study|Death|5
4731640|NCT03371381|7674098|FG000|Overall Study|Study terminated by sponsor|3
4731641|NCT03371381|7674098|FG000|Overall Study|Other|4
4731642|NCT03371459|7674102|FG000|Washout|Lost to Follow-up|0
4731643|NCT03371459|7674103|FG001|Washout|Lost to Follow-up|1
4731644|NCT03371732|7674111|FG000|Overall Study|Withdrawal by Subject|9
4731645|NCT03371732|7674112|FG001|Overall Study|Withdrawal by Subject|3
4731646|NCT03371732|7674111|FG000|Overall Study|Refusal to continue|3
4731647|NCT03371732|7674112|FG001|Overall Study|Refusal to continue|4
4731648|NCT03372083|7674124|FG000|Overall Study|Adverse Event|3
4731649|NCT03372083|7674124|FG000|Overall Study|Physician Decision|1
4731650|NCT03372083|7674124|FG000|Overall Study|Withdrawal by Subject|1
4731651|NCT03372096|7674128|FG000|Overall Study|Study Closed|8
4731652|NCT03372369|7674137|FG000|Qualification Period|Withdrawal by Subject|16
4731653|NCT03372369|7674138|FG001|Qualification Period|Withdrawal by Subject|13
4731654|NCT03372369|7674137|FG000|Qualification Period|Inconsistent Eligibility Results|10
4731655|NCT03372369|7674138|FG001|Qualification Period|Inconsistent Eligibility Results|9
4731656|NCT03372369|7674137|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3
4731657|NCT03372369|7674138|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3
4731658|NCT03372551|7674168|FG000|First Intervention (1 Week)|Withdrawal by Subject|1
4731659|NCT03372551|7674169|FG001|First Intervention (1 Week)|Withdrawal by Subject|0
4731660|NCT03372603|7674182|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1
4731661|NCT03372603|7674183|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0
4731662|NCT03372603|7674182|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1
4731663|NCT03372603|7674183|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0
4731664|NCT03373383|7674224|FG000|Treatment Period: Wk0-16|Adverse Event|7
4731665|NCT03373383|7674225|FG001|Treatment Period: Wk0-16|Adverse Event|6
4731666|NCT03373383|7674226|FG002|Treatment Period: Wk0-16|Adverse Event|11
4731667|NCT03373383|7674227|FG003|Treatment Period: Wk0-16|Adverse Event|15
4731668|NCT03373383|7674228|FG004|Treatment Period: Wk0-16|Adverse Event|21
4731669|NCT03373383|7674224|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2
4731670|NCT03373383|7674225|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1
4731671|NCT03373383|7674226|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0
4731672|NCT03373383|7674227|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0
4731673|NCT03373383|7674228|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0
4731674|NCT03373383|7674224|FG000|Treatment Period: Wk0-16|Protocol Violation|0
4731675|NCT03373383|7674225|FG001|Treatment Period: Wk0-16|Protocol Violation|4
4731676|NCT03373383|7674226|FG002|Treatment Period: Wk0-16|Protocol Violation|2
4731677|NCT03373383|7674227|FG003|Treatment Period: Wk0-16|Protocol Violation|1
4731678|NCT03373383|7674228|FG004|Treatment Period: Wk0-16|Protocol Violation|0
4731679|NCT03373383|7674224|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2
4731680|NCT03373383|7674225|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0
4731681|NCT03373383|7674226|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0
4731682|NCT03373383|7674227|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0
4731683|NCT03373383|7674228|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0
4731684|NCT03373383|7674224|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2
4731685|NCT03373383|7674225|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3
4731686|NCT03373383|7674226|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2
4731687|NCT03373383|7674227|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3
4731688|NCT03373383|7674228|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3
4731689|NCT03373383|7674224|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0
4731690|NCT03373383|7674225|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1
4731691|NCT03373383|7674226|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0
4731692|NCT03373383|7674227|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0
4731693|NCT03373383|7674228|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0
4731694|NCT03373383|7674224|FG000|Treatment Period: Wk0-16|By opinion of investigator|0
4731695|NCT03373383|7674225|FG001|Treatment Period: Wk0-16|By opinion of investigator|0
4731696|NCT03373383|7674226|FG002|Treatment Period: Wk0-16|By opinion of investigator|0
4731697|NCT03373383|7674227|FG003|Treatment Period: Wk0-16|By opinion of investigator|1
4731698|NCT03373383|7674228|FG004|Treatment Period: Wk0-16|By opinion of investigator|0
4731699|NCT03373383|7674224|FG000|Treatment Period: Wk0-16|Sponsor decision|0
4731700|NCT03373383|7674225|FG001|Treatment Period: Wk0-16|Sponsor decision|0
4731701|NCT03373383|7674226|FG002|Treatment Period: Wk0-16|Sponsor decision|0
4731702|NCT03373383|7674227|FG003|Treatment Period: Wk0-16|Sponsor decision|1
4731703|NCT03373383|7674228|FG004|Treatment Period: Wk0-16|Sponsor decision|0
4731704|NCT03373383|7674224|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1
4731705|NCT03373383|7674225|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0
4731706|NCT03373383|7674226|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0
4731707|NCT03373383|7674227|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0
4731708|NCT03373383|7674228|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0
4731709|NCT03374189|7674290|FG000|Overall Study|Lost to Follow-up|1
4731710|NCT03374189|7674291|FG001|Overall Study|Lost to Follow-up|0
4731711|NCT03374358|7674299|FG000|Overall Study|Withdrawal by Subject|0
4731712|NCT03374358|7674300|FG001|Overall Study|Withdrawal by Subject|2
4731713|NCT03374488|7674308|FG000|Overall Study|Death|13
4731714|NCT03374488|7674309|FG001|Overall Study|Death|13
4731715|NCT03374488|7674308|FG000|Overall Study|Withdrawal by Subject|3
4731716|NCT03374488|7674309|FG001|Overall Study|Withdrawal by Subject|1
4731717|NCT03374488|7674308|FG000|Overall Study|Physician Decision|3
4731718|NCT03374488|7674309|FG001|Overall Study|Physician Decision|0
4731719|NCT03374995|7674331|FG000|Overall Study|Withdrawal by Subject|0
4731720|NCT03374995|7674332|FG001|Overall Study|Withdrawal by Subject|1
4731721|NCT03376321|7674372|FG000|Overall Study|Other|5
4731722|NCT03376321|7674373|FG001|Overall Study|Other|1
4731723|NCT03376321|7674372|FG000|Overall Study|Withdrawal by Subject|8
4731724|NCT03376321|7674373|FG001|Overall Study|Withdrawal by Subject|14
4731725|NCT03376321|7674372|FG000|Overall Study|Lost to Follow-up|1
4731726|NCT03376321|7674373|FG001|Overall Study|Lost to Follow-up|7
4731727|NCT03376321|7674372|FG000|Overall Study|Death|4
4731728|NCT03376321|7674373|FG001|Overall Study|Death|0
4731729|NCT03376321|7674372|FG000|Overall Study|Randomized, not treated|5
4731730|NCT03376321|7674373|FG001|Overall Study|Randomized, not treated|3
4731731|NCT03376516|7674379|FG000|Overall Study|Not treated|1
4731732|NCT03376516|7674379|FG000|Overall Study|Consent withdrawn|1
4731733|NCT03377556|7674416|FG000|Overall Study|Adverse Event|5
4731734|NCT03377556|7674416|FG000|Overall Study|Refusal unrelated to adverse events|1
4731735|NCT03377556|7674416|FG000|Overall Study|Progression/relapse|38
4731736|NCT03377556|7674416|FG000|Overall Study|Death|3
4731737|NCT03377634|7674422|FG000|Study Period|Adverse Event|1
4731738|NCT03377634|7674423|FG001|Study Period|Adverse Event|0
4731739|NCT03377634|7674422|FG000|Study Period|Withdrawal by Subject|1
4731740|NCT03377634|7674423|FG001|Study Period|Withdrawal by Subject|0
4731741|NCT03378635|7674441|FG000|Overall Study|Adverse Event|1
4731742|NCT03378635|7674442|FG001|Overall Study|Adverse Event|0
4731743|NCT03378635|7674443|FG002|Overall Study|Adverse Event|0
4731744|NCT03378635|7674441|FG000|Overall Study|Withdrawal by Subject|1
4731745|NCT03378635|7674442|FG001|Overall Study|Withdrawal by Subject|0
4731746|NCT03378635|7674443|FG002|Overall Study|Withdrawal by Subject|0
4731747|NCT03379259|7674476|FG000|Overall Study|Commenced new anti-cancer therapy|1
4731748|NCT03379259|7674477|FG001|Overall Study|Commenced new anti-cancer therapy|0
4731749|NCT03379259|7674478|FG002|Overall Study|Commenced new anti-cancer therapy|0
4731750|NCT03379259|7674479|FG003|Overall Study|Commenced new anti-cancer therapy|0
4731751|NCT03379259|7674480|FG004|Overall Study|Commenced new anti-cancer therapy|0
4731752|NCT03379259|7674481|FG005|Overall Study|Commenced new anti-cancer therapy|0
4731753|NCT03379259|7674476|FG000|Overall Study|Death|0
4731754|NCT03379259|7674477|FG001|Overall Study|Death|1
4731755|NCT03379259|7674478|FG002|Overall Study|Death|2
4731756|NCT03379259|7674479|FG003|Overall Study|Death|1
4631288|NCT01891669|7500432|FG007|Overall Study|Death|1
4731757|NCT03379259|7674480|FG004|Overall Study|Death|4
4731758|NCT03379259|7674481|FG005|Overall Study|Death|2
4731759|NCT03379259|7674476|FG000|Overall Study|Withdrawal by Subject|0
4731760|NCT03379259|7674477|FG001|Overall Study|Withdrawal by Subject|0
4731761|NCT03379259|7674478|FG002|Overall Study|Withdrawal by Subject|1
4731762|NCT03379259|7674479|FG003|Overall Study|Withdrawal by Subject|0
4731763|NCT03379259|7674480|FG004|Overall Study|Withdrawal by Subject|2
4731764|NCT03379259|7674481|FG005|Overall Study|Withdrawal by Subject|0
4731765|NCT03379259|7674476|FG000|Overall Study|Study terminated by sponsor|0
4731766|NCT03379259|7674477|FG001|Overall Study|Study terminated by sponsor|0
4731767|NCT03379259|7674478|FG002|Overall Study|Study terminated by sponsor|0
4731768|NCT03379259|7674479|FG003|Overall Study|Study terminated by sponsor|1
4731769|NCT03379259|7674480|FG004|Overall Study|Study terminated by sponsor|1
4731770|NCT03379259|7674481|FG005|Overall Study|Study terminated by sponsor|4
4731771|NCT03379259|7674476|FG000|Overall Study|Disease progression|0
4731772|NCT03379259|7674477|FG001|Overall Study|Disease progression|0
4731773|NCT03379259|7674478|FG002|Overall Study|Disease progression|0
4731774|NCT03379259|7674479|FG003|Overall Study|Disease progression|1
4731775|NCT03379259|7674480|FG004|Overall Study|Disease progression|0
4731776|NCT03379259|7674481|FG005|Overall Study|Disease progression|1
4731777|NCT03379259|7674476|FG000|Overall Study|Lost to Follow-up|0
4731778|NCT03379259|7674477|FG001|Overall Study|Lost to Follow-up|0
4731779|NCT03379259|7674478|FG002|Overall Study|Lost to Follow-up|0
4731780|NCT03379259|7674479|FG003|Overall Study|Lost to Follow-up|0
4731781|NCT03379259|7674480|FG004|Overall Study|Lost to Follow-up|1
4731782|NCT03379259|7674481|FG005|Overall Study|Lost to Follow-up|0
4731783|NCT03379259|7674476|FG000|Overall Study|Deteriorating condition|0
4731784|NCT03379259|7674477|FG001|Overall Study|Deteriorating condition|0
4731785|NCT03379259|7674478|FG002|Overall Study|Deteriorating condition|0
4731786|NCT03379259|7674479|FG003|Overall Study|Deteriorating condition|0
4731787|NCT03379259|7674480|FG004|Overall Study|Deteriorating condition|1
4731788|NCT03379259|7674481|FG005|Overall Study|Deteriorating condition|0
4731789|NCT03379376|7674498|FG000|Overall Study|Lost to Follow-up|2
4731790|NCT03379376|7674498|FG000|Overall Study|Did not wish to complete follow up|1
4731791|NCT03379376|7674498|FG000|Overall Study|Overwhelmed, didn't want to continue|1
4731792|NCT03379376|7674498|FG000|Overall Study|Death|1
4731793|NCT03379753|7674551|FG000|Overall Study|Withdrawal by Subject|2
4731794|NCT03379753|7674552|FG001|Overall Study|Withdrawal by Subject|1
4731795|NCT03379753|7674551|FG000|Overall Study|not having correct procedure|1
4731796|NCT03379753|7674552|FG001|Overall Study|not having correct procedure|2
4731797|NCT03379753|7674551|FG000|Overall Study|No primary outcome|12
4731798|NCT03379753|7674552|FG001|Overall Study|No primary outcome|22
4731799|NCT03380091|7674574|FG000|Overall Study|Withdrawal by Subject|2
4731800|NCT03380091|7674575|FG001|Overall Study|Withdrawal by Subject|1
4731801|NCT03380390|7674583|FG000|Overall Study|Adverse Event|3
4731802|NCT03380429|7674592|FG000|Overall Study|Physician Decision|0
4731803|NCT03380429|7674593|FG001|Overall Study|Physician Decision|1
4731804|NCT03380429|7674594|FG002|Overall Study|Physician Decision|0
4631289|NCT01891669|7500433|FG008|Overall Study|Death|0
4631290|NCT01891669|7500434|FG009|Overall Study|Death|1
4731805|NCT03380429|7674595|FG003|Overall Study|Physician Decision|1
4731806|NCT03380429|7674596|FG004|Overall Study|Physician Decision|1
4731807|NCT03380429|7674592|FG000|Overall Study|Withdrawal by Subject|3
4731808|NCT03380429|7674593|FG001|Overall Study|Withdrawal by Subject|3
4731809|NCT03380429|7674594|FG002|Overall Study|Withdrawal by Subject|5
4731810|NCT03380429|7674595|FG003|Overall Study|Withdrawal by Subject|2
4731811|NCT03380429|7674596|FG004|Overall Study|Withdrawal by Subject|1
4731812|NCT03380429|7674592|FG000|Overall Study|Lost to Follow-up|0
4731813|NCT03380429|7674593|FG001|Overall Study|Lost to Follow-up|2
4731814|NCT03380429|7674594|FG002|Overall Study|Lost to Follow-up|4
4731815|NCT03380429|7674595|FG003|Overall Study|Lost to Follow-up|3
4731816|NCT03380429|7674596|FG004|Overall Study|Lost to Follow-up|1
4731817|NCT03380429|7674592|FG000|Overall Study|Protocol Violation|1
4731818|NCT03380429|7674593|FG001|Overall Study|Protocol Violation|0
4731819|NCT03380429|7674594|FG002|Overall Study|Protocol Violation|1
4731820|NCT03380429|7674595|FG003|Overall Study|Protocol Violation|0
4731821|NCT03380429|7674596|FG004|Overall Study|Protocol Violation|1
4731822|NCT03380429|7674592|FG000|Overall Study|Lack of Efficacy|0
4731823|NCT03380429|7674593|FG001|Overall Study|Lack of Efficacy|0
4731824|NCT03380429|7674594|FG002|Overall Study|Lack of Efficacy|0
4731825|NCT03380429|7674595|FG003|Overall Study|Lack of Efficacy|2
4731826|NCT03380429|7674596|FG004|Overall Study|Lack of Efficacy|1
4731827|NCT03380429|7674592|FG000|Overall Study|Adverse Event|1
4731828|NCT03380429|7674593|FG001|Overall Study|Adverse Event|1
4731829|NCT03380429|7674594|FG002|Overall Study|Adverse Event|1
4731830|NCT03380429|7674595|FG003|Overall Study|Adverse Event|2
4731831|NCT03380429|7674596|FG004|Overall Study|Adverse Event|0
4731832|NCT03381196|7674641|FG000|Overall Study|Withdrawal by Subject|7
4731833|NCT03381196|7674642|FG001|Overall Study|Withdrawal by Subject|7
4731834|NCT03381196|7674641|FG000|Overall Study|Other|0
4731835|NCT03381196|7674642|FG001|Overall Study|Other|1
4731836|NCT03381196|7674641|FG000|Overall Study|Lost to Follow-up|5
4731837|NCT03381196|7674642|FG001|Overall Study|Lost to Follow-up|4
4731838|NCT03381196|7674641|FG000|Overall Study|Death|0
4731839|NCT03381196|7674642|FG001|Overall Study|Death|1
4731840|NCT03381196|7674641|FG000|Overall Study|Adverse Event|1
4731841|NCT03381196|7674642|FG001|Overall Study|Adverse Event|0
4731842|NCT03381196|7674641|FG000|Overall Study|Randomized, not treated|3
4731843|NCT03381196|7674642|FG001|Overall Study|Randomized, not treated|6
4731844|NCT03381248|7674650|FG000|Overall Study|Withdrawal by Subject|5
4731845|NCT03381248|7674651|FG001|Overall Study|Withdrawal by Subject|3
4731846|NCT03381248|7674650|FG000|Overall Study|Lost to Follow-up|3
4731847|NCT03381248|7674651|FG001|Overall Study|Lost to Follow-up|2
4731848|NCT03381248|7674650|FG000|Overall Study|Lack of Efficacy|1
4731849|NCT03381248|7674651|FG001|Overall Study|Lack of Efficacy|0
4731850|NCT03381248|7674650|FG000|Overall Study|Adverse Event|2
4731851|NCT03381248|7674651|FG001|Overall Study|Adverse Event|0
4731852|NCT03381248|7674650|FG000|Overall Study|Protocol Violation|2
4731853|NCT03381248|7674651|FG001|Overall Study|Protocol Violation|1
4731854|NCT03381339|7674659|FG000|Overall Study|Protocol Violation|4
4731855|NCT03381339|7674660|FG001|Overall Study|Protocol Violation|3
4731856|NCT03381339|7674659|FG000|Overall Study|Lost to Follow-up|0
4731857|NCT03381339|7674660|FG001|Overall Study|Lost to Follow-up|1
4731858|NCT03382262|7674692|FG000|Overall Study|Physician Decision|0
4731859|NCT03382262|7674693|FG001|Overall Study|Physician Decision|0
4731860|NCT03382262|7674694|FG002|Overall Study|Physician Decision|1
4731861|NCT03382262|7674695|FG003|Overall Study|Physician Decision|0
4731862|NCT03382262|7674692|FG000|Overall Study|Withdrawal by Subject|0
4731863|NCT03382262|7674693|FG001|Overall Study|Withdrawal by Subject|0
4731864|NCT03382262|7674694|FG002|Overall Study|Withdrawal by Subject|0
4731865|NCT03382262|7674695|FG003|Overall Study|Withdrawal by Subject|1
4731866|NCT03382418|7674708|FG000|Overall Study|Withdrawal by Subject|1
4731867|NCT03382418|7674709|FG001|Overall Study|Withdrawal by Subject|0
4731868|NCT03382418|7674710|FG002|Overall Study|Withdrawal by Subject|0
4731869|NCT03382418|7674708|FG000|Overall Study|Lost to Follow-up|2
4731870|NCT03382418|7674709|FG001|Overall Study|Lost to Follow-up|3
4731871|NCT03382418|7674710|FG002|Overall Study|Lost to Follow-up|0
4731872|NCT03382821|7674739|FG000|Overall Study|Did not receive allocated intervention.|0
4731873|NCT03382821|7674740|FG001|Overall Study|Did not receive allocated intervention.|3
4731874|NCT03382899|7674753|FG000|Overall Study|Ineligibility Determined|0
4731875|NCT03382899|7674754|FG001|Overall Study|Ineligibility Determined|1
4731876|NCT03382899|7674753|FG000|Overall Study|Lost to Follow-up|0
4731877|NCT03382899|7674754|FG001|Overall Study|Lost to Follow-up|1
4731878|NCT03382899|7674753|FG000|Overall Study|Sponsor's decision|31
4731879|NCT03382899|7674754|FG001|Overall Study|Sponsor's decision|28
4731880|NCT03382899|7674753|FG000|Overall Study|Withdrawal by Subject|0
4731881|NCT03382899|7674754|FG001|Overall Study|Withdrawal by Subject|5
4731882|NCT03382912|7674762|FG000|Overall Study|Physician Decision|0
4731883|NCT03382912|7674763|FG001|Overall Study|Physician Decision|1
4731884|NCT03382912|7674762|FG000|Overall Study|Sponsor Decision|6
4731885|NCT03382912|7674763|FG001|Overall Study|Sponsor Decision|6
4731886|NCT03382912|7674762|FG000|Overall Study|Withdrawal by Subject|0
4731887|NCT03382912|7674763|FG001|Overall Study|Withdrawal by Subject|5
4731888|NCT03383146|7674771|FG000|Overall Study|Screen Failure|1
4731889|NCT03383146|7674772|FG001|Overall Study|Screen Failure|0
4731890|NCT03383146|7674771|FG000|Overall Study|Adverse Event|6
4731891|NCT03383146|7674772|FG001|Overall Study|Adverse Event|18
4731892|NCT03383146|7674771|FG000|Overall Study|Lack of Efficacy|0
4731893|NCT03383146|7674772|FG001|Overall Study|Lack of Efficacy|3
4731894|NCT03383146|7674771|FG000|Overall Study|Withdrawal by Subject|20
4731895|NCT03383146|7674772|FG001|Overall Study|Withdrawal by Subject|36
4731896|NCT03383146|7674771|FG000|Overall Study|Lost to Follow-up|5
4731897|NCT03383146|7674772|FG001|Overall Study|Lost to Follow-up|15
4731898|NCT03383146|7674771|FG000|Overall Study|Death|0
4731899|NCT03383146|7674772|FG001|Overall Study|Death|2
4731900|NCT03383146|7674771|FG000|Overall Study|Physician Decision|0
4731901|NCT03383146|7674772|FG001|Overall Study|Physician Decision|1
4731902|NCT03383146|7674771|FG000|Overall Study|Protocol Deviation|1
4731903|NCT03383146|7674772|FG001|Overall Study|Protocol Deviation|8
4731904|NCT03383146|7674771|FG000|Overall Study|Study Terminated by the Sponsor|48
4731905|NCT03383146|7674772|FG001|Overall Study|Study Terminated by the Sponsor|95
4731906|NCT03383146|7674771|FG000|Overall Study|Reason not Specified|4
4731907|NCT03383146|7674772|FG001|Overall Study|Reason not Specified|6
4731908|NCT03383614|7674834|FG000|Overall Study|Withdrawal by Subject|0
4731909|NCT03383614|7674835|FG001|Overall Study|Withdrawal by Subject|1
4731910|NCT03383614|7674836|FG002|Overall Study|Withdrawal by Subject|0
4731911|NCT03383614|7674837|FG003|Overall Study|Withdrawal by Subject|0
4731912|NCT03383783|7674860|FG000|Overall Study|Withdrawal by Subject|2
4731913|NCT03383887|7674876|FG000|Overall Study|Lost to Follow-up|0
4731914|NCT03383887|7674877|FG001|Overall Study|Lost to Follow-up|1
4731915|NCT03384316|7674897|FG000|Overall Study|Screen failure|0
4731916|NCT03384316|7674898|FG001|Overall Study|Screen failure|1
4731917|NCT03384693|7674915|FG000|Overall Study|Adverse Event|3
4731918|NCT03384745|7674925|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0
4731919|NCT03384745|7674926|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0
4731920|NCT03384745|7674927|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1
4731921|NCT03384745|7674928|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2
4731922|NCT03384745|7674929|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0
4731923|NCT03384745|7674930|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0
4731924|NCT03384745|7674925|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0
4731925|NCT03384745|7674926|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0
4731926|NCT03384745|7674927|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0
4731927|NCT03384745|7674928|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0
4731928|NCT03384745|7674929|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3
4731929|NCT03384745|7674930|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1
4731930|NCT03384745|7674925|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0
4731931|NCT03384745|7674926|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1
4731932|NCT03384745|7674927|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1
4731933|NCT03384745|7674928|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0
4731934|NCT03384745|7674929|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0
4731935|NCT03384745|7674930|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1
4731936|NCT03384745|7674925|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0
4731937|NCT03384745|7674926|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0
4731938|NCT03384745|7674927|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1
4731939|NCT03384745|7674928|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0
4731940|NCT03384745|7674929|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0
4731941|NCT03384745|7674930|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0
4731942|NCT03384745|7674925|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0
4731943|NCT03384745|7674926|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0
4731944|NCT03384745|7674927|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0
4731945|NCT03384745|7674928|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1
4731946|NCT03384745|7674929|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1
4731947|NCT03384745|7674930|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0
4731948|NCT03384745|7674925|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0
4731949|NCT03384745|7674926|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0
4731950|NCT03384745|7674927|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0
4731951|NCT03384745|7674928|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0
4731952|NCT03384745|7674929|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1
4731953|NCT03384745|7674930|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0
4731954|NCT03384745|7674925|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0
4731955|NCT03384745|7674926|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0
4731956|NCT03384745|7674927|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1
4731957|NCT03384745|7674928|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1
4731958|NCT03384745|7674929|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0
4731959|NCT03384745|7674930|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0
4731960|NCT03384745|7674925|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1
4731961|NCT03384745|7674926|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1
4731962|NCT03384745|7674927|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3
4731963|NCT03384745|7674928|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0
4731964|NCT03384745|7674929|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1
4731965|NCT03384745|7674930|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0
4731966|NCT03384745|7674925|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0
4731967|NCT03384745|7674926|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1
4731968|NCT03384745|7674927|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1
4731969|NCT03384745|7674928|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2
4731970|NCT03384745|7674929|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0
4731971|NCT03384745|7674930|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2
4731972|NCT03384745|7674925|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0
4731973|NCT03384745|7674926|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0
4731974|NCT03384745|7674927|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0
4731975|NCT03384745|7674928|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2
4731976|NCT03384745|7674929|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0
4731977|NCT03384745|7674930|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0
4731978|NCT03384745|7674925|FG000|Response Assess/Dose Hold (W24-W48)|Death|0
4731979|NCT03384745|7674926|FG001|Response Assess/Dose Hold (W24-W48)|Death|1
4731980|NCT03384745|7674927|FG002|Response Assess/Dose Hold (W24-W48)|Death|0
4731981|NCT03384745|7674928|FG003|Response Assess/Dose Hold (W24-W48)|Death|0
4731982|NCT03384745|7674929|FG004|Response Assess/Dose Hold (W24-W48)|Death|0
4731983|NCT03384745|7674930|FG005|Response Assess/Dose Hold (W24-W48)|Death|0
4731984|NCT03384940|7674953|FG000|Overall Study|Progressive disease|36
4731985|NCT03384940|7674954|FG001|Overall Study|Progressive disease|11
4731986|NCT03384940|7674955|FG002|Overall Study|Progressive disease|13
4731987|NCT03384940|7674953|FG000|Overall Study|Clinical progression|4
4731988|NCT03384940|7674954|FG001|Overall Study|Clinical progression|0
4731989|NCT03384940|7674955|FG002|Overall Study|Clinical progression|3
4731990|NCT03384940|7674953|FG000|Overall Study|Adverse Event|7
4731991|NCT03384940|7674954|FG001|Overall Study|Adverse Event|1
4731992|NCT03384940|7674955|FG002|Overall Study|Adverse Event|1
4731993|NCT03384940|7674953|FG000|Overall Study|Withdrawal by Subject|3
4731994|NCT03384940|7674954|FG001|Overall Study|Withdrawal by Subject|1
4731995|NCT03384940|7674955|FG002|Overall Study|Withdrawal by Subject|0
4731996|NCT03384940|7674953|FG000|Overall Study|Physician Decision|1
4731997|NCT03384940|7674954|FG001|Overall Study|Physician Decision|1
4731998|NCT03384940|7674955|FG002|Overall Study|Physician Decision|0
4731999|NCT03384940|7674953|FG000|Overall Study|Death|2
4732000|NCT03384940|7674954|FG001|Overall Study|Death|1
4732001|NCT03384940|7674955|FG002|Overall Study|Death|0
4732002|NCT03384940|7674953|FG000|Overall Study|Other|0
4732003|NCT03384940|7674954|FG001|Overall Study|Other|0
4732004|NCT03384940|7674955|FG002|Overall Study|Other|1
4732005|NCT03384966|7674975|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1
4732006|NCT03384966|7674976|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0
4732007|NCT03384966|7674977|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0
4732008|NCT03384966|7674975|FG000|Follow-up Period|Adverse Event|1
4732009|NCT03384966|7674976|FG001|Follow-up Period|Adverse Event|0
4732010|NCT03384966|7674977|FG002|Follow-up Period|Adverse Event|0
4732011|NCT03386032|7674997|FG000|Overall Study|Lack of Efficacy|6
4732012|NCT03386032|7674998|FG001|Overall Study|Lack of Efficacy|2
4732013|NCT03386032|7674999|FG002|Overall Study|Lack of Efficacy|0
4732014|NCT03386032|7674997|FG000|Overall Study|Adverse Event|2
4732015|NCT03386032|7674998|FG001|Overall Study|Adverse Event|2
4732016|NCT03386032|7674999|FG002|Overall Study|Adverse Event|0
4732017|NCT03386032|7674997|FG000|Overall Study|Withdrawal by Subject|1
4732018|NCT03386032|7674998|FG001|Overall Study|Withdrawal by Subject|0
4732019|NCT03386032|7674999|FG002|Overall Study|Withdrawal by Subject|0
4732020|NCT03386032|7674997|FG000|Overall Study|Lost to Follow-up|9
4732021|NCT03386032|7674998|FG001|Overall Study|Lost to Follow-up|3
4732022|NCT03386032|7674999|FG002|Overall Study|Lost to Follow-up|0
4732023|NCT03386344|7675019|FG000|Overall Study|Adverse Event|6
4732024|NCT03386344|7675020|FG001|Overall Study|Adverse Event|3
4732025|NCT03386344|7675021|FG002|Overall Study|Adverse Event|1
4732026|NCT03386344|7675019|FG000|Overall Study|Poor Compliance to Protocol|0
4732027|NCT03386344|7675020|FG001|Overall Study|Poor Compliance to Protocol|1
4732028|NCT03386344|7675021|FG002|Overall Study|Poor Compliance to Protocol|0
4732029|NCT03386344|7675019|FG000|Overall Study|Study Terminated by Sponsor|101
4732030|NCT03386344|7675020|FG001|Overall Study|Study Terminated by Sponsor|102
4732031|NCT03386344|7675021|FG002|Overall Study|Study Terminated by Sponsor|106
4732032|NCT03386344|7675019|FG000|Overall Study|Lost to Follow-up|3
4732033|NCT03386344|7675020|FG001|Overall Study|Lost to Follow-up|2
4732034|NCT03386344|7675021|FG002|Overall Study|Lost to Follow-up|1
4732035|NCT03386344|7675019|FG000|Overall Study|At the Participant's own Request|7
4732036|NCT03386344|7675020|FG001|Overall Study|At the Participant's own Request|7
4732037|NCT03386344|7675021|FG002|Overall Study|At the Participant's own Request|8
4732038|NCT03386344|7675019|FG000|Overall Study|Reason not Specified|0
4732039|NCT03386344|7675020|FG001|Overall Study|Reason not Specified|1
4732040|NCT03386344|7675021|FG002|Overall Study|Reason not Specified|0
4732041|NCT03386435|7675031|FG000|Overall Study|Protocol Violation|5
4732042|NCT03386435|7675032|FG001|Overall Study|Protocol Violation|7
4732043|NCT03386448|7675040|FG000|Overall Study|Adverse Event|0
4732044|NCT03386448|7675041|FG001|Overall Study|Adverse Event|2
4732045|NCT03386474|7675049|FG000|Overall Study|Death|1
4732046|NCT03386474|7675050|FG001|Overall Study|Death|0
4732047|NCT03386474|7675049|FG000|Overall Study|Adverse Event|0
4732048|NCT03386474|7675050|FG001|Overall Study|Adverse Event|1
4732049|NCT03386994|7675064|FG000|Overall Study|Lung transplant|1
4732050|NCT03386994|7675064|FG000|Overall Study|Adverse Event|14
4732051|NCT03386994|7675064|FG000|Overall Study|Lost to Follow-up|4
4732052|NCT03386994|7675064|FG000|Overall Study|Withdrawal by Subject|3
4732053|NCT03386994|7675064|FG000|Overall Study|Death|16
4732054|NCT03387020|7675082|FG000|Overall Study|Adverse Event|0
4732055|NCT03387020|7675083|FG001|Overall Study|Adverse Event|2
4732056|NCT03387020|7675084|FG002|Overall Study|Adverse Event|0
4732057|NCT03387020|7675082|FG000|Overall Study|Withdrawal by Subject|2
4732058|NCT03387020|7675083|FG001|Overall Study|Withdrawal by Subject|0
4732059|NCT03387020|7675084|FG002|Overall Study|Withdrawal by Subject|0
4732060|NCT03387046|7675108|FG000|Overall Study|Adverse Event|1
4732061|NCT03387046|7675109|FG001|Overall Study|Adverse Event|1
4737319|NCT03605836|7687423|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0
4737320|NCT03605836|7687424|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0
4737321|NCT03605836|7687421|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85
4737322|NCT03605836|7687422|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0
4737323|NCT03605836|7687423|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0
4737324|NCT03605836|7687424|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0
4737325|NCT03605836|7687421|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15
4737326|NCT03605836|7687422|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0
4737327|NCT03605836|7687423|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0
4737328|NCT03605836|7687424|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0
4737329|NCT03605836|7687421|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1
4737330|NCT03605836|7687422|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0
4737331|NCT03605836|7687423|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0
4737332|NCT03605836|7687424|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0
4737333|NCT03605836|7687421|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0
4737334|NCT03605836|7687422|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2
4737335|NCT03605836|7687423|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4
4737336|NCT03605836|7687424|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4
4737337|NCT03605836|7687421|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0
4737338|NCT03605836|7687422|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5
4737339|NCT03605836|7687423|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8
4737340|NCT03605836|7687424|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0
4737341|NCT03605836|7687421|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0
4737342|NCT03605836|7687422|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0
4737343|NCT03605836|7687423|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2
4737344|NCT03605836|7687424|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1
4737345|NCT03605836|7687421|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0
4737346|NCT03605836|7687422|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3
4737347|NCT03605836|7687423|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5
4737348|NCT03605836|7687424|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1
4737349|NCT03605836|7687421|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0
4737350|NCT03605836|7687422|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1
4737351|NCT03605836|7687423|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0
4737352|NCT03605836|7687424|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4
4737353|NCT03605836|7687421|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0
4737354|NCT03605836|7687422|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1
4737355|NCT03605836|7687423|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0
4737356|NCT03605836|7687424|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0
4732062|NCT03387462|7675129|FG000|Overall Study|Lost to Follow-up|1
4732063|NCT03387683|7675135|FG000|Overall Study|In receipt of disallowed medication|1
4732064|NCT03387683|7675136|FG001|Overall Study|In receipt of disallowed medication|0
4732065|NCT03387683|7675135|FG000|Overall Study|Did not receive treatment|1
4732066|NCT03387683|7675136|FG001|Overall Study|Did not receive treatment|0
4732067|NCT03388164|7675153|FG000|Overall Study|Withdrawal by Subject|3
4732068|NCT03388164|7675154|FG001|Overall Study|Withdrawal by Subject|1
4732069|NCT03389308|7675187|FG000|Overall Study|Withdrawal by Subject|5
4732070|NCT03389308|7675187|FG000|Overall Study|Lost to Follow-up|3
4732071|NCT03389308|7675187|FG000|Overall Study|Adverse Event|2
4732072|NCT03389308|7675187|FG000|Overall Study|Sponsor Request|2
4732073|NCT03389555|7675193|FG000|Overall Study|Protocol Violation|1
4732074|NCT03389555|7675194|FG001|Overall Study|Protocol Violation|3
4732075|NCT03389555|7675193|FG000|Overall Study|Death|1
4732076|NCT03389555|7675194|FG001|Overall Study|Death|0
4732077|NCT03389893|7675223|FG000|Randomized Double Blind Period|Withdrawal by Subject|1
4732078|NCT03389893|7675224|FG001|Randomized Double Blind Period|Withdrawal by Subject|0
4732079|NCT03389893|7675225|FG002|Randomized Double Blind Period|Withdrawal by Subject|0
4732080|NCT03389893|7675226|FG003|Randomized Double Blind Period|Withdrawal by Subject|0
4732081|NCT03389893|7675223|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0
4732082|NCT03389893|7675224|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0
4732083|NCT03389893|7675225|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2
4732084|NCT03389893|7675226|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1
4732085|NCT03389893|7675223|FG000|Open Label Extension and Follow-Up|Physician Decision|0
4732086|NCT03389893|7675224|FG001|Open Label Extension and Follow-Up|Physician Decision|0
4732087|NCT03389893|7675225|FG002|Open Label Extension and Follow-Up|Physician Decision|1
4732088|NCT03389893|7675226|FG003|Open Label Extension and Follow-Up|Physician Decision|0
4732089|NCT03389893|7675223|FG000|Open Label Extension and Follow-Up|Participant Moved|0
4732090|NCT03389893|7675224|FG001|Open Label Extension and Follow-Up|Participant Moved|0
4732091|NCT03389893|7675225|FG002|Open Label Extension and Follow-Up|Participant Moved|1
4732092|NCT03389893|7675226|FG003|Open Label Extension and Follow-Up|Participant Moved|0
4732093|NCT03390101|7675235|FG000|Weeks 0-12|Withdrawal by Subject|0
4732094|NCT03390101|7675236|FG001|Weeks 0-12|Withdrawal by Subject|1
4732095|NCT03390101|7675237|FG002|Weeks 0-12|Withdrawal by Subject|1
4732096|NCT03390101|7675235|FG000|Weeks 0-12|Lost to Follow-up|0
4732097|NCT03390101|7675236|FG001|Weeks 0-12|Lost to Follow-up|1
4732098|NCT03390101|7675237|FG002|Weeks 0-12|Lost to Follow-up|0
4732099|NCT03390101|7675235|FG000|Weeks 12-54|Withdrawal by Subject|0
4732100|NCT03390101|7675236|FG001|Weeks 12-54|Withdrawal by Subject|3
4732101|NCT03390101|7675237|FG002|Weeks 12-54|Withdrawal by Subject|1
4732102|NCT03390101|7675235|FG000|Weeks 12-54|Pregnancy|1
4732103|NCT03390101|7675236|FG001|Weeks 12-54|Pregnancy|0
4732104|NCT03390101|7675237|FG002|Weeks 12-54|Pregnancy|0
4732105|NCT03390101|7675235|FG000|Weeks 12-54|Adverse Event|2
4732106|NCT03390101|7675236|FG001|Weeks 12-54|Adverse Event|1
4732107|NCT03390101|7675237|FG002|Weeks 12-54|Adverse Event|1
4732108|NCT03390166|7675256|FG000|Overall Study|Death|0
4732109|NCT03390166|7675257|FG001|Overall Study|Death|1
4732110|NCT03390166|7675256|FG000|Overall Study|Lost to Follow-up|6
4732111|NCT03390166|7675257|FG001|Overall Study|Lost to Follow-up|4
4732112|NCT03390166|7675256|FG000|Overall Study|Physician Decision|2
4732113|NCT03390166|7675257|FG001|Overall Study|Physician Decision|1
4732114|NCT03390166|7675256|FG000|Overall Study|Move from study area|3
4732115|NCT03390166|7675257|FG001|Overall Study|Move from study area|2
4732116|NCT03390166|7675256|FG000|Overall Study|To militarycamp for conscript|1
4732117|NCT03390166|7675257|FG001|Overall Study|To militarycamp for conscript|0
4732118|NCT03390166|7675256|FG000|Overall Study|To drug therapy course|0
4732119|NCT03390166|7675257|FG001|Overall Study|To drug therapy course|1
4732120|NCT03390166|7675256|FG000|Overall Study|Move to work oversea|0
4732121|NCT03390166|7675257|FG001|Overall Study|Move to work oversea|1
4732122|NCT03390426|7675271|FG000|Overall Study|Protocol Violation|0
4732123|NCT03390426|7675272|FG001|Overall Study|Protocol Violation|1
4732124|NCT03391765|7675305|FG000|Overall Study|Adverse Event|2
4732125|NCT03391765|7675306|FG001|Overall Study|Adverse Event|0
4732126|NCT03391765|7675307|FG002|Overall Study|Adverse Event|0
4732127|NCT03391765|7675308|FG003|Overall Study|Adverse Event|2
4732128|NCT03391765|7675305|FG000|Overall Study|Withdrew consent|5
4732129|NCT03391765|7675306|FG001|Overall Study|Withdrew consent|7
4732130|NCT03391765|7675307|FG002|Overall Study|Withdrew consent|2
4732131|NCT03391765|7675308|FG003|Overall Study|Withdrew consent|5
4732132|NCT03391765|7675305|FG000|Overall Study|Other, not specified|44
4732133|NCT03391765|7675306|FG001|Overall Study|Other, not specified|38
4732134|NCT03391765|7675307|FG002|Overall Study|Other, not specified|21
4732135|NCT03391765|7675308|FG003|Overall Study|Other, not specified|16
4732136|NCT03392168|7675335|FG000|Period 2: Cohort 2|Lost to Follow-up|0
4732137|NCT03392168|7675336|FG001|Period 2: Cohort 2|Lost to Follow-up|1
4732138|NCT03392168|7675337|FG002|Period 2: Cohort 2|Lost to Follow-up|1
4732139|NCT03392168|7675338|FG003|Period 2: Cohort 2|Lost to Follow-up|1
4732140|NCT03392168|7675335|FG000|Period 2: Cohort 2|Other|0
4732141|NCT03392168|7675336|FG001|Period 2: Cohort 2|Other|1
4732142|NCT03392168|7675337|FG002|Period 2: Cohort 2|Other|0
4732143|NCT03392168|7675338|FG003|Period 2: Cohort 2|Other|0
4732144|NCT03392194|7675349|FG000|Overall Study|Withdrawal by Subject|1
4732145|NCT03392194|7675350|FG001|Overall Study|Withdrawal by Subject|2
4732146|NCT03392194|7675349|FG000|Overall Study|Conflicts with personal schedule|1
4732147|NCT03392194|7675350|FG001|Overall Study|Conflicts with personal schedule|0
4732148|NCT03393000|7675372|FG000|Overall Study|Death|11
4732149|NCT03393000|7675372|FG000|Overall Study|Withdrawal by Subject|2
4732150|NCT03393000|7675372|FG000|Overall Study|Physician Decision|1
4732151|NCT03393806|7675419|FG000|Overall Study|Physician Decision|1
4732152|NCT03393806|7675420|FG001|Overall Study|Physician Decision|0
4732153|NCT03394391|7675429|FG000|Overall Study|Lost to Follow-up|1
4732154|NCT03394391|7675430|FG001|Overall Study|Lost to Follow-up|2
4732155|NCT03394508|7675438|FG000|Overall Study|Protocol Violation|0
4732156|NCT03394508|7675439|FG001|Overall Study|Protocol Violation|3
4732157|NCT03394508|7675438|FG000|Overall Study|Lost to Follow-up|1
4732158|NCT03394508|7675439|FG001|Overall Study|Lost to Follow-up|0
4732159|NCT03394885|7675453|FG000|Overall Study|Adverse Event|4
4732160|NCT03394885|7675453|FG000|Overall Study|Lack of Efficacy|1
4732161|NCT03394885|7675453|FG000|Overall Study|Physician Decision|1
4732162|NCT03394885|7675453|FG000|Overall Study|Withdrawal by Subject|8
4732163|NCT03394885|7675453|FG000|Overall Study|Alternative Therapy|1
4732164|NCT03394924|7675460|FG000|Overall Study|Adverse Event|0
4732165|NCT03394924|7675461|FG001|Overall Study|Adverse Event|5
4732166|NCT03394924|7675462|FG002|Overall Study|Adverse Event|0
4732167|NCT03394924|7675460|FG000|Overall Study|Withdrawal by Subject|2
4732168|NCT03394924|7675461|FG001|Overall Study|Withdrawal by Subject|0
4732169|NCT03394924|7675462|FG002|Overall Study|Withdrawal by Subject|0
4732170|NCT03394924|7675460|FG000|Overall Study|Lost to Follow-up|0
4732171|NCT03394924|7675461|FG001|Overall Study|Lost to Follow-up|1
4732172|NCT03394924|7675462|FG002|Overall Study|Lost to Follow-up|0
4732173|NCT03394924|7675460|FG000|Overall Study|Did not meet all inclusion criteria|1
4732174|NCT03394924|7675461|FG001|Overall Study|Did not meet all inclusion criteria|0
4732175|NCT03394924|7675462|FG002|Overall Study|Did not meet all inclusion criteria|0
4732176|NCT03395353|7675472|FG000|Overall Study|Adverse Event|20
4732177|NCT03395353|7675472|FG000|Overall Study|Protocol Violation|1
4732178|NCT03395353|7675472|FG000|Overall Study|Lack of Efficacy|3
4732179|NCT03395353|7675472|FG000|Overall Study|Withdrawal by Subject|24
4732180|NCT03395353|7675472|FG000|Overall Study|Discontinued visit|1
4732181|NCT03395353|7675472|FG000|Overall Study|Refrain from visit due to COVID-19|1
4732182|NCT03395353|7675472|FG000|Overall Study|Physician Decision|4
4732183|NCT03395353|7675472|FG000|Overall Study|Early termination of overall study|33
4732184|NCT03396835|7675513|FG000|Overall Study|Withdrawn prior to completion|1
4732185|NCT03396835|7675513|FG000|Overall Study|Did not meet criteria for data analysis|1
4732186|NCT03396913|7675519|FG000|Overall Study|Lost to Follow-up|0
4732187|NCT03396913|7675520|FG001|Overall Study|Lost to Follow-up|6
4732188|NCT03397771|7675557|FG000|Overall Study|2 erroneously randomized, never treated|3
4732189|NCT03397771|7675558|FG001|Overall Study|2 erroneously randomized, never treated|1
4732190|NCT03397771|7675557|FG000|Overall Study|Withdrawal by Subject|1
4732191|NCT03397771|7675558|FG001|Overall Study|Withdrawal by Subject|3
4732192|NCT03397771|7675557|FG000|Overall Study|Protocol Violation|2
4732193|NCT03397771|7675558|FG001|Overall Study|Protocol Violation|2
4732194|NCT03397771|7675557|FG000|Overall Study|Adverse Event|2
4732195|NCT03397771|7675558|FG001|Overall Study|Adverse Event|1
4732196|NCT03398356|7675636|FG000|Before Treatment|Lost to Follow-up|1
4732197|NCT03398356|7675637|FG001|Before Treatment|Lost to Follow-up|2
4732198|NCT03398356|7675638|FG002|Before Treatment|Lost to Follow-up|0
4732199|NCT03398356|7675636|FG000|Before Treatment|drug intolerance|2
4732200|NCT03398356|7675637|FG001|Before Treatment|drug intolerance|1
4732201|NCT03398356|7675638|FG002|Before Treatment|drug intolerance|0
4732202|NCT03398356|7675636|FG000|Before Treatment|Withdrawal by Subject|0
4732203|NCT03398356|7675637|FG001|Before Treatment|Withdrawal by Subject|5
4732204|NCT03398356|7675638|FG002|Before Treatment|Withdrawal by Subject|0
4732205|NCT03398356|7675636|FG000|Before Treatment|Physician Decision|0
4732206|NCT03398356|7675637|FG001|Before Treatment|Physician Decision|0
4732207|NCT03398356|7675638|FG002|Before Treatment|Physician Decision|11
4732208|NCT03398356|7675636|FG000|After 6 Weeks of Treatment|Physician Decision|0
4732209|NCT03398356|7675637|FG001|After 6 Weeks of Treatment|Physician Decision|2
4732210|NCT03398356|7675638|FG002|After 6 Weeks of Treatment|Physician Decision|0
4732211|NCT03399786|7675693|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1
4732212|NCT03399786|7675694|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0
4732213|NCT03399786|7675695|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0
4732214|NCT03399786|7675696|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0
4732215|NCT03399786|7675693|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0
4732216|NCT03399786|7675694|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0
4732217|NCT03399786|7675695|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1
4732218|NCT03399786|7675696|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0
4732219|NCT03399786|7675693|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0
4732220|NCT03399786|7675694|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0
4732221|NCT03399786|7675695|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0
4732222|NCT03399786|7675696|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1
4732223|NCT03400033|7675706|FG000|Overall Study|Withdrawal by Subject|1
4732224|NCT03400033|7675707|FG001|Overall Study|Withdrawal by Subject|2
4732225|NCT03400787|7675762|FG000|Overall Study|Lost to Follow-up|1
4732226|NCT03400787|7675763|FG001|Overall Study|Lost to Follow-up|0
4732227|NCT03400787|7675762|FG000|Overall Study|Death|1
4732228|NCT03400787|7675763|FG001|Overall Study|Death|0
4732229|NCT03400787|7675762|FG000|Overall Study|Protocol Violation|0
4732230|NCT03400787|7675763|FG001|Overall Study|Protocol Violation|2
4732231|NCT03400787|7675762|FG000|Overall Study|Unblinded before 3-month follow-upa-|0
4732232|NCT03400787|7675763|FG001|Overall Study|Unblinded before 3-month follow-upa-|6
4732233|NCT03400852|7675780|FG000|Blinded Treatment Period|Physician Decision|0
4732234|NCT03400852|7675781|FG001|Blinded Treatment Period|Physician Decision|1
4732235|NCT03400852|7675782|FG002|Blinded Treatment Period|Physician Decision|0
4732236|NCT03400852|7675780|FG000|Blinded Treatment Period|Adverse Event|1
4732237|NCT03400852|7675781|FG001|Blinded Treatment Period|Adverse Event|1
4732238|NCT03400852|7675782|FG002|Blinded Treatment Period|Adverse Event|0
4732239|NCT03400852|7675780|FG000|Blinded Treatment Period|Study terminated by sponsor|8
4732240|NCT03400852|7675781|FG001|Blinded Treatment Period|Study terminated by sponsor|4
4631291|NCT01891669|7500425|FG000|Overall Study|Withdrawal by Subject|1
4631292|NCT01891669|7500426|FG001|Overall Study|Withdrawal by Subject|1
4631293|NCT01891669|7500427|FG002|Overall Study|Withdrawal by Subject|0
4732241|NCT03400852|7675782|FG002|Blinded Treatment Period|Study terminated by sponsor|0
4732242|NCT03400852|7675780|FG000|Open Label Period|Physician Decision|0
4732243|NCT03400852|7675781|FG001|Open Label Period|Physician Decision|0
4732244|NCT03400852|7675782|FG002|Open Label Period|Physician Decision|1
4732245|NCT03400852|7675780|FG000|Open Label Period|Study terminated by sponsor|0
4732246|NCT03400852|7675781|FG001|Open Label Period|Study terminated by sponsor|0
4732247|NCT03400852|7675782|FG002|Open Label Period|Study terminated by sponsor|21
4732248|NCT03400956|7675793|FG000|Treatment Period 1|Adverse Event|0
4732249|NCT03400956|7675794|FG001|Treatment Period 1|Adverse Event|1
4732250|NCT03400956|7675795|FG002|Treatment Period 1|Adverse Event|0
4732251|NCT03400956|7675793|FG000|Treatment Period 1|Lost to Follow-up|0
4732252|NCT03400956|7675794|FG001|Treatment Period 1|Lost to Follow-up|0
4732253|NCT03400956|7675795|FG002|Treatment Period 1|Lost to Follow-up|1
4732254|NCT03400956|7675793|FG000|Treatment Period 1|Protocol Violation|0
4732255|NCT03400956|7675794|FG001|Treatment Period 1|Protocol Violation|2
4732256|NCT03400956|7675795|FG002|Treatment Period 1|Protocol Violation|0
4732257|NCT03400956|7675793|FG000|Treatment Period 1|Study terminated by sponsor|3
4732258|NCT03400956|7675794|FG001|Treatment Period 1|Study terminated by sponsor|1
4732259|NCT03400956|7675795|FG002|Treatment Period 1|Study terminated by sponsor|1
4732260|NCT03400956|7675793|FG000|Treatment Period 1|Withdrawal by Subject|0
4732261|NCT03400956|7675794|FG001|Treatment Period 1|Withdrawal by Subject|2
4732262|NCT03400956|7675795|FG002|Treatment Period 1|Withdrawal by Subject|4
4732263|NCT03400956|7675793|FG000|Treatment Period 1|Other|1
4732264|NCT03400956|7675794|FG001|Treatment Period 1|Other|2
4732265|NCT03400956|7675795|FG002|Treatment Period 1|Other|3
4732266|NCT03400956|7675793|FG000|Post-treatment Period 1|Adverse Event|0
4732267|NCT03400956|7675794|FG001|Post-treatment Period 1|Adverse Event|0
4732268|NCT03400956|7675795|FG002|Post-treatment Period 1|Adverse Event|1
4732269|NCT03400956|7675793|FG000|Post-treatment Period 1|Physician Decision|2
4732270|NCT03400956|7675794|FG001|Post-treatment Period 1|Physician Decision|3
4732271|NCT03400956|7675795|FG002|Post-treatment Period 1|Physician Decision|0
4732272|NCT03400956|7675793|FG000|Post-treatment Period 1|Study terminated by sponsor|11
4732273|NCT03400956|7675794|FG001|Post-treatment Period 1|Study terminated by sponsor|10
4732274|NCT03400956|7675795|FG002|Post-treatment Period 1|Study terminated by sponsor|11
4732275|NCT03400956|7675793|FG000|Post-treatment Period 1|Withdrawal by Subject|5
4732276|NCT03400956|7675794|FG001|Post-treatment Period 1|Withdrawal by Subject|0
4732277|NCT03400956|7675795|FG002|Post-treatment Period 1|Withdrawal by Subject|0
4732278|NCT03400956|7675793|FG000|Post-treatment Period 1|Other|4
4732279|NCT03400956|7675794|FG001|Post-treatment Period 1|Other|3
4732280|NCT03400956|7675795|FG002|Post-treatment Period 1|Other|4
4732281|NCT03400956|7675793|FG000|Treatment Period 2|Adverse Event|2
4732282|NCT03400956|7675794|FG001|Treatment Period 2|Adverse Event|1
4732283|NCT03400956|7675795|FG002|Treatment Period 2|Adverse Event|1
4732284|NCT03400956|7675793|FG000|Treatment Period 2|Lost to Follow-up|1
4732285|NCT03400956|7675794|FG001|Treatment Period 2|Lost to Follow-up|1
4732286|NCT03400956|7675795|FG002|Treatment Period 2|Lost to Follow-up|0
4732287|NCT03400956|7675793|FG000|Treatment Period 2|Withdrawal by Subject|0
4732288|NCT03400956|7675794|FG001|Treatment Period 2|Withdrawal by Subject|0
4732289|NCT03400956|7675795|FG002|Treatment Period 2|Withdrawal by Subject|3
4732290|NCT03400956|7675793|FG000|Treatment Period 2|Other|1
4732291|NCT03400956|7675794|FG001|Treatment Period 2|Other|1
4732292|NCT03400956|7675795|FG002|Treatment Period 2|Other|0
4732293|NCT03400956|7675793|FG000|Follow-up Period|Withdrawal by Subject|0
4732294|NCT03400956|7675794|FG001|Follow-up Period|Withdrawal by Subject|0
4631294|NCT01891669|7500428|FG003|Overall Study|Withdrawal by Subject|0
4631295|NCT01891669|7500429|FG004|Overall Study|Withdrawal by Subject|0
4732295|NCT03400956|7675795|FG002|Follow-up Period|Withdrawal by Subject|1
4732296|NCT03400956|7675793|FG000|Follow-up Period|Other|0
4732297|NCT03400956|7675794|FG001|Follow-up Period|Other|0
4732298|NCT03400956|7675795|FG002|Follow-up Period|Other|1
4732299|NCT03401229|7675808|FG000|Overall Study|Lost to Follow-up|2
4732300|NCT03401229|7675809|FG001|Overall Study|Lost to Follow-up|1
4732301|NCT03401229|7675808|FG000|Overall Study|Other|1
4732302|NCT03401229|7675809|FG001|Overall Study|Other|3
4732303|NCT03401229|7675808|FG000|Overall Study|Adverse Event|8
4732304|NCT03401229|7675809|FG001|Overall Study|Adverse Event|6
4732305|NCT03401229|7675808|FG000|Overall Study|Withdrawal by Subject|29
4631296|NCT01891669|7500430|FG005|Overall Study|Withdrawal by Subject|0
4631297|NCT01891669|7500431|FG006|Overall Study|Withdrawal by Subject|1
4631298|NCT01891669|7500432|FG007|Overall Study|Withdrawal by Subject|2
4631299|NCT01891669|7500433|FG008|Overall Study|Withdrawal by Subject|1
4631300|NCT01891669|7500434|FG009|Overall Study|Withdrawal by Subject|1
4631301|NCT01891669|7500425|FG000|Overall Study|Other|1
4631302|NCT01891669|7500426|FG001|Overall Study|Other|0
4631303|NCT01891669|7500427|FG002|Overall Study|Other|0
4631304|NCT01891669|7500428|FG003|Overall Study|Other|0
4631305|NCT01891669|7500429|FG004|Overall Study|Other|0
4631306|NCT01891669|7500430|FG005|Overall Study|Other|0
4446850|NCT00486759|7231968|FG000|Safety Follow-up|Administrative/not specified|8
4446851|NCT00486759|7231969|FG001|Safety Follow-up|Administrative/not specified|6
4446852|NCT00486759|7231968|FG000|Safety Follow-up|Refused treatment/did not cooperate|6
4446853|NCT00486759|7231969|FG001|Safety Follow-up|Refused treatment/did not cooperate|4
4446854|NCT00486759|7231968|FG000|Safety Follow-up|Adverse event/intercurrent illness|4
4446855|NCT00486759|7231969|FG001|Safety Follow-up|Adverse event/intercurrent illness|0
4446856|NCT00486811|7231978|FG000|Overall Study|Adverse Event|28
4732306|NCT03401229|7675809|FG001|Overall Study|Withdrawal by Subject|26
4732307|NCT03401229|7675808|FG000|Overall Study|COVID-19|0
4732308|NCT03401229|7675809|FG001|Overall Study|COVID-19|1
4732309|NCT03401450|7675817|FG000|Overall Study|Lost to Follow-up|4
4732310|NCT03401450|7675818|FG001|Overall Study|Lost to Follow-up|6
4732311|NCT03401450|7675817|FG000|Overall Study|Anesthesia plan changed|2
4732312|NCT03401450|7675818|FG001|Overall Study|Anesthesia plan changed|2
4732313|NCT03401450|7675817|FG000|Overall Study|Did not complete medication diary|4
4732314|NCT03401450|7675818|FG001|Overall Study|Did not complete medication diary|2
4732315|NCT03401450|7675817|FG000|Overall Study|post surgery medication change|2
4732316|NCT03401450|7675818|FG001|Overall Study|post surgery medication change|1
4732317|NCT03401450|7675817|FG000|Overall Study|Cancelled surgery|0
4732318|NCT03401450|7675818|FG001|Overall Study|Cancelled surgery|2
4732319|NCT03402126|7675833|FG000|Overall Study|Lost to Follow-up|6
4732320|NCT03402126|7675833|FG000|Overall Study|Protocol Violation|10
4732321|NCT03402126|7675833|FG000|Overall Study|Sponsor request/Study termination|29
4732322|NCT03402126|7675833|FG000|Overall Study|Study product no longer in use|1
4732323|NCT03402126|7675833|FG000|Overall Study|Technical problems|1
4732324|NCT03402126|7675833|FG000|Overall Study|Withdrawal by Subject|6
4732325|NCT03402126|7675833|FG000|Overall Study|Physician Decision|2
4732326|NCT03402126|7675833|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3
4732327|NCT03402126|7675833|FG000|Overall Study|Death|4
4732328|NCT03402386|7675850|FG000|Overall Study|Adverse Event|3
4732329|NCT03402386|7675850|FG000|Overall Study|Physician Decision|1
4732330|NCT03402386|7675850|FG000|Overall Study|Difficult to control Hb|2
4732331|NCT03402750|7675869|FG000|Overall Study|Lost to Follow-up|2
4732332|NCT03402750|7675870|FG001|Overall Study|Lost to Follow-up|1
4732333|NCT03402893|7675876|FG000|Overall Study|Withdrawal by Subject|1
4732334|NCT03403036|7675902|FG000|Overall Study|Lack of Efficacy|5
4732335|NCT03403192|7675910|FG000|Overall Study|Lost to Follow-up|1
4732336|NCT03403192|7675911|FG001|Overall Study|Lost to Follow-up|2
4732337|NCT03403192|7675912|FG002|Overall Study|Lost to Follow-up|0
4732338|NCT03403192|7675913|FG003|Overall Study|Lost to Follow-up|0
4732339|NCT03403192|7675910|FG000|Overall Study|Unable to respond|0
4732340|NCT03403192|7675911|FG001|Overall Study|Unable to respond|1
4732341|NCT03403192|7675912|FG002|Overall Study|Unable to respond|0
4732342|NCT03403192|7675913|FG003|Overall Study|Unable to respond|0
4732343|NCT03403192|7675910|FG000|Overall Study|Incomplete|3
4732344|NCT03403192|7675911|FG001|Overall Study|Incomplete|1
4732345|NCT03403192|7675912|FG002|Overall Study|Incomplete|3
4732346|NCT03403192|7675913|FG003|Overall Study|Incomplete|6
4732347|NCT03403374|7675988|FG000|Overall Study|Lost to Follow-up|1
4732348|NCT03403400|7675995|FG000|Overall Study|Lost to Follow-up|1
4732349|NCT03403400|7675996|FG001|Overall Study|Lost to Follow-up|0
4732350|NCT03403400|7675997|FG002|Overall Study|Lost to Follow-up|1
4732351|NCT03403400|7675995|FG000|Overall Study|Hospitalization|1
4732352|NCT03403400|7675996|FG001|Overall Study|Hospitalization|0
4732353|NCT03403400|7675997|FG002|Overall Study|Hospitalization|0
4732354|NCT03403400|7675995|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0
4446857|NCT00486811|7231979|FG001|Overall Study|Adverse Event|60
4446858|NCT00486811|7231980|FG002|Overall Study|Adverse Event|135
4446859|NCT00486811|7231978|FG000|Overall Study|Lack of Efficacy|34
4446860|NCT00486811|7231979|FG001|Overall Study|Lack of Efficacy|14
4446861|NCT00486811|7231980|FG002|Overall Study|Lack of Efficacy|7
4446862|NCT00486811|7231978|FG000|Overall Study|Lost to Follow-up|4
4446863|NCT00486811|7231979|FG001|Overall Study|Lost to Follow-up|6
4446864|NCT00486811|7231980|FG002|Overall Study|Lost to Follow-up|4
4446865|NCT00486811|7231978|FG000|Overall Study|Withdrawal by Subject|33
4446866|NCT00486811|7231979|FG001|Overall Study|Withdrawal by Subject|44
4631307|NCT01891669|7500431|FG006|Overall Study|Other|0
4732355|NCT03403400|7675996|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0
4732356|NCT03403400|7675997|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1
4732357|NCT03403413|7676020|FG000|Overall Study|Lack of Efficacy|2
4732358|NCT03403426|7676026|FG000|Overall Study|Death|1
4732359|NCT03403426|7676026|FG000|Overall Study|Lost to Follow-up|2
4737357|NCT03605836|7687421|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0
4737358|NCT03605836|7687422|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5
4737359|NCT03605836|7687423|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1
4737360|NCT03605836|7687424|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1
4737361|NCT03605836|7687421|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0
4737362|NCT03605836|7687422|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10
4737363|NCT03605836|7687423|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6
4737364|NCT03605836|7687424|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4
4737365|NCT03605836|7687421|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0
4737366|NCT03605836|7687422|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3
4737367|NCT03605836|7687423|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1
4737368|NCT03605836|7687424|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0
4737369|NCT03605836|7687421|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0
4737370|NCT03605836|7687422|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6
4737371|NCT03605836|7687423|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16
4737372|NCT03605836|7687424|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7
4737373|NCT03605836|7687421|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0
4737374|NCT03605836|7687422|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0
4737375|NCT03605836|7687423|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2
4737376|NCT03605836|7687424|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1
4737377|NCT03606460|7687457|FG000|Overall Study|Lost to Follow-up|1
4737378|NCT03606460|7687458|FG001|Overall Study|Lost to Follow-up|8
4737379|NCT03607682|7687474|FG000|Overall Study|Withdrawal by Subject|1
4737380|NCT03607682|7687474|FG000|Overall Study|Disease progression|1
4737381|NCT03607695|7687478|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1
4737382|NCT03607695|7687478|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2
4737383|NCT03608774|7687501|FG000|Overall Study|Lost to Follow-up|5
4737384|NCT03608774|7687502|FG001|Overall Study|Lost to Follow-up|5
4737385|NCT03608774|7687501|FG000|Overall Study|Withdrawal by Subject|1
4737386|NCT03608774|7687502|FG001|Overall Study|Withdrawal by Subject|0
4737387|NCT03608774|7687501|FG000|Overall Study|Protocol Violation|1
4737388|NCT03608774|7687502|FG001|Overall Study|Protocol Violation|0
4737389|NCT03608774|7687501|FG000|Overall Study|Not eligible at enrollment|0
4737390|NCT03608774|7687502|FG001|Overall Study|Not eligible at enrollment|1
4737391|NCT03608774|7687501|FG000|Overall Study|Health related event|0
4737392|NCT03608774|7687502|FG001|Overall Study|Health related event|1
4737393|NCT03609619|7687523|FG000|Overall Study|Adverse Event|1
4737394|NCT03609619|7687524|FG001|Overall Study|Adverse Event|0
4737395|NCT03609619|7687523|FG000|Overall Study|Lack of Efficacy|1
4737396|NCT03609619|7687524|FG001|Overall Study|Lack of Efficacy|2
4737397|NCT03609619|7687523|FG000|Overall Study|Protocol Violation|5
4737398|NCT03609619|7687524|FG001|Overall Study|Protocol Violation|0
4737399|NCT03609619|7687523|FG000|Overall Study|Withdrawal by Subject|2
4737400|NCT03609619|7687524|FG001|Overall Study|Withdrawal by Subject|3
4737401|NCT03609619|7687523|FG000|Overall Study|Lost to Follow-up|1
4737402|NCT03609619|7687524|FG001|Overall Study|Lost to Follow-up|1
4737638|NCT03614156|7687817|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0
4737639|NCT03614156|7687814|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2
4737640|NCT03614156|7687815|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0
4737641|NCT03614156|7687816|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0
4737642|NCT03614156|7687817|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0
4737643|NCT03614156|7687814|FG000|Safety Follow-Up Period|Withdrawal by Subject|0
4737644|NCT03614156|7687815|FG001|Safety Follow-Up Period|Withdrawal by Subject|0
4737645|NCT03614156|7687816|FG002|Safety Follow-Up Period|Withdrawal by Subject|1
4737646|NCT03614156|7687817|FG003|Safety Follow-Up Period|Withdrawal by Subject|0
4737647|NCT03614156|7687814|FG000|Safety Follow-Up Period|Lost to Follow-up|1
4737648|NCT03614156|7687815|FG001|Safety Follow-Up Period|Lost to Follow-up|0
4737649|NCT03614156|7687816|FG002|Safety Follow-Up Period|Lost to Follow-up|0
4737650|NCT03614156|7687817|FG003|Safety Follow-Up Period|Lost to Follow-up|1
4737651|NCT03614975|7687834|FG000|Overall Study|Physician Decision|7
4732360|NCT03403751|7676128|FG000|Overall Study|Death|5
4732361|NCT03403751|7676129|FG001|Overall Study|Death|6
4732362|NCT03403751|7676128|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2
4732363|NCT03403751|7676129|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2
4732364|NCT03404206|7676146|FG000|Overall Study|Withdrawal by Subject|1
4732365|NCT03404206|7676147|FG001|Overall Study|Withdrawal by Subject|1
4732366|NCT03404206|7676148|FG002|Overall Study|Withdrawal by Subject|0
4732367|NCT03404206|7676146|FG000|Overall Study|Lost to Follow-up|3
4732368|NCT03404206|7676147|FG001|Overall Study|Lost to Follow-up|1
4732369|NCT03404206|7676148|FG002|Overall Study|Lost to Follow-up|0
4732370|NCT03404674|7676193|FG000|Overall Study|Inability to Attend Future Visits|0
4732371|NCT03404674|7676194|FG001|Overall Study|Inability to Attend Future Visits|1
4732372|NCT03404674|7676195|FG002|Overall Study|Inability to Attend Future Visits|1
4732373|NCT03404674|7676196|FG003|Overall Study|Inability to Attend Future Visits|0
4732374|NCT03404674|7676197|FG004|Overall Study|Inability to Attend Future Visits|0
4732375|NCT03404674|7676198|FG005|Overall Study|Inability to Attend Future Visits|0
4732376|NCT03404674|7676193|FG000|Overall Study|Behavioral Problems|0
4732377|NCT03404674|7676194|FG001|Overall Study|Behavioral Problems|0
4732378|NCT03404674|7676195|FG002|Overall Study|Behavioral Problems|1
4732379|NCT03404674|7676196|FG003|Overall Study|Behavioral Problems|0
4732380|NCT03404674|7676197|FG004|Overall Study|Behavioral Problems|0
4732381|NCT03404674|7676198|FG005|Overall Study|Behavioral Problems|0
4732382|NCT03404674|7676193|FG000|Overall Study|Started a Medication that Precluded Eligibility|0
4732383|NCT03404674|7676194|FG001|Overall Study|Started a Medication that Precluded Eligibility|0
4732384|NCT03404674|7676195|FG002|Overall Study|Started a Medication that Precluded Eligibility|0
4732385|NCT03404674|7676196|FG003|Overall Study|Started a Medication that Precluded Eligibility|1
4732386|NCT03404674|7676197|FG004|Overall Study|Started a Medication that Precluded Eligibility|0
4732387|NCT03404674|7676198|FG005|Overall Study|Started a Medication that Precluded Eligibility|1
4737403|NCT03610048|7687539|FG000|Overall Study|Study terminated by sponsor|84
4737404|NCT03610048|7687539|FG000|Overall Study|Adverse Event|32
4737405|NCT03610048|7687539|FG000|Overall Study|Withdrawal by Subject|31
4737406|NCT03610048|7687539|FG000|Overall Study|Lost to Follow-up|8
4737407|NCT03610048|7687539|FG000|Overall Study|Other|4
4737408|NCT03610048|7687539|FG000|Overall Study|Physician Decision|1
4737409|NCT03610048|7687539|FG000|Overall Study|Pregnancy|1
4737410|NCT03610165|7687545|FG000|Overall Study|Device didn't work|0
4737411|NCT03610165|7687546|FG001|Overall Study|Device didn't work|1
4737412|NCT03610269|7687552|FG000|Overall Study|Physician Decision|10
4737413|NCT03610269|7687552|FG000|Overall Study|Protocol Violation|1
4737414|NCT03610269|7687552|FG000|Overall Study|Unable to draw blood|1
4737415|NCT03610269|7687552|FG000|Overall Study|Screen fail|4
4737416|NCT03610581|7687576|FG000|Overall Study|Study terminated by sponsor|2
4737417|NCT03610581|7687577|FG001|Overall Study|Study terminated by sponsor|0
4737418|NCT03610581|7687576|FG000|Overall Study|Other|0
4737419|NCT03610581|7687577|FG001|Overall Study|Other|1
4737420|NCT03610581|7687576|FG000|Overall Study|Withdrawal by Subject|1
4737421|NCT03610581|7687577|FG001|Overall Study|Withdrawal by Subject|0
4737422|NCT03611075|7687610|FG000|Overall Study|Physician Decision|0
4737423|NCT03611075|7687611|FG001|Overall Study|Physician Decision|1
4737424|NCT03611075|7687612|FG002|Overall Study|Physician Decision|1
4737425|NCT03611075|7687613|FG003|Overall Study|Physician Decision|0
4737426|NCT03611075|7687614|FG004|Overall Study|Physician Decision|0
4737427|NCT03611075|7687615|FG005|Overall Study|Physician Decision|0
4737428|NCT03611075|7687616|FG006|Overall Study|Physician Decision|0
4737429|NCT03611075|7687617|FG007|Overall Study|Physician Decision|0
4737430|NCT03611075|7687618|FG008|Overall Study|Physician Decision|0
4737431|NCT03611075|7687610|FG000|Overall Study|Lost to Follow-up|1
4737432|NCT03611075|7687611|FG001|Overall Study|Lost to Follow-up|0
4737433|NCT03611075|7687612|FG002|Overall Study|Lost to Follow-up|0
4737434|NCT03611075|7687613|FG003|Overall Study|Lost to Follow-up|2
4737435|NCT03611075|7687614|FG004|Overall Study|Lost to Follow-up|0
4737436|NCT03611075|7687615|FG005|Overall Study|Lost to Follow-up|0
4737437|NCT03611075|7687616|FG006|Overall Study|Lost to Follow-up|0
4737438|NCT03611075|7687617|FG007|Overall Study|Lost to Follow-up|0
4737439|NCT03611075|7687618|FG008|Overall Study|Lost to Follow-up|0
4737440|NCT03611075|7687610|FG000|Overall Study|Withdrawal by Subject|0
4737441|NCT03611075|7687611|FG001|Overall Study|Withdrawal by Subject|1
4737442|NCT03611075|7687612|FG002|Overall Study|Withdrawal by Subject|1
4737443|NCT03611075|7687613|FG003|Overall Study|Withdrawal by Subject|1
4737444|NCT03611075|7687614|FG004|Overall Study|Withdrawal by Subject|0
4737445|NCT03611075|7687615|FG005|Overall Study|Withdrawal by Subject|0
4737446|NCT03611075|7687616|FG006|Overall Study|Withdrawal by Subject|1
4737447|NCT03611075|7687617|FG007|Overall Study|Withdrawal by Subject|0
4737448|NCT03611075|7687618|FG008|Overall Study|Withdrawal by Subject|0
4737449|NCT03611075|7687610|FG000|Overall Study|Reason unknown|0
4737450|NCT03611075|7687611|FG001|Overall Study|Reason unknown|0
4737451|NCT03611075|7687612|FG002|Overall Study|Reason unknown|0
4737452|NCT03611075|7687613|FG003|Overall Study|Reason unknown|1
4737453|NCT03611075|7687614|FG004|Overall Study|Reason unknown|0
4737454|NCT03611075|7687615|FG005|Overall Study|Reason unknown|0
4737455|NCT03611075|7687616|FG006|Overall Study|Reason unknown|1
4732388|NCT03404843|7676215|FG000|Overall Study|Study difficulties unrelated to Tx|4
4732389|NCT03404843|7676216|FG001|Overall Study|Study difficulties unrelated to Tx|1
4732390|NCT03405818|7676244|FG000|Overall Study|Withdrawal by Subject|4
4732391|NCT03405818|7676244|FG000|Overall Study|Lost to Follow-up|4
4732392|NCT03405935|7676248|FG000|Overall Study|Adverse Event|3
4732393|NCT03405935|7676248|FG000|Overall Study|Death|2
4732394|NCT03405935|7676248|FG000|Overall Study|Withdrawal by Subject|1
4732395|NCT03405935|7676248|FG000|Overall Study|Lost to Follow-up|2
4732396|NCT03406260|7676258|FG000|Period 1|Adverse Event|0
4732397|NCT03406260|7676259|FG001|Period 1|Adverse Event|0
4732398|NCT03406260|7676260|FG002|Period 1|Adverse Event|0
4732399|NCT03406260|7676261|FG003|Period 1|Adverse Event|0
4732400|NCT03406260|7676262|FG004|Period 1|Adverse Event|1
4732401|NCT03406260|7676263|FG005|Period 1|Adverse Event|0
4732402|NCT03406962|7676329|FG000|Overall Study|Death|2
4732403|NCT03406962|7676329|FG000|Overall Study|Adverse Event|1
4732404|NCT03407118|7676343|FG000|Period 2|Withdrawal by Subject|1
4732405|NCT03407118|7676344|FG001|Period 2|Withdrawal by Subject|0
4732406|NCT03407170|7676350|FG000|Overall Study|Adverse Event|1
4732407|NCT03407430|7676360|FG000|Washout|Protocol Violation|1
4732408|NCT03407430|7676361|FG001|Washout|Protocol Violation|0
4732409|NCT03407482|7676374|FG000|Overall Study|Adverse Event|12
4732410|NCT03407482|7676374|FG000|Overall Study|Disease Relapse|1
4732411|NCT03407482|7676374|FG000|Overall Study|Lost to Follow-up|1
4732412|NCT03407482|7676374|FG000|Overall Study|Non-Compliance With Study Drug|1
4732413|NCT03407482|7676374|FG000|Overall Study|Pregnancy|2
4732414|NCT03407482|7676374|FG000|Overall Study|Protocol Violation|1
4732415|NCT03407482|7676374|FG000|Overall Study|Study Terminated By Sponsor|106
4732416|NCT03407482|7676374|FG000|Overall Study|Withdrawal by Subject|6
4732417|NCT03407482|7676374|FG000|Overall Study|Data Entry Error|1
4732418|NCT03408483|7676434|FG000|Overall Study|Physician Decision|3
4732419|NCT03408483|7676435|FG001|Overall Study|Physician Decision|3
4732420|NCT03408483|7676434|FG000|Overall Study|Lost to Follow-up|3
4732421|NCT03408483|7676435|FG001|Overall Study|Lost to Follow-up|0
4732422|NCT03408639|7676443|FG000|Overall Study|Death|5
4732423|NCT03408639|7676444|FG001|Overall Study|Death|5
4732424|NCT03408639|7676443|FG000|Overall Study|Lost to Follow-up|1
4732425|NCT03408639|7676444|FG001|Overall Study|Lost to Follow-up|4
4732426|NCT03408639|7676443|FG000|Overall Study|Withdrawal by Subject|2
4732427|NCT03408639|7676444|FG001|Overall Study|Withdrawal by Subject|7
4732428|NCT03408639|7676443|FG000|Overall Study|Physician Decision|3
4732429|NCT03408639|7676444|FG001|Overall Study|Physician Decision|6
4732430|NCT03409107|7676482|FG000|Overall Study|Withdrawal by Subject|4
4732431|NCT03409107|7676483|FG001|Overall Study|Withdrawal by Subject|2
4732432|NCT03409107|7676482|FG000|Overall Study|Physician Decision|1
4732433|NCT03409107|7676483|FG001|Overall Study|Physician Decision|0
4732434|NCT03409107|7676482|FG000|Overall Study|Lost to Follow-up|7
4732435|NCT03409107|7676483|FG001|Overall Study|Lost to Follow-up|2
4732436|NCT03409107|7676482|FG000|Overall Study|Adverse Event|5
4732437|NCT03409107|7676483|FG001|Overall Study|Adverse Event|3
4732438|NCT03409796|7676491|FG000|Overall Study|Adverse Event|2
4732439|NCT03409796|7676492|FG001|Overall Study|Adverse Event|0
4732440|NCT03409796|7676491|FG000|Overall Study|Other|0
4732441|NCT03409796|7676492|FG001|Overall Study|Other|1
4732442|NCT03410056|7676502|FG000|Overall Study|Decision by Sponsor|0
4732443|NCT03410056|7676503|FG001|Overall Study|Decision by Sponsor|0
4732444|NCT03410056|7676504|FG002|Overall Study|Decision by Sponsor|3
4732445|NCT03410056|7676505|FG003|Overall Study|Decision by Sponsor|0
4732446|NCT03410056|7676506|FG004|Overall Study|Decision by Sponsor|0
4732447|NCT03410056|7676507|FG005|Overall Study|Decision by Sponsor|0
4732448|NCT03410056|7676508|FG006|Overall Study|Decision by Sponsor|0
4732449|NCT03410056|7676502|FG000|Overall Study|Withdrawal by Subject|0
4732450|NCT03410056|7676503|FG001|Overall Study|Withdrawal by Subject|2
4732451|NCT03410056|7676504|FG002|Overall Study|Withdrawal by Subject|5
4732452|NCT03410056|7676505|FG003|Overall Study|Withdrawal by Subject|5
4732453|NCT03410056|7676506|FG004|Overall Study|Withdrawal by Subject|0
4732454|NCT03410056|7676507|FG005|Overall Study|Withdrawal by Subject|0
4732455|NCT03410056|7676508|FG006|Overall Study|Withdrawal by Subject|0
4732456|NCT03411902|7676552|FG000|Overall Study|Lost to Follow-up|3
4732457|NCT03411902|7676553|FG001|Overall Study|Lost to Follow-up|0
4732458|NCT03412019|7676561|FG000|Overall Study|Withdrawal by Subject|1
4732459|NCT03412019|7676562|FG001|Overall Study|Withdrawal by Subject|1
4732460|NCT03412084|7676570|FG000|Overall Study|Withdrawal by Subject|2
4732461|NCT03412084|7676571|FG001|Overall Study|Withdrawal by Subject|0
4732462|NCT03412084|7676570|FG000|Overall Study|Participant moved|1
4732463|NCT03412084|7676571|FG001|Overall Study|Participant moved|0
4732464|NCT03412084|7676570|FG000|Overall Study|Lost to Follow-up|1
4732465|NCT03412084|7676571|FG001|Overall Study|Lost to Follow-up|1
4732466|NCT03412734|7676579|FG000|Overall Study|Incorrect labeling of samples|2
4732467|NCT03412734|7676580|FG001|Overall Study|Incorrect labeling of samples|0
4732468|NCT03412734|7676579|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1
4732469|NCT03412734|7676580|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0
4732470|NCT03412929|7676586|FG000|Overall Study|Protocol Violation|3
4732471|NCT03414047|7676603|FG000|Overall Study|Adverse Event|0
4732472|NCT03414047|7676604|FG001|Overall Study|Adverse Event|0
4732473|NCT03414047|7676605|FG002|Overall Study|Adverse Event|1
4732474|NCT03414047|7676606|FG003|Overall Study|Adverse Event|1
4732475|NCT03414047|7676603|FG000|Overall Study|Physician Decision|1
4732476|NCT03414047|7676604|FG001|Overall Study|Physician Decision|0
4732477|NCT03414047|7676605|FG002|Overall Study|Physician Decision|0
4732478|NCT03414047|7676606|FG003|Overall Study|Physician Decision|1
4732479|NCT03414047|7676603|FG000|Overall Study|Withdrawal by Subject|1
4732480|NCT03414047|7676604|FG001|Overall Study|Withdrawal by Subject|0
4732481|NCT03414047|7676605|FG002|Overall Study|Withdrawal by Subject|2
4732482|NCT03414047|7676606|FG003|Overall Study|Withdrawal by Subject|0
4732483|NCT03414359|7676619|FG000|Overall Study|Lack of Efficacy|1
4732484|NCT03414359|7676620|FG001|Overall Study|Lack of Efficacy|1
4732485|NCT03414359|7676619|FG000|Overall Study|Protocol Violation|0
4732486|NCT03414359|7676620|FG001|Overall Study|Protocol Violation|1
4732487|NCT03415178|7676635|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0
4732488|NCT03415178|7676636|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2
4732489|NCT03415178|7676635|FG000|Single Arm Period (up to Week 16)|Adverse Event|0
4732490|NCT03415178|7676636|FG001|Single Arm Period (up to Week 16)|Adverse Event|1
4732491|NCT03416127|7676669|FG000|Overall Study|Withdrawal by Subject|0
4732492|NCT03416127|7676670|FG001|Overall Study|Withdrawal by Subject|1
4732493|NCT03416127|7676671|FG002|Overall Study|Withdrawal by Subject|1
4732494|NCT03417024|7676720|FG000|Overall Study|Study Termination prior to follow-up|11
4732495|NCT03417024|7676720|FG000|Overall Study|Physician Decision|2
4732496|NCT03417141|7676724|FG000|Overall Study|Withdrawal by Subject|1
4732497|NCT03417141|7676724|FG000|Overall Study|Protocol Violation|3
4732498|NCT03417219|7676730|FG000|Overall Study|Lost to Follow-up|0
4732499|NCT03417219|7676731|FG001|Overall Study|Lost to Follow-up|3
4732500|NCT03417505|7676741|FG000|First Lens Type (30 Days)|Lost to Follow-up|1
4732501|NCT03417505|7676742|FG001|First Lens Type (30 Days)|Lost to Follow-up|1
4732502|NCT03417830|7676792|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1
4732503|NCT03417830|7676793|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0
4732504|NCT03418324|7676830|FG000|Overall Study|Death|0
4732505|NCT03418324|7676831|FG001|Overall Study|Death|1
4732506|NCT03418324|7676830|FG000|Overall Study|Physician Decision|1
4732507|NCT03418324|7676831|FG001|Overall Study|Physician Decision|1
4732508|NCT03418376|7676841|FG000|Overall Study|Musculoskeletal injury|1
4732509|NCT03418376|7676842|FG001|Overall Study|Musculoskeletal injury|2
4732510|NCT03418376|7676843|FG002|Overall Study|Musculoskeletal injury|1
4732511|NCT03418376|7676844|FG003|Overall Study|Musculoskeletal injury|0
4732512|NCT03418376|7676841|FG000|Overall Study|Personal reasons|0
4732513|NCT03418376|7676842|FG001|Overall Study|Personal reasons|2
4732514|NCT03418376|7676843|FG002|Overall Study|Personal reasons|2
4732515|NCT03418376|7676844|FG003|Overall Study|Personal reasons|1
4732516|NCT03418376|7676841|FG000|Overall Study|Exacerbation|0
4732517|NCT03418376|7676842|FG001|Overall Study|Exacerbation|1
4446867|NCT00486811|7231980|FG002|Overall Study|Withdrawal by Subject|58
4446868|NCT00486811|7231978|FG000|Overall Study|Study drug non-compliant|5
4446869|NCT00486811|7231979|FG001|Overall Study|Study drug non-compliant|6
4446870|NCT00486811|7231980|FG002|Overall Study|Study drug non-compliant|3
4446871|NCT00486811|7231978|FG000|Overall Study|All other|18
4446872|NCT00486811|7231979|FG001|Overall Study|All other|11
4446873|NCT00486811|7231980|FG002|Overall Study|All other|7
4446874|NCT00486837|7231999|FG000|Overall Study|Withdrawal by Subject|1
4446875|NCT00486837|7232000|FG001|Overall Study|Withdrawal by Subject|0
4446876|NCT00486837|7231999|FG000|Overall Study|Adverse Event|1
4446877|NCT00486837|7232000|FG001|Overall Study|Adverse Event|1
4446878|NCT00486837|7231999|FG000|Overall Study|Protocol Violation|4
4446879|NCT00486837|7232000|FG001|Overall Study|Protocol Violation|2
4446880|NCT00486837|7231999|FG000|Overall Study|No sputum, devise issues, exacerbation|3
4446881|NCT00486837|7232000|FG001|Overall Study|No sputum, devise issues, exacerbation|4
4446882|NCT00486902|7232020|FG000|Overall Study|Withdrawal by Subject|1
4446883|NCT00486902|7232021|FG001|Overall Study|Withdrawal by Subject|2
4446884|NCT00486902|7232020|FG000|Overall Study|decision for postpartum tubal ligation|3
4446885|NCT00486902|7232021|FG001|Overall Study|decision for postpartum tubal ligation|1
4446886|NCT00486902|7232020|FG000|Overall Study|spinal anesthetic protocal violation|1
4446887|NCT00486902|7232021|FG001|Overall Study|spinal anesthetic protocal violation|1
4446888|NCT00486902|7232020|FG000|Overall Study|Did not meet inclusion criteria|1
4446889|NCT00486902|7232021|FG001|Overall Study|Did not meet inclusion criteria|0
4446890|NCT00486902|7232020|FG000|Overall Study|No toradol due to hemmorhage or allergy|3
4446891|NCT00486902|7232021|FG001|Overall Study|No toradol due to hemmorhage or allergy|1
4446892|NCT00486954|7232031|FG000|Pilot Part|Adverse Event|4
4446893|NCT00486954|7232032|FG001|Pilot Part|Adverse Event|0
4446894|NCT00486954|7232033|FG002|Pilot Part|Adverse Event|5
4446895|NCT00486954|7232034|FG003|Pilot Part|Adverse Event|0
4446896|NCT00486954|7232035|FG004|Pilot Part|Adverse Event|0
4446897|NCT00486954|7232031|FG000|Pilot Part|Disease Progression|2
4446898|NCT00486954|7232032|FG001|Pilot Part|Disease Progression|0
4446899|NCT00486954|7232033|FG002|Pilot Part|Disease Progression|1
4446900|NCT00486954|7232034|FG003|Pilot Part|Disease Progression|0
4446901|NCT00486954|7232035|FG004|Pilot Part|Disease Progression|0
4446902|NCT00486954|7232031|FG000|Randomized Part|Lost to Follow-up|0
4446903|NCT00486954|7232032|FG001|Randomized Part|Lost to Follow-up|0
4446904|NCT00486954|7232033|FG002|Randomized Part|Lost to Follow-up|0
4446905|NCT00486954|7232034|FG003|Randomized Part|Lost to Follow-up|0
4446906|NCT00486954|7232035|FG004|Randomized Part|Lost to Follow-up|1
4446907|NCT00486954|7232031|FG000|Randomized Part|Withdrawal by Subject|0
4446908|NCT00486954|7232032|FG001|Randomized Part|Withdrawal by Subject|0
4732518|NCT03418376|7676843|FG002|Overall Study|Exacerbation|0
4732519|NCT03418376|7676844|FG003|Overall Study|Exacerbation|0
4732520|NCT03418545|7676856|FG000|Overall Study|Withdrawal by Participant|2
4732521|NCT03418545|7676857|FG001|Overall Study|Withdrawal by Participant|4
4732522|NCT03418545|7676856|FG000|Overall Study|Lost to Follow-up|3
4732523|NCT03418545|7676857|FG001|Overall Study|Lost to Follow-up|5
4732524|NCT03418545|7676856|FG000|Overall Study|Reason Not Specified|0
4732525|NCT03418545|7676857|FG001|Overall Study|Reason Not Specified|1
4732526|NCT03418545|7676856|FG000|Overall Study|Missing Completion Status|0
4732527|NCT03418545|7676857|FG001|Overall Study|Missing Completion Status|1
4732528|NCT03418571|7676868|FG000|Overall Study|Consent withdrawn by legal guardian|1
4446909|NCT00486954|7232033|FG002|Randomized Part|Withdrawal by Subject|0
4446910|NCT00486954|7232034|FG003|Randomized Part|Withdrawal by Subject|1
4446911|NCT00486954|7232035|FG004|Randomized Part|Withdrawal by Subject|0
4446912|NCT00486954|7232031|FG000|Randomized Part|Sponsor Terminated Study|0
4446913|NCT00486954|7232032|FG001|Randomized Part|Sponsor Terminated Study|0
4446914|NCT00486954|7232033|FG002|Randomized Part|Sponsor Terminated Study|0
4446915|NCT00486954|7232034|FG003|Randomized Part|Sponsor Terminated Study|19
4446916|NCT00486954|7232035|FG004|Randomized Part|Sponsor Terminated Study|13
4446917|NCT00487084|7232048|FG000|Overall Study|Did not receive intervention|4
4446918|NCT00487084|7232049|FG001|Overall Study|Did not receive intervention|3
4446919|NCT00487084|7232050|FG002|Overall Study|Did not receive intervention|5
4446920|NCT00487188|7232060|FG000|Induction Phase|Abnormality of Laboratory Test|0
4446921|NCT00487188|7232061|FG001|Induction Phase|Abnormality of Laboratory Test|1
4446922|NCT00487188|7232062|FG002|Induction Phase|Abnormality of Laboratory Test|0
4446923|NCT00487188|7232060|FG000|Induction Phase|Adverse Event|5
4446924|NCT00487188|7232061|FG001|Induction Phase|Adverse Event|0
4446925|NCT00487188|7232062|FG002|Induction Phase|Adverse Event|0
4446926|NCT00487188|7232060|FG000|Induction Phase|Lack of Efficacy|0
4446927|NCT00487188|7232061|FG001|Induction Phase|Lack of Efficacy|1
4446928|NCT00487188|7232062|FG002|Induction Phase|Lack of Efficacy|0
4446929|NCT00487188|7232060|FG000|Induction Phase|Protocol Violation|1
4446930|NCT00487188|7232061|FG001|Induction Phase|Protocol Violation|0
4446931|NCT00487188|7232062|FG002|Induction Phase|Protocol Violation|0
4446932|NCT00487188|7232060|FG000|Induction Phase|Refused Treatment|1
4446933|NCT00487188|7232061|FG001|Induction Phase|Refused Treatment|2
4446934|NCT00487188|7232062|FG002|Induction Phase|Refused Treatment|0
4446935|NCT00487188|7232060|FG000|Induction Phase|Lost to Follow-up|2
4446936|NCT00487188|7232061|FG001|Induction Phase|Lost to Follow-up|2
4446937|NCT00487188|7232062|FG002|Induction Phase|Lost to Follow-up|0
4446938|NCT00487188|7232060|FG000|Induction Phase|Administrative|0
4446939|NCT00487188|7232061|FG001|Induction Phase|Administrative|1
4446940|NCT00487188|7232062|FG002|Induction Phase|Administrative|0
4446941|NCT00487188|7232060|FG000|Maintenance Phase|Adverse Event|1
4446942|NCT00487188|7232061|FG001|Maintenance Phase|Adverse Event|0
4446943|NCT00487188|7232062|FG002|Maintenance Phase|Adverse Event|0
4446944|NCT00487188|7232060|FG000|Maintenance Phase|Death|1
4446945|NCT00487188|7232061|FG001|Maintenance Phase|Death|0
4446946|NCT00487188|7232062|FG002|Maintenance Phase|Death|0
4446947|NCT00487188|7232060|FG000|Maintenance Phase|Lost to Follow-up|1
4446948|NCT00487188|7232061|FG001|Maintenance Phase|Lost to Follow-up|0
4446949|NCT00487188|7232062|FG002|Maintenance Phase|Lost to Follow-up|0
4446950|NCT00487188|7232060|FG000|Maintenance Phase|Administrative|0
4446951|NCT00487188|7232061|FG001|Maintenance Phase|Administrative|0
4446952|NCT00487188|7232062|FG002|Maintenance Phase|Administrative|1
4446953|NCT00487240|7232080|FG000|Overall Study|Withdrawal by Subject|12
4446954|NCT00487240|7232081|FG001|Overall Study|Withdrawal by Subject|6
4446955|NCT00487240|7232080|FG000|Overall Study|Lost to Follow-up|7
4446956|NCT00487240|7232081|FG001|Overall Study|Lost to Follow-up|6
4446957|NCT00487240|7232080|FG000|Overall Study|Adverse Event|0
4446958|NCT00487240|7232081|FG001|Overall Study|Adverse Event|4
4446959|NCT00487240|7232080|FG000|Overall Study|Protocol Violation|5
4446960|NCT00487240|7232081|FG001|Overall Study|Protocol Violation|5
4446961|NCT00487240|7232080|FG000|Overall Study|Entry Criteria Not Met|3
4446962|NCT00487240|7232081|FG001|Overall Study|Entry Criteria Not Met|4
4446963|NCT00487240|7232080|FG000|Overall Study|Sponsor Decision|2
4446964|NCT00487240|7232081|FG001|Overall Study|Sponsor Decision|1
4446965|NCT00487240|7232080|FG000|Overall Study|Physician Decision|2
4446966|NCT00487240|7232081|FG001|Overall Study|Physician Decision|0
4446967|NCT00487279|7232089|FG000|Overall Study|Death|1
4446968|NCT00487279|7232090|FG001|Overall Study|Death|0
4446969|NCT00487279|7232089|FG000|Overall Study|Withdrawal by Subject|0
4446970|NCT00487279|7232090|FG001|Overall Study|Withdrawal by Subject|2
4446971|NCT00487435|7232105|FG000|Overall Study|Adverse Event|146
4446972|NCT00487435|7232105|FG000|Overall Study|Death|2
4446973|NCT00487435|7232105|FG000|Overall Study|Lack of Efficacy|33
4446974|NCT00487435|7232105|FG000|Overall Study|Lost to Follow-up|54
4446975|NCT00487435|7232105|FG000|Overall Study|Pregnancy|2
4446976|NCT00487435|7232105|FG000|Overall Study|Withdrawal by Subject|132
4446977|NCT00487435|7232105|FG000|Overall Study|Resolution Of Pain|1
4446978|NCT00487435|7232105|FG000|Overall Study|Study Medication Non-Compliant|32
4446979|NCT00487435|7232105|FG000|Overall Study|Other|83
4446980|NCT00487539|7232113|FG000|Overall Study|Adverse Event|3
4446981|NCT00487539|7232114|FG001|Overall Study|Adverse Event|2
4446982|NCT00487539|7232115|FG002|Overall Study|Adverse Event|1
4446983|NCT00487539|7232116|FG003|Overall Study|Adverse Event|1
4446984|NCT00487539|7232113|FG000|Overall Study|Unsatisfactory therapeutic effect|1
4446985|NCT00487539|7232114|FG001|Overall Study|Unsatisfactory therapeutic effect|0
4446986|NCT00487539|7232115|FG002|Overall Study|Unsatisfactory therapeutic effect|0
4446987|NCT00487539|7232116|FG003|Overall Study|Unsatisfactory therapeutic effect|1
4446988|NCT00487539|7232113|FG000|Overall Study|Other|3
4446989|NCT00487539|7232114|FG001|Overall Study|Other|1
4446990|NCT00487539|7232115|FG002|Overall Study|Other|2
4446991|NCT00487539|7232116|FG003|Overall Study|Other|2
4446992|NCT00487552|7232125|FG000|Overall Study|Unsuccessful magnet placements|3
4446993|NCT00487552|7232125|FG000|Overall Study|Death due to progressive malignancy|2
4446994|NCT00487552|7232125|FG000|Overall Study|Stent not placed|1
4446995|NCT00487695|7232140|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1
4446996|NCT00487695|7232141|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0
4446997|NCT00487695|7232140|FG000|First Procedure|active wheezing (did not have procedure)|1
4446998|NCT00487695|7232141|FG001|First Procedure|active wheezing (did not have procedure)|0
4446999|NCT00487695|7232140|FG000|First Procedure|esophageal stricture found (excl crit)|1
4447000|NCT00487695|7232141|FG001|First Procedure|esophageal stricture found (excl crit)|0
4447001|NCT00487695|7232140|FG000|Second Procedure|active wheezing|0
4447002|NCT00487695|7232141|FG001|Second Procedure|active wheezing|1
4447003|NCT00487695|7232140|FG000|Second Procedure|Withdrawal by Subject|1
4447004|NCT00487695|7232141|FG001|Second Procedure|Withdrawal by Subject|2
4447005|NCT00487747|7232155|FG000|Overall Study|Adverse Event|1
4447006|NCT00487747|7232155|FG000|Overall Study|Lost to Follow-up|9
4447007|NCT00487747|7232155|FG000|Overall Study|Lack of Efficacy|1
4447008|NCT00487825|7232161|FG000|Overall Study|Adverse Event|2
4447009|NCT00487825|7232162|FG001|Overall Study|Adverse Event|2
4447010|NCT00487825|7232161|FG000|Overall Study|Lack of Efficacy|1
4447011|NCT00487825|7232162|FG001|Overall Study|Lack of Efficacy|1
4447012|NCT00487825|7232161|FG000|Overall Study|Other|3
4447013|NCT00487825|7232162|FG001|Overall Study|Other|2
4447014|NCT00487942|7232172|FG000|Overall Study|Adverse Event|1
4447015|NCT00487942|7232173|FG001|Overall Study|Adverse Event|1
4447016|NCT00487942|7232174|FG002|Overall Study|Adverse Event|1
4447017|NCT00487942|7232175|FG003|Overall Study|Adverse Event|1
4447018|NCT00487942|7232172|FG000|Overall Study|Lost to Follow-up|1
4447019|NCT00487942|7232173|FG001|Overall Study|Lost to Follow-up|0
4447020|NCT00487942|7232174|FG002|Overall Study|Lost to Follow-up|0
4447021|NCT00487942|7232175|FG003|Overall Study|Lost to Follow-up|1
4447022|NCT00487942|7232172|FG000|Overall Study|Protocol Violation|1
4447023|NCT00487942|7232173|FG001|Overall Study|Protocol Violation|1
4447024|NCT00487942|7232174|FG002|Overall Study|Protocol Violation|0
4447025|NCT00487942|7232175|FG003|Overall Study|Protocol Violation|0
4447026|NCT00487942|7232172|FG000|Overall Study|Withdrawal by Subject|0
4447027|NCT00487942|7232173|FG001|Overall Study|Withdrawal by Subject|1
4447028|NCT00487942|7232174|FG002|Overall Study|Withdrawal by Subject|2
4447029|NCT00487942|7232175|FG003|Overall Study|Withdrawal by Subject|0
4447030|NCT00488033|7232187|FG000|Overall Study|Withdrawal by Subject|1
4447031|NCT00488033|7232188|FG001|Overall Study|Withdrawal by Subject|0
4447032|NCT00488293|7232211|FG000|Overall Study|Lost to Follow-up|28
4447033|NCT00488293|7232212|FG001|Overall Study|Lost to Follow-up|25
4447034|NCT00488293|7232211|FG000|Overall Study|Withdrawal by Subject|5
4447035|NCT00488293|7232212|FG001|Overall Study|Withdrawal by Subject|3
4447036|NCT00488293|7232211|FG000|Overall Study|Death|2
4447037|NCT00488293|7232212|FG001|Overall Study|Death|1
4447038|NCT00488293|7232211|FG000|Overall Study|Misrandomization/Other Unspecified|1
4447039|NCT00488293|7232212|FG001|Overall Study|Misrandomization/Other Unspecified|1
4447040|NCT00488319|7232221|FG000|Overall Study|Adverse Event|1
4447041|NCT00488319|7232222|FG001|Overall Study|Adverse Event|2
4447042|NCT00488319|7232223|FG002|Overall Study|Adverse Event|23
4447043|NCT00488319|7232221|FG000|Overall Study|Lack of Efficacy|6
4447044|NCT00488319|7232222|FG001|Overall Study|Lack of Efficacy|12
4447045|NCT00488319|7232223|FG002|Overall Study|Lack of Efficacy|27
4447046|NCT00488319|7232221|FG000|Overall Study|Lost to Follow-up|3
4447047|NCT00488319|7232222|FG001|Overall Study|Lost to Follow-up|5
4447048|NCT00488319|7232223|FG002|Overall Study|Lost to Follow-up|16
4447049|NCT00488319|7232221|FG000|Overall Study|Withdrawal by Subject|5
4447050|NCT00488319|7232222|FG001|Overall Study|Withdrawal by Subject|20
4447051|NCT00488319|7232223|FG002|Overall Study|Withdrawal by Subject|44
4447052|NCT00488319|7232221|FG000|Overall Study|Other reasons for withdrawal|0
4447053|NCT00488319|7232222|FG001|Overall Study|Other reasons for withdrawal|4
4447054|NCT00488319|7232223|FG002|Overall Study|Other reasons for withdrawal|12
4447055|NCT00488345|7232235|FG000|Overall Study|Adverse Event|0
4447056|NCT00488345|7232236|FG001|Overall Study|Adverse Event|1
4447057|NCT00488345|7232237|FG002|Overall Study|Adverse Event|1
4447058|NCT00488345|7232235|FG000|Overall Study|Unable to administer antibiotics at home|0
4447059|NCT00488345|7232236|FG001|Overall Study|Unable to administer antibiotics at home|1
4447060|NCT00488345|7232237|FG002|Overall Study|Unable to administer antibiotics at home|0
4447061|NCT00488345|7232235|FG000|Overall Study|Institutional Review Board review|0
4447062|NCT00488345|7232236|FG001|Overall Study|Institutional Review Board review|0
4447063|NCT00488345|7232237|FG002|Overall Study|Institutional Review Board review|1
4447064|NCT00488345|7232235|FG000|Overall Study|Surgical team recommendation|0
4447065|NCT00488345|7232236|FG001|Overall Study|Surgical team recommendation|1
4447066|NCT00488345|7232237|FG002|Overall Study|Surgical team recommendation|0
4447067|NCT00488345|7232235|FG000|Overall Study|Parent/legal guardian request|0
4447068|NCT00488345|7232236|FG001|Overall Study|Parent/legal guardian request|1
4447069|NCT00488345|7232237|FG002|Overall Study|Parent/legal guardian request|1
4515444|NCT00953524|7326351|FG002|Overall Study|Protocol Violation|11
4515445|NCT00953524|7326352|FG003|Overall Study|Protocol Violation|6
4515446|NCT00953524|7326349|FG000|Overall Study|Lost to Follow-up|0
4515447|NCT00953524|7326350|FG001|Overall Study|Lost to Follow-up|1
4515448|NCT00953524|7326351|FG002|Overall Study|Lost to Follow-up|1
4515449|NCT00953524|7326352|FG003|Overall Study|Lost to Follow-up|0
4515450|NCT00953524|7326349|FG000|Overall Study|Withdrawal by Subject|2
4515451|NCT00953524|7326350|FG001|Overall Study|Withdrawal by Subject|4
4515452|NCT00953524|7326351|FG002|Overall Study|Withdrawal by Subject|1
4515453|NCT00953524|7326352|FG003|Overall Study|Withdrawal by Subject|0
4515454|NCT00953576|7326364|FG000|Overall Study|Adverse Event|0
4515455|NCT00953576|7326365|FG001|Overall Study|Adverse Event|1
4515456|NCT00953576|7326364|FG000|Overall Study|Ineligible after Consent|2
4515457|NCT00953576|7326365|FG001|Overall Study|Ineligible after Consent|0
4515458|NCT00953667|7326387|FG000|Overall Study|Lost to Follow-up|11
4515459|NCT00953667|7326387|FG000|Overall Study|Physician Decision|35
4515460|NCT00953667|7326387|FG000|Overall Study|Withdrawal by Subject|63
4515461|NCT00953667|7326387|FG000|Overall Study|Adverse Event|10
4515462|NCT00953667|7326387|FG000|Overall Study|poor venous access,unable to draw blood|4
4515463|NCT00953706|7326393|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2
4515464|NCT00953706|7326394|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3
4515465|NCT00953706|7326395|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0
4515466|NCT00953706|7326396|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0
4515467|NCT00953706|7326393|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
4515468|NCT00953706|7326394|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1
4515469|NCT00953706|7326395|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
4515470|NCT00953706|7326396|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
4515471|NCT00953706|7326393|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
4515472|NCT00953706|7326394|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2
4515473|NCT00953706|7326395|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
4515474|NCT00953706|7326396|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
4515475|NCT00953706|7326393|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
4515476|NCT00953706|7326394|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1
4515477|NCT00953706|7326395|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
4515478|NCT00953706|7326396|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
4515479|NCT00953706|7326393|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
4515480|NCT00953706|7326394|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1
4515481|NCT00953706|7326395|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
4515482|NCT00953706|7326396|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
4515483|NCT00953706|7326393|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0
4515484|NCT00953706|7326394|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0
4515485|NCT00953706|7326395|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0
4515486|NCT00953706|7326396|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2
4515487|NCT00953706|7326393|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
4515488|NCT00953706|7326394|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
4515489|NCT00953706|7326395|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
4515490|NCT00953706|7326396|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1
4515491|NCT00953706|7326393|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
4515492|NCT00953706|7326394|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
4515493|NCT00953706|7326395|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
4447070|NCT00488475|7232246|FG000|Overall Study|Other|1754
4447071|NCT00488514|7232254|FG000|Overall Study|Adverse Event|41
4447072|NCT00488514|7232254|FG000|Overall Study|Lost to Follow-up|44
4447073|NCT00488514|7232254|FG000|Overall Study|Protocol Violation|32
4447074|NCT00488514|7232254|FG000|Overall Study|Withdrawal by Subject|106
4447075|NCT00488514|7232254|FG000|Overall Study|Lack of Efficacy|28
4447076|NCT00488514|7232254|FG000|Overall Study|Did not meet criteria for treatment|30
4447077|NCT00488514|7232254|FG000|Overall Study|Postive drug screen|1
4447078|NCT00488514|7232254|FG000|Overall Study|Withdrawn per medical monitor decision|2
4447079|NCT00488514|7232254|FG000|Overall Study|Investigator decision|1
4447080|NCT00488514|7232254|FG000|Overall Study|Participant had too few migraines|5
4447081|NCT00488514|7232254|FG000|Overall Study|Increase in number of migraines|2
4447082|NCT00488514|7232254|FG000|Overall Study|Increased use of concomitant medication|1
4447083|NCT00488592|7232275|FG000|Overall Study|Withdrawal by Subject|1
4447084|NCT00488592|7232275|FG000|Overall Study|Disease progression|1
4447085|NCT00488592|7232275|FG000|Overall Study|Enrolled but not treated|1
4447086|NCT00488618|7232281|FG000|Overall Study|Adverse Event|13
4447087|NCT00488618|7232282|FG001|Overall Study|Adverse Event|17
4447088|NCT00488618|7232281|FG000|Overall Study|Insufficient Therapeutic Response|18
4447089|NCT00488618|7232282|FG001|Overall Study|Insufficient Therapeutic Response|11
4447090|NCT00488618|7232281|FG000|Overall Study|Protocol Violation|0
4447091|NCT00488618|7232282|FG001|Overall Study|Protocol Violation|2
4447092|NCT00488618|7232281|FG000|Overall Study|Withdrawal of Consent|15
4447093|NCT00488618|7232282|FG001|Overall Study|Withdrawal of Consent|13
4447094|NCT00488618|7232281|FG000|Overall Study|Lost to Follow-up|1
4447095|NCT00488618|7232282|FG001|Overall Study|Lost to Follow-up|0
4447096|NCT00488631|7232294|FG000|Double Blind Period (Week 0-54)|Adverse Event|17
4447097|NCT00488631|7232295|FG001|Double Blind Period (Week 0-54)|Adverse Event|12
4447098|NCT00488631|7232296|FG002|Double Blind Period (Week 0-54)|Adverse Event|12
4447099|NCT00488631|7232297|FG003|Double Blind Period (Week 0-54)|Adverse Event|12
4447100|NCT00488631|7232298|FG004|Double Blind Period (Week 0-54)|Adverse Event|30
4447101|NCT00488631|7232299|FG005|Double Blind Period (Week 0-54)|Adverse Event|50
4447102|NCT00488631|7232300|FG006|Double Blind Period (Week 0-54)|Adverse Event|0
4447103|NCT00488631|7232301|FG007|Double Blind Period (Week 0-54)|Adverse Event|0
4447104|NCT00488631|7232302|FG008|Double Blind Period (Week 0-54)|Adverse Event|0
4447105|NCT00488631|7232303|FG009|Double Blind Period (Week 0-54)|Adverse Event|0
4447106|NCT00488631|7232294|FG000|Double Blind Period (Week 0-54)|Death|0
4447107|NCT00488631|7232295|FG001|Double Blind Period (Week 0-54)|Death|0
4447108|NCT00488631|7232296|FG002|Double Blind Period (Week 0-54)|Death|0
4447109|NCT00488631|7232297|FG003|Double Blind Period (Week 0-54)|Death|0
4447110|NCT00488631|7232298|FG004|Double Blind Period (Week 0-54)|Death|0
4447111|NCT00488631|7232299|FG005|Double Blind Period (Week 0-54)|Death|1
4447112|NCT00488631|7232300|FG006|Double Blind Period (Week 0-54)|Death|0
4447113|NCT00488631|7232301|FG007|Double Blind Period (Week 0-54)|Death|0
4447114|NCT00488631|7232302|FG008|Double Blind Period (Week 0-54)|Death|0
4447115|NCT00488631|7232303|FG009|Double Blind Period (Week 0-54)|Death|0
4732529|NCT03418571|7676869|FG001|Overall Study|Consent withdrawn by legal guardian|0
4732530|NCT03419403|7676904|FG000|Overall Study|Withdrawal by Subject|5
4732531|NCT03419403|7676905|FG001|Overall Study|Withdrawal by Subject|2
4732532|NCT03419403|7676906|FG002|Overall Study|Withdrawal by Subject|5
4732533|NCT03419403|7676907|FG003|Overall Study|Withdrawal by Subject|1
4732534|NCT03419403|7676904|FG000|Overall Study|Progressive disease (per protocol)|0
4732535|NCT03419403|7676905|FG001|Overall Study|Progressive disease (per protocol)|2
4732536|NCT03419403|7676906|FG002|Overall Study|Progressive disease (per protocol)|2
4732537|NCT03419403|7676907|FG003|Overall Study|Progressive disease (per protocol)|0
4732538|NCT03419403|7676904|FG000|Overall Study|Other, not specified|6
4732539|NCT03419403|7676905|FG001|Overall Study|Other, not specified|4
4732540|NCT03419403|7676906|FG002|Overall Study|Other, not specified|5
4732541|NCT03419403|7676907|FG003|Overall Study|Other, not specified|1
4447116|NCT00488631|7232294|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19
4447117|NCT00488631|7232295|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17
4447118|NCT00488631|7232296|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22
4447119|NCT00488631|7232297|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18
4447120|NCT00488631|7232298|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56
4447121|NCT00488631|7232299|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124
4447122|NCT00488631|7232300|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
4447123|NCT00488631|7232301|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
4447124|NCT00488631|7232302|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
4447125|NCT00488631|7232303|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
4447126|NCT00488631|7232294|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1
4447127|NCT00488631|7232295|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2
4447128|NCT00488631|7232296|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1
4447129|NCT00488631|7232297|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0
4447130|NCT00488631|7232298|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3
4447131|NCT00488631|7232299|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7
4447132|NCT00488631|7232300|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0
4447133|NCT00488631|7232301|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0
4447134|NCT00488631|7232302|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0
4447135|NCT00488631|7232303|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0
4447136|NCT00488631|7232294|FG000|Double Blind Period (Week 0-54)|Other|6
4447137|NCT00488631|7232295|FG001|Double Blind Period (Week 0-54)|Other|12
4447138|NCT00488631|7232296|FG002|Double Blind Period (Week 0-54)|Other|10
4447139|NCT00488631|7232297|FG003|Double Blind Period (Week 0-54)|Other|11
4447140|NCT00488631|7232298|FG004|Double Blind Period (Week 0-54)|Other|14
4447141|NCT00488631|7232299|FG005|Double Blind Period (Week 0-54)|Other|34
4447142|NCT00488631|7232300|FG006|Double Blind Period (Week 0-54)|Other|0
4447143|NCT00488631|7232301|FG007|Double Blind Period (Week 0-54)|Other|0
4447144|NCT00488631|7232302|FG008|Double Blind Period (Week 0-54)|Other|0
4447145|NCT00488631|7232303|FG009|Double Blind Period (Week 0-54)|Other|0
4447146|NCT00488631|7232294|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0
4447147|NCT00488631|7232295|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0
4447148|NCT00488631|7232296|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0
4447149|NCT00488631|7232297|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0
4447150|NCT00488631|7232298|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0
4447151|NCT00488631|7232299|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0
4447152|NCT00488631|7232300|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10
4447153|NCT00488631|7232301|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8
4447154|NCT00488631|7232302|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54
4447155|NCT00488631|7232303|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0
4447156|NCT00488631|7232294|FG000|Open Label Study Extension (Week 54-228)|Death|0
4447157|NCT00488631|7232295|FG001|Open Label Study Extension (Week 54-228)|Death|0
4447158|NCT00488631|7232296|FG002|Open Label Study Extension (Week 54-228)|Death|0
4447159|NCT00488631|7232297|FG003|Open Label Study Extension (Week 54-228)|Death|0
4447160|NCT00488631|7232298|FG004|Open Label Study Extension (Week 54-228)|Death|0
4447161|NCT00488631|7232299|FG005|Open Label Study Extension (Week 54-228)|Death|0
4447162|NCT00488631|7232300|FG006|Open Label Study Extension (Week 54-228)|Death|0
4447163|NCT00488631|7232301|FG007|Open Label Study Extension (Week 54-228)|Death|0
4447164|NCT00488631|7232302|FG008|Open Label Study Extension (Week 54-228)|Death|1
4447165|NCT00488631|7232303|FG009|Open Label Study Extension (Week 54-228)|Death|0
4447166|NCT00488631|7232294|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
4447167|NCT00488631|7232295|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
4447168|NCT00488631|7232296|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
4447169|NCT00488631|7232297|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
4447170|NCT00488631|7232298|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
4447171|NCT00488631|7232299|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
4447172|NCT00488631|7232300|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5
4447173|NCT00488631|7232301|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5
4447174|NCT00488631|7232302|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34
4447175|NCT00488631|7232303|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3
4447176|NCT00488631|7232294|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
4447177|NCT00488631|7232295|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
4447178|NCT00488631|7232296|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
4447179|NCT00488631|7232297|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
4447180|NCT00488631|7232298|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
4447181|NCT00488631|7232299|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
4447182|NCT00488631|7232300|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2
4447183|NCT00488631|7232301|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
4447184|NCT00488631|7232302|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6
4447185|NCT00488631|7232303|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
4447186|NCT00488631|7232294|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
4447187|NCT00488631|7232295|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
4447188|NCT00488631|7232296|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
4447189|NCT00488631|7232297|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
4447190|NCT00488631|7232298|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
4447191|NCT00488631|7232299|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
4447192|NCT00488631|7232300|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63
4447193|NCT00488631|7232301|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14
4447194|NCT00488631|7232302|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87
4447195|NCT00488631|7232303|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
4447196|NCT00488644|7232326|FG000|Overall Study|Not Eligible|1
4447197|NCT00488644|7232326|FG000|Overall Study|Not Evaluable|1
4447198|NCT00488683|7232333|FG000|Overall Study|Withdrawal by Subject|1
4447199|NCT00488683|7232334|FG001|Overall Study|Withdrawal by Subject|2
4447200|NCT00488683|7232335|FG002|Overall Study|Withdrawal by Subject|2
4447201|NCT00488683|7232333|FG000|Overall Study|Lost to Follow-up|5
4447202|NCT00488683|7232334|FG001|Overall Study|Lost to Follow-up|3
4447203|NCT00488683|7232335|FG002|Overall Study|Lost to Follow-up|0
4447204|NCT00488683|7232333|FG000|Overall Study|Protocol Violation|5
4447205|NCT00488683|7232334|FG001|Overall Study|Protocol Violation|1
4447206|NCT00488683|7232335|FG002|Overall Study|Protocol Violation|0
4447207|NCT00488683|7232333|FG000|Overall Study|Unable to Classify|1
4447208|NCT00488683|7232334|FG001|Overall Study|Unable to Classify|0
4447209|NCT00488683|7232335|FG002|Overall Study|Unable to Classify|0
4447210|NCT00488774|7232351|FG000|Overall Study|Withdrawal of consent|2
4447211|NCT00488774|7232352|FG001|Overall Study|Withdrawal of consent|2
4447212|NCT00488774|7232353|FG002|Overall Study|Withdrawal of consent|2
4447213|NCT00488774|7232354|FG003|Overall Study|Withdrawal of consent|0
4447214|NCT00488774|7232351|FG000|Overall Study|Other|6
4447215|NCT00488774|7232352|FG001|Overall Study|Other|3
4447216|NCT00488774|7232353|FG002|Overall Study|Other|2
4447217|NCT00488774|7232354|FG003|Overall Study|Other|2
4447218|NCT00488774|7232351|FG000|Overall Study|Lost to Follow-up|0
4447219|NCT00488774|7232352|FG001|Overall Study|Lost to Follow-up|0
4447220|NCT00488774|7232353|FG002|Overall Study|Lost to Follow-up|1
4447221|NCT00488774|7232354|FG003|Overall Study|Lost to Follow-up|1
4447222|NCT00488826|7232368|FG000|Overall Study|Withdrawal by Subject|40
4732542|NCT03419403|7676904|FG000|Overall Study|Left study due to COVID-19 restrictions|1
4447223|NCT00488826|7232369|FG001|Overall Study|Withdrawal by Subject|35
4447224|NCT00488826|7232370|FG002|Overall Study|Withdrawal by Subject|19
4447225|NCT00488826|7232368|FG000|Overall Study|Protocol Violation|0
4447226|NCT00488826|7232369|FG001|Overall Study|Protocol Violation|0
4447227|NCT00488826|7232370|FG002|Overall Study|Protocol Violation|2
4447228|NCT00488826|7232368|FG000|Overall Study|Adverse Event|9
4447229|NCT00488826|7232369|FG001|Overall Study|Adverse Event|15
4732543|NCT03419403|7676905|FG001|Overall Study|Left study due to COVID-19 restrictions|1
4732544|NCT03419403|7676906|FG002|Overall Study|Left study due to COVID-19 restrictions|0
4732545|NCT03419403|7676907|FG003|Overall Study|Left study due to COVID-19 restrictions|0
4732546|NCT03419598|7676932|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2
4732547|NCT03419962|7676947|FG000|Overall Study|Change to other medication|1
4732548|NCT03419962|7676947|FG000|Overall Study|Refusal of continuing with trial drug|1
4732549|NCT03419962|7676947|FG000|Overall Study|Lost to Follow-up|3
4732550|NCT03419962|7676947|FG000|Overall Study|Difficulty in inhaling the doses|1
4732551|NCT03419962|7676947|FG000|Overall Study|Missing completion data|31
4732552|NCT03420300|7676951|FG000|Overall Study|Death|2
4732553|NCT03421379|7676977|FG000|Period 1|Withdrawal by Subject|0
4732554|NCT03421379|7676978|FG001|Period 1|Withdrawal by Subject|1
4732555|NCT03421379|7676977|FG000|Period 1|Physician Decision|1
4732556|NCT03421379|7676978|FG001|Period 1|Physician Decision|1
4732557|NCT03421379|7676977|FG000|Period 1|Did not receive treatment|1
4732558|NCT03421379|7676978|FG001|Period 1|Did not receive treatment|2
4732559|NCT03421431|7676987|FG000|Overall Study|Adverse Event|2
4732560|NCT03421431|7676988|FG001|Overall Study|Adverse Event|1
4732561|NCT03421431|7676989|FG002|Overall Study|Adverse Event|12
4732562|NCT03421431|7676987|FG000|Overall Study|Lost to Follow-up|1
4732563|NCT03421431|7676988|FG001|Overall Study|Lost to Follow-up|1
4732564|NCT03421431|7676989|FG002|Overall Study|Lost to Follow-up|1
4732565|NCT03421431|7676987|FG000|Overall Study|Withdrawal by Subject|3
4732566|NCT03421431|7676988|FG001|Overall Study|Withdrawal by Subject|2
4732567|NCT03421431|7676989|FG002|Overall Study|Withdrawal by Subject|1
4732568|NCT03421431|7676987|FG000|Overall Study|Protocol Violation|0
4732569|NCT03421431|7676988|FG001|Overall Study|Protocol Violation|1
4732570|NCT03421431|7676989|FG002|Overall Study|Protocol Violation|0
4732571|NCT03421431|7676987|FG000|Overall Study|Participant met Stopping Rules|0
4732572|NCT03421431|7676988|FG001|Overall Study|Participant met Stopping Rules|1
4737456|NCT03611075|7687617|FG007|Overall Study|Reason unknown|0
4447230|NCT00488826|7232370|FG002|Overall Study|Adverse Event|4
4447231|NCT00488826|7232368|FG000|Overall Study|Lost to Follow-up|5
4447232|NCT00488826|7232369|FG001|Overall Study|Lost to Follow-up|1
4447233|NCT00488826|7232370|FG002|Overall Study|Lost to Follow-up|0
4447234|NCT00488826|7232368|FG000|Overall Study|Protocol Deviations|2
4447235|NCT00488826|7232369|FG001|Overall Study|Protocol Deviations|1
4447236|NCT00488826|7232370|FG002|Overall Study|Protocol Deviations|1
4447237|NCT00488982|7232382|FG000|Course 1|Physician Decision|0
4447238|NCT00488982|7232383|FG001|Course 1|Physician Decision|2
4447239|NCT00488982|7232384|FG002|Course 1|Physician Decision|4
4447240|NCT00488982|7232382|FG000|Course 1|Withdrawal by Subject|0
4447241|NCT00488982|7232383|FG001|Course 1|Withdrawal by Subject|8
4447242|NCT00488982|7232384|FG002|Course 1|Withdrawal by Subject|2
4447243|NCT00488982|7232382|FG000|Course 1|nonprotocol therapy|0
4447244|NCT00488982|7232383|FG001|Course 1|nonprotocol therapy|2
4447245|NCT00488982|7232384|FG002|Course 1|nonprotocol therapy|2
4447246|NCT00488982|7232382|FG000|Course 1|Adverse Event|0
4447247|NCT00488982|7232383|FG001|Course 1|Adverse Event|0
4447248|NCT00488982|7232384|FG002|Course 1|Adverse Event|6
4447249|NCT00489216|7232402|FG000|Overall Study|Adverse Event|1
4447250|NCT00489255|7232408|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9
4447251|NCT00489255|7232409|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3
4447252|NCT00489255|7232408|FG000|Period 1: Days 1 to 28|Adverse Event|21
4447253|NCT00489255|7232409|FG001|Period 1: Days 1 to 28|Adverse Event|8
4447254|NCT00489255|7232408|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5
4447255|NCT00489255|7232409|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0
4447256|NCT00489255|7232408|FG000|Period 1: Days 1 to 28|Physician Decision|1
4447257|NCT00489255|7232409|FG001|Period 1: Days 1 to 28|Physician Decision|4
4447258|NCT00489255|7232408|FG000|Period 1: Days 1 to 28|Noncompliance|2
4447259|NCT00489255|7232409|FG001|Period 1: Days 1 to 28|Noncompliance|0
4447260|NCT00489255|7232408|FG000|Period 2: Days 29 to 56|Adverse Event|3
4447261|NCT00489255|7232409|FG001|Period 2: Days 29 to 56|Adverse Event|1
4447262|NCT00489255|7232408|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0
4447263|NCT00489255|7232409|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3
4447264|NCT00489255|7232408|FG000|Period 3: Days 57 to 84|Adverse Event|3
4447265|NCT00489255|7232409|FG001|Period 3: Days 57 to 84|Adverse Event|3
4447266|NCT00489255|7232408|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1
4447267|NCT00489255|7232409|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0
4447268|NCT00489255|7232408|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0
4447269|NCT00489255|7232409|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1
4447270|NCT00489359|7232447|FG000|Overall Study|Death|0
4447271|NCT00489359|7232448|FG001|Overall Study|Death|2
4447272|NCT00489359|7232447|FG000|Overall Study|Progressive Disease|5
4447273|NCT00489359|7232448|FG001|Overall Study|Progressive Disease|6
4447274|NCT00489359|7232447|FG000|Overall Study|Lost to Follow-up|1
4447275|NCT00489359|7232448|FG001|Overall Study|Lost to Follow-up|0
4447276|NCT00489359|7232447|FG000|Overall Study|Withdrawal by Subject|1
4447277|NCT00489359|7232448|FG001|Overall Study|Withdrawal by Subject|5
4447278|NCT00489359|7232447|FG000|Overall Study|Adverse Event|0
4447279|NCT00489359|7232448|FG001|Overall Study|Adverse Event|16
4447280|NCT00489411|7232461|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6
4447281|NCT00489411|7232462|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5
4447282|NCT00489411|7232461|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21
4447283|NCT00489411|7232462|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12
4447284|NCT00489411|7232461|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1
4447285|NCT00489411|7232462|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5
4447286|NCT00489411|7232461|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11
4447287|NCT00489411|7232462|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12
4447288|NCT00489411|7232461|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7
4447289|NCT00489411|7232462|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7
4447290|NCT00489424|7232471|FG000|Overall Study|Adverse Event|3
4447291|NCT00489424|7232472|FG001|Overall Study|Adverse Event|3
4447292|NCT00489424|7232473|FG002|Overall Study|Adverse Event|4
4447293|NCT00489424|7232471|FG000|Overall Study|Lack of Efficacy|1
4447294|NCT00489424|7232472|FG001|Overall Study|Lack of Efficacy|0
4447295|NCT00489424|7232473|FG002|Overall Study|Lack of Efficacy|0
4447296|NCT00489424|7232471|FG000|Overall Study|Administrative problems|0
4447297|NCT00489424|7232472|FG001|Overall Study|Administrative problems|2
4447298|NCT00489424|7232473|FG002|Overall Study|Administrative problems|1
4447299|NCT00489476|7232485|FG000|Overall Study|Lost to Follow-up|0
4447300|NCT00489476|7232486|FG001|Overall Study|Lost to Follow-up|1
4447301|NCT00489476|7232487|FG002|Overall Study|Lost to Follow-up|0
4447302|NCT00489476|7232488|FG003|Overall Study|Lost to Follow-up|0
4447303|NCT00489489|7232501|FG000|Overall Study|Not treated due to protocol violation|0
4447304|NCT00489489|7232502|FG001|Overall Study|Not treated due to protocol violation|1
4447305|NCT00489489|7232503|FG002|Overall Study|Not treated due to protocol violation|1
4447306|NCT00489489|7232501|FG000|Overall Study|Adverse Event|1
4447307|NCT00489489|7232502|FG001|Overall Study|Adverse Event|1
4447308|NCT00489489|7232503|FG002|Overall Study|Adverse Event|1
4447309|NCT00489489|7232501|FG000|Overall Study|Protocol Violation|1
4447310|NCT00489489|7232502|FG001|Overall Study|Protocol Violation|0
4447311|NCT00489489|7232503|FG002|Overall Study|Protocol Violation|1
4447312|NCT00489489|7232501|FG000|Overall Study|Progressive disease|0
4447313|NCT00489489|7232502|FG001|Overall Study|Progressive disease|1
4447314|NCT00489489|7232503|FG002|Overall Study|Progressive disease|0
4447315|NCT00489489|7232501|FG000|Overall Study|Participant did not wish to continue|1
4447316|NCT00489489|7232502|FG001|Overall Study|Participant did not wish to continue|1
4447317|NCT00489489|7232503|FG002|Overall Study|Participant did not wish to continue|0
4447318|NCT00489489|7232501|FG000|Overall Study|Other than above|0
4447319|NCT00489489|7232502|FG001|Overall Study|Other than above|1
4447320|NCT00489489|7232503|FG002|Overall Study|Other than above|0
4447321|NCT00489541|7232515|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2
4447322|NCT00489541|7232516|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3
4447323|NCT00489541|7232515|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2
4447324|NCT00489541|7232516|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0
4447325|NCT00489541|7232515|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2
4447326|NCT00489541|7232516|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0
4447327|NCT00489541|7232515|FG000|12-Month Clinical Follow-up|Death|3
4447328|NCT00489541|7232516|FG001|12-Month Clinical Follow-up|Death|2
4447329|NCT00489541|7232515|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23
4447330|NCT00489541|7232516|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12
4447331|NCT00489541|7232515|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4
4732573|NCT03421431|7676989|FG002|Overall Study|Participant met Stopping Rules|0
4732574|NCT03421730|7676999|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
4732575|NCT03421730|7677000|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2
4732576|NCT03421730|7677001|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
4732577|NCT03421730|7677002|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
4732578|NCT03421730|7677003|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
4732579|NCT03421730|7677004|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
4732580|NCT03421730|7677005|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
4732581|NCT03421730|7677006|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
4732582|NCT03421730|7677007|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
4732583|NCT03421730|7677008|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
4732584|NCT03421730|7677009|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
4732585|NCT03421730|7677010|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
4732586|NCT03421730|7676999|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
4732587|NCT03421730|7677000|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
4732588|NCT03421730|7677001|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
4732589|NCT03421730|7677002|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
4732590|NCT03421730|7677003|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2
4732591|NCT03421730|7677004|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
4732592|NCT03421730|7677005|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
4732593|NCT03421730|7677006|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
4732594|NCT03421730|7677007|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
4732595|NCT03421730|7677008|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
4732596|NCT03421730|7677009|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
4732597|NCT03421730|7677010|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
4732598|NCT03422159|7677035|FG000|Overall Study|Exclusion due to terminal disease|2
4732599|NCT03422159|7677036|FG001|Overall Study|Exclusion due to terminal disease|1
4732600|NCT03422172|7677044|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1
4732601|NCT03422172|7677044|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1
4732602|NCT03422172|7677044|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3
4732603|NCT03422250|7677057|FG000|Intervention|Adverse Event|0
4732604|NCT03422250|7677058|FG001|Intervention|Adverse Event|1
4732605|NCT03422250|7677059|FG002|Intervention|Adverse Event|0
4732606|NCT03422250|7677060|FG003|Intervention|Adverse Event|1
4732607|NCT03422250|7677057|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1
4732608|NCT03422250|7677058|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0
4732609|NCT03422250|7677059|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2
4732610|NCT03422250|7677060|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0
4732611|NCT03422250|7677057|FG000|Follow-up|Withdrawal by Subject|0
4732612|NCT03422250|7677058|FG001|Follow-up|Withdrawal by Subject|0
4732613|NCT03422250|7677059|FG002|Follow-up|Withdrawal by Subject|0
4732614|NCT03422250|7677060|FG003|Follow-up|Withdrawal by Subject|1
4732615|NCT03422250|7677057|FG000|Follow-up|Adverse Event|0
4732616|NCT03422250|7677058|FG001|Follow-up|Adverse Event|0
4732617|NCT03422250|7677059|FG002|Follow-up|Adverse Event|0
4732618|NCT03422250|7677060|FG003|Follow-up|Adverse Event|1
4732619|NCT03423173|7677080|FG000|Overall Study|Randomized but not vaccinated|1
4732620|NCT03423173|7677081|FG001|Overall Study|Randomized but not vaccinated|0
4732621|NCT03423173|7677082|FG002|Overall Study|Randomized but not vaccinated|2
4732622|NCT03423173|7677083|FG003|Overall Study|Randomized but not vaccinated|1
4732623|NCT03423173|7677080|FG000|Overall Study|Adverse Event|1
4732624|NCT03423173|7677081|FG001|Overall Study|Adverse Event|1
4732625|NCT03423173|7677082|FG002|Overall Study|Adverse Event|1
4732626|NCT03423173|7677083|FG003|Overall Study|Adverse Event|1
4732627|NCT03423173|7677080|FG000|Overall Study|Lost to Follow-up|10
4732628|NCT03423173|7677081|FG001|Overall Study|Lost to Follow-up|19
4732629|NCT03423173|7677082|FG002|Overall Study|Lost to Follow-up|17
4732630|NCT03423173|7677083|FG003|Overall Study|Lost to Follow-up|22
4732631|NCT03423173|7677080|FG000|Overall Study|Withdrawal of consent|4
4732632|NCT03423173|7677081|FG001|Overall Study|Withdrawal of consent|10
4732633|NCT03423173|7677082|FG002|Overall Study|Withdrawal of consent|4
4732634|NCT03423173|7677083|FG003|Overall Study|Withdrawal of consent|5
4732635|NCT03423173|7677080|FG000|Overall Study|Death|1
4732636|NCT03423173|7677081|FG001|Overall Study|Death|0
4732637|NCT03423173|7677082|FG002|Overall Study|Death|0
4732638|NCT03423173|7677083|FG003|Overall Study|Death|0
4732639|NCT03423173|7677080|FG000|Overall Study|Reason not Specified|2
4732640|NCT03423173|7677081|FG001|Overall Study|Reason not Specified|5
4732641|NCT03423173|7677082|FG002|Overall Study|Reason not Specified|3
4732642|NCT03423173|7677083|FG003|Overall Study|Reason not Specified|1
4732643|NCT03423238|7677104|FG000|Overall Study|Lost to Follow-up|1
4732644|NCT03423238|7677105|FG001|Overall Study|Lost to Follow-up|0
4732645|NCT03423238|7677104|FG000|Overall Study|Withdrawal by Subject|1
4732646|NCT03423238|7677105|FG001|Overall Study|Withdrawal by Subject|0
4732647|NCT03424044|7677121|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
4732648|NCT03424044|7677122|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
4732649|NCT03424044|7677123|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1
4732650|NCT03424044|7677124|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
4732651|NCT03424044|7677125|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
4732652|NCT03424044|7677126|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
4732653|NCT03424044|7677127|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
4732654|NCT03424044|7677128|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
4732655|NCT03424044|7677129|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
4732656|NCT03424044|7677121|FG000|First Intervention (76 Hours)|Adverse Event|0
4732657|NCT03424044|7677122|FG001|First Intervention (76 Hours)|Adverse Event|0
4732658|NCT03424044|7677123|FG002|First Intervention (76 Hours)|Adverse Event|0
4732659|NCT03424044|7677124|FG003|First Intervention (76 Hours)|Adverse Event|0
4732660|NCT03424044|7677125|FG004|First Intervention (76 Hours)|Adverse Event|1
4732661|NCT03424044|7677126|FG005|First Intervention (76 Hours)|Adverse Event|0
4732662|NCT03424044|7677127|FG006|First Intervention (76 Hours)|Adverse Event|0
4732663|NCT03424044|7677128|FG007|First Intervention (76 Hours)|Adverse Event|0
4732664|NCT03424044|7677129|FG008|First Intervention (76 Hours)|Adverse Event|0
4732665|NCT03424044|7677121|FG000|First Intervention (76 Hours)|device issues|0
4732666|NCT03424044|7677122|FG001|First Intervention (76 Hours)|device issues|0
4732667|NCT03424044|7677123|FG002|First Intervention (76 Hours)|device issues|0
4732668|NCT03424044|7677124|FG003|First Intervention (76 Hours)|device issues|0
4732669|NCT03424044|7677125|FG004|First Intervention (76 Hours)|device issues|0
4732670|NCT03424044|7677126|FG005|First Intervention (76 Hours)|device issues|0
4732671|NCT03424044|7677127|FG006|First Intervention (76 Hours)|device issues|1
4732672|NCT03424044|7677128|FG007|First Intervention (76 Hours)|device issues|1
4732673|NCT03424044|7677129|FG008|First Intervention (76 Hours)|device issues|1
4732674|NCT03424044|7677121|FG000|Third Intervention (76 Hours)|Adverse Event|1
4732675|NCT03424044|7677122|FG001|Third Intervention (76 Hours)|Adverse Event|0
4732676|NCT03424044|7677123|FG002|Third Intervention (76 Hours)|Adverse Event|0
4447332|NCT00489541|7232516|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5
4732677|NCT03424044|7677124|FG003|Third Intervention (76 Hours)|Adverse Event|0
4732678|NCT03424044|7677125|FG004|Third Intervention (76 Hours)|Adverse Event|0
4732679|NCT03424044|7677126|FG005|Third Intervention (76 Hours)|Adverse Event|0
4732680|NCT03424044|7677127|FG006|Third Intervention (76 Hours)|Adverse Event|1
4732681|NCT03424044|7677128|FG007|Third Intervention (76 Hours)|Adverse Event|0
4732682|NCT03424044|7677129|FG008|Third Intervention (76 Hours)|Adverse Event|0
4732683|NCT03424044|7677121|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0
4732684|NCT03424044|7677122|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0
4732685|NCT03424044|7677123|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0
4732686|NCT03424044|7677124|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1
4447333|NCT00489554|7232522|FG000|Overall Study|Adverse Event|2
4447334|NCT00489554|7232522|FG000|Overall Study|Withdrawal by Subject|1
4447335|NCT00489554|7232522|FG000|Overall Study|Lost to Follow-up|1
4447336|NCT00489736|7232528|FG000|Overall Study|Lack of Efficacy|53
4447337|NCT00489736|7232529|FG001|Overall Study|Lack of Efficacy|14
4447338|NCT00489736|7232528|FG000|Overall Study|Adverse Event|32
4447339|NCT00489736|7232529|FG001|Overall Study|Adverse Event|45
4447340|NCT00489736|7232528|FG000|Overall Study|Poor compliance|6
4447341|NCT00489736|7232529|FG001|Overall Study|Poor compliance|2
4447342|NCT00489736|7232528|FG000|Overall Study|Not coded/ Not pre-specified|5
4447343|NCT00489736|7232529|FG001|Overall Study|Not coded/ Not pre-specified|8
4447344|NCT00489827|7232537|FG000|Overall Study|Intraoperative exclusion criteria|1
4447345|NCT00489827|7232538|FG001|Overall Study|Intraoperative exclusion criteria|1
4447346|NCT00489827|7232537|FG000|Overall Study|Intraoperative exclusion criteria|1
4447347|NCT00489827|7232538|FG001|Overall Study|Intraoperative exclusion criteria|1
4447348|NCT00489853|7232544|FG000|Wash-out Period 1|Withdrawal by Subject|1
4447349|NCT00489853|7232545|FG001|Wash-out Period 1|Withdrawal by Subject|0
4447350|NCT00489853|7232546|FG002|Wash-out Period 1|Withdrawal by Subject|0
4447351|NCT00489853|7232544|FG000|Wash-out Period 1|Adverse Event|0
4447352|NCT00489853|7232545|FG001|Wash-out Period 1|Adverse Event|1
4447353|NCT00489853|7232546|FG002|Wash-out Period 1|Adverse Event|1
4447354|NCT00489853|7232544|FG000|Wash-out Period 1|Protocol Violation|0
4447355|NCT00489853|7232545|FG001|Wash-out Period 1|Protocol Violation|1
4447356|NCT00489853|7232546|FG002|Wash-out Period 1|Protocol Violation|1
4447357|NCT00489853|7232544|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0
4447358|NCT00489853|7232545|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1
4447359|NCT00489853|7232546|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4
4447360|NCT00489853|7232544|FG000|Wash-out Period 2|Adverse Event|1
4447361|NCT00489853|7232545|FG001|Wash-out Period 2|Adverse Event|1
4447362|NCT00489853|7232546|FG002|Wash-out Period 2|Adverse Event|0
4447363|NCT00489853|7232544|FG000|Wash-out Period 2|Study specific discontinuation criteria|3
4447364|NCT00489853|7232545|FG001|Wash-out Period 2|Study specific discontinuation criteria|2
4447365|NCT00489853|7232546|FG002|Wash-out Period 2|Study specific discontinuation criteria|2
4732687|NCT03424044|7677125|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0
4732688|NCT03424044|7677126|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0
4732689|NCT03424044|7677127|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0
4732690|NCT03424044|7677128|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0
4732691|NCT03424044|7677129|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0
4732692|NCT03424239|7677163|FG000|Overall Study|Withdrawal by Subject|2
4732693|NCT03424265|7677169|FG000|Overall Study|screening failure|1
4732694|NCT03424265|7677170|FG001|Overall Study|screening failure|0
4732695|NCT03424265|7677169|FG000|Overall Study|Withdrawal by Subject|0
4732696|NCT03424265|7677170|FG001|Overall Study|Withdrawal by Subject|2
4732697|NCT03425188|7677200|FG000|Overall Study|Withdrawal by Subject|1
4732698|NCT03425253|7677205|FG000|Overall Study|Adverse Event|2
4732699|NCT03425253|7677205|FG000|Overall Study|Lost to Follow-up|3
4732700|NCT03425253|7677205|FG000|Overall Study|Withdrew Consent|6
4447366|NCT00489853|7232544|FG000|Treatment Period 3|Study specific discontinuation criteria|0
4447367|NCT00489853|7232545|FG001|Treatment Period 3|Study specific discontinuation criteria|1
4447368|NCT00489853|7232546|FG002|Treatment Period 3|Study specific discontinuation criteria|0
4447369|NCT00489918|7232576|FG000|Overall Study|Withdrawal by Subject|2
4447370|NCT00489918|7232577|FG001|Overall Study|Withdrawal by Subject|1
4447371|NCT00489918|7232578|FG002|Overall Study|Withdrawal by Subject|1
4732701|NCT03425253|7677205|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5
4732702|NCT03425396|7677215|FG000|Overall Study|Lost to Follow-up|2
4732703|NCT03425396|7677216|FG001|Overall Study|Lost to Follow-up|5
4732704|NCT03425396|7677217|FG002|Overall Study|Lost to Follow-up|2
4732705|NCT03425396|7677218|FG003|Overall Study|Lost to Follow-up|0
4732706|NCT03425396|7677219|FG004|Overall Study|Lost to Follow-up|0
4732707|NCT03425396|7677215|FG000|Overall Study|Withdrawal by Subject|0
4732708|NCT03425396|7677216|FG001|Overall Study|Withdrawal by Subject|1
4732709|NCT03425396|7677217|FG002|Overall Study|Withdrawal by Subject|0
4732710|NCT03425396|7677218|FG003|Overall Study|Withdrawal by Subject|1
4447372|NCT00489918|7232579|FG003|Overall Study|Withdrawal by Subject|0
4732711|NCT03425396|7677219|FG004|Overall Study|Withdrawal by Subject|0
4447373|NCT00489918|7232580|FG004|Overall Study|Withdrawal by Subject|1
4447374|NCT00489918|7232576|FG000|Overall Study|Adverse Event|0
4447375|NCT00489918|7232577|FG001|Overall Study|Adverse Event|1
4447376|NCT00489918|7232578|FG002|Overall Study|Adverse Event|1
4447377|NCT00489918|7232579|FG003|Overall Study|Adverse Event|0
4447378|NCT00489918|7232580|FG004|Overall Study|Adverse Event|0
4447379|NCT00489918|7232576|FG000|Overall Study|Lost to Follow-up|0
4447380|NCT00489918|7232577|FG001|Overall Study|Lost to Follow-up|0
4447381|NCT00489918|7232578|FG002|Overall Study|Lost to Follow-up|1
4447382|NCT00489918|7232579|FG003|Overall Study|Lost to Follow-up|1
4447383|NCT00489918|7232580|FG004|Overall Study|Lost to Follow-up|0
4447384|NCT00489918|7232576|FG000|Overall Study|Physician Decision|0
4447385|NCT00489918|7232577|FG001|Overall Study|Physician Decision|0
4447386|NCT00489918|7232578|FG002|Overall Study|Physician Decision|1
4447387|NCT00489918|7232579|FG003|Overall Study|Physician Decision|0
4447388|NCT00489918|7232580|FG004|Overall Study|Physician Decision|0
4447389|NCT00489970|7232595|FG000|Persistence Year 9|Lost to Follow-up|2
4447390|NCT00489970|7232596|FG001|Persistence Year 9|Lost to Follow-up|2
4447391|NCT00489970|7232597|FG002|Persistence Year 9|Lost to Follow-up|3
4447392|NCT00489970|7232595|FG000|Persistence Year 9|Other|1
4447393|NCT00489970|7232596|FG001|Persistence Year 9|Other|0
4447394|NCT00489970|7232597|FG002|Persistence Year 9|Other|2
4447395|NCT00490022|7232615|FG000|Overall Study|Adverse Event|0
4447396|NCT00490022|7232616|FG001|Overall Study|Adverse Event|2
4447397|NCT00490022|7232615|FG000|Overall Study|Withdrawal by Subject|1
4447398|NCT00490022|7232616|FG001|Overall Study|Withdrawal by Subject|0
4447399|NCT00490022|7232615|FG000|Overall Study|Subject failed to disclose concommitant|0
4447400|NCT00490022|7232616|FG001|Overall Study|Subject failed to disclose concommitant|1
4447401|NCT00490035|7232626|FG000|Overall Study|AE, non-serious non-fatal|3
4447402|NCT00490035|7232627|FG001|Overall Study|AE, non-serious non-fatal|4
4447403|NCT00490035|7232628|FG002|Overall Study|AE, non-serious non-fatal|4
4447404|NCT00490035|7232629|FG003|Overall Study|AE, non-serious non-fatal|5
4447405|NCT00490035|7232626|FG000|Overall Study|Lost to Follow-up|2
4447406|NCT00490035|7232627|FG001|Overall Study|Lost to Follow-up|0
4447407|NCT00490035|7232628|FG002|Overall Study|Lost to Follow-up|1
4447408|NCT00490035|7232629|FG003|Overall Study|Lost to Follow-up|0
4447409|NCT00490035|7232626|FG000|Overall Study|Withdrawal by Subject|2
4447410|NCT00490035|7232627|FG001|Overall Study|Withdrawal by Subject|1
4447411|NCT00490035|7232628|FG002|Overall Study|Withdrawal by Subject|1
4447412|NCT00490035|7232629|FG003|Overall Study|Withdrawal by Subject|0
4447413|NCT00490035|7232626|FG000|Overall Study|Other reason|0
4447414|NCT00490035|7232627|FG001|Overall Study|Other reason|1
4447415|NCT00490035|7232628|FG002|Overall Study|Other reason|3
4447416|NCT00490035|7232629|FG003|Overall Study|Other reason|1
4447417|NCT00490035|7232626|FG000|Overall Study|AE, serious fatal|1
4447418|NCT00490035|7232627|FG001|Overall Study|AE, serious fatal|0
4447419|NCT00490035|7232628|FG002|Overall Study|AE, serious fatal|0
4447420|NCT00490035|7232629|FG003|Overall Study|AE, serious fatal|0
4447421|NCT00490035|7232626|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0
4447422|NCT00490035|7232627|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0
4447423|NCT00490035|7232628|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1
4447424|NCT00490035|7232629|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0
4447425|NCT00490035|7232626|FG000|Overall Study|AE of unknown type|0
4447426|NCT00490035|7232627|FG001|Overall Study|AE of unknown type|0
4447427|NCT00490035|7232628|FG002|Overall Study|AE of unknown type|2
4447428|NCT00490035|7232629|FG003|Overall Study|AE of unknown type|0
4447429|NCT00490061|7232639|FG000|Overall Study|Physician Decision|1
4447430|NCT00490139|7232652|FG000|Overall Study|Death|106
4447431|NCT00490139|7232653|FG001|Overall Study|Death|119
4447432|NCT00490139|7232654|FG002|Overall Study|Death|168
4447433|NCT00490139|7232655|FG003|Overall Study|Death|135
4447434|NCT00490139|7232652|FG000|Overall Study|Lost to Follow-up|56
4447435|NCT00490139|7232653|FG001|Overall Study|Lost to Follow-up|46
4447436|NCT00490139|7232654|FG002|Overall Study|Lost to Follow-up|58
4732712|NCT03425396|7677215|FG000|Overall Study|Other|0
4732713|NCT03425396|7677216|FG001|Overall Study|Other|1
4732714|NCT03425396|7677217|FG002|Overall Study|Other|1
4732715|NCT03425396|7677218|FG003|Overall Study|Other|0
4732716|NCT03425396|7677219|FG004|Overall Study|Other|1
4737457|NCT03611075|7687618|FG008|Overall Study|Reason unknown|0
4737458|NCT03611582|7687663|FG000|Overall Study|Adverse Event|26
4737459|NCT03611582|7687664|FG001|Overall Study|Adverse Event|6
4737460|NCT03611582|7687663|FG000|Overall Study|Protocol Violation|0
4737461|NCT03611582|7687664|FG001|Overall Study|Protocol Violation|1
4737462|NCT03611582|7687663|FG000|Overall Study|Pregnancy|1
4732717|NCT03426267|7677244|FG000|Overall Study|Physician Decision|1
4732718|NCT03426267|7677245|FG001|Overall Study|Physician Decision|4
4732719|NCT03426267|7677244|FG000|Overall Study|Lost to Follow-up|1
4732720|NCT03426267|7677245|FG001|Overall Study|Lost to Follow-up|0
4732721|NCT03426267|7677244|FG000|Overall Study|Withdrawal by Subject|4
4732722|NCT03426267|7677245|FG001|Overall Study|Withdrawal by Subject|10
4732723|NCT03426267|7677244|FG000|Overall Study|Protocol Violation|1
4732724|NCT03426267|7677245|FG001|Overall Study|Protocol Violation|3
4732725|NCT03426267|7677244|FG000|Overall Study|Adverse Event|9
4732726|NCT03426267|7677245|FG001|Overall Study|Adverse Event|27
4732727|NCT03426267|7677244|FG000|Overall Study|Prohibited Treatment Intake|2
4732728|NCT03426267|7677245|FG001|Overall Study|Prohibited Treatment Intake|3
4732729|NCT03426267|7677244|FG000|Overall Study|Lack of Efficacy|0
4732730|NCT03426267|7677245|FG001|Overall Study|Lack of Efficacy|25
4732731|NCT03426267|7677244|FG000|Overall Study|other|3
4732732|NCT03426267|7677245|FG001|Overall Study|other|0
4732733|NCT03426345|7677253|FG000|Overall Study|Adverse Event|4
4732734|NCT03426345|7677254|FG001|Overall Study|Adverse Event|4
4732735|NCT03426345|7677253|FG000|Overall Study|Lack of Efficacy|1
4732736|NCT03426345|7677254|FG001|Overall Study|Lack of Efficacy|0
4732737|NCT03426345|7677253|FG000|Overall Study|Withdrawal by Subject|5
4732738|NCT03426345|7677254|FG001|Overall Study|Withdrawal by Subject|6
4732739|NCT03426345|7677253|FG000|Overall Study|Lost to Follow-up|3
4732740|NCT03426345|7677254|FG001|Overall Study|Lost to Follow-up|1
4732741|NCT03426345|7677253|FG000|Overall Study|Protocol Deviation|3
4732742|NCT03426345|7677254|FG001|Overall Study|Protocol Deviation|4
4732743|NCT03426345|7677253|FG000|Overall Study|Reason Not Specified|1
4732744|NCT03426345|7677254|FG001|Overall Study|Reason Not Specified|2
4732745|NCT03426345|7677253|FG000|Overall Study|Missing Completion Status|1
4732746|NCT03426345|7677254|FG001|Overall Study|Missing Completion Status|0
4732747|NCT03426436|7677261|FG000|Overall Study|Incorrect lead placement|12
4732748|NCT03426436|7677261|FG000|Overall Study|Withdrawal by Subject|2
4732749|NCT03426436|7677261|FG000|Overall Study|Consent issue|1
4732750|NCT03426436|7677261|FG000|Overall Study|ECGs not saved|4
4732751|NCT03426631|7677271|FG000|Overall Study|Lost to Follow-up|0
4732752|NCT03426631|7677272|FG001|Overall Study|Lost to Follow-up|1
4732753|NCT03426787|7677278|FG000|Overall Study|Withdrawal by Subject|6
4732754|NCT03426787|7677278|FG000|Overall Study|Lost to Follow-up|7
4732755|NCT03426787|7677278|FG000|Overall Study|Unrelated to intervention death|1
4732756|NCT03426995|7677307|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
4732757|NCT03426995|7677308|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
4732758|NCT03426995|7677309|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1
4732759|NCT03426995|7677310|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
4732760|NCT03426995|7677311|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
4732761|NCT03426995|7677312|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
4732762|NCT03426995|7677313|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
4732763|NCT03426995|7677314|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
4732764|NCT03426995|7677315|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
4732765|NCT03426995|7677316|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
4732766|NCT03426995|7677317|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
4732767|NCT03426995|7677318|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
4732768|NCT03426995|7677319|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
4732769|NCT03426995|7677320|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
4732770|NCT03426995|7677321|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
4732771|NCT03426995|7677322|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
4447437|NCT00490139|7232655|FG003|Overall Study|Lost to Follow-up|56
4447438|NCT00490139|7232652|FG000|Overall Study|Participant Withdrew Consent|146
4447439|NCT00490139|7232653|FG001|Overall Study|Participant Withdrew Consent|110
4447440|NCT00490139|7232654|FG002|Overall Study|Participant Withdrew Consent|208
4447441|NCT00490139|7232655|FG003|Overall Study|Participant Withdrew Consent|116
4447442|NCT00490282|7232685|FG000|Overall Study|Withdrawal by Subject|3
4447443|NCT00490451|7232692|FG000|Overall Study|Adverse Event|3
4447444|NCT00490451|7232693|FG001|Overall Study|Adverse Event|3
4447445|NCT00490451|7232692|FG000|Overall Study|Death|3
4447446|NCT00490451|7232693|FG001|Overall Study|Death|1
4447447|NCT00490451|7232692|FG000|Overall Study|Withdrawal by Subject|2
4447448|NCT00490451|7232693|FG001|Overall Study|Withdrawal by Subject|0
4447449|NCT00490451|7232692|FG000|Overall Study|Investigator Decision|1
4447450|NCT00490451|7232693|FG001|Overall Study|Investigator Decision|0
4447451|NCT00490451|7232692|FG000|Overall Study|Protocol Violation|1
4447452|NCT00490451|7232693|FG001|Overall Study|Protocol Violation|0
4447453|NCT00490451|7232692|FG000|Overall Study|Progressive Disease|53
4447454|NCT00490451|7232693|FG001|Overall Study|Progressive Disease|34
4447455|NCT00490490|7232708|FG000|Completed Assessment for TTP|Withdrawal by Subject|1
4447456|NCT00490490|7232708|FG000|Completed Assessment for TTP|Lost to Follow-up|2
4447457|NCT00490529|7232712|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4
4447458|NCT00490529|7232712|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4
4447459|NCT00490529|7232712|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1
4447460|NCT00490529|7232712|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1
4447461|NCT00490529|7232712|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1
4447462|NCT00490529|7232712|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1
4447463|NCT00490542|7232718|FG000|Overall Study|Lost to Follow-up|3
4447464|NCT00490542|7232719|FG001|Overall Study|Lost to Follow-up|0
4447465|NCT00490542|7232718|FG000|Overall Study|Adverse Event|3
4447466|NCT00490542|7232719|FG001|Overall Study|Adverse Event|3
4447467|NCT00490542|7232718|FG000|Overall Study|Lack of Efficacy|1
4447468|NCT00490542|7232719|FG001|Overall Study|Lack of Efficacy|1
4447469|NCT00490555|7232729|FG000|Overall Study|noncompliant with drug administration|0
4447470|NCT00490555|7232730|FG001|Overall Study|noncompliant with drug administration|0
4447471|NCT00490555|7232731|FG002|Overall Study|noncompliant with drug administration|2
4447472|NCT00490555|7232732|FG003|Overall Study|noncompliant with drug administration|0
4447473|NCT00490568|7232742|FG000|Overall Study|Adverse Event|116
4447474|NCT00490568|7232742|FG000|Overall Study|Lost to Follow-up|13
4447475|NCT00490568|7232742|FG000|Overall Study|Protocol Violation|45
4447476|NCT00490568|7232742|FG000|Overall Study|Withdrawal by Subject|135
4447477|NCT00490568|7232742|FG000|Overall Study|Still in the study at termination|974
4447478|NCT00490568|7232742|FG000|Overall Study|Other|1
4447479|NCT00490568|7232742|FG000|Overall Study|Exclusion criteria met|1
4447480|NCT00490568|7232742|FG000|Overall Study|Caregiver related|20
4447481|NCT00490568|7232742|FG000|Overall Study|Abnormal ECG|25
4447482|NCT00490568|7232742|FG000|Overall Study|Participant refused follow-up|9
4447483|NCT00490568|7232742|FG000|Overall Study|Legal representative withdrew consent|1
4447484|NCT00490568|7232742|FG000|Overall Study|Disease progression|4
4447485|NCT00490568|7232742|FG000|Overall Study|Unmet inclusion-exclusion criteria|5
4447486|NCT00490568|7232742|FG000|Overall Study|Investigator decision|3
4447487|NCT00490568|7232742|FG000|Overall Study|Non-Compliance|7
4447488|NCT00490568|7232742|FG000|Overall Study|Efficacy related|3
4447489|NCT00490568|7232742|FG000|Overall Study|Participant died|1
4447490|NCT00490568|7232742|FG000|Overall Study|Participant withdrawal due to surgery|1
4447491|NCT00490646|7232749|FG000|Overall Study|Still on trastuzumab monotherapy|1
4447492|NCT00490646|7232750|FG001|Overall Study|Still on trastuzumab monotherapy|1
4447493|NCT00490646|7232749|FG000|Overall Study|Never Treated (had an adverse event)|1
4447494|NCT00490646|7232750|FG001|Overall Study|Never Treated (had an adverse event)|0
4447495|NCT00490646|7232749|FG000|Overall Study|Never Treated (withdrew consent)|0
4447496|NCT00490646|7232750|FG001|Overall Study|Never Treated (withdrew consent)|1
4631308|NCT01891669|7500432|FG007|Overall Study|Other|1
4631309|NCT01891669|7500433|FG008|Overall Study|Other|0
4631310|NCT01891669|7500434|FG009|Overall Study|Other|0
4631311|NCT01891721|7500468|FG000|Overall Study|Lost to Follow-up|10
4631312|NCT01891721|7500469|FG001|Overall Study|Lost to Follow-up|5
4631313|NCT01891721|7500470|FG002|Overall Study|Lost to Follow-up|1
4631314|NCT01891864|7500491|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1
4631315|NCT01891864|7500492|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1
4631316|NCT01891864|7500493|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0
4631317|NCT01891864|7500494|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0
4631318|NCT01891864|7500495|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0
4631319|NCT01891864|7500496|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0
4631320|NCT01891864|7500491|FG000|Treatment Period 1|Physician Decision|0
4631321|NCT01891864|7500492|FG001|Treatment Period 1|Physician Decision|1
4631322|NCT01891864|7500493|FG002|Treatment Period 1|Physician Decision|0
4631323|NCT01891864|7500494|FG003|Treatment Period 1|Physician Decision|0
4631324|NCT01891864|7500495|FG004|Treatment Period 1|Physician Decision|0
4631325|NCT01891864|7500496|FG005|Treatment Period 1|Physician Decision|0
4631326|NCT01891864|7500491|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0
4631327|NCT01891864|7500492|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1
4631328|NCT01891864|7500493|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0
4631329|NCT01891864|7500494|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0
4631330|NCT01891864|7500495|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0
4631331|NCT01891864|7500496|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0
4631332|NCT01891864|7500491|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4
4631333|NCT01891864|7500492|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4
4631334|NCT01891864|7500493|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0
4631335|NCT01891864|7500494|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0
4631336|NCT01891864|7500495|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0
4631337|NCT01891864|7500496|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0
4631338|NCT01891864|7500491|FG000|Treatment Period 1|Withdrawal by Subject|2
4631339|NCT01891864|7500492|FG001|Treatment Period 1|Withdrawal by Subject|5
4631340|NCT01891864|7500493|FG002|Treatment Period 1|Withdrawal by Subject|0
4631341|NCT01891864|7500494|FG003|Treatment Period 1|Withdrawal by Subject|0
4631342|NCT01891864|7500495|FG004|Treatment Period 1|Withdrawal by Subject|0
4631343|NCT01891864|7500496|FG005|Treatment Period 1|Withdrawal by Subject|0
4631344|NCT01891864|7500491|FG000|Treatment Period 1|Lost to Follow-up|1
4631345|NCT01891864|7500492|FG001|Treatment Period 1|Lost to Follow-up|0
4631346|NCT01891864|7500493|FG002|Treatment Period 1|Lost to Follow-up|0
4631347|NCT01891864|7500494|FG003|Treatment Period 1|Lost to Follow-up|0
4631348|NCT01891864|7500495|FG004|Treatment Period 1|Lost to Follow-up|0
4631349|NCT01891864|7500496|FG005|Treatment Period 1|Lost to Follow-up|0
4631350|NCT01891864|7500491|FG000|Treatment Period 2|Protocol Violation|0
4631351|NCT01891864|7500492|FG001|Treatment Period 2|Protocol Violation|0
4631352|NCT01891864|7500493|FG002|Treatment Period 2|Protocol Violation|0
4631353|NCT01891864|7500494|FG003|Treatment Period 2|Protocol Violation|1
4631354|NCT01891864|7500495|FG004|Treatment Period 2|Protocol Violation|0
4631355|NCT01891864|7500496|FG005|Treatment Period 2|Protocol Violation|0
4631356|NCT01891864|7500491|FG000|Treatment Period 2|Physician Decision|0
4631357|NCT01891864|7500492|FG001|Treatment Period 2|Physician Decision|0
4631358|NCT01891864|7500493|FG002|Treatment Period 2|Physician Decision|1
4631359|NCT01891864|7500494|FG003|Treatment Period 2|Physician Decision|0
4631360|NCT01891864|7500495|FG004|Treatment Period 2|Physician Decision|0
4631361|NCT01891864|7500496|FG005|Treatment Period 2|Physician Decision|0
4631362|NCT01891864|7500491|FG000|Treatment Period 2|Site Termination|0
4631363|NCT01891864|7500492|FG001|Treatment Period 2|Site Termination|0
4631364|NCT01891864|7500493|FG002|Treatment Period 2|Site Termination|1
4631365|NCT01891864|7500494|FG003|Treatment Period 2|Site Termination|2
4631366|NCT01891864|7500495|FG004|Treatment Period 2|Site Termination|0
4631367|NCT01891864|7500496|FG005|Treatment Period 2|Site Termination|0
4631368|NCT01891864|7500491|FG000|Treatment Period 2|Lack of Efficacy|0
4631369|NCT01891864|7500492|FG001|Treatment Period 2|Lack of Efficacy|0
4631370|NCT01891864|7500493|FG002|Treatment Period 2|Lack of Efficacy|1
4447497|NCT00490698|7232756|FG000|Overall Study|Withdrawal by Subject|1
4631371|NCT01891864|7500494|FG003|Treatment Period 2|Lack of Efficacy|0
4631372|NCT01891864|7500495|FG004|Treatment Period 2|Lack of Efficacy|1
4631373|NCT01891864|7500496|FG005|Treatment Period 2|Lack of Efficacy|0
4631374|NCT01891864|7500491|FG000|Treatment Period 2|Adverse Event|0
4631375|NCT01891864|7500492|FG001|Treatment Period 2|Adverse Event|0
4631376|NCT01891864|7500493|FG002|Treatment Period 2|Adverse Event|1
4631377|NCT01891864|7500494|FG003|Treatment Period 2|Adverse Event|2
4631378|NCT01891864|7500495|FG004|Treatment Period 2|Adverse Event|0
4631379|NCT01891864|7500496|FG005|Treatment Period 2|Adverse Event|4
4631380|NCT01891864|7500491|FG000|Treatment Period 2|Termination of Site|0
4631381|NCT01891864|7500492|FG001|Treatment Period 2|Termination of Site|0
4631382|NCT01891864|7500493|FG002|Treatment Period 2|Termination of Site|0
4631383|NCT01891864|7500494|FG003|Treatment Period 2|Termination of Site|0
4631384|NCT01891864|7500495|FG004|Treatment Period 2|Termination of Site|2
4631385|NCT01891864|7500496|FG005|Treatment Period 2|Termination of Site|0
4631386|NCT01891864|7500491|FG000|Treatment Period 2|Withdrawal by Subject|0
4631387|NCT01891864|7500492|FG001|Treatment Period 2|Withdrawal by Subject|0
4631388|NCT01891864|7500493|FG002|Treatment Period 2|Withdrawal by Subject|3
4631389|NCT01891864|7500494|FG003|Treatment Period 2|Withdrawal by Subject|4
4631390|NCT01891864|7500495|FG004|Treatment Period 2|Withdrawal by Subject|1
4631391|NCT01891864|7500496|FG005|Treatment Period 2|Withdrawal by Subject|1
4631392|NCT01891864|7500491|FG000|Extension Period|Lack of Efficacy|0
4631393|NCT01891864|7500492|FG001|Extension Period|Lack of Efficacy|0
4631394|NCT01891864|7500493|FG002|Extension Period|Lack of Efficacy|0
4631395|NCT01891864|7500494|FG003|Extension Period|Lack of Efficacy|1
4631396|NCT01891864|7500495|FG004|Extension Period|Lack of Efficacy|1
4631397|NCT01891864|7500496|FG005|Extension Period|Lack of Efficacy|0
4631398|NCT01891864|7500491|FG000|Extension Period|Pregnancy|0
4631399|NCT01891864|7500492|FG001|Extension Period|Pregnancy|0
4631400|NCT01891864|7500493|FG002|Extension Period|Pregnancy|1
4631401|NCT01891864|7500494|FG003|Extension Period|Pregnancy|0
4631402|NCT01891864|7500495|FG004|Extension Period|Pregnancy|0
4631403|NCT01891864|7500496|FG005|Extension Period|Pregnancy|0
4631404|NCT01891864|7500491|FG000|Extension Period|Adverse Event|0
4631405|NCT01891864|7500492|FG001|Extension Period|Adverse Event|0
4631406|NCT01891864|7500493|FG002|Extension Period|Adverse Event|4
4631407|NCT01891864|7500494|FG003|Extension Period|Adverse Event|2
4631408|NCT01891864|7500495|FG004|Extension Period|Adverse Event|2
4631409|NCT01891864|7500496|FG005|Extension Period|Adverse Event|0
4631410|NCT01891864|7500491|FG000|Extension Period|Withdrawal by Subject|0
4631411|NCT01891864|7500492|FG001|Extension Period|Withdrawal by Subject|0
4631412|NCT01891864|7500493|FG002|Extension Period|Withdrawal by Subject|1
4631413|NCT01891864|7500494|FG003|Extension Period|Withdrawal by Subject|2
4631414|NCT01891864|7500495|FG004|Extension Period|Withdrawal by Subject|4
4631415|NCT01891864|7500496|FG005|Extension Period|Withdrawal by Subject|0
4631416|NCT01891864|7500491|FG000|Extension Period|Lost to Follow-up|0
4631417|NCT01891864|7500492|FG001|Extension Period|Lost to Follow-up|0
4631418|NCT01891864|7500493|FG002|Extension Period|Lost to Follow-up|2
4631419|NCT01891864|7500494|FG003|Extension Period|Lost to Follow-up|0
4631420|NCT01891864|7500495|FG004|Extension Period|Lost to Follow-up|0
4631421|NCT01891864|7500496|FG005|Extension Period|Lost to Follow-up|0
4631422|NCT01891890|7500511|FG000|Overall Study|Lost to Follow-up|0
4631423|NCT01891890|7500512|FG001|Overall Study|Lost to Follow-up|0
4631424|NCT01891890|7500513|FG002|Overall Study|Lost to Follow-up|1
4631425|NCT01891890|7500511|FG000|Overall Study|Study ended before endpoint reached|7
4633382|NCT01911442|7503532|FG002|Overall Study|Withdrawal by Subject|6
4732772|NCT03426995|7677323|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
4732773|NCT03426995|7677324|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
4732774|NCT03426995|7677325|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0
4732775|NCT03426995|7677307|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
4732776|NCT03426995|7677308|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
4732777|NCT03426995|7677309|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
4732778|NCT03426995|7677310|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
4732779|NCT03426995|7677311|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
4732780|NCT03426995|7677312|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1
4732781|NCT03426995|7677313|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
4732782|NCT03426995|7677314|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
4732783|NCT03426995|7677315|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
4732784|NCT03426995|7677316|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
4732785|NCT03426995|7677317|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
4732786|NCT03426995|7677318|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
4732787|NCT03426995|7677319|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
4732788|NCT03426995|7677320|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
4732789|NCT03426995|7677321|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
4732790|NCT03426995|7677322|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
4732791|NCT03426995|7677323|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
4732792|NCT03426995|7677324|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
4732793|NCT03426995|7677325|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0
4732794|NCT03426995|7677307|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
4732795|NCT03426995|7677308|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
4732796|NCT03426995|7677309|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
4732797|NCT03426995|7677310|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
4732798|NCT03426995|7677311|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1
4732799|NCT03426995|7677312|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1
4732800|NCT03426995|7677313|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
4732801|NCT03426995|7677314|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
4732802|NCT03426995|7677315|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
4732803|NCT03426995|7677316|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
4732804|NCT03426995|7677317|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
4732805|NCT03426995|7677318|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
4732806|NCT03426995|7677319|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
4732807|NCT03426995|7677320|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
4732808|NCT03426995|7677321|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
4732809|NCT03426995|7677322|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
4732810|NCT03426995|7677323|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
4732811|NCT03426995|7677324|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
4732812|NCT03426995|7677325|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0
4732813|NCT03426995|7677307|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
4732814|NCT03426995|7677308|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
4732815|NCT03426995|7677309|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
4732816|NCT03426995|7677310|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
4732817|NCT03426995|7677311|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
4732818|NCT03426995|7677312|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
4732819|NCT03426995|7677313|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
4732820|NCT03426995|7677314|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
4732821|NCT03426995|7677315|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
4732822|NCT03426995|7677316|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
4732823|NCT03426995|7677317|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1
4732824|NCT03426995|7677318|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
4732825|NCT03426995|7677319|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
4732826|NCT03426995|7677320|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
4732827|NCT03426995|7677321|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
4732828|NCT03426995|7677322|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
4732829|NCT03426995|7677323|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
4732830|NCT03426995|7677324|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
4732831|NCT03426995|7677325|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0
4732832|NCT03426995|7677307|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
4732833|NCT03426995|7677308|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
4732834|NCT03426995|7677309|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
4732835|NCT03426995|7677310|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
4732836|NCT03426995|7677311|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
4732837|NCT03426995|7677312|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
4732838|NCT03426995|7677313|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
4732839|NCT03426995|7677314|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1
4732840|NCT03426995|7677315|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
4732841|NCT03426995|7677316|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
4732842|NCT03426995|7677317|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
4732843|NCT03426995|7677318|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
4732844|NCT03426995|7677319|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
4732845|NCT03426995|7677320|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
4732846|NCT03426995|7677321|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
4732847|NCT03426995|7677322|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
4732848|NCT03426995|7677323|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
4732849|NCT03426995|7677324|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
4732850|NCT03426995|7677325|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0
4732851|NCT03426995|7677307|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
4732852|NCT03426995|7677308|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
4732853|NCT03426995|7677309|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
4732854|NCT03426995|7677310|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
4732855|NCT03426995|7677311|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
4732856|NCT03426995|7677312|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
4732857|NCT03426995|7677313|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
4732858|NCT03426995|7677314|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
4732859|NCT03426995|7677315|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
4732860|NCT03426995|7677316|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
4631426|NCT01891890|7500512|FG001|Overall Study|Study ended before endpoint reached|3
4631427|NCT01891890|7500513|FG002|Overall Study|Study ended before endpoint reached|6
4631428|NCT01892020|7500534|FG000|Period 1|Adverse Event|1
4631429|NCT01892020|7500535|FG001|Period 1|Adverse Event|1
4631430|NCT01892020|7500534|FG000|Period 1|Protocol Violation|2
4631431|NCT01892020|7500535|FG001|Period 1|Protocol Violation|4
4631432|NCT01892020|7500534|FG000|Period 1|Unclassified|0
4631433|NCT01892020|7500535|FG001|Period 1|Unclassified|1
4447498|NCT00490698|7232756|FG000|Overall Study|Disease Progression|7
4447499|NCT00490698|7232756|FG000|Overall Study|Physician Decision|2
4447500|NCT00490724|7232763|FG000|Period I|Physician Decision|0
4631434|NCT01892020|7500534|FG000|Period 2|Protocol Violation|1
4631435|NCT01892020|7500535|FG001|Period 2|Protocol Violation|0
4631436|NCT01892163|7500543|FG000|Overall Study|Death|1
4631437|NCT01892163|7500544|FG001|Overall Study|Death|1
4631438|NCT01892163|7500543|FG000|Overall Study|Lost to Follow-up|1
4631439|NCT01892163|7500544|FG001|Overall Study|Lost to Follow-up|0
4631440|NCT01892189|7500559|FG000|Washout Period 1 (7 Days)|Adverse Event|0
4631441|NCT01892189|7500560|FG001|Washout Period 1 (7 Days)|Adverse Event|0
4631442|NCT01892189|7500561|FG002|Washout Period 1 (7 Days)|Adverse Event|0
4631443|NCT01892189|7500562|FG003|Washout Period 1 (7 Days)|Adverse Event|0
4631444|NCT01892189|7500563|FG004|Washout Period 1 (7 Days)|Adverse Event|0
4631445|NCT01892189|7500564|FG005|Washout Period 1 (7 Days)|Adverse Event|0
4631446|NCT01892189|7500565|FG006|Washout Period 1 (7 Days)|Adverse Event|0
4631447|NCT01892189|7500566|FG007|Washout Period 1 (7 Days)|Adverse Event|0
4631448|NCT01892189|7500567|FG008|Washout Period 1 (7 Days)|Adverse Event|1
4631449|NCT01892189|7500559|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0
4631450|NCT01892189|7500560|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0
4631451|NCT01892189|7500561|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2
4732861|NCT03426995|7677317|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
4732862|NCT03426995|7677318|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
4732863|NCT03426995|7677319|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
4732864|NCT03426995|7677320|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
4732865|NCT03426995|7677321|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8
4732866|NCT03426995|7677322|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9
4732867|NCT03426995|7677323|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
4732868|NCT03426995|7677324|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
4732869|NCT03426995|7677325|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0
4732870|NCT03426995|7677307|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
4732871|NCT03426995|7677308|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
4732872|NCT03426995|7677309|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
4732873|NCT03426995|7677310|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
4732874|NCT03426995|7677311|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
4732875|NCT03426995|7677312|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
4631452|NCT01892189|7500562|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1
4631453|NCT01892189|7500563|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0
4631454|NCT01892189|7500564|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0
4631455|NCT01892189|7500565|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1
4631456|NCT01892189|7500566|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0
4631457|NCT01892189|7500567|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1
4631458|NCT01892189|7500559|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
4631459|NCT01892189|7500560|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
4631460|NCT01892189|7500561|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
4631461|NCT01892189|7500562|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
4631462|NCT01892189|7500563|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
4631463|NCT01892189|7500564|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1
4631464|NCT01892189|7500565|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
4631465|NCT01892189|7500566|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
4631466|NCT01892189|7500567|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
4631467|NCT01892293|7500591|FG000|Overall Study|Apheresed but not treated|4
4631468|NCT01892345|7500606|FG000|Overall Study|Adverse Event|0
4631469|NCT01892345|7500607|FG001|Overall Study|Adverse Event|2
4631470|NCT01892345|7500606|FG000|Overall Study|Death|1
4631471|NCT01892345|7500607|FG001|Overall Study|Death|0
4447501|NCT00490724|7232764|FG001|Period I|Physician Decision|0
4631472|NCT01892345|7500606|FG000|Overall Study|Lost to Follow-up|3
4631473|NCT01892345|7500607|FG001|Overall Study|Lost to Follow-up|0
4631474|NCT01892345|7500606|FG000|Overall Study|Withdrawal by Subject|12
4631475|NCT01892345|7500607|FG001|Overall Study|Withdrawal by Subject|1
4631476|NCT01892436|7500617|FG000|Overall Study|Withdrawal by Subject|8
4631477|NCT01892436|7500618|FG001|Overall Study|Withdrawal by Subject|15
4732876|NCT03426995|7677313|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
4732877|NCT03426995|7677314|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
4732878|NCT03426995|7677315|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
4732879|NCT03426995|7677316|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
4732880|NCT03426995|7677317|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
4732881|NCT03426995|7677318|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
4732882|NCT03426995|7677319|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
4732883|NCT03426995|7677320|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
4732884|NCT03426995|7677321|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1
4732885|NCT03426995|7677322|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3
4732886|NCT03426995|7677323|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
4732887|NCT03426995|7677324|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
4732888|NCT03426995|7677325|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0
4631478|NCT01892436|7500619|FG002|Overall Study|Withdrawal by Subject|4
4732889|NCT03427073|7677380|FG000|Overall Study|Disease Progression|1
4732890|NCT03427073|7677381|FG001|Overall Study|Disease Progression|1
4732891|NCT03427073|7677382|FG002|Overall Study|Disease Progression|1
4732892|NCT03427073|7677383|FG003|Overall Study|Disease Progression|3
4732893|NCT03427073|7677384|FG004|Overall Study|Disease Progression|3
4732894|NCT03427073|7677385|FG005|Overall Study|Disease Progression|4
4732895|NCT03427073|7677386|FG006|Overall Study|Disease Progression|2
4732896|NCT03427073|7677387|FG007|Overall Study|Disease Progression|3
4732897|NCT03427073|7677380|FG000|Overall Study|Physician Decision|0
4732898|NCT03427073|7677381|FG001|Overall Study|Physician Decision|0
4732899|NCT03427073|7677382|FG002|Overall Study|Physician Decision|0
4732900|NCT03427073|7677383|FG003|Overall Study|Physician Decision|0
4732901|NCT03427073|7677384|FG004|Overall Study|Physician Decision|0
4732902|NCT03427073|7677385|FG005|Overall Study|Physician Decision|0
4732903|NCT03427073|7677386|FG006|Overall Study|Physician Decision|1
4447502|NCT00490724|7232765|FG002|Period I|Physician Decision|1
4447503|NCT00490724|7232763|FG000|Period II|Treatment Discontinuation|3
4631479|NCT01892436|7500620|FG003|Overall Study|Withdrawal by Subject|4
4631480|NCT01892436|7500617|FG000|Overall Study|Death|1
4631481|NCT01892436|7500618|FG001|Overall Study|Death|1
4631482|NCT01892436|7500619|FG002|Overall Study|Death|0
4631483|NCT01892436|7500620|FG003|Overall Study|Death|0
4515494|NCT00953706|7326396|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1
4515495|NCT00953706|7326393|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0
4515496|NCT00953706|7326394|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0
4515497|NCT00953706|7326395|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4
4732904|NCT03427073|7677387|FG007|Overall Study|Physician Decision|1
4732905|NCT03427268|7677414|FG000|Overall Study|Progressive disease|25
4732906|NCT03427268|7677414|FG000|Overall Study|Never treated|2
4732907|NCT03427268|7677414|FG000|Overall Study|Compassionate use|1
4732908|NCT03427268|7677414|FG000|Overall Study|Withdrawal by Subject|1
4732909|NCT03427268|7677414|FG000|Overall Study|Adverse Event|3
4732910|NCT03427619|7677418|FG000|Overall Study|Physician Decision|3
4732911|NCT03427619|7677418|FG000|Overall Study|Withdrawal by Subject|4
4732912|NCT03427619|7677418|FG000|Overall Study|Lost to Follow-up|5
4732913|NCT03427619|7677418|FG000|Overall Study|Administrative|4
4631484|NCT01892436|7500617|FG000|Overall Study|Physician Decision|2
4631485|NCT01892436|7500618|FG001|Overall Study|Physician Decision|1
4631486|NCT01892436|7500619|FG002|Overall Study|Physician Decision|0
4631487|NCT01892436|7500620|FG003|Overall Study|Physician Decision|1
4631488|NCT01892436|7500617|FG000|Overall Study|Pregnancy|0
4631489|NCT01892436|7500618|FG001|Overall Study|Pregnancy|2
4631490|NCT01892436|7500619|FG002|Overall Study|Pregnancy|1
4631491|NCT01892436|7500620|FG003|Overall Study|Pregnancy|0
4631492|NCT01892436|7500617|FG000|Overall Study|Technical problems|2
4631493|NCT01892436|7500618|FG001|Overall Study|Technical problems|1
4631494|NCT01892436|7500619|FG002|Overall Study|Technical problems|1
4631495|NCT01892436|7500620|FG003|Overall Study|Technical problems|1
4631496|NCT01892436|7500617|FG000|Overall Study|Lack of Efficacy|1
4631497|NCT01892436|7500618|FG001|Overall Study|Lack of Efficacy|2
4732914|NCT03427619|7677418|FG000|Overall Study|Other|2
4732915|NCT03427619|7677418|FG000|Overall Study|Unknown or Missing Completion Status|48
4732916|NCT03427892|7677422|FG000|Overall Study|Lost to Follow-up|2
4732917|NCT03428100|7677434|FG000|Overall Study|Adverse Event|1
4732918|NCT03428100|7677435|FG001|Overall Study|Adverse Event|0
4732919|NCT03428100|7677436|FG002|Overall Study|Adverse Event|3
4732920|NCT03428100|7677437|FG003|Overall Study|Adverse Event|1
4732921|NCT03428100|7677434|FG000|Overall Study|Lack of Efficacy|16
4732922|NCT03428100|7677435|FG001|Overall Study|Lack of Efficacy|10
4732923|NCT03428100|7677436|FG002|Overall Study|Lack of Efficacy|7
4732924|NCT03428100|7677437|FG003|Overall Study|Lack of Efficacy|6
4732925|NCT03428100|7677434|FG000|Overall Study|Protocol Deviation|0
4732926|NCT03428100|7677435|FG001|Overall Study|Protocol Deviation|2
4732927|NCT03428100|7677436|FG002|Overall Study|Protocol Deviation|2
4732928|NCT03428100|7677437|FG003|Overall Study|Protocol Deviation|0
4732929|NCT03428100|7677434|FG000|Overall Study|Withdrawal by Subject|4
4732930|NCT03428100|7677435|FG001|Overall Study|Withdrawal by Subject|0
4732931|NCT03428100|7677436|FG002|Overall Study|Withdrawal by Subject|0
4732932|NCT03428100|7677437|FG003|Overall Study|Withdrawal by Subject|0
4732933|NCT03428100|7677434|FG000|Overall Study|Physician Decision|0
4732934|NCT03428100|7677435|FG001|Overall Study|Physician Decision|1
4732935|NCT03428100|7677436|FG002|Overall Study|Physician Decision|0
4732936|NCT03428100|7677437|FG003|Overall Study|Physician Decision|0
4732937|NCT03428152|7677459|FG000|Overall Study|Physician Decision|4
4732938|NCT03428152|7677460|FG001|Overall Study|Physician Decision|2
4732939|NCT03428152|7677459|FG000|Overall Study|Protocol Violation|3
4732940|NCT03428152|7677460|FG001|Overall Study|Protocol Violation|5
4732941|NCT03428152|7677459|FG000|Overall Study|Lack of Efficacy|0
4732942|NCT03428152|7677460|FG001|Overall Study|Lack of Efficacy|4
4732943|NCT03428360|7677483|FG000|Overall Study|Informed consent withdrawn|5
4732944|NCT03428360|7677483|FG000|Overall Study|Withdrawal by Subject|4
4732945|NCT03428360|7677483|FG000|Overall Study|Lost to Follow-up|5
4732946|NCT03428360|7677483|FG000|Overall Study|Physician Decision|2
4732947|NCT03428360|7677483|FG000|Overall Study|Informed consent withdrawn|5
4732948|NCT03428360|7677483|FG000|Overall Study|Study terminated by sponsor|10
4732949|NCT03428360|7677483|FG000|Overall Study|Non-compliant with study|1
4732950|NCT03428360|7677483|FG000|Overall Study|Non-compliant with study drug|3
4732951|NCT03428360|7677483|FG000|Overall Study|Death|3
4732952|NCT03428360|7677483|FG000|Overall Study|Adverse Event|1
4732953|NCT03428360|7677483|FG000|Overall Study|Not on antiepileptic drug|1
4732954|NCT03428750|7677493|FG000|Overall Study|Withdrawal by Subject|11
4732955|NCT03428750|7677494|FG001|Overall Study|Withdrawal by Subject|10
4732956|NCT03428750|7677493|FG000|Overall Study|Lost to Follow-up|3
4732957|NCT03428750|7677494|FG001|Overall Study|Lost to Follow-up|9
4732958|NCT03428750|7677493|FG000|Overall Study|Adverse Event|9
4732959|NCT03428750|7677494|FG001|Overall Study|Adverse Event|1
4732960|NCT03428750|7677493|FG000|Overall Study|Protocol Violation|1
4732961|NCT03428750|7677494|FG001|Overall Study|Protocol Violation|0
4732962|NCT03428750|7677493|FG000|Overall Study|Administrative|0
4732963|NCT03428750|7677494|FG001|Overall Study|Administrative|1
4732964|NCT03428815|7677525|FG000|Overall Study|Lost to Follow-up|2
4732965|NCT03428815|7677526|FG001|Overall Study|Lost to Follow-up|2
4732966|NCT03428815|7677525|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5
4732967|NCT03428815|7677526|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2
4732968|NCT03428815|7677525|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3
4732969|NCT03428815|7677526|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1
4732970|NCT03428997|7677532|FG000|Overall Study|Sponsor decision.|1
4732971|NCT03428997|7677532|FG000|Overall Study|Withdrawal by Subject|3
4732972|NCT03428997|7677532|FG000|Overall Study|Lost to Follow-up|4
4732973|NCT03429556|7677557|FG000|Overall Study|Lost to Follow-up|0
4732974|NCT03429556|7677558|FG001|Overall Study|Lost to Follow-up|1
4732975|NCT03429556|7677559|FG002|Overall Study|Lost to Follow-up|0
4732976|NCT03429556|7677560|FG003|Overall Study|Lost to Follow-up|0
4732977|NCT03430245|7677588|FG000|Overall Study|Withdrawal by Subject|6
4732978|NCT03430245|7677588|FG000|Overall Study|Lost to Follow-up|1
4732979|NCT03430856|7677605|FG000|Overall Study|Adverse Event|0
4732980|NCT03430856|7677606|FG001|Overall Study|Adverse Event|1
4732981|NCT03430856|7677607|FG002|Overall Study|Adverse Event|0
4732982|NCT03430856|7677605|FG000|Overall Study|Rescue criteria|1
4732983|NCT03430856|7677606|FG001|Overall Study|Rescue criteria|1
4732984|NCT03430856|7677607|FG002|Overall Study|Rescue criteria|0
4732985|NCT03430856|7677605|FG000|Overall Study|Voluntary withdrawal of consent|1
4732986|NCT03430856|7677606|FG001|Overall Study|Voluntary withdrawal of consent|1
4732987|NCT03430856|7677607|FG002|Overall Study|Voluntary withdrawal of consent|1
4631498|NCT01892436|7500619|FG002|Overall Study|Lack of Efficacy|2
4631499|NCT01892436|7500620|FG003|Overall Study|Lack of Efficacy|2
4631500|NCT01892436|7500617|FG000|Overall Study|Lost to Follow-up|1
4631501|NCT01892436|7500618|FG001|Overall Study|Lost to Follow-up|1
4631502|NCT01892436|7500619|FG002|Overall Study|Lost to Follow-up|1
4631503|NCT01892436|7500620|FG003|Overall Study|Lost to Follow-up|3
4631504|NCT01892436|7500617|FG000|Overall Study|non-compliance with treatment|1
4631505|NCT01892436|7500618|FG001|Overall Study|non-compliance with treatment|0
4631506|NCT01892436|7500619|FG002|Overall Study|non-compliance with treatment|0
4631507|NCT01892436|7500620|FG003|Overall Study|non-compliance with treatment|0
4631508|NCT01892436|7500617|FG000|Overall Study|Adverse Event|7
4631509|NCT01892436|7500618|FG001|Overall Study|Adverse Event|6
4631510|NCT01892436|7500619|FG002|Overall Study|Adverse Event|2
4631511|NCT01892436|7500620|FG003|Overall Study|Adverse Event|3
4631512|NCT01892501|7500630|FG000|Overall Study|Protocol Violation|2
4631513|NCT01892501|7500630|FG000|Overall Study|Puncture not carried out|9
4631514|NCT01892501|7500630|FG000|Overall Study|Radiological monitoring not carried out|5
4631515|NCT01892501|7500630|FG000|Overall Study|Non-contributory histological result|12
4631516|NCT01892540|7500637|FG000|Overall Study|Did not complete PET/MRI|0
4631517|NCT01892540|7500638|FG001|Overall Study|Did not complete PET/MRI|0
4631518|NCT01892540|7500639|FG002|Overall Study|Did not complete PET/MRI|2
4515498|NCT00953706|7326396|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25
4515499|NCT00953706|7326393|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0
4515500|NCT00953706|7326394|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0
4515501|NCT00953706|7326395|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1
4515502|NCT00953706|7326396|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2
4515503|NCT00953706|7326393|FG000|Part B (96-Week Open-Label Extension)|Other|0
4515504|NCT00953706|7326394|FG001|Part B (96-Week Open-Label Extension)|Other|0
4515505|NCT00953706|7326395|FG002|Part B (96-Week Open-Label Extension)|Other|0
4515506|NCT00953706|7326396|FG003|Part B (96-Week Open-Label Extension)|Other|2
4515507|NCT00953745|7326417|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1
4515508|NCT00953745|7326418|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0
4515509|NCT00953745|7326417|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2
4515510|NCT00953745|7326418|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0
4515511|NCT00953745|7326417|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3
4515512|NCT00953745|7326418|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0
4515513|NCT00953745|7326417|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1
4515514|NCT00953745|7326418|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0
4515515|NCT00953745|7326417|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6
4515516|NCT00953745|7326418|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0
4515517|NCT00953745|7326417|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1
4515518|NCT00953745|7326418|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0
4515519|NCT00953927|7326455|FG000|Overall Study|Lost to Follow-up|61
4515520|NCT00953927|7326456|FG001|Overall Study|Lost to Follow-up|65
4515521|NCT00953927|7326455|FG000|Overall Study|Withdrawal by Subject|36
4515522|NCT00953927|7326456|FG001|Overall Study|Withdrawal by Subject|25
4515523|NCT00953927|7326455|FG000|Overall Study|Death|7
4515524|NCT00953927|7326456|FG001|Overall Study|Death|4
4515525|NCT00953927|7326455|FG000|Overall Study|Other study discontinuation|1
4515526|NCT00953927|7326456|FG001|Overall Study|Other study discontinuation|1
4515527|NCT00954122|7326466|FG000|Overall Study|Withdrawal by Subject|5
4515528|NCT00954122|7326466|FG000|Overall Study|Adverse Event|1
4631519|NCT01892540|7500637|FG000|Overall Study|Did not fit in scanner|0
4631520|NCT01892540|7500638|FG001|Overall Study|Did not fit in scanner|0
4631521|NCT01892540|7500639|FG002|Overall Study|Did not fit in scanner|1
4631522|NCT01892657|7500647|FG000|Overall Study|Withdrawal by Subject|6
4631523|NCT01892657|7500647|FG000|Overall Study|Protocol Violation|12
4631524|NCT01893203|7500680|FG000|Overall Study|Withdrawal by Subject|1
4631525|NCT01893281|7500684|FG000|Overall Study|Adverse Event|1
4631526|NCT01893281|7500684|FG000|Overall Study|Protocol Violation|1
4631527|NCT01893281|7500684|FG000|Overall Study|Withdrawal by Subject|1
4631528|NCT01893346|7500692|FG000|Overall Study|Lost to Follow-up|0
4631529|NCT01893346|7500693|FG001|Overall Study|Lost to Follow-up|1
4631530|NCT01893346|7500694|FG002|Overall Study|Lost to Follow-up|0
4631531|NCT01893346|7500695|FG003|Overall Study|Lost to Follow-up|0
4631532|NCT01893346|7500692|FG000|Overall Study|Protocol Violation|1
4631533|NCT01893346|7500693|FG001|Overall Study|Protocol Violation|0
4631534|NCT01893346|7500694|FG002|Overall Study|Protocol Violation|0
4631535|NCT01893346|7500695|FG003|Overall Study|Protocol Violation|0
4631536|NCT01893346|7500692|FG000|Overall Study|Withdrawal by Subject|2
4631537|NCT01893346|7500693|FG001|Overall Study|Withdrawal by Subject|0
4631538|NCT01893346|7500694|FG002|Overall Study|Withdrawal by Subject|0
4631539|NCT01893346|7500695|FG003|Overall Study|Withdrawal by Subject|0
4631540|NCT01893411|7500717|FG000|Overall Study|Protocol Violation|1
4631541|NCT01893411|7500718|FG001|Overall Study|Protocol Violation|0
4631542|NCT01893411|7500719|FG002|Overall Study|Protocol Violation|0
4631543|NCT01893411|7500717|FG000|Overall Study|Physician Decision|1
4631544|NCT01893411|7500718|FG001|Overall Study|Physician Decision|1
4631545|NCT01893411|7500719|FG002|Overall Study|Physician Decision|2
4631546|NCT01893411|7500717|FG000|Overall Study|Lack of Efficacy|2
4631547|NCT01893411|7500718|FG001|Overall Study|Lack of Efficacy|1
4631548|NCT01893411|7500719|FG002|Overall Study|Lack of Efficacy|0
4631549|NCT01893411|7500717|FG000|Overall Study|Other|3
4631550|NCT01893411|7500718|FG001|Overall Study|Other|1
4631551|NCT01893411|7500719|FG002|Overall Study|Other|3
4631552|NCT01893411|7500717|FG000|Overall Study|Adverse Event|1
4631553|NCT01893411|7500718|FG001|Overall Study|Adverse Event|0
4631554|NCT01893411|7500719|FG002|Overall Study|Adverse Event|0
4631555|NCT01893411|7500717|FG000|Overall Study|Withdrawal by Subject|7
4631556|NCT01893411|7500718|FG001|Overall Study|Withdrawal by Subject|4
4631557|NCT01893411|7500719|FG002|Overall Study|Withdrawal by Subject|3
4631558|NCT01893411|7500717|FG000|Overall Study|Lost to Follow-up|2
4631559|NCT01893411|7500718|FG001|Overall Study|Lost to Follow-up|0
4631560|NCT01893411|7500719|FG002|Overall Study|Lost to Follow-up|1
4631561|NCT01893827|7500748|FG000|Overall Study|Lost to Follow-up|19
4631562|NCT01893827|7500749|FG001|Overall Study|Lost to Follow-up|26
4631563|NCT01893905|7500766|FG000|Overall Study|Withdrawal by Subject|1
4631564|NCT01893905|7500767|FG001|Overall Study|Withdrawal by Subject|0
4631565|NCT01893905|7500766|FG000|Overall Study|Adverse Event|9
4631566|NCT01893905|7500767|FG001|Overall Study|Adverse Event|3
4631567|NCT01893905|7500766|FG000|Overall Study|Lack of Efficacy|5
4631568|NCT01893905|7500767|FG001|Overall Study|Lack of Efficacy|7
4631569|NCT01893905|7500766|FG000|Overall Study|Lost to Follow-up|1
4732988|NCT03430986|7677620|FG000|24-week Control Period|Adverse Event|1
4732989|NCT03430986|7677621|FG001|24-week Control Period|Adverse Event|0
4732990|NCT03430986|7677620|FG000|24-week Control Period|Lost to Follow-up|2
4732991|NCT03430986|7677621|FG001|24-week Control Period|Lost to Follow-up|2
4732992|NCT03430986|7677620|FG000|24-week Control Period|Withdrawal by Participant|5
4732993|NCT03430986|7677621|FG001|24-week Control Period|Withdrawal by Participant|0
4732994|NCT03430986|7677620|FG000|24-week Control Period|Protocol Deviation|0
4732995|NCT03430986|7677621|FG001|24-week Control Period|Protocol Deviation|2
4732996|NCT03430986|7677620|FG000|24-week Post-Control Period|Lost to Follow-up|1
4732997|NCT03430986|7677621|FG001|24-week Post-Control Period|Lost to Follow-up|1
4631570|NCT01893905|7500767|FG001|Overall Study|Lost to Follow-up|0
4631571|NCT01893905|7500766|FG000|Overall Study|Protocol Violation|6
4631572|NCT01893905|7500767|FG001|Overall Study|Protocol Violation|1
4631573|NCT01893905|7500766|FG000|Overall Study|Lack of adherence to treatment|2
4631574|NCT01893905|7500767|FG001|Overall Study|Lack of adherence to treatment|0
4631575|NCT01893905|7500766|FG000|Overall Study|Other reason|1
4631576|NCT01893905|7500767|FG001|Overall Study|Other reason|3
4631577|NCT01894022|7500784|FG000|Overall Study|Death|1
4631578|NCT01894022|7500785|FG001|Overall Study|Death|0
4631579|NCT01894022|7500784|FG000|Overall Study|Adverse Event, non-fatal|1
4631580|NCT01894022|7500785|FG001|Overall Study|Adverse Event, non-fatal|0
4631581|NCT01894022|7500784|FG000|Overall Study|Study Closed/terminated|7
4631582|NCT01894022|7500785|FG001|Overall Study|Study Closed/terminated|10
4631583|NCT01894100|7500803|FG000|Overall Study|Lost to Follow-up|0
4631584|NCT01894100|7500804|FG001|Overall Study|Lost to Follow-up|1
4631585|NCT01894100|7500803|FG000|Overall Study|Withdrawal by Subject|3
4631586|NCT01894100|7500804|FG001|Overall Study|Withdrawal by Subject|0
4631587|NCT01894152|7500810|FG000|Overall Study|No DMR and no Stent thrombosis|151
4631588|NCT01894230|7500825|FG000|Overall Study|Lost to Follow-up|2
4631589|NCT01894230|7500826|FG001|Overall Study|Lost to Follow-up|2
4631590|NCT01894230|7500825|FG000|Overall Study|Withdrawal by Subject|4
4631591|NCT01894230|7500826|FG001|Overall Study|Withdrawal by Subject|4
4631592|NCT01894230|7500825|FG000|Overall Study|Non-adherent|0
4631593|NCT01894230|7500826|FG001|Overall Study|Non-adherent|1
4631594|NCT01894230|7500825|FG000|Overall Study|Death|1
4631595|NCT01894230|7500826|FG001|Overall Study|Death|0
4631596|NCT01894243|7500835|FG000|Overall Study|Adverse Event|0
4631597|NCT01894243|7500836|FG001|Overall Study|Adverse Event|1
4631598|NCT01894243|7500837|FG002|Overall Study|Adverse Event|2
4631599|NCT01894243|7500835|FG000|Overall Study|Death|0
4631600|NCT01894243|7500836|FG001|Overall Study|Death|0
4631601|NCT01894243|7500837|FG002|Overall Study|Death|3
4631602|NCT01894243|7500835|FG000|Overall Study|Lack of Efficacy|3
4631603|NCT01894243|7500836|FG001|Overall Study|Lack of Efficacy|3
4631604|NCT01894243|7500837|FG002|Overall Study|Lack of Efficacy|1
4631605|NCT01894243|7500835|FG000|Overall Study|Condition under investigation worsened|8
4631606|NCT01894243|7500836|FG001|Overall Study|Condition under investigation worsened|6
4631607|NCT01894243|7500837|FG002|Overall Study|Condition under investigation worsened|2
4631608|NCT01894243|7500835|FG000|Overall Study|Subject decision|1
4631609|NCT01894243|7500836|FG001|Overall Study|Subject decision|0
4631610|NCT01894243|7500837|FG002|Overall Study|Subject decision|0
4631611|NCT01894243|7500835|FG000|Overall Study|Other|1
4631612|NCT01894243|7500836|FG001|Overall Study|Other|0
4631613|NCT01894243|7500837|FG002|Overall Study|Other|0
4631614|NCT01894256|7500855|FG000|Part A|Adverse Event|0
4631615|NCT01894256|7500856|FG001|Part A|Adverse Event|1
4631616|NCT01894256|7500857|FG002|Part A|Adverse Event|0
4631617|NCT01894256|7500855|FG000|Part B|Death|0
4515529|NCT00954122|7326466|FG000|Overall Study|Safety Reason|1
4515530|NCT00954174|7326475|FG000|Overall Study|Adverse Event|28
4515531|NCT00954174|7326476|FG001|Overall Study|Adverse Event|23
4515532|NCT00954174|7326477|FG002|Overall Study|Adverse Event|4
4515533|NCT00954174|7326478|FG003|Overall Study|Adverse Event|9
4515534|NCT00954174|7326475|FG000|Overall Study|Death|4
4515535|NCT00954174|7326476|FG001|Overall Study|Death|2
4515536|NCT00954174|7326477|FG002|Overall Study|Death|0
4515537|NCT00954174|7326478|FG003|Overall Study|Death|0
4447504|NCT00490724|7232764|FG001|Period II|Treatment Discontinuation|1
4631618|NCT01894256|7500856|FG001|Part B|Death|1
4631619|NCT01894256|7500857|FG002|Part B|Death|1
4631620|NCT01894256|7500855|FG000|Part B|Withdrawal by Subject|0
4631621|NCT01894256|7500856|FG001|Part B|Withdrawal by Subject|1
4631622|NCT01894256|7500857|FG002|Part B|Withdrawal by Subject|0
4631623|NCT01894256|7500855|FG000|Part B|Lack of Efficacy|15
4631624|NCT01894256|7500856|FG001|Part B|Lack of Efficacy|12
4631625|NCT01894256|7500857|FG002|Part B|Lack of Efficacy|13
4631626|NCT01894477|7500870|FG000|Overall Study|Protocol Violation|0
4631627|NCT01894477|7500871|FG001|Overall Study|Protocol Violation|1
4631628|NCT01894477|7500870|FG000|Overall Study|protocol changed due SC changed to cord|0
4631629|NCT01894477|7500871|FG001|Overall Study|protocol changed due SC changed to cord|1
4631630|NCT01894516|7500886|FG000|Period 1 (Baseline up to Week 12)|Other|0
4631631|NCT01894516|7500887|FG001|Period 1 (Baseline up to Week 12)|Other|1
4631632|NCT01894516|7500888|FG002|Period 1 (Baseline up to Week 12)|Other|1
4631633|NCT01894516|7500889|FG003|Period 1 (Baseline up to Week 12)|Other|0
4631634|NCT01894516|7500886|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2
4631635|NCT01894516|7500887|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
4631636|NCT01894516|7500888|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
4631637|NCT01894516|7500889|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0
4631638|NCT01894516|7500886|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1
4633383|NCT01911442|7503530|FG000|Overall Study|Mother's Work Schedule|0
4631639|NCT01894516|7500887|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1
4631640|NCT01894516|7500888|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0
4631641|NCT01894516|7500889|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0
4631642|NCT01894516|7500886|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0
4631643|NCT01894516|7500887|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0
4631644|NCT01894516|7500888|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1
4631645|NCT01894516|7500889|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0
4631646|NCT01894516|7500886|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2
4631647|NCT01894516|7500887|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0
4631648|NCT01894516|7500888|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0
4631649|NCT01894516|7500889|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1
4631650|NCT01894516|7500886|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2
4631651|NCT01894516|7500887|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3
4631652|NCT01894516|7500888|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1
4631653|NCT01894516|7500889|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2
4631654|NCT01894516|7500886|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0
4631655|NCT01894516|7500887|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2
4631656|NCT01894516|7500888|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3
4732998|NCT03430986|7677620|FG000|24-week Post-Control Period|Withdrawal by Participant|0
4732999|NCT03430986|7677621|FG001|24-week Post-Control Period|Withdrawal by Participant|1
4733000|NCT03431337|7677653|FG000|Overall Study|Lost to Follow-up|21
4733001|NCT03431337|7677654|FG001|Overall Study|Lost to Follow-up|19
4733002|NCT03431337|7677653|FG000|Overall Study|Withdrawal by Subject|8
4733003|NCT03431337|7677654|FG001|Overall Study|Withdrawal by Subject|3
4733004|NCT03431441|7677664|FG000|Overall Study|Withdrawal by Subject|2
4733005|NCT03431441|7677664|FG000|Overall Study|Adverse Event|2
4733006|NCT03431441|7677664|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1
4733007|NCT03431857|7677668|FG000|Overall Study|Death|6
4733008|NCT03431857|7677668|FG000|Overall Study|Lost to Follow-up|41
4733009|NCT03431857|7677668|FG000|Overall Study|Adverse Event|6
4631657|NCT01894516|7500889|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1
4631658|NCT01894516|7500886|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
4733010|NCT03431857|7677668|FG000|Overall Study|Withdrawal by Subject|1
4733011|NCT03432390|7677674|FG000|Apnea Period|Protocol Violation|2
4733012|NCT03432390|7677675|FG001|Apnea Period|Protocol Violation|2
4733013|NCT03432533|7677683|FG000|Overall Study|Lost to Follow-up|1
4733014|NCT03432533|7677684|FG001|Overall Study|Lost to Follow-up|2
4733015|NCT03432533|7677683|FG000|Overall Study|Withdrawal by Subject|14
4733016|NCT03432533|7677684|FG001|Overall Study|Withdrawal by Subject|9
4733017|NCT03432858|7677693|FG000|Overall Study|Protocol Violation|2
4733018|NCT03432858|7677694|FG001|Overall Study|Protocol Violation|1
4733019|NCT03432858|7677695|FG002|Overall Study|Protocol Violation|9
4733020|NCT03432858|7677693|FG000|Overall Study|Withdrawal by Subject|0
4733021|NCT03432858|7677694|FG001|Overall Study|Withdrawal by Subject|1
4733022|NCT03432858|7677695|FG002|Overall Study|Withdrawal by Subject|1
4733023|NCT03432858|7677693|FG000|Overall Study|Procedure canceled/rescheduled|0
4733024|NCT03432858|7677694|FG001|Overall Study|Procedure canceled/rescheduled|9
4733025|NCT03432858|7677695|FG002|Overall Study|Procedure canceled/rescheduled|6
4733026|NCT03432858|7677693|FG000|Overall Study|Required postop mobilization with splinting|0
4733027|NCT03432858|7677694|FG001|Overall Study|Required postop mobilization with splinting|0
4733028|NCT03432858|7677695|FG002|Overall Study|Required postop mobilization with splinting|1
4733029|NCT03433482|7677707|FG000|Overall Study|Lost to Follow-up|1
4733030|NCT03433482|7677708|FG001|Overall Study|Lost to Follow-up|0
4733031|NCT03433482|7677709|FG002|Overall Study|Lost to Follow-up|1
4733032|NCT03433482|7677710|FG003|Overall Study|Lost to Follow-up|1
4733033|NCT03433482|7677707|FG000|Overall Study|Withdrawal by Subject|0
4733034|NCT03433482|7677708|FG001|Overall Study|Withdrawal by Subject|0
4733035|NCT03433482|7677709|FG002|Overall Study|Withdrawal by Subject|1
4733036|NCT03433482|7677710|FG003|Overall Study|Withdrawal by Subject|0
4733037|NCT03433482|7677707|FG000|Overall Study|Unknown reason|0
4631659|NCT01894516|7500887|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
4631660|NCT01894516|7500888|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2
4631661|NCT01894516|7500889|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0
4631662|NCT01894568|7500909|FG000|Overall Study|Adverse Event|2
4631663|NCT01894568|7500910|FG001|Overall Study|Adverse Event|3
4631664|NCT01894568|7500909|FG000|Overall Study|Protocol required discontinuation|2
4733038|NCT03433482|7677708|FG001|Overall Study|Unknown reason|0
4733039|NCT03433482|7677709|FG002|Overall Study|Unknown reason|2
4733040|NCT03433482|7677710|FG003|Overall Study|Unknown reason|0
4733041|NCT03433677|7677722|FG000|Period 1|Protocol Violation|1
4733042|NCT03433677|7677723|FG001|Period 1|Protocol Violation|0
4733043|NCT03433677|7677722|FG000|Period 2|Withdrawal by Subject|1
4631665|NCT01894568|7500910|FG001|Overall Study|Protocol required discontinuation|1
4631666|NCT01894568|7500909|FG000|Overall Study|Withdrawal by Subject|5
4631667|NCT01894568|7500910|FG001|Overall Study|Withdrawal by Subject|5
4631668|NCT01894568|7500909|FG000|Overall Study|Physician Decision|1
4631669|NCT01894568|7500910|FG001|Overall Study|Physician Decision|0
4631670|NCT01894568|7500909|FG000|Overall Study|Lost to Follow-up|0
4631671|NCT01894568|7500910|FG001|Overall Study|Lost to Follow-up|1
4631672|NCT01894581|7500919|FG000|Overall Study|Withdrawal by Subject|2
4631673|NCT01894581|7500920|FG001|Overall Study|Withdrawal by Subject|3
4631674|NCT01894581|7500919|FG000|Overall Study|Screen Failure|3
4631675|NCT01894581|7500920|FG001|Overall Study|Screen Failure|4
4631676|NCT01894607|7500926|FG000|Overall Study|Ineligible|1
4733044|NCT03433677|7677723|FG001|Period 2|Withdrawal by Subject|1
4733045|NCT03433703|7677730|FG000|Overall Study|Study terminated by Sponsor|2
4733046|NCT03433755|7677738|FG000|Overall Study|Lost to Follow-up|1
4733047|NCT03433755|7677739|FG001|Overall Study|Lost to Follow-up|0
4733048|NCT03433755|7677740|FG002|Overall Study|Lost to Follow-up|0
4733049|NCT03433755|7677741|FG003|Overall Study|Lost to Follow-up|0
4733050|NCT03433755|7677738|FG000|Overall Study|Decision by Sponsor|1
4733051|NCT03433755|7677739|FG001|Overall Study|Decision by Sponsor|0
4733052|NCT03433755|7677740|FG002|Overall Study|Decision by Sponsor|0
4733053|NCT03433755|7677741|FG003|Overall Study|Decision by Sponsor|0
4733054|NCT03434249|7677768|FG000|Overall Study|Adverse Event|1
4733055|NCT03434249|7677769|FG001|Overall Study|Adverse Event|0
4733056|NCT03434249|7677768|FG000|Overall Study|Lost to Follow-up|0
4733057|NCT03434249|7677769|FG001|Overall Study|Lost to Follow-up|1
4733058|NCT03434249|7677768|FG000|Overall Study|Non-compliance of family|2
4733059|NCT03434249|7677769|FG001|Overall Study|Non-compliance of family|1
4631677|NCT01894620|7500932|FG000|Overall Study|Withdrawal by Subject|0
4733060|NCT03434249|7677768|FG000|Overall Study|Difficulties in completing daily diary|2
4733061|NCT03434249|7677769|FG001|Overall Study|Difficulties in completing daily diary|1
4631678|NCT01894620|7500933|FG001|Overall Study|Withdrawal by Subject|1
4631679|NCT01894776|7500946|FG000|Overall Study|Withdrawal by Subject|1
4733062|NCT03434834|7677779|FG000|Overall Study|unable to swallow OCT probe|16
4631680|NCT01894841|7500952|FG000|Overall Study|Withdrawal by Subject|9
4631681|NCT01894841|7500953|FG001|Overall Study|Withdrawal by Subject|4
4631682|NCT01894841|7500952|FG000|Overall Study|Withdrawn by investigator|2
4631683|NCT01894841|7500953|FG001|Overall Study|Withdrawn by investigator|2
4631684|NCT01894841|7500952|FG000|Overall Study|Lost to Follow-up|7
4631685|NCT01894841|7500953|FG001|Overall Study|Lost to Follow-up|3
4631686|NCT01894919|7500997|FG000|Overall Study|Withdrawal by Subject|1
4631687|NCT01894919|7500998|FG001|Overall Study|Withdrawal by Subject|0
4631688|NCT01894919|7500999|FG002|Overall Study|Withdrawal by Subject|0
4631689|NCT01894919|7501000|FG003|Overall Study|Withdrawal by Subject|0
4631690|NCT01894919|7501001|FG004|Overall Study|Withdrawal by Subject|1
4631691|NCT01894919|7501002|FG005|Overall Study|Withdrawal by Subject|0
4631692|NCT01894919|7501003|FG006|Overall Study|Withdrawal by Subject|0
4631693|NCT01894919|7501004|FG007|Overall Study|Withdrawal by Subject|0
4631694|NCT01894919|7501005|FG008|Overall Study|Withdrawal by Subject|0
4631695|NCT01894919|7501006|FG009|Overall Study|Withdrawal by Subject|1
4631696|NCT01894919|7501007|FG010|Overall Study|Withdrawal by Subject|1
4631697|NCT01894919|7501008|FG011|Overall Study|Withdrawal by Subject|0
4631698|NCT01894919|7501009|FG012|Overall Study|Withdrawal by Subject|0
4631699|NCT01894919|7500997|FG000|Overall Study|Adverse Event|0
4631700|NCT01894919|7500998|FG001|Overall Study|Adverse Event|0
4631701|NCT01894919|7500999|FG002|Overall Study|Adverse Event|0
4631702|NCT01894919|7501000|FG003|Overall Study|Adverse Event|0
4631703|NCT01894919|7501001|FG004|Overall Study|Adverse Event|0
4631704|NCT01894919|7501002|FG005|Overall Study|Adverse Event|0
4631705|NCT01894919|7501003|FG006|Overall Study|Adverse Event|0
4631706|NCT01894919|7501004|FG007|Overall Study|Adverse Event|0
4631707|NCT01894919|7501005|FG008|Overall Study|Adverse Event|0
4631708|NCT01894919|7501006|FG009|Overall Study|Adverse Event|0
4631709|NCT01894919|7501007|FG010|Overall Study|Adverse Event|1
4631710|NCT01894919|7501008|FG011|Overall Study|Adverse Event|0
4631711|NCT01894919|7501009|FG012|Overall Study|Adverse Event|0
4631712|NCT01894919|7500997|FG000|Overall Study|Other-Unspecified|1
4631713|NCT01894919|7500998|FG001|Overall Study|Other-Unspecified|0
4631714|NCT01894919|7500999|FG002|Overall Study|Other-Unspecified|0
4631715|NCT01894919|7501000|FG003|Overall Study|Other-Unspecified|0
4631716|NCT01894919|7501001|FG004|Overall Study|Other-Unspecified|0
4631717|NCT01894919|7501002|FG005|Overall Study|Other-Unspecified|0
4631718|NCT01894919|7501003|FG006|Overall Study|Other-Unspecified|0
4631719|NCT01894919|7501004|FG007|Overall Study|Other-Unspecified|0
4631720|NCT01894919|7501005|FG008|Overall Study|Other-Unspecified|0
4631721|NCT01894919|7501006|FG009|Overall Study|Other-Unspecified|0
4631722|NCT01894919|7501007|FG010|Overall Study|Other-Unspecified|0
4631723|NCT01894919|7501008|FG011|Overall Study|Other-Unspecified|0
4631724|NCT01894919|7501009|FG012|Overall Study|Other-Unspecified|0
4631725|NCT01894919|7500997|FG000|Overall Study|Lost to Follow-up|0
4733063|NCT03434977|7677785|FG000|Washout Period (at Least 6 Days)|Adverse Event|0
4733064|NCT03434977|7677786|FG001|Washout Period (at Least 6 Days)|Adverse Event|1
4733065|NCT03435055|7677792|FG000|Screening|Physician Decision|2
4733066|NCT03435055|7677792|FG000|Received Intervention|Did not complete nitrous administration|3
4733067|NCT03435081|7677806|FG000|Overall Study|Lack of Efficacy|6
4733068|NCT03435081|7677807|FG001|Overall Study|Lack of Efficacy|5
4733069|NCT03435081|7677808|FG002|Overall Study|Lack of Efficacy|0
4733070|NCT03435081|7677806|FG000|Overall Study|Adverse Event|2
4733071|NCT03435081|7677807|FG001|Overall Study|Adverse Event|2
4733072|NCT03435081|7677808|FG002|Overall Study|Adverse Event|2
4733073|NCT03435081|7677806|FG000|Overall Study|Withdrawal by Subject|8
4733074|NCT03435081|7677807|FG001|Overall Study|Withdrawal by Subject|7
4733075|NCT03435081|7677808|FG002|Overall Study|Withdrawal by Subject|10
4733076|NCT03435081|7677806|FG000|Overall Study|Lost to Follow-up|3
4733077|NCT03435081|7677807|FG001|Overall Study|Lost to Follow-up|1
4733078|NCT03435081|7677808|FG002|Overall Study|Lost to Follow-up|4
4733079|NCT03435081|7677806|FG000|Overall Study|Pregnancy|1
4733080|NCT03435081|7677807|FG001|Overall Study|Pregnancy|0
4733081|NCT03435081|7677808|FG002|Overall Study|Pregnancy|0
4733082|NCT03435081|7677806|FG000|Overall Study|Non-compliance|1
4733083|NCT03435081|7677807|FG001|Overall Study|Non-compliance|0
4733084|NCT03435081|7677808|FG002|Overall Study|Non-compliance|2
4733085|NCT03435081|7677806|FG000|Overall Study|Inadequate Response|0
4733086|NCT03435081|7677807|FG001|Overall Study|Inadequate Response|1
4733087|NCT03435081|7677808|FG002|Overall Study|Inadequate Response|0
4733088|NCT03435081|7677806|FG000|Overall Study|Withdrawal Due to Caregiver Circumstance|0
4733089|NCT03435081|7677807|FG001|Overall Study|Withdrawal Due to Caregiver Circumstance|0
4733090|NCT03435081|7677808|FG002|Overall Study|Withdrawal Due to Caregiver Circumstance|1
4733091|NCT03435211|7677817|FG000|Overall Study|Unable to achieve minimum desaturation level|1
4733092|NCT03435224|7677821|FG000|Overall Study|Unable to achieve a minimum desaturation level|4
4733093|NCT03435497|7677827|FG000|Overall Study|Lost to Follow-up|1
4733094|NCT03435497|7677828|FG001|Overall Study|Lost to Follow-up|0
4733095|NCT03435497|7677827|FG000|Overall Study|Death|1
4733096|NCT03435497|7677828|FG001|Overall Study|Death|0
4733097|NCT03435497|7677827|FG000|Overall Study|Withdrawal by Subject|0
4733098|NCT03435497|7677828|FG001|Overall Study|Withdrawal by Subject|4
4733099|NCT03435497|7677827|FG000|Overall Study|Wrong survey administered|0
4733100|NCT03435497|7677828|FG001|Overall Study|Wrong survey administered|2
4733101|NCT03435692|7677858|FG000|Overall Study|Lack of Efficacy|2
4733102|NCT03435692|7677859|FG001|Overall Study|Lack of Efficacy|2
4733103|NCT03435692|7677860|FG002|Overall Study|Lack of Efficacy|0
4733104|NCT03436082|7677883|FG000|Overall Study|Did not undergo procedure|1
4733105|NCT03436082|7677884|FG001|Overall Study|Did not undergo procedure|0
4733106|NCT03436420|7677901|FG000|Overall Study|Lack of Efficacy|3
4733107|NCT03436732|7677907|FG000|Overall Study|Not treated-enrolled in different study|1
4733108|NCT03436732|7677908|FG001|Overall Study|Not treated-enrolled in different study|0
4733109|NCT03436732|7677907|FG000|Overall Study|Off study after cycle 1|1
4733110|NCT03436732|7677908|FG001|Overall Study|Off study after cycle 1|0
4733111|NCT03436732|7677907|FG000|Overall Study|Adverse Event|2
4733112|NCT03436732|7677908|FG001|Overall Study|Adverse Event|0
4733113|NCT03436732|7677907|FG000|Overall Study|Death|0
4733114|NCT03436732|7677908|FG001|Overall Study|Death|1
4733115|NCT03437265|7677944|FG000|Overall Study|Protocol Violation|6
4733125|NCT03437447|7677966|FG000|Treatment Period 1|Withdrawal by Subject|0
4733126|NCT03437447|7677967|FG001|Treatment Period 1|Withdrawal by Subject|0
4733127|NCT03437447|7677968|FG002|Treatment Period 1|Withdrawal by Subject|1
4733128|NCT03437512|7677978|FG000|Randomized|Withdrawal by Subject|0
4733129|NCT03437512|7677979|FG001|Randomized|Withdrawal by Subject|2
4733130|NCT03437512|7677978|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2
4737463|NCT03611582|7687664|FG001|Overall Study|Pregnancy|2
4631726|NCT01894919|7500998|FG001|Overall Study|Lost to Follow-up|0
4631727|NCT01894919|7500999|FG002|Overall Study|Lost to Follow-up|0
4631728|NCT01894919|7501000|FG003|Overall Study|Lost to Follow-up|0
4631729|NCT01894919|7501001|FG004|Overall Study|Lost to Follow-up|2
4631730|NCT01894919|7501002|FG005|Overall Study|Lost to Follow-up|0
4631731|NCT01894919|7501003|FG006|Overall Study|Lost to Follow-up|0
4631732|NCT01894919|7501004|FG007|Overall Study|Lost to Follow-up|0
4631733|NCT01894919|7501005|FG008|Overall Study|Lost to Follow-up|0
4733131|NCT03437512|7677979|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1
4733132|NCT03437577|7677997|FG000|Pre-Randomization|Withdrawal by Subject|0
4733133|NCT03437577|7677998|FG001|Pre-Randomization|Withdrawal by Subject|0
4733134|NCT03437577|7677999|FG002|Pre-Randomization|Withdrawal by Subject|10
4733135|NCT03437577|7677997|FG000|Post-Randomization|Physician Decision|0
4733136|NCT03437577|7677998|FG001|Post-Randomization|Physician Decision|2
4733137|NCT03437577|7677999|FG002|Post-Randomization|Physician Decision|0
4733138|NCT03437733|7678007|FG000|Overall Study|Eligibility criteria not met|0
4733139|NCT03437733|7678008|FG001|Overall Study|Eligibility criteria not met|3
4733140|NCT03438006|7678017|FG000|Overall Study|Adverse Event|1
4733141|NCT03438006|7678017|FG000|Overall Study|Lost to Follow-up|67
4733142|NCT03438006|7678017|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47
4733143|NCT03438006|7678017|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3
4631734|NCT01894919|7501006|FG009|Overall Study|Lost to Follow-up|0
4631735|NCT01894919|7501007|FG010|Overall Study|Lost to Follow-up|0
4631736|NCT01894919|7501008|FG011|Overall Study|Lost to Follow-up|0
4631737|NCT01894919|7501009|FG012|Overall Study|Lost to Follow-up|0
4631738|NCT01894984|7501053|FG000|Overall Study|Other|314
4631739|NCT01894984|7501054|FG001|Overall Study|Other|175
4631740|NCT01895101|7501080|FG000|Overall Study|OPCAB procedure|1
4631741|NCT01895101|7501081|FG001|Overall Study|OPCAB procedure|1
4515538|NCT00954174|7326475|FG000|Overall Study|Lack of Efficacy|32
4515539|NCT00954174|7326476|FG001|Overall Study|Lack of Efficacy|22
4515540|NCT00954174|7326477|FG002|Overall Study|Lack of Efficacy|8
4515541|NCT00954174|7326478|FG003|Overall Study|Lack of Efficacy|6
4515542|NCT00954174|7326475|FG000|Overall Study|Withdrawal by Subject|14
4515543|NCT00954174|7326476|FG001|Overall Study|Withdrawal by Subject|10
4515544|NCT00954174|7326477|FG002|Overall Study|Withdrawal by Subject|4
4515545|NCT00954174|7326478|FG003|Overall Study|Withdrawal by Subject|3
4515546|NCT00954174|7326475|FG000|Overall Study|Medical Reason|4
4515547|NCT00954174|7326476|FG001|Overall Study|Medical Reason|2
4515548|NCT00954174|7326477|FG002|Overall Study|Medical Reason|1
4515549|NCT00954174|7326478|FG003|Overall Study|Medical Reason|0
4733144|NCT03438383|7678033|FG000|Overall Study|Protocol Violation|9
4733145|NCT03438383|7678034|FG001|Overall Study|Protocol Violation|3
4733146|NCT03438396|7678040|FG000|Overall Study|Ongoing on study treatment|4
4733147|NCT03438396|7678040|FG000|Overall Study|Ongoing in survival follow-up|33
4733148|NCT03438396|7678040|FG000|Overall Study|Withdrawal by Subject|4
4733149|NCT03438396|7678040|FG000|Overall Study|Lost to Follow-up|2
4733150|NCT03438396|7678040|FG000|Overall Study|Death|58
4733151|NCT03438396|7678040|FG000|Overall Study|Not treated|1
4733152|NCT03438539|7678050|FG000|Overall Study|Lost to Follow-up|8
4733153|NCT03438539|7678051|FG001|Overall Study|Lost to Follow-up|4
4733154|NCT03438539|7678052|FG002|Overall Study|Lost to Follow-up|10
4733155|NCT03438539|7678053|FG003|Overall Study|Lost to Follow-up|9
4733156|NCT03438539|7678054|FG004|Overall Study|Lost to Follow-up|3
4733157|NCT03438539|7678055|FG005|Overall Study|Lost to Follow-up|8
4733158|NCT03439072|7678078|FG000|Overall Study|Withdrawal by Subject|2
4733159|NCT03439072|7678079|FG001|Overall Study|Withdrawal by Subject|3
4733160|NCT03439072|7678078|FG000|Overall Study|Physician Decision|0
4733161|NCT03439072|7678079|FG001|Overall Study|Physician Decision|1
4733162|NCT03439137|7678087|FG000|Overall Study|Adverse Event|16
4733163|NCT03439137|7678088|FG001|Overall Study|Adverse Event|12
4733164|NCT03439137|7678087|FG000|Overall Study|Physician Decision|0
4733165|NCT03439137|7678088|FG001|Overall Study|Physician Decision|5
4733166|NCT03439137|7678087|FG000|Overall Study|Withdrawal by Subject|14
4733167|NCT03439137|7678088|FG001|Overall Study|Withdrawal by Subject|4
4733168|NCT03439137|7678087|FG000|Overall Study|Conducting rescue therapy|2
4515550|NCT00954174|7326475|FG000|Overall Study|Ineligible|40
4733169|NCT03439137|7678088|FG001|Overall Study|Conducting rescue therapy|1
4447505|NCT00490724|7232765|FG002|Period II|Treatment Discontinuation|3
4631742|NCT01895101|7501082|FG002|Overall Study|OPCAB procedure|3
4631743|NCT01895101|7501080|FG000|Overall Study|Withdrawal by Subject|0
4631744|NCT01895101|7501081|FG001|Overall Study|Withdrawal by Subject|1
4733170|NCT03439137|7678087|FG000|Overall Study|Difficult to control Hb|10
4733171|NCT03439137|7678088|FG001|Overall Study|Difficult to control Hb|2
4733172|NCT03439137|7678087|FG000|Overall Study|Initiation of a renal transplant|0
4733173|NCT03439137|7678088|FG001|Overall Study|Initiation of a renal transplant|2
4733174|NCT03439189|7678094|FG000|Overall Study|Protocol Violation|19
4733175|NCT03439189|7678094|FG000|Overall Study|Lack of Efficacy|63
4733176|NCT03440320|7678112|FG000|Overall Study|Withdrawal by Subject|0
4733177|NCT03440320|7678113|FG001|Overall Study|Withdrawal by Subject|1
4733178|NCT03440411|7678125|FG000|Overall Study|Adverse Event|0
4733179|NCT03440411|7678126|FG001|Overall Study|Adverse Event|0
4733180|NCT03440411|7678127|FG002|Overall Study|Adverse Event|1
4733181|NCT03440411|7678128|FG003|Overall Study|Adverse Event|0
4733182|NCT03440411|7678125|FG000|Overall Study|PD|2
4733183|NCT03440411|7678126|FG001|Overall Study|PD|1
4733184|NCT03440411|7678127|FG002|Overall Study|PD|1
4733185|NCT03440411|7678128|FG003|Overall Study|PD|1
4733186|NCT03440411|7678125|FG000|Overall Study|Withdrawal by Subject|1
4733187|NCT03440411|7678126|FG001|Overall Study|Withdrawal by Subject|0
4733188|NCT03440411|7678127|FG002|Overall Study|Withdrawal by Subject|0
4733189|NCT03440411|7678128|FG003|Overall Study|Withdrawal by Subject|0
4733190|NCT03440411|7678125|FG000|Overall Study|Closed study by sponsor|0
4631745|NCT01895101|7501082|FG002|Overall Study|Withdrawal by Subject|2
4631746|NCT01895101|7501080|FG000|Overall Study|another study, enrolled in other study|0
4631747|NCT01895101|7501081|FG001|Overall Study|another study, enrolled in other study|1
4631748|NCT01895101|7501082|FG002|Overall Study|another study, enrolled in other study|0
4631749|NCT01895101|7501080|FG000|Overall Study|Death|0
4631750|NCT01895101|7501081|FG001|Overall Study|Death|1
4631751|NCT01895101|7501082|FG002|Overall Study|Death|0
4631752|NCT01895101|7501080|FG000|Overall Study|coagulation disorder|0
4733191|NCT03440411|7678126|FG001|Overall Study|Closed study by sponsor|0
4733192|NCT03440411|7678127|FG002|Overall Study|Closed study by sponsor|0
4733193|NCT03440411|7678128|FG003|Overall Study|Closed study by sponsor|1
4631753|NCT01895101|7501081|FG001|Overall Study|coagulation disorder|1
4733194|NCT03440918|7678172|FG000|Overall Study|Protocol Violation|0
4631754|NCT01895101|7501082|FG002|Overall Study|coagulation disorder|0
4631755|NCT01895270|7501102|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0
4631756|NCT01895270|7501103|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2
4631757|NCT01895270|7501102|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3
4631758|NCT01895270|7501103|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2
4631759|NCT01895270|7501102|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3
4631760|NCT01895270|7501103|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1
4631761|NCT01895270|7501102|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0
4631762|NCT01895270|7501103|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1
4631763|NCT01895270|7501102|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3
4631764|NCT01895270|7501103|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5
4631765|NCT01895270|7501102|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0
4631766|NCT01895270|7501103|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1
4631767|NCT01895270|7501102|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0
4631768|NCT01895270|7501103|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1
4631769|NCT01895309|7501111|FG000|Overall Study|Adverse Event|13
4631770|NCT01895309|7501112|FG001|Overall Study|Adverse Event|17
4631771|NCT01895309|7501111|FG000|Overall Study|Protocol Violation|1
4631772|NCT01895309|7501112|FG001|Overall Study|Protocol Violation|0
4631773|NCT01895309|7501111|FG000|Overall Study|Lack of Efficacy|1
4631774|NCT01895309|7501112|FG001|Overall Study|Lack of Efficacy|3
4631775|NCT01895309|7501111|FG000|Overall Study|Lost to Follow-up|1
4631776|NCT01895309|7501112|FG001|Overall Study|Lost to Follow-up|3
4631777|NCT01895309|7501111|FG000|Overall Study|Physician Decision|15
4631778|NCT01895309|7501112|FG001|Overall Study|Physician Decision|10
4631779|NCT01895309|7501111|FG000|Overall Study|Withdrawal by Subject|9
4631780|NCT01895309|7501112|FG001|Overall Study|Withdrawal by Subject|18
4631781|NCT01895322|7501122|FG000|Overall Study|Adverse Event|1
4631782|NCT01895322|7501122|FG000|Overall Study|Withdrawal by Subject|2
4631783|NCT01895322|7501122|FG000|Overall Study|Protocol Violation|10
4631784|NCT01895335|7501127|FG000|Overall Study|Adverse Event|106
4631785|NCT01895335|7501127|FG000|Overall Study|Lack of Efficacy|53
4733195|NCT03440918|7678173|FG001|Overall Study|Protocol Violation|16
4733196|NCT03440944|7678181|FG000|Overall Study|Physician Decision|1
4733197|NCT03440944|7678182|FG001|Overall Study|Physician Decision|0
4733198|NCT03440944|7678181|FG000|Overall Study|No Acceptable Vasculature|0
4733199|NCT03440944|7678182|FG001|Overall Study|No Acceptable Vasculature|1
4733200|NCT03441789|7678274|FG000|Overall Study|Withdrawal by Subject|1
4733201|NCT03441789|7678275|FG001|Overall Study|Withdrawal by Subject|1
4733202|NCT03441789|7678274|FG000|Overall Study|Adverse Event|0
4733203|NCT03441789|7678275|FG001|Overall Study|Adverse Event|1
4733204|NCT03441789|7678274|FG000|Overall Study|Protocol Violation|0
4733205|NCT03441789|7678275|FG001|Overall Study|Protocol Violation|1
4733206|NCT03441789|7678274|FG000|Overall Study|Lost to Follow-up|0
4733207|NCT03441789|7678275|FG001|Overall Study|Lost to Follow-up|1
4733208|NCT03441984|7678283|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
4631786|NCT01895335|7501127|FG000|Overall Study|Poor Compliance to Protocol|11
4631787|NCT01895335|7501127|FG000|Overall Study|Included But Not treated|1
4733209|NCT03441984|7678284|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
4733210|NCT03441984|7678285|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1
4733211|NCT03441984|7678286|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
4733212|NCT03441984|7678287|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
4733213|NCT03441984|7678288|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
4733214|NCT03441984|7678289|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
4733215|NCT03441984|7678290|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
4733216|NCT03441984|7678291|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
4733217|NCT03441984|7678292|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
4733218|NCT03441984|7678293|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
4733219|NCT03441984|7678294|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
4733220|NCT03442296|7678322|FG000|3 Month Follow-up|Death|3
4733221|NCT03442296|7678323|FG001|3 Month Follow-up|Death|1
4733222|NCT03442296|7678322|FG000|3 Month Follow-up|Lost to Follow-up|1
4733223|NCT03442296|7678323|FG001|3 Month Follow-up|Lost to Follow-up|1
4733224|NCT03442296|7678322|FG000|3 Month Follow-up|Withdrawal by Subject|1
4733225|NCT03442296|7678323|FG001|3 Month Follow-up|Withdrawal by Subject|0
4733226|NCT03442296|7678322|FG000|3 Month Follow-up|Obtained Hearing Aids|0
4733227|NCT03442296|7678323|FG001|3 Month Follow-up|Obtained Hearing Aids|1
4733228|NCT03442296|7678322|FG000|12 Month Follow-up|Incomplete measurement|1
4631788|NCT01895335|7501127|FG000|Overall Study|Other than Specified Above|44
4631789|NCT01895361|7501134|FG000|Overall Study|Adverse Event|1
4631790|NCT01895361|7501135|FG001|Overall Study|Adverse Event|1
4631791|NCT01895361|7501136|FG002|Overall Study|Adverse Event|3
4631792|NCT01895361|7501134|FG000|Overall Study|Death|2
4631793|NCT01895361|7501135|FG001|Overall Study|Death|1
4631794|NCT01895361|7501136|FG002|Overall Study|Death|2
4733229|NCT03442296|7678323|FG001|12 Month Follow-up|Incomplete measurement|1
4733230|NCT03442569|7678329|FG000|Overall Study|Subject was ineligible after enrollment|1
4733231|NCT03442595|7678335|FG000|Overall Study|Lost to Follow-up|94
4733232|NCT03442595|7678336|FG001|Overall Study|Lost to Follow-up|0
4737464|NCT03611582|7687663|FG000|Overall Study|Lack of Efficacy|0
4737465|NCT03611582|7687664|FG001|Overall Study|Lack of Efficacy|1
4737466|NCT03611582|7687663|FG000|Overall Study|At the discretion of the investigator|1
4737467|NCT03611582|7687664|FG001|Overall Study|At the discretion of the investigator|0
4737468|NCT03611582|7687663|FG000|Overall Study|Safety concern as judged by the investigator|1
4737469|NCT03611582|7687664|FG001|Overall Study|Safety concern as judged by the investigator|2
4447506|NCT00490815|7232785|FG000|Overall Study|Adverse Event|2
4447507|NCT00490815|7232786|FG001|Overall Study|Adverse Event|3
4447508|NCT00490815|7232785|FG000|Overall Study|Withdrawal by Subject|4
4447509|NCT00490815|7232786|FG001|Overall Study|Withdrawal by Subject|0
4447510|NCT00490815|7232785|FG000|Overall Study|Lost to Follow-up|1
4447511|NCT00490815|7232786|FG001|Overall Study|Lost to Follow-up|3
4447512|NCT00490815|7232785|FG000|Overall Study|Death|1
4447513|NCT00490815|7232786|FG001|Overall Study|Death|3
4447514|NCT00490841|7232792|FG000|Overall Study|Death|5
4447515|NCT00490841|7232792|FG000|Overall Study|Withdrawal by Subject|4
4447516|NCT00490841|7232792|FG000|Overall Study|Lost to Follow-up|1
4447517|NCT00490841|7232792|FG000|Overall Study|30 day f/u, only non-study stent used|3
4447518|NCT00490919|7232799|FG000|Open-label Run-in Period|Adverse Event|239
4447519|NCT00490919|7232800|FG001|Open-label Run-in Period|Adverse Event|0
4447520|NCT00490919|7232801|FG002|Open-label Run-in Period|Adverse Event|0
4447521|NCT00490919|7232799|FG000|Open-label Run-in Period|Withdrawal by Subject|37
4447522|NCT00490919|7232800|FG001|Open-label Run-in Period|Withdrawal by Subject|0
4447523|NCT00490919|7232801|FG002|Open-label Run-in Period|Withdrawal by Subject|0
4447524|NCT00490919|7232799|FG000|Open-label Run-in Period|Lost to Follow-up|21
4631795|NCT01895361|7501134|FG000|Overall Study|Lost to Follow-up|4
4631796|NCT01895361|7501135|FG001|Overall Study|Lost to Follow-up|4
4631797|NCT01895361|7501136|FG002|Overall Study|Lost to Follow-up|6
4631798|NCT01895361|7501134|FG000|Overall Study|Non-compliance with study|1
4733233|NCT03442777|7678359|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8
4733234|NCT03442777|7678360|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13
4733235|NCT03442777|7678361|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7
4733236|NCT03442829|7678369|FG000|Overall Study|Scheduling clash|3
4733237|NCT03442829|7678370|FG001|Overall Study|Scheduling clash|1
4733238|NCT03442829|7678369|FG000|Overall Study|Illness unrelated to study|1
4631799|NCT01895361|7501135|FG001|Overall Study|Non-compliance with study|3
4631800|NCT01895361|7501136|FG002|Overall Study|Non-compliance with study|1
4515551|NCT00954174|7326476|FG001|Overall Study|Ineligible|47
4515552|NCT00954174|7326477|FG002|Overall Study|Ineligible|7
4631801|NCT01895361|7501134|FG000|Overall Study|Physician Decision|2
4631802|NCT01895361|7501135|FG001|Overall Study|Physician Decision|2
4631803|NCT01895361|7501136|FG002|Overall Study|Physician Decision|2
4631804|NCT01895361|7501134|FG000|Overall Study|Withdrawal by Subject|7
4631805|NCT01895361|7501135|FG001|Overall Study|Withdrawal by Subject|6
4631806|NCT01895361|7501136|FG002|Overall Study|Withdrawal by Subject|6
4631807|NCT01895361|7501134|FG000|Overall Study|Lack of Efficacy|0
4631808|NCT01895361|7501135|FG001|Overall Study|Lack of Efficacy|1
4631809|NCT01895361|7501136|FG002|Overall Study|Lack of Efficacy|0
4631810|NCT01895361|7501134|FG000|Overall Study|Reasons different from categories above|7
4631811|NCT01895361|7501135|FG001|Overall Study|Reasons different from categories above|3
4631812|NCT01895361|7501136|FG002|Overall Study|Reasons different from categories above|4
4631813|NCT01895452|7501146|FG000|Overall Study|Adverse Event|1
4631814|NCT01895452|7501147|FG001|Overall Study|Adverse Event|4
4631815|NCT01895452|7501146|FG000|Overall Study|Lost to Follow-up|1
4631816|NCT01895452|7501147|FG001|Overall Study|Lost to Follow-up|5
4631817|NCT01895452|7501146|FG000|Overall Study|Pregnancy|0
4631818|NCT01895452|7501147|FG001|Overall Study|Pregnancy|1
4631819|NCT01895452|7501146|FG000|Overall Study|Withdrawal by Subject|2
4631820|NCT01895452|7501147|FG001|Overall Study|Withdrawal by Subject|14
4631821|NCT01895452|7501146|FG000|Overall Study|Underlying disease|0
4631822|NCT01895452|7501147|FG001|Overall Study|Underlying disease|3
4631823|NCT01895452|7501146|FG000|Overall Study|Noncompliance with study drug|0
4631824|NCT01895452|7501147|FG001|Overall Study|Noncompliance with study drug|1
4631825|NCT01895543|7501153|FG000|Overall Study|Withdrawal by Subject|43
4631826|NCT01895543|7501153|FG000|Overall Study|Lost to Follow-up|25
4631827|NCT01895543|7501153|FG000|Overall Study|Adverse Event|28
4631828|NCT01895543|7501153|FG000|Overall Study|Subject's substantial non-compliance|6
4631829|NCT01895543|7501153|FG000|Overall Study|Protocol Violation|1
4733239|NCT03442829|7678370|FG001|Overall Study|Illness unrelated to study|1
4733240|NCT03443024|7678394|FG000|Overall Study|Adverse Event|2
4733241|NCT03443024|7678395|FG001|Overall Study|Adverse Event|4
4733242|NCT03443024|7678396|FG002|Overall Study|Adverse Event|3
4733243|NCT03443024|7678397|FG003|Overall Study|Adverse Event|1
4733244|NCT03443024|7678394|FG000|Overall Study|Lost to Follow-up|9
4733245|NCT03443024|7678395|FG001|Overall Study|Lost to Follow-up|9
4733246|NCT03443024|7678396|FG002|Overall Study|Lost to Follow-up|7
4733247|NCT03443024|7678397|FG003|Overall Study|Lost to Follow-up|5
4733248|NCT03443024|7678394|FG000|Overall Study|Withdrawal by Subject|8
4733249|NCT03443024|7678395|FG001|Overall Study|Withdrawal by Subject|15
4733250|NCT03443024|7678396|FG002|Overall Study|Withdrawal by Subject|9
4733251|NCT03443024|7678397|FG003|Overall Study|Withdrawal by Subject|23
4733252|NCT03443024|7678394|FG000|Overall Study|Physician Decision|1
4733253|NCT03443024|7678395|FG001|Overall Study|Physician Decision|2
4733254|NCT03443024|7678396|FG002|Overall Study|Physician Decision|0
4733255|NCT03443024|7678397|FG003|Overall Study|Physician Decision|1
4631830|NCT01895543|7501153|FG000|Overall Study|Physician Decision|2
4733256|NCT03443024|7678394|FG000|Overall Study|Sponsor Decision|1
4733257|NCT03443024|7678395|FG001|Overall Study|Sponsor Decision|1
4733258|NCT03443024|7678396|FG002|Overall Study|Sponsor Decision|0
4733259|NCT03443024|7678397|FG003|Overall Study|Sponsor Decision|0
4733260|NCT03443024|7678394|FG000|Overall Study|Protocol Deviation|0
4733261|NCT03443024|7678395|FG001|Overall Study|Protocol Deviation|0
4733262|NCT03443024|7678396|FG002|Overall Study|Protocol Deviation|0
4733263|NCT03443024|7678397|FG003|Overall Study|Protocol Deviation|2
4733264|NCT03443414|7678423|FG000|Overall Study|Adverse Event|6
4733265|NCT03443414|7678424|FG001|Overall Study|Adverse Event|0
4733266|NCT03443414|7678425|FG002|Overall Study|Adverse Event|4
4733267|NCT03443414|7678426|FG003|Overall Study|Adverse Event|2
4733268|NCT03443414|7678427|FG004|Overall Study|Adverse Event|3
4733269|NCT03443414|7678423|FG000|Overall Study|Withdrawal by Subject|3
4733270|NCT03443414|7678424|FG001|Overall Study|Withdrawal by Subject|2
4733271|NCT03443414|7678425|FG002|Overall Study|Withdrawal by Subject|2
4733272|NCT03443414|7678426|FG003|Overall Study|Withdrawal by Subject|2
4733273|NCT03443414|7678427|FG004|Overall Study|Withdrawal by Subject|1
4733274|NCT03443414|7678423|FG000|Overall Study|Death|0
4733275|NCT03443414|7678424|FG001|Overall Study|Death|1
4733276|NCT03443414|7678425|FG002|Overall Study|Death|0
4733277|NCT03443414|7678426|FG003|Overall Study|Death|1
4733278|NCT03443414|7678427|FG004|Overall Study|Death|0
4733279|NCT03443414|7678423|FG000|Overall Study|Reason not specified|2
4733280|NCT03443414|7678424|FG001|Overall Study|Reason not specified|0
4733281|NCT03443414|7678425|FG002|Overall Study|Reason not specified|0
4733282|NCT03443414|7678426|FG003|Overall Study|Reason not specified|0
4733283|NCT03443414|7678427|FG004|Overall Study|Reason not specified|1
4733284|NCT03443427|7678441|FG000|Overall Study|Adverse Event|2
4733285|NCT03443427|7678442|FG001|Overall Study|Adverse Event|3
4733286|NCT03443427|7678441|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6
4733287|NCT03443427|7678442|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2
4733288|NCT03443427|7678441|FG000|Overall Study|Other|4
4733289|NCT03443427|7678442|FG001|Overall Study|Other|6
4515553|NCT00954174|7326478|FG003|Overall Study|Ineligible|4
4515554|NCT00954174|7326475|FG000|Overall Study|Never Treated|4
4515555|NCT00954174|7326476|FG001|Overall Study|Never Treated|17
4515556|NCT00954174|7326477|FG002|Overall Study|Never Treated|0
4515557|NCT00954174|7326478|FG003|Overall Study|Never Treated|3
4515558|NCT00954421|7326500|FG000|Screening|screen failures|3
4733290|NCT03443713|7678451|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0
4733291|NCT03443713|7678452|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0
4733292|NCT03443713|7678453|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1
4733293|NCT03444155|7678476|FG000|First Intervention (6 Weeks)|Adverse Event|1
4733294|NCT03444155|7678477|FG001|First Intervention (6 Weeks)|Adverse Event|0
4733295|NCT03444584|7678485|FG000|Overall Study|Withdrawal by Subject|0
4733296|NCT03444584|7678486|FG001|Overall Study|Withdrawal by Subject|1
4733297|NCT03444584|7678485|FG000|Overall Study|Other|0
4733298|NCT03444584|7678486|FG001|Overall Study|Other|1
4733299|NCT03444766|7678493|FG000|Overall Study|Other Reasons|2
4733300|NCT03444766|7678493|FG000|Overall Study|Participant Withdrew Consent|5
4733301|NCT03444766|7678493|FG000|Overall Study|Lost to Follow-up|2
4733302|NCT03444766|7678493|FG000|Overall Study|Death|2
4733303|NCT03444766|7678493|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6
4733304|NCT03444766|7678493|FG000|Overall Study|Disease Progression|49
4733305|NCT03445065|7678509|FG000|Overall Study|Withdrawal by Subject|3
4515559|NCT00954421|7326500|FG000|6 Months of DBS|Withdrawal by Subject|1
4515560|NCT00954421|7326500|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1
4515561|NCT00954447|7326508|FG000|Overall Study|Adverse Event|33
4515562|NCT00954447|7326509|FG001|Overall Study|Adverse Event|25
4515563|NCT00954447|7326508|FG000|Overall Study|Lack of Efficacy|17
4631831|NCT01895543|7501153|FG000|Overall Study|Other (Not fulfilling above criteria)|24
4631832|NCT01895608|7501161|FG000|Overall Study|change in health status|0
4631833|NCT01895608|7501162|FG001|Overall Study|change in health status|1
4631834|NCT01895608|7501163|FG002|Overall Study|change in health status|1
4631835|NCT01895608|7501164|FG003|Overall Study|change in health status|0
4631836|NCT01895608|7501161|FG000|Overall Study|Withdrawal by Subject|0
4631837|NCT01895608|7501162|FG001|Overall Study|Withdrawal by Subject|0
4631838|NCT01895608|7501163|FG002|Overall Study|Withdrawal by Subject|2
4631839|NCT01895608|7501164|FG003|Overall Study|Withdrawal by Subject|0
4515564|NCT00954447|7326509|FG001|Overall Study|Lack of Efficacy|3
4515565|NCT00954447|7326508|FG000|Overall Study|Protocol Violation|5
4515566|NCT00954447|7326509|FG001|Overall Study|Protocol Violation|7
4515567|NCT00954447|7326508|FG000|Overall Study|Lost to Follow-up|8
4515568|NCT00954447|7326509|FG001|Overall Study|Lost to Follow-up|14
4515569|NCT00954447|7326508|FG000|Overall Study|Withdrawal by Subject|26
4515570|NCT00954447|7326509|FG001|Overall Study|Withdrawal by Subject|21
4515571|NCT00954447|7326508|FG000|Overall Study|Other|21
4515572|NCT00954447|7326509|FG001|Overall Study|Other|18
4515573|NCT00954512|7326521|FG000|Overall Study|Withdrawal by Subject|0
4515574|NCT00954512|7326522|FG001|Overall Study|Withdrawal by Subject|0
4515575|NCT00954512|7326523|FG002|Overall Study|Withdrawal by Subject|0
4515576|NCT00954512|7326524|FG003|Overall Study|Withdrawal by Subject|0
4515577|NCT00954512|7326525|FG004|Overall Study|Withdrawal by Subject|0
4515578|NCT00954512|7326526|FG005|Overall Study|Withdrawal by Subject|1
4515579|NCT00954512|7326521|FG000|Overall Study|Adverse Event|0
4515580|NCT00954512|7326522|FG001|Overall Study|Adverse Event|0
4515581|NCT00954512|7326523|FG002|Overall Study|Adverse Event|0
4515582|NCT00954512|7326524|FG003|Overall Study|Adverse Event|0
4515583|NCT00954512|7326525|FG004|Overall Study|Adverse Event|1
4515584|NCT00954512|7326526|FG005|Overall Study|Adverse Event|2
4515585|NCT00954512|7326521|FG000|Overall Study|Physician Decision|0
4515586|NCT00954512|7326522|FG001|Overall Study|Physician Decision|1
4515587|NCT00954512|7326523|FG002|Overall Study|Physician Decision|0
4515588|NCT00954512|7326524|FG003|Overall Study|Physician Decision|1
4515589|NCT00954512|7326525|FG004|Overall Study|Physician Decision|0
4515590|NCT00954512|7326526|FG005|Overall Study|Physician Decision|0
4631840|NCT01895777|7501193|FG000|Overall Study|Adverse Event|1
4515591|NCT00954512|7326521|FG000|Overall Study|Symptomatic Deterioration|0
4631841|NCT01895777|7501194|FG001|Overall Study|Adverse Event|2
4631842|NCT01895777|7501193|FG000|Overall Study|Lost to Follow-up|2
4631843|NCT01895777|7501194|FG001|Overall Study|Lost to Follow-up|0
4631844|NCT01895777|7501193|FG000|Overall Study|Not treated|1
4631845|NCT01895777|7501194|FG001|Overall Study|Not treated|0
4631846|NCT01895777|7501193|FG000|Overall Study|Other reasons|3
4631847|NCT01895777|7501194|FG001|Overall Study|Other reasons|2
4733306|NCT03445065|7678510|FG001|Overall Study|Withdrawal by Subject|6
4631848|NCT01895777|7501193|FG000|Overall Study|Non-compliance with the CTP|2
4515592|NCT00954512|7326522|FG001|Overall Study|Symptomatic Deterioration|1
4515593|NCT00954512|7326523|FG002|Overall Study|Symptomatic Deterioration|0
4515594|NCT00954512|7326524|FG003|Overall Study|Symptomatic Deterioration|0
4515595|NCT00954512|7326525|FG004|Overall Study|Symptomatic Deterioration|2
4515596|NCT00954512|7326526|FG005|Overall Study|Symptomatic Deterioration|0
4515597|NCT00954512|7326521|FG000|Overall Study|Progression of Disease|2
4515598|NCT00954512|7326522|FG001|Overall Study|Progression of Disease|1
4515599|NCT00954512|7326523|FG002|Overall Study|Progression of Disease|0
4515600|NCT00954512|7326524|FG003|Overall Study|Progression of Disease|1
4631849|NCT01895777|7501194|FG001|Overall Study|Non-compliance with the CTP|1
4631850|NCT01896050|7501231|FG000|Overall Study|Adverse Event|37
4631851|NCT01896050|7501232|FG001|Overall Study|Adverse Event|2
4631852|NCT01896050|7501231|FG000|Overall Study|Death|1
4631853|NCT01896050|7501232|FG001|Overall Study|Death|0
4631854|NCT01896128|7501256|FG000|Overall Study|Withdrawal by Subject|3
4631855|NCT01896128|7501257|FG001|Overall Study|Withdrawal by Subject|3
4515601|NCT00954512|7326525|FG004|Overall Study|Progression of Disease|1
4515602|NCT00954512|7326526|FG005|Overall Study|Progression of Disease|1
4515603|NCT00954538|7326541|FG000|Part III|Withdrawal by Subject|0
4515604|NCT00954538|7326542|FG001|Part III|Withdrawal by Subject|0
4515605|NCT00954538|7326543|FG002|Part III|Withdrawal by Subject|0
4515606|NCT00954538|7326544|FG003|Part III|Withdrawal by Subject|0
4515607|NCT00954538|7326545|FG004|Part III|Withdrawal by Subject|1
4515608|NCT00954538|7326546|FG005|Part III|Withdrawal by Subject|0
4515609|NCT00954707|7326559|FG000|Overall Study|Death|34
4515610|NCT00954707|7326559|FG000|Overall Study|Withdrawal by Subject|100
4515611|NCT00954707|7326559|FG000|Overall Study|Lost to Follow-up|33
4515612|NCT00954733|7326563|FG000|Overall Study|blood gas machine did not work|1
4515613|NCT00954941|7326573|FG000|Overall Study|Received treatment at home|1
4515614|NCT00954941|7326574|FG001|Overall Study|Received treatment at home|0
4515615|NCT00954941|7326573|FG000|Overall Study|Withdrawal by Subject|1
4515616|NCT00954941|7326574|FG001|Overall Study|Withdrawal by Subject|0
4515617|NCT00954941|7326573|FG000|Overall Study|Insurance Denial|2
4515618|NCT00954941|7326574|FG001|Overall Study|Insurance Denial|2
4515619|NCT00954941|7326573|FG000|Overall Study|Physician Decision|2
4515620|NCT00954941|7326574|FG001|Overall Study|Physician Decision|2
4515621|NCT00954941|7326573|FG000|Overall Study|Ineligible|2
4515622|NCT00954941|7326574|FG001|Overall Study|Ineligible|2
4515623|NCT00954941|7326573|FG000|Overall Study|Adverse Event|0
4515624|NCT00954941|7326574|FG001|Overall Study|Adverse Event|1
4515625|NCT00955110|7326604|FG000|Qualification Phase|Did not meet eligibility criteria|24
4515626|NCT00955110|7326604|FG000|Treatment Phase|Adverse Event|2
4515627|NCT00955110|7326604|FG000|Treatment Phase|Administrative reasons|2
4515628|NCT00955110|7326604|FG000|Treatment Phase|Non-compliance with study restrictions|1
4515629|NCT00955110|7326604|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1
4515630|NCT00955279|7326660|FG000|Overall Study|Other|0
4515631|NCT00955279|7326661|FG001|Overall Study|Other|0
4515632|NCT00955279|7326662|FG002|Overall Study|Other|3
4515633|NCT00955279|7326660|FG000|Overall Study|Death|1
4515634|NCT00955279|7326661|FG001|Overall Study|Death|1
4631856|NCT01896193|7501267|FG000|Overall Study|Lack of Efficacy|20
4447525|NCT00490919|7232800|FG001|Open-label Run-in Period|Lost to Follow-up|0
4447526|NCT00490919|7232801|FG002|Open-label Run-in Period|Lost to Follow-up|0
4631857|NCT01896193|7501268|FG001|Overall Study|Lack of Efficacy|11
4631858|NCT01896193|7501267|FG000|Overall Study|Protocol Violation|0
4631859|NCT01896193|7501268|FG001|Overall Study|Protocol Violation|1
4631860|NCT01896193|7501267|FG000|Overall Study|Withdrew Consent|1
4733307|NCT03445065|7678511|FG002|Overall Study|Withdrawal by Subject|2
4733308|NCT03445065|7678512|FG003|Overall Study|Withdrawal by Subject|2
4733309|NCT03445065|7678509|FG000|Overall Study|Other|4
4733310|NCT03445065|7678510|FG001|Overall Study|Other|3
4733311|NCT03445065|7678511|FG002|Overall Study|Other|3
4733312|NCT03445065|7678512|FG003|Overall Study|Other|1
4733313|NCT03446781|7678619|FG000|Overall Study|Lost to Follow-up|11
4733314|NCT03446781|7678620|FG001|Overall Study|Lost to Follow-up|5
4733315|NCT03446781|7678619|FG000|Overall Study|Withdrawal by Subject|9
4733316|NCT03446781|7678620|FG001|Overall Study|Withdrawal by Subject|7
4733317|NCT03446781|7678619|FG000|Overall Study|Adverse Event|8
4733318|NCT03446781|7678620|FG001|Overall Study|Adverse Event|2
4631861|NCT01896193|7501268|FG001|Overall Study|Withdrew Consent|0
4631862|NCT01896232|7501282|FG000|Overall Study|Death|6
4631863|NCT01896232|7501283|FG001|Overall Study|Death|10
4631864|NCT01896232|7501282|FG000|Overall Study|Withdrawal by Subject|32
4733319|NCT03446781|7678619|FG000|Overall Study|Protocol Violation|0
4733320|NCT03446781|7678620|FG001|Overall Study|Protocol Violation|3
4733321|NCT03446885|7678661|FG000|Overall Study|Lost to Follow-up|1
4733322|NCT03446885|7678662|FG001|Overall Study|Lost to Follow-up|0
4733323|NCT03446885|7678661|FG000|Overall Study|Did not complete entire visit|1
4733324|NCT03446885|7678662|FG001|Overall Study|Did not complete entire visit|0
4733325|NCT03447249|7678681|FG000|Overall Study|Adverse Event|1
4733326|NCT03447249|7678682|FG001|Overall Study|Adverse Event|0
4733327|NCT03447249|7678681|FG000|Overall Study|Withdrawal of consent (not due to AE)|1
4733328|NCT03447249|7678682|FG001|Overall Study|Withdrawal of consent (not due to AE)|0
4733329|NCT03447249|7678681|FG000|Overall Study|Other|3
4733330|NCT03447249|7678682|FG001|Overall Study|Other|0
4733331|NCT03447353|7678690|FG000|Overall Study|Failure at Screening Visit|2
4733332|NCT03447353|7678690|FG000|Overall Study|Lost to Follow-up|4
4733333|NCT03447353|7678690|FG000|Overall Study|Scheduling Conflicts|3
4733334|NCT03447353|7678690|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1
4733335|NCT03447730|7678703|FG000|Overall Study|Adverse Event|0
4733336|NCT03447730|7678704|FG001|Overall Study|Adverse Event|2
4733337|NCT03447730|7678705|FG002|Overall Study|Adverse Event|0
4733338|NCT03447821|7678716|FG000|Overall Study|Withdrawal by Subject|1
4733339|NCT03447821|7678717|FG001|Overall Study|Withdrawal by Subject|1
4733340|NCT03447821|7678718|FG002|Overall Study|Withdrawal by Subject|0
4733341|NCT03447821|7678716|FG000|Overall Study|Lost to Follow-up|0
4631865|NCT01896232|7501283|FG001|Overall Study|Withdrawal by Subject|31
4631866|NCT01896232|7501282|FG000|Overall Study|Sponsor Decision|2
4631867|NCT01896232|7501283|FG001|Overall Study|Sponsor Decision|0
4631868|NCT01896232|7501282|FG000|Overall Study|Lost to Follow-up|9
4631869|NCT01896232|7501283|FG001|Overall Study|Lost to Follow-up|12
4631870|NCT01896271|7501289|FG000|Overall Study|Physician Decision|10
4631871|NCT01896297|7501293|FG000|Overall Study|Died in post treatment phase|1
4631872|NCT01896557|7501315|FG000|Clopidogrel Alone|Adverse Event|1
4631873|NCT01896557|7501316|FG001|Clopidogrel Alone|Adverse Event|0
4631874|NCT01896557|7501315|FG000|Clopidogrel + GI Protector|low adherence|1
4631875|NCT01896557|7501316|FG001|Clopidogrel + GI Protector|low adherence|1
4631876|NCT01896557|7501315|FG000|Clopidogrel + GI Protector|Reading error|1
4631877|NCT01896557|7501316|FG001|Clopidogrel + GI Protector|Reading error|3
4631878|NCT01896700|7501333|FG000|Overall Study|Adverse Event|4
4631879|NCT01896700|7501334|FG001|Overall Study|Adverse Event|5
4631880|NCT01896700|7501333|FG000|Overall Study|Withdrawal by Subject|0
4631881|NCT01896700|7501334|FG001|Overall Study|Withdrawal by Subject|1
4631882|NCT01896726|7501340|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1
4631883|NCT01896726|7501340|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1
4631884|NCT01896856|7501353|FG000|Overall Study|Transportation issues / Non-compliance|0
4631885|NCT01896856|7501354|FG001|Overall Study|Transportation issues / Non-compliance|0
4631886|NCT01896856|7501355|FG002|Overall Study|Transportation issues / Non-compliance|1
4631887|NCT01896856|7501356|FG003|Overall Study|Transportation issues / Non-compliance|0
4631888|NCT01896856|7501357|FG004|Overall Study|Transportation issues / Non-compliance|0
4631889|NCT01896856|7501358|FG005|Overall Study|Transportation issues / Non-compliance|0
4631890|NCT01896869|7501375|FG000|Overall Study|Withdrawal by Subject|0
4631891|NCT01896869|7501376|FG001|Overall Study|Withdrawal by Subject|6
4631892|NCT01896869|7501375|FG000|Overall Study|Lost to Follow-up|1
4631893|NCT01896869|7501376|FG001|Overall Study|Lost to Follow-up|0
4733342|NCT03447821|7678717|FG001|Overall Study|Lost to Follow-up|0
4733343|NCT03447821|7678718|FG002|Overall Study|Lost to Follow-up|1
4733344|NCT03448224|7678737|FG000|Overall Study|Provided same answer to every question|1
4733345|NCT03448224|7678738|FG001|Overall Study|Provided same answer to every question|0
4733346|NCT03448406|7678746|FG000|Overall Study|Noncompliance of scheduled visits|1
4733347|NCT03448406|7678747|FG001|Overall Study|Noncompliance of scheduled visits|2
4733348|NCT03448406|7678746|FG000|Overall Study|Withdrawal by Subject|1
4733349|NCT03448406|7678747|FG001|Overall Study|Withdrawal by Subject|2
4733350|NCT03448406|7678746|FG000|Overall Study|Protocol Violation|1
4733351|NCT03448406|7678747|FG001|Overall Study|Protocol Violation|0
4733352|NCT03448406|7678746|FG000|Overall Study|Adverse Event|8
4733353|NCT03448406|7678747|FG001|Overall Study|Adverse Event|9
4631894|NCT01896895|7501387|FG000|Double-blind MP|Physician Decision|0
4631895|NCT01896895|7501388|FG001|Double-blind MP|Physician Decision|0
4631896|NCT01896895|7501389|FG002|Double-blind MP|Physician Decision|1
4631897|NCT01896895|7501390|FG003|Double-blind MP|Physician Decision|0
4631898|NCT01896895|7501387|FG000|Double-blind MP|Withdrawal by Subject|0
4631899|NCT01896895|7501388|FG001|Double-blind MP|Withdrawal by Subject|2
4631900|NCT01896895|7501389|FG002|Double-blind MP|Withdrawal by Subject|1
4631901|NCT01896895|7501390|FG003|Double-blind MP|Withdrawal by Subject|0
4631902|NCT01896895|7501387|FG000|Double-blind MP|Lost to Follow-up|1
4631903|NCT01896895|7501388|FG001|Double-blind MP|Lost to Follow-up|0
4631904|NCT01896895|7501389|FG002|Double-blind MP|Lost to Follow-up|1
4631905|NCT01896895|7501390|FG003|Double-blind MP|Lost to Follow-up|0
4631906|NCT01896934|7501403|FG000|Overall Study|Adverse Event|1
4631907|NCT01896934|7501403|FG000|Overall Study|Withdrawal by Subject|1
4631908|NCT01896986|7501409|FG000|Overall Study|samples lost|14
4631909|NCT01896986|7501410|FG001|Overall Study|samples lost|23
4631910|NCT01897233|7501434|FG000|Part B (24 Weeks)|Adverse Event|1
4631911|NCT01897233|7501434|FG000|Part B (24 Weeks)|Withdrawal by Subject|2
4631912|NCT01897233|7501434|FG000|Part B (24 Weeks)|Physician Decision|1
4631913|NCT01897493|7501463|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1
4631914|NCT01897532|7501472|FG000|Discontinuation From Treatment|Not Treated|7
4631915|NCT01897532|7501473|FG001|Discontinuation From Treatment|Not Treated|5
4631916|NCT01897532|7501472|FG000|Discontinuation From Treatment|Other reason than specified|196
4631917|NCT01897532|7501473|FG001|Discontinuation From Treatment|Other reason than specified|176
4631918|NCT01897532|7501472|FG000|Discontinuation From Treatment|Withdrawal by Subject|333
4631919|NCT01897532|7501473|FG001|Discontinuation From Treatment|Withdrawal by Subject|281
4631920|NCT01897532|7501472|FG000|Discontinuation From Treatment|Non compliance|24
4631921|NCT01897532|7501473|FG001|Discontinuation From Treatment|Non compliance|15
4631922|NCT01897532|7501472|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402
4631923|NCT01897532|7501473|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362
4631924|NCT01897532|7501472|FG000|Discontinuation From Trial|Not Treated|7
4631925|NCT01897532|7501473|FG001|Discontinuation From Trial|Not Treated|5
4631926|NCT01897532|7501472|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55
4631927|NCT01897532|7501473|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36
4631928|NCT01897714|7501485|FG000|Phase I (Dose Escalation)|Disease progression|3
4631929|NCT01897714|7501486|FG001|Phase I (Dose Escalation)|Disease progression|5
4631930|NCT01897714|7501487|FG002|Phase I (Dose Escalation)|Disease progression|1
4631931|NCT01897714|7501488|FG003|Phase I (Dose Escalation)|Disease progression|3
4631932|NCT01897714|7501489|FG004|Phase I (Dose Escalation)|Disease progression|0
4631933|NCT01897714|7501490|FG005|Phase I (Dose Escalation)|Disease progression|0
4631934|NCT01897714|7501485|FG000|Phase I (Dose Escalation)|Adverse Event|0
4631935|NCT01897714|7501486|FG001|Phase I (Dose Escalation)|Adverse Event|1
4631936|NCT01897714|7501487|FG002|Phase I (Dose Escalation)|Adverse Event|4
4631937|NCT01897714|7501488|FG003|Phase I (Dose Escalation)|Adverse Event|3
4631938|NCT01897714|7501489|FG004|Phase I (Dose Escalation)|Adverse Event|0
4631939|NCT01897714|7501490|FG005|Phase I (Dose Escalation)|Adverse Event|0
4631940|NCT01897714|7501485|FG000|Phase I (Dose Escalation)|Other|0
4631941|NCT01897714|7501486|FG001|Phase I (Dose Escalation)|Other|1
4631942|NCT01897714|7501487|FG002|Phase I (Dose Escalation)|Other|0
4631943|NCT01897714|7501488|FG003|Phase I (Dose Escalation)|Other|0
4631944|NCT01897714|7501489|FG004|Phase I (Dose Escalation)|Other|0
4631945|NCT01897714|7501490|FG005|Phase I (Dose Escalation)|Other|0
4631946|NCT01897714|7501485|FG000|Phase II (MTD)|Withdrawal by Subject|0
4631947|NCT01897714|7501486|FG001|Phase II (MTD)|Withdrawal by Subject|0
4631948|NCT01897714|7501487|FG002|Phase II (MTD)|Withdrawal by Subject|0
4631949|NCT01897714|7501488|FG003|Phase II (MTD)|Withdrawal by Subject|0
4631950|NCT01897714|7501489|FG004|Phase II (MTD)|Withdrawal by Subject|0
4631951|NCT01897714|7501490|FG005|Phase II (MTD)|Withdrawal by Subject|1
4631952|NCT01897714|7501485|FG000|Phase II (MTD)|Lost to Follow-up|0
4631953|NCT01897714|7501486|FG001|Phase II (MTD)|Lost to Follow-up|0
4631954|NCT01897714|7501487|FG002|Phase II (MTD)|Lost to Follow-up|0
4631955|NCT01897714|7501488|FG003|Phase II (MTD)|Lost to Follow-up|0
4631956|NCT01897714|7501489|FG004|Phase II (MTD)|Lost to Follow-up|1
4631957|NCT01897714|7501490|FG005|Phase II (MTD)|Lost to Follow-up|0
4631958|NCT01897714|7501485|FG000|Phase II (MTD)|Death|0
4631959|NCT01897714|7501486|FG001|Phase II (MTD)|Death|0
4733354|NCT03448419|7678755|FG000|Overall Study|Adverse Event|10
4733355|NCT03448419|7678756|FG001|Overall Study|Adverse Event|9
4631960|NCT01897714|7501487|FG002|Phase II (MTD)|Death|0
4631961|NCT01897714|7501488|FG003|Phase II (MTD)|Death|0
4631962|NCT01897714|7501489|FG004|Phase II (MTD)|Death|25
4631963|NCT01897714|7501490|FG005|Phase II (MTD)|Death|10
4631964|NCT01897714|7501485|FG000|Phase II (MTD)|Study terminated with patient alive|0
4631965|NCT01897714|7501486|FG001|Phase II (MTD)|Study terminated with patient alive|0
4631966|NCT01897714|7501487|FG002|Phase II (MTD)|Study terminated with patient alive|0
4631967|NCT01897714|7501488|FG003|Phase II (MTD)|Study terminated with patient alive|0
4631968|NCT01897714|7501489|FG004|Phase II (MTD)|Study terminated with patient alive|1
4631969|NCT01897714|7501490|FG005|Phase II (MTD)|Study terminated with patient alive|0
4631970|NCT01897714|7501485|FG000|Phase II (MTD)|Other|0
4631971|NCT01897714|7501486|FG001|Phase II (MTD)|Other|0
4631972|NCT01897714|7501487|FG002|Phase II (MTD)|Other|0
4631973|NCT01897714|7501488|FG003|Phase II (MTD)|Other|0
4631974|NCT01897714|7501489|FG004|Phase II (MTD)|Other|3
4631975|NCT01897714|7501490|FG005|Phase II (MTD)|Other|0
4631976|NCT01897727|7501508|FG000|Overall Study|Exclusion: central sleep apnea|0
4631977|NCT01897727|7501509|FG001|Overall Study|Exclusion: central sleep apnea|1
4631978|NCT01897896|7501534|FG000|Overall Study|Death|1
4631979|NCT01897896|7501535|FG001|Overall Study|Death|0
4631980|NCT01897896|7501534|FG000|Overall Study|Adverse Event|11
4631981|NCT01897896|7501535|FG001|Overall Study|Adverse Event|1
4631982|NCT01897896|7501534|FG000|Overall Study|Lost to Follow-up|1
4631983|NCT01897896|7501535|FG001|Overall Study|Lost to Follow-up|0
4631984|NCT01897896|7501534|FG000|Overall Study|Non-compliance with study drug dosing|1
4631985|NCT01897896|7501535|FG001|Overall Study|Non-compliance with study drug dosing|1
4631986|NCT01897896|7501534|FG000|Overall Study|Withdrawal by Subject|7
4631987|NCT01897896|7501535|FG001|Overall Study|Withdrawal by Subject|1
4631988|NCT01897896|7501534|FG000|Overall Study|Require drug that interfere with study|1
4631989|NCT01897896|7501535|FG001|Overall Study|Require drug that interfere with study|4
4631990|NCT01897896|7501534|FG000|Overall Study|Protocol Violation|1
4631991|NCT01897896|7501535|FG001|Overall Study|Protocol Violation|1
4631992|NCT01897896|7501534|FG000|Overall Study|Withdrawal per Investigator's judgement|1
4631993|NCT01897896|7501535|FG001|Overall Study|Withdrawal per Investigator's judgement|1
4631994|NCT01897896|7501534|FG000|Overall Study|Caregiver can no longer participate|0
4631995|NCT01897896|7501535|FG001|Overall Study|Caregiver can no longer participate|2
4631996|NCT01897896|7501534|FG000|Overall Study|Other than specified|2
4631997|NCT01897896|7501535|FG001|Overall Study|Other than specified|1
4631998|NCT01898078|7501554|FG000|Overall Study|Progressive Disease|1
4631999|NCT01898078|7501555|FG001|Overall Study|Progressive Disease|5
4632000|NCT01898078|7501554|FG000|Overall Study|Adverse Event|2
4632001|NCT01898078|7501555|FG001|Overall Study|Adverse Event|1
4632002|NCT01898078|7501554|FG000|Overall Study|Withdrawal by Subject|1
4632003|NCT01898078|7501555|FG001|Overall Study|Withdrawal by Subject|1
4632004|NCT01898078|7501554|FG000|Overall Study|Symptomatic Deterioration|2
4632005|NCT01898078|7501555|FG001|Overall Study|Symptomatic Deterioration|0
4632006|NCT01898078|7501554|FG000|Overall Study|Reason not Specified|0
4632007|NCT01898078|7501555|FG001|Overall Study|Reason not Specified|1
4632008|NCT01898091|7501565|FG000|Overall Study|Lost to Follow-up|1
4632009|NCT01898091|7501566|FG001|Overall Study|Lost to Follow-up|1
4632010|NCT01898091|7501565|FG000|Overall Study|Withdrawal by Subject|1
4632011|NCT01898091|7501566|FG001|Overall Study|Withdrawal by Subject|5
4632012|NCT01898130|7501572|FG000|Treatment|Withdrawal by Subject|2
4632013|NCT01898130|7501572|FG000|Treatment|Progressive Disease|4
4632014|NCT01898130|7501572|FG000|Follow up Until PD or Death|Lost to Follow-up|1
4632015|NCT01898195|7501579|FG000|Smoking Abstinence|Did not have good measurements|35
4632016|NCT01898195|7501580|FG001|Smoking Abstinence|Did not have good measurements|38
4632017|NCT01898195|7501581|FG002|Smoking Abstinence|Did not have good measurements|36
4632018|NCT01898208|7501592|FG000|Overall Study|Positive blood culture|17
4632019|NCT01898208|7501593|FG001|Overall Study|Positive blood culture|23
4632020|NCT01898208|7501594|FG002|Overall Study|Positive blood culture|15
4632021|NCT01898208|7501592|FG000|Overall Study|Death/comfort care within 24 hours|10
4632022|NCT01898208|7501593|FG001|Overall Study|Death/comfort care within 24 hours|9
4632023|NCT01898208|7501594|FG002|Overall Study|Death/comfort care within 24 hours|8
4632024|NCT01898208|7501592|FG000|Overall Study|Negative Gram Stain|6
4632025|NCT01898208|7501593|FG001|Overall Study|Negative Gram Stain|9
4632026|NCT01898208|7501594|FG002|Overall Study|Negative Gram Stain|6
4632027|NCT01898208|7501592|FG000|Overall Study|Non-Blood Specimens in Bottles|3
4632028|NCT01898208|7501593|FG001|Overall Study|Non-Blood Specimens in Bottles|5
4632029|NCT01898208|7501594|FG002|Overall Study|Non-Blood Specimens in Bottles|4
4632030|NCT01898208|7501592|FG000|Overall Study|System/Technical Error|1
4632031|NCT01898208|7501593|FG001|Overall Study|System/Technical Error|2
4632032|NCT01898208|7501594|FG002|Overall Study|System/Technical Error|3
4632033|NCT01898208|7501592|FG000|Overall Study|Lost to Follow-up|3
4632034|NCT01898208|7501593|FG001|Overall Study|Lost to Follow-up|1
4632035|NCT01898208|7501594|FG002|Overall Study|Lost to Follow-up|1
4632036|NCT01898286|7501602|FG000|Overall Study|Withdrawal by Subject|1
4632037|NCT01898286|7501602|FG000|Overall Study|Protocol Violation|1
4632038|NCT01898286|7501602|FG000|Overall Study|Lost to Follow-up|1
4632039|NCT01898299|7501608|FG000|Post Treatment (One Month)|Lost to Follow-up|3
4632040|NCT01898299|7501609|FG001|Post Treatment (One Month)|Lost to Follow-up|4
4632041|NCT01898442|7501630|FG000|Overall Study|Hemolysis/technical problems|1
4632042|NCT01898442|7501631|FG001|Overall Study|Hemolysis/technical problems|2
4632043|NCT01898442|7501632|FG002|Overall Study|Hemolysis/technical problems|2
4632044|NCT01898442|7501630|FG000|Overall Study|Patient vomited pills|0
4632045|NCT01898442|7501631|FG001|Overall Study|Patient vomited pills|0
4632046|NCT01898442|7501632|FG002|Overall Study|Patient vomited pills|1
4632047|NCT01898598|7501642|FG000|Overall Study|Adverse Event|1
4632048|NCT01898598|7501643|FG001|Overall Study|Adverse Event|0
4733356|NCT03448419|7678755|FG000|Overall Study|Lost to Follow-up|0
4515635|NCT00955279|7326662|FG002|Overall Study|Death|1
4515636|NCT00955279|7326660|FG000|Overall Study|Lost to Follow-up|0
4515637|NCT00955279|7326661|FG001|Overall Study|Lost to Follow-up|3
4515638|NCT00955279|7326662|FG002|Overall Study|Lost to Follow-up|1
4515639|NCT00955279|7326660|FG000|Overall Study|Withdrawal by Subject|2
4515640|NCT00955279|7326661|FG001|Overall Study|Withdrawal by Subject|0
4515641|NCT00955279|7326662|FG002|Overall Study|Withdrawal by Subject|3
4515642|NCT00955305|7326672|FG000|Overall Study|Disease progression|39
4515643|NCT00955305|7326673|FG001|Overall Study|Disease progression|41
4515644|NCT00955305|7326672|FG000|Overall Study|Adverse Event|22
4515645|NCT00955305|7326673|FG001|Overall Study|Adverse Event|22
4515646|NCT00955305|7326672|FG000|Overall Study|Death|2
4515647|NCT00955305|7326673|FG001|Overall Study|Death|1
4515648|NCT00955305|7326672|FG000|Overall Study|Withdrawal by Subject|5
4515649|NCT00955305|7326673|FG001|Overall Study|Withdrawal by Subject|4
4515650|NCT00955305|7326672|FG000|Overall Study|Alternative therapy|4
4515651|NCT00955305|7326673|FG001|Overall Study|Alternative therapy|0
4515652|NCT00955305|7326672|FG000|Overall Study|Other complicating disease|2
4515653|NCT00955305|7326673|FG001|Overall Study|Other complicating disease|4
4515654|NCT00955305|7326672|FG000|Overall Study|Physician Decision|1
4515655|NCT00955305|7326673|FG001|Overall Study|Physician Decision|0
4515656|NCT00955305|7326672|FG000|Overall Study|Continued presence of residual disease|0
4515657|NCT00955305|7326673|FG001|Overall Study|Continued presence of residual disease|1
4515658|NCT00955305|7326672|FG000|Overall Study|Functional decline|2
4515659|NCT00955305|7326673|FG001|Overall Study|Functional decline|0
4515660|NCT00955305|7326672|FG000|Overall Study|Maximum response achieved|0
4515661|NCT00955305|7326673|FG001|Overall Study|Maximum response achieved|1
4515662|NCT00955305|7326672|FG000|Overall Study|Lost to Follow-up|0
4632049|NCT01898598|7501642|FG000|Overall Study|Withdrawal by Subject|3
4632050|NCT01898598|7501643|FG001|Overall Study|Withdrawal by Subject|0
4733357|NCT03448419|7678756|FG001|Overall Study|Lost to Follow-up|2
4733358|NCT03448419|7678755|FG000|Overall Study|Withdrawal by Subject|3
4733359|NCT03448419|7678756|FG001|Overall Study|Withdrawal by Subject|1
4733360|NCT03448419|7678755|FG000|Overall Study|Not treated|0
4733361|NCT03448419|7678756|FG001|Overall Study|Not treated|1
4733362|NCT03448419|7678755|FG000|Overall Study|Patient did not attend all visits|0
4733363|NCT03448419|7678756|FG001|Overall Study|Patient did not attend all visits|2
4733364|NCT03448419|7678755|FG000|Overall Study|Withdrawn by Sponsor|0
4733365|NCT03448419|7678756|FG001|Overall Study|Withdrawn by Sponsor|1
4733366|NCT03448536|7678766|FG000|Overall Study|Protocol Violation|2
4733367|NCT03448536|7678767|FG001|Overall Study|Protocol Violation|0
4733368|NCT03448536|7678766|FG000|Overall Study|Pregnancy|1
4733369|NCT03448536|7678767|FG001|Overall Study|Pregnancy|0
4733370|NCT03448536|7678766|FG000|Overall Study|Withdrawal by Subject|1
4733371|NCT03448536|7678767|FG001|Overall Study|Withdrawal by Subject|2
4733372|NCT03448536|7678766|FG000|Overall Study|Lost to Follow-up|3
4733373|NCT03448536|7678767|FG001|Overall Study|Lost to Follow-up|2
4733374|NCT03448536|7678766|FG000|Overall Study|Inadequate pain reporter|1
4733375|NCT03448536|7678767|FG001|Overall Study|Inadequate pain reporter|0
4733376|NCT03448536|7678766|FG000|Overall Study|Other|3
4733377|NCT03448536|7678767|FG001|Overall Study|Other|0
4733378|NCT03448536|7678766|FG000|Overall Study|Physician Decision|1
4733379|NCT03448536|7678767|FG001|Overall Study|Physician Decision|0
4733380|NCT03449030|7678783|FG000|Overall Study|Withdrawal by Subject|0
4733381|NCT03449030|7678784|FG001|Overall Study|Withdrawal by Subject|0
4733382|NCT03449030|7678785|FG002|Overall Study|Withdrawal by Subject|0
4733383|NCT03449030|7678786|FG003|Overall Study|Withdrawal by Subject|1
4733384|NCT03449030|7678787|FG004|Overall Study|Withdrawal by Subject|1
4515663|NCT00955305|7326673|FG001|Overall Study|Lost to Follow-up|1
4515664|NCT00955305|7326672|FG000|Overall Study|No off-treatment reason submitted|1
4515665|NCT00955305|7326673|FG001|Overall Study|No off-treatment reason submitted|0
4515666|NCT00955305|7326672|FG000|Overall Study|Never started protocol treatment|5
4632051|NCT01898598|7501642|FG000|Overall Study|Lost to Follow-up|0
4632052|NCT01898598|7501643|FG001|Overall Study|Lost to Follow-up|1
4632053|NCT01898598|7501642|FG000|Overall Study|Other|0
4632054|NCT01898598|7501643|FG001|Overall Study|Other|1
4632055|NCT01898806|7501678|FG000|Overall Study|Withdrawal by Subject|2
4632056|NCT01898806|7501678|FG000|Overall Study|Physician Decision|1
4632057|NCT01898884|7501687|FG000|Multiple Dose Period|Adverse Event|0
4632058|NCT01898884|7501688|FG001|Multiple Dose Period|Adverse Event|0
4632059|NCT01898884|7501689|FG002|Multiple Dose Period|Adverse Event|0
4632060|NCT01898884|7501690|FG003|Multiple Dose Period|Adverse Event|0
4632061|NCT01898884|7501691|FG004|Multiple Dose Period|Adverse Event|0
4632062|NCT01898884|7501692|FG005|Multiple Dose Period|Adverse Event|0
4632063|NCT01898884|7501693|FG006|Multiple Dose Period|Adverse Event|1
4632064|NCT01898884|7501694|FG007|Multiple Dose Period|Adverse Event|0
4632065|NCT01898884|7501695|FG008|Multiple Dose Period|Adverse Event|0
4632066|NCT01898884|7501687|FG000|Multiple Dose Period|Randomized Not Treated|0
4632067|NCT01898884|7501688|FG001|Multiple Dose Period|Randomized Not Treated|0
4632068|NCT01898884|7501689|FG002|Multiple Dose Period|Randomized Not Treated|0
4632069|NCT01898884|7501690|FG003|Multiple Dose Period|Randomized Not Treated|0
4632070|NCT01898884|7501691|FG004|Multiple Dose Period|Randomized Not Treated|0
4632071|NCT01898884|7501692|FG005|Multiple Dose Period|Randomized Not Treated|0
4632072|NCT01898884|7501693|FG006|Multiple Dose Period|Randomized Not Treated|0
4632073|NCT01898884|7501694|FG007|Multiple Dose Period|Randomized Not Treated|0
4632074|NCT01898884|7501695|FG008|Multiple Dose Period|Randomized Not Treated|1
4632075|NCT01898923|7501733|FG000|Overall Study|Lack of Efficacy|5
4632076|NCT01898923|7501734|FG001|Overall Study|Lack of Efficacy|6
4632077|NCT01898923|7501733|FG000|Overall Study|Adverse Event|3
4632078|NCT01898923|7501734|FG001|Overall Study|Adverse Event|1
4632079|NCT01898923|7501733|FG000|Overall Study|Lost to Follow-up|0
4632080|NCT01898923|7501734|FG001|Overall Study|Lost to Follow-up|1
4632081|NCT01898923|7501733|FG000|Overall Study|Withdrawal by Subject|4
4632082|NCT01898923|7501734|FG001|Overall Study|Withdrawal by Subject|7
4632083|NCT01898923|7501733|FG000|Overall Study|Physician Decision|3
4632084|NCT01898923|7501734|FG001|Overall Study|Physician Decision|4
4632085|NCT01898923|7501733|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1
4632086|NCT01898923|7501734|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2
4632087|NCT01899053|7501754|FG000|Overall Study|Progressive Disease|4
4632088|NCT01899053|7501755|FG001|Overall Study|Progressive Disease|0
4632089|NCT01899053|7501756|FG002|Overall Study|Progressive Disease|3
4733385|NCT03449030|7678788|FG005|Overall Study|Withdrawal by Subject|1
4733386|NCT03449030|7678789|FG006|Overall Study|Withdrawal by Subject|1
4733387|NCT03449030|7678790|FG007|Overall Study|Withdrawal by Subject|2
4733388|NCT03449030|7678791|FG008|Overall Study|Withdrawal by Subject|0
4733389|NCT03449030|7678792|FG009|Overall Study|Withdrawal by Subject|0
4733390|NCT03449030|7678783|FG000|Overall Study|Symptomatic Deterioration|0
4733391|NCT03449030|7678784|FG001|Overall Study|Symptomatic Deterioration|1
4733392|NCT03449030|7678785|FG002|Overall Study|Symptomatic Deterioration|0
4733393|NCT03449030|7678786|FG003|Overall Study|Symptomatic Deterioration|0
4733394|NCT03449030|7678787|FG004|Overall Study|Symptomatic Deterioration|0
4733395|NCT03449030|7678788|FG005|Overall Study|Symptomatic Deterioration|1
4733396|NCT03449030|7678789|FG006|Overall Study|Symptomatic Deterioration|1
4733397|NCT03449030|7678790|FG007|Overall Study|Symptomatic Deterioration|0
4733398|NCT03449030|7678791|FG008|Overall Study|Symptomatic Deterioration|2
4733399|NCT03449030|7678792|FG009|Overall Study|Symptomatic Deterioration|0
4733400|NCT03449030|7678783|FG000|Overall Study|Progressive Disease|1
4733401|NCT03449030|7678784|FG001|Overall Study|Progressive Disease|0
4733402|NCT03449030|7678785|FG002|Overall Study|Progressive Disease|1
4733403|NCT03449030|7678786|FG003|Overall Study|Progressive Disease|4
4733404|NCT03449030|7678787|FG004|Overall Study|Progressive Disease|5
4733405|NCT03449030|7678788|FG005|Overall Study|Progressive Disease|3
4733406|NCT03449030|7678789|FG006|Overall Study|Progressive Disease|0
4733407|NCT03449030|7678790|FG007|Overall Study|Progressive Disease|1
4733408|NCT03449030|7678791|FG008|Overall Study|Progressive Disease|1
4733409|NCT03449030|7678792|FG009|Overall Study|Progressive Disease|1
4733410|NCT03449030|7678783|FG000|Overall Study|Adverse Event|0
4733411|NCT03449030|7678784|FG001|Overall Study|Adverse Event|0
4733412|NCT03449030|7678785|FG002|Overall Study|Adverse Event|0
4733413|NCT03449030|7678786|FG003|Overall Study|Adverse Event|0
4733414|NCT03449030|7678787|FG004|Overall Study|Adverse Event|0
4733415|NCT03449030|7678788|FG005|Overall Study|Adverse Event|2
4733416|NCT03449030|7678789|FG006|Overall Study|Adverse Event|0
4733417|NCT03449030|7678790|FG007|Overall Study|Adverse Event|0
4733418|NCT03449030|7678791|FG008|Overall Study|Adverse Event|0
4733419|NCT03449030|7678792|FG009|Overall Study|Adverse Event|0
4733420|NCT03449030|7678783|FG000|Overall Study|Death|0
4632090|NCT01899053|7501757|FG003|Overall Study|Progressive Disease|0
4632091|NCT01899053|7501758|FG004|Overall Study|Progressive Disease|3
4733421|NCT03449030|7678784|FG001|Overall Study|Death|0
4733422|NCT03449030|7678785|FG002|Overall Study|Death|0
4733423|NCT03449030|7678786|FG003|Overall Study|Death|0
4733424|NCT03449030|7678787|FG004|Overall Study|Death|1
4733425|NCT03449030|7678788|FG005|Overall Study|Death|0
4733426|NCT03449030|7678789|FG006|Overall Study|Death|0
4733427|NCT03449030|7678790|FG007|Overall Study|Death|0
4733428|NCT03449030|7678791|FG008|Overall Study|Death|0
4733429|NCT03449030|7678792|FG009|Overall Study|Death|0
4733430|NCT03449134|7678818|FG000|52-Week Treatment Period|Death|2
4733431|NCT03449134|7678819|FG001|52-Week Treatment Period|Death|1
4733432|NCT03449134|7678820|FG002|52-Week Treatment Period|Death|0
4733433|NCT03449134|7678818|FG000|52-Week Treatment Period|Lost to Follow-up|2
4733434|NCT03449134|7678819|FG001|52-Week Treatment Period|Lost to Follow-up|1
4733435|NCT03449134|7678820|FG002|52-Week Treatment Period|Lost to Follow-up|1
4733436|NCT03449134|7678818|FG000|52-Week Treatment Period|Physician Decision|2
4733437|NCT03449134|7678819|FG001|52-Week Treatment Period|Physician Decision|3
4733438|NCT03449134|7678820|FG002|52-Week Treatment Period|Physician Decision|3
4733439|NCT03449134|7678818|FG000|52-Week Treatment Period|Screen Failure|1
4733440|NCT03449134|7678819|FG001|52-Week Treatment Period|Screen Failure|0
4733441|NCT03449134|7678820|FG002|52-Week Treatment Period|Screen Failure|1
4733442|NCT03449134|7678818|FG000|52-Week Treatment Period|Withdrawal by Subject|37
4733443|NCT03449134|7678819|FG001|52-Week Treatment Period|Withdrawal by Subject|39
4733444|NCT03449134|7678820|FG002|52-Week Treatment Period|Withdrawal by Subject|55
4733445|NCT03449134|7678818|FG000|52-Week Treatment Period|Site Closure|1
4733446|NCT03449134|7678819|FG001|52-Week Treatment Period|Site Closure|0
4733447|NCT03449134|7678820|FG002|52-Week Treatment Period|Site Closure|0
4733448|NCT03449147|7678834|FG000|52-week Treatment Period|Death|0
4733449|NCT03449147|7678835|FG001|52-week Treatment Period|Death|1
4733450|NCT03449147|7678836|FG002|52-week Treatment Period|Death|0
4733451|NCT03449147|7678834|FG000|52-week Treatment Period|Lost to Follow-up|6
4733452|NCT03449147|7678835|FG001|52-week Treatment Period|Lost to Follow-up|2
4733453|NCT03449147|7678836|FG002|52-week Treatment Period|Lost to Follow-up|5
4733454|NCT03449147|7678834|FG000|52-week Treatment Period|Other|0
4733455|NCT03449147|7678835|FG001|52-week Treatment Period|Other|1
4733456|NCT03449147|7678836|FG002|52-week Treatment Period|Other|2
4733457|NCT03449147|7678834|FG000|52-week Treatment Period|Physician Decision|1
4733458|NCT03449147|7678835|FG001|52-week Treatment Period|Physician Decision|0
4733459|NCT03449147|7678836|FG002|52-week Treatment Period|Physician Decision|3
4733460|NCT03449147|7678834|FG000|52-week Treatment Period|Screen Failure|1
4733461|NCT03449147|7678835|FG001|52-week Treatment Period|Screen Failure|2
4733462|NCT03449147|7678836|FG002|52-week Treatment Period|Screen Failure|0
4733463|NCT03449147|7678834|FG000|52-week Treatment Period|Withdrawal by Subject|46
4733464|NCT03449147|7678835|FG001|52-week Treatment Period|Withdrawal by Subject|68
4733465|NCT03449147|7678836|FG002|52-week Treatment Period|Withdrawal by Subject|74
4733466|NCT03449147|7678834|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1
4733467|NCT03449147|7678835|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0
4733468|NCT03449147|7678836|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0
4515667|NCT00955305|7326673|FG001|Overall Study|Never started protocol treatment|5
4733469|NCT03449147|7678834|FG000|12-Week Off-Treatment Durability Period|Other|0
4515668|NCT00955305|7326672|FG000|Overall Study|Ineligible|5
4515669|NCT00955305|7326673|FG001|Overall Study|Ineligible|7
4515670|NCT00955357|7326681|FG000|Titration Phase|Adverse Event|9
4515671|NCT00955357|7326682|FG001|Titration Phase|Adverse Event|46
4515672|NCT00955357|7326681|FG000|Titration Phase|Lack of Efficacy|0
4515673|NCT00955357|7326682|FG001|Titration Phase|Lack of Efficacy|2
4737470|NCT03611582|7687663|FG000|Overall Study|Withdrawal by Subject|4
4733470|NCT03449147|7678835|FG001|12-Week Off-Treatment Durability Period|Other|1
4733471|NCT03449147|7678836|FG002|12-Week Off-Treatment Durability Period|Other|0
4733472|NCT03449446|7678884|FG000|Overall Study|Randomized but Never Treated|0
4733473|NCT03449446|7678885|FG001|Overall Study|Randomized but Never Treated|0
4733474|NCT03449446|7678886|FG002|Overall Study|Randomized but Never Treated|1
4733475|NCT03449446|7678887|FG003|Overall Study|Randomized but Never Treated|1
4733476|NCT03449446|7678888|FG004|Overall Study|Randomized but Never Treated|1
4733477|NCT03449446|7678889|FG005|Overall Study|Randomized but Never Treated|0
4733478|NCT03449446|7678890|FG006|Overall Study|Randomized but Never Treated|0
4733479|NCT03449446|7678884|FG000|Overall Study|Unknown Reason|33
4733480|NCT03449446|7678885|FG001|Overall Study|Unknown Reason|1
4733481|NCT03449446|7678886|FG002|Overall Study|Unknown Reason|1
4733482|NCT03449446|7678887|FG003|Overall Study|Unknown Reason|1
4733483|NCT03449446|7678888|FG004|Overall Study|Unknown Reason|2
4733484|NCT03449446|7678889|FG005|Overall Study|Unknown Reason|2
4733485|NCT03449446|7678890|FG006|Overall Study|Unknown Reason|0
4733486|NCT03449446|7678884|FG000|Overall Study|Withdrew Consent|1
4733487|NCT03449446|7678885|FG001|Overall Study|Withdrew Consent|3
4733488|NCT03449446|7678886|FG002|Overall Study|Withdrew Consent|1
4733489|NCT03449446|7678887|FG003|Overall Study|Withdrew Consent|4
4733490|NCT03449446|7678888|FG004|Overall Study|Withdrew Consent|4
4733491|NCT03449446|7678889|FG005|Overall Study|Withdrew Consent|4
4733492|NCT03449446|7678890|FG006|Overall Study|Withdrew Consent|1
4733493|NCT03449446|7678884|FG000|Overall Study|Adverse Event|1
4733494|NCT03449446|7678885|FG001|Overall Study|Adverse Event|2
4733495|NCT03449446|7678886|FG002|Overall Study|Adverse Event|1
4733496|NCT03449446|7678887|FG003|Overall Study|Adverse Event|0
4733497|NCT03449446|7678888|FG004|Overall Study|Adverse Event|0
4733498|NCT03449446|7678889|FG005|Overall Study|Adverse Event|2
4733499|NCT03449446|7678890|FG006|Overall Study|Adverse Event|0
4733500|NCT03449446|7678884|FG000|Overall Study|Lost to Follow-up|0
4733501|NCT03449446|7678885|FG001|Overall Study|Lost to Follow-up|0
4733502|NCT03449446|7678886|FG002|Overall Study|Lost to Follow-up|2
4733503|NCT03449446|7678887|FG003|Overall Study|Lost to Follow-up|1
4733504|NCT03449446|7678888|FG004|Overall Study|Lost to Follow-up|3
4733505|NCT03449446|7678889|FG005|Overall Study|Lost to Follow-up|0
4733506|NCT03449446|7678890|FG006|Overall Study|Lost to Follow-up|0
4733507|NCT03449446|7678884|FG000|Overall Study|Investigator's Discretion|0
4733508|NCT03449446|7678885|FG001|Overall Study|Investigator's Discretion|1
4733509|NCT03449446|7678886|FG002|Overall Study|Investigator's Discretion|1
4733510|NCT03449446|7678887|FG003|Overall Study|Investigator's Discretion|2
4733511|NCT03449446|7678888|FG004|Overall Study|Investigator's Discretion|0
4733512|NCT03449446|7678889|FG005|Overall Study|Investigator's Discretion|0
4733513|NCT03449446|7678890|FG006|Overall Study|Investigator's Discretion|0
4733514|NCT03449446|7678884|FG000|Overall Study|Non Compliance with Study Drug|1
4733515|NCT03449446|7678885|FG001|Overall Study|Non Compliance with Study Drug|0
4733516|NCT03449446|7678886|FG002|Overall Study|Non Compliance with Study Drug|0
4733517|NCT03449446|7678887|FG003|Overall Study|Non Compliance with Study Drug|0
4733518|NCT03449446|7678888|FG004|Overall Study|Non Compliance with Study Drug|0
4733519|NCT03449446|7678889|FG005|Overall Study|Non Compliance with Study Drug|0
4733520|NCT03449446|7678890|FG006|Overall Study|Non Compliance with Study Drug|0
4733521|NCT03449446|7678884|FG000|Overall Study|Protocol Violation|0
4733522|NCT03449446|7678885|FG001|Overall Study|Protocol Violation|0
4733523|NCT03449446|7678886|FG002|Overall Study|Protocol Violation|0
4733524|NCT03449446|7678887|FG003|Overall Study|Protocol Violation|0
4733525|NCT03449446|7678888|FG004|Overall Study|Protocol Violation|1
4733526|NCT03449446|7678889|FG005|Overall Study|Protocol Violation|1
4733527|NCT03449446|7678890|FG006|Overall Study|Protocol Violation|0
4733528|NCT03449446|7678884|FG000|Overall Study|Death|0
4733529|NCT03449446|7678885|FG001|Overall Study|Death|0
4733530|NCT03449446|7678886|FG002|Overall Study|Death|0
4733531|NCT03449446|7678887|FG003|Overall Study|Death|0
4733532|NCT03449446|7678888|FG004|Overall Study|Death|1
4733533|NCT03449446|7678889|FG005|Overall Study|Death|0
4733534|NCT03449446|7678890|FG006|Overall Study|Death|0
4733540|NCT03449979|7678915|FG000|Overall Study|Technical difficulty|0
4733541|NCT03449979|7678916|FG001|Overall Study|Technical difficulty|0
4733542|NCT03449979|7678917|FG002|Overall Study|Technical difficulty|0
4733543|NCT03449979|7678918|FG003|Overall Study|Technical difficulty|1
4733544|NCT03450070|7678928|FG000|Overall Study|Withdrawal by Subject|8
4733545|NCT03451071|7678959|FG000|First Vaccine|Withdrawal by Subject|1
4733546|NCT03451071|7678959|FG000|Second Vaccine|Lost to Follow-up|19
4733547|NCT03451071|7678959|FG000|Third Vaccine|Lost to Follow-up|22
4733548|NCT03451071|7678959|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4
4733549|NCT03451084|7678967|FG000|Overall Study|Withdrawal by Subject|2
4733550|NCT03451084|7678968|FG001|Overall Study|Withdrawal by Subject|1
4733551|NCT03451084|7678969|FG002|Overall Study|Withdrawal by Subject|2
4733552|NCT03451084|7678970|FG003|Overall Study|Withdrawal by Subject|1
4733553|NCT03451084|7678967|FG000|Overall Study|Disease recurrence|0
4733554|NCT03451084|7678968|FG001|Overall Study|Disease recurrence|2
4733555|NCT03451084|7678969|FG002|Overall Study|Disease recurrence|0
4733556|NCT03451084|7678970|FG003|Overall Study|Disease recurrence|0
4733557|NCT03451084|7678967|FG000|Overall Study|Lack of Efficacy|0
4733558|NCT03451084|7678968|FG001|Overall Study|Lack of Efficacy|3
4733559|NCT03451084|7678969|FG002|Overall Study|Lack of Efficacy|0
4733560|NCT03451084|7678970|FG003|Overall Study|Lack of Efficacy|1
4733561|NCT03451084|7678967|FG000|Overall Study|Death|1
4733562|NCT03451084|7678968|FG001|Overall Study|Death|0
4733563|NCT03451084|7678969|FG002|Overall Study|Death|2
4733564|NCT03451084|7678970|FG003|Overall Study|Death|0
4733565|NCT03451084|7678967|FG000|Overall Study|Physician Decision|0
4733566|NCT03451084|7678968|FG001|Overall Study|Physician Decision|0
4733567|NCT03451084|7678969|FG002|Overall Study|Physician Decision|2
4733568|NCT03451084|7678970|FG003|Overall Study|Physician Decision|2
4733569|NCT03451084|7678967|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3
4733570|NCT03451084|7678968|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0
4733571|NCT03451084|7678969|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0
4733572|NCT03451084|7678970|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2
4733573|NCT03451721|7678980|FG000|Overall Study|Death|1
4733574|NCT03451773|7678986|FG000|Overall Study|Death on study|1
4733575|NCT03451773|7678987|FG001|Overall Study|Death on study|5
4733576|NCT03451773|7678986|FG000|Overall Study|Death during follow-up period|0
4733577|NCT03451773|7678987|FG001|Overall Study|Death during follow-up period|1
4733578|NCT03452189|7679031|FG000|First Intervention (3 Months)|Adverse Event|1
4733579|NCT03452189|7679032|FG001|First Intervention (3 Months)|Adverse Event|0
4733580|NCT03452189|7679031|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4
4733581|NCT03452189|7679032|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0
4733582|NCT03452527|7679049|FG000|Overall Study|Withdrawal by Subject|1
4733583|NCT03452527|7679050|FG001|Overall Study|Withdrawal by Subject|1
4733584|NCT03452527|7679049|FG000|Overall Study|Study Terminated|2
4733585|NCT03452527|7679050|FG001|Overall Study|Study Terminated|3
4733586|NCT03452943|7679058|FG000|Titration Period (7 Weeks)|Adverse Event|1
4733587|NCT03452943|7679059|FG001|Titration Period (7 Weeks)|Adverse Event|1
4733588|NCT03452943|7679058|FG000|Titration Period (7 Weeks)|Protocol Violation|0
4733589|NCT03452943|7679059|FG001|Titration Period (7 Weeks)|Protocol Violation|1
4733590|NCT03452943|7679058|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3
4733591|NCT03452943|7679059|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2
4733592|NCT03452943|7679058|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1
4733593|NCT03452943|7679059|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0
4733594|NCT03452943|7679058|FG000|Maintenance Period (5 Weeks)|Adverse Event|1
4733595|NCT03452943|7679059|FG001|Maintenance Period (5 Weeks)|Adverse Event|0
4733596|NCT03452943|7679058|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2
4733597|NCT03452943|7679059|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0
4733598|NCT03453151|7679086|FG000|Overall Study|Withdrawal by Subject|1
4733599|NCT03453151|7679086|FG000|Overall Study|Physician Decision|3
4733600|NCT03454412|7679118|FG000|Baseline Assesment|Physician Decision|12
4733601|NCT03455543|7679160|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2
4733602|NCT03455543|7679161|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5
4733603|NCT03455543|7679162|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0
4733604|NCT03455543|7679160|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7
4733605|NCT03455543|7679161|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2
4733606|NCT03455543|7679162|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0
4733607|NCT03455543|7679160|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2
4733608|NCT03455543|7679161|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0
4733609|NCT03455543|7679162|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0
4733610|NCT03455543|7679160|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0
4733611|NCT03455543|7679161|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0
4733612|NCT03455543|7679162|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3
4733613|NCT03455543|7679160|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0
4733614|NCT03455543|7679161|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0
4733615|NCT03455543|7679162|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20
4733616|NCT03455543|7679160|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0
4733617|NCT03455543|7679161|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0
4733618|NCT03455543|7679162|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7
4733619|NCT03455543|7679160|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0
4733620|NCT03455543|7679161|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0
4590611|NCT01523587|7436779|FG001|Overall Study|Worsening of underlying cancer disease|34
4590612|NCT01523587|7436778|FG000|Overall Study|Adverse Event|68
4590613|NCT01523587|7436779|FG001|Overall Study|Adverse Event|52
4590614|NCT01523587|7436778|FG000|Overall Study|Protocol Violation|5
4590615|NCT01523587|7436779|FG001|Overall Study|Protocol Violation|3
4590616|NCT01523587|7436778|FG000|Overall Study|Lost to Follow-up|2
4590617|NCT01523587|7436779|FG001|Overall Study|Lost to Follow-up|2
4590618|NCT01523587|7436778|FG000|Overall Study|Withdrawal by Subject|28
4590619|NCT01523587|7436779|FG001|Overall Study|Withdrawal by Subject|20
4590620|NCT01523587|7436778|FG000|Overall Study|Withdrew due to Progressive disease|265
4590621|NCT01523587|7436779|FG001|Overall Study|Withdrew due to Progressive disease|279
4590622|NCT01523587|7436778|FG000|Overall Study|Randomised but bot treated|6
4590623|NCT01523587|7436779|FG001|Overall Study|Randomised but bot treated|2
4590624|NCT01523743|7436808|FG000|Period 1|Adverse Event|1
4590625|NCT01523743|7436809|FG001|Period 1|Adverse Event|0
4590626|NCT01523743|7436808|FG000|Period 1|Withdrawal by Subject|6
4590627|NCT01523743|7436809|FG001|Period 1|Withdrawal by Subject|2
4590628|NCT01523743|7436808|FG000|Period 1|Lost to Follow-up|1
4590629|NCT01523743|7436809|FG001|Period 1|Lost to Follow-up|0
4590630|NCT01523743|7436808|FG000|Period 1|Lack of Efficacy|1
4590631|NCT01523743|7436809|FG001|Period 1|Lack of Efficacy|0
4590632|NCT01523743|7436808|FG000|Period 1|Felt unable to empty bladder|1
4590633|NCT01523743|7436809|FG001|Period 1|Felt unable to empty bladder|0
4590634|NCT01523743|7436808|FG000|Period 2|Withdrawal by Subject|0
4590635|NCT01523743|7436809|FG001|Period 2|Withdrawal by Subject|2
4590636|NCT01523743|7436808|FG000|Period 2|Adverse Event|1
4590637|NCT01523743|7436809|FG001|Period 2|Adverse Event|0
4590638|NCT01523756|7436815|FG000|Baseline Period|Adverse Event|0
4590639|NCT01523756|7436816|FG001|Baseline Period|Adverse Event|1
4590640|NCT01523756|7436815|FG000|Test Period 1|Adverse Event|1
4590641|NCT01523756|7436816|FG001|Test Period 1|Adverse Event|0
4590642|NCT01523756|7436815|FG000|Test Period 2|Withdrawal by Subject|0
4590643|NCT01523756|7436816|FG001|Test Period 2|Withdrawal by Subject|1
4590644|NCT01523873|7436881|FG000|Overall Study|Protocol Violation|422
4590645|NCT01523886|7436889|FG000|Overall Study|surgery cancelled|0
4590646|NCT01523886|7436890|FG001|Overall Study|surgery cancelled|1
4590647|NCT01524133|7436926|FG000|Treatment Phase|Withdrawal by Subject|13
4590648|NCT01524133|7436927|FG001|Treatment Phase|Withdrawal by Subject|28
4590649|NCT01524133|7436928|FG002|Treatment Phase|Withdrawal by Subject|31
4590650|NCT01524133|7436926|FG000|Treatment Phase|Physician Decision|6
4590651|NCT01524133|7436927|FG001|Treatment Phase|Physician Decision|3
4590652|NCT01524133|7436928|FG002|Treatment Phase|Physician Decision|3
4590653|NCT01524133|7436926|FG000|Treatment Phase|Lost to Follow-up|0
4590654|NCT01524133|7436927|FG001|Treatment Phase|Lost to Follow-up|1
4590655|NCT01524133|7436928|FG002|Treatment Phase|Lost to Follow-up|2
4590656|NCT01524133|7436926|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4
4590657|NCT01524133|7436927|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5
4590658|NCT01524133|7436928|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10
4590659|NCT01524133|7436926|FG000|Overall Study 52 Weeks|Physician Decision|1
4590660|NCT01524133|7436927|FG001|Overall Study 52 Weeks|Physician Decision|0
4590661|NCT01524133|7436928|FG002|Overall Study 52 Weeks|Physician Decision|2
4590662|NCT01524133|7436926|FG000|Overall Study 52 Weeks|Lost to Follow-up|16
4590663|NCT01524133|7436927|FG001|Overall Study 52 Weeks|Lost to Follow-up|15
4590664|NCT01524133|7436928|FG002|Overall Study 52 Weeks|Lost to Follow-up|15
4590665|NCT01524198|7436938|FG000|Overall Study|Protocol Violation|8
4590666|NCT01524198|7436939|FG001|Overall Study|Protocol Violation|6
4590667|NCT01524198|7436938|FG000|Overall Study|Withdrawal by Subject|15
4590668|NCT01524198|7436939|FG001|Overall Study|Withdrawal by Subject|10
4590669|NCT01524224|7436953|FG000|Overall Study|Progressive Disease|1
4590670|NCT01524224|7436954|FG001|Overall Study|Progressive Disease|0
4590671|NCT01524224|7436955|FG002|Overall Study|Progressive Disease|2
4590672|NCT01524224|7436956|FG003|Overall Study|Progressive Disease|1
4590673|NCT01524224|7436957|FG004|Overall Study|Progressive Disease|2
4590674|NCT01524224|7436958|FG005|Overall Study|Progressive Disease|1
4590675|NCT01524224|7436959|FG006|Overall Study|Progressive Disease|1
4590676|NCT01524224|7436960|FG007|Overall Study|Progressive Disease|5
4590677|NCT01524224|7436953|FG000|Overall Study|Withdrawal by Subject|2
4590678|NCT01524224|7436954|FG001|Overall Study|Withdrawal by Subject|0
4590679|NCT01524224|7436955|FG002|Overall Study|Withdrawal by Subject|0
4590680|NCT01524224|7436956|FG003|Overall Study|Withdrawal by Subject|0
4590681|NCT01524224|7436957|FG004|Overall Study|Withdrawal by Subject|0
4590682|NCT01524224|7436958|FG005|Overall Study|Withdrawal by Subject|0
4590683|NCT01524224|7436959|FG006|Overall Study|Withdrawal by Subject|2
4590684|NCT01524224|7436960|FG007|Overall Study|Withdrawal by Subject|0
4590685|NCT01524224|7436953|FG000|Overall Study|Adverse Event|0
4590686|NCT01524224|7436954|FG001|Overall Study|Adverse Event|1
4590687|NCT01524224|7436955|FG002|Overall Study|Adverse Event|0
4590688|NCT01524224|7436956|FG003|Overall Study|Adverse Event|0
4590689|NCT01524224|7436957|FG004|Overall Study|Adverse Event|0
4733621|NCT03455543|7679162|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4
4733622|NCT03455543|7679160|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0
4733623|NCT03455543|7679161|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0
4733624|NCT03455543|7679162|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2
4733625|NCT03455543|7679160|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0
4733626|NCT03455543|7679161|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0
4733627|NCT03455543|7679162|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1
4733628|NCT03456856|7679179|FG000|Overall Study|Lost to Follow-up|2
4733629|NCT03456856|7679179|FG000|Overall Study|Withdrawal by Subject|1
4733630|NCT03456960|7679189|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
4733631|NCT03456960|7679190|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
4733632|NCT03456960|7679191|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1
4733633|NCT03456960|7679192|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2
4733634|NCT03456960|7679193|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
4733635|NCT03456960|7679194|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
4733636|NCT03456960|7679189|FG000|Period 2 (1 Day)|Adverse Event|1
4733637|NCT03456960|7679190|FG001|Period 2 (1 Day)|Adverse Event|0
4733638|NCT03456960|7679191|FG002|Period 2 (1 Day)|Adverse Event|0
4733639|NCT03456960|7679192|FG003|Period 2 (1 Day)|Adverse Event|1
4733640|NCT03456960|7679193|FG004|Period 2 (1 Day)|Adverse Event|0
4733641|NCT03456960|7679194|FG005|Period 2 (1 Day)|Adverse Event|0
4733642|NCT03457103|7679212|FG000|Overall Study|illness/hospitalization|4
4733643|NCT03457103|7679213|FG001|Overall Study|illness/hospitalization|2
4733644|NCT03457103|7679212|FG000|Overall Study|Lost to Follow-up|2
4733645|NCT03457103|7679213|FG001|Overall Study|Lost to Follow-up|1
4733646|NCT03457103|7679212|FG000|Overall Study|Withdrawal by Subject|1
4733647|NCT03457103|7679213|FG001|Overall Study|Withdrawal by Subject|2
4733648|NCT03457103|7679212|FG000|Overall Study|financial/ insurance issues|1
4733649|NCT03457103|7679213|FG001|Overall Study|financial/ insurance issues|1
4733650|NCT03457636|7679228|FG000|Overall Study|Lost to Follow-up|2
4733651|NCT03457727|7679236|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0
4733652|NCT03457727|7679237|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0
4733653|NCT03457727|7679238|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0
4733654|NCT03457727|7679239|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1
4733655|NCT03458702|7679275|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4
4733656|NCT03458702|7679276|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6
4733657|NCT03458702|7679275|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4
4733658|NCT03458702|7679276|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2
4733659|NCT03459040|7679286|FG000|Overall Study|Death|8
4733660|NCT03459040|7679286|FG000|Overall Study|Withdrawal by Subject|1
4733661|NCT03459196|7679298|FG000|Overall Study|Subject didn't receive study catheter|2
4733662|NCT03461146|7679359|FG000|Overall Study|Adverse Event|2
4733663|NCT03461146|7679359|FG000|Overall Study|Physician Decision|1
4733664|NCT03461289|7679363|FG000|Overall Study|Death|1
4733665|NCT03461757|7679369|FG000|Overall Study|Adverse Event|1
4733666|NCT03461757|7679370|FG001|Overall Study|Adverse Event|0
4733667|NCT03461757|7679369|FG000|Overall Study|Lost to Follow-up|13
4733668|NCT03461757|7679370|FG001|Overall Study|Lost to Follow-up|7
4733669|NCT03461757|7679369|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28
4733670|NCT03461757|7679370|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25
4733671|NCT03461757|7679369|FG000|Overall Study|Non-compliance with study treatment|0
4733672|NCT03461757|7679370|FG001|Overall Study|Non-compliance with study treatment|1
4733673|NCT03461757|7679369|FG000|Overall Study|Pregnancy|2
4733674|NCT03461757|7679370|FG001|Overall Study|Pregnancy|0
4733675|NCT03461757|7679369|FG000|Overall Study|Protocol Violation|1
4733676|NCT03461757|7679370|FG001|Overall Study|Protocol Violation|1
4733677|NCT03461757|7679369|FG000|Overall Study|Withdrawal by Subject|7
4733678|NCT03461757|7679370|FG001|Overall Study|Withdrawal by Subject|7
4733679|NCT03461757|7679369|FG000|Overall Study|Other Reasons|1
4733680|NCT03461757|7679370|FG001|Overall Study|Other Reasons|4
4733681|NCT03462082|7679385|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0
4733682|NCT03462082|7679386|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0
4733683|NCT03462082|7679387|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0
4733684|NCT03462082|7679388|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0
4733685|NCT03462082|7679389|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0
4733686|NCT03462082|7679390|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0
4733687|NCT03462082|7679391|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1
4733688|NCT03462082|7679392|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2
4733689|NCT03462576|7679405|FG000|Overall Study|Protocol Violation|5
4733690|NCT03462576|7679406|FG001|Overall Study|Protocol Violation|11
4733691|NCT03462576|7679407|FG002|Overall Study|Protocol Violation|7
4733692|NCT03462576|7679405|FG000|Overall Study|Device Malfunction|0
4733693|NCT03462576|7679406|FG001|Overall Study|Device Malfunction|0
4733694|NCT03462576|7679407|FG002|Overall Study|Device Malfunction|1
4733695|NCT03462680|7679417|FG000|Overall Study|Withdrawal by Subject|3
4733696|NCT03462680|7679418|FG001|Overall Study|Withdrawal by Subject|5
4733697|NCT03463031|7679446|FG000|Overall Study|Withdrawal by Subject|4
4733698|NCT03463031|7679447|FG001|Overall Study|Withdrawal by Subject|2
4733699|NCT03463031|7679446|FG000|Overall Study|Investigator/Sponsor Decision|0
4733700|NCT03463031|7679447|FG001|Overall Study|Investigator/Sponsor Decision|1
4733701|NCT03463031|7679446|FG000|Overall Study|Lost to Follow-up|1
4733702|NCT03463031|7679447|FG001|Overall Study|Lost to Follow-up|1
4733703|NCT03463031|7679446|FG000|Overall Study|Adverse Event|4
4733704|NCT03463031|7679447|FG001|Overall Study|Adverse Event|1
4733705|NCT03463031|7679446|FG000|Overall Study|Use of prohibited medication by subject|1
4733706|NCT03463031|7679447|FG001|Overall Study|Use of prohibited medication by subject|0
4737471|NCT03611582|7687664|FG001|Overall Study|Withdrawal by Subject|3
4737472|NCT03611582|7687663|FG000|Overall Study|Lost to Follow-up|18
4737473|NCT03611582|7687664|FG001|Overall Study|Lost to Follow-up|7
4737474|NCT03611582|7687663|FG000|Overall Study|other|17
4737475|NCT03611582|7687664|FG001|Overall Study|other|16
4737476|NCT03613129|7687696|FG000|Pre-treatment Assessment|Protocol Violation|2
4737477|NCT03613129|7687697|FG001|Pre-treatment Assessment|Protocol Violation|0
4737478|NCT03613129|7687698|FG002|Pre-treatment Assessment|Protocol Violation|0
4737479|NCT03613129|7687699|FG003|Pre-treatment Assessment|Protocol Violation|0
4737480|NCT03613129|7687700|FG004|Pre-treatment Assessment|Protocol Violation|0
4737481|NCT03613129|7687696|FG000|Pre-treatment Assessment|Withdrawal by Subject|1
4737482|NCT03613129|7687697|FG001|Pre-treatment Assessment|Withdrawal by Subject|0
4737483|NCT03613129|7687698|FG002|Pre-treatment Assessment|Withdrawal by Subject|0
4737484|NCT03613129|7687699|FG003|Pre-treatment Assessment|Withdrawal by Subject|0
4737485|NCT03613129|7687700|FG004|Pre-treatment Assessment|Withdrawal by Subject|0
4737486|NCT03613454|7687714|FG000|Overall Study|Protocol Violation|1
4737487|NCT03613454|7687715|FG001|Overall Study|Protocol Violation|0
4737488|NCT03613454|7687714|FG000|Overall Study|Protocol Violation|0
4737489|NCT03613454|7687715|FG001|Overall Study|Protocol Violation|1
4737490|NCT03613649|7687749|FG000|Second Treatment|Lost to Follow-up|0
4737491|NCT03613649|7687750|FG001|Second Treatment|Lost to Follow-up|0
4737492|NCT03613649|7687751|FG002|Second Treatment|Lost to Follow-up|1
4737493|NCT03613649|7687752|FG003|Second Treatment|Lost to Follow-up|0
4737494|NCT03613649|7687753|FG004|Second Treatment|Lost to Follow-up|0
4737495|NCT03613649|7687754|FG005|Second Treatment|Lost to Follow-up|0
4737496|NCT03613649|7687755|FG006|Second Treatment|Lost to Follow-up|0
4737497|NCT03613649|7687756|FG007|Second Treatment|Lost to Follow-up|0
4737498|NCT03613649|7687757|FG008|Second Treatment|Lost to Follow-up|0
4737499|NCT03613649|7687758|FG009|Second Treatment|Lost to Follow-up|0
4737500|NCT03613649|7687759|FG010|Second Treatment|Lost to Follow-up|0
4737501|NCT03613649|7687760|FG011|Second Treatment|Lost to Follow-up|0
4737502|NCT03613649|7687749|FG000|Second Treatment|Withdrawal by Subject|0
4737503|NCT03613649|7687750|FG001|Second Treatment|Withdrawal by Subject|0
4737504|NCT03613649|7687751|FG002|Second Treatment|Withdrawal by Subject|0
4733707|NCT03464383|7679489|FG000|Overall Study|Lost to Follow-up|1
4733708|NCT03464383|7679490|FG001|Overall Study|Lost to Follow-up|0
4733709|NCT03464383|7679491|FG002|Overall Study|Lost to Follow-up|0
4733710|NCT03464383|7679489|FG000|Overall Study|Withdrawal by Subject|0
4733711|NCT03464383|7679490|FG001|Overall Study|Withdrawal by Subject|1
4733712|NCT03464383|7679491|FG002|Overall Study|Withdrawal by Subject|0
4733713|NCT03464422|7679500|FG000|Overall Study|Lost to Follow-up|2
4733714|NCT03464422|7679500|FG000|Overall Study|Withdrawal by Subject|2
4733715|NCT03465436|7679510|FG000|Period 1|Protocol Violation|0
4733716|NCT03465436|7679511|FG001|Period 1|Protocol Violation|0
4733717|NCT03465436|7679512|FG002|Period 1|Protocol Violation|1
4733718|NCT03465436|7679513|FG003|Period 1|Protocol Violation|0
4733719|NCT03465436|7679510|FG000|Period 2|Protocol Violation|0
4733720|NCT03465436|7679511|FG001|Period 2|Protocol Violation|1
4733721|NCT03465436|7679512|FG002|Period 2|Protocol Violation|0
4733722|NCT03465436|7679513|FG003|Period 2|Protocol Violation|0
4733723|NCT03465436|7679510|FG000|Period 3|Protocol Violation|1
4733724|NCT03465436|7679511|FG001|Period 3|Protocol Violation|1
4733725|NCT03465436|7679512|FG002|Period 3|Protocol Violation|0
4733726|NCT03465436|7679513|FG003|Period 3|Protocol Violation|0
4733727|NCT03465436|7679510|FG000|Period 4|Protocol Violation|0
4733728|NCT03465436|7679511|FG001|Period 4|Protocol Violation|0
4733729|NCT03465436|7679512|FG002|Period 4|Protocol Violation|1
4733730|NCT03465436|7679513|FG003|Period 4|Protocol Violation|0
4733731|NCT03465709|7679525|FG000|Overall Study|Study/Site Terminated by Sponsor|14
4733732|NCT03465709|7679525|FG000|Overall Study|Withdrawal by Subject|3
4733733|NCT03465722|7679533|FG000|End of Treatment|Patient Refused Treatment|3
4733734|NCT03465722|7679534|FG001|End of Treatment|Patient Refused Treatment|1
4733735|NCT03465722|7679533|FG000|End of Treatment|Withdrawal by Subject|6
4733736|NCT03465722|7679534|FG001|End of Treatment|Withdrawal by Subject|1
4733737|NCT03465722|7679533|FG000|End of Treatment|Adverse Event|30
4733738|NCT03465722|7679534|FG001|End of Treatment|Adverse Event|23
4632092|NCT01899053|7501759|FG005|Overall Study|Progressive Disease|1
4632093|NCT01899053|7501760|FG006|Overall Study|Progressive Disease|1
4632094|NCT01899053|7501761|FG007|Overall Study|Progressive Disease|1
4733739|NCT03465722|7679533|FG000|End of Treatment|Disease Progression (Confirmed by Central Review)|102
4733740|NCT03465722|7679534|FG001|End of Treatment|Disease Progression (Confirmed by Central Review)|101
4733741|NCT03465722|7679533|FG000|End of Treatment|Clinical Progression|17
4733742|NCT03465722|7679534|FG001|End of Treatment|Clinical Progression|5
4733743|NCT03465722|7679533|FG000|End of Treatment|Physician Decision|4
4733744|NCT03465722|7679534|FG001|End of Treatment|Physician Decision|5
4733745|NCT03465722|7679533|FG000|End of Treatment|Lost to Follow-up|3
4733746|NCT03465722|7679534|FG001|End of Treatment|Lost to Follow-up|1
4733747|NCT03465722|7679533|FG000|End of Treatment|Administrative/Other|6
4733748|NCT03465722|7679534|FG001|End of Treatment|Administrative/Other|3
4733749|NCT03465722|7679533|FG000|End of Treatment|Treatment Ongoing|68
4733750|NCT03465722|7679534|FG001|End of Treatment|Treatment Ongoing|94
4733751|NCT03465722|7679533|FG000|End of Treatment|Randomized But Not Treated|1
4733752|NCT03465722|7679534|FG001|End of Treatment|Randomized But Not Treated|2
4733753|NCT03465722|7679533|FG000|End of Study|Withdrawal by Subject|17
4733754|NCT03465722|7679534|FG001|End of Study|Withdrawal by Subject|7
4733755|NCT03465722|7679533|FG000|End of Study|Death|57
4632095|NCT01899053|7501762|FG008|Overall Study|Progressive Disease|4
4733756|NCT03465722|7679534|FG001|End of Study|Death|57
4733757|NCT03465722|7679533|FG000|End of Study|Lost to Follow-up|5
4733758|NCT03465722|7679534|FG001|End of Study|Lost to Follow-up|2
4733759|NCT03465722|7679533|FG000|End of Study|Administrative/Other|4
4733760|NCT03465722|7679534|FG001|End of Study|Administrative/Other|2
4733761|NCT03465722|7679533|FG000|End of Study|On Treatment or in Follow Up|157
4733762|NCT03465722|7679534|FG001|End of Study|On Treatment or in Follow Up|168
4733763|NCT03465878|7679542|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0
4733764|NCT03465878|7679543|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1
4733765|NCT03465878|7679544|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0
4733766|NCT03465878|7679545|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0
4733767|NCT03465878|7679542|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0
4733768|NCT03465878|7679543|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0
4733769|NCT03465878|7679544|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0
4733770|NCT03465878|7679545|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1
4733771|NCT03465878|7679542|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0
4632096|NCT01899053|7501763|FG009|Overall Study|Progressive Disease|3
4632097|NCT01899053|7501764|FG010|Overall Study|Progressive Disease|12
4632098|NCT01899053|7501765|FG011|Overall Study|Progressive Disease|5
4632099|NCT01899053|7501766|FG012|Overall Study|Progressive Disease|8
4632100|NCT01899053|7501767|FG013|Overall Study|Progressive Disease|17
4632101|NCT01899053|7501754|FG000|Overall Study|Adverse Event|1
4733772|NCT03465878|7679543|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0
4733773|NCT03465878|7679544|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0
4733774|NCT03465878|7679545|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1
4733775|NCT03465904|7679573|FG000|Overall Study|Withdrawal by Subject|9
4733776|NCT03465904|7679574|FG001|Overall Study|Withdrawal by Subject|5
4733777|NCT03465904|7679573|FG000|Overall Study|Lost to Follow-up|10
4733778|NCT03465904|7679574|FG001|Overall Study|Lost to Follow-up|9
4733779|NCT03465904|7679573|FG000|Overall Study|Protocol Violation|8
4733780|NCT03465904|7679574|FG001|Overall Study|Protocol Violation|5
4733781|NCT03465904|7679573|FG000|Overall Study|Ineligible for mITT analysis|62
4733782|NCT03465904|7679574|FG001|Overall Study|Ineligible for mITT analysis|47
4733783|NCT03466060|7679609|FG000|Period 1|Test Lens Damage|0
4733784|NCT03466060|7679610|FG001|Period 1|Test Lens Damage|2
4733785|NCT03466060|7679611|FG002|Period 1|Test Lens Damage|0
4733786|NCT03466060|7679612|FG003|Period 1|Test Lens Damage|0
4632102|NCT01899053|7501755|FG001|Overall Study|Adverse Event|1
4632103|NCT01899053|7501756|FG002|Overall Study|Adverse Event|1
4632104|NCT01899053|7501757|FG003|Overall Study|Adverse Event|3
4632105|NCT01899053|7501758|FG004|Overall Study|Adverse Event|1
4632106|NCT01899053|7501759|FG005|Overall Study|Adverse Event|1
4632107|NCT01899053|7501760|FG006|Overall Study|Adverse Event|1
4632108|NCT01899053|7501761|FG007|Overall Study|Adverse Event|0
4632109|NCT01899053|7501762|FG008|Overall Study|Adverse Event|2
4632110|NCT01899053|7501763|FG009|Overall Study|Adverse Event|0
4632111|NCT01899053|7501764|FG010|Overall Study|Adverse Event|3
4632112|NCT01899053|7501765|FG011|Overall Study|Adverse Event|1
4632113|NCT01899053|7501766|FG012|Overall Study|Adverse Event|2
4632114|NCT01899053|7501767|FG013|Overall Study|Adverse Event|2
4632115|NCT01899053|7501754|FG000|Overall Study|Reason Not Specified|0
4733787|NCT03466060|7679613|FG004|Period 1|Test Lens Damage|0
4733788|NCT03466060|7679614|FG005|Period 1|Test Lens Damage|0
4632116|NCT01899053|7501755|FG001|Overall Study|Reason Not Specified|0
4632117|NCT01899053|7501756|FG002|Overall Study|Reason Not Specified|0
4733789|NCT03466060|7679609|FG000|Period 1|Withdrawal by Subject|0
4733790|NCT03466060|7679610|FG001|Period 1|Withdrawal by Subject|0
4733791|NCT03466060|7679611|FG002|Period 1|Withdrawal by Subject|2
4733792|NCT03466060|7679612|FG003|Period 1|Withdrawal by Subject|0
4733793|NCT03466060|7679613|FG004|Period 1|Withdrawal by Subject|0
4733794|NCT03466060|7679614|FG005|Period 1|Withdrawal by Subject|0
4733795|NCT03466060|7679609|FG000|Period 1|Lost to Follow-up|0
4733796|NCT03466060|7679610|FG001|Period 1|Lost to Follow-up|0
4733797|NCT03466060|7679611|FG002|Period 1|Lost to Follow-up|0
4733798|NCT03466060|7679612|FG003|Period 1|Lost to Follow-up|1
4733799|NCT03466060|7679613|FG004|Period 1|Lost to Follow-up|0
4733800|NCT03466060|7679614|FG005|Period 1|Lost to Follow-up|0
4733801|NCT03466060|7679609|FG000|Period 1|Grade 2 Conjunctivitis|0
4733802|NCT03466060|7679610|FG001|Period 1|Grade 2 Conjunctivitis|0
4733803|NCT03466060|7679611|FG002|Period 1|Grade 2 Conjunctivitis|1
4733804|NCT03466060|7679612|FG003|Period 1|Grade 2 Conjunctivitis|0
4733805|NCT03466060|7679613|FG004|Period 1|Grade 2 Conjunctivitis|0
4733806|NCT03466060|7679614|FG005|Period 1|Grade 2 Conjunctivitis|0
4733807|NCT03466060|7679609|FG000|Period 2|Lens Handling Difficulties|0
4733808|NCT03466060|7679610|FG001|Period 2|Lens Handling Difficulties|0
4733809|NCT03466060|7679611|FG002|Period 2|Lens Handling Difficulties|1
4733810|NCT03466060|7679612|FG003|Period 2|Lens Handling Difficulties|0
4733811|NCT03466060|7679613|FG004|Period 2|Lens Handling Difficulties|0
4733812|NCT03466060|7679614|FG005|Period 2|Lens Handling Difficulties|0
4733813|NCT03466073|7679634|FG000|Overall Study|Death|1
4733814|NCT03466073|7679635|FG001|Overall Study|Death|0
4733815|NCT03466073|7679636|FG002|Overall Study|Death|0
4733816|NCT03466073|7679637|FG003|Overall Study|Death|0
4733817|NCT03466073|7679638|FG004|Overall Study|Death|0
4733818|NCT03466073|7679639|FG005|Overall Study|Death|1
4733819|NCT03466086|7679660|FG000|Period 1|Sponsor decision due to study timeline|1
4733820|NCT03466086|7679661|FG001|Period 1|Sponsor decision due to study timeline|0
4733821|NCT03466086|7679660|FG000|Period 1|Withdrawal by Subject|1
4733822|NCT03466086|7679661|FG001|Period 1|Withdrawal by Subject|0
4733823|NCT03466099|7679670|FG000|Overall Study|Adverse Event|1
4733824|NCT03466099|7679671|FG001|Overall Study|Adverse Event|1
4733825|NCT03466099|7679672|FG002|Overall Study|Adverse Event|1
4733826|NCT03466099|7679670|FG000|Overall Study|Withdrawal by Subject|2
4733827|NCT03466099|7679671|FG001|Overall Study|Withdrawal by Subject|3
4733828|NCT03466099|7679672|FG002|Overall Study|Withdrawal by Subject|1
4733829|NCT03466099|7679670|FG000|Overall Study|Use of rescue medication|8
4733830|NCT03466099|7679671|FG001|Overall Study|Use of rescue medication|9
4733831|NCT03466099|7679672|FG002|Overall Study|Use of rescue medication|13
4733832|NCT03466099|7679670|FG000|Overall Study|Rescued without meeting criteria|4
4733833|NCT03466099|7679671|FG001|Overall Study|Rescued without meeting criteria|1
4733834|NCT03466099|7679672|FG002|Overall Study|Rescued without meeting criteria|1
4733835|NCT03466099|7679670|FG000|Overall Study|Subject compliance|2
4733836|NCT03466099|7679671|FG001|Overall Study|Subject compliance|0
4733837|NCT03466099|7679672|FG002|Overall Study|Subject compliance|0
4733838|NCT03466099|7679670|FG000|Overall Study|Worsening disease|0
4733839|NCT03466099|7679671|FG001|Overall Study|Worsening disease|0
4632118|NCT01899053|7501757|FG003|Overall Study|Reason Not Specified|0
4632119|NCT01899053|7501758|FG004|Overall Study|Reason Not Specified|0
4632120|NCT01899053|7501759|FG005|Overall Study|Reason Not Specified|0
4632121|NCT01899053|7501760|FG006|Overall Study|Reason Not Specified|1
4632122|NCT01899053|7501761|FG007|Overall Study|Reason Not Specified|0
4632123|NCT01899053|7501762|FG008|Overall Study|Reason Not Specified|0
4632124|NCT01899053|7501763|FG009|Overall Study|Reason Not Specified|0
4733840|NCT03466099|7679672|FG002|Overall Study|Worsening disease|1
4733841|NCT03467217|7679696|FG000|Overall Study|Trial stopped early|5
4733842|NCT03467217|7679697|FG001|Overall Study|Trial stopped early|2
4733843|NCT03467217|7679696|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5
4733844|NCT03467217|7679697|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2
4733845|NCT03467217|7679696|FG000|Overall Study|Lost to Follow-up|0
4733846|NCT03467217|7679697|FG001|Overall Study|Lost to Follow-up|2
4733847|NCT03467425|7679728|FG000|Overall Study|Adverse Event|9
4733848|NCT03467425|7679729|FG001|Overall Study|Adverse Event|9
4733849|NCT03467425|7679728|FG000|Overall Study|Lack of Efficacy|3
4733850|NCT03467425|7679729|FG001|Overall Study|Lack of Efficacy|1
4733851|NCT03467425|7679728|FG000|Overall Study|Protocol Violation|0
4733852|NCT03467425|7679729|FG001|Overall Study|Protocol Violation|1
4733853|NCT03467425|7679728|FG000|Overall Study|Lost to Follow-up|18
4733854|NCT03467425|7679729|FG001|Overall Study|Lost to Follow-up|25
4733855|NCT03467425|7679728|FG000|Overall Study|Physician Decision|2
4733856|NCT03467425|7679729|FG001|Overall Study|Physician Decision|1
4733857|NCT03467425|7679728|FG000|Overall Study|Withdrawal by Subject|15
4733858|NCT03467425|7679729|FG001|Overall Study|Withdrawal by Subject|17
4733859|NCT03467763|7679751|FG000|Overall Study|Lost to Follow-up|1
4733860|NCT03467763|7679751|FG000|Overall Study|Protocol Violation|2
4733861|NCT03467945|7679761|FG000|Treatment Period 2|Withdrawal by Subject|0
4733862|NCT03467945|7679762|FG001|Treatment Period 2|Withdrawal by Subject|1
4733863|NCT03467945|7679763|FG002|Treatment Period 2|Withdrawal by Subject|0
4733864|NCT03467945|7679764|FG003|Treatment Period 2|Withdrawal by Subject|0
4733865|NCT03467945|7679761|FG000|Treatment Period 3|Withdrawal by Subject|1
4733866|NCT03467945|7679762|FG001|Treatment Period 3|Withdrawal by Subject|0
4515674|NCT00955357|7326681|FG000|Titration Phase|Protocol Violation|3
4733867|NCT03467945|7679763|FG002|Treatment Period 3|Withdrawal by Subject|2
4733868|NCT03467945|7679764|FG003|Treatment Period 3|Withdrawal by Subject|1
4733869|NCT03467971|7679777|FG000|Treatment Period 2|Withdrawal by Subject|0
4733870|NCT03467971|7679778|FG001|Treatment Period 2|Withdrawal by Subject|1
4733871|NCT03468543|7679796|FG000|Overall Study|Protocol stopping rules met|3
4733872|NCT03468855|7679811|FG000|Overall Study|Adverse Event|2
4733873|NCT03468855|7679811|FG000|Overall Study|Lost to Follow-up|5
4733874|NCT03468855|7679811|FG000|Overall Study|Withdrawal by Subject|3
4733875|NCT03468855|7679811|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1
4733876|NCT03469336|7679833|FG000|Overall Study|Adverse Event|1
4733877|NCT03469349|7679845|FG000|Overall Study|Withdrawal by Subject|1
4733878|NCT03469349|7679846|FG001|Overall Study|Withdrawal by Subject|3
4733879|NCT03469349|7679845|FG000|Overall Study|Progressive Disease|0
4733880|NCT03469349|7679846|FG001|Overall Study|Progressive Disease|1
4733881|NCT03469349|7679845|FG000|Overall Study|Lost to Follow-up|2
4733882|NCT03469349|7679846|FG001|Overall Study|Lost to Follow-up|2
4733883|NCT03469349|7679845|FG000|Overall Study|Adverse Event|2
4733884|NCT03469349|7679846|FG001|Overall Study|Adverse Event|4
4733885|NCT03470194|7679858|FG000|Overall Study|Lost to Follow-up|11
4733886|NCT03470194|7679859|FG001|Overall Study|Lost to Follow-up|17
4733887|NCT03470545|7679871|FG000|Overall Study|Death|0
4733888|NCT03470545|7679872|FG001|Overall Study|Death|1
4733889|NCT03470545|7679871|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1
4733890|NCT03470545|7679872|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0
4733891|NCT03470545|7679871|FG000|Overall Study|Adverse Event|2
4733892|NCT03470545|7679872|FG001|Overall Study|Adverse Event|0
4733893|NCT03470545|7679871|FG000|Overall Study|Withdrawal by Subject|1
4733894|NCT03470545|7679872|FG001|Overall Study|Withdrawal by Subject|1
4733895|NCT03470545|7679871|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0
4733896|NCT03470545|7679872|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1
4733897|NCT03471078|7679895|FG000|Overall Study|Withdrawal by Subject|9
4733898|NCT03471078|7679896|FG001|Overall Study|Withdrawal by Subject|1
4733899|NCT03471078|7679895|FG000|Overall Study|Adverse Event|4
4733900|NCT03471078|7679896|FG001|Overall Study|Adverse Event|1
4733901|NCT03471078|7679895|FG000|Overall Study|Physician Decision|3
4733902|NCT03471078|7679896|FG001|Overall Study|Physician Decision|2
4733903|NCT03471078|7679895|FG000|Overall Study|Death|2
4733904|NCT03471078|7679896|FG001|Overall Study|Death|0
4733905|NCT03471078|7679895|FG000|Overall Study|Other|3
4733906|NCT03471078|7679896|FG001|Overall Study|Other|2
4733907|NCT03471871|7679913|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0
4733908|NCT03471871|7679914|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0
4733909|NCT03471871|7679915|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1
4733910|NCT03471871|7679916|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0
4733911|NCT03471871|7679917|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0
4733912|NCT03471871|7679913|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0
4733913|NCT03471871|7679914|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0
4733914|NCT03471871|7679915|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0
4733915|NCT03471871|7679916|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1
4733916|NCT03471871|7679917|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1
4733917|NCT03471871|7679913|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0
4733918|NCT03471871|7679914|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0
4733919|NCT03471871|7679915|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0
4733920|NCT03471871|7679916|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0
4733921|NCT03471871|7679917|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1
4733922|NCT03471871|7679913|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0
4733923|NCT03471871|7679914|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0
4733924|NCT03471871|7679915|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0
4733925|NCT03471871|7679916|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0
4733926|NCT03471871|7679917|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1
4733927|NCT03471871|7679913|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0
4733928|NCT03471871|7679914|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0
4733929|NCT03471871|7679915|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0
4733930|NCT03471871|7679916|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1
4733931|NCT03471871|7679917|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0
4733932|NCT03472014|7679938|FG000|Overall Study|Lost to Follow-up|4
4733933|NCT03472326|7679953|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0
4733934|NCT03472326|7679954|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0
4733935|NCT03472326|7679955|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1
4733936|NCT03472326|7679956|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2
4733937|NCT03472326|7679953|FG000|Part 2: Combination Therapy|Pregnancy|0
4733938|NCT03472326|7679954|FG001|Part 2: Combination Therapy|Pregnancy|0
4733939|NCT03472326|7679955|FG002|Part 2: Combination Therapy|Pregnancy|0
4733940|NCT03472326|7679956|FG003|Part 2: Combination Therapy|Pregnancy|1
4733941|NCT03472521|7679976|FG000|Overall Study|Lost to Follow-up|3
4733942|NCT03472521|7679977|FG001|Overall Study|Lost to Follow-up|2
4733943|NCT03472521|7679976|FG000|Overall Study|Discontinued intervention|3
4733944|NCT03472521|7679977|FG001|Overall Study|Discontinued intervention|1
4733945|NCT03472534|7679983|FG000|Overall Study|Withdrawal by Subject|9
4733946|NCT03472534|7679983|FG000|Overall Study|Adverse Event|2
4733947|NCT03472547|7679987|FG000|Overall Study|Withdrawal by Subject|30
4733948|NCT03473197|7679999|FG000|Overall Study|Adverse Event|4
4733949|NCT03473197|7679999|FG000|Overall Study|Lost to Follow-up|1
4733950|NCT03473197|7679999|FG000|Overall Study|Withdrawal by Subject|5
4733951|NCT03473236|7680013|FG000|Overall Study|Withdrawal by Subject|0
4733952|NCT03473236|7680014|FG001|Overall Study|Withdrawal by Subject|0
4733953|NCT03473236|7680015|FG002|Overall Study|Withdrawal by Subject|0
4733954|NCT03473236|7680016|FG003|Overall Study|Withdrawal by Subject|0
4733955|NCT03473236|7680017|FG004|Overall Study|Withdrawal by Subject|0
4733956|NCT03473236|7680018|FG005|Overall Study|Withdrawal by Subject|1
4733957|NCT03473236|7680019|FG006|Overall Study|Withdrawal by Subject|0
4733958|NCT03473236|7680020|FG007|Overall Study|Withdrawal by Subject|0
4733959|NCT03473236|7680021|FG008|Overall Study|Withdrawal by Subject|1
4733960|NCT03473236|7680022|FG009|Overall Study|Withdrawal by Subject|0
4733961|NCT03473301|7680055|FG000|Overall Study|Protocol Violation|4
4733962|NCT03473301|7680056|FG001|Overall Study|Protocol Violation|0
4733963|NCT03473301|7680057|FG002|Overall Study|Protocol Violation|0
4733964|NCT03473301|7680055|FG000|Overall Study|Withdrawal by Subject|0
4733965|NCT03473301|7680056|FG001|Overall Study|Withdrawal by Subject|1
4733966|NCT03473301|7680057|FG002|Overall Study|Withdrawal by Subject|0
4733967|NCT03473301|7680055|FG000|Overall Study|Missed study visit due to pandemic restrictions|7
4733968|NCT03473301|7680056|FG001|Overall Study|Missed study visit due to pandemic restrictions|5
4733969|NCT03473301|7680057|FG002|Overall Study|Missed study visit due to pandemic restrictions|6
4733970|NCT03473808|7680076|FG000|Overall Study|Withdrawal by Subject|1
4733971|NCT03474081|7680086|FG000|Overall Study|Adverse Event|6
4733972|NCT03474081|7680087|FG001|Overall Study|Adverse Event|3
4733973|NCT03474081|7680086|FG000|Overall Study|Lost to Follow-up|2
4733974|NCT03474081|7680087|FG001|Overall Study|Lost to Follow-up|1
4733975|NCT03474081|7680086|FG000|Overall Study|Physician Decision|3
4733976|NCT03474081|7680087|FG001|Overall Study|Physician Decision|2
4733977|NCT03474081|7680086|FG000|Overall Study|Withdrawal by Subject|5
4733978|NCT03474081|7680087|FG001|Overall Study|Withdrawal by Subject|7
4733979|NCT03474081|7680086|FG000|Overall Study|Investigator site closed|1
4733980|NCT03474081|7680087|FG001|Overall Study|Investigator site closed|0
4733981|NCT03475056|7680117|FG000|Overall Study|Lost to Follow-up|0
4733982|NCT03475056|7680118|FG001|Overall Study|Lost to Follow-up|1
4733983|NCT03475056|7680117|FG000|Overall Study|Moved from Area|0
4733984|NCT03475056|7680118|FG001|Overall Study|Moved from Area|2
4733985|NCT03475316|7680127|FG000|6 Month Intervention|Adverse Event|2
4733986|NCT03475316|7680128|FG001|6 Month Intervention|Adverse Event|1
4733987|NCT03475316|7680127|FG000|6 Month Intervention|Withdrawal by Subject|2
4733988|NCT03475316|7680128|FG001|6 Month Intervention|Withdrawal by Subject|0
4733989|NCT03475316|7680127|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1
4733990|NCT03475316|7680128|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3
4733991|NCT03475316|7680127|FG000|9 Months|Study stopped due to COVID pandemic|3
4733992|NCT03475316|7680128|FG001|9 Months|Study stopped due to COVID pandemic|4
4733993|NCT03475875|7680134|FG000|Period 1|Lost to Follow-up|1
4733994|NCT03475875|7680135|FG001|Period 1|Lost to Follow-up|0
4733995|NCT03475875|7680134|FG000|Period 1|Adverse Event|2
4733996|NCT03475875|7680135|FG001|Period 1|Adverse Event|1
4733997|NCT03475875|7680134|FG000|Period 2|Adverse Event|3
4733998|NCT03475875|7680135|FG001|Period 2|Adverse Event|0
4733999|NCT03475875|7680134|FG000|Period 2|Protocol Violation|0
4734000|NCT03475875|7680135|FG001|Period 2|Protocol Violation|1
4734001|NCT03476798|7680168|FG000|Overall Study|Death|1
4734002|NCT03476798|7680168|FG000|Overall Study|Withdrawal by Subject|2
4734003|NCT03476798|7680168|FG000|Overall Study|Protocol Violation|2
4734004|NCT03477838|7680212|FG000|Overall Study|Lost to Follow-up|14
4734005|NCT03478371|7680230|FG000|Overall Study|non-compliance|1
4734006|NCT03478371|7680230|FG000|Overall Study|Lost to Follow-up|4
4734007|NCT03478644|7680242|FG000|Phase 2|Withdrawal by Subject|2
4734008|NCT03478644|7680243|FG001|Phase 2|Withdrawal by Subject|1
4734009|NCT03478644|7680242|FG000|Phase 2|Lost to Follow-up|1
4734010|NCT03478644|7680243|FG001|Phase 2|Lost to Follow-up|0
4734011|NCT03478657|7680251|FG000|Overall Study|Withdrawal by Subject|0
4734012|NCT03478657|7680252|FG001|Overall Study|Withdrawal by Subject|1
4734013|NCT03478683|7680260|FG000|Overall Study|Adverse Event|5
4734014|NCT03478683|7680261|FG001|Overall Study|Adverse Event|3
4734015|NCT03478683|7680260|FG000|Overall Study|Lost to Follow-up|0
4734016|NCT03478683|7680261|FG001|Overall Study|Lost to Follow-up|5
4734017|NCT03478683|7680260|FG000|Overall Study|Physician Decision|1
4734018|NCT03478683|7680261|FG001|Overall Study|Physician Decision|3
4734019|NCT03478683|7680260|FG000|Overall Study|Withdrawal by Subject|7
4734020|NCT03478683|7680261|FG001|Overall Study|Withdrawal by Subject|7
4734021|NCT03478696|7680269|FG000|Overall Study|Adverse Event|1
4734022|NCT03478696|7680270|FG001|Overall Study|Adverse Event|5
4734023|NCT03478696|7680269|FG000|Overall Study|Lost to Follow-up|1
4734024|NCT03478696|7680270|FG001|Overall Study|Lost to Follow-up|0
4734025|NCT03478696|7680269|FG000|Overall Study|Physician Decision|6
4734026|NCT03478696|7680270|FG001|Overall Study|Physician Decision|3
4734027|NCT03478696|7680269|FG000|Overall Study|Withdrawal by Subject|9
4734028|NCT03478696|7680270|FG001|Overall Study|Withdrawal by Subject|4
4734029|NCT03478787|7680278|FG000|Overall Study|Adverse Event|5
4734030|NCT03478787|7680279|FG001|Overall Study|Adverse Event|1
4734031|NCT03478787|7680278|FG000|Overall Study|Protocol Violation|3
4734032|NCT03478787|7680279|FG001|Overall Study|Protocol Violation|0
4734033|NCT03478787|7680278|FG000|Overall Study|Lack of Efficacy|7
4734034|NCT03478787|7680279|FG001|Overall Study|Lack of Efficacy|1
4734035|NCT03478787|7680278|FG000|Overall Study|Lost to Follow-up|9
4734036|NCT03478787|7680279|FG001|Overall Study|Lost to Follow-up|5
4734037|NCT03478787|7680278|FG000|Overall Study|Withdrawal by Subject|2
4734038|NCT03478787|7680279|FG001|Overall Study|Withdrawal by Subject|6
4734039|NCT03478787|7680278|FG000|Overall Study|Other, Not Specified|3
4734040|NCT03478787|7680279|FG001|Overall Study|Other, Not Specified|0
4734041|NCT03478891|7680288|FG000|Overall Study|Enrolled, but product never administered|0
4734042|NCT03478891|7680289|FG001|Overall Study|Enrolled, but product never administered|0
4734043|NCT03478891|7680290|FG002|Overall Study|Enrolled, but product never administered|1
4734044|NCT03478891|7680288|FG000|Overall Study|Moved from area|0
4734045|NCT03478891|7680289|FG001|Overall Study|Moved from area|0
4734046|NCT03478891|7680290|FG002|Overall Study|Moved from area|1
4734047|NCT03478891|7680288|FG000|Overall Study|Lost to Follow-up|1
4734048|NCT03478891|7680289|FG001|Overall Study|Lost to Follow-up|0
4734049|NCT03478891|7680290|FG002|Overall Study|Lost to Follow-up|1
4734050|NCT03478969|7680316|FG000|Overall Study|Withdrawal by Subject|4
4734051|NCT03478969|7680317|FG001|Overall Study|Withdrawal by Subject|7
4734052|NCT03478969|7680318|FG002|Overall Study|Withdrawal by Subject|6
4734053|NCT03478969|7680316|FG000|Overall Study|Adverse Event|2
4734054|NCT03478969|7680317|FG001|Overall Study|Adverse Event|0
4734055|NCT03478969|7680318|FG002|Overall Study|Adverse Event|1
4734056|NCT03478969|7680316|FG000|Overall Study|Pregnancy|1
4734057|NCT03478969|7680317|FG001|Overall Study|Pregnancy|0
4734058|NCT03478969|7680318|FG002|Overall Study|Pregnancy|0
4734059|NCT03478969|7680316|FG000|Overall Study|Personal Reasons|1
4734060|NCT03478969|7680317|FG001|Overall Study|Personal Reasons|0
4734061|NCT03478969|7680318|FG002|Overall Study|Personal Reasons|1
4734062|NCT03478969|7680316|FG000|Overall Study|Covid-19|1
4734063|NCT03478969|7680317|FG001|Overall Study|Covid-19|4
4734064|NCT03478969|7680318|FG002|Overall Study|Covid-19|3
4734065|NCT03478969|7680316|FG000|Overall Study|Multiple Reasons|0
4734066|NCT03478969|7680317|FG001|Overall Study|Multiple Reasons|1
4734067|NCT03478969|7680318|FG002|Overall Study|Multiple Reasons|1
4734068|NCT03478969|7680316|FG000|Overall Study|Eligibility Criteria|0
4734069|NCT03478969|7680317|FG001|Overall Study|Eligibility Criteria|0
4734070|NCT03478969|7680318|FG002|Overall Study|Eligibility Criteria|5
4734071|NCT03478969|7680316|FG000|Overall Study|Lost to Follow-up|0
4734072|NCT03478969|7680317|FG001|Overall Study|Lost to Follow-up|0
4734073|NCT03478969|7680318|FG002|Overall Study|Lost to Follow-up|1
4734074|NCT03479216|7680347|FG000|Overall Study|Withdrawal by Subject|3
4734075|NCT03479216|7680348|FG001|Overall Study|Withdrawal by Subject|2
4734076|NCT03479216|7680347|FG000|Overall Study|Physician Decision|2
4734077|NCT03479216|7680348|FG001|Overall Study|Physician Decision|3
4734078|NCT03480009|7680366|FG000|Overall Study|Lost to Follow-up|4
4734079|NCT03480009|7680367|FG001|Overall Study|Lost to Follow-up|5
4734080|NCT03480009|7680368|FG002|Overall Study|Lost to Follow-up|4
4734081|NCT03480009|7680369|FG003|Overall Study|Lost to Follow-up|0
4734082|NCT03480022|7680384|FG000|Overall Study|Pregnancy|2
4734083|NCT03480022|7680385|FG001|Overall Study|Pregnancy|0
4734084|NCT03480022|7680384|FG000|Overall Study|Adverse Event|6
4734085|NCT03480022|7680385|FG001|Overall Study|Adverse Event|0
4734086|NCT03480022|7680384|FG000|Overall Study|Lack of Efficacy|0
4515675|NCT00955357|7326682|FG001|Titration Phase|Protocol Violation|7
4515676|NCT00955357|7326681|FG000|Titration Phase|Lost to Follow-up|1
4515677|NCT00955357|7326682|FG001|Titration Phase|Lost to Follow-up|3
4734087|NCT03480022|7680385|FG001|Overall Study|Lack of Efficacy|2
4734088|NCT03480022|7680384|FG000|Overall Study|Physician Decision|0
4734089|NCT03480022|7680385|FG001|Overall Study|Physician Decision|1
4734090|NCT03480022|7680384|FG000|Overall Study|Withdrawal by Subject|2
4734091|NCT03480022|7680385|FG001|Overall Study|Withdrawal by Subject|0
4734092|NCT03480022|7680384|FG000|Overall Study|Medication concerns|1
4734093|NCT03480022|7680385|FG001|Overall Study|Medication concerns|0
4734094|NCT03480022|7680384|FG000|Overall Study|Family member COVID exposure|0
4734095|NCT03480022|7680385|FG001|Overall Study|Family member COVID exposure|1
4734096|NCT03480152|7680402|FG000|Phase I|Signed consent. Died before treatment.|1
4734097|NCT03480152|7680403|FG001|Phase I|Signed consent. Died before treatment.|0
4734098|NCT03480152|7680404|FG002|Phase I|Signed consent. Died before treatment.|0
4734099|NCT03480243|7680412|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1
4734100|NCT03480243|7680412|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1
4734101|NCT03480425|7680425|FG000|Overall Study|Force transducer technical failure|1
4734102|NCT03480750|7680441|FG000|Overall Study|Withdrawal by Subject|0
4734103|NCT03480750|7680442|FG001|Overall Study|Withdrawal by Subject|1
4632125|NCT01899053|7501764|FG010|Overall Study|Reason Not Specified|0
4632126|NCT01899053|7501765|FG011|Overall Study|Reason Not Specified|0
4632127|NCT01899053|7501766|FG012|Overall Study|Reason Not Specified|1
4632128|NCT01899053|7501767|FG013|Overall Study|Reason Not Specified|0
4632129|NCT01899053|7501754|FG000|Overall Study|Withdrawal by Subject|1
4632130|NCT01899053|7501755|FG001|Overall Study|Withdrawal by Subject|1
4632131|NCT01899053|7501756|FG002|Overall Study|Withdrawal by Subject|2
4632132|NCT01899053|7501757|FG003|Overall Study|Withdrawal by Subject|0
4632133|NCT01899053|7501758|FG004|Overall Study|Withdrawal by Subject|2
4632134|NCT01899053|7501759|FG005|Overall Study|Withdrawal by Subject|0
4734104|NCT03480750|7680443|FG002|Overall Study|Withdrawal by Subject|0
4734105|NCT03480750|7680444|FG003|Overall Study|Withdrawal by Subject|0
4734106|NCT03480750|7680445|FG004|Overall Study|Withdrawal by Subject|0
4632135|NCT01899053|7501760|FG006|Overall Study|Withdrawal by Subject|0
4734107|NCT03480750|7680446|FG005|Overall Study|Withdrawal by Subject|0
4734108|NCT03480750|7680441|FG000|Overall Study|The interruption in Trientine shippment|0
4734109|NCT03480750|7680442|FG001|Overall Study|The interruption in Trientine shippment|0
4734110|NCT03480750|7680443|FG002|Overall Study|The interruption in Trientine shippment|0
4734111|NCT03480750|7680444|FG003|Overall Study|The interruption in Trientine shippment|0
4734112|NCT03480750|7680445|FG004|Overall Study|The interruption in Trientine shippment|0
4734113|NCT03480750|7680446|FG005|Overall Study|The interruption in Trientine shippment|1
4734114|NCT03480763|7680471|FG000|Overall Study|Withdrawal by Subject|18
4734115|NCT03480763|7680472|FG001|Overall Study|Withdrawal by Subject|10
4734116|NCT03480763|7680471|FG000|Overall Study|Lost to Follow-up|4
4734117|NCT03480763|7680472|FG001|Overall Study|Lost to Follow-up|7
4734118|NCT03480763|7680471|FG000|Overall Study|non-study pneumococcal vaccine|1
4734119|NCT03480763|7680472|FG001|Overall Study|non-study pneumococcal vaccine|0
4734120|NCT03480763|7680471|FG000|Overall Study|oncological treatment|0
4734121|NCT03480763|7680472|FG001|Overall Study|oncological treatment|2
4734122|NCT03480763|7680471|FG000|Overall Study|pain with vaccination|1
4734123|NCT03480763|7680472|FG001|Overall Study|pain with vaccination|0
4734124|NCT03480802|7680486|FG000|Overall Study|Lost to Follow-up|5
4734125|NCT03480802|7680487|FG001|Overall Study|Lost to Follow-up|1
4734126|NCT03480802|7680486|FG000|Overall Study|Withdrawal by Subject|2
4734127|NCT03480802|7680487|FG001|Overall Study|Withdrawal by Subject|1
4734128|NCT03480802|7680486|FG000|Overall Study|Relocated|0
4734129|NCT03480802|7680487|FG001|Overall Study|Relocated|1
4734130|NCT03480841|7680495|FG000|Overall Study|Lost to Follow-up|2
4734131|NCT03480932|7680515|FG000|Overall Study|Death|1
4734132|NCT03480932|7680516|FG001|Overall Study|Death|1
4734133|NCT03480932|7680517|FG002|Overall Study|Death|0
4734134|NCT03480932|7680515|FG000|Overall Study|Lost to Follow-up|0
4734135|NCT03480932|7680516|FG001|Overall Study|Lost to Follow-up|2
4734136|NCT03480932|7680517|FG002|Overall Study|Lost to Follow-up|3
4734137|NCT03480932|7680515|FG000|Overall Study|Incarcerated|2
4734138|NCT03480932|7680516|FG001|Overall Study|Incarcerated|2
4734139|NCT03480932|7680517|FG002|Overall Study|Incarcerated|2
4734140|NCT03481309|7680540|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1
4734141|NCT03481309|7680541|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0
4734142|NCT03481309|7680542|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0
4734143|NCT03481309|7680543|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0
4734144|NCT03481309|7680544|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0
4734145|NCT03481309|7680545|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0
4737505|NCT03613649|7687752|FG003|Second Treatment|Withdrawal by Subject|0
4737506|NCT03613649|7687753|FG004|Second Treatment|Withdrawal by Subject|1
4737507|NCT03613649|7687754|FG005|Second Treatment|Withdrawal by Subject|0
4737508|NCT03613649|7687755|FG006|Second Treatment|Withdrawal by Subject|0
4737509|NCT03613649|7687756|FG007|Second Treatment|Withdrawal by Subject|0
4737510|NCT03613649|7687757|FG008|Second Treatment|Withdrawal by Subject|0
4737511|NCT03613649|7687758|FG009|Second Treatment|Withdrawal by Subject|0
4737512|NCT03613649|7687759|FG010|Second Treatment|Withdrawal by Subject|0
4737513|NCT03613649|7687760|FG011|Second Treatment|Withdrawal by Subject|0
4737514|NCT03613649|7687749|FG000|Third Treatment|Lost to Follow-up|0
4737515|NCT03613649|7687750|FG001|Third Treatment|Lost to Follow-up|0
4737516|NCT03613649|7687751|FG002|Third Treatment|Lost to Follow-up|0
4734146|NCT03481725|7680564|FG000|Overall Study|Withdrawal by Subject|1
4734147|NCT03481725|7680565|FG001|Overall Study|Withdrawal by Subject|0
4734148|NCT03481816|7680575|FG000|Starting Dose|Refused further vaccines after 1 dose|1
4734149|NCT03481816|7680576|FG001|Starting Dose|Refused further vaccines after 1 dose|0
4734150|NCT03481816|7680575|FG000|Dose Expansion|Off treatment due to progressive disease|0
4734151|NCT03481816|7680576|FG001|Dose Expansion|Off treatment due to progressive disease|5
4734152|NCT03481816|7680575|FG000|Dose Expansion|Withdrawal by Subject|0
4734153|NCT03481816|7680576|FG001|Dose Expansion|Withdrawal by Subject|2
4734154|NCT03481816|7680575|FG000|Dose Expansion|Physician Decision|0
4734155|NCT03481816|7680576|FG001|Dose Expansion|Physician Decision|5
4734156|NCT03482011|7680586|FG000|Induction Period (16 Weeks)|Adverse Event|1
4734157|NCT03482011|7680587|FG001|Induction Period (16 Weeks)|Adverse Event|3
4734158|NCT03482011|7680588|FG002|Induction Period (16 Weeks)|Adverse Event|0
4734159|NCT03482011|7680589|FG003|Induction Period (16 Weeks)|Adverse Event|0
4734160|NCT03482011|7680590|FG004|Induction Period (16 Weeks)|Adverse Event|0
4734161|NCT03482011|7680591|FG005|Induction Period (16 Weeks)|Adverse Event|0
4734162|NCT03482011|7680592|FG006|Induction Period (16 Weeks)|Adverse Event|0
4734163|NCT03482011|7680593|FG007|Induction Period (16 Weeks)|Adverse Event|0
4734164|NCT03482011|7680586|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3
4734165|NCT03482011|7680587|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1
4734166|NCT03482011|7680588|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0
4734167|NCT03482011|7680589|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0
4734168|NCT03482011|7680590|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0
4734169|NCT03482011|7680591|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0
4734170|NCT03482011|7680592|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0
4734171|NCT03482011|7680593|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0
4734172|NCT03482011|7680586|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0
4734173|NCT03482011|7680587|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1
4734174|NCT03482011|7680588|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0
4734175|NCT03482011|7680589|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0
4734176|NCT03482011|7680590|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0
4734177|NCT03482011|7680591|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0
4734178|NCT03482011|7680592|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0
4734179|NCT03482011|7680593|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0
4734180|NCT03482011|7680586|FG000|Induction Period (16 Weeks)|Screen Failure|0
4734181|NCT03482011|7680587|FG001|Induction Period (16 Weeks)|Screen Failure|1
4734182|NCT03482011|7680588|FG002|Induction Period (16 Weeks)|Screen Failure|0
4734183|NCT03482011|7680589|FG003|Induction Period (16 Weeks)|Screen Failure|0
4734184|NCT03482011|7680590|FG004|Induction Period (16 Weeks)|Screen Failure|0
4734185|NCT03482011|7680591|FG005|Induction Period (16 Weeks)|Screen Failure|0
4734186|NCT03482011|7680592|FG006|Induction Period (16 Weeks)|Screen Failure|0
4734187|NCT03482011|7680593|FG007|Induction Period (16 Weeks)|Screen Failure|0
4734188|NCT03482011|7680586|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2
4734189|NCT03482011|7680587|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5
4734190|NCT03482011|7680588|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0
4734191|NCT03482011|7680589|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0
4734192|NCT03482011|7680590|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0
4734193|NCT03482011|7680591|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0
4734194|NCT03482011|7680592|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0
4734195|NCT03482011|7680593|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0
4734196|NCT03482011|7680586|FG000|Maintenance Period (36 Weeks)|Adverse Event|0
4734197|NCT03482011|7680587|FG001|Maintenance Period (36 Weeks)|Adverse Event|0
4734198|NCT03482011|7680588|FG002|Maintenance Period (36 Weeks)|Adverse Event|0
4734199|NCT03482011|7680589|FG003|Maintenance Period (36 Weeks)|Adverse Event|0
4734200|NCT03482011|7680590|FG004|Maintenance Period (36 Weeks)|Adverse Event|0
4734201|NCT03482011|7680591|FG005|Maintenance Period (36 Weeks)|Adverse Event|1
4734202|NCT03482011|7680592|FG006|Maintenance Period (36 Weeks)|Adverse Event|1
4734203|NCT03482011|7680593|FG007|Maintenance Period (36 Weeks)|Adverse Event|4
4734204|NCT03482011|7680586|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0
4734205|NCT03482011|7680587|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0
4734206|NCT03482011|7680588|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1
4734207|NCT03482011|7680589|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2
4734208|NCT03482011|7680590|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1
4734209|NCT03482011|7680591|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1
4734210|NCT03482011|7680592|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0
4734211|NCT03482011|7680593|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9
4734212|NCT03482011|7680586|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0
4734213|NCT03482011|7680587|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0
4734214|NCT03482011|7680588|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0
4734215|NCT03482011|7680589|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0
4734216|NCT03482011|7680590|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2
4734217|NCT03482011|7680591|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0
4734218|NCT03482011|7680592|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0
4734219|NCT03482011|7680593|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1
4734220|NCT03482011|7680586|FG000|Maintenance Period (36 Weeks)|Physician Decision|0
4734221|NCT03482011|7680587|FG001|Maintenance Period (36 Weeks)|Physician Decision|0
4734222|NCT03482011|7680588|FG002|Maintenance Period (36 Weeks)|Physician Decision|0
4734223|NCT03482011|7680589|FG003|Maintenance Period (36 Weeks)|Physician Decision|1
4734224|NCT03482011|7680590|FG004|Maintenance Period (36 Weeks)|Physician Decision|0
4734225|NCT03482011|7680591|FG005|Maintenance Period (36 Weeks)|Physician Decision|1
4734226|NCT03482011|7680592|FG006|Maintenance Period (36 Weeks)|Physician Decision|1
4734227|NCT03482011|7680593|FG007|Maintenance Period (36 Weeks)|Physician Decision|1
4734228|NCT03482011|7680586|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
4734229|NCT03482011|7680587|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
4734230|NCT03482011|7680588|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
4734231|NCT03482011|7680589|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1
4734232|NCT03482011|7680590|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2
4734233|NCT03482011|7680591|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1
4734234|NCT03482011|7680592|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2
4734235|NCT03482011|7680593|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2
4734236|NCT03482011|7680586|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0
4734237|NCT03482011|7680587|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0
4734238|NCT03482011|7680588|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0
4734239|NCT03482011|7680589|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2
4734240|NCT03482011|7680590|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0
4734241|NCT03482011|7680591|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1
4734242|NCT03482011|7680592|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1
4734243|NCT03482011|7680593|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5
4734244|NCT03482011|7680586|FG000|Follow-up Period (12 Weeks)|Adverse Event|0
4734245|NCT03482011|7680587|FG001|Follow-up Period (12 Weeks)|Adverse Event|0
4734246|NCT03482011|7680588|FG002|Follow-up Period (12 Weeks)|Adverse Event|0
4734247|NCT03482011|7680589|FG003|Follow-up Period (12 Weeks)|Adverse Event|0
4734248|NCT03482011|7680590|FG004|Follow-up Period (12 Weeks)|Adverse Event|0
4734249|NCT03482011|7680591|FG005|Follow-up Period (12 Weeks)|Adverse Event|0
4734250|NCT03482011|7680592|FG006|Follow-up Period (12 Weeks)|Adverse Event|1
4734251|NCT03482011|7680593|FG007|Follow-up Period (12 Weeks)|Adverse Event|4
4734252|NCT03482011|7680586|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0
4734253|NCT03482011|7680587|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0
4734254|NCT03482011|7680588|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1
4734255|NCT03482011|7680589|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3
4734256|NCT03482011|7680590|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0
4734257|NCT03482011|7680591|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0
4632136|NCT01899053|7501761|FG007|Overall Study|Withdrawal by Subject|1
4632137|NCT01899053|7501762|FG008|Overall Study|Withdrawal by Subject|0
4632138|NCT01899053|7501763|FG009|Overall Study|Withdrawal by Subject|0
4632139|NCT01899053|7501764|FG010|Overall Study|Withdrawal by Subject|0
4632140|NCT01899053|7501765|FG011|Overall Study|Withdrawal by Subject|0
4632141|NCT01899053|7501766|FG012|Overall Study|Withdrawal by Subject|1
4632142|NCT01899053|7501767|FG013|Overall Study|Withdrawal by Subject|1
4632143|NCT01899053|7501754|FG000|Overall Study|Protocol Violation|0
4632144|NCT01899053|7501755|FG001|Overall Study|Protocol Violation|0
4632145|NCT01899053|7501756|FG002|Overall Study|Protocol Violation|1
4632146|NCT01899053|7501757|FG003|Overall Study|Protocol Violation|0
4632147|NCT01899053|7501758|FG004|Overall Study|Protocol Violation|0
4632148|NCT01899053|7501759|FG005|Overall Study|Protocol Violation|0
4632149|NCT01899053|7501760|FG006|Overall Study|Protocol Violation|0
4632150|NCT01899053|7501761|FG007|Overall Study|Protocol Violation|0
4632151|NCT01899053|7501762|FG008|Overall Study|Protocol Violation|0
4632152|NCT01899053|7501763|FG009|Overall Study|Protocol Violation|0
4632153|NCT01899053|7501764|FG010|Overall Study|Protocol Violation|0
4632154|NCT01899053|7501765|FG011|Overall Study|Protocol Violation|0
4632155|NCT01899053|7501766|FG012|Overall Study|Protocol Violation|0
4632156|NCT01899053|7501767|FG013|Overall Study|Protocol Violation|0
4734258|NCT03482011|7680592|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0
4734259|NCT03482011|7680593|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6
4734260|NCT03482011|7680586|FG000|Follow-up Period (12 Weeks)|Physician Decision|0
4734261|NCT03482011|7680587|FG001|Follow-up Period (12 Weeks)|Physician Decision|0
4734262|NCT03482011|7680588|FG002|Follow-up Period (12 Weeks)|Physician Decision|0
4734263|NCT03482011|7680589|FG003|Follow-up Period (12 Weeks)|Physician Decision|0
4734264|NCT03482011|7680590|FG004|Follow-up Period (12 Weeks)|Physician Decision|0
4734265|NCT03482011|7680591|FG005|Follow-up Period (12 Weeks)|Physician Decision|0
4734266|NCT03482011|7680592|FG006|Follow-up Period (12 Weeks)|Physician Decision|0
4734267|NCT03482011|7680593|FG007|Follow-up Period (12 Weeks)|Physician Decision|1
4734268|NCT03482011|7680586|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0
4734269|NCT03482011|7680587|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0
4734270|NCT03482011|7680588|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0
4734271|NCT03482011|7680589|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0
4734272|NCT03482011|7680590|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0
4734273|NCT03482011|7680591|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0
4734274|NCT03482011|7680592|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0
4734275|NCT03482011|7680593|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1
4734276|NCT03482453|7680630|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
4734277|NCT03482453|7680631|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
4734278|NCT03482453|7680632|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
4734279|NCT03482453|7680633|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
4734280|NCT03482453|7680634|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
4734281|NCT03482453|7680635|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
4734282|NCT03482453|7680636|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
4734283|NCT03482453|7680637|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
4734284|NCT03482453|7680638|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
4734285|NCT03482453|7680639|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
4734286|NCT03482453|7680640|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1
4734287|NCT03482453|7680641|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
4734288|NCT03482635|7680695|FG000|Overall Study|Lack of Efficacy|0
4734289|NCT03482635|7680696|FG001|Overall Study|Lack of Efficacy|0
4734290|NCT03482635|7680697|FG002|Overall Study|Lack of Efficacy|1
4734291|NCT03482635|7680698|FG003|Overall Study|Lack of Efficacy|3
4734292|NCT03482635|7680695|FG000|Overall Study|Adverse Event|2
4734293|NCT03482635|7680696|FG001|Overall Study|Adverse Event|2
4734294|NCT03482635|7680697|FG002|Overall Study|Adverse Event|0
4734295|NCT03482635|7680698|FG003|Overall Study|Adverse Event|3
4734296|NCT03482635|7680695|FG000|Overall Study|Withdrawal by Subject|2
4734297|NCT03482635|7680696|FG001|Overall Study|Withdrawal by Subject|1
4734298|NCT03482635|7680697|FG002|Overall Study|Withdrawal by Subject|0
4734299|NCT03482635|7680698|FG003|Overall Study|Withdrawal by Subject|1
4734300|NCT03482635|7680695|FG000|Overall Study|Withdrawn by Principle Investigator|1
4734301|NCT03482635|7680696|FG001|Overall Study|Withdrawn by Principle Investigator|0
4734302|NCT03482635|7680697|FG002|Overall Study|Withdrawn by Principle Investigator|0
4734303|NCT03482635|7680698|FG003|Overall Study|Withdrawn by Principle Investigator|0
4734304|NCT03482635|7680695|FG000|Overall Study|Not treated|0
4734305|NCT03482635|7680696|FG001|Overall Study|Not treated|0
4734306|NCT03482635|7680697|FG002|Overall Study|Not treated|0
4734307|NCT03482635|7680698|FG003|Overall Study|Not treated|1
4734308|NCT03482882|7680717|FG000|Overall Study|Adverse Event|3
4734309|NCT03482882|7680717|FG000|Overall Study|Lost to Follow-up|1
4734310|NCT03482882|7680717|FG000|Overall Study|Protocol Violation|2
4734311|NCT03482882|7680717|FG000|Overall Study|Not further specified|1
4734312|NCT03483623|7680736|FG000|Overall Study|43 complete sets achieved|1
4734313|NCT03483961|7680779|FG000|Overall Study|Lost to Follow-up|7
4734314|NCT03483961|7680780|FG001|Overall Study|Lost to Follow-up|6
4734315|NCT03483961|7680781|FG002|Overall Study|Lost to Follow-up|6
4734316|NCT03483961|7680782|FG003|Overall Study|Lost to Follow-up|6
4734317|NCT03483961|7680783|FG004|Overall Study|Lost to Follow-up|6
4734318|NCT03483961|7680784|FG005|Overall Study|Lost to Follow-up|4
4734319|NCT03483961|7680785|FG006|Overall Study|Lost to Follow-up|4
4734320|NCT03483961|7680786|FG007|Overall Study|Lost to Follow-up|11
4734321|NCT03483961|7680787|FG008|Overall Study|Lost to Follow-up|1
4734322|NCT03483961|7680788|FG009|Overall Study|Lost to Follow-up|0
4734323|NCT03483961|7680779|FG000|Overall Study|Withdrawal by Subject|3
4734324|NCT03483961|7680780|FG001|Overall Study|Withdrawal by Subject|4
4734325|NCT03483961|7680781|FG002|Overall Study|Withdrawal by Subject|5
4734326|NCT03483961|7680782|FG003|Overall Study|Withdrawal by Subject|3
4734327|NCT03483961|7680783|FG004|Overall Study|Withdrawal by Subject|4
4734328|NCT03483961|7680784|FG005|Overall Study|Withdrawal by Subject|2
4734329|NCT03483961|7680785|FG006|Overall Study|Withdrawal by Subject|1
4734330|NCT03483961|7680786|FG007|Overall Study|Withdrawal by Subject|2
4734331|NCT03483961|7680787|FG008|Overall Study|Withdrawal by Subject|1
4734332|NCT03483961|7680788|FG009|Overall Study|Withdrawal by Subject|0
4734333|NCT03483961|7680779|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1
4734334|NCT03483961|7680780|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0
4734335|NCT03483961|7680781|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0
4734336|NCT03483961|7680782|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0
4734337|NCT03483961|7680783|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0
4734338|NCT03483961|7680784|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0
4734339|NCT03483961|7680785|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0
4734340|NCT03483961|7680786|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0
4734341|NCT03483961|7680787|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0
4734342|NCT03483961|7680788|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0
4734343|NCT03483961|7680779|FG000|Overall Study|Adverse Event|0
4734344|NCT03483961|7680780|FG001|Overall Study|Adverse Event|0
4734345|NCT03483961|7680781|FG002|Overall Study|Adverse Event|1
4734346|NCT03483961|7680782|FG003|Overall Study|Adverse Event|0
4734347|NCT03483961|7680783|FG004|Overall Study|Adverse Event|0
4734348|NCT03483961|7680784|FG005|Overall Study|Adverse Event|0
4734349|NCT03483961|7680785|FG006|Overall Study|Adverse Event|0
4734350|NCT03483961|7680786|FG007|Overall Study|Adverse Event|0
4734351|NCT03483961|7680787|FG008|Overall Study|Adverse Event|0
4734352|NCT03483961|7680788|FG009|Overall Study|Adverse Event|0
4734353|NCT03484273|7680809|FG000|Overall Study|Equipment Malfunction|1
4734354|NCT03484273|7680809|FG000|Overall Study|Data excluded from analysis|1
4734355|NCT03484429|7680823|FG000|Overall Study|Withdrawal by Subject|1
4734356|NCT03484429|7680824|FG001|Overall Study|Withdrawal by Subject|0
4734357|NCT03484429|7680823|FG000|Overall Study|Adverse Event|2
4734358|NCT03484429|7680824|FG001|Overall Study|Adverse Event|0
4734359|NCT03485222|7680832|FG000|Overall Study|Death|0
4734360|NCT03485222|7680833|FG001|Overall Study|Death|1
4734361|NCT03485222|7680832|FG000|Overall Study|Lost to Follow-up|2
4734362|NCT03485222|7680833|FG001|Overall Study|Lost to Follow-up|1
4734363|NCT03485495|7680841|FG000|Overall Study|Non-compliance with inclusion criteria|1
4734364|NCT03485495|7680842|FG001|Overall Study|Non-compliance with inclusion criteria|0
4734365|NCT03486392|7680857|FG000|Overall Study|Lost to Follow-up|0
4734366|NCT03486392|7680858|FG001|Overall Study|Lost to Follow-up|0
4734367|NCT03486392|7680859|FG002|Overall Study|Lost to Follow-up|8
4734368|NCT03486392|7680860|FG003|Overall Study|Lost to Follow-up|5
4734369|NCT03486392|7680861|FG004|Overall Study|Lost to Follow-up|2
4734370|NCT03486392|7680857|FG000|Overall Study|Withdrawal by Subject|3
4734371|NCT03486392|7680858|FG001|Overall Study|Withdrawal by Subject|0
4734372|NCT03486392|7680859|FG002|Overall Study|Withdrawal by Subject|6
4734373|NCT03486392|7680860|FG003|Overall Study|Withdrawal by Subject|4
4734374|NCT03486392|7680861|FG004|Overall Study|Withdrawal by Subject|1
4734375|NCT03486392|7680857|FG000|Overall Study|Death|0
4734376|NCT03486392|7680858|FG001|Overall Study|Death|0
4734377|NCT03486392|7680859|FG002|Overall Study|Death|0
4734378|NCT03486392|7680860|FG003|Overall Study|Death|0
4734379|NCT03486392|7680861|FG004|Overall Study|Death|1
4734380|NCT03486834|7680876|FG000|Overall Study|Withdrawal by Subject|46
4734381|NCT03486834|7680877|FG001|Overall Study|Withdrawal by Subject|46
4734382|NCT03486834|7680878|FG002|Overall Study|Withdrawal by Subject|52
4734383|NCT03486834|7680876|FG000|Overall Study|Adverse Event|8
4734384|NCT03486834|7680877|FG001|Overall Study|Adverse Event|7
4734385|NCT03486834|7680878|FG002|Overall Study|Adverse Event|0
4734386|NCT03486834|7680876|FG000|Overall Study|Lost to Follow-up|41
4734387|NCT03486834|7680877|FG001|Overall Study|Lost to Follow-up|24
4734388|NCT03486834|7680878|FG002|Overall Study|Lost to Follow-up|39
4734389|NCT03486834|7680876|FG000|Overall Study|Non-compliance with Study Drug|2
4734390|NCT03486834|7680877|FG001|Overall Study|Non-compliance with Study Drug|2
4734391|NCT03486834|7680878|FG002|Overall Study|Non-compliance with Study Drug|0
4734392|NCT03486834|7680876|FG000|Overall Study|Physician Decision|5
4734393|NCT03486834|7680877|FG001|Overall Study|Physician Decision|2
4734394|NCT03486834|7680878|FG002|Overall Study|Physician Decision|3
4734395|NCT03486834|7680876|FG000|Overall Study|Pregnancy|10
4734396|NCT03486834|7680877|FG001|Overall Study|Pregnancy|12
4734397|NCT03486834|7680878|FG002|Overall Study|Pregnancy|12
4734398|NCT03486834|7680876|FG000|Overall Study|Protocol Deviation|2
4734399|NCT03486834|7680877|FG001|Overall Study|Protocol Deviation|3
4734400|NCT03486834|7680878|FG002|Overall Study|Protocol Deviation|3
4734401|NCT03486834|7680876|FG000|Overall Study|Withdrawal by Parent/Guardian|1
4734402|NCT03486834|7680877|FG001|Overall Study|Withdrawal by Parent/Guardian|2
4734403|NCT03486834|7680878|FG002|Overall Study|Withdrawal by Parent/Guardian|2
4734404|NCT03486834|7680876|FG000|Overall Study|Randomized but not treated|4
4734405|NCT03486834|7680877|FG001|Overall Study|Randomized but not treated|4
4734406|NCT03486834|7680878|FG002|Overall Study|Randomized but not treated|1
4734407|NCT03487445|7680973|FG000|Randomization|Not treated for administrative reasons|1
4734408|NCT03487445|7680974|FG001|Randomization|Not treated for administrative reasons|0
4734409|NCT03487549|7680982|FG000|Overall Study|Protocol Violation|0
4734410|NCT03487549|7680983|FG001|Overall Study|Protocol Violation|1
4734411|NCT03487549|7680982|FG000|Overall Study|Lost to Follow-up|2
4734412|NCT03487549|7680983|FG001|Overall Study|Lost to Follow-up|1
4734413|NCT03487549|7680982|FG000|Overall Study|Withdrawal by Subject|2
4734414|NCT03487549|7680983|FG001|Overall Study|Withdrawal by Subject|0
4734415|NCT03487848|7681002|FG000|Overall Study|Lost to Follow-up|1
4734416|NCT03488108|7681008|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0
4734417|NCT03488108|7681009|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1
4734418|NCT03488108|7681008|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1
4734419|NCT03488108|7681009|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0
4734420|NCT03488225|7681017|FG000|Overall Study|Off Protocol Therapy|2
4734421|NCT03488225|7681017|FG000|Overall Study|Stem Cell Transplant|2
4734422|NCT03488238|7681021|FG000|Overall Study|Equipment malfunction|1
4734423|NCT03488238|7681021|FG000|Overall Study|Adverse Event|1
4734424|NCT03488927|7681041|FG000|Overall Study|Withdrawal by Subject|44
4734425|NCT03488927|7681042|FG001|Overall Study|Withdrawal by Subject|118
4734426|NCT03488927|7681043|FG002|Overall Study|Withdrawal by Subject|217
4734427|NCT03489304|7681051|FG000|Overall Study|Lost to Follow-up|4
4734428|NCT03489343|7681062|FG000|Overall Study|Documented progressive disease|1
4734429|NCT03489343|7681063|FG001|Overall Study|Documented progressive disease|0
4734430|NCT03489343|7681064|FG002|Overall Study|Documented progressive disease|3
4734431|NCT03489343|7681065|FG003|Overall Study|Documented progressive disease|1
4734432|NCT03489343|7681066|FG004|Overall Study|Documented progressive disease|3
4734433|NCT03489343|7681067|FG005|Overall Study|Documented progressive disease|5
4734434|NCT03489343|7681068|FG006|Overall Study|Documented progressive disease|4
4734435|NCT03489343|7681062|FG000|Overall Study|Adverse Event|0
4734436|NCT03489343|7681063|FG001|Overall Study|Adverse Event|1
4734437|NCT03489343|7681064|FG002|Overall Study|Adverse Event|0
4734438|NCT03489343|7681065|FG003|Overall Study|Adverse Event|0
4734439|NCT03489343|7681066|FG004|Overall Study|Adverse Event|0
4734440|NCT03489343|7681067|FG005|Overall Study|Adverse Event|1
4734441|NCT03489343|7681068|FG006|Overall Study|Adverse Event|0
4734442|NCT03489343|7681062|FG000|Overall Study|Withdrawal by Subject|0
4734443|NCT03489343|7681063|FG001|Overall Study|Withdrawal by Subject|0
4734444|NCT03489343|7681064|FG002|Overall Study|Withdrawal by Subject|0
4734445|NCT03489343|7681065|FG003|Overall Study|Withdrawal by Subject|1
4734446|NCT03489343|7681066|FG004|Overall Study|Withdrawal by Subject|0
4734447|NCT03489343|7681067|FG005|Overall Study|Withdrawal by Subject|1
4734448|NCT03489343|7681068|FG006|Overall Study|Withdrawal by Subject|1
4734449|NCT03489343|7681062|FG000|Overall Study|Clinical progression|0
4734450|NCT03489343|7681063|FG001|Overall Study|Clinical progression|0
4734451|NCT03489343|7681064|FG002|Overall Study|Clinical progression|0
4734452|NCT03489343|7681065|FG003|Overall Study|Clinical progression|1
4734453|NCT03489343|7681066|FG004|Overall Study|Clinical progression|0
4734454|NCT03489343|7681067|FG005|Overall Study|Clinical progression|0
4734455|NCT03489343|7681068|FG006|Overall Study|Clinical progression|1
4734456|NCT03489369|7681088|FG000|Overall Study|Documented Progressive Disease|3
4734457|NCT03489369|7681089|FG001|Overall Study|Documented Progressive Disease|2
4734458|NCT03489369|7681090|FG002|Overall Study|Documented Progressive Disease|3
4734459|NCT03489369|7681091|FG003|Overall Study|Documented Progressive Disease|6
4734460|NCT03489369|7681088|FG000|Overall Study|Clinical Progression (Worsening of Clini|0
4734461|NCT03489369|7681089|FG001|Overall Study|Clinical Progression (Worsening of Clini|1
4734462|NCT03489369|7681090|FG002|Overall Study|Clinical Progression (Worsening of Clini|0
4734463|NCT03489369|7681091|FG003|Overall Study|Clinical Progression (Worsening of Clini|0
4734464|NCT03489551|7681101|FG000|Overall Study|Withdrawal by Subject|2
4734465|NCT03489720|7681107|FG000|Overall Study|Withdrawal by Subject|2
4632157|NCT01899053|7501754|FG000|Overall Study|Unsatisfactory Therapeutic Response|1
4632158|NCT01899053|7501755|FG001|Overall Study|Unsatisfactory Therapeutic Response|1
4632159|NCT01899053|7501756|FG002|Overall Study|Unsatisfactory Therapeutic Response|0
4632160|NCT01899053|7501757|FG003|Overall Study|Unsatisfactory Therapeutic Response|0
4734466|NCT03489720|7681108|FG001|Overall Study|Withdrawal by Subject|0
4734467|NCT03489863|7681129|FG000|Overall Study|Withdrawal by Subject|0
4734468|NCT03489863|7681130|FG001|Overall Study|Withdrawal by Subject|1
4734469|NCT03490032|7681147|FG000|Overall Study|family issue (child custody)|1
4734470|NCT03490032|7681148|FG001|Overall Study|family issue (child custody)|0
4734471|NCT03490032|7681149|FG002|Overall Study|family issue (child custody)|0
4734472|NCT03490981|7681182|FG000|Overall Study|Lost to Follow-up|1
4734473|NCT03490981|7681183|FG001|Overall Study|Lost to Follow-up|2
4734474|NCT03491150|7681191|FG000|Overall Study|Adverse Event|1
4734475|NCT03491150|7681192|FG001|Overall Study|Adverse Event|0
4734476|NCT03491150|7681191|FG000|Overall Study|Study Terminated by Sponsor|74
4734477|NCT03491150|7681192|FG001|Overall Study|Study Terminated by Sponsor|70
4734478|NCT03491150|7681191|FG000|Overall Study|Other|0
4734479|NCT03491150|7681192|FG001|Overall Study|Other|1
4734480|NCT03491150|7681191|FG000|Overall Study|Withdrawal by Subject|1
4632161|NCT01899053|7501758|FG004|Overall Study|Unsatisfactory Therapeutic Response|0
4632162|NCT01899053|7501759|FG005|Overall Study|Unsatisfactory Therapeutic Response|0
4632163|NCT01899053|7501760|FG006|Overall Study|Unsatisfactory Therapeutic Response|0
4632164|NCT01899053|7501761|FG007|Overall Study|Unsatisfactory Therapeutic Response|0
4632165|NCT01899053|7501762|FG008|Overall Study|Unsatisfactory Therapeutic Response|0
4632166|NCT01899053|7501763|FG009|Overall Study|Unsatisfactory Therapeutic Response|0
4632167|NCT01899053|7501764|FG010|Overall Study|Unsatisfactory Therapeutic Response|1
4632168|NCT01899053|7501765|FG011|Overall Study|Unsatisfactory Therapeutic Response|0
4632169|NCT01899053|7501766|FG012|Overall Study|Unsatisfactory Therapeutic Response|0
4632170|NCT01899053|7501767|FG013|Overall Study|Unsatisfactory Therapeutic Response|0
4632171|NCT01899053|7501754|FG000|Overall Study|Symptomatic Deterioration|0
4632172|NCT01899053|7501755|FG001|Overall Study|Symptomatic Deterioration|0
4632173|NCT01899053|7501756|FG002|Overall Study|Symptomatic Deterioration|0
4632174|NCT01899053|7501757|FG003|Overall Study|Symptomatic Deterioration|0
4632175|NCT01899053|7501758|FG004|Overall Study|Symptomatic Deterioration|0
4632176|NCT01899053|7501759|FG005|Overall Study|Symptomatic Deterioration|1
4632177|NCT01899053|7501760|FG006|Overall Study|Symptomatic Deterioration|0
4632178|NCT01899053|7501761|FG007|Overall Study|Symptomatic Deterioration|1
4632179|NCT01899053|7501762|FG008|Overall Study|Symptomatic Deterioration|0
4632180|NCT01899053|7501763|FG009|Overall Study|Symptomatic Deterioration|0
4632181|NCT01899053|7501764|FG010|Overall Study|Symptomatic Deterioration|0
4632182|NCT01899053|7501765|FG011|Overall Study|Symptomatic Deterioration|1
4632183|NCT01899053|7501766|FG012|Overall Study|Symptomatic Deterioration|2
4632184|NCT01899053|7501767|FG013|Overall Study|Symptomatic Deterioration|0
4632185|NCT01899742|7501817|FG000|Overall Study|Adverse Event|5
4632186|NCT01899742|7501818|FG001|Overall Study|Adverse Event|4
4734481|NCT03491150|7681192|FG001|Overall Study|Withdrawal by Subject|2
4734482|NCT03491553|7681208|FG000|Main Study (Up to Week 48)|Adverse Event|0
4734483|NCT03491553|7681209|FG001|Main Study (Up to Week 48)|Adverse Event|0
4734484|NCT03491553|7681210|FG002|Main Study (Up to Week 48)|Adverse Event|0
4734485|NCT03491553|7681211|FG003|Main Study (Up to Week 48)|Adverse Event|1
4734486|NCT03491553|7681212|FG004|Main Study (Up to Week 48)|Adverse Event|0
4734487|NCT03491553|7681213|FG005|Main Study (Up to Week 48)|Adverse Event|0
4734488|NCT03491553|7681208|FG000|Main Study (Up to Week 48)|Withdrew Consent|1
4734489|NCT03491553|7681209|FG001|Main Study (Up to Week 48)|Withdrew Consent|1
4734490|NCT03491553|7681210|FG002|Main Study (Up to Week 48)|Withdrew Consent|0
4734491|NCT03491553|7681211|FG003|Main Study (Up to Week 48)|Withdrew Consent|0
4734492|NCT03491553|7681212|FG004|Main Study (Up to Week 48)|Withdrew Consent|0
4734493|NCT03491553|7681213|FG005|Main Study (Up to Week 48)|Withdrew Consent|0
4632187|NCT01899742|7501817|FG000|Overall Study|Lack of Efficacy|1
4632188|NCT01899742|7501818|FG001|Overall Study|Lack of Efficacy|5
4632189|NCT01899742|7501817|FG000|Overall Study|Protocol Violation|2
4590690|NCT01524224|7436958|FG005|Overall Study|Adverse Event|1
4590691|NCT01524224|7436959|FG006|Overall Study|Adverse Event|0
4590692|NCT01524224|7436960|FG007|Overall Study|Adverse Event|0
4590693|NCT01524224|7436953|FG000|Overall Study|Physician Decision|0
4590694|NCT01524224|7436954|FG001|Overall Study|Physician Decision|0
4590695|NCT01524224|7436955|FG002|Overall Study|Physician Decision|0
4590696|NCT01524224|7436956|FG003|Overall Study|Physician Decision|1
4590697|NCT01524224|7436957|FG004|Overall Study|Physician Decision|1
4734494|NCT03492281|7681262|FG000|Overall Study|Withdrawal by Subject|21
4734495|NCT03492281|7681263|FG001|Overall Study|Withdrawal by Subject|14
4734496|NCT03492281|7681264|FG002|Overall Study|Withdrawal by Subject|13
4734497|NCT03492281|7681262|FG000|Overall Study|Lost to Follow-up|14
4734498|NCT03492281|7681263|FG001|Overall Study|Lost to Follow-up|15
4734499|NCT03492281|7681264|FG002|Overall Study|Lost to Follow-up|10
4734500|NCT03492281|7681262|FG000|Overall Study|Adverse Event|6
4734501|NCT03492281|7681263|FG001|Overall Study|Adverse Event|8
4734502|NCT03492281|7681264|FG002|Overall Study|Adverse Event|13
4734503|NCT03492281|7681262|FG000|Overall Study|Lack of Efficacy|3
4632190|NCT01899742|7501818|FG001|Overall Study|Protocol Violation|2
4632191|NCT01899742|7501817|FG000|Overall Study|Withdrawal by Subject|9
4632192|NCT01899742|7501818|FG001|Overall Study|Withdrawal by Subject|5
4734504|NCT03492281|7681263|FG001|Overall Study|Lack of Efficacy|0
4734505|NCT03492281|7681264|FG002|Overall Study|Lack of Efficacy|1
4734506|NCT03492281|7681262|FG000|Overall Study|Physician Decision|1
4734507|NCT03492281|7681263|FG001|Overall Study|Physician Decision|0
4734508|NCT03492281|7681264|FG002|Overall Study|Physician Decision|3
4734509|NCT03492281|7681262|FG000|Overall Study|Protocol Violation|0
4734510|NCT03492281|7681263|FG001|Overall Study|Protocol Violation|2
4734511|NCT03492281|7681264|FG002|Overall Study|Protocol Violation|1
4734512|NCT03492281|7681262|FG000|Overall Study|Withdrawn Due to Sponsor|1
4734513|NCT03492281|7681263|FG001|Overall Study|Withdrawn Due to Sponsor|0
4632193|NCT01899768|7501824|FG000|Part A|Adverse Event|2
4632194|NCT01899768|7501824|FG000|Part A|Withdrawal by Subject|1
4632195|NCT01899768|7501824|FG000|Part B|Adverse Event|1
4632196|NCT01899768|7501824|FG000|Part B|Withdrawal by Subject|1
4632197|NCT01900054|7501836|FG000|Overall Study|Physician Decision|1
4632198|NCT01900054|7501836|FG000|Overall Study|Withdrawal by Subject|1
4632199|NCT01900314|7501864|FG000|Overall Study|Lost to Follow-up|1
4632200|NCT01900314|7501865|FG001|Overall Study|Lost to Follow-up|0
4632201|NCT01900314|7501864|FG000|Overall Study|Protocol Violation|0
4632202|NCT01900314|7501865|FG001|Overall Study|Protocol Violation|1
4632203|NCT01900314|7501864|FG000|Overall Study|Withdrawal by Subject|3
4632204|NCT01900314|7501865|FG001|Overall Study|Withdrawal by Subject|3
4632205|NCT01900431|7501887|FG000|Principal Treatment Period (Part A)|Adverse Event|1
4632206|NCT01900431|7501888|FG001|Principal Treatment Period (Part A)|Adverse Event|3
4632207|NCT01900431|7501889|FG002|Principal Treatment Period (Part A)|Adverse Event|0
4632208|NCT01900431|7501887|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6
4632209|NCT01900431|7501888|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6
4632210|NCT01900431|7501889|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0
4632211|NCT01900431|7501887|FG000|Principal Treatment Period (Part A)|Other than specified above|0
4632212|NCT01900431|7501888|FG001|Principal Treatment Period (Part A)|Other than specified above|1
4632213|NCT01900431|7501889|FG002|Principal Treatment Period (Part A)|Other than specified above|0
4632214|NCT01900431|7501887|FG000|Extended Treatment Period (Part B)|Adverse Event|0
4632215|NCT01900431|7501888|FG001|Extended Treatment Period (Part B)|Adverse Event|2
4632216|NCT01900431|7501889|FG002|Extended Treatment Period (Part B)|Adverse Event|0
4632217|NCT01900431|7501887|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1
4632218|NCT01900431|7501888|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7
4632219|NCT01900431|7501889|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0
4632220|NCT01900431|7501887|FG000|Extended Treatment Period (Part B)|Other than specified above|0
4632221|NCT01900431|7501888|FG001|Extended Treatment Period (Part B)|Other than specified above|1
4632222|NCT01900431|7501889|FG002|Extended Treatment Period (Part B)|Other than specified above|0
4632223|NCT01900431|7501887|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0
4632224|NCT01900431|7501888|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0
4632225|NCT01900431|7501889|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2
4632226|NCT01900431|7501887|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0
4632227|NCT01900431|7501888|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0
4632228|NCT01900431|7501889|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3
4632229|NCT01900431|7501887|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0
4632230|NCT01900431|7501888|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0
4632231|NCT01900431|7501889|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3
4632232|NCT01900652|7501908|FG000|Overall Study|Progressive Disease|1
4632233|NCT01900652|7501909|FG001|Overall Study|Progressive Disease|0
4632234|NCT01900652|7501908|FG000|Overall Study|Consent withdrawn by subject|1
4632235|NCT01900652|7501909|FG001|Overall Study|Consent withdrawn by subject|1
4632236|NCT01900652|7501908|FG000|Overall Study|Death|3
4632237|NCT01900652|7501909|FG001|Overall Study|Death|0
4632238|NCT01900652|7501908|FG000|Overall Study|Adverse Event|2
4632239|NCT01900652|7501909|FG001|Overall Study|Adverse Event|1
4632240|NCT01900652|7501908|FG000|Overall Study|Physician Decision|1
4632241|NCT01900652|7501909|FG001|Overall Study|Physician Decision|1
4632242|NCT01900665|7501922|FG000|Placebo Controlled Period|Death|9
4632243|NCT01900665|7501923|FG001|Placebo Controlled Period|Death|16
4632244|NCT01900665|7501922|FG000|Placebo Controlled Period|Adverse Event|48
4632245|NCT01900665|7501923|FG001|Placebo Controlled Period|Adverse Event|39
4632246|NCT01900665|7501922|FG000|Placebo Controlled Period|Protocol Violation|1
4632247|NCT01900665|7501923|FG001|Placebo Controlled Period|Protocol Violation|7
4632248|NCT01900665|7501922|FG000|Placebo Controlled Period|Withdrawal by Subject|33
4632249|NCT01900665|7501923|FG001|Placebo Controlled Period|Withdrawal by Subject|45
4632250|NCT01900665|7501922|FG000|Placebo Controlled Period|Physician Decision|11
4632251|NCT01900665|7501923|FG001|Placebo Controlled Period|Physician Decision|7
4632252|NCT01900665|7501922|FG000|Placebo Controlled Period|Lost to Follow-up|3
4632253|NCT01900665|7501923|FG001|Placebo Controlled Period|Lost to Follow-up|0
4632254|NCT01900665|7501922|FG000|Placebo Controlled Period|Caregiver Decision|33
4632255|NCT01900665|7501923|FG001|Placebo Controlled Period|Caregiver Decision|41
4632256|NCT01900665|7501922|FG000|Placebo Controlled Period|Entry Criteria Not Met|5
4632257|NCT01900665|7501923|FG001|Placebo Controlled Period|Entry Criteria Not Met|9
4632258|NCT01900665|7501922|FG000|Open Label Period|Adverse Event|16
4632259|NCT01900665|7501923|FG001|Open Label Period|Adverse Event|20
4632260|NCT01900665|7501922|FG000|Open Label Period|Death|5
4632261|NCT01900665|7501923|FG001|Open Label Period|Death|6
4632262|NCT01900665|7501922|FG000|Open Label Period|Lost to Follow-up|1
4632263|NCT01900665|7501923|FG001|Open Label Period|Lost to Follow-up|1
4632264|NCT01900665|7501922|FG000|Open Label Period|Parent/Caregiver Decision|33
4632265|NCT01900665|7501923|FG001|Open Label Period|Parent/Caregiver Decision|34
4632266|NCT01900665|7501922|FG000|Open Label Period|Physician Decision|4
4632267|NCT01900665|7501923|FG001|Open Label Period|Physician Decision|4
4632268|NCT01900665|7501922|FG000|Open Label Period|Protocol Violation|0
4632269|NCT01900665|7501923|FG001|Open Label Period|Protocol Violation|1
4632270|NCT01900665|7501922|FG000|Open Label Period|Sponsor Decision|802
4632271|NCT01900665|7501923|FG001|Open Label Period|Sponsor Decision|765
4632272|NCT01900665|7501922|FG000|Open Label Period|Withdrawal by Subject|20
4632273|NCT01900665|7501923|FG001|Open Label Period|Withdrawal by Subject|28
4632274|NCT01900899|7501948|FG000|Overall Study|Withdrawal by Subject|7
4632275|NCT01900899|7501949|FG001|Overall Study|Withdrawal by Subject|1
4632276|NCT01900899|7501948|FG000|Overall Study|Migrated from study area|2
4632277|NCT01900899|7501949|FG001|Overall Study|Migrated from study area|0
4632278|NCT01901055|7501957|FG000|Randomization But Not Titrated|Did not come to titration study|1
4632279|NCT01901055|7501958|FG001|Randomization But Not Titrated|Did not come to titration study|1
4632280|NCT01901055|7501957|FG000|Randomization But Not Titrated|Physician Decision|0
4632281|NCT01901055|7501958|FG001|Randomization But Not Titrated|Physician Decision|1
4632282|NCT01901055|7501957|FG000|Started Protocol to Week 6|Physician Decision|2
4632283|NCT01901055|7501958|FG001|Started Protocol to Week 6|Physician Decision|1
4632284|NCT01901055|7501957|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0
4632285|NCT01901055|7501958|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2
4633384|NCT01911442|7503531|FG001|Overall Study|Mother's Work Schedule|1
4632286|NCT01901055|7501957|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1
4632287|NCT01901055|7501958|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0
4632288|NCT01901055|7501957|FG000|Started Protocol to Week 6|Withdrawal by Subject|0
4632289|NCT01901055|7501958|FG001|Started Protocol to Week 6|Withdrawal by Subject|1
4632290|NCT01901055|7501957|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1
4632291|NCT01901055|7501958|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0
4632292|NCT01901055|7501957|FG000|Week 12 Assessment|Withdrawal by Subject|0
4632293|NCT01901055|7501958|FG001|Week 12 Assessment|Withdrawal by Subject|4
4632294|NCT01901055|7501957|FG000|Week 24|Withdrawal by Subject|13
4632295|NCT01901055|7501958|FG001|Week 24|Withdrawal by Subject|19
4632296|NCT01901055|7501957|FG000|Week 24|Physician Decision|1
4632297|NCT01901055|7501958|FG001|Week 24|Physician Decision|0
4632298|NCT01901055|7501957|FG000|Week 36|Withdrawal by Subject|0
4632299|NCT01901055|7501958|FG001|Week 36|Withdrawal by Subject|5
4632300|NCT01901146|7501969|FG000|Neoadjuvant Phase|Death|1
4632301|NCT01901146|7501970|FG001|Neoadjuvant Phase|Death|2
4632302|NCT01901146|7501971|FG002|Neoadjuvant Phase|Death|0
4632303|NCT01901146|7501972|FG003|Neoadjuvant Phase|Death|0
4632304|NCT01901146|7501973|FG004|Neoadjuvant Phase|Death|0
4632305|NCT01901146|7501969|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2
4632306|NCT01901146|7501970|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3
4632307|NCT01901146|7501971|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0
4632308|NCT01901146|7501972|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0
4632309|NCT01901146|7501973|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0
4632310|NCT01901146|7501969|FG000|Neoadjuvant Phase|Lost to Follow-up|0
4632311|NCT01901146|7501970|FG001|Neoadjuvant Phase|Lost to Follow-up|1
4632312|NCT01901146|7501971|FG002|Neoadjuvant Phase|Lost to Follow-up|0
4632313|NCT01901146|7501972|FG003|Neoadjuvant Phase|Lost to Follow-up|0
4632314|NCT01901146|7501973|FG004|Neoadjuvant Phase|Lost to Follow-up|0
4632315|NCT01901146|7501969|FG000|Neoadjuvant Phase|Physician Decision|1
4632316|NCT01901146|7501970|FG001|Neoadjuvant Phase|Physician Decision|2
4632317|NCT01901146|7501971|FG002|Neoadjuvant Phase|Physician Decision|0
4632318|NCT01901146|7501972|FG003|Neoadjuvant Phase|Physician Decision|0
4632319|NCT01901146|7501973|FG004|Neoadjuvant Phase|Physician Decision|0
4632320|NCT01901146|7501969|FG000|Neoadjuvant Phase|Withdrawal by Subject|2
4632321|NCT01901146|7501970|FG001|Neoadjuvant Phase|Withdrawal by Subject|5
4632322|NCT01901146|7501971|FG002|Neoadjuvant Phase|Withdrawal by Subject|0
4632323|NCT01901146|7501972|FG003|Neoadjuvant Phase|Withdrawal by Subject|0
4632324|NCT01901146|7501973|FG004|Neoadjuvant Phase|Withdrawal by Subject|0
4632325|NCT01901146|7501969|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0
4632326|NCT01901146|7501970|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1
4632327|NCT01901146|7501971|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0
4632328|NCT01901146|7501972|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0
4632329|NCT01901146|7501973|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0
4632330|NCT01901146|7501969|FG000|Adjuvant Phase|Other|0
4632331|NCT01901146|7501970|FG001|Adjuvant Phase|Other|0
4632332|NCT01901146|7501971|FG002|Adjuvant Phase|Other|1
4632333|NCT01901146|7501972|FG003|Adjuvant Phase|Other|0
4632334|NCT01901146|7501973|FG004|Adjuvant Phase|Other|0
4632335|NCT01901146|7501969|FG000|Adjuvant Phase|Death|0
4632336|NCT01901146|7501970|FG001|Adjuvant Phase|Death|0
4632337|NCT01901146|7501971|FG002|Adjuvant Phase|Death|0
4632338|NCT01901146|7501972|FG003|Adjuvant Phase|Death|0
4632339|NCT01901146|7501973|FG004|Adjuvant Phase|Death|3
4632340|NCT01901146|7501969|FG000|Adjuvant Phase|Disease Progression or Recurrence|0
4632341|NCT01901146|7501970|FG001|Adjuvant Phase|Disease Progression or Recurrence|0
4632342|NCT01901146|7501971|FG002|Adjuvant Phase|Disease Progression or Recurrence|12
4632343|NCT01901146|7501972|FG003|Adjuvant Phase|Disease Progression or Recurrence|4
4632344|NCT01901146|7501973|FG004|Adjuvant Phase|Disease Progression or Recurrence|3
4632345|NCT01901146|7501969|FG000|Adjuvant Phase|Physician Decision|0
4632346|NCT01901146|7501970|FG001|Adjuvant Phase|Physician Decision|0
4632347|NCT01901146|7501971|FG002|Adjuvant Phase|Physician Decision|9
4632348|NCT01901146|7501972|FG003|Adjuvant Phase|Physician Decision|2
4632349|NCT01901146|7501973|FG004|Adjuvant Phase|Physician Decision|4
4632350|NCT01901146|7501969|FG000|Adjuvant Phase|Withdrawal by Subject|0
4632351|NCT01901146|7501970|FG001|Adjuvant Phase|Withdrawal by Subject|0
4632352|NCT01901146|7501971|FG002|Adjuvant Phase|Withdrawal by Subject|4
4632353|NCT01901146|7501972|FG003|Adjuvant Phase|Withdrawal by Subject|1
4632354|NCT01901146|7501973|FG004|Adjuvant Phase|Withdrawal by Subject|4
4632355|NCT01901185|7501982|FG000|Overall Study|Withdrawal by Subject|2
4632356|NCT01901302|7502006|FG000|Overall Study|Adverse Event|2
4632357|NCT01901302|7502007|FG001|Overall Study|Adverse Event|1
4632358|NCT01901302|7502006|FG000|Overall Study|Lack of Efficacy|0
4632359|NCT01901302|7502007|FG001|Overall Study|Lack of Efficacy|2
4632360|NCT01901302|7502006|FG000|Overall Study|Study Terminated by Sponsor|23
4632361|NCT01901302|7502007|FG001|Overall Study|Study Terminated by Sponsor|20
4632362|NCT01901302|7502006|FG000|Overall Study|Withdrawal by Subject|2
4632363|NCT01901302|7502007|FG001|Overall Study|Withdrawal by Subject|0
4632364|NCT01901328|7502015|FG000|Overall Study|Lost to Follow-up|1
4632365|NCT01901328|7502016|FG001|Overall Study|Lost to Follow-up|0
4632366|NCT01901328|7502015|FG000|Overall Study|Physician Decision|0
4632367|NCT01901328|7502016|FG001|Overall Study|Physician Decision|1
4632368|NCT01901328|7502015|FG000|Overall Study|Protocol Violation|1
4632369|NCT01901328|7502016|FG001|Overall Study|Protocol Violation|1
4632370|NCT01901328|7502015|FG000|Overall Study|Study Terminated by Sponsor|19
4632371|NCT01901328|7502016|FG001|Overall Study|Study Terminated by Sponsor|16
4632372|NCT01901328|7502015|FG000|Overall Study|Withdrawal by Subject|1
4632373|NCT01901328|7502016|FG001|Overall Study|Withdrawal by Subject|2
4632374|NCT01901328|7502015|FG000|Overall Study|Lack of Efficacy|0
4632375|NCT01901328|7502016|FG001|Overall Study|Lack of Efficacy|1
4632376|NCT01901341|7502025|FG000|Overall Study|Adverse Event|4
4632377|NCT01901341|7502026|FG001|Overall Study|Adverse Event|2
4632378|NCT01901341|7502025|FG000|Overall Study|Lack of Efficacy|0
4632379|NCT01901341|7502026|FG001|Overall Study|Lack of Efficacy|2
4632380|NCT01901341|7502025|FG000|Overall Study|Lost to Follow-up|0
4632381|NCT01901341|7502026|FG001|Overall Study|Lost to Follow-up|1
4632382|NCT01901341|7502025|FG000|Overall Study|Protocol Violation|2
4632383|NCT01901341|7502026|FG001|Overall Study|Protocol Violation|0
4632384|NCT01901341|7502025|FG000|Overall Study|Study Terminated by Sponsor|13
4632385|NCT01901341|7502026|FG001|Overall Study|Study Terminated by Sponsor|15
4632386|NCT01901341|7502025|FG000|Overall Study|Withdrawal by Subject|1
4632387|NCT01901341|7502026|FG001|Overall Study|Withdrawal by Subject|1
4632388|NCT01901393|7502035|FG000|Overall Study|Adverse Event|1
4632389|NCT01901393|7502036|FG001|Overall Study|Adverse Event|0
4632390|NCT01901419|7502044|FG000|Overall Study|Protocol Violation|2
4632391|NCT01901419|7502045|FG001|Overall Study|Protocol Violation|6
4632392|NCT01901419|7502044|FG000|Overall Study|unavailable researchers|6
4632393|NCT01901419|7502045|FG001|Overall Study|unavailable researchers|3
4734514|NCT03492281|7681264|FG002|Overall Study|Withdrawn Due to Sponsor|1
4734515|NCT03492281|7681262|FG000|Overall Study|Death|0
4734516|NCT03492281|7681263|FG001|Overall Study|Death|0
4734517|NCT03492281|7681264|FG002|Overall Study|Death|1
4734518|NCT03492281|7681262|FG000|Overall Study|Captured as Other in Database|8
4734519|NCT03492281|7681263|FG001|Overall Study|Captured as Other in Database|6
4734520|NCT03492281|7681264|FG002|Overall Study|Captured as Other in Database|3
4734521|NCT03492554|7681314|FG000|Overall Study|Protocol Violation|0
4734522|NCT03492554|7681315|FG001|Overall Study|Protocol Violation|14
4734523|NCT03493386|7681324|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0
4734524|NCT03493386|7681325|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1
4734525|NCT03493386|7681326|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0
4734526|NCT03493386|7681327|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0
4734527|NCT03493542|7681346|FG000|Overall Study|Ongoing|2
4734528|NCT03493542|7681347|FG001|Overall Study|Ongoing|3
4734529|NCT03493542|7681346|FG000|Overall Study|Withdrawal by parent or guardian|3
4632394|NCT01901614|7502067|FG000|Overall Study|Adverse Event|0
4632395|NCT01901614|7502068|FG001|Overall Study|Adverse Event|1
4632396|NCT01901614|7502067|FG000|Overall Study|Lost to Follow-up|1
4632397|NCT01901614|7502068|FG001|Overall Study|Lost to Follow-up|0
4734530|NCT03493542|7681347|FG001|Overall Study|Withdrawal by parent or guardian|0
4734531|NCT03493542|7681346|FG000|Overall Study|Withdrawal by Subject|2
4734532|NCT03493542|7681347|FG001|Overall Study|Withdrawal by Subject|6
4734533|NCT03493698|7681357|FG000|Treatment Period C|Adverse Event|1
4734534|NCT03493698|7681357|FG000|Treatment Period C|Withdrawal by Subject|1
4734535|NCT03494725|7681395|FG000|Overall Study|Withdrawal by Subject|0
4734536|NCT03494725|7681396|FG001|Overall Study|Withdrawal by Subject|2
4734537|NCT03494725|7681395|FG000|Overall Study|Antibiotic use|1
4734538|NCT03494725|7681396|FG001|Overall Study|Antibiotic use|0
4734539|NCT03494816|7681408|FG000|Overall Study|Protocol Violation|2
4734540|NCT03494816|7681408|FG000|Overall Study|Physician Decision|2
4734541|NCT03494816|7681408|FG000|Overall Study|Did not start trial treatment|1
4734542|NCT03494816|7681408|FG000|Overall Study|Adverse Event|1
4734543|NCT03494985|7681420|FG000|Overall Study|Adverse Event|3
4734544|NCT03494985|7681421|FG001|Overall Study|Adverse Event|2
4734545|NCT03494985|7681422|FG002|Overall Study|Adverse Event|3
4734546|NCT03494985|7681423|FG003|Overall Study|Adverse Event|0
4734547|NCT03494985|7681420|FG000|Overall Study|Other (Withdrawal of consent)|2
4734548|NCT03494985|7681421|FG001|Overall Study|Other (Withdrawal of consent)|3
4734549|NCT03494985|7681422|FG002|Overall Study|Other (Withdrawal of consent)|2
4734550|NCT03494985|7681423|FG003|Overall Study|Other (Withdrawal of consent)|5
4734551|NCT03494985|7681420|FG000|Overall Study|Other (Not specified)|0
4734552|NCT03494985|7681421|FG001|Overall Study|Other (Not specified)|1
4734553|NCT03494985|7681422|FG002|Overall Study|Other (Not specified)|1
4734554|NCT03494985|7681423|FG003|Overall Study|Other (Not specified)|0
4734555|NCT03495102|7681436|FG000|Overall Study|Adverse Event|5
4734556|NCT03495102|7681437|FG001|Overall Study|Adverse Event|7
4734557|NCT03495102|7681438|FG002|Overall Study|Adverse Event|10
4734558|NCT03495102|7681436|FG000|Overall Study|Death|3
4734559|NCT03495102|7681437|FG001|Overall Study|Death|4
4734560|NCT03495102|7681438|FG002|Overall Study|Death|4
4734561|NCT03495102|7681436|FG000|Overall Study|Lost to Follow-up|15
4734562|NCT03495102|7681437|FG001|Overall Study|Lost to Follow-up|16
4734563|NCT03495102|7681438|FG002|Overall Study|Lost to Follow-up|17
4734564|NCT03495102|7681436|FG000|Overall Study|Physician Decision|2
4734565|NCT03495102|7681437|FG001|Overall Study|Physician Decision|0
4632398|NCT01901614|7502067|FG000|Overall Study|Screen Fail|1
4632399|NCT01901614|7502068|FG001|Overall Study|Screen Fail|0
4632400|NCT01901653|7502087|FG000|Overall Study|Death|2
4632401|NCT01901653|7502088|FG001|Overall Study|Death|1
4632402|NCT01901653|7502089|FG002|Overall Study|Death|8
4632403|NCT01901653|7502090|FG003|Overall Study|Death|3
4632404|NCT01901653|7502091|FG004|Overall Study|Death|2
4632405|NCT01901653|7502092|FG005|Overall Study|Death|2
4632406|NCT01901653|7502093|FG006|Overall Study|Death|6
4632407|NCT01901653|7502094|FG007|Overall Study|Death|9
4632408|NCT01901653|7502095|FG008|Overall Study|Death|1
4632409|NCT01901653|7502096|FG009|Overall Study|Death|16
4632410|NCT01901653|7502097|FG010|Overall Study|Death|2
4632411|NCT01901653|7502098|FG011|Overall Study|Death|15
4632412|NCT01901653|7502099|FG012|Overall Study|Death|4
4632413|NCT01901653|7502087|FG000|Overall Study|Lost to Follow-up|1
4632414|NCT01901653|7502088|FG001|Overall Study|Lost to Follow-up|0
4632415|NCT01901653|7502089|FG002|Overall Study|Lost to Follow-up|2
4632416|NCT01901653|7502090|FG003|Overall Study|Lost to Follow-up|0
4632417|NCT01901653|7502091|FG004|Overall Study|Lost to Follow-up|0
4632418|NCT01901653|7502092|FG005|Overall Study|Lost to Follow-up|1
4632419|NCT01901653|7502093|FG006|Overall Study|Lost to Follow-up|0
4632420|NCT01901653|7502094|FG007|Overall Study|Lost to Follow-up|1
4632421|NCT01901653|7502095|FG008|Overall Study|Lost to Follow-up|0
4632422|NCT01901653|7502096|FG009|Overall Study|Lost to Follow-up|0
4734566|NCT03495102|7681438|FG002|Overall Study|Physician Decision|2
4734567|NCT03495102|7681436|FG000|Overall Study|Withdrawal by Subject|25
4734568|NCT03495102|7681437|FG001|Overall Study|Withdrawal by Subject|36
4734569|NCT03495102|7681438|FG002|Overall Study|Withdrawal by Subject|18
4734570|NCT03495102|7681436|FG000|Overall Study|Protocol Violation|1
4734571|NCT03495102|7681437|FG001|Overall Study|Protocol Violation|1
4734572|NCT03495102|7681438|FG002|Overall Study|Protocol Violation|0
4734573|NCT03495102|7681436|FG000|Overall Study|Site Closure|3
4734574|NCT03495102|7681437|FG001|Overall Study|Site Closure|1
4734575|NCT03495102|7681438|FG002|Overall Study|Site Closure|2
4734576|NCT03495102|7681436|FG000|Overall Study|Non-compliance|1
4734577|NCT03495102|7681437|FG001|Overall Study|Non-compliance|0
4734578|NCT03495102|7681438|FG002|Overall Study|Non-compliance|0
4734579|NCT03495102|7681436|FG000|Overall Study|Participant Duplicated at Another Site|0
4734580|NCT03495102|7681437|FG001|Overall Study|Participant Duplicated at Another Site|0
4734581|NCT03495102|7681438|FG002|Overall Study|Participant Duplicated at Another Site|1
4734582|NCT03495102|7681436|FG000|Overall Study|Primary Care Physician Recommendation|0
4734583|NCT03495102|7681437|FG001|Overall Study|Primary Care Physician Recommendation|1
4734584|NCT03495102|7681438|FG002|Overall Study|Primary Care Physician Recommendation|0
4734585|NCT03495102|7681436|FG000|Overall Study|Relocated to Another Country|0
4734586|NCT03495102|7681437|FG001|Overall Study|Relocated to Another Country|1
4734587|NCT03495102|7681438|FG002|Overall Study|Relocated to Another Country|0
4734588|NCT03495102|7681436|FG000|Overall Study|Participant was in Rehabilitation|1
4734589|NCT03495102|7681437|FG001|Overall Study|Participant was in Rehabilitation|0
4734590|NCT03495102|7681438|FG002|Overall Study|Participant was in Rehabilitation|0
4734591|NCT03495817|7681455|FG000|26 Week Open Label|Adverse Event|3
4734592|NCT03495817|7681455|FG000|26 Week Open Label|Withdrawal by Subject|4
4734593|NCT03495817|7681455|FG000|26 Week Open Label|Lost to Follow-up|1
4734594|NCT03495817|7681455|FG000|26 Week Extension|Lost to Follow-up|2
4734595|NCT03495869|7681467|FG000|Overall Study|Lost to Follow-up|4
4734596|NCT03495869|7681468|FG001|Overall Study|Lost to Follow-up|17
4734597|NCT03495869|7681469|FG002|Overall Study|Lost to Follow-up|8
4734598|NCT03495869|7681470|FG003|Overall Study|Lost to Follow-up|14
4734599|NCT03495869|7681467|FG000|Overall Study|Withdrawal by Subject|0
4734600|NCT03495869|7681468|FG001|Overall Study|Withdrawal by Subject|3
4734601|NCT03495869|7681469|FG002|Overall Study|Withdrawal by Subject|0
4734602|NCT03495869|7681470|FG003|Overall Study|Withdrawal by Subject|3
4734603|NCT03495869|7681467|FG000|Overall Study|Dropped from study|0
4734604|NCT03495869|7681468|FG001|Overall Study|Dropped from study|7
4734605|NCT03495869|7681469|FG002|Overall Study|Dropped from study|2
4734606|NCT03495869|7681470|FG003|Overall Study|Dropped from study|4
4734607|NCT03495908|7681482|FG000|Overall Study|Withdrawal by Subject|3
4734608|NCT03495908|7681483|FG001|Overall Study|Withdrawal by Subject|1
4734609|NCT03495908|7681482|FG000|Overall Study|Lost to Follow-up|1
4734610|NCT03495908|7681483|FG001|Overall Study|Lost to Follow-up|4
4734611|NCT03495908|7681482|FG000|Overall Study|Adverse Event|0
4734612|NCT03495908|7681483|FG001|Overall Study|Adverse Event|2
4734613|NCT03495908|7681482|FG000|Overall Study|Death|1
4734614|NCT03495908|7681483|FG001|Overall Study|Death|0
4734615|NCT03495908|7681482|FG000|Overall Study|Physician Decision|5
4734616|NCT03495908|7681483|FG001|Overall Study|Physician Decision|4
4734617|NCT03495908|7681482|FG000|Overall Study|No documented reason|0
4734618|NCT03495908|7681483|FG001|Overall Study|No documented reason|2
4734619|NCT03496298|7681502|FG000|Overall Study|Adverse Event|49
4734620|NCT03496298|7681503|FG001|Overall Study|Adverse Event|68
4734621|NCT03496298|7681504|FG002|Overall Study|Adverse Event|79
4734622|NCT03496298|7681502|FG000|Overall Study|Study terminated by Sponsor|1050
4734623|NCT03496298|7681503|FG001|Overall Study|Study terminated by Sponsor|1063
4734624|NCT03496298|7681504|FG002|Overall Study|Study terminated by Sponsor|1071
4734625|NCT03496298|7681502|FG000|Overall Study|Physician decision (other than Adverse event)|12
4737517|NCT03613649|7687752|FG003|Third Treatment|Lost to Follow-up|0
4632423|NCT01901653|7502097|FG010|Overall Study|Lost to Follow-up|0
4447527|NCT00490919|7232799|FG000|Open-label Run-in Period|Lack of Efficacy|143
4447528|NCT00490919|7232800|FG001|Open-label Run-in Period|Lack of Efficacy|0
4447529|NCT00490919|7232801|FG002|Open-label Run-in Period|Lack of Efficacy|0
4447530|NCT00490919|7232799|FG000|Open-label Run-in Period|Administrative|40
4447531|NCT00490919|7232800|FG001|Open-label Run-in Period|Administrative|0
4447532|NCT00490919|7232801|FG002|Open-label Run-in Period|Administrative|0
4447533|NCT00490919|7232799|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3
4447534|NCT00490919|7232800|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0
4447535|NCT00490919|7232801|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0
4447536|NCT00490919|7232799|FG000|Double-blind Phase|Adverse Event|0
4447537|NCT00490919|7232800|FG001|Double-blind Phase|Adverse Event|40
4447538|NCT00490919|7232801|FG002|Double-blind Phase|Adverse Event|20
4447539|NCT00490919|7232799|FG000|Double-blind Phase|Withdrawal by Subject|0
4447540|NCT00490919|7232800|FG001|Double-blind Phase|Withdrawal by Subject|10
4447541|NCT00490919|7232801|FG002|Double-blind Phase|Withdrawal by Subject|11
4447542|NCT00490919|7232799|FG000|Double-blind Phase|Lost to Follow-up|0
4447543|NCT00490919|7232800|FG001|Double-blind Phase|Lost to Follow-up|8
4447544|NCT00490919|7232801|FG002|Double-blind Phase|Lost to Follow-up|11
4447545|NCT00490919|7232799|FG000|Double-blind Phase|Lack of Efficacy|0
4447546|NCT00490919|7232800|FG001|Double-blind Phase|Lack of Efficacy|22
4447547|NCT00490919|7232801|FG002|Double-blind Phase|Lack of Efficacy|36
4447548|NCT00490919|7232799|FG000|Double-blind Phase|Administrative|0
4447549|NCT00490919|7232800|FG001|Double-blind Phase|Administrative|6
4447550|NCT00490919|7232801|FG002|Double-blind Phase|Administrative|6
4447551|NCT00490945|7232813|FG000|Overall Study|Adverse Event|0
4447552|NCT00490945|7232814|FG001|Overall Study|Adverse Event|1
4447553|NCT00490945|7232815|FG002|Overall Study|Adverse Event|0
4447554|NCT00490945|7232816|FG003|Overall Study|Adverse Event|0
4447555|NCT00490945|7232817|FG004|Overall Study|Adverse Event|0
4447556|NCT00490971|7232837|FG000|Acute/Continuation|Adverse Event|62
4447557|NCT00490971|7232838|FG001|Acute/Continuation|Adverse Event|13
4447558|NCT00490971|7232839|FG002|Acute/Continuation|Adverse Event|0
4447559|NCT00490971|7232840|FG003|Acute/Continuation|Adverse Event|0
4447560|NCT00490971|7232841|FG004|Acute/Continuation|Adverse Event|0
4447561|NCT00490971|7232837|FG000|Acute/Continuation|Death|2
4447562|NCT00490971|7232838|FG001|Acute/Continuation|Death|0
4447563|NCT00490971|7232839|FG002|Acute/Continuation|Death|0
4447564|NCT00490971|7232840|FG003|Acute/Continuation|Death|0
4447565|NCT00490971|7232841|FG004|Acute/Continuation|Death|0
4447566|NCT00490971|7232837|FG000|Acute/Continuation|Lack of Efficacy|106
4447567|NCT00490971|7232838|FG001|Acute/Continuation|Lack of Efficacy|12
4447568|NCT00490971|7232839|FG002|Acute/Continuation|Lack of Efficacy|0
4447569|NCT00490971|7232840|FG003|Acute/Continuation|Lack of Efficacy|0
4447570|NCT00490971|7232841|FG004|Acute/Continuation|Lack of Efficacy|0
4447571|NCT00490971|7232837|FG000|Acute/Continuation|Lost to Follow-up|23
4447572|NCT00490971|7232838|FG001|Acute/Continuation|Lost to Follow-up|7
4515678|NCT00955357|7326681|FG000|Titration Phase|Withdrawal by Subject|3
4515679|NCT00955357|7326682|FG001|Titration Phase|Withdrawal by Subject|5
4632424|NCT01901653|7502098|FG011|Overall Study|Lost to Follow-up|0
4632425|NCT01901653|7502099|FG012|Overall Study|Lost to Follow-up|0
4447573|NCT00490971|7232839|FG002|Acute/Continuation|Lost to Follow-up|0
4632426|NCT01901653|7502087|FG000|Overall Study|Withdrawal by Subject|0
4632427|NCT01901653|7502088|FG001|Overall Study|Withdrawal by Subject|0
4632428|NCT01901653|7502089|FG002|Overall Study|Withdrawal by Subject|0
4632429|NCT01901653|7502090|FG003|Overall Study|Withdrawal by Subject|0
4632430|NCT01901653|7502091|FG004|Overall Study|Withdrawal by Subject|0
4632431|NCT01901653|7502092|FG005|Overall Study|Withdrawal by Subject|0
4447574|NCT00490971|7232840|FG003|Acute/Continuation|Lost to Follow-up|0
4447575|NCT00490971|7232841|FG004|Acute/Continuation|Lost to Follow-up|0
4447576|NCT00490971|7232837|FG000|Acute/Continuation|Protocol Violation|10
4447577|NCT00490971|7232838|FG001|Acute/Continuation|Protocol Violation|2
4632432|NCT01901653|7502093|FG006|Overall Study|Withdrawal by Subject|1
4632433|NCT01901653|7502094|FG007|Overall Study|Withdrawal by Subject|0
4632434|NCT01901653|7502095|FG008|Overall Study|Withdrawal by Subject|0
4632435|NCT01901653|7502096|FG009|Overall Study|Withdrawal by Subject|0
4734626|NCT03496298|7681503|FG001|Overall Study|Physician decision (other than Adverse event)|17
4734627|NCT03496298|7681504|FG002|Overall Study|Physician decision (other than Adverse event)|10
4734628|NCT03496298|7681502|FG000|Overall Study|Withdrawal by Subject|176
4734629|NCT03496298|7681503|FG001|Overall Study|Withdrawal by Subject|154
4734630|NCT03496298|7681504|FG002|Overall Study|Withdrawal by Subject|151
4632436|NCT01901653|7502097|FG010|Overall Study|Withdrawal by Subject|0
4632437|NCT01901653|7502098|FG011|Overall Study|Withdrawal by Subject|0
4632438|NCT01901653|7502099|FG012|Overall Study|Withdrawal by Subject|0
4632439|NCT01901653|7502087|FG000|Overall Study|Alive at Study Termination by Sponsor|0
4632440|NCT01901653|7502088|FG001|Overall Study|Alive at Study Termination by Sponsor|0
4632441|NCT01901653|7502089|FG002|Overall Study|Alive at Study Termination by Sponsor|1
4632442|NCT01901653|7502090|FG003|Overall Study|Alive at Study Termination by Sponsor|0
4632443|NCT01901653|7502091|FG004|Overall Study|Alive at Study Termination by Sponsor|0
4632444|NCT01901653|7502092|FG005|Overall Study|Alive at Study Termination by Sponsor|0
4734631|NCT03496298|7681502|FG000|Overall Study|Other|29
4734632|NCT03496298|7681503|FG001|Overall Study|Other|20
4734633|NCT03496298|7681504|FG002|Overall Study|Other|23
4734634|NCT03496298|7681502|FG000|Overall Study|Randomized and not treated|1
4734635|NCT03496298|7681503|FG001|Overall Study|Randomized and not treated|1
4734636|NCT03496298|7681504|FG002|Overall Study|Randomized and not treated|1
4734637|NCT03497039|7681576|FG000|Overall Study|Withdrawal by Subject|1
4734638|NCT03497039|7681577|FG001|Overall Study|Withdrawal by Subject|0
4734639|NCT03497039|7681576|FG000|Overall Study|Protocol Violation|0
4734640|NCT03497039|7681577|FG001|Overall Study|Protocol Violation|1
4734641|NCT03497130|7681585|FG000|Overall Study|Lost to Follow-up|1
4734642|NCT03497130|7681586|FG001|Overall Study|Lost to Follow-up|1
4734643|NCT03497429|7681594|FG000|Overall Study|Progressive disease|3
4734644|NCT03497429|7681595|FG001|Overall Study|Progressive disease|4
4734645|NCT03497429|7681594|FG000|Overall Study|Adverse Event|0
4734646|NCT03497429|7681595|FG001|Overall Study|Adverse Event|2
4734647|NCT03498287|7681666|FG000|Overall Study|Withdrawal by Subject|3
4734648|NCT03498287|7681667|FG001|Overall Study|Withdrawal by Subject|0
4734649|NCT03498287|7681666|FG000|Overall Study|Protocol Violation|0
4734650|NCT03498287|7681667|FG001|Overall Study|Protocol Violation|4
4734651|NCT03498287|7681666|FG000|Overall Study|Adverse Event|0
4734652|NCT03498287|7681667|FG001|Overall Study|Adverse Event|1
4734653|NCT03499028|7681685|FG000|Overall Study|Lost to Follow-up|12
4734654|NCT03499028|7681686|FG001|Overall Study|Lost to Follow-up|9
4734655|NCT03499028|7681685|FG000|Overall Study|Withdrawal by Subject|5
4734656|NCT03499028|7681686|FG001|Overall Study|Withdrawal by Subject|8
4734657|NCT03499028|7681685|FG000|Overall Study|Unplanned SNF discharge|5
4734658|NCT03499028|7681686|FG001|Overall Study|Unplanned SNF discharge|8
4734659|NCT03499067|7681694|FG000|First Intervention|Physician Decision|2
4734660|NCT03499067|7681695|FG001|First Intervention|Physician Decision|1
4734661|NCT03499067|7681694|FG000|First Intervention|Withdrawal by Subject|3
4734662|NCT03499067|7681695|FG001|First Intervention|Withdrawal by Subject|6
4734663|NCT03499353|7681701|FG000|Treatment|Adverse Event|3
4734664|NCT03499353|7681701|FG000|Treatment|Progressive Disease|10
4734665|NCT03499353|7681701|FG000|Treatment|Other|1
4734666|NCT03499353|7681701|FG000|Treatment|Withdrawal by Subject|2
4734667|NCT03499353|7681701|FG000|Long-Term Follow-up|Death|2
4734668|NCT03499353|7681701|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55
4734669|NCT03499353|7681701|FG000|Long-Term Follow-up|Withdrawal by Subject|1
4734670|NCT03499873|7681708|FG000|Overall Study|Withdrawal by Subject|4
4632445|NCT01901653|7502093|FG006|Overall Study|Alive at Study Termination by Sponsor|0
4632446|NCT01901653|7502094|FG007|Overall Study|Alive at Study Termination by Sponsor|0
4734671|NCT03499873|7681709|FG001|Overall Study|Withdrawal by Subject|6
4734672|NCT03499873|7681710|FG002|Overall Study|Withdrawal by Subject|1
4734673|NCT03499873|7681708|FG000|Overall Study|Subjects condition worsened|0
4447578|NCT00490971|7232839|FG002|Acute/Continuation|Protocol Violation|0
4447579|NCT00490971|7232840|FG003|Acute/Continuation|Protocol Violation|0
4734674|NCT03499873|7681709|FG001|Overall Study|Subjects condition worsened|3
4734675|NCT03499873|7681710|FG002|Overall Study|Subjects condition worsened|11
4734676|NCT03499873|7681708|FG000|Overall Study|Adverse Event|8
4734677|NCT03499873|7681709|FG001|Overall Study|Adverse Event|3
4734678|NCT03499873|7681710|FG002|Overall Study|Adverse Event|6
4734679|NCT03499873|7681708|FG000|Overall Study|Physician Decision|1
4734680|NCT03499873|7681709|FG001|Overall Study|Physician Decision|0
4734681|NCT03499873|7681710|FG002|Overall Study|Physician Decision|0
4734682|NCT03499873|7681708|FG000|Overall Study|Administrative reasons|0
4734683|NCT03499873|7681709|FG001|Overall Study|Administrative reasons|1
4734684|NCT03499873|7681710|FG002|Overall Study|Administrative reasons|0
4734685|NCT03499873|7681708|FG000|Overall Study|Concomitant therapy|5
4734686|NCT03499873|7681709|FG001|Overall Study|Concomitant therapy|4
4734687|NCT03499873|7681710|FG002|Overall Study|Concomitant therapy|7
4734688|NCT03499873|7681708|FG000|Overall Study|Miscellaneous|1
4734689|NCT03499873|7681709|FG001|Overall Study|Miscellaneous|2
4632447|NCT01901653|7502095|FG008|Overall Study|Alive at Study Termination by Sponsor|0
4632448|NCT01901653|7502096|FG009|Overall Study|Alive at Study Termination by Sponsor|2
4632449|NCT01901653|7502097|FG010|Overall Study|Alive at Study Termination by Sponsor|0
4632450|NCT01901653|7502098|FG011|Overall Study|Alive at Study Termination by Sponsor|1
4632451|NCT01901653|7502099|FG012|Overall Study|Alive at Study Termination by Sponsor|1
4632452|NCT01901848|7502148|FG000|Randomized and Treated|Lost to Follow-up|3
4734690|NCT03499873|7681710|FG002|Overall Study|Miscellaneous|2
4734691|NCT03499873|7681708|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1
4734692|NCT03499873|7681709|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1
4734693|NCT03499873|7681710|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0
4734694|NCT03500094|7681718|FG000|Overall Study|Withdrawal by Subject|1
4734695|NCT03500094|7681718|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1
4734696|NCT03500094|7681718|FG000|Overall Study|Lost to Follow-up|1
4734697|NCT03500198|7681726|FG000|Overall Study|Lost to Follow-up|0
4734698|NCT03500198|7681727|FG001|Overall Study|Lost to Follow-up|1
4734699|NCT03500211|7681737|FG000|Overall Study|Withdrawal by Subject|1
4734700|NCT03500211|7681738|FG001|Overall Study|Withdrawal by Subject|1
4734701|NCT03500224|7681744|FG000|Overall Study|Withdrawal by Subject|2
4734702|NCT03500419|7681763|FG000|Overall Study|Withdrawal by Subject|2
4734703|NCT03500419|7681764|FG001|Overall Study|Withdrawal by Subject|25
4734704|NCT03500679|7681772|FG000|Overall Study|Lost to Follow-up|6
4734705|NCT03500679|7681773|FG001|Overall Study|Lost to Follow-up|3
4734706|NCT03500679|7681772|FG000|Overall Study|Withdrawal by Subject|3
4734707|NCT03500679|7681773|FG001|Overall Study|Withdrawal by Subject|0
4737518|NCT03613649|7687753|FG004|Third Treatment|Lost to Follow-up|1
4737519|NCT03613649|7687754|FG005|Third Treatment|Lost to Follow-up|0
4737520|NCT03613649|7687755|FG006|Third Treatment|Lost to Follow-up|0
4737521|NCT03613649|7687756|FG007|Third Treatment|Lost to Follow-up|0
4737522|NCT03613649|7687757|FG008|Third Treatment|Lost to Follow-up|0
4737523|NCT03613649|7687758|FG009|Third Treatment|Lost to Follow-up|0
4737524|NCT03613649|7687759|FG010|Third Treatment|Lost to Follow-up|0
4737525|NCT03613649|7687760|FG011|Third Treatment|Lost to Follow-up|1
4737526|NCT03613649|7687749|FG000|Third Treatment|Protocol Violation|0
4737527|NCT03613649|7687750|FG001|Third Treatment|Protocol Violation|0
4737528|NCT03613649|7687751|FG002|Third Treatment|Protocol Violation|0
4737529|NCT03613649|7687752|FG003|Third Treatment|Protocol Violation|0
4737530|NCT03613649|7687753|FG004|Third Treatment|Protocol Violation|0
4737531|NCT03613649|7687754|FG005|Third Treatment|Protocol Violation|0
4737532|NCT03613649|7687755|FG006|Third Treatment|Protocol Violation|1
4737533|NCT03613649|7687756|FG007|Third Treatment|Protocol Violation|0
4737534|NCT03613649|7687757|FG008|Third Treatment|Protocol Violation|0
4737535|NCT03613649|7687758|FG009|Third Treatment|Protocol Violation|0
4737536|NCT03613649|7687759|FG010|Third Treatment|Protocol Violation|0
4737537|NCT03613649|7687760|FG011|Third Treatment|Protocol Violation|1
4737538|NCT03613649|7687749|FG000|Fourth Treatment|Protocol Violation|1
4737539|NCT03613649|7687750|FG001|Fourth Treatment|Protocol Violation|0
4737540|NCT03613649|7687751|FG002|Fourth Treatment|Protocol Violation|0
4737541|NCT03613649|7687752|FG003|Fourth Treatment|Protocol Violation|0
4737542|NCT03613649|7687753|FG004|Fourth Treatment|Protocol Violation|1
4632453|NCT01901848|7502149|FG001|Randomized and Treated|Lost to Follow-up|6
4632454|NCT01901848|7502148|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10
4632455|NCT01901848|7502149|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0
4632456|NCT01901874|7502155|FG000|Screening Committee Retrospective Review|Protocol Violation|47
4632457|NCT01901874|7502155|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1
4632458|NCT01901874|7502155|FG000|1-Year (365-Day) MAE Evaluation|Death|7
4632459|NCT01901874|7502155|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5
4632460|NCT01901874|7502155|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2
4632461|NCT01901874|7502155|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6
4632462|NCT01902134|7502174|FG000|Overall Study|Adverse Event|3
4632463|NCT01902134|7502175|FG001|Overall Study|Adverse Event|1
4632464|NCT01902134|7502176|FG002|Overall Study|Adverse Event|2
4632465|NCT01902134|7502177|FG003|Overall Study|Adverse Event|1
4632466|NCT01902134|7502178|FG004|Overall Study|Adverse Event|1
4632467|NCT01902134|7502179|FG005|Overall Study|Adverse Event|3
4632468|NCT01902134|7502174|FG000|Overall Study|Lack of Efficacy|0
4632469|NCT01902134|7502175|FG001|Overall Study|Lack of Efficacy|0
4632470|NCT01902134|7502176|FG002|Overall Study|Lack of Efficacy|2
4632471|NCT01902134|7502177|FG003|Overall Study|Lack of Efficacy|0
4632472|NCT01902134|7502178|FG004|Overall Study|Lack of Efficacy|0
4632473|NCT01902134|7502179|FG005|Overall Study|Lack of Efficacy|1
4632474|NCT01902134|7502174|FG000|Overall Study|Physician Decision|0
4632475|NCT01902134|7502175|FG001|Overall Study|Physician Decision|1
4632476|NCT01902134|7502176|FG002|Overall Study|Physician Decision|0
4632477|NCT01902134|7502177|FG003|Overall Study|Physician Decision|0
4632478|NCT01902134|7502178|FG004|Overall Study|Physician Decision|0
4632479|NCT01902134|7502179|FG005|Overall Study|Physician Decision|0
4632480|NCT01902134|7502174|FG000|Overall Study|Protocol Violation|0
4632481|NCT01902134|7502175|FG001|Overall Study|Protocol Violation|0
4632482|NCT01902134|7502176|FG002|Overall Study|Protocol Violation|0
4632483|NCT01902134|7502177|FG003|Overall Study|Protocol Violation|0
4632484|NCT01902134|7502178|FG004|Overall Study|Protocol Violation|0
4632485|NCT01902134|7502179|FG005|Overall Study|Protocol Violation|1
4632486|NCT01902134|7502174|FG000|Overall Study|Withdrawal by Subject|4
4734708|NCT03500692|7681779|FG000|Overall Study|Death|76
4734709|NCT03500692|7681779|FG000|Overall Study|Missed visit|30
4734710|NCT03500692|7681779|FG000|Overall Study|Termination Reasons|3
4734711|NCT03501277|7681856|FG000|Intervention Period 1 (4 Days)|Other|0
4734712|NCT03501277|7681857|FG001|Intervention Period 1 (4 Days)|Other|0
4734713|NCT03501277|7681858|FG002|Intervention Period 1 (4 Days)|Other|1
4734714|NCT03501277|7681859|FG003|Intervention Period 1 (4 Days)|Other|0
4734715|NCT03501277|7681856|FG000|Intervention Period 1 (4 Days)|Adverse Event|0
4734716|NCT03501277|7681857|FG001|Intervention Period 1 (4 Days)|Adverse Event|0
4734717|NCT03501277|7681858|FG002|Intervention Period 1 (4 Days)|Adverse Event|0
4734718|NCT03501277|7681859|FG003|Intervention Period 1 (4 Days)|Adverse Event|1
4734719|NCT03501277|7681856|FG000|Intervention Period 2 (4 Days)|Adverse Event|0
4734720|NCT03501277|7681857|FG001|Intervention Period 2 (4 Days)|Adverse Event|0
4734721|NCT03501277|7681858|FG002|Intervention Period 2 (4 Days)|Adverse Event|0
4734722|NCT03501277|7681859|FG003|Intervention Period 2 (4 Days)|Adverse Event|1
4734723|NCT03501277|7681856|FG000|Intervention Period 3 (4 Days)|Adverse Event|0
4734724|NCT03501277|7681857|FG001|Intervention Period 3 (4 Days)|Adverse Event|0
4734725|NCT03501277|7681858|FG002|Intervention Period 3 (4 Days)|Adverse Event|0
4734726|NCT03501277|7681859|FG003|Intervention Period 3 (4 Days)|Adverse Event|1
4734727|NCT03502616|7681886|FG000|Up to Week 16|Withdrawal by Subject|1
4734728|NCT03502616|7681887|FG001|Up to Week 16|Withdrawal by Subject|2
4734729|NCT03502616|7681886|FG000|Up to Week 16|Lost to Follow-up|0
4734730|NCT03502616|7681887|FG001|Up to Week 16|Lost to Follow-up|1
4734731|NCT03502616|7681886|FG000|Up to Week 16|Randomized, but not treated|1
4734732|NCT03502616|7681887|FG001|Up to Week 16|Randomized, but not treated|0
4734733|NCT03502616|7681886|FG000|Week 16 to Week 48|Withdrawal by Subject|6
4734734|NCT03502616|7681887|FG001|Week 16 to Week 48|Withdrawal by Subject|6
4734735|NCT03502616|7681886|FG000|Week 16 to Week 48|Lost to Follow-up|1
4734736|NCT03502616|7681887|FG001|Week 16 to Week 48|Lost to Follow-up|0
4734737|NCT03502681|7681897|FG000|Overall Study|Adverse Event|1
4632487|NCT01902134|7502175|FG001|Overall Study|Withdrawal by Subject|8
4632488|NCT01902134|7502176|FG002|Overall Study|Withdrawal by Subject|9
4632489|NCT01902134|7502177|FG003|Overall Study|Withdrawal by Subject|1
4734738|NCT03502681|7681898|FG001|Overall Study|Adverse Event|1
4734739|NCT03502681|7681897|FG000|Overall Study|Disease Progression|2
4734740|NCT03502681|7681898|FG001|Overall Study|Disease Progression|1
4734741|NCT03502798|7681905|FG000|Overall Study|equipment failure|0
4734742|NCT03502798|7681906|FG001|Overall Study|equipment failure|7
4734743|NCT03503162|7681934|FG000|Overall Study|did not meet eligibility|1
4734744|NCT03503188|7681940|FG000|Overall Study|Non eligible in the sub study|0
4734745|NCT03503188|7681941|FG001|Overall Study|Non eligible in the sub study|1
4734746|NCT03504189|7681969|FG000|Overall Study|Withdrawal by Subject|1
4734747|NCT03504189|7681969|FG000|Overall Study|Screening Failure|1
4734748|NCT03504189|7681969|FG000|Overall Study|Device Failure|2
4734749|NCT03504852|7681985|FG000|Overall Study|Withdrawal of informed consent|2
4734750|NCT03504852|7681986|FG001|Overall Study|Withdrawal of informed consent|1
4734751|NCT03504852|7681987|FG002|Overall Study|Withdrawal of informed consent|0
4734752|NCT03504852|7681985|FG000|Overall Study|Withdrawal by Subject|5
4734753|NCT03504852|7681986|FG001|Overall Study|Withdrawal by Subject|5
4734754|NCT03504852|7681987|FG002|Overall Study|Withdrawal by Subject|1
4734755|NCT03504852|7681985|FG000|Overall Study|Lost to Follow-up|4
4632490|NCT01902134|7502178|FG004|Overall Study|Withdrawal by Subject|5
4632491|NCT01902134|7502179|FG005|Overall Study|Withdrawal by Subject|4
4632492|NCT01902134|7502174|FG000|Overall Study|no compliance|1
4632493|NCT01902134|7502175|FG001|Overall Study|no compliance|0
4632494|NCT01902134|7502176|FG002|Overall Study|no compliance|0
4734756|NCT03504852|7681986|FG001|Overall Study|Lost to Follow-up|1
4734757|NCT03504852|7681987|FG002|Overall Study|Lost to Follow-up|0
4734758|NCT03504852|7681985|FG000|Overall Study|New therapy for study indication|1
4734759|NCT03504852|7681986|FG001|Overall Study|New therapy for study indication|0
4734760|NCT03504852|7681987|FG002|Overall Study|New therapy for study indication|0
4734761|NCT03504852|7681985|FG000|Overall Study|Lack of Efficacy|1
4734762|NCT03504852|7681986|FG001|Overall Study|Lack of Efficacy|2
4734763|NCT03504852|7681987|FG002|Overall Study|Lack of Efficacy|0
4734764|NCT03504852|7681985|FG000|Overall Study|Death|0
4734765|NCT03504852|7681986|FG001|Overall Study|Death|1
4734766|NCT03504852|7681987|FG002|Overall Study|Death|0
4734767|NCT03504852|7681985|FG000|Overall Study|Adverse Event|4
4734768|NCT03504852|7681986|FG001|Overall Study|Adverse Event|8
4734769|NCT03504852|7681987|FG002|Overall Study|Adverse Event|2
4632495|NCT01902134|7502177|FG003|Overall Study|no compliance|0
4632496|NCT01902134|7502178|FG004|Overall Study|no compliance|0
4632497|NCT01902134|7502179|FG005|Overall Study|no compliance|0
4632498|NCT01902134|7502174|FG000|Overall Study|Other|0
4632499|NCT01902134|7502175|FG001|Overall Study|Other|1
4632500|NCT01902134|7502176|FG002|Overall Study|Other|2
4632501|NCT01902134|7502177|FG003|Overall Study|Other|0
4632502|NCT01902134|7502178|FG004|Overall Study|Other|1
4632503|NCT01902134|7502179|FG005|Overall Study|Other|0
4632504|NCT01902303|7502197|FG000|Overall Study|Adverse Event|0
4632505|NCT01902303|7502198|FG001|Overall Study|Adverse Event|1
4632506|NCT01902303|7502197|FG000|Overall Study|Lost to Follow-up|0
4632507|NCT01902303|7502198|FG001|Overall Study|Lost to Follow-up|1
4737543|NCT03613649|7687754|FG005|Fourth Treatment|Protocol Violation|0
4737544|NCT03613649|7687755|FG006|Fourth Treatment|Protocol Violation|0
4737545|NCT03613649|7687756|FG007|Fourth Treatment|Protocol Violation|0
4737546|NCT03613649|7687757|FG008|Fourth Treatment|Protocol Violation|0
4737547|NCT03613649|7687758|FG009|Fourth Treatment|Protocol Violation|0
4737548|NCT03613649|7687759|FG010|Fourth Treatment|Protocol Violation|0
4737549|NCT03613649|7687760|FG011|Fourth Treatment|Protocol Violation|0
4737550|NCT03613649|7687749|FG000|Fourth Treatment|Physician Decision|0
4737551|NCT03613649|7687750|FG001|Fourth Treatment|Physician Decision|0
4737552|NCT03613649|7687751|FG002|Fourth Treatment|Physician Decision|0
4737553|NCT03613649|7687752|FG003|Fourth Treatment|Physician Decision|0
4737554|NCT03613649|7687753|FG004|Fourth Treatment|Physician Decision|0
4737555|NCT03613649|7687754|FG005|Fourth Treatment|Physician Decision|0
4737556|NCT03613649|7687755|FG006|Fourth Treatment|Physician Decision|1
4737557|NCT03613649|7687756|FG007|Fourth Treatment|Physician Decision|0
4737558|NCT03613649|7687757|FG008|Fourth Treatment|Physician Decision|0
4737559|NCT03613649|7687758|FG009|Fourth Treatment|Physician Decision|0
4737560|NCT03613649|7687759|FG010|Fourth Treatment|Physician Decision|0
4737561|NCT03613649|7687760|FG011|Fourth Treatment|Physician Decision|0
4632508|NCT01902303|7502197|FG000|Overall Study|Protocol Violation|2
4632509|NCT01902303|7502198|FG001|Overall Study|Protocol Violation|2
4632510|NCT01902303|7502197|FG000|Overall Study|subject lost investigational product|0
4734770|NCT03504917|7681999|FG000|Blinded Treatment Period|Protocol Violation|1
4632511|NCT01902303|7502198|FG001|Overall Study|subject lost investigational product|1
4734771|NCT03504917|7682000|FG001|Blinded Treatment Period|Protocol Violation|0
4734772|NCT03504917|7681999|FG000|Blinded Treatment Period|Withdrawal by Subject|12
4734773|NCT03504917|7682000|FG001|Blinded Treatment Period|Withdrawal by Subject|9
4734774|NCT03504917|7681999|FG000|Blinded Treatment Period|Lack of Efficacy|1
4734775|NCT03504917|7682000|FG001|Blinded Treatment Period|Lack of Efficacy|1
4734776|NCT03504917|7681999|FG000|Blinded Treatment Period|Lost to Follow-up|1
4734777|NCT03504917|7682000|FG001|Blinded Treatment Period|Lost to Follow-up|4
4734778|NCT03504917|7681999|FG000|Blinded Treatment Period|Adverse Event|4
4734779|NCT03504917|7682000|FG001|Blinded Treatment Period|Adverse Event|4
4734780|NCT03504917|7681999|FG000|Blinded Treatment Period|Physician Decision|1
4734781|NCT03504917|7682000|FG001|Blinded Treatment Period|Physician Decision|0
4734782|NCT03504917|7681999|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1
4734783|NCT03504917|7682000|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3
4734784|NCT03504917|7681999|FG000|Blinded Treatment Period|Study terminated by sponsor|39
4734785|NCT03504917|7682000|FG001|Blinded Treatment Period|Study terminated by sponsor|34
4734786|NCT03504917|7681999|FG000|Blinded Treatment Period|Non-compliance with study drug|0
4447580|NCT00490971|7232841|FG004|Acute/Continuation|Protocol Violation|0
4447581|NCT00490971|7232837|FG000|Acute/Continuation|Withdrawal by Subject|92
4447582|NCT00490971|7232838|FG001|Acute/Continuation|Withdrawal by Subject|24
4447583|NCT00490971|7232839|FG002|Acute/Continuation|Withdrawal by Subject|0
4447584|NCT00490971|7232840|FG003|Acute/Continuation|Withdrawal by Subject|0
4632512|NCT01902303|7502197|FG000|Overall Study|Did not develop a cold sore|21
4632513|NCT01902303|7502198|FG001|Overall Study|Did not develop a cold sore|19
4632514|NCT01902628|7502215|FG000|Overall Study|Withdrawal of participant's consent|7
4632515|NCT01902628|7502215|FG000|Overall Study|Adverse Event|41
4632516|NCT01902628|7502215|FG000|Overall Study|Lost to Follow-up|35
4632517|NCT01903031|7502251|FG000|Overall Study|Not Able to Attend Clinic|1
4632518|NCT01903031|7502252|FG001|Overall Study|Not Able to Attend Clinic|1
4632519|NCT01903031|7502253|FG002|Overall Study|Not Able to Attend Clinic|0
4632520|NCT01903031|7502251|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1
4632521|NCT01903031|7502252|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0
4632522|NCT01903031|7502253|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0
4632523|NCT01903031|7502251|FG000|Overall Study|Adverse Event|0
4734787|NCT03504917|7682000|FG001|Blinded Treatment Period|Non-compliance with study drug|1
4632524|NCT01903031|7502252|FG001|Overall Study|Adverse Event|1
4632525|NCT01903031|7502253|FG002|Overall Study|Adverse Event|0
4632526|NCT01903031|7502251|FG000|Overall Study|Withdrawal by Subject|0
4632527|NCT01903031|7502252|FG001|Overall Study|Withdrawal by Subject|1
4632528|NCT01903031|7502253|FG002|Overall Study|Withdrawal by Subject|1
4632529|NCT01903031|7502251|FG000|Overall Study|Protocol Violation|0
4632530|NCT01903031|7502252|FG001|Overall Study|Protocol Violation|0
4447585|NCT00490971|7232841|FG004|Acute/Continuation|Withdrawal by Subject|0
4447586|NCT00490971|7232837|FG000|Acute/Continuation|Other|11
4447587|NCT00490971|7232838|FG001|Acute/Continuation|Other|4
4447588|NCT00490971|7232839|FG002|Acute/Continuation|Other|0
4447589|NCT00490971|7232840|FG003|Acute/Continuation|Other|0
4632531|NCT01903031|7502253|FG002|Overall Study|Protocol Violation|2
4632532|NCT01903031|7502251|FG000|Overall Study|Lost to Follow-up|0
4632533|NCT01903031|7502252|FG001|Overall Study|Lost to Follow-up|0
4632534|NCT01903031|7502253|FG002|Overall Study|Lost to Follow-up|1
4632535|NCT01903031|7502251|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0
4632536|NCT01903031|7502252|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0
4632537|NCT01903031|7502253|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1
4632538|NCT01903252|7502284|FG000|Double-Blind Induction|Adverse Event|20
4632539|NCT01903252|7502285|FG001|Double-Blind Induction|Adverse Event|18
4632540|NCT01903252|7502286|FG002|Double-Blind Induction|Adverse Event|0
4632541|NCT01903252|7502287|FG003|Double-Blind Induction|Adverse Event|0
4632542|NCT01903252|7502288|FG004|Double-Blind Induction|Adverse Event|0
4632543|NCT01903252|7502289|FG005|Double-Blind Induction|Adverse Event|0
4632544|NCT01903252|7502284|FG000|Double-Blind Induction|Withdrawal by Subject|10
4632545|NCT01903252|7502285|FG001|Double-Blind Induction|Withdrawal by Subject|13
4632546|NCT01903252|7502286|FG002|Double-Blind Induction|Withdrawal by Subject|0
4632547|NCT01903252|7502287|FG003|Double-Blind Induction|Withdrawal by Subject|0
4632548|NCT01903252|7502288|FG004|Double-Blind Induction|Withdrawal by Subject|0
4632549|NCT01903252|7502289|FG005|Double-Blind Induction|Withdrawal by Subject|0
4632550|NCT01903252|7502284|FG000|Double-Blind Induction|Physician Decision|2
4632551|NCT01903252|7502285|FG001|Double-Blind Induction|Physician Decision|3
4632552|NCT01903252|7502286|FG002|Double-Blind Induction|Physician Decision|0
4632553|NCT01903252|7502287|FG003|Double-Blind Induction|Physician Decision|0
4632554|NCT01903252|7502288|FG004|Double-Blind Induction|Physician Decision|0
4632555|NCT01903252|7502289|FG005|Double-Blind Induction|Physician Decision|0
4632556|NCT01903252|7502284|FG000|Double-Blind Induction|non-compliance,|7
4632557|NCT01903252|7502285|FG001|Double-Blind Induction|non-compliance,|7
4632558|NCT01903252|7502286|FG002|Double-Blind Induction|non-compliance,|0
4632559|NCT01903252|7502287|FG003|Double-Blind Induction|non-compliance,|0
4632560|NCT01903252|7502288|FG004|Double-Blind Induction|non-compliance,|0
4632561|NCT01903252|7502289|FG005|Double-Blind Induction|non-compliance,|0
4632562|NCT01903252|7502284|FG000|Extended Induction, Open-Label|Adverse Event|0
4632563|NCT01903252|7502285|FG001|Extended Induction, Open-Label|Adverse Event|0
4632564|NCT01903252|7502286|FG002|Extended Induction, Open-Label|Adverse Event|17
4632565|NCT01903252|7502287|FG003|Extended Induction, Open-Label|Adverse Event|0
4632566|NCT01903252|7502288|FG004|Extended Induction, Open-Label|Adverse Event|0
4632567|NCT01903252|7502289|FG005|Extended Induction, Open-Label|Adverse Event|0
4632568|NCT01903252|7502284|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0
4632569|NCT01903252|7502285|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0
4632570|NCT01903252|7502286|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5
4632571|NCT01903252|7502287|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0
4632572|NCT01903252|7502288|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0
4632573|NCT01903252|7502289|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0
4632574|NCT01903252|7502284|FG000|Extended Induction, Open-Label|Physician Decision|0
4632575|NCT01903252|7502285|FG001|Extended Induction, Open-Label|Physician Decision|0
4447590|NCT00490971|7232841|FG004|Acute/Continuation|Other|0
4447591|NCT00490971|7232837|FG000|Maintenance|Adverse Event|0
4734788|NCT03504917|7681999|FG000|Open Label Extension Treatment Period|The participant left the study site|0
4734789|NCT03504917|7682000|FG001|Open Label Extension Treatment Period|The participant left the study site|1
4734790|NCT03504917|7681999|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8
4734791|NCT03504917|7682000|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2
4734792|NCT03504917|7681999|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1
4734793|NCT03504917|7682000|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4
4734794|NCT03504917|7681999|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3
4737562|NCT03614078|7687790|FG000|Overall Study|Withdrawal by Subject|2
4632576|NCT01903252|7502286|FG002|Extended Induction, Open-Label|Physician Decision|1
4632577|NCT01903252|7502287|FG003|Extended Induction, Open-Label|Physician Decision|0
4632578|NCT01903252|7502288|FG004|Extended Induction, Open-Label|Physician Decision|0
4632579|NCT01903252|7502289|FG005|Extended Induction, Open-Label|Physician Decision|0
4632580|NCT01903252|7502284|FG000|Maintenance, Open-Label|Adverse Event|0
4632581|NCT01903252|7502285|FG001|Maintenance, Open-Label|Adverse Event|0
4632582|NCT01903252|7502286|FG002|Maintenance, Open-Label|Adverse Event|0
4632583|NCT01903252|7502287|FG003|Maintenance, Open-Label|Adverse Event|3
4632584|NCT01903252|7502288|FG004|Maintenance, Open-Label|Adverse Event|9
4632585|NCT01903252|7502289|FG005|Maintenance, Open-Label|Adverse Event|14
4632586|NCT01903252|7502284|FG000|Maintenance, Open-Label|Withdrawal by Subject|0
4632587|NCT01903252|7502285|FG001|Maintenance, Open-Label|Withdrawal by Subject|0
4590698|NCT01524224|7436958|FG005|Overall Study|Physician Decision|0
4590699|NCT01524224|7436959|FG006|Overall Study|Physician Decision|0
4590700|NCT01524224|7436960|FG007|Overall Study|Physician Decision|1
4590701|NCT01524224|7436953|FG000|Overall Study|Sponsor Decision|0
4590702|NCT01524224|7436954|FG001|Overall Study|Sponsor Decision|0
4590703|NCT01524224|7436955|FG002|Overall Study|Sponsor Decision|0
4590704|NCT01524224|7436956|FG003|Overall Study|Sponsor Decision|0
4590705|NCT01524224|7436957|FG004|Overall Study|Sponsor Decision|1
4590706|NCT01524224|7436958|FG005|Overall Study|Sponsor Decision|0
4590707|NCT01524224|7436959|FG006|Overall Study|Sponsor Decision|0
4590708|NCT01524224|7436960|FG007|Overall Study|Sponsor Decision|0
4590709|NCT01524289|7436980|FG000|Overall Study|Lost to Follow-up|0
4590710|NCT01524289|7436981|FG001|Overall Study|Lost to Follow-up|1
4590711|NCT01524289|7436980|FG000|Overall Study|Physician Decision|1
4590712|NCT01524289|7436981|FG001|Overall Study|Physician Decision|0
4590713|NCT01524289|7436980|FG000|Overall Study|Protocol Violation|5
4590714|NCT01524289|7436981|FG001|Overall Study|Protocol Violation|1
4590715|NCT01524289|7436980|FG000|Overall Study|Withdrawal by Subject|11
4590716|NCT01524289|7436981|FG001|Overall Study|Withdrawal by Subject|7
4590717|NCT01524289|7436980|FG000|Overall Study|Adverse Event|12
4590718|NCT01524289|7436981|FG001|Overall Study|Adverse Event|5
4590719|NCT01524289|7436980|FG000|Overall Study|Did not take study medication|1
4590720|NCT01524289|7436981|FG001|Overall Study|Did not take study medication|0
4590721|NCT01524627|7437004|FG000|Overall Study|Physician Decision|0
4633385|NCT01911442|7503532|FG002|Overall Study|Mother's Work Schedule|0
4633409|NCT01912222|7503608|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1
4633410|NCT01912222|7503609|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2
4633411|NCT01912222|7503610|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2
4633412|NCT01912222|7503608|FG000|Part B: Treatment Period|Progressive disease|10
4633413|NCT01912222|7503609|FG001|Part B: Treatment Period|Progressive disease|12
4633414|NCT01912222|7503610|FG002|Part B: Treatment Period|Progressive disease|15
4518757|NCT00976209|7331019|FG000|Treatment Period 2|Withdrawal by Subject|0
4518758|NCT00976209|7331020|FG001|Treatment Period 2|Withdrawal by Subject|1
4518759|NCT00976209|7331019|FG000|Treatment Period 2|Lost to Follow-up|0
4518760|NCT00976209|7331020|FG001|Treatment Period 2|Lost to Follow-up|1
4518761|NCT00976274|7331032|FG000|Overall Study|Lost to Follow-up|5
4518762|NCT00976274|7331033|FG001|Overall Study|Lost to Follow-up|5
4518763|NCT00976274|7331032|FG000|Overall Study|Withdrawal by Subject|1
4518764|NCT00976274|7331033|FG001|Overall Study|Withdrawal by Subject|1
4518765|NCT00976274|7331032|FG000|Overall Study|Physician Decision|1
4518766|NCT00976274|7331033|FG001|Overall Study|Physician Decision|2
4518767|NCT00976391|7331054|FG000|Treatment Period (52 Weeks)|Adverse Event|16
4518768|NCT00976391|7331055|FG001|Treatment Period (52 Weeks)|Adverse Event|2
4518769|NCT00976391|7331054|FG000|Treatment Period (52 Weeks)|Protocol Violation|1
4518770|NCT00976391|7331055|FG001|Treatment Period (52 Weeks)|Protocol Violation|1
4518771|NCT00976391|7331054|FG000|Treatment Period (52 Weeks)|Noncompliance|4
4518772|NCT00976391|7331055|FG001|Treatment Period (52 Weeks)|Noncompliance|4
4518773|NCT00976391|7331054|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10
4518774|NCT00976391|7331055|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8
4518775|NCT00976391|7331054|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9
4518776|NCT00976391|7331055|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19
4518777|NCT00976391|7331054|FG000|Treatment Period (52 Weeks)|Physician Decision|1
4518778|NCT00976391|7331055|FG001|Treatment Period (52 Weeks)|Physician Decision|1
4518779|NCT00976391|7331054|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0
4518780|NCT00976391|7331055|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4
4518781|NCT00976391|7331054|FG000|Treatment Period (52 Weeks)|Pregnancy|1
4518782|NCT00976391|7331055|FG001|Treatment Period (52 Weeks)|Pregnancy|0
4518783|NCT00976391|7331054|FG000|Follow-up Period (8 Weeks)|Adverse Event|3
4518784|NCT00976391|7331055|FG001|Follow-up Period (8 Weeks)|Adverse Event|1
4518785|NCT00976391|7331054|FG000|Follow-up Period (8 Weeks)|Noncompliance|2
4518786|NCT00976391|7331055|FG001|Follow-up Period (8 Weeks)|Noncompliance|2
4518787|NCT00976391|7331054|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14
4518788|NCT00976391|7331055|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12
4518789|NCT00976391|7331054|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6
4518790|NCT00976391|7331055|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8
4518791|NCT00976391|7331054|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4
4518792|NCT00976391|7331055|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7
4518793|NCT00976391|7331054|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0
4518794|NCT00976391|7331055|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
4518795|NCT00976456|7331074|FG000|Overall Study|Adverse Event|17
4518796|NCT00976456|7331075|FG001|Overall Study|Adverse Event|22
4518797|NCT00976456|7331074|FG000|Overall Study|Death|7
4518798|NCT00976456|7331075|FG001|Overall Study|Death|9
4518799|NCT00976456|7331074|FG000|Overall Study|Lack of Efficacy|5
4518800|NCT00976456|7331075|FG001|Overall Study|Lack of Efficacy|2
4518801|NCT00976456|7331074|FG000|Overall Study|Withdrawal by Subject|3
4518802|NCT00976456|7331075|FG001|Overall Study|Withdrawal by Subject|1
4518803|NCT00976456|7331074|FG000|Overall Study|screening failure, unknown|11
4518804|NCT00976456|7331075|FG001|Overall Study|screening failure, unknown|4
4518805|NCT00976482|7331081|FG000|Overall Study|Death|208
4518806|NCT00976482|7331081|FG000|Overall Study|Withdrawal by Subject|45
4518807|NCT00976482|7331081|FG000|Overall Study|Center terminated|1
4518808|NCT00976482|7331081|FG000|Overall Study|Protocol Violation|5
4518809|NCT00976495|7331088|FG000|Overall Study|Withdrawal by Subject|0
4518810|NCT00976495|7331089|FG001|Overall Study|Withdrawal by Subject|1
4518811|NCT00976495|7331090|FG002|Overall Study|Withdrawal by Subject|0
4518812|NCT00976508|7331100|FG000|Overall Study|Death|7
4518813|NCT00976508|7331101|FG001|Overall Study|Death|1
4518814|NCT00976508|7331100|FG000|Overall Study|Lost to Follow-up|1
4593850|NCT01555164|7442379|FG000|Overall Study|Lost to Follow-up|4
4593851|NCT01555164|7442380|FG001|Overall Study|Lost to Follow-up|3
4633415|NCT01912222|7503608|FG000|Part B: Treatment Period|Adverse Event|1
4633416|NCT01912222|7503609|FG001|Part B: Treatment Period|Adverse Event|2
4518815|NCT00976508|7331101|FG001|Overall Study|Lost to Follow-up|0
4518816|NCT00976508|7331100|FG000|Overall Study|Withdrawal by Subject|1
4518817|NCT00976508|7331101|FG001|Overall Study|Withdrawal by Subject|0
4518818|NCT00976508|7331100|FG000|Overall Study|Disease Progression|4
4518819|NCT00976508|7331101|FG001|Overall Study|Disease Progression|4
4518820|NCT00976508|7331100|FG000|Overall Study|Subject Enrolled in Hospice|1
4518821|NCT00976508|7331101|FG001|Overall Study|Subject Enrolled in Hospice|0
4518822|NCT00976508|7331100|FG000|Overall Study|Terminated by the Sponsor|0
4518823|NCT00976508|7331101|FG001|Overall Study|Terminated by the Sponsor|1
4518824|NCT00976560|7331130|FG000|Overall Study|Adverse Event|5
4518825|NCT00976560|7331131|FG001|Overall Study|Adverse Event|5
4518826|NCT00976560|7331130|FG000|Overall Study|Lack of Efficacy|3
4518827|NCT00976560|7331131|FG001|Overall Study|Lack of Efficacy|5
4518828|NCT00976560|7331130|FG000|Overall Study|Protocol Violation|1
4518829|NCT00976560|7331131|FG001|Overall Study|Protocol Violation|0
4518830|NCT00976560|7331130|FG000|Overall Study|Lost to Follow-up|1
4518831|NCT00976560|7331131|FG001|Overall Study|Lost to Follow-up|0
4518832|NCT00976560|7331130|FG000|Overall Study|Physician Decision|2
4518833|NCT00976560|7331131|FG001|Overall Study|Physician Decision|0
4518834|NCT00976560|7331130|FG000|Overall Study|Withdrawal by Subject|2
4518835|NCT00976560|7331131|FG001|Overall Study|Withdrawal by Subject|3
4518836|NCT00976573|7331139|FG000|Overall Study|Ineligible|0
4518837|NCT00976573|7331140|FG001|Overall Study|Ineligible|1
4518838|NCT00976573|7331139|FG000|Overall Study|Cancel prior to receiving treatment|4
4518839|NCT00976573|7331140|FG001|Overall Study|Cancel prior to receiving treatment|2
4518840|NCT00976677|7331166|FG000|Overall Study|Adverse Event|1
4518841|NCT00976677|7331167|FG001|Overall Study|Adverse Event|0
4518842|NCT00976677|7331166|FG000|Overall Study|Withdrawal by Subject|0
4518843|NCT00976677|7331167|FG001|Overall Study|Withdrawal by Subject|2
4518844|NCT00976677|7331166|FG000|Overall Study|Disease progression|1
4518845|NCT00976677|7331167|FG001|Overall Study|Disease progression|1
4518846|NCT00976677|7331166|FG000|Overall Study|Trial unblinded|2
4518847|NCT00976677|7331167|FG001|Overall Study|Trial unblinded|2
4518848|NCT00976677|7331166|FG000|Overall Study|Unknown/Missing|1
4518849|NCT00976677|7331167|FG001|Overall Study|Unknown/Missing|0
4518850|NCT00976703|7331175|FG000|Overall Study|Physician Decision|1
4518851|NCT00976703|7331176|FG001|Overall Study|Physician Decision|1
4518852|NCT00976703|7331175|FG000|Overall Study|ineligible for study|2
4518853|NCT00976703|7331176|FG001|Overall Study|ineligible for study|2
4518854|NCT00976716|7331182|FG000|Overall Study|Adverse Event|1
4518855|NCT00976820|7331191|FG000|Overall Study|Lost to Follow-up|5
4518856|NCT00976820|7331192|FG001|Overall Study|Lost to Follow-up|16
4518857|NCT00976820|7331193|FG002|Overall Study|Lost to Follow-up|2
4518858|NCT00976820|7331194|FG003|Overall Study|Lost to Follow-up|3
4518859|NCT00976820|7331191|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1
4518860|NCT00976820|7331192|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0
4518861|NCT00976820|7331193|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1
4518862|NCT00976820|7331194|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0
4518863|NCT00976820|7331191|FG000|Overall Study|Withdrawal by Subject|2
4518864|NCT00976820|7331192|FG001|Overall Study|Withdrawal by Subject|4
4518865|NCT00976820|7331193|FG002|Overall Study|Withdrawal by Subject|1
4518866|NCT00976820|7331194|FG003|Overall Study|Withdrawal by Subject|4
4518867|NCT00976898|7331245|FG000|Overall Study|Protocol Violation|1
4518868|NCT00976898|7331245|FG000|Overall Study|Adverse Event|1
4518869|NCT00976898|7331245|FG000|Overall Study|Physician Decision|1
4518870|NCT00976898|7331245|FG000|Overall Study|Liver Transplant|1
4518871|NCT00976898|7331245|FG000|Overall Study|Progressive Disease|1
4518872|NCT00976911|7331251|FG000|Overall Study|Withdrawal by Subject|4
4518873|NCT00976911|7331252|FG001|Overall Study|Withdrawal by Subject|6
4518874|NCT00976911|7331251|FG000|Overall Study|Death|138
4518875|NCT00976911|7331252|FG001|Overall Study|Death|126
4518876|NCT00976911|7331251|FG000|Overall Study|Adverse Event|0
4518877|NCT00976911|7331252|FG001|Overall Study|Adverse Event|1
4518878|NCT00976911|7331251|FG000|Overall Study|Protocol Violation|2
4518879|NCT00976911|7331252|FG001|Overall Study|Protocol Violation|0
4518880|NCT00976911|7331251|FG000|Overall Study|Other|8
4518881|NCT00976911|7331252|FG001|Overall Study|Other|9
4518882|NCT00976911|7331251|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30
4518883|NCT00976911|7331252|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37
4518884|NCT00976937|7331260|FG000|Overall Study|Adverse Event|4
4518885|NCT00976937|7331261|FG001|Overall Study|Adverse Event|5
4518886|NCT00976937|7331260|FG000|Overall Study|Lost to Follow-up|2
4518887|NCT00976937|7331261|FG001|Overall Study|Lost to Follow-up|1
4518888|NCT00976937|7331260|FG000|Overall Study|Withdrawal by Subject|5
4518889|NCT00976937|7331261|FG001|Overall Study|Withdrawal by Subject|3
4518890|NCT00976937|7331260|FG000|Overall Study|Poor compliance to protocol|3
4518891|NCT00976937|7331261|FG001|Overall Study|Poor compliance to protocol|0
4518892|NCT00976937|7331260|FG000|Overall Study|Personal and Familial Reason|2
4518893|NCT00976937|7331261|FG001|Overall Study|Personal and Familial Reason|2
4518894|NCT00976950|7331267|FG000|Overall Study|Adverse Event|3
4518895|NCT00976950|7331267|FG000|Overall Study|Events with no relationship to Aptivus|3
4518896|NCT00976989|7331274|FG000|Overall Study|Violation of Selection Criteria at Entry|1
4518897|NCT00976989|7331275|FG001|Overall Study|Violation of Selection Criteria at Entry|0
4518898|NCT00976989|7331276|FG002|Overall Study|Violation of Selection Criteria at Entry|1
4518899|NCT00976989|7331274|FG000|Overall Study|Death|5
4518900|NCT00976989|7331275|FG001|Overall Study|Death|7
4518901|NCT00976989|7331276|FG002|Overall Study|Death|10
4518902|NCT00976989|7331274|FG000|Overall Study|Refused Treatment|4
4518903|NCT00976989|7331275|FG001|Overall Study|Refused Treatment|3
4518904|NCT00976989|7331276|FG002|Overall Study|Refused Treatment|5
4518905|NCT00976989|7331274|FG000|Overall Study|Failure to Return|2
4518906|NCT00976989|7331275|FG001|Overall Study|Failure to Return|1
4518907|NCT00976989|7331276|FG002|Overall Study|Failure to Return|0
4518908|NCT00976989|7331274|FG000|Overall Study|Recurrence of Disease|0
4518909|NCT00976989|7331275|FG001|Overall Study|Recurrence of Disease|1
4518910|NCT00976989|7331276|FG002|Overall Study|Recurrence of Disease|0
4518911|NCT00976989|7331274|FG000|Overall Study|Other|1
4518912|NCT00976989|7331275|FG001|Overall Study|Other|0
4518913|NCT00976989|7331276|FG002|Overall Study|Other|1
4518914|NCT00977080|7331288|FG000|Overall Study|Adverse Event|2
4518915|NCT00977080|7331289|FG001|Overall Study|Adverse Event|7
4518916|NCT00977080|7331290|FG002|Overall Study|Adverse Event|7
4518917|NCT00977080|7331291|FG003|Overall Study|Adverse Event|7
4518918|NCT00977080|7331288|FG000|Overall Study|Withdrawal by Subject|1
4518919|NCT00977080|7331289|FG001|Overall Study|Withdrawal by Subject|5
4518920|NCT00977080|7331290|FG002|Overall Study|Withdrawal by Subject|1
4518921|NCT00977080|7331291|FG003|Overall Study|Withdrawal by Subject|5
4518922|NCT00977080|7331288|FG000|Overall Study|Protocol Violation|7
4518923|NCT00977080|7331289|FG001|Overall Study|Protocol Violation|3
4518924|NCT00977080|7331290|FG002|Overall Study|Protocol Violation|4
4518925|NCT00977080|7331291|FG003|Overall Study|Protocol Violation|3
4518926|NCT00977080|7331288|FG000|Overall Study|Noncompliance|0
4518927|NCT00977080|7331289|FG001|Overall Study|Noncompliance|2
4518928|NCT00977080|7331290|FG002|Overall Study|Noncompliance|1
4518929|NCT00977080|7331291|FG003|Overall Study|Noncompliance|0
4518930|NCT00977080|7331288|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
4518931|NCT00977080|7331289|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
4518932|NCT00977080|7331290|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
4518933|NCT00977080|7331291|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1
4518934|NCT00977080|7331288|FG000|Overall Study|Required kidney transplantation|1
4518935|NCT00977080|7331289|FG001|Overall Study|Required kidney transplantation|3
4518936|NCT00977080|7331290|FG002|Overall Study|Required kidney transplantation|3
4518937|NCT00977080|7331291|FG003|Overall Study|Required kidney transplantation|1
4518938|NCT00977080|7331288|FG000|Overall Study|Travel for family reasons|1
4518939|NCT00977080|7331289|FG001|Overall Study|Travel for family reasons|0
4518940|NCT00977080|7331290|FG002|Overall Study|Travel for family reasons|0
4518941|NCT00977080|7331291|FG003|Overall Study|Travel for family reasons|0
4518942|NCT00977106|7331303|FG000|Overall Study|Adverse Event|5
4518943|NCT00977106|7331304|FG001|Overall Study|Adverse Event|6
4518944|NCT00977106|7331303|FG000|Overall Study|Withdrawal by Subject|2
4518945|NCT00977106|7331304|FG001|Overall Study|Withdrawal by Subject|2
4518946|NCT00977106|7331303|FG000|Overall Study|Lack of Efficacy|2
4518947|NCT00977106|7331304|FG001|Overall Study|Lack of Efficacy|2
4633417|NCT01912222|7503610|FG002|Part B: Treatment Period|Adverse Event|3
4518948|NCT00977106|7331303|FG000|Overall Study|Protocol Violation|0
4518949|NCT00977106|7331304|FG001|Overall Study|Protocol Violation|1
4518950|NCT00977106|7331303|FG000|Overall Study|Other|1
4518951|NCT00977106|7331304|FG001|Overall Study|Other|0
4518952|NCT00977197|7331334|FG000|Overall Study|Withdrawal by Subject|3
4518953|NCT00977197|7331335|FG001|Overall Study|Withdrawal by Subject|4
4518954|NCT00977197|7331334|FG000|Overall Study|Adverse Event|3
4518955|NCT00977197|7331335|FG001|Overall Study|Adverse Event|1
4518956|NCT00977197|7331334|FG000|Overall Study|Lack of Efficacy|1
4518957|NCT00977197|7331335|FG001|Overall Study|Lack of Efficacy|0
4518958|NCT00977197|7331334|FG000|Overall Study|Lost to Follow-up|1
4518959|NCT00977197|7331335|FG001|Overall Study|Lost to Follow-up|3
4518960|NCT00977197|7331334|FG000|Overall Study|Nonadherence|1
4518961|NCT00977197|7331335|FG001|Overall Study|Nonadherence|1
4518962|NCT00977314|7331343|FG000|Overall Study|Withdrawal by Subject|1
4518963|NCT00977314|7331344|FG001|Overall Study|Withdrawal by Subject|0
4518964|NCT00977314|7331343|FG000|Overall Study|Physician Decision|1
4518965|NCT00977314|7331344|FG001|Overall Study|Physician Decision|0
4518966|NCT00977379|7331352|FG000|Overall Study|Withdrawal by Subject|1
4518967|NCT00977379|7331353|FG001|Overall Study|Withdrawal by Subject|1
4518968|NCT00977379|7331352|FG000|Overall Study|Death|7
4518969|NCT00977379|7331353|FG001|Overall Study|Death|9
4518970|NCT00977379|7331352|FG000|Overall Study|Premature Study Termination|4
4518971|NCT00977379|7331353|FG001|Overall Study|Premature Study Termination|0
4518972|NCT00977379|7331352|FG000|Overall Study|Participant Moving House|0
4518973|NCT00977379|7331353|FG001|Overall Study|Participant Moving House|1
4518974|NCT00977379|7331352|FG000|Overall Study|Randomization Error|0
4518975|NCT00977379|7331353|FG001|Overall Study|Randomization Error|1
4518976|NCT00977431|7331364|FG000|Overall Study|Other than listed|1
4518977|NCT00977431|7331365|FG001|Overall Study|Other than listed|0
4518978|NCT00977431|7331366|FG002|Overall Study|Other than listed|0
4518979|NCT00977431|7331367|FG003|Overall Study|Other than listed|0
4518980|NCT00977431|7331368|FG004|Overall Study|Other than listed|2
4518981|NCT00977431|7331364|FG000|Overall Study|Protocol Violation|0
4518982|NCT00977431|7331365|FG001|Overall Study|Protocol Violation|0
4518983|NCT00977431|7331366|FG002|Overall Study|Protocol Violation|1
4518984|NCT00977431|7331367|FG003|Overall Study|Protocol Violation|0
4518985|NCT00977431|7331368|FG004|Overall Study|Protocol Violation|0
4518986|NCT00977431|7331364|FG000|Overall Study|Adverse Event|3
4518987|NCT00977431|7331365|FG001|Overall Study|Adverse Event|0
4518988|NCT00977431|7331366|FG002|Overall Study|Adverse Event|4
4518989|NCT00977431|7331367|FG003|Overall Study|Adverse Event|0
4518990|NCT00977431|7331368|FG004|Overall Study|Adverse Event|6
4518991|NCT00977431|7331364|FG000|Overall Study|Dose-limiting toxicity (DLT)|1
4518992|NCT00977431|7331365|FG001|Overall Study|Dose-limiting toxicity (DLT)|0
4518993|NCT00977431|7331366|FG002|Overall Study|Dose-limiting toxicity (DLT)|1
4518994|NCT00977431|7331367|FG003|Overall Study|Dose-limiting toxicity (DLT)|0
4518995|NCT00977431|7331368|FG004|Overall Study|Dose-limiting toxicity (DLT)|0
4518996|NCT00977431|7331364|FG000|Overall Study|Progressive disease|2
4518997|NCT00977431|7331365|FG001|Overall Study|Progressive disease|6
4518998|NCT00977431|7331366|FG002|Overall Study|Progressive disease|1
4518999|NCT00977431|7331367|FG003|Overall Study|Progressive disease|3
4519000|NCT00977431|7331368|FG004|Overall Study|Progressive disease|5
4519001|NCT00977470|7331386|FG000|Overall Study|Lack of Efficacy|32
4519002|NCT00977470|7331387|FG001|Overall Study|Lack of Efficacy|30
4519003|NCT00977470|7331386|FG000|Overall Study|Physician Decision|2
4519004|NCT00977470|7331387|FG001|Overall Study|Physician Decision|0
4633418|NCT01912222|7503608|FG000|Part B: Treatment Period|Withdrawal by Subject|2
4519005|NCT00977470|7331386|FG000|Overall Study|Adverse Event|1
4519006|NCT00977470|7331387|FG001|Overall Study|Adverse Event|2
4519007|NCT00977470|7331386|FG000|Overall Study|Protocol Violation|1
4519008|NCT00977470|7331387|FG001|Overall Study|Protocol Violation|0
4519009|NCT00977470|7331386|FG000|Overall Study|Withdrawal by Subject|0
4519010|NCT00977470|7331387|FG001|Overall Study|Withdrawal by Subject|2
4519011|NCT00977470|7331386|FG000|Overall Study|Death|0
4519012|NCT00977470|7331387|FG001|Overall Study|Death|2
4519013|NCT00977470|7331386|FG000|Overall Study|clinical decline|0
4519014|NCT00977470|7331387|FG001|Overall Study|clinical decline|1
4519015|NCT00977470|7331386|FG000|Overall Study|prolonged recovery post-surgery|0
4519016|NCT00977470|7331387|FG001|Overall Study|prolonged recovery post-surgery|1
4519017|NCT00977470|7331386|FG000|Overall Study|Still on-study|2
4519018|NCT00977470|7331387|FG001|Overall Study|Still on-study|0
4519019|NCT00977548|7331393|FG000|Overall Study|Ineligible|4
4519020|NCT00977548|7331393|FG000|Overall Study|Adverse Event|8
4519021|NCT00977548|7331393|FG000|Overall Study|Withdrawal by Subject|1
4519022|NCT00977561|7331399|FG000|Overall Study|Death|3
4519023|NCT00977561|7331400|FG001|Overall Study|Death|2
4519024|NCT00977561|7331399|FG000|Overall Study|Study terminated|0
4519025|NCT00977561|7331400|FG001|Overall Study|Study terminated|2
4519026|NCT00977561|7331399|FG000|Overall Study|Other|2
4519027|NCT00977561|7331400|FG001|Overall Study|Other|0
4519028|NCT00977613|7331408|FG000|Overall Study|Lost to Follow-up|16
4519029|NCT00977665|7331414|FG000|Overall Study|Withdrawal by Subject|1
4519030|NCT00977665|7331415|FG001|Overall Study|Withdrawal by Subject|3
4519031|NCT00977665|7331414|FG000|Overall Study|Physician Decision|2
4519032|NCT00977665|7331415|FG001|Overall Study|Physician Decision|1
4519033|NCT00977665|7331414|FG000|Overall Study|Sponsor requested withdrawal|0
4519034|NCT00977665|7331415|FG001|Overall Study|Sponsor requested withdrawal|1
4519035|NCT00977665|7331414|FG000|Overall Study|Lost to Follow-up|1
4519036|NCT00977665|7331415|FG001|Overall Study|Lost to Follow-up|0
4519037|NCT00977665|7331414|FG000|Overall Study|Death|3
4519038|NCT00977665|7331415|FG001|Overall Study|Death|2
4519039|NCT00977665|7331414|FG000|Overall Study|Adverse Event|14
4737655|NCT03614975|7687834|FG000|Overall Study|Specimens not in lab batch shipment|1
4737656|NCT03614975|7687835|FG001|Overall Study|Specimens not in lab batch shipment|1
4737657|NCT03615066|7687848|FG000|Overall Study|Protocol Violation|1
4737658|NCT03615066|7687849|FG001|Overall Study|Protocol Violation|0
4737659|NCT03615066|7687850|FG002|Overall Study|Protocol Violation|0
4737660|NCT03615066|7687848|FG000|Overall Study|Withdrew Consent|0
4737661|NCT03615066|7687849|FG001|Overall Study|Withdrew Consent|2
4737662|NCT03615066|7687850|FG002|Overall Study|Withdrew Consent|1
4737663|NCT03615066|7687848|FG000|Overall Study|Lost to Follow-up|0
4737664|NCT03615066|7687849|FG001|Overall Study|Lost to Follow-up|0
4737665|NCT03615066|7687850|FG002|Overall Study|Lost to Follow-up|1
4737666|NCT03615066|7687848|FG000|Overall Study|Still on Study|8
4737667|NCT03615066|7687849|FG001|Overall Study|Still on Study|6
4737668|NCT03615066|7687850|FG002|Overall Study|Still on Study|2
4737669|NCT03615404|7687883|FG000|Overall Study|Death|1
4737670|NCT03615404|7687883|FG000|Overall Study|vaccine did not pass quality assurance|1
4737671|NCT03615482|7687889|FG000|Overall Study|Death|1
4737672|NCT03615482|7687890|FG001|Overall Study|Death|0
4737673|NCT03615482|7687889|FG000|Overall Study|Lost to Follow-up|7
4737674|NCT03615482|7687890|FG001|Overall Study|Lost to Follow-up|7
4519040|NCT00977665|7331415|FG001|Overall Study|Adverse Event|7
4519041|NCT00977665|7331414|FG000|Overall Study|Treatment failure|0
4519042|NCT00977665|7331415|FG001|Overall Study|Treatment failure|1
4519043|NCT00977938|7331462|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132
4519044|NCT00977938|7331463|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116
4737675|NCT03615482|7687889|FG000|Overall Study|Physician Decision|2
4519045|NCT00977938|7331464|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13
4519046|NCT00977938|7331465|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20
4519047|NCT00977938|7331462|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88
4519048|NCT00977938|7331463|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91
4519049|NCT00977938|7331464|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30
4519050|NCT00977938|7331465|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37
4519051|NCT00977938|7331462|FG000|Treatment (12-30 mo. Post Procedure)|Other|17
4519052|NCT00977938|7331463|FG001|Treatment (12-30 mo. Post Procedure)|Other|18
4519053|NCT00977938|7331464|FG002|Treatment (12-30 mo. Post Procedure)|Other|3
4519054|NCT00977938|7331465|FG003|Treatment (12-30 mo. Post Procedure)|Other|4
4519055|NCT00977938|7331462|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9
4519056|NCT00977938|7331463|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12
4519057|NCT00977938|7331464|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2
4519058|NCT00977938|7331465|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0
4519059|NCT00977938|7331462|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34
4519060|NCT00977938|7331463|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42
4519061|NCT00977938|7331464|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10
4519062|NCT00977938|7331465|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3
4519063|NCT00977938|7331462|FG000|Observation (30-33 mo. Post Procedure)|Other|8
4519064|NCT00977938|7331463|FG001|Observation (30-33 mo. Post Procedure)|Other|4
4519065|NCT00977938|7331464|FG002|Observation (30-33 mo. Post Procedure)|Other|0
4519066|NCT00977938|7331465|FG003|Observation (30-33 mo. Post Procedure)|Other|0
4519067|NCT00978029|7331480|FG000|Overall Study|Adverse Event|1
4519068|NCT00978029|7331481|FG001|Overall Study|Adverse Event|2
4519069|NCT00978029|7331482|FG002|Overall Study|Adverse Event|5
4519070|NCT00978029|7331480|FG000|Overall Study|Withdrawal by Subject|0
4519071|NCT00978029|7331481|FG001|Overall Study|Withdrawal by Subject|0
4519072|NCT00978029|7331482|FG002|Overall Study|Withdrawal by Subject|1
4519073|NCT00978029|7331480|FG000|Overall Study|Protocol Violation|0
4519074|NCT00978029|7331481|FG001|Overall Study|Protocol Violation|1
4519075|NCT00978029|7331482|FG002|Overall Study|Protocol Violation|0
4519076|NCT00978042|7331492|FG000|Initial Treatment Period|Treated in Error|0
4519077|NCT00978042|7331493|FG001|Initial Treatment Period|Treated in Error|3
4519078|NCT00978042|7331492|FG000|Initial Treatment Period|Ineligibility|1
4519079|NCT00978042|7331493|FG001|Initial Treatment Period|Ineligibility|0
4737676|NCT03615482|7687890|FG001|Overall Study|Physician Decision|3
4737677|NCT03615482|7687889|FG000|Overall Study|Withdrawal by Subject|7
4737678|NCT03615482|7687890|FG001|Overall Study|Withdrawal by Subject|7
4737679|NCT03615924|7687935|FG000|Overall Study|Withdrawal by Subject|2
4737680|NCT03615924|7687936|FG001|Overall Study|Withdrawal by Subject|5
4737681|NCT03615924|7687935|FG000|Overall Study|Death|3
4737682|NCT03615924|7687936|FG001|Overall Study|Death|1
4737683|NCT03615924|7687935|FG000|Overall Study|Lost to Follow-up|1
4737684|NCT03615924|7687936|FG001|Overall Study|Lost to Follow-up|0
4519080|NCT00978042|7331492|FG000|Initial Treatment Period|Lost to Follow-up|21
4519081|NCT00978042|7331493|FG001|Initial Treatment Period|Lost to Follow-up|3
4519082|NCT00978042|7331492|FG000|Initial Treatment Period|Adverse Event|2
4519083|NCT00978042|7331493|FG001|Initial Treatment Period|Adverse Event|0
4519084|NCT00978042|7331492|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2
4519085|NCT00978042|7331493|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0
4519086|NCT00978042|7331492|FG000|Initial Treatment Period|Consent withdrawn|22
4519087|NCT00978042|7331493|FG001|Initial Treatment Period|Consent withdrawn|9
4519088|NCT00978042|7331492|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13
4519089|NCT00978042|7331493|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0
4519090|NCT00978068|7331501|FG000|Overall Study|Were Awaiting Initiation of ART|2
4519091|NCT00978068|7331502|FG001|Overall Study|Were Awaiting Initiation of ART|2
4519092|NCT00978068|7331501|FG000|Overall Study|Death|1
4519093|NCT00978068|7331502|FG001|Overall Study|Death|2
4519094|NCT00978068|7331501|FG000|Overall Study|Lost to Follow-up|1
4519095|NCT00978068|7331502|FG001|Overall Study|Lost to Follow-up|2
4519096|NCT00978068|7331501|FG000|Overall Study|Physician Decision|0
4519097|NCT00978068|7331502|FG001|Overall Study|Physician Decision|1
4519098|NCT00978068|7331501|FG000|Overall Study|Unable to Comply with Study|0
4519099|NCT00978068|7331502|FG001|Overall Study|Unable to Comply with Study|2
4519100|NCT00978120|7331516|FG000|Overall Study|Death|0
4519101|NCT00978120|7331517|FG001|Overall Study|Death|0
4519102|NCT00978120|7331518|FG002|Overall Study|Death|0
4519103|NCT00978120|7331519|FG003|Overall Study|Death|1
4519104|NCT00978120|7331516|FG000|Overall Study|Lost to Follow-up|0
4519105|NCT00978120|7331517|FG001|Overall Study|Lost to Follow-up|0
4519106|NCT00978120|7331518|FG002|Overall Study|Lost to Follow-up|3
4519107|NCT00978120|7331519|FG003|Overall Study|Lost to Follow-up|0
4519108|NCT00978120|7331516|FG000|Overall Study|Withdrawal by Subject|2
4519109|NCT00978120|7331517|FG001|Overall Study|Withdrawal by Subject|0
4519110|NCT00978120|7331518|FG002|Overall Study|Withdrawal by Subject|0
4519111|NCT00978120|7331519|FG003|Overall Study|Withdrawal by Subject|0
4519112|NCT00978120|7331516|FG000|Overall Study|Moved out of state|0
4519113|NCT00978120|7331517|FG001|Overall Study|Moved out of state|0
4519114|NCT00978120|7331518|FG002|Overall Study|Moved out of state|0
4519115|NCT00978120|7331519|FG003|Overall Study|Moved out of state|1
4519116|NCT00978250|7331537|FG000|Overall Study|Late determination of ineligibility|0
4519117|NCT00978250|7331538|FG001|Overall Study|Late determination of ineligibility|1
4519118|NCT00978250|7331539|FG002|Overall Study|Late determination of ineligibility|0
4519119|NCT00978250|7331540|FG003|Overall Study|Late determination of ineligibility|1
4519120|NCT00978341|7331552|FG000|Washout Period of 2 Weeks|Adverse Event|1
4519121|NCT00978341|7331553|FG001|Washout Period of 2 Weeks|Adverse Event|0
4519122|NCT00978380|7331560|FG000|Overall Study|Protocol Violation|2
4519123|NCT00978380|7331560|FG000|Overall Study|Withdrawal criteria|9
4519124|NCT00978380|7331560|FG000|Overall Study|Unclassified|8
4519125|NCT00978432|7331568|FG000|Overall Study|Withdrawal by Subject|0
4519126|NCT00978432|7331569|FG001|Overall Study|Withdrawal by Subject|0
4519127|NCT00978432|7331570|FG002|Overall Study|Withdrawal by Subject|1
4519128|NCT00978432|7331568|FG000|Overall Study|Lack of Efficacy|1
4519129|NCT00978432|7331569|FG001|Overall Study|Lack of Efficacy|1
4519130|NCT00978432|7331570|FG002|Overall Study|Lack of Efficacy|3
4519131|NCT00978432|7331568|FG000|Overall Study|Adverse Event|2
4519132|NCT00978432|7331569|FG001|Overall Study|Adverse Event|0
4519133|NCT00978432|7331570|FG002|Overall Study|Adverse Event|1
4519134|NCT00978627|7331593|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4
4519135|NCT00978627|7331594|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3
4519136|NCT00978627|7331593|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2
4519137|NCT00978627|7331594|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0
4519138|NCT00978627|7331593|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8
4519139|NCT00978627|7331594|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6
4519140|NCT00978627|7331593|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7
4519141|NCT00978627|7331594|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5
4519142|NCT00978627|7331593|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25
4633419|NCT01912222|7503609|FG001|Part B: Treatment Period|Withdrawal by Subject|1
4633420|NCT01912222|7503610|FG002|Part B: Treatment Period|Withdrawal by Subject|2
4633421|NCT01912287|7503626|FG000|Overall Study|Ineligible|1
4633422|NCT01912287|7503627|FG001|Overall Study|Ineligible|0
4633423|NCT01912287|7503628|FG002|Overall Study|Ineligible|1
4633424|NCT01912287|7503626|FG000|Overall Study|No-show|0
4633425|NCT01912287|7503627|FG001|Overall Study|No-show|0
4633426|NCT01912287|7503628|FG002|Overall Study|No-show|1
4633427|NCT01912287|7503626|FG000|Overall Study|Dissatisfaction with assigned treatment|4
4633428|NCT01912287|7503627|FG001|Overall Study|Dissatisfaction with assigned treatment|2
4633429|NCT01912287|7503628|FG002|Overall Study|Dissatisfaction with assigned treatment|1
4519143|NCT00978627|7331594|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12
4519144|NCT00978627|7331593|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3
4519145|NCT00978627|7331594|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0
4519146|NCT00978627|7331593|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4
4519147|NCT00978627|7331594|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1
4519148|NCT00978627|7331593|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2
4519149|NCT00978627|7331594|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1
4519150|NCT00978627|7331593|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12
4519151|NCT00978627|7331594|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7
4519152|NCT00978731|7331604|FG000|Overall Study|Death|4
4519153|NCT00978731|7331605|FG001|Overall Study|Death|1
4519154|NCT00978731|7331606|FG002|Overall Study|Death|1
4519155|NCT00978731|7331607|FG003|Overall Study|Death|0
4519156|NCT00978731|7331604|FG000|Overall Study|Lost to Follow-up|0
4519157|NCT00978731|7331605|FG001|Overall Study|Lost to Follow-up|0
4737685|NCT03615924|7687935|FG000|Overall Study|Randomized in error|1
4737686|NCT03615924|7687936|FG001|Overall Study|Randomized in error|0
4737687|NCT03615924|7687935|FG000|Overall Study|Study termination by Sponsor|94
4737688|NCT03615924|7687936|FG001|Overall Study|Study termination by Sponsor|86
4737689|NCT03616106|7687944|FG000|Overall Study|Removed by PI|6
4737690|NCT03616106|7687945|FG001|Overall Study|Removed by PI|0
4737691|NCT03616106|7687944|FG000|Overall Study|Withdrawal by Subject|1
4737692|NCT03616106|7687945|FG001|Overall Study|Withdrawal by Subject|1
4737693|NCT03616106|7687944|FG000|Overall Study|Lost to Follow-up|7
4737694|NCT03616106|7687945|FG001|Overall Study|Lost to Follow-up|0
4737695|NCT03616600|7687962|FG000|Overall Study|Withdrawal by Subject|1
4737696|NCT03616600|7687963|FG001|Overall Study|Withdrawal by Subject|0
4737697|NCT03616977|7687979|FG000|Period 1|Physician Decision|0
4737698|NCT03616977|7687980|FG001|Period 1|Physician Decision|1
4737699|NCT03616977|7687979|FG000|Period 3|Adverse Event|1
4737700|NCT03616977|7687980|FG001|Period 3|Adverse Event|1
4737701|NCT03617588|7687993|FG000|Overall Study|Withdrawal by Subject|1
4737702|NCT03617588|7687994|FG001|Overall Study|Withdrawal by Subject|0
4737703|NCT03617770|7688006|FG000|Overall Study|Lost to Follow-up|1
4737704|NCT03617770|7688007|FG001|Overall Study|Lost to Follow-up|0
4737705|NCT03617861|7688015|FG000|Second Intervention (1 Day)|Adverse Event|0
4737706|NCT03617861|7688016|FG001|Second Intervention (1 Day)|Adverse Event|0
4737707|NCT03617861|7688017|FG002|Second Intervention (1 Day)|Adverse Event|1
4737708|NCT03617861|7688018|FG003|Second Intervention (1 Day)|Adverse Event|0
4737709|NCT03618628|7688070|FG000|Overall Study|Death|1
4737710|NCT03618628|7688070|FG000|Overall Study|Lost to Follow-up|1
4519158|NCT00978731|7331606|FG002|Overall Study|Lost to Follow-up|0
4633430|NCT01912287|7503626|FG000|Overall Study|Felt treatment no longer needed|0
4519159|NCT00978731|7331607|FG003|Overall Study|Lost to Follow-up|1
4519160|NCT00978731|7331604|FG000|Overall Study|Adverse Event|5
4519161|NCT00978731|7331605|FG001|Overall Study|Adverse Event|2
4519162|NCT00978731|7331606|FG002|Overall Study|Adverse Event|0
4519163|NCT00978731|7331607|FG003|Overall Study|Adverse Event|0
4519164|NCT00978731|7331604|FG000|Overall Study|Participant's request|1
4519165|NCT00978731|7331605|FG001|Overall Study|Participant's request|0
4519166|NCT00978731|7331606|FG002|Overall Study|Participant's request|0
4519167|NCT00978731|7331607|FG003|Overall Study|Participant's request|0
4519168|NCT00978731|7331604|FG000|Overall Study|Administrative reason|3
4519169|NCT00978731|7331605|FG001|Overall Study|Administrative reason|3
4519170|NCT00978731|7331606|FG002|Overall Study|Administrative reason|1
4519171|NCT00978731|7331607|FG003|Overall Study|Administrative reason|0
4519172|NCT00978731|7331604|FG000|Overall Study|Deterioration without progression|0
4519173|NCT00978731|7331605|FG001|Overall Study|Deterioration without progression|1
4519174|NCT00978731|7331606|FG002|Overall Study|Deterioration without progression|0
4519175|NCT00978731|7331607|FG003|Overall Study|Deterioration without progression|0
4519176|NCT00978731|7331604|FG000|Overall Study|Disease progression/relapse|5
4519177|NCT00978731|7331605|FG001|Overall Study|Disease progression/relapse|4
4519178|NCT00978731|7331606|FG002|Overall Study|Disease progression/relapse|2
4519179|NCT00978731|7331607|FG003|Overall Study|Disease progression/relapse|2
4519180|NCT00978731|7331604|FG000|Overall Study|Study closure|3
4519181|NCT00978731|7331605|FG001|Overall Study|Study closure|4
4519182|NCT00978731|7331606|FG002|Overall Study|Study closure|1
4519183|NCT00978731|7331607|FG003|Overall Study|Study closure|1
4519184|NCT00978731|7331604|FG000|Overall Study|No response|1
4519185|NCT00978731|7331605|FG001|Overall Study|No response|0
4519186|NCT00978731|7331606|FG002|Overall Study|No response|0
4519187|NCT00978731|7331607|FG003|Overall Study|No response|0
4519188|NCT00978757|7331623|FG000|Overall Study|Physician Decision|1
4519189|NCT00978757|7331624|FG001|Overall Study|Physician Decision|3
4519190|NCT00979134|7331661|FG000|Overall Study|Disease progression|18
4519191|NCT00979134|7331662|FG001|Overall Study|Disease progression|2
4519192|NCT00979134|7331663|FG002|Overall Study|Disease progression|5
4519193|NCT00979134|7331661|FG000|Overall Study|Adverse Event|0
4519194|NCT00979134|7331662|FG001|Overall Study|Adverse Event|0
4519195|NCT00979134|7331663|FG002|Overall Study|Adverse Event|2
4519196|NCT00979134|7331661|FG000|Overall Study|Withdrawal by Subject|1
4519197|NCT00979134|7331662|FG001|Overall Study|Withdrawal by Subject|1
4519198|NCT00979134|7331663|FG002|Overall Study|Withdrawal by Subject|2
4519199|NCT00979134|7331661|FG000|Overall Study|Lost to Follow-up|2
4519200|NCT00979134|7331662|FG001|Overall Study|Lost to Follow-up|2
4519201|NCT00979134|7331663|FG002|Overall Study|Lost to Follow-up|0
4519202|NCT00979134|7331661|FG000|Overall Study|Death|4
4519203|NCT00979134|7331662|FG001|Overall Study|Death|0
4519204|NCT00979134|7331663|FG002|Overall Study|Death|26
4519205|NCT00979134|7331661|FG000|Overall Study|Other|8
4519206|NCT00979134|7331662|FG001|Overall Study|Other|1
4519207|NCT00979134|7331663|FG002|Overall Study|Other|5
4519208|NCT00979212|7331682|FG000|Overall Study|Protocol Violation|1
4519209|NCT00979212|7331683|FG001|Overall Study|Protocol Violation|8
4519210|NCT00979212|7331682|FG000|Overall Study|No protocol therapy received|1
4519211|NCT00979212|7331683|FG001|Overall Study|No protocol therapy received|0
4519212|NCT00979407|7331700|FG000|Overall Study|Withdrawal by Subject|3
4519213|NCT00979407|7331701|FG001|Overall Study|Withdrawal by Subject|4
4519214|NCT00979407|7331700|FG000|Overall Study|Lost to Follow-up|3
4519215|NCT00979407|7331701|FG001|Overall Study|Lost to Follow-up|3
4519216|NCT00979420|7331713|FG000|Overall Study|Adverse Event|1
4519217|NCT00979420|7331714|FG001|Overall Study|Adverse Event|0
4519218|NCT00979420|7331715|FG002|Overall Study|Adverse Event|0
4519219|NCT00979420|7331716|FG003|Overall Study|Adverse Event|0
4519220|NCT00979420|7331713|FG000|Overall Study|Lack of Efficacy|3
4519221|NCT00979420|7331714|FG001|Overall Study|Lack of Efficacy|0
4519222|NCT00979420|7331715|FG002|Overall Study|Lack of Efficacy|1
4519223|NCT00979420|7331716|FG003|Overall Study|Lack of Efficacy|1
4519224|NCT00979420|7331713|FG000|Overall Study|Other reasons not related to Viramune|3
4519225|NCT00979420|7331714|FG001|Overall Study|Other reasons not related to Viramune|0
4519226|NCT00979420|7331715|FG002|Overall Study|Other reasons not related to Viramune|0
4519227|NCT00979420|7331716|FG003|Overall Study|Other reasons not related to Viramune|1
4519228|NCT00979576|7331736|FG000|Combination Treatment Phase|Progressive disease|3
4519229|NCT00979576|7331737|FG001|Combination Treatment Phase|Progressive disease|1
4519230|NCT00979576|7331738|FG002|Combination Treatment Phase|Progressive disease|5
4519231|NCT00979576|7331736|FG000|Combination Treatment Phase|Dose limiting toxicity|0
4519232|NCT00979576|7331737|FG001|Combination Treatment Phase|Dose limiting toxicity|3
4519233|NCT00979576|7331738|FG002|Combination Treatment Phase|Dose limiting toxicity|2
4519234|NCT00979576|7331736|FG000|Combination Treatment Phase|Adverse Event|0
4519235|NCT00979576|7331737|FG001|Combination Treatment Phase|Adverse Event|2
4519236|NCT00979576|7331738|FG002|Combination Treatment Phase|Adverse Event|2
4519237|NCT00979576|7331736|FG000|Combination Followed by Monotherapy|Progressive Disease|0
4519238|NCT00979576|7331737|FG001|Combination Followed by Monotherapy|Progressive Disease|2
4519239|NCT00979576|7331738|FG002|Combination Followed by Monotherapy|Progressive Disease|1
4519240|NCT00979602|7331749|FG000|Overall Study|Serious Adverse Event|5
4519241|NCT00979602|7331750|FG001|Overall Study|Serious Adverse Event|3
4519242|NCT00979602|7331749|FG000|Overall Study|Protocol Violation|3
4519243|NCT00979602|7331750|FG001|Overall Study|Protocol Violation|0
4519244|NCT00979602|7331749|FG000|Overall Study|Withdrawal by Subject|31
4519245|NCT00979602|7331750|FG001|Overall Study|Withdrawal by Subject|25
4519246|NCT00979602|7331749|FG000|Overall Study|Lost to Follow-up|100
4519247|NCT00979602|7331750|FG001|Overall Study|Lost to Follow-up|96
4519248|NCT00979602|7331749|FG000|Overall Study|Migrated/moved from study area|3
4519249|NCT00979602|7331750|FG001|Overall Study|Migrated/moved from study area|6
4519250|NCT00979602|7331749|FG000|Overall Study|Others|3
4519251|NCT00979602|7331750|FG001|Overall Study|Others|3
4519252|NCT00979628|7331780|FG000|Overall Study|received regimen < 24 hours|7
4519253|NCT00979628|7331781|FG001|Overall Study|received regimen < 24 hours|6
4519254|NCT00979628|7331782|FG002|Overall Study|received regimen < 24 hours|5
4519255|NCT00979628|7331780|FG000|Overall Study|received steroids|1
4519256|NCT00979628|7331781|FG001|Overall Study|received steroids|1
4519257|NCT00979628|7331782|FG002|Overall Study|received steroids|0
4519258|NCT00979628|7331780|FG000|Overall Study|transferred to ICU|1
4737711|NCT03618823|7688076|FG000|Overall Study|Lost to Follow-up|63
4737712|NCT03618823|7688077|FG001|Overall Study|Lost to Follow-up|61
4737713|NCT03619837|7688103|FG000|Screening|received organs from HCV-negative donors|47
4737714|NCT03619837|7688103|FG000|Screening|died on the wait-list|2
4737715|NCT03619837|7688103|FG000|Screening|remained on the wait list|40
4737716|NCT03619837|7688103|FG000|Screening|didn't meet eligibility criteria|3
4737717|NCT03619837|7688103|FG000|Screening|withdrew consent|2
4737718|NCT03619837|7688103|FG000|Screening|never listed for HCV-viremic donor|1
4737719|NCT03619837|7688103|FG000|Screening|developed exclusion criteria|2
4737720|NCT03619837|7688103|FG000|Screening|excluded by the investigator due to non-compliance|1
4737721|NCT03620162|7688121|FG000|Overall Study|Physician Decision|4
4737722|NCT03620162|7688122|FG001|Overall Study|Physician Decision|0
4737723|NCT03620162|7688123|FG002|Overall Study|Physician Decision|1
4737724|NCT03620162|7688124|FG003|Overall Study|Physician Decision|0
4737725|NCT03620162|7688125|FG004|Overall Study|Physician Decision|2
4737726|NCT03620162|7688121|FG000|Overall Study|Lost to Follow-up|2
4737727|NCT03620162|7688122|FG001|Overall Study|Lost to Follow-up|6
4737728|NCT03620162|7688123|FG002|Overall Study|Lost to Follow-up|7
4737729|NCT03620162|7688124|FG003|Overall Study|Lost to Follow-up|3
4737730|NCT03620162|7688125|FG004|Overall Study|Lost to Follow-up|2
4519259|NCT00979628|7331781|FG001|Overall Study|transferred to ICU|2
4519260|NCT00979628|7331782|FG002|Overall Study|transferred to ICU|1
4519261|NCT00979654|7331793|FG000|Overall Study|Lost to Follow-up|1
4519262|NCT00979654|7331793|FG000|Overall Study|Withdrawal by Subject|22
4519263|NCT00979654|7331793|FG000|Overall Study|Death|1
4519264|NCT00979654|7331793|FG000|Overall Study|Lack of Efficacy|6
4519265|NCT00979654|7331793|FG000|Overall Study|Adverse Event|1
4519266|NCT00979654|7331793|FG000|Overall Study|Adverse Event of Diverticulitis|1
4519267|NCT00979654|7331793|FG000|Overall Study|Per Principal Investigator's Discretion|1
4519268|NCT00979654|7331793|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1
4519269|NCT00979654|7331793|FG000|Overall Study|Serious Adverse Event|1
4519270|NCT00979654|7331793|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1
4519271|NCT00979953|7331847|FG000|Overall Study|Adverse Event|5
4519272|NCT00979953|7331848|FG001|Overall Study|Adverse Event|2
4519273|NCT00979953|7331849|FG002|Overall Study|Adverse Event|17
4519274|NCT00979953|7331850|FG003|Overall Study|Adverse Event|4
4519275|NCT00979953|7331847|FG000|Overall Study|Lack of Efficacy|1
4519276|NCT00979953|7331848|FG001|Overall Study|Lack of Efficacy|2
4519277|NCT00979953|7331849|FG002|Overall Study|Lack of Efficacy|0
4519278|NCT00979953|7331850|FG003|Overall Study|Lack of Efficacy|0
4519279|NCT00979953|7331847|FG000|Overall Study|Lost to Follow-up|1
4519280|NCT00979953|7331848|FG001|Overall Study|Lost to Follow-up|1
4519281|NCT00979953|7331849|FG002|Overall Study|Lost to Follow-up|1
4519282|NCT00979953|7331850|FG003|Overall Study|Lost to Follow-up|0
4519283|NCT00979953|7331847|FG000|Overall Study|Withdrawal by Subject|0
4519284|NCT00979953|7331848|FG001|Overall Study|Withdrawal by Subject|0
4519285|NCT00979953|7331849|FG002|Overall Study|Withdrawal by Subject|2
4519286|NCT00979953|7331850|FG003|Overall Study|Withdrawal by Subject|1
4519287|NCT00979953|7331847|FG000|Overall Study|Protocol Violation|1
4519288|NCT00979953|7331848|FG001|Overall Study|Protocol Violation|0
4737731|NCT03620162|7688121|FG000|Overall Study|Consent withdrawn by parent/guardian|9
4519289|NCT00979953|7331849|FG002|Overall Study|Protocol Violation|2
4519290|NCT00979953|7331850|FG003|Overall Study|Protocol Violation|2
4737732|NCT03620162|7688122|FG001|Overall Study|Consent withdrawn by parent/guardian|8
4737733|NCT03620162|7688123|FG002|Overall Study|Consent withdrawn by parent/guardian|25
4519291|NCT00979992|7331860|FG000|Overall Study|Ineligible - inadequate pathology|1
4519292|NCT00979992|7331860|FG000|Overall Study|Ineligible - wrong cell type|2
4519293|NCT00979992|7331860|FG000|Overall Study|Refused - Never Treated|2
4519294|NCT00980005|7331866|FG000|Overall Study|Withdrawal by Subject|6
4519295|NCT00980005|7331867|FG001|Overall Study|Withdrawal by Subject|17
4519296|NCT00980005|7331866|FG000|Overall Study|Lost to Follow-up|37
4519297|NCT00980005|7331867|FG001|Overall Study|Lost to Follow-up|43
4519298|NCT00980005|7331866|FG000|Overall Study|Other|4
4519299|NCT00980005|7331867|FG001|Overall Study|Other|3
4519300|NCT00980018|7331877|FG000|Overall Study|Adverse Event|8
4519301|NCT00980018|7331877|FG000|Overall Study|Patient withdrew consent|3
4519302|NCT00980018|7331877|FG000|Overall Study|Lost to Follow-up|1
4519303|NCT00980044|7331884|FG000|Overall Study|Withdrawal by Subject|5
4519304|NCT00980044|7331885|FG001|Overall Study|Withdrawal by Subject|7
4519305|NCT00980044|7331886|FG002|Overall Study|Withdrawal by Subject|3
4519306|NCT00980044|7331884|FG000|Overall Study|Protocol Violation|0
4519307|NCT00980044|7331885|FG001|Overall Study|Protocol Violation|0
4519308|NCT00980044|7331886|FG002|Overall Study|Protocol Violation|2
4519309|NCT00980057|7331899|FG000|Overall Study|Death|13
4519310|NCT00980057|7331900|FG001|Overall Study|Death|3
4519311|NCT00980057|7331899|FG000|Overall Study|Adverse Event|0
4519312|NCT00980057|7331900|FG001|Overall Study|Adverse Event|1
4519313|NCT00980057|7331899|FG000|Overall Study|Physician Decision|4
4519314|NCT00980057|7331900|FG001|Overall Study|Physician Decision|0
4519315|NCT00980057|7331899|FG000|Overall Study|Lost to Follow-up|1
4519316|NCT00980057|7331900|FG001|Overall Study|Lost to Follow-up|0
4519317|NCT00980057|7331899|FG000|Overall Study|Withdrawal by Subject|1
4519318|NCT00980057|7331900|FG001|Overall Study|Withdrawal by Subject|1
4519319|NCT00980148|7331909|FG000|Overall Study|Discharged from facility|89
4519320|NCT00980148|7331910|FG001|Overall Study|Discharged from facility|96
4519321|NCT00980148|7331909|FG000|Overall Study|Received other antichlamydia treatment|20
4519322|NCT00980148|7331910|FG001|Overall Study|Received other antichlamydia treatment|14
4519323|NCT00980148|7331909|FG000|Overall Study|Negative for chlamydia at enrollment|12
4519324|NCT00980148|7331910|FG001|Overall Study|Negative for chlamydia at enrollment|9
4519325|NCT00980148|7331909|FG000|Overall Study|Various other reasons|8
4519326|NCT00980148|7331910|FG001|Overall Study|Various other reasons|9
4519327|NCT00980174|7331918|FG000|Overall Study|Withdrawal by Subject|1
4519328|NCT00980174|7331919|FG001|Overall Study|Withdrawal by Subject|4
4519329|NCT00980174|7331918|FG000|Overall Study|Adverse Event|0
4519330|NCT00980174|7331919|FG001|Overall Study|Adverse Event|3
4519331|NCT00980174|7331918|FG000|Overall Study|Ineligibility determined|2
4519332|NCT00980174|7331919|FG001|Overall Study|Ineligibility determined|1
4519333|NCT00980174|7331918|FG000|Overall Study|Death|1
4519334|NCT00980174|7331919|FG001|Overall Study|Death|1
4519335|NCT00980174|7331918|FG000|Overall Study|Other|0
4519336|NCT00980174|7331919|FG001|Overall Study|Other|1
4519337|NCT00980200|7331925|FG000|7-day Treatment Period 1|Withdrawal by Subject|0
4519338|NCT00980200|7331926|FG001|7-day Treatment Period 1|Withdrawal by Subject|1
4519339|NCT00980200|7331927|FG002|7-day Treatment Period 1|Withdrawal by Subject|0
4519340|NCT00980200|7331928|FG003|7-day Treatment Period 1|Withdrawal by Subject|0
4519341|NCT00980200|7331929|FG004|7-day Treatment Period 1|Withdrawal by Subject|0
4519342|NCT00980200|7331925|FG000|7-day Treatment Period 3|Lack of Efficacy|0
4519343|NCT00980200|7331926|FG001|7-day Treatment Period 3|Lack of Efficacy|1
4519344|NCT00980200|7331927|FG002|7-day Treatment Period 3|Lack of Efficacy|0
4519345|NCT00980200|7331928|FG003|7-day Treatment Period 3|Lack of Efficacy|0
4519346|NCT00980200|7331929|FG004|7-day Treatment Period 3|Lack of Efficacy|1
4519347|NCT00980330|7331957|FG000|Overall Study|Adverse Event|0
4519348|NCT00980330|7331958|FG001|Overall Study|Adverse Event|0
4519349|NCT00980330|7331959|FG002|Overall Study|Adverse Event|0
4519350|NCT00980330|7331960|FG003|Overall Study|Adverse Event|1
4519351|NCT00980330|7331961|FG004|Overall Study|Adverse Event|0
4519352|NCT00980330|7331962|FG005|Overall Study|Adverse Event|0
4519353|NCT00980330|7331963|FG006|Overall Study|Adverse Event|0
4519354|NCT00980330|7331957|FG000|Overall Study|Lost to Follow-up|1
4519355|NCT00980330|7331958|FG001|Overall Study|Lost to Follow-up|1
4519356|NCT00980330|7331959|FG002|Overall Study|Lost to Follow-up|4
4519357|NCT00980330|7331960|FG003|Overall Study|Lost to Follow-up|2
4519358|NCT00980330|7331961|FG004|Overall Study|Lost to Follow-up|1
4519359|NCT00980330|7331962|FG005|Overall Study|Lost to Follow-up|1
4519360|NCT00980330|7331963|FG006|Overall Study|Lost to Follow-up|2
4519361|NCT00980330|7331957|FG000|Overall Study|Withdrawal by Subject|2
4519362|NCT00980330|7331958|FG001|Overall Study|Withdrawal by Subject|4
4519363|NCT00980330|7331959|FG002|Overall Study|Withdrawal by Subject|4
4519364|NCT00980330|7331960|FG003|Overall Study|Withdrawal by Subject|1
4519365|NCT00980330|7331961|FG004|Overall Study|Withdrawal by Subject|3
4519366|NCT00980330|7331962|FG005|Overall Study|Withdrawal by Subject|2
4737734|NCT03620162|7688124|FG003|Overall Study|Consent withdrawn by parent/guardian|17
4737735|NCT03620162|7688125|FG004|Overall Study|Consent withdrawn by parent/guardian|9
4737736|NCT03620708|7688151|FG000|Overall Study|Lost to Follow-up|1
4737737|NCT03620708|7688152|FG001|Overall Study|Lost to Follow-up|1
4737738|NCT03620708|7688153|FG002|Overall Study|Lost to Follow-up|2
4737739|NCT03620708|7688151|FG000|Overall Study|Withdrawal by Subject|0
4737740|NCT03620708|7688152|FG001|Overall Study|Withdrawal by Subject|0
4737741|NCT03620708|7688153|FG002|Overall Study|Withdrawal by Subject|1
4737742|NCT03621189|7688179|FG000|Overall Study|Withdrawal by Subject|0
4737743|NCT03621189|7688180|FG001|Overall Study|Withdrawal by Subject|3
4519367|NCT00980330|7331963|FG006|Overall Study|Withdrawal by Subject|5
4519368|NCT00980330|7331957|FG000|Overall Study|(not specified)|2
4519369|NCT00980330|7331958|FG001|Overall Study|(not specified)|0
4737744|NCT03621189|7688179|FG000|Overall Study|Physician Decision|0
4737745|NCT03621189|7688180|FG001|Overall Study|Physician Decision|2
4519370|NCT00980330|7331959|FG002|Overall Study|(not specified)|0
4519371|NCT00980330|7331960|FG003|Overall Study|(not specified)|1
4519372|NCT00980330|7331961|FG004|Overall Study|(not specified)|1
4519373|NCT00980330|7331962|FG005|Overall Study|(not specified)|1
4519374|NCT00980330|7331963|FG006|Overall Study|(not specified)|0
4519375|NCT00980343|7331982|FG000|Overall Study|no tumor at surgery - treatment effect|1
4519376|NCT00980343|7331983|FG001|Overall Study|no tumor at surgery - treatment effect|3
4593852|NCT01555164|7442379|FG000|Overall Study|Protocol Violation|9
4593853|NCT01555164|7442380|FG001|Overall Study|Protocol Violation|5
4593854|NCT01555164|7442379|FG000|Overall Study|Subject Non-compliance|14
4593855|NCT01555164|7442380|FG001|Overall Study|Subject Non-compliance|6
4593856|NCT01555164|7442379|FG000|Overall Study|Subject Withdrew Consent|6
4593857|NCT01555164|7442380|FG001|Overall Study|Subject Withdrew Consent|11
4593858|NCT01555463|7442388|FG000|Treatment|Adverse Event|6
4593859|NCT01555463|7442389|FG001|Treatment|Adverse Event|12
4593860|NCT01555463|7442388|FG000|Treatment|Withdrawal by Subject|24
4593861|NCT01555463|7442389|FG001|Treatment|Withdrawal by Subject|36
4593862|NCT01555463|7442388|FG000|Treatment|Lost to Follow-up|28
4593863|NCT01555463|7442389|FG001|Treatment|Lost to Follow-up|23
4593864|NCT01555463|7442388|FG000|Treatment|Protocol Violation|4
4593865|NCT01555463|7442389|FG001|Treatment|Protocol Violation|5
4593866|NCT01555463|7442388|FG000|Treatment|Other reason|2
4593867|NCT01555463|7442389|FG001|Treatment|Other reason|3
4593868|NCT01555463|7442388|FG000|Follow up|Adverse Event|2
4593869|NCT01555463|7442389|FG001|Follow up|Adverse Event|5
4593870|NCT01555463|7442388|FG000|Follow up|Death|0
4593871|NCT01555463|7442389|FG001|Follow up|Death|1
4593872|NCT01555463|7442388|FG000|Follow up|Withdrawal by Subject|22
4593873|NCT01555463|7442389|FG001|Follow up|Withdrawal by Subject|22
4593874|NCT01555463|7442388|FG000|Follow up|Lost to Follow-up|9
4593875|NCT01555463|7442389|FG001|Follow up|Lost to Follow-up|10
4593876|NCT01555463|7442388|FG000|Follow up|Protocol Violation|2
4593877|NCT01555463|7442389|FG001|Follow up|Protocol Violation|4
4593878|NCT01555463|7442388|FG000|Follow up|Other reason|3
4593879|NCT01555463|7442389|FG001|Follow up|Other reason|3
4593880|NCT01555671|7442419|FG000|Overall Study|Physician Decision|20
4593881|NCT01555671|7442420|FG001|Overall Study|Physician Decision|25
4593882|NCT01555762|7442455|FG000|Overall Study|No information on Bevacizumab intake|11
4593883|NCT01555762|7442455|FG000|Overall Study|Missing start date of infusion|8
4593884|NCT01555762|7442455|FG000|Overall Study|75 years old or more ticked No|1
4593885|NCT01555762|7442455|FG000|Overall Study|Treatment with Bevacizumab ticked No|24
4593886|NCT01555762|7442455|FG000|Overall Study|Death linked to progression of disease|165
4593887|NCT01555762|7442455|FG000|Overall Study|Lost follow-up/moved house/changed team|35
4593888|NCT01555762|7442455|FG000|Overall Study|Investigator's decision|10
4593889|NCT01555762|7442455|FG000|Overall Study|Participant not wishing to continue|5
4593890|NCT01555762|7442455|FG000|Overall Study|Missing data|1
4593891|NCT01555762|7442455|FG000|Overall Study|Death linked to an adverse event|14
4593892|NCT01555931|7442461|FG000|Overall Study|Lost to Follow-up|2
4519377|NCT00980655|7332015|FG000|Overall Study|Adverse Event|13
4519378|NCT00980655|7332016|FG001|Overall Study|Adverse Event|31
4519379|NCT00980655|7332015|FG000|Overall Study|Death|0
4519380|NCT00980655|7332016|FG001|Overall Study|Death|7
4519381|NCT00980655|7332015|FG000|Overall Study|Protocol Violation|2
4519382|NCT00980655|7332016|FG001|Overall Study|Protocol Violation|7
4519383|NCT00980655|7332015|FG000|Overall Study|Withdrawal by Subject|0
4519384|NCT00980655|7332016|FG001|Overall Study|Withdrawal by Subject|4
4519385|NCT00980655|7332015|FG000|Overall Study|Lost to Follow-up|0
4519386|NCT00980655|7332016|FG001|Overall Study|Lost to Follow-up|1
4519387|NCT00980655|7332015|FG000|Overall Study|Parent/legal guardian request|1
4519388|NCT00980655|7332016|FG001|Overall Study|Parent/legal guardian request|0
4519389|NCT00980655|7332015|FG000|Overall Study|Other|0
4519390|NCT00980655|7332016|FG001|Overall Study|Other|1
4519391|NCT00980798|7332069|FG000|Overall Study|Adverse Event|7
4519392|NCT00980798|7332070|FG001|Overall Study|Adverse Event|36
4519393|NCT00980798|7332069|FG000|Overall Study|Lack of Efficacy|16
4519394|NCT00980798|7332070|FG001|Overall Study|Lack of Efficacy|5
4519395|NCT00980798|7332069|FG000|Overall Study|Lost to Follow-up|0
4519396|NCT00980798|7332070|FG001|Overall Study|Lost to Follow-up|1
4519397|NCT00980798|7332069|FG000|Overall Study|Physician Decision|2
4519398|NCT00980798|7332070|FG001|Overall Study|Physician Decision|1
4519399|NCT00980798|7332069|FG000|Overall Study|Withdrawal by Subject|8
4519400|NCT00980798|7332070|FG001|Overall Study|Withdrawal by Subject|11
4519401|NCT00980798|7332069|FG000|Overall Study|Other|0
4519402|NCT00980798|7332070|FG001|Overall Study|Other|1
4519403|NCT00980980|7332079|FG000|Overall Study|Withdrawal by Hospital|0
4519404|NCT00980980|7332080|FG001|Overall Study|Withdrawal by Hospital|1
4519405|NCT00980980|7332081|FG002|Overall Study|Withdrawal by Hospital|0
4519406|NCT00981019|7332092|FG000|Overall Study|Did not respond|65
4519407|NCT00981019|7332092|FG000|Overall Study|Did not match target population|94
4519408|NCT00981019|7332092|FG000|Overall Study|Inadvertent exclusion|239
4519409|NCT00981019|7332092|FG000|Overall Study|Hit the survey after closure|79
4519410|NCT00981084|7332107|FG000|Post Intervention (Data Analysis)|poor effort|1
4519411|NCT00981084|7332108|FG001|Post Intervention (Data Analysis)|poor effort|1
4519412|NCT00981084|7332107|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1
4519413|NCT00981084|7332108|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0
4519414|NCT00981149|7332118|FG000|Overall Study|Lost to Follow-up|1
4519415|NCT00981149|7332119|FG001|Overall Study|Lost to Follow-up|2
4519416|NCT00981149|7332118|FG000|Overall Study|Withdrawal by Subject|1
4519417|NCT00981149|7332119|FG001|Overall Study|Withdrawal by Subject|1
4519418|NCT00981175|7332128|FG000|Primary Dose Vaccination|Adverse Event|1
4519419|NCT00981175|7332129|FG001|Primary Dose Vaccination|Adverse Event|0
4519420|NCT00981175|7332128|FG000|Primary Dose Vaccination|Protocol Violation|0
4519421|NCT00981175|7332129|FG001|Primary Dose Vaccination|Protocol Violation|1
4519422|NCT00981175|7332128|FG000|Primary Dose Vaccination|Lost to Follow-up|2
4519423|NCT00981175|7332129|FG001|Primary Dose Vaccination|Lost to Follow-up|1
4519424|NCT00981175|7332128|FG000|Booster Dose Vaccination|Lost to Follow-up|2
4519425|NCT00981175|7332129|FG001|Booster Dose Vaccination|Lost to Follow-up|3
4519426|NCT00981292|7332191|FG000|Day 1|Protocol Violation|1
4519427|NCT00981292|7332192|FG001|Day 1|Protocol Violation|0
4519428|NCT00981292|7332193|FG002|Day 1|Protocol Violation|0
4519429|NCT00981292|7332194|FG003|Day 1|Protocol Violation|0
4519430|NCT00981292|7332195|FG004|Day 1|Protocol Violation|0
4519431|NCT00981292|7332196|FG005|Day 1|Protocol Violation|2
4519432|NCT00981292|7332191|FG000|Day 2|Protocol Violation|2
4519433|NCT00981292|7332192|FG001|Day 2|Protocol Violation|0
4519434|NCT00981292|7332193|FG002|Day 2|Protocol Violation|0
4519435|NCT00981292|7332194|FG003|Day 2|Protocol Violation|0
4519436|NCT00981292|7332195|FG004|Day 2|Protocol Violation|0
4519437|NCT00981292|7332196|FG005|Day 2|Protocol Violation|0
4519438|NCT00981292|7332191|FG000|Day 3|Protocol Violation|0
4519439|NCT00981292|7332192|FG001|Day 3|Protocol Violation|0
4519440|NCT00981292|7332193|FG002|Day 3|Protocol Violation|0
4519441|NCT00981292|7332194|FG003|Day 3|Protocol Violation|0
4519442|NCT00981292|7332195|FG004|Day 3|Protocol Violation|0
4519443|NCT00981292|7332196|FG005|Day 3|Protocol Violation|1
4519444|NCT00981409|7332219|FG000|Overall Study|Adverse Event|4
4519445|NCT00981409|7332220|FG001|Overall Study|Adverse Event|0
4519446|NCT00981409|7332219|FG000|Overall Study|Protocol Violation|0
4519447|NCT00981409|7332220|FG001|Overall Study|Protocol Violation|1
4519448|NCT00981409|7332219|FG000|Overall Study|Prostate Cancer Treatment before Trial|2
4519449|NCT00981409|7332220|FG001|Overall Study|Prostate Cancer Treatment before Trial|0
4519450|NCT00981461|7332241|FG000|Overall Study|Lost to Follow-up|5
4519451|NCT00981461|7332242|FG001|Overall Study|Lost to Follow-up|2
4519452|NCT00981526|7332261|FG000|Overall Study|Withdrawal by Subject|0
4519453|NCT00981526|7332262|FG001|Overall Study|Withdrawal by Subject|2
4519454|NCT00981526|7332261|FG000|Overall Study|Physician Decision|4
4519455|NCT00981526|7332262|FG001|Overall Study|Physician Decision|4
4519456|NCT00981578|7332270|FG000|Overall Study|Death|1
4519457|NCT00981578|7332270|FG000|Overall Study|Withdrawal by Subject|2
4519458|NCT00981682|7332300|FG000|Overall Study|Adverse Event|48
4519459|NCT00981682|7332300|FG000|Overall Study|Withdrawal by Subject|52
4519460|NCT00981682|7332300|FG000|Overall Study|Lost to Follow-up|14
4519461|NCT00981682|7332300|FG000|Overall Study|Lack of Efficacy|13
4519462|NCT00981682|7332300|FG000|Overall Study|Protocol Violation|6
4519463|NCT00981682|7332300|FG000|Overall Study|administrative|9
4519464|NCT00981747|7332304|FG000|Losartan|Withdrawal by Subject|1
4519465|NCT00981747|7332304|FG000|Losartan|Death|1
4519466|NCT00981747|7332304|FG000|Placebo Oral Tablet|Withdrawal by Subject|1
4519467|NCT00981799|7332318|FG000|Overall Study|Adverse Event|1
4519468|NCT00981799|7332319|FG001|Overall Study|Adverse Event|1
4519469|NCT00981799|7332320|FG002|Overall Study|Adverse Event|0
4519470|NCT00981799|7332321|FG003|Overall Study|Adverse Event|0
4519471|NCT00982020|7332364|FG000|Overall Study|Adverse Event|19
4519472|NCT00982020|7332365|FG001|Overall Study|Adverse Event|15
4519473|NCT00982020|7332364|FG000|Overall Study|Withdrawal by Subject|11
4519474|NCT00982020|7332365|FG001|Overall Study|Withdrawal by Subject|14
4519475|NCT00982020|7332364|FG000|Overall Study|Lost to Follow-up|5
4519476|NCT00982020|7332365|FG001|Overall Study|Lost to Follow-up|11
4519477|NCT00982020|7332364|FG000|Overall Study|Lack of Efficacy|10
4519478|NCT00982020|7332365|FG001|Overall Study|Lack of Efficacy|4
4519479|NCT00982020|7332364|FG000|Overall Study|Parent/Caregiver Decision|5
4519480|NCT00982020|7332365|FG001|Overall Study|Parent/Caregiver Decision|5
4519481|NCT00982020|7332364|FG000|Overall Study|Treatment Non-compliance|3
4519482|NCT00982020|7332365|FG001|Overall Study|Treatment Non-compliance|6
4519483|NCT00982020|7332364|FG000|Overall Study|Physician Decision|2
4519484|NCT00982020|7332365|FG001|Overall Study|Physician Decision|5
4519485|NCT00982020|7332364|FG000|Overall Study|Entry Criteria Not Met|2
4519486|NCT00982020|7332365|FG001|Overall Study|Entry Criteria Not Met|1
4519487|NCT00982020|7332364|FG000|Overall Study|Protocol Violation|0
4519488|NCT00982020|7332365|FG001|Overall Study|Protocol Violation|2
4519489|NCT00982020|7332364|FG000|Overall Study|Clinical Relapse|0
4519490|NCT00982020|7332365|FG001|Overall Study|Clinical Relapse|1
4519491|NCT00982137|7332398|FG000|Overall Study|Lost to Follow-up|0
4519492|NCT00982137|7332399|FG001|Overall Study|Lost to Follow-up|0
4519493|NCT00982137|7332400|FG002|Overall Study|Lost to Follow-up|0
4519494|NCT00982137|7332401|FG003|Overall Study|Lost to Follow-up|1
4519495|NCT00982137|7332398|FG000|Overall Study|Withdrawal by Subject|0
4519496|NCT00982137|7332399|FG001|Overall Study|Withdrawal by Subject|1
4519497|NCT00982137|7332400|FG002|Overall Study|Withdrawal by Subject|0
4519498|NCT00982137|7332401|FG003|Overall Study|Withdrawal by Subject|0
4519499|NCT00982228|7332439|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12
4519500|NCT00982228|7332440|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2
4519501|NCT00982228|7332439|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2
4519502|NCT00982228|7332440|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0
4519503|NCT00982228|7332439|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11
4519504|NCT00982228|7332440|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2
4519505|NCT00982228|7332439|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15
4519506|NCT00982228|7332440|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3
4519507|NCT00982228|7332439|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28
4519508|NCT00982228|7332440|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13
4519509|NCT00982228|7332439|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3
4519510|NCT00982228|7332440|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2
4519511|NCT00982228|7332439|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1
4519512|NCT00982228|7332440|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0
4519513|NCT00982228|7332439|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1
4519514|NCT00982228|7332440|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2
4519515|NCT00982228|7332439|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5
4519516|NCT00982228|7332440|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0
4519517|NCT00982228|7332439|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11
4519518|NCT00982228|7332440|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1
4519519|NCT00982280|7332446|FG000|Observation Period|Not eligible to be dosed|19
4519520|NCT00982280|7332446|FG000|Titration and Optimal Dose Period|Adverse Event|5
4519521|NCT00982280|7332446|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2
4519522|NCT00982280|7332446|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1
4519523|NCT00982280|7332446|FG000|Maintenance Period|Adverse Event|1
4519524|NCT00982319|7332453|FG000|Overall Study|Surgery date change|1
4519525|NCT00982319|7332454|FG001|Overall Study|Surgery date change|0
4519526|NCT00982319|7332453|FG000|Overall Study|Preop values out of acceptable range|1
4519527|NCT00982319|7332454|FG001|Overall Study|Preop values out of acceptable range|1
4519528|NCT00982319|7332453|FG000|Overall Study|Pregnancy|0
4519529|NCT00982319|7332454|FG001|Overall Study|Pregnancy|1
4519530|NCT00982410|7332478|FG000|3-month Follow-up Assessment|Could not reach to schedule|8
4519531|NCT00982410|7332479|FG001|3-month Follow-up Assessment|Could not reach to schedule|9
4519532|NCT00982410|7332478|FG000|3-month Follow-up Assessment|Scheduled, no-show|1
4519533|NCT00982410|7332479|FG001|3-month Follow-up Assessment|Scheduled, no-show|2
4519534|NCT00982410|7332478|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0
4519535|NCT00982410|7332479|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2
4519536|NCT00982410|7332478|FG000|6-month Follow-up Assessment|Could not reach to schedule|5
4519537|NCT00982410|7332479|FG001|6-month Follow-up Assessment|Could not reach to schedule|7
4519538|NCT00982410|7332478|FG000|6-month Follow-up Assessment|participant no transportation|1
4519539|NCT00982410|7332479|FG001|6-month Follow-up Assessment|participant no transportation|0
4519540|NCT00982410|7332478|FG000|6-month Follow-up Assessment|incarceration|0
4519541|NCT00982410|7332479|FG001|6-month Follow-up Assessment|incarceration|2
4519542|NCT00982410|7332478|FG000|6-month Follow-up Assessment|patent surgery|0
4519543|NCT00982410|7332479|FG001|6-month Follow-up Assessment|patent surgery|1
4519544|NCT00982410|7332478|FG000|6-month Follow-up Assessment|scheduled, no-show|0
4519545|NCT00982410|7332479|FG001|6-month Follow-up Assessment|scheduled, no-show|1
4519546|NCT00982410|7332478|FG000|12-month Follow-up Assessment|Death|0
4519547|NCT00982410|7332479|FG001|12-month Follow-up Assessment|Death|2
4519548|NCT00982410|7332478|FG000|12-month Follow-up Assessment|could not reach to schedule|6
4519549|NCT00982410|7332479|FG001|12-month Follow-up Assessment|could not reach to schedule|5
4519550|NCT00982410|7332478|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0
4519551|NCT00982410|7332479|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1
4519552|NCT00982410|7332478|FG000|12-month Follow-up Assessment|incarceration|2
4519553|NCT00982410|7332479|FG001|12-month Follow-up Assessment|incarceration|1
4519554|NCT00982410|7332478|FG000|12-month Follow-up Assessment|scheduled, no-show|1
4519555|NCT00982410|7332479|FG001|12-month Follow-up Assessment|scheduled, no-show|0
4519556|NCT00982488|7332501|FG000|Overall Study|Administrative reason by sponsor|81
4519557|NCT00982488|7332502|FG001|Overall Study|Administrative reason by sponsor|3
4519558|NCT00982488|7332503|FG002|Overall Study|Administrative reason by sponsor|11
4519559|NCT00982488|7332504|FG003|Overall Study|Administrative reason by sponsor|0
4519560|NCT00982488|7332505|FG004|Overall Study|Administrative reason by sponsor|0
4519561|NCT00982488|7332501|FG000|Overall Study|Adverse event unrelated to study drug|5
4519562|NCT00982488|7332502|FG001|Overall Study|Adverse event unrelated to study drug|1
4519563|NCT00982488|7332503|FG002|Overall Study|Adverse event unrelated to study drug|0
4519564|NCT00982488|7332504|FG003|Overall Study|Adverse event unrelated to study drug|0
4519565|NCT00982488|7332505|FG004|Overall Study|Adverse event unrelated to study drug|0
4519566|NCT00982488|7332501|FG000|Overall Study|Death|11
4519567|NCT00982488|7332502|FG001|Overall Study|Death|0
4519568|NCT00982488|7332503|FG002|Overall Study|Death|2
4519569|NCT00982488|7332504|FG003|Overall Study|Death|0
4519570|NCT00982488|7332505|FG004|Overall Study|Death|0
4519571|NCT00982488|7332501|FG000|Overall Study|Disease progression|30
4519572|NCT00982488|7332502|FG001|Overall Study|Disease progression|5
4519573|NCT00982488|7332503|FG002|Overall Study|Disease progression|10
4519574|NCT00982488|7332504|FG003|Overall Study|Disease progression|1
4519575|NCT00982488|7332505|FG004|Overall Study|Disease progression|1
4519576|NCT00982488|7332501|FG000|Overall Study|Lost to Follow-up|1
4519577|NCT00982488|7332502|FG001|Overall Study|Lost to Follow-up|0
4519578|NCT00982488|7332503|FG002|Overall Study|Lost to Follow-up|0
4519579|NCT00982488|7332504|FG003|Overall Study|Lost to Follow-up|0
4519580|NCT00982488|7332505|FG004|Overall Study|Lost to Follow-up|0
4519581|NCT00982488|7332501|FG000|Overall Study|Maximum clinical benefit|1
4519582|NCT00982488|7332502|FG001|Overall Study|Maximum clinical benefit|1
4519583|NCT00982488|7332503|FG002|Overall Study|Maximum clinical benefit|1
4519584|NCT00982488|7332504|FG003|Overall Study|Maximum clinical benefit|0
4519585|NCT00982488|7332505|FG004|Overall Study|Maximum clinical benefit|0
4519586|NCT00982488|7332501|FG000|Overall Study|Other|15
4519587|NCT00982488|7332502|FG001|Overall Study|Other|1
4519588|NCT00982488|7332503|FG002|Overall Study|Other|3
4519589|NCT00982488|7332504|FG003|Overall Study|Other|1
4519590|NCT00982488|7332505|FG004|Overall Study|Other|0
4519591|NCT00982488|7332501|FG000|Overall Study|Poor compliance/noncompliance|0
4519592|NCT00982488|7332502|FG001|Overall Study|Poor compliance/noncompliance|1
4519593|NCT00982488|7332503|FG002|Overall Study|Poor compliance/noncompliance|0
4519594|NCT00982488|7332504|FG003|Overall Study|Poor compliance/noncompliance|0
4519595|NCT00982488|7332505|FG004|Overall Study|Poor compliance/noncompliance|0
4519596|NCT00982488|7332501|FG000|Overall Study|Stem cell transplant|2
4519597|NCT00982488|7332502|FG001|Overall Study|Stem cell transplant|0
4519598|NCT00982488|7332503|FG002|Overall Study|Stem cell transplant|0
4519599|NCT00982488|7332504|FG003|Overall Study|Stem cell transplant|1
4519600|NCT00982488|7332505|FG004|Overall Study|Stem cell transplant|0
4519601|NCT00982488|7332501|FG000|Overall Study|Study drug toxicity|34
4519602|NCT00982488|7332502|FG001|Overall Study|Study drug toxicity|1
4519603|NCT00982488|7332503|FG002|Overall Study|Study drug toxicity|6
4519604|NCT00982488|7332504|FG003|Overall Study|Study drug toxicity|0
4519605|NCT00982488|7332505|FG004|Overall Study|Study drug toxicity|0
4519606|NCT00982488|7332501|FG000|Overall Study|Withdrawal by Subject|5
4519607|NCT00982488|7332502|FG001|Overall Study|Withdrawal by Subject|1
4519608|NCT00982488|7332503|FG002|Overall Study|Withdrawal by Subject|1
4519609|NCT00982488|7332504|FG003|Overall Study|Withdrawal by Subject|0
4519610|NCT00982488|7332505|FG004|Overall Study|Withdrawal by Subject|0
4519611|NCT00982644|7332537|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20
4519612|NCT00982644|7332538|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5
4519613|NCT00982644|7332537|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7
4519614|NCT00982644|7332538|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2
4519615|NCT00982644|7332537|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46
4519616|NCT00982644|7332538|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18
4519617|NCT00982644|7332537|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9
4519618|NCT00982644|7332538|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5
4519619|NCT00982644|7332537|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84
4519620|NCT00982644|7332538|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30
4519621|NCT00982644|7332537|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12
4519622|NCT00982644|7332538|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5
4519623|NCT00982644|7332537|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3
4519624|NCT00982644|7332538|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1
4519625|NCT00982644|7332537|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2
4519626|NCT00982644|7332538|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4
4519627|NCT00982644|7332537|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6
4519628|NCT00982644|7332538|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3
4519629|NCT00982644|7332537|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23
4519630|NCT00982644|7332538|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7
4519631|NCT00982657|7332548|FG000|Overall Study|Death|1
4519632|NCT00982657|7332549|FG001|Overall Study|Death|0
4519633|NCT00982657|7332550|FG002|Overall Study|Death|1
4519634|NCT00982657|7332551|FG003|Overall Study|Death|1
4519635|NCT00982657|7332548|FG000|Overall Study|Withdrawal by Subject|0
4519636|NCT00982657|7332549|FG001|Overall Study|Withdrawal by Subject|0
4519637|NCT00982657|7332550|FG002|Overall Study|Withdrawal by Subject|1
4519638|NCT00982657|7332551|FG003|Overall Study|Withdrawal by Subject|3
4519639|NCT00982657|7332548|FG000|Overall Study|Other|0
4519640|NCT00982657|7332549|FG001|Overall Study|Other|0
4519641|NCT00982657|7332550|FG002|Overall Study|Other|0
4519642|NCT00982657|7332551|FG003|Overall Study|Other|4
4519643|NCT00982657|7332548|FG000|Overall Study|On going at date of cut-off|0
4519644|NCT00982657|7332549|FG001|Overall Study|On going at date of cut-off|0
4519645|NCT00982657|7332550|FG002|Overall Study|On going at date of cut-off|0
4519646|NCT00982657|7332551|FG003|Overall Study|On going at date of cut-off|1
4519647|NCT00982735|7332571|FG000|Overall Study|Lost to Follow-up|6
4519648|NCT00982735|7332571|FG000|Overall Study|Patient ineligible for trial|224
4519649|NCT00982878|7332629|FG000|Overall Study|Physician Decision|1
4519650|NCT00982930|7332633|FG000|Overall Study|Adverse Event|1
4519651|NCT00982930|7332633|FG000|Overall Study|Withdrawal by Subject|1
4519652|NCT00982930|7332633|FG000|Overall Study|Administrative Problems|2
4519653|NCT00983073|7332637|FG000|Titration and Optimal Dose Period|Adverse Event|19
4593893|NCT01555931|7442462|FG001|Overall Study|Lost to Follow-up|5
4519654|NCT00983073|7332637|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11
4519655|NCT00983073|7332637|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5
4519656|NCT00983073|7332637|FG000|Titration and Optimal Dose Period|Non-Compliance|1
4519657|NCT00983073|7332637|FG000|Titration and Optimal Dose Period|Other reason|4
4519658|NCT00983073|7332637|FG000|Maintenance Period|Adverse Event|5
4519659|NCT00983073|7332637|FG000|Maintenance Period|Withdrawal by Subject|2
4519660|NCT00983073|7332637|FG000|Maintenance Period|Lack of Efficacy|2
4519661|NCT00983073|7332637|FG000|Maintenance Period|Other Reason|7
4519662|NCT00983294|7332665|FG000|14 Day Washout Period|Withdrawal by Subject|2
4519663|NCT00983294|7332665|FG000|Colchicine With Azithromycin|Adverse Event|1
4519664|NCT00983372|7332684|FG000|14 Day Washout Period|Withdrawal by Subject|1
4519665|NCT00983372|7332684|FG000|Diltiazem ER Alone|missed diltiazem dose|2
4519666|NCT00983372|7332684|FG000|Diltiazem ER Alone|Adverse Event|1
4519667|NCT00983385|7332691|FG000|Observation Period|Not eligible to be dosed|20
4519668|NCT00983385|7332691|FG000|Observation Period|Not Evaluable due to Non Compliance|12
4519669|NCT00983476|7332713|FG000|Overall Study|Did not receive intervention|17
4519670|NCT00983476|7332714|FG001|Overall Study|Did not receive intervention|22
4519671|NCT00983476|7332715|FG002|Overall Study|Did not receive intervention|0
4519672|NCT00983515|7332742|FG000|Ritonavir Alone|liver panel out of range|6
4519673|NCT00983515|7332742|FG000|Colchicine With Ritonavir|Lost to Follow-up|1
4519674|NCT00983528|7332749|FG000|Overall Study|Death|4
4519675|NCT00983528|7332749|FG000|Overall Study|Lost to Follow-up|1
4593894|NCT01555983|7442477|FG000|Overall Study|Withdrawal by Subject|1
4593895|NCT01555983|7442478|FG001|Overall Study|Withdrawal by Subject|0
4593896|NCT01555983|7442479|FG002|Overall Study|Withdrawal by Subject|0
4593897|NCT01555983|7442480|FG003|Overall Study|Withdrawal by Subject|0
4593898|NCT01555983|7442481|FG004|Overall Study|Withdrawal by Subject|1
4593899|NCT01555983|7442482|FG005|Overall Study|Withdrawal by Subject|1
4593900|NCT01556165|7442507|FG000|Overall Study|Adverse Event|5
4593901|NCT01556165|7442508|FG001|Overall Study|Adverse Event|3
4593902|NCT01556165|7442507|FG000|Overall Study|Protocol Violation|0
4593903|NCT01556165|7442508|FG001|Overall Study|Protocol Violation|3
4593904|NCT01556165|7442507|FG000|Overall Study|Withdrawal of Consent|7
4593905|NCT01556165|7442508|FG001|Overall Study|Withdrawal of Consent|1
4593906|NCT01556438|7442570|FG000|Overall Study|Adverse Event|4
4593907|NCT01556438|7442571|FG001|Overall Study|Adverse Event|2
4593908|NCT01556438|7442570|FG000|Overall Study|Sponsor Decision|0
4593909|NCT01556438|7442571|FG001|Overall Study|Sponsor Decision|2
4593910|NCT01556438|7442570|FG000|Overall Study|Progressive Disease|0
4593911|NCT01556438|7442571|FG001|Overall Study|Progressive Disease|6
4593912|NCT01556438|7442570|FG000|Overall Study|Death|0
4593913|NCT01556438|7442571|FG001|Overall Study|Death|1
4593914|NCT01556763|7442640|FG000|Overall Study|Withdrawal by Subject|0
4593915|NCT01556763|7442641|FG001|Overall Study|Withdrawal by Subject|1
4593916|NCT01556763|7442642|FG002|Overall Study|Withdrawal by Subject|0
4593917|NCT01556932|7442656|FG000|Time Point 60 Minutes|Withdrawal by Subject|1
4593918|NCT01556932|7442657|FG001|Time Point 60 Minutes|Withdrawal by Subject|1
4593919|NCT01556997|7442665|FG000|Overall Study|Adverse Event|10
4593920|NCT01556997|7442666|FG001|Overall Study|Adverse Event|12
4593921|NCT01556997|7442667|FG002|Overall Study|Adverse Event|12
4593922|NCT01556997|7442665|FG000|Overall Study|Lost to Follow-up|6
4593923|NCT01556997|7442666|FG001|Overall Study|Lost to Follow-up|6
4593924|NCT01556997|7442667|FG002|Overall Study|Lost to Follow-up|4
4593925|NCT01556997|7442665|FG000|Overall Study|Physician Decision|1
4593926|NCT01556997|7442666|FG001|Overall Study|Physician Decision|1
4593927|NCT01556997|7442667|FG002|Overall Study|Physician Decision|1
4593928|NCT01556997|7442665|FG000|Overall Study|Withdrawal by Subject|7
4593929|NCT01556997|7442666|FG001|Overall Study|Withdrawal by Subject|6
4593930|NCT01556997|7442667|FG002|Overall Study|Withdrawal by Subject|8
4593931|NCT01556997|7442665|FG000|Overall Study|Other|2
4593932|NCT01556997|7442666|FG001|Overall Study|Other|3
4593933|NCT01556997|7442667|FG002|Overall Study|Other|7
4593934|NCT01557166|7442677|FG000|Overall Study|Adverse Event|20
4593935|NCT01557166|7442678|FG001|Overall Study|Adverse Event|6
4593936|NCT01557166|7442677|FG000|Overall Study|Lack of Efficacy|2
4593937|NCT01557166|7442678|FG001|Overall Study|Lack of Efficacy|1
4593938|NCT01557166|7442677|FG000|Overall Study|Protocol Violation|8
4593939|NCT01557166|7442678|FG001|Overall Study|Protocol Violation|5
4519676|NCT00983528|7332749|FG000|Overall Study|Study Terminated|1
4519677|NCT00983580|7332759|FG000|Overall Study|Cancel Prior to treatment|1
4519678|NCT00983580|7332760|FG001|Overall Study|Cancel Prior to treatment|3
4519679|NCT00983580|7332759|FG000|Overall Study|Protocol Violation|1
4519680|NCT00983580|7332760|FG001|Overall Study|Protocol Violation|1
4519681|NCT00983580|7332759|FG000|Overall Study|Ineligible|3
4519682|NCT00983580|7332760|FG001|Overall Study|Ineligible|0
4519683|NCT00983619|7332779|FG000|Overall Study|Lost to Follow-up|0
4519684|NCT00983619|7332780|FG001|Overall Study|Lost to Follow-up|1
4519685|NCT00983619|7332781|FG002|Overall Study|Lost to Follow-up|0
4519686|NCT00983619|7332782|FG003|Overall Study|Lost to Follow-up|0
4519687|NCT00983619|7332783|FG004|Overall Study|Lost to Follow-up|0
4519688|NCT00983619|7332784|FG005|Overall Study|Lost to Follow-up|2
4519689|NCT00983619|7332785|FG006|Overall Study|Lost to Follow-up|0
4519690|NCT00983619|7332786|FG007|Overall Study|Lost to Follow-up|0
4519691|NCT00983619|7332787|FG008|Overall Study|Lost to Follow-up|0
4519692|NCT00983619|7332788|FG009|Overall Study|Lost to Follow-up|0
4519693|NCT00983619|7332789|FG010|Overall Study|Lost to Follow-up|0
4519694|NCT00983619|7332790|FG011|Overall Study|Lost to Follow-up|2
4519695|NCT00983619|7332779|FG000|Overall Study|Withdrawal by Subject|2
4519696|NCT00983619|7332780|FG001|Overall Study|Withdrawal by Subject|1
4519697|NCT00983619|7332781|FG002|Overall Study|Withdrawal by Subject|1
4593940|NCT01557166|7442677|FG000|Overall Study|Withdrawn consent|12
4593941|NCT01557166|7442678|FG001|Overall Study|Withdrawn consent|20
4593942|NCT01557166|7442677|FG000|Overall Study|Target dose not tolerated|1
4519698|NCT00983619|7332782|FG003|Overall Study|Withdrawal by Subject|3
4519699|NCT00983619|7332783|FG004|Overall Study|Withdrawal by Subject|1
4519700|NCT00983619|7332784|FG005|Overall Study|Withdrawal by Subject|23
4519701|NCT00983619|7332785|FG006|Overall Study|Withdrawal by Subject|0
4519702|NCT00983619|7332786|FG007|Overall Study|Withdrawal by Subject|0
4519703|NCT00983619|7332787|FG008|Overall Study|Withdrawal by Subject|0
4519704|NCT00983619|7332788|FG009|Overall Study|Withdrawal by Subject|0
4519705|NCT00983619|7332789|FG010|Overall Study|Withdrawal by Subject|1
4519706|NCT00983619|7332790|FG011|Overall Study|Withdrawal by Subject|1
4519707|NCT00983619|7332779|FG000|Overall Study|Death|0
4519708|NCT00983619|7332780|FG001|Overall Study|Death|2
4633431|NCT01912287|7503627|FG001|Overall Study|Felt treatment no longer needed|1
4519709|NCT00983619|7332781|FG002|Overall Study|Death|2
4519710|NCT00983619|7332782|FG003|Overall Study|Death|1
4519711|NCT00983619|7332783|FG004|Overall Study|Death|2
4519712|NCT00983619|7332784|FG005|Overall Study|Death|30
4519713|NCT00983619|7332785|FG006|Overall Study|Death|1
4519714|NCT00983619|7332786|FG007|Overall Study|Death|0
4519715|NCT00983619|7332787|FG008|Overall Study|Death|1
4519716|NCT00983619|7332788|FG009|Overall Study|Death|2
4519717|NCT00983619|7332789|FG010|Overall Study|Death|9
4519718|NCT00983619|7332790|FG011|Overall Study|Death|8
4519719|NCT00983619|7332779|FG000|Overall Study|Other|1
4519720|NCT00983619|7332780|FG001|Overall Study|Other|0
4519721|NCT00983619|7332781|FG002|Overall Study|Other|0
4519722|NCT00983619|7332782|FG003|Overall Study|Other|1
4519723|NCT00983619|7332783|FG004|Overall Study|Other|0
4519724|NCT00983619|7332784|FG005|Overall Study|Other|12
4519725|NCT00983619|7332785|FG006|Overall Study|Other|2
4519726|NCT00983619|7332786|FG007|Overall Study|Other|2
4519727|NCT00983619|7332787|FG008|Overall Study|Other|0
4519728|NCT00983619|7332788|FG009|Overall Study|Other|1
4519729|NCT00983619|7332789|FG010|Overall Study|Other|1
4519730|NCT00983619|7332790|FG011|Overall Study|Other|0
4519731|NCT00983749|7332838|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1
4519732|NCT00983749|7332839|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3
4519733|NCT00983827|7332849|FG000|Overall Study|Withdrawal by Subject|1
4519734|NCT00983853|7332859|FG000|Overall Study|Lost to Follow-up|1
4519735|NCT00983853|7332860|FG001|Overall Study|Lost to Follow-up|1
4519736|NCT00983853|7332861|FG002|Overall Study|Lost to Follow-up|2
4519737|NCT00983853|7332862|FG003|Overall Study|Lost to Follow-up|2
4519738|NCT00983853|7332863|FG004|Overall Study|Lost to Follow-up|2
4519739|NCT00983853|7332864|FG005|Overall Study|Lost to Follow-up|1
4519740|NCT00983853|7332859|FG000|Overall Study|Withdrawal by Subject|0
4519741|NCT00983853|7332860|FG001|Overall Study|Withdrawal by Subject|0
4519742|NCT00983853|7332861|FG002|Overall Study|Withdrawal by Subject|1
4519743|NCT00983853|7332862|FG003|Overall Study|Withdrawal by Subject|0
4519744|NCT00983853|7332863|FG004|Overall Study|Withdrawal by Subject|1
4519745|NCT00983853|7332864|FG005|Overall Study|Withdrawal by Subject|0
4519746|NCT00983853|7332859|FG000|Overall Study|Unable to come to study follow-up visits|0
4519747|NCT00983853|7332860|FG001|Overall Study|Unable to come to study follow-up visits|1
4519748|NCT00983853|7332861|FG002|Overall Study|Unable to come to study follow-up visits|0
4519749|NCT00983853|7332862|FG003|Overall Study|Unable to come to study follow-up visits|0
4519750|NCT00983853|7332863|FG004|Overall Study|Unable to come to study follow-up visits|0
4519751|NCT00983853|7332864|FG005|Overall Study|Unable to come to study follow-up visits|0
4519752|NCT00983892|7332882|FG000|Overall Study|Withdrawal by Subject|10
4519753|NCT00983892|7332883|FG001|Overall Study|Withdrawal by Subject|12
4519754|NCT00983905|7332889|FG000|Theophylline Alone|Adverse Event|1
4519755|NCT00983905|7332889|FG000|Colchicine Alone|Adverse Event|2
4519756|NCT00983918|7332900|FG000|Overall Study|conversion to open cholecystectomy|0
4519757|NCT00983918|7332901|FG001|Overall Study|conversion to open cholecystectomy|2
4519758|NCT00983918|7332902|FG002|Overall Study|conversion to open cholecystectomy|2
4519759|NCT00983918|7332903|FG003|Overall Study|conversion to open cholecystectomy|2
4519760|NCT00983931|7332913|FG000|14 Day Washout Period|Physician Decision|1
4519761|NCT00983957|7332919|FG000|Overall Study|Adverse Event|1
4519762|NCT00983957|7332919|FG000|Overall Study|Personal Reasons|1
4519763|NCT00984009|7332943|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1
4519764|NCT00984022|7332952|FG000|Overall Study|Lost to Follow-up|10
4519765|NCT00984022|7332953|FG001|Overall Study|Lost to Follow-up|14
4519766|NCT00984061|7332959|FG000|Clarithromycin Alone|Protocol Violation|1
4519767|NCT00984126|7332970|FG000|Overall Study|Protocol Violation|0
4519768|NCT00984126|7332971|FG001|Overall Study|Protocol Violation|0
4519769|NCT00984126|7332972|FG002|Overall Study|Protocol Violation|1
4519770|NCT00984126|7332973|FG003|Overall Study|Protocol Violation|2
4519771|NCT00984126|7332970|FG000|Overall Study|Adverse Event|0
4519772|NCT00984126|7332971|FG001|Overall Study|Adverse Event|0
4519773|NCT00984126|7332972|FG002|Overall Study|Adverse Event|0
4519774|NCT00984126|7332973|FG003|Overall Study|Adverse Event|2
4519775|NCT00984126|7332970|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7
4519776|NCT00984126|7332971|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7
4519777|NCT00984126|7332972|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3
4519778|NCT00984126|7332973|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46
4519779|NCT00984126|7332970|FG000|Overall Study|Withdrawal criteria|0
4519780|NCT00984126|7332971|FG001|Overall Study|Withdrawal criteria|1
4519781|NCT00984126|7332972|FG002|Overall Study|Withdrawal criteria|3
4519782|NCT00984126|7332973|FG003|Overall Study|Withdrawal criteria|9
4519783|NCT00984165|7333000|FG000|Overall Study|Death on study|2
4519784|NCT00984165|7333001|FG001|Overall Study|Death on study|0
4519785|NCT00984165|7333002|FG002|Overall Study|Death on study|0
4519786|NCT00984165|7333003|FG003|Overall Study|Death on study|0
4519787|NCT00984165|7333000|FG000|Overall Study|Disease progression on study|5
4519788|NCT00984165|7333001|FG001|Overall Study|Disease progression on study|1
4519789|NCT00984165|7333002|FG002|Overall Study|Disease progression on study|0
4519790|NCT00984165|7333003|FG003|Overall Study|Disease progression on study|0
4519791|NCT00984165|7333000|FG000|Overall Study|Death of recipient|0
4519792|NCT00984165|7333001|FG001|Overall Study|Death of recipient|0
4519793|NCT00984165|7333002|FG002|Overall Study|Death of recipient|0
4519794|NCT00984165|7333003|FG003|Overall Study|Death of recipient|1
4519795|NCT00984165|7333000|FG000|Overall Study|New protocol|0
4519796|NCT00984165|7333001|FG001|Overall Study|New protocol|0
4519797|NCT00984165|7333002|FG002|Overall Study|New protocol|0
4519798|NCT00984165|7333003|FG003|Overall Study|New protocol|1
4519799|NCT00984165|7333000|FG000|Overall Study|P+/donor pair removed from protocol|0
4519800|NCT00984165|7333001|FG001|Overall Study|P+/donor pair removed from protocol|0
4519801|NCT00984165|7333002|FG002|Overall Study|P+/donor pair removed from protocol|0
4519802|NCT00984165|7333003|FG003|Overall Study|P+/donor pair removed from protocol|1
4519803|NCT00984165|7333000|FG000|Overall Study|removed with a pair recipient|0
4519804|NCT00984165|7333001|FG001|Overall Study|removed with a pair recipient|0
4519805|NCT00984165|7333002|FG002|Overall Study|removed with a pair recipient|0
4519806|NCT00984165|7333003|FG003|Overall Study|removed with a pair recipient|1
4519807|NCT00984204|7333014|FG000|Overall Study|Death|1
4519808|NCT00984204|7333014|FG000|Overall Study|Lost to Follow-up|4
4519809|NCT00984204|7333014|FG000|Overall Study|Lack of Efficacy|10
4519810|NCT00984256|7333020|FG000|Overall Study|Withdrawal by Subject|0
4519811|NCT00984256|7333021|FG001|Overall Study|Withdrawal by Subject|1
4519812|NCT00984282|7333038|FG000|Double Blind Treatment|Adverse Event|40
4519813|NCT00984282|7333039|FG001|Double Blind Treatment|Adverse Event|6
4519814|NCT00984282|7333038|FG000|Double Blind Treatment|Progression, recurrence or relapse|25
4519815|NCT00984282|7333039|FG001|Double Blind Treatment|Progression, recurrence or relapse|3
4519816|NCT00984282|7333038|FG000|Double Blind Treatment|Physician Decision|1
4519817|NCT00984282|7333039|FG001|Double Blind Treatment|Physician Decision|2
4519818|NCT00984282|7333038|FG000|Double Blind Treatment|Noncompliance with study medication|3
4519819|NCT00984282|7333039|FG001|Double Blind Treatment|Noncompliance with study medication|0
4519820|NCT00984282|7333038|FG000|Double Blind Treatment|Progression by clinical judgment|2
4519821|NCT00984282|7333039|FG001|Double Blind Treatment|Progression by clinical judgment|0
4519822|NCT00984282|7333038|FG000|Double Blind Treatment|Withdrawal by Subject|13
4519823|NCT00984282|7333039|FG001|Double Blind Treatment|Withdrawal by Subject|18
4519824|NCT00984282|7333038|FG000|Double Blind Treatment|Lost to Follow-up|3
4519825|NCT00984282|7333039|FG001|Double Blind Treatment|Lost to Follow-up|0
4519826|NCT00984282|7333038|FG000|Double Blind Treatment|Death|8
4519827|NCT00984282|7333039|FG001|Double Blind Treatment|Death|4
4519828|NCT00984282|7333038|FG000|Double Blind Treatment|Not treated|0
4519829|NCT00984282|7333039|FG001|Double Blind Treatment|Not treated|1
4519830|NCT00984282|7333038|FG000|Double Blind Treatment|Switched to commercial drug|6
4519831|NCT00984282|7333039|FG001|Double Blind Treatment|Switched to commercial drug|1
4519832|NCT00984282|7333038|FG000|Double Blind Treatment|protocol driven decision point|1
4519833|NCT00984282|7333039|FG001|Double Blind Treatment|protocol driven decision point|1
4519834|NCT00984282|7333038|FG000|Double Blind Treatment|Radiological and clinical progression|0
4519835|NCT00984282|7333039|FG001|Double Blind Treatment|Radiological and clinical progression|1
4519836|NCT00984282|7333038|FG000|Double Blind Treatment|Transferred to treat. continuation study|2
4519837|NCT00984282|7333039|FG001|Double Blind Treatment|Transferred to treat. continuation study|1
4519838|NCT00984282|7333038|FG000|Open-label Treatment|Adverse Event|20
4519839|NCT00984282|7333039|FG001|Open-label Treatment|Adverse Event|30
4519840|NCT00984282|7333038|FG000|Open-label Treatment|Withdrawal by Subject|6
4519841|NCT00984282|7333039|FG001|Open-label Treatment|Withdrawal by Subject|21
4519842|NCT00984282|7333038|FG000|Open-label Treatment|Death|7
4519843|NCT00984282|7333039|FG001|Open-label Treatment|Death|15
4519844|NCT00984282|7333038|FG000|Open-label Treatment|Progression, recurrence or relapse|40
4519845|NCT00984282|7333039|FG001|Open-label Treatment|Progression, recurrence or relapse|82
4519846|NCT00984282|7333038|FG000|Open-label Treatment|Lost to Follow-up|1
4519847|NCT00984282|7333039|FG001|Open-label Treatment|Lost to Follow-up|1
4519848|NCT00984282|7333038|FG000|Open-label Treatment|Patient convenience|1
4519849|NCT00984282|7333039|FG001|Open-label Treatment|Patient convenience|0
4519850|NCT00984282|7333038|FG000|Open-label Treatment|Non-compliant with study medication|1
4737746|NCT03622112|7688215|FG000|Overall Study|Withdrawal by Subject|6
4737747|NCT03622112|7688216|FG001|Overall Study|Withdrawal by Subject|2
4737748|NCT03622112|7688217|FG002|Overall Study|Withdrawal by Subject|4
4737749|NCT03622112|7688218|FG003|Overall Study|Withdrawal by Subject|2
4737750|NCT03622112|7688219|FG004|Overall Study|Withdrawal by Subject|1
4519851|NCT00984282|7333039|FG001|Open-label Treatment|Non-compliant with study medication|0
4519852|NCT00984282|7333038|FG000|Open-label Treatment|Target lesion removed|0
4519853|NCT00984282|7333039|FG001|Open-label Treatment|Target lesion removed|1
4519854|NCT00984282|7333038|FG000|Open-label Treatment|Protocol driven decision point|1
4519855|NCT00984282|7333039|FG001|Open-label Treatment|Protocol driven decision point|1
4519856|NCT00984282|7333038|FG000|Open-label Treatment|Transferred to treat. continuation study|2
4519857|NCT00984282|7333039|FG001|Open-label Treatment|Transferred to treat. continuation study|3
4519858|NCT00984282|7333038|FG000|Open-label Treatment|Switched to commercial drug|6
4519859|NCT00984282|7333039|FG001|Open-label Treatment|Switched to commercial drug|7
4519860|NCT00984282|7333038|FG000|Open-label Treatment|Physician Decision|1
4519861|NCT00984282|7333039|FG001|Open-label Treatment|Physician Decision|0
4519862|NCT00984282|7333038|FG000|Long Term Follow-up|Withdrawal by Subject|8
4519863|NCT00984282|7333039|FG001|Long Term Follow-up|Withdrawal by Subject|14
4519864|NCT00984282|7333038|FG000|Long Term Follow-up|Death|27
4519865|NCT00984282|7333039|FG001|Long Term Follow-up|Death|68
4519866|NCT00984282|7333038|FG000|Long Term Follow-up|Lost to Follow-up|3
4519867|NCT00984282|7333039|FG001|Long Term Follow-up|Lost to Follow-up|6
4519868|NCT00984282|7333038|FG000|Long Term Follow-up|Protocol driven decision point|25
4519869|NCT00984282|7333039|FG001|Long Term Follow-up|Protocol driven decision point|26
4519870|NCT00984282|7333038|FG000|Long Term Follow-up|Transferred to treat. continuation study|2
4519871|NCT00984282|7333039|FG001|Long Term Follow-up|Transferred to treat. continuation study|3
4519872|NCT00984282|7333038|FG000|Long Term Follow-up|Switched to commercial drug|4
4519873|NCT00984282|7333039|FG001|Long Term Follow-up|Switched to commercial drug|2
4519874|NCT00984282|7333038|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0
4519875|NCT00984282|7333039|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1
4519876|NCT00984295|7333050|FG000|Overall Study|Lost to Follow-up|31
4519877|NCT00984295|7333051|FG001|Overall Study|Lost to Follow-up|12
4519878|NCT00984295|7333052|FG002|Overall Study|Lost to Follow-up|13
4519879|NCT00984295|7333050|FG000|Overall Study|Protocol Violation|2
4519880|NCT00984295|7333051|FG001|Overall Study|Protocol Violation|1
4519881|NCT00984295|7333052|FG002|Overall Study|Protocol Violation|4
4519882|NCT00984295|7333050|FG000|Overall Study|Withdrawal by Subject|18
4519883|NCT00984295|7333051|FG001|Overall Study|Withdrawal by Subject|9
4519884|NCT00984295|7333052|FG002|Overall Study|Withdrawal by Subject|12
4519885|NCT00984295|7333050|FG000|Overall Study|CAE - discontinued test vaccine|0
4519886|NCT00984295|7333051|FG001|Overall Study|CAE - discontinued test vaccine|1
4519887|NCT00984295|7333052|FG002|Overall Study|CAE - discontinued test vaccine|3
4519888|NCT00984295|7333050|FG000|Overall Study|Missed one or more blood samplings|3
4519889|NCT00984295|7333051|FG001|Overall Study|Missed one or more blood samplings|7
4519890|NCT00984295|7333052|FG002|Overall Study|Missed one or more blood samplings|2
4519891|NCT00984295|7333050|FG000|Overall Study|Incomplete safety follow-up|11
4519892|NCT00984295|7333051|FG001|Overall Study|Incomplete safety follow-up|2
4519893|NCT00984295|7333052|FG002|Overall Study|Incomplete safety follow-up|3
4519894|NCT00984542|7333090|FG000|Overall Study|disease progression|19
4519895|NCT00984542|7333090|FG000|Overall Study|toxicity|7
4519896|NCT00984542|7333090|FG000|Overall Study|Death|7
4519897|NCT00984542|7333090|FG000|Overall Study|complicating disease|3
4519898|NCT00984542|7333090|FG000|Overall Study|Withdrawal by Subject|3
4519899|NCT00984542|7333090|FG000|Overall Study|clinical deterioration|2
4519900|NCT00984568|7333097|FG000|Overall Study|Withdrawal by Subject|1
4519901|NCT00984568|7333098|FG001|Overall Study|Withdrawal by Subject|2
4519902|NCT00984568|7333097|FG000|Overall Study|Lack of Efficacy|2
4519903|NCT00984568|7333098|FG001|Overall Study|Lack of Efficacy|0
4519904|NCT00984568|7333097|FG000|Overall Study|Adverse Event|2
4519905|NCT00984568|7333098|FG001|Overall Study|Adverse Event|0
4519906|NCT00984568|7333097|FG000|Overall Study|Did Not Meet Randomization Criteria|1
4519907|NCT00984568|7333098|FG001|Overall Study|Did Not Meet Randomization Criteria|0
4519908|NCT00984568|7333097|FG000|Overall Study|Lost to Follow-up|0
4519909|NCT00984568|7333098|FG001|Overall Study|Lost to Follow-up|1
4519910|NCT00984568|7333097|FG000|Overall Study|Opportunistic Infection|1
4519911|NCT00984568|7333098|FG001|Overall Study|Opportunistic Infection|0
4519912|NCT00984568|7333097|FG000|Overall Study|Unknown Reason|1
4519913|NCT00984568|7333098|FG001|Overall Study|Unknown Reason|3
4519914|NCT00984594|7333106|FG000|Overall Study|Lost to Follow-up|1
4519915|NCT00984594|7333107|FG001|Overall Study|Lost to Follow-up|0
4519916|NCT00984594|7333106|FG000|Overall Study|Withdrawal by Subject|0
4519917|NCT00984594|7333107|FG001|Overall Study|Withdrawal by Subject|1
4519918|NCT00984620|7333117|FG000|Overall Study|Adverse Event|5
4519919|NCT00984620|7333118|FG001|Overall Study|Adverse Event|5
4519920|NCT00984620|7333117|FG000|Overall Study|Lost to Follow-up|1
4519921|NCT00984620|7333118|FG001|Overall Study|Lost to Follow-up|1
4519922|NCT00984620|7333117|FG000|Overall Study|Withdrawal by Subject|0
4519923|NCT00984620|7333118|FG001|Overall Study|Withdrawal by Subject|2
4519924|NCT00984620|7333117|FG000|Overall Study|reason other than listed above|0
4519925|NCT00984620|7333118|FG001|Overall Study|reason other than listed above|4
4519926|NCT00984659|7333130|FG000|2-week Run-in Period|Adverse Event|8
4519927|NCT00984659|7333131|FG001|2-week Run-in Period|Adverse Event|0
4519928|NCT00984659|7333132|FG002|2-week Run-in Period|Adverse Event|0
4519929|NCT00984659|7333133|FG003|2-week Run-in Period|Adverse Event|0
4519930|NCT00984659|7333130|FG000|2-week Run-in Period|Protocol Violation|5
4519931|NCT00984659|7333131|FG001|2-week Run-in Period|Protocol Violation|0
4519932|NCT00984659|7333132|FG002|2-week Run-in Period|Protocol Violation|0
4519933|NCT00984659|7333133|FG003|2-week Run-in Period|Protocol Violation|0
4519934|NCT00984659|7333130|FG000|2-week Run-in Period|Study Closed/Terminated|2
4519935|NCT00984659|7333131|FG001|2-week Run-in Period|Study Closed/Terminated|0
4519936|NCT00984659|7333132|FG002|2-week Run-in Period|Study Closed/Terminated|0
4519937|NCT00984659|7333133|FG003|2-week Run-in Period|Study Closed/Terminated|0
4519938|NCT00984659|7333130|FG000|2-week Run-in Period|Lost to Follow-up|3
4519939|NCT00984659|7333131|FG001|2-week Run-in Period|Lost to Follow-up|0
4519940|NCT00984659|7333132|FG002|2-week Run-in Period|Lost to Follow-up|0
4519941|NCT00984659|7333133|FG003|2-week Run-in Period|Lost to Follow-up|0
4519942|NCT00984659|7333130|FG000|2-week Run-in Period|Physician Decision|10
4519943|NCT00984659|7333131|FG001|2-week Run-in Period|Physician Decision|0
4519944|NCT00984659|7333132|FG002|2-week Run-in Period|Physician Decision|0
4519945|NCT00984659|7333133|FG003|2-week Run-in Period|Physician Decision|0
4519946|NCT00984659|7333130|FG000|2-week Run-in Period|Withdrawal by Subject|10
4519947|NCT00984659|7333131|FG001|2-week Run-in Period|Withdrawal by Subject|0
4519948|NCT00984659|7333132|FG002|2-week Run-in Period|Withdrawal by Subject|0
4519949|NCT00984659|7333133|FG003|2-week Run-in Period|Withdrawal by Subject|0
4519950|NCT00984659|7333130|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14
4519951|NCT00984659|7333131|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0
4519952|NCT00984659|7333132|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0
4519953|NCT00984659|7333133|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0
4519954|NCT00984659|7333130|FG000|6-week Double-blind Treatment Period|Adverse Event|0
4519955|NCT00984659|7333131|FG001|6-week Double-blind Treatment Period|Adverse Event|3
4519956|NCT00984659|7333132|FG002|6-week Double-blind Treatment Period|Adverse Event|3
4519957|NCT00984659|7333133|FG003|6-week Double-blind Treatment Period|Adverse Event|7
4519958|NCT00984659|7333130|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0
4519959|NCT00984659|7333131|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2
4519960|NCT00984659|7333132|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0
4519961|NCT00984659|7333133|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1
4519962|NCT00984659|7333130|FG000|6-week Double-blind Treatment Period|Protocol Violation|0
4519963|NCT00984659|7333131|FG001|6-week Double-blind Treatment Period|Protocol Violation|0
4519964|NCT00984659|7333132|FG002|6-week Double-blind Treatment Period|Protocol Violation|0
4519965|NCT00984659|7333133|FG003|6-week Double-blind Treatment Period|Protocol Violation|4
4519966|NCT00984659|7333130|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0
4519967|NCT00984659|7333131|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0
4519968|NCT00984659|7333132|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1
4519969|NCT00984659|7333133|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0
4519970|NCT00984659|7333130|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0
4519971|NCT00984659|7333131|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1
4519972|NCT00984659|7333132|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7
4519973|NCT00984659|7333133|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1
4519974|NCT00984867|7333155|FG000|Overall Study|Adverse Event|3
4519975|NCT00984867|7333156|FG001|Overall Study|Adverse Event|7
4519976|NCT00984867|7333155|FG000|Overall Study|Death|1
4519977|NCT00984867|7333156|FG001|Overall Study|Death|0
4519978|NCT00984867|7333155|FG000|Overall Study|Withdrawal by Subject|13
4519979|NCT00984867|7333156|FG001|Overall Study|Withdrawal by Subject|4
4519980|NCT00984867|7333155|FG000|Overall Study|Lost to Follow-up|3
4519981|NCT00984867|7333156|FG001|Overall Study|Lost to Follow-up|4
4519982|NCT00984867|7333155|FG000|Overall Study|Poor/non-compliance|0
4519983|NCT00984867|7333156|FG001|Overall Study|Poor/non-compliance|1
4519984|NCT00984867|7333155|FG000|Overall Study|Subject no longer meets study criteria|1
4519985|NCT00984867|7333156|FG001|Overall Study|Subject no longer meets study criteria|1
4519986|NCT00984867|7333155|FG000|Overall Study|site closing|1
4519987|NCT00984867|7333156|FG001|Overall Study|site closing|0
4519988|NCT00984867|7333155|FG000|Overall Study|lack of efficacy and subject compliance|1
4519989|NCT00984867|7333156|FG001|Overall Study|lack of efficacy and subject compliance|0
4593943|NCT01557166|7442678|FG001|Overall Study|Target dose not tolerated|0
4593944|NCT01557166|7442677|FG000|Overall Study|Psychiatric disorder|1
4593945|NCT01557166|7442678|FG001|Overall Study|Psychiatric disorder|0
4593946|NCT01557166|7442677|FG000|Overall Study|Unclassified|2
4593947|NCT01557166|7442678|FG001|Overall Study|Unclassified|5
4593948|NCT01557244|7442689|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2
4593949|NCT01557244|7442690|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0
4593950|NCT01557244|7442691|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0
4593951|NCT01557244|7442692|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0
4633432|NCT01912287|7503628|FG002|Overall Study|Felt treatment no longer needed|0
4633433|NCT01912287|7503626|FG000|Overall Study|Life circumstances|4
4633434|NCT01912287|7503627|FG001|Overall Study|Life circumstances|2
4633435|NCT01912287|7503628|FG002|Overall Study|Life circumstances|0
4633436|NCT01912287|7503626|FG000|Overall Study|Lost Interest|1
4593952|NCT01557244|7442693|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0
4593953|NCT01557244|7442694|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2
4593954|NCT01557244|7442695|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0
4593955|NCT01557244|7442689|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2
4633437|NCT01912287|7503627|FG001|Overall Study|Lost Interest|0
4519990|NCT00985088|7333181|FG000|Overall Study|Serious Adverse Event|1
4519991|NCT00985088|7333182|FG001|Overall Study|Serious Adverse Event|1
4519992|NCT00985088|7333183|FG002|Overall Study|Serious Adverse Event|0
4519993|NCT00985088|7333184|FG003|Overall Study|Serious Adverse Event|0
4519994|NCT00985088|7333185|FG004|Overall Study|Serious Adverse Event|0
4519995|NCT00985088|7333186|FG005|Overall Study|Serious Adverse Event|0
4519996|NCT00985088|7333187|FG006|Overall Study|Serious Adverse Event|0
4519997|NCT00985088|7333188|FG007|Overall Study|Serious Adverse Event|1
4519998|NCT00985088|7333181|FG000|Overall Study|Adverse Event|0
4519999|NCT00985088|7333182|FG001|Overall Study|Adverse Event|0
4520000|NCT00985088|7333183|FG002|Overall Study|Adverse Event|1
4520001|NCT00985088|7333184|FG003|Overall Study|Adverse Event|0
4520002|NCT00985088|7333185|FG004|Overall Study|Adverse Event|0
4520003|NCT00985088|7333186|FG005|Overall Study|Adverse Event|0
4520004|NCT00985088|7333187|FG006|Overall Study|Adverse Event|0
4520005|NCT00985088|7333188|FG007|Overall Study|Adverse Event|0
4520006|NCT00985088|7333181|FG000|Overall Study|Withdrawal by Subject|4
4520007|NCT00985088|7333182|FG001|Overall Study|Withdrawal by Subject|0
4520008|NCT00985088|7333183|FG002|Overall Study|Withdrawal by Subject|0
4520009|NCT00985088|7333184|FG003|Overall Study|Withdrawal by Subject|1
4520010|NCT00985088|7333185|FG004|Overall Study|Withdrawal by Subject|3
4520011|NCT00985088|7333186|FG005|Overall Study|Withdrawal by Subject|2
4520012|NCT00985088|7333187|FG006|Overall Study|Withdrawal by Subject|1
4520013|NCT00985088|7333188|FG007|Overall Study|Withdrawal by Subject|2
4520014|NCT00985088|7333181|FG000|Overall Study|Migrated/moved from study area|0
4520015|NCT00985088|7333182|FG001|Overall Study|Migrated/moved from study area|0
4520016|NCT00985088|7333183|FG002|Overall Study|Migrated/moved from study area|1
4520017|NCT00985088|7333184|FG003|Overall Study|Migrated/moved from study area|0
4520018|NCT00985088|7333185|FG004|Overall Study|Migrated/moved from study area|0
4520019|NCT00985088|7333186|FG005|Overall Study|Migrated/moved from study area|0
4520020|NCT00985088|7333187|FG006|Overall Study|Migrated/moved from study area|0
4520021|NCT00985088|7333188|FG007|Overall Study|Migrated/moved from study area|1
4520022|NCT00985088|7333181|FG000|Overall Study|Lost to Follow-up|6
4520023|NCT00985088|7333182|FG001|Overall Study|Lost to Follow-up|1
4520024|NCT00985088|7333183|FG002|Overall Study|Lost to Follow-up|2
4520025|NCT00985088|7333184|FG003|Overall Study|Lost to Follow-up|6
4520026|NCT00985088|7333185|FG004|Overall Study|Lost to Follow-up|6
4520027|NCT00985088|7333186|FG005|Overall Study|Lost to Follow-up|5
4520028|NCT00985088|7333187|FG006|Overall Study|Lost to Follow-up|3
4520029|NCT00985088|7333188|FG007|Overall Study|Lost to Follow-up|2
4520030|NCT00985114|7333218|FG000|Overall Study|Adverse Event|1
4520031|NCT00985114|7333219|FG001|Overall Study|Adverse Event|0
4520032|NCT00985114|7333218|FG000|Overall Study|Withdrawal by Subject|0
4520033|NCT00985114|7333219|FG001|Overall Study|Withdrawal by Subject|2
4520034|NCT00985153|7333233|FG000|Overall Study|Lost to Follow-up|16
4520035|NCT00985153|7333234|FG001|Overall Study|Lost to Follow-up|19
4520036|NCT00985153|7333235|FG002|Overall Study|Lost to Follow-up|17
4520037|NCT00985153|7333236|FG003|Overall Study|Lost to Follow-up|20
4520038|NCT00985153|7333233|FG000|Overall Study|Protocol Violation|3
4520039|NCT00985153|7333234|FG001|Overall Study|Protocol Violation|2
4520040|NCT00985153|7333235|FG002|Overall Study|Protocol Violation|4
4520041|NCT00985153|7333236|FG003|Overall Study|Protocol Violation|3
4520042|NCT00985153|7333233|FG000|Overall Study|Withdrawal by Subject|6
4520043|NCT00985153|7333234|FG001|Overall Study|Withdrawal by Subject|11
4520044|NCT00985153|7333235|FG002|Overall Study|Withdrawal by Subject|11
4520045|NCT00985153|7333236|FG003|Overall Study|Withdrawal by Subject|10
4520046|NCT00985153|7333233|FG000|Overall Study|Missed One or More Bleeds|7
4520047|NCT00985153|7333234|FG001|Overall Study|Missed One or More Bleeds|7
4520048|NCT00985153|7333235|FG002|Overall Study|Missed One or More Bleeds|8
4520049|NCT00985153|7333236|FG003|Overall Study|Missed One or More Bleeds|10
4520050|NCT00985153|7333233|FG000|Overall Study|Incomplete Safety Follow-up|3
4520051|NCT00985153|7333234|FG001|Overall Study|Incomplete Safety Follow-up|5
4520052|NCT00985153|7333235|FG002|Overall Study|Incomplete Safety Follow-up|4
4520053|NCT00985153|7333236|FG003|Overall Study|Incomplete Safety Follow-up|4
4520054|NCT00985166|7333249|FG000|Overall Study|Lost to Follow-up|3
4520055|NCT00985166|7333250|FG001|Overall Study|Lost to Follow-up|2
4520056|NCT00985166|7333251|FG002|Overall Study|Lost to Follow-up|2
4520057|NCT00985166|7333249|FG000|Overall Study|Withdrawal by Subject|3
4520058|NCT00985166|7333250|FG001|Overall Study|Withdrawal by Subject|2
4520059|NCT00985166|7333251|FG002|Overall Study|Withdrawal by Subject|0
4520060|NCT00985166|7333249|FG000|Overall Study|Test not done|2
4520061|NCT00985166|7333250|FG001|Overall Study|Test not done|0
4520062|NCT00985166|7333251|FG002|Overall Study|Test not done|4
4520063|NCT00985166|7333249|FG000|Overall Study|Other|1
4520064|NCT00985166|7333250|FG001|Overall Study|Other|0
4520065|NCT00985166|7333251|FG002|Overall Study|Other|1
4520066|NCT00985192|7333261|FG000|Overall Study|Withdrawal by Subject|1
4520067|NCT00985192|7333261|FG000|Overall Study|Disease Progression|1
4520068|NCT00985192|7333261|FG000|Overall Study|Determined to be Ineligible During Trial|2
4520069|NCT00985231|7333267|FG000|Overall Study|ineligible|1
4520070|NCT00985231|7333268|FG001|Overall Study|ineligible|0
4520071|NCT00985231|7333267|FG000|Overall Study|Protocol Violation|1
4520072|NCT00985231|7333268|FG001|Overall Study|Protocol Violation|0
4520073|NCT00985231|7333267|FG000|Overall Study|Withdrawal by Subject|1
4520074|NCT00985231|7333268|FG001|Overall Study|Withdrawal by Subject|0
4520075|NCT00985231|7333267|FG000|Overall Study|Lost to Follow-up|0
4520076|NCT00985231|7333268|FG001|Overall Study|Lost to Follow-up|1
4520077|NCT00985231|7333267|FG000|Overall Study|Study related symptoms & complaints|0
4520078|NCT00985231|7333268|FG001|Overall Study|Study related symptoms & complaints|2
4520079|NCT00985426|7333280|FG000|Overall Study|Adverse Event|0
4520080|NCT00985426|7333281|FG001|Overall Study|Adverse Event|1
4520081|NCT00985426|7333280|FG000|Overall Study|Subject Non-Compliance|3
4520082|NCT00985426|7333281|FG001|Overall Study|Subject Non-Compliance|3
4520083|NCT00985426|7333280|FG000|Overall Study|Withdrawal by Subject|12
4520084|NCT00985426|7333281|FG001|Overall Study|Withdrawal by Subject|16
4520085|NCT00985426|7333280|FG000|Overall Study|Lost to Follow-up|8
4520086|NCT00985426|7333281|FG001|Overall Study|Lost to Follow-up|10
4520087|NCT00985426|7333280|FG000|Overall Study|Death|7
4520088|NCT00985426|7333281|FG001|Overall Study|Death|3
4520089|NCT00985426|7333280|FG000|Overall Study|Protocol Violation|2
4520090|NCT00985426|7333281|FG001|Overall Study|Protocol Violation|0
4520091|NCT00985426|7333280|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11
4520092|NCT00985426|7333281|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11
4520093|NCT00985439|7333291|FG000|Overall Study|Adverse Event|0
4520094|NCT00985439|7333292|FG001|Overall Study|Adverse Event|0
4520095|NCT00985439|7333293|FG002|Overall Study|Adverse Event|1
4520096|NCT00985439|7333294|FG003|Overall Study|Adverse Event|0
4520097|NCT00985465|7333306|FG000|Overall Study|Withdrawal by Subject|1
4520098|NCT00985465|7333307|FG001|Overall Study|Withdrawal by Subject|2
4520099|NCT00985465|7333306|FG000|Overall Study|Considered to be part of the other group|0
4520100|NCT00985465|7333307|FG001|Overall Study|Considered to be part of the other group|1
4520101|NCT00985491|7333314|FG000|Overall Study|Adverse Event|8
4520102|NCT00985491|7333314|FG000|Overall Study|device migration|7
4520103|NCT00985491|7333314|FG000|Overall Study|Withdrawal by Subject|1
4520104|NCT00985491|7333314|FG000|Overall Study|implant failure|3
4520105|NCT00985504|7333321|FG000|Acute Treatment Period|Adverse Event|3
4520106|NCT00985504|7333322|FG001|Acute Treatment Period|Adverse Event|4
4520107|NCT00985504|7333321|FG000|Acute Treatment Period|Entry Criteria Not Met|1
4520108|NCT00985504|7333322|FG001|Acute Treatment Period|Entry Criteria Not Met|2
4520109|NCT00985504|7333321|FG000|Acute Treatment Period|Protocol Violation|2
4520110|NCT00985504|7333322|FG001|Acute Treatment Period|Protocol Violation|0
4520111|NCT00985504|7333321|FG000|Acute Treatment Period|Sponsor Decision|0
4520112|NCT00985504|7333322|FG001|Acute Treatment Period|Sponsor Decision|1
4520113|NCT00985504|7333321|FG000|Acute Treatment Period|Withdrawal by Subject|9
4520114|NCT00985504|7333322|FG001|Acute Treatment Period|Withdrawal by Subject|5
4520115|NCT00985504|7333321|FG000|Optimization Period|Adverse Event|7
4520116|NCT00985504|7333322|FG001|Optimization Period|Adverse Event|9
4520117|NCT00985504|7333321|FG000|Optimization Period|Death|0
4520118|NCT00985504|7333322|FG001|Optimization Period|Death|1
4520119|NCT00985504|7333321|FG000|Optimization Period|Lack of Efficacy|5
4520120|NCT00985504|7333322|FG001|Optimization Period|Lack of Efficacy|3
4520121|NCT00985504|7333321|FG000|Optimization Period|Lost to Follow-up|0
4520122|NCT00985504|7333322|FG001|Optimization Period|Lost to Follow-up|1
4520123|NCT00985504|7333321|FG000|Optimization Period|Physician Decision|1
4520124|NCT00985504|7333322|FG001|Optimization Period|Physician Decision|0
4520125|NCT00985504|7333321|FG000|Optimization Period|Protocol Violation|3
4520126|NCT00985504|7333322|FG001|Optimization Period|Protocol Violation|1
4520127|NCT00985504|7333321|FG000|Optimization Period|Withdrawal by Subject|10
4520128|NCT00985504|7333322|FG001|Optimization Period|Withdrawal by Subject|8
4520129|NCT00985621|7333356|FG000|Overall Study|Adverse Event|2
4520130|NCT00985621|7333357|FG001|Overall Study|Adverse Event|3
4520131|NCT00985621|7333358|FG002|Overall Study|Adverse Event|4
4520132|NCT00985621|7333359|FG003|Overall Study|Adverse Event|16
4520133|NCT00985621|7333356|FG000|Overall Study|Lack of Efficacy|10
4520134|NCT00985621|7333357|FG001|Overall Study|Lack of Efficacy|6
4520135|NCT00985621|7333358|FG002|Overall Study|Lack of Efficacy|5
4520136|NCT00985621|7333359|FG003|Overall Study|Lack of Efficacy|12
4520137|NCT00985621|7333356|FG000|Overall Study|Lost to Follow-up|2
4520138|NCT00985621|7333357|FG001|Overall Study|Lost to Follow-up|3
4520139|NCT00985621|7333358|FG002|Overall Study|Lost to Follow-up|4
4520140|NCT00985621|7333359|FG003|Overall Study|Lost to Follow-up|4
4520141|NCT00985621|7333356|FG000|Overall Study|Study Terminated by Sponsor|89
4520142|NCT00985621|7333357|FG001|Overall Study|Study Terminated by Sponsor|108
4593956|NCT01557244|7442690|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0
4520143|NCT00985621|7333358|FG002|Overall Study|Study Terminated by Sponsor|99
4520144|NCT00985621|7333359|FG003|Overall Study|Study Terminated by Sponsor|92
4520145|NCT00985621|7333356|FG000|Overall Study|Protocol Violation|1
4520146|NCT00985621|7333357|FG001|Overall Study|Protocol Violation|1
4520147|NCT00985621|7333358|FG002|Overall Study|Protocol Violation|1
4520148|NCT00985621|7333359|FG003|Overall Study|Protocol Violation|0
4520149|NCT00985621|7333356|FG000|Overall Study|Withdrawal by Subject|8
4520150|NCT00985621|7333357|FG001|Overall Study|Withdrawal by Subject|10
4520151|NCT00985621|7333358|FG002|Overall Study|Withdrawal by Subject|8
4520152|NCT00985621|7333359|FG003|Overall Study|Withdrawal by Subject|12
4520153|NCT00985621|7333356|FG000|Overall Study|Other|1
4593957|NCT01557244|7442691|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1
4520154|NCT00985621|7333357|FG001|Overall Study|Other|0
4520155|NCT00985621|7333358|FG002|Overall Study|Other|0
4520156|NCT00985621|7333359|FG003|Overall Study|Other|0
4520157|NCT00985621|7333356|FG000|Overall Study|Randomized but not Treated|1
4520158|NCT00985621|7333357|FG001|Overall Study|Randomized but not Treated|0
4520159|NCT00985621|7333358|FG002|Overall Study|Randomized but not Treated|2
4520160|NCT00985621|7333359|FG003|Overall Study|Randomized but not Treated|1
4520161|NCT00985673|7333377|FG000|Overall Study|Lost to Follow-up|6
4520162|NCT00985673|7333378|FG001|Overall Study|Lost to Follow-up|7
4520163|NCT00985673|7333379|FG002|Overall Study|Lost to Follow-up|6
4520164|NCT00985673|7333380|FG003|Overall Study|Lost to Follow-up|10
4520165|NCT00985673|7333381|FG004|Overall Study|Lost to Follow-up|5
4520166|NCT00985673|7333382|FG005|Overall Study|Lost to Follow-up|3
4520167|NCT00985673|7333377|FG000|Overall Study|Withdrawal by Subject|0
4520168|NCT00985673|7333378|FG001|Overall Study|Withdrawal by Subject|4
4520169|NCT00985673|7333379|FG002|Overall Study|Withdrawal by Subject|5
4520170|NCT00985673|7333380|FG003|Overall Study|Withdrawal by Subject|2
4520171|NCT00985673|7333381|FG004|Overall Study|Withdrawal by Subject|2
4520172|NCT00985673|7333382|FG005|Overall Study|Withdrawal by Subject|3
4520173|NCT00985673|7333377|FG000|Overall Study|Other|1
4520174|NCT00985673|7333378|FG001|Overall Study|Other|0
4520175|NCT00985673|7333379|FG002|Overall Study|Other|1
4520176|NCT00985673|7333380|FG003|Overall Study|Other|0
4520177|NCT00985673|7333381|FG004|Overall Study|Other|1
4520178|NCT00985673|7333382|FG005|Overall Study|Other|0
4520179|NCT00985686|7333401|FG000|Overall Study|Lost to Follow-up|1
4520180|NCT00985686|7333402|FG001|Overall Study|Lost to Follow-up|1
4520181|NCT00985686|7333403|FG002|Overall Study|Lost to Follow-up|0
4520182|NCT00985686|7333404|FG003|Overall Study|Lost to Follow-up|2
4520183|NCT00985712|7333414|FG000|Overall Study|Adverse Event|0
4520184|NCT00985712|7333415|FG001|Overall Study|Adverse Event|1
4520185|NCT00985712|7333414|FG000|Overall Study|Lost to Follow-up|2
4520186|NCT00985712|7333415|FG001|Overall Study|Lost to Follow-up|2
4520187|NCT00985712|7333414|FG000|Overall Study|Protocol Violation|0
4520188|NCT00985712|7333415|FG001|Overall Study|Protocol Violation|1
4520189|NCT00985712|7333414|FG000|Overall Study|Withdrawal by Subject|4
4520190|NCT00985712|7333415|FG001|Overall Study|Withdrawal by Subject|1
4520191|NCT00985712|7333414|FG000|Overall Study|Sponsor decision|0
4520192|NCT00985712|7333415|FG001|Overall Study|Sponsor decision|2
4520193|NCT00985725|7333423|FG000|Overall Study|Adverse Event|4
4520194|NCT00985725|7333424|FG001|Overall Study|Adverse Event|1
4520195|NCT00985725|7333423|FG000|Overall Study|Protocol Violation|1
4520196|NCT00985725|7333424|FG001|Overall Study|Protocol Violation|3
4520197|NCT00985725|7333423|FG000|Overall Study|Withdrawal by Subject|4
4520198|NCT00985725|7333424|FG001|Overall Study|Withdrawal by Subject|4
4520199|NCT00985725|7333423|FG000|Overall Study|Lost to Follow-up|1
4520200|NCT00985725|7333424|FG001|Overall Study|Lost to Follow-up|1
4520201|NCT00985725|7333423|FG000|Overall Study|Lack of Efficacy|0
4520202|NCT00985725|7333424|FG001|Overall Study|Lack of Efficacy|1
4520203|NCT00985725|7333423|FG000|Overall Study|Non-compliance|1
4520204|NCT00985725|7333424|FG001|Overall Study|Non-compliance|2
4520205|NCT00985725|7333423|FG000|Overall Study|Out-of-window visits|0
4520206|NCT00985725|7333424|FG001|Overall Study|Out-of-window visits|1
4520207|NCT00985751|7333435|FG000|Overall Study|Adverse Event|0
4520208|NCT00985751|7333436|FG001|Overall Study|Adverse Event|0
4520209|NCT00985751|7333437|FG002|Overall Study|Adverse Event|0
4520210|NCT00985751|7333438|FG003|Overall Study|Adverse Event|0
4520211|NCT00985751|7333439|FG004|Overall Study|Adverse Event|1
4520212|NCT00985790|7333456|FG000|Overall Study|Withdrawal by Subject|1
4520213|NCT00985790|7333457|FG001|Overall Study|Withdrawal by Subject|1
4520214|NCT00985790|7333456|FG000|Overall Study|Lost to Follow-up|6
4520215|NCT00985790|7333457|FG001|Overall Study|Lost to Follow-up|7
4520216|NCT00985946|7333477|FG000|Overall Study|Lost to Follow-up|6
4520217|NCT00985946|7333477|FG000|Overall Study|Withdrawal by Subject|1
4520218|NCT00985959|7333484|FG000|Overall Study|Adverse Event|0
4520219|NCT00985959|7333485|FG001|Overall Study|Adverse Event|0
4520220|NCT00985959|7333486|FG002|Overall Study|Adverse Event|19
4520221|NCT00985959|7333484|FG000|Overall Study|Withdrawal by Subject|0
4520222|NCT00985959|7333485|FG001|Overall Study|Withdrawal by Subject|0
4520223|NCT00985959|7333486|FG002|Overall Study|Withdrawal by Subject|8
4520224|NCT00985959|7333484|FG000|Overall Study|Progressive disease|1
4520225|NCT00985959|7333485|FG001|Overall Study|Progressive disease|2
4520226|NCT00985959|7333486|FG002|Overall Study|Progressive disease|8
4520227|NCT00985959|7333484|FG000|Overall Study|Unrecovered toxicity|0
4520228|NCT00985959|7333485|FG001|Overall Study|Unrecovered toxicity|0
4520229|NCT00985959|7333486|FG002|Overall Study|Unrecovered toxicity|7
4520230|NCT00985959|7333484|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2
4520231|NCT00985959|7333485|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0
4520232|NCT00985959|7333486|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2
4520233|NCT00985959|7333484|FG000|Overall Study|Complete response observed over 2 cycles|0
4520234|NCT00985959|7333485|FG001|Overall Study|Complete response observed over 2 cycles|1
4520235|NCT00985959|7333486|FG002|Overall Study|Complete response observed over 2 cycles|4
4520236|NCT00985959|7333484|FG000|Overall Study|Other|0
4520237|NCT00985959|7333485|FG001|Overall Study|Other|0
4520238|NCT00985959|7333486|FG002|Overall Study|Other|11
4520239|NCT00985985|7333504|FG000|Overall Study|Adverse Event|4
4520240|NCT00985985|7333505|FG001|Overall Study|Adverse Event|2
4520241|NCT00985985|7333506|FG002|Overall Study|Adverse Event|2
4520242|NCT00985985|7333507|FG003|Overall Study|Adverse Event|2
4520243|NCT00985985|7333504|FG000|Overall Study|Lost to Follow-up|4
4520244|NCT00985985|7333505|FG001|Overall Study|Lost to Follow-up|11
4520245|NCT00985985|7333506|FG002|Overall Study|Lost to Follow-up|2
4520246|NCT00985985|7333507|FG003|Overall Study|Lost to Follow-up|3
4520247|NCT00985985|7333504|FG000|Overall Study|Protocol Violation|1
4520248|NCT00985985|7333505|FG001|Overall Study|Protocol Violation|2
4520249|NCT00985985|7333506|FG002|Overall Study|Protocol Violation|0
4520250|NCT00985985|7333507|FG003|Overall Study|Protocol Violation|1
4520251|NCT00985985|7333504|FG000|Overall Study|Lack of Efficacy|5
4520252|NCT00985985|7333505|FG001|Overall Study|Lack of Efficacy|6
4520253|NCT00985985|7333506|FG002|Overall Study|Lack of Efficacy|1
4520254|NCT00985985|7333507|FG003|Overall Study|Lack of Efficacy|3
4520255|NCT00985985|7333504|FG000|Overall Study|Withdrawal by Subject|4
4520256|NCT00985985|7333505|FG001|Overall Study|Withdrawal by Subject|2
4520257|NCT00985985|7333506|FG002|Overall Study|Withdrawal by Subject|2
4520258|NCT00985985|7333507|FG003|Overall Study|Withdrawal by Subject|2
4520259|NCT00985985|7333504|FG000|Overall Study|Other Reason|6
4520260|NCT00985985|7333505|FG001|Overall Study|Other Reason|1
4520261|NCT00985985|7333506|FG002|Overall Study|Other Reason|4
4520262|NCT00985985|7333507|FG003|Overall Study|Other Reason|2
4520263|NCT00986102|7333526|FG000|Overall Study|Lost to Follow-up|0
4520264|NCT00986102|7333527|FG001|Overall Study|Lost to Follow-up|1
4520265|NCT00986102|7333528|FG002|Overall Study|Lost to Follow-up|0
4520266|NCT00986102|7333529|FG003|Overall Study|Lost to Follow-up|1
4520267|NCT00986102|7333526|FG000|Overall Study|Withdrawal by Subject|1
4520268|NCT00986102|7333527|FG001|Overall Study|Withdrawal by Subject|1
4520269|NCT00986102|7333528|FG002|Overall Study|Withdrawal by Subject|0
4520270|NCT00986102|7333529|FG003|Overall Study|Withdrawal by Subject|0
4520271|NCT00986154|7333541|FG000|Overall Study|Death|136
4520272|NCT00986154|7333542|FG001|Overall Study|Death|127
4520273|NCT00986154|7333541|FG000|Overall Study|Lost to Follow-up|7
4520274|NCT00986154|7333542|FG001|Overall Study|Lost to Follow-up|4
4520275|NCT00986154|7333541|FG000|Overall Study|Withdrawal by Subject|32
4520276|NCT00986154|7333542|FG001|Overall Study|Withdrawal by Subject|33
4520277|NCT00986154|7333541|FG000|Overall Study|investigator/subject decide not continue|6
4520278|NCT00986154|7333542|FG001|Overall Study|investigator/subject decide not continue|3
4520279|NCT00986154|7333541|FG000|Overall Study|never received study drug|25
4520280|NCT00986154|7333542|FG001|Overall Study|never received study drug|27
4520281|NCT00986180|7333550|FG000|Overall Study|Adverse Event|21
4520282|NCT00986180|7333551|FG001|Overall Study|Adverse Event|23
4520283|NCT00986180|7333550|FG000|Overall Study|Lack of Efficacy|4
4520284|NCT00986180|7333551|FG001|Overall Study|Lack of Efficacy|3
4520285|NCT00986180|7333550|FG000|Overall Study|Lost to Follow-up|5
4520286|NCT00986180|7333551|FG001|Overall Study|Lost to Follow-up|7
4520287|NCT00986180|7333550|FG000|Overall Study|Physician Decision|1
4520288|NCT00986180|7333551|FG001|Overall Study|Physician Decision|3
4520289|NCT00986180|7333550|FG000|Overall Study|Protocol Violation|2
4520290|NCT00986180|7333551|FG001|Overall Study|Protocol Violation|0
4520291|NCT00986180|7333550|FG000|Overall Study|Withdrawal by Subject|1
4520292|NCT00986180|7333551|FG001|Overall Study|Withdrawal by Subject|9
4520293|NCT00986180|7333550|FG000|Overall Study|Miscellanies|10
4520294|NCT00986180|7333551|FG001|Overall Study|Miscellanies|11
4520295|NCT00986232|7333561|FG000|Overall Study|Adverse Event|1
4520296|NCT00986232|7333562|FG001|Overall Study|Adverse Event|2
4520297|NCT00986232|7333563|FG002|Overall Study|Adverse Event|3
4520298|NCT00986232|7333564|FG003|Overall Study|Adverse Event|0
4520299|NCT00986232|7333561|FG000|Overall Study|Lost to Follow-up|19
4520300|NCT00986232|7333562|FG001|Overall Study|Lost to Follow-up|12
4520301|NCT00986232|7333563|FG002|Overall Study|Lost to Follow-up|12
4520302|NCT00986232|7333564|FG003|Overall Study|Lost to Follow-up|7
4520303|NCT00986232|7333561|FG000|Overall Study|Protocol Violation|2
4520304|NCT00986232|7333562|FG001|Overall Study|Protocol Violation|3
4520305|NCT00986232|7333563|FG002|Overall Study|Protocol Violation|0
4520306|NCT00986232|7333564|FG003|Overall Study|Protocol Violation|1
4520307|NCT00986232|7333561|FG000|Overall Study|Withdrawal by Subject|13
4633438|NCT01912287|7503628|FG002|Overall Study|Lost Interest|0
4633439|NCT01912287|7503626|FG000|Overall Study|Uknown reason - subject drop out|5
4520308|NCT00986232|7333562|FG001|Overall Study|Withdrawal by Subject|16
4520309|NCT00986232|7333563|FG002|Overall Study|Withdrawal by Subject|12
4520310|NCT00986232|7333564|FG003|Overall Study|Withdrawal by Subject|3
4520311|NCT00986232|7333561|FG000|Overall Study|Missed one or more bleeds|13
4520312|NCT00986232|7333562|FG001|Overall Study|Missed one or more bleeds|10
4520313|NCT00986232|7333563|FG002|Overall Study|Missed one or more bleeds|6
4520314|NCT00986232|7333564|FG003|Overall Study|Missed one or more bleeds|7
4520315|NCT00986232|7333561|FG000|Overall Study|Incomplete safety follow-up|3
4520316|NCT00986232|7333562|FG001|Overall Study|Incomplete safety follow-up|7
4520317|NCT00986232|7333563|FG002|Overall Study|Incomplete safety follow-up|2
4520318|NCT00986232|7333564|FG003|Overall Study|Incomplete safety follow-up|2
4520319|NCT00986245|7333580|FG000|First Intervention|Poor compliance|8
4520320|NCT00986245|7333581|FG001|First Intervention|Poor compliance|4
4520321|NCT00986245|7333580|FG000|First Intervention|Lack of Efficacy|1
4520322|NCT00986245|7333581|FG001|First Intervention|Lack of Efficacy|2
4520323|NCT00986245|7333580|FG000|First Intervention|Withdrawal by Subject|0
4520324|NCT00986245|7333581|FG001|First Intervention|Withdrawal by Subject|1
4520325|NCT00986245|7333580|FG000|First Intervention|Protocol Violation|0
4520326|NCT00986245|7333581|FG001|First Intervention|Protocol Violation|1
4520327|NCT00986245|7333580|FG000|First Intervention|Out of indication|1
4520328|NCT00986245|7333581|FG001|First Intervention|Out of indication|0
4520329|NCT00986245|7333580|FG000|Second Intervention|Poor compliance|1
4520330|NCT00986245|7333581|FG001|Second Intervention|Poor compliance|0
4520331|NCT00986245|7333580|FG000|Second Intervention|Lost to Follow-up|1
4520332|NCT00986245|7333581|FG001|Second Intervention|Lost to Follow-up|0
4520333|NCT00986245|7333580|FG000|Second Intervention|Protocol Violation|0
4520334|NCT00986245|7333581|FG001|Second Intervention|Protocol Violation|1
4520335|NCT00986258|7333592|FG000|Observation Period|Not eligible to be dosed|11
4520336|NCT00986258|7333592|FG000|Titration and Optimal Dose Period|Adverse Event|15
4520337|NCT00986258|7333592|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3
4520338|NCT00986258|7333592|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3
4520339|NCT00986258|7333592|FG000|Titration and Optimal Dose Period|Non-Compliance|1
4520340|NCT00986258|7333592|FG000|Titration and Optimal Dose Period|Other|1
4520341|NCT00986258|7333592|FG000|Maintenance Period|Adverse Event|5
4520342|NCT00986258|7333592|FG000|Maintenance Period|Lack of Efficacy|2
4520343|NCT00986258|7333592|FG000|Maintenance Period|Withdrawal by Subject|2
4520344|NCT00986349|7333606|FG000|Overall Study|Unsuccessful implant procedure|3
4520345|NCT00986349|7333606|FG000|Overall Study|Adverse Event|2
4520346|NCT00986349|7333606|FG000|Overall Study|Physician Decision|1
4520347|NCT00986349|7333606|FG000|Overall Study|device migration|1
4520348|NCT00986362|7333621|FG000|Overall Study|Death|2
4520349|NCT00986362|7333622|FG001|Overall Study|Death|0
4520350|NCT00986362|7333621|FG000|Overall Study|Lost to Follow-up|0
4520351|NCT00986362|7333622|FG001|Overall Study|Lost to Follow-up|1
4520352|NCT00986427|7333642|FG000|Overall Study|Lost to Follow-up|2
4520353|NCT00986427|7333643|FG001|Overall Study|Lost to Follow-up|0
4520354|NCT00986427|7333642|FG000|Overall Study|Lack of Efficacy|1
4520355|NCT00986427|7333643|FG001|Overall Study|Lack of Efficacy|0
4520356|NCT00986427|7333642|FG000|Overall Study|Withdrawal by Subject|1
4520357|NCT00986427|7333643|FG001|Overall Study|Withdrawal by Subject|0
4520358|NCT00986440|7333655|FG000|Overall Study|Progressive disease|27
4520359|NCT00986440|7333656|FG001|Overall Study|Progressive disease|37
4520360|NCT00986440|7333655|FG000|Overall Study|Serious adverse event or adverse event|9
4520361|NCT00986440|7333656|FG001|Overall Study|Serious adverse event or adverse event|2
4520362|NCT00986440|7333655|FG000|Overall Study|Withdrawal by Subject|1
4520363|NCT00986440|7333656|FG001|Overall Study|Withdrawal by Subject|2
4520364|NCT00986440|7333655|FG000|Overall Study|Screen failure (not dosed)|4
4520365|NCT00986440|7333656|FG001|Overall Study|Screen failure (not dosed)|2
4520366|NCT00986479|7333670|FG000|Period 1|Improved mood|1
4520367|NCT00986479|7333671|FG001|Period 1|Improved mood|0
4520368|NCT00986479|7333670|FG000|Period 1|Administrative reasons|1
4520369|NCT00986479|7333671|FG001|Period 1|Administrative reasons|0
4520370|NCT00986570|7333687|FG000|Overall Study|Lost to Follow-up|6
4520371|NCT00986570|7333687|FG000|Overall Study|Potential bias for objective assessment|1
4520372|NCT00986674|7333704|FG000|Overall Study|Lack of Efficacy|28
4520373|NCT00986674|7333705|FG001|Overall Study|Lack of Efficacy|25
4520374|NCT00986674|7333706|FG002|Overall Study|Lack of Efficacy|23
4520375|NCT00986674|7333704|FG000|Overall Study|Adverse Event|4
4520376|NCT00986674|7333705|FG001|Overall Study|Adverse Event|8
4520377|NCT00986674|7333706|FG002|Overall Study|Adverse Event|9
4520378|NCT00986674|7333704|FG000|Overall Study|Death|5
4520379|NCT00986674|7333705|FG001|Overall Study|Death|0
4520380|NCT00986674|7333706|FG002|Overall Study|Death|4
4520381|NCT00986674|7333704|FG000|Overall Study|Withdrawal by Subject|6
4520382|NCT00986674|7333705|FG001|Overall Study|Withdrawal by Subject|2
4520383|NCT00986674|7333706|FG002|Overall Study|Withdrawal by Subject|1
4520384|NCT00986674|7333704|FG000|Overall Study|alternative therapy|0
4520385|NCT00986674|7333705|FG001|Overall Study|alternative therapy|0
4520386|NCT00986674|7333706|FG002|Overall Study|alternative therapy|1
4520387|NCT00986674|7333704|FG000|Overall Study|not start protocol therapy|4
4520388|NCT00986674|7333705|FG001|Overall Study|not start protocol therapy|3
4520389|NCT00986674|7333706|FG002|Overall Study|not start protocol therapy|1
4520390|NCT00986674|7333704|FG000|Overall Study|unknown/not specify|0
4520391|NCT00986674|7333705|FG001|Overall Study|unknown/not specify|7
4520392|NCT00986674|7333706|FG002|Overall Study|unknown/not specify|9
4520393|NCT00986830|7333714|FG000|Overall Study|Death|1
4520394|NCT00986830|7333714|FG000|Overall Study|Lost to Follow-up|1
4520395|NCT00986830|7333714|FG000|Overall Study|Lack of Efficacy|1
4520396|NCT00986830|7333714|FG000|Overall Study|Unable to access sinus with device|5
4520397|NCT00986921|7333729|FG000|Overall Study|Physician Decision|1
4520398|NCT00986921|7333730|FG001|Overall Study|Physician Decision|0
4520399|NCT00986973|7333739|FG000|Overall Study|Withdrawn by study team|1
4520400|NCT00986986|7333746|FG000|Overall Study|Lost to Follow-up|0
4520401|NCT00986986|7333747|FG001|Overall Study|Lost to Follow-up|1
4520402|NCT00987337|7333757|FG000|Overall Study|Adverse Event|10
4520403|NCT00987337|7333758|FG001|Overall Study|Adverse Event|9
4520404|NCT00987337|7333759|FG002|Overall Study|Adverse Event|8
4520405|NCT00987337|7333757|FG000|Overall Study|Insufficient Virologic Response|10
4520406|NCT00987337|7333758|FG001|Overall Study|Insufficient Virologic Response|7
4520407|NCT00987337|7333759|FG002|Overall Study|Insufficient Virologic Response|12
4520408|NCT00987337|7333757|FG000|Overall Study|Virologic Breakthrough|2
4520409|NCT00987337|7333758|FG001|Overall Study|Virologic Breakthrough|2
4520410|NCT00987337|7333759|FG002|Overall Study|Virologic Breakthrough|8
4520411|NCT00987337|7333757|FG000|Overall Study|Lost to Follow-up|10
4520412|NCT00987337|7333758|FG001|Overall Study|Lost to Follow-up|6
4520413|NCT00987337|7333759|FG002|Overall Study|Lost to Follow-up|2
4520414|NCT00987337|7333757|FG000|Overall Study|Withdrawal by Subject|6
4520415|NCT00987337|7333758|FG001|Overall Study|Withdrawal by Subject|9
4520416|NCT00987337|7333759|FG002|Overall Study|Withdrawal by Subject|9
4520417|NCT00987337|7333757|FG000|Overall Study|Other|0
4520418|NCT00987337|7333758|FG001|Overall Study|Other|2
4520419|NCT00987337|7333759|FG002|Overall Study|Other|5
4520420|NCT00987337|7333757|FG000|Overall Study|Protocol Violation|1
4520421|NCT00987337|7333758|FG001|Overall Study|Protocol Violation|0
4520422|NCT00987337|7333759|FG002|Overall Study|Protocol Violation|2
4520423|NCT00987337|7333757|FG000|Overall Study|Participant Relapsed|18
4520424|NCT00987337|7333758|FG001|Overall Study|Participant Relapsed|20
4520425|NCT00987337|7333759|FG002|Overall Study|Participant Relapsed|5
4520426|NCT00987389|7333771|FG000|Overall Study|Ineligible|0
4520427|NCT00987389|7333772|FG001|Overall Study|Ineligible|3
4520428|NCT00987389|7333773|FG002|Overall Study|Ineligible|0
4520429|NCT00987389|7333774|FG003|Overall Study|Ineligible|0
4520430|NCT00987389|7333771|FG000|Overall Study|Lost to Follow-up|4
4520431|NCT00987389|7333772|FG001|Overall Study|Lost to Follow-up|1
4520432|NCT00987389|7333773|FG002|Overall Study|Lost to Follow-up|3
4520433|NCT00987389|7333774|FG003|Overall Study|Lost to Follow-up|1
4520434|NCT00987389|7333771|FG000|Overall Study|Withdrawal by Subject|4
4520435|NCT00987389|7333772|FG001|Overall Study|Withdrawal by Subject|3
4520436|NCT00987389|7333773|FG002|Overall Study|Withdrawal by Subject|2
4520437|NCT00987389|7333774|FG003|Overall Study|Withdrawal by Subject|1
4520438|NCT00987389|7333771|FG000|Overall Study|Withdrawn from Treatment|0
4520439|NCT00987389|7333772|FG001|Overall Study|Withdrawn from Treatment|1
4520440|NCT00987389|7333773|FG002|Overall Study|Withdrawn from Treatment|0
4520441|NCT00987389|7333774|FG003|Overall Study|Withdrawn from Treatment|0
4520442|NCT00987389|7333771|FG000|Overall Study|Multiple different reasons|1
4520443|NCT00987389|7333772|FG001|Overall Study|Multiple different reasons|0
4520444|NCT00987389|7333773|FG002|Overall Study|Multiple different reasons|3
4520445|NCT00987389|7333774|FG003|Overall Study|Multiple different reasons|1
4520446|NCT00987402|7333784|FG000|Overall Study|Insufficient data entry|86
4520447|NCT00987402|7333785|FG001|Overall Study|Insufficient data entry|98
4520448|NCT00987467|7333800|FG000|Overall Study|Lost to Follow-up|2
4520449|NCT00987623|7333819|FG000|Overall Study|Lost to Follow-up|2
4520450|NCT00987623|7333820|FG001|Overall Study|Lost to Follow-up|1
4520451|NCT00987623|7333819|FG000|Overall Study|Time/job conflict|2
4520452|NCT00987623|7333820|FG001|Overall Study|Time/job conflict|0
4520453|NCT00987623|7333819|FG000|Overall Study|Discomfort|1
4520454|NCT00987623|7333820|FG001|Overall Study|Discomfort|0
4520455|NCT00987623|7333819|FG000|Overall Study|Biomicroscopy|0
4520456|NCT00987623|7333820|FG001|Overall Study|Biomicroscopy|1
4520457|NCT00987623|7333819|FG000|Overall Study|Influenza|0
4520458|NCT00987623|7333820|FG001|Overall Study|Influenza|1
4520459|NCT00987831|7333838|FG000|Overall Study|Never flared in 12 months|1
4520460|NCT00987831|7333839|FG001|Overall Study|Never flared in 12 months|0
4520461|NCT00987831|7333840|FG002|Overall Study|Never flared in 12 months|0
4520462|NCT00987831|7333838|FG000|Overall Study|Lost to Follow-up|0
4520463|NCT00987831|7333839|FG001|Overall Study|Lost to Follow-up|3
4520464|NCT00987831|7333840|FG002|Overall Study|Lost to Follow-up|0
4520465|NCT00987935|7333858|FG000|Overall Study|Progressive disease|3
4520466|NCT00987935|7333859|FG001|Overall Study|Progressive disease|2
4520467|NCT00987935|7333860|FG002|Overall Study|Progressive disease|3
4520468|NCT00987935|7333861|FG003|Overall Study|Progressive disease|2
4520469|NCT00987935|7333862|FG004|Overall Study|Progressive disease|5
4520470|NCT00987935|7333863|FG005|Overall Study|Progressive disease|3
4520471|NCT00987935|7333864|FG006|Overall Study|Progressive disease|9
4520472|NCT00987935|7333865|FG007|Overall Study|Progressive disease|48
4520473|NCT00987935|7333866|FG008|Overall Study|Progressive disease|23
4520474|NCT00987935|7333858|FG000|Overall Study|Adverse Event|0
4520475|NCT00987935|7333859|FG001|Overall Study|Adverse Event|1
4520476|NCT00987935|7333860|FG002|Overall Study|Adverse Event|0
4520477|NCT00987935|7333861|FG003|Overall Study|Adverse Event|1
4520478|NCT00987935|7333862|FG004|Overall Study|Adverse Event|1
4520479|NCT00987935|7333863|FG005|Overall Study|Adverse Event|0
4520480|NCT00987935|7333864|FG006|Overall Study|Adverse Event|2
4520481|NCT00987935|7333865|FG007|Overall Study|Adverse Event|10
4520482|NCT00987935|7333866|FG008|Overall Study|Adverse Event|6
4520483|NCT00987935|7333858|FG000|Overall Study|Refused to continue taking trial med.|1
4520484|NCT00987935|7333859|FG001|Overall Study|Refused to continue taking trial med.|0
4520485|NCT00987935|7333860|FG002|Overall Study|Refused to continue taking trial med.|0
4520486|NCT00987935|7333861|FG003|Overall Study|Refused to continue taking trial med.|0
4520487|NCT00987935|7333862|FG004|Overall Study|Refused to continue taking trial med.|1
4520488|NCT00987935|7333863|FG005|Overall Study|Refused to continue taking trial med.|0
4520489|NCT00987935|7333864|FG006|Overall Study|Refused to continue taking trial med.|4
4520490|NCT00987935|7333865|FG007|Overall Study|Refused to continue taking trial med.|4
4737751|NCT03622112|7688220|FG005|Overall Study|Withdrawal by Subject|2
4520491|NCT00987935|7333866|FG008|Overall Study|Refused to continue taking trial med.|2
4520492|NCT00987935|7333858|FG000|Overall Study|Reason other than those specified above|0
4520493|NCT00987935|7333859|FG001|Overall Study|Reason other than those specified above|0
4520494|NCT00987935|7333860|FG002|Overall Study|Reason other than those specified above|0
4520495|NCT00987935|7333861|FG003|Overall Study|Reason other than those specified above|0
4520496|NCT00987935|7333862|FG004|Overall Study|Reason other than those specified above|0
4520497|NCT00987935|7333863|FG005|Overall Study|Reason other than those specified above|0
4520498|NCT00987935|7333864|FG006|Overall Study|Reason other than those specified above|0
4520499|NCT00987935|7333865|FG007|Overall Study|Reason other than those specified above|0
4520500|NCT00987935|7333866|FG008|Overall Study|Reason other than those specified above|1
4520501|NCT00988065|7333933|FG000|Overall Study|Adverse Event|4
4520502|NCT00988065|7333934|FG001|Overall Study|Adverse Event|10
4520503|NCT00988065|7333935|FG002|Overall Study|Adverse Event|2
4520504|NCT00988065|7333933|FG000|Overall Study|Lost to Follow-up|1
4520505|NCT00988065|7333934|FG001|Overall Study|Lost to Follow-up|2
4520506|NCT00988065|7333935|FG002|Overall Study|Lost to Follow-up|2
4520507|NCT00988065|7333933|FG000|Overall Study|Subject withdrew consent|3
4520508|NCT00988065|7333934|FG001|Overall Study|Subject withdrew consent|5
4520509|NCT00988065|7333935|FG002|Overall Study|Subject withdrew consent|2
4520510|NCT00988065|7333933|FG000|Overall Study|Noncompliance with protocol|5
4520511|NCT00988065|7333934|FG001|Overall Study|Noncompliance with protocol|6
4520512|NCT00988065|7333935|FG002|Overall Study|Noncompliance with protocol|9
4520513|NCT00988091|7333945|FG000|Double-blind Period|Withdrawal by Subject|15
4520514|NCT00988091|7333946|FG001|Double-blind Period|Withdrawal by Subject|13
4520515|NCT00988091|7333945|FG000|Double-blind Period|Lost to Follow-up|12
4520516|NCT00988091|7333946|FG001|Double-blind Period|Lost to Follow-up|14
4520517|NCT00988091|7333945|FG000|Double-blind Period|Other|8
4520518|NCT00988091|7333946|FG001|Double-blind Period|Other|8
4520519|NCT00988091|7333945|FG000|Double-blind Period|Adverse Event|6
4520520|NCT00988091|7333946|FG001|Double-blind Period|Adverse Event|9
4520521|NCT00988091|7333945|FG000|Double-blind Period|Use of exclusionary medication|2
4520522|NCT00988091|7333946|FG001|Double-blind Period|Use of exclusionary medication|3
4520523|NCT00988091|7333945|FG000|Open-label Period|Adverse Event|4
4520524|NCT00988091|7333946|FG001|Open-label Period|Adverse Event|7
4520525|NCT00988091|7333945|FG000|Open-label Period|Use of exclusionary medication|1
4520526|NCT00988091|7333946|FG001|Open-label Period|Use of exclusionary medication|1
4520527|NCT00988091|7333945|FG000|Open-label Period|Protocol Violation|1
4520528|NCT00988091|7333946|FG001|Open-label Period|Protocol Violation|1
4520529|NCT00988091|7333945|FG000|Open-label Period|Withdrawal by Subject|10
4520530|NCT00988091|7333946|FG001|Open-label Period|Withdrawal by Subject|16
4520531|NCT00988091|7333945|FG000|Open-label Period|Lost to Follow-up|3
4520532|NCT00988091|7333946|FG001|Open-label Period|Lost to Follow-up|5
4520533|NCT00988091|7333945|FG000|Open-label Period|Other|2
4520534|NCT00988091|7333946|FG001|Open-label Period|Other|3
4520535|NCT00988117|7333953|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1
4520536|NCT00988117|7333953|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2
4520537|NCT00988169|7333980|FG000|Overall Study|Withdrawal by Subject|1
4520538|NCT00988208|7333986|FG000|Overall Study|Adverse Event|71
4520539|NCT00988208|7333987|FG001|Overall Study|Adverse Event|122
4520540|NCT00988208|7333986|FG000|Overall Study|Disease Progression|103
4520541|NCT00988208|7333987|FG001|Overall Study|Disease Progression|89
4520542|NCT00988208|7333986|FG000|Overall Study|Withdrawal by Subject|50
4520543|NCT00988208|7333987|FG001|Overall Study|Withdrawal by Subject|57
4520544|NCT00988208|7333986|FG000|Overall Study|Death|9
4520545|NCT00988208|7333987|FG001|Overall Study|Death|15
4520546|NCT00988208|7333986|FG000|Overall Study|Lost to Follow-up|2
4520547|NCT00988208|7333987|FG001|Overall Study|Lost to Follow-up|3
4520548|NCT00988208|7333986|FG000|Overall Study|Protocol Violation|9
4520549|NCT00988208|7333987|FG001|Overall Study|Protocol Violation|2
4520550|NCT00988208|7333986|FG000|Overall Study|Sponsor Decision|102
4520551|NCT00988208|7333987|FG001|Overall Study|Sponsor Decision|78
4520552|NCT00988208|7333986|FG000|Overall Study|Clinical Progression|17
4520553|NCT00988208|7333987|FG001|Overall Study|Clinical Progression|16
4520554|NCT00988208|7333986|FG000|Overall Study|Biochemical Progression|21
4520555|NCT00988208|7333987|FG001|Overall Study|Biochemical Progression|7
4520556|NCT00988208|7333986|FG000|Overall Study|Clinical Deterioration|7
4520557|NCT00988208|7333987|FG001|Overall Study|Clinical Deterioration|14
4520558|NCT00988208|7333986|FG000|Overall Study|Subject Decision/Investigator Discretion|32
4520559|NCT00988208|7333987|FG001|Overall Study|Subject Decision/Investigator Discretion|32
4520560|NCT00988208|7333986|FG000|Overall Study|Other|8
4520561|NCT00988208|7333987|FG001|Overall Study|Other|3
4520562|NCT00988221|7333996|FG000|Part I|Adverse Event|0
4520563|NCT00988221|7333997|FG001|Part I|Adverse Event|1
4520564|NCT00988221|7333998|FG002|Part I|Adverse Event|2
4520565|NCT00988221|7333999|FG003|Part I|Adverse Event|0
4520566|NCT00988221|7333996|FG000|Part I|Insufficient Therapeutic Response|4
4520567|NCT00988221|7333997|FG001|Part I|Insufficient Therapeutic Response|6
4520568|NCT00988221|7333998|FG002|Part I|Insufficient Therapeutic Response|5
4520569|NCT00988221|7333999|FG003|Part I|Insufficient Therapeutic Response|0
4520570|NCT00988221|7333996|FG000|Part I|Refused Treatment|0
4520571|NCT00988221|7333997|FG001|Part I|Refused Treatment|2
4520572|NCT00988221|7333998|FG002|Part I|Refused Treatment|1
4520573|NCT00988221|7333999|FG003|Part I|Refused Treatment|0
4520574|NCT00988221|7333996|FG000|Part I|Lost to Follow-up|0
4520575|NCT00988221|7333997|FG001|Part I|Lost to Follow-up|1
4520576|NCT00988221|7333998|FG002|Part I|Lost to Follow-up|0
4520577|NCT00988221|7333999|FG003|Part I|Lost to Follow-up|0
4520578|NCT00988221|7333996|FG000|Part II|Adverse Event|1
4520579|NCT00988221|7333997|FG001|Part II|Adverse Event|0
4520580|NCT00988221|7333998|FG002|Part II|Adverse Event|0
4520581|NCT00988221|7333999|FG003|Part II|Adverse Event|1
4520582|NCT00988221|7333996|FG000|Part II|Withdrawal by Subject|0
4520583|NCT00988221|7333997|FG001|Part II|Withdrawal by Subject|0
4520584|NCT00988221|7333998|FG002|Part II|Withdrawal by Subject|2
4520585|NCT00988221|7333999|FG003|Part II|Withdrawal by Subject|2
4520586|NCT00988221|7333996|FG000|Part II|Reason not Specified|0
4520587|NCT00988221|7333997|FG001|Part II|Reason not Specified|0
4520588|NCT00988221|7333998|FG002|Part II|Reason not Specified|1
4520589|NCT00988221|7333999|FG003|Part II|Reason not Specified|0
4520590|NCT00988221|7333996|FG000|Part III|Adverse Event|1
4520591|NCT00988221|7333997|FG001|Part III|Adverse Event|0
4520592|NCT00988221|7333998|FG002|Part III|Adverse Event|1
4520593|NCT00988221|7333999|FG003|Part III|Adverse Event|0
4520594|NCT00988221|7333996|FG000|Part III|Insufficient Therapeutic Response|0
4520595|NCT00988221|7333997|FG001|Part III|Insufficient Therapeutic Response|1
4520596|NCT00988221|7333998|FG002|Part III|Insufficient Therapeutic Response|1
4520597|NCT00988221|7333999|FG003|Part III|Insufficient Therapeutic Response|0
4520598|NCT00988221|7333996|FG000|Part III|Refused Treatment|0
4520599|NCT00988221|7333997|FG001|Part III|Refused Treatment|0
4520600|NCT00988221|7333998|FG002|Part III|Refused Treatment|1
4520601|NCT00988221|7333999|FG003|Part III|Refused Treatment|0
4520602|NCT00988351|7334037|FG000|Overall Study|Withdrawal by Subject|8
4520603|NCT00988351|7334038|FG001|Overall Study|Withdrawal by Subject|0
4520604|NCT00988351|7334037|FG000|Overall Study|Lost to Follow-up|6
4520605|NCT00988351|7334038|FG001|Overall Study|Lost to Follow-up|9
4520606|NCT00988351|7334037|FG000|Overall Study|not using CPAP|5
4520607|NCT00988351|7334038|FG001|Overall Study|not using CPAP|3
4520608|NCT00988429|7334047|FG000|Overall Study|Adverse Event|9
4520609|NCT00988429|7334048|FG001|Overall Study|Adverse Event|21
4520610|NCT00988429|7334049|FG002|Overall Study|Adverse Event|45
4520611|NCT00988429|7334047|FG000|Overall Study|Lack of Efficacy|0
4520612|NCT00988429|7334048|FG001|Overall Study|Lack of Efficacy|0
4520613|NCT00988429|7334049|FG002|Overall Study|Lack of Efficacy|1
4520614|NCT00988429|7334047|FG000|Overall Study|Non-Compliance with Study Drug|5
4520615|NCT00988429|7334048|FG001|Overall Study|Non-Compliance with Study Drug|1
4520616|NCT00988429|7334049|FG002|Overall Study|Non-Compliance with Study Drug|3
4520617|NCT00988429|7334047|FG000|Overall Study|Physician Decision|1
4520618|NCT00988429|7334048|FG001|Overall Study|Physician Decision|0
4520619|NCT00988429|7334049|FG002|Overall Study|Physician Decision|3
4520620|NCT00988429|7334047|FG000|Overall Study|Pregnancy|2
4520621|NCT00988429|7334048|FG001|Overall Study|Pregnancy|1
4520622|NCT00988429|7334049|FG002|Overall Study|Pregnancy|0
4520623|NCT00988429|7334047|FG000|Overall Study|Protocol Violation|4
4520624|NCT00988429|7334048|FG001|Overall Study|Protocol Violation|3
4520625|NCT00988429|7334049|FG002|Overall Study|Protocol Violation|3
4520626|NCT00988429|7334047|FG000|Overall Study|Withdrawal by Subject|7
4520627|NCT00988429|7334048|FG001|Overall Study|Withdrawal by Subject|7
4520628|NCT00988429|7334049|FG002|Overall Study|Withdrawal by Subject|12
4520629|NCT00988429|7334047|FG000|Overall Study|Administrative Reasons|1
4520630|NCT00988429|7334048|FG001|Overall Study|Administrative Reasons|2
4520631|NCT00988429|7334049|FG002|Overall Study|Administrative Reasons|1
4520632|NCT00988429|7334047|FG000|Overall Study|other reasons|8
4520633|NCT00988429|7334048|FG001|Overall Study|other reasons|8
4520634|NCT00988429|7334049|FG002|Overall Study|other reasons|1
4520635|NCT00988442|7334060|FG000|Overall Study|Death|1
4520636|NCT00988442|7334061|FG001|Overall Study|Death|2
4520637|NCT00988442|7334060|FG000|Overall Study|Lost to Follow-up|0
4593958|NCT01557244|7442692|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0
4593959|NCT01557244|7442693|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0
4593960|NCT01557244|7442694|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0
4593961|NCT01557244|7442695|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0
4593962|NCT01557244|7442689|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1
4593963|NCT01557244|7442690|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0
4593964|NCT01557244|7442691|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0
4593965|NCT01557244|7442692|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0
4593966|NCT01557244|7442693|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0
4593967|NCT01557244|7442694|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0
4593968|NCT01557244|7442695|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0
4633440|NCT01912287|7503627|FG001|Overall Study|Uknown reason - subject drop out|7
4737752|NCT03622112|7688221|FG006|Overall Study|Withdrawal by Subject|2
4520638|NCT00988442|7334061|FG001|Overall Study|Lost to Follow-up|1
4520639|NCT00988442|7334060|FG000|Overall Study|Early Study Closure|29
4520640|NCT00988442|7334061|FG001|Overall Study|Early Study Closure|25
4520641|NCT00988533|7334070|FG000|Overall Study|Lost to Follow-up|3
4520642|NCT00988559|7334078|FG000|Overall Study|Withdrawal by Subject|1
4520643|NCT00988559|7334079|FG001|Overall Study|Withdrawal by Subject|1
4520644|NCT00988559|7334080|FG002|Overall Study|Withdrawal by Subject|0
4520645|NCT00988559|7334081|FG003|Overall Study|Withdrawal by Subject|1
4520646|NCT00988559|7334078|FG000|Overall Study|Pregnancy|0
4520647|NCT00988559|7334079|FG001|Overall Study|Pregnancy|1
4520648|NCT00988559|7334080|FG002|Overall Study|Pregnancy|1
4520649|NCT00988559|7334081|FG003|Overall Study|Pregnancy|0
4520650|NCT00988559|7334078|FG000|Overall Study|Lost to Follow-up|0
4520651|NCT00988559|7334079|FG001|Overall Study|Lost to Follow-up|0
4520652|NCT00988559|7334080|FG002|Overall Study|Lost to Follow-up|1
4520653|NCT00988559|7334081|FG003|Overall Study|Lost to Follow-up|0
4520654|NCT00988598|7334093|FG000|Overall Study|Withdrawal by Subject|2
4520655|NCT00988598|7334094|FG001|Overall Study|Withdrawal by Subject|0
4520656|NCT00988637|7334102|FG000|Overall Study|Lost to Follow-up|2
4520657|NCT00988637|7334103|FG001|Overall Study|Lost to Follow-up|1
4520658|NCT00988637|7334102|FG000|Overall Study|Withdrawal by Subject|1
4520659|NCT00988637|7334103|FG001|Overall Study|Withdrawal by Subject|1
4520660|NCT00988637|7334102|FG000|Overall Study|non-compliance with study drug|0
4520661|NCT00988637|7334103|FG001|Overall Study|non-compliance with study drug|1
4520662|NCT00988858|7334116|FG000|Overall Study|Adverse Event|7
4520663|NCT00988858|7334116|FG000|Overall Study|Death|1
4520664|NCT00988858|7334116|FG000|Overall Study|Physician Decision|1
4520665|NCT00988858|7334116|FG000|Overall Study|Sponsor Decision|1
4520666|NCT00988884|7334122|FG000|Overall Study|Adverse Event|0
4520667|NCT00988884|7334123|FG001|Overall Study|Adverse Event|1
4520668|NCT00988884|7334122|FG000|Overall Study|Lost to Follow-up|20
4520669|NCT00988884|7334123|FG001|Overall Study|Lost to Follow-up|16
4520670|NCT00988884|7334122|FG000|Overall Study|Protocol Violation|0
4520671|NCT00988884|7334123|FG001|Overall Study|Protocol Violation|1
4520672|NCT00988884|7334122|FG000|Overall Study|Withdrawal by Subject|15
4520673|NCT00988884|7334123|FG001|Overall Study|Withdrawal by Subject|18
4520674|NCT00989092|7334148|FG000|Overall Study|Physician Decision|9
4520675|NCT00989092|7334149|FG001|Overall Study|Physician Decision|6
4520676|NCT00989092|7334148|FG000|Overall Study|Adverse Event|20
4520677|NCT00989092|7334149|FG001|Overall Study|Adverse Event|1
4520678|NCT00989092|7334148|FG000|Overall Study|Chemotherapy initiated|12
4520679|NCT00989092|7334149|FG001|Overall Study|Chemotherapy initiated|4
4520680|NCT00989092|7334148|FG000|Overall Study|Withdrawal by Subject|17
4520681|NCT00989092|7334149|FG001|Overall Study|Withdrawal by Subject|9
4520682|NCT00989092|7334148|FG000|Overall Study|Death|14
4520683|NCT00989092|7334149|FG001|Overall Study|Death|2
4520684|NCT00989092|7334148|FG000|Overall Study|Ineligibility determined|3
4520685|NCT00989092|7334149|FG001|Overall Study|Ineligibility determined|3
4520686|NCT00989092|7334148|FG000|Overall Study|Lost to Follow-up|6
4520687|NCT00989092|7334149|FG001|Overall Study|Lost to Follow-up|2
4520688|NCT00989092|7334148|FG000|Overall Study|Other|3
4520689|NCT00989092|7334149|FG001|Overall Study|Other|1
4520690|NCT00989092|7334148|FG000|Overall Study|Protocol deviation|2
4520691|NCT00989092|7334149|FG001|Overall Study|Protocol deviation|0
4737753|NCT03622112|7688215|FG000|Overall Study|Death|0
4520692|NCT00989092|7334148|FG000|Overall Study|Erythropoietin therapy initiated|2
4520693|NCT00989092|7334149|FG001|Overall Study|Erythropoietin therapy initiated|0
4520694|NCT00989092|7334148|FG000|Overall Study|Did not receive study drug|2
4520695|NCT00989092|7334149|FG001|Overall Study|Did not receive study drug|0
4520696|NCT00989196|7334167|FG000|Treatment Period|Lost to Follow-up|1
4520697|NCT00989196|7334168|FG001|Treatment Period|Lost to Follow-up|0
4520698|NCT00989235|7334176|FG000|Overall Study|Death|0
4520699|NCT00989235|7334177|FG001|Overall Study|Death|1
4520700|NCT00989235|7334176|FG000|Overall Study|Adverse Event|0
4520701|NCT00989235|7334177|FG001|Overall Study|Adverse Event|1
4520702|NCT00989235|7334176|FG000|Overall Study|Lack of Efficacy|1
4593969|NCT01557244|7442689|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2
4520703|NCT00989235|7334177|FG001|Overall Study|Lack of Efficacy|0
4520704|NCT00989235|7334176|FG000|Overall Study|Withdrawal of Consent|1
4520705|NCT00989235|7334177|FG001|Overall Study|Withdrawal of Consent|1
4520706|NCT00989235|7334176|FG000|Overall Study|Desire to Become Pregnant|1
4520707|NCT00989235|7334177|FG001|Overall Study|Desire to Become Pregnant|0
4520708|NCT00989235|7334176|FG000|Overall Study|Randomized by Mistake|0
4520709|NCT00989235|7334177|FG001|Overall Study|Randomized by Mistake|2
4520710|NCT00989235|7334176|FG000|Overall Study|Lost to Follow-up|0
4520711|NCT00989235|7334177|FG001|Overall Study|Lost to Follow-up|1
4520712|NCT00989261|7334188|FG000|Overall Study|Still in follow up|12
4520713|NCT00989261|7334189|FG001|Overall Study|Still in follow up|21
4520714|NCT00989261|7334188|FG000|Overall Study|Withdrawal by Subject|0
4520715|NCT00989261|7334189|FG001|Overall Study|Withdrawal by Subject|1
4520716|NCT00989261|7334188|FG000|Overall Study|Lost to Follow-up|3
4520717|NCT00989261|7334189|FG001|Overall Study|Lost to Follow-up|0
4520718|NCT00989287|7334197|FG000|Overall Study|Adverse Event|1
4520719|NCT00989287|7334198|FG001|Overall Study|Adverse Event|0
4520720|NCT00989287|7334197|FG000|Overall Study|Lost to Follow-up|0
4520721|NCT00989287|7334198|FG001|Overall Study|Lost to Follow-up|1
4520722|NCT00989573|7334220|FG000|Overall Study|Adverse Event|8
4520723|NCT00989573|7334221|FG001|Overall Study|Adverse Event|12
4520724|NCT00989573|7334222|FG002|Overall Study|Adverse Event|4
4520725|NCT00989573|7334220|FG000|Overall Study|Physician Decision|0
4520726|NCT00989573|7334221|FG001|Overall Study|Physician Decision|2
4520727|NCT00989573|7334222|FG002|Overall Study|Physician Decision|0
4520728|NCT00989573|7334220|FG000|Overall Study|Protocol Violation|1
4520729|NCT00989573|7334221|FG001|Overall Study|Protocol Violation|1
4520730|NCT00989573|7334222|FG002|Overall Study|Protocol Violation|1
4520731|NCT00989573|7334220|FG000|Overall Study|Withdrawal by Subject|4
4520732|NCT00989573|7334221|FG001|Overall Study|Withdrawal by Subject|7
4520733|NCT00989573|7334222|FG002|Overall Study|Withdrawal by Subject|3
4520734|NCT00989664|7334246|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1
4520735|NCT00989664|7334246|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2
4520736|NCT00989664|7334246|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49
4520737|NCT00989664|7334246|FG000|Dosimetric and Therapeutic Treatment|Death|1
4520738|NCT00989664|7334246|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7
4520739|NCT00989664|7334246|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1
4520740|NCT00989664|7334246|FG000|Long-Term Follow-Up|Death|3
4520741|NCT00989781|7334262|FG000|Ovarian Response to hCG|Lost to Follow-up|3
4520742|NCT00989781|7334263|FG001|Ovarian Response to hCG|Lost to Follow-up|2
4520743|NCT00989833|7334273|FG000|Overall Study|Lost to Follow-up|0
4520744|NCT00989833|7334274|FG001|Overall Study|Lost to Follow-up|1
4520745|NCT00989833|7334275|FG002|Overall Study|Lost to Follow-up|0
4520746|NCT00989833|7334273|FG000|Overall Study|Protocol Violation|1
4520747|NCT00989833|7334274|FG001|Overall Study|Protocol Violation|2
4520748|NCT00989833|7334275|FG002|Overall Study|Protocol Violation|1
4520749|NCT00989833|7334273|FG000|Overall Study|Withdrawal by Subject|0
4520750|NCT00989833|7334274|FG001|Overall Study|Withdrawal by Subject|0
4520751|NCT00989833|7334275|FG002|Overall Study|Withdrawal by Subject|1
4520752|NCT00989833|7334273|FG000|Overall Study|Incorrectly randomized|1
4520753|NCT00989833|7334274|FG001|Overall Study|Incorrectly randomized|0
4520754|NCT00989833|7334275|FG002|Overall Study|Incorrectly randomized|0
4520755|NCT00989950|7334291|FG000|Randomized Phase|Protocol Violation|1
4520756|NCT00989950|7334292|FG001|Randomized Phase|Protocol Violation|0
4520757|NCT00989950|7334293|FG002|Randomized Phase|Protocol Violation|0
4520758|NCT00989950|7334294|FG003|Randomized Phase|Protocol Violation|0
4633441|NCT01912287|7503628|FG002|Overall Study|Uknown reason - subject drop out|3
4633442|NCT01912287|7503626|FG000|Overall Study|Missed Assesment|1
4633443|NCT01912287|7503627|FG001|Overall Study|Missed Assesment|1
4633444|NCT01912287|7503628|FG002|Overall Study|Missed Assesment|1
4633445|NCT01912287|7503626|FG000|Overall Study|Scheduling/change in availability|17
4633446|NCT01912287|7503627|FG001|Overall Study|Scheduling/change in availability|10
4633447|NCT01912287|7503628|FG002|Overall Study|Scheduling/change in availability|8
4633448|NCT01912339|7503638|FG000|Blinded (0 to 3 Months)|Declined to participate|1
4633449|NCT01912339|7503639|FG001|Blinded (0 to 3 Months)|Declined to participate|0
4633450|NCT01912339|7503640|FG002|Blinded (0 to 3 Months)|Declined to participate|0
4633451|NCT01912339|7503638|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1
4520759|NCT00989950|7334291|FG000|Randomized Phase|Adverse Event|0
4520760|NCT00989950|7334292|FG001|Randomized Phase|Adverse Event|1
4520761|NCT00989950|7334293|FG002|Randomized Phase|Adverse Event|0
4520762|NCT00989950|7334294|FG003|Randomized Phase|Adverse Event|0
4520763|NCT00989963|7334307|FG000|Overall Study|Adverse Event|1
4520764|NCT00989963|7334308|FG001|Overall Study|Adverse Event|1
4520765|NCT00989963|7334309|FG002|Overall Study|Adverse Event|1
4593970|NCT01557244|7442690|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0
4593971|NCT01557244|7442691|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0
4593972|NCT01557244|7442692|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0
4593973|NCT01557244|7442693|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0
4593974|NCT01557244|7442694|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3
4593975|NCT01557244|7442695|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0
4593976|NCT01557244|7442689|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0
4593977|NCT01557244|7442690|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1
4593978|NCT01557244|7442691|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0
4593979|NCT01557244|7442692|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0
4593980|NCT01557244|7442693|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0
4593981|NCT01557244|7442694|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0
4593982|NCT01557244|7442695|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0
4593983|NCT01557244|7442689|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0
4593984|NCT01557244|7442690|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0
4593985|NCT01557244|7442691|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0
4593986|NCT01557244|7442692|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0
4593987|NCT01557244|7442693|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0
4593988|NCT01557244|7442694|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1
4593989|NCT01557244|7442695|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1
4593990|NCT01557244|7442689|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0
4593991|NCT01557244|7442690|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1
4593992|NCT01557244|7442691|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1
4520766|NCT00990093|7334330|FG000|Test Period 1 (1-14 Days)|Adverse Event|1
4520767|NCT00990093|7334331|FG001|Test Period 1 (1-14 Days)|Adverse Event|0
4520768|NCT00990093|7334330|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2
4520769|NCT00990093|7334331|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0
4520770|NCT00990093|7334330|FG000|Test Period 1 (1-14 Days)|Other|1
4520771|NCT00990093|7334331|FG001|Test Period 1 (1-14 Days)|Other|0
4520772|NCT00990093|7334330|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0
4520773|NCT00990093|7334331|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2
4520774|NCT00990093|7334330|FG000|Test Period 2 (15-28 Days)|Adverse Event|1
4520775|NCT00990093|7334331|FG001|Test Period 2 (15-28 Days)|Adverse Event|0
4520776|NCT00990093|7334330|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1
4520777|NCT00990093|7334331|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0
4520778|NCT00990093|7334330|FG000|Test Period 2 (15-28 Days)|Other|0
4520779|NCT00990093|7334331|FG001|Test Period 2 (15-28 Days)|Other|1
4520780|NCT00990106|7334339|FG000|Overall Study|"too busy to continue"|1
4520781|NCT00990106|7334340|FG001|Overall Study|"too busy to continue"|2
4520782|NCT00990106|7334339|FG000|Overall Study|Lost to Follow-up|1
4520783|NCT00990106|7334340|FG001|Overall Study|Lost to Follow-up|3
4520784|NCT00990106|7334339|FG000|Overall Study|Withdrawal by Subject|2
4520785|NCT00990106|7334340|FG001|Overall Study|Withdrawal by Subject|1
4520786|NCT00990106|7334339|FG000|Overall Study|opted for open label prazosin|1
4520787|NCT00990106|7334340|FG001|Overall Study|opted for open label prazosin|1
4520788|NCT00990106|7334339|FG000|Overall Study|relocation/deployment|4
4520789|NCT00990106|7334340|FG001|Overall Study|relocation/deployment|1
4520790|NCT00990106|7334339|FG000|Overall Study|started exclusionary medication|0
4520791|NCT00990106|7334340|FG001|Overall Study|started exclusionary medication|1
4520792|NCT00990106|7334339|FG000|Overall Study|planned major surgery|0
4520793|NCT00990106|7334340|FG001|Overall Study|planned major surgery|1
4520794|NCT00990106|7334339|FG000|Overall Study|scheduling conflicts|0
4520795|NCT00990106|7334340|FG001|Overall Study|scheduling conflicts|2
4520796|NCT00990184|7334346|FG000|Overall Study|Physician Decision|1
4520797|NCT00990249|7334361|FG000|Overall Study|Disease Progression|8
4520798|NCT00990249|7334361|FG000|Overall Study|Non-Compliance|1
4520799|NCT00990249|7334361|FG000|Overall Study|Death|2
4520800|NCT00990249|7334361|FG000|Overall Study|Not treated|2
4520801|NCT00990314|7334374|FG000|Overall Study|Death|2
4520802|NCT00990314|7334374|FG000|Overall Study|Adverse Event|2
4520803|NCT00990314|7334374|FG000|Overall Study|Withdrawal by Subject|3
4520804|NCT00990314|7334374|FG000|Overall Study|Non-Compliance|1
4520805|NCT00990314|7334374|FG000|Overall Study|Physician Decision|3
4520806|NCT00990314|7334374|FG000|Overall Study|Lack of Efficacy|1
4520807|NCT00990340|7334380|FG000|First 14-day Treatment|Not Compliant|2
4520808|NCT00990340|7334381|FG001|First 14-day Treatment|Not Compliant|1
4520809|NCT00990340|7334380|FG000|First 14-day Treatment|Lost to Follow-up|2
4520810|NCT00990340|7334381|FG001|First 14-day Treatment|Lost to Follow-up|1
4520811|NCT00990340|7334380|FG000|First 14-day Treatment|Protocol Violation|2
4520812|NCT00990340|7334381|FG001|First 14-day Treatment|Protocol Violation|2
4520813|NCT00990652|7334409|FG000|Pre-surgical Bortezomib|Adverse Event|1
4520814|NCT00990652|7334409|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1
4520815|NCT00990665|7334414|FG000|Overall Study|Unsuccessful Implant|8
4520816|NCT00990665|7334414|FG000|Overall Study|Death|29
4520817|NCT00990665|7334414|FG000|Overall Study|Heart Transplant|1
4520818|NCT00990665|7334414|FG000|Overall Study|Withdrawal by Subject|6
4520819|NCT00990665|7334414|FG000|Overall Study|Lost to Follow-up|1
4520820|NCT00990665|7334414|FG000|Overall Study|System Explant|3
4520821|NCT00990704|7334422|FG000|Overall Study|Adverse Event|1
4520822|NCT00990704|7334423|FG001|Overall Study|Adverse Event|1
4520823|NCT00990704|7334422|FG000|Overall Study|Physician Decision|0
4520824|NCT00990704|7334423|FG001|Overall Study|Physician Decision|1
4520825|NCT00990821|7334456|FG000|Overall Study|Withdrawal by Subject|0
4520826|NCT00990821|7334457|FG001|Overall Study|Withdrawal by Subject|2
4520827|NCT00990821|7334458|FG002|Overall Study|Withdrawal by Subject|0
4520828|NCT00990821|7334459|FG003|Overall Study|Withdrawal by Subject|0
4520829|NCT00990821|7334460|FG004|Overall Study|Withdrawal by Subject|3
4520830|NCT00990821|7334461|FG005|Overall Study|Withdrawal by Subject|3
4520831|NCT00990821|7334462|FG006|Overall Study|Withdrawal by Subject|1
4520832|NCT00990821|7334463|FG007|Overall Study|Withdrawal by Subject|0
4520833|NCT00990821|7334464|FG008|Overall Study|Withdrawal by Subject|0
4520834|NCT00990821|7334465|FG009|Overall Study|Withdrawal by Subject|1
4520835|NCT00990821|7334466|FG010|Overall Study|Withdrawal by Subject|3
4520836|NCT00990821|7334467|FG011|Overall Study|Withdrawal by Subject|5
4520837|NCT00990821|7334468|FG012|Overall Study|Withdrawal by Subject|2
4520838|NCT00990821|7334469|FG013|Overall Study|Withdrawal by Subject|1
4520839|NCT00991276|7334545|FG000|First Intervention Period|Adverse Event|0
4520840|NCT00991276|7334546|FG001|First Intervention Period|Adverse Event|1
4520841|NCT00991276|7334547|FG002|First Intervention Period|Adverse Event|0
4520842|NCT00991276|7334548|FG003|First Intervention Period|Adverse Event|1
4520843|NCT00991276|7334549|FG004|First Intervention Period|Adverse Event|0
4520844|NCT00991276|7334550|FG005|First Intervention Period|Adverse Event|0
4520845|NCT00991276|7334545|FG000|First Intervention Period|Protocol Violation|0
4520846|NCT00991276|7334546|FG001|First Intervention Period|Protocol Violation|0
4520847|NCT00991276|7334547|FG002|First Intervention Period|Protocol Violation|0
4520848|NCT00991276|7334548|FG003|First Intervention Period|Protocol Violation|0
4520849|NCT00991276|7334549|FG004|First Intervention Period|Protocol Violation|2
4520850|NCT00991276|7334550|FG005|First Intervention Period|Protocol Violation|0
4520851|NCT00991276|7334545|FG000|First Intervention Period|Insufficient clinical response|0
4520852|NCT00991276|7334546|FG001|First Intervention Period|Insufficient clinical response|0
4520853|NCT00991276|7334547|FG002|First Intervention Period|Insufficient clinical response|0
4520854|NCT00991276|7334548|FG003|First Intervention Period|Insufficient clinical response|0
4520855|NCT00991276|7334549|FG004|First Intervention Period|Insufficient clinical response|1
4520856|NCT00991276|7334550|FG005|First Intervention Period|Insufficient clinical response|0
4520857|NCT00991276|7334545|FG000|First Intervention Period|Other|0
4520858|NCT00991276|7334546|FG001|First Intervention Period|Other|0
4520859|NCT00991276|7334547|FG002|First Intervention Period|Other|0
4520860|NCT00991276|7334548|FG003|First Intervention Period|Other|1
4520861|NCT00991276|7334549|FG004|First Intervention Period|Other|1
4520862|NCT00991276|7334550|FG005|First Intervention Period|Other|0
4520863|NCT00991276|7334545|FG000|First Intervention Period|Withdrawal by Subject|0
4520864|NCT00991276|7334546|FG001|First Intervention Period|Withdrawal by Subject|1
4520865|NCT00991276|7334547|FG002|First Intervention Period|Withdrawal by Subject|0
4520866|NCT00991276|7334548|FG003|First Intervention Period|Withdrawal by Subject|1
4520867|NCT00991276|7334549|FG004|First Intervention Period|Withdrawal by Subject|0
4520868|NCT00991276|7334550|FG005|First Intervention Period|Withdrawal by Subject|1
4520869|NCT00991276|7334545|FG000|First Intervention Period|Lost to Follow-up|0
4520870|NCT00991276|7334546|FG001|First Intervention Period|Lost to Follow-up|1
4520871|NCT00991276|7334547|FG002|First Intervention Period|Lost to Follow-up|0
4520872|NCT00991276|7334548|FG003|First Intervention Period|Lost to Follow-up|1
4520873|NCT00991276|7334549|FG004|First Intervention Period|Lost to Follow-up|0
4520874|NCT00991276|7334550|FG005|First Intervention Period|Lost to Follow-up|0
4520875|NCT00991276|7334545|FG000|Second Intervention Period|Adverse Event|0
4520876|NCT00991276|7334546|FG001|Second Intervention Period|Adverse Event|2
4520877|NCT00991276|7334547|FG002|Second Intervention Period|Adverse Event|0
4520878|NCT00991276|7334548|FG003|Second Intervention Period|Adverse Event|1
4520879|NCT00991276|7334549|FG004|Second Intervention Period|Adverse Event|1
4520880|NCT00991276|7334550|FG005|Second Intervention Period|Adverse Event|0
4520881|NCT00991276|7334545|FG000|Second Intervention Period|Protocol Violation|1
4520882|NCT00991276|7334546|FG001|Second Intervention Period|Protocol Violation|0
4520883|NCT00991276|7334547|FG002|Second Intervention Period|Protocol Violation|0
4520884|NCT00991276|7334548|FG003|Second Intervention Period|Protocol Violation|0
4520885|NCT00991276|7334549|FG004|Second Intervention Period|Protocol Violation|0
4520886|NCT00991276|7334550|FG005|Second Intervention Period|Protocol Violation|0
4520887|NCT00991276|7334545|FG000|Second Intervention Period|Other|0
4520888|NCT00991276|7334546|FG001|Second Intervention Period|Other|0
4520889|NCT00991276|7334547|FG002|Second Intervention Period|Other|0
4520890|NCT00991276|7334548|FG003|Second Intervention Period|Other|1
4520891|NCT00991276|7334549|FG004|Second Intervention Period|Other|0
4520892|NCT00991276|7334550|FG005|Second Intervention Period|Other|1
4520893|NCT00991276|7334545|FG000|Third Intervention Period|Protocol Violation|1
4520894|NCT00991276|7334546|FG001|Third Intervention Period|Protocol Violation|0
4520895|NCT00991276|7334547|FG002|Third Intervention Period|Protocol Violation|0
4520896|NCT00991276|7334548|FG003|Third Intervention Period|Protocol Violation|0
4520897|NCT00991276|7334549|FG004|Third Intervention Period|Protocol Violation|0
4520898|NCT00991276|7334550|FG005|Third Intervention Period|Protocol Violation|0
4520899|NCT00991276|7334545|FG000|Third Intervention Period|Other|0
4520900|NCT00991276|7334546|FG001|Third Intervention Period|Other|0
4520901|NCT00991276|7334547|FG002|Third Intervention Period|Other|0
4520902|NCT00991276|7334548|FG003|Third Intervention Period|Other|0
4520903|NCT00991276|7334549|FG004|Third Intervention Period|Other|0
4520904|NCT00991276|7334550|FG005|Third Intervention Period|Other|1
4520905|NCT00991276|7334545|FG000|Third Intervention Period|Adverse Event|0
4520906|NCT00991276|7334546|FG001|Third Intervention Period|Adverse Event|0
4520907|NCT00991276|7334547|FG002|Third Intervention Period|Adverse Event|1
4520908|NCT00991276|7334548|FG003|Third Intervention Period|Adverse Event|0
4520909|NCT00991276|7334549|FG004|Third Intervention Period|Adverse Event|0
4520910|NCT00991276|7334550|FG005|Third Intervention Period|Adverse Event|0
4520911|NCT00991276|7334545|FG000|Third Intervention Period|Withdrawal by Subject|0
4520912|NCT00991276|7334546|FG001|Third Intervention Period|Withdrawal by Subject|0
4520913|NCT00991276|7334547|FG002|Third Intervention Period|Withdrawal by Subject|0
4520914|NCT00991276|7334548|FG003|Third Intervention Period|Withdrawal by Subject|1
4520915|NCT00991276|7334549|FG004|Third Intervention Period|Withdrawal by Subject|0
4520916|NCT00991276|7334550|FG005|Third Intervention Period|Withdrawal by Subject|0
4520917|NCT00991289|7334559|FG000|Overall Study|Adverse Event|1
4520918|NCT00991289|7334559|FG000|Overall Study|Physician Decision|2
4520919|NCT00991289|7334559|FG000|Overall Study|Withdrawal by Subject|3
4520920|NCT00991289|7334559|FG000|Overall Study|Lost to Follow-up|4
4520921|NCT00991289|7334559|FG000|Overall Study|Protocol Violation|2
4520922|NCT00991302|7334565|FG000|Overall Study|Death|0
4520923|NCT00991302|7334566|FG001|Overall Study|Death|1
4520924|NCT00991302|7334565|FG000|Overall Study|Lost to Follow-up|14
4520925|NCT00991302|7334566|FG001|Overall Study|Lost to Follow-up|12
4520926|NCT00991341|7334574|FG000|Overall Study|no surgery w/in 30 days of randomization|11
4520927|NCT00991341|7334575|FG001|Overall Study|no surgery w/in 30 days of randomization|18
4520928|NCT00991341|7334574|FG000|Overall Study|Death|3
4520929|NCT00991341|7334575|FG001|Overall Study|Death|0
4520930|NCT00991341|7334574|FG000|Overall Study|no RBCs received 96hrs after randomized|186
4520931|NCT00991341|7334575|FG001|Overall Study|no RBCs received 96hrs after randomized|155
4520932|NCT00991341|7334574|FG000|Overall Study|Physician Decision|1
4520933|NCT00991341|7334575|FG001|Overall Study|Physician Decision|2
4520934|NCT00991341|7334574|FG000|Overall Study|Withdrawal by Subject|3
4520935|NCT00991341|7334575|FG001|Overall Study|Withdrawal by Subject|4
4520936|NCT00991406|7334581|FG000|Overall Study|One participant did not respond to FES.|1
4520937|NCT00991510|7334600|FG000|Period I (Days 1-14)|Adverse Event|1
4520938|NCT00991510|7334601|FG001|Period I (Days 1-14)|Adverse Event|0
4520939|NCT00991510|7334600|FG000|Period III (Days 29-112)|Adverse Event|1
4520940|NCT00991510|7334601|FG001|Period III (Days 29-112)|Adverse Event|1
4520941|NCT00991939|7334624|FG000|Overall Study|Lost to Follow-up|0
4520942|NCT00991939|7334625|FG001|Overall Study|Lost to Follow-up|1
4520943|NCT00991939|7334624|FG000|Overall Study|Withdrawal by Subject|1
4520944|NCT00991939|7334625|FG001|Overall Study|Withdrawal by Subject|0
4520945|NCT00991939|7334624|FG000|Overall Study|Entire study terminated|4
4520946|NCT00991939|7334625|FG001|Overall Study|Entire study terminated|1
4520947|NCT00991952|7334635|FG000|Overall Study|Adverse Event|0
4520948|NCT00991952|7334636|FG001|Overall Study|Adverse Event|1
4520949|NCT00992017|7334642|FG000|Overall Study|Lost to Follow-up|2
4520950|NCT00992017|7334642|FG000|Overall Study|Withdrawal by Subject|2
4520951|NCT00992017|7334642|FG000|Overall Study|Unable to get to clinic|5
4520952|NCT00992017|7334642|FG000|Overall Study|Not adhere to study requirements|1
4520953|NCT00992056|7334653|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1
4520954|NCT00992056|7334654|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2
4520955|NCT00992056|7334653|FG000|Washout Period (2 Weeks)|Physician Decision|1
4520956|NCT00992056|7334654|FG001|Washout Period (2 Weeks)|Physician Decision|0
4520957|NCT00992108|7334662|FG000|Overall Study|Lost to Follow-up|0
4520958|NCT00992108|7334663|FG001|Overall Study|Lost to Follow-up|1
4520959|NCT00992186|7334669|FG000|Overall Study|Withdrawal by Subject|2
4520960|NCT00992186|7334669|FG000|Overall Study|Protocol Violation|1
4520961|NCT00992186|7334669|FG000|Overall Study|Physician Decision|1
4520962|NCT00992186|7334669|FG000|Overall Study|Adverse Event|9
4520963|NCT00992186|7334669|FG000|Overall Study|Progressive Disease|30
4520964|NCT00992186|7334669|FG000|Overall Study|Refusal To Receive Study Agent|3
4520965|NCT00992225|7334674|FG000|Overall Study|Entry Criteria Not Met|8
4520966|NCT00992225|7334674|FG000|Overall Study|Adverse Event|2
4520967|NCT00992394|7334722|FG000|Overall Study|Lack of Efficacy|6
4520968|NCT00992394|7334723|FG001|Overall Study|Lack of Efficacy|3
4520969|NCT00992394|7334722|FG000|Overall Study|Adverse Event|4
4520970|NCT00992394|7334723|FG001|Overall Study|Adverse Event|5
4520971|NCT00992394|7334722|FG000|Overall Study|Withdrawal by Subject|8
4520972|NCT00992394|7334723|FG001|Overall Study|Withdrawal by Subject|2
4520973|NCT00992394|7334722|FG000|Overall Study|Physician Decision|1
4520974|NCT00992394|7334723|FG001|Overall Study|Physician Decision|0
4520975|NCT00992394|7334722|FG000|Overall Study|Protocol Violation|2
4520976|NCT00992394|7334723|FG001|Overall Study|Protocol Violation|4
4520977|NCT00992394|7334722|FG000|Overall Study|Lost to Follow-up|2
4520978|NCT00992394|7334723|FG001|Overall Study|Lost to Follow-up|0
4520979|NCT00992394|7334722|FG000|Overall Study|Other event|1
4520980|NCT00992394|7334723|FG001|Overall Study|Other event|0
4520981|NCT00992407|7334731|FG000|Overall Study|Protocol Violation|2
4520982|NCT00992407|7334732|FG001|Overall Study|Protocol Violation|1
4520983|NCT00992407|7334731|FG000|Overall Study|Lost to Follow-up|3
4520984|NCT00992407|7334732|FG001|Overall Study|Lost to Follow-up|3
4520985|NCT00992407|7334731|FG000|Overall Study|Adverse Event|3
4520986|NCT00992407|7334732|FG001|Overall Study|Adverse Event|2
4520987|NCT00992407|7334731|FG000|Overall Study|protocol Violation & Adverse events|2
4593993|NCT01557244|7442692|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0
4520988|NCT00992407|7334732|FG001|Overall Study|protocol Violation & Adverse events|4
4520989|NCT00992407|7334731|FG000|Overall Study|Other|2
4520990|NCT00992407|7334732|FG001|Overall Study|Other|0
4520991|NCT00992407|7334731|FG000|Overall Study|Loss of follow-up & Adverse events|2
4520992|NCT00992407|7334732|FG001|Overall Study|Loss of follow-up & Adverse events|1
4520993|NCT00992407|7334731|FG000|Overall Study|Study medication not administered|17
4520994|NCT00992407|7334732|FG001|Overall Study|Study medication not administered|13
4520995|NCT00992446|7334750|FG000|Overall Study|Disease Progression|1
4520996|NCT00992446|7334750|FG000|Overall Study|Withdrawal by Subject|2
4520997|NCT00992446|7334750|FG000|Overall Study|Maintenance Therapy Screen Fail|5
4520998|NCT00992459|7334756|FG000|Overall Study|Withdrawal by Subject|0
4520999|NCT00992459|7334757|FG001|Overall Study|Withdrawal by Subject|1
4521000|NCT00992459|7334756|FG000|Overall Study|Adverse Event|1
4521001|NCT00992459|7334757|FG001|Overall Study|Adverse Event|0
4521002|NCT00992511|7334767|FG000|Overall Study|Migrated/moved from study area|1
4521003|NCT00992511|7334768|FG001|Overall Study|Migrated/moved from study area|0
4521004|NCT00992511|7334769|FG002|Overall Study|Migrated/moved from study area|1
4521005|NCT00992511|7334770|FG003|Overall Study|Migrated/moved from study area|2
4521006|NCT00992511|7334767|FG000|Overall Study|Lost to Follow-up|1
4521007|NCT00992511|7334768|FG001|Overall Study|Lost to Follow-up|0
4521008|NCT00992511|7334769|FG002|Overall Study|Lost to Follow-up|0
4521009|NCT00992511|7334770|FG003|Overall Study|Lost to Follow-up|2
4521010|NCT00992511|7334767|FG000|Overall Study|Withdrawal by Subject|0
4521011|NCT00992511|7334768|FG001|Overall Study|Withdrawal by Subject|0
4521012|NCT00992511|7334769|FG002|Overall Study|Withdrawal by Subject|1
4521013|NCT00992511|7334770|FG003|Overall Study|Withdrawal by Subject|1
4521014|NCT00992589|7334780|FG000|Open-Label Phase|Adverse Event|4
4521015|NCT00992589|7334781|FG001|Open-Label Phase|Adverse Event|0
4521016|NCT00992589|7334782|FG002|Open-Label Phase|Adverse Event|0
4521017|NCT00992589|7334783|FG003|Open-Label Phase|Adverse Event|0
4521018|NCT00992589|7334780|FG000|Open-Label Phase|Withdrawal by Subject|20
4521019|NCT00992589|7334781|FG001|Open-Label Phase|Withdrawal by Subject|0
4521020|NCT00992589|7334782|FG002|Open-Label Phase|Withdrawal by Subject|0
4633452|NCT01912339|7503639|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0
4737754|NCT03622112|7688216|FG001|Overall Study|Death|0
4521021|NCT00992589|7334783|FG003|Open-Label Phase|Withdrawal by Subject|0
4521022|NCT00992589|7334780|FG000|Open-Label Phase|Lost to Follow-up|1
4521023|NCT00992589|7334781|FG001|Open-Label Phase|Lost to Follow-up|0
4521024|NCT00992589|7334782|FG002|Open-Label Phase|Lost to Follow-up|0
4521025|NCT00992589|7334783|FG003|Open-Label Phase|Lost to Follow-up|0
4521026|NCT00992589|7334780|FG000|Open-Label Phase|Protocol Violation|3
4521027|NCT00992589|7334781|FG001|Open-Label Phase|Protocol Violation|0
4521028|NCT00992589|7334782|FG002|Open-Label Phase|Protocol Violation|0
4521029|NCT00992589|7334783|FG003|Open-Label Phase|Protocol Violation|0
4521030|NCT00992589|7334780|FG000|Open-Label Phase|Physician Decision|4
4521031|NCT00992589|7334781|FG001|Open-Label Phase|Physician Decision|0
4521032|NCT00992589|7334782|FG002|Open-Label Phase|Physician Decision|0
4521033|NCT00992589|7334783|FG003|Open-Label Phase|Physician Decision|0
4521034|NCT00992589|7334780|FG000|Open-Label Phase|Other|45
4521035|NCT00992589|7334781|FG001|Open-Label Phase|Other|0
4521036|NCT00992589|7334782|FG002|Open-Label Phase|Other|0
4521037|NCT00992589|7334783|FG003|Open-Label Phase|Other|0
4521038|NCT00992589|7334780|FG000|Double-Blind Phase|Adverse Event|0
4521039|NCT00992589|7334781|FG001|Double-Blind Phase|Adverse Event|6
4521040|NCT00992589|7334782|FG002|Double-Blind Phase|Adverse Event|2
4521041|NCT00992589|7334783|FG003|Double-Blind Phase|Adverse Event|3
4521042|NCT00992589|7334780|FG000|Double-Blind Phase|Withdrawal by Subject|0
4521043|NCT00992589|7334781|FG001|Double-Blind Phase|Withdrawal by Subject|6
4521044|NCT00992589|7334782|FG002|Double-Blind Phase|Withdrawal by Subject|5
4521045|NCT00992589|7334783|FG003|Double-Blind Phase|Withdrawal by Subject|2
4521046|NCT00992589|7334780|FG000|Double-Blind Phase|Lost to Follow-up|0
4521047|NCT00992589|7334781|FG001|Double-Blind Phase|Lost to Follow-up|0
4521048|NCT00992589|7334782|FG002|Double-Blind Phase|Lost to Follow-up|0
4521049|NCT00992589|7334783|FG003|Double-Blind Phase|Lost to Follow-up|2
4521050|NCT00992589|7334780|FG000|Double-Blind Phase|Other|0
4521051|NCT00992589|7334781|FG001|Double-Blind Phase|Other|1
4521052|NCT00992589|7334782|FG002|Double-Blind Phase|Other|6
4521053|NCT00992589|7334783|FG003|Double-Blind Phase|Other|3
4521054|NCT00992784|7334821|FG000|Overall Study|Adverse Event|2
4521055|NCT00992784|7334822|FG001|Overall Study|Adverse Event|1
4521056|NCT00992784|7334823|FG002|Overall Study|Adverse Event|0
4521057|NCT00992784|7334821|FG000|Overall Study|Withdrawal by Subject|1
4521058|NCT00992784|7334822|FG001|Overall Study|Withdrawal by Subject|1
4521059|NCT00992784|7334823|FG002|Overall Study|Withdrawal by Subject|1
4521060|NCT00992836|7334831|FG000|Overall Study|Lost to Follow-up|1
4521061|NCT00992836|7334831|FG000|Overall Study|Withdrawal by Subject|2
4521062|NCT00992836|7334831|FG000|Overall Study|Protocol Violation|2
4521063|NCT00992992|7334850|FG000|Overall Study|Lost to Follow-up|3
4521064|NCT00992992|7334850|FG000|Overall Study|Death|16
4521065|NCT00992992|7334850|FG000|Overall Study|GlaxoSmithKline Closed the Study|2
4521066|NCT00992992|7334850|FG000|Overall Study|Sponsor Closed the Study|4
4521067|NCT00993031|7334856|FG000|Overall Study|Death|0
4521068|NCT00993031|7334857|FG001|Overall Study|Death|1
4521069|NCT00993031|7334856|FG000|Overall Study|Physician Decision|0
4521070|NCT00993031|7334857|FG001|Overall Study|Physician Decision|2
4521071|NCT00993031|7334856|FG000|Overall Study|Withdrawal by Subject|3
4521072|NCT00993031|7334857|FG001|Overall Study|Withdrawal by Subject|3
4521073|NCT00993031|7334856|FG000|Overall Study|Lost to Follow-up|19
4521074|NCT00993031|7334857|FG001|Overall Study|Lost to Follow-up|13
4521075|NCT00993044|7334867|FG000|Irinotecan 50 mg|Physician Decision|1
4521076|NCT00993148|7334872|FG000|Overall Study|Lost to Follow-up|2
4521077|NCT00993148|7334872|FG000|Overall Study|never initiated treatment|1
4521078|NCT00993265|7334911|FG000|Overall Study|Adverse Event|1
4521079|NCT00993265|7334912|FG001|Overall Study|Adverse Event|0
4521080|NCT00993265|7334911|FG000|Overall Study|Changed dose of concomitant drug|2
4521081|NCT00993265|7334912|FG001|Overall Study|Changed dose of concomitant drug|0
4521082|NCT00993265|7334911|FG000|Overall Study|Non-compliant with study medication|1
4521083|NCT00993265|7334912|FG001|Overall Study|Non-compliant with study medication|0
4521084|NCT00993291|7334918|FG000|Overall Study|Withdrawal by Subject|1
4521085|NCT00993317|7334924|FG000|Overall Study|Adverse Event|2
4521086|NCT00993317|7334925|FG001|Overall Study|Adverse Event|4
4521087|NCT00993317|7334924|FG000|Overall Study|Lack of Efficacy|18
4521088|NCT00993317|7334925|FG001|Overall Study|Lack of Efficacy|18
4521089|NCT00993317|7334924|FG000|Overall Study|Withdrawal by Subject|0
4521090|NCT00993317|7334925|FG001|Overall Study|Withdrawal by Subject|2
4521091|NCT00993317|7334924|FG000|Overall Study|Investigator's opinion|0
4521092|NCT00993317|7334925|FG001|Overall Study|Investigator's opinion|1
4521093|NCT00993317|7334924|FG000|Overall Study|Early study termination at the site|1
4521094|NCT00993317|7334925|FG001|Overall Study|Early study termination at the site|0
4521095|NCT00993421|7334938|FG000|Overall Study|Adverse Event|2
4521096|NCT00993421|7334939|FG001|Overall Study|Adverse Event|7
4521097|NCT00993421|7334940|FG002|Overall Study|Adverse Event|6
4521098|NCT00993421|7334941|FG003|Overall Study|Adverse Event|9
4521099|NCT00993421|7334942|FG004|Overall Study|Adverse Event|5
4521100|NCT00993421|7334943|FG005|Overall Study|Adverse Event|7
4521101|NCT00993421|7334944|FG006|Overall Study|Adverse Event|1
4521102|NCT00993421|7334938|FG000|Overall Study|Sponsor Decision|36
4521103|NCT00993421|7334939|FG001|Overall Study|Sponsor Decision|31
4521104|NCT00993421|7334940|FG002|Overall Study|Sponsor Decision|28
4521105|NCT00993421|7334941|FG003|Overall Study|Sponsor Decision|30
4521106|NCT00993421|7334942|FG004|Overall Study|Sponsor Decision|38
4521107|NCT00993421|7334943|FG005|Overall Study|Sponsor Decision|30
4521108|NCT00993421|7334944|FG006|Overall Study|Sponsor Decision|29
4521109|NCT00993421|7334938|FG000|Overall Study|Lost to Follow-up|3
4521110|NCT00993421|7334939|FG001|Overall Study|Lost to Follow-up|5
4521111|NCT00993421|7334940|FG002|Overall Study|Lost to Follow-up|5
4521112|NCT00993421|7334941|FG003|Overall Study|Lost to Follow-up|0
4521113|NCT00993421|7334942|FG004|Overall Study|Lost to Follow-up|0
4521114|NCT00993421|7334943|FG005|Overall Study|Lost to Follow-up|0
4521115|NCT00993421|7334944|FG006|Overall Study|Lost to Follow-up|6
4521116|NCT00993421|7334938|FG000|Overall Study|Withdrawal by Subject|3
4633453|NCT01912339|7503640|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0
4521117|NCT00993421|7334939|FG001|Overall Study|Withdrawal by Subject|2
4521118|NCT00993421|7334940|FG002|Overall Study|Withdrawal by Subject|3
4521119|NCT00993421|7334941|FG003|Overall Study|Withdrawal by Subject|3
4521120|NCT00993421|7334942|FG004|Overall Study|Withdrawal by Subject|3
4521121|NCT00993421|7334943|FG005|Overall Study|Withdrawal by Subject|5
4521122|NCT00993421|7334944|FG006|Overall Study|Withdrawal by Subject|3
4521123|NCT00993421|7334938|FG000|Overall Study|Death|0
4521124|NCT00993421|7334939|FG001|Overall Study|Death|0
4521125|NCT00993421|7334940|FG002|Overall Study|Death|0
4521126|NCT00993421|7334941|FG003|Overall Study|Death|0
4521127|NCT00993421|7334942|FG004|Overall Study|Death|0
4521128|NCT00993421|7334943|FG005|Overall Study|Death|0
4521129|NCT00993421|7334944|FG006|Overall Study|Death|1
4521130|NCT00993421|7334938|FG000|Overall Study|Entry Criteria Exclusion|0
4521131|NCT00993421|7334939|FG001|Overall Study|Entry Criteria Exclusion|0
4521132|NCT00993421|7334940|FG002|Overall Study|Entry Criteria Exclusion|1
4521133|NCT00993421|7334941|FG003|Overall Study|Entry Criteria Exclusion|3
4521134|NCT00993421|7334942|FG004|Overall Study|Entry Criteria Exclusion|0
4521135|NCT00993421|7334943|FG005|Overall Study|Entry Criteria Exclusion|1
4521136|NCT00993421|7334944|FG006|Overall Study|Entry Criteria Exclusion|0
4521137|NCT00993421|7334938|FG000|Overall Study|Physician Decision|0
4521138|NCT00993421|7334939|FG001|Overall Study|Physician Decision|0
4521139|NCT00993421|7334940|FG002|Overall Study|Physician Decision|0
4521140|NCT00993421|7334941|FG003|Overall Study|Physician Decision|0
4521141|NCT00993421|7334942|FG004|Overall Study|Physician Decision|0
4521142|NCT00993421|7334943|FG005|Overall Study|Physician Decision|1
4521143|NCT00993421|7334944|FG006|Overall Study|Physician Decision|1
4521144|NCT00993421|7334938|FG000|Overall Study|Protocol Violation|0
4521145|NCT00993421|7334939|FG001|Overall Study|Protocol Violation|0
4521146|NCT00993421|7334940|FG002|Overall Study|Protocol Violation|0
4521147|NCT00993421|7334941|FG003|Overall Study|Protocol Violation|0
4521148|NCT00993421|7334942|FG004|Overall Study|Protocol Violation|0
4521149|NCT00993421|7334943|FG005|Overall Study|Protocol Violation|2
4521150|NCT00993421|7334944|FG006|Overall Study|Protocol Violation|1
4521151|NCT00993473|7334962|FG000|Overall Study|Adverse Event|0
4521152|NCT00993473|7334963|FG001|Overall Study|Adverse Event|2
4521153|NCT00993473|7334962|FG000|Overall Study|Protocol Violation|1
4521154|NCT00993473|7334963|FG001|Overall Study|Protocol Violation|2
4521155|NCT00993473|7334962|FG000|Overall Study|Lost to Follow-up|1
4521156|NCT00993473|7334963|FG001|Overall Study|Lost to Follow-up|0
4521157|NCT00993473|7334962|FG000|Overall Study|Withdrawal by Subject|1
4521158|NCT00993473|7334963|FG001|Overall Study|Withdrawal by Subject|5
4521159|NCT00993473|7334962|FG000|Overall Study|Technical problem with CGM device|0
4521160|NCT00993473|7334963|FG001|Overall Study|Technical problem with CGM device|1
4521161|NCT00993473|7334962|FG000|Overall Study|Family event|1
4521162|NCT00993473|7334963|FG001|Overall Study|Family event|0
4521163|NCT00993499|7334975|FG000|Run-in Period (8 Days)|Adverse Event|0
4521164|NCT00993499|7334976|FG001|Run-in Period (8 Days)|Adverse Event|1
4521165|NCT00993499|7334977|FG002|Run-in Period (8 Days)|Adverse Event|0
4521166|NCT00993499|7334978|FG003|Run-in Period (8 Days)|Adverse Event|0
4521167|NCT00993499|7334979|FG004|Run-in Period (8 Days)|Adverse Event|0
4521168|NCT00993499|7334980|FG005|Run-in Period (8 Days)|Adverse Event|0
4521169|NCT00993499|7334975|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1
4521170|NCT00993499|7334976|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
4521171|NCT00993499|7334977|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
4521172|NCT00993499|7334978|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
4521173|NCT00993499|7334979|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
4521174|NCT00993499|7334980|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
4521175|NCT00993499|7334975|FG000|Run-in Period (8 Days)|Consent withdrawn|0
4521176|NCT00993499|7334976|FG001|Run-in Period (8 Days)|Consent withdrawn|1
4521177|NCT00993499|7334977|FG002|Run-in Period (8 Days)|Consent withdrawn|0
4521178|NCT00993499|7334978|FG003|Run-in Period (8 Days)|Consent withdrawn|0
4521179|NCT00993499|7334979|FG004|Run-in Period (8 Days)|Consent withdrawn|0
4521180|NCT00993499|7334980|FG005|Run-in Period (8 Days)|Consent withdrawn|0
4521181|NCT00993499|7334975|FG000|Run-in Period (8 Days)|Progressive disease|0
4521182|NCT00993499|7334976|FG001|Run-in Period (8 Days)|Progressive disease|1
4521183|NCT00993499|7334977|FG002|Run-in Period (8 Days)|Progressive disease|1
4521184|NCT00993499|7334978|FG003|Run-in Period (8 Days)|Progressive disease|0
4521185|NCT00993499|7334979|FG004|Run-in Period (8 Days)|Progressive disease|0
4521186|NCT00993499|7334980|FG005|Run-in Period (8 Days)|Progressive disease|0
4521187|NCT00993499|7334975|FG000|Discontinued Before Starting Course 3|Progressive Disease|2
4521188|NCT00993499|7334976|FG001|Discontinued Before Starting Course 3|Progressive Disease|2
4521189|NCT00993499|7334977|FG002|Discontinued Before Starting Course 3|Progressive Disease|0
4521190|NCT00993499|7334978|FG003|Discontinued Before Starting Course 3|Progressive Disease|0
4521191|NCT00993499|7334979|FG004|Discontinued Before Starting Course 3|Progressive Disease|0
4521192|NCT00993499|7334980|FG005|Discontinued Before Starting Course 3|Progressive Disease|0
4521193|NCT00993499|7334975|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2
4521194|NCT00993499|7334976|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2
4521195|NCT00993499|7334977|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0
4521196|NCT00993499|7334978|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0
4521197|NCT00993499|7334979|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0
4633454|NCT01912339|7503638|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1
4633455|NCT01912339|7503639|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0
4521198|NCT00993499|7334980|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0
4633456|NCT01912339|7503640|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0
4633457|NCT01912339|7503638|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5
4633458|NCT01912339|7503639|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0
4633459|NCT01912339|7503640|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0
4633460|NCT01912339|7503638|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5
4633461|NCT01912339|7503639|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0
4633462|NCT01912339|7503640|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0
4521199|NCT00993499|7334975|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
4521200|NCT00993499|7334976|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
4521201|NCT00993499|7334977|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1
4521202|NCT00993499|7334978|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1
4521203|NCT00993499|7334979|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
4521204|NCT00993499|7334980|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
4521205|NCT00993499|7334975|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0
4521206|NCT00993499|7334976|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0
4521207|NCT00993499|7334977|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2
4521208|NCT00993499|7334978|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0
4521209|NCT00993499|7334979|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0
4521210|NCT00993499|7334980|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0
4521211|NCT00993499|7334975|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0
4521212|NCT00993499|7334976|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1
4521213|NCT00993499|7334977|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0
4521214|NCT00993499|7334978|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0
4521215|NCT00993499|7334979|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0
4521216|NCT00993499|7334980|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0
4521217|NCT00993499|7334975|FG000|Discontinued After Starting Course 3|Progressive Disease|6
4521218|NCT00993499|7334976|FG001|Discontinued After Starting Course 3|Progressive Disease|4
4521219|NCT00993499|7334977|FG002|Discontinued After Starting Course 3|Progressive Disease|3
4521220|NCT00993499|7334978|FG003|Discontinued After Starting Course 3|Progressive Disease|1
4521221|NCT00993499|7334979|FG004|Discontinued After Starting Course 3|Progressive Disease|3
4521222|NCT00993499|7334980|FG005|Discontinued After Starting Course 3|Progressive Disease|3
4521223|NCT00993499|7334975|FG000|Discontinued After Starting Course 3|DLT|1
4521224|NCT00993499|7334976|FG001|Discontinued After Starting Course 3|DLT|0
4521225|NCT00993499|7334977|FG002|Discontinued After Starting Course 3|DLT|2
4521226|NCT00993499|7334978|FG003|Discontinued After Starting Course 3|DLT|1
4521227|NCT00993499|7334979|FG004|Discontinued After Starting Course 3|DLT|0
4521228|NCT00993499|7334980|FG005|Discontinued After Starting Course 3|DLT|0
4521229|NCT00993499|7334975|FG000|Discontinued After Starting Course 3|Other adverse event|1
4521230|NCT00993499|7334976|FG001|Discontinued After Starting Course 3|Other adverse event|0
4521231|NCT00993499|7334977|FG002|Discontinued After Starting Course 3|Other adverse event|1
4521232|NCT00993499|7334978|FG003|Discontinued After Starting Course 3|Other adverse event|0
4633463|NCT01912339|7503638|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1
4521233|NCT00993499|7334979|FG004|Discontinued After Starting Course 3|Other adverse event|0
4521234|NCT00993499|7334980|FG005|Discontinued After Starting Course 3|Other adverse event|0
4521235|NCT00993616|7334994|FG000|Overall Study|No tumor at entry|1
4521236|NCT00993616|7334994|FG000|Overall Study|Never treated|1
4521237|NCT00993668|7335022|FG000|Single-Blind Period|Adverse Event|1
4521238|NCT00993668|7335023|FG001|Single-Blind Period|Adverse Event|1
4521239|NCT00993668|7335022|FG000|Single-Blind Period|Lack of Efficacy|0
4521240|NCT00993668|7335023|FG001|Single-Blind Period|Lack of Efficacy|1
4521241|NCT00993668|7335022|FG000|Single-Blind Period|Lost to Follow-up|3
4521242|NCT00993668|7335023|FG001|Single-Blind Period|Lost to Follow-up|1
4633464|NCT01912339|7503639|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0
4633465|NCT01912339|7503640|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3
4521243|NCT00993668|7335022|FG000|Open-Label Period|Adverse Event|9
4521244|NCT00993668|7335023|FG001|Open-Label Period|Adverse Event|8
4521245|NCT00993668|7335022|FG000|Open-Label Period|Lack of Efficacy|4
4521246|NCT00993668|7335023|FG001|Open-Label Period|Lack of Efficacy|3
4521247|NCT00993668|7335022|FG000|Open-Label Period|Withdrawal by Subject|4
4521248|NCT00993668|7335023|FG001|Open-Label Period|Withdrawal by Subject|3
4521249|NCT00993668|7335022|FG000|Open-Label Period|Lost to Follow-up|6
4521250|NCT00993668|7335023|FG001|Open-Label Period|Lost to Follow-up|1
4521251|NCT00993915|7335056|FG000|Overall Study|Insufficient clinical response|3
4521252|NCT00993915|7335056|FG000|Overall Study|Withdrawal by Subject|2
4521253|NCT00993915|7335056|FG000|Overall Study|Other|1
4521254|NCT00993915|7335056|FG000|Overall Study|Ongoing|3
4521255|NCT00993928|7335062|FG000|Overall Study|Withdrawal by Subject|4
4521256|NCT00993928|7335063|FG001|Overall Study|Withdrawal by Subject|7
4521257|NCT00993928|7335062|FG000|Overall Study|ineligible|1
4521258|NCT00993928|7335063|FG001|Overall Study|ineligible|0
4521259|NCT00993954|7335075|FG000|Overall Study|Protocol Violation|21
4521260|NCT00993954|7335076|FG001|Overall Study|Protocol Violation|2
4521261|NCT00993967|7335082|FG000|Overall Study|Adverse Event|8
4521262|NCT00993967|7335082|FG000|Overall Study|Death|1
4521263|NCT00993967|7335082|FG000|Overall Study|Lost to Follow-up|14
4521264|NCT00993967|7335082|FG000|Overall Study|Withdrawal by Subject|36
4521265|NCT00993967|7335082|FG000|Overall Study|Protocol Violation|2
4521266|NCT00994110|7335088|FG000|Overall Study|Withdrawal by Subject|9
4521267|NCT00994110|7335089|FG001|Overall Study|Withdrawal by Subject|9
4521268|NCT00994110|7335088|FG000|Overall Study|Not Treated|4
4521269|NCT00994110|7335089|FG001|Overall Study|Not Treated|8
4521270|NCT00994110|7335088|FG000|Overall Study|Adverse Event|1
4521271|NCT00994110|7335089|FG001|Overall Study|Adverse Event|0
4521272|NCT00994110|7335088|FG000|Overall Study|Patient not resected|41
4521273|NCT00994110|7335089|FG001|Overall Study|Patient not resected|52
4521274|NCT00994110|7335088|FG000|Overall Study|Pt not eligible|10
4521275|NCT00994110|7335089|FG001|Overall Study|Pt not eligible|5
4521276|NCT00994214|7335130|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0
4521277|NCT00994214|7335131|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1
4521278|NCT00994214|7335132|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0
4521279|NCT00994214|7335133|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0
4521280|NCT00994214|7335130|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
4521281|NCT00994214|7335131|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
4521282|NCT00994214|7335132|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
4521283|NCT00994214|7335133|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1
4521284|NCT00994214|7335130|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1
4521285|NCT00994214|7335131|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
4521286|NCT00994214|7335132|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
4521287|NCT00994214|7335133|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
4521288|NCT00994214|7335130|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13
4521289|NCT00994214|7335131|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12
4521290|NCT00994214|7335132|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13
4521291|NCT00994214|7335133|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14
4521292|NCT00994214|7335130|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
4521293|NCT00994214|7335131|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
4521294|NCT00994214|7335132|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
4521295|NCT00994214|7335133|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1
4521296|NCT00994214|7335130|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4
4521297|NCT00994214|7335131|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3
4521298|NCT00994214|7335132|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2
4521299|NCT00994214|7335133|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2
4521300|NCT00994240|7335163|FG000|Overall Study|Lost to Follow-up|3
4521301|NCT00994240|7335164|FG001|Overall Study|Lost to Follow-up|2
4521302|NCT00994240|7335163|FG000|Overall Study|Withdrawal by Subject|1
4521303|NCT00994240|7335164|FG001|Overall Study|Withdrawal by Subject|0
4521304|NCT00994240|7335163|FG000|Overall Study|study termination|2
4521305|NCT00994240|7335164|FG001|Overall Study|study termination|3
4521306|NCT00994279|7335172|FG000|Overall Study|Withdrawal by Subject|2
4521307|NCT00994279|7335173|FG001|Overall Study|Withdrawal by Subject|2
4521308|NCT00994279|7335172|FG000|Overall Study|Toxicity|1
4521309|NCT00994279|7335173|FG001|Overall Study|Toxicity|0
4521310|NCT00994279|7335172|FG000|Overall Study|Multiple reasons|1
4521311|NCT00994279|7335173|FG001|Overall Study|Multiple reasons|3
4521312|NCT00994422|7335194|FG000|Overall Study|Lost to Follow-up|7
4521313|NCT00994422|7335195|FG001|Overall Study|Lost to Follow-up|1
4521314|NCT00994448|7335205|FG000|Overall Study|Adverse Event|1
4521315|NCT00994448|7335206|FG001|Overall Study|Adverse Event|0
4521316|NCT00994448|7335205|FG000|Overall Study|Lost to Follow-up|5
4521317|NCT00994448|7335206|FG001|Overall Study|Lost to Follow-up|1
4521318|NCT00994448|7335205|FG000|Overall Study|Withdrawal by Subject|1
4521319|NCT00994448|7335206|FG001|Overall Study|Withdrawal by Subject|1
4521320|NCT00994448|7335205|FG000|Overall Study|Physician Decision|1
4521321|NCT00994448|7335206|FG001|Overall Study|Physician Decision|0
4521322|NCT00994461|7335215|FG000|Overall Study|Adverse Event|2
4521323|NCT00994461|7335216|FG001|Overall Study|Adverse Event|1
4521324|NCT00994461|7335217|FG002|Overall Study|Adverse Event|0
4521325|NCT00994643|7335232|FG000|Overall Study|Withdrawal by Subject|1
4521326|NCT00994682|7335238|FG000|Double Bilnd|Withdrawal by Subject|5
4521327|NCT00994682|7335239|FG001|Double Bilnd|Withdrawal by Subject|6
4521328|NCT00994682|7335238|FG000|Double Bilnd|Lost to Follow-up|3
4521329|NCT00994682|7335239|FG001|Double Bilnd|Lost to Follow-up|3
4521330|NCT00994682|7335238|FG000|Double Bilnd|Adverse Event|1
4521331|NCT00994682|7335239|FG001|Double Bilnd|Adverse Event|0
4521332|NCT00994682|7335238|FG000|Pioglitazone Open Label|Withdrawal by Subject|4
4521333|NCT00994682|7335239|FG001|Pioglitazone Open Label|Withdrawal by Subject|4
4521334|NCT00994682|7335238|FG000|Pioglitazone Open Label|Lost to Follow-up|3
4521335|NCT00994682|7335239|FG001|Pioglitazone Open Label|Lost to Follow-up|2
4521336|NCT00994682|7335238|FG000|Pioglitazone Open Label|Physician Decision|6
4521337|NCT00994682|7335239|FG001|Pioglitazone Open Label|Physician Decision|1
4521338|NCT00994890|7335270|FG000|Overall Study|Adverse Event|13
4521339|NCT00994890|7335271|FG001|Overall Study|Adverse Event|9
4521340|NCT00994890|7335272|FG002|Overall Study|Adverse Event|11
4521341|NCT00994890|7335270|FG000|Overall Study|Lack of Efficacy|0
4521342|NCT00994890|7335271|FG001|Overall Study|Lack of Efficacy|0
4521343|NCT00994890|7335272|FG002|Overall Study|Lack of Efficacy|1
4521344|NCT00994890|7335270|FG000|Overall Study|Lost to Follow-up|6
4521345|NCT00994890|7335271|FG001|Overall Study|Lost to Follow-up|1
4521346|NCT00994890|7335272|FG002|Overall Study|Lost to Follow-up|3
4521347|NCT00994890|7335270|FG000|Overall Study|No longer willing to participate|8
4521348|NCT00994890|7335271|FG001|Overall Study|No longer willing to participate|5
4521349|NCT00994890|7335272|FG002|Overall Study|No longer willing to participate|13
4521350|NCT00994890|7335270|FG000|Overall Study|Protocol Violation|2
4521351|NCT00994890|7335271|FG001|Overall Study|Protocol Violation|4
4521352|NCT00994890|7335272|FG002|Overall Study|Protocol Violation|0
4521353|NCT00994890|7335270|FG000|Overall Study|Study terminated by sponsor|199
4521354|NCT00994890|7335271|FG001|Overall Study|Study terminated by sponsor|201
4521355|NCT00994890|7335272|FG002|Overall Study|Study terminated by sponsor|197
4521356|NCT00994890|7335270|FG000|Overall Study|Randomized, but not treated|1
4521357|NCT00994890|7335271|FG001|Overall Study|Randomized, but not treated|0
4521358|NCT00994890|7335272|FG002|Overall Study|Randomized, but not treated|0
4521359|NCT00994890|7335270|FG000|Overall Study|Other|2
4521360|NCT00994890|7335271|FG001|Overall Study|Other|2
4521361|NCT00994890|7335272|FG002|Overall Study|Other|1
4521362|NCT00995007|7335287|FG000|Overall Study|Withdrew consent|1
4521363|NCT00995007|7335288|FG001|Overall Study|Withdrew consent|0
4521364|NCT00995007|7335287|FG000|Overall Study|Refused further treatment|8
4521365|NCT00995007|7335288|FG001|Overall Study|Refused further treatment|2
4521366|NCT00995007|7335287|FG000|Overall Study|Toxicity|8
4521367|NCT00995007|7335288|FG001|Overall Study|Toxicity|0
4521368|NCT00995020|7335305|FG000|Overall Study|margin analysis not performed|2
4521369|NCT00995020|7335306|FG001|Overall Study|margin analysis not performed|5
4521370|NCT00995020|7335305|FG000|Overall Study|specimen fragmentation, thermal damage|1
4521371|NCT00995020|7335306|FG001|Overall Study|specimen fragmentation, thermal damage|2
4521372|NCT00995085|7335323|FG000|Overall Study|Withdrawal by Subject|5
4521373|NCT00995345|7335337|FG000|Overall Study|Withdrawal by Subject|4
4521374|NCT00995345|7335338|FG001|Overall Study|Withdrawal by Subject|2
4521375|NCT00995345|7335339|FG002|Overall Study|Withdrawal by Subject|1
4521376|NCT00995345|7335340|FG003|Overall Study|Withdrawal by Subject|3
4521377|NCT00995345|7335341|FG004|Overall Study|Withdrawal by Subject|1
4521378|NCT00995345|7335337|FG000|Overall Study|Adverse Event|3
4521379|NCT00995345|7335338|FG001|Overall Study|Adverse Event|1
4521380|NCT00995345|7335339|FG002|Overall Study|Adverse Event|2
4521381|NCT00995345|7335340|FG003|Overall Study|Adverse Event|0
4521382|NCT00995345|7335341|FG004|Overall Study|Adverse Event|1
4521383|NCT00995345|7335337|FG000|Overall Study|Lost to Follow-up|2
4521384|NCT00995345|7335338|FG001|Overall Study|Lost to Follow-up|2
4521385|NCT00995345|7335339|FG002|Overall Study|Lost to Follow-up|2
4521386|NCT00995345|7335340|FG003|Overall Study|Lost to Follow-up|1
4521387|NCT00995345|7335341|FG004|Overall Study|Lost to Follow-up|0
4521388|NCT00995345|7335337|FG000|Overall Study|all other reasons combined|2
4521389|NCT00995345|7335338|FG001|Overall Study|all other reasons combined|2
4521390|NCT00995345|7335339|FG002|Overall Study|all other reasons combined|2
4521391|NCT00995345|7335340|FG003|Overall Study|all other reasons combined|1
4521392|NCT00995345|7335341|FG004|Overall Study|all other reasons combined|3
4521393|NCT00995371|7335355|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5
4521394|NCT00995371|7335356|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5
4521395|NCT00995410|7335364|FG000|Overall Study|Adverse Event|51
4521396|NCT00995410|7335364|FG000|Overall Study|Withdrawal by Subject|7
4521397|NCT00995410|7335364|FG000|Overall Study|Lost to Follow-up|2
4521398|NCT00995410|7335364|FG000|Overall Study|Misc|28
4521399|NCT00995436|7335371|FG000|Overall Study|Withdrawal by Subject|2
4521400|NCT00995436|7335372|FG001|Overall Study|Withdrawal by Subject|5
4521401|NCT00995436|7335373|FG002|Overall Study|Withdrawal by Subject|0
4521402|NCT00995488|7335403|FG000|Overall Study|Withdrawal by Subject|1
4593994|NCT01557244|7442693|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0
4737755|NCT03622112|7688217|FG002|Overall Study|Death|0
4593995|NCT01557244|7442694|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1
4593996|NCT01557244|7442695|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0
4593997|NCT01557244|7442689|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2
4593998|NCT01557244|7442690|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0
4593999|NCT01557244|7442691|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2
4594000|NCT01557244|7442692|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0
4594001|NCT01557244|7442693|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0
4594002|NCT01557244|7442694|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0
4594003|NCT01557244|7442695|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0
4594004|NCT01557244|7442689|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1
4594005|NCT01557244|7442690|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1
4594006|NCT01557244|7442691|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0
4594007|NCT01557244|7442692|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0
4594008|NCT01557244|7442693|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0
4594009|NCT01557244|7442694|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1
4594010|NCT01557244|7442695|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0
4594011|NCT01557244|7442689|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1
4594012|NCT01557244|7442690|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1
4594013|NCT01557244|7442691|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0
4594014|NCT01557244|7442692|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0
4594015|NCT01557244|7442693|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0
4594016|NCT01557244|7442694|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0
4594017|NCT01557244|7442695|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0
4594018|NCT01557244|7442689|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0
4594019|NCT01557244|7442690|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0
4594020|NCT01557244|7442691|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0
4594021|NCT01557244|7442692|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1
4594022|NCT01557244|7442693|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0
4594023|NCT01557244|7442694|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0
4594024|NCT01557244|7442695|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0
4594025|NCT01557244|7442689|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1
4594026|NCT01557244|7442690|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2
4594027|NCT01557244|7442691|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0
4594028|NCT01557244|7442692|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0
4594029|NCT01557244|7442693|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0
4594030|NCT01557244|7442694|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0
4594031|NCT01557244|7442695|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0
4594032|NCT01557283|7442723|FG000|Overall Study|Lost to Follow-up|7
4594033|NCT01557283|7442723|FG000|Overall Study|Non-responder|19
4594034|NCT01557283|7442723|FG000|Overall Study|Adverse Event|7
4594035|NCT01557283|7442723|FG000|Overall Study|Lack of Efficacy|1
4594036|NCT01557283|7442723|FG000|Overall Study|Non-compliance|1
4594037|NCT01557283|7442723|FG000|Overall Study|Withdrawal by Subject|1
4594038|NCT01557283|7442723|FG000|Overall Study|Participant's weight too high for dose|1
4594039|NCT01557283|7442723|FG000|Overall Study|Worsening of psoriasis|1
4594040|NCT01557283|7442723|FG000|Overall Study|Other|6
4594041|NCT01557348|7442738|FG000|Overall Study|Adverse Event|6
4594042|NCT01557348|7442739|FG001|Overall Study|Adverse Event|16
4594043|NCT01557348|7442738|FG000|Overall Study|Infusion reaction event|5
4594044|NCT01557348|7442739|FG001|Overall Study|Infusion reaction event|5
4594045|NCT01557348|7442738|FG000|Overall Study|Death|7
4594046|NCT01557348|7442739|FG001|Overall Study|Death|4
4594047|NCT01557348|7442738|FG000|Overall Study|Insufficient Therapeutic Response|13
4594048|NCT01557348|7442739|FG001|Overall Study|Insufficient Therapeutic Response|28
4594049|NCT01557348|7442738|FG000|Overall Study|Withdrawal by Subject|5
4594050|NCT01557348|7442739|FG001|Overall Study|Withdrawal by Subject|4
4594051|NCT01557348|7442738|FG000|Overall Study|Lost to Follow-up|26
4594052|NCT01557348|7442739|FG001|Overall Study|Lost to Follow-up|22
4594053|NCT01557348|7442738|FG000|Overall Study|Administrative|18
4737756|NCT03622112|7688218|FG003|Overall Study|Death|1
4737757|NCT03622112|7688219|FG004|Overall Study|Death|0
4521403|NCT00995553|7335442|FG000|Overall Study|Withdrawal by Subject|2
4521404|NCT00995553|7335443|FG001|Overall Study|Withdrawal by Subject|6
4521405|NCT00995566|7335449|FG000|Overall Study|Adverse Event|2
4521406|NCT00995566|7335449|FG000|Overall Study|Early study termination|52
4521407|NCT00995670|7335456|FG000|Overall Study|Failed arterial cannulation|1
4521408|NCT00995670|7335457|FG001|Overall Study|Failed arterial cannulation|0
4521409|NCT00995670|7335458|FG002|Overall Study|Failed arterial cannulation|3
4521410|NCT00995709|7335469|FG000|Overall Study|Adverse Event|4
4521411|NCT00995709|7335470|FG001|Overall Study|Adverse Event|2
4521412|NCT00995709|7335471|FG002|Overall Study|Adverse Event|0
4521413|NCT00995709|7335469|FG000|Overall Study|Lack of Efficacy|0
4521414|NCT00995709|7335470|FG001|Overall Study|Lack of Efficacy|1
4521415|NCT00995709|7335471|FG002|Overall Study|Lack of Efficacy|4
4521416|NCT00995709|7335469|FG000|Overall Study|Withdrawal by Subject|0
4521417|NCT00995709|7335470|FG001|Overall Study|Withdrawal by Subject|4
4521418|NCT00995709|7335471|FG002|Overall Study|Withdrawal by Subject|1
4521419|NCT00995709|7335469|FG000|Overall Study|Lost to Follow-up|1
4521420|NCT00995709|7335470|FG001|Overall Study|Lost to Follow-up|0
4521421|NCT00995709|7335471|FG002|Overall Study|Lost to Follow-up|0
4521422|NCT00995709|7335469|FG000|Overall Study|Death|0
4594054|NCT01557348|7442739|FG001|Overall Study|Administrative|11
4594055|NCT01557400|7442746|FG000|Overall Study|Transitioned to Commercial Drug Product|40
4594056|NCT01557400|7442746|FG000|Overall Study|Adverse Event|3
4594057|NCT01557400|7442746|FG000|Overall Study|Lost to Follow-up|5
4594058|NCT01557400|7442746|FG000|Overall Study|Withdrawal by Subject|9
4594059|NCT01557504|7442757|FG000|Overall Study|Physician Decision|1
4521423|NCT00995709|7335470|FG001|Overall Study|Death|1
4521424|NCT00995709|7335471|FG002|Overall Study|Death|0
4521425|NCT00995709|7335469|FG000|Overall Study|Protocol Violation|2
4521426|NCT00995709|7335470|FG001|Overall Study|Protocol Violation|1
4521427|NCT00995709|7335471|FG002|Overall Study|Protocol Violation|0
4521428|NCT00995774|7335494|FG000|Training Period 2|Withdrawal by Subject|2
4521429|NCT00995774|7335495|FG001|Training Period 2|Withdrawal by Subject|0
4521430|NCT00995865|7335504|FG000|Overall Study|Protocol Violation|2
4521431|NCT00995865|7335505|FG001|Overall Study|Protocol Violation|0
4521432|NCT00995865|7335506|FG002|Overall Study|Protocol Violation|0
4521433|NCT00995865|7335504|FG000|Overall Study|Lost to Follow-up|0
4521434|NCT00995865|7335505|FG001|Overall Study|Lost to Follow-up|0
4521435|NCT00995865|7335506|FG002|Overall Study|Lost to Follow-up|1
4521436|NCT00995930|7335537|FG000|Overall Study|Protocol deviation|2
4521437|NCT00995930|7335538|FG001|Overall Study|Protocol deviation|5
4521438|NCT00995930|7335537|FG000|Overall Study|Death|0
4521439|NCT00995930|7335538|FG001|Overall Study|Death|1
4521440|NCT00995930|7335537|FG000|Overall Study|Administrative problems|4
4521441|NCT00995930|7335538|FG001|Overall Study|Administrative problems|2
4521442|NCT00995930|7335537|FG000|Overall Study|Lost to Follow-up|1
4521443|NCT00995930|7335538|FG001|Overall Study|Lost to Follow-up|2
4521444|NCT00995930|7335537|FG000|Overall Study|Withdrawal by Subject|3
4521445|NCT00995930|7335538|FG001|Overall Study|Withdrawal by Subject|4
4521446|NCT00995930|7335537|FG000|Overall Study|Adverse Event|11
4521447|NCT00995930|7335538|FG001|Overall Study|Adverse Event|14
4521448|NCT00996034|7335545|FG000|Overall Study|Lost to Follow-up|2
4521449|NCT00996034|7335545|FG000|Overall Study|withdrawn by PI|1
4521450|NCT00996125|7335551|FG000|Overall Study|Adverse Event|0
4521451|NCT00996125|7335552|FG001|Overall Study|Adverse Event|2
4521452|NCT00996125|7335551|FG000|Overall Study|Lost to Follow-up|1
4521453|NCT00996125|7335552|FG001|Overall Study|Lost to Follow-up|6
4521454|NCT00996125|7335551|FG000|Overall Study|Withdrawal by Subject|4
4521455|NCT00996125|7335552|FG001|Overall Study|Withdrawal by Subject|3
4521456|NCT00996203|7335567|FG000|Overall Study|Adverse Event|3
4521457|NCT00996203|7335567|FG000|Overall Study|Lost to Follow-up|1
4521458|NCT00996203|7335567|FG000|Overall Study|Lack of Efficacy|1
4521459|NCT00996203|7335567|FG000|Overall Study|Protocol Violation|2
4594060|NCT01557504|7442758|FG001|Overall Study|Physician Decision|0
4594061|NCT01557517|7442772|FG000|Overall Study|Death|1
4594062|NCT01557517|7442773|FG001|Overall Study|Death|0
4594063|NCT01557517|7442772|FG000|Overall Study|Refused further treatment|0
4594064|NCT01557517|7442773|FG001|Overall Study|Refused further treatment|2
4594065|NCT01557517|7442772|FG000|Overall Study|Adverse Event|0
4594066|NCT01557517|7442773|FG001|Overall Study|Adverse Event|2
4594067|NCT01557517|7442772|FG000|Overall Study|Pt declined before treatment started|1
4594068|NCT01557517|7442773|FG001|Overall Study|Pt declined before treatment started|0
4594069|NCT01557569|7442788|FG000|Overall Study|Adverse Event|2
4594070|NCT01557569|7442789|FG001|Overall Study|Adverse Event|0
4594071|NCT01557569|7442788|FG000|Overall Study|high blood pressure|0
4594072|NCT01557569|7442789|FG001|Overall Study|high blood pressure|1
4594073|NCT01557569|7442788|FG000|Overall Study|Withdrawal by Subject|3
4594074|NCT01557569|7442789|FG001|Overall Study|Withdrawal by Subject|5
4594075|NCT01557569|7442788|FG000|Overall Study|noncompliance with rules of residential|0
4594076|NCT01557569|7442789|FG001|Overall Study|noncompliance with rules of residential|1
4594077|NCT01557582|7442795|FG000|Overall Study|Protocol Violation|4
4594078|NCT01557582|7442795|FG000|Overall Study|Operator error|2
4594079|NCT01557842|7442825|FG000|Overall Study|Lost to Follow-up|0
4594080|NCT01557842|7442826|FG001|Overall Study|Lost to Follow-up|1
4594081|NCT01557842|7442825|FG000|Overall Study|Death|1
4594082|NCT01557842|7442826|FG001|Overall Study|Death|0
4521460|NCT00996216|7335572|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1
4521461|NCT00996216|7335572|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3
4521462|NCT00996216|7335572|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1
4521463|NCT00996281|7335579|FG000|Overall Study|Adverse Event|75
4521464|NCT00996281|7335580|FG001|Overall Study|Adverse Event|37
4521465|NCT00996281|7335579|FG000|Overall Study|Major Protocol Deviation|6
4521466|NCT00996281|7335580|FG001|Overall Study|Major Protocol Deviation|7
4521467|NCT00996281|7335579|FG000|Overall Study|Lost to Follow-up|14
4521468|NCT00996281|7335580|FG001|Overall Study|Lost to Follow-up|16
4521469|NCT00996281|7335579|FG000|Overall Study|Withdrawal by Subject|31
4521470|NCT00996281|7335580|FG001|Overall Study|Withdrawal by Subject|20
4521471|NCT00996281|7335579|FG000|Overall Study|Lack of Efficacy|0
4521472|NCT00996281|7335580|FG001|Overall Study|Lack of Efficacy|2
4521473|NCT00996281|7335579|FG000|Overall Study|Other|5
4521474|NCT00996281|7335580|FG001|Overall Study|Other|7
4521475|NCT00996307|7335590|FG000|Overall Study|Adverse Event|0
4521476|NCT00996307|7335591|FG001|Overall Study|Adverse Event|1
4521477|NCT00996307|7335592|FG002|Overall Study|Adverse Event|0
4521478|NCT00996307|7335593|FG003|Overall Study|Adverse Event|0
4521479|NCT00996307|7335590|FG000|Overall Study|Withdrawal by Subject|3
4521480|NCT00996307|7335591|FG001|Overall Study|Withdrawal by Subject|2
4521481|NCT00996307|7335592|FG002|Overall Study|Withdrawal by Subject|5
4521482|NCT00996307|7335593|FG003|Overall Study|Withdrawal by Subject|5
4521483|NCT00996307|7335590|FG000|Overall Study|Lost to Follow-up|13
4521484|NCT00996307|7335591|FG001|Overall Study|Lost to Follow-up|13
4521485|NCT00996307|7335592|FG002|Overall Study|Lost to Follow-up|7
4521486|NCT00996307|7335593|FG003|Overall Study|Lost to Follow-up|15
4521487|NCT00996307|7335590|FG000|Overall Study|Administrative reason|0
4521488|NCT00996307|7335591|FG001|Overall Study|Administrative reason|1
4521489|NCT00996307|7335592|FG002|Overall Study|Administrative reason|0
4521490|NCT00996307|7335593|FG003|Overall Study|Administrative reason|0
4521491|NCT00996307|7335590|FG000|Overall Study|Unable to classify|4
4521492|NCT00996307|7335591|FG001|Overall Study|Unable to classify|0
4521493|NCT00996307|7335592|FG002|Overall Study|Unable to classify|2
4521494|NCT00996307|7335593|FG003|Overall Study|Unable to classify|1
4521495|NCT00996437|7335645|FG000|Overall Study|Death|1
4521496|NCT00996437|7335646|FG001|Overall Study|Death|0
4521497|NCT00996437|7335645|FG000|Overall Study|Dropped|2
4521498|NCT00996437|7335646|FG001|Overall Study|Dropped|2
4521499|NCT00996437|7335645|FG000|Overall Study|Missed|2
4521500|NCT00996437|7335646|FG001|Overall Study|Missed|5
4521501|NCT00996476|7335657|FG000|Overall Study|Withdrawal by Subject|1
4521502|NCT00996476|7335658|FG001|Overall Study|Withdrawal by Subject|2
4521503|NCT00996476|7335659|FG002|Overall Study|Withdrawal by Subject|1
4521504|NCT00996476|7335660|FG003|Overall Study|Withdrawal by Subject|0
4521505|NCT00996476|7335661|FG004|Overall Study|Withdrawal by Subject|1
4521506|NCT00996476|7335657|FG000|Overall Study|Adverse Event|0
4521507|NCT00996476|7335658|FG001|Overall Study|Adverse Event|1
4521508|NCT00996476|7335659|FG002|Overall Study|Adverse Event|0
4521509|NCT00996476|7335660|FG003|Overall Study|Adverse Event|0
4521510|NCT00996476|7335661|FG004|Overall Study|Adverse Event|1
4521511|NCT00996489|7335678|FG000|Overall Study|Device failure|45
4521512|NCT00996489|7335678|FG000|Overall Study|Discontinued|116
4737758|NCT03622112|7688220|FG005|Overall Study|Death|0
4737759|NCT03622112|7688221|FG006|Overall Study|Death|0
4737760|NCT03622112|7688215|FG000|Overall Study|Lost to Follow-up|1
4737761|NCT03622112|7688216|FG001|Overall Study|Lost to Follow-up|1
4737762|NCT03622112|7688217|FG002|Overall Study|Lost to Follow-up|0
4521513|NCT00996580|7335682|FG000|Overall Study|Adverse Event|466
4521514|NCT00996580|7335682|FG000|Overall Study|Lost to Follow-up|480
4521515|NCT00996580|7335682|FG000|Overall Study|Noncompliance with the protocol|137
4521516|NCT00996580|7335682|FG000|Overall Study|Physician Decision|5
4521517|NCT00996580|7335682|FG000|Overall Study|Pregnancy|68
4521518|NCT00996580|7335682|FG000|Overall Study|Protocol Violation|16
4521519|NCT00996580|7335682|FG000|Overall Study|Sponsor requested participant withdrawal|35
4737763|NCT03622112|7688218|FG003|Overall Study|Lost to Follow-up|0
4521520|NCT00996580|7335682|FG000|Overall Study|Withdrawal by Subject|217
4737764|NCT03622112|7688219|FG004|Overall Study|Lost to Follow-up|0
4737765|NCT03622112|7688220|FG005|Overall Study|Lost to Follow-up|0
4737766|NCT03622112|7688221|FG006|Overall Study|Lost to Follow-up|0
4737767|NCT03622112|7688215|FG000|Overall Study|Study-specific withdrawal criteria|10
4737768|NCT03622112|7688216|FG001|Overall Study|Study-specific withdrawal criteria|8
4737769|NCT03622112|7688217|FG002|Overall Study|Study-specific withdrawal criteria|7
4521521|NCT00996580|7335682|FG000|Overall Study|Other|29
4521522|NCT00996593|7335689|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7
4521523|NCT00996593|7335689|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3
4521524|NCT00996593|7335689|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22
4521525|NCT00996593|7335689|FG000|Dosimetric and Therapeutic Treatment|Death|1
4521526|NCT00996593|7335689|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6
4521527|NCT00996593|7335689|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3
4521528|NCT00996593|7335689|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1
4521529|NCT00996593|7335689|FG000|Long-Term Follow-Up|Withdrawal by Subject|2
4521530|NCT00996593|7335689|FG000|Long-Term Follow-Up|Site Closed|1
4521531|NCT00996606|7335693|FG000|Overall Study|Adverse Event or Intercurrent Illness|2
4521532|NCT00996606|7335693|FG000|Overall Study|Insufficient Therapeutic Response|2
4521533|NCT00996606|7335693|FG000|Overall Study|Protocol Violation|1
4521534|NCT00996606|7335693|FG000|Overall Study|Withdrawal by Subject|3
4521535|NCT00996632|7335699|FG000|Overall Study|Physician Decision|0
4521536|NCT00996632|7335700|FG001|Overall Study|Physician Decision|0
4521537|NCT00996658|7335708|FG000|Overall Study|Adverse Event|2
4521538|NCT00996658|7335709|FG001|Overall Study|Adverse Event|5
4521539|NCT00996658|7335708|FG000|Overall Study|Protocol Violation|0
4521540|NCT00996658|7335709|FG001|Overall Study|Protocol Violation|1
4521541|NCT00996658|7335708|FG000|Overall Study|Lost to Follow-up|2
4521542|NCT00996658|7335709|FG001|Overall Study|Lost to Follow-up|5
4521543|NCT00996658|7335708|FG000|Overall Study|Non-compliance issues|3
4521544|NCT00996658|7335709|FG001|Overall Study|Non-compliance issues|3
4521545|NCT00996658|7335708|FG000|Overall Study|Other|9
4521546|NCT00996658|7335709|FG001|Overall Study|Other|7
4521547|NCT00996736|7335717|FG000|Overall Study|Death|1
4521548|NCT00996736|7335718|FG001|Overall Study|Death|1
4521549|NCT00996736|7335717|FG000|Overall Study|Lost to Follow-up|15
4521550|NCT00996736|7335718|FG001|Overall Study|Lost to Follow-up|14
4521551|NCT00996736|7335717|FG000|Overall Study|Visit not within 3-month window|5
4521552|NCT00996736|7335718|FG001|Overall Study|Visit not within 3-month window|3
4521553|NCT00996801|7335739|FG000|Overall Study|Adverse Event|6
4521554|NCT00996801|7335740|FG001|Overall Study|Adverse Event|4
4521555|NCT00996801|7335741|FG002|Overall Study|Adverse Event|12
4521556|NCT00996801|7335742|FG003|Overall Study|Adverse Event|17
4521557|NCT00996801|7335743|FG004|Overall Study|Adverse Event|31
4521558|NCT00996801|7335744|FG005|Overall Study|Adverse Event|3
4521559|NCT00996801|7335739|FG000|Overall Study|Lack of Efficacy|3
4521560|NCT00996801|7335740|FG001|Overall Study|Lack of Efficacy|0
4521561|NCT00996801|7335741|FG002|Overall Study|Lack of Efficacy|1
4521562|NCT00996801|7335742|FG003|Overall Study|Lack of Efficacy|3
4521563|NCT00996801|7335743|FG004|Overall Study|Lack of Efficacy|0
4521564|NCT00996801|7335744|FG005|Overall Study|Lack of Efficacy|1
4521565|NCT00996801|7335739|FG000|Overall Study|Lost to Follow-up|0
4521566|NCT00996801|7335740|FG001|Overall Study|Lost to Follow-up|0
4521567|NCT00996801|7335741|FG002|Overall Study|Lost to Follow-up|0
4521568|NCT00996801|7335742|FG003|Overall Study|Lost to Follow-up|3
4521569|NCT00996801|7335743|FG004|Overall Study|Lost to Follow-up|3
4521570|NCT00996801|7335744|FG005|Overall Study|Lost to Follow-up|2
4521571|NCT00996801|7335739|FG000|Overall Study|Physician Decision|0
4521572|NCT00996801|7335740|FG001|Overall Study|Physician Decision|0
4521573|NCT00996801|7335741|FG002|Overall Study|Physician Decision|0
4521574|NCT00996801|7335742|FG003|Overall Study|Physician Decision|1
4521575|NCT00996801|7335743|FG004|Overall Study|Physician Decision|0
4521576|NCT00996801|7335744|FG005|Overall Study|Physician Decision|0
4521577|NCT00996801|7335739|FG000|Overall Study|Progressive Disease|0
4521578|NCT00996801|7335740|FG001|Overall Study|Progressive Disease|1
4521579|NCT00996801|7335741|FG002|Overall Study|Progressive Disease|0
4521580|NCT00996801|7335742|FG003|Overall Study|Progressive Disease|0
4521581|NCT00996801|7335743|FG004|Overall Study|Progressive Disease|0
4521582|NCT00996801|7335744|FG005|Overall Study|Progressive Disease|0
4521583|NCT00996801|7335739|FG000|Overall Study|Protocol Violation|3
4521584|NCT00996801|7335740|FG001|Overall Study|Protocol Violation|4
4521585|NCT00996801|7335741|FG002|Overall Study|Protocol Violation|1
4521586|NCT00996801|7335742|FG003|Overall Study|Protocol Violation|2
4521587|NCT00996801|7335743|FG004|Overall Study|Protocol Violation|3
4521588|NCT00996801|7335744|FG005|Overall Study|Protocol Violation|4
4521589|NCT00996801|7335739|FG000|Overall Study|Study Terminated by Sponsor|0
4521590|NCT00996801|7335740|FG001|Overall Study|Study Terminated by Sponsor|1
4521591|NCT00996801|7335741|FG002|Overall Study|Study Terminated by Sponsor|0
4521592|NCT00996801|7335742|FG003|Overall Study|Study Terminated by Sponsor|0
4521593|NCT00996801|7335743|FG004|Overall Study|Study Terminated by Sponsor|46
4521594|NCT00996801|7335744|FG005|Overall Study|Study Terminated by Sponsor|0
4521595|NCT00996801|7335739|FG000|Overall Study|Withdrawal by Subject|8
4521596|NCT00996801|7335740|FG001|Overall Study|Withdrawal by Subject|6
4521597|NCT00996801|7335741|FG002|Overall Study|Withdrawal by Subject|9
4521598|NCT00996801|7335742|FG003|Overall Study|Withdrawal by Subject|5
4521599|NCT00996801|7335743|FG004|Overall Study|Withdrawal by Subject|5
4521600|NCT00996801|7335744|FG005|Overall Study|Withdrawal by Subject|9
4521601|NCT00996840|7335765|FG000|Overall Study|Adverse Event|0
4521602|NCT00996840|7335766|FG001|Overall Study|Adverse Event|1
4521603|NCT00996840|7335767|FG002|Overall Study|Adverse Event|0
4521604|NCT00996840|7335768|FG003|Overall Study|Adverse Event|0
4521605|NCT00996840|7335769|FG004|Overall Study|Adverse Event|0
4521606|NCT00996840|7335765|FG000|Overall Study|Physician Decision|0
4521607|NCT00996840|7335766|FG001|Overall Study|Physician Decision|0
4521608|NCT00996840|7335767|FG002|Overall Study|Physician Decision|1
4521609|NCT00996840|7335768|FG003|Overall Study|Physician Decision|1
4521610|NCT00996840|7335769|FG004|Overall Study|Physician Decision|2
4521611|NCT00996840|7335765|FG000|Overall Study|Withdrawal by Subject|1
4521612|NCT00996840|7335766|FG001|Overall Study|Withdrawal by Subject|1
4521613|NCT00996840|7335767|FG002|Overall Study|Withdrawal by Subject|0
4521614|NCT00996840|7335768|FG003|Overall Study|Withdrawal by Subject|0
4521615|NCT00996840|7335769|FG004|Overall Study|Withdrawal by Subject|0
4521616|NCT00996892|7335785|FG000|Dose-Escalation Stage 1|Adverse Event|0
4521617|NCT00996892|7335786|FG001|Dose-Escalation Stage 1|Adverse Event|0
4521618|NCT00996892|7335787|FG002|Dose-Escalation Stage 1|Adverse Event|0
4521619|NCT00996892|7335788|FG003|Dose-Escalation Stage 1|Adverse Event|2
4521620|NCT00996892|7335789|FG004|Dose-Escalation Stage 1|Adverse Event|0
4521621|NCT00996892|7335790|FG005|Dose-Escalation Stage 1|Adverse Event|0
4521622|NCT00996892|7335791|FG006|Dose-Escalation Stage 1|Adverse Event|1
4521623|NCT00996892|7335792|FG007|Dose-Escalation Stage 1|Adverse Event|0
4521624|NCT00996892|7335793|FG008|Dose-Escalation Stage 1|Adverse Event|0
4521625|NCT00996892|7335794|FG009|Dose-Escalation Stage 1|Adverse Event|0
4521626|NCT00996892|7335795|FG010|Dose-Escalation Stage 1|Adverse Event|0
4521627|NCT00996892|7335796|FG011|Dose-Escalation Stage 1|Adverse Event|0
4521628|NCT00996892|7335797|FG012|Dose-Escalation Stage 1|Adverse Event|0
4521629|NCT00996892|7335798|FG013|Dose-Escalation Stage 1|Adverse Event|0
4521630|NCT00996892|7335799|FG014|Dose-Escalation Stage 1|Adverse Event|0
4521631|NCT00996892|7335800|FG015|Dose-Escalation Stage 1|Adverse Event|0
4521632|NCT00996892|7335801|FG016|Dose-Escalation Stage 1|Adverse Event|0
4521633|NCT00996892|7335802|FG017|Dose-Escalation Stage 1|Adverse Event|0
4521634|NCT00996892|7335803|FG018|Dose-Escalation Stage 1|Adverse Event|0
4521635|NCT00996892|7335804|FG019|Dose-Escalation Stage 1|Adverse Event|0
4521636|NCT00996892|7335785|FG000|Dose-Escalation Stage 1|Death|1
4521637|NCT00996892|7335786|FG001|Dose-Escalation Stage 1|Death|0
4521638|NCT00996892|7335787|FG002|Dose-Escalation Stage 1|Death|0
4521639|NCT00996892|7335788|FG003|Dose-Escalation Stage 1|Death|0
4521640|NCT00996892|7335789|FG004|Dose-Escalation Stage 1|Death|0
4521641|NCT00996892|7335790|FG005|Dose-Escalation Stage 1|Death|1
4737770|NCT03622112|7688218|FG003|Overall Study|Study-specific withdrawal criteria|6
4737771|NCT03622112|7688219|FG004|Overall Study|Study-specific withdrawal criteria|4
4737772|NCT03622112|7688220|FG005|Overall Study|Study-specific withdrawal criteria|18
4737773|NCT03622112|7688221|FG006|Overall Study|Study-specific withdrawal criteria|4
4521642|NCT00996892|7335791|FG006|Dose-Escalation Stage 1|Death|0
4521643|NCT00996892|7335792|FG007|Dose-Escalation Stage 1|Death|0
4521644|NCT00996892|7335793|FG008|Dose-Escalation Stage 1|Death|0
4521645|NCT00996892|7335794|FG009|Dose-Escalation Stage 1|Death|0
4521646|NCT00996892|7335795|FG010|Dose-Escalation Stage 1|Death|0
4521647|NCT00996892|7335796|FG011|Dose-Escalation Stage 1|Death|0
4521648|NCT00996892|7335797|FG012|Dose-Escalation Stage 1|Death|0
4521649|NCT00996892|7335798|FG013|Dose-Escalation Stage 1|Death|0
4521650|NCT00996892|7335799|FG014|Dose-Escalation Stage 1|Death|0
4521651|NCT00996892|7335800|FG015|Dose-Escalation Stage 1|Death|0
4521652|NCT00996892|7335801|FG016|Dose-Escalation Stage 1|Death|0
4521653|NCT00996892|7335802|FG017|Dose-Escalation Stage 1|Death|0
4521654|NCT00996892|7335803|FG018|Dose-Escalation Stage 1|Death|0
4521655|NCT00996892|7335804|FG019|Dose-Escalation Stage 1|Death|0
4521656|NCT00996892|7335785|FG000|Dose-Escalation Stage 1|Physician Decision|1
4521657|NCT00996892|7335786|FG001|Dose-Escalation Stage 1|Physician Decision|0
4521658|NCT00996892|7335787|FG002|Dose-Escalation Stage 1|Physician Decision|0
4521659|NCT00996892|7335788|FG003|Dose-Escalation Stage 1|Physician Decision|1
4633466|NCT01912339|7503638|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1
4633467|NCT01912339|7503639|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0
4633468|NCT01912339|7503640|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0
4737774|NCT03622112|7688215|FG000|Overall Study|Protocol Violation|2
4521660|NCT00996892|7335789|FG004|Dose-Escalation Stage 1|Physician Decision|0
4521661|NCT00996892|7335790|FG005|Dose-Escalation Stage 1|Physician Decision|1
4521662|NCT00996892|7335791|FG006|Dose-Escalation Stage 1|Physician Decision|2
4521663|NCT00996892|7335792|FG007|Dose-Escalation Stage 1|Physician Decision|0
4737775|NCT03622112|7688216|FG001|Overall Study|Protocol Violation|0
4737776|NCT03622112|7688217|FG002|Overall Study|Protocol Violation|1
4737777|NCT03622112|7688218|FG003|Overall Study|Protocol Violation|1
4737778|NCT03622112|7688219|FG004|Overall Study|Protocol Violation|0
4737779|NCT03622112|7688220|FG005|Overall Study|Protocol Violation|0
4737780|NCT03622112|7688221|FG006|Overall Study|Protocol Violation|0
4737781|NCT03622112|7688215|FG000|Overall Study|Adverse Event|6
4737782|NCT03622112|7688216|FG001|Overall Study|Adverse Event|8
4737783|NCT03622112|7688217|FG002|Overall Study|Adverse Event|4
4737784|NCT03622112|7688218|FG003|Overall Study|Adverse Event|11
4737785|NCT03622112|7688219|FG004|Overall Study|Adverse Event|4
4737786|NCT03622112|7688220|FG005|Overall Study|Adverse Event|20
4737787|NCT03622112|7688221|FG006|Overall Study|Adverse Event|2
4521664|NCT00996892|7335793|FG008|Dose-Escalation Stage 1|Physician Decision|0
4737788|NCT03622112|7688215|FG000|Overall Study|Reason not specified|0
4521665|NCT00996892|7335794|FG009|Dose-Escalation Stage 1|Physician Decision|0
4521666|NCT00996892|7335795|FG010|Dose-Escalation Stage 1|Physician Decision|0
4521667|NCT00996892|7335796|FG011|Dose-Escalation Stage 1|Physician Decision|0
4521668|NCT00996892|7335797|FG012|Dose-Escalation Stage 1|Physician Decision|0
4521669|NCT00996892|7335798|FG013|Dose-Escalation Stage 1|Physician Decision|0
4521670|NCT00996892|7335799|FG014|Dose-Escalation Stage 1|Physician Decision|0
4521671|NCT00996892|7335800|FG015|Dose-Escalation Stage 1|Physician Decision|0
4521672|NCT00996892|7335801|FG016|Dose-Escalation Stage 1|Physician Decision|0
4521673|NCT00996892|7335802|FG017|Dose-Escalation Stage 1|Physician Decision|0
4521674|NCT00996892|7335803|FG018|Dose-Escalation Stage 1|Physician Decision|0
4521675|NCT00996892|7335804|FG019|Dose-Escalation Stage 1|Physician Decision|0
4521676|NCT00996892|7335785|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0
4521677|NCT00996892|7335786|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1
4521678|NCT00996892|7335787|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0
4521679|NCT00996892|7335788|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2
4521680|NCT00996892|7335789|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1
4521681|NCT00996892|7335790|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1
4521682|NCT00996892|7335791|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1
4521683|NCT00996892|7335792|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0
4521684|NCT00996892|7335793|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0
4521685|NCT00996892|7335794|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0
4633469|NCT01912339|7503638|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1
4633470|NCT01912339|7503639|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0
4633471|NCT01912339|7503640|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0
4633472|NCT01912339|7503638|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0
4633473|NCT01912339|7503639|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0
4633474|NCT01912339|7503640|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1
4633475|NCT01912339|7503638|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0
4633476|NCT01912339|7503639|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0
4633477|NCT01912339|7503640|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1
4633478|NCT01912339|7503638|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0
4633479|NCT01912339|7503639|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0
4633480|NCT01912339|7503640|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1
4633481|NCT01912339|7503638|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0
4633482|NCT01912339|7503639|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0
4633483|NCT01912339|7503640|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1
4633484|NCT01912339|7503638|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120
4633485|NCT01912339|7503639|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0
4633486|NCT01912339|7503640|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46
4633487|NCT01912456|7503652|FG000|Period 1|Physician Decision|0
4633488|NCT01912456|7503653|FG001|Period 1|Physician Decision|0
4633489|NCT01912456|7503654|FG002|Period 1|Physician Decision|1
4633490|NCT01912456|7503655|FG003|Period 1|Physician Decision|0
4633491|NCT01912456|7503652|FG000|Period 1|non-compliance|1
4633492|NCT01912456|7503653|FG001|Period 1|non-compliance|0
4633493|NCT01912456|7503654|FG002|Period 1|non-compliance|0
4633494|NCT01912456|7503655|FG003|Period 1|non-compliance|1
4633495|NCT01912456|7503652|FG000|Period 1|Adverse Event|1
4633496|NCT01912456|7503653|FG001|Period 1|Adverse Event|0
4633497|NCT01912456|7503654|FG002|Period 1|Adverse Event|0
4633498|NCT01912456|7503655|FG003|Period 1|Adverse Event|1
4633499|NCT01912456|7503652|FG000|Period 1|Withdrawal by Subject|0
4633500|NCT01912456|7503653|FG001|Period 1|Withdrawal by Subject|1
4633501|NCT01912456|7503654|FG002|Period 1|Withdrawal by Subject|1
4633502|NCT01912456|7503655|FG003|Period 1|Withdrawal by Subject|1
4633503|NCT01912456|7503652|FG000|Period 2|Lack of Efficacy|0
4633504|NCT01912456|7503653|FG001|Period 2|Lack of Efficacy|2
4521686|NCT00996892|7335795|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0
4521687|NCT00996892|7335796|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0
4521688|NCT00996892|7335797|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0
4521689|NCT00996892|7335798|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0
4521690|NCT00996892|7335799|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0
4521691|NCT00996892|7335800|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0
4521692|NCT00996892|7335801|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0
4521693|NCT00996892|7335802|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0
4521694|NCT00996892|7335803|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0
4521695|NCT00996892|7335804|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0
4521696|NCT00996892|7335785|FG000|Dose-Escalation Stage 1|Disease Progression|2
4521697|NCT00996892|7335786|FG001|Dose-Escalation Stage 1|Disease Progression|2
4521698|NCT00996892|7335787|FG002|Dose-Escalation Stage 1|Disease Progression|3
4521699|NCT00996892|7335788|FG003|Dose-Escalation Stage 1|Disease Progression|4
4521700|NCT00996892|7335789|FG004|Dose-Escalation Stage 1|Disease Progression|10
4633505|NCT01912456|7503654|FG002|Period 2|Lack of Efficacy|0
4633506|NCT01912456|7503655|FG003|Period 2|Lack of Efficacy|0
4633507|NCT01912456|7503652|FG000|Period 2|Adverse Event|0
4633508|NCT01912456|7503653|FG001|Period 2|Adverse Event|0
4633509|NCT01912456|7503654|FG002|Period 2|Adverse Event|0
4521701|NCT00996892|7335790|FG005|Dose-Escalation Stage 1|Disease Progression|7
4521702|NCT00996892|7335791|FG006|Dose-Escalation Stage 1|Disease Progression|0
4521703|NCT00996892|7335792|FG007|Dose-Escalation Stage 1|Disease Progression|0
4521704|NCT00996892|7335793|FG008|Dose-Escalation Stage 1|Disease Progression|0
4521705|NCT00996892|7335794|FG009|Dose-Escalation Stage 1|Disease Progression|0
4521706|NCT00996892|7335795|FG010|Dose-Escalation Stage 1|Disease Progression|0
4521707|NCT00996892|7335796|FG011|Dose-Escalation Stage 1|Disease Progression|0
4521708|NCT00996892|7335797|FG012|Dose-Escalation Stage 1|Disease Progression|0
4521709|NCT00996892|7335798|FG013|Dose-Escalation Stage 1|Disease Progression|0
4521710|NCT00996892|7335799|FG014|Dose-Escalation Stage 1|Disease Progression|0
4521711|NCT00996892|7335800|FG015|Dose-Escalation Stage 1|Disease Progression|0
4521712|NCT00996892|7335801|FG016|Dose-Escalation Stage 1|Disease Progression|0
4521713|NCT00996892|7335802|FG017|Dose-Escalation Stage 1|Disease Progression|0
4521714|NCT00996892|7335803|FG018|Dose-Escalation Stage 1|Disease Progression|0
4521715|NCT00996892|7335804|FG019|Dose-Escalation Stage 1|Disease Progression|0
4521716|NCT00996892|7335785|FG000|Dose-Escalation Stage 1A|Adverse Event|0
4521717|NCT00996892|7335786|FG001|Dose-Escalation Stage 1A|Adverse Event|0
4521718|NCT00996892|7335787|FG002|Dose-Escalation Stage 1A|Adverse Event|0
4521719|NCT00996892|7335788|FG003|Dose-Escalation Stage 1A|Adverse Event|0
4521720|NCT00996892|7335789|FG004|Dose-Escalation Stage 1A|Adverse Event|0
4521721|NCT00996892|7335790|FG005|Dose-Escalation Stage 1A|Adverse Event|0
4521722|NCT00996892|7335791|FG006|Dose-Escalation Stage 1A|Adverse Event|0
4521723|NCT00996892|7335792|FG007|Dose-Escalation Stage 1A|Adverse Event|0
4521724|NCT00996892|7335793|FG008|Dose-Escalation Stage 1A|Adverse Event|0
4633510|NCT01912456|7503655|FG003|Period 2|Adverse Event|1
4633511|NCT01912599|7503674|FG000|Overall Study|Withdrawal by Subject|0
4633512|NCT01912599|7503675|FG001|Overall Study|Withdrawal by Subject|1
4633513|NCT01912612|7503683|FG000|Overall Study|Adverse Event|4
4521725|NCT00996892|7335794|FG009|Dose-Escalation Stage 1A|Adverse Event|0
4521726|NCT00996892|7335795|FG010|Dose-Escalation Stage 1A|Adverse Event|1
4521727|NCT00996892|7335796|FG011|Dose-Escalation Stage 1A|Adverse Event|0
4521728|NCT00996892|7335797|FG012|Dose-Escalation Stage 1A|Adverse Event|0
4521729|NCT00996892|7335798|FG013|Dose-Escalation Stage 1A|Adverse Event|1
4521730|NCT00996892|7335799|FG014|Dose-Escalation Stage 1A|Adverse Event|0
4521731|NCT00996892|7335800|FG015|Dose-Escalation Stage 1A|Adverse Event|0
4521732|NCT00996892|7335801|FG016|Dose-Escalation Stage 1A|Adverse Event|0
4521733|NCT00996892|7335802|FG017|Dose-Escalation Stage 1A|Adverse Event|0
4521734|NCT00996892|7335803|FG018|Dose-Escalation Stage 1A|Adverse Event|0
4521735|NCT00996892|7335804|FG019|Dose-Escalation Stage 1A|Adverse Event|0
4521736|NCT00996892|7335785|FG000|Dose-Escalation Stage 1A|Death|0
4521737|NCT00996892|7335786|FG001|Dose-Escalation Stage 1A|Death|0
4521738|NCT00996892|7335787|FG002|Dose-Escalation Stage 1A|Death|0
4521739|NCT00996892|7335788|FG003|Dose-Escalation Stage 1A|Death|0
4521740|NCT00996892|7335789|FG004|Dose-Escalation Stage 1A|Death|0
4521741|NCT00996892|7335790|FG005|Dose-Escalation Stage 1A|Death|0
4521742|NCT00996892|7335791|FG006|Dose-Escalation Stage 1A|Death|0
4521743|NCT00996892|7335792|FG007|Dose-Escalation Stage 1A|Death|0
4521744|NCT00996892|7335793|FG008|Dose-Escalation Stage 1A|Death|0
4521745|NCT00996892|7335794|FG009|Dose-Escalation Stage 1A|Death|2
4521746|NCT00996892|7335795|FG010|Dose-Escalation Stage 1A|Death|0
4521747|NCT00996892|7335796|FG011|Dose-Escalation Stage 1A|Death|1
4521748|NCT00996892|7335797|FG012|Dose-Escalation Stage 1A|Death|1
4521749|NCT00996892|7335798|FG013|Dose-Escalation Stage 1A|Death|0
4521750|NCT00996892|7335799|FG014|Dose-Escalation Stage 1A|Death|0
4521751|NCT00996892|7335800|FG015|Dose-Escalation Stage 1A|Death|0
4521752|NCT00996892|7335801|FG016|Dose-Escalation Stage 1A|Death|0
4521753|NCT00996892|7335802|FG017|Dose-Escalation Stage 1A|Death|0
4521754|NCT00996892|7335803|FG018|Dose-Escalation Stage 1A|Death|0
4521755|NCT00996892|7335804|FG019|Dose-Escalation Stage 1A|Death|0
4521756|NCT00996892|7335785|FG000|Dose-Escalation Stage 1A|Physician Decision|0
4521757|NCT00996892|7335786|FG001|Dose-Escalation Stage 1A|Physician Decision|0
4633514|NCT01912612|7503684|FG001|Overall Study|Adverse Event|0
4633515|NCT01912612|7503685|FG002|Overall Study|Adverse Event|0
4633516|NCT01912612|7503683|FG000|Overall Study|Withdrew consent|1
4633517|NCT01912612|7503684|FG001|Overall Study|Withdrew consent|0
4633518|NCT01912612|7503685|FG002|Overall Study|Withdrew consent|0
4633519|NCT01912612|7503683|FG000|Overall Study|Study design change|0
4633520|NCT01912612|7503684|FG001|Overall Study|Study design change|0
4633521|NCT01912612|7503685|FG002|Overall Study|Study design change|3
4521758|NCT00996892|7335787|FG002|Dose-Escalation Stage 1A|Physician Decision|0
4521759|NCT00996892|7335788|FG003|Dose-Escalation Stage 1A|Physician Decision|0
4521760|NCT00996892|7335789|FG004|Dose-Escalation Stage 1A|Physician Decision|0
4521761|NCT00996892|7335790|FG005|Dose-Escalation Stage 1A|Physician Decision|0
4521762|NCT00996892|7335791|FG006|Dose-Escalation Stage 1A|Physician Decision|0
4521763|NCT00996892|7335792|FG007|Dose-Escalation Stage 1A|Physician Decision|1
4521764|NCT00996892|7335793|FG008|Dose-Escalation Stage 1A|Physician Decision|0
4521765|NCT00996892|7335794|FG009|Dose-Escalation Stage 1A|Physician Decision|0
4521766|NCT00996892|7335795|FG010|Dose-Escalation Stage 1A|Physician Decision|0
4633522|NCT01912729|7503704|FG000|Overall Study|Withdrawal by Subject|0
4633523|NCT01912729|7503705|FG001|Overall Study|Withdrawal by Subject|1
4633524|NCT01912768|7503713|FG000|Overall Study|Adverse Event|2
4521767|NCT00996892|7335796|FG011|Dose-Escalation Stage 1A|Physician Decision|0
4521768|NCT00996892|7335797|FG012|Dose-Escalation Stage 1A|Physician Decision|0
4521769|NCT00996892|7335798|FG013|Dose-Escalation Stage 1A|Physician Decision|0
4521770|NCT00996892|7335799|FG014|Dose-Escalation Stage 1A|Physician Decision|0
4521771|NCT00996892|7335800|FG015|Dose-Escalation Stage 1A|Physician Decision|0
4521772|NCT00996892|7335801|FG016|Dose-Escalation Stage 1A|Physician Decision|0
4521773|NCT00996892|7335802|FG017|Dose-Escalation Stage 1A|Physician Decision|0
4521774|NCT00996892|7335803|FG018|Dose-Escalation Stage 1A|Physician Decision|0
4521775|NCT00996892|7335804|FG019|Dose-Escalation Stage 1A|Physician Decision|0
4521776|NCT00996892|7335785|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0
4521777|NCT00996892|7335786|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0
4521778|NCT00996892|7335787|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0
4521779|NCT00996892|7335788|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0
4521780|NCT00996892|7335789|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0
4521781|NCT00996892|7335790|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0
4521782|NCT00996892|7335791|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0
4521783|NCT00996892|7335792|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0
4521784|NCT00996892|7335793|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0
4521785|NCT00996892|7335794|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1
4521786|NCT00996892|7335795|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1
4521787|NCT00996892|7335796|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1
4521788|NCT00996892|7335797|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1
4521789|NCT00996892|7335798|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0
4594083|NCT01557842|7442825|FG000|Overall Study|Lack of Efficacy|0
4594084|NCT01557842|7442826|FG001|Overall Study|Lack of Efficacy|1
4594085|NCT01557842|7442825|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3
4594086|NCT01557842|7442826|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0
4594087|NCT01557842|7442825|FG000|Overall Study|Study Terminated by Sponsor|3
4594088|NCT01557842|7442826|FG001|Overall Study|Study Terminated by Sponsor|4
4594089|NCT01557842|7442825|FG000|Overall Study|Not Ablated|2
4594090|NCT01557842|7442826|FG001|Overall Study|Not Ablated|0
4594091|NCT01557920|7442851|FG000|Overall Study|Withdrawal by Subject|2
4594092|NCT01557920|7442852|FG001|Overall Study|Withdrawal by Subject|3
4594093|NCT01557920|7442851|FG000|Overall Study|Lack of Efficacy|1
4594094|NCT01557920|7442852|FG001|Overall Study|Lack of Efficacy|0
4594095|NCT01557946|7442887|FG000|Overall Study|Adverse Event|3
4594096|NCT01557946|7442888|FG001|Overall Study|Adverse Event|0
4594097|NCT01558089|7442919|FG000|Overall Study|Adverse Event|1
4594098|NCT01558089|7442919|FG000|Overall Study|Lack of Efficacy|1
4594099|NCT01558089|7442919|FG000|Overall Study|Lost to Follow-up|5
4594100|NCT01558089|7442919|FG000|Overall Study|Withdrawal by Subject|6
4594101|NCT01558271|7442930|FG000|Overall Study|Adverse Event|6
4594102|NCT01558271|7442931|FG001|Overall Study|Adverse Event|3
4594103|NCT01558271|7442932|FG002|Overall Study|Adverse Event|4
4594104|NCT01558271|7442930|FG000|Overall Study|Lost to Follow-up|1
4594105|NCT01558271|7442931|FG001|Overall Study|Lost to Follow-up|0
4594106|NCT01558271|7442932|FG002|Overall Study|Lost to Follow-up|0
4594107|NCT01558271|7442930|FG000|Overall Study|Protocol Violation|1
4594108|NCT01558271|7442931|FG001|Overall Study|Protocol Violation|0
4594109|NCT01558271|7442932|FG002|Overall Study|Protocol Violation|0
4594110|NCT01558271|7442930|FG000|Overall Study|Withdrawal by Subject|10
4594111|NCT01558271|7442931|FG001|Overall Study|Withdrawal by Subject|6
4594112|NCT01558271|7442932|FG002|Overall Study|Withdrawal by Subject|12
4594113|NCT01558271|7442930|FG000|Overall Study|Physician Decision|0
4594114|NCT01558271|7442931|FG001|Overall Study|Physician Decision|2
4594115|NCT01558271|7442932|FG002|Overall Study|Physician Decision|1
4594116|NCT01558297|7442947|FG000|Overall Study|Withdrawal by Subject|2
4594117|NCT01558297|7442948|FG001|Overall Study|Withdrawal by Subject|2
4594118|NCT01558297|7442949|FG002|Overall Study|Withdrawal by Subject|1
4594119|NCT01558596|7442959|FG000|Overall Study|Withdrawal by Subject|1
4594120|NCT01558596|7442960|FG001|Overall Study|Withdrawal by Subject|0
4594121|NCT01558596|7442959|FG000|Overall Study|surgery elsewhere or cancelled|1
4594122|NCT01558596|7442960|FG001|Overall Study|surgery elsewhere or cancelled|1
4594123|NCT01558596|7442959|FG000|Overall Study|Protocol Violation|1
4594124|NCT01558596|7442960|FG001|Overall Study|Protocol Violation|0
4594125|NCT01558635|7442966|FG000|Overall Study|Death|1
4594126|NCT01558635|7442966|FG000|Overall Study|Withdrawal by Subject|2
4594127|NCT01558635|7442966|FG000|Overall Study|Physician Decision|1
4594128|NCT01558635|7442966|FG000|Overall Study|Subject received other treatment|1
4594129|NCT01558635|7442966|FG000|Overall Study|Reveal XT was explanted|1
4594130|NCT01558674|7442983|FG000|Part 1|Study Terminated by Sponsor|10
4594131|NCT01558674|7442984|FG001|Part 1|Study Terminated by Sponsor|0
4594132|NCT01558674|7442983|FG000|Part 1|Withdrawal by Subject|1
4594133|NCT01558674|7442984|FG001|Part 1|Withdrawal by Subject|0
4594134|NCT01558739|7443012|FG000|Overall Study|Adverse Event|7
4594135|NCT01558739|7443012|FG000|Overall Study|Withdrawal by Subject|2
4594136|NCT01558739|7443012|FG000|Overall Study|Death|3
4594137|NCT01558739|7443012|FG000|Overall Study|Disease Progression|4
4594138|NCT01558739|7443012|FG000|Overall Study|Protocol Violation|1
4594139|NCT01558752|7443018|FG000|Overall Study|Physician Decision|2
4594140|NCT01558752|7443019|FG001|Overall Study|Physician Decision|0
4594141|NCT01559012|7443038|FG000|Overall Study|Withdrawal by Subject|0
4521790|NCT00996892|7335799|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0
4521791|NCT00996892|7335800|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0
4521792|NCT00996892|7335801|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0
4521793|NCT00996892|7335802|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0
4521794|NCT00996892|7335803|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0
4521795|NCT00996892|7335804|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0
4521796|NCT00996892|7335785|FG000|Dose-Escalation Stage 1A|Disease Progression|0
4521797|NCT00996892|7335786|FG001|Dose-Escalation Stage 1A|Disease Progression|0
4521798|NCT00996892|7335787|FG002|Dose-Escalation Stage 1A|Disease Progression|0
4521799|NCT00996892|7335788|FG003|Dose-Escalation Stage 1A|Disease Progression|0
4521800|NCT00996892|7335789|FG004|Dose-Escalation Stage 1A|Disease Progression|0
4521801|NCT00996892|7335790|FG005|Dose-Escalation Stage 1A|Disease Progression|0
4521802|NCT00996892|7335791|FG006|Dose-Escalation Stage 1A|Disease Progression|0
4521803|NCT00996892|7335792|FG007|Dose-Escalation Stage 1A|Disease Progression|2
4521804|NCT00996892|7335793|FG008|Dose-Escalation Stage 1A|Disease Progression|3
4521805|NCT00996892|7335794|FG009|Dose-Escalation Stage 1A|Disease Progression|1
4521806|NCT00996892|7335795|FG010|Dose-Escalation Stage 1A|Disease Progression|5
4521807|NCT00996892|7335796|FG011|Dose-Escalation Stage 1A|Disease Progression|7
4521808|NCT00996892|7335797|FG012|Dose-Escalation Stage 1A|Disease Progression|6
4521809|NCT00996892|7335798|FG013|Dose-Escalation Stage 1A|Disease Progression|4
4521810|NCT00996892|7335799|FG014|Dose-Escalation Stage 1A|Disease Progression|0
4521811|NCT00996892|7335800|FG015|Dose-Escalation Stage 1A|Disease Progression|0
4521812|NCT00996892|7335801|FG016|Dose-Escalation Stage 1A|Disease Progression|0
4521813|NCT00996892|7335802|FG017|Dose-Escalation Stage 1A|Disease Progression|0
4521814|NCT00996892|7335803|FG018|Dose-Escalation Stage 1A|Disease Progression|0
4521815|NCT00996892|7335804|FG019|Dose-Escalation Stage 1A|Disease Progression|0
4521816|NCT00996892|7335785|FG000|Dose-Escalation Stage 1B|Physician Decision|0
4521817|NCT00996892|7335786|FG001|Dose-Escalation Stage 1B|Physician Decision|0
4521818|NCT00996892|7335787|FG002|Dose-Escalation Stage 1B|Physician Decision|0
4521819|NCT00996892|7335788|FG003|Dose-Escalation Stage 1B|Physician Decision|0
4521820|NCT00996892|7335789|FG004|Dose-Escalation Stage 1B|Physician Decision|0
4521821|NCT00996892|7335790|FG005|Dose-Escalation Stage 1B|Physician Decision|0
4521822|NCT00996892|7335791|FG006|Dose-Escalation Stage 1B|Physician Decision|0
4521823|NCT00996892|7335792|FG007|Dose-Escalation Stage 1B|Physician Decision|0
4521824|NCT00996892|7335793|FG008|Dose-Escalation Stage 1B|Physician Decision|0
4521825|NCT00996892|7335794|FG009|Dose-Escalation Stage 1B|Physician Decision|0
4521826|NCT00996892|7335795|FG010|Dose-Escalation Stage 1B|Physician Decision|0
4521827|NCT00996892|7335796|FG011|Dose-Escalation Stage 1B|Physician Decision|0
4521828|NCT00996892|7335797|FG012|Dose-Escalation Stage 1B|Physician Decision|0
4521829|NCT00996892|7335798|FG013|Dose-Escalation Stage 1B|Physician Decision|0
4521830|NCT00996892|7335799|FG014|Dose-Escalation Stage 1B|Physician Decision|0
4521831|NCT00996892|7335800|FG015|Dose-Escalation Stage 1B|Physician Decision|0
4521832|NCT00996892|7335801|FG016|Dose-Escalation Stage 1B|Physician Decision|0
4521833|NCT00996892|7335802|FG017|Dose-Escalation Stage 1B|Physician Decision|2
4521834|NCT00996892|7335803|FG018|Dose-Escalation Stage 1B|Physician Decision|0
4521835|NCT00996892|7335804|FG019|Dose-Escalation Stage 1B|Physician Decision|0
4521836|NCT00996892|7335785|FG000|Dose-Escalation Stage 1B|Disease Progression|0
4521837|NCT00996892|7335786|FG001|Dose-Escalation Stage 1B|Disease Progression|0
4521838|NCT00996892|7335787|FG002|Dose-Escalation Stage 1B|Disease Progression|0
4521839|NCT00996892|7335788|FG003|Dose-Escalation Stage 1B|Disease Progression|0
4521840|NCT00996892|7335789|FG004|Dose-Escalation Stage 1B|Disease Progression|0
4521841|NCT00996892|7335790|FG005|Dose-Escalation Stage 1B|Disease Progression|0
4521842|NCT00996892|7335791|FG006|Dose-Escalation Stage 1B|Disease Progression|0
4521843|NCT00996892|7335792|FG007|Dose-Escalation Stage 1B|Disease Progression|0
4521844|NCT00996892|7335793|FG008|Dose-Escalation Stage 1B|Disease Progression|0
4521845|NCT00996892|7335794|FG009|Dose-Escalation Stage 1B|Disease Progression|0
4594142|NCT01559012|7443039|FG001|Overall Study|Withdrawal by Subject|1
4594143|NCT01559090|7443076|FG000|Stage I|Withdrawal by Subject|2
4594144|NCT01559090|7443077|FG001|Stage I|Withdrawal by Subject|2
4594145|NCT01559090|7443078|FG002|Stage I|Withdrawal by Subject|3
4594146|NCT01559090|7443076|FG000|Stage II|Withdrawal by Subject|1
4594147|NCT01559090|7443077|FG001|Stage II|Withdrawal by Subject|0
4594148|NCT01559090|7443078|FG002|Stage II|Withdrawal by Subject|0
4594149|NCT01559116|7443086|FG000|Overall Study|Adverse Event|10
4594150|NCT01559116|7443086|FG000|Overall Study|Lack of Efficacy|1
4594151|NCT01559116|7443086|FG000|Overall Study|Lost to Follow-up|1
4594152|NCT01559116|7443086|FG000|Overall Study|Protocol Violation|1
4594153|NCT01559116|7443086|FG000|Overall Study|Withdrawal by Subject|4
4594154|NCT01559116|7443086|FG000|Overall Study|other than stated above|9
4594155|NCT01559129|7443105|FG000|Treatment Phase|Adverse Event|0
4594156|NCT01559129|7443106|FG001|Treatment Phase|Adverse Event|2
4594157|NCT01559129|7443105|FG000|Treatment Phase|Progressive Disease|1
4594158|NCT01559129|7443106|FG001|Treatment Phase|Progressive Disease|1
4594159|NCT01559129|7443105|FG000|Treatment Phase|Lack of Efficacy|0
4594160|NCT01559129|7443106|FG001|Treatment Phase|Lack of Efficacy|1
4594161|NCT01559129|7443105|FG000|Treatment Phase|Study Terminated by Sponsor|3
4737789|NCT03622112|7688216|FG001|Overall Study|Reason not specified|1
4521846|NCT00996892|7335795|FG010|Dose-Escalation Stage 1B|Disease Progression|0
4521847|NCT00996892|7335796|FG011|Dose-Escalation Stage 1B|Disease Progression|0
4521848|NCT00996892|7335797|FG012|Dose-Escalation Stage 1B|Disease Progression|0
4521849|NCT00996892|7335798|FG013|Dose-Escalation Stage 1B|Disease Progression|0
4521850|NCT00996892|7335799|FG014|Dose-Escalation Stage 1B|Disease Progression|4
4521851|NCT00996892|7335800|FG015|Dose-Escalation Stage 1B|Disease Progression|3
4521852|NCT00996892|7335801|FG016|Dose-Escalation Stage 1B|Disease Progression|3
4521853|NCT00996892|7335802|FG017|Dose-Escalation Stage 1B|Disease Progression|3
4521854|NCT00996892|7335803|FG018|Dose-Escalation Stage 1B|Disease Progression|0
4521855|NCT00996892|7335804|FG019|Dose-Escalation Stage 1B|Disease Progression|0
4521856|NCT00996892|7335785|FG000|Expansion Stage 2|Adverse Event|0
4521857|NCT00996892|7335786|FG001|Expansion Stage 2|Adverse Event|0
4521858|NCT00996892|7335787|FG002|Expansion Stage 2|Adverse Event|0
4521859|NCT00996892|7335788|FG003|Expansion Stage 2|Adverse Event|0
4521860|NCT00996892|7335789|FG004|Expansion Stage 2|Adverse Event|0
4521861|NCT00996892|7335790|FG005|Expansion Stage 2|Adverse Event|0
4521862|NCT00996892|7335791|FG006|Expansion Stage 2|Adverse Event|0
4521863|NCT00996892|7335792|FG007|Expansion Stage 2|Adverse Event|0
4521864|NCT00996892|7335793|FG008|Expansion Stage 2|Adverse Event|0
4521865|NCT00996892|7335794|FG009|Expansion Stage 2|Adverse Event|0
4521866|NCT00996892|7335795|FG010|Expansion Stage 2|Adverse Event|0
4521867|NCT00996892|7335796|FG011|Expansion Stage 2|Adverse Event|0
4521868|NCT00996892|7335797|FG012|Expansion Stage 2|Adverse Event|0
4521869|NCT00996892|7335798|FG013|Expansion Stage 2|Adverse Event|0
4521870|NCT00996892|7335799|FG014|Expansion Stage 2|Adverse Event|0
4521871|NCT00996892|7335800|FG015|Expansion Stage 2|Adverse Event|0
4521872|NCT00996892|7335801|FG016|Expansion Stage 2|Adverse Event|0
4521873|NCT00996892|7335802|FG017|Expansion Stage 2|Adverse Event|0
4521874|NCT00996892|7335803|FG018|Expansion Stage 2|Adverse Event|3
4521875|NCT00996892|7335804|FG019|Expansion Stage 2|Adverse Event|0
4521876|NCT00996892|7335785|FG000|Expansion Stage 2|Death|0
4521877|NCT00996892|7335786|FG001|Expansion Stage 2|Death|0
4521878|NCT00996892|7335787|FG002|Expansion Stage 2|Death|0
4521879|NCT00996892|7335788|FG003|Expansion Stage 2|Death|0
4521880|NCT00996892|7335789|FG004|Expansion Stage 2|Death|0
4521881|NCT00996892|7335790|FG005|Expansion Stage 2|Death|0
4521882|NCT00996892|7335791|FG006|Expansion Stage 2|Death|0
4521883|NCT00996892|7335792|FG007|Expansion Stage 2|Death|0
4521884|NCT00996892|7335793|FG008|Expansion Stage 2|Death|0
4521885|NCT00996892|7335794|FG009|Expansion Stage 2|Death|0
4521886|NCT00996892|7335795|FG010|Expansion Stage 2|Death|0
4521887|NCT00996892|7335796|FG011|Expansion Stage 2|Death|0
4521888|NCT00996892|7335797|FG012|Expansion Stage 2|Death|0
4521889|NCT00996892|7335798|FG013|Expansion Stage 2|Death|0
4521890|NCT00996892|7335799|FG014|Expansion Stage 2|Death|0
4521891|NCT00996892|7335800|FG015|Expansion Stage 2|Death|0
4521892|NCT00996892|7335801|FG016|Expansion Stage 2|Death|0
4521893|NCT00996892|7335802|FG017|Expansion Stage 2|Death|0
4521894|NCT00996892|7335803|FG018|Expansion Stage 2|Death|2
4521895|NCT00996892|7335804|FG019|Expansion Stage 2|Death|0
4521896|NCT00996892|7335785|FG000|Expansion Stage 2|Physician Decision|0
4521897|NCT00996892|7335786|FG001|Expansion Stage 2|Physician Decision|0
4521898|NCT00996892|7335787|FG002|Expansion Stage 2|Physician Decision|0
4521899|NCT00996892|7335788|FG003|Expansion Stage 2|Physician Decision|0
4521900|NCT00996892|7335789|FG004|Expansion Stage 2|Physician Decision|0
4521901|NCT00996892|7335790|FG005|Expansion Stage 2|Physician Decision|0
4521902|NCT00996892|7335791|FG006|Expansion Stage 2|Physician Decision|0
4521903|NCT00996892|7335792|FG007|Expansion Stage 2|Physician Decision|0
4521904|NCT00996892|7335793|FG008|Expansion Stage 2|Physician Decision|0
4521905|NCT00996892|7335794|FG009|Expansion Stage 2|Physician Decision|0
4521906|NCT00996892|7335795|FG010|Expansion Stage 2|Physician Decision|0
4594162|NCT01559129|7443106|FG001|Treatment Phase|Study Terminated by Sponsor|2
4594163|NCT01559129|7443105|FG000|Treatment Phase|Protocol Exclusion Criteria|1
4594164|NCT01559129|7443106|FG001|Treatment Phase|Protocol Exclusion Criteria|0
4594165|NCT01559129|7443105|FG000|Treatment Phase|Did Not Receive Study Drug|0
4594166|NCT01559129|7443106|FG001|Treatment Phase|Did Not Receive Study Drug|1
4594167|NCT01559129|7443105|FG000|Open-label Extension Period|Adverse Event|1
4594168|NCT01559129|7443106|FG001|Open-label Extension Period|Adverse Event|0
4594169|NCT01559129|7443105|FG000|Open-label Extension Period|Study Terminated by Sponsor|5
4594170|NCT01559129|7443106|FG001|Open-label Extension Period|Study Terminated by Sponsor|2
4594171|NCT01559259|7443123|FG000|Overall Study|Withdrawal by Subject|0
4594172|NCT01559259|7443124|FG001|Overall Study|Withdrawal by Subject|0
4521907|NCT00996892|7335796|FG011|Expansion Stage 2|Physician Decision|0
4521908|NCT00996892|7335797|FG012|Expansion Stage 2|Physician Decision|0
4521909|NCT00996892|7335798|FG013|Expansion Stage 2|Physician Decision|0
4521910|NCT00996892|7335799|FG014|Expansion Stage 2|Physician Decision|0
4521911|NCT00996892|7335800|FG015|Expansion Stage 2|Physician Decision|0
4521912|NCT00996892|7335801|FG016|Expansion Stage 2|Physician Decision|0
4521913|NCT00996892|7335802|FG017|Expansion Stage 2|Physician Decision|0
4594173|NCT01559259|7443125|FG002|Overall Study|Withdrawal by Subject|0
4521914|NCT00996892|7335803|FG018|Expansion Stage 2|Physician Decision|1
4521915|NCT00996892|7335804|FG019|Expansion Stage 2|Physician Decision|0
4521916|NCT00996892|7335785|FG000|Expansion Stage 2|Withdrawal by Subject|0
4521917|NCT00996892|7335786|FG001|Expansion Stage 2|Withdrawal by Subject|0
4521918|NCT00996892|7335787|FG002|Expansion Stage 2|Withdrawal by Subject|0
4521919|NCT00996892|7335788|FG003|Expansion Stage 2|Withdrawal by Subject|0
4521920|NCT00996892|7335789|FG004|Expansion Stage 2|Withdrawal by Subject|0
4521921|NCT00996892|7335790|FG005|Expansion Stage 2|Withdrawal by Subject|0
4521922|NCT00996892|7335791|FG006|Expansion Stage 2|Withdrawal by Subject|0
4521923|NCT00996892|7335792|FG007|Expansion Stage 2|Withdrawal by Subject|0
4521924|NCT00996892|7335793|FG008|Expansion Stage 2|Withdrawal by Subject|0
4521925|NCT00996892|7335794|FG009|Expansion Stage 2|Withdrawal by Subject|0
4521926|NCT00996892|7335795|FG010|Expansion Stage 2|Withdrawal by Subject|0
4521927|NCT00996892|7335796|FG011|Expansion Stage 2|Withdrawal by Subject|0
4521928|NCT00996892|7335797|FG012|Expansion Stage 2|Withdrawal by Subject|0
4521929|NCT00996892|7335798|FG013|Expansion Stage 2|Withdrawal by Subject|0
4521930|NCT00996892|7335799|FG014|Expansion Stage 2|Withdrawal by Subject|0
4521931|NCT00996892|7335800|FG015|Expansion Stage 2|Withdrawal by Subject|0
4521932|NCT00996892|7335801|FG016|Expansion Stage 2|Withdrawal by Subject|0
4521933|NCT00996892|7335802|FG017|Expansion Stage 2|Withdrawal by Subject|0
4521934|NCT00996892|7335803|FG018|Expansion Stage 2|Withdrawal by Subject|1
4521935|NCT00996892|7335804|FG019|Expansion Stage 2|Withdrawal by Subject|0
4521936|NCT00996892|7335785|FG000|Expansion Stage 2|Disease Progression|0
4521937|NCT00996892|7335786|FG001|Expansion Stage 2|Disease Progression|0
4521938|NCT00996892|7335787|FG002|Expansion Stage 2|Disease Progression|0
4521939|NCT00996892|7335788|FG003|Expansion Stage 2|Disease Progression|0
4521940|NCT00996892|7335789|FG004|Expansion Stage 2|Disease Progression|0
4521941|NCT00996892|7335790|FG005|Expansion Stage 2|Disease Progression|0
4521942|NCT00996892|7335791|FG006|Expansion Stage 2|Disease Progression|0
4521943|NCT00996892|7335792|FG007|Expansion Stage 2|Disease Progression|0
4521944|NCT00996892|7335793|FG008|Expansion Stage 2|Disease Progression|0
4521945|NCT00996892|7335794|FG009|Expansion Stage 2|Disease Progression|0
4521946|NCT00996892|7335795|FG010|Expansion Stage 2|Disease Progression|0
4521947|NCT00996892|7335796|FG011|Expansion Stage 2|Disease Progression|0
4521948|NCT00996892|7335797|FG012|Expansion Stage 2|Disease Progression|0
4521949|NCT00996892|7335798|FG013|Expansion Stage 2|Disease Progression|0
4521950|NCT00996892|7335799|FG014|Expansion Stage 2|Disease Progression|0
4521951|NCT00996892|7335800|FG015|Expansion Stage 2|Disease Progression|0
4521952|NCT00996892|7335801|FG016|Expansion Stage 2|Disease Progression|0
4521953|NCT00996892|7335802|FG017|Expansion Stage 2|Disease Progression|0
4521954|NCT00996892|7335803|FG018|Expansion Stage 2|Disease Progression|28
4521955|NCT00996892|7335804|FG019|Expansion Stage 2|Disease Progression|0
4521956|NCT00996892|7335785|FG000|Expansion Stage 2A|Adverse Event|0
4521957|NCT00996892|7335786|FG001|Expansion Stage 2A|Adverse Event|0
4521958|NCT00996892|7335787|FG002|Expansion Stage 2A|Adverse Event|0
4521959|NCT00996892|7335788|FG003|Expansion Stage 2A|Adverse Event|0
4521960|NCT00996892|7335789|FG004|Expansion Stage 2A|Adverse Event|0
4633525|NCT01912768|7503714|FG001|Overall Study|Adverse Event|0
4521961|NCT00996892|7335790|FG005|Expansion Stage 2A|Adverse Event|0
4521962|NCT00996892|7335791|FG006|Expansion Stage 2A|Adverse Event|0
4521963|NCT00996892|7335792|FG007|Expansion Stage 2A|Adverse Event|0
4521964|NCT00996892|7335793|FG008|Expansion Stage 2A|Adverse Event|0
4521965|NCT00996892|7335794|FG009|Expansion Stage 2A|Adverse Event|0
4521966|NCT00996892|7335795|FG010|Expansion Stage 2A|Adverse Event|0
4521967|NCT00996892|7335796|FG011|Expansion Stage 2A|Adverse Event|0
4521968|NCT00996892|7335797|FG012|Expansion Stage 2A|Adverse Event|0
4521969|NCT00996892|7335798|FG013|Expansion Stage 2A|Adverse Event|0
4521970|NCT00996892|7335799|FG014|Expansion Stage 2A|Adverse Event|0
4521971|NCT00996892|7335800|FG015|Expansion Stage 2A|Adverse Event|0
4521972|NCT00996892|7335801|FG016|Expansion Stage 2A|Adverse Event|0
4521973|NCT00996892|7335802|FG017|Expansion Stage 2A|Adverse Event|0
4521974|NCT00996892|7335803|FG018|Expansion Stage 2A|Adverse Event|0
4521975|NCT00996892|7335804|FG019|Expansion Stage 2A|Adverse Event|8
4521976|NCT00996892|7335785|FG000|Expansion Stage 2A|Physician Decision|0
4521977|NCT00996892|7335786|FG001|Expansion Stage 2A|Physician Decision|0
4521978|NCT00996892|7335787|FG002|Expansion Stage 2A|Physician Decision|0
4521979|NCT00996892|7335788|FG003|Expansion Stage 2A|Physician Decision|0
4521980|NCT00996892|7335789|FG004|Expansion Stage 2A|Physician Decision|0
4521981|NCT00996892|7335790|FG005|Expansion Stage 2A|Physician Decision|0
4521982|NCT00996892|7335791|FG006|Expansion Stage 2A|Physician Decision|0
4521983|NCT00996892|7335792|FG007|Expansion Stage 2A|Physician Decision|0
4521984|NCT00996892|7335793|FG008|Expansion Stage 2A|Physician Decision|0
4521985|NCT00996892|7335794|FG009|Expansion Stage 2A|Physician Decision|0
4521986|NCT00996892|7335795|FG010|Expansion Stage 2A|Physician Decision|0
4521987|NCT00996892|7335796|FG011|Expansion Stage 2A|Physician Decision|0
4521988|NCT00996892|7335797|FG012|Expansion Stage 2A|Physician Decision|0
4521989|NCT00996892|7335798|FG013|Expansion Stage 2A|Physician Decision|0
4521990|NCT00996892|7335799|FG014|Expansion Stage 2A|Physician Decision|0
4521991|NCT00996892|7335800|FG015|Expansion Stage 2A|Physician Decision|0
4521992|NCT00996892|7335801|FG016|Expansion Stage 2A|Physician Decision|0
4521993|NCT00996892|7335802|FG017|Expansion Stage 2A|Physician Decision|0
4521994|NCT00996892|7335803|FG018|Expansion Stage 2A|Physician Decision|0
4521995|NCT00996892|7335804|FG019|Expansion Stage 2A|Physician Decision|2
4521996|NCT00996892|7335785|FG000|Expansion Stage 2A|Withdrawal by Subject|0
4521997|NCT00996892|7335786|FG001|Expansion Stage 2A|Withdrawal by Subject|0
4521998|NCT00996892|7335787|FG002|Expansion Stage 2A|Withdrawal by Subject|0
4633526|NCT01912768|7503713|FG000|Overall Study|Lost to Follow-up|2
4521999|NCT00996892|7335788|FG003|Expansion Stage 2A|Withdrawal by Subject|0
4522000|NCT00996892|7335789|FG004|Expansion Stage 2A|Withdrawal by Subject|0
4522001|NCT00996892|7335790|FG005|Expansion Stage 2A|Withdrawal by Subject|0
4522002|NCT00996892|7335791|FG006|Expansion Stage 2A|Withdrawal by Subject|0
4522003|NCT00996892|7335792|FG007|Expansion Stage 2A|Withdrawal by Subject|0
4522004|NCT00996892|7335793|FG008|Expansion Stage 2A|Withdrawal by Subject|0
4522005|NCT00996892|7335794|FG009|Expansion Stage 2A|Withdrawal by Subject|0
4522006|NCT00996892|7335795|FG010|Expansion Stage 2A|Withdrawal by Subject|0
4522007|NCT00996892|7335796|FG011|Expansion Stage 2A|Withdrawal by Subject|0
4522008|NCT00996892|7335797|FG012|Expansion Stage 2A|Withdrawal by Subject|0
4522009|NCT00996892|7335798|FG013|Expansion Stage 2A|Withdrawal by Subject|0
4522010|NCT00996892|7335799|FG014|Expansion Stage 2A|Withdrawal by Subject|0
4522011|NCT00996892|7335800|FG015|Expansion Stage 2A|Withdrawal by Subject|0
4522012|NCT00996892|7335801|FG016|Expansion Stage 2A|Withdrawal by Subject|0
4522013|NCT00996892|7335802|FG017|Expansion Stage 2A|Withdrawal by Subject|0
4522014|NCT00996892|7335803|FG018|Expansion Stage 2A|Withdrawal by Subject|0
4522015|NCT00996892|7335804|FG019|Expansion Stage 2A|Withdrawal by Subject|4
4522016|NCT00996892|7335785|FG000|Expansion Stage 2A|Disease Progression|0
4522017|NCT00996892|7335786|FG001|Expansion Stage 2A|Disease Progression|0
4522018|NCT00996892|7335787|FG002|Expansion Stage 2A|Disease Progression|0
4522019|NCT00996892|7335788|FG003|Expansion Stage 2A|Disease Progression|0
4522020|NCT00996892|7335789|FG004|Expansion Stage 2A|Disease Progression|0
4522021|NCT00996892|7335790|FG005|Expansion Stage 2A|Disease Progression|0
4522022|NCT00996892|7335791|FG006|Expansion Stage 2A|Disease Progression|0
4522023|NCT00996892|7335792|FG007|Expansion Stage 2A|Disease Progression|0
4522024|NCT00996892|7335793|FG008|Expansion Stage 2A|Disease Progression|0
4522025|NCT00996892|7335794|FG009|Expansion Stage 2A|Disease Progression|0
4522026|NCT00996892|7335795|FG010|Expansion Stage 2A|Disease Progression|0
4522027|NCT00996892|7335796|FG011|Expansion Stage 2A|Disease Progression|0
4522028|NCT00996892|7335797|FG012|Expansion Stage 2A|Disease Progression|0
4522029|NCT00996892|7335798|FG013|Expansion Stage 2A|Disease Progression|0
4522030|NCT00996892|7335799|FG014|Expansion Stage 2A|Disease Progression|0
4522031|NCT00996892|7335800|FG015|Expansion Stage 2A|Disease Progression|0
4522032|NCT00996892|7335801|FG016|Expansion Stage 2A|Disease Progression|0
4522033|NCT00996892|7335802|FG017|Expansion Stage 2A|Disease Progression|0
4522034|NCT00996892|7335803|FG018|Expansion Stage 2A|Disease Progression|0
4522035|NCT00996892|7335804|FG019|Expansion Stage 2A|Disease Progression|31
4522036|NCT00996918|7335870|FG000|Overall Study|Lack of Efficacy|1
4522037|NCT00996918|7335871|FG001|Overall Study|Lack of Efficacy|1
4522038|NCT00996918|7335872|FG002|Overall Study|Lack of Efficacy|2
4522039|NCT00996918|7335873|FG003|Overall Study|Lack of Efficacy|2
4522040|NCT00996918|7335874|FG004|Overall Study|Lack of Efficacy|0
4522041|NCT00996918|7335870|FG000|Overall Study|Adverse Event|2
4522042|NCT00996918|7335871|FG001|Overall Study|Adverse Event|5
4522043|NCT00996918|7335872|FG002|Overall Study|Adverse Event|2
4522044|NCT00996918|7335873|FG003|Overall Study|Adverse Event|6
4522045|NCT00996918|7335874|FG004|Overall Study|Adverse Event|0
4522046|NCT00996918|7335870|FG000|Overall Study|Withdrawal by Subject|1
4522047|NCT00996918|7335871|FG001|Overall Study|Withdrawal by Subject|4
4522048|NCT00996918|7335872|FG002|Overall Study|Withdrawal by Subject|3
4522049|NCT00996918|7335873|FG003|Overall Study|Withdrawal by Subject|3
4522050|NCT00996918|7335874|FG004|Overall Study|Withdrawal by Subject|2
4522051|NCT00996918|7335870|FG000|Overall Study|Physician Decision|1
4522052|NCT00996918|7335871|FG001|Overall Study|Physician Decision|0
4522053|NCT00996918|7335872|FG002|Overall Study|Physician Decision|0
4522054|NCT00996918|7335873|FG003|Overall Study|Physician Decision|0
4522055|NCT00996918|7335874|FG004|Overall Study|Physician Decision|0
4522056|NCT00996918|7335870|FG000|Overall Study|Discontinuation of Study by Sponsor|31
4522057|NCT00996918|7335871|FG001|Overall Study|Discontinuation of Study by Sponsor|54
4522058|NCT00996918|7335872|FG002|Overall Study|Discontinuation of Study by Sponsor|30
4522059|NCT00996918|7335873|FG003|Overall Study|Discontinuation of Study by Sponsor|45
4522060|NCT00996918|7335874|FG004|Overall Study|Discontinuation of Study by Sponsor|2
4522061|NCT00996918|7335870|FG000|Overall Study|Loss of Caregiver|0
4522062|NCT00996918|7335871|FG001|Overall Study|Loss of Caregiver|1
4522063|NCT00996918|7335872|FG002|Overall Study|Loss of Caregiver|0
4522064|NCT00996918|7335873|FG003|Overall Study|Loss of Caregiver|0
4522065|NCT00996918|7335874|FG004|Overall Study|Loss of Caregiver|0
4522066|NCT00996918|7335870|FG000|Overall Study|Other|3
4522067|NCT00996918|7335871|FG001|Overall Study|Other|1
4522068|NCT00996918|7335872|FG002|Overall Study|Other|0
4522069|NCT00996918|7335873|FG003|Overall Study|Other|0
4522070|NCT00996918|7335874|FG004|Overall Study|Other|0
4522071|NCT00996944|7335893|FG000|Double-blind Treatment Period|Adverse Event|2
4522072|NCT00996944|7335894|FG001|Double-blind Treatment Period|Adverse Event|1
4522073|NCT00996944|7335893|FG000|Double-blind Treatment Period|Protocol Violation|1
4522074|NCT00996944|7335894|FG001|Double-blind Treatment Period|Protocol Violation|0
4522075|NCT00996944|7335893|FG000|Double-blind Treatment Period|Study Closed/Terminated|6
4522076|NCT00996944|7335894|FG001|Double-blind Treatment Period|Study Closed/Terminated|5
4522077|NCT00996944|7335893|FG000|Double-blind Treatment Period|Withdrawal by Subject|1
4522078|NCT00996944|7335894|FG001|Double-blind Treatment Period|Withdrawal by Subject|1
4522079|NCT00996944|7335893|FG000|Long-term Treatment Period|Study Closed/Terminated|12
4522080|NCT00996944|7335894|FG001|Long-term Treatment Period|Study Closed/Terminated|5
4522081|NCT00996996|7335902|FG000|Overall Study|Progressive Disease|10
4522082|NCT00996996|7335902|FG000|Overall Study|Non-compliance|8
4522083|NCT00996996|7335902|FG000|Overall Study|Lost to Follow-up|9
4522084|NCT00996996|7335902|FG000|Overall Study|Death|5
4522085|NCT00996996|7335902|FG000|Overall Study|Did Not Receive Study Medications|1
4522086|NCT00997035|7335908|FG000|3-week Followup Visit|Lost to Follow-up|9
4522087|NCT00997035|7335909|FG001|3-week Followup Visit|Lost to Follow-up|6
4522088|NCT00997035|7335908|FG000|3-month Follow-up Visit|Lost to Follow-up|12
4522089|NCT00997035|7335909|FG001|3-month Follow-up Visit|Lost to Follow-up|6
4522090|NCT00997126|7335936|FG000|Overall Study|Physician Decision|7
4522091|NCT00997126|7335937|FG001|Overall Study|Physician Decision|11
4522092|NCT00997243|7335962|FG000|Overall Study|Early termination of study by sponsor|7
4522093|NCT00997321|7335968|FG000|Overall Study|did not undergo sedation after enrollmen|0
4522094|NCT00997321|7335969|FG001|Overall Study|did not undergo sedation after enrollmen|3
4522095|NCT00997334|7335981|FG000|Overall Study|still on therapy|12
4522096|NCT00997334|7335981|FG000|Overall Study|Adverse Event|3
4522097|NCT00997334|7335981|FG000|Overall Study|Patient non-compliance|1
4522098|NCT00997334|7335981|FG000|Overall Study|Withdrawal by Subject|3
4522099|NCT00997334|7335981|FG000|Overall Study|Death|2
4522100|NCT00997334|7335981|FG000|Overall Study|Urgent Palliative Care|2
4522101|NCT00997334|7335981|FG000|Overall Study|No lesion amenable|1
4522102|NCT00997334|7335981|FG000|Overall Study|Ineligible|1
4522103|NCT00997373|7335987|FG000|Overall Study|Withdrawal by Subject|5
4522104|NCT00997373|7335988|FG001|Overall Study|Withdrawal by Subject|0
4522105|NCT00997373|7335987|FG000|Overall Study|wrong tumor type|4
4522106|NCT00997373|7335988|FG001|Overall Study|wrong tumor type|0
4633527|NCT01912768|7503714|FG001|Overall Study|Lost to Follow-up|1
4633528|NCT01912768|7503713|FG000|Overall Study|Withdrawal by Subject|5
4633529|NCT01912768|7503714|FG001|Overall Study|Withdrawal by Subject|3
4633530|NCT01912768|7503713|FG000|Overall Study|Randomized in error|1
4633531|NCT01912768|7503714|FG001|Overall Study|Randomized in error|0
4633532|NCT01912781|7503723|FG000|Overall Study|Withdrawal by Subject|2
4633533|NCT01912781|7503724|FG001|Overall Study|Withdrawal by Subject|0
4633534|NCT01912807|7503733|FG000|Overall Study|Did not meet elegibility criteria|6
4633535|NCT01912807|7503734|FG001|Overall Study|Did not meet elegibility criteria|4
4633536|NCT01912807|7503733|FG000|Overall Study|Lost to Follow-up|36
4633537|NCT01912807|7503734|FG001|Overall Study|Lost to Follow-up|37
4633538|NCT01912872|7503744|FG000|Overall Study|Lost to Follow-up|2
4633539|NCT01912872|7503745|FG001|Overall Study|Lost to Follow-up|3
4633540|NCT01912872|7503746|FG002|Overall Study|Lost to Follow-up|5
4633541|NCT01912872|7503747|FG003|Overall Study|Lost to Follow-up|5
4633542|NCT01912872|7503744|FG000|Overall Study|Other unspecified|3
4633543|NCT01912872|7503745|FG001|Overall Study|Other unspecified|1
4633544|NCT01912872|7503746|FG002|Overall Study|Other unspecified|3
4633545|NCT01912872|7503747|FG003|Overall Study|Other unspecified|0
4633546|NCT01912872|7503744|FG000|Overall Study|Informed consent withdrawn|0
4633547|NCT01912872|7503745|FG001|Overall Study|Informed consent withdrawn|0
4633548|NCT01912872|7503746|FG002|Overall Study|Informed consent withdrawn|1
4522107|NCT00997373|7335987|FG000|Overall Study|could not have hysterectomy|6
4522108|NCT00997373|7335988|FG001|Overall Study|could not have hysterectomy|0
4522109|NCT00997438|7336002|FG000|Overall Study|Blood draw difficulty|2
4522110|NCT00997438|7336003|FG001|Overall Study|Blood draw difficulty|0
4522111|NCT00997438|7336004|FG002|Overall Study|Blood draw difficulty|1
4522112|NCT00997438|7336002|FG000|Overall Study|Withdrawal by Subject|1
4522113|NCT00997438|7336003|FG001|Overall Study|Withdrawal by Subject|1
4522114|NCT00997438|7336004|FG002|Overall Study|Withdrawal by Subject|0
4522115|NCT00997438|7336002|FG000|Overall Study|Exclusion criteria at visit 1|2
4522116|NCT00997438|7336003|FG001|Overall Study|Exclusion criteria at visit 1|2
4522117|NCT00997438|7336004|FG002|Overall Study|Exclusion criteria at visit 1|3
4522118|NCT00997503|7336013|FG000|Overall Study|Death|53
4522119|NCT00997503|7336013|FG000|Overall Study|Withdrawal by Subject|76
4522120|NCT00997503|7336013|FG000|Overall Study|Lost to Follow-up|33
4522121|NCT00997503|7336013|FG000|Overall Study|Adverse Event|3
4522122|NCT00997503|7336013|FG000|Overall Study|Physician Decision|10
4522123|NCT00997503|7336013|FG000|Overall Study|Missed 12-month follow-up|85
4522124|NCT00997503|7336013|FG000|Overall Study|Other reason|13
4522125|NCT00997893|7336071|FG000|Overall Study|Adverse Event|1
4522126|NCT00997893|7336072|FG001|Overall Study|Adverse Event|0
4522127|NCT00997893|7336073|FG002|Overall Study|Adverse Event|0
4522128|NCT00997893|7336071|FG000|Overall Study|Unable to meet study timelines|1
4522129|NCT00997893|7336072|FG001|Overall Study|Unable to meet study timelines|0
4522130|NCT00997893|7336073|FG002|Overall Study|Unable to meet study timelines|0
4522131|NCT00997893|7336071|FG000|Overall Study|Pain/pain meds during Visit 4|0
4522132|NCT00997893|7336072|FG001|Overall Study|Pain/pain meds during Visit 4|1
4522133|NCT00997893|7336073|FG002|Overall Study|Pain/pain meds during Visit 4|0
4522134|NCT00997984|7336089|FG000|Overall Study|Adverse Event|1
4522135|NCT00997984|7336090|FG001|Overall Study|Adverse Event|8
4522136|NCT00997984|7336091|FG002|Overall Study|Adverse Event|8
4633549|NCT01912872|7503747|FG003|Overall Study|Informed consent withdrawn|1
4633550|NCT01912872|7503744|FG000|Overall Study|Non-compliance with lab inc/exclusion|0
4633551|NCT01912872|7503745|FG001|Overall Study|Non-compliance with lab inc/exclusion|0
4633552|NCT01912872|7503746|FG002|Overall Study|Non-compliance with lab inc/exclusion|0
4522137|NCT00997984|7336089|FG000|Overall Study|Protocol Violation|1
4522138|NCT00997984|7336090|FG001|Overall Study|Protocol Violation|3
4522139|NCT00997984|7336091|FG002|Overall Study|Protocol Violation|0
4522140|NCT00997984|7336089|FG000|Overall Study|Withdrawal by Subject|6
4522141|NCT00997984|7336090|FG001|Overall Study|Withdrawal by Subject|9
4522142|NCT00997984|7336091|FG002|Overall Study|Withdrawal by Subject|5
4522143|NCT00997984|7336089|FG000|Overall Study|Lost to Follow-up|8
4522144|NCT00997984|7336090|FG001|Overall Study|Lost to Follow-up|5
4522145|NCT00997984|7336091|FG002|Overall Study|Lost to Follow-up|4
4522146|NCT00997984|7336089|FG000|Overall Study|Lack of Efficacy|20
4522147|NCT00997984|7336090|FG001|Overall Study|Lack of Efficacy|6
4522148|NCT00997984|7336091|FG002|Overall Study|Lack of Efficacy|3
4522149|NCT00997984|7336089|FG000|Overall Study|Met exclusion criteria|1
4522150|NCT00997984|7336090|FG001|Overall Study|Met exclusion criteria|0
4522151|NCT00997984|7336091|FG002|Overall Study|Met exclusion criteria|0
4522152|NCT00997984|7336089|FG000|Overall Study|non-compliance|0
4522153|NCT00997984|7336090|FG001|Overall Study|non-compliance|2
4522154|NCT00997984|7336091|FG002|Overall Study|non-compliance|3
4522155|NCT00997984|7336089|FG000|Overall Study|Wrong medication dispensed|0
4522156|NCT00997984|7336090|FG001|Overall Study|Wrong medication dispensed|1
4522157|NCT00997984|7336091|FG002|Overall Study|Wrong medication dispensed|0
4522158|NCT00997984|7336089|FG000|Overall Study|Suicidal ideation|0
4522159|NCT00997984|7336090|FG001|Overall Study|Suicidal ideation|0
4522160|NCT00997984|7336091|FG002|Overall Study|Suicidal ideation|1
4522161|NCT00997984|7336089|FG000|Overall Study|Work schedule|0
4522162|NCT00997984|7336090|FG001|Overall Study|Work schedule|0
4522163|NCT00997984|7336091|FG002|Overall Study|Work schedule|2
4522164|NCT00998296|7336134|FG000|Overall Study|Progressive disease|0
4522165|NCT00998296|7336135|FG001|Overall Study|Progressive disease|1
4522166|NCT00998296|7336136|FG002|Overall Study|Progressive disease|0
4522167|NCT00998296|7336137|FG003|Overall Study|Progressive disease|0
4522168|NCT00998296|7336138|FG004|Overall Study|Progressive disease|0
4522169|NCT00998296|7336139|FG005|Overall Study|Progressive disease|0
4522170|NCT00998296|7336140|FG006|Overall Study|Progressive disease|1
4522171|NCT00998296|7336141|FG007|Overall Study|Progressive disease|0
4522172|NCT00998296|7336142|FG008|Overall Study|Progressive disease|0
4522173|NCT00998296|7336143|FG009|Overall Study|Progressive disease|14
4522174|NCT00998296|7336144|FG010|Overall Study|Progressive disease|5
4522175|NCT00998296|7336134|FG000|Overall Study|Dose limiting or dose reducing toxicity|0
4522176|NCT00998296|7336135|FG001|Overall Study|Dose limiting or dose reducing toxicity|0
4522177|NCT00998296|7336136|FG002|Overall Study|Dose limiting or dose reducing toxicity|0
4522178|NCT00998296|7336137|FG003|Overall Study|Dose limiting or dose reducing toxicity|0
4522179|NCT00998296|7336138|FG004|Overall Study|Dose limiting or dose reducing toxicity|1
4522180|NCT00998296|7336139|FG005|Overall Study|Dose limiting or dose reducing toxicity|0
4522181|NCT00998296|7336140|FG006|Overall Study|Dose limiting or dose reducing toxicity|0
4522182|NCT00998296|7336141|FG007|Overall Study|Dose limiting or dose reducing toxicity|2
4522183|NCT00998296|7336142|FG008|Overall Study|Dose limiting or dose reducing toxicity|2
4522184|NCT00998296|7336143|FG009|Overall Study|Dose limiting or dose reducing toxicity|0
4522185|NCT00998296|7336144|FG010|Overall Study|Dose limiting or dose reducing toxicity|0
4522186|NCT00998296|7336134|FG000|Overall Study|Other adverse event|0
4522187|NCT00998296|7336135|FG001|Overall Study|Other adverse event|0
4522188|NCT00998296|7336136|FG002|Overall Study|Other adverse event|0
4522189|NCT00998296|7336137|FG003|Overall Study|Other adverse event|0
4522190|NCT00998296|7336138|FG004|Overall Study|Other adverse event|1
4522191|NCT00998296|7336139|FG005|Overall Study|Other adverse event|0
4522192|NCT00998296|7336140|FG006|Overall Study|Other adverse event|0
4522193|NCT00998296|7336141|FG007|Overall Study|Other adverse event|0
4522194|NCT00998296|7336142|FG008|Overall Study|Other adverse event|0
4522195|NCT00998296|7336143|FG009|Overall Study|Other adverse event|1
4522196|NCT00998296|7336144|FG010|Overall Study|Other adverse event|2
4522197|NCT00998296|7336134|FG000|Overall Study|Refused to continue taking trial med.|0
4522198|NCT00998296|7336135|FG001|Overall Study|Refused to continue taking trial med.|0
4522199|NCT00998296|7336136|FG002|Overall Study|Refused to continue taking trial med.|0
4522200|NCT00998296|7336137|FG003|Overall Study|Refused to continue taking trial med.|0
4522201|NCT00998296|7336138|FG004|Overall Study|Refused to continue taking trial med.|0
4522202|NCT00998296|7336139|FG005|Overall Study|Refused to continue taking trial med.|0
4522203|NCT00998296|7336140|FG006|Overall Study|Refused to continue taking trial med.|0
4522204|NCT00998296|7336141|FG007|Overall Study|Refused to continue taking trial med.|0
4522205|NCT00998296|7336142|FG008|Overall Study|Refused to continue taking trial med.|0
4522206|NCT00998296|7336143|FG009|Overall Study|Refused to continue taking trial med.|2
4522207|NCT00998296|7336144|FG010|Overall Study|Refused to continue taking trial med.|0
4522208|NCT00998296|7336134|FG000|Overall Study|Reason other than those specified above|0
4522209|NCT00998296|7336135|FG001|Overall Study|Reason other than those specified above|0
4522210|NCT00998296|7336136|FG002|Overall Study|Reason other than those specified above|0
4522211|NCT00998296|7336137|FG003|Overall Study|Reason other than those specified above|0
4522212|NCT00998296|7336138|FG004|Overall Study|Reason other than those specified above|0
4522213|NCT00998296|7336139|FG005|Overall Study|Reason other than those specified above|0
4522214|NCT00998296|7336140|FG006|Overall Study|Reason other than those specified above|0
4522215|NCT00998296|7336141|FG007|Overall Study|Reason other than those specified above|0
4522216|NCT00998296|7336142|FG008|Overall Study|Reason other than those specified above|0
4522217|NCT00998296|7336143|FG009|Overall Study|Reason other than those specified above|1
4522218|NCT00998296|7336144|FG010|Overall Study|Reason other than those specified above|0
4522219|NCT00998309|7336173|FG000|Overall Study|Protocol Violation|4
4522220|NCT00998335|7336227|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0
4522221|NCT00998335|7336228|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2
4522222|NCT00998400|7336253|FG000|Overall Study|Lack of interest/motivation|1
4522223|NCT00998400|7336254|FG001|Overall Study|Lack of interest/motivation|2
4522224|NCT00998400|7336253|FG000|Overall Study|Logistical problems|1
4522225|NCT00998400|7336254|FG001|Overall Study|Logistical problems|0
4522226|NCT00998764|7336297|FG000|Overall Study|Lack of Efficacy|3
4522227|NCT00998764|7336298|FG001|Overall Study|Lack of Efficacy|6
4522228|NCT00998764|7336297|FG000|Overall Study|Adverse Event|17
4522229|NCT00998764|7336298|FG001|Overall Study|Adverse Event|12
4522230|NCT00998764|7336297|FG000|Overall Study|Withdrawal by Subject|19
4522231|NCT00998764|7336298|FG001|Overall Study|Withdrawal by Subject|25
4522232|NCT00998764|7336297|FG000|Overall Study|Physician Decision|3
4522233|NCT00998764|7336298|FG001|Overall Study|Physician Decision|3
4522234|NCT00998764|7336297|FG000|Overall Study|Death|3
4522235|NCT00998764|7336298|FG001|Overall Study|Death|1
4522236|NCT00998764|7336297|FG000|Overall Study|Discontinuation of Study by Sponsor|164
4522237|NCT00998764|7336298|FG001|Overall Study|Discontinuation of Study by Sponsor|217
4522238|NCT00998764|7336297|FG000|Overall Study|Protocol Violation|0
4522239|NCT00998764|7336298|FG001|Overall Study|Protocol Violation|1
4522240|NCT00998764|7336297|FG000|Overall Study|Failed to Return|1
4522241|NCT00998764|7336298|FG001|Overall Study|Failed to Return|1
4522242|NCT00998764|7336297|FG000|Overall Study|Lost to Follow-up|1
4522243|NCT00998764|7336298|FG001|Overall Study|Lost to Follow-up|1
4522244|NCT00998764|7336297|FG000|Overall Study|Loss of Caregiver|0
4522245|NCT00998764|7336298|FG001|Overall Study|Loss of Caregiver|3
4522246|NCT00998764|7336297|FG000|Overall Study|Other|4
4522247|NCT00998764|7336298|FG001|Overall Study|Other|4
4522248|NCT00998764|7336297|FG000|Overall Study|Recurrent Episode of vasogenic edema|1
4522249|NCT00998764|7336298|FG001|Overall Study|Recurrent Episode of vasogenic edema|0
4522250|NCT00998790|7336306|FG000|Overall Study|Withdrawal by Subject|21
4522251|NCT00998881|7336316|FG000|Overall Study|Adverse Event|2
4522252|NCT00998881|7336317|FG001|Overall Study|Adverse Event|2
4522253|NCT00998881|7336316|FG000|Overall Study|Lack of Efficacy|1
4522254|NCT00998881|7336317|FG001|Overall Study|Lack of Efficacy|0
4737790|NCT03622112|7688217|FG002|Overall Study|Reason not specified|0
4522255|NCT00998881|7336316|FG000|Overall Study|Physician Decision|3
4522256|NCT00998881|7336317|FG001|Overall Study|Physician Decision|0
4522257|NCT00998881|7336316|FG000|Overall Study|Withdrawal by Subject|1
4522258|NCT00998881|7336317|FG001|Overall Study|Withdrawal by Subject|0
4522259|NCT00998881|7336316|FG000|Overall Study|Personal matter|1
4522260|NCT00998881|7336317|FG001|Overall Study|Personal matter|0
4522261|NCT00998946|7336323|FG000|Overall Study|Lost to Follow-up|1
4522262|NCT00998946|7336323|FG000|Overall Study|Withdrawal by Subject|1
4522263|NCT00998946|7336323|FG000|Overall Study|Death|2
4522264|NCT00998946|7336323|FG000|Overall Study|Reason Unspecified|3
4522265|NCT00998946|7336323|FG000|Overall Study|Enrolled but not Dosed|2
4522266|NCT00998985|7336341|FG000|Overall Study|Withdrawal by Subject|0
4522267|NCT00998985|7336342|FG001|Overall Study|Withdrawal by Subject|0
4522268|NCT00998985|7336343|FG002|Overall Study|Withdrawal by Subject|0
4522269|NCT00998985|7336344|FG003|Overall Study|Withdrawal by Subject|0
4522270|NCT00998985|7336345|FG004|Overall Study|Withdrawal by Subject|0
4522271|NCT00998985|7336346|FG005|Overall Study|Withdrawal by Subject|0
4522272|NCT00998985|7336347|FG006|Overall Study|Withdrawal by Subject|0
4522273|NCT00998985|7336348|FG007|Overall Study|Withdrawal by Subject|0
4522274|NCT00998985|7336349|FG008|Overall Study|Withdrawal by Subject|1
4522275|NCT00998985|7336350|FG009|Overall Study|Withdrawal by Subject|0
4522276|NCT00998985|7336351|FG010|Overall Study|Withdrawal by Subject|0
4522277|NCT00998985|7336352|FG011|Overall Study|Withdrawal by Subject|0
4522278|NCT00998985|7336353|FG012|Overall Study|Withdrawal by Subject|0
4522279|NCT00998985|7336354|FG013|Overall Study|Withdrawal by Subject|0
4522280|NCT00998985|7336341|FG000|Overall Study|Protocol Violation|0
4522281|NCT00998985|7336342|FG001|Overall Study|Protocol Violation|0
4522282|NCT00998985|7336343|FG002|Overall Study|Protocol Violation|0
4522283|NCT00998985|7336344|FG003|Overall Study|Protocol Violation|0
4522284|NCT00998985|7336345|FG004|Overall Study|Protocol Violation|0
4522285|NCT00998985|7336346|FG005|Overall Study|Protocol Violation|1
4522286|NCT00998985|7336347|FG006|Overall Study|Protocol Violation|0
4522287|NCT00998985|7336348|FG007|Overall Study|Protocol Violation|0
4522288|NCT00998985|7336349|FG008|Overall Study|Protocol Violation|0
4522289|NCT00998985|7336350|FG009|Overall Study|Protocol Violation|0
4522290|NCT00998985|7336351|FG010|Overall Study|Protocol Violation|0
4522291|NCT00998985|7336352|FG011|Overall Study|Protocol Violation|0
4522292|NCT00998985|7336353|FG012|Overall Study|Protocol Violation|0
4522293|NCT00998985|7336354|FG013|Overall Study|Protocol Violation|0
4522294|NCT00999167|7336479|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4
4522295|NCT00999167|7336480|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0
4522296|NCT00999167|7336481|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0
4522297|NCT00999167|7336479|FG000|Part A: Open Label Safety run-in|Adverse Event|3
4522298|NCT00999167|7336480|FG001|Part A: Open Label Safety run-in|Adverse Event|0
4522299|NCT00999167|7336481|FG002|Part A: Open Label Safety run-in|Adverse Event|0
4522300|NCT00999167|7336479|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0
4522301|NCT00999167|7336480|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19
4522302|NCT00999167|7336481|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16
4522303|NCT00999167|7336479|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0
4522304|NCT00999167|7336480|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7
4522305|NCT00999167|7336481|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4
4522306|NCT00999167|7336479|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0
4522307|NCT00999167|7336480|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6
4522308|NCT00999167|7336481|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1
4522309|NCT00999167|7336479|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0
4522310|NCT00999167|7336480|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1
4522311|NCT00999167|7336481|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0
4522312|NCT00999167|7336479|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0
4522313|NCT00999167|7336480|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1
4522314|NCT00999167|7336481|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0
4522315|NCT00999167|7336479|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0
4522316|NCT00999167|7336480|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1
4522317|NCT00999167|7336481|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0
4522318|NCT00999466|7336494|FG000|Main Part|Withdrawal by Subject|0
4522319|NCT00999466|7336495|FG001|Main Part|Withdrawal by Subject|0
4522320|NCT00999466|7336496|FG002|Main Part|Withdrawal by Subject|2
4522321|NCT00999466|7336494|FG000|Main Part|Adverse Event|0
4522322|NCT00999466|7336495|FG001|Main Part|Adverse Event|4
4522323|NCT00999466|7336496|FG002|Main Part|Adverse Event|2
4522324|NCT00999518|7336509|FG000|Overall Study|Adverse Event|1
4522325|NCT00999518|7336510|FG001|Overall Study|Adverse Event|6
4522326|NCT00999518|7336511|FG002|Overall Study|Adverse Event|3
4522327|NCT00999518|7336512|FG003|Overall Study|Adverse Event|1
4522328|NCT00999518|7336513|FG004|Overall Study|Adverse Event|2
4522329|NCT00999518|7336509|FG000|Overall Study|Lack of Efficacy|2
4522330|NCT00999518|7336510|FG001|Overall Study|Lack of Efficacy|0
4522331|NCT00999518|7336511|FG002|Overall Study|Lack of Efficacy|0
4522332|NCT00999518|7336512|FG003|Overall Study|Lack of Efficacy|2
4522333|NCT00999518|7336513|FG004|Overall Study|Lack of Efficacy|2
4522334|NCT00999518|7336509|FG000|Overall Study|Lost to Follow-up|0
4522335|NCT00999518|7336510|FG001|Overall Study|Lost to Follow-up|0
4522336|NCT00999518|7336511|FG002|Overall Study|Lost to Follow-up|0
4522337|NCT00999518|7336512|FG003|Overall Study|Lost to Follow-up|4
4522338|NCT00999518|7336513|FG004|Overall Study|Lost to Follow-up|1
4522339|NCT00999518|7336509|FG000|Overall Study|Did not meet entrance criteria|0
4522340|NCT00999518|7336510|FG001|Overall Study|Did not meet entrance criteria|0
4522341|NCT00999518|7336511|FG002|Overall Study|Did not meet entrance criteria|0
4522342|NCT00999518|7336512|FG003|Overall Study|Did not meet entrance criteria|0
4522343|NCT00999518|7336513|FG004|Overall Study|Did not meet entrance criteria|1
4522344|NCT00999518|7336509|FG000|Overall Study|Study terminated by sponsor|10
4522345|NCT00999518|7336510|FG001|Overall Study|Study terminated by sponsor|6
4522346|NCT00999518|7336511|FG002|Overall Study|Study terminated by sponsor|5
4522347|NCT00999518|7336512|FG003|Overall Study|Study terminated by sponsor|5
4522348|NCT00999518|7336513|FG004|Overall Study|Study terminated by sponsor|9
4522349|NCT00999518|7336509|FG000|Overall Study|Pregnancy|0
4737791|NCT03622112|7688218|FG003|Overall Study|Reason not specified|1
4737792|NCT03622112|7688219|FG004|Overall Study|Reason not specified|1
4737793|NCT03622112|7688220|FG005|Overall Study|Reason not specified|2
4737794|NCT03622112|7688221|FG006|Overall Study|Reason not specified|1
4737795|NCT03624192|7688274|FG000|Overall Study|Lost to Follow-up|1
4737796|NCT03624192|7688275|FG001|Overall Study|Lost to Follow-up|1
4737797|NCT03624504|7688283|FG000|Overall Study|Unsuccessful Implant|1
4737798|NCT03624946|7688308|FG000|Overall Study|Lost to Follow-up|0
4737799|NCT03624946|7688309|FG001|Overall Study|Lost to Follow-up|1
4737800|NCT03624972|7688322|FG000|Overall Study|Lost to Follow-up|2
4737801|NCT03624972|7688323|FG001|Overall Study|Lost to Follow-up|0
4737802|NCT03624972|7688324|FG002|Overall Study|Lost to Follow-up|0
4737803|NCT03624972|7688322|FG000|Overall Study|Withdrawal by Subject|0
4737804|NCT03624972|7688323|FG001|Overall Study|Withdrawal by Subject|2
4737805|NCT03624972|7688324|FG002|Overall Study|Withdrawal by Subject|0
4737806|NCT03627065|7688359|FG000|Overall Study|Study Terminated by sponsor|1
4737807|NCT03627065|7688359|FG000|Overall Study|Withdrawal by Subject|2
4737808|NCT03627195|7688369|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1
4737809|NCT03627195|7688370|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0
4737810|NCT03627195|7688371|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0
4737811|NCT03627195|7688372|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0
4737812|NCT03627195|7688373|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0
4522350|NCT00999518|7336510|FG001|Overall Study|Pregnancy|0
4522351|NCT00999518|7336511|FG002|Overall Study|Pregnancy|1
4737813|NCT03627195|7688374|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0
4737814|NCT03627416|7688394|FG000|Overall Study|Adverse Event|0
4522352|NCT00999518|7336512|FG003|Overall Study|Pregnancy|0
4522353|NCT00999518|7336513|FG004|Overall Study|Pregnancy|0
4522354|NCT00999518|7336509|FG000|Overall Study|Protocol Violation|0
4522355|NCT00999518|7336510|FG001|Overall Study|Protocol Violation|1
4522356|NCT00999518|7336511|FG002|Overall Study|Protocol Violation|0
4522357|NCT00999518|7336512|FG003|Overall Study|Protocol Violation|0
4522358|NCT00999518|7336513|FG004|Overall Study|Protocol Violation|2
4522359|NCT00999518|7336509|FG000|Overall Study|Withdrawal by Subject|5
4522360|NCT00999518|7336510|FG001|Overall Study|Withdrawal by Subject|4
4522361|NCT00999518|7336511|FG002|Overall Study|Withdrawal by Subject|10
4522362|NCT00999518|7336512|FG003|Overall Study|Withdrawal by Subject|6
4522363|NCT00999518|7336513|FG004|Overall Study|Withdrawal by Subject|1
4522364|NCT00999518|7336509|FG000|Overall Study|Other|5
4522365|NCT00999518|7336510|FG001|Overall Study|Other|7
4522366|NCT00999518|7336511|FG002|Overall Study|Other|1
4522367|NCT00999518|7336512|FG003|Overall Study|Other|4
4522368|NCT00999518|7336513|FG004|Overall Study|Other|5
4522369|NCT00999518|7336509|FG000|Overall Study|Randomized but not Treated|1
4522370|NCT00999518|7336510|FG001|Overall Study|Randomized but not Treated|1
4522371|NCT00999518|7336511|FG002|Overall Study|Randomized but not Treated|2
4522372|NCT00999518|7336512|FG003|Overall Study|Randomized but not Treated|0
4522373|NCT00999518|7336513|FG004|Overall Study|Randomized but not Treated|1
4522374|NCT00999544|7336529|FG000|Overall Study|Withdrawal by Subject|1
4522375|NCT00999596|7336562|FG000|Overall Study|Statistical population not required|101
4522376|NCT00999661|7336567|FG000|Overall Study|Lost to Follow-up|59
4522377|NCT00999661|7336567|FG000|Overall Study|Adverse Event|1
4522378|NCT00999661|7336567|FG000|Overall Study|Withdrawal by Subject|1
4522379|NCT00999661|7336567|FG000|Overall Study|Not meeting eligibility criteria|9
4522380|NCT00999687|7336571|FG000|First Intervention|Withdrawal by Subject|1
4522381|NCT00999687|7336571|FG000|Second Intervention|Withdrawal by Subject|2
4522382|NCT00999687|7336571|FG000|Second Intervention|Lack of Efficacy|1
4522383|NCT00999713|7336579|FG000|Overall Study|Physician Decision|2
4522384|NCT00999713|7336580|FG001|Overall Study|Physician Decision|0
4522385|NCT00999804|7336588|FG000|Overall Study|Lack of Efficacy|9
4522386|NCT00999804|7336589|FG001|Overall Study|Lack of Efficacy|2
4522387|NCT00999804|7336588|FG000|Overall Study|Adverse Event|4
4522388|NCT00999804|7336589|FG001|Overall Study|Adverse Event|3
4522389|NCT00999804|7336588|FG000|Overall Study|Withdrawal by Subject|4
4522390|NCT00999804|7336589|FG001|Overall Study|Withdrawal by Subject|0
4522391|NCT00999804|7336588|FG000|Overall Study|Death|1
4522392|NCT00999804|7336589|FG001|Overall Study|Death|0
4522393|NCT00999804|7336588|FG000|Overall Study|Ineligible|3
4522394|NCT00999804|7336589|FG001|Overall Study|Ineligible|0
4522395|NCT00999908|7336604|FG000|Treatment Period 1|Subject withdrew consent|2
4522396|NCT00999908|7336605|FG001|Treatment Period 1|Subject withdrew consent|0
4522397|NCT00999908|7336606|FG002|Treatment Period 1|Subject withdrew consent|0
4522398|NCT00999908|7336604|FG000|Treatment Period 2|Protocol Violation|1
4522399|NCT00999908|7336605|FG001|Treatment Period 2|Protocol Violation|0
4522400|NCT00999908|7336606|FG002|Treatment Period 2|Protocol Violation|0
4522401|NCT00999921|7336616|FG000|Overall Study|Lost to Follow-up|10
4522402|NCT00999921|7336617|FG001|Overall Study|Lost to Follow-up|19
4522403|NCT01000025|7336628|FG000|Overall Study|Adverse Event|43
4522404|NCT01000025|7336629|FG001|Overall Study|Adverse Event|2
4522405|NCT01000025|7336628|FG000|Overall Study|Withdrawal by Subject|13
4522406|NCT01000025|7336629|FG001|Overall Study|Withdrawal by Subject|8
4522407|NCT01000025|7336628|FG000|Overall Study|Death|23
4522408|NCT01000025|7336629|FG001|Overall Study|Death|13
4522409|NCT01000025|7336628|FG000|Overall Study|Lack of Efficacy|363
4522410|NCT01000025|7336629|FG001|Overall Study|Lack of Efficacy|208
4522411|NCT01000025|7336628|FG000|Overall Study|Intercurrent Illness|26
4737815|NCT03627416|7688395|FG001|Overall Study|Adverse Event|1
4737816|NCT03627494|7688413|FG000|Part A Washout 2 (7 Days)|Adverse Event|1
4737817|NCT03627494|7688414|FG001|Part A Washout 2 (7 Days)|Adverse Event|0
4737818|NCT03627494|7688415|FG002|Part A Washout 2 (7 Days)|Adverse Event|1
4737819|NCT03627494|7688416|FG003|Part A Washout 2 (7 Days)|Adverse Event|0
4737820|NCT03627494|7688417|FG004|Part A Washout 2 (7 Days)|Adverse Event|0
4737821|NCT03627494|7688418|FG005|Part A Washout 2 (7 Days)|Adverse Event|0
4737822|NCT03627494|7688419|FG006|Part A Washout 2 (7 Days)|Adverse Event|0
4737823|NCT03627494|7688420|FG007|Part A Washout 2 (7 Days)|Adverse Event|0
4737824|NCT03627494|7688421|FG008|Part A Washout 2 (7 Days)|Adverse Event|0
4737825|NCT03627494|7688422|FG009|Part A Washout 2 (7 Days)|Adverse Event|0
4737826|NCT03627494|7688423|FG010|Part A Washout 2 (7 Days)|Adverse Event|0
4737827|NCT03627494|7688424|FG011|Part A Washout 2 (7 Days)|Adverse Event|0
4737828|NCT03627494|7688413|FG000|Part B (Maximum of 34 Days)|Adverse Event|0
4737829|NCT03627494|7688414|FG001|Part B (Maximum of 34 Days)|Adverse Event|0
4737830|NCT03627494|7688415|FG002|Part B (Maximum of 34 Days)|Adverse Event|0
4737831|NCT03627494|7688416|FG003|Part B (Maximum of 34 Days)|Adverse Event|0
4522412|NCT01000025|7336629|FG001|Overall Study|Intercurrent Illness|7
4522413|NCT01000051|7336637|FG000|Overall Study|Withdrawal by Subject|1
4737832|NCT03627494|7688417|FG004|Part B (Maximum of 34 Days)|Adverse Event|0
4522414|NCT01000051|7336638|FG001|Overall Study|Withdrawal by Subject|1
4522415|NCT01000051|7336637|FG000|Overall Study|Disease Progression|1
4522416|NCT01000051|7336638|FG001|Overall Study|Disease Progression|0
4522417|NCT01000051|7336637|FG000|Overall Study|Serious noncompliance|1
4522418|NCT01000051|7336638|FG001|Overall Study|Serious noncompliance|0
4522419|NCT01000064|7336644|FG000|Overall Study|Withdrawal by Subject|1
4522420|NCT01000064|7336645|FG001|Overall Study|Withdrawal by Subject|1
4522421|NCT01000155|7336654|FG000|Overall Study|Withdrawal by Subject|1
4522422|NCT01000155|7336654|FG000|Overall Study|Adverse Event|1
4522423|NCT01000311|7336676|FG000|Overall Study|Adverse Event|2
4522424|NCT01000311|7336677|FG001|Overall Study|Adverse Event|5
4522425|NCT01000311|7336676|FG000|Overall Study|Withdrawal by Subject|16
4522426|NCT01000311|7336677|FG001|Overall Study|Withdrawal by Subject|24
4522427|NCT01000311|7336676|FG000|Overall Study|Lost to Follow-up|15
4522428|NCT01000311|7336677|FG001|Overall Study|Lost to Follow-up|24
4522429|NCT01000311|7336676|FG000|Overall Study|Protocol Violation|1
4522430|NCT01000311|7336677|FG001|Overall Study|Protocol Violation|2
4522431|NCT01000311|7336676|FG000|Overall Study|Inappropriate enrollment|2
4522432|NCT01000311|7336677|FG001|Overall Study|Inappropriate enrollment|0
4522433|NCT01000311|7336676|FG000|Overall Study|Administrative reason|9
4522434|NCT01000311|7336677|FG001|Overall Study|Administrative reason|15
4522435|NCT01000337|7336690|FG000|Overall Study|Lost to Follow-up|4
4522436|NCT01000337|7336691|FG001|Overall Study|Lost to Follow-up|3
4522437|NCT01000376|7336699|FG000|Cycle 1 Day 1|Adverse Event|1
4522438|NCT01000376|7336700|FG001|Cycle 1 Day 1|Adverse Event|0
4522439|NCT01000376|7336699|FG000|Cycle 1 Day 1|Progressive Disease|1
4522440|NCT01000376|7336700|FG001|Cycle 1 Day 1|Progressive Disease|0
4522441|NCT01000480|7336706|FG000|Induction Phase|Adverse Event|2
4522442|NCT01000480|7336706|FG000|Induction Phase|Lost to Follow-up|1
4522443|NCT01000480|7336706|FG000|Induction Phase|Physician Decision|1
4522444|NCT01000480|7336706|FG000|Induction Phase|Entry Criteria Not Met|3
4522445|NCT01000480|7336706|FG000|Concurrent Therapy Phase|Adverse Event|4
4522446|NCT01000480|7336706|FG000|Concurrent Therapy Phase|Protocol Violation|2
4522447|NCT01000480|7336706|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3
4522448|NCT01000480|7336706|FG000|Concurrent Therapy Phase|Physician Decision|1
4594174|NCT01559259|7443126|FG003|Overall Study|Withdrawal by Subject|1
4594175|NCT01559259|7443127|FG004|Overall Study|Withdrawal by Subject|0
4594176|NCT01559259|7443123|FG000|Overall Study|Adverse Event|0
4594177|NCT01559259|7443124|FG001|Overall Study|Adverse Event|1
4594178|NCT01559259|7443125|FG002|Overall Study|Adverse Event|1
4594179|NCT01559259|7443126|FG003|Overall Study|Adverse Event|0
4594180|NCT01559259|7443127|FG004|Overall Study|Adverse Event|0
4594181|NCT01559311|7443142|FG000|Overall Study|Protocol Violation|0
4594182|NCT01559311|7443143|FG001|Overall Study|Protocol Violation|0
4594183|NCT01559311|7443144|FG002|Overall Study|Protocol Violation|2
4594184|NCT01559311|7443142|FG000|Overall Study|Difficulty in cannulating the lateral ve|1
4594185|NCT01559311|7443143|FG001|Overall Study|Difficulty in cannulating the lateral ve|0
4594186|NCT01559311|7443144|FG002|Overall Study|Difficulty in cannulating the lateral ve|0
4594187|NCT01559311|7443142|FG000|Overall Study|Withdrawal by Subject|2
4594188|NCT01559311|7443143|FG001|Overall Study|Withdrawal by Subject|1
4594189|NCT01559311|7443144|FG002|Overall Study|Withdrawal by Subject|0
4594190|NCT01559311|7443142|FG000|Overall Study|Death|0
4594191|NCT01559311|7443143|FG001|Overall Study|Death|2
4737833|NCT03627494|7688418|FG005|Part B (Maximum of 34 Days)|Adverse Event|0
4594192|NCT01559311|7443144|FG002|Overall Study|Death|3
4594193|NCT01559311|7443142|FG000|Overall Study|Lost to Follow-up|0
4594194|NCT01559311|7443143|FG001|Overall Study|Lost to Follow-up|3
4594195|NCT01559311|7443144|FG002|Overall Study|Lost to Follow-up|2
4594196|NCT01559311|7443142|FG000|Overall Study|Adverse Event|0
4594197|NCT01559311|7443143|FG001|Overall Study|Adverse Event|0
4594198|NCT01559311|7443144|FG002|Overall Study|Adverse Event|1
4594199|NCT01559389|7443154|FG000|Overall Study|Withdrawal by Subject|20
4737834|NCT03627494|7688419|FG006|Part B (Maximum of 34 Days)|Adverse Event|0
4737835|NCT03627494|7688420|FG007|Part B (Maximum of 34 Days)|Adverse Event|0
4737836|NCT03627494|7688421|FG008|Part B (Maximum of 34 Days)|Adverse Event|2
4737837|NCT03627494|7688422|FG009|Part B (Maximum of 34 Days)|Adverse Event|0
4737838|NCT03627494|7688423|FG010|Part B (Maximum of 34 Days)|Adverse Event|0
4594200|NCT01559389|7443155|FG001|Overall Study|Withdrawal by Subject|20
4594201|NCT01559454|7443167|FG000|Overall Study|Lost to Follow-up|3
4594202|NCT01559454|7443168|FG001|Overall Study|Lost to Follow-up|2
4594203|NCT01559454|7443167|FG000|Overall Study|Withdrawal by Subject|0
4594204|NCT01559454|7443168|FG001|Overall Study|Withdrawal by Subject|1
4594205|NCT01559454|7443167|FG000|Overall Study|Physician Decision|0
4594206|NCT01559454|7443168|FG001|Overall Study|Physician Decision|1
4594207|NCT01559454|7443167|FG000|Overall Study|Protocol Violation|0
4594208|NCT01559454|7443168|FG001|Overall Study|Protocol Violation|1
4737839|NCT03627494|7688424|FG011|Part B (Maximum of 34 Days)|Adverse Event|0
4737840|NCT03627494|7688413|FG000|Part C Washout 1 (7 Days)|Adverse Event|0
4737841|NCT03627494|7688414|FG001|Part C Washout 1 (7 Days)|Adverse Event|0
4737842|NCT03627494|7688415|FG002|Part C Washout 1 (7 Days)|Adverse Event|0
4737843|NCT03627494|7688416|FG003|Part C Washout 1 (7 Days)|Adverse Event|0
4737844|NCT03627494|7688417|FG004|Part C Washout 1 (7 Days)|Adverse Event|0
4737845|NCT03627494|7688418|FG005|Part C Washout 1 (7 Days)|Adverse Event|0
4737846|NCT03627494|7688419|FG006|Part C Washout 1 (7 Days)|Adverse Event|0
4737847|NCT03627494|7688420|FG007|Part C Washout 1 (7 Days)|Adverse Event|0
4522449|NCT01000493|7336712|FG000|Overall Study|Adverse Event|3
4522450|NCT01000493|7336713|FG001|Overall Study|Adverse Event|6
4522451|NCT01000493|7336712|FG000|Overall Study|Lack of Efficacy|1
4522452|NCT01000493|7336713|FG001|Overall Study|Lack of Efficacy|1
4522453|NCT01000493|7336712|FG000|Overall Study|Protocol Violation|1
4522454|NCT01000493|7336713|FG001|Overall Study|Protocol Violation|8
4522455|NCT01000493|7336712|FG000|Overall Study|Study closed/terminated|25
4522456|NCT01000493|7336713|FG001|Overall Study|Study closed/terminated|23
4522457|NCT01000493|7336712|FG000|Overall Study|Lost to Follow-up|5
4522458|NCT01000493|7336713|FG001|Overall Study|Lost to Follow-up|9
4522459|NCT01000493|7336712|FG000|Overall Study|Physician Decision|1
4522460|NCT01000493|7336713|FG001|Overall Study|Physician Decision|1
4522461|NCT01000493|7336712|FG000|Overall Study|Withdrawal by Subject|3
4522462|NCT01000493|7336713|FG001|Overall Study|Withdrawal by Subject|7
4522463|NCT01000506|7336723|FG000|Overall Study|Adverse Event|6
4522464|NCT01000506|7336724|FG001|Overall Study|Adverse Event|5
4522465|NCT01000506|7336725|FG002|Overall Study|Adverse Event|8
4522466|NCT01000506|7336726|FG003|Overall Study|Adverse Event|9
4522467|NCT01000506|7336723|FG000|Overall Study|Lack of Efficacy|8
4522468|NCT01000506|7336724|FG001|Overall Study|Lack of Efficacy|6
4522469|NCT01000506|7336725|FG002|Overall Study|Lack of Efficacy|4
4522470|NCT01000506|7336726|FG003|Overall Study|Lack of Efficacy|4
4522471|NCT01000506|7336723|FG000|Overall Study|Protocol Violation|1
4522472|NCT01000506|7336724|FG001|Overall Study|Protocol Violation|1
4522473|NCT01000506|7336725|FG002|Overall Study|Protocol Violation|0
4522474|NCT01000506|7336726|FG003|Overall Study|Protocol Violation|0
4522475|NCT01000506|7336723|FG000|Overall Study|Lost to Follow-up|1
4522476|NCT01000506|7336724|FG001|Overall Study|Lost to Follow-up|1
4522477|NCT01000506|7336725|FG002|Overall Study|Lost to Follow-up|4
4522478|NCT01000506|7336726|FG003|Overall Study|Lost to Follow-up|0
4522479|NCT01000506|7336723|FG000|Overall Study|Physician Decision|1
4522480|NCT01000506|7336724|FG001|Overall Study|Physician Decision|3
4522481|NCT01000506|7336725|FG002|Overall Study|Physician Decision|3
4522482|NCT01000506|7336726|FG003|Overall Study|Physician Decision|3
4522483|NCT01000506|7336723|FG000|Overall Study|Withdrawal by Subject|11
4522484|NCT01000506|7336724|FG001|Overall Study|Withdrawal by Subject|8
4522485|NCT01000506|7336725|FG002|Overall Study|Withdrawal by Subject|2
4522486|NCT01000506|7336726|FG003|Overall Study|Withdrawal by Subject|7
4522487|NCT01000610|7336736|FG000|Overall Study|Adverse Event|1
4522488|NCT01000610|7336736|FG000|Overall Study|Lost to Follow-up|4
4522489|NCT01000610|7336736|FG000|Overall Study|Treatment failure|1
4522490|NCT01000636|7336740|FG000|Overall Study|Withdrawal by Subject|1
4522491|NCT01000636|7336740|FG000|Overall Study|Adverse Event|1
4522492|NCT01000649|7336748|FG000|Overall Study|Adverse Event|5
4522493|NCT01000649|7336749|FG001|Overall Study|Adverse Event|1
4522494|NCT01000649|7336750|FG002|Overall Study|Adverse Event|2
4522495|NCT01000649|7336751|FG003|Overall Study|Adverse Event|4
4522496|NCT01000649|7336748|FG000|Overall Study|Lost to Follow-up|0
4522497|NCT01000649|7336749|FG001|Overall Study|Lost to Follow-up|2
4522498|NCT01000649|7336750|FG002|Overall Study|Lost to Follow-up|0
4522499|NCT01000649|7336751|FG003|Overall Study|Lost to Follow-up|2
4522500|NCT01000727|7336773|FG000|Overall Study|Lost to Follow-up|41
4522501|NCT01000727|7336774|FG001|Overall Study|Lost to Follow-up|43
4522502|NCT01000727|7336773|FG000|Overall Study|Withdrawal by Subject|111
4522503|NCT01000727|7336774|FG001|Overall Study|Withdrawal by Subject|109
4522504|NCT01000727|7336773|FG000|Overall Study|Study closed/terminated|23
4522505|NCT01000727|7336774|FG001|Overall Study|Study closed/terminated|24
4522506|NCT01000805|7336784|FG000|Overall Study|Adverse Event|21
4522507|NCT01000805|7336785|FG001|Overall Study|Adverse Event|9
4522508|NCT01000805|7336784|FG000|Overall Study|Lack of Efficacy|5
4522509|NCT01000805|7336785|FG001|Overall Study|Lack of Efficacy|16
4522510|NCT01000805|7336784|FG000|Overall Study|Lost to Follow-up|16
4522511|NCT01000805|7336785|FG001|Overall Study|Lost to Follow-up|21
4522512|NCT01000805|7336784|FG000|Overall Study|Physician Decision|0
4522513|NCT01000805|7336785|FG001|Overall Study|Physician Decision|1
4522514|NCT01000805|7336784|FG000|Overall Study|Protocol Violation|12
4522515|NCT01000805|7336785|FG001|Overall Study|Protocol Violation|8
4522516|NCT01000805|7336784|FG000|Overall Study|Withdrawal by Subject|16
4522517|NCT01000805|7336785|FG001|Overall Study|Withdrawal by Subject|6
4522518|NCT01000805|7336784|FG000|Overall Study|Sponsor Decision|0
4522519|NCT01000805|7336785|FG001|Overall Study|Sponsor Decision|1
4522520|NCT01000961|7336801|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0
4522521|NCT01000961|7336802|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1
4522522|NCT01000961|7336801|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0
4522523|NCT01000961|7336802|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1
4522524|NCT01000974|7336813|FG000|Primary Vaccination Phase|Withdrawal by Subject|109
4633553|NCT01912872|7503747|FG003|Overall Study|Non-compliance with lab inc/exclusion|1
4633554|NCT01912872|7503744|FG000|Overall Study|Protocol Violation|0
4633555|NCT01912872|7503745|FG001|Overall Study|Protocol Violation|0
4522525|NCT01000974|7336814|FG001|Primary Vaccination Phase|Withdrawal by Subject|17
4522526|NCT01000974|7336815|FG002|Primary Vaccination Phase|Withdrawal by Subject|21
4522527|NCT01000974|7336813|FG000|Primary Vaccination Phase|Lost to Follow-up|171
4522528|NCT01000974|7336814|FG001|Primary Vaccination Phase|Lost to Follow-up|19
4522529|NCT01000974|7336815|FG002|Primary Vaccination Phase|Lost to Follow-up|26
4522530|NCT01000974|7336813|FG000|Primary Vaccination Phase|Protocol Violation|40
4522531|NCT01000974|7336814|FG001|Primary Vaccination Phase|Protocol Violation|3
4522532|NCT01000974|7336815|FG002|Primary Vaccination Phase|Protocol Violation|2
4522533|NCT01000974|7336813|FG000|Primary Vaccination Phase|Adverse Event|14
4522534|NCT01000974|7336814|FG001|Primary Vaccination Phase|Adverse Event|2
4522535|NCT01000974|7336815|FG002|Primary Vaccination Phase|Adverse Event|2
4522536|NCT01000974|7336813|FG000|Primary Vaccination Phase|Other|4
4522537|NCT01000974|7336814|FG001|Primary Vaccination Phase|Other|9
4522538|NCT01000974|7336815|FG002|Primary Vaccination Phase|Other|12
4522539|NCT01000974|7336813|FG000|Booster Vaccination Phase|Protocol Violation|0
4522540|NCT01000974|7336814|FG001|Booster Vaccination Phase|Protocol Violation|0
4522541|NCT01000974|7336815|FG002|Booster Vaccination Phase|Protocol Violation|2
4522542|NCT01000974|7336813|FG000|Booster Vaccination Phase|Withdrawal by Subject|3
4522543|NCT01000974|7336814|FG001|Booster Vaccination Phase|Withdrawal by Subject|1
4522544|NCT01000974|7336815|FG002|Booster Vaccination Phase|Withdrawal by Subject|1
4522545|NCT01000974|7336813|FG000|Booster Vaccination Phase|Lost to Follow-up|40
4522546|NCT01000974|7336814|FG001|Booster Vaccination Phase|Lost to Follow-up|5
4522547|NCT01000974|7336815|FG002|Booster Vaccination Phase|Lost to Follow-up|7
4633556|NCT01912872|7503746|FG002|Overall Study|Protocol Violation|1
4633557|NCT01912872|7503747|FG003|Overall Study|Protocol Violation|0
4522548|NCT01000974|7336813|FG000|Booster Vaccination Phase|Other|24
4522549|NCT01000974|7336814|FG001|Booster Vaccination Phase|Other|6
4522550|NCT01000974|7336815|FG002|Booster Vaccination Phase|Other|4
4522551|NCT01001104|7336861|FG000|Overall Study|Adverse Event|2
4522552|NCT01001104|7336862|FG001|Overall Study|Adverse Event|1
4522553|NCT01001104|7336863|FG002|Overall Study|Adverse Event|0
4522554|NCT01001104|7336864|FG003|Overall Study|Adverse Event|0
4522555|NCT01001104|7336861|FG000|Overall Study|Lost to Follow-up|0
4522556|NCT01001104|7336862|FG001|Overall Study|Lost to Follow-up|0
4522557|NCT01001104|7336863|FG002|Overall Study|Lost to Follow-up|1
4522558|NCT01001104|7336864|FG003|Overall Study|Lost to Follow-up|0
4522559|NCT01001104|7336861|FG000|Overall Study|Entry Criteria Not Met|0
4522560|NCT01001104|7336862|FG001|Overall Study|Entry Criteria Not Met|0
4522561|NCT01001104|7336863|FG002|Overall Study|Entry Criteria Not Met|0
4522562|NCT01001104|7336864|FG003|Overall Study|Entry Criteria Not Met|1
4522563|NCT01001104|7336861|FG000|Overall Study|Withdrawal by Subject|0
4633558|NCT01912872|7503744|FG000|Overall Study|Unsatisfactory therapeutic effect|0
4633559|NCT01912872|7503745|FG001|Overall Study|Unsatisfactory therapeutic effect|0
4633560|NCT01912872|7503746|FG002|Overall Study|Unsatisfactory therapeutic effect|0
4633561|NCT01912872|7503747|FG003|Overall Study|Unsatisfactory therapeutic effect|2
4633562|NCT01912872|7503744|FG000|Overall Study|Withdrawal of study medication|0
4633563|NCT01912872|7503745|FG001|Overall Study|Withdrawal of study medication|0
4633564|NCT01912872|7503746|FG002|Overall Study|Withdrawal of study medication|0
4633565|NCT01912872|7503747|FG003|Overall Study|Withdrawal of study medication|2
4633566|NCT01912872|7503744|FG000|Overall Study|Missing|0
4633567|NCT01912872|7503745|FG001|Overall Study|Missing|0
4633568|NCT01912872|7503746|FG002|Overall Study|Missing|0
4633569|NCT01912872|7503747|FG003|Overall Study|Missing|1
4633570|NCT01912963|7503761|FG000|Overall Study|Disease Progression (RECIST1.1)|6
4633571|NCT01912963|7503762|FG001|Overall Study|Disease Progression (RECIST1.1)|9
4633572|NCT01912963|7503763|FG002|Overall Study|Disease Progression (RECIST1.1)|5
4633573|NCT01912963|7503761|FG000|Overall Study|Disease Progression (not RECIST1.1)|0
4633574|NCT01912963|7503762|FG001|Overall Study|Disease Progression (not RECIST1.1)|7
4633575|NCT01912963|7503763|FG002|Overall Study|Disease Progression (not RECIST1.1)|1
4633576|NCT01912963|7503761|FG000|Overall Study|Adverse Event|0
4633577|NCT01912963|7503762|FG001|Overall Study|Adverse Event|1
4633578|NCT01912963|7503763|FG002|Overall Study|Adverse Event|1
4633579|NCT01912963|7503761|FG000|Overall Study|Withdrawal by Subject|0
4633580|NCT01912963|7503762|FG001|Overall Study|Withdrawal by Subject|1
4633581|NCT01912963|7503763|FG002|Overall Study|Withdrawal by Subject|0
4522564|NCT01001104|7336862|FG001|Overall Study|Withdrawal by Subject|0
4522565|NCT01001104|7336863|FG002|Overall Study|Withdrawal by Subject|0
4522566|NCT01001104|7336864|FG003|Overall Study|Withdrawal by Subject|2
4522567|NCT01001169|7336879|FG000|Overall Study|Withdrawal by Subject|2
4522568|NCT01001169|7336880|FG001|Overall Study|Withdrawal by Subject|1
4522569|NCT01001208|7336913|FG000|Overall Study|Adverse Event|10
4522570|NCT01001208|7336914|FG001|Overall Study|Adverse Event|5
4522571|NCT01001208|7336913|FG000|Overall Study|Lost to Follow-up|5
4522572|NCT01001208|7336914|FG001|Overall Study|Lost to Follow-up|9
4522573|NCT01001208|7336913|FG000|Overall Study|Physician Decision|1
4522574|NCT01001208|7336914|FG001|Overall Study|Physician Decision|0
4522575|NCT01001208|7336913|FG000|Overall Study|Withdrawal by Subject|4
4522576|NCT01001208|7336914|FG001|Overall Study|Withdrawal by Subject|5
4522577|NCT01001208|7336913|FG000|Overall Study|Ineligibility Determined|4
4522578|NCT01001208|7336914|FG001|Overall Study|Ineligibility Determined|2
4522579|NCT01001208|7336913|FG000|Overall Study|Noncompliance|4
4522580|NCT01001208|7336914|FG001|Overall Study|Noncompliance|7
4522581|NCT01001208|7336913|FG000|Overall Study|Disease Progression|0
4522582|NCT01001208|7336914|FG001|Overall Study|Disease Progression|3
4522583|NCT01001208|7336913|FG000|Overall Study|Other|0
4522584|NCT01001208|7336914|FG001|Overall Study|Other|2
4522585|NCT01001221|7336924|FG000|Overall Study|Adverse Event|1
4522586|NCT01001221|7336925|FG001|Overall Study|Adverse Event|2
4522587|NCT01001221|7336926|FG002|Overall Study|Adverse Event|0
4522588|NCT01001221|7336927|FG003|Overall Study|Adverse Event|2
4522589|NCT01001221|7336928|FG004|Overall Study|Adverse Event|0
4522590|NCT01001221|7336924|FG000|Overall Study|Disease progression|3
4522591|NCT01001221|7336925|FG001|Overall Study|Disease progression|2
4522592|NCT01001221|7336926|FG002|Overall Study|Disease progression|2
4522593|NCT01001221|7336927|FG003|Overall Study|Disease progression|4
4522594|NCT01001221|7336928|FG004|Overall Study|Disease progression|0
4522595|NCT01001221|7336924|FG000|Overall Study|Other|1
4522596|NCT01001221|7336925|FG001|Overall Study|Other|1
4522597|NCT01001221|7336926|FG002|Overall Study|Other|0
4522598|NCT01001221|7336927|FG003|Overall Study|Other|0
4522599|NCT01001221|7336928|FG004|Overall Study|Other|0
4522600|NCT01001221|7336924|FG000|Overall Study|Not treated; protocol exclusion|0
4522601|NCT01001221|7336925|FG001|Overall Study|Not treated; protocol exclusion|0
4522602|NCT01001221|7336926|FG002|Overall Study|Not treated; protocol exclusion|1
4522603|NCT01001221|7336927|FG003|Overall Study|Not treated; protocol exclusion|0
4522604|NCT01001221|7336928|FG004|Overall Study|Not treated; protocol exclusion|0
4522605|NCT01001299|7336939|FG000|Overall Study|Insufficient Therapeutic Response|20
4522606|NCT01001299|7336939|FG000|Overall Study|Adverse event or Intercurrent Illness|1
4522607|NCT01001299|7336939|FG000|Overall Study|Death|1
4522608|NCT01001299|7336939|FG000|Overall Study|Began Taking Commercially Available Drug|2
4522609|NCT01001299|7336939|FG000|Overall Study|Withdrew Consent|1
4522610|NCT01001325|7336945|FG000|Overall Study|Lost to Follow-up|16
4522611|NCT01001325|7336946|FG001|Overall Study|Lost to Follow-up|10
4522612|NCT01001325|7336945|FG000|Overall Study|Protocol Violation|2
4522613|NCT01001325|7336946|FG001|Overall Study|Protocol Violation|0
4522614|NCT01001377|7336954|FG000|Overall Study|Ineligibility determined|2
4522615|NCT01001377|7336955|FG001|Overall Study|Ineligibility determined|0
4522616|NCT01001377|7336954|FG000|Overall Study|Withdrawal by Subject|19
4522617|NCT01001377|7336955|FG001|Overall Study|Withdrawal by Subject|20
4522618|NCT01001377|7336954|FG000|Overall Study|Lost to Follow-up|14
4522619|NCT01001377|7336955|FG001|Overall Study|Lost to Follow-up|17
4522620|NCT01001377|7336954|FG000|Overall Study|Death|391
4522621|NCT01001377|7336955|FG001|Overall Study|Death|384
4522622|NCT01001429|7336972|FG000|Overall Study|surgery cancelled|0
4522623|NCT01001429|7336973|FG001|Overall Study|surgery cancelled|1
4522624|NCT01001494|7337043|FG000|Overall Study|Adverse Event|8
4522625|NCT01001494|7337044|FG001|Overall Study|Adverse Event|4
4522626|NCT01001494|7337045|FG002|Overall Study|Adverse Event|6
4522627|NCT01001494|7337043|FG000|Overall Study|Protocol Violation|0
4522628|NCT01001494|7337044|FG001|Overall Study|Protocol Violation|1
4522629|NCT01001494|7337045|FG002|Overall Study|Protocol Violation|1
4522630|NCT01001494|7337043|FG000|Overall Study|Lost to Follow-up|2
4522631|NCT01001494|7337044|FG001|Overall Study|Lost to Follow-up|0
4522632|NCT01001494|7337045|FG002|Overall Study|Lost to Follow-up|1
4522633|NCT01001494|7337043|FG000|Overall Study|Withdrawal by Subject|9
4522634|NCT01001494|7337044|FG001|Overall Study|Withdrawal by Subject|7
4522635|NCT01001494|7337045|FG002|Overall Study|Withdrawal by Subject|17
4522636|NCT01001494|7337043|FG000|Overall Study|COPD exacerbation|3
4522637|NCT01001494|7337044|FG001|Overall Study|COPD exacerbation|4
4522638|NCT01001494|7337045|FG002|Overall Study|COPD exacerbation|5
4522639|NCT01001494|7337043|FG000|Overall Study|Lack of Efficacy|2
4522640|NCT01001494|7337044|FG001|Overall Study|Lack of Efficacy|0
4522641|NCT01001494|7337045|FG002|Overall Study|Lack of Efficacy|8
4522642|NCT01001494|7337043|FG000|Overall Study|Other|0
4522643|NCT01001494|7337044|FG001|Overall Study|Other|1
4522644|NCT01001494|7337045|FG002|Overall Study|Other|3
4522645|NCT01001520|7337053|FG000|Medication Period 1|Withdrawal by Subject|2
4522646|NCT01001520|7337054|FG001|Medication Period 1|Withdrawal by Subject|2
4522647|NCT01001520|7337053|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0
4522648|NCT01001520|7337054|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3
4522649|NCT01001520|7337053|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0
4522650|NCT01001520|7337054|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2
4522651|NCT01001520|7337053|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2
4522652|NCT01001520|7337054|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0
4522653|NCT01001520|7337053|FG000|Washout Period|Withdrawal by Subject|2
4522654|NCT01001520|7337054|FG001|Washout Period|Withdrawal by Subject|1
4594209|NCT01559454|7443167|FG000|Overall Study|Lack of Efficacy|0
4594210|NCT01559454|7443168|FG001|Overall Study|Lack of Efficacy|1
4594211|NCT01559675|7443195|FG000|Overall Study|Protocol Violation|1
4594212|NCT01559675|7443196|FG001|Overall Study|Protocol Violation|2
4594213|NCT01559675|7443195|FG000|Overall Study|2nd operation on same patient excluded|14
4594214|NCT01559675|7443196|FG001|Overall Study|2nd operation on same patient excluded|12
4594215|NCT01559844|7443202|FG000|Overall Study|Consent Withdrawn|7
4594216|NCT01559844|7443202|FG000|Overall Study|Death|5
4594217|NCT01559844|7443202|FG000|Overall Study|Efficacy Failure|10
4633582|NCT01912963|7503761|FG000|Overall Study|Sought treatment locally|0
4522655|NCT01001520|7337053|FG000|Medication Period 2|Withdrawal by Subject|0
4522656|NCT01001520|7337054|FG001|Medication Period 2|Withdrawal by Subject|3
4594218|NCT01559844|7443202|FG000|Overall Study|No Longer A Transplant Candidate|3
4594219|NCT01559935|7443226|FG000|Car Phase|Toxicity|4
4594220|NCT01559935|7443226|FG000|Car Phase|Death|1
4522657|NCT01001572|7337083|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32
4522658|NCT01001572|7337084|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0
4522659|NCT01001572|7337085|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0
4522660|NCT01001572|7337083|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11
4522661|NCT01001572|7337084|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0
4522662|NCT01001572|7337085|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0
4522663|NCT01001572|7337083|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96
4522664|NCT01001572|7337084|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0
4522665|NCT01001572|7337085|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0
4522666|NCT01001572|7337083|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7
4522667|NCT01001572|7337084|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0
4522668|NCT01001572|7337085|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0
4522669|NCT01001572|7337083|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1
4522670|NCT01001572|7337084|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0
4522671|NCT01001572|7337085|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0
4522672|NCT01001572|7337083|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4
4522673|NCT01001572|7337084|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0
4522674|NCT01001572|7337085|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0
4522675|NCT01001572|7337083|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82
4522676|NCT01001572|7337084|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0
4522677|NCT01001572|7337085|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0
4522678|NCT01001572|7337083|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45
4522679|NCT01001572|7337084|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0
4522680|NCT01001572|7337085|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0
4522681|NCT01001572|7337083|FG000|Double-Blind Treatment Phase|Adverse Event|0
4522682|NCT01001572|7337084|FG001|Double-Blind Treatment Phase|Adverse Event|2
4522683|NCT01001572|7337085|FG002|Double-Blind Treatment Phase|Adverse Event|2
4522684|NCT01001572|7337083|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0
4522685|NCT01001572|7337084|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8
4522686|NCT01001572|7337085|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13
4522687|NCT01001572|7337083|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0
4522688|NCT01001572|7337084|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0
4522689|NCT01001572|7337085|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1
4522690|NCT01001572|7337083|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
4522691|NCT01001572|7337084|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
4522692|NCT01001572|7337085|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1
4522693|NCT01001572|7337083|FG000|Double-Blind Treatment Phase|Protocol deviation|0
4522694|NCT01001572|7337084|FG001|Double-Blind Treatment Phase|Protocol deviation|0
4522695|NCT01001572|7337085|FG002|Double-Blind Treatment Phase|Protocol deviation|1
4522696|NCT01001572|7337083|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0
4522697|NCT01001572|7337084|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0
4522698|NCT01001572|7337085|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1
4522699|NCT01001598|7337091|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1
4522700|NCT01001598|7337091|FG000|Overall Study|Adverse Event|1
4522701|NCT01001702|7337095|FG000|Overall Study|Lost to Follow-up|7
4522702|NCT01001702|7337095|FG000|Overall Study|Adverse Event|7
4522703|NCT01001702|7337095|FG000|Overall Study|Sponsor Discontinued Study|4
4522704|NCT01001702|7337095|FG000|Overall Study|Subject met Withdrawal Criteria|22
4522705|NCT01001702|7337095|FG000|Overall Study|Investigator withdrew Subject|10
4522706|NCT01001702|7337095|FG000|Overall Study|Withdrawal by Subject|19
4522707|NCT01001702|7337095|FG000|Overall Study|Lack of Efficacy per Investigator|3
4522708|NCT01001767|7337101|FG000|Overall Study|no baseline study performed|1
4522709|NCT01001767|7337102|FG001|Overall Study|no baseline study performed|0
4522710|NCT01001767|7337101|FG000|Overall Study|Protocol Violation|1
4522711|NCT01001767|7337102|FG001|Overall Study|Protocol Violation|0
4522712|NCT01001767|7337101|FG000|Overall Study|Lost to Follow-up|1
4522713|NCT01001767|7337102|FG001|Overall Study|Lost to Follow-up|0
4522714|NCT01001767|7337101|FG000|Overall Study|Physician Decision|1
4522715|NCT01001767|7337102|FG001|Overall Study|Physician Decision|0
4522716|NCT01001832|7337123|FG000|Short-term Period|Adverse Event|2
4522717|NCT01001832|7337124|FG001|Short-term Period|Adverse Event|3
4522718|NCT01001832|7337123|FG000|Long-term Period|Adverse Event|2
4522719|NCT01001832|7337124|FG001|Long-term Period|Adverse Event|1
4522720|NCT01001832|7337123|FG000|Long-term Period|Withdrawal by Subject|1
4522721|NCT01001832|7337124|FG001|Long-term Period|Withdrawal by Subject|0
4522722|NCT01001832|7337123|FG000|Long-term Period|Lack of Efficacy|0
4522723|NCT01001832|7337124|FG001|Long-term Period|Lack of Efficacy|2
4522724|NCT01001832|7337123|FG000|Long-term Period|Other|1
4522725|NCT01001832|7337124|FG001|Long-term Period|Other|2
4522726|NCT01001832|7337123|FG000|Follow-up Period|Withdrawal by Subject|1
4522727|NCT01001832|7337124|FG001|Follow-up Period|Withdrawal by Subject|0
4522728|NCT01001832|7337123|FG000|Follow-up Period|Follow-up no longer required /protocol|15
4522729|NCT01001832|7337124|FG001|Follow-up Period|Follow-up no longer required /protocol|20
4522730|NCT01001832|7337123|FG000|Follow-up Period|Other|2
4522731|NCT01001832|7337124|FG001|Follow-up Period|Other|1
4522732|NCT01001910|7337133|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6
4522733|NCT01001988|7337146|FG000|Overall Study|Protocol Violation|84
4522734|NCT01001988|7337146|FG000|Overall Study|Withdrawal by Subject|18
4522735|NCT01001988|7337146|FG000|Overall Study|Lost to Follow-up|15
4522736|NCT01002105|7337152|FG000|Overall Study|Lost to Follow-up|10
4522737|NCT01002105|7337153|FG001|Overall Study|Lost to Follow-up|16
4522738|NCT01002105|7337152|FG000|Overall Study|non compliance|5
4522739|NCT01002105|7337153|FG001|Overall Study|non compliance|3
4522740|NCT01002105|7337152|FG000|Overall Study|condition worsened|4
4522741|NCT01002105|7337153|FG001|Overall Study|condition worsened|2
4522742|NCT01002339|7337178|FG000|Overall Study|Withdrawal by Subject|0
4522743|NCT01002339|7337179|FG001|Overall Study|Withdrawal by Subject|1
4522744|NCT01002339|7337180|FG002|Overall Study|Withdrawal by Subject|0
4522745|NCT01002339|7337178|FG000|Overall Study|Incorrect treatment assignment|0
4522746|NCT01002339|7337179|FG001|Overall Study|Incorrect treatment assignment|0
4522747|NCT01002339|7337180|FG002|Overall Study|Incorrect treatment assignment|1
4522748|NCT01002339|7337178|FG000|Overall Study|Protocol Violation|0
4522749|NCT01002339|7337179|FG001|Overall Study|Protocol Violation|0
4522750|NCT01002339|7337180|FG002|Overall Study|Protocol Violation|2
4522751|NCT01002339|7337178|FG000|Overall Study|Lung cancer detected before transplant|0
4522752|NCT01002339|7337179|FG001|Overall Study|Lung cancer detected before transplant|0
4522753|NCT01002339|7337180|FG002|Overall Study|Lung cancer detected before transplant|1
4522754|NCT01002339|7337178|FG000|Overall Study|Randomized. Not transplanted|0
4522755|NCT01002339|7337179|FG001|Overall Study|Randomized. Not transplanted|0
4522756|NCT01002339|7337180|FG002|Overall Study|Randomized. Not transplanted|1
4522757|NCT01002482|7337201|FG000|Overall Study|Withdrawal by Subject|14
4522758|NCT01002482|7337202|FG001|Overall Study|Withdrawal by Subject|21
4522759|NCT01002482|7337201|FG000|Overall Study|Included twice|1
4522760|NCT01002482|7337202|FG001|Overall Study|Included twice|0
4522761|NCT01002547|7337211|FG000|Overall Study|Withdrawal by Subject|4
4522762|NCT01002547|7337212|FG001|Overall Study|Withdrawal by Subject|0
4522763|NCT01002547|7337213|FG002|Overall Study|Withdrawal by Subject|5
4522764|NCT01002547|7337211|FG000|Overall Study|Lost to Follow-up|2
4522765|NCT01002547|7337212|FG001|Overall Study|Lost to Follow-up|1
4522766|NCT01002547|7337213|FG002|Overall Study|Lost to Follow-up|1
4522767|NCT01002547|7337211|FG000|Overall Study|Physician Decision|1
4522768|NCT01002547|7337212|FG001|Overall Study|Physician Decision|0
4522769|NCT01002547|7337213|FG002|Overall Study|Physician Decision|0
4522770|NCT01002547|7337211|FG000|Overall Study|Death|0
4522771|NCT01002547|7337212|FG001|Overall Study|Death|2
4522772|NCT01002547|7337213|FG002|Overall Study|Death|2
4522773|NCT01002547|7337211|FG000|Overall Study|Adverse Event|1
4522774|NCT01002547|7337212|FG001|Overall Study|Adverse Event|0
4522775|NCT01002547|7337213|FG002|Overall Study|Adverse Event|0
4522776|NCT01002573|7337223|FG000|Overall Study|Subject did not receive at least 1 dose|11
4522777|NCT01002573|7337224|FG001|Overall Study|Subject did not receive at least 1 dose|7
4522778|NCT01002742|7337232|FG000|Overall Study|Determined to be ineligible|0
4522779|NCT01002742|7337233|FG001|Overall Study|Determined to be ineligible|1
4633583|NCT01912963|7503762|FG001|Overall Study|Sought treatment locally|1
4633584|NCT01912963|7503763|FG002|Overall Study|Sought treatment locally|0
4633585|NCT01913041|7503771|FG000|Overall Study|Protocol Violation|35
4633586|NCT01913041|7503771|FG000|Overall Study|Withdrawal by Subject|3
4633587|NCT01913041|7503771|FG000|Overall Study|Physician Decision|1
4633588|NCT01913340|7503781|FG000|Overall Study|Death|2
4633589|NCT01913340|7503782|FG001|Overall Study|Death|5
4633590|NCT01913340|7503781|FG000|Overall Study|Lost to Follow-up|1
4633591|NCT01913340|7503782|FG001|Overall Study|Lost to Follow-up|1
4522780|NCT01002989|7337243|FG000|Overall Study|exclusion criteria, no consent|5
4522781|NCT01003184|7337292|FG000|Overall Study|Adverse Event|12
4522782|NCT01003184|7337293|FG001|Overall Study|Adverse Event|5
4522783|NCT01003184|7337292|FG000|Overall Study|Lost to Follow-up|1
4522784|NCT01003184|7337293|FG001|Overall Study|Lost to Follow-up|0
4522785|NCT01003184|7337292|FG000|Overall Study|Loss of glucose control|1
4522786|NCT01003184|7337293|FG001|Overall Study|Loss of glucose control|1
4522787|NCT01003184|7337292|FG000|Overall Study|Protocol Violation|3
4522788|NCT01003184|7337293|FG001|Overall Study|Protocol Violation|0
4522789|NCT01003184|7337292|FG000|Overall Study|Withdrawal by Subject|1
4522790|NCT01003184|7337293|FG001|Overall Study|Withdrawal by Subject|6
4522791|NCT01003184|7337292|FG000|Overall Study|Physician Decision|1
4522792|NCT01003184|7337293|FG001|Overall Study|Physician Decision|0
4522793|NCT01003210|7337301|FG000|Overall Study|Lost to Follow-up|1
4522794|NCT01003210|7337302|FG001|Overall Study|Lost to Follow-up|3
4522795|NCT01003249|7337308|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1
4522796|NCT01003249|7337309|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1
4522797|NCT01003249|7337308|FG000|First Intervention (4 Weeks)|Non-Serious Event|1
4633592|NCT01913353|7503790|FG000|Overall Study|Adverse Event|2
4633593|NCT01913353|7503791|FG001|Overall Study|Adverse Event|0
4633594|NCT01913353|7503790|FG000|Overall Study|Physician Decision|0
4633595|NCT01913353|7503791|FG001|Overall Study|Physician Decision|2
4522798|NCT01003249|7337309|FG001|First Intervention (4 Weeks)|Non-Serious Event|1
4522799|NCT01003249|7337308|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0
4633596|NCT01913353|7503790|FG000|Overall Study|Withdrawal by Subject|20
4522800|NCT01003249|7337309|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1
4522801|NCT01003249|7337308|FG000|Second Intervention (4 Weeks)|Adverse Event|1
4522802|NCT01003249|7337309|FG001|Second Intervention (4 Weeks)|Adverse Event|0
4522803|NCT01003639|7337355|FG000|Overall Study|Lost to Follow-up|6
4522804|NCT01003639|7337356|FG001|Overall Study|Lost to Follow-up|9
4522805|NCT01003639|7337355|FG000|Overall Study|Withdrawal by Subject|9
4522806|NCT01003639|7337356|FG001|Overall Study|Withdrawal by Subject|5
4522807|NCT01003639|7337355|FG000|Overall Study|Lack of Efficacy|1
4522808|NCT01003639|7337356|FG001|Overall Study|Lack of Efficacy|6
4522809|NCT01003639|7337355|FG000|Overall Study|Adverse Event|0
4522810|NCT01003639|7337356|FG001|Overall Study|Adverse Event|1
4522811|NCT01003639|7337355|FG000|Overall Study|Protocol Violation|0
4522812|NCT01003639|7337356|FG001|Overall Study|Protocol Violation|1
4522813|NCT01003639|7337355|FG000|Overall Study|Physician Decision|1
4522814|NCT01003639|7337356|FG001|Overall Study|Physician Decision|0
4522815|NCT01003886|7337366|FG000|Overall Study|Lack of Efficacy|5
4522816|NCT01003886|7337366|FG000|Overall Study|Lost to Follow-up|169
4522817|NCT01003886|7337366|FG000|Overall Study|Withdrawal by Subject|39
4522818|NCT01003886|7337366|FG000|Overall Study|Other|14
4522819|NCT01003886|7337366|FG000|Overall Study|Adverse Event|3
4522820|NCT01003899|7337370|FG000|Overall Study|Other Adverse Event|8
4522821|NCT01003899|7337370|FG000|Overall Study|Not entered|4
4522822|NCT01003899|7337370|FG000|Overall Study|Not treated|1
4522823|NCT01003899|7337370|FG000|Overall Study|Progressive disease|34
4522824|NCT01003990|7337381|FG000|Overall Study|Adverse Event|8
4522825|NCT01003990|7337382|FG001|Overall Study|Adverse Event|5
4522826|NCT01003990|7337383|FG002|Overall Study|Adverse Event|11
4522827|NCT01003990|7337381|FG000|Overall Study|Death|0
4522828|NCT01003990|7337382|FG001|Overall Study|Death|8
4522829|NCT01003990|7337383|FG002|Overall Study|Death|1
4522830|NCT01003990|7337381|FG000|Overall Study|Lack of Efficacy|10
4522831|NCT01003990|7337382|FG001|Overall Study|Lack of Efficacy|2
4522832|NCT01003990|7337383|FG002|Overall Study|Lack of Efficacy|3
4522833|NCT01003990|7337381|FG000|Overall Study|Lost to Follow-up|30
4522834|NCT01003990|7337382|FG001|Overall Study|Lost to Follow-up|12
4522835|NCT01003990|7337383|FG002|Overall Study|Lost to Follow-up|7
4522836|NCT01003990|7337381|FG000|Overall Study|Reasons Not Identified|14
4522837|NCT01003990|7337382|FG001|Overall Study|Reasons Not Identified|13
4522838|NCT01003990|7337383|FG002|Overall Study|Reasons Not Identified|8
4522839|NCT01003990|7337381|FG000|Overall Study|Poor/Non-compliance|4
4522840|NCT01003990|7337382|FG001|Overall Study|Poor/Non-compliance|3
4522841|NCT01003990|7337383|FG002|Overall Study|Poor/Non-compliance|2
4522842|NCT01003990|7337381|FG000|Overall Study|Pregnancy|10
4522843|NCT01003990|7337382|FG001|Overall Study|Pregnancy|2
4522844|NCT01003990|7337383|FG002|Overall Study|Pregnancy|4
4522845|NCT01003990|7337381|FG000|Overall Study|No Longer Met Study Criteria|4
4522846|NCT01003990|7337382|FG001|Overall Study|No Longer Met Study Criteria|1
4522847|NCT01003990|7337383|FG002|Overall Study|No Longer Met Study Criteria|0
4522848|NCT01003990|7337381|FG000|Overall Study|Subject Withdrew Consent|12
4522849|NCT01003990|7337382|FG001|Overall Study|Subject Withdrew Consent|5
4522850|NCT01003990|7337383|FG002|Overall Study|Subject Withdrew Consent|7
4522851|NCT01004003|7337400|FG000|Overall Study|Progressive disease|2
4522852|NCT01004003|7337401|FG001|Overall Study|Progressive disease|1
4522853|NCT01004003|7337402|FG002|Overall Study|Progressive disease|1
4522854|NCT01004003|7337403|FG003|Overall Study|Progressive disease|0
4522855|NCT01004003|7337404|FG004|Overall Study|Progressive disease|2
4522856|NCT01004003|7337405|FG005|Overall Study|Progressive disease|1
4522857|NCT01004003|7337406|FG006|Overall Study|Progressive disease|1
4522858|NCT01004003|7337407|FG007|Overall Study|Progressive disease|39
4522859|NCT01004003|7337408|FG008|Overall Study|Progressive disease|22
4522860|NCT01004003|7337400|FG000|Overall Study|Adverse Event|4
4522861|NCT01004003|7337401|FG001|Overall Study|Adverse Event|2
4522862|NCT01004003|7337402|FG002|Overall Study|Adverse Event|3
4522863|NCT01004003|7337403|FG003|Overall Study|Adverse Event|3
4522864|NCT01004003|7337404|FG004|Overall Study|Adverse Event|2
4522865|NCT01004003|7337405|FG005|Overall Study|Adverse Event|2
4522866|NCT01004003|7337406|FG006|Overall Study|Adverse Event|7
4522867|NCT01004003|7337407|FG007|Overall Study|Adverse Event|21
4522868|NCT01004003|7337408|FG008|Overall Study|Adverse Event|6
4522869|NCT01004003|7337400|FG000|Overall Study|Refused to continue taking trial med.|0
4522870|NCT01004003|7337401|FG001|Overall Study|Refused to continue taking trial med.|0
4522871|NCT01004003|7337402|FG002|Overall Study|Refused to continue taking trial med.|0
4522872|NCT01004003|7337403|FG003|Overall Study|Refused to continue taking trial med.|0
4522873|NCT01004003|7337404|FG004|Overall Study|Refused to continue taking trial med.|0
4522874|NCT01004003|7337405|FG005|Overall Study|Refused to continue taking trial med.|0
4522875|NCT01004003|7337406|FG006|Overall Study|Refused to continue taking trial med.|0
4522876|NCT01004003|7337407|FG007|Overall Study|Refused to continue taking trial med.|0
4522877|NCT01004003|7337408|FG008|Overall Study|Refused to continue taking trial med.|2
4522878|NCT01004003|7337400|FG000|Overall Study|Other|0
4522879|NCT01004003|7337401|FG001|Overall Study|Other|0
4522880|NCT01004003|7337402|FG002|Overall Study|Other|0
4522881|NCT01004003|7337403|FG003|Overall Study|Other|0
4522882|NCT01004003|7337404|FG004|Overall Study|Other|0
4522883|NCT01004003|7337405|FG005|Overall Study|Other|1
4522884|NCT01004003|7337406|FG006|Overall Study|Other|0
4522885|NCT01004003|7337407|FG007|Overall Study|Other|0
4522886|NCT01004003|7337408|FG008|Overall Study|Other|0
4522887|NCT01004146|7337479|FG000|Overall Study|Withdrawal by Subject|4
4522888|NCT01004146|7337480|FG001|Overall Study|Withdrawal by Subject|5
4522889|NCT01004159|7337486|FG000|Overall Study|Adverse Event|2
4522890|NCT01004159|7337486|FG000|Overall Study|Disease Progression|18
4522891|NCT01004172|7337490|FG000|Overall Study|Progressive Disease in CNS Only|16
4522892|NCT01004172|7337490|FG000|Overall Study|Progressive Disease in Non-CNS Only|16
4522893|NCT01004172|7337490|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2
4522894|NCT01004172|7337490|FG000|Overall Study|Adverse Event|1
4522895|NCT01004172|7337490|FG000|Overall Study|Physician Decision|1
4522896|NCT01004172|7337490|FG000|Overall Study|Symptomatic Deterioration|2
4522897|NCT01004185|7337497|FG000|Overall Study|Adverse Event|1
4522898|NCT01004185|7337498|FG001|Overall Study|Adverse Event|1
4522899|NCT01004185|7337497|FG000|Overall Study|Lost to Follow-up|0
4522900|NCT01004185|7337498|FG001|Overall Study|Lost to Follow-up|1
4522901|NCT01004185|7337497|FG000|Overall Study|Lack of Efficacy|2
4522902|NCT01004185|7337498|FG001|Overall Study|Lack of Efficacy|1
4522903|NCT01004185|7337497|FG000|Overall Study|Sponsor Terminated Study|4
4522904|NCT01004185|7337498|FG001|Overall Study|Sponsor Terminated Study|5
4522905|NCT01004185|7337497|FG000|Overall Study|Withdrawal by Subject|2
4522906|NCT01004185|7337498|FG001|Overall Study|Withdrawal by Subject|1
4522907|NCT01004250|7337504|FG000|Induction Therapy Period|Adverse Event|10
4522908|NCT01004250|7337504|FG000|Induction Therapy Period|Entry Criteria Not Met|1
4522909|NCT01004250|7337504|FG000|Induction Therapy Period|Withdrawal by Subject|2
4522910|NCT01004250|7337504|FG000|Induction Therapy Period|Physician Decision|2
4522911|NCT01004250|7337504|FG000|Maintenance Therapy Period|Adverse Event|15
4522912|NCT01004250|7337504|FG000|Maintenance Therapy Period|Lost to Follow-up|1
4522913|NCT01004250|7337504|FG000|Maintenance Therapy Period|Protocol Violation|1
4522914|NCT01004250|7337504|FG000|Maintenance Therapy Period|Withdrawal by Subject|5
4522915|NCT01004250|7337504|FG000|Maintenance Therapy Period|Physician Decision|4
4522916|NCT01004250|7337504|FG000|Follow-Up (FU) Period|Lost to Follow-up|1
4522917|NCT01004406|7337522|FG000|Overall Study|Withdrawal by Subject|2
4522918|NCT01004406|7337523|FG001|Overall Study|Withdrawal by Subject|0
4522919|NCT01004406|7337522|FG000|Overall Study|Lost to Follow-up|1
4522920|NCT01004406|7337523|FG001|Overall Study|Lost to Follow-up|0
4522921|NCT01004432|7337529|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20
4522922|NCT01004432|7337530|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0
4522923|NCT01004432|7337531|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0
4522924|NCT01004432|7337532|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0
4522925|NCT01004432|7337533|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0
4522926|NCT01004432|7337529|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29
4522927|NCT01004432|7337530|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0
4522928|NCT01004432|7337531|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0
4522929|NCT01004432|7337532|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0
4522930|NCT01004432|7337533|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0
4522931|NCT01004432|7337529|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17
4522932|NCT01004432|7337530|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0
4522933|NCT01004432|7337531|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0
4522934|NCT01004432|7337532|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0
4522935|NCT01004432|7337533|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0
4522936|NCT01004432|7337529|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15
4522937|NCT01004432|7337530|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0
4522938|NCT01004432|7337531|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0
4522939|NCT01004432|7337532|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0
4522940|NCT01004432|7337533|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0
4522941|NCT01004432|7337529|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2
4522942|NCT01004432|7337530|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0
4522943|NCT01004432|7337531|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0
4522944|NCT01004432|7337532|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0
4522945|NCT01004432|7337533|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0
4522946|NCT01004432|7337529|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0
4522947|NCT01004432|7337530|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1
4522948|NCT01004432|7337531|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5
4522949|NCT01004432|7337532|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6
4522950|NCT01004432|7337533|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0
4522951|NCT01004432|7337529|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0
4522952|NCT01004432|7337530|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3
4522953|NCT01004432|7337531|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3
4522954|NCT01004432|7337532|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4
4522955|NCT01004432|7337533|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0
4522956|NCT01004432|7337529|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0
4522957|NCT01004432|7337530|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1
4522958|NCT01004432|7337531|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4
4522959|NCT01004432|7337532|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7
4522960|NCT01004432|7337533|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0
4522961|NCT01004432|7337529|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
4522962|NCT01004432|7337530|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
4522963|NCT01004432|7337531|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
4522964|NCT01004432|7337532|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1
4522965|NCT01004432|7337533|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
4522966|NCT01004432|7337529|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0
4522967|NCT01004432|7337530|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2
4522968|NCT01004432|7337531|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24
4522969|NCT01004432|7337532|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37
4522970|NCT01004432|7337533|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0
4522971|NCT01004432|7337529|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0
4522972|NCT01004432|7337530|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3
4522973|NCT01004432|7337531|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1
4522974|NCT01004432|7337532|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3
4522975|NCT01004432|7337533|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0
4522976|NCT01004432|7337529|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0
4522977|NCT01004432|7337530|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0
4522978|NCT01004432|7337531|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0
4522979|NCT01004432|7337532|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0
4522980|NCT01004432|7337533|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2
4522981|NCT01004432|7337529|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0
4522982|NCT01004432|7337530|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0
4522983|NCT01004432|7337531|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0
4522984|NCT01004432|7337532|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0
4522985|NCT01004432|7337533|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4
4522986|NCT01004432|7337529|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
4522987|NCT01004432|7337530|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
4522988|NCT01004432|7337531|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
4522989|NCT01004432|7337532|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
4522990|NCT01004432|7337533|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2
4522991|NCT01004432|7337529|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
4522992|NCT01004432|7337530|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
4522993|NCT01004432|7337531|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
4522994|NCT01004432|7337532|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
4522995|NCT01004432|7337533|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10
4522996|NCT01004614|7337551|FG000|Washout|Withdrawal by Subject|0
4522997|NCT01004614|7337552|FG001|Washout|Withdrawal by Subject|1
4522998|NCT01004614|7337553|FG002|Washout|Withdrawal by Subject|0
4522999|NCT01004614|7337554|FG003|Washout|Withdrawal by Subject|0
4523000|NCT01004822|7337611|FG000|Overall Study|Objective progression or relapse|3
4523001|NCT01004822|7337612|FG001|Overall Study|Objective progression or relapse|3
4523002|NCT01004822|7337613|FG002|Overall Study|Objective progression or relapse|0
4523003|NCT01004822|7337614|FG003|Overall Study|Objective progression or relapse|1
4523004|NCT01004822|7337615|FG004|Overall Study|Objective progression or relapse|2
4523005|NCT01004822|7337616|FG005|Overall Study|Objective progression or relapse|2
4523006|NCT01004822|7337617|FG006|Overall Study|Objective progression or relapse|1
4523007|NCT01004822|7337618|FG007|Overall Study|Objective progression or relapse|4
4523008|NCT01004822|7337611|FG000|Overall Study|Global deterioration of health status|0
4523009|NCT01004822|7337612|FG001|Overall Study|Global deterioration of health status|0
4523010|NCT01004822|7337613|FG002|Overall Study|Global deterioration of health status|0
4523011|NCT01004822|7337614|FG003|Overall Study|Global deterioration of health status|1
4523012|NCT01004822|7337615|FG004|Overall Study|Global deterioration of health status|0
4523013|NCT01004822|7337616|FG005|Overall Study|Global deterioration of health status|0
4523014|NCT01004822|7337617|FG006|Overall Study|Global deterioration of health status|1
4523015|NCT01004822|7337618|FG007|Overall Study|Global deterioration of health status|0
4523016|NCT01004822|7337611|FG000|Overall Study|No longer willing to continue|0
4523017|NCT01004822|7337612|FG001|Overall Study|No longer willing to continue|0
4523018|NCT01004822|7337613|FG002|Overall Study|No longer willing to continue|0
4523019|NCT01004822|7337614|FG003|Overall Study|No longer willing to continue|1
4523020|NCT01004822|7337615|FG004|Overall Study|No longer willing to continue|2
4523021|NCT01004822|7337616|FG005|Overall Study|No longer willing to continue|1
4523022|NCT01004822|7337617|FG006|Overall Study|No longer willing to continue|1
4523023|NCT01004822|7337618|FG007|Overall Study|No longer willing to continue|0
4523024|NCT01004822|7337611|FG000|Overall Study|Adverse Event|0
4523025|NCT01004822|7337612|FG001|Overall Study|Adverse Event|0
4523026|NCT01004822|7337613|FG002|Overall Study|Adverse Event|0
4523027|NCT01004822|7337614|FG003|Overall Study|Adverse Event|0
4523028|NCT01004822|7337615|FG004|Overall Study|Adverse Event|0
4523029|NCT01004822|7337616|FG005|Overall Study|Adverse Event|0
4523030|NCT01004822|7337617|FG006|Overall Study|Adverse Event|1
4523031|NCT01004822|7337618|FG007|Overall Study|Adverse Event|1
4523032|NCT01004822|7337611|FG000|Overall Study|Other|0
4523033|NCT01004822|7337612|FG001|Overall Study|Other|0
4523034|NCT01004822|7337613|FG002|Overall Study|Other|4
4523035|NCT01004822|7337614|FG003|Overall Study|Other|1
4523036|NCT01004822|7337615|FG004|Overall Study|Other|0
4523037|NCT01004822|7337616|FG005|Overall Study|Other|1
4523038|NCT01004822|7337617|FG006|Overall Study|Other|0
4523039|NCT01004822|7337618|FG007|Overall Study|Other|0
4523040|NCT01004848|7337640|FG000|Overall Study|Lost to Follow-up|55
4523041|NCT01004848|7337641|FG001|Overall Study|Lost to Follow-up|45
4523042|NCT01005251|7337664|FG000|Overall Study|Withdrawal by Subject|2
4523043|NCT01005251|7337665|FG001|Overall Study|Withdrawal by Subject|5
4523044|NCT01005251|7337666|FG002|Overall Study|Withdrawal by Subject|3
4523045|NCT01005251|7337667|FG003|Overall Study|Withdrawal by Subject|4
4523046|NCT01005251|7337668|FG004|Overall Study|Withdrawal by Subject|9
4523047|NCT01005251|7337664|FG000|Overall Study|Eligibility criteria not fulfilled|4
4523048|NCT01005251|7337665|FG001|Overall Study|Eligibility criteria not fulfilled|0
4523049|NCT01005251|7337666|FG002|Overall Study|Eligibility criteria not fulfilled|4
4523050|NCT01005251|7337667|FG003|Overall Study|Eligibility criteria not fulfilled|1
4523051|NCT01005251|7337668|FG004|Overall Study|Eligibility criteria not fulfilled|0
4523052|NCT01005251|7337664|FG000|Overall Study|Adverse Event|2
4523053|NCT01005251|7337665|FG001|Overall Study|Adverse Event|6
4523054|NCT01005251|7337666|FG002|Overall Study|Adverse Event|8
4523055|NCT01005251|7337667|FG003|Overall Study|Adverse Event|5
4523056|NCT01005251|7337668|FG004|Overall Study|Adverse Event|4
4523057|NCT01005251|7337664|FG000|Overall Study|Protocol Violation|1
4523058|NCT01005251|7337665|FG001|Overall Study|Protocol Violation|0
4523059|NCT01005251|7337666|FG002|Overall Study|Protocol Violation|0
4523060|NCT01005251|7337667|FG003|Overall Study|Protocol Violation|0
4523061|NCT01005251|7337668|FG004|Overall Study|Protocol Violation|2
4523062|NCT01005251|7337664|FG000|Overall Study|Developed study-specific withdrawal crit|2
4523063|NCT01005251|7337665|FG001|Overall Study|Developed study-specific withdrawal crit|0
4523064|NCT01005251|7337666|FG002|Overall Study|Developed study-specific withdrawal crit|3
4523065|NCT01005251|7337667|FG003|Overall Study|Developed study-specific withdrawal crit|0
4523066|NCT01005251|7337668|FG004|Overall Study|Developed study-specific withdrawal crit|1
4523067|NCT01005251|7337664|FG000|Overall Study|Lost to Follow-up|1
4523068|NCT01005251|7337665|FG001|Overall Study|Lost to Follow-up|4
4523069|NCT01005251|7337666|FG002|Overall Study|Lost to Follow-up|2
4523070|NCT01005251|7337667|FG003|Overall Study|Lost to Follow-up|0
4523071|NCT01005251|7337668|FG004|Overall Study|Lost to Follow-up|0
4523072|NCT01005251|7337664|FG000|Overall Study|Physician Decision|0
4523073|NCT01005251|7337665|FG001|Overall Study|Physician Decision|0
4523074|NCT01005251|7337666|FG002|Overall Study|Physician Decision|0
4523075|NCT01005251|7337667|FG003|Overall Study|Physician Decision|0
4523076|NCT01005251|7337668|FG004|Overall Study|Physician Decision|2
4523077|NCT01005251|7337664|FG000|Overall Study|Patient moved|1
4523078|NCT01005251|7337665|FG001|Overall Study|Patient moved|0
4523079|NCT01005251|7337666|FG002|Overall Study|Patient moved|0
4523080|NCT01005251|7337667|FG003|Overall Study|Patient moved|0
4523081|NCT01005251|7337668|FG004|Overall Study|Patient moved|0
4523082|NCT01005251|7337664|FG000|Overall Study|Wrong drug dispensed|0
4523083|NCT01005251|7337665|FG001|Overall Study|Wrong drug dispensed|1
4523084|NCT01005251|7337666|FG002|Overall Study|Wrong drug dispensed|0
4523085|NCT01005251|7337667|FG003|Overall Study|Wrong drug dispensed|0
4523086|NCT01005251|7337668|FG004|Overall Study|Wrong drug dispensed|0
4523087|NCT01005251|7337664|FG000|Overall Study|Randomized in error|0
4523088|NCT01005251|7337665|FG001|Overall Study|Randomized in error|0
4523089|NCT01005251|7337666|FG002|Overall Study|Randomized in error|1
4523090|NCT01005251|7337667|FG003|Overall Study|Randomized in error|1
4523091|NCT01005251|7337668|FG004|Overall Study|Randomized in error|0
4523092|NCT01005251|7337664|FG000|Overall Study|Lack of Efficacy|0
4523093|NCT01005251|7337665|FG001|Overall Study|Lack of Efficacy|0
4523094|NCT01005251|7337666|FG002|Overall Study|Lack of Efficacy|1
4523095|NCT01005251|7337667|FG003|Overall Study|Lack of Efficacy|1
4523096|NCT01005251|7337668|FG004|Overall Study|Lack of Efficacy|0
4737848|NCT03627494|7688421|FG008|Part C Washout 1 (7 Days)|Adverse Event|0
4737849|NCT03627494|7688422|FG009|Part C Washout 1 (7 Days)|Adverse Event|0
4737850|NCT03627494|7688423|FG010|Part C Washout 1 (7 Days)|Adverse Event|1
4737851|NCT03627494|7688424|FG011|Part C Washout 1 (7 Days)|Adverse Event|1
4737852|NCT03627767|7688466|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48
4737853|NCT03627767|7688467|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0
4737854|NCT03627767|7688468|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0
4737855|NCT03627767|7688469|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0
4737856|NCT03627767|7688470|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0
4737857|NCT03627767|7688466|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1
4737858|NCT03627767|7688467|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0
4523097|NCT01005316|7337692|FG000|Overall Study|Adverse Event|0
4523098|NCT01005316|7337693|FG001|Overall Study|Adverse Event|0
4523099|NCT01005316|7337694|FG002|Overall Study|Adverse Event|0
4523100|NCT01005316|7337695|FG003|Overall Study|Adverse Event|1
4523101|NCT01005316|7337692|FG000|Overall Study|Death|20
4523102|NCT01005316|7337693|FG001|Overall Study|Death|5
4523103|NCT01005316|7337694|FG002|Overall Study|Death|1
4523104|NCT01005316|7337695|FG003|Overall Study|Death|15
4523105|NCT01005316|7337692|FG000|Overall Study|Study Termination|5
4523106|NCT01005316|7337693|FG001|Overall Study|Study Termination|63
4523107|NCT01005316|7337694|FG002|Overall Study|Study Termination|9
4523108|NCT01005316|7337695|FG003|Overall Study|Study Termination|85
4523109|NCT01005316|7337692|FG000|Overall Study|Lost to Follow-up|1
4523110|NCT01005316|7337693|FG001|Overall Study|Lost to Follow-up|3
4523111|NCT01005316|7337694|FG002|Overall Study|Lost to Follow-up|0
4523112|NCT01005316|7337695|FG003|Overall Study|Lost to Follow-up|2
4523113|NCT01005316|7337692|FG000|Overall Study|Physician Decision|6
4523114|NCT01005316|7337693|FG001|Overall Study|Physician Decision|0
4523115|NCT01005316|7337694|FG002|Overall Study|Physician Decision|0
4523116|NCT01005316|7337695|FG003|Overall Study|Physician Decision|0
4523117|NCT01005316|7337692|FG000|Overall Study|Sponsor Decision|6
4523118|NCT01005316|7337693|FG001|Overall Study|Sponsor Decision|3
4523119|NCT01005316|7337694|FG002|Overall Study|Sponsor Decision|0
4523120|NCT01005316|7337695|FG003|Overall Study|Sponsor Decision|0
4523121|NCT01005316|7337692|FG000|Overall Study|Withdrawal by Subject|1
4523122|NCT01005316|7337693|FG001|Overall Study|Withdrawal by Subject|1
4523123|NCT01005316|7337694|FG002|Overall Study|Withdrawal by Subject|0
4523124|NCT01005316|7337695|FG003|Overall Study|Withdrawal by Subject|2
4523125|NCT01005316|7337692|FG000|Overall Study|Consented to Another Study|2
4523126|NCT01005316|7337693|FG001|Overall Study|Consented to Another Study|0
4523127|NCT01005316|7337694|FG002|Overall Study|Consented to Another Study|0
4523128|NCT01005316|7337695|FG003|Overall Study|Consented to Another Study|0
4523129|NCT01005316|7337692|FG000|Overall Study|Delisted|8
4523130|NCT01005316|7337693|FG001|Overall Study|Delisted|0
4633597|NCT01913353|7503791|FG001|Overall Study|Withdrawal by Subject|6
4633598|NCT01913353|7503790|FG000|Overall Study|multiple reasons|10
4633599|NCT01913353|7503791|FG001|Overall Study|multiple reasons|7
4523131|NCT01005316|7337694|FG002|Overall Study|Delisted|0
4523132|NCT01005316|7337695|FG003|Overall Study|Delisted|0
4523133|NCT01005316|7337692|FG000|Overall Study|Transferred Care|1
4523134|NCT01005316|7337693|FG001|Overall Study|Transferred Care|0
4523135|NCT01005316|7337694|FG002|Overall Study|Transferred Care|1
4523136|NCT01005316|7337695|FG003|Overall Study|Transferred Care|3
4523137|NCT01005316|7337692|FG000|Overall Study|Retransplanted|0
4523138|NCT01005316|7337693|FG001|Overall Study|Retransplanted|1
4523139|NCT01005316|7337694|FG002|Overall Study|Retransplanted|0
4523140|NCT01005316|7337695|FG003|Overall Study|Retransplanted|0
4523141|NCT01005329|7337706|FG000|Overall Study|Ineligible or received no protocol trt.|4
4523142|NCT01005602|7337751|FG000|Overall Study|Excluded due to unreliable clinical data|1
4523143|NCT01005602|7337752|FG001|Overall Study|Excluded due to unreliable clinical data|0
4523144|NCT01005680|7337767|FG000|Overall Study|Lost to Follow-up|4
4523145|NCT01005680|7337768|FG001|Overall Study|Lost to Follow-up|6
4523146|NCT01005680|7337767|FG000|Overall Study|Withdrawal by Subject|1
4523147|NCT01005680|7337768|FG001|Overall Study|Withdrawal by Subject|4
4523148|NCT01005680|7337767|FG000|Overall Study|Physician Decision|1
4523149|NCT01005680|7337768|FG001|Overall Study|Physician Decision|1
4523150|NCT01005719|7337784|FG000|Period 1|Adverse Event|0
4523151|NCT01005719|7337785|FG001|Period 1|Adverse Event|0
4523152|NCT01005719|7337786|FG002|Period 1|Adverse Event|0
4523153|NCT01005719|7337787|FG003|Period 1|Adverse Event|1
4523154|NCT01005719|7337788|FG004|Period 1|Adverse Event|0
4523155|NCT01005719|7337789|FG005|Period 1|Adverse Event|0
4523156|NCT01005719|7337784|FG000|Period 1|Delay in completing study procedures|0
4523157|NCT01005719|7337785|FG001|Period 1|Delay in completing study procedures|0
4523158|NCT01005719|7337786|FG002|Period 1|Delay in completing study procedures|0
4633600|NCT01913405|7503804|FG000|Overall Study|Withdrawal by Subject|1
4633601|NCT01913405|7503804|FG000|Overall Study|Adverse Event|1
4633602|NCT01913470|7503823|FG000|Overall Study|Lost to Follow-up|0
4633603|NCT01913470|7503824|FG001|Overall Study|Lost to Follow-up|1
4633604|NCT01913470|7503823|FG000|Overall Study|Physician Decision|0
4633605|NCT01913470|7503824|FG001|Overall Study|Physician Decision|1
4633606|NCT01913470|7503823|FG000|Overall Study|Withdrawal by Subject|0
4633607|NCT01913470|7503824|FG001|Overall Study|Withdrawal by Subject|1
4633608|NCT01913483|7503833|FG000|Overall Study|Withdrawal by Subject|1
4737859|NCT03627767|7688468|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0
4737860|NCT03627767|7688469|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0
4737861|NCT03627767|7688470|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0
4737862|NCT03627767|7688466|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315
4737863|NCT03627767|7688467|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0
4737864|NCT03627767|7688468|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0
4737865|NCT03627767|7688469|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0
4737866|NCT03627767|7688470|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0
4737867|NCT03627767|7688466|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13
4737868|NCT03627767|7688467|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0
4523159|NCT01005719|7337787|FG003|Period 1|Delay in completing study procedures|0
4523160|NCT01005719|7337788|FG004|Period 1|Delay in completing study procedures|0
4523161|NCT01005719|7337789|FG005|Period 1|Delay in completing study procedures|1
4523162|NCT01005719|7337784|FG000|Period 2|Adverse Event|0
4633609|NCT01913483|7503834|FG001|Overall Study|Withdrawal by Subject|2
4523163|NCT01005719|7337785|FG001|Period 2|Adverse Event|0
4523164|NCT01005719|7337786|FG002|Period 2|Adverse Event|0
4523165|NCT01005719|7337787|FG003|Period 2|Adverse Event|0
4633610|NCT01913483|7503833|FG000|Overall Study|Lost to Follow-up|6
4633611|NCT01913483|7503834|FG001|Overall Study|Lost to Follow-up|3
4633612|NCT01913483|7503833|FG000|Overall Study|Death|14
4633613|NCT01913483|7503834|FG001|Overall Study|Death|17
4633614|NCT01913639|7503866|FG000|Overall Study|Not Eligible|3
4633615|NCT01914393|7503903|FG000|Overall Study|Protocol Violation|11
4633616|NCT01914393|7503904|FG001|Overall Study|Protocol Violation|3
4633617|NCT01914393|7503905|FG002|Overall Study|Protocol Violation|19
4633618|NCT01914393|7503903|FG000|Overall Study|Lack of Efficacy|11
4633619|NCT01914393|7503904|FG001|Overall Study|Lack of Efficacy|16
4523166|NCT01005719|7337788|FG004|Period 2|Adverse Event|1
4523167|NCT01005719|7337789|FG005|Period 2|Adverse Event|1
4523168|NCT01005732|7337798|FG000|Overall Study|Lost to Follow-up|10
4523169|NCT01005732|7337798|FG000|Overall Study|Death|1
4594221|NCT01559935|7443226|FG000|Car Phase|Lack of Efficacy|2
4594222|NCT01559935|7443226|FG000|Car Phase|Lost to Follow-up|1
4594223|NCT01559935|7443226|FG000|Car Phase|Physician Decision|1
4594224|NCT01559935|7443226|FG000|Car Phase|Withdrawal by Subject|2
4594225|NCT01559935|7443226|FG000|Car Phase|Per protocol|1
4594226|NCT01559935|7443226|FG000|Car Phase|Insurance|1
4594227|NCT01559935|7443226|FG000|Car Phase|non-compliance|1
4594228|NCT01559935|7443226|FG000|BiRD Phase|Toxicity|1
4594229|NCT01559935|7443226|FG000|BiRD Phase|Lack of Efficacy|1
4594230|NCT01559935|7443226|FG000|BiRD Phase|Withdrawal by Subject|2
4594231|NCT01559935|7443226|FG000|Maintenance Phase|Remains on study|28
4594232|NCT01559935|7443226|FG000|Maintenance Phase|Toxicity|1
4594233|NCT01559935|7443226|FG000|Maintenance Phase|Lack of Efficacy|18
4594234|NCT01559935|7443226|FG000|Maintenance Phase|Withdrawal by Subject|5
4594235|NCT01559935|7443226|FG000|Maintenance Phase|Non-compliance|2
4594236|NCT01560234|7443255|FG000|Overall Study|Lost to Follow-up|3
4594237|NCT01560234|7443256|FG001|Overall Study|Lost to Follow-up|0
4594238|NCT01560234|7443257|FG002|Overall Study|Lost to Follow-up|1
4594239|NCT01560234|7443258|FG003|Overall Study|Lost to Follow-up|0
4594240|NCT01560234|7443259|FG004|Overall Study|Lost to Follow-up|0
4594241|NCT01560234|7443260|FG005|Overall Study|Lost to Follow-up|2
4594242|NCT01560234|7443261|FG006|Overall Study|Lost to Follow-up|0
4594243|NCT01560234|7443262|FG007|Overall Study|Lost to Follow-up|2
4594244|NCT01560403|7443296|FG000|Overall Study|Lost to Follow-up|0
4594245|NCT01560403|7443297|FG001|Overall Study|Lost to Follow-up|1
4594246|NCT01560416|7443305|FG000|Randomized Phase|Crossover Participants|7
4594247|NCT01560416|7443306|FG001|Randomized Phase|Crossover Participants|0
4594248|NCT01560429|7443316|FG000|Overall Study|Protocol Violation|3
4594249|NCT01560429|7443317|FG001|Overall Study|Protocol Violation|6
4594250|NCT01560780|7443336|FG000|Overall Study|Death|2
4594251|NCT01560780|7443337|FG001|Overall Study|Death|1
4594252|NCT01560780|7443336|FG000|Overall Study|Patient Preference|11
4594253|NCT01560780|7443337|FG001|Overall Study|Patient Preference|11
4594254|NCT01560819|7443345|FG000|Overall Study|Physician Decision|1
4594255|NCT01560819|7443346|FG001|Overall Study|Physician Decision|0
4594256|NCT01560871|7443352|FG000|Overall Study|transportation issues|2
4594257|NCT01560871|7443353|FG001|Overall Study|transportation issues|1
4594258|NCT01560871|7443352|FG000|Overall Study|relocation|1
4594259|NCT01560871|7443353|FG001|Overall Study|relocation|0
4594260|NCT01560871|7443352|FG000|Overall Study|readmission to a hospital|2
4594261|NCT01560871|7443353|FG001|Overall Study|readmission to a hospital|1
4594262|NCT01560871|7443352|FG000|Overall Study|Lost to Follow-up|1
4594263|NCT01560871|7443353|FG001|Overall Study|Lost to Follow-up|0
4594264|NCT01560949|7443369|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6
4594265|NCT01560949|7443369|FG000|Surgery Phase|Physician Decision|3
4633620|NCT01914393|7503905|FG002|Overall Study|Lack of Efficacy|5
4633621|NCT01914393|7503903|FG000|Overall Study|no reason given|14
4633622|NCT01914393|7503904|FG001|Overall Study|no reason given|8
4633623|NCT01914393|7503905|FG002|Overall Study|no reason given|16
4633624|NCT01914393|7503903|FG000|Overall Study|Adverse Event|29
4633625|NCT01914393|7503904|FG001|Overall Study|Adverse Event|18
4633626|NCT01914393|7503905|FG002|Overall Study|Adverse Event|31
4633627|NCT01914393|7503903|FG000|Overall Study|Withdrawal by Subject|38
4633628|NCT01914393|7503904|FG001|Overall Study|Withdrawal by Subject|20
4633629|NCT01914393|7503905|FG002|Overall Study|Withdrawal by Subject|47
4633630|NCT01914393|7503903|FG000|Overall Study|Lost to Follow-up|12
4633631|NCT01914393|7503904|FG001|Overall Study|Lost to Follow-up|6
4633632|NCT01914393|7503905|FG002|Overall Study|Lost to Follow-up|19
4633633|NCT01914393|7503903|FG000|Overall Study|subject never dosed|0
4633634|NCT01914393|7503904|FG001|Overall Study|subject never dosed|0
4633635|NCT01914393|7503905|FG002|Overall Study|subject never dosed|1
4633636|NCT01914666|7503925|FG000|Treatment Period|Lack of Efficacy|0
4633637|NCT01914666|7503926|FG001|Treatment Period|Lack of Efficacy|0
4633638|NCT01914666|7503927|FG002|Treatment Period|Lack of Efficacy|2
4633639|NCT01914666|7503925|FG000|Treatment Period|Adverse Event|10
4633640|NCT01914666|7503926|FG001|Treatment Period|Adverse Event|4
4633641|NCT01914666|7503927|FG002|Treatment Period|Adverse Event|2
4633642|NCT01914666|7503925|FG000|Treatment Period|Withdrawal by Subject|3
4633643|NCT01914666|7503926|FG001|Treatment Period|Withdrawal by Subject|2
4633644|NCT01914666|7503927|FG002|Treatment Period|Withdrawal by Subject|2
4633645|NCT01914666|7503925|FG000|Treatment Period|Physician Decision|0
4633646|NCT01914666|7503926|FG001|Treatment Period|Physician Decision|0
4633647|NCT01914666|7503927|FG002|Treatment Period|Physician Decision|2
4633648|NCT01914679|7503933|FG000|Overall Study|Lack of Efficacy|1
4523170|NCT01005875|7337815|FG000|Overall Study|Death|3
4523171|NCT01005901|7337832|FG000|Overall Study|Withdrawal by Subject|38
4523172|NCT01005901|7337833|FG001|Overall Study|Withdrawal by Subject|14
4523173|NCT01005901|7337832|FG000|Overall Study|Adverse Event|30
4523174|NCT01005901|7337833|FG001|Overall Study|Adverse Event|16
4523175|NCT01005901|7337832|FG000|Overall Study|Administrative problems|21
4523176|NCT01005901|7337833|FG001|Overall Study|Administrative problems|13
4523177|NCT01005901|7337832|FG000|Overall Study|Unsatisfactory therapeutic effect|5
4523178|NCT01005901|7337833|FG001|Overall Study|Unsatisfactory therapeutic effect|5
4523179|NCT01005901|7337832|FG000|Overall Study|Protocol Violation|4
4523180|NCT01005901|7337833|FG001|Overall Study|Protocol Violation|3
4523181|NCT01005901|7337832|FG000|Overall Study|Death|2
4523182|NCT01005901|7337833|FG001|Overall Study|Death|3
4523183|NCT01005901|7337832|FG000|Overall Study|Lost to Follow-up|1
4523184|NCT01005901|7337833|FG001|Overall Study|Lost to Follow-up|2
4523185|NCT01005901|7337832|FG000|Overall Study|Patient's inability to use the device|1
4523186|NCT01005901|7337833|FG001|Overall Study|Patient's inability to use the device|1
4523187|NCT01005901|7337832|FG000|Overall Study|No longer requires study drug|0
4523188|NCT01005901|7337833|FG001|Overall Study|No longer requires study drug|1
4523189|NCT01005966|7337839|FG000|Treatment Period 1 (14 Days)|Adverse Event|1
4523190|NCT01005966|7337840|FG001|Treatment Period 1 (14 Days)|Adverse Event|0
4523191|NCT01005966|7337841|FG002|Treatment Period 1 (14 Days)|Adverse Event|0
4523192|NCT01005966|7337842|FG003|Treatment Period 1 (14 Days)|Adverse Event|0
4523193|NCT01005966|7337843|FG004|Treatment Period 1 (14 Days)|Adverse Event|0
4523194|NCT01005966|7337839|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1
4523195|NCT01005966|7337840|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0
4523196|NCT01005966|7337841|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1
4523197|NCT01005966|7337842|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0
4523198|NCT01005966|7337843|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0
4523199|NCT01005966|7337839|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0
4523200|NCT01005966|7337840|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0
4523201|NCT01005966|7337841|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0
4523202|NCT01005966|7337842|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1
4523203|NCT01005966|7337843|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0
4523204|NCT01005966|7337839|FG000|Treatment Period 2 (14 Days)|Adverse Event|0
4523205|NCT01005966|7337840|FG001|Treatment Period 2 (14 Days)|Adverse Event|1
4523206|NCT01005966|7337841|FG002|Treatment Period 2 (14 Days)|Adverse Event|1
4523207|NCT01005966|7337842|FG003|Treatment Period 2 (14 Days)|Adverse Event|0
4523208|NCT01005966|7337843|FG004|Treatment Period 2 (14 Days)|Adverse Event|0
4523209|NCT01005966|7337839|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0
4523210|NCT01005966|7337840|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0
4523211|NCT01005966|7337841|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0
4523212|NCT01005966|7337842|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1
4523213|NCT01005966|7337843|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0
4523214|NCT01005966|7337839|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
4523215|NCT01005966|7337840|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
4523216|NCT01005966|7337841|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1
4523217|NCT01005966|7337842|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
4523218|NCT01005966|7337843|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
4523219|NCT01005966|7337839|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0
4523220|NCT01005966|7337840|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1
4523221|NCT01005966|7337841|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0
4523222|NCT01005966|7337842|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0
4523223|NCT01005966|7337843|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1
4523224|NCT01005966|7337839|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0
4523225|NCT01005966|7337840|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1
4523226|NCT01005966|7337841|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0
4523227|NCT01005966|7337842|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0
4523228|NCT01005966|7337843|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0
4523229|NCT01005966|7337839|FG000|Treatment Period 4 (14 Days)|Other Reason|0
4523230|NCT01005966|7337840|FG001|Treatment Period 4 (14 Days)|Other Reason|0
4523231|NCT01005966|7337841|FG002|Treatment Period 4 (14 Days)|Other Reason|0
4523232|NCT01005966|7337842|FG003|Treatment Period 4 (14 Days)|Other Reason|0
4523233|NCT01005966|7337843|FG004|Treatment Period 4 (14 Days)|Other Reason|1
4523234|NCT01006122|7337860|FG000|First Double-blind Intervention Period|Lost to Follow-up|0
4523235|NCT01006122|7337861|FG001|First Double-blind Intervention Period|Lost to Follow-up|2
4523236|NCT01006122|7337860|FG000|First Double-blind Intervention Period|Protocol Violation|1
4523237|NCT01006122|7337861|FG001|First Double-blind Intervention Period|Protocol Violation|1
4523238|NCT01006122|7337860|FG000|First Double-blind Intervention Period|Pregnancy|0
4523239|NCT01006122|7337861|FG001|First Double-blind Intervention Period|Pregnancy|1
4523240|NCT01006122|7337860|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9
4523241|NCT01006122|7337861|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8
4523242|NCT01006122|7337860|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1
4523243|NCT01006122|7337861|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0
4523244|NCT01006122|7337860|FG000|First Double-blind Intervention Period|Lack of Efficacy|2
4523245|NCT01006122|7337861|FG001|First Double-blind Intervention Period|Lack of Efficacy|1
4523246|NCT01006122|7337860|FG000|First Double-blind Intervention Period|Other|3
4523247|NCT01006122|7337861|FG001|First Double-blind Intervention Period|Other|0
4523248|NCT01006122|7337860|FG000|First Double-blind Intervention Period|Adverse Event|0
4523249|NCT01006122|7337861|FG001|First Double-blind Intervention Period|Adverse Event|4
4523250|NCT01006122|7337860|FG000|Second Double-blind Intervention Period|Adverse Event|1
4523251|NCT01006122|7337861|FG001|Second Double-blind Intervention Period|Adverse Event|1
4523252|NCT01006122|7337860|FG000|Second Double-blind Intervention Period|Protocol Violation|1
4523253|NCT01006122|7337861|FG001|Second Double-blind Intervention Period|Protocol Violation|0
4523254|NCT01006122|7337860|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0
4523255|NCT01006122|7337861|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3
4523256|NCT01006122|7337860|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0
4523257|NCT01006122|7337861|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2
4523258|NCT01006122|7337860|FG000|Second Double-blind Intervention Period|Death|0
4523259|NCT01006122|7337861|FG001|Second Double-blind Intervention Period|Death|1
4523260|NCT01006135|7337867|FG000|Overall Study|Adverse Event|22
4523261|NCT01006135|7337867|FG000|Overall Study|Protocol Violation|14
4523262|NCT01006135|7337867|FG000|Overall Study|Lost to Follow-up|32
4523263|NCT01006135|7337867|FG000|Overall Study|Other|72
4523264|NCT01006291|7337887|FG000|Overall Study|Adverse Event|2
4523265|NCT01006291|7337888|FG001|Overall Study|Adverse Event|1
4523266|NCT01006291|7337889|FG002|Overall Study|Adverse Event|2
4523267|NCT01006291|7337887|FG000|Overall Study|Lack of Efficacy|2
4523268|NCT01006291|7337888|FG001|Overall Study|Lack of Efficacy|2
4523269|NCT01006291|7337889|FG002|Overall Study|Lack of Efficacy|1
4523270|NCT01006291|7337887|FG000|Overall Study|Protocol Violation|3
4523271|NCT01006291|7337888|FG001|Overall Study|Protocol Violation|3
4523272|NCT01006291|7337889|FG002|Overall Study|Protocol Violation|3
4523273|NCT01006291|7337887|FG000|Overall Study|Withdrawal criteria|5
4523274|NCT01006291|7337888|FG001|Overall Study|Withdrawal criteria|4
4523275|NCT01006291|7337889|FG002|Overall Study|Withdrawal criteria|4
4523276|NCT01006291|7337887|FG000|Overall Study|Other|14
4523277|NCT01006291|7337888|FG001|Overall Study|Other|14
4523278|NCT01006291|7337889|FG002|Overall Study|Other|17
4523279|NCT01006356|7337897|FG000|Overall Study|Adverse Event|6
4523280|NCT01006356|7337897|FG000|Overall Study|Physician Decision|1
4523281|NCT01006356|7337897|FG000|Overall Study|Paticipants did not cooperate|6
4523282|NCT01006356|7337897|FG000|Overall Study|Withdrawal by Subject|1
4523283|NCT01006356|7337897|FG000|Overall Study|Choice by participants|2
4523284|NCT01006356|7337897|FG000|Overall Study|Protocol Violation|3
4523285|NCT01006356|7337897|FG000|Overall Study|Other|23
4523286|NCT01006590|7337920|FG000|Overall Study|Adverse Event|2
4523287|NCT01006590|7337921|FG001|Overall Study|Adverse Event|3
4737869|NCT03627767|7688468|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0
4737870|NCT03627767|7688469|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0
4737871|NCT03627767|7688470|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0
4737872|NCT03627767|7688466|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11
4737873|NCT03627767|7688467|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0
4737874|NCT03627767|7688468|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0
4737875|NCT03627767|7688469|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0
4737876|NCT03627767|7688470|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0
4523288|NCT01006590|7337920|FG000|Overall Study|Death|1
4523289|NCT01006590|7337921|FG001|Overall Study|Death|1
4523290|NCT01006590|7337920|FG000|Overall Study|Lost to Follow-up|1
4523291|NCT01006590|7337921|FG001|Overall Study|Lost to Follow-up|1
4523292|NCT01006590|7337920|FG000|Overall Study|Protocol Violation|1
4523293|NCT01006590|7337921|FG001|Overall Study|Protocol Violation|0
4523294|NCT01006590|7337920|FG000|Overall Study|Withdrawal by Subject|4
4523295|NCT01006590|7337921|FG001|Overall Study|Withdrawal by Subject|2
4523296|NCT01006590|7337920|FG000|Overall Study|Study specific discontinuation criteria|16
4523297|NCT01006590|7337921|FG001|Overall Study|Study specific discontinuation criteria|23
4523298|NCT01006590|7337920|FG000|Overall Study|Other|3
4523299|NCT01006590|7337921|FG001|Overall Study|Other|2
4523300|NCT01006603|7337929|FG000|Overall Study|Withdrawal by Subject|17
4523301|NCT01006603|7337930|FG001|Overall Study|Withdrawal by Subject|19
4523302|NCT01006603|7337929|FG000|Overall Study|Lost to Follow-up|0
4523303|NCT01006603|7337930|FG001|Overall Study|Lost to Follow-up|1
4523304|NCT01006603|7337929|FG000|Overall Study|Safety reason|1
4523305|NCT01006603|7337930|FG001|Overall Study|Safety reason|1
4523306|NCT01006603|7337929|FG000|Overall Study|Protocol Violation|1
4523307|NCT01006603|7337930|FG001|Overall Study|Protocol Violation|3
4523308|NCT01006603|7337929|FG000|Overall Study|Incorrect enrolment|0
4523309|NCT01006603|7337930|FG001|Overall Study|Incorrect enrolment|2
4523310|NCT01006603|7337929|FG000|Overall Study|Adverse Event|15
4523311|NCT01006603|7337930|FG001|Overall Study|Adverse Event|7
4523312|NCT01006603|7337929|FG000|Overall Study|Death|1
4523313|NCT01006603|7337930|FG001|Overall Study|Death|1
4523314|NCT01006603|7337929|FG000|Overall Study|Study specific discontinuation criteria|33
4523315|NCT01006603|7337930|FG001|Overall Study|Study specific discontinuation criteria|34
4523316|NCT01006603|7337929|FG000|Overall Study|Other|3
4523317|NCT01006603|7337930|FG001|Overall Study|Other|7
4523318|NCT01006616|7337940|FG000|Period 1 (6 Months)|Adverse Event|10
4523319|NCT01006616|7337941|FG001|Period 1 (6 Months)|Adverse Event|31
4523320|NCT01006616|7337942|FG002|Period 1 (6 Months)|Adverse Event|37
4523321|NCT01006616|7337943|FG003|Period 1 (6 Months)|Adverse Event|9
4523322|NCT01006616|7337940|FG000|Period 1 (6 Months)|Lack of Efficacy|3
4523323|NCT01006616|7337941|FG001|Period 1 (6 Months)|Lack of Efficacy|4
4523324|NCT01006616|7337942|FG002|Period 1 (6 Months)|Lack of Efficacy|0
4523325|NCT01006616|7337943|FG003|Period 1 (6 Months)|Lack of Efficacy|4
4523326|NCT01006616|7337940|FG000|Period 1 (6 Months)|Lost to Follow-up|0
4523327|NCT01006616|7337941|FG001|Period 1 (6 Months)|Lost to Follow-up|0
4523328|NCT01006616|7337942|FG002|Period 1 (6 Months)|Lost to Follow-up|1
4523329|NCT01006616|7337943|FG003|Period 1 (6 Months)|Lost to Follow-up|0
4523330|NCT01006616|7337940|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6
4523331|NCT01006616|7337941|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5
4523332|NCT01006616|7337942|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2
4523333|NCT01006616|7337943|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3
4523334|NCT01006616|7337940|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0
4523335|NCT01006616|7337941|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3
4523336|NCT01006616|7337942|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1
4523337|NCT01006616|7337943|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2
4523338|NCT01006616|7337940|FG000|Period 1 (6 Months)|Withdrawal by Subject|2
4523339|NCT01006616|7337941|FG001|Period 1 (6 Months)|Withdrawal by Subject|2
4523340|NCT01006616|7337942|FG002|Period 1 (6 Months)|Withdrawal by Subject|2
4523341|NCT01006616|7337943|FG003|Period 1 (6 Months)|Withdrawal by Subject|0
4523342|NCT01006616|7337940|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
4633649|NCT01914679|7503933|FG000|Overall Study|Sponsor terminated study|4
4737877|NCT03627767|7688466|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40
4737878|NCT03627767|7688467|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0
4737879|NCT03627767|7688468|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0
4737880|NCT03627767|7688469|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0
4737881|NCT03627767|7688470|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0
4737882|NCT03627767|7688466|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1
4737883|NCT03627767|7688467|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0
4523343|NCT01006616|7337941|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7
4633650|NCT01914757|7503940|FG000|Overall Study|Severe non-compliance to protocol|3
4633651|NCT01914757|7503941|FG001|Overall Study|Severe non-compliance to protocol|1
4633652|NCT01914757|7503942|FG002|Overall Study|Severe non-compliance to protocol|2
4633653|NCT01914757|7503940|FG000|Overall Study|Lost to Follow-up|5
4633654|NCT01914757|7503941|FG001|Overall Study|Lost to Follow-up|8
4633655|NCT01914757|7503942|FG002|Overall Study|Lost to Follow-up|6
4633656|NCT01914757|7503940|FG000|Overall Study|Withdrawal by Subject|15
4633657|NCT01914757|7503941|FG001|Overall Study|Withdrawal by Subject|27
4633658|NCT01914757|7503942|FG002|Overall Study|Withdrawal by Subject|19
4633659|NCT01914757|7503940|FG000|Overall Study|Death|2
4633660|NCT01914757|7503941|FG001|Overall Study|Death|2
4633661|NCT01914757|7503942|FG002|Overall Study|Death|1
4633662|NCT01914757|7503940|FG000|Overall Study|Adverse Event|4
4633663|NCT01914757|7503941|FG001|Overall Study|Adverse Event|3
4633664|NCT01914757|7503942|FG002|Overall Study|Adverse Event|4
4633665|NCT01914757|7503940|FG000|Overall Study|Study specific withdrawal criteria|0
4633666|NCT01914757|7503941|FG001|Overall Study|Study specific withdrawal criteria|1
4633667|NCT01914757|7503942|FG002|Overall Study|Study specific withdrawal criteria|0
4633668|NCT01914757|7503940|FG000|Overall Study|Eligibility criteria not fulfilled|2
4633669|NCT01914757|7503941|FG001|Overall Study|Eligibility criteria not fulfilled|0
4523344|NCT01006616|7337942|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
4523345|NCT01006616|7337943|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
4523346|NCT01006616|7337940|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0
4523347|NCT01006616|7337941|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2
4523348|NCT01006616|7337942|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2
4523349|NCT01006616|7337943|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3
4523350|NCT01006616|7337940|FG000|Period 1 (6 Months)|Not Treated|0
4523351|NCT01006616|7337941|FG001|Period 1 (6 Months)|Not Treated|0
4523352|NCT01006616|7337942|FG002|Period 1 (6 Months)|Not Treated|1
4523353|NCT01006616|7337943|FG003|Period 1 (6 Months)|Not Treated|1
4523354|NCT01006616|7337940|FG000|Period 2 (18 Months)|Adverse Event|6
4523355|NCT01006616|7337941|FG001|Period 2 (18 Months)|Adverse Event|6
4523356|NCT01006616|7337942|FG002|Period 2 (18 Months)|Adverse Event|6
4523357|NCT01006616|7337943|FG003|Period 2 (18 Months)|Adverse Event|4
4523358|NCT01006616|7337940|FG000|Period 2 (18 Months)|Lack of Efficacy|0
4523359|NCT01006616|7337941|FG001|Period 2 (18 Months)|Lack of Efficacy|0
4523360|NCT01006616|7337942|FG002|Period 2 (18 Months)|Lack of Efficacy|1
4523361|NCT01006616|7337943|FG003|Period 2 (18 Months)|Lack of Efficacy|2
4523362|NCT01006616|7337940|FG000|Period 2 (18 Months)|Lost to Follow-up|2
4523363|NCT01006616|7337941|FG001|Period 2 (18 Months)|Lost to Follow-up|0
4523364|NCT01006616|7337942|FG002|Period 2 (18 Months)|Lost to Follow-up|0
4523365|NCT01006616|7337943|FG003|Period 2 (18 Months)|Lost to Follow-up|0
4523366|NCT01006616|7337940|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3
4523367|NCT01006616|7337941|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0
4523368|NCT01006616|7337942|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3
4523369|NCT01006616|7337943|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2
4523370|NCT01006616|7337940|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0
4523371|NCT01006616|7337941|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6
4523372|NCT01006616|7337942|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1
4523373|NCT01006616|7337943|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2
4523374|NCT01006616|7337940|FG000|Period 2 (18 Months)|Withdrawal by Subject|1
4523375|NCT01006616|7337941|FG001|Period 2 (18 Months)|Withdrawal by Subject|4
4523376|NCT01006616|7337942|FG002|Period 2 (18 Months)|Withdrawal by Subject|0
4523377|NCT01006616|7337943|FG003|Period 2 (18 Months)|Withdrawal by Subject|1
4523378|NCT01006616|7337940|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0
4523379|NCT01006616|7337941|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1
4523380|NCT01006616|7337942|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0
4523381|NCT01006616|7337943|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1
4523382|NCT01006616|7337940|FG000|Period 2 (18 Months)|Study Terminated|63
4523383|NCT01006616|7337941|FG001|Period 2 (18 Months)|Study Terminated|46
4523384|NCT01006616|7337942|FG002|Period 2 (18 Months)|Study Terminated|44
4523385|NCT01006616|7337943|FG003|Period 2 (18 Months)|Study Terminated|70
4523386|NCT01006629|7337953|FG000|Overall Study|Adverse Event|1
4523387|NCT01006629|7337953|FG000|Overall Study|Parent refused to continue participation|1
4523388|NCT01006629|7337953|FG000|Overall Study|Parent unable to perform site visit|4
4523389|NCT01006707|7337966|FG000|Study Session 1|Lost to Follow-up|2
4523390|NCT01006707|7337967|FG001|Study Session 1|Lost to Follow-up|0
4523391|NCT01006707|7337968|FG002|Study Session 1|Lost to Follow-up|0
4523392|NCT01006707|7337966|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3
4523393|NCT01006707|7337967|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0
4523394|NCT01006707|7337968|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0
4523395|NCT01006889|7337976|FG000|Overall Study|Withdrawal by Subject|3
4523396|NCT01006980|7337994|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1
4523397|NCT01006980|7337995|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45
4523398|NCT01006980|7337994|FG000|Vemurafenib and Dacarbazine|Adverse Event|25
4523399|NCT01006980|7337995|FG001|Vemurafenib and Dacarbazine|Adverse Event|5
4523400|NCT01006980|7337994|FG000|Vemurafenib and Dacarbazine|Death|13
4523401|NCT01006980|7337995|FG001|Vemurafenib and Dacarbazine|Death|12
4523402|NCT01006980|7337994|FG000|Vemurafenib and Dacarbazine|Progression|257
4523403|NCT01006980|7337995|FG001|Vemurafenib and Dacarbazine|Progression|218
4523404|NCT01006980|7337994|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4
4523405|NCT01006980|7337995|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6
4523406|NCT01006980|7337994|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9
4523407|NCT01006980|7337995|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6
4523408|NCT01006980|7337994|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2
4523409|NCT01006980|7337995|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3
4523410|NCT01006980|7337994|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26
4523411|NCT01006980|7337995|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43
4523412|NCT01006980|7337994|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0
4523413|NCT01006980|7337995|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4
4523414|NCT01006980|7337994|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0
4523415|NCT01006980|7337995|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4
4523416|NCT01006980|7337994|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0
4523417|NCT01006980|7337995|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65
4523418|NCT01006980|7337994|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0
4523419|NCT01006980|7337995|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1
4523420|NCT01006980|7337994|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0
4523421|NCT01006980|7337995|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10
4523422|NCT01007032|7338006|FG000|Overall Study|On Study Treatment at Cut-off Date|0
4523423|NCT01007032|7338007|FG001|Overall Study|On Study Treatment at Cut-off Date|1
4523424|NCT01007032|7338008|FG002|Overall Study|On Study Treatment at Cut-off Date|1
4523425|NCT01007032|7338009|FG003|Overall Study|On Study Treatment at Cut-off Date|0
4523426|NCT01007032|7338006|FG000|Overall Study|Withdrawal by Subject|0
4523427|NCT01007032|7338007|FG001|Overall Study|Withdrawal by Subject|0
4523428|NCT01007032|7338008|FG002|Overall Study|Withdrawal by Subject|0
4523429|NCT01007032|7338009|FG003|Overall Study|Withdrawal by Subject|1
4523430|NCT01007123|7338048|FG000|Overall Study|Adverse Event|3
4523431|NCT01007123|7338049|FG001|Overall Study|Adverse Event|4
4523432|NCT01007123|7338050|FG002|Overall Study|Adverse Event|7
4523433|NCT01007123|7338051|FG003|Overall Study|Adverse Event|1
4523434|NCT01007123|7338048|FG000|Overall Study|Lack of Efficacy|1
4523435|NCT01007123|7338049|FG001|Overall Study|Lack of Efficacy|0
4523436|NCT01007123|7338050|FG002|Overall Study|Lack of Efficacy|1
4523437|NCT01007123|7338051|FG003|Overall Study|Lack of Efficacy|4
4523438|NCT01007123|7338048|FG000|Overall Study|Protocol Violation|1
4523439|NCT01007123|7338049|FG001|Overall Study|Protocol Violation|1
4523440|NCT01007123|7338050|FG002|Overall Study|Protocol Violation|2
4523441|NCT01007123|7338051|FG003|Overall Study|Protocol Violation|1
4523442|NCT01007123|7338048|FG000|Overall Study|Withdrawal by Subject|1
4523443|NCT01007123|7338049|FG001|Overall Study|Withdrawal by Subject|0
4523444|NCT01007123|7338050|FG002|Overall Study|Withdrawal by Subject|1
4523445|NCT01007123|7338051|FG003|Overall Study|Withdrawal by Subject|0
4523446|NCT01007123|7338048|FG000|Overall Study|Lost to Follow-up|0
4523447|NCT01007123|7338049|FG001|Overall Study|Lost to Follow-up|1
4523448|NCT01007123|7338050|FG002|Overall Study|Lost to Follow-up|0
4523449|NCT01007123|7338051|FG003|Overall Study|Lost to Follow-up|0
4523450|NCT01007149|7338084|FG000|Overall Study|Administrative problems|0
4523451|NCT01007149|7338085|FG001|Overall Study|Administrative problems|1
4523452|NCT01007253|7338091|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1
4523453|NCT01007253|7338092|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0
4523454|NCT01007253|7338093|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0
4523455|NCT01007253|7338094|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0
4523456|NCT01007396|7338104|FG000|Overall Study|Lost to Follow-up|47
4523457|NCT01007435|7338112|FG000|Overall Study|Adverse Event|16
4523458|NCT01007435|7338113|FG001|Overall Study|Adverse Event|25
4523459|NCT01007435|7338114|FG002|Overall Study|Adverse Event|47
4523460|NCT01007435|7338115|FG003|Overall Study|Adverse Event|31
4523461|NCT01007435|7338112|FG000|Overall Study|Death|2
4523462|NCT01007435|7338113|FG001|Overall Study|Death|4
4523463|NCT01007435|7338114|FG002|Overall Study|Death|2
4523464|NCT01007435|7338115|FG003|Overall Study|Death|1
4523465|NCT01007435|7338112|FG000|Overall Study|Insufficient Therapeutic Response|21
4523466|NCT01007435|7338113|FG001|Overall Study|Insufficient Therapeutic Response|7
4523467|NCT01007435|7338114|FG002|Overall Study|Insufficient Therapeutic Response|2
4523468|NCT01007435|7338115|FG003|Overall Study|Insufficient Therapeutic Response|9
4523469|NCT01007435|7338112|FG000|Overall Study|Violation of Selection Criteria at Entry|3
4523470|NCT01007435|7338113|FG001|Overall Study|Violation of Selection Criteria at Entry|5
4523471|NCT01007435|7338114|FG002|Overall Study|Violation of Selection Criteria at Entry|2
4523472|NCT01007435|7338115|FG003|Overall Study|Violation of Selection Criteria at Entry|0
4523473|NCT01007435|7338112|FG000|Overall Study|Other Protocol Violation|2
4523474|NCT01007435|7338113|FG001|Overall Study|Other Protocol Violation|0
4523475|NCT01007435|7338114|FG002|Overall Study|Other Protocol Violation|1
4523476|NCT01007435|7338115|FG003|Overall Study|Other Protocol Violation|0
4523477|NCT01007435|7338112|FG000|Overall Study|Refused Treatment|13
4523478|NCT01007435|7338113|FG001|Overall Study|Refused Treatment|13
4523479|NCT01007435|7338114|FG002|Overall Study|Refused Treatment|5
4523480|NCT01007435|7338115|FG003|Overall Study|Refused Treatment|8
4523481|NCT01007435|7338112|FG000|Overall Study|Failure to Return|5
4523482|NCT01007435|7338113|FG001|Overall Study|Failure to Return|4
4523483|NCT01007435|7338114|FG002|Overall Study|Failure to Return|3
4523484|NCT01007435|7338115|FG003|Overall Study|Failure to Return|6
4523485|NCT01007435|7338112|FG000|Overall Study|Reason not Specified|1
4523486|NCT01007435|7338113|FG001|Overall Study|Reason not Specified|1
4523487|NCT01007435|7338114|FG002|Overall Study|Reason not Specified|2
4523488|NCT01007435|7338115|FG003|Overall Study|Reason not Specified|1
4523489|NCT01007448|7338127|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1
4523490|NCT01007448|7338128|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0
4523491|NCT01007448|7338127|FG000|Overall Study|Staph Skin Infection Flare|1
4523492|NCT01007448|7338128|FG001|Overall Study|Staph Skin Infection Flare|0
4523493|NCT01007448|7338127|FG000|Overall Study|Participant Leaving the Country|1
4523494|NCT01007448|7338128|FG001|Overall Study|Participant Leaving the Country|0
4523495|NCT01007448|7338127|FG000|Overall Study|Participant Given Prohibited Medication|1
4523496|NCT01007448|7338128|FG001|Overall Study|Participant Given Prohibited Medication|0
4523497|NCT01007448|7338127|FG000|Overall Study|Progressive Disease|1
4523498|NCT01007448|7338128|FG001|Overall Study|Progressive Disease|2
4523499|NCT01007448|7338127|FG000|Overall Study|Lack of Efficacy|2
4523500|NCT01007448|7338128|FG001|Overall Study|Lack of Efficacy|0
4523501|NCT01007448|7338127|FG000|Overall Study|Withdrawal by Subject|2
4523502|NCT01007448|7338128|FG001|Overall Study|Withdrawal by Subject|3
4523503|NCT01007448|7338127|FG000|Overall Study|Adverse Event|1
4523504|NCT01007448|7338128|FG001|Overall Study|Adverse Event|4
4523505|NCT01007552|7338138|FG000|Overall Study|Withdrawal by Subject|1
4523506|NCT01007812|7338164|FG000|Period 1, One Week|Lost to Follow-up|0
4523507|NCT01007812|7338165|FG001|Period 1, One Week|Lost to Follow-up|1
4523508|NCT01007812|7338164|FG000|Period 1, One Week|Discomfort|1
4523509|NCT01007812|7338165|FG001|Period 1, One Week|Discomfort|0
4523510|NCT01007838|7338175|FG000|Overall Study|Withdrawal by Subject|1
4523511|NCT01007838|7338176|FG001|Overall Study|Withdrawal by Subject|0
4523512|NCT01007838|7338177|FG002|Overall Study|Withdrawal by Subject|0
4523513|NCT01007838|7338178|FG003|Overall Study|Withdrawal by Subject|0
4523514|NCT01007838|7338175|FG000|Overall Study|Physician Decision|1
4523515|NCT01007838|7338176|FG001|Overall Study|Physician Decision|0
4523516|NCT01007838|7338177|FG002|Overall Study|Physician Decision|0
4523517|NCT01007838|7338178|FG003|Overall Study|Physician Decision|0
4523518|NCT01007838|7338175|FG000|Overall Study|Started home haemodialysis|1
4523519|NCT01007838|7338176|FG001|Overall Study|Started home haemodialysis|0
4523520|NCT01007838|7338177|FG002|Overall Study|Started home haemodialysis|0
4523521|NCT01007838|7338178|FG003|Overall Study|Started home haemodialysis|0
4523522|NCT01007916|7338188|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1
4523523|NCT01007916|7338189|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0
4523524|NCT01007916|7338188|FG000|Period 2, 4 Weeks of Wear|Relocation|1
4523525|NCT01007916|7338189|FG001|Period 2, 4 Weeks of Wear|Relocation|0
4523526|NCT01007942|7338197|FG000|Overall Study|Adverse Event|29
4523527|NCT01007942|7338198|FG001|Overall Study|Adverse Event|14
4523528|NCT01007942|7338197|FG000|Overall Study|Abnormal test procedure|0
4523529|NCT01007942|7338198|FG001|Overall Study|Abnormal test procedure|1
4523530|NCT01007942|7338197|FG000|Overall Study|Disease progression|217
4523531|NCT01007942|7338198|FG001|Overall Study|Disease progression|242
4523532|NCT01007942|7338197|FG000|Overall Study|New cancer therapy|5
4523533|NCT01007942|7338198|FG001|Overall Study|New cancer therapy|1
4523534|NCT01007942|7338197|FG000|Overall Study|Protocol Violation|1
4523535|NCT01007942|7338198|FG001|Overall Study|Protocol Violation|1
4523536|NCT01007942|7338197|FG000|Overall Study|Withdrawal by Subject|19
4523537|NCT01007942|7338198|FG001|Overall Study|Withdrawal by Subject|14
4523538|NCT01007942|7338197|FG000|Overall Study|Lost to Follow-up|1
4523539|NCT01007942|7338198|FG001|Overall Study|Lost to Follow-up|0
4523540|NCT01007942|7338197|FG000|Overall Study|Administrative problems|2
4523541|NCT01007942|7338198|FG001|Overall Study|Administrative problems|0
4523542|NCT01007942|7338197|FG000|Overall Study|Death|3
4523543|NCT01007942|7338198|FG001|Overall Study|Death|2
4523544|NCT01007942|7338197|FG000|Overall Study|Patients untreated|4
4523545|NCT01007942|7338198|FG001|Overall Study|Patients untreated|3
4523546|NCT01008150|7338239|FG000|Overall Study|did not receive study drug|1
4523547|NCT01008150|7338240|FG001|Overall Study|did not receive study drug|1
4523548|NCT01008150|7338241|FG002|Overall Study|did not receive study drug|1
4523549|NCT01008150|7338242|FG003|Overall Study|did not receive study drug|0
4523550|NCT01008410|7338277|FG000|Overall Study|Adverse Event|13
4523551|NCT01008410|7338278|FG001|Overall Study|Adverse Event|7
4523552|NCT01008410|7338277|FG000|Overall Study|Withdrawal by Subject|6
4523553|NCT01008410|7338278|FG001|Overall Study|Withdrawal by Subject|2
4523554|NCT01008410|7338277|FG000|Overall Study|Lost to Follow-up|1
4523555|NCT01008410|7338278|FG001|Overall Study|Lost to Follow-up|0
4523556|NCT01008410|7338277|FG000|Overall Study|Noncompliance|1
4523557|NCT01008410|7338278|FG001|Overall Study|Noncompliance|0
4523558|NCT01008410|7338277|FG000|Overall Study|Low Cortisol|2
4523559|NCT01008410|7338278|FG001|Overall Study|Low Cortisol|0
4523560|NCT01008410|7338277|FG000|Overall Study|Lack of Efficacy|2
4523561|NCT01008410|7338278|FG001|Overall Study|Lack of Efficacy|6
4523562|NCT01008410|7338277|FG000|Overall Study|Met Exclusion Criterion|0
4523563|NCT01008410|7338278|FG001|Overall Study|Met Exclusion Criterion|1
4523564|NCT01008423|7338286|FG000|Overall Study|Adverse Event|13
4523565|NCT01008423|7338287|FG001|Overall Study|Adverse Event|6
4523566|NCT01008423|7338286|FG000|Overall Study|Withdrawal by Subject|4
4523567|NCT01008423|7338287|FG001|Overall Study|Withdrawal by Subject|7
4523568|NCT01008423|7338286|FG000|Overall Study|Lost to Follow-up|0
4523569|NCT01008423|7338287|FG001|Overall Study|Lost to Follow-up|2
4523570|NCT01008423|7338286|FG000|Overall Study|Low Cortisol|0
4523571|NCT01008423|7338287|FG001|Overall Study|Low Cortisol|1
4523572|NCT01008423|7338286|FG000|Overall Study|Lack of Efficacy|0
4523573|NCT01008423|7338287|FG001|Overall Study|Lack of Efficacy|5
4523574|NCT01008423|7338286|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1
4523575|NCT01008423|7338287|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0
4523576|NCT01008423|7338286|FG000|Overall Study|Personal Conflict|1
4523577|NCT01008423|7338287|FG001|Overall Study|Personal Conflict|0
4523578|NCT01008423|7338286|FG000|Overall Study|Other|0
4523579|NCT01008423|7338287|FG001|Overall Study|Other|1
4523580|NCT01008449|7338295|FG000|Overall Study|Lost to Follow-up|29
4523581|NCT01008449|7338296|FG001|Overall Study|Lost to Follow-up|19
4523582|NCT01008475|7338313|FG000|Overall Study|Ongoing treatment at data cut-off date|0
4523583|NCT01008475|7338314|FG001|Overall Study|Ongoing treatment at data cut-off date|0
4523584|NCT01008475|7338315|FG002|Overall Study|Ongoing treatment at data cut-off date|0
4523585|NCT01008475|7338316|FG003|Overall Study|Ongoing treatment at data cut-off date|0
4523586|NCT01008475|7338317|FG004|Overall Study|Ongoing treatment at data cut-off date|5
4523587|NCT01008475|7338318|FG005|Overall Study|Ongoing treatment at data cut-off date|6
4523588|NCT01008475|7338319|FG006|Overall Study|Ongoing treatment at data cut-off date|4
4523589|NCT01008553|7338335|FG000|Period 1 (Titration Period)|Physician Decision|2
4523590|NCT01008553|7338336|FG001|Period 1 (Titration Period)|Physician Decision|0
4523591|NCT01008553|7338337|FG002|Period 1 (Titration Period)|Physician Decision|0
4523592|NCT01008553|7338335|FG000|Period 1 (Titration Period)|Adverse Event|33
4523593|NCT01008553|7338336|FG001|Period 1 (Titration Period)|Adverse Event|0
4523594|NCT01008553|7338337|FG002|Period 1 (Titration Period)|Adverse Event|0
4523595|NCT01008553|7338335|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6
4523596|NCT01008553|7338336|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0
4523597|NCT01008553|7338337|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0
4523598|NCT01008553|7338335|FG000|Period 1 (Titration Period)|Determined to increase dosage|3
4523599|NCT01008553|7338336|FG001|Period 1 (Titration Period)|Determined to increase dosage|0
4523600|NCT01008553|7338337|FG002|Period 1 (Titration Period)|Determined to increase dosage|0
4523601|NCT01008553|7338335|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50
4523602|NCT01008553|7338336|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
4523603|NCT01008553|7338337|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
4523604|NCT01008553|7338335|FG000|Period 1 (Titration Period)|Not appropriate for this study|1
4523605|NCT01008553|7338336|FG001|Period 1 (Titration Period)|Not appropriate for this study|0
4523606|NCT01008553|7338337|FG002|Period 1 (Titration Period)|Not appropriate for this study|0
4523607|NCT01008553|7338335|FG000|Period 2 (Double-Blind Period)|Physician Decision|0
4523608|NCT01008553|7338336|FG001|Period 2 (Double-Blind Period)|Physician Decision|1
4523609|NCT01008553|7338337|FG002|Period 2 (Double-Blind Period)|Physician Decision|2
4523610|NCT01008553|7338335|FG000|Period 2 (Double-Blind Period)|Adverse Event|0
4523611|NCT01008553|7338336|FG001|Period 2 (Double-Blind Period)|Adverse Event|14
4523612|NCT01008553|7338337|FG002|Period 2 (Double-Blind Period)|Adverse Event|4
4523613|NCT01008553|7338335|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0
4523614|NCT01008553|7338336|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
4523615|NCT01008553|7338337|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
4523616|NCT01008553|7338335|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0
4523617|NCT01008553|7338336|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1
4523618|NCT01008553|7338337|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0
4523619|NCT01008553|7338335|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
4523620|NCT01008553|7338336|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1
4523621|NCT01008553|7338337|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4
4523622|NCT01008553|7338335|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0
4523623|NCT01008553|7338336|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0
4523624|NCT01008553|7338337|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3
4523625|NCT01008553|7338335|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
4523626|NCT01008553|7338336|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
4523627|NCT01008553|7338337|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1
4737884|NCT03627767|7688468|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0
4737885|NCT03627767|7688469|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0
4737886|NCT03627767|7688470|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0
4737887|NCT03627767|7688466|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2
4737888|NCT03627767|7688467|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0
4737889|NCT03627767|7688468|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0
4737890|NCT03627767|7688469|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0
4737891|NCT03627767|7688470|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0
4737892|NCT03627767|7688466|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4
4737893|NCT03627767|7688467|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0
4737894|NCT03627767|7688468|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0
4737895|NCT03627767|7688469|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0
4737896|NCT03627767|7688470|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0
4737897|NCT03627767|7688466|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2
4737898|NCT03627767|7688467|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0
4737899|NCT03627767|7688468|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0
4737900|NCT03627767|7688469|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0
4737901|NCT03627767|7688470|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0
4737902|NCT03627767|7688466|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0
4737903|NCT03627767|7688467|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6
4737904|NCT03627767|7688468|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7
4523628|NCT01008553|7338335|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0
4523629|NCT01008553|7338336|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18
4523630|NCT01008553|7338337|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35
4523631|NCT01008618|7338358|FG000|Period 1 (Titration Period)|Physician Decision|2
4523632|NCT01008618|7338359|FG001|Period 1 (Titration Period)|Physician Decision|0
4523633|NCT01008618|7338360|FG002|Period 1 (Titration Period)|Physician Decision|0
4523634|NCT01008618|7338358|FG000|Period 1 (Titration Period)|Adverse Event|33
4523635|NCT01008618|7338359|FG001|Period 1 (Titration Period)|Adverse Event|0
4523636|NCT01008618|7338360|FG002|Period 1 (Titration Period)|Adverse Event|0
4523637|NCT01008618|7338358|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11
4523638|NCT01008618|7338359|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0
4523639|NCT01008618|7338360|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0
4523640|NCT01008618|7338358|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20
4523641|NCT01008618|7338359|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
4523642|NCT01008618|7338360|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
4523643|NCT01008618|7338358|FG000|Period 1 (Titration Period)|Aggravated symptom|2
4523644|NCT01008618|7338359|FG001|Period 1 (Titration Period)|Aggravated symptom|0
4523645|NCT01008618|7338360|FG002|Period 1 (Titration Period)|Aggravated symptom|0
4523646|NCT01008618|7338358|FG000|Period 2 (Double-Blind Period)|Adverse Event|0
4523647|NCT01008618|7338359|FG001|Period 2 (Double-Blind Period)|Adverse Event|11
4523648|NCT01008618|7338360|FG002|Period 2 (Double-Blind Period)|Adverse Event|2
4523649|NCT01008618|7338358|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0
4523650|NCT01008618|7338359|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3
4523651|NCT01008618|7338360|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
4523652|NCT01008618|7338358|FG000|Period 2 (Double-Blind Period)|Physician Decision|0
4523653|NCT01008618|7338359|FG001|Period 2 (Double-Blind Period)|Physician Decision|1
4523654|NCT01008618|7338360|FG002|Period 2 (Double-Blind Period)|Physician Decision|0
4523655|NCT01008618|7338358|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
4523656|NCT01008618|7338359|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
4523657|NCT01008618|7338360|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3
4523658|NCT01008618|7338358|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
4523659|NCT01008618|7338359|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
4523660|NCT01008618|7338360|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1
4523661|NCT01008618|7338358|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0
4523662|NCT01008618|7338359|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21
4523663|NCT01008618|7338360|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29
4523664|NCT01008618|7338358|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0
4523665|NCT01008618|7338359|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0
4523666|NCT01008618|7338360|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1
4523667|NCT01008696|7338371|FG000|Overall Study|Participant's evasion of hospital visit|5
4523668|NCT01008696|7338372|FG001|Overall Study|Participant's evasion of hospital visit|4
4523669|NCT01008696|7338371|FG000|Overall Study|Withdrawal by Subject|2
4523670|NCT01008696|7338372|FG001|Overall Study|Withdrawal by Subject|4
4523671|NCT01008696|7338371|FG000|Overall Study|Physician Decision|5
4523672|NCT01008696|7338372|FG001|Overall Study|Physician Decision|1
4523673|NCT01008696|7338371|FG000|Overall Study|Adverse Event|1
4523674|NCT01008696|7338372|FG001|Overall Study|Adverse Event|0
4523675|NCT01008696|7338371|FG000|Overall Study|Participants' non-cooperation|2
4523676|NCT01008696|7338372|FG001|Overall Study|Participants' non-cooperation|3
4523677|NCT01008696|7338371|FG000|Overall Study|Other|2
4523678|NCT01008696|7338372|FG001|Overall Study|Other|3
4523679|NCT01008696|7338371|FG000|Overall Study|Other|0
4523680|NCT01008696|7338372|FG001|Overall Study|Other|2
4523681|NCT01008748|7338388|FG000|Overall Study|Lost to Follow-up|80
4523682|NCT01008748|7338388|FG000|Overall Study|Other|1
4523683|NCT01008904|7338392|FG000|Overall Study|Lost to Follow-up|1
4523684|NCT01008904|7338392|FG000|Overall Study|Adverse Event|2
4523685|NCT01008904|7338392|FG000|Overall Study|unexpected unrelated surgery|1
4523686|NCT01008943|7338396|FG000|Overall Study|Withdrawal by Subject|1
4523687|NCT01008995|7338406|FG000|Controlled Period|Adverse Event|1
4523688|NCT01008995|7338407|FG001|Controlled Period|Adverse Event|2
4523689|NCT01008995|7338408|FG002|Controlled Period|Adverse Event|0
4523690|NCT01008995|7338409|FG003|Controlled Period|Adverse Event|0
4523691|NCT01008995|7338406|FG000|Controlled Period|Other|2
4523692|NCT01008995|7338407|FG001|Controlled Period|Other|1
4523693|NCT01008995|7338408|FG002|Controlled Period|Other|0
4523694|NCT01008995|7338409|FG003|Controlled Period|Other|0
4523695|NCT01008995|7338406|FG000|After Controlled Period|Adverse Event|0
4523696|NCT01008995|7338407|FG001|After Controlled Period|Adverse Event|0
4523697|NCT01008995|7338408|FG002|After Controlled Period|Adverse Event|1
4523698|NCT01008995|7338409|FG003|After Controlled Period|Adverse Event|1
4523699|NCT01008995|7338406|FG000|After Controlled Period|Other|0
4523700|NCT01008995|7338407|FG001|After Controlled Period|Other|0
4523701|NCT01008995|7338408|FG002|After Controlled Period|Other|1
4523702|NCT01008995|7338409|FG003|After Controlled Period|Other|0
4523703|NCT01009034|7338417|FG000|Overall Study|Lost to Follow-up|2
4523704|NCT01009034|7338417|FG000|Overall Study|Withdrawal by Subject|2
4523705|NCT01009047|7338423|FG000|Overall Study|Adverse Event|5
4523706|NCT01009047|7338424|FG001|Overall Study|Adverse Event|0
4523707|NCT01009047|7338423|FG000|Overall Study|Lost to Follow-up|0
4523708|NCT01009047|7338424|FG001|Overall Study|Lost to Follow-up|2
4523709|NCT01009047|7338423|FG000|Overall Study|Lack of Efficacy|4
4523710|NCT01009047|7338424|FG001|Overall Study|Lack of Efficacy|11
4523711|NCT01009047|7338423|FG000|Overall Study|Withdrawal by consent|16
4523712|NCT01009047|7338424|FG001|Overall Study|Withdrawal by consent|11
4523713|NCT01009047|7338423|FG000|Overall Study|Other|3
4523714|NCT01009047|7338424|FG001|Overall Study|Other|2
4523715|NCT01009060|7338432|FG000|Overall Study|Adverse Event|1
4523716|NCT01009060|7338433|FG001|Overall Study|Adverse Event|2
4523717|NCT01009060|7338432|FG000|Overall Study|Protocol Violation|0
4523718|NCT01009060|7338433|FG001|Overall Study|Protocol Violation|1
4523719|NCT01009060|7338432|FG000|Overall Study|Lost to Follow-up|1
4523720|NCT01009060|7338433|FG001|Overall Study|Lost to Follow-up|0
4523721|NCT01009060|7338432|FG000|Overall Study|Physician Decision|1
4523722|NCT01009060|7338433|FG001|Overall Study|Physician Decision|1
4523723|NCT01009060|7338432|FG000|Overall Study|Withdrawal by Subject|1
4523724|NCT01009060|7338433|FG001|Overall Study|Withdrawal by Subject|1
4523725|NCT01009086|7338446|FG000|Overall Study|Lack of Efficacy|16
4523726|NCT01009086|7338447|FG001|Overall Study|Lack of Efficacy|15
4523727|NCT01009086|7338448|FG002|Overall Study|Lack of Efficacy|9
4523728|NCT01009086|7338446|FG000|Overall Study|Lost to Follow-up|4
4523729|NCT01009086|7338447|FG001|Overall Study|Lost to Follow-up|5
4523730|NCT01009086|7338448|FG002|Overall Study|Lost to Follow-up|3
4523731|NCT01009086|7338446|FG000|Overall Study|Adverse Event|12
4523732|NCT01009086|7338447|FG001|Overall Study|Adverse Event|11
4523733|NCT01009086|7338448|FG002|Overall Study|Adverse Event|8
4523734|NCT01009086|7338446|FG000|Overall Study|Withdrawal by Subject|9
4523735|NCT01009086|7338447|FG001|Overall Study|Withdrawal by Subject|11
4523736|NCT01009086|7338448|FG002|Overall Study|Withdrawal by Subject|13
4523737|NCT01009086|7338446|FG000|Overall Study|Other|3
4523738|NCT01009086|7338447|FG001|Overall Study|Other|5
4523739|NCT01009086|7338448|FG002|Overall Study|Other|1
4523740|NCT01009099|7338463|FG000|Overall Study|Lost to Follow-up|1
4523741|NCT01009099|7338464|FG001|Overall Study|Lost to Follow-up|0
4523742|NCT01009099|7338463|FG000|Overall Study|Physician Decision|3
4523743|NCT01009099|7338464|FG001|Overall Study|Physician Decision|2
4523744|NCT01009099|7338463|FG000|Overall Study|Withdrawal by Subject|1
4523745|NCT01009099|7338464|FG001|Overall Study|Withdrawal by Subject|1
4523746|NCT01009099|7338463|FG000|Overall Study|Death|0
4523747|NCT01009099|7338464|FG001|Overall Study|Death|1
4523748|NCT01009203|7338479|FG000|Overall Study|Withdrawal by Subject|1
4523749|NCT01009203|7338479|FG000|Overall Study|Adverse Event|5
4633670|NCT01914757|7503942|FG002|Overall Study|Eligibility criteria not fulfilled|2
4737905|NCT03627767|7688469|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19
4737906|NCT03627767|7688470|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0
4737907|NCT03627767|7688466|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0
4737908|NCT03627767|7688467|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0
4737909|NCT03627767|7688468|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2
4737910|NCT03627767|7688469|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3
4737911|NCT03627767|7688470|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0
4737912|NCT03627767|7688466|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0
4737913|NCT03627767|7688467|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1
4737914|NCT03627767|7688468|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5
4523750|NCT01009203|7338479|FG000|Overall Study|Treatment-unrelated death|1
4523751|NCT01009281|7338483|FG000|Overall Study|Administrative problems|7
4523752|NCT01009346|7338500|FG000|Overall Study|Adverse Event|4
4523753|NCT01009463|7338509|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373
4523754|NCT01009463|7338510|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
4523755|NCT01009463|7338511|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
4523756|NCT01009463|7338512|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
4523757|NCT01009463|7338513|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
4523758|NCT01009463|7338509|FG000|4-week, Open-label Run-In Period|Adverse Event|10
4523759|NCT01009463|7338510|FG001|4-week, Open-label Run-In Period|Adverse Event|0
4523760|NCT01009463|7338511|FG002|4-week, Open-label Run-In Period|Adverse Event|0
4523761|NCT01009463|7338512|FG003|4-week, Open-label Run-In Period|Adverse Event|0
4523762|NCT01009463|7338513|FG004|4-week, Open-label Run-In Period|Adverse Event|0
4523763|NCT01009463|7338509|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6
4523764|NCT01009463|7338510|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0
4523765|NCT01009463|7338511|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0
4523766|NCT01009463|7338512|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0
4523767|NCT01009463|7338513|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0
4523768|NCT01009463|7338509|FG000|4-week, Open-label Run-In Period|Physician Decision|10
4523769|NCT01009463|7338510|FG001|4-week, Open-label Run-In Period|Physician Decision|0
4523770|NCT01009463|7338511|FG002|4-week, Open-label Run-In Period|Physician Decision|0
4523771|NCT01009463|7338512|FG003|4-week, Open-label Run-In Period|Physician Decision|0
4523772|NCT01009463|7338513|FG004|4-week, Open-label Run-In Period|Physician Decision|0
4523773|NCT01009463|7338509|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50
4523774|NCT01009463|7338510|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0
4523775|NCT01009463|7338511|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0
4523776|NCT01009463|7338512|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0
4523777|NCT01009463|7338513|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0
4523778|NCT01009463|7338509|FG000|52-week, Double-blind Treatment Period|Adverse Event|0
4523779|NCT01009463|7338510|FG001|52-week, Double-blind Treatment Period|Adverse Event|22
4523780|NCT01009463|7338511|FG002|52-week, Double-blind Treatment Period|Adverse Event|25
4523781|NCT01009463|7338512|FG003|52-week, Double-blind Treatment Period|Adverse Event|29
4523782|NCT01009463|7338513|FG004|52-week, Double-blind Treatment Period|Adverse Event|31
4523783|NCT01009463|7338509|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0
4523784|NCT01009463|7338510|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34
4523785|NCT01009463|7338511|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18
4523786|NCT01009463|7338512|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17
4523787|NCT01009463|7338513|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22
4523788|NCT01009463|7338509|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0
4523789|NCT01009463|7338510|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24
4523790|NCT01009463|7338511|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16
4523791|NCT01009463|7338512|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11
4523792|NCT01009463|7338513|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18
4523793|NCT01009463|7338509|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0
4523794|NCT01009463|7338510|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8
4523795|NCT01009463|7338511|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7
4737915|NCT03627767|7688469|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2
4737916|NCT03627767|7688470|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0
4737917|NCT03627767|7688466|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0
4737918|NCT03627767|7688467|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9
4737919|NCT03627767|7688468|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6
4737920|NCT03627767|7688469|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10
4737921|NCT03627767|7688470|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0
4737922|NCT03627767|7688466|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0
4737923|NCT03627767|7688467|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0
4737924|NCT03627767|7688468|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1
4737925|NCT03627767|7688469|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0
4737926|NCT03627767|7688470|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0
4737927|NCT03627767|7688466|FG000|Double-blind Treatment Period (40 Weeks)|Other|0
4737928|NCT03627767|7688467|FG001|Double-blind Treatment Period (40 Weeks)|Other|0
4737929|NCT03627767|7688468|FG002|Double-blind Treatment Period (40 Weeks)|Other|1
4737930|NCT03627767|7688469|FG003|Double-blind Treatment Period (40 Weeks)|Other|1
4737931|NCT03627767|7688470|FG004|Double-blind Treatment Period (40 Weeks)|Other|0
4737932|NCT03627767|7688466|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0
4523796|NCT01009463|7338512|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8
4523797|NCT01009463|7338513|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7
4523798|NCT01009463|7338509|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
4523799|NCT01009463|7338510|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10
4523800|NCT01009463|7338511|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14
4523801|NCT01009463|7338512|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
4523802|NCT01009463|7338513|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10
4523803|NCT01009463|7338509|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
4523804|NCT01009463|7338510|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2
4523805|NCT01009463|7338511|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
4523806|NCT01009463|7338512|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
4523807|NCT01009463|7338513|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
4523808|NCT01009463|7338509|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0
4523809|NCT01009463|7338510|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11
4523810|NCT01009463|7338511|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7
4523811|NCT01009463|7338512|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6
4523812|NCT01009463|7338513|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5
4523813|NCT01009463|7338509|FG000|52-week, Double-blind Treatment Period|Physician Decision|0
4523814|NCT01009463|7338510|FG001|52-week, Double-blind Treatment Period|Physician Decision|4
4523815|NCT01009463|7338511|FG002|52-week, Double-blind Treatment Period|Physician Decision|6
4523816|NCT01009463|7338512|FG003|52-week, Double-blind Treatment Period|Physician Decision|6
4523817|NCT01009463|7338513|FG004|52-week, Double-blind Treatment Period|Physician Decision|8
4523818|NCT01009515|7338524|FG000|Overall Study|Withdrawal by Subject|3
4523819|NCT01009554|7338530|FG000|Overall Study|Adverse Event|1
4523820|NCT01009554|7338531|FG001|Overall Study|Adverse Event|1
4523821|NCT01009554|7338530|FG000|Overall Study|Withdrawal by Subject|1
4523822|NCT01009554|7338531|FG001|Overall Study|Withdrawal by Subject|3
4523823|NCT01009554|7338530|FG000|Overall Study|Noncompliant with Study Product|0
4523824|NCT01009554|7338531|FG001|Overall Study|Noncompliant with Study Product|3
4523825|NCT01009580|7338539|FG000|Overall Study|Adverse Event|4
4523826|NCT01009580|7338540|FG001|Overall Study|Adverse Event|4
4523827|NCT01009580|7338539|FG000|Overall Study|Lack of Efficacy|0
4523828|NCT01009580|7338540|FG001|Overall Study|Lack of Efficacy|1
4523829|NCT01009580|7338539|FG000|Overall Study|Protocol Violation|2
4523830|NCT01009580|7338540|FG001|Overall Study|Protocol Violation|3
4523831|NCT01009580|7338539|FG000|Overall Study|Withdrawal Criteria|4
4523832|NCT01009580|7338540|FG001|Overall Study|Withdrawal Criteria|6
4523833|NCT01009580|7338539|FG000|Overall Study|Unclassified|17
4523834|NCT01009580|7338540|FG001|Overall Study|Unclassified|21
4523835|NCT01009645|7338559|FG000|Overall Study|Lost to Follow-up|2
4523836|NCT01009645|7338560|FG001|Overall Study|Lost to Follow-up|8
4523837|NCT01009645|7338561|FG002|Overall Study|Lost to Follow-up|4
4523838|NCT01009645|7338562|FG003|Overall Study|Lost to Follow-up|5
4523839|NCT01009814|7338588|FG000|Overall Study|No longer met study criteria|1
4523840|NCT01009814|7338589|FG001|Overall Study|No longer met study criteria|1
4523841|NCT01009814|7338590|FG002|Overall Study|No longer met study criteria|0
4523842|NCT01009814|7338591|FG003|Overall Study|No longer met study criteria|0
4523843|NCT01009814|7338592|FG004|Overall Study|No longer met study criteria|0
4523844|NCT01009840|7338608|FG000|Overall Study|Lost to Follow-up|1
4523845|NCT01009840|7338608|FG000|Overall Study|Adverse Event|4
4523846|NCT01009840|7338608|FG000|Overall Study|Subject Met Withdrawal Criteria|7
4523847|NCT01009840|7338608|FG000|Overall Study|Subject was Withdrawn by Investigator|1
4523848|NCT01009840|7338608|FG000|Overall Study|Subject Withdrew Consent to Participate|1
4523849|NCT01009983|7338625|FG000|Overall Study|necessary scans not completed|1
4523850|NCT01010061|7338644|FG000|Overall Study|Adverse Events or Intercurrent Illness|33
4523851|NCT01010061|7338645|FG001|Overall Study|Adverse Events or Intercurrent Illness|16
4523852|NCT01010061|7338644|FG000|Overall Study|Disease Progression|2
4523853|NCT01010061|7338645|FG001|Overall Study|Disease Progression|8
4523854|NCT01010061|7338644|FG000|Overall Study|Withdrew Consent|5
4523855|NCT01010061|7338645|FG001|Overall Study|Withdrew Consent|1
4523856|NCT01010061|7338644|FG000|Overall Study|Death|3
4523857|NCT01010061|7338645|FG001|Overall Study|Death|6
4523858|NCT01010061|7338644|FG000|Overall Study|Administrative/Other|0
4523859|NCT01010061|7338645|FG001|Overall Study|Administrative/Other|1
4523860|NCT01010061|7338644|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2
4523861|NCT01010061|7338645|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0
4523862|NCT01010061|7338644|FG000|Overall Study|Insufficient Therapeutic Response|1
4523863|NCT01010061|7338645|FG001|Overall Study|Insufficient Therapeutic Response|5
4523864|NCT01010061|7338644|FG000|Overall Study|Violation of Selection Criteria|0
4523865|NCT01010061|7338645|FG001|Overall Study|Violation of Selection Criteria|1
4523866|NCT01010061|7338644|FG000|Overall Study|Did Not Receive Treatment|2
4523867|NCT01010061|7338645|FG001|Overall Study|Did Not Receive Treatment|2
4523868|NCT01010126|7338659|FG000|Overall Study|Withdrawal by Subject|1
4523869|NCT01010126|7338660|FG001|Overall Study|Withdrawal by Subject|0
4523870|NCT01010126|7338661|FG002|Overall Study|Withdrawal by Subject|1
4523871|NCT01010126|7338662|FG003|Overall Study|Withdrawal by Subject|0
4523872|NCT01010126|7338663|FG004|Overall Study|Withdrawal by Subject|3
4523873|NCT01010126|7338664|FG005|Overall Study|Withdrawal by Subject|0
4523874|NCT01010204|7338680|FG000|Overall Study|Lost to Follow-up|2
4523875|NCT01010204|7338681|FG001|Overall Study|Lost to Follow-up|2
4523876|NCT01010204|7338680|FG000|Overall Study|Adverse Event|1
4523877|NCT01010204|7338681|FG001|Overall Study|Adverse Event|3
4523878|NCT01010204|7338680|FG000|Overall Study|Withdrawal by Subject|2
4523879|NCT01010204|7338681|FG001|Overall Study|Withdrawal by Subject|3
4523880|NCT01010204|7338680|FG000|Overall Study|psychiatric hospitalization|2
4523881|NCT01010204|7338681|FG001|Overall Study|psychiatric hospitalization|1
4523882|NCT01010217|7338692|FG000|Overall Study|Lost to Follow-up|4
4523883|NCT01010217|7338693|FG001|Overall Study|Lost to Follow-up|5
4523884|NCT01010217|7338694|FG002|Overall Study|Lost to Follow-up|1
4523885|NCT01010217|7338695|FG003|Overall Study|Lost to Follow-up|0
4523886|NCT01010217|7338696|FG004|Overall Study|Lost to Follow-up|0
4523887|NCT01010217|7338692|FG000|Overall Study|Withdrawal by Subject|1
4523888|NCT01010217|7338693|FG001|Overall Study|Withdrawal by Subject|0
4523889|NCT01010217|7338694|FG002|Overall Study|Withdrawal by Subject|0
4523890|NCT01010217|7338695|FG003|Overall Study|Withdrawal by Subject|0
4523891|NCT01010217|7338696|FG004|Overall Study|Withdrawal by Subject|0
4523892|NCT01010217|7338692|FG000|Overall Study|Physician Decision|0
4523893|NCT01010217|7338693|FG001|Overall Study|Physician Decision|0
4523894|NCT01010217|7338694|FG002|Overall Study|Physician Decision|0
4523895|NCT01010217|7338695|FG003|Overall Study|Physician Decision|6
4523896|NCT01010217|7338696|FG004|Overall Study|Physician Decision|3
4523897|NCT01010230|7338710|FG000|Overall Study|Withdrawal by Subject|6
4523898|NCT01010230|7338711|FG001|Overall Study|Withdrawal by Subject|5
4523899|NCT01010230|7338710|FG000|Overall Study|Lost to Follow-up|4
4523900|NCT01010230|7338711|FG001|Overall Study|Lost to Follow-up|2
4523901|NCT01010503|7338743|FG000|Overall Study|Adverse Event|1
4523902|NCT01010503|7338743|FG000|Overall Study|Death|1
4523903|NCT01010633|7338765|FG000|Overall Study|Adverse Event|1
4523904|NCT01010633|7338766|FG001|Overall Study|Adverse Event|1
4523905|NCT01010633|7338765|FG000|Overall Study|Protocol Violation|1
4523906|NCT01010633|7338766|FG001|Overall Study|Protocol Violation|2
4523907|NCT01010633|7338765|FG000|Overall Study|Withdrawal by Subject|2
4523908|NCT01010633|7338766|FG001|Overall Study|Withdrawal by Subject|1
4523909|NCT01010633|7338765|FG000|Overall Study|Investigator decision|0
4523910|NCT01010633|7338766|FG001|Overall Study|Investigator decision|1
4523911|NCT01010750|7338778|FG000|Second Intervention|Adverse Event|0
4523912|NCT01010750|7338779|FG001|Second Intervention|Adverse Event|1
4523913|NCT01010750|7338780|FG002|Second Intervention|Adverse Event|0
4523914|NCT01010750|7338781|FG003|Second Intervention|Adverse Event|0
4523915|NCT01010750|7338782|FG004|Second Intervention|Adverse Event|0
4523916|NCT01010750|7338783|FG005|Second Intervention|Adverse Event|0
4523917|NCT01010776|7338800|FG000|Main Phase|Withdrawal by Subject|14
4737933|NCT03627767|7688467|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0
4737934|NCT03627767|7688468|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0
4737935|NCT03627767|7688469|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0
4737936|NCT03627767|7688470|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9
4737937|NCT03627767|7688466|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0
4523918|NCT01010776|7338800|FG000|Main Phase|Lack of Efficacy|8
4737938|NCT03627767|7688467|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0
4523919|NCT01010776|7338800|FG000|Main Phase|Adverse Event|7
4737939|NCT03627767|7688468|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0
4737940|NCT03627767|7688469|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0
4737941|NCT03627767|7688470|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1
4737942|NCT03627767|7688466|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0
4737943|NCT03627767|7688467|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0
4737944|NCT03627767|7688468|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0
4737945|NCT03627767|7688469|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0
4737946|NCT03627767|7688470|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9
4737947|NCT03627767|7688466|FG000|Open-label Rescue Period (12 Weeks)|Other|0
4737948|NCT03627767|7688467|FG001|Open-label Rescue Period (12 Weeks)|Other|0
4737949|NCT03627767|7688468|FG002|Open-label Rescue Period (12 Weeks)|Other|0
4737950|NCT03627767|7688469|FG003|Open-label Rescue Period (12 Weeks)|Other|0
4737951|NCT03627767|7688470|FG004|Open-label Rescue Period (12 Weeks)|Other|1
4737952|NCT03627832|7688483|FG000|Overall Study|Withdrawal by Subject|10
4737953|NCT03627832|7688484|FG001|Overall Study|Withdrawal by Subject|1
4737954|NCT03628417|7688490|FG000|Overall Study|Death|1
4737955|NCT03628417|7688491|FG001|Overall Study|Death|1
4737956|NCT03628508|7688509|FG000|Overall Study|Lost to Follow-up|1
4737957|NCT03628599|7688515|FG000|Overall Study|Adverse Event|0
4737958|NCT03628599|7688516|FG001|Overall Study|Adverse Event|1
4737959|NCT03628898|7688539|FG000|Overall Study|Device deficiency|1
4523920|NCT01010776|7338800|FG000|Main Phase|Lost to Follow-up|6
4523921|NCT01010776|7338800|FG000|Main Phase|Non-compliance to study medication|5
4523922|NCT01010776|7338800|FG000|Main Phase|Selection failure|2
4523923|NCT01010776|7338800|FG000|Main Phase|Inform consent withdrawal|1
4523924|NCT01010776|7338800|FG000|Main Phase|Other|1
4523925|NCT01010776|7338800|FG000|Main Phase|Did not received study medication|5
4523926|NCT01010776|7338800|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15
4594266|NCT01560988|7443385|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7
4737960|NCT03628924|7688546|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2
4737961|NCT03628924|7688547|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0
4737962|NCT03628924|7688548|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0
4737963|NCT03628924|7688549|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0
4737964|NCT03628924|7688550|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0
4523927|NCT01010776|7338800|FG000|Extension Phase|Other|3
4523928|NCT01010867|7338819|FG000|Overall Study|< 50% adherence to probiotic|1
4594267|NCT01560988|7443386|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4
4594268|NCT01560988|7443385|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3
4594269|NCT01560988|7443386|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0
4594270|NCT01560988|7443385|FG000|Washout (Six Weeks)|Lost to Follow-up|2
4594271|NCT01560988|7443386|FG001|Washout (Six Weeks)|Lost to Follow-up|2
4737965|NCT03628924|7688551|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0
4737966|NCT03628924|7688552|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0
4737967|NCT03628924|7688546|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
4523929|NCT01010971|7338859|FG000|Overall Study|Adverse Event|2
4523930|NCT01010971|7338860|FG001|Overall Study|Adverse Event|4
4523931|NCT01010971|7338861|FG002|Overall Study|Adverse Event|3
4523932|NCT01010971|7338859|FG000|Overall Study|Withdrawal by Subject|0
4523933|NCT01010971|7338860|FG001|Overall Study|Withdrawal by Subject|2
4523934|NCT01010971|7338861|FG002|Overall Study|Withdrawal by Subject|5
4523935|NCT01010971|7338859|FG000|Overall Study|Lost to Follow-up|0
4523936|NCT01010971|7338860|FG001|Overall Study|Lost to Follow-up|2
4523937|NCT01010971|7338861|FG002|Overall Study|Lost to Follow-up|3
4523938|NCT01010971|7338859|FG000|Overall Study|Other|1
4523939|NCT01010971|7338860|FG001|Overall Study|Other|0
4523940|NCT01010971|7338861|FG002|Overall Study|Other|2
4523941|NCT01011049|7338878|FG000|Overall Study|Protocol Violation|0
4523942|NCT01011049|7338879|FG001|Overall Study|Protocol Violation|0
4523943|NCT01011049|7338880|FG002|Overall Study|Protocol Violation|2
4523944|NCT01011049|7338881|FG003|Overall Study|Protocol Violation|0
4523945|NCT01011049|7338878|FG000|Overall Study|Lost to Follow-up|1
4523946|NCT01011049|7338879|FG001|Overall Study|Lost to Follow-up|2
4523947|NCT01011049|7338880|FG002|Overall Study|Lost to Follow-up|1
4523948|NCT01011049|7338881|FG003|Overall Study|Lost to Follow-up|0
4523949|NCT01011049|7338878|FG000|Overall Study|Withdrawal by Subject|0
4523950|NCT01011049|7338879|FG001|Overall Study|Withdrawal by Subject|0
4523951|NCT01011049|7338880|FG002|Overall Study|Withdrawal by Subject|1
4523952|NCT01011049|7338881|FG003|Overall Study|Withdrawal by Subject|0
4523953|NCT01011153|7338898|FG000|Overall Study|Less than 78 cases completed|8
4523954|NCT01011153|7338899|FG001|Overall Study|Less than 78 cases completed|11
4523955|NCT01011153|7338900|FG002|Overall Study|Less than 78 cases completed|9
4523956|NCT01011283|7338946|FG000|Overall Study|Adverse Event|4
4523957|NCT01011283|7338947|FG001|Overall Study|Adverse Event|2
4523958|NCT01011283|7338946|FG000|Overall Study|Progressive Disease|0
4523959|NCT01011283|7338947|FG001|Overall Study|Progressive Disease|2
4523960|NCT01011283|7338946|FG000|Overall Study|Terminated by Sponsor|5
4523961|NCT01011283|7338947|FG001|Overall Study|Terminated by Sponsor|5
4523962|NCT01011283|7338946|FG000|Overall Study|Other|2
4523963|NCT01011283|7338947|FG001|Overall Study|Other|2
4523964|NCT01011309|7338956|FG000|Overall Study|Adverse Event|2
4523965|NCT01011309|7338957|FG001|Overall Study|Adverse Event|1
4523966|NCT01011309|7338958|FG002|Overall Study|Adverse Event|2
4523967|NCT01011309|7338956|FG000|Overall Study|Lack of Efficacy|0
4523968|NCT01011309|7338957|FG001|Overall Study|Lack of Efficacy|1
4523969|NCT01011309|7338958|FG002|Overall Study|Lack of Efficacy|0
4523970|NCT01011309|7338956|FG000|Overall Study|Protocol Violation|0
4523971|NCT01011309|7338957|FG001|Overall Study|Protocol Violation|1
4523972|NCT01011309|7338958|FG002|Overall Study|Protocol Violation|3
4523973|NCT01011335|7338970|FG000|Overall Study|Lost to Follow-up|0
4523974|NCT01011335|7338971|FG001|Overall Study|Lost to Follow-up|0
4523975|NCT01011335|7338972|FG002|Overall Study|Lost to Follow-up|1
4737968|NCT03628924|7688547|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
4737969|NCT03628924|7688548|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1
4737970|NCT03628924|7688549|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
4737971|NCT03628924|7688550|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
4737972|NCT03628924|7688551|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
4737973|NCT03628924|7688552|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
4737974|NCT03628924|7688546|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1
4737975|NCT03628924|7688547|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2
4737976|NCT03628924|7688548|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1
4737977|NCT03628924|7688549|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0
4737978|NCT03628924|7688550|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0
4737979|NCT03628924|7688551|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0
4737980|NCT03628924|7688552|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0
4737981|NCT03628924|7688546|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
4737982|NCT03628924|7688547|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1
4737983|NCT03628924|7688548|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
4737984|NCT03628924|7688549|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
4737985|NCT03628924|7688550|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
4737986|NCT03628924|7688551|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
4737987|NCT03628924|7688552|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
4737988|NCT03628924|7688546|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3
4737989|NCT03628924|7688547|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0
4737990|NCT03628924|7688548|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1
4737991|NCT03628924|7688549|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0
4523976|NCT01011335|7338973|FG003|Overall Study|Lost to Follow-up|1
4523977|NCT01011335|7338974|FG004|Overall Study|Lost to Follow-up|1
4523978|NCT01011335|7338975|FG005|Overall Study|Lost to Follow-up|1
4523979|NCT01011335|7338976|FG006|Overall Study|Lost to Follow-up|2
4594272|NCT01561079|7443415|FG000|Overall Study|Physician Decision|17
4523980|NCT01011335|7338977|FG007|Overall Study|Lost to Follow-up|2
4523981|NCT01011335|7338978|FG008|Overall Study|Lost to Follow-up|1
4523982|NCT01011335|7338979|FG009|Overall Study|Lost to Follow-up|0
4523983|NCT01011335|7338980|FG010|Overall Study|Lost to Follow-up|0
4523984|NCT01011335|7338981|FG011|Overall Study|Lost to Follow-up|1
4523985|NCT01011335|7338982|FG012|Overall Study|Lost to Follow-up|2
4523986|NCT01011335|7338970|FG000|Overall Study|Protocol Violation|0
4523987|NCT01011335|7338971|FG001|Overall Study|Protocol Violation|1
4523988|NCT01011335|7338972|FG002|Overall Study|Protocol Violation|0
4523989|NCT01011335|7338973|FG003|Overall Study|Protocol Violation|0
4737992|NCT03628924|7688550|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0
4737993|NCT03628924|7688551|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0
4737994|NCT03628924|7688552|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0
4737995|NCT03628924|7688546|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0
4737996|NCT03628924|7688547|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0
4737997|NCT03628924|7688548|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0
4737998|NCT03628924|7688549|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1
4737999|NCT03628924|7688550|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1
4738000|NCT03628924|7688551|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2
4738001|NCT03628924|7688552|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1
4738002|NCT03628924|7688546|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0
4738003|NCT03628924|7688547|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0
4738004|NCT03628924|7688548|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0
4738005|NCT03628924|7688549|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1
4738006|NCT03628924|7688550|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0
4738007|NCT03628924|7688551|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2
4738008|NCT03628924|7688552|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4
4738009|NCT03628924|7688546|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0
4738010|NCT03628924|7688547|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0
4738011|NCT03628924|7688548|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0
4738012|NCT03628924|7688549|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1
4738013|NCT03628924|7688550|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1
4738014|NCT03628924|7688551|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0
4738015|NCT03628924|7688552|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1
4738016|NCT03628924|7688546|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0
4738017|NCT03628924|7688547|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0
4738018|NCT03628924|7688548|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0
4738019|NCT03628924|7688549|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5
4738020|NCT03628924|7688550|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1
4738021|NCT03628924|7688551|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4
4738022|NCT03628924|7688552|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2
4738023|NCT03628924|7688546|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0
4523990|NCT01011335|7338974|FG004|Overall Study|Protocol Violation|0
4523991|NCT01011335|7338975|FG005|Overall Study|Protocol Violation|0
4523992|NCT01011335|7338976|FG006|Overall Study|Protocol Violation|0
4523993|NCT01011335|7338977|FG007|Overall Study|Protocol Violation|0
4523994|NCT01011335|7338978|FG008|Overall Study|Protocol Violation|0
4523995|NCT01011335|7338979|FG009|Overall Study|Protocol Violation|0
4594273|NCT01561079|7443415|FG000|Overall Study|Withdrawal by Subject|59
4594274|NCT01561079|7443415|FG000|Overall Study|Protocol Violation|2
4738024|NCT03628924|7688547|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0
4738025|NCT03628924|7688548|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0
4738026|NCT03628924|7688549|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0
4738027|NCT03628924|7688550|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1
4738028|NCT03628924|7688551|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5
4738029|NCT03628924|7688552|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3
4738030|NCT03629028|7688566|FG000|Overall Study|Lost to Follow-up|26
4738031|NCT03629028|7688567|FG001|Overall Study|Lost to Follow-up|23
4738032|NCT03629028|7688566|FG000|Overall Study|Pregnancy|4
4738033|NCT03629028|7688567|FG001|Overall Study|Pregnancy|2
4738034|NCT03629028|7688566|FG000|Overall Study|intolerance to examination|2
4738035|NCT03629028|7688567|FG001|Overall Study|intolerance to examination|0
4738036|NCT03629041|7688583|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0
4738037|NCT03629041|7688584|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1
4738038|NCT03629041|7688585|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0
4738039|NCT03629041|7688586|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0
4738040|NCT03629054|7688606|FG000|Period 2 (4 Days)|Not treated|0
4738041|NCT03629054|7688607|FG001|Period 2 (4 Days)|Not treated|1
4738042|NCT03629184|7688615|FG000|Overall Study|Withdrawal by Subject|2
4523996|NCT01011335|7338980|FG010|Overall Study|Protocol Violation|0
4523997|NCT01011335|7338981|FG011|Overall Study|Protocol Violation|0
4523998|NCT01011335|7338982|FG012|Overall Study|Protocol Violation|0
4523999|NCT01011335|7338970|FG000|Overall Study|Moved/deployed or no booster|1
4524000|NCT01011335|7338971|FG001|Overall Study|Moved/deployed or no booster|0
4524001|NCT01011335|7338972|FG002|Overall Study|Moved/deployed or no booster|0
4524002|NCT01011335|7338973|FG003|Overall Study|Moved/deployed or no booster|1
4524003|NCT01011335|7338974|FG004|Overall Study|Moved/deployed or no booster|0
4524004|NCT01011335|7338975|FG005|Overall Study|Moved/deployed or no booster|0
4524005|NCT01011335|7338976|FG006|Overall Study|Moved/deployed or no booster|1
4524006|NCT01011335|7338977|FG007|Overall Study|Moved/deployed or no booster|0
4524007|NCT01011335|7338978|FG008|Overall Study|Moved/deployed or no booster|1
4524008|NCT01011335|7338979|FG009|Overall Study|Moved/deployed or no booster|0
4524009|NCT01011335|7338980|FG010|Overall Study|Moved/deployed or no booster|2
4524010|NCT01011335|7338981|FG011|Overall Study|Moved/deployed or no booster|0
4524011|NCT01011335|7338982|FG012|Overall Study|Moved/deployed or no booster|0
4524012|NCT01011335|7338970|FG000|Overall Study|Adverse Event|0
4524013|NCT01011335|7338971|FG001|Overall Study|Adverse Event|0
4524014|NCT01011335|7338972|FG002|Overall Study|Adverse Event|0
4524015|NCT01011335|7338973|FG003|Overall Study|Adverse Event|0
4524016|NCT01011335|7338974|FG004|Overall Study|Adverse Event|0
4524017|NCT01011335|7338975|FG005|Overall Study|Adverse Event|0
4524018|NCT01011335|7338976|FG006|Overall Study|Adverse Event|0
4524019|NCT01011335|7338977|FG007|Overall Study|Adverse Event|0
4524020|NCT01011335|7338978|FG008|Overall Study|Adverse Event|0
4524021|NCT01011335|7338979|FG009|Overall Study|Adverse Event|0
4524022|NCT01011335|7338980|FG010|Overall Study|Adverse Event|4
4524023|NCT01011335|7338981|FG011|Overall Study|Adverse Event|0
4524024|NCT01011335|7338982|FG012|Overall Study|Adverse Event|1
4524025|NCT01011387|7339019|FG000|Overall Study|Withdrawal by Subject|3
4524026|NCT01011387|7339019|FG000|Overall Study|Adverse Event|2
4524027|NCT01011387|7339019|FG000|Overall Study|Protocol Violation|1
4524028|NCT01011439|7339039|FG000|Overall Study|Death|37
4524029|NCT01011439|7339039|FG000|Overall Study|Lost to Follow-up|4
4524030|NCT01011439|7339039|FG000|Overall Study|Withdrawal by Subject|1
4738043|NCT03629184|7688616|FG001|Overall Study|Withdrawal by Subject|1
4738044|NCT03629184|7688615|FG000|Overall Study|Physician Decision|1
4738045|NCT03629184|7688616|FG001|Overall Study|Physician Decision|0
4738046|NCT03629249|7688625|FG000|Overall Study|Study terminated by sponsor|197
4738047|NCT03629249|7688626|FG001|Overall Study|Study terminated by sponsor|197
4738048|NCT03629249|7688627|FG002|Overall Study|Study terminated by sponsor|194
4738049|NCT03629249|7688625|FG000|Overall Study|Protocol deviation|0
4738050|NCT03629249|7688626|FG001|Overall Study|Protocol deviation|2
4738051|NCT03629249|7688627|FG002|Overall Study|Protocol deviation|5
4738052|NCT03629249|7688625|FG000|Overall Study|Subject decision|1
4738053|NCT03629249|7688626|FG001|Overall Study|Subject decision|1
4738054|NCT03629249|7688627|FG002|Overall Study|Subject decision|3
4738055|NCT03629249|7688625|FG000|Overall Study|Adverse Event|1
4738056|NCT03629249|7688626|FG001|Overall Study|Adverse Event|1
4738057|NCT03629249|7688627|FG002|Overall Study|Adverse Event|0
4738058|NCT03629249|7688625|FG000|Overall Study|Death|1
4738059|NCT03629249|7688626|FG001|Overall Study|Death|0
4738060|NCT03629249|7688627|FG002|Overall Study|Death|0
4738061|NCT03629249|7688625|FG000|Overall Study|Physician Decision|1
4738062|NCT03629249|7688626|FG001|Overall Study|Physician Decision|0
4738063|NCT03629249|7688627|FG002|Overall Study|Physician Decision|0
4738064|NCT03629886|7688641|FG000|Overall Study|Migrated / moved from the study area|0
4738065|NCT03629886|7688642|FG001|Overall Study|Migrated / moved from the study area|55
4738066|NCT03629886|7688641|FG000|Overall Study|Consent withdrawal, not due to an AE|0
4738067|NCT03629886|7688642|FG001|Overall Study|Consent withdrawal, not due to an AE|50
4738068|NCT03629886|7688641|FG000|Overall Study|Study vaccine not administrated|0
4738069|NCT03629886|7688642|FG001|Overall Study|Study vaccine not administrated|3
4524031|NCT01011439|7339039|FG000|Overall Study|Sponsor's decision|15
4524032|NCT01011465|7339052|FG000|Overall Study|Withdrawal by Subject|2
4524033|NCT01011465|7339053|FG001|Overall Study|Withdrawal by Subject|1
4524034|NCT01011465|7339054|FG002|Overall Study|Withdrawal by Subject|0
4524035|NCT01011465|7339055|FG003|Overall Study|Withdrawal by Subject|0
4524036|NCT01011465|7339056|FG004|Overall Study|Withdrawal by Subject|1
4524037|NCT01011465|7339057|FG005|Overall Study|Withdrawal by Subject|0
4524038|NCT01011465|7339058|FG006|Overall Study|Withdrawal by Subject|1
4524039|NCT01011465|7339059|FG007|Overall Study|Withdrawal by Subject|0
4524040|NCT01011556|7339079|FG000|Overall Study|Adverse Event|1
4524041|NCT01011556|7339080|FG001|Overall Study|Adverse Event|3
4524042|NCT01011556|7339081|FG002|Overall Study|Adverse Event|2
4524043|NCT01011556|7339082|FG003|Overall Study|Adverse Event|1
4524044|NCT01011556|7339079|FG000|Overall Study|Lost to Follow-up|1
4524045|NCT01011556|7339080|FG001|Overall Study|Lost to Follow-up|0
4524046|NCT01011556|7339081|FG002|Overall Study|Lost to Follow-up|0
4524047|NCT01011556|7339082|FG003|Overall Study|Lost to Follow-up|0
4524048|NCT01011556|7339079|FG000|Overall Study|Physician Decision|1
4524049|NCT01011556|7339080|FG001|Overall Study|Physician Decision|0
4524050|NCT01011556|7339081|FG002|Overall Study|Physician Decision|0
4524051|NCT01011556|7339082|FG003|Overall Study|Physician Decision|1
4524052|NCT01011556|7339079|FG000|Overall Study|Protocol Violation|0
4524053|NCT01011556|7339080|FG001|Overall Study|Protocol Violation|1
4524054|NCT01011556|7339081|FG002|Overall Study|Protocol Violation|0
4524055|NCT01011556|7339082|FG003|Overall Study|Protocol Violation|0
4524056|NCT01011556|7339079|FG000|Overall Study|Withdrawal by Subject|1
4524057|NCT01011556|7339080|FG001|Overall Study|Withdrawal by Subject|2
4524058|NCT01011556|7339081|FG002|Overall Study|Withdrawal by Subject|4
4524059|NCT01011556|7339082|FG003|Overall Study|Withdrawal by Subject|4
4524060|NCT01011556|7339079|FG000|Overall Study|Sponsor decision|0
4524061|NCT01011556|7339080|FG001|Overall Study|Sponsor decision|1
4524062|NCT01011556|7339081|FG002|Overall Study|Sponsor decision|1
4524063|NCT01011556|7339082|FG003|Overall Study|Sponsor decision|2
4524064|NCT01011556|7339079|FG000|Overall Study|Inclusion/exclusion criteria not met|2
4524065|NCT01011556|7339080|FG001|Overall Study|Inclusion/exclusion criteria not met|1
4524066|NCT01011556|7339081|FG002|Overall Study|Inclusion/exclusion criteria not met|3
4524067|NCT01011556|7339082|FG003|Overall Study|Inclusion/exclusion criteria not met|5
4524068|NCT01011673|7339097|FG000|Randomized|Secondary headache|2
4524069|NCT01011673|7339098|FG001|Randomized|Secondary headache|1
4524070|NCT01011673|7339097|FG000|24 Hour Follow-up|Lost to Follow-up|3
4738070|NCT03629886|7688641|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0
4738071|NCT03629886|7688642|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28
4738072|NCT03629886|7688641|FG000|Overall Study|Refused vaccination step of the study|0
4738073|NCT03629886|7688642|FG001|Overall Study|Refused vaccination step of the study|44
4738074|NCT03630016|7688658|FG000|Overall Study|Poor Sensor Placement|1
4524071|NCT01011673|7339098|FG001|24 Hour Follow-up|Lost to Follow-up|3
4524072|NCT01011738|7339107|FG000|Overall Study|Death|12
4524073|NCT01011738|7339108|FG001|Overall Study|Death|3
4524074|NCT01011738|7339109|FG002|Overall Study|Death|0
4524075|NCT01011738|7339107|FG000|Overall Study|Unknown reasons|312
4524076|NCT01011738|7339108|FG001|Overall Study|Unknown reasons|291
4524077|NCT01011738|7339109|FG002|Overall Study|Unknown reasons|17
4524078|NCT01011868|7339141|FG000|After Week 18 Follow-up|Adverse Event|8
4524079|NCT01011868|7339142|FG001|After Week 18 Follow-up|Adverse Event|6
4524080|NCT01011868|7339143|FG002|After Week 18 Follow-up|Adverse Event|13
4524081|NCT01011868|7339141|FG000|After Week 18 Follow-up|Lack of Efficacy|1
4524082|NCT01011868|7339142|FG001|After Week 18 Follow-up|Lack of Efficacy|0
4524083|NCT01011868|7339143|FG002|After Week 18 Follow-up|Lack of Efficacy|0
4524084|NCT01011868|7339141|FG000|After Week 18 Follow-up|Protocol Violation|1
4524085|NCT01011868|7339142|FG001|After Week 18 Follow-up|Protocol Violation|1
4524086|NCT01011868|7339143|FG002|After Week 18 Follow-up|Protocol Violation|1
4524087|NCT01011868|7339141|FG000|After Week 18 Follow-up|Lost to Follow-up|5
4524088|NCT01011868|7339142|FG001|After Week 18 Follow-up|Lost to Follow-up|3
4524089|NCT01011868|7339143|FG002|After Week 18 Follow-up|Lost to Follow-up|0
4524090|NCT01011868|7339141|FG000|After Week 18 Follow-up|Withdrawal by Subject|6
4524091|NCT01011868|7339142|FG001|After Week 18 Follow-up|Withdrawal by Subject|3
4524092|NCT01011868|7339143|FG002|After Week 18 Follow-up|Withdrawal by Subject|0
4524093|NCT01011868|7339141|FG000|After Week 18 Follow-up|Other reason not defined above|2
4524094|NCT01011868|7339142|FG001|After Week 18 Follow-up|Other reason not defined above|3
4524095|NCT01011868|7339143|FG002|After Week 18 Follow-up|Other reason not defined above|12
4524096|NCT01011868|7339141|FG000|After Week 78 Follow-up|Adverse Event|14
4524097|NCT01011868|7339142|FG001|After Week 78 Follow-up|Adverse Event|18
4524098|NCT01011868|7339143|FG002|After Week 78 Follow-up|Adverse Event|21
4524099|NCT01011868|7339141|FG000|After Week 78 Follow-up|Lack of Efficacy|4
4524100|NCT01011868|7339142|FG001|After Week 78 Follow-up|Lack of Efficacy|0
4524101|NCT01011868|7339143|FG002|After Week 78 Follow-up|Lack of Efficacy|0
4524102|NCT01011868|7339141|FG000|After Week 78 Follow-up|Protocol Violation|9
4524103|NCT01011868|7339142|FG001|After Week 78 Follow-up|Protocol Violation|1
4524104|NCT01011868|7339143|FG002|After Week 78 Follow-up|Protocol Violation|2
4524105|NCT01011868|7339141|FG000|After Week 78 Follow-up|Lost to Follow-up|11
4524106|NCT01011868|7339142|FG001|After Week 78 Follow-up|Lost to Follow-up|6
4524107|NCT01011868|7339143|FG002|After Week 78 Follow-up|Lost to Follow-up|4
4524108|NCT01011868|7339141|FG000|After Week 78 Follow-up|Withdrawal by Subject|9
4524109|NCT01011868|7339142|FG001|After Week 78 Follow-up|Withdrawal by Subject|8
4524110|NCT01011868|7339143|FG002|After Week 78 Follow-up|Withdrawal by Subject|1
4524111|NCT01011868|7339141|FG000|After Week 78 Follow-up|Other reason not defined above|5
4738075|NCT03630302|7688680|FG000|Surgery|hardware issue prevented LFP recordings|1
4738076|NCT03630302|7688680|FG000|3 Month Visit|Adverse Event|2
4738077|NCT03630302|7688680|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2
4738078|NCT03631355|7688695|FG000|Overall Study|Lost to Follow-up|1
4738079|NCT03631355|7688696|FG001|Overall Study|Lost to Follow-up|2
4738080|NCT03631732|7688713|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3
4738081|NCT03631732|7688714|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0
4738082|NCT03631732|7688713|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1
4738083|NCT03631732|7688714|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2
4738084|NCT03631732|7688713|FG000|Randomized Phase Up to Week 24|Adverse Event|2
4738085|NCT03631732|7688714|FG001|Randomized Phase Up to Week 24|Adverse Event|0
4738086|NCT03631732|7688713|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1
4738087|NCT03631732|7688714|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0
4738088|NCT03631732|7688713|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6
4738089|NCT03631732|7688714|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1
4738090|NCT03631732|7688713|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3
4738091|NCT03631732|7688714|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3
4738092|NCT03631732|7688713|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4
4594275|NCT01561300|7443458|FG000|Run in on Placebo|Adverse Event|1
4524112|NCT01011868|7339142|FG001|After Week 78 Follow-up|Other reason not defined above|5
4524113|NCT01011868|7339143|FG002|After Week 78 Follow-up|Other reason not defined above|16
4524114|NCT01011907|7339157|FG000|Overall Study|Withdrawal by Subject|13
4524115|NCT01011907|7339158|FG001|Overall Study|Withdrawal by Subject|11
4524116|NCT01011907|7339157|FG000|Overall Study|Adverse Event|1
4524117|NCT01011907|7339158|FG001|Overall Study|Adverse Event|4
4524118|NCT01011933|7339164|FG000|Overall Study|Wrong cell type|1
4524119|NCT01011933|7339164|FG000|Overall Study|Improper pre-protocol Rx|1
4524120|NCT01011933|7339164|FG000|Overall Study|Inadequate pathology|1
4524121|NCT01011933|7339164|FG000|Overall Study|Never treated|1
4524122|NCT01011946|7339174|FG000|Overall Study|Transferred to another hospital|2
4524123|NCT01011946|7339174|FG000|Overall Study|No pathological lab value|1
4524124|NCT01012037|7339181|FG000|Overall Study|Adverse Event|0
4524125|NCT01012037|7339182|FG001|Overall Study|Adverse Event|8
4524126|NCT01012037|7339183|FG002|Overall Study|Adverse Event|3
4524127|NCT01012037|7339181|FG000|Overall Study|Protocol Violation|0
4524128|NCT01012037|7339182|FG001|Overall Study|Protocol Violation|3
4524129|NCT01012037|7339183|FG002|Overall Study|Protocol Violation|5
4524130|NCT01012037|7339181|FG000|Overall Study|Withdrawal by Subject|0
4524131|NCT01012037|7339182|FG001|Overall Study|Withdrawal by Subject|4
4524132|NCT01012037|7339183|FG002|Overall Study|Withdrawal by Subject|1
4524133|NCT01012037|7339181|FG000|Overall Study|Other reason (not specified)|1
4524134|NCT01012037|7339182|FG001|Overall Study|Other reason (not specified)|1
4524135|NCT01012037|7339183|FG002|Overall Study|Other reason (not specified)|1
4524136|NCT01012219|7339199|FG000|Period 1|Withdrawal by Subject|1
4524137|NCT01012219|7339199|FG000|Period 2|Withdrawal by Subject|1
4524138|NCT01012258|7339221|FG000|Overall Study|Death|14
4524139|NCT01012258|7339221|FG000|Overall Study|Lost to Follow-up|1
4524140|NCT01012258|7339221|FG000|Overall Study|Adverse Event|1
4524141|NCT01012258|7339221|FG000|Overall Study|Progressive Disease (PD)|18
4524142|NCT01012258|7339221|FG000|Overall Study|Symptomatic Deterioration|1
4524143|NCT01012258|7339221|FG000|Overall Study|Another Anti-cancer Drug Received|1
4524144|NCT01012258|7339221|FG000|Overall Study|Another Tumor Discovered|1
4524145|NCT01012258|7339221|FG000|Overall Study|Ongoing|29
4524146|NCT01012323|7339235|FG000|Overall Study|Investigator Judgment|1
4524147|NCT01012440|7339272|FG000|Overall Study|Withdrawal by Subject|2
4524148|NCT01012622|7339280|FG000|Overall Study|Withdrawal by Subject|6
4633671|NCT01914757|7503940|FG000|Overall Study|Other reasons|5
4633672|NCT01914757|7503941|FG001|Overall Study|Other reasons|9
4524149|NCT01012622|7339280|FG000|Overall Study|Lost to Follow-up|5
4524150|NCT01012622|7339280|FG000|Overall Study|Adverse Event|7
4524151|NCT01012622|7339280|FG000|Overall Study|non-compliance with the drug|9
4524152|NCT01012622|7339280|FG000|Overall Study|Other|1
4524153|NCT01012622|7339280|FG000|Overall Study|screening failure|1
4524154|NCT01012622|7339280|FG000|Overall Study|withdrawal of consent by a parent|2
4524155|NCT01012713|7339298|FG000|Overall Study|Lack of Efficacy|3
4524156|NCT01012739|7339303|FG000|Treatment Period 1|Adverse Event|0
4524157|NCT01012739|7339304|FG001|Treatment Period 1|Adverse Event|0
4524158|NCT01012739|7339305|FG002|Treatment Period 1|Adverse Event|0
4524159|NCT01012739|7339306|FG003|Treatment Period 1|Adverse Event|1
4524160|NCT01012739|7339303|FG000|Treatment Period 2|Abnormal test procedure results|0
4524161|NCT01012739|7339304|FG001|Treatment Period 2|Abnormal test procedure results|0
4524162|NCT01012739|7339305|FG002|Treatment Period 2|Abnormal test procedure results|0
4524163|NCT01012739|7339306|FG003|Treatment Period 2|Abnormal test procedure results|1
4524164|NCT01012765|7339317|FG000|Treatment Period 1|Adverse Event|1
4524165|NCT01012765|7339318|FG001|Treatment Period 1|Adverse Event|0
4524166|NCT01012765|7339319|FG002|Treatment Period 1|Adverse Event|1
4524167|NCT01012765|7339320|FG003|Treatment Period 1|Adverse Event|0
4524168|NCT01012765|7339321|FG004|Treatment Period 1|Adverse Event|0
4524169|NCT01012765|7339322|FG005|Treatment Period 1|Adverse Event|0
4738093|NCT03631732|7688714|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1
4738094|NCT03631732|7688713|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1
4738095|NCT03631732|7688714|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0
4738096|NCT03631732|7688713|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1
4738097|NCT03631732|7688714|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0
4738098|NCT03631732|7688713|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1
4738099|NCT03631732|7688714|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0
4738100|NCT03633331|7688771|FG000|Overall Study|Withdrawal by Subject|1
4738101|NCT03633825|7688809|FG000|Enrollment|Did not post on network|5066
4738102|NCT03633825|7688810|FG001|Enrollment|Did not post on network|5080
4738103|NCT03633825|7688809|FG000|Enrollment|Post not classified as crisis|13967
4738104|NCT03633825|7688810|FG001|Enrollment|Post not classified as crisis|13757
4738105|NCT03633825|7688809|FG000|Follow up|Lost to Follow-up|478
4738106|NCT03633825|7688810|FG001|Follow up|Lost to Follow-up|450
4738107|NCT03633903|7688818|FG000|Overall Study|Withdrawal by Subject|1
4738108|NCT03633903|7688819|FG001|Overall Study|Withdrawal by Subject|2
4524170|NCT01012765|7339317|FG000|Treatment Period 1|Withdrawal by Subject|2
4524171|NCT01012765|7339318|FG001|Treatment Period 1|Withdrawal by Subject|0
4524172|NCT01012765|7339319|FG002|Treatment Period 1|Withdrawal by Subject|0
4524173|NCT01012765|7339320|FG003|Treatment Period 1|Withdrawal by Subject|0
4633673|NCT01914757|7503942|FG002|Overall Study|Other reasons|4
4524174|NCT01012765|7339321|FG004|Treatment Period 1|Withdrawal by Subject|0
4633674|NCT01914926|7503952|FG000|Overall Study|Adverse Event|1
4633675|NCT01914926|7503953|FG001|Overall Study|Adverse Event|0
4633676|NCT01914926|7503952|FG000|Overall Study|uncooperative, agitated and removed|0
4633677|NCT01914926|7503953|FG001|Overall Study|uncooperative, agitated and removed|1
4633678|NCT01915095|7503966|FG000|Overall Study|Some subjects were unable to commit to the training study.|0
4738109|NCT03633903|7688818|FG000|Overall Study|Lost to Follow-up|5
4524175|NCT01012765|7339322|FG005|Treatment Period 1|Withdrawal by Subject|0
4738110|NCT03633903|7688819|FG001|Overall Study|Lost to Follow-up|5
4738111|NCT03633929|7688825|FG000|Overall Study|Lost to Follow-up|1
4738112|NCT03633929|7688825|FG000|Overall Study|Did not login to software. Did not participate|3
4738113|NCT03634085|7688831|FG000|Overall Study|Adverse Event|1
4738114|NCT03634085|7688832|FG001|Overall Study|Adverse Event|0
4738115|NCT03634085|7688831|FG000|Overall Study|Withdrawal by Subject|0
4738116|NCT03634085|7688832|FG001|Overall Study|Withdrawal by Subject|2
4738117|NCT03634579|7688858|FG000|Overall Study|study termination|9
4738118|NCT03634800|7688862|FG000|Overall Study|Adverse Event|1
4738119|NCT03634800|7688862|FG000|Overall Study|Disease Progression|4
4738120|NCT03634800|7688862|FG000|Overall Study|Withdrawal by Subject|1
4738121|NCT03635086|7688881|FG000|Overall Study|Withdrawal of consent|0
4738122|NCT03635086|7688882|FG001|Overall Study|Withdrawal of consent|0
4738123|NCT03635086|7688883|FG002|Overall Study|Withdrawal of consent|1
4738124|NCT03635086|7688884|FG003|Overall Study|Withdrawal of consent|0
4738125|NCT03635086|7688885|FG004|Overall Study|Withdrawal of consent|0
4738126|NCT03635086|7688881|FG000|Overall Study|Adverse Event|0
4738127|NCT03635086|7688882|FG001|Overall Study|Adverse Event|1
4738128|NCT03635086|7688883|FG002|Overall Study|Adverse Event|0
4738129|NCT03635086|7688884|FG003|Overall Study|Adverse Event|0
4738130|NCT03635086|7688885|FG004|Overall Study|Adverse Event|0
4738131|NCT03635086|7688881|FG000|Overall Study|Lost to Follow-up|1
4738132|NCT03635086|7688882|FG001|Overall Study|Lost to Follow-up|0
4738133|NCT03635086|7688883|FG002|Overall Study|Lost to Follow-up|0
4738134|NCT03635086|7688884|FG003|Overall Study|Lost to Follow-up|0
4738135|NCT03635086|7688885|FG004|Overall Study|Lost to Follow-up|0
4738136|NCT03635320|7688900|FG000|Overall Study|not implanted the device|1
4738137|NCT03635320|7688901|FG001|Overall Study|not implanted the device|2
4738138|NCT03635320|7688900|FG000|Overall Study|Withdrawal by Subject|11
4738139|NCT03635320|7688901|FG001|Overall Study|Withdrawal by Subject|6
4738143|NCT03635775|7688915|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0
4524176|NCT01012765|7339317|FG000|Treatment Period 1|Administrative problems|0
4524177|NCT01012765|7339318|FG001|Treatment Period 1|Administrative problems|0
4524178|NCT01012765|7339319|FG002|Treatment Period 1|Administrative problems|1
4524179|NCT01012765|7339320|FG003|Treatment Period 1|Administrative problems|1
4524180|NCT01012765|7339321|FG004|Treatment Period 1|Administrative problems|1
4524181|NCT01012765|7339322|FG005|Treatment Period 1|Administrative problems|0
4524182|NCT01012765|7339317|FG000|Treatment Period 1|Protocol Violation|0
4524183|NCT01012765|7339318|FG001|Treatment Period 1|Protocol Violation|0
4524184|NCT01012765|7339319|FG002|Treatment Period 1|Protocol Violation|0
4524185|NCT01012765|7339320|FG003|Treatment Period 1|Protocol Violation|2
4524186|NCT01012765|7339321|FG004|Treatment Period 1|Protocol Violation|1
4524187|NCT01012765|7339322|FG005|Treatment Period 1|Protocol Violation|0
4524188|NCT01012765|7339317|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0
4524189|NCT01012765|7339318|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0
4524190|NCT01012765|7339319|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0
4524191|NCT01012765|7339320|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0
4524192|NCT01012765|7339321|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1
4524193|NCT01012765|7339322|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0
4524194|NCT01012765|7339317|FG000|Treatment Period 2|Withdrawal by Subject|1
4524195|NCT01012765|7339318|FG001|Treatment Period 2|Withdrawal by Subject|0
4524196|NCT01012765|7339319|FG002|Treatment Period 2|Withdrawal by Subject|1
4524197|NCT01012765|7339320|FG003|Treatment Period 2|Withdrawal by Subject|0
4524198|NCT01012765|7339321|FG004|Treatment Period 2|Withdrawal by Subject|1
4524199|NCT01012765|7339322|FG005|Treatment Period 2|Withdrawal by Subject|0
4524200|NCT01012765|7339317|FG000|Treatment Period 2|Abnormal laboratory value(s)|0
4524201|NCT01012765|7339318|FG001|Treatment Period 2|Abnormal laboratory value(s)|0
4524202|NCT01012765|7339319|FG002|Treatment Period 2|Abnormal laboratory value(s)|0
4524203|NCT01012765|7339320|FG003|Treatment Period 2|Abnormal laboratory value(s)|0
4524204|NCT01012765|7339321|FG004|Treatment Period 2|Abnormal laboratory value(s)|0
4524205|NCT01012765|7339322|FG005|Treatment Period 2|Abnormal laboratory value(s)|1
4524206|NCT01012765|7339317|FG000|Treatment Period 2|Adverse Event|0
4524207|NCT01012765|7339318|FG001|Treatment Period 2|Adverse Event|1
4524208|NCT01012765|7339319|FG002|Treatment Period 2|Adverse Event|1
4524209|NCT01012765|7339320|FG003|Treatment Period 2|Adverse Event|0
4524210|NCT01012765|7339321|FG004|Treatment Period 2|Adverse Event|0
4524211|NCT01012765|7339322|FG005|Treatment Period 2|Adverse Event|0
4524212|NCT01012765|7339317|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0
4524213|NCT01012765|7339318|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1
4524214|NCT01012765|7339319|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1
4524215|NCT01012765|7339320|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0
4524216|NCT01012765|7339321|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0
4524217|NCT01012765|7339322|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0
4524218|NCT01012947|7339344|FG000|Overall Study|Lost to Follow-up|131
4524219|NCT01012947|7339345|FG001|Overall Study|Lost to Follow-up|135
4524220|NCT01012947|7339346|FG002|Overall Study|Lost to Follow-up|130
4524221|NCT01012947|7339347|FG003|Overall Study|Lost to Follow-up|118
4524222|NCT01012947|7339348|FG004|Overall Study|Lost to Follow-up|142
4524223|NCT01012973|7339362|FG000|Overall Study|Adverse Event|5
4524224|NCT01012973|7339363|FG001|Overall Study|Adverse Event|5
4524225|NCT01012973|7339362|FG000|Overall Study|Lack of Efficacy|0
4524226|NCT01012973|7339363|FG001|Overall Study|Lack of Efficacy|5
4524227|NCT01012973|7339362|FG000|Overall Study|Lost to Follow-up|1
4524228|NCT01012973|7339363|FG001|Overall Study|Lost to Follow-up|0
4524229|NCT01012973|7339362|FG000|Overall Study|(Overseas travel - indefinite period)|1
4524230|NCT01012973|7339363|FG001|Overall Study|(Overseas travel - indefinite period)|0
4524231|NCT01012973|7339362|FG000|Overall Study|Increase in vis. acuity, never injected|0
4524232|NCT01012973|7339363|FG001|Overall Study|Increase in vis. acuity, never injected|1
4738144|NCT03635775|7688916|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0
4738145|NCT03635775|7688917|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0
4738146|NCT03635775|7688918|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1
4738147|NCT03635957|7688928|FG000|Run-In Period|Lost to Follow-up|1
4738148|NCT03635957|7688928|FG000|Pegloticase + IMM Period|Lack of Efficacy|3
4738149|NCT03636893|7688964|FG000|Overall Study|Death|0
4738150|NCT03636893|7688965|FG001|Overall Study|Death|1
4738151|NCT03636893|7688964|FG000|Overall Study|Protocol Violation|0
4738152|NCT03636893|7688965|FG001|Overall Study|Protocol Violation|3
4738153|NCT03636893|7688964|FG000|Overall Study|Withdrawal by Subject|1
4738154|NCT03636893|7688965|FG001|Overall Study|Withdrawal by Subject|2
4738155|NCT03636893|7688964|FG000|Overall Study|Refusal to surgery|4
4738156|NCT03636893|7688965|FG001|Overall Study|Refusal to surgery|3
4738157|NCT03636893|7688964|FG000|Overall Study|Early surgery (for acute bleeding)|3
4738158|NCT03636893|7688965|FG001|Overall Study|Early surgery (for acute bleeding)|0
4738159|NCT03636893|7688964|FG000|Overall Study|Adverse Event|1
4738160|NCT03636893|7688965|FG001|Overall Study|Adverse Event|1
4738161|NCT03638635|7689041|FG000|Initial Hospitalization|Study terminated prematurely|0
4738162|NCT03638635|7689042|FG001|Initial Hospitalization|Study terminated prematurely|1
4738163|NCT03638635|7689041|FG000|Initial Hospitalization|Withdrawal by study personnel|0
4738164|NCT03638635|7689042|FG001|Initial Hospitalization|Withdrawal by study personnel|1
4524233|NCT01012973|7339362|FG000|Overall Study|Protocol Violation|5
4524234|NCT01012973|7339363|FG001|Overall Study|Protocol Violation|2
4524235|NCT01012973|7339362|FG000|Overall Study|Withdrawal by Subject|4
4524236|NCT01012973|7339363|FG001|Overall Study|Withdrawal by Subject|6
4524237|NCT01012999|7339373|FG000|Overall Study|Protocol Violation|1
4524238|NCT01013207|7339390|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6
4524239|NCT01013285|7339396|FG000|Overall Study|Death|48
4524240|NCT01013285|7339397|FG001|Overall Study|Death|89
4524241|NCT01013350|7339404|FG000|Overall Study|Lost to Follow-up|15
4524242|NCT01013350|7339405|FG001|Overall Study|Lost to Follow-up|95
4524243|NCT01013350|7339404|FG000|Overall Study|Adverse Event|0
4524244|NCT01013350|7339405|FG001|Overall Study|Adverse Event|1
4524245|NCT01013350|7339404|FG000|Overall Study|Physician Decision|4
4524246|NCT01013350|7339405|FG001|Overall Study|Physician Decision|20
4524247|NCT01013350|7339404|FG000|Overall Study|Withdrawal by Subject|15
4524248|NCT01013350|7339405|FG001|Overall Study|Withdrawal by Subject|38
4524249|NCT01013350|7339404|FG000|Overall Study|Death|3
4524250|NCT01013350|7339405|FG001|Overall Study|Death|5
4524251|NCT01013350|7339404|FG000|Overall Study|Participant entered interventional study|0
4524252|NCT01013350|7339405|FG001|Overall Study|Participant entered interventional study|8
4524253|NCT01013350|7339404|FG000|Overall Study|Other|1
4524254|NCT01013350|7339405|FG001|Overall Study|Other|25
4524255|NCT01013597|7339412|FG000|Overall Study|Withdrawal by Subject|1
4633679|NCT01915095|7503967|FG001|Overall Study|Some subjects were unable to commit to the training study.|0
4633680|NCT01915095|7503968|FG002|Overall Study|Some subjects were unable to commit to the training study.|0
4738165|NCT03638635|7689041|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39
4738166|NCT03638635|7689042|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22
4738167|NCT03639675|7689056|FG000|Overall Study|Withdrawal by Subject|1
4738168|NCT03639779|7689066|FG000|Overall Study|Lost to Follow-up|1
4738169|NCT03639987|7689084|FG000|Overall Study|Study terminated by sponsor|26
4738170|NCT03639987|7689085|FG001|Overall Study|Study terminated by sponsor|25
4738171|NCT03639987|7689084|FG000|Overall Study|Lost to Follow-up|0
4738172|NCT03639987|7689085|FG001|Overall Study|Lost to Follow-up|1
4738173|NCT03640052|7689091|FG000|Overall Study|Lost to Follow-up|0
4738174|NCT03640052|7689092|FG001|Overall Study|Lost to Follow-up|1
4738175|NCT03640052|7689093|FG002|Overall Study|Lost to Follow-up|0
4738176|NCT03640052|7689094|FG003|Overall Study|Lost to Follow-up|0
4738177|NCT03640052|7689095|FG004|Overall Study|Lost to Follow-up|0
4738178|NCT03640507|7689110|FG000|Overall Study|Withdrawal by Subject|0
4738179|NCT03640507|7689111|FG001|Overall Study|Withdrawal by Subject|0
4738180|NCT03640507|7689112|FG002|Overall Study|Withdrawal by Subject|1
4738181|NCT03640559|7689122|FG000|Overall Study|Physician Decision|1
4738182|NCT03640559|7689123|FG001|Overall Study|Physician Decision|1
4738183|NCT03640559|7689122|FG000|Overall Study|Withdrawal by Subject|1
4738184|NCT03640559|7689123|FG001|Overall Study|Withdrawal by Subject|0
4738185|NCT03641508|7689140|FG000|First Injection|Lost to Follow-up|2
4738186|NCT03641508|7689141|FG001|First Injection|Lost to Follow-up|0
4738187|NCT03642262|7689151|FG000|Period 1|Withdrawal by Subject|1
4738188|NCT03642262|7689152|FG001|Period 1|Withdrawal by Subject|1
4738189|NCT03642262|7689151|FG000|Period 1|Adverse Event|0
4738190|NCT03642262|7689152|FG001|Period 1|Adverse Event|1
4738191|NCT03642717|7689168|FG000|Overall Study|Lost to Follow-up|2
4738192|NCT03642717|7689168|FG000|Overall Study|Inclusion/exclusion criteria violation|33
4738193|NCT03642717|7689168|FG000|Overall Study|Taken study drug prior to contract date|3
4738194|NCT03642873|7689173|FG000|Third Intervention (1 Day)|Screen failure|0
4738195|NCT03642873|7689174|FG001|Third Intervention (1 Day)|Screen failure|0
4738196|NCT03642873|7689175|FG002|Third Intervention (1 Day)|Screen failure|0
4738197|NCT03642873|7689176|FG003|Third Intervention (1 Day)|Screen failure|0
4738198|NCT03642873|7689177|FG004|Third Intervention (1 Day)|Screen failure|1
4738199|NCT03642873|7689178|FG005|Third Intervention (1 Day)|Screen failure|0
4738200|NCT03643432|7689192|FG000|Overall Study|Lost to Follow-up|1
4738201|NCT03643432|7689193|FG001|Overall Study|Lost to Follow-up|0
4738202|NCT03643575|7689199|FG000|Washout: 7 Days|Withdrew consent due to illness|0
4738203|NCT03643575|7689200|FG001|Washout: 7 Days|Withdrew consent due to illness|0
4738204|NCT03643575|7689201|FG002|Washout: 7 Days|Withdrew consent due to illness|0
4738205|NCT03643575|7689202|FG003|Washout: 7 Days|Withdrew consent due to illness|1
4738206|NCT03643575|7689203|FG004|Washout: 7 Days|Withdrew consent due to illness|0
4738207|NCT03643575|7689204|FG005|Washout: 7 Days|Withdrew consent due to illness|0
4738208|NCT03643575|7689199|FG000|Washout: 7 Days|Adverse Event|1
4738209|NCT03643575|7689200|FG001|Washout: 7 Days|Adverse Event|0
4738210|NCT03643575|7689201|FG002|Washout: 7 Days|Adverse Event|0
4738211|NCT03643575|7689202|FG003|Washout: 7 Days|Adverse Event|0
4738212|NCT03643575|7689203|FG004|Washout: 7 Days|Adverse Event|0
4738213|NCT03643575|7689204|FG005|Washout: 7 Days|Adverse Event|0
4738214|NCT03643575|7689199|FG000|Washout: 7 Days|Non compliance check in|0
4738215|NCT03643575|7689200|FG001|Washout: 7 Days|Non compliance check in|1
4738216|NCT03643575|7689201|FG002|Washout: 7 Days|Non compliance check in|0
4738217|NCT03643575|7689202|FG003|Washout: 7 Days|Non compliance check in|0
4524256|NCT01013740|7339418|FG000|Overall Study|Lost to Follow-up|3
4524257|NCT01013740|7339419|FG001|Overall Study|Lost to Follow-up|5
4524258|NCT01013740|7339418|FG000|Overall Study|Physician Decision|2
4524259|NCT01013740|7339419|FG001|Overall Study|Physician Decision|0
4524260|NCT01013740|7339418|FG000|Overall Study|Withdrawal by Subject|2
4524261|NCT01013740|7339419|FG001|Overall Study|Withdrawal by Subject|10
4524262|NCT01013740|7339418|FG000|Overall Study|study close / terminated : done in error|2
4524263|NCT01013740|7339419|FG001|Overall Study|study close / terminated : done in error|1
4524264|NCT01013740|7339418|FG000|Overall Study|Missing|2
4524265|NCT01013740|7339419|FG001|Overall Study|Missing|1
4524266|NCT01013740|7339418|FG000|Overall Study|Ongoing: Study records not completed|0
4524267|NCT01013740|7339419|FG001|Overall Study|Ongoing: Study records not completed|2
4524268|NCT01013753|7339427|FG000|Overall Study|Adverse Event|8
4524269|NCT01013753|7339427|FG000|Overall Study|Protocol Violation|3
4524270|NCT01013753|7339427|FG000|Overall Study|Lost to Follow-up|1
4524271|NCT01013753|7339427|FG000|Overall Study|Withdrawal by Subject|2
4524272|NCT01013753|7339427|FG000|Overall Study|Other|2
4524273|NCT01013792|7339443|FG000|Overall Study|Study suspended|2
4524274|NCT01013792|7339444|FG001|Overall Study|Study suspended|1
4524275|NCT01013792|7339443|FG000|Overall Study|Adverse Event|0
4633681|NCT01915095|7503969|FG003|Overall Study|Some subjects were unable to commit to the training study.|4
4633682|NCT01915095|7503970|FG004|Overall Study|Some subjects were unable to commit to the training study.|6
4633683|NCT01915303|7504025|FG000|Core Phase|Adverse Event|7
4633684|NCT01915303|7504025|FG000|Core Phase|Unsatisfactory therapeutic effect|3
4738218|NCT03643575|7689203|FG004|Washout: 7 Days|Non compliance check in|0
4738219|NCT03643575|7689204|FG005|Washout: 7 Days|Non compliance check in|0
4738220|NCT03643952|7689216|FG000|Overall Study|Lack of Efficacy|1
4738221|NCT03644173|7689239|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21
4738222|NCT03644173|7689239|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2
4738223|NCT03644173|7689239|FG000|Participants at the 1-month Follow up|Death|2
4738224|NCT03644173|7689239|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2
4738225|NCT03645421|7689257|FG000|Overall Study|Adverse Event|0
4738226|NCT03645421|7689258|FG001|Overall Study|Adverse Event|0
4738227|NCT03645421|7689259|FG002|Overall Study|Adverse Event|4
4738228|NCT03645421|7689260|FG003|Overall Study|Adverse Event|1
4738229|NCT03645421|7689257|FG000|Overall Study|Withdrawal by patient|0
4738230|NCT03645421|7689258|FG001|Overall Study|Withdrawal by patient|0
4738231|NCT03645421|7689259|FG002|Overall Study|Withdrawal by patient|0
4738232|NCT03645421|7689260|FG003|Overall Study|Withdrawal by patient|3
4738233|NCT03645421|7689257|FG000|Overall Study|Study specific withdrawal criteria|0
4738234|NCT03645421|7689258|FG001|Overall Study|Study specific withdrawal criteria|0
4738235|NCT03645421|7689259|FG002|Overall Study|Study specific withdrawal criteria|1
4738236|NCT03645421|7689260|FG003|Overall Study|Study specific withdrawal criteria|0
4738237|NCT03645434|7689273|FG000|Period 1|Adverse Event|0
4738238|NCT03645434|7689274|FG001|Period 1|Adverse Event|0
4738239|NCT03645434|7689275|FG002|Period 1|Adverse Event|0
4738240|NCT03645434|7689276|FG003|Period 1|Adverse Event|1
4738241|NCT03645434|7689277|FG004|Period 1|Adverse Event|0
4738242|NCT03645434|7689278|FG005|Period 1|Adverse Event|0
4738243|NCT03645434|7689273|FG000|Period 1|COPD exacerbation|0
4738244|NCT03645434|7689274|FG001|Period 1|COPD exacerbation|0
4738245|NCT03645434|7689275|FG002|Period 1|COPD exacerbation|0
4524276|NCT01013792|7339444|FG001|Overall Study|Adverse Event|3
4524277|NCT01013792|7339443|FG000|Overall Study|Lost to Follow-up|0
4524278|NCT01013792|7339444|FG001|Overall Study|Lost to Follow-up|1
4524279|NCT01013870|7339465|FG000|Overall Study|Lost to Follow-up|1
4524280|NCT01013870|7339466|FG001|Overall Study|Lost to Follow-up|3
4524281|NCT01013883|7339474|FG000|Overall Study|Lost to Follow-up|2
4524282|NCT01013883|7339475|FG001|Overall Study|Lost to Follow-up|2
4524283|NCT01013961|7339483|FG000|Overall Study|Adverse Event|2
4524284|NCT01013961|7339484|FG001|Overall Study|Adverse Event|2
4524285|NCT01013961|7339483|FG000|Overall Study|Withdrawal by Subject|1
4524286|NCT01013961|7339484|FG001|Overall Study|Withdrawal by Subject|0
4633685|NCT01915303|7504025|FG000|Core Phase|Death|2
4738246|NCT03645434|7689276|FG003|Period 1|COPD exacerbation|0
4524287|NCT01013961|7339483|FG000|Overall Study|Physician Decision|0
4738247|NCT03645434|7689277|FG004|Period 1|COPD exacerbation|1
4738248|NCT03645434|7689278|FG005|Period 1|COPD exacerbation|0
4524288|NCT01013961|7339484|FG001|Overall Study|Physician Decision|1
4524289|NCT01014013|7339492|FG000|Overall Study|Inclusion/Exclusion criteria not met|1
4524290|NCT01014013|7339493|FG001|Overall Study|Inclusion/Exclusion criteria not met|3
4524291|NCT01014013|7339492|FG000|Overall Study|Clinical adverse experience|4
4524292|NCT01014013|7339493|FG001|Overall Study|Clinical adverse experience|2
4738249|NCT03646305|7689328|FG000|Overall Study|Lost to Follow-up|4
4738250|NCT03646305|7689329|FG001|Overall Study|Lost to Follow-up|2
4738251|NCT03646305|7689330|FG002|Overall Study|Lost to Follow-up|2
4738252|NCT03646305|7689331|FG003|Overall Study|Lost to Follow-up|1
4738253|NCT03646305|7689328|FG000|Overall Study|Withdrawal by Subject|1
4738254|NCT03646305|7689329|FG001|Overall Study|Withdrawal by Subject|0
4738255|NCT03646305|7689330|FG002|Overall Study|Withdrawal by Subject|0
4738256|NCT03646305|7689331|FG003|Overall Study|Withdrawal by Subject|1
4738257|NCT03646656|7689347|FG000|Overall Study|Lost to Follow-up|1
4738258|NCT03646656|7689348|FG001|Overall Study|Lost to Follow-up|0
4738259|NCT03646656|7689347|FG000|Overall Study|Withdrawal by Subject|2
4738260|NCT03646656|7689348|FG001|Overall Study|Withdrawal by Subject|0
4738261|NCT03647267|7689373|FG000|Overall Study|Lost to Follow-up|1
4738262|NCT03647267|7689374|FG001|Overall Study|Lost to Follow-up|0
4738263|NCT03647709|7689386|FG000|Overall Study|Lost to Follow-up|5
4738264|NCT03647709|7689386|FG000|Overall Study|Physician Decision|6
4738265|NCT03647709|7689386|FG000|Overall Study|Withdrawal by Subject|3
4738266|NCT03648879|7689396|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1
4738267|NCT03649412|7689402|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1
4738268|NCT03649412|7689403|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0
4738269|NCT03649412|7689402|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1
4738270|NCT03649412|7689403|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0
4738271|NCT03649412|7689402|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1
4738272|NCT03649412|7689403|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0
4738273|NCT03649412|7689402|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1
4738274|NCT03649412|7689403|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0
4738275|NCT03649412|7689402|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0
4738276|NCT03649412|7689403|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1
4738277|NCT03649412|7689402|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0
4738278|NCT03649412|7689403|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1
4738279|NCT03649477|7689449|FG000|Overall Study|Adverse Event|2
4738280|NCT03649477|7689450|FG001|Overall Study|Adverse Event|0
4738281|NCT03649477|7689451|FG002|Overall Study|Adverse Event|0
4738282|NCT03650387|7689496|FG000|Overall Study|Withdrawal by Subject|13
4738283|NCT03650387|7689496|FG000|Overall Study|Lost to Follow-up|12
4738284|NCT03650387|7689496|FG000|Overall Study|Adverse Event (Not related)|1
4738285|NCT03650387|7689496|FG000|Overall Study|Due to COVID-19 Pandemic|8
4738286|NCT03650400|7689511|FG000|Overall Study|Study terminated by sponsor|0
4738287|NCT03650400|7689512|FG001|Overall Study|Study terminated by sponsor|5
4738288|NCT03650452|7689520|FG000|Overall Study|Physician Decision|1
4738289|NCT03650452|7689521|FG001|Overall Study|Physician Decision|0
4738290|NCT03650452|7689520|FG000|Overall Study|Withdrawal by Parent/Guardian|3
4738291|NCT03650452|7689521|FG001|Overall Study|Withdrawal by Parent/Guardian|1
4738292|NCT03650452|7689520|FG000|Overall Study|Adverse Event|3
4738293|NCT03650452|7689521|FG001|Overall Study|Adverse Event|4
4738294|NCT03650452|7689520|FG000|Overall Study|Early Withdrawal from Study Treatment|3
4738295|NCT03650452|7689521|FG001|Overall Study|Early Withdrawal from Study Treatment|0
4738296|NCT03652610|7689546|FG000|Overall Study|Lost to Follow-up|1
4738297|NCT03652610|7689547|FG001|Overall Study|Lost to Follow-up|0
4738298|NCT03652610|7689546|FG000|Overall Study|Withdrawal by Subject|3
4738299|NCT03652610|7689547|FG001|Overall Study|Withdrawal by Subject|5
4738300|NCT03652662|7689555|FG000|Overall Study|Withdrawal by Subject|2
4738301|NCT03652662|7689556|FG001|Overall Study|Withdrawal by Subject|1
4738302|NCT03652662|7689555|FG000|Overall Study|Lost to Follow-up|1
4738303|NCT03652662|7689556|FG001|Overall Study|Lost to Follow-up|0
4738304|NCT03652675|7689564|FG000|Overall Study|Lost to Follow-up|4
4738305|NCT03652675|7689565|FG001|Overall Study|Lost to Follow-up|4
4738306|NCT03652818|7689576|FG000|Overall Study|Adverse Event|1
4738307|NCT03652818|7689577|FG001|Overall Study|Adverse Event|0
4738308|NCT03652818|7689578|FG002|Overall Study|Adverse Event|0
4738309|NCT03652818|7689579|FG003|Overall Study|Adverse Event|0
4738310|NCT03652818|7689580|FG004|Overall Study|Adverse Event|0
4738311|NCT03652818|7689576|FG000|Overall Study|Physician Decision|1
4738312|NCT03652818|7689577|FG001|Overall Study|Physician Decision|0
4738313|NCT03652818|7689578|FG002|Overall Study|Physician Decision|0
4738314|NCT03652818|7689579|FG003|Overall Study|Physician Decision|0
4738315|NCT03652818|7689580|FG004|Overall Study|Physician Decision|0
4738316|NCT03652818|7689576|FG000|Overall Study|Lost to Follow-up|0
4738317|NCT03652818|7689577|FG001|Overall Study|Lost to Follow-up|1
4738318|NCT03652818|7689578|FG002|Overall Study|Lost to Follow-up|2
4738319|NCT03652818|7689579|FG003|Overall Study|Lost to Follow-up|1
4738320|NCT03652818|7689580|FG004|Overall Study|Lost to Follow-up|1
4738321|NCT03653208|7689601|FG000|Overall Study|Withdrawal by Subject|0
4738322|NCT03653208|7689602|FG001|Overall Study|Withdrawal by Subject|0
4738323|NCT03653208|7689603|FG002|Overall Study|Withdrawal by Subject|0
4524293|NCT01014013|7339492|FG000|Overall Study|Laboratory adverse experience|1
4524294|NCT01014013|7339493|FG001|Overall Study|Laboratory adverse experience|1
4524295|NCT01014013|7339492|FG000|Overall Study|Protocol Violation|1
4524296|NCT01014013|7339493|FG001|Overall Study|Protocol Violation|3
4633686|NCT01915303|7504025|FG000|Core Phase|Protocol Violation|2
4633687|NCT01915303|7504025|FG000|Core Phase|Abnormal lab value|1
4633688|NCT01915303|7504025|FG000|Core Phase|Withdrawal by Subject|1
4633689|NCT01915303|7504025|FG000|Extension Phase|Unsatisfactory therapeutic effect|8
4633690|NCT01915303|7504025|FG000|Extension Phase|Withdrawal by Subject|4
4633691|NCT01915303|7504025|FG000|Extension Phase|Adverse Event|3
4633692|NCT01915303|7504025|FG000|Extension Phase|Death|1
4633693|NCT01915303|7504025|FG000|Extension Phase|Protocol Violation|1
4738324|NCT03653208|7689604|FG003|Overall Study|Withdrawal by Subject|0
4738325|NCT03653208|7689605|FG004|Overall Study|Withdrawal by Subject|1
4738326|NCT03653208|7689606|FG005|Overall Study|Withdrawal by Subject|0
4738327|NCT03653208|7689607|FG006|Overall Study|Withdrawal by Subject|0
4738328|NCT03653208|7689608|FG007|Overall Study|Withdrawal by Subject|1
4738329|NCT03653208|7689609|FG008|Overall Study|Withdrawal by Subject|1
4738330|NCT03653416|7689640|FG000|Overall Study|Protocol Violation|6
4738331|NCT03653416|7689641|FG001|Overall Study|Protocol Violation|1
4738332|NCT03653429|7689649|FG000|Overall Study|Physician Decision|4
4738333|NCT03653429|7689650|FG001|Overall Study|Physician Decision|10
4633694|NCT01915732|7504040|FG000|Overall Study|Withdrawal by Subject|18
4633695|NCT01915732|7504041|FG001|Overall Study|Withdrawal by Subject|18
4633696|NCT01915732|7504040|FG000|Overall Study|Failure to Meet Randomization Criteria|1
4633697|NCT01915732|7504041|FG001|Overall Study|Failure to Meet Randomization Criteria|0
4633698|NCT01915732|7504040|FG000|Overall Study|Adverse Event|12
4633699|NCT01915732|7504041|FG001|Overall Study|Adverse Event|4
4633700|NCT01915732|7504040|FG000|Overall Study|Protocol Violation|5
4633701|NCT01915732|7504041|FG001|Overall Study|Protocol Violation|5
4524297|NCT01014013|7339492|FG000|Overall Study|Withdrawal by Subject|7
4524298|NCT01014013|7339493|FG001|Overall Study|Withdrawal by Subject|4
4524299|NCT01014013|7339492|FG000|Overall Study|Clinical/microbiologic failure|1
4524300|NCT01014013|7339493|FG001|Overall Study|Clinical/microbiologic failure|2
4524301|NCT01014013|7339492|FG000|Overall Study|Pathogen culture = no growth|26
4524302|NCT01014013|7339493|FG001|Overall Study|Pathogen culture = no growth|34
4524303|NCT01014013|7339492|FG000|Overall Study|Negative urine culture|2
4524304|NCT01014013|7339493|FG001|Overall Study|Negative urine culture|0
4524305|NCT01014013|7339492|FG000|Overall Study|Pathogen resistant|7
4524306|NCT01014013|7339493|FG001|Overall Study|Pathogen resistant|4
4524307|NCT01014013|7339492|FG000|Overall Study|Physician Decision|0
4524308|NCT01014013|7339493|FG001|Overall Study|Physician Decision|1
4524309|NCT01014013|7339492|FG000|Overall Study|Another antibiotic therapy required|0
4524310|NCT01014013|7339493|FG001|Overall Study|Another antibiotic therapy required|1
4524311|NCT01014013|7339492|FG000|Overall Study|Appendectomy|1
4524312|NCT01014013|7339493|FG001|Overall Study|Appendectomy|0
4633702|NCT01915732|7504040|FG000|Overall Study|Lack of Efficacy|6
4633703|NCT01915732|7504041|FG001|Overall Study|Lack of Efficacy|11
4738334|NCT03654326|7689658|FG000|Overall Study|Withdrawal by Subject|5
4738335|NCT03654326|7689659|FG001|Overall Study|Withdrawal by Subject|3
4738336|NCT03654326|7689658|FG000|Overall Study|Physician Decision|0
4738337|NCT03654326|7689659|FG001|Overall Study|Physician Decision|1
4738338|NCT03654326|7689658|FG000|Overall Study|Unable to adhere to study schedule|0
4738339|NCT03654326|7689659|FG001|Overall Study|Unable to adhere to study schedule|1
4738340|NCT03654326|7689658|FG000|Overall Study|Lost to Follow-up|1
4738341|NCT03654326|7689659|FG001|Overall Study|Lost to Follow-up|1
4738342|NCT03654560|7689676|FG000|Overall Study|Death|3
4738343|NCT03654560|7689677|FG001|Overall Study|Death|1
4738344|NCT03654560|7689676|FG000|Overall Study|Lost to Follow-up|1
4738345|NCT03654560|7689677|FG001|Overall Study|Lost to Follow-up|0
4738346|NCT03655054|7689683|FG000|Overall Study|Lost to Follow-up|1
4738347|NCT03655106|7689693|FG000|Overall Study|Withdrawal by Subject|3
4738348|NCT03655106|7689694|FG001|Overall Study|Withdrawal by Subject|2
4738349|NCT03655106|7689693|FG000|Overall Study|Lost to Follow-up|2
4738350|NCT03655106|7689694|FG001|Overall Study|Lost to Follow-up|1
4738351|NCT03655106|7689693|FG000|Overall Study|Duplicate Enrollment|1
4738352|NCT03655106|7689694|FG001|Overall Study|Duplicate Enrollment|1
4738353|NCT03655106|7689693|FG000|Overall Study|Protocol Violation|3
4738354|NCT03655106|7689694|FG001|Overall Study|Protocol Violation|0
4738355|NCT03655405|7689706|FG000|Overall Study|Death after initial data collection|4
4738356|NCT03655405|7689707|FG001|Overall Study|Death after initial data collection|2
4738357|NCT03655405|7689706|FG000|Overall Study|Died before initial data collection|1
4738358|NCT03655405|7689707|FG001|Overall Study|Died before initial data collection|2
4738359|NCT03655405|7689706|FG000|Overall Study|Protocol Violation|0
4738360|NCT03655405|7689707|FG001|Overall Study|Protocol Violation|1
4738361|NCT03655951|7689724|FG000|Overall Study|Lost to Follow-up|39
4738362|NCT03655951|7689725|FG001|Overall Study|Lost to Follow-up|20
4738363|NCT03655951|7689724|FG000|Overall Study|Withdrawal by Subject|0
4738364|NCT03655951|7689725|FG001|Overall Study|Withdrawal by Subject|1
4738365|NCT03657095|7689739|FG000|Overall Study|Withdrawal by Subject|1
4738366|NCT03657095|7689740|FG001|Overall Study|Withdrawal by Subject|1
4738367|NCT03657095|7689739|FG000|Overall Study|Adverse Event|0
4738368|NCT03657095|7689740|FG001|Overall Study|Adverse Event|3
4738369|NCT03657095|7689739|FG000|Overall Study|Study Terminated by Sponsor|58
4738370|NCT03657095|7689740|FG001|Overall Study|Study Terminated by Sponsor|49
4738371|NCT03657277|7689769|FG000|Overall Study|Physician Decision|2
4738372|NCT03657277|7689769|FG000|Overall Study|Lost to Follow-up|1
4738373|NCT03657277|7689769|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8
4738374|NCT03658811|7689782|FG000|Overall Study|Lost to Follow-up|3
4738375|NCT03658876|7689788|FG000|Overall Study|Protocol Violation|3
4738376|NCT03658876|7689789|FG001|Overall Study|Protocol Violation|2
4738377|NCT03658876|7689788|FG000|Overall Study|Withdrawal by Subject|2
4738378|NCT03658876|7689789|FG001|Overall Study|Withdrawal by Subject|0
4738379|NCT03658876|7689788|FG000|Overall Study|Death|0
4738380|NCT03658876|7689789|FG001|Overall Study|Death|1
4738381|NCT03658876|7689788|FG000|Overall Study|Intercurrent illness|6
4738382|NCT03658876|7689789|FG001|Overall Study|Intercurrent illness|4
4738383|NCT03658876|7689788|FG000|Overall Study|Transplantation/other operation|1
4738384|NCT03658876|7689789|FG001|Overall Study|Transplantation/other operation|5
4738385|NCT03658889|7689797|FG000|Overall Study|Protocol Violation|2
4738386|NCT03658889|7689798|FG001|Overall Study|Protocol Violation|0
4738387|NCT03661983|7689869|FG000|Open Label Stabilization Phase|Adverse Event|5
4524313|NCT01014013|7339492|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0
4594276|NCT01561300|7443459|FG001|Run in on Placebo|Adverse Event|0
4633704|NCT01915732|7504040|FG000|Overall Study|Lost to Follow-up|22
4738388|NCT03661983|7689870|FG001|Open Label Stabilization Phase|Adverse Event|0
4738389|NCT03661983|7689871|FG002|Open Label Stabilization Phase|Adverse Event|0
4738390|NCT03661983|7689872|FG003|Open Label Stabilization Phase|Adverse Event|0
4738391|NCT03661983|7689869|FG000|Open Label Stabilization Phase|Lack of Efficacy|1
4738392|NCT03661983|7689870|FG001|Open Label Stabilization Phase|Lack of Efficacy|0
4738393|NCT03661983|7689871|FG002|Open Label Stabilization Phase|Lack of Efficacy|0
4738394|NCT03661983|7689872|FG003|Open Label Stabilization Phase|Lack of Efficacy|0
4524314|NCT01014013|7339493|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1
4524315|NCT01014143|7339538|FG000|Second Intervention|Lost to Follow-up|2
4524316|NCT01014143|7339539|FG001|Second Intervention|Lost to Follow-up|0
4524317|NCT01014143|7339540|FG002|Second Intervention|Lost to Follow-up|0
4524318|NCT01014208|7339559|FG000|Overall Study|Lost to Follow-up|2
4524319|NCT01014208|7339560|FG001|Overall Study|Lost to Follow-up|5
4524320|NCT01014208|7339559|FG000|Overall Study|Participant Withdrew Consent|12
4524321|NCT01014208|7339560|FG001|Overall Study|Participant Withdrew Consent|12
4524322|NCT01014208|7339559|FG000|Overall Study|Did Not Receive Study Drug|2
4524323|NCT01014208|7339560|FG001|Overall Study|Did Not Receive Study Drug|0
4524324|NCT01014208|7339559|FG000|Overall Study|Study Closed/terminated|78
4524325|NCT01014208|7339560|FG001|Overall Study|Study Closed/terminated|83
4524326|NCT01014442|7339585|FG000|Overall Study|Adverse Event|0
4524327|NCT01014442|7339586|FG001|Overall Study|Adverse Event|8
4524328|NCT01014442|7339585|FG000|Overall Study|Withdrawal by Subject|4
4524329|NCT01014442|7339586|FG001|Overall Study|Withdrawal by Subject|4
4524330|NCT01014442|7339585|FG000|Overall Study|Protocol Violation|2
4524331|NCT01014442|7339586|FG001|Overall Study|Protocol Violation|5
4524332|NCT01014442|7339585|FG000|Overall Study|Lack of Compliance|0
4524333|NCT01014442|7339586|FG001|Overall Study|Lack of Compliance|1
4633705|NCT01915732|7504041|FG001|Overall Study|Lost to Follow-up|26
4633706|NCT01915732|7504040|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1
4633707|NCT01915732|7504041|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0
4633708|NCT01915732|7504040|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1
4633709|NCT01915732|7504041|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0
4738395|NCT03661983|7689869|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2
4738396|NCT03661983|7689870|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0
4738397|NCT03661983|7689871|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0
4738398|NCT03661983|7689872|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0
4738399|NCT03661983|7689869|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3
4738400|NCT03661983|7689870|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0
4738401|NCT03661983|7689871|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0
4738402|NCT03661983|7689872|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0
4738403|NCT03661983|7689869|FG000|Double-blind Randomized Phase|Adverse Event|0
4738404|NCT03661983|7689870|FG001|Double-blind Randomized Phase|Adverse Event|1
4738405|NCT03661983|7689871|FG002|Double-blind Randomized Phase|Adverse Event|0
4738406|NCT03661983|7689872|FG003|Double-blind Randomized Phase|Adverse Event|0
4738407|NCT03661983|7689869|FG000|Double-blind Randomized Phase|Disease Relapse|0
4738408|NCT03661983|7689870|FG001|Double-blind Randomized Phase|Disease Relapse|0
4738409|NCT03661983|7689871|FG002|Double-blind Randomized Phase|Disease Relapse|0
4738410|NCT03661983|7689872|FG003|Double-blind Randomized Phase|Disease Relapse|6
4738411|NCT03661983|7689869|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0
4738412|NCT03661983|7689870|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0
4738413|NCT03661983|7689871|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0
4738414|NCT03661983|7689872|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1
4633710|NCT01915732|7504040|FG000|Overall Study|Drug Release Error|1
4633711|NCT01915732|7504041|FG001|Overall Study|Drug Release Error|0
4633712|NCT01915732|7504040|FG000|Overall Study|Recovered|1
4633713|NCT01915732|7504041|FG001|Overall Study|Recovered|0
4633714|NCT01915732|7504040|FG000|Overall Study|Pregnancy|1
4633715|NCT01915732|7504041|FG001|Overall Study|Pregnancy|0
4633716|NCT01915732|7504040|FG000|Overall Study|Poor Perceived Efficacy|1
4633717|NCT01915732|7504041|FG001|Overall Study|Poor Perceived Efficacy|0
4633718|NCT01915732|7504040|FG000|Overall Study|Par. Unable to Come to the Hospital|0
4633719|NCT01915732|7504041|FG001|Overall Study|Par. Unable to Come to the Hospital|1
4633720|NCT01915732|7504040|FG000|Overall Study|Got Well|0
4738415|NCT03661983|7689869|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0
4524334|NCT01014442|7339585|FG000|Overall Study|Unspecified Reason|1
4524335|NCT01014442|7339586|FG001|Overall Study|Unspecified Reason|1
4524336|NCT01014533|7339607|FG000|Overall Study|Protocol Violation|3
4524337|NCT01014533|7339608|FG001|Overall Study|Protocol Violation|2
4524338|NCT01014533|7339607|FG000|Overall Study|Withdrawal by Subject|2
4524339|NCT01014533|7339608|FG001|Overall Study|Withdrawal by Subject|0
4524340|NCT01014533|7339607|FG000|Overall Study|unable to come to appointment|0
4524341|NCT01014533|7339608|FG001|Overall Study|unable to come to appointment|3
4633721|NCT01915732|7504041|FG001|Overall Study|Got Well|1
4633722|NCT01915732|7504040|FG000|Overall Study|Par. not Willing to Continue Treatment|0
4633723|NCT01915732|7504041|FG001|Overall Study|Par. not Willing to Continue Treatment|1
4633724|NCT01915732|7504040|FG000|Overall Study|Par. Refused to Hospital Visits|0
4633725|NCT01915732|7504041|FG001|Overall Study|Par. Refused to Hospital Visits|1
4633726|NCT01915732|7504040|FG000|Overall Study|Job Transfer|0
4633727|NCT01915732|7504041|FG001|Overall Study|Job Transfer|1
4633728|NCT01915732|7504040|FG000|Overall Study|Improper Facial Procedure|0
4633729|NCT01915732|7504041|FG001|Overall Study|Improper Facial Procedure|1
4633730|NCT01915732|7504040|FG000|Overall Study|Poor Conscious Effect|0
4633731|NCT01915732|7504041|FG001|Overall Study|Poor Conscious Effect|1
4633732|NCT01915771|7504047|FG000|Day 1|Withdrawal by Subject|1
4633733|NCT01915771|7504047|FG000|Day 15|Withdrawal by Subject|1
4633734|NCT01915849|7504068|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1
4633735|NCT01915849|7504069|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0
4633736|NCT01915849|7504070|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0
4633737|NCT01915849|7504071|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0
4633738|NCT01915849|7504068|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
4633739|NCT01915849|7504069|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
4633740|NCT01915849|7504070|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
4633741|NCT01915849|7504071|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
4633742|NCT01915914|7504081|FG000|Acute Phase|Withdrawal by Subject|4
4633743|NCT01915914|7504082|FG001|Acute Phase|Withdrawal by Subject|0
4633744|NCT01915914|7504083|FG002|Acute Phase|Withdrawal by Subject|0
4633745|NCT01915914|7504084|FG003|Acute Phase|Withdrawal by Subject|0
4633746|NCT01915914|7504081|FG000|Acute Phase|Lost to Follow-up|4
4633747|NCT01915914|7504082|FG001|Acute Phase|Lost to Follow-up|0
4633748|NCT01915914|7504083|FG002|Acute Phase|Lost to Follow-up|0
4633749|NCT01915914|7504084|FG003|Acute Phase|Lost to Follow-up|0
4633750|NCT01915914|7504081|FG000|Acute Phase|Physician Decision|1
4633751|NCT01915914|7504082|FG001|Acute Phase|Physician Decision|0
4633752|NCT01915914|7504083|FG002|Acute Phase|Physician Decision|0
4633753|NCT01915914|7504084|FG003|Acute Phase|Physician Decision|0
4633754|NCT01915914|7504081|FG000|Acute Phase|Accepted Other Topic Therapies|1
4633755|NCT01915914|7504082|FG001|Acute Phase|Accepted Other Topic Therapies|0
4633756|NCT01915914|7504083|FG002|Acute Phase|Accepted Other Topic Therapies|0
4738416|NCT03661983|7689870|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1
4738417|NCT03661983|7689871|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1
4738418|NCT03661983|7689872|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1
4738419|NCT03662334|7689902|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1
4738420|NCT03662334|7689903|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0
4738421|NCT03662750|7689919|FG000|Overall Study|Withdrawal by Subject|1
4738422|NCT03662789|7689925|FG000|Overall Study|Lost to Follow-up|1
4738423|NCT03662789|7689926|FG001|Overall Study|Lost to Follow-up|2
4738424|NCT03662789|7689925|FG000|Overall Study|Could not perform treadmill test|4
4738425|NCT03662789|7689926|FG001|Overall Study|Could not perform treadmill test|4
4738426|NCT03662789|7689925|FG000|Overall Study|Death|0
4738427|NCT03662789|7689926|FG001|Overall Study|Death|1
4738428|NCT03662997|7689936|FG000|Overall Study|Adverse Event|0
4738429|NCT03662997|7689937|FG001|Overall Study|Adverse Event|2
4738430|NCT03662997|7689938|FG002|Overall Study|Adverse Event|0
4524342|NCT01014585|7339619|FG000|Overall Study|Adverse Event|0
4524343|NCT01014585|7339620|FG001|Overall Study|Adverse Event|2
4524344|NCT01014585|7339621|FG002|Overall Study|Adverse Event|0
4524345|NCT01014585|7339622|FG003|Overall Study|Adverse Event|3
4524346|NCT01014585|7339619|FG000|Overall Study|Withdrawal by Subject|2
4524347|NCT01014585|7339620|FG001|Overall Study|Withdrawal by Subject|0
4524348|NCT01014585|7339621|FG002|Overall Study|Withdrawal by Subject|1
4524349|NCT01014585|7339622|FG003|Overall Study|Withdrawal by Subject|3
4524350|NCT01014585|7339619|FG000|Overall Study|Lost to Follow-up|0
4524351|NCT01014585|7339620|FG001|Overall Study|Lost to Follow-up|0
4738431|NCT03662997|7689939|FG003|Overall Study|Adverse Event|0
4738432|NCT03663179|7689970|FG000|Overall Study|Withdrawal by Subject|2
4738433|NCT03663179|7689971|FG001|Overall Study|Withdrawal by Subject|0
4738434|NCT03663179|7689970|FG000|Overall Study|Lost to Follow-up|1
4738435|NCT03663179|7689971|FG001|Overall Study|Lost to Follow-up|1
4738436|NCT03663179|7689970|FG000|Overall Study|Revealed exclusionary condition|1
4738437|NCT03663179|7689971|FG001|Overall Study|Revealed exclusionary condition|0
4738438|NCT03663569|7689995|FG000|Overall Study|Discontinuation of study|11
4738439|NCT03663569|7689995|FG000|Overall Study|Never taken Spiolto® Respimat®|1
4738440|NCT03663569|7689995|FG000|Overall Study|Deceased patient|6
4738441|NCT03663569|7689995|FG000|Overall Study|Lost to Follow-up|18
4738442|NCT03663569|7689995|FG000|Overall Study|Withdrawal of consent|5
4738443|NCT03663569|7689995|FG000|Overall Study|Patient's request|11
4738444|NCT03663569|7689995|FG000|Overall Study|Adverse Event|4
4738445|NCT03663569|7689995|FG000|Overall Study|Not come to second visit|3
4738446|NCT03663569|7689995|FG000|Overall Study|Not meet inclusion / exclusion criterion|3
4738447|NCT03663569|7689995|FG000|Overall Study|Serious adverse event|1
4738448|NCT03663582|7689999|FG000|Overall Study|Physician Decision|1
4738449|NCT03666858|7690065|FG000|Cohort 1|Adverse Event|1
4738450|NCT03666858|7690066|FG001|Cohort 1|Adverse Event|0
4738451|NCT03666858|7690065|FG000|Cohort 2|Adverse Event|0
4738452|NCT03666858|7690066|FG001|Cohort 2|Adverse Event|1
4738453|NCT03667053|7690075|FG000|Overall Study|Withdrawal by Subject|1
4738454|NCT03667053|7690076|FG001|Overall Study|Withdrawal by Subject|0
4738455|NCT03667053|7690077|FG002|Overall Study|Withdrawal by Subject|0
4738456|NCT03668600|7690096|FG000|Overall Study|Study Terminated by the Sponsor|157
4738457|NCT03668600|7690096|FG000|Overall Study|Protocol Violation|1
4738458|NCT03668600|7690096|FG000|Overall Study|Pregnancy|1
4738459|NCT03668600|7690096|FG000|Overall Study|Lost to Follow-up|7
4738460|NCT03668600|7690096|FG000|Overall Study|Withdrawal by Subject|56
4738461|NCT03668600|7690096|FG000|Overall Study|Lack of Efficacy|7
4738462|NCT03668600|7690096|FG000|Overall Study|Adverse Event|1
4738463|NCT03668613|7690102|FG000|Overall Study|Adverse Event|0
4738464|NCT03668613|7690103|FG001|Overall Study|Adverse Event|2
4738465|NCT03668613|7690102|FG000|Overall Study|Lack of Efficacy|0
4738466|NCT03668613|7690103|FG001|Overall Study|Lack of Efficacy|1
4738467|NCT03669081|7690112|FG000|Overall Study|Data could not be validated|1
4738468|NCT03669081|7690113|FG001|Overall Study|Data could not be validated|1
4738469|NCT03669549|7690137|FG000|Overall Study|Adverse Event|4
4738470|NCT03669549|7690137|FG000|Overall Study|Withdrawal by Subject|1
4738471|NCT03669549|7690137|FG000|Overall Study|Study terminated by the Sponsor|1
4738472|NCT03669861|7690145|FG000|Overall Study|Disease Flare|5
4738473|NCT03669861|7690145|FG000|Overall Study|Lack of Efficacy|2
4738474|NCT03670537|7690179|FG000|Overall Study|Protocol Violation|1
4738475|NCT03670641|7690183|FG000|Overall Study|Lost to Follow-up|3
4738476|NCT03670810|7690193|FG000|Overall Study|Adverse Event|36
4738477|NCT03670810|7690194|FG001|Overall Study|Adverse Event|38
4738478|NCT03670810|7690195|FG002|Overall Study|Adverse Event|2
4738479|NCT03670810|7690196|FG003|Overall Study|Adverse Event|4
4738480|NCT03670810|7690193|FG000|Overall Study|Lack of Efficacy|8
4738481|NCT03670810|7690194|FG001|Overall Study|Lack of Efficacy|8
4738482|NCT03670810|7690195|FG002|Overall Study|Lack of Efficacy|3
4738483|NCT03670810|7690196|FG003|Overall Study|Lack of Efficacy|4
4738484|NCT03670810|7690193|FG000|Overall Study|Lost to Follow-up|6
4738485|NCT03670810|7690194|FG001|Overall Study|Lost to Follow-up|6
4738486|NCT03670810|7690195|FG002|Overall Study|Lost to Follow-up|4
4738487|NCT03670810|7690196|FG003|Overall Study|Lost to Follow-up|6
4738488|NCT03670810|7690193|FG000|Overall Study|Non-compliance with Study Drug|0
4738489|NCT03670810|7690194|FG001|Overall Study|Non-compliance with Study Drug|2
4738490|NCT03670810|7690195|FG002|Overall Study|Non-compliance with Study Drug|3
4738491|NCT03670810|7690196|FG003|Overall Study|Non-compliance with Study Drug|0
4738492|NCT03670810|7690193|FG000|Overall Study|Missing|1
4738493|NCT03670810|7690194|FG001|Overall Study|Missing|1
4738494|NCT03670810|7690195|FG002|Overall Study|Missing|0
4738495|NCT03670810|7690196|FG003|Overall Study|Missing|1
4738496|NCT03670810|7690193|FG000|Overall Study|Physician Decision|3
4738497|NCT03670810|7690194|FG001|Overall Study|Physician Decision|0
4738498|NCT03670810|7690195|FG002|Overall Study|Physician Decision|1
4738499|NCT03670810|7690196|FG003|Overall Study|Physician Decision|0
4738500|NCT03670810|7690193|FG000|Overall Study|Pregnancy|1
4738501|NCT03670810|7690194|FG001|Overall Study|Pregnancy|1
4524352|NCT01014585|7339621|FG002|Overall Study|Lost to Follow-up|0
4524353|NCT01014585|7339622|FG003|Overall Study|Lost to Follow-up|2
4524354|NCT01014585|7339619|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18
4738502|NCT03670810|7690195|FG002|Overall Study|Pregnancy|0
4738503|NCT03670810|7690196|FG003|Overall Study|Pregnancy|0
4524355|NCT01014585|7339620|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23
4524356|NCT01014585|7339621|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22
4524357|NCT01014585|7339622|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22
4524358|NCT01014624|7339634|FG000|Overall Study|Adverse Event|0
4524359|NCT01014624|7339635|FG001|Overall Study|Adverse Event|1
4524360|NCT01014624|7339634|FG000|Overall Study|Protocol Violation|1
4524361|NCT01014624|7339635|FG001|Overall Study|Protocol Violation|0
4524362|NCT01014624|7339634|FG000|Overall Study|Withdrawal by Subject|1
4524363|NCT01014624|7339635|FG001|Overall Study|Withdrawal by Subject|0
4524364|NCT01014689|7339645|FG000|Overall Study|Lack of Efficacy|0
4524365|NCT01014689|7339646|FG001|Overall Study|Lack of Efficacy|1
4524366|NCT01014689|7339645|FG000|Overall Study|Adverse Event|3
4524367|NCT01014689|7339646|FG001|Overall Study|Adverse Event|0
4524368|NCT01014689|7339645|FG000|Overall Study|Withdrawal by Subject|5
4524369|NCT01014689|7339646|FG001|Overall Study|Withdrawal by Subject|4
4524370|NCT01014689|7339645|FG000|Overall Study|Protocol Violation|1
4524371|NCT01014689|7339646|FG001|Overall Study|Protocol Violation|1
4633757|NCT01915914|7504084|FG003|Acute Phase|Accepted Other Topic Therapies|0
4633758|NCT01915914|7504081|FG000|Acute Phase|"Not Achieved treatment success"|1
4633759|NCT01915914|7504082|FG001|Acute Phase|"Not Achieved treatment success"|0
4633760|NCT01915914|7504083|FG002|Acute Phase|"Not Achieved treatment success"|0
4524372|NCT01014689|7339645|FG000|Overall Study|Lost to Follow-up|3
4524373|NCT01014689|7339646|FG001|Overall Study|Lost to Follow-up|7
4524374|NCT01014689|7339645|FG000|Overall Study|Pregnancy|1
4524375|NCT01014689|7339646|FG001|Overall Study|Pregnancy|0
4524376|NCT01014910|7339678|FG000|Overall Study|Withdrawal by Subject|0
4524377|NCT01014910|7339679|FG001|Overall Study|Withdrawal by Subject|2
4524378|NCT01014975|7339756|FG000|Overall Study|Withdrawal by Subject|1
4524379|NCT01014975|7339757|FG001|Overall Study|Withdrawal by Subject|0
4524380|NCT01014975|7339758|FG002|Overall Study|Withdrawal by Subject|1
4738504|NCT03670810|7690193|FG000|Overall Study|Protocol Violation|2
4738505|NCT03670810|7690194|FG001|Overall Study|Protocol Violation|12
4738506|NCT03670810|7690195|FG002|Overall Study|Protocol Violation|8
4738507|NCT03670810|7690196|FG003|Overall Study|Protocol Violation|4
4738508|NCT03670810|7690193|FG000|Overall Study|Withdrawal by Subject|20
4738509|NCT03670810|7690194|FG001|Overall Study|Withdrawal by Subject|20
4738510|NCT03670810|7690195|FG002|Overall Study|Withdrawal by Subject|8
4738511|NCT03670810|7690196|FG003|Overall Study|Withdrawal by Subject|9
4738512|NCT03670810|7690193|FG000|Overall Study|Continuing Study|27
4738513|NCT03670810|7690194|FG001|Overall Study|Continuing Study|29
4738514|NCT03670810|7690195|FG002|Overall Study|Continuing Study|12
4738515|NCT03670810|7690196|FG003|Overall Study|Continuing Study|10
4738516|NCT03672006|7690208|FG000|Overall Study|exclusion criteria met|0
4738517|NCT03672006|7690209|FG001|Overall Study|exclusion criteria met|1
4738518|NCT03672097|7690226|FG000|Period 1|Withdrawal by Subject|2
4738519|NCT03672097|7690226|FG000|Period 1|Adverse Event|1
4738520|NCT03672097|7690226|FG000|Period 1|Did not receive treatment|1
4738521|NCT03672097|7690226|FG000|Period 2|Withdrawal by Subject|3
4738522|NCT03672097|7690226|FG000|Period 2|Other|1
4738523|NCT03672396|7690234|FG000|Overall Study|Withdrawal by Subject|4
4738524|NCT03672396|7690234|FG000|Overall Study|Physician Decision|1
4738525|NCT03672396|7690234|FG000|Overall Study|Adverse Event|1
4738526|NCT03673670|7690244|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1
4738527|NCT03673670|7690245|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
4738528|NCT03673670|7690246|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
4738529|NCT03673670|7690247|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
4738530|NCT03673670|7690248|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
4738531|NCT03673670|7690249|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
4738532|NCT03673670|7690244|FG000|Treatment Period 1 (3 Days)|Physician Decision|0
4738533|NCT03673670|7690245|FG001|Treatment Period 1 (3 Days)|Physician Decision|0
4738534|NCT03673670|7690246|FG002|Treatment Period 1 (3 Days)|Physician Decision|1
4738535|NCT03673670|7690247|FG003|Treatment Period 1 (3 Days)|Physician Decision|0
4738536|NCT03673670|7690248|FG004|Treatment Period 1 (3 Days)|Physician Decision|0
4738537|NCT03673670|7690249|FG005|Treatment Period 1 (3 Days)|Physician Decision|0
4738538|NCT03673670|7690244|FG000|Treatment Period 1 (3 Days)|Adverse Event|0
4738539|NCT03673670|7690245|FG001|Treatment Period 1 (3 Days)|Adverse Event|0
4738540|NCT03673670|7690246|FG002|Treatment Period 1 (3 Days)|Adverse Event|0
4738541|NCT03673670|7690247|FG003|Treatment Period 1 (3 Days)|Adverse Event|0
4738542|NCT03673670|7690248|FG004|Treatment Period 1 (3 Days)|Adverse Event|0
4738543|NCT03673670|7690249|FG005|Treatment Period 1 (3 Days)|Adverse Event|1
4738544|NCT03673670|7690244|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
4524381|NCT01014975|7339756|FG000|Overall Study|Death|3
4524382|NCT01014975|7339757|FG001|Overall Study|Death|3
4524383|NCT01014975|7339758|FG002|Overall Study|Death|4
4524384|NCT01014975|7339756|FG000|Overall Study|Lost to Follow-up|0
4524385|NCT01014975|7339757|FG001|Overall Study|Lost to Follow-up|0
4524386|NCT01014975|7339758|FG002|Overall Study|Lost to Follow-up|1
4524387|NCT01014988|7339772|FG000|Overall Study|Adverse Event|20
4738545|NCT03673670|7690245|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
4738546|NCT03673670|7690246|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
4738547|NCT03673670|7690247|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
4738548|NCT03673670|7690248|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
4738549|NCT03673670|7690249|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1
4738550|NCT03673670|7690244|FG000|Treatment Period 2 (3 Days)|Adverse Event|0
4738551|NCT03673670|7690245|FG001|Treatment Period 2 (3 Days)|Adverse Event|0
4738552|NCT03673670|7690246|FG002|Treatment Period 2 (3 Days)|Adverse Event|1
4738553|NCT03673670|7690247|FG003|Treatment Period 2 (3 Days)|Adverse Event|0
4738554|NCT03673670|7690248|FG004|Treatment Period 2 (3 Days)|Adverse Event|1
4738555|NCT03673670|7690249|FG005|Treatment Period 2 (3 Days)|Adverse Event|0
4738556|NCT03673670|7690244|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
4738557|NCT03673670|7690245|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
4738558|NCT03673670|7690246|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
4738559|NCT03673670|7690247|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
4738560|NCT03673670|7690248|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1
4738561|NCT03673670|7690249|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
4738562|NCT03673670|7690244|FG000|Treatment Period 3 (3 Days)|Adverse Event|0
4738563|NCT03673670|7690245|FG001|Treatment Period 3 (3 Days)|Adverse Event|0
4738564|NCT03673670|7690246|FG002|Treatment Period 3 (3 Days)|Adverse Event|0
4738565|NCT03673670|7690247|FG003|Treatment Period 3 (3 Days)|Adverse Event|0
4738566|NCT03673670|7690248|FG004|Treatment Period 3 (3 Days)|Adverse Event|1
4738567|NCT03673670|7690249|FG005|Treatment Period 3 (3 Days)|Adverse Event|0
4738568|NCT03674177|7690270|FG000|Overall Study|Lost to Follow-up|2
4738569|NCT03674177|7690271|FG001|Overall Study|Lost to Follow-up|1
4738570|NCT03674177|7690272|FG002|Overall Study|Lost to Follow-up|0
4738571|NCT03674177|7690273|FG003|Overall Study|Lost to Follow-up|2
4738572|NCT03674281|7690286|FG000|Overall Study|screen failure|2
4738573|NCT03674281|7690287|FG001|Overall Study|screen failure|0
4738574|NCT03674281|7690288|FG002|Overall Study|screen failure|0
4738575|NCT03674281|7690286|FG000|Overall Study|Withdrawal by Subject|1
4524388|NCT01014988|7339773|FG001|Overall Study|Adverse Event|0
4524389|NCT01014988|7339774|FG002|Overall Study|Adverse Event|1
4738576|NCT03674281|7690287|FG001|Overall Study|Withdrawal by Subject|3
4738577|NCT03674281|7690288|FG002|Overall Study|Withdrawal by Subject|3
4738578|NCT03675776|7690347|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5
4738579|NCT03675776|7690348|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6
4738580|NCT03675776|7690349|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8
4738581|NCT03675776|7690347|FG000|Double Blind Treatment Period|Lack of Efficacy|1
4738582|NCT03675776|7690348|FG001|Double Blind Treatment Period|Lack of Efficacy|0
4738583|NCT03675776|7690349|FG002|Double Blind Treatment Period|Lack of Efficacy|0
4738584|NCT03676634|7690361|FG000|Overall Study|Red blood cell loss|1
4738585|NCT03676634|7690361|FG000|Overall Study|Out-of-limit pulse|2
4738586|NCT03677375|7690413|FG000|Overall Study|Incomplete procedure|8
4738587|NCT03677375|7690413|FG000|Overall Study|Adverse Event|3
4738588|NCT03677375|7690413|FG000|Overall Study|Physician Decision|1
4738589|NCT03677401|7690419|FG000|Overall Study|Adverse Event|4
4738590|NCT03677401|7690420|FG001|Overall Study|Adverse Event|14
4738591|NCT03677401|7690419|FG000|Overall Study|Lack of Efficacy|3
4738592|NCT03677401|7690420|FG001|Overall Study|Lack of Efficacy|1
4738593|NCT03677401|7690419|FG000|Overall Study|Withdrawal by Subject|2
4738594|NCT03677401|7690420|FG001|Overall Study|Withdrawal by Subject|2
4738595|NCT03677401|7690419|FG000|Overall Study|Sponsor decision|0
4738596|NCT03677401|7690420|FG001|Overall Study|Sponsor decision|1
4738597|NCT03677401|7690419|FG000|Overall Study|Reason Unspecified|1
4738598|NCT03677401|7690420|FG001|Overall Study|Reason Unspecified|0
4738599|NCT03677869|7690426|FG000|Overall Study|Withdrawal by Subject|1
4738600|NCT03678103|7690430|FG000|Overall Study|Withdrawn prior to completion|4
4738601|NCT03678285|7690434|FG000|Overall Study|Adverse Event|2
4738602|NCT03678285|7690434|FG000|Overall Study|Withdrawal by subject prior to start of workout|1
4738603|NCT03678285|7690434|FG000|Overall Study|Dehydrated prior to start of workout|1
4738604|NCT03678870|7690444|FG000|Overall Study|prescribed non- protocol medications|10
4738605|NCT03678870|7690445|FG001|Overall Study|prescribed non- protocol medications|6
4738606|NCT03678870|7690444|FG000|Overall Study|Lost to Follow-up|3
4738607|NCT03678870|7690445|FG001|Overall Study|Lost to Follow-up|2
4738608|NCT03679741|7690460|FG000|Period 1|No longer meet eligibility criteria|1
4524390|NCT01014988|7339775|FG003|Overall Study|Adverse Event|0
4524391|NCT01014988|7339776|FG004|Overall Study|Adverse Event|1
4524392|NCT01014988|7339777|FG005|Overall Study|Adverse Event|3
4524393|NCT01014988|7339772|FG000|Overall Study|Lost to Follow-up|1
4524394|NCT01014988|7339773|FG001|Overall Study|Lost to Follow-up|0
4524395|NCT01014988|7339774|FG002|Overall Study|Lost to Follow-up|1
4524396|NCT01014988|7339775|FG003|Overall Study|Lost to Follow-up|0
4524397|NCT01014988|7339776|FG004|Overall Study|Lost to Follow-up|0
4524398|NCT01014988|7339777|FG005|Overall Study|Lost to Follow-up|0
4524399|NCT01014988|7339772|FG000|Overall Study|Physician Decision|1
4524400|NCT01014988|7339773|FG001|Overall Study|Physician Decision|0
4524401|NCT01014988|7339774|FG002|Overall Study|Physician Decision|0
4524402|NCT01014988|7339775|FG003|Overall Study|Physician Decision|0
4524403|NCT01014988|7339776|FG004|Overall Study|Physician Decision|0
4524404|NCT01014988|7339777|FG005|Overall Study|Physician Decision|0
4524405|NCT01014988|7339772|FG000|Overall Study|Withdrawal by Subject|1
4524406|NCT01014988|7339773|FG001|Overall Study|Withdrawal by Subject|0
4524407|NCT01014988|7339774|FG002|Overall Study|Withdrawal by Subject|0
4524408|NCT01014988|7339775|FG003|Overall Study|Withdrawal by Subject|0
4524409|NCT01014988|7339776|FG004|Overall Study|Withdrawal by Subject|0
4524410|NCT01014988|7339777|FG005|Overall Study|Withdrawal by Subject|0
4524411|NCT01015118|7339801|FG000|Overall Study|Protocol Violation|5
4524412|NCT01015118|7339802|FG001|Overall Study|Protocol Violation|6
4524413|NCT01015118|7339801|FG000|Overall Study|Withdrawal by Subject|103
4524414|NCT01015118|7339802|FG001|Overall Study|Withdrawal by Subject|27
4524415|NCT01015118|7339801|FG000|Overall Study|Other Adverse Event (AE)|141
4524416|NCT01015118|7339802|FG001|Overall Study|Other Adverse Event (AE)|33
4524417|NCT01015118|7339801|FG000|Overall Study|Worsening or AE of underlying disease|5
4524418|NCT01015118|7339802|FG001|Overall Study|Worsening or AE of underlying disease|4
4524419|NCT01015118|7339801|FG000|Overall Study|Progressive disease|364
4524420|NCT01015118|7339802|FG001|Overall Study|Progressive disease|229
4738609|NCT03679741|7690461|FG001|Period 1|No longer meet eligibility criteria|0
4738610|NCT03679741|7690460|FG000|Period 1|Lost to Follow-up|0
4738611|NCT03679741|7690461|FG001|Period 1|Lost to Follow-up|1
4738612|NCT03679741|7690460|FG000|Period 1|Adverse Event|1
4738613|NCT03679741|7690461|FG001|Period 1|Adverse Event|1
4738614|NCT03679741|7690460|FG000|Period 1|Withdrawal by Subject|0
4738615|NCT03679741|7690461|FG001|Period 1|Withdrawal by Subject|1
4738616|NCT03679741|7690460|FG000|Period 2|Adverse Event|2
4738617|NCT03679741|7690461|FG001|Period 2|Adverse Event|1
4738618|NCT03679741|7690460|FG000|Period 2|Withdrawal by Subject|1
4524421|NCT01015118|7339801|FG000|Overall Study|Not treated|9
4524422|NCT01015118|7339802|FG001|Overall Study|Not treated|5
4524423|NCT01015118|7339801|FG000|Overall Study|Other than stated above|42
4524424|NCT01015118|7339802|FG001|Overall Study|Other than stated above|23
4524425|NCT01015131|7339808|FG000|Overall Study|Physician Decision|1
4524426|NCT01015131|7339808|FG000|Overall Study|Protocol Violation|1
4524427|NCT01015131|7339808|FG000|Overall Study|Withdrawal by Subject|2
4524428|NCT01015131|7339808|FG000|Overall Study|Other Protocol Specified Criteria|4
4738619|NCT03679741|7690461|FG001|Period 2|Withdrawal by Subject|1
4738620|NCT03680521|7690514|FG000|Overall Study|Ongoing in long-term follow up|7
4738621|NCT03680521|7690515|FG001|Overall Study|Ongoing in long-term follow up|11
4738622|NCT03680742|7690524|FG000|Overall Study|Unsuccessful Implant Attempt|2
4738623|NCT03681093|7690531|FG000|Overall Study|Subject decision|0
4738624|NCT03681093|7690532|FG001|Overall Study|Subject decision|2
4738625|NCT03681093|7690533|FG002|Overall Study|Subject decision|1
4738626|NCT03681119|7690543|FG000|Overall Study|No specific reason|4
4738627|NCT03681119|7690544|FG001|Overall Study|No specific reason|0
4738628|NCT03681119|7690543|FG000|Overall Study|Sickness|2
4738629|NCT03681119|7690544|FG001|Overall Study|Sickness|0
4738630|NCT03681353|7690548|FG000|Overall Study|Lost to Follow-up|2
4738631|NCT03681353|7690548|FG000|Overall Study|Withdrawal by Subject|3
4738632|NCT03681353|7690548|FG000|Overall Study|withdrawn by PI|2
4738633|NCT03681405|7690554|FG000|Overall Study|Found to be ineligible after randomized|1
4738634|NCT03681405|7690555|FG001|Overall Study|Found to be ineligible after randomized|0
4524429|NCT01015287|7339820|FG000|Overall Study|Death|21
4524430|NCT01015287|7339821|FG001|Overall Study|Death|16
4524431|NCT01015287|7339820|FG000|Overall Study|Adverse Event|1
4738635|NCT03681951|7690601|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1
4738636|NCT03681951|7690602|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
4738637|NCT03681951|7690603|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
4738638|NCT03681951|7690604|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
4738639|NCT03681951|7690605|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
4738640|NCT03681951|7690606|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
4738641|NCT03681951|7690607|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
4738642|NCT03681951|7690608|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
4738643|NCT03681951|7690601|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4
4738644|NCT03681951|7690602|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
4738645|NCT03681951|7690603|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
4738646|NCT03681951|7690604|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
4738647|NCT03681951|7690605|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
4738648|NCT03681951|7690606|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
4738649|NCT03681951|7690607|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
4738650|NCT03681951|7690608|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
4738651|NCT03681951|7690601|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3
4738652|NCT03681951|7690602|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
4738653|NCT03681951|7690603|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
4738654|NCT03681951|7690604|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
4738655|NCT03681951|7690605|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
4738656|NCT03681951|7690606|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
4738657|NCT03681951|7690607|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
4738658|NCT03681951|7690608|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
4738659|NCT03682107|7690636|FG000|Overall Study|Withdrawal by Subject|0
4738660|NCT03682107|7690637|FG001|Overall Study|Withdrawal by Subject|1
4738661|NCT03682107|7690638|FG002|Overall Study|Withdrawal by Subject|0
4738662|NCT03682107|7690639|FG003|Overall Study|Withdrawal by Subject|0
4738663|NCT03682107|7690640|FG004|Overall Study|Withdrawal by Subject|0
4738664|NCT03682120|7690656|FG000|Overall Study|Lost to Follow-up|11
4738665|NCT03682120|7690657|FG001|Overall Study|Lost to Follow-up|4
4738666|NCT03682120|7690658|FG002|Overall Study|Lost to Follow-up|5
4738667|NCT03682120|7690659|FG003|Overall Study|Lost to Follow-up|2
4738668|NCT03682120|7690656|FG000|Overall Study|Physician Decision|1
4738669|NCT03682120|7690657|FG001|Overall Study|Physician Decision|0
4738670|NCT03682120|7690658|FG002|Overall Study|Physician Decision|0
4738671|NCT03682120|7690659|FG003|Overall Study|Physician Decision|0
4738672|NCT03682120|7690656|FG000|Overall Study|Withdrawal by Subject|1
4738673|NCT03682120|7690657|FG001|Overall Study|Withdrawal by Subject|2
4738674|NCT03682120|7690658|FG002|Overall Study|Withdrawal by Subject|3
4738675|NCT03682120|7690659|FG003|Overall Study|Withdrawal by Subject|0
4738676|NCT03682120|7690656|FG000|Overall Study|Death|0
4738677|NCT03682120|7690657|FG001|Overall Study|Death|1
4738678|NCT03682120|7690658|FG002|Overall Study|Death|0
4738679|NCT03682120|7690659|FG003|Overall Study|Death|0
4738680|NCT03682120|7690656|FG000|Overall Study|Enrolled but Treatment Not Administered|0
4738681|NCT03682120|7690657|FG001|Overall Study|Enrolled but Treatment Not Administered|1
4738682|NCT03682120|7690658|FG002|Overall Study|Enrolled but Treatment Not Administered|0
4738683|NCT03682120|7690659|FG003|Overall Study|Enrolled but Treatment Not Administered|0
4738684|NCT03682302|7690675|FG000|Overall Study|Lost to Follow-up|1
4738685|NCT03682302|7690676|FG001|Overall Study|Lost to Follow-up|2
4738686|NCT03682302|7690677|FG002|Overall Study|Lost to Follow-up|0
4738687|NCT03682302|7690678|FG003|Overall Study|Lost to Follow-up|1
4738688|NCT03682302|7690675|FG000|Overall Study|Study drug was not administered|0
4738689|NCT03682302|7690676|FG001|Overall Study|Study drug was not administered|0
4738690|NCT03682302|7690677|FG002|Overall Study|Study drug was not administered|1
4738691|NCT03682302|7690678|FG003|Overall Study|Study drug was not administered|1
4738692|NCT03682705|7690694|FG000|Overall Study|Adverse Event|1
4738693|NCT03682705|7690695|FG001|Overall Study|Adverse Event|1
4738694|NCT03682705|7690696|FG002|Overall Study|Adverse Event|1
4738695|NCT03682705|7690697|FG003|Overall Study|Adverse Event|0
4738696|NCT03682705|7690698|FG004|Overall Study|Adverse Event|1
4738697|NCT03682705|7690699|FG005|Overall Study|Adverse Event|1
4738698|NCT03682705|7690694|FG000|Overall Study|Withdrawal by Subject|1
4738699|NCT03682705|7690695|FG001|Overall Study|Withdrawal by Subject|3
4738700|NCT03682705|7690696|FG002|Overall Study|Withdrawal by Subject|2
4738701|NCT03682705|7690697|FG003|Overall Study|Withdrawal by Subject|4
4738702|NCT03682705|7690698|FG004|Overall Study|Withdrawal by Subject|0
4738703|NCT03682705|7690699|FG005|Overall Study|Withdrawal by Subject|1
4738704|NCT03682705|7690694|FG000|Overall Study|Other, not specified|0
4524432|NCT01015287|7339821|FG001|Overall Study|Adverse Event|0
4524433|NCT01015287|7339820|FG000|Overall Study|Sponsor Decision|3
4524434|NCT01015287|7339821|FG001|Overall Study|Sponsor Decision|7
4524435|NCT01015287|7339820|FG000|Overall Study|Physician Decision|19
4524436|NCT01015287|7339821|FG001|Overall Study|Physician Decision|21
4524437|NCT01015287|7339820|FG000|Overall Study|Withdrawal by Subject|14
4524438|NCT01015287|7339821|FG001|Overall Study|Withdrawal by Subject|19
4524439|NCT01015287|7339820|FG000|Overall Study|Entry Criteria not Met|11
4524440|NCT01015287|7339821|FG001|Overall Study|Entry Criteria not Met|14
4524441|NCT01015287|7339820|FG000|Overall Study|Lost to Follow-up|2
4524442|NCT01015287|7339821|FG001|Overall Study|Lost to Follow-up|1
4524443|NCT01015287|7339820|FG000|Overall Study|Protocol Violation|1
4524444|NCT01015287|7339821|FG001|Overall Study|Protocol Violation|1
4524445|NCT01015560|7339859|FG000|Overall Study|Adverse Event|1
4524446|NCT01015560|7339859|FG000|Overall Study|Not protocol specified|1
4524447|NCT01015560|7339859|FG000|Overall Study|Withdrawal by Subject|1
4524448|NCT01015612|7339872|FG000|Overall Study|Death|113
4524449|NCT01015612|7339872|FG000|Overall Study|Withdrawal by Subject|40
4524450|NCT01015638|7339878|FG000|Overall Study|Withdrawal by Subject|1
4524451|NCT01015638|7339879|FG001|Overall Study|Withdrawal by Subject|0
4524452|NCT01015677|7339888|FG000|Overall Study|Adverse Event|0
4524453|NCT01015677|7339889|FG001|Overall Study|Adverse Event|1
4524454|NCT01015677|7339890|FG002|Overall Study|Adverse Event|0
4738705|NCT03682705|7690695|FG001|Overall Study|Other, not specified|0
4738706|NCT03682705|7690696|FG002|Overall Study|Other, not specified|0
4738707|NCT03682705|7690697|FG003|Overall Study|Other, not specified|1
4738708|NCT03682705|7690698|FG004|Overall Study|Other, not specified|2
4738709|NCT03682705|7690699|FG005|Overall Study|Other, not specified|0
4738710|NCT03682705|7690694|FG000|Overall Study|Lost to Follow-up|0
4738711|NCT03682705|7690695|FG001|Overall Study|Lost to Follow-up|0
4738712|NCT03682705|7690696|FG002|Overall Study|Lost to Follow-up|0
4738713|NCT03682705|7690697|FG003|Overall Study|Lost to Follow-up|0
4738714|NCT03682705|7690698|FG004|Overall Study|Lost to Follow-up|3
4633761|NCT01915914|7504084|FG003|Acute Phase|"Not Achieved treatment success"|0
4633762|NCT01915914|7504081|FG000|Acute Phase|Missing|1
4633763|NCT01915914|7504082|FG001|Acute Phase|Missing|0
4633764|NCT01915914|7504083|FG002|Acute Phase|Missing|0
4738715|NCT03682705|7690699|FG005|Overall Study|Lost to Follow-up|0
4738716|NCT03683576|7690735|FG000|Overall Study|Withdrawal by Subject|2
4738717|NCT03683576|7690736|FG001|Overall Study|Withdrawal by Subject|0
4738718|NCT03683576|7690737|FG002|Overall Study|Withdrawal by Subject|8
4738719|NCT03683576|7690738|FG003|Overall Study|Withdrawal by Subject|3
4738720|NCT03683576|7690735|FG000|Overall Study|Adverse Event|3
4738721|NCT03683576|7690736|FG001|Overall Study|Adverse Event|0
4738722|NCT03683576|7690737|FG002|Overall Study|Adverse Event|0
4738723|NCT03683576|7690738|FG003|Overall Study|Adverse Event|4
4738724|NCT03683576|7690735|FG000|Overall Study|Lack of Efficacy|1
4738725|NCT03683576|7690736|FG001|Overall Study|Lack of Efficacy|0
4738726|NCT03683576|7690737|FG002|Overall Study|Lack of Efficacy|1
4738727|NCT03683576|7690738|FG003|Overall Study|Lack of Efficacy|1
4738728|NCT03683576|7690735|FG000|Overall Study|Lost to Follow-up|0
4738729|NCT03683576|7690736|FG001|Overall Study|Lost to Follow-up|1
4738730|NCT03683576|7690737|FG002|Overall Study|Lost to Follow-up|2
4738731|NCT03683576|7690738|FG003|Overall Study|Lost to Follow-up|0
4738732|NCT03683576|7690735|FG000|Overall Study|Other, Not Specified|0
4738733|NCT03683576|7690736|FG001|Overall Study|Other, Not Specified|2
4738734|NCT03683576|7690737|FG002|Overall Study|Other, Not Specified|0
4738735|NCT03683576|7690738|FG003|Overall Study|Other, Not Specified|0
4738736|NCT03683576|7690735|FG000|Overall Study|Protocol Violation|0
4738737|NCT03683576|7690736|FG001|Overall Study|Protocol Violation|1
4738738|NCT03683576|7690737|FG002|Overall Study|Protocol Violation|1
4738739|NCT03683576|7690738|FG003|Overall Study|Protocol Violation|0
4738740|NCT03683719|7690753|FG000|Overall Study|Lack of Efficacy|1
4738741|NCT03683719|7690754|FG001|Overall Study|Lack of Efficacy|3
4738742|NCT03683719|7690755|FG002|Overall Study|Lack of Efficacy|4
4738743|NCT03683719|7690756|FG003|Overall Study|Lack of Efficacy|0
4738744|NCT03683719|7690757|FG004|Overall Study|Lack of Efficacy|4
4738745|NCT03683719|7690753|FG000|Overall Study|Adverse Event|6
4738746|NCT03683719|7690754|FG001|Overall Study|Adverse Event|6
4738747|NCT03683719|7690755|FG002|Overall Study|Adverse Event|0
4738748|NCT03683719|7690756|FG003|Overall Study|Adverse Event|1
4738749|NCT03683719|7690757|FG004|Overall Study|Adverse Event|3
4738750|NCT03683719|7690753|FG000|Overall Study|Withdrawal by Subject|4
4738751|NCT03683719|7690754|FG001|Overall Study|Withdrawal by Subject|4
4738752|NCT03683719|7690755|FG002|Overall Study|Withdrawal by Subject|3
4738753|NCT03683719|7690756|FG003|Overall Study|Withdrawal by Subject|5
4738754|NCT03683719|7690757|FG004|Overall Study|Withdrawal by Subject|5
4738755|NCT03683719|7690753|FG000|Overall Study|Lost to Follow-up|1
4738756|NCT03683719|7690754|FG001|Overall Study|Lost to Follow-up|0
4738757|NCT03683719|7690755|FG002|Overall Study|Lost to Follow-up|0
4738758|NCT03683719|7690756|FG003|Overall Study|Lost to Follow-up|1
4738759|NCT03683719|7690757|FG004|Overall Study|Lost to Follow-up|1
4738760|NCT03683719|7690753|FG000|Overall Study|Other personal reasons|0
4738761|NCT03683719|7690754|FG001|Overall Study|Other personal reasons|0
4738762|NCT03683719|7690755|FG002|Overall Study|Other personal reasons|1
4738763|NCT03683719|7690756|FG003|Overall Study|Other personal reasons|0
4738764|NCT03683719|7690757|FG004|Overall Study|Other personal reasons|1
4738765|NCT03683758|7690771|FG000|Overall Study|Non-study commitment conflict|1
4738766|NCT03683758|7690772|FG001|Overall Study|Non-study commitment conflict|3
4738767|NCT03683758|7690771|FG000|Overall Study|Illness preventing participation|1
4738768|NCT03683758|7690772|FG001|Overall Study|Illness preventing participation|0
4738769|NCT03683758|7690771|FG000|Overall Study|Adverse Event|1
4738770|NCT03683758|7690772|FG001|Overall Study|Adverse Event|0
4738771|NCT03684044|7690786|FG000|Overall Study|Adverse Event|3
4738772|NCT03684044|7690787|FG001|Overall Study|Adverse Event|0
4738773|NCT03684044|7690786|FG000|Overall Study|Death|4
4738774|NCT03684044|7690787|FG001|Overall Study|Death|7
4738775|NCT03684044|7690786|FG000|Overall Study|Lost to Follow-up|3
4738776|NCT03684044|7690787|FG001|Overall Study|Lost to Follow-up|2
4738777|NCT03684044|7690786|FG000|Overall Study|Patient Not Available|0
4738778|NCT03684044|7690787|FG001|Overall Study|Patient Not Available|2
4738779|NCT03684044|7690786|FG000|Overall Study|Physician Decision|1
4738780|NCT03684044|7690787|FG001|Overall Study|Physician Decision|0
4738781|NCT03684044|7690786|FG000|Overall Study|Withdrawal by Subject|11
4738782|NCT03684044|7690787|FG001|Overall Study|Withdrawal by Subject|9
4738783|NCT03684642|7690805|FG000|Overall Study|Adverse Event|6
4738784|NCT03684642|7690806|FG001|Overall Study|Adverse Event|15
4738785|NCT03684642|7690807|FG002|Overall Study|Adverse Event|11
4524455|NCT01015677|7339888|FG000|Overall Study|Lack of Efficacy|0
4524456|NCT01015677|7339889|FG001|Overall Study|Lack of Efficacy|1
4738786|NCT03684642|7690805|FG000|Overall Study|Withdrawal by Subject|35
4633765|NCT01915914|7504084|FG003|Acute Phase|Missing|0
4738787|NCT03684642|7690806|FG001|Overall Study|Withdrawal by Subject|53
4738788|NCT03684642|7690807|FG002|Overall Study|Withdrawal by Subject|23
4738789|NCT03684642|7690805|FG000|Overall Study|Lack of Efficacy|0
4738790|NCT03684642|7690806|FG001|Overall Study|Lack of Efficacy|0
4738791|NCT03684642|7690807|FG002|Overall Study|Lack of Efficacy|1
4738792|NCT03684642|7690805|FG000|Overall Study|Poor compliance to protocol|0
4738793|NCT03684642|7690806|FG001|Overall Study|Poor compliance to protocol|4
4738794|NCT03684642|7690807|FG002|Overall Study|Poor compliance to protocol|1
4738795|NCT03684642|7690805|FG000|Overall Study|Other than specified|62
4738796|NCT03684642|7690806|FG001|Overall Study|Other than specified|60
4738797|NCT03684642|7690807|FG002|Overall Study|Other than specified|67
4738798|NCT03684642|7690805|FG000|Overall Study|Randomized and not treated|0
4738799|NCT03684642|7690806|FG001|Overall Study|Randomized and not treated|0
4738800|NCT03684642|7690807|FG002|Overall Study|Randomized and not treated|1
4738801|NCT03684642|7690805|FG000|Overall Study|Missing completion status but alive at last contact|0
4738802|NCT03684642|7690806|FG001|Overall Study|Missing completion status but alive at last contact|1
4738803|NCT03684642|7690807|FG002|Overall Study|Missing completion status but alive at last contact|2
4738804|NCT03684928|7690815|FG000|First Intervention|Lost to Follow-up|0
4738805|NCT03684928|7690816|FG001|First Intervention|Lost to Follow-up|1
4738806|NCT03684928|7690815|FG000|First Intervention|Withdrawal by Subject|0
4738807|NCT03684928|7690816|FG001|First Intervention|Withdrawal by Subject|2
4738808|NCT03684928|7690815|FG000|Second Intervention|Soft Tissue Injury|1
4738809|NCT03684928|7690816|FG001|Second Intervention|Soft Tissue Injury|0
4738810|NCT03685344|7690826|FG000|Overall Study|Withdrawal by Subject|1
4738811|NCT03685344|7690827|FG001|Overall Study|Withdrawal by Subject|1
4738812|NCT03685344|7690828|FG002|Overall Study|Withdrawal by Subject|2
4738813|NCT03685344|7690829|FG003|Overall Study|Withdrawal by Subject|0
4738814|NCT03685344|7690826|FG000|Overall Study|Physician Decision|1
4738815|NCT03685344|7690827|FG001|Overall Study|Physician Decision|1
4738816|NCT03685344|7690828|FG002|Overall Study|Physician Decision|5
4738817|NCT03685344|7690829|FG003|Overall Study|Physician Decision|0
4738818|NCT03685344|7690826|FG000|Overall Study|Death|1
4738819|NCT03685344|7690827|FG001|Overall Study|Death|1
4738820|NCT03685344|7690828|FG002|Overall Study|Death|0
4738821|NCT03685344|7690829|FG003|Overall Study|Death|0
4738822|NCT03685643|7690850|FG000|Overall Study|Lost to Follow-up|14
4738823|NCT03685643|7690851|FG001|Overall Study|Lost to Follow-up|22
4738824|NCT03686033|7690870|FG000|Treatment Period 2 (1 Day)|Adverse Event|0
4738825|NCT03686033|7690871|FG001|Treatment Period 2 (1 Day)|Adverse Event|0
4738826|NCT03686033|7690872|FG002|Treatment Period 2 (1 Day)|Adverse Event|0
4738827|NCT03686033|7690873|FG003|Treatment Period 2 (1 Day)|Adverse Event|0
4738828|NCT03686033|7690874|FG004|Treatment Period 2 (1 Day)|Adverse Event|1
4738829|NCT03686033|7690875|FG005|Treatment Period 2 (1 Day)|Adverse Event|0
4738830|NCT03686176|7690892|FG000|Overall Study|Procedure cancelled|1
4738831|NCT03686176|7690893|FG001|Overall Study|Procedure cancelled|0
4738832|NCT03686176|7690894|FG002|Overall Study|Procedure cancelled|0
4738833|NCT03686176|7690892|FG000|Overall Study|VR Malfunction|1
4738834|NCT03686176|7690893|FG001|Overall Study|VR Malfunction|0
4738835|NCT03686176|7690894|FG002|Overall Study|VR Malfunction|0
4738836|NCT03687125|7690904|FG000|Overall Study|Progressive Disease|2
4738837|NCT03687125|7690905|FG001|Overall Study|Progressive Disease|1
4738838|NCT03687125|7690904|FG000|Overall Study|Protocol Violation|1
4738839|NCT03687125|7690905|FG001|Overall Study|Protocol Violation|0
4738840|NCT03687372|7690915|FG000|Overall Study|Lost to Follow-up|12
4738841|NCT03687372|7690916|FG001|Overall Study|Lost to Follow-up|21
4738842|NCT03687372|7690915|FG000|Overall Study|Withdrawal by Subject|4
4738843|NCT03687372|7690916|FG001|Overall Study|Withdrawal by Subject|17
4738844|NCT03687372|7690915|FG000|Overall Study|Investigator Decision|1
4738845|NCT03687372|7690916|FG001|Overall Study|Investigator Decision|1
4738846|NCT03687736|7690980|FG000|Overall Study|Lost to Follow-up|7
4738847|NCT03687736|7690980|FG000|Overall Study|Withdrawal by Subject|3
4738848|NCT03687827|7690986|FG000|Treatment Period 1|Death|0
4738849|NCT03687827|7690987|FG001|Treatment Period 1|Death|1
4738850|NCT03687827|7690986|FG000|Treatment Period 1|Lost to Follow-up|2
4524457|NCT01015677|7339890|FG002|Overall Study|Lack of Efficacy|0
4524458|NCT01015677|7339888|FG000|Overall Study|Protocol Violation|0
4524459|NCT01015677|7339889|FG001|Overall Study|Protocol Violation|1
4738851|NCT03687827|7690987|FG001|Treatment Period 1|Lost to Follow-up|2
4738852|NCT03687827|7690986|FG000|Treatment Period 1|Physician Decision|5
4738853|NCT03687827|7690987|FG001|Treatment Period 1|Physician Decision|2
4738854|NCT03687827|7690986|FG000|Treatment Period 1|Withdrawal by Subject|7
4738855|NCT03687827|7690987|FG001|Treatment Period 1|Withdrawal by Subject|3
4738856|NCT03687827|7690986|FG000|Treatment Period 2|Physician Decision|4
4738857|NCT03687827|7690987|FG001|Treatment Period 2|Physician Decision|1
4738858|NCT03687827|7690986|FG000|Treatment Period 2|Withdrawal by Subject|1
4738859|NCT03687827|7690987|FG001|Treatment Period 2|Withdrawal by Subject|2
4738860|NCT03687970|7690995|FG000|Overall Study|visit scheduling conflicts|2
4738861|NCT03687970|7690996|FG001|Overall Study|visit scheduling conflicts|0
4738862|NCT03688620|7691022|FG000|Overall Study|Other|0
4738863|NCT03688620|7691023|FG001|Overall Study|Other|0
4738864|NCT03688620|7691024|FG002|Overall Study|Other|1
4738865|NCT03688620|7691022|FG000|Overall Study|Unwilling to attend the scheduled visit|0
4738866|NCT03688620|7691023|FG001|Overall Study|Unwilling to attend the scheduled visit|1
4738867|NCT03688620|7691024|FG002|Overall Study|Unwilling to attend the scheduled visit|0
4738868|NCT03688620|7691022|FG000|Overall Study|Lost to Follow-up|16
4738869|NCT03688620|7691023|FG001|Overall Study|Lost to Follow-up|0
4738870|NCT03688620|7691024|FG002|Overall Study|Lost to Follow-up|1
4738871|NCT03688620|7691022|FG000|Overall Study|Withdrawal by Subject|0
4738872|NCT03688620|7691023|FG001|Overall Study|Withdrawal by Subject|0
4738873|NCT03688620|7691024|FG002|Overall Study|Withdrawal by Subject|6
4738874|NCT03688711|7691040|FG000|Overall Study|Withdrawal by Subject|0
4738875|NCT03688711|7691041|FG001|Overall Study|Withdrawal by Subject|1
4738876|NCT03688880|7691049|FG000|Overall Study|Withdrawal by Subject|0
4738877|NCT03688880|7691050|FG001|Overall Study|Withdrawal by Subject|2
4738878|NCT03688880|7691049|FG000|Overall Study|Use of non-permitted concurrent therapy|0
4738879|NCT03688880|7691050|FG001|Overall Study|Use of non-permitted concurrent therapy|2
4738880|NCT03688880|7691049|FG000|Overall Study|Lost to Follow-up|4
4738881|NCT03688880|7691050|FG001|Overall Study|Lost to Follow-up|7
4738882|NCT03688880|7691049|FG000|Overall Study|Adverse Event|0
4738883|NCT03688880|7691050|FG001|Overall Study|Adverse Event|2
4738884|NCT03688880|7691049|FG000|Overall Study|Device deficiencies|0
4738885|NCT03688880|7691050|FG001|Overall Study|Device deficiencies|2
4738886|NCT03688880|7691049|FG000|Overall Study|Other|10
4738887|NCT03688880|7691050|FG001|Overall Study|Other|16
4738888|NCT03689452|7691058|FG000|Overall Study|Lost to Follow-up|1
4738889|NCT03689452|7691059|FG001|Overall Study|Lost to Follow-up|1
4738890|NCT03691779|7691086|FG000|Part B (24 Weeks)|Adverse Event|0
4738891|NCT03691779|7691087|FG001|Part B (24 Weeks)|Adverse Event|1
4738892|NCT03691779|7691086|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0
4738893|NCT03691779|7691087|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1
4738894|NCT03691831|7691096|FG000|Overall Study|Lost to Follow-up|16
4738895|NCT03691831|7691097|FG001|Overall Study|Lost to Follow-up|12
4738896|NCT03691831|7691096|FG000|Overall Study|Withdrawal by Subject|9
4738897|NCT03691831|7691097|FG001|Overall Study|Withdrawal by Subject|17
4738898|NCT03691831|7691096|FG000|Overall Study|Investigator Decision|2
4738899|NCT03691831|7691097|FG001|Overall Study|Investigator Decision|2
4738900|NCT03691948|7691124|FG000|Overall Study|Lost to Follow-up|1
4738901|NCT03691948|7691125|FG001|Overall Study|Lost to Follow-up|3
4738902|NCT03692676|7691136|FG000|Overall Study|exclude patients with prior use|4424
4524460|NCT01015677|7339890|FG002|Overall Study|Protocol Violation|0
4524461|NCT01015677|7339888|FG000|Overall Study|Withdrawal by Subject|1
4524462|NCT01015677|7339889|FG001|Overall Study|Withdrawal by Subject|1
4524463|NCT01015677|7339890|FG002|Overall Study|Withdrawal by Subject|0
4524464|NCT01015703|7339903|FG000|Overall Study|Withdrawal by Subject|0
4524465|NCT01015703|7339904|FG001|Overall Study|Withdrawal by Subject|1
4738903|NCT03692676|7691137|FG001|Overall Study|exclude patients with prior use|24726
4738904|NCT03692676|7691138|FG002|Overall Study|exclude patients with prior use|0
4738905|NCT03692676|7691139|FG003|Overall Study|exclude patients with prior use|0
4738906|NCT03692676|7691136|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480
4738907|NCT03692676|7691137|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037
4738908|NCT03692676|7691138|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0
4738909|NCT03692676|7691139|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0
4738910|NCT03692676|7691136|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881
4738911|NCT03692676|7691137|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563
4738912|NCT03692676|7691138|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281
4738913|NCT03692676|7691139|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558
4738914|NCT03692676|7691136|FG000|Overall Study|exclude patients less than 18 years of age on index date|8
4738915|NCT03692676|7691137|FG001|Overall Study|exclude patients less than 18 years of age on index date|613
4738916|NCT03692676|7691138|FG002|Overall Study|exclude patients less than 18 years of age on index date|836
4738917|NCT03692676|7691139|FG003|Overall Study|exclude patients less than 18 years of age on index date|193
4738918|NCT03692676|7691136|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149
4738919|NCT03692676|7691137|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717
4524466|NCT01015703|7339905|FG002|Overall Study|Withdrawal by Subject|0
4738920|NCT03692676|7691138|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723
4738921|NCT03692676|7691139|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273
4738922|NCT03692676|7691136|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208
4738923|NCT03692676|7691137|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759
4738924|NCT03692676|7691138|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419
4738925|NCT03692676|7691139|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684
4738926|NCT03692676|7691136|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275
4738927|NCT03692676|7691137|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218
4738928|NCT03692676|7691138|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515
4738929|NCT03692676|7691139|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173
4738930|NCT03692676|7691136|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0
4738931|NCT03692676|7691137|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0
4738932|NCT03692676|7691138|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147
4738933|NCT03692676|7691139|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4
4738934|NCT03692676|7691136|FG000|Overall Study|exclude patients with prior use of same substances and device|0
4738935|NCT03692676|7691137|FG001|Overall Study|exclude patients with prior use of same substances and device|0
4738936|NCT03692676|7691138|FG002|Overall Study|exclude patients with prior use of same substances and device|3700
4738937|NCT03692676|7691139|FG003|Overall Study|exclude patients with prior use of same substances and device|0
4738938|NCT03692676|7691136|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0
4738939|NCT03692676|7691137|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0
4738940|NCT03692676|7691138|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965
4738941|NCT03692676|7691139|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198
4738942|NCT03692676|7691136|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0
4738943|NCT03692676|7691137|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0
4738944|NCT03692676|7691138|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0
4738945|NCT03692676|7691139|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223
4738946|NCT03692676|7691136|FG000|Overall Study|Other|0
4738947|NCT03692676|7691137|FG001|Overall Study|Other|805
4738948|NCT03692676|7691138|FG002|Overall Study|Other|758
4738949|NCT03692676|7691139|FG003|Overall Study|Other|277
4738950|NCT03692676|7691136|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0
4738951|NCT03692676|7691137|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0
4738952|NCT03692676|7691138|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0
4738953|NCT03692676|7691139|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3
4524467|NCT01015703|7339906|FG003|Overall Study|Withdrawal by Subject|0
4524468|NCT01015703|7339907|FG004|Overall Study|Withdrawal by Subject|0
4524469|NCT01015703|7339903|FG000|Overall Study|Adverse Event|1
4524470|NCT01015703|7339904|FG001|Overall Study|Adverse Event|0
4524471|NCT01015703|7339905|FG002|Overall Study|Adverse Event|0
4524472|NCT01015703|7339906|FG003|Overall Study|Adverse Event|0
4524473|NCT01015703|7339907|FG004|Overall Study|Adverse Event|0
4524474|NCT01015703|7339903|FG000|Overall Study|Protocol Violation|1
4738954|NCT03693625|7691151|FG000|Overall Study|Adverse Event|2
4738955|NCT03693625|7691152|FG001|Overall Study|Adverse Event|0
4738956|NCT03693625|7691151|FG000|Overall Study|Study Terminated By Sponsor|20
4738957|NCT03693625|7691152|FG001|Overall Study|Study Terminated By Sponsor|7
4738958|NCT03693625|7691151|FG000|Overall Study|Withdrawal by Subject|1
4738959|NCT03693625|7691152|FG001|Overall Study|Withdrawal by Subject|1
4738960|NCT03693950|7691175|FG000|Overall Study|Withdrawal by Subject|1
4738961|NCT03693950|7691176|FG001|Overall Study|Withdrawal by Subject|0
4738962|NCT03693989|7691184|FG000|Overall Study|Protocol Violation|3
4738963|NCT03693989|7691185|FG001|Overall Study|Protocol Violation|4
4738964|NCT03694197|7691191|FG000|Overall Study|Adverse Event|9
4738965|NCT03694197|7691191|FG000|Overall Study|Protocol became inconvenient to participate|1
4738966|NCT03694197|7691191|FG000|Overall Study|Physician Decision|4
4738967|NCT03694197|7691191|FG000|Overall Study|Study terminated by sponsor|1350
4738968|NCT03694197|7691191|FG000|Overall Study|Participant moved|5
4738969|NCT03694197|7691191|FG000|Overall Study|Participant withdrew consent|10
4738970|NCT03694197|7691191|FG000|Overall Study|Related to IMP administration|1
4738971|NCT03694197|7691191|FG000|Overall Study|Not disclosed|5
4738972|NCT03694210|7691195|FG000|Overall Study|Death|1
4738973|NCT03694210|7691195|FG000|Overall Study|Screen Failure|7
4738974|NCT03694275|7691203|FG000|Overall Study|Adverse Event|0
4738975|NCT03694275|7691204|FG001|Overall Study|Adverse Event|1
4738976|NCT03694275|7691203|FG000|Overall Study|Reason not Specified|0
4738977|NCT03694275|7691204|FG001|Overall Study|Reason not Specified|1
4738978|NCT03694548|7691213|FG000|Part A Survey|Protocol Violation|3
4738979|NCT03694548|7691214|FG001|Part A Survey|Protocol Violation|3
4738980|NCT03694548|7691215|FG002|Part A Survey|Protocol Violation|0
4738981|NCT03694548|7691213|FG000|Part B Yoga Program|Protocol Violation|0
4738982|NCT03694548|7691214|FG001|Part B Yoga Program|Protocol Violation|0
4738983|NCT03694548|7691215|FG002|Part B Yoga Program|Protocol Violation|3
4738984|NCT03694548|7691213|FG000|Part B Yoga Program|Did not attend intervention|0
4738985|NCT03694548|7691214|FG001|Part B Yoga Program|Did not attend intervention|0
4738986|NCT03694548|7691215|FG002|Part B Yoga Program|Did not attend intervention|8
4524475|NCT01015703|7339904|FG001|Overall Study|Protocol Violation|0
4524476|NCT01015703|7339905|FG002|Overall Study|Protocol Violation|0
4524477|NCT01015703|7339906|FG003|Overall Study|Protocol Violation|0
4524478|NCT01015703|7339907|FG004|Overall Study|Protocol Violation|0
4524479|NCT01015768|7339919|FG000|Overall Study|Some subject data unuseable|4
4524480|NCT01015768|7339920|FG001|Overall Study|Some subject data unuseable|4
4524481|NCT01015820|7339952|FG000|Overall Study|Suboptimal measurements|1
4524482|NCT01015820|7339953|FG001|Overall Study|Suboptimal measurements|0
4524483|NCT01016015|7339964|FG000|Overall Study|Not Treated|3
4524484|NCT01016015|7339964|FG000|Overall Study|Withdrawal by Subject|1
4524485|NCT01016015|7339964|FG000|Overall Study|Adverse Event|15
4524486|NCT01016067|7339970|FG000|Overall Study|Lost to Follow-up|1
4524487|NCT01016067|7339971|FG001|Overall Study|Lost to Follow-up|2
4524488|NCT01016067|7339970|FG000|Overall Study|Physician Decision|1
4524489|NCT01016067|7339971|FG001|Overall Study|Physician Decision|1
4524490|NCT01016067|7339970|FG000|Overall Study|Withdrew due to Relocation|0
4524491|NCT01016067|7339971|FG001|Overall Study|Withdrew due to Relocation|1
4594277|NCT01561313|7443468|FG000|Overall Study|Withdrawal by Subject|1
4738987|NCT03694925|7691241|FG000|Overall Study|Inadequate laboratory testing|0
4738988|NCT03694925|7691242|FG001|Overall Study|Inadequate laboratory testing|3
4738989|NCT03694925|7691243|FG002|Overall Study|Inadequate laboratory testing|0
4738990|NCT03695094|7691255|FG000|Overall Study|Adverse Event|1
4738991|NCT03695094|7691256|FG001|Overall Study|Adverse Event|1
4738992|NCT03695094|7691255|FG000|Overall Study|Withdrawal by Subject|1
4738993|NCT03695094|7691256|FG001|Overall Study|Withdrawal by Subject|0
4738994|NCT03695367|7691266|FG000|Overall Study|Missed the Day 28 visit.|1
4738995|NCT03695367|7691267|FG001|Overall Study|Missed the Day 28 visit.|0
4738996|NCT03695367|7691266|FG000|Overall Study|Lost to Follow-up|0
4738997|NCT03695367|7691267|FG001|Overall Study|Lost to Follow-up|1
4738998|NCT03695367|7691266|FG000|Overall Study|Withdrawal by Subject|0
4738999|NCT03695367|7691267|FG001|Overall Study|Withdrawal by Subject|1
4739000|NCT03695367|7691266|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0
4739001|NCT03695367|7691267|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2
4739002|NCT03695393|7691275|FG000|Overall Study|Death|3
4739003|NCT03695393|7691276|FG001|Overall Study|Death|1
4739004|NCT03695393|7691275|FG000|Overall Study|Lost to Follow-up|0
4739005|NCT03695393|7691276|FG001|Overall Study|Lost to Follow-up|1
4739006|NCT03696108|7691288|FG000|Overall Study|Physician Decision|1
4739007|NCT03696108|7691289|FG001|Overall Study|Physician Decision|0
4739008|NCT03696108|7691288|FG000|Overall Study|Withdrawal by Subject|3
4739009|NCT03696108|7691289|FG001|Overall Study|Withdrawal by Subject|6
4739010|NCT03696342|7691297|FG000|Overall Study|Lost to Follow-up|1
4739011|NCT03696342|7691298|FG001|Overall Study|Lost to Follow-up|0
4739012|NCT03696576|7691306|FG000|Overall Study|Soreness of throat after therapy|1
4739013|NCT03696576|7691307|FG001|Overall Study|Soreness of throat after therapy|1
4739014|NCT03696576|7691306|FG000|Overall Study|Lost to Follow-up|2
4739015|NCT03696576|7691307|FG001|Overall Study|Lost to Follow-up|4
4739016|NCT03697252|7691352|FG000|Overall Study|Adverse Event|3
4739017|NCT03697252|7691353|FG001|Overall Study|Adverse Event|2
4739018|NCT03697252|7691352|FG000|Overall Study|Withdrawal by Subject|14
4739019|NCT03697252|7691353|FG001|Overall Study|Withdrawal by Subject|14
4739020|NCT03697252|7691352|FG000|Overall Study|Lost to Follow-up|0
4739021|NCT03697252|7691353|FG001|Overall Study|Lost to Follow-up|1
4739022|NCT03697252|7691352|FG000|Overall Study|Physician Decision|1
4739023|NCT03697252|7691353|FG001|Overall Study|Physician Decision|1
4739024|NCT03697252|7691352|FG000|Overall Study|Other|0
4739025|NCT03697252|7691353|FG001|Overall Study|Other|1
4739026|NCT03697460|7691359|FG000|Overall Study|Withdrawal by Subject|3
4739027|NCT03697993|7691365|FG000|Overall Study|Became Ineligible after Enrollment|1
4739028|NCT03697993|7691366|FG001|Overall Study|Became Ineligible after Enrollment|3
4739029|NCT03697993|7691365|FG000|Overall Study|Enrolled but Treatment not Administered|2
4739030|NCT03697993|7691366|FG001|Overall Study|Enrolled but Treatment not Administered|1
4739031|NCT03697993|7691365|FG000|Overall Study|Lost to Follow-up|3
4739032|NCT03697993|7691366|FG001|Overall Study|Lost to Follow-up|0
4739033|NCT03697993|7691365|FG000|Overall Study|Physician Decision|4
4739034|NCT03697993|7691366|FG001|Overall Study|Physician Decision|0
4739035|NCT03697993|7691365|FG000|Overall Study|Initial Urine Culture Negative|0
4739036|NCT03697993|7691366|FG001|Overall Study|Initial Urine Culture Negative|1
4739037|NCT03698331|7691375|FG000|Overall Study|Adverse Event|2
4739038|NCT03698331|7691376|FG001|Overall Study|Adverse Event|3
4739039|NCT03698331|7691375|FG000|Overall Study|Withdrawal by Subject|1
4739040|NCT03698331|7691376|FG001|Overall Study|Withdrawal by Subject|1
4739041|NCT03698331|7691375|FG000|Overall Study|Lost to Follow-up|0
4739042|NCT03698331|7691376|FG001|Overall Study|Lost to Follow-up|2
4739043|NCT03698331|7691375|FG000|Overall Study|Non-compliance with study drug|1
4739044|NCT03698331|7691376|FG001|Overall Study|Non-compliance with study drug|0
4739045|NCT03698591|7691384|FG000|Overall Study|Withdrawal by Subject|2
4739046|NCT03698591|7691385|FG001|Overall Study|Withdrawal by Subject|2
4739047|NCT03698591|7691384|FG000|Overall Study|Failed drug screen|1
4739048|NCT03698591|7691385|FG001|Overall Study|Failed drug screen|1
4739049|NCT03698591|7691384|FG000|Overall Study|Failed health screen|0
4739050|NCT03698591|7691385|FG001|Overall Study|Failed health screen|1
4739051|NCT03698591|7691384|FG000|Overall Study|Ineligible for financial compensation|1
4739052|NCT03698591|7691385|FG001|Overall Study|Ineligible for financial compensation|0
4739053|NCT03698591|7691384|FG000|Overall Study|Equipment Error|1
4739054|NCT03698591|7691385|FG001|Overall Study|Equipment Error|0
4739055|NCT03698591|7691384|FG000|Overall Study|Could not establish TMS dosage|0
4739056|NCT03698591|7691385|FG001|Overall Study|Could not establish TMS dosage|1
4739057|NCT03699124|7691394|FG000|Overall Study|Adverse Event|6
4739058|NCT03699124|7691395|FG001|Overall Study|Adverse Event|5
4739059|NCT03699124|7691396|FG002|Overall Study|Adverse Event|2
4739060|NCT03699124|7691394|FG000|Overall Study|Death|0
4739061|NCT03699124|7691395|FG001|Overall Study|Death|2
4739062|NCT03699124|7691396|FG002|Overall Study|Death|0
4739063|NCT03699124|7691394|FG000|Overall Study|Lost to Follow-up|20
4739064|NCT03699124|7691395|FG001|Overall Study|Lost to Follow-up|16
4739065|NCT03699124|7691396|FG002|Overall Study|Lost to Follow-up|15
4739066|NCT03699124|7691394|FG000|Overall Study|Protocol Violation|1
4739067|NCT03699124|7691395|FG001|Overall Study|Protocol Violation|0
4739068|NCT03699124|7691396|FG002|Overall Study|Protocol Violation|0
4739069|NCT03699124|7691394|FG000|Overall Study|Withdrawal by Subject|13
4739070|NCT03699124|7691395|FG001|Overall Study|Withdrawal by Subject|14
4739071|NCT03699124|7691396|FG002|Overall Study|Withdrawal by Subject|13
4739072|NCT03699124|7691394|FG000|Overall Study|Other reasons|5
4524492|NCT01016132|7339986|FG000|Overall Study|Discomfort|1
4524493|NCT01016262|7339993|FG000|Double-blind Phase|Adverse Event|0
4524494|NCT01016262|7339994|FG001|Double-blind Phase|Adverse Event|0
4524495|NCT01016262|7339995|FG002|Double-blind Phase|Adverse Event|1
4524496|NCT01016262|7339996|FG003|Double-blind Phase|Adverse Event|0
4524497|NCT01016262|7339997|FG004|Double-blind Phase|Adverse Event|0
4524498|NCT01016262|7339998|FG005|Double-blind Phase|Adverse Event|0
4524499|NCT01016262|7339993|FG000|Double-blind Phase|Lack of Efficacy|1
4524500|NCT01016262|7339994|FG001|Double-blind Phase|Lack of Efficacy|0
4524501|NCT01016262|7339995|FG002|Double-blind Phase|Lack of Efficacy|5
4524502|NCT01016262|7339996|FG003|Double-blind Phase|Lack of Efficacy|0
4524503|NCT01016262|7339997|FG004|Double-blind Phase|Lack of Efficacy|0
4524504|NCT01016262|7339998|FG005|Double-blind Phase|Lack of Efficacy|0
4524505|NCT01016262|7339993|FG000|Double-blind Phase|Disease Progression|0
4524506|NCT01016262|7339994|FG001|Double-blind Phase|Disease Progression|1
4524507|NCT01016262|7339995|FG002|Double-blind Phase|Disease Progression|2
4524508|NCT01016262|7339996|FG003|Double-blind Phase|Disease Progression|0
4524509|NCT01016262|7339997|FG004|Double-blind Phase|Disease Progression|0
4524510|NCT01016262|7339998|FG005|Double-blind Phase|Disease Progression|0
4524511|NCT01016262|7339993|FG000|Double-blind Phase|Withdrawal of Informed Consent|0
4524512|NCT01016262|7339994|FG001|Double-blind Phase|Withdrawal of Informed Consent|0
4524513|NCT01016262|7339995|FG002|Double-blind Phase|Withdrawal of Informed Consent|1
4524514|NCT01016262|7339996|FG003|Double-blind Phase|Withdrawal of Informed Consent|0
4524515|NCT01016262|7339997|FG004|Double-blind Phase|Withdrawal of Informed Consent|0
4524516|NCT01016262|7339998|FG005|Double-blind Phase|Withdrawal of Informed Consent|0
4524517|NCT01016262|7339993|FG000|Open-Label Phase|Adverse Event|0
4524518|NCT01016262|7339994|FG001|Open-Label Phase|Adverse Event|0
4524519|NCT01016262|7339995|FG002|Open-Label Phase|Adverse Event|0
4524520|NCT01016262|7339996|FG003|Open-Label Phase|Adverse Event|1
4524521|NCT01016262|7339997|FG004|Open-Label Phase|Adverse Event|0
4524522|NCT01016262|7339998|FG005|Open-Label Phase|Adverse Event|0
4524523|NCT01016262|7339993|FG000|Open-Label Phase|Lost to Follow-up|0
4524524|NCT01016262|7339994|FG001|Open-Label Phase|Lost to Follow-up|0
4524525|NCT01016262|7339995|FG002|Open-Label Phase|Lost to Follow-up|0
4524526|NCT01016262|7339996|FG003|Open-Label Phase|Lost to Follow-up|0
4524527|NCT01016262|7339997|FG004|Open-Label Phase|Lost to Follow-up|1
4524528|NCT01016262|7339998|FG005|Open-Label Phase|Lost to Follow-up|0
4524529|NCT01016262|7339993|FG000|Open-Label Phase|Lack of Efficacy|0
4524530|NCT01016262|7339994|FG001|Open-Label Phase|Lack of Efficacy|0
4524531|NCT01016262|7339995|FG002|Open-Label Phase|Lack of Efficacy|0
4524532|NCT01016262|7339996|FG003|Open-Label Phase|Lack of Efficacy|1
4524533|NCT01016262|7339997|FG004|Open-Label Phase|Lack of Efficacy|0
4524534|NCT01016262|7339998|FG005|Open-Label Phase|Lack of Efficacy|0
4524535|NCT01016262|7339993|FG000|Open-Label Phase|Withdrawal of Informed Consent|0
4524536|NCT01016262|7339994|FG001|Open-Label Phase|Withdrawal of Informed Consent|0
4739073|NCT03699124|7691395|FG001|Overall Study|Other reasons|3
4739074|NCT03699124|7691396|FG002|Overall Study|Other reasons|10
4739075|NCT03700320|7691406|FG000|Overall Study|Adverse Event|5
4739076|NCT03700320|7691407|FG001|Overall Study|Adverse Event|31
4739077|NCT03700320|7691406|FG000|Overall Study|Lack of Efficacy|2
4739078|NCT03700320|7691407|FG001|Overall Study|Lack of Efficacy|5
4739079|NCT03700320|7691406|FG000|Overall Study|Withdrawal by Subject|29
4739080|NCT03700320|7691407|FG001|Overall Study|Withdrawal by Subject|75
4739081|NCT03700320|7691406|FG000|Overall Study|Lost to Follow-up|16
4739082|NCT03700320|7691407|FG001|Overall Study|Lost to Follow-up|23
4739083|NCT03700320|7691406|FG000|Overall Study|Pregnancy|2
4739084|NCT03700320|7691407|FG001|Overall Study|Pregnancy|4
4739085|NCT03700320|7691406|FG000|Overall Study|Protocol Deviation|7
4739086|NCT03700320|7691407|FG001|Overall Study|Protocol Deviation|31
4739087|NCT03700320|7691406|FG000|Overall Study|Non-compliance with Study Drug|1
4739088|NCT03700320|7691407|FG001|Overall Study|Non-compliance with Study Drug|3
4739089|NCT03700320|7691406|FG000|Overall Study|Reason not Specified|0
4739090|NCT03700320|7691407|FG001|Overall Study|Reason not Specified|1
4739091|NCT03700385|7691417|FG000|Overall Study|Lost to Follow-up|1
4739092|NCT03700671|7691423|FG000|Overall Study|Lack of Efficacy|1
4739093|NCT03700671|7691424|FG001|Overall Study|Lack of Efficacy|2
4739094|NCT03700736|7691434|FG000|Overall Study|Pregnancy|1
4739095|NCT03700736|7691435|FG001|Overall Study|Pregnancy|1
4739096|NCT03700736|7691434|FG000|Overall Study|Withdrawal by Subject|2
4739097|NCT03700736|7691435|FG001|Overall Study|Withdrawal by Subject|6
4739098|NCT03700892|7691446|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0
4739099|NCT03700892|7691447|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1
4739100|NCT03700892|7691448|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0
4739101|NCT03701074|7691468|FG000|Overall Study|Physician Decision|1
4739102|NCT03701074|7691469|FG001|Overall Study|Physician Decision|0
4739103|NCT03702010|7691477|FG000|Follow-up (30days)|Lack of Efficacy|2
4739104|NCT03702010|7691478|FG001|Follow-up (30days)|Lack of Efficacy|2
4739105|NCT03702166|7691490|FG000|Overall Study|Lost to Follow-up|1
4739106|NCT03702166|7691490|FG000|Overall Study|Withdrawal by Subject|1
4739107|NCT03703336|7691501|FG000|Overall Study|Parent withdrew consent|29
4739108|NCT03703336|7691502|FG001|Overall Study|Parent withdrew consent|8
4739109|NCT03703336|7691501|FG000|Overall Study|Migration|3
4739110|NCT03703336|7691502|FG001|Overall Study|Migration|3
4739111|NCT03703336|7691501|FG000|Overall Study|Protocol Violation|3
4739112|NCT03703336|7691502|FG001|Overall Study|Protocol Violation|1
4739113|NCT03703336|7691501|FG000|Overall Study|Physician Decision|2
4524537|NCT01016262|7339995|FG002|Open-Label Phase|Withdrawal of Informed Consent|0
4524538|NCT01016262|7339996|FG003|Open-Label Phase|Withdrawal of Informed Consent|0
4524539|NCT01016262|7339997|FG004|Open-Label Phase|Withdrawal of Informed Consent|1
4524540|NCT01016262|7339998|FG005|Open-Label Phase|Withdrawal of Informed Consent|0
4524541|NCT01016600|7340067|FG000|Overall Study|Did not start treatment|1
4524542|NCT01016600|7340068|FG001|Overall Study|Did not start treatment|0
4524543|NCT01016600|7340069|FG002|Overall Study|Did not start treatment|0
4524544|NCT01016600|7340070|FG003|Overall Study|Did not start treatment|0
4524545|NCT01016912|7340165|FG000|End of Treatment Period|Lack of Efficacy|0
4524546|NCT01016912|7340166|FG001|End of Treatment Period|Lack of Efficacy|1
4739114|NCT03703336|7691502|FG001|Overall Study|Physician Decision|0
4739115|NCT03703336|7691501|FG000|Overall Study|Adverse Event|0
4739116|NCT03703336|7691502|FG001|Overall Study|Adverse Event|2
4739117|NCT03703336|7691501|FG000|Overall Study|Lost to Follow-up|1
4739118|NCT03703336|7691502|FG001|Overall Study|Lost to Follow-up|0
4739119|NCT03703466|7691511|FG000|Overall Study|Death|2
4739120|NCT03703466|7691512|FG001|Overall Study|Death|1
4739121|NCT03703466|7691513|FG002|Overall Study|Death|0
4739122|NCT03703466|7691511|FG000|Overall Study|Protocol Violation|1
4739123|NCT03703466|7691512|FG001|Overall Study|Protocol Violation|0
4739124|NCT03703466|7691513|FG002|Overall Study|Protocol Violation|0
4739125|NCT03703466|7691511|FG000|Overall Study|Withdrawal by Subject|0
4739126|NCT03703466|7691512|FG001|Overall Study|Withdrawal by Subject|3
4739127|NCT03703466|7691513|FG002|Overall Study|Withdrawal by Subject|0
4739128|NCT03703466|7691511|FG000|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|1
4739129|NCT03703466|7691512|FG001|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|2
4739130|NCT03703466|7691513|FG002|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|2
4739131|NCT03703817|7691524|FG000|Overall Study|Not meeting eligibility criteria|7
4739132|NCT03703817|7691525|FG001|Overall Study|Not meeting eligibility criteria|4
4739133|NCT03704194|7691533|FG000|Overall Study|Withdrawal by Subject|0
4739134|NCT03704194|7691534|FG001|Overall Study|Withdrawal by Subject|1
4739135|NCT03705494|7691573|FG000|Overall Study|Lost to Follow-up|2
4739136|NCT03705494|7691574|FG001|Overall Study|Lost to Follow-up|1
4739137|NCT03705494|7691573|FG000|Overall Study|Withdrawal by Subject|5
4739138|NCT03705494|7691574|FG001|Overall Study|Withdrawal by Subject|2
4739139|NCT03705793|7691582|FG000|Overall Study|Lost to Follow-up|3
4739140|NCT03705793|7691583|FG001|Overall Study|Lost to Follow-up|4
4739141|NCT03705793|7691582|FG000|Overall Study|Withdrawal by Subject|2
4524547|NCT01016912|7340167|FG002|End of Treatment Period|Lack of Efficacy|0
4524548|NCT01016912|7340168|FG003|End of Treatment Period|Lack of Efficacy|4
4524549|NCT01016912|7340169|FG004|End of Treatment Period|Lack of Efficacy|4
4524550|NCT01016912|7340165|FG000|End of Treatment Period|Adverse Event|0
4524551|NCT01016912|7340166|FG001|End of Treatment Period|Adverse Event|1
4524552|NCT01016912|7340167|FG002|End of Treatment Period|Adverse Event|1
4524553|NCT01016912|7340168|FG003|End of Treatment Period|Adverse Event|0
4524554|NCT01016912|7340169|FG004|End of Treatment Period|Adverse Event|0
4524555|NCT01016912|7340165|FG000|End of Treatment Period|Completed double-blind period only|0
4524556|NCT01016912|7340166|FG001|End of Treatment Period|Completed double-blind period only|1
4524557|NCT01016912|7340167|FG002|End of Treatment Period|Completed double-blind period only|0
4524558|NCT01016912|7340168|FG003|End of Treatment Period|Completed double-blind period only|0
4524559|NCT01016912|7340169|FG004|End of Treatment Period|Completed double-blind period only|0
4524560|NCT01016912|7340165|FG000|Follow-up Period|Other reason|0
4524561|NCT01016912|7340166|FG001|Follow-up Period|Other reason|0
4524562|NCT01016912|7340167|FG002|Follow-up Period|Other reason|1
4524563|NCT01016912|7340168|FG003|Follow-up Period|Other reason|1
4524564|NCT01016912|7340169|FG004|Follow-up Period|Other reason|0
4524565|NCT01016964|7340208|FG000|Overall Study|Lost to Follow-up|3
4524566|NCT01016964|7340209|FG001|Overall Study|Lost to Follow-up|3
4524567|NCT01016977|7340217|FG000|Overall Study|Lost to Follow-up|1
4524568|NCT01016977|7340218|FG001|Overall Study|Lost to Follow-up|0
4524569|NCT01016977|7340217|FG000|Overall Study|Withdrawal by Subject|2
4524570|NCT01016977|7340218|FG001|Overall Study|Withdrawal by Subject|2
4524571|NCT01017029|7340235|FG000|Overall Study|Lost to Follow-up|1
4524572|NCT01017029|7340236|FG001|Overall Study|Lost to Follow-up|0
4524573|NCT01017029|7340235|FG000|Overall Study|Administrative problem|0
4524574|NCT01017029|7340236|FG001|Overall Study|Administrative problem|1
4524575|NCT01017029|7340235|FG000|Overall Study|Death|3
4524576|NCT01017029|7340236|FG001|Overall Study|Death|1
4594278|NCT01561313|7443469|FG001|Overall Study|Withdrawal by Subject|0
4739142|NCT03705793|7691583|FG001|Overall Study|Withdrawal by Subject|1
4739143|NCT03706040|7691592|FG000|Period A (Week 0 to Week 16)|Adverse Event|3
4739144|NCT03706040|7691593|FG001|Period A (Week 0 to Week 16)|Adverse Event|2
4739145|NCT03706040|7691594|FG002|Period A (Week 0 to Week 16)|Adverse Event|1
4739146|NCT03706040|7691595|FG003|Period A (Week 0 to Week 16)|Adverse Event|0
4739147|NCT03706040|7691596|FG004|Period A (Week 0 to Week 16)|Adverse Event|0
4739148|NCT03706040|7691597|FG005|Period A (Week 0 to Week 16)|Adverse Event|0
4739149|NCT03706040|7691598|FG006|Period A (Week 0 to Week 16)|Adverse Event|0
4739150|NCT03706040|7691592|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3
4739151|NCT03706040|7691593|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5
4739152|NCT03706040|7691594|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4
4739153|NCT03706040|7691595|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0
4739154|NCT03706040|7691596|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0
4739155|NCT03706040|7691597|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0
4739156|NCT03706040|7691598|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0
4739157|NCT03706040|7691592|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1
4739158|NCT03706040|7691593|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1
4739159|NCT03706040|7691594|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4
4739160|NCT03706040|7691595|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0
4739161|NCT03706040|7691596|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0
4739162|NCT03706040|7691597|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0
4739163|NCT03706040|7691598|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0
4739164|NCT03706040|7691592|FG000|Period A (Week 0 to Week 16)|Other|2
4739165|NCT03706040|7691593|FG001|Period A (Week 0 to Week 16)|Other|0
4739166|NCT03706040|7691594|FG002|Period A (Week 0 to Week 16)|Other|2
4739167|NCT03706040|7691595|FG003|Period A (Week 0 to Week 16)|Other|0
4739168|NCT03706040|7691596|FG004|Period A (Week 0 to Week 16)|Other|0
4739169|NCT03706040|7691597|FG005|Period A (Week 0 to Week 16)|Other|0
4739170|NCT03706040|7691598|FG006|Period A (Week 0 to Week 16)|Other|0
4739171|NCT03706040|7691592|FG000|Period B (Week 16 to Week 52)|Adverse Event|0
4739172|NCT03706040|7691593|FG001|Period B (Week 16 to Week 52)|Adverse Event|0
4739173|NCT03706040|7691594|FG002|Period B (Week 16 to Week 52)|Adverse Event|0
4739174|NCT03706040|7691595|FG003|Period B (Week 16 to Week 52)|Adverse Event|1
4739175|NCT03706040|7691596|FG004|Period B (Week 16 to Week 52)|Adverse Event|2
4739176|NCT03706040|7691597|FG005|Period B (Week 16 to Week 52)|Adverse Event|3
4739177|NCT03706040|7691598|FG006|Period B (Week 16 to Week 52)|Adverse Event|0
4739178|NCT03706040|7691592|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0
4739179|NCT03706040|7691593|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0
4739180|NCT03706040|7691594|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0
4739181|NCT03706040|7691595|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3
4739182|NCT03706040|7691596|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2
4739183|NCT03706040|7691597|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1
4739184|NCT03706040|7691598|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10
4739185|NCT03706040|7691592|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0
4739186|NCT03706040|7691593|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0
4739187|NCT03706040|7691594|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0
4739188|NCT03706040|7691595|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0
4739189|NCT03706040|7691596|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0
4739190|NCT03706040|7691597|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1
4739191|NCT03706040|7691598|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1
4739192|NCT03706040|7691592|FG000|Period B (Week 16 to Week 52)|Other|0
4739193|NCT03706040|7691593|FG001|Period B (Week 16 to Week 52)|Other|0
4739194|NCT03706040|7691594|FG002|Period B (Week 16 to Week 52)|Other|0
4739195|NCT03706040|7691595|FG003|Period B (Week 16 to Week 52)|Other|4
4739196|NCT03706040|7691596|FG004|Period B (Week 16 to Week 52)|Other|5
4739197|NCT03706040|7691597|FG005|Period B (Week 16 to Week 52)|Other|23
4739198|NCT03706040|7691598|FG006|Period B (Week 16 to Week 52)|Other|17
4739199|NCT03706456|7691623|FG000|Overall Study|Lack of Efficacy|1
4739200|NCT03706456|7691623|FG000|Overall Study|Ongoing|21
4739201|NCT03707522|7691675|FG000|Overall Study|Lost to Follow-up|24
4739202|NCT03707522|7691676|FG001|Overall Study|Lost to Follow-up|27
4739203|NCT03707522|7691677|FG002|Overall Study|Lost to Follow-up|41
4739204|NCT03707522|7691678|FG003|Overall Study|Lost to Follow-up|36
4739205|NCT03707587|7691690|FG000|Overall Study|Death|0
4739206|NCT03707587|7691691|FG001|Overall Study|Death|1
4739207|NCT03707821|7691699|FG000|Overall Study|Protocol Violation|0
4739208|NCT03707821|7691700|FG001|Overall Study|Protocol Violation|1
4739209|NCT03707821|7691699|FG000|Overall Study|Unsatisfactory Visual Response|1
4739210|NCT03707821|7691700|FG001|Overall Study|Unsatisfactory Visual Response|0
4739211|NCT03707821|7691699|FG000|Overall Study|Unsatisfactory Lens Fitting|1
4739212|NCT03707821|7691700|FG001|Overall Study|Unsatisfactory Lens Fitting|0
4739213|NCT03707912|7691708|FG000|Overall Study|Violation of inclusion criteria|1
4739214|NCT03707912|7691709|FG001|Overall Study|Violation of inclusion criteria|0
4739215|NCT03708211|7691717|FG000|Overall Study|Progressive Disease|10
4739216|NCT03708211|7691718|FG001|Overall Study|Progressive Disease|7
4739217|NCT03708211|7691717|FG000|Overall Study|Withdrawal by Subject|0
4739218|NCT03708211|7691718|FG001|Overall Study|Withdrawal by Subject|1
4739219|NCT03708211|7691717|FG000|Overall Study|Other|2
4739220|NCT03708211|7691718|FG001|Overall Study|Other|0
4739221|NCT03708744|7691749|FG000|Overall Study|Withdrawal by Subject|0
4739222|NCT03708744|7691750|FG001|Overall Study|Withdrawal by Subject|0
4739223|NCT03708744|7691751|FG002|Overall Study|Withdrawal by Subject|1
4739224|NCT03708744|7691752|FG003|Overall Study|Withdrawal by Subject|0
4739225|NCT03709654|7691779|FG000|Overall Study|Lost to Follow-up|1
4739226|NCT03709654|7691780|FG001|Overall Study|Lost to Follow-up|1
4739227|NCT03709654|7691779|FG000|Overall Study|Withdrawal by Subject|1
4739228|NCT03709654|7691780|FG001|Overall Study|Withdrawal by Subject|1
4739229|NCT03709654|7691779|FG000|Overall Study|Adverse Event|1
4739230|NCT03709654|7691780|FG001|Overall Study|Adverse Event|0
4739231|NCT03709823|7691799|FG000|Overall Study|Adverse Event|0
4739232|NCT03709823|7691800|FG001|Overall Study|Adverse Event|0
4739233|NCT03709823|7691801|FG002|Overall Study|Adverse Event|1
4739234|NCT03709823|7691802|FG003|Overall Study|Adverse Event|0
4739235|NCT03709823|7691803|FG004|Overall Study|Adverse Event|0
4739236|NCT03709823|7691804|FG005|Overall Study|Adverse Event|0
4739237|NCT03709823|7691799|FG000|Overall Study|Lost to Follow-up|2
4739238|NCT03709823|7691800|FG001|Overall Study|Lost to Follow-up|2
4739239|NCT03709823|7691801|FG002|Overall Study|Lost to Follow-up|2
4739240|NCT03709823|7691802|FG003|Overall Study|Lost to Follow-up|1
4739241|NCT03709823|7691803|FG004|Overall Study|Lost to Follow-up|1
4739242|NCT03709823|7691804|FG005|Overall Study|Lost to Follow-up|0
4739243|NCT03709823|7691799|FG000|Overall Study|Withdrawal by Subject|1
4739244|NCT03709823|7691800|FG001|Overall Study|Withdrawal by Subject|3
4739245|NCT03709823|7691801|FG002|Overall Study|Withdrawal by Subject|0
4739246|NCT03709823|7691802|FG003|Overall Study|Withdrawal by Subject|0
4739247|NCT03709823|7691803|FG004|Overall Study|Withdrawal by Subject|0
4739248|NCT03709823|7691804|FG005|Overall Study|Withdrawal by Subject|0
4739249|NCT03709823|7691799|FG000|Overall Study|Other, Not Specified|0
4739250|NCT03709823|7691800|FG001|Overall Study|Other, Not Specified|0
4739251|NCT03709823|7691801|FG002|Overall Study|Other, Not Specified|0
4739252|NCT03709823|7691802|FG003|Overall Study|Other, Not Specified|1
4524577|NCT01017120|7340253|FG000|Overall Study|Adverse Event|9
4524578|NCT01017120|7340254|FG001|Overall Study|Adverse Event|0
4524579|NCT01017120|7340253|FG000|Overall Study|Lost to Follow-up|13
4524580|NCT01017120|7340254|FG001|Overall Study|Lost to Follow-up|11
4524581|NCT01017120|7340253|FG000|Overall Study|Lack of Efficacy|1
4524582|NCT01017120|7340254|FG001|Overall Study|Lack of Efficacy|0
4524583|NCT01017120|7340253|FG000|Overall Study|Withdrawal by Subject|39
4524584|NCT01017120|7340254|FG001|Overall Study|Withdrawal by Subject|21
4524585|NCT01017120|7340253|FG000|Overall Study|Pregnancy|1
4524586|NCT01017120|7340254|FG001|Overall Study|Pregnancy|1
4524587|NCT01017120|7340253|FG000|Overall Study|Did Not Meet Eligibility Criteria|1
4524588|NCT01017120|7340254|FG001|Overall Study|Did Not Meet Eligibility Criteria|0
4524589|NCT01017120|7340253|FG000|Overall Study|Relocated Out of Town|0
4524590|NCT01017120|7340254|FG001|Overall Study|Relocated Out of Town|2
4524591|NCT01017120|7340253|FG000|Overall Study|Protocol Violation|1
4524592|NCT01017120|7340254|FG001|Overall Study|Protocol Violation|0
4524593|NCT01017120|7340253|FG000|Overall Study|Parent Unable to Provide Transportation|1
4524594|NCT01017120|7340254|FG001|Overall Study|Parent Unable to Provide Transportation|0
4524595|NCT01017146|7340262|FG000|Overall Study|Adverse Event|11
4524596|NCT01017146|7340263|FG001|Overall Study|Adverse Event|1
4739253|NCT03709823|7691803|FG004|Overall Study|Other, Not Specified|0
4739254|NCT03709823|7691804|FG005|Overall Study|Other, Not Specified|0
4739255|NCT03710083|7691821|FG000|Overall Study|Withdrawal by Subject|2
4739256|NCT03710083|7691821|FG000|Overall Study|Unsuccessful Procedure|1
4739257|NCT03710161|7691827|FG000|Overall Study|Study halted due to COVID pandemic|3
4739258|NCT03710161|7691828|FG001|Overall Study|Study halted due to COVID pandemic|2
4739259|NCT03710590|7691854|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10
4739260|NCT03710590|7691855|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8
4739261|NCT03710889|7691861|FG000|Overall Study|Adverse Event|2
4739262|NCT03710889|7691861|FG000|Overall Study|Protocol Deviation|1
4739263|NCT03712280|7691890|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0
4739264|NCT03712280|7691891|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1
4739265|NCT03712280|7691892|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0
4739266|NCT03712280|7691893|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1
4739267|NCT03712280|7691890|FG000|Overall Study|Withdrawal by Participant or Caregiver|1
4739268|NCT03712280|7691891|FG001|Overall Study|Withdrawal by Participant or Caregiver|0
4739269|NCT03712280|7691892|FG002|Overall Study|Withdrawal by Participant or Caregiver|0
4739270|NCT03712280|7691893|FG003|Overall Study|Withdrawal by Participant or Caregiver|0
4739271|NCT03712280|7691890|FG000|Overall Study|Adverse Event|0
4739272|NCT03712280|7691891|FG001|Overall Study|Adverse Event|0
4739273|NCT03712280|7691892|FG002|Overall Study|Adverse Event|1
4739274|NCT03712280|7691893|FG003|Overall Study|Adverse Event|0
4739275|NCT03712449|7691905|FG000|Overall Study|Withdraw Consent|0
4739276|NCT03712449|7691906|FG001|Overall Study|Withdraw Consent|1
4739277|NCT03712917|7691928|FG000|Overall Study|Pregnancy|0
4739278|NCT03712917|7691929|FG001|Overall Study|Pregnancy|0
4739279|NCT03712917|7691930|FG002|Overall Study|Pregnancy|1
4739280|NCT03712917|7691928|FG000|Overall Study|Adverse Event|0
4739281|NCT03712917|7691929|FG001|Overall Study|Adverse Event|4
4739282|NCT03712917|7691930|FG002|Overall Study|Adverse Event|3
4524597|NCT01017146|7340262|FG000|Overall Study|Lost to Follow-up|14
4524598|NCT01017146|7340263|FG001|Overall Study|Lost to Follow-up|14
4524599|NCT01017146|7340262|FG000|Overall Study|Noncompliance with Study Product|1
4524600|NCT01017146|7340263|FG001|Overall Study|Noncompliance with Study Product|1
4524601|NCT01017146|7340262|FG000|Overall Study|Withdrawal by Subject|32
4524602|NCT01017146|7340263|FG001|Overall Study|Withdrawal by Subject|16
4524603|NCT01017146|7340262|FG000|Overall Study|Relocation|0
4524604|NCT01017146|7340263|FG001|Overall Study|Relocation|4
4524605|NCT01017146|7340262|FG000|Overall Study|Pregnancy|2
4524606|NCT01017146|7340263|FG001|Overall Study|Pregnancy|1
4524607|NCT01017146|7340262|FG000|Overall Study|Protocol Violation|2
4524608|NCT01017146|7340263|FG001|Overall Study|Protocol Violation|0
4524609|NCT01017146|7340262|FG000|Overall Study|Took Excluded Medication|2
4524610|NCT01017146|7340263|FG001|Overall Study|Took Excluded Medication|0
4524611|NCT01017146|7340262|FG000|Overall Study|Did Not Meet Eligibility Criteria|1
4524612|NCT01017146|7340263|FG001|Overall Study|Did Not Meet Eligibility Criteria|2
4524613|NCT01017146|7340262|FG000|Overall Study|Change in Work Situation|1
4524614|NCT01017146|7340263|FG001|Overall Study|Change in Work Situation|0
4524615|NCT01017549|7340301|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1
4524616|NCT01017549|7340301|FG000|One-year Follow-up|Lost to Follow-up|2
4524617|NCT01017549|7340301|FG000|One-year Follow-up|Withdrawal by Subject|5
4524618|NCT01017549|7340301|FG000|5 Year Follow-up|Lost to Follow-up|9
4524619|NCT01017549|7340301|FG000|5 Year Follow-up|Mastectomy|3
4524620|NCT01017575|7340310|FG000|Overall Study|Lack of Efficacy|0
4524621|NCT01017575|7340311|FG001|Overall Study|Lack of Efficacy|1
4524622|NCT01017575|7340312|FG002|Overall Study|Lack of Efficacy|0
4524623|NCT01017575|7340313|FG003|Overall Study|Lack of Efficacy|1
4524624|NCT01017575|7340314|FG004|Overall Study|Lack of Efficacy|1
4524625|NCT01017575|7340310|FG000|Overall Study|Adverse Event|0
4524626|NCT01017575|7340311|FG001|Overall Study|Adverse Event|1
4524627|NCT01017575|7340312|FG002|Overall Study|Adverse Event|0
4524628|NCT01017575|7340313|FG003|Overall Study|Adverse Event|0
4524629|NCT01017575|7340314|FG004|Overall Study|Adverse Event|2
4524630|NCT01017575|7340310|FG000|Overall Study|Withdrawal by Subject|1
4524631|NCT01017575|7340311|FG001|Overall Study|Withdrawal by Subject|0
4524632|NCT01017575|7340312|FG002|Overall Study|Withdrawal by Subject|0
4524633|NCT01017575|7340313|FG003|Overall Study|Withdrawal by Subject|0
4524634|NCT01017575|7340314|FG004|Overall Study|Withdrawal by Subject|0
4739283|NCT03712917|7691928|FG000|Overall Study|Lost to Follow-up|9
4524635|NCT01017601|7340328|FG000|Overall Study|Disease Progression|12
4524636|NCT01017601|7340329|FG001|Overall Study|Disease Progression|12
4739284|NCT03712917|7691929|FG001|Overall Study|Lost to Follow-up|4
4739285|NCT03712917|7691930|FG002|Overall Study|Lost to Follow-up|5
4739286|NCT03712930|7691938|FG000|Overall Study|Death|7
4739287|NCT03712930|7691938|FG000|Overall Study|Physician Decision|1
4739288|NCT03712930|7691938|FG000|Overall Study|Study Terminated by Sponsor|3
4739289|NCT03712930|7691938|FG000|Overall Study|Progressive Disease|2
4739290|NCT03714022|7691953|FG000|Overall Study|Adverse Event|1
4739291|NCT03714022|7691954|FG001|Overall Study|Adverse Event|0
4739292|NCT03714022|7691953|FG000|Overall Study|Consent withdrawal|0
4739293|NCT03714022|7691954|FG001|Overall Study|Consent withdrawal|1
4739294|NCT03714022|7691953|FG000|Overall Study|Lost to Follow-up|3
4739295|NCT03714022|7691954|FG001|Overall Study|Lost to Follow-up|2
4739296|NCT03714672|7691977|FG000|Overall Study|Adverse Event|0
4739297|NCT03714672|7691978|FG001|Overall Study|Adverse Event|0
4739298|NCT03714672|7691979|FG002|Overall Study|Adverse Event|3
4739299|NCT03714672|7691980|FG003|Overall Study|Adverse Event|0
4739300|NCT03714672|7691977|FG000|Overall Study|Physician Decision|0
4739301|NCT03714672|7691978|FG001|Overall Study|Physician Decision|1
4739302|NCT03714672|7691979|FG002|Overall Study|Physician Decision|0
4739303|NCT03714672|7691980|FG003|Overall Study|Physician Decision|0
4739304|NCT03714672|7691977|FG000|Overall Study|Other Reason|1
4739305|NCT03714672|7691978|FG001|Overall Study|Other Reason|2
4739306|NCT03714672|7691979|FG002|Overall Study|Other Reason|1
4739307|NCT03714672|7691980|FG003|Overall Study|Other Reason|1
4739308|NCT03714672|7691977|FG000|Overall Study|Lost to Follow-up|1
4739309|NCT03714672|7691978|FG001|Overall Study|Lost to Follow-up|1
4739310|NCT03714672|7691979|FG002|Overall Study|Lost to Follow-up|0
4739311|NCT03714672|7691980|FG003|Overall Study|Lost to Follow-up|0
4739312|NCT03715530|7692011|FG000|Overall Study|Lost to Follow-up|3
4739313|NCT03715530|7692012|FG001|Overall Study|Lost to Follow-up|1
4739314|NCT03715530|7692013|FG002|Overall Study|Lost to Follow-up|2
4739315|NCT03716024|7692032|FG000|Overall Study|Randomized, not Treated|7
4739316|NCT03716024|7692033|FG001|Overall Study|Randomized, not Treated|8
4739317|NCT03716024|7692032|FG000|Overall Study|Adverse Event|1
4739318|NCT03716024|7692033|FG001|Overall Study|Adverse Event|2
4739319|NCT03716024|7692032|FG000|Overall Study|Treatment Failure|1
4739320|NCT03716024|7692033|FG001|Overall Study|Treatment Failure|0
4739321|NCT03716024|7692032|FG000|Overall Study|Lost to Follow-up|2
4739322|NCT03716024|7692033|FG001|Overall Study|Lost to Follow-up|6
4739323|NCT03716024|7692032|FG000|Overall Study|Withdrawal by Subject|0
4739324|NCT03716024|7692033|FG001|Overall Study|Withdrawal by Subject|1
4739325|NCT03716024|7692032|FG000|Overall Study|Missing Reason|0
4739326|NCT03716024|7692033|FG001|Overall Study|Missing Reason|1
4633766|NCT01915914|7504081|FG000|Maintenance Phase|Withdrawal by Subject|0
4633767|NCT01915914|7504082|FG001|Maintenance Phase|Withdrawal by Subject|1
4633768|NCT01915914|7504083|FG002|Maintenance Phase|Withdrawal by Subject|1
4633769|NCT01915914|7504084|FG003|Maintenance Phase|Withdrawal by Subject|0
4739327|NCT03716050|7692047|FG000|Overall Study|Lost to Follow-up|0
4739328|NCT03716050|7692048|FG001|Overall Study|Lost to Follow-up|0
4739329|NCT03716050|7692049|FG002|Overall Study|Lost to Follow-up|1
4739330|NCT03716050|7692050|FG003|Overall Study|Lost to Follow-up|0
4739331|NCT03716050|7692051|FG004|Overall Study|Lost to Follow-up|0
4739332|NCT03716050|7692052|FG005|Overall Study|Lost to Follow-up|0
4739333|NCT03716050|7692053|FG006|Overall Study|Lost to Follow-up|0
4739334|NCT03716050|7692054|FG007|Overall Study|Lost to Follow-up|0
4739335|NCT03716050|7692047|FG000|Overall Study|Physician Decision|0
4739336|NCT03716050|7692048|FG001|Overall Study|Physician Decision|0
4739337|NCT03716050|7692049|FG002|Overall Study|Physician Decision|0
4739338|NCT03716050|7692050|FG003|Overall Study|Physician Decision|1
4739339|NCT03716050|7692051|FG004|Overall Study|Physician Decision|0
4739340|NCT03716050|7692052|FG005|Overall Study|Physician Decision|0
4739341|NCT03716050|7692053|FG006|Overall Study|Physician Decision|0
4739342|NCT03716050|7692054|FG007|Overall Study|Physician Decision|0
4739343|NCT03716050|7692047|FG000|Overall Study|Protocol Violation|0
4739344|NCT03716050|7692048|FG001|Overall Study|Protocol Violation|0
4739345|NCT03716050|7692049|FG002|Overall Study|Protocol Violation|0
4739346|NCT03716050|7692050|FG003|Overall Study|Protocol Violation|1
4739347|NCT03716050|7692051|FG004|Overall Study|Protocol Violation|0
4739348|NCT03716050|7692052|FG005|Overall Study|Protocol Violation|0
4739349|NCT03716050|7692053|FG006|Overall Study|Protocol Violation|0
4739350|NCT03716050|7692054|FG007|Overall Study|Protocol Violation|2
4739351|NCT03717012|7692082|FG000|Overall Study|Due to trial termination|1
4739352|NCT03717012|7692083|FG001|Overall Study|Due to trial termination|2
4739353|NCT03717012|7692082|FG000|Overall Study|Protocol Violation|0
4739354|NCT03717012|7692083|FG001|Overall Study|Protocol Violation|2
4739355|NCT03717012|7692082|FG000|Overall Study|Adverse Event|0
4739356|NCT03717012|7692083|FG001|Overall Study|Adverse Event|1
4739357|NCT03717012|7692082|FG000|Overall Study|Lung transplant|0
4739358|NCT03717012|7692083|FG001|Overall Study|Lung transplant|1
4739359|NCT03717064|7692098|FG000|Period 2|Adverse Event|1
4739360|NCT03718000|7692121|FG000|Overall Study|Relocation|2
4739361|NCT03718000|7692122|FG001|Overall Study|Relocation|4
4739362|NCT03718000|7692121|FG000|Overall Study|Pregnancy|0
4739363|NCT03718000|7692122|FG001|Overall Study|Pregnancy|1
4739364|NCT03719586|7692156|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8
4739365|NCT03719586|7692157|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7
4739366|NCT03719586|7692158|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4
4739367|NCT03719586|7692159|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0
4739368|NCT03720470|7692193|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5
4739369|NCT03720470|7692194|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0
4739370|NCT03720470|7692195|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0
4739371|NCT03720470|7692196|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5
4739372|NCT03720470|7692197|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8
4739373|NCT03720470|7692198|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6
4739374|NCT03720470|7692193|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0
4739375|NCT03720470|7692194|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0
4739376|NCT03720470|7692195|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0
4739377|NCT03720470|7692196|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1
4739378|NCT03720470|7692197|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0
4739379|NCT03720470|7692198|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1
4739380|NCT03720470|7692193|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1
4739381|NCT03720470|7692194|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0
4739382|NCT03720470|7692195|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0
4739383|NCT03720470|7692196|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2
4739384|NCT03720470|7692197|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1
4739385|NCT03720470|7692198|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2
4739386|NCT03720470|7692193|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0
4739387|NCT03720470|7692194|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0
4739388|NCT03720470|7692195|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0
4739389|NCT03720470|7692196|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0
4739390|NCT03720470|7692197|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1
4739391|NCT03720470|7692198|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1
4739392|NCT03720470|7692193|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2
4739393|NCT03720470|7692194|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0
4739394|NCT03720470|7692195|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0
4739395|NCT03720470|7692196|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2
4739396|NCT03720470|7692197|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2
4739397|NCT03720470|7692198|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1
4739398|NCT03720470|7692193|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5
4739399|NCT03720470|7692194|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0
4739400|NCT03720470|7692195|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0
4739401|NCT03720470|7692196|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9
4739402|NCT03720470|7692197|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3
4739403|NCT03720470|7692198|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6
4739404|NCT03720470|7692193|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0
4739405|NCT03720470|7692194|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0
4739406|NCT03720470|7692195|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0
4739407|NCT03720470|7692196|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1
4739408|NCT03720470|7692197|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1
4739409|NCT03720470|7692198|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0
4739410|NCT03720470|7692193|FG000|Treatment Period: First Part 16 Weeks|Other|1
4739411|NCT03720470|7692194|FG001|Treatment Period: First Part 16 Weeks|Other|0
4739412|NCT03720470|7692195|FG002|Treatment Period: First Part 16 Weeks|Other|0
4739413|NCT03720470|7692196|FG003|Treatment Period: First Part 16 Weeks|Other|1
4739414|NCT03720470|7692197|FG004|Treatment Period: First Part 16 Weeks|Other|2
4739415|NCT03720470|7692198|FG005|Treatment Period: First Part 16 Weeks|Other|2
4739416|NCT03720470|7692193|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0
4739417|NCT03720470|7692194|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0
4739418|NCT03720470|7692195|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0
4739419|NCT03720470|7692196|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0
4739420|NCT03720470|7692197|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0
4739421|NCT03720470|7692198|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1
4739422|NCT03720470|7692193|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0
4739423|NCT03720470|7692194|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0
4739424|NCT03720470|7692195|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0
4739425|NCT03720470|7692196|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2
4739426|NCT03720470|7692197|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1
4739427|NCT03720470|7692198|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1
4739428|NCT03720470|7692193|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0
4739429|NCT03720470|7692194|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0
4739430|NCT03720470|7692195|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1
4739431|NCT03720470|7692196|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0
4739432|NCT03720470|7692197|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0
4739433|NCT03720470|7692198|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0
4739434|NCT03720470|7692193|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0
4739435|NCT03720470|7692194|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0
4739436|NCT03720470|7692195|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0
4739437|NCT03720470|7692196|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1
4739438|NCT03720470|7692197|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0
4739439|NCT03720470|7692198|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1
4739440|NCT03720470|7692193|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0
4739441|NCT03720470|7692194|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0
4739442|NCT03720470|7692195|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0
4739443|NCT03720470|7692196|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0
4739444|NCT03720470|7692197|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0
4739445|NCT03720470|7692198|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1
4739446|NCT03720470|7692193|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0
4739447|NCT03720470|7692194|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0
4739448|NCT03720470|7692195|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1
4739449|NCT03720470|7692196|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0
4739450|NCT03720470|7692197|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0
4739451|NCT03720470|7692198|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0
4739452|NCT03720470|7692193|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0
4739453|NCT03720470|7692194|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1
4739454|NCT03720470|7692195|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0
4633770|NCT01915914|7504081|FG000|Maintenance Phase|Lost to Follow-up|0
4739455|NCT03720470|7692196|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2
4739456|NCT03720470|7692197|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2
4739457|NCT03720470|7692198|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2
4739458|NCT03720470|7692193|FG000|Treatment Period: Final 4 Weeks|Other|0
4739459|NCT03720470|7692194|FG001|Treatment Period: Final 4 Weeks|Other|1
4739460|NCT03720470|7692195|FG002|Treatment Period: Final 4 Weeks|Other|0
4633771|NCT01915914|7504082|FG001|Maintenance Phase|Lost to Follow-up|4
4633772|NCT01915914|7504083|FG002|Maintenance Phase|Lost to Follow-up|1
4633773|NCT01915914|7504084|FG003|Maintenance Phase|Lost to Follow-up|0
4633774|NCT01915914|7504081|FG000|Maintenance Phase|Missing|0
4633775|NCT01915914|7504082|FG001|Maintenance Phase|Missing|1
4633776|NCT01915914|7504083|FG002|Maintenance Phase|Missing|0
4633777|NCT01915914|7504084|FG003|Maintenance Phase|Missing|0
4633778|NCT01915914|7504081|FG000|Follow-up Phase|Withdrawal by Subject|0
4633779|NCT01915914|7504082|FG001|Follow-up Phase|Withdrawal by Subject|0
4633780|NCT01915914|7504083|FG002|Follow-up Phase|Withdrawal by Subject|0
4633781|NCT01915914|7504084|FG003|Follow-up Phase|Withdrawal by Subject|1
4633782|NCT01915914|7504081|FG000|Follow-up Phase|Physician Decision|0
4739461|NCT03720470|7692196|FG003|Treatment Period: Final 4 Weeks|Other|2
4739462|NCT03720470|7692197|FG004|Treatment Period: Final 4 Weeks|Other|1
4739463|NCT03720470|7692198|FG005|Treatment Period: Final 4 Weeks|Other|0
4739464|NCT03720652|7692220|FG000|Overall Study|Withdrawal by Subject|2
4739465|NCT03720652|7692221|FG001|Overall Study|Withdrawal by Subject|7
4739466|NCT03720652|7692220|FG000|Overall Study|Lost to Follow-up|0
4739467|NCT03720652|7692221|FG001|Overall Study|Lost to Follow-up|4
4739468|NCT03720847|7692229|FG000|Washout|Physician Decision|1
4739469|NCT03720847|7692230|FG001|Washout|Physician Decision|2
4739470|NCT03721172|7692259|FG000|Placebo-controlled Phase|Adverse Event|7
4739471|NCT03721172|7692260|FG001|Placebo-controlled Phase|Adverse Event|7
4739472|NCT03721172|7692261|FG002|Placebo-controlled Phase|Adverse Event|0
4739473|NCT03721172|7692259|FG000|Placebo-controlled Phase|Lack of Efficacy|4
4739474|NCT03721172|7692260|FG001|Placebo-controlled Phase|Lack of Efficacy|0
4739475|NCT03721172|7692261|FG002|Placebo-controlled Phase|Lack of Efficacy|0
4739476|NCT03721172|7692259|FG000|Placebo-controlled Phase|Non-compliance with study drug|0
4739477|NCT03721172|7692260|FG001|Placebo-controlled Phase|Non-compliance with study drug|1
4739478|NCT03721172|7692261|FG002|Placebo-controlled Phase|Non-compliance with study drug|0
4739479|NCT03721172|7692259|FG000|Placebo-controlled Phase|Lost to Follow-up|15
4739480|NCT03721172|7692260|FG001|Placebo-controlled Phase|Lost to Follow-up|13
4739481|NCT03721172|7692261|FG002|Placebo-controlled Phase|Lost to Follow-up|0
4739482|NCT03721172|7692259|FG000|Placebo-controlled Phase|Withdrawal by Subject|23
4739483|NCT03721172|7692260|FG001|Placebo-controlled Phase|Withdrawal by Subject|18
4739484|NCT03721172|7692261|FG002|Placebo-controlled Phase|Withdrawal by Subject|0
4739485|NCT03721172|7692259|FG000|Placebo-controlled Phase|Other|3
4739486|NCT03721172|7692260|FG001|Placebo-controlled Phase|Other|0
4739487|NCT03721172|7692261|FG002|Placebo-controlled Phase|Other|0
4739488|NCT03721172|7692259|FG000|Apremilast Extension Phase|Adverse Event|0
4739489|NCT03721172|7692260|FG001|Apremilast Extension Phase|Adverse Event|0
4739490|NCT03721172|7692261|FG002|Apremilast Extension Phase|Adverse Event|10
4739491|NCT03721172|7692259|FG000|Apremilast Extension Phase|Lack of Efficacy|0
4739492|NCT03721172|7692260|FG001|Apremilast Extension Phase|Lack of Efficacy|0
4739493|NCT03721172|7692261|FG002|Apremilast Extension Phase|Lack of Efficacy|2
4739494|NCT03721172|7692259|FG000|Apremilast Extension Phase|Non-compliance with study drug|0
4739495|NCT03721172|7692260|FG001|Apremilast Extension Phase|Non-compliance with study drug|0
4739496|NCT03721172|7692261|FG002|Apremilast Extension Phase|Non-compliance with study drug|1
4739497|NCT03721172|7692259|FG000|Apremilast Extension Phase|Lost to Follow-up|0
4739498|NCT03721172|7692260|FG001|Apremilast Extension Phase|Lost to Follow-up|0
4739499|NCT03721172|7692261|FG002|Apremilast Extension Phase|Lost to Follow-up|20
4739500|NCT03721172|7692259|FG000|Apremilast Extension Phase|Protocol Violation|0
4739501|NCT03721172|7692260|FG001|Apremilast Extension Phase|Protocol Violation|0
4739502|NCT03721172|7692261|FG002|Apremilast Extension Phase|Protocol Violation|1
4739503|NCT03721172|7692259|FG000|Apremilast Extension Phase|Physician Decision|0
4739504|NCT03721172|7692260|FG001|Apremilast Extension Phase|Physician Decision|0
4739505|NCT03721172|7692261|FG002|Apremilast Extension Phase|Physician Decision|1
4739506|NCT03721172|7692259|FG000|Apremilast Extension Phase|Withdrawal by Subject|0
4739507|NCT03721172|7692260|FG001|Apremilast Extension Phase|Withdrawal by Subject|0
4739508|NCT03721172|7692261|FG002|Apremilast Extension Phase|Withdrawal by Subject|21
4739509|NCT03721172|7692259|FG000|Apremilast Extension Phase|Other|0
4739510|NCT03721172|7692260|FG001|Apremilast Extension Phase|Other|0
4739511|NCT03721172|7692261|FG002|Apremilast Extension Phase|Other|3
4739512|NCT03721172|7692259|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0
4739513|NCT03721172|7692260|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0
4739514|NCT03721172|7692261|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7
4739515|NCT03722030|7692280|FG000|Overall Study|Withdrawal by Subject|1
4739516|NCT03722030|7692281|FG001|Overall Study|Withdrawal by Subject|0
4739517|NCT03722238|7692290|FG000|Overall Study|Protocol Violation|1
4739518|NCT03722238|7692291|FG001|Overall Study|Protocol Violation|0
4739519|NCT03722238|7692290|FG000|Overall Study|Physician Decision|1
4739520|NCT03722238|7692291|FG001|Overall Study|Physician Decision|0
4739521|NCT03722238|7692290|FG000|Overall Study|Death|1
4739522|NCT03722238|7692291|FG001|Overall Study|Death|0
4739523|NCT03722238|7692290|FG000|Overall Study|Lost to Follow-up|6
4739524|NCT03722238|7692291|FG001|Overall Study|Lost to Follow-up|0
4739525|NCT03722238|7692290|FG000|Overall Study|Partial missing data|44
4739526|NCT03722238|7692291|FG001|Overall Study|Partial missing data|1
4739527|NCT03722238|7692290|FG000|Overall Study|Withdrawal by Subject|2
4739528|NCT03722238|7692291|FG001|Overall Study|Withdrawal by Subject|0
4739529|NCT03722238|7692290|FG000|Overall Study|Other|4
4739530|NCT03722238|7692291|FG001|Overall Study|Other|0
4739531|NCT03722238|7692290|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2
4633783|NCT01915914|7504082|FG001|Follow-up Phase|Physician Decision|0
4739532|NCT03722238|7692291|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0
4739533|NCT03722238|7692290|FG000|Overall Study|Did not meet risk classification group criteria|90
4739534|NCT03722238|7692291|FG001|Overall Study|Did not meet risk classification group criteria|0
4739535|NCT03722238|7692290|FG000|Overall Study|Did not sign consent|17
4739536|NCT03722238|7692291|FG001|Overall Study|Did not sign consent|0
4739537|NCT03722238|7692290|FG000|Overall Study|Other eligibility criteria not met pre-consent|22
4739538|NCT03722238|7692291|FG001|Overall Study|Other eligibility criteria not met pre-consent|0
4739539|NCT03722238|7692290|FG000|Overall Study|Not willing to purchase study medication|142
4739540|NCT03722238|7692291|FG001|Overall Study|Not willing to purchase study medication|0
4739541|NCT03722238|7692290|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133
4739542|NCT03722238|7692291|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0
4739543|NCT03722264|7692297|FG000|Overall Study|Physician Decision|3
4739544|NCT03722446|7692305|FG000|Overall Study|Protocol Violation|15
4739545|NCT03722446|7692306|FG001|Overall Study|Protocol Violation|2
4739546|NCT03722524|7692312|FG000|Overall Study|Protocol Violation|86
4739547|NCT03722524|7692312|FG000|Overall Study|Adverse Event|7
4739548|NCT03722524|7692312|FG000|Overall Study|Lost to Follow-up|1
4739549|NCT03722524|7692312|FG000|Overall Study|Reason is not stated|1
4739550|NCT03722524|7692312|FG000|Overall Study|Physician Decision|1
4739551|NCT03722524|7692312|FG000|Overall Study|Patient's decision (refusal to continue participation)|3
4739552|NCT03722576|7692316|FG000|Overall Study|Withdrawal by Subject|3
4739553|NCT03722576|7692316|FG000|Overall Study|Adverse Event|2
4739554|NCT03722576|7692316|FG000|Overall Study|Physician Decision|1
4739555|NCT03722576|7692316|FG000|Overall Study|Lost to Follow-up|1
4739556|NCT03722784|7692322|FG000|Overall Study|Withdrawal by Subject|1
4739557|NCT03722784|7692323|FG001|Overall Study|Withdrawal by Subject|0
4739558|NCT03722784|7692322|FG000|Overall Study|Physician Decision|1
4739559|NCT03722784|7692323|FG001|Overall Study|Physician Decision|1
4739560|NCT03722784|7692322|FG000|Overall Study|Protocol Violation|0
4633784|NCT01915914|7504083|FG002|Follow-up Phase|Physician Decision|0
4739561|NCT03722784|7692323|FG001|Overall Study|Protocol Violation|1
4739562|NCT03723915|7692330|FG000|Screening|Failed to meet screening requirements.|2
4739563|NCT03723915|7692330|FG000|On Treatment|Failed to meet treatment requirements|2
4739564|NCT03724812|7692334|FG000|Overall Study|Missed Visit|1
4739565|NCT03724812|7692334|FG000|Overall Study|Death|2
4739566|NCT03724812|7692334|FG000|Overall Study|Withdrawal by Subject|1
4739567|NCT03725982|7692341|FG000|First Intervention|Withdrawal by Subject|0
4633785|NCT01915914|7504084|FG003|Follow-up Phase|Physician Decision|1
4633786|NCT01915940|7504104|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39
4739568|NCT03725982|7692342|FG001|First Intervention|Withdrawal by Subject|1
4739569|NCT03725982|7692341|FG000|First Intervention|Physician Decision|1
4739570|NCT03725982|7692342|FG001|First Intervention|Physician Decision|1
4739571|NCT03727841|7692356|FG000|Overall Study|Physician Decision|2
4739572|NCT03727841|7692357|FG001|Overall Study|Physician Decision|1
4739573|NCT03736967|7692367|FG000|Overall Study|Withdrawal by Subject|26
4739574|NCT03736967|7692368|FG001|Overall Study|Withdrawal by Subject|25
4739575|NCT03736967|7692369|FG002|Overall Study|Withdrawal by Subject|23
4739576|NCT03736967|7692370|FG003|Overall Study|Withdrawal by Subject|26
4739577|NCT03736967|7692367|FG000|Overall Study|Lost to Follow-up|3
4739578|NCT03736967|7692368|FG001|Overall Study|Lost to Follow-up|2
4739579|NCT03736967|7692369|FG002|Overall Study|Lost to Follow-up|1
4739580|NCT03736967|7692370|FG003|Overall Study|Lost to Follow-up|1
4739581|NCT03736967|7692367|FG000|Overall Study|Physician Decision|1
4739582|NCT03736967|7692368|FG001|Overall Study|Physician Decision|0
4739583|NCT03736967|7692369|FG002|Overall Study|Physician Decision|0
4739584|NCT03736967|7692370|FG003|Overall Study|Physician Decision|1
4739585|NCT03736967|7692367|FG000|Overall Study|Adverse Event|0
4739586|NCT03736967|7692368|FG001|Overall Study|Adverse Event|1
4739587|NCT03736967|7692369|FG002|Overall Study|Adverse Event|0
4739588|NCT03736967|7692370|FG003|Overall Study|Adverse Event|1
4739589|NCT03736967|7692367|FG000|Overall Study|Death|0
4739590|NCT03736967|7692368|FG001|Overall Study|Death|0
4739591|NCT03736967|7692369|FG002|Overall Study|Death|0
4739592|NCT03736967|7692370|FG003|Overall Study|Death|1
4739593|NCT03736967|7692367|FG000|Overall Study|Randomized but never treated|1
4739594|NCT03736967|7692368|FG001|Overall Study|Randomized but never treated|0
4739595|NCT03736967|7692369|FG002|Overall Study|Randomized but never treated|0
4739596|NCT03736967|7692370|FG003|Overall Study|Randomized but never treated|0
4739597|NCT03739840|7692387|FG000|Treatment Period: Wk0-16|Adverse Event|2
4739598|NCT03739840|7692388|FG001|Treatment Period: Wk0-16|Adverse Event|6
4739599|NCT03739840|7692389|FG002|Treatment Period: Wk0-16|Adverse Event|6
4739600|NCT03739840|7692390|FG003|Treatment Period: Wk0-16|Adverse Event|12
4739601|NCT03739840|7692387|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0
4739602|NCT03739840|7692388|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1
4739603|NCT03739840|7692389|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0
4739604|NCT03739840|7692390|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3
4739605|NCT03739840|7692387|FG000|Treatment Period: Wk0-16|Protocol Violation|0
4739606|NCT03739840|7692388|FG001|Treatment Period: Wk0-16|Protocol Violation|0
4739607|NCT03739840|7692389|FG002|Treatment Period: Wk0-16|Protocol Violation|1
4739608|NCT03739840|7692390|FG003|Treatment Period: Wk0-16|Protocol Violation|0
4739609|NCT03739840|7692387|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1
4739610|NCT03739840|7692388|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3
4739611|NCT03739840|7692389|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1
4739612|NCT03739840|7692390|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1
4739613|NCT03739840|7692387|FG000|Treatment Period: Wk0-16|Program Termination|3
4739614|NCT03739840|7692388|FG001|Treatment Period: Wk0-16|Program Termination|0
4739615|NCT03739840|7692389|FG002|Treatment Period: Wk0-16|Program Termination|1
4739616|NCT03739840|7692390|FG003|Treatment Period: Wk0-16|Program Termination|1
4739617|NCT03739840|7692387|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1
4739618|NCT03739840|7692388|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0
4739619|NCT03739840|7692389|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0
4739620|NCT03739840|7692390|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0
4739621|NCT03739840|7692387|FG000|Treatment Period: Wk0-16|Sponsors Decision|3
4739622|NCT03739840|7692388|FG001|Treatment Period: Wk0-16|Sponsors Decision|2
4739623|NCT03739840|7692389|FG002|Treatment Period: Wk0-16|Sponsors Decision|1
4739624|NCT03739840|7692390|FG003|Treatment Period: Wk0-16|Sponsors Decision|3
4739625|NCT03739840|7692387|FG000|Treatment Period: Wk0-16|Promotor Decision|0
4739626|NCT03739840|7692388|FG001|Treatment Period: Wk0-16|Promotor Decision|1
4739627|NCT03739840|7692389|FG002|Treatment Period: Wk0-16|Promotor Decision|0
4739628|NCT03739840|7692390|FG003|Treatment Period: Wk0-16|Promotor Decision|0
4739629|NCT03739840|7692387|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0
4739630|NCT03739840|7692388|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1
4739631|NCT03739840|7692389|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0
4739632|NCT03739840|7692390|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0
4739633|NCT03739840|7692387|FG000|Treatment Period: Wk0-16|Premature Program Termination|0
4739634|NCT03739840|7692388|FG001|Treatment Period: Wk0-16|Premature Program Termination|1
4739635|NCT03739840|7692389|FG002|Treatment Period: Wk0-16|Premature Program Termination|0
4739636|NCT03739840|7692390|FG003|Treatment Period: Wk0-16|Premature Program Termination|0
4739637|NCT03739840|7692387|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0
4739638|NCT03739840|7692388|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1
4739639|NCT03739840|7692389|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0
4739640|NCT03739840|7692390|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0
4739641|NCT03739840|7692387|FG000|Treatment Period: Wk0-16|Study Early Closure|0
4739642|NCT03739840|7692388|FG001|Treatment Period: Wk0-16|Study Early Closure|0
4739643|NCT03739840|7692389|FG002|Treatment Period: Wk0-16|Study Early Closure|1
4739644|NCT03739840|7692390|FG003|Treatment Period: Wk0-16|Study Early Closure|0
4739645|NCT03739840|7692387|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0
4739646|NCT03739840|7692388|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0
4739647|NCT03739840|7692389|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1
4739648|NCT03739840|7692390|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0
4739649|NCT03739840|7692387|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0
4739650|NCT03739840|7692388|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0
4739651|NCT03739840|7692389|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1
4739652|NCT03739840|7692390|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0
4739653|NCT03739840|7692387|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0
4739654|NCT03739840|7692388|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0
4739655|NCT03739840|7692389|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0
4739656|NCT03739840|7692390|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1
4739657|NCT03739840|7692387|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0
4739658|NCT03739840|7692388|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0
4739659|NCT03739840|7692389|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0
4739660|NCT03739840|7692390|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1
4739661|NCT03739840|7692387|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0
4739662|NCT03739840|7692388|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0
4739663|NCT03739840|7692389|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0
4739664|NCT03739840|7692390|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1
4739665|NCT03739840|7692387|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3
4739666|NCT03739840|7692388|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0
4739667|NCT03739840|7692389|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0
4739668|NCT03739840|7692390|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0
4739669|NCT03739840|7692387|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0
4739670|NCT03739840|7692388|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0
4739671|NCT03739840|7692389|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0
4739672|NCT03739840|7692390|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1
4739673|NCT03739840|7692387|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1
4739674|NCT03739840|7692388|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0
4739675|NCT03739840|7692389|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0
4739676|NCT03739840|7692390|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0
4739677|NCT03739840|7692387|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0
4739678|NCT03739840|7692388|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1
4739679|NCT03739840|7692389|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0
4633787|NCT01915940|7504105|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0
4633788|NCT01915940|7504106|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0
4739680|NCT03739840|7692390|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0
4739681|NCT03739840|7692387|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0
4739682|NCT03739840|7692388|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1
4739683|NCT03739840|7692389|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0
4739684|NCT03739840|7692390|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0
4739685|NCT03739840|7692387|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0
4739686|NCT03739840|7692388|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0
4739687|NCT03739840|7692389|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1
4739688|NCT03739840|7692390|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0
4739689|NCT03739840|7692387|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0
4739690|NCT03739840|7692388|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0
4739691|NCT03739840|7692389|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1
4739692|NCT03739840|7692390|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0
4739693|NCT03739840|7692387|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0
4739694|NCT03739840|7692388|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0
4739695|NCT03739840|7692389|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1
4739696|NCT03739840|7692390|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0
4739697|NCT03753763|7692449|FG000|Overall Study|Adverse Event|2
4739698|NCT03753763|7692450|FG001|Overall Study|Adverse Event|0
4739699|NCT03753763|7692449|FG000|Overall Study|Withdrawal by Subject|3
4739700|NCT03753763|7692450|FG001|Overall Study|Withdrawal by Subject|1
4739701|NCT03753763|7692449|FG000|Overall Study|clinical deterioration|1
4739702|NCT03753763|7692450|FG001|Overall Study|clinical deterioration|0
4739703|NCT03756571|7692458|FG000|Overall Study|Lost to Follow-up|1
4739704|NCT03756571|7692459|FG001|Overall Study|Lost to Follow-up|1
4739705|NCT03763877|7692486|FG000|Overall Study|Withdrawal by Subject|3
4739706|NCT03763877|7692487|FG001|Overall Study|Withdrawal by Subject|1
4739707|NCT03763877|7692488|FG002|Overall Study|Withdrawal by Subject|3
4739708|NCT03763877|7692489|FG003|Overall Study|Withdrawal by Subject|4
4739709|NCT03763877|7692486|FG000|Overall Study|Adverse Event|1
4739710|NCT03763877|7692487|FG001|Overall Study|Adverse Event|1
4739711|NCT03763877|7692488|FG002|Overall Study|Adverse Event|3
4739712|NCT03763877|7692489|FG003|Overall Study|Adverse Event|1
4739713|NCT03763877|7692486|FG000|Overall Study|Protocol Violation|1
4739714|NCT03763877|7692487|FG001|Overall Study|Protocol Violation|1
4739715|NCT03763877|7692488|FG002|Overall Study|Protocol Violation|0
4739716|NCT03763877|7692489|FG003|Overall Study|Protocol Violation|0
4739717|NCT03763877|7692486|FG000|Overall Study|Lost to Follow-up|0
4739718|NCT03763877|7692487|FG001|Overall Study|Lost to Follow-up|1
4739719|NCT03763877|7692488|FG002|Overall Study|Lost to Follow-up|1
4739720|NCT03763877|7692489|FG003|Overall Study|Lost to Follow-up|0
4739721|NCT03772587|7692512|FG000|Overall Study|COVID-19|0
4739722|NCT03772587|7692513|FG001|Overall Study|COVID-19|0
4739723|NCT03772587|7692514|FG002|Overall Study|COVID-19|1
4739724|NCT03772587|7692515|FG003|Overall Study|COVID-19|1
4739725|NCT03772587|7692516|FG004|Overall Study|COVID-19|0
4633789|NCT01915940|7504104|FG000|Treatment Period|Decision of Participant|0
4633790|NCT01915940|7504105|FG001|Treatment Period|Decision of Participant|1
4633791|NCT01915940|7504106|FG002|Treatment Period|Decision of Participant|3
4633792|NCT01915940|7504104|FG000|Treatment Period|Adverse Event|0
4633793|NCT01915940|7504105|FG001|Treatment Period|Adverse Event|9
4633794|NCT01915940|7504106|FG002|Treatment Period|Adverse Event|1
4633795|NCT01915940|7504104|FG000|Treatment Period|Other Miscellaneous Reasons|0
4633796|NCT01915940|7504105|FG001|Treatment Period|Other Miscellaneous Reasons|1
4633797|NCT01915940|7504106|FG002|Treatment Period|Other Miscellaneous Reasons|0
4633798|NCT01916109|7504112|FG000|Overall Study|Withdrawal by Subject|1
4633799|NCT01916226|7504120|FG000|Overall Study|Adverse Event|1
4633800|NCT01916226|7504121|FG001|Overall Study|Adverse Event|0
4633801|NCT01916226|7504122|FG002|Overall Study|Adverse Event|1
4739726|NCT03772587|7692512|FG000|Overall Study|Withdrawal by Subject|1
4739727|NCT03772587|7692513|FG001|Overall Study|Withdrawal by Subject|0
4739728|NCT03772587|7692514|FG002|Overall Study|Withdrawal by Subject|0
4739729|NCT03772587|7692515|FG003|Overall Study|Withdrawal by Subject|0
4739730|NCT03772587|7692516|FG004|Overall Study|Withdrawal by Subject|0
4739731|NCT03789292|7692540|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7
4739732|NCT03789292|7692541|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8
4739733|NCT03789292|7692542|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0
4739734|NCT03789292|7692540|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2
4739735|NCT03789292|7692541|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0
4739736|NCT03789292|7692542|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0
4739737|NCT03789292|7692540|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1
4739738|NCT03789292|7692541|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0
4739739|NCT03789292|7692542|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0
4739740|NCT03789292|7692540|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1
4739741|NCT03789292|7692541|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1
4739742|NCT03789292|7692542|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0
4739743|NCT03789292|7692540|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9
4739744|NCT03789292|7692541|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8
4739745|NCT03789292|7692542|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0
4739746|NCT03789292|7692540|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1
4739747|NCT03789292|7692541|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0
4739748|NCT03789292|7692542|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0
4739749|NCT03789292|7692540|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0
4739750|NCT03789292|7692541|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2
4739751|NCT03789292|7692542|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0
4739752|NCT03789292|7692540|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3
4739753|NCT03789292|7692541|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3
4739754|NCT03789292|7692542|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6
4739755|NCT03789292|7692540|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0
4739756|NCT03789292|7692541|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0
4739757|NCT03789292|7692542|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1
4739758|NCT03789292|7692540|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1
4739759|NCT03789292|7692541|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0
4739760|NCT03789292|7692542|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0
4739761|NCT03789292|7692540|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9
4739762|NCT03789292|7692541|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2
4739763|NCT03789292|7692542|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2
4739764|NCT03789292|7692540|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1
4739765|NCT03789292|7692541|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0
4739766|NCT03789292|7692542|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0
4739767|NCT03789292|7692540|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2
4739768|NCT03789292|7692541|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1
4739769|NCT03789292|7692542|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0
4739770|NCT03805438|7692569|FG000|Overall Study|Lack of Efficacy|1
4739771|NCT03805438|7692569|FG000|Overall Study|Protocol Violation|1
4739772|NCT03812224|7692583|FG000|Double-blind Treatment Period|Withdrawal by Subject|4
4739773|NCT03812224|7692584|FG001|Double-blind Treatment Period|Withdrawal by Subject|2
4739774|NCT03812224|7692583|FG000|Double-blind Treatment Period|Decision by Sponsor|0
4739775|NCT03812224|7692584|FG001|Double-blind Treatment Period|Decision by Sponsor|1
4739776|NCT03812224|7692583|FG000|Open-label Treatment Period|Withdrawal by Subject|2
4739777|NCT03812224|7692584|FG001|Open-label Treatment Period|Withdrawal by Subject|2
4739778|NCT03812224|7692583|FG000|Open-label Treatment Period|Decision by Sponsor|0
4739779|NCT03812224|7692584|FG001|Open-label Treatment Period|Decision by Sponsor|1
4739780|NCT03817528|7692591|FG000|Overall Study|Withdrawal by Subject|1
4739781|NCT03817528|7692591|FG000|Overall Study|Adverse Event|2
4739782|NCT03829228|7692618|FG000|Overall Study|Protocol Violation|1
4739783|NCT03830333|7692637|FG000|Overall Study|Death|0
4739784|NCT03830333|7692638|FG001|Overall Study|Death|1
4739785|NCT03830333|7692637|FG000|Overall Study|Withdrawal by Subject|5
4739786|NCT03830333|7692638|FG001|Overall Study|Withdrawal by Subject|1
4739787|NCT03830333|7692637|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3
4739788|NCT03830333|7692638|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2
4739789|NCT03831880|7692646|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0
4739790|NCT03831880|7692647|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1
4739791|NCT03831880|7692646|FG000|Period 2 (12 Weeks)|Protocol Deviation|0
4739792|NCT03831880|7692647|FG001|Period 2 (12 Weeks)|Protocol Deviation|1
4739793|NCT03831945|7692657|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4
4739794|NCT03831945|7692658|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4
4739795|NCT03831945|7692657|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1
4739796|NCT03831945|7692658|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1
4739797|NCT03831945|7692657|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2
4739798|NCT03831945|7692658|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1
4739799|NCT03840174|7692677|FG000|Overall Study|Withdrawal by Subject|1
4739800|NCT03840174|7692678|FG001|Overall Study|Withdrawal by Subject|0
4739801|NCT03840174|7692679|FG002|Overall Study|Withdrawal by Subject|0
4739802|NCT03840174|7692680|FG003|Overall Study|Withdrawal by Subject|0
4633802|NCT01916226|7504123|FG003|Overall Study|Adverse Event|1
4633803|NCT01916226|7504120|FG000|Overall Study|Lack of Efficacy|0
4633804|NCT01916226|7504121|FG001|Overall Study|Lack of Efficacy|0
4633805|NCT01916226|7504122|FG002|Overall Study|Lack of Efficacy|2
4633806|NCT01916226|7504123|FG003|Overall Study|Lack of Efficacy|1
4633807|NCT01916226|7504120|FG000|Overall Study|Protocol Violation|0
4633808|NCT01916226|7504121|FG001|Overall Study|Protocol Violation|1
4633809|NCT01916226|7504122|FG002|Overall Study|Protocol Violation|0
4633810|NCT01916226|7504123|FG003|Overall Study|Protocol Violation|1
4633811|NCT01916226|7504120|FG000|Overall Study|Physician Decision|0
4633812|NCT01916226|7504121|FG001|Overall Study|Physician Decision|0
4633813|NCT01916226|7504122|FG002|Overall Study|Physician Decision|0
4633814|NCT01916226|7504123|FG003|Overall Study|Physician Decision|1
4633815|NCT01916304|7504134|FG000|Overall Study|Screening failure|17
4633816|NCT01916824|7504180|FG000|Overall Study|Lost to Follow-up|3
4633817|NCT01916824|7504181|FG001|Overall Study|Lost to Follow-up|6
4633818|NCT01916824|7504180|FG000|Overall Study|Physician Decision|2
4633819|NCT01916824|7504181|FG001|Overall Study|Physician Decision|0
4633820|NCT01916824|7504180|FG000|Overall Study|Withdrawal by Subject|2
4739803|NCT03857841|7692709|FG000|Overall Study|Death|1
4739804|NCT03857841|7692710|FG001|Overall Study|Death|0
4739805|NCT03857841|7692711|FG002|Overall Study|Death|0
4739806|NCT03857841|7692712|FG003|Overall Study|Death|0
4739807|NCT03857841|7692709|FG000|Overall Study|Study Terminated by Sponsor|1
4739808|NCT03857841|7692710|FG001|Overall Study|Study Terminated by Sponsor|0
4739809|NCT03857841|7692711|FG002|Overall Study|Study Terminated by Sponsor|0
4739810|NCT03857841|7692712|FG003|Overall Study|Study Terminated by Sponsor|0
4739811|NCT03862625|7692737|FG000|Overall Study|Lost to Follow-up|0
4739812|NCT03862625|7692738|FG001|Overall Study|Lost to Follow-up|1
4739813|NCT03877224|7692766|FG000|Overall Study|Death|3
4739814|NCT03877224|7692767|FG001|Overall Study|Death|2
4739815|NCT03877224|7692766|FG000|Overall Study|Withdrawal by Subject|1
4739816|NCT03877224|7692767|FG001|Overall Study|Withdrawal by Subject|6
4739817|NCT03877224|7692766|FG000|Overall Study|Participant is alive, just unable to come for visits|1
4739818|NCT03877224|7692767|FG001|Overall Study|Participant is alive, just unable to come for visits|0
4739819|NCT03885596|7692786|FG000|Overall Study|Withdrawal by Subject|2
4739820|NCT03885596|7692787|FG001|Overall Study|Withdrawal by Subject|1
4739821|NCT03885596|7692788|FG002|Overall Study|Withdrawal by Subject|0
4739822|NCT03885596|7692789|FG003|Overall Study|Withdrawal by Subject|0
4739823|NCT03885661|7692804|FG000|Overall Study|Withdrawal by Subject|0
4739824|NCT03885661|7692805|FG001|Overall Study|Withdrawal by Subject|1
4739825|NCT03885661|7692804|FG000|Overall Study|Unwilling to undergo required study procedure|1
4739826|NCT03885661|7692805|FG001|Overall Study|Unwilling to undergo required study procedure|0
4739827|NCT03886493|7692811|FG000|Overall Study|Adverse Event|1
4739828|NCT03888235|7692818|FG000|Overall Study|Lost to Follow-up|1
4739829|NCT03888235|7692819|FG001|Overall Study|Lost to Follow-up|1
4739830|NCT03888235|7692820|FG002|Overall Study|Lost to Follow-up|0
4739831|NCT03900416|7692892|FG000|Six Week Follow-up|Lost to Follow-up|1
4739832|NCT03900416|7692893|FG001|Six Week Follow-up|Lost to Follow-up|0
4739833|NCT03900416|7692892|FG000|Six Week Follow-up|Withdrawal by Subject|1
4739834|NCT03900416|7692893|FG001|Six Week Follow-up|Withdrawal by Subject|0
4739835|NCT03900416|7692892|FG000|Twelve Week Follow-up|Lost to Follow-up|0
4739836|NCT03900416|7692893|FG001|Twelve Week Follow-up|Lost to Follow-up|2
4739837|NCT03900416|7692892|FG000|Twelve Week Follow-up|Withdrawal by Subject|0
4739838|NCT03900416|7692893|FG001|Twelve Week Follow-up|Withdrawal by Subject|1
4739839|NCT03900416|7692892|FG000|Twelve Week Follow-up|Adverse Event|1
4739840|NCT03900416|7692893|FG001|Twelve Week Follow-up|Adverse Event|1
4739841|NCT03900416|7692892|FG000|Six Month Follow-up|Lost to Follow-up|4
4739842|NCT03900416|7692893|FG001|Six Month Follow-up|Lost to Follow-up|3
4739843|NCT03900416|7692892|FG000|Six Month Follow-up|Withdrawal by Subject|1
4739844|NCT03900416|7692893|FG001|Six Month Follow-up|Withdrawal by Subject|1
4739845|NCT03905863|7692901|FG000|Overall Study|Adverse Event|2
4739846|NCT03905863|7692902|FG001|Overall Study|Adverse Event|4
4739847|NCT03905863|7692901|FG000|Overall Study|Withdrawal by Subject|2
4739848|NCT03905863|7692902|FG001|Overall Study|Withdrawal by Subject|2
4739849|NCT03905863|7692901|FG000|Overall Study|Physician Decision|0
4739850|NCT03905863|7692902|FG001|Overall Study|Physician Decision|3
4739851|NCT03905863|7692901|FG000|Overall Study|Lost to Follow-up|1
4739852|NCT03905863|7692902|FG001|Overall Study|Lost to Follow-up|0
4739853|NCT03905863|7692901|FG000|Overall Study|Protocol Violation|0
4739854|NCT03905863|7692902|FG001|Overall Study|Protocol Violation|2
4739855|NCT03905863|7692901|FG000|Overall Study|Death|0
4739856|NCT03905863|7692902|FG001|Overall Study|Death|1
4739857|NCT03909971|7692930|FG000|Overall Study|Other Reasons Not Specified|0
4739858|NCT03909971|7692931|FG001|Overall Study|Other Reasons Not Specified|1
4739859|NCT03909971|7692930|FG000|Overall Study|Global Deterioration of Health Status|2
4739860|NCT03909971|7692931|FG001|Overall Study|Global Deterioration of Health Status|1
4739861|NCT03909971|7692930|FG000|Overall Study|Progressive Disease|6
4739862|NCT03909971|7692931|FG001|Overall Study|Progressive Disease|14
4739863|NCT03909971|7692930|FG000|Overall Study|Death|2
4739864|NCT03909971|7692931|FG001|Overall Study|Death|6
4739865|NCT03920215|7692942|FG000|Overall Study|Lost to Follow-up|1
4739866|NCT03920215|7692943|FG001|Overall Study|Lost to Follow-up|2
4739867|NCT03920215|7692944|FG002|Overall Study|Lost to Follow-up|0
4739868|NCT03920215|7692945|FG003|Overall Study|Lost to Follow-up|0
4739869|NCT03920215|7692942|FG000|Overall Study|Death|0
4739870|NCT03920215|7692943|FG001|Overall Study|Death|0
4739871|NCT03920215|7692944|FG002|Overall Study|Death|0
4739872|NCT03920215|7692945|FG003|Overall Study|Death|1
4739873|NCT03921151|7692957|FG000|Overall Study|Withdrawal by Subject|11
4739874|NCT03921151|7692958|FG001|Overall Study|Withdrawal by Subject|16
4739875|NCT03927911|7692979|FG000|Overall Study|problems with eDiary|0
4739876|NCT03927911|7692980|FG001|Overall Study|problems with eDiary|1
4739877|NCT03927911|7692981|FG002|Overall Study|problems with eDiary|0
4739878|NCT03927911|7692982|FG003|Overall Study|problems with eDiary|1
4739879|NCT03927911|7692983|FG004|Overall Study|problems with eDiary|0
4739880|NCT03927911|7692984|FG005|Overall Study|problems with eDiary|4
4739881|NCT03927911|7692979|FG000|Overall Study|Adverse Event|0
4739882|NCT03927911|7692980|FG001|Overall Study|Adverse Event|0
4739883|NCT03927911|7692981|FG002|Overall Study|Adverse Event|0
4739884|NCT03927911|7692982|FG003|Overall Study|Adverse Event|0
4739885|NCT03927911|7692983|FG004|Overall Study|Adverse Event|0
4739886|NCT03927911|7692984|FG005|Overall Study|Adverse Event|1
4739887|NCT03927911|7692979|FG000|Overall Study|not treated -study terminated by sponsor|0
4739888|NCT03927911|7692980|FG001|Overall Study|not treated -study terminated by sponsor|1
4739889|NCT03927911|7692981|FG002|Overall Study|not treated -study terminated by sponsor|0
4739890|NCT03927911|7692982|FG003|Overall Study|not treated -study terminated by sponsor|0
4739891|NCT03927911|7692983|FG004|Overall Study|not treated -study terminated by sponsor|0
4739892|NCT03927911|7692984|FG005|Overall Study|not treated -study terminated by sponsor|0
4739893|NCT03927911|7692979|FG000|Overall Study|Surgery cancelled|0
4739894|NCT03927911|7692980|FG001|Overall Study|Surgery cancelled|0
4739895|NCT03927911|7692981|FG002|Overall Study|Surgery cancelled|0
4524637|NCT01017601|7340328|FG000|Overall Study|Withdrawal by Subject|0
4524638|NCT01017601|7340329|FG001|Overall Study|Withdrawal by Subject|1
4524639|NCT01017731|7340339|FG000|Overall Study|Lost to Follow-up|2
4524640|NCT01017731|7340339|FG000|Overall Study|Withdrawal by Subject|3
4524641|NCT01017731|7340339|FG000|Overall Study|Physician Decision|2
4524642|NCT01017731|7340339|FG000|Overall Study|Adverse Event|1
4524643|NCT01017874|7340346|FG000|Overall Study|Withdrawal by Subject|23
4524644|NCT01017874|7340347|FG001|Overall Study|Withdrawal by Subject|20
4524645|NCT01017874|7340346|FG000|Overall Study|Sponsor decision|3
4524646|NCT01017874|7340347|FG001|Overall Study|Sponsor decision|1
4524647|NCT01017874|7340346|FG000|Overall Study|Lost to Follow-up|3
4524648|NCT01017874|7340347|FG001|Overall Study|Lost to Follow-up|2
4524649|NCT01017874|7340346|FG000|Overall Study|Physician Decision|1
4524650|NCT01017874|7340347|FG001|Overall Study|Physician Decision|3
4524651|NCT01017952|7340357|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356
4524652|NCT01017952|7340358|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
4524653|NCT01017952|7340359|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
4524654|NCT01017952|7340360|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
4594279|NCT01561313|7443468|FG000|Overall Study|Adverse event and withdrawal by subject|1
4594280|NCT01561313|7443469|FG001|Overall Study|Adverse event and withdrawal by subject|0
4594281|NCT01561560|7443484|FG000|First Two Weeks of Wear|Time/job conflict|0
4594282|NCT01561560|7443485|FG001|First Two Weeks of Wear|Time/job conflict|1
4594283|NCT01561560|7443484|FG000|First Two Weeks of Wear|Adverse Event|0
4594284|NCT01561560|7443485|FG001|First Two Weeks of Wear|Adverse Event|1
4594285|NCT01561560|7443484|FG000|Second Two Weeks of Wear|Adverse Event|0
4594286|NCT01561560|7443485|FG001|Second Two Weeks of Wear|Adverse Event|1
4594287|NCT01561755|7443527|FG000|Overall Study|Lost to Follow-up|0
4594288|NCT01561755|7443528|FG001|Overall Study|Lost to Follow-up|1
4594289|NCT01561898|7443542|FG000|Overall Study|Withdrawal by Subject|0
4633821|NCT01916824|7504181|FG001|Overall Study|Withdrawal by Subject|3
4739896|NCT03927911|7692982|FG003|Overall Study|Surgery cancelled|1
4739897|NCT03927911|7692983|FG004|Overall Study|Surgery cancelled|0
4739898|NCT03927911|7692984|FG005|Overall Study|Surgery cancelled|1
4739899|NCT03927911|7692979|FG000|Overall Study|Protocol Violation|0
4739900|NCT03927911|7692980|FG001|Overall Study|Protocol Violation|0
4739901|NCT03927911|7692981|FG002|Overall Study|Protocol Violation|0
4739902|NCT03927911|7692982|FG003|Overall Study|Protocol Violation|0
4739903|NCT03927911|7692983|FG004|Overall Study|Protocol Violation|0
4739904|NCT03927911|7692984|FG005|Overall Study|Protocol Violation|1
4739905|NCT03938857|7693011|FG000|Overall Study|Physician Decision|1
4739906|NCT03938857|7693012|FG001|Overall Study|Physician Decision|0
4739907|NCT03938857|7693013|FG002|Overall Study|Physician Decision|0
4739908|NCT03938857|7693014|FG003|Overall Study|Physician Decision|0
4739909|NCT03945981|7693028|FG000|Overall Study|Lost to Follow-up|12
4739910|NCT03945981|7693028|FG000|Overall Study|Physician Decision|4
4739911|NCT03945981|7693028|FG000|Overall Study|Withdrawal by Subject|6
4739912|NCT03945981|7693028|FG000|Overall Study|Protocol Violation|1
4739913|NCT03954834|7693045|FG000|Overall Study|Adverse Event|1
4739914|NCT03954834|7693046|FG001|Overall Study|Adverse Event|3
4739915|NCT03954834|7693047|FG002|Overall Study|Adverse Event|1
4739916|NCT03954834|7693048|FG003|Overall Study|Adverse Event|1
4739917|NCT03954834|7693045|FG000|Overall Study|Death|0
4739918|NCT03954834|7693046|FG001|Overall Study|Death|0
4739919|NCT03954834|7693047|FG002|Overall Study|Death|0
4739920|NCT03954834|7693048|FG003|Overall Study|Death|1
4739921|NCT03954834|7693045|FG000|Overall Study|Physician Decision|0
4739922|NCT03954834|7693046|FG001|Overall Study|Physician Decision|1
4739923|NCT03954834|7693047|FG002|Overall Study|Physician Decision|0
4739924|NCT03954834|7693048|FG003|Overall Study|Physician Decision|2
4524655|NCT01017952|7340361|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
4524656|NCT01017952|7340357|FG000|4-week, Open-label Run-In Period|Adverse Event|23
4524657|NCT01017952|7340358|FG001|4-week, Open-label Run-In Period|Adverse Event|0
4524658|NCT01017952|7340359|FG002|4-week, Open-label Run-In Period|Adverse Event|0
4524659|NCT01017952|7340360|FG003|4-week, Open-label Run-In Period|Adverse Event|0
4594290|NCT01561898|7443543|FG001|Overall Study|Withdrawal by Subject|8
4739925|NCT03954834|7693045|FG000|Overall Study|Protocol Violation|1
4739926|NCT03954834|7693046|FG001|Overall Study|Protocol Violation|0
4739927|NCT03954834|7693047|FG002|Overall Study|Protocol Violation|0
4739928|NCT03954834|7693048|FG003|Overall Study|Protocol Violation|1
4633822|NCT01917006|7504207|FG000|Randomized-treatment Period|Lost to Follow-up|1
4633823|NCT01917006|7504208|FG001|Randomized-treatment Period|Lost to Follow-up|0
4633824|NCT01917006|7504209|FG002|Randomized-treatment Period|Lost to Follow-up|0
4633825|NCT01917006|7504210|FG003|Randomized-treatment Period|Lost to Follow-up|1
4633826|NCT01917006|7504211|FG004|Randomized-treatment Period|Lost to Follow-up|0
4633827|NCT01917006|7504212|FG005|Randomized-treatment Period|Lost to Follow-up|0
4633828|NCT01917006|7504213|FG006|Randomized-treatment Period|Lost to Follow-up|0
4633829|NCT01917006|7504214|FG007|Randomized-treatment Period|Lost to Follow-up|0
4633830|NCT01917006|7504207|FG000|Randomized-treatment Period|Personal Reasons|0
4633831|NCT01917006|7504208|FG001|Randomized-treatment Period|Personal Reasons|0
4633832|NCT01917006|7504209|FG002|Randomized-treatment Period|Personal Reasons|0
4633833|NCT01917006|7504210|FG003|Randomized-treatment Period|Personal Reasons|0
4633834|NCT01917006|7504211|FG004|Randomized-treatment Period|Personal Reasons|0
4633835|NCT01917006|7504212|FG005|Randomized-treatment Period|Personal Reasons|1
4633836|NCT01917006|7504213|FG006|Randomized-treatment Period|Personal Reasons|0
4633837|NCT01917006|7504214|FG007|Randomized-treatment Period|Personal Reasons|0
4633838|NCT01917006|7504207|FG000|Randomized-treatment Period|Protocol Violation|1
4633839|NCT01917006|7504208|FG001|Randomized-treatment Period|Protocol Violation|0
4633840|NCT01917006|7504209|FG002|Randomized-treatment Period|Protocol Violation|0
4633841|NCT01917006|7504210|FG003|Randomized-treatment Period|Protocol Violation|0
4633842|NCT01917006|7504211|FG004|Randomized-treatment Period|Protocol Violation|0
4633843|NCT01917006|7504212|FG005|Randomized-treatment Period|Protocol Violation|0
4633844|NCT01917006|7504213|FG006|Randomized-treatment Period|Protocol Violation|0
4633845|NCT01917006|7504214|FG007|Randomized-treatment Period|Protocol Violation|0
4633846|NCT01917006|7504207|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0
4633847|NCT01917006|7504208|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0
4633848|NCT01917006|7504209|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0
4633849|NCT01917006|7504210|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0
4633850|NCT01917006|7504211|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0
4633851|NCT01917006|7504212|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0
4633852|NCT01917006|7504213|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1
4633853|NCT01917006|7504214|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0
4633854|NCT01917006|7504207|FG000|Open-label Period|Adverse Event|0
4633855|NCT01917006|7504208|FG001|Open-label Period|Adverse Event|0
4633856|NCT01917006|7504209|FG002|Open-label Period|Adverse Event|0
4633857|NCT01917006|7504210|FG003|Open-label Period|Adverse Event|0
4633858|NCT01917006|7504211|FG004|Open-label Period|Adverse Event|0
4633859|NCT01917006|7504212|FG005|Open-label Period|Adverse Event|0
4633860|NCT01917006|7504213|FG006|Open-label Period|Adverse Event|0
4633861|NCT01917006|7504214|FG007|Open-label Period|Adverse Event|1
4633862|NCT01917006|7504207|FG000|Open-label Period|Lost to Follow-up|0
4633863|NCT01917006|7504208|FG001|Open-label Period|Lost to Follow-up|0
4633864|NCT01917006|7504209|FG002|Open-label Period|Lost to Follow-up|0
4633865|NCT01917006|7504210|FG003|Open-label Period|Lost to Follow-up|0
4633866|NCT01917006|7504211|FG004|Open-label Period|Lost to Follow-up|0
4633867|NCT01917006|7504212|FG005|Open-label Period|Lost to Follow-up|0
4633868|NCT01917006|7504213|FG006|Open-label Period|Lost to Follow-up|0
4633869|NCT01917006|7504214|FG007|Open-label Period|Lost to Follow-up|1
4633870|NCT01917084|7504231|FG000|Overall Study|Withdrawal by Subject|1
4633871|NCT01917344|7504257|FG000|Overall Study|Withdrawal by Subject|1
4633872|NCT01917526|7504272|FG000|Overall Study|Protocol Violation|1
4633873|NCT01917526|7504273|FG001|Overall Study|Protocol Violation|1
4633874|NCT01917656|7504281|FG000|Overall Study|Adverse Event|11
4633875|NCT01917656|7504282|FG001|Overall Study|Adverse Event|0
4633876|NCT01917656|7504281|FG000|Overall Study|Withdrawal criteria|8
4633877|NCT01917656|7504282|FG001|Overall Study|Withdrawal criteria|14
4633878|NCT01917656|7504281|FG000|Overall Study|Unclassified|0
4633879|NCT01917656|7504282|FG001|Overall Study|Unclassified|3
4633880|NCT01917656|7504281|FG000|Overall Study|Withdrawal by Subject|4
4633881|NCT01917656|7504282|FG001|Overall Study|Withdrawal by Subject|3
4633882|NCT01917656|7504281|FG000|Overall Study|Lost to Follow-up|3
4633883|NCT01917656|7504282|FG001|Overall Study|Lost to Follow-up|4
4633884|NCT01917747|7504295|FG000|Overall Study|Withdrawal by Subject|1
4633885|NCT01917747|7504296|FG001|Overall Study|Withdrawal by Subject|2
4633886|NCT01917747|7504295|FG000|Overall Study|Lost to Follow-up|18
4633887|NCT01917747|7504296|FG001|Overall Study|Lost to Follow-up|9
4633888|NCT01917968|7504327|FG000|Overall Study|Death|3
4633889|NCT01917968|7504328|FG001|Overall Study|Death|2
4633890|NCT01917968|7504327|FG000|Overall Study|Lost to Follow-up|21
4633891|NCT01917968|7504328|FG001|Overall Study|Lost to Follow-up|39
4633892|NCT01917968|7504327|FG000|Overall Study|Physician Decision|1
4633893|NCT01917968|7504328|FG001|Overall Study|Physician Decision|2
4633894|NCT01917968|7504327|FG000|Overall Study|Withdrawal by Subject|20
4633895|NCT01917968|7504328|FG001|Overall Study|Withdrawal by Subject|35
4633896|NCT01917968|7504327|FG000|Overall Study|Subject Relocation|5
4633897|NCT01917968|7504328|FG001|Overall Study|Subject Relocation|1
4633898|NCT01917968|7504327|FG000|Overall Study|36M Missed Visit|3
4739929|NCT03954834|7693045|FG000|Overall Study|Withdrawal by Subject|2
4739930|NCT03954834|7693046|FG001|Overall Study|Withdrawal by Subject|3
4739931|NCT03954834|7693047|FG002|Overall Study|Withdrawal by Subject|13
4739932|NCT03954834|7693048|FG003|Overall Study|Withdrawal by Subject|6
4739933|NCT03954834|7693045|FG000|Overall Study|Participant left the country|0
4739934|NCT03954834|7693046|FG001|Overall Study|Participant left the country|0
4739935|NCT03954834|7693047|FG002|Overall Study|Participant left the country|1
4739936|NCT03954834|7693048|FG003|Overall Study|Participant left the country|0
4739937|NCT03954834|7693045|FG000|Overall Study|Lost to Follow-up|3
4739938|NCT03954834|7693046|FG001|Overall Study|Lost to Follow-up|2
4739939|NCT03954834|7693047|FG002|Overall Study|Lost to Follow-up|3
4739940|NCT03954834|7693048|FG003|Overall Study|Lost to Follow-up|5
4739941|NCT03961529|7693075|FG000|Overall Study|Adverse Event|13
4739942|NCT03961529|7693076|FG001|Overall Study|Adverse Event|5
4739943|NCT03961529|7693077|FG002|Overall Study|Adverse Event|2
4739944|NCT03961529|7693075|FG000|Overall Study|Withdrawal by Subject|17
4739945|NCT03961529|7693076|FG001|Overall Study|Withdrawal by Subject|2
4739946|NCT03961529|7693077|FG002|Overall Study|Withdrawal by Subject|1
4739947|NCT03961529|7693075|FG000|Overall Study|Withdrawal by parent/guardian|0
4739948|NCT03961529|7693076|FG001|Overall Study|Withdrawal by parent/guardian|7
4739949|NCT03961529|7693077|FG002|Overall Study|Withdrawal by parent/guardian|0
4739950|NCT03961529|7693075|FG000|Overall Study|Physician Decision|2
4739951|NCT03961529|7693076|FG001|Overall Study|Physician Decision|1
4739952|NCT03961529|7693077|FG002|Overall Study|Physician Decision|1
4739953|NCT03961529|7693075|FG000|Overall Study|Lost to Follow-up|2
4739954|NCT03961529|7693076|FG001|Overall Study|Lost to Follow-up|1
4739955|NCT03961529|7693077|FG002|Overall Study|Lost to Follow-up|0
4739956|NCT03961529|7693075|FG000|Overall Study|Lack of Efficacy|2
4739957|NCT03961529|7693076|FG001|Overall Study|Lack of Efficacy|0
4739958|NCT03961529|7693077|FG002|Overall Study|Lack of Efficacy|1
4739959|NCT03961529|7693075|FG000|Overall Study|Other|6
4739960|NCT03961529|7693076|FG001|Overall Study|Other|1
4739961|NCT03961529|7693077|FG002|Overall Study|Other|0
4739962|NCT03968159|7693087|FG000|Overall Study|Adverse Event|4
4739963|NCT03968159|7693088|FG001|Overall Study|Adverse Event|4
4739964|NCT03968159|7693087|FG000|Overall Study|Lost to Follow-up|1
4739965|NCT03968159|7693088|FG001|Overall Study|Lost to Follow-up|1
4739966|NCT03968159|7693087|FG000|Overall Study|Use of prohibited medication|0
4739967|NCT03968159|7693088|FG001|Overall Study|Use of prohibited medication|1
4739968|NCT03968159|7693087|FG000|Overall Study|Protocol Violation|2
4739969|NCT03968159|7693088|FG001|Overall Study|Protocol Violation|2
4739970|NCT03968159|7693087|FG000|Overall Study|Withdrawal by Subject|4
4739971|NCT03968159|7693088|FG001|Overall Study|Withdrawal by Subject|6
4739972|NCT03968159|7693087|FG000|Overall Study|Lack of Efficacy|0
4739973|NCT03968159|7693088|FG001|Overall Study|Lack of Efficacy|1
4739974|NCT03968159|7693087|FG000|Overall Study|Not further specified|2
4739975|NCT03968159|7693088|FG001|Overall Study|Not further specified|0
4739976|NCT03970824|7693106|FG000|Overall Study|Withdrawal by Subject|1
4739977|NCT03970824|7693107|FG001|Overall Study|Withdrawal by Subject|1
4739978|NCT03970824|7693108|FG002|Overall Study|Withdrawal by Subject|3
4739979|NCT03970824|7693106|FG000|Overall Study|Lost to Follow-up|0
4739980|NCT03970824|7693107|FG001|Overall Study|Lost to Follow-up|2
4739981|NCT03970824|7693108|FG002|Overall Study|Lost to Follow-up|1
4739982|NCT03970824|7693106|FG000|Overall Study|Adverse Event|1
4739983|NCT03970824|7693107|FG001|Overall Study|Adverse Event|0
4739984|NCT03970824|7693108|FG002|Overall Study|Adverse Event|0
4739985|NCT03982069|7693154|FG000|Overall Study|Lost to Follow-up|5
4739986|NCT03982069|7693155|FG001|Overall Study|Lost to Follow-up|5
4739987|NCT03982069|7693156|FG002|Overall Study|Lost to Follow-up|3
4739988|NCT03982069|7693157|FG003|Overall Study|Lost to Follow-up|5
4739989|NCT03982069|7693154|FG000|Overall Study|Physician Decision|0
4739990|NCT03982069|7693155|FG001|Overall Study|Physician Decision|1
4739991|NCT03982069|7693156|FG002|Overall Study|Physician Decision|0
4739992|NCT03982069|7693157|FG003|Overall Study|Physician Decision|0
4739993|NCT03982069|7693154|FG000|Overall Study|Withdrawal by Subject|2
4739994|NCT03982069|7693155|FG001|Overall Study|Withdrawal by Subject|1
4739995|NCT03982069|7693156|FG002|Overall Study|Withdrawal by Subject|5
4739996|NCT03982069|7693157|FG003|Overall Study|Withdrawal by Subject|2
4739997|NCT03982069|7693154|FG000|Overall Study|Specimen loss|3
4739998|NCT03982069|7693155|FG001|Overall Study|Specimen loss|3
4739999|NCT03982069|7693156|FG002|Overall Study|Specimen loss|1
4740000|NCT03982069|7693157|FG003|Overall Study|Specimen loss|1
4740001|NCT03984812|7693176|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0
4740002|NCT03984812|7693177|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0
4740003|NCT03984812|7693178|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1
4740004|NCT03984812|7693179|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0
4740005|NCT03984812|7693180|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0
4740006|NCT03984812|7693181|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0
4740007|NCT03984812|7693182|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0
4740008|NCT03984812|7693183|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0
4740009|NCT03984812|7693184|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0
4740010|NCT03984812|7693185|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0
4740011|NCT03984812|7693186|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0
4740012|NCT04006171|7693249|FG000|Overall Study|Withdrawal by Subject|8
4740013|NCT04006171|7693250|FG001|Overall Study|Withdrawal by Subject|7
4740014|NCT04006171|7693249|FG000|Overall Study|missing serum samples|2
4740015|NCT04006171|7693250|FG001|Overall Study|missing serum samples|2
4740016|NCT04006171|7693249|FG000|Overall Study|insufficient sample volume|2
4740017|NCT04006171|7693250|FG001|Overall Study|insufficient sample volume|3
4740018|NCT04013529|7693277|FG000|Overall Study|Withdrawal by Subject|1
4740019|NCT04013529|7693278|FG001|Overall Study|Withdrawal by Subject|1
4740020|NCT04018066|7693293|FG000|Overall Study|participants started taking medications during the study period|3
4740021|NCT04018066|7693293|FG000|Overall Study|participant dropped out due to schedule conflicts.|1
4740022|NCT04041440|7693338|FG000|Overall Study|Withdrawal by Subject|0
4740023|NCT04041440|7693339|FG001|Overall Study|Withdrawal by Subject|1
4524660|NCT01017952|7340361|FG004|4-week, Open-label Run-In Period|Adverse Event|0
4524661|NCT01017952|7340357|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1
4524662|NCT01017952|7340358|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
4524663|NCT01017952|7340359|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
4524664|NCT01017952|7340360|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
4524665|NCT01017952|7340361|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
4524666|NCT01017952|7340357|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6
4524667|NCT01017952|7340358|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0
4524668|NCT01017952|7340359|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0
4524669|NCT01017952|7340360|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0
4524670|NCT01017952|7340361|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0
4524671|NCT01017952|7340357|FG000|4-week, Open-label Run-In Period|Physician Decision|10
4524672|NCT01017952|7340358|FG001|4-week, Open-label Run-In Period|Physician Decision|0
4524673|NCT01017952|7340359|FG002|4-week, Open-label Run-In Period|Physician Decision|0
4524674|NCT01017952|7340360|FG003|4-week, Open-label Run-In Period|Physician Decision|0
4524675|NCT01017952|7340361|FG004|4-week, Open-label Run-In Period|Physician Decision|0
4524676|NCT01017952|7340357|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63
4524677|NCT01017952|7340358|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0
4524678|NCT01017952|7340359|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0
4524679|NCT01017952|7340360|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0
4524680|NCT01017952|7340361|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0
4524681|NCT01017952|7340357|FG000|52-week, Double-blind Treatment Period|Adverse Event|0
4594291|NCT01561898|7443544|FG002|Overall Study|Withdrawal by Subject|12
4633899|NCT01917968|7504328|FG001|Overall Study|36M Missed Visit|2
4633900|NCT01917968|7504327|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1
4633901|NCT01917968|7504328|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0
4633902|NCT01917968|7504327|FG000|Overall Study|Change in Family Circumstances|0
4633903|NCT01917968|7504328|FG001|Overall Study|Change in Family Circumstances|1
4633904|NCT01917968|7504327|FG000|Overall Study|No Data Available|0
4633905|NCT01917968|7504328|FG001|Overall Study|No Data Available|2
4633906|NCT01918085|7504355|FG000|Test Period 1: Strata Strip|Adverse Event|0
4633907|NCT01918085|7504356|FG001|Test Period 1: Strata Strip|Adverse Event|1
4633908|NCT01918306|7504371|FG000|Overall Study|progresive disease|4
4633909|NCT01918306|7504372|FG001|Overall Study|progresive disease|0
4633910|NCT01918306|7504373|FG002|Overall Study|progresive disease|1
4633911|NCT01918306|7504374|FG003|Overall Study|progresive disease|1
4740024|NCT04041440|7693338|FG000|Overall Study|Lost to Follow-up|0
4740025|NCT04041440|7693339|FG001|Overall Study|Lost to Follow-up|1
4740026|NCT04041570|7693348|FG000|Overall Study|Moved from Area|0
4633912|NCT01918306|7504371|FG000|Overall Study|Withdrawal by Subject|0
4633913|NCT01918306|7504372|FG001|Overall Study|Withdrawal by Subject|0
4633914|NCT01918306|7504373|FG002|Overall Study|Withdrawal by Subject|0
4633915|NCT01918306|7504374|FG003|Overall Study|Withdrawal by Subject|2
4633916|NCT01918306|7504371|FG000|Overall Study|neutropenia|1
4633917|NCT01918306|7504372|FG001|Overall Study|neutropenia|0
4633918|NCT01918306|7504373|FG002|Overall Study|neutropenia|0
4633919|NCT01918306|7504374|FG003|Overall Study|neutropenia|0
4633920|NCT01918306|7504371|FG000|Overall Study|Lack of Efficacy|1
4633921|NCT01918306|7504372|FG001|Overall Study|Lack of Efficacy|0
4633922|NCT01918306|7504373|FG002|Overall Study|Lack of Efficacy|0
4633923|NCT01918306|7504374|FG003|Overall Study|Lack of Efficacy|0
4633924|NCT01918306|7504371|FG000|Overall Study|progress disease, crossover|0
4633925|NCT01918306|7504372|FG001|Overall Study|progress disease, crossover|0
4633926|NCT01918306|7504373|FG002|Overall Study|progress disease, crossover|1
4633927|NCT01918306|7504374|FG003|Overall Study|progress disease, crossover|0
4633928|NCT01918332|7504398|FG000|Overall Study|Adverse Event|0
4633929|NCT01918332|7504399|FG001|Overall Study|Adverse Event|0
4633930|NCT01918332|7504400|FG002|Overall Study|Adverse Event|0
4633931|NCT01918332|7504401|FG003|Overall Study|Adverse Event|1
4633932|NCT01918332|7504398|FG000|Overall Study|Withdrawal by Subject|2
4633933|NCT01918332|7504399|FG001|Overall Study|Withdrawal by Subject|3
4633934|NCT01918332|7504400|FG002|Overall Study|Withdrawal by Subject|2
4633935|NCT01918332|7504401|FG003|Overall Study|Withdrawal by Subject|3
4633936|NCT01918332|7504398|FG000|Overall Study|Protocol Violation|6
4633937|NCT01918332|7504399|FG001|Overall Study|Protocol Violation|2
4633938|NCT01918332|7504400|FG002|Overall Study|Protocol Violation|6
4633939|NCT01918332|7504401|FG003|Overall Study|Protocol Violation|3
4633940|NCT01918332|7504398|FG000|Overall Study|lipid result by central lab did not meet|0
4633941|NCT01918332|7504399|FG001|Overall Study|lipid result by central lab did not meet|0
4633942|NCT01918332|7504400|FG002|Overall Study|lipid result by central lab did not meet|1
4633943|NCT01918332|7504401|FG003|Overall Study|lipid result by central lab did not meet|0
4633944|NCT01918371|7504413|FG000|Overall Study|Missing Data|1
4633945|NCT01918371|7504414|FG001|Overall Study|Missing Data|1
4633946|NCT01918774|7504424|FG000|Overall Study|Lost prior to first CBTw session|4
4740027|NCT04041570|7693349|FG001|Overall Study|Moved from Area|2
4740028|NCT04043143|7693358|FG000|Overall Study|Lost to Follow-up|5
4740029|NCT04043143|7693359|FG001|Overall Study|Lost to Follow-up|5
4740030|NCT04043143|7693358|FG000|Overall Study|screen failure|1
4740031|NCT04043143|7693359|FG001|Overall Study|screen failure|0
4740032|NCT04052204|7693384|FG000|Overall Study|Death|1
4740033|NCT04052204|7693385|FG001|Overall Study|Death|0
4740034|NCT04052204|7693386|FG002|Overall Study|Death|0
4740035|NCT04052204|7693384|FG000|Overall Study|Progressive disease|1
4740036|NCT04052204|7693385|FG001|Overall Study|Progressive disease|0
4740037|NCT04052204|7693386|FG002|Overall Study|Progressive disease|0
4740038|NCT04052204|7693384|FG000|Overall Study|Other|1
4740039|NCT04052204|7693385|FG001|Overall Study|Other|0
4740040|NCT04052204|7693386|FG002|Overall Study|Other|0
4740041|NCT04067011|7693406|FG000|Overall Study|Not Treated|8
4740042|NCT04067011|7693407|FG001|Overall Study|Not Treated|7
4740043|NCT04067011|7693408|FG002|Overall Study|Not Treated|5
4740044|NCT04067011|7693406|FG000|Overall Study|Adverse Event|2
4740045|NCT04067011|7693407|FG001|Overall Study|Adverse Event|1
4740046|NCT04067011|7693408|FG002|Overall Study|Adverse Event|0
4740047|NCT04067011|7693406|FG000|Overall Study|Withdrawal by Subject|6
4740048|NCT04067011|7693407|FG001|Overall Study|Withdrawal by Subject|2
4740049|NCT04067011|7693408|FG002|Overall Study|Withdrawal by Subject|1
4740050|NCT04067011|7693406|FG000|Overall Study|Lost to Follow-up|0
4740051|NCT04067011|7693407|FG001|Overall Study|Lost to Follow-up|0
4740052|NCT04067011|7693408|FG002|Overall Study|Lost to Follow-up|1
4740053|NCT04067011|7693406|FG000|Overall Study|Physician Decision|1
4740054|NCT04067011|7693407|FG001|Overall Study|Physician Decision|1
4740055|NCT04067011|7693408|FG002|Overall Study|Physician Decision|0
4740056|NCT04067011|7693406|FG000|Overall Study|Other Reasons|2
4740057|NCT04067011|7693407|FG001|Overall Study|Other Reasons|0
4740058|NCT04067011|7693408|FG002|Overall Study|Other Reasons|1
4740059|NCT04067011|7693406|FG000|Overall Study|Missing|0
4740060|NCT04067011|7693407|FG001|Overall Study|Missing|2
4740061|NCT04067011|7693408|FG002|Overall Study|Missing|0
4740062|NCT04072159|7693420|FG000|Overall Study|Lost to Follow-up|6
4740063|NCT04072159|7693421|FG001|Overall Study|Lost to Follow-up|6
4740064|NCT04072159|7693420|FG000|Overall Study|Withdrawal by Subject|2
4633947|NCT01918774|7504424|FG000|Overall Study|Lost to Follow-up|1
4633948|NCT01919112|7504440|FG000|Secondary Analysis-day 30|Death|1
4740065|NCT04072159|7693421|FG001|Overall Study|Withdrawal by Subject|0
4740066|NCT04094870|7693440|FG000|Overall Study|Lost to Follow-up|1
4740067|NCT04094870|7693441|FG001|Overall Study|Lost to Follow-up|1
4740068|NCT04123405|7693482|FG000|Overall Study|Adverse Event|1
4633949|NCT01919112|7504441|FG001|Secondary Analysis-day 30|Death|1
4633950|NCT01919112|7504442|FG002|Secondary Analysis-day 30|Death|1
4633951|NCT01919112|7504440|FG000|Secondary Analysis-day 30|Lost to Follow-up|1
4740069|NCT04123405|7693483|FG001|Overall Study|Adverse Event|2
4740070|NCT04123405|7693484|FG002|Overall Study|Adverse Event|3
4740071|NCT04123405|7693485|FG003|Overall Study|Adverse Event|3
4740072|NCT04123405|7693482|FG000|Overall Study|Exclusion criteria met|1
4740073|NCT04123405|7693483|FG001|Overall Study|Exclusion criteria met|2
4740074|NCT04123405|7693484|FG002|Overall Study|Exclusion criteria met|0
4740075|NCT04123405|7693485|FG003|Overall Study|Exclusion criteria met|2
4740076|NCT04123405|7693482|FG000|Overall Study|Withdrawal by Subject|1
4740077|NCT04123405|7693483|FG001|Overall Study|Withdrawal by Subject|3
4740078|NCT04123405|7693484|FG002|Overall Study|Withdrawal by Subject|0
4740079|NCT04123405|7693485|FG003|Overall Study|Withdrawal by Subject|2
4740080|NCT04123405|7693482|FG000|Overall Study|Contact to subject lost|0
4740081|NCT04123405|7693483|FG001|Overall Study|Contact to subject lost|0
4740082|NCT04123405|7693484|FG002|Overall Study|Contact to subject lost|0
4740083|NCT04123405|7693485|FG003|Overall Study|Contact to subject lost|1
4740084|NCT04123405|7693482|FG000|Overall Study|screening failure|1
4740085|NCT04123405|7693483|FG001|Overall Study|screening failure|0
4740086|NCT04123405|7693484|FG002|Overall Study|screening failure|0
4740087|NCT04123405|7693485|FG003|Overall Study|screening failure|0
4740088|NCT04147715|7693528|FG000|Overall Study|Adverse Event|0
4740089|NCT04147715|7693529|FG001|Overall Study|Adverse Event|0
4740090|NCT04147715|7693530|FG002|Overall Study|Adverse Event|0
4740091|NCT04147715|7693531|FG003|Overall Study|Adverse Event|0
4740092|NCT04147715|7693532|FG004|Overall Study|Adverse Event|0
4740093|NCT04147715|7693533|FG005|Overall Study|Adverse Event|0
4740094|NCT04147715|7693534|FG006|Overall Study|Adverse Event|0
4740095|NCT04147715|7693535|FG007|Overall Study|Adverse Event|2
4524682|NCT01017952|7340358|FG001|52-week, Double-blind Treatment Period|Adverse Event|25
4524683|NCT01017952|7340359|FG002|52-week, Double-blind Treatment Period|Adverse Event|32
4524684|NCT01017952|7340360|FG003|52-week, Double-blind Treatment Period|Adverse Event|35
4524685|NCT01017952|7340361|FG004|52-week, Double-blind Treatment Period|Adverse Event|30
4524686|NCT01017952|7340357|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0
4524687|NCT01017952|7340358|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30
4524688|NCT01017952|7340359|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22
4524689|NCT01017952|7340360|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25
4524690|NCT01017952|7340361|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25
4524691|NCT01017952|7340357|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0
4524692|NCT01017952|7340358|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35
4524693|NCT01017952|7340359|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14
4524694|NCT01017952|7340360|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16
4524695|NCT01017952|7340361|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14
4524696|NCT01017952|7340357|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0
4524697|NCT01017952|7340358|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7
4524698|NCT01017952|7340359|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11
4524699|NCT01017952|7340360|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9
4524700|NCT01017952|7340361|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8
4740096|NCT04147715|7693536|FG008|Overall Study|Adverse Event|1
4740097|NCT04147715|7693537|FG009|Overall Study|Adverse Event|0
4740098|NCT04147715|7693538|FG010|Overall Study|Adverse Event|0
4740099|NCT04147715|7693539|FG011|Overall Study|Adverse Event|0
4740100|NCT04150068|7693614|FG000|Overall Study|Still on study|24
4740101|NCT04150068|7693615|FG001|Overall Study|Still on study|12
4740102|NCT04150068|7693616|FG002|Overall Study|Still on study|16
4740103|NCT04154605|7693625|FG000|Overall Study|Procedure Canceled|1
4740104|NCT04154605|7693626|FG001|Overall Study|Procedure Canceled|1
4740105|NCT04154605|7693625|FG000|Overall Study|Missed follow up|1
4740106|NCT04154605|7693626|FG001|Overall Study|Missed follow up|1
4740107|NCT04154605|7693625|FG000|Overall Study|Withdrawal by Subject|1
4740108|NCT04154605|7693626|FG001|Overall Study|Withdrawal by Subject|0
4740109|NCT04160091|7693636|FG000|Overall Study|Terminated by Sponsor|7
4740110|NCT04160091|7693637|FG001|Overall Study|Terminated by Sponsor|3
4740111|NCT04160091|7693638|FG002|Overall Study|Terminated by Sponsor|5
4740112|NCT04160091|7693639|FG003|Overall Study|Terminated by Sponsor|2
4740113|NCT04160091|7693636|FG000|Overall Study|Noncompliance|0
4740114|NCT04160091|7693637|FG001|Overall Study|Noncompliance|0
4740115|NCT04160091|7693638|FG002|Overall Study|Noncompliance|0
4740116|NCT04160091|7693639|FG003|Overall Study|Noncompliance|1
4740117|NCT04160091|7693636|FG000|Overall Study|Withdrawal by Subject|0
4740118|NCT04160091|7693637|FG001|Overall Study|Withdrawal by Subject|0
4740119|NCT04160091|7693638|FG002|Overall Study|Withdrawal by Subject|0
4740120|NCT04160091|7693639|FG003|Overall Study|Withdrawal by Subject|1
4740121|NCT04164758|7693656|FG000|Overall Study|COVID-19 withdrawal of consent|1
4740122|NCT04164758|7693657|FG001|Overall Study|COVID-19 withdrawal of consent|0
4740123|NCT04164758|7693658|FG002|Overall Study|COVID-19 withdrawal of consent|0
4740124|NCT04164758|7693656|FG000|Overall Study|Adverse Event|0
4740125|NCT04164758|7693657|FG001|Overall Study|Adverse Event|1
4740126|NCT04164758|7693658|FG002|Overall Study|Adverse Event|0
4740127|NCT04165031|7693672|FG000|Overall Study|Adverse Event|1
4740128|NCT04165031|7693673|FG001|Overall Study|Adverse Event|1
4740129|NCT04165031|7693674|FG002|Overall Study|Adverse Event|0
4740130|NCT04165031|7693675|FG003|Overall Study|Adverse Event|0
4740131|NCT04165031|7693676|FG004|Overall Study|Adverse Event|0
4740132|NCT04165031|7693677|FG005|Overall Study|Adverse Event|0
4740133|NCT04165031|7693672|FG000|Overall Study|Withdrawal by Subject|0
4740134|NCT04165031|7693673|FG001|Overall Study|Withdrawal by Subject|0
4740135|NCT04165031|7693674|FG002|Overall Study|Withdrawal by Subject|1
4740136|NCT04165031|7693675|FG003|Overall Study|Withdrawal by Subject|0
4740137|NCT04165031|7693676|FG004|Overall Study|Withdrawal by Subject|0
4740138|NCT04165031|7693677|FG005|Overall Study|Withdrawal by Subject|0
4740139|NCT04171414|7693696|FG000|Overall Study|Death|1
4740140|NCT04171414|7693696|FG000|Overall Study|Withdrawal by Subject|1
4740141|NCT04175808|7693700|FG000|Part A|Miscellaneous|2
4740142|NCT04175808|7693701|FG001|Part A|Miscellaneous|0
4740143|NCT04175808|7693702|FG002|Part A|Miscellaneous|0
4740144|NCT04175808|7693703|FG003|Part A|Miscellaneous|0
4740145|NCT04175808|7693704|FG004|Part A|Miscellaneous|0
4740146|NCT04175808|7693705|FG005|Part A|Miscellaneous|0
4740147|NCT04175808|7693706|FG006|Part A|Miscellaneous|0
4740148|NCT04178720|7693724|FG000|Overall Study|Withdrawal by Subject|2
4740149|NCT04178720|7693725|FG001|Overall Study|Withdrawal by Subject|0
4740150|NCT04178720|7693724|FG000|Overall Study|Relocation|0
4740151|NCT04178720|7693725|FG001|Overall Study|Relocation|1
4740152|NCT04218110|7693768|FG000|Overall Study|Withdrawal by Subject|0
4740153|NCT04218110|7693769|FG001|Overall Study|Withdrawal by Subject|0
4740154|NCT04218110|7693770|FG002|Overall Study|Withdrawal by Subject|0
4740155|NCT04218110|7693771|FG003|Overall Study|Withdrawal by Subject|1
4740156|NCT04222725|7693785|FG000|Overall Study|Adverse Event|0
4740157|NCT04222725|7693786|FG001|Overall Study|Adverse Event|1
4740158|NCT04222725|7693787|FG002|Overall Study|Adverse Event|0
4740159|NCT04222725|7693788|FG003|Overall Study|Adverse Event|0
4740160|NCT04258995|7693883|FG000|Overall Study|Lost to Follow-up|1
4740161|NCT04258995|7693884|FG001|Overall Study|Lost to Follow-up|1
4740162|NCT04317040|7693923|FG000|Overall Study|Lost to Follow-up|2
4740163|NCT04317040|7693924|FG001|Overall Study|Lost to Follow-up|0
4740164|NCT04317040|7693923|FG000|Overall Study|Death|16
4740165|NCT04317040|7693924|FG001|Overall Study|Death|18
4740166|NCT04317040|7693923|FG000|Overall Study|Withdrawal by Subject|0
4740167|NCT04317040|7693924|FG001|Overall Study|Withdrawal by Subject|1
4740168|NCT04317040|7693923|FG000|Overall Study|Incomplete assessments|0
4740169|NCT04317040|7693924|FG001|Overall Study|Incomplete assessments|1
4740170|NCT04319159|7693941|FG000|Overall Study|Screening failure|13
4740171|NCT04319159|7693941|FG000|Overall Study|Re-screening due to COVID-19 implications|2
4740172|NCT04319159|7693941|FG000|Overall Study|Withdrawal by Subject|1
4740173|NCT04331899|7693971|FG000|Trial Period (28 Days)|Withdrawal by Subject|2
4740174|NCT04331899|7693972|FG001|Trial Period (28 Days)|Withdrawal by Subject|2
4740175|NCT04334148|7693980|FG000|Overall Study|positive nasal swab at baseline|0
4740176|NCT04334148|7693981|FG001|Overall Study|positive nasal swab at baseline|1
4740177|NCT04347954|7694001|FG000|Overall Study|Did not present to study site for allocated intervention|3
4740178|NCT04347954|7694002|FG001|Overall Study|Did not present to study site for allocated intervention|0
4740179|NCT04347954|7694003|FG002|Overall Study|Did not present to study site for allocated intervention|3
4740180|NCT04347954|7694001|FG000|Overall Study|Lost to Follow-up|0
4740181|NCT04347954|7694002|FG001|Overall Study|Lost to Follow-up|1
4740182|NCT04347954|7694003|FG002|Overall Study|Lost to Follow-up|0
4740183|NCT04349098|7694013|FG000|Overall Study|Death|16
4740184|NCT04349098|7694014|FG001|Overall Study|Death|8
4740185|NCT04349098|7694013|FG000|Overall Study|Lost to Follow-up|11
4740186|NCT04349098|7694014|FG001|Overall Study|Lost to Follow-up|8
4740187|NCT04349098|7694013|FG000|Overall Study|Withdrawal by Subject|8
4740188|NCT04349098|7694014|FG001|Overall Study|Withdrawal by Subject|5
4740189|NCT04349098|7694013|FG000|Overall Study|Other|3
4740190|NCT04349098|7694014|FG001|Overall Study|Other|5
4740191|NCT04353037|7694024|FG000|Overall Study|Lost to Follow-up|0
4740192|NCT04353037|7694025|FG001|Overall Study|Lost to Follow-up|1
4740193|NCT04353037|7694026|FG002|Overall Study|Lost to Follow-up|2
4740194|NCT04353037|7694027|FG003|Overall Study|Lost to Follow-up|3
4740195|NCT04353037|7694024|FG000|Overall Study|Withdrawal by Subject|0
4740196|NCT04353037|7694025|FG001|Overall Study|Withdrawal by Subject|2
4740197|NCT04353037|7694026|FG002|Overall Study|Withdrawal by Subject|3
4740198|NCT04353037|7694027|FG003|Overall Study|Withdrawal by Subject|5
4740199|NCT04353037|7694024|FG000|Overall Study|Adverse Event|0
4740200|NCT04353037|7694025|FG001|Overall Study|Adverse Event|0
4740201|NCT04353037|7694026|FG002|Overall Study|Adverse Event|2
4740202|NCT04353037|7694027|FG003|Overall Study|Adverse Event|0
4740203|NCT04353037|7694024|FG000|Overall Study|Exposure Change|0
4740204|NCT04353037|7694025|FG001|Overall Study|Exposure Change|0
4740205|NCT04353037|7694026|FG002|Overall Study|Exposure Change|0
4740206|NCT04353037|7694027|FG003|Overall Study|Exposure Change|2
4740207|NCT04355767|7694047|FG000|Overall Study|Withdrawal by Subject|2
4740208|NCT04355767|7694048|FG001|Overall Study|Withdrawal by Subject|2
4740209|NCT04355767|7694047|FG000|Overall Study|Death|5
4740210|NCT04355767|7694048|FG001|Overall Study|Death|1
4740211|NCT04356573|7694056|FG000|Overall Study|Didn't Qualify|1
4740212|NCT04356573|7694057|FG001|Overall Study|Didn't Qualify|0
4740213|NCT04358068|7694069|FG000|Overall Study|Did not initiate study treatment|2
4740214|NCT04358068|7694070|FG001|Overall Study|Did not initiate study treatment|2
4740215|NCT04366349|7694082|FG000|Overall Study|Withdrawal by Subject|1
4740216|NCT04366349|7694083|FG001|Overall Study|Withdrawal by Subject|0
4740217|NCT04366349|7694084|FG002|Overall Study|Withdrawal by Subject|0
4740218|NCT04366349|7694085|FG003|Overall Study|Withdrawal by Subject|0
4740219|NCT04366349|7694086|FG004|Overall Study|Withdrawal by Subject|0
4740220|NCT04366349|7694087|FG005|Overall Study|Withdrawal by Subject|0
4740221|NCT04382053|7694131|FG000|Overall Study|Death|6
4740222|NCT04382053|7694132|FG001|Overall Study|Death|8
4740223|NCT04382053|7694131|FG000|Overall Study|Lost to Follow-up|0
4740224|NCT04382053|7694132|FG001|Overall Study|Lost to Follow-up|2
4740225|NCT04382053|7694131|FG000|Overall Study|Protocol Deviation|1
4524701|NCT01017952|7340357|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
4524702|NCT01017952|7340358|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11
4524703|NCT01017952|7340359|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
4524704|NCT01017952|7340360|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12
4524705|NCT01017952|7340361|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9
4524706|NCT01017952|7340357|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
4524707|NCT01017952|7340358|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
4524708|NCT01017952|7340359|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
4524709|NCT01017952|7340360|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
4524710|NCT01017952|7340361|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
4524711|NCT01017952|7340357|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0
4524712|NCT01017952|7340358|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6
4524713|NCT01017952|7340359|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8
4524714|NCT01017952|7340360|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6
4524715|NCT01017952|7340361|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10
4524716|NCT01017952|7340357|FG000|52-week, Double-blind Treatment Period|Physician Decision|0
4524717|NCT01017952|7340358|FG001|52-week, Double-blind Treatment Period|Physician Decision|10
4524718|NCT01017952|7340359|FG002|52-week, Double-blind Treatment Period|Physician Decision|8
4524719|NCT01017952|7340360|FG003|52-week, Double-blind Treatment Period|Physician Decision|9
4524720|NCT01017952|7340361|FG004|52-week, Double-blind Treatment Period|Physician Decision|7
4524721|NCT01018030|7340374|FG000|Overall Study|Adverse Event|10
4524722|NCT01018030|7340375|FG001|Overall Study|Adverse Event|5
4524723|NCT01018030|7340376|FG002|Overall Study|Adverse Event|5
4524724|NCT01018030|7340374|FG000|Overall Study|Withdrawal by Subject|2
4524725|NCT01018030|7340375|FG001|Overall Study|Withdrawal by Subject|2
4524726|NCT01018030|7340376|FG002|Overall Study|Withdrawal by Subject|4
4524727|NCT01018030|7340374|FG000|Overall Study|Lost to Follow-up|2
4524728|NCT01018030|7340375|FG001|Overall Study|Lost to Follow-up|0
4524729|NCT01018030|7340376|FG002|Overall Study|Lost to Follow-up|3
4524730|NCT01018030|7340374|FG000|Overall Study|Protocol Violation|2
4524731|NCT01018030|7340375|FG001|Overall Study|Protocol Violation|1
4524732|NCT01018030|7340376|FG002|Overall Study|Protocol Violation|0
4524733|NCT01018030|7340374|FG000|Overall Study|Physician Decision|1
4524734|NCT01018030|7340375|FG001|Overall Study|Physician Decision|0
4740226|NCT04382053|7694132|FG001|Overall Study|Protocol Deviation|2
4740227|NCT04382053|7694131|FG000|Overall Study|Withdrawal by Subject|2
4740228|NCT04382053|7694132|FG001|Overall Study|Withdrawal by Subject|1
4740229|NCT04388826|7694141|FG000|Overall Study|Lost to Follow-up|3
4740230|NCT04388826|7694142|FG001|Overall Study|Lost to Follow-up|2
4740231|NCT04388826|7694141|FG000|Overall Study|Adverse Event|1
4740232|NCT04388826|7694142|FG001|Overall Study|Adverse Event|0
4740233|NCT04398732|7694154|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50
4740234|NCT04401293|7694162|FG000|Overall Study|Withdrawal by Subject|1
4740235|NCT04401293|7694163|FG001|Overall Study|Withdrawal by Subject|3
4740236|NCT04411628|7694173|FG000|Overall Study|Withdrawal by Subject|1
4740237|NCT04411628|7694174|FG001|Overall Study|Withdrawal by Subject|1
4740238|NCT04411628|7694175|FG002|Overall Study|Withdrawal by Subject|2
4740239|NCT04411628|7694176|FG003|Overall Study|Withdrawal by Subject|0
4740240|NCT04411628|7694173|FG000|Overall Study|Lost to Follow-up|0
4740241|NCT04411628|7694174|FG001|Overall Study|Lost to Follow-up|1
4740242|NCT04411628|7694175|FG002|Overall Study|Lost to Follow-up|0
4740243|NCT04411628|7694176|FG003|Overall Study|Lost to Follow-up|0
4740244|NCT04428411|7694228|FG000|Overall Study|Lost to Follow-up|114
4740245|NCT04435184|7694237|FG000|Overall Study|follow-up blood draws missing|3
4740246|NCT04435184|7694238|FG001|Overall Study|follow-up blood draws missing|5
4740247|NCT04476784|7694246|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1
4740248|NCT04476784|7694247|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0
4740249|NCT04495283|7694279|FG000|Overall Study|Physician Decision|0
4740250|NCT04495283|7694280|FG001|Overall Study|Physician Decision|0
4740251|NCT04495283|7694281|FG002|Overall Study|Physician Decision|1
4740252|NCT04495283|7694279|FG000|Overall Study|Withdrawal by Subject|0
4740253|NCT04495283|7694280|FG001|Overall Study|Withdrawal by Subject|1
4740254|NCT04495283|7694281|FG002|Overall Study|Withdrawal by Subject|1
4740255|NCT04495283|7694279|FG000|Overall Study|Other|1
4740256|NCT04495283|7694280|FG001|Overall Study|Other|0
4740257|NCT04495283|7694281|FG002|Overall Study|Other|1
4740258|NCT04497948|7694292|FG000|Overall Study|Death|2
4740259|NCT04501952|7694319|FG000|Overall Study|Adverse Event|0
4740260|NCT04501952|7694320|FG001|Overall Study|Adverse Event|3
4740261|NCT04501952|7694319|FG000|Overall Study|Investigator's Discretion|0
4740262|NCT04501952|7694320|FG001|Overall Study|Investigator's Discretion|1
4740263|NCT04501952|7694319|FG000|Overall Study|Protocol Violation|1
4740264|NCT04501952|7694320|FG001|Overall Study|Protocol Violation|1
4740265|NCT04501952|7694319|FG000|Overall Study|Withdrew Consent|5
4740266|NCT04501952|7694320|FG001|Overall Study|Withdrew Consent|4
4740267|NCT04501952|7694319|FG000|Overall Study|Lost to Follow-up|7
4740268|NCT04501952|7694320|FG001|Overall Study|Lost to Follow-up|2
4740269|NCT04501952|7694319|FG000|Overall Study|Randomized and Never Treated|13
4740270|NCT04501952|7694320|FG001|Overall Study|Randomized and Never Treated|9
4740271|NCT04504032|7694329|FG000|Overall Study|Adverse Event|1
4740272|NCT04504032|7694330|FG001|Overall Study|Adverse Event|2
4740273|NCT04504032|7694329|FG000|Overall Study|Lost to Follow-up|6
4740274|NCT04504032|7694330|FG001|Overall Study|Lost to Follow-up|9
4740275|NCT04504032|7694329|FG000|Overall Study|Protocol Violation|2
4740276|NCT04504032|7694330|FG001|Overall Study|Protocol Violation|0
4740277|NCT04504032|7694329|FG000|Overall Study|Study terminated by sponsor|1
4740278|NCT04504032|7694330|FG001|Overall Study|Study terminated by sponsor|2
4740279|NCT04504032|7694329|FG000|Overall Study|Withdrawal by Subject|9
4740280|NCT04504032|7694330|FG001|Overall Study|Withdrawal by Subject|11
4740281|NCT04504032|7694329|FG000|Overall Study|Disease progression prior to dosing|15
4740282|NCT04504032|7694330|FG001|Overall Study|Disease progression prior to dosing|3
4740283|NCT04504032|7694329|FG000|Overall Study|Drug supply issues|1
4740284|NCT04504032|7694330|FG001|Overall Study|Drug supply issues|1
4740285|NCT04504032|7694329|FG000|Overall Study|Progressed to moderate/severe COVID-19|1
4740286|NCT04504032|7694330|FG001|Overall Study|Progressed to moderate/severe COVID-19|0
4740287|NCT04507763|7694336|FG000|Overall Study|Participants did not meet entrance criteria|201
4740288|NCT04507867|7694345|FG000|Overall Study|Death|7
4740289|NCT04507867|7694346|FG001|Overall Study|Death|1
4740290|NCT04527978|7694391|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1
4740291|NCT04527978|7694392|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0
4740292|NCT04529109|7694413|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0
4740293|NCT04529109|7694414|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1
4740294|NCT04601103|7694529|FG000|Overall Study|Needed crown & cleaning|0
4740295|NCT04601103|7694530|FG001|Overall Study|Needed crown & cleaning|0
4524735|NCT01018030|7340376|FG002|Overall Study|Physician Decision|1
4524736|NCT01018030|7340374|FG000|Overall Study|Lack of Efficacy|1
4524737|NCT01018030|7340375|FG001|Overall Study|Lack of Efficacy|0
4524738|NCT01018030|7340376|FG002|Overall Study|Lack of Efficacy|0
4524739|NCT01018030|7340374|FG000|Overall Study|Did Not Receive Study Drug|1
4524740|NCT01018030|7340375|FG001|Overall Study|Did Not Receive Study Drug|3
4524741|NCT01018030|7340376|FG002|Overall Study|Did Not Receive Study Drug|0
4524742|NCT01018186|7340439|FG000|2-week Run-in Period|Protocol Violation|1
4524743|NCT01018186|7340440|FG001|2-week Run-in Period|Protocol Violation|0
4524744|NCT01018186|7340441|FG002|2-week Run-in Period|Protocol Violation|0
4524745|NCT01018186|7340442|FG003|2-week Run-in Period|Protocol Violation|0
4524746|NCT01018186|7340439|FG000|2-week Run-in Period|Lost to Follow-up|2
4524747|NCT01018186|7340440|FG001|2-week Run-in Period|Lost to Follow-up|0
4524748|NCT01018186|7340441|FG002|2-week Run-in Period|Lost to Follow-up|0
4524749|NCT01018186|7340442|FG003|2-week Run-in Period|Lost to Follow-up|0
4524750|NCT01018186|7340439|FG000|2-week Run-in Period|Physician Decision|3
4524751|NCT01018186|7340440|FG001|2-week Run-in Period|Physician Decision|0
4524752|NCT01018186|7340441|FG002|2-week Run-in Period|Physician Decision|0
4524753|NCT01018186|7340442|FG003|2-week Run-in Period|Physician Decision|0
4524754|NCT01018186|7340439|FG000|2-week Run-in Period|Withdrawal by Subject|11
4524755|NCT01018186|7340440|FG001|2-week Run-in Period|Withdrawal by Subject|0
4524756|NCT01018186|7340441|FG002|2-week Run-in Period|Withdrawal by Subject|0
4524757|NCT01018186|7340442|FG003|2-week Run-in Period|Withdrawal by Subject|0
4524758|NCT01018186|7340439|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97
4524759|NCT01018186|7340440|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0
4524760|NCT01018186|7340441|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0
4524761|NCT01018186|7340442|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0
4524762|NCT01018186|7340439|FG000|52-week Double-blind Treatment Period|Adverse Event|0
4524763|NCT01018186|7340440|FG001|52-week Double-blind Treatment Period|Adverse Event|5
4524764|NCT01018186|7340441|FG002|52-week Double-blind Treatment Period|Adverse Event|3
4524765|NCT01018186|7340442|FG003|52-week Double-blind Treatment Period|Adverse Event|6
4524766|NCT01018186|7340439|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0
4524767|NCT01018186|7340440|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1
4524768|NCT01018186|7340441|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4
4524769|NCT01018186|7340442|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1
4740296|NCT04601103|7694531|FG002|Overall Study|Needed crown & cleaning|1
4740297|NCT04601103|7694529|FG000|Overall Study|study was terminated|18
4740298|NCT04601103|7694530|FG001|Overall Study|study was terminated|18
4740299|NCT04601103|7694531|FG002|Overall Study|study was terminated|16
4524770|NCT01018186|7340439|FG000|52-week Double-blind Treatment Period|Protocol Violation|0
4740300|NCT04664855|7694559|FG000|Overall Study|Withdrawal by Subject|0
4740301|NCT04664855|7694560|FG001|Overall Study|Withdrawal by Subject|2
4740302|NCT04701658|7694566|FG000|Overall Study|Lost to Follow-up|6
4740303|NCT04706416|7694572|FG000|Overall Study|Lost to Follow-up|2
4740304|NCT04706416|7694573|FG001|Overall Study|Lost to Follow-up|0
4740305|NCT04727749|7694593|FG000|Overall Study|Lost to Follow-up|10
4740306|NCT04727749|7694594|FG001|Overall Study|Lost to Follow-up|3
4740307|NCT04854707|7694616|FG000|Overall Study|Lack of Efficacy|78
4740308|NCT04854707|7694617|FG001|Overall Study|Lack of Efficacy|59
4740309|NCT04854707|7694618|FG002|Overall Study|Lack of Efficacy|30
4740310|NCT04947436|7694713|FG000|Overall Study|Lost to Follow-up|3
4740311|NCT04947436|7694714|FG001|Overall Study|Lost to Follow-up|7
4740312|NCT04947436|7694715|FG002|Overall Study|Lost to Follow-up|5
4740313|NCT04947436|7694713|FG000|Overall Study|Death|1
4740314|NCT04947436|7694714|FG001|Overall Study|Death|1
4740315|NCT04947436|7694715|FG002|Overall Study|Death|1
4740316|NCT05002972|7694723|FG000|Overall Study|Withdrawal by Subject|2
4740317|NCT05002985|7694727|FG000|Overall Study|Withdrawal by Subject|1
4740318|NCT04512482|7694733|FG000|Second Intervention (1 Day)|Protocol Violation|2
4740319|NCT04512482|7694734|FG001|Second Intervention (1 Day)|Protocol Violation|1
4740320|NCT04523831|7694759|FG000|Overall Study|Lost to Follow-up|15
4740321|NCT04523831|7694760|FG001|Overall Study|Lost to Follow-up|17
4740322|NCT04523831|7694759|FG000|Overall Study|Death|0
4740323|NCT04523831|7694760|FG001|Overall Study|Death|3
4740324|NCT04523831|7694759|FG000|Overall Study|Adverse Event|2
4740325|NCT04523831|7694760|FG001|Overall Study|Adverse Event|0
4740326|NCT04521777|7694769|FG000|Overall Study|Death|2
4740327|NCT04521777|7694769|FG000|Overall Study|Withdrawal by Subject|2
4740328|NCT04507776|7694799|FG000|Overall Study|Participants did not meet the entrance criteria|201
4740329|NCT04502979|7694810|FG000|Overall Study|Lost to Follow-up|1
4740330|NCT04502979|7694811|FG001|Overall Study|Lost to Follow-up|3
4740331|NCT04502979|7694810|FG000|Overall Study|Withdrawal by Subject|2
4740332|NCT04502979|7694811|FG001|Overall Study|Withdrawal by Subject|1
4740333|NCT04498403|7694854|FG000|Overall Study|Adverse Event|1
4740334|NCT04498403|7694855|FG001|Overall Study|Adverse Event|0
4740335|NCT04498403|7694854|FG000|Overall Study|Study Terminated By Sponsor|29
4740336|NCT04498403|7694855|FG001|Overall Study|Study Terminated By Sponsor|10
4740337|NCT04495374|7694863|FG000|Overall Study|Protocol Violation|2
4740338|NCT04495374|7694864|FG001|Overall Study|Protocol Violation|1
4740339|NCT04491994|7694888|FG000|Overall Study|Withdrawal by Subject|10
4740340|NCT04491994|7694889|FG001|Overall Study|Withdrawal by Subject|5
4740341|NCT04491994|7694888|FG000|Overall Study|developed fever > 3 days|4
4740342|NCT04491994|7694889|FG001|Overall Study|developed fever > 3 days|1
4740343|NCT04491994|7694888|FG000|Overall Study|Protocol Violation|11
4740344|NCT04491994|7694889|FG001|Overall Study|Protocol Violation|2
4740345|NCT04491994|7694888|FG000|Overall Study|Lost to Follow-up|4
4740346|NCT04491994|7694889|FG001|Overall Study|Lost to Follow-up|3
4740347|NCT04490499|7694912|FG000|Overall Study|Withdrawal by Subject|2
4740348|NCT04486235|7694922|FG000|Overall Study|Pregnancy|1
4740349|NCT04486235|7694923|FG001|Overall Study|Pregnancy|0
4740350|NCT04486235|7694922|FG000|Overall Study|Lost to Follow-up|1
4740351|NCT04486235|7694923|FG001|Overall Study|Lost to Follow-up|0
4740352|NCT04483011|7694932|FG000|Washout (7 Days)|Withdrawal by Subject|0
4740353|NCT04483011|7694933|FG001|Washout (7 Days)|Withdrawal by Subject|1
4740354|NCT04475588|7694943|FG000|Overall Study|Adverse Event|2
4740355|NCT04475588|7694944|FG001|Overall Study|Adverse Event|0
4740356|NCT04474405|7694970|FG000|Overall Study|Withdrawal by Subject|0
4740357|NCT04474405|7694971|FG001|Overall Study|Withdrawal by Subject|0
4740358|NCT04474405|7694972|FG002|Overall Study|Withdrawal by Subject|1
4740359|NCT04474405|7694973|FG003|Overall Study|Withdrawal by Subject|0
4740360|NCT04474405|7694974|FG004|Overall Study|Withdrawal by Subject|1
4740361|NCT04474405|7694975|FG005|Overall Study|Withdrawal by Subject|0
4740362|NCT04474405|7694970|FG000|Overall Study|Other|0
4740363|NCT04474405|7694971|FG001|Overall Study|Other|0
4740364|NCT04474405|7694972|FG002|Overall Study|Other|0
4740365|NCT04474405|7694973|FG003|Overall Study|Other|0
4740366|NCT04474405|7694974|FG004|Overall Study|Other|3
4740367|NCT04474405|7694975|FG005|Overall Study|Other|0
4740368|NCT04468347|7694997|FG000|Overall Study|Withdrawal by Subject|0
4740369|NCT04468347|7694998|FG001|Overall Study|Withdrawal by Subject|1
4740370|NCT04468347|7694999|FG002|Overall Study|Withdrawal by Subject|3
4740371|NCT04468347|7695000|FG003|Overall Study|Withdrawal by Subject|3
4740372|NCT04468347|7694997|FG000|Overall Study|Lost to Follow-up|0
4740373|NCT04468347|7694998|FG001|Overall Study|Lost to Follow-up|0
4740374|NCT04468347|7694999|FG002|Overall Study|Lost to Follow-up|1
4740375|NCT04468347|7695000|FG003|Overall Study|Lost to Follow-up|1
4740376|NCT04468347|7694997|FG000|Overall Study|Physician Decision|1
4740377|NCT04468347|7694998|FG001|Overall Study|Physician Decision|0
4740378|NCT04468347|7694999|FG002|Overall Study|Physician Decision|2
4740379|NCT04468347|7695000|FG003|Overall Study|Physician Decision|0
4740380|NCT04468347|7694997|FG000|Overall Study|Protocol Violation|1
4740381|NCT04468347|7694998|FG001|Overall Study|Protocol Violation|0
4740382|NCT04468347|7694999|FG002|Overall Study|Protocol Violation|0
4740383|NCT04468347|7695000|FG003|Overall Study|Protocol Violation|0
4740384|NCT04465422|7695025|FG000|Overall Study|Lost to Follow-up|0
4740385|NCT04465422|7695026|FG001|Overall Study|Lost to Follow-up|2
4740386|NCT04463069|7695045|FG000|Overall Study|Withdrawal by Subject|2
4740387|NCT04463069|7695046|FG001|Overall Study|Withdrawal by Subject|10
4740388|NCT04463069|7695045|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0
4740389|NCT04463069|7695046|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13
4740390|NCT04448561|7695054|FG000|Overall Study|Noncompliance|1
4740391|NCT04448561|7695055|FG001|Overall Study|Noncompliance|0
4740392|NCT04450381|7695130|FG000|Overall Study|Protocol Violation|4
4740393|NCT04450381|7695130|FG000|Overall Study|Wrong device setting|2
4740394|NCT04449341|7695136|FG000|Overall Study|Protocol Violation|1
4740395|NCT04449341|7695137|FG001|Overall Study|Protocol Violation|0
4740396|NCT04440449|7695154|FG000|Overall Study|Lost to Follow-up|2
4740397|NCT04440449|7695155|FG001|Overall Study|Lost to Follow-up|0
4740398|NCT04439214|7695162|FG000|Overall Study|Adverse Event|13
4740399|NCT04439214|7695162|FG000|Overall Study|Disease progression|16
4740400|NCT04439214|7695162|FG000|Overall Study|Death|1
4740401|NCT04439214|7695162|FG000|Overall Study|Withdrawal by Subject|2
4740402|NCT04439214|7695162|FG000|Overall Study|Declining health|1
4740403|NCT04439214|7695162|FG000|Overall Study|Still receiving treatment at the time of the analysis|9
4740404|NCT04439214|7695162|FG000|Overall Study|Ineligible|5
4740405|NCT04439240|7695166|FG000|Overall Study|Ineligible|2
4740406|NCT04439240|7695166|FG000|Overall Study|Never started treatment|2
4524771|NCT01018186|7340440|FG001|52-week Double-blind Treatment Period|Protocol Violation|8
4524772|NCT01018186|7340441|FG002|52-week Double-blind Treatment Period|Protocol Violation|8
4524773|NCT01018186|7340442|FG003|52-week Double-blind Treatment Period|Protocol Violation|2
4524774|NCT01018186|7340439|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0
4524775|NCT01018186|7340440|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14
4524776|NCT01018186|7340441|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16
4524777|NCT01018186|7340442|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4
4524778|NCT01018186|7340439|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0
4524779|NCT01018186|7340440|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1
4524780|NCT01018186|7340441|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3
4524781|NCT01018186|7340442|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4
4524782|NCT01018186|7340439|FG000|52-week Double-blind Treatment Period|Physician Decision|0
4524783|NCT01018186|7340440|FG001|52-week Double-blind Treatment Period|Physician Decision|1
4524784|NCT01018186|7340441|FG002|52-week Double-blind Treatment Period|Physician Decision|0
4524785|NCT01018186|7340442|FG003|52-week Double-blind Treatment Period|Physician Decision|3
4524786|NCT01018186|7340439|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0
4524787|NCT01018186|7340440|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10
4524788|NCT01018186|7340441|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7
4524789|NCT01018186|7340442|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9
4524790|NCT01018264|7340456|FG000|Overall Study|Withdrawal by Subject|1
4524791|NCT01018264|7340457|FG001|Overall Study|Withdrawal by Subject|0
4524792|NCT01018264|7340456|FG000|Overall Study|Lost to Follow-up|0
4524793|NCT01018264|7340457|FG001|Overall Study|Lost to Follow-up|1
4524794|NCT01018394|7340465|FG000|Overall Study|Withdrawal by Subject|5
4524795|NCT01018394|7340466|FG001|Overall Study|Withdrawal by Subject|5
4524796|NCT01018394|7340465|FG000|Overall Study|Lost to Follow-up|4
4524797|NCT01018394|7340466|FG001|Overall Study|Lost to Follow-up|3
4524798|NCT01018511|7340502|FG000|Overall Study|Not fulfilling eligibility criteria|6
4524799|NCT01018511|7340503|FG001|Overall Study|Not fulfilling eligibility criteria|7
4524800|NCT01018511|7340504|FG002|Overall Study|Not fulfilling eligibility criteria|7
4524801|NCT01018511|7340505|FG003|Overall Study|Not fulfilling eligibility criteria|3
4524802|NCT01018511|7340502|FG000|Overall Study|Adverse Event|5
4524803|NCT01018511|7340503|FG001|Overall Study|Adverse Event|9
4524804|NCT01018511|7340504|FG002|Overall Study|Adverse Event|13
4524805|NCT01018511|7340505|FG003|Overall Study|Adverse Event|10
4524806|NCT01018511|7340502|FG000|Overall Study|Lack of Efficacy|4
4524807|NCT01018511|7340503|FG001|Overall Study|Lack of Efficacy|1
4524808|NCT01018511|7340504|FG002|Overall Study|Lack of Efficacy|1
4524809|NCT01018511|7340505|FG003|Overall Study|Lack of Efficacy|2
4524810|NCT01018511|7340502|FG000|Overall Study|Withdrawal by Subject|6
4524811|NCT01018511|7340503|FG001|Overall Study|Withdrawal by Subject|5
4524812|NCT01018511|7340504|FG002|Overall Study|Withdrawal by Subject|11
4524813|NCT01018511|7340505|FG003|Overall Study|Withdrawal by Subject|9
4524814|NCT01018511|7340502|FG000|Overall Study|Lost to Follow-up|0
4524815|NCT01018511|7340503|FG001|Overall Study|Lost to Follow-up|0
4524816|NCT01018511|7340504|FG002|Overall Study|Lost to Follow-up|1
4740407|NCT04439240|7695166|FG000|Overall Study|Adverse Event|12
4740408|NCT04439240|7695166|FG000|Overall Study|Death|2
4740409|NCT04439240|7695166|FG000|Overall Study|Disease progression|25
4740410|NCT04439240|7695166|FG000|Overall Study|Other diseases|2
4740411|NCT04439240|7695166|FG000|Overall Study|Withdrawal by Subject|3
4740412|NCT04439240|7695166|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1
4740413|NCT04439240|7695166|FG000|Overall Study|Symptomatic decline|1
4740414|NCT04439240|7695166|FG000|Overall Study|Pogression of the lymphadenopathy|1
4740415|NCT04439240|7695166|FG000|Overall Study|Clinical progression|1
4740416|NCT04438785|7695172|FG000|Overall Study|change of weight, give up intervention|2
4740417|NCT04438785|7695173|FG001|Overall Study|change of weight, give up intervention|10
4740418|NCT04428502|7695262|FG000|Overall Study|Did not meet entrance criteria|14
4740419|NCT04428424|7695267|FG000|Overall Study|Does not meet entrance criteria|132
4740420|NCT04428424|7695267|FG000|Overall Study|Lost to Follow-up|115
4740421|NCT04425863|7695311|FG000|Overall Study|Death|0
4740422|NCT04425863|7695312|FG001|Overall Study|Death|0
4740423|NCT04425863|7695313|FG002|Overall Study|Death|1
4740424|NCT04422561|7695346|FG000|Overall Study|Lost to Follow-up|25
4740425|NCT04422561|7695347|FG001|Overall Study|Lost to Follow-up|11
4740426|NCT04419311|7695364|FG000|Overall Study|Lost to Follow-up|1
4740427|NCT04419311|7695365|FG001|Overall Study|Lost to Follow-up|0
4740428|NCT04411667|7695385|FG000|Overall Study|Physician Decision|1
4740429|NCT04411667|7695386|FG001|Overall Study|Physician Decision|0
4740430|NCT04407507|7695398|FG000|Overall Study|Withdrawal by Subject|0
4740431|NCT04407507|7695399|FG001|Overall Study|Withdrawal by Subject|1
4740432|NCT04406194|7695407|FG000|Period 1|Withdrawal by Subject|0
4740433|NCT04406194|7695408|FG001|Period 1|Withdrawal by Subject|1
4740434|NCT04404010|7695428|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1
4740435|NCT04404010|7695429|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0
4740436|NCT04403399|7695439|FG000|Period 2|Physician Decision|0
4740437|NCT04403399|7695440|FG001|Period 2|Physician Decision|1
4740438|NCT04401202|7695470|FG000|Overall Study|Lost to Follow-up|2
4740439|NCT04401202|7695471|FG001|Overall Study|Lost to Follow-up|2
4740440|NCT04401202|7695470|FG000|Overall Study|Adverse Event|0
4740441|NCT04401202|7695471|FG001|Overall Study|Adverse Event|1
4740442|NCT04401202|7695470|FG000|Overall Study|Hospitalized|4
4740443|NCT04401202|7695471|FG001|Overall Study|Hospitalized|1
4740444|NCT04400682|7695480|FG000|Period 1|Withdrawal by Subject|1
4740445|NCT04400682|7695481|FG001|Period 1|Withdrawal by Subject|4
4740446|NCT04399161|7695490|FG000|Overall Study|Withdrawal by Subject|1
4740447|NCT04399161|7695491|FG001|Overall Study|Withdrawal by Subject|0
4633952|NCT01919112|7504441|FG001|Secondary Analysis-day 30|Lost to Follow-up|0
4740448|NCT04399161|7695492|FG002|Overall Study|Withdrawal by Subject|2
4740449|NCT04399161|7695490|FG000|Overall Study|Protocol Violation|1
4740450|NCT04399161|7695491|FG001|Overall Study|Protocol Violation|2
4740451|NCT04399161|7695492|FG002|Overall Study|Protocol Violation|0
4740452|NCT04399122|7695511|FG000|Overall Study|Lost to Follow-up|2
4740453|NCT04399122|7695512|FG001|Overall Study|Lost to Follow-up|0
4633953|NCT01919112|7504442|FG002|Secondary Analysis-day 30|Lost to Follow-up|0
4633954|NCT01919164|7504455|FG000|Overall Study|Adverse Event|6
4633955|NCT01919164|7504456|FG001|Overall Study|Adverse Event|4
4633956|NCT01919164|7504457|FG002|Overall Study|Adverse Event|9
4633957|NCT01919164|7504458|FG003|Overall Study|Adverse Event|3
4633958|NCT01919164|7504459|FG004|Overall Study|Adverse Event|2
4633959|NCT01919164|7504455|FG000|Overall Study|Lost to Follow-up|2
4633960|NCT01919164|7504456|FG001|Overall Study|Lost to Follow-up|2
4633961|NCT01919164|7504457|FG002|Overall Study|Lost to Follow-up|2
4633962|NCT01919164|7504458|FG003|Overall Study|Lost to Follow-up|0
4633963|NCT01919164|7504459|FG004|Overall Study|Lost to Follow-up|4
4633964|NCT01919164|7504455|FG000|Overall Study|Death|1
4633965|NCT01919164|7504456|FG001|Overall Study|Death|0
4633966|NCT01919164|7504457|FG002|Overall Study|Death|0
4633967|NCT01919164|7504458|FG003|Overall Study|Death|0
4633968|NCT01919164|7504459|FG004|Overall Study|Death|0
4633969|NCT01919164|7504455|FG000|Overall Study|Protocol Violation|6
4633970|NCT01919164|7504456|FG001|Overall Study|Protocol Violation|0
4633971|NCT01919164|7504457|FG002|Overall Study|Protocol Violation|3
4633972|NCT01919164|7504458|FG003|Overall Study|Protocol Violation|2
4633973|NCT01919164|7504459|FG004|Overall Study|Protocol Violation|2
4633974|NCT01919164|7504455|FG000|Overall Study|Disease progression|2
4633975|NCT01919164|7504456|FG001|Overall Study|Disease progression|2
4633976|NCT01919164|7504457|FG002|Overall Study|Disease progression|1
4633977|NCT01919164|7504458|FG003|Overall Study|Disease progression|2
4633978|NCT01919164|7504459|FG004|Overall Study|Disease progression|1
4633979|NCT01919164|7504455|FG000|Overall Study|Withdrew consent|13
4633980|NCT01919164|7504456|FG001|Overall Study|Withdrew consent|13
4633981|NCT01919164|7504457|FG002|Overall Study|Withdrew consent|14
4633982|NCT01919164|7504458|FG003|Overall Study|Withdrew consent|14
4740454|NCT04399122|7695511|FG000|Overall Study|Withdrawal by Subject|1
4740455|NCT04399122|7695512|FG001|Overall Study|Withdrawal by Subject|0
4740456|NCT04397445|7695518|FG000|Overall Study|Withdrawal by Subject|1
4740457|NCT04397445|7695519|FG001|Overall Study|Withdrawal by Subject|0
4740458|NCT04397445|7695520|FG002|Overall Study|Withdrawal by Subject|0
4633983|NCT01919164|7504459|FG004|Overall Study|Withdrew consent|9
4633984|NCT01919164|7504455|FG000|Overall Study|Other Un-specified|13
4633985|NCT01919164|7504456|FG001|Overall Study|Other Un-specified|9
4633986|NCT01919164|7504457|FG002|Overall Study|Other Un-specified|8
4740459|NCT04397445|7695521|FG003|Overall Study|Withdrawal by Subject|0
4740460|NCT04396639|7695547|FG000|Overall Study|Withdrawal by Subject|1
4740461|NCT04396639|7695547|FG000|Overall Study|Other|1
4740462|NCT04393493|7695566|FG000|First 4 Days of Intervention|Early improvement|5
4740463|NCT04393493|7695567|FG001|First 4 Days of Intervention|Early improvement|7
4740464|NCT04391842|7695666|FG000|Overall Study|Withdrawal by Subject|2
4740465|NCT04386902|7695679|FG000|Overall Study|Withdrawal by Subject|5
4740466|NCT04386902|7695679|FG000|Overall Study|Technical problems in the recording|5
4740467|NCT04384523|7695698|FG000|Overall Study|Lost to Follow-up|0
4740468|NCT04384523|7695699|FG001|Overall Study|Lost to Follow-up|0
4740469|NCT04384523|7695700|FG002|Overall Study|Lost to Follow-up|0
4740470|NCT04384523|7695701|FG003|Overall Study|Lost to Follow-up|0
4740471|NCT04384523|7695702|FG004|Overall Study|Lost to Follow-up|0
4740472|NCT04384523|7695703|FG005|Overall Study|Lost to Follow-up|1
4740473|NCT04384523|7695698|FG000|Overall Study|Protocol Violation|0
4740474|NCT04384523|7695699|FG001|Overall Study|Protocol Violation|1
4740475|NCT04384523|7695700|FG002|Overall Study|Protocol Violation|0
4740476|NCT04384523|7695701|FG003|Overall Study|Protocol Violation|0
4740477|NCT04384523|7695702|FG004|Overall Study|Protocol Violation|0
4740478|NCT04384523|7695703|FG005|Overall Study|Protocol Violation|0
4740479|NCT04384523|7695698|FG000|Overall Study|Withdrawal by Subject|1
4740480|NCT04384523|7695699|FG001|Overall Study|Withdrawal by Subject|0
4740481|NCT04384523|7695700|FG002|Overall Study|Withdrawal by Subject|0
4740482|NCT04384523|7695701|FG003|Overall Study|Withdrawal by Subject|0
4740483|NCT04384523|7695702|FG004|Overall Study|Withdrawal by Subject|0
4740484|NCT04384523|7695703|FG005|Overall Study|Withdrawal by Subject|0
4740485|NCT04382066|7695748|FG000|Overall Study|Adverse Event|1
4740486|NCT04382066|7695749|FG001|Overall Study|Adverse Event|0
4740487|NCT04382066|7695750|FG002|Overall Study|Adverse Event|0
4740488|NCT04382066|7695748|FG000|Overall Study|Death|1
4740489|NCT04382066|7695749|FG001|Overall Study|Death|0
4740490|NCT04382066|7695750|FG002|Overall Study|Death|1
4740491|NCT04380688|7695811|FG000|Overall Study|Death|2
4740492|NCT04380688|7695812|FG001|Overall Study|Death|2
4740493|NCT04380688|7695811|FG000|Overall Study|Lost to Follow-up|2
4740494|NCT04380688|7695812|FG001|Overall Study|Lost to Follow-up|4
4740495|NCT04380688|7695811|FG000|Overall Study|Withdrawal by Subject|3
4740496|NCT04380688|7695812|FG001|Overall Study|Withdrawal by Subject|3
4740497|NCT04376060|7695818|FG000|Overall Study|Physician Decision|1
4740498|NCT04372186|7695837|FG000|Overall Study|Death|24
4740499|NCT04372186|7695838|FG001|Overall Study|Death|11
4740500|NCT04372186|7695837|FG000|Overall Study|Transferred to a different facility for care|0
4740501|NCT04372186|7695838|FG001|Overall Study|Transferred to a different facility for care|2
4740502|NCT04370028|7695912|FG000|Overall Study|Withdrawal by Subject|695
4740503|NCT04370028|7695912|FG000|Overall Study|Protocol Violation|9
4740504|NCT04370028|7695912|FG000|Overall Study|Adverse Event|3
4740505|NCT04363736|7695925|FG000|Overall Study|Withdrawal by Subject|1
4740506|NCT04363736|7695926|FG001|Overall Study|Withdrawal by Subject|0
4740507|NCT04363736|7695925|FG000|Overall Study|Lost to Follow-up|10
4740508|NCT04363736|7695926|FG001|Overall Study|Lost to Follow-up|7
4740509|NCT04363736|7695925|FG000|Overall Study|Death|8
4740510|NCT04363736|7695926|FG001|Overall Study|Death|6
4740511|NCT04365699|7695944|FG000|Overall Study|Death|2
4740512|NCT04365699|7695945|FG001|Overall Study|Death|5
4740513|NCT04365699|7695946|FG002|Overall Study|Death|15
4740514|NCT04362137|7695979|FG000|Overall Study|Death|9
4740515|NCT04362137|7695980|FG001|Overall Study|Death|3
4740516|NCT04362137|7695979|FG000|Overall Study|Patient decision|6
4740517|NCT04362137|7695980|FG001|Overall Study|Patient decision|3
4740518|NCT04362137|7695979|FG000|Overall Study|Adverse Event|1
4740519|NCT04362137|7695980|FG001|Overall Study|Adverse Event|0
4740520|NCT04362137|7695979|FG000|Overall Study|Lost to Follow-up|1
4740521|NCT04362137|7695980|FG001|Overall Study|Lost to Follow-up|0
4740522|NCT04362137|7695979|FG000|Overall Study|Protocol deviation|1
4740523|NCT04362137|7695980|FG001|Overall Study|Protocol deviation|0
4740524|NCT04359771|7695988|FG000|Overall Study|Lack of Efficacy|2
4740525|NCT04359771|7695989|FG001|Overall Study|Lack of Efficacy|2
4740526|NCT04358081|7696002|FG000|Treatment Phase of Study|Withdrawal by Subject|0
4740527|NCT04358081|7696003|FG001|Treatment Phase of Study|Withdrawal by Subject|1
4740528|NCT04358081|7696004|FG002|Treatment Phase of Study|Withdrawal by Subject|1
4740529|NCT04358081|7696002|FG000|Treatment Phase of Study|Adverse Event|1
4740530|NCT04358081|7696003|FG001|Treatment Phase of Study|Adverse Event|0
4740531|NCT04358081|7696004|FG002|Treatment Phase of Study|Adverse Event|1
4740532|NCT04358081|7696002|FG000|Treatment Phase of Study|Physician Decision|2
4740533|NCT04358081|7696003|FG001|Treatment Phase of Study|Physician Decision|0
4740534|NCT04358081|7696004|FG002|Treatment Phase of Study|Physician Decision|1
4740535|NCT04358081|7696002|FG000|Treatment Phase of Study|Protocol Violation|1
4740536|NCT04358081|7696003|FG001|Treatment Phase of Study|Protocol Violation|0
4740537|NCT04358081|7696004|FG002|Treatment Phase of Study|Protocol Violation|0
4740538|NCT04358081|7696002|FG000|Study Completion Phase|Death|0
4740539|NCT04358081|7696003|FG001|Study Completion Phase|Death|0
4740540|NCT04358081|7696004|FG002|Study Completion Phase|Death|1
4740541|NCT04358081|7696002|FG000|Study Completion Phase|Lost to Follow-up|1
4740542|NCT04358081|7696003|FG001|Study Completion Phase|Lost to Follow-up|0
4740543|NCT04358081|7696004|FG002|Study Completion Phase|Lost to Follow-up|1
4740544|NCT04356937|7696016|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0
4740545|NCT04356937|7696017|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1
4740546|NCT04355663|7696026|FG000|Overall Study|Physician Decision|2
4740547|NCT04355663|7696027|FG001|Overall Study|Physician Decision|7
4740548|NCT04355663|7696028|FG002|Overall Study|Physician Decision|0
4740549|NCT04355663|7696026|FG000|Overall Study|Adverse Event|0
4740550|NCT04355663|7696027|FG001|Overall Study|Adverse Event|0
4740551|NCT04355663|7696028|FG002|Overall Study|Adverse Event|1
4740552|NCT04355663|7696026|FG000|Overall Study|Withdrawal by Subject|0
4740553|NCT04355663|7696027|FG001|Overall Study|Withdrawal by Subject|8
4740554|NCT04355663|7696028|FG002|Overall Study|Withdrawal by Subject|3
4740555|NCT04354870|7696038|FG000|Overall Study|Lost to Follow-up|32
4740556|NCT04354870|7696039|FG001|Overall Study|Lost to Follow-up|12
4740557|NCT04354870|7696038|FG000|Overall Study|Withdrawal by Subject|10
4740558|NCT04354870|7696039|FG001|Overall Study|Withdrawal by Subject|16
4740559|NCT04354870|7696038|FG000|Overall Study|Did not complete all study visits|6
4740560|NCT04354870|7696039|FG001|Overall Study|Did not complete all study visits|5
4740561|NCT04350788|7696065|FG000|Overall Study|Lost to Follow-up|6
4740562|NCT04350788|7696066|FG001|Overall Study|Lost to Follow-up|2
4740563|NCT04350788|7696065|FG000|Overall Study|Withdrawal by Subject|2
4740564|NCT04350788|7696066|FG001|Overall Study|Withdrawal by Subject|4
4740565|NCT04350788|7696065|FG000|Overall Study|Protocol Violation|4
4740566|NCT04350788|7696066|FG001|Overall Study|Protocol Violation|0
4740567|NCT04349917|7696079|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0
4740568|NCT04349917|7696080|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1
4740569|NCT04349917|7696079|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0
4740570|NCT04349917|7696080|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1
4524817|NCT01018511|7340505|FG003|Overall Study|Lost to Follow-up|0
4524818|NCT01018511|7340502|FG000|Overall Study|Protocol Violation|5
4524819|NCT01018511|7340503|FG001|Overall Study|Protocol Violation|8
4524820|NCT01018511|7340504|FG002|Overall Study|Protocol Violation|7
4524821|NCT01018511|7340505|FG003|Overall Study|Protocol Violation|9
4524822|NCT01018511|7340502|FG000|Overall Study|Miscellaneous|0
4524823|NCT01018511|7340503|FG001|Overall Study|Miscellaneous|2
4524824|NCT01018511|7340504|FG002|Overall Study|Miscellaneous|0
4524825|NCT01018511|7340505|FG003|Overall Study|Miscellaneous|0
4524826|NCT01018680|7340523|FG000|Overall Study|Adverse Event|23
4524827|NCT01018680|7340524|FG001|Overall Study|Adverse Event|40
4524828|NCT01018680|7340523|FG000|Overall Study|Withdrawal by Subject|10
4524829|NCT01018680|7340524|FG001|Overall Study|Withdrawal by Subject|10
4524830|NCT01018680|7340523|FG000|Overall Study|Protocol Violation|5
4740571|NCT04348851|7696091|FG000|Post-Test 1|Withdrawal by Subject|0
4740572|NCT04348851|7696092|FG001|Post-Test 1|Withdrawal by Subject|1
4740573|NCT04348851|7696093|FG002|Post-Test 1|Withdrawal by Subject|0
4740574|NCT04348851|7696094|FG003|Post-Test 1|Withdrawal by Subject|0
4524831|NCT01018680|7340524|FG001|Overall Study|Protocol Violation|8
4740575|NCT04348851|7696091|FG000|Post-Test 1|Lost to Follow-up|0
4740576|NCT04348851|7696092|FG001|Post-Test 1|Lost to Follow-up|1
4740577|NCT04348851|7696093|FG002|Post-Test 1|Lost to Follow-up|0
4740578|NCT04348851|7696094|FG003|Post-Test 1|Lost to Follow-up|0
4740579|NCT04348851|7696091|FG000|Post-Test 2|Stroke survivor death|0
4740580|NCT04348851|7696092|FG001|Post-Test 2|Stroke survivor death|1
4740581|NCT04348851|7696093|FG002|Post-Test 2|Stroke survivor death|0
4740582|NCT04348851|7696094|FG003|Post-Test 2|Stroke survivor death|1
4740583|NCT04346199|7696115|FG000|Overall Study|Death|8
4740584|NCT04346199|7696116|FG001|Overall Study|Death|9
4740585|NCT04346199|7696115|FG000|Overall Study|Lost to Follow-up|0
4740586|NCT04346199|7696116|FG001|Overall Study|Lost to Follow-up|1
4740587|NCT04346199|7696115|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2
4740588|NCT04346199|7696116|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0
4740589|NCT04346199|7696115|FG000|Overall Study|Withdrawal by Subject|5
4740590|NCT04346199|7696116|FG001|Overall Study|Withdrawal by Subject|1
4740591|NCT04345653|7696122|FG000|Overall Study|Withdrawal by Subject|2
4740592|NCT04343261|7696127|FG000|Overall Study|Adverse Event|1
4740593|NCT04343261|7696127|FG000|Overall Study|received inadequate amount of antibodies|7
4740594|NCT04342897|7696159|FG000|Overall Study|Death|7
4740595|NCT04342897|7696160|FG001|Overall Study|Death|4
4740596|NCT04342897|7696159|FG000|Overall Study|Lost to Follow-up|6
4740597|NCT04342897|7696160|FG001|Overall Study|Lost to Follow-up|6
4740598|NCT04342897|7696159|FG000|Overall Study|Withdrawal by Subject|1
4740599|NCT04342897|7696160|FG001|Overall Study|Withdrawal by Subject|2
4740600|NCT04340557|7696172|FG000|Overall Study|Transferred to ICU and/or death|1
4740601|NCT04340557|7696173|FG001|Overall Study|Transferred to ICU and/or death|2
4740602|NCT04339972|7696181|FG000|Overall Study|Scheduling Issues|3
4740603|NCT04339972|7696182|FG001|Overall Study|Scheduling Issues|3
4740604|NCT04339972|7696181|FG000|Overall Study|dropout|1
4740605|NCT04339972|7696182|FG001|Overall Study|dropout|1
4740606|NCT04339972|7696181|FG000|Overall Study|Technical issues|1
4740607|NCT04339972|7696182|FG001|Overall Study|Technical issues|0
4740608|NCT04339972|7696181|FG000|Overall Study|Claustraphobia|0
4740609|NCT04339972|7696182|FG001|Overall Study|Claustraphobia|1
4740610|NCT04339296|7696190|FG000|Overall Study|Refuse to participate after allocation|1
4740611|NCT04339296|7696191|FG001|Overall Study|Refuse to participate after allocation|1
4740612|NCT04339296|7696190|FG000|Overall Study|Withdrew after completion of baseline|2
4740613|NCT04339296|7696191|FG001|Overall Study|Withdrew after completion of baseline|1
4740614|NCT04339296|7696190|FG000|Overall Study|Lost to Follow-up|0
4740615|NCT04339296|7696191|FG001|Overall Study|Lost to Follow-up|4
4740616|NCT04339296|7696190|FG000|Overall Study|Discontinued intervention|5
4740617|NCT04339296|7696191|FG001|Overall Study|Discontinued intervention|3
4740618|NCT04336475|7696221|FG000|Overall Study|pain|1
4740619|NCT04336475|7696222|FG001|Overall Study|pain|0
4740620|NCT04336475|7696221|FG000|Overall Study|upper respiratory infection|1
4740621|NCT04336475|7696222|FG001|Overall Study|upper respiratory infection|0
4740622|NCT04336475|7696221|FG000|Overall Study|Lost to Follow-up|0
4740623|NCT04336475|7696222|FG001|Overall Study|Lost to Follow-up|2
4740624|NCT04335929|7696228|FG000|Overall Study|Lost to Follow-up|10
4740625|NCT04335812|7696234|FG000|Overall Study|Withdrawal by Subject|1
4740626|NCT04335812|7696235|FG001|Overall Study|Withdrawal by Subject|3
4740627|NCT04335812|7696234|FG000|Overall Study|Lost to Follow-up|12
4740628|NCT04335812|7696235|FG001|Overall Study|Lost to Follow-up|12
4740629|NCT04335812|7696234|FG000|Overall Study|Did not engage in the intervention|22
4740630|NCT04335812|7696235|FG001|Overall Study|Did not engage in the intervention|18
4740631|NCT04335136|7696243|FG000|Overall Study|Death|8
4740632|NCT04335136|7696244|FG001|Overall Study|Death|4
4740633|NCT04335136|7696243|FG000|Overall Study|Lost to Follow-up|2
4740634|NCT04335136|7696244|FG001|Overall Study|Lost to Follow-up|0
4740635|NCT04335136|7696243|FG000|Overall Study|Protocol Violation|1
4740636|NCT04335136|7696244|FG001|Overall Study|Protocol Violation|0
4740637|NCT04335136|7696243|FG000|Overall Study|Withdrawal by Subject|1
4740638|NCT04335136|7696244|FG001|Overall Study|Withdrawal by Subject|1
4740639|NCT04335136|7696243|FG000|Overall Study|Health-threatening condition|0
4740640|NCT04335136|7696244|FG001|Overall Study|Health-threatening condition|1
4740641|NCT04335136|7696243|FG000|Overall Study|Adverse Event|0
4740642|NCT04335136|7696244|FG001|Overall Study|Adverse Event|1
4740643|NCT04335136|7696243|FG000|Overall Study|Erroneously randomized|2
4740644|NCT04335136|7696244|FG001|Overall Study|Erroneously randomized|0
4740645|NCT04333199|7696294|FG000|Evaluated Patients|Lost to Follow-up|0
4740646|NCT04333199|7696295|FG001|Evaluated Patients|Lost to Follow-up|1
4740647|NCT04333199|7696296|FG002|Evaluated Patients|Lost to Follow-up|2
4740648|NCT04332419|7696357|FG000|Overall Study|Withdrawal by Subject|1
4740649|NCT04332107|7696372|FG000|Day 3|Lost to Follow-up|23
4740650|NCT04332107|7696373|FG001|Day 3|Lost to Follow-up|14
4740651|NCT04332107|7696372|FG000|Day 3|Missing outcome data|3
4740652|NCT04332107|7696373|FG001|Day 3|Missing outcome data|6
4740653|NCT04332107|7696372|FG000|Day 14|Lost to Follow-up|13
4740654|NCT04332107|7696373|FG001|Day 14|Lost to Follow-up|4
4740655|NCT04332107|7696372|FG000|Day 14|Missing outcome data|4
4740656|NCT04332107|7696373|FG001|Day 14|Missing outcome data|4
4740657|NCT04332107|7696372|FG000|Day 21|Lost to Follow-up|10
4740658|NCT04332107|7696373|FG001|Day 21|Lost to Follow-up|2
4740659|NCT04329923|7696407|FG000|Overall Study|Withdrawal by Subject|1
4740660|NCT04329923|7696408|FG001|Overall Study|Withdrawal by Subject|4
4740661|NCT04329923|7696409|FG002|Overall Study|Withdrawal by Subject|1
4740662|NCT04329923|7696410|FG003|Overall Study|Withdrawal by Subject|1
4740663|NCT04329923|7696411|FG004|Overall Study|Withdrawal by Subject|1
4740664|NCT04329923|7696412|FG005|Overall Study|Withdrawal by Subject|1
4740665|NCT04329923|7696407|FG000|Overall Study|early termination of study|0
4740666|NCT04329923|7696408|FG001|Overall Study|early termination of study|0
4740667|NCT04329923|7696409|FG002|Overall Study|early termination of study|0
4740668|NCT04329923|7696410|FG003|Overall Study|early termination of study|0
4740669|NCT04329923|7696411|FG004|Overall Study|early termination of study|1
4740670|NCT04329923|7696412|FG005|Overall Study|early termination of study|2
4740671|NCT04329923|7696407|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0
4740672|NCT04329923|7696408|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0
4740673|NCT04329923|7696409|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0
4740674|NCT04329923|7696410|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0
4740675|NCT04329923|7696411|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0
4740676|NCT04329923|7696412|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2
4740677|NCT04328467|7696429|FG000|Overall Study|Did not meet inclusion criteria after randomization|4
4740678|NCT04328467|7696430|FG001|Overall Study|Did not meet inclusion criteria after randomization|2
4740679|NCT04328467|7696431|FG002|Overall Study|Did not meet inclusion criteria after randomization|1
4740680|NCT04322526|7696441|FG000|First Intervention (1 Day)|Withdrawal by Subject|1
4740681|NCT04322526|7696442|FG001|First Intervention (1 Day)|Withdrawal by Subject|1
4740682|NCT04322526|7696441|FG000|Washout (1 Week)|Lost to Follow-up|1
4740683|NCT04322526|7696442|FG001|Washout (1 Week)|Lost to Follow-up|2
4740684|NCT04322682|7696459|FG000|Overall Study|Withdrawal by Subject|33
4740685|NCT04322682|7696460|FG001|Overall Study|Withdrawal by Subject|47
4740686|NCT04322682|7696459|FG000|Overall Study|Death|5
4740687|NCT04322682|7696460|FG001|Overall Study|Death|9
4740688|NCT04322682|7696459|FG000|Overall Study|Lost to Follow-up|4
4740689|NCT04322682|7696460|FG001|Overall Study|Lost to Follow-up|8
4740690|NCT04322682|7696459|FG000|Overall Study|Admitted to Hospital and Intubated|1
4740691|NCT04322682|7696460|FG001|Overall Study|Admitted to Hospital and Intubated|0
4740692|NCT04320615|7696511|FG000|Overall Study|Withdrawal by Subject|4
4740693|NCT04320615|7696512|FG001|Overall Study|Withdrawal by Subject|10
4740694|NCT04320615|7696511|FG000|Overall Study|Physician Decision|2
4740695|NCT04320615|7696512|FG001|Overall Study|Physician Decision|0
4740696|NCT04320615|7696511|FG000|Overall Study|Other|2
4740697|NCT04320615|7696512|FG001|Overall Study|Other|0
4740698|NCT04320615|7696511|FG000|Overall Study|Lost to Follow-up|5
4740699|NCT04320615|7696512|FG001|Overall Study|Lost to Follow-up|23
4740700|NCT04320615|7696511|FG000|Overall Study|Death|35
4740701|NCT04320615|7696512|FG001|Overall Study|Death|71
4740702|NCT04318535|7696522|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0
4740703|NCT04318535|7696523|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1
4740704|NCT04318535|7696524|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0
4740705|NCT04314037|7696545|FG000|Treatment Period 2|Adverse Event|1
4740706|NCT04314037|7696546|FG001|Treatment Period 2|Adverse Event|0
4740707|NCT04314037|7696545|FG000|Treatment Period 3|Protocol Violation|1
4740708|NCT04314037|7696546|FG001|Treatment Period 3|Protocol Violation|0
4740709|NCT04314037|7696545|FG000|Treatment Period 3|Adverse Event|0
4740710|NCT04314037|7696546|FG001|Treatment Period 3|Adverse Event|1
4740711|NCT04315298|7696577|FG000|Overall Study|Withdrawal by Subject|0
4740712|NCT04315298|7696578|FG001|Overall Study|Withdrawal by Subject|0
4524832|NCT01018680|7340523|FG000|Overall Study|Sponsor Decision|6
4740713|NCT04315298|7696579|FG002|Overall Study|Withdrawal by Subject|0
4740714|NCT04315298|7696580|FG003|Overall Study|Withdrawal by Subject|2
4740715|NCT04315298|7696581|FG004|Overall Study|Withdrawal by Subject|2
4740716|NCT04315298|7696582|FG005|Overall Study|Withdrawal by Subject|2
4740717|NCT04315298|7696583|FG006|Overall Study|Withdrawal by Subject|0
4740718|NCT04315298|7696584|FG007|Overall Study|Withdrawal by Subject|1
4740719|NCT04315298|7696585|FG008|Overall Study|Withdrawal by Subject|1
4740720|NCT04315298|7696586|FG009|Overall Study|Withdrawal by Subject|1
4740721|NCT04315298|7696587|FG010|Overall Study|Withdrawal by Subject|0
4740722|NCT04315298|7696588|FG011|Overall Study|Withdrawal by Subject|0
4740723|NCT04315298|7696589|FG012|Overall Study|Withdrawal by Subject|0
4740724|NCT04315298|7696590|FG013|Overall Study|Withdrawal by Subject|0
4740725|NCT04315298|7696591|FG014|Overall Study|Withdrawal by Subject|0
4740726|NCT04315298|7696592|FG015|Overall Study|Withdrawal by Subject|0
4740727|NCT04315298|7696593|FG016|Overall Study|Withdrawal by Subject|0
4740728|NCT04315298|7696594|FG017|Overall Study|Withdrawal by Subject|0
4740729|NCT04315298|7696595|FG018|Overall Study|Withdrawal by Subject|0
4740730|NCT04315298|7696577|FG000|Overall Study|Physician Decision|0
4740731|NCT04315298|7696578|FG001|Overall Study|Physician Decision|0
4740732|NCT04315298|7696579|FG002|Overall Study|Physician Decision|0
4740733|NCT04315298|7696580|FG003|Overall Study|Physician Decision|0
4740734|NCT04315298|7696581|FG004|Overall Study|Physician Decision|1
4740735|NCT04315298|7696582|FG005|Overall Study|Physician Decision|0
4740736|NCT04315298|7696583|FG006|Overall Study|Physician Decision|0
4740737|NCT04315298|7696584|FG007|Overall Study|Physician Decision|0
4740738|NCT04315298|7696585|FG008|Overall Study|Physician Decision|0
4740739|NCT04315298|7696586|FG009|Overall Study|Physician Decision|0
4740740|NCT04315298|7696587|FG010|Overall Study|Physician Decision|0
4740741|NCT04315298|7696588|FG011|Overall Study|Physician Decision|0
4740742|NCT04315298|7696589|FG012|Overall Study|Physician Decision|0
4740743|NCT04315298|7696590|FG013|Overall Study|Physician Decision|0
4740744|NCT04315298|7696591|FG014|Overall Study|Physician Decision|0
4740745|NCT04315298|7696592|FG015|Overall Study|Physician Decision|0
4740746|NCT04315298|7696593|FG016|Overall Study|Physician Decision|0
4740747|NCT04315298|7696594|FG017|Overall Study|Physician Decision|0
4740748|NCT04315298|7696595|FG018|Overall Study|Physician Decision|0
4740749|NCT04315298|7696577|FG000|Overall Study|Lost to Follow-up|5
4740750|NCT04315298|7696578|FG001|Overall Study|Lost to Follow-up|10
4740751|NCT04315298|7696579|FG002|Overall Study|Lost to Follow-up|6
4740752|NCT04315298|7696580|FG003|Overall Study|Lost to Follow-up|8
4740753|NCT04315298|7696581|FG004|Overall Study|Lost to Follow-up|12
4740754|NCT04315298|7696582|FG005|Overall Study|Lost to Follow-up|13
4740755|NCT04315298|7696583|FG006|Overall Study|Lost to Follow-up|9
4740756|NCT04315298|7696584|FG007|Overall Study|Lost to Follow-up|16
4740757|NCT04315298|7696585|FG008|Overall Study|Lost to Follow-up|14
4524833|NCT01018680|7340524|FG001|Overall Study|Sponsor Decision|7
4524834|NCT01018680|7340523|FG000|Overall Study|Lack of Efficacy|8
4524835|NCT01018680|7340524|FG001|Overall Study|Lack of Efficacy|2
4524836|NCT01018680|7340523|FG000|Overall Study|Lost to Follow-up|5
4524837|NCT01018680|7340524|FG001|Overall Study|Lost to Follow-up|3
4524838|NCT01018680|7340523|FG000|Overall Study|Entry Criteria Not Met|1
4524839|NCT01018680|7340524|FG001|Overall Study|Entry Criteria Not Met|4
4524840|NCT01018680|7340523|FG000|Overall Study|Physician Decision|3
4594292|NCT01561898|7443545|FG003|Overall Study|Withdrawal by Subject|5
4740758|NCT04315298|7696586|FG009|Overall Study|Lost to Follow-up|0
4740759|NCT04315298|7696587|FG010|Overall Study|Lost to Follow-up|2
4740760|NCT04315298|7696588|FG011|Overall Study|Lost to Follow-up|1
4740761|NCT04315298|7696589|FG012|Overall Study|Lost to Follow-up|0
4740762|NCT04315298|7696590|FG013|Overall Study|Lost to Follow-up|0
4740763|NCT04315298|7696591|FG014|Overall Study|Lost to Follow-up|0
4740764|NCT04315298|7696592|FG015|Overall Study|Lost to Follow-up|2
4740765|NCT04315298|7696593|FG016|Overall Study|Lost to Follow-up|0
4740766|NCT04315298|7696594|FG017|Overall Study|Lost to Follow-up|0
4740767|NCT04315298|7696595|FG018|Overall Study|Lost to Follow-up|0
4740768|NCT04315298|7696577|FG000|Overall Study|Death|24
4740769|NCT04315298|7696578|FG001|Overall Study|Death|60
4740770|NCT04315298|7696579|FG002|Overall Study|Death|49
4740771|NCT04315298|7696580|FG003|Overall Study|Death|59
4740772|NCT04315298|7696581|FG004|Overall Study|Death|70
4740773|NCT04315298|7696582|FG005|Overall Study|Death|114
4740774|NCT04315298|7696583|FG006|Overall Study|Death|9
4740775|NCT04315298|7696584|FG007|Overall Study|Death|12
4740776|NCT04315298|7696585|FG008|Overall Study|Death|21
4740777|NCT04315298|7696586|FG009|Overall Study|Death|16
4740778|NCT04315298|7696587|FG010|Overall Study|Death|40
4740779|NCT04315298|7696588|FG011|Overall Study|Death|40
4740780|NCT04315298|7696589|FG012|Overall Study|Death|3
4740781|NCT04315298|7696590|FG013|Overall Study|Death|4
4740782|NCT04315298|7696591|FG014|Overall Study|Death|6
4740783|NCT04315298|7696592|FG015|Overall Study|Death|4
4740784|NCT04315298|7696593|FG016|Overall Study|Death|3
4740785|NCT04315298|7696594|FG017|Overall Study|Death|1
4740786|NCT04315298|7696595|FG018|Overall Study|Death|0
4740787|NCT04308239|7696705|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2
4740788|NCT04308239|7696706|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1
4740789|NCT04308239|7696705|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1
4740790|NCT04308239|7696706|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2
4740791|NCT04308239|7696705|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1
4740792|NCT04308239|7696706|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2
4740793|NCT04308239|7696705|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0
4740794|NCT04308239|7696706|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2
4740795|NCT04308668|7696718|FG000|Overall Study|Lost to Follow-up|32
4740796|NCT04308668|7696719|FG001|Overall Study|Lost to Follow-up|38
4740797|NCT04308668|7696718|FG000|Overall Study|Withdrawal by Subject|4
4740798|NCT04308668|7696719|FG001|Overall Study|Withdrawal by Subject|4
4740799|NCT04307940|7696728|FG000|Overall Study|Adverse Event|1
4740800|NCT04307940|7696729|FG001|Overall Study|Adverse Event|0
4740801|NCT04307940|7696730|FG002|Overall Study|Adverse Event|0
4740802|NCT04307940|7696728|FG000|Overall Study|Withdrawal by Subject|2
4740803|NCT04307940|7696729|FG001|Overall Study|Withdrawal by Subject|3
4740804|NCT04307940|7696730|FG002|Overall Study|Withdrawal by Subject|1
4740805|NCT04307940|7696728|FG000|Overall Study|Lost to Follow-up|2
4740806|NCT04307940|7696729|FG001|Overall Study|Lost to Follow-up|0
4740807|NCT04307940|7696730|FG002|Overall Study|Lost to Follow-up|1
4740808|NCT04302545|7696740|FG000|Overall Study|Lost to Follow-up|3
4740809|NCT04302545|7696741|FG001|Overall Study|Lost to Follow-up|4
4740810|NCT04297241|7696763|FG000|Overall Study|Withdrawal by Subject|1
4740811|NCT04297241|7696763|FG000|Overall Study|Adverse Event|1
4740812|NCT04297241|7696763|FG000|Overall Study|Physician Decision|3
4740813|NCT04295356|7696792|FG000|Overall Study|Physician Decision|1
4740814|NCT04295356|7696793|FG001|Overall Study|Physician Decision|0
4740815|NCT04295356|7696792|FG000|Overall Study|Lost to Follow-up|0
4740816|NCT04295356|7696793|FG001|Overall Study|Lost to Follow-up|3
4740817|NCT04295356|7696792|FG000|Overall Study|Protocol Violation|0
4740818|NCT04295356|7696793|FG001|Overall Study|Protocol Violation|1
4740819|NCT04292535|7696817|FG000|Overall Study|Withdrawal by Subject|0
4740820|NCT04292535|7696818|FG001|Overall Study|Withdrawal by Subject|0
4740821|NCT04292535|7696819|FG002|Overall Study|Withdrawal by Subject|0
4740822|NCT04292535|7696820|FG003|Overall Study|Withdrawal by Subject|0
4740823|NCT04292535|7696821|FG004|Overall Study|Withdrawal by Subject|0
4740824|NCT04292535|7696822|FG005|Overall Study|Withdrawal by Subject|0
4740825|NCT04292535|7696823|FG006|Overall Study|Withdrawal by Subject|0
4740826|NCT04292535|7696824|FG007|Overall Study|Withdrawal by Subject|1
4740827|NCT04292535|7696825|FG008|Overall Study|Withdrawal by Subject|0
4740828|NCT04292535|7696826|FG009|Overall Study|Withdrawal by Subject|0
4740829|NCT04292535|7696827|FG010|Overall Study|Withdrawal by Subject|0
4740830|NCT04292535|7696828|FG011|Overall Study|Withdrawal by Subject|0
4740831|NCT04292535|7696829|FG012|Overall Study|Withdrawal by Subject|0
4740832|NCT04292535|7696830|FG013|Overall Study|Withdrawal by Subject|0
4740833|NCT04292535|7696817|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
4740834|NCT04292535|7696818|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
4740835|NCT04292535|7696819|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
4740836|NCT04292535|7696820|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
4740837|NCT04292535|7696821|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
4740838|NCT04292535|7696822|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
4740839|NCT04292535|7696823|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
4740840|NCT04292535|7696824|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1
4740841|NCT04292535|7696825|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
4740842|NCT04292535|7696826|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
4740843|NCT04292535|7696827|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
4740844|NCT04292535|7696828|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0
4740845|NCT04292535|7696829|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1
4740846|NCT04292535|7696830|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1
4740847|NCT04292535|7696817|FG000|Overall Study|Report of Dizziness|0
4740848|NCT04292535|7696818|FG001|Overall Study|Report of Dizziness|0
4740849|NCT04292535|7696819|FG002|Overall Study|Report of Dizziness|0
4740850|NCT04292535|7696820|FG003|Overall Study|Report of Dizziness|0
4740851|NCT04292535|7696821|FG004|Overall Study|Report of Dizziness|0
4740852|NCT04292535|7696822|FG005|Overall Study|Report of Dizziness|0
4740853|NCT04292535|7696823|FG006|Overall Study|Report of Dizziness|0
4740854|NCT04292535|7696824|FG007|Overall Study|Report of Dizziness|0
4740855|NCT04292535|7696825|FG008|Overall Study|Report of Dizziness|0
4740856|NCT04292535|7696826|FG009|Overall Study|Report of Dizziness|0
4740857|NCT04292535|7696827|FG010|Overall Study|Report of Dizziness|0
4740858|NCT04292535|7696828|FG011|Overall Study|Report of Dizziness|0
4740859|NCT04292535|7696829|FG012|Overall Study|Report of Dizziness|0
4740860|NCT04292535|7696830|FG013|Overall Study|Report of Dizziness|1
4740861|NCT04292535|7696817|FG000|Overall Study|Equipment Failure|0
4740862|NCT04292535|7696818|FG001|Overall Study|Equipment Failure|0
4740863|NCT04292535|7696819|FG002|Overall Study|Equipment Failure|0
4740864|NCT04292535|7696820|FG003|Overall Study|Equipment Failure|0
4740865|NCT04292535|7696821|FG004|Overall Study|Equipment Failure|0
4740866|NCT04292535|7696822|FG005|Overall Study|Equipment Failure|0
4740867|NCT04292535|7696823|FG006|Overall Study|Equipment Failure|0
4740868|NCT04292535|7696824|FG007|Overall Study|Equipment Failure|0
4740869|NCT04292535|7696825|FG008|Overall Study|Equipment Failure|0
4740870|NCT04292535|7696826|FG009|Overall Study|Equipment Failure|0
4740871|NCT04292535|7696827|FG010|Overall Study|Equipment Failure|0
4740872|NCT04292535|7696828|FG011|Overall Study|Equipment Failure|1
4740873|NCT04292535|7696829|FG012|Overall Study|Equipment Failure|0
4740874|NCT04292535|7696830|FG013|Overall Study|Equipment Failure|0
4740875|NCT04292171|7696862|FG000|Overall Study|Pharmacy error|2
4740876|NCT04292171|7696863|FG001|Overall Study|Pharmacy error|0
4740877|NCT04292171|7696862|FG000|Overall Study|Delivered prior to procedure|0
4740878|NCT04292171|7696863|FG001|Overall Study|Delivered prior to procedure|1
4740879|NCT04292899|7696873|FG000|Overall Study|Death|21
4740880|NCT04292899|7696874|FG001|Overall Study|Death|28
4740881|NCT04292899|7696875|FG002|Overall Study|Death|188
4740882|NCT04292899|7696876|FG003|Overall Study|Death|371
4740883|NCT04292899|7696873|FG000|Overall Study|Lost to Follow-up|8
4740884|NCT04292899|7696874|FG001|Overall Study|Lost to Follow-up|4
4740885|NCT04292899|7696875|FG002|Overall Study|Lost to Follow-up|22
4740886|NCT04292899|7696876|FG003|Overall Study|Lost to Follow-up|235
4524841|NCT01018680|7340524|FG001|Overall Study|Physician Decision|1
4524842|NCT01018732|7340533|FG000|Overall Study|Lost to Follow-up|0
4524843|NCT01018732|7340534|FG001|Overall Study|Lost to Follow-up|0
4524844|NCT01018732|7340535|FG002|Overall Study|Lost to Follow-up|3
4524845|NCT01018732|7340533|FG000|Overall Study|Protocol Violation|1
4524846|NCT01018732|7340534|FG001|Overall Study|Protocol Violation|1
4524847|NCT01018732|7340535|FG002|Overall Study|Protocol Violation|0
4524848|NCT01018732|7340533|FG000|Overall Study|Inappropriate Enrollment|0
4524849|NCT01018732|7340534|FG001|Overall Study|Inappropriate Enrollment|1
4740887|NCT04292899|7696873|FG000|Overall Study|Withdrew consent|1
4740888|NCT04292899|7696874|FG001|Overall Study|Withdrew consent|0
4740889|NCT04292899|7696875|FG002|Overall Study|Withdrew consent|11
4740890|NCT04292899|7696876|FG003|Overall Study|Withdrew consent|32
4740891|NCT04292899|7696873|FG000|Overall Study|Adverse Event|2
4740892|NCT04292899|7696874|FG001|Overall Study|Adverse Event|1
4740893|NCT04292899|7696875|FG002|Overall Study|Adverse Event|2
4740894|NCT04292899|7696876|FG003|Overall Study|Adverse Event|2
4740895|NCT04292899|7696873|FG000|Overall Study|Investigator's Discretion|0
4740896|NCT04292899|7696874|FG001|Overall Study|Investigator's Discretion|0
4740897|NCT04292899|7696875|FG002|Overall Study|Investigator's Discretion|0
4740898|NCT04292899|7696876|FG003|Overall Study|Investigator's Discretion|3
4740899|NCT04292899|7696873|FG000|Overall Study|Non-compliance With Study Drug|0
4740900|NCT04292899|7696874|FG001|Overall Study|Non-compliance With Study Drug|0
4740901|NCT04292899|7696875|FG002|Overall Study|Non-compliance With Study Drug|0
4740902|NCT04292899|7696876|FG003|Overall Study|Non-compliance With Study Drug|1
4740903|NCT04292899|7696873|FG000|Overall Study|Protocol Violation|0
4740904|NCT04292899|7696874|FG001|Overall Study|Protocol Violation|0
4740905|NCT04292899|7696875|FG002|Overall Study|Protocol Violation|0
4740906|NCT04292899|7696876|FG003|Overall Study|Protocol Violation|1
4740907|NCT04292730|7696888|FG000|Overall Study|Lost to Follow-up|8
4740908|NCT04292730|7696889|FG001|Overall Study|Lost to Follow-up|12
4740909|NCT04292730|7696890|FG002|Overall Study|Lost to Follow-up|12
4740910|NCT04292730|7696891|FG003|Overall Study|Lost to Follow-up|48
4740911|NCT04292730|7696888|FG000|Overall Study|Death|2
4740912|NCT04292730|7696889|FG001|Overall Study|Death|2
4740913|NCT04292730|7696890|FG002|Overall Study|Death|4
4740914|NCT04292730|7696891|FG003|Overall Study|Death|12
4740915|NCT04292730|7696888|FG000|Overall Study|Withdrew Consent|2
4740916|NCT04292730|7696889|FG001|Overall Study|Withdrew Consent|2
4740917|NCT04292730|7696890|FG002|Overall Study|Withdrew Consent|5
4740918|NCT04292730|7696891|FG003|Overall Study|Withdrew Consent|6
4740919|NCT04292730|7696888|FG000|Overall Study|Non-Compliance with Study Drug|0
4740920|NCT04292730|7696889|FG001|Overall Study|Non-Compliance with Study Drug|1
4740921|NCT04292730|7696890|FG002|Overall Study|Non-Compliance with Study Drug|0
4740922|NCT04292730|7696891|FG003|Overall Study|Non-Compliance with Study Drug|0
4740923|NCT04292730|7696888|FG000|Overall Study|Protocol Violation|0
4740924|NCT04292730|7696889|FG001|Overall Study|Protocol Violation|0
4740925|NCT04292730|7696890|FG002|Overall Study|Protocol Violation|1
4740926|NCT04292730|7696891|FG003|Overall Study|Protocol Violation|0
4740927|NCT04292730|7696888|FG000|Overall Study|Randomized but not Treated|8
4740928|NCT04292730|7696889|FG001|Overall Study|Randomized but not Treated|4
4740929|NCT04292730|7696890|FG002|Overall Study|Randomized but not Treated|0
4740930|NCT04292730|7696891|FG003|Overall Study|Randomized but not Treated|14
4740931|NCT04289623|7696924|FG000|Wave 1 Emails|Email was not delivered|268
4740932|NCT04289623|7696925|FG001|Wave 1 Emails|Email was not delivered|257
4740933|NCT04289623|7696926|FG002|Wave 1 Emails|Email was not delivered|0
4740934|NCT04289623|7696927|FG003|Wave 1 Emails|Email was not delivered|0
4740935|NCT04289623|7696928|FG004|Wave 1 Emails|Email was not delivered|0
4740936|NCT04289623|7696929|FG005|Wave 1 Emails|Email was not delivered|0
4740937|NCT04276207|7696943|FG000|Period 1|Withdrawal by Subject|0
4740938|NCT04276207|7696944|FG001|Period 1|Withdrawal by Subject|1
4740939|NCT04287517|7696974|FG000|Overall Study|Withdrawal by Subject|1
4740940|NCT04287517|7696975|FG001|Overall Study|Withdrawal by Subject|1
4740941|NCT04275336|7697045|FG000|Overall Study|First venipuncture failed|4
4740942|NCT04275336|7697046|FG001|Overall Study|First venipuncture failed|6
4740943|NCT04275336|7697047|FG002|Overall Study|First venipuncture failed|5
4740944|NCT04275336|7697045|FG000|Overall Study|Unscheduled venipuncture|9
4740945|NCT04275336|7697046|FG001|Overall Study|Unscheduled venipuncture|13
4740946|NCT04275336|7697047|FG002|Overall Study|Unscheduled venipuncture|7
4740947|NCT04275336|7697045|FG000|Overall Study|Failed specimen of saliva|4
4740948|NCT04275336|7697046|FG001|Overall Study|Failed specimen of saliva|3
4740949|NCT04275336|7697047|FG002|Overall Study|Failed specimen of saliva|4
4740950|NCT04272775|7697060|FG000|Overall Study|Study Terminated by Sponsor|1
4740951|NCT04272775|7697061|FG001|Overall Study|Study Terminated by Sponsor|0
4740952|NCT04272775|7697060|FG000|Overall Study|Protocol Violation|0
4740953|NCT04272775|7697061|FG001|Overall Study|Protocol Violation|1
4740954|NCT04272775|7697060|FG000|Overall Study|Symptomatic Deterioration|1
4740955|NCT04272775|7697061|FG001|Overall Study|Symptomatic Deterioration|1
4740956|NCT04272775|7697060|FG000|Overall Study|Withdrawal by Subject|1
4740957|NCT04272775|7697061|FG001|Overall Study|Withdrawal by Subject|2
4740958|NCT04272775|7697060|FG000|Overall Study|Adverse Event|1
4740959|NCT04272775|7697061|FG001|Overall Study|Adverse Event|2
4740960|NCT04272775|7697060|FG000|Overall Study|Progressive Disease|3
4740961|NCT04272775|7697061|FG001|Overall Study|Progressive Disease|1
4740962|NCT04271605|7697093|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5
4740963|NCT04268316|7697104|FG000|Overall Study|Withdrawal by Subject|2
4740964|NCT04268316|7697105|FG001|Overall Study|Withdrawal by Subject|1
4740965|NCT04268316|7697106|FG002|Overall Study|Withdrawal by Subject|0
4740966|NCT04263142|7697149|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0
4740967|NCT04263142|7697150|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0
4740968|NCT04263142|7697151|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0
4740969|NCT04263142|7697152|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0
4740970|NCT04263142|7697153|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1
4740971|NCT04263142|7697149|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0
4740972|NCT04263142|7697150|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0
4740973|NCT04263142|7697151|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0
4740974|NCT04263142|7697152|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0
4740975|NCT04263142|7697153|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1
4740976|NCT04256785|7697168|FG000|Overall Study|Adverse Event|8
4740977|NCT04256785|7697169|FG001|Overall Study|Adverse Event|6
4740978|NCT04256785|7697168|FG000|Overall Study|Lack of Efficacy|3
4740979|NCT04256785|7697169|FG001|Overall Study|Lack of Efficacy|4
4740980|NCT04256785|7697168|FG000|Overall Study|Lost to Follow-up|7
4740981|NCT04256785|7697169|FG001|Overall Study|Lost to Follow-up|7
4740982|NCT04256785|7697168|FG000|Overall Study|Protocol Violation|1
4740983|NCT04256785|7697169|FG001|Overall Study|Protocol Violation|0
4740984|NCT04256785|7697168|FG000|Overall Study|Withdrawal by Subject|4
4740985|NCT04256785|7697169|FG001|Overall Study|Withdrawal by Subject|1
4740986|NCT04256785|7697168|FG000|Overall Study|Surgery or quarantined due to Covid-19|5
4740987|NCT04256785|7697169|FG001|Overall Study|Surgery or quarantined due to Covid-19|7
4740988|NCT04249336|7697194|FG000|Overall Study|Lost to Follow-up|3
4740989|NCT04249336|7697195|FG001|Overall Study|Lost to Follow-up|3
4740990|NCT04249336|7697196|FG002|Overall Study|Lost to Follow-up|3
4740991|NCT04249336|7697197|FG003|Overall Study|Lost to Follow-up|3
4740992|NCT04247061|7697225|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6
4740993|NCT04247061|7697225|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2
4740994|NCT04247061|7697225|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1
4740995|NCT04245202|7697231|FG000|Overall Study|Lack of Efficacy|10
4740996|NCT04245202|7697232|FG001|Overall Study|Lack of Efficacy|1
4740997|NCT04238650|7697263|FG000|Overall Study|Withdrawal by Subject|0
4740998|NCT04238650|7697264|FG001|Overall Study|Withdrawal by Subject|1
4740999|NCT04238663|7697273|FG000|Overall Study|Lost to Follow-up|0
4741000|NCT04238663|7697274|FG001|Overall Study|Lost to Follow-up|1
4741001|NCT04238663|7697275|FG002|Overall Study|Lost to Follow-up|0
4741002|NCT04222699|7697349|FG000|Overall Study|Lost to Follow-up|2
4741003|NCT04206293|7697372|FG000|Overall Study|Consent withdrawal|1
4741004|NCT04228302|7697383|FG000|Overall Study|Adverse Event|0
4741005|NCT04228302|7697384|FG001|Overall Study|Adverse Event|0
4741006|NCT04228302|7697385|FG002|Overall Study|Adverse Event|0
4741007|NCT04228302|7697386|FG003|Overall Study|Adverse Event|0
4741008|NCT04228302|7697387|FG004|Overall Study|Adverse Event|1
4741009|NCT04228302|7697388|FG005|Overall Study|Adverse Event|0
4741010|NCT04223687|7697426|FG000|Overall Study|Missing primary outcome|1
4741011|NCT04223687|7697427|FG001|Overall Study|Missing primary outcome|0
4741012|NCT04223232|7697433|FG000|Overall Study|Withdrawal by Subject|1
4741013|NCT04189224|7697437|FG000|Period 2|Adverse Event|0
4741014|NCT04189224|7697438|FG001|Period 2|Adverse Event|1
4741015|NCT04214600|7697446|FG000|Overall Study|Lost to Follow-up|9
4741016|NCT04214600|7697447|FG001|Overall Study|Lost to Follow-up|14
4741017|NCT04202497|7697454|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1
4741018|NCT04202497|7697455|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0
4741019|NCT04202497|7697456|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0
4741020|NCT04202497|7697457|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0
4524850|NCT01018732|7340535|FG002|Overall Study|Inappropriate Enrollment|0
4524851|NCT01018732|7340533|FG000|Overall Study|Unable to Classify|0
4524852|NCT01018732|7340534|FG001|Overall Study|Unable to Classify|0
4524853|NCT01018732|7340535|FG002|Overall Study|Unable to Classify|1
4524854|NCT01018862|7340546|FG000|Overall Study|Adverse Event|2
4524855|NCT01018862|7340547|FG001|Overall Study|Adverse Event|0
4524856|NCT01018862|7340548|FG002|Overall Study|Adverse Event|6
4524857|NCT01018862|7340546|FG000|Overall Study|Lack of Efficacy|1
4524858|NCT01018862|7340547|FG001|Overall Study|Lack of Efficacy|0
4524859|NCT01018862|7340548|FG002|Overall Study|Lack of Efficacy|2
4524860|NCT01018862|7340546|FG000|Overall Study|Lost to Follow-up|3
4524861|NCT01018862|7340547|FG001|Overall Study|Lost to Follow-up|1
4524862|NCT01018862|7340548|FG002|Overall Study|Lost to Follow-up|0
4524863|NCT01018862|7340546|FG000|Overall Study|Protocol Violation|1
4524864|NCT01018862|7340547|FG001|Overall Study|Protocol Violation|3
4524865|NCT01018862|7340548|FG002|Overall Study|Protocol Violation|3
4524866|NCT01018862|7340546|FG000|Overall Study|Withdrawal by Subject|1
4524867|NCT01018862|7340547|FG001|Overall Study|Withdrawal by Subject|2
4524868|NCT01018862|7340548|FG002|Overall Study|Withdrawal by Subject|1
4524869|NCT01018862|7340546|FG000|Overall Study|administrative problems|5
4524870|NCT01018862|7340547|FG001|Overall Study|administrative problems|4
4524871|NCT01018862|7340548|FG002|Overall Study|administrative problems|4
4524872|NCT01018953|7340556|FG000|Overall Study|Adverse Event|2
4524873|NCT01018953|7340556|FG000|Overall Study|Withdrawal by Subject|1
4524874|NCT01018953|7340556|FG000|Overall Study|Study termination by sponsor|5
4524875|NCT01018979|7340563|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3
4524876|NCT01018979|7340564|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9
4524877|NCT01018979|7340563|FG000|Overall Study|Not received at least one dose|0
4524878|NCT01018979|7340564|FG001|Overall Study|Not received at least one dose|1
4524879|NCT01018992|7340575|FG000|Overall Study|Adverse Event|8
4524880|NCT01018992|7340576|FG001|Overall Study|Adverse Event|3
4633987|NCT01919164|7504458|FG003|Overall Study|Other Un-specified|7
4633988|NCT01919164|7504459|FG004|Overall Study|Other Un-specified|15
4524881|NCT01018992|7340575|FG000|Overall Study|Withdrawal by Subject|3
4524882|NCT01018992|7340576|FG001|Overall Study|Withdrawal by Subject|8
4524883|NCT01018992|7340575|FG000|Overall Study|Protocol Violation|0
4524884|NCT01018992|7340576|FG001|Overall Study|Protocol Violation|4
4524885|NCT01018992|7340575|FG000|Overall Study|Lost to Follow-up|5
4524886|NCT01018992|7340576|FG001|Overall Study|Lost to Follow-up|1
4524887|NCT01019135|7340585|FG000|Overall Study|Did not receive allocated intervention|12
4524888|NCT01019135|7340586|FG001|Overall Study|Did not receive allocated intervention|6
4524889|NCT01019135|7340587|FG002|Overall Study|Did not receive allocated intervention|25
4524890|NCT01019135|7340585|FG000|Overall Study|Did not attend CR|8
4524891|NCT01019135|7340586|FG001|Overall Study|Did not attend CR|13
4524892|NCT01019135|7340587|FG002|Overall Study|Did not attend CR|6
4741021|NCT04209530|7697484|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4
4741022|NCT04209530|7697485|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2
4741023|NCT04209530|7697484|FG000|Overall Study|Withdrawal by Subject|0
4741024|NCT04209530|7697485|FG001|Overall Study|Withdrawal by Subject|1
4741025|NCT04207840|7697505|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0
4741026|NCT04207840|7697506|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0
4741027|NCT04207840|7697507|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1
4741028|NCT04207840|7697505|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0
4741029|NCT04207840|7697506|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0
4741030|NCT04207840|7697507|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1
4741031|NCT04206384|7697542|FG000|Overall Study|Withdrawal by Subject|8
4741032|NCT04206384|7697542|FG000|Overall Study|Adverse Event|2
4741033|NCT04195893|7697563|FG000|Second Intervention|Withdrawal by Subject|1
4741034|NCT04195893|7697564|FG001|Second Intervention|Withdrawal by Subject|0
4741035|NCT04195581|7697579|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4
4741036|NCT04195581|7697579|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5
4741037|NCT04195581|7697579|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1
4741038|NCT04195581|7697579|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1
4741039|NCT04195581|7697579|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3
4741040|NCT04195581|7697579|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2
4741041|NCT04194151|7697603|FG000|Overall Study|Physician Decision|1
4741042|NCT04194151|7697604|FG001|Overall Study|Physician Decision|1
4741043|NCT04194151|7697605|FG002|Overall Study|Physician Decision|1
4633989|NCT01919190|7504473|FG000|Overall Study|Intra-op findings, etc.|3
4633990|NCT01919190|7504474|FG001|Overall Study|Intra-op findings, etc.|0
4633991|NCT01919229|7504497|FG000|Overall Study|Subject/guardian decision|0
4633992|NCT01919229|7504498|FG001|Overall Study|Subject/guardian decision|0
4633993|NCT01919229|7504499|FG002|Overall Study|Subject/guardian decision|1
4741044|NCT04194151|7697606|FG003|Overall Study|Physician Decision|1
4741045|NCT04194151|7697607|FG004|Overall Study|Physician Decision|0
4741046|NCT04194151|7697608|FG005|Overall Study|Physician Decision|1
4741047|NCT04194151|7697603|FG000|Overall Study|Monitorization problem|0
4741048|NCT04194151|7697604|FG001|Overall Study|Monitorization problem|1
4741049|NCT04194151|7697605|FG002|Overall Study|Monitorization problem|0
4741050|NCT04194151|7697606|FG003|Overall Study|Monitorization problem|0
4741051|NCT04194151|7697607|FG004|Overall Study|Monitorization problem|0
4741052|NCT04194151|7697608|FG005|Overall Study|Monitorization problem|0
4741053|NCT04194008|7697622|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19
4741054|NCT04194008|7697622|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6
4741055|NCT04194008|7697622|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2
4741056|NCT04194008|7697622|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3
4741057|NCT04194008|7697622|FG000|Treatment Phase With Nerivio|Missing data|4
4741058|NCT04194008|7697622|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1
4741059|NCT04189081|7697633|FG000|Overall Study|Lost to Follow-up|1
4741060|NCT04189081|7697634|FG001|Overall Study|Lost to Follow-up|0
4741061|NCT04189081|7697635|FG002|Overall Study|Lost to Follow-up|0
4741062|NCT04189081|7697633|FG000|Overall Study|Withdrawal by Subject|0
4741063|NCT04189081|7697634|FG001|Overall Study|Withdrawal by Subject|0
4741064|NCT04189081|7697635|FG002|Overall Study|Withdrawal by Subject|1
4741065|NCT04186806|7697656|FG000|Period 1: 7 Days|Adverse Event|1
4741066|NCT04186806|7697657|FG001|Period 1: 7 Days|Adverse Event|0
4741067|NCT04179838|7697691|FG000|First Intervention (1 Day)|Withdrawal by Subject|0
4741068|NCT04179838|7697692|FG001|First Intervention (1 Day)|Withdrawal by Subject|3
4741069|NCT04179838|7697691|FG000|Second Intervention (1 Day)|Protocol Violation|0
4741070|NCT04179838|7697692|FG001|Second Intervention (1 Day)|Protocol Violation|1
4741071|NCT04179461|7697698|FG000|Overall Study|Lost to Follow-up|4
4741072|NCT04178590|7697726|FG000|Overall Study|Pregnancy|1
4741073|NCT04178590|7697726|FG000|Overall Study|Lost to Follow-up|1
4741074|NCT04177862|7697754|FG000|Overall Study|Protocol Violation|2
4633994|NCT01919307|7504507|FG000|Overall Study|Withdrawal by Subject|9
4633995|NCT01919398|7504514|FG000|Overall Study|Progressive Disease|0
4633996|NCT01919398|7504515|FG001|Overall Study|Progressive Disease|0
4633997|NCT01919398|7504516|FG002|Overall Study|Progressive Disease|4
4633998|NCT01919411|7504526|FG000|Overall Study|Lost to Follow-up|2
4633999|NCT01919411|7504527|FG001|Overall Study|Lost to Follow-up|4
4634000|NCT01919411|7504526|FG000|Overall Study|Physician Decision|1
4634001|NCT01919411|7504527|FG001|Overall Study|Physician Decision|0
4634002|NCT01919411|7504526|FG000|Overall Study|Protocol Violation|2
4634003|NCT01919411|7504527|FG001|Overall Study|Protocol Violation|1
4634004|NCT01919489|7504552|FG000|Overall Study|Rejected the need of injections|4
4634005|NCT01919489|7504553|FG001|Overall Study|Rejected the need of injections|7
4634006|NCT01919489|7504552|FG000|Overall Study|Adverse Event|10
4634007|NCT01919489|7504553|FG001|Overall Study|Adverse Event|0
4634008|NCT01919489|7504552|FG000|Overall Study|Hospital readmission|2
4634009|NCT01919489|7504553|FG001|Overall Study|Hospital readmission|9
4634010|NCT01919489|7504552|FG000|Overall Study|Death|2
4634011|NCT01919489|7504553|FG001|Overall Study|Death|1
4634012|NCT01919489|7504552|FG000|Overall Study|Lost to Follow-up|38
4634013|NCT01919489|7504553|FG001|Overall Study|Lost to Follow-up|27
4741075|NCT04177862|7697755|FG001|Overall Study|Protocol Violation|7
4741076|NCT04173741|7697830|FG000|Overall Study|IVC measurement cannot be done|1
4741077|NCT04173741|7697831|FG001|Overall Study|IVC measurement cannot be done|1
4741078|NCT04169061|7697837|FG000|Overall Study|Adverse Event|2
4741079|NCT04169061|7697837|FG000|Overall Study|Death|1
4741080|NCT04169061|7697837|FG000|Overall Study|Withdrawal by Subject|1
4741081|NCT04169061|7697837|FG000|Overall Study|Protocol Violation|1
4741082|NCT04157738|7697843|FG000|Overall Study|Moved out of state|0
4741083|NCT04157738|7697844|FG001|Overall Study|Moved out of state|2
4741084|NCT04157738|7697843|FG000|Overall Study|Did not show up to the Follow-up appointment|1
4741085|NCT04157738|7697844|FG001|Overall Study|Did not show up to the Follow-up appointment|0
4741086|NCT04156646|7697852|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0
4741087|NCT04156646|7697853|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1
4741088|NCT04170686|7697864|FG000|Screening|Physician Decision|12
4741089|NCT04170686|7697865|FG001|Screening|Physician Decision|13
4741090|NCT04170686|7697864|FG000|Randomization and Treatment|Lost to Follow-up|26
4741091|NCT04170686|7697865|FG001|Randomization and Treatment|Lost to Follow-up|15
4741092|NCT04162795|7697917|FG000|Overall Study|Other|16
4741093|NCT04162795|7697917|FG000|Overall Study|Screen failures|10
4741094|NCT04161807|7697921|FG000|Overall Study|Withdrawal by Subject|2
4741095|NCT04161807|7697921|FG000|Overall Study|Performed only 1 treatment|2
4741096|NCT04161144|7697927|FG000|Overall Study|Withdrawal by Subject|0
4741097|NCT04161144|7697928|FG001|Overall Study|Withdrawal by Subject|1
4741098|NCT04161144|7697927|FG000|Overall Study|Protocol Violation|1
4741099|NCT04161144|7697928|FG001|Overall Study|Protocol Violation|0
4741100|NCT04161131|7697934|FG000|Overall Study|Ineligible|2
4741101|NCT04161131|7697934|FG000|Overall Study|Lost to Follow-up|4
4741102|NCT04161079|7697938|FG000|Clinical Investigation 2010-040|Adverse Event|1
4741103|NCT04152083|7697957|FG000|Overall Study|Lost to Follow-up|2
4741104|NCT04152083|7697958|FG001|Overall Study|Lost to Follow-up|1
4741105|NCT04152083|7697957|FG000|Overall Study|Adverse Event|1
4741106|NCT04152083|7697958|FG001|Overall Study|Adverse Event|0
4741107|NCT04152083|7697957|FG000|Overall Study|Randomized but not treated|3
4741108|NCT04152083|7697958|FG001|Overall Study|Randomized but not treated|2
4741109|NCT04155047|7697970|FG000|Overall Study|Adverse Event|1
4741110|NCT04155047|7697971|FG001|Overall Study|Adverse Event|0
4741111|NCT04155047|7697970|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1
4741112|NCT04155047|7697971|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0
4741113|NCT04150250|7698000|FG000|Overall Study|Lost to Follow-up|0
4741114|NCT04150250|7698001|FG001|Overall Study|Lost to Follow-up|2
4741115|NCT04149353|7698086|FG000|Overall Study|Study terminated|1
4741116|NCT04136444|7698106|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0
4741117|NCT04136444|7698107|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1
4741118|NCT04147611|7698141|FG000|Overall Study|Physician Decision|0
4741119|NCT04147611|7698142|FG001|Overall Study|Physician Decision|1
4741120|NCT04142216|7698211|FG000|Overall Study|Hospitalization|0
4741121|NCT04142216|7698212|FG001|Overall Study|Hospitalization|2
4741122|NCT04142216|7698211|FG000|Overall Study|Death|3
4741123|NCT04142216|7698212|FG001|Overall Study|Death|1
4741124|NCT04142216|7698211|FG000|Overall Study|Referral to another hemodialysis unit|3
4741125|NCT04142216|7698212|FG001|Overall Study|Referral to another hemodialysis unit|2
4741126|NCT04142216|7698211|FG000|Overall Study|Use of clove|0
4741127|NCT04142216|7698212|FG001|Overall Study|Use of clove|1
4741128|NCT04142450|7698223|FG000|Overall Study|Screen Failure|1
4741129|NCT04142450|7698223|FG000|Overall Study|Lost to Follow-up|1
4741130|NCT04142242|7698233|FG000|Overall Study|Non-compliance with the protocol|1
4741131|NCT04142242|7698234|FG001|Overall Study|Non-compliance with the protocol|0
4741132|NCT04142242|7698235|FG002|Overall Study|Non-compliance with the protocol|0
4741133|NCT04142242|7698236|FG003|Overall Study|Non-compliance with the protocol|0
4741134|NCT04142242|7698237|FG004|Overall Study|Non-compliance with the protocol|0
4741135|NCT04142242|7698238|FG005|Overall Study|Non-compliance with the protocol|1
4741136|NCT04142242|7698233|FG000|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0
4741137|NCT04142242|7698234|FG001|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|1
4524893|NCT01019252|7340597|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2
4524894|NCT01019252|7340598|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0
4524895|NCT01019252|7340597|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1
4524896|NCT01019252|7340598|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0
4524897|NCT01019252|7340597|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0
4524898|NCT01019252|7340598|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2
4524899|NCT01019252|7340597|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0
4524900|NCT01019252|7340598|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5
4524901|NCT01019317|7340604|FG000|Overall Study|Not Eligible|4
4524902|NCT01019369|7340610|FG000|Overall Study|Lost to Follow-up|10
4524903|NCT01019369|7340611|FG001|Overall Study|Lost to Follow-up|6
4524904|NCT01019369|7340610|FG000|Overall Study|Withdrawal by Subject|0
4524905|NCT01019369|7340611|FG001|Overall Study|Withdrawal by Subject|1
4524906|NCT01019486|7340621|FG000|Overall Study|Withdrawal by Subject|1
4524907|NCT01019486|7340622|FG001|Overall Study|Withdrawal by Subject|1
4524908|NCT01019486|7340623|FG002|Overall Study|Withdrawal by Subject|1
4524909|NCT01019694|7340635|FG000|Overall Study|Adverse Event|12
4741138|NCT04142242|7698235|FG002|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0
4741139|NCT04142242|7698236|FG003|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0
4741140|NCT04142242|7698237|FG004|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0
4741141|NCT04142242|7698238|FG005|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0
4741142|NCT04142242|7698233|FG000|Overall Study|Ongoing|0
4741143|NCT04142242|7698234|FG001|Overall Study|Ongoing|0
4741144|NCT04142242|7698235|FG002|Overall Study|Ongoing|31
4741145|NCT04142242|7698236|FG003|Overall Study|Ongoing|39
4741146|NCT04142242|7698237|FG004|Overall Study|Ongoing|0
4741147|NCT04142242|7698238|FG005|Overall Study|Ongoing|0
4741148|NCT04140890|7698253|FG000|Overall Study|Withdrawal by Subject|0
4741149|NCT04140890|7698254|FG001|Overall Study|Withdrawal by Subject|1
4741150|NCT04139018|7698265|FG000|Overall Study|Screen fail|1
4741151|NCT04139018|7698266|FG001|Overall Study|Screen fail|0
4741152|NCT04139018|7698265|FG000|Overall Study|Withdrawal by Subject|2
4741153|NCT04139018|7698266|FG001|Overall Study|Withdrawal by Subject|0
4741154|NCT04139018|7698265|FG000|Overall Study|Lost to Follow-up|0
4741155|NCT04139018|7698266|FG001|Overall Study|Lost to Follow-up|1
4741156|NCT04138810|7698274|FG000|Overall Study|Withdrawal by Subject|0
4741157|NCT04138810|7698275|FG001|Overall Study|Withdrawal by Subject|1
4741158|NCT04138810|7698274|FG000|Overall Study|Subject cancelled surgery|1
4741159|NCT04138810|7698275|FG001|Overall Study|Subject cancelled surgery|0
4741160|NCT04131556|7698281|FG000|Overall Study|Adverse Event|1
4741161|NCT04131556|7698281|FG000|Overall Study|Withdrawal by Subject|1
4741162|NCT04126174|7698288|FG000|Overall Study|Lost to Follow-up|3
4741163|NCT04126174|7698289|FG001|Overall Study|Lost to Follow-up|3
4741164|NCT04138043|7698333|FG000|Overall Study|Withdrawal by Subject|0
4741165|NCT04138043|7698334|FG001|Overall Study|Withdrawal by Subject|1
4741166|NCT04132336|7698367|FG000|Overall Study|Investigator Decision|0
4741167|NCT04132336|7698368|FG001|Overall Study|Investigator Decision|1
4741168|NCT04132336|7698369|FG002|Overall Study|Investigator Decision|0
4741169|NCT04132336|7698370|FG003|Overall Study|Investigator Decision|0
4741170|NCT04132336|7698371|FG004|Overall Study|Investigator Decision|0
4741171|NCT04132336|7698372|FG005|Overall Study|Investigator Decision|0
4741172|NCT04132336|7698373|FG006|Overall Study|Investigator Decision|0
4741173|NCT04128293|7698413|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4
4741174|NCT04128293|7698414|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4
4741175|NCT04128293|7698415|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4
4741176|NCT04128293|7698416|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4
4741177|NCT04126343|7698437|FG000|Overall Study|Adverse Event|0
4741178|NCT04126343|7698438|FG001|Overall Study|Adverse Event|0
4741179|NCT04126343|7698439|FG002|Overall Study|Adverse Event|0
4741180|NCT04126343|7698440|FG003|Overall Study|Adverse Event|0
4741181|NCT04126343|7698441|FG004|Overall Study|Adverse Event|0
4741182|NCT04126343|7698442|FG005|Overall Study|Adverse Event|1
4741183|NCT04126343|7698437|FG000|Overall Study|Withdrawal by Subject|0
4741184|NCT04126343|7698438|FG001|Overall Study|Withdrawal by Subject|0
4741185|NCT04126343|7698439|FG002|Overall Study|Withdrawal by Subject|0
4741186|NCT04126343|7698440|FG003|Overall Study|Withdrawal by Subject|1
4741187|NCT04126343|7698441|FG004|Overall Study|Withdrawal by Subject|0
4741188|NCT04126343|7698442|FG005|Overall Study|Withdrawal by Subject|0
4741189|NCT04126343|7698437|FG000|Overall Study|Related to COVID-19 pandemic|3
4741190|NCT04126343|7698438|FG001|Overall Study|Related to COVID-19 pandemic|4
4741191|NCT04126343|7698439|FG002|Overall Study|Related to COVID-19 pandemic|3
4741192|NCT04126343|7698440|FG003|Overall Study|Related to COVID-19 pandemic|3
4741193|NCT04126343|7698441|FG004|Overall Study|Related to COVID-19 pandemic|3
4741194|NCT04126343|7698442|FG005|Overall Study|Related to COVID-19 pandemic|3
4741195|NCT04124952|7698461|FG000|Overall Study|Lost to Follow-up|1
4741196|NCT04123665|7698467|FG000|Overall Study|Withdrawal by Subject|7
4741197|NCT04123665|7698468|FG001|Overall Study|Withdrawal by Subject|0
4741198|NCT04123665|7698467|FG000|Overall Study|Lost to Follow-up|1
4741199|NCT04123665|7698468|FG001|Overall Study|Lost to Follow-up|0
4741200|NCT04122534|7698474|FG000|Overall Study|Lost to Follow-up|4
4741201|NCT04117607|7698490|FG000|Overall Study|Early Termination|0
4741202|NCT04117607|7698491|FG001|Overall Study|Early Termination|1
4741203|NCT04117607|7698492|FG002|Overall Study|Early Termination|0
4741204|NCT04117607|7698493|FG003|Overall Study|Early Termination|0
4741205|NCT04117607|7698494|FG004|Overall Study|Early Termination|0
4741206|NCT04117607|7698495|FG005|Overall Study|Early Termination|0
4741207|NCT04117607|7698496|FG006|Overall Study|Early Termination|1
4741208|NCT04117607|7698497|FG007|Overall Study|Early Termination|0
4741209|NCT04117607|7698498|FG008|Overall Study|Early Termination|0
4741210|NCT04117607|7698499|FG009|Overall Study|Early Termination|0
4741211|NCT04117607|7698500|FG010|Overall Study|Early Termination|0
4741212|NCT04117607|7698501|FG011|Overall Study|Early Termination|0
4741213|NCT04117607|7698502|FG012|Overall Study|Early Termination|0
4741214|NCT04117607|7698503|FG013|Overall Study|Early Termination|0
4741215|NCT04096365|7698528|FG000|Overall Study|Adverse Event|1
4741216|NCT04080297|7698534|FG000|Overall Study|Adverse Event|1
4741217|NCT04080297|7698535|FG001|Overall Study|Adverse Event|3
4741218|NCT04080297|7698534|FG000|Overall Study|concurrent illness|1
4741219|NCT04080297|7698535|FG001|Overall Study|concurrent illness|0
4741220|NCT04115358|7698544|FG000|Overall Study|exfoliation|0
4741221|NCT04115358|7698545|FG001|Overall Study|exfoliation|0
4741222|NCT04115358|7698546|FG002|Overall Study|exfoliation|1
4741223|NCT04113694|7698570|FG000|Overall Study|Adverse Event|2
4741224|NCT04113694|7698570|FG000|Overall Study|Lost to Follow-up|2
4741225|NCT04113694|7698570|FG000|Overall Study|Withdrawal by Subject|6
4741226|NCT04113694|7698570|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1
4741227|NCT04106817|7698626|FG000|Overall Study|Lost to Follow-up|1
4741228|NCT04106817|7698627|FG001|Overall Study|Lost to Follow-up|0
4741229|NCT04106817|7698628|FG002|Overall Study|Lost to Follow-up|0
4741230|NCT04105972|7698638|FG000|Overall Study|Adverse Event|2
4741231|NCT04105972|7698639|FG001|Overall Study|Adverse Event|1
4741232|NCT04105218|7698647|FG000|Overall Study|Withdrawal by Subject|3
4741233|NCT04105218|7698648|FG001|Overall Study|Withdrawal by Subject|2
4741234|NCT04105218|7698647|FG000|Overall Study|Study was terminated; unable to complete study visits|1
4741235|NCT04105218|7698648|FG001|Overall Study|Study was terminated; unable to complete study visits|3
4741236|NCT04105218|7698647|FG000|Overall Study|Failed screening tests|2
4741237|NCT04105218|7698648|FG001|Overall Study|Failed screening tests|1
4741238|NCT04102540|7698663|FG000|Overall Study|Withdrawn by PI|2
4741239|NCT04102540|7698663|FG000|Overall Study|Lost to Follow-up|6
4741240|NCT04102345|7698669|FG000|Overall Study|Withdrawal by Subject|1
4741241|NCT04102345|7698670|FG001|Overall Study|Withdrawal by Subject|0
4741242|NCT04099277|7698710|FG000|Overall Study|Physician Decision|1
4741243|NCT04099277|7698710|FG000|Overall Study|Withdrawal by Subject|1
4741244|NCT04098809|7698716|FG000|Overall Study|Withdrawal by Subject|1
4741245|NCT04098809|7698717|FG001|Overall Study|Withdrawal by Subject|3
4741246|NCT04098809|7698716|FG000|Overall Study|Physician Decision|2
4741247|NCT04098809|7698717|FG001|Overall Study|Physician Decision|1
4741248|NCT04098458|7698736|FG000|Overall Study|Death|1
4741249|NCT04098458|7698736|FG000|Overall Study|did not meet study inclusion criteria|3
4741250|NCT04095286|7698741|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
4741251|NCT04095286|7698742|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1
4741252|NCT04095286|7698743|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
4741253|NCT04095286|7698744|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
4741254|NCT04095286|7698745|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
4741255|NCT04095286|7698746|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
4741256|NCT04095286|7698741|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1
4741257|NCT04095286|7698742|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0
4741258|NCT04095286|7698743|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0
4741259|NCT04095286|7698744|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0
4741260|NCT04095286|7698745|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0
4741261|NCT04095286|7698746|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0
4741262|NCT04095286|7698741|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0
4741263|NCT04095286|7698742|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0
4741264|NCT04095286|7698743|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1
4741265|NCT04095286|7698744|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0
4741266|NCT04095286|7698745|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0
4741267|NCT04095286|7698746|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0
4741268|NCT04095286|7698741|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
4741269|NCT04095286|7698742|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
4741270|NCT04095286|7698743|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2
4741271|NCT04095286|7698744|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
4741272|NCT04095286|7698745|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
4741273|NCT04095286|7698746|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
4741274|NCT04095286|7698741|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0
4741275|NCT04095286|7698742|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0
4741276|NCT04095286|7698743|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0
4741277|NCT04095286|7698744|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0
4741278|NCT04095286|7698745|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1
4741279|NCT04095286|7698746|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0
4741280|NCT04094883|7698754|FG000|Overall Study|Withdrawal by Subject|1
4741281|NCT04091659|7698760|FG000|Overall Study|Protocol Violation|3
4741282|NCT04091659|7698761|FG001|Overall Study|Protocol Violation|0
4741283|NCT04091659|7698760|FG000|Overall Study|Lost to Follow-up|0
4741284|NCT04091659|7698761|FG001|Overall Study|Lost to Follow-up|1
4741285|NCT04090242|7698786|FG000|Overall Study|Withdrawal by Subject|1
4741286|NCT04090242|7698787|FG001|Overall Study|Withdrawal by Subject|0
4741287|NCT04089761|7698794|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14
4741288|NCT04089761|7698794|FG000|"Run In Phase"|Lost to Follow-up|1
4741289|NCT04089761|7698794|FG000|"Treatment Phase"|No evaluable data|5
4741290|NCT04089761|7698794|FG000|"Treatment Phase"|Lost to Follow-up|1
4741291|NCT04079803|7698801|FG000|Overall Study|Withdrawal by Subject|0
4741292|NCT04079803|7698802|FG001|Overall Study|Withdrawal by Subject|0
4741293|NCT04079803|7698803|FG002|Overall Study|Withdrawal by Subject|1
4741294|NCT04086641|7698859|FG000|Foot 1 (Two Week Utilization)|COVID-19|1
4741295|NCT04086641|7698860|FG001|Foot 1 (Two Week Utilization)|COVID-19|2
4741296|NCT04086472|7698880|FG000|Overall Study|Lost to Follow-up|1
4741297|NCT04086472|7698881|FG001|Overall Study|Lost to Follow-up|0
4741298|NCT04086472|7698882|FG002|Overall Study|Lost to Follow-up|0
4741299|NCT04086472|7698883|FG003|Overall Study|Lost to Follow-up|0
4741300|NCT04086472|7698884|FG004|Overall Study|Lost to Follow-up|1
4741301|NCT04086472|7698880|FG000|Overall Study|Physician Decision|0
4741302|NCT04086472|7698881|FG001|Overall Study|Physician Decision|1
4741303|NCT04086472|7698882|FG002|Overall Study|Physician Decision|1
4741304|NCT04086472|7698883|FG003|Overall Study|Physician Decision|0
4741305|NCT04086472|7698884|FG004|Overall Study|Physician Decision|0
4741306|NCT04086472|7698880|FG000|Overall Study|Withdrawal by Subject|1
4741307|NCT04086472|7698881|FG001|Overall Study|Withdrawal by Subject|1
4741308|NCT04086472|7698882|FG002|Overall Study|Withdrawal by Subject|1
4741309|NCT04086472|7698883|FG003|Overall Study|Withdrawal by Subject|0
4741310|NCT04086472|7698884|FG004|Overall Study|Withdrawal by Subject|0
4741311|NCT04086472|7698880|FG000|Overall Study|Various reasons|2
4741312|NCT04086472|7698881|FG001|Overall Study|Various reasons|0
4741313|NCT04086472|7698882|FG002|Overall Study|Various reasons|0
4741314|NCT04086472|7698883|FG003|Overall Study|Various reasons|3
4741315|NCT04086472|7698884|FG004|Overall Study|Various reasons|1
4741316|NCT04085289|7698899|FG000|Overall Study|Withdrawal by Subject|0
4741317|NCT04085289|7698900|FG001|Overall Study|Withdrawal by Subject|0
4741318|NCT04085289|7698901|FG002|Overall Study|Withdrawal by Subject|1
4741319|NCT04082663|7698912|FG000|Overall Study|Adverse Event|6
4741320|NCT04082663|7698912|FG000|Overall Study|Lost to Follow-up|1
4741321|NCT04079790|7698993|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1
4741322|NCT04079790|7698994|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0
4741323|NCT04079790|7698995|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0
4741324|NCT04079790|7698996|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0
4741325|NCT04079790|7698993|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0
4741326|NCT04079790|7698994|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0
4741327|NCT04079790|7698995|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1
4741328|NCT04079790|7698996|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0
4741329|NCT04079790|7698993|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0
4741330|NCT04079790|7698994|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0
4741331|NCT04079790|7698995|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2
4741332|NCT04079790|7698996|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0
4741333|NCT04073407|7699087|FG000|Part 1|Withdrawal by Subject|1
4741334|NCT04073407|7699088|FG001|Part 1|Withdrawal by Subject|0
4741335|NCT04073407|7699087|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4
4741336|NCT04073407|7699088|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1
4741337|NCT04073407|7699087|FG000|Part 2|Withdrawal by Subject|0
4741338|NCT04073407|7699088|FG001|Part 2|Withdrawal by Subject|1
4741339|NCT04073368|7699098|FG000|Overall Study|Adverse Event|2
4741340|NCT04073368|7699099|FG001|Overall Study|Adverse Event|0
4741341|NCT04073368|7699100|FG002|Overall Study|Adverse Event|1
4741342|NCT04073368|7699101|FG003|Overall Study|Adverse Event|1
4524910|NCT01019694|7340636|FG001|Overall Study|Adverse Event|16
4524911|NCT01019694|7340637|FG002|Overall Study|Adverse Event|19
4524912|NCT01019694|7340635|FG000|Overall Study|Protocol Violation|2
4524913|NCT01019694|7340636|FG001|Overall Study|Protocol Violation|6
4524914|NCT01019694|7340637|FG002|Overall Study|Protocol Violation|4
4524915|NCT01019694|7340635|FG000|Overall Study|Lost to Follow-up|5
4524916|NCT01019694|7340636|FG001|Overall Study|Lost to Follow-up|3
4524917|NCT01019694|7340637|FG002|Overall Study|Lost to Follow-up|3
4524918|NCT01019694|7340635|FG000|Overall Study|Withdrawal by Subject|4
4524919|NCT01019694|7340636|FG001|Overall Study|Withdrawal by Subject|6
4524920|NCT01019694|7340637|FG002|Overall Study|Withdrawal by Subject|12
4524921|NCT01019694|7340635|FG000|Overall Study|Not treated|0
4524922|NCT01019694|7340636|FG001|Overall Study|Not treated|2
4524923|NCT01019694|7340637|FG002|Overall Study|Not treated|3
4524924|NCT01019694|7340635|FG000|Overall Study|Other reason (not specified)|1
4524925|NCT01019694|7340636|FG001|Overall Study|Other reason (not specified)|5
4524926|NCT01019694|7340637|FG002|Overall Study|Other reason (not specified)|6
4524927|NCT01020019|7340676|FG000|Overall Study|Lost to Follow-up|21
4524928|NCT01020019|7340677|FG001|Overall Study|Lost to Follow-up|18
4524929|NCT01020019|7340676|FG000|Overall Study|Adverse Event|1
4524930|NCT01020019|7340677|FG001|Overall Study|Adverse Event|5
4524931|NCT01020019|7340676|FG000|Overall Study|not interested in treatment|4
4524932|NCT01020019|7340677|FG001|Overall Study|not interested in treatment|4
4524933|NCT01020019|7340676|FG000|Overall Study|moving|0
4524934|NCT01020019|7340677|FG001|Overall Study|moving|2
4524935|NCT01020123|7340690|FG000|Main Period|Withdrawal by Subject|6
4524936|NCT01020123|7340691|FG001|Main Period|Withdrawal by Subject|5
4524937|NCT01020123|7340692|FG002|Main Period|Withdrawal by Subject|3
4524938|NCT01020123|7340693|FG003|Main Period|Withdrawal by Subject|1
4524939|NCT01020123|7340694|FG004|Main Period|Withdrawal by Subject|6
4524940|NCT01020123|7340695|FG005|Main Period|Withdrawal by Subject|3
4524941|NCT01020123|7340696|FG006|Main Period|Withdrawal by Subject|2
4524942|NCT01020123|7340690|FG000|Main Period|Eligibility Criteria not fullfilled|0
4524943|NCT01020123|7340691|FG001|Main Period|Eligibility Criteria not fullfilled|1
4524944|NCT01020123|7340692|FG002|Main Period|Eligibility Criteria not fullfilled|0
4524945|NCT01020123|7340693|FG003|Main Period|Eligibility Criteria not fullfilled|0
4524946|NCT01020123|7340694|FG004|Main Period|Eligibility Criteria not fullfilled|1
4524947|NCT01020123|7340695|FG005|Main Period|Eligibility Criteria not fullfilled|0
4524948|NCT01020123|7340696|FG006|Main Period|Eligibility Criteria not fullfilled|0
4634014|NCT01919723|7504580|FG000|Overall Study|Blood Samples Hemolyzed|2
4634015|NCT01919723|7504581|FG001|Overall Study|Blood Samples Hemolyzed|2
4634016|NCT01919801|7504589|FG000|Overall Study|Withdrawal by Subject|1
4634017|NCT01919801|7504590|FG001|Overall Study|Withdrawal by Subject|0
4524949|NCT01020123|7340690|FG000|Main Period|Adverse Event|5
4524950|NCT01020123|7340691|FG001|Main Period|Adverse Event|2
4524951|NCT01020123|7340692|FG002|Main Period|Adverse Event|2
4524952|NCT01020123|7340693|FG003|Main Period|Adverse Event|1
4524953|NCT01020123|7340694|FG004|Main Period|Adverse Event|1
4634018|NCT01919801|7504589|FG000|Overall Study|Physician Decision|0
4634019|NCT01919801|7504590|FG001|Overall Study|Physician Decision|1
4524954|NCT01020123|7340695|FG005|Main Period|Adverse Event|2
4524955|NCT01020123|7340696|FG006|Main Period|Adverse Event|1
4524956|NCT01020123|7340690|FG000|Main Period|Protocol Violation|4
4524957|NCT01020123|7340691|FG001|Main Period|Protocol Violation|4
4524958|NCT01020123|7340692|FG002|Main Period|Protocol Violation|2
4741343|NCT04073368|7699098|FG000|Overall Study|Withdrawal by Subject|2
4741344|NCT04073368|7699099|FG001|Overall Study|Withdrawal by Subject|2
4634020|NCT01919801|7504589|FG000|Overall Study|Lost to Follow-up|0
4634021|NCT01919801|7504590|FG001|Overall Study|Lost to Follow-up|1
4634022|NCT01919801|7504589|FG000|Overall Study|Other|0
4634023|NCT01919801|7504590|FG001|Overall Study|Other|1
4741345|NCT04073368|7699100|FG002|Overall Study|Withdrawal by Subject|1
4741346|NCT04073368|7699101|FG003|Overall Study|Withdrawal by Subject|1
4741347|NCT04073368|7699098|FG000|Overall Study|Lost to Follow-up|1
4741348|NCT04073368|7699099|FG001|Overall Study|Lost to Follow-up|1
4741349|NCT04073368|7699100|FG002|Overall Study|Lost to Follow-up|1
4741350|NCT04073368|7699101|FG003|Overall Study|Lost to Follow-up|0
4741351|NCT04073368|7699098|FG000|Overall Study|Protocol Violation|0
4741352|NCT04073368|7699099|FG001|Overall Study|Protocol Violation|1
4741353|NCT04073368|7699100|FG002|Overall Study|Protocol Violation|0
4741354|NCT04073368|7699101|FG003|Overall Study|Protocol Violation|0
4741355|NCT04073368|7699098|FG000|Overall Study|Subject noncompliance|7
4741356|NCT04073368|7699099|FG001|Overall Study|Subject noncompliance|4
4741357|NCT04073368|7699100|FG002|Overall Study|Subject noncompliance|0
4741358|NCT04073368|7699101|FG003|Overall Study|Subject noncompliance|0
4741359|NCT04073186|7699111|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1
4741360|NCT04073186|7699111|FG000|First Wearing Cycle|Withdrawal by Subject|1
4741361|NCT04073186|7699111|FG000|First Wearing Cycle|Protocol Violation|1
4741362|NCT04073186|7699111|FG000|First Wearing Cycle|Lens Discomfort|2
4741363|NCT04073186|7699111|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1
4741364|NCT04073186|7699111|FG000|Second Wearing Cycle|Adverse Event|1
4741365|NCT04071301|7699179|FG000|Overall Study|Withdrawal by Subject|6
4741366|NCT04071301|7699179|FG000|Overall Study|Death|1
4741367|NCT04071158|7699188|FG000|Overall Study|Lost to Follow-up|1
4741368|NCT04071158|7699189|FG001|Overall Study|Lost to Follow-up|2
4741369|NCT04071158|7699190|FG002|Overall Study|Lost to Follow-up|3
4741370|NCT04071158|7699191|FG003|Overall Study|Lost to Follow-up|3
4741371|NCT04071158|7699192|FG004|Overall Study|Lost to Follow-up|5
4741372|NCT04071158|7699188|FG000|Overall Study|Randomized but not treated|2
4741373|NCT04071158|7699189|FG001|Overall Study|Randomized but not treated|2
4741374|NCT04071158|7699190|FG002|Overall Study|Randomized but not treated|0
4741375|NCT04071158|7699191|FG003|Overall Study|Randomized but not treated|0
4741376|NCT04071158|7699192|FG004|Overall Study|Randomized but not treated|0
4741377|NCT04069715|7699233|FG000|Overall Study|Lost to Follow-up|1
4741378|NCT04069715|7699234|FG001|Overall Study|Lost to Follow-up|1
4741379|NCT04069715|7699233|FG000|Overall Study|Physician Decision|1
4741380|NCT04069715|7699234|FG001|Overall Study|Physician Decision|1
4741381|NCT04069715|7699233|FG000|Overall Study|Withdrawal by Subject|3
4741382|NCT04069715|7699234|FG001|Overall Study|Withdrawal by Subject|3
4741383|NCT04050722|7699242|FG000|Overall Study|Withdrawal by Subject|1
4741384|NCT04050722|7699243|FG001|Overall Study|Withdrawal by Subject|0
4741385|NCT04067141|7699264|FG000|First Intervention|Withdrawal by Subject|0
4741386|NCT04067141|7699265|FG001|First Intervention|Withdrawal by Subject|1
4741387|NCT04067141|7699264|FG000|Second Intervention|Adverse Event|0
4741388|NCT04067141|7699265|FG001|Second Intervention|Adverse Event|2
4741389|NCT04049578|7699271|FG000|Overall Study|Physician Decision|1
4741390|NCT04067401|7699277|FG000|Overall Study|Withdrawal by Subject|7
4741391|NCT04067401|7699278|FG001|Overall Study|Withdrawal by Subject|0
4741392|NCT04067401|7699277|FG000|Overall Study|no data provided|1
4741393|NCT04067401|7699278|FG001|Overall Study|no data provided|0
4741394|NCT04067050|7699286|FG000|One Month|Lost to Follow-up|4
4741395|NCT04067050|7699287|FG001|One Month|Lost to Follow-up|0
4741396|NCT04067050|7699286|FG000|Two Month|Lost to Follow-up|1
4741397|NCT04067050|7699287|FG001|Two Month|Lost to Follow-up|0
4741398|NCT04067050|7699286|FG000|Two Month|Adverse Event|1
4741399|NCT04067050|7699287|FG001|Two Month|Adverse Event|0
4741400|NCT04060654|7699323|FG000|Overall Study|Withdrawal by Subject|1
4741401|NCT04060654|7699323|FG000|Overall Study|Lost to Follow-up|5
4741402|NCT04058353|7699336|FG000|Overall Study|Adverse Event|2
4741403|NCT04058353|7699337|FG001|Overall Study|Adverse Event|1
4741404|NCT04058353|7699336|FG000|Overall Study|Physician Decision|1
4741405|NCT04058353|7699337|FG001|Overall Study|Physician Decision|0
4741406|NCT04058353|7699336|FG000|Overall Study|Other|1
4634024|NCT01919814|7504596|FG000|Overall Study|Adverse Event|1
4741407|NCT04058353|7699337|FG001|Overall Study|Other|0
4741408|NCT04054765|7699369|FG000|Baseline|Withdrawal by Subject|5
4741409|NCT04054765|7699370|FG001|Baseline|Withdrawal by Subject|3
4741410|NCT04054765|7699369|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8
4741411|NCT04054765|7699370|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3
4741412|NCT04054765|7699369|FG000|3-month Follow up|Withdrawal by Subject|0
4741413|NCT04054765|7699370|FG001|3-month Follow up|Withdrawal by Subject|3
4741414|NCT04054765|7699369|FG000|6-month Follow up|Lost to Follow-up|32
4741415|NCT04054765|7699370|FG001|6-month Follow up|Lost to Follow-up|32
4741416|NCT04054011|7699376|FG000|Overall Study|COVID|3
4741417|NCT04059094|7699387|FG000|Overall Study|Adverse Event|0
4741418|NCT04059094|7699388|FG001|Overall Study|Adverse Event|0
4741419|NCT04059094|7699389|FG002|Overall Study|Adverse Event|0
4741420|NCT04059094|7699390|FG003|Overall Study|Adverse Event|0
4741421|NCT04059094|7699391|FG004|Overall Study|Adverse Event|1
4741422|NCT04059094|7699387|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0
4741423|NCT04059094|7699388|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2
4741424|NCT04059094|7699389|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0
4741425|NCT04059094|7699390|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0
4741426|NCT04059094|7699391|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0
4741427|NCT04046341|7699416|FG000|Overall Study|Lost to Follow-up|2
4741428|NCT04046341|7699416|FG000|Overall Study|Withdrawal by Subject|1
4741429|NCT04043416|7699431|FG000|Washout|Change in health condition|0
4741430|NCT04043416|7699432|FG001|Washout|Change in health condition|1
4741431|NCT04054193|7699494|FG000|Cycle 1|Physician Decision|1
4741432|NCT04054193|7699494|FG000|Cycle 1|Consent withdrawn by parent/guardian|1
4741433|NCT04054193|7699494|FG000|Cycle 1|Allocated but not treated|3
4741434|NCT04054193|7699494|FG000|Cycles 2-3|Physician Decision|2
4741435|NCT04054193|7699494|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2
4741436|NCT04054193|7699494|FG000|Cycles 2-3|Various reasons|17
4741437|NCT04050618|7699501|FG000|First Intervention|Withdrawal by Subject|2
4741438|NCT04050618|7699502|FG001|First Intervention|Withdrawal by Subject|0
4741439|NCT04050618|7699501|FG000|Second Intervention|Withdrawal by Subject|1
4741440|NCT04050618|7699502|FG001|Second Intervention|Withdrawal by Subject|0
4741441|NCT04053465|7699515|FG000|Overall Study|Withdrawal by Subject|4
4741442|NCT04053465|7699516|FG001|Overall Study|Withdrawal by Subject|4
4741443|NCT04049552|7699535|FG000|Overall Study|Lost to Follow-up|1
4741444|NCT04053023|7699543|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1
4741445|NCT04053023|7699544|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0
4741446|NCT04050865|7699569|FG000|Overall Study|Adverse Event|1
4741447|NCT04050865|7699570|FG001|Overall Study|Adverse Event|0
4741448|NCT04050865|7699569|FG000|Overall Study|no insert|1
4741449|NCT04050865|7699570|FG001|Overall Study|no insert|0
4741450|NCT04050865|7699569|FG000|Overall Study|Only 1 insert|2
4741451|NCT04050865|7699570|FG001|Overall Study|Only 1 insert|3
4741452|NCT04050865|7699569|FG000|Overall Study|Physician Decision|0
4741453|NCT04050865|7699570|FG001|Overall Study|Physician Decision|1
4741454|NCT04050865|7699569|FG000|Overall Study|Withdrawal by Subject|0
4741455|NCT04050865|7699570|FG001|Overall Study|Withdrawal by Subject|1
4741456|NCT04050371|7699588|FG000|Overall Study|Withdrawal by Subject|1
4741457|NCT04050371|7699589|FG001|Overall Study|Withdrawal by Subject|0
4741458|NCT04048681|7699599|FG000|Overall Study|family emergency|0
4741459|NCT04048681|7699600|FG001|Overall Study|family emergency|0
4741460|NCT04048681|7699601|FG002|Overall Study|family emergency|0
4741461|NCT04048681|7699602|FG003|Overall Study|family emergency|1
4741462|NCT04048681|7699603|FG004|Overall Study|family emergency|0
4741463|NCT04046250|7699613|FG000|Overall Study|Death|0
4741464|NCT04046250|7699614|FG001|Overall Study|Death|1
4741465|NCT04046250|7699613|FG000|Overall Study|Withdrawal by Subject|3
4741466|NCT04046250|7699614|FG001|Overall Study|Withdrawal by Subject|3
4741467|NCT04044352|7699629|FG000|Overall Study|Lost to Follow-up|9
4524959|NCT01020123|7340693|FG003|Main Period|Protocol Violation|5
4524960|NCT01020123|7340694|FG004|Main Period|Protocol Violation|2
4524961|NCT01020123|7340695|FG005|Main Period|Protocol Violation|3
4524962|NCT01020123|7340696|FG006|Main Period|Protocol Violation|2
4524963|NCT01020123|7340690|FG000|Main Period|Lost to Follow-up|0
4524964|NCT01020123|7340691|FG001|Main Period|Lost to Follow-up|2
4524965|NCT01020123|7340692|FG002|Main Period|Lost to Follow-up|0
4524966|NCT01020123|7340693|FG003|Main Period|Lost to Follow-up|0
4524967|NCT01020123|7340694|FG004|Main Period|Lost to Follow-up|0
4741468|NCT04044352|7699629|FG000|Overall Study|Withdrawal by Subject|2
4741469|NCT04043728|7699637|FG000|Overall Study|Lost to Follow-up|1
4741470|NCT04043728|7699638|FG001|Overall Study|Lost to Follow-up|2
4741471|NCT04043728|7699639|FG002|Overall Study|Lost to Follow-up|0
4524968|NCT01020123|7340695|FG005|Main Period|Lost to Follow-up|0
4524969|NCT01020123|7340696|FG006|Main Period|Lost to Follow-up|0
4524970|NCT01020123|7340690|FG000|Main Period|Unclasified|2
4524971|NCT01020123|7340691|FG001|Main Period|Unclasified|0
4741472|NCT04041414|7699668|FG000|Overall Study|Lost to Follow-up|1
4741473|NCT04041414|7699669|FG001|Overall Study|Lost to Follow-up|2
4741474|NCT04041700|7699682|FG000|Overall Study|Pregnancy|1
4741475|NCT04041700|7699682|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1
4741476|NCT04040933|7699686|FG000|Overall Study|Protocol Violation|1
4741477|NCT04040933|7699686|FG000|Overall Study|Withdrawal by Subject|2
4741478|NCT04029519|7699727|FG000|Overall Study|Protocol Violation|1
4741479|NCT04029519|7699727|FG000|Overall Study|Withdrawal by Subject|3
4741480|NCT04029519|7699727|FG000|Overall Study|Lost to Follow-up|1
4741481|NCT04039919|7699736|FG000|Treatment Period 1|Withdrawal by Subject|1
4741482|NCT04039919|7699737|FG001|Treatment Period 1|Withdrawal by Subject|0
4741483|NCT04039919|7699738|FG002|Treatment Period 1|Withdrawal by Subject|0
4741484|NCT04039919|7699739|FG003|Treatment Period 1|Withdrawal by Subject|0
4741485|NCT04039919|7699740|FG004|Treatment Period 1|Withdrawal by Subject|0
4741486|NCT04039919|7699736|FG000|Treatment Period 1|Sponsor's decision|0
4741487|NCT04039919|7699737|FG001|Treatment Period 1|Sponsor's decision|0
4741488|NCT04039919|7699738|FG002|Treatment Period 1|Sponsor's decision|0
4741489|NCT04039919|7699739|FG003|Treatment Period 1|Sponsor's decision|0
4741490|NCT04039919|7699740|FG004|Treatment Period 1|Sponsor's decision|16
4741491|NCT04039919|7699736|FG000|Treatment Period 5|Withdrawal by Subject|1
4741492|NCT04039919|7699737|FG001|Treatment Period 5|Withdrawal by Subject|0
4741493|NCT04039919|7699738|FG002|Treatment Period 5|Withdrawal by Subject|0
4741494|NCT04039919|7699739|FG003|Treatment Period 5|Withdrawal by Subject|0
4741495|NCT04039919|7699740|FG004|Treatment Period 5|Withdrawal by Subject|0
4741496|NCT04037748|7699789|FG000|Treatment Period 1|Withdrawal by Subject|3
4741497|NCT04037748|7699790|FG001|Treatment Period 1|Withdrawal by Subject|0
4741498|NCT04037748|7699789|FG000|Treatment Period 1|Adverse Event|1
4741499|NCT04037748|7699790|FG001|Treatment Period 1|Adverse Event|1
4741500|NCT04037748|7699789|FG000|Treatment Period 1|Protocol Violation|4
4741501|NCT04037748|7699790|FG001|Treatment Period 1|Protocol Violation|5
4741502|NCT04037748|7699789|FG000|Treatment Period 2|Adverse Event|0
4741503|NCT04037748|7699790|FG001|Treatment Period 2|Adverse Event|1
4741504|NCT04037748|7699789|FG000|Treatment Period 2|Protocol Violation|2
4741505|NCT04037748|7699790|FG001|Treatment Period 2|Protocol Violation|0
4741506|NCT04027686|7699807|FG000|Overall Study|Lost to Follow-up|2
4741507|NCT04027686|7699808|FG001|Overall Study|Lost to Follow-up|0
4741508|NCT04027686|7699807|FG000|Overall Study|Withdrawal by Subject|0
4741509|NCT04027686|7699808|FG001|Overall Study|Withdrawal by Subject|1
4741510|NCT04036110|7699838|FG000|Overall Study|Lost to Follow-up|3
4741511|NCT04036110|7699839|FG001|Overall Study|Lost to Follow-up|2
4741512|NCT04036110|7699840|FG002|Overall Study|Lost to Follow-up|1
4741513|NCT04036110|7699838|FG000|Overall Study|Study Suspended|4
4741514|NCT04036110|7699839|FG001|Overall Study|Study Suspended|5
4741515|NCT04036110|7699840|FG002|Overall Study|Study Suspended|1
4741516|NCT04035577|7699857|FG000|Overall Study|Lost to Follow-up|1
4741517|NCT04035577|7699857|FG000|Overall Study|Withdrawal by Subject|1
4741518|NCT04035564|7699865|FG000|Overall Study|Protocol Violation|1
4741519|NCT04035564|7699866|FG001|Overall Study|Protocol Violation|2
4741520|NCT04035564|7699865|FG000|Overall Study|No laboratory available|2
4741521|NCT04035564|7699866|FG001|Overall Study|No laboratory available|2
4741522|NCT04035564|7699865|FG000|Overall Study|Guardian declined consent|1
4741523|NCT04035564|7699866|FG001|Overall Study|Guardian declined consent|2
4741524|NCT04032977|7699874|FG000|Overall Study|Withdrawal by Subject|6
4741525|NCT04032977|7699875|FG001|Overall Study|Withdrawal by Subject|1
4741526|NCT04032977|7699874|FG000|Overall Study|Lost to Follow-up|2
4741527|NCT04032977|7699875|FG001|Overall Study|Lost to Follow-up|7
4741528|NCT04032977|7699874|FG000|Overall Study|Pregnancy|1
4741529|NCT04032977|7699875|FG001|Overall Study|Pregnancy|0
4741530|NCT04032652|7699883|FG000|Overall Study|The study was terminated and the PI has|1
4741531|NCT04032652|7699884|FG001|Overall Study|The study was terminated and the PI has|1
4741532|NCT04032613|7699904|FG000|Overall Study|Did not complete post-program assessment|5
4741533|NCT04032613|7699905|FG001|Overall Study|Did not complete post-program assessment|2
4741534|NCT04032171|7699913|FG000|Overall Study|Study Termination|1
4741535|NCT04032171|7699914|FG001|Overall Study|Study Termination|0
4741536|NCT04032158|7699922|FG000|Overall Study|Study Termination|2
4741537|NCT04032158|7699923|FG001|Overall Study|Study Termination|1
4741538|NCT04031404|7699929|FG000|Baseline|Lost to Follow-up|0
4741539|NCT04031404|7699930|FG001|Baseline|Lost to Follow-up|1
4741540|NCT04031404|7699929|FG000|Baseline|Did not meet full inclusion/exclusion.|2
4741541|NCT04031404|7699930|FG001|Baseline|Did not meet full inclusion/exclusion.|4
4741542|NCT04031404|7699929|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1
4741543|NCT04031404|7699930|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3
4741544|NCT04031404|7699929|FG000|Pre-randomization|Disqualified by TMS safety screening|1
4741545|NCT04031404|7699930|FG001|Pre-randomization|Disqualified by TMS safety screening|0
4741546|NCT04031404|7699929|FG000|Washout (5 Day Min)|Lost to Follow-up|1
4741547|NCT04031404|7699930|FG001|Washout (5 Day Min)|Lost to Follow-up|0
4741548|NCT04029961|7699975|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1
4741549|NCT04029961|7699976|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0
4741550|NCT04029961|7699975|FG000|Overall Study|Change in Treatment Course|0
4741551|NCT04029961|7699976|FG001|Overall Study|Change in Treatment Course|1
4741552|NCT04025684|7699986|FG000|Overall Study|Withdrawal by Subject|1
4741553|NCT04025684|7699987|FG001|Overall Study|Withdrawal by Subject|1
4741554|NCT04025684|7699988|FG002|Overall Study|Withdrawal by Subject|0
4524972|NCT01020123|7340692|FG002|Main Period|Unclasified|1
4524973|NCT01020123|7340693|FG003|Main Period|Unclasified|0
4524974|NCT01020123|7340694|FG004|Main Period|Unclasified|1
4524975|NCT01020123|7340695|FG005|Main Period|Unclasified|3
4524976|NCT01020123|7340696|FG006|Main Period|Unclasified|6
4524977|NCT01020123|7340690|FG000|Extention Period|Withdrawal by Subject|2
4524978|NCT01020123|7340691|FG001|Extention Period|Withdrawal by Subject|1
4524979|NCT01020123|7340692|FG002|Extention Period|Withdrawal by Subject|1
4524980|NCT01020123|7340693|FG003|Extention Period|Withdrawal by Subject|0
4524981|NCT01020123|7340694|FG004|Extention Period|Withdrawal by Subject|0
4524982|NCT01020123|7340695|FG005|Extention Period|Withdrawal by Subject|0
4524983|NCT01020123|7340696|FG006|Extention Period|Withdrawal by Subject|0
4524984|NCT01020123|7340690|FG000|Extention Period|Adverse Event|0
4524985|NCT01020123|7340691|FG001|Extention Period|Adverse Event|0
4524986|NCT01020123|7340692|FG002|Extention Period|Adverse Event|0
4524987|NCT01020123|7340693|FG003|Extention Period|Adverse Event|1
4524988|NCT01020123|7340694|FG004|Extention Period|Adverse Event|0
4524989|NCT01020123|7340695|FG005|Extention Period|Adverse Event|0
4524990|NCT01020123|7340696|FG006|Extention Period|Adverse Event|0
4524991|NCT01020123|7340690|FG000|Extention Period|Protocol Violation|1
4524992|NCT01020123|7340691|FG001|Extention Period|Protocol Violation|1
4524993|NCT01020123|7340692|FG002|Extention Period|Protocol Violation|1
4524994|NCT01020123|7340693|FG003|Extention Period|Protocol Violation|0
4524995|NCT01020123|7340694|FG004|Extention Period|Protocol Violation|0
4524996|NCT01020123|7340695|FG005|Extention Period|Protocol Violation|0
4524997|NCT01020123|7340696|FG006|Extention Period|Protocol Violation|1
4524998|NCT01020123|7340690|FG000|Extention Period|Lost to Follow-up|0
4524999|NCT01020123|7340691|FG001|Extention Period|Lost to Follow-up|0
4525000|NCT01020123|7340692|FG002|Extention Period|Lost to Follow-up|0
4525001|NCT01020123|7340693|FG003|Extention Period|Lost to Follow-up|0
4525002|NCT01020123|7340694|FG004|Extention Period|Lost to Follow-up|0
4525003|NCT01020123|7340695|FG005|Extention Period|Lost to Follow-up|2
4525004|NCT01020123|7340696|FG006|Extention Period|Lost to Follow-up|0
4525005|NCT01020305|7340713|FG000|Overall Study|Adverse Event|2
4525006|NCT01020435|7340719|FG000|Overall Study|Lost to Follow-up|0
4525007|NCT01020435|7340720|FG001|Overall Study|Lost to Follow-up|1
4525008|NCT01020448|7340727|FG000|Pre-assignment|Adverse Event|6
4525009|NCT01020448|7340727|FG000|Pre-assignment|Withdrawal by Subject|5
4525010|NCT01020448|7340727|FG000|Pre-assignment|Does Not Meet Entry Criteria|2
4525011|NCT01020448|7340727|FG000|Treatment|Adverse Event|11
4525012|NCT01020448|7340727|FG000|Treatment|Consent Withdrawn|3
4525013|NCT01020448|7340727|FG000|Treatment|Disease Progression|2
4525014|NCT01020448|7340727|FG000|Treatment|Lack of Efficacy|8
4741555|NCT04025684|7699989|FG003|Overall Study|Withdrawal by Subject|0
4525015|NCT01020448|7340727|FG000|Treatment|Lost to Follow-up|2
4525016|NCT01020474|7340734|FG000|Overall Study|Adverse Event|4
4525017|NCT01020474|7340735|FG001|Overall Study|Adverse Event|4
4525018|NCT01020474|7340734|FG000|Overall Study|Protocol Violation|0
4525019|NCT01020474|7340735|FG001|Overall Study|Protocol Violation|2
4525020|NCT01020474|7340734|FG000|Overall Study|Withdrawal by Subject|5
4525021|NCT01020474|7340735|FG001|Overall Study|Withdrawal by Subject|7
4525022|NCT01020474|7340734|FG000|Overall Study|Other Reasons|1
4525023|NCT01020474|7340735|FG001|Overall Study|Other Reasons|1
4525024|NCT01020474|7340734|FG000|Overall Study|Insufficient Clinical Response|0
4525025|NCT01020474|7340735|FG001|Overall Study|Insufficient Clinical Response|3
4741556|NCT04025684|7699986|FG000|Overall Study|Multiple reasons|1
4741557|NCT04025684|7699987|FG001|Overall Study|Multiple reasons|3
4741558|NCT04025684|7699988|FG002|Overall Study|Multiple reasons|0
4741559|NCT04025684|7699989|FG003|Overall Study|Multiple reasons|1
4741560|NCT04019054|7700001|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0
4741561|NCT04019054|7700002|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1
4741562|NCT04019054|7700001|FG000|Overall Study|Withdrawal by Subject|3
4741563|NCT04019054|7700002|FG001|Overall Study|Withdrawal by Subject|1
4741564|NCT04016311|7700135|FG000|Overall Study|Withdrawal by Subject|1
4741565|NCT04016311|7700136|FG001|Overall Study|Withdrawal by Subject|0
4741566|NCT04023682|7700229|FG000|Overall Study|Clinical schedules did not allow continued participation|6
4741567|NCT04023994|7700276|FG000|Overall Study|Lost to Follow-up|0
4741568|NCT04023994|7700277|FG001|Overall Study|Lost to Follow-up|1
4741569|NCT04023994|7700278|FG002|Overall Study|Lost to Follow-up|2
4741570|NCT04023994|7700279|FG003|Overall Study|Lost to Follow-up|0
4741571|NCT04023994|7700280|FG004|Overall Study|Lost to Follow-up|0
4741572|NCT04023994|7700281|FG005|Overall Study|Lost to Follow-up|0
4741573|NCT04023994|7700276|FG000|Overall Study|Withdrawal by Subject|0
4741574|NCT04023994|7700277|FG001|Overall Study|Withdrawal by Subject|0
4741575|NCT04023994|7700278|FG002|Overall Study|Withdrawal by Subject|0
4741576|NCT04023994|7700279|FG003|Overall Study|Withdrawal by Subject|1
4741577|NCT04023994|7700280|FG004|Overall Study|Withdrawal by Subject|0
4741578|NCT04023994|7700281|FG005|Overall Study|Withdrawal by Subject|0
4741579|NCT04017611|7700324|FG000|Overall Study|Withdrawn prior to completion|1
4741580|NCT04015232|7700330|FG000|Overall Study|Withdrawal by Subject|7
4741581|NCT04015232|7700331|FG001|Overall Study|Withdrawal by Subject|4
4741582|NCT04015232|7700330|FG000|Overall Study|Protocol Violation|1
4741583|NCT04015232|7700331|FG001|Overall Study|Protocol Violation|0
4741584|NCT04015232|7700330|FG000|Overall Study|Medical Grounds|3
4741585|NCT04015232|7700331|FG001|Overall Study|Medical Grounds|3
4741586|NCT04014062|7700371|FG000|Period I: Dosing|Medical Grounds|4
4741587|NCT04014062|7700372|FG001|Period I: Dosing|Medical Grounds|5
4634025|NCT01919814|7504597|FG001|Overall Study|Adverse Event|0
4634026|NCT01919814|7504596|FG000|Overall Study|Protocol Violation|1
4634027|NCT01919814|7504597|FG001|Overall Study|Protocol Violation|0
4634028|NCT01919814|7504596|FG000|Overall Study|Withdrawal by Subject|1
4634029|NCT01919814|7504597|FG001|Overall Study|Withdrawal by Subject|0
4634030|NCT01919970|7504605|FG000|Overall Study|Withdrawal by Subject|3
4634031|NCT01919970|7504606|FG001|Overall Study|Withdrawal by Subject|0
4634032|NCT01920061|7504636|FG000|Overall Study|Death|1
4634033|NCT01920061|7504637|FG001|Overall Study|Death|1
4634034|NCT01920061|7504638|FG002|Overall Study|Death|0
4634035|NCT01920061|7504639|FG003|Overall Study|Death|1
4634036|NCT01920061|7504640|FG004|Overall Study|Death|1
4634037|NCT01920061|7504641|FG005|Overall Study|Death|0
4634038|NCT01920061|7504642|FG006|Overall Study|Death|0
4634039|NCT01920061|7504643|FG007|Overall Study|Death|1
4634040|NCT01920061|7504644|FG008|Overall Study|Death|0
4741588|NCT04014062|7700371|FG000|Period I: Dosing|Withdrawal by Subject|3
4741589|NCT04014062|7700372|FG001|Period I: Dosing|Withdrawal by Subject|1
4741590|NCT04013191|7700409|FG000|Overall Study|Adverse Event|1
4741591|NCT04013191|7700410|FG001|Overall Study|Adverse Event|0
4741592|NCT04011735|7700427|FG000|Overall Study|Withdrawal by Subject|1
4741593|NCT04011735|7700428|FG001|Overall Study|Withdrawal by Subject|0
4741594|NCT04011735|7700429|FG002|Overall Study|Withdrawal by Subject|1
4741595|NCT04011735|7700427|FG000|Overall Study|Met exclusion criteria after study entry|0
4741596|NCT04011735|7700428|FG001|Overall Study|Met exclusion criteria after study entry|1
4741597|NCT04011735|7700429|FG002|Overall Study|Met exclusion criteria after study entry|0
4741598|NCT04009577|7700448|FG000|Core Study|Adverse Event|1
4741599|NCT04009577|7700449|FG001|Core Study|Adverse Event|0
4741600|NCT04009577|7700450|FG002|Core Study|Adverse Event|2
4741601|NCT04009577|7700451|FG003|Core Study|Adverse Event|4
4741602|NCT04009577|7700448|FG000|Core Study|Withdrawal by Subject|0
4741603|NCT04009577|7700449|FG001|Core Study|Withdrawal by Subject|0
4741604|NCT04009577|7700450|FG002|Core Study|Withdrawal by Subject|2
4741605|NCT04009577|7700451|FG003|Core Study|Withdrawal by Subject|0
4741606|NCT04009577|7700448|FG000|Core Study|Other|0
4741607|NCT04009577|7700449|FG001|Core Study|Other|0
4741608|NCT04009577|7700450|FG002|Core Study|Other|0
4741609|NCT04009577|7700451|FG003|Core Study|Other|1
4741610|NCT04009577|7700448|FG000|Extension Phase|Adverse Event|0
4741611|NCT04009577|7700449|FG001|Extension Phase|Adverse Event|0
4741612|NCT04009577|7700450|FG002|Extension Phase|Adverse Event|0
4741613|NCT04009577|7700451|FG003|Extension Phase|Adverse Event|1
4741614|NCT04009577|7700448|FG000|Extension Phase|Inadequate therapeutic effect|0
4741615|NCT04009577|7700449|FG001|Extension Phase|Inadequate therapeutic effect|0
4634041|NCT01920061|7504645|FG009|Overall Study|Death|1
4741616|NCT04009577|7700450|FG002|Extension Phase|Inadequate therapeutic effect|1
4634042|NCT01920061|7504646|FG010|Overall Study|Death|0
4634043|NCT01920061|7504647|FG011|Overall Study|Death|1
4634044|NCT01920061|7504648|FG012|Overall Study|Death|0
4634045|NCT01920061|7504649|FG013|Overall Study|Death|2
4634046|NCT01920061|7504650|FG014|Overall Study|Death|0
4741617|NCT04009577|7700451|FG003|Extension Phase|Inadequate therapeutic effect|0
4741618|NCT04009577|7700448|FG000|Extension Phase|Withdrawal by Subject|0
4741619|NCT04009577|7700449|FG001|Extension Phase|Withdrawal by Subject|0
4741620|NCT04009577|7700450|FG002|Extension Phase|Withdrawal by Subject|1
4741621|NCT04009577|7700451|FG003|Extension Phase|Withdrawal by Subject|0
4741622|NCT04009577|7700448|FG000|Extension Phase|Not Treated|0
4741623|NCT04009577|7700449|FG001|Extension Phase|Not Treated|0
4741624|NCT04009577|7700450|FG002|Extension Phase|Not Treated|2
4741625|NCT04009577|7700451|FG003|Extension Phase|Not Treated|0
4741626|NCT04007159|7700477|FG000|Induction Phase|(missed study visits)|16
4741627|NCT04007159|7700477|FG000|Induction Phase|Withdrawal by Subject|4
4741628|NCT04007159|7700477|FG000|Induction Phase|Adverse Event|2
4741629|NCT04007159|7700477|FG000|Challenge Phase|missed study visits|3
4741630|NCT04007107|7700488|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0
4741631|NCT04007107|7700489|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1
4741632|NCT04007107|7700490|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0
4741633|NCT04007107|7700491|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0
4741634|NCT04005885|7700507|FG000|First Intervention|Withdrawal by Subject|1
4741635|NCT04005885|7700508|FG001|First Intervention|Withdrawal by Subject|1
4741636|NCT04005885|7700507|FG000|Second Intervention|Withdrawal by Subject|0
4741637|NCT04005885|7700508|FG001|Second Intervention|Withdrawal by Subject|2
4741638|NCT04000815|7700522|FG000|Overall Study|Lost to Follow-up|9
4741639|NCT04000815|7700523|FG001|Overall Study|Lost to Follow-up|2
4741640|NCT04000815|7700524|FG002|Overall Study|Lost to Follow-up|3
4741641|NCT04000815|7700522|FG000|Overall Study|Withdrawal by Subject|4
4741642|NCT04000815|7700523|FG001|Overall Study|Withdrawal by Subject|3
4741643|NCT04000815|7700524|FG002|Overall Study|Withdrawal by Subject|2
4741644|NCT04000815|7700522|FG000|Overall Study|Right ovarian cyst occured|1
4634047|NCT01920061|7504651|FG015|Overall Study|Death|0
4634048|NCT01920061|7504652|FG016|Overall Study|Death|0
4634049|NCT01920061|7504653|FG017|Overall Study|Death|0
4634050|NCT01920061|7504654|FG018|Overall Study|Death|1
4634051|NCT01920061|7504655|FG019|Overall Study|Death|0
4634052|NCT01920061|7504636|FG000|Overall Study|Lost to Follow-up|0
4634053|NCT01920061|7504637|FG001|Overall Study|Lost to Follow-up|2
4634054|NCT01920061|7504638|FG002|Overall Study|Lost to Follow-up|0
4634055|NCT01920061|7504639|FG003|Overall Study|Lost to Follow-up|0
4634056|NCT01920061|7504640|FG004|Overall Study|Lost to Follow-up|0
4634057|NCT01920061|7504641|FG005|Overall Study|Lost to Follow-up|0
4634058|NCT01920061|7504642|FG006|Overall Study|Lost to Follow-up|1
4634059|NCT01920061|7504643|FG007|Overall Study|Lost to Follow-up|0
4634060|NCT01920061|7504644|FG008|Overall Study|Lost to Follow-up|0
4634061|NCT01920061|7504645|FG009|Overall Study|Lost to Follow-up|0
4634062|NCT01920061|7504646|FG010|Overall Study|Lost to Follow-up|3
4634063|NCT01920061|7504647|FG011|Overall Study|Lost to Follow-up|0
4634064|NCT01920061|7504648|FG012|Overall Study|Lost to Follow-up|0
4741645|NCT04000815|7700523|FG001|Overall Study|Right ovarian cyst occured|0
4741646|NCT04000815|7700524|FG002|Overall Study|Right ovarian cyst occured|0
4741647|NCT04000815|7700522|FG000|Overall Study|Hypertension occured on follow up|0
4741648|NCT04000815|7700523|FG001|Overall Study|Hypertension occured on follow up|0
4741649|NCT04000815|7700524|FG002|Overall Study|Hypertension occured on follow up|2
4741650|NCT04006366|7700549|FG000|Overall Study|Withdrawal by Subject|1
4741651|NCT04006145|7700555|FG000|Overall Study|Lost to Follow-up|0
4741652|NCT04006145|7700556|FG001|Overall Study|Lost to Follow-up|1
4741653|NCT04006145|7700555|FG000|Overall Study|Other|1
4741654|NCT04006145|7700556|FG001|Overall Study|Other|2
4741655|NCT04005755|7700562|FG000|Overall Study|Adverse Event|6
4741656|NCT04005755|7700562|FG000|Overall Study|Physician Decision|3
4741657|NCT04005755|7700562|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4
4741658|NCT04005755|7700562|FG000|Overall Study|Withdrawal by Subject|3
4741659|NCT04005755|7700562|FG000|Overall Study|Lost to Follow-up|1
4741660|NCT03993288|7700585|FG000|Overall Study|Lost to Follow-up|2
4741661|NCT03993288|7700586|FG001|Overall Study|Lost to Follow-up|1
4741662|NCT03993288|7700585|FG000|Overall Study|non-compliance to the inclusion criteria|0
4741663|NCT03993288|7700586|FG001|Overall Study|non-compliance to the inclusion criteria|1
4741664|NCT03993288|7700585|FG000|Overall Study|wrong randomization|0
4741665|NCT03993288|7700586|FG001|Overall Study|wrong randomization|1
4741666|NCT03993288|7700585|FG000|Overall Study|improper enrollment|0
4741667|NCT03993288|7700586|FG001|Overall Study|improper enrollment|1
4741668|NCT03993288|7700585|FG000|Overall Study|prescribed with prohibited concomitant therapy|1
4741669|NCT03993288|7700586|FG001|Overall Study|prescribed with prohibited concomitant therapy|0
4741670|NCT03993288|7700585|FG000|Overall Study|developed SAE|2
4741671|NCT03993288|7700586|FG001|Overall Study|developed SAE|0
4741672|NCT03993288|7700585|FG000|Overall Study|consent withdrawal|1
4741673|NCT03993288|7700586|FG001|Overall Study|consent withdrawal|0
4741674|NCT03993288|7700585|FG000|Overall Study|did not follow the treatment schedule|1
4741675|NCT03993288|7700586|FG001|Overall Study|did not follow the treatment schedule|0
4741676|NCT03993288|7700585|FG000|Overall Study|did not follow the treatment regimen|1
4741677|NCT03993288|7700586|FG001|Overall Study|did not follow the treatment regimen|0
4741678|NCT03993288|7700585|FG000|Overall Study|Adverse Event|1
4634065|NCT01920061|7504649|FG013|Overall Study|Lost to Follow-up|0
4634066|NCT01920061|7504650|FG014|Overall Study|Lost to Follow-up|0
4634067|NCT01920061|7504651|FG015|Overall Study|Lost to Follow-up|0
4634068|NCT01920061|7504652|FG016|Overall Study|Lost to Follow-up|0
4634069|NCT01920061|7504653|FG017|Overall Study|Lost to Follow-up|1
4741679|NCT03993288|7700586|FG001|Overall Study|Adverse Event|0
4741680|NCT03993288|7700585|FG000|Overall Study|Withdrawal by Subject|1
4741681|NCT03993288|7700586|FG001|Overall Study|Withdrawal by Subject|1
4525026|NCT01020487|7340744|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0
4525027|NCT01020487|7340745|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2
4525028|NCT01020487|7340746|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1
4525029|NCT01020487|7340744|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0
4525030|NCT01020487|7340745|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0
4525031|NCT01020487|7340746|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1
4525032|NCT01020487|7340744|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0
4525033|NCT01020487|7340745|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0
4525034|NCT01020487|7340746|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3
4525035|NCT01020487|7340744|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0
4525036|NCT01020487|7340745|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0
4525037|NCT01020487|7340746|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1
4525038|NCT01020487|7340744|FG000|Part 2 Open-label Period|Adverse Event|0
4525039|NCT01020487|7340745|FG001|Part 2 Open-label Period|Adverse Event|4
4525040|NCT01020487|7340746|FG002|Part 2 Open-label Period|Adverse Event|1
4525041|NCT01020526|7340756|FG000|Overall Study|Withdrawal by Subject|5
4525042|NCT01020526|7340756|FG000|Overall Study|Other reasons|3
4525043|NCT01020526|7340756|FG000|Overall Study|Insufficient clinical response|3
4525044|NCT01020526|7340756|FG000|Overall Study|Lost to Follow-up|1
4525045|NCT01020526|7340756|FG000|Overall Study|Adverse Event|2
4525046|NCT01020747|7340771|FG000|Overall Study|Withdrawal by Subject|1
4525047|NCT01020773|7340778|FG000|Overall Study|Withdrawal by Subject|4
4525048|NCT01020773|7340779|FG001|Overall Study|Withdrawal by Subject|3
4525049|NCT01020786|7340785|FG000|Induction Period|Entry Criteria Not Met|2
4525050|NCT01020786|7340785|FG000|Induction Period|Adverse Event|10
4525051|NCT01020786|7340785|FG000|Induction Period|Progressive Disease|31
4525052|NCT01020786|7340785|FG000|Induction Period|Investigator Decision|3
4525053|NCT01020786|7340785|FG000|Induction Period|Withdrawal by Subject|3
4525054|NCT01020786|7340785|FG000|Maintenance Period|Adverse Event|8
4525055|NCT01020786|7340785|FG000|Maintenance Period|Progressive Disease|43
4525056|NCT01020786|7340785|FG000|Maintenance Period|Withdrawal by Subject|8
4525057|NCT01020786|7340785|FG000|Maintenance Period|Sponsor Decision|1
4525058|NCT01020799|7340793|FG000|Overall Study|Adverse Event|4
4525059|NCT01020799|7340794|FG001|Overall Study|Adverse Event|3
4525060|NCT01020799|7340795|FG002|Overall Study|Adverse Event|2
4525061|NCT01020799|7340793|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4
4525062|NCT01020799|7340794|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3
4525063|NCT01020799|7340795|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0
4525064|NCT01020799|7340793|FG000|Overall Study|Protocol Violation|3
4525065|NCT01020799|7340794|FG001|Overall Study|Protocol Violation|2
4525066|NCT01020799|7340795|FG002|Overall Study|Protocol Violation|0
4525067|NCT01020799|7340793|FG000|Overall Study|Withdrawal by Subject|2
4525068|NCT01020799|7340794|FG001|Overall Study|Withdrawal by Subject|2
4525069|NCT01020799|7340795|FG002|Overall Study|Withdrawal by Subject|3
4525070|NCT01020799|7340793|FG000|Overall Study|Lost to Follow-up|6
4525071|NCT01020799|7340794|FG001|Overall Study|Lost to Follow-up|4
4525072|NCT01020799|7340795|FG002|Overall Study|Lost to Follow-up|2
4525073|NCT01020812|7340803|FG000|Overall Study|Physician Decision|1
4525074|NCT01020812|7340803|FG000|Overall Study|Withdrawal by Subject|1
4525075|NCT01020812|7340803|FG000|Overall Study|Protocol Violation|1
4741682|NCT03978832|7700617|FG000|Overall Study|Adverse Event|1
4741683|NCT03978832|7700617|FG000|Overall Study|Lost to Follow-up|1
4741684|NCT03978832|7700617|FG000|Overall Study|Withdrawal by Subject|6
4741685|NCT03978832|7700617|FG000|Overall Study|Physician Decision|2
4741686|NCT03978832|7700617|FG000|Overall Study|did not pass screening criteria|44
4525076|NCT01020838|7340807|FG000|Overall Study|Death|90
4741687|NCT04004260|7700658|FG000|Overall Study|Withdrawal by Subject|7
4741688|NCT04004260|7700659|FG001|Overall Study|Withdrawal by Subject|3
4741689|NCT04004260|7700658|FG000|Overall Study|Lost to Follow-up|22
4741690|NCT04004260|7700659|FG001|Overall Study|Lost to Follow-up|12
4741691|NCT04004260|7700658|FG000|Overall Study|Did not engage in intervention|13
4741692|NCT04004260|7700659|FG001|Overall Study|Did not engage in intervention|17
4741693|NCT04002960|7700692|FG000|Overall Study|Withdrawn prior to Completion|2
4741694|NCT04002648|7700702|FG000|Overall Study|Lost to Follow-up|2
4741695|NCT04002648|7700703|FG001|Overall Study|Lost to Follow-up|0
4741696|NCT03990649|7700732|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0
4741697|NCT03990649|7700733|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1
4741698|NCT03990649|7700734|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0
4741699|NCT03990649|7700732|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0
4741700|NCT03990649|7700733|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1
4741701|NCT03990649|7700734|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0
4741702|NCT03990649|7700732|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2
4741703|NCT03990649|7700733|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0
4741704|NCT03990649|7700734|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0
4741705|NCT03990649|7700732|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1
4741706|NCT03990649|7700733|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1
4741707|NCT03990649|7700734|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0
4525077|NCT01020838|7340807|FG000|Overall Study|Adverse Event|1
4525078|NCT01020838|7340807|FG000|Overall Study|Withdrawal by Subject|9
4525079|NCT01020838|7340807|FG000|Overall Study|Lost to Follow-up|6
4525080|NCT01020838|7340807|FG000|Overall Study|Most common: Study ended by sponsor|77
4525081|NCT01020877|7340822|FG000|Second Intervention|Withdrawal by Subject|1
4525082|NCT01020877|7340823|FG001|Second Intervention|Withdrawal by Subject|0
4525083|NCT01020981|7340831|FG000|Overall Study|Did not return mailed survey|74
4525084|NCT01020981|7340832|FG001|Overall Study|Did not return mailed survey|58
4525085|NCT01020981|7340831|FG000|Overall Study|Survey returned undeliverable|8
4525086|NCT01020981|7340832|FG001|Overall Study|Survey returned undeliverable|32
4525087|NCT01020981|7340831|FG000|Overall Study|Participant declined to complete survey|2
4525088|NCT01020981|7340832|FG001|Overall Study|Participant declined to complete survey|0
4525089|NCT01021007|7340842|FG000|Overall Study|Lost to Follow-up|1
4525090|NCT01021007|7340843|FG001|Overall Study|Lost to Follow-up|1
4525091|NCT01021007|7340842|FG000|Overall Study|Adverse Event|1
4525092|NCT01021007|7340843|FG001|Overall Study|Adverse Event|3
4525093|NCT01021020|7340849|FG000|Period I|Protocol Violation|1
4525094|NCT01021020|7340849|FG000|Period I|Withdrawal by Subject|1
4525095|NCT01021020|7340849|FG000|14 Day Washout Period A|Physician Decision|1
4525096|NCT01021137|7340869|FG000|Overall Study|Lost to Follow-up|9
4525097|NCT01021137|7340870|FG001|Overall Study|Lost to Follow-up|4
4525098|NCT01021137|7340871|FG002|Overall Study|Lost to Follow-up|2
4525099|NCT01021137|7340872|FG003|Overall Study|Lost to Follow-up|6
4525100|NCT01021137|7340869|FG000|Overall Study|Withdrawal by Subject|1
4525101|NCT01021137|7340870|FG001|Overall Study|Withdrawal by Subject|0
4525102|NCT01021137|7340871|FG002|Overall Study|Withdrawal by Subject|0
4525103|NCT01021137|7340872|FG003|Overall Study|Withdrawal by Subject|3
4525104|NCT01021215|7340885|FG000|Overall Study|Lost to Follow-up|3
4594293|NCT01561898|7443542|FG000|Overall Study|Lack of Efficacy|0
4594294|NCT01561898|7443543|FG001|Overall Study|Lack of Efficacy|8
4525105|NCT01021215|7340886|FG001|Overall Study|Lost to Follow-up|0
4525106|NCT01021293|7340894|FG000|Overall Study|Serious Adverse Event|2
4525107|NCT01021293|7340895|FG001|Overall Study|Serious Adverse Event|1
4525108|NCT01021293|7340894|FG000|Overall Study|Adverse Event|2
4525109|NCT01021293|7340895|FG001|Overall Study|Adverse Event|1
4525110|NCT01021293|7340894|FG000|Overall Study|Withdrawal by Subject|1
4741708|NCT03990649|7700732|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0
4741709|NCT03990649|7700733|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0
4741710|NCT03990649|7700734|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1
4741711|NCT03990649|7700732|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0
4741712|NCT03990649|7700733|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0
4741713|NCT03990649|7700734|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2
4741714|NCT03990649|7700732|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0
4741715|NCT03990649|7700733|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0
4741716|NCT03990649|7700734|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1
4741717|NCT04000581|7700752|FG000|Overall Study|Withdrawal by Subject|0
4741718|NCT04000581|7700753|FG001|Overall Study|Withdrawal by Subject|1
4741719|NCT03996694|7700759|FG000|First Washout (7 Days)|positive urine drug screen|0
4741720|NCT03996694|7700760|FG001|First Washout (7 Days)|positive urine drug screen|0
4741721|NCT03996694|7700761|FG002|First Washout (7 Days)|positive urine drug screen|1
4741722|NCT03996694|7700762|FG003|First Washout (7 Days)|positive urine drug screen|0
4741723|NCT03996694|7700763|FG004|First Washout (7 Days)|positive urine drug screen|0
4741724|NCT03996694|7700764|FG005|First Washout (7 Days)|positive urine drug screen|0
4741725|NCT03996694|7700759|FG000|First Washout (7 Days)|Adverse Event|0
4741726|NCT03996694|7700760|FG001|First Washout (7 Days)|Adverse Event|1
4741727|NCT03996694|7700761|FG002|First Washout (7 Days)|Adverse Event|0
4525111|NCT01021293|7340895|FG001|Overall Study|Withdrawal by Subject|3
4525112|NCT01021293|7340894|FG000|Overall Study|Migrated/moved from study area|6
4525113|NCT01021293|7340895|FG001|Overall Study|Migrated/moved from study area|18
4525114|NCT01021293|7340894|FG000|Overall Study|Lost to Follow-up|1
4525115|NCT01021293|7340895|FG001|Overall Study|Lost to Follow-up|1
4525116|NCT01021332|7340919|FG000|Overall Study|Not fulfilling incl./excl.criteria|5
4525117|NCT01021332|7340919|FG000|Overall Study|Adverse Event|43
4525118|NCT01021332|7340919|FG000|Overall Study|Lack of Efficacy|19
4525119|NCT01021332|7340919|FG000|Overall Study|Withdrawal of Consent|23
4525120|NCT01021332|7340919|FG000|Overall Study|Lost to Follow-up|4
4525121|NCT01021332|7340919|FG000|Overall Study|Protocol Violation|9
4525122|NCT01021332|7340919|FG000|Overall Study|Miscellaneous|3
4525123|NCT01021423|7340927|FG000|Overall Study|Study terminated|4
4741728|NCT03996694|7700762|FG003|First Washout (7 Days)|Adverse Event|0
4525124|NCT01021423|7340928|FG001|Overall Study|Study terminated|5
4525125|NCT01021553|7340937|FG000|Overall Study|Adverse Event|1
4525126|NCT01021553|7340938|FG001|Overall Study|Adverse Event|0
4741729|NCT03996694|7700763|FG004|First Washout (7 Days)|Adverse Event|0
4741730|NCT03996694|7700764|FG005|First Washout (7 Days)|Adverse Event|0
4741731|NCT03996694|7700759|FG000|First Washout (7 Days)|Lost to Follow-up|0
4741732|NCT03996694|7700760|FG001|First Washout (7 Days)|Lost to Follow-up|0
4741733|NCT03996694|7700761|FG002|First Washout (7 Days)|Lost to Follow-up|1
4741734|NCT03996694|7700762|FG003|First Washout (7 Days)|Lost to Follow-up|0
4741735|NCT03996694|7700763|FG004|First Washout (7 Days)|Lost to Follow-up|0
4741736|NCT03996694|7700764|FG005|First Washout (7 Days)|Lost to Follow-up|0
4741737|NCT03996694|7700759|FG000|Third Washout (7 Days)|Withdrawal by Subject|0
4741738|NCT03996694|7700760|FG001|Third Washout (7 Days)|Withdrawal by Subject|0
4741739|NCT03996694|7700761|FG002|Third Washout (7 Days)|Withdrawal by Subject|0
4741740|NCT03996694|7700762|FG003|Third Washout (7 Days)|Withdrawal by Subject|0
4741741|NCT03996694|7700763|FG004|Third Washout (7 Days)|Withdrawal by Subject|1
4741742|NCT03996694|7700764|FG005|Third Washout (7 Days)|Withdrawal by Subject|0
4741743|NCT03988907|7700780|FG000|Overall Study|Unable to complete visit|0
4741744|NCT03988907|7700781|FG001|Overall Study|Unable to complete visit|1
4741745|NCT03988088|7700795|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0
4741746|NCT03988088|7700796|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1
4741747|NCT03988088|7700797|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0
4741748|NCT03988088|7700798|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0
4741749|NCT03988088|7700795|FG000|Open-Label Addendum|Lost to Follow-up|0
4741750|NCT03988088|7700796|FG001|Open-Label Addendum|Lost to Follow-up|0
4741751|NCT03988088|7700797|FG002|Open-Label Addendum|Lost to Follow-up|1
4741752|NCT03988088|7700798|FG003|Open-Label Addendum|Lost to Follow-up|0
4741753|NCT03980522|7700811|FG000|Treatment Period|Adverse Event|1
4741754|NCT03980522|7700812|FG001|Treatment Period|Adverse Event|0
4741755|NCT03980522|7700813|FG002|Treatment Period|Adverse Event|0
4741756|NCT03980522|7700814|FG003|Treatment Period|Adverse Event|0
4741757|NCT03980522|7700815|FG004|Treatment Period|Adverse Event|0
4741758|NCT03995784|7700831|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1
4741759|NCT03993392|7700842|FG000|Overall Study|Withdrawal by Subject|3
4741760|NCT03993392|7700842|FG000|Overall Study|Lost to Follow-up|2
4741761|NCT03993392|7700842|FG000|Overall Study|Did not meet Day 1 check-in criteria|1
4741762|NCT03981822|7700865|FG000|Overall Study|Lost to Follow-up|0
4741763|NCT03981822|7700866|FG001|Overall Study|Lost to Follow-up|1
4741764|NCT03981822|7700867|FG002|Overall Study|Lost to Follow-up|1
4741765|NCT03981822|7700868|FG003|Overall Study|Lost to Follow-up|0
4741766|NCT03981822|7700869|FG004|Overall Study|Lost to Follow-up|6
4741767|NCT03981822|7700870|FG005|Overall Study|Lost to Follow-up|4
4741768|NCT03981822|7700871|FG006|Overall Study|Lost to Follow-up|4
4741769|NCT03981822|7700872|FG007|Overall Study|Lost to Follow-up|2
4741770|NCT03981822|7700865|FG000|Overall Study|Withdrawal by Subject|0
4741771|NCT03981822|7700866|FG001|Overall Study|Withdrawal by Subject|1
4741772|NCT03981822|7700867|FG002|Overall Study|Withdrawal by Subject|0
4741773|NCT03981822|7700868|FG003|Overall Study|Withdrawal by Subject|0
4741774|NCT03981822|7700869|FG004|Overall Study|Withdrawal by Subject|0
4741775|NCT03981822|7700870|FG005|Overall Study|Withdrawal by Subject|1
4741776|NCT03981822|7700871|FG006|Overall Study|Withdrawal by Subject|0
4741777|NCT03981822|7700872|FG007|Overall Study|Withdrawal by Subject|2
4741778|NCT03981822|7700865|FG000|Overall Study|COVID-19 Related|0
4741779|NCT03981822|7700866|FG001|Overall Study|COVID-19 Related|0
4741780|NCT03981822|7700867|FG002|Overall Study|COVID-19 Related|0
4741781|NCT03981822|7700868|FG003|Overall Study|COVID-19 Related|0
4741782|NCT03981822|7700869|FG004|Overall Study|COVID-19 Related|2
4741783|NCT03981822|7700870|FG005|Overall Study|COVID-19 Related|1
4741784|NCT03981822|7700871|FG006|Overall Study|COVID-19 Related|2
4741785|NCT03981822|7700872|FG007|Overall Study|COVID-19 Related|1
4741786|NCT03991494|7700925|FG000|Overall Study|Progressive Disease|4
4741787|NCT03988803|7700944|FG000|Period 2|Prematurely discontinued from medication|2
4741788|NCT03988803|7700944|FG000|Period 2|Adverse Event|1
4741789|NCT03987932|7700955|FG000|Overall Study|Lost to Follow-up|2
4741790|NCT03987932|7700956|FG001|Overall Study|Lost to Follow-up|1
4741791|NCT03987932|7700957|FG002|Overall Study|Lost to Follow-up|1
4741792|NCT03987932|7700955|FG000|Overall Study|Non-study related elective surgery|0
4741793|NCT03987932|7700956|FG001|Overall Study|Non-study related elective surgery|0
4741794|NCT03987932|7700957|FG002|Overall Study|Non-study related elective surgery|1
4741795|NCT03987191|7700967|FG000|Overall Study|COVID-19 related research disruption|0
4741796|NCT03987191|7700968|FG001|Overall Study|COVID-19 related research disruption|2
4525127|NCT01021553|7340939|FG002|Overall Study|Adverse Event|0
4525128|NCT01021553|7340937|FG000|Overall Study|Lack of Efficacy|2
4525129|NCT01021553|7340938|FG001|Overall Study|Lack of Efficacy|2
4525130|NCT01021553|7340939|FG002|Overall Study|Lack of Efficacy|0
4525131|NCT01021553|7340937|FG000|Overall Study|Protocol Violation|0
4525132|NCT01021553|7340938|FG001|Overall Study|Protocol Violation|2
4525133|NCT01021553|7340939|FG002|Overall Study|Protocol Violation|2
4525134|NCT01021553|7340937|FG000|Overall Study|Lost to Follow-up|0
4525135|NCT01021553|7340938|FG001|Overall Study|Lost to Follow-up|0
4634070|NCT01920061|7504654|FG018|Overall Study|Lost to Follow-up|4
4634071|NCT01920061|7504655|FG019|Overall Study|Lost to Follow-up|3
4634072|NCT01920061|7504636|FG000|Overall Study|Other|1
4634073|NCT01920061|7504637|FG001|Overall Study|Other|1
4634074|NCT01920061|7504638|FG002|Overall Study|Other|2
4634075|NCT01920061|7504639|FG003|Overall Study|Other|1
4634076|NCT01920061|7504640|FG004|Overall Study|Other|0
4525136|NCT01021553|7340939|FG002|Overall Study|Lost to Follow-up|1
4525137|NCT01021553|7340937|FG000|Overall Study|Withdrawal by Subject|1
4525138|NCT01021553|7340938|FG001|Overall Study|Withdrawal by Subject|1
4525139|NCT01021553|7340939|FG002|Overall Study|Withdrawal by Subject|0
4525140|NCT01021683|7340961|FG000|Overall Study|Lack of Efficacy|12
4525141|NCT01021683|7340961|FG000|Overall Study|Recovery of neutrophil count|51
4525142|NCT01021683|7340961|FG000|Overall Study|Other|8
4525143|NCT01021748|7340974|FG000|Overall Study|Adverse Event|2
4525144|NCT01021748|7340975|FG001|Overall Study|Adverse Event|1
4525145|NCT01021748|7340976|FG002|Overall Study|Adverse Event|2
4525146|NCT01021748|7340977|FG003|Overall Study|Adverse Event|0
4525147|NCT01021748|7340978|FG004|Overall Study|Adverse Event|2
4525148|NCT01021748|7340979|FG005|Overall Study|Adverse Event|0
4525149|NCT01021748|7340980|FG006|Overall Study|Adverse Event|1
4525150|NCT01021748|7340981|FG007|Overall Study|Adverse Event|0
4525151|NCT01021748|7340982|FG008|Overall Study|Adverse Event|7
4525152|NCT01021748|7340974|FG000|Overall Study|Physician Decision|1
4525153|NCT01021748|7340975|FG001|Overall Study|Physician Decision|0
4525154|NCT01021748|7340976|FG002|Overall Study|Physician Decision|1
4525155|NCT01021748|7340977|FG003|Overall Study|Physician Decision|1
4634077|NCT01920061|7504641|FG005|Overall Study|Other|1
4741797|NCT03988842|7700974|FG000|Overall Study|Death|1
4525156|NCT01021748|7340978|FG004|Overall Study|Physician Decision|0
4525157|NCT01021748|7340979|FG005|Overall Study|Physician Decision|0
4525158|NCT01021748|7340980|FG006|Overall Study|Physician Decision|1
4525159|NCT01021748|7340981|FG007|Overall Study|Physician Decision|1
4634078|NCT01920061|7504642|FG006|Overall Study|Other|0
4741798|NCT03981861|7700979|FG000|Overall Study|Withdrawal by Subject|3
4741799|NCT03974334|7700983|FG000|Overall Study|Lost to Follow-up|1
4741800|NCT03987074|7701011|FG000|Overall Study|Withdrew Consent|1
4741801|NCT03987074|7701012|FG001|Overall Study|Withdrew Consent|1
4741802|NCT03987074|7701013|FG002|Overall Study|Withdrew Consent|0
4741803|NCT03987074|7701014|FG003|Overall Study|Withdrew Consent|2
4741804|NCT03987074|7701015|FG004|Overall Study|Withdrew Consent|1
4741805|NCT03987074|7701011|FG000|Overall Study|Adverse Event|2
4741806|NCT03987074|7701012|FG001|Overall Study|Adverse Event|1
4741807|NCT03987074|7701013|FG002|Overall Study|Adverse Event|0
4741808|NCT03987074|7701014|FG003|Overall Study|Adverse Event|0
4741809|NCT03987074|7701015|FG004|Overall Study|Adverse Event|1
4741810|NCT03987074|7701011|FG000|Overall Study|Lost to Follow-up|0
4741811|NCT03987074|7701012|FG001|Overall Study|Lost to Follow-up|0
4741812|NCT03987074|7701013|FG002|Overall Study|Lost to Follow-up|1
4741813|NCT03987074|7701014|FG003|Overall Study|Lost to Follow-up|1
4741814|NCT03987074|7701015|FG004|Overall Study|Lost to Follow-up|0
4741815|NCT03987074|7701011|FG000|Overall Study|Investigator's Discretion|0
4741816|NCT03987074|7701012|FG001|Overall Study|Investigator's Discretion|0
4741817|NCT03987074|7701013|FG002|Overall Study|Investigator's Discretion|0
4741818|NCT03987074|7701014|FG003|Overall Study|Investigator's Discretion|1
4741819|NCT03987074|7701015|FG004|Overall Study|Investigator's Discretion|0
4741820|NCT03979820|7701049|FG000|Overall Study|Protocol Violation|1
4741821|NCT03979820|7701050|FG001|Overall Study|Protocol Violation|0
4741822|NCT03979820|7701051|FG002|Overall Study|Protocol Violation|0
4741823|NCT03979820|7701052|FG003|Overall Study|Protocol Violation|0
4741824|NCT03979820|7701049|FG000|Overall Study|Withdrawal by Subject|0
4741825|NCT03979820|7701050|FG001|Overall Study|Withdrawal by Subject|0
4525160|NCT01021748|7340982|FG008|Overall Study|Physician Decision|2
4525161|NCT01021748|7340974|FG000|Overall Study|Progressive Disease|3
4525162|NCT01021748|7340975|FG001|Overall Study|Progressive Disease|3
4525163|NCT01021748|7340976|FG002|Overall Study|Progressive Disease|4
4525164|NCT01021748|7340977|FG003|Overall Study|Progressive Disease|6
4525165|NCT01021748|7340978|FG004|Overall Study|Progressive Disease|7
4525166|NCT01021748|7340979|FG005|Overall Study|Progressive Disease|3
4525167|NCT01021748|7340980|FG006|Overall Study|Progressive Disease|0
4525168|NCT01021748|7340981|FG007|Overall Study|Progressive Disease|5
4525169|NCT01021748|7340982|FG008|Overall Study|Progressive Disease|6
4525170|NCT01021748|7340974|FG000|Overall Study|Withdrawal by Subject|0
4525171|NCT01021748|7340975|FG001|Overall Study|Withdrawal by Subject|0
4525172|NCT01021748|7340976|FG002|Overall Study|Withdrawal by Subject|0
4741826|NCT03979820|7701051|FG002|Overall Study|Withdrawal by Subject|1
4741827|NCT03979820|7701052|FG003|Overall Study|Withdrawal by Subject|0
4741828|NCT03979820|7701049|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5
4741829|NCT03979820|7701050|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0
4525173|NCT01021748|7340977|FG003|Overall Study|Withdrawal by Subject|0
4525174|NCT01021748|7340978|FG004|Overall Study|Withdrawal by Subject|0
4741830|NCT03979820|7701051|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0
4741831|NCT03979820|7701052|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10
4741832|NCT03972137|7701066|FG000|Overall Study|Lost to Follow-up|2
4741833|NCT03972137|7701066|FG000|Overall Study|Withdrawal by Subject|4
4741834|NCT03970395|7701084|FG000|Overall Study|Withdrawal by Subject|3
4741835|NCT03970395|7701085|FG001|Overall Study|Withdrawal by Subject|4
4741836|NCT03970395|7701084|FG000|Overall Study|Lost to Follow-up|4
4741837|NCT03970395|7701085|FG001|Overall Study|Lost to Follow-up|8
4741838|NCT03987620|7701097|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43
4741839|NCT03987620|7701098|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41
4741840|NCT03987620|7701097|FG000|Overall Study|Adverse Event|3
4741841|NCT03987620|7701098|FG001|Overall Study|Adverse Event|0
4741842|NCT03987620|7701097|FG000|Overall Study|Lost to Follow-up|1
4741843|NCT03987620|7701098|FG001|Overall Study|Lost to Follow-up|2
4741844|NCT03987620|7701097|FG000|Overall Study|Physician Decision|0
4741845|NCT03987620|7701098|FG001|Overall Study|Physician Decision|1
4741846|NCT03987620|7701097|FG000|Overall Study|Pregnancy|1
4741847|NCT03987620|7701098|FG001|Overall Study|Pregnancy|0
4741848|NCT03987620|7701097|FG000|Overall Study|Withdrawal by Subject|7
4741849|NCT03987620|7701098|FG001|Overall Study|Withdrawal by Subject|1
4741850|NCT03987620|7701097|FG000|Overall Study|Other|2
4741851|NCT03987620|7701098|FG001|Overall Study|Other|5
4741852|NCT03983317|7701104|FG000|Overall Study|Physician Decision|5
4741853|NCT03984825|7701167|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2
4741854|NCT03984825|7701167|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1
4741855|NCT03984825|7701167|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3
4741856|NCT03982433|7701180|FG000|Overall Study|Lost to Follow-up|1
4741857|NCT03976466|7701190|FG000|Overall Study|Lost to Follow-up|1
4741858|NCT03976466|7701191|FG001|Overall Study|Lost to Follow-up|3
4741859|NCT03979638|7701201|FG000|Period 1|Physician Decision|1
4741860|NCT03979638|7701202|FG001|Period 1|Physician Decision|1
4741861|NCT03979638|7701201|FG000|Period 1|Withdrawal by Subject|4
4741862|NCT03979638|7701202|FG001|Period 1|Withdrawal by Subject|3
4741863|NCT03979638|7701201|FG000|Period 1|Study terminated by Sponsor|1
4741864|NCT03979638|7701202|FG001|Period 1|Study terminated by Sponsor|3
4741865|NCT03979638|7701201|FG000|Period 1|Protocol Violation|1
4741866|NCT03979638|7701202|FG001|Period 1|Protocol Violation|0
4741867|NCT03979638|7701201|FG000|Period 2|Study terminated by Sponsor|1
4741868|NCT03979638|7701202|FG001|Period 2|Study terminated by Sponsor|1
4741869|NCT03979274|7701217|FG000|Treatment Period 2|Withdrawal by Subject|0
4741870|NCT03979274|7701218|FG001|Treatment Period 2|Withdrawal by Subject|1
4741871|NCT03977727|7701235|FG000|Second Treatment|Lost to Follow-up|0
4741872|NCT03977727|7701236|FG001|Second Treatment|Lost to Follow-up|3
4741873|NCT03977155|7701245|FG000|Overall Study|Adverse Event|3
4741874|NCT03977155|7701246|FG001|Overall Study|Adverse Event|0
4741875|NCT03977155|7701247|FG002|Overall Study|Adverse Event|0
4741876|NCT03977155|7701245|FG000|Overall Study|Lost to Follow-up|0
4741877|NCT03977155|7701246|FG001|Overall Study|Lost to Follow-up|1
4741878|NCT03977155|7701247|FG002|Overall Study|Lost to Follow-up|0
4741879|NCT03977155|7701245|FG000|Overall Study|Withdrawal by Subject|1
4741880|NCT03977155|7701246|FG001|Overall Study|Withdrawal by Subject|1
4741881|NCT03977155|7701247|FG002|Overall Study|Withdrawal by Subject|2
4741882|NCT03977155|7701245|FG000|Overall Study|Participant was unable to come in for the Visit|1
4741883|NCT03977155|7701246|FG001|Overall Study|Participant was unable to come in for the Visit|0
4741884|NCT03977155|7701247|FG002|Overall Study|Participant was unable to come in for the Visit|0
4741885|NCT03970733|7701269|FG000|Overall Study|Withdrawal by Subject|0
4741886|NCT03970733|7701270|FG001|Overall Study|Withdrawal by Subject|5
4741887|NCT03970733|7701271|FG002|Overall Study|Withdrawal by Subject|1
4741888|NCT03970733|7701269|FG000|Overall Study|e.g.: moved from study area|1
4741889|NCT03970733|7701270|FG001|Overall Study|e.g.: moved from study area|0
4741890|NCT03970733|7701271|FG002|Overall Study|e.g.: moved from study area|0
4741891|NCT03970733|7701269|FG000|Overall Study|Lost to Follow-up|2
4741892|NCT03970733|7701270|FG001|Overall Study|Lost to Follow-up|1
4741893|NCT03970733|7701271|FG002|Overall Study|Lost to Follow-up|1
4741894|NCT03970733|7701269|FG000|Overall Study|Other|1
4741895|NCT03970733|7701270|FG001|Overall Study|Other|0
4741896|NCT03970733|7701271|FG002|Overall Study|Other|0
4741897|NCT03968978|7701281|FG000|Overall Study|Adverse Event|1
4741898|NCT03968978|7701282|FG001|Overall Study|Adverse Event|0
4741899|NCT03967444|7701299|FG000|Overall Study|Lost to Follow-up|1
4741900|NCT03967444|7701300|FG001|Overall Study|Lost to Follow-up|2
4741901|NCT03966911|7701312|FG000|Overall Study|Adverse Event|1
4741902|NCT03966911|7701313|FG001|Overall Study|Adverse Event|1
4741903|NCT03966911|7701312|FG000|Overall Study|Withdrawal by Subject|8
4741904|NCT03966911|7701313|FG001|Overall Study|Withdrawal by Subject|2
4741905|NCT03966911|7701312|FG000|Overall Study|Unable to complete study visits due to COVID-19|0
4741906|NCT03966911|7701313|FG001|Overall Study|Unable to complete study visits due to COVID-19|13
4741907|NCT03966365|7701323|FG000|Overall Study|Protocol Violation|1
4741908|NCT03966365|7701324|FG001|Overall Study|Protocol Violation|0
4741909|NCT03965403|7701330|FG000|Overall Study|Subject not meeting eligibility criteria|1
4741910|NCT03965351|7701387|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0
4741911|NCT03965351|7701388|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1
4741912|NCT03965351|7701387|FG000|Second Intervention (4 Weeks)|Adverse Event|0
4741913|NCT03965351|7701388|FG001|Second Intervention (4 Weeks)|Adverse Event|1
4741914|NCT03958955|7701403|FG000|Overall Study|Adverse Event|1
4741915|NCT03965052|7701411|FG000|Overall Study|Protocol Violation|1
4741916|NCT03965052|7701412|FG001|Overall Study|Protocol Violation|0
4741917|NCT03963401|7701441|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1
4741918|NCT03963401|7701442|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2
4741919|NCT03963401|7701443|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0
4741920|NCT03963401|7701444|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0
4741921|NCT03963401|7701445|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1
4741922|NCT03963401|7701446|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2
4741923|NCT03963401|7701441|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0
4741924|NCT03963401|7701442|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0
4741925|NCT03963401|7701443|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1
4741926|NCT03963401|7701444|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1
4741927|NCT03963401|7701445|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0
4741928|NCT03963401|7701446|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0
4741929|NCT03963401|7701441|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2
4741930|NCT03963401|7701442|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1
4741931|NCT03963401|7701443|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1
4741932|NCT03963401|7701444|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1
4741933|NCT03963401|7701445|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2
4741934|NCT03963401|7701446|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0
4741935|NCT03963401|7701441|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0
4741936|NCT03963401|7701442|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1
4741937|NCT03963401|7701443|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0
4634079|NCT01920061|7504643|FG007|Overall Study|Other|0
4741938|NCT03963401|7701444|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0
4741939|NCT03963401|7701445|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0
4741940|NCT03963401|7701446|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0
4741941|NCT03963401|7701441|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6
4741942|NCT03963401|7701442|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3
4525175|NCT01021748|7340979|FG005|Overall Study|Withdrawal by Subject|0
4525176|NCT01021748|7340980|FG006|Overall Study|Withdrawal by Subject|1
4525177|NCT01021748|7340981|FG007|Overall Study|Withdrawal by Subject|0
4525178|NCT01021748|7340982|FG008|Overall Study|Withdrawal by Subject|1
4525179|NCT01021748|7340974|FG000|Overall Study|Not Treated|0
4525180|NCT01021748|7340975|FG001|Overall Study|Not Treated|1
4525181|NCT01021748|7340976|FG002|Overall Study|Not Treated|0
4741943|NCT03963401|7701443|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2
4525182|NCT01021748|7340977|FG003|Overall Study|Not Treated|0
4525183|NCT01021748|7340978|FG004|Overall Study|Not Treated|0
4741944|NCT03963401|7701444|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0
4741945|NCT03963401|7701445|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4
4741946|NCT03963401|7701446|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3
4741947|NCT03963401|7701441|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1
4741948|NCT03963401|7701442|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0
4741949|NCT03963401|7701443|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1
4741950|NCT03963401|7701444|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0
4741951|NCT03963401|7701445|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0
4741952|NCT03963401|7701446|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0
4741953|NCT03963401|7701441|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0
4741954|NCT03963401|7701442|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0
4741955|NCT03963401|7701443|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1
4741956|NCT03963401|7701444|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0
4741957|NCT03963401|7701445|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0
4741958|NCT03963401|7701446|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0
4741959|NCT03963401|7701441|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1
4741960|NCT03963401|7701442|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0
4741961|NCT03963401|7701443|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0
4741962|NCT03963401|7701444|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0
4741963|NCT03963401|7701445|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0
4741964|NCT03963401|7701446|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0
4741965|NCT03963401|7701441|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4
4741966|NCT03963401|7701442|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1
4741967|NCT03963401|7701443|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0
4741968|NCT03963401|7701444|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0
4741969|NCT03963401|7701445|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1
4741970|NCT03963401|7701446|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1
4741971|NCT03963401|7701441|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1
4741972|NCT03963401|7701442|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0
4741973|NCT03963401|7701443|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0
4741974|NCT03963401|7701444|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0
4741975|NCT03963401|7701445|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0
4741976|NCT03963401|7701446|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0
4741977|NCT03963401|7701441|FG000|Extension Period (Week 17 - Week 52)|Other|1
4741978|NCT03963401|7701442|FG001|Extension Period (Week 17 - Week 52)|Other|1
4741979|NCT03963401|7701443|FG002|Extension Period (Week 17 - Week 52)|Other|0
4741980|NCT03963401|7701444|FG003|Extension Period (Week 17 - Week 52)|Other|1
4741981|NCT03963401|7701445|FG004|Extension Period (Week 17 - Week 52)|Other|1
4741982|NCT03963401|7701446|FG005|Extension Period (Week 17 - Week 52)|Other|1
4741983|NCT03962790|7701473|FG000|Period 1|Adverse Event|0
4741984|NCT03962790|7701474|FG001|Period 1|Adverse Event|1
4741985|NCT03962790|7701473|FG000|Period 1|Failed to meet all eligibility criteria|1
4741986|NCT03962790|7701474|FG001|Period 1|Failed to meet all eligibility criteria|1
4741987|NCT03962790|7701473|FG000|Period 1|No Longer Meets Eligibility Criteria|1
4741988|NCT03962790|7701474|FG001|Period 1|No Longer Meets Eligibility Criteria|0
4741989|NCT03962790|7701473|FG000|Period 1|Withdrawal by Subject|1
4741990|NCT03962790|7701474|FG001|Period 1|Withdrawal by Subject|0
4741991|NCT03956225|7701482|FG000|Overall Study|Lack of Efficacy|1
4741992|NCT03956225|7701483|FG001|Overall Study|Lack of Efficacy|1
4741993|NCT03956225|7701482|FG000|Overall Study|Lost to Follow-up|0
4741994|NCT03956225|7701483|FG001|Overall Study|Lost to Follow-up|1
4741995|NCT03956225|7701482|FG000|Overall Study|Withdrawal by Subject|2
4741996|NCT03956225|7701483|FG001|Overall Study|Withdrawal by Subject|1
4741997|NCT03956225|7701482|FG000|Overall Study|Other Reasons|2
4741998|NCT03956225|7701483|FG001|Overall Study|Other Reasons|1
4741999|NCT03958149|7701501|FG000|Overall Study|Withdrawal by Subject|0
4742000|NCT03958149|7701502|FG001|Overall Study|Withdrawal by Subject|1
4742001|NCT03953183|7701514|FG000|Overall Study|Physician Decision|0
4742002|NCT03953183|7701515|FG001|Overall Study|Physician Decision|1
4742003|NCT03953183|7701514|FG000|Overall Study|Withdrawal by Subject|0
4742004|NCT03953183|7701515|FG001|Overall Study|Withdrawal by Subject|1
4742005|NCT03962738|7701536|FG000|Overall Study|Protocol Deviation|3
4634080|NCT01920061|7504644|FG008|Overall Study|Other|0
4634081|NCT01920061|7504645|FG009|Overall Study|Other|1
4634082|NCT01920061|7504646|FG010|Overall Study|Other|1
4634083|NCT01920061|7504647|FG011|Overall Study|Other|2
4634084|NCT01920061|7504648|FG012|Overall Study|Other|1
4742006|NCT03962738|7701537|FG001|Overall Study|Protocol Deviation|0
4742007|NCT03962738|7701538|FG002|Overall Study|Protocol Deviation|1
4742008|NCT03962738|7701539|FG003|Overall Study|Protocol Deviation|1
4742009|NCT03962738|7701536|FG000|Overall Study|Withdrawal by Subject|4
4742010|NCT03962738|7701537|FG001|Overall Study|Withdrawal by Subject|0
4742011|NCT03962738|7701538|FG002|Overall Study|Withdrawal by Subject|0
4634085|NCT01920061|7504649|FG013|Overall Study|Other|4
4742012|NCT03962738|7701539|FG003|Overall Study|Withdrawal by Subject|0
4742013|NCT03962738|7701536|FG000|Overall Study|Lost to Follow-up|0
4742014|NCT03962738|7701537|FG001|Overall Study|Lost to Follow-up|0
4594295|NCT01561898|7443544|FG002|Overall Study|Lack of Efficacy|10
4594296|NCT01561898|7443545|FG003|Overall Study|Lack of Efficacy|5
4594297|NCT01561898|7443542|FG000|Overall Study|Worsening of complications|0
4594298|NCT01561898|7443543|FG001|Overall Study|Worsening of complications|1
4594299|NCT01561898|7443544|FG002|Overall Study|Worsening of complications|0
4594300|NCT01561898|7443545|FG003|Overall Study|Worsening of complications|0
4594301|NCT01561898|7443542|FG000|Overall Study|Lost to Follow-up|0
4594302|NCT01561898|7443543|FG001|Overall Study|Lost to Follow-up|0
4594303|NCT01561898|7443544|FG002|Overall Study|Lost to Follow-up|1
4594304|NCT01561898|7443545|FG003|Overall Study|Lost to Follow-up|0
4594305|NCT01561898|7443542|FG000|Overall Study|Adverse Event|1
4594306|NCT01561898|7443543|FG001|Overall Study|Adverse Event|19
4594307|NCT01561898|7443544|FG002|Overall Study|Adverse Event|14
4594308|NCT01561898|7443545|FG003|Overall Study|Adverse Event|9
4594309|NCT01561898|7443542|FG000|Overall Study|Physician Decision|1
4594310|NCT01561898|7443543|FG001|Overall Study|Physician Decision|5
4594311|NCT01561898|7443544|FG002|Overall Study|Physician Decision|7
4594312|NCT01561898|7443545|FG003|Overall Study|Physician Decision|1
4594313|NCT01561963|7443553|FG000|Overall Study|Adverse Event|1
4594314|NCT01561976|7443568|FG000|Period 1|Adverse Event|0
4594315|NCT01561976|7443569|FG001|Period 1|Adverse Event|0
4594316|NCT01561976|7443570|FG002|Period 1|Adverse Event|1
4594317|NCT01561976|7443571|FG003|Period 1|Adverse Event|0
4594318|NCT01561976|7443572|FG004|Period 1|Adverse Event|0
4594319|NCT01561976|7443573|FG005|Period 1|Adverse Event|0
4594320|NCT01561976|7443568|FG000|Washout Period 1 (7 Days)|Adverse Event|0
4594321|NCT01561976|7443569|FG001|Washout Period 1 (7 Days)|Adverse Event|0
4634086|NCT01920061|7504650|FG014|Overall Study|Other|0
4634087|NCT01920061|7504651|FG015|Overall Study|Other|1
4634088|NCT01920061|7504652|FG016|Overall Study|Other|1
4634089|NCT01920061|7504653|FG017|Overall Study|Other|0
4634090|NCT01920061|7504654|FG018|Overall Study|Other|1
4634091|NCT01920061|7504655|FG019|Overall Study|Other|1
4634092|NCT01920061|7504636|FG000|Overall Study|Participant refused further follow-up|0
4634093|NCT01920061|7504637|FG001|Overall Study|Participant refused further follow-up|0
4634094|NCT01920061|7504638|FG002|Overall Study|Participant refused further follow-up|0
4634095|NCT01920061|7504639|FG003|Overall Study|Participant refused further follow-up|0
4634096|NCT01920061|7504640|FG004|Overall Study|Participant refused further follow-up|1
4634097|NCT01920061|7504641|FG005|Overall Study|Participant refused further follow-up|1
4634098|NCT01920061|7504642|FG006|Overall Study|Participant refused further follow-up|0
4634099|NCT01920061|7504643|FG007|Overall Study|Participant refused further follow-up|0
4634100|NCT01920061|7504644|FG008|Overall Study|Participant refused further follow-up|1
4634101|NCT01920061|7504645|FG009|Overall Study|Participant refused further follow-up|0
4634102|NCT01920061|7504646|FG010|Overall Study|Participant refused further follow-up|1
4634103|NCT01920061|7504647|FG011|Overall Study|Participant refused further follow-up|0
4634104|NCT01920061|7504648|FG012|Overall Study|Participant refused further follow-up|1
4634105|NCT01920061|7504649|FG013|Overall Study|Participant refused further follow-up|0
4634106|NCT01920061|7504650|FG014|Overall Study|Participant refused further follow-up|1
4634107|NCT01920061|7504651|FG015|Overall Study|Participant refused further follow-up|2
4634108|NCT01920061|7504652|FG016|Overall Study|Participant refused further follow-up|1
4634109|NCT01920061|7504653|FG017|Overall Study|Participant refused further follow-up|1
4634110|NCT01920061|7504654|FG018|Overall Study|Participant refused further follow-up|0
4634111|NCT01920061|7504655|FG019|Overall Study|Participant refused further follow-up|0
4634112|NCT01920152|7504720|FG000|Overall Study|Withdrawal by Subject|1
4742015|NCT03962738|7701538|FG002|Overall Study|Lost to Follow-up|1
4742016|NCT03962738|7701539|FG003|Overall Study|Lost to Follow-up|0
4742017|NCT03962101|7701557|FG000|Overall Study|Adverse Event|1
4742018|NCT03962101|7701557|FG000|Overall Study|Physician Decision|2
4742019|NCT03962101|7701557|FG000|Overall Study|Not related to medical events|1
4594322|NCT01561976|7443570|FG002|Washout Period 1 (7 Days)|Adverse Event|0
4594323|NCT01561976|7443571|FG003|Washout Period 1 (7 Days)|Adverse Event|1
4594324|NCT01561976|7443572|FG004|Washout Period 1 (7 Days)|Adverse Event|0
4594325|NCT01561976|7443573|FG005|Washout Period 1 (7 Days)|Adverse Event|0
4594326|NCT01561976|7443568|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0
4594327|NCT01561976|7443569|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0
4594328|NCT01561976|7443570|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0
4594329|NCT01561976|7443571|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0
4594330|NCT01561976|7443572|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0
4742020|NCT03959137|7701562|FG000|Overall Study|Protocol Violation|6
4742021|NCT03946124|7701566|FG000|Overall Study|Withdrawal by Subject|19
4742022|NCT03961308|7701572|FG000|Overall Study|Withdrawal by Subject|1
4742023|NCT03961308|7701573|FG001|Overall Study|Withdrawal by Subject|0
4742024|NCT03961308|7701572|FG000|Overall Study|Other|1
4742025|NCT03961308|7701573|FG001|Overall Study|Other|0
4742026|NCT03961308|7701572|FG000|Overall Study|Lost to Follow-up|0
4742027|NCT03961308|7701573|FG001|Overall Study|Lost to Follow-up|1
4742028|NCT03961308|7701572|FG000|Overall Study|Adverse Event|0
4742029|NCT03961308|7701573|FG001|Overall Study|Adverse Event|1
4742030|NCT03956862|7701599|FG000|Overall Study|Lost to Follow-up|1
4742031|NCT03956862|7701600|FG001|Overall Study|Lost to Follow-up|1
4742032|NCT03956862|7701599|FG000|Overall Study|Withdrawal by Subject|1
4742033|NCT03956862|7701600|FG001|Overall Study|Withdrawal by Subject|1
4742034|NCT03954444|7701609|FG000|Overall Study|Withdrawal by Subject|5
4742035|NCT03954444|7701610|FG001|Overall Study|Withdrawal by Subject|5
4742036|NCT03954444|7701611|FG002|Overall Study|Withdrawal by Subject|5
4742037|NCT03954444|7701609|FG000|Overall Study|Adverse Event|1
4742038|NCT03954444|7701610|FG001|Overall Study|Adverse Event|3
4742039|NCT03954444|7701611|FG002|Overall Study|Adverse Event|2
4742040|NCT03954444|7701609|FG000|Overall Study|Protocol Violation|0
4742041|NCT03954444|7701610|FG001|Overall Study|Protocol Violation|3
4742042|NCT03954444|7701611|FG002|Overall Study|Protocol Violation|5
4742043|NCT03954444|7701609|FG000|Overall Study|Use of prohibited therapy|1
4742044|NCT03954444|7701610|FG001|Overall Study|Use of prohibited therapy|1
4742045|NCT03954444|7701611|FG002|Overall Study|Use of prohibited therapy|2
4742046|NCT03954444|7701609|FG000|Overall Study|Lost to Follow-up|1
4742047|NCT03954444|7701610|FG001|Overall Study|Lost to Follow-up|0
4742048|NCT03954444|7701611|FG002|Overall Study|Lost to Follow-up|1
4742049|NCT03954444|7701609|FG000|Overall Study|Non-compliant with study drug application|2
4742050|NCT03954444|7701610|FG001|Overall Study|Non-compliant with study drug application|2
4742051|NCT03954444|7701611|FG002|Overall Study|Non-compliant with study drug application|0
4742052|NCT03954444|7701609|FG000|Overall Study|Administrative reasons|0
4742053|NCT03954444|7701610|FG001|Overall Study|Administrative reasons|0
4742054|NCT03954444|7701611|FG002|Overall Study|Administrative reasons|1
4742055|NCT03954444|7701609|FG000|Overall Study|Miscellaneous|3
4742056|NCT03954444|7701610|FG001|Overall Study|Miscellaneous|2
4742057|NCT03954444|7701611|FG002|Overall Study|Miscellaneous|1
4742058|NCT03953820|7701619|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1
4742059|NCT03953820|7701620|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0
4742060|NCT03953820|7701621|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0
4742061|NCT03953820|7701619|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1
4742062|NCT03953820|7701620|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0
4742063|NCT03953820|7701621|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0
4742064|NCT03951766|7701634|FG000|Treatment Phase|Lost to Follow-up|1
4742065|NCT03951766|7701634|FG000|Follow-up Phase|Lost to Follow-up|10
4742066|NCT03950856|7701664|FG000|Overall Study|Death|1
4742067|NCT03950856|7701665|FG001|Overall Study|Death|2
4742068|NCT03950856|7701666|FG002|Overall Study|Death|0
4742069|NCT03950856|7701667|FG003|Overall Study|Death|0
4742070|NCT03950856|7701664|FG000|Overall Study|Lost to Follow-up|5
4742071|NCT03950856|7701665|FG001|Overall Study|Lost to Follow-up|6
4742072|NCT03950856|7701666|FG002|Overall Study|Lost to Follow-up|8
4742073|NCT03950856|7701667|FG003|Overall Study|Lost to Follow-up|2
4742074|NCT03950856|7701664|FG000|Overall Study|Protocol Violation|2
4742075|NCT03950856|7701665|FG001|Overall Study|Protocol Violation|0
4742076|NCT03950856|7701666|FG002|Overall Study|Protocol Violation|0
4742077|NCT03950856|7701667|FG003|Overall Study|Protocol Violation|1
4742078|NCT03950856|7701664|FG000|Overall Study|Withdrawal by Subject|4
4742079|NCT03950856|7701665|FG001|Overall Study|Withdrawal by Subject|1
4742080|NCT03950856|7701666|FG002|Overall Study|Withdrawal by Subject|3
4742081|NCT03950856|7701667|FG003|Overall Study|Withdrawal by Subject|1
4742082|NCT03950856|7701664|FG000|Overall Study|Unable to phone|7
4742083|NCT03950856|7701665|FG001|Overall Study|Unable to phone|6
4742084|NCT03950856|7701666|FG002|Overall Study|Unable to phone|7
4742085|NCT03950856|7701667|FG003|Overall Study|Unable to phone|2
4742086|NCT03956550|7701720|FG000|Overall Study|Sponsor decision|65
4742087|NCT03956550|7701721|FG001|Overall Study|Sponsor decision|66
4742088|NCT03956550|7701722|FG002|Overall Study|Sponsor decision|64
4742089|NCT03956550|7701720|FG000|Overall Study|Adverse Event|0
4742090|NCT03956550|7701721|FG001|Overall Study|Adverse Event|1
4742091|NCT03956550|7701722|FG002|Overall Study|Adverse Event|0
4742092|NCT03956550|7701720|FG000|Overall Study|Withdrawal by Subject|5
4742093|NCT03956550|7701721|FG001|Overall Study|Withdrawal by Subject|5
4742094|NCT03956550|7701722|FG002|Overall Study|Withdrawal by Subject|6
4742095|NCT03958656|7701774|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0
4742096|NCT03958656|7701775|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1
4742097|NCT03958656|7701776|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0
4742098|NCT03958656|7701777|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0
4742099|NCT03958656|7701774|FG000|Overall Study|No longer meets eligibility criteria|0
4742100|NCT03958656|7701775|FG001|Overall Study|No longer meets eligibility criteria|0
4742101|NCT03958656|7701776|FG002|Overall Study|No longer meets eligibility criteria|1
4742102|NCT03958656|7701777|FG003|Overall Study|No longer meets eligibility criteria|0
4742103|NCT03958656|7701774|FG000|Overall Study|Started anti-cancer treatment|0
4742104|NCT03958656|7701775|FG001|Overall Study|Started anti-cancer treatment|0
4742105|NCT03958656|7701776|FG002|Overall Study|Started anti-cancer treatment|1
4742106|NCT03958656|7701777|FG003|Overall Study|Started anti-cancer treatment|0
4742107|NCT03951805|7701800|FG000|Overall Study|Adverse Event|1
4742108|NCT03951805|7701801|FG001|Overall Study|Adverse Event|0
4742109|NCT03951805|7701802|FG002|Overall Study|Adverse Event|0
4742110|NCT03951805|7701803|FG003|Overall Study|Adverse Event|0
4742111|NCT03950622|7701828|FG000|Overall Study|Withdrawal by Subject|1
4742112|NCT03950622|7701829|FG001|Overall Study|Withdrawal by Subject|0
4742113|NCT03950622|7701828|FG000|Overall Study|Protocol Deviation|0
4742114|NCT03950622|7701829|FG001|Overall Study|Protocol Deviation|1
4742115|NCT03950622|7701828|FG000|Overall Study|Physician Decision|1
4742116|NCT03950622|7701829|FG001|Overall Study|Physician Decision|0
4742117|NCT03950622|7701828|FG000|Overall Study|Lost to Follow-up|5
4742118|NCT03950622|7701829|FG001|Overall Study|Lost to Follow-up|5
4742119|NCT03950622|7701828|FG000|Overall Study|Death|1
4742120|NCT03950622|7701829|FG001|Overall Study|Death|1
4742121|NCT03948581|7701859|FG000|Overall Study|Lost to Follow-up|0
4742122|NCT03948581|7701860|FG001|Overall Study|Lost to Follow-up|1
4742123|NCT03948334|7701881|FG000|Overall Study|Adverse Event|1
4742124|NCT03948334|7701882|FG001|Overall Study|Adverse Event|4
4742125|NCT03948334|7701881|FG000|Overall Study|Lack of Efficacy|2
4742126|NCT03948334|7701882|FG001|Overall Study|Lack of Efficacy|0
4742127|NCT03948334|7701881|FG000|Overall Study|Lost to Follow-up|1
4742128|NCT03948334|7701882|FG001|Overall Study|Lost to Follow-up|0
4742129|NCT03948334|7701881|FG000|Overall Study|Physician Decision|1
4742130|NCT03948334|7701882|FG001|Overall Study|Physician Decision|0
4742131|NCT03948334|7701881|FG000|Overall Study|Pregnancy|0
4742132|NCT03948334|7701882|FG001|Overall Study|Pregnancy|1
4742133|NCT03948334|7701881|FG000|Overall Study|Protocol Deviation|1
4742134|NCT03948334|7701882|FG001|Overall Study|Protocol Deviation|0
4742135|NCT03948334|7701881|FG000|Overall Study|Study terminated by Sponsor|50
4742136|NCT03948334|7701882|FG001|Overall Study|Study terminated by Sponsor|51
4742137|NCT03948334|7701881|FG000|Overall Study|Subject Decision /Guardian Decision|4
4742138|NCT03948334|7701882|FG001|Overall Study|Subject Decision /Guardian Decision|7
4742139|NCT03944707|7701909|FG000|Overall Study|Adverse Event|0
4742140|NCT03944707|7701910|FG001|Overall Study|Adverse Event|2
4742141|NCT03944707|7701909|FG000|Overall Study|Study terminated by sponsor|12
4742142|NCT03944707|7701910|FG001|Overall Study|Study terminated by sponsor|7
4742143|NCT03944707|7701909|FG000|Overall Study|Subject decision|0
4742144|NCT03944707|7701910|FG001|Overall Study|Subject decision|1
4742145|NCT03943095|7701927|FG000|Overall Study|Incorrectly dispensed wrong box kit|0
4742146|NCT03943095|7701928|FG001|Overall Study|Incorrectly dispensed wrong box kit|1
4742147|NCT03943095|7701927|FG000|Overall Study|Withdrawal by Subject|1
4742148|NCT03943095|7701928|FG001|Overall Study|Withdrawal by Subject|0
4742149|NCT03943290|7701944|FG000|Overall Study|Sponsor Terminated Study|6
4742150|NCT03943290|7701945|FG001|Overall Study|Sponsor Terminated Study|1
4742151|NCT03943290|7701946|FG002|Overall Study|Sponsor Terminated Study|11
4742152|NCT03943290|7701947|FG003|Overall Study|Sponsor Terminated Study|6
4742153|NCT03943290|7701948|FG004|Overall Study|Sponsor Terminated Study|7
4742154|NCT03943290|7701949|FG005|Overall Study|Sponsor Terminated Study|6
4742155|NCT03943290|7701950|FG006|Overall Study|Sponsor Terminated Study|6
4742156|NCT03943290|7701951|FG007|Overall Study|Sponsor Terminated Study|7
4742157|NCT03943290|7701952|FG008|Overall Study|Sponsor Terminated Study|8
4742158|NCT03943290|7701944|FG000|Overall Study|Lost to Follow-up|1
4742159|NCT03943290|7701945|FG001|Overall Study|Lost to Follow-up|0
4742160|NCT03943290|7701946|FG002|Overall Study|Lost to Follow-up|1
4742161|NCT03943290|7701947|FG003|Overall Study|Lost to Follow-up|0
4742162|NCT03943290|7701948|FG004|Overall Study|Lost to Follow-up|0
4742163|NCT03943290|7701949|FG005|Overall Study|Lost to Follow-up|0
4742164|NCT03943290|7701950|FG006|Overall Study|Lost to Follow-up|0
4742165|NCT03943290|7701951|FG007|Overall Study|Lost to Follow-up|1
4742166|NCT03943290|7701952|FG008|Overall Study|Lost to Follow-up|0
4742167|NCT03943290|7701944|FG000|Overall Study|Withdrawal by Subject|0
4742168|NCT03943290|7701945|FG001|Overall Study|Withdrawal by Subject|0
4742169|NCT03943290|7701946|FG002|Overall Study|Withdrawal by Subject|1
4742170|NCT03943290|7701947|FG003|Overall Study|Withdrawal by Subject|0
4742171|NCT03943290|7701948|FG004|Overall Study|Withdrawal by Subject|0
4742172|NCT03943290|7701949|FG005|Overall Study|Withdrawal by Subject|0
4742173|NCT03943290|7701950|FG006|Overall Study|Withdrawal by Subject|0
4742174|NCT03943290|7701951|FG007|Overall Study|Withdrawal by Subject|0
4742175|NCT03943290|7701952|FG008|Overall Study|Withdrawal by Subject|0
4742176|NCT03942042|7701987|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0
4742177|NCT03942042|7701988|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1
4742178|NCT03942042|7701987|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1
4742179|NCT03942042|7701988|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0
4742180|NCT03923530|7702007|FG000|Overall Study|Withdrawal by Subject|1
4742181|NCT03923530|7702007|FG000|Overall Study|screen failure|3
4742182|NCT03914417|7702011|FG000|Overall Study|Withdrawal by Subject|2
4742183|NCT03913377|7702017|FG000|Period 1|Test Article no longer available|0
4742184|NCT03913377|7702018|FG001|Period 1|Test Article no longer available|1
4742185|NCT03913377|7702019|FG002|Period 1|Test Article no longer available|0
4742186|NCT03913377|7702017|FG000|Period 1|No Longer Meets Eligibility Criteria|0
4742187|NCT03913377|7702018|FG001|Period 1|No Longer Meets Eligibility Criteria|0
4742188|NCT03913377|7702019|FG002|Period 1|No Longer Meets Eligibility Criteria|1
4742189|NCT03937778|7702030|FG000|Overall Study|Withdrawal by Subject|1
4742190|NCT03937778|7702030|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1
4742191|NCT03937479|7702039|FG000|Overall Study|Adverse Event|2
4742192|NCT03937479|7702040|FG001|Overall Study|Adverse Event|3
4742193|NCT03937479|7702041|FG002|Overall Study|Adverse Event|0
4742194|NCT03937479|7702042|FG003|Overall Study|Adverse Event|0
4742195|NCT03937479|7702043|FG004|Overall Study|Adverse Event|1
4742196|NCT03937479|7702039|FG000|Overall Study|Withdrawal by Subject|3
4742197|NCT03937479|7702040|FG001|Overall Study|Withdrawal by Subject|5
4742198|NCT03937479|7702041|FG002|Overall Study|Withdrawal by Subject|2
4742199|NCT03937479|7702042|FG003|Overall Study|Withdrawal by Subject|2
4742200|NCT03937479|7702043|FG004|Overall Study|Withdrawal by Subject|1
4742201|NCT03937479|7702039|FG000|Overall Study|Protocol Violation|5
4742202|NCT03937479|7702040|FG001|Overall Study|Protocol Violation|6
4742203|NCT03937479|7702041|FG002|Overall Study|Protocol Violation|4
4742204|NCT03937479|7702042|FG003|Overall Study|Protocol Violation|3
4742205|NCT03937479|7702043|FG004|Overall Study|Protocol Violation|2
4742206|NCT03937479|7702039|FG000|Overall Study|Lost to Follow-up|0
4742207|NCT03937479|7702040|FG001|Overall Study|Lost to Follow-up|1
4742208|NCT03937479|7702041|FG002|Overall Study|Lost to Follow-up|0
4742209|NCT03937479|7702042|FG003|Overall Study|Lost to Follow-up|1
4742210|NCT03937479|7702043|FG004|Overall Study|Lost to Follow-up|0
4742211|NCT03937479|7702039|FG000|Overall Study|Physician Decision|0
4742212|NCT03937479|7702040|FG001|Overall Study|Physician Decision|0
4742213|NCT03937479|7702041|FG002|Overall Study|Physician Decision|1
4742214|NCT03937479|7702042|FG003|Overall Study|Physician Decision|0
4742215|NCT03937479|7702043|FG004|Overall Study|Physician Decision|1
4742216|NCT03936244|7702079|FG000|Overall Study|Lost to Follow-up|5
4742217|NCT03936244|7702080|FG001|Overall Study|Lost to Follow-up|1
4742218|NCT03936244|7702079|FG000|Overall Study|Physician Decision|7
4742219|NCT03936244|7702080|FG001|Overall Study|Physician Decision|3
4742220|NCT03935126|7702087|FG000|Overall Study|Study termination by sponsor|3
4742221|NCT03933462|7702106|FG000|Overall Study|Adverse Event|2
4742222|NCT03933462|7702107|FG001|Overall Study|Adverse Event|0
4742223|NCT03931330|7702122|FG000|Overall Study|Physician Decision|1
4742224|NCT03931785|7702165|FG000|Overall Study|Lost to Follow-up|4
4742225|NCT03931785|7702166|FG001|Overall Study|Lost to Follow-up|1
4742226|NCT03931785|7702167|FG002|Overall Study|Lost to Follow-up|4
4742227|NCT03931785|7702168|FG003|Overall Study|Lost to Follow-up|3
4742228|NCT03931785|7702165|FG000|Overall Study|Adverse Event|1
4742229|NCT03931785|7702166|FG001|Overall Study|Adverse Event|0
4742230|NCT03931785|7702167|FG002|Overall Study|Adverse Event|3
4742231|NCT03931785|7702168|FG003|Overall Study|Adverse Event|4
4742232|NCT03931785|7702165|FG000|Overall Study|Protocol Violation|0
4742233|NCT03931785|7702166|FG001|Overall Study|Protocol Violation|1
4742234|NCT03931785|7702167|FG002|Overall Study|Protocol Violation|0
4742235|NCT03931785|7702168|FG003|Overall Study|Protocol Violation|0
4742236|NCT03931785|7702165|FG000|Overall Study|Noncompliance With Study drug|0
4742237|NCT03931785|7702166|FG001|Overall Study|Noncompliance With Study drug|1
4742238|NCT03931785|7702167|FG002|Overall Study|Noncompliance With Study drug|0
4742239|NCT03931785|7702168|FG003|Overall Study|Noncompliance With Study drug|0
4742240|NCT03931785|7702165|FG000|Overall Study|Other Not specified|0
4742241|NCT03931785|7702166|FG001|Overall Study|Other Not specified|2
4742242|NCT03931785|7702167|FG002|Overall Study|Other Not specified|2
4742243|NCT03931785|7702168|FG003|Overall Study|Other Not specified|2
4742244|NCT03931785|7702165|FG000|Overall Study|Withdrawal by Subject|0
4742245|NCT03931785|7702166|FG001|Overall Study|Withdrawal by Subject|2
4742246|NCT03931785|7702167|FG002|Overall Study|Withdrawal by Subject|4
4742247|NCT03931785|7702168|FG003|Overall Study|Withdrawal by Subject|1
4742248|NCT03931785|7702165|FG000|Overall Study|Pregnancy|0
4742249|NCT03931785|7702166|FG001|Overall Study|Pregnancy|0
4742250|NCT03931785|7702167|FG002|Overall Study|Pregnancy|0
4742251|NCT03931785|7702168|FG003|Overall Study|Pregnancy|1
4742252|NCT03927846|7702184|FG000|Overall Study|Lost to Follow-up|10
4742253|NCT03927846|7702185|FG001|Overall Study|Lost to Follow-up|11
4742254|NCT03927105|7702191|FG000|Overall Study|Death|1
4742255|NCT03927105|7702191|FG000|Overall Study|In observation for potential re-treatment|2
4742256|NCT03927105|7702191|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1
4742257|NCT03923933|7702197|FG000|Overall Study|Lost to Follow-up|1
4742258|NCT03923933|7702198|FG001|Overall Study|Lost to Follow-up|0
4742259|NCT03923933|7702197|FG000|Overall Study|Withdrawal by Subject|0
4742260|NCT03923933|7702198|FG001|Overall Study|Withdrawal by Subject|1
4742261|NCT03909295|7702204|FG000|Overall Study|Adverse Event|2
4742262|NCT03909295|7702204|FG000|Overall Study|Study terminated by sponsor|50
4742263|NCT03908970|7702210|FG000|Overall Study|Adverse Event|7
4742264|NCT03908970|7702211|FG001|Overall Study|Adverse Event|21
4742265|NCT03908970|7702210|FG000|Overall Study|Physician Decision|1
4742266|NCT03908970|7702211|FG001|Overall Study|Physician Decision|4
4742267|NCT03908970|7702210|FG000|Overall Study|Withdrawal by Subject|9
4742268|NCT03908970|7702211|FG001|Overall Study|Withdrawal by Subject|22
4742269|NCT03897179|7702217|FG000|Overall Study|Withdrawal by Subject|1
4742270|NCT03927950|7702281|FG000|Overall Study|Adverse Event|9
4742271|NCT03920670|7702303|FG000|Overall Study|Protocol Violation|2
4742272|NCT03920670|7702304|FG001|Overall Study|Protocol Violation|2
4742273|NCT03920670|7702303|FG000|Overall Study|Adverse Event|1
4742274|NCT03920670|7702304|FG001|Overall Study|Adverse Event|0
4742275|NCT03898063|7702334|FG000|Overall Study|Withdrawal by Subject|10
4742276|NCT03898063|7702335|FG001|Overall Study|Withdrawal by Subject|8
4742277|NCT03909100|7702381|FG000|Overall Study|Protocol Deviation|2
4742278|NCT03909100|7702381|FG000|Overall Study|Technical Problems|4
4742279|NCT03909100|7702381|FG000|Overall Study|Withdrawal by Subject|4
4742280|NCT03909100|7702381|FG000|Overall Study|Lost to Follow-up|1
4742281|NCT03909100|7702381|FG000|Overall Study|Reason not Specified|4
4742282|NCT03905642|7702388|FG000|Overall Study|Withdrawal by Subject|3
4742283|NCT03905642|7702388|FG000|Overall Study|Pregnancy|1
4742284|NCT03905642|7702388|FG000|Overall Study|Adverse Event|1
4742285|NCT03905642|7702388|FG000|Overall Study|Lack of Efficacy|1
4742286|NCT03905642|7702388|FG000|Overall Study|Completed study but not 24 of 28 days|2
4742287|NCT03892889|7702392|FG000|Overall Study|Adverse Event|17
4742288|NCT03892889|7702392|FG000|Overall Study|Lack of Efficacy|1
4742289|NCT03892889|7702392|FG000|Overall Study|Lost to Follow-up|46
4742290|NCT03892889|7702392|FG000|Overall Study|Non-compliance with study drug|22
4742291|NCT03892889|7702392|FG000|Overall Study|Pregnancy|1
4742292|NCT03892889|7702392|FG000|Overall Study|Protocol Deviation|3
4742293|NCT03892889|7702392|FG000|Overall Study|Withdrawal by Subject|50
4742294|NCT03892889|7702392|FG000|Overall Study|Withdrawal by Caregiver|1
4742295|NCT03892889|7702392|FG000|Overall Study|Study Terminated by Sponsor|50
4742296|NCT03892889|7702392|FG000|Overall Study|Physician Decision|8
4742297|NCT03892889|7702392|FG000|Overall Study|Reason not Specified|5
4742298|NCT03921723|7702396|FG000|Period 2 (4 Days)|Withdrawal by Subject|3
4742299|NCT03921723|7702396|FG000|Period 3 (4 Days)|Withdrawal by Subject|1
4742300|NCT03918239|7702440|FG000|Overall Study|Lost to Follow-up|3
4742301|NCT03918239|7702441|FG001|Overall Study|Lost to Follow-up|1
4742302|NCT03918239|7702440|FG000|Overall Study|Pregnancy|0
4742303|NCT03918239|7702441|FG001|Overall Study|Pregnancy|2
4742304|NCT03918239|7702440|FG000|Overall Study|Withdrawal by Subject|3
4742305|NCT03918239|7702441|FG001|Overall Study|Withdrawal by Subject|3
4742306|NCT03918239|7702440|FG000|Overall Study|positive urine drug screening results|4
4742307|NCT03918239|7702441|FG001|Overall Study|positive urine drug screening results|1
4742308|NCT03917823|7702449|FG000|Overall Study|Lost to Follow-up|1
4742309|NCT03917823|7702450|FG001|Overall Study|Lost to Follow-up|1
4742310|NCT03917823|7702449|FG000|Overall Study|Withdrawal by Subject|0
4742311|NCT03917823|7702450|FG001|Overall Study|Withdrawal by Subject|1
4742312|NCT03902613|7702471|FG000|Overall Study|Physician Decision|1
4742313|NCT03902574|7702478|FG000|Overall Study|Urinary drug test was positive on Day 20|0
4742314|NCT03902574|7702479|FG001|Overall Study|Urinary drug test was positive on Day 20|0
4742315|NCT03902574|7702480|FG002|Overall Study|Urinary drug test was positive on Day 20|1
4742316|NCT03914950|7702488|FG000|Overall Study|Physician Decision|54
4742317|NCT03911843|7702500|FG000|Overall Study|Adverse Event|2
4742318|NCT03911843|7702501|FG001|Overall Study|Adverse Event|0
4742319|NCT03911843|7702500|FG000|Overall Study|Protocol Violation|2
4742320|NCT03911843|7702501|FG001|Overall Study|Protocol Violation|0
4742321|NCT03911843|7702500|FG000|Overall Study|Lost to Follow-up|0
4742322|NCT03911843|7702501|FG001|Overall Study|Lost to Follow-up|1
4742323|NCT03894813|7702518|FG000|Overall Study|Adverse Event|1
4742324|NCT03894813|7702519|FG001|Overall Study|Adverse Event|1
4742325|NCT03894813|7702518|FG000|Overall Study|Lack of Efficacy|3
4742326|NCT03894813|7702519|FG001|Overall Study|Lack of Efficacy|3
4742327|NCT03894813|7702518|FG000|Overall Study|Lost to Follow-up|1
4742328|NCT03894813|7702519|FG001|Overall Study|Lost to Follow-up|0
4742329|NCT03894813|7702518|FG000|Overall Study|Pregnancy|2
4742330|NCT03894813|7702519|FG001|Overall Study|Pregnancy|1
4742331|NCT03894813|7702518|FG000|Overall Study|Protocol Violation|3
4742332|NCT03894813|7702519|FG001|Overall Study|Protocol Violation|7
4742333|NCT03894813|7702518|FG000|Overall Study|Withdrawal by Subject|1
4742334|NCT03894813|7702519|FG001|Overall Study|Withdrawal by Subject|3
4742335|NCT03894813|7702518|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0
4742336|NCT03894813|7702519|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1
4742337|NCT03911960|7702527|FG000|Overall Study|Lost to Follow-up|5
4742338|NCT03911960|7702528|FG001|Overall Study|Lost to Follow-up|3
4742339|NCT03907072|7702538|FG000|Overall Study|Study Terminated by Sponsor|2
4742340|NCT03907072|7702539|FG001|Overall Study|Study Terminated by Sponsor|2
4742341|NCT03907072|7702540|FG002|Overall Study|Study Terminated by Sponsor|2
4742342|NCT03911401|7702560|FG000|Overall Study|Adverse Event|1
4742343|NCT03911401|7702561|FG001|Overall Study|Adverse Event|2
4742344|NCT03911401|7702562|FG002|Overall Study|Adverse Event|5
4742345|NCT03911401|7702560|FG000|Overall Study|Lack of Efficacy|1
4742346|NCT03911401|7702561|FG001|Overall Study|Lack of Efficacy|1
4742347|NCT03911401|7702562|FG002|Overall Study|Lack of Efficacy|8
4742348|NCT03911401|7702560|FG000|Overall Study|Physician Decision|0
4742349|NCT03911401|7702561|FG001|Overall Study|Physician Decision|0
4742350|NCT03911401|7702562|FG002|Overall Study|Physician Decision|1
4742351|NCT03911401|7702560|FG000|Overall Study|Withdrawal by Subject|1
4742352|NCT03911401|7702561|FG001|Overall Study|Withdrawal by Subject|2
4742353|NCT03911401|7702562|FG002|Overall Study|Withdrawal by Subject|0
4634113|NCT01920152|7504721|FG001|Overall Study|Withdrawal by Subject|2
4634114|NCT01920178|7504729|FG000|Overall Study|Lost to Follow-up|2
4634115|NCT01920178|7504730|FG001|Overall Study|Lost to Follow-up|1
4634116|NCT01920477|7504751|FG000|Overall Study|Adverse Event|0
4634117|NCT01920477|7504752|FG001|Overall Study|Adverse Event|1
4742354|NCT03911401|7702560|FG000|Overall Study|Withdrawal by parent/guardian|4
4742355|NCT03911401|7702561|FG001|Overall Study|Withdrawal by parent/guardian|4
4742356|NCT03911401|7702562|FG002|Overall Study|Withdrawal by parent/guardian|11
4742357|NCT03904420|7702589|FG000|Overall Study|Study terminated|2
4742358|NCT03904420|7702590|FG001|Overall Study|Study terminated|2
4742359|NCT03903822|7702604|FG000|Treatment Phase (6 Weeks)|Adverse Event|3
4742360|NCT03903822|7702605|FG001|Treatment Phase (6 Weeks)|Adverse Event|3
4742361|NCT03903822|7702606|FG002|Treatment Phase (6 Weeks)|Adverse Event|1
4742362|NCT03903822|7702607|FG003|Treatment Phase (6 Weeks)|Adverse Event|1
4742363|NCT03903822|7702608|FG004|Treatment Phase (6 Weeks)|Adverse Event|1
4742364|NCT03903822|7702609|FG005|Treatment Phase (6 Weeks)|Adverse Event|6
4742365|NCT03903822|7702610|FG006|Treatment Phase (6 Weeks)|Adverse Event|1
4742366|NCT03903822|7702611|FG007|Treatment Phase (6 Weeks)|Adverse Event|0
4742367|NCT03903822|7702604|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0
4742368|NCT03903822|7702605|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0
4742369|NCT03903822|7702606|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0
4742370|NCT03903822|7702607|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0
4742371|NCT03903822|7702608|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1
4742372|NCT03903822|7702609|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1
4742373|NCT03903822|7702610|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0
4742374|NCT03903822|7702611|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0
4742375|NCT03903822|7702604|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0
4742376|NCT03903822|7702605|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0
4742377|NCT03903822|7702606|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0
4742378|NCT03903822|7702607|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0
4742379|NCT03903822|7702608|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0
4742380|NCT03903822|7702609|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0
4742381|NCT03903822|7702610|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1
4742382|NCT03903822|7702611|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1
4742383|NCT03903822|7702604|FG000|Treatment Phase (6 Weeks)|Physician Decision|0
4742384|NCT03903822|7702605|FG001|Treatment Phase (6 Weeks)|Physician Decision|2
4742385|NCT03903822|7702606|FG002|Treatment Phase (6 Weeks)|Physician Decision|0
4742386|NCT03903822|7702607|FG003|Treatment Phase (6 Weeks)|Physician Decision|0
4742387|NCT03903822|7702608|FG004|Treatment Phase (6 Weeks)|Physician Decision|0
4742388|NCT03903822|7702609|FG005|Treatment Phase (6 Weeks)|Physician Decision|0
4742389|NCT03903822|7702610|FG006|Treatment Phase (6 Weeks)|Physician Decision|0
4742390|NCT03903822|7702611|FG007|Treatment Phase (6 Weeks)|Physician Decision|0
4742391|NCT03903822|7702604|FG000|Treatment Phase (6 Weeks)|Pregnancy|0
4742392|NCT03903822|7702605|FG001|Treatment Phase (6 Weeks)|Pregnancy|0
4742393|NCT03903822|7702606|FG002|Treatment Phase (6 Weeks)|Pregnancy|0
4742394|NCT03903822|7702607|FG003|Treatment Phase (6 Weeks)|Pregnancy|1
4742395|NCT03903822|7702608|FG004|Treatment Phase (6 Weeks)|Pregnancy|1
4742396|NCT03903822|7702609|FG005|Treatment Phase (6 Weeks)|Pregnancy|0
4742397|NCT03903822|7702610|FG006|Treatment Phase (6 Weeks)|Pregnancy|0
4742398|NCT03903822|7702611|FG007|Treatment Phase (6 Weeks)|Pregnancy|0
4742399|NCT03903822|7702604|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0
4742400|NCT03903822|7702605|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0
4742401|NCT03903822|7702606|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0
4742402|NCT03903822|7702607|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1
4742403|NCT03903822|7702608|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0
4742404|NCT03903822|7702609|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0
4742405|NCT03903822|7702610|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0
4742406|NCT03903822|7702611|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0
4742407|NCT03903822|7702604|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2
4742408|NCT03903822|7702605|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4
4742409|NCT03903822|7702606|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2
4742410|NCT03903822|7702607|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2
4742411|NCT03903822|7702608|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1
4742412|NCT03903822|7702609|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2
4742413|NCT03903822|7702610|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3
4634118|NCT01920477|7504751|FG000|Overall Study|Lack of Efficacy|1
4634119|NCT01920477|7504752|FG001|Overall Study|Lack of Efficacy|0
4742414|NCT03903822|7702611|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3
4742415|NCT03903822|7702604|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2
4742416|NCT03903822|7702605|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0
4742417|NCT03903822|7702606|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0
4742418|NCT03903822|7702607|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0
4742419|NCT03903822|7702608|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0
4742420|NCT03903822|7702609|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1
4742421|NCT03903822|7702610|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0
4742422|NCT03903822|7702611|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0
4742423|NCT03903822|7702604|FG000|Treatment Phase (6 Weeks)|Other|2
4742424|NCT03903822|7702605|FG001|Treatment Phase (6 Weeks)|Other|1
4742425|NCT03903822|7702606|FG002|Treatment Phase (6 Weeks)|Other|0
4742426|NCT03903822|7702607|FG003|Treatment Phase (6 Weeks)|Other|0
4742427|NCT03903822|7702608|FG004|Treatment Phase (6 Weeks)|Other|1
4742428|NCT03903822|7702609|FG005|Treatment Phase (6 Weeks)|Other|1
4742429|NCT03903822|7702610|FG006|Treatment Phase (6 Weeks)|Other|0
4742430|NCT03903822|7702611|FG007|Treatment Phase (6 Weeks)|Other|0
4742431|NCT03903822|7702604|FG000|Follow up Phase (4 Weeks)|Adverse Event|3
4742432|NCT03903822|7702605|FG001|Follow up Phase (4 Weeks)|Adverse Event|2
4742433|NCT03903822|7702606|FG002|Follow up Phase (4 Weeks)|Adverse Event|1
4742434|NCT03903822|7702607|FG003|Follow up Phase (4 Weeks)|Adverse Event|1
4742435|NCT03903822|7702608|FG004|Follow up Phase (4 Weeks)|Adverse Event|0
4742436|NCT03903822|7702609|FG005|Follow up Phase (4 Weeks)|Adverse Event|5
4742437|NCT03903822|7702610|FG006|Follow up Phase (4 Weeks)|Adverse Event|1
4742438|NCT03903822|7702611|FG007|Follow up Phase (4 Weeks)|Adverse Event|0
4742439|NCT03903822|7702604|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0
4742440|NCT03903822|7702605|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0
4742441|NCT03903822|7702606|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0
4742442|NCT03903822|7702607|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0
4742443|NCT03903822|7702608|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1
4742444|NCT03903822|7702609|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0
4742445|NCT03903822|7702610|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0
4742446|NCT03903822|7702611|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0
4742447|NCT03903822|7702604|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2
4742448|NCT03903822|7702605|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0
4742449|NCT03903822|7702606|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0
4742450|NCT03903822|7702607|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0
4742451|NCT03903822|7702608|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0
4742452|NCT03903822|7702609|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0
4742453|NCT03903822|7702610|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1
4742454|NCT03903822|7702611|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3
4742455|NCT03903822|7702604|FG000|Follow up Phase (4 Weeks)|Pregnancy|0
4742456|NCT03903822|7702605|FG001|Follow up Phase (4 Weeks)|Pregnancy|0
4742457|NCT03903822|7702606|FG002|Follow up Phase (4 Weeks)|Pregnancy|0
4742458|NCT03903822|7702607|FG003|Follow up Phase (4 Weeks)|Pregnancy|1
4742459|NCT03903822|7702608|FG004|Follow up Phase (4 Weeks)|Pregnancy|1
4742460|NCT03903822|7702609|FG005|Follow up Phase (4 Weeks)|Pregnancy|0
4742461|NCT03903822|7702610|FG006|Follow up Phase (4 Weeks)|Pregnancy|0
4742462|NCT03903822|7702611|FG007|Follow up Phase (4 Weeks)|Pregnancy|0
4742463|NCT03903822|7702604|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2
4742464|NCT03903822|7702605|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5
4742465|NCT03903822|7702606|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3
4742466|NCT03903822|7702607|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2
4742467|NCT03903822|7702608|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2
4742468|NCT03903822|7702609|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2
4742469|NCT03903822|7702610|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3
4742470|NCT03903822|7702611|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3
4742471|NCT03903822|7702604|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0
4742472|NCT03903822|7702605|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0
4742473|NCT03903822|7702606|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0
4742474|NCT03903822|7702607|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0
4742475|NCT03903822|7702608|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0
4742476|NCT03903822|7702609|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1
4742477|NCT03903822|7702610|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0
4742478|NCT03903822|7702611|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0
4742479|NCT03903822|7702604|FG000|Follow up Phase (4 Weeks)|Other|1
4742480|NCT03903822|7702605|FG001|Follow up Phase (4 Weeks)|Other|1
4742481|NCT03903822|7702606|FG002|Follow up Phase (4 Weeks)|Other|0
4742482|NCT03903822|7702607|FG003|Follow up Phase (4 Weeks)|Other|0
4742483|NCT03903822|7702608|FG004|Follow up Phase (4 Weeks)|Other|0
4742484|NCT03903822|7702609|FG005|Follow up Phase (4 Weeks)|Other|0
4742485|NCT03903822|7702610|FG006|Follow up Phase (4 Weeks)|Other|0
4742486|NCT03903822|7702611|FG007|Follow up Phase (4 Weeks)|Other|0
4742487|NCT03905096|7702631|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1
4742488|NCT03905096|7702632|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0
4742489|NCT03899064|7702645|FG000|Overall Study|Lost to Follow-up|1
4525184|NCT01021748|7340979|FG005|Overall Study|Not Treated|0
4525185|NCT01021748|7340980|FG006|Overall Study|Not Treated|0
4525186|NCT01021748|7340981|FG007|Overall Study|Not Treated|0
4525187|NCT01021748|7340982|FG008|Overall Study|Not Treated|0
4525188|NCT01021813|7341017|FG000|DB Treatment Phase|Adverse Event|60
4525189|NCT01021813|7341018|FG001|DB Treatment Phase|Adverse Event|22
4525190|NCT01021813|7341019|FG002|DB Treatment Phase|Adverse Event|0
4525191|NCT01021813|7341020|FG003|DB Treatment Phase|Adverse Event|0
4525192|NCT01021813|7341021|FG004|DB Treatment Phase|Adverse Event|0
4525193|NCT01021813|7341017|FG000|DB Treatment Phase|Lack of Efficacy|44
4525194|NCT01021813|7341018|FG001|DB Treatment Phase|Lack of Efficacy|28
4525195|NCT01021813|7341019|FG002|DB Treatment Phase|Lack of Efficacy|0
4742490|NCT03899064|7702645|FG000|Overall Study|Protocol Violation|2
4525196|NCT01021813|7341020|FG003|DB Treatment Phase|Lack of Efficacy|0
4525197|NCT01021813|7341021|FG004|DB Treatment Phase|Lack of Efficacy|0
4525198|NCT01021813|7341017|FG000|DB Treatment Phase|Lost to Follow-up|14
4525199|NCT01021813|7341018|FG001|DB Treatment Phase|Lost to Follow-up|12
4525200|NCT01021813|7341019|FG002|DB Treatment Phase|Lost to Follow-up|0
4525201|NCT01021813|7341020|FG003|DB Treatment Phase|Lost to Follow-up|0
4525202|NCT01021813|7341021|FG004|DB Treatment Phase|Lost to Follow-up|0
4525203|NCT01021813|7341017|FG000|DB Treatment Phase|Physician Decision|17
4525204|NCT01021813|7341018|FG001|DB Treatment Phase|Physician Decision|8
4525205|NCT01021813|7341019|FG002|DB Treatment Phase|Physician Decision|0
4525206|NCT01021813|7341020|FG003|DB Treatment Phase|Physician Decision|0
4525207|NCT01021813|7341021|FG004|DB Treatment Phase|Physician Decision|0
4525208|NCT01021813|7341017|FG000|DB Treatment Phase|Pregnancy|1
4525209|NCT01021813|7341018|FG001|DB Treatment Phase|Pregnancy|0
4742491|NCT03899064|7702645|FG000|Overall Study|Withdrawal by Subject|2
4742492|NCT03899064|7702645|FG000|Overall Study|Other|2
4742493|NCT03894969|7702654|FG000|Overall Study|Adverse Event|0
4742494|NCT03894969|7702655|FG001|Overall Study|Adverse Event|2
4742495|NCT03894969|7702656|FG002|Overall Study|Adverse Event|0
4742496|NCT03894969|7702657|FG003|Overall Study|Adverse Event|3
4742497|NCT03894969|7702658|FG004|Overall Study|Adverse Event|3
4742498|NCT03894969|7702654|FG000|Overall Study|Lost to Follow-up|1
4742499|NCT03894969|7702655|FG001|Overall Study|Lost to Follow-up|0
4742500|NCT03894969|7702656|FG002|Overall Study|Lost to Follow-up|1
4742501|NCT03894969|7702657|FG003|Overall Study|Lost to Follow-up|0
4742502|NCT03894969|7702658|FG004|Overall Study|Lost to Follow-up|0
4742503|NCT03894969|7702654|FG000|Overall Study|Withdrawal by Subject|1
4742504|NCT03894969|7702655|FG001|Overall Study|Withdrawal by Subject|1
4742505|NCT03894969|7702656|FG002|Overall Study|Withdrawal by Subject|1
4742506|NCT03894969|7702657|FG003|Overall Study|Withdrawal by Subject|3
4742507|NCT03894969|7702658|FG004|Overall Study|Withdrawal by Subject|8
4742508|NCT03894969|7702654|FG000|Overall Study|Other|0
4742509|NCT03894969|7702655|FG001|Overall Study|Other|0
4525210|NCT01021813|7341019|FG002|DB Treatment Phase|Pregnancy|0
4525211|NCT01021813|7341020|FG003|DB Treatment Phase|Pregnancy|0
4525212|NCT01021813|7341021|FG004|DB Treatment Phase|Pregnancy|0
4525213|NCT01021813|7341017|FG000|DB Treatment Phase|Protocol Violation|4
4525214|NCT01021813|7341018|FG001|DB Treatment Phase|Protocol Violation|3
4525215|NCT01021813|7341019|FG002|DB Treatment Phase|Protocol Violation|0
4525216|NCT01021813|7341020|FG003|DB Treatment Phase|Protocol Violation|0
4742510|NCT03894969|7702656|FG002|Overall Study|Other|0
4525217|NCT01021813|7341021|FG004|DB Treatment Phase|Protocol Violation|0
4525218|NCT01021813|7341017|FG000|DB Treatment Phase|Withdrawal by Subject|60
4742511|NCT03894969|7702657|FG003|Overall Study|Other|0
4742512|NCT03894969|7702658|FG004|Overall Study|Other|3
4742513|NCT03903159|7702671|FG000|Overall Study|Discharged with Staff Approval|2
4742514|NCT03903159|7702671|FG000|Overall Study|Discharged at Staff Request|2
4742515|NCT03903159|7702671|FG000|Overall Study|Discharged Against Staff Advice|1
4742516|NCT03902392|7702677|FG000|Overall Study|Lost to Follow-up|7
4742517|NCT03902392|7702678|FG001|Overall Study|Lost to Follow-up|7
4742518|NCT03895034|7702731|FG000|Overall Study|Lost to Follow-up|2
4742519|NCT03900728|7702738|FG000|Overall Study|No text responses|0
4742520|NCT03900728|7702739|FG001|Overall Study|No text responses|0
4742521|NCT03900728|7702740|FG002|Overall Study|No text responses|4
4742522|NCT03895372|7702779|FG000|Investigational Treatment Period|Adverse Event|1
4742523|NCT03895372|7702780|FG001|Investigational Treatment Period|Adverse Event|0
4742524|NCT03895372|7702781|FG002|Investigational Treatment Period|Adverse Event|0
4742525|NCT03895372|7702782|FG003|Investigational Treatment Period|Adverse Event|0
4742526|NCT03895372|7702783|FG004|Investigational Treatment Period|Adverse Event|0
4742527|NCT03895372|7702784|FG005|Investigational Treatment Period|Adverse Event|0
4742528|NCT03895372|7702785|FG006|Investigational Treatment Period|Adverse Event|4
4742529|NCT03895372|7702786|FG007|Investigational Treatment Period|Adverse Event|3
4742530|NCT03895372|7702779|FG000|Investigational Treatment Period|Lack of Efficacy|1
4742531|NCT03895372|7702780|FG001|Investigational Treatment Period|Lack of Efficacy|0
4742532|NCT03895372|7702781|FG002|Investigational Treatment Period|Lack of Efficacy|0
4742533|NCT03895372|7702782|FG003|Investigational Treatment Period|Lack of Efficacy|0
4634120|NCT01920477|7504751|FG000|Overall Study|Study closed/terminated|14
4634121|NCT01920477|7504752|FG001|Overall Study|Study closed/terminated|15
4525219|NCT01021813|7341018|FG001|DB Treatment Phase|Withdrawal by Subject|24
4742534|NCT03895372|7702783|FG004|Investigational Treatment Period|Lack of Efficacy|0
4742535|NCT03895372|7702784|FG005|Investigational Treatment Period|Lack of Efficacy|0
4742536|NCT03895372|7702785|FG006|Investigational Treatment Period|Lack of Efficacy|0
4742537|NCT03895372|7702786|FG007|Investigational Treatment Period|Lack of Efficacy|0
4742538|NCT03895372|7702779|FG000|Investigational Treatment Period|Lost to Follow-up|0
4742539|NCT03895372|7702780|FG001|Investigational Treatment Period|Lost to Follow-up|0
4742540|NCT03895372|7702781|FG002|Investigational Treatment Period|Lost to Follow-up|0
4742541|NCT03895372|7702782|FG003|Investigational Treatment Period|Lost to Follow-up|0
4742542|NCT03895372|7702783|FG004|Investigational Treatment Period|Lost to Follow-up|0
4742543|NCT03895372|7702784|FG005|Investigational Treatment Period|Lost to Follow-up|0
4742544|NCT03895372|7702785|FG006|Investigational Treatment Period|Lost to Follow-up|1
4742545|NCT03895372|7702786|FG007|Investigational Treatment Period|Lost to Follow-up|0
4742546|NCT03895372|7702779|FG000|Investigational Treatment Period|Other|0
4742547|NCT03895372|7702780|FG001|Investigational Treatment Period|Other|0
4742548|NCT03895372|7702781|FG002|Investigational Treatment Period|Other|0
4742549|NCT03895372|7702782|FG003|Investigational Treatment Period|Other|0
4742550|NCT03895372|7702783|FG004|Investigational Treatment Period|Other|0
4742551|NCT03895372|7702784|FG005|Investigational Treatment Period|Other|1
4742552|NCT03895372|7702785|FG006|Investigational Treatment Period|Other|0
4742553|NCT03895372|7702786|FG007|Investigational Treatment Period|Other|2
4742554|NCT03895372|7702779|FG000|Investigational Treatment Period|Protocol Violation|0
4742555|NCT03895372|7702780|FG001|Investigational Treatment Period|Protocol Violation|0
4742556|NCT03895372|7702781|FG002|Investigational Treatment Period|Protocol Violation|0
4742557|NCT03895372|7702782|FG003|Investigational Treatment Period|Protocol Violation|1
4742558|NCT03895372|7702783|FG004|Investigational Treatment Period|Protocol Violation|0
4742559|NCT03895372|7702784|FG005|Investigational Treatment Period|Protocol Violation|0
4742560|NCT03895372|7702785|FG006|Investigational Treatment Period|Protocol Violation|0
4742561|NCT03895372|7702786|FG007|Investigational Treatment Period|Protocol Violation|0
4742562|NCT03895372|7702779|FG000|Investigational Treatment Period|Withdrawal by Subject|2
4742563|NCT03895372|7702780|FG001|Investigational Treatment Period|Withdrawal by Subject|3
4742564|NCT03895372|7702781|FG002|Investigational Treatment Period|Withdrawal by Subject|1
4742565|NCT03895372|7702782|FG003|Investigational Treatment Period|Withdrawal by Subject|1
4742566|NCT03895372|7702783|FG004|Investigational Treatment Period|Withdrawal by Subject|0
4742567|NCT03895372|7702784|FG005|Investigational Treatment Period|Withdrawal by Subject|1
4742568|NCT03895372|7702785|FG006|Investigational Treatment Period|Withdrawal by Subject|3
4742569|NCT03895372|7702786|FG007|Investigational Treatment Period|Withdrawal by Subject|0
4742570|NCT03895372|7702779|FG000|Extension Treatment Period|Adverse Event|0
4742571|NCT03895372|7702780|FG001|Extension Treatment Period|Adverse Event|1
4742572|NCT03895372|7702781|FG002|Extension Treatment Period|Adverse Event|0
4742573|NCT03895372|7702782|FG003|Extension Treatment Period|Adverse Event|1
4742574|NCT03895372|7702783|FG004|Extension Treatment Period|Adverse Event|0
4742575|NCT03895372|7702784|FG005|Extension Treatment Period|Adverse Event|0
4742576|NCT03895372|7702785|FG006|Extension Treatment Period|Adverse Event|3
4742577|NCT03895372|7702786|FG007|Extension Treatment Period|Adverse Event|3
4742578|NCT03895372|7702779|FG000|Extension Treatment Period|Other|1
4742579|NCT03895372|7702780|FG001|Extension Treatment Period|Other|3
4742580|NCT03895372|7702781|FG002|Extension Treatment Period|Other|0
4742581|NCT03895372|7702782|FG003|Extension Treatment Period|Other|0
4742582|NCT03895372|7702783|FG004|Extension Treatment Period|Other|1
4742583|NCT03895372|7702784|FG005|Extension Treatment Period|Other|0
4742584|NCT03895372|7702785|FG006|Extension Treatment Period|Other|0
4742585|NCT03895372|7702786|FG007|Extension Treatment Period|Other|2
4742586|NCT03895372|7702779|FG000|Extension Treatment Period|Pregnancy|0
4742587|NCT03895372|7702780|FG001|Extension Treatment Period|Pregnancy|0
4742588|NCT03895372|7702781|FG002|Extension Treatment Period|Pregnancy|0
4742589|NCT03895372|7702782|FG003|Extension Treatment Period|Pregnancy|0
4742590|NCT03895372|7702783|FG004|Extension Treatment Period|Pregnancy|1
4742591|NCT03895372|7702784|FG005|Extension Treatment Period|Pregnancy|0
4742592|NCT03895372|7702785|FG006|Extension Treatment Period|Pregnancy|0
4742593|NCT03895372|7702786|FG007|Extension Treatment Period|Pregnancy|0
4742594|NCT03895372|7702779|FG000|Extension Treatment Period|Withdrawal by Subject|2
4742595|NCT03895372|7702780|FG001|Extension Treatment Period|Withdrawal by Subject|1
4742596|NCT03895372|7702781|FG002|Extension Treatment Period|Withdrawal by Subject|0
4742597|NCT03895372|7702782|FG003|Extension Treatment Period|Withdrawal by Subject|0
4742598|NCT03895372|7702783|FG004|Extension Treatment Period|Withdrawal by Subject|1
4525220|NCT01021813|7341019|FG002|DB Treatment Phase|Withdrawal by Subject|0
4525221|NCT01021813|7341020|FG003|DB Treatment Phase|Withdrawal by Subject|0
4742599|NCT03895372|7702784|FG005|Extension Treatment Period|Withdrawal by Subject|1
4742600|NCT03895372|7702785|FG006|Extension Treatment Period|Withdrawal by Subject|1
4742601|NCT03895372|7702786|FG007|Extension Treatment Period|Withdrawal by Subject|1
4742602|NCT03896022|7702812|FG000|Overall Study|Withdrawal by Subject|1
4742603|NCT03896022|7702813|FG001|Overall Study|Withdrawal by Subject|0
4742604|NCT03896022|7702814|FG002|Overall Study|Withdrawal by Subject|0
4742605|NCT03896022|7702812|FG000|Overall Study|Did not have procedure|3
4742606|NCT03896022|7702813|FG001|Overall Study|Did not have procedure|0
4742607|NCT03896022|7702814|FG002|Overall Study|Did not have procedure|0
4742608|NCT03891862|7702826|FG000|Open-label Period|Adverse Event|2
4742609|NCT03891862|7702827|FG001|Open-label Period|Adverse Event|0
4742610|NCT03891862|7702828|FG002|Open-label Period|Adverse Event|0
4742611|NCT03891862|7702826|FG000|Open-label Period|Protocol Violation|5
4742612|NCT03891862|7702827|FG001|Open-label Period|Protocol Violation|0
4742613|NCT03891862|7702828|FG002|Open-label Period|Protocol Violation|0
4742614|NCT03891862|7702826|FG000|Open-label Period|Withdrawal by Subject|6
4742615|NCT03891862|7702827|FG001|Open-label Period|Withdrawal by Subject|0
4742616|NCT03891862|7702828|FG002|Open-label Period|Withdrawal by Subject|0
4742617|NCT03891862|7702826|FG000|Open-label Period|Death|1
4742618|NCT03891862|7702827|FG001|Open-label Period|Death|0
4742619|NCT03891862|7702828|FG002|Open-label Period|Death|0
4742620|NCT03891862|7702826|FG000|Open-label Period|Lost to Follow-up|2
4742621|NCT03891862|7702827|FG001|Open-label Period|Lost to Follow-up|0
4525222|NCT01021813|7341021|FG004|DB Treatment Phase|Withdrawal by Subject|0
4525223|NCT01021813|7341017|FG000|DB Randomized Discontinuation Phase|Adverse Event|0
4525224|NCT01021813|7341018|FG001|DB Randomized Discontinuation Phase|Adverse Event|0
4525225|NCT01021813|7341019|FG002|DB Randomized Discontinuation Phase|Adverse Event|0
4525226|NCT01021813|7341020|FG003|DB Randomized Discontinuation Phase|Adverse Event|3
4525227|NCT01021813|7341021|FG004|DB Randomized Discontinuation Phase|Adverse Event|1
4525228|NCT01021813|7341017|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0
4525229|NCT01021813|7341018|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0
4525230|NCT01021813|7341019|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0
4525231|NCT01021813|7341020|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1
4742622|NCT03891862|7702828|FG002|Open-label Period|Lost to Follow-up|0
4742623|NCT03891862|7702826|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0
4525232|NCT01021813|7341021|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0
4525233|NCT01021813|7341017|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0
4525234|NCT01021813|7341018|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0
4525235|NCT01021813|7341019|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0
4525236|NCT01021813|7341020|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0
4525237|NCT01021813|7341021|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1
4525238|NCT01021813|7341017|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0
4525239|NCT01021813|7341018|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0
4525240|NCT01021813|7341019|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1
4525241|NCT01021813|7341020|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0
4525242|NCT01021813|7341021|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0
4525243|NCT01021813|7341017|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0
4525244|NCT01021813|7341018|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0
4634122|NCT01920477|7504751|FG000|Overall Study|Withdrawal by Subject|0
4742624|NCT03891862|7702827|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1
4742625|NCT03891862|7702828|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1
4742626|NCT03891862|7702826|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0
4742627|NCT03891862|7702827|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2
4742628|NCT03891862|7702828|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1
4742629|NCT03891862|7702826|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0
4742630|NCT03891862|7702827|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1
4742631|NCT03891862|7702828|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2
4742632|NCT03891862|7702826|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0
4742633|NCT03891862|7702827|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2
4742634|NCT03891862|7702828|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0
4742635|NCT03892564|7702856|FG000|Overall Study|Withdrawal by Subject|2
4742636|NCT03892707|7702863|FG000|Overall Study|Screen failure|6
4742637|NCT03892707|7702864|FG001|Overall Study|Screen failure|0
4742638|NCT03892707|7702863|FG000|Overall Study|Pain resolution|0
4742639|NCT03892707|7702864|FG001|Overall Study|Pain resolution|4
4742640|NCT03892707|7702863|FG000|Overall Study|Withdrawal by Subject|0
4742641|NCT03892707|7702864|FG001|Overall Study|Withdrawal by Subject|1
4634123|NCT01920477|7504752|FG001|Overall Study|Withdrawal by Subject|1
4634124|NCT01920555|7504763|FG000|Overall Study|Physician Decision|1
4634125|NCT01920555|7504764|FG001|Overall Study|Physician Decision|2
4634126|NCT01920555|7504765|FG002|Overall Study|Physician Decision|1
4634127|NCT01920555|7504766|FG003|Overall Study|Physician Decision|2
4634128|NCT01920555|7504767|FG004|Overall Study|Physician Decision|0
4742642|NCT03892707|7702863|FG000|Overall Study|Other (long business trip)|0
4742643|NCT03892707|7702864|FG001|Overall Study|Other (long business trip)|1
4742644|NCT03891641|7702883|FG000|Overall Study|Study Stoppage Due to COVID-19|2
4742645|NCT03891641|7702884|FG001|Overall Study|Study Stoppage Due to COVID-19|2
4742646|NCT03889704|7702890|FG000|Overall Study|Study terminated due to pandemic|1
4742647|NCT03888391|7702904|FG000|Overall Study|Lost to Follow-up|15
4742648|NCT03888482|7702910|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0
4742649|NCT03888482|7702911|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1
4742650|NCT03888482|7702910|FG000|Second Wear (8 -1/+2 Days)|Other|1
4742651|NCT03888482|7702911|FG001|Second Wear (8 -1/+2 Days)|Other|0
4742652|NCT03887442|7702946|FG000|Overall Study|Adverse Event|1
4742653|NCT03887442|7702947|FG001|Overall Study|Adverse Event|0
4742654|NCT03878602|7702971|FG000|Overall Study|cord blood donation|7
4742655|NCT03878602|7702972|FG001|Overall Study|cord blood donation|1
4742656|NCT03878602|7702971|FG000|Overall Study|incomplete data collection|2
4742657|NCT03878602|7702972|FG001|Overall Study|incomplete data collection|0
4742658|NCT03875118|7702982|FG000|Overall Study|Withdrawal by Subject|4
4742659|NCT03875118|7702983|FG001|Overall Study|Withdrawal by Subject|4
4742660|NCT03873987|7702991|FG000|Overall Study|Adverse Event|1
4742661|NCT03873987|7702992|FG001|Overall Study|Adverse Event|0
4742662|NCT03873987|7702991|FG000|Overall Study|staff was unable to start a new IV line|1
4742663|NCT03873987|7702992|FG001|Overall Study|staff was unable to start a new IV line|0
4742664|NCT03873987|7702991|FG000|Overall Study|Lost to Follow-up|0
4742665|NCT03873987|7702992|FG001|Overall Study|Lost to Follow-up|1
4742666|NCT03878758|7703018|FG000|Overall Study|Withdrawal by Subject|1
4742667|NCT03878758|7703018|FG000|Overall Study|Protocol defined|2
4742668|NCT03878758|7703018|FG000|Overall Study|Improper consent documentation|1
4742669|NCT03849300|7703035|FG000|Overall Study|move out to different area|1
4742670|NCT03849300|7703036|FG001|Overall Study|move out to different area|3
4634129|NCT01920555|7504763|FG000|Overall Study|Lack of Efficacy|2
4634130|NCT01920555|7504764|FG001|Overall Study|Lack of Efficacy|0
4634131|NCT01920555|7504765|FG002|Overall Study|Lack of Efficacy|0
4634132|NCT01920555|7504766|FG003|Overall Study|Lack of Efficacy|0
4634133|NCT01920555|7504767|FG004|Overall Study|Lack of Efficacy|0
4634134|NCT01920555|7504763|FG000|Overall Study|Travel Difficulties|1
4634135|NCT01920555|7504764|FG001|Overall Study|Travel Difficulties|1
4634136|NCT01920555|7504765|FG002|Overall Study|Travel Difficulties|0
4634137|NCT01920555|7504766|FG003|Overall Study|Travel Difficulties|0
4634138|NCT01920555|7504767|FG004|Overall Study|Travel Difficulties|1
4634139|NCT01920555|7504763|FG000|Overall Study|Lost to Follow-up|0
4634140|NCT01920555|7504764|FG001|Overall Study|Lost to Follow-up|1
4634141|NCT01920555|7504765|FG002|Overall Study|Lost to Follow-up|0
4634142|NCT01920555|7504766|FG003|Overall Study|Lost to Follow-up|1
4634143|NCT01920555|7504767|FG004|Overall Study|Lost to Follow-up|0
4742671|NCT03849300|7703037|FG002|Overall Study|move out to different area|1
4742672|NCT03849300|7703038|FG003|Overall Study|move out to different area|4
4742673|NCT03849300|7703035|FG000|Overall Study|scheduling/transportation conflict|4
4742674|NCT03849300|7703036|FG001|Overall Study|scheduling/transportation conflict|4
4742675|NCT03849300|7703037|FG002|Overall Study|scheduling/transportation conflict|3
4742676|NCT03849300|7703038|FG003|Overall Study|scheduling/transportation conflict|2
4742677|NCT03883113|7703080|FG000|Overall Study|Physician Decision|4
4742678|NCT03883113|7703081|FG001|Overall Study|Physician Decision|2
4634144|NCT01920568|7504781|FG000|Overall Study|Adverse Event|27
4634145|NCT01920568|7504782|FG001|Overall Study|Adverse Event|8
4742679|NCT03883113|7703080|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9
4742680|NCT03883113|7703081|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7
4742681|NCT03883113|7703080|FG000|Overall Study|Pregnancy|1
4742682|NCT03883113|7703081|FG001|Overall Study|Pregnancy|0
4742683|NCT03883113|7703080|FG000|Overall Study|Adverse Event|0
4742684|NCT03883113|7703081|FG001|Overall Study|Adverse Event|1
4742685|NCT03883113|7703080|FG000|Overall Study|Withdrawal by Subject|1
4742686|NCT03883113|7703081|FG001|Overall Study|Withdrawal by Subject|2
4742687|NCT03883113|7703080|FG000|Overall Study|Lost to Follow-up|1
4742688|NCT03883113|7703081|FG001|Overall Study|Lost to Follow-up|0
4742689|NCT03880227|7703103|FG000|First Visit|Withdrawal by Subject|1
4742690|NCT03880227|7703104|FG001|First Visit|Withdrawal by Subject|0
4742691|NCT03880227|7703105|FG002|First Visit|Withdrawal by Subject|0
4742692|NCT03880227|7703106|FG003|First Visit|Withdrawal by Subject|0
4742693|NCT03880227|7703103|FG000|1 Week Washout/ Delay|Lost to Follow-up|0
4742694|NCT03880227|7703104|FG001|1 Week Washout/ Delay|Lost to Follow-up|1
4742695|NCT03880227|7703105|FG002|1 Week Washout/ Delay|Lost to Follow-up|0
4742696|NCT03880227|7703106|FG003|1 Week Washout/ Delay|Lost to Follow-up|0
4742697|NCT03880227|7703103|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0
4525245|NCT01021813|7341019|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3
4742698|NCT03880227|7703104|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0
4742699|NCT03880227|7703105|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2
4742700|NCT03880227|7703106|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0
4742701|NCT03880227|7703103|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0
4742702|NCT03880227|7703104|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0
4742703|NCT03880227|7703105|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1
4742704|NCT03880227|7703106|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0
4742705|NCT03876743|7703120|FG000|Overall Study|Lost to Follow-up|6
4742706|NCT03876743|7703121|FG001|Overall Study|Lost to Follow-up|4
4742707|NCT03876743|7703122|FG002|Overall Study|Lost to Follow-up|4
4742708|NCT03876743|7703123|FG003|Overall Study|Lost to Follow-up|7
4742709|NCT03885934|7703143|FG000|Overall Study|Withdrawn by Parent/Guardian|1
4742710|NCT03885934|7703144|FG001|Overall Study|Withdrawn by Parent/Guardian|0
4742711|NCT03885934|7703145|FG002|Overall Study|Withdrawn by Parent/Guardian|0
4742712|NCT03885934|7703146|FG003|Overall Study|Withdrawn by Parent/Guardian|0
4742713|NCT03885934|7703147|FG004|Overall Study|Withdrawn by Parent/Guardian|0
4742714|NCT03885934|7703148|FG005|Overall Study|Withdrawn by Parent/Guardian|0
4742715|NCT03885726|7703162|FG000|Overall Study|Staffing issues/lost interest|1
4742716|NCT03885726|7703162|FG000|Overall Study|Early discharge from hospital|3
4742717|NCT03883386|7703187|FG000|First Assignment|Lost to Follow-up|1
4742718|NCT03883386|7703188|FG001|First Assignment|Lost to Follow-up|0
4742719|NCT03883386|7703187|FG000|First Assignment|Withdrawal by Subject|1
4742720|NCT03883386|7703188|FG001|First Assignment|Withdrawal by Subject|1
4742721|NCT03882801|7703200|FG000|Period 1|Adverse Event|0
4742722|NCT03882801|7703201|FG001|Period 1|Adverse Event|1
4742723|NCT03882801|7703200|FG000|Period 1|Non-compliance with study drug|1
4742724|NCT03882801|7703201|FG001|Period 1|Non-compliance with study drug|1
4742725|NCT03882801|7703200|FG000|Period 1|Never treated with study drug|1
4742726|NCT03882801|7703201|FG001|Period 1|Never treated with study drug|0
4742727|NCT03882801|7703200|FG000|Washout Period|Physician Decision|0
4742728|NCT03882801|7703201|FG001|Washout Period|Physician Decision|1
4742729|NCT03882801|7703200|FG000|Period 2|Non-compliance with study drug|0
4742730|NCT03882801|7703201|FG001|Period 2|Non-compliance with study drug|1
4742731|NCT03882424|7703212|FG000|Overall Study|Lost to Follow-up|3
4742732|NCT03882424|7703213|FG001|Overall Study|Lost to Follow-up|0
4742733|NCT03882424|7703214|FG002|Overall Study|Lost to Follow-up|0
4742734|NCT03882424|7703212|FG000|Overall Study|schedule conflict|1
4742735|NCT03882424|7703213|FG001|Overall Study|schedule conflict|0
4742736|NCT03882424|7703214|FG002|Overall Study|schedule conflict|0
4742737|NCT03880266|7703247|FG000|Overall Study|Withdrawal by Subject|0
4742738|NCT03880266|7703248|FG001|Overall Study|Withdrawal by Subject|1
4742739|NCT03880266|7703249|FG002|Overall Study|Withdrawal by Subject|1
4742740|NCT03880266|7703250|FG003|Overall Study|Withdrawal by Subject|0
4742741|NCT03880266|7703251|FG004|Overall Study|Withdrawal by Subject|0
4742742|NCT03880266|7703252|FG005|Overall Study|Withdrawal by Subject|0
4742743|NCT03880266|7703253|FG006|Overall Study|Withdrawal by Subject|0
4742744|NCT03880266|7703254|FG007|Overall Study|Withdrawal by Subject|0
4742745|NCT03878160|7703297|FG000|Overall Study|Lost to Follow-up|1
4742746|NCT03878160|7703298|FG001|Overall Study|Lost to Follow-up|1
4742747|NCT03878160|7703299|FG002|Overall Study|Lost to Follow-up|1
4742748|NCT03878160|7703297|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1
4742749|NCT03878160|7703298|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0
4742750|NCT03878160|7703299|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0
4742751|NCT03864627|7703309|FG000|Overall Study|Adverse Event|0
4742752|NCT03864627|7703310|FG001|Overall Study|Adverse Event|1
4742753|NCT03864627|7703309|FG000|Overall Study|Lack of Efficacy|0
4742754|NCT03864627|7703310|FG001|Overall Study|Lack of Efficacy|1
4742755|NCT03864627|7703309|FG000|Overall Study|Lost to Follow-up|0
4742756|NCT03864627|7703310|FG001|Overall Study|Lost to Follow-up|1
4742757|NCT03864627|7703309|FG000|Overall Study|Withdrawal by Subject|4
4742758|NCT03864627|7703310|FG001|Overall Study|Withdrawal by Subject|8
4742759|NCT03864627|7703309|FG000|Overall Study|Study terminated by sponsor|0
4742760|NCT03864627|7703310|FG001|Overall Study|Study terminated by sponsor|1
4742761|NCT03848403|7703325|FG000|Period 2 (Day 8)|Adverse Event|1
4742762|NCT03848403|7703326|FG001|Period 2 (Day 8)|Adverse Event|2
4742763|NCT03848403|7703327|FG002|Period 2 (Day 8)|Adverse Event|2
4742764|NCT03848403|7703325|FG000|Period 2 (Day 8)|Physician Decision|0
4742765|NCT03848403|7703326|FG001|Period 2 (Day 8)|Physician Decision|1
4742766|NCT03848403|7703327|FG002|Period 2 (Day 8)|Physician Decision|0
4742767|NCT03848403|7703325|FG000|Period 2 (Day 8)|Sponsor Decision|8
4742768|NCT03848403|7703326|FG001|Period 2 (Day 8)|Sponsor Decision|6
4742769|NCT03848403|7703327|FG002|Period 2 (Day 8)|Sponsor Decision|5
4742770|NCT03878108|7703394|FG000|Overall Study|Adverse Event|1
4742771|NCT03878108|7703395|FG001|Overall Study|Adverse Event|0
4742772|NCT03877237|7703411|FG000|Overall Study|Adverse Event|1
4742773|NCT03877237|7703412|FG001|Overall Study|Adverse Event|2
4742774|NCT03877237|7703411|FG000|Overall Study|Death|3
4742775|NCT03877237|7703412|FG001|Overall Study|Death|2
4742776|NCT03877237|7703411|FG000|Overall Study|Physician Decision|1
4742777|NCT03877237|7703412|FG001|Overall Study|Physician Decision|0
4742778|NCT03877237|7703411|FG000|Overall Study|Withdrawal by Subject|0
4742779|NCT03877237|7703412|FG001|Overall Study|Withdrawal by Subject|2
4742780|NCT03859323|7703441|FG000|Overall Study|Lost to Follow-up|0
4742781|NCT03859323|7703442|FG001|Overall Study|Lost to Follow-up|0
4742782|NCT03859323|7703443|FG002|Overall Study|Lost to Follow-up|0
4742783|NCT03859323|7703444|FG003|Overall Study|Lost to Follow-up|0
4742784|NCT03859323|7703445|FG004|Overall Study|Lost to Follow-up|0
4742785|NCT03859323|7703446|FG005|Overall Study|Lost to Follow-up|0
4742786|NCT03859323|7703447|FG006|Overall Study|Lost to Follow-up|1
4742787|NCT03859323|7703448|FG007|Overall Study|Lost to Follow-up|0
4742788|NCT03859323|7703449|FG008|Overall Study|Lost to Follow-up|0
4742789|NCT03859323|7703450|FG009|Overall Study|Lost to Follow-up|0
4742790|NCT03859323|7703451|FG010|Overall Study|Lost to Follow-up|0
4742791|NCT03859323|7703452|FG011|Overall Study|Lost to Follow-up|0
4742792|NCT03859323|7703453|FG012|Overall Study|Lost to Follow-up|0
4742793|NCT03859323|7703441|FG000|Overall Study|Withdrawal by Subject|0
4742794|NCT03859323|7703442|FG001|Overall Study|Withdrawal by Subject|0
4742795|NCT03859323|7703443|FG002|Overall Study|Withdrawal by Subject|1
4742796|NCT03859323|7703444|FG003|Overall Study|Withdrawal by Subject|0
4742797|NCT03859323|7703445|FG004|Overall Study|Withdrawal by Subject|0
4742798|NCT03859323|7703446|FG005|Overall Study|Withdrawal by Subject|1
4742799|NCT03859323|7703447|FG006|Overall Study|Withdrawal by Subject|0
4742800|NCT03859323|7703448|FG007|Overall Study|Withdrawal by Subject|0
4742801|NCT03859323|7703449|FG008|Overall Study|Withdrawal by Subject|0
4742802|NCT03859323|7703450|FG009|Overall Study|Withdrawal by Subject|1
4742803|NCT03859323|7703451|FG010|Overall Study|Withdrawal by Subject|1
4742804|NCT03859323|7703452|FG011|Overall Study|Withdrawal by Subject|2
4742805|NCT03859323|7703453|FG012|Overall Study|Withdrawal by Subject|1
4742806|NCT03859323|7703441|FG000|Overall Study|Pregnancy|0
4742807|NCT03859323|7703442|FG001|Overall Study|Pregnancy|0
4742808|NCT03859323|7703443|FG002|Overall Study|Pregnancy|0
4742809|NCT03859323|7703444|FG003|Overall Study|Pregnancy|0
4742810|NCT03859323|7703445|FG004|Overall Study|Pregnancy|0
4742811|NCT03859323|7703446|FG005|Overall Study|Pregnancy|0
4742812|NCT03859323|7703447|FG006|Overall Study|Pregnancy|0
4742813|NCT03859323|7703448|FG007|Overall Study|Pregnancy|0
4742814|NCT03859323|7703449|FG008|Overall Study|Pregnancy|0
4742815|NCT03859323|7703450|FG009|Overall Study|Pregnancy|1
4742816|NCT03859323|7703451|FG010|Overall Study|Pregnancy|0
4742817|NCT03859323|7703452|FG011|Overall Study|Pregnancy|0
4742818|NCT03859323|7703453|FG012|Overall Study|Pregnancy|0
4742819|NCT03875508|7703518|FG000|Overall Study|Adverse Event|1
4742820|NCT03875508|7703518|FG000|Overall Study|Lost to Follow-up|8
4742821|NCT03875508|7703518|FG000|Overall Study|Lack of Efficacy|1
4742822|NCT03875508|7703518|FG000|Overall Study|Other, not specified|2
4742823|NCT03869333|7703526|FG000|Overall Study|Lost to Follow-up|1
4742824|NCT03869333|7703527|FG001|Overall Study|Lost to Follow-up|0
4742825|NCT03869333|7703528|FG002|Overall Study|Lost to Follow-up|0
4742826|NCT03869333|7703529|FG003|Overall Study|Lost to Follow-up|0
4742827|NCT03869333|7703526|FG000|Overall Study|Pregnancy|1
4742828|NCT03869333|7703527|FG001|Overall Study|Pregnancy|0
4742829|NCT03869333|7703528|FG002|Overall Study|Pregnancy|0
4742830|NCT03869333|7703529|FG003|Overall Study|Pregnancy|0
4742831|NCT03869333|7703526|FG000|Overall Study|Physician Decision|0
4742832|NCT03869333|7703527|FG001|Overall Study|Physician Decision|1
4742833|NCT03869333|7703528|FG002|Overall Study|Physician Decision|0
4742834|NCT03869333|7703529|FG003|Overall Study|Physician Decision|0
4742835|NCT03864900|7703541|FG000|Overall Study|Withdrawal by Subject|1
4742836|NCT03864900|7703542|FG001|Overall Study|Withdrawal by Subject|1
4742837|NCT03864900|7703541|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2
4742838|NCT03864900|7703542|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5
4742839|NCT03875482|7703567|FG000|Overall Study|Adverse Event|0
4742840|NCT03875482|7703568|FG001|Overall Study|Adverse Event|1
4742841|NCT03875482|7703567|FG000|Overall Study|Withdrew consent|5
4742842|NCT03875482|7703568|FG001|Overall Study|Withdrew consent|6
4742843|NCT03875482|7703567|FG000|Overall Study|Lost to Follow-up|8
4742844|NCT03875482|7703568|FG001|Overall Study|Lost to Follow-up|2
4742845|NCT03875482|7703567|FG000|Overall Study|Lack of Efficacy|0
4742846|NCT03875482|7703568|FG001|Overall Study|Lack of Efficacy|11
4742847|NCT03874013|7703586|FG000|Overall Study|Adverse Event|0
4742848|NCT03874013|7703587|FG001|Overall Study|Adverse Event|1
4742849|NCT03873116|7703596|FG000|Overall Study|Study drug discontinuation due to rash|0
4742850|NCT03873116|7703597|FG001|Overall Study|Study drug discontinuation due to rash|0
4742851|NCT03873116|7703598|FG002|Overall Study|Study drug discontinuation due to rash|1
4742852|NCT03872843|7703608|FG000|Overall Study|Lost to Follow-up|5
4742853|NCT03872843|7703609|FG001|Overall Study|Lost to Follow-up|7
4742854|NCT03870997|7703621|FG000|Overall Study|Did not complete mid-study/final survey|10544
4742855|NCT03870997|7703622|FG001|Overall Study|Did not complete mid-study/final survey|10431
4742856|NCT03870997|7703623|FG002|Overall Study|Did not complete mid-study/final survey|10978
4742857|NCT03870997|7703624|FG003|Overall Study|Did not complete mid-study/final survey|10947
4742858|NCT03870997|7703625|FG004|Overall Study|Did not complete mid-study/final survey|10588
4742859|NCT03870997|7703626|FG005|Overall Study|Did not complete mid-study/final survey|10531
4742860|NCT03869684|7703638|FG000|Overall Study|Adverse Event|0
4742861|NCT03869684|7703639|FG001|Overall Study|Adverse Event|3
4742862|NCT03869684|7703640|FG002|Overall Study|Adverse Event|1
4742863|NCT03869684|7703638|FG000|Overall Study|Withdrawal by Subject|1
4742864|NCT03869684|7703639|FG001|Overall Study|Withdrawal by Subject|0
4742865|NCT03869684|7703640|FG002|Overall Study|Withdrawal by Subject|0
4742866|NCT03869684|7703638|FG000|Overall Study|Lost to Follow-up|1
4742867|NCT03869684|7703639|FG001|Overall Study|Lost to Follow-up|0
4742868|NCT03869684|7703640|FG002|Overall Study|Lost to Follow-up|0
4742869|NCT03869684|7703638|FG000|Overall Study|Study prematurely terminated by sponsor|0
4742870|NCT03869684|7703639|FG001|Overall Study|Study prematurely terminated by sponsor|0
4742871|NCT03869684|7703640|FG002|Overall Study|Study prematurely terminated by sponsor|2
4742872|NCT03848416|7703694|FG000|Overall Study|Withdrawal by Subject|1
4742873|NCT03848416|7703695|FG001|Overall Study|Withdrawal by Subject|0
4742874|NCT03848416|7703696|FG002|Overall Study|Withdrawal by Subject|0
4742875|NCT03848416|7703694|FG000|Overall Study|Death|0
4742876|NCT03848416|7703695|FG001|Overall Study|Death|0
4742877|NCT03848416|7703696|FG002|Overall Study|Death|1
4742878|NCT03847987|7703706|FG000|Overall Study|Lost to Follow-up|1
4742879|NCT03847987|7703707|FG001|Overall Study|Lost to Follow-up|0
4742880|NCT03847987|7703706|FG000|Overall Study|Adverse Event|2
4742881|NCT03847987|7703707|FG001|Overall Study|Adverse Event|0
4742882|NCT03853551|7703769|FG000|Overall Study|Death|2
4742883|NCT03853551|7703769|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7
4742884|NCT03870555|7703776|FG000|Period 3 (2 Days)|Adverse Event|1
4742885|NCT03870555|7703777|FG001|Period 3 (2 Days)|Adverse Event|0
4742886|NCT03870555|7703778|FG002|Period 3 (2 Days)|Adverse Event|0
4742887|NCT03851094|7703804|FG000|Overall Study|Withdrawal by Subject|0
4525246|NCT01021813|7341020|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1
4525247|NCT01021813|7341021|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3
4525248|NCT01021852|7341046|FG000|Treatment Period 1|Adverse Event|3
4525249|NCT01021852|7341047|FG001|Treatment Period 1|Adverse Event|1
4525250|NCT01021852|7341048|FG002|Treatment Period 1|Adverse Event|1
4525251|NCT01021852|7341049|FG003|Treatment Period 1|Adverse Event|0
4525252|NCT01021852|7341050|FG004|Treatment Period 1|Adverse Event|2
4525253|NCT01021852|7341051|FG005|Treatment Period 1|Adverse Event|2
4525254|NCT01021852|7341052|FG006|Treatment Period 1|Adverse Event|0
4525255|NCT01021852|7341053|FG007|Treatment Period 1|Adverse Event|0
4525256|NCT01021852|7341046|FG000|Treatment Period 1|Pregnancy|0
4525257|NCT01021852|7341047|FG001|Treatment Period 1|Pregnancy|0
4525258|NCT01021852|7341048|FG002|Treatment Period 1|Pregnancy|1
4525259|NCT01021852|7341049|FG003|Treatment Period 1|Pregnancy|0
4525260|NCT01021852|7341050|FG004|Treatment Period 1|Pregnancy|0
4525261|NCT01021852|7341051|FG005|Treatment Period 1|Pregnancy|0
4525262|NCT01021852|7341052|FG006|Treatment Period 1|Pregnancy|0
4525263|NCT01021852|7341053|FG007|Treatment Period 1|Pregnancy|0
4525264|NCT01021852|7341046|FG000|Treatment Period 1|Withdrawal by Subject|0
4525265|NCT01021852|7341047|FG001|Treatment Period 1|Withdrawal by Subject|0
4525266|NCT01021852|7341048|FG002|Treatment Period 1|Withdrawal by Subject|0
4525267|NCT01021852|7341049|FG003|Treatment Period 1|Withdrawal by Subject|0
4525268|NCT01021852|7341050|FG004|Treatment Period 1|Withdrawal by Subject|1
4525269|NCT01021852|7341051|FG005|Treatment Period 1|Withdrawal by Subject|0
4525270|NCT01021852|7341052|FG006|Treatment Period 1|Withdrawal by Subject|0
4525271|NCT01021852|7341053|FG007|Treatment Period 1|Withdrawal by Subject|1
4525272|NCT01021852|7341046|FG000|Treatment Period 1|Not Treated|0
4525273|NCT01021852|7341047|FG001|Treatment Period 1|Not Treated|0
4525274|NCT01021852|7341048|FG002|Treatment Period 1|Not Treated|0
4525275|NCT01021852|7341049|FG003|Treatment Period 1|Not Treated|2
4525276|NCT01021852|7341050|FG004|Treatment Period 1|Not Treated|0
4525277|NCT01021852|7341051|FG005|Treatment Period 1|Not Treated|0
4525278|NCT01021852|7341052|FG006|Treatment Period 1|Not Treated|0
4525279|NCT01021852|7341053|FG007|Treatment Period 1|Not Treated|0
4525280|NCT01021852|7341046|FG000|Washout Period-Placebo|Adverse Event|0
4525281|NCT01021852|7341047|FG001|Washout Period-Placebo|Adverse Event|0
4525282|NCT01021852|7341048|FG002|Washout Period-Placebo|Adverse Event|0
4525283|NCT01021852|7341049|FG003|Washout Period-Placebo|Adverse Event|1
4525284|NCT01021852|7341050|FG004|Washout Period-Placebo|Adverse Event|0
4525285|NCT01021852|7341051|FG005|Washout Period-Placebo|Adverse Event|1
4525286|NCT01021852|7341052|FG006|Washout Period-Placebo|Adverse Event|0
4525287|NCT01021852|7341053|FG007|Washout Period-Placebo|Adverse Event|0
4525288|NCT01021852|7341046|FG000|Washout Period-Placebo|Lost to Follow-up|0
4525289|NCT01021852|7341047|FG001|Washout Period-Placebo|Lost to Follow-up|0
4525290|NCT01021852|7341048|FG002|Washout Period-Placebo|Lost to Follow-up|0
4525291|NCT01021852|7341049|FG003|Washout Period-Placebo|Lost to Follow-up|0
4525292|NCT01021852|7341050|FG004|Washout Period-Placebo|Lost to Follow-up|1
4525293|NCT01021852|7341051|FG005|Washout Period-Placebo|Lost to Follow-up|0
4525294|NCT01021852|7341052|FG006|Washout Period-Placebo|Lost to Follow-up|0
4525295|NCT01021852|7341053|FG007|Washout Period-Placebo|Lost to Follow-up|0
4525296|NCT01021852|7341046|FG000|Washout Period-Placebo|Protocol Violation|0
4525297|NCT01021852|7341047|FG001|Washout Period-Placebo|Protocol Violation|0
4525298|NCT01021852|7341048|FG002|Washout Period-Placebo|Protocol Violation|0
4525299|NCT01021852|7341049|FG003|Washout Period-Placebo|Protocol Violation|0
4525300|NCT01021852|7341050|FG004|Washout Period-Placebo|Protocol Violation|0
4525301|NCT01021852|7341051|FG005|Washout Period-Placebo|Protocol Violation|0
4742888|NCT03851094|7703805|FG001|Overall Study|Withdrawal by Subject|1
4742889|NCT03851094|7703804|FG000|Overall Study|Participant lost device|0
4742890|NCT03851094|7703805|FG001|Overall Study|Participant lost device|1
4742891|NCT03851094|7703804|FG000|Overall Study|Participant returned device|0
4742892|NCT03851094|7703805|FG001|Overall Study|Participant returned device|2
4742893|NCT03868631|7703828|FG000|Baseline to Week 6|Adverse Event|0
4742894|NCT03868631|7703829|FG001|Baseline to Week 6|Adverse Event|3
4742895|NCT03868631|7703828|FG000|Baseline to Week 6|Protocol Violation|1
4742896|NCT03868631|7703829|FG001|Baseline to Week 6|Protocol Violation|1
4742897|NCT03868631|7703828|FG000|Baseline to Week 6|Withdrawal by Subject|3
4742898|NCT03868631|7703829|FG001|Baseline to Week 6|Withdrawal by Subject|0
4742899|NCT03868631|7703828|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2
4742900|NCT03868631|7703829|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0
4742901|NCT03868631|7703828|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1
4742902|NCT03868631|7703829|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0
4742903|NCT03868631|7703828|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1
4742904|NCT03868631|7703829|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1
4742905|NCT03865953|7703837|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2
4742906|NCT03865953|7703838|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0
4742907|NCT03865953|7703837|FG000|First Intervention (4 Weeks)|Protocol Violation|0
4742908|NCT03865953|7703838|FG001|First Intervention (4 Weeks)|Protocol Violation|1
4742909|NCT03865953|7703837|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0
4742910|NCT03865953|7703838|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2
4742911|NCT03865381|7703844|FG000|Overall Study|Protocol Violation/Non-Compliance|3
4742912|NCT03865381|7703844|FG000|Overall Study|Withdrawal by Subject|2
4742913|NCT03868059|7703872|FG000|Overall Study|Adverse Event|3
4742914|NCT03868059|7703872|FG000|Overall Study|Lost to Follow-up|3
4742915|NCT03868059|7703872|FG000|Overall Study|Withdrawal by Subject|6
4742916|NCT03865407|7703887|FG000|Overall Study|Adverse Event|1
4742917|NCT03865407|7703888|FG001|Overall Study|Adverse Event|0
4742918|NCT03865407|7703887|FG000|Overall Study|Withdrawal by Subject|1
4742919|NCT03865407|7703888|FG001|Overall Study|Withdrawal by Subject|0
4742920|NCT03865407|7703887|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1
4742921|NCT03865407|7703888|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0
4742922|NCT03864653|7703907|FG000|Overall Study|Withdrawal by Subject|1
4742923|NCT03853213|7703924|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1
4742924|NCT03853213|7703925|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0
4742925|NCT03853213|7703924|FG000|Overall Study|Other (e.g., too busy)|0
4742926|NCT03853213|7703925|FG001|Overall Study|Other (e.g., too busy)|2
4742927|NCT03847610|7703931|FG000|Overall Study|Withdrawal by Subject|1
4742928|NCT03850093|7703938|FG000|Overall Study|Withdrawal by Subject|1
4742929|NCT03850093|7703939|FG001|Overall Study|Withdrawal by Subject|0
4742930|NCT03850093|7703940|FG002|Overall Study|Withdrawal by Subject|2
4742931|NCT03861936|7704021|FG000|Overall Study|Withdrawal by Subject|4
4742932|NCT03861936|7704022|FG001|Overall Study|Withdrawal by Subject|1
4742933|NCT03861936|7704023|FG002|Overall Study|Withdrawal by Subject|3
4742934|NCT03861936|7704021|FG000|Overall Study|Lost to Follow-up|5
4742935|NCT03861936|7704022|FG001|Overall Study|Lost to Follow-up|3
4742936|NCT03861936|7704023|FG002|Overall Study|Lost to Follow-up|3
4742937|NCT03861936|7704021|FG000|Overall Study|Physician Decision|0
4742938|NCT03861936|7704022|FG001|Overall Study|Physician Decision|1
4742939|NCT03861936|7704023|FG002|Overall Study|Physician Decision|0
4742940|NCT03861936|7704021|FG000|Overall Study|Protocol Deviation|0
4742941|NCT03861936|7704022|FG001|Overall Study|Protocol Deviation|0
4742942|NCT03861936|7704023|FG002|Overall Study|Protocol Deviation|1
4742943|NCT03861936|7704021|FG000|Overall Study|Reason not Specified|5
4742944|NCT03861936|7704022|FG001|Overall Study|Reason not Specified|5
4742945|NCT03861936|7704023|FG002|Overall Study|Reason not Specified|3
4742946|NCT03850509|7704063|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2
4742947|NCT03850509|7704064|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1
4742948|NCT03851016|7704149|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1
4742949|NCT03851016|7704150|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2
4742950|NCT03850496|7704159|FG000|Overall Study|Withdrawal by Subject|1
4742951|NCT03850496|7704160|FG001|Overall Study|Withdrawal by Subject|0
4742952|NCT03850496|7704161|FG002|Overall Study|Withdrawal by Subject|0
4742953|NCT03850496|7704159|FG000|Overall Study|Lost to Follow-up|0
4742954|NCT03850496|7704160|FG001|Overall Study|Lost to Follow-up|1
4742955|NCT03850496|7704161|FG002|Overall Study|Lost to Follow-up|4
4742956|NCT03848949|7704171|FG000|Overall Study|Lost to Follow-up|5
4742957|NCT03848949|7704172|FG001|Overall Study|Lost to Follow-up|7
4742958|NCT03844945|7704200|FG000|Overall Study|Adverse Event|1
4742959|NCT03844945|7704201|FG001|Overall Study|Adverse Event|1
4742960|NCT03844945|7704202|FG002|Overall Study|Adverse Event|4
4742961|NCT03844945|7704203|FG003|Overall Study|Adverse Event|0
4742962|NCT03844945|7704200|FG000|Overall Study|Withdrawal by Subject|0
4742963|NCT03844945|7704201|FG001|Overall Study|Withdrawal by Subject|0
4634146|NCT01920568|7504781|FG000|Overall Study|Protocol Violation|5
4634147|NCT01920568|7504782|FG001|Overall Study|Protocol Violation|3
4525302|NCT01021852|7341052|FG006|Washout Period-Placebo|Protocol Violation|1
4525303|NCT01021852|7341053|FG007|Washout Period-Placebo|Protocol Violation|0
4525304|NCT01021852|7341046|FG000|Washout Period-No Drug|Adverse Event|1
4525305|NCT01021852|7341047|FG001|Washout Period-No Drug|Adverse Event|0
4525306|NCT01021852|7341048|FG002|Washout Period-No Drug|Adverse Event|0
4525307|NCT01021852|7341049|FG003|Washout Period-No Drug|Adverse Event|0
4525308|NCT01021852|7341050|FG004|Washout Period-No Drug|Adverse Event|0
4525309|NCT01021852|7341051|FG005|Washout Period-No Drug|Adverse Event|1
4525310|NCT01021852|7341052|FG006|Washout Period-No Drug|Adverse Event|0
4525311|NCT01021852|7341053|FG007|Washout Period-No Drug|Adverse Event|0
4525312|NCT01021852|7341046|FG000|Treatment Period 2|Adverse Event|0
4525313|NCT01021852|7341047|FG001|Treatment Period 2|Adverse Event|1
4525314|NCT01021852|7341048|FG002|Treatment Period 2|Adverse Event|0
4525315|NCT01021852|7341049|FG003|Treatment Period 2|Adverse Event|0
4525316|NCT01021852|7341050|FG004|Treatment Period 2|Adverse Event|1
4634148|NCT01920568|7504781|FG000|Overall Study|Lost to Follow-up|2
4634149|NCT01920568|7504782|FG001|Overall Study|Lost to Follow-up|2
4525317|NCT01021852|7341051|FG005|Treatment Period 2|Adverse Event|0
4525318|NCT01021852|7341052|FG006|Treatment Period 2|Adverse Event|1
4525319|NCT01021852|7341053|FG007|Treatment Period 2|Adverse Event|0
4634150|NCT01920568|7504781|FG000|Overall Study|Physician Decision|13
4742964|NCT03844945|7704202|FG002|Overall Study|Withdrawal by Subject|1
4742965|NCT03844945|7704203|FG003|Overall Study|Withdrawal by Subject|0
4742966|NCT03844945|7704200|FG000|Overall Study|Lack of Efficacy|0
4742967|NCT03844945|7704201|FG001|Overall Study|Lack of Efficacy|0
4742968|NCT03844945|7704202|FG002|Overall Study|Lack of Efficacy|0
4742969|NCT03844945|7704203|FG003|Overall Study|Lack of Efficacy|1
4742970|NCT03843632|7704226|FG000|Overall Study|Withdrawal by Subject|1
4742971|NCT03843632|7704227|FG001|Overall Study|Withdrawal by Subject|0
4742972|NCT03843632|7704228|FG002|Overall Study|Withdrawal by Subject|0
4742973|NCT03843632|7704229|FG003|Overall Study|Withdrawal by Subject|0
4742974|NCT03840811|7704242|FG000|Overall Study|Lost to Follow-up|0
4742975|NCT03840811|7704243|FG001|Overall Study|Lost to Follow-up|0
4742976|NCT03840811|7704244|FG002|Overall Study|Lost to Follow-up|1
4742977|NCT03837028|7704256|FG000|Overall Study|Lost to Follow-up|4
4742978|NCT03837028|7704257|FG001|Overall Study|Lost to Follow-up|0
4742979|NCT03837028|7704258|FG002|Overall Study|Lost to Follow-up|2
4742980|NCT03837028|7704259|FG003|Overall Study|Lost to Follow-up|0
4742981|NCT03837028|7704256|FG000|Overall Study|Withdrawal by Subject|12
4742982|NCT03837028|7704257|FG001|Overall Study|Withdrawal by Subject|11
4742983|NCT03837028|7704258|FG002|Overall Study|Withdrawal by Subject|11
4742984|NCT03837028|7704259|FG003|Overall Study|Withdrawal by Subject|7
4742985|NCT03841331|7704302|FG000|Overall Study|Withdrawal by Subject|4
4742986|NCT03841331|7704303|FG001|Overall Study|Withdrawal by Subject|9
4742987|NCT03841331|7704302|FG000|Overall Study|Lost to Follow-up|5
4742988|NCT03841331|7704303|FG001|Overall Study|Lost to Follow-up|1
4742989|NCT03840135|7704318|FG000|Overall Study|Protocol Violation|6
4742990|NCT03840135|7704319|FG001|Overall Study|Protocol Violation|1
4742991|NCT03840135|7704318|FG000|Overall Study|Withdrawal by Subject|1
4742992|NCT03840135|7704319|FG001|Overall Study|Withdrawal by Subject|0
4742993|NCT03839641|7704331|FG000|Overall Study|Withdrawal by Subject|1
4742994|NCT03839641|7704332|FG001|Overall Study|Withdrawal by Subject|1
4742995|NCT03839212|7704340|FG000|Overall Study|COVID-19 related suspension of research activities.|4
4742996|NCT03839355|7704346|FG000|Overall Study|Withdrawal by Subject|1
4742997|NCT03839355|7704347|FG001|Overall Study|Withdrawal by Subject|0
4742998|NCT03838731|7704364|FG000|Overall Study|Pregnancy|0
4742999|NCT03838731|7704365|FG001|Overall Study|Pregnancy|1
4743000|NCT03838731|7704364|FG000|Overall Study|Withdrawal of consent|1
4743001|NCT03838731|7704365|FG001|Overall Study|Withdrawal of consent|0
4743002|NCT03838198|7704373|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0
4743003|NCT03838198|7704374|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0
4743004|NCT03838198|7704375|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1
4743005|NCT03838198|7704376|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0
4743006|NCT03838198|7704373|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0
4743007|NCT03838198|7704374|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22
4743008|NCT03838198|7704375|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0
4743009|NCT03838198|7704376|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22
4743010|NCT03836677|7704495|FG000|Period 1|Adverse Event|0
4743011|NCT03836677|7704496|FG001|Period 1|Adverse Event|1
4743012|NCT03836677|7704495|FG000|Period 2|Severe non-compliance to protocol|1
4743013|NCT03836677|7704496|FG001|Period 2|Severe non-compliance to protocol|0
4743014|NCT03827564|7704516|FG000|Overall Study|Discontinued due to Study Termination|1
4743015|NCT03827564|7704517|FG001|Overall Study|Discontinued due to Study Termination|0
4743016|NCT03824236|7704526|FG000|Overall Study|Lost to Follow-up|0
4743017|NCT03824236|7704527|FG001|Overall Study|Lost to Follow-up|0
4743018|NCT03824236|7704528|FG002|Overall Study|Lost to Follow-up|1
4743019|NCT03810235|7704549|FG000|Overall Study|Withdrawal by Subject|2
4743020|NCT03810235|7704550|FG001|Overall Study|Withdrawal by Subject|0
4743021|NCT03836664|7704569|FG000|Overall Study|Didn't complete forms and lost drug|3
4743022|NCT03836664|7704570|FG001|Overall Study|Didn't complete forms and lost drug|3
4743023|NCT03832738|7704583|FG000|Overall Study|Withdrawal by Subject|6
4743024|NCT03832738|7704584|FG001|Overall Study|Withdrawal by Subject|7
4743025|NCT03832738|7704585|FG002|Overall Study|Withdrawal by Subject|16
4743026|NCT03832738|7704583|FG000|Overall Study|Physician Decision|0
4743027|NCT03832738|7704584|FG001|Overall Study|Physician Decision|1
4743028|NCT03832738|7704585|FG002|Overall Study|Physician Decision|2
4743029|NCT03832738|7704583|FG000|Overall Study|Adverse Event|2
4743030|NCT03832738|7704584|FG001|Overall Study|Adverse Event|3
4743031|NCT03832738|7704585|FG002|Overall Study|Adverse Event|1
4743032|NCT03832738|7704583|FG000|Overall Study|Pregnancy|0
4743033|NCT03832738|7704584|FG001|Overall Study|Pregnancy|1
4743034|NCT03832738|7704585|FG002|Overall Study|Pregnancy|0
4743035|NCT03823391|7704595|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1
4743036|NCT03823391|7704596|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1
4743037|NCT03823391|7704595|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1
4743038|NCT03823391|7704596|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0
4743039|NCT03808298|7704618|FG000|Overall Study|Adverse Event|3
4743040|NCT03808298|7704618|FG000|Overall Study|Physician Decision|1
4743041|NCT03808298|7704618|FG000|Overall Study|Withdrawal by Subject|1
4743042|NCT03808298|7704618|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3
4743043|NCT03836729|7704647|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1
4743044|NCT03835975|7704660|FG000|Overall Study|Lost to Follow-up|1
4743045|NCT03835975|7704661|FG001|Overall Study|Lost to Follow-up|1
4743046|NCT03835975|7704662|FG002|Overall Study|Lost to Follow-up|0
4743047|NCT03835975|7704663|FG003|Overall Study|Lost to Follow-up|0
4743048|NCT03835975|7704664|FG004|Overall Study|Lost to Follow-up|0
4743049|NCT03835975|7704660|FG000|Overall Study|No longer met eligibility criteria|0
4743050|NCT03835975|7704661|FG001|Overall Study|No longer met eligibility criteria|1
4743051|NCT03835975|7704662|FG002|Overall Study|No longer met eligibility criteria|0
4743052|NCT03835975|7704663|FG003|Overall Study|No longer met eligibility criteria|0
4743053|NCT03835975|7704664|FG004|Overall Study|No longer met eligibility criteria|0
4743054|NCT03835975|7704660|FG000|Overall Study|Protocol Violation|1
4743055|NCT03835975|7704661|FG001|Overall Study|Protocol Violation|1
4743056|NCT03835975|7704662|FG002|Overall Study|Protocol Violation|2
4743057|NCT03835975|7704663|FG003|Overall Study|Protocol Violation|0
4743058|NCT03835975|7704664|FG004|Overall Study|Protocol Violation|0
4743059|NCT03835975|7704660|FG000|Overall Study|Withdrawal by Subject|1
4743060|NCT03835975|7704661|FG001|Overall Study|Withdrawal by Subject|0
4743061|NCT03835975|7704662|FG002|Overall Study|Withdrawal by Subject|1
4743062|NCT03835975|7704663|FG003|Overall Study|Withdrawal by Subject|1
4743063|NCT03835975|7704664|FG004|Overall Study|Withdrawal by Subject|0
4743064|NCT03835221|7704719|FG000|Methafilcon A|Withdrawal by Subject|1
4743065|NCT03819634|7704725|FG000|Overall Study|Physician Decision|2
4743066|NCT03812679|7704729|FG000|Overall Study|Adverse Event|2
4743067|NCT03812679|7704729|FG000|Overall Study|Missed >4 consecutive therapy days|1
4743068|NCT03812679|7704729|FG000|Overall Study|Renal transplant|1
4743069|NCT03812679|7704729|FG000|Overall Study|Withdrawal by Subject|1
4743070|NCT03812679|7704729|FG000|Overall Study|Termination of study|2
4743071|NCT03812679|7704729|FG000|Overall Study|Water device replacement|1
4743072|NCT03801148|7704784|FG000|Period 1 (2 Days)|Adverse Event|1
4743073|NCT03801148|7704785|FG001|Period 1 (2 Days)|Adverse Event|1
4743074|NCT03801148|7704786|FG002|Period 1 (2 Days)|Adverse Event|0
4743075|NCT03801148|7704787|FG003|Period 1 (2 Days)|Adverse Event|0
4743076|NCT03801148|7704784|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0
4743077|NCT03801148|7704785|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0
4743078|NCT03801148|7704786|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0
4743079|NCT03801148|7704787|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1
4743080|NCT03801148|7704784|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
4743081|NCT03801148|7704785|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
4743082|NCT03801148|7704786|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1
4743083|NCT03801148|7704787|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
4743084|NCT03801148|7704784|FG000|Follow-Up (12 Days)|Lost to Follow-up|0
4743085|NCT03801148|7704785|FG001|Follow-Up (12 Days)|Lost to Follow-up|1
4743086|NCT03801148|7704786|FG002|Follow-Up (12 Days)|Lost to Follow-up|1
4743087|NCT03801148|7704787|FG003|Follow-Up (12 Days)|Lost to Follow-up|0
4743088|NCT03832322|7704803|FG000|Overall Study|Failed cecal intubation in 2nd exam|3
4743089|NCT03832322|7704804|FG001|Overall Study|Failed cecal intubation in 2nd exam|1
4743090|NCT03832387|7704814|FG000|Overall Study|Protocol Violation|2
4743091|NCT03832387|7704815|FG001|Overall Study|Protocol Violation|6
4743092|NCT03832387|7704814|FG000|Overall Study|EXCLUSION CRITERIA|3
4743093|NCT03832387|7704815|FG001|Overall Study|EXCLUSION CRITERIA|1
4743094|NCT03807739|7704838|FG000|Overall Study|Adverse Event|1
4743095|NCT03807739|7704839|FG001|Overall Study|Adverse Event|0
4743096|NCT03807739|7704840|FG002|Overall Study|Adverse Event|0
4743097|NCT03807739|7704841|FG003|Overall Study|Adverse Event|0
4743098|NCT03807739|7704838|FG000|Overall Study|Withdrawal by Subject|1
4743099|NCT03807739|7704839|FG001|Overall Study|Withdrawal by Subject|0
4743100|NCT03807739|7704840|FG002|Overall Study|Withdrawal by Subject|0
4743101|NCT03807739|7704841|FG003|Overall Study|Withdrawal by Subject|0
4743102|NCT03831282|7704851|FG000|Overall Study|Could not place sensor|1
4743103|NCT03824912|7704858|FG000|Overall Study|Lost to Follow-up|18
4743104|NCT03824912|7704859|FG001|Overall Study|Lost to Follow-up|15
4743105|NCT03824912|7704860|FG002|Overall Study|Lost to Follow-up|8
4743106|NCT03824912|7704858|FG000|Overall Study|Negative Baseline Culture Result|118
4743107|NCT03824912|7704859|FG001|Overall Study|Negative Baseline Culture Result|112
4743108|NCT03824912|7704860|FG002|Overall Study|Negative Baseline Culture Result|57
4743109|NCT03824912|7704858|FG000|Overall Study|Non-Compliance with Study Drug|0
4743110|NCT03824912|7704859|FG001|Overall Study|Non-Compliance with Study Drug|0
4743111|NCT03824912|7704860|FG002|Overall Study|Non-Compliance with Study Drug|1
4743112|NCT03824912|7704858|FG000|Overall Study|Protocol Violation|1
4743113|NCT03824912|7704859|FG001|Overall Study|Protocol Violation|4
4743114|NCT03824912|7704860|FG002|Overall Study|Protocol Violation|1
4743115|NCT03824912|7704858|FG000|Overall Study|Withdrawal by Subject|3
4743116|NCT03824912|7704859|FG001|Overall Study|Withdrawal by Subject|2
4743117|NCT03824912|7704860|FG002|Overall Study|Withdrawal by Subject|1
4743118|NCT03824912|7704858|FG000|Overall Study|Participation in another study|0
4743119|NCT03824912|7704859|FG001|Overall Study|Participation in another study|1
4743120|NCT03824912|7704860|FG002|Overall Study|Participation in another study|0
4743121|NCT03822884|7704874|FG000|Overall Study|Withdrawal by Subject|0
4743122|NCT03822884|7704875|FG001|Overall Study|Withdrawal by Subject|0
4743123|NCT03822884|7704876|FG002|Overall Study|Withdrawal by Subject|0
4743124|NCT03822884|7704877|FG003|Overall Study|Withdrawal by Subject|0
4743125|NCT03822884|7704878|FG004|Overall Study|Withdrawal by Subject|1
4743126|NCT03822884|7704879|FG005|Overall Study|Withdrawal by Subject|0
4743127|NCT03810014|7704895|FG000|Overall Study|Pregnancy|2
4743128|NCT03810014|7704896|FG001|Overall Study|Pregnancy|2
4743129|NCT03810014|7704897|FG002|Overall Study|Pregnancy|0
4743130|NCT03810014|7704898|FG003|Overall Study|Pregnancy|2
4743131|NCT03830892|7704923|FG000|Overall Study|Physician Decision|2
4743132|NCT03830892|7704924|FG001|Overall Study|Physician Decision|3
4743133|NCT03830892|7704923|FG000|Overall Study|Study terminated due to COVID|4
4743134|NCT03830892|7704924|FG001|Overall Study|Study terminated due to COVID|0
4743135|NCT03830892|7704923|FG000|Overall Study|Protocol Violation|0
4743136|NCT03830892|7704924|FG001|Overall Study|Protocol Violation|1
4743137|NCT03830892|7704923|FG000|Overall Study|Withdrawal by Subject|0
4743138|NCT03830892|7704924|FG001|Overall Study|Withdrawal by Subject|2
4743139|NCT03825042|7704936|FG000|Overall Study|Adverse Event|1
4743140|NCT03825042|7704937|FG001|Overall Study|Adverse Event|0
4743141|NCT03825042|7704936|FG000|Overall Study|Withdrawal by Subject|1
4743142|NCT03825042|7704937|FG001|Overall Study|Withdrawal by Subject|0
4743143|NCT03823378|7704949|FG000|Overall Study|Adverse Event|2
4743144|NCT03823378|7704950|FG001|Overall Study|Adverse Event|2
4743145|NCT03823378|7704951|FG002|Overall Study|Adverse Event|0
4743146|NCT03823378|7704952|FG003|Overall Study|Adverse Event|0
4743147|NCT03823378|7704953|FG004|Overall Study|Adverse Event|0
4743148|NCT03823378|7704954|FG005|Overall Study|Adverse Event|0
4743149|NCT03823378|7704949|FG000|Overall Study|Lost to Follow-up|0
4743150|NCT03823378|7704950|FG001|Overall Study|Lost to Follow-up|1
4743151|NCT03823378|7704951|FG002|Overall Study|Lost to Follow-up|0
4743152|NCT03823378|7704952|FG003|Overall Study|Lost to Follow-up|0
4743153|NCT03823378|7704953|FG004|Overall Study|Lost to Follow-up|1
4743154|NCT03823378|7704954|FG005|Overall Study|Lost to Follow-up|0
4743155|NCT03823378|7704949|FG000|Overall Study|Withdrawal by Subject|0
4743156|NCT03823378|7704950|FG001|Overall Study|Withdrawal by Subject|1
4743157|NCT03823378|7704951|FG002|Overall Study|Withdrawal by Subject|4
4743158|NCT03823378|7704952|FG003|Overall Study|Withdrawal by Subject|2
4743159|NCT03823378|7704953|FG004|Overall Study|Withdrawal by Subject|0
4743160|NCT03823378|7704954|FG005|Overall Study|Withdrawal by Subject|1
4743161|NCT03823378|7704949|FG000|Overall Study|Other, not specified|19
4743162|NCT03823378|7704950|FG001|Overall Study|Other, not specified|12
4743163|NCT03823378|7704951|FG002|Overall Study|Other, not specified|6
4743164|NCT03823378|7704952|FG003|Overall Study|Other, not specified|8
4743165|NCT03823378|7704953|FG004|Overall Study|Other, not specified|17
4743166|NCT03823378|7704954|FG005|Overall Study|Other, not specified|7
4743167|NCT03831191|7704972|FG000|Induction Period (16 Weeks)|Adverse Event|2
4743168|NCT03831191|7704973|FG001|Induction Period (16 Weeks)|Adverse Event|1
4743169|NCT03831191|7704974|FG002|Induction Period (16 Weeks)|Adverse Event|3
4743170|NCT03831191|7704975|FG003|Induction Period (16 Weeks)|Adverse Event|4
4743171|NCT03831191|7704976|FG004|Induction Period (16 Weeks)|Adverse Event|0
4743172|NCT03831191|7704977|FG005|Induction Period (16 Weeks)|Adverse Event|0
4743173|NCT03831191|7704978|FG006|Induction Period (16 Weeks)|Adverse Event|0
4743174|NCT03831191|7704979|FG007|Induction Period (16 Weeks)|Adverse Event|0
4743175|NCT03831191|7704980|FG008|Induction Period (16 Weeks)|Adverse Event|0
4743176|NCT03831191|7704981|FG009|Induction Period (16 Weeks)|Adverse Event|0
4743177|NCT03831191|7704982|FG010|Induction Period (16 Weeks)|Adverse Event|0
4743178|NCT03831191|7704983|FG011|Induction Period (16 Weeks)|Adverse Event|0
4743179|NCT03831191|7704984|FG012|Induction Period (16 Weeks)|Adverse Event|0
4743180|NCT03831191|7704985|FG013|Induction Period (16 Weeks)|Adverse Event|0
4743181|NCT03831191|7704986|FG014|Induction Period (16 Weeks)|Adverse Event|0
4743182|NCT03831191|7704972|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2
4743183|NCT03831191|7704973|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3
4743184|NCT03831191|7704974|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0
4743185|NCT03831191|7704975|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0
4743186|NCT03831191|7704976|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0
4743187|NCT03831191|7704977|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0
4743188|NCT03831191|7704978|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0
4743189|NCT03831191|7704979|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0
4525320|NCT01021852|7341046|FG000|Treatment Period 2|Lack of Efficacy|0
4525321|NCT01021852|7341047|FG001|Treatment Period 2|Lack of Efficacy|0
4525322|NCT01021852|7341048|FG002|Treatment Period 2|Lack of Efficacy|0
4525323|NCT01021852|7341049|FG003|Treatment Period 2|Lack of Efficacy|0
4525324|NCT01021852|7341050|FG004|Treatment Period 2|Lack of Efficacy|0
4525325|NCT01021852|7341051|FG005|Treatment Period 2|Lack of Efficacy|1
4525326|NCT01021852|7341052|FG006|Treatment Period 2|Lack of Efficacy|0
4525327|NCT01021852|7341053|FG007|Treatment Period 2|Lack of Efficacy|0
4525328|NCT01021852|7341046|FG000|Treatment Period 2|Physician Decision|0
4525329|NCT01021852|7341047|FG001|Treatment Period 2|Physician Decision|0
4525330|NCT01021852|7341048|FG002|Treatment Period 2|Physician Decision|1
4525331|NCT01021852|7341049|FG003|Treatment Period 2|Physician Decision|0
4525332|NCT01021852|7341050|FG004|Treatment Period 2|Physician Decision|0
4525333|NCT01021852|7341051|FG005|Treatment Period 2|Physician Decision|0
4525334|NCT01021852|7341052|FG006|Treatment Period 2|Physician Decision|0
4525335|NCT01021852|7341053|FG007|Treatment Period 2|Physician Decision|0
4525336|NCT01021852|7341046|FG000|Treatment Period 2|Protocol Violation|0
4525337|NCT01021852|7341047|FG001|Treatment Period 2|Protocol Violation|0
4525338|NCT01021852|7341048|FG002|Treatment Period 2|Protocol Violation|0
4525339|NCT01021852|7341049|FG003|Treatment Period 2|Protocol Violation|0
4525340|NCT01021852|7341050|FG004|Treatment Period 2|Protocol Violation|1
4525341|NCT01021852|7341051|FG005|Treatment Period 2|Protocol Violation|0
4525342|NCT01021852|7341052|FG006|Treatment Period 2|Protocol Violation|1
4525343|NCT01021852|7341053|FG007|Treatment Period 2|Protocol Violation|0
4525344|NCT01021852|7341046|FG000|Treatment Period 2|Withdrawal by Subject|0
4525345|NCT01021852|7341047|FG001|Treatment Period 2|Withdrawal by Subject|0
4525346|NCT01021852|7341048|FG002|Treatment Period 2|Withdrawal by Subject|0
4525347|NCT01021852|7341049|FG003|Treatment Period 2|Withdrawal by Subject|0
4525348|NCT01021852|7341050|FG004|Treatment Period 2|Withdrawal by Subject|0
4525349|NCT01021852|7341051|FG005|Treatment Period 2|Withdrawal by Subject|0
4525350|NCT01021852|7341052|FG006|Treatment Period 2|Withdrawal by Subject|1
4525351|NCT01021852|7341053|FG007|Treatment Period 2|Withdrawal by Subject|2
4525352|NCT01021878|7341069|FG000|Overall Study|Lost to Follow-up|4
4525353|NCT01021878|7341070|FG001|Overall Study|Lost to Follow-up|3
4525354|NCT01021878|7341069|FG000|Overall Study|Death|0
4525355|NCT01021878|7341070|FG001|Overall Study|Death|1
4525356|NCT01021878|7341069|FG000|Overall Study|Adverse Event|6
4525357|NCT01021878|7341070|FG001|Overall Study|Adverse Event|5
4525358|NCT01021878|7341069|FG000|Overall Study|Transplantation|6
4525359|NCT01021878|7341070|FG001|Overall Study|Transplantation|1
4525360|NCT01022112|7341111|FG000|Overall Study|Adverse Event|1
4525361|NCT01022112|7341112|FG001|Overall Study|Adverse Event|2
4525362|NCT01022112|7341113|FG002|Overall Study|Adverse Event|0
4525363|NCT01022112|7341114|FG003|Overall Study|Adverse Event|1
4525364|NCT01022112|7341115|FG004|Overall Study|Adverse Event|0
4525365|NCT01022112|7341111|FG000|Overall Study|Lack of Efficacy|1
4525366|NCT01022112|7341112|FG001|Overall Study|Lack of Efficacy|0
4525367|NCT01022112|7341113|FG002|Overall Study|Lack of Efficacy|0
4525368|NCT01022112|7341114|FG003|Overall Study|Lack of Efficacy|0
4525369|NCT01022112|7341115|FG004|Overall Study|Lack of Efficacy|1
4525370|NCT01022112|7341111|FG000|Overall Study|Physician Decision|0
4525371|NCT01022112|7341112|FG001|Overall Study|Physician Decision|0
4525372|NCT01022112|7341113|FG002|Overall Study|Physician Decision|1
4525373|NCT01022112|7341114|FG003|Overall Study|Physician Decision|0
4743190|NCT03831191|7704980|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0
4743191|NCT03831191|7704981|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0
4743192|NCT03831191|7704982|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0
4743193|NCT03831191|7704983|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0
4743194|NCT03831191|7704984|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0
4743195|NCT03831191|7704985|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0
4743196|NCT03831191|7704986|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0
4743197|NCT03831191|7704972|FG000|Induction Period (16 Weeks)|Pregnancy|0
4743198|NCT03831191|7704973|FG001|Induction Period (16 Weeks)|Pregnancy|0
4743199|NCT03831191|7704974|FG002|Induction Period (16 Weeks)|Pregnancy|1
4743200|NCT03831191|7704975|FG003|Induction Period (16 Weeks)|Pregnancy|0
4743201|NCT03831191|7704976|FG004|Induction Period (16 Weeks)|Pregnancy|0
4743202|NCT03831191|7704977|FG005|Induction Period (16 Weeks)|Pregnancy|0
4743203|NCT03831191|7704978|FG006|Induction Period (16 Weeks)|Pregnancy|0
4743204|NCT03831191|7704979|FG007|Induction Period (16 Weeks)|Pregnancy|0
4743205|NCT03831191|7704980|FG008|Induction Period (16 Weeks)|Pregnancy|0
4743206|NCT03831191|7704981|FG009|Induction Period (16 Weeks)|Pregnancy|0
4743207|NCT03831191|7704982|FG010|Induction Period (16 Weeks)|Pregnancy|0
4743208|NCT03831191|7704983|FG011|Induction Period (16 Weeks)|Pregnancy|0
4743209|NCT03831191|7704984|FG012|Induction Period (16 Weeks)|Pregnancy|0
4743210|NCT03831191|7704985|FG013|Induction Period (16 Weeks)|Pregnancy|0
4743211|NCT03831191|7704986|FG014|Induction Period (16 Weeks)|Pregnancy|0
4743212|NCT03831191|7704972|FG000|Induction Period (16 Weeks)|Protocol Violation|0
4743213|NCT03831191|7704973|FG001|Induction Period (16 Weeks)|Protocol Violation|0
4743214|NCT03831191|7704974|FG002|Induction Period (16 Weeks)|Protocol Violation|0
4743215|NCT03831191|7704975|FG003|Induction Period (16 Weeks)|Protocol Violation|2
4743216|NCT03831191|7704976|FG004|Induction Period (16 Weeks)|Protocol Violation|0
4743217|NCT03831191|7704977|FG005|Induction Period (16 Weeks)|Protocol Violation|0
4743218|NCT03831191|7704978|FG006|Induction Period (16 Weeks)|Protocol Violation|0
4743219|NCT03831191|7704979|FG007|Induction Period (16 Weeks)|Protocol Violation|0
4743220|NCT03831191|7704980|FG008|Induction Period (16 Weeks)|Protocol Violation|0
4743221|NCT03831191|7704981|FG009|Induction Period (16 Weeks)|Protocol Violation|0
4743222|NCT03831191|7704982|FG010|Induction Period (16 Weeks)|Protocol Violation|0
4743223|NCT03831191|7704983|FG011|Induction Period (16 Weeks)|Protocol Violation|0
4743224|NCT03831191|7704984|FG012|Induction Period (16 Weeks)|Protocol Violation|0
4743225|NCT03831191|7704985|FG013|Induction Period (16 Weeks)|Protocol Violation|0
4743226|NCT03831191|7704986|FG014|Induction Period (16 Weeks)|Protocol Violation|0
4743227|NCT03831191|7704972|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7
4743228|NCT03831191|7704973|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2
4743229|NCT03831191|7704974|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1
4743230|NCT03831191|7704975|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3
4743231|NCT03831191|7704976|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0
4743232|NCT03831191|7704977|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0
4743233|NCT03831191|7704978|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0
4743234|NCT03831191|7704979|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0
4743235|NCT03831191|7704980|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0
4743236|NCT03831191|7704981|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0
4743237|NCT03831191|7704982|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0
4743238|NCT03831191|7704983|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0
4743239|NCT03831191|7704984|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0
4743240|NCT03831191|7704985|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0
4743241|NCT03831191|7704986|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0
4743242|NCT03831191|7704972|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12
4743243|NCT03831191|7704973|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15
4743244|NCT03831191|7704974|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16
4743245|NCT03831191|7704975|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13
4743246|NCT03831191|7704976|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
4743247|NCT03831191|7704977|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
4743248|NCT03831191|7704978|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
4743249|NCT03831191|7704979|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
4743250|NCT03831191|7704980|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
4743251|NCT03831191|7704981|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
4743252|NCT03831191|7704982|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
4743253|NCT03831191|7704983|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
4743254|NCT03831191|7704984|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
4634151|NCT01920568|7504782|FG001|Overall Study|Physician Decision|4
4634152|NCT01920568|7504781|FG000|Overall Study|Withdrawal by Subject|79
4634153|NCT01920568|7504782|FG001|Overall Study|Withdrawal by Subject|55
4634154|NCT01920568|7504781|FG000|Overall Study|Death due to disease progression|25
4634155|NCT01920568|7504782|FG001|Overall Study|Death due to disease progression|12
4634156|NCT01920594|7504791|FG000|Overall Study|Adverse Event|4
4634157|NCT01920594|7504792|FG001|Overall Study|Adverse Event|2
4634158|NCT01920594|7504791|FG000|Overall Study|Lost to Follow-up|1
4634159|NCT01920594|7504792|FG001|Overall Study|Lost to Follow-up|0
4634160|NCT01920594|7504791|FG000|Overall Study|Recovery|2
4634161|NCT01920594|7504792|FG001|Overall Study|Recovery|0
4634162|NCT01920594|7504791|FG000|Overall Study|Investigator discretion|0
4634163|NCT01920594|7504792|FG001|Overall Study|Investigator discretion|1
4634164|NCT01920711|7504800|FG000|Overall Study|Death|347
4743255|NCT03831191|7704985|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
4743256|NCT03831191|7704986|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0
4743257|NCT03831191|7704972|FG000|Induction Period (16 Weeks)|Sponsor Decision|0
4743258|NCT03831191|7704973|FG001|Induction Period (16 Weeks)|Sponsor Decision|0
4743259|NCT03831191|7704974|FG002|Induction Period (16 Weeks)|Sponsor Decision|0
4743260|NCT03831191|7704975|FG003|Induction Period (16 Weeks)|Sponsor Decision|1
4743261|NCT03831191|7704976|FG004|Induction Period (16 Weeks)|Sponsor Decision|0
4743262|NCT03831191|7704977|FG005|Induction Period (16 Weeks)|Sponsor Decision|0
4743263|NCT03831191|7704978|FG006|Induction Period (16 Weeks)|Sponsor Decision|0
4743264|NCT03831191|7704979|FG007|Induction Period (16 Weeks)|Sponsor Decision|0
4743265|NCT03831191|7704980|FG008|Induction Period (16 Weeks)|Sponsor Decision|0
4743266|NCT03831191|7704981|FG009|Induction Period (16 Weeks)|Sponsor Decision|0
4743267|NCT03831191|7704982|FG010|Induction Period (16 Weeks)|Sponsor Decision|0
4743268|NCT03831191|7704983|FG011|Induction Period (16 Weeks)|Sponsor Decision|0
4743269|NCT03831191|7704984|FG012|Induction Period (16 Weeks)|Sponsor Decision|0
4743270|NCT03831191|7704985|FG013|Induction Period (16 Weeks)|Sponsor Decision|0
4743271|NCT03831191|7704986|FG014|Induction Period (16 Weeks)|Sponsor Decision|0
4743272|NCT03831191|7704972|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0
4743273|NCT03831191|7704973|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0
4743274|NCT03831191|7704974|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0
4743275|NCT03831191|7704975|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0
4743276|NCT03831191|7704976|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4
4743277|NCT03831191|7704977|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5
4743278|NCT03831191|7704978|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2
4743279|NCT03831191|7704979|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4
4743280|NCT03831191|7704980|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8
4743281|NCT03831191|7704981|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1
4743282|NCT03831191|7704982|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4
4743283|NCT03831191|7704983|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7
4743284|NCT03831191|7704984|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1
4743285|NCT03831191|7704985|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1
4743286|NCT03831191|7704986|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6
4743287|NCT03831191|7704972|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
4743288|NCT03831191|7704973|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
4743289|NCT03831191|7704974|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
4743290|NCT03831191|7704975|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
4743291|NCT03831191|7704976|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
4743292|NCT03831191|7704977|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
4743293|NCT03831191|7704978|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
4743294|NCT03831191|7704979|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
4743295|NCT03831191|7704980|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
4743296|NCT03831191|7704981|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
4743297|NCT03831191|7704982|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
4743298|NCT03831191|7704983|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
4743299|NCT03831191|7704984|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
4743300|NCT03831191|7704985|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
4743301|NCT03831191|7704986|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2
4743302|NCT03831191|7704972|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0
4743303|NCT03831191|7704973|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0
4743304|NCT03831191|7704974|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0
4743305|NCT03831191|7704975|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0
4743306|NCT03831191|7704976|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0
4743307|NCT03831191|7704977|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0
4743308|NCT03831191|7704978|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0
4743309|NCT03831191|7704979|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0
4743310|NCT03831191|7704980|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0
4743311|NCT03831191|7704981|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0
4743312|NCT03831191|7704982|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0
4743313|NCT03831191|7704983|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0
4743314|NCT03831191|7704984|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0
4743315|NCT03831191|7704985|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0
4743316|NCT03831191|7704986|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1
4743317|NCT03830281|7705021|FG000|Lead-in Period (2 Weeks)|Adverse Event|2
4743318|NCT03830281|7705022|FG001|Lead-in Period (2 Weeks)|Adverse Event|0
4743319|NCT03830281|7705021|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6
4743320|NCT03830281|7705022|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0
4743321|NCT03830281|7705021|FG000|Lead-in Period (2 Weeks)|Physician Decision|2
4743322|NCT03830281|7705022|FG001|Lead-in Period (2 Weeks)|Physician Decision|0
4743323|NCT03830281|7705021|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29
4743324|NCT03830281|7705022|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0
4743325|NCT03830281|7705021|FG000|Treatment Period (16 Weeks)|Adverse Event|1
4743326|NCT03830281|7705022|FG001|Treatment Period (16 Weeks)|Adverse Event|7
4743327|NCT03830281|7705021|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4
4743328|NCT03830281|7705022|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3
4743329|NCT03830281|7705021|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1
4743330|NCT03830281|7705022|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1
4743331|NCT03830281|7705021|FG000|Treatment Period (16 Weeks)|Physician Decision|1
4743332|NCT03830281|7705022|FG001|Treatment Period (16 Weeks)|Physician Decision|0
4743333|NCT03830281|7705021|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5
4743334|NCT03830281|7705022|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6
4743335|NCT03827395|7705038|FG000|Overall Study|Lost to Follow-up|1
4743336|NCT03827395|7705039|FG001|Overall Study|Lost to Follow-up|0
4743337|NCT03827395|7705038|FG000|Overall Study|Protocol Violation|1
4743338|NCT03827395|7705039|FG001|Overall Study|Protocol Violation|0
4743339|NCT03827395|7705038|FG000|Overall Study|Became ineligible after enrollment|1
4743340|NCT03827395|7705039|FG001|Overall Study|Became ineligible after enrollment|2
4743341|NCT03819218|7705045|FG000|Overall Study|Protocol Violation|1
4743342|NCT03828487|7705058|FG000|Overall Study|Physician Decision|1
4743343|NCT03828617|7705066|FG000|Overall Study|Lost to Follow-up|22
4743344|NCT03828617|7705067|FG001|Overall Study|Lost to Follow-up|12
4743345|NCT03828617|7705068|FG002|Overall Study|Lost to Follow-up|23
4743346|NCT03828617|7705069|FG003|Overall Study|Lost to Follow-up|7
4743347|NCT03828617|7705066|FG000|Overall Study|No longer met eligibility criteria|0
4743348|NCT03828617|7705067|FG001|Overall Study|No longer met eligibility criteria|1
4743349|NCT03828617|7705068|FG002|Overall Study|No longer met eligibility criteria|1
4743350|NCT03828617|7705069|FG003|Overall Study|No longer met eligibility criteria|3
4743351|NCT03828617|7705066|FG000|Overall Study|Protocol Violation|0
4743352|NCT03828617|7705067|FG001|Overall Study|Protocol Violation|2
4743353|NCT03828617|7705068|FG002|Overall Study|Protocol Violation|0
4743354|NCT03828617|7705069|FG003|Overall Study|Protocol Violation|0
4743355|NCT03828617|7705066|FG000|Overall Study|Withdrawal by Subject|2
4743356|NCT03828617|7705067|FG001|Overall Study|Withdrawal by Subject|0
4743357|NCT03828617|7705068|FG002|Overall Study|Withdrawal by Subject|2
4743358|NCT03828617|7705069|FG003|Overall Study|Withdrawal by Subject|0
4743359|NCT03828539|7705080|FG000|Overall Study|Adverse Event|3
4743360|NCT03828539|7705081|FG001|Overall Study|Adverse Event|12
4743361|NCT03828539|7705080|FG000|Overall Study|Patient's/guardian's decision|3
4743362|NCT03828539|7705081|FG001|Overall Study|Patient's/guardian's decision|5
4743363|NCT03828539|7705080|FG000|Overall Study|Lost to Follow-up|4
4743364|NCT03828539|7705081|FG001|Overall Study|Lost to Follow-up|2
4743365|NCT03828539|7705080|FG000|Overall Study|Protocol Violation|3
4743366|NCT03828539|7705081|FG001|Overall Study|Protocol Violation|2
4743367|NCT03828539|7705080|FG000|Overall Study|Withdrawal of informed consent|2
4743368|NCT03828539|7705081|FG001|Overall Study|Withdrawal of informed consent|1
4743369|NCT03828539|7705080|FG000|Overall Study|New therapy for study indication|1
4743370|NCT03828539|7705081|FG001|Overall Study|New therapy for study indication|0
4743371|NCT03824704|7705087|FG000|Overall Study|Study Terminated by Sponsor|1
4743372|NCT03817879|7705102|FG000|Overall Study|Drop out|5
4743373|NCT03817879|7705103|FG001|Overall Study|Drop out|12
4743374|NCT03817879|7705102|FG000|Overall Study|Withdrawal by Subject|0
4743375|NCT03817879|7705103|FG001|Overall Study|Withdrawal by Subject|1
4743376|NCT03811834|7705109|FG000|Period 1 ( 7 Days)|Adverse Event|1
4743377|NCT03806127|7705124|FG000|Overall Study|Withdrawal by Subject|4
4743378|NCT03806127|7705125|FG001|Overall Study|Withdrawal by Subject|5
4743379|NCT03806127|7705124|FG000|Overall Study|Protocol Violation|3
4743380|NCT03806127|7705125|FG001|Overall Study|Protocol Violation|1
4743381|NCT03806127|7705124|FG000|Overall Study|Adverse Event|3
4743382|NCT03806127|7705125|FG001|Overall Study|Adverse Event|0
4743383|NCT03806127|7705124|FG000|Overall Study|Unable to Complete Procedures|0
4743384|NCT03806127|7705125|FG001|Overall Study|Unable to Complete Procedures|1
4743385|NCT03806127|7705124|FG000|Overall Study|Pregnancy|0
4743386|NCT03806127|7705125|FG001|Overall Study|Pregnancy|1
4743387|NCT03806127|7705124|FG000|Overall Study|Lost to Follow-up|5
4743388|NCT03806127|7705125|FG001|Overall Study|Lost to Follow-up|1
4743389|NCT03806127|7705124|FG000|Overall Study|Physician Decision|1
4743390|NCT03806127|7705125|FG001|Overall Study|Physician Decision|1
4743391|NCT03806127|7705124|FG000|Overall Study|Could Not Come Due to Covid|1
4743392|NCT03806127|7705125|FG001|Overall Study|Could Not Come Due to Covid|0
4743393|NCT03806127|7705124|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1
4743394|NCT03806127|7705125|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0
4743395|NCT03806127|7705124|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1
4743396|NCT03806127|7705125|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0
4743397|NCT03806127|7705124|FG000|Overall Study|Covid 19 Restrictions|2
4743398|NCT03806127|7705125|FG001|Overall Study|Covid 19 Restrictions|0
4743399|NCT03806127|7705124|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0
4743400|NCT03806127|7705125|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1
4743401|NCT03806127|7705124|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0
4743402|NCT03806127|7705125|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1
4743403|NCT03827473|7705133|FG000|Overall Study|Withdrawal by Subject|1
4743404|NCT03827473|7705134|FG001|Overall Study|Withdrawal by Subject|0
4743405|NCT03826914|7705142|FG000|Overall Study|Withdrawal by Subject|1
4743406|NCT03826914|7705143|FG001|Overall Study|Withdrawal by Subject|1
4743407|NCT03808688|7705166|FG000|Overall Study|Adverse Event|13
4743408|NCT03808688|7705167|FG001|Overall Study|Adverse Event|17
4743409|NCT03808688|7705166|FG000|Overall Study|Lack of Efficacy|2
4743410|NCT03808688|7705167|FG001|Overall Study|Lack of Efficacy|0
4743411|NCT03808688|7705166|FG000|Overall Study|Lost to Follow-up|0
4525374|NCT01022112|7341115|FG004|Overall Study|Physician Decision|1
4525375|NCT01022112|7341111|FG000|Overall Study|Withdrawal by Subject|0
4525376|NCT01022112|7341112|FG001|Overall Study|Withdrawal by Subject|1
4525377|NCT01022112|7341113|FG002|Overall Study|Withdrawal by Subject|2
4525378|NCT01022112|7341114|FG003|Overall Study|Withdrawal by Subject|2
4525379|NCT01022112|7341115|FG004|Overall Study|Withdrawal by Subject|1
4525380|NCT01022112|7341111|FG000|Overall Study|Fasting plasma glucose level increased|1
4525381|NCT01022112|7341112|FG001|Overall Study|Fasting plasma glucose level increased|0
4525382|NCT01022112|7341113|FG002|Overall Study|Fasting plasma glucose level increased|0
4525383|NCT01022112|7341114|FG003|Overall Study|Fasting plasma glucose level increased|0
4743412|NCT03808688|7705167|FG001|Overall Study|Lost to Follow-up|2
4743413|NCT03808688|7705166|FG000|Overall Study|Withdrawal by Subject|1
4743414|NCT03808688|7705167|FG001|Overall Study|Withdrawal by Subject|0
4743415|NCT03808688|7705166|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1
4743416|NCT03808688|7705167|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0
4743417|NCT03808688|7705166|FG000|Overall Study|IOP Too High|1
4743418|NCT03808688|7705167|FG001|Overall Study|IOP Too High|1
4743419|NCT03808688|7705166|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0
4743420|NCT03808688|7705167|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1
4743421|NCT03808688|7705166|FG000|Overall Study|Visit Out of Window|0
4743422|NCT03808688|7705167|FG001|Overall Study|Visit Out of Window|1
4743423|NCT03808688|7705166|FG000|Overall Study|Medication Non-Compliance|0
4743424|NCT03808688|7705167|FG001|Overall Study|Medication Non-Compliance|1
4743425|NCT03811093|7705177|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0
4743426|NCT03811093|7705178|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4
4743427|NCT03811093|7705177|FG000|Overall Study|Unable to measure body fat percentage|2
4743428|NCT03811093|7705178|FG001|Overall Study|Unable to measure body fat percentage|0
4743429|NCT03822182|7705190|FG000|Overall Study|Protocol Violation|0
4743430|NCT03822182|7705191|FG001|Overall Study|Protocol Violation|1
4743431|NCT03822182|7705192|FG002|Overall Study|Protocol Violation|1
4743432|NCT03822416|7705203|FG000|Overall Study|Lost to Follow-up|1
4743433|NCT03822416|7705204|FG001|Overall Study|Lost to Follow-up|0
4743434|NCT03822416|7705203|FG000|Overall Study|Withdrawal by Subject|0
4743435|NCT03822416|7705204|FG001|Overall Study|Withdrawal by Subject|1
4743436|NCT03809104|7705210|FG000|Overall Study|Withdrawal by Subject|3
4743437|NCT03806231|7705225|FG000|Overall Study|Physician Decision|1
4743438|NCT03806231|7705226|FG001|Overall Study|Physician Decision|0
4743439|NCT03806231|7705225|FG000|Overall Study|Withdrawal by Subject|1
4743440|NCT03806231|7705226|FG001|Overall Study|Withdrawal by Subject|0
4743441|NCT03804710|7705234|FG000|Overall Study|Adverse Event|0
4743442|NCT03804710|7705235|FG001|Overall Study|Adverse Event|3
4743443|NCT03804710|7705234|FG000|Overall Study|Withdrawal by Subject|2
4743444|NCT03804710|7705235|FG001|Overall Study|Withdrawal by Subject|1
4743445|NCT03804710|7705234|FG000|Overall Study|Other|0
4743446|NCT03804710|7705235|FG001|Overall Study|Other|1
4743447|NCT03821064|7705279|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1
4743448|NCT03820024|7705294|FG000|Overall Study|Physician Decision|1
4743449|NCT03820024|7705295|FG001|Overall Study|Physician Decision|2
4743450|NCT03816761|7705320|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0
4743451|NCT03816761|7705321|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0
4743452|NCT03816761|7705322|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0
4743453|NCT03816761|7705323|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0
4743454|NCT03816761|7705324|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0
4743455|NCT03816761|7705325|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1
4743456|NCT03816761|7705320|FG000|Second Treatment Period (7 Days)|Unclassified|0
4743457|NCT03816761|7705321|FG001|Second Treatment Period (7 Days)|Unclassified|0
4743458|NCT03816761|7705322|FG002|Second Treatment Period (7 Days)|Unclassified|0
4743459|NCT03816761|7705323|FG003|Second Treatment Period (7 Days)|Unclassified|1
4743460|NCT03816761|7705324|FG004|Second Treatment Period (7 Days)|Unclassified|0
4743461|NCT03816761|7705325|FG005|Second Treatment Period (7 Days)|Unclassified|0
4743462|NCT03812510|7705390|FG000|Overall Study|Lost to Follow-up|39
4743463|NCT03812510|7705390|FG000|Overall Study|Withdrawal by Subject|42
4743464|NCT03812510|7705390|FG000|Overall Study|Physician Decision|2
4743465|NCT03812510|7705390|FG000|Overall Study|Study Terminated by Sponsor|9
4743466|NCT03812510|7705390|FG000|Overall Study|Did Not Start Study Medication|55
4743467|NCT03812510|7705390|FG000|Overall Study|Adverse Event|5
4743468|NCT03802994|7705400|FG000|Overall Study|Lost to Follow-up|0
4743469|NCT03802994|7705401|FG001|Overall Study|Lost to Follow-up|2
4743470|NCT03802994|7705402|FG002|Overall Study|Lost to Follow-up|3
4743471|NCT03802994|7705403|FG003|Overall Study|Lost to Follow-up|2
4743472|NCT03802994|7705404|FG004|Overall Study|Lost to Follow-up|2
4743473|NCT03810183|7705429|FG000|Overall Study|Study terminated by Sponsor|2
4743474|NCT03810183|7705430|FG001|Overall Study|Study terminated by Sponsor|1
4743475|NCT03809611|7705459|FG000|Overall Study|Withdrawal by Subject|1
4743476|NCT03809611|7705460|FG001|Overall Study|Withdrawal by Subject|1
4743477|NCT03805971|7705480|FG000|Overall Study|Withdrawal by Subject|1
4743478|NCT03805971|7705480|FG000|Overall Study|Protocol Violation|2
4743479|NCT03802916|7705487|FG000|Overall Study|Adverse Event|0
4743480|NCT03802916|7705488|FG001|Overall Study|Adverse Event|1
4743481|NCT03802916|7705487|FG000|Overall Study|Withdrawal by Subject|0
4743482|NCT03802916|7705488|FG001|Overall Study|Withdrawal by Subject|1
4743483|NCT03809039|7705505|FG000|Part 1|Withdrawal by Subject|1
4743484|NCT03809039|7705506|FG001|Part 1|Withdrawal by Subject|0
4743485|NCT03809039|7705507|FG002|Part 1|Withdrawal by Subject|0
4743486|NCT03809039|7705508|FG003|Part 1|Withdrawal by Subject|1
4743487|NCT03809039|7705509|FG004|Part 1|Withdrawal by Subject|0
4743488|NCT03809039|7705510|FG005|Part 1|Withdrawal by Subject|0
4743489|NCT03809039|7705511|FG006|Part 1|Withdrawal by Subject|0
4743490|NCT03809039|7705512|FG007|Part 1|Withdrawal by Subject|0
4743491|NCT03809039|7705513|FG008|Part 1|Withdrawal by Subject|0
4743492|NCT03809039|7705505|FG000|Part 3|Withdrawn by study termination|0
4743493|NCT03809039|7705506|FG001|Part 3|Withdrawn by study termination|0
4743494|NCT03809039|7705507|FG002|Part 3|Withdrawn by study termination|0
4743495|NCT03809039|7705508|FG003|Part 3|Withdrawn by study termination|0
4743496|NCT03809039|7705509|FG004|Part 3|Withdrawn by study termination|0
4743497|NCT03809039|7705510|FG005|Part 3|Withdrawn by study termination|0
4743498|NCT03809039|7705511|FG006|Part 3|Withdrawn by study termination|0
4743499|NCT03809039|7705512|FG007|Part 3|Withdrawn by study termination|2
4743500|NCT03809039|7705513|FG008|Part 3|Withdrawn by study termination|6
4743501|NCT03807700|7705548|FG000|Overall Study|Withdrawal by Subject|2
4743502|NCT03807700|7705549|FG001|Overall Study|Withdrawal by Subject|1
4743503|NCT03804918|7705556|FG000|Overall Study|Participant did not use the app|1
4743504|NCT03803475|7705572|FG000|Overall Study|Physician Decision|1
4743505|NCT03801928|7705625|FG000|Overall Study|Adverse Event|1
4743506|NCT03801928|7705626|FG001|Overall Study|Adverse Event|0
4743507|NCT03801928|7705627|FG002|Overall Study|Adverse Event|1
4743508|NCT03801928|7705628|FG003|Overall Study|Adverse Event|2
4743509|NCT03801928|7705629|FG004|Overall Study|Adverse Event|0
4743510|NCT03801928|7705630|FG005|Overall Study|Adverse Event|2
4743511|NCT03801928|7705625|FG000|Overall Study|Lack of Efficacy|0
4743512|NCT03801928|7705626|FG001|Overall Study|Lack of Efficacy|0
4743513|NCT03801928|7705627|FG002|Overall Study|Lack of Efficacy|1
4743514|NCT03801928|7705628|FG003|Overall Study|Lack of Efficacy|0
4743515|NCT03801928|7705629|FG004|Overall Study|Lack of Efficacy|0
4743516|NCT03801928|7705630|FG005|Overall Study|Lack of Efficacy|0
4743517|NCT03801928|7705625|FG000|Overall Study|Lost to Follow-up|5
4743518|NCT03801928|7705626|FG001|Overall Study|Lost to Follow-up|1
4743519|NCT03801928|7705627|FG002|Overall Study|Lost to Follow-up|1
4743520|NCT03801928|7705628|FG003|Overall Study|Lost to Follow-up|4
4743521|NCT03801928|7705629|FG004|Overall Study|Lost to Follow-up|4
4743522|NCT03801928|7705630|FG005|Overall Study|Lost to Follow-up|2
4743523|NCT03801928|7705625|FG000|Overall Study|Withdrawal by Subject|0
4743524|NCT03801928|7705626|FG001|Overall Study|Withdrawal by Subject|0
4525384|NCT01022112|7341115|FG004|Overall Study|Fasting plasma glucose level increased|7
4525385|NCT01022203|7341133|FG000|Post Treatment Assessment|Withdrawal by Subject|12
4525386|NCT01022203|7341134|FG001|Post Treatment Assessment|Withdrawal by Subject|12
4525387|NCT01022203|7341133|FG000|Post Treatment Assessment|Physician Decision|2
4634165|NCT01920711|7504801|FG001|Overall Study|Death|356
4634166|NCT01920711|7504800|FG000|Overall Study|Lost to Follow-up|13
4634167|NCT01920711|7504801|FG001|Overall Study|Lost to Follow-up|14
4634168|NCT01920711|7504800|FG000|Overall Study|Withdrawal by Subject|4
4634169|NCT01920711|7504801|FG001|Overall Study|Withdrawal by Subject|3
4743525|NCT03801928|7705627|FG002|Overall Study|Withdrawal by Subject|2
4743526|NCT03801928|7705628|FG003|Overall Study|Withdrawal by Subject|1
4743527|NCT03801928|7705629|FG004|Overall Study|Withdrawal by Subject|0
4743528|NCT03801928|7705630|FG005|Overall Study|Withdrawal by Subject|0
4743529|NCT03801928|7705625|FG000|Overall Study|Other|0
4743530|NCT03801928|7705626|FG001|Overall Study|Other|2
4743531|NCT03801928|7705627|FG002|Overall Study|Other|0
4743532|NCT03801928|7705628|FG003|Overall Study|Other|1
4743533|NCT03801928|7705629|FG004|Overall Study|Other|0
4743534|NCT03801928|7705630|FG005|Overall Study|Other|1
4743535|NCT03800173|7705652|FG000|Overall Study|Lost to Follow-up|0
4743536|NCT03800173|7705653|FG001|Overall Study|Lost to Follow-up|0
4743537|NCT03800173|7705654|FG002|Overall Study|Lost to Follow-up|0
4743538|NCT03800173|7705655|FG003|Overall Study|Lost to Follow-up|0
4743539|NCT03800173|7705656|FG004|Overall Study|Lost to Follow-up|1
4743540|NCT03799211|7705691|FG000|Overall Study|Lost to Follow-up|2
4743541|NCT03799211|7705692|FG001|Overall Study|Lost to Follow-up|13
4743542|NCT03799211|7705691|FG000|Overall Study|Withdrawal by Subject|2
4743543|NCT03799211|7705692|FG001|Overall Study|Withdrawal by Subject|0
4743544|NCT03798717|7705706|FG000|Overall Study|Failed Screening|0
4743545|NCT03798717|7705707|FG001|Overall Study|Failed Screening|0
4743546|NCT03798717|7705708|FG002|Overall Study|Failed Screening|0
4743547|NCT03798717|7705709|FG003|Overall Study|Failed Screening|0
4743548|NCT03798717|7705710|FG004|Overall Study|Failed Screening|0
4743549|NCT03798717|7705711|FG005|Overall Study|Failed Screening|1
4743550|NCT03798717|7705706|FG000|Overall Study|Physician Decision|1
4743551|NCT03798717|7705707|FG001|Overall Study|Physician Decision|0
4743552|NCT03798717|7705708|FG002|Overall Study|Physician Decision|1
4743553|NCT03798717|7705709|FG003|Overall Study|Physician Decision|0
4743554|NCT03798717|7705710|FG004|Overall Study|Physician Decision|0
4743555|NCT03798717|7705711|FG005|Overall Study|Physician Decision|0
4743556|NCT03798717|7705706|FG000|Overall Study|Withdrawal by Subject|0
4743557|NCT03798717|7705707|FG001|Overall Study|Withdrawal by Subject|0
4743558|NCT03798717|7705708|FG002|Overall Study|Withdrawal by Subject|0
4743559|NCT03798717|7705709|FG003|Overall Study|Withdrawal by Subject|1
4743560|NCT03798717|7705710|FG004|Overall Study|Withdrawal by Subject|0
4743561|NCT03798717|7705711|FG005|Overall Study|Withdrawal by Subject|0
4743562|NCT03798717|7705706|FG000|Overall Study|Lost to Follow-up|1
4743563|NCT03798717|7705707|FG001|Overall Study|Lost to Follow-up|0
4743564|NCT03798717|7705708|FG002|Overall Study|Lost to Follow-up|0
4743565|NCT03798717|7705709|FG003|Overall Study|Lost to Follow-up|1
4743566|NCT03798717|7705710|FG004|Overall Study|Lost to Follow-up|0
4743567|NCT03798717|7705711|FG005|Overall Study|Lost to Follow-up|0
4743568|NCT03798717|7705706|FG000|Overall Study|Adverse Event|0
4743569|NCT03798717|7705707|FG001|Overall Study|Adverse Event|1
4743570|NCT03798717|7705708|FG002|Overall Study|Adverse Event|0
4743571|NCT03798717|7705709|FG003|Overall Study|Adverse Event|0
4743572|NCT03798717|7705710|FG004|Overall Study|Adverse Event|0
4743573|NCT03798717|7705711|FG005|Overall Study|Adverse Event|0
4743574|NCT03798717|7705706|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0
4743575|NCT03798717|7705707|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0
4743576|NCT03798717|7705708|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0
4743577|NCT03798717|7705709|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0
4743578|NCT03798717|7705710|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1
4743579|NCT03798717|7705711|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0
4743580|NCT03798483|7705720|FG000|Overall Study|Lost to Follow-up|2
4743581|NCT03798366|7705730|FG000|Overall Study|Lost to Follow-up|0
4743582|NCT03798366|7705731|FG001|Overall Study|Lost to Follow-up|1
4743583|NCT03799952|7705739|FG000|Overall Study|Program was too easy, discontinued|1
4743584|NCT03799952|7705740|FG001|Overall Study|Program was too easy, discontinued|0
4743585|NCT03799952|7705739|FG000|Overall Study|Lost to Follow-up|0
4743586|NCT03799952|7705740|FG001|Overall Study|Lost to Follow-up|2
4743587|NCT03796728|7705774|FG000|Overall Study|Lost to Follow-up|8
4743588|NCT03796728|7705774|FG000|Overall Study|Reason not Specified|16
4743589|NCT03797144|7705780|FG000|Enrollment|Protocol Violation|4
4743590|NCT03797144|7705781|FG001|Enrollment|Protocol Violation|1
4743591|NCT03797144|7705780|FG000|Surgery|Protocol Violation|1
4743592|NCT03797144|7705781|FG001|Surgery|Protocol Violation|0
4743593|NCT03797144|7705780|FG000|3 Month|Early termination cut-off date|2
4743594|NCT03797144|7705781|FG001|3 Month|Early termination cut-off date|0
4743595|NCT03797144|7705780|FG000|12 Month|Early termination cut-off date|8
4743596|NCT03797144|7705781|FG001|12 Month|Early termination cut-off date|9
4743597|NCT03797144|7705780|FG000|24 Month|Early termination cut-off date|1
4743598|NCT03797144|7705781|FG001|24 Month|Early termination cut-off date|1
4743599|NCT03782571|7705788|FG000|Period 1|Withdrawal by Subject|1
4743600|NCT03782571|7705789|FG001|Period 1|Withdrawal by Subject|0
4743601|NCT03782571|7705790|FG002|Period 1|Withdrawal by Subject|0
4743602|NCT03782571|7705791|FG003|Period 1|Withdrawal by Subject|0
4743603|NCT03782571|7705788|FG000|Period 3|Subject Unable to Attend V5|1
4743604|NCT03782571|7705789|FG001|Period 3|Subject Unable to Attend V5|0
4743605|NCT03782571|7705790|FG002|Period 3|Subject Unable to Attend V5|0
4743606|NCT03782571|7705791|FG003|Period 3|Subject Unable to Attend V5|0
4743607|NCT03782571|7705788|FG000|Period 3|Adverse Event|1
4743608|NCT03782571|7705789|FG001|Period 3|Adverse Event|0
4743609|NCT03782571|7705790|FG002|Period 3|Adverse Event|0
4743610|NCT03782571|7705791|FG003|Period 3|Adverse Event|0
4743611|NCT03796039|7705814|FG000|Overall Study|Death|2
4525388|NCT01022203|7341134|FG001|Post Treatment Assessment|Physician Decision|0
4525389|NCT01022203|7341133|FG000|Post Treatment Assessment|Adverse Event|0
4525390|NCT01022203|7341134|FG001|Post Treatment Assessment|Adverse Event|2
4525391|NCT01022203|7341133|FG000|Follow-Up Assessment|Lost to Follow-up|2
4525392|NCT01022203|7341134|FG001|Follow-Up Assessment|Lost to Follow-up|2
4525393|NCT01022424|7341170|FG000|Overall Study|Adverse Event|1
4525394|NCT01022424|7341170|FG000|Overall Study|Physician Decision|1
4525395|NCT01022424|7341170|FG000|Overall Study|eGFR under the withdrawal criteria|2
4525396|NCT01022502|7341178|FG000|Overall Study|Adverse Event|1
4525397|NCT01022502|7341178|FG000|Overall Study|employment related reasons|1
4525398|NCT01022502|7341178|FG000|Overall Study|Withdrawal by Subject|1
4594331|NCT01561976|7443573|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1
4594332|NCT01561976|7443568|FG000|Washout Period 2 (7 Days)|Non-compliance|1
4743612|NCT03796039|7705815|FG001|Overall Study|Death|1
4743613|NCT03796039|7705814|FG000|Overall Study|Withdrawal by Subject|7
4743614|NCT03796039|7705815|FG001|Overall Study|Withdrawal by Subject|4
4743615|NCT03783780|7705821|FG000|Overall Study|Withdrawn prior to completion|1
4743616|NCT03780959|7705829|FG000|Part 1|Adverse Event|1
4743617|NCT03780959|7705830|FG001|Part 1|Adverse Event|0
4743618|NCT03780959|7705831|FG002|Part 1|Adverse Event|0
4743619|NCT03780959|7705829|FG000|Part 1|Withdrawal by Subject|1
4743620|NCT03780959|7705830|FG001|Part 1|Withdrawal by Subject|0
4743621|NCT03780959|7705831|FG002|Part 1|Withdrawal by Subject|0
4743622|NCT03780959|7705829|FG000|Part 1|Withdrawal by Parent/Guardian|1
4743623|NCT03780959|7705830|FG001|Part 1|Withdrawal by Parent/Guardian|0
4743624|NCT03780959|7705831|FG002|Part 1|Withdrawal by Parent/Guardian|0
4743625|NCT03780959|7705829|FG000|Part 1|Response Status|2
4743626|NCT03780959|7705830|FG001|Part 1|Response Status|0
4743627|NCT03780959|7705831|FG002|Part 1|Response Status|0
4743628|NCT03780959|7705829|FG000|Part 2|Withdrawal by Parent/Guardian|0
4743629|NCT03780959|7705830|FG001|Part 2|Withdrawal by Parent/Guardian|1
4743630|NCT03780959|7705831|FG002|Part 2|Withdrawal by Parent/Guardian|0
4743631|NCT03780959|7705829|FG000|Part 2|Response Status|0
4743632|NCT03780959|7705830|FG001|Part 2|Response Status|18
4743633|NCT03780959|7705831|FG002|Part 2|Response Status|6
4743634|NCT03792477|7705871|FG000|Overall Study|Adverse Event|0
4743635|NCT03792477|7705872|FG001|Overall Study|Adverse Event|0
4743636|NCT03792477|7705873|FG002|Overall Study|Adverse Event|0
4743637|NCT03792477|7705874|FG003|Overall Study|Adverse Event|1
4743638|NCT03792477|7705875|FG004|Overall Study|Adverse Event|0
4743639|NCT03792477|7705871|FG000|Overall Study|Lost to Follow-up|0
4743640|NCT03792477|7705872|FG001|Overall Study|Lost to Follow-up|0
4743641|NCT03792477|7705873|FG002|Overall Study|Lost to Follow-up|2
4743642|NCT03792477|7705874|FG003|Overall Study|Lost to Follow-up|0
4743643|NCT03792477|7705875|FG004|Overall Study|Lost to Follow-up|0
4743644|NCT03792477|7705871|FG000|Overall Study|Other|0
4743645|NCT03792477|7705872|FG001|Overall Study|Other|0
4743646|NCT03792477|7705873|FG002|Overall Study|Other|0
4743647|NCT03792477|7705874|FG003|Overall Study|Other|0
4743648|NCT03792477|7705875|FG004|Overall Study|Other|1
4743649|NCT03783962|7705883|FG000|Overall Study|Lost to Follow-up|3
4743650|NCT03783962|7705884|FG001|Overall Study|Lost to Follow-up|6
4743651|NCT03783962|7705883|FG000|Overall Study|Protocol Violation|0
4743652|NCT03783962|7705884|FG001|Overall Study|Protocol Violation|1
4743653|NCT03793556|7705948|FG000|Overall Study|Withdrawal by Subject|12
4743654|NCT03793556|7705949|FG001|Overall Study|Withdrawal by Subject|1
4743655|NCT03793556|7705948|FG000|Overall Study|Lost to Follow-up|1
4743656|NCT03793556|7705949|FG001|Overall Study|Lost to Follow-up|1
4743657|NCT03785548|7705960|FG000|Overall Study|age > 80|1
4743658|NCT03785548|7705961|FG001|Overall Study|age > 80|0
4743659|NCT03785548|7705960|FG000|Overall Study|no Postop queries|1
4743660|NCT03785548|7705961|FG001|Overall Study|no Postop queries|0
4743661|NCT03773133|7705973|FG000|Overall Study|Screen Failure|8
4743662|NCT03792672|7705978|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1
4743663|NCT03792672|7705979|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0
4743664|NCT03792672|7705980|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0
4743665|NCT03792672|7705981|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2
4525399|NCT01022580|7341195|FG000|Overall Study|Death|18
4525400|NCT01022580|7341196|FG001|Overall Study|Death|22
4525401|NCT01022762|7341210|FG000|Overall Study|Adverse Event|3
4525402|NCT01022762|7341211|FG001|Overall Study|Adverse Event|1
4525403|NCT01022762|7341210|FG000|Overall Study|Lack of Efficacy|0
4525404|NCT01022762|7341211|FG001|Overall Study|Lack of Efficacy|1
4525405|NCT01022762|7341210|FG000|Overall Study|Protocol Violation|7
4743666|NCT03792672|7705982|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0
4525406|NCT01022762|7341211|FG001|Overall Study|Protocol Violation|6
4525407|NCT01022762|7341210|FG000|Overall Study|Unclassified|12
4743667|NCT03792672|7705983|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0
4743668|NCT03792672|7705978|FG000|Washout Period 3 (10 Days)|Physician Decision|0
4743669|NCT03792672|7705979|FG001|Washout Period 3 (10 Days)|Physician Decision|0
4743670|NCT03792672|7705980|FG002|Washout Period 3 (10 Days)|Physician Decision|1
4743671|NCT03792672|7705981|FG003|Washout Period 3 (10 Days)|Physician Decision|0
4743672|NCT03792672|7705982|FG004|Washout Period 3 (10 Days)|Physician Decision|0
4743673|NCT03792672|7705983|FG005|Washout Period 3 (10 Days)|Physician Decision|0
4743674|NCT03792672|7705978|FG000|Treatment Period 4 (2 Days)|Other|1
4743675|NCT03792672|7705979|FG001|Treatment Period 4 (2 Days)|Other|0
4743676|NCT03792672|7705980|FG002|Treatment Period 4 (2 Days)|Other|0
4743677|NCT03792672|7705981|FG003|Treatment Period 4 (2 Days)|Other|0
4743678|NCT03792672|7705982|FG004|Treatment Period 4 (2 Days)|Other|0
4743679|NCT03792672|7705983|FG005|Treatment Period 4 (2 Days)|Other|0
4743680|NCT03787615|7706092|FG000|Overall Study|Withdrawal by Subject|2
4743681|NCT03787615|7706092|FG000|Overall Study|Lost to Follow-up|2
4743682|NCT03786718|7706097|FG000|Overall Study|Lost to Follow-up|3
4743683|NCT03786718|7706097|FG000|Overall Study|Withdrawal by Subject|1
4743684|NCT03786718|7706097|FG000|Overall Study|Did not use the intervention|2
4743685|NCT03786718|7706097|FG000|Overall Study|diagnosis changed from type 2 to type 1|1
4743686|NCT03784963|7706106|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12
4743687|NCT03784963|7706107|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10
4743688|NCT03784963|7706108|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1
4743689|NCT03784963|7706109|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0
4743690|NCT03787212|7706130|FG000|Period 1|Study Termination|2
4743691|NCT03787212|7706131|FG001|Period 1|Study Termination|2
4743692|NCT03783702|7706152|FG000|Overall Study|Lost to Follow-up|6
4743693|NCT03783702|7706153|FG001|Overall Study|Lost to Follow-up|8
4743694|NCT03783702|7706152|FG000|Overall Study|Protocol Violation|1
4743695|NCT03783702|7706153|FG001|Overall Study|Protocol Violation|3
4743696|NCT03783039|7706211|FG000|Overall Study|Death|2
4743697|NCT03783039|7706212|FG001|Overall Study|Death|1
4743698|NCT03776175|7706240|FG000|Treatment Period (42 Days)|Adverse Event|0
4743699|NCT03776175|7706241|FG001|Treatment Period (42 Days)|Adverse Event|1
4743700|NCT03776175|7706242|FG002|Treatment Period (42 Days)|Adverse Event|1
4743701|NCT03776175|7706243|FG003|Treatment Period (42 Days)|Adverse Event|0
4743702|NCT03776175|7706240|FG000|Treatment Period (42 Days)|Lost to Follow-up|0
4743703|NCT03776175|7706241|FG001|Treatment Period (42 Days)|Lost to Follow-up|0
4743704|NCT03776175|7706242|FG002|Treatment Period (42 Days)|Lost to Follow-up|0
4743705|NCT03776175|7706243|FG003|Treatment Period (42 Days)|Lost to Follow-up|2
4743706|NCT03776175|7706240|FG000|Treatment Period (42 Days)|Participants screened at other site|0
4743707|NCT03776175|7706241|FG001|Treatment Period (42 Days)|Participants screened at other site|2
4743708|NCT03776175|7706242|FG002|Treatment Period (42 Days)|Participants screened at other site|0
4743709|NCT03776175|7706243|FG003|Treatment Period (42 Days)|Participants screened at other site|0
4743710|NCT03776175|7706240|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1
4743711|NCT03776175|7706241|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2
4743712|NCT03776175|7706242|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3
4743713|NCT03776175|7706243|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0
4743714|NCT03776175|7706240|FG000|Treatment Period (42 Days)|Unable to attend study visits|0
4743715|NCT03776175|7706241|FG001|Treatment Period (42 Days)|Unable to attend study visits|2
4743716|NCT03776175|7706242|FG002|Treatment Period (42 Days)|Unable to attend study visits|0
4743717|NCT03776175|7706243|FG003|Treatment Period (42 Days)|Unable to attend study visits|0
4743718|NCT03776175|7706240|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0
4634170|NCT01920854|7504828|FG000|Overall Study|Withdrawal by Subject|1
4634171|NCT01920854|7504829|FG001|Overall Study|Withdrawal by Subject|0
4634172|NCT01920854|7504830|FG002|Overall Study|Withdrawal by Subject|0
4634173|NCT01920854|7504831|FG003|Overall Study|Withdrawal by Subject|0
4634174|NCT01920854|7504832|FG004|Overall Study|Withdrawal by Subject|1
4634175|NCT01920854|7504833|FG005|Overall Study|Withdrawal by Subject|0
4634176|NCT01920854|7504834|FG006|Overall Study|Withdrawal by Subject|1
4634177|NCT01920893|7504871|FG000|Overall Study|Adverse Event|5
4634178|NCT01920893|7504872|FG001|Overall Study|Adverse Event|2
4634179|NCT01920893|7504871|FG000|Overall Study|Lack of Efficacy|2
4634180|NCT01920893|7504872|FG001|Overall Study|Lack of Efficacy|0
4634181|NCT01920958|7504879|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5
4634182|NCT01921101|7504885|FG000|Overall Study|Death|16
4634183|NCT01921101|7504886|FG001|Overall Study|Death|6
4634184|NCT01921179|7504894|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3
4634185|NCT01921179|7504895|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3
4634186|NCT01921179|7504894|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2
4634187|NCT01921179|7504895|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0
4634188|NCT01921205|7504904|FG000|Overall Study|Adverse Event|12
4634189|NCT01921205|7504905|FG001|Overall Study|Adverse Event|7
4634190|NCT01921205|7504904|FG000|Overall Study|Lack of Efficacy|1
4634191|NCT01921205|7504905|FG001|Overall Study|Lack of Efficacy|0
4634192|NCT01921205|7504904|FG000|Overall Study|Protocol Violation|1
4634193|NCT01921205|7504905|FG001|Overall Study|Protocol Violation|3
4634194|NCT01921205|7504904|FG000|Overall Study|Lost to Follow-up|1
4634195|NCT01921205|7504905|FG001|Overall Study|Lost to Follow-up|1
4634196|NCT01921205|7504904|FG000|Overall Study|Withdrawal by Subject|6
4634197|NCT01921205|7504905|FG001|Overall Study|Withdrawal by Subject|5
4743719|NCT03776175|7706241|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0
4743720|NCT03776175|7706242|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0
4743721|NCT03776175|7706243|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2
4743722|NCT03771963|7706253|FG000|Overall Study|Lost to Follow-up|22
4743723|NCT03771963|7706253|FG000|Overall Study|Withdrawal of Consent|10
4743724|NCT03771352|7706257|FG000|Overall Study|Screen failure|2
4743725|NCT03771352|7706257|FG000|Overall Study|Withdrawal by Subject|2
4743726|NCT03773796|7706261|FG000|Overall Study|Adverse Event|1
4743727|NCT03773796|7706261|FG000|Overall Study|Withdrawal by Subject|1
4743728|NCT03773796|7706261|FG000|Overall Study|Lack of Efficacy|1
4743729|NCT03781375|7706278|FG000|Double-blind Phase|Adverse Event|0
4634198|NCT01921205|7504904|FG000|Overall Study|Use Of Prohibited Medication|0
4634199|NCT01921205|7504905|FG001|Overall Study|Use Of Prohibited Medication|1
4634200|NCT01921205|7504904|FG000|Overall Study|The Excessive Use Of Rescue Medication|0
4743730|NCT03781375|7706279|FG001|Double-blind Phase|Adverse Event|1
4743731|NCT03781375|7706278|FG000|Double-blind Phase|Lack of Response|6
4743732|NCT03781375|7706279|FG001|Double-blind Phase|Lack of Response|2
4743733|NCT03781375|7706278|FG000|Double-blind Phase|Other|1
4743734|NCT03781375|7706279|FG001|Double-blind Phase|Other|3
4743735|NCT03781375|7706278|FG000|Open-label Phase|Protocol Issues|0
4634201|NCT01921205|7504905|FG001|Overall Study|The Excessive Use Of Rescue Medication|1
4634202|NCT01921205|7504904|FG000|Overall Study|Non Compliance Of The Parent|0
4634203|NCT01921205|7504905|FG001|Overall Study|Non Compliance Of The Parent|1
4634204|NCT01921205|7504904|FG000|Overall Study|Non Compliance Of Child|0
4634205|NCT01921205|7504905|FG001|Overall Study|Non Compliance Of Child|1
4634206|NCT01921257|7504911|FG000|Overall Study|Adverse Event|1
4634207|NCT01921257|7504911|FG000|Overall Study|Protocol Violation|1
4634208|NCT01921257|7504911|FG000|Overall Study|Withdrawal by Subject|1
4634209|NCT01921270|7504916|FG000|Overall Study|Withdrawal by Subject|1
4634210|NCT01921348|7504935|FG000|Overall Study|Withdrawal by Subject|1
4634211|NCT01921348|7504936|FG001|Overall Study|Withdrawal by Subject|0
4634212|NCT01921348|7504935|FG000|Overall Study|Lost to Follow-up|0
4634213|NCT01921348|7504936|FG001|Overall Study|Lost to Follow-up|2
4634214|NCT01921387|7504942|FG000|Overall Study|Adverse Event|1
4634215|NCT01921517|7504953|FG000|Overall Study|Lost to Follow-up|5
4634216|NCT01921517|7504954|FG001|Overall Study|Lost to Follow-up|0
4634217|NCT01921517|7504953|FG000|Overall Study|Newly diagnosed health concern|2
4634218|NCT01921517|7504954|FG001|Overall Study|Newly diagnosed health concern|0
4634219|NCT01921517|7504953|FG000|Overall Study|Physician Decision|0
4634220|NCT01921517|7504954|FG001|Overall Study|Physician Decision|2
4634221|NCT01921517|7504953|FG000|Overall Study|Withdrawal by Subject|7
4634222|NCT01921517|7504954|FG001|Overall Study|Withdrawal by Subject|3
4634223|NCT01921517|7504953|FG000|Overall Study|Subject missed final imaging|1
4634224|NCT01921517|7504954|FG001|Overall Study|Subject missed final imaging|4
4743736|NCT03781375|7706279|FG001|Open-label Phase|Protocol Issues|1
4743737|NCT03781375|7706278|FG000|Open-label Phase|Suboptimal Clinical Response|1
4743738|NCT03781375|7706279|FG001|Open-label Phase|Suboptimal Clinical Response|0
4743739|NCT03781375|7706278|FG000|Open-label Phase|Other|2
4743740|NCT03781375|7706279|FG001|Open-label Phase|Other|2
4743741|NCT03781336|7706288|FG000|Overall Study|Withdrawal by Subject|2
4743742|NCT03781336|7706289|FG001|Overall Study|Withdrawal by Subject|2
4743743|NCT03780400|7706295|FG000|Overall Study|Lost to Follow-up|5
4743744|NCT03780400|7706295|FG000|Overall Study|Withdrawal by Subject|2
4743745|NCT03779503|7706308|FG000|First Intervention|Adverse Event|0
4743746|NCT03779503|7706309|FG001|First Intervention|Adverse Event|1
4743747|NCT03779503|7706308|FG000|First Intervention|Withdrawal by Subject|1
4743748|NCT03779503|7706309|FG001|First Intervention|Withdrawal by Subject|0
4743749|NCT03777059|7706343|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6
4743750|NCT03777059|7706344|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9
4743751|NCT03777059|7706345|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4
4743752|NCT03777059|7706346|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6
4743753|NCT03777059|7706343|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1
4743754|NCT03777059|7706344|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0
4743755|NCT03777059|7706345|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0
4743756|NCT03777059|7706346|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1
4743757|NCT03777059|7706343|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8
4743758|NCT03777059|7706344|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9
4743759|NCT03777059|7706345|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8
4743760|NCT03777059|7706346|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10
4743761|NCT03777059|7706343|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3
4743762|NCT03777059|7706344|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3
4743763|NCT03777059|7706345|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4
4743764|NCT03777059|7706346|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5
4743765|NCT03777059|7706343|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0
4743766|NCT03777059|7706344|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1
4525408|NCT01022762|7341211|FG001|Overall Study|Unclassified|20
4743767|NCT03777059|7706345|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0
4743768|NCT03777059|7706346|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0
4743769|NCT03777059|7706343|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4
4743770|NCT03777059|7706344|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5
4743771|NCT03777059|7706345|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7
4743772|NCT03777059|7706346|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8
4743773|NCT03777059|7706343|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0
4743774|NCT03777059|7706344|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2
4743775|NCT03777059|7706345|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0
4743776|NCT03777059|7706346|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1
4743777|NCT03777059|7706343|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5
4743778|NCT03777059|7706344|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3
4743779|NCT03777059|7706345|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4
4743780|NCT03777059|7706346|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5
4743781|NCT03777059|7706343|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0
4743782|NCT03777059|7706344|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1
4743783|NCT03777059|7706345|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0
4743784|NCT03777059|7706346|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3
4743785|NCT03777059|7706343|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0
4743786|NCT03777059|7706344|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1
4743787|NCT03777059|7706345|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1
4743788|NCT03777059|7706346|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0
4743789|NCT03777059|7706343|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0
4743790|NCT03777059|7706344|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0
4743791|NCT03777059|7706345|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1
4743792|NCT03777059|7706346|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1
4743793|NCT03772522|7706358|FG000|Pre-intervention|Withdrawal by Subject|3
4743794|NCT03772522|7706359|FG001|Pre-intervention|Withdrawal by Subject|4
4743795|NCT03772522|7706358|FG000|Intervention|Withdrawal by Subject|1
4743796|NCT03772522|7706359|FG001|Intervention|Withdrawal by Subject|0
4743797|NCT03772522|7706358|FG000|Post-intervention Follow-up|Lost to Follow-up|1
4743798|NCT03772522|7706359|FG001|Post-intervention Follow-up|Lost to Follow-up|0
4743799|NCT03772327|7706371|FG000|Overall Study|Lost to Follow-up|3
4743800|NCT03772327|7706372|FG001|Overall Study|Lost to Follow-up|4
4743801|NCT03772327|7706371|FG000|Overall Study|Withdrawal by Subject|2
4743802|NCT03772327|7706372|FG001|Overall Study|Withdrawal by Subject|3
4743803|NCT03774576|7706382|FG000|Period 2|Adverse Event|1
4743804|NCT03772041|7706410|FG000|Overall Study|Adverse Event|8
4743805|NCT03772041|7706411|FG001|Overall Study|Adverse Event|3
4743806|NCT03772041|7706410|FG000|Overall Study|Withdrawal by Subject|0
4743807|NCT03772041|7706411|FG001|Overall Study|Withdrawal by Subject|2
4743808|NCT03772041|7706410|FG000|Overall Study|Protocol Violation|4
4743809|NCT03772041|7706411|FG001|Overall Study|Protocol Violation|2
4743810|NCT03772041|7706410|FG000|Overall Study|Physician Decision|2
4743811|NCT03772041|7706411|FG001|Overall Study|Physician Decision|3
4743812|NCT03775681|7706417|FG000|Overall Study|Physician Decision|3
4743813|NCT03774823|7706423|FG000|Overall Study|Withdrawal by Subject|1
4743814|NCT03774823|7706424|FG001|Overall Study|Withdrawal by Subject|1
4743815|NCT03774433|7706439|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14
4743816|NCT03769896|7706462|FG000|Open-label Phase|Lack of Efficacy|5
4743817|NCT03769896|7706463|FG001|Open-label Phase|Lack of Efficacy|0
4743818|NCT03769896|7706462|FG000|Open-label Phase|Adverse Event|3
4743819|NCT03769896|7706463|FG001|Open-label Phase|Adverse Event|0
4743820|NCT03769896|7706462|FG000|Open-label Phase|Withdrawal by Subject|1
4743821|NCT03769896|7706463|FG001|Open-label Phase|Withdrawal by Subject|0
4743822|NCT03769649|7706470|FG000|Overall Study|Lost to Follow-up|4
4743823|NCT03768726|7706484|FG000|Treatment Phase|Adverse Event|2
4743824|NCT03768726|7706485|FG001|Treatment Phase|Adverse Event|2
4743825|NCT03768726|7706484|FG000|Treatment Phase|Lost to Follow-up|1
4743826|NCT03768726|7706485|FG001|Treatment Phase|Lost to Follow-up|0
4743827|NCT03768726|7706484|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2
4743828|NCT03768726|7706485|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0
4743829|NCT03768726|7706484|FG000|Treatment Phase|Withdrawal by Subject|3
4743830|NCT03768726|7706485|FG001|Treatment Phase|Withdrawal by Subject|1
4743831|NCT03768726|7706484|FG000|Follow-Up|Adverse Event|2
4743832|NCT03768726|7706485|FG001|Follow-Up|Adverse Event|2
4743833|NCT03768726|7706484|FG000|Follow-Up|Withdrawal By Parent/Guardian|1
4743834|NCT03768726|7706485|FG001|Follow-Up|Withdrawal By Parent/Guardian|1
4743835|NCT03768726|7706484|FG000|Follow-Up|Withdrawal by Subject|2
4743836|NCT03768726|7706485|FG001|Follow-Up|Withdrawal by Subject|0
4743837|NCT03768726|7706484|FG000|Follow-Up|Other|1
4743838|NCT03768726|7706485|FG001|Follow-Up|Other|0
4743839|NCT03768206|7706493|FG000|Overall Study|Lost to Follow-up|2
4743840|NCT03768206|7706494|FG001|Overall Study|Lost to Follow-up|1
4743841|NCT03768206|7706493|FG000|Overall Study|Withdrawal by Subject|0
4743842|NCT03768206|7706494|FG001|Overall Study|Withdrawal by Subject|1
4743843|NCT03767894|7706501|FG000|Overall Study|Withdrawal by Subject|1
4743844|NCT03766646|7706534|FG000|Overall Study|Withdrawal by Subject|1
4743845|NCT03766646|7706535|FG001|Overall Study|Withdrawal by Subject|0
4743846|NCT03766646|7706534|FG000|Overall Study|Protocol Violation|0
4743847|NCT03766646|7706535|FG001|Overall Study|Protocol Violation|3
4743848|NCT03765164|7706607|FG000|Pre-intervention|Withdrawal by Subject|5
4743849|NCT03765164|7706608|FG001|Pre-intervention|Withdrawal by Subject|6
4743850|NCT03765138|7706614|FG000|Overall Study|Lost to Follow-up|1
4743851|NCT03762681|7706682|FG000|Part 1|Withdrawal by Subject|0
4743852|NCT03762681|7706683|FG001|Part 1|Withdrawal by Subject|0
4743853|NCT03762681|7706684|FG002|Part 1|Withdrawal by Subject|0
4743854|NCT03762681|7706685|FG003|Part 1|Withdrawal by Subject|1
4743855|NCT03762681|7706686|FG004|Part 1|Withdrawal by Subject|0
4743856|NCT03762681|7706687|FG005|Part 1|Withdrawal by Subject|0
4743857|NCT03762681|7706688|FG006|Part 1|Withdrawal by Subject|0
4743858|NCT03762681|7706689|FG007|Part 1|Withdrawal by Subject|0
4743859|NCT03762681|7706682|FG000|Part 2a|Pandemic Travel Restrictions|0
4743860|NCT03762681|7706683|FG001|Part 2a|Pandemic Travel Restrictions|0
4743861|NCT03762681|7706684|FG002|Part 2a|Pandemic Travel Restrictions|0
4525409|NCT01022853|7341222|FG000|Overall Study|Progressive disease|2
4525410|NCT01022853|7341223|FG001|Overall Study|Progressive disease|3
4525411|NCT01022853|7341224|FG002|Overall Study|Progressive disease|11
4525412|NCT01022853|7341225|FG003|Overall Study|Progressive disease|7
4525413|NCT01022853|7341226|FG004|Overall Study|Progressive disease|1
4525414|NCT01022853|7341222|FG000|Overall Study|Dose-limiting toxicity|0
4525415|NCT01022853|7341223|FG001|Overall Study|Dose-limiting toxicity|0
4525416|NCT01022853|7341224|FG002|Overall Study|Dose-limiting toxicity|0
4525417|NCT01022853|7341225|FG003|Overall Study|Dose-limiting toxicity|0
4525418|NCT01022853|7341226|FG004|Overall Study|Dose-limiting toxicity|1
4525419|NCT01022853|7341222|FG000|Overall Study|Withdrawal by Subject|0
4525420|NCT01022853|7341223|FG001|Overall Study|Withdrawal by Subject|1
4525421|NCT01022853|7341224|FG002|Overall Study|Withdrawal by Subject|1
4525422|NCT01022853|7341225|FG003|Overall Study|Withdrawal by Subject|1
4525423|NCT01022853|7341226|FG004|Overall Study|Withdrawal by Subject|0
4525424|NCT01022853|7341222|FG000|Overall Study|Other not stated above|1
4525425|NCT01022853|7341223|FG001|Overall Study|Other not stated above|0
4525426|NCT01022853|7341224|FG002|Overall Study|Other not stated above|1
4525427|NCT01022853|7341225|FG003|Overall Study|Other not stated above|0
4525428|NCT01022853|7341226|FG004|Overall Study|Other not stated above|0
4525429|NCT01022996|7341241|FG000|Overall Study|Adverse Event|14
4525430|NCT01022996|7341241|FG000|Overall Study|Withdrawal by Subject|3
4525431|NCT01022996|7341241|FG000|Overall Study|Lost to Follow-up|1
4525432|NCT01022996|7341241|FG000|Overall Study|Administrative problems|6
4525433|NCT01022996|7341241|FG000|Overall Study|Disease Progression|32
4525434|NCT01022996|7341241|FG000|Overall Study|Protocol Violation|1
4525435|NCT01023022|7341245|FG000|Overall Study|Death|5
4525436|NCT01023022|7341245|FG000|Overall Study|Lost to Follow-up|7
4525437|NCT01023022|7341245|FG000|Overall Study|due to technical issues|2
4525438|NCT01023035|7341252|FG000|Treatment Period|Adverse Event|27
4525439|NCT01023035|7341253|FG001|Treatment Period|Adverse Event|32
4525440|NCT01023035|7341254|FG002|Treatment Period|Adverse Event|50
4525441|NCT01023035|7341252|FG000|Treatment Period|Non-Medical Reasons|19
4525442|NCT01023035|7341253|FG001|Treatment Period|Non-Medical Reasons|22
4525443|NCT01023035|7341254|FG002|Treatment Period|Non-Medical Reasons|44
4525444|NCT01023035|7341252|FG000|Treatment Period|Treatment Failure|26
4525445|NCT01023035|7341253|FG001|Treatment Period|Treatment Failure|31
4525446|NCT01023035|7341254|FG002|Treatment Period|Treatment Failure|24
4525447|NCT01023035|7341252|FG000|Follow-up Period (up to Week 72)|Adverse Event|2
4525448|NCT01023035|7341253|FG001|Follow-up Period (up to Week 72)|Adverse Event|0
4743862|NCT03762681|7706685|FG003|Part 2a|Pandemic Travel Restrictions|0
4743863|NCT03762681|7706686|FG004|Part 2a|Pandemic Travel Restrictions|0
4525449|NCT01023035|7341254|FG002|Follow-up Period (up to Week 72)|Adverse Event|1
4525450|NCT01023035|7341252|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26
4525451|NCT01023035|7341253|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28
4743864|NCT03762681|7706687|FG005|Part 2a|Pandemic Travel Restrictions|0
4743865|NCT03762681|7706688|FG006|Part 2a|Pandemic Travel Restrictions|0
4743866|NCT03762681|7706689|FG007|Part 2a|Pandemic Travel Restrictions|1
4743867|NCT03762668|7706718|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0
4743868|NCT03762668|7706719|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1
4743869|NCT03762616|7706725|FG000|Overall Study|Protocol Violation|2
4743870|NCT03762200|7706740|FG000|Overall Study|Death|2
4743871|NCT03761147|7706755|FG000|Overall Study|Withdrawal by Subject|6
4743872|NCT03761147|7706756|FG001|Overall Study|Withdrawal by Subject|1
4743873|NCT03761147|7706755|FG000|Overall Study|Adverse Event|1
4743874|NCT03761147|7706756|FG001|Overall Study|Adverse Event|3
4743875|NCT03760510|7706870|FG000|Overall Study|Not ventilated for 24 hours|105
4743876|NCT03760510|7706871|FG001|Overall Study|Not ventilated for 24 hours|97
4743877|NCT03760250|7706877|FG000|Overall Study|Withdrawal by Subject|1
4743878|NCT03760250|7706877|FG000|Overall Study|Physician Decision|1
4743879|NCT03759600|7706881|FG000|Overall Study|Ongoing at Data Cut-off|16
4743880|NCT03759600|7706881|FG000|Overall Study|Adverse Event|1
4743881|NCT03759600|7706881|FG000|Overall Study|Progressive Disease|3
4743882|NCT03759340|7706885|FG000|Overall Study|Adverse Event|2
4743883|NCT03759340|7706885|FG000|Overall Study|Lost to Follow-up|1
4743884|NCT03759340|7706885|FG000|Overall Study|Withdrawal by Subject|15
4743885|NCT03759340|7706885|FG000|Overall Study|Study Terminated by Sponsor|38
4743886|NCT03757988|7706908|FG000|Overall Study|Withdrawal by Subject|1
4743887|NCT03757234|7706929|FG000|Overall Study|Adverse Event|0
4743888|NCT03757234|7706930|FG001|Overall Study|Adverse Event|0
4743889|NCT03757234|7706931|FG002|Overall Study|Adverse Event|0
4743890|NCT03757234|7706932|FG003|Overall Study|Adverse Event|0
4743891|NCT03757234|7706933|FG004|Overall Study|Adverse Event|1
4743892|NCT03757234|7706929|FG000|Overall Study|Lost to Follow-up|1
4743893|NCT03757234|7706930|FG001|Overall Study|Lost to Follow-up|0
4743894|NCT03757234|7706931|FG002|Overall Study|Lost to Follow-up|0
4743895|NCT03757234|7706932|FG003|Overall Study|Lost to Follow-up|0
4743896|NCT03757234|7706933|FG004|Overall Study|Lost to Follow-up|1
4743897|NCT03757234|7706929|FG000|Overall Study|Withdrawal by Subject|1
4743898|NCT03757234|7706930|FG001|Overall Study|Withdrawal by Subject|1
4743899|NCT03757234|7706931|FG002|Overall Study|Withdrawal by Subject|0
4743900|NCT03757234|7706932|FG003|Overall Study|Withdrawal by Subject|1
4743901|NCT03757234|7706933|FG004|Overall Study|Withdrawal by Subject|2
4743902|NCT03757234|7706929|FG000|Overall Study|Other|1
4743903|NCT03757234|7706930|FG001|Overall Study|Other|1
4743904|NCT03757234|7706931|FG002|Overall Study|Other|0
4743905|NCT03757234|7706932|FG003|Overall Study|Other|0
4743906|NCT03757234|7706933|FG004|Overall Study|Other|0
4743907|NCT03756883|7706961|FG000|Overall Study|Adverse Event|2
4743908|NCT03756883|7706962|FG001|Overall Study|Adverse Event|2
4743909|NCT03756883|7706963|FG002|Overall Study|Adverse Event|2
4743910|NCT03756883|7706961|FG000|Overall Study|Lack of Efficacy|0
4743911|NCT03756883|7706962|FG001|Overall Study|Lack of Efficacy|1
4743912|NCT03756883|7706963|FG002|Overall Study|Lack of Efficacy|2
4743913|NCT03756883|7706961|FG000|Overall Study|Lost to Follow-up|3
4743914|NCT03756883|7706962|FG001|Overall Study|Lost to Follow-up|3
4743915|NCT03756883|7706963|FG002|Overall Study|Lost to Follow-up|0
4743916|NCT03756883|7706961|FG000|Overall Study|Protocol Violation|2
4743917|NCT03756883|7706962|FG001|Overall Study|Protocol Violation|0
4743918|NCT03756883|7706963|FG002|Overall Study|Protocol Violation|1
4743919|NCT03756883|7706961|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0
4743920|NCT03756883|7706962|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0
4743921|NCT03756883|7706963|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2
4743922|NCT03756883|7706961|FG000|Overall Study|Withdrawal by Subject|4
4743923|NCT03756883|7706962|FG001|Overall Study|Withdrawal by Subject|1
4743924|NCT03756883|7706963|FG002|Overall Study|Withdrawal by Subject|0
4743925|NCT03756883|7706961|FG000|Overall Study|Other Reasons|2
4743926|NCT03756883|7706962|FG001|Overall Study|Other Reasons|4
4743927|NCT03756883|7706963|FG002|Overall Study|Other Reasons|0
4743928|NCT03756285|7706982|FG000|Overall Study|Lost to Follow-up|0
4743929|NCT03756285|7706983|FG001|Overall Study|Lost to Follow-up|1
4743930|NCT03756285|7706982|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0
4743931|NCT03756285|7706983|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1
4743932|NCT03756285|7706982|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3
4743933|NCT03756285|7706983|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3
4743934|NCT03756129|7706996|FG000|Overall Study|Adverse Event|1
4743935|NCT03756129|7706997|FG001|Overall Study|Adverse Event|1
4743936|NCT03756129|7706998|FG002|Overall Study|Adverse Event|0
4743937|NCT03756129|7706999|FG003|Overall Study|Adverse Event|2
4743938|NCT03756129|7707000|FG004|Overall Study|Adverse Event|0
4743939|NCT03756129|7707001|FG005|Overall Study|Adverse Event|0
4743940|NCT03756129|7706996|FG000|Overall Study|Withdrawal by Subject|2
4743941|NCT03756129|7706997|FG001|Overall Study|Withdrawal by Subject|1
4743942|NCT03756129|7706998|FG002|Overall Study|Withdrawal by Subject|3
4743943|NCT03756129|7706999|FG003|Overall Study|Withdrawal by Subject|1
4743944|NCT03756129|7707000|FG004|Overall Study|Withdrawal by Subject|1
4743945|NCT03756129|7707001|FG005|Overall Study|Withdrawal by Subject|3
4743946|NCT03756129|7706996|FG000|Overall Study|Lost to Follow-up|0
4743947|NCT03756129|7706997|FG001|Overall Study|Lost to Follow-up|0
4743948|NCT03756129|7706998|FG002|Overall Study|Lost to Follow-up|0
4743949|NCT03756129|7706999|FG003|Overall Study|Lost to Follow-up|0
4743950|NCT03756129|7707000|FG004|Overall Study|Lost to Follow-up|0
4743951|NCT03756129|7707001|FG005|Overall Study|Lost to Follow-up|1
4743952|NCT03756129|7706996|FG000|Overall Study|Physician Decision|0
4743953|NCT03756129|7706997|FG001|Overall Study|Physician Decision|0
4743954|NCT03756129|7706998|FG002|Overall Study|Physician Decision|0
4743955|NCT03756129|7706999|FG003|Overall Study|Physician Decision|0
4743956|NCT03756129|7707000|FG004|Overall Study|Physician Decision|0
4743957|NCT03756129|7707001|FG005|Overall Study|Physician Decision|1
4743958|NCT03755882|7707037|FG000|Period 1|Protocol Violation|1
4743959|NCT03755882|7707038|FG001|Period 1|Protocol Violation|0
4743960|NCT03755882|7707037|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3
4743961|NCT03755882|7707038|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0
4743962|NCT03755661|7707046|FG000|Overall Study|Lost to Follow-up|1
4743963|NCT03755661|7707047|FG001|Overall Study|Lost to Follow-up|0
4743964|NCT03754582|7707053|FG000|Treatment Phase|Adverse Event|0
4743965|NCT03754582|7707054|FG001|Treatment Phase|Adverse Event|1
4743966|NCT03754582|7707055|FG002|Treatment Phase|Adverse Event|0
4743967|NCT03754582|7707053|FG000|Follow-up Phase|Other|0
4743968|NCT03754582|7707054|FG001|Follow-up Phase|Other|0
4743969|NCT03754582|7707055|FG002|Follow-up Phase|Other|1
4743970|NCT03752528|7707088|FG000|Part A|Lost to Follow-up|1
4743971|NCT03752528|7707088|FG000|Part A|Protocol Violation|1
4743972|NCT03752528|7707088|FG000|Part B|Protocol Violation|1
4743973|NCT03752528|7707088|FG000|Part B|Study terminated by sponsor|3
4743974|NCT03752151|7707095|FG000|Overall Study|Withdrawal by Subject|1
4743975|NCT03752151|7707095|FG000|Overall Study|Protocol Violation|1
4743976|NCT03751657|7707102|FG000|Overall Study|Physician Decision|0
4743977|NCT03751657|7707103|FG001|Overall Study|Physician Decision|1
4743978|NCT03751657|7707102|FG000|Overall Study|Withdrawal by Subject|1
4743979|NCT03751657|7707103|FG001|Overall Study|Withdrawal by Subject|1
4743980|NCT03751657|7707102|FG000|Overall Study|Lost to Follow-up|2
4743981|NCT03751657|7707103|FG001|Overall Study|Lost to Follow-up|1
4743982|NCT03751280|7707111|FG000|Overall Study|Adverse Event|0
4743983|NCT03751280|7707112|FG001|Overall Study|Adverse Event|1
4743984|NCT03751280|7707111|FG000|Overall Study|Lost to Follow-up|3
4743985|NCT03751280|7707112|FG001|Overall Study|Lost to Follow-up|5
4743986|NCT03751280|7707111|FG000|Overall Study|Physician Decision|0
4743987|NCT03751280|7707112|FG001|Overall Study|Physician Decision|2
4743988|NCT03751280|7707111|FG000|Overall Study|Protocol Violation|0
4743989|NCT03751280|7707112|FG001|Overall Study|Protocol Violation|2
4743990|NCT03751280|7707111|FG000|Overall Study|Withdrawal by Subject|5
4743991|NCT03751280|7707112|FG001|Overall Study|Withdrawal by Subject|2
4743992|NCT03751020|7707122|FG000|Overall Study|Withdrawal by Subject|2
4743993|NCT03751020|7707123|FG001|Overall Study|Withdrawal by Subject|0
4743994|NCT03751020|7707124|FG002|Overall Study|Withdrawal by Subject|0
4743995|NCT03751020|7707122|FG000|Overall Study|Lost to Follow-up|7
4743996|NCT03751020|7707123|FG001|Overall Study|Lost to Follow-up|4
4743997|NCT03751020|7707124|FG002|Overall Study|Lost to Follow-up|10
4743998|NCT03750955|7707134|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2
4743999|NCT03750955|7707135|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2
4744000|NCT03750955|7707134|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1
4744001|NCT03750955|7707135|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1
4744002|NCT03750695|7707143|FG000|Overall Study|Lost to Follow-up|0
4744003|NCT03750695|7707144|FG001|Overall Study|Lost to Follow-up|1
4744004|NCT03748706|7707252|FG000|Overall Study|Lost to Follow-up|1
4744005|NCT03746405|7707280|FG000|Overall Study|Withdrawal by Subject|3
4744006|NCT03746405|7707281|FG001|Overall Study|Withdrawal by Subject|0
4744007|NCT03746405|7707280|FG000|Overall Study|technical difficulties|0
4744008|NCT03746405|7707281|FG001|Overall Study|technical difficulties|2
4744009|NCT03745937|7707291|FG000|Overall Study|Withdrawal by Subject|0
4744010|NCT03745937|7707292|FG001|Overall Study|Withdrawal by Subject|0
4744011|NCT03745937|7707293|FG002|Overall Study|Withdrawal by Subject|0
4744012|NCT03745937|7707294|FG003|Overall Study|Withdrawal by Subject|1
4744013|NCT03745937|7707291|FG000|Overall Study|Not-specifed|0
4744014|NCT03745937|7707292|FG001|Overall Study|Not-specifed|1
4744015|NCT03745937|7707293|FG002|Overall Study|Not-specifed|0
4744016|NCT03745937|7707294|FG003|Overall Study|Not-specifed|1
4744017|NCT03745222|7707308|FG000|Overall Study|Withdrawal by Subject|0
4744018|NCT03745222|7707309|FG001|Overall Study|Withdrawal by Subject|1
4744019|NCT03745222|7707310|FG002|Overall Study|Withdrawal by Subject|0
4634225|NCT01921829|7504981|FG000|Overall Study|Withdrawal by Subject|0
4634226|NCT01921829|7504982|FG001|Overall Study|Withdrawal by Subject|1
4744020|NCT03743038|7707345|FG000|Overall Study|Physician Decision|1
4744021|NCT03742271|7707368|FG000|Overall Study|Unsatisfactory Visual Response|1
4744022|NCT03742271|7707368|FG000|Overall Study|Withdrawal by Subject|3
4744023|NCT03742271|7707368|FG000|Overall Study|Lost to Follow-up|4
4744024|NCT03742271|7707368|FG000|Overall Study|Failed Insertion & removal|3
4744025|NCT03742271|7707368|FG000|Overall Study|Protocol Violation|1
4744026|NCT03741062|7707403|FG000|Overall Study|Protocol Violation|1
4744027|NCT03741062|7707404|FG001|Overall Study|Protocol Violation|0
4744028|NCT03739866|7707435|FG000|Overall Study|Lost to Follow-up|0
4744029|NCT03739866|7707436|FG001|Overall Study|Lost to Follow-up|0
4744030|NCT03739866|7707437|FG002|Overall Study|Lost to Follow-up|0
4744031|NCT03739866|7707438|FG003|Overall Study|Lost to Follow-up|1
4744032|NCT03739866|7707439|FG004|Overall Study|Lost to Follow-up|0
4744033|NCT03739866|7707440|FG005|Overall Study|Lost to Follow-up|0
4744034|NCT03739866|7707441|FG006|Overall Study|Lost to Follow-up|0
4744035|NCT03739866|7707442|FG007|Overall Study|Lost to Follow-up|0
4744036|NCT03739866|7707435|FG000|Overall Study|Enrolled but not treated|0
4744037|NCT03739866|7707436|FG001|Overall Study|Enrolled but not treated|0
4744038|NCT03739866|7707437|FG002|Overall Study|Enrolled but not treated|1
4744039|NCT03739866|7707438|FG003|Overall Study|Enrolled but not treated|0
4744040|NCT03739866|7707439|FG004|Overall Study|Enrolled but not treated|1
4744041|NCT03739866|7707440|FG005|Overall Study|Enrolled but not treated|0
4744042|NCT03739866|7707441|FG006|Overall Study|Enrolled but not treated|0
4744043|NCT03739866|7707442|FG007|Overall Study|Enrolled but not treated|0
4744044|NCT03739528|7707470|FG000|Overall Study|Not treated|8
4744045|NCT03739528|7707471|FG001|Overall Study|Not treated|12
4744046|NCT03739528|7707470|FG000|Overall Study|Treatment and study discontinued|6
4744047|NCT03739528|7707471|FG001|Overall Study|Treatment and study discontinued|2
4744048|NCT03739528|7707470|FG000|Overall Study|Treatment discontinued + study completed|1
4744049|NCT03739528|7707471|FG001|Overall Study|Treatment discontinued + study completed|3
4744050|NCT03739242|7707482|FG000|Overall Study|Withdrawal by Subject|1
4744051|NCT03739242|7707483|FG001|Overall Study|Withdrawal by Subject|1
4744052|NCT03739242|7707482|FG000|Overall Study|Protocol Violation|0
4744053|NCT03739242|7707483|FG001|Overall Study|Protocol Violation|1
4744054|NCT03738865|7707491|FG000|Overall Study|Withdrawal by Subject|3
4744055|NCT03738865|7707492|FG001|Overall Study|Withdrawal by Subject|3
4744056|NCT03738865|7707491|FG000|Overall Study|Adverse Event|2
4744057|NCT03738865|7707492|FG001|Overall Study|Adverse Event|0
4744058|NCT03738865|7707491|FG000|Overall Study|Physician Decision|0
4744059|NCT03738865|7707492|FG001|Overall Study|Physician Decision|1
4744060|NCT03738475|7707509|FG000|Overall Study|Participant Non-Compliance|1
4744061|NCT03738475|7707510|FG001|Overall Study|Participant Non-Compliance|0
4744062|NCT03738241|7707526|FG000|Overall Study|Withdrawal by Subject|0
4744063|NCT03738241|7707527|FG001|Overall Study|Withdrawal by Subject|0
4744064|NCT03738241|7707528|FG002|Overall Study|Withdrawal by Subject|0
4744065|NCT03738241|7707529|FG003|Overall Study|Withdrawal by Subject|0
4744066|NCT03738241|7707530|FG004|Overall Study|Withdrawal by Subject|0
4744067|NCT03738241|7707531|FG005|Overall Study|Withdrawal by Subject|0
4744068|NCT03738241|7707532|FG006|Overall Study|Withdrawal by Subject|0
4744069|NCT03738241|7707533|FG007|Overall Study|Withdrawal by Subject|0
4744070|NCT03738241|7707534|FG008|Overall Study|Withdrawal by Subject|0
4744071|NCT03738241|7707535|FG009|Overall Study|Withdrawal by Subject|1
4744072|NCT03738241|7707526|FG000|Overall Study|Physician Decision|0
4744073|NCT03738241|7707527|FG001|Overall Study|Physician Decision|0
4744074|NCT03738241|7707528|FG002|Overall Study|Physician Decision|0
4744075|NCT03738241|7707529|FG003|Overall Study|Physician Decision|0
4744076|NCT03738241|7707530|FG004|Overall Study|Physician Decision|0
4744077|NCT03738241|7707531|FG005|Overall Study|Physician Decision|0
4744078|NCT03738241|7707532|FG006|Overall Study|Physician Decision|0
4744079|NCT03738241|7707533|FG007|Overall Study|Physician Decision|0
4744080|NCT03738241|7707534|FG008|Overall Study|Physician Decision|1
4744081|NCT03738241|7707535|FG009|Overall Study|Physician Decision|0
4744082|NCT03738241|7707526|FG000|Overall Study|Adverse Event|1
4744083|NCT03738241|7707527|FG001|Overall Study|Adverse Event|0
4744084|NCT03738241|7707528|FG002|Overall Study|Adverse Event|0
4744085|NCT03738241|7707529|FG003|Overall Study|Adverse Event|0
4744086|NCT03738241|7707530|FG004|Overall Study|Adverse Event|0
4744087|NCT03738241|7707531|FG005|Overall Study|Adverse Event|0
4744088|NCT03738241|7707532|FG006|Overall Study|Adverse Event|0
4744089|NCT03738241|7707533|FG007|Overall Study|Adverse Event|0
4744090|NCT03738241|7707534|FG008|Overall Study|Adverse Event|0
4744091|NCT03738241|7707535|FG009|Overall Study|Adverse Event|0
4744092|NCT03736785|7707592|FG000|Overall Study|Adverse Event|1
4744093|NCT03736785|7707593|FG001|Overall Study|Adverse Event|1
4744094|NCT03736785|7707594|FG002|Overall Study|Adverse Event|1
4744095|NCT03736785|7707592|FG000|Overall Study|Death|1
4744096|NCT03736785|7707593|FG001|Overall Study|Death|0
4744097|NCT03736785|7707594|FG002|Overall Study|Death|1
4744098|NCT03736785|7707592|FG000|Overall Study|Lost to Follow-up|0
4744099|NCT03736785|7707593|FG001|Overall Study|Lost to Follow-up|2
4744100|NCT03736785|7707594|FG002|Overall Study|Lost to Follow-up|3
4744101|NCT03736785|7707592|FG000|Overall Study|Non compliance with study drug|1
4744102|NCT03736785|7707593|FG001|Overall Study|Non compliance with study drug|1
4744103|NCT03736785|7707594|FG002|Overall Study|Non compliance with study drug|0
4744104|NCT03736785|7707592|FG000|Overall Study|Physician Decision|0
4744105|NCT03736785|7707593|FG001|Overall Study|Physician Decision|1
4744106|NCT03736785|7707594|FG002|Overall Study|Physician Decision|1
4744107|NCT03736785|7707592|FG000|Overall Study|Protocol Violation|1
4744108|NCT03736785|7707593|FG001|Overall Study|Protocol Violation|4
4744109|NCT03736785|7707594|FG002|Overall Study|Protocol Violation|3
4744110|NCT03736785|7707592|FG000|Overall Study|Sponsor Decision|1
4744111|NCT03736785|7707593|FG001|Overall Study|Sponsor Decision|0
4744112|NCT03736785|7707594|FG002|Overall Study|Sponsor Decision|0
4744113|NCT03736785|7707592|FG000|Overall Study|Unknown/Missing data|3
4744114|NCT03736785|7707593|FG001|Overall Study|Unknown/Missing data|2
4744115|NCT03736785|7707594|FG002|Overall Study|Unknown/Missing data|1
4744116|NCT03736785|7707592|FG000|Overall Study|Withdrawal by Subject|9
4744117|NCT03736785|7707593|FG001|Overall Study|Withdrawal by Subject|6
4744118|NCT03736785|7707594|FG002|Overall Study|Withdrawal by Subject|4
4744119|NCT03736031|7707605|FG000|Overall Study|Death|2
4744120|NCT03736031|7707606|FG001|Overall Study|Death|4
4744121|NCT03736031|7707605|FG000|Overall Study|Lost to Follow-up|21
4744122|NCT03736031|7707606|FG001|Overall Study|Lost to Follow-up|2
4744123|NCT03736031|7707605|FG000|Overall Study|Withdrawal by Subject|9
4744124|NCT03736031|7707606|FG001|Overall Study|Withdrawal by Subject|0
4525452|NCT01023035|7341254|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38
4744125|NCT03734991|7707618|FG000|Overall Study|Adverse Event|4
4744126|NCT03734991|7707619|FG001|Overall Study|Adverse Event|0
4744127|NCT03734991|7707618|FG000|Overall Study|Lost to Follow-up|4
4744128|NCT03734991|7707619|FG001|Overall Study|Lost to Follow-up|0
4744129|NCT03734991|7707618|FG000|Overall Study|Physician Decision|0
4744130|NCT03734991|7707619|FG001|Overall Study|Physician Decision|1
4744131|NCT03734991|7707618|FG000|Overall Study|Pregnancy|1
4744132|NCT03734991|7707619|FG001|Overall Study|Pregnancy|0
4744133|NCT03734991|7707618|FG000|Overall Study|Withdrawal by Subject|6
4744134|NCT03734991|7707619|FG001|Overall Study|Withdrawal by Subject|3
4744135|NCT03734991|7707618|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49
4744136|NCT03734991|7707619|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41
4744137|NCT03734991|7707618|FG000|Overall Study|Other|2
4744138|NCT03734991|7707619|FG001|Overall Study|Other|2
4744139|NCT03733899|7707633|FG000|Period 1|Protocol Violation|0
4744140|NCT03733899|7707634|FG001|Period 1|Protocol Violation|0
4744141|NCT03733899|7707635|FG002|Period 1|Protocol Violation|0
4744142|NCT03733899|7707636|FG003|Period 1|Protocol Violation|0
4744143|NCT03733899|7707637|FG004|Period 1|Protocol Violation|0
4744144|NCT03733899|7707638|FG005|Period 1|Protocol Violation|1
4744145|NCT03733899|7707633|FG000|Period 2|Unscuccessful Treatment|0
4744146|NCT03733899|7707634|FG001|Period 2|Unscuccessful Treatment|1
4744147|NCT03733899|7707635|FG002|Period 2|Unscuccessful Treatment|0
4744148|NCT03733899|7707636|FG003|Period 2|Unscuccessful Treatment|0
4744149|NCT03733899|7707637|FG004|Period 2|Unscuccessful Treatment|0
4744150|NCT03733899|7707638|FG005|Period 2|Unscuccessful Treatment|0
4744151|NCT03733899|7707633|FG000|Period 3|Withdrawal by Subject|1
4744152|NCT03733899|7707634|FG001|Period 3|Withdrawal by Subject|0
4744153|NCT03733899|7707635|FG002|Period 3|Withdrawal by Subject|0
4744154|NCT03733899|7707636|FG003|Period 3|Withdrawal by Subject|0
4744155|NCT03733899|7707637|FG004|Period 3|Withdrawal by Subject|0
4744156|NCT03733899|7707638|FG005|Period 3|Withdrawal by Subject|0
4744157|NCT03733470|7707657|FG000|Overall Study|PI Decision|1
4744158|NCT03733470|7707658|FG001|Overall Study|PI Decision|1
4744159|NCT03733301|7707667|FG000|Overall Study|Screen Fail|1
4744160|NCT03733301|7707668|FG001|Overall Study|Screen Fail|0
4744161|NCT03733301|7707669|FG002|Overall Study|Screen Fail|0
4744162|NCT03733301|7707667|FG000|Overall Study|Non-compliance|1
4744163|NCT03733301|7707668|FG001|Overall Study|Non-compliance|0
4744164|NCT03733301|7707669|FG002|Overall Study|Non-compliance|0
4744165|NCT03733301|7707667|FG000|Overall Study|Lack of Efficacy|2
4744166|NCT03733301|7707668|FG001|Overall Study|Lack of Efficacy|3
4744167|NCT03733301|7707669|FG002|Overall Study|Lack of Efficacy|0
4744168|NCT03733301|7707667|FG000|Overall Study|Adverse Event|0
4744169|NCT03733301|7707668|FG001|Overall Study|Adverse Event|1
4744170|NCT03733301|7707669|FG002|Overall Study|Adverse Event|3
4744171|NCT03733301|7707667|FG000|Overall Study|Withdrawal by Subject|3
4744172|NCT03733301|7707668|FG001|Overall Study|Withdrawal by Subject|5
4744173|NCT03733301|7707669|FG002|Overall Study|Withdrawal by Subject|1
4744174|NCT03732638|7707680|FG000|Overall Study|Adverse Event|5
4744175|NCT03732638|7707681|FG001|Overall Study|Adverse Event|2
4744176|NCT03732638|7707680|FG000|Overall Study|Eligibility failure due to baseline laboratory values|8
4744177|NCT03732638|7707681|FG001|Overall Study|Eligibility failure due to baseline laboratory values|13
4744178|NCT03732638|7707680|FG000|Overall Study|Lack of Efficacy|1
4744179|NCT03732638|7707681|FG001|Overall Study|Lack of Efficacy|1
4744180|NCT03732638|7707680|FG000|Overall Study|Lost to Follow-up|19
4744181|NCT03732638|7707681|FG001|Overall Study|Lost to Follow-up|12
4744182|NCT03732638|7707680|FG000|Overall Study|Non-compliance|6
4744183|NCT03732638|7707681|FG001|Overall Study|Non-compliance|5
4744184|NCT03732638|7707680|FG000|Overall Study|Physician Decision|0
4744185|NCT03732638|7707681|FG001|Overall Study|Physician Decision|1
4744186|NCT03732638|7707680|FG000|Overall Study|Protocol deviation|4
4744187|NCT03732638|7707681|FG001|Overall Study|Protocol deviation|5
4744188|NCT03732638|7707680|FG000|Overall Study|Withdrawal by Subject|11
4744189|NCT03732638|7707681|FG001|Overall Study|Withdrawal by Subject|22
4744190|NCT03732248|7707690|FG000|Overall Study|Withdrawal by Subject|1
4744191|NCT03732248|7707691|FG001|Overall Study|Withdrawal by Subject|0
4744192|NCT03731182|7707699|FG000|Overall Study|Lost to Follow-up|2
4744193|NCT03731182|7707700|FG001|Overall Study|Lost to Follow-up|0
4744194|NCT03731182|7707699|FG000|Overall Study|Physician Decision|1
4744195|NCT03731182|7707700|FG001|Overall Study|Physician Decision|0
4744196|NCT03731182|7707699|FG000|Overall Study|Withdrawal By Parent/Guardian|2
4744197|NCT03731182|7707700|FG001|Overall Study|Withdrawal By Parent/Guardian|0
4744198|NCT03730961|7707709|FG000|Overall Study|Adverse Event|0
4744199|NCT03730961|7707710|FG001|Overall Study|Adverse Event|1
4744200|NCT03730103|7707726|FG000|Overall Study|Did not meet inclusion criteria|0
4744201|NCT03730103|7707727|FG001|Overall Study|Did not meet inclusion criteria|5
4744202|NCT03728140|7707757|FG000|Overall Study|Abnormal embryo transfer operation|10
4744203|NCT03728140|7707758|FG001|Overall Study|Abnormal embryo transfer operation|7
4744204|NCT03727347|7707777|FG000|Overall Study|Withdrawal by Subject|2
4744205|NCT03727347|7707777|FG000|Overall Study|Lost to Follow-up|1
4744206|NCT03726996|7707790|FG000|Overall Study|Parent's decision|2
4744207|NCT03726996|7707790|FG000|Overall Study|Study early termination|2
4744208|NCT03725852|7707805|FG000|Overall Study|Death|1
4744209|NCT03725852|7707806|FG001|Overall Study|Death|0
4744210|NCT03725852|7707805|FG000|Overall Study|Withdrawal by Subject|1
4744211|NCT03725852|7707806|FG001|Overall Study|Withdrawal by Subject|0
4744212|NCT03725852|7707805|FG000|Overall Study|Travel restrictions due to COVID-19|2
4744213|NCT03725852|7707806|FG001|Overall Study|Travel restrictions due to COVID-19|0
4744214|NCT03725722|7707817|FG000|Overall Study|Lack of Efficacy|2
4744215|NCT03725722|7707818|FG001|Overall Study|Lack of Efficacy|1
4744216|NCT03725722|7707819|FG002|Overall Study|Lack of Efficacy|2
4744217|NCT03725722|7707820|FG003|Overall Study|Lack of Efficacy|0
4744218|NCT03725722|7707821|FG004|Overall Study|Lack of Efficacy|2
4744219|NCT03725722|7707817|FG000|Overall Study|Adverse Event|2
4744220|NCT03725722|7707818|FG001|Overall Study|Adverse Event|2
4744221|NCT03725722|7707819|FG002|Overall Study|Adverse Event|1
4525453|NCT01023061|7341264|FG000|Overall Study|Withdrawal prior to treatment|2
4525454|NCT01023217|7341300|FG000|Overall Study|Withdrawal by Subject|1
4525455|NCT01023217|7341301|FG001|Overall Study|Withdrawal by Subject|0
4525456|NCT01023256|7341311|FG000|Overall Study|Protocol Violation|2
4525457|NCT01023256|7341312|FG001|Overall Study|Protocol Violation|3
4525458|NCT01023256|7341313|FG002|Overall Study|Protocol Violation|0
4525459|NCT01023256|7341314|FG003|Overall Study|Protocol Violation|0
4744222|NCT03725722|7707820|FG003|Overall Study|Adverse Event|0
4744223|NCT03725722|7707821|FG004|Overall Study|Adverse Event|6
4744224|NCT03725722|7707817|FG000|Overall Study|Withdrawal by Subject|4
4744225|NCT03725722|7707818|FG001|Overall Study|Withdrawal by Subject|1
4744226|NCT03725722|7707819|FG002|Overall Study|Withdrawal by Subject|0
4744227|NCT03725722|7707820|FG003|Overall Study|Withdrawal by Subject|4
4744228|NCT03725722|7707821|FG004|Overall Study|Withdrawal by Subject|4
4744229|NCT03725722|7707817|FG000|Overall Study|Lost to Follow-up|3
4744230|NCT03725722|7707818|FG001|Overall Study|Lost to Follow-up|1
4744231|NCT03725722|7707819|FG002|Overall Study|Lost to Follow-up|2
4744232|NCT03725722|7707820|FG003|Overall Study|Lost to Follow-up|2
4744233|NCT03725722|7707821|FG004|Overall Study|Lost to Follow-up|1
4744234|NCT03725722|7707817|FG000|Overall Study|Personal reasons|0
4744235|NCT03725722|7707818|FG001|Overall Study|Personal reasons|0
4744236|NCT03725722|7707819|FG002|Overall Study|Personal reasons|1
4744237|NCT03725722|7707820|FG003|Overall Study|Personal reasons|0
4744238|NCT03725722|7707821|FG004|Overall Study|Personal reasons|1
4744239|NCT03725722|7707817|FG000|Overall Study|COVID-19 situation|0
4744240|NCT03725722|7707818|FG001|Overall Study|COVID-19 situation|1
4744241|NCT03725722|7707819|FG002|Overall Study|COVID-19 situation|0
4744242|NCT03725722|7707820|FG003|Overall Study|COVID-19 situation|0
4744243|NCT03725722|7707821|FG004|Overall Study|COVID-19 situation|0
4634227|NCT01922011|7505015|FG000|Overall Study|Protocol Violation|0
4744244|NCT03725085|7707842|FG000|Overall Study|Lost to Follow-up|2
4744245|NCT03724981|7707858|FG000|First Device|Protocol Violation|1
4744246|NCT03724981|7707859|FG001|First Device|Protocol Violation|1
4744247|NCT03724968|7707869|FG000|Overall Study|Insurance issues|0
4744248|NCT03724968|7707870|FG001|Overall Study|Insurance issues|1
4744249|NCT03724968|7707869|FG000|Overall Study|Study closed|0
4744250|NCT03724968|7707870|FG001|Overall Study|Study closed|1
4744251|NCT03723070|7707934|FG000|Overall Study|Lost to Follow-up|2
4744252|NCT03723070|7707934|FG000|Overall Study|Physician Decision|1
4634228|NCT01922011|7505016|FG001|Overall Study|Protocol Violation|1
4634229|NCT01922011|7505015|FG000|Overall Study|Physician Decision|0
4634230|NCT01922011|7505016|FG001|Overall Study|Physician Decision|1
4634231|NCT01922011|7505015|FG000|Overall Study|Parent/Guardian Decision|3
4634232|NCT01922011|7505016|FG001|Overall Study|Parent/Guardian Decision|0
4634233|NCT01922011|7505015|FG000|Overall Study|Lost to Follow-up|0
4634234|NCT01922011|7505016|FG001|Overall Study|Lost to Follow-up|1
4634235|NCT01922011|7505015|FG000|Overall Study|Missed Test-of-Cure Visit|0
4634236|NCT01922011|7505016|FG001|Overall Study|Missed Test-of-Cure Visit|2
4634237|NCT01922011|7505015|FG000|Overall Study|Not Treated|1
4634238|NCT01922011|7505016|FG001|Overall Study|Not Treated|0
4634239|NCT01922011|7505015|FG000|Overall Study|Lack of willing home health agency|1
4634240|NCT01922011|7505016|FG001|Overall Study|Lack of willing home health agency|0
4634241|NCT01922011|7505015|FG000|Overall Study|Randomized in error|1
4634242|NCT01922011|7505016|FG001|Overall Study|Randomized in error|0
4634243|NCT01922037|7505039|FG000|Overall Study|Withdrawal by Subject|2
4634244|NCT01922037|7505040|FG001|Overall Study|Withdrawal by Subject|44
4634245|NCT01922037|7505039|FG000|Overall Study|Adverse Event|1
4634246|NCT01922037|7505040|FG001|Overall Study|Adverse Event|7
4634247|NCT01922037|7505039|FG000|Overall Study|Death|0
4634248|NCT01922037|7505040|FG001|Overall Study|Death|5
4634249|NCT01922037|7505039|FG000|Overall Study|Pregnancy|0
4634250|NCT01922037|7505040|FG001|Overall Study|Pregnancy|2
4634251|NCT01922037|7505039|FG000|Overall Study|Participant non-compliance|4
4634252|NCT01922037|7505040|FG001|Overall Study|Participant non-compliance|46
4744253|NCT03723070|7707934|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6
4744254|NCT03720210|7707938|FG000|Overall Study|Lost to Follow-up|1
4744255|NCT03718143|7707946|FG000|Overall Study|Death|1
4744256|NCT03718143|7707947|FG001|Overall Study|Death|0
4744257|NCT03718143|7707948|FG002|Overall Study|Death|0
4744258|NCT03718143|7707946|FG000|Overall Study|Progression of Disease|1
4744259|NCT03718143|7707947|FG001|Overall Study|Progression of Disease|0
4744260|NCT03718143|7707948|FG002|Overall Study|Progression of Disease|0
4744261|NCT03718143|7707946|FG000|Overall Study|Withdrawal of Informed Consent|1
4744262|NCT03718143|7707947|FG001|Overall Study|Withdrawal of Informed Consent|2
4744263|NCT03718143|7707948|FG002|Overall Study|Withdrawal of Informed Consent|1
4744264|NCT03709576|7707956|FG000|Overall Study|progression prior to enrollment|1
4634253|NCT01922037|7505039|FG000|Overall Study|Investigator/Sponsor decision|1
4634254|NCT01922037|7505040|FG001|Overall Study|Investigator/Sponsor decision|4
4744265|NCT03704636|7707961|FG000|Overall Study|Inadequate Venous Flow|3
4744266|NCT03694821|7707985|FG000|Overall Study|Study terminated|4
4634255|NCT01922037|7505039|FG000|Overall Study|Other unspecified|2
4634256|NCT01922037|7505040|FG001|Overall Study|Other unspecified|66
4634257|NCT01922089|7505107|FG000|Overall Study|Adverse Event|18
4634258|NCT01922089|7505108|FG001|Overall Study|Adverse Event|13
4634259|NCT01922089|7505107|FG000|Overall Study|Protocol Deviation|10
4634260|NCT01922089|7505108|FG001|Overall Study|Protocol Deviation|7
4634261|NCT01922089|7505107|FG000|Overall Study|Withdrawal by Subject|3
4634262|NCT01922089|7505108|FG001|Overall Study|Withdrawal by Subject|4
4634263|NCT01922089|7505107|FG000|Overall Study|administrative problems|4
4634264|NCT01922089|7505108|FG001|Overall Study|administrative problems|1
4634265|NCT01922089|7505107|FG000|Overall Study|Physician Decision|2
4634266|NCT01922089|7505108|FG001|Overall Study|Physician Decision|3
4634267|NCT01922089|7505107|FG000|Overall Study|Death|2
4634268|NCT01922089|7505108|FG001|Overall Study|Death|1
4634269|NCT01922089|7505107|FG000|Overall Study|Lost to Follow-up|0
4634270|NCT01922089|7505108|FG001|Overall Study|Lost to Follow-up|1
4634271|NCT01922102|7505117|FG000|Overall Study|Withdrawal by Subject|7
4634272|NCT01922102|7505118|FG001|Overall Study|Withdrawal by Subject|3
4634273|NCT01922102|7505119|FG002|Overall Study|Withdrawal by Subject|7
4634274|NCT01922102|7505117|FG000|Overall Study|Physician Decision|0
4634275|NCT01922102|7505118|FG001|Overall Study|Physician Decision|2
4744267|NCT03694821|7707986|FG001|Overall Study|Study terminated|8
4744268|NCT03694821|7707987|FG002|Overall Study|Study terminated|4
4744269|NCT03686969|7707997|FG000|Overall Study|Study terminated|1
4744270|NCT03686969|7707998|FG001|Overall Study|Study terminated|0
4744271|NCT03682367|7708006|FG000|Overall Study|Protocol Violation|2
4744272|NCT03682367|7708007|FG001|Overall Study|Protocol Violation|1
4744273|NCT03682367|7708006|FG000|Overall Study|Closed Study Early|0
4744274|NCT03682367|7708007|FG001|Overall Study|Closed Study Early|3
4744275|NCT03680911|7708015|FG000|At Home Treatment|Study Termination|3
4744276|NCT03680911|7708016|FG001|At Home Treatment|Study Termination|0
4634276|NCT01922102|7505119|FG002|Overall Study|Physician Decision|1
4634277|NCT01922102|7505117|FG000|Overall Study|Adverse Event|1
4634278|NCT01922102|7505118|FG001|Overall Study|Adverse Event|2
4634279|NCT01922102|7505119|FG002|Overall Study|Adverse Event|0
4634280|NCT01922102|7505117|FG000|Overall Study|Lost to Follow-up|1
4634281|NCT01922102|7505118|FG001|Overall Study|Lost to Follow-up|0
4634282|NCT01922102|7505119|FG002|Overall Study|Lost to Follow-up|0
4634283|NCT01922102|7505117|FG000|Overall Study|Administrative problems|0
4634284|NCT01922102|7505118|FG001|Overall Study|Administrative problems|2
4634285|NCT01922102|7505119|FG002|Overall Study|Administrative problems|0
4634286|NCT01922258|7505146|FG000|Overall Study|Lost to Follow-up|1
4634287|NCT01922258|7505147|FG001|Overall Study|Lost to Follow-up|1
4634288|NCT01922258|7505146|FG000|Overall Study|Adverse Event|9
4634289|NCT01922258|7505147|FG001|Overall Study|Adverse Event|2
4634290|NCT01922258|7505146|FG000|Overall Study|Met Withdrawal Criteria|0
4634291|NCT01922258|7505147|FG001|Overall Study|Met Withdrawal Criteria|4
4634292|NCT01922258|7505146|FG000|Overall Study|Withdrawn by the Investigator|1
4634293|NCT01922258|7505147|FG001|Overall Study|Withdrawn by the Investigator|4
4634294|NCT01922258|7505146|FG000|Overall Study|Withdrawal by participant|5
4634295|NCT01922258|7505147|FG001|Overall Study|Withdrawal by participant|5
4634296|NCT01922271|7505155|FG000|WASHOUT Period|Withdrawal by Subject|1
4634297|NCT01922271|7505156|FG001|WASHOUT Period|Withdrawal by Subject|0
4634298|NCT01922349|7505179|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0
4634299|NCT01922349|7505180|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0
4634300|NCT01922349|7505181|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0
4634301|NCT01922349|7505182|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1
4634302|NCT01922739|7505218|FG000|Titration/Adjustment Period|Adverse Event|3
4634303|NCT01922739|7505218|FG000|Titration/Adjustment Period|Withdrawal by Subject|5
4634304|NCT01922739|7505218|FG000|Titration/Adjustment Period|Lost to Follow-up|1
4634305|NCT01922739|7505218|FG000|Titration/Adjustment Period|Lack of Efficacy|3
4634306|NCT01922739|7505218|FG000|Open-label Treatment Period|Adverse Event|6
4634307|NCT01922739|7505218|FG000|Open-label Treatment Period|Withdrawal by Subject|14
4634308|NCT01922739|7505218|FG000|Open-label Treatment Period|Noncompliance to study medication|3
4634309|NCT01922739|7505218|FG000|Open-label Treatment Period|Protocol Violation|5
4634310|NCT01922739|7505218|FG000|Open-label Treatment Period|Pregnancy|1
4634311|NCT01922739|7505218|FG000|Open-label Treatment Period|Noncompliance to study procedures|1
4634312|NCT01922739|7505218|FG000|Open-label Treatment Period|Lost to Follow-up|2
4634313|NCT01922739|7505218|FG000|Open-label Treatment Period|Physician Decision|1
4634314|NCT01922739|7505218|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1
4634315|NCT01922934|7505236|FG000|Eligible Patients|Death|0
4634316|NCT01922934|7505237|FG001|Eligible Patients|Death|7
4634317|NCT01922934|7505236|FG000|Eligible Patients|Physician Decision|17
4634318|NCT01922934|7505237|FG001|Eligible Patients|Physician Decision|0
4634319|NCT01922934|7505236|FG000|Eligible Patients|Did not meet inclusion criteria|36
4634320|NCT01922934|7505237|FG001|Eligible Patients|Did not meet inclusion criteria|81
4634321|NCT01922934|7505236|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169
4634322|NCT01922934|7505237|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0
4634323|NCT01922934|7505236|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66
4744277|NCT03680911|7708015|FG000|At Home Treatment|Lost to Follow-up|0
4634324|NCT01922934|7505237|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0
4634325|NCT01922934|7505236|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21
4634326|NCT01922934|7505237|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284
4634327|NCT01923181|7505272|FG000|Overall Study|Protocol Violation|2
4634328|NCT01923181|7505273|FG001|Overall Study|Protocol Violation|2
4634329|NCT01923181|7505274|FG002|Overall Study|Protocol Violation|0
4634330|NCT01923181|7505275|FG003|Overall Study|Protocol Violation|2
4634331|NCT01923181|7505276|FG004|Overall Study|Protocol Violation|2
4634332|NCT01923181|7505277|FG005|Overall Study|Protocol Violation|1
4634333|NCT01923181|7505278|FG006|Overall Study|Protocol Violation|1
4634334|NCT01923181|7505279|FG007|Overall Study|Protocol Violation|2
4634335|NCT01923181|7505280|FG008|Overall Study|Protocol Violation|1
4634336|NCT01923181|7505272|FG000|Overall Study|Withdrawal by Subject|0
4634337|NCT01923181|7505273|FG001|Overall Study|Withdrawal by Subject|1
4634338|NCT01923181|7505274|FG002|Overall Study|Withdrawal by Subject|0
4634339|NCT01923181|7505275|FG003|Overall Study|Withdrawal by Subject|1
4634340|NCT01923181|7505276|FG004|Overall Study|Withdrawal by Subject|4
4634341|NCT01923181|7505277|FG005|Overall Study|Withdrawal by Subject|2
4634342|NCT01923181|7505278|FG006|Overall Study|Withdrawal by Subject|4
4634343|NCT01923181|7505279|FG007|Overall Study|Withdrawal by Subject|3
4634344|NCT01923181|7505280|FG008|Overall Study|Withdrawal by Subject|1
4634345|NCT01923181|7505272|FG000|Overall Study|Other|1
4634346|NCT01923181|7505273|FG001|Overall Study|Other|0
4634347|NCT01923181|7505274|FG002|Overall Study|Other|0
4634348|NCT01923181|7505275|FG003|Overall Study|Other|1
4634349|NCT01923181|7505276|FG004|Overall Study|Other|0
4634350|NCT01923181|7505277|FG005|Overall Study|Other|0
4634351|NCT01923181|7505278|FG006|Overall Study|Other|0
4634352|NCT01923181|7505279|FG007|Overall Study|Other|0
4634353|NCT01923181|7505280|FG008|Overall Study|Other|0
4634354|NCT01923181|7505272|FG000|Overall Study|Lost to Follow-up|0
4634355|NCT01923181|7505273|FG001|Overall Study|Lost to Follow-up|3
4634356|NCT01923181|7505274|FG002|Overall Study|Lost to Follow-up|2
4634357|NCT01923181|7505275|FG003|Overall Study|Lost to Follow-up|1
4634358|NCT01923181|7505276|FG004|Overall Study|Lost to Follow-up|2
4634359|NCT01923181|7505277|FG005|Overall Study|Lost to Follow-up|1
4634360|NCT01923181|7505278|FG006|Overall Study|Lost to Follow-up|3
4634361|NCT01923181|7505279|FG007|Overall Study|Lost to Follow-up|3
4634362|NCT01923181|7505280|FG008|Overall Study|Lost to Follow-up|1
4634363|NCT01923285|7505305|FG000|Overall Study|Withdrawal by Subject|7
4634364|NCT01923285|7505306|FG001|Overall Study|Withdrawal by Subject|6
4634365|NCT01923311|7505314|FG000|Overall Study|Pregnancy|1
4634366|NCT01923311|7505315|FG001|Overall Study|Pregnancy|0
4634367|NCT01923311|7505314|FG000|Overall Study|Investigator's Discretion|1
4634368|NCT01923311|7505315|FG001|Overall Study|Investigator's Discretion|0
4744278|NCT03680911|7708016|FG001|At Home Treatment|Lost to Follow-up|1
4744279|NCT03680911|7708015|FG000|At Home Treatment|Withdrawal by Subject|0
4744280|NCT03680911|7708016|FG001|At Home Treatment|Withdrawal by Subject|2
4744281|NCT03680911|7708015|FG000|Visit 3 (4 Month Follow up)|Study Termination|0
4744282|NCT03680911|7708016|FG001|Visit 3 (4 Month Follow up)|Study Termination|1
4744283|NCT03656692|7708022|FG000|Overall Study|Worsening of disease activity|2
4744284|NCT03656692|7708022|FG000|Overall Study|Physician Decision|1
4744285|NCT03648983|7708026|FG000|Overall Study|Study was terminated due to PI departure|95
4744286|NCT03643159|7708033|FG000|Overall Study|Adverse Event|1
4634369|NCT01923311|7505314|FG000|Overall Study|Non-Compliance with Study Drug|2
4634370|NCT01923311|7505315|FG001|Overall Study|Non-Compliance with Study Drug|1
4634371|NCT01923311|7505314|FG000|Overall Study|Withdrew Consent|1
4634372|NCT01923311|7505315|FG001|Overall Study|Withdrew Consent|0
4634373|NCT01923311|7505314|FG000|Overall Study|Study Terminated by Sponsor|12
4634374|NCT01923311|7505315|FG001|Overall Study|Study Terminated by Sponsor|0
4634375|NCT01923363|7505322|FG000|Overall Study|Protocol Violation|1
4634376|NCT01923389|7505328|FG000|Overall Study|Protocol Violation|1
4634377|NCT01923389|7505329|FG001|Overall Study|Protocol Violation|0
4634378|NCT01923428|7505340|FG000|Overall Study|Adverse Event|8
4634379|NCT01923428|7505341|FG001|Overall Study|Adverse Event|6
4634380|NCT01923428|7505342|FG002|Overall Study|Adverse Event|3
4634381|NCT01923428|7505343|FG003|Overall Study|Adverse Event|3
4634382|NCT01923428|7505340|FG000|Overall Study|Withdrawal by Subject|5
4634383|NCT01923428|7505341|FG001|Overall Study|Withdrawal by Subject|3
4634384|NCT01923428|7505342|FG002|Overall Study|Withdrawal by Subject|0
4634385|NCT01923428|7505343|FG003|Overall Study|Withdrawal by Subject|4
4634386|NCT01923428|7505340|FG000|Overall Study|Lost to Follow-up|2
4634387|NCT01923428|7505341|FG001|Overall Study|Lost to Follow-up|1
4634388|NCT01923428|7505342|FG002|Overall Study|Lost to Follow-up|5
4634389|NCT01923428|7505343|FG003|Overall Study|Lost to Follow-up|0
4634390|NCT01923428|7505340|FG000|Overall Study|Protocol Violation|3
4634391|NCT01923428|7505341|FG001|Overall Study|Protocol Violation|0
4634392|NCT01923428|7505342|FG002|Overall Study|Protocol Violation|2
4744287|NCT03643159|7708033|FG000|Overall Study|Withdrawal by Subject|1
4634393|NCT01923428|7505343|FG003|Overall Study|Protocol Violation|1
4634394|NCT01923428|7505340|FG000|Overall Study|Non Compliance to treatment|1
4634395|NCT01923428|7505341|FG001|Overall Study|Non Compliance to treatment|2
4634396|NCT01923428|7505342|FG002|Overall Study|Non Compliance to treatment|0
4634397|NCT01923428|7505343|FG003|Overall Study|Non Compliance to treatment|1
4634398|NCT01923428|7505340|FG000|Overall Study|Lack of Efficacy|0
4634399|NCT01923428|7505341|FG001|Overall Study|Lack of Efficacy|0
4634400|NCT01923428|7505342|FG002|Overall Study|Lack of Efficacy|1
4634401|NCT01923428|7505343|FG003|Overall Study|Lack of Efficacy|1
4634402|NCT01923467|7505353|FG000|Overall Study|Lost to Follow-up|62
4634403|NCT01923467|7505353|FG000|Overall Study|Subject non-interest|479
4634404|NCT01923740|7505359|FG000|Overall Study|Lost to Follow-up|4
4634405|NCT01923740|7505360|FG001|Overall Study|Lost to Follow-up|9
4634406|NCT01923740|7505359|FG000|Overall Study|Withdrawal by Subject|2
4634407|NCT01923740|7505360|FG001|Overall Study|Withdrawal by Subject|0
4634408|NCT01923896|7505377|FG000|Overall Study|Adverse Event|1
4634409|NCT01923896|7505378|FG001|Overall Study|Adverse Event|0
4634410|NCT01924182|7505403|FG000|Overall Study|Withdrawal by Subject|1
4634411|NCT01924182|7505404|FG001|Overall Study|Withdrawal by Subject|0
4634412|NCT01924299|7505412|FG000|Period 2|Withdrawal by Subject|1
4634413|NCT01924299|7505413|FG001|Period 2|Withdrawal by Subject|0
4634414|NCT01924299|7505412|FG000|Period 2|Adverse Event|0
4634415|NCT01924299|7505413|FG001|Period 2|Adverse Event|1
4634416|NCT01924364|7505425|FG000|Overall Study|Physician Decision|3
4744288|NCT03630120|7708051|FG000|Overall Study|Disease progression|0
4744289|NCT03630120|7708052|FG001|Overall Study|Disease progression|1
4744290|NCT03630120|7708053|FG002|Overall Study|Disease progression|1
4744291|NCT03630120|7708054|FG003|Overall Study|Disease progression|1
4744292|NCT03615144|7708081|FG000|Overall Study|Participant no longer eligible for this protocol|1
4744293|NCT03615144|7708082|FG001|Overall Study|Participant no longer eligible for this protocol|0
4744294|NCT03605303|7708088|FG000|Period 1|Study Terminated|2
4744295|NCT03605303|7708089|FG001|Period 1|Study Terminated|1
4744296|NCT03600740|7708095|FG000|Overall Study|Surgical plan was altered-subject not eligible|1
4744297|NCT03598140|7708101|FG000|Overall Study|enrolled but didn't start|1
4744298|NCT03598140|7708102|FG001|Overall Study|enrolled but didn't start|0
4744299|NCT03598036|7708110|FG000|Overall Study|Withdrawal by Subject|1
4744300|NCT03598036|7708111|FG001|Overall Study|Withdrawal by Subject|0
4744301|NCT03590743|7708130|FG000|Overall Study|Withdrawal by Subject|0
4744302|NCT03590743|7708131|FG001|Overall Study|Withdrawal by Subject|1
4744303|NCT03580382|7708139|FG000|Overall Study|Early Termination of Study|0
4744304|NCT03580382|7708140|FG001|Overall Study|Early Termination of Study|3
4744305|NCT03571646|7708147|FG000|Overall Study|Adverse Event|1
4744306|NCT03571646|7708148|FG001|Overall Study|Adverse Event|0
4744307|NCT03571646|7708147|FG000|Overall Study|Withdrawal by Subject|1
4744308|NCT03571646|7708148|FG001|Overall Study|Withdrawal by Subject|1
4744309|NCT03543358|7708171|FG000|Overall Study|Death|1
4744310|NCT03543358|7708172|FG001|Overall Study|Death|0
4744311|NCT03543358|7708171|FG000|Overall Study|Disease Progression|1
4744312|NCT03543358|7708172|FG001|Overall Study|Disease Progression|0
4744313|NCT03543358|7708171|FG000|Overall Study|Parent Study Closure|1
4744314|NCT03543358|7708172|FG001|Overall Study|Parent Study Closure|0
4744315|NCT03509207|7708200|FG000|Overall Study|Death|2
4744316|NCT03500341|7708217|FG000|Overall Study|Withdrawn prior to Completion|2
4744317|NCT03500159|7708223|FG000|Overall Study|Study Terminated|2
4744318|NCT03500159|7708224|FG001|Overall Study|Study Terminated|1
4744319|NCT03477903|7708250|FG000|Overall Study|Study Terminated by Sponsor|1
4744320|NCT03469258|7708254|FG000|Overall Study|Upon surgery, did not meet criteria|4
4525460|NCT01023256|7341311|FG000|Overall Study|Randomized but not treated|1
4525461|NCT01023256|7341312|FG001|Overall Study|Randomized but not treated|0
4525462|NCT01023256|7341313|FG002|Overall Study|Randomized but not treated|1
4525463|NCT01023256|7341314|FG003|Overall Study|Randomized but not treated|0
4525464|NCT01023256|7341311|FG000|Overall Study|Other|1
4525465|NCT01023256|7341312|FG001|Overall Study|Other|0
4525466|NCT01023256|7341313|FG002|Overall Study|Other|0
4525467|NCT01023256|7341314|FG003|Overall Study|Other|2
4525468|NCT01023256|7341311|FG000|Overall Study|Adverse Event|0
4525469|NCT01023256|7341312|FG001|Overall Study|Adverse Event|0
4525470|NCT01023256|7341313|FG002|Overall Study|Adverse Event|0
4525471|NCT01023256|7341314|FG003|Overall Study|Adverse Event|1
4525472|NCT01023256|7341311|FG000|Overall Study|Withdrawal by Subject|0
4525473|NCT01023256|7341312|FG001|Overall Study|Withdrawal by Subject|0
4525474|NCT01023256|7341313|FG002|Overall Study|Withdrawal by Subject|0
4525475|NCT01023256|7341314|FG003|Overall Study|Withdrawal by Subject|2
4525476|NCT01023269|7341327|FG000|Overall Study|early termination of the study|2
4525477|NCT01023269|7341328|FG001|Overall Study|early termination of the study|0
4525478|NCT01023308|7341334|FG000|Overall Study|Abnormal test proceedure results|3
4525479|NCT01023308|7341335|FG001|Overall Study|Abnormal test proceedure results|8
4525480|NCT01023308|7341334|FG000|Overall Study|Administrative problems|2
4525481|NCT01023308|7341335|FG001|Overall Study|Administrative problems|1
4525482|NCT01023308|7341334|FG000|Overall Study|Adverse Event|130
4525483|NCT01023308|7341335|FG001|Overall Study|Adverse Event|66
4525484|NCT01023308|7341334|FG000|Overall Study|Death|21
4525485|NCT01023308|7341335|FG001|Overall Study|Death|17
4525486|NCT01023308|7341334|FG000|Overall Study|Disease progression|82
4525487|NCT01023308|7341335|FG001|Overall Study|Disease progression|153
4525488|NCT01023308|7341334|FG000|Overall Study|New Cancer therapy|4
4525489|NCT01023308|7341335|FG001|Overall Study|New Cancer therapy|7
4525490|NCT01023308|7341334|FG000|Overall Study|Protocol Violation|3
4525491|NCT01023308|7341335|FG001|Overall Study|Protocol Violation|4
4525492|NCT01023308|7341334|FG000|Overall Study|Untreated|5
4525493|NCT01023308|7341335|FG001|Overall Study|Untreated|5
4525494|NCT01023308|7341334|FG000|Overall Study|Lost to Follow-up|1
4525495|NCT01023308|7341335|FG001|Overall Study|Lost to Follow-up|0
4525496|NCT01023308|7341334|FG000|Overall Study|Withdrawal by Subject|34
4525497|NCT01023308|7341335|FG001|Overall Study|Withdrawal by Subject|18
4525498|NCT01023516|7341352|FG000|Overall Study|Voluntary discontinuation|7
4525499|NCT01023516|7341353|FG001|Overall Study|Voluntary discontinuation|5
4525500|NCT01023516|7341352|FG000|Overall Study|Adverse Event|9
4525501|NCT01023516|7341353|FG001|Overall Study|Adverse Event|6
4525502|NCT01023516|7341352|FG000|Overall Study|Safety reason|0
4525503|NCT01023516|7341353|FG001|Overall Study|Safety reason|3
4525504|NCT01023516|7341352|FG000|Overall Study|Study-specific criteria|4
4525505|NCT01023516|7341353|FG001|Overall Study|Study-specific criteria|2
4525506|NCT01023516|7341352|FG000|Overall Study|Incorrect enrolment|4
4525507|NCT01023516|7341353|FG001|Overall Study|Incorrect enrolment|2
4525508|NCT01023581|7341379|FG000|Overall Study|Adverse Event|4
4525509|NCT01023581|7341380|FG001|Overall Study|Adverse Event|4
4525510|NCT01023581|7341381|FG002|Overall Study|Adverse Event|7
4525511|NCT01023581|7341382|FG003|Overall Study|Adverse Event|3
4525512|NCT01023581|7341383|FG004|Overall Study|Adverse Event|2
4744321|NCT03466658|7708258|FG000|Overall Study|Withdrawal by Subject|3
4744322|NCT03465891|7708266|FG000|Overall Study|Withdrawal by Subject|0
4744323|NCT03465891|7708267|FG001|Overall Study|Withdrawal by Subject|1
4744324|NCT03465891|7708266|FG000|Overall Study|Disease progression|1
4744325|NCT03465891|7708267|FG001|Overall Study|Disease progression|0
4744326|NCT03387059|7708345|FG000|Overall Study|Study termination|5
4744327|NCT03387059|7708346|FG001|Overall Study|Study termination|4
4744328|NCT03379233|7708363|FG000|Overall Study|Technical issues with Concept 2 inhalers|1
4744329|NCT03379233|7708364|FG001|Overall Study|Technical issues with Concept 2 inhalers|6
4744330|NCT03361228|7708380|FG000|Overall Study|Other|1
4744331|NCT03361228|7708381|FG001|Overall Study|Other|1
4744332|NCT03361228|7708380|FG000|Overall Study|Death|3
4744333|NCT03361228|7708381|FG001|Overall Study|Death|0
4744334|NCT03359174|7708396|FG000|Overall Study|Adverse Event|1
4744335|NCT03348904|7708407|FG000|Overall Study|Administrative reason by the sponsor|0
4744336|NCT03348904|7708408|FG001|Overall Study|Administrative reason by the sponsor|1
4744337|NCT03348904|7708409|FG002|Overall Study|Administrative reason by the sponsor|0
4744338|NCT03345901|7708417|FG000|Overall Study|The study was terminated|18
4744339|NCT03344562|7708424|FG000|Overall Study|Withdrawal by Subject|2
4744340|NCT03344562|7708425|FG001|Overall Study|Withdrawal by Subject|0
4744341|NCT03342638|7708433|FG000|Overall Study|Withdrawal by Subject|1
4744342|NCT03342638|7708434|FG001|Overall Study|Withdrawal by Subject|0
4744343|NCT03342638|7708433|FG000|Overall Study|Physician Decision|0
4744344|NCT03342638|7708434|FG001|Overall Study|Physician Decision|1
4744345|NCT03339401|7708451|FG000|Overall Study|Death|2
4744346|NCT03339401|7708452|FG001|Overall Study|Death|1
4744347|NCT03339401|7708451|FG000|Overall Study|Withdrawal by Subject|2
4744348|NCT03339401|7708452|FG001|Overall Study|Withdrawal by Subject|0
4744349|NCT03339401|7708451|FG000|Overall Study|Study terminated|4
4744350|NCT03339401|7708452|FG001|Overall Study|Study terminated|3
4744351|NCT03339401|7708451|FG000|Overall Study|Investigator Decision|1
4744352|NCT03339401|7708452|FG001|Overall Study|Investigator Decision|0
4744353|NCT03339245|7708460|FG000|Overall Study|Adverse Event|1
4744354|NCT03339245|7708461|FG001|Overall Study|Adverse Event|1
4744355|NCT03339245|7708460|FG000|Overall Study|Withdrawal by Subject|1
4744356|NCT03339245|7708461|FG001|Overall Study|Withdrawal by Subject|0
4744357|NCT03329404|7708473|FG000|Overall Study|The study was suspended.|1
4744358|NCT03329404|7708474|FG001|Overall Study|The study was suspended.|4
4744359|NCT03326869|7708482|FG000|Overall Study|Study data has been lost to natural disa|1
4744360|NCT03326869|7708483|FG001|Overall Study|Study data has been lost to natural disa|1
4744361|NCT03305055|7708508|FG000|Overall Study|Withdrawal by Subject|0
4744362|NCT03305055|7708509|FG001|Overall Study|Withdrawal by Subject|1
4744363|NCT03305055|7708508|FG000|Overall Study|Adverse Event|1
4744364|NCT03305055|7708509|FG001|Overall Study|Adverse Event|1
4744365|NCT03303469|7708515|FG000|Overall Study|Lost to Follow-up|2
4744366|NCT03302247|7708519|FG000|Overall Study|the study has closed prematurely|2
4744367|NCT03302247|7708519|FG000|Overall Study|Death|1
4744368|NCT03300024|7708525|FG000|Overall Study|Physician Decision|4
4744369|NCT03300024|7708526|FG001|Overall Study|Physician Decision|6
4744370|NCT03283709|7708536|FG000|Overall Study|trial terminated|0
4744371|NCT03283709|7708537|FG001|Overall Study|trial terminated|1
4744372|NCT03263806|7708572|FG000|Overall Study|Elevated Troponin (failed screen)|1
4744373|NCT03263806|7708573|FG001|Overall Study|Elevated Troponin (failed screen)|0
4744374|NCT03263806|7708572|FG000|Overall Study|Withdrawal by Subject|0
4744375|NCT03263806|7708573|FG001|Overall Study|Withdrawal by Subject|1
4744376|NCT03263806|7708572|FG000|Overall Study|Study Termination|5
4744377|NCT03263806|7708573|FG001|Overall Study|Study Termination|6
4744378|NCT03261531|7708579|FG000|Overall Study|Withdrawal by Subject|4
4744379|NCT03219372|7708598|FG000|Overall Study|Withdrawal by Subject|1
4744380|NCT03219372|7708599|FG001|Overall Study|Withdrawal by Subject|0
4744381|NCT03217175|7708605|FG000|Overall Study|Physician Decision|4
4744382|NCT03217175|7708606|FG001|Overall Study|Physician Decision|1
4744383|NCT03223662|7708633|FG000|Overall Study|Physician Decision|1
4744384|NCT03223662|7708633|FG000|Overall Study|Study closure|1
4744385|NCT03212144|7708639|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1
4744386|NCT03212144|7708640|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0
4744387|NCT03212144|7708639|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1
4744388|NCT03212144|7708640|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1
4744389|NCT03204539|7708656|FG000|Overall Study|Loss of funding|0
4744390|NCT03204539|7708657|FG001|Overall Study|Loss of funding|1
4744391|NCT03206216|7708665|FG000|Overall Study|Withdrawal by Subject|0
4744392|NCT03206216|7708666|FG001|Overall Study|Withdrawal by Subject|1
4744393|NCT03195660|7708672|FG000|Overall Study|The study was terminated|2
4744394|NCT03166618|7708682|FG000|Overall Study|Study was Terminated|0
4744395|NCT03166618|7708683|FG001|Overall Study|Study was Terminated|1
4744396|NCT03169530|7708691|FG000|Overall Study|Study ended by NIH|15
4744397|NCT03169530|7708692|FG001|Overall Study|Study ended by NIH|17
4744398|NCT03151226|7708707|FG000|Overall Study|Withdrawal by Subject|2
4744399|NCT03151226|7708707|FG000|Overall Study|not wear device correctly|1
4744400|NCT03168906|7708722|FG000|Overall Study|Lack of Efficacy|6
4744401|NCT03168906|7708723|FG001|Overall Study|Lack of Efficacy|6
4744402|NCT03178201|7708730|FG000|Overall Study|Off study|5
4744403|NCT03172026|7708736|FG000|Overall Study|Withdrawal by Subject|1
4744404|NCT03172026|7708737|FG001|Overall Study|Withdrawal by Subject|0
4744405|NCT03172026|7708736|FG000|Overall Study|COVID restrictions|1
4744406|NCT03172026|7708737|FG001|Overall Study|COVID restrictions|0
4744407|NCT03152526|7708746|FG000|Overall Study|Withdrawal by Subject|0
4744408|NCT03152526|7708747|FG001|Overall Study|Withdrawal by Subject|1
4744409|NCT03123393|7708782|FG000|Overall Study|Study Terminated by Sponsor|6
4744410|NCT03123393|7708783|FG001|Overall Study|Study Terminated by Sponsor|9
4744411|NCT03123393|7708782|FG000|Overall Study|Withdrawal by Subject|2
4744412|NCT03123393|7708783|FG001|Overall Study|Withdrawal by Subject|1
4744413|NCT03123393|7708782|FG000|Overall Study|Reason not Specified|13
4744414|NCT03123393|7708783|FG001|Overall Study|Reason not Specified|13
4744415|NCT03119662|7708795|FG000|Overall Study|Withdrawal by Subject|0
4744416|NCT03119662|7708796|FG001|Overall Study|Withdrawal by Subject|1
4744417|NCT03120676|7708811|FG000|Overall Study|Not treated|1
4744418|NCT03113071|7708836|FG000|Overall Study|Withdrawal by Subject|1
4744419|NCT03113071|7708837|FG001|Overall Study|Withdrawal by Subject|0
4744420|NCT03110900|7708845|FG000|Overall Study|Sponsor withdrew|1
4744421|NCT03110900|7708846|FG001|Overall Study|Sponsor withdrew|1
4744422|NCT03078868|7708852|FG000|Overall Study|Physician Decision|3
4744423|NCT03065933|7708865|FG000|Overall Study|study terminated|5
4744424|NCT03070002|7708869|FG000|Follow up for 2 Years|Death|1
4744425|NCT03058705|7708873|FG000|Overall Study|Withdrawal by Subject|2
4744426|NCT03058705|7708873|FG000|Overall Study|Physician Decision|2
4744427|NCT03053518|7708895|FG000|Overall Study|Withdrawal by Subject|3
4744428|NCT03053518|7708895|FG000|Overall Study|Lost to Follow-up|2
4744429|NCT03053518|7708895|FG000|Overall Study|Ineligible|5
4744430|NCT03050398|7708899|FG000|Overall Study|Study terminated by sponsor|8
4744431|NCT03029832|7708917|FG000|Overall Study|Safety Follow-Up Completed|2
4744432|NCT03029832|7708918|FG001|Overall Study|Safety Follow-Up Completed|0
4744433|NCT03029832|7708917|FG000|Overall Study|Death due to Disease Progression|1
4744434|NCT03029832|7708918|FG001|Overall Study|Death due to Disease Progression|0
4744435|NCT03029832|7708917|FG000|Overall Study|Study Terminated By Sponsor|1
4744436|NCT03029832|7708918|FG001|Overall Study|Study Terminated By Sponsor|1
4744437|NCT03010423|7708953|FG000|Overall Study|Study termination|8
4634417|NCT01924429|7505451|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3
4525513|NCT01023581|7341384|FG005|Overall Study|Adverse Event|5
4525514|NCT01023581|7341385|FG006|Overall Study|Adverse Event|11
4525515|NCT01023581|7341379|FG000|Overall Study|Major protocol deviation|2
4634418|NCT01924429|7505452|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2
4634419|NCT01924689|7505489|FG000|Overall Study|Death|0
4634420|NCT01924689|7505490|FG001|Overall Study|Death|1
4634421|NCT01924689|7505491|FG002|Overall Study|Death|0
4634422|NCT01924689|7505492|FG003|Overall Study|Death|1
4634423|NCT01924689|7505493|FG004|Overall Study|Death|0
4634424|NCT01924689|7505494|FG005|Overall Study|Death|0
4634425|NCT01924689|7505489|FG000|Overall Study|Disease progression|0
4525516|NCT01023581|7341380|FG001|Overall Study|Major protocol deviation|0
4525517|NCT01023581|7341381|FG002|Overall Study|Major protocol deviation|3
4525518|NCT01023581|7341382|FG003|Overall Study|Major protocol deviation|0
4525519|NCT01023581|7341383|FG004|Overall Study|Major protocol deviation|0
4525520|NCT01023581|7341384|FG005|Overall Study|Major protocol deviation|0
4525521|NCT01023581|7341385|FG006|Overall Study|Major protocol deviation|0
4525522|NCT01023581|7341379|FG000|Overall Study|Lost to Follow-up|4
4525523|NCT01023581|7341380|FG001|Overall Study|Lost to Follow-up|8
4525524|NCT01023581|7341381|FG002|Overall Study|Lost to Follow-up|7
4525525|NCT01023581|7341382|FG003|Overall Study|Lost to Follow-up|2
4525526|NCT01023581|7341383|FG004|Overall Study|Lost to Follow-up|5
4744438|NCT02991430|7708969|FG000|Treatment Period 1|Adverse Event|1
4744439|NCT02991430|7708970|FG001|Treatment Period 1|Adverse Event|0
4744440|NCT02991430|7708971|FG002|Treatment Period 1|Adverse Event|2
4744441|NCT02991430|7708969|FG000|Treatment Period 1|Withdrawal by Subject|0
4744442|NCT02991430|7708970|FG001|Treatment Period 1|Withdrawal by Subject|4
4744443|NCT02991430|7708971|FG002|Treatment Period 1|Withdrawal by Subject|0
4744444|NCT02991430|7708969|FG000|Treatment Period 2|Study Termination|6
4744445|NCT02991430|7708970|FG001|Treatment Period 2|Study Termination|3
4744446|NCT02991430|7708971|FG002|Treatment Period 2|Study Termination|3
4744447|NCT02991430|7708969|FG000|Treatment Period 2|Lost to Follow-up|0
4744448|NCT02991430|7708970|FG001|Treatment Period 2|Lost to Follow-up|0
4744449|NCT02991430|7708971|FG002|Treatment Period 2|Lost to Follow-up|1
4744450|NCT02991430|7708969|FG000|Post-treatment Observation Period|Study Termination|3
4744451|NCT02991430|7708970|FG001|Post-treatment Observation Period|Study Termination|6
4744452|NCT02991430|7708971|FG002|Post-treatment Observation Period|Study Termination|5
4744453|NCT02978833|7709004|FG000|Overall Study|Study terminated|1
4744454|NCT02978833|7709005|FG001|Overall Study|Study terminated|1
4744455|NCT02966223|7709042|FG000|Overall Study|Physician Decision|3
4744456|NCT02966223|7709042|FG000|Overall Study|Withdrawal by Subject|11
4744457|NCT02966223|7709042|FG000|Overall Study|Lost to Follow-up|1
4744458|NCT02965846|7709049|FG000|Overall Study|Lost to Follow-up|1
4744459|NCT02965846|7709050|FG001|Overall Study|Lost to Follow-up|0
4744460|NCT02965846|7709051|FG002|Overall Study|Lost to Follow-up|0
4744461|NCT02965846|7709049|FG000|Overall Study|Withdrawal by Subject|0
4744462|NCT02965846|7709050|FG001|Overall Study|Withdrawal by Subject|1
4744463|NCT02965846|7709051|FG002|Overall Study|Withdrawal by Subject|0
4744464|NCT02965846|7709049|FG000|Overall Study|Study Terminated By Sponsor|4
4744465|NCT02965846|7709050|FG001|Overall Study|Study Terminated By Sponsor|4
4744466|NCT02965846|7709051|FG002|Overall Study|Study Terminated By Sponsor|0
4744467|NCT02965846|7709049|FG000|Overall Study|Participants not randomized|0
4744468|NCT02965846|7709050|FG001|Overall Study|Participants not randomized|0
4744469|NCT02965846|7709051|FG002|Overall Study|Participants not randomized|33
4744470|NCT02956005|7709072|FG000|Overall Study|Not eligible|1
4744471|NCT02956005|7709072|FG000|Overall Study|Withdrawal by Subject|3
4744472|NCT02956005|7709072|FG000|Overall Study|Physician Decision|12
4744473|NCT02940223|7709087|FG000|Overall Study|Failed Requirement|2
4744474|NCT02940223|7709088|FG001|Overall Study|Failed Requirement|0
4744475|NCT02954159|7709096|FG000|Overall Study|Study ended prematurely due to low enrol|1
4744476|NCT02954159|7709097|FG001|Overall Study|Study ended prematurely due to low enrol|0
4744477|NCT02954159|7709096|FG000|Overall Study|Withdrawal by Subject|0
4744478|NCT02954159|7709097|FG001|Overall Study|Withdrawal by Subject|1
4744479|NCT02954952|7709106|FG000|Overall Study|Withdrawal by Subject|1
4744480|NCT02954952|7709107|FG001|Overall Study|Withdrawal by Subject|0
4744481|NCT02954952|7709108|FG002|Overall Study|Withdrawal by Subject|0
4744482|NCT02954952|7709106|FG000|Overall Study|No data collected|0
4744483|NCT02954952|7709107|FG001|Overall Study|No data collected|1
4744484|NCT02954952|7709108|FG002|Overall Study|No data collected|0
4744485|NCT02947022|7709120|FG000|Overall Study|Study Stopped|1
4525527|NCT01023581|7341384|FG005|Overall Study|Lost to Follow-up|2
4744486|NCT02950480|7709135|FG000|Overall Study|Withdrawal by Subject|1
4744487|NCT02950480|7709136|FG001|Overall Study|Withdrawal by Subject|0
4744488|NCT02949947|7709144|FG000|Overall Study|Non Compliance|0
4744489|NCT02949947|7709145|FG001|Overall Study|Non Compliance|1
4744490|NCT02949947|7709144|FG000|Overall Study|Insurance change|1
4744491|NCT02949947|7709145|FG001|Overall Study|Insurance change|0
4744492|NCT02947100|7709151|FG000|Overall Study|study terminated early|3
4744493|NCT02947100|7709151|FG000|Overall Study|did not meet inclusion criteria|1
4744494|NCT02908516|7709172|FG000|Overall Study|Study Terminated|3
4744495|NCT02908516|7709173|FG001|Overall Study|Study Terminated|3
4744496|NCT02923830|7709181|FG000|Overall Study|Physician Decision|13
4744497|NCT02923830|7709182|FG001|Overall Study|Physician Decision|15
4744498|NCT02920450|7709188|FG000|Overall Study|Death|1
4744499|NCT02920450|7709189|FG001|Overall Study|Death|0
4744500|NCT02920450|7709190|FG002|Overall Study|Death|0
4744501|NCT02920450|7709191|FG003|Overall Study|Death|0
4744502|NCT02920450|7709188|FG000|Overall Study|Withdrawal by Subject|1
4744503|NCT02920450|7709189|FG001|Overall Study|Withdrawal by Subject|0
4744504|NCT02920450|7709190|FG002|Overall Study|Withdrawal by Subject|0
4744505|NCT02920450|7709191|FG003|Overall Study|Withdrawal by Subject|0
4744506|NCT02920177|7709200|FG000|Overall Study|Withdrawal by Subject|1
4744507|NCT02920177|7709201|FG001|Overall Study|Withdrawal by Subject|1
4744508|NCT02920177|7709200|FG000|Overall Study|Physician Decision|1
4744509|NCT02920177|7709201|FG001|Overall Study|Physician Decision|0
4744510|NCT02920177|7709200|FG000|Overall Study|Lost to Follow-up|0
4744511|NCT02920177|7709201|FG001|Overall Study|Lost to Follow-up|1
4744512|NCT02926638|7709209|FG000|Overall Study|Progression|2
4744513|NCT02926638|7709210|FG001|Overall Study|Progression|5
4744514|NCT02926638|7709209|FG000|Overall Study|Ineligible|1
4744515|NCT02926638|7709210|FG001|Overall Study|Ineligible|0
4744516|NCT02926638|7709209|FG000|Overall Study|Not protocol specified|1
4744517|NCT02926638|7709210|FG001|Overall Study|Not protocol specified|0
4744518|NCT02920242|7709219|FG000|Overall Study|Withdrawal by Subject|1
4744519|NCT02920242|7709220|FG001|Overall Study|Withdrawal by Subject|0
4744520|NCT02920242|7709221|FG002|Overall Study|Withdrawal by Subject|1
4744521|NCT02920242|7709219|FG000|Overall Study|Did not meet inc./exc. criteria|1
4744522|NCT02920242|7709220|FG001|Overall Study|Did not meet inc./exc. criteria|0
4744523|NCT02920242|7709221|FG002|Overall Study|Did not meet inc./exc. criteria|0
4744524|NCT02899728|7709253|FG000|Overall Study|Withdrawal by Subject|1
4744525|NCT02899728|7709254|FG001|Overall Study|Withdrawal by Subject|1
4744526|NCT02875067|7709260|FG000|Overall Study|Withdrawal by Subject|1
4744527|NCT02875067|7709260|FG000|Overall Study|Withdrawal by Termination of Study|5
4744528|NCT02860169|7709275|FG000|Part A|Withdrawal by Subject|1
4744529|NCT02860169|7709275|FG000|Part A|Other (Screening failure)|6
4744530|NCT02860169|7709275|FG000|Part A|Other (Survey not completed)|3
4744531|NCT02860169|7709275|FG000|Part A|Other (did not completed consent)|1
4744532|NCT02860169|7709275|FG000|Part B|Other (Screening failure)|10
4744533|NCT02860169|7709275|FG000|Part B|Withdrawal by Subject|1
4744534|NCT02860169|7709275|FG000|Part C|Other (Screening failure)|1
4744535|NCT02865395|7709284|FG000|Overall Study|Physician Decision|6
4744536|NCT02865395|7709285|FG001|Overall Study|Physician Decision|10
4744537|NCT02865395|7709286|FG002|Overall Study|Physician Decision|7
4744538|NCT02868892|7709294|FG000|Overall Study|Investigator left site and no follow-up|6
4744539|NCT02865083|7709300|FG000|Overall Study|Early Termination|3
4744540|NCT02865083|7709301|FG001|Overall Study|Early Termination|1
4744541|NCT02865122|7709310|FG000|Overall Study|Adverse Event|1
4744542|NCT02865122|7709311|FG001|Overall Study|Adverse Event|0
4744543|NCT02865122|7709312|FG002|Overall Study|Adverse Event|0
4744544|NCT02865915|7709322|FG000|Overall Study|Pregnancy|1
4744545|NCT02865915|7709323|FG001|Overall Study|Pregnancy|0
4744546|NCT02865915|7709322|FG000|Overall Study|Withdrawal by Subject|1
4744547|NCT02865915|7709323|FG001|Overall Study|Withdrawal by Subject|1
4744548|NCT02865915|7709322|FG000|Overall Study|Adverse Event|0
4744549|NCT02865915|7709323|FG001|Overall Study|Adverse Event|4
4744550|NCT02865915|7709322|FG000|Overall Study|Lost to Follow-up|0
4744551|NCT02865915|7709323|FG001|Overall Study|Lost to Follow-up|1
4744552|NCT02865915|7709322|FG000|Overall Study|Protocol Violation|0
4744553|NCT02865915|7709323|FG001|Overall Study|Protocol Violation|1
4744554|NCT02865915|7709322|FG000|Overall Study|Study terminated by sponsor|23
4744555|NCT02865915|7709323|FG001|Overall Study|Study terminated by sponsor|18
4744556|NCT02865915|7709322|FG000|Overall Study|Dosing group discontinued|0
4744557|NCT02865915|7709323|FG001|Overall Study|Dosing group discontinued|5
4744558|NCT02855411|7709329|FG000|Overall Study|Study terminated by sponsor|21
4744559|NCT02855411|7709329|FG000|Overall Study|Does not meet entrance criteria|14
4744560|NCT02828124|7709337|FG000|Overall Study|Disease Progression|1
4744561|NCT02828124|7709338|FG001|Overall Study|Disease Progression|2
4744562|NCT02828124|7709339|FG002|Overall Study|Disease Progression|1
4744563|NCT02828124|7709340|FG003|Overall Study|Disease Progression|4
4744564|NCT02828124|7709337|FG000|Overall Study|AE Unrelated to Study Drug|0
4744565|NCT02828124|7709338|FG001|Overall Study|AE Unrelated to Study Drug|0
4744566|NCT02828124|7709339|FG002|Overall Study|AE Unrelated to Study Drug|0
4744567|NCT02828124|7709340|FG003|Overall Study|AE Unrelated to Study Drug|1
4744568|NCT02828124|7709337|FG000|Overall Study|Subject Withdrew Consent|0
4744569|NCT02828124|7709338|FG001|Overall Study|Subject Withdrew Consent|0
4525528|NCT01023581|7341385|FG006|Overall Study|Lost to Follow-up|2
4525529|NCT01023581|7341379|FG000|Overall Study|Withdrawal by Subject|13
4525530|NCT01023581|7341380|FG001|Overall Study|Withdrawal by Subject|8
4525531|NCT01023581|7341381|FG002|Overall Study|Withdrawal by Subject|16
4525532|NCT01023581|7341382|FG003|Overall Study|Withdrawal by Subject|10
4525533|NCT01023581|7341383|FG004|Overall Study|Withdrawal by Subject|6
4525534|NCT01023581|7341384|FG005|Overall Study|Withdrawal by Subject|8
4525535|NCT01023581|7341385|FG006|Overall Study|Withdrawal by Subject|5
4525536|NCT01023581|7341379|FG000|Overall Study|Pregnancy|0
4525537|NCT01023581|7341380|FG001|Overall Study|Pregnancy|0
4525538|NCT01023581|7341381|FG002|Overall Study|Pregnancy|0
4525539|NCT01023581|7341382|FG003|Overall Study|Pregnancy|2
4525540|NCT01023581|7341383|FG004|Overall Study|Pregnancy|0
4525541|NCT01023581|7341384|FG005|Overall Study|Pregnancy|1
4525542|NCT01023581|7341385|FG006|Overall Study|Pregnancy|0
4525543|NCT01023581|7341379|FG000|Overall Study|Lack of Efficacy|9
4525544|NCT01023581|7341380|FG001|Overall Study|Lack of Efficacy|3
4525545|NCT01023581|7341381|FG002|Overall Study|Lack of Efficacy|6
4525546|NCT01023581|7341382|FG003|Overall Study|Lack of Efficacy|2
4634426|NCT01924689|7505490|FG001|Overall Study|Disease progression|0
4634427|NCT01924689|7505491|FG002|Overall Study|Disease progression|2
4634428|NCT01924689|7505492|FG003|Overall Study|Disease progression|0
4634429|NCT01924689|7505493|FG004|Overall Study|Disease progression|3
4634430|NCT01924689|7505494|FG005|Overall Study|Disease progression|2
4634431|NCT01924689|7505489|FG000|Overall Study|New therapy or study|3
4634432|NCT01924689|7505490|FG001|Overall Study|New therapy or study|2
4634433|NCT01924689|7505491|FG002|Overall Study|New therapy or study|1
4634434|NCT01924689|7505492|FG003|Overall Study|New therapy or study|4
4634435|NCT01924689|7505493|FG004|Overall Study|New therapy or study|2
4634436|NCT01924689|7505494|FG005|Overall Study|New therapy or study|0
4634437|NCT01924689|7505489|FG000|Overall Study|Withdrawal of consent|0
4634438|NCT01924689|7505490|FG001|Overall Study|Withdrawal of consent|0
4634439|NCT01924689|7505491|FG002|Overall Study|Withdrawal of consent|1
4634440|NCT01924689|7505492|FG003|Overall Study|Withdrawal of consent|1
4634441|NCT01924689|7505493|FG004|Overall Study|Withdrawal of consent|0
4634442|NCT01924689|7505494|FG005|Overall Study|Withdrawal of consent|0
4634443|NCT01924689|7505489|FG000|Overall Study|Other|0
4634444|NCT01924689|7505490|FG001|Overall Study|Other|0
4634445|NCT01924689|7505491|FG002|Overall Study|Other|0
4634446|NCT01924689|7505492|FG003|Overall Study|Other|0
4634447|NCT01924689|7505493|FG004|Overall Study|Other|1
4634448|NCT01924689|7505494|FG005|Overall Study|Other|0
4634449|NCT01924754|7505515|FG000|Overall Study|Lost to Follow-up|1
4634450|NCT01924754|7505516|FG001|Overall Study|Lost to Follow-up|2
4634451|NCT01924754|7505517|FG002|Overall Study|Lost to Follow-up|1
4634452|NCT01924754|7505515|FG000|Overall Study|Pregnancy|0
4634453|NCT01924754|7505516|FG001|Overall Study|Pregnancy|1
4634454|NCT01924754|7505517|FG002|Overall Study|Pregnancy|2
4634455|NCT01924767|7505533|FG000|Overall Study|Adverse Event|1
4634456|NCT01924767|7505534|FG001|Overall Study|Adverse Event|0
4634457|NCT01924767|7505535|FG002|Overall Study|Adverse Event|1
4634458|NCT01924767|7505536|FG003|Overall Study|Adverse Event|0
4634459|NCT01924767|7505537|FG004|Overall Study|Adverse Event|0
4634460|NCT01924806|7505556|FG000|Overall Study|Physician Decision|2
4634461|NCT01924806|7505557|FG001|Overall Study|Physician Decision|1
4634462|NCT01924845|7505563|FG000|Overall Study|Adverse Event|3
4634463|NCT01924845|7505563|FG000|Overall Study|Withdrawal by Subject|2
4634464|NCT01924845|7505563|FG000|Overall Study|Protocol Violation|1
4634465|NCT01925014|7505598|FG000|Overall Study|Inappropriate enrollment|4
4634466|NCT01925014|7505599|FG001|Overall Study|Inappropriate enrollment|6
4634467|NCT01925014|7505598|FG000|Overall Study|Withdrawal by Subject|5
4634468|NCT01925014|7505599|FG001|Overall Study|Withdrawal by Subject|13
4634469|NCT01925170|7505612|FG000|Overall Study|Unverified cancer status|53
4634470|NCT01925183|7505620|FG000|Overall Study|Adverse Event|1
4634471|NCT01925183|7505621|FG001|Overall Study|Adverse Event|0
4634472|NCT01925209|7505631|FG000|Treatment Epoch|Physician Decision|1
4634473|NCT01925209|7505632|FG001|Treatment Epoch|Physician Decision|0
4634474|NCT01925209|7505633|FG002|Treatment Epoch|Physician Decision|0
4525547|NCT01023581|7341383|FG004|Overall Study|Lack of Efficacy|1
4744570|NCT02828124|7709339|FG002|Overall Study|Subject Withdrew Consent|0
4744571|NCT02828124|7709340|FG003|Overall Study|Subject Withdrew Consent|1
4744572|NCT02825043|7709359|FG000|Overall Study|Lost to Follow-up|4
4744573|NCT02819804|7709363|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1
4744574|NCT02809118|7709370|FG000|Overall Study|Withdrawal by Subject|0
4744575|NCT02809118|7709371|FG001|Overall Study|Withdrawal by Subject|1
4744576|NCT02809118|7709372|FG002|Overall Study|Withdrawal by Subject|1
4744577|NCT02806960|7709408|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3
4744578|NCT02806960|7709409|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3
4744579|NCT02806960|7709410|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3
4744580|NCT02806960|7709411|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3
4744581|NCT02815397|7709421|FG000|Overall Study|Physician Decision|2
4744582|NCT02802592|7709425|FG000|Overall Study|Study terminated due to loss of funding|4
4744583|NCT02730793|7709450|FG000|Overall Study|Physician Decision|0
4744584|NCT02730793|7709451|FG001|Overall Study|Physician Decision|1
4744585|NCT02730793|7709450|FG000|Overall Study|Withdrawal by Subject|0
4744586|NCT02730793|7709451|FG001|Overall Study|Withdrawal by Subject|1
4744587|NCT02760602|7709468|FG000|Overall Study|Withdrawal by Subject|1
4744588|NCT02760602|7709469|FG001|Overall Study|Withdrawal by Subject|0
4744589|NCT02760602|7709468|FG000|Overall Study|Terminated by sponsor|12
4744590|NCT02760602|7709469|FG001|Overall Study|Terminated by sponsor|13
4744591|NCT02757521|7709477|FG000|Overall Study|Adverse Event|1
4744592|NCT02757521|7709478|FG001|Overall Study|Adverse Event|0
4744593|NCT02725671|7709531|FG000|Overall Study|Lost to Follow-up|1
4744594|NCT02732327|7709552|FG000|Overall Study|Protocol Violation|0
4744595|NCT02732327|7709553|FG001|Overall Study|Protocol Violation|1
4744596|NCT02726399|7709559|FG000|Overall Study|Participant Non-Compliance|1
4744597|NCT02726399|7709559|FG000|Overall Study|Adverse Event|2
4744598|NCT02726399|7709559|FG000|Overall Study|Progression of disease|4
4744599|NCT02720510|7709565|FG000|Overall Study|Study Terminated by the sponsor|2
4744600|NCT02720510|7709566|FG001|Overall Study|Study Terminated by the sponsor|0
4744601|NCT02720510|7709565|FG000|Overall Study|Adverse Event|0
4744602|NCT02720510|7709566|FG001|Overall Study|Adverse Event|1
4744603|NCT02720510|7709565|FG000|Overall Study|Physician Decision|1
4744604|NCT02720510|7709566|FG001|Overall Study|Physician Decision|2
4744605|NCT02715765|7709575|FG000|Overall Study|Study Termination|3
4744606|NCT02715765|7709576|FG001|Overall Study|Study Termination|0
4744607|NCT02715765|7709577|FG002|Overall Study|Study Termination|0
4744608|NCT02717130|7709596|FG000|Overall Study|Withdrawal by Subject|1
4744609|NCT02717130|7709596|FG000|Overall Study|Adverse Event|1
4744610|NCT02717130|7709596|FG000|Overall Study|Physician Decision|1
4744611|NCT02717130|7709596|FG000|Overall Study|Study Closure|4
4744612|NCT02685202|7709600|FG000|Overall Study|Lost to Follow-up|9
4744613|NCT02709083|7709604|FG000|Overall Study|Original PI left institution|7
4744614|NCT02693171|7709608|FG000|Overall Study|Adverse Event|1
4744615|NCT02693171|7709608|FG000|Overall Study|Discontinuation of Study by Sponsor|8
4744616|NCT02696226|7709616|FG000|Overall Study|Study terminated - lack of enrollment|1
4744617|NCT02696226|7709617|FG001|Overall Study|Study terminated - lack of enrollment|0
4744618|NCT02696226|7709618|FG002|Overall Study|Study terminated - lack of enrollment|2
4744619|NCT02696226|7709619|FG003|Overall Study|Study terminated - lack of enrollment|0
4744620|NCT02693743|7709631|FG000|Overall Study|Physician Decision|1
4744621|NCT02693743|7709632|FG001|Overall Study|Physician Decision|0
4744622|NCT02706691|7709638|FG000|Overall Study|Adverse Event|1
4744623|NCT02694757|7709656|FG000|Overall Study|Lack of Efficacy|3
4744624|NCT02693002|7709662|FG000|Overall Study|Withdrawal by Subject|1
4744625|NCT02693002|7709663|FG001|Overall Study|Withdrawal by Subject|0
4744626|NCT02689518|7709669|FG000|Overall Study|Withdrawal by Subject|3
4744627|NCT02673684|7709700|FG000|Overall Study|Study not completed d/t loss of funding|9
4744628|NCT02673684|7709701|FG001|Overall Study|Study not completed d/t loss of funding|8
4744629|NCT02674204|7709711|FG000|Overall Study|Adverse Event|1
4744630|NCT02674204|7709712|FG001|Overall Study|Adverse Event|0
4744631|NCT02671461|7709734|FG000|Treatment|Adverse Event|0
4744632|NCT02671461|7709735|FG001|Treatment|Adverse Event|0
4744633|NCT02671461|7709736|FG002|Treatment|Adverse Event|1
4744634|NCT02671461|7709734|FG000|Treatment|Administrative Reason by Sponsor|1
4744635|NCT02671461|7709735|FG001|Treatment|Administrative Reason by Sponsor|3
4744636|NCT02671461|7709736|FG002|Treatment|Administrative Reason by Sponsor|4
4744637|NCT02671461|7709734|FG000|Treatment|Randomized, not treated|1
4744638|NCT02671461|7709735|FG001|Treatment|Randomized, not treated|0
4744639|NCT02671461|7709736|FG002|Treatment|Randomized, not treated|0
4744640|NCT02671461|7709734|FG000|Follow-up|Withdrawal by Subject|1
4744641|NCT02671461|7709735|FG001|Follow-up|Withdrawal by Subject|0
4744642|NCT02671461|7709736|FG002|Follow-up|Withdrawal by Subject|0
4744643|NCT02671461|7709734|FG000|Follow-up|Lost to Follow-up|0
4744644|NCT02671461|7709735|FG001|Follow-up|Lost to Follow-up|0
4744645|NCT02671461|7709736|FG002|Follow-up|Lost to Follow-up|1
4744646|NCT02671461|7709734|FG000|Follow-up|Administrative Reason by Sponsor|0
4744647|NCT02671461|7709735|FG001|Follow-up|Administrative Reason by Sponsor|1
4744648|NCT02671461|7709736|FG002|Follow-up|Administrative Reason by Sponsor|0
4744649|NCT02653495|7709807|FG000|Overall Study|Lost to Follow-up|2
4744650|NCT02653495|7709808|FG001|Overall Study|Lost to Follow-up|0
4744651|NCT02653495|7709807|FG000|Overall Study|Screening Failure|10
4744652|NCT02653495|7709808|FG001|Overall Study|Screening Failure|0
4744653|NCT02639390|7709820|FG000|Overall Study|Subject unable to comply with treatment schedule.|0
4744654|NCT02639390|7709821|FG001|Overall Study|Subject unable to comply with treatment schedule.|2
4744655|NCT02634606|7709827|FG000|Overall Study|unable to obtain the drug at start|13
4744656|NCT02636283|7709841|FG000|Overall Study|Adverse Event|2
4744657|NCT02636283|7709842|FG001|Overall Study|Adverse Event|0
4744658|NCT02636283|7709841|FG000|Overall Study|Trial Terminated Prematurely|0
4744659|NCT02636283|7709842|FG001|Overall Study|Trial Terminated Prematurely|3
4744660|NCT02638129|7709850|FG000|Overall Study|Study terminated|28
4744661|NCT02638129|7709851|FG001|Overall Study|Study terminated|30
4744662|NCT02615990|7709859|FG000|Overall Study|study terminated|1
4744663|NCT02615990|7709860|FG001|Overall Study|study terminated|1
4744664|NCT02640677|7709866|FG000|Overall Study|Lost to Follow-up|1
4744665|NCT02640677|7709866|FG000|Overall Study|Withdrawal by Subject|1
4744666|NCT02623959|7709876|FG000|Overall Study|Progression|0
4744667|NCT02623959|7709877|FG001|Overall Study|Progression|1
4744668|NCT02631148|7709887|FG000|Overall Study|8 were ineligible|8
4744669|NCT02631148|7709888|FG001|Overall Study|8 were ineligible|0
4744670|NCT02631148|7709887|FG000|Overall Study|Withdrawal by Subject|1
4744671|NCT02631148|7709888|FG001|Overall Study|Withdrawal by Subject|0
4744672|NCT02631148|7709887|FG000|Overall Study|PAH not available to study participant|1
4744673|NCT02631148|7709888|FG001|Overall Study|PAH not available to study participant|0
4744674|NCT02630472|7709896|FG000|Overall Study|Physician Decision|10
4744675|NCT02630472|7709897|FG001|Overall Study|Physician Decision|0
4744676|NCT02626520|7709906|FG000|Overall Study|Physician Decision|1
4744677|NCT02626520|7709907|FG001|Overall Study|Physician Decision|1
4744678|NCT02626520|7709906|FG000|Overall Study|Adverse Event|0
4744679|NCT02626520|7709907|FG001|Overall Study|Adverse Event|4
4744680|NCT02626520|7709906|FG000|Overall Study|Lack of Efficacy|0
4744681|NCT02626520|7709907|FG001|Overall Study|Lack of Efficacy|2
4744682|NCT02626520|7709906|FG000|Overall Study|Did not start protocol therapy|0
4744683|NCT02626520|7709907|FG001|Overall Study|Did not start protocol therapy|2
4744684|NCT02626520|7709906|FG000|Overall Study|Study terminated|0
4744685|NCT02626520|7709907|FG001|Overall Study|Study terminated|1
4744686|NCT02614898|7709915|FG000|Overall Study|Participated until study termination|10
4744687|NCT02614898|7709916|FG001|Overall Study|Participated until study termination|26
4744688|NCT02614898|7709915|FG000|Overall Study|Lost to Follow-up|0
4744689|NCT02614898|7709916|FG001|Overall Study|Lost to Follow-up|2
4744690|NCT02614898|7709915|FG000|Overall Study|Physician Decision|1
4744691|NCT02614898|7709916|FG001|Overall Study|Physician Decision|8
4744692|NCT02614898|7709915|FG000|Overall Study|Study Terminated by Sponsor|3
4744693|NCT02614898|7709916|FG001|Overall Study|Study Terminated by Sponsor|0
4744694|NCT02614898|7709915|FG000|Overall Study|Withdrawal by Subject|0
4744695|NCT02614898|7709916|FG001|Overall Study|Withdrawal by Subject|2
4744696|NCT02614898|7709915|FG000|Overall Study|Withdrawal by Parent/Guardian|1
4744697|NCT02614898|7709916|FG001|Overall Study|Withdrawal by Parent/Guardian|1
4744698|NCT02614898|7709915|FG000|Overall Study|Other-Additional Information Unavailable|0
4744699|NCT02614898|7709916|FG001|Overall Study|Other-Additional Information Unavailable|11
4744700|NCT02614898|7709915|FG000|Overall Study|Missing|0
4744701|NCT02614898|7709916|FG001|Overall Study|Missing|1
4744702|NCT02622828|7709923|FG000|Overall Study|participant withdrew|3
4744703|NCT02619812|7709949|FG000|Overall Study|Withdrawal by Subject|0
4744704|NCT02619812|7709950|FG001|Overall Study|Withdrawal by Subject|0
4744705|NCT02619812|7709951|FG002|Overall Study|Withdrawal by Subject|1
4744706|NCT02619812|7709952|FG003|Overall Study|Withdrawal by Subject|2
4744707|NCT02612285|7709962|FG000|Overall Study|Withdrawal by Subject|1
4744708|NCT02606279|7709972|FG000|Overall Study|Lost to Follow-up|0
4744709|NCT02606279|7709973|FG001|Overall Study|Lost to Follow-up|1
4744710|NCT02605824|7709981|FG000|Overall Study|Physician Decision|1
4744711|NCT02605824|7709982|FG001|Overall Study|Physician Decision|0
4744712|NCT02598622|7709990|FG000|Overall Study|Withdrawal by Subject|3
4744713|NCT02598622|7709991|FG001|Overall Study|Withdrawal by Subject|0
4744714|NCT02598622|7709990|FG000|Overall Study|Physician Decision|3
4744715|NCT02598622|7709991|FG001|Overall Study|Physician Decision|0
4744716|NCT02582749|7710012|FG000|Overall Study|Study terminated by funder|5
4744717|NCT02582749|7710013|FG001|Overall Study|Study terminated by funder|10
4744718|NCT02582749|7710012|FG000|Overall Study|Withdrawal by Subject|0
4744719|NCT02582749|7710013|FG001|Overall Study|Withdrawal by Subject|1
4744720|NCT02569957|7710046|FG000|Overall Study|Withdrawal by Subject|0
4744721|NCT02569957|7710047|FG001|Overall Study|Withdrawal by Subject|1
4744722|NCT02575365|7710066|FG000|Overall Study|Lost to Follow-up|4
4744723|NCT02547129|7710076|FG000|Overall Study|Difficulty with ongoing infection|1
4744724|NCT02547129|7710077|FG001|Overall Study|Difficulty with ongoing infection|0
4744725|NCT02533531|7710116|FG000|Overall Study|Device did not turn on|1
4744726|NCT02520726|7710132|FG000|Overall Study|Lost to Follow-up|3
4744727|NCT02520726|7710133|FG001|Overall Study|Lost to Follow-up|2
4744728|NCT02519712|7710143|FG000|Overall Study|Disease Relapse|1
4744729|NCT02519712|7710143|FG000|Overall Study|Disease Progression|1
4744730|NCT02519712|7710143|FG000|Overall Study|Accruals are donors|2
4744731|NCT02516228|7710151|FG000|Overall Study|Lost to Follow-up|1
4744732|NCT02516228|7710151|FG000|Overall Study|Withdrawal by Subject|1
4744733|NCT02516228|7710151|FG000|Overall Study|Physician Decision|1
4744734|NCT02506101|7710191|FG000|Overall Study|Transportation issues|1
4744735|NCT02506101|7710192|FG001|Overall Study|Transportation issues|0
4744736|NCT02506101|7710191|FG000|Overall Study|No enrollment and staff unavailability|1
4744737|NCT02506101|7710192|FG001|Overall Study|No enrollment and staff unavailability|0
4744738|NCT02500901|7710211|FG000|Overall Study|Disease ProgressionDD|2
4744739|NCT02483533|7710217|FG000|Overall Study|Lack of Efficacy|50
4744740|NCT02483533|7710218|FG001|Overall Study|Lack of Efficacy|50
4744741|NCT02496039|7710224|FG000|Overall Study|Adverse Event|3
4744742|NCT02496039|7710224|FG000|Overall Study|Protocol Violation|1
4744743|NCT02494206|7710233|FG000|Overall Study|Adverse Event|1
4744744|NCT02494206|7710233|FG000|Overall Study|Disease Progression|1
4744745|NCT02473445|7710237|FG000|Overall Study|Withdrawal by Subject|2
4744746|NCT02473445|7710237|FG000|Overall Study|Sponsor Decision|20
4744747|NCT02491411|7710241|FG000|Overall Study|Physician Decision|4
4744748|NCT02476994|7710247|FG000|Overall Study|Based on feedback from FDA|1
4744749|NCT02476994|7710248|FG001|Overall Study|Based on feedback from FDA|0
4744750|NCT02473523|7710254|FG000|Overall Study|Death|1
4744751|NCT02473523|7710254|FG000|Overall Study|Lost to Follow-up|1
4744752|NCT02472639|7710273|FG000|Overall Study|Physician Decision|4
4744753|NCT02472639|7710274|FG001|Overall Study|Physician Decision|3
4744754|NCT02469415|7710280|FG000|Overall Study|Withdrawal by Subject|1
4744755|NCT02469415|7710280|FG000|Overall Study|Investigational agent placed on hold|2
4744756|NCT02452359|7710292|FG000|Overall Study|Adverse Event|1
4744757|NCT02452359|7710292|FG000|Overall Study|Lost to Follow-up|15
4744758|NCT02452359|7710292|FG000|Overall Study|Pregnancy|1
4744759|NCT02452359|7710292|FG000|Overall Study|Withdrawal by Subject|4
4744760|NCT02452398|7710300|FG000|Overall Study|Adverse Event|1
4744761|NCT02452398|7710300|FG000|Overall Study|Lost to Follow-up|28
4744762|NCT02452398|7710300|FG000|Overall Study|Physician Decision|2
4744763|NCT02452398|7710300|FG000|Overall Study|Withdrawal by Subject|6
4744764|NCT02452398|7710300|FG000|Overall Study|Moved away|4
4744765|NCT02447887|7710304|FG000|Overall Study|Study was terminated|3
4744766|NCT02439970|7710325|FG000|Overall Study|Study Terminated|2
4744767|NCT02439970|7710326|FG001|Overall Study|Study Terminated|3
4744768|NCT02439957|7710334|FG000|Overall Study|Study Terminated|3
4744769|NCT02439957|7710335|FG001|Overall Study|Study Terminated|3
4744770|NCT02441036|7710346|FG000|Overall Study|No tissue resected|0
4744771|NCT02441036|7710347|FG001|Overall Study|No tissue resected|1
4744772|NCT02441036|7710348|FG002|Overall Study|No tissue resected|0
4744773|NCT02441036|7710349|FG003|Overall Study|No tissue resected|1
4744774|NCT02441036|7710350|FG004|Overall Study|No tissue resected|0
4744775|NCT02430532|7710387|FG000|Overall Study|Sponsor Decision to Stop Study Early|30
4744776|NCT02430532|7710388|FG001|Overall Study|Sponsor Decision to Stop Study Early|25
4744777|NCT02430532|7710387|FG000|Overall Study|Consent Withdrawn|0
4744778|NCT02430532|7710388|FG001|Overall Study|Consent Withdrawn|2
4744779|NCT02430532|7710387|FG000|Overall Study|Adverse Event|0
4744780|NCT02430532|7710388|FG001|Overall Study|Adverse Event|1
4744781|NCT02428231|7710398|FG000|Overall Study|Other|10
4744782|NCT02428231|7710399|FG001|Overall Study|Other|16
4744783|NCT02428231|7710398|FG000|Overall Study|Required Symptomatic Therapy|0
4744784|NCT02428231|7710399|FG001|Overall Study|Required Symptomatic Therapy|1
4744785|NCT02428231|7710398|FG000|Overall Study|Adverse Event|3
4744786|NCT02428231|7710399|FG001|Overall Study|Adverse Event|0
4744787|NCT02424565|7710405|FG000|Period 1 (D0)|Protocol Violation|0
4744788|NCT02424565|7710406|FG001|Period 1 (D0)|Protocol Violation|1
4744789|NCT02422303|7710427|FG000|Overall Study|Lost to Follow-up|1
4744790|NCT02422303|7710428|FG001|Overall Study|Lost to Follow-up|1
4744791|NCT02414152|7710451|FG000|Overall Study|Withdrawal by Subject|1
4744792|NCT02414152|7710451|FG000|Overall Study|Lack of Efficacy|1
4744793|NCT02410551|7710455|FG000|Overall Study|Adverse Event|1
4744794|NCT02410551|7710455|FG000|Overall Study|Withdrawal by Subject|1
4744795|NCT02410551|7710455|FG000|Overall Study|FDA Clinical hold-patients taken off|2
4744796|NCT02410954|7710466|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6
4744797|NCT02410954|7710467|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0
4744798|NCT02410954|7710466|FG000|Overall Study|Instrument malfunction generated unusable data|8
4744799|NCT02410954|7710467|FG001|Overall Study|Instrument malfunction generated unusable data|0
4744800|NCT02409355|7710479|FG000|Overall Study|Withdrawal by Subject|1
4744801|NCT02409355|7710480|FG001|Overall Study|Withdrawal by Subject|0
4744802|NCT02409355|7710479|FG000|Overall Study|Death|1
4594333|NCT01561976|7443569|FG001|Washout Period 2 (7 Days)|Non-compliance|0
4744803|NCT02409355|7710480|FG001|Overall Study|Death|1
4744804|NCT02409355|7710479|FG000|Overall Study|Study terminated by Sponsor|2
4744805|NCT02409355|7710480|FG001|Overall Study|Study terminated by Sponsor|3
4744806|NCT02404545|7710505|FG000|Overall Study|Sponsor Termination|6
4744807|NCT02404545|7710506|FG001|Overall Study|Sponsor Termination|6
4744808|NCT02392377|7710515|FG000|Overall Study|Withdrawal by Subject|0
4744809|NCT02392377|7710516|FG001|Overall Study|Withdrawal by Subject|1
4525548|NCT01023581|7341384|FG005|Overall Study|Lack of Efficacy|2
4525549|NCT01023581|7341385|FG006|Overall Study|Lack of Efficacy|1
4525550|NCT01023581|7341379|FG000|Overall Study|Physician Decision|2
4525551|NCT01023581|7341380|FG001|Overall Study|Physician Decision|0
4525552|NCT01023581|7341381|FG002|Overall Study|Physician Decision|2
4525553|NCT01023581|7341382|FG003|Overall Study|Physician Decision|1
4525554|NCT01023581|7341383|FG004|Overall Study|Physician Decision|1
4525555|NCT01023581|7341384|FG005|Overall Study|Physician Decision|1
4525556|NCT01023581|7341385|FG006|Overall Study|Physician Decision|1
4525557|NCT01023581|7341379|FG000|Overall Study|Other|1
4525558|NCT01023581|7341380|FG001|Overall Study|Other|0
4525559|NCT01023581|7341381|FG002|Overall Study|Other|1
4525560|NCT01023581|7341382|FG003|Overall Study|Other|0
4525561|NCT01023581|7341383|FG004|Overall Study|Other|1
4525562|NCT01023581|7341384|FG005|Overall Study|Other|0
4525563|NCT01023581|7341385|FG006|Overall Study|Other|0
4525564|NCT01023659|7341404|FG000|Overall Study|Lost to Follow-up|73
4525565|NCT01023659|7341405|FG001|Overall Study|Lost to Follow-up|228
4525566|NCT01023659|7341406|FG002|Overall Study|Lost to Follow-up|99
4525567|NCT01023672|7341415|FG000|Overall Study|Worsening disease|2
4525568|NCT01023672|7341415|FG000|Overall Study|Death|1
4525569|NCT01023789|7341437|FG000|3 - Year Visit|Death|29
4525570|NCT01023789|7341437|FG000|3 - Year Visit|Withdrawal of consent|1
4525571|NCT01023789|7341437|FG000|3 - Year Visit|Lost to Follow-up|13
4525572|NCT01023815|7341445|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144
4525573|NCT01023815|7341446|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
4525574|NCT01023815|7341447|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
4525575|NCT01023815|7341448|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
4525576|NCT01023815|7341445|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0
4525577|NCT01023815|7341446|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0
4525578|NCT01023815|7341447|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1
4525579|NCT01023815|7341448|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1
4525580|NCT01023815|7341445|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0
4525581|NCT01023815|7341446|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1
4525582|NCT01023815|7341447|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1
4525583|NCT01023815|7341448|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0
4525584|NCT01023815|7341445|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0
4525585|NCT01023815|7341446|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1
4525586|NCT01023815|7341447|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6
4525587|NCT01023815|7341448|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2
4744810|NCT02394665|7710550|FG000|Overall Study|Physician Decision|1
4744811|NCT02394665|7710551|FG001|Overall Study|Physician Decision|0
4744812|NCT02394665|7710552|FG002|Overall Study|Physician Decision|0
4744813|NCT02390362|7710571|FG000|Overall Study|Withdrawal by Subject|0
4744814|NCT02390362|7710572|FG001|Overall Study|Withdrawal by Subject|1
4744815|NCT02388776|7710578|FG000|Overall Study|Death|1
4744816|NCT02388776|7710578|FG000|Overall Study|Lost to Follow-up|1
4744817|NCT02383433|7710583|FG000|Overall Study|Disease progression|2
4744818|NCT02379390|7710611|FG000|Overall Study|Adverse Event|1
4744819|NCT02379390|7710612|FG001|Overall Study|Adverse Event|1
4744820|NCT02379390|7710611|FG000|Overall Study|Investigator's decision|1
4744821|NCT02379390|7710612|FG001|Overall Study|Investigator's decision|0
4744822|NCT02379390|7710611|FG000|Overall Study|Study Termination|0
4744823|NCT02379390|7710612|FG001|Overall Study|Study Termination|1
4744824|NCT02361580|7710636|FG000|Overall Study|Lost to Follow-up|6
4744825|NCT02361580|7710637|FG001|Overall Study|Lost to Follow-up|3
4744826|NCT02370888|7710668|FG000|Overall Study|disease progression|2
4744827|NCT02370888|7710668|FG000|Overall Study|did not meet chimerism criteria|6
4744828|NCT02365233|7710692|FG000|Overall Study|IRB withheld the data|1
4744829|NCT02365233|7710693|FG001|Overall Study|IRB withheld the data|2
4744830|NCT02365233|7710694|FG002|Overall Study|IRB withheld the data|2
4744831|NCT02347943|7710705|FG000|Overall Study|Study was cancelled|140
4744832|NCT02347943|7710706|FG001|Overall Study|Study was cancelled|67
4744833|NCT02347943|7710707|FG002|Overall Study|Study was cancelled|45
4744834|NCT02365207|7710715|FG000|Overall Study|Withdrawal by Subject|1
4744835|NCT02365207|7710715|FG000|Overall Study|Physician Decision|1
4744836|NCT02360111|7710719|FG000|Overall Study|Death|2
4744837|NCT02353468|7710723|FG000|Overall Study|Study terminated|3
4744838|NCT02346877|7710751|FG000|Overall Study|Adverse Event|1
4744839|NCT02346877|7710752|FG001|Overall Study|Adverse Event|0
4744840|NCT02346877|7710751|FG000|Overall Study|Administrative Decision|1
4744841|NCT02346877|7710752|FG001|Overall Study|Administrative Decision|0
4744842|NCT02346877|7710751|FG000|Overall Study|Sponsor Decision|12
4744843|NCT02346877|7710752|FG001|Overall Study|Sponsor Decision|0
4744844|NCT02346877|7710751|FG000|Overall Study|Missing|5
4744845|NCT02346877|7710752|FG001|Overall Study|Missing|0
4744846|NCT02353572|7710775|FG000|Overall Study|Withdrawal by Subject|1
4744847|NCT02353572|7710775|FG000|Overall Study|Study terminated|2
4744848|NCT02343263|7710791|FG000|Overall Study|Physician Decision|5
4744849|NCT02343263|7710792|FG001|Overall Study|Physician Decision|3
4744850|NCT02343263|7710793|FG002|Overall Study|Physician Decision|1
4744851|NCT02343159|7710808|FG000|Overall Study|Early Study Termination|16
4744852|NCT02343159|7710809|FG001|Overall Study|Early Study Termination|19
4744853|NCT02343159|7710810|FG002|Overall Study|Early Study Termination|23
4744854|NCT02343159|7710808|FG000|Overall Study|Physician Decision|2
4744855|NCT02343159|7710809|FG001|Overall Study|Physician Decision|0
4744856|NCT02343159|7710810|FG002|Overall Study|Physician Decision|1
4525588|NCT01023815|7341445|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0
4525589|NCT01023815|7341446|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1
4525590|NCT01023815|7341447|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0
4525591|NCT01023815|7341448|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0
4525592|NCT01023958|7341468|FG000|Overall Study|Progressive disease|48
4525593|NCT01023958|7341468|FG000|Overall Study|Other adverse event|1
4525594|NCT01023958|7341468|FG000|Overall Study|Refused to continue medication|1
4525595|NCT01024036|7341483|FG000|Blinded Treatment|Adverse Event|1
4525596|NCT01024036|7341484|FG001|Blinded Treatment|Adverse Event|1
4744857|NCT02343159|7710808|FG000|Overall Study|Withdrawal by Subject|3
4744858|NCT02343159|7710809|FG001|Overall Study|Withdrawal by Subject|0
4744859|NCT02343159|7710810|FG002|Overall Study|Withdrawal by Subject|2
4744860|NCT02343159|7710808|FG000|Overall Study|Lost to Follow-up|0
4744861|NCT02343159|7710809|FG001|Overall Study|Lost to Follow-up|2
4525597|NCT01024036|7341483|FG000|Blinded Treatment|Lack of Efficacy|16
4744862|NCT02343159|7710810|FG002|Overall Study|Lost to Follow-up|2
4744863|NCT02343159|7710808|FG000|Overall Study|Adverse Event|4
4744864|NCT02343159|7710809|FG001|Overall Study|Adverse Event|4
4744865|NCT02343159|7710810|FG002|Overall Study|Adverse Event|2
4744866|NCT02343159|7710808|FG000|Overall Study|Sponsor Decision|0
4744867|NCT02343159|7710809|FG001|Overall Study|Sponsor Decision|1
4744868|NCT02343159|7710810|FG002|Overall Study|Sponsor Decision|0
4744869|NCT02343159|7710808|FG000|Overall Study|Enrollment Error|1
4744870|NCT02343159|7710809|FG001|Overall Study|Enrollment Error|0
4744871|NCT02343159|7710810|FG002|Overall Study|Enrollment Error|0
4744872|NCT02336425|7710827|FG000|Overall Study|Study terminated.|2
4744873|NCT02336425|7710828|FG001|Overall Study|Study terminated.|2
4744874|NCT02336425|7710829|FG002|Overall Study|Study terminated.|3
4744875|NCT02336425|7710830|FG003|Overall Study|Study terminated.|3
4744876|NCT02308735|7710891|FG000|Overall Study|Physician Decision|2
4744877|NCT02308735|7710892|FG001|Overall Study|Physician Decision|0
4744878|NCT02308735|7710893|FG002|Overall Study|Physician Decision|0
4744879|NCT02308735|7710894|FG003|Overall Study|Physician Decision|2
4744880|NCT02299206|7710904|FG000|Overall Study|Lost to Follow-up|1
4744881|NCT02299206|7710904|FG000|Overall Study|Withdrawal by Subject|1
4744882|NCT02302859|7710910|FG000|Overall Study|Lost Phone|1
4744883|NCT02302859|7710911|FG001|Overall Study|Lost Phone|1
4744884|NCT02302859|7710910|FG000|Overall Study|Withdrawal by Subject|0
4744885|NCT02302859|7710911|FG001|Overall Study|Withdrawal by Subject|1
4744886|NCT02299934|7710917|FG000|Overall Study|Termination of study|13
4744887|NCT02294981|7710944|FG000|Overall Study|Lost to Follow-up|1
4744888|NCT02284906|7710951|FG000|Overall Study|Pretreatment Event/Adverse Event|0
4744889|NCT02284906|7710952|FG001|Overall Study|Pretreatment Event/Adverse Event|1
4744890|NCT02284906|7710953|FG002|Overall Study|Pretreatment Event/Adverse Event|0
4744891|NCT02284906|7710951|FG000|Overall Study|Major Protocol Deviation|0
4744892|NCT02284906|7710952|FG001|Overall Study|Major Protocol Deviation|1
4744893|NCT02284906|7710953|FG002|Overall Study|Major Protocol Deviation|0
4744894|NCT02284906|7710951|FG000|Overall Study|Voluntary Withdrawal|2
4744895|NCT02284906|7710952|FG001|Overall Study|Voluntary Withdrawal|4
4744896|NCT02284906|7710953|FG002|Overall Study|Voluntary Withdrawal|5
4744897|NCT02284906|7710951|FG000|Overall Study|Study Termination|0
4744898|NCT02284906|7710952|FG001|Overall Study|Study Termination|11
4744899|NCT02284906|7710953|FG002|Overall Study|Study Termination|14
4744900|NCT02284906|7710951|FG000|Overall Study|Reason not Specified|1
4744901|NCT02284906|7710952|FG001|Overall Study|Reason not Specified|1
4744902|NCT02284906|7710953|FG002|Overall Study|Reason not Specified|0
4744903|NCT02287025|7710963|FG000|Overall Study|Not treated|2
4744904|NCT02287025|7710964|FG001|Overall Study|Not treated|0
4744905|NCT02287025|7710963|FG000|Overall Study|Progression of disease|3
4744906|NCT02287025|7710964|FG001|Overall Study|Progression of disease|2
4744907|NCT02287025|7710963|FG000|Overall Study|Adverse Event|2
4744908|NCT02287025|7710964|FG001|Overall Study|Adverse Event|4
4744909|NCT02287025|7710963|FG000|Overall Study|Withdrawal by Subject|2
4744910|NCT02287025|7710964|FG001|Overall Study|Withdrawal by Subject|2
4744911|NCT02287025|7710963|FG000|Overall Study|Screening failed|1
4744912|NCT02287025|7710964|FG001|Overall Study|Screening failed|1
4744913|NCT02276560|7710979|FG000|Overall Study|Adverse Event|1
4744914|NCT02276560|7710980|FG001|Overall Study|Adverse Event|0
4744915|NCT02276560|7710981|FG002|Overall Study|Adverse Event|0
4744916|NCT02284373|7710996|FG000|Overall Study|Withdrawal by Subject|0
4744917|NCT02284373|7710997|FG001|Overall Study|Withdrawal by Subject|1
4744918|NCT02284373|7710998|FG002|Overall Study|Withdrawal by Subject|0
4744919|NCT02284373|7710996|FG000|Overall Study|Other|0
4744920|NCT02284373|7710997|FG001|Overall Study|Other|1
4744921|NCT02284373|7710998|FG002|Overall Study|Other|0
4744922|NCT02284373|7710996|FG000|Overall Study|Lost to Follow-up|0
4744923|NCT02284373|7710997|FG001|Overall Study|Lost to Follow-up|1
4744924|NCT02284373|7710998|FG002|Overall Study|Lost to Follow-up|0
4744925|NCT02285270|7711006|FG000|Overall Study|Lost to Follow-up|1
4744926|NCT02285270|7711006|FG000|Overall Study|Physician Decision|3
4744927|NCT02285270|7711006|FG000|Overall Study|Determined to be ineligible|1
4744928|NCT02275481|7711012|FG000|Overall Study|Death|2
4744929|NCT02275481|7711013|FG001|Overall Study|Death|1
4744930|NCT02275481|7711012|FG000|Overall Study|Lost to Follow-up|2
4744931|NCT02275481|7711013|FG001|Overall Study|Lost to Follow-up|0
4744932|NCT02275481|7711012|FG000|Overall Study|Withdrawal by Subject|3
4744933|NCT02275481|7711013|FG001|Overall Study|Withdrawal by Subject|0
4744934|NCT02275481|7711012|FG000|Overall Study|all other reasons combined|2
4744935|NCT02275481|7711013|FG001|Overall Study|all other reasons combined|1
4744936|NCT02275481|7711012|FG000|Overall Study|Physician Decision|0
4744937|NCT02275481|7711013|FG001|Overall Study|Physician Decision|1
4744938|NCT02273752|7711023|FG000|Overall Study|Trial was terminated early|2
4744939|NCT02270684|7711029|FG000|Overall Study|Lost to Follow-up|0
4744940|NCT02270684|7711030|FG001|Overall Study|Lost to Follow-up|3
4744941|NCT02270684|7711029|FG000|Overall Study|Study terminated|1
4744942|NCT02270684|7711030|FG001|Overall Study|Study terminated|0
4744943|NCT02271594|7711047|FG000|Overall Study|Study closed; recruiting failure|19
4744944|NCT02271594|7711048|FG001|Overall Study|Study closed; recruiting failure|12
4744945|NCT02263365|7711058|FG000|Overall Study|Physician Decision|22
4744946|NCT02263365|7711059|FG001|Overall Study|Physician Decision|18
4744947|NCT02241551|7711093|FG000|Overall Study|Adverse Event|1
4744948|NCT02241551|7711094|FG001|Overall Study|Adverse Event|0
4744949|NCT02246114|7711104|FG000|Overall Study|miscarriage|1
4744950|NCT02246114|7711105|FG001|Overall Study|miscarriage|0
4744951|NCT02232880|7711111|FG000|Overall Study|study stopped prior to randomization|1
4744952|NCT02244944|7711133|FG000|Overall Study|Withdrawal by Subject|1
4744953|NCT02244944|7711133|FG000|Overall Study|Study Terminated|1
4744954|NCT02241187|7711137|FG000|Overall Study|Protocol closed due to lack of accrual.|2
4744955|NCT02239926|7711143|FG000|Overall Study|Withdrawal by Subject|0
4744956|NCT02239926|7711144|FG001|Overall Study|Withdrawal by Subject|1
4744957|NCT02231892|7711153|FG000|Overall Study|Lost to Follow-up|1
4744958|NCT02231892|7711154|FG001|Overall Study|Lost to Follow-up|0
4744959|NCT02231892|7711155|FG002|Overall Study|Lost to Follow-up|3
4744960|NCT02231892|7711153|FG000|Overall Study|Withdrawal by Subject|4
4744961|NCT02231892|7711154|FG001|Overall Study|Withdrawal by Subject|3
4744962|NCT02231892|7711155|FG002|Overall Study|Withdrawal by Subject|15
4744963|NCT02231892|7711153|FG000|Overall Study|Physician Decision|0
4744964|NCT02231892|7711154|FG001|Overall Study|Physician Decision|2
4744965|NCT02231892|7711155|FG002|Overall Study|Physician Decision|4
4744966|NCT02231892|7711153|FG000|Overall Study|Motor activity when stimulating ante ACC|4
4744967|NCT02231892|7711154|FG001|Overall Study|Motor activity when stimulating ante ACC|7
4744968|NCT02231892|7711155|FG002|Overall Study|Motor activity when stimulating ante ACC|12
4744969|NCT02231892|7711153|FG000|Overall Study|Participant motor threshold was >83%|0
4744970|NCT02231892|7711154|FG001|Overall Study|Participant motor threshold was >83%|0
4744971|NCT02231892|7711155|FG002|Overall Study|Participant motor threshold was >83%|9
4744972|NCT02231892|7711153|FG000|Overall Study|Could not find motor threshold|2
4744973|NCT02231892|7711154|FG001|Overall Study|Could not find motor threshold|0
4744974|NCT02231892|7711155|FG002|Overall Study|Could not find motor threshold|1
4744975|NCT02231892|7711153|FG000|Overall Study|Could not find reliable motor hotspot|0
4744976|NCT02231892|7711154|FG001|Overall Study|Could not find reliable motor hotspot|0
4744977|NCT02231892|7711155|FG002|Overall Study|Could not find reliable motor hotspot|1
4744978|NCT02241343|7711169|FG000|Overall Study|Adverse Event|1
4744979|NCT02224599|7711204|FG000|Overall Study|Physician Decision|1
4744980|NCT02224599|7711204|FG000|Overall Study|Progression of Disease|1
4744981|NCT02201472|7711208|FG000|Overall Study|Lack of Efficacy|2
4744982|NCT02200042|7711231|FG000|Overall Study|Withdrawal by Subject|0
4744983|NCT02200042|7711232|FG001|Overall Study|Withdrawal by Subject|1
4744984|NCT02181790|7711240|FG000|Overall Study|study terminated|2
4744985|NCT02181790|7711241|FG001|Overall Study|study terminated|0
4744986|NCT02177266|7711269|FG000|Overall Study|Adverse Event|0
4744987|NCT02177266|7711270|FG001|Overall Study|Adverse Event|1
4744988|NCT02177266|7711269|FG000|Overall Study|Withdrawal by Subject|1
4744989|NCT02177266|7711270|FG001|Overall Study|Withdrawal by Subject|0
4744990|NCT02170298|7711287|FG000|Overall Study|Withdrawal by Subject|0
4744991|NCT02170298|7711288|FG001|Overall Study|Withdrawal by Subject|1
4744992|NCT02170298|7711287|FG000|Overall Study|unblinded, rerandomized to intervention|1
4744993|NCT02170298|7711288|FG001|Overall Study|unblinded, rerandomized to intervention|0
4744994|NCT02169830|7711310|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0
4744995|NCT02169830|7711311|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0
4744996|NCT02169830|7711312|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1
4744997|NCT02169830|7711310|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1
4744998|NCT02169830|7711311|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0
4744999|NCT02169830|7711312|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0
4745000|NCT02169830|7711310|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2
4745001|NCT02169830|7711311|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5
4745002|NCT02169830|7711312|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0
4745003|NCT02169830|7711310|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0
4745004|NCT02169830|7711311|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1
4745005|NCT02169830|7711312|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0
4745006|NCT02169830|7711310|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0
4745007|NCT02169830|7711311|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1
4745008|NCT02169830|7711312|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0
4745009|NCT02163187|7711322|FG000|Overall Study|Device removed|1
4745010|NCT02163187|7711323|FG001|Overall Study|Device removed|0
4745011|NCT02163187|7711322|FG000|Overall Study|Progressive disease|1
4745012|NCT02163187|7711323|FG001|Overall Study|Progressive disease|0
4745013|NCT02161016|7711329|FG000|Overall Study|withdrawn by IRB|1
4745014|NCT02159040|7711333|FG000|Overall Study|Death|1
4745015|NCT02168270|7711337|FG000|Overall Study|Lack of Efficacy|4
4745016|NCT02157116|7711341|FG000|Overall Study|Withdrawal by Subject|4
4745017|NCT02157116|7711341|FG000|Overall Study|Physician Decision|3
4525598|NCT01024036|7341484|FG001|Blinded Treatment|Lack of Efficacy|14
4525599|NCT01024036|7341483|FG000|Blinded Treatment|Physician Decision|1
4525600|NCT01024036|7341484|FG001|Blinded Treatment|Physician Decision|0
4525601|NCT01024036|7341483|FG000|Blinded Treatment|Death|0
4525602|NCT01024036|7341484|FG001|Blinded Treatment|Death|2
4525603|NCT01024036|7341483|FG000|Blinded Treatment|Withdrawal by Subject|4
4525604|NCT01024036|7341484|FG001|Blinded Treatment|Withdrawal by Subject|3
4525605|NCT01024036|7341483|FG000|Unblinded Treatment|Adverse Event|0
4525606|NCT01024036|7341484|FG001|Unblinded Treatment|Adverse Event|1
4525607|NCT01024036|7341483|FG000|Unblinded Treatment|Lack of Efficacy|0
4525608|NCT01024036|7341484|FG001|Unblinded Treatment|Lack of Efficacy|2
4525609|NCT01024036|7341483|FG000|Follow-Up Period|Lost to Follow-up|1
4525610|NCT01024036|7341484|FG001|Follow-Up Period|Lost to Follow-up|1
4525611|NCT01024036|7341483|FG000|Follow-Up Period|Withdrawal by Subject|0
4525612|NCT01024036|7341484|FG001|Follow-Up Period|Withdrawal by Subject|1
4525613|NCT01024036|7341483|FG000|Follow-Up Period|Adverse Event|4
4525614|NCT01024036|7341484|FG001|Follow-Up Period|Adverse Event|1
4525615|NCT01024231|7341500|FG000|Overall Study|Other Reasons|1
4525616|NCT01024231|7341501|FG001|Overall Study|Other Reasons|2
4525617|NCT01024231|7341502|FG002|Overall Study|Other Reasons|0
4525618|NCT01024231|7341503|FG003|Overall Study|Other Reasons|0
4525619|NCT01024231|7341504|FG004|Overall Study|Other Reasons|2
4525620|NCT01024231|7341505|FG005|Overall Study|Other Reasons|0
4525621|NCT01024231|7341506|FG006|Overall Study|Other Reasons|1
4525622|NCT01024231|7341500|FG000|Overall Study|Maximum Clinical Benefit|1
4525623|NCT01024231|7341501|FG001|Overall Study|Maximum Clinical Benefit|2
4525624|NCT01024231|7341502|FG002|Overall Study|Maximum Clinical Benefit|0
4525625|NCT01024231|7341503|FG003|Overall Study|Maximum Clinical Benefit|1
4525626|NCT01024231|7341504|FG004|Overall Study|Maximum Clinical Benefit|1
4525627|NCT01024231|7341505|FG005|Overall Study|Maximum Clinical Benefit|0
4525628|NCT01024231|7341506|FG006|Overall Study|Maximum Clinical Benefit|0
4525629|NCT01024231|7341500|FG000|Overall Study|Disease Progression|3
4525630|NCT01024231|7341501|FG001|Overall Study|Disease Progression|1
4525631|NCT01024231|7341502|FG002|Overall Study|Disease Progression|3
4525632|NCT01024231|7341503|FG003|Overall Study|Disease Progression|0
4525633|NCT01024231|7341504|FG004|Overall Study|Disease Progression|4
4525634|NCT01024231|7341505|FG005|Overall Study|Disease Progression|11
4745018|NCT02157116|7711341|FG000|Overall Study|Failed Screening|2
4745019|NCT02154087|7711345|FG000|Overall Study|Study Termination|1
4745020|NCT02152566|7711353|FG000|Overall Study|Lost to Follow-up|1
4745021|NCT02152566|7711353|FG000|Overall Study|Withdrawal by Subject|2
4745022|NCT02145390|7711370|FG000|Overall Study|Withdrawal by Subject|1
4525635|NCT01024231|7341506|FG006|Overall Study|Disease Progression|6
4525636|NCT01024231|7341500|FG000|Overall Study|AE unrelated to Study Drug|0
4525637|NCT01024231|7341501|FG001|Overall Study|AE unrelated to Study Drug|1
4525638|NCT01024231|7341502|FG002|Overall Study|AE unrelated to Study Drug|0
4525639|NCT01024231|7341503|FG003|Overall Study|AE unrelated to Study Drug|0
4525640|NCT01024231|7341504|FG004|Overall Study|AE unrelated to Study Drug|0
4525641|NCT01024231|7341505|FG005|Overall Study|AE unrelated to Study Drug|0
4525642|NCT01024231|7341506|FG006|Overall Study|AE unrelated to Study Drug|0
4525643|NCT01024231|7341500|FG000|Overall Study|No longer meets criteria|0
4525644|NCT01024231|7341501|FG001|Overall Study|No longer meets criteria|0
4525645|NCT01024231|7341502|FG002|Overall Study|No longer meets criteria|0
4525646|NCT01024231|7341503|FG003|Overall Study|No longer meets criteria|0
4525647|NCT01024231|7341504|FG004|Overall Study|No longer meets criteria|1
4525648|NCT01024231|7341505|FG005|Overall Study|No longer meets criteria|0
4525649|NCT01024231|7341506|FG006|Overall Study|No longer meets criteria|1
4525650|NCT01024231|7341500|FG000|Overall Study|Study Drug Toxicity|1
4525651|NCT01024231|7341501|FG001|Overall Study|Study Drug Toxicity|6
4525652|NCT01024231|7341502|FG002|Overall Study|Study Drug Toxicity|6
4525653|NCT01024231|7341503|FG003|Overall Study|Study Drug Toxicity|4
4525654|NCT01024231|7341504|FG004|Overall Study|Study Drug Toxicity|2
4525655|NCT01024231|7341505|FG005|Overall Study|Study Drug Toxicity|0
4525656|NCT01024231|7341506|FG006|Overall Study|Study Drug Toxicity|7
4525657|NCT01024231|7341500|FG000|Overall Study|Death|6
4525658|NCT01024231|7341501|FG001|Overall Study|Death|2
4525659|NCT01024231|7341502|FG002|Overall Study|Death|1
4634475|NCT01925209|7505634|FG003|Treatment Epoch|Physician Decision|0
4634476|NCT01925209|7505631|FG000|Treatment Epoch|Non-compliance with study treatment|0
4634477|NCT01925209|7505632|FG001|Treatment Epoch|Non-compliance with study treatment|0
4525660|NCT01024231|7341503|FG003|Overall Study|Death|0
4525661|NCT01024231|7341504|FG004|Overall Study|Death|4
4525662|NCT01024231|7341505|FG005|Overall Study|Death|3
4525663|NCT01024231|7341506|FG006|Overall Study|Death|5
4525664|NCT01024231|7341500|FG000|Overall Study|Lost to Follow-up|0
4525665|NCT01024231|7341501|FG001|Overall Study|Lost to Follow-up|0
4525666|NCT01024231|7341502|FG002|Overall Study|Lost to Follow-up|0
4525667|NCT01024231|7341503|FG003|Overall Study|Lost to Follow-up|0
4525668|NCT01024231|7341504|FG004|Overall Study|Lost to Follow-up|0
4525669|NCT01024231|7341505|FG005|Overall Study|Lost to Follow-up|0
4525670|NCT01024231|7341506|FG006|Overall Study|Lost to Follow-up|1
4525671|NCT01024231|7341500|FG000|Overall Study|Withdrew Consent|0
4525672|NCT01024231|7341501|FG001|Overall Study|Withdrew Consent|1
4525673|NCT01024231|7341502|FG002|Overall Study|Withdrew Consent|0
4525674|NCT01024231|7341503|FG003|Overall Study|Withdrew Consent|0
4525675|NCT01024231|7341504|FG004|Overall Study|Withdrew Consent|0
4525676|NCT01024231|7341505|FG005|Overall Study|Withdrew Consent|0
4525677|NCT01024231|7341506|FG006|Overall Study|Withdrew Consent|0
4634478|NCT01925209|7505633|FG002|Treatment Epoch|Non-compliance with study treatment|0
4634479|NCT01925209|7505634|FG003|Treatment Epoch|Non-compliance with study treatment|1
4634480|NCT01925209|7505631|FG000|Treatment Epoch|Death|1
4525678|NCT01024231|7341500|FG000|Overall Study|Continuing on Treatment|0
4525679|NCT01024231|7341501|FG001|Overall Study|Continuing on Treatment|0
4525680|NCT01024231|7341502|FG002|Overall Study|Continuing on Treatment|0
4525681|NCT01024231|7341503|FG003|Overall Study|Continuing on Treatment|0
4525682|NCT01024231|7341504|FG004|Overall Study|Continuing on Treatment|3
4525683|NCT01024231|7341505|FG005|Overall Study|Continuing on Treatment|2
4745023|NCT02150863|7711403|FG000|Overall Study|Lost to Follow-up|0
4525684|NCT01024231|7341506|FG006|Overall Study|Continuing on Treatment|0
4745024|NCT02150863|7711404|FG001|Overall Study|Lost to Follow-up|1
4745025|NCT02150863|7711405|FG002|Overall Study|Lost to Follow-up|0
4745026|NCT02131155|7711441|FG000|Overall Study|Adverse Event|1
4745027|NCT02131155|7711442|FG001|Overall Study|Adverse Event|0
4745028|NCT02131155|7711441|FG000|Overall Study|Treatment completed|1
4745029|NCT02131155|7711442|FG001|Overall Study|Treatment completed|0
4745030|NCT02131155|7711441|FG000|Overall Study|Primary tumour recurrence|2
4745031|NCT02131155|7711442|FG001|Overall Study|Primary tumour recurrence|1
4745032|NCT02131155|7711441|FG000|Overall Study|Refused to continue study medication|1
4745033|NCT02131155|7711442|FG001|Overall Study|Refused to continue study medication|0
4745034|NCT02131155|7711441|FG000|Overall Study|Study early termination|20
4745035|NCT02131155|7711442|FG001|Overall Study|Study early termination|10
4745036|NCT02117050|7711448|FG000|Overall Study|Subject Enrolled but not Dosed|1
4745037|NCT02105116|7711470|FG000|Overall Study|not eligible for step 2 of trial|5
4745038|NCT02105116|7711470|FG000|Overall Study|Death|1
4634481|NCT01925209|7505632|FG001|Treatment Epoch|Death|0
4634482|NCT01925209|7505633|FG002|Treatment Epoch|Death|0
4745039|NCT02099344|7711487|FG000|Overall Study|Physician Decision|1
4745040|NCT02099344|7711488|FG001|Overall Study|Physician Decision|0
4745041|NCT02096042|7711505|FG000|Overall Study|Disease Progression|1
4745042|NCT02096042|7711506|FG001|Overall Study|Disease Progression|0
4745043|NCT02096042|7711507|FG002|Overall Study|Disease Progression|0
4745044|NCT02088957|7711514|FG000|Overall Study|Lack of Efficacy|1
4745045|NCT02088957|7711515|FG001|Overall Study|Lack of Efficacy|0
4745046|NCT02093689|7711524|FG000|Overall Study|Physician Decision|4
4745047|NCT02093689|7711525|FG001|Overall Study|Physician Decision|0
4745048|NCT02093689|7711526|FG002|Overall Study|Physician Decision|0
4745049|NCT02091752|7711532|FG000|Overall Study|Study terminated by Sponsor|2
4745050|NCT02091752|7711532|FG000|Overall Study|Adverse Event|1
4745051|NCT02068547|7711538|FG000|Overall Study|Lost to Follow-up|3
4745052|NCT02068547|7711539|FG001|Overall Study|Lost to Follow-up|3
4745053|NCT02068547|7711538|FG000|Overall Study|Physician Decision|1
4745054|NCT02068547|7711539|FG001|Overall Study|Physician Decision|0
4745055|NCT02081183|7711577|FG000|Overall Study|Lost to Follow-up|0
4745056|NCT02081183|7711578|FG001|Overall Study|Lost to Follow-up|1
4745057|NCT02081183|7711577|FG000|Overall Study|Protocol Violation|1
4745058|NCT02081183|7711578|FG001|Overall Study|Protocol Violation|0
4745059|NCT02081183|7711577|FG000|Overall Study|Other|3
4745060|NCT02081183|7711578|FG001|Overall Study|Other|3
4745061|NCT02067104|7711598|FG000|Overall Study|Study termination due to low accrual|4
4745062|NCT02067104|7711599|FG001|Overall Study|Study termination due to low accrual|5
4745063|NCT02057874|7711609|FG000|Overall Study|participant did not return for scan|1
4745064|NCT02058537|7711623|FG000|Overall Study|Withdrawal by Subject|1
4745065|NCT02038153|7711636|FG000|Overall Study|Withdrawal by Subject|1
4745066|NCT02054910|7711642|FG000|Overall Study|Lost to Follow-up|4
4745067|NCT02054910|7711643|FG001|Overall Study|Lost to Follow-up|1
4745068|NCT02044302|7711653|FG000|Overall Study|study terminated|2
4745069|NCT02044302|7711654|FG001|Overall Study|study terminated|0
4745070|NCT02046226|7711658|FG000|Overall Study|Lost to Follow-up|7
4745071|NCT02044848|7711665|FG000|Overall Study|Administrative Problems|2
4745072|NCT02044848|7711666|FG001|Overall Study|Administrative Problems|3
4745073|NCT02042950|7711672|FG000|Overall Study|Progressive Disease|4
4745074|NCT02048904|7711676|FG000|Overall Study|Withdrawal by Subject|7
4745075|NCT02048904|7711676|FG000|Overall Study|Physician Decision|70
4745076|NCT02044822|7711680|FG000|Overall Study|Study Terminated by Sponsor|77
4745077|NCT02044822|7711680|FG000|Overall Study|Investigator's Discretion|10
4745078|NCT02044822|7711680|FG000|Overall Study|Withdrew Consent|3
4745079|NCT02044822|7711680|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2
4745080|NCT02044822|7711680|FG000|Overall Study|Lost to Follow-up|1
4745081|NCT02042924|7711684|FG000|Overall Study|Early Death|1
4745082|NCT02017522|7711692|FG000|Overall Study|Withdrawal by Subject|1
4745083|NCT02030015|7711697|FG000|Overall Study|Withdrawal by Subject|3
4745084|NCT02030015|7711697|FG000|Overall Study|Death|13
4745085|NCT02015663|7711703|FG000|Overall Study|unsatisfactory therapeutic effect|1
4745086|NCT02015663|7711704|FG001|Overall Study|unsatisfactory therapeutic effect|0
4745087|NCT02015663|7711703|FG000|Overall Study|Withdrawal by Subject|1
4745088|NCT02015663|7711704|FG001|Overall Study|Withdrawal by Subject|0
4745089|NCT02015663|7711703|FG000|Overall Study|Protocol Violation|0
4745090|NCT02015663|7711704|FG001|Overall Study|Protocol Violation|1
4745091|NCT02015663|7711703|FG000|Overall Study|Adverse Event|3
4745092|NCT02015663|7711704|FG001|Overall Study|Adverse Event|0
4745093|NCT02015663|7711703|FG000|Overall Study|Administrative problems|10
4745094|NCT02015663|7711704|FG001|Overall Study|Administrative problems|11
4745095|NCT02029846|7711713|FG000|Overall Study|n=1 each arm|1
4745096|NCT02029846|7711714|FG001|Overall Study|n=1 each arm|1
4745097|NCT02011542|7711751|FG000|Overall Study|Physician Decision|1
4745098|NCT02008370|7711755|FG000|Overall Study|Lost to Follow-up|7
4745099|NCT02005445|7711776|FG000|Overall Study|Dual study enrollment|0
4745100|NCT02005445|7711777|FG001|Overall Study|Dual study enrollment|1
4745101|NCT02006927|7711796|FG000|Overall Study|Adverse Event|2
4745102|NCT02006927|7711796|FG000|Overall Study|Withdrawal by Subject|1
4745103|NCT01996982|7711800|FG000|Overall Study|PI/team left institution|7
4745104|NCT01986751|7711810|FG000|Overall Study|improperly consented|10
4745105|NCT01986751|7711811|FG001|Overall Study|improperly consented|2
4745106|NCT01977729|7711870|FG000|Overall Study|Study terminated|1
4745107|NCT01982253|7711883|FG000|Overall Study|Withdrawal by Subject|1
4745108|NCT01982253|7711884|FG001|Overall Study|Withdrawal by Subject|0
4745109|NCT01982253|7711885|FG002|Overall Study|Withdrawal by Subject|0
4745110|NCT01982253|7711883|FG000|Overall Study|Study terminated by sponsor|1
4745111|NCT01982253|7711884|FG001|Overall Study|Study terminated by sponsor|4
4745112|NCT01982253|7711885|FG002|Overall Study|Study terminated by sponsor|4
4745113|NCT01984268|7711893|FG000|Overall Study|Study Terminated|15
4745114|NCT01980875|7711913|FG000|Overall Study|Withdrew Consent|1
4745115|NCT01980875|7711914|FG001|Overall Study|Withdrew Consent|1
4745116|NCT01980875|7711915|FG002|Overall Study|Withdrew Consent|1
4634483|NCT01925209|7505634|FG003|Treatment Epoch|Death|0
4745117|NCT01980875|7711913|FG000|Overall Study|Study Terminated by Sponsor|7
4745118|NCT01980875|7711914|FG001|Overall Study|Study Terminated by Sponsor|24
4745119|NCT01980875|7711915|FG002|Overall Study|Study Terminated by Sponsor|22
4745120|NCT01980875|7711913|FG000|Overall Study|Lost to Follow-up|0
4745121|NCT01980875|7711914|FG001|Overall Study|Lost to Follow-up|0
4745122|NCT01980875|7711915|FG002|Overall Study|Lost to Follow-up|1
4745123|NCT01970462|7711961|FG000|Overall Study|Lost to Follow-up|0
4745124|NCT01970462|7711962|FG001|Overall Study|Lost to Follow-up|2
4745125|NCT01969565|7711968|FG000|Overall Study|Withdrawal by Subject|1
4745126|NCT01968226|7711973|FG000|Overall Study|[F-18] RDG-K5 was not available|2
4745127|NCT01962974|7711992|FG000|Overall Study|Study termination|7
4745128|NCT01951378|7712009|FG000|Overall Study|Study Terminated-Not completed|23
4745129|NCT01951378|7712010|FG001|Overall Study|Study Terminated-Not completed|17
4745130|NCT01944059|7712033|FG000|Overall Study|Lost to Follow-up|1
4745131|NCT01944059|7712033|FG000|Overall Study|Physician Decision|3
4745132|NCT01944059|7712033|FG000|Overall Study|Withdrawal by Subject|1
4745133|NCT01944059|7712033|FG000|Overall Study|Adverse Event|2
4745134|NCT01935947|7712041|FG000|Overall Study|Adverse Event|0
4745135|NCT01935947|7712042|FG001|Overall Study|Adverse Event|2
4745136|NCT01935947|7712043|FG002|Overall Study|Adverse Event|0
4745137|NCT01935947|7712041|FG000|Overall Study|Diease Progression|2
4745138|NCT01935947|7712042|FG001|Overall Study|Diease Progression|2
4745139|NCT01935947|7712043|FG002|Overall Study|Diease Progression|2
4745140|NCT01935947|7712041|FG000|Overall Study|Death|1
4745141|NCT01935947|7712042|FG001|Overall Study|Death|0
4745142|NCT01935947|7712043|FG002|Overall Study|Death|0
4745143|NCT01939223|7712056|FG000|Overall Study|AE not assoc. with disease recurrence|1
4745144|NCT01939223|7712057|FG001|Overall Study|AE not assoc. with disease recurrence|1
4745145|NCT01939223|7712056|FG000|Overall Study|Disease recurrence (radiological)|1
4745146|NCT01939223|7712057|FG001|Overall Study|Disease recurrence (radiological)|3
4745147|NCT01939223|7712056|FG000|Overall Study|Study stopped by Sponsor|5
4634484|NCT01925209|7505631|FG000|Treatment Epoch|Protocol deviation|0
4525685|NCT01024244|7341532|FG000|Overall Study|Adverse Event|1
4525686|NCT01024244|7341533|FG001|Overall Study|Adverse Event|2
4525687|NCT01024244|7341534|FG002|Overall Study|Adverse Event|0
4525688|NCT01024244|7341535|FG003|Overall Study|Adverse Event|1
4525689|NCT01024244|7341536|FG004|Overall Study|Adverse Event|2
4525690|NCT01024244|7341532|FG000|Overall Study|Entry Criteria Not Met|0
4525691|NCT01024244|7341533|FG001|Overall Study|Entry Criteria Not Met|1
4525692|NCT01024244|7341534|FG002|Overall Study|Entry Criteria Not Met|0
4525693|NCT01024244|7341535|FG003|Overall Study|Entry Criteria Not Met|0
4525694|NCT01024244|7341536|FG004|Overall Study|Entry Criteria Not Met|0
4525695|NCT01024244|7341532|FG000|Overall Study|Lack of Efficacy|1
4525696|NCT01024244|7341533|FG001|Overall Study|Lack of Efficacy|0
4525697|NCT01024244|7341534|FG002|Overall Study|Lack of Efficacy|0
4525698|NCT01024244|7341535|FG003|Overall Study|Lack of Efficacy|0
4745148|NCT01939223|7712057|FG001|Overall Study|Study stopped by Sponsor|7
4745149|NCT01939223|7712056|FG000|Overall Study|Withdrawal by Subject|6
4745150|NCT01939223|7712057|FG001|Overall Study|Withdrawal by Subject|0
4745151|NCT01938716|7712063|FG000|Overall Study|Physician Decision|2
4745152|NCT01938716|7712063|FG000|Overall Study|Withdrawal by Subject|2
4745153|NCT01936974|7712069|FG000|Overall Study|Physician Decision|2
4745154|NCT01936974|7712070|FG001|Overall Study|Physician Decision|5
4525699|NCT01024244|7341536|FG004|Overall Study|Lack of Efficacy|0
4525700|NCT01024244|7341532|FG000|Overall Study|Protocol Violation|1
4525701|NCT01024244|7341533|FG001|Overall Study|Protocol Violation|0
4525702|NCT01024244|7341534|FG002|Overall Study|Protocol Violation|0
4525703|NCT01024244|7341535|FG003|Overall Study|Protocol Violation|0
4525704|NCT01024244|7341536|FG004|Overall Study|Protocol Violation|2
4525705|NCT01024244|7341532|FG000|Overall Study|Sponsor Decision|14
4525706|NCT01024244|7341533|FG001|Overall Study|Sponsor Decision|7
4525707|NCT01024244|7341534|FG002|Overall Study|Sponsor Decision|14
4525708|NCT01024244|7341535|FG003|Overall Study|Sponsor Decision|12
4525709|NCT01024244|7341536|FG004|Overall Study|Sponsor Decision|10
4525710|NCT01024244|7341532|FG000|Overall Study|Withdrawal by Subject|0
4525711|NCT01024244|7341533|FG001|Overall Study|Withdrawal by Subject|1
4525712|NCT01024244|7341534|FG002|Overall Study|Withdrawal by Subject|0
4525713|NCT01024244|7341535|FG003|Overall Study|Withdrawal by Subject|0
4525714|NCT01024244|7341536|FG004|Overall Study|Withdrawal by Subject|0
4525715|NCT01024309|7341554|FG000|Overall Study|Physician Decision|4
4525716|NCT01024309|7341555|FG001|Overall Study|Physician Decision|0
4525717|NCT01024309|7341554|FG000|Overall Study|Withdrawal by Subject|4
4525718|NCT01024309|7341555|FG001|Overall Study|Withdrawal by Subject|4
4525719|NCT01024387|7341570|FG000|Overall Study|Radiographic Progression|29
4525720|NCT01024387|7341570|FG000|Overall Study|Symptomatic Progression|10
4525721|NCT01024387|7341570|FG000|Overall Study|Physician Decision|5
4525722|NCT01024387|7341570|FG000|Overall Study|Withdrawal by Subject|5
4525723|NCT01024387|7341570|FG000|Overall Study|Death|2
4525724|NCT01024387|7341570|FG000|Overall Study|Prolonged Treatment Delay|1
4745155|NCT01934504|7712097|FG000|Overall Study|Protocol Deviation|0
4745156|NCT01934504|7712098|FG001|Overall Study|Protocol Deviation|0
4745157|NCT01934504|7712099|FG002|Overall Study|Protocol Deviation|0
4745158|NCT01934504|7712100|FG003|Overall Study|Protocol Deviation|2
4745159|NCT01934504|7712097|FG000|Overall Study|Study Terminated by Sponsor|1
4745160|NCT01934504|7712098|FG001|Overall Study|Study Terminated by Sponsor|0
4745161|NCT01934504|7712099|FG002|Overall Study|Study Terminated by Sponsor|5
4745162|NCT01934504|7712100|FG003|Overall Study|Study Terminated by Sponsor|5
4745163|NCT01928082|7712110|FG000|Overall Study|Study terminated.|1
4745164|NCT01928615|7712114|FG000|Overall Study|Study Terminated by Sponsor|2
4745165|NCT01911793|7712121|FG000|Overall Study|Physician Decision|1
4745166|NCT01911793|7712122|FG001|Overall Study|Physician Decision|5
4745167|NCT01912404|7712130|FG000|Overall Study|Due to personal reasons|1
4745168|NCT01912404|7712131|FG001|Overall Study|Due to personal reasons|0
4745169|NCT01910389|7712139|FG000|Overall Study|Withdrawal by Subject|2
4745170|NCT01910389|7712140|FG001|Overall Study|Withdrawal by Subject|0
4745171|NCT01910389|7712139|FG000|Overall Study|Study Closed|13
4745172|NCT01910389|7712140|FG001|Overall Study|Study Closed|8
4745173|NCT01913327|7712166|FG000|Overall Study|Withdrawal by Subject|0
4745174|NCT01913327|7712167|FG001|Overall Study|Withdrawal by Subject|1
4745175|NCT01902888|7712173|FG000|Overall Study|Study Terminated|3
4745176|NCT01901224|7712177|FG000|Overall Study|study was not funded and terminated|2
4745177|NCT01910441|7712183|FG000|Overall Study|Sponsor decision|0
4745178|NCT01910441|7712184|FG001|Overall Study|Sponsor decision|2
4525725|NCT01024387|7341570|FG000|Overall Study|Adverse Event|3
4525726|NCT01024387|7341570|FG000|Overall Study|Other|5
4525727|NCT01024465|7341574|FG000|Overall Study|Adverse Event|2
4525728|NCT01024465|7341574|FG000|Overall Study|Physician Decision|1
4525729|NCT01024751|7341617|FG000|Enrolled Participants|Ineligible at baseline|3
4745179|NCT01910441|7712183|FG000|Overall Study|Lost to Follow-up|6
4745180|NCT01910441|7712184|FG001|Overall Study|Lost to Follow-up|5
4745181|NCT01910441|7712183|FG000|Overall Study|Withdrawal by Subject|0
4745182|NCT01910441|7712184|FG001|Overall Study|Withdrawal by Subject|1
4745183|NCT01910441|7712183|FG000|Overall Study|Non-compliance|0
4745184|NCT01910441|7712184|FG001|Overall Study|Non-compliance|1
4745185|NCT01910441|7712183|FG000|Overall Study|Adverse Event|1
4745186|NCT01910441|7712184|FG001|Overall Study|Adverse Event|0
4745187|NCT01910441|7712183|FG000|Overall Study|Physician Decision|0
4745188|NCT01910441|7712184|FG001|Overall Study|Physician Decision|1
4745189|NCT01902966|7712190|FG000|Overall Study|Death|1
4745190|NCT01902966|7712190|FG000|Overall Study|Physician Decision|1
4745191|NCT01902966|7712190|FG000|Overall Study|Withdrawal by Subject|1
4745192|NCT01900730|7712205|FG000|Overall Study|Withdrawal by Subject|1
4745193|NCT01900730|7712206|FG001|Overall Study|Withdrawal by Subject|0
4745194|NCT01900730|7712205|FG000|Overall Study|Screen Failure|1
4745195|NCT01900730|7712206|FG001|Overall Study|Screen Failure|0
4745196|NCT01900626|7712234|FG000|Overall Study|study was closed due to low enrollment|1
4745197|NCT01900626|7712235|FG001|Overall Study|study was closed due to low enrollment|1
4745198|NCT01884077|7712257|FG000|Overall Study|screen fail|0
4745199|NCT01884077|7712258|FG001|Overall Study|screen fail|2
4745200|NCT01884077|7712257|FG000|Overall Study|canceled surgery|2
4745201|NCT01884077|7712258|FG001|Overall Study|canceled surgery|0
4745202|NCT01884077|7712257|FG000|Overall Study|Lost to Follow-up|0
4745203|NCT01884077|7712258|FG001|Overall Study|Lost to Follow-up|4
4745204|NCT01884077|7712257|FG000|Overall Study|study closed|6
4745205|NCT01884077|7712258|FG001|Overall Study|study closed|4
4745206|NCT01887288|7712290|FG000|Overall Study|The study was terminated and the PI has|16
4745207|NCT01861717|7712333|FG000|Overall Study|Lost to Follow-up|1
4745208|NCT01861717|7712333|FG000|Overall Study|Withdrawal by Subject|1
4745209|NCT01866709|7712340|FG000|Overall Study|Adverse Event|1
4745210|NCT01866709|7712341|FG001|Overall Study|Adverse Event|0
4745211|NCT01860040|7712349|FG000|Overall Study|Withdrawal by Subject|1
4745212|NCT01860040|7712350|FG001|Overall Study|Withdrawal by Subject|0
4634485|NCT01925209|7505632|FG001|Treatment Epoch|Protocol deviation|0
4745213|NCT01856322|7712395|FG000|Overall Study|off study due to lack of accrual|0
4745214|NCT01856322|7712396|FG001|Overall Study|off study due to lack of accrual|0
4745215|NCT01856322|7712397|FG002|Overall Study|off study due to lack of accrual|3
4745216|NCT01853176|7712406|FG000|Overall Study|Study terminated|4
4745217|NCT01853176|7712407|FG001|Overall Study|Study terminated|0
4745218|NCT01857271|7712413|FG000|Overall Study|Lost to Follow-up|1
4745219|NCT01853982|7712428|FG000|Overall Study|Withdrawal by Subject|1
4745220|NCT01853982|7712429|FG001|Overall Study|Withdrawal by Subject|0
4745221|NCT01853982|7712428|FG000|Overall Study|Death|1
4745222|NCT01853982|7712429|FG001|Overall Study|Death|0
4745223|NCT01853982|7712428|FG000|Overall Study|Lost to Follow-up|0
4745224|NCT01853982|7712429|FG001|Overall Study|Lost to Follow-up|1
4745225|NCT01831596|7712460|FG000|Overall Study|Other|8
4745226|NCT01821963|7712473|FG000|Overall Study|Adverse Event|1
4745227|NCT01821898|7712479|FG000|Overall Study|Withdrawal by Subject|2
4634486|NCT01925209|7505633|FG002|Treatment Epoch|Protocol deviation|1
4634487|NCT01925209|7505634|FG003|Treatment Epoch|Protocol deviation|1
4634488|NCT01925209|7505631|FG000|Treatment Epoch|Withdrawal by Subject|4
4634489|NCT01925209|7505632|FG001|Treatment Epoch|Withdrawal by Subject|3
4634490|NCT01925209|7505633|FG002|Treatment Epoch|Withdrawal by Subject|3
4634491|NCT01925209|7505634|FG003|Treatment Epoch|Withdrawal by Subject|2
4634492|NCT01925209|7505631|FG000|Treatment Epoch|Adverse Event|3
4634493|NCT01925209|7505632|FG001|Treatment Epoch|Adverse Event|5
4634494|NCT01925209|7505633|FG002|Treatment Epoch|Adverse Event|3
4634495|NCT01925209|7505634|FG003|Treatment Epoch|Adverse Event|1
4634496|NCT01925209|7505631|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0
4634497|NCT01925209|7505632|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1
4634498|NCT01925209|7505633|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1
4634499|NCT01925209|7505634|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2
4634500|NCT01925209|7505631|FG000|Maintenance Treatment Epoch|Adverse Event|0
4525730|NCT01024751|7341618|FG001|Enrolled Participants|Ineligible at baseline|4
4525731|NCT01024751|7341617|FG000|Eligible Participants|Withdrawal by Subject|0
4525732|NCT01024751|7341618|FG001|Eligible Participants|Withdrawal by Subject|1
4525733|NCT01024751|7341617|FG000|Eligible Participants|Lost to Follow-up|0
4525734|NCT01024751|7341618|FG001|Eligible Participants|Lost to Follow-up|1
4525735|NCT01024751|7341617|FG000|Eligible Participants|Ineligible|0
4525736|NCT01024751|7341618|FG001|Eligible Participants|Ineligible|1
4525737|NCT01024855|7341624|FG000|Overall Study|Inclusion/exclusion criteria|1
4525738|NCT01024920|7341631|FG000|Overall Study|Progressive disease|47
4525739|NCT01024920|7341632|FG001|Overall Study|Progressive disease|25
4525740|NCT01024920|7341631|FG000|Overall Study|Adverse Event|8
4525741|NCT01024920|7341632|FG001|Overall Study|Adverse Event|4
4525742|NCT01024920|7341631|FG000|Overall Study|Lost to Follow-up|0
4525743|NCT01024920|7341632|FG001|Overall Study|Lost to Follow-up|1
4525744|NCT01024920|7341631|FG000|Overall Study|Patient refusal to continue|4
4525745|NCT01024920|7341632|FG001|Overall Study|Patient refusal to continue|0
4525746|NCT01024920|7341631|FG000|Overall Study|Other than listed|5
4525747|NCT01024920|7341632|FG001|Overall Study|Other than listed|1
4525748|NCT01024920|7341631|FG000|Overall Study|Not treated|3
4525749|NCT01024920|7341632|FG001|Overall Study|Not treated|0
4525750|NCT01024920|7341631|FG000|Overall Study|Protocol Violation|0
4634501|NCT01925209|7505632|FG001|Maintenance Treatment Epoch|Adverse Event|0
4634502|NCT01925209|7505633|FG002|Maintenance Treatment Epoch|Adverse Event|1
4634503|NCT01925209|7505634|FG003|Maintenance Treatment Epoch|Adverse Event|0
4745228|NCT01821898|7712480|FG001|Overall Study|Withdrawal by Subject|1
4745229|NCT01829477|7712511|FG000|Overall Study|Study Terminated by Sponsor|15
4745230|NCT01829477|7712512|FG001|Overall Study|Study Terminated by Sponsor|15
4745231|NCT01829477|7712511|FG000|Overall Study|Withdrawal by Subject|1
4745232|NCT01829477|7712512|FG001|Overall Study|Withdrawal by Subject|0
4745233|NCT01803711|7712520|FG000|Overall Study|Adverse Event|1
4745234|NCT01803711|7712521|FG001|Overall Study|Adverse Event|1
4745235|NCT01806051|7712549|FG000|Overall Study|Withdrawal by Subject|6
4745236|NCT01810302|7712576|FG000|Overall Study|Death|1
4745237|NCT01810302|7712577|FG001|Overall Study|Death|0
4745238|NCT01810302|7712576|FG000|Overall Study|Physician Decision|0
4745239|NCT01810302|7712577|FG001|Overall Study|Physician Decision|1
4745240|NCT01806961|7712583|FG000|Overall Study|sponsor decision|16
4745241|NCT01783015|7712593|FG000|Blinded Treatment|Adverse Event|0
4745242|NCT01783015|7712594|FG001|Blinded Treatment|Adverse Event|1
4745243|NCT01783015|7712595|FG002|Blinded Treatment|Adverse Event|0
4745244|NCT01783015|7712593|FG000|Blinded Treatment|Protocol Violation|0
4745245|NCT01783015|7712594|FG001|Blinded Treatment|Protocol Violation|1
4745246|NCT01783015|7712595|FG002|Blinded Treatment|Protocol Violation|0
4745247|NCT01783015|7712593|FG000|Blinded Treatment|Withdrawal by Subject|0
4745248|NCT01783015|7712594|FG001|Blinded Treatment|Withdrawal by Subject|1
4745249|NCT01783015|7712595|FG002|Blinded Treatment|Withdrawal by Subject|0
4745250|NCT01783015|7712593|FG000|Blinded Treatment|Study Terminated by Sponsor|2
4745251|NCT01783015|7712594|FG001|Blinded Treatment|Study Terminated by Sponsor|0
4745252|NCT01783015|7712595|FG002|Blinded Treatment|Study Terminated by Sponsor|0
4745253|NCT01783015|7712593|FG000|Open Label Treatment|Study Terminated by Sponsor|0
4745254|NCT01783015|7712594|FG001|Open Label Treatment|Study Terminated by Sponsor|0
4745255|NCT01783015|7712595|FG002|Open Label Treatment|Study Terminated by Sponsor|6
4745256|NCT01781026|7712629|FG000|Overall Study|Lack of Efficacy|2
4745257|NCT01777854|7712655|FG000|Overall Study|Physician Decision|3
4745258|NCT01777854|7712656|FG001|Overall Study|Physician Decision|3
4745259|NCT01772719|7712664|FG000|Overall Study|Withdrawal by Subject|3
4745260|NCT01772719|7712664|FG000|Overall Study|Adverse Event|2
4745261|NCT01772719|7712664|FG000|Overall Study|Protocol Violation|1
4745262|NCT01772719|7712664|FG000|Overall Study|Lost to Follow-up|1
4745263|NCT01764997|7712676|FG000|Run-in Period|Adverse Event|15
4745264|NCT01764997|7712677|FG001|Run-in Period|Adverse Event|0
4745265|NCT01764997|7712678|FG002|Run-in Period|Adverse Event|0
4745266|NCT01764997|7712679|FG003|Run-in Period|Adverse Event|0
4745267|NCT01764997|7712680|FG004|Run-in Period|Adverse Event|0
4745268|NCT01764997|7712676|FG000|Run-in Period|Lack of Efficacy|5
4745269|NCT01764997|7712677|FG001|Run-in Period|Lack of Efficacy|0
4745270|NCT01764997|7712678|FG002|Run-in Period|Lack of Efficacy|0
4745271|NCT01764997|7712679|FG003|Run-in Period|Lack of Efficacy|0
4745272|NCT01764997|7712680|FG004|Run-in Period|Lack of Efficacy|0
4745273|NCT01764997|7712676|FG000|Run-in Period|Poor compliance to protocol|1
4745274|NCT01764997|7712677|FG001|Run-in Period|Poor compliance to protocol|0
4745275|NCT01764997|7712678|FG002|Run-in Period|Poor compliance to protocol|0
4745276|NCT01764997|7712679|FG003|Run-in Period|Poor compliance to protocol|0
4745277|NCT01764997|7712680|FG004|Run-in Period|Poor compliance to protocol|0
4745278|NCT01764997|7712676|FG000|Run-in Period|Other than specified above|17
4745279|NCT01764997|7712677|FG001|Run-in Period|Other than specified above|0
4745280|NCT01764997|7712678|FG002|Run-in Period|Other than specified above|0
4745281|NCT01764997|7712679|FG003|Run-in Period|Other than specified above|0
4745282|NCT01764997|7712680|FG004|Run-in Period|Other than specified above|0
4745283|NCT01764997|7712676|FG000|Study Drug Treatment Period|Adverse Event|0
4745284|NCT01764997|7712677|FG001|Study Drug Treatment Period|Adverse Event|1
4745285|NCT01764997|7712678|FG002|Study Drug Treatment Period|Adverse Event|0
4745286|NCT01764997|7712679|FG003|Study Drug Treatment Period|Adverse Event|0
4745287|NCT01764997|7712680|FG004|Study Drug Treatment Period|Adverse Event|24
4745288|NCT01764997|7712676|FG000|Study Drug Treatment Period|Lack of Efficacy|0
4745289|NCT01764997|7712677|FG001|Study Drug Treatment Period|Lack of Efficacy|0
4745290|NCT01764997|7712678|FG002|Study Drug Treatment Period|Lack of Efficacy|0
4745291|NCT01764997|7712679|FG003|Study Drug Treatment Period|Lack of Efficacy|0
4745292|NCT01764997|7712680|FG004|Study Drug Treatment Period|Lack of Efficacy|2
4745293|NCT01764997|7712676|FG000|Study Drug Treatment Period|Other than specified above|0
4745294|NCT01764997|7712677|FG001|Study Drug Treatment Period|Other than specified above|0
4745295|NCT01764997|7712678|FG002|Study Drug Treatment Period|Other than specified above|0
4745296|NCT01764997|7712679|FG003|Study Drug Treatment Period|Other than specified above|0
4745297|NCT01764997|7712680|FG004|Study Drug Treatment Period|Other than specified above|10
4745298|NCT01769443|7712696|FG000|Overall Study|Study closure|1
4745299|NCT01769443|7712697|FG001|Overall Study|Study closure|0
4745300|NCT01749826|7712719|FG000|Overall Study|Study Terminated|20
4745301|NCT01749826|7712720|FG001|Overall Study|Study Terminated|0
4745302|NCT01752023|7712781|FG000|Overall Study|Physician Decision|2
4745303|NCT01752023|7712782|FG001|Overall Study|Physician Decision|1
4745304|NCT01740154|7712792|FG000|Overall Study|Adverse Event|1
4745305|NCT01748890|7712796|FG000|Overall Study|Insufficient recruitment for analysis|4
4745306|NCT01748162|7712802|FG000|Overall Study|no additional croup episodes to evaluate|2
4745307|NCT01748162|7712803|FG001|Overall Study|no additional croup episodes to evaluate|2
4745308|NCT01748162|7712802|FG000|Overall Study|participant consented but did not begin|0
4745309|NCT01748162|7712803|FG001|Overall Study|participant consented but did not begin|1
4745310|NCT01748162|7712802|FG000|Overall Study|reasons not available|3
4745311|NCT01748162|7712803|FG001|Overall Study|reasons not available|2
4745312|NCT01732926|7712828|FG000|Overall Study|Study Terminated by Sponsor|168
4745313|NCT01732926|7712829|FG001|Overall Study|Study Terminated by Sponsor|80
4745314|NCT01732926|7712828|FG000|Overall Study|Withdrawal by Subject|46
4745315|NCT01732926|7712829|FG001|Overall Study|Withdrawal by Subject|8
4745316|NCT01732926|7712828|FG000|Overall Study|Physician Decision|24
4745317|NCT01732926|7712829|FG001|Overall Study|Physician Decision|11
4745318|NCT01732926|7712828|FG000|Overall Study|Other Reason|21
4745319|NCT01732926|7712829|FG001|Overall Study|Other Reason|4
4745320|NCT01732926|7712828|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7
4745321|NCT01732926|7712829|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6
4745322|NCT01732926|7712828|FG000|Overall Study|Blind Broken by Subject or Study Site|1
4745323|NCT01732926|7712829|FG001|Overall Study|Blind Broken by Subject or Study Site|1
4745324|NCT01732913|7712846|FG000|Overall Study|Study Terminated by Sponsor|105
4745325|NCT01732913|7712847|FG001|Overall Study|Study Terminated by Sponsor|55
4745326|NCT01732913|7712846|FG000|Overall Study|Withdrawal by Subject|27
4745327|NCT01732913|7712847|FG001|Overall Study|Withdrawal by Subject|4
4745328|NCT01732913|7712846|FG000|Overall Study|Physician Decision|14
4745329|NCT01732913|7712847|FG001|Overall Study|Physician Decision|7
4745330|NCT01732913|7712846|FG000|Overall Study|Other|7
4745331|NCT01732913|7712847|FG001|Overall Study|Other|1
4745332|NCT01732913|7712846|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3
4634504|NCT01925209|7505631|FG000|Follow-up|Adverse Event|1
4634505|NCT01925209|7505632|FG001|Follow-up|Adverse Event|4
4745333|NCT01732913|7712847|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2
4745334|NCT01716052|7712859|FG000|Overall Study|Withdrawal of funding|1
4745335|NCT01716052|7712860|FG001|Overall Study|Withdrawal of funding|1
4745336|NCT01712854|7712875|FG000|Overall Study|Physician Decision|1
4745337|NCT01708057|7712902|FG000|Overall Study|Withdrawal due to study termination.|1
4745338|NCT01708057|7712903|FG001|Overall Study|Withdrawal due to study termination.|1
4745339|NCT01708057|7712904|FG002|Overall Study|Withdrawal due to study termination.|1
4745340|NCT01693367|7712924|FG000|Overall Study|Withdrawal by Subject|1
4745341|NCT01693367|7712925|FG001|Overall Study|Withdrawal by Subject|1
4745342|NCT01693367|7712924|FG000|Overall Study|Physician Decision|0
4745343|NCT01693367|7712925|FG001|Overall Study|Physician Decision|1
4634506|NCT01925209|7505633|FG002|Follow-up|Adverse Event|0
4745344|NCT01697800|7712946|FG000|Overall Study|Death|0
4745345|NCT01697800|7712947|FG001|Overall Study|Death|1
4745346|NCT01700348|7712953|FG000|Overall Study|Withdrawal by Subject|22
4745347|NCT01700348|7712953|FG000|Overall Study|Lost to Follow-up|1
4745348|NCT01689974|7712998|FG000|Overall Study|Termination of Study|5
4745349|NCT01689974|7712999|FG001|Overall Study|Termination of Study|5
4745350|NCT01676961|7713005|FG000|Overall Study|Death|3
4745351|NCT01676961|7713005|FG000|Overall Study|Lost to Follow-up|1
4745352|NCT01676961|7713005|FG000|Overall Study|Withdrawal by Subject|1
4745353|NCT01675011|7713073|FG000|Overall Study|Trial terminated by Sponsor|3
4745354|NCT01675011|7713074|FG001|Overall Study|Trial terminated by Sponsor|1
4745355|NCT01668147|7713102|FG000|Overall Study|Withdrawal by Subject|6
4745356|NCT01676701|7713112|FG000|Overall Study|Protocol Violation|1
4745357|NCT01676701|7713113|FG001|Overall Study|Protocol Violation|0
4745358|NCT01676701|7713112|FG000|Overall Study|Sponsor Decision|3
4745359|NCT01676701|7713113|FG001|Overall Study|Sponsor Decision|4
4745360|NCT01662102|7713128|FG000|Overall Study|Sponsor's decision|1
4745361|NCT01662102|7713129|FG001|Overall Study|Sponsor's decision|0
4745362|NCT01659554|7713136|FG000|Overall Study|Study Termination|4
4745363|NCT01658813|7713140|FG000|Overall Study|Disease progression|3
4745364|NCT01642732|7713168|FG000|Overall Study|Withdrawal by Subject|1
4745365|NCT01648270|7713181|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12
4745366|NCT01641601|7713197|FG000|Overall Study|Study discontinued.|3
4745367|NCT01641601|7713198|FG001|Overall Study|Study discontinued.|5
4745368|NCT01627899|7713226|FG000|Overall Study|Study terminated early by sponsor.|5
4745369|NCT01632020|7713232|FG000|Overall Study|Withdrawal by Subject|1
4745370|NCT01632020|7713233|FG001|Overall Study|Withdrawal by Subject|0
4745371|NCT01632020|7713232|FG000|Overall Study|Adverse Event|1
4745372|NCT01632020|7713233|FG001|Overall Study|Adverse Event|0
4745373|NCT01619800|7713245|FG000|Overall Study|study terminated|2
4745374|NCT01619800|7713246|FG001|Overall Study|study terminated|0
4745375|NCT01614067|7713263|FG000|Overall Study|Pregnancy|1
4745376|NCT01614067|7713264|FG001|Overall Study|Pregnancy|0
4745377|NCT01614067|7713263|FG000|Overall Study|Physician Decision|6
4745378|NCT01614067|7713264|FG001|Overall Study|Physician Decision|5
4745379|NCT01614067|7713263|FG000|Overall Study|Withdrawal by Subject|0
4745380|NCT01614067|7713264|FG001|Overall Study|Withdrawal by Subject|1
4745381|NCT01614067|7713263|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8
4745382|NCT01614067|7713264|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9
4745383|NCT01605019|7713277|FG000|Overall Study|pt did not meet transplant endpoint|3
4745384|NCT01605019|7713278|FG001|Overall Study|pt did not meet transplant endpoint|0
4745385|NCT01609231|7713286|FG000|Overall Study|Adverse Event|1
4745386|NCT01609231|7713287|FG001|Overall Study|Adverse Event|3
4745387|NCT01609231|7713286|FG000|Overall Study|Physician Decision|1
4745388|NCT01609231|7713287|FG001|Overall Study|Physician Decision|0
4745389|NCT01609231|7713286|FG000|Overall Study|Withdrawal by Subject|1
4745390|NCT01609231|7713287|FG001|Overall Study|Withdrawal by Subject|0
4745391|NCT01603043|7713313|FG000|Overall Study|Study Futility|7
4745392|NCT01603043|7713314|FG001|Overall Study|Study Futility|3
4745393|NCT01605370|7713322|FG000|Overall Study|Adverse Event|1
4745394|NCT01605370|7713323|FG001|Overall Study|Adverse Event|0
4525751|NCT01024920|7341632|FG001|Overall Study|Protocol Violation|1
4525752|NCT01024946|7341638|FG000|Overall Study|Screen Failure|3
4525753|NCT01024946|7341638|FG000|Overall Study|Withdrawal by Subject|1
4525754|NCT01024946|7341638|FG000|Overall Study|Adverse Event|1
4525755|NCT01024959|7341642|FG000|Overall Study|ineligible|12
4525756|NCT01024959|7341642|FG000|Overall Study|results not evaluable|12
4525757|NCT01024959|7341642|FG000|Overall Study|missing results required for analysis|17
4525758|NCT01025037|7341661|FG000|Overall Study|Adverse Event|3
4525759|NCT01025037|7341661|FG000|Overall Study|Lost to Follow-up|7
4525760|NCT01025037|7341661|FG000|Overall Study|Withdrawal by Subject|1
4525761|NCT01025154|7341669|FG000|Overall Study|Lost to Follow-up|1
4525762|NCT01025154|7341669|FG000|Overall Study|Withdrawal by Subject|1
4525763|NCT01025193|7341673|FG000|Overall Study|Protocol Violation|1
4525764|NCT01025193|7341673|FG000|Overall Study|Adverse Event|3
4525765|NCT01025232|7341683|FG000|Overall Study|Study drug no longer available|3
4525766|NCT01025232|7341684|FG001|Overall Study|Study drug no longer available|6
4525767|NCT01025284|7341693|FG000|Overall Study|Investigator Decision|0
4745395|NCT01605617|7713331|FG000|First Intervention|Adverse Event|0
4745396|NCT01605617|7713332|FG001|First Intervention|Adverse Event|1
4525768|NCT01025284|7341694|FG001|Overall Study|Investigator Decision|1
4745397|NCT01605617|7713331|FG000|Washout Period of 4 Weeks|Study Terminated|2
4745398|NCT01605617|7713332|FG001|Washout Period of 4 Weeks|Study Terminated|1
4745399|NCT01603121|7713349|FG000|Second Intervention, 10 Hours|Adverse Event|1
4745400|NCT01603121|7713350|FG001|Second Intervention, 10 Hours|Adverse Event|0
4745401|NCT01603394|7713363|FG000|Overall Study|Adverse Event|1
4745402|NCT01592383|7713367|FG000|Overall Study|Adverse Event|1
4745403|NCT01591096|7713389|FG000|Overall Study|Adverse Event|1
4745404|NCT01576575|7713406|FG000|Buprenorphine Control|Withdrawal by Subject|3
4745405|NCT01576575|7713406|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3
4745406|NCT01576575|7713406|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1
4745407|NCT01582100|7713430|FG000|Overall Study|Adverse Event|1
4745408|NCT01582100|7713430|FG000|Overall Study|Withdrawal by Subject|1
4745409|NCT01575028|7713443|FG000|Overall Study|Physician Decision|0
4745410|NCT01575028|7713444|FG001|Overall Study|Physician Decision|1
4745411|NCT01578785|7713452|FG000|Overall Study|Withdrawal by Subject|0
4745412|NCT01578785|7713453|FG001|Overall Study|Withdrawal by Subject|1
4745413|NCT01578785|7713452|FG000|Overall Study|Study terminated by sponsor|59
4745414|NCT01578785|7713453|FG001|Overall Study|Study terminated by sponsor|118
4745415|NCT01576549|7713459|FG000|Overall Study|Sponsor Decision|2
4745416|NCT01561989|7713479|FG000|Overall Study|accural target not met.|5
4745417|NCT01561989|7713480|FG001|Overall Study|accural target not met.|6
4745418|NCT01564732|7713488|FG000|Overall Study|Early termination by the study sponsor|6
4745419|NCT01564732|7713489|FG001|Overall Study|Early termination by the study sponsor|5
4745420|NCT01560507|7713498|FG000|Overall Study|Lost to Follow-up|3
4745421|NCT01560507|7713499|FG001|Overall Study|Lost to Follow-up|1
4745422|NCT01560507|7713500|FG002|Overall Study|Lost to Follow-up|2
4745423|NCT01560507|7713498|FG000|Overall Study|Withdrawal by Subject|1
4745424|NCT01560507|7713499|FG001|Overall Study|Withdrawal by Subject|1
4745425|NCT01560507|7713500|FG002|Overall Study|Withdrawal by Subject|0
4745426|NCT01555073|7713544|FG000|Overall Study|Lost to Follow-up|1
4745427|NCT01555073|7713545|FG001|Overall Study|Lost to Follow-up|2
4745428|NCT01555073|7713546|FG002|Overall Study|Lost to Follow-up|0
4745429|NCT01555073|7713547|FG003|Overall Study|Lost to Follow-up|5
4745430|NCT01541397|7713582|FG000|Overall Study|Study ended prior to data collection|4
4745431|NCT01541397|7713583|FG001|Overall Study|Study ended prior to data collection|2
4745432|NCT01546207|7713589|FG000|Overall Study|Death|1
4745433|NCT01547728|7713597|FG000|Overall Study|Change in procedure and equipment|1
4745434|NCT01547728|7713597|FG000|Overall Study|Drug not ready for subject|1
4745435|NCT01547728|7713597|FG000|Overall Study|Screen failure|39
4745436|NCT01546883|7713614|FG000|Overall Study|Withdrawal by Subject|3
4745437|NCT01546883|7713614|FG000|Overall Study|Adverse Event|4
4745438|NCT01546883|7713614|FG000|Overall Study|Lost to Follow-up|2
4525769|NCT01025284|7341695|FG002|Overall Study|Investigator Decision|0
4525770|NCT01025284|7341693|FG000|Overall Study|Withdrawal by Subject|0
4745439|NCT01546883|7713614|FG000|Overall Study|early closure of study|2
4745440|NCT01546883|7713614|FG000|Overall Study|other unrelated illness|1
4745441|NCT01536015|7713624|FG000|Overall Study|Adverse Event|1
4745442|NCT01536015|7713625|FG001|Overall Study|Adverse Event|4
4745443|NCT01536015|7713624|FG000|Overall Study|Lost to Follow-up|0
4745444|NCT01536015|7713625|FG001|Overall Study|Lost to Follow-up|1
4745445|NCT01536015|7713624|FG000|Overall Study|Inclusion Criterion not met|2
4745446|NCT01536015|7713625|FG001|Overall Study|Inclusion Criterion not met|0
4745447|NCT01536015|7713624|FG000|Overall Study|Study closure|5
4745448|NCT01536015|7713625|FG001|Overall Study|Study closure|5
4745449|NCT01534676|7713651|FG000|Overall Study|Study closed due to poor enrollment|2
4745450|NCT01534676|7713652|FG001|Overall Study|Study closed due to poor enrollment|1
4745451|NCT01530087|7713676|FG000|Overall Study|Physician Decision|2
4525771|NCT01025284|7341694|FG001|Overall Study|Withdrawal by Subject|1
4525772|NCT01025284|7341695|FG002|Overall Study|Withdrawal by Subject|0
4525773|NCT01025336|7341710|FG000|Overall Study|Protocol Violation|0
4525774|NCT01025336|7341711|FG001|Overall Study|Protocol Violation|0
4525775|NCT01025336|7341712|FG002|Overall Study|Protocol Violation|0
4745452|NCT01531387|7713713|FG000|Overall Study|Early termination of study|11
4745453|NCT01531387|7713714|FG001|Overall Study|Early termination of study|11
4745454|NCT01527292|7713733|FG000|Overall Study|Physician Decision|0
4745455|NCT01527292|7713734|FG001|Overall Study|Physician Decision|3
4745456|NCT01528696|7713753|FG000|Overall Study|See detailed description|18
4745457|NCT01528696|7713754|FG001|Overall Study|See detailed description|19
4745458|NCT01520714|7713788|FG000|Overall Study|Protocol Violation|0
4745459|NCT01520714|7713789|FG001|Overall Study|Protocol Violation|3
4745460|NCT01520714|7713788|FG000|Overall Study|Adverse Event|0
4745461|NCT01520714|7713789|FG001|Overall Study|Adverse Event|2
4745462|NCT01520714|7713788|FG000|Overall Study|Lack of Efficacy|0
4745463|NCT01520714|7713789|FG001|Overall Study|Lack of Efficacy|1
4745464|NCT01516034|7713804|FG000|Overall Study|Physician Decision|1
4745465|NCT01516034|7713804|FG000|Overall Study|Lack of Efficacy|7
4745466|NCT01510756|7713829|FG000|Overall Study|Death|1
4745467|NCT01510756|7713829|FG000|Overall Study|Lack of Efficacy|2
4745468|NCT01510756|7713829|FG000|Overall Study|Physician Decision|1
4745469|NCT01509053|7713855|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11
4745470|NCT01509053|7713855|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1
4745471|NCT01509053|7713855|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13
4745472|NCT01509053|7713855|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1
4745473|NCT01509053|7713855|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1
4745474|NCT01509053|7713855|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3
4745475|NCT01478113|7713904|FG000|Overall Study|Withdrawal by Subject|0
4745476|NCT01478113|7713905|FG001|Overall Study|Withdrawal by Subject|1
4745477|NCT01478113|7713904|FG000|Overall Study|Physician Decision|1
4745478|NCT01478113|7713905|FG001|Overall Study|Physician Decision|0
4745479|NCT01482598|7713923|FG000|Overall Study|Death|7
4745480|NCT01482598|7713924|FG001|Overall Study|Death|10
4745481|NCT01482598|7713923|FG000|Overall Study|Physician Decision|0
4745482|NCT01482598|7713924|FG001|Overall Study|Physician Decision|3
4745483|NCT01482598|7713923|FG000|Overall Study|Withdrawal by Subject|4
4745484|NCT01482598|7713924|FG001|Overall Study|Withdrawal by Subject|5
4745485|NCT01482598|7713923|FG000|Overall Study|Lost to Follow-up|5
4745486|NCT01482598|7713924|FG001|Overall Study|Lost to Follow-up|4
4745487|NCT01473732|7713944|FG000|Overall Study|Adverse Event|1
4745488|NCT01473732|7713945|FG001|Overall Study|Adverse Event|0
4745489|NCT01473732|7713944|FG000|Overall Study|Death|1
4745490|NCT01473732|7713945|FG001|Overall Study|Death|0
4745491|NCT01465230|7713960|FG000|Overall Study|Withdrawal by Subject|2
4745492|NCT01463293|7713982|FG000|Overall Study|Lost to Follow-up|1
4745493|NCT01463293|7713983|FG001|Overall Study|Lost to Follow-up|4
4745494|NCT01463293|7713984|FG002|Overall Study|Lost to Follow-up|5
4745495|NCT01463293|7713982|FG000|Overall Study|Adverse Event|1
4745496|NCT01463293|7713983|FG001|Overall Study|Adverse Event|2
4745497|NCT01463293|7713984|FG002|Overall Study|Adverse Event|0
4745498|NCT01463293|7713982|FG000|Overall Study|Withdrawal by Subject|4
4745499|NCT01463293|7713983|FG001|Overall Study|Withdrawal by Subject|10
4745500|NCT01463293|7713984|FG002|Overall Study|Withdrawal by Subject|5
4745501|NCT01463293|7713982|FG000|Overall Study|Other|0
4745502|NCT01463293|7713983|FG001|Overall Study|Other|0
4745503|NCT01463293|7713984|FG002|Overall Study|Other|2
4745504|NCT01457053|7713992|FG000|Overall Study|Unable to undergo selected treatment|1
4745505|NCT01457053|7713993|FG001|Overall Study|Unable to undergo selected treatment|1
4745506|NCT01451723|7714001|FG000|Overall Study|study halted|6
4745507|NCT01451723|7714002|FG001|Overall Study|study halted|5
4745508|NCT01440517|7714012|FG000|Overall Study|Subject withdrawn prior to dosing|1
4745509|NCT01440595|7714018|FG000|Overall Study|Lost to Follow-up|0
4745510|NCT01440595|7714019|FG001|Overall Study|Lost to Follow-up|1
4745511|NCT01440595|7714020|FG002|Overall Study|Lost to Follow-up|0
4745512|NCT01440595|7714018|FG000|Overall Study|Study terminated by sponsor.|1
4745513|NCT01440595|7714019|FG001|Overall Study|Study terminated by sponsor.|2
4745514|NCT01440595|7714020|FG002|Overall Study|Study terminated by sponsor.|1
4745515|NCT01446796|7714026|FG000|Overall Study|Withdrawal by Subject|1
4745516|NCT01446796|7714027|FG001|Overall Study|Withdrawal by Subject|0
4745517|NCT01443923|7714037|FG000|Overall Study|Adverse Event|1
4745518|NCT01443923|7714038|FG001|Overall Study|Adverse Event|0
4745519|NCT01439347|7714046|FG000|Overall Study|Death|10
4745520|NCT01439347|7714047|FG001|Overall Study|Death|9
4745521|NCT01439347|7714046|FG000|Overall Study|Withdrawal by Subject|0
4745522|NCT01439347|7714047|FG001|Overall Study|Withdrawal by Subject|1
4745523|NCT01439347|7714046|FG000|Overall Study|Physician Decision|1
4745524|NCT01439347|7714047|FG001|Overall Study|Physician Decision|0
4745525|NCT01439347|7714046|FG000|Overall Study|Sponsor Terminated Study|2
4745526|NCT01439347|7714047|FG001|Overall Study|Sponsor Terminated Study|3
4745527|NCT01433471|7714072|FG000|Overall Study|Withdrawal by Subject|0
4745528|NCT01433471|7714073|FG001|Overall Study|Withdrawal by Subject|1
4745529|NCT01436084|7714081|FG000|Overall Study|Disease Progression|2
4745530|NCT01436084|7714081|FG000|Overall Study|Withdrawal by Subject|1
4745531|NCT01436084|7714081|FG000|Overall Study|Early Closure of Study|1
4525776|NCT01025336|7341713|FG003|Overall Study|Protocol Violation|2
4525777|NCT01025336|7341714|FG004|Overall Study|Protocol Violation|0
4525778|NCT01025635|7341748|FG000|Overall Study|Withdrawal by Subject|6
4525779|NCT01025635|7341749|FG001|Overall Study|Withdrawal by Subject|7
4525780|NCT01025635|7341748|FG000|Overall Study|Protocol Violation|4
4525781|NCT01025635|7341749|FG001|Overall Study|Protocol Violation|2
4525782|NCT01025635|7341748|FG000|Overall Study|Lack of Efficacy|0
4525783|NCT01025635|7341749|FG001|Overall Study|Lack of Efficacy|1
4525784|NCT01025635|7341748|FG000|Overall Study|Lost to Follow-up|9
4525785|NCT01025635|7341749|FG001|Overall Study|Lost to Follow-up|13
4745532|NCT01415986|7714109|FG000|Overall Study|Lost to Follow-up|1
4745533|NCT01410799|7714114|FG000|Overall Study|PI decision|13
4745534|NCT01426113|7714120|FG000|Overall Study|Study Discontinued|1
4745535|NCT01426113|7714121|FG001|Overall Study|Study Discontinued|1
4745536|NCT01426113|7714120|FG000|Overall Study|Adverse Event|0
4745537|NCT01426113|7714121|FG001|Overall Study|Adverse Event|1
4634507|NCT01925209|7505634|FG003|Follow-up|Adverse Event|1
4634508|NCT01925209|7505631|FG000|Follow-up|Physician Decision|0
4745538|NCT01420965|7714139|FG000|Overall Study|Withdrawal by Subject|1
4745539|NCT01420965|7714140|FG001|Overall Study|Withdrawal by Subject|0
4745540|NCT01420965|7714141|FG002|Overall Study|Withdrawal by Subject|0
4745541|NCT01420965|7714139|FG000|Overall Study|Adverse Event|0
4745542|NCT01420965|7714140|FG001|Overall Study|Adverse Event|1
4745543|NCT01420965|7714141|FG002|Overall Study|Adverse Event|0
4745544|NCT01417377|7714149|FG000|Overall Study|Lost to Follow-up|12
4745545|NCT01417377|7714149|FG000|Overall Study|Enrolled, but not treated|1
4745546|NCT01416272|7714153|FG000|Overall Study|Unacceptable distance visual acuity|2
4745547|NCT01416272|7714153|FG000|Overall Study|Lost to Follow-up|1
4745548|NCT01416272|7714153|FG000|Overall Study|Study related complaints|1
4745549|NCT01414166|7714159|FG000|Overall Study|Adverse Event|10
4745550|NCT01414166|7714160|FG001|Overall Study|Adverse Event|2
4745551|NCT01414166|7714159|FG000|Overall Study|Lost to Follow-up|4
4745552|NCT01414166|7714160|FG001|Overall Study|Lost to Follow-up|1
4745553|NCT01414166|7714159|FG000|Overall Study|Non-compliance with study drug|2
4745554|NCT01414166|7714160|FG001|Overall Study|Non-compliance with study drug|0
4745555|NCT01414166|7714159|FG000|Overall Study|Physician Decision|2
4745556|NCT01414166|7714160|FG001|Overall Study|Physician Decision|0
4745557|NCT01414166|7714159|FG000|Overall Study|Protocol Violation|2
4745558|NCT01414166|7714160|FG001|Overall Study|Protocol Violation|0
4745559|NCT01414166|7714159|FG000|Overall Study|Study terminated by Sponsor|68
4745560|NCT01414166|7714160|FG001|Overall Study|Study terminated by Sponsor|75
4745561|NCT01414166|7714159|FG000|Overall Study|Withdrawal by Subject|3
4745562|NCT01414166|7714160|FG001|Overall Study|Withdrawal by Subject|5
4745563|NCT01409031|7714187|FG000|Overall Study|transferred to other hosp|1
4745564|NCT01409031|7714188|FG001|Overall Study|transferred to other hosp|0
4745565|NCT01403194|7714211|FG000|Overall Study|Screen Failure|2
4745566|NCT01403194|7714211|FG000|Overall Study|Lost to Follow-up|8
4745567|NCT01397552|7714217|FG000|Overall Study|Adverse Event|1
4745568|NCT01397552|7714218|FG001|Overall Study|Adverse Event|0
4745569|NCT01397552|7714217|FG000|Overall Study|Withdrawal by Subject|2
4745570|NCT01397552|7714218|FG001|Overall Study|Withdrawal by Subject|1
4745571|NCT01392170|7714224|FG000|Overall Study|Withdrawal by Subject|1
4745572|NCT01392170|7714224|FG000|Overall Study|Ineligible|1
4745573|NCT01389817|7714230|FG000|Overall Study|Physician Decision|1
4745574|NCT01389817|7714231|FG001|Overall Study|Physician Decision|0
4745575|NCT01389817|7714230|FG000|Overall Study|Lost to Follow-up|1
4745576|NCT01389817|7714231|FG001|Overall Study|Lost to Follow-up|0
4745577|NCT01389817|7714230|FG000|Overall Study|Withdrawal by Subject|2
4745578|NCT01389817|7714231|FG001|Overall Study|Withdrawal by Subject|0
4745579|NCT01390181|7714241|FG000|Overall Study|Lost to Follow-up|1
4745580|NCT01390181|7714241|FG000|Overall Study|Study Terminated due to Low Accrual|3
4745581|NCT01372618|7714276|FG000|Overall Study|PI Died. Study Terminated|9
4745582|NCT01379274|7714284|FG000|Overall Study|funding withdrawn|1
4745583|NCT01369641|7714297|FG000|Overall Study|Withdrawal by Subject|1
4745584|NCT01359254|7714312|FG000|Overall Study|Death|1
4745585|NCT01359254|7714313|FG001|Overall Study|Death|0
4745586|NCT01352416|7714350|FG000|Overall Study|Physician Decision|1
4745587|NCT01352416|7714351|FG001|Overall Study|Physician Decision|2
4745588|NCT01352416|7714352|FG002|Overall Study|Physician Decision|2
4745589|NCT01352416|7714353|FG003|Overall Study|Physician Decision|1
4745590|NCT01349595|7714369|FG000|Overall Study|Lack of funding|2
4745591|NCT01349595|7714370|FG001|Overall Study|Lack of funding|2
4745592|NCT01347840|7714389|FG000|Overall Study|Withdrawal by Subject|1
4745593|NCT01335997|7714400|FG000|Period I and II|Adverse Event|63
4745594|NCT01335997|7714401|FG001|Period I and II|Adverse Event|43
4745595|NCT01335997|7714400|FG000|Period I and II|Noncompliance with Study Drug|1
4745596|NCT01335997|7714401|FG001|Period I and II|Noncompliance with Study Drug|1
4745597|NCT01335997|7714400|FG000|Period I and II|Lost to Follow-up|3
4745598|NCT01335997|7714401|FG001|Period I and II|Lost to Follow-up|5
4745599|NCT01335997|7714400|FG000|Period I and II|Withdrawal by Subject|9
4745600|NCT01335997|7714401|FG001|Period I and II|Withdrawal by Subject|4
4745601|NCT01335997|7714400|FG000|Period I and II|Study Terminated by Sponsor|406
4745602|NCT01335997|7714401|FG001|Period I and II|Study Terminated by Sponsor|415
4745603|NCT01335997|7714400|FG000|Period I and II|Protocol Violation|9
4745604|NCT01335997|7714401|FG001|Period I and II|Protocol Violation|10
4745605|NCT01335997|7714400|FG000|Period I and II|Physician Decision|2
4745606|NCT01335997|7714401|FG001|Period I and II|Physician Decision|1
4745607|NCT01335997|7714400|FG000|Period III|Adverse Event|0
4745608|NCT01335997|7714401|FG001|Period III|Adverse Event|2
4745609|NCT01335997|7714400|FG000|Period III|Study Terminated by Sponsor|77
4745610|NCT01335997|7714401|FG001|Period III|Study Terminated by Sponsor|76
4745611|NCT01335997|7714400|FG000|Period III|Protocol Violation|0
4745612|NCT01335997|7714401|FG001|Period III|Protocol Violation|1
4745613|NCT01335997|7714400|FG000|Period III|Lost to Follow-up|1
4745614|NCT01335997|7714401|FG001|Period III|Lost to Follow-up|0
4745615|NCT01341587|7714424|FG000|Overall Study|Lost to Follow-up|2
4745616|NCT01341587|7714425|FG001|Overall Study|Lost to Follow-up|0
4745617|NCT01341587|7714424|FG000|Overall Study|stopped using the meters|2
4745618|NCT01341587|7714425|FG001|Overall Study|stopped using the meters|10
4745619|NCT01332799|7714437|FG000|Overall Study|Insufficient funding|10
4745620|NCT01332799|7714438|FG001|Overall Study|Insufficient funding|10
4745621|NCT01329549|7714444|FG000|Overall Study|Withdrawal by Subject|1
4745622|NCT01329549|7714444|FG000|Overall Study|Adverse Event|1
4745623|NCT01326845|7714450|FG000|Overall Study|Administrative Problems|5
4745624|NCT01326845|7714451|FG001|Overall Study|Administrative Problems|2
4745625|NCT01326845|7714450|FG000|Overall Study|Adverse Event|1
4745626|NCT01326845|7714451|FG001|Overall Study|Adverse Event|0
4745627|NCT01326845|7714450|FG000|Overall Study|Misisng|1
4745628|NCT01326845|7714451|FG001|Overall Study|Misisng|3
4745629|NCT01329341|7714457|FG000|Overall Study|Withdrawal by Subject|44
4745630|NCT01320683|7714470|FG000|Overall Study|Positive antibody response|1
4745631|NCT01313273|7714476|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1
4745632|NCT01313273|7714477|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0
4745633|NCT01313273|7714476|FG000|Overall Study|Withdrawal by Subject|1
4745634|NCT01313273|7714477|FG001|Overall Study|Withdrawal by Subject|0
4745635|NCT01313273|7714476|FG000|Overall Study|Screening Chromogranin A-in normal range|0
4745636|NCT01313273|7714477|FG001|Overall Study|Screening Chromogranin A-in normal range|1
4745637|NCT01321008|7714483|FG000|Overall Study|Early Study Termination|1
4745638|NCT01310803|7714489|FG000|Overall Study|Subject terminated by Sponsor|1
4745639|NCT01310803|7714490|FG001|Overall Study|Subject terminated by Sponsor|0
4745640|NCT01313923|7714509|FG000|Overall Study|Physician Decision|3
4745641|NCT01321697|7714513|FG000|Overall Study|Study Terminated|7
4745642|NCT01312428|7714519|FG000|Overall Study|Study Termination|3
4745643|NCT01312428|7714520|FG001|Overall Study|Study Termination|4
4745644|NCT01290822|7714578|FG000|Overall Study|Withdrawal by Subject|1
4745645|NCT01290822|7714578|FG000|Overall Study|Physician Decision|10
4745646|NCT01290718|7714582|FG000|Overall Study|Early termination of the study|4
4745647|NCT01293123|7714588|FG000|Overall Study|Lost to Follow-up|0
4745648|NCT01293123|7714589|FG001|Overall Study|Lost to Follow-up|1
4745649|NCT01294046|7714595|FG000|Overall Study|Infection and surgical explant|1
4745650|NCT01294046|7714595|FG000|Overall Study|Eligibility criteria expanded|1
4745651|NCT01294046|7714595|FG000|Overall Study|Stimulation response inadqequate|1
4745652|NCT01281124|7714639|FG000|Overall Study|Death|1
4745653|NCT01282216|7714651|FG000|Overall Study|Graft failure|0
4745654|NCT01282216|7714652|FG001|Overall Study|Graft failure|0
4745655|NCT01282216|7714653|FG002|Overall Study|Graft failure|3
4745656|NCT01282216|7714654|FG003|Overall Study|Graft failure|2
4745657|NCT01282216|7714651|FG000|Overall Study|Physician Decision|0
4745658|NCT01282216|7714652|FG001|Overall Study|Physician Decision|0
4745659|NCT01282216|7714653|FG002|Overall Study|Physician Decision|11
4745660|NCT01282216|7714654|FG003|Overall Study|Physician Decision|0
4745661|NCT01282216|7714651|FG000|Overall Study|Relapse|0
4745662|NCT01282216|7714652|FG001|Overall Study|Relapse|0
4745663|NCT01282216|7714653|FG002|Overall Study|Relapse|17
4745664|NCT01282216|7714654|FG003|Overall Study|Relapse|6
4745665|NCT01282216|7714651|FG000|Overall Study|Death|0
4745666|NCT01282216|7714652|FG001|Overall Study|Death|0
4745667|NCT01282216|7714653|FG002|Overall Study|Death|2
4745668|NCT01282216|7714654|FG003|Overall Study|Death|0
4745669|NCT01284491|7714660|FG000|Overall Study|Study termination|13
4745670|NCT01274533|7714692|FG000|Overall Study|Withdrawal by Subject|1
4745671|NCT01274533|7714692|FG000|Overall Study|Non-compliance|1
4745672|NCT01274533|7714692|FG000|Overall Study|Disease progression|2
4745673|NCT01279616|7714696|FG000|Overall Study|donor could not be located|5
4745674|NCT01279616|7714696|FG000|Overall Study|no signs of sickle cell disease|2
4745675|NCT01276054|7714702|FG000|Overall Study|No one to oversee trial after P.I. left|2
4745676|NCT01276054|7714703|FG001|Overall Study|No one to oversee trial after P.I. left|2
4745677|NCT01264965|7714709|FG000|Overall Study|Withdrawal by Subject|10
4745678|NCT01266824|7714715|FG000|Overall Study|Study terminated prior to completion|2
4525786|NCT01025635|7341748|FG000|Overall Study|Reason not known|4
4525787|NCT01025635|7341749|FG001|Overall Study|Reason not known|2
4525788|NCT01025752|7341757|FG000|Overall Study|Lost to Follow-up|7
4525789|NCT01025752|7341758|FG001|Overall Study|Lost to Follow-up|10
4525790|NCT01025752|7341757|FG000|Overall Study|Physician Decision|1
4525791|NCT01025752|7341758|FG001|Overall Study|Physician Decision|3
4525792|NCT01025817|7341833|FG000|Completed Study Medication|Adverse Event|66
4525793|NCT01025817|7341834|FG001|Completed Study Medication|Adverse Event|39
4525794|NCT01025817|7341833|FG000|Completed Study Medication|Protocol Deviation|9
4525795|NCT01025817|7341834|FG001|Completed Study Medication|Protocol Deviation|8
4525796|NCT01025817|7341833|FG000|Completed Study Medication|Withdrawal by Subject|8
4525797|NCT01025817|7341834|FG001|Completed Study Medication|Withdrawal by Subject|9
4525798|NCT01025817|7341833|FG000|Completed Study Medication|Administrative problems|7
4525799|NCT01025817|7341834|FG001|Completed Study Medication|Administrative problems|5
4525800|NCT01025817|7341833|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7
4525801|NCT01025817|7341834|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0
4525802|NCT01025817|7341833|FG000|Completed Study Medication|Abnormal test procedure|4
4525803|NCT01025817|7341834|FG001|Completed Study Medication|Abnormal test procedure|0
4525804|NCT01025817|7341833|FG000|Completed Study Medication|Graft loss|2
4525805|NCT01025817|7341834|FG001|Completed Study Medication|Graft loss|5
4525806|NCT01025817|7341833|FG000|Completed Study Medication|Death|2
4525807|NCT01025817|7341834|FG001|Completed Study Medication|Death|2
4525808|NCT01025817|7341833|FG000|Completed Study Medication|Abnormal lab values|0
4525809|NCT01025817|7341834|FG001|Completed Study Medication|Abnormal lab values|2
4525810|NCT01025817|7341833|FG000|Completed Study Medication|Subject no longer required study drug|0
4525811|NCT01025817|7341834|FG001|Completed Study Medication|Subject no longer required study drug|1
4525812|NCT01025817|7341833|FG000|Completed Study Medication|Lost to Follow-up|0
4525813|NCT01025817|7341834|FG001|Completed Study Medication|Lost to Follow-up|1
4525814|NCT01025817|7341833|FG000|Completed Study|Withdrawal by Subject|8
4525815|NCT01025817|7341834|FG001|Completed Study|Withdrawal by Subject|16
4525816|NCT01025817|7341833|FG000|Completed Study|Death|6
4525817|NCT01025817|7341834|FG001|Completed Study|Death|5
4525818|NCT01025817|7341833|FG000|Completed Study|Missing|2
4525819|NCT01025817|7341834|FG001|Completed Study|Missing|0
4525820|NCT01025817|7341833|FG000|Completed Study|Lost to Follow-up|0
4525821|NCT01025817|7341834|FG001|Completed Study|Lost to Follow-up|1
4525822|NCT01025843|7341862|FG000|Washout 4|Withdrawal by Subject|0
4525823|NCT01025843|7341863|FG001|Washout 4|Withdrawal by Subject|0
4525824|NCT01025843|7341864|FG002|Washout 4|Withdrawal by Subject|1
4525825|NCT01025843|7341865|FG003|Washout 4|Withdrawal by Subject|1
4525826|NCT01025843|7341866|FG004|Washout 4|Withdrawal by Subject|0
4525827|NCT01025843|7341867|FG005|Washout 4|Withdrawal by Subject|0
4525828|NCT01025843|7341868|FG006|Washout 4|Withdrawal by Subject|0
4525829|NCT01025843|7341869|FG007|Washout 4|Withdrawal by Subject|0
4525830|NCT01025843|7341870|FG008|Washout 4|Withdrawal by Subject|0
4525831|NCT01025843|7341871|FG009|Washout 4|Withdrawal by Subject|0
4525832|NCT01026038|7341906|FG000|Overall Study|Lost to Follow-up|1
4525833|NCT01026038|7341907|FG001|Overall Study|Lost to Follow-up|1
4525834|NCT01026038|7341908|FG002|Overall Study|Lost to Follow-up|0
4525835|NCT01026103|7341916|FG000|Overall Study|Physician Decision|1
4525836|NCT01026103|7341916|FG000|Overall Study|did not receive study device bc of error|1
4525837|NCT01026142|7341922|FG000|Overall Study|Death|136
4525838|NCT01026142|7341923|FG001|Overall Study|Death|134
4525839|NCT01026142|7341922|FG000|Overall Study|Withdrew consent or lost to follow-up|36
4525840|NCT01026142|7341923|FG001|Overall Study|Withdrew consent or lost to follow-up|29
4525841|NCT01026194|7341944|FG000|Period 1：Double Blind Period|Adverse Event|2
4525842|NCT01026194|7341945|FG001|Period 1：Double Blind Period|Adverse Event|1
4525843|NCT01026194|7341944|FG000|Period 1：Double Blind Period|Lack of Efficacy|1
4745679|NCT01266824|7714716|FG001|Overall Study|Study terminated prior to completion|3
4745680|NCT01264835|7714722|FG000|Overall Study|Lost to Follow-up|1
4745681|NCT01274429|7714726|FG000|Overall Study|Study closed do to lack of funding|5
4745682|NCT01273064|7714735|FG000|Overall Study|Adverse Event|5
4745683|NCT01273064|7714736|FG001|Overall Study|Adverse Event|1
4745684|NCT01273064|7714737|FG002|Overall Study|Adverse Event|3
4745685|NCT01273064|7714738|FG003|Overall Study|Adverse Event|2
4745686|NCT01273064|7714739|FG004|Overall Study|Adverse Event|1
4745687|NCT01273064|7714735|FG000|Overall Study|Withdrawal by Subject|4
4745688|NCT01273064|7714736|FG001|Overall Study|Withdrawal by Subject|2
4745689|NCT01273064|7714737|FG002|Overall Study|Withdrawal by Subject|2
4745690|NCT01273064|7714738|FG003|Overall Study|Withdrawal by Subject|2
4745691|NCT01273064|7714739|FG004|Overall Study|Withdrawal by Subject|0
4745692|NCT01273064|7714735|FG000|Overall Study|Study Termination|13
4745693|NCT01273064|7714736|FG001|Overall Study|Study Termination|27
4745694|NCT01273064|7714737|FG002|Overall Study|Study Termination|26
4745695|NCT01273064|7714738|FG003|Overall Study|Study Termination|16
4745696|NCT01273064|7714739|FG004|Overall Study|Study Termination|8
4745697|NCT01273064|7714735|FG000|Overall Study|Lost to Follow-up|1
4745698|NCT01273064|7714736|FG001|Overall Study|Lost to Follow-up|0
4745699|NCT01273064|7714737|FG002|Overall Study|Lost to Follow-up|0
4745700|NCT01273064|7714738|FG003|Overall Study|Lost to Follow-up|0
4745701|NCT01273064|7714739|FG004|Overall Study|Lost to Follow-up|0
4745702|NCT01273064|7714735|FG000|Overall Study|Physician Decision|0
4745703|NCT01273064|7714736|FG001|Overall Study|Physician Decision|0
4745704|NCT01273064|7714737|FG002|Overall Study|Physician Decision|0
4745705|NCT01273064|7714738|FG003|Overall Study|Physician Decision|0
4745706|NCT01273064|7714739|FG004|Overall Study|Physician Decision|1
4745707|NCT01274559|7714753|FG000|Overall Study|Adverse Event|57
4745708|NCT01274559|7714754|FG001|Overall Study|Adverse Event|13
4745709|NCT01274559|7714753|FG000|Overall Study|Death|1
4745710|NCT01274559|7714754|FG001|Overall Study|Death|1
4745711|NCT01274559|7714753|FG000|Overall Study|Lost to Follow-up|3
4745712|NCT01274559|7714754|FG001|Overall Study|Lost to Follow-up|3
4745713|NCT01274559|7714753|FG000|Overall Study|Non-compliance with Study Drug|2
4745714|NCT01274559|7714754|FG001|Overall Study|Non-compliance with Study Drug|4
4745715|NCT01274559|7714753|FG000|Overall Study|Physician Decision|2
4745716|NCT01274559|7714754|FG001|Overall Study|Physician Decision|1
4745717|NCT01274559|7714753|FG000|Overall Study|Protocol Violation|28
4745718|NCT01274559|7714754|FG001|Overall Study|Protocol Violation|23
4745719|NCT01274559|7714753|FG000|Overall Study|Study Terminated by Sponsor|79
4745720|NCT01274559|7714754|FG001|Overall Study|Study Terminated by Sponsor|87
4745721|NCT01274559|7714753|FG000|Overall Study|Withdrawal by Subject|25
4745722|NCT01274559|7714754|FG001|Overall Study|Withdrawal by Subject|13
4745723|NCT01267825|7714788|FG000|Overall Study|study terminated. no data collected.|1
4745724|NCT01267825|7714789|FG001|Overall Study|study terminated. no data collected.|0
4745729|NCT01259284|7714803|FG000|Overall Study|Study Termination|2
4745730|NCT01259284|7714804|FG001|Overall Study|Study Termination|0
4745731|NCT01259284|7714805|FG002|Overall Study|Study Termination|0
4745732|NCT01249157|7714813|FG000|Overall Study|Withdrawal by Subject|1
4745733|NCT01263028|7714817|FG000|Overall Study|Withdrawal by Subject|1
4745734|NCT01263028|7714817|FG000|Overall Study|Adverse Event|1
4745735|NCT01263028|7714817|FG000|Overall Study|Study terminated due to low enrollment.|4
4745736|NCT01259024|7714829|FG000|Overall Study|Physician Decision|1
4745737|NCT01251952|7714833|FG000|Overall Study|Adverse Event|1
4745738|NCT01251120|7714839|FG000|Overall Study|Lack of Efficacy|0
4745739|NCT01251120|7714840|FG001|Overall Study|Lack of Efficacy|1
4745740|NCT01248130|7714848|FG000|Overall Study|Protocol Violation|1
4745741|NCT01248130|7714849|FG001|Overall Study|Protocol Violation|0
4745742|NCT01248130|7714848|FG000|Overall Study|Ineligible|1
4745743|NCT01248130|7714849|FG001|Overall Study|Ineligible|0
4745744|NCT01243892|7714857|FG000|Overall Study|Did not meet eligibility criteria|2
4745745|NCT01243892|7714858|FG001|Overall Study|Did not meet eligibility criteria|0
4745746|NCT01246011|7714867|FG000|Overall Study|If needed warfarin clinically, withdrawn|0
4745747|NCT01246011|7714868|FG001|Overall Study|If needed warfarin clinically, withdrawn|0
4745748|NCT01246011|7714869|FG002|Overall Study|If needed warfarin clinically, withdrawn|3
4745749|NCT01246011|7714867|FG000|Overall Study|Withdrawal by Subject|0
4745750|NCT01246011|7714868|FG001|Overall Study|Withdrawal by Subject|0
4745751|NCT01246011|7714869|FG002|Overall Study|Withdrawal by Subject|1
4745752|NCT01242020|7714880|FG000|Overall Study|Withdrawal by Subject|2
4745753|NCT01242020|7714881|FG001|Overall Study|Withdrawal by Subject|0
4745754|NCT01242020|7714880|FG000|Overall Study|Failed screening|1
4745755|NCT01242020|7714881|FG001|Overall Study|Failed screening|0
4745756|NCT01244620|7714887|FG000|Overall Study|Study terminated|4
4745757|NCT01244620|7714888|FG001|Overall Study|Study terminated|4
4745758|NCT01244620|7714889|FG002|Overall Study|Study terminated|4
4745759|NCT01244620|7714890|FG003|Overall Study|Study terminated|4
4745760|NCT01241279|7714906|FG000|Overall Study|Lost to Follow-up|0
4745761|NCT01241279|7714907|FG001|Overall Study|Lost to Follow-up|1
4745762|NCT01230788|7714913|FG000|Overall Study|Prescribed exclusion drug|1
4745763|NCT01239680|7714919|FG000|Overall Study|Withdrawal by Subject|2
4745764|NCT01239680|7714920|FG001|Overall Study|Withdrawal by Subject|0
4745765|NCT01230307|7714951|FG000|Overall Study|LVAD Placement|0
4745766|NCT01230307|7714952|FG001|Overall Study|LVAD Placement|2
4745767|NCT01230489|7714958|FG000|Overall Study|Death|2
4745768|NCT01230489|7714958|FG000|Overall Study|Adverse Event|2
4745769|NCT01230489|7714958|FG000|Overall Study|Treatment modality changed|1
4745770|NCT01217060|7715014|FG000|Overall Study|Withdrawal by Subject|1
4745771|NCT01217047|7715022|FG000|Overall Study|Lost to Follow-up|0
4745772|NCT01217047|7715023|FG001|Overall Study|Lost to Follow-up|1
4745773|NCT01217047|7715024|FG002|Overall Study|Lost to Follow-up|0
4745774|NCT01206101|7715035|FG000|Overall Study|Adverse Event|1
4745775|NCT01206101|7715036|FG001|Overall Study|Adverse Event|0
4745776|NCT01206101|7715035|FG000|Overall Study|Physician Decision|0
4745777|NCT01206101|7715036|FG001|Overall Study|Physician Decision|1
4745778|NCT01206101|7715035|FG000|Overall Study|Unclassified|1
4745779|NCT01206101|7715036|FG001|Overall Study|Unclassified|0
4745780|NCT01209520|7715059|FG000|Overall Study|Withdrawal by Subject|3
4745781|NCT01207102|7715080|FG000|Overall Study|Withdrawal by Subject|5
4745782|NCT01207102|7715080|FG000|Overall Study|Adverse Event|2
4745783|NCT01207102|7715080|FG000|Overall Study|progression|2
4745784|NCT01207102|7715080|FG000|Overall Study|Withdrawal by Treating Physician|1
4745785|NCT01206439|7715098|FG000|Overall Study|subject did not meet inclusion criteria|1
4745786|NCT01198548|7715120|FG000|Overall Study|Disease Progression|9
4745787|NCT01198548|7715120|FG000|Overall Study|Administrative Decision|1
4745788|NCT01193556|7715143|FG000|Overall Study|Study termination|26
4745789|NCT01193556|7715144|FG001|Overall Study|Study termination|25
4745790|NCT01189435|7715150|FG000|Overall Study|Withdrawal by Subject|1
4745791|NCT01189435|7715150|FG000|Overall Study|Physician Decision|1
4745792|NCT01193530|7715156|FG000|Overall Study|Withdrawal by Subject|2
4745793|NCT01193530|7715157|FG001|Overall Study|Withdrawal by Subject|2
4745794|NCT01193530|7715156|FG000|Overall Study|Began Contraindicated Therapy|1
4745795|NCT01193530|7715157|FG001|Overall Study|Began Contraindicated Therapy|0
4745796|NCT01193530|7715156|FG000|Overall Study|Lost Light Box|0
4745797|NCT01193530|7715157|FG001|Overall Study|Lost Light Box|1
4745798|NCT01193530|7715156|FG000|Overall Study|Returned home - out of state|0
4745799|NCT01193530|7715157|FG001|Overall Study|Returned home - out of state|1
4745800|NCT01193530|7715156|FG000|Overall Study|Non-Compliance|0
4745801|NCT01193530|7715157|FG001|Overall Study|Non-Compliance|1
4745802|NCT01183221|7715191|FG000|3 Weeks Wash Out|Lost to Follow-up|1
4745803|NCT01183221|7715192|FG001|3 Weeks Wash Out|Lost to Follow-up|1
4745804|NCT01189227|7715200|FG000|Overall Study|Study terminated due to low accrual|6
4745805|NCT01189227|7715201|FG001|Overall Study|Study terminated due to low accrual|3
4745806|NCT01179737|7715220|FG000|Cohort 1 & Cohort 2|Adverse Event|3
4745807|NCT01179737|7715221|FG001|Cohort 1 & Cohort 2|Adverse Event|1
4745808|NCT01179737|7715222|FG002|Cohort 1 & Cohort 2|Adverse Event|1
4745809|NCT01179737|7715223|FG003|Cohort 1 & Cohort 2|Adverse Event|0
4745810|NCT01179737|7715220|FG000|Cohort 1 & Cohort 2|Withdrew consent|2
4745811|NCT01179737|7715221|FG001|Cohort 1 & Cohort 2|Withdrew consent|0
4745812|NCT01179737|7715222|FG002|Cohort 1 & Cohort 2|Withdrew consent|0
4745813|NCT01179737|7715223|FG003|Cohort 1 & Cohort 2|Withdrew consent|0
4745814|NCT01179737|7715220|FG000|Cohort 1 & Cohort 2|Administrative problems|0
4745815|NCT01179737|7715221|FG001|Cohort 1 & Cohort 2|Administrative problems|0
4745816|NCT01179737|7715222|FG002|Cohort 1 & Cohort 2|Administrative problems|2
4745817|NCT01179737|7715223|FG003|Cohort 1 & Cohort 2|Administrative problems|4
4745818|NCT01179737|7715220|FG000|Cohort 1 & Cohort 2|Death|0
4745819|NCT01179737|7715221|FG001|Cohort 1 & Cohort 2|Death|0
4745820|NCT01179737|7715222|FG002|Cohort 1 & Cohort 2|Death|1
4745821|NCT01179737|7715223|FG003|Cohort 1 & Cohort 2|Death|0
4745822|NCT01179737|7715220|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
4745823|NCT01179737|7715221|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1
4745824|NCT01179737|7715222|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
4745825|NCT01179737|7715223|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
4745826|NCT01179737|7715220|FG000|Cohort 1 & Cohort 2 Expansion|Death|1
4745827|NCT01179737|7715221|FG001|Cohort 1 & Cohort 2 Expansion|Death|0
4745828|NCT01179737|7715222|FG002|Cohort 1 & Cohort 2 Expansion|Death|0
4745829|NCT01179737|7715223|FG003|Cohort 1 & Cohort 2 Expansion|Death|0
4745830|NCT01179737|7715220|FG000|Extension|The study was terminated|3
4745831|NCT01179737|7715221|FG001|Extension|The study was terminated|0
4745832|NCT01179737|7715222|FG002|Extension|The study was terminated|0
4745833|NCT01179737|7715223|FG003|Extension|The study was terminated|0
4745834|NCT01183468|7715236|FG000|Overall Study|Lost to Follow-up|2
4525844|NCT01026194|7341945|FG001|Period 1：Double Blind Period|Lack of Efficacy|0
4525845|NCT01026194|7341944|FG000|Period 1：Double Blind Period|Physician Decision|0
4525846|NCT01026194|7341945|FG001|Period 1：Double Blind Period|Physician Decision|4
4525847|NCT01026194|7341944|FG000|Period 2：Open-label Period|Adverse Event|4
4525848|NCT01026194|7341945|FG001|Period 2：Open-label Period|Adverse Event|5
4525849|NCT01026194|7341944|FG000|Period 2：Open-label Period|Physician Decision|3
4525850|NCT01026194|7341945|FG001|Period 2：Open-label Period|Physician Decision|1
4525851|NCT01026194|7341944|FG000|Period 2：Open-label Period|Withdrawal by Subject|0
4525852|NCT01026194|7341945|FG001|Period 2：Open-label Period|Withdrawal by Subject|4
4525853|NCT01026324|7341956|FG000|Follow up/Survival|Withdrawal by Subject|1
4525854|NCT01026324|7341957|FG001|Follow up/Survival|Withdrawal by Subject|0
4594334|NCT01561976|7443570|FG002|Washout Period 2 (7 Days)|Non-compliance|1
4594335|NCT01561976|7443571|FG003|Washout Period 2 (7 Days)|Non-compliance|0
4594336|NCT01561976|7443572|FG004|Washout Period 2 (7 Days)|Non-compliance|0
4594337|NCT01561976|7443573|FG005|Washout Period 2 (7 Days)|Non-compliance|0
4594338|NCT01562028|7443583|FG000|Overall Study|Withdrawal by Subject|1
4594339|NCT01562028|7443584|FG001|Overall Study|Withdrawal by Subject|1
4594340|NCT01562028|7443583|FG000|Overall Study|Lost to Follow-up|2
4594341|NCT01562028|7443584|FG001|Overall Study|Lost to Follow-up|1
4594342|NCT01562275|7443616|FG000|Stage 1|Adverse Event|0
4594343|NCT01562275|7443617|FG001|Stage 1|Adverse Event|0
4594344|NCT01562275|7443618|FG002|Stage 1|Adverse Event|0
4594345|NCT01562275|7443619|FG003|Stage 1|Adverse Event|1
4594346|NCT01562275|7443620|FG004|Stage 1|Adverse Event|1
4594347|NCT01562275|7443621|FG005|Stage 1|Adverse Event|0
4525855|NCT01026324|7341958|FG002|Follow up/Survival|Withdrawal by Subject|0
4525856|NCT01026389|7341969|FG000|Overall Study|Withdrawal by Subject|1
4525857|NCT01026389|7341970|FG001|Overall Study|Withdrawal by Subject|3
4525858|NCT01026389|7341969|FG000|Overall Study|change of treatment, patient moved|4
4525859|NCT01026389|7341970|FG001|Overall Study|change of treatment, patient moved|2
4525860|NCT01026454|7342050|FG000|Second Intervention|Pregnancy|1
4525861|NCT01026454|7342051|FG001|Second Intervention|Pregnancy|1
4525862|NCT01026493|7342065|FG000|Overall Study|Protocol Violation|0
4525863|NCT01026493|7342066|FG001|Overall Study|Protocol Violation|1
4525864|NCT01026493|7342067|FG002|Overall Study|Protocol Violation|0
4525865|NCT01026493|7342068|FG003|Overall Study|Protocol Violation|0
4525866|NCT01026493|7342069|FG004|Overall Study|Protocol Violation|2
4525867|NCT01026493|7342070|FG005|Overall Study|Protocol Violation|3
4525868|NCT01026493|7342071|FG006|Overall Study|Protocol Violation|4
4525869|NCT01026493|7342072|FG007|Overall Study|Protocol Violation|1
4594348|NCT01562275|7443622|FG006|Stage 1|Adverse Event|0
4525870|NCT01026792|7342104|FG000|Overall Study|Protocol Violation|1
4594349|NCT01562275|7443623|FG007|Stage 1|Adverse Event|0
4594350|NCT01562275|7443624|FG008|Stage 1|Adverse Event|0
4745835|NCT01183468|7715237|FG001|Overall Study|Lost to Follow-up|1
4745836|NCT01183468|7715238|FG002|Overall Study|Lost to Follow-up|0
4745837|NCT01183468|7715239|FG003|Overall Study|Lost to Follow-up|0
4745838|NCT01183468|7715236|FG000|Overall Study|Physician Decision|1
4745839|NCT01183468|7715237|FG001|Overall Study|Physician Decision|0
4745840|NCT01183468|7715238|FG002|Overall Study|Physician Decision|0
4745841|NCT01183468|7715239|FG003|Overall Study|Physician Decision|0
4745842|NCT01183468|7715236|FG000|Overall Study|Withdrawal by Subject|0
4745843|NCT01183468|7715237|FG001|Overall Study|Withdrawal by Subject|1
4745844|NCT01183468|7715238|FG002|Overall Study|Withdrawal by Subject|0
4745845|NCT01183468|7715239|FG003|Overall Study|Withdrawal by Subject|0
4745846|NCT01181921|7715247|FG000|Overall Study|Lost to Follow-up|1
4745847|NCT01188798|7715253|FG000|Overall Study|Death|0
4745848|NCT01188798|7715254|FG001|Overall Study|Death|1
4745849|NCT01188798|7715253|FG000|Overall Study|Required additional transplant|1
4745850|NCT01188798|7715254|FG001|Overall Study|Required additional transplant|1
4745851|NCT01188798|7715253|FG000|Overall Study|Protocol closure|1
4745852|NCT01188798|7715254|FG001|Overall Study|Protocol closure|1
4745853|NCT01174368|7715261|FG000|Overall Study|Withdrawal by Subject|1
4745854|NCT01183884|7715269|FG000|Overall Study|Progressive Disease|26
4745855|NCT01183884|7715269|FG000|Overall Study|Adverse Event|3
4745856|NCT01183884|7715269|FG000|Overall Study|Withdrawal by Subject|1
4745857|NCT01183884|7715269|FG000|Overall Study|Other Complicating Disease|3
4745858|NCT01183884|7715269|FG000|Overall Study|Not Treated|1
4745859|NCT01183884|7715269|FG000|Overall Study|Other|4
4745860|NCT01166178|7715279|FG000|Overall Study|Withdrawal by Subject|1
4745861|NCT01166178|7715280|FG001|Overall Study|Withdrawal by Subject|0
4745862|NCT01166178|7715279|FG000|Overall Study|Study was terminated|20
4745863|NCT01166178|7715280|FG001|Overall Study|Study was terminated|8
4745864|NCT01176513|7715286|FG000|Overall Study|Withdrew subjects prior to dosing|3
4745865|NCT01179399|7715294|FG000|Overall Study|Adverse Event|1
4745866|NCT01179399|7715294|FG000|Overall Study|Lack of Efficacy|30
4745867|NCT01179399|7715294|FG000|Overall Study|Withdrawal by Subject|1
4745868|NCT01171534|7715309|FG000|Overall Study|Lost to Follow-up|0
4745869|NCT01171534|7715310|FG001|Overall Study|Lost to Follow-up|2
4745870|NCT01171534|7715309|FG000|Overall Study|screen failure|0
4745871|NCT01171534|7715310|FG001|Overall Study|screen failure|1
4745874|NCT01162304|7715356|FG000|Overall Study|Beck scale to high|11
4745875|NCT01147393|7715408|FG000|Dose Level 1|Dose limiting Toxicity|2
4745876|NCT01147393|7715408|FG000|Dose Level -1|Dose Limited Toxicity|1
4745877|NCT01147536|7715421|FG000|Overall Study|Administrative study close|2
4745878|NCT01147536|7715421|FG000|Overall Study|Death|1
4745879|NCT01133288|7715434|FG000|Eligibility Assessment|met exclusion criteria|5
4745880|NCT01133288|7715434|FG000|Intervention Allocation|study terminated|2
4745881|NCT01142128|7715442|FG000|Overall Study|Physician Decision|1
4745882|NCT01142128|7715442|FG000|Overall Study|Lost to Follow-up|1
4745883|NCT01142128|7715442|FG000|Overall Study|Withdrawal by Subject|2
4745884|NCT01128114|7715461|FG000|Overall Study|Treatment Withdrawn|6
4745885|NCT01128114|7715461|FG000|Overall Study|Screening Failed|2
4745886|NCT01126879|7715467|FG000|Overall Study|Progressive Disease|3
4745887|NCT01126879|7715468|FG001|Overall Study|Progressive Disease|1
4745888|NCT01126879|7715467|FG000|Overall Study|Withdrawal by Subject|1
4745889|NCT01126879|7715468|FG001|Overall Study|Withdrawal by Subject|0
4745890|NCT01126879|7715467|FG000|Overall Study|Adverse Event|0
4745891|NCT01126879|7715468|FG001|Overall Study|Adverse Event|1
4745892|NCT01126879|7715467|FG000|Overall Study|Physician Decision|1
4745893|NCT01126879|7715468|FG001|Overall Study|Physician Decision|0
4745894|NCT01136811|7715474|FG000|Overall Study|Physician Decision|11
4745895|NCT01139125|7715487|FG000|Overall Study|Withdrawal by Subject|1
4745896|NCT01131455|7715511|FG000|Overall Study|Death of PI|6
4745897|NCT01131455|7715512|FG001|Overall Study|Death of PI|4
4745898|NCT01131455|7715513|FG002|Overall Study|Death of PI|0
4745899|NCT01123850|7715530|FG000|Overall Study|Slow enrollment|45
4745900|NCT01122381|7715563|FG000|Overall Study|study terminated early|0
4745901|NCT01122381|7715564|FG001|Overall Study|study terminated early|1
4745902|NCT01116232|7715570|FG000|Overall Study|Progressive diease|4
4745903|NCT01108523|7715598|FG000|Overall Study|Protocol Violation|4
4745904|NCT01106534|7715606|FG000|Overall Study|Withdrawal by Subject|18
4745905|NCT01106534|7715606|FG000|Overall Study|Lost to Follow-up|2
4745906|NCT01106534|7715606|FG000|Overall Study|Death|16
4745907|NCT01106534|7715606|FG000|Overall Study|Physician Decision|1
4525871|NCT01026818|7342115|FG000|Screening Period|Entry Criteria Not Met|105
4525872|NCT01026818|7342116|FG001|Screening Period|Entry Criteria Not Met|0
4525873|NCT01026818|7342117|FG002|Screening Period|Entry Criteria Not Met|0
4525874|NCT01026818|7342118|FG003|Screening Period|Entry Criteria Not Met|0
4525875|NCT01026818|7342115|FG000|Screening Period|Withdrawal by Subject|49
4525876|NCT01026818|7342116|FG001|Screening Period|Withdrawal by Subject|0
4525877|NCT01026818|7342117|FG002|Screening Period|Withdrawal by Subject|0
4525878|NCT01026818|7342118|FG003|Screening Period|Withdrawal by Subject|0
4525879|NCT01026818|7342115|FG000|Screening Period|Protocol Deviation|3
4525880|NCT01026818|7342116|FG001|Screening Period|Protocol Deviation|0
4525881|NCT01026818|7342117|FG002|Screening Period|Protocol Deviation|0
4525882|NCT01026818|7342118|FG003|Screening Period|Protocol Deviation|0
4525883|NCT01026818|7342115|FG000|Screening Period|Adverse Event|2
4525884|NCT01026818|7342116|FG001|Screening Period|Adverse Event|0
4525885|NCT01026818|7342117|FG002|Screening Period|Adverse Event|0
4525886|NCT01026818|7342118|FG003|Screening Period|Adverse Event|0
4525887|NCT01026818|7342115|FG000|Screening Period|Physician Decision|1
4525888|NCT01026818|7342116|FG001|Screening Period|Physician Decision|0
4525889|NCT01026818|7342117|FG002|Screening Period|Physician Decision|0
4525890|NCT01026818|7342118|FG003|Screening Period|Physician Decision|0
4525891|NCT01026818|7342115|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0
4525892|NCT01026818|7342116|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10
4525893|NCT01026818|7342117|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6
4525894|NCT01026818|7342118|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4
4525895|NCT01026818|7342115|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0
4745908|NCT01100658|7715615|FG000|Overall Study|Withdrawal by Subject|1
4525896|NCT01026818|7342116|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7
4745909|NCT01103180|7715621|FG000|Overall Study|Withdrawal by Subject|8
4745910|NCT01103180|7715622|FG001|Overall Study|Withdrawal by Subject|13
4745911|NCT01103180|7715621|FG000|Overall Study|Lost to Follow-up|13
4745912|NCT01103180|7715622|FG001|Overall Study|Lost to Follow-up|7
4745913|NCT01103180|7715621|FG000|Overall Study|Physician Decision|1
4745914|NCT01103180|7715622|FG001|Overall Study|Physician Decision|0
4745915|NCT01103180|7715621|FG000|Overall Study|Protocol Violation|0
4745916|NCT01103180|7715622|FG001|Overall Study|Protocol Violation|1
4745917|NCT01102140|7715639|FG000|Overall Study|Lost to Follow-up|1
4745918|NCT01102140|7715640|FG001|Overall Study|Lost to Follow-up|0
4745919|NCT01102140|7715639|FG000|Overall Study|Investigator terminated study|2
4745920|NCT01102140|7715640|FG001|Overall Study|Investigator terminated study|2
4745921|NCT01095250|7715652|FG000|Overall Study|administrative reasons|8
4745922|NCT01095250|7715653|FG001|Overall Study|administrative reasons|10
4745923|NCT01095250|7715654|FG002|Overall Study|administrative reasons|7
4745924|NCT01095250|7715655|FG003|Overall Study|administrative reasons|5
4745925|NCT01095250|7715652|FG000|Overall Study|Withdrawal by Subject|0
4745926|NCT01095250|7715653|FG001|Overall Study|Withdrawal by Subject|0
4745927|NCT01095250|7715654|FG002|Overall Study|Withdrawal by Subject|1
4745928|NCT01095250|7715655|FG003|Overall Study|Withdrawal by Subject|0
4745929|NCT01093846|7715672|FG000|Overall Study|Adverse Event|0
4745930|NCT01093846|7715673|FG001|Overall Study|Adverse Event|0
4745931|NCT01093846|7715674|FG002|Overall Study|Adverse Event|1
4745932|NCT01093846|7715672|FG000|Overall Study|Lack of Efficacy|0
4745933|NCT01093846|7715673|FG001|Overall Study|Lack of Efficacy|0
4745934|NCT01093846|7715674|FG002|Overall Study|Lack of Efficacy|4
4745935|NCT01093846|7715672|FG000|Overall Study|Condition no longer required study drug|1
4745936|NCT01093846|7715673|FG001|Overall Study|Condition no longer required study drug|1
4745937|NCT01093846|7715674|FG002|Overall Study|Condition no longer required study drug|1
4745938|NCT01093846|7715672|FG000|Overall Study|Administrative Problems|18
4745939|NCT01093846|7715673|FG001|Overall Study|Administrative Problems|17
4745940|NCT01093846|7715674|FG002|Overall Study|Administrative Problems|15
4745941|NCT01081886|7715687|FG000|Overall Study|Study termination|11
4745942|NCT01081886|7715688|FG001|Overall Study|Study termination|13
4745943|NCT01080768|7715709|FG000|Overall Study|Protocol Deviation|2
4745944|NCT01080768|7715710|FG001|Overall Study|Protocol Deviation|1
4745945|NCT01074502|7715720|FG000|Overall Study|Withdrawal by Subject|1
4745946|NCT01069861|7715733|FG000|Overall Study|Death|1
4745947|NCT01069861|7715733|FG000|Overall Study|Adverse Event|1
4745948|NCT01069861|7715733|FG000|Overall Study|Did not meet entrance criteria|1
4745949|NCT01069120|7715766|FG000|Overall Study|Study prematurely terminated|27
4745950|NCT01058642|7715785|FG000|Treatment Period 1|Adverse Event|0
4745951|NCT01058642|7715786|FG001|Treatment Period 1|Adverse Event|1
4745952|NCT01058642|7715787|FG002|Treatment Period 1|Adverse Event|1
4745953|NCT01058642|7715788|FG003|Treatment Period 1|Adverse Event|0
4745954|NCT01058642|7715785|FG000|Treatment Period 1|Physician Decision|0
4745955|NCT01058642|7715786|FG001|Treatment Period 1|Physician Decision|0
4745956|NCT01058642|7715787|FG002|Treatment Period 1|Physician Decision|1
4745957|NCT01058642|7715788|FG003|Treatment Period 1|Physician Decision|0
4745958|NCT01058642|7715785|FG000|Treatment Period 1|Withdrawal by Subject|1
4745959|NCT01058642|7715786|FG001|Treatment Period 1|Withdrawal by Subject|0
4745960|NCT01058642|7715787|FG002|Treatment Period 1|Withdrawal by Subject|0
4745961|NCT01058642|7715788|FG003|Treatment Period 1|Withdrawal by Subject|0
4745962|NCT01058642|7715785|FG000|Treatment Period 1|Lack of Efficacy|0
4745963|NCT01058642|7715786|FG001|Treatment Period 1|Lack of Efficacy|0
4745964|NCT01058642|7715787|FG002|Treatment Period 1|Lack of Efficacy|0
4745965|NCT01058642|7715788|FG003|Treatment Period 1|Lack of Efficacy|1
4745966|NCT01058642|7715785|FG000|Treatment Period 1|Protocol Violation|0
4745967|NCT01058642|7715786|FG001|Treatment Period 1|Protocol Violation|0
4745968|NCT01058642|7715787|FG002|Treatment Period 1|Protocol Violation|0
4745969|NCT01058642|7715788|FG003|Treatment Period 1|Protocol Violation|1
4745970|NCT01058642|7715785|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1
4745971|NCT01058642|7715786|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0
4745972|NCT01058642|7715787|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0
4745973|NCT01058642|7715788|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0
4745974|NCT01065818|7715796|FG000|Overall Study|Withdrawal by Subject|1
4745975|NCT01065818|7715796|FG000|Overall Study|Not a candidate for surgery|1
4745976|NCT01051921|7715800|FG000|Overall Study|Physician Decision|9
4745977|NCT01051921|7715800|FG000|Overall Study|Adverse Event|8
4745978|NCT01051921|7715800|FG000|Overall Study|Withdrawal by Subject|7
4745979|NCT01051921|7715800|FG000|Overall Study|Lost to Follow-up|4
4745980|NCT01051921|7715800|FG000|Overall Study|virological failure|1
4745981|NCT01051921|7715800|FG000|Overall Study|patient moved|1
4745982|NCT01058369|7715822|FG000|Overall Study|Adverse Event|1
4745983|NCT01058369|7715822|FG000|Overall Study|Early termination study|1
4745984|NCT01053221|7715832|FG000|Overall Study|The study was closed prematurely|5
4745985|NCT01053221|7715833|FG001|Overall Study|The study was closed prematurely|9
4745986|NCT01038752|7715841|FG000|Overall Study|Tumor Progression|2
4745987|NCT01038752|7715842|FG001|Overall Study|Tumor Progression|2
4745988|NCT01038752|7715841|FG000|Overall Study|Lost to Follow-up|3
4745989|NCT01038752|7715842|FG001|Overall Study|Lost to Follow-up|3
4745990|NCT01050218|7715848|FG000|Overall Study|Adverse Event|37
4745991|NCT01050218|7715848|FG000|Overall Study|Lack of Efficacy|8
4745992|NCT01050218|7715848|FG000|Overall Study|Protocol Violation|3
4745993|NCT01050218|7715848|FG000|Overall Study|Withdrawal by Subject|18
4745994|NCT01050218|7715848|FG000|Overall Study|Discontinued by sponsor|18
4745995|NCT01050218|7715848|FG000|Overall Study|Compliance|2
4745996|NCT01050218|7715848|FG000|Overall Study|Failed to return|7
4745997|NCT01050218|7715848|FG000|Overall Study|Serious Adverse Event|1
4745998|NCT01050218|7715848|FG000|Overall Study|Family emergency|1
4745999|NCT01045694|7715852|FG000|Overall Study|Withdrawal by Subject|2
4746000|NCT01031628|7715877|FG000|Overall Study|Study terminated early|0
4746001|NCT01031628|7715878|FG001|Overall Study|Study terminated early|1
4746002|NCT01031628|7715879|FG002|Overall Study|Study terminated early|3
4746003|NCT01031628|7715880|FG003|Overall Study|Study terminated early|0
4746004|NCT01030198|7715911|FG000|Overall Study|Could not measure efficacy accurately|0
4746005|NCT01030198|7715912|FG001|Overall Study|Could not measure efficacy accurately|7
4746006|NCT01028300|7715918|FG000|Overall Study|Study Terminated|4
4746007|NCT01022398|7715929|FG000|Overall Study|Study terminated|2
4746008|NCT01022398|7715930|FG001|Overall Study|Study terminated|2
4746009|NCT01019980|7715937|FG000|Overall Study|Drug not available.|2
4746010|NCT01019980|7715938|FG001|Overall Study|Drug not available.|0
4746011|NCT01017263|7715948|FG000|Overall Study|not eligible|12
4634509|NCT01925209|7505632|FG001|Follow-up|Physician Decision|0
4634510|NCT01925209|7505633|FG002|Follow-up|Physician Decision|1
4634511|NCT01925209|7505634|FG003|Follow-up|Physician Decision|0
4634512|NCT01925209|7505631|FG000|Follow-up|Non-compliance with study treatment|0
4634513|NCT01925209|7505632|FG001|Follow-up|Non-compliance with study treatment|0
4634514|NCT01925209|7505633|FG002|Follow-up|Non-compliance with study treatment|0
4634515|NCT01925209|7505634|FG003|Follow-up|Non-compliance with study treatment|1
4634516|NCT01925209|7505631|FG000|Follow-up|Withdrawal by Subject|0
4746012|NCT01018810|7715975|FG000|Overall Study|Withdrawal by Subject|0
4746013|NCT01018810|7715976|FG001|Overall Study|Withdrawal by Subject|1
4746014|NCT01018810|7715977|FG002|Overall Study|Withdrawal by Subject|0
4746015|NCT01018810|7715978|FG003|Overall Study|Withdrawal by Subject|0
4746016|NCT01018810|7715979|FG004|Overall Study|Withdrawal by Subject|0
4746017|NCT01018810|7715975|FG000|Overall Study|Sponsor Decision|2
4746018|NCT01018810|7715976|FG001|Overall Study|Sponsor Decision|0
4746019|NCT01018810|7715977|FG002|Overall Study|Sponsor Decision|1
4746020|NCT01018810|7715978|FG003|Overall Study|Sponsor Decision|1
4746021|NCT01018810|7715979|FG004|Overall Study|Sponsor Decision|1
4746022|NCT01014767|7716008|FG000|Overall Study|PI left institution, data unavailable|12
4746023|NCT01014767|7716009|FG001|Overall Study|PI left institution, data unavailable|1
4746024|NCT01014767|7716010|FG002|Overall Study|PI left institution, data unavailable|4
4746025|NCT01014767|7716011|FG003|Overall Study|PI left institution, data unavailable|1
4746026|NCT01013701|7716021|FG000|Overall Study|study prematurely terminated|7
4746027|NCT01012414|7716026|FG000|Overall Study|Withdrawal by Subject|2
4746028|NCT01012414|7716026|FG000|Overall Study|Lost to Follow-up|1
4746029|NCT01012414|7716026|FG000|Overall Study|Trial was stopped before completed|7
4746030|NCT01001390|7716045|FG000|Overall Study|Failure to wear AFO device|2
4746031|NCT01001390|7716046|FG001|Overall Study|Failure to wear AFO device|0
4746032|NCT01004510|7716064|FG000|Overall Study|Adverse Event|1
4746033|NCT01005914|7716068|FG000|Overall Study|Adverse Event|4
4746034|NCT01005914|7716068|FG000|Overall Study|Death|4
4746035|NCT01005914|7716068|FG000|Overall Study|Lack of Efficacy|1
4746036|NCT01005914|7716068|FG000|Overall Study|Withdrawal by Subject|1
4746037|NCT00996333|7716072|FG000|Overall Study|Screen failure|1
4746038|NCT00996333|7716072|FG000|Overall Study|Withdrawal by Subject|1
4746039|NCT00996333|7716072|FG000|Overall Study|Death|4
4746040|NCT00996333|7716072|FG000|Overall Study|Adverse Event|1
4746041|NCT00996333|7716072|FG000|Overall Study|Physician Decision|1
4746042|NCT00996333|7716072|FG000|Overall Study|Other|5
4746043|NCT00998738|7716076|FG000|Overall Study|Uknown|1
4746044|NCT00997386|7716084|FG000|Overall Study|Death|7
4634517|NCT01925209|7505632|FG001|Follow-up|Withdrawal by Subject|2
4746045|NCT00985738|7716090|FG000|Overall Study|Study closed prematurely|8
4746046|NCT00985738|7716091|FG001|Overall Study|Study closed prematurely|8
4746047|NCT00975611|7716184|FG000|Overall Study|Screen Fail|16
4746048|NCT00975611|7716184|FG000|Overall Study|Physician Decision|1
4746049|NCT00974922|7716209|FG000|Overall Study|study terminated|24
4746050|NCT00965146|7716224|FG000|Overall Study|Death|7
4746051|NCT00965146|7716224|FG000|Overall Study|Lost to Follow-up|22
4746052|NCT00965146|7716224|FG000|Overall Study|Withdrawal by Subject|17
4746053|NCT00965146|7716224|FG000|Overall Study|Unable to return|1
4746054|NCT00965146|7716224|FG000|Overall Study|Unwilling to return|11
4746055|NCT00965146|7716224|FG000|Overall Study|Intercurrent illness|1
4746056|NCT00965146|7716224|FG000|Overall Study|Revision / Removal of Study Implant|6
4746057|NCT00965146|7716224|FG000|Overall Study|Overall Study Termination|145
4746058|NCT00972023|7716228|FG000|Overall Study|Withdrawal by Subject|1
4746059|NCT00953329|7716247|FG000|Overall Study|Lack of Efficacy|1
4746060|NCT00958893|7716264|FG000|Overall Study|Study prematurely terminated|4
4746061|NCT00966654|7716268|FG000|Overall Study|Study was terminated,PI left institution|12
4746062|NCT00960154|7716276|FG000|Overall Study|Study termination|25
4746063|NCT00960154|7716277|FG001|Overall Study|Study termination|25
4746064|NCT00960752|7716286|FG000|Overall Study|Adverse Event|0
4746065|NCT00960752|7716287|FG001|Overall Study|Adverse Event|0
4746066|NCT00960752|7716288|FG002|Overall Study|Adverse Event|1
4746067|NCT00960752|7716286|FG000|Overall Study|Progression|0
4746068|NCT00960752|7716287|FG001|Overall Study|Progression|0
4746069|NCT00960752|7716288|FG002|Overall Study|Progression|1
4746070|NCT00958347|7716296|FG000|Overall Study|Death|43
4746071|NCT00958347|7716296|FG000|Overall Study|Withdrawal by Subject|23
4746072|NCT00958347|7716296|FG000|Overall Study|Lost to Follow-up|15
4746073|NCT00958347|7716296|FG000|Overall Study|revision/removal|10
4746074|NCT00958347|7716296|FG000|Overall Study|study termination|135
4746075|NCT00953615|7716309|FG000|Overall Study|Adverse Event|1
4746076|NCT00957034|7716321|FG000|Overall Study|Adverse Event|0
4746077|NCT00957034|7716322|FG001|Overall Study|Adverse Event|1
4746078|NCT00957034|7716323|FG002|Overall Study|Adverse Event|1
4746079|NCT00957034|7716321|FG000|Overall Study|Sponsor Terminated Study|6
4746080|NCT00957034|7716322|FG001|Overall Study|Sponsor Terminated Study|1
4746081|NCT00957034|7716323|FG002|Overall Study|Sponsor Terminated Study|5
4746082|NCT00957034|7716321|FG000|Overall Study|Withdrawal by Subject|0
4746083|NCT00957034|7716322|FG001|Overall Study|Withdrawal by Subject|2
4746084|NCT00957034|7716323|FG002|Overall Study|Withdrawal by Subject|0
4746085|NCT00949988|7716331|FG000|Overall Study|Withdrawal by Subject|3
4746086|NCT00948194|7716337|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1
4746087|NCT00948194|7716338|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0
4746088|NCT00946985|7716344|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4
4746089|NCT00946985|7716344|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3
4746090|NCT00946985|7716344|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5
4746091|NCT00946985|7716344|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4
4746092|NCT00946985|7716344|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139
4746093|NCT00946985|7716344|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2
4746094|NCT00946985|7716344|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1
4746095|NCT00946985|7716344|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2
4746096|NCT00946985|7716344|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2
4746097|NCT00950690|7716352|FG000|Overall Study|Death|4
4746098|NCT00950690|7716352|FG000|Overall Study|Adverse Event|15
4746099|NCT00950690|7716352|FG000|Overall Study|Lack of Efficacy|22
4746100|NCT00950690|7716352|FG000|Overall Study|Lost to Follow-up|40
4746101|NCT00950690|7716352|FG000|Overall Study|Other|163
4746102|NCT00944229|7716356|FG000|Overall Study|Withdrawal by Subject|11
4746103|NCT00944229|7716356|FG000|Overall Study|Physician Decision|14
4746104|NCT00941928|7716360|FG000|Overall Study|Withdrawal by Subject|1
4634518|NCT01925209|7505633|FG002|Follow-up|Withdrawal by Subject|0
4634519|NCT01925209|7505634|FG003|Follow-up|Withdrawal by Subject|2
4634520|NCT01925274|7505647|FG000|Overall Study|Death|1
4634521|NCT01925274|7505648|FG001|Overall Study|Death|0
4634522|NCT01925274|7505649|FG002|Overall Study|Death|0
4634523|NCT01925274|7505647|FG000|Overall Study|Lost to Follow-up|0
4634524|NCT01925274|7505648|FG001|Overall Study|Lost to Follow-up|1
4634525|NCT01925274|7505649|FG002|Overall Study|Lost to Follow-up|0
4634526|NCT01925274|7505647|FG000|Overall Study|Withdrawal by Subject|1
4634527|NCT01925274|7505648|FG001|Overall Study|Withdrawal by Subject|2
4634528|NCT01925274|7505649|FG002|Overall Study|Withdrawal by Subject|0
4634529|NCT01925274|7505647|FG000|Overall Study|Study terminated by sponsor|4
4634530|NCT01925274|7505648|FG001|Overall Study|Study terminated by sponsor|0
4634531|NCT01925274|7505649|FG002|Overall Study|Study terminated by sponsor|0
4634532|NCT01925274|7505647|FG000|Overall Study|Protocol amendment|1
4634533|NCT01925274|7505648|FG001|Overall Study|Protocol amendment|3
4634534|NCT01925274|7505649|FG002|Overall Study|Protocol amendment|6
4634535|NCT01925339|7505661|FG000|Overall Study|Adverse Event|2
4634536|NCT01925339|7505662|FG001|Overall Study|Adverse Event|0
4634537|NCT01925417|7505685|FG000|Overall Study|Withdrawal by Subject|2
4634538|NCT01925417|7505685|FG000|Overall Study|Death|1
4634539|NCT01925612|7505704|FG000|Overall Study|Progressive Disease|1
4634540|NCT01925612|7505705|FG001|Overall Study|Progressive Disease|1
4634541|NCT01925612|7505706|FG002|Overall Study|Progressive Disease|1
4634542|NCT01925612|7505707|FG003|Overall Study|Progressive Disease|0
4634543|NCT01925612|7505708|FG004|Overall Study|Progressive Disease|0
4746105|NCT00941928|7716360|FG000|Overall Study|Disease Progression|1
4746106|NCT00947011|7716377|FG000|Overall Study|Study was terminated,PI left institution|12
4746107|NCT00943605|7716385|FG000|Overall Study|Study termination|30
4746108|NCT00943605|7716386|FG001|Overall Study|Study termination|30
4746109|NCT00942409|7716392|FG000|Overall Study|Lack of Efficacy|1
4746110|NCT00942409|7716392|FG000|Overall Study|study drug unavailable|2
4746111|NCT00936598|7716402|FG000|Overall Study|Withdrawal by Subject|1
4746112|NCT00936598|7716403|FG001|Overall Study|Withdrawal by Subject|0
4746113|NCT00936598|7716402|FG000|Overall Study|Ineligible after consent|1
4746114|NCT00936598|7716403|FG001|Overall Study|Ineligible after consent|0
4746115|NCT00934791|7716427|FG000|Overall Study|Withdrawal by Subject|1
4746116|NCT00934791|7716428|FG001|Overall Study|Withdrawal by Subject|0
4746117|NCT00925548|7716476|FG000|Overall Study|Discontinuation of trial by sponsor|10
4746118|NCT00925548|7716477|FG001|Overall Study|Discontinuation of trial by sponsor|5
4746119|NCT00926575|7716486|FG000|Overall Study|Adverse Event|1
4525897|NCT01026818|7342117|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3
4525898|NCT01026818|7342118|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3
4525899|NCT01026818|7342115|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0
4525900|NCT01026818|7342116|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3
4525901|NCT01026818|7342117|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2
4525902|NCT01026818|7342118|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6
4525903|NCT01026818|7342115|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0
4525904|NCT01026818|7342116|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3
4525905|NCT01026818|7342117|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0
4525906|NCT01026818|7342118|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4
4525907|NCT01026818|7342115|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0
4525908|NCT01026818|7342116|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2
4525909|NCT01026818|7342117|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9
4525910|NCT01026818|7342118|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7
4525911|NCT01026818|7342115|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0
4525912|NCT01026818|7342116|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0
4525913|NCT01026818|7342117|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1
4525914|NCT01026818|7342118|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2
4525915|NCT01026818|7342115|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0
4525916|NCT01026818|7342116|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2
4525917|NCT01026818|7342117|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1
4525918|NCT01026818|7342118|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2
4525919|NCT01026818|7342115|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0
4525920|NCT01026818|7342116|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2
4525921|NCT01026818|7342117|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1
4525922|NCT01026818|7342118|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2
4525923|NCT01026818|7342115|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
4525924|NCT01026818|7342116|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1
4525925|NCT01026818|7342117|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
4525926|NCT01026818|7342118|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
4525927|NCT01026818|7342115|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0
4525928|NCT01026818|7342116|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1
4525929|NCT01026818|7342117|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0
4525930|NCT01026818|7342118|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2
4525931|NCT01026818|7342115|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0
4525932|NCT01026818|7342116|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1
4525933|NCT01026818|7342117|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1
4525934|NCT01026818|7342118|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0
4746120|NCT00926575|7716487|FG001|Overall Study|Adverse Event|1
4746121|NCT00926575|7716486|FG000|Overall Study|Death|4
4746122|NCT00926575|7716487|FG001|Overall Study|Death|4
4746123|NCT00926575|7716486|FG000|Overall Study|Lost to Follow-up|1
4746124|NCT00926575|7716487|FG001|Overall Study|Lost to Follow-up|1
4746125|NCT00926575|7716486|FG000|Overall Study|Physician Decision|1
4746126|NCT00926575|7716487|FG001|Overall Study|Physician Decision|2
4746127|NCT00926575|7716486|FG000|Overall Study|Protocol Violation|1
4746128|NCT00926575|7716487|FG001|Overall Study|Protocol Violation|0
4746129|NCT00926575|7716486|FG000|Overall Study|Withdrawal by Subject|8
4746130|NCT00926575|7716487|FG001|Overall Study|Withdrawal by Subject|9
4746131|NCT00918463|7716514|FG000|Overall Study|Death|1
4746132|NCT00918463|7716514|FG000|Overall Study|Lack of Efficacy|1
4746133|NCT00913692|7716518|FG000|Screening (4 Months)|Physician Decision|3
4746134|NCT00913692|7716518|FG000|Screening (4 Months)|Not eligible after screening phase.|6
4746135|NCT00913692|7716518|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1
4746136|NCT00918645|7716525|FG000|Overall Study|Withdrawal by Subject|1
4746137|NCT00906035|7716558|FG000|Overall Study|Withdrawal by Subject|2
4746138|NCT00906035|7716559|FG001|Overall Study|Withdrawal by Subject|3
4746139|NCT00906035|7716560|FG002|Overall Study|Withdrawal by Subject|0
4746140|NCT00894790|7716591|FG000|Overall Study|Protocol Violation|0
4746141|NCT00894790|7716592|FG001|Overall Study|Protocol Violation|1
4746142|NCT00894790|7716591|FG000|Overall Study|Lost to Follow-up|0
4746143|NCT00894790|7716592|FG001|Overall Study|Lost to Follow-up|1
4746144|NCT00894790|7716591|FG000|Overall Study|Did not meet entrance criteria|1
4746145|NCT00894790|7716592|FG001|Overall Study|Did not meet entrance criteria|0
4746146|NCT00902668|7716598|FG000|Overall Study|Protocol stopped due to slow accrual.|3
4746147|NCT00881205|7716604|FG000|Overall Study|Adverse Event|8
4746148|NCT00881205|7716605|FG001|Overall Study|Adverse Event|3
4746149|NCT00881205|7716604|FG000|Overall Study|Withdrawal by Subject|1
4746150|NCT00881205|7716605|FG001|Overall Study|Withdrawal by Subject|2
4746151|NCT00881205|7716604|FG000|Overall Study|Lost to Follow-up|0
4746152|NCT00881205|7716605|FG001|Overall Study|Lost to Follow-up|1
4746153|NCT00881205|7716604|FG000|Overall Study|Administrative problems|1
4746154|NCT00881205|7716605|FG001|Overall Study|Administrative problems|1
4746155|NCT00881205|7716604|FG000|Overall Study|Condition no longer requires drug|1
4746156|NCT00881205|7716605|FG001|Overall Study|Condition no longer requires drug|0
4746157|NCT00903006|7716622|FG000|Overall Study|Withdrawal by Subject|2
4746158|NCT00903006|7716623|FG001|Overall Study|Withdrawal by Subject|0
4746159|NCT00903006|7716624|FG002|Overall Study|Withdrawal by Subject|0
4746160|NCT00903006|7716625|FG003|Overall Study|Withdrawal by Subject|0
4746161|NCT00903006|7716622|FG000|Overall Study|Progressive Disease|0
4746162|NCT00903006|7716623|FG001|Overall Study|Progressive Disease|3
4746163|NCT00903006|7716624|FG002|Overall Study|Progressive Disease|1
4746164|NCT00903006|7716625|FG003|Overall Study|Progressive Disease|0
4746165|NCT00887315|7716642|FG000|Overall Study|Study termination|7
4746166|NCT00887315|7716643|FG001|Overall Study|Study termination|4
4746167|NCT00891904|7716649|FG000|Overall Study|Death|1
4746168|NCT00891904|7716649|FG000|Overall Study|Adverse Event|1
4746169|NCT00881608|7716658|FG000|Overall Study|Study prematurely terminated|11
4746170|NCT00889421|7716670|FG000|Overall Study|Lack of Efficacy|3
4746171|NCT00882310|7716687|FG000|Overall Study|Screen Failure|10
4746172|NCT00882310|7716687|FG000|Overall Study|Never received treatment|1
4525935|NCT01026818|7342115|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
4525936|NCT01026818|7342116|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1
4525937|NCT01026818|7342117|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
4525938|NCT01026818|7342118|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
4525939|NCT01026818|7342115|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0
4525940|NCT01026818|7342116|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1
4525941|NCT01026818|7342117|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2
4525942|NCT01026818|7342118|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0
4525943|NCT01026818|7342115|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0
4525944|NCT01026818|7342116|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0
4525945|NCT01026818|7342117|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0
4525946|NCT01026818|7342118|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1
4525947|NCT01026818|7342115|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
4525948|NCT01026818|7342116|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2
4525949|NCT01026818|7342117|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
4525950|NCT01026818|7342118|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
4525951|NCT01026818|7342115|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
4525952|NCT01026818|7342116|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1
4525953|NCT01026818|7342117|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
4525954|NCT01026818|7342118|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
4525955|NCT01026818|7342115|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0
4525956|NCT01026818|7342116|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1
4525957|NCT01026818|7342117|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2
4525958|NCT01026818|7342118|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1
4525959|NCT01026818|7342115|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0
4525960|NCT01026818|7342116|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1
4525961|NCT01026818|7342117|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3
4525962|NCT01026818|7342118|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1
4525963|NCT01026818|7342115|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0
4525964|NCT01026818|7342116|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2
4525965|NCT01026818|7342117|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0
4525966|NCT01026818|7342118|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1
4525967|NCT01026831|7342132|FG000|Overall Study|Adverse Event|4
4525968|NCT01026831|7342133|FG001|Overall Study|Adverse Event|3
4525969|NCT01026831|7342132|FG000|Overall Study|Lost to Follow-up|2
4525970|NCT01026831|7342133|FG001|Overall Study|Lost to Follow-up|0
4525971|NCT01026831|7342132|FG000|Overall Study|Physician Decision|1
4525972|NCT01026831|7342133|FG001|Overall Study|Physician Decision|1
4525973|NCT01026831|7342132|FG000|Overall Study|Protocol Violation|0
4525974|NCT01026831|7342133|FG001|Overall Study|Protocol Violation|2
4525975|NCT01026831|7342132|FG000|Overall Study|Withdrawal by Subject|7
4525976|NCT01026831|7342133|FG001|Overall Study|Withdrawal by Subject|5
4525977|NCT01026948|7342157|FG000|Overall Study|Physician Decision|8
4525978|NCT01026974|7342166|FG000|Overall Study|Withdrawal by Subject|0
4525979|NCT01026974|7342167|FG001|Overall Study|Withdrawal by Subject|1
4525980|NCT01026974|7342168|FG002|Overall Study|Withdrawal by Subject|7
4525981|NCT01026974|7342169|FG003|Overall Study|Withdrawal by Subject|2
4525982|NCT01026974|7342166|FG000|Overall Study|Lost to Follow-up|1
4525983|NCT01026974|7342167|FG001|Overall Study|Lost to Follow-up|1
4525984|NCT01026974|7342168|FG002|Overall Study|Lost to Follow-up|4
4525985|NCT01026974|7342169|FG003|Overall Study|Lost to Follow-up|0
4525986|NCT01026974|7342166|FG000|Overall Study|Adverse Event|0
4525987|NCT01026974|7342167|FG001|Overall Study|Adverse Event|0
4525988|NCT01026974|7342168|FG002|Overall Study|Adverse Event|0
4525989|NCT01026974|7342169|FG003|Overall Study|Adverse Event|1
4525990|NCT01026974|7342166|FG000|Overall Study|Inappropriate enrollment|0
4525991|NCT01026974|7342167|FG001|Overall Study|Inappropriate enrollment|0
4746173|NCT00882310|7716687|FG000|Overall Study|Death|6
4746174|NCT00882310|7716687|FG000|Overall Study|Progression of disease|4
4746175|NCT00882310|7716687|FG000|Overall Study|Adverse Event|1
4746176|NCT00880542|7716691|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1
4746177|NCT00880542|7716691|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2
4746178|NCT00880542|7716691|FG000|REP: Surgical Resection|progressive disease|1
4746179|NCT00874939|7716699|FG000|Overall Study|Study terminated|4
4746180|NCT00877071|7716726|FG000|Overall Study|disease progression|2
4746181|NCT00878969|7716733|FG000|Overall Study|Physician Decision|5
4746182|NCT00878969|7716734|FG001|Overall Study|Physician Decision|3
4746183|NCT00878969|7716735|FG002|Overall Study|Physician Decision|2
4746184|NCT00878969|7716733|FG000|Overall Study|Withdrawal by Subject|1
4746185|NCT00878969|7716734|FG001|Overall Study|Withdrawal by Subject|6
4746186|NCT00878969|7716735|FG002|Overall Study|Withdrawal by Subject|3
4746187|NCT00878969|7716733|FG000|Overall Study|kidney transplant|2
4746188|NCT00878969|7716734|FG001|Overall Study|kidney transplant|3
4746189|NCT00878969|7716735|FG002|Overall Study|kidney transplant|2
4746190|NCT00878969|7716733|FG000|Overall Study|Adverse Event|3
4746191|NCT00878969|7716734|FG001|Overall Study|Adverse Event|1
4746192|NCT00878969|7716735|FG002|Overall Study|Adverse Event|2
4746193|NCT00878969|7716733|FG000|Overall Study|Lost to Follow-up|2
4746194|NCT00878969|7716734|FG001|Overall Study|Lost to Follow-up|1
4746195|NCT00878969|7716735|FG002|Overall Study|Lost to Follow-up|0
4746196|NCT00878969|7716733|FG000|Overall Study|Protocol Violation|2
4746197|NCT00878969|7716734|FG001|Overall Study|Protocol Violation|0
4746198|NCT00878969|7716735|FG002|Overall Study|Protocol Violation|0
4746199|NCT00878969|7716733|FG000|Overall Study|Death|0
4746200|NCT00878969|7716734|FG001|Overall Study|Death|0
4746201|NCT00878969|7716735|FG002|Overall Study|Death|2
4746202|NCT00878969|7716733|FG000|Overall Study|Pregnancy|0
4746203|NCT00878969|7716734|FG001|Overall Study|Pregnancy|1
4746204|NCT00878969|7716735|FG002|Overall Study|Pregnancy|0
4746205|NCT00865514|7716743|FG000|Overall Study|Infusion cost exceeded funding|2
4746206|NCT00863512|7716760|FG000|Overall Study|Adverse Event|2
4746207|NCT00863512|7716761|FG001|Overall Study|Adverse Event|0
4746208|NCT00863512|7716760|FG000|Overall Study|Withdrawal by Subject|11
4746209|NCT00863512|7716761|FG001|Overall Study|Withdrawal by Subject|0
4746210|NCT00863512|7716760|FG000|Overall Study|Physician Decision|1
4746211|NCT00863512|7716761|FG001|Overall Study|Physician Decision|0
4746212|NCT00868998|7716767|FG000|Overall Study|Screen Failure|1
4746213|NCT00868998|7716767|FG000|Overall Study|Withdrawal by Subject|1
4746214|NCT00868998|7716767|FG000|Overall Study|Progression of disease|2
4746215|NCT00868998|7716767|FG000|Overall Study|Death|1
4746216|NCT00869258|7716771|FG000|Overall Study|Physician Decision|1
4746217|NCT00863330|7716775|FG000|Overall Study|study terminated early due to administra|6
4746218|NCT00853229|7716781|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8
4746219|NCT00853229|7716782|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8
4746220|NCT00860249|7716793|FG000|Overall Study|trial was terminated prior to completion|21
4746221|NCT00860249|7716794|FG001|Overall Study|trial was terminated prior to completion|18
4746222|NCT00860249|7716795|FG002|Overall Study|trial was terminated prior to completion|21
4746223|NCT00860158|7716803|FG000|Overall Study|Study Terminated|1
4746224|NCT00853567|7716810|FG000|Overall Study|Study prematurely terminated|71
4746225|NCT00849524|7716818|FG000|Overall Study|Lack of Efficacy|3
4746226|NCT00851682|7716833|FG000|Overall Study|screen failure|5
4746227|NCT00851682|7716834|FG001|Overall Study|screen failure|0
4746228|NCT00851747|7716856|FG000|Overall Study|Physician Decision|6
4746229|NCT00851747|7716857|FG001|Overall Study|Physician Decision|6
4746230|NCT00851747|7716858|FG002|Overall Study|Physician Decision|6
4746231|NCT00852241|7716865|FG000|Overall Study|Physician Decision|18
4746232|NCT00851552|7716869|FG000|Overall Study|Death|2
4746233|NCT00851552|7716869|FG000|Overall Study|Adverse Event|1
4746234|NCT00851552|7716869|FG000|Overall Study|Disease Progression|4
4746235|NCT00845845|7716879|FG000|Overall Study|Lost to Follow-up|0
4746236|NCT00845845|7716880|FG001|Overall Study|Lost to Follow-up|4
4746237|NCT00851591|7716888|FG000|Overall Study|Withdrawal by Subject|2
4746238|NCT00851591|7716889|FG001|Overall Study|Withdrawal by Subject|0
4746239|NCT00835679|7716926|FG000|Overall Study|Withdrawal by Subject|1
4746240|NCT00835679|7716927|FG001|Overall Study|Withdrawal by Subject|0
4746241|NCT00835679|7716928|FG002|Overall Study|Withdrawal by Subject|0
4746242|NCT00835679|7716929|FG003|Overall Study|Withdrawal by Subject|0
4746243|NCT00841035|7716943|FG000|Phase 1 Overall Study|Physician Decision|13
4746244|NCT00840827|7716961|FG000|Overall Study|Adverse Event|1
4746245|NCT00840827|7716961|FG000|Overall Study|Lack of Efficacy|4
4746246|NCT00840827|7716961|FG000|Overall Study|Physician Decision|1
4746247|NCT00832624|7716995|FG000|Overall Study|Study Terminated|10
4746248|NCT00827567|7717038|FG000|Overall Study|Progression of Disease/Screen Failure|4
4746249|NCT00815633|7717042|FG000|Overall Study|study terminated|1
4746250|NCT00814983|7717048|FG000|Overall Study|Screen failure|1
4746251|NCT00814983|7717049|FG001|Overall Study|Screen failure|0
4746252|NCT00814983|7717048|FG000|Overall Study|Withdrawal by Subject|1
4746253|NCT00814983|7717049|FG001|Overall Study|Withdrawal by Subject|0
4746254|NCT00814983|7717048|FG000|Overall Study|Graft failure|1
4746255|NCT00814983|7717049|FG001|Overall Study|Graft failure|0
4746256|NCT00819832|7717072|FG000|Overall Study|Sponsor Termination of Study|3
4746257|NCT00819832|7717073|FG001|Overall Study|Sponsor Termination of Study|0
4746258|NCT00819832|7717074|FG002|Overall Study|Sponsor Termination of Study|0
4746259|NCT00819832|7717075|FG003|Overall Study|Sponsor Termination of Study|0
4746260|NCT00819832|7717076|FG004|Overall Study|Sponsor Termination of Study|0
4746261|NCT00819832|7717077|FG005|Overall Study|Sponsor Termination of Study|0
4746262|NCT00814892|7717100|FG000|Overall Study|Disease Progression|1
4746263|NCT00814892|7717100|FG000|Overall Study|Study Termination|1
4746264|NCT00802659|7717117|FG000|Overall Study|Physician Decision|0
4746265|NCT00802659|7717118|FG001|Overall Study|Physician Decision|1
4746266|NCT00802659|7717119|FG002|Overall Study|Physician Decision|0
4746267|NCT00802659|7717120|FG003|Overall Study|Physician Decision|0
4746268|NCT00807365|7717130|FG000|Overall Study|Study Terminated|5
4746269|NCT00814333|7717136|FG000|Enrollment|Lost to Follow-up|1
4746270|NCT00814333|7717137|FG001|Enrollment|Lost to Follow-up|0
4746271|NCT00808080|7717143|FG000|Overall Study|Patients Became Ineligible for infusion|6
4746272|NCT00802893|7717148|FG000|Overall Study|study terminated|3
4746273|NCT00809341|7717154|FG000|Overall Study|Physician Decision|0
4746274|NCT00809341|7717155|FG001|Overall Study|Physician Decision|1
4746275|NCT00808899|7717183|FG000|Overall Study|Death|1
4746276|NCT00808899|7717183|FG000|Overall Study|Physician Decision|3
4746277|NCT00803179|7717194|FG000|Overall Study|Lost to Follow-up|3
4746278|NCT00790452|7717233|FG000|Overall Study|Drug supply issue|1
4746279|NCT00790452|7717234|FG001|Overall Study|Drug supply issue|0
4746280|NCT00787917|7717246|FG000|Blinded Treatment|Adverse Event|1
4746281|NCT00787917|7717247|FG001|Blinded Treatment|Adverse Event|0
4746282|NCT00787917|7717246|FG000|Blinded Treatment|Lack of Efficacy|1
4746283|NCT00787917|7717247|FG001|Blinded Treatment|Lack of Efficacy|0
4746284|NCT00787917|7717246|FG000|Blinded Treatment|Administrative problems|3
4746285|NCT00787917|7717247|FG001|Blinded Treatment|Administrative problems|2
4746286|NCT00787917|7717246|FG000|Open Label|Unsatisfactory therapeutic effect|1
4746287|NCT00787917|7717247|FG001|Open Label|Unsatisfactory therapeutic effect|0
4746288|NCT00787917|7717246|FG000|Open Label|Administrative problems|3
4746289|NCT00787917|7717247|FG001|Open Label|Administrative problems|0
4746290|NCT00798590|7717257|FG000|Overall Study|P.I, Left institution. Study terminated|11
4746291|NCT00798590|7717258|FG001|Overall Study|P.I, Left institution. Study terminated|8
4746292|NCT00796510|7717266|FG000|Overall Study|Death|1
4746293|NCT00796510|7717267|FG001|Overall Study|Death|0
4746294|NCT00796510|7717266|FG000|Overall Study|Study Terminated|2
4746295|NCT00796510|7717267|FG001|Overall Study|Study Terminated|0
4746296|NCT00796861|7717273|FG000|Overall Study|Withdrawal by Subject|2
4746297|NCT00796861|7717273|FG000|Overall Study|Death|2
4746298|NCT00791076|7717277|FG000|Overall Study|Study was terminated,PI left institution|8
4746299|NCT00796107|7717292|FG000|Overall Study|Lack of Efficacy|1
4746300|NCT00796107|7717292|FG000|Overall Study|Progressive Disease|5
4746301|NCT00785356|7717316|FG000|Overall Study|Study prematurely terminated|8
4746302|NCT00782483|7717324|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6
4746303|NCT00784043|7717334|FG000|Overall Study|Withdrawal by Subject|8
4746304|NCT00784043|7717335|FG001|Overall Study|Withdrawal by Subject|5
4746305|NCT00784043|7717334|FG000|Overall Study|Protocol Terminated|23
4746306|NCT00784043|7717335|FG001|Overall Study|Protocol Terminated|1
4746307|NCT00774306|7717358|FG000|Overall Study|Adverse Event|3
4746308|NCT00774306|7717359|FG001|Overall Study|Adverse Event|0
4746309|NCT00774306|7717360|FG002|Overall Study|Adverse Event|0
4746310|NCT00774306|7717361|FG003|Overall Study|Adverse Event|0
4746311|NCT00774306|7717358|FG000|Overall Study|Protocol Violation|2
4746312|NCT00774306|7717359|FG001|Overall Study|Protocol Violation|0
4746313|NCT00774306|7717360|FG002|Overall Study|Protocol Violation|3
4746314|NCT00774306|7717361|FG003|Overall Study|Protocol Violation|0
4746315|NCT00774306|7717358|FG000|Overall Study|Withdrawal by Subject|6
4746316|NCT00774306|7717359|FG001|Overall Study|Withdrawal by Subject|1
4746317|NCT00774306|7717360|FG002|Overall Study|Withdrawal by Subject|1
4746318|NCT00774306|7717361|FG003|Overall Study|Withdrawal by Subject|0
4746319|NCT00774306|7717358|FG000|Overall Study|Lost to Follow-up|6
4746320|NCT00774306|7717359|FG001|Overall Study|Lost to Follow-up|0
4746321|NCT00774306|7717360|FG002|Overall Study|Lost to Follow-up|4
4746322|NCT00774306|7717361|FG003|Overall Study|Lost to Follow-up|5
4746323|NCT00774306|7717358|FG000|Overall Study|Death|1
4746324|NCT00774306|7717359|FG001|Overall Study|Death|1
4746325|NCT00774306|7717360|FG002|Overall Study|Death|0
4746326|NCT00774306|7717361|FG003|Overall Study|Death|0
4746327|NCT00779038|7717384|FG000|Overall Study|Study Prematurely Terminated|13
4746328|NCT00776100|7717399|FG000|Overall Study|Disease Progression|1
4746329|NCT00776100|7717400|FG001|Overall Study|Disease Progression|0
4746330|NCT00771316|7717408|FG000|Overall Study|Adverse Event|0
4746331|NCT00771316|7717409|FG001|Overall Study|Adverse Event|1
4746332|NCT00771316|7717408|FG000|Overall Study|Patient withdrew consent|1
4746333|NCT00771316|7717409|FG001|Overall Study|Patient withdrew consent|0
4746334|NCT00771316|7717408|FG000|Overall Study|Discontinued due to early termination|1
4746335|NCT00771316|7717409|FG001|Overall Study|Discontinued due to early termination|0
4746336|NCT00768040|7717430|FG000|Overall Study|Adverse Event|3
4746337|NCT00768040|7717431|FG001|Overall Study|Adverse Event|2
4746338|NCT00768040|7717430|FG000|Overall Study|Abnormal laboratory value|1
4634544|NCT01925612|7505704|FG000|Overall Study|Adverse Event|3
4634545|NCT01925612|7505705|FG001|Overall Study|Adverse Event|3
4634546|NCT01925612|7505706|FG002|Overall Study|Adverse Event|0
4634547|NCT01925612|7505707|FG003|Overall Study|Adverse Event|1
4634548|NCT01925612|7505708|FG004|Overall Study|Adverse Event|2
4634549|NCT01925703|7505724|FG000|Overall Study|Physician Decision|1
4634550|NCT01925703|7505724|FG000|Overall Study|Lost to Follow-up|2
4634551|NCT01925703|7505724|FG000|Overall Study|Discharge prior to full iron repletion|1
4634552|NCT01925768|7505730|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
4634553|NCT01925768|7505731|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
4634554|NCT01925768|7505730|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
4525992|NCT01026974|7342168|FG002|Overall Study|Inappropriate enrollment|1
4594351|NCT01562275|7443625|FG009|Stage 1|Adverse Event|1
4594352|NCT01562275|7443626|FG010|Stage 1|Adverse Event|0
4594353|NCT01562275|7443627|FG011|Stage 1|Adverse Event|0
4525993|NCT01026974|7342169|FG003|Overall Study|Inappropriate enrollment|0
4525994|NCT01027273|7342199|FG000|Overall Study|Lost to Follow-up|57
4525995|NCT01027273|7342200|FG001|Overall Study|Lost to Follow-up|31
4525996|NCT01027273|7342199|FG000|Overall Study|Death|2
4525997|NCT01027273|7342200|FG001|Overall Study|Death|2
4525998|NCT01027286|7342208|FG000|Overall Study|Unable to Obtain Required Blood Volume|1
4525999|NCT01027286|7342209|FG001|Overall Study|Unable to Obtain Required Blood Volume|0
4526000|NCT01027286|7342208|FG000|Overall Study|Lost to Follow-up|0
4526001|NCT01027286|7342209|FG001|Overall Study|Lost to Follow-up|1
4526002|NCT01027351|7342221|FG000|Overall Study|Withdrawal by Subject|1
4526003|NCT01027351|7342222|FG001|Overall Study|Withdrawal by Subject|0
4526004|NCT01027351|7342223|FG002|Overall Study|Withdrawal by Subject|1
4526005|NCT01027351|7342224|FG003|Overall Study|Withdrawal by Subject|0
4526006|NCT01027351|7342225|FG004|Overall Study|Withdrawal by Subject|3
4526007|NCT01027351|7342226|FG005|Overall Study|Withdrawal by Subject|5
4526008|NCT01027351|7342221|FG000|Overall Study|Lost to Follow-up|1
4526009|NCT01027351|7342222|FG001|Overall Study|Lost to Follow-up|1
4526010|NCT01027351|7342223|FG002|Overall Study|Lost to Follow-up|0
4526011|NCT01027351|7342224|FG003|Overall Study|Lost to Follow-up|1
4526012|NCT01027351|7342225|FG004|Overall Study|Lost to Follow-up|6
4526013|NCT01027351|7342226|FG005|Overall Study|Lost to Follow-up|0
4526014|NCT01027351|7342221|FG000|Overall Study|Inappropriate enrollment|0
4526015|NCT01027351|7342222|FG001|Overall Study|Inappropriate enrollment|0
4526016|NCT01027351|7342223|FG002|Overall Study|Inappropriate enrollment|0
4526017|NCT01027351|7342224|FG003|Overall Study|Inappropriate enrollment|0
4526018|NCT01027351|7342225|FG004|Overall Study|Inappropriate enrollment|1
4526019|NCT01027351|7342226|FG005|Overall Study|Inappropriate enrollment|0
4526020|NCT01027351|7342221|FG000|Overall Study|Protocol Violation|1
4526021|NCT01027351|7342222|FG001|Overall Study|Protocol Violation|0
4526022|NCT01027351|7342223|FG002|Overall Study|Protocol Violation|0
4526023|NCT01027351|7342224|FG003|Overall Study|Protocol Violation|1
4526024|NCT01027351|7342225|FG004|Overall Study|Protocol Violation|1
4526025|NCT01027351|7342226|FG005|Overall Study|Protocol Violation|0
4526026|NCT01027364|7342251|FG000|Overall Study|Adverse Event|1
4526027|NCT01027364|7342252|FG001|Overall Study|Adverse Event|0
4526028|NCT01027364|7342253|FG002|Overall Study|Adverse Event|1
4526029|NCT01027364|7342254|FG003|Overall Study|Adverse Event|0
4526030|NCT01027364|7342251|FG000|Overall Study|Lost to Follow-up|1
4526031|NCT01027364|7342252|FG001|Overall Study|Lost to Follow-up|0
4526032|NCT01027364|7342253|FG002|Overall Study|Lost to Follow-up|0
4526033|NCT01027364|7342254|FG003|Overall Study|Lost to Follow-up|0
4526034|NCT01027364|7342251|FG000|Overall Study|Protocol Violation|1
4526035|NCT01027364|7342252|FG001|Overall Study|Protocol Violation|0
4526036|NCT01027364|7342253|FG002|Overall Study|Protocol Violation|0
4526037|NCT01027364|7342254|FG003|Overall Study|Protocol Violation|1
4526038|NCT01027364|7342251|FG000|Overall Study|Withdrawal by Subject|1
4526039|NCT01027364|7342252|FG001|Overall Study|Withdrawal by Subject|2
4526040|NCT01027364|7342253|FG002|Overall Study|Withdrawal by Subject|0
4526041|NCT01027364|7342254|FG003|Overall Study|Withdrawal by Subject|0
4526042|NCT01027416|7342282|FG000|Overall Study|Withdrawal by Subject|0
4526043|NCT01027416|7342283|FG001|Overall Study|Withdrawal by Subject|1
4526044|NCT01027416|7342282|FG000|Overall Study|Physician Decision|1
4526045|NCT01027416|7342283|FG001|Overall Study|Physician Decision|4
4526046|NCT01027650|7342324|FG000|Overall Study|Personal Reasons|0
4526047|NCT01027650|7342325|FG001|Overall Study|Personal Reasons|0
4526048|NCT01027650|7342326|FG002|Overall Study|Personal Reasons|0
4526049|NCT01027650|7342327|FG003|Overall Study|Personal Reasons|0
4526050|NCT01027650|7342328|FG004|Overall Study|Personal Reasons|2
4526051|NCT01027650|7342329|FG005|Overall Study|Personal Reasons|1
4526052|NCT01027650|7342330|FG006|Overall Study|Personal Reasons|0
4526053|NCT01027650|7342331|FG007|Overall Study|Personal Reasons|0
4526054|NCT01027650|7342324|FG000|Overall Study|Lost to Follow-up|0
4526055|NCT01027650|7342325|FG001|Overall Study|Lost to Follow-up|0
4526056|NCT01027650|7342326|FG002|Overall Study|Lost to Follow-up|0
4594354|NCT01562275|7443628|FG012|Stage 1|Adverse Event|0
4526057|NCT01027650|7342327|FG003|Overall Study|Lost to Follow-up|0
4526058|NCT01027650|7342328|FG004|Overall Study|Lost to Follow-up|0
4526059|NCT01027650|7342329|FG005|Overall Study|Lost to Follow-up|0
4526060|NCT01027650|7342330|FG006|Overall Study|Lost to Follow-up|1
4526061|NCT01027650|7342331|FG007|Overall Study|Lost to Follow-up|0
4526062|NCT01027650|7342324|FG000|Overall Study|Lack of Efficacy|0
4526063|NCT01027650|7342325|FG001|Overall Study|Lack of Efficacy|0
4526064|NCT01027650|7342326|FG002|Overall Study|Lack of Efficacy|0
4526065|NCT01027650|7342327|FG003|Overall Study|Lack of Efficacy|0
4526066|NCT01027650|7342328|FG004|Overall Study|Lack of Efficacy|0
4526067|NCT01027650|7342329|FG005|Overall Study|Lack of Efficacy|1
4526068|NCT01027650|7342330|FG006|Overall Study|Lack of Efficacy|0
4526069|NCT01027650|7342331|FG007|Overall Study|Lack of Efficacy|0
4526070|NCT01027754|7342351|FG000|Overall Study|withdrew/lost to follow-up after interve|2
4526071|NCT01027754|7342352|FG001|Overall Study|withdrew/lost to follow-up after interve|3
4526072|NCT01027754|7342351|FG000|Overall Study|Withdrawal by Subject|0
4526073|NCT01027754|7342352|FG001|Overall Study|Withdrawal by Subject|5
4526074|NCT01027845|7342397|FG000|Primary Vaccination Phase|Serious Adverse Event|2
4526075|NCT01027845|7342398|FG001|Primary Vaccination Phase|Serious Adverse Event|0
4526076|NCT01027845|7342399|FG002|Primary Vaccination Phase|Serious Adverse Event|0
4526077|NCT01027845|7342400|FG003|Primary Vaccination Phase|Serious Adverse Event|0
4526078|NCT01027845|7342397|FG000|Primary Vaccination Phase|Adverse Event|1
4526079|NCT01027845|7342398|FG001|Primary Vaccination Phase|Adverse Event|0
4526080|NCT01027845|7342399|FG002|Primary Vaccination Phase|Adverse Event|0
4526081|NCT01027845|7342400|FG003|Primary Vaccination Phase|Adverse Event|0
4526082|NCT01027845|7342397|FG000|Primary Vaccination Phase|Protocol Violation|1
4526083|NCT01027845|7342398|FG001|Primary Vaccination Phase|Protocol Violation|0
4526084|NCT01027845|7342399|FG002|Primary Vaccination Phase|Protocol Violation|0
4526085|NCT01027845|7342400|FG003|Primary Vaccination Phase|Protocol Violation|0
4526086|NCT01027845|7342397|FG000|Primary Vaccination Phase|Migrated/moved from study area|0
4526087|NCT01027845|7342398|FG001|Primary Vaccination Phase|Migrated/moved from study area|1
4526088|NCT01027845|7342399|FG002|Primary Vaccination Phase|Migrated/moved from study area|0
4526089|NCT01027845|7342400|FG003|Primary Vaccination Phase|Migrated/moved from study area|0
4526090|NCT01027845|7342397|FG000|Booster Vaccination Phase|Withdrawal by Subject|1
4526091|NCT01027845|7342398|FG001|Booster Vaccination Phase|Withdrawal by Subject|0
4526092|NCT01027845|7342399|FG002|Booster Vaccination Phase|Withdrawal by Subject|0
4526093|NCT01027845|7342400|FG003|Booster Vaccination Phase|Withdrawal by Subject|0
4526094|NCT01027845|7342397|FG000|Booster Vaccination Phase|Migrated/moved from study area|1
4526095|NCT01027845|7342398|FG001|Booster Vaccination Phase|Migrated/moved from study area|0
4526096|NCT01027845|7342399|FG002|Booster Vaccination Phase|Migrated/moved from study area|0
4526097|NCT01027845|7342400|FG003|Booster Vaccination Phase|Migrated/moved from study area|0
4526098|NCT01027871|7342412|FG000|Overall Study|Physician Decision|1
4526099|NCT01027871|7342413|FG001|Overall Study|Physician Decision|5
4526100|NCT01027871|7342414|FG002|Overall Study|Physician Decision|0
4526101|NCT01027871|7342412|FG000|Overall Study|Protocol Violation|0
4526102|NCT01027871|7342413|FG001|Overall Study|Protocol Violation|2
4526103|NCT01027871|7342414|FG002|Overall Study|Protocol Violation|2
4526104|NCT01027871|7342412|FG000|Overall Study|Withdrawal by Subject|1
4526105|NCT01027871|7342413|FG001|Overall Study|Withdrawal by Subject|2
4526106|NCT01027871|7342414|FG002|Overall Study|Withdrawal by Subject|2
4526107|NCT01027871|7342412|FG000|Overall Study|Adverse Event|0
4526108|NCT01027871|7342413|FG001|Overall Study|Adverse Event|2
4526109|NCT01027871|7342414|FG002|Overall Study|Adverse Event|2
4526110|NCT01027871|7342412|FG000|Overall Study|Sponsor Decision|0
4526111|NCT01027871|7342413|FG001|Overall Study|Sponsor Decision|2
4526112|NCT01027871|7342414|FG002|Overall Study|Sponsor Decision|0
4526113|NCT01027871|7342412|FG000|Overall Study|Discontinued Prior to Treatment|0
4526114|NCT01027871|7342413|FG001|Overall Study|Discontinued Prior to Treatment|0
4526115|NCT01027871|7342414|FG002|Overall Study|Discontinued Prior to Treatment|1
4526116|NCT01027884|7342429|FG000|Overall Study|Adverse Event|2
4526117|NCT01027884|7342430|FG001|Overall Study|Adverse Event|1
4526118|NCT01027884|7342429|FG000|Overall Study|Protocol Violation|1
4526119|NCT01027884|7342430|FG001|Overall Study|Protocol Violation|0
4526120|NCT01027884|7342429|FG000|Overall Study|Non-compliance|1
4526121|NCT01027884|7342430|FG001|Overall Study|Non-compliance|1
4526122|NCT01027884|7342429|FG000|Overall Study|Withdrawal by Subject|0
4526123|NCT01027884|7342430|FG001|Overall Study|Withdrawal by Subject|1
4526124|NCT01027884|7342429|FG000|Overall Study|Lost to Follow-up|0
4526125|NCT01027884|7342430|FG001|Overall Study|Lost to Follow-up|1
4526126|NCT01027884|7342429|FG000|Overall Study|Spinal fixation surgery|0
4526127|NCT01027884|7342430|FG001|Overall Study|Spinal fixation surgery|3
4526128|NCT01027897|7342438|FG000|Overall Study|Protocol Violation|1
4526129|NCT01027897|7342438|FG000|Overall Study|Withdrawal by Subject|1
4594355|NCT01562275|7443616|FG000|Stage 1|Death|1
4594356|NCT01562275|7443617|FG001|Stage 1|Death|0
4594357|NCT01562275|7443618|FG002|Stage 1|Death|0
4594358|NCT01562275|7443619|FG003|Stage 1|Death|0
4594359|NCT01562275|7443620|FG004|Stage 1|Death|0
4594360|NCT01562275|7443621|FG005|Stage 1|Death|0
4594361|NCT01562275|7443622|FG006|Stage 1|Death|0
4594362|NCT01562275|7443623|FG007|Stage 1|Death|0
4594363|NCT01562275|7443624|FG008|Stage 1|Death|0
4594364|NCT01562275|7443625|FG009|Stage 1|Death|0
4594365|NCT01562275|7443626|FG010|Stage 1|Death|0
4594366|NCT01562275|7443627|FG011|Stage 1|Death|0
4594367|NCT01562275|7443628|FG012|Stage 1|Death|0
4594368|NCT01562275|7443616|FG000|Stage 1|Non Compliance|0
4594369|NCT01562275|7443617|FG001|Stage 1|Non Compliance|0
4594370|NCT01562275|7443618|FG002|Stage 1|Non Compliance|1
4594371|NCT01562275|7443619|FG003|Stage 1|Non Compliance|0
4594372|NCT01562275|7443620|FG004|Stage 1|Non Compliance|0
4594373|NCT01562275|7443621|FG005|Stage 1|Non Compliance|0
4594374|NCT01562275|7443622|FG006|Stage 1|Non Compliance|0
4594375|NCT01562275|7443623|FG007|Stage 1|Non Compliance|0
4594376|NCT01562275|7443624|FG008|Stage 1|Non Compliance|0
4594377|NCT01562275|7443625|FG009|Stage 1|Non Compliance|0
4594378|NCT01562275|7443626|FG010|Stage 1|Non Compliance|0
4594379|NCT01562275|7443627|FG011|Stage 1|Non Compliance|0
4594380|NCT01562275|7443628|FG012|Stage 1|Non Compliance|0
4594381|NCT01562275|7443616|FG000|Stage 1|Physician Decision|0
4594382|NCT01562275|7443617|FG001|Stage 1|Physician Decision|0
4594383|NCT01562275|7443618|FG002|Stage 1|Physician Decision|0
4594384|NCT01562275|7443619|FG003|Stage 1|Physician Decision|0
4594385|NCT01562275|7443620|FG004|Stage 1|Physician Decision|1
4594386|NCT01562275|7443621|FG005|Stage 1|Physician Decision|0
4594387|NCT01562275|7443622|FG006|Stage 1|Physician Decision|1
4594388|NCT01562275|7443623|FG007|Stage 1|Physician Decision|0
4594389|NCT01562275|7443624|FG008|Stage 1|Physician Decision|1
4594390|NCT01562275|7443625|FG009|Stage 1|Physician Decision|0
4594391|NCT01562275|7443626|FG010|Stage 1|Physician Decision|0
4594392|NCT01562275|7443627|FG011|Stage 1|Physician Decision|0
4594393|NCT01562275|7443628|FG012|Stage 1|Physician Decision|0
4594394|NCT01562275|7443616|FG000|Stage 1|Progression of Disease|2
4526130|NCT01027949|7342453|FG000|Overall Study|Death|174
4526131|NCT01027949|7342453|FG000|Overall Study|Progressive Disease|163
4526132|NCT01027949|7342453|FG000|Overall Study|Adverse Event|172
4526133|NCT01027949|7342453|FG000|Overall Study|Withdrawal by Subject|113
4526134|NCT01027949|7342453|FG000|Overall Study|Lost to Follow-up|17
4526135|NCT01027949|7342453|FG000|Overall Study|Protocol Violation|13
4526136|NCT01027949|7342453|FG000|Overall Study|PI Decision|8
4526137|NCT01027949|7342453|FG000|Overall Study|Limited Study Drug Effectiveness|7
4526138|NCT01027949|7342453|FG000|Overall Study|Non-compliance with Study Procedures|7
4526139|NCT01027949|7342453|FG000|Overall Study|Lung Transplant|5
4526140|NCT01027949|7342453|FG000|Overall Study|Unable to Tolerate Study Drug|2
4526141|NCT01027949|7342453|FG000|Overall Study|Use of Excluded Medication|2
4526142|NCT01027949|7342453|FG000|Overall Study|Patient Self-discontinuation|1
4526143|NCT01027949|7342453|FG000|Overall Study|Pregnancy|1
4526144|NCT01027949|7342453|FG000|Overall Study|Surgery|1
4526145|NCT01028014|7342463|FG000|Overall Study|Lost to Follow-up|1
4526146|NCT01028014|7342464|FG001|Overall Study|Lost to Follow-up|2
4526147|NCT01028014|7342465|FG002|Overall Study|Lost to Follow-up|0
4526148|NCT01028014|7342466|FG003|Overall Study|Lost to Follow-up|1
4526149|NCT01028014|7342467|FG004|Overall Study|Lost to Follow-up|1
4526150|NCT01028014|7342468|FG005|Overall Study|Lost to Follow-up|2
4526151|NCT01028027|7342484|FG000|Overall Study|Lost to Follow-up|4
4526152|NCT01028027|7342485|FG001|Overall Study|Lost to Follow-up|1
4526153|NCT01028027|7342484|FG000|Overall Study|Withdrawal by Subject|5
4526154|NCT01028027|7342485|FG001|Overall Study|Withdrawal by Subject|3
4526155|NCT01028027|7342484|FG000|Overall Study|Adverse Event|4
4526156|NCT01028027|7342485|FG001|Overall Study|Adverse Event|7
4526157|NCT01028027|7342484|FG000|Overall Study|Protocol Violation|3
4526158|NCT01028027|7342485|FG001|Overall Study|Protocol Violation|1
4526159|NCT01028027|7342484|FG000|Overall Study|Lack of Efficacy|0
4526160|NCT01028027|7342485|FG001|Overall Study|Lack of Efficacy|1
4526161|NCT01028053|7342491|FG000|Overall Study|Screen Failure|113
4526162|NCT01028053|7342491|FG000|Overall Study|Patient Request|11
4526163|NCT01028053|7342491|FG000|Overall Study|Protocol Violation|1
4526164|NCT01028053|7342491|FG000|Overall Study|Physician Decision|2
4526165|NCT01028053|7342491|FG000|Overall Study|Technical Problem|1
4526166|NCT01028053|7342491|FG000|Overall Study|Terminated by Sponsor|1
4526167|NCT01028053|7342491|FG000|Overall Study|Various reasons|4
4526168|NCT01028222|7342516|FG000|Overall Study|Protocol deviation|1
4526169|NCT01028222|7342517|FG001|Overall Study|Protocol deviation|0
4526170|NCT01028222|7342516|FG000|Overall Study|Disease progression|33
4526171|NCT01028222|7342517|FG001|Overall Study|Disease progression|9
4526172|NCT01028222|7342516|FG000|Overall Study|Administrative problems|1
4526173|NCT01028222|7342517|FG001|Overall Study|Administrative problems|1
4526174|NCT01028222|7342516|FG000|Overall Study|Lost to Follow-up|0
4526175|NCT01028222|7342517|FG001|Overall Study|Lost to Follow-up|1
4526176|NCT01028222|7342516|FG000|Overall Study|Withdrawal by Subject|1
4526177|NCT01028222|7342517|FG001|Overall Study|Withdrawal by Subject|0
4526178|NCT01028222|7342516|FG000|Overall Study|Crossover to nilotinib w/out progression|0
4526179|NCT01028222|7342517|FG001|Overall Study|Crossover to nilotinib w/out progression|2
4526180|NCT01028222|7342516|FG000|Overall Study|Adverse Event|2
4526181|NCT01028222|7342517|FG001|Overall Study|Adverse Event|0
4526182|NCT01028352|7342524|FG000|Overall Study|Ineligible due to baseline average pain|5
4526183|NCT01028352|7342524|FG000|Overall Study|Withdrawal by Subject|1
4526184|NCT01028378|7342528|FG000|Overall Study|Lost to Follow-up|12
4526185|NCT01028378|7342528|FG000|Overall Study|Withdrawal by Subject|1
4526186|NCT01028378|7342528|FG000|Overall Study|Adminstrative Reasons|4
4526187|NCT01028391|7342534|FG000|Overall Study|Adverse Event|4
4526188|NCT01028391|7342535|FG001|Overall Study|Adverse Event|0
4526189|NCT01028391|7342534|FG000|Overall Study|Lack of Efficacy|0
4526190|NCT01028391|7342535|FG001|Overall Study|Lack of Efficacy|2
4526191|NCT01028391|7342534|FG000|Overall Study|Lost to Follow-up|3
4526192|NCT01028391|7342535|FG001|Overall Study|Lost to Follow-up|4
4526193|NCT01028391|7342534|FG000|Overall Study|Physician Decision|0
4526194|NCT01028391|7342535|FG001|Overall Study|Physician Decision|1
4526195|NCT01028391|7342534|FG000|Overall Study|Withdrawal by Subject|6
4526196|NCT01028391|7342535|FG001|Overall Study|Withdrawal by Subject|3
4526197|NCT01028391|7342534|FG000|Overall Study|Needed excluded medication|1
4526198|NCT01028391|7342535|FG001|Overall Study|Needed excluded medication|1
4526199|NCT01028560|7342543|FG000|Overall Study|Lack of Efficacy|3
4526200|NCT01028560|7342544|FG001|Overall Study|Lack of Efficacy|6
4526201|NCT01028560|7342543|FG000|Overall Study|Withdrawal by Subject|7
4526202|NCT01028560|7342544|FG001|Overall Study|Withdrawal by Subject|12
4526203|NCT01028651|7342551|FG000|Overall Study|Death|2
4526204|NCT01028651|7342551|FG000|Overall Study|Adverse Event|1
4526205|NCT01029262|7342592|FG000|Overall Study|Adverse Event|9
4526206|NCT01029262|7342593|FG001|Overall Study|Adverse Event|52
4526207|NCT01029262|7342592|FG000|Overall Study|Lack of therapeutic effect|57
4526208|NCT01029262|7342593|FG001|Overall Study|Lack of therapeutic effect|76
4526209|NCT01029262|7342592|FG000|Overall Study|Withdrawal by Subject|10
4526210|NCT01029262|7342593|FG001|Overall Study|Withdrawal by Subject|17
4526211|NCT01029262|7342592|FG000|Overall Study|Protocol Violation|2
4526212|NCT01029262|7342593|FG001|Overall Study|Protocol Violation|3
4526213|NCT01029262|7342592|FG000|Overall Study|Miscellaneous|1
4526214|NCT01029262|7342593|FG001|Overall Study|Miscellaneous|9
4526215|NCT01029262|7342592|FG000|Overall Study|Death|0
4526216|NCT01029262|7342593|FG001|Overall Study|Death|3
4526217|NCT01029340|7342609|FG000|Part B Treatment Period|Withdrawal by Subject|0
4526218|NCT01029340|7342610|FG001|Part B Treatment Period|Withdrawal by Subject|0
4526219|NCT01029340|7342611|FG002|Part B Treatment Period|Withdrawal by Subject|1
4526220|NCT01029340|7342612|FG003|Part B Treatment Period|Withdrawal by Subject|0
4526221|NCT01029340|7342613|FG004|Part B Treatment Period|Withdrawal by Subject|0
4526222|NCT01029340|7342614|FG005|Part B Treatment Period|Withdrawal by Subject|0
4526223|NCT01029340|7342609|FG000|Part B Treatment Period|Protocol Violation|0
4526224|NCT01029340|7342610|FG001|Part B Treatment Period|Protocol Violation|0
4526225|NCT01029340|7342611|FG002|Part B Treatment Period|Protocol Violation|1
4526226|NCT01029340|7342612|FG003|Part B Treatment Period|Protocol Violation|0
4526227|NCT01029340|7342613|FG004|Part B Treatment Period|Protocol Violation|0
4526228|NCT01029340|7342614|FG005|Part B Treatment Period|Protocol Violation|0
4526229|NCT01029340|7342609|FG000|Extension Period|Adverse Event|0
4526230|NCT01029340|7342610|FG001|Extension Period|Adverse Event|0
4526231|NCT01029340|7342611|FG002|Extension Period|Adverse Event|0
4526232|NCT01029340|7342612|FG003|Extension Period|Adverse Event|0
4526233|NCT01029340|7342613|FG004|Extension Period|Adverse Event|0
4526234|NCT01029340|7342614|FG005|Extension Period|Adverse Event|1
4526235|NCT01029340|7342609|FG000|Extension Period|starting another study|0
4526236|NCT01029340|7342610|FG001|Extension Period|starting another study|0
4526237|NCT01029340|7342611|FG002|Extension Period|starting another study|0
4526238|NCT01029340|7342612|FG003|Extension Period|starting another study|0
4526239|NCT01029340|7342613|FG004|Extension Period|starting another study|0
4526240|NCT01029340|7342614|FG005|Extension Period|starting another study|8
4526241|NCT01029340|7342609|FG000|Extension Period|non-compliance|0
4526242|NCT01029340|7342610|FG001|Extension Period|non-compliance|0
4526243|NCT01029340|7342611|FG002|Extension Period|non-compliance|0
4526244|NCT01029340|7342612|FG003|Extension Period|non-compliance|0
4526245|NCT01029340|7342613|FG004|Extension Period|non-compliance|0
4526246|NCT01029340|7342614|FG005|Extension Period|non-compliance|1
4526247|NCT01029340|7342609|FG000|Extension Period|Withdrawal by Subject|0
4526248|NCT01029340|7342610|FG001|Extension Period|Withdrawal by Subject|0
4526249|NCT01029340|7342611|FG002|Extension Period|Withdrawal by Subject|0
4526250|NCT01029340|7342612|FG003|Extension Period|Withdrawal by Subject|0
4526251|NCT01029340|7342613|FG004|Extension Period|Withdrawal by Subject|0
4526252|NCT01029340|7342614|FG005|Extension Period|Withdrawal by Subject|1
4526253|NCT01029340|7342609|FG000|Extension Period|Physician Decision|0
4526254|NCT01029340|7342610|FG001|Extension Period|Physician Decision|0
4526255|NCT01029340|7342611|FG002|Extension Period|Physician Decision|0
4526256|NCT01029340|7342612|FG003|Extension Period|Physician Decision|0
4526257|NCT01029340|7342613|FG004|Extension Period|Physician Decision|0
4526258|NCT01029340|7342614|FG005|Extension Period|Physician Decision|1
4526259|NCT01029353|7342631|FG000|Overall Study|Lost to Follow-up|4
4526260|NCT01029353|7342632|FG001|Overall Study|Lost to Follow-up|5
4526261|NCT01029353|7342633|FG002|Overall Study|Lost to Follow-up|5
4526262|NCT01029353|7342634|FG003|Overall Study|Lost to Follow-up|4
4526263|NCT01029353|7342631|FG000|Overall Study|Consent Withdrawn|2
4526264|NCT01029353|7342632|FG001|Overall Study|Consent Withdrawn|0
4526265|NCT01029353|7342633|FG002|Overall Study|Consent Withdrawn|0
4526266|NCT01029353|7342634|FG003|Overall Study|Consent Withdrawn|0
4526267|NCT01029353|7342631|FG000|Overall Study|Primary Outcome Indeterminate|1
4526268|NCT01029353|7342632|FG001|Overall Study|Primary Outcome Indeterminate|3
4526269|NCT01029353|7342633|FG002|Overall Study|Primary Outcome Indeterminate|2
4526270|NCT01029353|7342634|FG003|Overall Study|Primary Outcome Indeterminate|0
4526271|NCT01029366|7342646|FG000|Overall Study|Withdrawal by Subject|1
4526272|NCT01029366|7342647|FG001|Overall Study|Withdrawal by Subject|0
4526273|NCT01029366|7342646|FG000|Overall Study|Death|1
4526274|NCT01029366|7342647|FG001|Overall Study|Death|1
4526275|NCT01029366|7342646|FG000|Overall Study|disease progression|2
4526276|NCT01029366|7342647|FG001|Overall Study|disease progression|0
4526277|NCT01029366|7342646|FG000|Overall Study|manufacturing failure|0
4526278|NCT01029366|7342647|FG001|Overall Study|manufacturing failure|1
4526279|NCT01029392|7342656|FG000|Overall Study|Withdrawal by Subject|18
4526280|NCT01029392|7342657|FG001|Overall Study|Withdrawal by Subject|11
4526281|NCT01029392|7342656|FG000|Overall Study|Physician Decision|2
4526282|NCT01029392|7342657|FG001|Overall Study|Physician Decision|0
4526283|NCT01029405|7342669|FG000|Overall Study|Withdrawal by Subject|0
4526284|NCT01029405|7342670|FG001|Overall Study|Withdrawal by Subject|1
4526285|NCT01029405|7342671|FG002|Overall Study|Withdrawal by Subject|2
4526286|NCT01029405|7342672|FG003|Overall Study|Withdrawal by Subject|0
4526287|NCT01029405|7342669|FG000|Overall Study|Protocol Violation|0
4526288|NCT01029405|7342670|FG001|Overall Study|Protocol Violation|0
4526289|NCT01029405|7342671|FG002|Overall Study|Protocol Violation|0
4526290|NCT01029405|7342672|FG003|Overall Study|Protocol Violation|1
4526291|NCT01029405|7342669|FG000|Overall Study|Adverse Event|0
4526292|NCT01029405|7342670|FG001|Overall Study|Adverse Event|0
4526293|NCT01029405|7342671|FG002|Overall Study|Adverse Event|1
4526294|NCT01029405|7342672|FG003|Overall Study|Adverse Event|1
4526295|NCT01029405|7342669|FG000|Overall Study|Lost to Follow-up|2
4526296|NCT01029405|7342670|FG001|Overall Study|Lost to Follow-up|1
4526297|NCT01029405|7342671|FG002|Overall Study|Lost to Follow-up|1
4526298|NCT01029405|7342672|FG003|Overall Study|Lost to Follow-up|2
4526299|NCT01029405|7342669|FG000|Overall Study|Other|0
4526300|NCT01029405|7342670|FG001|Overall Study|Other|1
4526301|NCT01029405|7342671|FG002|Overall Study|Other|0
4526302|NCT01029405|7342672|FG003|Overall Study|Other|1
4526303|NCT01029535|7342682|FG000|Overall Study|Lost to Follow-up|24
4526304|NCT01029535|7342682|FG000|Overall Study|Protocol Violation|2
4526305|NCT01029535|7342682|FG000|Overall Study|Participant Withdrew Consent|2
4526306|NCT01029535|7342682|FG000|Overall Study|Adverse Event|1
4526307|NCT01029535|7342682|FG000|Overall Study|Use of Another Treatment|1
4526308|NCT01029535|7342682|FG000|Overall Study|Death|1
4526309|NCT01029652|7342693|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0
4526310|NCT01029652|7342694|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4
4526311|NCT01029652|7342693|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1
4526312|NCT01029652|7342694|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3
4526313|NCT01029652|7342693|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3
4526314|NCT01029652|7342694|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1
4526315|NCT01029652|7342693|FG000|Core Study (0-12 Weeks)|Administrative problems|2
4526316|NCT01029652|7342694|FG001|Core Study (0-12 Weeks)|Administrative problems|1
4526317|NCT01029652|7342693|FG000|Core Study (0-12 Weeks)|Death|0
4526318|NCT01029652|7342694|FG001|Core Study (0-12 Weeks)|Death|1
4526319|NCT01029652|7342693|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0
4526320|NCT01029652|7342694|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1
4526321|NCT01029652|7342693|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2
4526322|NCT01029652|7342694|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3
4526323|NCT01029652|7342693|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1
4526324|NCT01029652|7342694|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0
4526325|NCT01029652|7342693|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0
4526326|NCT01029652|7342694|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1
4526327|NCT01029652|7342693|FG000|Extension Study 2 (25-72 Weeks)|Death|1
4526328|NCT01029652|7342694|FG001|Extension Study 2 (25-72 Weeks)|Death|1
4526329|NCT01029652|7342693|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0
4526330|NCT01029652|7342694|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1
4526331|NCT01029652|7342693|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0
4526332|NCT01029652|7342694|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1
4526333|NCT01029691|7342721|FG000|Continued APAP to Delivery|Death|0
4526334|NCT01029691|7342722|FG001|Continued APAP to Delivery|Death|0
4526335|NCT01029691|7342723|FG002|Continued APAP to Delivery|Death|1
4526336|NCT01029704|7342741|FG000|Overall Study|Adverse Event|0
4526337|NCT01029704|7342742|FG001|Overall Study|Adverse Event|0
4526338|NCT01029704|7342743|FG002|Overall Study|Adverse Event|0
4526339|NCT01029704|7342744|FG003|Overall Study|Adverse Event|0
4526340|NCT01029704|7342745|FG004|Overall Study|Adverse Event|0
4526341|NCT01029704|7342746|FG005|Overall Study|Adverse Event|0
4526342|NCT01029704|7342747|FG006|Overall Study|Adverse Event|1
4526343|NCT01029704|7342748|FG007|Overall Study|Adverse Event|1
4526344|NCT01029704|7342749|FG008|Overall Study|Adverse Event|0
4526345|NCT01029704|7342741|FG000|Overall Study|Withdrawal by Subject|0
4526346|NCT01029704|7342742|FG001|Overall Study|Withdrawal by Subject|0
4526347|NCT01029704|7342743|FG002|Overall Study|Withdrawal by Subject|0
4526348|NCT01029704|7342744|FG003|Overall Study|Withdrawal by Subject|0
4526349|NCT01029704|7342745|FG004|Overall Study|Withdrawal by Subject|2
4526350|NCT01029704|7342746|FG005|Overall Study|Withdrawal by Subject|1
4526351|NCT01029704|7342747|FG006|Overall Study|Withdrawal by Subject|1
4526352|NCT01029704|7342748|FG007|Overall Study|Withdrawal by Subject|1
4526353|NCT01029704|7342749|FG008|Overall Study|Withdrawal by Subject|0
4526354|NCT01029704|7342741|FG000|Overall Study|Lost to Follow-up|0
4526355|NCT01029704|7342742|FG001|Overall Study|Lost to Follow-up|0
4526356|NCT01029704|7342743|FG002|Overall Study|Lost to Follow-up|0
4526357|NCT01029704|7342744|FG003|Overall Study|Lost to Follow-up|0
4526358|NCT01029704|7342745|FG004|Overall Study|Lost to Follow-up|0
4526359|NCT01029704|7342746|FG005|Overall Study|Lost to Follow-up|0
4526360|NCT01029704|7342747|FG006|Overall Study|Lost to Follow-up|1
4526361|NCT01029704|7342748|FG007|Overall Study|Lost to Follow-up|1
4526362|NCT01029704|7342749|FG008|Overall Study|Lost to Follow-up|1
4526363|NCT01029704|7342741|FG000|Overall Study|Lack of Efficacy|0
4526364|NCT01029704|7342742|FG001|Overall Study|Lack of Efficacy|0
4526365|NCT01029704|7342743|FG002|Overall Study|Lack of Efficacy|0
4526366|NCT01029704|7342744|FG003|Overall Study|Lack of Efficacy|0
4526367|NCT01029704|7342745|FG004|Overall Study|Lack of Efficacy|2
4526368|NCT01029704|7342746|FG005|Overall Study|Lack of Efficacy|3
4526369|NCT01029704|7342747|FG006|Overall Study|Lack of Efficacy|1
4526370|NCT01029704|7342748|FG007|Overall Study|Lack of Efficacy|2
4526371|NCT01029704|7342749|FG008|Overall Study|Lack of Efficacy|0
4526372|NCT01029704|7342741|FG000|Overall Study|Withdrawn due to major protocol violation|0
4526373|NCT01029704|7342742|FG001|Overall Study|Withdrawn due to major protocol violation|0
4526374|NCT01029704|7342743|FG002|Overall Study|Withdrawn due to major protocol violation|0
4526375|NCT01029704|7342744|FG003|Overall Study|Withdrawn due to major protocol violation|0
4526376|NCT01029704|7342745|FG004|Overall Study|Withdrawn due to major protocol violation|1
4526377|NCT01029704|7342746|FG005|Overall Study|Withdrawn due to major protocol violation|0
4526378|NCT01029704|7342747|FG006|Overall Study|Withdrawn due to major protocol violation|0
4526379|NCT01029704|7342748|FG007|Overall Study|Withdrawn due to major protocol violation|1
4526380|NCT01029704|7342749|FG008|Overall Study|Withdrawn due to major protocol violation|0
4526381|NCT01029782|7342775|FG000|Overall Study|Lost to Follow-up|2
4526382|NCT01029782|7342776|FG001|Overall Study|Lost to Follow-up|2
4526383|NCT01029782|7342775|FG000|Overall Study|Diagnosis changed|1
4526384|NCT01029782|7342776|FG001|Overall Study|Diagnosis changed|1
4526385|NCT01029782|7342775|FG000|Overall Study|Adverse Event|0
4526386|NCT01029782|7342776|FG001|Overall Study|Adverse Event|1
4526387|NCT01029782|7342775|FG000|Overall Study|Physician Decision|0
4526388|NCT01029782|7342776|FG001|Overall Study|Physician Decision|1
4526389|NCT01029782|7342775|FG000|Overall Study|Protocol Violation|0
4526390|NCT01029782|7342776|FG001|Overall Study|Protocol Violation|2
4526391|NCT01029782|7342775|FG000|Overall Study|Withdrawal by Subject|0
4526392|NCT01029782|7342776|FG001|Overall Study|Withdrawal by Subject|1
4526393|NCT01029795|7342784|FG000|Overall Study|Entry Criteria Not Met|2
4526394|NCT01029795|7342785|FG001|Overall Study|Entry Criteria Not Met|1
4526395|NCT01029795|7342784|FG000|Overall Study|Physician Decision|2
4526396|NCT01029795|7342785|FG001|Overall Study|Physician Decision|1
4526397|NCT01029795|7342784|FG000|Overall Study|Sponsor Decision|11
4526398|NCT01029795|7342785|FG001|Overall Study|Sponsor Decision|17
4526399|NCT01029795|7342784|FG000|Overall Study|Withdrawal by Subject|1
4526400|NCT01029795|7342785|FG001|Overall Study|Withdrawal by Subject|3
4526401|NCT01029886|7342793|FG000|Overall Study|Adverse Event|12
4526402|NCT01029886|7342794|FG001|Overall Study|Adverse Event|25
4526403|NCT01029886|7342793|FG000|Overall Study|Lost to Follow-up|1
4526404|NCT01029886|7342794|FG001|Overall Study|Lost to Follow-up|0
4526405|NCT01029886|7342793|FG000|Overall Study|Physician Decision|2
4526406|NCT01029886|7342794|FG001|Overall Study|Physician Decision|6
4526407|NCT01029886|7342793|FG000|Overall Study|Protocol Violation|17
4526408|NCT01029886|7342794|FG001|Overall Study|Protocol Violation|5
4526409|NCT01029886|7342793|FG000|Overall Study|Withdrawal by Subject|8
4526410|NCT01029886|7342794|FG001|Overall Study|Withdrawal by Subject|18
4526411|NCT01029886|7342793|FG000|Overall Study|Entry Criteria Not Met|13
4526412|NCT01029886|7342794|FG001|Overall Study|Entry Criteria Not Met|5
4526413|NCT01029886|7342793|FG000|Overall Study|Sponsor Decision|1
4526414|NCT01029886|7342794|FG001|Overall Study|Sponsor Decision|0
4526415|NCT01029886|7342793|FG000|Overall Study|Loss Glucose Control|7
4526416|NCT01029886|7342794|FG001|Overall Study|Loss Glucose Control|1
4526417|NCT01029925|7342813|FG000|Completion of Cycle 1 (28 Days)|Death|2
4526418|NCT01029925|7342813|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2
4526419|NCT01029925|7342813|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1
4526420|NCT01030133|7342819|FG000|Overall Study|failed to experience pain at level 7/10|2
4526421|NCT01030133|7342820|FG001|Overall Study|failed to experience pain at level 7/10|2
4526422|NCT01030458|7342861|FG000|Overall Study|Lost to Follow-up|9
4526423|NCT01030458|7342862|FG001|Overall Study|Lost to Follow-up|10
4526424|NCT01030458|7342861|FG000|Overall Study|Withdrawal by Subject|2
4526425|NCT01030458|7342862|FG001|Overall Study|Withdrawal by Subject|3
4526426|NCT01030458|7342861|FG000|Overall Study|Logistical reasons|9
4526427|NCT01030458|7342862|FG001|Overall Study|Logistical reasons|5
4526428|NCT01030458|7342861|FG000|Overall Study|Moved or changed job|6
4526429|NCT01030458|7342862|FG001|Overall Study|Moved or changed job|13
4526430|NCT01030458|7342861|FG000|Overall Study|Side effect of medication|1
4526431|NCT01030458|7342862|FG001|Overall Study|Side effect of medication|1
4526432|NCT01030523|7342870|FG000|Overall Study|Death|1
4526433|NCT01030523|7342871|FG001|Overall Study|Death|0
4526434|NCT01030523|7342870|FG000|Overall Study|Lost to Follow-up|4
4526435|NCT01030523|7342871|FG001|Overall Study|Lost to Follow-up|4
4526436|NCT01030523|7342870|FG000|Overall Study|Implant failure|1
4526437|NCT01030523|7342871|FG001|Overall Study|Implant failure|0
4526438|NCT01030523|7342870|FG000|Overall Study|Withdrawal by Subject|0
4526439|NCT01030523|7342871|FG001|Overall Study|Withdrawal by Subject|1
4526440|NCT01030536|7342882|FG000|Overall Study|Withdrawal by Subject|0
4526441|NCT01030536|7342883|FG001|Overall Study|Withdrawal by Subject|0
4526442|NCT01030536|7342884|FG002|Overall Study|Withdrawal by Subject|1
4526443|NCT01030536|7342885|FG003|Overall Study|Withdrawal by Subject|0
4526444|NCT01030536|7342886|FG004|Overall Study|Withdrawal by Subject|0
4526445|NCT01030536|7342882|FG000|Overall Study|undefined|1
4526446|NCT01030536|7342883|FG001|Overall Study|undefined|0
4526447|NCT01030536|7342884|FG002|Overall Study|undefined|1
4526448|NCT01030536|7342885|FG003|Overall Study|undefined|1
4526449|NCT01030536|7342886|FG004|Overall Study|undefined|0
4526450|NCT01030536|7342882|FG000|Overall Study|Adverse Event|0
4526451|NCT01030536|7342883|FG001|Overall Study|Adverse Event|3
4526452|NCT01030536|7342884|FG002|Overall Study|Adverse Event|1
4526453|NCT01030536|7342885|FG003|Overall Study|Adverse Event|0
4526454|NCT01030536|7342886|FG004|Overall Study|Adverse Event|1
4526455|NCT01030536|7342882|FG000|Overall Study|Progressive disease|6
4526456|NCT01030536|7342883|FG001|Overall Study|Progressive disease|2
4526457|NCT01030536|7342884|FG002|Overall Study|Progressive disease|3
4526458|NCT01030536|7342885|FG003|Overall Study|Progressive disease|2
4526459|NCT01030536|7342886|FG004|Overall Study|Progressive disease|0
4526460|NCT01030536|7342882|FG000|Overall Study|Death|0
4526461|NCT01030536|7342883|FG001|Overall Study|Death|1
4526462|NCT01030536|7342884|FG002|Overall Study|Death|0
4526463|NCT01030536|7342885|FG003|Overall Study|Death|0
4526464|NCT01030536|7342886|FG004|Overall Study|Death|0
4526465|NCT01030666|7342914|FG000|Overall Study|Lost to Follow-up|3
4526466|NCT01030666|7342915|FG001|Overall Study|Lost to Follow-up|2
4526467|NCT01030718|7342925|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1
4526468|NCT01030718|7342926|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1
4526469|NCT01030718|7342927|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11
4526470|NCT01030718|7342925|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3
4526471|NCT01030718|7342926|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5
4526472|NCT01030718|7342927|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1
4526473|NCT01030718|7342925|FG000|Studies CA180-031 and -036 Combined|Death|0
4526474|NCT01030718|7342926|FG001|Studies CA180-031 and -036 Combined|Death|1
4526475|NCT01030718|7342927|FG002|Studies CA180-031 and -036 Combined|Death|0
4526476|NCT01030718|7342925|FG000|Studies CA180-031 and -036 Combined|other reasons|0
4526477|NCT01030718|7342926|FG001|Studies CA180-031 and -036 Combined|other reasons|2
4526478|NCT01030718|7342927|FG002|Studies CA180-031 and -036 Combined|other reasons|0
4526479|NCT01030718|7342925|FG000|Study CA180-036 Only|insufficient effect|1
4526480|NCT01030718|7342926|FG001|Study CA180-036 Only|insufficient effect|1
4526481|NCT01030718|7342927|FG002|Study CA180-036 Only|insufficient effect|5
4526482|NCT01030718|7342925|FG000|Study CA180-036 Only|Adverse Event|2
4526483|NCT01030718|7342926|FG001|Study CA180-036 Only|Adverse Event|3
4526484|NCT01030718|7342927|FG002|Study CA180-036 Only|Adverse Event|0
4526485|NCT01030718|7342925|FG000|Study CA180-036 Only|Death|0
4526486|NCT01030718|7342926|FG001|Study CA180-036 Only|Death|1
4526487|NCT01030718|7342927|FG002|Study CA180-036 Only|Death|0
4526488|NCT01030718|7342925|FG000|Study CA180-036 Only|Other Reasons|0
4526489|NCT01030718|7342926|FG001|Study CA180-036 Only|Other Reasons|2
4526490|NCT01030718|7342927|FG002|Study CA180-036 Only|Other Reasons|0
4526491|NCT01030822|7342957|FG000|Overall Study|Moved/migrated from study area|6
4526492|NCT01030822|7342958|FG001|Overall Study|Moved/migrated from study area|7
4526493|NCT01030822|7342959|FG002|Overall Study|Moved/migrated from study area|3
4526494|NCT01030822|7342957|FG000|Overall Study|Withdrawal by Subject|16
4526495|NCT01030822|7342958|FG001|Overall Study|Withdrawal by Subject|13
4526496|NCT01030822|7342959|FG002|Overall Study|Withdrawal by Subject|16
4526497|NCT01030822|7342957|FG000|Overall Study|Lost to Follow-up|9
4526498|NCT01030822|7342958|FG001|Overall Study|Lost to Follow-up|4
4526499|NCT01030822|7342959|FG002|Overall Study|Lost to Follow-up|7
4526500|NCT01030874|7342979|FG000|Overall Study|Withdrawal by Subject|1
4526501|NCT01030874|7342980|FG001|Overall Study|Withdrawal by Subject|0
4526502|NCT01030874|7342979|FG000|Overall Study|Discharged in first 2 weeks|17
4526503|NCT01030874|7342980|FG001|Overall Study|Discharged in first 2 weeks|16
4526504|NCT01030952|7342988|FG000|Overall Study|Protocol Violation|0
4526505|NCT01030952|7342989|FG001|Overall Study|Protocol Violation|1
4526506|NCT01030952|7342988|FG000|Overall Study|Informed consent withdrawal|1
4526507|NCT01030952|7342989|FG001|Overall Study|Informed consent withdrawal|0
4526508|NCT01030952|7342988|FG000|Overall Study|Lost to Follow-up|0
4526509|NCT01030952|7342989|FG001|Overall Study|Lost to Follow-up|1
4526510|NCT01030952|7342988|FG000|Overall Study|Unexplained|1
4526511|NCT01030952|7342989|FG001|Overall Study|Unexplained|1
4526512|NCT01030965|7343001|FG000|Overall Study|Lack of Efficacy|3
4526513|NCT01030965|7343002|FG001|Overall Study|Lack of Efficacy|2
4526514|NCT01030965|7343003|FG002|Overall Study|Lack of Efficacy|0
4526515|NCT01030965|7343004|FG003|Overall Study|Lack of Efficacy|3
4526516|NCT01030965|7343001|FG000|Overall Study|Protocol Violation|1
4526517|NCT01030965|7343002|FG001|Overall Study|Protocol Violation|1
4526518|NCT01030965|7343003|FG002|Overall Study|Protocol Violation|1
4526519|NCT01030965|7343004|FG003|Overall Study|Protocol Violation|1
4526520|NCT01030965|7343001|FG000|Overall Study|Adverse Event|0
4526521|NCT01030965|7343002|FG001|Overall Study|Adverse Event|1
4526522|NCT01030965|7343003|FG002|Overall Study|Adverse Event|2
4526523|NCT01030965|7343004|FG003|Overall Study|Adverse Event|1
4526524|NCT01030965|7343001|FG000|Overall Study|Protocol-defined Stopping Criteria|0
4526525|NCT01030965|7343002|FG001|Overall Study|Protocol-defined Stopping Criteria|1
4526526|NCT01030965|7343003|FG002|Overall Study|Protocol-defined Stopping Criteria|1
4526527|NCT01030965|7343004|FG003|Overall Study|Protocol-defined Stopping Criteria|0
4526528|NCT01030965|7343001|FG000|Overall Study|Withdrawal by Subject|0
4526529|NCT01030965|7343002|FG001|Overall Study|Withdrawal by Subject|1
4526530|NCT01030965|7343003|FG002|Overall Study|Withdrawal by Subject|0
4526531|NCT01030965|7343004|FG003|Overall Study|Withdrawal by Subject|2
4526532|NCT01031004|7343016|FG000|Overall Study|Protocol Violation|0
4526533|NCT01031004|7343017|FG001|Overall Study|Protocol Violation|1
4526534|NCT01031004|7343016|FG000|Overall Study|Lost to Follow-up|1
4526535|NCT01031004|7343017|FG001|Overall Study|Lost to Follow-up|0
4526536|NCT01031069|7343031|FG000|Overall Study|Serious Adverse Event|0
4526537|NCT01031069|7343032|FG001|Overall Study|Serious Adverse Event|1
4526538|NCT01031069|7343033|FG002|Overall Study|Serious Adverse Event|0
4526539|NCT01031069|7343034|FG003|Overall Study|Serious Adverse Event|0
4526540|NCT01031069|7343031|FG000|Overall Study|Withdrawal by Subject|2
4526541|NCT01031069|7343032|FG001|Overall Study|Withdrawal by Subject|3
4526542|NCT01031069|7343033|FG002|Overall Study|Withdrawal by Subject|18
4526543|NCT01031069|7343034|FG003|Overall Study|Withdrawal by Subject|18
4526544|NCT01031069|7343031|FG000|Overall Study|Migrated/moved from study area|1
4526545|NCT01031069|7343032|FG001|Overall Study|Migrated/moved from study area|2
4526546|NCT01031069|7343033|FG002|Overall Study|Migrated/moved from study area|1
4526547|NCT01031069|7343034|FG003|Overall Study|Migrated/moved from study area|1
4526548|NCT01031069|7343031|FG000|Overall Study|Lost to Follow-up|9
4526549|NCT01031069|7343032|FG001|Overall Study|Lost to Follow-up|5
4526550|NCT01031069|7343033|FG002|Overall Study|Lost to Follow-up|21
4526551|NCT01031069|7343034|FG003|Overall Study|Lost to Follow-up|15
4526552|NCT01031069|7343031|FG000|Overall Study|Other|0
4526553|NCT01031069|7343032|FG001|Overall Study|Other|0
4526554|NCT01031069|7343033|FG002|Overall Study|Other|1
4526555|NCT01031069|7343034|FG003|Overall Study|Other|0
4526556|NCT01031381|7343064|FG000|Overall Study|Physician Decision|3
4526557|NCT01031381|7343064|FG000|Overall Study|Withdrawal by Subject|6
4526558|NCT01031446|7343073|FG000|Overall Study|Disease Progression|38
4526559|NCT01031446|7343073|FG000|Overall Study|Adverse Event|9
4526560|NCT01031446|7343073|FG000|Overall Study|Physician Decision|4
4526561|NCT01031446|7343073|FG000|Overall Study|Withdrawal by Subject|3
4526562|NCT01031446|7343073|FG000|Overall Study|Still on treatment|1
4526563|NCT01031537|7343092|FG000|Overall Study|medical reasons not related to study|3
4526564|NCT01031537|7343092|FG000|Overall Study|Lack of Efficacy|1
4526565|NCT01031537|7343092|FG000|Overall Study|retired from NIH, met exclusion criteria|1
4526566|NCT01031537|7343092|FG000|Overall Study|moved, met exclusion criteria|10
4526567|NCT01031537|7343092|FG000|Overall Study|Withdrawal by Subject|5
4526568|NCT01031537|7343092|FG000|Overall Study|PI removal, no longer met eligibility|12
4526569|NCT01031680|7343098|FG000|Overall Study|Adverse Event|8
4526570|NCT01031680|7343099|FG001|Overall Study|Adverse Event|3
4526571|NCT01031680|7343098|FG000|Overall Study|Lost to Follow-up|2
4526572|NCT01031680|7343099|FG001|Overall Study|Lost to Follow-up|10
4526573|NCT01031680|7343098|FG000|Overall Study|Withdrawal by Subject|12
4526574|NCT01031680|7343099|FG001|Overall Study|Withdrawal by Subject|16
4526575|NCT01031680|7343098|FG000|Overall Study|Death|2
4594395|NCT01562275|7443617|FG001|Stage 1|Progression of Disease|6
4526576|NCT01031680|7343099|FG001|Overall Study|Death|1
4526577|NCT01031680|7343098|FG000|Overall Study|Subject No Longer Meets Study Criteria|26
4526578|NCT01031680|7343099|FG001|Overall Study|Subject No Longer Meets Study Criteria|17
4594396|NCT01562275|7443618|FG002|Stage 1|Progression of Disease|2
4526579|NCT01031680|7343098|FG000|Overall Study|Poor/Non-compliance|5
4526580|NCT01031680|7343099|FG001|Overall Study|Poor/Non-compliance|6
4526581|NCT01031680|7343098|FG000|Overall Study|Safety|1
4526582|NCT01031680|7343099|FG001|Overall Study|Safety|0
4526583|NCT01031680|7343098|FG000|Overall Study|Incorrect Enrolment|1
4526584|NCT01031680|7343099|FG001|Overall Study|Incorrect Enrolment|2
4526585|NCT01031680|7343098|FG000|Overall Study|Administrative Reason by Sponsor|0
4526586|NCT01031680|7343099|FG001|Overall Study|Administrative Reason by Sponsor|1
4526587|NCT01031680|7343098|FG000|Overall Study|Various|0
4526588|NCT01031680|7343099|FG001|Overall Study|Various|2
4526589|NCT01031706|7343107|FG000|Overall Study|Adverse Event|1
4526590|NCT01031706|7343108|FG001|Overall Study|Adverse Event|0
4526591|NCT01031706|7343107|FG000|Overall Study|Withdrawal by Subject|1
4526592|NCT01031706|7343108|FG001|Overall Study|Withdrawal by Subject|1
4526593|NCT01031836|7343126|FG000|Stage I|Adverse Event|1
4526594|NCT01031836|7343127|FG001|Stage I|Adverse Event|1
4526595|NCT01031836|7343128|FG002|Stage I|Adverse Event|0
4526596|NCT01031836|7343129|FG003|Stage I|Adverse Event|0
4526597|NCT01031836|7343130|FG004|Stage I|Adverse Event|0
4526598|NCT01031836|7343131|FG005|Stage I|Adverse Event|0
4526599|NCT01031836|7343126|FG000|Stage I|Other|0
4526600|NCT01031836|7343127|FG001|Stage I|Other|1
4526601|NCT01031836|7343128|FG002|Stage I|Other|0
4526602|NCT01031836|7343129|FG003|Stage I|Other|0
4526603|NCT01031836|7343130|FG004|Stage I|Other|0
4526604|NCT01031836|7343131|FG005|Stage I|Other|1
4526605|NCT01031836|7343126|FG000|Stage II|Adverse Event|0
4526606|NCT01031836|7343127|FG001|Stage II|Adverse Event|0
4526607|NCT01031836|7343128|FG002|Stage II|Adverse Event|2
4526608|NCT01031836|7343129|FG003|Stage II|Adverse Event|2
4526609|NCT01031836|7343130|FG004|Stage II|Adverse Event|1
4526610|NCT01031836|7343131|FG005|Stage II|Adverse Event|1
4526611|NCT01031836|7343126|FG000|Stage II|Other|2
4526612|NCT01031836|7343127|FG001|Stage II|Other|0
4526613|NCT01031836|7343128|FG002|Stage II|Other|0
4526614|NCT01031836|7343129|FG003|Stage II|Other|1
4526615|NCT01031836|7343130|FG004|Stage II|Other|1
4526616|NCT01031836|7343131|FG005|Stage II|Other|0
4526617|NCT01031979|7343161|FG000|Overall Study|Lost to Follow-up|5
4526618|NCT01031979|7343162|FG001|Overall Study|Lost to Follow-up|4
4526619|NCT01032018|7343170|FG000|Overall Study|Lost to Follow-up|6
4526620|NCT01032018|7343171|FG001|Overall Study|Lost to Follow-up|5
4526621|NCT01032018|7343170|FG000|Overall Study|Death|0
4526622|NCT01032018|7343171|FG001|Overall Study|Death|1
4526623|NCT01032044|7343179|FG000|Overall Study|Protocol Violation|14
4526624|NCT01032044|7343180|FG001|Overall Study|Protocol Violation|8
4526625|NCT01032044|7343179|FG000|Overall Study|Adverse Event|0
4526626|NCT01032044|7343180|FG001|Overall Study|Adverse Event|1
4526627|NCT01032044|7343179|FG000|Overall Study|Lost to Follow-up|11
4526628|NCT01032044|7343180|FG001|Overall Study|Lost to Follow-up|11
4526629|NCT01032070|7343188|FG000|Overall Study|Disease progression|13
4526630|NCT01032070|7343189|FG001|Overall Study|Disease progression|8
4526631|NCT01032070|7343188|FG000|Overall Study|Medical or ethical reasons|0
4594397|NCT01562275|7443619|FG003|Stage 1|Progression of Disease|1
4594398|NCT01562275|7443620|FG004|Stage 1|Progression of Disease|2
4746339|NCT00768040|7717431|FG001|Overall Study|Abnormal laboratory value|1
4746340|NCT00776555|7717439|FG000|Overall Study|Study terminated|3
4746341|NCT00776555|7717440|FG001|Overall Study|Study terminated|0
4746342|NCT00775190|7717448|FG000|Overall Study|Lost to Follow-up|2
4746343|NCT00775190|7717449|FG001|Overall Study|Lost to Follow-up|3
4746344|NCT00775190|7717448|FG000|Overall Study|Withdrawal by Subject|1
4746345|NCT00775190|7717449|FG001|Overall Study|Withdrawal by Subject|2
4746346|NCT00775190|7717448|FG000|Overall Study|Protocol Violation|1
4526632|NCT01032070|7343189|FG001|Overall Study|Medical or ethical reasons|2
4526633|NCT01032070|7343188|FG000|Overall Study|Withdrawal by Subject|0
4526634|NCT01032070|7343189|FG001|Overall Study|Withdrawal by Subject|2
4526635|NCT01032174|7343222|FG000|Overall Study|Adverse Event|0
4526636|NCT01032174|7343223|FG001|Overall Study|Adverse Event|1
4526637|NCT01032200|7343231|FG000|Overall Study|Death|1
4526638|NCT01032200|7343232|FG001|Overall Study|Death|1
4526639|NCT01032200|7343231|FG000|Overall Study|Withdrawal by Subject|1
4526640|NCT01032200|7343232|FG001|Overall Study|Withdrawal by Subject|3
4746347|NCT00775190|7717449|FG001|Overall Study|Protocol Violation|0
4526641|NCT01032200|7343231|FG000|Overall Study|Toxicity|0
4526642|NCT01032200|7343232|FG001|Overall Study|Toxicity|2
4526643|NCT01032200|7343231|FG000|Overall Study|Progression|1
4526644|NCT01032200|7343232|FG001|Overall Study|Progression|0
4526645|NCT01032200|7343231|FG000|Overall Study|Multiple|1
4526646|NCT01032200|7343232|FG001|Overall Study|Multiple|1
4634555|NCT01925768|7505731|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2
4634556|NCT01925768|7505730|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5
4634557|NCT01925768|7505731|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10
4634558|NCT01925768|7505730|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
4634559|NCT01925768|7505731|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6
4634560|NCT01925768|7505730|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1
4634561|NCT01925768|7505731|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
4634562|NCT01925768|7505730|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0
4634563|NCT01925768|7505731|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1
4634564|NCT01925768|7505730|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6
4634565|NCT01925768|7505731|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6
4634566|NCT01925768|7505730|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7
4634567|NCT01925768|7505731|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9
4634568|NCT01925768|7505730|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2
4634569|NCT01925768|7505731|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1
4634570|NCT01925768|7505730|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0
4526647|NCT01032239|7343240|FG000|Overall Study|Lost to Follow-up|3
4526648|NCT01032239|7343241|FG001|Overall Study|Lost to Follow-up|2
4526649|NCT01032239|7343240|FG000|Overall Study|Withdrawal by Subject|2
4526650|NCT01032239|7343241|FG001|Overall Study|Withdrawal by Subject|3
4634571|NCT01925768|7505731|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1
4634572|NCT01925768|7505730|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5
4634573|NCT01925768|7505731|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1
4526651|NCT01032239|7343240|FG000|Overall Study|Death|1
4526652|NCT01032239|7343241|FG001|Overall Study|Death|0
4526653|NCT01032239|7343240|FG000|Overall Study|Protocol Violation|1
4526654|NCT01032239|7343241|FG001|Overall Study|Protocol Violation|0
4526655|NCT01032291|7343250|FG000|Safety Lead-in|Adverse Event|1
4526656|NCT01032291|7343251|FG001|Safety Lead-in|Adverse Event|0
4526657|NCT01032291|7343252|FG002|Safety Lead-in|Adverse Event|0
4526658|NCT01032291|7343250|FG000|Safety Lead-in|Death|1
4526659|NCT01032291|7343251|FG001|Safety Lead-in|Death|0
4526660|NCT01032291|7343252|FG002|Safety Lead-in|Death|0
4526661|NCT01032291|7343250|FG000|Proof of Concept|Adverse Event|0
4526662|NCT01032291|7343251|FG001|Proof of Concept|Adverse Event|5
4526663|NCT01032291|7343252|FG002|Proof of Concept|Adverse Event|1
4526664|NCT01032291|7343250|FG000|Proof of Concept|Death|0
4526665|NCT01032291|7343251|FG001|Proof of Concept|Death|1
4526666|NCT01032291|7343252|FG002|Proof of Concept|Death|2
4526667|NCT01032291|7343250|FG000|Proof of Concept|Lack of Efficacy|0
4526668|NCT01032291|7343251|FG001|Proof of Concept|Lack of Efficacy|1
4526669|NCT01032291|7343252|FG002|Proof of Concept|Lack of Efficacy|0
4526670|NCT01032291|7343250|FG000|Proof of Concept|Never Received Study Drug|0
4526671|NCT01032291|7343251|FG001|Proof of Concept|Never Received Study Drug|1
4526672|NCT01032291|7343252|FG002|Proof of Concept|Never Received Study Drug|0
4526673|NCT01032382|7343290|FG000|Overall Study|Disease dissemination|1
4526674|NCT01032382|7343291|FG001|Overall Study|Disease dissemination|1
4526675|NCT01032382|7343290|FG000|Overall Study|Treatment failure|3
4526676|NCT01032382|7343291|FG001|Overall Study|Treatment failure|1
4526677|NCT01032382|7343290|FG000|Overall Study|Index lesion relapse|1
4526678|NCT01032382|7343291|FG001|Overall Study|Index lesion relapse|3
4526679|NCT01032629|7343306|FG000|Overall Study|Closed Site|21
4526680|NCT01032629|7343307|FG001|Overall Study|Closed Site|18
4526681|NCT01032629|7343308|FG002|Overall Study|Closed Site|16
4526682|NCT01032629|7343306|FG000|Overall Study|Withdrawal by Subject|50
4526683|NCT01032629|7343307|FG001|Overall Study|Withdrawal by Subject|36
4526684|NCT01032629|7343308|FG002|Overall Study|Withdrawal by Subject|35
4526685|NCT01032629|7343306|FG000|Overall Study|Lost to Follow-up|74
4526686|NCT01032629|7343307|FG001|Overall Study|Lost to Follow-up|47
4526687|NCT01032629|7343308|FG002|Overall Study|Lost to Follow-up|37
4526688|NCT01032837|7343349|FG000|Overall Study|Adverse event/internal illness|0
4526689|NCT01032837|7343350|FG001|Overall Study|Adverse event/internal illness|1
4526690|NCT01032837|7343351|FG002|Overall Study|Adverse event/internal illness|0
4526691|NCT01032837|7343352|FG003|Overall Study|Adverse event/internal illness|1
4526692|NCT01032837|7343349|FG000|Overall Study|Withdrew consent|0
4526693|NCT01032837|7343350|FG001|Overall Study|Withdrew consent|2
4526694|NCT01032837|7343351|FG002|Overall Study|Withdrew consent|0
4526695|NCT01032837|7343352|FG003|Overall Study|Withdrew consent|1
4526696|NCT01032837|7343349|FG000|Overall Study|Failed to return|0
4526697|NCT01032837|7343350|FG001|Overall Study|Failed to return|0
4526698|NCT01032837|7343351|FG002|Overall Study|Failed to return|1
4526699|NCT01032837|7343352|FG003|Overall Study|Failed to return|0
4526700|NCT01032837|7343349|FG000|Overall Study|Refused treatment|0
4526701|NCT01032837|7343350|FG001|Overall Study|Refused treatment|0
4634574|NCT01925950|7505752|FG000|Part 2|Withdrawal by Subject|1
4634575|NCT01925950|7505753|FG001|Part 2|Withdrawal by Subject|0
4634576|NCT01925989|7505761|FG000|Period 1|Sponsor Decision|1
4634577|NCT01925989|7505762|FG001|Period 1|Sponsor Decision|1
4634578|NCT01925989|7505763|FG002|Period 1|Sponsor Decision|0
4634579|NCT01925989|7505761|FG000|Period 1|Withdrawal by Subject|0
4634580|NCT01925989|7505762|FG001|Period 1|Withdrawal by Subject|1
4634581|NCT01925989|7505763|FG002|Period 1|Withdrawal by Subject|0
4634582|NCT01926015|7505777|FG000|Overall Study|Withdrawal by parent/guardian|0
4634583|NCT01926015|7505778|FG001|Overall Study|Withdrawal by parent/guardian|1
4634584|NCT01926015|7505777|FG000|Overall Study|Randomized not treated|2
4634585|NCT01926015|7505778|FG001|Overall Study|Randomized not treated|0
4634586|NCT01926028|7505787|FG000|Overall Study|Lost to Follow-up|7
4634587|NCT01926028|7505788|FG001|Overall Study|Lost to Follow-up|6
4634588|NCT01926028|7505789|FG002|Overall Study|Lost to Follow-up|0
4634589|NCT01926028|7505787|FG000|Overall Study|Physician Decision|1
4634590|NCT01926028|7505788|FG001|Overall Study|Physician Decision|5
4634591|NCT01926028|7505789|FG002|Overall Study|Physician Decision|0
4634592|NCT01926028|7505787|FG000|Overall Study|Withdrawal by Subject|9
4634593|NCT01926028|7505788|FG001|Overall Study|Withdrawal by Subject|9
4634594|NCT01926028|7505789|FG002|Overall Study|Withdrawal by Subject|2
4634595|NCT01926028|7505787|FG000|Overall Study|Non compliance or other reasons|4
4634596|NCT01926028|7505788|FG001|Overall Study|Non compliance or other reasons|2
4634597|NCT01926028|7505789|FG002|Overall Study|Non compliance or other reasons|0
4634598|NCT01926119|7505798|FG000|Overall Study|Withdrawal by Subject|1
4526702|NCT01032837|7343351|FG002|Overall Study|Refused treatment|0
4526703|NCT01032837|7343352|FG003|Overall Study|Refused treatment|1
4526704|NCT01032889|7343369|FG000|Overall Study|Adverse Event|2
4526705|NCT01032889|7343370|FG001|Overall Study|Adverse Event|2
4526706|NCT01032889|7343371|FG002|Overall Study|Adverse Event|0
4526707|NCT01032889|7343369|FG000|Overall Study|Withdrawal of Consent|1
4526708|NCT01032889|7343370|FG001|Overall Study|Withdrawal of Consent|2
4526709|NCT01032889|7343371|FG002|Overall Study|Withdrawal of Consent|1
4526710|NCT01032889|7343369|FG000|Overall Study|Patient Request|0
4526711|NCT01032889|7343370|FG001|Overall Study|Patient Request|1
4526712|NCT01032889|7343371|FG002|Overall Study|Patient Request|0
4634599|NCT01926444|7505806|FG000|Overall Study|Colonoscopy not performed|0
4634600|NCT01926444|7505807|FG001|Overall Study|Colonoscopy not performed|0
4634601|NCT01926444|7505808|FG002|Overall Study|Colonoscopy not performed|4
4634602|NCT01926444|7505809|FG003|Overall Study|Colonoscopy not performed|2
4634603|NCT01926509|7505836|FG000|Overall Study|vital sign met discontinuation criteria|1
4634604|NCT01926509|7505837|FG001|Overall Study|vital sign met discontinuation criteria|0
4634605|NCT01926509|7505838|FG002|Overall Study|vital sign met discontinuation criteria|0
4634606|NCT01926509|7505839|FG003|Overall Study|vital sign met discontinuation criteria|0
4634607|NCT01926626|7505849|FG000|Overall Study|Withdrawal by Subject|15
4634608|NCT01926626|7505849|FG000|Overall Study|Lost to Follow-up|7
4634609|NCT01926782|7505859|FG000|Overall Study|Participant moved|2
4634610|NCT01926782|7505860|FG001|Overall Study|Participant moved|0
4634611|NCT01926782|7505861|FG002|Overall Study|Participant moved|1
4634612|NCT01926782|7505862|FG003|Overall Study|Participant moved|1
4634613|NCT01926782|7505863|FG004|Overall Study|Participant moved|0
4634614|NCT01926782|7505864|FG005|Overall Study|Participant moved|3
4634615|NCT01926782|7505859|FG000|Overall Study|Physician Decision|0
4634616|NCT01926782|7505860|FG001|Overall Study|Physician Decision|2
4634617|NCT01926782|7505861|FG002|Overall Study|Physician Decision|1
4634618|NCT01926782|7505862|FG003|Overall Study|Physician Decision|1
4634619|NCT01926782|7505863|FG004|Overall Study|Physician Decision|0
4634620|NCT01926782|7505864|FG005|Overall Study|Physician Decision|0
4634621|NCT01926782|7505859|FG000|Overall Study|Other than specified|2
4634622|NCT01926782|7505860|FG001|Overall Study|Other than specified|3
4634623|NCT01926782|7505861|FG002|Overall Study|Other than specified|5
4634624|NCT01926782|7505862|FG003|Overall Study|Other than specified|12
4634625|NCT01926782|7505863|FG004|Overall Study|Other than specified|4
4634626|NCT01926782|7505864|FG005|Overall Study|Other than specified|11
4634627|NCT01926782|7505859|FG000|Overall Study|Adverse Event|13
4634628|NCT01926782|7505860|FG001|Overall Study|Adverse Event|4
4634629|NCT01926782|7505861|FG002|Overall Study|Adverse Event|17
4526713|NCT01032889|7343369|FG000|Overall Study|Lost to Follow-up|1
4526714|NCT01032889|7343370|FG001|Overall Study|Lost to Follow-up|1
4526715|NCT01032889|7343371|FG002|Overall Study|Lost to Follow-up|0
4526716|NCT01032889|7343369|FG000|Overall Study|Lack of Submental Fat|2
4526717|NCT01032889|7343370|FG001|Overall Study|Lack of Submental Fat|8
4526718|NCT01032889|7343371|FG002|Overall Study|Lack of Submental Fat|1
4526719|NCT01032889|7343369|FG000|Overall Study|Miscellaneous Reasons|2
4526720|NCT01032889|7343370|FG001|Overall Study|Miscellaneous Reasons|1
4526721|NCT01032889|7343371|FG002|Overall Study|Miscellaneous Reasons|1
4526722|NCT01032915|7343383|FG000|Overall Study|Adverse Event|2
4634630|NCT01926782|7505862|FG003|Overall Study|Adverse Event|4
4634631|NCT01926782|7505863|FG004|Overall Study|Adverse Event|3
4634632|NCT01926782|7505864|FG005|Overall Study|Adverse Event|14
4634633|NCT01926782|7505859|FG000|Overall Study|Poor compliance to protocol|5
4634634|NCT01926782|7505860|FG001|Overall Study|Poor compliance to protocol|3
4634635|NCT01926782|7505861|FG002|Overall Study|Poor compliance to protocol|8
4634636|NCT01926782|7505862|FG003|Overall Study|Poor compliance to protocol|0
4526723|NCT01032915|7343384|FG001|Overall Study|Adverse Event|2
4526724|NCT01032915|7343385|FG002|Overall Study|Adverse Event|1
4526725|NCT01032915|7343386|FG003|Overall Study|Adverse Event|1
4634637|NCT01926782|7505863|FG004|Overall Study|Poor compliance to protocol|1
4634638|NCT01926782|7505864|FG005|Overall Study|Poor compliance to protocol|6
4634639|NCT01926782|7505859|FG000|Overall Study|Randomized and not treated|0
4634640|NCT01926782|7505860|FG001|Overall Study|Randomized and not treated|0
4526726|NCT01032915|7343383|FG000|Overall Study|Abnormal test procedure result|0
4526727|NCT01032915|7343384|FG001|Overall Study|Abnormal test procedure result|0
4526728|NCT01032915|7343385|FG002|Overall Study|Abnormal test procedure result|1
4526729|NCT01032915|7343386|FG003|Overall Study|Abnormal test procedure result|0
4526730|NCT01032915|7343383|FG000|Overall Study|Withdrawal by Subject|0
4526731|NCT01032915|7343384|FG001|Overall Study|Withdrawal by Subject|3
4526732|NCT01032915|7343385|FG002|Overall Study|Withdrawal by Subject|1
4526733|NCT01032915|7343386|FG003|Overall Study|Withdrawal by Subject|1
4526734|NCT01032915|7343383|FG000|Overall Study|Administrative reasons|5
4526735|NCT01032915|7343384|FG001|Overall Study|Administrative reasons|6
4526736|NCT01032915|7343385|FG002|Overall Study|Administrative reasons|4
4526737|NCT01032915|7343386|FG003|Overall Study|Administrative reasons|4
4526738|NCT01032915|7343383|FG000|Overall Study|Protocol Violation|1
4526739|NCT01032915|7343384|FG001|Overall Study|Protocol Violation|0
4526740|NCT01032915|7343385|FG002|Overall Study|Protocol Violation|0
4526741|NCT01032915|7343386|FG003|Overall Study|Protocol Violation|1
4526742|NCT01033019|7343428|FG000|Overall Study|Withdrawal by Subject|1
4526743|NCT01033019|7343429|FG001|Overall Study|Withdrawal by Subject|0
4526744|NCT01033071|7343446|FG000|Overall Study|Adverse Event|28
4526745|NCT01033071|7343447|FG001|Overall Study|Adverse Event|51
4526746|NCT01033071|7343448|FG002|Overall Study|Adverse Event|26
4526747|NCT01033071|7343446|FG000|Overall Study|Protocol Violation|0
4526748|NCT01033071|7343447|FG001|Overall Study|Protocol Violation|2
4526749|NCT01033071|7343448|FG002|Overall Study|Protocol Violation|1
4526750|NCT01033071|7343446|FG000|Overall Study|Lost to Follow-up|4
4526751|NCT01033071|7343447|FG001|Overall Study|Lost to Follow-up|5
4526752|NCT01033071|7343448|FG002|Overall Study|Lost to Follow-up|5
4526753|NCT01033071|7343446|FG000|Overall Study|Withdrawal by Subject|17
4526754|NCT01033071|7343447|FG001|Overall Study|Withdrawal by Subject|14
4526755|NCT01033071|7343448|FG002|Overall Study|Withdrawal by Subject|11
4526756|NCT01033071|7343446|FG000|Overall Study|Lack of Efficacy|0
4526757|NCT01033071|7343447|FG001|Overall Study|Lack of Efficacy|1
4526758|NCT01033071|7343448|FG002|Overall Study|Lack of Efficacy|1
4526759|NCT01033071|7343446|FG000|Overall Study|Other|6
4526760|NCT01033071|7343447|FG001|Overall Study|Other|4
4526761|NCT01033071|7343448|FG002|Overall Study|Other|3
4526762|NCT01033136|7343458|FG000|Follow-Up (3 Month)|Lost to Follow-up|2
4526763|NCT01033136|7343459|FG001|Follow-Up (3 Month)|Lost to Follow-up|2
4526764|NCT01033240|7343481|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10
4526765|NCT01033240|7343482|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8
4526766|NCT01033240|7343483|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6
4526767|NCT01033240|7343481|FG000|Overall Study|Death|2
4526768|NCT01033240|7343482|FG001|Overall Study|Death|0
4526769|NCT01033240|7343483|FG002|Overall Study|Death|0
4526770|NCT01033240|7343481|FG000|Overall Study|Withdrew Consent|2
4526771|NCT01033240|7343482|FG001|Overall Study|Withdrew Consent|9
4526772|NCT01033240|7343483|FG002|Overall Study|Withdrew Consent|2
4526773|NCT01033240|7343481|FG000|Overall Study|Disease Progression|35
4526774|NCT01033240|7343482|FG001|Overall Study|Disease Progression|32
4526775|NCT01033240|7343483|FG002|Overall Study|Disease Progression|41
4526776|NCT01033240|7343481|FG000|Overall Study|Investigator Discretion|0
4526777|NCT01033240|7343482|FG001|Overall Study|Investigator Discretion|0
4526778|NCT01033240|7343483|FG002|Overall Study|Investigator Discretion|2
4526779|NCT01033240|7343481|FG000|Overall Study|Other|0
4526780|NCT01033240|7343482|FG001|Overall Study|Other|1
4526781|NCT01033240|7343483|FG002|Overall Study|Other|2
4526782|NCT01033448|7343521|FG000|Overall Study|Withdrawal by Subject|4
4526783|NCT01033448|7343521|FG000|Overall Study|Positive HCV-RNA at week 48|1
4526784|NCT01033448|7343521|FG000|Overall Study|Lost to Follow-up|3
4526785|NCT01033448|7343521|FG000|Overall Study|Withdrew due to other reasons|3
4526786|NCT01033448|7343521|FG000|Overall Study|Unknown disposition|1
4526787|NCT01033487|7343527|FG000|Fourth Intervention Period|Adverse Event|0
4526788|NCT01033487|7343528|FG001|Fourth Intervention Period|Adverse Event|0
4526789|NCT01033487|7343529|FG002|Fourth Intervention Period|Adverse Event|0
4526790|NCT01033487|7343530|FG003|Fourth Intervention Period|Adverse Event|0
4526791|NCT01033487|7343531|FG004|Fourth Intervention Period|Adverse Event|0
4526792|NCT01033487|7343532|FG005|Fourth Intervention Period|Adverse Event|0
4526793|NCT01033487|7343533|FG006|Fourth Intervention Period|Adverse Event|0
4526794|NCT01033487|7343534|FG007|Fourth Intervention Period|Adverse Event|0
4526795|NCT01033487|7343535|FG008|Fourth Intervention Period|Adverse Event|1
4526796|NCT01033487|7343536|FG009|Fourth Intervention Period|Adverse Event|0
4526797|NCT01033643|7343559|FG000|Overall Study|Withdrew Consent|0
4526798|NCT01033643|7343560|FG001|Overall Study|Withdrew Consent|3
4526799|NCT01033643|7343561|FG002|Overall Study|Withdrew Consent|0
4526800|NCT01033643|7343562|FG003|Overall Study|Withdrew Consent|0
4526801|NCT01033643|7343563|FG004|Overall Study|Withdrew Consent|0
4526802|NCT01033643|7343564|FG005|Overall Study|Withdrew Consent|1
4594399|NCT01562275|7443621|FG005|Stage 1|Progression of Disease|4
4594400|NCT01562275|7443622|FG006|Stage 1|Progression of Disease|1
4594401|NCT01562275|7443623|FG007|Stage 1|Progression of Disease|7
4594402|NCT01562275|7443624|FG008|Stage 1|Progression of Disease|2
4594403|NCT01562275|7443625|FG009|Stage 1|Progression of Disease|5
4594404|NCT01562275|7443626|FG010|Stage 1|Progression of Disease|3
4594405|NCT01562275|7443627|FG011|Stage 1|Progression of Disease|0
4594406|NCT01562275|7443628|FG012|Stage 1|Progression of Disease|0
4594407|NCT01562275|7443616|FG000|Stage 1|Withdrawal by Subject|0
4594408|NCT01562275|7443617|FG001|Stage 1|Withdrawal by Subject|1
4594409|NCT01562275|7443618|FG002|Stage 1|Withdrawal by Subject|0
4594410|NCT01562275|7443619|FG003|Stage 1|Withdrawal by Subject|2
4594411|NCT01562275|7443620|FG004|Stage 1|Withdrawal by Subject|0
4594412|NCT01562275|7443621|FG005|Stage 1|Withdrawal by Subject|0
4594413|NCT01562275|7443622|FG006|Stage 1|Withdrawal by Subject|1
4594414|NCT01562275|7443623|FG007|Stage 1|Withdrawal by Subject|0
4594415|NCT01562275|7443624|FG008|Stage 1|Withdrawal by Subject|0
4594416|NCT01562275|7443625|FG009|Stage 1|Withdrawal by Subject|1
4594417|NCT01562275|7443626|FG010|Stage 1|Withdrawal by Subject|0
4594418|NCT01562275|7443627|FG011|Stage 1|Withdrawal by Subject|0
4594419|NCT01562275|7443628|FG012|Stage 1|Withdrawal by Subject|0
4594420|NCT01562275|7443616|FG000|Stage 2|Death|0
4594421|NCT01562275|7443617|FG001|Stage 2|Death|0
4594422|NCT01562275|7443618|FG002|Stage 2|Death|0
4594423|NCT01562275|7443619|FG003|Stage 2|Death|0
4594424|NCT01562275|7443620|FG004|Stage 2|Death|0
4594425|NCT01562275|7443621|FG005|Stage 2|Death|0
4594426|NCT01562275|7443622|FG006|Stage 2|Death|0
4594427|NCT01562275|7443623|FG007|Stage 2|Death|0
4594428|NCT01562275|7443624|FG008|Stage 2|Death|0
4594429|NCT01562275|7443625|FG009|Stage 2|Death|0
4594430|NCT01562275|7443626|FG010|Stage 2|Death|0
4594431|NCT01562275|7443627|FG011|Stage 2|Death|2
4594432|NCT01562275|7443628|FG012|Stage 2|Death|1
4594433|NCT01562275|7443616|FG000|Stage 2|Progression of Disease|0
4594434|NCT01562275|7443617|FG001|Stage 2|Progression of Disease|0
4594435|NCT01562275|7443618|FG002|Stage 2|Progression of Disease|0
4594436|NCT01562275|7443619|FG003|Stage 2|Progression of Disease|0
4594437|NCT01562275|7443620|FG004|Stage 2|Progression of Disease|0
4594438|NCT01562275|7443621|FG005|Stage 2|Progression of Disease|0
4594439|NCT01562275|7443622|FG006|Stage 2|Progression of Disease|0
4594440|NCT01562275|7443623|FG007|Stage 2|Progression of Disease|0
4594441|NCT01562275|7443624|FG008|Stage 2|Progression of Disease|0
4594442|NCT01562275|7443625|FG009|Stage 2|Progression of Disease|0
4594443|NCT01562275|7443626|FG010|Stage 2|Progression of Disease|0
4594444|NCT01562275|7443627|FG011|Stage 2|Progression of Disease|12
4594445|NCT01562275|7443628|FG012|Stage 2|Progression of Disease|4
4594446|NCT01562314|7443660|FG000|Overall Study|Adverse Event|10
4594447|NCT01562314|7443661|FG001|Overall Study|Adverse Event|5
4594448|NCT01562314|7443660|FG000|Overall Study|Met Withdrawal Criteria|3
4594449|NCT01562314|7443661|FG001|Overall Study|Met Withdrawal Criteria|2
4594450|NCT01562314|7443660|FG000|Overall Study|Withdrawal by Subject|0
4594451|NCT01562314|7443661|FG001|Overall Study|Withdrawal by Subject|1
4594452|NCT01562327|7443667|FG000|Overall Study|Adverse Event|2
4594453|NCT01562327|7443667|FG000|Overall Study|Lack of Efficacy|1
4594454|NCT01562327|7443667|FG000|Overall Study|Participant drop-out|1
4594455|NCT01562327|7443667|FG000|Overall Study|Infusion not received at 6 month window|4
4594456|NCT01562444|7443696|FG000|Overall Study|Did not meet entry criteria|2
4594457|NCT01562444|7443697|FG001|Overall Study|Did not meet entry criteria|0
4594458|NCT01562444|7443698|FG002|Overall Study|Did not meet entry criteria|3
4594459|NCT01562444|7443696|FG000|Overall Study|Did not comply with blood draw schedule|1
4594460|NCT01562444|7443697|FG001|Overall Study|Did not comply with blood draw schedule|0
4594461|NCT01562444|7443698|FG002|Overall Study|Did not comply with blood draw schedule|1
4594462|NCT01562444|7443696|FG000|Overall Study|Unavailable serological results|0
4594463|NCT01562444|7443697|FG001|Overall Study|Unavailable serological results|2
4634641|NCT01926782|7505861|FG002|Overall Study|Randomized and not treated|0
4526803|NCT01033734|7343578|FG000|Overall Study|Withdrawal by Subject|1
4526804|NCT01033747|7343593|FG000|Overall Study|Adverse Event|9
4526805|NCT01033747|7343594|FG001|Overall Study|Adverse Event|4
4526806|NCT01033747|7343593|FG000|Overall Study|Abnormal Laboratory Value|1
4526807|NCT01033747|7343594|FG001|Overall Study|Abnormal Laboratory Value|0
4526808|NCT01033747|7343593|FG000|Overall Study|Abnormal test procedure|0
4526809|NCT01033747|7343594|FG001|Overall Study|Abnormal test procedure|1
4526810|NCT01033747|7343593|FG000|Overall Study|Unsatisfactory therapeutic effect|14
4526811|NCT01033747|7343594|FG001|Overall Study|Unsatisfactory therapeutic effect|4
4526812|NCT01033747|7343593|FG000|Overall Study|Protocol Violation|1
4526813|NCT01033747|7343594|FG001|Overall Study|Protocol Violation|0
4526814|NCT01033747|7343593|FG000|Overall Study|Withdrawal by Subject|9
4526815|NCT01033747|7343594|FG001|Overall Study|Withdrawal by Subject|6
4526816|NCT01033747|7343593|FG000|Overall Study|Stopped at end of prolongation visit 1|1
4526817|NCT01033747|7343594|FG001|Overall Study|Stopped at end of prolongation visit 1|0
4526818|NCT01033747|7343593|FG000|Overall Study|Stopped at end of Extension 1|2
4526819|NCT01033747|7343594|FG001|Overall Study|Stopped at end of Extension 1|0
4526820|NCT01033825|7343611|FG000|Overall Study|Withdrawal by Subject|2
4526821|NCT01033825|7343612|FG001|Overall Study|Withdrawal by Subject|3
4526822|NCT01033825|7343613|FG002|Overall Study|Withdrawal by Subject|2
4526823|NCT01033825|7343614|FG003|Overall Study|Withdrawal by Subject|1
4526824|NCT01033825|7343615|FG004|Overall Study|Withdrawal by Subject|1
4526825|NCT01033825|7343616|FG005|Overall Study|Withdrawal by Subject|0
4526826|NCT01033825|7343617|FG006|Overall Study|Withdrawal by Subject|0
4526827|NCT01033825|7343611|FG000|Overall Study|Adverse Event|0
4526828|NCT01033825|7343612|FG001|Overall Study|Adverse Event|0
4526829|NCT01033825|7343613|FG002|Overall Study|Adverse Event|0
4526830|NCT01033825|7343614|FG003|Overall Study|Adverse Event|1
4526831|NCT01033825|7343615|FG004|Overall Study|Adverse Event|0
4526832|NCT01033825|7343616|FG005|Overall Study|Adverse Event|0
4526833|NCT01033825|7343617|FG006|Overall Study|Adverse Event|0
4526834|NCT01033825|7343611|FG000|Overall Study|Protocol Violation|1
4526835|NCT01033825|7343612|FG001|Overall Study|Protocol Violation|0
4526836|NCT01033825|7343613|FG002|Overall Study|Protocol Violation|0
4526837|NCT01033825|7343614|FG003|Overall Study|Protocol Violation|0
4526838|NCT01033825|7343615|FG004|Overall Study|Protocol Violation|0
4526839|NCT01033825|7343616|FG005|Overall Study|Protocol Violation|0
4526840|NCT01033825|7343617|FG006|Overall Study|Protocol Violation|0
4526841|NCT01033825|7343611|FG000|Overall Study|Other|0
4526842|NCT01033825|7343612|FG001|Overall Study|Other|0
4526843|NCT01033825|7343613|FG002|Overall Study|Other|0
4526844|NCT01033825|7343614|FG003|Overall Study|Other|0
4526845|NCT01033825|7343615|FG004|Overall Study|Other|1
4526846|NCT01033825|7343616|FG005|Overall Study|Other|0
4526847|NCT01033825|7343617|FG006|Overall Study|Other|0
4526848|NCT01033851|7343637|FG000|Overall Study|Withdrawal by Subject|3
4526849|NCT01033851|7343638|FG001|Overall Study|Withdrawal by Subject|7
4526850|NCT01033942|7343656|FG000|Overall Study|Withdrawal by Subject|1
4526851|NCT01033942|7343657|FG001|Overall Study|Withdrawal by Subject|1
4526852|NCT01033942|7343658|FG002|Overall Study|Withdrawal by Subject|1
4526853|NCT01033942|7343656|FG000|Overall Study|Lost to Follow-up|1
4526854|NCT01033942|7343657|FG001|Overall Study|Lost to Follow-up|0
4526855|NCT01033942|7343658|FG002|Overall Study|Lost to Follow-up|0
4526856|NCT01033942|7343656|FG000|Overall Study|Enrolled in Extension Study|0
4526857|NCT01033942|7343657|FG001|Overall Study|Enrolled in Extension Study|3
4526858|NCT01033942|7343658|FG002|Overall Study|Enrolled in Extension Study|0
4526859|NCT01034137|7343675|FG000|Overall Study|Adverse Event|9
4526860|NCT01034137|7343676|FG001|Overall Study|Adverse Event|10
4526861|NCT01034137|7343677|FG002|Overall Study|Adverse Event|8
4526862|NCT01034137|7343675|FG000|Overall Study|Withdrawal by Subject|4
4526863|NCT01034137|7343676|FG001|Overall Study|Withdrawal by Subject|3
4526864|NCT01034137|7343677|FG002|Overall Study|Withdrawal by Subject|3
4526865|NCT01034137|7343675|FG000|Overall Study|Lack of Efficacy|9
4526866|NCT01034137|7343676|FG001|Overall Study|Lack of Efficacy|4
4526867|NCT01034137|7343677|FG002|Overall Study|Lack of Efficacy|13
4526868|NCT01034137|7343675|FG000|Overall Study|Protocol Violation|2
4526869|NCT01034137|7343676|FG001|Overall Study|Protocol Violation|2
4526870|NCT01034137|7343677|FG002|Overall Study|Protocol Violation|1
4526871|NCT01034137|7343675|FG000|Overall Study|Refused treatment or did not cooperate|2
4526872|NCT01034137|7343676|FG001|Overall Study|Refused treatment or did not cooperate|0
4526873|NCT01034137|7343677|FG002|Overall Study|Refused treatment or did not cooperate|1
4526874|NCT01034137|7343675|FG000|Overall Study|Administrative or other|2
4526875|NCT01034137|7343676|FG001|Overall Study|Administrative or other|3
4526876|NCT01034137|7343677|FG002|Overall Study|Administrative or other|4
4526877|NCT01034163|7343688|FG000|Overall Study|Treatment completed as per protocol|8
4526878|NCT01034163|7343689|FG001|Overall Study|Treatment completed as per protocol|7
4526879|NCT01034163|7343688|FG000|Overall Study|Withdrawal by Subject|8
4526880|NCT01034163|7343689|FG001|Overall Study|Withdrawal by Subject|2
4526881|NCT01034163|7343688|FG000|Overall Study|Protocol deviation|1
4526882|NCT01034163|7343689|FG001|Overall Study|Protocol deviation|0
4526883|NCT01034163|7343688|FG000|Overall Study|Disease progression|3
4526884|NCT01034163|7343689|FG001|Overall Study|Disease progression|4
4526885|NCT01034163|7343688|FG000|Overall Study|Adverse Event|6
4526886|NCT01034163|7343689|FG001|Overall Study|Adverse Event|0
4526887|NCT01034163|7343688|FG000|Overall Study|Administrative problems|0
4526888|NCT01034163|7343689|FG001|Overall Study|Administrative problems|1
4634642|NCT01926782|7505862|FG003|Overall Study|Randomized and not treated|1
4526889|NCT01034163|7343688|FG000|Overall Study|Abnormal laboratory value|1
4526890|NCT01034163|7343689|FG001|Overall Study|Abnormal laboratory value|0
4526891|NCT01034176|7343697|FG000|Overall Study|Physician Decision|2
4526892|NCT01034176|7343698|FG001|Overall Study|Physician Decision|0
4526893|NCT01034176|7343697|FG000|Overall Study|Withdrawal by Subject|0
4526894|NCT01034176|7343698|FG001|Overall Study|Withdrawal by Subject|1
4526895|NCT01034176|7343697|FG000|Overall Study|Lost to Follow-up|0
4526896|NCT01034176|7343698|FG001|Overall Study|Lost to Follow-up|1
4526897|NCT01034358|7343704|FG000|Overall Study|Withdrawal by Subject|1
4526898|NCT01034358|7343704|FG000|Overall Study|Protocol Violation|1
4526899|NCT01034397|7343710|FG000|Overall Study|Lack of compliance|0
4526900|NCT01034397|7343711|FG001|Overall Study|Lack of compliance|1
4526901|NCT01034397|7343710|FG000|Overall Study|Lack of Efficacy|3
4526902|NCT01034397|7343711|FG001|Overall Study|Lack of Efficacy|0
4526903|NCT01034397|7343710|FG000|Overall Study|Adverse Event|4
4526904|NCT01034397|7343711|FG001|Overall Study|Adverse Event|0
4526905|NCT01034397|7343710|FG000|Overall Study|Other|0
4526906|NCT01034397|7343711|FG001|Overall Study|Other|1
4526907|NCT01034462|7343728|FG000|Overall Study|Adverse Event|7
4526908|NCT01034462|7343729|FG001|Overall Study|Adverse Event|17
4526909|NCT01034462|7343728|FG000|Overall Study|Lack of Efficacy|4
4526910|NCT01034462|7343729|FG001|Overall Study|Lack of Efficacy|4
4526911|NCT01034462|7343728|FG000|Overall Study|Protocol Violation|10
4526912|NCT01034462|7343729|FG001|Overall Study|Protocol Violation|7
4526913|NCT01034462|7343728|FG000|Overall Study|Withdrawal by Subject|9
4526914|NCT01034462|7343729|FG001|Overall Study|Withdrawal by Subject|8
4526915|NCT01034462|7343728|FG000|Overall Study|Lost to Follow-up|14
4526916|NCT01034462|7343729|FG001|Overall Study|Lost to Follow-up|16
4526917|NCT01034462|7343728|FG000|Overall Study|Other reasons|1
4526918|NCT01034462|7343729|FG001|Overall Study|Other reasons|2
4526919|NCT01034540|7343748|FG000|Overall Study|Adverse Event|0
4526920|NCT01034540|7343749|FG001|Overall Study|Adverse Event|1
4526921|NCT01034631|7343793|FG000|Phase I|Symptomatic Deterioration before Treatme|3
4526922|NCT01034631|7343794|FG001|Phase I|Symptomatic Deterioration before Treatme|0
4526923|NCT01034631|7343795|FG002|Phase I|Symptomatic Deterioration before Treatme|0
4526924|NCT01034631|7343793|FG000|Phase II|Not Evaluable per protocol|0
4526925|NCT01034631|7343794|FG001|Phase II|Not Evaluable per protocol|0
4526926|NCT01034631|7343795|FG002|Phase II|Not Evaluable per protocol|2
4526927|NCT01034631|7343793|FG000|Phase II|Determined Ineligible per protocol|0
4526928|NCT01034631|7343794|FG001|Phase II|Determined Ineligible per protocol|1
4526929|NCT01034631|7343795|FG002|Phase II|Determined Ineligible per protocol|0
4526930|NCT01034657|7343805|FG000|Core Phase|Withdrawal by Subject|1
4526931|NCT01034657|7343806|FG001|Core Phase|Withdrawal by Subject|0
4526932|NCT01034657|7343807|FG002|Core Phase|Withdrawal by Subject|0
4526933|NCT01034657|7343805|FG000|Core Phase|Lack of Efficacy|2
4526934|NCT01034657|7343806|FG001|Core Phase|Lack of Efficacy|0
4526935|NCT01034657|7343807|FG002|Core Phase|Lack of Efficacy|0
4526936|NCT01034657|7343805|FG000|Core Phase|Abnormal laboratory value|1
4526937|NCT01034657|7343806|FG001|Core Phase|Abnormal laboratory value|0
4526938|NCT01034657|7343807|FG002|Core Phase|Abnormal laboratory value|0
4526939|NCT01034657|7343805|FG000|Core Phase|Adverse Event|8
4526940|NCT01034657|7343806|FG001|Core Phase|Adverse Event|0
4526941|NCT01034657|7343807|FG002|Core Phase|Adverse Event|0
4526942|NCT01034657|7343805|FG000|Core Phase|Protocol Violation|2
4526943|NCT01034657|7343806|FG001|Core Phase|Protocol Violation|0
4526944|NCT01034657|7343807|FG002|Core Phase|Protocol Violation|0
4526945|NCT01034657|7343805|FG000|Randomized Phase|Withdrawal by Subject|0
4526946|NCT01034657|7343806|FG001|Randomized Phase|Withdrawal by Subject|2
4526947|NCT01034657|7343807|FG002|Randomized Phase|Withdrawal by Subject|0
4526948|NCT01034657|7343805|FG000|Randomized Phase|Lack of Efficacy|5
4526949|NCT01034657|7343806|FG001|Randomized Phase|Lack of Efficacy|1
4526950|NCT01034657|7343807|FG002|Randomized Phase|Lack of Efficacy|0
4526951|NCT01034657|7343805|FG000|Randomized Phase|Abnormal laboratory value|0
4526952|NCT01034657|7343806|FG001|Randomized Phase|Abnormal laboratory value|1
4526953|NCT01034657|7343807|FG002|Randomized Phase|Abnormal laboratory value|0
4526954|NCT01034657|7343805|FG000|Randomized Phase|Adverse Event|0
4526955|NCT01034657|7343806|FG001|Randomized Phase|Adverse Event|2
4526956|NCT01034657|7343807|FG002|Randomized Phase|Adverse Event|1
4526957|NCT01034709|7343819|FG000|Overall Study|Protocol Violation|9
4526958|NCT01034709|7343820|FG001|Overall Study|Protocol Violation|16
4526959|NCT01035060|7343837|FG000|Overall Study|Lost to Follow-up|0
4526960|NCT01035060|7343838|FG001|Overall Study|Lost to Follow-up|7
4526961|NCT01035060|7343837|FG000|Overall Study|Did not quality after 2nd screening|14
4526962|NCT01035060|7343838|FG001|Overall Study|Did not quality after 2nd screening|1
4526963|NCT01035060|7343837|FG000|Overall Study|Withdrawal by Subject|8
4526964|NCT01035060|7343838|FG001|Overall Study|Withdrawal by Subject|6
4526965|NCT01035060|7343837|FG000|Overall Study|Physician Decision|2
4526966|NCT01035060|7343838|FG001|Overall Study|Physician Decision|0
4526967|NCT01035138|7343857|FG000|Overall Study|Adverse Event|4
4526968|NCT01035138|7343858|FG001|Overall Study|Adverse Event|0
4526969|NCT01035138|7343859|FG002|Overall Study|Adverse Event|2
4526970|NCT01035138|7343857|FG000|Overall Study|Caregiver Decision|2
4526971|NCT01035138|7343858|FG001|Overall Study|Caregiver Decision|0
4526972|NCT01035138|7343859|FG002|Overall Study|Caregiver Decision|1
4526973|NCT01035138|7343857|FG000|Overall Study|Withdrawal by Subject|1
4526974|NCT01035138|7343858|FG001|Overall Study|Withdrawal by Subject|0
4526975|NCT01035138|7343859|FG002|Overall Study|Withdrawal by Subject|0
4526976|NCT01035138|7343857|FG000|Overall Study|Physician Decision|0
4526977|NCT01035138|7343858|FG001|Overall Study|Physician Decision|0
4526978|NCT01035138|7343859|FG002|Overall Study|Physician Decision|1
4526979|NCT01035138|7343857|FG000|Overall Study|Sponsor Decision|66
4526980|NCT01035138|7343858|FG001|Overall Study|Sponsor Decision|60
4526981|NCT01035138|7343859|FG002|Overall Study|Sponsor Decision|42
4526982|NCT01035138|7343857|FG000|Overall Study|Lost to Follow-up|0
4526983|NCT01035138|7343858|FG001|Overall Study|Lost to Follow-up|0
4526984|NCT01035138|7343859|FG002|Overall Study|Lost to Follow-up|1
4526985|NCT01035229|7343880|FG000|Overall Study|Adverse Event|61
4526986|NCT01035229|7343881|FG001|Overall Study|Adverse Event|14
4526987|NCT01035229|7343880|FG000|Overall Study|Withdrawal by Subject|20
4526988|NCT01035229|7343881|FG001|Overall Study|Withdrawal by Subject|7
4526989|NCT01035229|7343880|FG000|Overall Study|Lost to Follow-up|1
4526990|NCT01035229|7343881|FG001|Overall Study|Lost to Follow-up|0
4526991|NCT01035229|7343880|FG000|Overall Study|Administrative problems|1
4526992|NCT01035229|7343881|FG001|Overall Study|Administrative problems|1
4526993|NCT01035229|7343880|FG000|Overall Study|Death|13
4526994|NCT01035229|7343881|FG001|Overall Study|Death|5
4526995|NCT01035229|7343880|FG000|Overall Study|New cancer therapy|2
4526996|NCT01035229|7343881|FG001|Overall Study|New cancer therapy|0
4526997|NCT01035229|7343880|FG000|Overall Study|Protocol Violation|0
4526998|NCT01035229|7343881|FG001|Overall Study|Protocol Violation|2
4526999|NCT01035229|7343880|FG000|Overall Study|Sponsor's decision to end study|3
4527000|NCT01035229|7343881|FG001|Overall Study|Sponsor's decision to end study|3
4527001|NCT01035229|7343880|FG000|Overall Study|Disease Progression|261
4527002|NCT01035229|7343881|FG001|Overall Study|Disease Progression|152
4527003|NCT01035255|7343891|FG000|Overall Study|Death|724
4527004|NCT01035255|7343892|FG001|Overall Study|Death|844
4527005|NCT01035255|7343891|FG000|Overall Study|Lost to Follow-up|2
4527006|NCT01035255|7343892|FG001|Overall Study|Lost to Follow-up|5
4527007|NCT01035255|7343891|FG000|Overall Study|patient's request|15
4527008|NCT01035255|7343892|FG001|Overall Study|patient's request|13
4527009|NCT01035463|7343913|FG000|Overall Study|Adverse Event|0
4527010|NCT01035463|7343914|FG001|Overall Study|Adverse Event|0
4527011|NCT01035463|7343915|FG002|Overall Study|Adverse Event|4
4527012|NCT01035463|7343916|FG003|Overall Study|Adverse Event|1
4527013|NCT01035463|7343917|FG004|Overall Study|Adverse Event|5
4527014|NCT01035463|7343918|FG005|Overall Study|Adverse Event|7
4527015|NCT01035463|7343913|FG000|Overall Study|Withdrawal by Subject|0
4527016|NCT01035463|7343914|FG001|Overall Study|Withdrawal by Subject|2
4527017|NCT01035463|7343915|FG002|Overall Study|Withdrawal by Subject|1
4527018|NCT01035463|7343916|FG003|Overall Study|Withdrawal by Subject|0
4527019|NCT01035463|7343917|FG004|Overall Study|Withdrawal by Subject|1
4527020|NCT01035463|7343918|FG005|Overall Study|Withdrawal by Subject|4
4527021|NCT01035463|7343913|FG000|Overall Study|Disease progression|0
4527022|NCT01035463|7343914|FG001|Overall Study|Disease progression|0
4527023|NCT01035463|7343915|FG002|Overall Study|Disease progression|0
4527024|NCT01035463|7343916|FG003|Overall Study|Disease progression|0
4527025|NCT01035463|7343917|FG004|Overall Study|Disease progression|0
4527026|NCT01035463|7343918|FG005|Overall Study|Disease progression|3
4594464|NCT01562444|7443698|FG002|Overall Study|Unavailable serological results|2
4527027|NCT01035463|7343913|FG000|Overall Study|Other Malignancy|0
4527028|NCT01035463|7343914|FG001|Overall Study|Other Malignancy|0
4527029|NCT01035463|7343915|FG002|Overall Study|Other Malignancy|0
4527030|NCT01035463|7343916|FG003|Overall Study|Other Malignancy|0
4527031|NCT01035463|7343917|FG004|Overall Study|Other Malignancy|0
4527032|NCT01035463|7343918|FG005|Overall Study|Other Malignancy|2
4527033|NCT01035463|7343913|FG000|Overall Study|Other|0
4634643|NCT01926782|7505863|FG004|Overall Study|Randomized and not treated|0
4527034|NCT01035463|7343914|FG001|Overall Study|Other|0
4527035|NCT01035463|7343915|FG002|Overall Study|Other|0
4527036|NCT01035463|7343916|FG003|Overall Study|Other|1
4527037|NCT01035463|7343917|FG004|Overall Study|Other|0
4527038|NCT01035463|7343918|FG005|Overall Study|Other|2
4527039|NCT01035606|7343928|FG000|Overall Study|change in health, job demands,family|3
4527040|NCT01035606|7343929|FG001|Overall Study|change in health, job demands,family|3
4527041|NCT01035606|7343930|FG002|Overall Study|change in health, job demands,family|4
4527042|NCT01035905|7343986|FG000|Overall Study|Lack of Efficacy|1
4527043|NCT01035905|7343987|FG001|Overall Study|Lack of Efficacy|1
4527044|NCT01036022|7344009|FG000|Overall Study|Adverse Event|1
4527045|NCT01036022|7344010|FG001|Overall Study|Adverse Event|3
4527046|NCT01036022|7344011|FG002|Overall Study|Adverse Event|2
4527047|NCT01036022|7344012|FG003|Overall Study|Adverse Event|1
4527048|NCT01036022|7344013|FG004|Overall Study|Adverse Event|0
4527049|NCT01036022|7344014|FG005|Overall Study|Adverse Event|2
4527050|NCT01036022|7344009|FG000|Overall Study|Lack of Efficacy|1
4527051|NCT01036022|7344010|FG001|Overall Study|Lack of Efficacy|1
4527052|NCT01036022|7344011|FG002|Overall Study|Lack of Efficacy|1
4527053|NCT01036022|7344012|FG003|Overall Study|Lack of Efficacy|0
4527054|NCT01036022|7344013|FG004|Overall Study|Lack of Efficacy|1
4527055|NCT01036022|7344014|FG005|Overall Study|Lack of Efficacy|1
4527056|NCT01036022|7344009|FG000|Overall Study|Physician Decision|0
4527057|NCT01036022|7344010|FG001|Overall Study|Physician Decision|0
4527058|NCT01036022|7344011|FG002|Overall Study|Physician Decision|1
4527059|NCT01036022|7344012|FG003|Overall Study|Physician Decision|0
4527060|NCT01036022|7344013|FG004|Overall Study|Physician Decision|0
4527061|NCT01036022|7344014|FG005|Overall Study|Physician Decision|0
4527062|NCT01036022|7344009|FG000|Overall Study|Withdrawal by Subject|0
4527063|NCT01036022|7344010|FG001|Overall Study|Withdrawal by Subject|0
4527064|NCT01036022|7344011|FG002|Overall Study|Withdrawal by Subject|0
4527065|NCT01036022|7344012|FG003|Overall Study|Withdrawal by Subject|1
4527066|NCT01036022|7344013|FG004|Overall Study|Withdrawal by Subject|2
4527067|NCT01036022|7344014|FG005|Overall Study|Withdrawal by Subject|0
4527068|NCT01036165|7344036|FG000|Overall Study|Adverse Event|6
4527069|NCT01036165|7344036|FG000|Overall Study|Lost to Follow-up|2
4527070|NCT01036165|7344036|FG000|Overall Study|Withdrawal by Subject|3
4527071|NCT01036165|7344036|FG000|Overall Study|Device Related Issues|3
4527072|NCT01036165|7344036|FG000|Overall Study|Problems finding proper area to inject|1
4527073|NCT01036321|7344042|FG000|Overall Study|Ineligible after randomization|0
4527074|NCT01036321|7344043|FG001|Overall Study|Ineligible after randomization|1
4527075|NCT01036321|7344042|FG000|Overall Study|Withdrawal by Subject|3
4527076|NCT01036321|7344043|FG001|Overall Study|Withdrawal by Subject|2
4527077|NCT01036321|7344042|FG000|Overall Study|Adverse Event|2
4527078|NCT01036321|7344043|FG001|Overall Study|Adverse Event|1
4527079|NCT01036438|7344051|FG000|Overall Study|Adverse Event|7
4527080|NCT01036438|7344052|FG001|Overall Study|Adverse Event|8
4527081|NCT01036438|7344051|FG000|Overall Study|Death|0
4527082|NCT01036438|7344052|FG001|Overall Study|Death|1
4527083|NCT01036438|7344051|FG000|Overall Study|No effect of study treatment|3
4527084|NCT01036438|7344052|FG001|Overall Study|No effect of study treatment|1
4527085|NCT01036529|7344069|FG000|Overall Study|Adverse Event|0
4527086|NCT01036529|7344070|FG001|Overall Study|Adverse Event|1
4527087|NCT01036529|7344069|FG000|Overall Study|Lost to Follow-up|0
4527088|NCT01036529|7344070|FG001|Overall Study|Lost to Follow-up|1
4527089|NCT01036529|7344069|FG000|Overall Study|Physician Decision|1
4527090|NCT01036529|7344070|FG001|Overall Study|Physician Decision|0
4527091|NCT01036529|7344069|FG000|Overall Study|Withdrawal by Subject|1
4527092|NCT01036529|7344070|FG001|Overall Study|Withdrawal by Subject|1
4527093|NCT01036529|7344069|FG000|Overall Study|Sponsor study termination|11
4527094|NCT01036529|7344070|FG001|Overall Study|Sponsor study termination|12
4527095|NCT01036594|7344076|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1
4527096|NCT01036594|7344077|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0
4527097|NCT01036594|7344076|FG000|First Treatment Regimen|Withdrawal by Subject|1
4527098|NCT01036594|7344077|FG001|First Treatment Regimen|Withdrawal by Subject|0
4527099|NCT01036594|7344076|FG000|Week 12 Evaluation|Adverse Event|5
4527100|NCT01036594|7344077|FG001|Week 12 Evaluation|Adverse Event|0
4527101|NCT01036594|7344076|FG000|Week 12 Evaluation|Physician Decision|1
4527102|NCT01036594|7344077|FG001|Week 12 Evaluation|Physician Decision|0
4527103|NCT01036594|7344076|FG000|Treatment Regiments Post Week 12|Physician Decision|1
4527104|NCT01036594|7344077|FG001|Treatment Regiments Post Week 12|Physician Decision|1
4527105|NCT01036594|7344076|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1
4527106|NCT01036594|7344077|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0
4527107|NCT01036594|7344076|FG000|Treatment Regiments Post Week 12|Adverse Event|0
4527108|NCT01036594|7344077|FG001|Treatment Regiments Post Week 12|Adverse Event|1
4527109|NCT01036594|7344076|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0
4527110|NCT01036594|7344077|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1
4527111|NCT01036594|7344076|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0
4527112|NCT01036594|7344077|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1
4527113|NCT01036724|7344085|FG000|Overall Study|Adverse Event|1
4527114|NCT01036724|7344086|FG001|Overall Study|Adverse Event|2
4527115|NCT01036724|7344085|FG000|Overall Study|Lack of Efficacy|1
4527116|NCT01036724|7344086|FG001|Overall Study|Lack of Efficacy|1
4527117|NCT01036724|7344085|FG000|Overall Study|Protocol Violation|4
4527118|NCT01036724|7344086|FG001|Overall Study|Protocol Violation|5
4527119|NCT01036763|7344092|FG000|Overall Study|Adverse Event|25
4527120|NCT01036763|7344092|FG000|Overall Study|Lost to Follow-up|28
4527121|NCT01036763|7344092|FG000|Overall Study|Other reason (not specified)|40
4527122|NCT01037088|7344106|FG000|Overall Study|Withdrawal by Subject|3
4527123|NCT01037114|7344115|FG000|Year 20|Others|1
4527124|NCT01037127|7344121|FG000|Overall Study|Lost to Follow-up|2
4527125|NCT01037127|7344122|FG001|Overall Study|Lost to Follow-up|4
4527126|NCT01037127|7344121|FG000|Overall Study|Physician Decision|1
4527127|NCT01037127|7344122|FG001|Overall Study|Physician Decision|0
4527128|NCT01037127|7344121|FG000|Overall Study|Study Closed Terminated|2
4527129|NCT01037127|7344122|FG001|Overall Study|Study Closed Terminated|17
4527130|NCT01037218|7344153|FG000|Overall Study|Adverse Event|4
4527131|NCT01037218|7344154|FG001|Overall Study|Adverse Event|2
4527132|NCT01037218|7344155|FG002|Overall Study|Adverse Event|2
4527133|NCT01037218|7344156|FG003|Overall Study|Adverse Event|1
4527134|NCT01037218|7344153|FG000|Overall Study|Lack of Efficacy|0
4527135|NCT01037218|7344154|FG001|Overall Study|Lack of Efficacy|2
4527136|NCT01037218|7344155|FG002|Overall Study|Lack of Efficacy|1
4527137|NCT01037218|7344156|FG003|Overall Study|Lack of Efficacy|5
4527138|NCT01037218|7344153|FG000|Overall Study|Lost to Follow-up|3
4527139|NCT01037218|7344154|FG001|Overall Study|Lost to Follow-up|5
4527140|NCT01037218|7344155|FG002|Overall Study|Lost to Follow-up|4
4527141|NCT01037218|7344156|FG003|Overall Study|Lost to Follow-up|2
4527142|NCT01037218|7344153|FG000|Overall Study|Withdrawal by Subject|6
4527143|NCT01037218|7344154|FG001|Overall Study|Withdrawal by Subject|7
4746348|NCT00762723|7717462|FG000|Overall Study|Study Terminated slow enrollement|5
4746349|NCT00762723|7717463|FG001|Overall Study|Study Terminated slow enrollement|5
4746350|NCT00762723|7717464|FG002|Overall Study|Study Terminated slow enrollement|3
4746351|NCT00770965|7717476|FG000|Safety Set|Withdrawal by Subject|0
4746352|NCT00770965|7717477|FG001|Safety Set|Withdrawal by Subject|0
4746353|NCT00770965|7717478|FG002|Safety Set|Withdrawal by Subject|0
4746354|NCT00770965|7717479|FG003|Safety Set|Withdrawal by Subject|1
4746355|NCT00770965|7717476|FG000|Safety Set|Protocol deviation|0
4746356|NCT00770965|7717477|FG001|Safety Set|Protocol deviation|0
4746357|NCT00770965|7717478|FG002|Safety Set|Protocol deviation|1
4746358|NCT00770965|7717479|FG003|Safety Set|Protocol deviation|0
4746359|NCT00770965|7717476|FG000|Excluded Set|Administrative problems|14
4746360|NCT00770965|7717477|FG001|Excluded Set|Administrative problems|12
4746361|NCT00770965|7717478|FG002|Excluded Set|Administrative problems|12
4746362|NCT00770965|7717479|FG003|Excluded Set|Administrative problems|10
4746363|NCT00770965|7717476|FG000|Excluded Set|Withdrawal by Subject|1
4746364|NCT00770965|7717477|FG001|Excluded Set|Withdrawal by Subject|1
4746365|NCT00770965|7717478|FG002|Excluded Set|Withdrawal by Subject|2
4746366|NCT00770965|7717479|FG003|Excluded Set|Withdrawal by Subject|3
4527144|NCT01037218|7344155|FG002|Overall Study|Withdrawal by Subject|7
4527145|NCT01037218|7344156|FG003|Overall Study|Withdrawal by Subject|4
4527146|NCT01037218|7344153|FG000|Overall Study|Partner Withdrew Consent|0
4527147|NCT01037218|7344154|FG001|Overall Study|Partner Withdrew Consent|3
4527148|NCT01037218|7344155|FG002|Overall Study|Partner Withdrew Consent|2
4527149|NCT01037218|7344156|FG003|Overall Study|Partner Withdrew Consent|1
4527150|NCT01037218|7344153|FG000|Overall Study|Protocol Violation|0
4527151|NCT01037218|7344154|FG001|Overall Study|Protocol Violation|0
4527152|NCT01037218|7344155|FG002|Overall Study|Protocol Violation|2
4527153|NCT01037218|7344156|FG003|Overall Study|Protocol Violation|2
4527154|NCT01037218|7344153|FG000|Overall Study|Various|3
4527155|NCT01037218|7344154|FG001|Overall Study|Various|2
4527156|NCT01037218|7344155|FG002|Overall Study|Various|3
4527157|NCT01037218|7344156|FG003|Overall Study|Various|1
4527158|NCT01037244|7344170|FG000|Overall Study|Adverse Event|3
4527159|NCT01037244|7344171|FG001|Overall Study|Adverse Event|2
4527160|NCT01037244|7344172|FG002|Overall Study|Adverse Event|6
4527161|NCT01037244|7344173|FG003|Overall Study|Adverse Event|3
4527162|NCT01037244|7344170|FG000|Overall Study|Lack of Efficacy|1
4527163|NCT01037244|7344171|FG001|Overall Study|Lack of Efficacy|1
4527164|NCT01037244|7344172|FG002|Overall Study|Lack of Efficacy|0
4527165|NCT01037244|7344173|FG003|Overall Study|Lack of Efficacy|1
4527166|NCT01037244|7344170|FG000|Overall Study|Lost to Follow-up|3
4527167|NCT01037244|7344171|FG001|Overall Study|Lost to Follow-up|3
4527168|NCT01037244|7344172|FG002|Overall Study|Lost to Follow-up|4
4527169|NCT01037244|7344173|FG003|Overall Study|Lost to Follow-up|4
4527170|NCT01037244|7344170|FG000|Overall Study|Withdrawal by Subject|1
4527171|NCT01037244|7344171|FG001|Overall Study|Withdrawal by Subject|5
4527172|NCT01037244|7344172|FG002|Overall Study|Withdrawal by Subject|3
4527173|NCT01037244|7344173|FG003|Overall Study|Withdrawal by Subject|5
4527174|NCT01037244|7344170|FG000|Overall Study|Partner Withdrew Consent|2
4527175|NCT01037244|7344171|FG001|Overall Study|Partner Withdrew Consent|1
4527176|NCT01037244|7344172|FG002|Overall Study|Partner Withdrew Consent|0
4527177|NCT01037244|7344173|FG003|Overall Study|Partner Withdrew Consent|0
4527178|NCT01037244|7344170|FG000|Overall Study|Various|3
4527179|NCT01037244|7344171|FG001|Overall Study|Various|2
4527180|NCT01037244|7344172|FG002|Overall Study|Various|1
4527181|NCT01037244|7344173|FG003|Overall Study|Various|1
4527182|NCT01037413|7344220|FG000|Part A: Skin Testing|Adverse Event|1
4527183|NCT01037413|7344221|FG001|Part A: Skin Testing|Adverse Event|0
4527184|NCT01037413|7344220|FG000|Part A: Skin Testing|Protocol Violation|1
4527185|NCT01037413|7344221|FG001|Part A: Skin Testing|Protocol Violation|0
4527186|NCT01037413|7344220|FG000|Part B: Scar Revision|Withdrawal by Subject|0
4527187|NCT01037413|7344221|FG001|Part B: Scar Revision|Withdrawal by Subject|1
4527188|NCT01037413|7344220|FG000|Part B: Scar Revision|Assigned But Not Treated|0
4527189|NCT01037413|7344221|FG001|Part B: Scar Revision|Assigned But Not Treated|1
4527190|NCT01037985|7344310|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3
4527191|NCT01037985|7344311|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0
4527192|NCT01037985|7344310|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1
4527193|NCT01037985|7344311|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0
4527194|NCT01037985|7344310|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0
4527195|NCT01037985|7344311|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1
4527196|NCT01037985|7344310|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0
4527197|NCT01037985|7344311|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4
4527198|NCT01038128|7344321|FG000|Overall Study|Lack of Efficacy|1
4527199|NCT01038128|7344321|FG000|Overall Study|Lost to Follow-up|1
4527200|NCT01038128|7344321|FG000|Overall Study|Withdrawal by Subject|2
4527201|NCT01038297|7344330|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1
4527202|NCT01038297|7344331|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0
4527203|NCT01038297|7344332|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0
4527204|NCT01038323|7344352|FG000|Overall Study|Withdrawal by Subject|3
4527205|NCT01038323|7344353|FG001|Overall Study|Withdrawal by Subject|2
4527206|NCT01038323|7344354|FG002|Overall Study|Withdrawal by Subject|4
4527207|NCT01038427|7344383|FG000|Overall Study|Lost to follow up|1
4527208|NCT01038427|7344384|FG001|Overall Study|Lost to follow up|1
4527209|NCT01038427|7344385|FG002|Overall Study|Lost to follow up|0
4527210|NCT01038427|7344383|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0
4527211|NCT01038427|7344384|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0
4527212|NCT01038427|7344385|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1
4527213|NCT01038427|7344383|FG000|Overall Study|Withdrew consent|0
4527214|NCT01038427|7344384|FG001|Overall Study|Withdrew consent|0
4527215|NCT01038427|7344385|FG002|Overall Study|Withdrew consent|1
4527216|NCT01038427|7344383|FG000|Overall Study|Adverse Event|2
4527217|NCT01038427|7344384|FG001|Overall Study|Adverse Event|2
4527218|NCT01038427|7344385|FG002|Overall Study|Adverse Event|1
4594465|NCT01562444|7443696|FG000|Overall Study|Protocol forbidden concomitant vaccine|1
4594466|NCT01562444|7443697|FG001|Overall Study|Protocol forbidden concomitant vaccine|0
4594467|NCT01562444|7443698|FG002|Overall Study|Protocol forbidden concomitant vaccine|1
4594468|NCT01562444|7443696|FG000|Overall Study|Protocol forbidden medication|1
4594469|NCT01562444|7443697|FG001|Overall Study|Protocol forbidden medication|0
4746367|NCT00769002|7717493|FG000|Overall Study|Study was not completed, no data|9
4746368|NCT00769002|7717494|FG001|Overall Study|Study was not completed, no data|9
4527219|NCT01038427|7344383|FG000|Overall Study|Enrolled in error|0
4527220|NCT01038427|7344384|FG001|Overall Study|Enrolled in error|1
4527221|NCT01038427|7344385|FG002|Overall Study|Enrolled in error|1
4527222|NCT01038427|7344383|FG000|Overall Study|Other|0
4527223|NCT01038427|7344384|FG001|Overall Study|Other|2
4527224|NCT01038427|7344385|FG002|Overall Study|Other|0
4527225|NCT01038609|7344411|FG000|Overall Study|Adverse Event|0
4527226|NCT01038609|7344412|FG001|Overall Study|Adverse Event|0
4527227|NCT01038609|7344413|FG002|Overall Study|Adverse Event|1
4527228|NCT01038609|7344414|FG003|Overall Study|Adverse Event|0
4527229|NCT01038609|7344415|FG004|Overall Study|Adverse Event|0
4527230|NCT01038609|7344411|FG000|Overall Study|Dosing Error|0
4527231|NCT01038609|7344412|FG001|Overall Study|Dosing Error|0
4527232|NCT01038609|7344413|FG002|Overall Study|Dosing Error|0
4527233|NCT01038609|7344414|FG003|Overall Study|Dosing Error|1
4527234|NCT01038609|7344415|FG004|Overall Study|Dosing Error|1
4527235|NCT01038609|7344411|FG000|Overall Study|Death in the Family|1
4527236|NCT01038609|7344412|FG001|Overall Study|Death in the Family|0
4527237|NCT01038609|7344413|FG002|Overall Study|Death in the Family|0
4527238|NCT01038609|7344414|FG003|Overall Study|Death in the Family|0
4527239|NCT01038609|7344415|FG004|Overall Study|Death in the Family|0
4527240|NCT01038609|7344411|FG000|Overall Study|Refusal of Blood Draws|0
4527241|NCT01038609|7344412|FG001|Overall Study|Refusal of Blood Draws|1
4527242|NCT01038609|7344413|FG002|Overall Study|Refusal of Blood Draws|0
4527243|NCT01038609|7344414|FG003|Overall Study|Refusal of Blood Draws|0
4527244|NCT01038609|7344415|FG004|Overall Study|Refusal of Blood Draws|0
4527245|NCT01038635|7344436|FG000|Overall Study|Disease Progression|2
4527246|NCT01038635|7344437|FG001|Overall Study|Disease Progression|0
4634644|NCT01926782|7505864|FG005|Overall Study|Randomized and not treated|0
4527247|NCT01038635|7344438|FG002|Overall Study|Disease Progression|0
4527248|NCT01038635|7344439|FG003|Overall Study|Disease Progression|0
4527249|NCT01038635|7344440|FG004|Overall Study|Disease Progression|0
4527250|NCT01038635|7344441|FG005|Overall Study|Disease Progression|0
4527251|NCT01038635|7344442|FG006|Overall Study|Disease Progression|1
4527252|NCT01038635|7344443|FG007|Overall Study|Disease Progression|4
4527253|NCT01038635|7344444|FG008|Overall Study|Disease Progression|0
4527254|NCT01038635|7344436|FG000|Overall Study|Death|0
4527255|NCT01038635|7344437|FG001|Overall Study|Death|0
4527256|NCT01038635|7344438|FG002|Overall Study|Death|0
4527257|NCT01038635|7344439|FG003|Overall Study|Death|0
4527258|NCT01038635|7344440|FG004|Overall Study|Death|1
4527259|NCT01038635|7344441|FG005|Overall Study|Death|0
4527260|NCT01038635|7344442|FG006|Overall Study|Death|1
4527261|NCT01038635|7344443|FG007|Overall Study|Death|1
4527262|NCT01038635|7344444|FG008|Overall Study|Death|2
4527263|NCT01038687|7344468|FG000|Overall Study|Adverse Event|0
4527264|NCT01038687|7344469|FG001|Overall Study|Adverse Event|2
4527265|NCT01038687|7344470|FG002|Overall Study|Adverse Event|1
4527266|NCT01038713|7344481|FG000|Overall Study|Patient to hospice|1
4527267|NCT01038713|7344482|FG001|Overall Study|Patient to hospice|1
4527268|NCT01038713|7344483|FG002|Overall Study|Patient to hospice|1
4527269|NCT01038713|7344481|FG000|Overall Study|Lost to Follow-up|3
4527270|NCT01038713|7344482|FG001|Overall Study|Lost to Follow-up|0
4527271|NCT01038713|7344483|FG002|Overall Study|Lost to Follow-up|0
4527272|NCT01038713|7344481|FG000|Overall Study|Neuroendocrine Tumor|0
4527273|NCT01038713|7344482|FG001|Overall Study|Neuroendocrine Tumor|1
4527274|NCT01038713|7344483|FG002|Overall Study|Neuroendocrine Tumor|0
4527275|NCT01038713|7344481|FG000|Overall Study|died from PEP|0
4527276|NCT01038713|7344482|FG001|Overall Study|died from PEP|1
4527277|NCT01038713|7344483|FG002|Overall Study|died from PEP|0
4527278|NCT01038713|7344481|FG000|Overall Study|Autoimmune Pancreatitis|1
4527279|NCT01038713|7344482|FG001|Overall Study|Autoimmune Pancreatitis|0
4527280|NCT01038713|7344483|FG002|Overall Study|Autoimmune Pancreatitis|0
4634645|NCT01926782|7505859|FG000|Overall Study|Withdrawal by Subject|6
4634646|NCT01926782|7505860|FG001|Overall Study|Withdrawal by Subject|1
4527281|NCT01038778|7344493|FG000|Overall Study|Withdrawal by Subject|0
4527282|NCT01038778|7344494|FG001|Overall Study|Withdrawal by Subject|2
4527283|NCT01038778|7344495|FG002|Overall Study|Withdrawal by Subject|3
4527284|NCT01038856|7344502|FG000|Overall Study|Adverse Event|2
4527285|NCT01038869|7344508|FG000|Overall Study|Withdrawal by Subject|1
4527286|NCT01038869|7344508|FG000|Overall Study|Lost to Follow-up|6
4527287|NCT01038921|7344518|FG000|Overall Study|Withdrawal by Subject|1
4527288|NCT01038921|7344519|FG001|Overall Study|Withdrawal by Subject|0
4527289|NCT01038921|7344518|FG000|Overall Study|Physician Decision|1
4527290|NCT01038921|7344519|FG001|Overall Study|Physician Decision|0
4527291|NCT01039376|7344531|FG000|Overall Study|Lost to Follow-up|5
4527292|NCT01039376|7344532|FG001|Overall Study|Lost to Follow-up|12
4527293|NCT01039376|7344531|FG000|Overall Study|Physician Decision|15
4527294|NCT01039376|7344532|FG001|Overall Study|Physician Decision|10
4527295|NCT01039376|7344531|FG000|Overall Study|Withdrawal by Subject|20
4527296|NCT01039376|7344532|FG001|Overall Study|Withdrawal by Subject|32
4527297|NCT01039376|7344531|FG000|Overall Study|Study terminated by Sponsor|90
4527298|NCT01039376|7344532|FG001|Overall Study|Study terminated by Sponsor|72
4527299|NCT01039428|7344541|FG000|Overall Study|Protocol Violation|1
4527300|NCT01039428|7344542|FG001|Overall Study|Protocol Violation|0
4527301|NCT01039428|7344541|FG000|Overall Study|Withdrawal by Subject|1
4527302|NCT01039428|7344542|FG001|Overall Study|Withdrawal by Subject|0
4527303|NCT01039519|7344559|FG000|Treatment|Progressive disease|20
4527304|NCT01039519|7344559|FG000|Treatment|Treatment failure|2
4527305|NCT01039519|7344559|FG000|Treatment|Adverse Event|3
4527306|NCT01039519|7344559|FG000|Treatment|Physician Decision|2
4527307|NCT01039519|7344559|FG000|Survival Follow-up|Death|23
4527308|NCT01039519|7344559|FG000|Survival Follow-up|Sponsor decision|4
4527309|NCT01039584|7344566|FG000|Overall Study|Withdrawal by Subject|4
4527310|NCT01039584|7344567|FG001|Overall Study|Withdrawal by Subject|2
4527311|NCT01039584|7344568|FG002|Overall Study|Withdrawal by Subject|1
4527312|NCT01039584|7344566|FG000|Overall Study|Protocol Violation|10
4527313|NCT01039584|7344567|FG001|Overall Study|Protocol Violation|4
4527314|NCT01039584|7344568|FG002|Overall Study|Protocol Violation|6
4527315|NCT01039584|7344566|FG000|Overall Study|Lost to Follow-up|5
4527316|NCT01039584|7344567|FG001|Overall Study|Lost to Follow-up|3
4527317|NCT01039584|7344568|FG002|Overall Study|Lost to Follow-up|4
4527318|NCT01039584|7344566|FG000|Overall Study|Negative Baseline culture for Candida|59
4527319|NCT01039584|7344567|FG001|Overall Study|Negative Baseline culture for Candida|59
4634647|NCT01926782|7505861|FG002|Overall Study|Withdrawal by Subject|8
4527320|NCT01039584|7344568|FG002|Overall Study|Negative Baseline culture for Candida|24
4527321|NCT01039584|7344566|FG000|Overall Study|Lack of Efficacy|7
4527322|NCT01039584|7344567|FG001|Overall Study|Lack of Efficacy|6
4527323|NCT01039584|7344568|FG002|Overall Study|Lack of Efficacy|10
4527324|NCT01039584|7344566|FG000|Overall Study|other|1
4527325|NCT01039584|7344567|FG001|Overall Study|other|3
4527326|NCT01039584|7344568|FG002|Overall Study|other|1
4527327|NCT01039584|7344566|FG000|Overall Study|Pap smear with significant pathology|10
4527328|NCT01039584|7344567|FG001|Overall Study|Pap smear with significant pathology|10
4527329|NCT01039584|7344568|FG002|Overall Study|Pap smear with significant pathology|3
4527330|NCT01039584|7344566|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7
4527331|NCT01039584|7344567|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10
4527332|NCT01039584|7344568|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8
4527333|NCT01039675|7344578|FG000|Overall Study|Adverse Event|0
4527334|NCT01039675|7344579|FG001|Overall Study|Adverse Event|2
4527335|NCT01039675|7344578|FG000|Overall Study|Lack of Efficacy|0
4527336|NCT01039675|7344579|FG001|Overall Study|Lack of Efficacy|2
4527337|NCT01039675|7344578|FG000|Overall Study|Withdrawal by Subject|0
4527338|NCT01039675|7344579|FG001|Overall Study|Withdrawal by Subject|1
4527339|NCT01039675|7344578|FG000|Overall Study|Lost to Follow-up|0
4527340|NCT01039675|7344579|FG001|Overall Study|Lost to Follow-up|1
4527341|NCT01039675|7344578|FG000|Overall Study|Physician Decision|0
4527342|NCT01039675|7344579|FG001|Overall Study|Physician Decision|1
4527343|NCT01039688|7344588|FG000|Overall Study|Adverse Event|38
4527344|NCT01039688|7344589|FG001|Overall Study|Adverse Event|39
4634648|NCT01926782|7505862|FG003|Overall Study|Withdrawal by Subject|1
4527345|NCT01039688|7344590|FG002|Overall Study|Adverse Event|24
4527346|NCT01039688|7344588|FG000|Overall Study|Lack of Efficacy|20
4527347|NCT01039688|7344589|FG001|Overall Study|Lack of Efficacy|11
4527348|NCT01039688|7344590|FG002|Overall Study|Lack of Efficacy|26
4527349|NCT01039688|7344588|FG000|Overall Study|Lost to Follow-up|11
4527350|NCT01039688|7344589|FG001|Overall Study|Lost to Follow-up|9
4527351|NCT01039688|7344590|FG002|Overall Study|Lost to Follow-up|5
4527352|NCT01039688|7344588|FG000|Overall Study|Other|13
4527353|NCT01039688|7344589|FG001|Overall Study|Other|25
4527354|NCT01039688|7344590|FG002|Overall Study|Other|12
4527355|NCT01039688|7344588|FG000|Overall Study|Withdrawal by Subject|23
4527356|NCT01039688|7344589|FG001|Overall Study|Withdrawal by Subject|27
4527357|NCT01039688|7344590|FG002|Overall Study|Withdrawal by Subject|13
4527358|NCT01039688|7344588|FG000|Overall Study|Death|2
4527359|NCT01039688|7344589|FG001|Overall Study|Death|0
4527360|NCT01039688|7344590|FG002|Overall Study|Death|0
4527361|NCT01040130|7344614|FG000|Overall Study|Adverse Event|1
4527362|NCT01040130|7344615|FG001|Overall Study|Adverse Event|1
4527363|NCT01040130|7344616|FG002|Overall Study|Adverse Event|0
4527364|NCT01040130|7344617|FG003|Overall Study|Adverse Event|5
4527365|NCT01040130|7344618|FG004|Overall Study|Adverse Event|0
4527366|NCT01040130|7344619|FG005|Overall Study|Adverse Event|3
4527367|NCT01040130|7344614|FG000|Overall Study|Protocol Violation|0
4527368|NCT01040130|7344615|FG001|Overall Study|Protocol Violation|0
4527369|NCT01040130|7344616|FG002|Overall Study|Protocol Violation|2
4527370|NCT01040130|7344617|FG003|Overall Study|Protocol Violation|0
4527371|NCT01040130|7344618|FG004|Overall Study|Protocol Violation|0
4527372|NCT01040130|7344619|FG005|Overall Study|Protocol Violation|0
4634649|NCT01926782|7505863|FG004|Overall Study|Withdrawal by Subject|0
4527373|NCT01040130|7344614|FG000|Overall Study|Withdrawal by Subject|0
4527374|NCT01040130|7344615|FG001|Overall Study|Withdrawal by Subject|2
4527375|NCT01040130|7344616|FG002|Overall Study|Withdrawal by Subject|0
4527376|NCT01040130|7344617|FG003|Overall Study|Withdrawal by Subject|0
4527377|NCT01040130|7344618|FG004|Overall Study|Withdrawal by Subject|0
4527378|NCT01040130|7344619|FG005|Overall Study|Withdrawal by Subject|1
4527379|NCT01040130|7344614|FG000|Overall Study|Other reasons not listed above|2
4527380|NCT01040130|7344615|FG001|Overall Study|Other reasons not listed above|0
4527381|NCT01040130|7344616|FG002|Overall Study|Other reasons not listed above|0
4527382|NCT01040130|7344617|FG003|Overall Study|Other reasons not listed above|0
4527383|NCT01040130|7344618|FG004|Overall Study|Other reasons not listed above|0
4527384|NCT01040130|7344619|FG005|Overall Study|Other reasons not listed above|0
4527385|NCT01040169|7344631|FG000|Overall Study|Lost to Follow-up|3
4527386|NCT01040169|7344632|FG001|Overall Study|Lost to Follow-up|8
4527387|NCT01040260|7344658|FG000|Overall Study|Withdrawal by Subject|12
4527388|NCT01040260|7344659|FG001|Overall Study|Withdrawal by Subject|6
4527389|NCT01040260|7344658|FG000|Overall Study|Lost to Follow-up|3
4527390|NCT01040260|7344659|FG001|Overall Study|Lost to Follow-up|5
4527391|NCT01040351|7344667|FG000|Overall Study|poor ovarian response|1
4527392|NCT01040351|7344668|FG001|Overall Study|poor ovarian response|2
4527393|NCT01040403|7344674|FG000|Overall Study|Adverse Event|10
4527394|NCT01040403|7344674|FG000|Overall Study|Protocol Violation|2
4527395|NCT01040403|7344674|FG000|Overall Study|Lost to Follow-up|1
4527396|NCT01040403|7344674|FG000|Overall Study|Not treated|1
4527397|NCT01040403|7344674|FG000|Overall Study|Other reason not defined above|6
4527398|NCT01040689|7344693|FG000|Overall Study|Adverse Event|0
4527399|NCT01040689|7344694|FG001|Overall Study|Adverse Event|0
4527400|NCT01040689|7344695|FG002|Overall Study|Adverse Event|2
4527401|NCT01040689|7344696|FG003|Overall Study|Adverse Event|4
4527402|NCT01040689|7344693|FG000|Overall Study|Lack of Efficacy|0
4527403|NCT01040689|7344694|FG001|Overall Study|Lack of Efficacy|0
4527404|NCT01040689|7344695|FG002|Overall Study|Lack of Efficacy|1
4527405|NCT01040689|7344696|FG003|Overall Study|Lack of Efficacy|0
4527406|NCT01040689|7344693|FG000|Overall Study|Lost to Follow-up|1
4527407|NCT01040689|7344694|FG001|Overall Study|Lost to Follow-up|0
4527408|NCT01040689|7344695|FG002|Overall Study|Lost to Follow-up|0
4527409|NCT01040689|7344696|FG003|Overall Study|Lost to Follow-up|0
4527410|NCT01040689|7344693|FG000|Overall Study|Withdrawal by Subject|2
4527411|NCT01040689|7344694|FG001|Overall Study|Withdrawal by Subject|1
4527412|NCT01040689|7344695|FG002|Overall Study|Withdrawal by Subject|1
4527413|NCT01040689|7344696|FG003|Overall Study|Withdrawal by Subject|0
4527414|NCT01040689|7344693|FG000|Overall Study|Other reasons not listed above|0
4527415|NCT01040689|7344694|FG001|Overall Study|Other reasons not listed above|1
4527416|NCT01040689|7344695|FG002|Overall Study|Other reasons not listed above|0
4527417|NCT01040689|7344696|FG003|Overall Study|Other reasons not listed above|0
4527418|NCT01040728|7344711|FG000|Overall Study|Adverse Event|4
4527419|NCT01040728|7344712|FG001|Overall Study|Adverse Event|8
4527420|NCT01040728|7344713|FG002|Overall Study|Adverse Event|0
4527421|NCT01040728|7344714|FG003|Overall Study|Adverse Event|4
4527422|NCT01040728|7344711|FG000|Overall Study|Withdrawal by Subject|0
4527423|NCT01040728|7344712|FG001|Overall Study|Withdrawal by Subject|1
4527424|NCT01040728|7344713|FG002|Overall Study|Withdrawal by Subject|1
4527425|NCT01040728|7344714|FG003|Overall Study|Withdrawal by Subject|0
4527426|NCT01040728|7344711|FG000|Overall Study|Protocol Violation|0
4527427|NCT01040728|7344712|FG001|Overall Study|Protocol Violation|0
4527428|NCT01040728|7344713|FG002|Overall Study|Protocol Violation|0
4527429|NCT01040728|7344714|FG003|Overall Study|Protocol Violation|1
4527430|NCT01040728|7344711|FG000|Overall Study|Lack of Efficacy|0
4527431|NCT01040728|7344712|FG001|Overall Study|Lack of Efficacy|1
4527432|NCT01040728|7344713|FG002|Overall Study|Lack of Efficacy|0
4527433|NCT01040728|7344714|FG003|Overall Study|Lack of Efficacy|1
4527434|NCT01040728|7344711|FG000|Overall Study|Other reasons not listed above|0
4527435|NCT01040728|7344712|FG001|Overall Study|Other reasons not listed above|1
4527436|NCT01040728|7344713|FG002|Overall Study|Other reasons not listed above|0
4527437|NCT01040728|7344714|FG003|Overall Study|Other reasons not listed above|0
4527438|NCT01040780|7344732|FG000|Overall Study|Protocol Violation|1
4527439|NCT01040780|7344733|FG001|Overall Study|Protocol Violation|3
4527440|NCT01040793|7344742|FG000|Overall Study|Adverse Event|5
4527441|NCT01040793|7344743|FG001|Overall Study|Adverse Event|3
4527442|NCT01040793|7344744|FG002|Overall Study|Adverse Event|0
4527443|NCT01040793|7344745|FG003|Overall Study|Adverse Event|2
4527444|NCT01040793|7344746|FG004|Overall Study|Adverse Event|2
4527445|NCT01040793|7344747|FG005|Overall Study|Adverse Event|1
4527446|NCT01040793|7344742|FG000|Overall Study|Protocol Violation|1
4527447|NCT01040793|7344743|FG001|Overall Study|Protocol Violation|1
4527448|NCT01040793|7344744|FG002|Overall Study|Protocol Violation|1
4527449|NCT01040793|7344745|FG003|Overall Study|Protocol Violation|0
4527450|NCT01040793|7344746|FG004|Overall Study|Protocol Violation|1
4527451|NCT01040793|7344747|FG005|Overall Study|Protocol Violation|0
4527452|NCT01040793|7344742|FG000|Overall Study|Lost to Follow-up|0
4527453|NCT01040793|7344743|FG001|Overall Study|Lost to Follow-up|1
4527454|NCT01040793|7344744|FG002|Overall Study|Lost to Follow-up|1
4527455|NCT01040793|7344745|FG003|Overall Study|Lost to Follow-up|0
4527456|NCT01040793|7344746|FG004|Overall Study|Lost to Follow-up|0
4527457|NCT01040793|7344747|FG005|Overall Study|Lost to Follow-up|0
4527458|NCT01040793|7344742|FG000|Overall Study|Withdrawal by Subject|0
4527459|NCT01040793|7344743|FG001|Overall Study|Withdrawal by Subject|0
4527460|NCT01040793|7344744|FG002|Overall Study|Withdrawal by Subject|0
4527461|NCT01040793|7344745|FG003|Overall Study|Withdrawal by Subject|2
4527462|NCT01040793|7344746|FG004|Overall Study|Withdrawal by Subject|0
4527463|NCT01040793|7344747|FG005|Overall Study|Withdrawal by Subject|0
4527464|NCT01040793|7344742|FG000|Overall Study|Other reasons not listed above|0
4527465|NCT01040793|7344743|FG001|Overall Study|Other reasons not listed above|0
4527466|NCT01040793|7344744|FG002|Overall Study|Other reasons not listed above|1
4527467|NCT01040793|7344745|FG003|Overall Study|Other reasons not listed above|0
4527468|NCT01040793|7344746|FG004|Overall Study|Other reasons not listed above|1
4527469|NCT01040793|7344747|FG005|Overall Study|Other reasons not listed above|0
4527470|NCT01040832|7344768|FG000|Overall Study|Adverse Event|4
4527471|NCT01040832|7344769|FG001|Overall Study|Adverse Event|5
4527472|NCT01040832|7344768|FG000|Overall Study|Death|4
4527473|NCT01040832|7344769|FG001|Overall Study|Death|6
4527474|NCT01040832|7344768|FG000|Overall Study|Withdrawal by Subject|2
4527475|NCT01040832|7344769|FG001|Overall Study|Withdrawal by Subject|3
4527476|NCT01040832|7344768|FG000|Overall Study|Progressive disease|32
4527477|NCT01040832|7344769|FG001|Overall Study|Progressive disease|17
4527478|NCT01040832|7344768|FG000|Overall Study|Symptomatic deterioration|2
4527479|NCT01040832|7344769|FG001|Overall Study|Symptomatic deterioration|5
4527480|NCT01040832|7344768|FG000|Overall Study|Other|2
4527481|NCT01040832|7344769|FG001|Overall Study|Other|1
4527482|NCT01040845|7344777|FG000|Overall Study|Withdrawal by Subject|1
4527483|NCT01040845|7344778|FG001|Overall Study|Withdrawal by Subject|1
4527484|NCT01040845|7344777|FG000|Overall Study|Physician Decision|1
4527485|NCT01040845|7344778|FG001|Overall Study|Physician Decision|0
4527486|NCT01040871|7344800|FG000|Overall Study|Adverse Event|6
4527487|NCT01040871|7344801|FG001|Overall Study|Adverse Event|2
4527488|NCT01040871|7344800|FG000|Overall Study|Withdrawal by Subject|2
4527489|NCT01040871|7344801|FG001|Overall Study|Withdrawal by Subject|0
4527490|NCT01040871|7344800|FG000|Overall Study|Death|1
4527491|NCT01040871|7344801|FG001|Overall Study|Death|3
4527492|NCT01040871|7344800|FG000|Overall Study|Lack of Efficacy|1
4527493|NCT01040871|7344801|FG001|Overall Study|Lack of Efficacy|1
4527494|NCT01040871|7344800|FG000|Overall Study|drug supply issue|1
4527495|NCT01040871|7344801|FG001|Overall Study|drug supply issue|0
4527496|NCT01040871|7344800|FG000|Overall Study|Randomized and Not Treated|2
4527497|NCT01040871|7344801|FG001|Overall Study|Randomized and Not Treated|1
4594470|NCT01562444|7443698|FG002|Overall Study|Protocol forbidden medication|0
4594471|NCT01562548|7443710|FG000|Overall Study|Lost to Follow-up|0
4594472|NCT01562548|7443711|FG001|Overall Study|Lost to Follow-up|0
4594473|NCT01562548|7443712|FG002|Overall Study|Lost to Follow-up|1
4594474|NCT01562548|7443713|FG003|Overall Study|Lost to Follow-up|0
4594475|NCT01562613|7443725|FG000|Overall Study|Lost to Follow-up|2
4594476|NCT01562613|7443725|FG000|Overall Study|Withdrawal by Subject|2
4594477|NCT01562743|7443738|FG000|Overall Study|Adverse Event|29
4594478|NCT01562743|7443738|FG000|Overall Study|Lack of Efficacy|3
4594479|NCT01562743|7443738|FG000|Overall Study|Withdrawal by Subject|13
4594480|NCT01562743|7443738|FG000|Overall Study|Protocol Violation|1
4594481|NCT01562743|7443738|FG000|Overall Study|Discontinuation criteria|2
4594482|NCT01562743|7443738|FG000|Overall Study|Lost to Follow-up|2
4594483|NCT01562743|7443738|FG000|Overall Study|Physician Decision|2
4594484|NCT01562782|7443748|FG000|Overall Study|Withdrawal by Subject|3
4594485|NCT01562782|7443749|FG001|Overall Study|Withdrawal by Subject|3
4594486|NCT01562782|7443748|FG000|Overall Study|screen failure|1
4594487|NCT01562782|7443749|FG001|Overall Study|screen failure|2
4594488|NCT01562873|7443755|FG000|Overall Study|Disease Progression per RECIST|10
4594489|NCT01562873|7443756|FG001|Overall Study|Disease Progression per RECIST|0
4594490|NCT01562873|7443755|FG000|Overall Study|Adverse Event|1
4594491|NCT01562873|7443756|FG001|Overall Study|Adverse Event|0
4594492|NCT01562873|7443755|FG000|Overall Study|Clinical Disease Progression|9
4594493|NCT01562873|7443756|FG001|Overall Study|Clinical Disease Progression|0
4594494|NCT01562873|7443755|FG000|Overall Study|Clinical PD and adverse event|1
4594495|NCT01562873|7443756|FG001|Overall Study|Clinical PD and adverse event|0
4594496|NCT01563029|7443778|FG000|Overall Study|Adverse Event|1
4594497|NCT01563029|7443779|FG001|Overall Study|Adverse Event|0
4594498|NCT01563029|7443780|FG002|Overall Study|Adverse Event|1
4594499|NCT01563029|7443781|FG003|Overall Study|Adverse Event|2
4594500|NCT01563029|7443782|FG004|Overall Study|Adverse Event|1
4594501|NCT01563029|7443778|FG000|Overall Study|Lack of Efficacy|42
4594502|NCT01563029|7443779|FG001|Overall Study|Lack of Efficacy|16
4594503|NCT01563029|7443780|FG002|Overall Study|Lack of Efficacy|23
4594504|NCT01563029|7443781|FG003|Overall Study|Lack of Efficacy|21
4594505|NCT01563029|7443782|FG004|Overall Study|Lack of Efficacy|19
4594506|NCT01563029|7443778|FG000|Overall Study|Protocol Violation|1
4594507|NCT01563029|7443779|FG001|Overall Study|Protocol Violation|2
4594508|NCT01563029|7443780|FG002|Overall Study|Protocol Violation|3
4594509|NCT01563029|7443781|FG003|Overall Study|Protocol Violation|1
4594510|NCT01563029|7443782|FG004|Overall Study|Protocol Violation|3
4594511|NCT01563029|7443778|FG000|Overall Study|Protocol defined stopping criteria|1
4594512|NCT01563029|7443779|FG001|Overall Study|Protocol defined stopping criteria|0
4594513|NCT01563029|7443780|FG002|Overall Study|Protocol defined stopping criteria|0
4594514|NCT01563029|7443781|FG003|Overall Study|Protocol defined stopping criteria|0
4594515|NCT01563029|7443782|FG004|Overall Study|Protocol defined stopping criteria|0
4594516|NCT01563029|7443778|FG000|Overall Study|Lost to Follow-up|1
4594517|NCT01563029|7443779|FG001|Overall Study|Lost to Follow-up|0
4594518|NCT01563029|7443780|FG002|Overall Study|Lost to Follow-up|1
4594519|NCT01563029|7443781|FG003|Overall Study|Lost to Follow-up|1
4594520|NCT01563029|7443782|FG004|Overall Study|Lost to Follow-up|1
4594521|NCT01563029|7443778|FG000|Overall Study|Physician Decision|3
4594522|NCT01563029|7443779|FG001|Overall Study|Physician Decision|5
4594523|NCT01563029|7443780|FG002|Overall Study|Physician Decision|2
4594524|NCT01563029|7443781|FG003|Overall Study|Physician Decision|4
4594525|NCT01563029|7443782|FG004|Overall Study|Physician Decision|2
4594526|NCT01563029|7443778|FG000|Overall Study|Withdrawal by Subject|4
4594527|NCT01563029|7443779|FG001|Overall Study|Withdrawal by Subject|1
4594528|NCT01563029|7443780|FG002|Overall Study|Withdrawal by Subject|3
4594529|NCT01563029|7443781|FG003|Overall Study|Withdrawal by Subject|4
4527498|NCT01041287|7344833|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3
4527499|NCT01041287|7344834|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3
4527500|NCT01041287|7344833|FG000|Treatment Period 2 (3 Months)|Adverse Event|0
4527501|NCT01041287|7344834|FG001|Treatment Period 2 (3 Months)|Adverse Event|2
4527502|NCT01041404|7344842|FG000|Overall Study|Adverse Event|45
4527503|NCT01041404|7344843|FG001|Overall Study|Adverse Event|35
4527504|NCT01041404|7344842|FG000|Overall Study|Lack of Efficacy|200
4527505|NCT01041404|7344843|FG001|Overall Study|Lack of Efficacy|210
4527506|NCT01041404|7344842|FG000|Overall Study|Violation of Selection Criteria|0
4527507|NCT01041404|7344843|FG001|Overall Study|Violation of Selection Criteria|1
4527508|NCT01041404|7344842|FG000|Overall Study|Protocol Violation|4
4527509|NCT01041404|7344843|FG001|Overall Study|Protocol Violation|0
4527510|NCT01041404|7344842|FG000|Overall Study|Withdrawal by Subject|29
4527511|NCT01041404|7344843|FG001|Overall Study|Withdrawal by Subject|23
4527512|NCT01041404|7344842|FG000|Overall Study|Failure to Return|1
4527513|NCT01041404|7344843|FG001|Overall Study|Failure to Return|2
4527514|NCT01041404|7344842|FG000|Overall Study|Other|11
4527515|NCT01041404|7344843|FG001|Overall Study|Other|23
4527516|NCT01041417|7344854|FG000|Overall Study|Adverse Event|5
4527517|NCT01041417|7344855|FG001|Overall Study|Adverse Event|2
4527518|NCT01041417|7344854|FG000|Overall Study|Lost to Follow-up|1
4527519|NCT01041417|7344855|FG001|Overall Study|Lost to Follow-up|1
4527520|NCT01041417|7344854|FG000|Overall Study|Death|1
4527521|NCT01041417|7344855|FG001|Overall Study|Death|0
4527522|NCT01041495|7344865|FG000|Overall Study|Withdrawal by Subject|2
4527523|NCT01041495|7344866|FG001|Overall Study|Withdrawal by Subject|5
4527524|NCT01041495|7344865|FG000|Overall Study|Adverse Event|2
4527525|NCT01041495|7344866|FG001|Overall Study|Adverse Event|1
4527526|NCT01041495|7344865|FG000|Overall Study|Lost to Follow-up|0
4527527|NCT01041495|7344866|FG001|Overall Study|Lost to Follow-up|1
4527528|NCT01041573|7344885|FG000|Overall Study|Withdrawal by Subject|2
4527529|NCT01041573|7344886|FG001|Overall Study|Withdrawal by Subject|5
4527530|NCT01041573|7344887|FG002|Overall Study|Withdrawal by Subject|2
4527531|NCT01041573|7344888|FG003|Overall Study|Withdrawal by Subject|0
4527532|NCT01041573|7344885|FG000|Overall Study|Death|1
4527533|NCT01041573|7344886|FG001|Overall Study|Death|0
4527534|NCT01041573|7344887|FG002|Overall Study|Death|0
4527535|NCT01041573|7344888|FG003|Overall Study|Death|0
4527536|NCT01041573|7344885|FG000|Overall Study|Lost to Follow-up|0
4527537|NCT01041573|7344886|FG001|Overall Study|Lost to Follow-up|1
4527538|NCT01041573|7344887|FG002|Overall Study|Lost to Follow-up|2
4527539|NCT01041573|7344888|FG003|Overall Study|Lost to Follow-up|1
4527540|NCT01041573|7344885|FG000|Overall Study|Adverse Event|0
4527541|NCT01041573|7344886|FG001|Overall Study|Adverse Event|2
4527542|NCT01041573|7344887|FG002|Overall Study|Adverse Event|0
4527543|NCT01041573|7344888|FG003|Overall Study|Adverse Event|0
4527544|NCT01041573|7344885|FG000|Overall Study|relocation|1
4527545|NCT01041573|7344886|FG001|Overall Study|relocation|4
4527546|NCT01041573|7344887|FG002|Overall Study|relocation|3
4527547|NCT01041573|7344888|FG003|Overall Study|relocation|1
4527548|NCT01041573|7344885|FG000|Overall Study|further blood extraction|0
4527549|NCT01041573|7344886|FG001|Overall Study|further blood extraction|1
4527550|NCT01041573|7344887|FG002|Overall Study|further blood extraction|0
4527551|NCT01041573|7344888|FG003|Overall Study|further blood extraction|0
4527552|NCT01041573|7344885|FG000|Overall Study|positive to anti-HCV|1
4527553|NCT01041573|7344886|FG001|Overall Study|positive to anti-HCV|0
4527554|NCT01041573|7344887|FG002|Overall Study|positive to anti-HCV|0
4527555|NCT01041573|7344888|FG003|Overall Study|positive to anti-HCV|0
4527556|NCT01041638|7344907|FG000|Overall Study|Adverse Event|4
4527557|NCT01041638|7344907|FG000|Overall Study|Death|1
4527558|NCT01041638|7344907|FG000|Overall Study|Lack of Efficacy|7
4527559|NCT01041638|7344907|FG000|Overall Study|Physician Decision|4
4527560|NCT01041638|7344907|FG000|Overall Study|Withdrawal by Subject|11
4527561|NCT01041859|7344930|FG000|Open-Label Titration|Adverse Event|69
4527562|NCT01041859|7344931|FG001|Open-Label Titration|Adverse Event|0
4527563|NCT01041859|7344932|FG002|Open-Label Titration|Adverse Event|0
4527564|NCT01041859|7344930|FG000|Open-Label Titration|Lack of Efficacy|3
4527565|NCT01041859|7344931|FG001|Open-Label Titration|Lack of Efficacy|0
4527566|NCT01041859|7344932|FG002|Open-Label Titration|Lack of Efficacy|0
4527567|NCT01041859|7344930|FG000|Open-Label Titration|Lost to Follow-up|1
4527568|NCT01041859|7344931|FG001|Open-Label Titration|Lost to Follow-up|0
4527569|NCT01041859|7344932|FG002|Open-Label Titration|Lost to Follow-up|0
4527570|NCT01041859|7344930|FG000|Open-Label Titration|Physician Decision|1
4527571|NCT01041859|7344931|FG001|Open-Label Titration|Physician Decision|0
4527572|NCT01041859|7344932|FG002|Open-Label Titration|Physician Decision|0
4527573|NCT01041859|7344930|FG000|Open-Label Titration|Protocol Violation|1
4527574|NCT01041859|7344931|FG001|Open-Label Titration|Protocol Violation|0
4527575|NCT01041859|7344932|FG002|Open-Label Titration|Protocol Violation|0
4527576|NCT01041859|7344930|FG000|Open-Label Titration|Other|7
4527577|NCT01041859|7344931|FG001|Open-Label Titration|Other|0
4527578|NCT01041859|7344932|FG002|Open-Label Titration|Other|0
4527579|NCT01041859|7344930|FG000|Open-Label Titration|Noncompliance With Study Drug|8
4527580|NCT01041859|7344931|FG001|Open-Label Titration|Noncompliance With Study Drug|0
4527581|NCT01041859|7344932|FG002|Open-Label Titration|Noncompliance With Study Drug|0
4527582|NCT01041859|7344930|FG000|Open-Label Titration|Withdrawal by Subject|11
4527583|NCT01041859|7344931|FG001|Open-Label Titration|Withdrawal by Subject|0
4527584|NCT01041859|7344932|FG002|Open-Label Titration|Withdrawal by Subject|0
4527585|NCT01041859|7344930|FG000|Double-Blind Maintenance|Adverse Event|0
4527586|NCT01041859|7344931|FG001|Double-Blind Maintenance|Adverse Event|23
4527587|NCT01041859|7344932|FG002|Double-Blind Maintenance|Adverse Event|13
4527588|NCT01041859|7344930|FG000|Double-Blind Maintenance|Lack of Efficacy|0
4527589|NCT01041859|7344931|FG001|Double-Blind Maintenance|Lack of Efficacy|3
4527590|NCT01041859|7344932|FG002|Double-Blind Maintenance|Lack of Efficacy|11
4527591|NCT01041859|7344930|FG000|Double-Blind Maintenance|Lost to Follow-up|0
4527592|NCT01041859|7344931|FG001|Double-Blind Maintenance|Lost to Follow-up|1
4527593|NCT01041859|7344932|FG002|Double-Blind Maintenance|Lost to Follow-up|0
4527594|NCT01041859|7344930|FG000|Double-Blind Maintenance|Physician Decision|0
4527595|NCT01041859|7344931|FG001|Double-Blind Maintenance|Physician Decision|2
4527596|NCT01041859|7344932|FG002|Double-Blind Maintenance|Physician Decision|1
4527597|NCT01041859|7344930|FG000|Double-Blind Maintenance|Protocol Violation|0
4527598|NCT01041859|7344931|FG001|Double-Blind Maintenance|Protocol Violation|1
4527599|NCT01041859|7344932|FG002|Double-Blind Maintenance|Protocol Violation|3
4527600|NCT01041859|7344930|FG000|Double-Blind Maintenance|Other|0
4527601|NCT01041859|7344931|FG001|Double-Blind Maintenance|Other|6
4527602|NCT01041859|7344932|FG002|Double-Blind Maintenance|Other|2
4527603|NCT01041859|7344930|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0
4527604|NCT01041859|7344931|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2
4527605|NCT01041859|7344932|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6
4527606|NCT01041859|7344930|FG000|Double-Blind Maintenance|Withdrawal by Subject|0
4527607|NCT01041859|7344931|FG001|Double-Blind Maintenance|Withdrawal by Subject|8
4527608|NCT01041859|7344932|FG002|Double-Blind Maintenance|Withdrawal by Subject|9
4527609|NCT01041976|7344941|FG000|Overall Study|Withdrawal by Subject|3
4527610|NCT01041976|7344942|FG001|Overall Study|Withdrawal by Subject|0
4527611|NCT01041976|7344941|FG000|Overall Study|Incarceration|2
4527612|NCT01041976|7344942|FG001|Overall Study|Incarceration|0
4527613|NCT01041976|7344941|FG000|Overall Study|Death|0
4527614|NCT01041976|7344942|FG001|Overall Study|Death|4
4527615|NCT01042093|7344952|FG000|Overall Study|Protocol Violation|2
4527616|NCT01042093|7344953|FG001|Overall Study|Protocol Violation|2
4527617|NCT01042093|7344954|FG002|Overall Study|Protocol Violation|2
4527618|NCT01042093|7344955|FG003|Overall Study|Protocol Violation|3
4527619|NCT01042093|7344952|FG000|Overall Study|Withdrawal by Subject|0
4527620|NCT01042093|7344953|FG001|Overall Study|Withdrawal by Subject|0
4527621|NCT01042093|7344954|FG002|Overall Study|Withdrawal by Subject|0
4527622|NCT01042093|7344955|FG003|Overall Study|Withdrawal by Subject|1
4594530|NCT01563029|7443782|FG004|Overall Study|Withdrawal by Subject|3
4527623|NCT01042158|7344977|FG000|Overall Study|Physician Decision|1
4527624|NCT01042236|7344981|FG000|Treatment Period 1|Adverse Event|0
4527625|NCT01042236|7344982|FG001|Treatment Period 1|Adverse Event|1
4527626|NCT01042236|7344983|FG002|Treatment Period 1|Adverse Event|0
4527627|NCT01042236|7344984|FG003|Treatment Period 1|Adverse Event|0
4527628|NCT01042236|7344985|FG004|Treatment Period 1|Adverse Event|1
4527629|NCT01042236|7344986|FG005|Treatment Period 1|Adverse Event|0
4527630|NCT01042236|7344981|FG000|Treatment Period 3|Adverse Event|0
4527631|NCT01042236|7344982|FG001|Treatment Period 3|Adverse Event|0
4527632|NCT01042236|7344983|FG002|Treatment Period 3|Adverse Event|0
4594531|NCT01563172|7443815|FG000|Overall Study|Adverse Event|5
4527633|NCT01042236|7344984|FG003|Treatment Period 3|Adverse Event|1
4527634|NCT01042236|7344985|FG004|Treatment Period 3|Adverse Event|0
4527635|NCT01042236|7344986|FG005|Treatment Period 3|Adverse Event|0
4527636|NCT01042236|7344981|FG000|Treatment Period 3|Protocol Violation|0
4634650|NCT01926782|7505864|FG005|Overall Study|Withdrawal by Subject|5
4634651|NCT01926782|7505859|FG000|Overall Study|Related to study drug administration|0
4634652|NCT01926782|7505860|FG001|Overall Study|Related to study drug administration|0
4634653|NCT01926782|7505861|FG002|Overall Study|Related to study drug administration|0
4746369|NCT00766636|7717501|FG000|Overall Study|Withdrawal by Subject|1
4746370|NCT00766636|7717502|FG001|Overall Study|Withdrawal by Subject|1
4746371|NCT00766636|7717501|FG000|Overall Study|Incomplete Treatment|0
4746372|NCT00766636|7717502|FG001|Overall Study|Incomplete Treatment|1
4746373|NCT00766636|7717501|FG000|Overall Study|Adverse Event|1
4746374|NCT00766636|7717502|FG001|Overall Study|Adverse Event|0
4746375|NCT00766636|7717501|FG000|Overall Study|Disease Progression|1
4746376|NCT00766636|7717502|FG001|Overall Study|Disease Progression|0
4746377|NCT00768248|7717510|FG000|Overall Study|Research coordinator didn't collect data|1
4746378|NCT00768248|7717511|FG001|Overall Study|Research coordinator didn't collect data|1
4746379|NCT00764699|7717521|FG000|Overall Study|PI left and study terminated|3
4746380|NCT00763009|7717529|FG000|Overall Study|Coronary Anatomy unsuitable|1
4746381|NCT00761176|7717536|FG000|Overall Study|Death|1
4746382|NCT00761176|7717537|FG001|Overall Study|Death|0
4746383|NCT00761176|7717536|FG000|Overall Study|Withdrawal by Subject|1
4746384|NCT00761176|7717537|FG001|Overall Study|Withdrawal by Subject|1
4746385|NCT00754793|7717562|FG000|Overall Study|voluntary withdrawn from study|0
4746386|NCT00754793|7717563|FG001|Overall Study|voluntary withdrawn from study|1
4746387|NCT00754052|7717571|FG000|Overall Study|Study terminated by Sponsor|5
4746388|NCT00754052|7717572|FG001|Overall Study|Study terminated by Sponsor|3
4746389|NCT00750204|7717594|FG000|Overall Study|study halted prematurely|1
4746390|NCT00750204|7717595|FG001|Overall Study|study halted prematurely|1
4746391|NCT00752986|7717617|FG000|Overall Study|Withdrawal by Subject|2
4746392|NCT00752986|7717618|FG001|Overall Study|Withdrawal by Subject|1
4746393|NCT00752986|7717619|FG002|Overall Study|Withdrawal by Subject|2
4746394|NCT00752986|7717617|FG000|Overall Study|Protocol Violation|3
4746395|NCT00752986|7717618|FG001|Overall Study|Protocol Violation|0
4746396|NCT00752986|7717619|FG002|Overall Study|Protocol Violation|0
4746397|NCT00754013|7717642|FG000|Overall Study|Lost to Follow-up|1
4746398|NCT00754013|7717643|FG001|Overall Study|Lost to Follow-up|1
4746399|NCT00754013|7717642|FG000|Overall Study|didn't return after study termed|3
4746400|NCT00754013|7717643|FG001|Overall Study|didn't return after study termed|4
4746401|NCT00735553|7717652|FG000|Overall Study|Study prematurely terminated|77
4746402|NCT00751933|7717660|FG000|Overall Study|Withdrawal by Subject|0
4746403|NCT00751933|7717661|FG001|Overall Study|Withdrawal by Subject|1
4527637|NCT01042236|7344982|FG001|Treatment Period 3|Protocol Violation|0
4527638|NCT01042236|7344983|FG002|Treatment Period 3|Protocol Violation|0
4527639|NCT01042236|7344984|FG003|Treatment Period 3|Protocol Violation|1
4527640|NCT01042236|7344985|FG004|Treatment Period 3|Protocol Violation|0
4527641|NCT01042236|7344986|FG005|Treatment Period 3|Protocol Violation|0
4746404|NCT00751933|7717662|FG002|Overall Study|Withdrawal by Subject|0
4746405|NCT00751933|7717663|FG003|Overall Study|Withdrawal by Subject|0
4746406|NCT00751933|7717660|FG000|Overall Study|Physician Decision|0
4746407|NCT00751933|7717661|FG001|Overall Study|Physician Decision|0
4746408|NCT00751933|7717662|FG002|Overall Study|Physician Decision|1
4746409|NCT00751933|7717663|FG003|Overall Study|Physician Decision|1
4746410|NCT00747461|7717680|FG000|Overall Study|study terminated by sponsor|5
4746411|NCT00736385|7717695|FG000|Overall Study|Withdrawal by Subject|2
4746412|NCT00736385|7717696|FG001|Overall Study|Withdrawal by Subject|2
4746413|NCT00736385|7717695|FG000|Overall Study|Adverse Event|0
4746414|NCT00736385|7717696|FG001|Overall Study|Adverse Event|1
4746415|NCT00739063|7717719|FG000|Overall Study|Screen failures|8
4746416|NCT00740597|7717723|FG000|Overall Study|insurance would not cover treatment|1
4746417|NCT00737282|7717742|FG000|Overall Study|Study prematurely terminated|175
4746418|NCT00739882|7717750|FG000|Double-blind Period|Adverse Event|1
4746419|NCT00739882|7717751|FG001|Double-blind Period|Adverse Event|2
4746420|NCT00739882|7717750|FG000|Double-blind Period|Protocol Violation|1
4527642|NCT01042392|7345011|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6
4527643|NCT01042392|7345012|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0
4527644|NCT01042392|7345013|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5
4527645|NCT01042392|7345014|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0
4527646|NCT01042392|7345011|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1
4527647|NCT01042392|7345012|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
4527648|NCT01042392|7345013|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
4527649|NCT01042392|7345014|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
4527650|NCT01042392|7345011|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1
4527651|NCT01042392|7345012|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0
4527652|NCT01042392|7345013|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2
4527653|NCT01042392|7345014|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0
4527654|NCT01042392|7345011|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
4527655|NCT01042392|7345012|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
4527656|NCT01042392|7345013|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1
4527657|NCT01042392|7345014|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
4527658|NCT01042392|7345011|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2
4527659|NCT01042392|7345012|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
4527660|NCT01042392|7345013|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
4527661|NCT01042392|7345014|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
4527662|NCT01042392|7345011|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
4527663|NCT01042392|7345012|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
4527664|NCT01042392|7345013|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1
4527665|NCT01042392|7345014|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
4527666|NCT01042392|7345011|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2
4527667|NCT01042392|7345012|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
4527668|NCT01042392|7345013|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
4527669|NCT01042392|7345014|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
4527670|NCT01042392|7345011|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
4527671|NCT01042392|7345012|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
4527672|NCT01042392|7345013|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2
4527673|NCT01042392|7345014|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
4527674|NCT01042392|7345011|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0
4527675|NCT01042392|7345012|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
4527676|NCT01042392|7345013|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
4527677|NCT01042392|7345014|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
4527678|NCT01042535|7345043|FG000|Overall Study|disease progression prior to treatment|3
4527679|NCT01042535|7345043|FG000|Overall Study|disease progression during treatment|3
4527680|NCT01042535|7345043|FG000|Overall Study|complications from other disease|2
4527681|NCT01042600|7345049|FG000|Overall Study|Ineligible|1
4527682|NCT01042600|7345050|FG001|Overall Study|Ineligible|0
4527683|NCT01042678|7345069|FG000|Overall Study|Physician Decision|1
4527684|NCT01042678|7345070|FG001|Overall Study|Physician Decision|0
4527685|NCT01042678|7345071|FG002|Overall Study|Physician Decision|0
4527686|NCT01042678|7345072|FG003|Overall Study|Physician Decision|0
4527687|NCT01042678|7345073|FG004|Overall Study|Physician Decision|0
4527688|NCT01042678|7345074|FG005|Overall Study|Physician Decision|0
4527689|NCT01042938|7345088|FG000|Overall Study|Withdrawal by Subject|1
4527690|NCT01042938|7345089|FG001|Overall Study|Withdrawal by Subject|1
4527691|NCT01042938|7345088|FG000|Overall Study|Protocol Violation|1
4527692|NCT01042938|7345089|FG001|Overall Study|Protocol Violation|1
4527693|NCT01042938|7345088|FG000|Overall Study|Ineligible: RTOG study conflict|1
4527694|NCT01042938|7345089|FG001|Overall Study|Ineligible: RTOG study conflict|0
4527695|NCT01042977|7345099|FG000|Overall Study|Adverse Event|4
4527696|NCT01042977|7345100|FG001|Overall Study|Adverse Event|12
4527697|NCT01042977|7345099|FG000|Overall Study|Death|2
4527698|NCT01042977|7345100|FG001|Overall Study|Death|1
4527699|NCT01042977|7345099|FG000|Overall Study|Withdrawal by Subject|8
4527700|NCT01042977|7345100|FG001|Overall Study|Withdrawal by Subject|16
4527701|NCT01042977|7345099|FG000|Overall Study|Lost to Follow-up|0
4527702|NCT01042977|7345100|FG001|Overall Study|Lost to Follow-up|2
4527703|NCT01042977|7345099|FG000|Overall Study|Poor/non-compliance|3
4527704|NCT01042977|7345100|FG001|Overall Study|Poor/non-compliance|4
4527705|NCT01042977|7345099|FG000|Overall Study|Subject no longer meets study criteria|15
4527706|NCT01042977|7345100|FG001|Overall Study|Subject no longer meets study criteria|13
4527707|NCT01042977|7345099|FG000|Overall Study|Incorrect enrollment|6
4527708|NCT01042977|7345100|FG001|Overall Study|Incorrect enrollment|4
4527709|NCT01042977|7345099|FG000|Overall Study|Safety|0
4527710|NCT01042977|7345100|FG001|Overall Study|Safety|2
4527711|NCT01042977|7345099|FG000|Overall Study|Administrative reason by sponsor|0
4527712|NCT01042977|7345100|FG001|Overall Study|Administrative reason by sponsor|1
4527713|NCT01042977|7345099|FG000|Overall Study|Various|3
4527714|NCT01042977|7345100|FG001|Overall Study|Various|0
4527715|NCT01043185|7345149|FG000|Period 6 - Third Washout Period|Protocol Violation|0
4527716|NCT01043185|7345150|FG001|Period 6 - Third Washout Period|Protocol Violation|0
4527717|NCT01043185|7345151|FG002|Period 6 - Third Washout Period|Protocol Violation|0
4527718|NCT01043185|7345152|FG003|Period 6 - Third Washout Period|Protocol Violation|0
4527719|NCT01043185|7345153|FG004|Period 6 - Third Washout Period|Protocol Violation|0
4527720|NCT01043185|7345154|FG005|Period 6 - Third Washout Period|Protocol Violation|0
4527721|NCT01043185|7345155|FG006|Period 6 - Third Washout Period|Protocol Violation|0
4527722|NCT01043185|7345156|FG007|Period 6 - Third Washout Period|Protocol Violation|0
4527723|NCT01043185|7345157|FG008|Period 6 - Third Washout Period|Protocol Violation|1
4527724|NCT01043185|7345158|FG009|Period 6 - Third Washout Period|Protocol Violation|0
4527725|NCT01043705|7345219|FG000|Overall Study|Death|28
4527726|NCT01043705|7345220|FG001|Overall Study|Death|60
4527727|NCT01043705|7345221|FG002|Overall Study|Death|26
4527728|NCT01043705|7345219|FG000|Overall Study|Lost to Follow-up|27
4527729|NCT01043705|7345220|FG001|Overall Study|Lost to Follow-up|12
4527730|NCT01043705|7345221|FG002|Overall Study|Lost to Follow-up|0
4527731|NCT01043705|7345219|FG000|Overall Study|Multiple Reasons|4
4527732|NCT01043705|7345220|FG001|Overall Study|Multiple Reasons|7
4527733|NCT01043705|7345221|FG002|Overall Study|Multiple Reasons|0
4527734|NCT01043705|7345219|FG000|Overall Study|Protocol Violation|2
4527735|NCT01043705|7345220|FG001|Overall Study|Protocol Violation|1
4527736|NCT01043705|7345221|FG002|Overall Study|Protocol Violation|0
4527737|NCT01043705|7345219|FG000|Overall Study|Withdrawal by Subject|8
4527738|NCT01043705|7345220|FG001|Overall Study|Withdrawal by Subject|6
4527739|NCT01043705|7345221|FG002|Overall Study|Withdrawal by Subject|0
4527740|NCT01043705|7345219|FG000|Overall Study|Site Closure|8
4527741|NCT01043705|7345220|FG001|Overall Study|Site Closure|0
4527742|NCT01043705|7345221|FG002|Overall Study|Site Closure|0
4527743|NCT01043705|7345219|FG000|Overall Study|Subsequent Procedure|9
4527744|NCT01043705|7345220|FG001|Overall Study|Subsequent Procedure|24
4527745|NCT01043705|7345221|FG002|Overall Study|Subsequent Procedure|29
4527746|NCT01043705|7345219|FG000|Overall Study|Adverse Event|0
4527747|NCT01043705|7345220|FG001|Overall Study|Adverse Event|2
4527748|NCT01043705|7345221|FG002|Overall Study|Adverse Event|0
4527749|NCT01043705|7345219|FG000|Overall Study|Screen Fail|21
4527750|NCT01043705|7345220|FG001|Overall Study|Screen Fail|0
4527751|NCT01043705|7345221|FG002|Overall Study|Screen Fail|0
4527752|NCT01043705|7345219|FG000|Overall Study|Other|0
4527753|NCT01043705|7345220|FG001|Overall Study|Other|19
4527754|NCT01043705|7345221|FG002|Overall Study|Other|25
4527755|NCT01043874|7345229|FG000|Overall Study|Adverse Event|3
4527756|NCT01043874|7345229|FG000|Overall Study|Withdrawal by Subject|1
4527757|NCT01043874|7345229|FG000|Overall Study|Lack of Efficacy|1
4527758|NCT01043874|7345229|FG000|Overall Study|Administrative Problems|1
4527759|NCT01044290|7345288|FG000|Follow-up 1|Death|3
4527760|NCT01044290|7345289|FG001|Follow-up 1|Death|3
4527761|NCT01044290|7345290|FG002|Follow-up 1|Death|1
4527762|NCT01044290|7345288|FG000|Follow-up 1|Withdrawal by Subject|2
4527763|NCT01044290|7345289|FG001|Follow-up 1|Withdrawal by Subject|2
4527764|NCT01044290|7345290|FG002|Follow-up 1|Withdrawal by Subject|0
4527765|NCT01044290|7345288|FG000|Follow-Up 2|Death|0
4527766|NCT01044290|7345289|FG001|Follow-Up 2|Death|1
4527767|NCT01044290|7345290|FG002|Follow-Up 2|Death|1
4527768|NCT01044290|7345288|FG000|Follow-Up 2|Withdrawal by Subject|0
4527769|NCT01044290|7345289|FG001|Follow-Up 2|Withdrawal by Subject|1
4527770|NCT01044290|7345290|FG002|Follow-Up 2|Withdrawal by Subject|1
4527771|NCT01044303|7345308|FG000|Overall Study|Lost to Follow-up|2
4527772|NCT01044433|7345315|FG000|Overall Study|Lost to Follow-up|3
4527773|NCT01044433|7345315|FG000|Overall Study|Withdrawal by Subject|3
4527774|NCT01044459|7345322|FG000|Overall Study|Withdrawal by Subject|21
4527775|NCT01044459|7345323|FG001|Overall Study|Withdrawal by Subject|28
4527776|NCT01044459|7345322|FG000|Overall Study|Terminated by Sponsor|22
4527777|NCT01044459|7345323|FG001|Overall Study|Terminated by Sponsor|21
4634654|NCT01926782|7505862|FG003|Overall Study|Related to study drug administration|0
4527778|NCT01044459|7345322|FG000|Overall Study|Adverse Event|22
4527779|NCT01044459|7345323|FG001|Overall Study|Adverse Event|20
4527780|NCT01044459|7345322|FG000|Overall Study|Lack of Efficacy|23
4527781|NCT01044459|7345323|FG001|Overall Study|Lack of Efficacy|12
4527782|NCT01044459|7345322|FG000|Overall Study|Protocol Violation|11
4527783|NCT01044459|7345323|FG001|Overall Study|Protocol Violation|16
4527784|NCT01044459|7345322|FG000|Overall Study|Other Reason|7
4527785|NCT01044459|7345323|FG001|Overall Study|Other Reason|14
4527786|NCT01044459|7345322|FG000|Overall Study|COPD exacerbation|9
4527787|NCT01044459|7345323|FG001|Overall Study|COPD exacerbation|8
4527788|NCT01044459|7345322|FG000|Overall Study|Lost to Follow-up|18
4527789|NCT01044459|7345323|FG001|Overall Study|Lost to Follow-up|12
4527790|NCT01044498|7345331|FG000|Overall Study|Withdrew consent|1
4527791|NCT01044498|7345332|FG001|Overall Study|Withdrew consent|1
4527792|NCT01044498|7345331|FG000|Overall Study|Adverse Event|1
4634655|NCT01926782|7505863|FG004|Overall Study|Related to study drug administration|0
4527793|NCT01044498|7345332|FG001|Overall Study|Adverse Event|1
4527794|NCT01044498|7345331|FG000|Overall Study|Other|1
4527795|NCT01044498|7345332|FG001|Overall Study|Other|0
4527796|NCT01044732|7345416|FG000|Overall Study|Lost to Follow-up|2
4527797|NCT01044732|7345417|FG001|Overall Study|Lost to Follow-up|1
4527798|NCT01044732|7345416|FG000|Overall Study|Physician Decision|5
4527799|NCT01044732|7345417|FG001|Overall Study|Physician Decision|3
4527800|NCT01044732|7345416|FG000|Overall Study|Protocol Violation|11
4527801|NCT01044732|7345417|FG001|Overall Study|Protocol Violation|12
4527802|NCT01044732|7345416|FG000|Overall Study|Withdrawal by Subject|0
4527803|NCT01044732|7345417|FG001|Overall Study|Withdrawal by Subject|1
4527804|NCT01044732|7345416|FG000|Overall Study|Inadequate bowel preparation|11
4527805|NCT01044732|7345417|FG001|Overall Study|Inadequate bowel preparation|17
4527806|NCT01044732|7345416|FG000|Overall Study|Inability to reach cecum|5
4527807|NCT01044732|7345417|FG001|Overall Study|Inability to reach cecum|2
4527808|NCT01044732|7345416|FG000|Overall Study|Technical error or malfunction|15
4527809|NCT01044732|7345417|FG001|Overall Study|Technical error or malfunction|14
4527810|NCT01044745|7345425|FG000|Overall Study|Ineiligible|2
4527811|NCT01045096|7345507|FG000|Overall Study|Withdrawal by Subject|2
4527812|NCT01045096|7345508|FG001|Overall Study|Withdrawal by Subject|0
4527813|NCT01045096|7345509|FG002|Overall Study|Withdrawal by Subject|0
4527814|NCT01045096|7345507|FG000|Overall Study|Other|1
4527815|NCT01045096|7345508|FG001|Overall Study|Other|0
4527816|NCT01045096|7345509|FG002|Overall Study|Other|0
4527817|NCT01045161|7345533|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8
4527818|NCT01045161|7345534|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12
4527819|NCT01045161|7345535|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6
4527820|NCT01045161|7345533|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4
4527821|NCT01045161|7345534|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3
4527822|NCT01045161|7345535|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8
4527823|NCT01045161|7345533|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6
4527824|NCT01045161|7345534|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3
4527825|NCT01045161|7345535|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2
4527826|NCT01045161|7345533|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4
4527827|NCT01045161|7345534|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1
4527828|NCT01045161|7345535|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6
4527829|NCT01045161|7345533|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
4527830|NCT01045161|7345534|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
4527831|NCT01045161|7345535|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
4527832|NCT01045161|7345533|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3
4527833|NCT01045161|7345534|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4
4527834|NCT01045161|7345535|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3
4527835|NCT01045161|7345533|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3
4527836|NCT01045161|7345534|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3
4527837|NCT01045161|7345535|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2
4527838|NCT01045161|7345533|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10
4527839|NCT01045161|7345534|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7
4527840|NCT01045161|7345535|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9
4527841|NCT01045161|7345533|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10
4527842|NCT01045161|7345534|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10
4527843|NCT01045161|7345535|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7
4527844|NCT01045161|7345533|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3
4527845|NCT01045161|7345534|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5
4527846|NCT01045161|7345535|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5
4527847|NCT01045161|7345533|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1
4527848|NCT01045161|7345534|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5
4527849|NCT01045161|7345535|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1
4527850|NCT01045161|7345533|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4
4527851|NCT01045161|7345534|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2
4527852|NCT01045161|7345535|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1
4527853|NCT01045161|7345533|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3
4527854|NCT01045161|7345534|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6
4527855|NCT01045161|7345535|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3
4527856|NCT01045161|7345533|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5
4634656|NCT01926782|7505864|FG005|Overall Study|Related to study drug administration|2
4634657|NCT01926886|7505879|FG000|Overall Study|Administrative/other|1
4634658|NCT01926886|7505880|FG001|Overall Study|Administrative/other|0
4634659|NCT01926886|7505879|FG000|Overall Study|Adverse event/intercurrent illness|4
4634660|NCT01926886|7505880|FG001|Overall Study|Adverse event/intercurrent illness|0
4634661|NCT01926886|7505879|FG000|Overall Study|Disease progression/recurrence|4
4634662|NCT01926886|7505880|FG001|Overall Study|Disease progression/recurrence|0
4634663|NCT01926886|7505879|FG000|Overall Study|Withdrawal by Subject|15
4634664|NCT01926886|7505880|FG001|Overall Study|Withdrawal by Subject|0
4634665|NCT01926886|7505879|FG000|Overall Study|Failure to return|3
4634666|NCT01926886|7505880|FG001|Overall Study|Failure to return|0
4634667|NCT01926886|7505879|FG000|Overall Study|Recurrence of disease|1
4634668|NCT01926886|7505880|FG001|Overall Study|Recurrence of disease|0
4634669|NCT01926886|7505879|FG000|Overall Study|Progression of disease|2
4527857|NCT01045161|7345534|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1
4527858|NCT01045161|7345535|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6
4527859|NCT01045421|7345575|FG000|Phase 1|Progressive Disease|0
4527860|NCT01045421|7345576|FG001|Phase 1|Progressive Disease|0
4527861|NCT01045421|7345577|FG002|Phase 1|Progressive Disease|0
4527862|NCT01045421|7345578|FG003|Phase 1|Progressive Disease|0
4527863|NCT01045421|7345579|FG004|Phase 1|Progressive Disease|1
4527864|NCT01045421|7345580|FG005|Phase 1|Progressive Disease|0
4527865|NCT01045421|7345581|FG006|Phase 1|Progressive Disease|0
4527866|NCT01045421|7345582|FG007|Phase 1|Progressive Disease|0
4527867|NCT01045421|7345583|FG008|Phase 1|Progressive Disease|0
4527868|NCT01045421|7345584|FG009|Phase 1|Progressive Disease|0
4527869|NCT01045421|7345585|FG010|Phase 1|Progressive Disease|0
4527870|NCT01045421|7345575|FG000|Phase 1|Withdrawal by Subject|0
4527871|NCT01045421|7345576|FG001|Phase 1|Withdrawal by Subject|0
4527872|NCT01045421|7345577|FG002|Phase 1|Withdrawal by Subject|0
4527873|NCT01045421|7345578|FG003|Phase 1|Withdrawal by Subject|1
4527874|NCT01045421|7345579|FG004|Phase 1|Withdrawal by Subject|0
4527875|NCT01045421|7345580|FG005|Phase 1|Withdrawal by Subject|0
4527876|NCT01045421|7345581|FG006|Phase 1|Withdrawal by Subject|0
4527877|NCT01045421|7345582|FG007|Phase 1|Withdrawal by Subject|0
4527878|NCT01045421|7345583|FG008|Phase 1|Withdrawal by Subject|0
4527879|NCT01045421|7345584|FG009|Phase 1|Withdrawal by Subject|0
4527880|NCT01045421|7345585|FG010|Phase 1|Withdrawal by Subject|0
4527881|NCT01045421|7345575|FG000|Phase 2|Progressive Disease|0
4527882|NCT01045421|7345576|FG001|Phase 2|Progressive Disease|0
4527883|NCT01045421|7345577|FG002|Phase 2|Progressive Disease|0
4527884|NCT01045421|7345578|FG003|Phase 2|Progressive Disease|0
4527885|NCT01045421|7345579|FG004|Phase 2|Progressive Disease|0
4527886|NCT01045421|7345580|FG005|Phase 2|Progressive Disease|0
4527887|NCT01045421|7345581|FG006|Phase 2|Progressive Disease|0
4527888|NCT01045421|7345582|FG007|Phase 2|Progressive Disease|1
4527889|NCT01045421|7345583|FG008|Phase 2|Progressive Disease|1
4527890|NCT01045421|7345584|FG009|Phase 2|Progressive Disease|1
4527891|NCT01045421|7345585|FG010|Phase 2|Progressive Disease|1
4527892|NCT01045421|7345575|FG000|Phase 2|Death|0
4527893|NCT01045421|7345576|FG001|Phase 2|Death|0
4527894|NCT01045421|7345577|FG002|Phase 2|Death|0
4527895|NCT01045421|7345578|FG003|Phase 2|Death|0
4527896|NCT01045421|7345579|FG004|Phase 2|Death|0
4527897|NCT01045421|7345580|FG005|Phase 2|Death|0
4527898|NCT01045421|7345581|FG006|Phase 2|Death|0
4527899|NCT01045421|7345582|FG007|Phase 2|Death|1
4527900|NCT01045421|7345583|FG008|Phase 2|Death|1
4527901|NCT01045421|7345584|FG009|Phase 2|Death|2
4527902|NCT01045421|7345585|FG010|Phase 2|Death|0
4527903|NCT01045421|7345575|FG000|Phase 2|Other|0
4527904|NCT01045421|7345576|FG001|Phase 2|Other|0
4527905|NCT01045421|7345577|FG002|Phase 2|Other|0
4527906|NCT01045421|7345578|FG003|Phase 2|Other|0
4527907|NCT01045421|7345579|FG004|Phase 2|Other|0
4527908|NCT01045421|7345580|FG005|Phase 2|Other|0
4527909|NCT01045421|7345581|FG006|Phase 2|Other|0
4527910|NCT01045421|7345582|FG007|Phase 2|Other|3
4634670|NCT01926886|7505880|FG001|Overall Study|Progression of disease|0
4634671|NCT01926886|7505879|FG000|Overall Study|Death|1
4527911|NCT01045421|7345583|FG008|Phase 2|Other|0
4527912|NCT01045421|7345584|FG009|Phase 2|Other|0
4527913|NCT01045421|7345585|FG010|Phase 2|Other|1
4527914|NCT01045447|7345608|FG000|Overall Study|Adverse Event|0
4527915|NCT01045447|7345609|FG001|Overall Study|Adverse Event|1
4527916|NCT01045447|7345608|FG000|Overall Study|Lack of Efficacy|3
4527917|NCT01045447|7345609|FG001|Overall Study|Lack of Efficacy|1
4527918|NCT01045447|7345608|FG000|Overall Study|Protocol Violation|6
4527919|NCT01045447|7345609|FG001|Overall Study|Protocol Violation|3
4527920|NCT01045447|7345608|FG000|Overall Study|Withdrawal Criteria|10
4527921|NCT01045447|7345609|FG001|Overall Study|Withdrawal Criteria|10
4527922|NCT01045447|7345608|FG000|Overall Study|Unclassified|17
4527923|NCT01045447|7345609|FG001|Overall Study|Unclassified|13
4527924|NCT01045460|7345617|FG000|Overall Study|Physician Decision|3
4527925|NCT01045460|7345618|FG001|Overall Study|Physician Decision|2
4527926|NCT01045460|7345617|FG000|Overall Study|Lost to Follow-up|0
4527927|NCT01045460|7345618|FG001|Overall Study|Lost to Follow-up|1
4527928|NCT01045460|7345617|FG000|Overall Study|Lack of Efficacy|3
4527929|NCT01045460|7345618|FG001|Overall Study|Lack of Efficacy|0
4527930|NCT01045707|7345637|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5
4527931|NCT01045707|7345638|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3
4527932|NCT01045707|7345637|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4
4527933|NCT01045707|7345638|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2
4527934|NCT01045707|7345637|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6
4527935|NCT01045707|7345638|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5
4527936|NCT01045707|7345637|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22
4527937|NCT01045707|7345638|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11
4527938|NCT01045707|7345637|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10
4527939|NCT01045707|7345638|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11
4527940|NCT01045707|7345637|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3
4527941|NCT01045707|7345638|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3
4527942|NCT01045707|7345637|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2
4527943|NCT01045707|7345638|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3
4527944|NCT01045707|7345637|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2
4527945|NCT01045707|7345638|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1
4527946|NCT01045707|7345637|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6
4527947|NCT01045707|7345638|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5
4527948|NCT01045798|7345646|FG000|Overall Study|Changed to Open-Label Caspofungin|1
4527949|NCT01045798|7345647|FG001|Overall Study|Changed to Open-Label Caspofungin|0
4527950|NCT01045798|7345646|FG000|Overall Study|Invasive Fungal Infection at Baseline|0
4527951|NCT01045798|7345647|FG001|Overall Study|Invasive Fungal Infection at Baseline|1
4527952|NCT01045798|7345646|FG000|Overall Study|Changed to Other Antifungal Therapy|1
4527953|NCT01045798|7345647|FG001|Overall Study|Changed to Other Antifungal Therapy|2
4527954|NCT01045798|7345646|FG000|Overall Study|Received Systemic Antifungal Prestudy|0
4527955|NCT01045798|7345647|FG001|Overall Study|Received Systemic Antifungal Prestudy|1
4527956|NCT01045967|7345655|FG000|Second Intervention|Protocol Violation|0
4527957|NCT01045967|7345656|FG001|Second Intervention|Protocol Violation|1
4527958|NCT01045993|7345666|FG000|Overall Study|Treated-later found eligibility not met|0
4527959|NCT01045993|7345667|FG001|Overall Study|Treated-later found eligibility not met|1
4527960|NCT01045993|7345668|FG002|Overall Study|Treated-later found eligibility not met|0
4527961|NCT01045993|7345669|FG003|Overall Study|Treated-later found eligibility not met|0
4527962|NCT01046084|7345681|FG000|Third Washout of 7 Days|Withdrawal by Subject|2
4527963|NCT01046084|7345682|FG001|Third Washout of 7 Days|Withdrawal by Subject|0
4527964|NCT01046110|7345690|FG000|Overall Study|Adverse Event|9
4527965|NCT01046110|7345691|FG001|Overall Study|Adverse Event|2
4527966|NCT01046110|7345690|FG000|Overall Study|Lack of Efficacy|0
4527967|NCT01046110|7345691|FG001|Overall Study|Lack of Efficacy|1
4527968|NCT01046110|7345690|FG000|Overall Study|Protocol Violation|7
4527969|NCT01046110|7345691|FG001|Overall Study|Protocol Violation|12
4527970|NCT01046110|7345690|FG000|Overall Study|Withdrawal Criteria|3
4527971|NCT01046110|7345691|FG001|Overall Study|Withdrawal Criteria|5
4527972|NCT01046110|7345690|FG000|Overall Study|Unclassified|36
4527973|NCT01046110|7345691|FG001|Overall Study|Unclassified|35
4527974|NCT01046136|7345699|FG000|Overall Study|Withdrawal by Subject|0
4527975|NCT01046136|7345700|FG001|Overall Study|Withdrawal by Subject|4
4527976|NCT01046136|7345699|FG000|Overall Study|Physician Decision|1
4527977|NCT01046136|7345700|FG001|Overall Study|Physician Decision|1
4527978|NCT01046136|7345699|FG000|Overall Study|Lost to Follow-up|3
4527979|NCT01046136|7345700|FG001|Overall Study|Lost to Follow-up|3
4527980|NCT01046253|7345710|FG000|Second Intervention|Adverse Event|0
4527981|NCT01046253|7345711|FG001|Second Intervention|Adverse Event|1
4527982|NCT01046253|7345710|FG000|Second Intervention|Protocol Violation|0
4527983|NCT01046253|7345711|FG001|Second Intervention|Protocol Violation|1
4527984|NCT01046396|7345717|FG000|Overall Study|Withdrawal by Subject|5
4527985|NCT01046565|7345724|FG000|Overall Study|Adverse Event|2
4527986|NCT01046565|7345724|FG000|Overall Study|Withdrawal by Subject|7
4527987|NCT01046643|7345735|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0
4527988|NCT01046643|7345736|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1
4527989|NCT01046643|7345737|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0
4527990|NCT01046643|7345738|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0
4527991|NCT01046682|7345759|FG000|Overall Study|Adverse Event|2
4527992|NCT01046682|7345760|FG001|Overall Study|Adverse Event|0
4527993|NCT01046695|7345768|FG000|Overall Study|Subject had a pacemaker|0
4527994|NCT01046695|7345769|FG001|Overall Study|Subject had a pacemaker|1
4527995|NCT01046695|7345768|FG000|Overall Study|TENS interfered with the cardiac monitor|0
4527996|NCT01046695|7345769|FG001|Overall Study|TENS interfered with the cardiac monitor|1
4527997|NCT01046877|7345775|FG000|Overall Study|Exited voluntarily before tube extrusion|7
4527998|NCT01046877|7345775|FG000|Overall Study|Exited voluntarily after tube extrusion|11
4527999|NCT01046903|7345779|FG000|Overall Study|Lost to Follow-up|16
4528000|NCT01046903|7345779|FG000|Overall Study|Adverse Event|4
4528001|NCT01046903|7345779|FG000|Overall Study|Withdrawal by Subject|3
4528002|NCT01046903|7345779|FG000|Overall Study|Other|5
4528003|NCT01047007|7345787|FG000|Overall Study|Adverse Event|0
4528004|NCT01047007|7345788|FG001|Overall Study|Adverse Event|2
4528005|NCT01047007|7345789|FG002|Overall Study|Adverse Event|1
4528006|NCT01047007|7345790|FG003|Overall Study|Adverse Event|0
4528007|NCT01047007|7345787|FG000|Overall Study|Progressive Disease|2
4528008|NCT01047007|7345788|FG001|Overall Study|Progressive Disease|4
4528009|NCT01047007|7345789|FG002|Overall Study|Progressive Disease|1
4528010|NCT01047007|7345790|FG003|Overall Study|Progressive Disease|0
4528011|NCT01047293|7345816|FG000|Overall Study|DLT criteria not fulfilled|1
4528012|NCT01047293|7345817|FG001|Overall Study|DLT criteria not fulfilled|1
4528013|NCT01047293|7345818|FG002|Overall Study|DLT criteria not fulfilled|0
4528014|NCT01047293|7345819|FG003|Overall Study|DLT criteria not fulfilled|0
4528015|NCT01047306|7345828|FG000|Overall Study|Withdrawal by Subject|2
4528016|NCT01047306|7345829|FG001|Overall Study|Withdrawal by Subject|0
4528017|NCT01047306|7345828|FG000|Overall Study|Lost to Follow-up|1
4528018|NCT01047306|7345829|FG001|Overall Study|Lost to Follow-up|0
4528019|NCT01047332|7345839|FG000|Overall Study|SEMS Obstruction|11
4528020|NCT01047332|7345840|FG001|Overall Study|SEMS Obstruction|20
4528021|NCT01047332|7345839|FG000|Overall Study|Died Unobstructed|38
4528022|NCT01047332|7345840|FG001|Overall Study|Died Unobstructed|41
4528023|NCT01047332|7345839|FG000|Overall Study|Lost to Follow-up|8
4528024|NCT01047332|7345840|FG001|Overall Study|Lost to Follow-up|3
4528025|NCT01047345|7345848|FG000|Base Study|Adverse Event|3
4528026|NCT01047345|7345849|FG001|Base Study|Adverse Event|0
4528027|NCT01047345|7345850|FG002|Base Study|Adverse Event|0
4634672|NCT01926886|7505880|FG001|Overall Study|Death|0
4528028|NCT01047345|7345848|FG000|Base Study|Lost to Follow-up|4
4528029|NCT01047345|7345849|FG001|Base Study|Lost to Follow-up|1
4528030|NCT01047345|7345850|FG002|Base Study|Lost to Follow-up|0
4528031|NCT01047345|7345848|FG000|Base Study|Protocol Violation|3
4528032|NCT01047345|7345849|FG001|Base Study|Protocol Violation|1
4528033|NCT01047345|7345850|FG002|Base Study|Protocol Violation|0
4528034|NCT01047345|7345848|FG000|Base Study|Withdrawal by Subject|12
4528035|NCT01047345|7345849|FG001|Base Study|Withdrawal by Subject|4
4528036|NCT01047345|7345850|FG002|Base Study|Withdrawal by Subject|0
4528037|NCT01047345|7345848|FG000|Extension|Withdrawal by Subject|0
4528038|NCT01047345|7345849|FG001|Extension|Withdrawal by Subject|0
4528039|NCT01047345|7345850|FG002|Extension|Withdrawal by Subject|1
4528040|NCT01047345|7345848|FG000|Extension|Lost to Follow-up|0
4528041|NCT01047345|7345849|FG001|Extension|Lost to Follow-up|0
4528042|NCT01047345|7345850|FG002|Extension|Lost to Follow-up|5
4528043|NCT01047436|7345865|FG000|Overall Study|Protocol Violation|1
4528044|NCT01047436|7345866|FG001|Overall Study|Protocol Violation|0
4594532|NCT01563172|7443815|FG000|Overall Study|Lost to Follow-up|2
4594533|NCT01563172|7443815|FG000|Overall Study|Other (Protocol deviation)|5
4528045|NCT01047553|7345897|FG000|Overall Study|Adverse Event|10
4528046|NCT01047553|7345898|FG001|Overall Study|Adverse Event|5
4528047|NCT01047553|7345897|FG000|Overall Study|Withdrawal by Subject|4
4528048|NCT01047553|7345898|FG001|Overall Study|Withdrawal by Subject|2
4528049|NCT01047553|7345897|FG000|Overall Study|Development of Study-Specific Withdrawal|1
4528050|NCT01047553|7345898|FG001|Overall Study|Development of Study-Specific Withdrawal|1
4528051|NCT01047553|7345897|FG000|Overall Study|Lost to Follow-up|1
4528052|NCT01047553|7345898|FG001|Overall Study|Lost to Follow-up|0
4528053|NCT01047553|7345897|FG000|Overall Study|Sever Non-Compliance to Protocol|1
4528054|NCT01047553|7345898|FG001|Overall Study|Sever Non-Compliance to Protocol|0
4528055|NCT01047553|7345897|FG000|Overall Study|PI's decision|0
4528056|NCT01047553|7345898|FG001|Overall Study|PI's decision|1
4528057|NCT01048099|7345931|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57
4528058|NCT01048099|7345931|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202
4528059|NCT01048242|7345939|FG000|Overall Study|See study flow chart|4
4528060|NCT01048242|7345940|FG001|Overall Study|See study flow chart|2
4528061|NCT01048333|7345946|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
4528062|NCT01048333|7345947|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1
4528063|NCT01048333|7345948|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
4528064|NCT01048333|7345949|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
4528065|NCT01048333|7345950|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
4528066|NCT01048333|7345951|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
4528067|NCT01048502|7345973|FG000|Overall Study|Lost to Follow-up|2
4528068|NCT01048502|7345974|FG001|Overall Study|Lost to Follow-up|0
4528069|NCT01048502|7345975|FG002|Overall Study|Lost to Follow-up|0
4528070|NCT01048502|7345976|FG003|Overall Study|Lost to Follow-up|0
4634673|NCT01926886|7505879|FG000|Overall Study|Did not cooperate|1
4634674|NCT01926886|7505880|FG001|Overall Study|Did not cooperate|0
4634675|NCT01927055|7505898|FG000|Open-label|Adverse Event|6
4634676|NCT01927055|7505899|FG001|Open-label|Adverse Event|0
4634677|NCT01927055|7505900|FG002|Open-label|Adverse Event|0
4634678|NCT01927055|7505898|FG000|Open-label|Withdrawal by Subject|1
4634679|NCT01927055|7505899|FG001|Open-label|Withdrawal by Subject|0
4634680|NCT01927055|7505900|FG002|Open-label|Withdrawal by Subject|0
4634681|NCT01927055|7505898|FG000|Open-label|Study Stopped|4
4634682|NCT01927055|7505899|FG001|Open-label|Study Stopped|0
4634683|NCT01927055|7505900|FG002|Open-label|Study Stopped|0
4634684|NCT01927055|7505898|FG000|Open-label|Supine Hypertension|4
4634685|NCT01927055|7505899|FG001|Open-label|Supine Hypertension|0
4634686|NCT01927055|7505900|FG002|Open-label|Supine Hypertension|0
4634687|NCT01927055|7505898|FG000|Open-label|Difficulty attending study visits|1
4634688|NCT01927055|7505899|FG001|Open-label|Difficulty attending study visits|0
4634689|NCT01927055|7505900|FG002|Open-label|Difficulty attending study visits|0
4634690|NCT01927055|7505898|FG000|Double-Blind|Adverse Event|0
4634691|NCT01927055|7505899|FG001|Double-Blind|Adverse Event|1
4634692|NCT01927055|7505900|FG002|Double-Blind|Adverse Event|1
4634693|NCT01927055|7505898|FG000|Double-Blind|Protocol Violation|0
4634694|NCT01927055|7505899|FG001|Double-Blind|Protocol Violation|0
4634695|NCT01927055|7505900|FG002|Double-Blind|Protocol Violation|1
4634696|NCT01927055|7505898|FG000|Double-Blind|Withdrawal by Subject|0
4528071|NCT01048502|7345973|FG000|Overall Study|Adverse Event|1
4528072|NCT01048502|7345974|FG001|Overall Study|Adverse Event|0
4528073|NCT01048502|7345975|FG002|Overall Study|Adverse Event|0
4528074|NCT01048502|7345976|FG003|Overall Study|Adverse Event|0
4528075|NCT01048502|7345973|FG000|Overall Study|Withdrawal by Subject|1
4528076|NCT01048502|7345974|FG001|Overall Study|Withdrawal by Subject|4
4528077|NCT01048502|7345975|FG002|Overall Study|Withdrawal by Subject|5
4634697|NCT01927055|7505899|FG001|Double-Blind|Withdrawal by Subject|2
4634698|NCT01927055|7505900|FG002|Double-Blind|Withdrawal by Subject|3
4528078|NCT01048502|7345976|FG003|Overall Study|Withdrawal by Subject|3
4528079|NCT01048502|7345973|FG000|Overall Study|Physician Decision|0
4528080|NCT01048502|7345974|FG001|Overall Study|Physician Decision|3
4528081|NCT01048502|7345975|FG002|Overall Study|Physician Decision|0
4528082|NCT01048502|7345976|FG003|Overall Study|Physician Decision|1
4528083|NCT01048541|7345987|FG000|Overall Study|Withdrawal by Subject|1
4528084|NCT01048541|7345988|FG001|Overall Study|Withdrawal by Subject|0
4528085|NCT01048671|7346036|FG000|Overall Study|Protocol Violation|0
4528086|NCT01048671|7346037|FG001|Overall Study|Protocol Violation|1
4528087|NCT01048671|7346038|FG002|Overall Study|Protocol Violation|1
4528088|NCT01048788|7346053|FG000|Overall Study|Adverse Event|5
4528089|NCT01048788|7346054|FG001|Overall Study|Adverse Event|1
4528090|NCT01048788|7346055|FG002|Overall Study|Adverse Event|1
4634699|NCT01927055|7505898|FG000|Double-Blind|Study Stopped|0
4634700|NCT01927055|7505899|FG001|Double-Blind|Study Stopped|7
4528091|NCT01048788|7346053|FG000|Overall Study|Lack of Efficacy|0
4634701|NCT01927055|7505900|FG002|Double-Blind|Study Stopped|7
4634702|NCT01927055|7505898|FG000|Double-Blind|Supine Hypertension|0
4634703|NCT01927055|7505899|FG001|Double-Blind|Supine Hypertension|0
4634704|NCT01927055|7505900|FG002|Double-Blind|Supine Hypertension|1
4634705|NCT01927055|7505898|FG000|Double-Blind|Extended Vacation|0
4634706|NCT01927055|7505899|FG001|Double-Blind|Extended Vacation|1
4634707|NCT01927055|7505900|FG002|Double-Blind|Extended Vacation|0
4634708|NCT01927341|7505916|FG000|Phase 1b|Lost to Follow-up|1
4634709|NCT01927341|7505917|FG001|Phase 1b|Lost to Follow-up|0
4634710|NCT01927341|7505918|FG002|Phase 1b|Lost to Follow-up|0
4634711|NCT01927341|7505919|FG003|Phase 1b|Lost to Follow-up|0
4634712|NCT01927341|7505920|FG004|Phase 1b|Lost to Follow-up|0
4634713|NCT01927341|7505916|FG000|Phase 1b|Death|2
4634714|NCT01927341|7505917|FG001|Phase 1b|Death|0
4634715|NCT01927341|7505918|FG002|Phase 1b|Death|0
4528092|NCT01048788|7346054|FG001|Overall Study|Lack of Efficacy|0
4528093|NCT01048788|7346055|FG002|Overall Study|Lack of Efficacy|1
4528094|NCT01048788|7346053|FG000|Overall Study|Withdrawal by Subject|0
4528095|NCT01048788|7346054|FG001|Overall Study|Withdrawal by Subject|1
4528096|NCT01048788|7346055|FG002|Overall Study|Withdrawal by Subject|0
4528097|NCT01048866|7346065|FG000|Overall Study|Adverse Event|1
4528098|NCT01048866|7346066|FG001|Overall Study|Adverse Event|0
4528099|NCT01048866|7346065|FG000|Overall Study|Protocol Violation|1
4528100|NCT01048866|7346066|FG001|Overall Study|Protocol Violation|0
4528101|NCT01048866|7346065|FG000|Overall Study|Physician Decision|1
4528102|NCT01048866|7346066|FG001|Overall Study|Physician Decision|0
4528103|NCT01048866|7346065|FG000|Overall Study|Withdrawal by Subject|0
4528104|NCT01048866|7346066|FG001|Overall Study|Withdrawal by Subject|2
4528105|NCT01048866|7346065|FG000|Overall Study|Lost to Follow-up|0
4528106|NCT01048866|7346066|FG001|Overall Study|Lost to Follow-up|2
4528107|NCT01048866|7346065|FG000|Overall Study|Other|1
4528108|NCT01048866|7346066|FG001|Overall Study|Other|1
4528109|NCT01048944|7346093|FG000|Overall Study|Protocol Violation|8
4528110|NCT01048944|7346094|FG001|Overall Study|Protocol Violation|10
4528111|NCT01048944|7346095|FG002|Overall Study|Protocol Violation|10
4528112|NCT01048944|7346096|FG003|Overall Study|Protocol Violation|2
4528113|NCT01049009|7346108|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2
4528114|NCT01049009|7346109|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2
4528115|NCT01049009|7346108|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
4528116|NCT01049009|7346109|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
4528117|NCT01049009|7346108|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2
4528118|NCT01049009|7346109|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3
4528119|NCT01049009|7346108|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8
4528120|NCT01049009|7346109|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7
4528121|NCT01049217|7346117|FG000|Overall Study|Adverse Event|2
4528122|NCT01049217|7346118|FG001|Overall Study|Adverse Event|1
4528123|NCT01049217|7346117|FG000|Overall Study|Lack of Efficacy|1
4528124|NCT01049217|7346118|FG001|Overall Study|Lack of Efficacy|1
4528125|NCT01049217|7346117|FG000|Overall Study|Lost to Follow-up|3
4528126|NCT01049217|7346118|FG001|Overall Study|Lost to Follow-up|8
4528127|NCT01049217|7346117|FG000|Overall Study|Withdrawal by Subject|4
4528128|NCT01049217|7346118|FG001|Overall Study|Withdrawal by Subject|3
4528129|NCT01049217|7346117|FG000|Overall Study|Protocol Violation|1
4528130|NCT01049217|7346118|FG001|Overall Study|Protocol Violation|3
4528131|NCT01049217|7346117|FG000|Overall Study|Pregnancy|1
4528132|NCT01049217|7346118|FG001|Overall Study|Pregnancy|0
4528133|NCT01049217|7346117|FG000|Overall Study|Study Terminated by Sponsor|43
4528134|NCT01049217|7346118|FG001|Overall Study|Study Terminated by Sponsor|43
4528135|NCT01049217|7346117|FG000|Overall Study|Other|1
4528136|NCT01049217|7346118|FG001|Overall Study|Other|2
4528137|NCT01049217|7346117|FG000|Overall Study|Randomized but not Treated|0
4528138|NCT01049217|7346118|FG001|Overall Study|Randomized but not Treated|2
4528139|NCT01049308|7346129|FG000|Pill Counts|Withdrawal by Subject|83
4528140|NCT01049334|7346138|FG000|Overall Study|Withdrawal by Subject|5
4528141|NCT01049334|7346139|FG001|Overall Study|Withdrawal by Subject|3
4528142|NCT01049334|7346138|FG000|Overall Study|Adverse Event|2
4634716|NCT01927341|7505919|FG003|Phase 1b|Death|0
4528143|NCT01049334|7346139|FG001|Overall Study|Adverse Event|3
4528144|NCT01049334|7346138|FG000|Overall Study|Physician Decision|2
4634717|NCT01927341|7505920|FG004|Phase 1b|Death|0
4634718|NCT01927341|7505916|FG000|Phase 1b|Follow-up completed|7
4528145|NCT01049334|7346139|FG001|Overall Study|Physician Decision|0
4528146|NCT01049334|7346138|FG000|Overall Study|Protocol Violation|0
4528147|NCT01049334|7346139|FG001|Overall Study|Protocol Violation|1
4528148|NCT01049360|7346145|FG000|Period 1|Adverse Event|0
4528149|NCT01049360|7346146|FG001|Period 1|Adverse Event|1
4528150|NCT01049360|7346147|FG002|Period 1|Adverse Event|0
4528151|NCT01049360|7346148|FG003|Period 1|Adverse Event|1
4528152|NCT01049360|7346149|FG004|Period 1|Adverse Event|0
4528153|NCT01049360|7346150|FG005|Period 1|Adverse Event|0
4528154|NCT01049360|7346151|FG006|Period 1|Adverse Event|0
4528155|NCT01049360|7346152|FG007|Period 1|Adverse Event|1
4528156|NCT01049360|7346153|FG008|Period 1|Adverse Event|0
4528157|NCT01049360|7346154|FG009|Period 1|Adverse Event|0
4528158|NCT01049360|7346155|FG010|Period 1|Adverse Event|0
4528159|NCT01049360|7346156|FG011|Period 1|Adverse Event|0
4528160|NCT01049360|7346157|FG012|Period 1|Adverse Event|1
4528161|NCT01049360|7346158|FG013|Period 1|Adverse Event|1
4528162|NCT01049360|7346159|FG014|Period 1|Adverse Event|0
4528163|NCT01049360|7346160|FG015|Period 1|Adverse Event|0
4528164|NCT01049360|7346161|FG016|Period 1|Adverse Event|1
4528165|NCT01049360|7346162|FG017|Period 1|Adverse Event|0
4528166|NCT01049360|7346163|FG018|Period 1|Adverse Event|1
4528167|NCT01049360|7346164|FG019|Period 1|Adverse Event|0
4528168|NCT01049360|7346145|FG000|Period 1|Did not meet inc/exc criteria|0
4528169|NCT01049360|7346146|FG001|Period 1|Did not meet inc/exc criteria|0
4528170|NCT01049360|7346147|FG002|Period 1|Did not meet inc/exc criteria|0
4528171|NCT01049360|7346148|FG003|Period 1|Did not meet inc/exc criteria|0
4528172|NCT01049360|7346149|FG004|Period 1|Did not meet inc/exc criteria|0
4528173|NCT01049360|7346150|FG005|Period 1|Did not meet inc/exc criteria|0
4528174|NCT01049360|7346151|FG006|Period 1|Did not meet inc/exc criteria|0
4528175|NCT01049360|7346152|FG007|Period 1|Did not meet inc/exc criteria|1
4528176|NCT01049360|7346153|FG008|Period 1|Did not meet inc/exc criteria|1
4528177|NCT01049360|7346154|FG009|Period 1|Did not meet inc/exc criteria|0
4528178|NCT01049360|7346155|FG010|Period 1|Did not meet inc/exc criteria|0
4528179|NCT01049360|7346156|FG011|Period 1|Did not meet inc/exc criteria|0
4528180|NCT01049360|7346157|FG012|Period 1|Did not meet inc/exc criteria|0
4528181|NCT01049360|7346158|FG013|Period 1|Did not meet inc/exc criteria|0
4528182|NCT01049360|7346159|FG014|Period 1|Did not meet inc/exc criteria|0
4528183|NCT01049360|7346160|FG015|Period 1|Did not meet inc/exc criteria|0
4528184|NCT01049360|7346161|FG016|Period 1|Did not meet inc/exc criteria|0
4528185|NCT01049360|7346162|FG017|Period 1|Did not meet inc/exc criteria|0
4528186|NCT01049360|7346163|FG018|Period 1|Did not meet inc/exc criteria|0
4528187|NCT01049360|7346164|FG019|Period 1|Did not meet inc/exc criteria|0
4528188|NCT01049360|7346145|FG000|Period 1|Withdrawal by Subject|0
4528189|NCT01049360|7346146|FG001|Period 1|Withdrawal by Subject|0
4528190|NCT01049360|7346147|FG002|Period 1|Withdrawal by Subject|0
4528191|NCT01049360|7346148|FG003|Period 1|Withdrawal by Subject|0
4528192|NCT01049360|7346149|FG004|Period 1|Withdrawal by Subject|0
4528193|NCT01049360|7346150|FG005|Period 1|Withdrawal by Subject|0
4528194|NCT01049360|7346151|FG006|Period 1|Withdrawal by Subject|0
4528195|NCT01049360|7346152|FG007|Period 1|Withdrawal by Subject|0
4528196|NCT01049360|7346153|FG008|Period 1|Withdrawal by Subject|1
4528197|NCT01049360|7346154|FG009|Period 1|Withdrawal by Subject|0
4528198|NCT01049360|7346155|FG010|Period 1|Withdrawal by Subject|1
4528199|NCT01049360|7346156|FG011|Period 1|Withdrawal by Subject|0
4528200|NCT01049360|7346157|FG012|Period 1|Withdrawal by Subject|1
4528201|NCT01049360|7346158|FG013|Period 1|Withdrawal by Subject|0
4528202|NCT01049360|7346159|FG014|Period 1|Withdrawal by Subject|0
4528203|NCT01049360|7346160|FG015|Period 1|Withdrawal by Subject|0
4528204|NCT01049360|7346161|FG016|Period 1|Withdrawal by Subject|0
4528205|NCT01049360|7346162|FG017|Period 1|Withdrawal by Subject|0
4528206|NCT01049360|7346163|FG018|Period 1|Withdrawal by Subject|0
4528207|NCT01049360|7346164|FG019|Period 1|Withdrawal by Subject|0
4528208|NCT01049360|7346145|FG000|Period 2|Protocol Violation|0
4528209|NCT01049360|7346146|FG001|Period 2|Protocol Violation|0
4528210|NCT01049360|7346147|FG002|Period 2|Protocol Violation|0
4528211|NCT01049360|7346148|FG003|Period 2|Protocol Violation|1
4528212|NCT01049360|7346149|FG004|Period 2|Protocol Violation|0
4528213|NCT01049360|7346150|FG005|Period 2|Protocol Violation|0
4528214|NCT01049360|7346151|FG006|Period 2|Protocol Violation|0
4528215|NCT01049360|7346152|FG007|Period 2|Protocol Violation|0
4528216|NCT01049360|7346153|FG008|Period 2|Protocol Violation|0
4528217|NCT01049360|7346154|FG009|Period 2|Protocol Violation|0
4528218|NCT01049360|7346155|FG010|Period 2|Protocol Violation|0
4528219|NCT01049360|7346156|FG011|Period 2|Protocol Violation|0
4528220|NCT01049360|7346157|FG012|Period 2|Protocol Violation|0
4528221|NCT01049360|7346158|FG013|Period 2|Protocol Violation|0
4528222|NCT01049360|7346159|FG014|Period 2|Protocol Violation|1
4528223|NCT01049360|7346160|FG015|Period 2|Protocol Violation|1
4528224|NCT01049360|7346161|FG016|Period 2|Protocol Violation|0
4528225|NCT01049360|7346162|FG017|Period 2|Protocol Violation|0
4528226|NCT01049360|7346163|FG018|Period 2|Protocol Violation|0
4528227|NCT01049360|7346164|FG019|Period 2|Protocol Violation|0
4528228|NCT01049360|7346145|FG000|Period 2|Adverse Event|0
4528229|NCT01049360|7346146|FG001|Period 2|Adverse Event|1
4528230|NCT01049360|7346147|FG002|Period 2|Adverse Event|0
4634719|NCT01927341|7505917|FG001|Phase 1b|Follow-up completed|0
4528231|NCT01049360|7346148|FG003|Period 2|Adverse Event|0
4528232|NCT01049360|7346149|FG004|Period 2|Adverse Event|0
4528233|NCT01049360|7346150|FG005|Period 2|Adverse Event|0
4528234|NCT01049360|7346151|FG006|Period 2|Adverse Event|0
4634720|NCT01927341|7505918|FG002|Phase 1b|Follow-up completed|0
4634721|NCT01927341|7505919|FG003|Phase 1b|Follow-up completed|0
4634722|NCT01927341|7505920|FG004|Phase 1b|Follow-up completed|0
4634723|NCT01927341|7505916|FG000|Phase 2|Lost to Follow-up|0
4634724|NCT01927341|7505917|FG001|Phase 2|Lost to Follow-up|1
4634725|NCT01927341|7505918|FG002|Phase 2|Lost to Follow-up|0
4634726|NCT01927341|7505919|FG003|Phase 2|Lost to Follow-up|0
4634727|NCT01927341|7505920|FG004|Phase 2|Lost to Follow-up|0
4634728|NCT01927341|7505916|FG000|Phase 2|Participant withdrew consent|0
4634729|NCT01927341|7505917|FG001|Phase 2|Participant withdrew consent|2
4634730|NCT01927341|7505918|FG002|Phase 2|Participant withdrew consent|1
4634731|NCT01927341|7505919|FG003|Phase 2|Participant withdrew consent|2
4634732|NCT01927341|7505920|FG004|Phase 2|Participant withdrew consent|3
4634733|NCT01927341|7505916|FG000|Phase 2|Death|0
4634734|NCT01927341|7505917|FG001|Phase 2|Death|4
4634735|NCT01927341|7505918|FG002|Phase 2|Death|0
4634736|NCT01927341|7505919|FG003|Phase 2|Death|3
4634737|NCT01927341|7505920|FG004|Phase 2|Death|2
4634738|NCT01927341|7505916|FG000|Phase 2|New cancer therapy|0
4634739|NCT01927341|7505917|FG001|Phase 2|New cancer therapy|1
4634740|NCT01927341|7505918|FG002|Phase 2|New cancer therapy|0
4634741|NCT01927341|7505919|FG003|Phase 2|New cancer therapy|4
4634742|NCT01927341|7505920|FG004|Phase 2|New cancer therapy|1
4634743|NCT01927341|7505916|FG000|Phase 2|Disease progression|0
4634744|NCT01927341|7505917|FG001|Phase 2|Disease progression|1
4634745|NCT01927341|7505918|FG002|Phase 2|Disease progression|1
4634746|NCT01927341|7505919|FG003|Phase 2|Disease progression|1
4634747|NCT01927341|7505920|FG004|Phase 2|Disease progression|0
4634748|NCT01927341|7505916|FG000|Phase 2|Follow-up completed|0
4634749|NCT01927341|7505917|FG001|Phase 2|Follow-up completed|6
4634750|NCT01927341|7505918|FG002|Phase 2|Follow-up completed|3
4634751|NCT01927341|7505919|FG003|Phase 2|Follow-up completed|5
4634752|NCT01927341|7505920|FG004|Phase 2|Follow-up completed|2
4634753|NCT01927367|7505938|FG000|Overall Study|Withdrawal by Subject|7
4634754|NCT01927367|7505939|FG001|Overall Study|Withdrawal by Subject|4
4634755|NCT01927367|7505938|FG000|Overall Study|No baseline data|0
4634756|NCT01927367|7505939|FG001|Overall Study|No baseline data|1
4634757|NCT01927497|7505947|FG000|Overall Study|Death|0
4634758|NCT01927497|7505948|FG001|Overall Study|Death|1
4634759|NCT01927497|7505947|FG000|Overall Study|Protocol Violation|2
4634760|NCT01927497|7505948|FG001|Overall Study|Protocol Violation|0
4634761|NCT01927562|7505954|FG000|Overall Study|Lost to Follow-up|30
4634762|NCT01927562|7505954|FG000|Overall Study|Withdrawal by Subject|3
4634763|NCT01927562|7505954|FG000|Overall Study|Physician Decision|5
4634764|NCT01927627|7505966|FG000|Overall Study|Adverse Event|3
4634765|NCT01927627|7505966|FG000|Overall Study|Lack of Efficacy|1
4634766|NCT01927627|7505966|FG000|Overall Study|Financial Concerns|1
4634767|NCT01927757|7505974|FG000|Overall Study|Withdrawal by Subject|14
4634768|NCT01927757|7505974|FG000|Overall Study|Lost to Follow-up|2
4746421|NCT00739882|7717751|FG001|Double-blind Period|Protocol Violation|0
4746422|NCT00739882|7717750|FG000|Double-blind Period|Lack of Efficacy|1
4746423|NCT00739882|7717751|FG001|Double-blind Period|Lack of Efficacy|1
4746424|NCT00739882|7717750|FG000|Double-blind Period|Other|16
4746425|NCT00739882|7717751|FG001|Double-blind Period|Other|8
4746426|NCT00739882|7717750|FG000|Open-label Period|Adverse Event|1
4746427|NCT00739882|7717751|FG001|Open-label Period|Adverse Event|0
4746428|NCT00739882|7717750|FG000|Open-label Period|Other|9
4746429|NCT00739882|7717751|FG001|Open-label Period|Other|5
4746430|NCT00735254|7717783|FG000|Overall Study|Protocol Violation|1
4746431|NCT00735254|7717784|FG001|Overall Study|Protocol Violation|1
4746432|NCT00735254|7717785|FG002|Overall Study|Protocol Violation|1
4746433|NCT00735254|7717786|FG003|Overall Study|Protocol Violation|0
4746434|NCT00729365|7717799|FG000|Overall Study|Physician Decision|33
4746435|NCT00729365|7717800|FG001|Overall Study|Physician Decision|6
4634769|NCT01927757|7505974|FG000|Overall Study|Decision by Sponsor|2
4634770|NCT01927757|7505974|FG000|Overall Study|Other|1
4634771|NCT01927757|7505974|FG000|Overall Study|Ethical Reasons|4
4634772|NCT01927861|7505984|FG000|Extension Phase (104 Weeks)|Adverse Event|0
4746436|NCT00729365|7717801|FG002|Overall Study|Physician Decision|7
4746437|NCT00724282|7717819|FG000|Overall Study|Withdrawal by Subject|3
4746438|NCT00724282|7717819|FG000|Overall Study|Physician Decision|1
4746439|NCT00730886|7717825|FG000|Overall Study|Lost to Follow-up|1
4746440|NCT00730886|7717826|FG001|Overall Study|Lost to Follow-up|0
4746441|NCT00730886|7717825|FG000|Overall Study|Physician Decision|1
4746442|NCT00730886|7717826|FG001|Overall Study|Physician Decision|0
4746443|NCT00729560|7717854|FG000|Overall Study|Withdrawal by Subject|3
4746444|NCT00714948|7717875|FG000|Overall Study|Adverse Event|2
4746445|NCT00720343|7717879|FG000|Overall Study|Physician Decision|3
4746446|NCT00720343|7717879|FG000|Overall Study|No data|3
4746447|NCT00718640|7717894|FG000|Overall Study|Adverse Event|4
4746448|NCT00718640|7717894|FG000|Overall Study|Death|1
4746449|NCT00718640|7717894|FG000|Overall Study|Unresolved toxicity after 2 weeks|2
4746450|NCT00720083|7717900|FG000|Overall Study|Ineligible|1
4746451|NCT00720083|7717901|FG001|Overall Study|Ineligible|2
4746452|NCT00717275|7717907|FG000|Overall Study|Premature study termination.|3
4746453|NCT00708734|7717911|FG000|Overall Study|scheduling conflict|2
4746454|NCT00708734|7717911|FG000|Overall Study|moved|1
4746455|NCT00708734|7717911|FG000|Overall Study|leg injury|1
4746456|NCT00708734|7717911|FG000|Overall Study|knee replacement|1
4528235|NCT01049360|7346152|FG007|Period 2|Adverse Event|0
4528236|NCT01049360|7346153|FG008|Period 2|Adverse Event|1
4528237|NCT01049360|7346154|FG009|Period 2|Adverse Event|0
4528238|NCT01049360|7346155|FG010|Period 2|Adverse Event|0
4528239|NCT01049360|7346156|FG011|Period 2|Adverse Event|0
4528240|NCT01049360|7346157|FG012|Period 2|Adverse Event|0
4528241|NCT01049360|7346158|FG013|Period 2|Adverse Event|0
4528242|NCT01049360|7346159|FG014|Period 2|Adverse Event|0
4528243|NCT01049360|7346160|FG015|Period 2|Adverse Event|0
4528244|NCT01049360|7346161|FG016|Period 2|Adverse Event|0
4528245|NCT01049360|7346162|FG017|Period 2|Adverse Event|0
4528246|NCT01049360|7346163|FG018|Period 2|Adverse Event|0
4528247|NCT01049360|7346164|FG019|Period 2|Adverse Event|1
4528248|NCT01049360|7346145|FG000|Period 2|Withdrawal by Subject|0
4528249|NCT01049360|7346146|FG001|Period 2|Withdrawal by Subject|0
4528250|NCT01049360|7346147|FG002|Period 2|Withdrawal by Subject|0
4528251|NCT01049360|7346148|FG003|Period 2|Withdrawal by Subject|1
4528252|NCT01049360|7346149|FG004|Period 2|Withdrawal by Subject|0
4528253|NCT01049360|7346150|FG005|Period 2|Withdrawal by Subject|0
4528254|NCT01049360|7346151|FG006|Period 2|Withdrawal by Subject|0
4528255|NCT01049360|7346152|FG007|Period 2|Withdrawal by Subject|0
4528256|NCT01049360|7346153|FG008|Period 2|Withdrawal by Subject|0
4528257|NCT01049360|7346154|FG009|Period 2|Withdrawal by Subject|0
4528258|NCT01049360|7346155|FG010|Period 2|Withdrawal by Subject|0
4528259|NCT01049360|7346156|FG011|Period 2|Withdrawal by Subject|0
4528260|NCT01049360|7346157|FG012|Period 2|Withdrawal by Subject|0
4528261|NCT01049360|7346158|FG013|Period 2|Withdrawal by Subject|0
4528262|NCT01049360|7346159|FG014|Period 2|Withdrawal by Subject|1
4528263|NCT01049360|7346160|FG015|Period 2|Withdrawal by Subject|0
4528264|NCT01049360|7346161|FG016|Period 2|Withdrawal by Subject|0
4528265|NCT01049360|7346162|FG017|Period 2|Withdrawal by Subject|0
4528266|NCT01049360|7346163|FG018|Period 2|Withdrawal by Subject|0
4528267|NCT01049360|7346164|FG019|Period 2|Withdrawal by Subject|1
4528268|NCT01049360|7346145|FG000|Period 2|Lack of Efficacy|0
4528269|NCT01049360|7346146|FG001|Period 2|Lack of Efficacy|0
4528270|NCT01049360|7346147|FG002|Period 2|Lack of Efficacy|0
4528271|NCT01049360|7346148|FG003|Period 2|Lack of Efficacy|0
4528272|NCT01049360|7346149|FG004|Period 2|Lack of Efficacy|0
4528273|NCT01049360|7346150|FG005|Period 2|Lack of Efficacy|1
4528274|NCT01049360|7346151|FG006|Period 2|Lack of Efficacy|0
4528275|NCT01049360|7346152|FG007|Period 2|Lack of Efficacy|0
4528276|NCT01049360|7346153|FG008|Period 2|Lack of Efficacy|0
4528277|NCT01049360|7346154|FG009|Period 2|Lack of Efficacy|0
4528278|NCT01049360|7346155|FG010|Period 2|Lack of Efficacy|0
4528279|NCT01049360|7346156|FG011|Period 2|Lack of Efficacy|0
4528280|NCT01049360|7346157|FG012|Period 2|Lack of Efficacy|0
4528281|NCT01049360|7346158|FG013|Period 2|Lack of Efficacy|0
4528282|NCT01049360|7346159|FG014|Period 2|Lack of Efficacy|0
4528283|NCT01049360|7346160|FG015|Period 2|Lack of Efficacy|0
4528284|NCT01049360|7346161|FG016|Period 2|Lack of Efficacy|0
4528285|NCT01049360|7346162|FG017|Period 2|Lack of Efficacy|0
4528286|NCT01049360|7346163|FG018|Period 2|Lack of Efficacy|0
4528287|NCT01049360|7346164|FG019|Period 2|Lack of Efficacy|0
4528288|NCT01049360|7346145|FG000|Period 4|Protocol Violation|0
4528289|NCT01049360|7346146|FG001|Period 4|Protocol Violation|0
4528290|NCT01049360|7346147|FG002|Period 4|Protocol Violation|0
4528291|NCT01049360|7346148|FG003|Period 4|Protocol Violation|0
4528292|NCT01049360|7346149|FG004|Period 4|Protocol Violation|0
4528293|NCT01049360|7346150|FG005|Period 4|Protocol Violation|0
4528294|NCT01049360|7346151|FG006|Period 4|Protocol Violation|0
4528295|NCT01049360|7346152|FG007|Period 4|Protocol Violation|0
4528296|NCT01049360|7346153|FG008|Period 4|Protocol Violation|0
4528297|NCT01049360|7346154|FG009|Period 4|Protocol Violation|0
4528298|NCT01049360|7346155|FG010|Period 4|Protocol Violation|0
4528299|NCT01049360|7346156|FG011|Period 4|Protocol Violation|0
4528300|NCT01049360|7346157|FG012|Period 4|Protocol Violation|0
4528301|NCT01049360|7346158|FG013|Period 4|Protocol Violation|0
4528302|NCT01049360|7346159|FG014|Period 4|Protocol Violation|0
4528303|NCT01049360|7346160|FG015|Period 4|Protocol Violation|0
4528304|NCT01049360|7346161|FG016|Period 4|Protocol Violation|0
4528305|NCT01049360|7346162|FG017|Period 4|Protocol Violation|1
4528306|NCT01049360|7346163|FG018|Period 4|Protocol Violation|0
4528307|NCT01049360|7346164|FG019|Period 4|Protocol Violation|0
4528308|NCT01049360|7346145|FG000|Period 4|Withdrawal by Subject|0
4528309|NCT01049360|7346146|FG001|Period 4|Withdrawal by Subject|0
4528310|NCT01049360|7346147|FG002|Period 4|Withdrawal by Subject|0
4528311|NCT01049360|7346148|FG003|Period 4|Withdrawal by Subject|1
4528312|NCT01049360|7346149|FG004|Period 4|Withdrawal by Subject|0
4528313|NCT01049360|7346150|FG005|Period 4|Withdrawal by Subject|0
4528314|NCT01049360|7346151|FG006|Period 4|Withdrawal by Subject|0
4528315|NCT01049360|7346152|FG007|Period 4|Withdrawal by Subject|0
4528316|NCT01049360|7346153|FG008|Period 4|Withdrawal by Subject|0
4528317|NCT01049360|7346154|FG009|Period 4|Withdrawal by Subject|0
4528318|NCT01049360|7346155|FG010|Period 4|Withdrawal by Subject|0
4528319|NCT01049360|7346156|FG011|Period 4|Withdrawal by Subject|0
4528320|NCT01049360|7346157|FG012|Period 4|Withdrawal by Subject|0
4528321|NCT01049360|7346158|FG013|Period 4|Withdrawal by Subject|0
4528322|NCT01049360|7346159|FG014|Period 4|Withdrawal by Subject|0
4528323|NCT01049360|7346160|FG015|Period 4|Withdrawal by Subject|0
4528324|NCT01049360|7346161|FG016|Period 4|Withdrawal by Subject|0
4528325|NCT01049360|7346162|FG017|Period 4|Withdrawal by Subject|0
4528326|NCT01049360|7346163|FG018|Period 4|Withdrawal by Subject|0
4528327|NCT01049360|7346164|FG019|Period 4|Withdrawal by Subject|0
4528328|NCT01049373|7346178|FG000|Overall Study|Protocol Violation|9
4528329|NCT01049373|7346179|FG001|Overall Study|Protocol Violation|9
4528330|NCT01049373|7346178|FG000|Overall Study|Withdrawal by Subject|8
4528331|NCT01049373|7346179|FG001|Overall Study|Withdrawal by Subject|5
4528332|NCT01049373|7346178|FG000|Overall Study|Adverse Event|3
4528333|NCT01049373|7346179|FG001|Overall Study|Adverse Event|3
4528334|NCT01049373|7346178|FG000|Overall Study|Lost to Follow-up|9
4528335|NCT01049373|7346179|FG001|Overall Study|Lost to Follow-up|4
4528336|NCT01049373|7346178|FG000|Overall Study|no evaluable study values|9
4528337|NCT01049373|7346179|FG001|Overall Study|no evaluable study values|21
4528338|NCT01049373|7346178|FG000|Overall Study|Other|1
4528339|NCT01049373|7346179|FG001|Overall Study|Other|1
4528340|NCT01049373|7346178|FG000|Overall Study|Non-cooperation|0
4528341|NCT01049373|7346179|FG001|Overall Study|Non-cooperation|1
4528342|NCT01049412|7346189|FG000|Period I|Withdrawal by Subject|4
4528343|NCT01049412|7346190|FG001|Period I|Withdrawal by Subject|6
4528344|NCT01049412|7346189|FG000|Period I|Lost to Follow-up|2
4528345|NCT01049412|7346190|FG001|Period I|Lost to Follow-up|2
4528346|NCT01049412|7346189|FG000|Period I|Physician Decision|0
4528347|NCT01049412|7346190|FG001|Period I|Physician Decision|3
4528348|NCT01049412|7346189|FG000|Period I|Protocol Violation|1
4528349|NCT01049412|7346190|FG001|Period I|Protocol Violation|2
4528350|NCT01049412|7346189|FG000|Period I|Adverse Event|1
4528351|NCT01049412|7346190|FG001|Period I|Adverse Event|0
4528352|NCT01049412|7346189|FG000|Period II|Withdrawal by Subject|2
4528353|NCT01049412|7346190|FG001|Period II|Withdrawal by Subject|3
4528354|NCT01049412|7346189|FG000|Period II|Adverse Event|1
4528355|NCT01049412|7346190|FG001|Period II|Adverse Event|0
4528356|NCT01049412|7346189|FG000|Period II|Lost to Follow-up|1
4528357|NCT01049412|7346190|FG001|Period II|Lost to Follow-up|0
4528358|NCT01049503|7346204|FG000|Overall Study|Lost to Follow-up|11
4528359|NCT01049503|7346205|FG001|Overall Study|Lost to Follow-up|12
4528360|NCT01049503|7346206|FG002|Overall Study|Lost to Follow-up|24
4528361|NCT01049503|7346207|FG003|Overall Study|Lost to Follow-up|26
4528362|NCT01049503|7346208|FG004|Overall Study|Lost to Follow-up|27
4528363|NCT01049503|7346209|FG005|Overall Study|Lost to Follow-up|8
4528364|NCT01049581|7346234|FG000|Overall Study|Lost to Follow-up|2
4528365|NCT01049581|7346235|FG001|Overall Study|Lost to Follow-up|1
4528366|NCT01049919|7346259|FG000|Overall Study|Met study endpoint (major amputation, death)|36
4528367|NCT01049919|7346260|FG001|Overall Study|Met study endpoint (major amputation, death)|16
4528368|NCT01049919|7346259|FG000|Overall Study|Withdrawal by Subject|5
4528369|NCT01049919|7346260|FG001|Overall Study|Withdrawal by Subject|0
4528370|NCT01049919|7346259|FG000|Overall Study|Lost to Follow-up|6
4528371|NCT01049919|7346260|FG001|Overall Study|Lost to Follow-up|1
4528372|NCT01049919|7346259|FG000|Overall Study|Physician Decision|2
4528373|NCT01049919|7346260|FG001|Overall Study|Physician Decision|0
4634773|NCT01927861|7505985|FG001|Extension Phase (104 Weeks)|Adverse Event|2
4634774|NCT01927861|7505984|FG000|Extension Phase (104 Weeks)|Unclassified|0
4634775|NCT01927861|7505985|FG001|Extension Phase (104 Weeks)|Unclassified|1
4634776|NCT01928225|7506020|FG000|Overall Study|Pregnancy|1
4634777|NCT01928225|7506021|FG001|Overall Study|Pregnancy|0
4634778|NCT01928225|7506020|FG000|Overall Study|basaloid cervical cancer|1
4634779|NCT01928225|7506021|FG001|Overall Study|basaloid cervical cancer|0
4634780|NCT01928225|7506020|FG000|Overall Study|Lost to Follow-up|1
4634781|NCT01928225|7506021|FG001|Overall Study|Lost to Follow-up|3
4634782|NCT01928329|7506039|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1
4634783|NCT01928329|7506040|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3
4634784|NCT01928329|7506039|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0
4634785|NCT01928329|7506040|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1
4634786|NCT01928329|7506039|FG000|Overall Study|Adverse Event|5
4634787|NCT01928329|7506040|FG001|Overall Study|Adverse Event|3
4634788|NCT01928329|7506039|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4
4634789|NCT01928329|7506040|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1
4634790|NCT01928329|7506039|FG000|Overall Study|Withdrawal by Subject|1
4634791|NCT01928329|7506040|FG001|Overall Study|Withdrawal by Subject|5
4634792|NCT01928329|7506039|FG000|Overall Study|Physician Decision|1
4634793|NCT01928329|7506040|FG001|Overall Study|Physician Decision|1
4634794|NCT01928381|7506046|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60
4634795|NCT01928381|7506047|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
4634796|NCT01928381|7506048|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
4634797|NCT01928381|7506049|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
4634798|NCT01928381|7506050|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
4634799|NCT01928381|7506051|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
4634800|NCT01928381|7506052|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
4634801|NCT01928381|7506046|FG000|Part 1 - Pain Training|Pain training criteria not met|29
4634802|NCT01928381|7506047|FG001|Part 1 - Pain Training|Pain training criteria not met|0
4634803|NCT01928381|7506048|FG002|Part 1 - Pain Training|Pain training criteria not met|0
4634804|NCT01928381|7506049|FG003|Part 1 - Pain Training|Pain training criteria not met|0
4634805|NCT01928381|7506050|FG004|Part 1 - Pain Training|Pain training criteria not met|0
4634806|NCT01928381|7506051|FG005|Part 1 - Pain Training|Pain training criteria not met|0
4634807|NCT01928381|7506052|FG006|Part 1 - Pain Training|Pain training criteria not met|0
4634808|NCT01928381|7506046|FG000|Part 1 - Pain Training|Withdrawal by Subject|1
4634809|NCT01928381|7506047|FG001|Part 1 - Pain Training|Withdrawal by Subject|0
4634810|NCT01928381|7506048|FG002|Part 1 - Pain Training|Withdrawal by Subject|0
4634811|NCT01928381|7506049|FG003|Part 1 - Pain Training|Withdrawal by Subject|0
4634812|NCT01928381|7506050|FG004|Part 1 - Pain Training|Withdrawal by Subject|0
4634813|NCT01928381|7506051|FG005|Part 1 - Pain Training|Withdrawal by Subject|0
4634814|NCT01928381|7506052|FG006|Part 1 - Pain Training|Withdrawal by Subject|0
4634815|NCT01928381|7506046|FG000|Part 1 - Pain Training|Lost to Follow-up|4
4634816|NCT01928381|7506047|FG001|Part 1 - Pain Training|Lost to Follow-up|0
4634817|NCT01928381|7506048|FG002|Part 1 - Pain Training|Lost to Follow-up|0
4634818|NCT01928381|7506049|FG003|Part 1 - Pain Training|Lost to Follow-up|0
4634819|NCT01928381|7506050|FG004|Part 1 - Pain Training|Lost to Follow-up|0
4634820|NCT01928381|7506051|FG005|Part 1 - Pain Training|Lost to Follow-up|0
4634821|NCT01928381|7506052|FG006|Part 1 - Pain Training|Lost to Follow-up|0
4634822|NCT01928381|7506046|FG000|Part 1 - Pain Training|Protocol Violation|1
4634823|NCT01928381|7506047|FG001|Part 1 - Pain Training|Protocol Violation|0
4528374|NCT01049919|7346259|FG000|Overall Study|Received 2nd treatment via compassionate use|1
4528375|NCT01049919|7346260|FG001|Overall Study|Received 2nd treatment via compassionate use|0
4528376|NCT01049919|7346259|FG000|Overall Study|Early study termination by sponsor.|2
4528377|NCT01049919|7346260|FG001|Overall Study|Early study termination by sponsor.|0
4528378|NCT01049984|7346289|FG000|Overall Study|Withdrawal by Subject|1
4528379|NCT01049984|7346290|FG001|Overall Study|Withdrawal by Subject|5
4528380|NCT01049984|7346289|FG000|Overall Study|Protocol Violation|3
4528381|NCT01049984|7346290|FG001|Overall Study|Protocol Violation|4
4528382|NCT01049984|7346289|FG000|Overall Study|Lost to Follow-up|2
4528383|NCT01049984|7346290|FG001|Overall Study|Lost to Follow-up|1
4528384|NCT01049984|7346289|FG000|Overall Study|Adverse Event|13
4528385|NCT01049984|7346290|FG001|Overall Study|Adverse Event|7
4528386|NCT01049984|7346289|FG000|Overall Study|Treatment failure|0
4528387|NCT01049984|7346290|FG001|Overall Study|Treatment failure|2
4528388|NCT01050062|7346298|FG000|Overall Study|Adverse Event|75
4528389|NCT01050062|7346299|FG001|Overall Study|Adverse Event|22
4528390|NCT01050062|7346298|FG000|Overall Study|Lost to Follow-up|83
4528391|NCT01050062|7346299|FG001|Overall Study|Lost to Follow-up|35
4528392|NCT01050062|7346298|FG000|Overall Study|Lack of Efficacy|22
4528393|NCT01050062|7346299|FG001|Overall Study|Lack of Efficacy|35
4528394|NCT01050062|7346298|FG000|Overall Study|Physician Decision|74
4528395|NCT01050062|7346299|FG001|Overall Study|Physician Decision|9
4528396|NCT01050062|7346298|FG000|Overall Study|Others|17
4528397|NCT01050062|7346299|FG001|Overall Study|Others|11
4528398|NCT01050205|7346318|FG000|Overall Study|Lost to Follow-up|7
4528399|NCT01050205|7346319|FG001|Overall Study|Lost to Follow-up|1
4528400|NCT01050205|7346318|FG000|Overall Study|Withdrawal by Subject|1
4528401|NCT01050205|7346319|FG001|Overall Study|Withdrawal by Subject|1
4528402|NCT01050205|7346318|FG000|Overall Study|Relocated from area|1
4528403|NCT01050205|7346319|FG001|Overall Study|Relocated from area|2
4528404|NCT01050205|7346318|FG000|Overall Study|Discontinued Intervention|2
4528405|NCT01050205|7346319|FG001|Overall Study|Discontinued Intervention|0
4528406|NCT01050257|7346337|FG000|Overall Study|Adverse Event|4
4528407|NCT01050257|7346338|FG001|Overall Study|Adverse Event|4
4528408|NCT01050257|7346339|FG002|Overall Study|Adverse Event|2
4528409|NCT01050257|7346337|FG000|Overall Study|Admin/Other (did not switch to oral)|6
4528410|NCT01050257|7346338|FG001|Overall Study|Admin/Other (did not switch to oral)|2
4528411|NCT01050257|7346339|FG002|Overall Study|Admin/Other (did not switch to oral)|2
4528412|NCT01050257|7346337|FG000|Overall Study|Withdrawal by Subject|0
4528413|NCT01050257|7346338|FG001|Overall Study|Withdrawal by Subject|3
4528414|NCT01050257|7346339|FG002|Overall Study|Withdrawal by Subject|0
4528415|NCT01050257|7346337|FG000|Overall Study|No reason specified|0
4528416|NCT01050257|7346338|FG001|Overall Study|No reason specified|0
4528417|NCT01050257|7346339|FG002|Overall Study|No reason specified|2
4528418|NCT01050257|7346337|FG000|Overall Study|Refused treatment/ Did not Cooperate|1
4528419|NCT01050257|7346338|FG001|Overall Study|Refused treatment/ Did not Cooperate|1
4528420|NCT01050257|7346339|FG002|Overall Study|Refused treatment/ Did not Cooperate|0
4528421|NCT01050257|7346337|FG000|Overall Study|Violation criteria|0
4528422|NCT01050257|7346338|FG001|Overall Study|Violation criteria|1
4528423|NCT01050257|7346339|FG002|Overall Study|Violation criteria|0
4528424|NCT01050257|7346337|FG000|Overall Study|Failure to return|0
4528425|NCT01050257|7346338|FG001|Overall Study|Failure to return|2
4528426|NCT01050257|7346339|FG002|Overall Study|Failure to return|0
4528427|NCT01050257|7346337|FG000|Overall Study|Death|0
4528428|NCT01050257|7346338|FG001|Overall Study|Death|0
4528429|NCT01050257|7346339|FG002|Overall Study|Death|1
4528430|NCT01050530|7346349|FG000|Overall Study|Adverse Event|6
4528431|NCT01050530|7346350|FG001|Overall Study|Adverse Event|3
4528432|NCT01050530|7346349|FG000|Overall Study|Lack of Efficacy|1
4528433|NCT01050530|7346350|FG001|Overall Study|Lack of Efficacy|4
4528434|NCT01050530|7346349|FG000|Overall Study|Withdrawal by Subject|0
4528435|NCT01050530|7346350|FG001|Overall Study|Withdrawal by Subject|3
4528436|NCT01050530|7346349|FG000|Overall Study|Protocol Violation|1
4528437|NCT01050530|7346350|FG001|Overall Study|Protocol Violation|0
4528438|NCT01050543|7346358|FG000|Overall Study|Withdrawal by Subject|0
4528439|NCT01050543|7346359|FG001|Overall Study|Withdrawal by Subject|2
4528440|NCT01050543|7346358|FG000|Overall Study|Protocol Violation|0
4528441|NCT01050543|7346359|FG001|Overall Study|Protocol Violation|1
4528442|NCT01050543|7346358|FG000|Overall Study|Administrative|4
4528443|NCT01050543|7346359|FG001|Overall Study|Administrative|1
4528444|NCT01050569|7346368|FG000|Overall Study|Lost to Follow-up|20
4528445|NCT01050569|7346369|FG001|Overall Study|Lost to Follow-up|14
4528446|NCT01050569|7346370|FG002|Overall Study|Lost to Follow-up|16
4528447|NCT01050569|7346368|FG000|Overall Study|Withdrawal by Subject|9
4528448|NCT01050569|7346369|FG001|Overall Study|Withdrawal by Subject|3
4528449|NCT01050569|7346370|FG002|Overall Study|Withdrawal by Subject|11
4528450|NCT01050569|7346368|FG000|Overall Study|Lack of Efficacy|5
4528451|NCT01050569|7346369|FG001|Overall Study|Lack of Efficacy|4
4528452|NCT01050569|7346370|FG002|Overall Study|Lack of Efficacy|3
4528453|NCT01050569|7346368|FG000|Overall Study|Adverse Event|1
4528454|NCT01050569|7346369|FG001|Overall Study|Adverse Event|0
4528455|NCT01050569|7346370|FG002|Overall Study|Adverse Event|0
4528456|NCT01050569|7346368|FG000|Overall Study|Physician Decision|3
4528457|NCT01050569|7346369|FG001|Overall Study|Physician Decision|3
4528458|NCT01050569|7346370|FG002|Overall Study|Physician Decision|3
4528459|NCT01050634|7346391|FG000|Overall Study|Enrolled, but Not Treated|56
4528460|NCT01050634|7346391|FG000|Overall Study|Death|2
4528461|NCT01050634|7346391|FG000|Overall Study|Adverse Event|42
4528462|NCT01050634|7346391|FG000|Overall Study|Lost to Follow-up|2
4528463|NCT01050634|7346391|FG000|Overall Study|Other|21
4528464|NCT01050634|7346391|FG000|Overall Study|Ongoing at Date of Cut-Off|5
4528465|NCT01050673|7346415|FG000|Overall Study|Physician Decision|4
4528466|NCT01050673|7346416|FG001|Overall Study|Physician Decision|5
4528467|NCT01050764|7346422|FG000|Overall Study|Death, before HSCT|1
4528468|NCT01050764|7346422|FG000|Overall Study|Donor mobilization failure, death|1
4528469|NCT01050764|7346422|FG000|Overall Study|Death after HSCT, before T-cell infusion|1
4528470|NCT01050790|7346426|FG000|Overall Study|Adverse Event|1
4528471|NCT01050816|7346431|FG000|Overall Study|Lost to Follow-up|2
4528472|NCT01050816|7346431|FG000|Overall Study|patient's refusal|2
4528473|NCT01050998|7346449|FG000|Overall Study|Adverse Event|1
4528474|NCT01050998|7346450|FG001|Overall Study|Adverse Event|0
4528475|NCT01050998|7346451|FG002|Overall Study|Adverse Event|1
4528476|NCT01050998|7346452|FG003|Overall Study|Adverse Event|0
4528477|NCT01050998|7346453|FG004|Overall Study|Adverse Event|2
4528478|NCT01050998|7346449|FG000|Overall Study|Withdrawal by Subject|0
4528479|NCT01050998|7346450|FG001|Overall Study|Withdrawal by Subject|0
4528480|NCT01050998|7346451|FG002|Overall Study|Withdrawal by Subject|0
4528481|NCT01050998|7346452|FG003|Overall Study|Withdrawal by Subject|1
4528482|NCT01050998|7346453|FG004|Overall Study|Withdrawal by Subject|3
4528483|NCT01050998|7346449|FG000|Overall Study|Other|3
4528484|NCT01050998|7346450|FG001|Overall Study|Other|2
4528485|NCT01050998|7346451|FG002|Overall Study|Other|1
4528486|NCT01050998|7346452|FG003|Overall Study|Other|1
4528487|NCT01050998|7346453|FG004|Overall Study|Other|5
4528488|NCT01050998|7346449|FG000|Overall Study|Data integrity issues|0
4528489|NCT01050998|7346450|FG001|Overall Study|Data integrity issues|0
4528490|NCT01050998|7346451|FG002|Overall Study|Data integrity issues|1
4528491|NCT01050998|7346452|FG003|Overall Study|Data integrity issues|1
4528492|NCT01050998|7346453|FG004|Overall Study|Data integrity issues|4
4528493|NCT01051063|7346471|FG000|Overall Study|Death|2
4528494|NCT01051063|7346472|FG001|Overall Study|Death|2
4528495|NCT01051063|7346471|FG000|Overall Study|Withdrawal by Subject|1
4528496|NCT01051063|7346472|FG001|Overall Study|Withdrawal by Subject|1
4528497|NCT01051063|7346471|FG000|Overall Study|Termination of the study|5
4528498|NCT01051063|7346472|FG001|Overall Study|Termination of the study|0
4528499|NCT01051063|7346471|FG000|Overall Study|Moved from the study site area|1
4528500|NCT01051063|7346472|FG001|Overall Study|Moved from the study site area|0
4528501|NCT01051063|7346471|FG000|Overall Study|Other|1
4528502|NCT01051063|7346472|FG001|Overall Study|Other|0
4528503|NCT01051063|7346471|FG000|Overall Study|Lost to Follow-up|0
4528504|NCT01051063|7346472|FG001|Overall Study|Lost to Follow-up|1
4528505|NCT01051323|7346485|FG000|Overall Study|Discontinuation of treatment|103
4528506|NCT01051323|7346485|FG000|Overall Study|Transplantation|28
4528507|NCT01051323|7346485|FG000|Overall Study|Dialysis dependency|22
4528508|NCT01051323|7346485|FG000|Overall Study|Withdrawal by Subject|13
4528509|NCT01051323|7346485|FG000|Overall Study|Lost to Follow-up|31
4528510|NCT01051323|7346485|FG000|Overall Study|Death|129
4528511|NCT01051323|7346485|FG000|Overall Study|Hospitalization|28
4528512|NCT01051323|7346485|FG000|Overall Study|Other|148
4528513|NCT01051323|7346485|FG000|Overall Study|Missing|37
4528514|NCT01051349|7346493|FG000|Overall Study|Adverse Event|88
4528515|NCT01051349|7346493|FG000|Overall Study|Consent Withdrawn|54
4528516|NCT01051349|7346493|FG000|Overall Study|Investigator Decision|6
4528517|NCT01051349|7346493|FG000|Overall Study|Lost to Follow-up|6
4528518|NCT01051349|7346493|FG000|Overall Study|Subject non-compliance|7
4528519|NCT01051349|7346493|FG000|Overall Study|Reason not Specified|12
4528520|NCT01051466|7346511|FG000|Overall Study|Adverse Event|1
4528521|NCT01051466|7346512|FG001|Overall Study|Adverse Event|0
4528522|NCT01051466|7346511|FG000|Overall Study|Lost to Follow-up|1
4528523|NCT01051466|7346512|FG001|Overall Study|Lost to Follow-up|1
4528524|NCT01051466|7346511|FG000|Overall Study|Withdrawal by Subject|5
4528525|NCT01051466|7346512|FG001|Overall Study|Withdrawal by Subject|1
4528526|NCT01051466|7346511|FG000|Overall Study|Entry Criteria Not Met|0
4528527|NCT01051466|7346512|FG001|Overall Study|Entry Criteria Not Met|3
4528528|NCT01051466|7346511|FG000|Overall Study|Physician Decision|1
4528529|NCT01051466|7346512|FG001|Overall Study|Physician Decision|0
4528530|NCT01051557|7346538|FG000|Overall Study|Physician Decision|1
4528531|NCT01051557|7346539|FG001|Overall Study|Physician Decision|0
4528532|NCT01051557|7346540|FG002|Overall Study|Physician Decision|0
4528533|NCT01051557|7346541|FG003|Overall Study|Physician Decision|0
4528534|NCT01051557|7346542|FG004|Overall Study|Physician Decision|0
4528535|NCT01051557|7346543|FG005|Overall Study|Physician Decision|0
4528536|NCT01051557|7346544|FG006|Overall Study|Physician Decision|0
4528537|NCT01051557|7346538|FG000|Overall Study|disease progression|3
4528538|NCT01051557|7346539|FG001|Overall Study|disease progression|3
4528539|NCT01051557|7346540|FG002|Overall Study|disease progression|5
4528540|NCT01051557|7346541|FG003|Overall Study|disease progression|2
4528541|NCT01051557|7346542|FG004|Overall Study|disease progression|4
4528542|NCT01051557|7346543|FG005|Overall Study|disease progression|3
4528543|NCT01051557|7346544|FG006|Overall Study|disease progression|1
4528544|NCT01051557|7346538|FG000|Overall Study|Withdrawal by Subject|0
4528545|NCT01051557|7346539|FG001|Overall Study|Withdrawal by Subject|0
4528546|NCT01051557|7346540|FG002|Overall Study|Withdrawal by Subject|1
4634824|NCT01928381|7506048|FG002|Part 1 - Pain Training|Protocol Violation|0
4594534|NCT01563172|7443815|FG000|Overall Study|Other (Not specified)|1
4594535|NCT01563185|7443830|FG000|Overall Study|Withdrawal by Subject|1
4594536|NCT01563185|7443830|FG000|Overall Study|Non-Compliance with study drug|1
4594537|NCT01563237|7443838|FG000|Overall Study|Lost to Follow-up|6
4634825|NCT01928381|7506049|FG003|Part 1 - Pain Training|Protocol Violation|0
4634826|NCT01928381|7506050|FG004|Part 1 - Pain Training|Protocol Violation|0
4634827|NCT01928381|7506051|FG005|Part 1 - Pain Training|Protocol Violation|0
4634828|NCT01928381|7506052|FG006|Part 1 - Pain Training|Protocol Violation|0
4634829|NCT01928381|7506046|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1
4634830|NCT01928381|7506047|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0
4634831|NCT01928381|7506048|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0
4634832|NCT01928381|7506049|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0
4634833|NCT01928381|7506050|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0
4594538|NCT01563237|7443839|FG001|Overall Study|Lost to Follow-up|0
4594539|NCT01563237|7443838|FG000|Overall Study|Withdrawal by Subject|1
4594540|NCT01563237|7443839|FG001|Overall Study|Withdrawal by Subject|0
4594541|NCT01563237|7443838|FG000|Overall Study|Adverse Event|1
4594542|NCT01563237|7443839|FG001|Overall Study|Adverse Event|0
4594543|NCT01563237|7443838|FG000|Overall Study|Medical Reasons|1
4594544|NCT01563237|7443839|FG001|Overall Study|Medical Reasons|0
4594545|NCT01563237|7443838|FG000|Overall Study|Death|1
4594546|NCT01563237|7443839|FG001|Overall Study|Death|0
4594547|NCT01563354|7443847|FG000|Core Phase|Adverse Event|5
4594548|NCT01563354|7443848|FG001|Core Phase|Adverse Event|15
4594549|NCT01563354|7443849|FG002|Core Phase|Adverse Event|13
4594550|NCT01563354|7443847|FG000|Core Phase|Withdrawal by Subject|1
4594551|NCT01563354|7443848|FG001|Core Phase|Withdrawal by Subject|0
4594552|NCT01563354|7443849|FG002|Core Phase|Withdrawal by Subject|3
4594553|NCT01563354|7443847|FG000|Core Phase|Lost to Follow-up|1
4594554|NCT01563354|7443848|FG001|Core Phase|Lost to Follow-up|0
4594555|NCT01563354|7443849|FG002|Core Phase|Lost to Follow-up|0
4594556|NCT01563354|7443847|FG000|Core Phase|Death|1
4594557|NCT01563354|7443848|FG001|Core Phase|Death|5
4594558|NCT01563354|7443849|FG002|Core Phase|Death|2
4634834|NCT01928381|7506051|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0
4528547|NCT01051557|7346541|FG003|Overall Study|Withdrawal by Subject|0
4528548|NCT01051557|7346542|FG004|Overall Study|Withdrawal by Subject|2
4528549|NCT01051557|7346543|FG005|Overall Study|Withdrawal by Subject|0
4528550|NCT01051557|7346544|FG006|Overall Study|Withdrawal by Subject|1
4528551|NCT01051557|7346538|FG000|Overall Study|Adverse Event|0
4528552|NCT01051557|7346539|FG001|Overall Study|Adverse Event|0
4528553|NCT01051557|7346540|FG002|Overall Study|Adverse Event|0
4528554|NCT01051557|7346541|FG003|Overall Study|Adverse Event|1
4528555|NCT01051557|7346542|FG004|Overall Study|Adverse Event|1
4528556|NCT01051557|7346543|FG005|Overall Study|Adverse Event|3
4528557|NCT01051557|7346544|FG006|Overall Study|Adverse Event|4
4528558|NCT01051661|7346575|FG000|Overall Study|Adverse Event|1
4528559|NCT01051661|7346576|FG001|Overall Study|Adverse Event|1
4528560|NCT01051661|7346577|FG002|Overall Study|Adverse Event|1
4528561|NCT01051661|7346578|FG003|Overall Study|Adverse Event|1
4528562|NCT01051661|7346579|FG004|Overall Study|Adverse Event|0
4528563|NCT01051661|7346580|FG005|Overall Study|Adverse Event|0
4528564|NCT01051661|7346575|FG000|Overall Study|Lost to Follow-up|13
4528565|NCT01051661|7346576|FG001|Overall Study|Lost to Follow-up|22
4528566|NCT01051661|7346577|FG002|Overall Study|Lost to Follow-up|15
4528567|NCT01051661|7346578|FG003|Overall Study|Lost to Follow-up|17
4528568|NCT01051661|7346579|FG004|Overall Study|Lost to Follow-up|10
4528569|NCT01051661|7346580|FG005|Overall Study|Lost to Follow-up|24
4528570|NCT01051661|7346575|FG000|Overall Study|Migrated/moved from study area|1
4528571|NCT01051661|7346576|FG001|Overall Study|Migrated/moved from study area|6
4528572|NCT01051661|7346577|FG002|Overall Study|Migrated/moved from study area|6
4528573|NCT01051661|7346578|FG003|Overall Study|Migrated/moved from study area|8
4528574|NCT01051661|7346579|FG004|Overall Study|Migrated/moved from study area|7
4528575|NCT01051661|7346580|FG005|Overall Study|Migrated/moved from study area|3
4528576|NCT01051661|7346575|FG000|Overall Study|Refused blood sampling|0
4528577|NCT01051661|7346576|FG001|Overall Study|Refused blood sampling|0
4528578|NCT01051661|7346577|FG002|Overall Study|Refused blood sampling|0
4528579|NCT01051661|7346578|FG003|Overall Study|Refused blood sampling|0
4528580|NCT01051661|7346579|FG004|Overall Study|Refused blood sampling|0
4528581|NCT01051661|7346580|FG005|Overall Study|Refused blood sampling|1
4528582|NCT01051661|7346575|FG000|Overall Study|Data not reliable|1
4528583|NCT01051661|7346576|FG001|Overall Study|Data not reliable|0
4528584|NCT01051661|7346577|FG002|Overall Study|Data not reliable|0
4528585|NCT01051661|7346578|FG003|Overall Study|Data not reliable|0
4528586|NCT01051661|7346579|FG004|Overall Study|Data not reliable|0
4528587|NCT01051661|7346580|FG005|Overall Study|Data not reliable|1
4528588|NCT01051661|7346575|FG000|Overall Study|Unable to attend visit(s)|2
4528589|NCT01051661|7346576|FG001|Overall Study|Unable to attend visit(s)|4
4528590|NCT01051661|7346577|FG002|Overall Study|Unable to attend visit(s)|2
4528591|NCT01051661|7346578|FG003|Overall Study|Unable to attend visit(s)|1
4528592|NCT01051661|7346579|FG004|Overall Study|Unable to attend visit(s)|3
4528593|NCT01051661|7346580|FG005|Overall Study|Unable to attend visit(s)|2
4528594|NCT01051661|7346575|FG000|Overall Study|Consent not received from both parents|0
4528595|NCT01051661|7346576|FG001|Overall Study|Consent not received from both parents|0
4528596|NCT01051661|7346577|FG002|Overall Study|Consent not received from both parents|0
4528597|NCT01051661|7346578|FG003|Overall Study|Consent not received from both parents|0
4528598|NCT01051661|7346579|FG004|Overall Study|Consent not received from both parents|0
4528599|NCT01051661|7346580|FG005|Overall Study|Consent not received from both parents|1
4528600|NCT01051661|7346575|FG000|Overall Study|Failure to comply with protocol|0
4528601|NCT01051661|7346576|FG001|Overall Study|Failure to comply with protocol|0
4528602|NCT01051661|7346577|FG002|Overall Study|Failure to comply with protocol|2
4528603|NCT01051661|7346578|FG003|Overall Study|Failure to comply with protocol|0
4528604|NCT01051661|7346579|FG004|Overall Study|Failure to comply with protocol|0
4528605|NCT01051661|7346580|FG005|Overall Study|Failure to comply with protocol|0
4528606|NCT01051661|7346575|FG000|Overall Study|Subject lost legal representation|0
4528607|NCT01051661|7346576|FG001|Overall Study|Subject lost legal representation|0
4528608|NCT01051661|7346577|FG002|Overall Study|Subject lost legal representation|0
4528609|NCT01051661|7346578|FG003|Overall Study|Subject lost legal representation|0
4528610|NCT01051661|7346579|FG004|Overall Study|Subject lost legal representation|1
4528611|NCT01051661|7346580|FG005|Overall Study|Subject lost legal representation|0
4528612|NCT01051661|7346575|FG000|Overall Study|Protocol Violation|0
4528613|NCT01051661|7346576|FG001|Overall Study|Protocol Violation|0
4528614|NCT01051661|7346577|FG002|Overall Study|Protocol Violation|0
4528615|NCT01051661|7346578|FG003|Overall Study|Protocol Violation|1
4528616|NCT01051661|7346579|FG004|Overall Study|Protocol Violation|2
4528617|NCT01051661|7346580|FG005|Overall Study|Protocol Violation|1
4634835|NCT01928381|7506052|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0
4634836|NCT01928381|7506046|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2
4634837|NCT01928381|7506047|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
4634838|NCT01928381|7506048|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
4634839|NCT01928381|7506049|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
4634840|NCT01928381|7506050|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
4634841|NCT01928381|7506051|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
4634842|NCT01928381|7506052|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
4634843|NCT01928381|7506046|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1
4634844|NCT01928381|7506047|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
4634845|NCT01928381|7506048|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
4634846|NCT01928381|7506049|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
4634847|NCT01928381|7506050|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
4634848|NCT01928381|7506051|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
4634849|NCT01928381|7506052|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
4528618|NCT01051661|7346575|FG000|Overall Study|Withdrawal by Subject|16
4528619|NCT01051661|7346576|FG001|Overall Study|Withdrawal by Subject|30
4528620|NCT01051661|7346577|FG002|Overall Study|Withdrawal by Subject|13
4528621|NCT01051661|7346578|FG003|Overall Study|Withdrawal by Subject|28
4528622|NCT01051661|7346579|FG004|Overall Study|Withdrawal by Subject|12
4528623|NCT01051661|7346580|FG005|Overall Study|Withdrawal by Subject|34
4528624|NCT01051739|7346617|FG000|Overall Study|Death|3
4528625|NCT01051739|7346618|FG001|Overall Study|Death|3
4528626|NCT01051739|7346617|FG000|Overall Study|Withdrawal by Subject|25
4528627|NCT01051739|7346618|FG001|Overall Study|Withdrawal by Subject|10
4528628|NCT01051791|7346633|FG000|Overall Study|Failed screening|3
4528629|NCT01051791|7346633|FG000|Overall Study|Withdrawal by Subject|1
4528630|NCT01051817|7346640|FG000|Overall Study|Adverse Event|0
4528631|NCT01051817|7346641|FG001|Overall Study|Adverse Event|2
4528632|NCT01051817|7346640|FG000|Overall Study|Abnormal Test Proceedure reults|0
4528633|NCT01051817|7346641|FG001|Overall Study|Abnormal Test Proceedure reults|1
4528634|NCT01051817|7346640|FG000|Overall Study|Withdrawal by Subject|3
4634850|NCT01928381|7506046|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10
4634851|NCT01928381|7506047|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
4634852|NCT01928381|7506048|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
4634853|NCT01928381|7506049|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
4634854|NCT01928381|7506050|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
4634855|NCT01928381|7506051|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
4634856|NCT01928381|7506052|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
4634857|NCT01928381|7506046|FG000|Part 2 - First Intervention|Withdrawal by Subject|0
4634858|NCT01928381|7506047|FG001|Part 2 - First Intervention|Withdrawal by Subject|0
4634859|NCT01928381|7506048|FG002|Part 2 - First Intervention|Withdrawal by Subject|1
4634860|NCT01928381|7506049|FG003|Part 2 - First Intervention|Withdrawal by Subject|0
4634861|NCT01928381|7506050|FG004|Part 2 - First Intervention|Withdrawal by Subject|0
4634862|NCT01928381|7506051|FG005|Part 2 - First Intervention|Withdrawal by Subject|0
4634863|NCT01928381|7506052|FG006|Part 2 - First Intervention|Withdrawal by Subject|0
4634864|NCT01928381|7506046|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0
4634865|NCT01928381|7506047|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0
4634866|NCT01928381|7506048|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1
4528635|NCT01051817|7346641|FG001|Overall Study|Withdrawal by Subject|5
4528636|NCT01051817|7346640|FG000|Overall Study|Protocol Violation|0
4528637|NCT01051817|7346641|FG001|Overall Study|Protocol Violation|1
4528638|NCT01051856|7346649|FG000|Overall Study|Withdrawal by Subject|1
4528639|NCT01051856|7346650|FG001|Overall Study|Withdrawal by Subject|0
4528640|NCT01051960|7346656|FG000|Overall Study|Adverse Event|1
4528641|NCT01051986|7346662|FG000|Overall Study|Death|1
4528642|NCT01051986|7346663|FG001|Overall Study|Death|0
4528643|NCT01051986|7346662|FG000|Overall Study|Withdrawal by Subject|2
4528644|NCT01051986|7346663|FG001|Overall Study|Withdrawal by Subject|1
4528645|NCT01051986|7346662|FG000|Overall Study|Protocol Violation|2
4528646|NCT01051986|7346663|FG001|Overall Study|Protocol Violation|3
4528647|NCT01052012|7346675|FG000|Overall Study|Not treated|2
4528648|NCT01052012|7346676|FG001|Overall Study|Not treated|5
4528649|NCT01052012|7346677|FG002|Overall Study|Not treated|0
4528650|NCT01052012|7346678|FG003|Overall Study|Not treated|0
4528651|NCT01052012|7346679|FG004|Overall Study|Not treated|11
4528652|NCT01052012|7346680|FG005|Overall Study|Not treated|8
4528653|NCT01052012|7346675|FG000|Overall Study|Adverse Event|1
4528654|NCT01052012|7346676|FG001|Overall Study|Adverse Event|0
4528655|NCT01052012|7346677|FG002|Overall Study|Adverse Event|0
4528656|NCT01052012|7346678|FG003|Overall Study|Adverse Event|1
4528657|NCT01052012|7346679|FG004|Overall Study|Adverse Event|0
4528658|NCT01052012|7346680|FG005|Overall Study|Adverse Event|0
4528659|NCT01052012|7346675|FG000|Overall Study|Lost to Follow-up|0
4528660|NCT01052012|7346676|FG001|Overall Study|Lost to Follow-up|0
4528661|NCT01052012|7346677|FG002|Overall Study|Lost to Follow-up|0
4528662|NCT01052012|7346678|FG003|Overall Study|Lost to Follow-up|0
4528663|NCT01052012|7346679|FG004|Overall Study|Lost to Follow-up|1
4528664|NCT01052012|7346680|FG005|Overall Study|Lost to Follow-up|0
4528665|NCT01052012|7346675|FG000|Overall Study|Withdrawal by Subject|1
4528666|NCT01052012|7346676|FG001|Overall Study|Withdrawal by Subject|1
4528667|NCT01052012|7346677|FG002|Overall Study|Withdrawal by Subject|0
4528668|NCT01052012|7346678|FG003|Overall Study|Withdrawal by Subject|0
4528669|NCT01052012|7346679|FG004|Overall Study|Withdrawal by Subject|3
4528670|NCT01052012|7346680|FG005|Overall Study|Withdrawal by Subject|1
4528671|NCT01052012|7346675|FG000|Overall Study|Physician Decision|0
4528672|NCT01052012|7346676|FG001|Overall Study|Physician Decision|0
4528673|NCT01052012|7346677|FG002|Overall Study|Physician Decision|0
4528674|NCT01052012|7346678|FG003|Overall Study|Physician Decision|0
4528675|NCT01052012|7346679|FG004|Overall Study|Physician Decision|0
4528676|NCT01052012|7346680|FG005|Overall Study|Physician Decision|1
4528677|NCT01052012|7346675|FG000|Overall Study|Other|0
4528678|NCT01052012|7346676|FG001|Overall Study|Other|0
4528679|NCT01052012|7346677|FG002|Overall Study|Other|0
4528680|NCT01052012|7346678|FG003|Overall Study|Other|0
4528681|NCT01052012|7346679|FG004|Overall Study|Other|1
4528682|NCT01052012|7346680|FG005|Overall Study|Other|0
4528683|NCT01052038|7346697|FG000|Overall Study|Lost to Follow-up|2
4528684|NCT01052038|7346698|FG001|Overall Study|Lost to Follow-up|3
4528685|NCT01052038|7346699|FG002|Overall Study|Lost to Follow-up|1
4528686|NCT01052038|7346697|FG000|Overall Study|Protocol Violation|2
4528687|NCT01052038|7346698|FG001|Overall Study|Protocol Violation|3
4528688|NCT01052038|7346699|FG002|Overall Study|Protocol Violation|3
4528689|NCT01052077|7346709|FG000|Phase A|Lost to Follow-up|22
4528690|NCT01052077|7346710|FG001|Phase A|Lost to Follow-up|0
4528691|NCT01052077|7346711|FG002|Phase A|Lost to Follow-up|0
4528692|NCT01052077|7346712|FG003|Phase A|Lost to Follow-up|0
4528693|NCT01052077|7346709|FG000|Phase A|Adverse Event|32
4528694|NCT01052077|7346710|FG001|Phase A|Adverse Event|0
4528695|NCT01052077|7346711|FG002|Phase A|Adverse Event|0
4528696|NCT01052077|7346712|FG003|Phase A|Adverse Event|0
4528697|NCT01052077|7346709|FG000|Phase A|Met Withdrawal Criteria|26
4528698|NCT01052077|7346710|FG001|Phase A|Met Withdrawal Criteria|0
4528699|NCT01052077|7346711|FG002|Phase A|Met Withdrawal Criteria|0
4528700|NCT01052077|7346712|FG003|Phase A|Met Withdrawal Criteria|0
4528701|NCT01052077|7346709|FG000|Phase A|Physician Decision|10
4528702|NCT01052077|7346710|FG001|Phase A|Physician Decision|0
4528703|NCT01052077|7346711|FG002|Phase A|Physician Decision|0
4528704|NCT01052077|7346712|FG003|Phase A|Physician Decision|0
4528705|NCT01052077|7346709|FG000|Phase A|Withdrawal by Subject|29
4528706|NCT01052077|7346710|FG001|Phase A|Withdrawal by Subject|0
4528707|NCT01052077|7346711|FG002|Phase A|Withdrawal by Subject|0
4528708|NCT01052077|7346712|FG003|Phase A|Withdrawal by Subject|0
4528709|NCT01052077|7346709|FG000|Phase A|Protocol Deviation|27
4528710|NCT01052077|7346710|FG001|Phase A|Protocol Deviation|0
4528711|NCT01052077|7346711|FG002|Phase A|Protocol Deviation|0
4528712|NCT01052077|7346712|FG003|Phase A|Protocol Deviation|0
4528713|NCT01052077|7346709|FG000|Phase B|Lost to Follow-up|0
4528714|NCT01052077|7346710|FG001|Phase B|Lost to Follow-up|2
4528715|NCT01052077|7346711|FG002|Phase B|Lost to Follow-up|3
4528716|NCT01052077|7346712|FG003|Phase B|Lost to Follow-up|0
4528717|NCT01052077|7346709|FG000|Phase B|Adverse Event|0
4528718|NCT01052077|7346710|FG001|Phase B|Adverse Event|9
4528719|NCT01052077|7346711|FG002|Phase B|Adverse Event|2
4528720|NCT01052077|7346712|FG003|Phase B|Adverse Event|0
4528721|NCT01052077|7346709|FG000|Phase B|Met Withdrawal Criteria|0
4528722|NCT01052077|7346710|FG001|Phase B|Met Withdrawal Criteria|2
4528723|NCT01052077|7346711|FG002|Phase B|Met Withdrawal Criteria|1
4528724|NCT01052077|7346712|FG003|Phase B|Met Withdrawal Criteria|0
4528725|NCT01052077|7346709|FG000|Phase B|Physician Decision|0
4528726|NCT01052077|7346710|FG001|Phase B|Physician Decision|1
4528727|NCT01052077|7346711|FG002|Phase B|Physician Decision|1
4528728|NCT01052077|7346712|FG003|Phase B|Physician Decision|0
4528729|NCT01052077|7346709|FG000|Phase B|Withdrawal by Subject|0
4528730|NCT01052077|7346710|FG001|Phase B|Withdrawal by Subject|0
4528731|NCT01052077|7346711|FG002|Phase B|Withdrawal by Subject|5
4528732|NCT01052077|7346712|FG003|Phase B|Withdrawal by Subject|0
4528733|NCT01052077|7346709|FG000|Phase B|Protocol Deviation|0
4528734|NCT01052077|7346710|FG001|Phase B|Protocol Deviation|3
4528735|NCT01052077|7346711|FG002|Phase B|Protocol Deviation|4
4528736|NCT01052077|7346712|FG003|Phase B|Protocol Deviation|0
4528737|NCT01052077|7346709|FG000|Phase B|Lack of Efficacy|0
4528738|NCT01052077|7346710|FG001|Phase B|Lack of Efficacy|1
4528739|NCT01052077|7346711|FG002|Phase B|Lack of Efficacy|0
4528740|NCT01052077|7346712|FG003|Phase B|Lack of Efficacy|0
4528741|NCT01052077|7346709|FG000|Phase A+|Lost to Follow-up|0
4528742|NCT01052077|7346710|FG001|Phase A+|Lost to Follow-up|0
4528743|NCT01052077|7346711|FG002|Phase A+|Lost to Follow-up|0
4528744|NCT01052077|7346712|FG003|Phase A+|Lost to Follow-up|8
4528745|NCT01052077|7346709|FG000|Phase A+|Adverse Event|0
4528746|NCT01052077|7346710|FG001|Phase A+|Adverse Event|0
4528747|NCT01052077|7346711|FG002|Phase A+|Adverse Event|0
4528748|NCT01052077|7346712|FG003|Phase A+|Adverse Event|4
4528749|NCT01052077|7346709|FG000|Phase A+|Met Withdrawal Criteria|0
4528750|NCT01052077|7346710|FG001|Phase A+|Met Withdrawal Criteria|0
4528751|NCT01052077|7346711|FG002|Phase A+|Met Withdrawal Criteria|0
4528752|NCT01052077|7346712|FG003|Phase A+|Met Withdrawal Criteria|2
4528753|NCT01052077|7346709|FG000|Phase A+|Withdrawal by Subject|0
4528754|NCT01052077|7346710|FG001|Phase A+|Withdrawal by Subject|0
4528755|NCT01052077|7346711|FG002|Phase A+|Withdrawal by Subject|0
4528756|NCT01052077|7346712|FG003|Phase A+|Withdrawal by Subject|7
4528757|NCT01052103|7346720|FG000|Overall Study|Adverse Event|10
4528758|NCT01052103|7346721|FG001|Overall Study|Adverse Event|6
4528759|NCT01052103|7346720|FG000|Overall Study|Entry Criteria Not Met|3
4528760|NCT01052103|7346721|FG001|Overall Study|Entry Criteria Not Met|1
4528761|NCT01052103|7346720|FG000|Overall Study|Lost to Follow-up|3
4528762|NCT01052103|7346721|FG001|Overall Study|Lost to Follow-up|5
4528763|NCT01052103|7346720|FG000|Overall Study|Protocol Violation|10
4528764|NCT01052103|7346721|FG001|Overall Study|Protocol Violation|4
4528765|NCT01052103|7346720|FG000|Overall Study|Scheduling conflict|2
4528766|NCT01052103|7346721|FG001|Overall Study|Scheduling conflict|1
4528767|NCT01052103|7346720|FG000|Overall Study|Sponsor Decision|2
4528768|NCT01052103|7346721|FG001|Overall Study|Sponsor Decision|0
4528769|NCT01052103|7346720|FG000|Overall Study|Withdrawal by Subject|3
4528770|NCT01052103|7346721|FG001|Overall Study|Withdrawal by Subject|6
4528771|NCT01052103|7346720|FG000|Overall Study|Perceived Lack of Efficacy|1
4528772|NCT01052103|7346721|FG001|Overall Study|Perceived Lack of Efficacy|0
4528773|NCT01052116|7346730|FG000|Overall Study|Lost to Follow-up|11
4528774|NCT01052116|7346731|FG001|Overall Study|Lost to Follow-up|17
4528775|NCT01052116|7346730|FG000|Overall Study|Withdrawal by Subject|3
4634867|NCT01928381|7506049|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0
4528776|NCT01052116|7346731|FG001|Overall Study|Withdrawal by Subject|6
4528777|NCT01052116|7346730|FG000|Overall Study|Spirometry not performed|0
4528778|NCT01052116|7346731|FG001|Overall Study|Spirometry not performed|4
4528779|NCT01052272|7346750|FG000|Overall Study|Death|0
4528780|NCT01052272|7346751|FG001|Overall Study|Death|0
4528781|NCT01052272|7346752|FG002|Overall Study|Death|1
4528782|NCT01052272|7346753|FG003|Overall Study|Death|1
4528783|NCT01052272|7346750|FG000|Overall Study|Physician Decision|0
4528784|NCT01052272|7346751|FG001|Overall Study|Physician Decision|1
4528785|NCT01052272|7346752|FG002|Overall Study|Physician Decision|0
4634868|NCT01928381|7506050|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0
4634869|NCT01928381|7506051|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0
4528786|NCT01052272|7346753|FG003|Overall Study|Physician Decision|0
4528787|NCT01052272|7346750|FG000|Overall Study|patient refuses follow-up|5
4528788|NCT01052272|7346751|FG001|Overall Study|patient refuses follow-up|4
4528789|NCT01052272|7346752|FG002|Overall Study|patient refuses follow-up|2
4528790|NCT01052272|7346753|FG003|Overall Study|patient refuses follow-up|4
4528791|NCT01052272|7346750|FG000|Overall Study|Withdrawal by Subject|0
4528792|NCT01052272|7346751|FG001|Overall Study|Withdrawal by Subject|2
4528793|NCT01052272|7346752|FG002|Overall Study|Withdrawal by Subject|3
4528794|NCT01052272|7346753|FG003|Overall Study|Withdrawal by Subject|2
4528795|NCT01052272|7346750|FG000|Overall Study|placed in long-term care|0
4528796|NCT01052272|7346751|FG001|Overall Study|placed in long-term care|0
4528797|NCT01052272|7346752|FG002|Overall Study|placed in long-term care|1
4528798|NCT01052272|7346753|FG003|Overall Study|placed in long-term care|0
4528799|NCT01052272|7346750|FG000|Overall Study|decline in health|0
4528800|NCT01052272|7346751|FG001|Overall Study|decline in health|0
4528801|NCT01052272|7346752|FG002|Overall Study|decline in health|1
4528802|NCT01052272|7346753|FG003|Overall Study|decline in health|0
4528803|NCT01052428|7346765|FG000|Overall Study|Death|1
4528804|NCT01052428|7346766|FG001|Overall Study|Death|0
4528805|NCT01052428|7346765|FG000|Overall Study|Withdrawal by Subject|0
4528806|NCT01052428|7346766|FG001|Overall Study|Withdrawal by Subject|1
4528807|NCT01052480|7346774|FG000|Overall Study|Lost to Follow-up|3
4528808|NCT01052480|7346775|FG001|Overall Study|Lost to Follow-up|3
4528809|NCT01052480|7346774|FG000|Overall Study|Protocol Violation|1
4528810|NCT01052480|7346775|FG001|Overall Study|Protocol Violation|0
4528811|NCT01052480|7346774|FG000|Overall Study|Withdrawal by Subject|3
4528812|NCT01052480|7346775|FG001|Overall Study|Withdrawal by Subject|7
4528813|NCT01052480|7346774|FG000|Overall Study|Physician Decision|0
4528814|NCT01052480|7346775|FG001|Overall Study|Physician Decision|2
4528815|NCT01052480|7346774|FG000|Overall Study|Death|1
4528816|NCT01052480|7346775|FG001|Overall Study|Death|5
4528817|NCT01052493|7346781|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1
4528818|NCT01052493|7346782|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0
4528819|NCT01052493|7346783|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0
4528820|NCT01052662|7346820|FG000|Overall Study|Lost to Follow-up|15
4528821|NCT01052662|7346821|FG001|Overall Study|Lost to Follow-up|13
4528822|NCT01052662|7346822|FG002|Overall Study|Lost to Follow-up|18
4528823|NCT01052662|7346820|FG000|Overall Study|Withdrawal by Subject|3
4528824|NCT01052662|7346821|FG001|Overall Study|Withdrawal by Subject|2
4528825|NCT01052662|7346822|FG002|Overall Study|Withdrawal by Subject|1
4528826|NCT01052662|7346820|FG000|Overall Study|Pharmacy issue|1
4594559|NCT01563354|7443847|FG000|Core Phase|Diseasse progression|18
4594560|NCT01563354|7443848|FG001|Core Phase|Diseasse progression|7
4594561|NCT01563354|7443849|FG002|Core Phase|Diseasse progression|8
4594562|NCT01563354|7443847|FG000|Core Phase|Protocol deviation|2
4594563|NCT01563354|7443848|FG001|Core Phase|Protocol deviation|0
4594564|NCT01563354|7443849|FG002|Core Phase|Protocol deviation|0
4594565|NCT01563354|7443847|FG000|Core Phase|PI decision - did not enter extension|0
4594566|NCT01563354|7443848|FG001|Core Phase|PI decision - did not enter extension|1
4528827|NCT01052662|7346821|FG001|Overall Study|Pharmacy issue|3
4528828|NCT01052662|7346822|FG002|Overall Study|Pharmacy issue|3
4528829|NCT01052662|7346820|FG000|Overall Study|Adverse Event|1
4528830|NCT01052662|7346821|FG001|Overall Study|Adverse Event|1
4528831|NCT01052662|7346822|FG002|Overall Study|Adverse Event|0
4528832|NCT01052662|7346820|FG000|Overall Study|Legal Problem|2
4528833|NCT01052662|7346821|FG001|Overall Study|Legal Problem|0
4528834|NCT01052662|7346822|FG002|Overall Study|Legal Problem|0
4528835|NCT01052662|7346820|FG000|Overall Study|Administrative|0
4528836|NCT01052662|7346821|FG001|Overall Study|Administrative|3
4528837|NCT01052662|7346822|FG002|Overall Study|Administrative|0
4528838|NCT01052714|7346841|FG000|Overall Study|Adverse Event|6
4528839|NCT01052714|7346842|FG001|Overall Study|Adverse Event|3
4528840|NCT01052714|7346843|FG002|Overall Study|Adverse Event|0
4528841|NCT01052714|7346841|FG000|Overall Study|Death|1
4528842|NCT01052714|7346842|FG001|Overall Study|Death|2
4528843|NCT01052714|7346843|FG002|Overall Study|Death|0
4528844|NCT01052714|7346841|FG000|Overall Study|Lost to Follow-up|2
4528845|NCT01052714|7346842|FG001|Overall Study|Lost to Follow-up|3
4528846|NCT01052714|7346843|FG002|Overall Study|Lost to Follow-up|0
4528847|NCT01052714|7346841|FG000|Overall Study|Physician Decision|9
4528848|NCT01052714|7346842|FG001|Overall Study|Physician Decision|9
4528849|NCT01052714|7346843|FG002|Overall Study|Physician Decision|1
4528850|NCT01052714|7346841|FG000|Overall Study|Withdrawal by Subject|7
4528851|NCT01052714|7346842|FG001|Overall Study|Withdrawal by Subject|12
4528852|NCT01052714|7346843|FG002|Overall Study|Withdrawal by Subject|1
4528853|NCT01052779|7346851|FG000|Overall Study|Adverse Event|1
4528854|NCT01052779|7346852|FG001|Overall Study|Adverse Event|4
4528855|NCT01052779|7346851|FG000|Overall Study|Withdrawal by Subject|1
4528856|NCT01052779|7346852|FG001|Overall Study|Withdrawal by Subject|2
4528857|NCT01052779|7346851|FG000|Overall Study|Other-Protocol Violation|1
4528858|NCT01052779|7346852|FG001|Overall Study|Other-Protocol Violation|1
4528859|NCT01052779|7346851|FG000|Overall Study|Other-Surgery|0
4528860|NCT01052779|7346852|FG001|Overall Study|Other-Surgery|2
4528861|NCT01052779|7346851|FG000|Overall Study|Other-Missed Week 5 Visit|2
4528862|NCT01052779|7346852|FG001|Overall Study|Other-Missed Week 5 Visit|0
4528863|NCT01052844|7346869|FG000|Overall Study|Adverse Event|0
4528864|NCT01052844|7346870|FG001|Overall Study|Adverse Event|1
4528865|NCT01053247|7347031|FG000|Overall Study|Withdrawal by Subject|9
4528866|NCT01053247|7347032|FG001|Overall Study|Withdrawal by Subject|4
4528867|NCT01053247|7347033|FG002|Overall Study|Withdrawal by Subject|15
4528868|NCT01053247|7347031|FG000|Overall Study|Lack of Efficacy|1
4634870|NCT01928381|7506052|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0
4634871|NCT01928381|7506046|FG000|Part 2 - First Intervention|Eligibility criterion not met|0
4634872|NCT01928381|7506047|FG001|Part 2 - First Intervention|Eligibility criterion not met|0
4634873|NCT01928381|7506048|FG002|Part 2 - First Intervention|Eligibility criterion not met|0
4634874|NCT01928381|7506049|FG003|Part 2 - First Intervention|Eligibility criterion not met|0
4634875|NCT01928381|7506050|FG004|Part 2 - First Intervention|Eligibility criterion not met|0
4634876|NCT01928381|7506051|FG005|Part 2 - First Intervention|Eligibility criterion not met|1
4746457|NCT00708734|7717911|FG000|Overall Study|vertigo|1
4746458|NCT00708734|7717911|FG000|Overall Study|leg fracture|1
4746459|NCT00711087|7717917|FG000|Overall Study|Lost to Follow-up|1
4746460|NCT00711087|7717918|FG001|Overall Study|Lost to Follow-up|0
4746461|NCT00706797|7717926|FG000|Overall Study|Lack of Efficacy|3
4746462|NCT00706797|7717927|FG001|Overall Study|Lack of Efficacy|0
4746463|NCT00706797|7717926|FG000|Overall Study|Adverse Event|0
4746464|NCT00706797|7717927|FG001|Overall Study|Adverse Event|3
4746465|NCT00706797|7717926|FG000|Overall Study|Withdrawal by Subject|8
4746466|NCT00706797|7717927|FG001|Overall Study|Withdrawal by Subject|1
4528869|NCT01053247|7347032|FG001|Overall Study|Lack of Efficacy|0
4528870|NCT01053247|7347033|FG002|Overall Study|Lack of Efficacy|1
4528871|NCT01053247|7347031|FG000|Overall Study|Protocol Violation|2
4528872|NCT01053247|7347032|FG001|Overall Study|Protocol Violation|1
4528873|NCT01053247|7347033|FG002|Overall Study|Protocol Violation|2
4528874|NCT01053247|7347031|FG000|Overall Study|Lost to Follow-up|8
4528875|NCT01053247|7347032|FG001|Overall Study|Lost to Follow-up|5
4528876|NCT01053247|7347033|FG002|Overall Study|Lost to Follow-up|7
4528877|NCT01053247|7347031|FG000|Overall Study|Adverse Event|0
4528878|NCT01053247|7347032|FG001|Overall Study|Adverse Event|9
4528879|NCT01053247|7347033|FG002|Overall Study|Adverse Event|3
4528880|NCT01053429|7347059|FG000|Overall Study|Adverse Event|64
4528881|NCT01053429|7347059|FG000|Overall Study|Other|309
4528882|NCT01053663|7347075|FG000|Overall Study|Death|2
4528883|NCT01053663|7347075|FG000|Overall Study|Lost to Follow-up|1
4528884|NCT01053663|7347075|FG000|Overall Study|Poor IV Access|1
4528885|NCT01053663|7347075|FG000|Overall Study|Transferred to Another Hospital|1
4528886|NCT01053663|7347075|FG000|Overall Study|Negative Influenza Diagnosis|1
4594567|NCT01563354|7443849|FG002|Core Phase|PI decision - did not enter extension|0
4594568|NCT01563354|7443847|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1
4594569|NCT01563354|7443848|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0
4594570|NCT01563354|7443849|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0
4594571|NCT01563354|7443847|FG000|Extension Phase|Adverse Event|0
4594572|NCT01563354|7443848|FG001|Extension Phase|Adverse Event|3
4594573|NCT01563354|7443849|FG002|Extension Phase|Adverse Event|2
4594574|NCT01563354|7443847|FG000|Extension Phase|Withdrawal by Subject|0
4594575|NCT01563354|7443848|FG001|Extension Phase|Withdrawal by Subject|1
4594576|NCT01563354|7443849|FG002|Extension Phase|Withdrawal by Subject|0
4594577|NCT01563354|7443847|FG000|Extension Phase|Administration problems|3
4594578|NCT01563354|7443848|FG001|Extension Phase|Administration problems|2
4594579|NCT01563354|7443849|FG002|Extension Phase|Administration problems|3
4594580|NCT01563354|7443847|FG000|Extension Phase|Disease progression|9
4594581|NCT01563354|7443848|FG001|Extension Phase|Disease progression|8
4594582|NCT01563354|7443849|FG002|Extension Phase|Disease progression|10
4594583|NCT01563536|7443880|FG000|Overall Study|Withdrawal by Subject|0
4594584|NCT01563536|7443881|FG001|Overall Study|Withdrawal by Subject|2
4594585|NCT01563536|7443880|FG000|Overall Study|Lost to Follow-up|1
4594586|NCT01563536|7443881|FG001|Overall Study|Lost to Follow-up|0
4594587|NCT01563913|7443889|FG000|Overall Study|Physician Decision|1
4594588|NCT01563913|7443890|FG001|Overall Study|Physician Decision|0
4594589|NCT01563913|7443889|FG000|Overall Study|Spouse Passed Away|1
4594590|NCT01563913|7443890|FG001|Overall Study|Spouse Passed Away|0
4594591|NCT01563978|7443898|FG000|Overall Study|Physician Decision|1
4594592|NCT01563978|7443899|FG001|Overall Study|Physician Decision|0
4594593|NCT01563978|7443898|FG000|Overall Study|Lost to Follow-up|1
4594594|NCT01563978|7443899|FG001|Overall Study|Lost to Follow-up|0
4594595|NCT01563978|7443898|FG000|Overall Study|Dev. of study specific discont. criteria|1
4594596|NCT01563978|7443899|FG001|Overall Study|Dev. of study specific discont. criteria|0
4594597|NCT01563978|7443898|FG000|Overall Study|Adverse Event|1
4594598|NCT01563978|7443899|FG001|Overall Study|Adverse Event|2
4594599|NCT01564277|7443907|FG000|Overall Study|Protocol Violation|0
4594600|NCT01564277|7443908|FG001|Overall Study|Protocol Violation|1
4634877|NCT01928381|7506052|FG006|Part 2 - First Intervention|Eligibility criterion not met|1
4634878|NCT01928381|7506046|FG000|Part 2 - First Intervention|Lost to Follow-up|0
4634879|NCT01928381|7506047|FG001|Part 2 - First Intervention|Lost to Follow-up|0
4634880|NCT01928381|7506048|FG002|Part 2 - First Intervention|Lost to Follow-up|0
4634881|NCT01928381|7506049|FG003|Part 2 - First Intervention|Lost to Follow-up|1
4634882|NCT01928381|7506050|FG004|Part 2 - First Intervention|Lost to Follow-up|0
4634883|NCT01928381|7506051|FG005|Part 2 - First Intervention|Lost to Follow-up|0
4634884|NCT01928381|7506052|FG006|Part 2 - First Intervention|Lost to Follow-up|0
4634885|NCT01928381|7506046|FG000|Washout First Intervention|Protocol Violation|0
4634886|NCT01928381|7506047|FG001|Washout First Intervention|Protocol Violation|0
4634887|NCT01928381|7506048|FG002|Washout First Intervention|Protocol Violation|0
4634888|NCT01928381|7506049|FG003|Washout First Intervention|Protocol Violation|0
4634889|NCT01928381|7506050|FG004|Washout First Intervention|Protocol Violation|1
4634890|NCT01928381|7506051|FG005|Washout First Intervention|Protocol Violation|0
4634891|NCT01928381|7506052|FG006|Washout First Intervention|Protocol Violation|0
4634892|NCT01928381|7506046|FG000|Part 2 - Second Intervention|Lost to Follow-up|0
4634893|NCT01928381|7506047|FG001|Part 2 - Second Intervention|Lost to Follow-up|1
4634894|NCT01928381|7506048|FG002|Part 2 - Second Intervention|Lost to Follow-up|0
4634895|NCT01928381|7506049|FG003|Part 2 - Second Intervention|Lost to Follow-up|1
4634896|NCT01928381|7506050|FG004|Part 2 - Second Intervention|Lost to Follow-up|0
4634897|NCT01928381|7506051|FG005|Part 2 - Second Intervention|Lost to Follow-up|0
4634898|NCT01928381|7506052|FG006|Part 2 - Second Intervention|Lost to Follow-up|0
4634899|NCT01928381|7506046|FG000|Part 2 - Post Third Intervention|Protocol Violation|0
4634900|NCT01928381|7506047|FG001|Part 2 - Post Third Intervention|Protocol Violation|0
4634901|NCT01928381|7506048|FG002|Part 2 - Post Third Intervention|Protocol Violation|1
4634902|NCT01928381|7506049|FG003|Part 2 - Post Third Intervention|Protocol Violation|0
4634903|NCT01928381|7506050|FG004|Part 2 - Post Third Intervention|Protocol Violation|0
4634904|NCT01928381|7506051|FG005|Part 2 - Post Third Intervention|Protocol Violation|0
4634905|NCT01928381|7506052|FG006|Part 2 - Post Third Intervention|Protocol Violation|0
4634906|NCT01928433|7506065|FG000|Overall Study|Adverse Event|5
4634907|NCT01928433|7506066|FG001|Overall Study|Adverse Event|2
4634908|NCT01928433|7506067|FG002|Overall Study|Adverse Event|5
4634909|NCT01928433|7506065|FG000|Overall Study|Protocol Violation|0
4634910|NCT01928433|7506066|FG001|Overall Study|Protocol Violation|0
4634911|NCT01928433|7506067|FG002|Overall Study|Protocol Violation|2
4634912|NCT01928433|7506065|FG000|Overall Study|Lack of Efficacy|5
4634913|NCT01928433|7506066|FG001|Overall Study|Lack of Efficacy|4
4634914|NCT01928433|7506067|FG002|Overall Study|Lack of Efficacy|4
4634915|NCT01928433|7506065|FG000|Overall Study|Withdrawal by Subject|0
4634916|NCT01928433|7506066|FG001|Overall Study|Withdrawal by Subject|4
4634917|NCT01928433|7506067|FG002|Overall Study|Withdrawal by Subject|0
4634918|NCT01928433|7506065|FG000|Overall Study|Negative screening urine culture|7
4634919|NCT01928433|7506066|FG001|Overall Study|Negative screening urine culture|6
4528887|NCT01053741|7347087|FG000|2nd Study Intervention|Physician Decision|0
4528888|NCT01053741|7347088|FG001|2nd Study Intervention|Physician Decision|1
4528889|NCT01053962|7347114|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0
4528890|NCT01053962|7347115|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0
4528891|NCT01053962|7347116|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0
4528892|NCT01053962|7347117|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1
4528893|NCT01053962|7347118|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2
4528894|NCT01053962|7347114|FG000|Pretreatment Period|Venipuncture Failure|0
4528895|NCT01053962|7347115|FG001|Pretreatment Period|Venipuncture Failure|0
4528896|NCT01053962|7347116|FG002|Pretreatment Period|Venipuncture Failure|1
4528897|NCT01053962|7347117|FG003|Pretreatment Period|Venipuncture Failure|0
4528898|NCT01053962|7347118|FG004|Pretreatment Period|Venipuncture Failure|0
4528899|NCT01053962|7347114|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0
4528900|NCT01053962|7347115|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1
4528901|NCT01053962|7347116|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0
4528902|NCT01053962|7347117|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0
4528903|NCT01053962|7347118|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0
4528904|NCT01053962|7347114|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0
4528905|NCT01053962|7347115|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0
4528906|NCT01053962|7347116|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0
4528907|NCT01053962|7347117|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1
4528908|NCT01053962|7347118|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0
4528909|NCT01053962|7347114|FG000|Treatment Period|Lack of Efficacy|0
4528910|NCT01053962|7347115|FG001|Treatment Period|Lack of Efficacy|0
4528911|NCT01053962|7347116|FG002|Treatment Period|Lack of Efficacy|0
4528912|NCT01053962|7347117|FG003|Treatment Period|Lack of Efficacy|0
4528913|NCT01053962|7347118|FG004|Treatment Period|Lack of Efficacy|1
4528914|NCT01053962|7347114|FG000|Treatment Period|Adverse Event|0
4528915|NCT01053962|7347115|FG001|Treatment Period|Adverse Event|0
4528916|NCT01053962|7347116|FG002|Treatment Period|Adverse Event|0
4528917|NCT01053962|7347117|FG003|Treatment Period|Adverse Event|0
4528918|NCT01053962|7347118|FG004|Treatment Period|Adverse Event|1
4528919|NCT01053962|7347114|FG000|Treatment Period|Withdrawal by Subject|0
4528920|NCT01053962|7347115|FG001|Treatment Period|Withdrawal by Subject|0
4528921|NCT01053962|7347116|FG002|Treatment Period|Withdrawal by Subject|0
4528922|NCT01053962|7347117|FG003|Treatment Period|Withdrawal by Subject|0
4528923|NCT01053962|7347118|FG004|Treatment Period|Withdrawal by Subject|1
4528924|NCT01053962|7347114|FG000|Treatment Period|Noncompliance with protocol|1
4528925|NCT01053962|7347115|FG001|Treatment Period|Noncompliance with protocol|0
4528926|NCT01053962|7347116|FG002|Treatment Period|Noncompliance with protocol|0
4528927|NCT01053962|7347117|FG003|Treatment Period|Noncompliance with protocol|0
4528928|NCT01053962|7347118|FG004|Treatment Period|Noncompliance with protocol|0
4528929|NCT01053988|7347140|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220
4528930|NCT01053988|7347141|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
4528931|NCT01053988|7347142|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
4528932|NCT01053988|7347143|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
4528933|NCT01053988|7347144|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
4528934|NCT01053988|7347145|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
4528935|NCT01053988|7347140|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98
4528936|NCT01053988|7347141|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
4528937|NCT01053988|7347142|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
4528938|NCT01053988|7347143|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
4528939|NCT01053988|7347144|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
4528940|NCT01053988|7347145|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
4528941|NCT01053988|7347140|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30
4528942|NCT01053988|7347141|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
4528943|NCT01053988|7347142|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
4528944|NCT01053988|7347143|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
4528945|NCT01053988|7347144|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
4528946|NCT01053988|7347145|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
4528947|NCT01053988|7347140|FG000|2-week, Single-blind Run-In Period|Adverse Event|6
4528948|NCT01053988|7347141|FG001|2-week, Single-blind Run-In Period|Adverse Event|0
4528949|NCT01053988|7347142|FG002|2-week, Single-blind Run-In Period|Adverse Event|0
4528950|NCT01053988|7347143|FG003|2-week, Single-blind Run-In Period|Adverse Event|0
4528951|NCT01053988|7347144|FG004|2-week, Single-blind Run-In Period|Adverse Event|0
4528952|NCT01053988|7347145|FG005|2-week, Single-blind Run-In Period|Adverse Event|0
4528953|NCT01053988|7347140|FG000|2-week, Single-blind Run-In Period|Physician Decision|5
4528954|NCT01053988|7347141|FG001|2-week, Single-blind Run-In Period|Physician Decision|0
4528955|NCT01053988|7347142|FG002|2-week, Single-blind Run-In Period|Physician Decision|0
4528956|NCT01053988|7347143|FG003|2-week, Single-blind Run-In Period|Physician Decision|0
4528957|NCT01053988|7347144|FG004|2-week, Single-blind Run-In Period|Physician Decision|0
4528958|NCT01053988|7347145|FG005|2-week, Single-blind Run-In Period|Physician Decision|0
4528959|NCT01053988|7347140|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1
4528960|NCT01053988|7347141|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0
4528961|NCT01053988|7347142|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0
4528962|NCT01053988|7347143|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0
4594601|NCT01564277|7443907|FG000|Overall Study|Physician Decision|1
4594602|NCT01564277|7443908|FG001|Overall Study|Physician Decision|0
4594603|NCT01564394|7443916|FG000|Overall Study|Withdrawal by Subject|6
4746467|NCT00706797|7717926|FG000|Overall Study|Death|1
4746468|NCT00706797|7717927|FG001|Overall Study|Death|0
4746469|NCT00706797|7717926|FG000|Overall Study|Discontinuation of study by sponsor|52
4746470|NCT00706797|7717927|FG001|Overall Study|Discontinuation of study by sponsor|63
4746471|NCT00706797|7717926|FG000|Overall Study|Protocol Violation|3
4746472|NCT00706797|7717927|FG001|Overall Study|Protocol Violation|2
4746473|NCT00706797|7717926|FG000|Overall Study|Lost to Follow-up|1
4746474|NCT00706797|7717927|FG001|Overall Study|Lost to Follow-up|2
4746475|NCT00706797|7717926|FG000|Overall Study|Other|1
4746476|NCT00706797|7717927|FG001|Overall Study|Other|0
4746477|NCT00713596|7717936|FG000|Overall Study|Study was terminated|2
4746478|NCT00713596|7717937|FG001|Overall Study|Study was terminated|3
4746479|NCT00713596|7717938|FG002|Overall Study|Study was terminated|2
4746480|NCT00703092|7717951|FG000|Overall Study|Withdrawal by Subject|2
4746481|NCT00713258|7717957|FG000|Overall Study|Adverse Event|2
4746482|NCT00713258|7717958|FG001|Overall Study|Adverse Event|4
4746483|NCT00713258|7717957|FG000|Overall Study|Non-Compliance|2
4746484|NCT00713258|7717958|FG001|Overall Study|Non-Compliance|1
4746485|NCT00713258|7717957|FG000|Overall Study|Other|1
4746486|NCT00713258|7717958|FG001|Overall Study|Other|1
4746487|NCT00707434|7717968|FG000|Overall Study|Adverse Event|1
4746488|NCT00707161|7717972|FG000|Overall Study|Physician Decision|6
4746489|NCT00708916|7717985|FG000|Overall Study|Subject Noncompliance|2
4746490|NCT00708916|7717985|FG000|Overall Study|Adverse Event|2
4746491|NCT00700778|7717990|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2
4746492|NCT00699842|7717997|FG000|Overall Study|Death|0
4746493|NCT00699842|7717998|FG001|Overall Study|Death|1
4746494|NCT00699842|7717999|FG002|Overall Study|Death|0
4746495|NCT00702962|7718009|FG000|Overall Study|Progressive disease|0
4746496|NCT00702962|7718010|FG001|Overall Study|Progressive disease|1
4746497|NCT00702962|7718009|FG000|Overall Study|Hospitalized for other health disorder|1
4528963|NCT01053988|7347144|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0
4528964|NCT01053988|7347145|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0
4528965|NCT01053988|7347140|FG000|24-week, Double-blind Treatment Period|Adverse Event|0
4528966|NCT01053988|7347141|FG001|24-week, Double-blind Treatment Period|Adverse Event|15
4528967|NCT01053988|7347142|FG002|24-week, Double-blind Treatment Period|Adverse Event|23
4528968|NCT01053988|7347143|FG003|24-week, Double-blind Treatment Period|Adverse Event|24
4528969|NCT01053988|7347144|FG004|24-week, Double-blind Treatment Period|Adverse Event|17
4528970|NCT01053988|7347145|FG005|24-week, Double-blind Treatment Period|Adverse Event|14
4528971|NCT01053988|7347140|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
4528972|NCT01053988|7347141|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
4528973|NCT01053988|7347142|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
4528974|NCT01053988|7347143|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
4528975|NCT01053988|7347144|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
4528976|NCT01053988|7347145|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
4528977|NCT01053988|7347140|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
4528978|NCT01053988|7347141|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17
4528979|NCT01053988|7347142|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16
4634920|NCT01928433|7506067|FG002|Overall Study|Negative screening urine culture|10
4634921|NCT01928433|7506065|FG000|Overall Study|Lost to Follow-up|0
4634922|NCT01928433|7506066|FG001|Overall Study|Lost to Follow-up|2
4634923|NCT01928433|7506067|FG002|Overall Study|Lost to Follow-up|3
4634924|NCT01928433|7506065|FG000|Overall Study|Other reasons|3
4634925|NCT01928433|7506066|FG001|Overall Study|Other reasons|3
4634926|NCT01928433|7506067|FG002|Overall Study|Other reasons|4
4634927|NCT01928472|7506093|FG000|Overall Study|Death|0
4634928|NCT01928472|7506094|FG001|Overall Study|Death|0
4634929|NCT01928472|7506095|FG002|Overall Study|Death|1
4634930|NCT01928472|7506096|FG003|Overall Study|Death|0
4634931|NCT01928472|7506093|FG000|Overall Study|Withdrawal by Subject|4
4634932|NCT01928472|7506094|FG001|Overall Study|Withdrawal by Subject|4
4634933|NCT01928472|7506095|FG002|Overall Study|Withdrawal by Subject|1
4634934|NCT01928472|7506096|FG003|Overall Study|Withdrawal by Subject|2
4746498|NCT00702962|7718010|FG001|Overall Study|Hospitalized for other health disorder|0
4528980|NCT01053988|7347143|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
4528981|NCT01053988|7347144|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9
4528982|NCT01053988|7347145|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12
4528983|NCT01053988|7347140|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0
4528984|NCT01053988|7347141|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3
4528985|NCT01053988|7347142|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4
4528986|NCT01053988|7347143|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2
4528987|NCT01053988|7347144|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1
4528988|NCT01053988|7347145|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4
4528989|NCT01053988|7347140|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
4746499|NCT00703534|7718020|FG000|Overall Study|Adverse Event|14
4746500|NCT00703534|7718021|FG001|Overall Study|Adverse Event|3
4746501|NCT00703534|7718020|FG000|Overall Study|Withdrawal by Subject|8
4528990|NCT01053988|7347141|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11
4528991|NCT01053988|7347142|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5
4528992|NCT01053988|7347143|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8
4528993|NCT01053988|7347144|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
4528994|NCT01053988|7347145|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9
4528995|NCT01053988|7347140|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0
4528996|NCT01053988|7347141|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4
4528997|NCT01053988|7347142|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0
4528998|NCT01053988|7347143|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2
4528999|NCT01053988|7347144|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1
4529000|NCT01053988|7347145|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3
4529001|NCT01053988|7347140|FG000|24-week, Double-blind Treatment Period|Physician Decision|0
4529002|NCT01053988|7347141|FG001|24-week, Double-blind Treatment Period|Physician Decision|5
4529003|NCT01053988|7347142|FG002|24-week, Double-blind Treatment Period|Physician Decision|2
4529004|NCT01053988|7347143|FG003|24-week, Double-blind Treatment Period|Physician Decision|5
4529005|NCT01053988|7347144|FG004|24-week, Double-blind Treatment Period|Physician Decision|5
4529006|NCT01053988|7347145|FG005|24-week, Double-blind Treatment Period|Physician Decision|4
4529007|NCT01053988|7347140|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
4529008|NCT01053988|7347141|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11
4529009|NCT01053988|7347142|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
4529010|NCT01053988|7347143|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
4529011|NCT01053988|7347144|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10
4529012|NCT01053988|7347145|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
4529013|NCT01054144|7347161|FG000|Overall Study|Death|2
4529014|NCT01054170|7347170|FG000|Overall Study|Protocol Violation|1
4529015|NCT01054170|7347171|FG001|Overall Study|Protocol Violation|0
4529016|NCT01054170|7347170|FG000|Overall Study|Withdrawal by Subject|3
4529017|NCT01054170|7347171|FG001|Overall Study|Withdrawal by Subject|2
4529018|NCT01054170|7347170|FG000|Overall Study|Adverse Event|0
4529019|NCT01054170|7347171|FG001|Overall Study|Adverse Event|4
4529020|NCT01054222|7347195|FG000|Overall Study|Lack of Efficacy|1
4529021|NCT01054222|7347195|FG000|Overall Study|Lost to Follow-up|4
4529022|NCT01054222|7347195|FG000|Overall Study|Withdrawal by Subject|6
4529023|NCT01054300|7347201|FG000|Period 1|Adverse Event|1
4529024|NCT01054300|7347202|FG001|Period 1|Adverse Event|0
4529025|NCT01054300|7347203|FG002|Period 1|Adverse Event|0
4529026|NCT01054300|7347204|FG003|Period 1|Adverse Event|0
4529027|NCT01054300|7347201|FG000|Period 2|Withdrawal by Subject|0
4529028|NCT01054300|7347202|FG001|Period 2|Withdrawal by Subject|0
4529029|NCT01054300|7347203|FG002|Period 2|Withdrawal by Subject|1
4529030|NCT01054300|7347204|FG003|Period 2|Withdrawal by Subject|0
4529031|NCT01054443|7347242|FG000|Overall Study|Withdrawal by Subject|0
4529032|NCT01054443|7347243|FG001|Overall Study|Withdrawal by Subject|0
4529033|NCT01054443|7347244|FG002|Overall Study|Withdrawal by Subject|0
4529034|NCT01054443|7347245|FG003|Overall Study|Withdrawal by Subject|1
4529035|NCT01054456|7347258|FG000|Overall Study|Other|1
4529036|NCT01054560|7347264|FG000|Overall Study|Death|10
4529037|NCT01054560|7347265|FG001|Overall Study|Death|21
4529038|NCT01054560|7347264|FG000|Overall Study|Lost to Follow-up|2
4529039|NCT01054560|7347265|FG001|Overall Study|Lost to Follow-up|5
4529040|NCT01054560|7347264|FG000|Overall Study|Withdrawal by Subject|0
4529041|NCT01054560|7347265|FG001|Overall Study|Withdrawal by Subject|2
4529042|NCT01054560|7347264|FG000|Overall Study|Physician Decision|1
4529043|NCT01054560|7347265|FG001|Overall Study|Physician Decision|0
4529044|NCT01054573|7347277|FG000|Overall Study|Adverse Event|1
4529045|NCT01054573|7347278|FG001|Overall Study|Adverse Event|0
4529046|NCT01054573|7347279|FG002|Overall Study|Adverse Event|1
4529047|NCT01054573|7347280|FG003|Overall Study|Adverse Event|1
4529048|NCT01054573|7347277|FG000|Overall Study|Lost to Follow-up|0
4529049|NCT01054573|7347278|FG001|Overall Study|Lost to Follow-up|2
4529050|NCT01054573|7347279|FG002|Overall Study|Lost to Follow-up|0
4529051|NCT01054573|7347280|FG003|Overall Study|Lost to Follow-up|0
4529052|NCT01054573|7347277|FG000|Overall Study|Withdrawal by Subject|0
4529053|NCT01054573|7347278|FG001|Overall Study|Withdrawal by Subject|2
4529054|NCT01054573|7347279|FG002|Overall Study|Withdrawal by Subject|2
4529055|NCT01054573|7347280|FG003|Overall Study|Withdrawal by Subject|1
4529056|NCT01054599|7347328|FG000|Overall Study|Dizziness due to phenytoin toxicity|1
4529057|NCT01054599|7347329|FG001|Overall Study|Dizziness due to phenytoin toxicity|0
4529058|NCT01054599|7347328|FG000|Overall Study|Protocol Violation|1
4529059|NCT01054599|7347329|FG001|Overall Study|Protocol Violation|0
4529060|NCT01054599|7347328|FG000|Overall Study|Spells/seizure-like episodes|1
4529061|NCT01054599|7347329|FG001|Overall Study|Spells/seizure-like episodes|1
4529062|NCT01054599|7347328|FG000|Overall Study|Timing/scheduling difficulties|1
4529063|NCT01054599|7347329|FG001|Overall Study|Timing/scheduling difficulties|1
4529064|NCT01054599|7347328|FG000|Overall Study|Visual impairment, WTAR <80|0
4529065|NCT01054599|7347329|FG001|Overall Study|Visual impairment, WTAR <80|1
4529066|NCT01054599|7347328|FG000|Overall Study|Lost to Follow-up|0
4529067|NCT01054599|7347329|FG001|Overall Study|Lost to Follow-up|2
4529068|NCT01054599|7347328|FG000|Overall Study|Adverse Event|0
4529069|NCT01054599|7347329|FG001|Overall Study|Adverse Event|1
4529070|NCT01054599|7347328|FG000|Overall Study|Withdrawal by Subject|0
4529071|NCT01054599|7347329|FG001|Overall Study|Withdrawal by Subject|1
4529072|NCT01054729|7347356|FG000|Overall Study|Randomized but Not Treated|0
4529073|NCT01054729|7347357|FG001|Overall Study|Randomized but Not Treated|1
4529074|NCT01054729|7347358|FG002|Overall Study|Randomized but Not Treated|0
4529075|NCT01054729|7347359|FG003|Overall Study|Randomized but Not Treated|0
4529076|NCT01054729|7347356|FG000|Overall Study|Adverse Event|1
4529077|NCT01054729|7347357|FG001|Overall Study|Adverse Event|1
4529078|NCT01054729|7347358|FG002|Overall Study|Adverse Event|2
4634935|NCT01928472|7506093|FG000|Overall Study|Lost to Follow-up|2
4529079|NCT01054729|7347359|FG003|Overall Study|Adverse Event|1
4529080|NCT01054729|7347356|FG000|Overall Study|Withdrawal by Subject|1
4529081|NCT01054729|7347357|FG001|Overall Study|Withdrawal by Subject|0
4529082|NCT01054729|7347358|FG002|Overall Study|Withdrawal by Subject|1
4529083|NCT01054729|7347359|FG003|Overall Study|Withdrawal by Subject|0
4529084|NCT01054729|7347356|FG000|Overall Study|Lost to Follow-up|0
4529085|NCT01054729|7347357|FG001|Overall Study|Lost to Follow-up|1
4529086|NCT01054729|7347358|FG002|Overall Study|Lost to Follow-up|0
4529087|NCT01054729|7347359|FG003|Overall Study|Lost to Follow-up|0
4529088|NCT01054729|7347356|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0
4529089|NCT01054729|7347357|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1
4529090|NCT01054729|7347358|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0
4529091|NCT01054729|7347359|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0
4529092|NCT01054729|7347356|FG000|Overall Study|Non-responder|1
4529093|NCT01054729|7347357|FG001|Overall Study|Non-responder|0
4529094|NCT01054729|7347358|FG002|Overall Study|Non-responder|1
4529095|NCT01054729|7347359|FG003|Overall Study|Non-responder|1
4529096|NCT01054729|7347356|FG000|Overall Study|PEG/RBV Non-responder|1
4529097|NCT01054729|7347357|FG001|Overall Study|PEG/RBV Non-responder|0
4529098|NCT01054729|7347358|FG002|Overall Study|PEG/RBV Non-responder|1
4529099|NCT01054729|7347359|FG003|Overall Study|PEG/RBV Non-responder|0
4529100|NCT01054729|7347356|FG000|Overall Study|Personal/Obligations|0
4529101|NCT01054729|7347357|FG001|Overall Study|Personal/Obligations|1
4529102|NCT01054729|7347358|FG002|Overall Study|Personal/Obligations|0
4529103|NCT01054729|7347359|FG003|Overall Study|Personal/Obligations|0
4529104|NCT01054729|7347356|FG000|Overall Study|Subject moved|0
4529105|NCT01054729|7347357|FG001|Overall Study|Subject moved|0
4529106|NCT01054729|7347358|FG002|Overall Study|Subject moved|1
4529107|NCT01054729|7347359|FG003|Overall Study|Subject moved|0
4529108|NCT01054729|7347356|FG000|Overall Study|Lack of Efficacy|0
4529109|NCT01054729|7347357|FG001|Overall Study|Lack of Efficacy|0
4529110|NCT01054729|7347358|FG002|Overall Study|Lack of Efficacy|0
4529111|NCT01054729|7347359|FG003|Overall Study|Lack of Efficacy|1
4529112|NCT01054820|7347382|FG000|Overall Study|Withdrawal by Subject|2
4529113|NCT01054846|7347388|FG000|Overall Study|Lost to Follow-up|76
4529114|NCT01054846|7347389|FG001|Overall Study|Lost to Follow-up|17
4529115|NCT01054885|7347400|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246
4529116|NCT01054885|7347401|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
4634936|NCT01928472|7506094|FG001|Overall Study|Lost to Follow-up|3
4634937|NCT01928472|7506095|FG002|Overall Study|Lost to Follow-up|4
4634938|NCT01928472|7506096|FG003|Overall Study|Lost to Follow-up|0
4634939|NCT01928472|7506093|FG000|Overall Study|Administrative Reason|2
4634940|NCT01928472|7506094|FG001|Overall Study|Administrative Reason|1
4529117|NCT01054885|7347402|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
4529118|NCT01054885|7347403|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
4529119|NCT01054885|7347404|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
4529120|NCT01054885|7347405|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
4529121|NCT01054885|7347406|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
4529122|NCT01054885|7347400|FG000|2-week, Single-blind Run-In Period|Physician Decision|6
4529123|NCT01054885|7347401|FG001|2-week, Single-blind Run-In Period|Physician Decision|0
4529124|NCT01054885|7347402|FG002|2-week, Single-blind Run-In Period|Physician Decision|0
4529125|NCT01054885|7347403|FG003|2-week, Single-blind Run-In Period|Physician Decision|0
4634941|NCT01928472|7506095|FG002|Overall Study|Administrative Reason|0
4529126|NCT01054885|7347404|FG004|2-week, Single-blind Run-In Period|Physician Decision|0
4529127|NCT01054885|7347405|FG005|2-week, Single-blind Run-In Period|Physician Decision|0
4529128|NCT01054885|7347406|FG006|2-week, Single-blind Run-In Period|Physician Decision|0
4529129|NCT01054885|7347400|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23
4529130|NCT01054885|7347401|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
4529131|NCT01054885|7347402|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
4529132|NCT01054885|7347403|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
4529133|NCT01054885|7347404|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
4529134|NCT01054885|7347405|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
4529135|NCT01054885|7347406|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
4529136|NCT01054885|7347400|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1
4529137|NCT01054885|7347401|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0
4529138|NCT01054885|7347402|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0
4529139|NCT01054885|7347403|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0
4529140|NCT01054885|7347404|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0
4529141|NCT01054885|7347405|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0
4529142|NCT01054885|7347406|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0
4529143|NCT01054885|7347400|FG000|2-week, Single-blind Run-In Period|Adverse Event|7
4529144|NCT01054885|7347401|FG001|2-week, Single-blind Run-In Period|Adverse Event|0
4529145|NCT01054885|7347402|FG002|2-week, Single-blind Run-In Period|Adverse Event|0
4529146|NCT01054885|7347403|FG003|2-week, Single-blind Run-In Period|Adverse Event|0
4529147|NCT01054885|7347404|FG004|2-week, Single-blind Run-In Period|Adverse Event|0
4529148|NCT01054885|7347405|FG005|2-week, Single-blind Run-In Period|Adverse Event|0
4529149|NCT01054885|7347406|FG006|2-week, Single-blind Run-In Period|Adverse Event|0
4529150|NCT01054885|7347400|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68
4529151|NCT01054885|7347401|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
4529152|NCT01054885|7347402|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
4529153|NCT01054885|7347403|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
4529154|NCT01054885|7347404|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
4529155|NCT01054885|7347405|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
4529156|NCT01054885|7347406|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
4529157|NCT01054885|7347400|FG000|24-week, Double-blind Treatment Period|Adverse Event|0
4529158|NCT01054885|7347401|FG001|24-week, Double-blind Treatment Period|Adverse Event|18
4529159|NCT01054885|7347402|FG002|24-week, Double-blind Treatment Period|Adverse Event|12
4529160|NCT01054885|7347403|FG003|24-week, Double-blind Treatment Period|Adverse Event|15
4529161|NCT01054885|7347404|FG004|24-week, Double-blind Treatment Period|Adverse Event|15
4529162|NCT01054885|7347405|FG005|24-week, Double-blind Treatment Period|Adverse Event|17
4529163|NCT01054885|7347406|FG006|24-week, Double-blind Treatment Period|Adverse Event|19
4529164|NCT01054885|7347400|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
4529165|NCT01054885|7347401|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
4529166|NCT01054885|7347402|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
4529167|NCT01054885|7347403|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1
4529168|NCT01054885|7347404|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
4529169|NCT01054885|7347405|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1
4529170|NCT01054885|7347406|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
4529171|NCT01054885|7347400|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
4529172|NCT01054885|7347401|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12
4529173|NCT01054885|7347402|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2
4529174|NCT01054885|7347403|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5
4529175|NCT01054885|7347404|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11
4529176|NCT01054885|7347405|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7
4529177|NCT01054885|7347406|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7
4529178|NCT01054885|7347400|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0
4529179|NCT01054885|7347401|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7
4529180|NCT01054885|7347402|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7
4529181|NCT01054885|7347403|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2
4529182|NCT01054885|7347404|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3
4529183|NCT01054885|7347405|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8
4529184|NCT01054885|7347406|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4
4529185|NCT01054885|7347400|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0
4529186|NCT01054885|7347401|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
4529187|NCT01054885|7347402|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12
4529188|NCT01054885|7347403|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
4529189|NCT01054885|7347404|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
4529190|NCT01054885|7347405|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15
4529191|NCT01054885|7347406|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12
4529192|NCT01054885|7347400|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
4529193|NCT01054885|7347401|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
4529194|NCT01054885|7347402|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1
4529195|NCT01054885|7347403|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
4529196|NCT01054885|7347404|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
4529197|NCT01054885|7347405|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
4529198|NCT01054885|7347406|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1
4529199|NCT01054885|7347400|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0
4529200|NCT01054885|7347401|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3
4529201|NCT01054885|7347402|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2
4529202|NCT01054885|7347403|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0
4529203|NCT01054885|7347404|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0
4529204|NCT01054885|7347405|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2
4529205|NCT01054885|7347406|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1
4529206|NCT01054885|7347400|FG000|24-week, Double-blind Treatment Period|Physician Decision|0
4529207|NCT01054885|7347401|FG001|24-week, Double-blind Treatment Period|Physician Decision|4
4529208|NCT01054885|7347402|FG002|24-week, Double-blind Treatment Period|Physician Decision|1
4529209|NCT01054885|7347403|FG003|24-week, Double-blind Treatment Period|Physician Decision|6
4529210|NCT01054885|7347404|FG004|24-week, Double-blind Treatment Period|Physician Decision|3
4529211|NCT01054885|7347405|FG005|24-week, Double-blind Treatment Period|Physician Decision|1
4529212|NCT01054885|7347406|FG006|24-week, Double-blind Treatment Period|Physician Decision|1
4529213|NCT01054885|7347400|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
4529214|NCT01054885|7347401|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8
4529215|NCT01054885|7347402|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
4529216|NCT01054885|7347403|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
4529217|NCT01054885|7347404|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3
4529218|NCT01054885|7347405|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
4529219|NCT01054885|7347406|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2
4529220|NCT01054976|7347427|FG000|Overall Study|Adverse Event|16
4529221|NCT01054976|7347427|FG000|Overall Study|Uncooperative participations to study|7
4529222|NCT01054976|7347427|FG000|Overall Study|Withdrawal by Subject|4
4529223|NCT01054976|7347427|FG000|Overall Study|Other|8
4594604|NCT01564394|7443917|FG001|Overall Study|Withdrawal by Subject|10
4594605|NCT01564407|7443928|FG000|Overall Study|Lost to Follow-up|0
4594606|NCT01564407|7443929|FG001|Overall Study|Lost to Follow-up|1
4594607|NCT01564407|7443930|FG002|Overall Study|Lost to Follow-up|0
4594608|NCT01564407|7443931|FG003|Overall Study|Lost to Follow-up|0
4594609|NCT01564407|7443932|FG004|Overall Study|Lost to Follow-up|0
4594610|NCT01564407|7443928|FG000|Overall Study|Withdrawal by Subject|0
4594611|NCT01564407|7443929|FG001|Overall Study|Withdrawal by Subject|1
4594612|NCT01564407|7443930|FG002|Overall Study|Withdrawal by Subject|0
4594613|NCT01564407|7443931|FG003|Overall Study|Withdrawal by Subject|0
4594614|NCT01564407|7443932|FG004|Overall Study|Withdrawal by Subject|0
4594615|NCT01564407|7443928|FG000|Overall Study|funding lost, study ended|0
4594616|NCT01564407|7443929|FG001|Overall Study|funding lost, study ended|0
4594617|NCT01564407|7443930|FG002|Overall Study|funding lost, study ended|0
4594618|NCT01564407|7443931|FG003|Overall Study|funding lost, study ended|1
4594619|NCT01564407|7443932|FG004|Overall Study|funding lost, study ended|0
4594620|NCT01564459|7443956|FG000|Run-In|Adverse Event|7
4594621|NCT01564459|7443957|FG001|Run-In|Adverse Event|0
4594622|NCT01564459|7443958|FG002|Run-In|Adverse Event|0
4594623|NCT01564459|7443956|FG000|Run-In|Lost to Follow-up|1
4594624|NCT01564459|7443957|FG001|Run-In|Lost to Follow-up|0
4594625|NCT01564459|7443958|FG002|Run-In|Lost to Follow-up|0
4594626|NCT01564459|7443956|FG000|Run-In|Non-compliance with study drug|2
4594627|NCT01564459|7443957|FG001|Run-In|Non-compliance with study drug|0
4594628|NCT01564459|7443958|FG002|Run-In|Non-compliance with study drug|0
4594629|NCT01564459|7443956|FG000|Run-In|Protocol Violation|1
4594630|NCT01564459|7443957|FG001|Run-In|Protocol Violation|0
4594631|NCT01564459|7443958|FG002|Run-In|Protocol Violation|0
4594632|NCT01564459|7443956|FG000|Run-In|Withdrawal by Subject|1
4594633|NCT01564459|7443957|FG001|Run-In|Withdrawal by Subject|0
4594634|NCT01564459|7443958|FG002|Run-In|Withdrawal by Subject|0
4594635|NCT01564459|7443956|FG000|Double-blind Treatment|Adverse Event|0
4594636|NCT01564459|7443957|FG001|Double-blind Treatment|Adverse Event|0
4594637|NCT01564459|7443958|FG002|Double-blind Treatment|Adverse Event|1
4594638|NCT01564758|7444005|FG000|Overall Study|Death|8
4594639|NCT01564758|7444005|FG000|Overall Study|Adverse Event|3
4594640|NCT01564758|7444005|FG000|Overall Study|Other|3
4594641|NCT01564784|7444011|FG000|Overall Study|Other|1
4594642|NCT01564784|7444012|FG001|Overall Study|Other|0
4594643|NCT01564784|7444011|FG000|Overall Study|Subject refused further follow-up|1
4594644|NCT01564784|7444012|FG001|Overall Study|Subject refused further follow-up|6
4594645|NCT01564784|7444011|FG000|Overall Study|Lost to Follow-up|1
4594646|NCT01564784|7444012|FG001|Overall Study|Lost to Follow-up|1
4594647|NCT01564784|7444011|FG000|Overall Study|Death|131
4594648|NCT01564784|7444012|FG001|Overall Study|Death|126
4594649|NCT01564862|7444021|FG000|Overall Study|Pretreatment Event or Adverse Event|6
4594650|NCT01564862|7444022|FG001|Overall Study|Pretreatment Event or Adverse Event|12
4594651|NCT01564862|7444023|FG002|Overall Study|Pretreatment Event or Adverse Event|6
4594652|NCT01564862|7444021|FG000|Overall Study|Major Protocol Deviation|3
4594653|NCT01564862|7444022|FG001|Overall Study|Major Protocol Deviation|3
4594654|NCT01564862|7444023|FG002|Overall Study|Major Protocol Deviation|4
4594655|NCT01564862|7444021|FG000|Overall Study|Lost to Follow-up|10
4594656|NCT01564862|7444022|FG001|Overall Study|Lost to Follow-up|8
4594657|NCT01564862|7444023|FG002|Overall Study|Lost to Follow-up|6
4594658|NCT01564862|7444021|FG000|Overall Study|Voluntary Withdrawal|9
4594659|NCT01564862|7444022|FG001|Overall Study|Voluntary Withdrawal|6
4594660|NCT01564862|7444023|FG002|Overall Study|Voluntary Withdrawal|8
4594661|NCT01564862|7444021|FG000|Overall Study|Lack of Efficacy|1
4594662|NCT01564862|7444022|FG001|Overall Study|Lack of Efficacy|5
4594663|NCT01564862|7444023|FG002|Overall Study|Lack of Efficacy|6
4594664|NCT01564862|7444021|FG000|Overall Study|Other reason(s)|1
4594665|NCT01564862|7444022|FG001|Overall Study|Other reason(s)|0
4594666|NCT01564862|7444023|FG002|Overall Study|Other reason(s)|0
4594667|NCT01565083|7444053|FG000|Overall Study|Withdrawal by Subject|6
4594668|NCT01565083|7444054|FG001|Overall Study|Withdrawal by Subject|4
4594669|NCT01565083|7444053|FG000|Overall Study|Lost to Follow-up|2
4594670|NCT01565083|7444054|FG001|Overall Study|Lost to Follow-up|7
4594671|NCT01565083|7444053|FG000|Overall Study|Death|22
4594672|NCT01565083|7444054|FG001|Overall Study|Death|23
4594673|NCT01565083|7444053|FG000|Overall Study|Other|3
4594674|NCT01565083|7444054|FG001|Overall Study|Other|5
4594675|NCT01565148|7444064|FG000|Overall Study|Withdrawal by Subject|1
4594676|NCT01565148|7444065|FG001|Overall Study|Withdrawal by Subject|1
4594677|NCT01565148|7444066|FG002|Overall Study|Withdrawal by Subject|1
4594678|NCT01565148|7444067|FG003|Overall Study|Withdrawal by Subject|2
4594679|NCT01565148|7444064|FG000|Overall Study|Lost to Follow-up|4
4594680|NCT01565148|7444065|FG001|Overall Study|Lost to Follow-up|4
4594681|NCT01565148|7444066|FG002|Overall Study|Lost to Follow-up|0
4594682|NCT01565148|7444067|FG003|Overall Study|Lost to Follow-up|3
4594683|NCT01565148|7444064|FG000|Overall Study|Rescue Therapy|8
4594684|NCT01565148|7444065|FG001|Overall Study|Rescue Therapy|5
4594685|NCT01565148|7444066|FG002|Overall Study|Rescue Therapy|5
4594686|NCT01565148|7444067|FG003|Overall Study|Rescue Therapy|8
4594687|NCT01565148|7444064|FG000|Overall Study|Death|0
4594688|NCT01565148|7444065|FG001|Overall Study|Death|0
4594689|NCT01565148|7444066|FG002|Overall Study|Death|1
4594690|NCT01565148|7444067|FG003|Overall Study|Death|0
4594691|NCT01565148|7444064|FG000|Overall Study|Physician Decision|2
4594692|NCT01565148|7444065|FG001|Overall Study|Physician Decision|5
4594693|NCT01565148|7444066|FG002|Overall Study|Physician Decision|0
4594694|NCT01565148|7444067|FG003|Overall Study|Physician Decision|0
4594695|NCT01565291|7444083|FG000|Overall Study|Withdrawal by Subject|1
4594696|NCT01565291|7444084|FG001|Overall Study|Withdrawal by Subject|0
4594697|NCT01565343|7444111|FG000|Overall Study|Administrative decision/technical issues|1
4594698|NCT01565343|7444112|FG001|Overall Study|Administrative decision/technical issues|0
4594699|NCT01565343|7444113|FG002|Overall Study|Administrative decision/technical issues|0
4594700|NCT01565499|7444135|FG000|Overall Study|Physician Decision|1
4594701|NCT01565499|7444135|FG000|Overall Study|Adverse Event|5
4594702|NCT01565499|7444135|FG000|Overall Study|Withdrawal by Subject|2
4594703|NCT01565564|7444159|FG000|Overall Study|Lost to Follow-up|5
4594704|NCT01565564|7444160|FG001|Overall Study|Lost to Follow-up|1
4594705|NCT01565642|7444172|FG000|Overall Study|Withdrawal by Subject|2
4594706|NCT01565642|7444173|FG001|Overall Study|Withdrawal by Subject|1
4594707|NCT01565668|7444181|FG000|Overall Study|Death|2
4594708|NCT01565668|7444182|FG001|Overall Study|Death|1
4594709|NCT01565668|7444181|FG000|Overall Study|Lack of Efficacy|4
4594710|NCT01565668|7444182|FG001|Overall Study|Lack of Efficacy|2
4594711|NCT01565668|7444181|FG000|Overall Study|Participant went on Hospice Care|1
4594712|NCT01565668|7444182|FG001|Overall Study|Participant went on Hospice Care|0
4594713|NCT01565668|7444181|FG000|Overall Study|Adverse Event|6
4594714|NCT01565668|7444182|FG001|Overall Study|Adverse Event|1
4594715|NCT01565668|7444181|FG000|Overall Study|Randomized, but never received drug|0
4594716|NCT01565668|7444182|FG001|Overall Study|Randomized, but never received drug|2
4594717|NCT01565668|7444181|FG000|Overall Study|Progressive disease|13
4594718|NCT01565668|7444182|FG001|Overall Study|Progressive disease|14
4594719|NCT01565668|7444181|FG000|Overall Study|Withdrawal by Subject|1
4594720|NCT01565668|7444182|FG001|Overall Study|Withdrawal by Subject|3
4594721|NCT01565668|7444181|FG000|Overall Study|HSCT Transplant|11
4594722|NCT01565668|7444182|FG001|Overall Study|HSCT Transplant|15
4594723|NCT01565694|7444188|FG000|Dose-Titration Period|Adverse Event|4
4594724|NCT01565694|7444188|FG000|Dose-Titration Period|Protocol Violation|10
4594725|NCT01565694|7444188|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4
4594726|NCT01565707|7444196|FG000|Overall Study|Adverse Event|1
4594727|NCT01565707|7444197|FG001|Overall Study|Adverse Event|6
4594728|NCT01565707|7444198|FG002|Overall Study|Adverse Event|2
4594729|NCT01565707|7444199|FG003|Overall Study|Adverse Event|1
4594730|NCT01565707|7444196|FG000|Overall Study|Lost to Follow-up|1
4594731|NCT01565707|7444197|FG001|Overall Study|Lost to Follow-up|0
4594732|NCT01565707|7444198|FG002|Overall Study|Lost to Follow-up|0
4594733|NCT01565707|7444199|FG003|Overall Study|Lost to Follow-up|0
4594734|NCT01565707|7444196|FG000|Overall Study|Protocol Violation|1
4594735|NCT01565707|7444197|FG001|Overall Study|Protocol Violation|0
4594736|NCT01565707|7444198|FG002|Overall Study|Protocol Violation|0
4594737|NCT01565707|7444199|FG003|Overall Study|Protocol Violation|1
4594738|NCT01565707|7444196|FG000|Overall Study|Withdrawal by Subject|3
4594739|NCT01565707|7444197|FG001|Overall Study|Withdrawal by Subject|1
4594740|NCT01565707|7444198|FG002|Overall Study|Withdrawal by Subject|1
4594741|NCT01565707|7444199|FG003|Overall Study|Withdrawal by Subject|1
4594742|NCT01565707|7444196|FG000|Overall Study|Randomized but not evaluable|2
4594743|NCT01565707|7444197|FG001|Overall Study|Randomized but not evaluable|0
4594744|NCT01565707|7444198|FG002|Overall Study|Randomized but not evaluable|0
4594745|NCT01565707|7444199|FG003|Overall Study|Randomized but not evaluable|0
4594746|NCT01565707|7444196|FG000|Overall Study|Miscellaneous|1
4594747|NCT01565707|7444197|FG001|Overall Study|Miscellaneous|1
4594748|NCT01565707|7444198|FG002|Overall Study|Miscellaneous|0
4594749|NCT01565707|7444199|FG003|Overall Study|Miscellaneous|2
4594750|NCT01565850|7444218|FG000|Overall Study|Adverse Event|0
4594751|NCT01565850|7444219|FG001|Overall Study|Adverse Event|1
4594752|NCT01565850|7444218|FG000|Overall Study|Lost to Follow-up|12
4594753|NCT01565850|7444219|FG001|Overall Study|Lost to Follow-up|4
4594754|NCT01565850|7444218|FG000|Overall Study|Investigator's Discretion|2
4594755|NCT01565850|7444219|FG001|Overall Study|Investigator's Discretion|1
4594756|NCT01565850|7444218|FG000|Overall Study|Participant noncompliance|2
4594757|NCT01565850|7444219|FG001|Overall Study|Participant noncompliance|0
4594758|NCT01565850|7444218|FG000|Overall Study|Withdrew Consent|4
4594759|NCT01565850|7444219|FG001|Overall Study|Withdrew Consent|2
4594760|NCT01565889|7444231|FG000|Part A|Withdrawal by Subject|1
4594761|NCT01565889|7444232|FG001|Part A|Withdrawal by Subject|0
4594762|NCT01565889|7444233|FG002|Part A|Withdrawal by Subject|0
4594763|NCT01565889|7444234|FG003|Part A|Withdrawal by Subject|0
4594764|NCT01565889|7444235|FG004|Part A|Withdrawal by Subject|0
4594765|NCT01565889|7444236|FG005|Part A|Withdrawal by Subject|0
4594766|NCT01565889|7444231|FG000|Part B|Withdrawal by Subject|0
4594767|NCT01565889|7444232|FG001|Part B|Withdrawal by Subject|0
4594768|NCT01565889|7444233|FG002|Part B|Withdrawal by Subject|0
4594769|NCT01565889|7444234|FG003|Part B|Withdrawal by Subject|0
4594770|NCT01565889|7444235|FG004|Part B|Withdrawal by Subject|0
4594771|NCT01565889|7444236|FG005|Part B|Withdrawal by Subject|1
4594772|NCT01565889|7444231|FG000|Part B|Lack of Efficacy|0
4594773|NCT01565889|7444232|FG001|Part B|Lack of Efficacy|0
4594774|NCT01565889|7444233|FG002|Part B|Lack of Efficacy|0
4594775|NCT01565889|7444234|FG003|Part B|Lack of Efficacy|0
4594776|NCT01565889|7444235|FG004|Part B|Lack of Efficacy|0
4594777|NCT01565889|7444236|FG005|Part B|Lack of Efficacy|2
4594778|NCT01565889|7444231|FG000|Part B|Lost to Follow-up|0
4594779|NCT01565889|7444232|FG001|Part B|Lost to Follow-up|0
4594780|NCT01565889|7444233|FG002|Part B|Lost to Follow-up|0
4594781|NCT01565889|7444234|FG003|Part B|Lost to Follow-up|0
4594782|NCT01565889|7444235|FG004|Part B|Lost to Follow-up|0
4594783|NCT01565889|7444236|FG005|Part B|Lost to Follow-up|1
4594784|NCT01565928|7444271|FG000|Overall Study|Adverse Event|3
4594785|NCT01565928|7444271|FG000|Overall Study|Other|3
4594786|NCT01565928|7444271|FG000|Overall Study|Progressive Disease|13
4594787|NCT01565928|7444271|FG000|Overall Study|Withdrawal by Subject|1
4594788|NCT01565928|7444271|FG000|Overall Study|Death|2
4594789|NCT01565941|7444280|FG000|Overall Study|Withdrawn by parent/guardian|3
4594790|NCT01565941|7444281|FG001|Overall Study|Withdrawn by parent/guardian|2
4594791|NCT01565941|7444280|FG000|Overall Study|Randomized; did not receive intevention|8
4594792|NCT01565941|7444281|FG001|Overall Study|Randomized; did not receive intevention|2
4594793|NCT01565980|7444291|FG000|Overall Study|Death|1
4594794|NCT01565980|7444292|FG001|Overall Study|Death|0
4594795|NCT01565980|7444291|FG000|Overall Study|Lost to Follow-up|1
4594796|NCT01565980|7444292|FG001|Overall Study|Lost to Follow-up|0
4594797|NCT01565980|7444291|FG000|Overall Study|health complications|1
4594798|NCT01565980|7444292|FG001|Overall Study|health complications|1
4594799|NCT01565980|7444291|FG000|Overall Study|stopped medical treatment|1
4594800|NCT01565980|7444292|FG001|Overall Study|stopped medical treatment|0
4594801|NCT01565980|7444291|FG000|Overall Study|Withdrawal by Subject|0
4594802|NCT01565980|7444292|FG001|Overall Study|Withdrawal by Subject|3
4594803|NCT01565993|7444304|FG000|Overall Study|Physician Decision|0
4594804|NCT01565993|7444305|FG001|Overall Study|Physician Decision|3
4594805|NCT01566214|7444334|FG000|Overall Study|Lost to Follow-up|3
4594806|NCT01566214|7444335|FG001|Overall Study|Lost to Follow-up|0
4594807|NCT01566435|7444359|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1
4594808|NCT01566604|7444428|FG000|Overall Study|Patient's inability to use the device|1
4594809|NCT01566604|7444429|FG001|Overall Study|Patient's inability to use the device|0
4594810|NCT01566604|7444428|FG000|Overall Study|Administrative problems|1
4594811|NCT01566604|7444429|FG001|Overall Study|Administrative problems|0
4594812|NCT01566604|7444428|FG000|Overall Study|Lack of Efficacy|1
4594813|NCT01566604|7444429|FG001|Overall Study|Lack of Efficacy|2
4594814|NCT01566604|7444428|FG000|Overall Study|Protocol deviation|2
4594815|NCT01566604|7444429|FG001|Overall Study|Protocol deviation|0
4594816|NCT01566604|7444428|FG000|Overall Study|Abnormal laboratory value|2
4594817|NCT01566604|7444429|FG001|Overall Study|Abnormal laboratory value|0
4594818|NCT01566604|7444428|FG000|Overall Study|Death|4
4594819|NCT01566604|7444429|FG001|Overall Study|Death|1
4594820|NCT01566604|7444428|FG000|Overall Study|Adverse Event|4
4594821|NCT01566604|7444429|FG001|Overall Study|Adverse Event|2
4594822|NCT01566604|7444428|FG000|Overall Study|Withdrawal by Subject|9
4594823|NCT01566604|7444429|FG001|Overall Study|Withdrawal by Subject|6
4594824|NCT01566721|7444456|FG000|Treatment Period|Withdrawal by Subject|35
4594825|NCT01566721|7444457|FG001|Treatment Period|Withdrawal by Subject|9
4594826|NCT01566721|7444456|FG000|Treatment Period|Disease Progression/Recurrence|37
4594827|NCT01566721|7444457|FG001|Treatment Period|Disease Progression/Recurrence|13
4594828|NCT01566721|7444456|FG000|Treatment Period|Investigator/Sponsor Decision|6
4594829|NCT01566721|7444457|FG001|Treatment Period|Investigator/Sponsor Decision|3
4594830|NCT01566721|7444456|FG000|Treatment Period|Other|13
4594831|NCT01566721|7444457|FG001|Treatment Period|Other|2
4594832|NCT01566721|7444456|FG000|Treatment Period|Lack of Compliance|5
4594833|NCT01566721|7444457|FG001|Treatment Period|Lack of Compliance|1
4594834|NCT01566721|7444456|FG000|Treatment Period|Adverse Event|100
4594835|NCT01566721|7444457|FG001|Treatment Period|Adverse Event|30
4594836|NCT01566721|7444456|FG000|Treatment Period|Pregnancy|1
4594837|NCT01566721|7444457|FG001|Treatment Period|Pregnancy|0
4594838|NCT01566721|7444456|FG000|Safety Follow-up|Physician Decision|6
4594839|NCT01566721|7444457|FG001|Safety Follow-up|Physician Decision|4
4594840|NCT01566721|7444456|FG000|Safety Follow-up|Lost to Follow-up|101
4594841|NCT01566721|7444457|FG001|Safety Follow-up|Lost to Follow-up|48
4594842|NCT01566721|7444456|FG000|Safety Follow-up|Withdrawal by Subject|155
4594843|NCT01566721|7444457|FG001|Safety Follow-up|Withdrawal by Subject|49
4594844|NCT01566721|7444456|FG000|Safety Follow-up|Death|28
4594845|NCT01566721|7444457|FG001|Safety Follow-up|Death|4
4594846|NCT01566721|7444456|FG000|Safety Follow-up|Non-compliance|7
4594847|NCT01566721|7444457|FG001|Safety Follow-up|Non-compliance|3
4594848|NCT01566721|7444456|FG000|Safety Follow-up|Protocol Violation|7
4594849|NCT01566721|7444457|FG001|Safety Follow-up|Protocol Violation|0
4594850|NCT01566721|7444456|FG000|Safety Follow-up|Site closure|2
4594851|NCT01566721|7444457|FG001|Safety Follow-up|Site closure|3
4594852|NCT01566721|7444456|FG000|Safety Follow-up|Erroneous reporting or late reporting|2
4594853|NCT01566721|7444457|FG001|Safety Follow-up|Erroneous reporting or late reporting|0
4594854|NCT01566721|7444456|FG000|Safety Follow-up|Missing|7
4594855|NCT01566721|7444457|FG001|Safety Follow-up|Missing|2
4594856|NCT01566721|7444456|FG000|Safety Follow-up|Disease progression /disease recurrence|223
4594857|NCT01566721|7444457|FG001|Safety Follow-up|Disease progression /disease recurrence|90
4594858|NCT01566721|7444456|FG000|Safety Follow-up|Sponsor decision|1
4594859|NCT01566721|7444457|FG001|Safety Follow-up|Sponsor decision|0
4594860|NCT01566721|7444456|FG000|Safety Follow-up|Adverse Event|8
4594861|NCT01566721|7444457|FG001|Safety Follow-up|Adverse Event|4
4594862|NCT01566773|7444470|FG000|Overall Study|Protocol specified criteria|4
4594863|NCT01566773|7444470|FG000|Overall Study|Protocol Violation|4
4594864|NCT01566773|7444470|FG000|Overall Study|Withdrawal by Subject|9
4594865|NCT01566773|7444470|FG000|Overall Study|Administrative reason|1
4594866|NCT01566773|7444470|FG000|Overall Study|Adverse Event|10
4594867|NCT01566773|7444470|FG000|Overall Study|Physician Decision|2
4594868|NCT01566981|7444501|FG000|Overall Study|Lost to Follow-up|5
4594869|NCT01566981|7444502|FG001|Overall Study|Lost to Follow-up|8
4634942|NCT01928472|7506096|FG003|Overall Study|Administrative Reason|0
4634943|NCT01928472|7506093|FG000|Overall Study|Unclassified|0
4634944|NCT01928472|7506094|FG001|Overall Study|Unclassified|0
4634945|NCT01928472|7506095|FG002|Overall Study|Unclassified|1
4634946|NCT01928472|7506096|FG003|Overall Study|Unclassified|0
4634947|NCT01928485|7506109|FG000|Overall Study|Physician Decision|0
4634948|NCT01928485|7506110|FG001|Overall Study|Physician Decision|1
4634949|NCT01928719|7506164|FG000|Overall Study|Lost to Follow-up|26
4634950|NCT01928719|7506165|FG001|Overall Study|Lost to Follow-up|11
4634951|NCT01928719|7506164|FG000|Overall Study|Withdrawal by Subject|22
4634952|NCT01928719|7506165|FG001|Overall Study|Withdrawal by Subject|7
4634953|NCT01928719|7506164|FG000|Overall Study|Protocol Violation|3
4634954|NCT01928719|7506165|FG001|Overall Study|Protocol Violation|1
4634955|NCT01928719|7506164|FG000|Overall Study|Adverse Event|1
4634956|NCT01928719|7506165|FG001|Overall Study|Adverse Event|0
4634957|NCT01928758|7506175|FG000|Overall Study|Lost to Follow-up|14
4634958|NCT01928758|7506176|FG001|Overall Study|Lost to Follow-up|9
4634959|NCT01928758|7506175|FG000|Overall Study|Withdrawal by Subject|5
4634960|NCT01928758|7506176|FG001|Overall Study|Withdrawal by Subject|2
4634961|NCT01928758|7506175|FG000|Overall Study|Adverse Event|3
4634962|NCT01928758|7506176|FG001|Overall Study|Adverse Event|5
4634963|NCT01928758|7506175|FG000|Overall Study|Protocol Violation|3
4634964|NCT01928758|7506176|FG001|Overall Study|Protocol Violation|4
4634965|NCT01928771|7506186|FG000|Overall Study|Adverse Event|6
4634966|NCT01928771|7506187|FG001|Overall Study|Adverse Event|5
4634967|NCT01928771|7506188|FG002|Overall Study|Adverse Event|1
4634968|NCT01928771|7506186|FG000|Overall Study|Death|2
4634969|NCT01928771|7506187|FG001|Overall Study|Death|2
4634970|NCT01928771|7506188|FG002|Overall Study|Death|2
4634971|NCT01928771|7506186|FG000|Overall Study|Lost to Follow-up|5
4634972|NCT01928771|7506187|FG001|Overall Study|Lost to Follow-up|6
4634973|NCT01928771|7506188|FG002|Overall Study|Lost to Follow-up|3
4634974|NCT01928771|7506186|FG000|Overall Study|Withdrawal by Subject|20
4634975|NCT01928771|7506187|FG001|Overall Study|Withdrawal by Subject|15
4634976|NCT01928771|7506188|FG002|Overall Study|Withdrawal by Subject|17
4634977|NCT01928771|7506186|FG000|Overall Study|Study-Specific Withdrawal Criteria|0
4634978|NCT01928771|7506187|FG001|Overall Study|Study-Specific Withdrawal Criteria|1
4634979|NCT01928771|7506188|FG002|Overall Study|Study-Specific Withdrawal Criteria|1
4634980|NCT01928771|7506186|FG000|Overall Study|Other Reasons|9
4634981|NCT01928771|7506187|FG001|Overall Study|Other Reasons|9
4634982|NCT01928771|7506188|FG002|Overall Study|Other Reasons|14
4634983|NCT01928771|7506186|FG000|Overall Study|Severe Non-Compliance to Protocol|4
4634984|NCT01928771|7506187|FG001|Overall Study|Severe Non-Compliance to Protocol|2
4634985|NCT01928771|7506188|FG002|Overall Study|Severe Non-Compliance to Protocol|2
4634986|NCT01928862|7506221|FG000|Overall Study|Lost to Follow-up|1
4634987|NCT01928862|7506222|FG001|Overall Study|Lost to Follow-up|0
4634988|NCT01928862|7506223|FG002|Overall Study|Lost to Follow-up|0
4634989|NCT01928862|7506224|FG003|Overall Study|Lost to Follow-up|0
4634990|NCT01928862|7506225|FG004|Overall Study|Lost to Follow-up|1
4634991|NCT01928927|7506240|FG000|Overall Study|Lost to Follow-up|1
4634992|NCT01928927|7506241|FG001|Overall Study|Lost to Follow-up|0
4634993|NCT01928927|7506240|FG000|Overall Study|Withdrawal by Subject|1
4634994|NCT01928927|7506241|FG001|Overall Study|Withdrawal by Subject|1
4634995|NCT01928940|7506253|FG000|Overall Study|Adverse Event|0
4634996|NCT01928940|7506254|FG001|Overall Study|Adverse Event|1
4634997|NCT01929018|7506263|FG000|Overall Study|Lost to Follow-up|1
4594870|NCT01567085|7444527|FG000|Overall Study|Death|6
4594871|NCT01567085|7444527|FG000|Overall Study|Adverse Event|6
4594872|NCT01567085|7444527|FG000|Overall Study|Lost to Follow-up|3
4594873|NCT01567085|7444527|FG000|Overall Study|Graft loss|2
4594874|NCT01567085|7444527|FG000|Overall Study|Renal transplantectomy|1
4594875|NCT01567085|7444527|FG000|Overall Study|Returned to chronic dialysis|1
4594876|NCT01567085|7444527|FG000|Overall Study|Terminal chronic kidney dysfunction|1
4594877|NCT01567163|7444540|FG000|Overall Study|Progressive Disease|2
4594878|NCT01567163|7444540|FG000|Overall Study|Lost to Follow-up|2
4594879|NCT01567306|7444555|FG000|Overall Study|Protocol Violation|2
4594880|NCT01567306|7444556|FG001|Overall Study|Protocol Violation|2
4594881|NCT01567306|7444557|FG002|Overall Study|Protocol Violation|0
4594882|NCT01567306|7444558|FG003|Overall Study|Protocol Violation|3
4594883|NCT01567306|7444559|FG004|Overall Study|Protocol Violation|1
4594884|NCT01567306|7444560|FG005|Overall Study|Protocol Violation|1
4594885|NCT01567306|7444555|FG000|Overall Study|Change site living|1
4594886|NCT01567306|7444556|FG001|Overall Study|Change site living|0
4594887|NCT01567306|7444557|FG002|Overall Study|Change site living|0
4594888|NCT01567306|7444558|FG003|Overall Study|Change site living|0
4594889|NCT01567306|7444559|FG004|Overall Study|Change site living|0
4594890|NCT01567306|7444560|FG005|Overall Study|Change site living|0
4594891|NCT01567306|7444555|FG000|Overall Study|Adverse Event|0
4594892|NCT01567306|7444556|FG001|Overall Study|Adverse Event|0
4594893|NCT01567306|7444557|FG002|Overall Study|Adverse Event|0
4594894|NCT01567306|7444558|FG003|Overall Study|Adverse Event|2
4594895|NCT01567306|7444559|FG004|Overall Study|Adverse Event|4
4594896|NCT01567306|7444560|FG005|Overall Study|Adverse Event|1
4594897|NCT01567306|7444555|FG000|Overall Study|Lost to Follow-up|0
4594898|NCT01567306|7444556|FG001|Overall Study|Lost to Follow-up|0
4594899|NCT01567306|7444557|FG002|Overall Study|Lost to Follow-up|0
4594900|NCT01567306|7444558|FG003|Overall Study|Lost to Follow-up|0
4594901|NCT01567306|7444559|FG004|Overall Study|Lost to Follow-up|2
4594902|NCT01567306|7444560|FG005|Overall Study|Lost to Follow-up|0
4594903|NCT01567306|7444555|FG000|Overall Study|Withdrawal by Subject|0
4594904|NCT01567306|7444556|FG001|Overall Study|Withdrawal by Subject|0
4594905|NCT01567306|7444557|FG002|Overall Study|Withdrawal by Subject|0
4594906|NCT01567306|7444558|FG003|Overall Study|Withdrawal by Subject|0
4594907|NCT01567306|7444559|FG004|Overall Study|Withdrawal by Subject|0
4594908|NCT01567306|7444560|FG005|Overall Study|Withdrawal by Subject|1
4594909|NCT01567462|7444580|FG000|Overall Study|Withdrawal by Subject|4
4594910|NCT01567462|7444581|FG001|Overall Study|Withdrawal by Subject|7
4594911|NCT01567527|7444589|FG000|Conversion Phase.|Protocol deviation|3
4594912|NCT01567527|7444590|FG001|Conversion Phase.|Protocol deviation|0
4634998|NCT01929018|7506264|FG001|Overall Study|Lost to Follow-up|0
4634999|NCT01929018|7506263|FG000|Overall Study|Hospitalization|0
4594913|NCT01567527|7444591|FG002|Conversion Phase.|Protocol deviation|0
4594914|NCT01567527|7444592|FG003|Conversion Phase.|Protocol deviation|0
4594915|NCT01567527|7444593|FG004|Conversion Phase.|Protocol deviation|0
4594916|NCT01567527|7444589|FG000|Conversion Phase.|Met withdrawal criteria|10
4594917|NCT01567527|7444590|FG001|Conversion Phase.|Met withdrawal criteria|0
4594918|NCT01567527|7444591|FG002|Conversion Phase.|Met withdrawal criteria|0
4594919|NCT01567527|7444592|FG003|Conversion Phase.|Met withdrawal criteria|0
4594920|NCT01567527|7444593|FG004|Conversion Phase.|Met withdrawal criteria|0
4594921|NCT01567527|7444589|FG000|Conversion Phase.|Withdrawal by Subject|32
4594922|NCT01567527|7444590|FG001|Conversion Phase.|Withdrawal by Subject|0
4594923|NCT01567527|7444591|FG002|Conversion Phase.|Withdrawal by Subject|0
4594924|NCT01567527|7444592|FG003|Conversion Phase.|Withdrawal by Subject|0
4594925|NCT01567527|7444593|FG004|Conversion Phase.|Withdrawal by Subject|0
4594926|NCT01567527|7444589|FG000|Conversion Phase.|Lost to Follow-up|16
4594927|NCT01567527|7444590|FG001|Conversion Phase.|Lost to Follow-up|0
4635000|NCT01929018|7506264|FG001|Overall Study|Hospitalization|1
4635001|NCT01929031|7506274|FG000|Overall Study|Adverse Event|3
4635002|NCT01929031|7506275|FG001|Overall Study|Adverse Event|1
4635003|NCT01929031|7506276|FG002|Overall Study|Adverse Event|1
4635004|NCT01929031|7506277|FG003|Overall Study|Adverse Event|0
4635005|NCT01929031|7506278|FG004|Overall Study|Adverse Event|0
4635006|NCT01929031|7506279|FG005|Overall Study|Adverse Event|0
4635007|NCT01929031|7506274|FG000|Overall Study|Protocol Violation|1
4635008|NCT01929031|7506275|FG001|Overall Study|Protocol Violation|0
4635009|NCT01929031|7506276|FG002|Overall Study|Protocol Violation|0
4594928|NCT01567527|7444591|FG002|Conversion Phase.|Lost to Follow-up|0
4594929|NCT01567527|7444592|FG003|Conversion Phase.|Lost to Follow-up|0
4594930|NCT01567527|7444593|FG004|Conversion Phase.|Lost to Follow-up|0
4594931|NCT01567527|7444589|FG000|Conversion Phase.|Lack of Efficacy|2
4594932|NCT01567527|7444590|FG001|Conversion Phase.|Lack of Efficacy|0
4594933|NCT01567527|7444591|FG002|Conversion Phase.|Lack of Efficacy|0
4594934|NCT01567527|7444592|FG003|Conversion Phase.|Lack of Efficacy|0
4594935|NCT01567527|7444593|FG004|Conversion Phase.|Lack of Efficacy|0
4594936|NCT01567527|7444589|FG000|Conversion Phase.|Adverse Event|33
4594937|NCT01567527|7444590|FG001|Conversion Phase.|Adverse Event|0
4594938|NCT01567527|7444591|FG002|Conversion Phase.|Adverse Event|0
4594939|NCT01567527|7444592|FG003|Conversion Phase.|Adverse Event|0
4635010|NCT01929031|7506277|FG003|Overall Study|Protocol Violation|0
4594940|NCT01567527|7444593|FG004|Conversion Phase.|Adverse Event|0
4594941|NCT01567527|7444589|FG000|Conversion Phase.|Withdrawn by the investigator|3
4635011|NCT01929031|7506278|FG004|Overall Study|Protocol Violation|0
4635012|NCT01929031|7506279|FG005|Overall Study|Protocol Violation|1
4594942|NCT01567527|7444590|FG001|Conversion Phase.|Withdrawn by the investigator|0
4594943|NCT01567527|7444591|FG002|Conversion Phase.|Withdrawn by the investigator|0
4594944|NCT01567527|7444592|FG003|Conversion Phase.|Withdrawn by the investigator|0
4594945|NCT01567527|7444593|FG004|Conversion Phase.|Withdrawn by the investigator|0
4594946|NCT01567527|7444589|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
4594947|NCT01567527|7444590|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41
4594948|NCT01567527|7444591|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
4594949|NCT01567527|7444592|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
4594950|NCT01567527|7444593|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
4594951|NCT01567527|7444589|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
4594952|NCT01567527|7444590|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45
4594953|NCT01567527|7444591|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
4594954|NCT01567527|7444592|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
4594955|NCT01567527|7444593|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
4594956|NCT01567527|7444589|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
4594957|NCT01567527|7444590|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44
4594958|NCT01567527|7444591|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
4594959|NCT01567527|7444592|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
4594960|NCT01567527|7444593|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
4594961|NCT01567527|7444589|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
4594962|NCT01567527|7444590|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12
4594963|NCT01567527|7444591|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
4594964|NCT01567527|7444592|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
4594965|NCT01567527|7444593|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
4594966|NCT01567527|7444589|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
4594967|NCT01567527|7444590|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63
4594968|NCT01567527|7444591|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
4594969|NCT01567527|7444592|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
4594970|NCT01567527|7444593|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
4594971|NCT01567527|7444589|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
4594972|NCT01567527|7444590|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2
4594973|NCT01567527|7444591|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
4594974|NCT01567527|7444592|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
4594975|NCT01567527|7444593|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
4594976|NCT01567527|7444589|FG000|IM Depot Stabilization.|Protocol deviation|0
4594977|NCT01567527|7444590|FG001|IM Depot Stabilization.|Protocol deviation|0
4594978|NCT01567527|7444591|FG002|IM Depot Stabilization.|Protocol deviation|5
4594979|NCT01567527|7444592|FG003|IM Depot Stabilization.|Protocol deviation|0
4594980|NCT01567527|7444593|FG004|IM Depot Stabilization.|Protocol deviation|0
4594981|NCT01567527|7444589|FG000|IM Depot Stabilization.|Met withdrawal criteria|0
4594982|NCT01567527|7444590|FG001|IM Depot Stabilization.|Met withdrawal criteria|0
4594983|NCT01567527|7444591|FG002|IM Depot Stabilization.|Met withdrawal criteria|26
4594984|NCT01567527|7444592|FG003|IM Depot Stabilization.|Met withdrawal criteria|0
4594985|NCT01567527|7444593|FG004|IM Depot Stabilization.|Met withdrawal criteria|0
4594986|NCT01567527|7444589|FG000|IM Depot Stabilization.|Withdrawal by Subject|0
4594987|NCT01567527|7444590|FG001|IM Depot Stabilization.|Withdrawal by Subject|0
4594988|NCT01567527|7444591|FG002|IM Depot Stabilization.|Withdrawal by Subject|56
4594989|NCT01567527|7444592|FG003|IM Depot Stabilization.|Withdrawal by Subject|0
4594990|NCT01567527|7444593|FG004|IM Depot Stabilization.|Withdrawal by Subject|0
4594991|NCT01567527|7444589|FG000|IM Depot Stabilization.|Sponsor discontinued study|0
4594992|NCT01567527|7444590|FG001|IM Depot Stabilization.|Sponsor discontinued study|0
4594993|NCT01567527|7444591|FG002|IM Depot Stabilization.|Sponsor discontinued study|1
4594994|NCT01567527|7444592|FG003|IM Depot Stabilization.|Sponsor discontinued study|0
4594995|NCT01567527|7444593|FG004|IM Depot Stabilization.|Sponsor discontinued study|0
4594996|NCT01567527|7444589|FG000|IM Depot Stabilization.|Lost to Follow-up|0
4594997|NCT01567527|7444590|FG001|IM Depot Stabilization.|Lost to Follow-up|0
4594998|NCT01567527|7444591|FG002|IM Depot Stabilization.|Lost to Follow-up|21
4594999|NCT01567527|7444592|FG003|IM Depot Stabilization.|Lost to Follow-up|0
4595000|NCT01567527|7444593|FG004|IM Depot Stabilization.|Lost to Follow-up|0
4595001|NCT01567527|7444589|FG000|IM Depot Stabilization.|Lack of Efficacy|0
4595002|NCT01567527|7444590|FG001|IM Depot Stabilization.|Lack of Efficacy|0
4595003|NCT01567527|7444591|FG002|IM Depot Stabilization.|Lack of Efficacy|7
4635013|NCT01929031|7506274|FG000|Overall Study|Reason other than specified above|0
4635014|NCT01929031|7506275|FG001|Overall Study|Reason other than specified above|1
4635015|NCT01929031|7506276|FG002|Overall Study|Reason other than specified above|0
4635016|NCT01929031|7506277|FG003|Overall Study|Reason other than specified above|0
4635017|NCT01929031|7506278|FG004|Overall Study|Reason other than specified above|1
4635018|NCT01929031|7506279|FG005|Overall Study|Reason other than specified above|0
4635019|NCT01929044|7506291|FG000|Overall Study|Adverse Event|1
4635020|NCT01929044|7506292|FG001|Overall Study|Adverse Event|0
4635021|NCT01929044|7506291|FG000|Overall Study|Protocol Violation|9
4635022|NCT01929044|7506292|FG001|Overall Study|Protocol Violation|14
4635023|NCT01929044|7506291|FG000|Overall Study|Not Treated|1
4635024|NCT01929044|7506292|FG001|Overall Study|Not Treated|3
4595004|NCT01567527|7444592|FG003|IM Depot Stabilization.|Lack of Efficacy|0
4595005|NCT01567527|7444593|FG004|IM Depot Stabilization.|Lack of Efficacy|0
4595006|NCT01567527|7444589|FG000|IM Depot Stabilization.|Adverse Event|0
4595007|NCT01567527|7444590|FG001|IM Depot Stabilization.|Adverse Event|0
4595008|NCT01567527|7444591|FG002|IM Depot Stabilization.|Adverse Event|37
4595009|NCT01567527|7444592|FG003|IM Depot Stabilization.|Adverse Event|0
4595010|NCT01567527|7444593|FG004|IM Depot Stabilization.|Adverse Event|0
4595011|NCT01567527|7444589|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0
4595012|NCT01567527|7444590|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0
4595013|NCT01567527|7444591|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6
4595014|NCT01567527|7444592|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0
4595015|NCT01567527|7444593|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0
4595016|NCT01567527|7444589|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0
4595017|NCT01567527|7444590|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0
4595018|NCT01567527|7444591|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0
4595019|NCT01567527|7444592|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1
4595020|NCT01567527|7444593|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1
4595021|NCT01567527|7444589|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0
4595022|NCT01567527|7444590|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0
4595023|NCT01567527|7444591|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0
4595024|NCT01567527|7444592|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16
4595025|NCT01567527|7444593|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33
4595026|NCT01567527|7444589|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0
4595027|NCT01567527|7444590|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0
4595028|NCT01567527|7444591|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0
4595029|NCT01567527|7444592|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4
4595030|NCT01567527|7444593|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7
4595031|NCT01567527|7444589|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0
4595032|NCT01567527|7444590|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0
4595033|NCT01567527|7444591|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0
4595034|NCT01567527|7444592|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7
4595035|NCT01567527|7444593|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1
4595036|NCT01567527|7444589|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
4595037|NCT01567527|7444590|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
4595038|NCT01567527|7444591|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
4595039|NCT01567527|7444592|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13
4595040|NCT01567527|7444593|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10
4595041|NCT01567527|7444589|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0
4595042|NCT01567527|7444590|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0
4595043|NCT01567527|7444591|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0
4595044|NCT01567527|7444592|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1
4595045|NCT01567527|7444593|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3
4595046|NCT01567527|7444589|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0
4595047|NCT01567527|7444590|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0
4635025|NCT01929083|7506309|FG000|Intervention 1|Lost to Follow-up|2
4635026|NCT01929083|7506310|FG001|Intervention 1|Lost to Follow-up|0
4595048|NCT01567527|7444591|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0
4595049|NCT01567527|7444592|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19
4595050|NCT01567527|7444593|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35
4595051|NCT01567527|7444589|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
4595052|NCT01567527|7444590|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
4595053|NCT01567527|7444591|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
4595054|NCT01567527|7444592|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8
4595055|NCT01567527|7444593|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5
4595056|NCT01567826|7444604|FG000|Overall Study|Lost to Follow-up|3
4595057|NCT01567826|7444605|FG001|Overall Study|Lost to Follow-up|2
4595058|NCT01567852|7444623|FG000|Overall Study|Withdrawal by Subject|3
4595059|NCT01567852|7444624|FG001|Overall Study|Withdrawal by Subject|6
4595060|NCT01567852|7444623|FG000|Overall Study|ECT discontinued|1
4595061|NCT01567852|7444624|FG001|Overall Study|ECT discontinued|1
4595062|NCT01567865|7444634|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0
4595063|NCT01567865|7444635|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1
4595064|NCT01567865|7444636|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3
4595065|NCT01567865|7444637|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2
4595066|NCT01567865|7444634|FG000|Evaluated for Immunogenicity|Missing blood sample|17
4595067|NCT01567865|7444635|FG001|Evaluated for Immunogenicity|Missing blood sample|24
4595068|NCT01567865|7444636|FG002|Evaluated for Immunogenicity|Missing blood sample|16
4595069|NCT01567865|7444637|FG003|Evaluated for Immunogenicity|Missing blood sample|28
4595070|NCT01568034|7444679|FG000|Overall Study|Withdrawal by Subject|1
4595071|NCT01568034|7444680|FG001|Overall Study|Withdrawal by Subject|0
4595072|NCT01568034|7444681|FG002|Overall Study|Withdrawal by Subject|0
4595073|NCT01568034|7444682|FG003|Overall Study|Withdrawal by Subject|0
4595074|NCT01568047|7444696|FG000|Overall Study|Ineligibility|1
4595075|NCT01568047|7444697|FG001|Overall Study|Ineligibility|0
4595076|NCT01568047|7444698|FG002|Overall Study|Ineligibility|0
4595077|NCT01568047|7444699|FG003|Overall Study|Ineligibility|0
4595078|NCT01568047|7444696|FG000|Overall Study|Withdrawal by Subject|0
4595079|NCT01568047|7444697|FG001|Overall Study|Withdrawal by Subject|1
4595080|NCT01568047|7444698|FG002|Overall Study|Withdrawal by Subject|0
4595081|NCT01568047|7444699|FG003|Overall Study|Withdrawal by Subject|0
4595082|NCT01568047|7444696|FG000|Overall Study|Adverse Event|0
4595083|NCT01568047|7444697|FG001|Overall Study|Adverse Event|0
4595084|NCT01568047|7444698|FG002|Overall Study|Adverse Event|1
4595085|NCT01568047|7444699|FG003|Overall Study|Adverse Event|1
4595086|NCT01568112|7444734|FG000|Overall Study|Randomized But Not Treated|0
4595087|NCT01568112|7444735|FG001|Overall Study|Randomized But Not Treated|1
4595088|NCT01568112|7444736|FG002|Overall Study|Randomized But Not Treated|0
4595089|NCT01568112|7444737|FG003|Overall Study|Randomized But Not Treated|0
4595090|NCT01568112|7444734|FG000|Overall Study|Withdrew due to Adverse Event|2
4595091|NCT01568112|7444735|FG001|Overall Study|Withdrew due to Adverse Event|4
4595092|NCT01568112|7444736|FG002|Overall Study|Withdrew due to Adverse Event|6
4595093|NCT01568112|7444737|FG003|Overall Study|Withdrew due to Adverse Event|3
4595094|NCT01568112|7444734|FG000|Overall Study|Lost to Follow-up|0
4595095|NCT01568112|7444735|FG001|Overall Study|Lost to Follow-up|0
4595096|NCT01568112|7444736|FG002|Overall Study|Lost to Follow-up|0
4595097|NCT01568112|7444737|FG003|Overall Study|Lost to Follow-up|1
4595098|NCT01568112|7444734|FG000|Overall Study|Withdrawal by Subject|2
4595099|NCT01568112|7444735|FG001|Overall Study|Withdrawal by Subject|3
4595100|NCT01568112|7444736|FG002|Overall Study|Withdrawal by Subject|0
4595101|NCT01568112|7444737|FG003|Overall Study|Withdrawal by Subject|7
4595102|NCT01568112|7444734|FG000|Overall Study|Withdrawal by Physician|1
4595103|NCT01568112|7444735|FG001|Overall Study|Withdrawal by Physician|0
4595104|NCT01568112|7444736|FG002|Overall Study|Withdrawal by Physician|1
4595105|NCT01568112|7444737|FG003|Overall Study|Withdrawal by Physician|1
4595106|NCT01568320|7444757|FG000|Overall Study|Death|20
4595107|NCT01568320|7444757|FG000|Overall Study|Lost to Follow-up|9
4595108|NCT01568320|7444757|FG000|Overall Study|Withdrawal by Subject|10
4595109|NCT01568320|7444757|FG000|Overall Study|Conversion to open repair|1
4595110|NCT01568320|7444757|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1
4595111|NCT01568593|7444780|FG000|Overall Study|Lack of Efficacy|4
4595112|NCT01568593|7444781|FG001|Overall Study|Lack of Efficacy|1
4595113|NCT01568593|7444780|FG000|Overall Study|Adverse Event|3
4595114|NCT01568593|7444781|FG001|Overall Study|Adverse Event|2
4746502|NCT00703534|7718021|FG001|Overall Study|Withdrawal by Subject|7
4746503|NCT00703534|7718020|FG000|Overall Study|Incorrect Enrollment|6
4746504|NCT00703534|7718021|FG001|Overall Study|Incorrect Enrollment|6
4746505|NCT00703534|7718020|FG000|Overall Study|Lost to Follow-up|1
4746506|NCT00703534|7718021|FG001|Overall Study|Lost to Follow-up|4
4746507|NCT00703534|7718020|FG000|Overall Study|Severe Non Compliance|1
4746508|NCT00703534|7718021|FG001|Overall Study|Severe Non Compliance|5
4746509|NCT00698009|7718027|FG000|Overall Study|Withdrawal by Subject|1
4635027|NCT01929083|7506309|FG000|Intervention 1|Nonadherent to study medications|1
4635028|NCT01929083|7506310|FG001|Intervention 1|Nonadherent to study medications|0
4635029|NCT01929083|7506309|FG000|Intervention 2|Adverse Event|0
4635030|NCT01929083|7506310|FG001|Intervention 2|Adverse Event|1
4635031|NCT01929109|7506321|FG000|Period 1 (All Groups)|Deviation from protocol|0
4635032|NCT01929109|7506322|FG001|Period 1 (All Groups)|Deviation from protocol|0
4595115|NCT01568866|7444802|FG000|Overall Study|Disease Progression|208
4595116|NCT01568866|7444803|FG001|Overall Study|Disease Progression|183
4595117|NCT01568866|7444802|FG000|Overall Study|Adverse Event|94
4595118|NCT01568866|7444803|FG001|Overall Study|Adverse Event|96
4595119|NCT01568866|7444802|FG000|Overall Study|Patient Request|55
4595120|NCT01568866|7444803|FG001|Overall Study|Patient Request|71
4595121|NCT01568866|7444802|FG000|Overall Study|Physician Decision|40
4595122|NCT01568866|7444803|FG001|Overall Study|Physician Decision|32
4595123|NCT01568866|7444802|FG000|Overall Study|Withdrawal by Subject|19
4595124|NCT01568866|7444803|FG001|Overall Study|Withdrawal by Subject|11
4595125|NCT01568866|7444802|FG000|Overall Study|Death|10
4595126|NCT01568866|7444803|FG001|Overall Study|Death|18
4595127|NCT01568866|7444802|FG000|Overall Study|Protocol Non-compliance|2
4595128|NCT01568866|7444803|FG001|Overall Study|Protocol Non-compliance|4
4595129|NCT01568866|7444802|FG000|Overall Study|Lost to Follow-up|1
4595130|NCT01568866|7444803|FG001|Overall Study|Lost to Follow-up|0
4595131|NCT01568866|7444802|FG000|Overall Study|Randomized but Not Dosed|9
4595132|NCT01568866|7444803|FG001|Overall Study|Randomized but Not Dosed|1
4595133|NCT01568892|7444811|FG000|Open-label Phase|Adverse Event|2
4595134|NCT01568892|7444812|FG001|Open-label Phase|Adverse Event|0
4595135|NCT01568892|7444811|FG000|Open-label Phase|Lack of Efficacy|4
4595136|NCT01568892|7444812|FG001|Open-label Phase|Lack of Efficacy|2
4595137|NCT01568892|7444811|FG000|Open-label Phase|Lost to Follow-up|0
4635033|NCT01929109|7506323|FG002|Period 1 (All Groups)|Deviation from protocol|1
4635034|NCT01929109|7506324|FG003|Period 1 (All Groups)|Deviation from protocol|0
4635035|NCT01929109|7506325|FG004|Period 1 (All Groups)|Deviation from protocol|0
4595138|NCT01568892|7444812|FG001|Open-label Phase|Lost to Follow-up|1
4595139|NCT01569022|7444841|FG000|First Intervention|Lost to Follow-up|2
4595140|NCT01569022|7444842|FG001|First Intervention|Lost to Follow-up|1
4595141|NCT01569022|7444841|FG000|Second Intervention|Lost to Follow-up|2
4595142|NCT01569022|7444842|FG001|Second Intervention|Lost to Follow-up|2
4595143|NCT01569074|7444855|FG000|Overall Study|Study stopped|6
4595144|NCT01569074|7444856|FG001|Overall Study|Study stopped|6
4595145|NCT01569074|7444857|FG002|Overall Study|Study stopped|8
4595146|NCT01569074|7444858|FG003|Overall Study|Study stopped|7
4595147|NCT01569074|7444859|FG004|Overall Study|Study stopped|7
4595148|NCT01569074|7444855|FG000|Overall Study|Study-specific discontinuation criteria|0
4595149|NCT01569074|7444856|FG001|Overall Study|Study-specific discontinuation criteria|1
4595150|NCT01569074|7444857|FG002|Overall Study|Study-specific discontinuation criteria|0
4595151|NCT01569074|7444858|FG003|Overall Study|Study-specific discontinuation criteria|0
4595152|NCT01569074|7444859|FG004|Overall Study|Study-specific discontinuation criteria|0
4595153|NCT01569074|7444855|FG000|Overall Study|Severe non-compliance to protocol|0
4595154|NCT01569074|7444856|FG001|Overall Study|Severe non-compliance to protocol|0
4595155|NCT01569074|7444857|FG002|Overall Study|Severe non-compliance to protocol|1
4595156|NCT01569074|7444858|FG003|Overall Study|Severe non-compliance to protocol|0
4595157|NCT01569074|7444859|FG004|Overall Study|Severe non-compliance to protocol|0
4595158|NCT01569074|7444855|FG000|Overall Study|eg change in circumstances|0
4595159|NCT01569074|7444856|FG001|Overall Study|eg change in circumstances|2
4595160|NCT01569074|7444857|FG002|Overall Study|eg change in circumstances|0
4595161|NCT01569074|7444858|FG003|Overall Study|eg change in circumstances|1
4595162|NCT01569074|7444859|FG004|Overall Study|eg change in circumstances|1
4595163|NCT01569074|7444855|FG000|Overall Study|Adverse Event|1
4595164|NCT01569074|7444856|FG001|Overall Study|Adverse Event|0
4595165|NCT01569074|7444857|FG002|Overall Study|Adverse Event|3
4595166|NCT01569074|7444858|FG003|Overall Study|Adverse Event|0
4595167|NCT01569074|7444859|FG004|Overall Study|Adverse Event|0
4595168|NCT01569152|7444920|FG000|Phase IIa, Period 1|Early Escape|5
4595169|NCT01569152|7444921|FG001|Phase IIa, Period 1|Early Escape|22
4595170|NCT01569152|7444922|FG002|Phase IIa, Period 1|Early Escape|0
4595171|NCT01569152|7444920|FG000|Phase IIa, Period 1|Adverse Event|4
4595172|NCT01569152|7444921|FG001|Phase IIa, Period 1|Adverse Event|0
4595173|NCT01569152|7444922|FG002|Phase IIa, Period 1|Adverse Event|0
4595174|NCT01569152|7444920|FG000|Phase IIa, Period 1|Lost to Follow-up|1
4595175|NCT01569152|7444921|FG001|Phase IIa, Period 1|Lost to Follow-up|0
4595176|NCT01569152|7444922|FG002|Phase IIa, Period 1|Lost to Follow-up|0
4595177|NCT01569152|7444920|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9
4595178|NCT01569152|7444921|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8
4595179|NCT01569152|7444922|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0
4595180|NCT01569152|7444920|FG000|Phase IIa, Period 1|Protocol Violation|0
4595181|NCT01569152|7444921|FG001|Phase IIa, Period 1|Protocol Violation|1
4595182|NCT01569152|7444922|FG002|Phase IIa, Period 1|Protocol Violation|0
4595183|NCT01569152|7444920|FG000|Phase IIa, Period 1|Withdrawal by Subject|2
4595184|NCT01569152|7444921|FG001|Phase IIa, Period 1|Withdrawal by Subject|1
4595185|NCT01569152|7444922|FG002|Phase IIa, Period 1|Withdrawal by Subject|0
4595186|NCT01569152|7444920|FG000|Safety Extension, Period 3|Adverse Event|0
4595187|NCT01569152|7444921|FG001|Safety Extension, Period 3|Adverse Event|0
4595188|NCT01569152|7444922|FG002|Safety Extension, Period 3|Adverse Event|4
4595189|NCT01569152|7444920|FG000|Safety Extension, Period 3|Withdrawal by Subject|0
4595190|NCT01569152|7444921|FG001|Safety Extension, Period 3|Withdrawal by Subject|0
4595191|NCT01569152|7444922|FG002|Safety Extension, Period 3|Withdrawal by Subject|2
4595192|NCT01569152|7444920|FG000|Safety Extension, Period 3|Physician Decision|0
4595193|NCT01569152|7444921|FG001|Safety Extension, Period 3|Physician Decision|0
4595194|NCT01569152|7444922|FG002|Safety Extension, Period 3|Physician Decision|2
4595195|NCT01569152|7444920|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0
4595196|NCT01569152|7444921|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0
4595197|NCT01569152|7444922|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47
4595198|NCT01569295|7444944|FG000|Overall Study|Progressive Disease|75
4595199|NCT01569295|7444945|FG001|Overall Study|Progressive Disease|139
4595200|NCT01569295|7444944|FG000|Overall Study|Adverse Event|39
4595201|NCT01569295|7444945|FG001|Overall Study|Adverse Event|14
4595202|NCT01569295|7444944|FG000|Overall Study|Withdrawal by Subject|25
4595203|NCT01569295|7444945|FG001|Overall Study|Withdrawal by Subject|12
4595204|NCT01569295|7444944|FG000|Overall Study|Death|19
4595205|NCT01569295|7444945|FG001|Overall Study|Death|15
4595206|NCT01569295|7444944|FG000|Overall Study|Physician Decision|13
4595207|NCT01569295|7444945|FG001|Overall Study|Physician Decision|18
4595208|NCT01569295|7444944|FG000|Overall Study|Study Terminated by Sponsor|24
4595209|NCT01569295|7444945|FG001|Overall Study|Study Terminated by Sponsor|2
4595210|NCT01569295|7444944|FG000|Overall Study|Other Reason not Specified|3
4595211|NCT01569295|7444945|FG001|Overall Study|Other Reason not Specified|5
4595212|NCT01569295|7444944|FG000|Overall Study|Non-Compliance with Study Drug|6
4595213|NCT01569295|7444945|FG001|Overall Study|Non-Compliance with Study Drug|1
4595214|NCT01569295|7444944|FG000|Overall Study|Other Anticancer/Experimental Therapy|2
4595215|NCT01569295|7444945|FG001|Overall Study|Other Anticancer/Experimental Therapy|2
4595216|NCT01569295|7444944|FG000|Overall Study|Lost to Follow-up|1
4595217|NCT01569295|7444945|FG001|Overall Study|Lost to Follow-up|1
4595218|NCT01569438|7444954|FG000|Overall Study|Lack of Efficacy|1
4595219|NCT01569438|7444955|FG001|Overall Study|Lack of Efficacy|2
4595220|NCT01569438|7444954|FG000|Overall Study|Withdrawal by Subject|0
4595221|NCT01569438|7444955|FG001|Overall Study|Withdrawal by Subject|3
4595222|NCT01569438|7444954|FG000|Overall Study|Adverse Event|2
4595223|NCT01569438|7444955|FG001|Overall Study|Adverse Event|15
4595224|NCT01569438|7444954|FG000|Overall Study|Protocol Violation|2
4595225|NCT01569438|7444955|FG001|Overall Study|Protocol Violation|0
4595226|NCT01569438|7444954|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1
4595227|NCT01569438|7444955|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0
4595228|NCT01569438|7444954|FG000|Overall Study|Sponsor/Physician decision|1
4595229|NCT01569438|7444955|FG001|Overall Study|Sponsor/Physician decision|1
4595230|NCT01569438|7444954|FG000|Overall Study|Unable to adhere to study schedule|0
4595231|NCT01569438|7444955|FG001|Overall Study|Unable to adhere to study schedule|1
4595232|NCT01569464|7444974|FG000|Overall Study|Adverse Event|4
4595233|NCT01569464|7444975|FG001|Overall Study|Adverse Event|0
4595234|NCT01569464|7444974|FG000|Overall Study|Lack of Efficacy|1
4595235|NCT01569464|7444975|FG001|Overall Study|Lack of Efficacy|0
4595236|NCT01569464|7444974|FG000|Overall Study|Protocol Violation|1
4595237|NCT01569464|7444975|FG001|Overall Study|Protocol Violation|0
4595238|NCT01569464|7444974|FG000|Overall Study|Lost to Follow-up|2
4595239|NCT01569464|7444975|FG001|Overall Study|Lost to Follow-up|3
4595240|NCT01569464|7444974|FG000|Overall Study|Withdrawal by Subject|1
4595241|NCT01569464|7444975|FG001|Overall Study|Withdrawal by Subject|1
4595242|NCT01569464|7444974|FG000|Overall Study|Other|1
4595243|NCT01569464|7444975|FG001|Overall Study|Other|1
4595244|NCT01569568|7444994|FG000|Overall Study|Physician Decision|0
4595245|NCT01569568|7444995|FG001|Overall Study|Physician Decision|2
4595246|NCT01569594|7445001|FG000|Overall Study|Physician Decision|4
4595247|NCT01569594|7445001|FG000|Overall Study|Death|13
4595248|NCT01569594|7445001|FG000|Overall Study|Lost to Follow-up|22
4595249|NCT01569594|7445001|FG000|Overall Study|Adverse Event|2
4595250|NCT01569594|7445001|FG000|Overall Study|Withdrawal by Subject|13
4595251|NCT01569594|7445001|FG000|Overall Study|Other|4
4595252|NCT01569594|7445001|FG000|Overall Study|No ECM used|9
4595253|NCT01569763|7445020|FG000|Overall Study|Lack of Efficacy|2
4595254|NCT01569763|7445021|FG001|Overall Study|Lack of Efficacy|7
4595255|NCT01569763|7445020|FG000|Overall Study|Adverse Event|1
4595256|NCT01569763|7445021|FG001|Overall Study|Adverse Event|0
4595257|NCT01569841|7445055|FG000|Period A (6 Weeks)|Withdrawal by Subject|0
4595258|NCT01569841|7445056|FG001|Period A (6 Weeks)|Withdrawal by Subject|1
4595259|NCT01570192|7445075|FG000|Overall Study|no qualifying organism|6
4595260|NCT01570192|7445076|FG001|Overall Study|no qualifying organism|12
4595261|NCT01570192|7445075|FG000|Overall Study|changed to palliative care|1
4595262|NCT01570192|7445076|FG001|Overall Study|changed to palliative care|0
4595263|NCT01570192|7445075|FG000|Overall Study|Physician Decision|0
4595264|NCT01570192|7445076|FG001|Overall Study|Physician Decision|1
4595265|NCT01570244|7445087|FG000|Microgynon+Faldaprevir|Adverse Event|1
4595266|NCT01570283|7445096|FG000|Cohort 1: Dose Level 1|Death|0
4595267|NCT01570283|7445097|FG001|Cohort 1: Dose Level 1|Death|1
4595268|NCT01570283|7445098|FG002|Cohort 1: Dose Level 1|Death|0
4595269|NCT01570283|7445099|FG003|Cohort 1: Dose Level 1|Death|0
4595270|NCT01570283|7445100|FG004|Cohort 1: Dose Level 1|Death|0
4595271|NCT01570283|7445101|FG005|Cohort 1: Dose Level 1|Death|0
4595272|NCT01570283|7445096|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
4595273|NCT01570283|7445097|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1
4595274|NCT01570283|7445098|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
4595275|NCT01570283|7445099|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
4595276|NCT01570283|7445100|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
4595277|NCT01570283|7445101|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
4595278|NCT01570283|7445096|FG000|Cohort 2: Dose Level 2|Death|0
4595279|NCT01570283|7445097|FG001|Cohort 2: Dose Level 2|Death|0
4595280|NCT01570283|7445098|FG002|Cohort 2: Dose Level 2|Death|1
4595281|NCT01570283|7445099|FG003|Cohort 2: Dose Level 2|Death|0
4595282|NCT01570283|7445100|FG004|Cohort 2: Dose Level 2|Death|0
4595283|NCT01570283|7445101|FG005|Cohort 2: Dose Level 2|Death|0
4595284|NCT01570283|7445096|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
4595285|NCT01570283|7445097|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
4595286|NCT01570283|7445098|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
4595287|NCT01570283|7445099|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1
4595288|NCT01570283|7445100|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
4595289|NCT01570283|7445101|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
4595290|NCT01570283|7445096|FG000|Cohort 3: Dose Level 3|Death|0
4595291|NCT01570283|7445097|FG001|Cohort 3: Dose Level 3|Death|0
4595292|NCT01570283|7445098|FG002|Cohort 3: Dose Level 3|Death|0
4595293|NCT01570283|7445099|FG003|Cohort 3: Dose Level 3|Death|0
4595294|NCT01570283|7445100|FG004|Cohort 3: Dose Level 3|Death|0
4595295|NCT01570283|7445101|FG005|Cohort 3: Dose Level 3|Death|1
4595296|NCT01570283|7445096|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
4595297|NCT01570283|7445097|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
4595298|NCT01570283|7445098|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
4595299|NCT01570283|7445099|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
4595300|NCT01570283|7445100|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
4595301|NCT01570283|7445101|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1
4595302|NCT01570309|7445117|FG000|Overall Study|Withdrawal by Subject|3
4595303|NCT01570309|7445118|FG001|Overall Study|Withdrawal by Subject|3
4595304|NCT01570361|7445134|FG000|Overall Study|Subject discontinued|1
4595305|NCT01570361|7445135|FG001|Overall Study|Subject discontinued|2
4595306|NCT01570361|7445134|FG000|Overall Study|Sponsor closing the study|51
4595307|NCT01570361|7445135|FG001|Overall Study|Sponsor closing the study|50
4595308|NCT01570361|7445134|FG000|Overall Study|Subject excluded|5
4595309|NCT01570361|7445135|FG001|Overall Study|Subject excluded|3
4595310|NCT01570361|7445134|FG000|Overall Study|Subject withdrew consent|14
4595311|NCT01570361|7445135|FG001|Overall Study|Subject withdrew consent|9
4595312|NCT01570361|7445134|FG000|Overall Study|Adverse Event|2
4595313|NCT01570361|7445135|FG001|Overall Study|Adverse Event|1
4595314|NCT01570361|7445134|FG000|Overall Study|Lost to Follow-up|4
4595315|NCT01570361|7445135|FG001|Overall Study|Lost to Follow-up|4
4595316|NCT01570361|7445134|FG000|Overall Study|Death|5
4595317|NCT01570361|7445135|FG001|Overall Study|Death|4
4595318|NCT01570361|7445134|FG000|Overall Study|Other|0
4595319|NCT01570361|7445135|FG001|Overall Study|Other|2
4595320|NCT01570387|7445148|FG000|Overall Study|Adverse Event|1
4595321|NCT01570387|7445149|FG001|Overall Study|Adverse Event|0
4595322|NCT01570387|7445150|FG002|Overall Study|Adverse Event|0
4595323|NCT01570387|7445151|FG003|Overall Study|Adverse Event|0
4595324|NCT01570387|7445148|FG000|Overall Study|Death|0
4595325|NCT01570387|7445149|FG001|Overall Study|Death|0
4595326|NCT01570387|7445150|FG002|Overall Study|Death|0
4595327|NCT01570387|7445151|FG003|Overall Study|Death|1
4595328|NCT01570387|7445148|FG000|Overall Study|Withdrawal by Subject|0
4595329|NCT01570387|7445149|FG001|Overall Study|Withdrawal by Subject|0
4595330|NCT01570387|7445150|FG002|Overall Study|Withdrawal by Subject|0
4595331|NCT01570387|7445151|FG003|Overall Study|Withdrawal by Subject|1
4595332|NCT01570491|7445160|FG000|Overall Study|Lost to Follow-up|3
4595333|NCT01570491|7445161|FG001|Overall Study|Lost to Follow-up|1
4595334|NCT01570491|7445160|FG000|Overall Study|treatment: not given or discontinued|2
4595335|NCT01570491|7445161|FG001|Overall Study|treatment: not given or discontinued|0
4595336|NCT01570686|7445169|FG000|Overall Study|Abnormal test procedure result(s)|1
4595337|NCT01570686|7445170|FG001|Overall Study|Abnormal test procedure result(s)|1
4595338|NCT01570686|7445169|FG000|Overall Study|Administrative problems|0
4595339|NCT01570686|7445170|FG001|Overall Study|Administrative problems|1
4595340|NCT01570686|7445169|FG000|Overall Study|Adverse Event|8
4595341|NCT01570686|7445170|FG001|Overall Study|Adverse Event|6
4595342|NCT01570686|7445169|FG000|Overall Study|Lost to Follow-up|4
4595343|NCT01570686|7445170|FG001|Overall Study|Lost to Follow-up|3
4595344|NCT01570686|7445169|FG000|Overall Study|Protocol Deviation|3
4595345|NCT01570686|7445170|FG001|Overall Study|Protocol Deviation|0
4595346|NCT01570686|7445169|FG000|Overall Study|Withdrawal by Subject|4
4595347|NCT01570686|7445170|FG001|Overall Study|Withdrawal by Subject|4
4595348|NCT01570686|7445169|FG000|Overall Study|Unsatisfactory therapeutic effect|2
4595349|NCT01570686|7445170|FG001|Overall Study|Unsatisfactory therapeutic effect|1
4635036|NCT01929135|7506342|FG000|Overall Study|Lost to Follow-up|1
4635037|NCT01929135|7506343|FG001|Overall Study|Lost to Follow-up|1
4595350|NCT01570751|7445178|FG000|Period A (16 Weeks)|Protocol Violation|1
4595351|NCT01570751|7445179|FG001|Period A (16 Weeks)|Protocol Violation|1
4595352|NCT01570751|7445178|FG000|Period A (16 Weeks)|Withdrawal criteria|0
4595353|NCT01570751|7445179|FG001|Period A (16 Weeks)|Withdrawal criteria|1
4595354|NCT01570751|7445178|FG000|Period A (16 Weeks)|Unclassified|2
4595355|NCT01570751|7445179|FG001|Period A (16 Weeks)|Unclassified|3
4595356|NCT01570751|7445178|FG000|Period B (16 Weeks)|Adverse Event|1
4595357|NCT01570751|7445179|FG001|Period B (16 Weeks)|Adverse Event|0
4595358|NCT01570751|7445178|FG000|Period B (16 Weeks)|Protocol Violation|0
4595359|NCT01570751|7445179|FG001|Period B (16 Weeks)|Protocol Violation|1
4595360|NCT01570868|7445198|FG000|Overall Study|Adverse Event|8
4595361|NCT01570868|7445199|FG001|Overall Study|Adverse Event|1
4595362|NCT01570868|7445198|FG000|Overall Study|FDA Recommendation|23
4595363|NCT01570868|7445199|FG001|Overall Study|FDA Recommendation|3
4595364|NCT01570868|7445198|FG000|Overall Study|Physician Decision|10
4595365|NCT01570868|7445199|FG001|Overall Study|Physician Decision|4
4595366|NCT01570868|7445198|FG000|Overall Study|Lost to Follow-up|1
4595367|NCT01570868|7445199|FG001|Overall Study|Lost to Follow-up|0
4595368|NCT01570868|7445198|FG000|Overall Study|Withdrawal by Subject|1
4595369|NCT01570868|7445199|FG001|Overall Study|Withdrawal by Subject|0
4595370|NCT01571232|7445211|FG000|Overall Study|Lost to Follow-up|0
4595371|NCT01571232|7445212|FG001|Overall Study|Lost to Follow-up|1
4595372|NCT01571232|7445211|FG000|Overall Study|Withdrawal by Subject|1
4595373|NCT01571232|7445212|FG001|Overall Study|Withdrawal by Subject|0
4595374|NCT01571284|7445219|FG000|Overall Study|Participant's decision|84
4595375|NCT01571284|7445219|FG000|Overall Study|Lost to Follow-up|3
4595376|NCT01571284|7445219|FG000|Overall Study|Enrolled but not treated|2
4595377|NCT01571284|7445219|FG000|Overall Study|Other than specified above|80
4595378|NCT01571362|7445223|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11
4595379|NCT01571362|7445224|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0
4595380|NCT01571362|7445225|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0
4595381|NCT01571362|7445223|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7
4595382|NCT01571362|7445224|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0
4595383|NCT01571362|7445225|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0
4595384|NCT01571362|7445223|FG000|Open-Label Conversion + Titration Period|Adverse Event|57
4595385|NCT01571362|7445224|FG001|Open-Label Conversion + Titration Period|Adverse Event|0
4595386|NCT01571362|7445225|FG002|Open-Label Conversion + Titration Period|Adverse Event|0
4595387|NCT01571362|7445223|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10
4595388|NCT01571362|7445224|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0
4595389|NCT01571362|7445225|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0
4595390|NCT01571362|7445223|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41
4595391|NCT01571362|7445224|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0
4595392|NCT01571362|7445225|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0
4595393|NCT01571362|7445223|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3
4595394|NCT01571362|7445224|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0
4595395|NCT01571362|7445225|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0
4595396|NCT01571362|7445223|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0
4595397|NCT01571362|7445224|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11
4595398|NCT01571362|7445225|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5
4595399|NCT01571362|7445223|FG000|Double-Blind Treatment Period|Protocol Violation|0
4595400|NCT01571362|7445224|FG001|Double-Blind Treatment Period|Protocol Violation|8
4595401|NCT01571362|7445225|FG002|Double-Blind Treatment Period|Protocol Violation|9
4595402|NCT01571362|7445223|FG000|Double-Blind Treatment Period|Adverse Event|0
4595403|NCT01571362|7445224|FG001|Double-Blind Treatment Period|Adverse Event|9
4595404|NCT01571362|7445225|FG002|Double-Blind Treatment Period|Adverse Event|14
4595405|NCT01571362|7445223|FG000|Double-Blind Treatment Period|Lost to Follow-up|0
4595406|NCT01571362|7445224|FG001|Double-Blind Treatment Period|Lost to Follow-up|3
4595407|NCT01571362|7445225|FG002|Double-Blind Treatment Period|Lost to Follow-up|6
4595408|NCT01571362|7445223|FG000|Double-Blind Treatment Period|Insufficient clinical response|0
4595409|NCT01571362|7445224|FG001|Double-Blind Treatment Period|Insufficient clinical response|16
4595410|NCT01571362|7445225|FG002|Double-Blind Treatment Period|Insufficient clinical response|4
4595411|NCT01571362|7445223|FG000|Double-Blind Treatment Period|Other - unspecified|0
4595412|NCT01571362|7445224|FG001|Double-Blind Treatment Period|Other - unspecified|6
4595413|NCT01571362|7445225|FG002|Double-Blind Treatment Period|Other - unspecified|1
4595414|NCT01571453|7445244|FG000|Overall Study|Adverse Event|14
4595415|NCT01571453|7445245|FG001|Overall Study|Adverse Event|32
4595416|NCT01571453|7445244|FG000|Overall Study|Lack of Efficacy|8
4595417|NCT01571453|7445245|FG001|Overall Study|Lack of Efficacy|3
4595418|NCT01571453|7445244|FG000|Overall Study|Non-compliance|2
4595419|NCT01571453|7445245|FG001|Overall Study|Non-compliance|4
4595420|NCT01571453|7445244|FG000|Overall Study|Protocol Violation|1
4595421|NCT01571453|7445245|FG001|Overall Study|Protocol Violation|5
4595422|NCT01571453|7445244|FG000|Overall Study|Withdrawal of consent|5
4595423|NCT01571453|7445245|FG001|Overall Study|Withdrawal of consent|13
4595424|NCT01571453|7445244|FG000|Overall Study|Lost to Follow-up|4
4595425|NCT01571453|7445245|FG001|Overall Study|Lost to Follow-up|2
4595426|NCT01571453|7445244|FG000|Overall Study|Administrative or other reason(s)|4
4595427|NCT01571453|7445245|FG001|Overall Study|Administrative or other reason(s)|3
4595428|NCT01571596|7445258|FG000|Overall Study|Adverse Event|2
4595429|NCT01571596|7445259|FG001|Overall Study|Adverse Event|0
4595430|NCT01571596|7445260|FG002|Overall Study|Adverse Event|0
4595431|NCT01571596|7445258|FG000|Overall Study|Study Terminated by the Sponsor|0
4595432|NCT01571596|7445259|FG001|Overall Study|Study Terminated by the Sponsor|1
4595433|NCT01571596|7445260|FG002|Overall Study|Study Terminated by the Sponsor|1
4595434|NCT01572038|7445270|FG000|Overall Study|Death|648
4595435|NCT01572038|7445270|FG000|Overall Study|Withdrawal by Subject|204
4595436|NCT01572038|7445270|FG000|Overall Study|Lost to Follow-up|81
4595437|NCT01572038|7445270|FG000|Overall Study|Physician Decision|20
4595438|NCT01572038|7445270|FG000|Overall Study|Patient Decision|14
4595439|NCT01572038|7445270|FG000|Overall Study|Progressive Disease|8
4595440|NCT01572038|7445270|FG000|Overall Study|Site Closed Before Completing Form|6
4595441|NCT01572038|7445270|FG000|Overall Study|Enrolled into Another Trial|3
4595442|NCT01572038|7445270|FG000|Overall Study|Participated in Another Trial|3
4595443|NCT01572038|7445270|FG000|Overall Study|Termination by Sponsor|2
4595444|NCT01572038|7445270|FG000|Overall Study|Patient Deterioration|1
4595445|NCT01572038|7445270|FG000|Overall Study|Sponsor Decision|1
4595446|NCT01572389|7445309|FG000|Overall Study|Death|1
4595447|NCT01572389|7445310|FG001|Overall Study|Death|3
4595448|NCT01572389|7445309|FG000|Overall Study|Withdrawal by Subject|14
4595449|NCT01572389|7445310|FG001|Overall Study|Withdrawal by Subject|2
4595450|NCT01572389|7445309|FG000|Overall Study|Lost to Follow-up|25
4595451|NCT01572389|7445310|FG001|Overall Study|Lost to Follow-up|14
4595452|NCT01572389|7445309|FG000|Overall Study|Only A1C or Assessment was Collected|6
4595453|NCT01572389|7445310|FG001|Overall Study|Only A1C or Assessment was Collected|2
4595454|NCT01572727|7445327|FG000|Overall Study|Adverse Event|43
4595455|NCT01572727|7445328|FG001|Overall Study|Adverse Event|15
4595456|NCT01572727|7445327|FG000|Overall Study|Lost to Follow-up|1
4595457|NCT01572727|7445328|FG001|Overall Study|Lost to Follow-up|1
4595458|NCT01572727|7445327|FG000|Overall Study|Physician Decision|23
4595459|NCT01572727|7445328|FG001|Overall Study|Physician Decision|9
4595460|NCT01572727|7445327|FG000|Overall Study|Progressive disease|59
4595461|NCT01572727|7445328|FG001|Overall Study|Progressive disease|82
4595462|NCT01572727|7445327|FG000|Overall Study|Protocol Violation|0
4595463|NCT01572727|7445328|FG001|Overall Study|Protocol Violation|1
4595464|NCT01572727|7445327|FG000|Overall Study|Study terminated by sponsor|61
4595465|NCT01572727|7445328|FG001|Overall Study|Study terminated by sponsor|83
4595466|NCT01572727|7445327|FG000|Overall Study|Parent/guardian decision|14
4595467|NCT01572727|7445328|FG001|Overall Study|Parent/guardian decision|9
4595468|NCT01572727|7445327|FG000|Overall Study|Death|2
4595469|NCT01572727|7445328|FG001|Overall Study|Death|2
4595470|NCT01572727|7445327|FG000|Overall Study|Untreated|4
4595471|NCT01572727|7445328|FG001|Overall Study|Untreated|7
4595472|NCT01572740|7445336|FG000|Overall Study|Adverse Event|1
4595473|NCT01572740|7445337|FG001|Overall Study|Adverse Event|1
4595474|NCT01572740|7445336|FG000|Overall Study|Withdrawal by Subject|1
4595475|NCT01572740|7445337|FG001|Overall Study|Withdrawal by Subject|1
4595476|NCT01572740|7445336|FG000|Overall Study|unclassified|4
4595477|NCT01572740|7445337|FG001|Overall Study|unclassified|3
4595478|NCT01572792|7445348|FG000|Lead-in Study|Lost to Follow-up|5
4595479|NCT01572792|7445349|FG001|Lead-in Study|Lost to Follow-up|9
4595480|NCT01572792|7445350|FG002|Lead-in Study|Lost to Follow-up|4
4595481|NCT01572792|7445351|FG003|Lead-in Study|Lost to Follow-up|2
4595482|NCT01572792|7445352|FG004|Lead-in Study|Lost to Follow-up|4
4595483|NCT01572792|7445348|FG000|Lead-in Study|Withdrawal by Subject|22
4595484|NCT01572792|7445349|FG001|Lead-in Study|Withdrawal by Subject|11
4595485|NCT01572792|7445350|FG002|Lead-in Study|Withdrawal by Subject|12
4595486|NCT01572792|7445351|FG003|Lead-in Study|Withdrawal by Subject|24
4595487|NCT01572792|7445352|FG004|Lead-in Study|Withdrawal by Subject|11
4595488|NCT01572792|7445348|FG000|Lead-in Study|Protocol Violation|19
4595489|NCT01572792|7445349|FG001|Lead-in Study|Protocol Violation|10
4595490|NCT01572792|7445350|FG002|Lead-in Study|Protocol Violation|12
4595491|NCT01572792|7445351|FG003|Lead-in Study|Protocol Violation|13
4595492|NCT01572792|7445352|FG004|Lead-in Study|Protocol Violation|21
4595493|NCT01572792|7445348|FG000|Lead-in Study|Lack of Efficacy|20
4595494|NCT01572792|7445349|FG001|Lead-in Study|Lack of Efficacy|5
4595495|NCT01572792|7445350|FG002|Lead-in Study|Lack of Efficacy|4
4595496|NCT01572792|7445351|FG003|Lead-in Study|Lack of Efficacy|8
4595497|NCT01572792|7445352|FG004|Lead-in Study|Lack of Efficacy|10
4595498|NCT01572792|7445348|FG000|Lead-in Study|Adverse Event|21
4595499|NCT01572792|7445349|FG001|Lead-in Study|Adverse Event|21
4595500|NCT01572792|7445350|FG002|Lead-in Study|Adverse Event|22
4595501|NCT01572792|7445351|FG003|Lead-in Study|Adverse Event|16
4595502|NCT01572792|7445352|FG004|Lead-in Study|Adverse Event|14
4595503|NCT01572792|7445348|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14
4595504|NCT01572792|7445349|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10
4595505|NCT01572792|7445350|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8
4595506|NCT01572792|7445351|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9
4595507|NCT01572792|7445352|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9
4595508|NCT01572792|7445348|FG000|Extension Study|Lost to Follow-up|6
4595509|NCT01572792|7445349|FG001|Extension Study|Lost to Follow-up|2
4595510|NCT01572792|7445350|FG002|Extension Study|Lost to Follow-up|0
4595511|NCT01572792|7445351|FG003|Extension Study|Lost to Follow-up|3
4595512|NCT01572792|7445352|FG004|Extension Study|Lost to Follow-up|3
4595513|NCT01572792|7445348|FG000|Extension Study|Withdrawal by Subject|7
4595514|NCT01572792|7445349|FG001|Extension Study|Withdrawal by Subject|6
4595515|NCT01572792|7445350|FG002|Extension Study|Withdrawal by Subject|11
4595516|NCT01572792|7445351|FG003|Extension Study|Withdrawal by Subject|8
4595517|NCT01572792|7445352|FG004|Extension Study|Withdrawal by Subject|14
4595518|NCT01572792|7445348|FG000|Extension Study|Protocol Violation|0
4595519|NCT01572792|7445349|FG001|Extension Study|Protocol Violation|4
4595520|NCT01572792|7445350|FG002|Extension Study|Protocol Violation|3
4595521|NCT01572792|7445351|FG003|Extension Study|Protocol Violation|4
4595522|NCT01572792|7445352|FG004|Extension Study|Protocol Violation|3
4595523|NCT01572792|7445348|FG000|Extension Study|Lack of Efficacy|2
4595524|NCT01572792|7445349|FG001|Extension Study|Lack of Efficacy|3
4595525|NCT01572792|7445350|FG002|Extension Study|Lack of Efficacy|3
4595526|NCT01572792|7445351|FG003|Extension Study|Lack of Efficacy|2
4595527|NCT01572792|7445352|FG004|Extension Study|Lack of Efficacy|2
4595528|NCT01572792|7445348|FG000|Extension Study|Adverse Event|7
4595529|NCT01572792|7445349|FG001|Extension Study|Adverse Event|6
4595530|NCT01572792|7445350|FG002|Extension Study|Adverse Event|5
4595531|NCT01572792|7445351|FG003|Extension Study|Adverse Event|6
4595532|NCT01572792|7445352|FG004|Extension Study|Adverse Event|4
4595533|NCT01572792|7445348|FG000|Extension Study|Site termination/COPD exacerbation/other|3
4595534|NCT01572792|7445349|FG001|Extension Study|Site termination/COPD exacerbation/other|8
4595535|NCT01572792|7445350|FG002|Extension Study|Site termination/COPD exacerbation/other|4
4595536|NCT01572792|7445351|FG003|Extension Study|Site termination/COPD exacerbation/other|6
4595537|NCT01572792|7445352|FG004|Extension Study|Site termination/COPD exacerbation/other|6
4595538|NCT01572844|7445365|FG000|Overall Study|Physician Decision|1
4595539|NCT01572844|7445366|FG001|Overall Study|Physician Decision|1
4595540|NCT01572909|7445377|FG000|Overall Study|Adverse Event|7
4595541|NCT01572909|7445378|FG001|Overall Study|Adverse Event|2
4595542|NCT01572909|7445377|FG000|Overall Study|Death|3
4595543|NCT01572909|7445378|FG001|Overall Study|Death|1
4595544|NCT01572909|7445377|FG000|Overall Study|Lost to Follow-up|8
4595545|NCT01572909|7445378|FG001|Overall Study|Lost to Follow-up|7
4595546|NCT01572909|7445377|FG000|Overall Study|Physician Decision|1
4595547|NCT01572909|7445378|FG001|Overall Study|Physician Decision|1
4595548|NCT01572909|7445377|FG000|Overall Study|Technical Issues|1
4595549|NCT01572909|7445378|FG001|Overall Study|Technical Issues|0
4595550|NCT01572909|7445377|FG000|Overall Study|Withdrawal by Subject|12
4595551|NCT01572909|7445378|FG001|Overall Study|Withdrawal by Subject|11
4595552|NCT01572909|7445377|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0
4595553|NCT01572909|7445378|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3
4595554|NCT01572922|7445386|FG000|Overall Study|Adverse Event|1
4595555|NCT01572922|7445386|FG000|Overall Study|Protocol Violation|1
4595556|NCT01572922|7445386|FG000|Overall Study|Death|1
4595557|NCT01572948|7445397|FG000|Overall Study|Lost to Follow-up|1
4595558|NCT01572948|7445398|FG001|Overall Study|Lost to Follow-up|0
4595559|NCT01572948|7445397|FG000|Overall Study|unable to contact|0
4595560|NCT01572948|7445398|FG001|Overall Study|unable to contact|1
4595561|NCT01573000|7445410|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27
4595562|NCT01573000|7445411|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32
4595563|NCT01573000|7445410|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4
4595564|NCT01573000|7445411|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2
4595565|NCT01573000|7445410|FG000|Dosimetric and Therapeutic Treatment|Death|0
4595566|NCT01573000|7445411|FG001|Dosimetric and Therapeutic Treatment|Death|1
4595567|NCT01573000|7445410|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2
4595568|NCT01573000|7445411|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0
4595569|NCT01573000|7445410|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2
4595570|NCT01573000|7445411|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0
4595571|NCT01573000|7445410|FG000|Crossover Phase|Lack of Efficacy|0
4595572|NCT01573000|7445411|FG001|Crossover Phase|Lack of Efficacy|13
4595573|NCT01573000|7445410|FG000|Crossover Phase|Lost to Follow-up|0
4595574|NCT01573000|7445411|FG001|Crossover Phase|Lost to Follow-up|2
4595575|NCT01573000|7445410|FG000|Crossover Phase|Death|0
4595576|NCT01573000|7445411|FG001|Crossover Phase|Death|3
4595577|NCT01573000|7445410|FG000|Long-Term Follow-Up|Death|3
4595578|NCT01573000|7445411|FG001|Long-Term Follow-Up|Death|0
4595579|NCT01573000|7445410|FG000|Long-Term Follow-Up|Lost to Follow-up|0
4595580|NCT01573000|7445411|FG001|Long-Term Follow-Up|Lost to Follow-up|1
4595581|NCT01573442|7445499|FG000|Overall Study|Cancels|9
4595582|NCT01573442|7445500|FG001|Overall Study|Cancels|10
4595583|NCT01573624|7445514|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
4595584|NCT01573624|7445515|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
4595585|NCT01573624|7445516|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1
4595586|NCT01573624|7445517|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
4595587|NCT01573624|7445518|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
4595588|NCT01573624|7445519|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1
4595589|NCT01573624|7445520|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
4595590|NCT01573624|7445514|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4
4595591|NCT01573624|7445515|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3
4595592|NCT01573624|7445516|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6
4595593|NCT01573624|7445517|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1
4595594|NCT01573624|7445518|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2
4595595|NCT01573624|7445519|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0
4595596|NCT01573624|7445520|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1
4595597|NCT01573624|7445514|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1
4595598|NCT01573624|7445515|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
4595599|NCT01573624|7445516|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
4595600|NCT01573624|7445517|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
4595601|NCT01573624|7445518|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
4595602|NCT01573624|7445519|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
4595603|NCT01573624|7445520|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
4595604|NCT01573624|7445514|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1
4595605|NCT01573624|7445515|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
4595606|NCT01573624|7445516|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1
4595607|NCT01573624|7445517|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
4595608|NCT01573624|7445518|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
4595609|NCT01573624|7445519|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2
4595610|NCT01573624|7445520|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
4595611|NCT01573624|7445514|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
4595612|NCT01573624|7445515|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
4595613|NCT01573624|7445516|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
4595614|NCT01573624|7445517|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
4595615|NCT01573624|7445518|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
4595616|NCT01573624|7445519|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
4595617|NCT01573624|7445520|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
4595618|NCT01573624|7445514|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
4595619|NCT01573624|7445515|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
4595620|NCT01573624|7445516|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
4595621|NCT01573624|7445517|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
4595622|NCT01573624|7445518|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
4595623|NCT01573624|7445519|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1
4595624|NCT01573624|7445520|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
4595625|NCT01573624|7445514|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
4595626|NCT01573624|7445515|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
4595627|NCT01573624|7445516|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
4595628|NCT01573624|7445517|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
4635038|NCT01929226|7506353|FG000|Overall Study|Lost to Follow-up|4
4635039|NCT01929226|7506354|FG001|Overall Study|Lost to Follow-up|0
4635040|NCT01929226|7506353|FG000|Overall Study|Withdrawal by Subject|1
4635041|NCT01929226|7506354|FG001|Overall Study|Withdrawal by Subject|1
4635042|NCT01929317|7506367|FG000|Dose Increase Effect Verification Phase|Adverse Event|5
4635043|NCT01929317|7506368|FG001|Dose Increase Effect Verification Phase|Adverse Event|1
4635044|NCT01929317|7506367|FG000|Dose Increase Effect Verification Phase|Physician Decision|1
4635045|NCT01929317|7506368|FG001|Dose Increase Effect Verification Phase|Physician Decision|0
4635046|NCT01929317|7506367|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3
4635047|NCT01929317|7506368|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0
4635048|NCT01929317|7506367|FG000|Long-term Phase|Adverse Event|5
4635049|NCT01929317|7506368|FG001|Long-term Phase|Adverse Event|1
4635050|NCT01929317|7506367|FG000|Long-term Phase|Physician Decision|3
4635051|NCT01929317|7506368|FG001|Long-term Phase|Physician Decision|0
4595629|NCT01573624|7445518|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
4595630|NCT01573624|7445519|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
4595631|NCT01573624|7445520|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
4595632|NCT01573624|7445514|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1
4595633|NCT01573624|7445515|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
4595634|NCT01573624|7445516|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2
4595635|NCT01573624|7445517|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1
4595636|NCT01573624|7445518|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
4595637|NCT01573624|7445519|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
4595638|NCT01573624|7445520|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
4595639|NCT01573624|7445514|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
4595640|NCT01573624|7445515|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
4595641|NCT01573624|7445516|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
4595642|NCT01573624|7445517|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
4595643|NCT01573624|7445518|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
4595644|NCT01573624|7445519|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1
4595645|NCT01573624|7445520|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
4595646|NCT01573624|7445514|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
4595647|NCT01573624|7445515|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
4595648|NCT01573624|7445516|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
4595649|NCT01573624|7445517|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2
4595650|NCT01573624|7445518|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
4595651|NCT01573624|7445519|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
4595652|NCT01573624|7445520|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
4595653|NCT01573624|7445514|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
4595654|NCT01573624|7445515|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
4595655|NCT01573624|7445516|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
4595656|NCT01573624|7445517|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
4595657|NCT01573624|7445518|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
4595658|NCT01573624|7445519|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
4595659|NCT01573624|7445520|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
4595660|NCT01573624|7445514|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5
4595661|NCT01573624|7445515|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4
4595662|NCT01573624|7445516|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2
4595663|NCT01573624|7445517|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1
4595664|NCT01573624|7445518|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3
4595665|NCT01573624|7445519|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2
4595666|NCT01573624|7445520|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0
4595667|NCT01573624|7445514|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
4595668|NCT01573624|7445515|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1
4595669|NCT01573624|7445516|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
4595670|NCT01573624|7445517|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
4595671|NCT01573624|7445518|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
4595672|NCT01573624|7445519|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2
4595673|NCT01573624|7445520|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
4595674|NCT01573624|7445514|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1
4595675|NCT01573624|7445515|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
4595676|NCT01573624|7445516|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
4595677|NCT01573624|7445517|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
4635052|NCT01929317|7506367|FG000|Long-term Phase|Withdrawal by Subject|4
4595678|NCT01573624|7445518|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
4595679|NCT01573624|7445519|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
4595680|NCT01573624|7445520|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
4595681|NCT01573624|7445514|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
4595682|NCT01573624|7445515|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
4595683|NCT01573624|7445516|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
4595684|NCT01573624|7445517|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
4595685|NCT01573624|7445518|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
4595686|NCT01573624|7445519|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
4595687|NCT01573624|7445520|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
4595688|NCT01573624|7445514|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1
4595689|NCT01573624|7445515|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
4595690|NCT01573624|7445516|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
4595691|NCT01573624|7445517|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
4595692|NCT01573624|7445518|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
4595693|NCT01573624|7445519|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
4595694|NCT01573624|7445520|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
4635053|NCT01929317|7506368|FG001|Long-term Phase|Withdrawal by Subject|0
4595695|NCT01573624|7445514|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1
4595696|NCT01573624|7445515|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
4595697|NCT01573624|7445516|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
4595698|NCT01573624|7445517|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
4595699|NCT01573624|7445518|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
4595700|NCT01573624|7445519|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
4595701|NCT01573624|7445520|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1
4595702|NCT01573624|7445514|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0
4595703|NCT01573624|7445515|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
4595704|NCT01573624|7445516|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
4595705|NCT01573624|7445517|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
4595706|NCT01573624|7445518|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
4595707|NCT01573624|7445519|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0
4595708|NCT01573624|7445520|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
4595709|NCT01573624|7445514|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
4595710|NCT01573624|7445515|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1
4595711|NCT01573624|7445516|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
4595712|NCT01573624|7445517|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
4595713|NCT01573624|7445518|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
4635054|NCT01929317|7506367|FG000|Long-term Phase|Protocol Violation|1
4635055|NCT01929317|7506368|FG001|Long-term Phase|Protocol Violation|0
4635056|NCT01929317|7506367|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1
4635057|NCT01929317|7506368|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0
4635058|NCT01929317|7506367|FG000|Long-term Phase|Study Closed/Terminated|5
4635059|NCT01929317|7506368|FG001|Long-term Phase|Study Closed/Terminated|3
4635060|NCT01929343|7506383|FG000|Overall Study|Physician Decision|0
4635061|NCT01929343|7506384|FG001|Overall Study|Physician Decision|2
4635062|NCT01929343|7506385|FG002|Overall Study|Physician Decision|0
4635063|NCT01929343|7506383|FG000|Overall Study|Withdrawal by Subject|1
4635064|NCT01929343|7506384|FG001|Overall Study|Withdrawal by Subject|0
4635065|NCT01929343|7506385|FG002|Overall Study|Withdrawal by Subject|0
4635066|NCT01929395|7506396|FG000|Overall Study|Did not complete - non-related toxicity|1
4635067|NCT01929395|7506397|FG001|Overall Study|Did not complete - non-related toxicity|0
4635068|NCT01929395|7506398|FG002|Overall Study|Did not complete - non-related toxicity|0
4635069|NCT01929395|7506396|FG000|Overall Study|Withdrawal by Subject|0
4635070|NCT01929395|7506397|FG001|Overall Study|Withdrawal by Subject|1
4635071|NCT01929395|7506398|FG002|Overall Study|Withdrawal by Subject|0
4635072|NCT01929395|7506396|FG000|Overall Study|Screen Fail|0
4635073|NCT01929395|7506397|FG001|Overall Study|Screen Fail|0
4635074|NCT01929395|7506398|FG002|Overall Study|Screen Fail|1
4635075|NCT01929408|7506406|FG000|Overall Study|received HCT as initial treatment|8
4635076|NCT01929681|7506431|FG000|Overall Study|Withdrawal by Subject|1
4635077|NCT01929681|7506432|FG001|Overall Study|Withdrawal by Subject|0
4635078|NCT01929681|7506431|FG000|Overall Study|Physician Decision|1
4635079|NCT01929681|7506432|FG001|Overall Study|Physician Decision|1
4635080|NCT01929707|7506438|FG000|Intervention Period 1|Lost to Follow-up|0
4635081|NCT01929707|7506439|FG001|Intervention Period 1|Lost to Follow-up|0
4635082|NCT01929707|7506440|FG002|Intervention Period 1|Lost to Follow-up|0
4635083|NCT01929707|7506441|FG003|Intervention Period 1|Lost to Follow-up|1
4635084|NCT01929707|7506442|FG004|Intervention Period 1|Lost to Follow-up|0
4635085|NCT01929707|7506443|FG005|Intervention Period 1|Lost to Follow-up|0
4595714|NCT01573624|7445519|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
4595715|NCT01573624|7445520|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
4595716|NCT01573624|7445514|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
4595717|NCT01573624|7445515|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1
4595718|NCT01573624|7445516|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
4595719|NCT01573624|7445517|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
4595720|NCT01573624|7445518|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
4595721|NCT01573624|7445519|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
4635086|NCT01929707|7506444|FG006|Intervention Period 1|Lost to Follow-up|0
4635087|NCT01929707|7506445|FG007|Intervention Period 1|Lost to Follow-up|0
4635088|NCT01929707|7506438|FG000|Intervention Period 1|Withdrawal by Subject|0
4635089|NCT01929707|7506439|FG001|Intervention Period 1|Withdrawal by Subject|0
4635090|NCT01929707|7506440|FG002|Intervention Period 1|Withdrawal by Subject|0
4635091|NCT01929707|7506441|FG003|Intervention Period 1|Withdrawal by Subject|2
4635092|NCT01929707|7506442|FG004|Intervention Period 1|Withdrawal by Subject|0
4635093|NCT01929707|7506443|FG005|Intervention Period 1|Withdrawal by Subject|0
4635094|NCT01929707|7506444|FG006|Intervention Period 1|Withdrawal by Subject|0
4635095|NCT01929707|7506445|FG007|Intervention Period 1|Withdrawal by Subject|0
4635096|NCT01929707|7506438|FG000|Intervention Period 2|Withdrawal by Subject|0
4635097|NCT01929707|7506439|FG001|Intervention Period 2|Withdrawal by Subject|0
4635098|NCT01929707|7506440|FG002|Intervention Period 2|Withdrawal by Subject|0
4635099|NCT01929707|7506441|FG003|Intervention Period 2|Withdrawal by Subject|0
4635100|NCT01929707|7506442|FG004|Intervention Period 2|Withdrawal by Subject|0
4635101|NCT01929707|7506443|FG005|Intervention Period 2|Withdrawal by Subject|2
4635102|NCT01929707|7506444|FG006|Intervention Period 2|Withdrawal by Subject|0
4635103|NCT01929707|7506445|FG007|Intervention Period 2|Withdrawal by Subject|0
4635104|NCT01929863|7506470|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1
4595722|NCT01573624|7445520|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
4595723|NCT01573624|7445514|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
4595724|NCT01573624|7445515|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
4595725|NCT01573624|7445516|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
4595726|NCT01573624|7445517|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
4595727|NCT01573624|7445518|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
4595728|NCT01573624|7445519|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
4595729|NCT01573624|7445520|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
4595730|NCT01573624|7445514|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
4595731|NCT01573624|7445515|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
4595732|NCT01573624|7445516|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
4595733|NCT01573624|7445517|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
4635105|NCT01929863|7506471|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0
4635106|NCT01929863|7506470|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0
4635107|NCT01929863|7506471|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1
4635108|NCT01929863|7506470|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0
4635109|NCT01929863|7506471|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1
4635110|NCT01929876|7506482|FG000|Period 2|Non-Compliance|1
4635111|NCT01929980|7506490|FG000|Overall Study|Physician Decision|1
4635112|NCT01929993|7506496|FG000|Overall Study|Protocol Violation|4
4635113|NCT01929993|7506497|FG001|Overall Study|Protocol Violation|6
4635114|NCT01929993|7506496|FG000|Overall Study|Absent CIN, invasion present or artifact|26
4635115|NCT01929993|7506497|FG001|Overall Study|Absent CIN, invasion present or artifact|22
4635116|NCT01930045|7506503|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0
4635117|NCT01930045|7506504|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0
4635118|NCT01930045|7506505|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0
4635119|NCT01930045|7506506|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0
4635120|NCT01930045|7506507|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0
4595734|NCT01573624|7445518|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
4595735|NCT01573624|7445519|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
4595736|NCT01573624|7445520|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
4595737|NCT01573624|7445514|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2
4595738|NCT01573624|7445515|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
4595739|NCT01573624|7445516|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
4595740|NCT01573624|7445517|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
4595741|NCT01573624|7445518|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1
4595742|NCT01573624|7445519|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1
4595743|NCT01573624|7445520|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4
4595744|NCT01573624|7445514|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
4595745|NCT01573624|7445515|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1
4595746|NCT01573624|7445516|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
4595747|NCT01573624|7445517|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
4595748|NCT01573624|7445518|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
4595749|NCT01573624|7445519|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1
4595750|NCT01573624|7445520|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
4595751|NCT01573624|7445514|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1
4595752|NCT01573624|7445515|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
4595753|NCT01573624|7445516|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
4595754|NCT01573624|7445517|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
4595755|NCT01573624|7445518|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
4595756|NCT01573624|7445519|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
4595757|NCT01573624|7445520|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
4595758|NCT01573624|7445514|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
4595759|NCT01573624|7445515|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
4595760|NCT01573624|7445516|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
4595761|NCT01573624|7445517|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
4595762|NCT01573624|7445518|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2
4595763|NCT01573624|7445519|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1
4595764|NCT01573624|7445520|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
4595765|NCT01573624|7445514|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1
4595766|NCT01573624|7445515|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
4595767|NCT01573624|7445516|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
4595768|NCT01573624|7445517|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
4595769|NCT01573624|7445518|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
4595770|NCT01573624|7445519|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
4595771|NCT01573624|7445520|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
4595772|NCT01573767|7445551|FG000|Overall Study|Adverse Event|0
4595773|NCT01573767|7445552|FG001|Overall Study|Adverse Event|1
4595774|NCT01573767|7445553|FG002|Overall Study|Adverse Event|0
4595775|NCT01573767|7445554|FG003|Overall Study|Adverse Event|1
4595776|NCT01573767|7445551|FG000|Overall Study|Lack of Efficacy|18
4595777|NCT01573767|7445552|FG001|Overall Study|Lack of Efficacy|15
4595778|NCT01573767|7445553|FG002|Overall Study|Lack of Efficacy|12
4595779|NCT01573767|7445554|FG003|Overall Study|Lack of Efficacy|17
4595780|NCT01573767|7445551|FG000|Overall Study|Protocol Violation|3
4595781|NCT01573767|7445552|FG001|Overall Study|Protocol Violation|1
4595782|NCT01573767|7445553|FG002|Overall Study|Protocol Violation|1
4595783|NCT01573767|7445554|FG003|Overall Study|Protocol Violation|3
4595784|NCT01573767|7445551|FG000|Overall Study|Lost to Follow-up|0
4595785|NCT01573767|7445552|FG001|Overall Study|Lost to Follow-up|1
4595786|NCT01573767|7445553|FG002|Overall Study|Lost to Follow-up|1
4595787|NCT01573767|7445554|FG003|Overall Study|Lost to Follow-up|1
4595788|NCT01573767|7445551|FG000|Overall Study|Physician Decision|1
4595789|NCT01573767|7445552|FG001|Overall Study|Physician Decision|2
4595790|NCT01573767|7445553|FG002|Overall Study|Physician Decision|0
4595791|NCT01573767|7445554|FG003|Overall Study|Physician Decision|2
4595792|NCT01573767|7445551|FG000|Overall Study|Withdrawal by Subject|0
4595793|NCT01573767|7445552|FG001|Overall Study|Withdrawal by Subject|1
4595794|NCT01573767|7445553|FG002|Overall Study|Withdrawal by Subject|0
4595795|NCT01573767|7445554|FG003|Overall Study|Withdrawal by Subject|0
4595796|NCT01573910|7445566|FG000|Overall Study|Adverse Event|4
4595797|NCT01573910|7445567|FG001|Overall Study|Adverse Event|4
4595798|NCT01573910|7445566|FG000|Overall Study|Lost to Follow-up|2
4595799|NCT01573910|7445567|FG001|Overall Study|Lost to Follow-up|1
4595800|NCT01573910|7445566|FG000|Overall Study|Withdrawal by Subject|0
4595801|NCT01573910|7445567|FG001|Overall Study|Withdrawal by Subject|1
4595802|NCT01573910|7445566|FG000|Overall Study|Protocol Violation|3
4595803|NCT01573910|7445567|FG001|Overall Study|Protocol Violation|0
4595804|NCT01573910|7445566|FG000|Overall Study|Patient decision unrelated to Advs Event|11
4595805|NCT01573910|7445567|FG001|Overall Study|Patient decision unrelated to Advs Event|11
4595806|NCT01574079|7445579|FG000|Overall Study|Physician Decision|0
4595807|NCT01574079|7445580|FG001|Overall Study|Physician Decision|2
4595808|NCT01574079|7445579|FG000|Overall Study|Lost to Follow-up|1
4595809|NCT01574079|7445580|FG001|Overall Study|Lost to Follow-up|0
4595810|NCT01574157|7445602|FG000|Overall Study|Withdrawal by Subject|4
4595811|NCT01574157|7445603|FG001|Overall Study|Withdrawal by Subject|5
4595812|NCT01574157|7445602|FG000|Overall Study|Lost to Follow-up|0
4595813|NCT01574157|7445603|FG001|Overall Study|Lost to Follow-up|3
4595814|NCT01574248|7445626|FG000|Overall Study|Withdrawal by Subject|2
4595815|NCT01574248|7445627|FG001|Overall Study|Withdrawal by Subject|0
4595816|NCT01574248|7445626|FG000|Overall Study|Missing primary endpoint data|1
4595817|NCT01574248|7445627|FG001|Overall Study|Missing primary endpoint data|0
4635121|NCT01930045|7506508|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1
4595818|NCT01574326|7445639|FG000|Overall Study|Randomized but not treated|0
4595819|NCT01574326|7445640|FG001|Overall Study|Randomized but not treated|1
4595820|NCT01574326|7445639|FG000|Overall Study|Withdrawal by Participant|2
4595821|NCT01574326|7445640|FG001|Overall Study|Withdrawal by Participant|4
4595822|NCT01574326|7445639|FG000|Overall Study|Physician Decision|5
4595823|NCT01574326|7445640|FG001|Overall Study|Physician Decision|3
4595824|NCT01574326|7445639|FG000|Overall Study|Adverse Event|1
4595825|NCT01574326|7445640|FG001|Overall Study|Adverse Event|3
4595826|NCT01574326|7445639|FG000|Overall Study|Other: Mainly kidney transplant|8
4595827|NCT01574326|7445640|FG001|Overall Study|Other: Mainly kidney transplant|8
4595828|NCT01574352|7445653|FG000|Overall Study|Withdrawal by Subject|6
4595829|NCT01574352|7445654|FG001|Overall Study|Withdrawal by Subject|13
4595830|NCT01574352|7445653|FG000|Overall Study|Injury in non-camp related sport|1
4595831|NCT01574352|7445654|FG001|Overall Study|Injury in non-camp related sport|0
4635122|NCT01930045|7506503|FG000|Pause (up to 37 Days)|Protocol Violation|0
4635123|NCT01930045|7506504|FG001|Pause (up to 37 Days)|Protocol Violation|0
4635124|NCT01930045|7506505|FG002|Pause (up to 37 Days)|Protocol Violation|0
4635125|NCT01930045|7506506|FG003|Pause (up to 37 Days)|Protocol Violation|0
4635126|NCT01930045|7506507|FG004|Pause (up to 37 Days)|Protocol Violation|0
4635127|NCT01930045|7506508|FG005|Pause (up to 37 Days)|Protocol Violation|1
4635128|NCT01930162|7506532|FG000|Overall Study|Abnormal test procedure result(s)|4
4595832|NCT01574612|7445660|FG000|Overall Study|Adverse Event|3
4595833|NCT01574612|7445660|FG000|Overall Study|non compliant with drug|2
4595834|NCT01574612|7445660|FG000|Overall Study|Withdrawal by Subject|1
4595835|NCT01574612|7445660|FG000|Overall Study|Lost to Follow-up|2
4595836|NCT01574651|7445666|FG000|Overall Study|Lost to Follow-up|2
4595837|NCT01574651|7445667|FG001|Overall Study|Lost to Follow-up|4
4595838|NCT01574651|7445666|FG000|Overall Study|Administrative problems|0
4595839|NCT01574651|7445667|FG001|Overall Study|Administrative problems|1
4595840|NCT01574651|7445666|FG000|Overall Study|Death|3
4595841|NCT01574651|7445667|FG001|Overall Study|Death|3
4595842|NCT01574651|7445666|FG000|Overall Study|Patient's inability to use the device|0
4595843|NCT01574651|7445667|FG001|Overall Study|Patient's inability to use the device|1
4595844|NCT01574651|7445666|FG000|Overall Study|Adverse Event|36
4595845|NCT01574651|7445667|FG001|Overall Study|Adverse Event|27
4595846|NCT01574651|7445666|FG000|Overall Study|Abnormal laboratory value(s)|1
4595847|NCT01574651|7445667|FG001|Overall Study|Abnormal laboratory value(s)|0
4595848|NCT01574651|7445666|FG000|Overall Study|Abnormal test procedure result(s)|1
4595849|NCT01574651|7445667|FG001|Overall Study|Abnormal test procedure result(s)|1
4595850|NCT01574651|7445666|FG000|Overall Study|Unsatisfactory therapeutic effect|6
4595851|NCT01574651|7445667|FG001|Overall Study|Unsatisfactory therapeutic effect|0
4595852|NCT01574651|7445666|FG000|Overall Study|Protocol Violation|3
4595853|NCT01574651|7445667|FG001|Overall Study|Protocol Violation|5
4595854|NCT01574651|7445666|FG000|Overall Study|Withdrawal by Subject|9
4595855|NCT01574651|7445667|FG001|Overall Study|Withdrawal by Subject|10
4595856|NCT01574703|7445677|FG000|Overall Study|Adverse Event|0
4595857|NCT01574703|7445678|FG001|Overall Study|Adverse Event|2
4595858|NCT01574703|7445679|FG002|Overall Study|Adverse Event|1
4595859|NCT01574703|7445680|FG003|Overall Study|Adverse Event|1
4595860|NCT01574703|7445677|FG000|Overall Study|Protocol Violation|0
4595861|NCT01574703|7445678|FG001|Overall Study|Protocol Violation|0
4595862|NCT01574703|7445679|FG002|Overall Study|Protocol Violation|0
4595863|NCT01574703|7445680|FG003|Overall Study|Protocol Violation|1
4595864|NCT01574703|7445677|FG000|Overall Study|Unspecified Reason|27
4595865|NCT01574703|7445678|FG001|Overall Study|Unspecified Reason|15
4595866|NCT01574703|7445679|FG002|Overall Study|Unspecified Reason|20
4595867|NCT01574703|7445680|FG003|Overall Study|Unspecified Reason|16
4595868|NCT01574703|7445677|FG000|Overall Study|Withdrawal by Subject|53
4595869|NCT01574703|7445678|FG001|Overall Study|Withdrawal by Subject|52
4595870|NCT01574703|7445679|FG002|Overall Study|Withdrawal by Subject|36
4595871|NCT01574703|7445680|FG003|Overall Study|Withdrawal by Subject|61
4595872|NCT01574703|7445677|FG000|Overall Study|Met Withdrawal Criteria|0
4595873|NCT01574703|7445678|FG001|Overall Study|Met Withdrawal Criteria|1
4595874|NCT01574703|7445679|FG002|Overall Study|Met Withdrawal Criteria|1
4595875|NCT01574703|7445680|FG003|Overall Study|Met Withdrawal Criteria|0
4595876|NCT01574703|7445677|FG000|Overall Study|Lost to Follow-up|43
4595877|NCT01574703|7445678|FG001|Overall Study|Lost to Follow-up|41
4595878|NCT01574703|7445679|FG002|Overall Study|Lost to Follow-up|46
4595879|NCT01574703|7445680|FG003|Overall Study|Lost to Follow-up|35
4595880|NCT01574703|7445677|FG000|Overall Study|Death|2
4595881|NCT01574703|7445678|FG001|Overall Study|Death|1
4635129|NCT01930162|7506532|FG000|Overall Study|Death|1
4595882|NCT01574703|7445679|FG002|Overall Study|Death|1
4595883|NCT01574703|7445680|FG003|Overall Study|Death|0
4595884|NCT01574716|7445695|FG000|Part 1|Death|3
4595885|NCT01574716|7445696|FG001|Part 1|Death|1
4595886|NCT01574716|7445697|FG002|Part 1|Death|8
4595887|NCT01574716|7445698|FG003|Part 1|Death|0
4595888|NCT01574716|7445699|FG004|Part 1|Death|0
4595889|NCT01574716|7445695|FG000|Part 1|Discontinuation of study by sponsor|0
4595890|NCT01574716|7445696|FG001|Part 1|Discontinuation of study by sponsor|0
4595891|NCT01574716|7445697|FG002|Part 1|Discontinuation of study by sponsor|1
4595892|NCT01574716|7445698|FG003|Part 1|Discontinuation of study by sponsor|0
4595893|NCT01574716|7445699|FG004|Part 1|Discontinuation of study by sponsor|0
4595894|NCT01574716|7445695|FG000|Part 1|Withdrawal by Subject|0
4595895|NCT01574716|7445696|FG001|Part 1|Withdrawal by Subject|2
4595896|NCT01574716|7445697|FG002|Part 1|Withdrawal by Subject|0
4595897|NCT01574716|7445698|FG003|Part 1|Withdrawal by Subject|0
4595898|NCT01574716|7445699|FG004|Part 1|Withdrawal by Subject|0
4595899|NCT01574716|7445695|FG000|Part 1|Lost to Follow-up|0
4595900|NCT01574716|7445696|FG001|Part 1|Lost to Follow-up|1
4595901|NCT01574716|7445697|FG002|Part 1|Lost to Follow-up|0
4595902|NCT01574716|7445698|FG003|Part 1|Lost to Follow-up|0
4595903|NCT01574716|7445699|FG004|Part 1|Lost to Follow-up|0
4595904|NCT01574716|7445695|FG000|Part 2|Progressive disease|0
4595905|NCT01574716|7445696|FG001|Part 2|Progressive disease|0
4595906|NCT01574716|7445697|FG002|Part 2|Progressive disease|0
4595907|NCT01574716|7445698|FG003|Part 2|Progressive disease|1
4595908|NCT01574716|7445699|FG004|Part 2|Progressive disease|0
4595909|NCT01574716|7445695|FG000|Part 2|Death|0
4595910|NCT01574716|7445696|FG001|Part 2|Death|0
4595911|NCT01574716|7445697|FG002|Part 2|Death|0
4635130|NCT01930175|7506540|FG000|Core Study|Lost to Follow-up|0
4635131|NCT01930175|7506541|FG001|Core Study|Lost to Follow-up|1
4635132|NCT01930175|7506542|FG002|Core Study|Lost to Follow-up|0
4635133|NCT01930175|7506540|FG000|Core Study|Adverse Event|0
4595912|NCT01574716|7445698|FG003|Part 2|Death|76
4595913|NCT01574716|7445699|FG004|Part 2|Death|35
4595914|NCT01574716|7445695|FG000|Part 2|Discontinuation of study by sponsor|0
4635134|NCT01930175|7506541|FG001|Core Study|Adverse Event|0
4595915|NCT01574716|7445696|FG001|Part 2|Discontinuation of study by sponsor|0
4595916|NCT01574716|7445697|FG002|Part 2|Discontinuation of study by sponsor|0
4595917|NCT01574716|7445698|FG003|Part 2|Discontinuation of study by sponsor|51
4595918|NCT01574716|7445699|FG004|Part 2|Discontinuation of study by sponsor|31
4595919|NCT01574716|7445695|FG000|Part 2|Withdrawal by Subject|0
4635135|NCT01930175|7506542|FG002|Core Study|Adverse Event|1
4595920|NCT01574716|7445696|FG001|Part 2|Withdrawal by Subject|0
4595921|NCT01574716|7445697|FG002|Part 2|Withdrawal by Subject|0
4595922|NCT01574716|7445698|FG003|Part 2|Withdrawal by Subject|5
4595923|NCT01574716|7445699|FG004|Part 2|Withdrawal by Subject|4
4595924|NCT01574716|7445695|FG000|Part 2|Brain metastases|0
4595925|NCT01574716|7445696|FG001|Part 2|Brain metastases|0
4595926|NCT01574716|7445697|FG002|Part 2|Brain metastases|0
4595927|NCT01574716|7445698|FG003|Part 2|Brain metastases|1
4595928|NCT01574716|7445699|FG004|Part 2|Brain metastases|0
4595929|NCT01574716|7445695|FG000|Part 2|Lost to Follow-up|0
4595930|NCT01574716|7445696|FG001|Part 2|Lost to Follow-up|0
4595931|NCT01574716|7445697|FG002|Part 2|Lost to Follow-up|0
4595932|NCT01574716|7445698|FG003|Part 2|Lost to Follow-up|3
4595933|NCT01574716|7445699|FG004|Part 2|Lost to Follow-up|0
4595934|NCT01575054|7445716|FG000|Overall Study|Other Reasons|5
4595935|NCT01575054|7445717|FG001|Overall Study|Other Reasons|3
4595936|NCT01575054|7445716|FG000|Overall Study|Protocol Violation|2
4595937|NCT01575054|7445717|FG001|Overall Study|Protocol Violation|1
4595938|NCT01575054|7445716|FG000|Overall Study|Personal Reasons|10
4595939|NCT01575054|7445717|FG001|Overall Study|Personal Reasons|11
4595940|NCT01575054|7445716|FG000|Overall Study|Lost to Follow-up|3
4595941|NCT01575054|7445717|FG001|Overall Study|Lost to Follow-up|3
4595942|NCT01575054|7445716|FG000|Overall Study|Adverse Event|9
4595943|NCT01575054|7445717|FG001|Overall Study|Adverse Event|8
4595944|NCT01575197|7445735|FG000|Overall Study|Migration out of study area|1
4595945|NCT01575197|7445736|FG001|Overall Study|Migration out of study area|5
4595946|NCT01575197|7445737|FG002|Overall Study|Migration out of study area|4
4595947|NCT01575197|7445735|FG000|Overall Study|SAE|0
4595948|NCT01575197|7445736|FG001|Overall Study|SAE|1
4595949|NCT01575197|7445737|FG002|Overall Study|SAE|0
4595950|NCT01575197|7445735|FG000|Overall Study|Lost to Follow-up|0
4595951|NCT01575197|7445736|FG001|Overall Study|Lost to Follow-up|1
4595952|NCT01575197|7445737|FG002|Overall Study|Lost to Follow-up|0
4595953|NCT01575197|7445735|FG000|Overall Study|Withdrawal by Subject|0
4595954|NCT01575197|7445736|FG001|Overall Study|Withdrawal by Subject|1
4595955|NCT01575197|7445737|FG002|Overall Study|Withdrawal by Subject|1
4595956|NCT01575197|7445735|FG000|Overall Study|Protocol Violation|2
4595957|NCT01575197|7445736|FG001|Overall Study|Protocol Violation|1
4595958|NCT01575197|7445737|FG002|Overall Study|Protocol Violation|1
4595959|NCT01575561|7445756|FG000|Overall Study|Adverse Event|9
4595960|NCT01575561|7445756|FG000|Overall Study|Lack of Efficacy|8
4595961|NCT01575561|7445756|FG000|Overall Study|Lost to Follow-up|6
4595962|NCT01575561|7445756|FG000|Overall Study|Protocol Violation|4
4595963|NCT01575561|7445756|FG000|Overall Study|Withdrawal by Subject|11
4595964|NCT01575561|7445756|FG000|Overall Study|administration|1
4595965|NCT01575769|7445768|FG000|Overall Study|Adverse Event|1
4595966|NCT01575769|7445768|FG000|Overall Study|Study terminated by sponsor|40
4595967|NCT01575808|7445776|FG000|Overall Study|Death|2
4595968|NCT01575808|7445777|FG001|Overall Study|Death|0
4595969|NCT01575808|7445776|FG000|Overall Study|Withdrawal by Subject|1
4595970|NCT01575808|7445777|FG001|Overall Study|Withdrawal by Subject|0
4595971|NCT01575834|7445787|FG000|Overall Study|Withdrawal by Subject|352
4595972|NCT01575834|7445788|FG001|Overall Study|Withdrawal by Subject|390
4595973|NCT01575834|7445787|FG000|Overall Study|Death|81
4595974|NCT01575834|7445788|FG001|Overall Study|Death|74
4595975|NCT01575834|7445787|FG000|Overall Study|Other|70
4595976|NCT01575834|7445788|FG001|Overall Study|Other|70
4595977|NCT01575834|7445787|FG000|Overall Study|Adverse Event|63
4595978|NCT01575834|7445788|FG001|Overall Study|Adverse Event|61
4595979|NCT01575834|7445787|FG000|Overall Study|Lost to Follow-up|55
4595980|NCT01575834|7445788|FG001|Overall Study|Lost to Follow-up|68
4595981|NCT01575834|7445787|FG000|Overall Study|Noncompliance|52
4595982|NCT01575834|7445788|FG001|Overall Study|Noncompliance|27
4595983|NCT01575834|7445787|FG000|Overall Study|Administrative decision|15
4595984|NCT01575834|7445788|FG001|Overall Study|Administrative decision|33
4595985|NCT01575834|7445787|FG000|Overall Study|Ineligibility Determined|5
4595986|NCT01575834|7445788|FG001|Overall Study|Ineligibility Determined|8
4746510|NCT00702702|7718051|FG000|Overall Study|Study prematurely terminated|56
4595987|NCT01575834|7445787|FG000|Overall Study|Protocol Deviation|4
4595988|NCT01575834|7445788|FG001|Overall Study|Protocol Deviation|3
4595989|NCT01575834|7445787|FG000|Overall Study|Requirement for Alternative Therapy|2
4595990|NCT01575834|7445788|FG001|Overall Study|Requirement for Alternative Therapy|4
4595991|NCT01575860|7445798|FG000|Overall Study|Withdrawal by Subject|1
4595992|NCT01575860|7445798|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1
4595993|NCT01575873|7445807|FG000|Overall Study|Withdrawal by Subject|15
4746511|NCT00699413|7718070|FG000|Overall Study|Withdrawal by Subject|0
4595994|NCT01575873|7445808|FG001|Overall Study|Withdrawal by Subject|20
4595995|NCT01575873|7445809|FG002|Overall Study|Withdrawal by Subject|34
4595996|NCT01575873|7445810|FG003|Overall Study|Withdrawal by Subject|34
4595997|NCT01575873|7445807|FG000|Overall Study|Adverse Event|7
4595998|NCT01575873|7445808|FG001|Overall Study|Adverse Event|7
4595999|NCT01575873|7445809|FG002|Overall Study|Adverse Event|9
4596000|NCT01575873|7445810|FG003|Overall Study|Adverse Event|12
4596001|NCT01575873|7445807|FG000|Overall Study|Lost to Follow-up|1
4596002|NCT01575873|7445808|FG001|Overall Study|Lost to Follow-up|3
4596003|NCT01575873|7445809|FG002|Overall Study|Lost to Follow-up|13
4596004|NCT01575873|7445810|FG003|Overall Study|Lost to Follow-up|5
4596005|NCT01575873|7445807|FG000|Overall Study|Death|3
4596006|NCT01575873|7445808|FG001|Overall Study|Death|2
4596007|NCT01575873|7445809|FG002|Overall Study|Death|8
4596008|NCT01575873|7445810|FG003|Overall Study|Death|9
4596009|NCT01575873|7445807|FG000|Overall Study|Noncompliance|1
4596010|NCT01575873|7445808|FG001|Overall Study|Noncompliance|2
4596011|NCT01575873|7445809|FG002|Overall Study|Noncompliance|4
4596012|NCT01575873|7445810|FG003|Overall Study|Noncompliance|3
4596013|NCT01575873|7445807|FG000|Overall Study|Administrative decision|1
4596014|NCT01575873|7445808|FG001|Overall Study|Administrative decision|1
4596015|NCT01575873|7445809|FG002|Overall Study|Administrative decision|1
4596016|NCT01575873|7445810|FG003|Overall Study|Administrative decision|0
4596017|NCT01575873|7445807|FG000|Overall Study|Protocol deviation|0
4596018|NCT01575873|7445808|FG001|Overall Study|Protocol deviation|1
4596019|NCT01575873|7445809|FG002|Overall Study|Protocol deviation|0
4596020|NCT01575873|7445810|FG003|Overall Study|Protocol deviation|1
4596021|NCT01575873|7445807|FG000|Overall Study|Requirement for Alternative Therapy|0
4596022|NCT01575873|7445808|FG001|Overall Study|Requirement for Alternative Therapy|0
4596023|NCT01575873|7445809|FG002|Overall Study|Requirement for Alternative Therapy|1
4596024|NCT01575873|7445810|FG003|Overall Study|Requirement for Alternative Therapy|1
4596025|NCT01575873|7445807|FG000|Overall Study|Other|0
4596026|NCT01575873|7445808|FG001|Overall Study|Other|0
4596027|NCT01575873|7445809|FG002|Overall Study|Other|4
4596028|NCT01575873|7445810|FG003|Overall Study|Other|2
4596029|NCT01575899|7445821|FG000|Overall Study|Lost to Follow-up|3
4596030|NCT01575899|7445822|FG001|Overall Study|Lost to Follow-up|4
4596031|NCT01575899|7445823|FG002|Overall Study|Lost to Follow-up|2
4596032|NCT01575899|7445821|FG000|Overall Study|Protocol Violation|2
4596033|NCT01575899|7445822|FG001|Overall Study|Protocol Violation|1
4596034|NCT01575899|7445823|FG002|Overall Study|Protocol Violation|0
4596035|NCT01576016|7445861|FG000|Lead Safety|Death|132
4596036|NCT01576016|7445862|FG001|Lead Safety|Death|0
4596037|NCT01576016|7445861|FG000|Lead Safety|Withdrawal by Subject|81
4596038|NCT01576016|7445862|FG001|Lead Safety|Withdrawal by Subject|0
4596039|NCT01576016|7445861|FG000|Lead Safety|System Explanted without Replacement|24
4596040|NCT01576016|7445862|FG001|Lead Safety|System Explanted without Replacement|0
4596041|NCT01576016|7445861|FG000|Lead Safety|Physician Decision|14
4596042|NCT01576016|7445862|FG001|Lead Safety|Physician Decision|0
4596043|NCT01576016|7445861|FG000|Lead Safety|Lost to Follow-up|13
4596044|NCT01576016|7445862|FG001|Lead Safety|Lost to Follow-up|0
4596045|NCT01576016|7445861|FG000|Lead Safety|Unsuccessful implant|2
4596046|NCT01576016|7445862|FG001|Lead Safety|Unsuccessful implant|0
4596047|NCT01576016|7445861|FG000|Lead Safety|Sponsor request|1
4596048|NCT01576016|7445862|FG001|Lead Safety|Sponsor request|0
4596049|NCT01576016|7445861|FG000|Lead Safety|Device replaced with CRT-D|1
4596050|NCT01576016|7445862|FG001|Lead Safety|Device replaced with CRT-D|0
4596051|NCT01576016|7445861|FG000|Lead Safety|Patient on Palliative Care|1
4596052|NCT01576016|7445862|FG001|Lead Safety|Patient on Palliative Care|0
4596053|NCT01576016|7445861|FG000|Lead Safety|Patient noncompliance|1
4596054|NCT01576016|7445862|FG001|Lead Safety|Patient noncompliance|0
4596055|NCT01576016|7445861|FG000|Lead Safety|Too far from study site|1
4596056|NCT01576016|7445862|FG001|Lead Safety|Too far from study site|0
4596057|NCT01576016|7445861|FG000|Lead Safety|System deactivated|1
4596058|NCT01576016|7445862|FG001|Lead Safety|System deactivated|0
4596059|NCT01576016|7445861|FG000|Lead Safety|Patient no longer followed by study PI|1
4596060|NCT01576016|7445862|FG001|Lead Safety|Patient no longer followed by study PI|0
4596061|NCT01576016|7445861|FG000|MRI Safety|Withdrawal by Subject|0
4596062|NCT01576016|7445862|FG001|MRI Safety|Withdrawal by Subject|10
4596063|NCT01576016|7445861|FG000|MRI Safety|Non-MRI Compatible Device or Material|0
4596064|NCT01576016|7445862|FG001|MRI Safety|Non-MRI Compatible Device or Material|5
4596065|NCT01576016|7445861|FG000|MRI Safety|Has not yet completed MRI scan|0
4596066|NCT01576016|7445862|FG001|MRI Safety|Has not yet completed MRI scan|56
4596067|NCT01576016|7445861|FG000|MRI Safety|MRI scan not performed at MRI visit|0
4596068|NCT01576016|7445862|FG001|MRI Safety|MRI scan not performed at MRI visit|3
4596069|NCT01576042|7445872|FG000|Overall Study|Physician Decision|2
4596070|NCT01576042|7445873|FG001|Overall Study|Physician Decision|0
4596071|NCT01576146|7445897|FG000|Extension Period 1|Adverse Event|2
4596072|NCT01576146|7445897|FG000|Extension Period 1|Death|2
4596073|NCT01576146|7445897|FG000|Extension Period 1|Physician Decision|2
4596074|NCT01576146|7445897|FG000|Extension Period 1|Withdrawal by Subject|1
4596075|NCT01576146|7445897|FG000|Extension Period 1|Lost to Follow-up|1
4596076|NCT01576146|7445897|FG000|Extension Period 1|Parathyroidectomy|1
4596077|NCT01576146|7445897|FG000|Extension Period 1|Renal Transplant|1
4596078|NCT01576146|7445897|FG000|Extension Period 2|Sponsor Decision|13
4596079|NCT01576146|7445897|FG000|Extension Period 2|Death|1
4596080|NCT01576146|7445897|FG000|Extension Period 2|Adverse Event|1
4596081|NCT01576146|7445897|FG000|Extension Period 2|Renal Transplant|1
4596082|NCT01576146|7445897|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1
4596083|NCT01576159|7445905|FG000|Overall Study|Withdrawal by Subject|0
4596084|NCT01576159|7445906|FG001|Overall Study|Withdrawal by Subject|1
4596085|NCT01576159|7445907|FG002|Overall Study|Withdrawal by Subject|0
4596086|NCT01576159|7445908|FG003|Overall Study|Withdrawal by Subject|0
4596087|NCT01576159|7445905|FG000|Overall Study|Physician Decision|0
4596088|NCT01576159|7445906|FG001|Overall Study|Physician Decision|0
4596089|NCT01576159|7445907|FG002|Overall Study|Physician Decision|1
4596090|NCT01576159|7445908|FG003|Overall Study|Physician Decision|0
4596091|NCT01576159|7445905|FG000|Overall Study|Lost to Follow-up|0
4596092|NCT01576159|7445906|FG001|Overall Study|Lost to Follow-up|0
4596093|NCT01576159|7445907|FG002|Overall Study|Lost to Follow-up|0
4596094|NCT01576159|7445908|FG003|Overall Study|Lost to Follow-up|1
4596095|NCT01576159|7445905|FG000|Overall Study|Protocol Violation|1
4596096|NCT01576159|7445906|FG001|Overall Study|Protocol Violation|0
4596097|NCT01576159|7445907|FG002|Overall Study|Protocol Violation|0
4596098|NCT01576159|7445908|FG003|Overall Study|Protocol Violation|0
4596099|NCT01576172|7445927|FG000|Overall Study|Ineligible|2
4596100|NCT01576172|7445928|FG001|Overall Study|Ineligible|1
4596101|NCT01576172|7445927|FG000|Overall Study|Withdrawal by Subject|2
4596102|NCT01576172|7445928|FG001|Overall Study|Withdrawal by Subject|0
4596103|NCT01576172|7445927|FG000|Overall Study|Insurance issue|1
4596104|NCT01576172|7445928|FG001|Overall Study|Insurance issue|0
4596105|NCT01576341|7445946|FG000|Overall Study|Withdrawal by Subject|24
4596106|NCT01576341|7445946|FG000|Overall Study|Adverse Event|10
4596107|NCT01576341|7445946|FG000|Overall Study|Death|21
4596108|NCT01576341|7445946|FG000|Overall Study|Physician Decision|2
4596109|NCT01576341|7445946|FG000|Overall Study|Lost to Follow-up|2
4596110|NCT01576341|7445946|FG000|Overall Study|Kidney transplantation|10
4596111|NCT01576341|7445946|FG000|Overall Study|Protocol Violation|12
4596112|NCT01576341|7445946|FG000|Overall Study|Other|12
4596113|NCT01576367|7445953|FG000|Overall Study|Unsatisfactory therapeutic effect|2
4596114|NCT01576367|7445953|FG000|Overall Study|Moved to commercial use after 6 months|1
4596115|NCT01576406|7445963|FG000|Overall Study|Lost to Follow-up|1
4596116|NCT01576406|7445964|FG001|Overall Study|Lost to Follow-up|2
4596117|NCT01576406|7445965|FG002|Overall Study|Lost to Follow-up|0
4596118|NCT01576406|7445966|FG003|Overall Study|Lost to Follow-up|0
4596119|NCT01576406|7445967|FG004|Overall Study|Lost to Follow-up|0
4596120|NCT01576406|7445968|FG005|Overall Study|Lost to Follow-up|0
4596121|NCT01576406|7445963|FG000|Overall Study|Death|3
4596122|NCT01576406|7445964|FG001|Overall Study|Death|4
4596123|NCT01576406|7445965|FG002|Overall Study|Death|8
4596124|NCT01576406|7445966|FG003|Overall Study|Death|5
4596125|NCT01576406|7445967|FG004|Overall Study|Death|7
4596126|NCT01576406|7445968|FG005|Overall Study|Death|9
4596127|NCT01576406|7445963|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0
4596128|NCT01576406|7445964|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0
4596129|NCT01576406|7445965|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1
4596130|NCT01576406|7445966|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1
4596131|NCT01576406|7445967|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0
4596132|NCT01576406|7445968|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0
4596133|NCT01576406|7445963|FG000|Overall Study|Withdrawal the consent|2
4596134|NCT01576406|7445964|FG001|Overall Study|Withdrawal the consent|2
4596135|NCT01576406|7445965|FG002|Overall Study|Withdrawal the consent|5
4596136|NCT01576406|7445966|FG003|Overall Study|Withdrawal the consent|1
4596137|NCT01576406|7445967|FG004|Overall Study|Withdrawal the consent|1
4596138|NCT01576406|7445968|FG005|Overall Study|Withdrawal the consent|3
4596139|NCT01576406|7445963|FG000|Overall Study|Other|0
4596140|NCT01576406|7445964|FG001|Overall Study|Other|0
4596141|NCT01576406|7445965|FG002|Overall Study|Other|2
4596142|NCT01576406|7445966|FG003|Overall Study|Other|2
4596143|NCT01576406|7445967|FG004|Overall Study|Other|0
4596144|NCT01576406|7445968|FG005|Overall Study|Other|0
4596145|NCT01576484|7445993|FG000|Overall Study|Adverse Event|1
4596146|NCT01576484|7445994|FG001|Overall Study|Adverse Event|1
4596147|NCT01576484|7445993|FG000|Overall Study|Protocol Violation|0
4596148|NCT01576484|7445994|FG001|Overall Study|Protocol Violation|2
4596149|NCT01576484|7445993|FG000|Overall Study|Sponsor Decision|2
4596150|NCT01576484|7445994|FG001|Overall Study|Sponsor Decision|8
4596151|NCT01576484|7445993|FG000|Overall Study|Withdrawal by Subject|0
4596152|NCT01576484|7445994|FG001|Overall Study|Withdrawal by Subject|3
4596153|NCT01576484|7445993|FG000|Overall Study|Other|2
4596154|NCT01576484|7445994|FG001|Overall Study|Other|5
4596155|NCT01576705|7446035|FG000|Overall Study|TSH > 7 mIU/L at baseline|3
4596156|NCT01576705|7446036|FG001|Overall Study|TSH > 7 mIU/L at baseline|7
4596157|NCT01576705|7446037|FG002|Overall Study|TSH > 7 mIU/L at baseline|5
4596158|NCT01576705|7446038|FG003|Overall Study|TSH > 7 mIU/L at baseline|3
4596159|NCT01576705|7446035|FG000|Overall Study|invalid ICF|0
4596160|NCT01576705|7446036|FG001|Overall Study|invalid ICF|1
4596161|NCT01576705|7446037|FG002|Overall Study|invalid ICF|0
4635136|NCT01930188|7506554|FG000|Overall Study|unclassified|4
4635137|NCT01930188|7506555|FG001|Overall Study|unclassified|5
4635138|NCT01930188|7506556|FG002|Overall Study|unclassified|3
4635139|NCT01930188|7506554|FG000|Overall Study|Missing follow-up information|2
4635140|NCT01930188|7506555|FG001|Overall Study|Missing follow-up information|2
4596162|NCT01576705|7446038|FG003|Overall Study|invalid ICF|0
4596163|NCT01576718|7446054|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49
4596164|NCT01576718|7446055|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
4596165|NCT01576718|7446056|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
4596166|NCT01576718|7446057|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
4596167|NCT01576718|7446058|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
4596168|NCT01576718|7446059|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
4596169|NCT01576718|7446060|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
4596170|NCT01576718|7446054|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17
4596171|NCT01576718|7446055|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
4596172|NCT01576718|7446056|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
4596173|NCT01576718|7446057|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
4596174|NCT01576718|7446058|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
4596175|NCT01576718|7446059|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
4596176|NCT01576718|7446060|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
4596177|NCT01576718|7446054|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166
4596178|NCT01576718|7446055|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
4596179|NCT01576718|7446056|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
4596180|NCT01576718|7446057|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
4596181|NCT01576718|7446058|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
4596182|NCT01576718|7446059|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
4596183|NCT01576718|7446060|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
4596184|NCT01576718|7446054|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2
4596185|NCT01576718|7446055|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
4596186|NCT01576718|7446056|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
4596187|NCT01576718|7446057|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
4596188|NCT01576718|7446058|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
4596189|NCT01576718|7446059|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
4596190|NCT01576718|7446060|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
4596191|NCT01576718|7446054|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15
4596192|NCT01576718|7446055|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0
4596193|NCT01576718|7446056|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0
4596194|NCT01576718|7446057|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0
4596195|NCT01576718|7446058|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0
4596196|NCT01576718|7446059|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0
4596197|NCT01576718|7446060|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0
4596198|NCT01576718|7446054|FG000|Treatment Period|Adverse Event|0
4596199|NCT01576718|7446055|FG001|Treatment Period|Adverse Event|1
4596200|NCT01576718|7446056|FG002|Treatment Period|Adverse Event|1
4596201|NCT01576718|7446057|FG003|Treatment Period|Adverse Event|1
4596202|NCT01576718|7446058|FG004|Treatment Period|Adverse Event|1
4596203|NCT01576718|7446059|FG005|Treatment Period|Adverse Event|1
4596204|NCT01576718|7446060|FG006|Treatment Period|Adverse Event|0
4596205|NCT01576718|7446054|FG000|Treatment Period|Withdrawal by Subject|0
4596206|NCT01576718|7446055|FG001|Treatment Period|Withdrawal by Subject|1
4596207|NCT01576718|7446056|FG002|Treatment Period|Withdrawal by Subject|1
4596208|NCT01576718|7446057|FG003|Treatment Period|Withdrawal by Subject|0
4596209|NCT01576718|7446058|FG004|Treatment Period|Withdrawal by Subject|2
4596210|NCT01576718|7446059|FG005|Treatment Period|Withdrawal by Subject|4
4596211|NCT01576718|7446060|FG006|Treatment Period|Withdrawal by Subject|2
4596212|NCT01576718|7446054|FG000|Treatment Period|Physician Decision|0
4596213|NCT01576718|7446055|FG001|Treatment Period|Physician Decision|1
4596214|NCT01576718|7446056|FG002|Treatment Period|Physician Decision|1
4596215|NCT01576718|7446057|FG003|Treatment Period|Physician Decision|1
4596216|NCT01576718|7446058|FG004|Treatment Period|Physician Decision|1
4596217|NCT01576718|7446059|FG005|Treatment Period|Physician Decision|0
4596218|NCT01576718|7446060|FG006|Treatment Period|Physician Decision|0
4596219|NCT01576718|7446054|FG000|Treatment Period|Protocol Violation|0
4596220|NCT01576718|7446055|FG001|Treatment Period|Protocol Violation|5
4596221|NCT01576718|7446056|FG002|Treatment Period|Protocol Violation|4
4596222|NCT01576718|7446057|FG003|Treatment Period|Protocol Violation|10
4596223|NCT01576718|7446058|FG004|Treatment Period|Protocol Violation|6
4596224|NCT01576718|7446059|FG005|Treatment Period|Protocol Violation|8
4596225|NCT01576718|7446060|FG006|Treatment Period|Protocol Violation|12
4596226|NCT01576718|7446054|FG000|Treatment Period|Sponsor request|0
4596227|NCT01576718|7446055|FG001|Treatment Period|Sponsor request|1
4596228|NCT01576718|7446056|FG002|Treatment Period|Sponsor request|0
4596229|NCT01576718|7446057|FG003|Treatment Period|Sponsor request|0
4596230|NCT01576718|7446058|FG004|Treatment Period|Sponsor request|0
4596231|NCT01576718|7446059|FG005|Treatment Period|Sponsor request|1
4596232|NCT01576718|7446060|FG006|Treatment Period|Sponsor request|0
4596233|NCT01576718|7446054|FG000|Treatment Period|Met stopping criteria|0
4596234|NCT01576718|7446055|FG001|Treatment Period|Met stopping criteria|16
4596235|NCT01576718|7446056|FG002|Treatment Period|Met stopping criteria|13
4596236|NCT01576718|7446057|FG003|Treatment Period|Met stopping criteria|19
4596237|NCT01576718|7446058|FG004|Treatment Period|Met stopping criteria|16
4596238|NCT01576718|7446059|FG005|Treatment Period|Met stopping criteria|33
4596239|NCT01576718|7446060|FG006|Treatment Period|Met stopping criteria|15
4596240|NCT01576718|7446054|FG000|Treatment Period|Lost to Follow-up|0
4596241|NCT01576718|7446055|FG001|Treatment Period|Lost to Follow-up|0
4596242|NCT01576718|7446056|FG002|Treatment Period|Lost to Follow-up|0
4596243|NCT01576718|7446057|FG003|Treatment Period|Lost to Follow-up|0
4596244|NCT01576718|7446058|FG004|Treatment Period|Lost to Follow-up|1
4596245|NCT01576718|7446059|FG005|Treatment Period|Lost to Follow-up|0
4596246|NCT01576718|7446060|FG006|Treatment Period|Lost to Follow-up|0
4596247|NCT01576718|7446054|FG000|Treatment Period|Noncompliance to study medication|0
4596248|NCT01576718|7446055|FG001|Treatment Period|Noncompliance to study medication|0
4596249|NCT01576718|7446056|FG002|Treatment Period|Noncompliance to study medication|0
4596250|NCT01576718|7446057|FG003|Treatment Period|Noncompliance to study medication|0
4596251|NCT01576718|7446058|FG004|Treatment Period|Noncompliance to study medication|0
4596252|NCT01576718|7446059|FG005|Treatment Period|Noncompliance to study medication|1
4596253|NCT01576718|7446060|FG006|Treatment Period|Noncompliance to study medication|1
4596254|NCT01576783|7446076|FG000|Overall Study|Change in Medical Care|1
4596255|NCT01576783|7446077|FG001|Overall Study|Change in Medical Care|0
4596256|NCT01576783|7446076|FG000|Overall Study|Lost to Follow-up|14
4596257|NCT01576783|7446077|FG001|Overall Study|Lost to Follow-up|16
4596258|NCT01576783|7446076|FG000|Overall Study|Withdrawal by Subject|5
4596259|NCT01576783|7446077|FG001|Overall Study|Withdrawal by Subject|1
4596260|NCT01577160|7446118|FG000|Overall Study|Adverse Event|9
4596261|NCT01577160|7446118|FG000|Overall Study|Lack of Efficacy|15
4596262|NCT01577160|7446118|FG000|Overall Study|Lost to Follow-up|40
4596263|NCT01577160|7446118|FG000|Overall Study|Withdrawal by Subject|18
4596264|NCT01577160|7446118|FG000|Overall Study|Subject Uncooperative|7
4596265|NCT01577160|7446118|FG000|Overall Study|Other|9
4596266|NCT01577186|7446122|FG000|Overall Study|Adverse Event|23
4596267|NCT01577186|7446122|FG000|Overall Study|Death|1
4596268|NCT01577186|7446122|FG000|Overall Study|Lost to Follow-up|28
4596269|NCT01577186|7446122|FG000|Overall Study|Withdrawal by Subject|35
4596270|NCT01577186|7446122|FG000|Overall Study|Insufficient Response|18
4596271|NCT01577186|7446122|FG000|Overall Study|Ineligible to Continue|15
4596272|NCT01577186|7446122|FG000|Overall Study|Non-Compliant|8
4596273|NCT01577186|7446122|FG000|Overall Study|Other|2
4596274|NCT01577381|7446148|FG000|Overall Study|Discontinued|2
4596275|NCT01577381|7446149|FG001|Overall Study|Discontinued|1
4596276|NCT01577381|7446150|FG002|Overall Study|Discontinued|2
4596277|NCT01577381|7446151|FG003|Overall Study|Discontinued|2
4596278|NCT01577381|7446148|FG000|Overall Study|Ongoing at Date of Cut-Off|0
4596279|NCT01577381|7446149|FG001|Overall Study|Ongoing at Date of Cut-Off|2
4596280|NCT01577381|7446150|FG002|Overall Study|Ongoing at Date of Cut-Off|1
4596281|NCT01577381|7446151|FG003|Overall Study|Ongoing at Date of Cut-Off|0
4596282|NCT01577745|7446190|FG000|Overall Study|Withdrawal by Subject|0
4596283|NCT01577745|7446191|FG001|Overall Study|Withdrawal by Subject|1
4596284|NCT01577745|7446192|FG002|Overall Study|Withdrawal by Subject|0
4596285|NCT01577745|7446193|FG003|Overall Study|Withdrawal by Subject|3
4596286|NCT01577745|7446194|FG004|Overall Study|Withdrawal by Subject|2
4596287|NCT01577745|7446195|FG005|Overall Study|Withdrawal by Subject|0
4596288|NCT01577745|7446190|FG000|Overall Study|Death|3
4596289|NCT01577745|7446191|FG001|Overall Study|Death|2
4596290|NCT01577745|7446192|FG002|Overall Study|Death|2
4596291|NCT01577745|7446193|FG003|Overall Study|Death|1
4596292|NCT01577745|7446194|FG004|Overall Study|Death|1
4596293|NCT01577745|7446195|FG005|Overall Study|Death|3
4596294|NCT01577745|7446190|FG000|Overall Study|Physician Decision|0
4596295|NCT01577745|7446191|FG001|Overall Study|Physician Decision|0
4596296|NCT01577745|7446192|FG002|Overall Study|Physician Decision|0
4596297|NCT01577745|7446193|FG003|Overall Study|Physician Decision|1
4596298|NCT01577745|7446194|FG004|Overall Study|Physician Decision|1
4596299|NCT01577745|7446195|FG005|Overall Study|Physician Decision|0
4596300|NCT01577745|7446190|FG000|Overall Study|Lost to Follow-up|0
4596301|NCT01577745|7446191|FG001|Overall Study|Lost to Follow-up|0
4596302|NCT01577745|7446192|FG002|Overall Study|Lost to Follow-up|0
4596303|NCT01577745|7446193|FG003|Overall Study|Lost to Follow-up|0
4596304|NCT01577745|7446194|FG004|Overall Study|Lost to Follow-up|0
4596305|NCT01577745|7446195|FG005|Overall Study|Lost to Follow-up|1
4596306|NCT01577745|7446190|FG000|Overall Study|Alternative Therapy|0
4596307|NCT01577745|7446191|FG001|Overall Study|Alternative Therapy|0
4596308|NCT01577745|7446192|FG002|Overall Study|Alternative Therapy|0
4596309|NCT01577745|7446193|FG003|Overall Study|Alternative Therapy|1
4596310|NCT01577745|7446194|FG004|Overall Study|Alternative Therapy|1
4596311|NCT01577745|7446195|FG005|Overall Study|Alternative Therapy|0
4596312|NCT01577758|7446214|FG000|Dose Escalation Phase|Adverse Event|0
4596313|NCT01577758|7446215|FG001|Dose Escalation Phase|Adverse Event|0
4596314|NCT01577758|7446216|FG002|Dose Escalation Phase|Adverse Event|0
4596315|NCT01577758|7446217|FG003|Dose Escalation Phase|Adverse Event|0
4596316|NCT01577758|7446218|FG004|Dose Escalation Phase|Adverse Event|0
4596317|NCT01577758|7446219|FG005|Dose Escalation Phase|Adverse Event|2
4596318|NCT01577758|7446220|FG006|Dose Escalation Phase|Adverse Event|1
4596319|NCT01577758|7446221|FG007|Dose Escalation Phase|Adverse Event|0
4596320|NCT01577758|7446214|FG000|Dose Escalation Phase|Symptomatic Deterioration|0
4596321|NCT01577758|7446215|FG001|Dose Escalation Phase|Symptomatic Deterioration|0
4596322|NCT01577758|7446216|FG002|Dose Escalation Phase|Symptomatic Deterioration|1
4596323|NCT01577758|7446217|FG003|Dose Escalation Phase|Symptomatic Deterioration|0
4596324|NCT01577758|7446218|FG004|Dose Escalation Phase|Symptomatic Deterioration|1
4596325|NCT01577758|7446219|FG005|Dose Escalation Phase|Symptomatic Deterioration|1
4596326|NCT01577758|7446220|FG006|Dose Escalation Phase|Symptomatic Deterioration|0
4596327|NCT01577758|7446221|FG007|Dose Escalation Phase|Symptomatic Deterioration|0
4596328|NCT01577758|7446214|FG000|Dose Escalation Phase|Withdrawal by Subject|0
4596329|NCT01577758|7446215|FG001|Dose Escalation Phase|Withdrawal by Subject|0
4596330|NCT01577758|7446216|FG002|Dose Escalation Phase|Withdrawal by Subject|0
4596331|NCT01577758|7446217|FG003|Dose Escalation Phase|Withdrawal by Subject|0
4596332|NCT01577758|7446218|FG004|Dose Escalation Phase|Withdrawal by Subject|0
4596333|NCT01577758|7446219|FG005|Dose Escalation Phase|Withdrawal by Subject|1
4596334|NCT01577758|7446220|FG006|Dose Escalation Phase|Withdrawal by Subject|0
4596335|NCT01577758|7446221|FG007|Dose Escalation Phase|Withdrawal by Subject|0
4596336|NCT01577758|7446214|FG000|Dose Escalation Phase|Progression Disease|2
4596337|NCT01577758|7446215|FG001|Dose Escalation Phase|Progression Disease|2
4596338|NCT01577758|7446216|FG002|Dose Escalation Phase|Progression Disease|1
4596339|NCT01577758|7446217|FG003|Dose Escalation Phase|Progression Disease|2
4596340|NCT01577758|7446218|FG004|Dose Escalation Phase|Progression Disease|5
4596341|NCT01577758|7446219|FG005|Dose Escalation Phase|Progression Disease|0
4596342|NCT01577758|7446220|FG006|Dose Escalation Phase|Progression Disease|0
4596343|NCT01577758|7446221|FG007|Dose Escalation Phase|Progression Disease|0
4596344|NCT01577758|7446214|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0
4596345|NCT01577758|7446215|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0
4596346|NCT01577758|7446216|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0
4596347|NCT01577758|7446217|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0
4596348|NCT01577758|7446218|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0
4596349|NCT01577758|7446219|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0
4596350|NCT01577758|7446220|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0
4596351|NCT01577758|7446221|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4
4596352|NCT01577758|7446214|FG000|mCRC Expansion Phase|Withdrawal by Subject|0
4596353|NCT01577758|7446215|FG001|mCRC Expansion Phase|Withdrawal by Subject|0
4596354|NCT01577758|7446216|FG002|mCRC Expansion Phase|Withdrawal by Subject|0
4596355|NCT01577758|7446217|FG003|mCRC Expansion Phase|Withdrawal by Subject|0
4596356|NCT01577758|7446218|FG004|mCRC Expansion Phase|Withdrawal by Subject|0
4596357|NCT01577758|7446219|FG005|mCRC Expansion Phase|Withdrawal by Subject|0
4596358|NCT01577758|7446220|FG006|mCRC Expansion Phase|Withdrawal by Subject|0
4596359|NCT01577758|7446221|FG007|mCRC Expansion Phase|Withdrawal by Subject|2
4596360|NCT01577758|7446214|FG000|mCRC Expansion Phase|Progression Disease|0
4596361|NCT01577758|7446215|FG001|mCRC Expansion Phase|Progression Disease|0
4596362|NCT01577758|7446216|FG002|mCRC Expansion Phase|Progression Disease|0
4596363|NCT01577758|7446217|FG003|mCRC Expansion Phase|Progression Disease|0
4596364|NCT01577758|7446218|FG004|mCRC Expansion Phase|Progression Disease|0
4596365|NCT01577758|7446219|FG005|mCRC Expansion Phase|Progression Disease|0
4596366|NCT01577758|7446220|FG006|mCRC Expansion Phase|Progression Disease|0
4596367|NCT01577758|7446221|FG007|mCRC Expansion Phase|Progression Disease|19
4596368|NCT01578187|7446269|FG000|Usability Phase|Withdrawal by Subject|1
4596369|NCT01578330|7446301|FG000|Overall Study|Adverse Event|2
4596370|NCT01578330|7446301|FG000|Overall Study|Protocol Violation|5
4596371|NCT01578486|7446305|FG000|Overall Study|Physician Decision|3
4596372|NCT01578486|7446305|FG000|Overall Study|Withdrawal by Subject|2
4596373|NCT01578499|7446311|FG000|Overall Study|Reason not Specified|0
4596374|NCT01578499|7446312|FG001|Overall Study|Reason not Specified|1
4596375|NCT01578499|7446311|FG000|Overall Study|Lost to Follow-up|2
4596376|NCT01578499|7446312|FG001|Overall Study|Lost to Follow-up|1
4596377|NCT01578499|7446311|FG000|Overall Study|Withdrawal by Subject|10
4596378|NCT01578499|7446312|FG001|Overall Study|Withdrawal by Subject|16
4596379|NCT01578499|7446311|FG000|Overall Study|Death|20
4596380|NCT01578499|7446312|FG001|Overall Study|Death|25
4596381|NCT01578499|7446311|FG000|Overall Study|Died and End of Study Page not Completed|2
4596382|NCT01578499|7446312|FG001|Overall Study|Died and End of Study Page not Completed|0
4596383|NCT01578551|7446324|FG000|Overall Study|Adverse Event|1
4596384|NCT01578551|7446325|FG001|Overall Study|Adverse Event|0
4596385|NCT01578850|7446371|FG000|Period 1|Insufficient Clinical Response|1
4596386|NCT01578850|7446372|FG001|Period 1|Insufficient Clinical Response|0
4596387|NCT01578850|7446373|FG002|Period 1|Insufficient Clinical Response|0
4596388|NCT01578850|7446371|FG000|Period 1|Adverse Event|11
4596389|NCT01578850|7446372|FG001|Period 1|Adverse Event|0
4596390|NCT01578850|7446373|FG002|Period 1|Adverse Event|0
4596391|NCT01578850|7446371|FG000|Period 1|Death|1
4596392|NCT01578850|7446372|FG001|Period 1|Death|0
4596393|NCT01578850|7446373|FG002|Period 1|Death|0
4596394|NCT01578850|7446371|FG000|Period 1|Does Not Meet Entrance Criteria|12
4596395|NCT01578850|7446372|FG001|Period 1|Does Not Meet Entrance Criteria|0
4596396|NCT01578850|7446373|FG002|Period 1|Does Not Meet Entrance Criteria|0
4596397|NCT01578850|7446371|FG000|Period 1|Withdrawal by Subject|9
4596398|NCT01578850|7446372|FG001|Period 1|Withdrawal by Subject|0
4596399|NCT01578850|7446373|FG002|Period 1|Withdrawal by Subject|0
4596400|NCT01578850|7446371|FG000|Period 1|Study Terminated by Sponsor|3
4596401|NCT01578850|7446372|FG001|Period 1|Study Terminated by Sponsor|0
4596402|NCT01578850|7446373|FG002|Period 1|Study Terminated by Sponsor|0
4596403|NCT01578850|7446371|FG000|Period 2|Insufficient Clinical Response|0
4596404|NCT01578850|7446372|FG001|Period 2|Insufficient Clinical Response|1
4596405|NCT01578850|7446373|FG002|Period 2|Insufficient Clinical Response|0
4596406|NCT01578850|7446371|FG000|Period 2|Adverse Event|0
4596407|NCT01578850|7446372|FG001|Period 2|Adverse Event|3
4596408|NCT01578850|7446373|FG002|Period 2|Adverse Event|6
4596409|NCT01578850|7446371|FG000|Period 2|Lost to Follow-up|0
4596410|NCT01578850|7446372|FG001|Period 2|Lost to Follow-up|1
4596411|NCT01578850|7446373|FG002|Period 2|Lost to Follow-up|2
4596412|NCT01578850|7446371|FG000|Period 2|Withdrawal by Subject|0
4596413|NCT01578850|7446372|FG001|Period 2|Withdrawal by Subject|2
4596414|NCT01578850|7446373|FG002|Period 2|Withdrawal by Subject|2
4596415|NCT01578850|7446371|FG000|Period 2|Study Terminated by Sponsor|0
4596416|NCT01578850|7446372|FG001|Period 2|Study Terminated by Sponsor|5
4596417|NCT01578850|7446373|FG002|Period 2|Study Terminated by Sponsor|4
4596418|NCT01578850|7446371|FG000|Period 2|Unspecified Reasons|0
4596419|NCT01578850|7446372|FG001|Period 2|Unspecified Reasons|1
4596420|NCT01578850|7446373|FG002|Period 2|Unspecified Reasons|0
4596421|NCT01579006|7446396|FG000|Overall Study|Lack of Efficacy|10
4596422|NCT01579006|7446396|FG000|Overall Study|Adverse Event|13
4596423|NCT01579006|7446396|FG000|Overall Study|Withdrawal by Subject|5
4596424|NCT01579006|7446396|FG000|Overall Study|Non-compliance|3
4596425|NCT01579006|7446396|FG000|Overall Study|Due to participant's health fund|1
4596426|NCT01579006|7446396|FG000|Overall Study|Scheduled surgery|1
4596427|NCT01579318|7446487|FG000|Overall Study|Disease Progression|1
4596428|NCT01579474|7446497|FG000|Overall Study|Adverse Event|1
4596429|NCT01579474|7446498|FG001|Overall Study|Adverse Event|13
4596430|NCT01579474|7446499|FG002|Overall Study|Adverse Event|2
4596431|NCT01579474|7446500|FG003|Overall Study|Adverse Event|0
4596432|NCT01579474|7446501|FG004|Overall Study|Adverse Event|0
4596433|NCT01579474|7446502|FG005|Overall Study|Adverse Event|1
4596434|NCT01579474|7446497|FG000|Overall Study|Lack of Efficacy|1
4596435|NCT01579474|7446498|FG001|Overall Study|Lack of Efficacy|0
4596436|NCT01579474|7446499|FG002|Overall Study|Lack of Efficacy|0
4596437|NCT01579474|7446500|FG003|Overall Study|Lack of Efficacy|0
4596438|NCT01579474|7446501|FG004|Overall Study|Lack of Efficacy|1
4596439|NCT01579474|7446502|FG005|Overall Study|Lack of Efficacy|0
4596440|NCT01579474|7446497|FG000|Overall Study|Withdrawal by Subject|1
4596441|NCT01579474|7446498|FG001|Overall Study|Withdrawal by Subject|0
4596442|NCT01579474|7446499|FG002|Overall Study|Withdrawal by Subject|0
4596443|NCT01579474|7446500|FG003|Overall Study|Withdrawal by Subject|0
4596444|NCT01579474|7446501|FG004|Overall Study|Withdrawal by Subject|0
4596445|NCT01579474|7446502|FG005|Overall Study|Withdrawal by Subject|0
4596446|NCT01579565|7446526|FG000|Randomized|Adverse Event|1
4596447|NCT01579565|7446527|FG001|Randomized|Adverse Event|3
4596448|NCT01579565|7446526|FG000|Randomized|Withdrawal by Subject|3
4596449|NCT01579565|7446527|FG001|Randomized|Withdrawal by Subject|0
4596450|NCT01579565|7446526|FG000|Randomized|inadequate preoperative pupil dilation|0
4596451|NCT01579565|7446527|FG001|Randomized|inadequate preoperative pupil dilation|1
4596452|NCT01579565|7446526|FG000|Randomized|prohibited preoperative eating|1
4596453|NCT01579565|7446527|FG001|Randomized|prohibited preoperative eating|0
4596454|NCT01579565|7446526|FG000|Randomized|prohibited preoperative medication|0
4596455|NCT01579565|7446527|FG001|Randomized|prohibited preoperative medication|1
4596456|NCT01579565|7446526|FG000|Treated|Physician Decision|0
4596457|NCT01579565|7446527|FG001|Treated|Physician Decision|1
4596458|NCT01579565|7446526|FG000|Treated|Lost to Follow-up|2
4596459|NCT01579565|7446527|FG001|Treated|Lost to Follow-up|1
4596460|NCT01579565|7446526|FG000|Treated|declined to return for final visit|0
4596461|NCT01579565|7446527|FG001|Treated|declined to return for final visit|1
4596462|NCT01579578|7446537|FG000|Overall Study|Death|4
4596463|NCT01579578|7446538|FG001|Overall Study|Death|1
4596464|NCT01579578|7446537|FG000|Overall Study|Lost to Follow-up|1
4596465|NCT01579578|7446538|FG001|Overall Study|Lost to Follow-up|1
4596466|NCT01579578|7446537|FG000|Overall Study|Withdrawal by Subject|2
4596467|NCT01579578|7446538|FG001|Overall Study|Withdrawal by Subject|1
4596468|NCT01579578|7446537|FG000|Overall Study|Eligibility criteria|3
4596469|NCT01579578|7446538|FG001|Overall Study|Eligibility criteria|9
4596470|NCT01579578|7446537|FG000|Overall Study|Ongoing|3
4596471|NCT01579578|7446538|FG001|Overall Study|Ongoing|0
4596472|NCT01579812|7446562|FG000|Overall Study|Ineligible after treatment start|40
4596473|NCT01579812|7446562|FG000|Overall Study|Patient choice|3
4596474|NCT01579812|7446562|FG000|Overall Study|Noncompliance|3
4596475|NCT01579812|7446562|FG000|Overall Study|Withdrawal by Subject|6
4596476|NCT01579916|7446571|FG000|Overall Study|Lost to Follow-up|6
4596477|NCT01579916|7446572|FG001|Overall Study|Lost to Follow-up|1
4596478|NCT01579916|7446571|FG000|Overall Study|Withdrawal by Subject|1
4596479|NCT01579916|7446572|FG001|Overall Study|Withdrawal by Subject|1
4596480|NCT01579916|7446571|FG000|Overall Study|Death|1
4596481|NCT01579916|7446572|FG001|Overall Study|Death|0
4596482|NCT01580020|7446580|FG000|Overall Study|Lack of Efficacy|0
4596483|NCT01580020|7446581|FG001|Overall Study|Lack of Efficacy|5
4596484|NCT01580020|7446582|FG002|Overall Study|Lack of Efficacy|0
4596485|NCT01580020|7446583|FG003|Overall Study|Lack of Efficacy|1
4596486|NCT01580020|7446580|FG000|Overall Study|Withdrawal by Subject|0
4596487|NCT01580020|7446581|FG001|Overall Study|Withdrawal by Subject|1
4596488|NCT01580020|7446582|FG002|Overall Study|Withdrawal by Subject|1
4596489|NCT01580020|7446583|FG003|Overall Study|Withdrawal by Subject|0
4596490|NCT01580020|7446580|FG000|Overall Study|Adverse Event|1
4596491|NCT01580020|7446581|FG001|Overall Study|Adverse Event|1
4596492|NCT01580020|7446582|FG002|Overall Study|Adverse Event|1
4596493|NCT01580020|7446583|FG003|Overall Study|Adverse Event|1
4596494|NCT01580020|7446580|FG000|Overall Study|Administrative Problems|0
4596495|NCT01580020|7446581|FG001|Overall Study|Administrative Problems|0
4596496|NCT01580020|7446582|FG002|Overall Study|Administrative Problems|1
4596497|NCT01580020|7446583|FG003|Overall Study|Administrative Problems|0
4596498|NCT01580020|7446580|FG000|Overall Study|Lost to Follow-up|0
4596499|NCT01580020|7446581|FG001|Overall Study|Lost to Follow-up|0
4596500|NCT01580020|7446582|FG002|Overall Study|Lost to Follow-up|1
4596501|NCT01580020|7446583|FG003|Overall Study|Lost to Follow-up|0
4596502|NCT01580293|7446624|FG000|Part A_Main Trial|Adverse Event|0
4596503|NCT01580293|7446625|FG001|Part A_Main Trial|Adverse Event|2
4596504|NCT01580293|7446626|FG002|Part A_Main Trial|Adverse Event|0
4596505|NCT01580293|7446624|FG000|Part A_Main Trial|Withdrawal by Subject|1
4596506|NCT01580293|7446625|FG001|Part A_Main Trial|Withdrawal by Subject|4
4596507|NCT01580293|7446626|FG002|Part A_Main Trial|Withdrawal by Subject|0
4596508|NCT01580293|7446624|FG000|Part A_Main Trial|Non-adherence to the protocol|1
4596509|NCT01580293|7446625|FG001|Part A_Main Trial|Non-adherence to the protocol|0
4596510|NCT01580293|7446626|FG002|Part A_Main Trial|Non-adherence to the protocol|0
4596511|NCT01580293|7446624|FG000|Part A_Extension|Adverse Event|0
4596512|NCT01580293|7446625|FG001|Part A_Extension|Adverse Event|2
4596513|NCT01580293|7446626|FG002|Part A_Extension|Adverse Event|0
4596514|NCT01580293|7446624|FG000|Part A_Extension|Withdrawal by Subject|0
4596515|NCT01580293|7446625|FG001|Part A_Extension|Withdrawal by Subject|3
4596516|NCT01580293|7446626|FG002|Part A_Extension|Withdrawal by Subject|0
4596517|NCT01580293|7446624|FG000|Part A_Extension|Lost to Follow-up|0
4596518|NCT01580293|7446625|FG001|Part A_Extension|Lost to Follow-up|1
4596519|NCT01580293|7446626|FG002|Part A_Extension|Lost to Follow-up|0
4596520|NCT01580293|7446624|FG000|Part A_Extension|Other Reason|0
4596521|NCT01580293|7446625|FG001|Part A_Extension|Other Reason|1
4596522|NCT01580293|7446626|FG002|Part A_Extension|Other Reason|0
4596523|NCT01580293|7446624|FG000|Part A_Extension|Completed Japan only|0
4596524|NCT01580293|7446625|FG001|Part A_Extension|Completed Japan only|5
4596525|NCT01580293|7446626|FG002|Part A_Extension|Completed Japan only|0
4596526|NCT01580293|7446624|FG000|Part B|Withdrawal by Subject|0
4596527|NCT01580293|7446625|FG001|Part B|Withdrawal by Subject|0
4596528|NCT01580293|7446626|FG002|Part B|Withdrawal by Subject|1
4596529|NCT01580293|7446624|FG000|Part B|Other reason|0
4596530|NCT01580293|7446625|FG001|Part B|Other reason|0
4596531|NCT01580293|7446626|FG002|Part B|Other reason|1
4596532|NCT01580488|7446687|FG000|Overall Study|Withdrawal by Subject|1
4635141|NCT01930188|7506556|FG002|Overall Study|Missing follow-up information|3
4635142|NCT01930188|7506554|FG000|Overall Study|Lost to Follow-up|5
4635143|NCT01930188|7506555|FG001|Overall Study|Lost to Follow-up|2
4635144|NCT01930188|7506556|FG002|Overall Study|Lost to Follow-up|2
4635145|NCT01930188|7506554|FG000|Overall Study|Death|2
4635146|NCT01930188|7506555|FG001|Overall Study|Death|1
4635147|NCT01930188|7506556|FG002|Overall Study|Death|3
4635148|NCT01930188|7506554|FG000|Overall Study|Withdrawal by Subject|9
4635149|NCT01930188|7506555|FG001|Overall Study|Withdrawal by Subject|11
4635150|NCT01930188|7506556|FG002|Overall Study|Withdrawal by Subject|8
4635151|NCT01930214|7506568|FG000|Overall Study|Death|4
4635152|NCT01930214|7506569|FG001|Overall Study|Death|4
4635153|NCT01930214|7506570|FG002|Overall Study|Death|11
4635154|NCT01930214|7506568|FG000|Overall Study|Lost to Follow-up|12
4635155|NCT01930214|7506569|FG001|Overall Study|Lost to Follow-up|13
4635156|NCT01930214|7506570|FG002|Overall Study|Lost to Follow-up|12
4635157|NCT01930214|7506568|FG000|Overall Study|Voluntary withdrawal of infomed consent|2
4635158|NCT01930214|7506569|FG001|Overall Study|Voluntary withdrawal of infomed consent|4
4635159|NCT01930214|7506570|FG002|Overall Study|Voluntary withdrawal of infomed consent|2
4635160|NCT01930214|7506568|FG000|Overall Study|Physician Decision|2
4635161|NCT01930214|7506569|FG001|Overall Study|Physician Decision|0
4635162|NCT01930214|7506570|FG002|Overall Study|Physician Decision|0
4635163|NCT01930799|7506612|FG000|Overall Study|Withdrawal by Subject|3
4635164|NCT01930799|7506612|FG000|Overall Study|Lost to Follow-up|5
4635165|NCT01930890|7506620|FG000|Overall Study|Study Termination|14
4635166|NCT01930890|7506621|FG001|Overall Study|Study Termination|28
4635167|NCT01930890|7506622|FG002|Overall Study|Study Termination|13
4635168|NCT01930890|7506623|FG003|Overall Study|Study Termination|25
4635169|NCT01930890|7506620|FG000|Overall Study|Death|0
4635170|NCT01930890|7506621|FG001|Overall Study|Death|0
4635171|NCT01930890|7506622|FG002|Overall Study|Death|0
4635172|NCT01930890|7506623|FG003|Overall Study|Death|1
4635173|NCT01930890|7506620|FG000|Overall Study|Investigator Decision|0
4635174|NCT01930890|7506621|FG001|Overall Study|Investigator Decision|1
4635175|NCT01930890|7506622|FG002|Overall Study|Investigator Decision|0
4635176|NCT01930890|7506623|FG003|Overall Study|Investigator Decision|0
4635177|NCT01930890|7506620|FG000|Overall Study|Consent Withdrawn|0
4635178|NCT01930890|7506621|FG001|Overall Study|Consent Withdrawn|3
4635179|NCT01930890|7506622|FG002|Overall Study|Consent Withdrawn|0
4635180|NCT01930890|7506623|FG003|Overall Study|Consent Withdrawn|1
4635181|NCT01930890|7506620|FG000|Overall Study|Adverse Event|0
4635182|NCT01930890|7506621|FG001|Overall Study|Adverse Event|1
4635183|NCT01930890|7506622|FG002|Overall Study|Adverse Event|0
4635184|NCT01930890|7506623|FG003|Overall Study|Adverse Event|0
4635185|NCT01931059|7506635|FG000|Day 1|Pregnancy|0
4635186|NCT01931059|7506636|FG001|Day 1|Pregnancy|1
4596533|NCT01580670|7446723|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1
4596534|NCT01580670|7446723|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1
4596535|NCT01580969|7446740|FG000|Overall Study|Physician Decision|3
4596536|NCT01580969|7446741|FG001|Overall Study|Physician Decision|0
4596537|NCT01580969|7446742|FG002|Overall Study|Physician Decision|0
4596538|NCT01580995|7446752|FG000|Overall Study|Lost to Follow-up|2
4596539|NCT01580995|7446753|FG001|Overall Study|Lost to Follow-up|2
4596540|NCT01581021|7446771|FG000|Overall Study|Lost to Follow-up|4
4596541|NCT01581021|7446772|FG001|Overall Study|Lost to Follow-up|6
4596542|NCT01581021|7446771|FG000|Overall Study|More than 2 hooks in thoracic|3
4596543|NCT01581021|7446772|FG001|Overall Study|More than 2 hooks in thoracic|0
4596544|NCT01581021|7446771|FG000|Overall Study|Neuromuscular|2
4596545|NCT01581021|7446772|FG001|Overall Study|Neuromuscular|1
4596546|NCT01581021|7446771|FG000|Overall Study|Not Randomized|1
4596547|NCT01581021|7446772|FG001|Overall Study|Not Randomized|2
4596548|NCT01581021|7446771|FG000|Overall Study|Lenke 6 Classification|0
4596549|NCT01581021|7446772|FG001|Overall Study|Lenke 6 Classification|1
4596550|NCT01581021|7446771|FG000|Overall Study|Lack of Efficacy|0
4596551|NCT01581021|7446772|FG001|Overall Study|Lack of Efficacy|1
4596552|NCT01581281|7446781|FG000|Overall Study|Early Study Closure|15
4596553|NCT01581281|7446782|FG001|Overall Study|Early Study Closure|6
4596554|NCT01581281|7446783|FG002|Overall Study|Early Study Closure|12
4596555|NCT01581307|7446792|FG000|Overall Study|Withdrawal by Subject|1
4596556|NCT01581593|7446839|FG000|Overall Study|Withdrawal by Subject|1
4596557|NCT01581619|7446847|FG000|Overall Study|Withdrawal by Subject|1
4596558|NCT01581619|7446847|FG000|Overall Study|Lost to Follow-up|1
4596559|NCT01581684|7446880|FG000|Overall Study|Other reason not defined|0
4596560|NCT01581684|7446881|FG001|Overall Study|Other reason not defined|0
4596561|NCT01581684|7446882|FG002|Overall Study|Other reason not defined|0
4596562|NCT01581684|7446883|FG003|Overall Study|Other reason not defined|0
4596563|NCT01581684|7446884|FG004|Overall Study|Other reason not defined|0
4596564|NCT01581684|7446885|FG005|Overall Study|Other reason not defined|0
4596565|NCT01581684|7446886|FG006|Overall Study|Other reason not defined|0
4596566|NCT01581684|7446887|FG007|Overall Study|Other reason not defined|0
4596567|NCT01581684|7446888|FG008|Overall Study|Other reason not defined|1
4596568|NCT01581684|7446889|FG009|Overall Study|Other reason not defined|0
4596569|NCT01581931|7446933|FG000|Washout|Adverse Event|0
4596570|NCT01581931|7446934|FG001|Washout|Adverse Event|1
4596571|NCT01582009|7446944|FG000|Overall Study|Withdrawal by Subject|1
4596572|NCT01582009|7446944|FG000|Overall Study|Physician Decision|1
4596573|NCT01582061|7446950|FG000|Overall Study|Lack of Efficacy|3
4596574|NCT01582061|7446951|FG001|Overall Study|Lack of Efficacy|23
4596575|NCT01582061|7446950|FG000|Overall Study|Adverse Event|12
4596576|NCT01582061|7446951|FG001|Overall Study|Adverse Event|8
4596577|NCT01582061|7446950|FG000|Overall Study|Withdrawal by Subject|10
4596578|NCT01582061|7446951|FG001|Overall Study|Withdrawal by Subject|4
4596579|NCT01582061|7446950|FG000|Overall Study|Abnormal laboratory value(s)|1
4596580|NCT01582061|7446951|FG001|Overall Study|Abnormal laboratory value(s)|0
4596581|NCT01582061|7446950|FG000|Overall Study|Death|0
4596582|NCT01582061|7446951|FG001|Overall Study|Death|1
4596583|NCT01582061|7446950|FG000|Overall Study|condition no longer requires study drug|1
4596584|NCT01582061|7446951|FG001|Overall Study|condition no longer requires study drug|0
4596585|NCT01582061|7446950|FG000|Overall Study|Lost to Follow-up|1
4596586|NCT01582061|7446951|FG001|Overall Study|Lost to Follow-up|0
4596587|NCT01582152|7446978|FG000|Overall Study|Disease Progression|4
4596588|NCT01582152|7446979|FG001|Overall Study|Disease Progression|5
4596589|NCT01582152|7446978|FG000|Overall Study|Adverse Event|2
4596590|NCT01582152|7446979|FG001|Overall Study|Adverse Event|1
4596591|NCT01582178|7446987|FG000|Overall Study|Physician Decision|6
4596592|NCT01582178|7446988|FG001|Overall Study|Physician Decision|5
4596593|NCT01582243|7446994|FG000|Overall Study|Withdrawal by Subject|1
4596594|NCT01582243|7446994|FG000|Overall Study|Adverse Event|1
4596595|NCT01582243|7446994|FG000|Overall Study|Lost to Follow-up|1
4596596|NCT01582282|7447001|FG000|Overall Study|Adverse Event|1
4596597|NCT01582282|7447002|FG001|Overall Study|Adverse Event|1
4596598|NCT01582282|7447003|FG002|Overall Study|Adverse Event|0
4596599|NCT01582282|7447001|FG000|Overall Study|Lost to Follow-up|1
4596600|NCT01582282|7447002|FG001|Overall Study|Lost to Follow-up|0
4596601|NCT01582282|7447003|FG002|Overall Study|Lost to Follow-up|0
4596602|NCT01582282|7447001|FG000|Overall Study|fasting blood glucose outside Protocol|0
4596603|NCT01582282|7447002|FG001|Overall Study|fasting blood glucose outside Protocol|1
4596604|NCT01582282|7447003|FG002|Overall Study|fasting blood glucose outside Protocol|0
4596605|NCT01582308|7447011|FG000|Period 1|Withdrawal by Subject|0
4596606|NCT01582308|7447012|FG001|Period 1|Withdrawal by Subject|0
4596607|NCT01582308|7447013|FG002|Period 1|Withdrawal by Subject|0
4596608|NCT01582308|7447014|FG003|Period 1|Withdrawal by Subject|0
4596609|NCT01582308|7447015|FG004|Period 1|Withdrawal by Subject|0
4596610|NCT01582308|7447016|FG005|Period 1|Withdrawal by Subject|0
4596611|NCT01582308|7447017|FG006|Period 1|Withdrawal by Subject|1
4596612|NCT01582308|7447018|FG007|Period 1|Withdrawal by Subject|0
4596613|NCT01582308|7447019|FG008|Period 1|Withdrawal by Subject|0
4596614|NCT01582308|7447020|FG009|Period 1|Withdrawal by Subject|0
4596615|NCT01582308|7447011|FG000|10-day Washout Following Period 1|Physician Decision|0
4596616|NCT01582308|7447012|FG001|10-day Washout Following Period 1|Physician Decision|0
4596617|NCT01582308|7447013|FG002|10-day Washout Following Period 1|Physician Decision|0
4596618|NCT01582308|7447014|FG003|10-day Washout Following Period 1|Physician Decision|0
4596619|NCT01582308|7447015|FG004|10-day Washout Following Period 1|Physician Decision|1
4596620|NCT01582308|7447016|FG005|10-day Washout Following Period 1|Physician Decision|0
4596621|NCT01582308|7447017|FG006|10-day Washout Following Period 1|Physician Decision|0
4596622|NCT01582308|7447018|FG007|10-day Washout Following Period 1|Physician Decision|0
4596623|NCT01582308|7447019|FG008|10-day Washout Following Period 1|Physician Decision|0
4596624|NCT01582308|7447020|FG009|10-day Washout Following Period 1|Physician Decision|0
4596625|NCT01582308|7447011|FG000|Period 4|Physician Decision|1
4596626|NCT01582308|7447012|FG001|Period 4|Physician Decision|0
4596627|NCT01582308|7447013|FG002|Period 4|Physician Decision|0
4596628|NCT01582308|7447014|FG003|Period 4|Physician Decision|0
4596629|NCT01582308|7447015|FG004|Period 4|Physician Decision|0
4596630|NCT01582308|7447016|FG005|Period 4|Physician Decision|1
4596631|NCT01582308|7447017|FG006|Period 4|Physician Decision|0
4596632|NCT01582308|7447018|FG007|Period 4|Physician Decision|0
4596633|NCT01582308|7447019|FG008|Period 4|Physician Decision|0
4596634|NCT01582308|7447020|FG009|Period 4|Physician Decision|1
4596635|NCT01582451|7447035|FG000|Overall Study|Adverse Event|1
4596636|NCT01582451|7447036|FG001|Overall Study|Adverse Event|3
4596637|NCT01582451|7447035|FG000|Overall Study|Death|3
4596638|NCT01582451|7447036|FG001|Overall Study|Death|3
4596639|NCT01582451|7447035|FG000|Overall Study|Lost to Follow-up|0
4596640|NCT01582451|7447036|FG001|Overall Study|Lost to Follow-up|2
4596641|NCT01582451|7447035|FG000|Overall Study|Protocol Violation|11
4596642|NCT01582451|7447036|FG001|Overall Study|Protocol Violation|3
4596643|NCT01582451|7447035|FG000|Overall Study|Withdrawal by Subject|13
4596644|NCT01582451|7447036|FG001|Overall Study|Withdrawal by Subject|9
4596645|NCT01582451|7447035|FG000|Overall Study|Physician Decision|3
4596646|NCT01582451|7447036|FG001|Overall Study|Physician Decision|0
4596647|NCT01582451|7447035|FG000|Overall Study|Sponsor Decision|1
4596648|NCT01582451|7447036|FG001|Overall Study|Sponsor Decision|0
4596649|NCT01582789|7447062|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1
4596650|NCT01582789|7447063|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0
4596651|NCT01582854|7447073|FG000|Overall Study|Death|8
4596652|NCT01582854|7447074|FG001|Overall Study|Death|5
4596653|NCT01582854|7447073|FG000|Overall Study|Adverse Event|2
4596654|NCT01582854|7447074|FG001|Overall Study|Adverse Event|3
4596655|NCT01582854|7447073|FG000|Overall Study|Withdrawal by Participant|8
4596656|NCT01582854|7447074|FG001|Overall Study|Withdrawal by Participant|11
4596657|NCT01582854|7447073|FG000|Overall Study|Lost to Follow-up|1
4596658|NCT01582854|7447074|FG001|Overall Study|Lost to Follow-up|2
4635187|NCT01931059|7506635|FG000|Day3|Lost to Follow-up|1
4635188|NCT01931059|7506636|FG001|Day3|Lost to Follow-up|0
4635189|NCT01931150|7506650|FG000|Overall Study|Withdrawal by Subject|1
4596659|NCT01582854|7447073|FG000|Overall Study|Physician Decision|0
4596660|NCT01582854|7447074|FG001|Overall Study|Physician Decision|1
4596661|NCT01582854|7447073|FG000|Overall Study|Recurrent Stroke|13
4596662|NCT01582854|7447074|FG001|Overall Study|Recurrent Stroke|8
4596663|NCT01582854|7447073|FG000|Overall Study|Disallowed Concomitant Medication|3
4596664|NCT01582854|7447074|FG001|Overall Study|Disallowed Concomitant Medication|2
4596665|NCT01582854|7447073|FG000|Overall Study|Carotid or Neurosurgery|0
4596666|NCT01582854|7447074|FG001|Overall Study|Carotid or Neurosurgery|1
4596667|NCT01582854|7447073|FG000|Overall Study|General Anaesthesia|0
4596668|NCT01582854|7447074|FG001|Overall Study|General Anaesthesia|1
4596669|NCT01582854|7447073|FG000|Overall Study|Other Miscellaneous Reason|1
4596670|NCT01582854|7447074|FG001|Overall Study|Other Miscellaneous Reason|0
4596671|NCT01582945|7447084|FG000|Overall Study|Intolerable side-effects|1
4596672|NCT01582945|7447084|FG000|Overall Study|Scheduling conflicts|1
4596673|NCT01582971|7447090|FG000|Overall Study|Death|2
4596674|NCT01582971|7447091|FG001|Overall Study|Death|1
4596675|NCT01582971|7447090|FG000|Overall Study|Lost to Follow-up|18
4596676|NCT01582971|7447091|FG001|Overall Study|Lost to Follow-up|21
4596677|NCT01582971|7447090|FG000|Overall Study|Withdrawal by Subject|4
4596678|NCT01582971|7447091|FG001|Overall Study|Withdrawal by Subject|2
4596679|NCT01582971|7447090|FG000|Overall Study|Other|15
4596680|NCT01582971|7447091|FG001|Overall Study|Other|13
4596681|NCT01583166|7447114|FG000|Overall Study|Withdrawal by Subject|4
4596682|NCT01583166|7447115|FG001|Overall Study|Withdrawal by Subject|6
4596683|NCT01583179|7447123|FG000|Overall Study|Screen failure|1
4596684|NCT01583179|7447124|FG001|Overall Study|Screen failure|2
4596685|NCT01583218|7447132|FG000|Overall Study|Withdrawal by Subject|43
4596686|NCT01583218|7447133|FG001|Overall Study|Withdrawal by Subject|29
4596687|NCT01583218|7447132|FG000|Overall Study|Death|206
4596688|NCT01583218|7447133|FG001|Overall Study|Death|211
4596689|NCT01583218|7447132|FG000|Overall Study|Lost to Follow-up|11
4596690|NCT01583218|7447133|FG001|Overall Study|Lost to Follow-up|17
4596691|NCT01583218|7447132|FG000|Overall Study|Adverse event or serious adverse event|3
4596692|NCT01583218|7447133|FG001|Overall Study|Adverse event or serious adverse event|3
4596693|NCT01583218|7447132|FG000|Overall Study|Patient /Family decision|3
4596694|NCT01583218|7447133|FG001|Overall Study|Patient /Family decision|0
4596695|NCT01583218|7447132|FG000|Overall Study|Cannot contact patient directly|1
4635190|NCT01931150|7506651|FG001|Overall Study|Withdrawal by Subject|2
4596696|NCT01583218|7447133|FG001|Overall Study|Cannot contact patient directly|2
4596697|NCT01583218|7447132|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0
4596698|NCT01583218|7447133|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2
4596699|NCT01583218|7447132|FG000|Overall Study|Patient did not wish to attend visits|0
4596700|NCT01583218|7447133|FG001|Overall Study|Patient did not wish to attend visits|1
4596701|NCT01583218|7447132|FG000|Overall Study|Patient randomized but not dosed|17
4596702|NCT01583218|7447133|FG001|Overall Study|Patient randomized but not dosed|16
4596703|NCT01583218|7447132|FG000|Overall Study|Patient was assessed via phone in person|1
4596704|NCT01583218|7447133|FG001|Overall Study|Patient was assessed via phone in person|0
4596705|NCT01583218|7447132|FG000|Overall Study|Patient deemed ineligible after random|2
4596706|NCT01583218|7447133|FG001|Overall Study|Patient deemed ineligible after random|0
4596707|NCT01583218|7447132|FG000|Overall Study|Patient was early terminated from study|0
4596708|NCT01583218|7447133|FG001|Overall Study|Patient was early terminated from study|1
4596709|NCT01583218|7447132|FG000|Overall Study|Patient was randomized due to mistake|1
4596710|NCT01583218|7447133|FG001|Overall Study|Patient was randomized due to mistake|0
4596711|NCT01583218|7447132|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0
4596712|NCT01583218|7447133|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1
4596713|NCT01583218|7447132|FG000|Overall Study|Withdraw of consent on day of random|1
4596714|NCT01583218|7447133|FG001|Overall Study|Withdraw of consent on day of random|0
4596715|NCT01583296|7447141|FG000|Overall Study|Withdrawal by Subject|11
4596716|NCT01583296|7447142|FG001|Overall Study|Withdrawal by Subject|10
4596717|NCT01583374|7447151|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6
4596718|NCT01583374|7447152|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7
4596719|NCT01583374|7447153|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12
4596720|NCT01583374|7447154|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
4596721|NCT01583374|7447155|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
4596722|NCT01583374|7447156|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
4596723|NCT01583374|7447157|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
4596724|NCT01583374|7447158|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
4596725|NCT01583374|7447159|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
4596726|NCT01583374|7447151|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3
4596727|NCT01583374|7447152|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2
4596728|NCT01583374|7447153|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5
4596729|NCT01583374|7447154|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
4596730|NCT01583374|7447155|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
4596731|NCT01583374|7447156|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
4596732|NCT01583374|7447157|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
4596733|NCT01583374|7447158|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
4596734|NCT01583374|7447159|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
4596735|NCT01583374|7447151|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1
4596736|NCT01583374|7447152|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1
4596737|NCT01583374|7447153|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
4596738|NCT01583374|7447154|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
4596739|NCT01583374|7447155|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
4596740|NCT01583374|7447156|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
4596741|NCT01583374|7447157|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
4596742|NCT01583374|7447158|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
4596743|NCT01583374|7447159|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
4596744|NCT01583374|7447151|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8
4596745|NCT01583374|7447152|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3
4596746|NCT01583374|7447153|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5
4596747|NCT01583374|7447154|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
4596748|NCT01583374|7447155|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
4596749|NCT01583374|7447156|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
4596750|NCT01583374|7447157|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
4596751|NCT01583374|7447158|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
4596752|NCT01583374|7447159|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
4596753|NCT01583374|7447151|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1
4596754|NCT01583374|7447152|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2
4596755|NCT01583374|7447153|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
4596756|NCT01583374|7447154|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
4596757|NCT01583374|7447155|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
4596758|NCT01583374|7447156|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
4596759|NCT01583374|7447157|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
4596760|NCT01583374|7447158|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
4596761|NCT01583374|7447159|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
4596762|NCT01583374|7447151|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
4596763|NCT01583374|7447152|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
4596764|NCT01583374|7447153|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3
4596765|NCT01583374|7447154|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
4596766|NCT01583374|7447155|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
4596767|NCT01583374|7447156|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
4596768|NCT01583374|7447157|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
4596769|NCT01583374|7447158|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
4596770|NCT01583374|7447159|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
4596771|NCT01583374|7447151|FG000|Placebo-controlled Phase (Week 0-24)|Other|0
4596772|NCT01583374|7447152|FG001|Placebo-controlled Phase (Week 0-24)|Other|1
4596773|NCT01583374|7447153|FG002|Placebo-controlled Phase (Week 0-24)|Other|0
4596774|NCT01583374|7447154|FG003|Placebo-controlled Phase (Week 0-24)|Other|0
4596775|NCT01583374|7447155|FG004|Placebo-controlled Phase (Week 0-24)|Other|0
4596776|NCT01583374|7447156|FG005|Placebo-controlled Phase (Week 0-24)|Other|0
4596777|NCT01583374|7447157|FG006|Placebo-controlled Phase (Week 0-24)|Other|0
4596778|NCT01583374|7447158|FG007|Placebo-controlled Phase (Week 0-24)|Other|0
4596779|NCT01583374|7447159|FG008|Placebo-controlled Phase (Week 0-24)|Other|0
4596780|NCT01583374|7447151|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
4596781|NCT01583374|7447152|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
4596782|NCT01583374|7447153|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
4596783|NCT01583374|7447154|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
4596784|NCT01583374|7447155|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
4596785|NCT01583374|7447156|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
4596786|NCT01583374|7447157|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
4596787|NCT01583374|7447158|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1
4596788|NCT01583374|7447159|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
4596789|NCT01583374|7447151|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0
4596790|NCT01583374|7447152|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1
4596791|NCT01583374|7447153|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2
4596792|NCT01583374|7447154|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0
4596793|NCT01583374|7447155|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1
4596794|NCT01583374|7447156|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1
4596795|NCT01583374|7447157|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0
4596796|NCT01583374|7447158|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1
4596797|NCT01583374|7447159|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0
4596798|NCT01583374|7447151|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0
4596799|NCT01583374|7447152|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2
4596800|NCT01583374|7447153|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0
4596801|NCT01583374|7447154|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6
4596802|NCT01583374|7447155|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3
4596803|NCT01583374|7447156|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2
4596804|NCT01583374|7447157|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5
4596805|NCT01583374|7447158|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1
4596806|NCT01583374|7447159|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2
4596807|NCT01583374|7447151|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
4596808|NCT01583374|7447152|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2
4596809|NCT01583374|7447153|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1
4596810|NCT01583374|7447154|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
4596811|NCT01583374|7447155|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1
4596812|NCT01583374|7447156|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
4596813|NCT01583374|7447157|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
4596814|NCT01583374|7447158|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
4596815|NCT01583374|7447159|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
4596816|NCT01583374|7447151|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
4596817|NCT01583374|7447152|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
4596818|NCT01583374|7447153|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1
4596819|NCT01583374|7447154|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
4596820|NCT01583374|7447155|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1
4596821|NCT01583374|7447156|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2
4596822|NCT01583374|7447157|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
4596823|NCT01583374|7447158|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
4596824|NCT01583374|7447159|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
4596825|NCT01583374|7447151|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0
4596826|NCT01583374|7447152|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5
4596827|NCT01583374|7447153|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
4596828|NCT01583374|7447154|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
4596829|NCT01583374|7447155|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6
4596830|NCT01583374|7447156|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
4596831|NCT01583374|7447157|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
4596832|NCT01583374|7447158|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3
4746512|NCT00699413|7718071|FG001|Overall Study|Withdrawal by Subject|2
4746513|NCT00699413|7718070|FG000|Overall Study|Study terminated by sponsor|4
4746514|NCT00699413|7718071|FG001|Overall Study|Study terminated by sponsor|2
4746515|NCT00686972|7718081|FG000|Overall Study|P.I, Left institution. Study terminated|51
4746516|NCT00693017|7718087|FG000|Overall Study|Sponsor Decision|2
4746517|NCT00693017|7718088|FG001|Overall Study|Sponsor Decision|1
4746518|NCT00693017|7718087|FG000|Overall Study|Death|0
4746519|NCT00693017|7718088|FG001|Overall Study|Death|1
4746520|NCT00692003|7718127|FG000|Overall Study|Sponsor Decision|5
4746521|NCT00692003|7718128|FG001|Overall Study|Sponsor Decision|1
4746522|NCT00678288|7718136|FG000|Overall Study|Adverse Event|0
4746523|NCT00678288|7718137|FG001|Overall Study|Adverse Event|2
4746524|NCT00678288|7718136|FG000|Overall Study|Withdrawal by Subject|1
4746525|NCT00678288|7718137|FG001|Overall Study|Withdrawal by Subject|1
4746526|NCT00678288|7718136|FG000|Overall Study|Study terminated by the sponsor|2
4746527|NCT00678288|7718137|FG001|Overall Study|Study terminated by the sponsor|0
4746528|NCT00678288|7718136|FG000|Overall Study|Not compliant with study medication|0
4746529|NCT00678288|7718137|FG001|Overall Study|Not compliant with study medication|1
4746530|NCT00678288|7718136|FG000|Overall Study|Switch to commercial drug|0
4746531|NCT00678288|7718137|FG001|Overall Study|Switch to commercial drug|1
4746532|NCT00678288|7718136|FG000|Overall Study|Reason not reported|1
4746533|NCT00678288|7718137|FG001|Overall Study|Reason not reported|0
4746534|NCT00678288|7718136|FG000|Overall Study|Disease progression/recurrence/relapse|6
4746535|NCT00678288|7718137|FG001|Overall Study|Disease progression/recurrence/relapse|1
4746536|NCT00689052|7718149|FG000|Overall Study|Adverse Event|4
4746537|NCT00689052|7718150|FG001|Overall Study|Adverse Event|6
4746538|NCT00689052|7718149|FG000|Overall Study|Protocol Violation|1
4746539|NCT00689052|7718150|FG001|Overall Study|Protocol Violation|0
4746540|NCT00689052|7718149|FG000|Overall Study|Lost to Follow-up|2
4746541|NCT00689052|7718150|FG001|Overall Study|Lost to Follow-up|0
4746542|NCT00689052|7718149|FG000|Overall Study|Withdrawal by Subject|2
4746543|NCT00689052|7718150|FG001|Overall Study|Withdrawal by Subject|0
4746544|NCT00689052|7718149|FG000|Overall Study|Early termination of the trial|22
4746545|NCT00689052|7718150|FG001|Overall Study|Early termination of the trial|24
4746546|NCT00683917|7718170|FG000|Overall Study|Study prematurely terminated|10
4746547|NCT00686036|7718193|FG000|Overall Study|Adverse Event|3
4746548|NCT00686036|7718194|FG001|Overall Study|Adverse Event|0
4596833|NCT01583374|7447159|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1
4596834|NCT01583374|7447151|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0
4596835|NCT01583374|7447152|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4
4596836|NCT01583374|7447153|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6
4596837|NCT01583374|7447154|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7
4596838|NCT01583374|7447155|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10
4596839|NCT01583374|7447156|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7
4596840|NCT01583374|7447157|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4
4596841|NCT01583374|7447158|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2
4596842|NCT01583374|7447159|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4
4596843|NCT01583374|7447151|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
4596844|NCT01583374|7447152|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
4596845|NCT01583374|7447153|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
4596846|NCT01583374|7447154|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
4596847|NCT01583374|7447155|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1
4596848|NCT01583374|7447156|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
4596849|NCT01583374|7447157|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
4596850|NCT01583374|7447158|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1
4596851|NCT01583374|7447159|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1
4596852|NCT01583374|7447151|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0
4596853|NCT01583374|7447152|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11
4596854|NCT01583374|7447153|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11
4596855|NCT01583374|7447154|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1
4596856|NCT01583374|7447155|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12
4596857|NCT01583374|7447156|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7
4596858|NCT01583374|7447157|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5
4596859|NCT01583374|7447158|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3
4596860|NCT01583374|7447159|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3
4596861|NCT01583374|7447151|FG000|Long-Term Extension Phase Weeks 52-260|Death|0
4596862|NCT01583374|7447152|FG001|Long-Term Extension Phase Weeks 52-260|Death|0
4596863|NCT01583374|7447153|FG002|Long-Term Extension Phase Weeks 52-260|Death|0
4596864|NCT01583374|7447154|FG003|Long-Term Extension Phase Weeks 52-260|Death|0
4596865|NCT01583374|7447155|FG004|Long-Term Extension Phase Weeks 52-260|Death|1
4596866|NCT01583374|7447156|FG005|Long-Term Extension Phase Weeks 52-260|Death|0
4596867|NCT01583374|7447157|FG006|Long-Term Extension Phase Weeks 52-260|Death|1
4596868|NCT01583374|7447158|FG007|Long-Term Extension Phase Weeks 52-260|Death|0
4596869|NCT01583374|7447159|FG008|Long-Term Extension Phase Weeks 52-260|Death|0
4596870|NCT01583374|7447151|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
4746549|NCT00686036|7718193|FG000|Overall Study|Withdrawal by Subject|3
4596871|NCT01583374|7447152|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
4596872|NCT01583374|7447153|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
4596873|NCT01583374|7447154|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
4596874|NCT01583374|7447155|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
4596875|NCT01583374|7447156|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
4596876|NCT01583374|7447157|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
4596877|NCT01583374|7447158|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
4596878|NCT01583374|7447159|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
4596879|NCT01583374|7447151|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0
4596880|NCT01583374|7447152|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5
4596881|NCT01583374|7447153|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1
4596882|NCT01583374|7447154|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2
4596883|NCT01583374|7447155|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0
4596884|NCT01583374|7447156|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1
4596885|NCT01583374|7447157|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5
4596886|NCT01583374|7447158|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0
4596887|NCT01583374|7447159|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1
4596888|NCT01583530|7447196|FG000|Overall Study|Adverse Event|0
4596889|NCT01583530|7447197|FG001|Overall Study|Adverse Event|0
4596890|NCT01583530|7447198|FG002|Overall Study|Adverse Event|0
4596891|NCT01583530|7447199|FG003|Overall Study|Adverse Event|0
4596892|NCT01583530|7447200|FG004|Overall Study|Adverse Event|0
4596893|NCT01583530|7447201|FG005|Overall Study|Adverse Event|1
4596894|NCT01583530|7447196|FG000|Overall Study|Withdrawal by Subject|0
4596895|NCT01583530|7447197|FG001|Overall Study|Withdrawal by Subject|3
4596896|NCT01583530|7447198|FG002|Overall Study|Withdrawal by Subject|0
4596897|NCT01583530|7447199|FG003|Overall Study|Withdrawal by Subject|1
4596898|NCT01583530|7447200|FG004|Overall Study|Withdrawal by Subject|1
4596899|NCT01583530|7447201|FG005|Overall Study|Withdrawal by Subject|2
4596900|NCT01583530|7447196|FG000|Overall Study|Lost to Follow-up|0
4596901|NCT01583530|7447197|FG001|Overall Study|Lost to Follow-up|0
4596902|NCT01583530|7447198|FG002|Overall Study|Lost to Follow-up|0
4596903|NCT01583530|7447199|FG003|Overall Study|Lost to Follow-up|0
4596904|NCT01583530|7447200|FG004|Overall Study|Lost to Follow-up|3
4596905|NCT01583530|7447201|FG005|Overall Study|Lost to Follow-up|0
4596906|NCT01583530|7447196|FG000|Overall Study|Lack of compliance|0
4596907|NCT01583530|7447197|FG001|Overall Study|Lack of compliance|0
4596908|NCT01583530|7447198|FG002|Overall Study|Lack of compliance|0
4596909|NCT01583530|7447199|FG003|Overall Study|Lack of compliance|0
4596910|NCT01583530|7447200|FG004|Overall Study|Lack of compliance|1
4596911|NCT01583530|7447201|FG005|Overall Study|Lack of compliance|0
4596912|NCT01584024|7447275|FG000|Overall Study|Lost to Follow-up|10
4596913|NCT01584024|7447275|FG000|Overall Study|Withdrawal by Subject|3
4596914|NCT01584232|7447282|FG000|Overall Study|Adverse Event|3
4596915|NCT01584232|7447283|FG001|Overall Study|Adverse Event|1
4596916|NCT01584232|7447282|FG000|Overall Study|Withdrawal by Subject|2
4596917|NCT01584232|7447283|FG001|Overall Study|Withdrawal by Subject|1
4596918|NCT01584232|7447282|FG000|Overall Study|Physician Decision|2
4596919|NCT01584232|7447283|FG001|Overall Study|Physician Decision|1
4596920|NCT01584232|7447282|FG000|Overall Study|Lost to Follow-up|1
4596921|NCT01584232|7447283|FG001|Overall Study|Lost to Follow-up|0
4596922|NCT01584440|7447309|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1
4596923|NCT01584440|7447310|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0
4596924|NCT01584440|7447311|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0
4596925|NCT01584440|7447312|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0
4596926|NCT01584440|7447313|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0
4596927|NCT01584440|7447309|FG000|Stage 1 (5 Weeks)|Adverse Event|5
4596928|NCT01584440|7447310|FG001|Stage 1 (5 Weeks)|Adverse Event|3
4596929|NCT01584440|7447311|FG002|Stage 1 (5 Weeks)|Adverse Event|0
4596930|NCT01584440|7447312|FG003|Stage 1 (5 Weeks)|Adverse Event|0
4596931|NCT01584440|7447313|FG004|Stage 1 (5 Weeks)|Adverse Event|0
4596932|NCT01584440|7447309|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1
4596933|NCT01584440|7447310|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0
4596934|NCT01584440|7447311|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0
4596935|NCT01584440|7447312|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0
4596936|NCT01584440|7447313|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0
4596937|NCT01584440|7447309|FG000|Stage 1 (5 Weeks)|Protocol Violation|2
4596938|NCT01584440|7447310|FG001|Stage 1 (5 Weeks)|Protocol Violation|3
4596939|NCT01584440|7447311|FG002|Stage 1 (5 Weeks)|Protocol Violation|0
4596940|NCT01584440|7447312|FG003|Stage 1 (5 Weeks)|Protocol Violation|0
4596941|NCT01584440|7447313|FG004|Stage 1 (5 Weeks)|Protocol Violation|0
4596942|NCT01584440|7447309|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1
4596943|NCT01584440|7447310|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0
4596944|NCT01584440|7447311|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0
4596945|NCT01584440|7447312|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0
4596946|NCT01584440|7447313|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0
4596947|NCT01584440|7447309|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0
4596948|NCT01584440|7447310|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2
4596949|NCT01584440|7447311|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0
4596950|NCT01584440|7447312|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0
4596951|NCT01584440|7447313|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0
4596952|NCT01584440|7447309|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0
4596953|NCT01584440|7447310|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0
4596954|NCT01584440|7447311|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1
4596955|NCT01584440|7447312|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2
4596956|NCT01584440|7447313|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0
4596957|NCT01584440|7447309|FG000|Stage 2 (5 Weeks)|Adverse Event|0
4596958|NCT01584440|7447310|FG001|Stage 2 (5 Weeks)|Adverse Event|0
4596959|NCT01584440|7447311|FG002|Stage 2 (5 Weeks)|Adverse Event|1
4596960|NCT01584440|7447312|FG003|Stage 2 (5 Weeks)|Adverse Event|2
4596961|NCT01584440|7447313|FG004|Stage 2 (5 Weeks)|Adverse Event|1
4596962|NCT01584440|7447309|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0
4596963|NCT01584440|7447310|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0
4596964|NCT01584440|7447311|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1
4596965|NCT01584440|7447312|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0
4596966|NCT01584440|7447313|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0
4596967|NCT01584648|7447384|FG000|Overall Study|Death|136
4596968|NCT01584648|7447385|FG001|Overall Study|Death|146
4596969|NCT01584648|7447384|FG000|Overall Study|Lost to Follow-up|9
4596970|NCT01584648|7447385|FG001|Overall Study|Lost to Follow-up|9
4596971|NCT01584648|7447384|FG000|Overall Study|Investigator discretion|3
4596972|NCT01584648|7447385|FG001|Overall Study|Investigator discretion|2
4596973|NCT01584648|7447384|FG000|Overall Study|Withdrew consent|13
4596974|NCT01584648|7447385|FG001|Overall Study|Withdrew consent|4
4596975|NCT01584648|7447384|FG000|Overall Study|Study closed/terminated|50
4596976|NCT01584648|7447385|FG001|Overall Study|Study closed/terminated|23
4596977|NCT01584648|7447384|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0
4596978|NCT01584648|7447385|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28
4596979|NCT01584843|7447398|FG000|First Treatment Period|Adverse Event|0
4596980|NCT01584843|7447399|FG001|First Treatment Period|Adverse Event|0
4596981|NCT01584843|7447400|FG002|First Treatment Period|Adverse Event|1
4596982|NCT01584843|7447401|FG003|First Treatment Period|Adverse Event|0
4596983|NCT01584843|7447402|FG004|First Treatment Period|Adverse Event|0
4596984|NCT01584843|7447403|FG005|First Treatment Period|Adverse Event|0
4596985|NCT01584843|7447398|FG000|First Treatment Period|Protocol Violation|0
4596986|NCT01584843|7447399|FG001|First Treatment Period|Protocol Violation|0
4596987|NCT01584843|7447400|FG002|First Treatment Period|Protocol Violation|0
4596988|NCT01584843|7447401|FG003|First Treatment Period|Protocol Violation|0
4596989|NCT01584843|7447402|FG004|First Treatment Period|Protocol Violation|0
4596990|NCT01584843|7447403|FG005|First Treatment Period|Protocol Violation|1
4596991|NCT01584843|7447398|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0
4596992|NCT01584843|7447399|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0
4596993|NCT01584843|7447400|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0
4596994|NCT01584843|7447401|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0
4596995|NCT01584843|7447402|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0
4596996|NCT01584843|7447403|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1
4596997|NCT01584843|7447398|FG000|Second Treatment Period|Withdrawal by Subject|0
4596998|NCT01584843|7447399|FG001|Second Treatment Period|Withdrawal by Subject|0
4596999|NCT01584843|7447400|FG002|Second Treatment Period|Withdrawal by Subject|0
4597000|NCT01584843|7447401|FG003|Second Treatment Period|Withdrawal by Subject|0
4597001|NCT01584843|7447402|FG004|Second Treatment Period|Withdrawal by Subject|0
4597002|NCT01584843|7447403|FG005|Second Treatment Period|Withdrawal by Subject|1
4597003|NCT01585025|7447422|FG000|Overall Study|Withdrawal by Subject|0
4597004|NCT01585025|7447423|FG001|Overall Study|Withdrawal by Subject|3
4597005|NCT01585025|7447424|FG002|Overall Study|Withdrawal by Subject|4
4597006|NCT01585038|7447434|FG000|Overall Study|Adverse Event|2
4597007|NCT01585038|7447435|FG001|Overall Study|Adverse Event|2
4597008|NCT01585155|7447450|FG000|Overall Study|Adverse Event|1
4597009|NCT01585155|7447450|FG000|Overall Study|Lack of Efficacy|2
4597010|NCT01585155|7447450|FG000|Overall Study|Worsening ulcerative colitis|2
4597011|NCT01585168|7447456|FG000|Overall Study|Lost to Follow-up|3
4597012|NCT01585168|7447457|FG001|Overall Study|Lost to Follow-up|1
4597013|NCT01585168|7447458|FG002|Overall Study|Lost to Follow-up|1
4597014|NCT01585168|7447459|FG003|Overall Study|Lost to Follow-up|1
4597015|NCT01585194|7447467|FG000|Overall Study|Withdrawal by Subject|1
4597016|NCT01585194|7447467|FG000|Overall Study|Physician Decision|2
4597017|NCT01585194|7447467|FG000|Overall Study|Lack of insurance|1
4597018|NCT01585246|7447480|FG000|Overall Study|Lost to Follow-up|0
4597019|NCT01585246|7447481|FG001|Overall Study|Lost to Follow-up|0
4597020|NCT01585246|7447482|FG002|Overall Study|Lost to Follow-up|2
4597021|NCT01585246|7447483|FG003|Overall Study|Lost to Follow-up|1
4635191|NCT01931202|7506664|FG000|Overall Study|Withdrawal by Subject|0
4597022|NCT01585246|7447484|FG004|Overall Study|Lost to Follow-up|0
4597023|NCT01585246|7447480|FG000|Overall Study|Protocol Violation|0
4597024|NCT01585246|7447481|FG001|Overall Study|Protocol Violation|0
4597025|NCT01585246|7447482|FG002|Overall Study|Protocol Violation|0
4597026|NCT01585246|7447483|FG003|Overall Study|Protocol Violation|0
4597027|NCT01585246|7447484|FG004|Overall Study|Protocol Violation|1
4597028|NCT01585246|7447480|FG000|Overall Study|Withdrawal by Subject|0
4597029|NCT01585246|7447481|FG001|Overall Study|Withdrawal by Subject|0
4597030|NCT01585246|7447482|FG002|Overall Study|Withdrawal by Subject|1
4597031|NCT01585246|7447483|FG003|Overall Study|Withdrawal by Subject|2
4597032|NCT01585246|7447484|FG004|Overall Study|Withdrawal by Subject|1
4597033|NCT01585246|7447480|FG000|Overall Study|Other|0
4597034|NCT01585246|7447481|FG001|Overall Study|Other|1
4597035|NCT01585246|7447482|FG002|Overall Study|Other|1
4597036|NCT01585246|7447483|FG003|Overall Study|Other|1
4597037|NCT01585246|7447484|FG004|Overall Study|Other|0
4597038|NCT01585272|7447499|FG000|Overall Study|Adverse Event|22
4597039|NCT01585272|7447499|FG000|Overall Study|Protocol Violation|7
4597040|NCT01585272|7447499|FG000|Overall Study|Withdrawal by Subject|10
4597041|NCT01585298|7447503|FG000|Overall Study|Study completion was not documented.|1
4597042|NCT01585298|7447503|FG000|Overall Study|Protocol deviation|1
4597043|NCT01585298|7447503|FG000|Overall Study|Administrative problems|4
4597044|NCT01585298|7447503|FG000|Overall Study|Lost to Follow-up|2
4597045|NCT01585298|7447503|FG000|Overall Study|Withdrawal by Subject|4
4597046|NCT01585298|7447503|FG000|Overall Study|Abnormal test procedure results|1
4597047|NCT01585298|7447503|FG000|Overall Study|Adverse Event|24
4597048|NCT01585428|7447515|FG000|Overall Study|Death during treatment|1
4597049|NCT01585428|7447516|FG001|Overall Study|Death during treatment|0
4597050|NCT01585558|7447535|FG000|Overall Study|Withdrawal by Subject|4
4597051|NCT01585558|7447536|FG001|Overall Study|Withdrawal by Subject|5
4597052|NCT01585558|7447537|FG002|Overall Study|Withdrawal by Subject|8
4597053|NCT01585558|7447535|FG000|Overall Study|Lost to Follow-up|2
4597054|NCT01585558|7447536|FG001|Overall Study|Lost to Follow-up|0
4597055|NCT01585558|7447537|FG002|Overall Study|Lost to Follow-up|3
4597056|NCT01585558|7447535|FG000|Overall Study|Adverse Event|3
4597057|NCT01585558|7447536|FG001|Overall Study|Adverse Event|4
4597058|NCT01585558|7447537|FG002|Overall Study|Adverse Event|1
4597059|NCT01585558|7447535|FG000|Overall Study|Protocol Violation|4
4597060|NCT01585558|7447536|FG001|Overall Study|Protocol Violation|3
4597061|NCT01585558|7447537|FG002|Overall Study|Protocol Violation|2
4597062|NCT01585558|7447535|FG000|Overall Study|Lack of Efficacy|0
4597063|NCT01585558|7447536|FG001|Overall Study|Lack of Efficacy|0
4597064|NCT01585558|7447537|FG002|Overall Study|Lack of Efficacy|1
4597065|NCT01585584|7447545|FG000|Overall Study|Lack of Efficacy|1
4597066|NCT01585584|7447545|FG000|Overall Study|Withdrawal by Subject|1
4597067|NCT01585584|7447545|FG000|Overall Study|Physician Decision|2
4597068|NCT01585766|7447559|FG000|Overall Study|Withdrawal by Subject|0
4597069|NCT01585766|7447560|FG001|Overall Study|Withdrawal by Subject|1
4597070|NCT01585766|7447561|FG002|Overall Study|Withdrawal by Subject|1
4597071|NCT01585766|7447562|FG003|Overall Study|Withdrawal by Subject|0
4597072|NCT01585766|7447563|FG004|Overall Study|Withdrawal by Subject|0
4597073|NCT01585766|7447564|FG005|Overall Study|Withdrawal by Subject|0
4597074|NCT01585766|7447559|FG000|Overall Study|Death|0
4597075|NCT01585766|7447560|FG001|Overall Study|Death|1
4597076|NCT01585766|7447561|FG002|Overall Study|Death|0
4597077|NCT01585766|7447562|FG003|Overall Study|Death|0
4597078|NCT01585766|7447563|FG004|Overall Study|Death|0
4597079|NCT01585766|7447564|FG005|Overall Study|Death|0
4597080|NCT01585766|7447559|FG000|Overall Study|Physician Decision|0
4597081|NCT01585766|7447560|FG001|Overall Study|Physician Decision|0
4597082|NCT01585766|7447561|FG002|Overall Study|Physician Decision|1
4597083|NCT01585766|7447562|FG003|Overall Study|Physician Decision|0
4597084|NCT01585766|7447563|FG004|Overall Study|Physician Decision|0
4597085|NCT01585766|7447564|FG005|Overall Study|Physician Decision|0
4597086|NCT01585831|7447597|FG000|Overall Study|Physician Decision|0
4597087|NCT01585831|7447598|FG001|Overall Study|Physician Decision|1
4597088|NCT01585831|7447597|FG000|Overall Study|Withdrawal by Subject|2
4597089|NCT01585831|7447598|FG001|Overall Study|Withdrawal by Subject|1
4597090|NCT01585961|7447604|FG000|Overall Study|Death|6
4597091|NCT01585961|7447604|FG000|Overall Study|Physician Decision|1
4597092|NCT01585961|7447604|FG000|Overall Study|Decision to use non-study catheter|1
4597093|NCT01585961|7447604|FG000|Overall Study|Withdrawal by Subject|1
4597094|NCT01585961|7447604|FG000|Overall Study|Lost to Follow-up|23
4597095|NCT01585961|7447604|FG000|Overall Study|Ablation cancelled for slow-heal wound|1
4597096|NCT01585987|7447610|FG000|Randomized|Withdrawal by Subject|0
4597097|NCT01585987|7447611|FG001|Randomized|Withdrawal by Subject|4
4597098|NCT01585987|7447610|FG000|Randomized|No longer met criteria|0
4597099|NCT01585987|7447611|FG001|Randomized|No longer met criteria|2
4597100|NCT01585987|7447610|FG000|Treated|Disease Progression|39
4597101|NCT01585987|7447611|FG001|Treated|Disease Progression|36
4597102|NCT01585987|7447610|FG000|Treated|Study Drug Toxicity|9
4597103|NCT01585987|7447611|FG001|Treated|Study Drug Toxicity|5
4597104|NCT01585987|7447610|FG000|Treated|Adverse Event|3
4597105|NCT01585987|7447611|FG001|Treated|Adverse Event|0
4597106|NCT01585987|7447610|FG000|Treated|Withdrawal by Subject|1
4597107|NCT01585987|7447611|FG001|Treated|Withdrawal by Subject|2
4597108|NCT01585987|7447610|FG000|Treated|Death|1
4597109|NCT01585987|7447611|FG001|Treated|Death|0
4597110|NCT01585987|7447610|FG000|Treated|Lost to Follow-up|0
4597111|NCT01585987|7447611|FG001|Treated|Lost to Follow-up|1
4597112|NCT01585987|7447610|FG000|Treated|Maximum Clinical Benefit|0
4597113|NCT01585987|7447611|FG001|Treated|Maximum Clinical Benefit|1
4597114|NCT01585987|7447610|FG000|Treated|Non-Specified|1
4597115|NCT01585987|7447611|FG001|Treated|Non-Specified|2
4597116|NCT01585987|7447610|FG000|Treated|Subject Request|0
4597117|NCT01585987|7447611|FG001|Treated|Subject Request|1
4597118|NCT01585987|7447610|FG000|Treated|Poor/Non-Compliance|0
4597119|NCT01585987|7447611|FG001|Treated|Poor/Non-Compliance|1
4597120|NCT01586156|7447664|FG000|Overall Study|Pregnancy|0
4597121|NCT01586156|7447665|FG001|Overall Study|Pregnancy|1
4597122|NCT01586156|7447666|FG002|Overall Study|Pregnancy|0
4597123|NCT01586195|7447674|FG000|Overall Study|Death|11
4597124|NCT01586195|7447674|FG000|Overall Study|Withdrawal of Consent|5
4597125|NCT01586195|7447674|FG000|Overall Study|Started new anti-melanoma therapy|1
4597126|NCT01586195|7447674|FG000|Overall Study|Reason not specified|9
4597127|NCT01586338|7447687|FG000|Overall Study|Adverse Event|3
4597128|NCT01586338|7447687|FG000|Overall Study|Lost to Follow-up|1
4597129|NCT01586338|7447687|FG000|Overall Study|Withdrawal by participant|3
4597130|NCT01586338|7447687|FG000|Overall Study|Other|1
4597131|NCT01586364|7447691|FG000|Overall Study|Withdrawal by Subject|40
4597132|NCT01586364|7447691|FG000|Overall Study|Adverse Event|37
4597133|NCT01586364|7447691|FG000|Overall Study|Lost to Follow-up|17
4597134|NCT01586364|7447691|FG000|Overall Study|Protocol Violation|16
4597135|NCT01586364|7447691|FG000|Overall Study|Lack of Efficacy|1
4597136|NCT01586364|7447691|FG000|Overall Study|Other-Did not feel better post-treatment|1
4597137|NCT01586364|7447691|FG000|Overall Study|Other-Subject wasn't getting much relief|1
4597138|NCT01586364|7447691|FG000|Overall Study|Other-Site closure due to PI illness|1
4597139|NCT01586364|7447691|FG000|Overall Study|Other-PI discretion, site closing|2
4597140|NCT01586364|7447691|FG000|Overall Study|Other-Not specified|1
4597141|NCT01586624|7447703|FG000|Overall Study|Adverse Event|3
4597142|NCT01586624|7447704|FG001|Overall Study|Adverse Event|0
4597143|NCT01586624|7447705|FG002|Overall Study|Adverse Event|2
4597144|NCT01586624|7447706|FG003|Overall Study|Adverse Event|1
4597145|NCT01586624|7447707|FG004|Overall Study|Adverse Event|3
4597146|NCT01586624|7447708|FG005|Overall Study|Adverse Event|3
4597147|NCT01586624|7447709|FG006|Overall Study|Adverse Event|2
4597148|NCT01586624|7447710|FG007|Overall Study|Adverse Event|3
4597149|NCT01586624|7447703|FG000|Overall Study|Physician Decision|0
4597150|NCT01586624|7447704|FG001|Overall Study|Physician Decision|1
4597151|NCT01586624|7447705|FG002|Overall Study|Physician Decision|1
4597152|NCT01586624|7447706|FG003|Overall Study|Physician Decision|0
4597153|NCT01586624|7447707|FG004|Overall Study|Physician Decision|2
4597154|NCT01586624|7447708|FG005|Overall Study|Physician Decision|0
4597155|NCT01586624|7447709|FG006|Overall Study|Physician Decision|1
4597156|NCT01586624|7447710|FG007|Overall Study|Physician Decision|1
4597157|NCT01586624|7447703|FG000|Overall Study|Withdrawal by Subject|0
4597158|NCT01586624|7447704|FG001|Overall Study|Withdrawal by Subject|0
4597159|NCT01586624|7447705|FG002|Overall Study|Withdrawal by Subject|0
4597160|NCT01586624|7447706|FG003|Overall Study|Withdrawal by Subject|1
4597161|NCT01586624|7447707|FG004|Overall Study|Withdrawal by Subject|0
4597162|NCT01586624|7447708|FG005|Overall Study|Withdrawal by Subject|0
4597163|NCT01586624|7447709|FG006|Overall Study|Withdrawal by Subject|0
4597164|NCT01586624|7447710|FG007|Overall Study|Withdrawal by Subject|0
4597165|NCT01586624|7447703|FG000|Overall Study|Evidence of disease progression|1
4597166|NCT01586624|7447704|FG001|Overall Study|Evidence of disease progression|3
4597167|NCT01586624|7447705|FG002|Overall Study|Evidence of disease progression|2
4597168|NCT01586624|7447706|FG003|Overall Study|Evidence of disease progression|5
4597169|NCT01586624|7447707|FG004|Overall Study|Evidence of disease progression|3
4597170|NCT01586624|7447708|FG005|Overall Study|Evidence of disease progression|5
4597171|NCT01586624|7447709|FG006|Overall Study|Evidence of disease progression|4
4597172|NCT01586624|7447710|FG007|Overall Study|Evidence of disease progression|6
4597173|NCT01586624|7447703|FG000|Overall Study|Screen failure (no treatment received)|0
4597174|NCT01586624|7447704|FG001|Overall Study|Screen failure (no treatment received)|0
4597175|NCT01586624|7447705|FG002|Overall Study|Screen failure (no treatment received)|0
4597176|NCT01586624|7447706|FG003|Overall Study|Screen failure (no treatment received)|0
4597177|NCT01586624|7447707|FG004|Overall Study|Screen failure (no treatment received)|0
4597178|NCT01586624|7447708|FG005|Overall Study|Screen failure (no treatment received)|0
4597179|NCT01586624|7447709|FG006|Overall Study|Screen failure (no treatment received)|1
4597180|NCT01586624|7447710|FG007|Overall Study|Screen failure (no treatment received)|0
4597181|NCT01586806|7447745|FG000|Overall Study|Protocol Violation|0
4597182|NCT01586806|7447746|FG001|Overall Study|Protocol Violation|1
4597183|NCT01586806|7447747|FG002|Overall Study|Protocol Violation|0
4597184|NCT01586806|7447745|FG000|Overall Study|Withdrawal by Subject|1
4597185|NCT01586806|7447746|FG001|Overall Study|Withdrawal by Subject|0
4597186|NCT01586806|7447747|FG002|Overall Study|Withdrawal by Subject|0
4597187|NCT01586806|7447745|FG000|Overall Study|Lost to Follow-up|2
4597188|NCT01586806|7447746|FG001|Overall Study|Lost to Follow-up|3
4597189|NCT01586806|7447747|FG002|Overall Study|Lost to Follow-up|2
4597190|NCT01586819|7447757|FG000|Overall Study|Withdrawal by Subject|1
4597191|NCT01586819|7447758|FG001|Overall Study|Withdrawal by Subject|0
4597198|NCT01587001|7447818|FG000|Overall Study|Lost to Follow-up|2
4597199|NCT01587001|7447819|FG001|Overall Study|Lost to Follow-up|0
4597200|NCT01587001|7447818|FG000|Overall Study|Insufficient samples to complete testing|4
4597201|NCT01587001|7447819|FG001|Overall Study|Insufficient samples to complete testing|1
4597202|NCT01587014|7447826|FG000|Overall Study|Death|2
4597203|NCT01587079|7447839|FG000|Overall Study|Protocol-specified criteria|9
4597204|NCT01587079|7447839|FG000|Overall Study|Protocol Violation|5
4597205|NCT01587079|7447839|FG000|Overall Study|Lost to Follow-up|2
4597206|NCT01587079|7447839|FG000|Overall Study|Physician Decision|2
4597207|NCT01587079|7447839|FG000|Overall Study|Withdrawal by Subject|7
4597208|NCT01587079|7447839|FG000|Overall Study|Adverse Event|14
4597209|NCT01587118|7447882|FG000|Overall Study|Adverse Event|3
4597210|NCT01587118|7447882|FG000|Overall Study|Lost to Follow-up|2
4597211|NCT01587118|7447882|FG000|Overall Study|Relocation|1
4597212|NCT01587118|7447882|FG000|Overall Study|nonresponse|1
4635192|NCT01931202|7506665|FG001|Overall Study|Withdrawal by Subject|0
4635193|NCT01931202|7506666|FG002|Overall Study|Withdrawal by Subject|2
4635194|NCT01931202|7506664|FG000|Overall Study|Lost to Follow-up|0
4635195|NCT01931202|7506665|FG001|Overall Study|Lost to Follow-up|5
4635196|NCT01931202|7506666|FG002|Overall Study|Lost to Follow-up|2
4635197|NCT01931397|7506677|FG000|Overall Study|Physician Decision|2
4635198|NCT01931397|7506677|FG000|Overall Study|Withdrawal by Subject|8
4635199|NCT01931397|7506677|FG000|Overall Study|moved out of state|1
4635200|NCT01931462|7506685|FG000|Overall Study|Withdrawal by Subject|1
4635201|NCT01931475|7506691|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20
4635202|NCT01931475|7506692|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10
4635203|NCT01931475|7506691|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1
4635204|NCT01931475|7506692|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0
4635205|NCT01931475|7506691|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16
4635206|NCT01931475|7506692|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12
4635207|NCT01931475|7506691|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2
4635208|NCT01931475|7506692|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3
4635209|NCT01931475|7506691|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0
4635210|NCT01931475|7506692|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1
4635211|NCT01931475|7506691|FG000|Period 2: Extension Treatment Phase|Adverse Event|0
4635212|NCT01931475|7506692|FG001|Period 2: Extension Treatment Phase|Adverse Event|8
4635213|NCT01931475|7506691|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1
4635214|NCT01931475|7506692|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0
4635215|NCT01931475|7506691|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0
4635216|NCT01931475|7506692|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9
4635217|NCT01931475|7506691|FG000|Period 2: Extension Treatment Phase|Physician Decision|1
4635218|NCT01931475|7506692|FG001|Period 2: Extension Treatment Phase|Physician Decision|1
4635219|NCT01931475|7506691|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1
4635220|NCT01931475|7506692|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0
4635221|NCT01931475|7506691|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1
4635222|NCT01931475|7506692|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1
4635223|NCT01931566|7506719|FG000|Overall Study|Randomized But Not Treated|6
4635224|NCT01931566|7506720|FG001|Overall Study|Randomized But Not Treated|9
4635225|NCT01931566|7506721|FG002|Overall Study|Randomized But Not Treated|14
4635226|NCT01931566|7506719|FG000|Overall Study|Adverse Event|37
4635227|NCT01931566|7506720|FG001|Overall Study|Adverse Event|167
4635228|NCT01931566|7506721|FG002|Overall Study|Adverse Event|132
4635229|NCT01931566|7506719|FG000|Overall Study|Major Protocol Deviation|5
4635230|NCT01931566|7506720|FG001|Overall Study|Major Protocol Deviation|14
4635231|NCT01931566|7506721|FG002|Overall Study|Major Protocol Deviation|21
4635232|NCT01931566|7506719|FG000|Overall Study|Lost to Follow-up|3
4635233|NCT01931566|7506720|FG001|Overall Study|Lost to Follow-up|26
4635234|NCT01931566|7506721|FG002|Overall Study|Lost to Follow-up|23
4635235|NCT01931566|7506719|FG000|Overall Study|Voluntary Withdrawal|78
4635236|NCT01931566|7506720|FG001|Overall Study|Voluntary Withdrawal|245
4635237|NCT01931566|7506721|FG002|Overall Study|Voluntary Withdrawal|225
4635238|NCT01931566|7506719|FG000|Overall Study|Study Termination|289
4635239|NCT01931566|7506720|FG001|Overall Study|Study Termination|968
4635240|NCT01931566|7506721|FG002|Overall Study|Study Termination|1037
4635241|NCT01931566|7506719|FG000|Overall Study|Reason Not Specified|11
4635242|NCT01931566|7506720|FG001|Overall Study|Reason Not Specified|47
4635243|NCT01931566|7506721|FG002|Overall Study|Reason Not Specified|53
4635244|NCT01931566|7506719|FG000|Overall Study|Missing|0
4635245|NCT01931566|7506720|FG001|Overall Study|Missing|0
4635246|NCT01931566|7506721|FG002|Overall Study|Missing|1
4635247|NCT01931670|7506733|FG000|Treatment Period|Exclusionary Medication Received|1
4635248|NCT01931670|7506734|FG001|Treatment Period|Exclusionary Medication Received|1
4635249|NCT01931670|7506735|FG002|Treatment Period|Exclusionary Medication Received|1
4635250|NCT01931670|7506733|FG000|Treatment Period|Surgery/Invasive Intervention|4
4635251|NCT01931670|7506734|FG001|Treatment Period|Surgery/Invasive Intervention|2
4635252|NCT01931670|7506735|FG002|Treatment Period|Surgery/Invasive Intervention|0
4635253|NCT01931670|7506733|FG000|Treatment Period|Subject Noncompliant|4
4635254|NCT01931670|7506734|FG001|Treatment Period|Subject Noncompliant|9
4635255|NCT01931670|7506735|FG002|Treatment Period|Subject Noncompliant|5
4597213|NCT01587274|7447889|FG000|Overall Study|Lost to Follow-up|4
4597214|NCT01587274|7447890|FG001|Overall Study|Lost to Follow-up|5
4597215|NCT01587274|7447891|FG002|Overall Study|Lost to Follow-up|3
4597216|NCT01587651|7447902|FG000|Overall Study|Adverse Event|0
4597217|NCT01587651|7447903|FG001|Overall Study|Adverse Event|1
4597218|NCT01587651|7447904|FG002|Overall Study|Adverse Event|0
4597219|NCT01587651|7447902|FG000|Overall Study|Protocol Violation|0
4597220|NCT01587651|7447903|FG001|Overall Study|Protocol Violation|1
4597221|NCT01587651|7447904|FG002|Overall Study|Protocol Violation|1
4597222|NCT01587651|7447902|FG000|Overall Study|Withdrawal by Subject|0
4597223|NCT01587651|7447903|FG001|Overall Study|Withdrawal by Subject|1
4597224|NCT01587651|7447904|FG002|Overall Study|Withdrawal by Subject|0
4597225|NCT01587703|7447931|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1
4597226|NCT01587703|7447932|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
4597227|NCT01587703|7447933|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
4597228|NCT01587703|7447934|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
4597229|NCT01587703|7447935|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
4597230|NCT01587703|7447936|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
4597231|NCT01587703|7447937|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
4597232|NCT01587703|7447938|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
4597233|NCT01587703|7447939|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
4597234|NCT01587703|7447940|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
4597235|NCT01587703|7447941|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
4597236|NCT01587703|7447942|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
4597237|NCT01587703|7447943|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
4597238|NCT01587703|7447944|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
4597239|NCT01587703|7447945|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
4597240|NCT01587703|7447946|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
4597241|NCT01587703|7447947|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
4597242|NCT01587703|7447948|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
4597243|NCT01587703|7447949|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
4597244|NCT01587703|7447931|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
4597245|NCT01587703|7447932|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
4597246|NCT01587703|7447933|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
4597247|NCT01587703|7447934|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
4597248|NCT01587703|7447935|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
4597249|NCT01587703|7447936|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1
4597250|NCT01587703|7447937|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
4597251|NCT01587703|7447938|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2
4597252|NCT01587703|7447939|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
4597253|NCT01587703|7447940|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
4597254|NCT01587703|7447941|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
4597255|NCT01587703|7447942|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
4597256|NCT01587703|7447943|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
4597257|NCT01587703|7447944|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
4597258|NCT01587703|7447945|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
4597259|NCT01587703|7447946|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
4597260|NCT01587703|7447947|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
4597261|NCT01587703|7447948|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
4597262|NCT01587703|7447949|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
4597263|NCT01587703|7447931|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0
4597264|NCT01587703|7447932|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0
4597265|NCT01587703|7447933|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0
4597266|NCT01587703|7447934|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0
4597267|NCT01587703|7447935|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0
4597268|NCT01587703|7447936|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0
4597269|NCT01587703|7447937|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2
4597270|NCT01587703|7447938|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0
4597271|NCT01587703|7447939|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0
4597272|NCT01587703|7447940|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0
4597273|NCT01587703|7447941|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0
4597274|NCT01587703|7447942|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0
4597275|NCT01587703|7447943|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0
4597276|NCT01587703|7447944|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0
4597277|NCT01587703|7447945|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0
4597278|NCT01587703|7447946|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0
4597279|NCT01587703|7447947|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0
4597280|NCT01587703|7447948|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0
4597281|NCT01587703|7447949|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0
4597282|NCT01587703|7447931|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2
4597283|NCT01587703|7447932|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4
4597284|NCT01587703|7447933|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1
4597285|NCT01587703|7447934|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3
4597286|NCT01587703|7447935|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4
4597287|NCT01587703|7447936|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7
4597288|NCT01587703|7447937|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30
4597289|NCT01587703|7447938|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7
4597290|NCT01587703|7447939|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0
4597291|NCT01587703|7447940|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0
4597292|NCT01587703|7447941|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0
4597293|NCT01587703|7447942|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0
4597294|NCT01587703|7447943|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0
4597295|NCT01587703|7447944|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0
4597296|NCT01587703|7447945|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0
4597297|NCT01587703|7447946|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0
4597298|NCT01587703|7447947|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0
4597299|NCT01587703|7447948|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0
4597300|NCT01587703|7447949|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0
4597301|NCT01587703|7447931|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0
4597302|NCT01587703|7447932|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0
4597303|NCT01587703|7447933|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0
4597304|NCT01587703|7447934|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0
4597305|NCT01587703|7447935|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0
4597306|NCT01587703|7447936|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0
4597307|NCT01587703|7447937|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0
4597308|NCT01587703|7447938|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0
4597309|NCT01587703|7447939|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1
4597310|NCT01587703|7447940|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9
4597311|NCT01587703|7447941|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3
4597312|NCT01587703|7447942|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0
4597313|NCT01587703|7447943|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0
4597314|NCT01587703|7447944|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0
4597315|NCT01587703|7447945|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0
4597316|NCT01587703|7447946|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0
4597317|NCT01587703|7447947|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0
4597318|NCT01587703|7447948|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0
4597319|NCT01587703|7447949|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0
4597320|NCT01587703|7447931|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
4597321|NCT01587703|7447932|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
4597322|NCT01587703|7447933|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
4597323|NCT01587703|7447934|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
4597324|NCT01587703|7447935|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
4597325|NCT01587703|7447936|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
4597326|NCT01587703|7447937|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
4597327|NCT01587703|7447938|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
4597328|NCT01587703|7447939|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1
4597329|NCT01587703|7447940|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
4597330|NCT01587703|7447941|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1
4597331|NCT01587703|7447942|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
4597332|NCT01587703|7447943|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
4597333|NCT01587703|7447944|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
4597334|NCT01587703|7447945|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
4597335|NCT01587703|7447946|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
4597336|NCT01587703|7447947|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
4597337|NCT01587703|7447948|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
4597338|NCT01587703|7447949|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
4597339|NCT01587703|7447931|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0
4597340|NCT01587703|7447932|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0
4597341|NCT01587703|7447933|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0
4597342|NCT01587703|7447934|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0
4597343|NCT01587703|7447935|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0
4597344|NCT01587703|7447936|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0
4597345|NCT01587703|7447937|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0
4597346|NCT01587703|7447938|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0
4597347|NCT01587703|7447939|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0
4746550|NCT00686036|7718194|FG001|Overall Study|Withdrawal by Subject|1
4746551|NCT00686036|7718193|FG000|Overall Study|Study terminated by AstraZeneca|2
4746552|NCT00686036|7718194|FG001|Overall Study|Study terminated by AstraZeneca|1
4746553|NCT00686036|7718193|FG000|Overall Study|PSA ≥ 10ng/mL|1
4597348|NCT01587703|7447940|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1
4597349|NCT01587703|7447941|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1
4597350|NCT01587703|7447942|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0
4597351|NCT01587703|7447943|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0
4597352|NCT01587703|7447944|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0
4597353|NCT01587703|7447945|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0
4597354|NCT01587703|7447946|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0
4597355|NCT01587703|7447947|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0
4597356|NCT01587703|7447948|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0
4597357|NCT01587703|7447949|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0
4597358|NCT01587703|7447931|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
4597359|NCT01587703|7447932|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
4597360|NCT01587703|7447933|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
4597361|NCT01587703|7447934|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
4597362|NCT01587703|7447935|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
4597363|NCT01587703|7447936|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
4597364|NCT01587703|7447937|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
4597365|NCT01587703|7447938|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
4597366|NCT01587703|7447939|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1
4597367|NCT01587703|7447940|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
4597368|NCT01587703|7447941|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
4597369|NCT01587703|7447942|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
4597370|NCT01587703|7447943|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
4597371|NCT01587703|7447944|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
4597372|NCT01587703|7447945|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
4597373|NCT01587703|7447946|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
4597374|NCT01587703|7447947|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
4597375|NCT01587703|7447948|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
4597376|NCT01587703|7447949|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
4597377|NCT01587703|7447931|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
4597378|NCT01587703|7447932|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
4597379|NCT01587703|7447933|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
4597380|NCT01587703|7447934|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
4597381|NCT01587703|7447935|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
4597382|NCT01587703|7447936|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
4597383|NCT01587703|7447937|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
4635256|NCT01931670|7506733|FG000|Treatment Period|Adverse Event|19
4635257|NCT01931670|7506734|FG001|Treatment Period|Adverse Event|8
4635258|NCT01931670|7506735|FG002|Treatment Period|Adverse Event|21
4635259|NCT01931670|7506733|FG000|Treatment Period|Lack of Efficacy|11
4597384|NCT01587703|7447938|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
4597385|NCT01587703|7447939|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
4597386|NCT01587703|7447940|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
4597387|NCT01587703|7447941|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
4597388|NCT01587703|7447942|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
4597389|NCT01587703|7447943|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
4597390|NCT01587703|7447944|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
4597391|NCT01587703|7447945|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
4597392|NCT01587703|7447946|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
4597393|NCT01587703|7447947|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
4597394|NCT01587703|7447948|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
4597395|NCT01587703|7447949|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1
4597396|NCT01587703|7447931|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0
4597397|NCT01587703|7447932|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0
4597398|NCT01587703|7447933|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0
4597399|NCT01587703|7447934|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0
4597400|NCT01587703|7447935|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0
4597401|NCT01587703|7447936|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0
4597402|NCT01587703|7447937|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0
4597403|NCT01587703|7447938|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0
4597404|NCT01587703|7447939|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0
4597405|NCT01587703|7447940|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0
4597406|NCT01587703|7447941|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0
4597407|NCT01587703|7447942|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0
4597408|NCT01587703|7447943|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0
4597409|NCT01587703|7447944|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0
4597410|NCT01587703|7447945|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0
4597411|NCT01587703|7447946|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0
4597412|NCT01587703|7447947|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0
4635260|NCT01931670|7506734|FG001|Treatment Period|Lack of Efficacy|2
4635261|NCT01931670|7506735|FG002|Treatment Period|Lack of Efficacy|2
4597413|NCT01587703|7447948|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5
4597414|NCT01587703|7447949|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4
4597415|NCT01587703|7447931|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
4597416|NCT01587703|7447932|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
4597417|NCT01587703|7447933|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
4597418|NCT01587703|7447934|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
4597419|NCT01587703|7447935|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
4597420|NCT01587703|7447936|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
4597421|NCT01587703|7447937|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
4597422|NCT01587703|7447938|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
4597423|NCT01587703|7447939|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
4597424|NCT01587703|7447940|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
4635262|NCT01931670|7506733|FG000|Treatment Period|Pregnancy|7
4635263|NCT01931670|7506734|FG001|Treatment Period|Pregnancy|2
4635264|NCT01931670|7506735|FG002|Treatment Period|Pregnancy|0
4635265|NCT01931670|7506733|FG000|Treatment Period|Other|8
4635266|NCT01931670|7506734|FG001|Treatment Period|Other|7
4635267|NCT01931670|7506735|FG002|Treatment Period|Other|2
4635268|NCT01931670|7506733|FG000|Treatment Period|Consent Withdrawn by Subject|17
4635269|NCT01931670|7506734|FG001|Treatment Period|Consent Withdrawn by Subject|12
4635270|NCT01931670|7506735|FG002|Treatment Period|Consent Withdrawn by Subject|7
4635271|NCT01931670|7506733|FG000|Treatment Period|Lost to Follow-up|19
4597425|NCT01587703|7447941|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
4597426|NCT01587703|7447942|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
4597427|NCT01587703|7447943|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
4597428|NCT01587703|7447944|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
4597429|NCT01587703|7447945|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
4597430|NCT01587703|7447946|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1
4597431|NCT01587703|7447947|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
4597432|NCT01587703|7447948|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
4597433|NCT01587703|7447949|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
4597434|NCT01587703|7447931|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
4597435|NCT01587703|7447932|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
4597436|NCT01587703|7447933|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
4597437|NCT01587703|7447934|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
4597438|NCT01587703|7447935|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
4597439|NCT01587703|7447936|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
4597440|NCT01587703|7447937|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
4597441|NCT01587703|7447938|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
4597442|NCT01587703|7447939|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
4597443|NCT01587703|7447940|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
4597444|NCT01587703|7447941|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
4597445|NCT01587703|7447942|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1
4597446|NCT01587703|7447943|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
4597447|NCT01587703|7447944|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
4597448|NCT01587703|7447945|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2
4597449|NCT01587703|7447946|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
4597450|NCT01587703|7447947|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
4597451|NCT01587703|7447948|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
4597452|NCT01587703|7447949|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
4597453|NCT01587703|7447931|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0
4597454|NCT01587703|7447932|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0
4597455|NCT01587703|7447933|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0
4597456|NCT01587703|7447934|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0
4597457|NCT01587703|7447935|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0
4597458|NCT01587703|7447936|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0
4597459|NCT01587703|7447937|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0
4597460|NCT01587703|7447938|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0
4597461|NCT01587703|7447939|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0
4597462|NCT01587703|7447940|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0
4597463|NCT01587703|7447941|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0
4597464|NCT01587703|7447942|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2
4597465|NCT01587703|7447943|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2
4597466|NCT01587703|7447944|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1
4597467|NCT01587703|7447945|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1
4597468|NCT01587703|7447946|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3
4597469|NCT01587703|7447947|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8
4597470|NCT01587703|7447948|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0
4597471|NCT01587703|7447949|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0
4635272|NCT01931670|7506734|FG001|Treatment Period|Lost to Follow-up|5
4597472|NCT01587703|7447931|FG000|Part2(Median Exposure of 1.41 Months)|Death|0
4597473|NCT01587703|7447932|FG001|Part2(Median Exposure of 1.41 Months)|Death|0
4597474|NCT01587703|7447933|FG002|Part2(Median Exposure of 1.41 Months)|Death|0
4597475|NCT01587703|7447934|FG003|Part2(Median Exposure of 1.41 Months)|Death|0
4597476|NCT01587703|7447935|FG004|Part2(Median Exposure of 1.41 Months)|Death|0
4597477|NCT01587703|7447936|FG005|Part2(Median Exposure of 1.41 Months)|Death|0
4597478|NCT01587703|7447937|FG006|Part2(Median Exposure of 1.41 Months)|Death|0
4597479|NCT01587703|7447938|FG007|Part2(Median Exposure of 1.41 Months)|Death|0
4597480|NCT01587703|7447939|FG008|Part2(Median Exposure of 1.41 Months)|Death|0
4597481|NCT01587703|7447940|FG009|Part2(Median Exposure of 1.41 Months)|Death|0
4597482|NCT01587703|7447941|FG010|Part2(Median Exposure of 1.41 Months)|Death|0
4597483|NCT01587703|7447942|FG011|Part2(Median Exposure of 1.41 Months)|Death|8
4597484|NCT01587703|7447943|FG012|Part2(Median Exposure of 1.41 Months)|Death|12
4597485|NCT01587703|7447944|FG013|Part2(Median Exposure of 1.41 Months)|Death|21
4597486|NCT01587703|7447945|FG014|Part2(Median Exposure of 1.41 Months)|Death|16
4597487|NCT01587703|7447946|FG015|Part2(Median Exposure of 1.41 Months)|Death|17
4597488|NCT01587703|7447947|FG016|Part2(Median Exposure of 1.41 Months)|Death|5
4597489|NCT01587703|7447948|FG017|Part2(Median Exposure of 1.41 Months)|Death|0
4597490|NCT01587703|7447949|FG018|Part2(Median Exposure of 1.41 Months)|Death|0
4597491|NCT01587703|7447931|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
4597492|NCT01587703|7447932|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
4597493|NCT01587703|7447933|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
4597494|NCT01587703|7447934|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
4597495|NCT01587703|7447935|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
4597496|NCT01587703|7447936|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
4597497|NCT01587703|7447937|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
4597498|NCT01587703|7447938|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
4597499|NCT01587703|7447939|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
4597500|NCT01587703|7447940|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
4597501|NCT01587703|7447941|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
4597502|NCT01587703|7447942|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1
4597503|NCT01587703|7447943|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
4597504|NCT01587703|7447944|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
4597505|NCT01587703|7447945|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
4597506|NCT01587703|7447946|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
4597507|NCT01587703|7447947|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
4597508|NCT01587703|7447948|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
4597509|NCT01587703|7447949|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
4597510|NCT01587885|7448008|FG000|Treatment Period 1|Failure to Return|0
4597511|NCT01587885|7448009|FG001|Treatment Period 1|Failure to Return|1
4597512|NCT01587885|7448008|FG000|Treatment Period 1|Protocol Violation|0
4597513|NCT01587885|7448009|FG001|Treatment Period 1|Protocol Violation|2
4597514|NCT01587898|7448020|FG000|Overall Study|Adverse Event|1
4597515|NCT01587898|7448021|FG001|Overall Study|Adverse Event|1
4597516|NCT01587898|7448022|FG002|Overall Study|Adverse Event|0
4597517|NCT01587898|7448023|FG003|Overall Study|Adverse Event|0
4597518|NCT01587898|7448020|FG000|Overall Study|Protocol Violation|0
4597519|NCT01587898|7448021|FG001|Overall Study|Protocol Violation|2
4597520|NCT01587898|7448022|FG002|Overall Study|Protocol Violation|1
4597521|NCT01587898|7448023|FG003|Overall Study|Protocol Violation|1
4597522|NCT01587898|7448020|FG000|Overall Study|Lost to Follow-up|0
4597523|NCT01587898|7448021|FG001|Overall Study|Lost to Follow-up|0
4597524|NCT01587898|7448022|FG002|Overall Study|Lost to Follow-up|0
4597525|NCT01587898|7448023|FG003|Overall Study|Lost to Follow-up|1
4597526|NCT01587898|7448020|FG000|Overall Study|Withdrawal by Subject|2
4597527|NCT01587898|7448021|FG001|Overall Study|Withdrawal by Subject|1
4597528|NCT01587898|7448022|FG002|Overall Study|Withdrawal by Subject|0
4597529|NCT01587898|7448023|FG003|Overall Study|Withdrawal by Subject|0
4597530|NCT01587898|7448020|FG000|Overall Study|Met haemoglobin stopping criteria|1
4597531|NCT01587898|7448021|FG001|Overall Study|Met haemoglobin stopping criteria|1
4597532|NCT01587898|7448022|FG002|Overall Study|Met haemoglobin stopping criteria|1
4597533|NCT01587898|7448023|FG003|Overall Study|Met haemoglobin stopping criteria|0
4597534|NCT01587924|7448040|FG000|Overall Study|Adverse Event|0
4597535|NCT01587924|7448041|FG001|Overall Study|Adverse Event|2
4597536|NCT01587924|7448042|FG002|Overall Study|Adverse Event|0
4597537|NCT01587924|7448043|FG003|Overall Study|Adverse Event|0
4597538|NCT01587924|7448040|FG000|Overall Study|Protocol Violation|2
4597539|NCT01587924|7448041|FG001|Overall Study|Protocol Violation|1
4597540|NCT01587924|7448042|FG002|Overall Study|Protocol Violation|2
4597541|NCT01587924|7448043|FG003|Overall Study|Protocol Violation|1
4597542|NCT01587924|7448040|FG000|Overall Study|Met Hemoglobin stopping criteria|2
4597543|NCT01587924|7448041|FG001|Overall Study|Met Hemoglobin stopping criteria|0
4597544|NCT01587924|7448042|FG002|Overall Study|Met Hemoglobin stopping criteria|1
4597545|NCT01587924|7448043|FG003|Overall Study|Met Hemoglobin stopping criteria|0
4597546|NCT01587924|7448040|FG000|Overall Study|Withdrawal by Subject|0
4597547|NCT01587924|7448041|FG001|Overall Study|Withdrawal by Subject|1
4597548|NCT01587924|7448042|FG002|Overall Study|Withdrawal by Subject|1
4597549|NCT01587924|7448043|FG003|Overall Study|Withdrawal by Subject|0
4597550|NCT01587989|7448068|FG000|12-Week Open-Label Run-In Period|Physician Decision|7
4597551|NCT01587989|7448069|FG001|12-Week Open-Label Run-In Period|Physician Decision|0
4597552|NCT01587989|7448070|FG002|12-Week Open-Label Run-In Period|Physician Decision|0
4597553|NCT01587989|7448068|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1
4597554|NCT01587989|7448069|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0
4597555|NCT01587989|7448070|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0
4597556|NCT01587989|7448068|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4
4597557|NCT01587989|7448069|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0
4597558|NCT01587989|7448070|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0
4597559|NCT01587989|7448068|FG000|Randomized Study Treatment|Withdrawal by Subject|0
4597560|NCT01587989|7448069|FG001|Randomized Study Treatment|Withdrawal by Subject|1
4597561|NCT01587989|7448070|FG002|Randomized Study Treatment|Withdrawal by Subject|0
4597562|NCT01587989|7448068|FG000|Randomized Study Treatment|Screening failure|0
4597563|NCT01587989|7448069|FG001|Randomized Study Treatment|Screening failure|1
4597564|NCT01587989|7448070|FG002|Randomized Study Treatment|Screening failure|0
4597565|NCT01587989|7448068|FG000|Randomized Study Treatment|Physician Decision|0
4597566|NCT01587989|7448069|FG001|Randomized Study Treatment|Physician Decision|0
4597567|NCT01587989|7448070|FG002|Randomized Study Treatment|Physician Decision|1
4597568|NCT01588106|7448078|FG000|Overall Study|Withdrawal by Subject|5
4597569|NCT01588106|7448079|FG001|Overall Study|Withdrawal by Subject|4
4597570|NCT01588184|7448100|FG000|Overall Study|Death|1
4597571|NCT01588184|7448101|FG001|Overall Study|Death|0
4597572|NCT01588184|7448102|FG002|Overall Study|Death|0
4597573|NCT01588184|7448103|FG003|Overall Study|Death|1
4597574|NCT01588184|7448104|FG004|Overall Study|Death|1
4597575|NCT01588184|7448105|FG005|Overall Study|Death|1
4597576|NCT01588184|7448100|FG000|Overall Study|Withdrawal by Subject|2
4597577|NCT01588184|7448101|FG001|Overall Study|Withdrawal by Subject|4
4597578|NCT01588184|7448102|FG002|Overall Study|Withdrawal by Subject|0
4597579|NCT01588184|7448103|FG003|Overall Study|Withdrawal by Subject|1
4597580|NCT01588184|7448104|FG004|Overall Study|Withdrawal by Subject|0
4597581|NCT01588184|7448105|FG005|Overall Study|Withdrawal by Subject|0
4597582|NCT01588184|7448100|FG000|Overall Study|Bevacizumab treatment provision changed|0
4597583|NCT01588184|7448101|FG001|Overall Study|Bevacizumab treatment provision changed|6
4597584|NCT01588184|7448102|FG002|Overall Study|Bevacizumab treatment provision changed|2
4597585|NCT01588184|7448103|FG003|Overall Study|Bevacizumab treatment provision changed|0
4597586|NCT01588184|7448104|FG004|Overall Study|Bevacizumab treatment provision changed|1
4597587|NCT01588184|7448105|FG005|Overall Study|Bevacizumab treatment provision changed|3
4597588|NCT01588184|7448100|FG000|Overall Study|multiple reasons|0
4597589|NCT01588184|7448101|FG001|Overall Study|multiple reasons|3
4597590|NCT01588184|7448102|FG002|Overall Study|multiple reasons|0
4597591|NCT01588184|7448103|FG003|Overall Study|multiple reasons|1
4597592|NCT01588184|7448104|FG004|Overall Study|multiple reasons|0
4597593|NCT01588184|7448105|FG005|Overall Study|multiple reasons|0
4597594|NCT01588197|7448121|FG000|Overall Study|Lack of Efficacy|0
4597595|NCT01588197|7448122|FG001|Overall Study|Lack of Efficacy|1
4597596|NCT01588197|7448121|FG000|Overall Study|No MRI|1
4597597|NCT01588197|7448122|FG001|Overall Study|No MRI|0
4597598|NCT01588353|7448144|FG000|Step2|Withdrawal by Subject|0
4597599|NCT01588353|7448145|FG001|Step2|Withdrawal by Subject|1
4597600|NCT01588353|7448146|FG002|Step2|Withdrawal by Subject|0
4597601|NCT01588353|7448144|FG000|Step3|Adverse Event|0
4597602|NCT01588353|7448145|FG001|Step3|Adverse Event|0
4597603|NCT01588353|7448146|FG002|Step3|Adverse Event|2
4597604|NCT01588366|7448158|FG000|Overall Study|Adverse Event|0
4597605|NCT01588366|7448159|FG001|Overall Study|Adverse Event|1
4597606|NCT01588366|7448160|FG002|Overall Study|Adverse Event|0
4597607|NCT01588366|7448161|FG003|Overall Study|Adverse Event|1
4597608|NCT01588366|7448162|FG004|Overall Study|Adverse Event|0
4597609|NCT01588366|7448163|FG005|Overall Study|Adverse Event|2
4597610|NCT01588405|7448179|FG000|Overall Study|Adverse Event|1
4597611|NCT01588405|7448179|FG000|Overall Study|Clinical Worsening|1
4597612|NCT01588496|7448239|FG000|Overall Study|Withdrawal by Subject|0
4597613|NCT01588496|7448240|FG001|Overall Study|Withdrawal by Subject|1
4597614|NCT01588496|7448241|FG002|Overall Study|Withdrawal by Subject|0
4597615|NCT01588509|7448251|FG000|Overall Study|Lost to Follow-up|1
4597616|NCT01588509|7448252|FG001|Overall Study|Lost to Follow-up|0
4597617|NCT01588548|7448264|FG000|Overall Study|Withdrawal by Subject|0
4597618|NCT01588548|7448265|FG001|Overall Study|Withdrawal by Subject|1
4597619|NCT01588548|7448266|FG002|Overall Study|Withdrawal by Subject|1
4597620|NCT01588548|7448267|FG003|Overall Study|Withdrawal by Subject|1
4597621|NCT01588548|7448268|FG004|Overall Study|Withdrawal by Subject|2
4597622|NCT01588548|7448269|FG005|Overall Study|Withdrawal by Subject|3
4597623|NCT01588548|7448264|FG000|Overall Study|Adverse Event|0
4597624|NCT01588548|7448265|FG001|Overall Study|Adverse Event|0
4597625|NCT01588548|7448266|FG002|Overall Study|Adverse Event|1
4597626|NCT01588548|7448267|FG003|Overall Study|Adverse Event|2
4597627|NCT01588548|7448268|FG004|Overall Study|Adverse Event|1
4597628|NCT01588548|7448269|FG005|Overall Study|Adverse Event|0
4597629|NCT01588548|7448264|FG000|Overall Study|Condition Under Investigation Worsened|3
4635273|NCT01931670|7506735|FG002|Treatment Period|Lost to Follow-up|7
4597630|NCT01588548|7448265|FG001|Overall Study|Condition Under Investigation Worsened|6
4597631|NCT01588548|7448266|FG002|Overall Study|Condition Under Investigation Worsened|4
4597632|NCT01588548|7448267|FG003|Overall Study|Condition Under Investigation Worsened|4
4597633|NCT01588548|7448268|FG004|Overall Study|Condition Under Investigation Worsened|3
4597634|NCT01588548|7448269|FG005|Overall Study|Condition Under Investigation Worsened|3
4597635|NCT01588951|7448298|FG000|Overall Study|Ineligible in retrospect|0
4597636|NCT01588951|7448299|FG001|Overall Study|Ineligible in retrospect|0
4597637|NCT01588951|7448300|FG002|Overall Study|Ineligible in retrospect|1
4597638|NCT01588990|7448308|FG000|Phase A|Withdrawal by Subject|5
4597639|NCT01588990|7448308|FG000|Phase A|Physician Decision|11
4597640|NCT01588990|7448308|FG000|Phase A|Other|14
4597641|NCT01588990|7448308|FG000|Phase A|Lost to Follow-up|1
4597642|NCT01588990|7448308|FG000|Phase A|Death|5
4597643|NCT01588990|7448308|FG000|Phase A|Adverse Event|28
4597644|NCT01588990|7448308|FG000|Phase A|Still on therapy at end of study|6
4597645|NCT01588990|7448308|FG000|Phase B|Adverse Event|2
4597646|NCT01588990|7448308|FG000|Phase B|Still on therapy at end of study|5
4597647|NCT01588990|7448308|FG000|Phase B|Withdrawal by Subject|3
4597648|NCT01588990|7448308|FG000|Phase B|Physician Decision|4
4597649|NCT01588990|7448308|FG000|Phase B|Other|2
4597650|NCT01589094|7448316|FG000|Overall Study|Did not receive treatment|2
4597651|NCT01589185|7448325|FG000|Overall Study|Death|1
4597652|NCT01589185|7448326|FG001|Overall Study|Death|2
4597653|NCT01589185|7448327|FG002|Overall Study|Death|2
4597654|NCT01589185|7448328|FG003|Overall Study|Death|0
4597655|NCT01589185|7448329|FG004|Overall Study|Death|1
4597656|NCT01589185|7448325|FG000|Overall Study|Lost to Follow-up|1
4597657|NCT01589185|7448326|FG001|Overall Study|Lost to Follow-up|0
4597658|NCT01589185|7448327|FG002|Overall Study|Lost to Follow-up|2
4597659|NCT01589185|7448328|FG003|Overall Study|Lost to Follow-up|3
4597660|NCT01589185|7448329|FG004|Overall Study|Lost to Follow-up|0
4597661|NCT01589237|7448346|FG000|Part A (52 Weeks)|Subject/guardian decision|2
4597662|NCT01589237|7448347|FG001|Part A (52 Weeks)|Subject/guardian decision|3
4597663|NCT01589237|7448348|FG002|Part A (52 Weeks)|Subject/guardian decision|2
4597664|NCT01589237|7448349|FG003|Part A (52 Weeks)|Subject/guardian decision|0
4597665|NCT01589237|7448346|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
4597666|NCT01589237|7448347|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1
4597667|NCT01589237|7448348|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
4597668|NCT01589237|7448349|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
4597669|NCT01589237|7448346|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5
4597670|NCT01589237|7448347|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5
4597671|NCT01589237|7448348|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4
4597672|NCT01589237|7448349|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3
4597673|NCT01589237|7448346|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0
4597674|NCT01589237|7448347|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0
4597675|NCT01589237|7448348|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0
4597676|NCT01589237|7448349|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1
4597677|NCT01589445|7448381|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1
4597678|NCT01589445|7448381|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1
4597679|NCT01589445|7448381|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2
4597680|NCT01589445|7448381|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1
4597681|NCT01589445|7448381|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2
4597682|NCT01589445|7448381|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1
4597683|NCT01589445|7448381|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2
4597684|NCT01589445|7448381|FG000|002 (Metformin)-3 Months|Protocol Violation|2
4597685|NCT01589445|7448381|FG000|002 (Metformin)-3 Months|Adverse Event|2
4597686|NCT01589445|7448381|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2
4597687|NCT01589497|7448398|FG000|Overall Study|Withdrawal by Subject|0
4597688|NCT01589497|7448399|FG001|Overall Study|Withdrawal by Subject|1
4597689|NCT01589497|7448400|FG002|Overall Study|Withdrawal by Subject|0
4597690|NCT01589497|7448401|FG003|Overall Study|Withdrawal by Subject|1
4597691|NCT01589497|7448398|FG000|Overall Study|Death|1
4597692|NCT01589497|7448399|FG001|Overall Study|Death|0
4597693|NCT01589497|7448400|FG002|Overall Study|Death|0
4597694|NCT01589497|7448401|FG003|Overall Study|Death|0
4597695|NCT01589497|7448398|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0
4597696|NCT01589497|7448399|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0
4597697|NCT01589497|7448400|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1
4597698|NCT01589497|7448401|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0
4597699|NCT01589653|7448431|FG000|Overall Study|Protocol Violation|3
4597700|NCT01589653|7448432|FG001|Overall Study|Protocol Violation|1
4597701|NCT01589653|7448431|FG000|Overall Study|Withdrawal criteria|4
4597702|NCT01589653|7448432|FG001|Overall Study|Withdrawal criteria|7
4597703|NCT01589653|7448431|FG000|Overall Study|Unclassified|0
4597704|NCT01589653|7448432|FG001|Overall Study|Unclassified|3
4597705|NCT01589770|7448440|FG000|Overall Study|EGFR <60ml/min|6
4597706|NCT01589770|7448441|FG001|Overall Study|EGFR <60ml/min|4
4597707|NCT01589770|7448440|FG000|Overall Study|claustrophobic when entering cardiac MRI|2
4597708|NCT01589770|7448441|FG001|Overall Study|claustrophobic when entering cardiac MRI|1
4597709|NCT01589822|7448450|FG000|Overall Study|Withdrawal by Subject|1
4597710|NCT01589822|7448451|FG001|Overall Study|Withdrawal by Subject|2
4597711|NCT01589822|7448452|FG002|Overall Study|Withdrawal by Subject|0
4597712|NCT01589822|7448450|FG000|Overall Study|Death|1
4597713|NCT01589822|7448451|FG001|Overall Study|Death|0
4597714|NCT01589822|7448452|FG002|Overall Study|Death|0
4597715|NCT01589822|7448450|FG000|Overall Study|Missed 90 day visit|2
4597716|NCT01589822|7448451|FG001|Overall Study|Missed 90 day visit|1
4597717|NCT01589822|7448452|FG002|Overall Study|Missed 90 day visit|1
4597718|NCT01590017|7448467|FG000|Overall Study|Adverse Event|1
4597719|NCT01590017|7448467|FG000|Overall Study|Withdrawal by Subject|1
4597720|NCT01590017|7448467|FG000|Overall Study|Lack of Efficacy|1
4597721|NCT01590017|7448467|FG000|Overall Study|Physician Decision|1
4597722|NCT01590082|7448473|FG000|Overall Study|Withdrawal by Subject|1
4597723|NCT01590082|7448474|FG001|Overall Study|Withdrawal by Subject|0
4597724|NCT01590082|7448473|FG000|Overall Study|Ineligible|1
4597725|NCT01590082|7448474|FG001|Overall Study|Ineligible|0
4597726|NCT01590212|7448483|FG000|Overall Study|Withdrawal by Subject|2
4597727|NCT01590212|7448484|FG001|Overall Study|Withdrawal by Subject|2
4597728|NCT01590212|7448485|FG002|Overall Study|Withdrawal by Subject|2
4597729|NCT01590212|7448483|FG000|Overall Study|Lost to Follow-up|1
4597730|NCT01590212|7448484|FG001|Overall Study|Lost to Follow-up|2
4597731|NCT01590212|7448485|FG002|Overall Study|Lost to Follow-up|3
4597732|NCT01590433|7448504|FG000|Overall Study|Lost to Follow-up|20
4597733|NCT01590433|7448505|FG001|Overall Study|Lost to Follow-up|8
4597734|NCT01590433|7448504|FG000|Overall Study|Withdrawal by Subject|21
4597735|NCT01590433|7448505|FG001|Overall Study|Withdrawal by Subject|11
4597736|NCT01590433|7448504|FG000|Overall Study|Adverse Event|11
4597737|NCT01590433|7448505|FG001|Overall Study|Adverse Event|3
4597738|NCT01590563|7448516|FG000|Overall Study|simple uterine hyperplasia - not related|1
4597739|NCT01590758|7448523|FG000|Overall Study|Withdrawal by Subject|0
4597740|NCT01590758|7448524|FG001|Overall Study|Withdrawal by Subject|3
4597741|NCT01590758|7448523|FG000|Overall Study|Physician Decision|1
4597742|NCT01590758|7448524|FG001|Overall Study|Physician Decision|2
4597743|NCT01590758|7448523|FG000|Overall Study|Lost to Follow-up|4
4597744|NCT01590758|7448524|FG001|Overall Study|Lost to Follow-up|2
4597745|NCT01590771|7448532|FG000|Overall Study|Other Protocol Specified Criteria|5
4597746|NCT01590771|7448533|FG001|Overall Study|Other Protocol Specified Criteria|14
4597747|NCT01590771|7448532|FG000|Overall Study|Withdrawal by Subject|8
4597748|NCT01590771|7448533|FG001|Overall Study|Withdrawal by Subject|15
4597749|NCT01590771|7448532|FG000|Overall Study|Protocol Violation|1
4597750|NCT01590771|7448533|FG001|Overall Study|Protocol Violation|2
4597751|NCT01590771|7448532|FG000|Overall Study|Lost to Follow-up|1
4597752|NCT01590771|7448533|FG001|Overall Study|Lost to Follow-up|1
4597753|NCT01590771|7448532|FG000|Overall Study|Lack of Efficacy|1
4597754|NCT01590771|7448533|FG001|Overall Study|Lack of Efficacy|0
4597755|NCT01590771|7448532|FG000|Overall Study|Adverse Event|3
4597756|NCT01590771|7448533|FG001|Overall Study|Adverse Event|7
4597757|NCT01590797|7448541|FG000|Overall Study|Adverse Event|4
4597758|NCT01590797|7448542|FG001|Overall Study|Adverse Event|3
4597759|NCT01590797|7448541|FG000|Overall Study|Lack of Efficacy|0
4597760|NCT01590797|7448542|FG001|Overall Study|Lack of Efficacy|2
4597761|NCT01590797|7448541|FG000|Overall Study|Lost to Follow-up|0
4597762|NCT01590797|7448542|FG001|Overall Study|Lost to Follow-up|1
4597763|NCT01590797|7448541|FG000|Overall Study|Protocol Violation|4
4597764|NCT01590797|7448542|FG001|Overall Study|Protocol Violation|1
4597765|NCT01590797|7448541|FG000|Overall Study|Withdrawal by Subject|7
4597766|NCT01590797|7448542|FG001|Overall Study|Withdrawal by Subject|5
4597767|NCT01590797|7448541|FG000|Overall Study|Other Protocol Specified Criteria|2
4597768|NCT01590797|7448542|FG001|Overall Study|Other Protocol Specified Criteria|4
4597769|NCT01590810|7448553|FG000|Overall Study|Physician Decision|0
4597770|NCT01590810|7448554|FG001|Overall Study|Physician Decision|1
4597771|NCT01590810|7448555|FG002|Overall Study|Physician Decision|1
4597772|NCT01590810|7448556|FG003|Overall Study|Physician Decision|0
4597773|NCT01590810|7448557|FG004|Overall Study|Physician Decision|0
4597774|NCT01590888|7448604|FG000|Overall Study|Adverse Event|3
4597775|NCT01590888|7448605|FG001|Overall Study|Adverse Event|0
4597776|NCT01590888|7448606|FG002|Overall Study|Adverse Event|1
4597777|NCT01590888|7448604|FG000|Overall Study|Lost to Follow-up|1
4597778|NCT01590888|7448605|FG001|Overall Study|Lost to Follow-up|0
4597779|NCT01590888|7448606|FG002|Overall Study|Lost to Follow-up|0
4597780|NCT01591330|7448689|FG000|Period 1|Adverse Event|1
4597781|NCT01591330|7448690|FG001|Period 1|Adverse Event|0
4597782|NCT01591330|7448691|FG002|Period 1|Adverse Event|0
4597783|NCT01591330|7448692|FG003|Period 1|Adverse Event|0
4597784|NCT01591330|7448689|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1
4597785|NCT01591330|7448690|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0
4597786|NCT01591330|7448691|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0
4597787|NCT01591330|7448692|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0
4746554|NCT00686036|7718194|FG001|Overall Study|PSA ≥ 10ng/mL|0
4597788|NCT01591330|7448689|FG000|Period 2|Adverse Event|1
4597789|NCT01591330|7448690|FG001|Period 2|Adverse Event|0
4597790|NCT01591330|7448691|FG002|Period 2|Adverse Event|0
4597791|NCT01591330|7448692|FG003|Period 2|Adverse Event|0
4597792|NCT01591382|7448704|FG000|Overall Study|Discharged Prior to Study Completion|2
4597793|NCT01591382|7448705|FG001|Overall Study|Discharged Prior to Study Completion|1
4597794|NCT01591382|7448704|FG000|Overall Study|Participant Opted for Morphine PCA|1
4597795|NCT01591382|7448705|FG001|Overall Study|Participant Opted for Morphine PCA|1
4597796|NCT01591460|7448720|FG000|Overall Study|Adverse Event or Intercurrent Illness|5
4597797|NCT01591460|7448720|FG000|Overall Study|Futility Rule (Week 12)|7
4597798|NCT01591460|7448720|FG000|Overall Study|Futility Rule (Week 24)|3
4597799|NCT01591460|7448720|FG000|Overall Study|Rebound or Breakthrough|3
4597800|NCT01591460|7448720|FG000|Overall Study|Treatment Discontinued by Error|1
4597801|NCT01591460|7448720|FG000|Overall Study|Lost to Follow-up|1
4597802|NCT01591460|7448720|FG000|Overall Study|Noncompliance|1
4597803|NCT01591460|7448720|FG000|Overall Study|Participant Refusal|3
4597804|NCT01591460|7448720|FG000|Overall Study|Withdrawal by Subject|1
4597805|NCT01591460|7448720|FG000|Overall Study|Protocol Violation|1
4597806|NCT01591499|7448732|FG000|Baseline Visit|Withdrawal by Subject|0
4597807|NCT01591499|7448733|FG001|Baseline Visit|Withdrawal by Subject|2
4597808|NCT01591499|7448734|FG002|Baseline Visit|Withdrawal by Subject|0
4597809|NCT01591499|7448735|FG003|Baseline Visit|Withdrawal by Subject|2
4597810|NCT01591499|7448732|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2
4597811|NCT01591499|7448733|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0
4597812|NCT01591499|7448734|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2
4597813|NCT01591499|7448735|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0
4597814|NCT01591499|7448732|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4
4597815|NCT01591499|7448733|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3
4597816|NCT01591499|7448734|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1
4597817|NCT01591499|7448735|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3
4597818|NCT01591616|7448759|FG000|Overall Study|Withdrawal by Subject|1
4597819|NCT01591681|7448907|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3
4597820|NCT01591681|7448907|FG000|Overall Study|Failed to use system during run-in|1
4597821|NCT01591785|7448930|FG000|Overall Study|worsening condition|1
4597822|NCT01591785|7448931|FG001|Overall Study|worsening condition|2
4597823|NCT01591785|7448930|FG000|Overall Study|Protocol Violation|2
4597824|NCT01591785|7448931|FG001|Overall Study|Protocol Violation|0
4597825|NCT01591785|7448930|FG000|Overall Study|Lost to Follow-up|1
4597826|NCT01591785|7448931|FG001|Overall Study|Lost to Follow-up|0
4597827|NCT01591863|7448946|FG000|Overall Study|Adverse Event|3
4597828|NCT01591863|7448946|FG000|Overall Study|Withdrawal by Subject|1
4597829|NCT01591863|7448946|FG000|Overall Study|recurrence|9
4597830|NCT01591863|7448946|FG000|Overall Study|Lack of Efficacy|1
4597831|NCT01592045|7448956|FG000|Overall Study|Disease Progression|1
4597832|NCT01592045|7448957|FG001|Overall Study|Disease Progression|1
4597833|NCT01592045|7448956|FG000|Overall Study|Adverse Event|1
4597834|NCT01592045|7448957|FG001|Overall Study|Adverse Event|1
4597835|NCT01592045|7448956|FG000|Overall Study|Withdrawal by Subject|1
4597836|NCT01592045|7448957|FG001|Overall Study|Withdrawal by Subject|0
4597837|NCT01592045|7448956|FG000|Overall Study|Moved out of country|2
4597838|NCT01592045|7448957|FG001|Overall Study|Moved out of country|0
4597839|NCT01592240|7448974|FG000|Overall Study|Adverse Event|1
4597840|NCT01592240|7448975|FG001|Overall Study|Adverse Event|0
4597841|NCT01592240|7448976|FG002|Overall Study|Adverse Event|0
4597842|NCT01592240|7448977|FG003|Overall Study|Adverse Event|1
4597843|NCT01592240|7448978|FG004|Overall Study|Adverse Event|1
4597844|NCT01592240|7448979|FG005|Overall Study|Adverse Event|0
4597845|NCT01592240|7448980|FG006|Overall Study|Adverse Event|0
4597846|NCT01592240|7448974|FG000|Overall Study|Death|0
4597847|NCT01592240|7448975|FG001|Overall Study|Death|1
4597848|NCT01592240|7448976|FG002|Overall Study|Death|0
4597849|NCT01592240|7448977|FG003|Overall Study|Death|0
4597850|NCT01592240|7448978|FG004|Overall Study|Death|0
4597851|NCT01592240|7448979|FG005|Overall Study|Death|0
4597852|NCT01592240|7448980|FG006|Overall Study|Death|0
4597853|NCT01592240|7448974|FG000|Overall Study|Lost to Follow-up|1
4597854|NCT01592240|7448975|FG001|Overall Study|Lost to Follow-up|3
4597855|NCT01592240|7448976|FG002|Overall Study|Lost to Follow-up|1
4597856|NCT01592240|7448977|FG003|Overall Study|Lost to Follow-up|0
4597857|NCT01592240|7448978|FG004|Overall Study|Lost to Follow-up|3
4597858|NCT01592240|7448979|FG005|Overall Study|Lost to Follow-up|2
4597859|NCT01592240|7448980|FG006|Overall Study|Lost to Follow-up|0
4597860|NCT01592240|7448974|FG000|Overall Study|Protocol Violation|0
4597861|NCT01592240|7448975|FG001|Overall Study|Protocol Violation|0
4597862|NCT01592240|7448976|FG002|Overall Study|Protocol Violation|0
4597863|NCT01592240|7448977|FG003|Overall Study|Protocol Violation|0
4597864|NCT01592240|7448978|FG004|Overall Study|Protocol Violation|0
4597865|NCT01592240|7448979|FG005|Overall Study|Protocol Violation|1
4597866|NCT01592240|7448980|FG006|Overall Study|Protocol Violation|0
4597867|NCT01592240|7448974|FG000|Overall Study|Withdrawal by Subject|0
4597868|NCT01592240|7448975|FG001|Overall Study|Withdrawal by Subject|4
4597869|NCT01592240|7448976|FG002|Overall Study|Withdrawal by Subject|4
4597870|NCT01592240|7448977|FG003|Overall Study|Withdrawal by Subject|1
4597871|NCT01592240|7448978|FG004|Overall Study|Withdrawal by Subject|3
4597872|NCT01592240|7448979|FG005|Overall Study|Withdrawal by Subject|0
4597873|NCT01592240|7448980|FG006|Overall Study|Withdrawal by Subject|2
4597874|NCT01592240|7448974|FG000|Overall Study|Other|0
4597875|NCT01592240|7448975|FG001|Overall Study|Other|3
4597876|NCT01592240|7448976|FG002|Overall Study|Other|1
4597877|NCT01592240|7448977|FG003|Overall Study|Other|1
4597878|NCT01592240|7448978|FG004|Overall Study|Other|0
4597879|NCT01592240|7448979|FG005|Overall Study|Other|0
4597880|NCT01592240|7448980|FG006|Overall Study|Other|1
4597881|NCT01592240|7448974|FG000|Overall Study|Did Not Meet Entrance Criteria|1
4597882|NCT01592240|7448975|FG001|Overall Study|Did Not Meet Entrance Criteria|0
4597883|NCT01592240|7448976|FG002|Overall Study|Did Not Meet Entrance Criteria|1
4597884|NCT01592240|7448977|FG003|Overall Study|Did Not Meet Entrance Criteria|0
4597885|NCT01592240|7448978|FG004|Overall Study|Did Not Meet Entrance Criteria|0
4597886|NCT01592240|7448979|FG005|Overall Study|Did Not Meet Entrance Criteria|0
4597887|NCT01592240|7448980|FG006|Overall Study|Did Not Meet Entrance Criteria|0
4597888|NCT01592292|7449003|FG000|Overall Study|Follow-up loss|3
4597889|NCT01592292|7449004|FG001|Overall Study|Follow-up loss|3
4597890|NCT01592292|7449005|FG002|Overall Study|Follow-up loss|1
4597891|NCT01592292|7449006|FG003|Overall Study|Follow-up loss|0
4597892|NCT01592292|7449003|FG000|Overall Study|Withdrew consent|2
4597893|NCT01592292|7449004|FG001|Overall Study|Withdrew consent|1
4597894|NCT01592292|7449005|FG002|Overall Study|Withdrew consent|0
4597895|NCT01592292|7449006|FG003|Overall Study|Withdrew consent|0
4597896|NCT01592292|7449003|FG000|Overall Study|Other|1
4597897|NCT01592292|7449004|FG001|Overall Study|Other|1
4597898|NCT01592292|7449005|FG002|Overall Study|Other|2
4597899|NCT01592292|7449006|FG003|Overall Study|Other|1
4597900|NCT01592344|7449014|FG000|Overall Study|Adverse Event|1
4597901|NCT01592344|7449015|FG001|Overall Study|Adverse Event|1
4597902|NCT01592344|7449014|FG000|Overall Study|Lack of Efficacy|1
4597903|NCT01592344|7449015|FG001|Overall Study|Lack of Efficacy|0
4597904|NCT01592344|7449014|FG000|Overall Study|not available at primary outcome visit|2
4597905|NCT01592344|7449015|FG001|Overall Study|not available at primary outcome visit|4
4597906|NCT01592409|7449033|FG000|Overall Study|Withdrawal by Subject|0
4597907|NCT01592409|7449034|FG001|Overall Study|Withdrawal by Subject|1
4597908|NCT01592695|7449065|FG000|Overall Study|Lost to Follow-up|8
4597909|NCT01592695|7449066|FG001|Overall Study|Lost to Follow-up|4
4597910|NCT01592708|7449074|FG000|Overall Study|Protocol Violation|3
4597911|NCT01592708|7449075|FG001|Overall Study|Protocol Violation|0
4597912|NCT01592747|7449087|FG000|Overall Study|Loss of Therapeutic Response|107
4597913|NCT01592747|7449088|FG001|Overall Study|Loss of Therapeutic Response|108
4597914|NCT01592747|7449089|FG002|Overall Study|Loss of Therapeutic Response|100
4597915|NCT01592747|7449087|FG000|Overall Study|Inclusion/Exclusion criteria not met|0
4597916|NCT01592747|7449088|FG001|Overall Study|Inclusion/Exclusion criteria not met|1
4597917|NCT01592747|7449089|FG002|Overall Study|Inclusion/Exclusion criteria not met|1
4597918|NCT01592747|7449087|FG000|Overall Study|Adverse Event|1
4597919|NCT01592747|7449088|FG001|Overall Study|Adverse Event|0
4597920|NCT01592747|7449089|FG002|Overall Study|Adverse Event|0
4597921|NCT01592747|7449087|FG000|Overall Study|Protocol Violation|4
4597922|NCT01592747|7449088|FG001|Overall Study|Protocol Violation|0
4597923|NCT01592747|7449089|FG002|Overall Study|Protocol Violation|4
4597924|NCT01592747|7449087|FG000|Overall Study|Lack of Efficacy|0
4597925|NCT01592747|7449088|FG001|Overall Study|Lack of Efficacy|1
4597926|NCT01592747|7449089|FG002|Overall Study|Lack of Efficacy|0
4597927|NCT01592747|7449087|FG000|Overall Study|Withdrawal by Subject|2
4597928|NCT01592747|7449088|FG001|Overall Study|Withdrawal by Subject|0
4597929|NCT01592747|7449089|FG002|Overall Study|Withdrawal by Subject|2
4597930|NCT01592747|7449087|FG000|Overall Study|Lost to Follow-up|1
4597931|NCT01592747|7449088|FG001|Overall Study|Lost to Follow-up|0
4597932|NCT01592747|7449089|FG002|Overall Study|Lost to Follow-up|1
4597933|NCT01592747|7449087|FG000|Overall Study|Other Reasons|1
4597934|NCT01592747|7449088|FG001|Overall Study|Other Reasons|1
4597935|NCT01592747|7449089|FG002|Overall Study|Other Reasons|0
4597936|NCT01592760|7449101|FG000|24-hour Follow-Up|Lost to Follow-up|4
4597937|NCT01592760|7449102|FG001|24-hour Follow-Up|Lost to Follow-up|3
4597938|NCT01592760|7449103|FG002|24-hour Follow-Up|Lost to Follow-up|2
4597939|NCT01592773|7449114|FG000|Overall Study|Study Terminated by Sponsor|582
4597940|NCT01592773|7449114|FG000|Overall Study|Withdrawal by Subject|35
4597941|NCT01592773|7449114|FG000|Overall Study|Lost to Follow-up|19
4597942|NCT01592773|7449114|FG000|Overall Study|Adverse Event|17
4597943|NCT01592773|7449114|FG000|Overall Study|Lack of Efficacy|9
4597944|NCT01592773|7449114|FG000|Overall Study|Protocol Violation|2
4597945|NCT01592773|7449114|FG000|Overall Study|Inclusion/exclusion not meet|1
4597946|NCT01592773|7449114|FG000|Overall Study|Other Reason|1
4597947|NCT01592786|7449118|FG000|Overall Study|Adverse Event|60
4597948|NCT01592786|7449118|FG000|Overall Study|Lack of Efficacy|19
4597949|NCT01592786|7449118|FG000|Overall Study|Protocol Violation|14
4597950|NCT01592786|7449118|FG000|Overall Study|Withdrawal by Subject|23
4597951|NCT01592786|7449118|FG000|Overall Study|Lost to Follow-up|19
4597952|NCT01592786|7449118|FG000|Overall Study|Other|3
4597953|NCT01592864|7449139|FG000|Overall Study|Withdrawal by Subject|0
4597954|NCT01592864|7449140|FG001|Overall Study|Withdrawal by Subject|1
4597955|NCT01593020|7449148|FG000|Overall Study|Adverse Event|1
4597956|NCT01593020|7449149|FG001|Overall Study|Adverse Event|1
4597957|NCT01593020|7449148|FG000|Overall Study|Death|0
4597958|NCT01593020|7449149|FG001|Overall Study|Death|1
4597959|NCT01593020|7449148|FG000|Overall Study|Ineligible|1
4597960|NCT01593020|7449149|FG001|Overall Study|Ineligible|0
4597961|NCT01593696|7449181|FG000|Dose Escalation|Progressive Disease|2
4597962|NCT01593696|7449182|FG001|Dose Escalation|Progressive Disease|0
4597963|NCT01593696|7449183|FG002|Dose Escalation|Progressive Disease|0
4597964|NCT01593696|7449184|FG003|Dose Escalation|Progressive Disease|0
4597965|NCT01593696|7449181|FG000|Dose Expansion|Fungal infection|0
4597966|NCT01593696|7449182|FG001|Dose Expansion|Fungal infection|0
4597967|NCT01593696|7449183|FG002|Dose Expansion|Fungal infection|1
4597968|NCT01593696|7449184|FG003|Dose Expansion|Fungal infection|0
4635274|NCT01931670|7506733|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3
4635275|NCT01931670|7506734|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0
4635276|NCT01931670|7506735|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0
4635277|NCT01931670|7506733|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0
4635278|NCT01931670|7506734|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2
4635279|NCT01931670|7506735|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1
4635280|NCT01931670|7506733|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4
4635281|NCT01931670|7506734|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4
4635282|NCT01931670|7506735|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2
4635283|NCT01931670|7506733|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6
4635284|NCT01931670|7506734|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3
4635285|NCT01931670|7506735|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3
4635286|NCT01931670|7506733|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6
4635287|NCT01931670|7506734|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3
4635288|NCT01931670|7506735|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13
4635289|NCT01931670|7506733|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0
4635290|NCT01931670|7506734|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0
4635291|NCT01931670|7506735|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2
4635292|NCT01931735|7506753|FG000|Randomized Phase|Lost to Follow-up|2
4635293|NCT01931735|7506754|FG001|Randomized Phase|Lost to Follow-up|2
4635294|NCT01931735|7506755|FG002|Randomized Phase|Lost to Follow-up|5
4635295|NCT01931735|7506756|FG003|Randomized Phase|Lost to Follow-up|0
4635296|NCT01931735|7506753|FG000|Observational Non-Randomized Phase|Adverse Event|0
4635297|NCT01931735|7506754|FG001|Observational Non-Randomized Phase|Adverse Event|0
4635298|NCT01931735|7506755|FG002|Observational Non-Randomized Phase|Adverse Event|0
4635299|NCT01931735|7506756|FG003|Observational Non-Randomized Phase|Adverse Event|1
4635300|NCT01931735|7506753|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0
4635301|NCT01931735|7506754|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0
4635302|NCT01931735|7506755|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0
4635303|NCT01931735|7506756|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1
4635304|NCT01931839|7506773|FG000|Overall Study|Death|0
4635305|NCT01931839|7506774|FG001|Overall Study|Death|1
4635306|NCT01931839|7506775|FG002|Overall Study|Death|2
4635307|NCT01931839|7506776|FG003|Overall Study|Death|0
4635308|NCT01931839|7506777|FG004|Overall Study|Death|0
4635309|NCT01931839|7506778|FG005|Overall Study|Death|0
4635310|NCT01931839|7506779|FG006|Overall Study|Death|0
4635311|NCT01931839|7506773|FG000|Overall Study|Physician Decision|1
4635312|NCT01931839|7506774|FG001|Overall Study|Physician Decision|0
4635313|NCT01931839|7506775|FG002|Overall Study|Physician Decision|1
4635314|NCT01931839|7506776|FG003|Overall Study|Physician Decision|0
4635315|NCT01931839|7506777|FG004|Overall Study|Physician Decision|0
4635316|NCT01931839|7506778|FG005|Overall Study|Physician Decision|0
4635317|NCT01931839|7506779|FG006|Overall Study|Physician Decision|1
4635318|NCT01931839|7506773|FG000|Overall Study|Withdrawal of consent|0
4635319|NCT01931839|7506774|FG001|Overall Study|Withdrawal of consent|0
4635320|NCT01931839|7506775|FG002|Overall Study|Withdrawal of consent|0
4635321|NCT01931839|7506776|FG003|Overall Study|Withdrawal of consent|0
4635322|NCT01931839|7506777|FG004|Overall Study|Withdrawal of consent|1
4635323|NCT01931839|7506778|FG005|Overall Study|Withdrawal of consent|0
4635324|NCT01931839|7506779|FG006|Overall Study|Withdrawal of consent|0
4635325|NCT01931839|7506773|FG000|Overall Study|Adverse Event|9
4635326|NCT01931839|7506774|FG001|Overall Study|Adverse Event|4
4635327|NCT01931839|7506775|FG002|Overall Study|Adverse Event|1
4635328|NCT01931839|7506776|FG003|Overall Study|Adverse Event|3
4635329|NCT01931839|7506777|FG004|Overall Study|Adverse Event|0
4635330|NCT01931839|7506778|FG005|Overall Study|Adverse Event|0
4635331|NCT01931839|7506779|FG006|Overall Study|Adverse Event|1
4635332|NCT01931839|7506773|FG000|Overall Study|Withdrawal of consent (not due to AE)|11
4635333|NCT01931839|7506774|FG001|Overall Study|Withdrawal of consent (not due to AE)|8
4635334|NCT01931839|7506775|FG002|Overall Study|Withdrawal of consent (not due to AE)|13
4635335|NCT01931839|7506776|FG003|Overall Study|Withdrawal of consent (not due to AE)|3
4635336|NCT01931839|7506777|FG004|Overall Study|Withdrawal of consent (not due to AE)|0
4635337|NCT01931839|7506778|FG005|Overall Study|Withdrawal of consent (not due to AE)|2
4635338|NCT01931839|7506779|FG006|Overall Study|Withdrawal of consent (not due to AE)|2
4635339|NCT01931839|7506773|FG000|Overall Study|Other non-compliance|15
4635340|NCT01931839|7506774|FG001|Overall Study|Other non-compliance|9
4635341|NCT01931839|7506775|FG002|Overall Study|Other non-compliance|12
4597969|NCT01593787|7449217|FG000|Overall Study|Adverse Event|1
4597970|NCT01593787|7449218|FG001|Overall Study|Adverse Event|0
4597971|NCT01593787|7449219|FG002|Overall Study|Adverse Event|0
4597972|NCT01593917|7449229|FG000|Overall Study|Death|67
4597973|NCT01593917|7449229|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60
4597974|NCT01593917|7449229|FG000|Overall Study|Withdrawal by Subject|23
4597975|NCT01593917|7449229|FG000|Overall Study|Lost to Follow-up|12
4597976|NCT01593917|7449229|FG000|Overall Study|Protocol Violation|5
4597977|NCT01593917|7449229|FG000|Overall Study|Physician Decision|3
4597978|NCT01594125|7449238|FG000|Overall Study|Withdrawal by Subject|1
4597979|NCT01594125|7449239|FG001|Overall Study|Withdrawal by Subject|0
4597980|NCT01594125|7449240|FG002|Overall Study|Withdrawal by Subject|0
4597981|NCT01594125|7449241|FG003|Overall Study|Withdrawal by Subject|1
4597982|NCT01594125|7449242|FG004|Overall Study|Withdrawal by Subject|0
4597983|NCT01594125|7449238|FG000|Overall Study|Progressive Disease|3
4597984|NCT01594125|7449239|FG001|Overall Study|Progressive Disease|12
4597985|NCT01594125|7449240|FG002|Overall Study|Progressive Disease|3
4597986|NCT01594125|7449241|FG003|Overall Study|Progressive Disease|3
4597987|NCT01594125|7449242|FG004|Overall Study|Progressive Disease|7
4597988|NCT01594281|7449257|FG000|Interventional Core Phase|Protocol Deviation|1
4597989|NCT01594281|7449258|FG001|Interventional Core Phase|Protocol Deviation|0
4597990|NCT01594281|7449259|FG002|Interventional Core Phase|Protocol Deviation|0
4597991|NCT01594281|7449257|FG000|Interventional Core Phase|Subject Withdrew Consent|0
4597992|NCT01594281|7449258|FG001|Interventional Core Phase|Subject Withdrew Consent|1
4597993|NCT01594281|7449259|FG002|Interventional Core Phase|Subject Withdrew Consent|1
4597994|NCT01594281|7449257|FG000|Interventional Core Phase|Death|1
4597995|NCT01594281|7449258|FG001|Interventional Core Phase|Death|1
4597996|NCT01594281|7449259|FG002|Interventional Core Phase|Death|2
4597997|NCT01594281|7449257|FG000|Interventional Core Phase|Lost to Follow-up|1
4597998|NCT01594281|7449258|FG001|Interventional Core Phase|Lost to Follow-up|4
4597999|NCT01594281|7449259|FG002|Interventional Core Phase|Lost to Follow-up|1
4598000|NCT01594281|7449257|FG000|Interventional Core Phase|Adverse Event|4
4598001|NCT01594281|7449258|FG001|Interventional Core Phase|Adverse Event|4
4598002|NCT01594281|7449259|FG002|Interventional Core Phase|Adverse Event|4
4598003|NCT01594281|7449257|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2
4598004|NCT01594281|7449258|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2
4598005|NCT01594281|7449259|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0
4598006|NCT01594281|7449257|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0
4598007|NCT01594281|7449258|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0
4598008|NCT01594281|7449259|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1
4598009|NCT01594281|7449257|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1
4598010|NCT01594281|7449258|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0
4598011|NCT01594281|7449259|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1
4598012|NCT01594333|7449281|FG000|Overall Study|Death|96
4598013|NCT01594333|7449282|FG001|Overall Study|Death|83
4598014|NCT01594333|7449281|FG000|Overall Study|Lost to Follow-up|5
4598015|NCT01594333|7449282|FG001|Overall Study|Lost to Follow-up|5
4598016|NCT01594333|7449281|FG000|Overall Study|Withdrawal by Subject|60
4598017|NCT01594333|7449282|FG001|Overall Study|Withdrawal by Subject|63
4598018|NCT01594411|7449301|FG000|Overall Study|Lost to Follow-up|2
4598019|NCT01594476|7449314|FG000|Overall Study|Protocol Violation|1
4598020|NCT01594476|7449315|FG001|Overall Study|Protocol Violation|3
4598021|NCT01594749|7449379|FG000|Overall Study|Adverse Event|2
4598022|NCT01594749|7449380|FG001|Overall Study|Adverse Event|1
4598023|NCT01594749|7449379|FG000|Overall Study|Withdrawal by Subject|2
4598024|NCT01594749|7449380|FG001|Overall Study|Withdrawal by Subject|2
4598025|NCT01594749|7449379|FG000|Overall Study|Protocol Violation|2
4598026|NCT01594749|7449380|FG001|Overall Study|Protocol Violation|0
4598027|NCT01594749|7449379|FG000|Overall Study|Physician Decision|1
4598028|NCT01594749|7449380|FG001|Overall Study|Physician Decision|1
4598029|NCT01594749|7449379|FG000|Overall Study|Non-compliance with Protocol|0
4598030|NCT01594749|7449380|FG001|Overall Study|Non-compliance with Protocol|1
4598031|NCT01594749|7449379|FG000|Overall Study|Lost to Follow-up|1
4598032|NCT01594749|7449380|FG001|Overall Study|Lost to Follow-up|0
4598033|NCT01594749|7449379|FG000|Overall Study|Death|9
4598034|NCT01594749|7449380|FG001|Overall Study|Death|3
4598035|NCT01594749|7449379|FG000|Overall Study|Not Treated|4
4598036|NCT01594749|7449380|FG001|Overall Study|Not Treated|10
4598037|NCT01594749|7449379|FG000|Overall Study|Lost Source Documentation|1
4598038|NCT01594749|7449380|FG001|Overall Study|Lost Source Documentation|0
4598039|NCT01594762|7449388|FG000|Overall Study|Withdrawal by Subject|1
4598040|NCT01594762|7449389|FG001|Overall Study|Withdrawal by Subject|0
4598041|NCT01594762|7449388|FG000|Overall Study|Lost to Follow-up|10
4598042|NCT01594762|7449389|FG001|Overall Study|Lost to Follow-up|10
4598043|NCT01594827|7449397|FG000|Overall Study|Adverse Event|1
4598044|NCT01594827|7449398|FG001|Overall Study|Adverse Event|0
4598045|NCT01594827|7449397|FG000|Overall Study|Physician Decision|3
4635342|NCT01931839|7506776|FG003|Overall Study|Other non-compliance|3
4598046|NCT01594827|7449398|FG001|Overall Study|Physician Decision|0
4598047|NCT01594853|7449408|FG000|Overall Study|Withdrawal by Subject|1
4598048|NCT01594853|7449409|FG001|Overall Study|Withdrawal by Subject|1
4598049|NCT01594853|7449408|FG000|Overall Study|Lost to Follow-up|1
4598050|NCT01594853|7449409|FG001|Overall Study|Lost to Follow-up|1
4598051|NCT01594853|7449408|FG000|Overall Study|noncompliance with exercise|0
4598052|NCT01594853|7449409|FG001|Overall Study|noncompliance with exercise|1
4598053|NCT01594931|7449418|FG000|Overall Study|Adverse Event|3
4598054|NCT01594931|7449419|FG001|Overall Study|Adverse Event|1
4598055|NCT01594931|7449420|FG002|Overall Study|Adverse Event|1
4598056|NCT01594931|7449418|FG000|Overall Study|Withdrawal by Subject|2
4598057|NCT01594931|7449419|FG001|Overall Study|Withdrawal by Subject|1
4598058|NCT01594931|7449420|FG002|Overall Study|Withdrawal by Subject|1
4598059|NCT01594931|7449418|FG000|Overall Study|Lack of Efficacy|7
4598060|NCT01594931|7449419|FG001|Overall Study|Lack of Efficacy|2
4598061|NCT01594931|7449420|FG002|Overall Study|Lack of Efficacy|2
4598062|NCT01594931|7449418|FG000|Overall Study|Lost to Follow-up|4
4598063|NCT01594931|7449419|FG001|Overall Study|Lost to Follow-up|3
4598064|NCT01594931|7449420|FG002|Overall Study|Lost to Follow-up|3
4598065|NCT01594931|7449418|FG000|Overall Study|Protocol Violation|2
4598066|NCT01594931|7449419|FG001|Overall Study|Protocol Violation|1
4598067|NCT01594931|7449420|FG002|Overall Study|Protocol Violation|0
4598068|NCT01594931|7449418|FG000|Overall Study|No defiined|11
4598069|NCT01594931|7449419|FG001|Overall Study|No defiined|4
4598070|NCT01594931|7449420|FG002|Overall Study|No defiined|7
4598071|NCT01594970|7449431|FG000|Overall Study|Non-Adverse Event Related|4
4598072|NCT01594970|7449432|FG001|Overall Study|Non-Adverse Event Related|5
4598073|NCT01594970|7449433|FG002|Overall Study|Non-Adverse Event Related|6
4598074|NCT01594970|7449431|FG000|Overall Study|Adverse Event|17
4598075|NCT01594970|7449432|FG001|Overall Study|Adverse Event|23
4598076|NCT01594970|7449433|FG002|Overall Study|Adverse Event|23
4598077|NCT01594970|7449431|FG000|Overall Study|Lost to Follow-up|54
4598078|NCT01594970|7449432|FG001|Overall Study|Lost to Follow-up|54
4598079|NCT01594970|7449433|FG002|Overall Study|Lost to Follow-up|37
4598080|NCT01595438|7449461|FG000|Overall Study|Lost to Follow-up|20
4598081|NCT01595438|7449462|FG001|Overall Study|Lost to Follow-up|20
4598082|NCT01595438|7449461|FG000|Overall Study|Withdrawal by Subject|12
4598083|NCT01595438|7449462|FG001|Overall Study|Withdrawal by Subject|12
4598084|NCT01595438|7449461|FG000|Overall Study|Other Eligibility criteria|11
4598085|NCT01595438|7449462|FG001|Overall Study|Other Eligibility criteria|9
4598086|NCT01595529|7449497|FG000|Overall Study|Adverse Event|2
4598087|NCT01595529|7449498|FG001|Overall Study|Adverse Event|0
4598088|NCT01595529|7449497|FG000|Overall Study|Subject Non-Compliant|2
4598089|NCT01595529|7449498|FG001|Overall Study|Subject Non-Compliant|0
4598090|NCT01595529|7449497|FG000|Overall Study|Lost to Follow-up|8
4598091|NCT01595529|7449498|FG001|Overall Study|Lost to Follow-up|14
4598092|NCT01595529|7449497|FG000|Overall Study|Protocol Violation|1
4598093|NCT01595529|7449498|FG001|Overall Study|Protocol Violation|2
4598094|NCT01595529|7449497|FG000|Overall Study|Physician Decision|1
4598095|NCT01595529|7449498|FG001|Overall Study|Physician Decision|0
4598096|NCT01595529|7449497|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3
4598097|NCT01595529|7449498|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3
4598098|NCT01595529|7449497|FG000|Overall Study|Administrative Decision|1
4598099|NCT01595529|7449498|FG001|Overall Study|Administrative Decision|0
4598100|NCT01595529|7449497|FG000|Overall Study|Entry Failure/Screening Failure|6
4598101|NCT01595529|7449498|FG001|Overall Study|Entry Failure/Screening Failure|1
4598102|NCT01595646|7449507|FG000|Overall Study|Withdrawal by Subject|1
4598103|NCT01595646|7449508|FG001|Overall Study|Withdrawal by Subject|0
4598104|NCT01595646|7449509|FG002|Overall Study|Withdrawal by Subject|0
4598105|NCT01596062|7449550|FG000|Overall Study|Adverse Event|1
4598106|NCT01596062|7449551|FG001|Overall Study|Adverse Event|0
4598107|NCT01596062|7449552|FG002|Overall Study|Adverse Event|2
4598108|NCT01596062|7449550|FG000|Overall Study|Lack of Efficacy|0
4598109|NCT01596062|7449551|FG001|Overall Study|Lack of Efficacy|0
4598110|NCT01596062|7449552|FG002|Overall Study|Lack of Efficacy|1
4598111|NCT01596127|7449564|FG000|Overall Study|Patient Ineligible|1
4598112|NCT01596335|7449590|FG000|Overall Study|exacerbation of primary disease|5
4598113|NCT01596335|7449591|FG001|Overall Study|exacerbation of primary disease|9
4598114|NCT01596504|7449600|FG000|Overall Study|Participant's Private Reason|0
4598115|NCT01596504|7449601|FG001|Overall Study|Participant's Private Reason|1
4598116|NCT01596504|7449602|FG002|Overall Study|Participant's Private Reason|0
4598117|NCT01596504|7449600|FG000|Overall Study|Adverse Event|1
4598118|NCT01596504|7449601|FG001|Overall Study|Adverse Event|2
4598119|NCT01596504|7449602|FG002|Overall Study|Adverse Event|1
4598120|NCT01596504|7449600|FG000|Overall Study|Withdrawal by Subject|1
4598121|NCT01596504|7449601|FG001|Overall Study|Withdrawal by Subject|0
4598122|NCT01596504|7449602|FG002|Overall Study|Withdrawal by Subject|0
4598123|NCT01596582|7449613|FG000|Overall Study|Deemed ineligible after study visit|3
4598124|NCT01596582|7449614|FG001|Overall Study|Deemed ineligible after study visit|6
4598125|NCT01596582|7449613|FG000|Overall Study|Missing all outcome data|1
4598126|NCT01596582|7449614|FG001|Overall Study|Missing all outcome data|1
4598127|NCT01596972|7449685|FG000|Overall Study|Physician Decision|1
4598128|NCT01596972|7449686|FG001|Overall Study|Physician Decision|9
4598129|NCT01596972|7449685|FG000|Overall Study|Lost to Follow-up|0
4598130|NCT01596972|7449686|FG001|Overall Study|Lost to Follow-up|4
4598131|NCT01596972|7449685|FG000|Overall Study|Withdrawal by Subject|0
4598132|NCT01596972|7449686|FG001|Overall Study|Withdrawal by Subject|1
4598133|NCT01597050|7449694|FG000|Overall Study|Withdrawal by Subject|1
4598134|NCT01597050|7449695|FG001|Overall Study|Withdrawal by Subject|0
4598135|NCT01597193|7449728|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7
4598136|NCT01597193|7449729|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8
4598137|NCT01597193|7449730|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0
4598138|NCT01597193|7449731|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0
4598139|NCT01597193|7449732|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0
4598140|NCT01597193|7449733|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0
4598141|NCT01597193|7449734|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0
4598142|NCT01597193|7449728|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
4598143|NCT01597193|7449729|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
4598144|NCT01597193|7449730|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
4598145|NCT01597193|7449731|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1
4598146|NCT01597193|7449732|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2
4598147|NCT01597193|7449733|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3
4598148|NCT01597193|7449734|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
4598149|NCT01597193|7449728|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0
4598150|NCT01597193|7449729|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0
4598151|NCT01597193|7449730|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14
4598152|NCT01597193|7449731|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18
4598153|NCT01597193|7449732|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14
4598154|NCT01597193|7449733|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18
4598155|NCT01597193|7449734|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11
4598156|NCT01597193|7449728|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0
4598157|NCT01597193|7449729|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0
4598158|NCT01597193|7449730|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0
4598159|NCT01597193|7449731|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0
4598160|NCT01597193|7449732|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0
4598161|NCT01597193|7449733|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1
4598162|NCT01597193|7449734|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0
4598163|NCT01597193|7449728|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
4598164|NCT01597193|7449729|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
4598165|NCT01597193|7449730|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
4598166|NCT01597193|7449731|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1
4598167|NCT01597193|7449732|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
4598168|NCT01597193|7449733|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1
4598169|NCT01597193|7449734|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
4598170|NCT01597245|7449759|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1
4598171|NCT01597245|7449760|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5
4598172|NCT01597245|7449761|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5
4598173|NCT01597245|7449762|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4
4598174|NCT01597245|7449763|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0
4598175|NCT01597245|7449764|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0
4598176|NCT01597245|7449765|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0
4598177|NCT01597245|7449766|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0
4598178|NCT01597245|7449767|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0
4598179|NCT01597245|7449768|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0
4598180|NCT01597245|7449769|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0
4598181|NCT01597245|7449770|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0
4598182|NCT01597245|7449771|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0
4598183|NCT01597245|7449772|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0
4598184|NCT01597245|7449773|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0
4598185|NCT01597245|7449774|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0
4598186|NCT01597245|7449775|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0
4598187|NCT01597245|7449776|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0
4598188|NCT01597245|7449777|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0
4635343|NCT01931839|7506777|FG004|Overall Study|Other non-compliance|0
4635344|NCT01931839|7506778|FG005|Overall Study|Other non-compliance|3
4635345|NCT01931839|7506779|FG006|Overall Study|Other non-compliance|0
4635346|NCT01931839|7506773|FG000|Overall Study|Lost to Follow-up|1
4635347|NCT01931839|7506774|FG001|Overall Study|Lost to Follow-up|2
4635348|NCT01931839|7506775|FG002|Overall Study|Lost to Follow-up|4
4635349|NCT01931839|7506776|FG003|Overall Study|Lost to Follow-up|5
4635350|NCT01931839|7506777|FG004|Overall Study|Lost to Follow-up|0
4635351|NCT01931839|7506778|FG005|Overall Study|Lost to Follow-up|0
4635352|NCT01931839|7506779|FG006|Overall Study|Lost to Follow-up|0
4635353|NCT01931839|7506773|FG000|Overall Study|Other|4
4635354|NCT01931839|7506774|FG001|Overall Study|Other|2
4635355|NCT01931839|7506775|FG002|Overall Study|Other|6
4635356|NCT01931839|7506776|FG003|Overall Study|Other|0
4635357|NCT01931839|7506777|FG004|Overall Study|Other|0
4635358|NCT01931839|7506778|FG005|Overall Study|Other|0
4746555|NCT00686036|7718193|FG000|Overall Study|Other reasons not identified|0
4635359|NCT01931839|7506779|FG006|Overall Study|Other|0
4635360|NCT01931865|7506799|FG000|Overall Study|Lost to Follow-up|2
4635361|NCT01931865|7506799|FG000|Overall Study|Withdrawal by Subject|2
4746556|NCT00686036|7718194|FG001|Overall Study|Other reasons not identified|4
4598189|NCT01597245|7449778|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0
4598190|NCT01597245|7449779|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0
4598191|NCT01597245|7449759|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2
4598192|NCT01597245|7449760|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8
4598193|NCT01597245|7449761|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6
4598194|NCT01597245|7449762|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2
4598195|NCT01597245|7449763|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
4598196|NCT01597245|7449764|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
4598197|NCT01597245|7449765|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
4598198|NCT01597245|7449766|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
4598199|NCT01597245|7449767|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
4598200|NCT01597245|7449768|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
4598201|NCT01597245|7449769|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
4598202|NCT01597245|7449770|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
4598203|NCT01597245|7449771|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
4598204|NCT01597245|7449772|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
4598205|NCT01597245|7449773|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
4598206|NCT01597245|7449774|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
4598207|NCT01597245|7449775|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
4598208|NCT01597245|7449776|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
4598209|NCT01597245|7449777|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
4598210|NCT01597245|7449778|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
4598211|NCT01597245|7449779|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
4598212|NCT01597245|7449759|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2
4598213|NCT01597245|7449760|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4
4598214|NCT01597245|7449761|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5
4598215|NCT01597245|7449762|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2
4598216|NCT01597245|7449763|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0
4598217|NCT01597245|7449764|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0
4598218|NCT01597245|7449765|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0
4598219|NCT01597245|7449766|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0
4598220|NCT01597245|7449767|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0
4598221|NCT01597245|7449768|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0
4598222|NCT01597245|7449769|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0
4598223|NCT01597245|7449770|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0
4598224|NCT01597245|7449771|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0
4598225|NCT01597245|7449772|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0
4598226|NCT01597245|7449773|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0
4598227|NCT01597245|7449774|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0
4598228|NCT01597245|7449775|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0
4598229|NCT01597245|7449776|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0
4598230|NCT01597245|7449777|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0
4598231|NCT01597245|7449778|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0
4746557|NCT00683787|7718216|FG000|Overall Study|Progression|3
4746558|NCT00683787|7718217|FG001|Overall Study|Progression|3
4746559|NCT00683787|7718218|FG002|Overall Study|Progression|0
4746560|NCT00683787|7718216|FG000|Overall Study|Adverse Event|0
4746561|NCT00683787|7718217|FG001|Overall Study|Adverse Event|0
4746562|NCT00683787|7718218|FG002|Overall Study|Adverse Event|2
4598232|NCT01597245|7449779|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0
4598233|NCT01597245|7449759|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1
4598234|NCT01597245|7449760|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5
4598235|NCT01597245|7449761|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2
4598236|NCT01597245|7449762|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
4598237|NCT01597245|7449763|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
4598238|NCT01597245|7449764|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
4598239|NCT01597245|7449765|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
4598240|NCT01597245|7449766|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
4598241|NCT01597245|7449767|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
4598242|NCT01597245|7449768|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
4598243|NCT01597245|7449769|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
4598244|NCT01597245|7449770|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
4598245|NCT01597245|7449771|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
4598246|NCT01597245|7449772|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
4598247|NCT01597245|7449773|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
4598248|NCT01597245|7449774|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
4598249|NCT01597245|7449775|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
4598250|NCT01597245|7449776|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
4598251|NCT01597245|7449777|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
4598252|NCT01597245|7449778|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
4598253|NCT01597245|7449779|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
4598254|NCT01597245|7449759|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1
4598255|NCT01597245|7449760|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0
4598256|NCT01597245|7449761|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0
4598257|NCT01597245|7449762|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1
4598258|NCT01597245|7449763|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0
4598259|NCT01597245|7449764|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0
4598260|NCT01597245|7449765|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0
4598261|NCT01597245|7449766|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0
4598262|NCT01597245|7449767|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0
4598263|NCT01597245|7449768|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0
4598264|NCT01597245|7449769|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0
4598265|NCT01597245|7449770|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0
4598266|NCT01597245|7449771|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0
4598267|NCT01597245|7449772|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0
4598268|NCT01597245|7449773|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0
4598269|NCT01597245|7449774|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0
4598270|NCT01597245|7449775|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0
4598271|NCT01597245|7449776|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0
4598272|NCT01597245|7449777|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0
4598273|NCT01597245|7449778|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0
4598274|NCT01597245|7449779|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0
4598275|NCT01597245|7449759|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3
4598276|NCT01597245|7449760|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3
4598277|NCT01597245|7449761|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1
4598278|NCT01597245|7449762|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
4598279|NCT01597245|7449763|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
4598280|NCT01597245|7449764|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
4598281|NCT01597245|7449765|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
4598282|NCT01597245|7449766|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
4598283|NCT01597245|7449767|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
4598284|NCT01597245|7449768|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
4598285|NCT01597245|7449769|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
4598286|NCT01597245|7449770|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
4598287|NCT01597245|7449771|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
4598288|NCT01597245|7449772|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
4598289|NCT01597245|7449773|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
4598290|NCT01597245|7449774|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
4598291|NCT01597245|7449775|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
4598292|NCT01597245|7449776|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
4598293|NCT01597245|7449777|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
4598294|NCT01597245|7449778|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
4598295|NCT01597245|7449779|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
4598296|NCT01597245|7449759|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0
4598297|NCT01597245|7449760|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0
4598298|NCT01597245|7449761|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0
4598299|NCT01597245|7449762|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0
4598300|NCT01597245|7449763|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0
4598301|NCT01597245|7449764|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1
4598302|NCT01597245|7449765|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1
4598303|NCT01597245|7449766|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0
4598304|NCT01597245|7449767|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0
4598305|NCT01597245|7449768|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0
4598306|NCT01597245|7449769|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0
4598307|NCT01597245|7449770|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0
4598308|NCT01597245|7449771|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0
4598309|NCT01597245|7449772|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0
4598310|NCT01597245|7449773|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0
4598311|NCT01597245|7449774|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0
4598312|NCT01597245|7449775|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0
4598313|NCT01597245|7449776|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0
4598314|NCT01597245|7449777|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0
4598315|NCT01597245|7449778|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0
4635362|NCT01931956|7506819|FG000|Overall Study|Death|42
4635363|NCT01931956|7506820|FG001|Overall Study|Death|7
4635364|NCT01931956|7506821|FG002|Overall Study|Death|379
4598316|NCT01597245|7449779|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0
4598317|NCT01597245|7449759|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0
4598318|NCT01597245|7449760|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0
4598319|NCT01597245|7449761|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0
4598320|NCT01597245|7449762|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0
4598321|NCT01597245|7449763|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150
4598322|NCT01597245|7449764|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22
4598323|NCT01597245|7449765|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80
4598324|NCT01597245|7449766|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2
4598325|NCT01597245|7449767|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0
4598326|NCT01597245|7449768|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114
4598327|NCT01597245|7449769|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0
4598328|NCT01597245|7449770|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0
4598329|NCT01597245|7449771|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0
4598330|NCT01597245|7449772|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0
4598331|NCT01597245|7449773|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0
4598332|NCT01597245|7449774|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0
4598333|NCT01597245|7449775|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0
4598334|NCT01597245|7449776|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0
4598335|NCT01597245|7449777|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0
4598336|NCT01597245|7449778|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0
4598337|NCT01597245|7449779|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0
4598338|NCT01597245|7449759|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
4598339|NCT01597245|7449760|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
4598340|NCT01597245|7449761|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
4598341|NCT01597245|7449762|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
4598342|NCT01597245|7449763|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
4598343|NCT01597245|7449764|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1
4598344|NCT01597245|7449765|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
4598345|NCT01597245|7449766|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
4598346|NCT01597245|7449767|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3
4598347|NCT01597245|7449768|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
4598348|NCT01597245|7449769|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2
4598349|NCT01597245|7449770|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10
4598350|NCT01597245|7449771|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4
4598351|NCT01597245|7449772|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
4598352|NCT01597245|7449773|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
4598353|NCT01597245|7449774|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
4598354|NCT01597245|7449775|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
4598355|NCT01597245|7449776|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
4598356|NCT01597245|7449777|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
4598357|NCT01597245|7449778|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
4598358|NCT01597245|7449779|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
4598359|NCT01597245|7449759|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
4598360|NCT01597245|7449760|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
4598361|NCT01597245|7449761|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
4598362|NCT01597245|7449762|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
4598363|NCT01597245|7449763|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4
4598364|NCT01597245|7449764|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6
4598365|NCT01597245|7449765|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6
4598366|NCT01597245|7449766|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1
4598367|NCT01597245|7449767|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8
4598368|NCT01597245|7449768|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2
4598369|NCT01597245|7449769|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8
4598370|NCT01597245|7449770|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1
4598371|NCT01597245|7449771|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2
4598372|NCT01597245|7449772|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
4598373|NCT01597245|7449773|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
4598374|NCT01597245|7449774|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
4598375|NCT01597245|7449775|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
4598376|NCT01597245|7449776|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
4598377|NCT01597245|7449777|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
4598378|NCT01597245|7449778|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
4598379|NCT01597245|7449779|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
4598380|NCT01597245|7449759|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
4598381|NCT01597245|7449760|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
4598382|NCT01597245|7449761|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
4598383|NCT01597245|7449762|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
4598384|NCT01597245|7449763|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3
4598385|NCT01597245|7449764|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3
4598386|NCT01597245|7449765|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1
4598387|NCT01597245|7449766|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
4598388|NCT01597245|7449767|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4
4598389|NCT01597245|7449768|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1
4598390|NCT01597245|7449769|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6
4598391|NCT01597245|7449770|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5
4598392|NCT01597245|7449771|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4
4598393|NCT01597245|7449772|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
4598394|NCT01597245|7449773|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
4598395|NCT01597245|7449774|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
4598396|NCT01597245|7449775|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
4598397|NCT01597245|7449776|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
4598398|NCT01597245|7449777|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
4598399|NCT01597245|7449778|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
4598400|NCT01597245|7449779|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
4598401|NCT01597245|7449759|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
4598402|NCT01597245|7449760|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
4598403|NCT01597245|7449761|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
4598404|NCT01597245|7449762|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
4598405|NCT01597245|7449763|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
4598406|NCT01597245|7449764|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
4598407|NCT01597245|7449765|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
4598408|NCT01597245|7449766|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
4598409|NCT01597245|7449767|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3
4598410|NCT01597245|7449768|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
4598411|NCT01597245|7449769|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2
4598412|NCT01597245|7449770|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
4598413|NCT01597245|7449771|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
4598414|NCT01597245|7449772|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
4598415|NCT01597245|7449773|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
4598416|NCT01597245|7449774|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
4598417|NCT01597245|7449775|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
4598418|NCT01597245|7449776|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
4598419|NCT01597245|7449777|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
4598420|NCT01597245|7449778|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
4598421|NCT01597245|7449779|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
4598422|NCT01597245|7449759|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
4598423|NCT01597245|7449760|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
4598424|NCT01597245|7449761|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
4598425|NCT01597245|7449762|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
4598426|NCT01597245|7449763|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3
4598427|NCT01597245|7449764|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4
4598428|NCT01597245|7449765|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
4598429|NCT01597245|7449766|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
4598430|NCT01597245|7449767|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
4598431|NCT01597245|7449768|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
4598432|NCT01597245|7449769|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
4598433|NCT01597245|7449770|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
4598434|NCT01597245|7449771|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
4598435|NCT01597245|7449772|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
4598436|NCT01597245|7449773|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
4598437|NCT01597245|7449774|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
4598438|NCT01597245|7449775|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
4598439|NCT01597245|7449776|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
4598440|NCT01597245|7449777|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
4598441|NCT01597245|7449778|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
4598442|NCT01597245|7449779|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
4598443|NCT01597245|7449759|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
4598444|NCT01597245|7449760|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
4598445|NCT01597245|7449761|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
4598446|NCT01597245|7449762|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
4598447|NCT01597245|7449763|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
4598448|NCT01597245|7449764|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
4598449|NCT01597245|7449765|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
4598450|NCT01597245|7449766|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
4598451|NCT01597245|7449767|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
4598452|NCT01597245|7449768|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
4598453|NCT01597245|7449769|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
4598454|NCT01597245|7449770|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
4598455|NCT01597245|7449771|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
4598456|NCT01597245|7449772|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
4598457|NCT01597245|7449773|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
4598458|NCT01597245|7449774|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
4598459|NCT01597245|7449775|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
4598460|NCT01597245|7449776|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
4598461|NCT01597245|7449777|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
4598462|NCT01597245|7449778|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
4598463|NCT01597245|7449779|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
4598464|NCT01597245|7449759|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
4598465|NCT01597245|7449760|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
4598466|NCT01597245|7449761|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
4598467|NCT01597245|7449762|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
4598468|NCT01597245|7449763|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
4598469|NCT01597245|7449764|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
4598470|NCT01597245|7449765|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
4598471|NCT01597245|7449766|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
4598472|NCT01597245|7449767|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
4598473|NCT01597245|7449768|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
4598474|NCT01597245|7449769|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1
4635365|NCT01931956|7506822|FG003|Overall Study|Death|96
4635366|NCT01931956|7506819|FG000|Overall Study|Withdrawal by Subject|5
4635367|NCT01931956|7506820|FG001|Overall Study|Withdrawal by Subject|0
4635368|NCT01931956|7506821|FG002|Overall Study|Withdrawal by Subject|70
4635369|NCT01931956|7506822|FG003|Overall Study|Withdrawal by Subject|30
4635370|NCT01931956|7506819|FG000|Overall Study|Lost to Follow-up|2
4635371|NCT01931956|7506820|FG001|Overall Study|Lost to Follow-up|0
4635372|NCT01931956|7506821|FG002|Overall Study|Lost to Follow-up|11
4598475|NCT01597245|7449770|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
4598476|NCT01597245|7449771|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
4598477|NCT01597245|7449772|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
4598478|NCT01597245|7449773|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
4598479|NCT01597245|7449774|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
4598480|NCT01597245|7449775|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
4598481|NCT01597245|7449776|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
4598482|NCT01597245|7449777|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
4598483|NCT01597245|7449778|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
4598484|NCT01597245|7449779|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
4598485|NCT01597245|7449759|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
4598486|NCT01597245|7449760|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
4598487|NCT01597245|7449761|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
4598488|NCT01597245|7449762|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
4598489|NCT01597245|7449763|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
4598490|NCT01597245|7449764|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
4598491|NCT01597245|7449765|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
4598492|NCT01597245|7449766|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
4598493|NCT01597245|7449767|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
4598494|NCT01597245|7449768|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
4598495|NCT01597245|7449769|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
4598496|NCT01597245|7449770|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
4598497|NCT01597245|7449771|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
4598498|NCT01597245|7449772|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1
4598499|NCT01597245|7449773|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69
4598500|NCT01597245|7449774|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70
4598501|NCT01597245|7449775|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
4598502|NCT01597245|7449776|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
4598503|NCT01597245|7449777|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
4598504|NCT01597245|7449778|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
4598505|NCT01597245|7449779|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
4598506|NCT01597245|7449759|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
4598507|NCT01597245|7449760|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
4598508|NCT01597245|7449761|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
4598509|NCT01597245|7449762|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
4598510|NCT01597245|7449763|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
4635373|NCT01931956|7506822|FG003|Overall Study|Lost to Follow-up|7
4635374|NCT01931956|7506819|FG000|Overall Study|Expected|2
4635375|NCT01931956|7506820|FG001|Overall Study|Expected|0
4635376|NCT01931956|7506821|FG002|Overall Study|Expected|6
4598511|NCT01597245|7449764|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
4598512|NCT01597245|7449765|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
4598513|NCT01597245|7449766|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
4598514|NCT01597245|7449767|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
4598515|NCT01597245|7449768|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
4598516|NCT01597245|7449769|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
4598517|NCT01597245|7449770|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
4598518|NCT01597245|7449771|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
4598519|NCT01597245|7449772|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1
4598520|NCT01597245|7449773|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62
4598521|NCT01597245|7449774|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63
4598522|NCT01597245|7449775|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
4598523|NCT01597245|7449776|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
4598524|NCT01597245|7449777|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
4598525|NCT01597245|7449778|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
4598526|NCT01597245|7449779|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
4598527|NCT01597245|7449759|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
4598528|NCT01597245|7449760|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
4598529|NCT01597245|7449761|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
4598530|NCT01597245|7449762|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
4598531|NCT01597245|7449763|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
4598532|NCT01597245|7449764|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
4598533|NCT01597245|7449765|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
4598534|NCT01597245|7449766|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
4598535|NCT01597245|7449767|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
4598536|NCT01597245|7449768|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
4598537|NCT01597245|7449769|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
4598538|NCT01597245|7449770|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
4598539|NCT01597245|7449771|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
4598540|NCT01597245|7449772|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
4598541|NCT01597245|7449773|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38
4598542|NCT01597245|7449774|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38
4598543|NCT01597245|7449775|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
4598544|NCT01597245|7449776|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
4598545|NCT01597245|7449777|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
4598546|NCT01597245|7449778|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
4598547|NCT01597245|7449779|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
4598548|NCT01597245|7449759|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
4598549|NCT01597245|7449760|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
4598550|NCT01597245|7449761|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
4598551|NCT01597245|7449762|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
4598552|NCT01597245|7449763|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
4598553|NCT01597245|7449764|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
4598554|NCT01597245|7449765|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
4598555|NCT01597245|7449766|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
4598556|NCT01597245|7449767|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
4598557|NCT01597245|7449768|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
4598558|NCT01597245|7449769|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
4598559|NCT01597245|7449770|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
4598560|NCT01597245|7449771|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
4598561|NCT01597245|7449772|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
4598562|NCT01597245|7449773|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26
4598563|NCT01597245|7449774|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26
4598564|NCT01597245|7449775|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
4598565|NCT01597245|7449776|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
4598566|NCT01597245|7449777|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
4598567|NCT01597245|7449778|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
4598568|NCT01597245|7449779|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
4598569|NCT01597245|7449759|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
4598570|NCT01597245|7449760|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
4598571|NCT01597245|7449761|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
4598572|NCT01597245|7449762|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
4598573|NCT01597245|7449763|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
4598574|NCT01597245|7449764|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
4598575|NCT01597245|7449765|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
4598576|NCT01597245|7449766|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
4598577|NCT01597245|7449767|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
4598578|NCT01597245|7449768|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
4598579|NCT01597245|7449769|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
4598580|NCT01597245|7449770|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
4598581|NCT01597245|7449771|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
4598582|NCT01597245|7449772|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1
4598583|NCT01597245|7449773|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11
4598584|NCT01597245|7449774|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12
4598585|NCT01597245|7449775|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
4598586|NCT01597245|7449776|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
4598587|NCT01597245|7449777|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
4598588|NCT01597245|7449778|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
4598589|NCT01597245|7449779|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
4598590|NCT01597245|7449759|FG000|Long Term Extension (Week 60 - Week 264)|Death|0
4598591|NCT01597245|7449760|FG001|Long Term Extension (Week 60 - Week 264)|Death|0
4598592|NCT01597245|7449761|FG002|Long Term Extension (Week 60 - Week 264)|Death|0
4598593|NCT01597245|7449762|FG003|Long Term Extension (Week 60 - Week 264)|Death|0
4598594|NCT01597245|7449763|FG004|Long Term Extension (Week 60 - Week 264)|Death|0
4598595|NCT01597245|7449764|FG005|Long Term Extension (Week 60 - Week 264)|Death|0
4598596|NCT01597245|7449765|FG006|Long Term Extension (Week 60 - Week 264)|Death|0
4598597|NCT01597245|7449766|FG007|Long Term Extension (Week 60 - Week 264)|Death|0
4598598|NCT01597245|7449767|FG008|Long Term Extension (Week 60 - Week 264)|Death|0
4598599|NCT01597245|7449768|FG009|Long Term Extension (Week 60 - Week 264)|Death|0
4598600|NCT01597245|7449769|FG010|Long Term Extension (Week 60 - Week 264)|Death|0
4598601|NCT01597245|7449770|FG011|Long Term Extension (Week 60 - Week 264)|Death|0
4598602|NCT01597245|7449771|FG012|Long Term Extension (Week 60 - Week 264)|Death|0
4598603|NCT01597245|7449772|FG013|Long Term Extension (Week 60 - Week 264)|Death|0
4598604|NCT01597245|7449773|FG014|Long Term Extension (Week 60 - Week 264)|Death|8
4598605|NCT01597245|7449774|FG015|Long Term Extension (Week 60 - Week 264)|Death|8
4598606|NCT01597245|7449775|FG016|Long Term Extension (Week 60 - Week 264)|Death|0
4598607|NCT01597245|7449776|FG017|Long Term Extension (Week 60 - Week 264)|Death|0
4598608|NCT01597245|7449777|FG018|Long Term Extension (Week 60 - Week 264)|Death|0
4598609|NCT01597245|7449778|FG019|Long Term Extension (Week 60 - Week 264)|Death|0
4598610|NCT01597245|7449779|FG020|Long Term Extension (Week 60 - Week 264)|Death|0
4598611|NCT01597245|7449759|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
4598612|NCT01597245|7449760|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
4598613|NCT01597245|7449761|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
4598614|NCT01597245|7449762|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
4598615|NCT01597245|7449763|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
4598616|NCT01597245|7449764|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
4598617|NCT01597245|7449765|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
4598618|NCT01597245|7449766|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
4598619|NCT01597245|7449767|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
4598620|NCT01597245|7449768|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
4598621|NCT01597245|7449769|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
4598622|NCT01597245|7449770|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
4598623|NCT01597245|7449771|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
4598624|NCT01597245|7449772|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
4598625|NCT01597245|7449773|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6
4598626|NCT01597245|7449774|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6
4598627|NCT01597245|7449775|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
4598628|NCT01597245|7449776|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
4598629|NCT01597245|7449777|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
4598630|NCT01597245|7449778|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
4598631|NCT01597245|7449779|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
4598632|NCT01597245|7449759|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
4598633|NCT01597245|7449760|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
4598634|NCT01597245|7449761|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
4598635|NCT01597245|7449762|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
4598636|NCT01597245|7449763|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
4598637|NCT01597245|7449764|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
4598638|NCT01597245|7449765|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
4598639|NCT01597245|7449766|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
4598640|NCT01597245|7449767|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
4598641|NCT01597245|7449768|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
4598642|NCT01597245|7449769|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
4598643|NCT01597245|7449770|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
4598644|NCT01597245|7449771|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
4635377|NCT01931956|7506822|FG003|Overall Study|Expected|0
4598645|NCT01597245|7449772|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
4598646|NCT01597245|7449773|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4
4598647|NCT01597245|7449774|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4
4598648|NCT01597245|7449775|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
4598649|NCT01597245|7449776|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
4598650|NCT01597245|7449777|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
4598651|NCT01597245|7449778|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
4598652|NCT01597245|7449779|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
4598653|NCT01597245|7449759|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
4598654|NCT01597245|7449760|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
4598655|NCT01597245|7449761|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
4598656|NCT01597245|7449762|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
4598657|NCT01597245|7449763|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
4598658|NCT01597245|7449764|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
4598659|NCT01597245|7449765|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
4598660|NCT01597245|7449766|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
4598661|NCT01597245|7449767|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
4598662|NCT01597245|7449768|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
4598663|NCT01597245|7449769|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
4598664|NCT01597245|7449770|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
4598665|NCT01597245|7449771|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
4598666|NCT01597245|7449772|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
4598667|NCT01597245|7449773|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1
4598668|NCT01597245|7449774|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1
4598669|NCT01597245|7449775|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
4598670|NCT01597245|7449776|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
4598671|NCT01597245|7449777|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
4598672|NCT01597245|7449778|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
4598673|NCT01597245|7449779|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
4598674|NCT01597245|7449759|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
4598675|NCT01597245|7449760|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
4598676|NCT01597245|7449761|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
4598677|NCT01597245|7449762|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
4598678|NCT01597245|7449763|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
4598679|NCT01597245|7449764|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
4598680|NCT01597245|7449765|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
4598681|NCT01597245|7449766|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
4598682|NCT01597245|7449767|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
4598683|NCT01597245|7449768|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
4598684|NCT01597245|7449769|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
4598685|NCT01597245|7449770|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
4598686|NCT01597245|7449771|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
4598687|NCT01597245|7449772|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23
4598688|NCT01597245|7449773|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
4598689|NCT01597245|7449774|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
4598690|NCT01597245|7449775|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
4598691|NCT01597245|7449776|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
4598692|NCT01597245|7449777|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
4598693|NCT01597245|7449778|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
4598694|NCT01597245|7449779|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
4598695|NCT01597245|7449759|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
4598696|NCT01597245|7449760|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
4598697|NCT01597245|7449761|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
4598698|NCT01597245|7449762|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
4598699|NCT01597245|7449763|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
4598700|NCT01597245|7449764|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
4598701|NCT01597245|7449765|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
4598702|NCT01597245|7449766|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
4598703|NCT01597245|7449767|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
4598704|NCT01597245|7449768|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
4598705|NCT01597245|7449769|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
4598706|NCT01597245|7449770|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
4598707|NCT01597245|7449771|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
4598708|NCT01597245|7449772|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
4598709|NCT01597245|7449773|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
4598710|NCT01597245|7449774|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
4598711|NCT01597245|7449775|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9
4598712|NCT01597245|7449776|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5
4598713|NCT01597245|7449777|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8
4598714|NCT01597245|7449778|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63
4598715|NCT01597245|7449779|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13
4598716|NCT01597245|7449759|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
4598717|NCT01597245|7449760|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
4598718|NCT01597245|7449761|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
4598719|NCT01597245|7449762|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
4598720|NCT01597245|7449763|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
4598721|NCT01597245|7449764|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
4598722|NCT01597245|7449765|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
4598723|NCT01597245|7449766|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
4598724|NCT01597245|7449767|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
4598725|NCT01597245|7449768|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
4598726|NCT01597245|7449769|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
4598727|NCT01597245|7449770|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
4598728|NCT01597245|7449771|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
4598729|NCT01597245|7449772|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
4598730|NCT01597245|7449773|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
4598731|NCT01597245|7449774|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
4598732|NCT01597245|7449775|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
4598733|NCT01597245|7449776|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1
4598734|NCT01597245|7449777|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1
4598735|NCT01597245|7449778|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41
4598736|NCT01597245|7449779|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13
4598737|NCT01597245|7449759|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
4598738|NCT01597245|7449760|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
4598739|NCT01597245|7449761|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
4598740|NCT01597245|7449762|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
4598741|NCT01597245|7449763|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
4598742|NCT01597245|7449764|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
4598743|NCT01597245|7449765|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
4598744|NCT01597245|7449766|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
4598745|NCT01597245|7449767|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
4598746|NCT01597245|7449768|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
4598747|NCT01597245|7449769|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
4598748|NCT01597245|7449770|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
4598749|NCT01597245|7449771|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
4598750|NCT01597245|7449772|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
4598751|NCT01597245|7449773|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
4598752|NCT01597245|7449774|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
4598753|NCT01597245|7449775|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2
4598754|NCT01597245|7449776|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
4598755|NCT01597245|7449777|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
4598756|NCT01597245|7449778|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29
4598757|NCT01597245|7449779|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3
4598758|NCT01597245|7449759|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
4598759|NCT01597245|7449760|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
4598760|NCT01597245|7449761|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
4598761|NCT01597245|7449762|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
4598762|NCT01597245|7449763|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
4598763|NCT01597245|7449764|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
4598764|NCT01597245|7449765|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
4598765|NCT01597245|7449766|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
4598766|NCT01597245|7449767|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
4598767|NCT01597245|7449768|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
4598768|NCT01597245|7449769|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
4598769|NCT01597245|7449770|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
4598770|NCT01597245|7449771|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
4598771|NCT01597245|7449772|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
4598772|NCT01597245|7449773|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
4598773|NCT01597245|7449774|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
4598774|NCT01597245|7449775|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
4598775|NCT01597245|7449776|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
4598776|NCT01597245|7449777|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1
4598777|NCT01597245|7449778|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14
4635378|NCT01931956|7506819|FG000|Overall Study|Not due|0
4598778|NCT01597245|7449779|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4
4598779|NCT01597245|7449759|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
4598780|NCT01597245|7449760|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
4598781|NCT01597245|7449761|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
4598782|NCT01597245|7449762|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
4598783|NCT01597245|7449763|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
4598784|NCT01597245|7449764|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
4598785|NCT01597245|7449765|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
4598786|NCT01597245|7449766|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
4598787|NCT01597245|7449767|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
4598788|NCT01597245|7449768|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
4598789|NCT01597245|7449769|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
4598790|NCT01597245|7449770|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
4598791|NCT01597245|7449771|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
4598792|NCT01597245|7449772|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
4598793|NCT01597245|7449773|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
4598794|NCT01597245|7449774|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
4598795|NCT01597245|7449775|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1
4598796|NCT01597245|7449776|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
4598797|NCT01597245|7449777|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
4598798|NCT01597245|7449778|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9
4598799|NCT01597245|7449779|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1
4598800|NCT01597245|7449759|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
4598801|NCT01597245|7449760|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
4598802|NCT01597245|7449761|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
4598803|NCT01597245|7449762|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
4598804|NCT01597245|7449763|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
4598805|NCT01597245|7449764|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
4598806|NCT01597245|7449765|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
4598807|NCT01597245|7449766|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
4598808|NCT01597245|7449767|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
4598809|NCT01597245|7449768|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
4598810|NCT01597245|7449769|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
4598811|NCT01597245|7449770|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
4598812|NCT01597245|7449771|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
4598813|NCT01597245|7449772|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
4598814|NCT01597245|7449773|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
4598815|NCT01597245|7449774|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
4598816|NCT01597245|7449775|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1
4598817|NCT01597245|7449776|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
4598818|NCT01597245|7449777|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
4598819|NCT01597245|7449778|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6
4598820|NCT01597245|7449779|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2
4598821|NCT01597245|7449759|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
4598822|NCT01597245|7449760|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
4598823|NCT01597245|7449761|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
4598824|NCT01597245|7449762|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
4598825|NCT01597245|7449763|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
4598826|NCT01597245|7449764|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
4598827|NCT01597245|7449765|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
4598828|NCT01597245|7449766|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
4598829|NCT01597245|7449767|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
4598830|NCT01597245|7449768|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
4598831|NCT01597245|7449769|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
4598832|NCT01597245|7449770|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
4598833|NCT01597245|7449771|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
4598834|NCT01597245|7449772|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
4598835|NCT01597245|7449773|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
4598836|NCT01597245|7449774|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
4598837|NCT01597245|7449775|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2
4635379|NCT01931956|7506820|FG001|Overall Study|Not due|0
4635380|NCT01931956|7506821|FG002|Overall Study|Not due|21
4635381|NCT01931956|7506822|FG003|Overall Study|Not due|0
4635382|NCT01931995|7506847|FG000|First Intervention (1 Day)|Withdrawal by Subject|2
4635383|NCT01931995|7506848|FG001|First Intervention (1 Day)|Withdrawal by Subject|2
4635384|NCT01931995|7506847|FG000|First Intervention (1 Day)|Physician Decision|1
4598838|NCT01597245|7449776|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
4598839|NCT01597245|7449777|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
4598840|NCT01597245|7449778|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3
4598841|NCT01597245|7449779|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
4598842|NCT01597245|7449759|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
4598843|NCT01597245|7449760|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
4598844|NCT01597245|7449761|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
4598845|NCT01597245|7449762|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
4598846|NCT01597245|7449763|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
4598847|NCT01597245|7449764|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
4598848|NCT01597245|7449765|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
4598849|NCT01597245|7449766|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
4598850|NCT01597245|7449767|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
4598851|NCT01597245|7449768|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
4598852|NCT01597245|7449769|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
4598853|NCT01597245|7449770|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
4598854|NCT01597245|7449771|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
4598855|NCT01597245|7449772|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
4598856|NCT01597245|7449773|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
4635385|NCT01931995|7506848|FG001|First Intervention (1 Day)|Physician Decision|1
4635386|NCT01931995|7506847|FG000|First Intervention (1 Day)|Lost to Follow-up|1
4635387|NCT01931995|7506848|FG001|First Intervention (1 Day)|Lost to Follow-up|1
4635388|NCT01932294|7506880|FG000|Overall Study|Death|43
4635389|NCT01932294|7506880|FG000|Overall Study|Lost to Follow-up|8
4598857|NCT01597245|7449774|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
4598858|NCT01597245|7449775|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1
4598859|NCT01597245|7449776|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
4598860|NCT01597245|7449777|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
4598861|NCT01597245|7449778|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1
4598862|NCT01597245|7449779|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
4598863|NCT01597245|7449759|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
4598864|NCT01597245|7449760|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
4598865|NCT01597245|7449761|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
4598866|NCT01597245|7449762|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
4598867|NCT01597245|7449763|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
4598868|NCT01597245|7449764|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
4598869|NCT01597245|7449765|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
4598870|NCT01597245|7449766|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
4598871|NCT01597245|7449767|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
4598872|NCT01597245|7449768|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
4598873|NCT01597245|7449769|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
4598874|NCT01597245|7449770|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
4598875|NCT01597245|7449771|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
4598876|NCT01597245|7449772|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
4598877|NCT01597245|7449773|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
4598878|NCT01597245|7449774|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
4598879|NCT01597245|7449775|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
4598880|NCT01597245|7449776|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
4598881|NCT01597245|7449777|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
4598882|NCT01597245|7449778|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1
4598883|NCT01597245|7449779|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
4598884|NCT01597258|7449812|FG000|Overall Study|No Drug Administration|1
4635390|NCT01932294|7506880|FG000|Overall Study|VAD Implantation|20
4635391|NCT01932294|7506880|FG000|Overall Study|Heart Transplantation|16
4598885|NCT01597375|7449816|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1
4598886|NCT01597375|7449817|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0
4598887|NCT01597375|7449816|FG000|First Intervention (4 Weeks)|Needed surgery|1
4598888|NCT01597375|7449817|FG001|First Intervention (4 Weeks)|Needed surgery|0
4598889|NCT01597375|7449816|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0
4598890|NCT01597375|7449817|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1
4598891|NCT01597375|7449816|FG000|Washout (2 Weeks)|Adverse Event|1
4598892|NCT01597375|7449817|FG001|Washout (2 Weeks)|Adverse Event|0
4598893|NCT01597375|7449816|FG000|Second Intervention|Failed to react at both Aspirin|1
4598894|NCT01597375|7449817|FG001|Second Intervention|Failed to react at both Aspirin|1
4598895|NCT01597479|7449837|FG000|Overall Study|Protocol Violation|1
4598896|NCT01597479|7449838|FG001|Overall Study|Protocol Violation|0
4598897|NCT01597479|7449837|FG000|Overall Study|Lost to Follow-up|1
4598898|NCT01597479|7449838|FG001|Overall Study|Lost to Follow-up|0
4598899|NCT01597492|7449847|FG000|Overall Study|Withdrawal by Subject|1
4598900|NCT01597492|7449848|FG001|Overall Study|Withdrawal by Subject|2
4598901|NCT01597492|7449847|FG000|Overall Study|Adverse Event|3
4598902|NCT01597492|7449848|FG001|Overall Study|Adverse Event|0
4635392|NCT01932294|7506880|FG000|Overall Study|Transferred to other hospitals|12
4635393|NCT01932437|7506887|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
4635394|NCT01932437|7506888|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
4598903|NCT01597492|7449847|FG000|Overall Study|Lost to Follow-up|0
4598904|NCT01597492|7449848|FG001|Overall Study|Lost to Follow-up|2
4598905|NCT01597492|7449847|FG000|Overall Study|Other Reason|2
4598906|NCT01597492|7449848|FG001|Overall Study|Other Reason|0
4598907|NCT01597505|7449856|FG000|Overall Study|Physician Decision|5
4598908|NCT01597505|7449857|FG001|Overall Study|Physician Decision|0
4598909|NCT01597505|7449856|FG000|Overall Study|Adverse Event|19
4598910|NCT01597505|7449857|FG001|Overall Study|Adverse Event|7
4598911|NCT01597505|7449856|FG000|Overall Study|Lost to Follow-up|4
4598912|NCT01597505|7449857|FG001|Overall Study|Lost to Follow-up|2
4598913|NCT01597505|7449856|FG000|Overall Study|Withdrawal by Subject|10
4598914|NCT01597505|7449857|FG001|Overall Study|Withdrawal by Subject|18
4598915|NCT01597505|7449856|FG000|Overall Study|Other|5
4598916|NCT01597505|7449857|FG001|Overall Study|Other|6
4598917|NCT01597505|7449856|FG000|Overall Study|Missing|1
4598918|NCT01597505|7449857|FG001|Overall Study|Missing|0
4598919|NCT01597557|7449866|FG000|Overall Study|Did not undergo cardioversion procedure|4
4598920|NCT01597557|7449867|FG001|Overall Study|Did not undergo cardioversion procedure|3
4598921|NCT01597596|7449875|FG000|Overall Study|Study terminated by sponsor|1
4598922|NCT01597596|7449876|FG001|Overall Study|Study terminated by sponsor|0
4598923|NCT01597596|7449875|FG000|Overall Study|Physician Decision|0
4598924|NCT01597596|7449876|FG001|Overall Study|Physician Decision|1
4598925|NCT01597622|7449882|FG000|Overall Study|Adverse Event|7
4598926|NCT01597622|7449882|FG000|Overall Study|Lack of Efficacy|3
4598927|NCT01597622|7449882|FG000|Overall Study|Protocol Violation|1
4598928|NCT01597622|7449882|FG000|Overall Study|Lost to Follow-up|1
4598929|NCT01597622|7449882|FG000|Overall Study|Investigator Discretion|5
4598930|NCT01597622|7449882|FG000|Overall Study|Withdrawal by Subject|20
4598931|NCT01597622|7449882|FG000|Overall Study|Death|1
4598932|NCT01597635|7449889|FG000|Part A|Adverse Event|3
4598933|NCT01597635|7449890|FG001|Part A|Adverse Event|0
4598934|NCT01597635|7449891|FG002|Part A|Adverse Event|0
4598935|NCT01597635|7449889|FG000|Part B|Adverse Event|0
4598936|NCT01597635|7449890|FG001|Part B|Adverse Event|0
4598937|NCT01597635|7449891|FG002|Part B|Adverse Event|1
4598938|NCT01597635|7449889|FG000|Part B|Protocol Violation|0
4598939|NCT01597635|7449890|FG001|Part B|Protocol Violation|1
4598940|NCT01597635|7449891|FG002|Part B|Protocol Violation|0
4598941|NCT01597635|7449889|FG000|Part B|Protocol-defined stopping criteria|0
4598942|NCT01597635|7449890|FG001|Part B|Protocol-defined stopping criteria|4
4598943|NCT01597635|7449891|FG002|Part B|Protocol-defined stopping criteria|3
4598944|NCT01597635|7449889|FG000|Part B|Withdrawal by Subject|0
4635395|NCT01932437|7506889|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
4635396|NCT01932437|7506890|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
4635397|NCT01932437|7506891|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
4635398|NCT01932437|7506892|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1
4635399|NCT01932697|7506924|FG000|Overall Study|Received a different amount of tx|1
4635400|NCT01932697|7506925|FG001|Overall Study|Received a different amount of tx|0
4635401|NCT01932697|7506924|FG000|Overall Study|Ineligible|1
4635402|NCT01932697|7506925|FG001|Overall Study|Ineligible|0
4635403|NCT01932762|7506937|FG000|Overall Study|Withdrawal by Subject|1
4635404|NCT01932762|7506938|FG001|Overall Study|Withdrawal by Subject|2
4635405|NCT01932762|7506939|FG002|Overall Study|Withdrawal by Subject|0
4635406|NCT01932762|7506940|FG003|Overall Study|Withdrawal by Subject|0
4635407|NCT01932762|7506937|FG000|Overall Study|Lost to Follow-up|4
4635408|NCT01932762|7506938|FG001|Overall Study|Lost to Follow-up|0
4635409|NCT01932762|7506939|FG002|Overall Study|Lost to Follow-up|0
4635410|NCT01932762|7506940|FG003|Overall Study|Lost to Follow-up|1
4635411|NCT01932762|7506937|FG000|Overall Study|Physician Decision|1
4635412|NCT01932762|7506938|FG001|Overall Study|Physician Decision|0
4635413|NCT01932762|7506939|FG002|Overall Study|Physician Decision|0
4635414|NCT01932762|7506940|FG003|Overall Study|Physician Decision|0
4746563|NCT00678041|7718233|FG000|Overall Study|Physician Decision|5
4746564|NCT00678041|7718234|FG001|Overall Study|Physician Decision|5
4746565|NCT00681629|7718252|FG000|Overall Study|Study termination|4
4746566|NCT00681629|7718253|FG001|Overall Study|Study termination|2
4746567|NCT00681629|7718252|FG000|Overall Study|Adverse Event|1
4746568|NCT00681629|7718253|FG001|Overall Study|Adverse Event|0
4746569|NCT00673361|7718313|FG000|Overall Study|Screen Failure|2
4746570|NCT00673179|7718330|FG000|Overall Study|Toxicity/Complications|3
4746571|NCT00673179|7718331|FG001|Overall Study|Toxicity/Complications|0
4746572|NCT00660348|7718350|FG000|Overall Study|Withdrawal by Subject|1
4746573|NCT00660348|7718351|FG001|Overall Study|Withdrawal by Subject|0
4746574|NCT00664066|7718357|FG000|Overall Study|Study terminated|3
4746575|NCT00667017|7718361|FG000|Overall Study|Withdrawal by Subject|1
4598945|NCT01597635|7449890|FG001|Part B|Withdrawal by Subject|1
4598946|NCT01597635|7449891|FG002|Part B|Withdrawal by Subject|0
4598947|NCT01597791|7449931|FG000|Overall Study|Physician Decision|2
4598948|NCT01597791|7449932|FG001|Overall Study|Physician Decision|1
4598949|NCT01597791|7449931|FG000|Overall Study|Cesarean Section|6
4598950|NCT01597791|7449932|FG001|Overall Study|Cesarean Section|7
4598951|NCT01597791|7449931|FG000|Overall Study|Subject withdrawal|0
4598952|NCT01597791|7449932|FG001|Overall Study|Subject withdrawal|1
4598953|NCT01597791|7449931|FG000|Overall Study|Protocol Violation|0
4598954|NCT01597791|7449932|FG001|Overall Study|Protocol Violation|1
4598955|NCT01597908|7449967|FG000|Randomized Phase|Death|217
4598956|NCT01597908|7449968|FG001|Randomized Phase|Death|238
4598957|NCT01597908|7449969|FG002|Randomized Phase|Death|0
4598958|NCT01597908|7449967|FG000|Randomized Phase|Sponsor Decision|93
4598959|NCT01597908|7449968|FG001|Randomized Phase|Sponsor Decision|39
4598960|NCT01597908|7449969|FG002|Randomized Phase|Sponsor Decision|0
4598961|NCT01597908|7449967|FG000|Randomized Phase|Lost to Follow-up|9
4598962|NCT01597908|7449968|FG001|Randomized Phase|Lost to Follow-up|16
4598963|NCT01597908|7449969|FG002|Randomized Phase|Lost to Follow-up|0
4598964|NCT01597908|7449967|FG000|Randomized Phase|Physician Decision|6
4598965|NCT01597908|7449968|FG001|Randomized Phase|Physician Decision|3
4598966|NCT01597908|7449969|FG002|Randomized Phase|Physician Decision|0
4598967|NCT01597908|7449967|FG000|Randomized Phase|Withdrawal by Subject|26
4598968|NCT01597908|7449968|FG001|Randomized Phase|Withdrawal by Subject|22
4598969|NCT01597908|7449969|FG002|Randomized Phase|Withdrawal by Subject|0
4598970|NCT01597908|7449967|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0
4598971|NCT01597908|7449968|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34
4598972|NCT01597908|7449969|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0
4598973|NCT01597908|7449967|FG000|Crossover Phase|Death|0
4598974|NCT01597908|7449968|FG001|Crossover Phase|Death|0
4598975|NCT01597908|7449969|FG002|Crossover Phase|Death|11
4598976|NCT01597908|7449967|FG000|Crossover Phase|Withdrawal by Subject|0
4598977|NCT01597908|7449968|FG001|Crossover Phase|Withdrawal by Subject|0
4598978|NCT01597908|7449969|FG002|Crossover Phase|Withdrawal by Subject|3
4598979|NCT01597908|7449967|FG000|Crossover Phase|Sponsor Decision|0
4598980|NCT01597908|7449968|FG001|Crossover Phase|Sponsor Decision|0
4598981|NCT01597908|7449969|FG002|Crossover Phase|Sponsor Decision|20
4598982|NCT01597973|7449980|FG000|Overall Study|Found ineligible before study medication started|4
4598983|NCT01597973|7449981|FG001|Overall Study|Found ineligible before study medication started|2
4598984|NCT01597973|7449980|FG000|Overall Study|Eligible pathogen not confirmed|14
4598985|NCT01597973|7449981|FG001|Overall Study|Eligible pathogen not confirmed|15
4598986|NCT01597973|7449980|FG000|Overall Study|LAR not authorized to consent|0
4598987|NCT01597973|7449981|FG001|Overall Study|LAR not authorized to consent|1
4598988|NCT01597973|7449980|FG000|Overall Study|Ineligible due to early seizures|1
4598989|NCT01597973|7449981|FG001|Overall Study|Ineligible due to early seizures|0
4598990|NCT01597973|7449980|FG000|Overall Study|Ineligible due to non-target infection|1
4598991|NCT01597973|7449981|FG001|Overall Study|Ineligible due to non-target infection|1
4598992|NCT01598090|7450003|FG000|Treatment Period|Poor/non-compliance|0
4598993|NCT01598090|7450004|FG001|Treatment Period|Poor/non-compliance|2
4598994|NCT01598090|7450005|FG002|Treatment Period|Poor/non-compliance|0
4598995|NCT01598090|7450003|FG000|Treatment Period|No longer meet study criteria|0
4598996|NCT01598090|7450004|FG001|Treatment Period|No longer meet study criteria|1
4598997|NCT01598090|7450005|FG002|Treatment Period|No longer meet study criteria|0
4598998|NCT01598090|7450003|FG000|Treatment Period|Lack of Efficacy|5
4598999|NCT01598090|7450004|FG001|Treatment Period|Lack of Efficacy|14
4599000|NCT01598090|7450005|FG002|Treatment Period|Lack of Efficacy|6
4599001|NCT01598090|7450003|FG000|Treatment Period|Adverse Event|2
4599002|NCT01598090|7450004|FG001|Treatment Period|Adverse Event|33
4599003|NCT01598090|7450005|FG002|Treatment Period|Adverse Event|17
4599004|NCT01598090|7450003|FG000|Treatment Period|Other reasons|0
4599005|NCT01598090|7450004|FG001|Treatment Period|Other reasons|4
4599006|NCT01598090|7450005|FG002|Treatment Period|Other reasons|1
4599007|NCT01598090|7450003|FG000|Treatment Period|Withdrawal by Subject|3
4599008|NCT01598090|7450004|FG001|Treatment Period|Withdrawal by Subject|13
4599009|NCT01598090|7450005|FG002|Treatment Period|Withdrawal by Subject|10
4599010|NCT01598090|7450003|FG000|Treatment Period|Lost to Follow-up|1
4599011|NCT01598090|7450004|FG001|Treatment Period|Lost to Follow-up|5
4599012|NCT01598090|7450005|FG002|Treatment Period|Lost to Follow-up|1
4599013|NCT01598090|7450003|FG000|Follow-up Period|Death|0
4599014|NCT01598090|7450004|FG001|Follow-up Period|Death|1
4599015|NCT01598090|7450005|FG002|Follow-up Period|Death|0
4599016|NCT01598090|7450003|FG000|Follow-up Period|No longer required per protocol|1
4599017|NCT01598090|7450004|FG001|Follow-up Period|No longer required per protocol|3
4599018|NCT01598090|7450005|FG002|Follow-up Period|No longer required per protocol|2
4599019|NCT01598090|7450003|FG000|Follow-up Period|Not reported|0
4599020|NCT01598090|7450004|FG001|Follow-up Period|Not reported|10
4599021|NCT01598090|7450005|FG002|Follow-up Period|Not reported|4
4599022|NCT01598090|7450003|FG000|Follow-up Period|Withdrawal by Subject|0
4599023|NCT01598090|7450004|FG001|Follow-up Period|Withdrawal by Subject|3
4599024|NCT01598090|7450005|FG002|Follow-up Period|Withdrawal by Subject|2
4599025|NCT01598090|7450003|FG000|Follow-up Period|Other reasons|2
4599026|NCT01598090|7450004|FG001|Follow-up Period|Other reasons|8
4599027|NCT01598090|7450005|FG002|Follow-up Period|Other reasons|8
4599028|NCT01598090|7450003|FG000|Follow-up Period|Lost to Follow-up|2
4599029|NCT01598090|7450004|FG001|Follow-up Period|Lost to Follow-up|10
4599030|NCT01598090|7450005|FG002|Follow-up Period|Lost to Follow-up|12
4599031|NCT01598129|7450016|FG000|Overall Study|Disease progression|6
4599032|NCT01598129|7450016|FG000|Overall Study|Deterioration of WHO status to WHO 4|2
4599033|NCT01598129|7450016|FG000|Overall Study|Withdrawal by Subject|1
4599034|NCT01598298|7450045|FG000|Overall Study|Not eligible|5
4599035|NCT01598298|7450046|FG001|Overall Study|Not eligible|5
4599036|NCT01598298|7450045|FG000|Overall Study|Adverse Event|21
4599037|NCT01598298|7450046|FG001|Overall Study|Adverse Event|19
4599038|NCT01598298|7450045|FG000|Overall Study|Progression/relapse|0
4599039|NCT01598298|7450046|FG001|Overall Study|Progression/relapse|2
4599040|NCT01598298|7450045|FG000|Overall Study|Withdrawal by Subject|10
4599041|NCT01598298|7450046|FG001|Overall Study|Withdrawal by Subject|15
4599042|NCT01598298|7450045|FG000|Overall Study|Other reason (not protocol specified)|4
4599043|NCT01598298|7450046|FG001|Overall Study|Other reason (not protocol specified)|0
4599044|NCT01598311|7450054|FG000|Overall Study|Physician Decision|4
4599045|NCT01598311|7450055|FG001|Overall Study|Physician Decision|5
4599046|NCT01598311|7450054|FG000|Overall Study|Adverse Event|9
4599047|NCT01598311|7450055|FG001|Overall Study|Adverse Event|13
4599048|NCT01598311|7450054|FG000|Overall Study|Lost to Follow-up|7
4599049|NCT01598311|7450055|FG001|Overall Study|Lost to Follow-up|12
4599050|NCT01598311|7450054|FG000|Overall Study|Withdrawal by Subject|9
4599051|NCT01598311|7450055|FG001|Overall Study|Withdrawal by Subject|13
4599052|NCT01598311|7450054|FG000|Overall Study|No reason provided.|0
4599053|NCT01598311|7450055|FG001|Overall Study|No reason provided.|5
4599054|NCT01598311|7450054|FG000|Overall Study|Randomized but never treated|8
4599055|NCT01598311|7450055|FG001|Overall Study|Randomized but never treated|5
4599056|NCT01598311|7450054|FG000|Overall Study|Treated but no confirmed CDAD|9
4599057|NCT01598311|7450055|FG001|Overall Study|Treated but no confirmed CDAD|8
4599058|NCT01598311|7450054|FG000|Overall Study|Assigned to CB but received vancomycin|1
4599059|NCT01598311|7450055|FG001|Overall Study|Assigned to CB but received vancomycin|0
4599060|NCT01598506|7450070|FG000|Overall Study|Withdrawal by Subject|2
4599061|NCT01598532|7450075|FG000|Overall Study|Lost to Follow-up|3
4599062|NCT01598532|7450075|FG000|Overall Study|Did not meet inclusion criteria|8
4599063|NCT01598610|7450086|FG000|Overall Study|Adverse Event|1
4599064|NCT01598662|7450092|FG000|Overall Study|Lost to Follow-up|10
4599065|NCT01598662|7450093|FG001|Overall Study|Lost to Follow-up|17
4599066|NCT01598662|7450092|FG000|Overall Study|Physician Decision|1
4599067|NCT01598662|7450093|FG001|Overall Study|Physician Decision|2
4599068|NCT01598662|7450092|FG000|Overall Study|IUD expelled before month 6|0
4599069|NCT01598662|7450093|FG001|Overall Study|IUD expelled before month 6|2
4599070|NCT01598753|7450122|FG000|Overall Study|Adverse Event|1
4599071|NCT01598753|7450123|FG001|Overall Study|Adverse Event|9
4599072|NCT01598753|7450124|FG002|Overall Study|Adverse Event|1
4599073|NCT01598753|7450125|FG003|Overall Study|Adverse Event|7
4599074|NCT01598753|7450122|FG000|Overall Study|Lost to Follow-up|4
4599075|NCT01598753|7450123|FG001|Overall Study|Lost to Follow-up|3
4599076|NCT01598753|7450124|FG002|Overall Study|Lost to Follow-up|7
4599077|NCT01598753|7450125|FG003|Overall Study|Lost to Follow-up|5
4599078|NCT01598753|7450122|FG000|Overall Study|Physician Decision|0
4599079|NCT01598753|7450123|FG001|Overall Study|Physician Decision|1
4599080|NCT01598753|7450124|FG002|Overall Study|Physician Decision|0
4599081|NCT01598753|7450125|FG003|Overall Study|Physician Decision|2
4599082|NCT01598753|7450122|FG000|Overall Study|Withdrawal by Subject|7
4599083|NCT01598753|7450123|FG001|Overall Study|Withdrawal by Subject|2
4599084|NCT01598753|7450124|FG002|Overall Study|Withdrawal by Subject|0
4599085|NCT01598753|7450125|FG003|Overall Study|Withdrawal by Subject|1
4599086|NCT01598896|7450150|FG000|Overall Study|Withdrawal by Subject|0
4599087|NCT01598896|7450151|FG001|Overall Study|Withdrawal by Subject|1
4599088|NCT01598896|7450150|FG000|Overall Study|Lack of Efficacy|0
4599089|NCT01598896|7450151|FG001|Overall Study|Lack of Efficacy|1
4599090|NCT01598987|7450166|FG000|Baseline to Month 12|Administrative problems|2
4599091|NCT01598987|7450166|FG000|Baseline to Month 12|Withdrawal by Subject|4
4599092|NCT01598987|7450166|FG000|Baseline to 24 Month|Withdrawal by Subject|5
4599093|NCT01598987|7450166|FG000|Baseline to 24 Month|Administrative problems|2
4599094|NCT01598987|7450166|FG000|Baseline to 24 Month|Lost to Follow-up|1
4599095|NCT01599104|7450180|FG000|Overall Study|Withdrawal by Subject|1
4599096|NCT01599104|7450181|FG001|Overall Study|Withdrawal by Subject|1
4599097|NCT01599104|7450182|FG002|Overall Study|Withdrawal by Subject|2
4599098|NCT01599104|7450180|FG000|Overall Study|Technical Problems|1
4599099|NCT01599104|7450181|FG001|Overall Study|Technical Problems|0
4599100|NCT01599104|7450182|FG002|Overall Study|Technical Problems|0
4599101|NCT01599104|7450180|FG000|Overall Study|Physician Decision|3
4599102|NCT01599104|7450181|FG001|Overall Study|Physician Decision|2
4599103|NCT01599104|7450182|FG002|Overall Study|Physician Decision|2
4599104|NCT01599104|7450180|FG000|Overall Study|Non-compliance with study treatment|0
4599105|NCT01599104|7450181|FG001|Overall Study|Non-compliance with study treatment|1
4599106|NCT01599104|7450182|FG002|Overall Study|Non-compliance with study treatment|0
4599107|NCT01599104|7450180|FG000|Overall Study|Lack of Efficacy|4
4599108|NCT01599104|7450181|FG001|Overall Study|Lack of Efficacy|4
4599109|NCT01599104|7450182|FG002|Overall Study|Lack of Efficacy|10
4599110|NCT01599104|7450180|FG000|Overall Study|Adverse Event|7
4599111|NCT01599104|7450181|FG001|Overall Study|Adverse Event|6
4599112|NCT01599104|7450182|FG002|Overall Study|Adverse Event|12
4599113|NCT01599234|7450192|FG000|Overall Study|Adverse Event|9
4599114|NCT01599234|7450193|FG001|Overall Study|Adverse Event|5
4599115|NCT01599234|7450192|FG000|Overall Study|Withdrawal by Subject|2
4599116|NCT01599234|7450193|FG001|Overall Study|Withdrawal by Subject|1
4599117|NCT01599234|7450192|FG000|Overall Study|Lost to Follow-up|1
4599118|NCT01599234|7450193|FG001|Overall Study|Lost to Follow-up|2
4599119|NCT01599234|7450192|FG000|Overall Study|Lack of Efficacy|2
4599120|NCT01599234|7450193|FG001|Overall Study|Lack of Efficacy|4
4599121|NCT01599234|7450192|FG000|Overall Study|Unable to operate spray|1
4599122|NCT01599234|7450193|FG001|Overall Study|Unable to operate spray|0
4599123|NCT01599234|7450192|FG000|Overall Study|Sponsor request as creatinine levels <50|0
4599124|NCT01599234|7450193|FG001|Overall Study|Sponsor request as creatinine levels <50|1
4599125|NCT01599234|7450192|FG000|Overall Study|Death|1
4599126|NCT01599234|7450193|FG001|Overall Study|Death|0
4599127|NCT01599234|7450192|FG000|Overall Study|Patient would not stop driving|1
4599128|NCT01599234|7450193|FG001|Overall Study|Patient would not stop driving|0
4599129|NCT01599234|7450192|FG000|Overall Study|Contra-indication discovered|0
4599130|NCT01599234|7450193|FG001|Overall Study|Contra-indication discovered|1
4599131|NCT01599234|7450192|FG000|Overall Study|Pregnancy|0
4599132|NCT01599234|7450193|FG001|Overall Study|Pregnancy|1
4599133|NCT01599325|7450208|FG000|Primary Parent Phase|Adverse Event|5
4599134|NCT01599325|7450208|FG000|Primary Parent Phase|Disease Progression|7
4599135|NCT01599325|7450208|FG000|Primary Parent Phase|Withdrawal by Subject|20
4599136|NCT01599325|7450208|FG000|Primary Parent Phase|Death|13
4599137|NCT01599325|7450208|FG000|Primary Parent Phase|Protocol Violation|1
4599138|NCT01599325|7450208|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9
4599139|NCT01599325|7450208|FG000|Primary Parent Phase|Other|2
4599140|NCT01599325|7450208|FG000|Extension Phase|Study Closure|1
4599141|NCT01599325|7450208|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1
4599142|NCT01599325|7450208|FG000|Extension Phase|Lack of Therapeutic Effect|4
4599143|NCT01599325|7450208|FG000|Extension Phase|Disease Progression|1
4599144|NCT01599325|7450208|FG000|Extension Phase|Withdrawal by Subject|8
4599145|NCT01599585|7450215|FG000|Overall Study|Withdrawal by Subject|16
4599146|NCT01599585|7450216|FG001|Overall Study|Withdrawal by Subject|9
4599147|NCT01599585|7450215|FG000|Overall Study|Lost to Follow-up|3
4599148|NCT01599585|7450216|FG001|Overall Study|Lost to Follow-up|5
4599149|NCT01599585|7450215|FG000|Overall Study|randomized did not start treatment|3
4599150|NCT01599585|7450216|FG001|Overall Study|randomized did not start treatment|3
4599151|NCT01599637|7450225|FG000|Overall Study|administrative problems|0
4599152|NCT01599637|7450226|FG001|Overall Study|administrative problems|2
4599153|NCT01599637|7450227|FG002|Overall Study|administrative problems|0
4599154|NCT01599637|7450225|FG000|Overall Study|Adverse Event|1
4599155|NCT01599637|7450226|FG001|Overall Study|Adverse Event|0
4599156|NCT01599637|7450227|FG002|Overall Study|Adverse Event|0
4599157|NCT01599650|7450240|FG000|Overall Study|Administrative issue|1
4599158|NCT01599650|7450241|FG001|Overall Study|Administrative issue|0
4599159|NCT01599650|7450242|FG002|Overall Study|Administrative issue|1
4599160|NCT01599650|7450240|FG000|Overall Study|Physician Decision|2
4599161|NCT01599650|7450241|FG001|Overall Study|Physician Decision|0
4599162|NCT01599650|7450242|FG002|Overall Study|Physician Decision|7
4599163|NCT01599650|7450240|FG000|Overall Study|Protocol Violation|0
4599164|NCT01599650|7450241|FG001|Overall Study|Protocol Violation|3
4599165|NCT01599650|7450242|FG002|Overall Study|Protocol Violation|0
4599166|NCT01599650|7450240|FG000|Overall Study|Death|2
4599167|NCT01599650|7450241|FG001|Overall Study|Death|1
4599168|NCT01599650|7450242|FG002|Overall Study|Death|2
4599169|NCT01599650|7450240|FG000|Overall Study|Lost to Follow-up|3
4599170|NCT01599650|7450241|FG001|Overall Study|Lost to Follow-up|3
4599171|NCT01599650|7450242|FG002|Overall Study|Lost to Follow-up|3
4599172|NCT01599650|7450240|FG000|Overall Study|Withdrawal by Subject|11
4599173|NCT01599650|7450241|FG001|Overall Study|Withdrawal by Subject|11
4599174|NCT01599650|7450242|FG002|Overall Study|Withdrawal by Subject|10
4599175|NCT01599650|7450240|FG000|Overall Study|Adverse Event|3
4599176|NCT01599650|7450241|FG001|Overall Study|Adverse Event|8
4635415|NCT01932788|7506952|FG000|Overall Study|Protocol Violation|18
4635416|NCT01932788|7506953|FG001|Overall Study|Protocol Violation|0
4635417|NCT01932788|7506952|FG000|Overall Study|Lost to Follow-up|18
4635418|NCT01932788|7506953|FG001|Overall Study|Lost to Follow-up|46
4635419|NCT01932788|7506952|FG000|Overall Study|Lack of Efficacy|2
4635420|NCT01932788|7506953|FG001|Overall Study|Lack of Efficacy|0
4635421|NCT01932788|7506952|FG000|Overall Study|Withdrawal by Subject|0
4635422|NCT01932788|7506953|FG001|Overall Study|Withdrawal by Subject|5
4635423|NCT01932970|7506959|FG000|Overall Study|Withdrawal by Subject|5
4635424|NCT01932970|7506959|FG000|Overall Study|Death|1
4635425|NCT01932970|7506959|FG000|Overall Study|Lost to Follow-up|2
4635426|NCT01932970|7506959|FG000|Overall Study|Protocol Specified Criteria|10
4635427|NCT01932996|7506965|FG000|Overall Study|Protocol Violation|2
4635428|NCT01932996|7506966|FG001|Overall Study|Protocol Violation|0
4635429|NCT01933048|7506974|FG000|Overall Study|Lost to Follow-up|15
4635430|NCT01933048|7506975|FG001|Overall Study|Lost to Follow-up|18
4635431|NCT01933048|7506974|FG000|Overall Study|personal reasons|1
4635432|NCT01933048|7506975|FG001|Overall Study|personal reasons|1
4635433|NCT01933048|7506974|FG000|Overall Study|Protocol Violation|7
4635434|NCT01933048|7506975|FG001|Overall Study|Protocol Violation|8
4599177|NCT01599650|7450242|FG002|Overall Study|Adverse Event|4
4599178|NCT01599754|7450254|FG000|Overall Study|Anticancer therapy need not in protocol|5
4599179|NCT01599754|7450255|FG001|Overall Study|Anticancer therapy need not in protocol|2
4599180|NCT01599754|7450254|FG000|Overall Study|Participant noncompliance|4
4599181|NCT01599754|7450255|FG001|Overall Study|Participant noncompliance|4
4599182|NCT01599754|7450254|FG000|Overall Study|Lost to Follow-up|13
4599183|NCT01599754|7450255|FG001|Overall Study|Lost to Follow-up|6
4599184|NCT01599754|7450254|FG000|Overall Study|Death|31
4599185|NCT01599754|7450255|FG001|Overall Study|Death|33
4599186|NCT01599754|7450254|FG000|Overall Study|Adverse Event|3
4599187|NCT01599754|7450255|FG001|Overall Study|Adverse Event|2
4599188|NCT01599754|7450254|FG000|Overall Study|Investigator decision|1
4599189|NCT01599754|7450255|FG001|Overall Study|Investigator decision|3
4599190|NCT01599754|7450254|FG000|Overall Study|Withdrawal by Subject|24
4599191|NCT01599754|7450255|FG001|Overall Study|Withdrawal by Subject|25
4599192|NCT01599754|7450254|FG000|Overall Study|Study terminated by sponsor|282
4599193|NCT01599754|7450255|FG001|Overall Study|Study terminated by sponsor|285
4599194|NCT01599793|7450261|FG000|Overall Study|Adverse Event|2
4599195|NCT01599806|7450267|FG000|Overall Study|Lost to Follow-up|20
4599196|NCT01599806|7450268|FG001|Overall Study|Lost to Follow-up|20
4599197|NCT01599806|7450267|FG000|Overall Study|Withdrawal by Subject|12
4599198|NCT01599806|7450268|FG001|Overall Study|Withdrawal by Subject|12
4599199|NCT01599806|7450267|FG000|Overall Study|Other Eligibility criteria|11
4599200|NCT01599806|7450268|FG001|Overall Study|Other Eligibility criteria|9
4599201|NCT01600014|7450278|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24
4599202|NCT01600014|7450279|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0
4599203|NCT01600014|7450278|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203
4599204|NCT01600014|7450279|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0
4599205|NCT01600014|7450278|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6
4599206|NCT01600014|7450279|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0
4599207|NCT01600014|7450278|FG000|1. Cycle & Observation Period D1 to W52|Other|27
4599208|NCT01600014|7450279|FG001|1. Cycle & Observation Period D1 to W52|Other|0
4599209|NCT01600014|7450278|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14
4599210|NCT01600014|7450279|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0
4599211|NCT01600014|7450278|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6
4599212|NCT01600014|7450279|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0
4599213|NCT01600014|7450278|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8
4599214|NCT01600014|7450279|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0
4599215|NCT01600014|7450278|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1
4599216|NCT01600014|7450279|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2
4599217|NCT01600014|7450278|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1
4599218|NCT01600014|7450279|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3
4599219|NCT01600014|7450278|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2
4599220|NCT01600014|7450279|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1
4599221|NCT01600014|7450278|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1
4599222|NCT01600014|7450279|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0
4599223|NCT01600014|7450278|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5
4599224|NCT01600014|7450279|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0
4599225|NCT01600014|7450278|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1
4599226|NCT01600014|7450279|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1
4599227|NCT01600014|7450278|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1
4599228|NCT01600014|7450279|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3
4599229|NCT01600014|7450278|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1
4635435|NCT01933048|7506974|FG000|Overall Study|Physician Decision|1
4599230|NCT01600014|7450279|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0
4599231|NCT01600014|7450278|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1
4599232|NCT01600014|7450279|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0
4599233|NCT01600014|7450278|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1
4599234|NCT01600014|7450279|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0
4599235|NCT01600053|7450297|FG000|Overall Study|Adverse Event|2
4599236|NCT01600053|7450297|FG000|Overall Study|trial will not meet the interim endpoint|9
4635436|NCT01933048|7506975|FG001|Overall Study|Physician Decision|0
4635437|NCT01933048|7506974|FG000|Overall Study|unknown reasons|1
4635438|NCT01933048|7506975|FG001|Overall Study|unknown reasons|1
4635439|NCT01933113|7506984|FG000|Overall Study|Fractured nonfunctioning lead.|1
4635440|NCT01933217|7506990|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1
4635441|NCT01933217|7506991|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3
4635442|NCT01933217|7506990|FG000|Randomization (4 Weeks)|Lost to Follow-up|1
4635443|NCT01933217|7506991|FG001|Randomization (4 Weeks)|Lost to Follow-up|1
4635444|NCT01933334|7507014|FG000|Overall Study|Adverse Event|5
4635445|NCT01933334|7507015|FG001|Overall Study|Adverse Event|1
4635446|NCT01933334|7507014|FG000|Overall Study|Withdrawal by Subject|0
4635447|NCT01933334|7507015|FG001|Overall Study|Withdrawal by Subject|1
4635448|NCT01933594|7507058|FG000|Overall Study|Lost to Follow-up|1
4599237|NCT01600092|7450303|FG000|Overall Study|Adverse Event|2
4635449|NCT01933594|7507059|FG001|Overall Study|Lost to Follow-up|0
4635450|NCT01933594|7507060|FG002|Overall Study|Lost to Follow-up|0
4635451|NCT01933594|7507061|FG003|Overall Study|Lost to Follow-up|0
4635452|NCT01933594|7507062|FG004|Overall Study|Lost to Follow-up|1
4599238|NCT01600092|7450304|FG001|Overall Study|Adverse Event|0
4599239|NCT01600092|7450303|FG000|Overall Study|Lost to Follow-up|4
4599240|NCT01600092|7450304|FG001|Overall Study|Lost to Follow-up|6
4599241|NCT01600092|7450303|FG000|Overall Study|Withdrawal by parent/guardian|8
4599242|NCT01600092|7450304|FG001|Overall Study|Withdrawal by parent/guardian|6
4599243|NCT01600092|7450303|FG000|Overall Study|Physician Decision|1
4599244|NCT01600092|7450304|FG001|Overall Study|Physician Decision|1
4599245|NCT01600092|7450303|FG000|Overall Study|Randomized but not vaccinated|3
4599246|NCT01600092|7450304|FG001|Overall Study|Randomized but not vaccinated|3
4599247|NCT01600105|7450312|FG000|Total Participants|Withdrawal by Subject|1
4599248|NCT01600105|7450313|FG001|Total Participants|Withdrawal by Subject|0
4599249|NCT01600105|7450312|FG000|Total Participants|No images in PACS|10
4599250|NCT01600105|7450313|FG001|Total Participants|No images in PACS|0
4599251|NCT01600105|7450312|FG000|Total Participants|Insufficient image quality|30
4599252|NCT01600105|7450313|FG001|Total Participants|Insufficient image quality|10
4599253|NCT01600105|7450312|FG000|Sub Study I|Insufficient image quality|0
4599254|NCT01600105|7450313|FG001|Sub Study I|Insufficient image quality|10
4599255|NCT01600105|7450312|FG000|Sub Study II|Withdrawal by Subject|1
4599256|NCT01600105|7450313|FG001|Sub Study II|Withdrawal by Subject|0
4599257|NCT01600105|7450312|FG000|Sub Study II|No images in PACS|1
4599258|NCT01600105|7450313|FG001|Sub Study II|No images in PACS|0
4599259|NCT01600105|7450312|FG000|Sub Study II|Insufficient image quality|3
4599260|NCT01600105|7450313|FG001|Sub Study II|Insufficient image quality|0
4599261|NCT01600105|7450312|FG000|Sub Study III|Insufficient image quality|5
4599262|NCT01600105|7450313|FG001|Sub Study III|Insufficient image quality|0
4599263|NCT01600105|7450312|FG000|Sub Study V|Poor Image Quality|2
4599264|NCT01600105|7450313|FG001|Sub Study V|Poor Image Quality|0
4635453|NCT01933594|7507063|FG005|Overall Study|Lost to Follow-up|0
4635454|NCT01933594|7507058|FG000|Overall Study|Ineligible for subsequent study step|0
4635455|NCT01933594|7507059|FG001|Overall Study|Ineligible for subsequent study step|0
4635456|NCT01933594|7507060|FG002|Overall Study|Ineligible for subsequent study step|0
4635457|NCT01933594|7507061|FG003|Overall Study|Ineligible for subsequent study step|0
4635458|NCT01933594|7507062|FG004|Overall Study|Ineligible for subsequent study step|1
4635459|NCT01933594|7507063|FG005|Overall Study|Ineligible for subsequent study step|0
4635460|NCT01933672|7507081|FG000|Metformin Run-in Period|Adverse Event|1
4635461|NCT01933672|7507082|FG001|Metformin Run-in Period|Adverse Event|0
4635462|NCT01933672|7507083|FG002|Metformin Run-in Period|Adverse Event|0
4635463|NCT01933672|7507084|FG003|Metformin Run-in Period|Adverse Event|0
4635464|NCT01933672|7507085|FG004|Metformin Run-in Period|Adverse Event|0
4635465|NCT01933672|7507086|FG005|Metformin Run-in Period|Adverse Event|0
4635466|NCT01933672|7507087|FG006|Metformin Run-in Period|Adverse Event|0
4635467|NCT01933672|7507081|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4
4635468|NCT01933672|7507082|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0
4635469|NCT01933672|7507083|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0
4635470|NCT01933672|7507084|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0
4635471|NCT01933672|7507085|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0
4635472|NCT01933672|7507086|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0
4635473|NCT01933672|7507087|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0
4635474|NCT01933672|7507081|FG000|Metformin Run-in Period|Other|5
4635475|NCT01933672|7507082|FG001|Metformin Run-in Period|Other|0
4635476|NCT01933672|7507083|FG002|Metformin Run-in Period|Other|0
4635477|NCT01933672|7507084|FG003|Metformin Run-in Period|Other|0
4635478|NCT01933672|7507085|FG004|Metformin Run-in Period|Other|0
4635479|NCT01933672|7507086|FG005|Metformin Run-in Period|Other|0
4635480|NCT01933672|7507087|FG006|Metformin Run-in Period|Other|0
4635481|NCT01933672|7507081|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0
4635482|NCT01933672|7507082|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0
4635483|NCT01933672|7507083|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0
4635484|NCT01933672|7507084|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0
4635485|NCT01933672|7507085|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1
4635486|NCT01933672|7507086|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0
4635487|NCT01933672|7507087|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0
4635488|NCT01933672|7507081|FG000|First Intervention Period (12-16 Days)|Other|0
4635489|NCT01933672|7507082|FG001|First Intervention Period (12-16 Days)|Other|0
4635490|NCT01933672|7507083|FG002|First Intervention Period (12-16 Days)|Other|1
4635491|NCT01933672|7507084|FG003|First Intervention Period (12-16 Days)|Other|0
4635492|NCT01933672|7507085|FG004|First Intervention Period (12-16 Days)|Other|0
4635493|NCT01933672|7507086|FG005|First Intervention Period (12-16 Days)|Other|1
4635494|NCT01933672|7507087|FG006|First Intervention Period (12-16 Days)|Other|0
4635495|NCT01933672|7507081|FG000|Second Intervention Period (12-16 Days)|Other|0
4635496|NCT01933672|7507082|FG001|Second Intervention Period (12-16 Days)|Other|1
4635497|NCT01933672|7507083|FG002|Second Intervention Period (12-16 Days)|Other|1
4635498|NCT01933672|7507084|FG003|Second Intervention Period (12-16 Days)|Other|0
4635499|NCT01933672|7507085|FG004|Second Intervention Period (12-16 Days)|Other|0
4635500|NCT01933672|7507086|FG005|Second Intervention Period (12-16 Days)|Other|0
4635501|NCT01933672|7507087|FG006|Second Intervention Period (12-16 Days)|Other|0
4635502|NCT01933672|7507081|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
4599265|NCT01600326|7450350|FG000|Overall Study|Lost to Follow-up|1
4599266|NCT01600326|7450351|FG001|Overall Study|Lost to Follow-up|1
4599267|NCT01600586|7450378|FG000|Overall Study|Physician Decision|3
4599268|NCT01600586|7450379|FG001|Overall Study|Physician Decision|3
4599269|NCT01600716|7450414|FG000|Overall Study|Other Reasons|3
4599270|NCT01600716|7450415|FG001|Overall Study|Other Reasons|1
4599271|NCT01600716|7450414|FG000|Overall Study|Personal Reasons|0
4599272|NCT01600716|7450415|FG001|Overall Study|Personal Reasons|2
4599273|NCT01600716|7450414|FG000|Overall Study|Lost to Follow-up|0
4599274|NCT01600716|7450415|FG001|Overall Study|Lost to Follow-up|2
4599275|NCT01600716|7450414|FG000|Overall Study|Pregnancy|1
4599276|NCT01600716|7450415|FG001|Overall Study|Pregnancy|0
4599277|NCT01600716|7450414|FG000|Overall Study|Lack of Efficacy|2
4599278|NCT01600716|7450415|FG001|Overall Study|Lack of Efficacy|1
4599279|NCT01600716|7450414|FG000|Overall Study|Adverse Event|1
4599280|NCT01600716|7450415|FG001|Overall Study|Adverse Event|1
4599281|NCT01600885|7450427|FG000|First Period|Adverse Event|1
4599282|NCT01600885|7450428|FG001|First Period|Adverse Event|1
4599283|NCT01600885|7450427|FG000|First Period|moved out of area|1
4599284|NCT01600885|7450428|FG001|First Period|moved out of area|0
4599285|NCT01601132|7450450|FG000|Overall Study|Patient withdrew consent|1
4599286|NCT01601132|7450450|FG000|Overall Study|Protocol deviation|1
4599287|NCT01601470|7450486|FG000|Period 2 - LCZ696|Physician Decision|1
4599288|NCT01601496|7450492|FG000|Overall Study|Physician Decision|1
4599289|NCT01601496|7450492|FG000|Overall Study|Withdrawal by Subject|1
4599290|NCT01601496|7450492|FG000|Overall Study|Lost to Follow-up|6
4599291|NCT01601496|7450492|FG000|Overall Study|Death|4
4599292|NCT01601496|7450492|FG000|Overall Study|Other: patient refusal to continue|3
4599293|NCT01601535|7450502|FG000|Phase 1|Adverse Event|1
4599294|NCT01601535|7450503|FG001|Phase 1|Adverse Event|0
4599295|NCT01601535|7450504|FG002|Phase 1|Adverse Event|2
4599296|NCT01601535|7450505|FG003|Phase 1|Adverse Event|1
4599297|NCT01601535|7450506|FG004|Phase 1|Adverse Event|0
4599298|NCT01601535|7450507|FG005|Phase 1|Adverse Event|0
4599299|NCT01601535|7450502|FG000|Phase 1|Withdrawal by Subject|2
4599300|NCT01601535|7450503|FG001|Phase 1|Withdrawal by Subject|1
4599301|NCT01601535|7450504|FG002|Phase 1|Withdrawal by Subject|1
4599302|NCT01601535|7450505|FG003|Phase 1|Withdrawal by Subject|2
4599303|NCT01601535|7450506|FG004|Phase 1|Withdrawal by Subject|0
4599304|NCT01601535|7450507|FG005|Phase 1|Withdrawal by Subject|0
4599305|NCT01601535|7450502|FG000|Phase 1|Progressive Disease|2
4599306|NCT01601535|7450503|FG001|Phase 1|Progressive Disease|3
4599307|NCT01601535|7450504|FG002|Phase 1|Progressive Disease|2
4599308|NCT01601535|7450505|FG003|Phase 1|Progressive Disease|1
4599309|NCT01601535|7450506|FG004|Phase 1|Progressive Disease|0
4599310|NCT01601535|7450507|FG005|Phase 1|Progressive Disease|0
4599311|NCT01601535|7450502|FG000|Phase 1|Started Another Treatment|1
4599312|NCT01601535|7450503|FG001|Phase 1|Started Another Treatment|2
4599313|NCT01601535|7450504|FG002|Phase 1|Started Another Treatment|0
4599314|NCT01601535|7450505|FG003|Phase 1|Started Another Treatment|0
4599315|NCT01601535|7450506|FG004|Phase 1|Started Another Treatment|0
4599316|NCT01601535|7450507|FG005|Phase 1|Started Another Treatment|0
4599317|NCT01601535|7450502|FG000|Phase 2|Adverse Event|0
4599318|NCT01601535|7450503|FG001|Phase 2|Adverse Event|0
4599319|NCT01601535|7450504|FG002|Phase 2|Adverse Event|0
4599320|NCT01601535|7450505|FG003|Phase 2|Adverse Event|0
4599321|NCT01601535|7450506|FG004|Phase 2|Adverse Event|5
4599322|NCT01601535|7450507|FG005|Phase 2|Adverse Event|1
4599323|NCT01601535|7450502|FG000|Phase 2|Withdrawal by Subject|0
4599324|NCT01601535|7450503|FG001|Phase 2|Withdrawal by Subject|0
4599325|NCT01601535|7450504|FG002|Phase 2|Withdrawal by Subject|0
4599326|NCT01601535|7450505|FG003|Phase 2|Withdrawal by Subject|0
4599327|NCT01601535|7450506|FG004|Phase 2|Withdrawal by Subject|8
4599328|NCT01601535|7450507|FG005|Phase 2|Withdrawal by Subject|2
4599329|NCT01601535|7450502|FG000|Phase 2|Progressive Disease|0
4599330|NCT01601535|7450503|FG001|Phase 2|Progressive Disease|0
4599331|NCT01601535|7450504|FG002|Phase 2|Progressive Disease|0
4599332|NCT01601535|7450505|FG003|Phase 2|Progressive Disease|0
4599333|NCT01601535|7450506|FG004|Phase 2|Progressive Disease|5
4599334|NCT01601535|7450507|FG005|Phase 2|Progressive Disease|7
4599335|NCT01601535|7450502|FG000|Phase 2|Started Another Treatment|0
4599336|NCT01601535|7450503|FG001|Phase 2|Started Another Treatment|0
4599337|NCT01601535|7450504|FG002|Phase 2|Started Another Treatment|0
4599338|NCT01601535|7450505|FG003|Phase 2|Started Another Treatment|0
4599339|NCT01601535|7450506|FG004|Phase 2|Started Another Treatment|1
4599340|NCT01601535|7450507|FG005|Phase 2|Started Another Treatment|2
4599341|NCT01601626|7450533|FG000|Overall Study|Death|1
4599342|NCT01601626|7450534|FG001|Overall Study|Death|1
4599343|NCT01601626|7450535|FG002|Overall Study|Death|1
4599344|NCT01601626|7450533|FG000|Overall Study|Lost to Follow-up|1
4599345|NCT01601626|7450534|FG001|Overall Study|Lost to Follow-up|2
4599346|NCT01601626|7450535|FG002|Overall Study|Lost to Follow-up|0
4599347|NCT01601626|7450533|FG000|Overall Study|Unable to Get to Clinic|0
4599348|NCT01601626|7450534|FG001|Overall Study|Unable to Get to Clinic|1
4599349|NCT01601626|7450535|FG002|Overall Study|Unable to Get to Clinic|0
4599350|NCT01601626|7450533|FG000|Overall Study|Withdrawal by Subject|0
4599351|NCT01601626|7450534|FG001|Overall Study|Withdrawal by Subject|1
4599352|NCT01601626|7450535|FG002|Overall Study|Withdrawal by Subject|1
4599353|NCT01601626|7450533|FG000|Overall Study|Not Willing to Adhere to Requirements|1
4599354|NCT01601626|7450534|FG001|Overall Study|Not Willing to Adhere to Requirements|0
4599355|NCT01601626|7450535|FG002|Overall Study|Not Willing to Adhere to Requirements|0
4599356|NCT01601652|7450543|FG000|Overall Study|Death|1
4599357|NCT01601704|7450553|FG000|Overall Study|Randomized but not dispensed study med|1
4599358|NCT01601704|7450554|FG001|Overall Study|Randomized but not dispensed study med|4
4599359|NCT01601821|7450566|FG000|Overall Study|Death|2
4599360|NCT01601821|7450567|FG001|Overall Study|Death|5
4599361|NCT01601821|7450566|FG000|Overall Study|Protocol Violation|2
4599362|NCT01601821|7450567|FG001|Overall Study|Protocol Violation|2
4599363|NCT01601821|7450566|FG000|Overall Study|Lost to Follow-up|6
4599364|NCT01601821|7450567|FG001|Overall Study|Lost to Follow-up|14
4599365|NCT01601821|7450566|FG000|Overall Study|Withdrawal by Subject|1
4599366|NCT01601821|7450567|FG001|Overall Study|Withdrawal by Subject|0
4599367|NCT01601821|7450566|FG000|Overall Study|Graft Loss|6
4599368|NCT01601821|7450567|FG001|Overall Study|Graft Loss|6
4599369|NCT01601821|7450566|FG000|Overall Study|Study Events|7
4599370|NCT01601821|7450567|FG001|Overall Study|Study Events|1
4599371|NCT01601821|7450566|FG000|Overall Study|Other|5
4599372|NCT01601821|7450567|FG001|Overall Study|Other|1
4599373|NCT01601847|7450575|FG000|Overall Study|Death|1
4599374|NCT01601847|7450576|FG001|Overall Study|Death|0
4599375|NCT01601847|7450575|FG000|Overall Study|Withdrawal by Subject|11
4599376|NCT01601847|7450576|FG001|Overall Study|Withdrawal by Subject|7
4599377|NCT01601847|7450575|FG000|Overall Study|Lost to Follow-up|1
4599378|NCT01601847|7450576|FG001|Overall Study|Lost to Follow-up|3
4599379|NCT01601873|7450594|FG000|Overall Study|Lost to Follow-up|2
4599380|NCT01601873|7450595|FG001|Overall Study|Lost to Follow-up|3
4599381|NCT01602120|7450620|FG000|Overall Study|Adverse Event|3
4599382|NCT01602120|7450621|FG001|Overall Study|Adverse Event|6
4599383|NCT01602120|7450622|FG002|Overall Study|Adverse Event|0
4599384|NCT01602120|7450623|FG003|Overall Study|Adverse Event|2
4599385|NCT01602120|7450620|FG000|Overall Study|Death|0
4599386|NCT01602120|7450621|FG001|Overall Study|Death|4
4599387|NCT01602120|7450622|FG002|Overall Study|Death|0
4599388|NCT01602120|7450623|FG003|Overall Study|Death|0
4599389|NCT01602120|7450620|FG000|Overall Study|Lost to Follow-up|0
4599390|NCT01602120|7450621|FG001|Overall Study|Lost to Follow-up|1
4599391|NCT01602120|7450622|FG002|Overall Study|Lost to Follow-up|0
4599392|NCT01602120|7450623|FG003|Overall Study|Lost to Follow-up|1
4599393|NCT01602120|7450620|FG000|Overall Study|Protocol Violation|1
4599394|NCT01602120|7450621|FG001|Overall Study|Protocol Violation|1
4599395|NCT01602120|7450622|FG002|Overall Study|Protocol Violation|0
4599396|NCT01602120|7450623|FG003|Overall Study|Protocol Violation|0
4599397|NCT01602120|7450620|FG000|Overall Study|Non-compliance|0
4599398|NCT01602120|7450621|FG001|Overall Study|Non-compliance|3
4599399|NCT01602120|7450622|FG002|Overall Study|Non-compliance|0
4599400|NCT01602120|7450623|FG003|Overall Study|Non-compliance|1
4599401|NCT01602120|7450620|FG000|Overall Study|Withdrawal by Subject|8
4599402|NCT01602120|7450621|FG001|Overall Study|Withdrawal by Subject|17
4599403|NCT01602120|7450622|FG002|Overall Study|Withdrawal by Subject|0
4599404|NCT01602120|7450623|FG003|Overall Study|Withdrawal by Subject|3
4599405|NCT01602120|7450620|FG000|Overall Study|Study Terminated by Sponsor|12
4599406|NCT01602120|7450621|FG001|Overall Study|Study Terminated by Sponsor|24
4599407|NCT01602120|7450622|FG002|Overall Study|Study Terminated by Sponsor|17
4599408|NCT01602120|7450623|FG003|Overall Study|Study Terminated by Sponsor|44
4599409|NCT01602120|7450620|FG000|Overall Study|Physician Decision|2
4599410|NCT01602120|7450621|FG001|Overall Study|Physician Decision|3
4599411|NCT01602120|7450622|FG002|Overall Study|Physician Decision|0
4599412|NCT01602120|7450623|FG003|Overall Study|Physician Decision|0
4599413|NCT01602120|7450620|FG000|Overall Study|Unspecified Reason|3
4599414|NCT01602120|7450621|FG001|Overall Study|Unspecified Reason|1
4599415|NCT01602120|7450622|FG002|Overall Study|Unspecified Reason|0
4599416|NCT01602120|7450623|FG003|Overall Study|Unspecified Reason|2
4599417|NCT01602224|7450657|FG000|Overall Study|Adverse Event|0
4599418|NCT01602224|7450658|FG001|Overall Study|Adverse Event|1
4599419|NCT01602224|7450659|FG002|Overall Study|Adverse Event|0
4599420|NCT01602224|7450657|FG000|Overall Study|Investigator Decison|1
4599421|NCT01602224|7450658|FG001|Overall Study|Investigator Decison|0
4599422|NCT01602224|7450659|FG002|Overall Study|Investigator Decison|0
4599423|NCT01602224|7450657|FG000|Overall Study|Lost to Follow-up|0
4599424|NCT01602224|7450658|FG001|Overall Study|Lost to Follow-up|0
4599425|NCT01602224|7450659|FG002|Overall Study|Lost to Follow-up|1
4599426|NCT01602224|7450657|FG000|Overall Study|Protocol Violation|0
4599427|NCT01602224|7450658|FG001|Overall Study|Protocol Violation|1
4599428|NCT01602224|7450659|FG002|Overall Study|Protocol Violation|0
4599429|NCT01602224|7450657|FG000|Overall Study|Sponsor Decision|2
4599430|NCT01602224|7450658|FG001|Overall Study|Sponsor Decision|3
4599431|NCT01602224|7450659|FG002|Overall Study|Sponsor Decision|2
4599432|NCT01602224|7450657|FG000|Overall Study|Withdrawal by Subject|5
4599433|NCT01602224|7450658|FG001|Overall Study|Withdrawal by Subject|3
4599434|NCT01602224|7450659|FG002|Overall Study|Withdrawal by Subject|3
4599435|NCT01602315|7450676|FG000|Overall Study|Protocol Violation|0
4599436|NCT01602315|7450677|FG001|Overall Study|Protocol Violation|0
4599437|NCT01602315|7450678|FG002|Overall Study|Protocol Violation|0
4599438|NCT01602315|7450679|FG003|Overall Study|Protocol Violation|0
4599439|NCT01602315|7450680|FG004|Overall Study|Protocol Violation|0
4599440|NCT01602315|7450681|FG005|Overall Study|Protocol Violation|1
4599441|NCT01602315|7450682|FG006|Overall Study|Protocol Violation|0
4599442|NCT01602315|7450676|FG000|Overall Study|Physician Decision|2
4599443|NCT01602315|7450677|FG001|Overall Study|Physician Decision|0
4599444|NCT01602315|7450678|FG002|Overall Study|Physician Decision|0
4599445|NCT01602315|7450679|FG003|Overall Study|Physician Decision|0
4599446|NCT01602315|7450680|FG004|Overall Study|Physician Decision|2
4599447|NCT01602315|7450681|FG005|Overall Study|Physician Decision|1
4599448|NCT01602315|7450682|FG006|Overall Study|Physician Decision|1
4599449|NCT01602315|7450676|FG000|Overall Study|Disease progression|6
4599450|NCT01602315|7450677|FG001|Overall Study|Disease progression|3
4599451|NCT01602315|7450678|FG002|Overall Study|Disease progression|10
4599452|NCT01602315|7450679|FG003|Overall Study|Disease progression|1
4599453|NCT01602315|7450680|FG004|Overall Study|Disease progression|41
4599454|NCT01602315|7450681|FG005|Overall Study|Disease progression|12
4599455|NCT01602315|7450682|FG006|Overall Study|Disease progression|15
4599456|NCT01602315|7450676|FG000|Overall Study|Death|1
4599457|NCT01602315|7450677|FG001|Overall Study|Death|1
4599458|NCT01602315|7450678|FG002|Overall Study|Death|1
4599459|NCT01602315|7450679|FG003|Overall Study|Death|1
4599460|NCT01602315|7450680|FG004|Overall Study|Death|7
4599461|NCT01602315|7450681|FG005|Overall Study|Death|2
4599462|NCT01602315|7450682|FG006|Overall Study|Death|2
4599463|NCT01602315|7450676|FG000|Overall Study|Withdrawal by Subject|2
4599464|NCT01602315|7450677|FG001|Overall Study|Withdrawal by Subject|0
4599465|NCT01602315|7450678|FG002|Overall Study|Withdrawal by Subject|2
4599466|NCT01602315|7450679|FG003|Overall Study|Withdrawal by Subject|0
4599467|NCT01602315|7450680|FG004|Overall Study|Withdrawal by Subject|6
4599468|NCT01602315|7450681|FG005|Overall Study|Withdrawal by Subject|0
4599469|NCT01602315|7450682|FG006|Overall Study|Withdrawal by Subject|1
4599470|NCT01602315|7450676|FG000|Overall Study|Adverse Event|5
4599471|NCT01602315|7450677|FG001|Overall Study|Adverse Event|1
4599472|NCT01602315|7450678|FG002|Overall Study|Adverse Event|5
4599473|NCT01602315|7450679|FG003|Overall Study|Adverse Event|4
4599474|NCT01602315|7450680|FG004|Overall Study|Adverse Event|15
4599475|NCT01602315|7450681|FG005|Overall Study|Adverse Event|3
4599476|NCT01602315|7450682|FG006|Overall Study|Adverse Event|9
4599477|NCT01602315|7450676|FG000|Overall Study|Subject/guardian decision|0
4599478|NCT01602315|7450677|FG001|Overall Study|Subject/guardian decision|0
4599479|NCT01602315|7450678|FG002|Overall Study|Subject/guardian decision|0
4599480|NCT01602315|7450679|FG003|Overall Study|Subject/guardian decision|0
4599481|NCT01602315|7450680|FG004|Overall Study|Subject/guardian decision|0
4599482|NCT01602315|7450681|FG005|Overall Study|Subject/guardian decision|0
4599483|NCT01602315|7450682|FG006|Overall Study|Subject/guardian decision|1
4599484|NCT01602315|7450676|FG000|Overall Study|Cross-over patients to combo treatment|0
4599485|NCT01602315|7450677|FG001|Overall Study|Cross-over patients to combo treatment|0
4599486|NCT01602315|7450678|FG002|Overall Study|Cross-over patients to combo treatment|0
4599487|NCT01602315|7450679|FG003|Overall Study|Cross-over patients to combo treatment|0
4599488|NCT01602315|7450680|FG004|Overall Study|Cross-over patients to combo treatment|0
4599489|NCT01602315|7450681|FG005|Overall Study|Cross-over patients to combo treatment|16
4599490|NCT01602315|7450682|FG006|Overall Study|Cross-over patients to combo treatment|0
4599491|NCT01602341|7450720|FG000|Overall Study|Adverse Event|0
4599492|NCT01602341|7450721|FG001|Overall Study|Adverse Event|1
4599493|NCT01602419|7450731|FG000|Overall Study|Not treated with Wilate|9
4599494|NCT01602419|7450731|FG000|Overall Study|Adverse Drug Reaction|4
4599495|NCT01602419|7450731|FG000|Overall Study|Insurance issues|3
4599496|NCT01602419|7450731|FG000|Overall Study|Changed treatment centre|1
4599497|NCT01602419|7450731|FG000|Overall Study|Treatment centre closed|1
4599498|NCT01602419|7450731|FG000|Overall Study|Withdrawal by Subject|5
4599499|NCT01602419|7450731|FG000|Overall Study|Lost to Follow-up|6
4599500|NCT01602484|7450778|FG000|Overall Study|Airway issues unrelated to study|0
4599501|NCT01602484|7450779|FG001|Overall Study|Airway issues unrelated to study|1
4599502|NCT01602510|7450785|FG000|Open Label Phase|Adverse Event|46
4599503|NCT01602510|7450786|FG001|Open Label Phase|Adverse Event|0
4599504|NCT01602510|7450787|FG002|Open Label Phase|Adverse Event|0
4599505|NCT01602510|7450785|FG000|Open Label Phase|Lack of Efficacy|22
4599506|NCT01602510|7450786|FG001|Open Label Phase|Lack of Efficacy|0
4599507|NCT01602510|7450787|FG002|Open Label Phase|Lack of Efficacy|0
4599508|NCT01602510|7450785|FG000|Open Label Phase|Protocol Violation|15
4599509|NCT01602510|7450786|FG001|Open Label Phase|Protocol Violation|0
4599510|NCT01602510|7450787|FG002|Open Label Phase|Protocol Violation|0
4599511|NCT01602510|7450785|FG000|Open Label Phase|Met protocol-defined stopping criteria|122
4599512|NCT01602510|7450786|FG001|Open Label Phase|Met protocol-defined stopping criteria|0
4599513|NCT01602510|7450787|FG002|Open Label Phase|Met protocol-defined stopping criteria|0
4599514|NCT01602510|7450785|FG000|Open Label Phase|Lost to Follow-up|22
4599515|NCT01602510|7450786|FG001|Open Label Phase|Lost to Follow-up|0
4599516|NCT01602510|7450787|FG002|Open Label Phase|Lost to Follow-up|0
4599517|NCT01602510|7450785|FG000|Open Label Phase|Physician Decision|19
4599518|NCT01602510|7450786|FG001|Open Label Phase|Physician Decision|0
4599519|NCT01602510|7450787|FG002|Open Label Phase|Physician Decision|0
4599520|NCT01602510|7450785|FG000|Open Label Phase|Withdrawal by Subject|57
4599521|NCT01602510|7450786|FG001|Open Label Phase|Withdrawal by Subject|0
4599522|NCT01602510|7450787|FG002|Open Label Phase|Withdrawal by Subject|0
4599523|NCT01602510|7450785|FG000|Randomized Phase|Adverse Event|0
4599524|NCT01602510|7450786|FG001|Randomized Phase|Adverse Event|2
4599525|NCT01602510|7450787|FG002|Randomized Phase|Adverse Event|6
4599526|NCT01602510|7450785|FG000|Randomized Phase|Lack of Efficacy|0
4599527|NCT01602510|7450786|FG001|Randomized Phase|Lack of Efficacy|4
4599528|NCT01602510|7450787|FG002|Randomized Phase|Lack of Efficacy|4
4599529|NCT01602510|7450785|FG000|Randomized Phase|Protocol Violation|0
4599530|NCT01602510|7450786|FG001|Randomized Phase|Protocol Violation|3
4599531|NCT01602510|7450787|FG002|Randomized Phase|Protocol Violation|3
4599532|NCT01602510|7450785|FG000|Randomized Phase|Met protocol-defined stopping criteria|0
4599533|NCT01602510|7450786|FG001|Randomized Phase|Met protocol-defined stopping criteria|58
4599534|NCT01602510|7450787|FG002|Randomized Phase|Met protocol-defined stopping criteria|48
4599535|NCT01602510|7450785|FG000|Randomized Phase|Lost to Follow-up|0
4599536|NCT01602510|7450786|FG001|Randomized Phase|Lost to Follow-up|1
4599537|NCT01602510|7450787|FG002|Randomized Phase|Lost to Follow-up|3
4599538|NCT01602510|7450785|FG000|Randomized Phase|Physician Decision|0
4599539|NCT01602510|7450786|FG001|Randomized Phase|Physician Decision|0
4599540|NCT01602510|7450787|FG002|Randomized Phase|Physician Decision|2
4599541|NCT01602510|7450785|FG000|Randomized Phase|Withdrawal by Subject|0
4599542|NCT01602510|7450786|FG001|Randomized Phase|Withdrawal by Subject|6
4599543|NCT01602510|7450787|FG002|Randomized Phase|Withdrawal by Subject|7
4599544|NCT01602549|7450795|FG000|Overall Study|Protocol Violation|0
4599545|NCT01602549|7450796|FG001|Overall Study|Protocol Violation|1
4599546|NCT01602549|7450795|FG000|Overall Study|Withdrawal by Subject|1
4599547|NCT01602549|7450796|FG001|Overall Study|Withdrawal by Subject|0
4599548|NCT01602562|7450806|FG000|Overall Study|Adverse Event|3
4599549|NCT01602562|7450807|FG001|Overall Study|Adverse Event|1
4599550|NCT01602562|7450806|FG000|Overall Study|Physician Decision|1
4599551|NCT01602562|7450807|FG001|Overall Study|Physician Decision|1
4599552|NCT01602562|7450806|FG000|Overall Study|Withdrawal by Subject|1
4599553|NCT01602562|7450807|FG001|Overall Study|Withdrawal by Subject|1
4599554|NCT01602744|7450865|FG000|Overall Study|Death|17
4599555|NCT01602744|7450866|FG001|Overall Study|Death|15
4599556|NCT01602744|7450865|FG000|Overall Study|Lost to Follow-up|13
4599557|NCT01602744|7450866|FG001|Overall Study|Lost to Follow-up|8
4599558|NCT01602965|7450874|FG000|Overall Study|Lost to Follow-up|4
4599559|NCT01602965|7450875|FG001|Overall Study|Lost to Follow-up|2
4599560|NCT01603082|7450892|FG000|Overall Study|Adverse Event|0
4599561|NCT01603082|7450893|FG001|Overall Study|Adverse Event|1
4599562|NCT01603082|7450892|FG000|Overall Study|Withdrawal by Subject|1
4746576|NCT00665444|7718365|FG000|Overall Study|Physician Decision|1
4599563|NCT01603082|7450893|FG001|Overall Study|Withdrawal by Subject|0
4599564|NCT01603082|7450892|FG000|Overall Study|Failed inclusion criterion after dosed|1
4599565|NCT01603082|7450893|FG001|Overall Study|Failed inclusion criterion after dosed|0
4599566|NCT01603277|7450901|FG000|Overall Study|Adverse Event|1
4599567|NCT01603277|7450902|FG001|Overall Study|Adverse Event|2
4599568|NCT01603277|7450901|FG000|Overall Study|Physician Decision|0
4599569|NCT01603277|7450902|FG001|Overall Study|Physician Decision|1
4599570|NCT01603277|7450901|FG000|Overall Study|Protocol Violation|6
4599571|NCT01603277|7450902|FG001|Overall Study|Protocol Violation|10
4599572|NCT01603277|7450901|FG000|Overall Study|Withdrawal by Subject|5
4599573|NCT01603277|7450902|FG001|Overall Study|Withdrawal by Subject|4
4599574|NCT01603277|7450901|FG000|Overall Study|Non-Compliance|2
4599575|NCT01603277|7450902|FG001|Overall Study|Non-Compliance|1
4599576|NCT01603355|7450908|FG000|Overall Study|Lack of Efficacy|2
4599577|NCT01603459|7450933|FG000|Overall Study|Adverse Event|5
4599578|NCT01603459|7450933|FG000|Overall Study|Withdrawal by Subject|5
4599579|NCT01603459|7450933|FG000|Overall Study|Lost to Follow-up|3
4599580|NCT01603459|7450933|FG000|Overall Study|Predefined discontinuation criteria|3
4599581|NCT01603459|7450933|FG000|Overall Study|Non-compliance|1
4599582|NCT01603459|7450933|FG000|Overall Study|Administrative reason|1
4599583|NCT01603602|7450958|FG000|Overall Study|Adverse Event|1
4599584|NCT01603602|7450959|FG001|Overall Study|Adverse Event|0
4599585|NCT01603602|7450960|FG002|Overall Study|Adverse Event|0
4599586|NCT01603602|7450958|FG000|Overall Study|Personal Reasons|1
4599587|NCT01603602|7450959|FG001|Overall Study|Personal Reasons|0
4599588|NCT01603602|7450960|FG002|Overall Study|Personal Reasons|1
4599589|NCT01603615|7450968|FG000|Overall Study|Did not Receive Treatment|7
4599590|NCT01603615|7450968|FG000|Overall Study|Lost to Follow-up|9
4599591|NCT01603615|7450968|FG000|Overall Study|Personal Reasons|17
4599592|NCT01603615|7450968|FG000|Overall Study|Other Miscellaneous|1
4599593|NCT01603628|7450975|FG000|Overall Study|Personal Reasons|1
4599594|NCT01603628|7450976|FG001|Overall Study|Personal Reasons|1
4599595|NCT01603628|7450977|FG002|Overall Study|Personal Reasons|2
4599596|NCT01603628|7450975|FG000|Overall Study|Protocol Violation|1
4599597|NCT01603628|7450976|FG001|Overall Study|Protocol Violation|1
4599598|NCT01603628|7450977|FG002|Overall Study|Protocol Violation|0
4599599|NCT01603628|7450975|FG000|Overall Study|Lost to Follow-up|0
4599600|NCT01603628|7450976|FG001|Overall Study|Lost to Follow-up|1
4599601|NCT01603628|7450977|FG002|Overall Study|Lost to Follow-up|0
4599602|NCT01603628|7450975|FG000|Overall Study|Other Miscellaneous Reason|1
4599603|NCT01603628|7450976|FG001|Overall Study|Other Miscellaneous Reason|0
4599604|NCT01603628|7450977|FG002|Overall Study|Other Miscellaneous Reason|0
4599605|NCT01603641|7450985|FG000|Overall Study|Did not Receive Treatment|3
4599606|NCT01603641|7450985|FG000|Overall Study|Adverse Event|1
4599607|NCT01603641|7450985|FG000|Overall Study|Lack of Efficacy|1
4599608|NCT01603641|7450985|FG000|Overall Study|Lost to Follow-up|6
4599609|NCT01603641|7450985|FG000|Overall Study|Personal Reasons|18
4599610|NCT01603641|7450985|FG000|Overall Study|Other Miscellaneous Reasons|6
4599611|NCT01603875|7450992|FG000|Overall Study|Preexisting rabies antibody|3
4599612|NCT01603875|7450993|FG001|Overall Study|Preexisting rabies antibody|4
4599613|NCT01603875|7450994|FG002|Overall Study|Preexisting rabies antibody|3
4599614|NCT01603875|7450992|FG000|Overall Study|Lost to Follow-up|4
4599615|NCT01603875|7450993|FG001|Overall Study|Lost to Follow-up|3
4599616|NCT01603875|7450994|FG002|Overall Study|Lost to Follow-up|6
4599617|NCT01603875|7450992|FG000|Overall Study|Protocol Violation|0
4746577|NCT00665444|7718365|FG000|Overall Study|Study Terminated by Study Sponsor|1
4746578|NCT00660595|7718380|FG000|Overall Study|Lost to Follow-up|0
4746579|NCT00660595|7718381|FG001|Overall Study|Lost to Follow-up|1
4599618|NCT01603875|7450993|FG001|Overall Study|Protocol Violation|1
4599619|NCT01603875|7450994|FG002|Overall Study|Protocol Violation|0
4599620|NCT01604265|7451032|FG000|Overall Study|Adverse Event|1
4599621|NCT01604265|7451033|FG001|Overall Study|Adverse Event|0
4599622|NCT01604265|7451032|FG000|Overall Study|Withdrawal by Subject|1
4599623|NCT01604265|7451033|FG001|Overall Study|Withdrawal by Subject|0
4599624|NCT01604278|7451041|FG000|Overall Study|Lack of Efficacy|0
4599625|NCT01604278|7451042|FG001|Overall Study|Lack of Efficacy|1
4599626|NCT01604278|7451041|FG000|Overall Study|Lost to Follow-up|1
4599627|NCT01604278|7451042|FG001|Overall Study|Lost to Follow-up|0
4599628|NCT01604278|7451041|FG000|Overall Study|Administrative problems|2
4599629|NCT01604278|7451042|FG001|Overall Study|Administrative problems|1
4599630|NCT01604278|7451041|FG000|Overall Study|Withdrawal by Subject|3
4599631|NCT01604278|7451042|FG001|Overall Study|Withdrawal by Subject|3
4599632|NCT01604278|7451041|FG000|Overall Study|Adverse Event|3
4599633|NCT01604278|7451042|FG001|Overall Study|Adverse Event|5
4599634|NCT01604278|7451041|FG000|Overall Study|Protocol Deviation|5
4599635|NCT01604278|7451042|FG001|Overall Study|Protocol Deviation|3
4599636|NCT01604343|7451076|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5
4599637|NCT01604343|7451077|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0
4599638|NCT01604343|7451078|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4
4599639|NCT01604343|7451079|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0
4599640|NCT01604343|7451080|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3
4599641|NCT01604343|7451076|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19
4599642|NCT01604343|7451077|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0
4599643|NCT01604343|7451078|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12
4599644|NCT01604343|7451079|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0
4599645|NCT01604343|7451080|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16
4599646|NCT01604343|7451076|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25
4599647|NCT01604343|7451077|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0
4599648|NCT01604343|7451078|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41
4599649|NCT01604343|7451079|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0
4599650|NCT01604343|7451080|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42
4599651|NCT01604343|7451076|FG000|Prior to W52 Administration(Through W52)|Death|5
4599652|NCT01604343|7451077|FG001|Prior to W52 Administration(Through W52)|Death|0
4599653|NCT01604343|7451078|FG002|Prior to W52 Administration(Through W52)|Death|2
4599654|NCT01604343|7451079|FG003|Prior to W52 Administration(Through W52)|Death|0
4599655|NCT01604343|7451080|FG004|Prior to W52 Administration(Through W52)|Death|4
4599656|NCT01604343|7451076|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24
4599657|NCT01604343|7451077|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0
4599658|NCT01604343|7451078|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5
4599659|NCT01604343|7451079|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0
4599660|NCT01604343|7451080|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14
4599661|NCT01604343|7451076|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4
4599662|NCT01604343|7451077|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0
4599663|NCT01604343|7451078|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1
4599664|NCT01604343|7451079|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0
4599665|NCT01604343|7451080|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2
4599666|NCT01604343|7451076|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1
4599667|NCT01604343|7451077|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0
4599668|NCT01604343|7451078|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1
4599669|NCT01604343|7451079|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0
4599670|NCT01604343|7451080|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0
4599671|NCT01604343|7451076|FG000|Prior to W52 Administration(Through W52)|Other|15
4599672|NCT01604343|7451077|FG001|Prior to W52 Administration(Through W52)|Other|0
4599673|NCT01604343|7451078|FG002|Prior to W52 Administration(Through W52)|Other|10
4599674|NCT01604343|7451079|FG003|Prior to W52 Administration(Through W52)|Other|0
4599675|NCT01604343|7451080|FG004|Prior to W52 Administration(Through W52)|Other|6
4599676|NCT01604343|7451076|FG000|Week 52 to Week 104|Lost to Follow-up|0
4599677|NCT01604343|7451077|FG001|Week 52 to Week 104|Lost to Follow-up|2
4599678|NCT01604343|7451078|FG002|Week 52 to Week 104|Lost to Follow-up|4
4599679|NCT01604343|7451079|FG003|Week 52 to Week 104|Lost to Follow-up|2
4599680|NCT01604343|7451080|FG004|Week 52 to Week 104|Lost to Follow-up|1
4599681|NCT01604343|7451076|FG000|Week 52 to Week 104|Withdrawal by Subject|0
4599682|NCT01604343|7451077|FG001|Week 52 to Week 104|Withdrawal by Subject|7
4599683|NCT01604343|7451078|FG002|Week 52 to Week 104|Withdrawal by Subject|12
4599684|NCT01604343|7451079|FG003|Week 52 to Week 104|Withdrawal by Subject|8
4599685|NCT01604343|7451080|FG004|Week 52 to Week 104|Withdrawal by Subject|4
4599686|NCT01604343|7451076|FG000|Week 52 to Week 104|Adverse Event|0
4599687|NCT01604343|7451077|FG001|Week 52 to Week 104|Adverse Event|12
4599688|NCT01604343|7451078|FG002|Week 52 to Week 104|Adverse Event|26
4599689|NCT01604343|7451079|FG003|Week 52 to Week 104|Adverse Event|21
4599690|NCT01604343|7451080|FG004|Week 52 to Week 104|Adverse Event|27
4599691|NCT01604343|7451076|FG000|Week 52 to Week 104|Death|0
4599692|NCT01604343|7451077|FG001|Week 52 to Week 104|Death|4
4599693|NCT01604343|7451078|FG002|Week 52 to Week 104|Death|2
4599694|NCT01604343|7451079|FG003|Week 52 to Week 104|Death|5
4599695|NCT01604343|7451080|FG004|Week 52 to Week 104|Death|0
4599696|NCT01604343|7451076|FG000|Week 52 to Week 104|Lack of Efficacy|0
4599697|NCT01604343|7451077|FG001|Week 52 to Week 104|Lack of Efficacy|6
4599698|NCT01604343|7451078|FG002|Week 52 to Week 104|Lack of Efficacy|11
4599699|NCT01604343|7451079|FG003|Week 52 to Week 104|Lack of Efficacy|2
4599700|NCT01604343|7451080|FG004|Week 52 to Week 104|Lack of Efficacy|3
4599701|NCT01604343|7451076|FG000|Week 52 to Week 104|Physician Decision|0
4599702|NCT01604343|7451077|FG001|Week 52 to Week 104|Physician Decision|1
4599703|NCT01604343|7451078|FG002|Week 52 to Week 104|Physician Decision|0
4599704|NCT01604343|7451079|FG003|Week 52 to Week 104|Physician Decision|0
4599705|NCT01604343|7451080|FG004|Week 52 to Week 104|Physician Decision|2
4599706|NCT01604343|7451076|FG000|Week 52 to Week 104|Pregnancy|0
4599707|NCT01604343|7451077|FG001|Week 52 to Week 104|Pregnancy|0
4599708|NCT01604343|7451078|FG002|Week 52 to Week 104|Pregnancy|1
4599709|NCT01604343|7451079|FG003|Week 52 to Week 104|Pregnancy|2
4599710|NCT01604343|7451080|FG004|Week 52 to Week 104|Pregnancy|1
4599711|NCT01604343|7451076|FG000|Week 52 to Week 104|Other|0
4599712|NCT01604343|7451077|FG001|Week 52 to Week 104|Other|11
4599713|NCT01604343|7451078|FG002|Week 52 to Week 104|Other|11
4599714|NCT01604343|7451079|FG003|Week 52 to Week 104|Other|6
4599715|NCT01604343|7451080|FG004|Week 52 to Week 104|Other|3
4599716|NCT01604343|7451076|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3
4599717|NCT01604343|7451077|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
4599718|NCT01604343|7451078|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2
4599719|NCT01604343|7451079|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
4599720|NCT01604343|7451080|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
4599721|NCT01604343|7451076|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12
4599722|NCT01604343|7451077|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4
4599723|NCT01604343|7451078|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11
4599724|NCT01604343|7451079|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3
4599725|NCT01604343|7451080|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14
4599726|NCT01604343|7451076|FG000|Safety Follow-up Period (Week 104-120)|Other|15
4599727|NCT01604343|7451077|FG001|Safety Follow-up Period (Week 104-120)|Other|2
4599728|NCT01604343|7451078|FG002|Safety Follow-up Period (Week 104-120)|Other|20
4599729|NCT01604343|7451079|FG003|Safety Follow-up Period (Week 104-120)|Other|6
4599730|NCT01604343|7451080|FG004|Safety Follow-up Period (Week 104-120)|Other|14
4599731|NCT01604408|7451092|FG000|Treatment Period 1|Protocol Violation|0
4599732|NCT01604408|7451093|FG001|Treatment Period 1|Protocol Violation|1
4599733|NCT01604408|7451092|FG000|Treatment Period 2|Withdrawal by Subject|1
4599734|NCT01604408|7451093|FG001|Treatment Period 2|Withdrawal by Subject|1
4599735|NCT01604408|7451092|FG000|Treatment Period 2|Protocol Violation|1
4599736|NCT01604408|7451093|FG001|Treatment Period 2|Protocol Violation|0
4599737|NCT01604408|7451092|FG000|Treatment Period 2|Adverse Event|0
4599738|NCT01604408|7451093|FG001|Treatment Period 2|Adverse Event|1
4599739|NCT01604408|7451092|FG000|Treatment Period 3|Protocol Violation|1
4599740|NCT01604408|7451093|FG001|Treatment Period 3|Protocol Violation|1
4599741|NCT01604408|7451092|FG000|Treatment Period 3|Adverse Event|0
4599742|NCT01604408|7451093|FG001|Treatment Period 3|Adverse Event|3
4635503|NCT01933672|7507082|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
4635504|NCT01933672|7507083|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
4635505|NCT01933672|7507084|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1
4599743|NCT01604408|7451092|FG000|Treatment Period 3|Withdrawal by Subject|3
4599744|NCT01604408|7451093|FG001|Treatment Period 3|Withdrawal by Subject|1
4599745|NCT01604408|7451092|FG000|Treatment Period 3|Sponsor Decision|1
4599746|NCT01604408|7451093|FG001|Treatment Period 3|Sponsor Decision|0
4599747|NCT01604408|7451092|FG000|Treatment Period 4|Death|1
4599748|NCT01604408|7451093|FG001|Treatment Period 4|Death|0
4599749|NCT01604408|7451092|FG000|Treatment Period 4|Withdrawal by Subject|2
4599750|NCT01604408|7451093|FG001|Treatment Period 4|Withdrawal by Subject|1
4599751|NCT01604408|7451092|FG000|Treatment Period 4|Adverse Event|0
4599752|NCT01604408|7451093|FG001|Treatment Period 4|Adverse Event|1
4599753|NCT01604408|7451092|FG000|Treatment Period 5|Adverse Event|4
4599754|NCT01604408|7451093|FG001|Treatment Period 5|Adverse Event|0
4599755|NCT01604408|7451092|FG000|Treatment Period 6|Lost to Follow-up|0
4599756|NCT01604408|7451093|FG001|Treatment Period 6|Lost to Follow-up|1
4599757|NCT01604408|7451092|FG000|Treatment Period 6|Adverse Event|2
4599758|NCT01604408|7451093|FG001|Treatment Period 6|Adverse Event|0
4599759|NCT01604408|7451092|FG000|Treatment Period 6|Sponsor decision|0
4599760|NCT01604408|7451093|FG001|Treatment Period 6|Sponsor decision|1
4599761|NCT01604408|7451092|FG000|Observation Period|Adverse Event|1
4599762|NCT01604408|7451093|FG001|Observation Period|Adverse Event|1
4599763|NCT01604408|7451092|FG000|Observation Period|Withdrawal by Subject|0
4599764|NCT01604408|7451093|FG001|Observation Period|Withdrawal by Subject|2
4599765|NCT01604785|7451106|FG000|Overall Study|Repeat Visits Not Included in Analysis|7
4599766|NCT01604785|7451107|FG001|Overall Study|Repeat Visits Not Included in Analysis|1
4599767|NCT01604824|7451117|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0
4599768|NCT01604824|7451118|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0
4599769|NCT01604824|7451119|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0
4599770|NCT01604824|7451120|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0
4599771|NCT01604824|7451121|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2
4599772|NCT01604824|7451122|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0
4599773|NCT01604824|7451117|FG000|Open-label Extension (OLE) Period|Refused to come into office|0
4599774|NCT01604824|7451118|FG001|Open-label Extension (OLE) Period|Refused to come into office|0
4599775|NCT01604824|7451119|FG002|Open-label Extension (OLE) Period|Refused to come into office|0
4599776|NCT01604824|7451120|FG003|Open-label Extension (OLE) Period|Refused to come into office|0
4599777|NCT01604824|7451121|FG004|Open-label Extension (OLE) Period|Refused to come into office|1
4599778|NCT01604824|7451122|FG005|Open-label Extension (OLE) Period|Refused to come into office|0
4599779|NCT01604850|7451136|FG000|Overall Study|Enrolled but never treated|0
4599780|NCT01604850|7451137|FG001|Overall Study|Enrolled but never treated|1
4599781|NCT01604850|7451136|FG000|Overall Study|Efficacy Failure|50
4599782|NCT01604850|7451137|FG001|Overall Study|Efficacy Failure|29
4599783|NCT01604850|7451136|FG000|Overall Study|Lost to Follow-up|1
4599784|NCT01604850|7451137|FG001|Overall Study|Lost to Follow-up|0
4599785|NCT01604850|7451136|FG000|Overall Study|Subject withdrew consent|1
4599786|NCT01604850|7451137|FG001|Overall Study|Subject withdrew consent|0
4599787|NCT01604941|7451145|FG000|Overall Study|Adverse Event|1
4599788|NCT01604941|7451146|FG001|Overall Study|Adverse Event|2
4599789|NCT01604941|7451147|FG002|Overall Study|Adverse Event|0
4599790|NCT01604941|7451148|FG003|Overall Study|Adverse Event|0
4599791|NCT01604941|7451149|FG004|Overall Study|Adverse Event|1
4599792|NCT01604941|7451150|FG005|Overall Study|Adverse Event|5
4599793|NCT01604941|7451145|FG000|Overall Study|Non-compliance|1
4599794|NCT01604941|7451146|FG001|Overall Study|Non-compliance|0
4599795|NCT01604941|7451147|FG002|Overall Study|Non-compliance|0
4599796|NCT01604941|7451148|FG003|Overall Study|Non-compliance|0
4599797|NCT01604941|7451149|FG004|Overall Study|Non-compliance|0
4599798|NCT01604941|7451150|FG005|Overall Study|Non-compliance|0
4599799|NCT01604941|7451145|FG000|Overall Study|Participant Decision|0
4599800|NCT01604941|7451146|FG001|Overall Study|Participant Decision|0
4599801|NCT01604941|7451147|FG002|Overall Study|Participant Decision|0
4599802|NCT01604941|7451148|FG003|Overall Study|Participant Decision|0
4599803|NCT01604941|7451149|FG004|Overall Study|Participant Decision|0
4599804|NCT01604941|7451150|FG005|Overall Study|Participant Decision|2
4599805|NCT01604941|7451145|FG000|Overall Study|Early Study Termination|9
4599806|NCT01604941|7451146|FG001|Overall Study|Early Study Termination|2
4599807|NCT01604941|7451147|FG002|Overall Study|Early Study Termination|3
4599808|NCT01604941|7451148|FG003|Overall Study|Early Study Termination|3
4599809|NCT01604941|7451149|FG004|Overall Study|Early Study Termination|0
4599810|NCT01604941|7451150|FG005|Overall Study|Early Study Termination|0
4599811|NCT01605071|7451162|FG000|Overall Study|Withdrawal by Subject|3
4599812|NCT01605071|7451163|FG001|Overall Study|Withdrawal by Subject|2
4599813|NCT01605097|7451171|FG000|Overall Study|Protocol Violation|1
4599814|NCT01605136|7451178|FG000|Study Period|Withdrawal by Subject|2
4599815|NCT01605136|7451179|FG001|Study Period|Withdrawal by Subject|0
4599816|NCT01605136|7451178|FG000|Study Period|Physician Decision|1
4599817|NCT01605136|7451179|FG001|Study Period|Physician Decision|1
4599818|NCT01605136|7451178|FG000|Study Period|Lost to Follow-up|0
4599819|NCT01605136|7451179|FG001|Study Period|Lost to Follow-up|2
4599820|NCT01605136|7451178|FG000|Safety Follow-Up Period|Withdrawal by Subject|1
4599821|NCT01605136|7451179|FG001|Safety Follow-Up Period|Withdrawal by Subject|2
4599822|NCT01605227|7451187|FG000|Overall Study|Did not receive study treatment|2
4599823|NCT01605227|7451188|FG001|Overall Study|Did not receive study treatment|3
4599824|NCT01605227|7451187|FG000|Overall Study|Adverse Event|228
4599825|NCT01605227|7451188|FG001|Overall Study|Adverse Event|42
4599826|NCT01605227|7451187|FG000|Overall Study|Progressive Disease|132
4599827|NCT01605227|7451188|FG001|Overall Study|Progressive Disease|128
4599828|NCT01605227|7451187|FG000|Overall Study|Clinical Deterioration|227
4599829|NCT01605227|7451188|FG001|Overall Study|Clinical Deterioration|133
4599830|NCT01605227|7451187|FG000|Overall Study|Lost to Follow-up|1
4599831|NCT01605227|7451188|FG001|Overall Study|Lost to Follow-up|0
4599832|NCT01605227|7451187|FG000|Overall Study|Protocol Violation|1
4599833|NCT01605227|7451188|FG001|Overall Study|Protocol Violation|0
4599834|NCT01605227|7451187|FG000|Overall Study|Physician Decision|9
4599835|NCT01605227|7451188|FG001|Overall Study|Physician Decision|7
4599836|NCT01605227|7451187|FG000|Overall Study|Withdrawal by Subject|18
4599837|NCT01605227|7451188|FG001|Overall Study|Withdrawal by Subject|14
4599838|NCT01605227|7451187|FG000|Overall Study|Sponsor Decision|2
4599839|NCT01605227|7451188|FG001|Overall Study|Sponsor Decision|0
4599840|NCT01605227|7451187|FG000|Overall Study|Started New Therapy|1
4599841|NCT01605227|7451188|FG001|Overall Study|Started New Therapy|0
4599842|NCT01605227|7451187|FG000|Overall Study|Subject Decision|0
4599843|NCT01605227|7451188|FG001|Overall Study|Subject Decision|1
4599844|NCT01605227|7451187|FG000|Overall Study|Dose Held >6 weeks|0
4599845|NCT01605227|7451188|FG001|Overall Study|Dose Held >6 weeks|1
4599846|NCT01605396|7451205|FG000|Overall Study|Adverse Event|5
4599847|NCT01605396|7451206|FG001|Overall Study|Adverse Event|3
4599848|NCT01605396|7451205|FG000|Overall Study|Lost to Follow-up|1
4599849|NCT01605396|7451206|FG001|Overall Study|Lost to Follow-up|0
4599850|NCT01605396|7451205|FG000|Overall Study|Non-Compliance With Study Drug|1
4599851|NCT01605396|7451206|FG001|Overall Study|Non-Compliance With Study Drug|1
4599852|NCT01605396|7451205|FG000|Overall Study|Physician Decision|2
4599853|NCT01605396|7451206|FG001|Overall Study|Physician Decision|2
4599854|NCT01605396|7451205|FG000|Overall Study|Progressive Disease|23
4599855|NCT01605396|7451206|FG001|Overall Study|Progressive Disease|27
4599856|NCT01605396|7451205|FG000|Overall Study|Withdrawal by Subject|4
4599857|NCT01605396|7451206|FG001|Overall Study|Withdrawal by Subject|2
4599858|NCT01605396|7451205|FG000|Overall Study|Transfer Off Study|4
4599859|NCT01605396|7451206|FG001|Overall Study|Transfer Off Study|5
4599860|NCT01605461|7451230|FG000|Overall Study|Lost to Follow-up|3
4599861|NCT01605461|7451230|FG000|Overall Study|Withdrawal by Subject|1
4599862|NCT01605799|7451263|FG000|Overall Study|Withdrawal by Subject|2
4599863|NCT01605799|7451264|FG001|Overall Study|Withdrawal by Subject|1
4599864|NCT01605825|7451272|FG000|Overall Study|Adverse Event|4
4599865|NCT01605825|7451273|FG001|Overall Study|Adverse Event|2
4599866|NCT01605825|7451272|FG000|Overall Study|Withdrawal by Subject|0
4599867|NCT01605825|7451273|FG001|Overall Study|Withdrawal by Subject|1
4599868|NCT01605825|7451272|FG000|Overall Study|Non-Compliance -Investigational Drug|3
4599869|NCT01605825|7451273|FG001|Overall Study|Non-Compliance -Investigational Drug|0
4599870|NCT01605825|7451272|FG000|Overall Study|Non-Compliance with Protocol|3
4599871|NCT01605825|7451273|FG001|Overall Study|Non-Compliance with Protocol|0
4599872|NCT01605877|7451279|FG000|Overall Study|Withdrawal by Subject|1
4599873|NCT01605916|7451319|FG000|Overall Study|Adverse Event|1
4599874|NCT01605916|7451320|FG001|Overall Study|Adverse Event|0
4599875|NCT01605916|7451321|FG002|Overall Study|Adverse Event|0
4599876|NCT01605916|7451322|FG003|Overall Study|Adverse Event|1
4599877|NCT01605916|7451323|FG004|Overall Study|Adverse Event|0
4599878|NCT01605916|7451319|FG000|Overall Study|Lack of Efficacy|2
4599879|NCT01605916|7451320|FG001|Overall Study|Lack of Efficacy|3
4599880|NCT01605916|7451321|FG002|Overall Study|Lack of Efficacy|3
4599881|NCT01605916|7451322|FG003|Overall Study|Lack of Efficacy|5
4599882|NCT01605916|7451323|FG004|Overall Study|Lack of Efficacy|4
4599883|NCT01605916|7451319|FG000|Overall Study|Withdrawal by Subject|1
4599884|NCT01605916|7451320|FG001|Overall Study|Withdrawal by Subject|1
4599885|NCT01605916|7451321|FG002|Overall Study|Withdrawal by Subject|0
4599886|NCT01605916|7451322|FG003|Overall Study|Withdrawal by Subject|0
4599887|NCT01605916|7451323|FG004|Overall Study|Withdrawal by Subject|2
4599888|NCT01606007|7451348|FG000|Overall Study|Reason 'Other' in the protocol|0
4599889|NCT01606007|7451349|FG001|Overall Study|Reason 'Other' in the protocol|1
4599890|NCT01606007|7451350|FG002|Overall Study|Reason 'Other' in the protocol|1
4599891|NCT01606007|7451348|FG000|Overall Study|Pregnancy|0
4599892|NCT01606007|7451349|FG001|Overall Study|Pregnancy|1
4599893|NCT01606007|7451350|FG002|Overall Study|Pregnancy|1
4599894|NCT01606007|7451348|FG000|Overall Study|Withdrawal by Subject|8
4599895|NCT01606007|7451349|FG001|Overall Study|Withdrawal by Subject|6
4599896|NCT01606007|7451350|FG002|Overall Study|Withdrawal by Subject|1
4599897|NCT01606007|7451348|FG000|Overall Study|Adverse Event|0
4599898|NCT01606007|7451349|FG001|Overall Study|Adverse Event|1
4599899|NCT01606007|7451350|FG002|Overall Study|Adverse Event|1
4599900|NCT01606007|7451348|FG000|Overall Study|discontinue study treatment|0
4599901|NCT01606007|7451349|FG001|Overall Study|discontinue study treatment|2
4599902|NCT01606007|7451350|FG002|Overall Study|discontinue study treatment|1
4599903|NCT01606007|7451348|FG000|Overall Study|Lost to Follow-up|6
4599904|NCT01606007|7451349|FG001|Overall Study|Lost to Follow-up|8
4599905|NCT01606007|7451350|FG002|Overall Study|Lost to Follow-up|5
4599906|NCT01606007|7451348|FG000|Overall Study|Poor/Non-compliance|1
4599907|NCT01606007|7451349|FG001|Overall Study|Poor/Non-compliance|0
4599908|NCT01606007|7451350|FG002|Overall Study|Poor/Non-compliance|0
4599909|NCT01606137|7451367|FG000|Overall Study|Adverse Event|85
4599910|NCT01606137|7451367|FG000|Overall Study|Withdrawal by Subject|74
4599911|NCT01606137|7451367|FG000|Overall Study|Lack of Efficacy|56
4599912|NCT01606137|7451367|FG000|Overall Study|Lost to Follow-up|15
4599913|NCT01606137|7451367|FG000|Overall Study|Protocol Violation|1
4599914|NCT01606137|7451367|FG000|Overall Study|Patient non-compliance|9
4599915|NCT01606137|7451367|FG000|Overall Study|Death|1
4599916|NCT01606137|7451367|FG000|Overall Study|Decreased/no pain|4
4599917|NCT01606137|7451367|FG000|Overall Study|Issues with driving|4
4599918|NCT01606137|7451367|FG000|Overall Study|multiple sclerosis less stable|1
4599919|NCT01606137|7451367|FG000|Overall Study|Increased bilirubin|1
4599920|NCT01606137|7451367|FG000|Overall Study|Spray causes nausea|1
4599921|NCT01606137|7451367|FG000|Overall Study|Not enough improvement|4
4599922|NCT01606137|7451367|FG000|Overall Study|Wanted to try another treatment|1
4599923|NCT01606137|7451367|FG000|Overall Study|Patient leaving country|1
4599924|NCT01606137|7451367|FG000|Overall Study|Personal reasons|1
4599925|NCT01606137|7451367|FG000|Overall Study|Unable to tolerate study med. taste|1
4599926|NCT01606137|7451367|FG000|Overall Study|Patient moving|1
4599927|NCT01606137|7451367|FG000|Overall Study|Unable to collect consistent data|1
4599928|NCT01606176|7451373|FG000|Overall Study|Adverse Event|2
4599929|NCT01606176|7451374|FG001|Overall Study|Adverse Event|3
4599930|NCT01606176|7451373|FG000|Overall Study|Disease progression|1
4599931|NCT01606176|7451374|FG001|Overall Study|Disease progression|0
4599932|NCT01606176|7451373|FG000|Overall Study|Withdrawal by Subject|1
4599933|NCT01606176|7451374|FG001|Overall Study|Withdrawal by Subject|0
4599934|NCT01606189|7451380|FG000|Second Intenvention (14-20 Days)|Adverse Event|0
4599935|NCT01606189|7451381|FG001|Second Intenvention (14-20 Days)|Adverse Event|0
4599936|NCT01606189|7451382|FG002|Second Intenvention (14-20 Days)|Adverse Event|0
4599937|NCT01606189|7451383|FG003|Second Intenvention (14-20 Days)|Adverse Event|0
4599938|NCT01606189|7451384|FG004|Second Intenvention (14-20 Days)|Adverse Event|0
4599939|NCT01606189|7451385|FG005|Second Intenvention (14-20 Days)|Adverse Event|1
4599940|NCT01606189|7451380|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
4599941|NCT01606189|7451381|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
4599942|NCT01606189|7451382|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
4599943|NCT01606189|7451383|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
4599944|NCT01606189|7451384|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
4599945|NCT01606189|7451385|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1
4599946|NCT01606202|7451395|FG000|Overall Study|Adverse Event|5
4599947|NCT01606202|7451396|FG001|Overall Study|Adverse Event|0
4599948|NCT01606202|7451395|FG000|Overall Study|Withdrawal by Subject|2
4599949|NCT01606202|7451396|FG001|Overall Study|Withdrawal by Subject|1
4599950|NCT01606202|7451395|FG000|Overall Study|Personal problems|0
4599951|NCT01606202|7451396|FG001|Overall Study|Personal problems|1
4599952|NCT01606202|7451395|FG000|Overall Study|Problems with administration|0
4599953|NCT01606202|7451396|FG001|Overall Study|Problems with administration|1
4599954|NCT01606228|7451402|FG000|Overall Study|Lost to Follow-up|20
4599955|NCT01606228|7451402|FG000|Overall Study|Withdrawal by Subject|3
4599956|NCT01606228|7451402|FG000|Overall Study|Non-compliant|3
4599957|NCT01606228|7451402|FG000|Overall Study|Lack of Efficacy|2
4599958|NCT01606228|7451402|FG000|Overall Study|Adverse Event|1
4599959|NCT01606254|7451410|FG000|Overall Study|Withdrawal by Subject|1
4599960|NCT01606254|7451411|FG001|Overall Study|Withdrawal by Subject|3
4599961|NCT01606254|7451412|FG002|Overall Study|Withdrawal by Subject|0
4599962|NCT01606254|7451413|FG003|Overall Study|Withdrawal by Subject|2
4599963|NCT01606254|7451410|FG000|Overall Study|Adverse Event|1
4599964|NCT01606254|7451411|FG001|Overall Study|Adverse Event|1
4599965|NCT01606254|7451412|FG002|Overall Study|Adverse Event|0
4599966|NCT01606254|7451413|FG003|Overall Study|Adverse Event|1
4599967|NCT01606306|7451429|FG000|Overall Study|Lack of Efficacy|2
4599968|NCT01606306|7451430|FG001|Overall Study|Lack of Efficacy|1
4599969|NCT01606306|7451431|FG002|Overall Study|Lack of Efficacy|4
4599970|NCT01606306|7451432|FG003|Overall Study|Lack of Efficacy|4
4599971|NCT01606306|7451433|FG004|Overall Study|Lack of Efficacy|1
4599972|NCT01606306|7451434|FG005|Overall Study|Lack of Efficacy|2
4599973|NCT01606306|7451429|FG000|Overall Study|Adverse Event|1
4599974|NCT01606306|7451430|FG001|Overall Study|Adverse Event|0
4599975|NCT01606306|7451431|FG002|Overall Study|Adverse Event|1
4599976|NCT01606306|7451432|FG003|Overall Study|Adverse Event|1
4599977|NCT01606306|7451433|FG004|Overall Study|Adverse Event|2
4599978|NCT01606306|7451434|FG005|Overall Study|Adverse Event|0
4599979|NCT01606306|7451429|FG000|Overall Study|Lost to Follow-up|7
4599980|NCT01606306|7451430|FG001|Overall Study|Lost to Follow-up|4
4599981|NCT01606306|7451431|FG002|Overall Study|Lost to Follow-up|5
4599982|NCT01606306|7451432|FG003|Overall Study|Lost to Follow-up|4
4599983|NCT01606306|7451433|FG004|Overall Study|Lost to Follow-up|3
4599984|NCT01606306|7451434|FG005|Overall Study|Lost to Follow-up|5
4599985|NCT01606306|7451429|FG000|Overall Study|Withdrawal by Subject|4
4599986|NCT01606306|7451430|FG001|Overall Study|Withdrawal by Subject|3
4599987|NCT01606306|7451431|FG002|Overall Study|Withdrawal by Subject|4
4599988|NCT01606306|7451432|FG003|Overall Study|Withdrawal by Subject|4
4599989|NCT01606306|7451433|FG004|Overall Study|Withdrawal by Subject|5
4599990|NCT01606306|7451434|FG005|Overall Study|Withdrawal by Subject|4
4599991|NCT01606306|7451429|FG000|Overall Study|Physician Decision|1
4599992|NCT01606306|7451430|FG001|Overall Study|Physician Decision|2
4599993|NCT01606306|7451431|FG002|Overall Study|Physician Decision|0
4599994|NCT01606306|7451432|FG003|Overall Study|Physician Decision|0
4599995|NCT01606306|7451433|FG004|Overall Study|Physician Decision|0
4599996|NCT01606306|7451434|FG005|Overall Study|Physician Decision|0
4599997|NCT01606319|7451442|FG000|Overall Study|Lost to Follow-up|17
4599998|NCT01606319|7451443|FG001|Overall Study|Lost to Follow-up|14
4599999|NCT01606319|7451442|FG000|Overall Study|Withdrawal by Subject|9
4600000|NCT01606319|7451443|FG001|Overall Study|Withdrawal by Subject|12
4600001|NCT01606319|7451442|FG000|Overall Study|Physician Decision|1
4600002|NCT01606319|7451443|FG001|Overall Study|Physician Decision|2
4600003|NCT01606319|7451442|FG000|Overall Study|Lack of Efficacy|6
4600004|NCT01606319|7451443|FG001|Overall Study|Lack of Efficacy|8
4600005|NCT01606319|7451442|FG000|Overall Study|Adverse Event|1
4600006|NCT01606319|7451443|FG001|Overall Study|Adverse Event|4
4600007|NCT01606670|7451449|FG000|Overall Study|Adverse Event|6
4600008|NCT01606670|7451449|FG000|Overall Study|Lack of Efficacy|2
4600009|NCT01606670|7451449|FG000|Overall Study|Lost to Follow-up|3
4600010|NCT01606670|7451449|FG000|Overall Study|Withdrawal by Subject|3
4600011|NCT01606670|7451449|FG000|Overall Study|Other Reason|2
4635506|NCT01933672|7507085|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
4635507|NCT01933672|7507086|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
4635508|NCT01933672|7507087|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
4635509|NCT01933672|7507081|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
4635510|NCT01933672|7507082|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1
4635511|NCT01933672|7507083|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
4635512|NCT01933672|7507084|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
4635513|NCT01933672|7507085|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
4635514|NCT01933672|7507086|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
4635515|NCT01933672|7507087|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
4635516|NCT01933789|7507118|FG000|Overall Study|Death|0
4635517|NCT01933789|7507119|FG001|Overall Study|Death|0
4635518|NCT01933789|7507120|FG002|Overall Study|Death|0
4635519|NCT01933789|7507121|FG003|Overall Study|Death|0
4635520|NCT01933789|7507122|FG004|Overall Study|Death|21
4635521|NCT01933789|7507123|FG005|Overall Study|Death|32
4635522|NCT01933789|7507124|FG006|Overall Study|Death|0
4635523|NCT01933789|7507125|FG007|Overall Study|Death|0
4635524|NCT01933789|7507126|FG008|Overall Study|Death|0
4635525|NCT01933789|7507118|FG000|Overall Study|Lost to Follow-up|0
4635526|NCT01933789|7507119|FG001|Overall Study|Lost to Follow-up|0
4635527|NCT01933789|7507120|FG002|Overall Study|Lost to Follow-up|0
4635528|NCT01933789|7507121|FG003|Overall Study|Lost to Follow-up|1
4635529|NCT01933789|7507122|FG004|Overall Study|Lost to Follow-up|8
4635530|NCT01933789|7507123|FG005|Overall Study|Lost to Follow-up|9
4635531|NCT01933789|7507124|FG006|Overall Study|Lost to Follow-up|1
4635532|NCT01933789|7507125|FG007|Overall Study|Lost to Follow-up|4
4635533|NCT01933789|7507126|FG008|Overall Study|Lost to Follow-up|0
4635534|NCT01933789|7507118|FG000|Overall Study|Withdrawal by Subject|2
4635535|NCT01933789|7507119|FG001|Overall Study|Withdrawal by Subject|1
4635536|NCT01933789|7507120|FG002|Overall Study|Withdrawal by Subject|0
4635537|NCT01933789|7507121|FG003|Overall Study|Withdrawal by Subject|0
4635538|NCT01933789|7507122|FG004|Overall Study|Withdrawal by Subject|17
4635539|NCT01933789|7507123|FG005|Overall Study|Withdrawal by Subject|16
4635540|NCT01933789|7507124|FG006|Overall Study|Withdrawal by Subject|1
4635541|NCT01933789|7507125|FG007|Overall Study|Withdrawal by Subject|4
4635542|NCT01933789|7507126|FG008|Overall Study|Withdrawal by Subject|0
4635543|NCT01933789|7507118|FG000|Overall Study|Became Ineligible|4
4635544|NCT01933789|7507119|FG001|Overall Study|Became Ineligible|0
4635545|NCT01933789|7507120|FG002|Overall Study|Became Ineligible|0
4635546|NCT01933789|7507121|FG003|Overall Study|Became Ineligible|0
4635547|NCT01933789|7507122|FG004|Overall Study|Became Ineligible|13
4635548|NCT01933789|7507123|FG005|Overall Study|Became Ineligible|10
4635549|NCT01933789|7507124|FG006|Overall Study|Became Ineligible|13
4635550|NCT01933789|7507125|FG007|Overall Study|Became Ineligible|6
4635551|NCT01933789|7507126|FG008|Overall Study|Became Ineligible|0
4635552|NCT01933880|7507148|FG000|Overall Study|Withdrawal by Subject|5
4635553|NCT01933880|7507149|FG001|Overall Study|Withdrawal by Subject|0
4635554|NCT01933880|7507148|FG000|Overall Study|Lack of Efficacy|1
4635555|NCT01933880|7507149|FG001|Overall Study|Lack of Efficacy|0
4635556|NCT01933880|7507148|FG000|Overall Study|Concomitant medication Interference|0
4635557|NCT01933880|7507149|FG001|Overall Study|Concomitant medication Interference|1
4635558|NCT01933880|7507148|FG000|Overall Study|Followup exceeded 4 days to visit window|19
4635559|NCT01933880|7507149|FG001|Overall Study|Followup exceeded 4 days to visit window|0
4635560|NCT01933880|7507148|FG000|Overall Study|Other|4
4635561|NCT01933880|7507149|FG001|Overall Study|Other|0
4635562|NCT01933880|7507148|FG000|Overall Study|Protocol Violation|1
4635563|NCT01933880|7507149|FG001|Overall Study|Protocol Violation|0
4635564|NCT01933919|7507162|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0
4635565|NCT01933919|7507163|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1
4635566|NCT01933919|7507162|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0
4635567|NCT01933919|7507163|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1
4635568|NCT01933919|7507162|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0
4635569|NCT01933919|7507163|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2
4635570|NCT01933919|7507162|FG000|Open-label Long-term Phase|Adverse Event|2
4635571|NCT01933919|7507163|FG001|Open-label Long-term Phase|Adverse Event|0
4635572|NCT01933919|7507162|FG000|Open-label Long-term Phase|Withdrawal by Subject|3
4635573|NCT01933919|7507163|FG001|Open-label Long-term Phase|Withdrawal by Subject|4
4635574|NCT01933919|7507162|FG000|Open-label Long-term Phase|Lost to Follow-up|1
4635575|NCT01933919|7507163|FG001|Open-label Long-term Phase|Lost to Follow-up|0
4635576|NCT01933919|7507162|FG000|Open-label Long-term Phase|Other|1
4635577|NCT01933919|7507163|FG001|Open-label Long-term Phase|Other|2
4635578|NCT01934010|7507197|FG000|Overall Study|Adverse Event|1
4635579|NCT01934010|7507198|FG001|Overall Study|Adverse Event|1
4600012|NCT01606748|7451468|FG000|Overall Study|Adverse Event|1
4600013|NCT01606748|7451469|FG001|Overall Study|Adverse Event|0
4600014|NCT01606748|7451468|FG000|Overall Study|Progressive Disease|1
4600015|NCT01606748|7451469|FG001|Overall Study|Progressive Disease|0
4600016|NCT01606748|7451468|FG000|Overall Study|Withdrawal by Subject|1
4600017|NCT01606748|7451469|FG001|Overall Study|Withdrawal by Subject|0
4600018|NCT01606761|7451490|FG000|Prior to Week 24|Lost to Follow-up|0
4600019|NCT01606761|7451491|FG001|Prior to Week 24|Lost to Follow-up|3
4600020|NCT01606761|7451492|FG002|Prior to Week 24|Lost to Follow-up|2
4600021|NCT01606761|7451493|FG003|Prior to Week 24|Lost to Follow-up|0
4600022|NCT01606761|7451494|FG004|Prior to Week 24|Lost to Follow-up|0
4600023|NCT01606761|7451490|FG000|Prior to Week 24|Withdrawal by Subject|12
4600024|NCT01606761|7451491|FG001|Prior to Week 24|Withdrawal by Subject|10
4600025|NCT01606761|7451492|FG002|Prior to Week 24|Withdrawal by Subject|9
4600026|NCT01606761|7451493|FG003|Prior to Week 24|Withdrawal by Subject|0
4600027|NCT01606761|7451494|FG004|Prior to Week 24|Withdrawal by Subject|0
4600028|NCT01606761|7451490|FG000|Prior to Week 24|Adverse Event|11
4600029|NCT01606761|7451491|FG001|Prior to Week 24|Adverse Event|18
4600030|NCT01606761|7451492|FG002|Prior to Week 24|Adverse Event|22
4600031|NCT01606761|7451493|FG003|Prior to Week 24|Adverse Event|0
4600032|NCT01606761|7451494|FG004|Prior to Week 24|Adverse Event|0
4600033|NCT01606761|7451490|FG000|Prior to Week 24|Lack of Efficacy|15
4600034|NCT01606761|7451491|FG001|Prior to Week 24|Lack of Efficacy|14
4600035|NCT01606761|7451492|FG002|Prior to Week 24|Lack of Efficacy|8
4600036|NCT01606761|7451493|FG003|Prior to Week 24|Lack of Efficacy|0
4600037|NCT01606761|7451494|FG004|Prior to Week 24|Lack of Efficacy|0
4600038|NCT01606761|7451490|FG000|Prior to Week 24|Physician Decision|0
4600039|NCT01606761|7451491|FG001|Prior to Week 24|Physician Decision|3
4600040|NCT01606761|7451492|FG002|Prior to Week 24|Physician Decision|1
4600041|NCT01606761|7451493|FG003|Prior to Week 24|Physician Decision|0
4600042|NCT01606761|7451494|FG004|Prior to Week 24|Physician Decision|0
4600043|NCT01606761|7451490|FG000|Prior to Week 24|Other|4
4600044|NCT01606761|7451491|FG001|Prior to Week 24|Other|7
4600045|NCT01606761|7451492|FG002|Prior to Week 24|Other|5
4600046|NCT01606761|7451493|FG003|Prior to Week 24|Other|0
4600047|NCT01606761|7451494|FG004|Prior to Week 24|Other|0
4600048|NCT01606761|7451490|FG000|Week 24 to Week 52|Lost to Follow-up|0
4600049|NCT01606761|7451491|FG001|Week 24 to Week 52|Lost to Follow-up|1
4600050|NCT01606761|7451492|FG002|Week 24 to Week 52|Lost to Follow-up|1
4600051|NCT01606761|7451493|FG003|Week 24 to Week 52|Lost to Follow-up|1
4600052|NCT01606761|7451494|FG004|Week 24 to Week 52|Lost to Follow-up|0
4600053|NCT01606761|7451490|FG000|Week 24 to Week 52|Withdrawal by Subject|0
4600054|NCT01606761|7451491|FG001|Week 24 to Week 52|Withdrawal by Subject|6
4600055|NCT01606761|7451492|FG002|Week 24 to Week 52|Withdrawal by Subject|3
4600056|NCT01606761|7451493|FG003|Week 24 to Week 52|Withdrawal by Subject|0
4600057|NCT01606761|7451494|FG004|Week 24 to Week 52|Withdrawal by Subject|0
4600058|NCT01606761|7451490|FG000|Week 24 to Week 52|Adverse Event|0
4600059|NCT01606761|7451491|FG001|Week 24 to Week 52|Adverse Event|11
4600060|NCT01606761|7451492|FG002|Week 24 to Week 52|Adverse Event|14
4600061|NCT01606761|7451493|FG003|Week 24 to Week 52|Adverse Event|3
4600062|NCT01606761|7451494|FG004|Week 24 to Week 52|Adverse Event|15
4600063|NCT01606761|7451490|FG000|Week 24 to Week 52|Death|0
4600064|NCT01606761|7451491|FG001|Week 24 to Week 52|Death|0
4600065|NCT01606761|7451492|FG002|Week 24 to Week 52|Death|2
4600066|NCT01606761|7451493|FG003|Week 24 to Week 52|Death|1
4600067|NCT01606761|7451494|FG004|Week 24 to Week 52|Death|0
4600068|NCT01606761|7451490|FG000|Week 24 to Week 52|Lack of Efficacy|0
4600069|NCT01606761|7451491|FG001|Week 24 to Week 52|Lack of Efficacy|13
4600070|NCT01606761|7451492|FG002|Week 24 to Week 52|Lack of Efficacy|7
4600071|NCT01606761|7451493|FG003|Week 24 to Week 52|Lack of Efficacy|10
4600072|NCT01606761|7451494|FG004|Week 24 to Week 52|Lack of Efficacy|3
4600073|NCT01606761|7451490|FG000|Week 24 to Week 52|Physician Decision|0
4600074|NCT01606761|7451491|FG001|Week 24 to Week 52|Physician Decision|1
4600075|NCT01606761|7451492|FG002|Week 24 to Week 52|Physician Decision|1
4600076|NCT01606761|7451493|FG003|Week 24 to Week 52|Physician Decision|0
4600077|NCT01606761|7451494|FG004|Week 24 to Week 52|Physician Decision|0
4600078|NCT01606761|7451490|FG000|Week 24 to Week 52|Other|0
4600079|NCT01606761|7451491|FG001|Week 24 to Week 52|Other|1
4600080|NCT01606761|7451492|FG002|Week 24 to Week 52|Other|5
4635580|NCT01934010|7507199|FG002|Overall Study|Adverse Event|0
4600081|NCT01606761|7451493|FG003|Week 24 to Week 52|Other|2
4600082|NCT01606761|7451494|FG004|Week 24 to Week 52|Other|2
4600083|NCT01606761|7451490|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0
4600084|NCT01606761|7451491|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1
4600085|NCT01606761|7451492|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2
4600086|NCT01606761|7451493|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0
4600087|NCT01606761|7451494|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1
4600088|NCT01606761|7451490|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4
4600089|NCT01606761|7451491|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6
4600090|NCT01606761|7451492|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6
4600091|NCT01606761|7451493|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1
4600092|NCT01606761|7451494|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3
4600093|NCT01606761|7451490|FG000|Safety Follow-up Period (Week 52-68)|Death|0
4635581|NCT01934010|7507197|FG000|Overall Study|Withdrawal by Subject|15
4635582|NCT01934010|7507198|FG001|Overall Study|Withdrawal by Subject|6
4635583|NCT01934010|7507199|FG002|Overall Study|Withdrawal by Subject|2
4635584|NCT01934010|7507197|FG000|Overall Study|Lost to Follow-up|7
4635585|NCT01934010|7507198|FG001|Overall Study|Lost to Follow-up|4
4635586|NCT01934010|7507199|FG002|Overall Study|Lost to Follow-up|0
4635587|NCT01934140|7507218|FG000|Persistence Phase (Year 6-10)|Other|24
4635588|NCT01934140|7507219|FG001|Persistence Phase (Year 6-10)|Other|6
4635589|NCT01934140|7507218|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5
4635590|NCT01934140|7507219|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2
4635591|NCT01934140|7507218|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31
4600094|NCT01606761|7451491|FG001|Safety Follow-up Period (Week 52-68)|Death|0
4600095|NCT01606761|7451492|FG002|Safety Follow-up Period (Week 52-68)|Death|0
4600096|NCT01606761|7451493|FG003|Safety Follow-up Period (Week 52-68)|Death|0
4600097|NCT01606761|7451494|FG004|Safety Follow-up Period (Week 52-68)|Death|1
4600098|NCT01606761|7451490|FG000|Safety Follow-up Period (Week 52-68)|Other|0
4600099|NCT01606761|7451491|FG001|Safety Follow-up Period (Week 52-68)|Other|3
4600100|NCT01606761|7451492|FG002|Safety Follow-up Period (Week 52-68)|Other|9
4600101|NCT01606761|7451493|FG003|Safety Follow-up Period (Week 52-68)|Other|1
4600102|NCT01606761|7451494|FG004|Safety Follow-up Period (Week 52-68)|Other|3
4600103|NCT01606787|7451511|FG000|Overall Study|Withdrawal by Subject|4
4600104|NCT01606787|7451512|FG001|Overall Study|Withdrawal by Subject|5
4600105|NCT01606787|7451511|FG000|Overall Study|Surgery canceled|0
4600106|NCT01606787|7451512|FG001|Overall Study|Surgery canceled|2
4600107|NCT01606800|7451520|FG000|Overall Study|Adverse Event|3
4600108|NCT01606800|7451521|FG001|Overall Study|Adverse Event|1
4600109|NCT01606800|7451520|FG000|Overall Study|Participant withdrew consent|0
4600110|NCT01606800|7451521|FG001|Overall Study|Participant withdrew consent|1
4600111|NCT01606800|7451520|FG000|Overall Study|Missing completion status|2
4600112|NCT01606800|7451521|FG001|Overall Study|Missing completion status|0
4600113|NCT01607073|7451536|FG000|Overall Study|Adverse Event|1
4600114|NCT01607346|7451579|FG000|Overall Study|Adverse Event|3
4600115|NCT01607398|7451585|FG000|Overall Study|Adverse Event|0
4600116|NCT01607398|7451586|FG001|Overall Study|Adverse Event|2
4600117|NCT01607398|7451585|FG000|Overall Study|Severe COPD|2
4600118|NCT01607398|7451586|FG001|Overall Study|Severe COPD|0
4600119|NCT01607476|7451642|FG000|Overall Study|Withdrawal by Subject|1
4600120|NCT01607476|7451643|FG001|Overall Study|Withdrawal by Subject|0
4600121|NCT01607476|7451644|FG002|Overall Study|Withdrawal by Subject|1
4600122|NCT01607476|7451642|FG000|Overall Study|Lost to Follow-up|0
4600123|NCT01607476|7451643|FG001|Overall Study|Lost to Follow-up|0
4600124|NCT01607476|7451644|FG002|Overall Study|Lost to Follow-up|2
4600125|NCT01607554|7451652|FG000|Overall Study|Disease progression|2
4600126|NCT01607593|7451656|FG000|Overall Study|Adverse Event|15
4600127|NCT01607593|7451656|FG000|Overall Study|Lack of Efficacy|16
4600128|NCT01607593|7451656|FG000|Overall Study|Lost to Follow-up|25
4600129|NCT01607593|7451656|FG000|Overall Study|Continuation|33
4600130|NCT01607593|7451656|FG000|Overall Study|Other|4
4600131|NCT01607892|7451698|FG000|Overall Study|Need of treatment not allowed per protocol|0
4600132|NCT01607892|7451699|FG001|Overall Study|Need of treatment not allowed per protocol|0
4600133|NCT01607892|7451700|FG002|Overall Study|Need of treatment not allowed per protocol|0
4600134|NCT01607892|7451701|FG003|Overall Study|Need of treatment not allowed per protocol|1
4600135|NCT01607892|7451702|FG004|Overall Study|Need of treatment not allowed per protocol|0
4600136|NCT01607892|7451698|FG000|Overall Study|Death|4
4600137|NCT01607892|7451699|FG001|Overall Study|Death|2
4600138|NCT01607892|7451700|FG002|Overall Study|Death|8
4600139|NCT01607892|7451701|FG003|Overall Study|Death|10
4600140|NCT01607892|7451702|FG004|Overall Study|Death|3
4600141|NCT01607892|7451698|FG000|Overall Study|Investigator discretion|2
4600142|NCT01607892|7451699|FG001|Overall Study|Investigator discretion|4
4600143|NCT01607892|7451700|FG002|Overall Study|Investigator discretion|4
4600144|NCT01607892|7451701|FG003|Overall Study|Investigator discretion|8
4600145|NCT01607892|7451702|FG004|Overall Study|Investigator discretion|0
4600146|NCT01607892|7451698|FG000|Overall Study|Other treatments became available|1
4600147|NCT01607892|7451699|FG001|Overall Study|Other treatments became available|1
4600148|NCT01607892|7451700|FG002|Overall Study|Other treatments became available|0
4635592|NCT01934140|7507219|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10
4600149|NCT01607892|7451701|FG003|Overall Study|Other treatments became available|0
4600150|NCT01607892|7451702|FG004|Overall Study|Other treatments became available|2
4600151|NCT01607892|7451698|FG000|Overall Study|Intercurrent illness|1
4600152|NCT01607892|7451699|FG001|Overall Study|Intercurrent illness|0
4600153|NCT01607892|7451700|FG002|Overall Study|Intercurrent illness|0
4600154|NCT01607892|7451701|FG003|Overall Study|Intercurrent illness|3
4600155|NCT01607892|7451702|FG004|Overall Study|Intercurrent illness|0
4600156|NCT01607892|7451698|FG000|Overall Study|Non-Compliance with study procedures|0
4600157|NCT01607892|7451699|FG001|Overall Study|Non-Compliance with study procedures|0
4600158|NCT01607892|7451700|FG002|Overall Study|Non-Compliance with study procedures|1
4600159|NCT01607892|7451701|FG003|Overall Study|Non-Compliance with study procedures|0
4600160|NCT01607892|7451702|FG004|Overall Study|Non-Compliance with study procedures|0
4600161|NCT01607892|7451698|FG000|Overall Study|Consent withdrawn by participant|9
4600162|NCT01607892|7451699|FG001|Overall Study|Consent withdrawn by participant|4
4600163|NCT01607892|7451700|FG002|Overall Study|Consent withdrawn by participant|24
4600164|NCT01607892|7451701|FG003|Overall Study|Consent withdrawn by participant|14
4600165|NCT01607892|7451702|FG004|Overall Study|Consent withdrawn by participant|4
4600166|NCT01607892|7451698|FG000|Overall Study|Disease progression|38
4600167|NCT01607892|7451699|FG001|Overall Study|Disease progression|13
4600168|NCT01607892|7451700|FG002|Overall Study|Disease progression|37
4600169|NCT01607892|7451701|FG003|Overall Study|Disease progression|57
4600170|NCT01607892|7451702|FG004|Overall Study|Disease progression|9
4600171|NCT01607892|7451698|FG000|Overall Study|Incidence or severity of Adverse events|3
4600172|NCT01607892|7451699|FG001|Overall Study|Incidence or severity of Adverse events|3
4600173|NCT01607892|7451700|FG002|Overall Study|Incidence or severity of Adverse events|7
4600174|NCT01607892|7451701|FG003|Overall Study|Incidence or severity of Adverse events|2
4600175|NCT01607892|7451702|FG004|Overall Study|Incidence or severity of Adverse events|6
4600176|NCT01607905|7451735|FG000|Overall Study|Withdrawal by participant|7
4600177|NCT01607905|7451736|FG001|Overall Study|Withdrawal by participant|2
4600178|NCT01607905|7451737|FG002|Overall Study|Withdrawal by participant|4
4600179|NCT01607905|7451738|FG003|Overall Study|Withdrawal by participant|6
4600180|NCT01607905|7451739|FG004|Overall Study|Withdrawal by participant|0
4600181|NCT01607905|7451740|FG005|Overall Study|Withdrawal by participant|4
4600182|NCT01607905|7451741|FG006|Overall Study|Withdrawal by participant|12
4600183|NCT01607905|7451735|FG000|Overall Study|Incidence or severity of AEs|5
4600184|NCT01607905|7451736|FG001|Overall Study|Incidence or severity of AEs|1
4600185|NCT01607905|7451737|FG002|Overall Study|Incidence or severity of AEs|1
4600186|NCT01607905|7451738|FG003|Overall Study|Incidence or severity of AEs|3
4600187|NCT01607905|7451739|FG004|Overall Study|Incidence or severity of AEs|0
4600188|NCT01607905|7451740|FG005|Overall Study|Incidence or severity of AEs|2
4600189|NCT01607905|7451741|FG006|Overall Study|Incidence or severity of AEs|8
4635593|NCT01934140|7507218|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2
4635594|NCT01934140|7507219|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0
4600190|NCT01607905|7451735|FG000|Overall Study|Disease progression|44
4600191|NCT01607905|7451736|FG001|Overall Study|Disease progression|16
4600192|NCT01607905|7451737|FG002|Overall Study|Disease progression|15
4600193|NCT01607905|7451738|FG003|Overall Study|Disease progression|11
4600194|NCT01607905|7451739|FG004|Overall Study|Disease progression|6
4600195|NCT01607905|7451740|FG005|Overall Study|Disease progression|7
4600196|NCT01607905|7451741|FG006|Overall Study|Disease progression|21
4600197|NCT01607905|7451735|FG000|Overall Study|Non-compliance with study procedures|0
4600198|NCT01607905|7451736|FG001|Overall Study|Non-compliance with study procedures|0
4600199|NCT01607905|7451737|FG002|Overall Study|Non-compliance with study procedures|0
4600200|NCT01607905|7451738|FG003|Overall Study|Non-compliance with study procedures|0
4600201|NCT01607905|7451739|FG004|Overall Study|Non-compliance with study procedures|0
4600202|NCT01607905|7451740|FG005|Overall Study|Non-compliance with study procedures|0
4600203|NCT01607905|7451741|FG006|Overall Study|Non-compliance with study procedures|1
4600204|NCT01607905|7451735|FG000|Overall Study|Death|1
4600205|NCT01607905|7451736|FG001|Overall Study|Death|1
4600206|NCT01607905|7451737|FG002|Overall Study|Death|1
4600207|NCT01607905|7451738|FG003|Overall Study|Death|1
4600208|NCT01607905|7451739|FG004|Overall Study|Death|0
4600209|NCT01607905|7451740|FG005|Overall Study|Death|0
4600210|NCT01607905|7451741|FG006|Overall Study|Death|3
4600211|NCT01607905|7451735|FG000|Overall Study|Other treatments become available|1
4600212|NCT01607905|7451736|FG001|Overall Study|Other treatments become available|0
4600213|NCT01607905|7451737|FG002|Overall Study|Other treatments become available|0
4600214|NCT01607905|7451738|FG003|Overall Study|Other treatments become available|0
4600215|NCT01607905|7451739|FG004|Overall Study|Other treatments become available|0
4600216|NCT01607905|7451740|FG005|Overall Study|Other treatments become available|0
4600217|NCT01607905|7451741|FG006|Overall Study|Other treatments become available|1
4600218|NCT01607905|7451735|FG000|Overall Study|Investigator discretion|0
4600219|NCT01607905|7451736|FG001|Overall Study|Investigator discretion|0
4600220|NCT01607905|7451737|FG002|Overall Study|Investigator discretion|0
4600221|NCT01607905|7451738|FG003|Overall Study|Investigator discretion|0
4600222|NCT01607905|7451739|FG004|Overall Study|Investigator discretion|0
4600223|NCT01607905|7451740|FG005|Overall Study|Investigator discretion|1
4600224|NCT01607905|7451741|FG006|Overall Study|Investigator discretion|0
4600225|NCT01607905|7451735|FG000|Overall Study|Other|1
4600226|NCT01607905|7451736|FG001|Overall Study|Other|0
4600227|NCT01607905|7451737|FG002|Overall Study|Other|0
4600228|NCT01607905|7451738|FG003|Overall Study|Other|0
4600229|NCT01607905|7451739|FG004|Overall Study|Other|0
4600230|NCT01607905|7451740|FG005|Overall Study|Other|0
4600231|NCT01607905|7451741|FG006|Overall Study|Other|1
4600232|NCT01607905|7451735|FG000|Overall Study|Randomized but not treated|1
4600233|NCT01607905|7451736|FG001|Overall Study|Randomized but not treated|0
4600234|NCT01607905|7451737|FG002|Overall Study|Randomized but not treated|0
4600235|NCT01607905|7451738|FG003|Overall Study|Randomized but not treated|0
4600236|NCT01607905|7451739|FG004|Overall Study|Randomized but not treated|1
4600237|NCT01607905|7451740|FG005|Overall Study|Randomized but not treated|1
4600238|NCT01607905|7451741|FG006|Overall Study|Randomized but not treated|0
4600239|NCT01607957|7451801|FG000|Overall Study|Not treated|1
4600240|NCT01607957|7451802|FG001|Overall Study|Not treated|1
4600241|NCT01607957|7451801|FG000|Overall Study|Death|367
4600242|NCT01607957|7451802|FG001|Overall Study|Death|211
4600243|NCT01607957|7451801|FG000|Overall Study|Lost to Follow-up|3
4600244|NCT01607957|7451802|FG001|Overall Study|Lost to Follow-up|3
4600245|NCT01607957|7451801|FG000|Overall Study|Participant refusal|1
4600246|NCT01607957|7451802|FG001|Overall Study|Participant refusal|0
4600247|NCT01608087|7451821|FG000|Overall Study|Lost to Follow-up|0
4600248|NCT01608087|7451822|FG001|Overall Study|Lost to Follow-up|1
4600249|NCT01608087|7451823|FG002|Overall Study|Lost to Follow-up|0
4600250|NCT01608087|7451821|FG000|Overall Study|Other Reason|0
4600251|NCT01608087|7451822|FG001|Overall Study|Other Reason|1
4600252|NCT01608087|7451823|FG002|Overall Study|Other Reason|0
4600253|NCT01608308|7451869|FG000|Overall Study|pretreatment medical and billing reasons|0
4600254|NCT01608308|7451870|FG001|Overall Study|pretreatment medical and billing reasons|2
4600255|NCT01608321|7451878|FG000|Overall Study|Withdrawal by Subject|1
4600256|NCT01608321|7451879|FG001|Overall Study|Withdrawal by Subject|0
4600257|NCT01608724|7451902|FG000|Overall Study|Withdrawal by Subject|131
4600258|NCT01608724|7451902|FG000|Overall Study|Lost to Follow-up|41
4600259|NCT01608724|7451902|FG000|Overall Study|Study-specific discontinuation criteria|32
4600260|NCT01608724|7451902|FG000|Overall Study|Adverse Event|29
4600261|NCT01608724|7451902|FG000|Overall Study|Protocol Violation|6
4600262|NCT01608724|7451902|FG000|Overall Study|bood sugar too high, etc.|3
4600263|NCT01608724|7451902|FG000|Overall Study|Safety reasons|1
4600264|NCT01609010|7451933|FG000|Overall Study|Stable disease (SD)|22
4600265|NCT01609010|7451934|FG001|Overall Study|Stable disease (SD)|16
4600266|NCT01609010|7451933|FG000|Overall Study|Progressive disease (PD)|8
4600267|NCT01609010|7451934|FG001|Overall Study|Progressive disease (PD)|10
4600268|NCT01609010|7451933|FG000|Overall Study|Adverse Event|3
4600269|NCT01609010|7451934|FG001|Overall Study|Adverse Event|6
4600270|NCT01609010|7451933|FG000|Overall Study|Withdrawal by Subject|2
4600271|NCT01609010|7451934|FG001|Overall Study|Withdrawal by Subject|2
4600272|NCT01609010|7451933|FG000|Overall Study|Other|2
4600273|NCT01609010|7451934|FG001|Overall Study|Other|0
4600274|NCT01609010|7451933|FG000|Overall Study|Other malignancy|1
4600275|NCT01609010|7451934|FG001|Overall Study|Other malignancy|0
4600276|NCT01609010|7451933|FG000|Overall Study|Pathology review|2
4600277|NCT01609010|7451934|FG001|Overall Study|Pathology review|1
4600278|NCT01609010|7451933|FG000|Overall Study|Protocol Violation|1
4600279|NCT01609010|7451934|FG001|Overall Study|Protocol Violation|1
4600280|NCT01609010|7451933|FG000|Overall Study|New cancer|1
4600281|NCT01609010|7451934|FG001|Overall Study|New cancer|0
4600282|NCT01609010|7451933|FG000|Overall Study|Lost to Follow-up|1
4600283|NCT01609010|7451934|FG001|Overall Study|Lost to Follow-up|1
4600284|NCT01609023|7451940|FG000|Overall Study|Lack of Efficacy|3
4600285|NCT01609023|7451940|FG000|Overall Study|Withdrawal by Subject|4
4600286|NCT01609023|7451940|FG000|Overall Study|Lost to Follow-up|8
4600287|NCT01609023|7451940|FG000|Overall Study|Toxicity|3
4600288|NCT01609023|7451940|FG000|Overall Study|Disease progression|10
4600289|NCT01609023|7451940|FG000|Overall Study|Physician Decision|2
4600290|NCT01609023|7451940|FG000|Overall Study|Death|2
4600291|NCT01609023|7451940|FG000|Overall Study|Personal reasons|1
4600292|NCT01609062|7451946|FG000|Extension Phase|Terminated by Sponsor|14
4600293|NCT01609062|7451947|FG001|Extension Phase|Terminated by Sponsor|9
4600294|NCT01609062|7451946|FG000|Extension Phase|Discontinued drug and then was pregnant|1
4600295|NCT01609062|7451947|FG001|Extension Phase|Discontinued drug and then was pregnant|0
4600296|NCT01609062|7451946|FG000|Extension Phase|Anticipated surgery & transition to EAP|0
4600297|NCT01609062|7451947|FG001|Extension Phase|Anticipated surgery & transition to EAP|1
4600298|NCT01609218|7451954|FG000|Period 1|Adverse Event|3
4600299|NCT01609218|7451955|FG001|Period 1|Adverse Event|5
4600300|NCT01609218|7451954|FG000|Period 1|Sponsor Decision|0
4600301|NCT01609218|7451955|FG001|Period 1|Sponsor Decision|1
4600302|NCT01609218|7451954|FG000|Period 2|Adverse Event|1
4600303|NCT01609218|7451955|FG001|Period 2|Adverse Event|0
4600304|NCT01609257|7451963|FG000|Overall Study|Lost to Follow-up|2
4600305|NCT01609257|7451964|FG001|Overall Study|Lost to Follow-up|1
4600306|NCT01609257|7451963|FG000|Overall Study|Voluntary Withdrawal by Subject|0
4600307|NCT01609257|7451964|FG001|Overall Study|Voluntary Withdrawal by Subject|1
4600308|NCT01609257|7451963|FG000|Overall Study|Non-compliance/Protocol deviation|4
4600309|NCT01609257|7451964|FG001|Overall Study|Non-compliance/Protocol deviation|6
4600310|NCT01609296|7451973|FG000|Overall Study|Death|253
4600311|NCT01609296|7451973|FG000|Overall Study|Withdrawal by Subject|151
4600312|NCT01609296|7451973|FG000|Overall Study|Lost to Follow-up|21
4600313|NCT01609296|7451973|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35
4600314|NCT01609296|7451973|FG000|Overall Study|missed visit but known to be alive|28
4600315|NCT01609478|7451993|FG000|Overall Study|Adverse Event|3
4600316|NCT01609478|7451994|FG001|Overall Study|Adverse Event|1
4600317|NCT01609478|7451995|FG002|Overall Study|Adverse Event|5
4600318|NCT01609478|7451993|FG000|Overall Study|Protocol Deviation|0
4600319|NCT01609478|7451994|FG001|Overall Study|Protocol Deviation|1
4600320|NCT01609478|7451995|FG002|Overall Study|Protocol Deviation|1
4600321|NCT01609478|7451993|FG000|Overall Study|Non-Compliance with study treatment|1
4600322|NCT01609478|7451994|FG001|Overall Study|Non-Compliance with study treatment|0
4600323|NCT01609478|7451995|FG002|Overall Study|Non-Compliance with study treatment|0
4600324|NCT01609478|7451993|FG000|Overall Study|Physician Decision|1
4600325|NCT01609478|7451994|FG001|Overall Study|Physician Decision|0
4600326|NCT01609478|7451995|FG002|Overall Study|Physician Decision|1
4600327|NCT01609478|7451993|FG000|Overall Study|Withdrawal by Subject|2
4600328|NCT01609478|7451994|FG001|Overall Study|Withdrawal by Subject|0
4600329|NCT01609478|7451995|FG002|Overall Study|Withdrawal by Subject|2
4600330|NCT01609543|7452003|FG000|Overall Study|Disease Progression|28
4600331|NCT01609543|7452003|FG000|Overall Study|Adverse Event|5
4600332|NCT01609543|7452003|FG000|Overall Study|Withdrawal by Subject|1
4600333|NCT01609543|7452003|FG000|Overall Study|Protocol Violation|1
4600334|NCT01609543|7452003|FG000|Overall Study|Death|7
4600335|NCT01609556|7452024|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
4600336|NCT01609556|7452025|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
4600337|NCT01609556|7452026|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
4600338|NCT01609556|7452027|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
4600339|NCT01609556|7452028|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1
4600340|NCT01609556|7452029|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
4600341|NCT01609556|7452030|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
4600342|NCT01609556|7452031|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1
4600343|NCT01609556|7452032|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1
4600344|NCT01609556|7452033|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
4600345|NCT01609556|7452034|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1
4600346|NCT01609556|7452035|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1
4600347|NCT01609556|7452036|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
4600348|NCT01609556|7452037|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
4600349|NCT01609556|7452038|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
4600350|NCT01609556|7452039|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0
4600351|NCT01609556|7452024|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0
4600352|NCT01609556|7452025|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1
4600353|NCT01609556|7452026|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1
4600354|NCT01609556|7452027|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1
4600355|NCT01609556|7452028|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8
4600356|NCT01609556|7452029|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13
4600357|NCT01609556|7452030|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5
4600358|NCT01609556|7452031|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4
4600359|NCT01609556|7452032|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3
4600360|NCT01609556|7452033|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3
4600361|NCT01609556|7452034|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6
4600362|NCT01609556|7452035|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3
4600363|NCT01609556|7452036|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0
4600364|NCT01609556|7452037|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0
4600365|NCT01609556|7452038|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0
4600366|NCT01609556|7452039|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0
4600367|NCT01609556|7452024|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
4600368|NCT01609556|7452025|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
4600369|NCT01609556|7452026|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
4600370|NCT01609556|7452027|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
4600371|NCT01609556|7452028|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
4600372|NCT01609556|7452029|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2
4600373|NCT01609556|7452030|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2
4600374|NCT01609556|7452031|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
4600375|NCT01609556|7452032|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
4600376|NCT01609556|7452033|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1
4600377|NCT01609556|7452034|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1
4600378|NCT01609556|7452035|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2
4600379|NCT01609556|7452036|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
4600380|NCT01609556|7452037|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
4600381|NCT01609556|7452038|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
4600382|NCT01609556|7452039|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0
4600383|NCT01609556|7452024|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
4600384|NCT01609556|7452025|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
4600385|NCT01609556|7452026|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
4600386|NCT01609556|7452027|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
4600387|NCT01609556|7452028|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
4600388|NCT01609556|7452029|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1
4600389|NCT01609556|7452030|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
4600390|NCT01609556|7452031|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
4600391|NCT01609556|7452032|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
4600392|NCT01609556|7452033|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
4600393|NCT01609556|7452034|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
4600394|NCT01609556|7452035|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1
4600395|NCT01609556|7452036|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
4600396|NCT01609556|7452037|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
4600397|NCT01609556|7452038|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
4600398|NCT01609556|7452039|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0
4600399|NCT01609556|7452024|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
4600400|NCT01609556|7452025|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
4600401|NCT01609556|7452026|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
4600402|NCT01609556|7452027|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
4600403|NCT01609556|7452028|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
4600404|NCT01609556|7452029|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1
4600405|NCT01609556|7452030|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
4600406|NCT01609556|7452031|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
4600407|NCT01609556|7452032|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
4600408|NCT01609556|7452033|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
4600409|NCT01609556|7452034|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
4600410|NCT01609556|7452035|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
4600411|NCT01609556|7452036|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
4600412|NCT01609556|7452037|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
4600413|NCT01609556|7452038|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
4600414|NCT01609556|7452039|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0
4600415|NCT01609556|7452024|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
4600416|NCT01609556|7452025|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
4600417|NCT01609556|7452026|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
4600418|NCT01609556|7452027|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
4600419|NCT01609556|7452028|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
4600420|NCT01609556|7452029|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
4600421|NCT01609556|7452030|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
4600422|NCT01609556|7452031|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
4600423|NCT01609556|7452032|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1
4600424|NCT01609556|7452033|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
4600425|NCT01609556|7452034|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
4600426|NCT01609556|7452035|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
4600427|NCT01609556|7452036|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
4600428|NCT01609556|7452037|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
4600429|NCT01609556|7452038|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
4600430|NCT01609556|7452039|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0
4600431|NCT01609556|7452024|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2
4600432|NCT01609556|7452025|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0
4600433|NCT01609556|7452026|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0
4600434|NCT01609556|7452027|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0
4600435|NCT01609556|7452028|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0
4600436|NCT01609556|7452029|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1
4600437|NCT01609556|7452030|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0
4600438|NCT01609556|7452031|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0
4600439|NCT01609556|7452032|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0
4600440|NCT01609556|7452033|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0
4600441|NCT01609556|7452034|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1
4600442|NCT01609556|7452035|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0
4600443|NCT01609556|7452036|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0
4600444|NCT01609556|7452037|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0
4600445|NCT01609556|7452038|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0
4600446|NCT01609556|7452039|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0
4600447|NCT01609556|7452024|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
4600448|NCT01609556|7452025|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
4600449|NCT01609556|7452026|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
4600450|NCT01609556|7452027|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
4600451|NCT01609556|7452028|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
4600452|NCT01609556|7452029|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
4600453|NCT01609556|7452030|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
4600454|NCT01609556|7452031|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
4600455|NCT01609556|7452032|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
4600456|NCT01609556|7452033|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
4600457|NCT01609556|7452034|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
4600458|NCT01609556|7452035|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0
4600459|NCT01609556|7452036|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4
4600460|NCT01609556|7452037|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2
4600461|NCT01609556|7452038|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2
4600462|NCT01609556|7452039|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2
4600463|NCT01609556|7452024|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
4600464|NCT01609556|7452025|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
4600465|NCT01609556|7452026|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
4600466|NCT01609556|7452027|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
4600467|NCT01609556|7452028|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
4600468|NCT01609556|7452029|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
4600469|NCT01609556|7452030|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
4600470|NCT01609556|7452031|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
4600471|NCT01609556|7452032|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
4600472|NCT01609556|7452033|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
4600473|NCT01609556|7452034|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
4600474|NCT01609556|7452035|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0
4600475|NCT01609556|7452036|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32
4600476|NCT01609556|7452037|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13
4600477|NCT01609556|7452038|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20
4600478|NCT01609556|7452039|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27
4600479|NCT01609556|7452024|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
4600480|NCT01609556|7452025|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
4600481|NCT01609556|7452026|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
4600482|NCT01609556|7452027|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
4600483|NCT01609556|7452028|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
4600484|NCT01609556|7452029|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
4600485|NCT01609556|7452030|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
4600486|NCT01609556|7452031|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
4600487|NCT01609556|7452032|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
4600488|NCT01609556|7452033|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
4600489|NCT01609556|7452034|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
4600490|NCT01609556|7452035|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0
4600491|NCT01609556|7452036|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3
4600492|NCT01609556|7452037|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3
4600493|NCT01609556|7452038|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3
4600494|NCT01609556|7452039|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2
4600495|NCT01609556|7452024|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
4600496|NCT01609556|7452025|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
4600497|NCT01609556|7452026|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
4600498|NCT01609556|7452027|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
4600499|NCT01609556|7452028|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
4600500|NCT01609556|7452029|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
4600501|NCT01609556|7452030|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
4600502|NCT01609556|7452031|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
4600503|NCT01609556|7452032|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
4600504|NCT01609556|7452033|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
4600505|NCT01609556|7452034|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
4600506|NCT01609556|7452035|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
4600507|NCT01609556|7452036|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1
4600508|NCT01609556|7452037|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
4600509|NCT01609556|7452038|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
4600510|NCT01609556|7452039|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0
4600511|NCT01609556|7452024|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
4600512|NCT01609556|7452025|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
4600513|NCT01609556|7452026|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
4600514|NCT01609556|7452027|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
4600515|NCT01609556|7452028|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
4600516|NCT01609556|7452029|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
4600517|NCT01609556|7452030|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
4600518|NCT01609556|7452031|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
4600519|NCT01609556|7452032|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
4600520|NCT01609556|7452033|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
4600521|NCT01609556|7452034|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
4600522|NCT01609556|7452035|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0
4600523|NCT01609556|7452036|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1
4600524|NCT01609556|7452037|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4
4600525|NCT01609556|7452038|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2
4600526|NCT01609556|7452039|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5
4600527|NCT01609556|7452024|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
4600528|NCT01609556|7452025|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
4600529|NCT01609556|7452026|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
4600530|NCT01609556|7452027|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
4600531|NCT01609556|7452028|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
4600532|NCT01609556|7452029|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
4600533|NCT01609556|7452030|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
4600534|NCT01609556|7452031|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
4600535|NCT01609556|7452032|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
4600536|NCT01609556|7452033|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
4600537|NCT01609556|7452034|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
4600538|NCT01609556|7452035|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
4600539|NCT01609556|7452036|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
4600540|NCT01609556|7452037|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
4600541|NCT01609556|7452038|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0
4600542|NCT01609556|7452039|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1
4600543|NCT01609556|7452024|FG000|Dose Expansion: Maximum 124 Weeks|Death|0
4600544|NCT01609556|7452025|FG001|Dose Expansion: Maximum 124 Weeks|Death|0
4600545|NCT01609556|7452026|FG002|Dose Expansion: Maximum 124 Weeks|Death|0
4600546|NCT01609556|7452027|FG003|Dose Expansion: Maximum 124 Weeks|Death|0
4600547|NCT01609556|7452028|FG004|Dose Expansion: Maximum 124 Weeks|Death|0
4600548|NCT01609556|7452029|FG005|Dose Expansion: Maximum 124 Weeks|Death|0
4600549|NCT01609556|7452030|FG006|Dose Expansion: Maximum 124 Weeks|Death|0
4600550|NCT01609556|7452031|FG007|Dose Expansion: Maximum 124 Weeks|Death|0
4600551|NCT01609556|7452032|FG008|Dose Expansion: Maximum 124 Weeks|Death|0
4600552|NCT01609556|7452033|FG009|Dose Expansion: Maximum 124 Weeks|Death|0
4600553|NCT01609556|7452034|FG010|Dose Expansion: Maximum 124 Weeks|Death|0
4600554|NCT01609556|7452035|FG011|Dose Expansion: Maximum 124 Weeks|Death|0
4600555|NCT01609556|7452036|FG012|Dose Expansion: Maximum 124 Weeks|Death|4
4600556|NCT01609556|7452037|FG013|Dose Expansion: Maximum 124 Weeks|Death|2
4600557|NCT01609556|7452038|FG014|Dose Expansion: Maximum 124 Weeks|Death|0
4600558|NCT01609556|7452039|FG015|Dose Expansion: Maximum 124 Weeks|Death|3
4600559|NCT01609556|7452024|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
4600560|NCT01609556|7452025|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
4600561|NCT01609556|7452026|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
4600562|NCT01609556|7452027|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
4600563|NCT01609556|7452028|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
4600564|NCT01609556|7452029|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
4600565|NCT01609556|7452030|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
4600566|NCT01609556|7452031|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
4600567|NCT01609556|7452032|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
4600568|NCT01609556|7452033|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
4600569|NCT01609556|7452034|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
4600570|NCT01609556|7452035|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
4600571|NCT01609556|7452036|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1
4600572|NCT01609556|7452037|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
4600573|NCT01609556|7452038|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
4600574|NCT01609556|7452039|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0
4600575|NCT01609582|7452082|FG000|Overall Study|Adverse Event|20
4600576|NCT01609582|7452083|FG001|Overall Study|Adverse Event|18
4600577|NCT01609582|7452082|FG000|Overall Study|Lost to Follow-up|10
4600578|NCT01609582|7452083|FG001|Overall Study|Lost to Follow-up|10
4600579|NCT01609582|7452082|FG000|Overall Study|Withdrawal by Subject|21
4600580|NCT01609582|7452083|FG001|Overall Study|Withdrawal by Subject|15
4600581|NCT01609582|7452082|FG000|Overall Study|Study Terminated by Sponsor|1543
4600582|NCT01609582|7452083|FG001|Overall Study|Study Terminated by Sponsor|1548
4600583|NCT01609582|7452082|FG000|Overall Study|Other|9
4600584|NCT01609582|7452083|FG001|Overall Study|Other|10
4600585|NCT01609582|7452082|FG000|Overall Study|Randomized, but not treated|0
4600586|NCT01609582|7452083|FG001|Overall Study|Randomized, but not treated|3
4600587|NCT01609933|7452089|FG000|Overall Study|Adverse Event|1
4600588|NCT01609933|7452089|FG000|Overall Study|Withdrawal by Subject|3
4600589|NCT01610037|7452107|FG000|All Patients|Adverse Event|27
4600590|NCT01610037|7452108|FG001|All Patients|Adverse Event|22
4600591|NCT01610037|7452109|FG002|All Patients|Adverse Event|26
4600592|NCT01610037|7452107|FG000|All Patients|Withdrawal by Subject|12
4600593|NCT01610037|7452108|FG001|All Patients|Withdrawal by Subject|10
4600594|NCT01610037|7452109|FG002|All Patients|Withdrawal by Subject|20
4600595|NCT01610037|7452107|FG000|All Patients|Unsatisfactory therapeutic effect|9
4600596|NCT01610037|7452108|FG001|All Patients|Unsatisfactory therapeutic effect|8
4600597|NCT01610037|7452109|FG002|All Patients|Unsatisfactory therapeutic effect|27
4600598|NCT01610037|7452107|FG000|All Patients|Death|4
4600599|NCT01610037|7452108|FG001|All Patients|Death|2
4600600|NCT01610037|7452109|FG002|All Patients|Death|1
4600601|NCT01610037|7452107|FG000|All Patients|Protocol deviation|4
4600602|NCT01610037|7452108|FG001|All Patients|Protocol deviation|3
4600603|NCT01610037|7452109|FG002|All Patients|Protocol deviation|3
4600604|NCT01610037|7452107|FG000|All Patients|Abnormal laboratory value|1
4600605|NCT01610037|7452108|FG001|All Patients|Abnormal laboratory value|1
4600606|NCT01610037|7452109|FG002|All Patients|Abnormal laboratory value|0
4600607|NCT01610037|7452107|FG000|All Patients|Administrative problems|1
4600608|NCT01610037|7452108|FG001|All Patients|Administrative problems|4
4600609|NCT01610037|7452109|FG002|All Patients|Administrative problems|4
4635595|NCT01934140|7507218|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21
4635596|NCT01934140|7507219|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7
4600610|NCT01610037|7452107|FG000|All Patients|Lost to Follow-up|1
4600611|NCT01610037|7452108|FG001|All Patients|Lost to Follow-up|0
4600612|NCT01610037|7452109|FG002|All Patients|Lost to Follow-up|0
4600613|NCT01610037|7452107|FG000|All Patients|Abnormal test procedure result(s)|0
4600614|NCT01610037|7452108|FG001|All Patients|Abnormal test procedure result(s)|1
4600615|NCT01610037|7452109|FG002|All Patients|Abnormal test procedure result(s)|3
4600616|NCT01610037|7452107|FG000|Treatment and Follow up Period|Subject withdrew consent|13
4600617|NCT01610037|7452108|FG001|Treatment and Follow up Period|Subject withdrew consent|14
4600618|NCT01610037|7452109|FG002|Treatment and Follow up Period|Subject withdrew consent|16
4600619|NCT01610037|7452107|FG000|Treatment and Follow up Period|Death|10
4600620|NCT01610037|7452108|FG001|Treatment and Follow up Period|Death|5
4600621|NCT01610037|7452109|FG002|Treatment and Follow up Period|Death|4
4600622|NCT01610037|7452107|FG000|Treatment and Follow up Period|Administrative problems|1
4600623|NCT01610037|7452108|FG001|Treatment and Follow up Period|Administrative problems|3
4600624|NCT01610037|7452109|FG002|Treatment and Follow up Period|Administrative problems|2
4600625|NCT01610037|7452107|FG000|Treatment and Follow up Period|Lost to Follow-up|1
4600626|NCT01610037|7452108|FG001|Treatment and Follow up Period|Lost to Follow-up|6
4600627|NCT01610037|7452109|FG002|Treatment and Follow up Period|Lost to Follow-up|4
4600628|NCT01610063|7452119|FG000|Overall Study|Lost to Follow-up|42
4600629|NCT01610063|7452120|FG001|Overall Study|Lost to Follow-up|20
4600630|NCT01610076|7452128|FG000|Overall Study|Technical issue with video|0
4600631|NCT01610076|7452129|FG001|Overall Study|Technical issue with video|1
4600632|NCT01610076|7452128|FG000|Overall Study|Lost to Follow-up|3
4600633|NCT01610076|7452129|FG001|Overall Study|Lost to Follow-up|4
4600634|NCT01610167|7452145|FG000|Overall Study|Scheduling conflict.|0
4600635|NCT01610167|7452146|FG001|Overall Study|Scheduling conflict.|0
4600636|NCT01610167|7452147|FG002|Overall Study|Scheduling conflict.|2
4600637|NCT01610206|7452157|FG000|Overall Study|Adverse Event|10
4600638|NCT01610206|7452158|FG001|Overall Study|Adverse Event|30
4600639|NCT01610271|7452166|FG000|Overall Study|Surgery not complete|0
4600640|NCT01610271|7452167|FG001|Overall Study|Surgery not complete|1
4600641|NCT01610271|7452166|FG000|Overall Study|Prosthesis not implanted|2
4600642|NCT01610271|7452167|FG001|Overall Study|Prosthesis not implanted|3
4600643|NCT01610284|7452177|FG000|Randomization Phase|Adverse Event|1
4600644|NCT01610284|7452178|FG001|Randomization Phase|Adverse Event|0
4600645|NCT01610284|7452177|FG000|Randomization Phase|Physician Decision|1
4600646|NCT01610284|7452178|FG001|Randomization Phase|Physician Decision|1
4600647|NCT01610284|7452177|FG000|Randomization Phase|Death|0
4600648|NCT01610284|7452178|FG001|Randomization Phase|Death|1
4600649|NCT01610284|7452177|FG000|Treatment Phase|Adverse Event|80
4600650|NCT01610284|7452178|FG001|Treatment Phase|Adverse Event|12
4600651|NCT01610284|7452177|FG000|Treatment Phase|Lost to Follow-up|1
4600652|NCT01610284|7452178|FG001|Treatment Phase|Lost to Follow-up|0
4600653|NCT01610284|7452177|FG000|Treatment Phase|Non-compliance with Study Treatment|8
4600654|NCT01610284|7452178|FG001|Treatment Phase|Non-compliance with Study Treatment|1
4600655|NCT01610284|7452177|FG000|Treatment Phase|Physician Decision|27
4600656|NCT01610284|7452178|FG001|Treatment Phase|Physician Decision|24
4600657|NCT01610284|7452177|FG000|Treatment Phase|Progressive Disease|377
4600658|NCT01610284|7452178|FG001|Treatment Phase|Progressive Disease|486
4600659|NCT01610284|7452177|FG000|Treatment Phase|Protocol Deviation|2
4600660|NCT01610284|7452178|FG001|Treatment Phase|Protocol Deviation|3
4600661|NCT01610284|7452177|FG000|Treatment Phase|Study terminated by Sponsor|18
4600662|NCT01610284|7452178|FG001|Treatment Phase|Study terminated by Sponsor|15
4600663|NCT01610284|7452177|FG000|Treatment Phase|Subject/Guardian Decision|55
4600664|NCT01610284|7452178|FG001|Treatment Phase|Subject/Guardian Decision|23
4600665|NCT01610284|7452177|FG000|Treatment Phase|Death|6
4600666|NCT01610284|7452178|FG001|Treatment Phase|Death|5
4600667|NCT01610284|7452177|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2
4600668|NCT01610284|7452178|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
4600669|NCT01610284|7452177|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10
4600670|NCT01610284|7452178|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3
4600671|NCT01610284|7452177|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24
4600672|NCT01610284|7452178|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8
4600673|NCT01610284|7452177|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11
4600674|NCT01610284|7452178|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1
4600675|NCT01610284|7452177|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4
4600676|NCT01610284|7452178|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4
4600677|NCT01610284|7452177|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38
4600678|NCT01610284|7452178|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13
4600679|NCT01610297|7452184|FG000|Overall Study|Lost to Follow-up|1
4600680|NCT01610336|7452199|FG000|Overall Study|Progressive Disease|4
4600681|NCT01610336|7452200|FG001|Overall Study|Progressive Disease|6
4600682|NCT01610336|7452201|FG002|Overall Study|Progressive Disease|6
4600683|NCT01610336|7452202|FG003|Overall Study|Progressive Disease|5
4600684|NCT01610336|7452203|FG004|Overall Study|Progressive Disease|3
4600685|NCT01610336|7452204|FG005|Overall Study|Progressive Disease|10
4600686|NCT01610336|7452205|FG006|Overall Study|Progressive Disease|1
4600687|NCT01610336|7452206|FG007|Overall Study|Progressive Disease|6
4600688|NCT01610336|7452207|FG008|Overall Study|Progressive Disease|6
4600689|NCT01610336|7452208|FG009|Overall Study|Progressive Disease|40
4635597|NCT01934140|7507218|FG000|Booster Phase (6 Months)|Lost to Follow-up|1
4635598|NCT01934140|7507219|FG001|Booster Phase (6 Months)|Lost to Follow-up|0
4600690|NCT01610336|7452209|FG010|Overall Study|Progressive Disease|36
4600691|NCT01610336|7452199|FG000|Overall Study|Adverse Event|0
4600692|NCT01610336|7452200|FG001|Overall Study|Adverse Event|0
4600693|NCT01610336|7452201|FG002|Overall Study|Adverse Event|0
4600694|NCT01610336|7452202|FG003|Overall Study|Adverse Event|1
4600695|NCT01610336|7452203|FG004|Overall Study|Adverse Event|1
4600696|NCT01610336|7452204|FG005|Overall Study|Adverse Event|1
4600697|NCT01610336|7452205|FG006|Overall Study|Adverse Event|0
4600698|NCT01610336|7452206|FG007|Overall Study|Adverse Event|0
4600699|NCT01610336|7452207|FG008|Overall Study|Adverse Event|2
4600700|NCT01610336|7452208|FG009|Overall Study|Adverse Event|8
4600701|NCT01610336|7452209|FG010|Overall Study|Adverse Event|6
4600702|NCT01610336|7452199|FG000|Overall Study|Subject/Guardian decision|1
4600703|NCT01610336|7452200|FG001|Overall Study|Subject/Guardian decision|1
4600704|NCT01610336|7452201|FG002|Overall Study|Subject/Guardian decision|0
4635599|NCT01934140|7507218|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2
4635600|NCT01934140|7507219|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1
4635601|NCT01934140|7507218|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2
4635602|NCT01934140|7507219|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2
4635603|NCT01934192|7507231|FG000|Overall Study|Protocol Violation|0
4635604|NCT01934192|7507232|FG001|Overall Study|Protocol Violation|0
4635605|NCT01934192|7507233|FG002|Overall Study|Protocol Violation|0
4635606|NCT01934192|7507234|FG003|Overall Study|Protocol Violation|1
4635607|NCT01934192|7507231|FG000|Overall Study|Other: reached stopping criteria|6
4635608|NCT01934192|7507232|FG001|Overall Study|Other: reached stopping criteria|5
4635609|NCT01934192|7507233|FG002|Overall Study|Other: reached stopping criteria|1
4600705|NCT01610336|7452202|FG003|Overall Study|Subject/Guardian decision|1
4600706|NCT01610336|7452203|FG004|Overall Study|Subject/Guardian decision|0
4600707|NCT01610336|7452204|FG005|Overall Study|Subject/Guardian decision|0
4600708|NCT01610336|7452205|FG006|Overall Study|Subject/Guardian decision|0
4600709|NCT01610336|7452206|FG007|Overall Study|Subject/Guardian decision|1
4600710|NCT01610336|7452207|FG008|Overall Study|Subject/Guardian decision|0
4600711|NCT01610336|7452208|FG009|Overall Study|Subject/Guardian decision|2
4600712|NCT01610336|7452209|FG010|Overall Study|Subject/Guardian decision|2
4600713|NCT01610336|7452199|FG000|Overall Study|Death|0
4600714|NCT01610336|7452200|FG001|Overall Study|Death|0
4600715|NCT01610336|7452201|FG002|Overall Study|Death|0
4600716|NCT01610336|7452202|FG003|Overall Study|Death|0
4600717|NCT01610336|7452203|FG004|Overall Study|Death|0
4600718|NCT01610336|7452204|FG005|Overall Study|Death|1
4600719|NCT01610336|7452205|FG006|Overall Study|Death|3
4600720|NCT01610336|7452206|FG007|Overall Study|Death|0
4600721|NCT01610336|7452207|FG008|Overall Study|Death|0
4600722|NCT01610336|7452208|FG009|Overall Study|Death|1
4600723|NCT01610336|7452209|FG010|Overall Study|Death|2
4600724|NCT01610336|7452199|FG000|Overall Study|Non-Compliance with study treatment|0
4600725|NCT01610336|7452200|FG001|Overall Study|Non-Compliance with study treatment|0
4600726|NCT01610336|7452201|FG002|Overall Study|Non-Compliance with study treatment|0
4600727|NCT01610336|7452202|FG003|Overall Study|Non-Compliance with study treatment|0
4600728|NCT01610336|7452203|FG004|Overall Study|Non-Compliance with study treatment|0
4600729|NCT01610336|7452204|FG005|Overall Study|Non-Compliance with study treatment|0
4600730|NCT01610336|7452205|FG006|Overall Study|Non-Compliance with study treatment|0
4600731|NCT01610336|7452206|FG007|Overall Study|Non-Compliance with study treatment|0
4600732|NCT01610336|7452207|FG008|Overall Study|Non-Compliance with study treatment|0
4600733|NCT01610336|7452208|FG009|Overall Study|Non-Compliance with study treatment|1
4600734|NCT01610336|7452209|FG010|Overall Study|Non-Compliance with study treatment|0
4600735|NCT01610336|7452199|FG000|Overall Study|Physician Decision|0
4600736|NCT01610336|7452200|FG001|Overall Study|Physician Decision|0
4600737|NCT01610336|7452201|FG002|Overall Study|Physician Decision|0
4635610|NCT01934192|7507234|FG003|Overall Study|Other: reached stopping criteria|0
4635611|NCT01934192|7507231|FG000|Overall Study|Physician Decision|3
4635612|NCT01934192|7507232|FG001|Overall Study|Physician Decision|2
4635613|NCT01934192|7507233|FG002|Overall Study|Physician Decision|0
4635614|NCT01934192|7507234|FG003|Overall Study|Physician Decision|0
4600738|NCT01610336|7452202|FG003|Overall Study|Physician Decision|0
4600739|NCT01610336|7452203|FG004|Overall Study|Physician Decision|0
4600740|NCT01610336|7452204|FG005|Overall Study|Physician Decision|0
4600741|NCT01610336|7452205|FG006|Overall Study|Physician Decision|1
4635615|NCT01934218|7507257|FG000|Double-blind Phase|Adverse Event|8
4635616|NCT01934218|7507258|FG001|Double-blind Phase|Adverse Event|8
4600742|NCT01610336|7452206|FG007|Overall Study|Physician Decision|0
4600743|NCT01610336|7452207|FG008|Overall Study|Physician Decision|0
4600744|NCT01610336|7452208|FG009|Overall Study|Physician Decision|0
4600745|NCT01610336|7452209|FG010|Overall Study|Physician Decision|0
4635617|NCT01934218|7507257|FG000|Double-blind Phase|Lack of Efficacy|6
4635618|NCT01934218|7507258|FG001|Double-blind Phase|Lack of Efficacy|7
4600746|NCT01610336|7452199|FG000|Overall Study|Protocol Deviation|0
4600747|NCT01610336|7452200|FG001|Overall Study|Protocol Deviation|0
4635619|NCT01934218|7507257|FG000|Double-blind Phase|Lost to Follow-up|7
4635620|NCT01934218|7507258|FG001|Double-blind Phase|Lost to Follow-up|14
4635621|NCT01934218|7507257|FG000|Double-blind Phase|Physician Decision|1
4600748|NCT01610336|7452201|FG002|Overall Study|Protocol Deviation|0
4600749|NCT01610336|7452202|FG003|Overall Study|Protocol Deviation|0
4600750|NCT01610336|7452203|FG004|Overall Study|Protocol Deviation|0
4600751|NCT01610336|7452204|FG005|Overall Study|Protocol Deviation|0
4600752|NCT01610336|7452205|FG006|Overall Study|Protocol Deviation|0
4600753|NCT01610336|7452206|FG007|Overall Study|Protocol Deviation|0
4600754|NCT01610336|7452207|FG008|Overall Study|Protocol Deviation|0
4600755|NCT01610336|7452208|FG009|Overall Study|Protocol Deviation|1
4600756|NCT01610336|7452209|FG010|Overall Study|Protocol Deviation|0
4600757|NCT01610336|7452199|FG000|Overall Study|Transfer to another trial|0
4600758|NCT01610336|7452200|FG001|Overall Study|Transfer to another trial|0
4600759|NCT01610336|7452201|FG002|Overall Study|Transfer to another trial|0
4600760|NCT01610336|7452202|FG003|Overall Study|Transfer to another trial|0
4600761|NCT01610336|7452203|FG004|Overall Study|Transfer to another trial|0
4600762|NCT01610336|7452204|FG005|Overall Study|Transfer to another trial|0
4600763|NCT01610336|7452205|FG006|Overall Study|Transfer to another trial|0
4600764|NCT01610336|7452206|FG007|Overall Study|Transfer to another trial|0
4600765|NCT01610336|7452207|FG008|Overall Study|Transfer to another trial|0
4600766|NCT01610336|7452208|FG009|Overall Study|Transfer to another trial|0
4600767|NCT01610336|7452209|FG010|Overall Study|Transfer to another trial|1
4600768|NCT01610414|7452239|FG000|Study Start - Month 13|Serious Adverse Event|65
4600769|NCT01610414|7452240|FG001|Study Start - Month 13|Serious Adverse Event|67
4600770|NCT01610414|7452239|FG000|Study Start - Month 13|Adverse Event|14
4600771|NCT01610414|7452240|FG001|Study Start - Month 13|Adverse Event|14
4600772|NCT01610414|7452239|FG000|Study Start - Month 13|Protocol Violation|3
4600773|NCT01610414|7452240|FG001|Study Start - Month 13|Protocol Violation|1
4600774|NCT01610414|7452239|FG000|Study Start - Month 13|Withdrawal by Subject|23
4600775|NCT01610414|7452240|FG001|Study Start - Month 13|Withdrawal by Subject|30
4600776|NCT01610414|7452239|FG000|Study Start - Month 13|Migrated/moved from study area|2
4600777|NCT01610414|7452240|FG001|Study Start - Month 13|Migrated/moved from study area|4
4600778|NCT01610414|7452239|FG000|Study Start - Month 13|Lost to Follow-up|4
4600779|NCT01610414|7452240|FG001|Study Start - Month 13|Lost to Follow-up|6
4600780|NCT01610414|7452239|FG000|Study Start - Month 13|Suspected HZ episode|1
4600781|NCT01610414|7452240|FG001|Study Start - Month 13|Suspected HZ episode|3
4600782|NCT01610414|7452239|FG000|Study Start - Month 13|Other reasons for withdrawal|3
4600783|NCT01610414|7452240|FG001|Study Start - Month 13|Other reasons for withdrawal|4
4600784|NCT01610414|7452239|FG000|Month 13 - Month 25|Serious Adverse Event|35
4600785|NCT01610414|7452240|FG001|Month 13 - Month 25|Serious Adverse Event|38
4600786|NCT01610414|7452239|FG000|Month 13 - Month 25|Adverse Event|8
4600787|NCT01610414|7452240|FG001|Month 13 - Month 25|Adverse Event|4
4600788|NCT01610414|7452239|FG000|Month 13 - Month 25|Withdrawal by Subject|7
4600789|NCT01610414|7452240|FG001|Month 13 - Month 25|Withdrawal by Subject|8
4600790|NCT01610414|7452239|FG000|Month 13 - Month 25|Migrated/moved from study area|4
4600791|NCT01610414|7452240|FG001|Month 13 - Month 25|Migrated/moved from study area|2
4600792|NCT01610414|7452239|FG000|Month 13 - Month 25|Protocol Violation|0
4600793|NCT01610414|7452240|FG001|Month 13 - Month 25|Protocol Violation|2
4600794|NCT01610414|7452239|FG000|Month 13 - Month 25|Lost to Follow-up|5
4600795|NCT01610414|7452240|FG001|Month 13 - Month 25|Lost to Follow-up|9
4600796|NCT01610414|7452239|FG000|Month 13 - Month 25|Other reasons for withdrawal|6
4600797|NCT01610414|7452240|FG001|Month 13 - Month 25|Other reasons for withdrawal|7
4600798|NCT01610414|7452239|FG000|After Month 25|Study end not reached|48
4600799|NCT01610414|7452240|FG001|After Month 25|Study end not reached|53
4600800|NCT01610492|7452256|FG000|Overall Study|Adverse Event|1
4600801|NCT01610492|7452256|FG000|Overall Study|Lack of Efficacy|3
4600802|NCT01610492|7452256|FG000|Overall Study|Other: Reached stopping criteria|1
4600803|NCT01610492|7452256|FG000|Overall Study|Other:Treatment stopped due to remission|1
4600804|NCT01610557|7452264|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
4600805|NCT01610557|7452265|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1
4600806|NCT01610557|7452266|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
4600807|NCT01610557|7452267|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
4600808|NCT01610557|7452268|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
4600809|NCT01610557|7452264|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0
4600810|NCT01610557|7452265|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0
4600811|NCT01610557|7452266|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0
4600812|NCT01610557|7452267|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0
4600813|NCT01610557|7452268|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3
4600814|NCT01610596|7452304|FG000|Overall Study|Lost to Follow-up|0
4600815|NCT01610596|7452305|FG001|Overall Study|Lost to Follow-up|1
4600816|NCT01610687|7452311|FG000|Overall Study|Lack of Efficacy|26
4600817|NCT01610687|7452311|FG000|Overall Study|Adverse Event|18
4600818|NCT01610687|7452311|FG000|Overall Study|Moved out of area|6
4635622|NCT01934218|7507258|FG001|Double-blind Phase|Physician Decision|2
4600819|NCT01610687|7452311|FG000|Overall Study|Withdrawal by Subject|7
4600820|NCT01610687|7452311|FG000|Overall Study|Lost to Follow-up|4
4600821|NCT01610687|7452311|FG000|Overall Study|Symptom control without study medication|2
4635623|NCT01934218|7507257|FG000|Double-blind Phase|Protocol Violation|4
4600822|NCT01610687|7452311|FG000|Overall Study|Unable to make journey|1
4600823|NCT01610687|7452311|FG000|Overall Study|Death|1
4600824|NCT01610687|7452311|FG000|Overall Study|Cannabis affecting job|1
4600825|NCT01610687|7452311|FG000|Overall Study|Felt more alter without study medication|1
4600826|NCT01610700|7452317|FG000|Overall Study|Adverse Event|3
4600827|NCT01610700|7452318|FG001|Overall Study|Adverse Event|1
4600828|NCT01610700|7452317|FG000|Overall Study|Withdrawal by Subject|0
4600829|NCT01610700|7452318|FG001|Overall Study|Withdrawal by Subject|1
4600830|NCT01610700|7452317|FG000|Overall Study|subject took one dose of street cannabis|0
4600831|NCT01610700|7452318|FG001|Overall Study|subject took one dose of street cannabis|1
4600832|NCT01610713|7452327|FG000|Overall Study|Adverse Event|3
4600833|NCT01610713|7452328|FG001|Overall Study|Adverse Event|0
4600834|NCT01610713|7452327|FG000|Overall Study|Lack of Efficacy|1
4600835|NCT01610713|7452328|FG001|Overall Study|Lack of Efficacy|0
4600836|NCT01610713|7452327|FG000|Overall Study|low mood and poor motivation|1
4600837|NCT01610713|7452328|FG001|Overall Study|low mood and poor motivation|0
4600838|NCT01610713|7452327|FG000|Overall Study|adv. to use original dose/amitriptyline|1
4600839|NCT01610713|7452328|FG001|Overall Study|adv. to use original dose/amitriptyline|0
4600840|NCT01610713|7452327|FG000|Overall Study|Lost to Follow-up|0
4600841|NCT01610713|7452328|FG001|Overall Study|Lost to Follow-up|1
4600842|NCT01610752|7452337|FG000|Overall Study|Miscarriage/Pregnancy loss|0
4600843|NCT01610752|7452338|FG001|Overall Study|Miscarriage/Pregnancy loss|0
4600844|NCT01610752|7452339|FG002|Overall Study|Miscarriage/Pregnancy loss|4
4600845|NCT01610791|7452347|FG000|Overall Study|Lost to Follow-up|7
4600846|NCT01610791|7452347|FG000|Overall Study|Adverse Event|6
4600847|NCT01610791|7452347|FG000|Overall Study|Physician Decision|1
4600848|NCT01610791|7452347|FG000|Overall Study|Adverse event and Investigator decision|1
4600849|NCT01610791|7452347|FG000|Overall Study|Death|1
4600850|NCT01610791|7452347|FG000|Overall Study|Not determined|5
4600851|NCT01611090|7452353|FG000|Randomized Period|Lost to Follow-up|8
4600852|NCT01611090|7452354|FG001|Randomized Period|Lost to Follow-up|3
4600853|NCT01611090|7452355|FG002|Randomized Period|Lost to Follow-up|0
4600854|NCT01611090|7452353|FG000|Randomized Period|Withdrawal by Subject|22
4600855|NCT01611090|7452354|FG001|Randomized Period|Withdrawal by Subject|26
4600856|NCT01611090|7452355|FG002|Randomized Period|Withdrawal by Subject|0
4600857|NCT01611090|7452353|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0
4600858|NCT01611090|7452354|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0
4600859|NCT01611090|7452355|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4
4600860|NCT01611090|7452353|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0
4600861|NCT01611090|7452354|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0
4600862|NCT01611090|7452355|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1
4600863|NCT01611155|7452364|FG000|Overall Study|Adverse Event|1
4600864|NCT01611155|7452365|FG001|Overall Study|Adverse Event|1
4600865|NCT01611155|7452364|FG000|Overall Study|Refused further treatment|6
4600866|NCT01611155|7452365|FG001|Overall Study|Refused further treatment|4
4600867|NCT01611155|7452364|FG000|Overall Study|Disease progression|1
4600868|NCT01611155|7452365|FG001|Overall Study|Disease progression|0
4600869|NCT01611155|7452364|FG000|Overall Study|Withdrawal by Subject|1
4600870|NCT01611155|7452365|FG001|Overall Study|Withdrawal by Subject|0
4600871|NCT01611155|7452364|FG000|Overall Study|Alternative treatment|0
4600872|NCT01611155|7452365|FG001|Overall Study|Alternative treatment|1
4600873|NCT01611155|7452364|FG000|Overall Study|Ineligible patient|0
4600874|NCT01611155|7452365|FG001|Overall Study|Ineligible patient|1
4600875|NCT01611194|7452373|FG000|Overall Study|Lost to Follow-up|0
4600876|NCT01611194|7452374|FG001|Overall Study|Lost to Follow-up|1
4600877|NCT01611194|7452373|FG000|Overall Study|Withdrawal by Subject|0
4600878|NCT01611194|7452374|FG001|Overall Study|Withdrawal by Subject|1
4600879|NCT01611194|7452373|FG000|Overall Study|drug use|0
4600880|NCT01611194|7452374|FG001|Overall Study|drug use|1
4635624|NCT01934218|7507258|FG001|Double-blind Phase|Protocol Violation|0
4635625|NCT01934218|7507257|FG000|Double-blind Phase|Withdrawal by Subject|16
4635626|NCT01934218|7507258|FG001|Double-blind Phase|Withdrawal by Subject|13
4635627|NCT01934218|7507257|FG000|Double-blind Phase|Noncompliance with Study Protocol|5
4635628|NCT01934218|7507258|FG001|Double-blind Phase|Noncompliance with Study Protocol|8
4635629|NCT01934218|7507257|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1
4635630|NCT01934218|7507258|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2
4600881|NCT01611259|7452380|FG000|Overall Study|Physician Decision|1
4600882|NCT01611259|7452380|FG000|Overall Study|Lack of Efficacy|2
4600883|NCT01611259|7452380|FG000|Overall Study|Adverse Event|4
4600884|NCT01611259|7452380|FG000|Overall Study|Withdrawal by Subject|7
4600885|NCT01611298|7452384|FG000|Overall Study|Relapsed|2
4600886|NCT01611454|7452390|FG000|Overall Study|Lack of Efficacy|18
4600887|NCT01611454|7452391|FG001|Overall Study|Lack of Efficacy|10
4600888|NCT01611558|7452401|FG000|Induction Phase|Study drug toxicity|15
4600889|NCT01611558|7452401|FG000|Induction Phase|Disease progression|18
4600890|NCT01611558|7452401|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1
4600891|NCT01611558|7452401|FG000|Induction Phase|Adverse event unrelated to study drug|3
4600892|NCT01611558|7452401|FG000|Induction Phase|Death|1
4600893|NCT01611558|7452401|FG000|Maintenance Phase|Withdrawal by Subject|1
4600894|NCT01611558|7452401|FG000|Maintenance Phase|Elevated Uric acid|1
4600895|NCT01611792|7452429|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12
4600896|NCT01611792|7452430|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9
4600897|NCT01611792|7452429|FG000|Followup: at 6 Months|Lost to Follow-up|6
4600898|NCT01611792|7452430|FG001|Followup: at 6 Months|Lost to Follow-up|13
4600899|NCT01611857|7452439|FG000|Overall Study|Withdrawal by Subject|0
4600900|NCT01611857|7452440|FG001|Overall Study|Withdrawal by Subject|2
4600901|NCT01611935|7452450|FG000|Overall Study|Family Declined Participation|1
4600902|NCT01611935|7452451|FG001|Overall Study|Family Declined Participation|0
4600903|NCT01611974|7452469|FG000|Overall Study|Death|10
4600904|NCT01611974|7452470|FG001|Overall Study|Death|12
4600905|NCT01611974|7452471|FG002|Overall Study|Death|10
4600906|NCT01611974|7452469|FG000|Overall Study|Lost to Follow-up|0
4600907|NCT01611974|7452470|FG001|Overall Study|Lost to Follow-up|1
4600908|NCT01611974|7452471|FG002|Overall Study|Lost to Follow-up|0
4600909|NCT01611974|7452469|FG000|Overall Study|Physician Decision|5
4600910|NCT01611974|7452470|FG001|Overall Study|Physician Decision|1
4600911|NCT01611974|7452471|FG002|Overall Study|Physician Decision|2
4600912|NCT01611974|7452469|FG000|Overall Study|Withdrawal by Subject|0
4600913|NCT01611974|7452470|FG001|Overall Study|Withdrawal by Subject|1
4600914|NCT01611974|7452471|FG002|Overall Study|Withdrawal by Subject|4
4600915|NCT01612000|7452483|FG000|Overall Study|Lost to Follow-up|6
4600916|NCT01612000|7452484|FG001|Overall Study|Lost to Follow-up|4
4600917|NCT01612000|7452485|FG002|Overall Study|Lost to Follow-up|4
4600918|NCT01612000|7452486|FG003|Overall Study|Lost to Follow-up|8
4600919|NCT01612000|7452483|FG000|Overall Study|Physician Decision|0
4635631|NCT01934218|7507257|FG000|Open-Label Phase|Adverse Event|2
4635632|NCT01934218|7507258|FG001|Open-Label Phase|Adverse Event|4
4635633|NCT01934218|7507257|FG000|Open-Label Phase|Lack of Efficacy|1
4635634|NCT01934218|7507258|FG001|Open-Label Phase|Lack of Efficacy|4
4635635|NCT01934218|7507257|FG000|Open-Label Phase|Lost to Follow-up|4
4635636|NCT01934218|7507258|FG001|Open-Label Phase|Lost to Follow-up|2
4635637|NCT01934218|7507257|FG000|Open-Label Phase|Physician Decision|1
4635638|NCT01934218|7507258|FG001|Open-Label Phase|Physician Decision|0
4635639|NCT01934218|7507257|FG000|Open-Label Phase|Protocol Violation|1
4635640|NCT01934218|7507258|FG001|Open-Label Phase|Protocol Violation|0
4635641|NCT01934218|7507257|FG000|Open-Label Phase|Withdrawal by Subject|13
4600920|NCT01612000|7452484|FG001|Overall Study|Physician Decision|0
4600921|NCT01612000|7452485|FG002|Overall Study|Physician Decision|1
4600922|NCT01612000|7452486|FG003|Overall Study|Physician Decision|0
4600923|NCT01612000|7452483|FG000|Overall Study|Withdrawal by Subject|3
4600924|NCT01612000|7452484|FG001|Overall Study|Withdrawal by Subject|1
4600925|NCT01612000|7452485|FG002|Overall Study|Withdrawal by Subject|2
4600926|NCT01612000|7452486|FG003|Overall Study|Withdrawal by Subject|2
4600927|NCT01612156|7452498|FG000|Overall Study|Protocol Violation|2
4600928|NCT01612156|7452499|FG001|Overall Study|Protocol Violation|0
4600929|NCT01612676|7452531|FG000|Overall Study|Adverse Event|2
4600930|NCT01612676|7452532|FG001|Overall Study|Adverse Event|3
4600931|NCT01612676|7452533|FG002|Overall Study|Adverse Event|1
4600932|NCT01612676|7452534|FG003|Overall Study|Adverse Event|3
4600933|NCT01612676|7452531|FG000|Overall Study|Protocol Violation|0
4600934|NCT01612676|7452532|FG001|Overall Study|Protocol Violation|1
4600935|NCT01612676|7452533|FG002|Overall Study|Protocol Violation|0
4600936|NCT01612676|7452534|FG003|Overall Study|Protocol Violation|0
4600937|NCT01612702|7452548|FG000|Overall Study|Protocol Violation|11
4600938|NCT01612702|7452549|FG001|Overall Study|Protocol Violation|11
4600939|NCT01612780|7452580|FG000|Overall Study|Treatment not completed|1
4600940|NCT01612780|7452580|FG000|Overall Study|Withdrawal by Subject|5
4600941|NCT01612858|7452595|FG000|Overall Study|Withdrawal by Subject|5
4600942|NCT01612858|7452596|FG001|Overall Study|Withdrawal by Subject|1
4600943|NCT01613027|7452620|FG000|Overall Study|Lost to Follow-up|5
4600944|NCT01613027|7452620|FG000|Overall Study|Switched Physician|1
4600945|NCT01613027|7452620|FG000|Overall Study|Lack of Efficacy|1
4600946|NCT01613027|7452620|FG000|Overall Study|Patient's Decision Due to Adverse Event|1
4635642|NCT01934218|7507258|FG001|Open-Label Phase|Withdrawal by Subject|11
4635643|NCT01934218|7507257|FG000|Open-Label Phase|Noncompliance with Study Protocol|4
4635644|NCT01934218|7507258|FG001|Open-Label Phase|Noncompliance with Study Protocol|2
4635645|NCT01934218|7507257|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0
4635646|NCT01934218|7507258|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1
4635647|NCT01934335|7507270|FG000|Overall Study|Withdrawal by Subject|1
4635648|NCT01934335|7507271|FG001|Overall Study|Withdrawal by Subject|1
4635649|NCT01934556|7507288|FG000|Overall Study|Withdrawal by Subject|0
4635650|NCT01934556|7507289|FG001|Overall Study|Withdrawal by Subject|1
4635651|NCT01934556|7507290|FG002|Overall Study|Withdrawal by Subject|1
4635652|NCT01934556|7507288|FG000|Overall Study|Lost to Follow-up|4
4635653|NCT01934556|7507289|FG001|Overall Study|Lost to Follow-up|10
4635654|NCT01934556|7507290|FG002|Overall Study|Lost to Follow-up|7
4635655|NCT01934556|7507288|FG000|Overall Study|Death|1
4635656|NCT01934556|7507289|FG001|Overall Study|Death|5
4635657|NCT01934556|7507290|FG002|Overall Study|Death|2
4635658|NCT01934790|7507304|FG000|Treatment|Adverse Event|3
4635659|NCT01934790|7507304|FG000|Treatment|Clinical progression|6
4635660|NCT01934790|7507304|FG000|Treatment|Radiological progression|4
4635661|NCT01934790|7507304|FG000|Treatment|Withdrawal by Subject|2
4635662|NCT01934790|7507304|FG000|Treatment|Study drug never administered|1
4600947|NCT01613131|7452644|FG000|Overall Study|Withdrawal by Subject|3
4600948|NCT01613131|7452645|FG001|Overall Study|Withdrawal by Subject|5
4746580|NCT00660595|7718380|FG000|Overall Study|Did not consent to participate in study|12
4600949|NCT01613222|7452651|FG000|Overall Study|Physician Decision|1
4600950|NCT01613222|7452651|FG000|Overall Study|Unable to place arterial line|1
4600951|NCT01613222|7452651|FG000|Overall Study|Reused disposable sensors|10
4600952|NCT01613248|7452670|FG000|Overall Study|Adverse Event|0
4600953|NCT01613248|7452671|FG001|Overall Study|Adverse Event|0
4600954|NCT01613248|7452672|FG002|Overall Study|Adverse Event|0
4600955|NCT01613248|7452673|FG003|Overall Study|Adverse Event|1
4600956|NCT01613248|7452674|FG004|Overall Study|Adverse Event|0
4600957|NCT01613248|7452675|FG005|Overall Study|Adverse Event|0
4600958|NCT01613248|7452670|FG000|Overall Study|Withdrawal by Subject|3
4600959|NCT01613248|7452671|FG001|Overall Study|Withdrawal by Subject|2
4600960|NCT01613248|7452672|FG002|Overall Study|Withdrawal by Subject|2
4600961|NCT01613248|7452673|FG003|Overall Study|Withdrawal by Subject|5
4600962|NCT01613248|7452674|FG004|Overall Study|Withdrawal by Subject|0
4600963|NCT01613248|7452675|FG005|Overall Study|Withdrawal by Subject|1
4600964|NCT01613248|7452670|FG000|Overall Study|Lost to Follow-up|5
4600965|NCT01613248|7452671|FG001|Overall Study|Lost to Follow-up|7
4600966|NCT01613248|7452672|FG002|Overall Study|Lost to Follow-up|4
4600967|NCT01613248|7452673|FG003|Overall Study|Lost to Follow-up|8
4600968|NCT01613248|7452674|FG004|Overall Study|Lost to Follow-up|4
4600969|NCT01613248|7452675|FG005|Overall Study|Lost to Follow-up|2
4600970|NCT01613248|7452670|FG000|Overall Study|Study Terminated by Sponsor|4
4600971|NCT01613248|7452671|FG001|Overall Study|Study Terminated by Sponsor|6
4600972|NCT01613248|7452672|FG002|Overall Study|Study Terminated by Sponsor|8
4600973|NCT01613248|7452673|FG003|Overall Study|Study Terminated by Sponsor|8
4600974|NCT01613248|7452674|FG004|Overall Study|Study Terminated by Sponsor|9
4600975|NCT01613248|7452675|FG005|Overall Study|Study Terminated by Sponsor|11
4600976|NCT01613248|7452670|FG000|Overall Study|Physician Decision|8
4600977|NCT01613248|7452671|FG001|Overall Study|Physician Decision|8
4600978|NCT01613248|7452672|FG002|Overall Study|Physician Decision|9
4600979|NCT01613248|7452673|FG003|Overall Study|Physician Decision|4
4600980|NCT01613248|7452674|FG004|Overall Study|Physician Decision|7
4600981|NCT01613248|7452675|FG005|Overall Study|Physician Decision|6
4600982|NCT01613248|7452670|FG000|Overall Study|Lack of Qualifying Event|9
4600983|NCT01613248|7452671|FG001|Overall Study|Lack of Qualifying Event|11
4600984|NCT01613248|7452672|FG002|Overall Study|Lack of Qualifying Event|10
4600985|NCT01613248|7452673|FG003|Overall Study|Lack of Qualifying Event|11
4600986|NCT01613248|7452674|FG004|Overall Study|Lack of Qualifying Event|15
4600987|NCT01613248|7452675|FG005|Overall Study|Lack of Qualifying Event|18
4600988|NCT01613248|7452670|FG000|Overall Study|Pregnancy|0
4600989|NCT01613248|7452671|FG001|Overall Study|Pregnancy|0
4600990|NCT01613248|7452672|FG002|Overall Study|Pregnancy|0
4600991|NCT01613248|7452673|FG003|Overall Study|Pregnancy|1
4600992|NCT01613248|7452674|FG004|Overall Study|Pregnancy|0
4600993|NCT01613248|7452675|FG005|Overall Study|Pregnancy|0
4600994|NCT01613326|7452708|FG000|Overall Study|Adverse Event|7
4600995|NCT01613326|7452709|FG001|Overall Study|Adverse Event|5
4600996|NCT01613326|7452708|FG000|Overall Study|Withdrawal by Subject|3
4600997|NCT01613326|7452709|FG001|Overall Study|Withdrawal by Subject|4
4600998|NCT01613326|7452708|FG000|Overall Study|Abnormal test procedure result(s)|2
4600999|NCT01613326|7452709|FG001|Overall Study|Abnormal test procedure result(s)|0
4601000|NCT01613326|7452708|FG000|Overall Study|inability to use device|1
4601001|NCT01613326|7452709|FG001|Overall Study|inability to use device|0
4601002|NCT01613326|7452708|FG000|Overall Study|Lack of Efficacy|0
4601003|NCT01613326|7452709|FG001|Overall Study|Lack of Efficacy|1
4601004|NCT01613326|7452708|FG000|Overall Study|Lost to Follow-up|0
4601005|NCT01613326|7452709|FG001|Overall Study|Lost to Follow-up|1
4601006|NCT01613326|7452708|FG000|Overall Study|Administrative|0
4601007|NCT01613326|7452709|FG001|Overall Study|Administrative|2
4601008|NCT01613326|7452708|FG000|Overall Study|Protocol Violation|0
4601009|NCT01613326|7452709|FG001|Overall Study|Protocol Violation|1
4601010|NCT01613378|7452723|FG000|Overall Study|Lack of Efficacy|13
4601011|NCT01613378|7452723|FG000|Overall Study|Adverse Event|11
4601012|NCT01613378|7452723|FG000|Overall Study|Withdrawal by Subject|8
4601013|NCT01613378|7452723|FG000|Overall Study|Death|2
4601014|NCT01613378|7452723|FG000|Overall Study|Lost to Follow-up|1
4601015|NCT01613378|7452723|FG000|Overall Study|Other Reason|4
4601016|NCT01613417|7452729|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13
4601017|NCT01613417|7452730|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7
4601018|NCT01613599|7452746|FG000|Overall Study|Death|9
4601019|NCT01613599|7452746|FG000|Overall Study|Lost to Follow-up|5
4601020|NCT01613599|7452746|FG000|Overall Study|Withdrawal by Subject|8
4601021|NCT01613599|7452746|FG000|Overall Study|Reason not specified|3
4601022|NCT01613716|7452750|FG000|Overall Study|screen failures|3
4601023|NCT01613716|7452750|FG000|Overall Study|Lost to Follow-up|4
4601024|NCT01614093|7452759|FG000|Overall Study|Withdrawal by Subject|1
4601025|NCT01614249|7452770|FG000|Overall Study|Lost to Follow-up|11
4601026|NCT01614249|7452771|FG001|Overall Study|Lost to Follow-up|23
4746581|NCT00660595|7718381|FG001|Overall Study|Did not consent to participate in study|8
4601027|NCT01614457|7452788|FG000|Overall Study|Non-Compliance|1
4746582|NCT00660595|7718380|FG000|Overall Study|Participant left hospital|1
4746583|NCT00660595|7718381|FG001|Overall Study|Participant left hospital|0
4601028|NCT01614457|7452789|FG001|Overall Study|Non-Compliance|0
4601029|NCT01614457|7452788|FG000|Overall Study|Pregnancy (Self or Partner)|1
4601030|NCT01614457|7452789|FG001|Overall Study|Pregnancy (Self or Partner)|0
4601031|NCT01614470|7452797|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1
4601032|NCT01614470|7452798|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
4601033|NCT01614470|7452799|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
4601034|NCT01614470|7452797|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1
4601035|NCT01614470|7452798|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1
4601036|NCT01614470|7452799|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0
4601037|NCT01614600|7452821|FG000|Overall Study|Unacceptable fit|1
4601038|NCT01614600|7452821|FG000|Overall Study|Discomfort|1
4601039|NCT01614600|7452821|FG000|Overall Study|Unable to remove lens at the end of day|1
4601040|NCT01614600|7452821|FG000|Overall Study|Protocol deviation|1
4601041|NCT01614769|7452839|FG000|Period 1|Discontinued due to Hypoglycemia|0
4601042|NCT01614769|7452840|FG001|Period 1|Discontinued due to Hypoglycemia|0
4601043|NCT01614769|7452841|FG002|Period 1|Discontinued due to Hypoglycemia|0
4601044|NCT01614769|7452842|FG003|Period 1|Discontinued due to Hypoglycemia|1
4601045|NCT01614769|7452843|FG004|Period 1|Discontinued due to Hypoglycemia|0
4601046|NCT01614769|7452844|FG005|Period 1|Discontinued due to Hypoglycemia|1
4601047|NCT01614769|7452839|FG000|Period 1|Protocol Violation|0
4601048|NCT01614769|7452840|FG001|Period 1|Protocol Violation|0
4601049|NCT01614769|7452841|FG002|Period 1|Protocol Violation|0
4601050|NCT01614769|7452842|FG003|Period 1|Protocol Violation|1
4601051|NCT01614769|7452843|FG004|Period 1|Protocol Violation|0
4601052|NCT01614769|7452844|FG005|Period 1|Protocol Violation|0
4601053|NCT01614769|7452839|FG000|Period 1|Withdrawal by Subject|1
4601054|NCT01614769|7452840|FG001|Period 1|Withdrawal by Subject|0
4601055|NCT01614769|7452841|FG002|Period 1|Withdrawal by Subject|0
4601056|NCT01614769|7452842|FG003|Period 1|Withdrawal by Subject|0
4601057|NCT01614769|7452843|FG004|Period 1|Withdrawal by Subject|0
4601058|NCT01614769|7452844|FG005|Period 1|Withdrawal by Subject|0
4601059|NCT01614769|7452839|FG000|Period 3|Withdrawal by Subject|0
4601060|NCT01614769|7452840|FG001|Period 3|Withdrawal by Subject|0
4601061|NCT01614769|7452841|FG002|Period 3|Withdrawal by Subject|1
4601062|NCT01614769|7452842|FG003|Period 3|Withdrawal by Subject|0
4601063|NCT01614769|7452843|FG004|Period 3|Withdrawal by Subject|0
4601064|NCT01614769|7452844|FG005|Period 3|Withdrawal by Subject|0
4601065|NCT01614795|7452856|FG000|Overall Study|Adverse Event|0
4601066|NCT01614795|7452857|FG001|Overall Study|Adverse Event|0
4601067|NCT01614795|7452858|FG002|Overall Study|Adverse Event|1
4601068|NCT01614795|7452859|FG003|Overall Study|Adverse Event|1
4601069|NCT01614795|7452856|FG000|Overall Study|Lack of Efficacy|10
4601070|NCT01614795|7452857|FG001|Overall Study|Lack of Efficacy|10
4601071|NCT01614795|7452858|FG002|Overall Study|Lack of Efficacy|9
4601072|NCT01614795|7452859|FG003|Overall Study|Lack of Efficacy|8
4601073|NCT01614795|7452856|FG000|Overall Study|Physician Decision|1
4601074|NCT01614795|7452857|FG001|Overall Study|Physician Decision|0
4601075|NCT01614795|7452858|FG002|Overall Study|Physician Decision|1
4601076|NCT01614795|7452859|FG003|Overall Study|Physician Decision|1
4601077|NCT01614795|7452856|FG000|Overall Study|Withdrawal by Subject|0
4601078|NCT01614795|7452857|FG001|Overall Study|Withdrawal by Subject|1
4601079|NCT01614795|7452858|FG002|Overall Study|Withdrawal by Subject|0
4601080|NCT01614795|7452859|FG003|Overall Study|Withdrawal by Subject|2
4601081|NCT01614795|7452856|FG000|Overall Study|Ineligible|0
4601082|NCT01614795|7452857|FG001|Overall Study|Ineligible|1
4601083|NCT01614795|7452858|FG002|Overall Study|Ineligible|0
4601084|NCT01614795|7452859|FG003|Overall Study|Ineligible|0
4601085|NCT01614886|7452890|FG000|Overall Study|Adverse Event|15
4601086|NCT01614886|7452891|FG001|Overall Study|Adverse Event|20
4601087|NCT01614886|7452890|FG000|Overall Study|Withdrawal by Subject|4
4601088|NCT01614886|7452891|FG001|Overall Study|Withdrawal by Subject|4
4601089|NCT01614886|7452890|FG000|Overall Study|Death|1
4601090|NCT01614886|7452891|FG001|Overall Study|Death|0
4601091|NCT01614886|7452890|FG000|Overall Study|Protocol deviation|0
4601092|NCT01614886|7452891|FG001|Overall Study|Protocol deviation|2
4601093|NCT01614925|7452899|FG000|Overall Study|Withdrawal by Subject|1
4601094|NCT01614925|7452900|FG001|Overall Study|Withdrawal by Subject|0
4601095|NCT01614925|7452899|FG000|Overall Study|Protocol Violation|3
4601096|NCT01614925|7452900|FG001|Overall Study|Protocol Violation|2
4601097|NCT01615198|7452917|FG000|Overall Study|Withdrawal by Subject|5
4601098|NCT01615198|7452918|FG001|Overall Study|Withdrawal by Subject|5
4601099|NCT01615198|7452917|FG000|Overall Study|Protocol deviation|1
4601100|NCT01615198|7452918|FG001|Overall Study|Protocol deviation|1
4601101|NCT01615198|7452917|FG000|Overall Study|Physician Decision|5
4601102|NCT01615198|7452918|FG001|Overall Study|Physician Decision|1
4601103|NCT01615198|7452917|FG000|Overall Study|Lost to Follow-up|1
4601104|NCT01615198|7452918|FG001|Overall Study|Lost to Follow-up|1
4601105|NCT01615198|7452917|FG000|Overall Study|Lack of Efficacy|1
4601106|NCT01615198|7452918|FG001|Overall Study|Lack of Efficacy|6
4601107|NCT01615198|7452917|FG000|Overall Study|Adverse Event|11
4601108|NCT01615198|7452918|FG001|Overall Study|Adverse Event|5
4601109|NCT01615263|7452926|FG000|Overall Study|Post-randomization exclusion|0
4601110|NCT01615263|7452927|FG001|Overall Study|Post-randomization exclusion|2
4601111|NCT01615328|7452935|FG000|Overall Study|Lost to Follow-up|3
4601112|NCT01615328|7452936|FG001|Overall Study|Lost to Follow-up|5
4601113|NCT01615822|7452980|FG000|Period 1|Withdrawal by Subject|0
4601114|NCT01615822|7452981|FG001|Period 1|Withdrawal by Subject|1
4601115|NCT01615822|7452982|FG002|Period 1|Withdrawal by Subject|0
4601116|NCT01615822|7452980|FG000|Period 1|Adverse Event|1
4601117|NCT01615822|7452981|FG001|Period 1|Adverse Event|1
4601118|NCT01615822|7452982|FG002|Period 1|Adverse Event|0
4601119|NCT01615822|7452980|FG000|Period 2|Lost to Follow-up|0
4601120|NCT01615822|7452981|FG001|Period 2|Lost to Follow-up|1
4601121|NCT01615822|7452982|FG002|Period 2|Lost to Follow-up|2
4601122|NCT01615939|7452995|FG000|Overall Study|Lost to Follow-up|5
4635663|NCT01934790|7507304|FG000|Active Follow up|Death|20
4601123|NCT01615939|7452996|FG001|Overall Study|Lost to Follow-up|0
4601124|NCT01616173|7453023|FG000|Overall Study|Lost to Follow-up|0
4601125|NCT01616173|7453024|FG001|Overall Study|Lost to Follow-up|2
4601126|NCT01616173|7453025|FG002|Overall Study|Lost to Follow-up|0
4601127|NCT01616459|7453037|FG000|Overall Study|Adverse Event|1
4601128|NCT01616459|7453038|FG001|Overall Study|Adverse Event|1
4601129|NCT01616459|7453039|FG002|Overall Study|Adverse Event|2
4601130|NCT01616459|7453040|FG003|Overall Study|Adverse Event|0
4601131|NCT01616459|7453037|FG000|Overall Study|Lost to Follow-up|1
4601132|NCT01616459|7453038|FG001|Overall Study|Lost to Follow-up|11
4601133|NCT01616459|7453039|FG002|Overall Study|Lost to Follow-up|3
4601134|NCT01616459|7453040|FG003|Overall Study|Lost to Follow-up|2
4601135|NCT01616459|7453037|FG000|Overall Study|Protocol Violation|0
4601136|NCT01616459|7453038|FG001|Overall Study|Protocol Violation|0
4601137|NCT01616459|7453039|FG002|Overall Study|Protocol Violation|0
4601138|NCT01616459|7453040|FG003|Overall Study|Protocol Violation|2
4601139|NCT01616459|7453037|FG000|Overall Study|Withdrawal by Subject|2
4601140|NCT01616459|7453038|FG001|Overall Study|Withdrawal by Subject|4
4601141|NCT01616459|7453039|FG002|Overall Study|Withdrawal by Subject|4
4601142|NCT01616459|7453040|FG003|Overall Study|Withdrawal by Subject|4
4601143|NCT01616459|7453037|FG000|Overall Study|Other reason|0
4601144|NCT01616459|7453038|FG001|Overall Study|Other reason|1
4601145|NCT01616459|7453039|FG002|Overall Study|Other reason|1
4601146|NCT01616459|7453040|FG003|Overall Study|Other reason|0
4601147|NCT01616563|7453055|FG000|Overall Study|Lost to Follow-up|40
4601148|NCT01616654|7453077|FG000|Overall Study|Lack of Efficacy|1
4601149|NCT01616654|7453078|FG001|Overall Study|Lack of Efficacy|0
4601150|NCT01616654|7453079|FG002|Overall Study|Lack of Efficacy|0
4601151|NCT01616654|7453080|FG003|Overall Study|Lack of Efficacy|0
4601152|NCT01616654|7453081|FG004|Overall Study|Lack of Efficacy|1
4601153|NCT01616654|7453077|FG000|Overall Study|Adverse Event|0
4601154|NCT01616654|7453078|FG001|Overall Study|Adverse Event|1
4601155|NCT01616654|7453079|FG002|Overall Study|Adverse Event|2
4601156|NCT01616654|7453080|FG003|Overall Study|Adverse Event|1
4601157|NCT01616654|7453081|FG004|Overall Study|Adverse Event|0
4601158|NCT01616654|7453077|FG000|Overall Study|Withdrawal by Subject|2
4601159|NCT01616654|7453078|FG001|Overall Study|Withdrawal by Subject|2
4601160|NCT01616654|7453079|FG002|Overall Study|Withdrawal by Subject|3
4601161|NCT01616654|7453080|FG003|Overall Study|Withdrawal by Subject|1
4601162|NCT01616654|7453081|FG004|Overall Study|Withdrawal by Subject|5
4601163|NCT01616654|7453077|FG000|Overall Study|Protocol Violation|0
4601164|NCT01616654|7453078|FG001|Overall Study|Protocol Violation|5
4601165|NCT01616654|7453079|FG002|Overall Study|Protocol Violation|2
4601166|NCT01616654|7453080|FG003|Overall Study|Protocol Violation|4
4601167|NCT01616654|7453081|FG004|Overall Study|Protocol Violation|4
4601168|NCT01616654|7453077|FG000|Overall Study|Lost to Follow-up|1
4601169|NCT01616654|7453078|FG001|Overall Study|Lost to Follow-up|0
4601170|NCT01616654|7453079|FG002|Overall Study|Lost to Follow-up|3
4601171|NCT01616654|7453080|FG003|Overall Study|Lost to Follow-up|2
4601172|NCT01616654|7453081|FG004|Overall Study|Lost to Follow-up|1
4601173|NCT01616654|7453077|FG000|Overall Study|Pregnancy|1
4601174|NCT01616654|7453078|FG001|Overall Study|Pregnancy|0
4601175|NCT01616654|7453079|FG002|Overall Study|Pregnancy|0
4601176|NCT01616654|7453080|FG003|Overall Study|Pregnancy|0
4601177|NCT01616654|7453081|FG004|Overall Study|Pregnancy|1
4601178|NCT01616693|7453098|FG000|Evaluated for Safety|Physician Decision|1
4601179|NCT01616693|7453099|FG001|Evaluated for Safety|Physician Decision|0
4601180|NCT01616693|7453100|FG002|Evaluated for Safety|Physician Decision|1
4601181|NCT01616693|7453101|FG003|Evaluated for Safety|Physician Decision|0
4601182|NCT01616693|7453098|FG000|Received Both Vaccines|Adverse Event|2
4601183|NCT01616693|7453099|FG001|Received Both Vaccines|Adverse Event|0
4601184|NCT01616693|7453100|FG002|Received Both Vaccines|Adverse Event|0
4601185|NCT01616693|7453101|FG003|Received Both Vaccines|Adverse Event|0
4601186|NCT01616693|7453098|FG000|Received Both Vaccines|Withdrawal by Subject|7
4601187|NCT01616693|7453099|FG001|Received Both Vaccines|Withdrawal by Subject|7
4601188|NCT01616693|7453100|FG002|Received Both Vaccines|Withdrawal by Subject|8
4601189|NCT01616693|7453101|FG003|Received Both Vaccines|Withdrawal by Subject|15
4635664|NCT01934790|7507304|FG000|Active Follow up|Physician Decision|2
4601190|NCT01616693|7453098|FG000|Received Both Vaccines|Lost to Follow-up|4
4635665|NCT01934790|7507304|FG000|Active Follow up|Progressive disease|1
4601191|NCT01616693|7453099|FG001|Received Both Vaccines|Lost to Follow-up|3
4601192|NCT01616693|7453100|FG002|Received Both Vaccines|Lost to Follow-up|4
4601193|NCT01616693|7453101|FG003|Received Both Vaccines|Lost to Follow-up|4
4601194|NCT01616693|7453098|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4
4601195|NCT01616693|7453099|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2
4601196|NCT01616693|7453100|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6
4601197|NCT01616693|7453101|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1
4601198|NCT01616771|7453115|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4
4601199|NCT01616953|7453126|FG000|Overall Study|Lost to Follow-up|1
4601200|NCT01616953|7453127|FG001|Overall Study|Lost to Follow-up|0
4601201|NCT01616953|7453126|FG000|Overall Study|lack of bone and soft tissue|1
4601202|NCT01616953|7453127|FG001|Overall Study|lack of bone and soft tissue|0
4601203|NCT01617005|7453133|FG000|Overall Study|Pregnancy|1
4601204|NCT01617005|7453133|FG000|Overall Study|Lack of motivation for treatment|1
4601205|NCT01617070|7453137|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1
4601206|NCT01617434|7453176|FG000|Overall Study|Adverse Event|12
4601207|NCT01617434|7453177|FG001|Overall Study|Adverse Event|3
4601208|NCT01617434|7453176|FG000|Overall Study|Protocol Violation|8
4601209|NCT01617434|7453177|FG001|Overall Study|Protocol Violation|7
4601210|NCT01617434|7453176|FG000|Overall Study|Withdrawal Criteria|12
4601211|NCT01617434|7453177|FG001|Overall Study|Withdrawal Criteria|37
4601212|NCT01617434|7453176|FG000|Overall Study|Unclassified|3
4601213|NCT01617434|7453177|FG001|Overall Study|Unclassified|4
4601214|NCT01617447|7453185|FG000|Overall Study|Adverse Event|0
4601215|NCT01617447|7453186|FG001|Overall Study|Adverse Event|1
4601216|NCT01617447|7453185|FG000|Overall Study|Physician Decision|0
4601217|NCT01617447|7453186|FG001|Overall Study|Physician Decision|2
4601218|NCT01617460|7453192|FG000|Overall Study|Adverse Event|10
4601219|NCT01617460|7453192|FG000|Overall Study|Physician Decision|16
4601220|NCT01617460|7453192|FG000|Overall Study|Protocol Violation|5
4601221|NCT01617460|7453192|FG000|Overall Study|Withdrawal by Subject|9
4601222|NCT01617629|7453219|FG000|Overall Study|Death|2
4601223|NCT01617629|7453219|FG000|Overall Study|Investigator's Clinical Judgement|1
4601224|NCT01617629|7453219|FG000|Overall Study|Reason Not Specified|1
4601225|NCT01617629|7453219|FG000|Overall Study|Participant Withdrew Consent|2
4601226|NCT01617655|7453225|FG000|Overall Study|Adverse Event|2
4601227|NCT01617655|7453226|FG001|Overall Study|Adverse Event|3
4601228|NCT01617655|7453225|FG000|Overall Study|Poor compliance to protocol|1
4601229|NCT01617655|7453226|FG001|Overall Study|Poor compliance to protocol|4
4601230|NCT01617655|7453225|FG000|Overall Study|Participants moved|0
4601231|NCT01617655|7453226|FG001|Overall Study|Participants moved|4
4601232|NCT01617655|7453225|FG000|Overall Study|Consent withdrawn by participant|1
4601233|NCT01617655|7453226|FG001|Overall Study|Consent withdrawn by participant|1
4601234|NCT01617655|7453225|FG000|Overall Study|Last visit outside protocol visit window|1
4601235|NCT01617655|7453226|FG001|Overall Study|Last visit outside protocol visit window|10
4601236|NCT01617655|7453225|FG000|Overall Study|Site closure|3
4601237|NCT01617655|7453226|FG001|Overall Study|Site closure|5
4601238|NCT01617655|7453225|FG000|Overall Study|Other than specified above|1
4601239|NCT01617655|7453226|FG001|Overall Study|Other than specified above|2
4601240|NCT01617668|7453236|FG000|Overall Study|Adverse Event|7
4601241|NCT01617668|7453237|FG001|Overall Study|Adverse Event|0
4601242|NCT01617668|7453238|FG002|Overall Study|Adverse Event|12
4601243|NCT01617668|7453239|FG003|Overall Study|Adverse Event|5
4601244|NCT01617668|7453236|FG000|Overall Study|Physician Decision|1
4601245|NCT01617668|7453237|FG001|Overall Study|Physician Decision|2
4601246|NCT01617668|7453238|FG002|Overall Study|Physician Decision|3
4601247|NCT01617668|7453239|FG003|Overall Study|Physician Decision|0
4601248|NCT01617668|7453236|FG000|Overall Study|Progressive Disease|4
4601249|NCT01617668|7453237|FG001|Overall Study|Progressive Disease|4
4601250|NCT01617668|7453238|FG002|Overall Study|Progressive Disease|6
4601251|NCT01617668|7453239|FG003|Overall Study|Progressive Disease|9
4601252|NCT01617668|7453236|FG000|Overall Study|Subject/guardian decision|1
4601253|NCT01617668|7453237|FG001|Overall Study|Subject/guardian decision|3
4601254|NCT01617668|7453238|FG002|Overall Study|Subject/guardian decision|2
4601255|NCT01617668|7453239|FG003|Overall Study|Subject/guardian decision|1
4601256|NCT01617681|7453257|FG000|Period 1 Double Blind|Adverse Event|2
4601257|NCT01617681|7453258|FG001|Period 1 Double Blind|Adverse Event|0
4601258|NCT01617681|7453259|FG002|Period 1 Double Blind|Adverse Event|0
4601259|NCT01617681|7453260|FG003|Period 1 Double Blind|Adverse Event|2
4601260|NCT01617681|7453261|FG004|Period 1 Double Blind|Adverse Event|0
4601261|NCT01617681|7453257|FG000|Period 1 Double Blind|Withdrawal by Subject|1
4601262|NCT01617681|7453258|FG001|Period 1 Double Blind|Withdrawal by Subject|1
4601263|NCT01617681|7453259|FG002|Period 1 Double Blind|Withdrawal by Subject|1
4601264|NCT01617681|7453260|FG003|Period 1 Double Blind|Withdrawal by Subject|0
4601265|NCT01617681|7453261|FG004|Period 1 Double Blind|Withdrawal by Subject|0
4635666|NCT01934790|7507304|FG000|Active Follow up|Other reason|1
4635667|NCT01934894|7507310|FG000|Overall Study|Adverse Event|1
4635668|NCT01934894|7507311|FG001|Overall Study|Adverse Event|2
4635669|NCT01934894|7507310|FG000|Overall Study|Death|2
4635670|NCT01934894|7507311|FG001|Overall Study|Death|0
4635671|NCT01934894|7507310|FG000|Overall Study|Withdrawal by Subject|0
4601266|NCT01617681|7453257|FG000|Period 2 Open Label|Adverse Event|0
4601267|NCT01617681|7453258|FG001|Period 2 Open Label|Adverse Event|0
4601268|NCT01617681|7453259|FG002|Period 2 Open Label|Adverse Event|0
4601269|NCT01617681|7453260|FG003|Period 2 Open Label|Adverse Event|0
4601270|NCT01617681|7453261|FG004|Period 2 Open Label|Adverse Event|3
4601271|NCT01617681|7453257|FG000|Period 2 Open Label|Withdrawal by Subject|0
4601272|NCT01617681|7453258|FG001|Period 2 Open Label|Withdrawal by Subject|0
4635672|NCT01934894|7507311|FG001|Overall Study|Withdrawal by Subject|1
4635673|NCT01934894|7507310|FG000|Overall Study|Progressive Disease|3
4635674|NCT01934894|7507311|FG001|Overall Study|Progressive Disease|2
4635675|NCT01934972|7507322|FG000|Overall Study|Withdrawal by Subject|9
4635676|NCT01934972|7507323|FG001|Overall Study|Withdrawal by Subject|6
4635677|NCT01935700|7507353|FG000|Overall Study|Withdrawal by Subject|1
4635678|NCT01935700|7507354|FG001|Overall Study|Withdrawal by Subject|0
4635679|NCT01935700|7507353|FG000|Overall Study|Physician Decision|4
4635680|NCT01935700|7507354|FG001|Overall Study|Physician Decision|0
4635681|NCT01936181|7507386|FG000|Randomised, Double-blind|Adverse Event|27
4635682|NCT01936181|7507387|FG001|Randomised, Double-blind|Adverse Event|21
4635683|NCT01936181|7507388|FG002|Randomised, Double-blind|Adverse Event|0
4635684|NCT01936181|7507389|FG003|Randomised, Double-blind|Adverse Event|0
4746584|NCT00660595|7718380|FG000|Overall Study|Non Specified reasons|5
4746585|NCT00660595|7718381|FG001|Overall Study|Non Specified reasons|0
4601273|NCT01617681|7453259|FG002|Period 2 Open Label|Withdrawal by Subject|0
4601274|NCT01617681|7453260|FG003|Period 2 Open Label|Withdrawal by Subject|0
4601275|NCT01617681|7453261|FG004|Period 2 Open Label|Withdrawal by Subject|3
4601276|NCT01617967|7453276|FG000|Overall Study|Protocol Violation|0
4601277|NCT01617967|7453277|FG001|Overall Study|Protocol Violation|0
4601278|NCT01617967|7453278|FG002|Overall Study|Protocol Violation|0
4601279|NCT01617967|7453279|FG003|Overall Study|Protocol Violation|1
4601280|NCT01617967|7453280|FG004|Overall Study|Protocol Violation|0
4601281|NCT01617967|7453281|FG005|Overall Study|Protocol Violation|0
4601282|NCT01617967|7453276|FG000|Overall Study|Withdrawal by Subject|0
4601283|NCT01617967|7453277|FG001|Overall Study|Withdrawal by Subject|0
4601284|NCT01617967|7453278|FG002|Overall Study|Withdrawal by Subject|0
4601285|NCT01617967|7453279|FG003|Overall Study|Withdrawal by Subject|0
4601286|NCT01617967|7453280|FG004|Overall Study|Withdrawal by Subject|0
4601287|NCT01617967|7453281|FG005|Overall Study|Withdrawal by Subject|1
4601288|NCT01617967|7453276|FG000|Overall Study|Dosing Suspended by Sponsor|1
4601289|NCT01617967|7453277|FG001|Overall Study|Dosing Suspended by Sponsor|0
4601290|NCT01617967|7453278|FG002|Overall Study|Dosing Suspended by Sponsor|0
4601291|NCT01617967|7453279|FG003|Overall Study|Dosing Suspended by Sponsor|0
4601292|NCT01617967|7453280|FG004|Overall Study|Dosing Suspended by Sponsor|0
4601293|NCT01617967|7453281|FG005|Overall Study|Dosing Suspended by Sponsor|0
4601294|NCT01618019|7453298|FG000|Overall Study|Withdrawal by Subject|14
4601295|NCT01618019|7453299|FG001|Overall Study|Withdrawal by Subject|14
4601296|NCT01618162|7453307|FG000|Overall Study|Protocol Violation|13
4601297|NCT01618162|7453308|FG001|Overall Study|Protocol Violation|10
4601298|NCT01618162|7453307|FG000|Overall Study|Adverse Event|9
4601299|NCT01618162|7453308|FG001|Overall Study|Adverse Event|2
4635685|NCT01936181|7507386|FG000|Randomised, Double-blind|Protocol Violation|1
4635686|NCT01936181|7507387|FG001|Randomised, Double-blind|Protocol Violation|5
4635687|NCT01936181|7507388|FG002|Randomised, Double-blind|Protocol Violation|0
4635688|NCT01936181|7507389|FG003|Randomised, Double-blind|Protocol Violation|0
4635689|NCT01936181|7507386|FG000|Randomised, Double-blind|Lack of Efficacy|5
4635690|NCT01936181|7507387|FG001|Randomised, Double-blind|Lack of Efficacy|6
4635691|NCT01936181|7507388|FG002|Randomised, Double-blind|Lack of Efficacy|0
4635692|NCT01936181|7507389|FG003|Randomised, Double-blind|Lack of Efficacy|0
4635693|NCT01936181|7507386|FG000|Randomised, Double-blind|Lost to Follow-up|0
4635694|NCT01936181|7507387|FG001|Randomised, Double-blind|Lost to Follow-up|1
4635695|NCT01936181|7507388|FG002|Randomised, Double-blind|Lost to Follow-up|0
4635696|NCT01936181|7507389|FG003|Randomised, Double-blind|Lost to Follow-up|0
4635697|NCT01936181|7507386|FG000|Randomised, Double-blind|Pregnancy|0
4635698|NCT01936181|7507387|FG001|Randomised, Double-blind|Pregnancy|1
4635699|NCT01936181|7507388|FG002|Randomised, Double-blind|Pregnancy|0
4635700|NCT01936181|7507389|FG003|Randomised, Double-blind|Pregnancy|0
4635701|NCT01936181|7507386|FG000|Randomised, Double-blind|Physician Decision|4
4635702|NCT01936181|7507387|FG001|Randomised, Double-blind|Physician Decision|4
4635703|NCT01936181|7507388|FG002|Randomised, Double-blind|Physician Decision|0
4635704|NCT01936181|7507389|FG003|Randomised, Double-blind|Physician Decision|0
4601300|NCT01618162|7453307|FG000|Overall Study|Withdrawal Criteria|2
4601301|NCT01618162|7453308|FG001|Overall Study|Withdrawal Criteria|10
4635705|NCT01936181|7507386|FG000|Randomised, Double-blind|Withdrawal by Subject|23
4635706|NCT01936181|7507387|FG001|Randomised, Double-blind|Withdrawal by Subject|26
4746586|NCT00646282|7718398|FG000|Overall Study|Protocol terminated|4
4746587|NCT00646282|7718399|FG001|Overall Study|Protocol terminated|4
4746588|NCT00657553|7718407|FG000|Overall Study|low accrual, no analysis run|5
4746589|NCT00657553|7718408|FG001|Overall Study|low accrual, no analysis run|5
4746590|NCT00648895|7718429|FG000|Overall Study|Lack of Efficacy|0
4746591|NCT00648895|7718430|FG001|Overall Study|Lack of Efficacy|1
4746592|NCT00647426|7718436|FG000|Overall Study|Withdrawal by Subject|2
4601302|NCT01618162|7453307|FG000|Overall Study|Unclassified|14
4601303|NCT01618162|7453308|FG001|Overall Study|Unclassified|13
4601304|NCT01618214|7453316|FG000|Overall Study|Adverse Event|3
4601305|NCT01618214|7453317|FG001|Overall Study|Adverse Event|1
4601306|NCT01618214|7453316|FG000|Overall Study|Lack of Efficacy|1
4601307|NCT01618214|7453317|FG001|Overall Study|Lack of Efficacy|1
4601308|NCT01618214|7453316|FG000|Overall Study|Protocol Violation|1
4601309|NCT01618214|7453317|FG001|Overall Study|Protocol Violation|4
4601310|NCT01618214|7453316|FG000|Overall Study|Withdrawal Criteria|1
4601311|NCT01618214|7453317|FG001|Overall Study|Withdrawal Criteria|2
4601312|NCT01618214|7453316|FG000|Overall Study|Unclassified|4
4601313|NCT01618214|7453317|FG001|Overall Study|Unclassified|5
4601314|NCT01618266|7453336|FG000|Overall Study|Lost to Follow-up|9
4601315|NCT01618266|7453336|FG000|Overall Study|Treatment satisfaction|10
4601316|NCT01618266|7453336|FG000|Overall Study|Other reasons|11
4601317|NCT01618266|7453336|FG000|Overall Study|Lack of Efficacy|23
4601318|NCT01618266|7453336|FG000|Overall Study|Protocol Violation|43
4601319|NCT01618305|7453342|FG000|Overall Study|Death|0
4601320|NCT01618305|7453343|FG001|Overall Study|Death|1
4601321|NCT01618305|7453342|FG000|Overall Study|Lost to Follow-up|11
4601322|NCT01618305|7453343|FG001|Overall Study|Lost to Follow-up|7
4601323|NCT01618305|7453342|FG000|Overall Study|Protocol Violation|1
4601324|NCT01618305|7453343|FG001|Overall Study|Protocol Violation|0
4601325|NCT01618305|7453342|FG000|Overall Study|Withdrawal by Subject|3
4601326|NCT01618305|7453343|FG001|Overall Study|Withdrawal by Subject|2
4601327|NCT01618669|7453368|FG000|Overall Study|Lost to Follow-up|1
4601328|NCT01618669|7453369|FG001|Overall Study|Lost to Follow-up|1
4601329|NCT01618669|7453368|FG000|Overall Study|Randomized but Never Received Study Drug|3
4601330|NCT01618669|7453369|FG001|Overall Study|Randomized but Never Received Study Drug|2
4601331|NCT01618669|7453368|FG000|Overall Study|Adverse Event|16
4601332|NCT01618669|7453369|FG001|Overall Study|Adverse Event|7
4601333|NCT01618669|7453368|FG000|Overall Study|Protocol Violation|5
4601334|NCT01618669|7453369|FG001|Overall Study|Protocol Violation|3
4601335|NCT01618669|7453368|FG000|Overall Study|Withdrawal by Subject|9
4601336|NCT01618669|7453369|FG001|Overall Study|Withdrawal by Subject|9
4601337|NCT01618669|7453368|FG000|Overall Study|Miscellaneous Reason|0
4601338|NCT01618669|7453369|FG001|Overall Study|Miscellaneous Reason|1
4601339|NCT01618695|7453391|FG000|Core Phase|Adverse Event|4
4601340|NCT01618695|7453392|FG001|Core Phase|Adverse Event|5
4601341|NCT01618695|7453393|FG002|Core Phase|Adverse Event|15
4601342|NCT01618695|7453394|FG003|Core Phase|Adverse Event|20
4601343|NCT01618695|7453391|FG000|Core Phase|Lost to Follow-up|0
4601344|NCT01618695|7453392|FG001|Core Phase|Lost to Follow-up|0
4601345|NCT01618695|7453393|FG002|Core Phase|Lost to Follow-up|1
4601346|NCT01618695|7453394|FG003|Core Phase|Lost to Follow-up|0
4601347|NCT01618695|7453391|FG000|Core Phase|Withdrawal by Subject|16
4601348|NCT01618695|7453392|FG001|Core Phase|Withdrawal by Subject|11
4601349|NCT01618695|7453393|FG002|Core Phase|Withdrawal by Subject|9
4601350|NCT01618695|7453394|FG003|Core Phase|Withdrawal by Subject|13
4601351|NCT01618695|7453391|FG000|Core Phase|Pregnancy|2
4601352|NCT01618695|7453392|FG001|Core Phase|Pregnancy|0
4601353|NCT01618695|7453393|FG002|Core Phase|Pregnancy|0
4601354|NCT01618695|7453394|FG003|Core Phase|Pregnancy|0
4601355|NCT01618695|7453391|FG000|Core Phase|Lack of Efficacy|1
4601356|NCT01618695|7453392|FG001|Core Phase|Lack of Efficacy|2
4601357|NCT01618695|7453393|FG002|Core Phase|Lack of Efficacy|1
4601358|NCT01618695|7453394|FG003|Core Phase|Lack of Efficacy|1
4601359|NCT01618695|7453391|FG000|Core Phase|Other than specified|1
4601360|NCT01618695|7453392|FG001|Core Phase|Other than specified|2
4601361|NCT01618695|7453393|FG002|Core Phase|Other than specified|2
4601362|NCT01618695|7453394|FG003|Core Phase|Other than specified|2
4601363|NCT01618695|7453391|FG000|Core Phase|Not treated|1
4601364|NCT01618695|7453392|FG001|Core Phase|Not treated|0
4601365|NCT01618695|7453393|FG002|Core Phase|Not treated|2
4601366|NCT01618695|7453394|FG003|Core Phase|Not treated|0
4601367|NCT01618695|7453391|FG000|Extension Phase|Lack of Efficacy|17
4601368|NCT01618695|7453392|FG001|Extension Phase|Lack of Efficacy|33
4601369|NCT01618695|7453393|FG002|Extension Phase|Lack of Efficacy|26
4601370|NCT01618695|7453394|FG003|Extension Phase|Lack of Efficacy|24
4601371|NCT01618695|7453391|FG000|Extension Phase|Pregnancy|2
4601372|NCT01618695|7453392|FG001|Extension Phase|Pregnancy|0
4601373|NCT01618695|7453393|FG002|Extension Phase|Pregnancy|1
4601374|NCT01618695|7453394|FG003|Extension Phase|Pregnancy|1
4601375|NCT01618695|7453391|FG000|Extension Phase|Withdrawal by Subject|43
4601376|NCT01618695|7453392|FG001|Extension Phase|Withdrawal by Subject|48
4601377|NCT01618695|7453393|FG002|Extension Phase|Withdrawal by Subject|42
4601378|NCT01618695|7453394|FG003|Extension Phase|Withdrawal by Subject|33
4601379|NCT01618695|7453391|FG000|Extension Phase|Adverse Event|18
4601380|NCT01618695|7453392|FG001|Extension Phase|Adverse Event|16
4601381|NCT01618695|7453393|FG002|Extension Phase|Adverse Event|9
4601382|NCT01618695|7453394|FG003|Extension Phase|Adverse Event|20
4601383|NCT01618695|7453391|FG000|Extension Phase|Lost to Follow-up|2
4601384|NCT01618695|7453392|FG001|Extension Phase|Lost to Follow-up|1
4601385|NCT01618695|7453393|FG002|Extension Phase|Lost to Follow-up|1
4601386|NCT01618695|7453394|FG003|Extension Phase|Lost to Follow-up|1
4601387|NCT01618695|7453391|FG000|Extension Phase|Other than specified|13
4601388|NCT01618695|7453392|FG001|Extension Phase|Other than specified|18
4601389|NCT01618695|7453393|FG002|Extension Phase|Other than specified|13
4601390|NCT01618695|7453394|FG003|Extension Phase|Other than specified|18
4601391|NCT01618708|7453407|FG000|Overall Study|Adverse Event|10
4601392|NCT01618708|7453408|FG001|Overall Study|Adverse Event|10
4601393|NCT01618708|7453407|FG000|Overall Study|Lost to Follow-up|3
4601394|NCT01618708|7453408|FG001|Overall Study|Lost to Follow-up|3
4601395|NCT01618708|7453407|FG000|Overall Study|Withdrawal by Subject|17
4601396|NCT01618708|7453408|FG001|Overall Study|Withdrawal by Subject|22
4601397|NCT01618708|7453407|FG000|Overall Study|Lack of Efficacy|8
4601398|NCT01618708|7453408|FG001|Overall Study|Lack of Efficacy|8
4601399|NCT01618708|7453407|FG000|Overall Study|Technical problems|2
4601400|NCT01618708|7453408|FG001|Overall Study|Technical problems|0
4601401|NCT01618708|7453407|FG000|Overall Study|Other than specified above|1
4601402|NCT01618708|7453408|FG001|Overall Study|Other than specified above|1
4601403|NCT01618708|7453407|FG000|Overall Study|Randomized but not treated|3
4601404|NCT01618708|7453408|FG001|Overall Study|Randomized but not treated|2
4601405|NCT01618838|7453415|FG000|Overall Study|slow accrual, trial closed prematurely.|4
4601406|NCT01618864|7453420|FG000|Overall Study|Withdrawal by Subject|2
4601407|NCT01618864|7453420|FG000|Overall Study|Lost to Follow-up|2
4601408|NCT01618916|7453435|FG000|Overall Study|Adverse Event|1
4601409|NCT01618916|7453436|FG001|Overall Study|Adverse Event|0
4601410|NCT01618916|7453437|FG002|Overall Study|Adverse Event|0
4601411|NCT01618916|7453438|FG003|Overall Study|Adverse Event|0
4601412|NCT01618916|7453439|FG004|Overall Study|Adverse Event|0
4601413|NCT01618916|7453440|FG005|Overall Study|Adverse Event|0
4601414|NCT01618916|7453435|FG000|Overall Study|Withdrawal by Subject|0
4601415|NCT01618916|7453436|FG001|Overall Study|Withdrawal by Subject|1
4601416|NCT01618916|7453437|FG002|Overall Study|Withdrawal by Subject|1
4601417|NCT01618916|7453438|FG003|Overall Study|Withdrawal by Subject|0
4601418|NCT01618916|7453439|FG004|Overall Study|Withdrawal by Subject|1
4601419|NCT01618916|7453440|FG005|Overall Study|Withdrawal by Subject|0
4601420|NCT01618916|7453435|FG000|Overall Study|Lost to Follow-up|1
4601421|NCT01618916|7453436|FG001|Overall Study|Lost to Follow-up|0
4601422|NCT01618916|7453437|FG002|Overall Study|Lost to Follow-up|0
4601423|NCT01618916|7453438|FG003|Overall Study|Lost to Follow-up|2
4601424|NCT01618916|7453439|FG004|Overall Study|Lost to Follow-up|0
4601425|NCT01618916|7453440|FG005|Overall Study|Lost to Follow-up|0
4601426|NCT01618968|7453483|FG000|Overall Study|Adverse Event|1
4601427|NCT01618968|7453484|FG001|Overall Study|Adverse Event|0
4601428|NCT01618968|7453485|FG002|Overall Study|Adverse Event|0
4601429|NCT01618968|7453486|FG003|Overall Study|Adverse Event|0
4601430|NCT01618968|7453483|FG000|Overall Study|Death|0
4601431|NCT01618968|7453484|FG001|Overall Study|Death|0
4601432|NCT01618968|7453485|FG002|Overall Study|Death|0
4601433|NCT01618968|7453486|FG003|Overall Study|Death|1
4601434|NCT01619059|7453497|FG000|Short-Term (ST) Treatment Period|Adverse Event|1
4601435|NCT01619059|7453498|FG001|Short-Term (ST) Treatment Period|Adverse Event|0
4601436|NCT01619059|7453497|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2
4601437|NCT01619059|7453498|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5
4601438|NCT01619059|7453497|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2
4601439|NCT01619059|7453498|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4
4601440|NCT01619059|7453497|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1
4601441|NCT01619059|7453498|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2
4601442|NCT01619059|7453497|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0
4601443|NCT01619059|7453498|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1
4601444|NCT01619059|7453497|FG000|Long-Term (LT) Treatment Period|Adverse Event|2
4601445|NCT01619059|7453498|FG001|Long-Term (LT) Treatment Period|Adverse Event|3
4601446|NCT01619059|7453497|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3
4601447|NCT01619059|7453498|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2
4601448|NCT01619059|7453497|FG000|Long-Term (LT) Treatment Period|Death|1
4601449|NCT01619059|7453498|FG001|Long-Term (LT) Treatment Period|Death|0
4601450|NCT01619059|7453497|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2
4601451|NCT01619059|7453498|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2
4601452|NCT01619059|7453497|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0
4601453|NCT01619059|7453498|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1
4601454|NCT01619410|7453506|FG000|Overall Study|Lost to Follow-up|7
4601455|NCT01619410|7453507|FG001|Overall Study|Lost to Follow-up|4
4601456|NCT01619423|7453517|FG000|Part 1 (Dose Escalation)|High basal Mn|0
4601457|NCT01619423|7453518|FG001|Part 1 (Dose Escalation)|High basal Mn|2
4601458|NCT01619423|7453519|FG002|Part 1 (Dose Escalation)|High basal Mn|0
4601459|NCT01619423|7453520|FG003|Part 1 (Dose Escalation)|High basal Mn|0
4601460|NCT01619579|7453533|FG000|Overall Study|Withdrawal by Subject|0
4601461|NCT01619579|7453534|FG001|Overall Study|Withdrawal by Subject|3
4601462|NCT01619787|7453546|FG000|Overall Study|Lost to Follow-up|5
4601463|NCT01619852|7453572|FG000|24 Hour Assessment|Withdrawal by Subject|1
4601464|NCT01619852|7453573|FG001|24 Hour Assessment|Withdrawal by Subject|1
4601465|NCT01619852|7453572|FG000|3 Month Follow up|Lost to Follow-up|31
4601466|NCT01619852|7453573|FG001|3 Month Follow up|Lost to Follow-up|34
4601467|NCT01619865|7453580|FG000|Overall Study|Adverse Event|1
4601468|NCT01619865|7453580|FG000|Overall Study|Death|2
4601469|NCT01619865|7453580|FG000|Overall Study|subject not able to comply|1
4601470|NCT01619878|7453585|FG000|6 Week Follow-up Phase|Adverse Event|1
4601471|NCT01619878|7453585|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1
4601472|NCT01619878|7453585|FG000|Follow-up at 12 Months of Age|Death|2
4601473|NCT01620060|7453615|FG000|Overall Study|Adverse Event|9
4601474|NCT01620060|7453615|FG000|Overall Study|Protocol Violation|1
4601475|NCT01620060|7453615|FG000|Overall Study|Withdrawal by Subject|1
4601476|NCT01620060|7453615|FG000|Overall Study|Did not comply with Study Produre|1
4601477|NCT01620060|7453615|FG000|Overall Study|Family emergency|1
4601478|NCT01620060|7453615|FG000|Overall Study|Per Sponsor Decision|2
4601479|NCT01620086|7453621|FG000|Overall Study|Withdrawal by Subject|3
4601480|NCT01620086|7453622|FG001|Overall Study|Withdrawal by Subject|3
4601481|NCT01620086|7453623|FG002|Overall Study|Withdrawal by Subject|0
4601482|NCT01620086|7453621|FG000|Overall Study|failed study criteria|1
4601483|NCT01620086|7453622|FG001|Overall Study|failed study criteria|4
4601484|NCT01620086|7453623|FG002|Overall Study|failed study criteria|0
4601485|NCT01620086|7453621|FG000|Overall Study|Physician Decision|1
4601486|NCT01620086|7453622|FG001|Overall Study|Physician Decision|0
4601487|NCT01620086|7453623|FG002|Overall Study|Physician Decision|0
4601488|NCT01620138|7453634|FG000|Overall Study|Withdrawal by Subject|3
4601489|NCT01620138|7453635|FG001|Overall Study|Withdrawal by Subject|0
4601490|NCT01620138|7453634|FG000|Overall Study|Lack of Efficacy|1
4601491|NCT01620138|7453635|FG001|Overall Study|Lack of Efficacy|0
4601492|NCT01620138|7453634|FG000|Overall Study|Adverse Event|2
4601493|NCT01620138|7453635|FG001|Overall Study|Adverse Event|0
4601494|NCT01620177|7453641|FG000|Overall Study|Failure at Screening Visit|43
4601495|NCT01620177|7453641|FG000|Overall Study|Withdrawal by Subject|26
4601496|NCT01620177|7453641|FG000|Overall Study|Lost to Follow-up|7
4601497|NCT01620177|7453641|FG000|Overall Study|Physician Decision|2
4601498|NCT01620177|7453641|FG000|Overall Study|Randomized, Not Active due to Scheduling|1
4635707|NCT01936181|7507388|FG002|Randomised, Double-blind|Withdrawal by Subject|0
4635708|NCT01936181|7507389|FG003|Randomised, Double-blind|Withdrawal by Subject|0
4635709|NCT01936181|7507386|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4
4635710|NCT01936181|7507387|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4
4635711|NCT01936181|7507388|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0
4635712|NCT01936181|7507389|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0
4635713|NCT01936181|7507386|FG000|Transition-extension|Adverse Event|3
4635714|NCT01936181|7507387|FG001|Transition-extension|Adverse Event|0
4635715|NCT01936181|7507388|FG002|Transition-extension|Adverse Event|3
4635716|NCT01936181|7507389|FG003|Transition-extension|Adverse Event|1
4635717|NCT01936181|7507386|FG000|Transition-extension|Lost to Follow-up|3
4635718|NCT01936181|7507387|FG001|Transition-extension|Lost to Follow-up|0
4635719|NCT01936181|7507388|FG002|Transition-extension|Lost to Follow-up|1
4635720|NCT01936181|7507389|FG003|Transition-extension|Lost to Follow-up|2
4635721|NCT01936181|7507386|FG000|Transition-extension|Physician Decision|2
4635722|NCT01936181|7507387|FG001|Transition-extension|Physician Decision|0
4635723|NCT01936181|7507388|FG002|Transition-extension|Physician Decision|0
4635724|NCT01936181|7507389|FG003|Transition-extension|Physician Decision|1
4635725|NCT01936181|7507386|FG000|Transition-extension|Withdrawal by Subject|7
4635726|NCT01936181|7507387|FG001|Transition-extension|Withdrawal by Subject|0
4635727|NCT01936181|7507388|FG002|Transition-extension|Withdrawal by Subject|2
4635728|NCT01936181|7507389|FG003|Transition-extension|Withdrawal by Subject|1
4635729|NCT01936623|7507466|FG000|Overall Study|Lost to Follow-up|0
4635730|NCT01936623|7507467|FG001|Overall Study|Lost to Follow-up|5
4635731|NCT01936649|7507473|FG000|Overall Study|Withdrawal by Subject|4
4635732|NCT01936649|7507473|FG000|Overall Study|Physician Decision|2
4635733|NCT01936649|7507473|FG000|Overall Study|Protocol Violation|2
4635734|NCT01936649|7507473|FG000|Overall Study|Other than specified above|5
4635735|NCT01936857|7507499|FG000|Overall Study|Sent to prison or 06 center|11
4635736|NCT01936857|7507500|FG001|Overall Study|Sent to prison or 06 center|12
4635737|NCT01936857|7507499|FG000|Overall Study|Lost to Follow-up|10
4635738|NCT01936857|7507500|FG001|Overall Study|Lost to Follow-up|7
4635739|NCT01936857|7507499|FG000|Overall Study|Death|7
4635740|NCT01936857|7507500|FG001|Overall Study|Death|3
4635741|NCT01936857|7507499|FG000|Overall Study|Moved|2
4635742|NCT01936857|7507500|FG001|Overall Study|Moved|1
4635743|NCT01936857|7507499|FG000|Overall Study|Withdrawal by Subject|1
4635744|NCT01936857|7507500|FG001|Overall Study|Withdrawal by Subject|0
4635745|NCT01936857|7507499|FG000|Overall Study|Side effect of medication|1
4635746|NCT01936857|7507500|FG001|Overall Study|Side effect of medication|0
4635747|NCT01936857|7507499|FG000|Overall Study|Other|2
4635748|NCT01936857|7507500|FG001|Overall Study|Other|2
4635749|NCT01936870|7507506|FG000|Overall Study|No Visit After Treatment|176
4635750|NCT01936870|7507506|FG000|Overall Study|Protocol Violation|12
4635751|NCT01936870|7507506|FG000|Overall Study|No Drug Administration|1
4635752|NCT01936948|7507531|FG000|Overall Study|no 30-day follow-up data|0
4635753|NCT01936948|7507532|FG001|Overall Study|no 30-day follow-up data|3
4635754|NCT01936948|7507533|FG002|Overall Study|no 30-day follow-up data|3
4635755|NCT01936948|7507534|FG003|Overall Study|no 30-day follow-up data|3
4635756|NCT01937117|7507549|FG000|Overall Study|Disease Progression|7
4635757|NCT01937117|7507549|FG000|Overall Study|Physician Decision|4
4635758|NCT01937117|7507549|FG000|Overall Study|Adverse Event|2
4635759|NCT01937130|7507557|FG000|Overall Study|Withdrawal by Subject|0
4601499|NCT01620255|7453696|FG000|Overall Study|Withdrawal by Subject|4
4601500|NCT01620255|7453697|FG001|Overall Study|Withdrawal by Subject|1
4601501|NCT01620255|7453698|FG002|Overall Study|Withdrawal by Subject|1
4601502|NCT01620255|7453699|FG003|Overall Study|Withdrawal by Subject|2
4601503|NCT01620255|7453700|FG004|Overall Study|Withdrawal by Subject|4
4601504|NCT01620255|7453696|FG000|Overall Study|Participant underwent fecal transplant|0
4601505|NCT01620255|7453697|FG001|Overall Study|Participant underwent fecal transplant|0
4601506|NCT01620255|7453698|FG002|Overall Study|Participant underwent fecal transplant|1
4601507|NCT01620255|7453699|FG003|Overall Study|Participant underwent fecal transplant|0
4601508|NCT01620255|7453700|FG004|Overall Study|Participant underwent fecal transplant|0
4601509|NCT01620255|7453696|FG000|Overall Study|Non-compliance|0
4601510|NCT01620255|7453697|FG001|Overall Study|Non-compliance|1
4601511|NCT01620255|7453698|FG002|Overall Study|Non-compliance|0
4601512|NCT01620255|7453699|FG003|Overall Study|Non-compliance|0
4601513|NCT01620255|7453700|FG004|Overall Study|Non-compliance|0
4601514|NCT01620255|7453696|FG000|Overall Study|Adverse Event|0
4601515|NCT01620255|7453697|FG001|Overall Study|Adverse Event|4
4601516|NCT01620255|7453698|FG002|Overall Study|Adverse Event|0
4601517|NCT01620255|7453699|FG003|Overall Study|Adverse Event|1
4601518|NCT01620255|7453700|FG004|Overall Study|Adverse Event|1
4601519|NCT01620255|7453696|FG000|Overall Study|Withdrawn at discretion of investigator|0
4601520|NCT01620255|7453697|FG001|Overall Study|Withdrawn at discretion of investigator|0
4601521|NCT01620255|7453698|FG002|Overall Study|Withdrawn at discretion of investigator|0
4601522|NCT01620255|7453699|FG003|Overall Study|Withdrawn at discretion of investigator|0
4601523|NCT01620255|7453700|FG004|Overall Study|Withdrawn at discretion of investigator|1
4601524|NCT01620489|7453714|FG000|Overall Study|Adverse Event|17
4601525|NCT01620489|7453715|FG001|Overall Study|Adverse Event|4
4601526|NCT01620489|7453714|FG000|Overall Study|Protocol Violation|0
4601527|NCT01620489|7453715|FG001|Overall Study|Protocol Violation|3
4601528|NCT01620489|7453714|FG000|Overall Study|Withdrawal Criteria|17
4601529|NCT01620489|7453715|FG001|Overall Study|Withdrawal Criteria|25
4601530|NCT01620489|7453714|FG000|Overall Study|Unclassified|1
4601531|NCT01620489|7453715|FG001|Overall Study|Unclassified|2
4601532|NCT01620528|7453724|FG000|Treatment Period|Did Not Receive Study Drug|0
4601533|NCT01620528|7453725|FG001|Treatment Period|Did Not Receive Study Drug|0
4601534|NCT01620528|7453726|FG002|Treatment Period|Did Not Receive Study Drug|1
4601535|NCT01620528|7453724|FG000|Treatment Period|Withdrawal by Subject|35
4601536|NCT01620528|7453725|FG001|Treatment Period|Withdrawal by Subject|21
4601537|NCT01620528|7453726|FG002|Treatment Period|Withdrawal by Subject|16
4601538|NCT01620528|7453724|FG000|Treatment Period|Adverse Event|17
4601539|NCT01620528|7453725|FG001|Treatment Period|Adverse Event|13
4601540|NCT01620528|7453726|FG002|Treatment Period|Adverse Event|21
4601541|NCT01620528|7453724|FG000|Treatment Period|Lost to Follow-up|16
4601542|NCT01620528|7453725|FG001|Treatment Period|Lost to Follow-up|8
4601543|NCT01620528|7453726|FG002|Treatment Period|Lost to Follow-up|14
4601544|NCT01620528|7453724|FG000|Treatment Period|Other|9
4601545|NCT01620528|7453725|FG001|Treatment Period|Other|5
4601546|NCT01620528|7453726|FG002|Treatment Period|Other|7
4601547|NCT01620528|7453724|FG000|Treatment Period|Subject Noncompliant|11
4601548|NCT01620528|7453725|FG001|Treatment Period|Subject Noncompliant|2
4601549|NCT01620528|7453726|FG002|Treatment Period|Subject Noncompliant|2
4601550|NCT01620528|7453724|FG000|Treatment Period|Pregnancy|7
4601551|NCT01620528|7453725|FG001|Treatment Period|Pregnancy|2
4601552|NCT01620528|7453726|FG002|Treatment Period|Pregnancy|2
4601553|NCT01620528|7453724|FG000|Treatment Period|Surgery/Invasive Intervention|5
4601554|NCT01620528|7453725|FG001|Treatment Period|Surgery/Invasive Intervention|1
4601555|NCT01620528|7453726|FG002|Treatment Period|Surgery/Invasive Intervention|3
4601556|NCT01620528|7453724|FG000|Treatment Period|Exclusionary Medication Received|0
4601557|NCT01620528|7453725|FG001|Treatment Period|Exclusionary Medication Received|1
4601558|NCT01620528|7453726|FG002|Treatment Period|Exclusionary Medication Received|0
4601559|NCT01620528|7453724|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3
4601560|NCT01620528|7453725|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7
4601561|NCT01620528|7453726|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3
4601562|NCT01620528|7453724|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3
4601563|NCT01620528|7453725|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2
4601564|NCT01620528|7453726|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4
4601565|NCT01620528|7453724|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0
4601566|NCT01620528|7453725|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1
4601567|NCT01620528|7453726|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1
4601568|NCT01620528|7453724|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8
4601569|NCT01620528|7453725|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3
4601570|NCT01620528|7453726|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4
4601571|NCT01620528|7453724|FG000|Post-Treatment Follow-Up Period|Other|6
4601572|NCT01620528|7453725|FG001|Post-Treatment Follow-Up Period|Other|4
4601573|NCT01620528|7453726|FG002|Post-Treatment Follow-Up Period|Other|2
4601574|NCT01620762|7453758|FG000|Overall Study|Protocol Violation|1
4601575|NCT01620762|7453759|FG001|Overall Study|Protocol Violation|1
4601576|NCT01620762|7453760|FG002|Overall Study|Protocol Violation|1
4601577|NCT01620762|7453758|FG000|Overall Study|Adverse Event|9
4601578|NCT01620762|7453759|FG001|Overall Study|Adverse Event|5
4601579|NCT01620762|7453760|FG002|Overall Study|Adverse Event|2
4601580|NCT01620762|7453758|FG000|Overall Study|Withdrawal by Subject|23
4601581|NCT01620762|7453759|FG001|Overall Study|Withdrawal by Subject|26
4601582|NCT01620762|7453760|FG002|Overall Study|Withdrawal by Subject|27
4601583|NCT01620762|7453758|FG000|Overall Study|Lost to Follow-up|11
4601584|NCT01620762|7453759|FG001|Overall Study|Lost to Follow-up|17
4601585|NCT01620762|7453760|FG002|Overall Study|Lost to Follow-up|10
4601586|NCT01620762|7453758|FG000|Overall Study|Protocol deviation|1
4601587|NCT01620762|7453759|FG001|Overall Study|Protocol deviation|1
4601588|NCT01620762|7453760|FG002|Overall Study|Protocol deviation|6
4601589|NCT01620762|7453758|FG000|Overall Study|Subject deterioration|0
4601590|NCT01620762|7453759|FG001|Overall Study|Subject deterioration|1
4601591|NCT01620762|7453760|FG002|Overall Study|Subject deterioration|1
4601592|NCT01620762|7453758|FG000|Overall Study|Non-specified|3
4601593|NCT01620762|7453759|FG001|Overall Study|Non-specified|6
4601594|NCT01620762|7453760|FG002|Overall Study|Non-specified|5
4601595|NCT01620762|7453758|FG000|Overall Study|Use of prohibted therapies|0
4601596|NCT01620762|7453759|FG001|Overall Study|Use of prohibted therapies|1
4601597|NCT01620762|7453760|FG002|Overall Study|Use of prohibted therapies|1
4601598|NCT01620983|7453771|FG000|Overall Study|Lost to Follow-up|8
4601599|NCT01620983|7453772|FG001|Overall Study|Lost to Follow-up|4
4601600|NCT01620983|7453773|FG002|Overall Study|Lost to Follow-up|9
4601601|NCT01620983|7453771|FG000|Overall Study|Withdrawal by Subject|6
4601602|NCT01620983|7453772|FG001|Overall Study|Withdrawal by Subject|8
4601603|NCT01620983|7453773|FG002|Overall Study|Withdrawal by Subject|1
4601604|NCT01620983|7453771|FG000|Overall Study|Death|2
4601605|NCT01620983|7453772|FG001|Overall Study|Death|0
4601606|NCT01620983|7453773|FG002|Overall Study|Death|0
4601607|NCT01620983|7453771|FG000|Overall Study|Physician Decision|3
4601608|NCT01620983|7453772|FG001|Overall Study|Physician Decision|10
4601609|NCT01620983|7453773|FG002|Overall Study|Physician Decision|5
4601610|NCT01621126|7453796|FG000|Overall Study|Physician Decision|6
4601611|NCT01621178|7453803|FG000|Overall Study|Adverse Event|5
4601612|NCT01621178|7453804|FG001|Overall Study|Adverse Event|2
4601613|NCT01621178|7453805|FG002|Overall Study|Adverse Event|8
4601614|NCT01621178|7453803|FG000|Overall Study|Death|6
4601615|NCT01621178|7453804|FG001|Overall Study|Death|7
4601616|NCT01621178|7453805|FG002|Overall Study|Death|2
4601617|NCT01621178|7453803|FG000|Overall Study|Lost to Follow-up|1
4601618|NCT01621178|7453804|FG001|Overall Study|Lost to Follow-up|2
4601619|NCT01621178|7453805|FG002|Overall Study|Lost to Follow-up|1
4601620|NCT01621178|7453803|FG000|Overall Study|Withdrawal by Subject|14
4601621|NCT01621178|7453804|FG001|Overall Study|Withdrawal by Subject|17
4601622|NCT01621178|7453805|FG002|Overall Study|Withdrawal by Subject|18
4601623|NCT01621178|7453803|FG000|Overall Study|Physician Decision|5
4601624|NCT01621178|7453804|FG001|Overall Study|Physician Decision|2
4601625|NCT01621178|7453805|FG002|Overall Study|Physician Decision|7
4601626|NCT01621191|7453817|FG000|Overall Study|Adverse Event|9
4601627|NCT01621191|7453817|FG000|Overall Study|Withdrawal by Subject|8
4601628|NCT01621191|7453817|FG000|Overall Study|Lack of Efficacy|6
4601629|NCT01621191|7453817|FG000|Overall Study|Lost to Follow-up|1
4601630|NCT01621191|7453817|FG000|Overall Study|Site Removed From Study|1
4601631|NCT01621490|7453847|FG000|Overall Study|Participant completed treatment|4
4601632|NCT01621490|7453848|FG001|Overall Study|Participant completed treatment|4
4601633|NCT01621490|7453849|FG002|Overall Study|Participant completed treatment|1
4601634|NCT01621490|7453850|FG003|Overall Study|Participant completed treatment|0
4601635|NCT01621490|7453851|FG004|Overall Study|Participant completed treatment|0
4601636|NCT01621490|7453852|FG005|Overall Study|Participant completed treatment|0
4601637|NCT01621490|7453853|FG006|Overall Study|Participant completed treatment|0
4601638|NCT01621490|7453854|FG007|Overall Study|Participant completed treatment|1
4601639|NCT01621490|7453855|FG008|Overall Study|Participant completed treatment|0
4601640|NCT01621490|7453847|FG000|Overall Study|Patient could not travel|1
4601641|NCT01621490|7453848|FG001|Overall Study|Patient could not travel|0
4601642|NCT01621490|7453849|FG002|Overall Study|Patient could not travel|0
4601643|NCT01621490|7453850|FG003|Overall Study|Patient could not travel|0
4601644|NCT01621490|7453851|FG004|Overall Study|Patient could not travel|0
4601645|NCT01621490|7453852|FG005|Overall Study|Patient could not travel|0
4601646|NCT01621490|7453853|FG006|Overall Study|Patient could not travel|0
4601647|NCT01621490|7453854|FG007|Overall Study|Patient could not travel|0
4601648|NCT01621490|7453855|FG008|Overall Study|Patient could not travel|0
4601649|NCT01621490|7453847|FG000|Overall Study|Subject no longer meets study criteria|0
4601650|NCT01621490|7453848|FG001|Overall Study|Subject no longer meets study criteria|0
4601651|NCT01621490|7453849|FG002|Overall Study|Subject no longer meets study criteria|0
4601652|NCT01621490|7453850|FG003|Overall Study|Subject no longer meets study criteria|0
4601653|NCT01621490|7453851|FG004|Overall Study|Subject no longer meets study criteria|1
4601654|NCT01621490|7453852|FG005|Overall Study|Subject no longer meets study criteria|0
4601655|NCT01621490|7453853|FG006|Overall Study|Subject no longer meets study criteria|0
4601656|NCT01621490|7453854|FG007|Overall Study|Subject no longer meets study criteria|0
4601657|NCT01621490|7453855|FG008|Overall Study|Subject no longer meets study criteria|0
4601658|NCT01621490|7453847|FG000|Overall Study|Maximum clinical benefit|3
4601659|NCT01621490|7453848|FG001|Overall Study|Maximum clinical benefit|2
4601660|NCT01621490|7453849|FG002|Overall Study|Maximum clinical benefit|0
4601661|NCT01621490|7453850|FG003|Overall Study|Maximum clinical benefit|0
4601662|NCT01621490|7453851|FG004|Overall Study|Maximum clinical benefit|0
4601663|NCT01621490|7453852|FG005|Overall Study|Maximum clinical benefit|0
4601664|NCT01621490|7453853|FG006|Overall Study|Maximum clinical benefit|1
4601665|NCT01621490|7453854|FG007|Overall Study|Maximum clinical benefit|2
4601666|NCT01621490|7453855|FG008|Overall Study|Maximum clinical benefit|0
4601667|NCT01621490|7453847|FG000|Overall Study|Withdrawal by Subject|1
4601668|NCT01621490|7453848|FG001|Overall Study|Withdrawal by Subject|0
4601669|NCT01621490|7453849|FG002|Overall Study|Withdrawal by Subject|0
4601670|NCT01621490|7453850|FG003|Overall Study|Withdrawal by Subject|0
4601671|NCT01621490|7453851|FG004|Overall Study|Withdrawal by Subject|0
4601672|NCT01621490|7453852|FG005|Overall Study|Withdrawal by Subject|3
4601673|NCT01621490|7453853|FG006|Overall Study|Withdrawal by Subject|0
4601674|NCT01621490|7453854|FG007|Overall Study|Withdrawal by Subject|0
4601675|NCT01621490|7453855|FG008|Overall Study|Withdrawal by Subject|0
4601676|NCT01621490|7453847|FG000|Overall Study|Subject request to discontinue study|1
4601677|NCT01621490|7453848|FG001|Overall Study|Subject request to discontinue study|3
4601678|NCT01621490|7453849|FG002|Overall Study|Subject request to discontinue study|1
4601679|NCT01621490|7453850|FG003|Overall Study|Subject request to discontinue study|1
4601680|NCT01621490|7453851|FG004|Overall Study|Subject request to discontinue study|0
4601681|NCT01621490|7453852|FG005|Overall Study|Subject request to discontinue study|2
4601682|NCT01621490|7453853|FG006|Overall Study|Subject request to discontinue study|1
4601683|NCT01621490|7453854|FG007|Overall Study|Subject request to discontinue study|0
4601684|NCT01621490|7453855|FG008|Overall Study|Subject request to discontinue study|1
4601685|NCT01621490|7453847|FG000|Overall Study|Adverse event unrelated to study drug|2
4601686|NCT01621490|7453848|FG001|Overall Study|Adverse event unrelated to study drug|1
4601687|NCT01621490|7453849|FG002|Overall Study|Adverse event unrelated to study drug|0
4601688|NCT01621490|7453850|FG003|Overall Study|Adverse event unrelated to study drug|0
4601689|NCT01621490|7453851|FG004|Overall Study|Adverse event unrelated to study drug|0
4601690|NCT01621490|7453852|FG005|Overall Study|Adverse event unrelated to study drug|0
4601691|NCT01621490|7453853|FG006|Overall Study|Adverse event unrelated to study drug|0
4601692|NCT01621490|7453854|FG007|Overall Study|Adverse event unrelated to study drug|2
4601693|NCT01621490|7453855|FG008|Overall Study|Adverse event unrelated to study drug|1
4601694|NCT01621490|7453847|FG000|Overall Study|Disease progression|27
4601695|NCT01621490|7453848|FG001|Overall Study|Disease progression|28
4601696|NCT01621490|7453849|FG002|Overall Study|Disease progression|1
4601697|NCT01621490|7453850|FG003|Overall Study|Disease progression|5
4601698|NCT01621490|7453851|FG004|Overall Study|Disease progression|3
4601699|NCT01621490|7453852|FG005|Overall Study|Disease progression|8
4601700|NCT01621490|7453853|FG006|Overall Study|Disease progression|7
4601701|NCT01621490|7453854|FG007|Overall Study|Disease progression|0
4601702|NCT01621490|7453855|FG008|Overall Study|Disease progression|4
4601703|NCT01621490|7453847|FG000|Overall Study|Study drug toxicity|1
4601704|NCT01621490|7453848|FG001|Overall Study|Study drug toxicity|4
4601705|NCT01621490|7453849|FG002|Overall Study|Study drug toxicity|5
4601706|NCT01621490|7453850|FG003|Overall Study|Study drug toxicity|3
4601707|NCT01621490|7453851|FG004|Overall Study|Study drug toxicity|1
4601708|NCT01621490|7453852|FG005|Overall Study|Study drug toxicity|10
4601709|NCT01621490|7453853|FG006|Overall Study|Study drug toxicity|1
4601710|NCT01621490|7453854|FG007|Overall Study|Study drug toxicity|4
4601711|NCT01621490|7453855|FG008|Overall Study|Study drug toxicity|1
4601712|NCT01621490|7453847|FG000|Overall Study|Death|0
4601713|NCT01621490|7453848|FG001|Overall Study|Death|0
4601714|NCT01621490|7453849|FG002|Overall Study|Death|0
4601715|NCT01621490|7453850|FG003|Overall Study|Death|0
4601716|NCT01621490|7453851|FG004|Overall Study|Death|0
4601717|NCT01621490|7453852|FG005|Overall Study|Death|0
4601718|NCT01621490|7453853|FG006|Overall Study|Death|0
4601719|NCT01621490|7453854|FG007|Overall Study|Death|1
4601720|NCT01621490|7453855|FG008|Overall Study|Death|0
4601721|NCT01621490|7453847|FG000|Overall Study|Grade 4 Lipase elevation|1
4601722|NCT01621490|7453848|FG001|Overall Study|Grade 4 Lipase elevation|0
4601723|NCT01621490|7453849|FG002|Overall Study|Grade 4 Lipase elevation|0
4601724|NCT01621490|7453850|FG003|Overall Study|Grade 4 Lipase elevation|0
4601725|NCT01621490|7453851|FG004|Overall Study|Grade 4 Lipase elevation|0
4601726|NCT01621490|7453852|FG005|Overall Study|Grade 4 Lipase elevation|0
4601727|NCT01621490|7453853|FG006|Overall Study|Grade 4 Lipase elevation|0
4601728|NCT01621490|7453854|FG007|Overall Study|Grade 4 Lipase elevation|0
4601729|NCT01621490|7453855|FG008|Overall Study|Grade 4 Lipase elevation|0
4601730|NCT01621490|7453847|FG000|Overall Study|BMS informed of patient status|0
4601731|NCT01621490|7453848|FG001|Overall Study|BMS informed of patient status|0
4601732|NCT01621490|7453849|FG002|Overall Study|BMS informed of patient status|1
4601733|NCT01621490|7453850|FG003|Overall Study|BMS informed of patient status|0
4601734|NCT01621490|7453851|FG004|Overall Study|BMS informed of patient status|0
4601735|NCT01621490|7453852|FG005|Overall Study|BMS informed of patient status|0
4601736|NCT01621490|7453853|FG006|Overall Study|BMS informed of patient status|0
4601737|NCT01621490|7453854|FG007|Overall Study|BMS informed of patient status|0
4601738|NCT01621490|7453855|FG008|Overall Study|BMS informed of patient status|0
4601739|NCT01621490|7453847|FG000|Overall Study|Investigator decision|0
4601740|NCT01621490|7453848|FG001|Overall Study|Investigator decision|0
4601741|NCT01621490|7453849|FG002|Overall Study|Investigator decision|1
4601742|NCT01621490|7453850|FG003|Overall Study|Investigator decision|0
4601743|NCT01621490|7453851|FG004|Overall Study|Investigator decision|1
4601744|NCT01621490|7453852|FG005|Overall Study|Investigator decision|0
4601745|NCT01621490|7453853|FG006|Overall Study|Investigator decision|1
4601746|NCT01621490|7453854|FG007|Overall Study|Investigator decision|0
4601747|NCT01621490|7453855|FG008|Overall Study|Investigator decision|0
4601748|NCT01621490|7453847|FG000|Overall Study|Documented disease progression|0
4601749|NCT01621490|7453848|FG001|Overall Study|Documented disease progression|0
4601750|NCT01621490|7453849|FG002|Overall Study|Documented disease progression|1
4601751|NCT01621490|7453850|FG003|Overall Study|Documented disease progression|0
4601752|NCT01621490|7453851|FG004|Overall Study|Documented disease progression|0
4601753|NCT01621490|7453852|FG005|Overall Study|Documented disease progression|0
4601754|NCT01621490|7453853|FG006|Overall Study|Documented disease progression|0
4601755|NCT01621490|7453854|FG007|Overall Study|Documented disease progression|0
4601756|NCT01621490|7453855|FG008|Overall Study|Documented disease progression|0
4601757|NCT01621490|7453847|FG000|Overall Study|Patient reached treatment 2 yr limit|0
4601758|NCT01621490|7453848|FG001|Overall Study|Patient reached treatment 2 yr limit|1
4601759|NCT01621490|7453849|FG002|Overall Study|Patient reached treatment 2 yr limit|0
4601760|NCT01621490|7453850|FG003|Overall Study|Patient reached treatment 2 yr limit|0
4601761|NCT01621490|7453851|FG004|Overall Study|Patient reached treatment 2 yr limit|0
4601762|NCT01621490|7453852|FG005|Overall Study|Patient reached treatment 2 yr limit|0
4601763|NCT01621490|7453853|FG006|Overall Study|Patient reached treatment 2 yr limit|0
4601764|NCT01621490|7453854|FG007|Overall Study|Patient reached treatment 2 yr limit|0
4601765|NCT01621490|7453855|FG008|Overall Study|Patient reached treatment 2 yr limit|0
4601766|NCT01621490|7453847|FG000|Overall Study|Clinical deterioration|0
4601767|NCT01621490|7453848|FG001|Overall Study|Clinical deterioration|1
4601768|NCT01621490|7453849|FG002|Overall Study|Clinical deterioration|0
4601769|NCT01621490|7453850|FG003|Overall Study|Clinical deterioration|0
4601770|NCT01621490|7453851|FG004|Overall Study|Clinical deterioration|0
4601771|NCT01621490|7453852|FG005|Overall Study|Clinical deterioration|0
4601772|NCT01621490|7453853|FG006|Overall Study|Clinical deterioration|0
4601773|NCT01621490|7453854|FG007|Overall Study|Clinical deterioration|0
4601774|NCT01621490|7453855|FG008|Overall Study|Clinical deterioration|0
4601775|NCT01621490|7453847|FG000|Overall Study|Complete response|0
4601776|NCT01621490|7453848|FG001|Overall Study|Complete response|0
4601777|NCT01621490|7453849|FG002|Overall Study|Complete response|0
4601778|NCT01621490|7453850|FG003|Overall Study|Complete response|0
4601779|NCT01621490|7453851|FG004|Overall Study|Complete response|0
4601780|NCT01621490|7453852|FG005|Overall Study|Complete response|0
4601781|NCT01621490|7453853|FG006|Overall Study|Complete response|0
4601782|NCT01621490|7453854|FG007|Overall Study|Complete response|0
4601783|NCT01621490|7453855|FG008|Overall Study|Complete response|1
4601784|NCT01621490|7453847|FG000|Overall Study|Patient delayed due to toxicity|0
4601785|NCT01621490|7453848|FG001|Overall Study|Patient delayed due to toxicity|0
4601786|NCT01621490|7453849|FG002|Overall Study|Patient delayed due to toxicity|0
4601787|NCT01621490|7453850|FG003|Overall Study|Patient delayed due to toxicity|0
4601788|NCT01621490|7453851|FG004|Overall Study|Patient delayed due to toxicity|0
4601789|NCT01621490|7453852|FG005|Overall Study|Patient delayed due to toxicity|1
4601790|NCT01621490|7453853|FG006|Overall Study|Patient delayed due to toxicity|0
4601791|NCT01621490|7453854|FG007|Overall Study|Patient delayed due to toxicity|0
4601792|NCT01621490|7453855|FG008|Overall Study|Patient delayed due to toxicity|0
4601793|NCT01621542|7453974|FG000|Overall Study|Adverse Event|0
4601794|NCT01621542|7453975|FG001|Overall Study|Adverse Event|0
4601795|NCT01621542|7453976|FG002|Overall Study|Adverse Event|1
4601796|NCT01621542|7453977|FG003|Overall Study|Adverse Event|3
4601797|NCT01621542|7453978|FG004|Overall Study|Adverse Event|0
4601798|NCT01621542|7453979|FG005|Overall Study|Adverse Event|0
4601799|NCT01621542|7453974|FG000|Overall Study|Death|0
4601800|NCT01621542|7453975|FG001|Overall Study|Death|1
4601801|NCT01621542|7453976|FG002|Overall Study|Death|0
4601802|NCT01621542|7453977|FG003|Overall Study|Death|0
4601803|NCT01621542|7453978|FG004|Overall Study|Death|0
4601804|NCT01621542|7453979|FG005|Overall Study|Death|0
4601805|NCT01621542|7453974|FG000|Overall Study|Physician Decision|1
4601806|NCT01621542|7453975|FG001|Overall Study|Physician Decision|0
4601807|NCT01621542|7453976|FG002|Overall Study|Physician Decision|1
4601808|NCT01621542|7453977|FG003|Overall Study|Physician Decision|13
4601809|NCT01621542|7453978|FG004|Overall Study|Physician Decision|3
4601810|NCT01621542|7453979|FG005|Overall Study|Physician Decision|1
4601811|NCT01621542|7453974|FG000|Overall Study|Withdrawal by Subject|2
4601812|NCT01621542|7453975|FG001|Overall Study|Withdrawal by Subject|0
4601813|NCT01621542|7453976|FG002|Overall Study|Withdrawal by Subject|1
4601814|NCT01621542|7453977|FG003|Overall Study|Withdrawal by Subject|3
4601815|NCT01621542|7453978|FG004|Overall Study|Withdrawal by Subject|3
4601816|NCT01621542|7453979|FG005|Overall Study|Withdrawal by Subject|3
4601817|NCT01621542|7453974|FG000|Overall Study|progression/treatment failure|2
4601818|NCT01621542|7453975|FG001|Overall Study|progression/treatment failure|4
4601819|NCT01621542|7453976|FG002|Overall Study|progression/treatment failure|3
4601820|NCT01621542|7453977|FG003|Overall Study|progression/treatment failure|7
4601821|NCT01621542|7453978|FG004|Overall Study|progression/treatment failure|3
4601822|NCT01621542|7453979|FG005|Overall Study|progression/treatment failure|5
4601823|NCT01621542|7453974|FG000|Overall Study|Protocol Violation|0
4601824|NCT01621542|7453975|FG001|Overall Study|Protocol Violation|0
4601825|NCT01621542|7453976|FG002|Overall Study|Protocol Violation|0
4601826|NCT01621542|7453977|FG003|Overall Study|Protocol Violation|1
4601827|NCT01621542|7453978|FG004|Overall Study|Protocol Violation|0
4601828|NCT01621542|7453979|FG005|Overall Study|Protocol Violation|0
4601829|NCT01621542|7453974|FG000|Overall Study|study stopped by sponsor|0
4601830|NCT01621542|7453975|FG001|Overall Study|study stopped by sponsor|0
4601831|NCT01621542|7453976|FG002|Overall Study|study stopped by sponsor|0
4601832|NCT01621542|7453977|FG003|Overall Study|study stopped by sponsor|1
4601833|NCT01621542|7453978|FG004|Overall Study|study stopped by sponsor|0
4601834|NCT01621542|7453979|FG005|Overall Study|study stopped by sponsor|0
4601835|NCT01621802|7454038|FG000|Overall Study|Protocol Violation|0
4601836|NCT01621802|7454039|FG001|Overall Study|Protocol Violation|0
4601837|NCT01621802|7454040|FG002|Overall Study|Protocol Violation|0
4601838|NCT01621802|7454041|FG003|Overall Study|Protocol Violation|0
4601839|NCT01621802|7454042|FG004|Overall Study|Protocol Violation|0
4601840|NCT01621802|7454043|FG005|Overall Study|Protocol Violation|1
4601841|NCT01621802|7454038|FG000|Overall Study|Withdrawal by Subject|8
4601842|NCT01621802|7454039|FG001|Overall Study|Withdrawal by Subject|4
4601843|NCT01621802|7454040|FG002|Overall Study|Withdrawal by Subject|4
4601844|NCT01621802|7454041|FG003|Overall Study|Withdrawal by Subject|2
4601845|NCT01621802|7454042|FG004|Overall Study|Withdrawal by Subject|2
4601846|NCT01621802|7454043|FG005|Overall Study|Withdrawal by Subject|0
4601847|NCT01621802|7454038|FG000|Overall Study|Migrated/moved from study area|0
4601848|NCT01621802|7454039|FG001|Overall Study|Migrated/moved from study area|0
4601849|NCT01621802|7454040|FG002|Overall Study|Migrated/moved from study area|2
4601850|NCT01621802|7454041|FG003|Overall Study|Migrated/moved from study area|0
4601851|NCT01621802|7454042|FG004|Overall Study|Migrated/moved from study area|1
4601852|NCT01621802|7454043|FG005|Overall Study|Migrated/moved from study area|0
4601853|NCT01621802|7454038|FG000|Overall Study|Others|3
4601854|NCT01621802|7454039|FG001|Overall Study|Others|3
4601855|NCT01621802|7454040|FG002|Overall Study|Others|3
4601856|NCT01621802|7454041|FG003|Overall Study|Others|2
4601857|NCT01621802|7454042|FG004|Overall Study|Others|1
4601858|NCT01621802|7454043|FG005|Overall Study|Others|0
4601859|NCT01621802|7454038|FG000|Overall Study|Lost to Follow-up|36
4601860|NCT01621802|7454039|FG001|Overall Study|Lost to Follow-up|16
4601861|NCT01621802|7454040|FG002|Overall Study|Lost to Follow-up|24
4601862|NCT01621802|7454041|FG003|Overall Study|Lost to Follow-up|7
4601863|NCT01621802|7454042|FG004|Overall Study|Lost to Follow-up|31
4601864|NCT01621802|7454043|FG005|Overall Study|Lost to Follow-up|11
4601865|NCT01621880|7454062|FG000|Overall Study|Adverse Event|5
4601866|NCT01621880|7454063|FG001|Overall Study|Adverse Event|1
4635760|NCT01937130|7507558|FG001|Overall Study|Withdrawal by Subject|0
4635761|NCT01937130|7507559|FG002|Overall Study|Withdrawal by Subject|0
4635762|NCT01937130|7507560|FG003|Overall Study|Withdrawal by Subject|1
4601867|NCT01621880|7454062|FG000|Overall Study|Withdrawal by Subject|5
4601868|NCT01621880|7454063|FG001|Overall Study|Withdrawal by Subject|4
4601869|NCT01622231|7454081|FG000|Overall Study|Physician Decision|1
4601870|NCT01622231|7454081|FG000|Overall Study|Withdrawal by Subject|1
4601871|NCT01622348|7454107|FG000|Overall Study|Withdrawal by Subject|1
4601872|NCT01622348|7454108|FG001|Overall Study|Withdrawal by Subject|0
4601873|NCT01622348|7454109|FG002|Overall Study|Withdrawal by Subject|1
4601874|NCT01622569|7454130|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4
4601875|NCT01622569|7454131|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2
4601876|NCT01622569|7454132|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3
4601877|NCT01622569|7454133|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1
4601878|NCT01622569|7454130|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0
4601879|NCT01622569|7454131|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0
4601880|NCT01622569|7454132|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1
4601881|NCT01622569|7454133|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0
4601882|NCT01622569|7454130|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6
4601883|NCT01622569|7454131|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0
4601884|NCT01622569|7454132|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3
4601885|NCT01622569|7454133|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2
4601886|NCT01622569|7454130|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
4601887|NCT01622569|7454131|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2
4601888|NCT01622569|7454132|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
4601889|NCT01622569|7454133|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1
4601890|NCT01622569|7454130|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2
4601891|NCT01622569|7454131|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2
4601892|NCT01622569|7454132|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2
4601893|NCT01622569|7454133|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0
4601894|NCT01622569|7454130|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0
4635763|NCT01937130|7507557|FG000|Overall Study|Adverse Event|0
4601895|NCT01622569|7454131|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2
4601896|NCT01622569|7454132|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
4601897|NCT01622569|7454133|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0
4601898|NCT01622569|7454130|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1
4601899|NCT01622569|7454131|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
4601900|NCT01622569|7454132|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2
4601901|NCT01622569|7454133|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1
4601902|NCT01622569|7454130|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
4601903|NCT01622569|7454131|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
4601904|NCT01622569|7454132|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
4601905|NCT01622569|7454133|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1
4601906|NCT01622660|7454153|FG000|Overall Study|Adverse Event|1
4601907|NCT01622673|7454163|FG000|Treatment Period 1|Withdrawal by Subject|0
4601908|NCT01622673|7454164|FG001|Treatment Period 1|Withdrawal by Subject|0
4601909|NCT01622673|7454165|FG002|Treatment Period 1|Withdrawal by Subject|0
4601910|NCT01622673|7454166|FG003|Treatment Period 1|Withdrawal by Subject|1
4601911|NCT01622673|7454167|FG004|Treatment Period 1|Withdrawal by Subject|0
4601912|NCT01622673|7454168|FG005|Treatment Period 1|Withdrawal by Subject|0
4601913|NCT01622673|7454163|FG000|Treatment Period 1|Protocol Violation|0
4601914|NCT01622673|7454164|FG001|Treatment Period 1|Protocol Violation|1
4601915|NCT01622673|7454165|FG002|Treatment Period 1|Protocol Violation|0
4601916|NCT01622673|7454166|FG003|Treatment Period 1|Protocol Violation|0
4601917|NCT01622673|7454167|FG004|Treatment Period 1|Protocol Violation|0
4601918|NCT01622673|7454168|FG005|Treatment Period 1|Protocol Violation|0
4601919|NCT01622673|7454163|FG000|Treatment Period 2|Withdrawal by Subject|0
4635764|NCT01937130|7507558|FG001|Overall Study|Adverse Event|1
4635765|NCT01937130|7507559|FG002|Overall Study|Adverse Event|0
4635766|NCT01937130|7507560|FG003|Overall Study|Adverse Event|1
4635767|NCT01937130|7507557|FG000|Overall Study|Death|1
4635768|NCT01937130|7507558|FG001|Overall Study|Death|1
4635769|NCT01937130|7507559|FG002|Overall Study|Death|1
4635770|NCT01937130|7507560|FG003|Overall Study|Death|0
4635771|NCT01937130|7507557|FG000|Overall Study|Lost to Follow-up|2
4635772|NCT01937130|7507558|FG001|Overall Study|Lost to Follow-up|0
4635773|NCT01937130|7507559|FG002|Overall Study|Lost to Follow-up|2
4635774|NCT01937130|7507560|FG003|Overall Study|Lost to Follow-up|0
4635775|NCT01937130|7507557|FG000|Overall Study|Physician Decision|0
4601920|NCT01622673|7454164|FG001|Treatment Period 2|Withdrawal by Subject|0
4601921|NCT01622673|7454165|FG002|Treatment Period 2|Withdrawal by Subject|0
4601922|NCT01622673|7454166|FG003|Treatment Period 2|Withdrawal by Subject|1
4601923|NCT01622673|7454167|FG004|Treatment Period 2|Withdrawal by Subject|0
4601924|NCT01622673|7454168|FG005|Treatment Period 2|Withdrawal by Subject|0
4601925|NCT01622673|7454163|FG000|Treatment Period 3|Protocol Violation|0
4601926|NCT01622673|7454164|FG001|Treatment Period 3|Protocol Violation|1
4601927|NCT01622673|7454165|FG002|Treatment Period 3|Protocol Violation|0
4601928|NCT01622673|7454166|FG003|Treatment Period 3|Protocol Violation|0
4601929|NCT01622673|7454167|FG004|Treatment Period 3|Protocol Violation|0
4601930|NCT01622673|7454168|FG005|Treatment Period 3|Protocol Violation|0
4601931|NCT01623050|7454202|FG000|Overall Study|Lost to Follow-up|9
4601932|NCT01623115|7454208|FG000|Overall Study|Randomized but not treated|0
4601933|NCT01623115|7454209|FG001|Overall Study|Randomized but not treated|1
4601934|NCT01623115|7454208|FG000|Overall Study|Physician Decision|1
4601935|NCT01623115|7454209|FG001|Overall Study|Physician Decision|0
4601936|NCT01623115|7454208|FG000|Overall Study|Participants moved|1
4601937|NCT01623115|7454209|FG001|Overall Study|Participants moved|5
4601938|NCT01623115|7454208|FG000|Overall Study|Adverse Event|10
4601939|NCT01623115|7454209|FG001|Overall Study|Adverse Event|13
4601940|NCT01623115|7454208|FG000|Overall Study|Poor compliance to protocol|4
4601941|NCT01623115|7454209|FG001|Overall Study|Poor compliance to protocol|10
4601942|NCT01623115|7454208|FG000|Overall Study|Consent withdrawn by participant|2
4601943|NCT01623115|7454209|FG001|Overall Study|Consent withdrawn by participant|6
4601944|NCT01623115|7454208|FG000|Overall Study|Related to study drug administration|0
4601945|NCT01623115|7454209|FG001|Overall Study|Related to study drug administration|2
4601946|NCT01623115|7454208|FG000|Overall Study|Last visit outside protocol visit window|14
4601947|NCT01623115|7454209|FG001|Overall Study|Last visit outside protocol visit window|26
4601948|NCT01623115|7454208|FG000|Overall Study|Site closure|1
4601949|NCT01623115|7454209|FG001|Overall Study|Site closure|7
4601950|NCT01623115|7454208|FG000|Overall Study|Death|0
4601951|NCT01623115|7454209|FG001|Overall Study|Death|4
4601952|NCT01623115|7454208|FG000|Overall Study|Other than specified above|0
4601953|NCT01623115|7454209|FG001|Overall Study|Other than specified above|3
4601954|NCT01623154|7454215|FG000|Overall Study|Did not drink Pranactin Citric|4
4601955|NCT01623271|7454221|FG000|Overall Study|Withdrawal by Subject|2
4601956|NCT01623310|7454225|FG000|Overall Study|Adverse Event|21
4601957|NCT01623310|7454225|FG000|Overall Study|Lost to Follow-up|18
4601958|NCT01623310|7454225|FG000|Overall Study|Lack of Efficacy|6
4601959|NCT01623310|7454225|FG000|Overall Study|Protocol Violation|6
4635776|NCT01937130|7507558|FG001|Overall Study|Physician Decision|1
4635777|NCT01937130|7507559|FG002|Overall Study|Physician Decision|0
4635778|NCT01937130|7507560|FG003|Overall Study|Physician Decision|0
4601960|NCT01623310|7454225|FG000|Overall Study|Withdrawal by Subject|25
4601961|NCT01623310|7454225|FG000|Overall Study|Became potentially child-bearing|1
4601962|NCT01623310|7454225|FG000|Overall Study|Diagnoses of bilateral cateracts|1
4601963|NCT01623310|7454225|FG000|Overall Study|Investigators Discretion-Noncompliant|1
4601964|NCT01623531|7454248|FG000|Overall Study|Death|1
4601965|NCT01623531|7454249|FG001|Overall Study|Death|0
4601966|NCT01623531|7454248|FG000|Overall Study|Protocol Violation|2
4601967|NCT01623531|7454249|FG001|Overall Study|Protocol Violation|1
4601968|NCT01623531|7454248|FG000|Overall Study|Missing data at primary outcome time poi|1
4601969|NCT01623531|7454249|FG001|Overall Study|Missing data at primary outcome time poi|1
4601970|NCT01623596|7454260|FG000|Overall Study|Abnormal laboratory values|2
4601971|NCT01623596|7454261|FG001|Overall Study|Abnormal laboratory values|0
4601972|NCT01623596|7454260|FG000|Overall Study|Administrative problems|9
4601973|NCT01623596|7454261|FG001|Overall Study|Administrative problems|13
4601974|NCT01623596|7454260|FG000|Overall Study|Adverse Event|20
4601975|NCT01623596|7454261|FG001|Overall Study|Adverse Event|29
4601976|NCT01623596|7454260|FG000|Overall Study|Death|0
4601977|NCT01623596|7454261|FG001|Overall Study|Death|2
4601978|NCT01623596|7454260|FG000|Overall Study|Lost to Follow-up|12
4601979|NCT01623596|7454261|FG001|Overall Study|Lost to Follow-up|16
4601980|NCT01623596|7454260|FG000|Overall Study|Withdrawal by Subject|13
4601981|NCT01623596|7454261|FG001|Overall Study|Withdrawal by Subject|31
4601982|NCT01623596|7454260|FG000|Overall Study|Patient no longer requires study drug|1
4601983|NCT01623596|7454261|FG001|Overall Study|Patient no longer requires study drug|0
4601984|NCT01623596|7454260|FG000|Overall Study|Protocol Violation|0
4601985|NCT01623596|7454261|FG001|Overall Study|Protocol Violation|6
4601986|NCT01623596|7454260|FG000|Overall Study|Lack of Efficacy|5
4601987|NCT01623596|7454261|FG001|Overall Study|Lack of Efficacy|3
4601988|NCT01623752|7454282|FG000|Phase 1 (78 Weeks)|No Data|249
4601989|NCT01623752|7454283|FG001|Phase 1 (78 Weeks)|No Data|66
4601990|NCT01623752|7454284|FG002|Phase 1 (78 Weeks)|No Data|2
4601991|NCT01623752|7454282|FG000|Phase 1 (78 Weeks)|Other|33
4601992|NCT01623752|7454283|FG001|Phase 1 (78 Weeks)|Other|20
4601993|NCT01623752|7454284|FG002|Phase 1 (78 Weeks)|Other|0
4601994|NCT01623752|7454282|FG000|Phase 1 (78 Weeks)|Adverse Event|122
4601995|NCT01623752|7454283|FG001|Phase 1 (78 Weeks)|Adverse Event|39
4601996|NCT01623752|7454284|FG002|Phase 1 (78 Weeks)|Adverse Event|0
4601997|NCT01623752|7454282|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227
4601998|NCT01623752|7454283|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82
4601999|NCT01623752|7454284|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0
4602000|NCT01623752|7454282|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14
4602001|NCT01623752|7454283|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2
4602002|NCT01623752|7454284|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0
4602003|NCT01623752|7454282|FG000|Phase 2 (78 Weeks)|Other|5
4602004|NCT01623752|7454283|FG001|Phase 2 (78 Weeks)|Other|1
4602005|NCT01623752|7454284|FG002|Phase 2 (78 Weeks)|Other|0
4602006|NCT01623752|7454282|FG000|Phase 2 (78 Weeks)|No Data|43
4602007|NCT01623752|7454283|FG001|Phase 2 (78 Weeks)|No Data|11
4602008|NCT01623752|7454284|FG002|Phase 2 (78 Weeks)|No Data|0
4602009|NCT01623752|7454282|FG000|Phase 2 (78 Weeks)|Adverse Event|4
4602010|NCT01623752|7454283|FG001|Phase 2 (78 Weeks)|Adverse Event|4
4602011|NCT01623752|7454284|FG002|Phase 2 (78 Weeks)|Adverse Event|0
4602012|NCT01623830|7454295|FG000|Overall Study|Withdrawal by Subject|6
4602013|NCT01623830|7454296|FG001|Overall Study|Withdrawal by Subject|7
4602014|NCT01623830|7454295|FG000|Overall Study|Exclusion from Study|1
4602015|NCT01623830|7454296|FG001|Overall Study|Exclusion from Study|2
4602016|NCT01624090|7454310|FG000|Overall Study|DLT, taken off therapy|0
4602017|NCT01624090|7454311|FG001|Overall Study|DLT, taken off therapy|1
4602018|NCT01624090|7454312|FG002|Overall Study|DLT, taken off therapy|0
4602019|NCT01624090|7454313|FG003|Overall Study|DLT, taken off therapy|0
4602020|NCT01624090|7454310|FG000|Overall Study|Withdrew prior to treatment|0
4602021|NCT01624090|7454311|FG001|Overall Study|Withdrew prior to treatment|1
4602022|NCT01624090|7454312|FG002|Overall Study|Withdrew prior to treatment|0
4602023|NCT01624090|7454313|FG003|Overall Study|Withdrew prior to treatment|0
4602024|NCT01624090|7454310|FG000|Overall Study|Died on study|0
4602025|NCT01624090|7454311|FG001|Overall Study|Died on study|0
4602026|NCT01624090|7454312|FG002|Overall Study|Died on study|2
4602027|NCT01624090|7454313|FG003|Overall Study|Died on study|0
4602028|NCT01624090|7454310|FG000|Overall Study|Did not complete 1 crse of therapy|0
4602029|NCT01624090|7454311|FG001|Overall Study|Did not complete 1 crse of therapy|0
4602030|NCT01624090|7454312|FG002|Overall Study|Did not complete 1 crse of therapy|2
4602031|NCT01624090|7454313|FG003|Overall Study|Did not complete 1 crse of therapy|0
4602032|NCT01624090|7454310|FG000|Overall Study|Dose escalated|0
4602033|NCT01624090|7454311|FG001|Overall Study|Dose escalated|0
4602034|NCT01624090|7454312|FG002|Overall Study|Dose escalated|3
4602035|NCT01624090|7454313|FG003|Overall Study|Dose escalated|0
4602036|NCT01624142|7454325|FG000|Overall Study|Withdrawal by Subject|14
4602037|NCT01624142|7454326|FG001|Overall Study|Withdrawal by Subject|4
4602038|NCT01624142|7454325|FG000|Overall Study|Death|3
4602039|NCT01624142|7454326|FG001|Overall Study|Death|6
4602040|NCT01624142|7454325|FG000|Overall Study|Study Closure|12
4602041|NCT01624142|7454326|FG001|Overall Study|Study Closure|6
4602042|NCT01624142|7454325|FG000|Overall Study|Lost to Follow-up|2
4602043|NCT01624142|7454326|FG001|Overall Study|Lost to Follow-up|0
4602044|NCT01624142|7454325|FG000|Overall Study|Other|1
4602045|NCT01624142|7454326|FG001|Overall Study|Other|0
4602046|NCT01624194|7454348|FG000|Overall Study|Lost to Follow-up|1
4602047|NCT01624194|7454349|FG001|Overall Study|Lost to Follow-up|0
4602048|NCT01624194|7454348|FG000|Overall Study|Withdrawal by Subject|1
4602049|NCT01624194|7454349|FG001|Overall Study|Withdrawal by Subject|0
4602050|NCT01624233|7454356|FG000|Period 2 - Induction|Adverse Event|1
4602051|NCT01624233|7454356|FG000|Period 3 - Maintenance|Adverse Event|2
4602052|NCT01624233|7454356|FG000|Period 3 - Maintenance|Lack of Efficacy|1
4602053|NCT01624233|7454356|FG000|Period 3 - Maintenance|Physician Decision|2
4635779|NCT01937130|7507557|FG000|Overall Study|Patients unable to swallow|0
4635780|NCT01937130|7507558|FG001|Overall Study|Patients unable to swallow|1
4635781|NCT01937130|7507559|FG002|Overall Study|Patients unable to swallow|0
4635782|NCT01937130|7507560|FG003|Overall Study|Patients unable to swallow|0
4635783|NCT01937130|7507557|FG000|Overall Study|Patient lost to FU due to death|2
4635784|NCT01937130|7507558|FG001|Overall Study|Patient lost to FU due to death|0
4602054|NCT01624233|7454356|FG000|Period 3 - Maintenance|Withdrawal by Subject|2
4602055|NCT01624233|7454356|FG000|Period 4 - Drug Free Period|Relapsed|61
4602056|NCT01624233|7454356|FG000|Period 5 - Retreatment Period|Adverse Event|5
4602057|NCT01624233|7454356|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1
4602058|NCT01624233|7454356|FG000|Period 5 - Retreatment Period|Physician Decision|1
4602059|NCT01624233|7454356|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3
4602060|NCT01624233|7454356|FG000|Period 6: Follow-up|Adverse Event|3
4602061|NCT01624233|7454356|FG000|Period 6: Follow-up|Lack of Efficacy|2
4602062|NCT01624233|7454356|FG000|Period 6: Follow-up|Physician Decision|1
4602063|NCT01624233|7454356|FG000|Period 6: Follow-up|Withdrawal by Subject|3
4602064|NCT01624259|7454366|FG000|Overall Study|Adverse Event|18
4602065|NCT01624259|7454367|FG001|Overall Study|Adverse Event|18
4602066|NCT01624259|7454366|FG000|Overall Study|Protocol Violation|1
4602067|NCT01624259|7454367|FG001|Overall Study|Protocol Violation|2
4602068|NCT01624259|7454366|FG000|Overall Study|Withdrawal by Subject|5
4602069|NCT01624259|7454367|FG001|Overall Study|Withdrawal by Subject|7
4602070|NCT01624259|7454366|FG000|Overall Study|Physician Decision|1
4602071|NCT01624259|7454367|FG001|Overall Study|Physician Decision|1
4602072|NCT01624259|7454366|FG000|Overall Study|Lost to Follow-up|2
4602073|NCT01624259|7454367|FG001|Overall Study|Lost to Follow-up|3
4602074|NCT01624259|7454366|FG000|Overall Study|Abnormal laboratory measure|3
4602075|NCT01624259|7454367|FG001|Overall Study|Abnormal laboratory measure|0
4602076|NCT01624467|7454399|FG000|Overall Study|Withdrawal by Subject|2
4602077|NCT01624467|7454399|FG000|Overall Study|Lost to Follow-up|1
4602078|NCT01624467|7454399|FG000|Overall Study|Adverse Event|7
4602079|NCT01624467|7454399|FG000|Overall Study|Progressive Disease|19
4602080|NCT01624467|7454399|FG000|Overall Study|Per Sponsor Requirement|1
4602081|NCT01624467|7454399|FG000|Overall Study|Subject Withdrew from Treatment|1
4602082|NCT01624506|7454407|FG000|Overall Study|Lost to Follow-up|29
4602083|NCT01624506|7454408|FG001|Overall Study|Lost to Follow-up|15
4602084|NCT01624506|7454407|FG000|Overall Study|Withdrawal by Subject|9
4602085|NCT01624506|7454408|FG001|Overall Study|Withdrawal by Subject|2
4602086|NCT01624506|7454407|FG000|Overall Study|Death|1
4602087|NCT01624506|7454408|FG001|Overall Study|Death|0
4602088|NCT01624506|7454407|FG000|Overall Study|LINX explants|23
4602089|NCT01624506|7454408|FG001|Overall Study|LINX explants|0
4602090|NCT01624506|7454407|FG000|Overall Study|Adverse Event|3
4602091|NCT01624506|7454408|FG001|Overall Study|Adverse Event|0
4602092|NCT01624662|7454418|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2
4602093|NCT01624662|7454419|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1
4602094|NCT01624662|7454420|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1
4602095|NCT01624662|7454421|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0
4602096|NCT01624662|7454418|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5
4602097|NCT01624662|7454419|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1
4602098|NCT01624662|7454420|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0
4602099|NCT01624662|7454421|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0
4602100|NCT01624662|7454418|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
4602101|NCT01624662|7454419|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1
4602102|NCT01624662|7454420|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
4602103|NCT01624662|7454421|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
4602104|NCT01624662|7454418|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3
4602105|NCT01624662|7454419|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0
4602106|NCT01624662|7454420|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3
4602107|NCT01624662|7454421|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0
4602108|NCT01624662|7454418|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
4602109|NCT01624662|7454419|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
4602110|NCT01624662|7454420|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0
4602111|NCT01624662|7454421|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
4602112|NCT01624662|7454418|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
4602113|NCT01624662|7454419|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1
4602114|NCT01624662|7454420|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
4602115|NCT01624662|7454421|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
4602116|NCT01624662|7454418|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
4602117|NCT01624662|7454419|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
4602118|NCT01624662|7454420|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1
4602119|NCT01624662|7454421|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
4602120|NCT01624870|7454442|FG000|Overall Study|Death|19
4602121|NCT01624870|7454442|FG000|Overall Study|Withdrawal by Subject|1
4602122|NCT01624870|7454442|FG000|Overall Study|CoreValve not implanted|6
4602123|NCT01624870|7454442|FG000|Overall Study|Lost to follow up|1
4602124|NCT01624974|7454473|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0
4602125|NCT01624974|7454474|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2
4602126|NCT01624974|7454473|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1
4602127|NCT01624974|7454474|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2
4602128|NCT01624974|7454473|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5
4602129|NCT01624974|7454474|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3
4602130|NCT01624974|7454473|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1
4602131|NCT01624974|7454474|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0
4602132|NCT01624974|7454473|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0
4602133|NCT01624974|7454474|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1
4602134|NCT01624974|7454473|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1
4602135|NCT01624974|7454474|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1
4602136|NCT01624974|7454473|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0
4602137|NCT01624974|7454474|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1
4602138|NCT01624974|7454473|FG000|Period IV Washout (4 Weeks)|Adverse Event|2
4602139|NCT01624974|7454474|FG001|Period IV Washout (4 Weeks)|Adverse Event|0
4602140|NCT01624974|7454473|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0
4602141|NCT01624974|7454474|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1
4602142|NCT01624974|7454473|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1
4602143|NCT01624974|7454474|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0
4602144|NCT01624974|7454473|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3
4602145|NCT01624974|7454474|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0
4602146|NCT01624974|7454473|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1
4602147|NCT01624974|7454474|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0
4602148|NCT01625000|7454486|FG000|Overall Study|Physician Decision|15
4602149|NCT01625000|7454487|FG001|Overall Study|Physician Decision|7
4602150|NCT01625000|7454488|FG002|Overall Study|Physician Decision|7
4602151|NCT01625000|7454489|FG003|Overall Study|Physician Decision|2
4602152|NCT01625000|7454490|FG004|Overall Study|Physician Decision|15
4602153|NCT01625000|7454486|FG000|Overall Study|Protocol Violation|3
4602154|NCT01625000|7454487|FG001|Overall Study|Protocol Violation|10
4602155|NCT01625000|7454488|FG002|Overall Study|Protocol Violation|4
4602156|NCT01625000|7454489|FG003|Overall Study|Protocol Violation|1
4602157|NCT01625000|7454490|FG004|Overall Study|Protocol Violation|2
4602158|NCT01625000|7454486|FG000|Overall Study|Withdrawal by Subject|19
4602159|NCT01625000|7454487|FG001|Overall Study|Withdrawal by Subject|16
4602160|NCT01625000|7454488|FG002|Overall Study|Withdrawal by Subject|11
4602161|NCT01625000|7454489|FG003|Overall Study|Withdrawal by Subject|9
4602162|NCT01625000|7454490|FG004|Overall Study|Withdrawal by Subject|17
4602163|NCT01625000|7454486|FG000|Overall Study|Adverse Event (including Death)|15
4602164|NCT01625000|7454487|FG001|Overall Study|Adverse Event (including Death)|19
4602165|NCT01625000|7454488|FG002|Overall Study|Adverse Event (including Death)|11
4602166|NCT01625000|7454489|FG003|Overall Study|Adverse Event (including Death)|7
4602167|NCT01625000|7454490|FG004|Overall Study|Adverse Event (including Death)|21
4602168|NCT01625091|7454509|FG000|Intervention|Death|1
4602169|NCT01625091|7454510|FG001|Intervention|Death|1
4602170|NCT01625091|7454509|FG000|Intervention|Withdrawal by Subject|4
4602171|NCT01625091|7454510|FG001|Intervention|Withdrawal by Subject|1
4602172|NCT01625091|7454509|FG000|Intervention|Adverse Event|0
4602173|NCT01625091|7454510|FG001|Intervention|Adverse Event|2
4602174|NCT01625091|7454509|FG000|Intervention|Lost to Follow-up|4
4602175|NCT01625091|7454510|FG001|Intervention|Lost to Follow-up|4
4602176|NCT01625091|7454509|FG000|Intervention|Study termination|2
4602177|NCT01625091|7454510|FG001|Intervention|Study termination|3
4602178|NCT01625091|7454509|FG000|Post-intervention|Death|0
4602179|NCT01625091|7454510|FG001|Post-intervention|Death|1
4602180|NCT01625091|7454509|FG000|Post-intervention|Lost to Follow-up|2
4602181|NCT01625091|7454510|FG001|Post-intervention|Lost to Follow-up|0
4602182|NCT01625091|7454509|FG000|Post-intervention|Study termination|2
4602183|NCT01625091|7454510|FG001|Post-intervention|Study termination|1
4602184|NCT01625182|7454531|FG000|Overall Study|Administrative problems|1
4602185|NCT01625182|7454532|FG001|Overall Study|Administrative problems|0
4602186|NCT01625182|7454531|FG000|Overall Study|Protocol deviation|0
4602187|NCT01625182|7454532|FG001|Overall Study|Protocol deviation|2
4602188|NCT01625182|7454531|FG000|Overall Study|Adverse Event|2
4602189|NCT01625182|7454532|FG001|Overall Study|Adverse Event|0
4602190|NCT01625182|7454531|FG000|Overall Study|Withdrawal by Subject|5
4602191|NCT01625182|7454532|FG001|Overall Study|Withdrawal by Subject|1
4602192|NCT01625182|7454531|FG000|Overall Study|Lack of Efficacy|12
4602193|NCT01625182|7454532|FG001|Overall Study|Lack of Efficacy|8
4602194|NCT01625338|7454546|FG000|Overall Study|Enrolled but not Treated|0
4602195|NCT01625338|7454547|FG001|Overall Study|Enrolled but not Treated|0
4602196|NCT01625338|7454548|FG002|Overall Study|Enrolled but not Treated|1
4602197|NCT01625338|7454546|FG000|Overall Study|Efficacy Failure|27
4602198|NCT01625338|7454547|FG001|Overall Study|Efficacy Failure|39
4602199|NCT01625338|7454548|FG002|Overall Study|Efficacy Failure|31
4602200|NCT01625338|7454546|FG000|Overall Study|Lost to Follow-up|3
4602201|NCT01625338|7454547|FG001|Overall Study|Lost to Follow-up|3
4602202|NCT01625338|7454548|FG002|Overall Study|Lost to Follow-up|2
4602203|NCT01625338|7454546|FG000|Overall Study|Investigator Decision|0
4602204|NCT01625338|7454547|FG001|Overall Study|Investigator Decision|2
4602205|NCT01625338|7454548|FG002|Overall Study|Investigator Decision|1
4602206|NCT01625338|7454546|FG000|Overall Study|Subject Withdrew Consent|1
4602207|NCT01625338|7454547|FG001|Overall Study|Subject Withdrew Consent|0
4602208|NCT01625338|7454548|FG002|Overall Study|Subject Withdrew Consent|2
4602209|NCT01625338|7454546|FG000|Overall Study|Adverse Event|1
4602210|NCT01625338|7454547|FG001|Overall Study|Adverse Event|0
4602211|NCT01625338|7454548|FG002|Overall Study|Adverse Event|1
4602212|NCT01625338|7454546|FG000|Overall Study|Study Discontinued by Sponsor|0
4602213|NCT01625338|7454547|FG001|Overall Study|Study Discontinued by Sponsor|0
4602214|NCT01625338|7454548|FG002|Overall Study|Study Discontinued by Sponsor|1
4602215|NCT01625377|7454558|FG000|Overall Study|Death|1
4602216|NCT01625377|7454559|FG001|Overall Study|Death|1
4602217|NCT01625377|7454558|FG000|Overall Study|Administrative Problem|1
4602218|NCT01625377|7454559|FG001|Overall Study|Administrative Problem|1
4602219|NCT01625377|7454558|FG000|Overall Study|Protocol Violation|0
4602220|NCT01625377|7454559|FG001|Overall Study|Protocol Violation|3
4602221|NCT01625377|7454558|FG000|Overall Study|Adverse Event|3
4602222|NCT01625377|7454559|FG001|Overall Study|Adverse Event|16
4602223|NCT01625377|7454558|FG000|Overall Study|Graft loss|1
4602224|NCT01625377|7454559|FG001|Overall Study|Graft loss|0
4602225|NCT01625377|7454558|FG000|Overall Study|Unsatisfactory therapeutic effect|0
4602226|NCT01625377|7454559|FG001|Overall Study|Unsatisfactory therapeutic effect|1
4602227|NCT01625377|7454558|FG000|Overall Study|Abnormal laboratory values|1
4602228|NCT01625377|7454559|FG001|Overall Study|Abnormal laboratory values|0
4602229|NCT01625689|7454591|FG000|Overall Study|Migration|2
4602230|NCT01625689|7454592|FG001|Overall Study|Migration|1
4602231|NCT01625845|7454600|FG000|Overall Study|Adverse Event|1
4602232|NCT01625845|7454601|FG001|Overall Study|Adverse Event|2
4602233|NCT01625845|7454600|FG000|Overall Study|Lost to Follow-up|2
4602234|NCT01625845|7454601|FG001|Overall Study|Lost to Follow-up|1
4602235|NCT01625845|7454600|FG000|Overall Study|Withdrawal by Subject|2
4602236|NCT01625845|7454601|FG001|Overall Study|Withdrawal by Subject|0
4602237|NCT01625897|7454609|FG000|Overall Study|Adverse Event|27
4602238|NCT01625897|7454610|FG001|Overall Study|Adverse Event|10
4602239|NCT01625897|7454609|FG000|Overall Study|Physician Decision|0
4602240|NCT01625897|7454610|FG001|Overall Study|Physician Decision|1
4602241|NCT01625897|7454609|FG000|Overall Study|Withdrawal by Subject|25
4602242|NCT01625897|7454610|FG001|Overall Study|Withdrawal by Subject|3
4602243|NCT01625910|7454618|FG000|Overall Study|Lost to Follow-up|3
4602244|NCT01625910|7454619|FG001|Overall Study|Lost to Follow-up|4
4602245|NCT01625988|7454634|FG000|Overall Study|Lost to Follow-up|5
4602246|NCT01625988|7454635|FG001|Overall Study|Lost to Follow-up|6
4602247|NCT01625988|7454634|FG000|Overall Study|Withdrawal by Subject|8
4602248|NCT01625988|7454635|FG001|Overall Study|Withdrawal by Subject|3
4602249|NCT01625988|7454634|FG000|Overall Study|Adverse Event|0
4602250|NCT01625988|7454635|FG001|Overall Study|Adverse Event|1
4602251|NCT01625988|7454634|FG000|Overall Study|Lack of Efficacy|0
4602252|NCT01625988|7454635|FG001|Overall Study|Lack of Efficacy|1
4602253|NCT01625988|7454634|FG000|Overall Study|Randomized Inappropriately|1
4602254|NCT01625988|7454635|FG001|Overall Study|Randomized Inappropriately|0
4602255|NCT01625988|7454634|FG000|Overall Study|Protocol Violation|0
4602256|NCT01625988|7454635|FG001|Overall Study|Protocol Violation|2
4602257|NCT01626079|7454646|FG000|Overall Study|Death|78
4602258|NCT01626079|7454647|FG001|Overall Study|Death|115
4602259|NCT01626079|7454646|FG000|Overall Study|Withdrawal by Subject|12
4602260|NCT01626079|7454647|FG001|Overall Study|Withdrawal by Subject|29
4602261|NCT01626079|7454646|FG000|Overall Study|Lost to Follow-up|3
4602262|NCT01626079|7454647|FG001|Overall Study|Lost to Follow-up|3
4602263|NCT01626079|7454646|FG000|Overall Study|Visits Expected or Not Due|74
4602264|NCT01626079|7454647|FG001|Overall Study|Visits Expected or Not Due|69
4602265|NCT01626118|7454662|FG000|Overall Study|Lack of Efficacy|1
4602266|NCT01626118|7454663|FG001|Overall Study|Lack of Efficacy|0
4602267|NCT01626118|7454664|FG002|Overall Study|Lack of Efficacy|1
4602268|NCT01626118|7454665|FG003|Overall Study|Lack of Efficacy|3
4602269|NCT01626118|7454662|FG000|Overall Study|Lost to Follow-up|1
4602270|NCT01626118|7454663|FG001|Overall Study|Lost to Follow-up|0
4602271|NCT01626118|7454664|FG002|Overall Study|Lost to Follow-up|0
4602272|NCT01626118|7454665|FG003|Overall Study|Lost to Follow-up|0
4602273|NCT01626118|7454662|FG000|Overall Study|Adverse Event|0
4602274|NCT01626118|7454663|FG001|Overall Study|Adverse Event|1
4602275|NCT01626118|7454664|FG002|Overall Study|Adverse Event|1
4602276|NCT01626118|7454665|FG003|Overall Study|Adverse Event|0
4635785|NCT01937130|7507559|FG002|Overall Study|Patient lost to FU due to death|0
4602277|NCT01626118|7454662|FG000|Overall Study|Investigator Decision|0
4602278|NCT01626118|7454663|FG001|Overall Study|Investigator Decision|1
4602279|NCT01626118|7454664|FG002|Overall Study|Investigator Decision|0
4602280|NCT01626118|7454665|FG003|Overall Study|Investigator Decision|0
4602281|NCT01626352|7454675|FG000|Overall Study|Disease Progression|3
4602282|NCT01626352|7454675|FG000|Overall Study|Intercurrent Illness|2
4602283|NCT01626352|7454675|FG000|Overall Study|Death|2
4602284|NCT01626352|7454675|FG000|Overall Study|Withdrawal by Subject|1
4602285|NCT01626352|7454675|FG000|Overall Study|Non-Compliance|1
4602286|NCT01626352|7454675|FG000|Overall Study|Never Treated|1
4602287|NCT01626391|7454684|FG000|Overall Study|Physician Decision|1
4602288|NCT01626391|7454685|FG001|Overall Study|Physician Decision|0
4602289|NCT01626391|7454684|FG000|Overall Study|Withdrawal by Subject|1
4602290|NCT01626391|7454685|FG001|Overall Study|Withdrawal by Subject|0
4602291|NCT01626456|7454693|FG000|Overall Study|Withdrawal by Subject|21
4602292|NCT01626456|7454694|FG001|Overall Study|Withdrawal by Subject|46
4602293|NCT01626456|7454693|FG000|Overall Study|Adverse Event|2
4602294|NCT01626456|7454694|FG001|Overall Study|Adverse Event|27
4602295|NCT01626456|7454693|FG000|Overall Study|Lost to Follow-up|2
4602296|NCT01626456|7454694|FG001|Overall Study|Lost to Follow-up|27
4602297|NCT01626456|7454693|FG000|Overall Study|Lack of Efficacy|6
4602298|NCT01626456|7454694|FG001|Overall Study|Lack of Efficacy|7
4602299|NCT01626456|7454693|FG000|Overall Study|Physician Decision|1
4602300|NCT01626456|7454694|FG001|Overall Study|Physician Decision|4
4602301|NCT01626456|7454693|FG000|Overall Study|Protocol Violation|1
4602302|NCT01626456|7454694|FG001|Overall Study|Protocol Violation|1
4602303|NCT01626456|7454693|FG000|Overall Study|Site Closure|2
4602304|NCT01626456|7454694|FG001|Overall Study|Site Closure|3
4602305|NCT01626456|7454693|FG000|Overall Study|Incarceration|0
4602306|NCT01626456|7454694|FG001|Overall Study|Incarceration|2
4602307|NCT01626495|7454709|FG000|Overall Study|Adverse Event|3
4602308|NCT01626495|7454709|FG000|Overall Study|Disease progression|27
4602309|NCT01626495|7454709|FG000|Overall Study|Withdrawal by Subject|1
4602310|NCT01626495|7454709|FG000|Overall Study|Administrative problem|1
4602311|NCT01626495|7454709|FG000|Overall Study|Death|2
4602312|NCT01626495|7454709|FG000|Overall Study|Physician Decision|1
4602313|NCT01626495|7454709|FG000|Overall Study|New cancer therapy|16
4602314|NCT01626495|7454709|FG000|Overall Study|Manufacturing failure|1
4602315|NCT01626690|7454726|FG000|Overall Study|Protocol Violation|1
4602316|NCT01626690|7454727|FG001|Overall Study|Protocol Violation|0
4602317|NCT01626690|7454726|FG000|Overall Study|Adverse Event|1
4602318|NCT01626690|7454727|FG001|Overall Study|Adverse Event|0
4602319|NCT01626859|7454748|FG000|Overall Study|Adverse Event|1
4602320|NCT01626859|7454749|FG001|Overall Study|Adverse Event|3
4602321|NCT01626859|7454750|FG002|Overall Study|Adverse Event|2
4602322|NCT01626859|7454748|FG000|Overall Study|Physician Decision|0
4602323|NCT01626859|7454749|FG001|Overall Study|Physician Decision|1
4602324|NCT01626859|7454750|FG002|Overall Study|Physician Decision|0
4602325|NCT01626859|7454748|FG000|Overall Study|Withdrawal by Subject|1
4602326|NCT01626859|7454749|FG001|Overall Study|Withdrawal by Subject|4
4602327|NCT01626859|7454750|FG002|Overall Study|Withdrawal by Subject|2
4602328|NCT01626872|7454761|FG000|Overall Study|Physician Decision|13
4602329|NCT01626872|7454762|FG001|Overall Study|Physician Decision|9
4602330|NCT01626872|7454763|FG002|Overall Study|Physician Decision|6
4602331|NCT01626872|7454761|FG000|Overall Study|Withdrawal by Subject|19
4602332|NCT01626872|7454762|FG001|Overall Study|Withdrawal by Subject|27
4602333|NCT01626872|7454763|FG002|Overall Study|Withdrawal by Subject|8
4602334|NCT01626872|7454761|FG000|Overall Study|Adverse Event (including Death)|20
4602335|NCT01626872|7454762|FG001|Overall Study|Adverse Event (including Death)|28
4602336|NCT01626872|7454763|FG002|Overall Study|Adverse Event (including Death)|8
4602337|NCT01626872|7454761|FG000|Overall Study|Protocol Violation (including Pregnancy)|0
4602338|NCT01626872|7454762|FG001|Overall Study|Protocol Violation (including Pregnancy)|2
4602339|NCT01626872|7454763|FG002|Overall Study|Protocol Violation (including Pregnancy)|2
4602340|NCT01626885|7454771|FG000|Overall Study|Adverse Event|8
4602341|NCT01626885|7454771|FG000|Overall Study|Withdrawal by Subject|4
4602342|NCT01626989|7454775|FG000|Screening Period|Screen Failure|15
4602343|NCT01626989|7454776|FG001|Screening Period|Screen Failure|0
4602344|NCT01626989|7454777|FG002|Screening Period|Screen Failure|0
4602345|NCT01626989|7454775|FG000|Screening Period|Withdrawal by Subject|2
4602346|NCT01626989|7454776|FG001|Screening Period|Withdrawal by Subject|0
4602347|NCT01626989|7454777|FG002|Screening Period|Withdrawal by Subject|0
4602348|NCT01627067|7454823|FG000|Overall Study|Screen Failure|1
4602349|NCT01627249|7454832|FG000|Overall Study|Death|3
4602350|NCT01627249|7454833|FG001|Overall Study|Death|5
4602351|NCT01627249|7454834|FG002|Overall Study|Death|3
4602352|NCT01627249|7454832|FG000|Overall Study|Withdrawal by Subject|12
4602353|NCT01627249|7454833|FG001|Overall Study|Withdrawal by Subject|6
4602354|NCT01627249|7454834|FG002|Overall Study|Withdrawal by Subject|9
4602355|NCT01627249|7454832|FG000|Overall Study|Missed Visit|1
4602356|NCT01627249|7454833|FG001|Overall Study|Missed Visit|1
4602357|NCT01627249|7454834|FG002|Overall Study|Missed Visit|0
4602358|NCT01627327|7454863|FG000|Overall Study|Adverse Event|6
4602359|NCT01627327|7454864|FG001|Overall Study|Adverse Event|12
4602360|NCT01627327|7454863|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0
4602361|NCT01627327|7454864|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2
4602362|NCT01627327|7454863|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4
4602363|NCT01627327|7454864|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9
4602364|NCT01627327|7454863|FG000|Overall Study|Protocol Violation|4
4602365|NCT01627327|7454864|FG001|Overall Study|Protocol Violation|10
4602366|NCT01627327|7454863|FG000|Overall Study|Lost to Follow-up|1
4602367|NCT01627327|7454864|FG001|Overall Study|Lost to Follow-up|3
4602368|NCT01627327|7454863|FG000|Overall Study|Physician Decision|1
4602369|NCT01627327|7454864|FG001|Overall Study|Physician Decision|0
4602370|NCT01627327|7454863|FG000|Overall Study|Withdrawal by Subject|3
4602371|NCT01627327|7454864|FG001|Overall Study|Withdrawal by Subject|3
4602372|NCT01627340|7454872|FG000|Overall Study|Adverse Event|1
4602373|NCT01627340|7454873|FG001|Overall Study|Adverse Event|0
4602374|NCT01627340|7454872|FG000|Overall Study|Lost to Follow-up|8
4602375|NCT01627340|7454873|FG001|Overall Study|Lost to Follow-up|4
4602376|NCT01627340|7454872|FG000|Overall Study|Pregnancy|1
4602377|NCT01627340|7454873|FG001|Overall Study|Pregnancy|0
4602378|NCT01627340|7454872|FG000|Overall Study|Withdrawal by Subject|2
4602379|NCT01627340|7454873|FG001|Overall Study|Withdrawal by Subject|0
4602380|NCT01627574|7454883|FG000|Overall Study|Withdrawal by Subject|8
4602381|NCT01627574|7454884|FG001|Overall Study|Withdrawal by Subject|5
4602382|NCT01627574|7454883|FG000|Overall Study|Lost to Follow-up|13
4602383|NCT01627574|7454884|FG001|Overall Study|Lost to Follow-up|13
4635786|NCT01937130|7507560|FG003|Overall Study|Patient lost to FU due to death|0
4635787|NCT01937299|7507585|FG000|Overall Study|Adverse Event|13
4635788|NCT01937299|7507586|FG001|Overall Study|Adverse Event|0
4635789|NCT01937299|7507585|FG000|Overall Study|Lack of Efficacy|0
4635790|NCT01937299|7507586|FG001|Overall Study|Lack of Efficacy|4
4635791|NCT01937299|7507585|FG000|Overall Study|Withdrawal by Subject|1
4635792|NCT01937299|7507586|FG001|Overall Study|Withdrawal by Subject|0
4635793|NCT01937312|7507595|FG000|Overall Study|Adverse Event|10
4635794|NCT01937312|7507596|FG001|Overall Study|Adverse Event|1
4635795|NCT01937312|7507595|FG000|Overall Study|Lack of Efficacy|0
4635796|NCT01937312|7507596|FG001|Overall Study|Lack of Efficacy|1
4635797|NCT01937312|7507595|FG000|Overall Study|Withdrawal of subject prior to treatment|1
4635798|NCT01937312|7507596|FG001|Overall Study|Withdrawal of subject prior to treatment|1
4635799|NCT01937351|7507605|FG000|Overall Study|Withdrawal by Subject|4
4635800|NCT01937351|7507606|FG001|Overall Study|Withdrawal by Subject|2
4635801|NCT01937351|7507605|FG000|Overall Study|Death|1
4635802|NCT01937351|7507606|FG001|Overall Study|Death|0
4635803|NCT01937351|7507605|FG000|Overall Study|Not treated w device, per protocol fail|4
4635804|NCT01937351|7507606|FG001|Overall Study|Not treated w device, per protocol fail|0
4635805|NCT01937364|7507613|FG000|Overall Study|Adverse Event|2
4635806|NCT01937364|7507614|FG001|Overall Study|Adverse Event|1
4635807|NCT01937390|7507620|FG000|Overall Study|Death|2
4635808|NCT01937390|7507620|FG000|Overall Study|Lost to Follow-up|7
4635809|NCT01937390|7507620|FG000|Overall Study|Withdrawal by Subject|5
4635810|NCT01937390|7507620|FG000|Overall Study|Fail to return|21
4635811|NCT01937559|7507637|FG000|Overall Study|Physician Decision|3
4635812|NCT01937559|7507638|FG001|Overall Study|Physician Decision|3
4635813|NCT01937559|7507639|FG002|Overall Study|Physician Decision|0
4635814|NCT01937559|7507637|FG000|Overall Study|Withdrawal by Subject|6
4635815|NCT01937559|7507638|FG001|Overall Study|Withdrawal by Subject|4
4635816|NCT01937559|7507639|FG002|Overall Study|Withdrawal by Subject|0
4635817|NCT01937559|7507637|FG000|Overall Study|screen fail|2
4635818|NCT01937559|7507638|FG001|Overall Study|screen fail|4
4635819|NCT01937559|7507639|FG002|Overall Study|screen fail|0
4746593|NCT00645567|7718441|FG000|Overall Study|Adverse Event|1
4746594|NCT00637806|7718452|FG000|Double-blind Phase|Study Discontinued|2
4746595|NCT00637806|7718453|FG001|Double-blind Phase|Study Discontinued|0
4746596|NCT00637806|7718454|FG002|Double-blind Phase|Study Discontinued|1
4746597|NCT00637806|7718455|FG003|Double-blind Phase|Study Discontinued|0
4746598|NCT00637806|7718452|FG000|Extension Phase|Study Discontinued|0
4746599|NCT00637806|7718453|FG001|Extension Phase|Study Discontinued|0
4746600|NCT00637806|7718454|FG002|Extension Phase|Study Discontinued|0
4746601|NCT00637806|7718455|FG003|Extension Phase|Study Discontinued|1
4746602|NCT00629798|7718480|FG000|Overall Study|Not Treated|4
4746603|NCT00637728|7718490|FG000|Double-blind Phase|Adverse Event|1
4746604|NCT00637728|7718491|FG001|Double-blind Phase|Adverse Event|0
4746605|NCT00637728|7718492|FG002|Double-blind Phase|Adverse Event|0
4746606|NCT00637728|7718490|FG000|Double-blind Phase|Non-compliance|2
4746607|NCT00637728|7718491|FG001|Double-blind Phase|Non-compliance|0
4746608|NCT00637728|7718492|FG002|Double-blind Phase|Non-compliance|0
4746609|NCT00637728|7718490|FG000|Double-blind Phase|Study Discontinued|1
4746610|NCT00637728|7718491|FG001|Double-blind Phase|Study Discontinued|1
4746611|NCT00637728|7718492|FG002|Double-blind Phase|Study Discontinued|0
4746612|NCT00637416|7718527|FG000|Overall Study|Lost to Follow-up|1
4746613|NCT00637416|7718528|FG001|Overall Study|Lost to Follow-up|1
4746614|NCT00637416|7718527|FG000|Overall Study|Unable to take study drug|0
4746615|NCT00637416|7718528|FG001|Overall Study|Unable to take study drug|1
4746616|NCT00631137|7718578|FG000|Overall Study|Withdrawal by Subject|1
4746617|NCT00631137|7718579|FG001|Overall Study|Withdrawal by Subject|0
4746618|NCT00633061|7718596|FG000|Overall Study|Study closed|86
4746619|NCT00633061|7718597|FG001|Overall Study|Study closed|0
4746620|NCT00630292|7718609|FG000|Overall Study|Withdrawal by Subject|1
4746621|NCT00634010|7718615|FG000|Overall Study|Adverse Event|2
4746622|NCT00634010|7718616|FG001|Overall Study|Adverse Event|5
4602384|NCT01627691|7454890|FG000|Overall Study|Death|11
4602385|NCT01627691|7454890|FG000|Overall Study|Lost to Follow-up|3
4602386|NCT01627691|7454890|FG000|Overall Study|Withdrawal by Subject|1
4602387|NCT01627691|7454890|FG000|Overall Study|Missed the visit|3
4602388|NCT01627782|7454898|FG000|Overall Study|Adverse Event|1
4602389|NCT01627782|7454899|FG001|Overall Study|Adverse Event|2
4602390|NCT01627782|7454900|FG002|Overall Study|Adverse Event|0
4602391|NCT01627782|7454901|FG003|Overall Study|Adverse Event|1
4602392|NCT01627782|7454898|FG000|Overall Study|Lack of Efficacy|11
4602393|NCT01627782|7454899|FG001|Overall Study|Lack of Efficacy|1
4602394|NCT01627782|7454900|FG002|Overall Study|Lack of Efficacy|15
4602395|NCT01627782|7454901|FG003|Overall Study|Lack of Efficacy|2
4602396|NCT01627782|7454898|FG000|Overall Study|Protocol Violation|1
4602397|NCT01627782|7454899|FG001|Overall Study|Protocol Violation|0
4602398|NCT01627782|7454900|FG002|Overall Study|Protocol Violation|0
4602399|NCT01627782|7454901|FG003|Overall Study|Protocol Violation|0
4602400|NCT01627782|7454898|FG000|Overall Study|Withdrawal by Subject|2
4602401|NCT01627782|7454899|FG001|Overall Study|Withdrawal by Subject|1
4602402|NCT01627782|7454900|FG002|Overall Study|Withdrawal by Subject|0
4602403|NCT01627782|7454901|FG003|Overall Study|Withdrawal by Subject|0
4602404|NCT01627782|7454898|FG000|Overall Study|Other|0
4602405|NCT01627782|7454899|FG001|Overall Study|Other|2
4602406|NCT01627782|7454900|FG002|Overall Study|Other|0
4602407|NCT01627782|7454901|FG003|Overall Study|Other|3
4602408|NCT01627782|7454898|FG000|Overall Study|Randomized But Not Treated|1
4602409|NCT01627782|7454899|FG001|Overall Study|Randomized But Not Treated|0
4602410|NCT01627782|7454900|FG002|Overall Study|Randomized But Not Treated|0
4602411|NCT01627782|7454901|FG003|Overall Study|Randomized But Not Treated|0
4602412|NCT01627860|7454915|FG000|Overall Study|Adverse Event|9
4602413|NCT01627860|7454916|FG001|Overall Study|Adverse Event|4
4602414|NCT01627860|7454915|FG000|Overall Study|Withdrawal by Subject|2
4602415|NCT01627860|7454916|FG001|Overall Study|Withdrawal by Subject|1
4602416|NCT01627860|7454915|FG000|Overall Study|Seizure frequency doubled|0
4602417|NCT01627860|7454916|FG001|Overall Study|Seizure frequency doubled|1
4602418|NCT01627860|7454915|FG000|Overall Study|Protocol Violation|1
4602419|NCT01627860|7454916|FG001|Overall Study|Protocol Violation|0
4602420|NCT01628107|7454954|FG000|Overall Study|Withdrawal by Subject|17
4602421|NCT01628107|7454954|FG000|Overall Study|Lost to Follow-up|4
4602422|NCT01628107|7454954|FG000|Overall Study|Adverse Event|33
4602423|NCT01628107|7454954|FG000|Overall Study|Physician Decision|2
4602424|NCT01628107|7454954|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1
4602425|NCT01628107|7454954|FG000|Overall Study|Non-compliant with Study Procedures|10
4602426|NCT01628107|7454954|FG000|Overall Study|Not Treated|8
4602427|NCT01628107|7454954|FG000|Overall Study|Sponsor Decision|11
4602428|NCT01628107|7454954|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7
4602429|NCT01628107|7454954|FG000|Overall Study|Relocated|8
4602430|NCT01628107|7454954|FG000|Overall Study|Kidney Transplant|9
4602431|NCT01628107|7454954|FG000|Overall Study|Use of Standard of Care|9
4602432|NCT01628120|7454958|FG000|Overall Study|Withdrawal by Subject|7
4602433|NCT01628120|7454958|FG000|Overall Study|Adverse Event|12
4602434|NCT01628120|7454958|FG000|Overall Study|Lost to Follow-up|1
4602435|NCT01628120|7454958|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2
4602436|NCT01628120|7454958|FG000|Overall Study|Non-compliant with Study Procedures|1
4602437|NCT01628120|7454958|FG000|Overall Study|Not Treated|3
4602438|NCT01628120|7454958|FG000|Overall Study|Sponsor Decision|5
4602439|NCT01628120|7454958|FG000|Overall Study|Switched Dialysis Method|2
4602440|NCT01628120|7454958|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3
4602441|NCT01628120|7454958|FG000|Overall Study|Moved or Relocated|5
4602442|NCT01628120|7454958|FG000|Overall Study|Kidney Transplant|2
4602443|NCT01628120|7454958|FG000|Overall Study|Use of Standard of Care|1
4602444|NCT01628198|7454966|FG000|Overall Study|Lost to Follow-up|7
4602445|NCT01628198|7454966|FG000|Overall Study|Withdrawal by Subject|10
4602446|NCT01628198|7454966|FG000|Overall Study|Screen failure|1
4602447|NCT01628367|7454981|FG000|Overall Study|Adverse Event|1
4602448|NCT01628367|7454982|FG001|Overall Study|Adverse Event|0
4602449|NCT01628393|7454991|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1
4602450|NCT01628393|7454992|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0
4602451|NCT01628393|7454993|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0
4602452|NCT01628393|7454994|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0
4602453|NCT01628393|7454995|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0
4602454|NCT01628393|7454991|FG000|Placebo-controlled Treatment Period|Protocol Violation|0
4602455|NCT01628393|7454992|FG001|Placebo-controlled Treatment Period|Protocol Violation|1
4602456|NCT01628393|7454993|FG002|Placebo-controlled Treatment Period|Protocol Violation|0
4602457|NCT01628393|7454994|FG003|Placebo-controlled Treatment Period|Protocol Violation|0
4602458|NCT01628393|7454995|FG004|Placebo-controlled Treatment Period|Protocol Violation|0
4602459|NCT01628393|7454991|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2
4602460|NCT01628393|7454992|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1
4602461|NCT01628393|7454993|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1
4602462|NCT01628393|7454994|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0
4602463|NCT01628393|7454995|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0
4602464|NCT01628393|7454991|FG000|Blinded Active Extension Period|Adverse Event|0
4602465|NCT01628393|7454992|FG001|Blinded Active Extension Period|Adverse Event|1
4602466|NCT01628393|7454993|FG002|Blinded Active Extension Period|Adverse Event|0
4602467|NCT01628393|7454994|FG003|Blinded Active Extension Period|Adverse Event|2
4602468|NCT01628393|7454995|FG004|Blinded Active Extension Period|Adverse Event|2
4602469|NCT01628393|7454991|FG000|Blinded Active Extension Period|Lack of Efficacy|0
4602470|NCT01628393|7454992|FG001|Blinded Active Extension Period|Lack of Efficacy|0
4602471|NCT01628393|7454993|FG002|Blinded Active Extension Period|Lack of Efficacy|2
4602472|NCT01628393|7454994|FG003|Blinded Active Extension Period|Lack of Efficacy|0
4602473|NCT01628393|7454995|FG004|Blinded Active Extension Period|Lack of Efficacy|2
4602474|NCT01628393|7454991|FG000|Blinded Active Extension Period|Physician Decision|0
4602475|NCT01628393|7454992|FG001|Blinded Active Extension Period|Physician Decision|3
4602476|NCT01628393|7454993|FG002|Blinded Active Extension Period|Physician Decision|0
4602477|NCT01628393|7454994|FG003|Blinded Active Extension Period|Physician Decision|1
4602478|NCT01628393|7454995|FG004|Blinded Active Extension Period|Physician Decision|0
4602479|NCT01628393|7454991|FG000|Blinded Active Extension Period|Protocol Violation|0
4602480|NCT01628393|7454992|FG001|Blinded Active Extension Period|Protocol Violation|0
4602481|NCT01628393|7454993|FG002|Blinded Active Extension Period|Protocol Violation|2
4602482|NCT01628393|7454994|FG003|Blinded Active Extension Period|Protocol Violation|1
4602483|NCT01628393|7454995|FG004|Blinded Active Extension Period|Protocol Violation|0
4602484|NCT01628393|7454991|FG000|Blinded Active Extension Period|Withdrawal by Subject|0
4635820|NCT01937715|7507667|FG000|Overall Study|Death|0
4602485|NCT01628393|7454992|FG001|Blinded Active Extension Period|Withdrawal by Subject|6
4602486|NCT01628393|7454993|FG002|Blinded Active Extension Period|Withdrawal by Subject|2
4602487|NCT01628393|7454994|FG003|Blinded Active Extension Period|Withdrawal by Subject|0
4602488|NCT01628393|7454995|FG004|Blinded Active Extension Period|Withdrawal by Subject|2
4602489|NCT01628510|7455011|FG000|Overall Study|Withdrawal by Subject|0
4602490|NCT01628510|7455012|FG001|Overall Study|Withdrawal by Subject|4
4602491|NCT01628510|7455011|FG000|Overall Study|Death|3
4602492|NCT01628510|7455012|FG001|Overall Study|Death|1
4602493|NCT01628549|7455029|FG000|Overall Study|Adverse Event|1
4602494|NCT01628549|7455030|FG001|Overall Study|Adverse Event|1
4602495|NCT01628549|7455031|FG002|Overall Study|Adverse Event|0
4602496|NCT01628549|7455032|FG003|Overall Study|Adverse Event|4
4602497|NCT01628549|7455029|FG000|Overall Study|Lost to Follow-up|3
4602498|NCT01628549|7455030|FG001|Overall Study|Lost to Follow-up|4
4602499|NCT01628549|7455031|FG002|Overall Study|Lost to Follow-up|3
4602500|NCT01628549|7455032|FG003|Overall Study|Lost to Follow-up|3
4602501|NCT01628549|7455029|FG000|Overall Study|Withdrawal by Subject|3
4602502|NCT01628549|7455030|FG001|Overall Study|Withdrawal by Subject|4
4602503|NCT01628549|7455031|FG002|Overall Study|Withdrawal by Subject|4
4602504|NCT01628549|7455032|FG003|Overall Study|Withdrawal by Subject|1
4602505|NCT01628549|7455029|FG000|Overall Study|Protocol Violation|2
4602506|NCT01628549|7455030|FG001|Overall Study|Protocol Violation|1
4602507|NCT01628549|7455031|FG002|Overall Study|Protocol Violation|1
4602508|NCT01628549|7455032|FG003|Overall Study|Protocol Violation|0
4602509|NCT01628549|7455029|FG000|Overall Study|withdrawn for noncompliance|0
4602510|NCT01628549|7455030|FG001|Overall Study|withdrawn for noncompliance|2
4602511|NCT01628549|7455031|FG002|Overall Study|withdrawn for noncompliance|1
4602512|NCT01628549|7455032|FG003|Overall Study|withdrawn for noncompliance|0
4602513|NCT01628549|7455029|FG000|Overall Study|abnormal laboratory test results|0
4602514|NCT01628549|7455030|FG001|Overall Study|abnormal laboratory test results|0
4602515|NCT01628549|7455031|FG002|Overall Study|abnormal laboratory test results|1
4602516|NCT01628549|7455032|FG003|Overall Study|abnormal laboratory test results|0
4602517|NCT01628549|7455029|FG000|Overall Study|positive pregnancy test|0
4602518|NCT01628549|7455030|FG001|Overall Study|positive pregnancy test|0
4602519|NCT01628549|7455031|FG002|Overall Study|positive pregnancy test|0
4602520|NCT01628549|7455032|FG003|Overall Study|positive pregnancy test|1
4602521|NCT01628692|7455060|FG000|Overall Study|Lack of Efficacy|4
4602522|NCT01628692|7455061|FG001|Overall Study|Lack of Efficacy|4
4602523|NCT01628692|7455062|FG002|Overall Study|Lack of Efficacy|5
4602524|NCT01628692|7455063|FG003|Overall Study|Lack of Efficacy|1
4602525|NCT01628692|7455064|FG004|Overall Study|Lack of Efficacy|4
4602526|NCT01628692|7455065|FG005|Overall Study|Lack of Efficacy|7
4602527|NCT01628692|7455060|FG000|Overall Study|Adverse Event|2
4602528|NCT01628692|7455061|FG001|Overall Study|Adverse Event|0
4602529|NCT01628692|7455062|FG002|Overall Study|Adverse Event|2
4602530|NCT01628692|7455063|FG003|Overall Study|Adverse Event|0
4602531|NCT01628692|7455064|FG004|Overall Study|Adverse Event|0
4602532|NCT01628692|7455065|FG005|Overall Study|Adverse Event|0
4602533|NCT01628692|7455060|FG000|Overall Study|Withdrawal by Subject|0
4602534|NCT01628692|7455061|FG001|Overall Study|Withdrawal by Subject|1
4602535|NCT01628692|7455062|FG002|Overall Study|Withdrawal by Subject|1
4602536|NCT01628692|7455063|FG003|Overall Study|Withdrawal by Subject|0
4602537|NCT01628692|7455064|FG004|Overall Study|Withdrawal by Subject|0
4602538|NCT01628692|7455065|FG005|Overall Study|Withdrawal by Subject|0
4602539|NCT01628692|7455060|FG000|Overall Study|Death|0
4602540|NCT01628692|7455061|FG001|Overall Study|Death|1
4602541|NCT01628692|7455062|FG002|Overall Study|Death|0
4602542|NCT01628692|7455063|FG003|Overall Study|Death|0
4602543|NCT01628692|7455064|FG004|Overall Study|Death|0
4602544|NCT01628692|7455065|FG005|Overall Study|Death|0
4602545|NCT01628692|7455060|FG000|Overall Study|Poor compliance/noncompliance|1
4602546|NCT01628692|7455061|FG001|Overall Study|Poor compliance/noncompliance|0
4602547|NCT01628692|7455062|FG002|Overall Study|Poor compliance/noncompliance|0
4602548|NCT01628692|7455063|FG003|Overall Study|Poor compliance/noncompliance|0
4602549|NCT01628692|7455064|FG004|Overall Study|Poor compliance/noncompliance|0
4602550|NCT01628692|7455065|FG005|Overall Study|Poor compliance/noncompliance|0
4602551|NCT01628692|7455060|FG000|Overall Study|Administrative reason by sponsor|0
4602552|NCT01628692|7455061|FG001|Overall Study|Administrative reason by sponsor|0
4602553|NCT01628692|7455062|FG002|Overall Study|Administrative reason by sponsor|0
4602554|NCT01628692|7455063|FG003|Overall Study|Administrative reason by sponsor|0
4602555|NCT01628692|7455064|FG004|Overall Study|Administrative reason by sponsor|0
4602556|NCT01628692|7455065|FG005|Overall Study|Administrative reason by sponsor|1
4602557|NCT01628692|7455060|FG000|Overall Study|Completed 12 Week only|0
4602558|NCT01628692|7455061|FG001|Overall Study|Completed 12 Week only|0
4602559|NCT01628692|7455062|FG002|Overall Study|Completed 12 Week only|0
4602560|NCT01628692|7455063|FG003|Overall Study|Completed 12 Week only|0
4602561|NCT01628692|7455064|FG004|Overall Study|Completed 12 Week only|0
4602562|NCT01628692|7455065|FG005|Overall Study|Completed 12 Week only|1
4602563|NCT01628848|7455093|FG000|Overall Study|Adverse Event|9
4602564|NCT01628848|7455094|FG001|Overall Study|Adverse Event|7
4602565|NCT01628848|7455093|FG000|Overall Study|Lack of Efficacy|0
4602566|NCT01628848|7455094|FG001|Overall Study|Lack of Efficacy|4
4602567|NCT01628848|7455093|FG000|Overall Study|Withdrawal by Subject|0
4602568|NCT01628848|7455094|FG001|Overall Study|Withdrawal by Subject|2
4602569|NCT01628848|7455093|FG000|Overall Study|Physician Decision|3
4602570|NCT01628848|7455094|FG001|Overall Study|Physician Decision|1
4602571|NCT01628874|7455102|FG000|Overall Study|Physician Decision|1
4602572|NCT01628874|7455103|FG001|Overall Study|Physician Decision|1
4602573|NCT01628874|7455102|FG000|Overall Study|Age >4 months|4
4602574|NCT01628874|7455103|FG001|Overall Study|Age >4 months|2
4602575|NCT01628913|7455111|FG000|Overall Study|Adverse Event|12
4602576|NCT01628913|7455112|FG001|Overall Study|Adverse Event|5
4602577|NCT01628913|7455111|FG000|Overall Study|Disease Progression|11
4602578|NCT01628913|7455112|FG001|Overall Study|Disease Progression|14
4602579|NCT01628913|7455111|FG000|Overall Study|Protocol Violation|1
4602580|NCT01628913|7455112|FG001|Overall Study|Protocol Violation|0
4602581|NCT01628913|7455111|FG000|Overall Study|Death|1
4602582|NCT01628913|7455112|FG001|Overall Study|Death|0
4602583|NCT01628913|7455111|FG000|Overall Study|study terminated by Sponsor|4
4602584|NCT01628913|7455112|FG001|Overall Study|study terminated by Sponsor|9
4602585|NCT01628913|7455111|FG000|Overall Study|Withdrawal by Subject|1
4602586|NCT01628913|7455112|FG001|Overall Study|Withdrawal by Subject|0
4602587|NCT01628913|7455111|FG000|Overall Study|Physician Decision|1
4602588|NCT01628913|7455112|FG001|Overall Study|Physician Decision|3
4602589|NCT01628926|7455121|FG000|Overall Study|Adverse Event|13
4602590|NCT01628926|7455122|FG001|Overall Study|Adverse Event|11
4602591|NCT01628926|7455123|FG002|Overall Study|Adverse Event|9
4602592|NCT01628926|7455121|FG000|Overall Study|Lack of Efficacy|2
4602593|NCT01628926|7455122|FG001|Overall Study|Lack of Efficacy|1
4602594|NCT01628926|7455123|FG002|Overall Study|Lack of Efficacy|5
4602595|NCT01628926|7455121|FG000|Overall Study|Withdrawal by Subject|6
4602596|NCT01628926|7455122|FG001|Overall Study|Withdrawal by Subject|4
4635821|NCT01937715|7507668|FG001|Overall Study|Death|0
4635822|NCT01937715|7507669|FG002|Overall Study|Death|0
4635823|NCT01937715|7507670|FG003|Overall Study|Death|1
4635824|NCT01937715|7507671|FG004|Overall Study|Death|0
4635825|NCT01937715|7507667|FG000|Overall Study|Withdrawal by Subject|0
4635826|NCT01937715|7507668|FG001|Overall Study|Withdrawal by Subject|1
4635827|NCT01937715|7507669|FG002|Overall Study|Withdrawal by Subject|0
4635828|NCT01937715|7507670|FG003|Overall Study|Withdrawal by Subject|0
4635829|NCT01937715|7507671|FG004|Overall Study|Withdrawal by Subject|2
4635830|NCT01937715|7507667|FG000|Overall Study|Other|0
4635831|NCT01937715|7507668|FG001|Overall Study|Other|0
4635832|NCT01937715|7507669|FG002|Overall Study|Other|0
4635833|NCT01937715|7507670|FG003|Overall Study|Other|3
4635834|NCT01937715|7507671|FG004|Overall Study|Other|0
4635835|NCT01937871|7507686|FG000|Overall Study|Adverse Event|6
4635836|NCT01937871|7507687|FG001|Overall Study|Adverse Event|6
4635837|NCT01937871|7507688|FG002|Overall Study|Adverse Event|2
4635838|NCT01937871|7507686|FG000|Overall Study|Lost to Follow-up|8
4635839|NCT01937871|7507687|FG001|Overall Study|Lost to Follow-up|2
4635840|NCT01937871|7507688|FG002|Overall Study|Lost to Follow-up|4
4635841|NCT01937871|7507686|FG000|Overall Study|Withdrawal by Subject|9
4635842|NCT01937871|7507687|FG001|Overall Study|Withdrawal by Subject|6
4635843|NCT01937871|7507688|FG002|Overall Study|Withdrawal by Subject|4
4635844|NCT01937871|7507686|FG000|Overall Study|Physician Decision|0
4635845|NCT01937871|7507687|FG001|Overall Study|Physician Decision|1
4635846|NCT01937871|7507688|FG002|Overall Study|Physician Decision|0
4635847|NCT01937871|7507686|FG000|Overall Study|Entry Criteria Not Met|1
4635848|NCT01937871|7507687|FG001|Overall Study|Entry Criteria Not Met|2
4602597|NCT01628926|7455123|FG002|Overall Study|Withdrawal by Subject|2
4635849|NCT01937871|7507688|FG002|Overall Study|Entry Criteria Not Met|1
4635850|NCT01937884|7507701|FG000|Overall Study|Withdrawal by Subject|1
4635851|NCT01937884|7507702|FG001|Overall Study|Withdrawal by Subject|0
4635852|NCT01938001|7507729|FG000|Overall Study|Withdrawal by Subject|25
4635853|NCT01938001|7507730|FG001|Overall Study|Withdrawal by Subject|17
4602598|NCT01628926|7455121|FG000|Overall Study|Protocol Violation|0
4602599|NCT01628926|7455122|FG001|Overall Study|Protocol Violation|1
4602600|NCT01628926|7455123|FG002|Overall Study|Protocol Violation|0
4602601|NCT01628926|7455121|FG000|Overall Study|Discontinuation criteria|3
4602602|NCT01628926|7455122|FG001|Overall Study|Discontinuation criteria|4
4602603|NCT01628926|7455123|FG002|Overall Study|Discontinuation criteria|0
4602604|NCT01628926|7455121|FG000|Overall Study|Physician Decision|2
4602605|NCT01628926|7455122|FG001|Overall Study|Physician Decision|2
4602606|NCT01628926|7455123|FG002|Overall Study|Physician Decision|1
4602607|NCT01628965|7455132|FG000|Overall Study|Adverse Event|30
4602608|NCT01628965|7455132|FG000|Overall Study|Lack of Efficacy|7
4602609|NCT01628965|7455132|FG000|Overall Study|Withdrawal by Subject|3
4602610|NCT01628965|7455132|FG000|Overall Study|Lost to Follow-up|1
4602611|NCT01628965|7455132|FG000|Overall Study|Discontinuation criteria|8
4602612|NCT01629381|7455152|FG000|Overall Study|Withdrawal by Subject|2
4602613|NCT01629381|7455153|FG001|Overall Study|Withdrawal by Subject|5
4602614|NCT01629563|7455165|FG000|Overall Study|Adverse Event|16
4602615|NCT01629563|7455166|FG001|Overall Study|Adverse Event|16
4602616|NCT01629563|7455165|FG000|Overall Study|Death|2
4602617|NCT01629563|7455166|FG001|Overall Study|Death|0
4602618|NCT01629563|7455165|FG000|Overall Study|Lack of Efficacy|2
4602619|NCT01629563|7455166|FG001|Overall Study|Lack of Efficacy|3
4602620|NCT01629563|7455165|FG000|Overall Study|Lost to Follow-up|1
4602621|NCT01629563|7455166|FG001|Overall Study|Lost to Follow-up|0
4602622|NCT01629563|7455165|FG000|Overall Study|Pregnancy|1
4602623|NCT01629563|7455166|FG001|Overall Study|Pregnancy|2
4602624|NCT01629563|7455165|FG000|Overall Study|Protocol Violation|0
4602625|NCT01629563|7455166|FG001|Overall Study|Protocol Violation|1
4602626|NCT01629563|7455165|FG000|Overall Study|Withdrawal by Subject|27
4602627|NCT01629563|7455166|FG001|Overall Study|Withdrawal by Subject|20
4602628|NCT01629563|7455165|FG000|Overall Study|surgery|0
4602629|NCT01629563|7455166|FG001|Overall Study|surgery|3
4602630|NCT01629563|7455165|FG000|Overall Study|Lack of return of menses|12
4602631|NCT01629563|7455166|FG001|Overall Study|Lack of return of menses|7
4602632|NCT01629563|7455165|FG000|Overall Study|Protocol Violation|0
4602633|NCT01629563|7455166|FG001|Overall Study|Protocol Violation|1
4602634|NCT01629589|7455174|FG000|Overall Study|Protocol Violation|4
4602635|NCT01629589|7455175|FG001|Overall Study|Protocol Violation|2
4602636|NCT01629589|7455174|FG000|Overall Study|Lost to Follow-up|2
4602637|NCT01629589|7455175|FG001|Overall Study|Lost to Follow-up|1
4602638|NCT01629589|7455174|FG000|Overall Study|Withdrawal by Subject|2
4602639|NCT01629589|7455175|FG001|Overall Study|Withdrawal by Subject|3
4602640|NCT01629589|7455174|FG000|Overall Study|Did not receive study vaccine|0
4602641|NCT01629589|7455175|FG001|Overall Study|Did not receive study vaccine|1
4602642|NCT01629667|7455188|FG000|Overall Study|Lost to Follow-up|0
4602643|NCT01629667|7455189|FG001|Overall Study|Lost to Follow-up|1
4602644|NCT01629667|7455190|FG002|Overall Study|Lost to Follow-up|1
4602645|NCT01629667|7455188|FG000|Overall Study|Withdrawal by Subject|31
4602646|NCT01629667|7455189|FG001|Overall Study|Withdrawal by Subject|20
4602647|NCT01629667|7455190|FG002|Overall Study|Withdrawal by Subject|28
4602648|NCT01629667|7455188|FG000|Overall Study|Death|1
4602649|NCT01629667|7455189|FG001|Overall Study|Death|5
4602650|NCT01629667|7455190|FG002|Overall Study|Death|3
4602651|NCT01629667|7455188|FG000|Overall Study|Randomized, not treated|2
4602652|NCT01629667|7455189|FG001|Overall Study|Randomized, not treated|1
4602653|NCT01629667|7455190|FG002|Overall Study|Randomized, not treated|0
4602654|NCT01629667|7455188|FG000|Overall Study|Ongoing AE worsening right heart failure|0
4602655|NCT01629667|7455189|FG001|Overall Study|Ongoing AE worsening right heart failure|1
4602656|NCT01629667|7455190|FG002|Overall Study|Ongoing AE worsening right heart failure|0
4602657|NCT01629667|7455188|FG000|Overall Study|Requiring lung transplant|2
4602658|NCT01629667|7455189|FG001|Overall Study|Requiring lung transplant|1
4602659|NCT01629667|7455190|FG002|Overall Study|Requiring lung transplant|3
4602660|NCT01629667|7455188|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9
4602661|NCT01629667|7455189|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11
4602662|NCT01629667|7455190|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8
4602663|NCT01629667|7455188|FG000|Overall Study|Started other medicine|1
4602664|NCT01629667|7455189|FG001|Overall Study|Started other medicine|0
4602665|NCT01629667|7455190|FG002|Overall Study|Started other medicine|1
4602666|NCT01629667|7455188|FG000|Overall Study|Site error in safety follow-up|0
4602667|NCT01629667|7455189|FG001|Overall Study|Site error in safety follow-up|0
4602668|NCT01629667|7455190|FG002|Overall Study|Site error in safety follow-up|1
4602669|NCT01629667|7455188|FG000|Overall Study|Enrolled in another clinical study|0
4602670|NCT01629667|7455189|FG001|Overall Study|Enrolled in another clinical study|1
4602671|NCT01629667|7455190|FG002|Overall Study|Enrolled in another clinical study|0
4602672|NCT01629667|7455188|FG000|Overall Study|Code break|1
4602673|NCT01629667|7455189|FG001|Overall Study|Code break|0
4602674|NCT01629667|7455190|FG002|Overall Study|Code break|0
4602675|NCT01629693|7455202|FG000|Overall Study|Lost to Follow-up|2
4602676|NCT01629693|7455203|FG001|Overall Study|Lost to Follow-up|4
4602677|NCT01629693|7455202|FG000|Overall Study|Withdrawal by Subject|2
4602678|NCT01629693|7455203|FG001|Overall Study|Withdrawal by Subject|2
4602679|NCT01629693|7455202|FG000|Overall Study|Adverse Event|1
4602680|NCT01629693|7455203|FG001|Overall Study|Adverse Event|0
4602681|NCT01629693|7455202|FG000|Overall Study|Investigator decision|0
4602682|NCT01629693|7455203|FG001|Overall Study|Investigator decision|1
4602683|NCT01629693|7455202|FG000|Overall Study|Poor comfort of study lenses|0
4602684|NCT01629693|7455203|FG001|Overall Study|Poor comfort of study lenses|2
4602685|NCT01629693|7455202|FG000|Overall Study|Subject decision unrelated to AE|0
4602686|NCT01629693|7455203|FG001|Overall Study|Subject decision unrelated to AE|1
4602687|NCT01629706|7455209|FG000|Phase 1 PureVision|Screen Failure|4
4602688|NCT01629706|7455209|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1
4602689|NCT01629706|7455209|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1
4602690|NCT01629706|7455209|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3
4602691|NCT01629706|7455209|FG000|Phase 2 Habitual|Screen Failure|6
4602692|NCT01629706|7455209|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1
4635854|NCT01938001|7507729|FG000|Overall Study|Non-compliant|1
4635855|NCT01938001|7507730|FG001|Overall Study|Non-compliant|0
4602693|NCT01629706|7455209|FG000|Phase 2 Habitual|Relocation prior to Dispense|1
4602694|NCT01629706|7455209|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1
4602695|NCT01629706|7455209|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1
4602696|NCT01629823|7455243|FG000|Trial Period|Missed visit|11
4602697|NCT01629823|7455244|FG001|Trial Period|Missed visit|9
4602698|NCT01629823|7455245|FG002|Trial Period|Missed visit|8
4602699|NCT01629823|7455243|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1
4602700|NCT01629823|7455244|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1
4602701|NCT01629823|7455245|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1
4602702|NCT01629823|7455243|FG000|Trial Period|Pregnancy|1
4602703|NCT01629823|7455244|FG001|Trial Period|Pregnancy|0
4602704|NCT01629823|7455245|FG002|Trial Period|Pregnancy|0
4602705|NCT01629823|7455243|FG000|Trial Period|Adverse Event|0
4602706|NCT01629823|7455244|FG001|Trial Period|Adverse Event|1
4602707|NCT01629823|7455245|FG002|Trial Period|Adverse Event|0
4602708|NCT01629823|7455243|FG000|Trial Period|Out-of-window visit|0
4602709|NCT01629823|7455244|FG001|Trial Period|Out-of-window visit|2
4602710|NCT01629823|7455245|FG002|Trial Period|Out-of-window visit|0
4602711|NCT01629823|7455243|FG000|Trial Period|Failed to hold medication|0
4602712|NCT01629823|7455244|FG001|Trial Period|Failed to hold medication|0
4602713|NCT01629823|7455245|FG002|Trial Period|Failed to hold medication|1
4602714|NCT01629823|7455243|FG000|Washout Period|Safety|2
4602715|NCT01629823|7455244|FG001|Washout Period|Safety|5
4602716|NCT01629823|7455245|FG002|Washout Period|Safety|0
4602717|NCT01629823|7455243|FG000|Washout Period|Pregnancy|1
4602718|NCT01629823|7455244|FG001|Washout Period|Pregnancy|0
4602719|NCT01629823|7455245|FG002|Washout Period|Pregnancy|0
4602720|NCT01629823|7455243|FG000|Washout Period|Protocol Violation|0
4602721|NCT01629823|7455244|FG001|Washout Period|Protocol Violation|1
4602722|NCT01629823|7455245|FG002|Washout Period|Protocol Violation|0
4602723|NCT01629953|7455264|FG000|Overall Study|Death|3
4602724|NCT01629953|7455265|FG001|Overall Study|Death|1
4602725|NCT01629953|7455264|FG000|Overall Study|Lost to Follow-up|10
4602726|NCT01629953|7455265|FG001|Overall Study|Lost to Follow-up|14
4602727|NCT01629966|7455274|FG000|Overall Study|Pregnancy|0
4602728|NCT01629966|7455275|FG001|Overall Study|Pregnancy|1
4602729|NCT01629966|7455276|FG002|Overall Study|Pregnancy|0
4602730|NCT01629966|7455274|FG000|Overall Study|Lost to Follow-up|10
4602731|NCT01629966|7455275|FG001|Overall Study|Lost to Follow-up|13
4602732|NCT01629966|7455276|FG002|Overall Study|Lost to Follow-up|9
4602733|NCT01629966|7455274|FG000|Overall Study|Withdrawal by Subject|8
4602734|NCT01629966|7455275|FG001|Overall Study|Withdrawal by Subject|9
4602735|NCT01629966|7455276|FG002|Overall Study|Withdrawal by Subject|16
4602736|NCT01629966|7455274|FG000|Overall Study|Protocol Violation|7
4602737|NCT01629966|7455275|FG001|Overall Study|Protocol Violation|9
4602738|NCT01629966|7455276|FG002|Overall Study|Protocol Violation|7
4602739|NCT01629966|7455274|FG000|Overall Study|Lack of Efficacy|5
4602740|NCT01629966|7455275|FG001|Overall Study|Lack of Efficacy|2
4602741|NCT01629966|7455276|FG002|Overall Study|Lack of Efficacy|4
4602742|NCT01629966|7455274|FG000|Overall Study|Adverse Event|11
4602743|NCT01629966|7455275|FG001|Overall Study|Adverse Event|18
4602744|NCT01629966|7455276|FG002|Overall Study|Adverse Event|30
4602745|NCT01630135|7455305|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0
4602746|NCT01630135|7455306|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2
4602747|NCT01630616|7455327|FG000|Overall Study|Adverse Event|0
4602748|NCT01630616|7455328|FG001|Overall Study|Adverse Event|0
4602749|NCT01630616|7455329|FG002|Overall Study|Adverse Event|0
4602750|NCT01630616|7455330|FG003|Overall Study|Adverse Event|1
4602751|NCT01630616|7455331|FG004|Overall Study|Adverse Event|0
4602752|NCT01630616|7455332|FG005|Overall Study|Adverse Event|0
4602753|NCT01630616|7455327|FG000|Overall Study|Withdrawal by Subject|0
4602754|NCT01630616|7455328|FG001|Overall Study|Withdrawal by Subject|0
4602755|NCT01630616|7455329|FG002|Overall Study|Withdrawal by Subject|0
4602756|NCT01630616|7455330|FG003|Overall Study|Withdrawal by Subject|2
4602757|NCT01630616|7455331|FG004|Overall Study|Withdrawal by Subject|0
4602758|NCT01630616|7455332|FG005|Overall Study|Withdrawal by Subject|0
4602759|NCT01630811|7455358|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1
4602760|NCT01630811|7455359|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0
4602761|NCT01630889|7455367|FG000|Overall Study|Death|2
4602762|NCT01630889|7455367|FG000|Overall Study|Withdrawal by Subject|1
4602763|NCT01630889|7455367|FG000|Overall Study|Other than Specified|2
4602764|NCT01630889|7455367|FG000|Overall Study|Lost to Follow-up|4
4602765|NCT01630889|7455367|FG000|Overall Study|Other|1
4602766|NCT01631188|7455398|FG000|Overall Study|Physician Decision|75
4602767|NCT01631214|7455404|FG000|Overall Study|Withdrawal by Subject|276
4602768|NCT01631214|7455405|FG001|Overall Study|Withdrawal by Subject|290
4602769|NCT01631214|7455404|FG000|Overall Study|Death|113
4602770|NCT01631214|7455405|FG001|Overall Study|Death|106
4602771|NCT01631214|7455404|FG000|Overall Study|Lost to Follow-up|54
4602772|NCT01631214|7455405|FG001|Overall Study|Lost to Follow-up|40
4602773|NCT01631214|7455404|FG000|Overall Study|Adverse Event|45
4602774|NCT01631214|7455405|FG001|Overall Study|Adverse Event|45
4602775|NCT01631214|7455404|FG000|Overall Study|Other|22
4602776|NCT01631214|7455405|FG001|Overall Study|Other|19
4602777|NCT01631214|7455404|FG000|Overall Study|Noncompliance|16
4602778|NCT01631214|7455405|FG001|Overall Study|Noncompliance|15
4602779|NCT01631214|7455404|FG000|Overall Study|Requirement for Alternative Therapy|8
4602780|NCT01631214|7455405|FG001|Overall Study|Requirement for Alternative Therapy|3
4602781|NCT01631214|7455404|FG000|Overall Study|Protocol Deviation|4
4602782|NCT01631214|7455405|FG001|Overall Study|Protocol Deviation|3
4602783|NCT01631214|7455404|FG000|Overall Study|Ineligibility determined|5
4602784|NCT01631214|7455405|FG001|Overall Study|Ineligibility determined|2
4635856|NCT01938001|7507729|FG000|Overall Study|Participant Moved|0
4635857|NCT01938001|7507730|FG001|Overall Study|Participant Moved|1
4635858|NCT01938001|7507729|FG000|Overall Study|Lost to Follow-up|1
4635859|NCT01938001|7507730|FG001|Overall Study|Lost to Follow-up|3
4635860|NCT01938001|7507729|FG000|Overall Study|Death|16
4635861|NCT01938001|7507730|FG001|Overall Study|Death|26
4635862|NCT01938391|7507794|FG000|6 Month Follow up|Withdrawal by Subject|1
4635863|NCT01938391|7507794|FG000|12 Month Follow up|Physician Decision|1
4635864|NCT01938391|7507794|FG000|12 Month Follow up|Withdrawal by Subject|1
4635865|NCT01938430|7507812|FG000|Overall Study|Randomized but Not Treated|0
4635866|NCT01938430|7507813|FG001|Overall Study|Randomized but Not Treated|0
4635867|NCT01938430|7507814|FG002|Overall Study|Randomized but Not Treated|0
4635868|NCT01938430|7507815|FG003|Overall Study|Randomized but Not Treated|0
4635869|NCT01938430|7507816|FG004|Overall Study|Randomized but Not Treated|0
4635870|NCT01938430|7507817|FG005|Overall Study|Randomized but Not Treated|0
4635871|NCT01938430|7507818|FG006|Overall Study|Randomized but Not Treated|0
4602785|NCT01631214|7455404|FG000|Overall Study|Administrative Decision|1
4602786|NCT01631214|7455405|FG001|Overall Study|Administrative Decision|0
4602787|NCT01631227|7455415|FG000|Overall Study|withdrawn consent|27
4602788|NCT01631227|7455416|FG001|Overall Study|withdrawn consent|21
4602789|NCT01631227|7455415|FG000|Overall Study|Adverse Event|1
4602790|NCT01631227|7455416|FG001|Overall Study|Adverse Event|0
4602791|NCT01631227|7455415|FG000|Overall Study|administrative|2
4602792|NCT01631227|7455416|FG001|Overall Study|administrative|1
4602793|NCT01631435|7455427|FG000|Overall Study|Adverse Event|2
4602794|NCT01631435|7455427|FG000|Overall Study|Withdrawal by Subject|2
4602795|NCT01631435|7455427|FG000|Overall Study|incomplete study procedure|5
4602796|NCT01631474|7455437|FG000|Overall Study|Lost to Follow-up|8
4602797|NCT01631474|7455438|FG001|Overall Study|Lost to Follow-up|5
4602798|NCT01631474|7455439|FG002|Overall Study|Lost to Follow-up|7
4602799|NCT01631474|7455440|FG003|Overall Study|Lost to Follow-up|5
4602800|NCT01631474|7455441|FG004|Overall Study|Lost to Follow-up|5
4602801|NCT01631474|7455437|FG000|Overall Study|Withdrawal by Subject|4
4602802|NCT01631474|7455438|FG001|Overall Study|Withdrawal by Subject|4
4602803|NCT01631474|7455439|FG002|Overall Study|Withdrawal by Subject|2
4602804|NCT01631474|7455440|FG003|Overall Study|Withdrawal by Subject|6
4602805|NCT01631474|7455441|FG004|Overall Study|Withdrawal by Subject|5
4602806|NCT01631474|7455437|FG000|Overall Study|Lack of Efficacy|2
4602807|NCT01631474|7455438|FG001|Overall Study|Lack of Efficacy|2
4602808|NCT01631474|7455439|FG002|Overall Study|Lack of Efficacy|0
4602809|NCT01631474|7455440|FG003|Overall Study|Lack of Efficacy|0
4602810|NCT01631474|7455441|FG004|Overall Study|Lack of Efficacy|2
4602811|NCT01631474|7455437|FG000|Overall Study|Noncompliance with Study Drug|0
4602812|NCT01631474|7455438|FG001|Overall Study|Noncompliance with Study Drug|0
4635872|NCT01938430|7507819|FG007|Overall Study|Randomized but Not Treated|0
4635873|NCT01938430|7507820|FG008|Overall Study|Randomized but Not Treated|0
4635874|NCT01938430|7507821|FG009|Overall Study|Randomized but Not Treated|0
4635875|NCT01938430|7507822|FG010|Overall Study|Randomized but Not Treated|1
4635876|NCT01938430|7507823|FG011|Overall Study|Randomized but Not Treated|0
4635877|NCT01938430|7507824|FG012|Overall Study|Randomized but Not Treated|0
4635878|NCT01938430|7507825|FG013|Overall Study|Randomized but Not Treated|1
4635879|NCT01938430|7507812|FG000|Overall Study|Adverse Event|0
4635880|NCT01938430|7507813|FG001|Overall Study|Adverse Event|0
4635881|NCT01938430|7507814|FG002|Overall Study|Adverse Event|0
4635882|NCT01938430|7507815|FG003|Overall Study|Adverse Event|0
4635883|NCT01938430|7507816|FG004|Overall Study|Adverse Event|0
4635884|NCT01938430|7507817|FG005|Overall Study|Adverse Event|0
4635885|NCT01938430|7507818|FG006|Overall Study|Adverse Event|1
4635886|NCT01938430|7507819|FG007|Overall Study|Adverse Event|0
4635887|NCT01938430|7507820|FG008|Overall Study|Adverse Event|0
4635888|NCT01938430|7507821|FG009|Overall Study|Adverse Event|0
4635889|NCT01938430|7507822|FG010|Overall Study|Adverse Event|0
4635890|NCT01938430|7507823|FG011|Overall Study|Adverse Event|0
4602813|NCT01631474|7455439|FG002|Overall Study|Noncompliance with Study Drug|0
4602814|NCT01631474|7455440|FG003|Overall Study|Noncompliance with Study Drug|0
4602815|NCT01631474|7455441|FG004|Overall Study|Noncompliance with Study Drug|1
4602816|NCT01631474|7455437|FG000|Overall Study|Adverse Event|0
4602817|NCT01631474|7455438|FG001|Overall Study|Adverse Event|1
4602818|NCT01631474|7455439|FG002|Overall Study|Adverse Event|0
4602819|NCT01631474|7455440|FG003|Overall Study|Adverse Event|0
4602820|NCT01631474|7455441|FG004|Overall Study|Adverse Event|0
4602821|NCT01631747|7455509|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1
4602822|NCT01631747|7455510|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0
4602823|NCT01631747|7455509|FG000|Live Birth|Pregnancy Termination|1
4602824|NCT01631747|7455510|FG001|Live Birth|Pregnancy Termination|0
4602825|NCT01631747|7455509|FG000|Live Birth|MIscarriage|2
4602826|NCT01631747|7455510|FG001|Live Birth|MIscarriage|0
4602827|NCT01631747|7455509|FG000|Live Birth|Stillbirth|1
4602828|NCT01631747|7455510|FG001|Live Birth|Stillbirth|1
4602829|NCT01631747|7455509|FG000|One Year Infant Outcomes|Patient Refused|13
4602830|NCT01631747|7455510|FG001|One Year Infant Outcomes|Patient Refused|9
4602831|NCT01631812|7455517|FG000|Overall Study|Adverse Event|25
4602832|NCT01631812|7455517|FG000|Overall Study|Lack of Efficacy|5
4602833|NCT01631812|7455517|FG000|Overall Study|Withdrawal by Subject|4
4602834|NCT01631812|7455517|FG000|Overall Study|Physician Decision|3
4602835|NCT01631825|7455521|FG000|Overall Study|Adverse Event|42
4602836|NCT01631825|7455521|FG000|Overall Study|Lack of Efficacy|7
4602837|NCT01631825|7455521|FG000|Overall Study|Withdrawal by Subject|9
4602838|NCT01631825|7455521|FG000|Overall Study|Protocol Violation|4
4602839|NCT01631825|7455521|FG000|Overall Study|Discontinuation criteria|1
4635891|NCT01938430|7507824|FG012|Overall Study|Adverse Event|0
4635892|NCT01938430|7507825|FG013|Overall Study|Adverse Event|0
4635893|NCT01938430|7507812|FG000|Overall Study|Death|1
4635894|NCT01938430|7507813|FG001|Overall Study|Death|2
4635895|NCT01938430|7507814|FG002|Overall Study|Death|2
4635896|NCT01938430|7507815|FG003|Overall Study|Death|1
4635897|NCT01938430|7507816|FG004|Overall Study|Death|0
4635898|NCT01938430|7507817|FG005|Overall Study|Death|0
4635899|NCT01938430|7507818|FG006|Overall Study|Death|1
4635900|NCT01938430|7507819|FG007|Overall Study|Death|1
4635901|NCT01938430|7507820|FG008|Overall Study|Death|2
4635902|NCT01938430|7507821|FG009|Overall Study|Death|3
4635903|NCT01938430|7507822|FG010|Overall Study|Death|0
4635904|NCT01938430|7507823|FG011|Overall Study|Death|0
4635905|NCT01938430|7507824|FG012|Overall Study|Death|0
4635906|NCT01938430|7507825|FG013|Overall Study|Death|0
4635907|NCT01938430|7507812|FG000|Overall Study|Investigator's Discretion|0
4635908|NCT01938430|7507813|FG001|Overall Study|Investigator's Discretion|0
4635909|NCT01938430|7507814|FG002|Overall Study|Investigator's Discretion|1
4635910|NCT01938430|7507815|FG003|Overall Study|Investigator's Discretion|0
4635911|NCT01938430|7507816|FG004|Overall Study|Investigator's Discretion|0
4635912|NCT01938430|7507817|FG005|Overall Study|Investigator's Discretion|0
4635913|NCT01938430|7507818|FG006|Overall Study|Investigator's Discretion|0
4635914|NCT01938430|7507819|FG007|Overall Study|Investigator's Discretion|0
4635915|NCT01938430|7507820|FG008|Overall Study|Investigator's Discretion|0
4635916|NCT01938430|7507821|FG009|Overall Study|Investigator's Discretion|0
4635917|NCT01938430|7507822|FG010|Overall Study|Investigator's Discretion|0
4635918|NCT01938430|7507823|FG011|Overall Study|Investigator's Discretion|0
4635919|NCT01938430|7507824|FG012|Overall Study|Investigator's Discretion|0
4635920|NCT01938430|7507825|FG013|Overall Study|Investigator's Discretion|0
4635921|NCT01938430|7507812|FG000|Overall Study|Lack of Efficacy|3
4635922|NCT01938430|7507813|FG001|Overall Study|Lack of Efficacy|1
4635923|NCT01938430|7507814|FG002|Overall Study|Lack of Efficacy|1
4635924|NCT01938430|7507815|FG003|Overall Study|Lack of Efficacy|1
4635925|NCT01938430|7507816|FG004|Overall Study|Lack of Efficacy|0
4635926|NCT01938430|7507817|FG005|Overall Study|Lack of Efficacy|0
4635927|NCT01938430|7507818|FG006|Overall Study|Lack of Efficacy|0
4635928|NCT01938430|7507819|FG007|Overall Study|Lack of Efficacy|0
4635929|NCT01938430|7507820|FG008|Overall Study|Lack of Efficacy|1
4635930|NCT01938430|7507821|FG009|Overall Study|Lack of Efficacy|0
4635931|NCT01938430|7507822|FG010|Overall Study|Lack of Efficacy|2
4635932|NCT01938430|7507823|FG011|Overall Study|Lack of Efficacy|1
4635933|NCT01938430|7507824|FG012|Overall Study|Lack of Efficacy|0
4635934|NCT01938430|7507825|FG013|Overall Study|Lack of Efficacy|0
4635935|NCT01938430|7507812|FG000|Overall Study|Lost to Follow-up|0
4635936|NCT01938430|7507813|FG001|Overall Study|Lost to Follow-up|0
4635937|NCT01938430|7507814|FG002|Overall Study|Lost to Follow-up|1
4635938|NCT01938430|7507815|FG003|Overall Study|Lost to Follow-up|0
4635939|NCT01938430|7507816|FG004|Overall Study|Lost to Follow-up|0
4635940|NCT01938430|7507817|FG005|Overall Study|Lost to Follow-up|1
4635941|NCT01938430|7507818|FG006|Overall Study|Lost to Follow-up|0
4635942|NCT01938430|7507819|FG007|Overall Study|Lost to Follow-up|0
4635943|NCT01938430|7507820|FG008|Overall Study|Lost to Follow-up|0
4635944|NCT01938430|7507821|FG009|Overall Study|Lost to Follow-up|0
4635945|NCT01938430|7507822|FG010|Overall Study|Lost to Follow-up|0
4635946|NCT01938430|7507823|FG011|Overall Study|Lost to Follow-up|0
4635947|NCT01938430|7507824|FG012|Overall Study|Lost to Follow-up|0
4635948|NCT01938430|7507825|FG013|Overall Study|Lost to Follow-up|0
4635949|NCT01938430|7507812|FG000|Overall Study|Withdrew Consent|0
4635950|NCT01938430|7507813|FG001|Overall Study|Withdrew Consent|0
4635951|NCT01938430|7507814|FG002|Overall Study|Withdrew Consent|0
4635952|NCT01938430|7507815|FG003|Overall Study|Withdrew Consent|0
4635953|NCT01938430|7507816|FG004|Overall Study|Withdrew Consent|0
4602840|NCT01631825|7455521|FG000|Overall Study|Physician Decision|2
4602841|NCT01631864|7455527|FG000|Overall Study|Withdrawal by Subject|0
4602842|NCT01631864|7455528|FG001|Overall Study|Withdrawal by Subject|1
4602843|NCT01631864|7455527|FG000|Overall Study|Adverse Event|2
4602844|NCT01631864|7455528|FG001|Overall Study|Adverse Event|3
4602845|NCT01632150|7455543|FG000|Overall Study|Disease progression|27
4602846|NCT01632150|7455543|FG000|Overall Study|Study drug toxicity|1
4602847|NCT01632150|7455543|FG000|Overall Study|Unrelated adverse event|7
4602848|NCT01632150|7455543|FG000|Overall Study|Withdrawal by Subject|2
4602849|NCT01632150|7455543|FG000|Overall Study|Patient underwent autologous transplant|1
4602850|NCT01632150|7455543|FG000|Overall Study|Moved to compassionate program|2
4602851|NCT01632241|7455570|FG000|Double-blinded (Up to Week 52)|Site Closed|3
4602852|NCT01632241|7455571|FG001|Double-blinded (Up to Week 52)|Site Closed|5
4602853|NCT01632241|7455570|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2
4602854|NCT01632241|7455571|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6
4602855|NCT01632241|7455570|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1
4602856|NCT01632241|7455571|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8
4602857|NCT01632241|7455570|FG000|Double-blinded (Up to Week 52)|Physician Decision|9
4602858|NCT01632241|7455571|FG001|Double-blinded (Up to Week 52)|Physician Decision|12
4602859|NCT01632241|7455570|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9
4602860|NCT01632241|7455571|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15
4602861|NCT01632241|7455570|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10
4602862|NCT01632241|7455571|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14
4602863|NCT01632241|7455570|FG000|Double-blinded (Up to Week 52)|Adverse Event|10
4602864|NCT01632241|7455571|FG001|Double-blinded (Up to Week 52)|Adverse Event|19
4602865|NCT01632241|7455570|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5
4602866|NCT01632241|7455571|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2
4602867|NCT01632241|7455570|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1
4602868|NCT01632241|7455571|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4
4602869|NCT01632241|7455570|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1
4602870|NCT01632241|7455571|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4
4602871|NCT01632241|7455570|FG000|Open-label (Week 52 to Week 76)|Site Closed|2
4602872|NCT01632241|7455571|FG001|Open-label (Week 52 to Week 76)|Site Closed|8
4602873|NCT01632241|7455570|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0
4602874|NCT01632241|7455571|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2
4602875|NCT01632241|7455570|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0
4602876|NCT01632241|7455571|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2
4602877|NCT01632241|7455570|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1
4602878|NCT01632241|7455571|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0
4602879|NCT01632280|7455589|FG000|Overall Study|Withdrawal by Subject|1
4602880|NCT01632280|7455590|FG001|Overall Study|Withdrawal by Subject|0
4602881|NCT01632306|7455598|FG000|Overall Study|Protocol Violation|1
4602882|NCT01632306|7455599|FG001|Overall Study|Protocol Violation|0
4602883|NCT01632306|7455600|FG002|Overall Study|Protocol Violation|0
4602884|NCT01632345|7455611|FG000|Treatment: Part I|Adverse Event|1
4602885|NCT01632345|7455612|FG001|Treatment: Part I|Adverse Event|4
4602886|NCT01632345|7455613|FG002|Treatment: Part I|Adverse Event|2
4602887|NCT01632345|7455614|FG003|Treatment: Part I|Adverse Event|1
4602888|NCT01632345|7455615|FG004|Treatment: Part I|Adverse Event|3
4602889|NCT01632345|7455616|FG005|Treatment: Part I|Adverse Event|0
4602890|NCT01632345|7455617|FG006|Treatment: Part I|Adverse Event|0
4602891|NCT01632345|7455611|FG000|Treatment: Part I|Lack of Efficacy|0
4602892|NCT01632345|7455612|FG001|Treatment: Part I|Lack of Efficacy|1
4602893|NCT01632345|7455613|FG002|Treatment: Part I|Lack of Efficacy|0
4602894|NCT01632345|7455614|FG003|Treatment: Part I|Lack of Efficacy|1
4602895|NCT01632345|7455615|FG004|Treatment: Part I|Lack of Efficacy|1
4602896|NCT01632345|7455616|FG005|Treatment: Part I|Lack of Efficacy|0
4602897|NCT01632345|7455617|FG006|Treatment: Part I|Lack of Efficacy|0
4602898|NCT01632345|7455611|FG000|Treatment: Part I|Lost to Follow-up|3
4602899|NCT01632345|7455612|FG001|Treatment: Part I|Lost to Follow-up|2
4602900|NCT01632345|7455613|FG002|Treatment: Part I|Lost to Follow-up|1
4602901|NCT01632345|7455614|FG003|Treatment: Part I|Lost to Follow-up|3
4602902|NCT01632345|7455615|FG004|Treatment: Part I|Lost to Follow-up|4
4602903|NCT01632345|7455616|FG005|Treatment: Part I|Lost to Follow-up|0
4602904|NCT01632345|7455617|FG006|Treatment: Part I|Lost to Follow-up|0
4602905|NCT01632345|7455611|FG000|Treatment: Part I|Non-Compliance with Study Drug|3
4602906|NCT01632345|7455612|FG001|Treatment: Part I|Non-Compliance with Study Drug|2
4602907|NCT01632345|7455613|FG002|Treatment: Part I|Non-Compliance with Study Drug|2
4602908|NCT01632345|7455614|FG003|Treatment: Part I|Non-Compliance with Study Drug|1
4602909|NCT01632345|7455615|FG004|Treatment: Part I|Non-Compliance with Study Drug|0
4602910|NCT01632345|7455616|FG005|Treatment: Part I|Non-Compliance with Study Drug|0
4602911|NCT01632345|7455617|FG006|Treatment: Part I|Non-Compliance with Study Drug|0
4602912|NCT01632345|7455611|FG000|Treatment: Part I|Physician Decision|2
4602913|NCT01632345|7455612|FG001|Treatment: Part I|Physician Decision|1
4602914|NCT01632345|7455613|FG002|Treatment: Part I|Physician Decision|0
4602915|NCT01632345|7455614|FG003|Treatment: Part I|Physician Decision|0
4602916|NCT01632345|7455615|FG004|Treatment: Part I|Physician Decision|1
4602917|NCT01632345|7455616|FG005|Treatment: Part I|Physician Decision|0
4602918|NCT01632345|7455617|FG006|Treatment: Part I|Physician Decision|0
4602919|NCT01632345|7455611|FG000|Treatment: Part I|Pregnancy|0
4602920|NCT01632345|7455612|FG001|Treatment: Part I|Pregnancy|1
4602921|NCT01632345|7455613|FG002|Treatment: Part I|Pregnancy|0
4602922|NCT01632345|7455614|FG003|Treatment: Part I|Pregnancy|0
4602923|NCT01632345|7455615|FG004|Treatment: Part I|Pregnancy|0
4602924|NCT01632345|7455616|FG005|Treatment: Part I|Pregnancy|0
4602925|NCT01632345|7455617|FG006|Treatment: Part I|Pregnancy|0
4602926|NCT01632345|7455611|FG000|Treatment: Part I|Protocol Deviation|0
4602927|NCT01632345|7455612|FG001|Treatment: Part I|Protocol Deviation|0
4602928|NCT01632345|7455613|FG002|Treatment: Part I|Protocol Deviation|1
4602929|NCT01632345|7455614|FG003|Treatment: Part I|Protocol Deviation|1
4602930|NCT01632345|7455615|FG004|Treatment: Part I|Protocol Deviation|0
4602931|NCT01632345|7455616|FG005|Treatment: Part I|Protocol Deviation|0
4602932|NCT01632345|7455617|FG006|Treatment: Part I|Protocol Deviation|0
4602933|NCT01632345|7455611|FG000|Treatment: Part I|Withdrawal by Subject|3
4602934|NCT01632345|7455612|FG001|Treatment: Part I|Withdrawal by Subject|4
4602935|NCT01632345|7455613|FG002|Treatment: Part I|Withdrawal by Subject|4
4602936|NCT01632345|7455614|FG003|Treatment: Part I|Withdrawal by Subject|1
4602937|NCT01632345|7455615|FG004|Treatment: Part I|Withdrawal by Subject|4
4602938|NCT01632345|7455616|FG005|Treatment: Part I|Withdrawal by Subject|0
4602939|NCT01632345|7455617|FG006|Treatment: Part I|Withdrawal by Subject|0
4602940|NCT01632345|7455611|FG000|Treatment: Part II|Adverse Event|0
4602941|NCT01632345|7455612|FG001|Treatment: Part II|Adverse Event|0
4602942|NCT01632345|7455613|FG002|Treatment: Part II|Adverse Event|0
4602943|NCT01632345|7455614|FG003|Treatment: Part II|Adverse Event|0
4602944|NCT01632345|7455615|FG004|Treatment: Part II|Adverse Event|0
4602945|NCT01632345|7455616|FG005|Treatment: Part II|Adverse Event|3
4602946|NCT01632345|7455617|FG006|Treatment: Part II|Adverse Event|8
4602947|NCT01632345|7455611|FG000|Treatment: Part II|Lost to Follow-up|0
4602948|NCT01632345|7455612|FG001|Treatment: Part II|Lost to Follow-up|0
4602949|NCT01632345|7455613|FG002|Treatment: Part II|Lost to Follow-up|0
4602950|NCT01632345|7455614|FG003|Treatment: Part II|Lost to Follow-up|0
4602951|NCT01632345|7455615|FG004|Treatment: Part II|Lost to Follow-up|0
4602952|NCT01632345|7455616|FG005|Treatment: Part II|Lost to Follow-up|3
4602953|NCT01632345|7455617|FG006|Treatment: Part II|Lost to Follow-up|1
4602954|NCT01632345|7455611|FG000|Treatment: Part II|Non-Compliance with Study Drug|0
4602955|NCT01632345|7455612|FG001|Treatment: Part II|Non-Compliance with Study Drug|0
4602956|NCT01632345|7455613|FG002|Treatment: Part II|Non-Compliance with Study Drug|0
4602957|NCT01632345|7455614|FG003|Treatment: Part II|Non-Compliance with Study Drug|0
4602958|NCT01632345|7455615|FG004|Treatment: Part II|Non-Compliance with Study Drug|0
4602959|NCT01632345|7455616|FG005|Treatment: Part II|Non-Compliance with Study Drug|3
4602960|NCT01632345|7455617|FG006|Treatment: Part II|Non-Compliance with Study Drug|0
4602961|NCT01632345|7455611|FG000|Treatment: Part II|Withdrawal by Subject|0
4602962|NCT01632345|7455612|FG001|Treatment: Part II|Withdrawal by Subject|0
4602963|NCT01632345|7455613|FG002|Treatment: Part II|Withdrawal by Subject|0
4602964|NCT01632345|7455614|FG003|Treatment: Part II|Withdrawal by Subject|0
4602965|NCT01632345|7455615|FG004|Treatment: Part II|Withdrawal by Subject|0
4602966|NCT01632345|7455616|FG005|Treatment: Part II|Withdrawal by Subject|2
4602967|NCT01632345|7455617|FG006|Treatment: Part II|Withdrawal by Subject|2
4602968|NCT01632566|7455641|FG000|Overall Study|Withdrawal by Subject|0
4602969|NCT01632566|7455642|FG001|Overall Study|Withdrawal by Subject|1
4602970|NCT01632566|7455643|FG002|Overall Study|Withdrawal by Subject|0
4602971|NCT01632566|7455644|FG003|Overall Study|Withdrawal by Subject|0
4602972|NCT01632566|7455645|FG004|Overall Study|Withdrawal by Subject|0
4602973|NCT01632566|7455641|FG000|Overall Study|Sponsor Decision|0
4602974|NCT01632566|7455642|FG001|Overall Study|Sponsor Decision|2
4602975|NCT01632566|7455643|FG002|Overall Study|Sponsor Decision|9
4602976|NCT01632566|7455644|FG003|Overall Study|Sponsor Decision|2
4602977|NCT01632566|7455645|FG004|Overall Study|Sponsor Decision|2
4602978|NCT01632579|7455661|FG000|Washout Period|Adverse Event|1
4602979|NCT01632579|7455662|FG001|Washout Period|Adverse Event|0
4602980|NCT01632579|7455663|FG002|Washout Period|Adverse Event|0
4602981|NCT01632579|7455664|FG003|Washout Period|Adverse Event|0
4602982|NCT01632579|7455665|FG004|Washout Period|Adverse Event|0
4602983|NCT01632579|7455666|FG005|Washout Period|Adverse Event|0
4602984|NCT01632579|7455667|FG006|Washout Period|Adverse Event|0
4602985|NCT01632579|7455668|FG007|Washout Period|Adverse Event|0
4602986|NCT01632579|7455669|FG008|Washout Period|Adverse Event|0
4602987|NCT01632579|7455661|FG000|Period 2 (Second Intervention)|Adverse Event|1
4602988|NCT01632579|7455662|FG001|Period 2 (Second Intervention)|Adverse Event|0
4602989|NCT01632579|7455663|FG002|Period 2 (Second Intervention)|Adverse Event|0
4602990|NCT01632579|7455664|FG003|Period 2 (Second Intervention)|Adverse Event|0
4602991|NCT01632579|7455665|FG004|Period 2 (Second Intervention)|Adverse Event|0
4602992|NCT01632579|7455666|FG005|Period 2 (Second Intervention)|Adverse Event|0
4602993|NCT01632579|7455667|FG006|Period 2 (Second Intervention)|Adverse Event|0
4602994|NCT01632579|7455668|FG007|Period 2 (Second Intervention)|Adverse Event|0
4602995|NCT01632579|7455669|FG008|Period 2 (Second Intervention)|Adverse Event|0
4602996|NCT01632800|7455726|FG000|Overall Study|Subject did not fit in apparatus|1
4602997|NCT01632891|7455732|FG000|Overall Study|Lost to Follow-up|0
4602998|NCT01632891|7455733|FG001|Overall Study|Lost to Follow-up|1
4602999|NCT01632891|7455732|FG000|Overall Study|Withdrawal by Subject|1
4603000|NCT01632891|7455733|FG001|Overall Study|Withdrawal by Subject|0
4603001|NCT01632904|7455745|FG000|Overall Study|Adverse Event|4
4603002|NCT01632904|7455746|FG001|Overall Study|Adverse Event|1
4603003|NCT01632904|7455745|FG000|Overall Study|Physician Decision|0
4603004|NCT01632904|7455746|FG001|Overall Study|Physician Decision|1
4603005|NCT01632904|7455745|FG000|Overall Study|Subject decision|3
4603006|NCT01632904|7455746|FG001|Overall Study|Subject decision|2
4603007|NCT01632904|7455745|FG000|Overall Study|Disease Progression|0
4603008|NCT01632904|7455746|FG001|Overall Study|Disease Progression|1
4603009|NCT01632904|7455745|FG000|Overall Study|Reason for discontinuation not available|0
4603010|NCT01632904|7455746|FG001|Overall Study|Reason for discontinuation not available|1
4603011|NCT01633060|7455760|FG000|Randomization Phase|Protocol deviation|1
4603012|NCT01633060|7455761|FG001|Randomization Phase|Protocol deviation|2
4603013|NCT01633060|7455760|FG000|Randomization Phase|Technical problem|0
4603014|NCT01633060|7455761|FG001|Randomization Phase|Technical problem|1
4603015|NCT01633060|7455760|FG000|Treatment Phase|Adverse Event|24
4603016|NCT01633060|7455761|FG001|Treatment Phase|Adverse Event|3
4603017|NCT01633060|7455760|FG000|Treatment Phase|Lost to Follow-up|1
4603018|NCT01633060|7455761|FG001|Treatment Phase|Lost to Follow-up|0
4603019|NCT01633060|7455760|FG000|Treatment Phase|Physician Decision|16
4603020|NCT01633060|7455761|FG001|Treatment Phase|Physician Decision|7
4603021|NCT01633060|7455760|FG000|Treatment Phase|Progressive Disease|210
4603022|NCT01633060|7455761|FG001|Treatment Phase|Progressive Disease|120
4603023|NCT01633060|7455760|FG000|Treatment Phase|Protocol Deviation|1
4603024|NCT01633060|7455761|FG001|Treatment Phase|Protocol Deviation|0
4603025|NCT01633060|7455760|FG000|Treatment Phase|Study Terminated by sponsor|7
4603026|NCT01633060|7455761|FG001|Treatment Phase|Study Terminated by sponsor|3
4603027|NCT01633060|7455760|FG000|Treatment Phase|Subject/guardian decision|25
4603028|NCT01633060|7455761|FG001|Treatment Phase|Subject/guardian decision|4
4603029|NCT01633060|7455760|FG000|Treatment Phase|Death|4
4603030|NCT01633060|7455761|FG001|Treatment Phase|Death|3
4603031|NCT01633060|7455760|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2
4603032|NCT01633060|7455761|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
4603033|NCT01633060|7455760|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1
4603034|NCT01633060|7455761|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0
4603035|NCT01633060|7455760|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10
4603036|NCT01633060|7455761|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1
4603037|NCT01633060|7455760|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1
4603038|NCT01633060|7455761|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0
4603039|NCT01633060|7455760|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1
4603040|NCT01633060|7455761|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1
4603041|NCT01633060|7455760|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1
4603042|NCT01633060|7455761|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0
4603043|NCT01633112|7455771|FG000|Overall Study|Lack of Efficacy|1
4603044|NCT01633112|7455772|FG001|Overall Study|Lack of Efficacy|6
4603045|NCT01633112|7455773|FG002|Overall Study|Lack of Efficacy|13
4603046|NCT01633112|7455771|FG000|Overall Study|Abnormal laboratory value(s)|3
4603047|NCT01633112|7455772|FG001|Overall Study|Abnormal laboratory value(s)|1
4603048|NCT01633112|7455773|FG002|Overall Study|Abnormal laboratory value(s)|0
4603049|NCT01633112|7455771|FG000|Overall Study|Abnormal test procedure result(s)|0
4603050|NCT01633112|7455772|FG001|Overall Study|Abnormal test procedure result(s)|1
4603051|NCT01633112|7455773|FG002|Overall Study|Abnormal test procedure result(s)|0
4603052|NCT01633112|7455771|FG000|Overall Study|Administrative problems|1
4603053|NCT01633112|7455772|FG001|Overall Study|Administrative problems|2
4603054|NCT01633112|7455773|FG002|Overall Study|Administrative problems|5
4603055|NCT01633112|7455771|FG000|Overall Study|Adverse Event|16
4603056|NCT01633112|7455772|FG001|Overall Study|Adverse Event|18
4603057|NCT01633112|7455773|FG002|Overall Study|Adverse Event|20
4603058|NCT01633112|7455771|FG000|Overall Study|Lost to Follow-up|7
4603059|NCT01633112|7455772|FG001|Overall Study|Lost to Follow-up|19
4603060|NCT01633112|7455773|FG002|Overall Study|Lost to Follow-up|6
4746623|NCT00634010|7718615|FG000|Overall Study|Withdrawal by Subject|5
4746624|NCT00634010|7718616|FG001|Overall Study|Withdrawal by Subject|6
4746625|NCT00634010|7718615|FG000|Overall Study|Physician Decision|1
4603061|NCT01633112|7455771|FG000|Overall Study|Protocol Violation|4
4603062|NCT01633112|7455772|FG001|Overall Study|Protocol Violation|0
4603063|NCT01633112|7455773|FG002|Overall Study|Protocol Violation|2
4603064|NCT01633112|7455771|FG000|Overall Study|Subject no longer requires study drug|0
4603065|NCT01633112|7455772|FG001|Overall Study|Subject no longer requires study drug|0
4603066|NCT01633112|7455773|FG002|Overall Study|Subject no longer requires study drug|1
4603067|NCT01633112|7455771|FG000|Overall Study|Withdrawal by Subject|20
4603068|NCT01633112|7455772|FG001|Overall Study|Withdrawal by Subject|12
4603069|NCT01633112|7455773|FG002|Overall Study|Withdrawal by Subject|41
4603070|NCT01633112|7455771|FG000|Overall Study|missing Study Completion CRF|1
4603071|NCT01633112|7455772|FG001|Overall Study|missing Study Completion CRF|1
4603072|NCT01633112|7455773|FG002|Overall Study|missing Study Completion CRF|4
4603073|NCT01633788|7455804|FG000|Overall Study|Adverse Event|1
4603074|NCT01633788|7455805|FG001|Overall Study|Adverse Event|3
4603075|NCT01633788|7455806|FG002|Overall Study|Adverse Event|3
4603076|NCT01633788|7455807|FG003|Overall Study|Adverse Event|3
4603077|NCT01633788|7455804|FG000|Overall Study|Lost to Follow-up|2
4603078|NCT01633788|7455805|FG001|Overall Study|Lost to Follow-up|2
4603079|NCT01633788|7455806|FG002|Overall Study|Lost to Follow-up|2
4603080|NCT01633788|7455807|FG003|Overall Study|Lost to Follow-up|0
4603081|NCT01633788|7455804|FG000|Overall Study|Personal Reasons|3
4603082|NCT01633788|7455805|FG001|Overall Study|Personal Reasons|1
4603083|NCT01633788|7455806|FG002|Overall Study|Personal Reasons|1
4603084|NCT01633788|7455807|FG003|Overall Study|Personal Reasons|3
4603085|NCT01633788|7455804|FG000|Overall Study|Protocol Violation|1
4603086|NCT01633788|7455805|FG001|Overall Study|Protocol Violation|0
4603087|NCT01633788|7455806|FG002|Overall Study|Protocol Violation|1
4603088|NCT01633788|7455807|FG003|Overall Study|Protocol Violation|0
4603089|NCT01633788|7455804|FG000|Overall Study|Other Reasons|0
4603090|NCT01633788|7455805|FG001|Overall Study|Other Reasons|2
4603091|NCT01633788|7455806|FG002|Overall Study|Other Reasons|3
4603092|NCT01633788|7455807|FG003|Overall Study|Other Reasons|7
4603093|NCT01633944|7455847|FG000|Open-label Titration Phase|Adverse Event|109
4603094|NCT01633944|7455848|FG001|Open-label Titration Phase|Adverse Event|0
4603095|NCT01633944|7455849|FG002|Open-label Titration Phase|Adverse Event|0
4603096|NCT01633944|7455847|FG000|Open-label Titration Phase|Lack of Efficacy|33
4603097|NCT01633944|7455848|FG001|Open-label Titration Phase|Lack of Efficacy|0
4603098|NCT01633944|7455849|FG002|Open-label Titration Phase|Lack of Efficacy|0
4603099|NCT01633944|7455847|FG000|Open-label Titration Phase|Withdrawal by Subject|34
4603100|NCT01633944|7455848|FG001|Open-label Titration Phase|Withdrawal by Subject|0
4603101|NCT01633944|7455849|FG002|Open-label Titration Phase|Withdrawal by Subject|0
4603102|NCT01633944|7455847|FG000|Open-label Titration Phase|Protocol Violation|24
4603103|NCT01633944|7455848|FG001|Open-label Titration Phase|Protocol Violation|0
4603104|NCT01633944|7455849|FG002|Open-label Titration Phase|Protocol Violation|0
4603105|NCT01633944|7455847|FG000|Open-label Titration Phase|Lost to Follow-up|22
4603106|NCT01633944|7455848|FG001|Open-label Titration Phase|Lost to Follow-up|0
4603107|NCT01633944|7455849|FG002|Open-label Titration Phase|Lost to Follow-up|0
4746626|NCT00634010|7718616|FG001|Overall Study|Physician Decision|1
4746627|NCT00634010|7718615|FG000|Overall Study|Disease Progression|1
4746628|NCT00634010|7718616|FG001|Overall Study|Disease Progression|1
4746629|NCT00634010|7718615|FG000|Overall Study|Non-Compliant|1
4746630|NCT00634010|7718616|FG001|Overall Study|Non-Compliant|1
4746631|NCT00626561|7718666|FG000|Overall Study|Withdrawal by Subject|2
4746632|NCT00626561|7718666|FG000|Overall Study|Disease Progression|2
4746633|NCT00613730|7718670|FG000|Overall Study|Disease progression|2
4746634|NCT00613730|7718670|FG000|Overall Study|Administrative decision|1
4746635|NCT00625586|7718674|FG000|Overall Study|Adverse Event|1
4746636|NCT00625742|7718682|FG000|Overall Study|Disease Progression|2
4746637|NCT00625742|7718682|FG000|Overall Study|Withdrawal by Subject|1
4746638|NCT00625742|7718682|FG000|Overall Study|Adverse Event|4
4746639|NCT00625742|7718682|FG000|Overall Study|Lost to Follow-up|4
4746640|NCT00625742|7718682|FG000|Overall Study|Ineligible|1
4746641|NCT00619151|7718692|FG000|Overall Study|Study terminated prior to followup|1
4746642|NCT00619151|7718693|FG001|Overall Study|Study terminated prior to followup|0
4746643|NCT00622167|7718699|FG000|Overall Study|Did not meet angiographic criteria|20
4746644|NCT00616759|7718718|FG000|Overall Study|Physician Decision|2
4746645|NCT00616759|7718719|FG001|Overall Study|Physician Decision|0
4746646|NCT00616759|7718718|FG000|Overall Study|Withdrawal by Subject|1
4746647|NCT00616759|7718719|FG001|Overall Study|Withdrawal by Subject|2
4746648|NCT00616642|7718727|FG000|Overall Study|Withdrawal by Subject|0
4746649|NCT00616642|7718728|FG001|Overall Study|Withdrawal by Subject|1
4746650|NCT00619515|7718734|FG000|Overall Study|Study Termination by IRB|73
4746651|NCT00612677|7718742|FG000|Overall Study|study closed before treatment started|1
4746652|NCT00616603|7718749|FG000|Overall Study|Physician Decision|2
4746653|NCT00616603|7718750|FG001|Overall Study|Physician Decision|0
4746654|NCT00616603|7718751|FG002|Overall Study|Physician Decision|2
4746655|NCT00609765|7718792|FG000|Overall Study|Study ended prior to 12 months|1
4746656|NCT00595920|7718817|FG000|Overall Study|The OLTERMS study was discontinued by th|116
4746657|NCT00596947|7718823|FG000|Overall Study|study halted due to low enrollment|5
4746658|NCT00596947|7718824|FG001|Overall Study|study halted due to low enrollment|3
4746659|NCT00596947|7718823|FG000|Overall Study|Lost to Follow-up|1
4603108|NCT01633944|7455847|FG000|Open-label Titration Phase|Other|68
4603109|NCT01633944|7455848|FG001|Open-label Titration Phase|Other|0
4603110|NCT01633944|7455849|FG002|Open-label Titration Phase|Other|0
4603111|NCT01633944|7455847|FG000|Double-blind Treatment Phase|Adverse Event|0
4603112|NCT01633944|7455848|FG001|Double-blind Treatment Phase|Adverse Event|13
4603113|NCT01633944|7455849|FG002|Double-blind Treatment Phase|Adverse Event|7
4603114|NCT01633944|7455847|FG000|Double-blind Treatment Phase|Lack of Efficacy|0
4603115|NCT01633944|7455848|FG001|Double-blind Treatment Phase|Lack of Efficacy|8
4603116|NCT01633944|7455849|FG002|Double-blind Treatment Phase|Lack of Efficacy|23
4603117|NCT01633944|7455847|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0
4603118|NCT01633944|7455848|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11
4603119|NCT01633944|7455849|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8
4603120|NCT01633944|7455847|FG000|Double-blind Treatment Phase|Protocol Violation|0
4746660|NCT00596947|7718824|FG001|Overall Study|Lost to Follow-up|0
4746661|NCT00584012|7718830|FG000|Overall Study|Withdrawal by Subject|1
4603121|NCT01633944|7455848|FG001|Double-blind Treatment Phase|Protocol Violation|7
4603122|NCT01633944|7455849|FG002|Double-blind Treatment Phase|Protocol Violation|10
4603123|NCT01633944|7455847|FG000|Double-blind Treatment Phase|Lost to Follow-up|0
4603124|NCT01633944|7455848|FG001|Double-blind Treatment Phase|Lost to Follow-up|4
4603125|NCT01633944|7455849|FG002|Double-blind Treatment Phase|Lost to Follow-up|9
4603126|NCT01633944|7455847|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0
4603127|NCT01633944|7455848|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3
4603128|NCT01633944|7455849|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1
4603129|NCT01633944|7455847|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0
4603130|NCT01633944|7455848|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1
4603131|NCT01633944|7455849|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0
4603132|NCT01633944|7455847|FG000|Double-blind Treatment Phase|Other|0
4603133|NCT01633944|7455848|FG001|Double-blind Treatment Phase|Other|7
4603134|NCT01633944|7455849|FG002|Double-blind Treatment Phase|Other|0
4603135|NCT01634100|7455866|FG000|Overall Study|Withdrawal by Subject|1
4603136|NCT01634100|7455867|FG001|Overall Study|Withdrawal by Subject|0
4603137|NCT01634100|7455868|FG002|Overall Study|Withdrawal by Subject|1
4603138|NCT01634100|7455869|FG003|Overall Study|Withdrawal by Subject|0
4603139|NCT01634100|7455870|FG004|Overall Study|Withdrawal by Subject|0
4603140|NCT01634100|7455871|FG005|Overall Study|Withdrawal by Subject|0
4603141|NCT01634113|7455882|FG000|Overall Study|Not treated|0
4603142|NCT01634113|7455883|FG001|Overall Study|Not treated|0
4603143|NCT01634113|7455884|FG002|Overall Study|Not treated|1
4603144|NCT01634139|7455895|FG000|Overall Study|Non compliant with protocol|1
4603145|NCT01634139|7455896|FG001|Overall Study|Non compliant with protocol|0
4603146|NCT01634139|7455897|FG002|Overall Study|Non compliant with protocol|0
4603147|NCT01634139|7455895|FG000|Overall Study|Consent withdrawn not due to AE|4
4603148|NCT01634139|7455896|FG001|Overall Study|Consent withdrawn not due to AE|3
4603149|NCT01634139|7455897|FG002|Overall Study|Consent withdrawn not due to AE|2
4603150|NCT01634139|7455895|FG000|Overall Study|Other|4
4603151|NCT01634139|7455896|FG001|Overall Study|Other|0
4603152|NCT01634139|7455897|FG002|Overall Study|Other|3
4603153|NCT01634139|7455895|FG000|Overall Study|Lost to Follow-up|0
4603154|NCT01634139|7455896|FG001|Overall Study|Lost to Follow-up|2
4603155|NCT01634139|7455897|FG002|Overall Study|Lost to Follow-up|0
4603156|NCT01634139|7455895|FG000|Overall Study|Not treated|1
4603157|NCT01634139|7455896|FG001|Overall Study|Not treated|1
4603158|NCT01634139|7455897|FG002|Overall Study|Not treated|0
4603159|NCT01634152|7455908|FG000|Overall Study|Adverse Event|2
4603160|NCT01634152|7455909|FG001|Overall Study|Adverse Event|0
4603161|NCT01634152|7455910|FG002|Overall Study|Adverse Event|2
4603162|NCT01634152|7455908|FG000|Overall Study|Consent withdrawn not due to AE|1
4603163|NCT01634152|7455909|FG001|Overall Study|Consent withdrawn not due to AE|0
4603164|NCT01634152|7455910|FG002|Overall Study|Consent withdrawn not due to AE|1
4603165|NCT01634152|7455908|FG000|Overall Study|Not treated|0
4603166|NCT01634152|7455909|FG001|Overall Study|Not treated|1
4603167|NCT01634152|7455910|FG002|Overall Study|Not treated|0
4603168|NCT01634152|7455908|FG000|Overall Study|Other reason not defined above|1
4603169|NCT01634152|7455909|FG001|Overall Study|Other reason not defined above|0
4603170|NCT01634152|7455910|FG002|Overall Study|Other reason not defined above|1
4603171|NCT01634165|7455918|FG000|Period 2|Adverse Event|0
4603172|NCT01634165|7455919|FG001|Period 2|Adverse Event|1
4603173|NCT01634165|7455920|FG002|Period 2|Adverse Event|0
4603174|NCT01634165|7455921|FG003|Period 2|Adverse Event|0
4603175|NCT01634178|7455931|FG000|Treatment Period 1|Adverse Event|0
4603176|NCT01634178|7455932|FG001|Treatment Period 1|Adverse Event|1
4603177|NCT01634178|7455931|FG000|Treatment Period 2|Adverse Event|1
4603178|NCT01634178|7455932|FG001|Treatment Period 2|Adverse Event|0
4635954|NCT01938430|7507817|FG005|Overall Study|Withdrew Consent|0
4635955|NCT01938430|7507818|FG006|Overall Study|Withdrew Consent|0
4635956|NCT01938430|7507819|FG007|Overall Study|Withdrew Consent|0
4635957|NCT01938430|7507820|FG008|Overall Study|Withdrew Consent|1
4635958|NCT01938430|7507821|FG009|Overall Study|Withdrew Consent|0
4635959|NCT01938430|7507822|FG010|Overall Study|Withdrew Consent|0
4635960|NCT01938430|7507823|FG011|Overall Study|Withdrew Consent|0
4635961|NCT01938430|7507824|FG012|Overall Study|Withdrew Consent|0
4635962|NCT01938430|7507825|FG013|Overall Study|Withdrew Consent|0
4635963|NCT01938573|7507880|FG000|Overall Study|Lack of Efficacy|1
4635964|NCT01938573|7507881|FG001|Overall Study|Lack of Efficacy|0
4635965|NCT01938573|7507880|FG000|Overall Study|Operation at other hospital|1
4635966|NCT01938573|7507881|FG001|Overall Study|Operation at other hospital|0
4635967|NCT01938625|7507888|FG000|Overall Study|Withdrawal by Subject|0
4635968|NCT01938625|7507889|FG001|Overall Study|Withdrawal by Subject|1
4635969|NCT01938625|7507888|FG000|Overall Study|Adverse Event|0
4635970|NCT01938625|7507889|FG001|Overall Study|Adverse Event|1
4635971|NCT01938846|7507907|FG000|Overall Study|Progressive disease|26
4635972|NCT01938846|7507908|FG001|Overall Study|Progressive disease|18
4635973|NCT01938846|7507909|FG002|Overall Study|Progressive disease|16
4635974|NCT01938846|7507907|FG000|Overall Study|Adverse Event|8
4635975|NCT01938846|7507908|FG001|Overall Study|Adverse Event|4
4635976|NCT01938846|7507909|FG002|Overall Study|Adverse Event|3
4635977|NCT01938846|7507907|FG000|Overall Study|Withdrawal by Subject|2
4635978|NCT01938846|7507908|FG001|Overall Study|Withdrawal by Subject|2
4603179|NCT01634243|7455963|FG000|Overall Study|Adverse Event|5
4603180|NCT01634243|7455964|FG001|Overall Study|Adverse Event|5
4603181|NCT01634243|7455963|FG000|Overall Study|Lack of Efficacy|1
4603182|NCT01634243|7455964|FG001|Overall Study|Lack of Efficacy|0
4603183|NCT01634360|7455991|FG000|Overall Study|Adverse Event|10
4603184|NCT01634360|7455992|FG001|Overall Study|Adverse Event|34
4603185|NCT01634360|7455991|FG000|Overall Study|subject withdrew consent|13
4603186|NCT01634360|7455992|FG001|Overall Study|subject withdrew consent|23
4603187|NCT01634360|7455991|FG000|Overall Study|Protocol Violation|1
4603188|NCT01634360|7455992|FG001|Overall Study|Protocol Violation|1
4603189|NCT01634360|7455991|FG000|Overall Study|Lack of Efficacy|4
4603190|NCT01634360|7455992|FG001|Overall Study|Lack of Efficacy|14
4603191|NCT01634360|7455991|FG000|Overall Study|Other|3
4603192|NCT01634360|7455992|FG001|Overall Study|Other|20
4603193|NCT01634360|7455991|FG000|Overall Study|Study termination by sponsor|18
4603194|NCT01634360|7455992|FG001|Overall Study|Study termination by sponsor|44
4603195|NCT01634555|7455998|FG000|Overall Study|Adverse Event|3
4603196|NCT01634555|7455998|FG000|Overall Study|Physician Decision|1
4603197|NCT01634659|7456014|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2
4603198|NCT01634659|7456015|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0
4603199|NCT01634659|7456014|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1
4603200|NCT01634659|7456015|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0
4603201|NCT01634854|7456023|FG000|Overall Study|Cesarean delivery|2
4603202|NCT01634854|7456024|FG001|Overall Study|Cesarean delivery|7
4603203|NCT01635153|7456061|FG000|Overall Study|Lost to Follow-up|40
4603204|NCT01635153|7456062|FG001|Overall Study|Lost to Follow-up|43
4603205|NCT01635218|7456071|FG000|Overall Study|Lost to Follow-up|3
4603206|NCT01635218|7456072|FG001|Overall Study|Lost to Follow-up|7
4603207|NCT01635218|7456073|FG002|Overall Study|Lost to Follow-up|6
4603208|NCT01635283|7456094|FG000|Overall Study|Tumor Progression|3
4603209|NCT01635283|7456094|FG000|Overall Study|Lost to Follow-up|1
4603210|NCT01635764|7456119|FG000|Overall Study|Adverse Event|46
4603211|NCT01635764|7456119|FG000|Overall Study|Lack of Efficacy|76
4603212|NCT01635764|7456119|FG000|Overall Study|Exceed Protocol-specified Interventions|2
4603213|NCT01635764|7456119|FG000|Overall Study|Protocol Deviation|1
4603214|NCT01635764|7456119|FG000|Overall Study|Withdrew Consent|67
4603215|NCT01635764|7456119|FG000|Overall Study|Lost to Follow-up|53
4603216|NCT01635764|7456119|FG000|Overall Study|Other|28
4603217|NCT01635855|7456130|FG000|Overall Study|Withdrawal by Subject|4
4603218|NCT01635920|7456140|FG000|Overall Study|Adverse Event|1
4603219|NCT01635920|7456141|FG001|Overall Study|Adverse Event|0
4603220|NCT01635920|7456140|FG000|Overall Study|Lost to Follow-up|0
4603221|NCT01635920|7456141|FG001|Overall Study|Lost to Follow-up|1
4603222|NCT01635920|7456140|FG000|Overall Study|Subject decision|2
4603223|NCT01635920|7456141|FG001|Overall Study|Subject decision|0
4603224|NCT01635933|7456150|FG000|Overall Study|Adverse Event|1
4603225|NCT01635933|7456151|FG001|Overall Study|Adverse Event|0
4603226|NCT01635933|7456150|FG000|Overall Study|Lost to Follow-up|0
4603227|NCT01635933|7456151|FG001|Overall Study|Lost to Follow-up|5
4603228|NCT01635933|7456150|FG000|Overall Study|Subject decision|1
4603229|NCT01635933|7456151|FG001|Overall Study|Subject decision|1
4603230|NCT01635933|7456150|FG000|Overall Study|Noncompliance|0
4635979|NCT01938846|7507909|FG002|Overall Study|Withdrawal by Subject|1
4635980|NCT01938846|7507907|FG000|Overall Study|Other than listed|5
4635981|NCT01938846|7507908|FG001|Overall Study|Other than listed|1
4635982|NCT01938846|7507909|FG002|Overall Study|Other than listed|4
4635983|NCT01939002|7507959|FG000|Overall Study|Adverse Event|13
4635984|NCT01939002|7507960|FG001|Overall Study|Adverse Event|13
4635985|NCT01939002|7507959|FG000|Overall Study|Withdrawal by Subject|5
4635986|NCT01939002|7507960|FG001|Overall Study|Withdrawal by Subject|3
4635987|NCT01939002|7507959|FG000|Overall Study|Other|1
4635988|NCT01939002|7507960|FG001|Overall Study|Other|2
4635989|NCT01939028|7507971|FG000|Overall Study|Withdrawal by Subject|5
4635990|NCT01939028|7507971|FG000|Overall Study|Physician Decision|7
4635991|NCT01939158|7507988|FG000|Overall Study|Adverse Event|1
4635992|NCT01939158|7507989|FG001|Overall Study|Adverse Event|0
4635993|NCT01939158|7507990|FG002|Overall Study|Adverse Event|0
4635994|NCT01939158|7507991|FG003|Overall Study|Adverse Event|0
4635995|NCT01939158|7507988|FG000|Overall Study|Withdrawal by Subject|22
4603231|NCT01635933|7456151|FG001|Overall Study|Noncompliance|1
4603232|NCT01635933|7456150|FG000|Overall Study|No longer had transportation|0
4603233|NCT01635933|7456151|FG001|Overall Study|No longer had transportation|1
4603234|NCT01635998|7456159|FG000|Overall Study|Death|1
4603235|NCT01635998|7456160|FG001|Overall Study|Death|1
4603236|NCT01635998|7456159|FG000|Overall Study|Lost to Follow-up|2
4603237|NCT01635998|7456160|FG001|Overall Study|Lost to Follow-up|1
4603238|NCT01635998|7456159|FG000|Overall Study|Withdrawal by Subject|1
4603239|NCT01635998|7456160|FG001|Overall Study|Withdrawal by Subject|5
4603240|NCT01636076|7456177|FG000|Overall Study|Terminated by sponsor|1
4603241|NCT01636076|7456178|FG001|Overall Study|Terminated by sponsor|1
4603242|NCT01636076|7456177|FG000|Overall Study|Lack of Efficacy|0
4635996|NCT01939158|7507989|FG001|Overall Study|Withdrawal by Subject|25
4635997|NCT01939158|7507990|FG002|Overall Study|Withdrawal by Subject|15
4635998|NCT01939158|7507991|FG003|Overall Study|Withdrawal by Subject|17
4635999|NCT01939158|7507988|FG000|Overall Study|Migrated/moved from study area|5
4636000|NCT01939158|7507989|FG001|Overall Study|Migrated/moved from study area|7
4636001|NCT01939158|7507990|FG002|Overall Study|Migrated/moved from study area|3
4636002|NCT01939158|7507991|FG003|Overall Study|Migrated/moved from study area|6
4636003|NCT01939158|7507988|FG000|Overall Study|Lost to Follow-up|18
4636004|NCT01939158|7507989|FG001|Overall Study|Lost to Follow-up|17
4636005|NCT01939158|7507990|FG002|Overall Study|Lost to Follow-up|17
4636006|NCT01939158|7507991|FG003|Overall Study|Lost to Follow-up|17
4636007|NCT01939158|7507988|FG000|Overall Study|Death|0
4636008|NCT01939158|7507989|FG001|Overall Study|Death|0
4603243|NCT01636076|7456178|FG001|Overall Study|Lack of Efficacy|1
4603244|NCT01636076|7456177|FG000|Overall Study|Lost to Follow-up|1
4603245|NCT01636076|7456178|FG001|Overall Study|Lost to Follow-up|0
4603246|NCT01636076|7456177|FG000|Overall Study|Physician Decision|1
4603247|NCT01636076|7456178|FG001|Overall Study|Physician Decision|1
4603248|NCT01636076|7456177|FG000|Overall Study|Non-compliance with study treatment|1
4603249|NCT01636076|7456178|FG001|Overall Study|Non-compliance with study treatment|1
4603250|NCT01636076|7456177|FG000|Overall Study|Adverse Event|6
4603251|NCT01636076|7456178|FG001|Overall Study|Adverse Event|11
4603252|NCT01636076|7456177|FG000|Overall Study|Withdrawal by Subject|7
4603253|NCT01636076|7456178|FG001|Overall Study|Withdrawal by Subject|10
4603254|NCT01636258|7456212|FG000|Overall Study|Lost to Follow-up|1
4603255|NCT01636258|7456213|FG001|Overall Study|Lost to Follow-up|0
4603256|NCT01636362|7456239|FG000|Overall Study|Physician Decision|6
4603257|NCT01636362|7456239|FG000|Overall Study|Subject healed, not returning|1
4603258|NCT01636362|7456239|FG000|Overall Study|Withdrawal by Subject|1
4603259|NCT01636687|7456272|FG000|Induction Period|Withdrawal by Subject|1
4603260|NCT01636687|7456273|FG001|Induction Period|Withdrawal by Subject|0
4603261|NCT01636687|7456274|FG002|Induction Period|Withdrawal by Subject|0
4603262|NCT01636687|7456275|FG003|Induction Period|Withdrawal by Subject|0
4603263|NCT01636687|7456276|FG004|Induction Period|Withdrawal by Subject|0
4603264|NCT01636687|7456272|FG000|Induction Period|Adverse Event|1
4603265|NCT01636687|7456273|FG001|Induction Period|Adverse Event|0
4603266|NCT01636687|7456274|FG002|Induction Period|Adverse Event|0
4603267|NCT01636687|7456275|FG003|Induction Period|Adverse Event|0
4603268|NCT01636687|7456276|FG004|Induction Period|Adverse Event|1
4603269|NCT01636687|7456272|FG000|Induction Period|Lack of Efficacy|0
4603270|NCT01636687|7456273|FG001|Induction Period|Lack of Efficacy|0
4603271|NCT01636687|7456274|FG002|Induction Period|Lack of Efficacy|0
4603272|NCT01636687|7456275|FG003|Induction Period|Lack of Efficacy|0
4603273|NCT01636687|7456276|FG004|Induction Period|Lack of Efficacy|1
4603274|NCT01636687|7456272|FG000|Induction Period|Physician Decision|1
4603275|NCT01636687|7456273|FG001|Induction Period|Physician Decision|0
4603276|NCT01636687|7456274|FG002|Induction Period|Physician Decision|0
4603277|NCT01636687|7456275|FG003|Induction Period|Physician Decision|0
4603278|NCT01636687|7456276|FG004|Induction Period|Physician Decision|0
4603279|NCT01636687|7456272|FG000|Maintenance Period|Withdrawal by Subject|2
4603280|NCT01636687|7456273|FG001|Maintenance Period|Withdrawal by Subject|0
4603281|NCT01636687|7456274|FG002|Maintenance Period|Withdrawal by Subject|2
4603282|NCT01636687|7456275|FG003|Maintenance Period|Withdrawal by Subject|0
4603283|NCT01636687|7456276|FG004|Maintenance Period|Withdrawal by Subject|0
4603284|NCT01636687|7456272|FG000|Maintenance Period|Adverse Event|1
4603285|NCT01636687|7456273|FG001|Maintenance Period|Adverse Event|0
4603286|NCT01636687|7456274|FG002|Maintenance Period|Adverse Event|0
4603287|NCT01636687|7456275|FG003|Maintenance Period|Adverse Event|0
4603288|NCT01636687|7456276|FG004|Maintenance Period|Adverse Event|0
4603289|NCT01636687|7456272|FG000|Maintenance Period|Lack of Efficacy|4
4603290|NCT01636687|7456273|FG001|Maintenance Period|Lack of Efficacy|1
4603291|NCT01636687|7456274|FG002|Maintenance Period|Lack of Efficacy|0
4603292|NCT01636687|7456275|FG003|Maintenance Period|Lack of Efficacy|0
4603293|NCT01636687|7456276|FG004|Maintenance Period|Lack of Efficacy|0
4603294|NCT01636687|7456272|FG000|Maintenance Period|Lost to Follow-up|1
4603295|NCT01636687|7456273|FG001|Maintenance Period|Lost to Follow-up|1
4603296|NCT01636687|7456274|FG002|Maintenance Period|Lost to Follow-up|0
4603297|NCT01636687|7456275|FG003|Maintenance Period|Lost to Follow-up|0
4603298|NCT01636687|7456276|FG004|Maintenance Period|Lost to Follow-up|1
4603299|NCT01636687|7456272|FG000|Maintenance Period|Physician Decision|0
4603300|NCT01636687|7456273|FG001|Maintenance Period|Physician Decision|0
4603301|NCT01636687|7456274|FG002|Maintenance Period|Physician Decision|0
4603302|NCT01636687|7456275|FG003|Maintenance Period|Physician Decision|0
4603303|NCT01636687|7456276|FG004|Maintenance Period|Physician Decision|1
4603304|NCT01636687|7456272|FG000|Extension Period|technical problems|0
4603305|NCT01636687|7456273|FG001|Extension Period|technical problems|1
4603306|NCT01636687|7456274|FG002|Extension Period|technical problems|2
4603307|NCT01636687|7456275|FG003|Extension Period|technical problems|1
4603308|NCT01636687|7456276|FG004|Extension Period|technical problems|0
4603309|NCT01636687|7456272|FG000|Extension Period|Adverse Event|4
4603310|NCT01636687|7456273|FG001|Extension Period|Adverse Event|3
4603311|NCT01636687|7456274|FG002|Extension Period|Adverse Event|2
4603312|NCT01636687|7456275|FG003|Extension Period|Adverse Event|1
4603313|NCT01636687|7456276|FG004|Extension Period|Adverse Event|0
4603314|NCT01636687|7456272|FG000|Extension Period|Lack of Efficacy|7
4636009|NCT01939158|7507990|FG002|Overall Study|Death|1
4636010|NCT01939158|7507991|FG003|Overall Study|Death|1
4746662|NCT00577772|7718866|FG000|Overall Study|Lost to Follow-up|0
4603315|NCT01636687|7456273|FG001|Extension Period|Lack of Efficacy|0
4603316|NCT01636687|7456274|FG002|Extension Period|Lack of Efficacy|2
4603317|NCT01636687|7456275|FG003|Extension Period|Lack of Efficacy|1
4603318|NCT01636687|7456276|FG004|Extension Period|Lack of Efficacy|0
4603319|NCT01636687|7456272|FG000|Extension Period|Lost to Follow-up|1
4603320|NCT01636687|7456273|FG001|Extension Period|Lost to Follow-up|0
4603321|NCT01636687|7456274|FG002|Extension Period|Lost to Follow-up|1
4603322|NCT01636687|7456275|FG003|Extension Period|Lost to Follow-up|0
4603323|NCT01636687|7456276|FG004|Extension Period|Lost to Follow-up|0
4603324|NCT01636687|7456272|FG000|Extension Period|Physician Decision|1
4603325|NCT01636687|7456273|FG001|Extension Period|Physician Decision|0
4603326|NCT01636687|7456274|FG002|Extension Period|Physician Decision|0
4603327|NCT01636687|7456275|FG003|Extension Period|Physician Decision|1
4603328|NCT01636687|7456276|FG004|Extension Period|Physician Decision|0
4603329|NCT01636687|7456272|FG000|Extension Period|study terminated by sponsor|33
4603330|NCT01636687|7456273|FG001|Extension Period|study terminated by sponsor|50
4603331|NCT01636687|7456274|FG002|Extension Period|study terminated by sponsor|17
4603332|NCT01636687|7456275|FG003|Extension Period|study terminated by sponsor|23
4603333|NCT01636687|7456276|FG004|Extension Period|study terminated by sponsor|0
4603334|NCT01636687|7456272|FG000|Extension Period|Withdrawal by Subject|1
4603335|NCT01636687|7456273|FG001|Extension Period|Withdrawal by Subject|0
4603336|NCT01636687|7456274|FG002|Extension Period|Withdrawal by Subject|1
4603337|NCT01636687|7456275|FG003|Extension Period|Withdrawal by Subject|1
4603338|NCT01636687|7456276|FG004|Extension Period|Withdrawal by Subject|0
4603339|NCT01636687|7456272|FG000|Follow-up Period|Withdrawal by Subject|1
4603340|NCT01636687|7456273|FG001|Follow-up Period|Withdrawal by Subject|0
4603341|NCT01636687|7456274|FG002|Follow-up Period|Withdrawal by Subject|0
4603342|NCT01636687|7456275|FG003|Follow-up Period|Withdrawal by Subject|0
4603343|NCT01636687|7456276|FG004|Follow-up Period|Withdrawal by Subject|1
4603344|NCT01636713|7456297|FG000|Overall Study|Adverse Event|16
4603345|NCT01636713|7456298|FG001|Overall Study|Adverse Event|16
4603346|NCT01636713|7456299|FG002|Overall Study|Adverse Event|7
4603347|NCT01636713|7456297|FG000|Overall Study|Lack of Efficacy|6
4603348|NCT01636713|7456298|FG001|Overall Study|Lack of Efficacy|6
4603349|NCT01636713|7456299|FG002|Overall Study|Lack of Efficacy|2
4603350|NCT01636713|7456297|FG000|Overall Study|Protocol Violation|3
4603351|NCT01636713|7456298|FG001|Overall Study|Protocol Violation|0
4603352|NCT01636713|7456299|FG002|Overall Study|Protocol Violation|1
4603353|NCT01636713|7456297|FG000|Overall Study|Lost to Follow-up|0
4603354|NCT01636713|7456298|FG001|Overall Study|Lost to Follow-up|0
4603355|NCT01636713|7456299|FG002|Overall Study|Lost to Follow-up|1
4603356|NCT01636713|7456297|FG000|Overall Study|Withdrawal by Subject|5
4603357|NCT01636713|7456298|FG001|Overall Study|Withdrawal by Subject|4
4603358|NCT01636713|7456299|FG002|Overall Study|Withdrawal by Subject|8
4603359|NCT01636713|7456297|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2
4603360|NCT01636713|7456298|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2
4603361|NCT01636713|7456299|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4
4603362|NCT01636778|7456311|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3
4603363|NCT01636778|7456312|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0
4603364|NCT01636778|7456313|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0
4603365|NCT01636778|7456311|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1
4603366|NCT01636778|7456312|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0
4603367|NCT01636778|7456313|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0
4603368|NCT01636778|7456311|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0
4603369|NCT01636778|7456312|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7
4603370|NCT01636778|7456313|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0
4603371|NCT01636778|7456311|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0
4603372|NCT01636778|7456312|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1
4603373|NCT01636778|7456313|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0
4603374|NCT01636778|7456311|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0
4603375|NCT01636778|7456312|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2
4603376|NCT01636778|7456313|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0
4603377|NCT01636778|7456311|FG000|Follow-up Period After Part 2|Other|0
4603378|NCT01636778|7456312|FG001|Follow-up Period After Part 2|Other|0
4603379|NCT01636778|7456313|FG002|Follow-up Period After Part 2|Other|1
4603380|NCT01636778|7456311|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0
4603381|NCT01636778|7456312|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0
4603382|NCT01636778|7456313|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1
4603383|NCT01636778|7456311|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0
4603384|NCT01636778|7456312|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0
4603385|NCT01636778|7456313|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2
4603386|NCT01636934|7456327|FG000|Overall Study|Withdrawal by Subject|3
4603387|NCT01636934|7456328|FG001|Overall Study|Withdrawal by Subject|2
4603388|NCT01636934|7456327|FG000|Overall Study|Chemo cancel|1
4603389|NCT01636934|7456328|FG001|Overall Study|Chemo cancel|0
4603390|NCT01636934|7456327|FG000|Overall Study|Too ill to continue|1
4603391|NCT01636934|7456328|FG001|Overall Study|Too ill to continue|0
4603392|NCT01636934|7456327|FG000|Overall Study|Never started study medication|1
4603393|NCT01636934|7456328|FG001|Overall Study|Never started study medication|1
4603394|NCT01636947|7456336|FG000|Overall Study|Not Treated|2
4603395|NCT01636947|7456337|FG001|Overall Study|Not Treated|2
4603396|NCT01636947|7456336|FG000|Overall Study|Lost to Follow-up|4
4603397|NCT01636947|7456337|FG001|Overall Study|Lost to Follow-up|0
4603398|NCT01636947|7456336|FG000|Overall Study|Protocol Violation|1
4603399|NCT01636947|7456337|FG001|Overall Study|Protocol Violation|1
4603400|NCT01636947|7456336|FG000|Overall Study|Withdrawal by Subject|3
4603401|NCT01636947|7456337|FG001|Overall Study|Withdrawal by Subject|3
4603402|NCT01636947|7456336|FG000|Overall Study|Adverse Event|1
4603403|NCT01636947|7456337|FG001|Overall Study|Adverse Event|1
4603404|NCT01636947|7456336|FG000|Overall Study|Did Not Meet Eligibility Criteria|1
4603405|NCT01636947|7456337|FG001|Overall Study|Did Not Meet Eligibility Criteria|4
4603406|NCT01636960|7456343|FG000|Induction Phase|Adverse Event|2
4603407|NCT01636960|7456343|FG000|Maintenance Phase|Continued drug after regulatory approval|3
4603408|NCT01636960|7456343|FG000|Maintenance Phase|Adverse Event|3
4603409|NCT01636960|7456343|FG000|Maintenance Phase|Progressive disease|1
4603410|NCT01636986|7456349|FG000|Overall Study|Withdrawal by Subject|0
4603411|NCT01636986|7456350|FG001|Overall Study|Withdrawal by Subject|1
4603412|NCT01636986|7456349|FG000|Overall Study|Corneal Staining|0
4603413|NCT01636986|7456350|FG001|Overall Study|Corneal Staining|1
4603414|NCT01637077|7456358|FG000|Overall Study|Cancel|1
4603415|NCT01637077|7456359|FG001|Overall Study|Cancel|1
4603416|NCT01637077|7456358|FG000|Overall Study|Withdrawal by Subject|1
4603417|NCT01637077|7456359|FG001|Overall Study|Withdrawal by Subject|0
4603418|NCT01637077|7456358|FG000|Overall Study|No cycle 1 questionnaire data|2
4603419|NCT01637077|7456359|FG001|Overall Study|No cycle 1 questionnaire data|0
4603420|NCT01637142|7456369|FG000|Washout Period (at Least 3 Days)|Physician Decision|1
4603421|NCT01637272|7456379|FG000|Overall Study|Adverse Event|6
4603422|NCT01637272|7456379|FG000|Overall Study|Unsatisfactory therapeutic effect|2
4603423|NCT01637272|7456379|FG000|Overall Study|Withdrawal by Subject|3
4603424|NCT01637272|7456379|FG000|Overall Study|Lost to Follow-up|2
4603425|NCT01637272|7456379|FG000|Overall Study|completed core, did not enter ext. phase|4
4603426|NCT01637272|7456379|FG000|Overall Study|Administrative problems|1
4603427|NCT01637272|7456379|FG000|Overall Study|Protocol Violation|2
4603428|NCT01637402|7456398|FG000|Standard Dose Regimen|Lack of Efficacy|2
4603429|NCT01637402|7456399|FG001|Standard Dose Regimen|Lack of Efficacy|0
4603430|NCT01637402|7456398|FG000|Standard Dose Regimen|Adverse Event|1
4603431|NCT01637402|7456399|FG001|Standard Dose Regimen|Adverse Event|0
4603432|NCT01637402|7456398|FG000|Week 12 Evaluation|Lack of Efficacy|6
4603433|NCT01637402|7456399|FG001|Week 12 Evaluation|Lack of Efficacy|0
4603434|NCT01637402|7456398|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0
4603435|NCT01637402|7456399|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4
4603436|NCT01637402|7456398|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4
4603437|NCT01637402|7456399|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0
4603438|NCT01637402|7456398|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5
4603439|NCT01637402|7456399|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0
4603440|NCT01637584|7456426|FG000|Overall Study|Withdrawal by Subject|1
4603441|NCT01637584|7456427|FG001|Overall Study|Withdrawal by Subject|3
4603442|NCT01637623|7456437|FG000|Overall Study|Lost to Follow-up|0
4603443|NCT01637623|7456438|FG001|Overall Study|Lost to Follow-up|0
4603444|NCT01637623|7456439|FG002|Overall Study|Lost to Follow-up|2
4603445|NCT01637623|7456437|FG000|Overall Study|Physician Decision|1
4603446|NCT01637623|7456438|FG001|Overall Study|Physician Decision|0
4603447|NCT01637623|7456439|FG002|Overall Study|Physician Decision|1
4603448|NCT01637922|7456453|FG000|Overall Study|Adverse Event|0
4603449|NCT01637922|7456454|FG001|Overall Study|Adverse Event|1
4603450|NCT01637922|7456453|FG000|Overall Study|Protocol Violation|0
4603451|NCT01637922|7456454|FG001|Overall Study|Protocol Violation|1
4603452|NCT01637922|7456453|FG000|Overall Study|Withdrawal by Subject|0
4603453|NCT01637922|7456454|FG001|Overall Study|Withdrawal by Subject|3
4603454|NCT01637922|7456453|FG000|Overall Study|Lost to Follow-up|2
4603455|NCT01637922|7456454|FG001|Overall Study|Lost to Follow-up|0
4603456|NCT01637961|7456470|FG000|Overall Study|Ineligible: wrong primary|1
4603457|NCT01637961|7456470|FG000|Overall Study|Ineligible: inadequate pathology|1
4603458|NCT01638000|7456482|FG000|Overall Study|Randomized but Never Received Drug|7
4603459|NCT01638000|7456483|FG001|Overall Study|Randomized but Never Received Drug|10
4603460|NCT01638000|7456482|FG000|Overall Study|Adverse Event|14
4603461|NCT01638000|7456483|FG001|Overall Study|Adverse Event|16
4603462|NCT01638000|7456482|FG000|Overall Study|Lack of Efficacy|5
4603463|NCT01638000|7456483|FG001|Overall Study|Lack of Efficacy|6
4603464|NCT01638000|7456482|FG000|Overall Study|Protocol Violation|11
4603465|NCT01638000|7456483|FG001|Overall Study|Protocol Violation|13
4603466|NCT01638000|7456482|FG000|Overall Study|Withdrawal by Subject|21
4603467|NCT01638000|7456483|FG001|Overall Study|Withdrawal by Subject|24
4636011|NCT01939158|7507988|FG000|Overall Study|No longer meets eligibility criteria|0
4603468|NCT01638000|7456482|FG000|Overall Study|Miscellaneous|2
4603469|NCT01638000|7456483|FG001|Overall Study|Miscellaneous|2
4603470|NCT01638013|7456492|FG000|Overall Study|Adverse Event|36
4603471|NCT01638013|7456493|FG001|Overall Study|Adverse Event|29
4603472|NCT01638013|7456494|FG002|Overall Study|Adverse Event|48
4603473|NCT01638013|7456492|FG000|Overall Study|Lack of Efficacy|39
4603474|NCT01638013|7456493|FG001|Overall Study|Lack of Efficacy|11
4603475|NCT01638013|7456494|FG002|Overall Study|Lack of Efficacy|14
4603476|NCT01638013|7456492|FG000|Overall Study|Protocol Violation|10
4603477|NCT01638013|7456493|FG001|Overall Study|Protocol Violation|7
4603478|NCT01638013|7456494|FG002|Overall Study|Protocol Violation|11
4603479|NCT01638013|7456492|FG000|Overall Study|Met discontinuation criteria|4
4603480|NCT01638013|7456493|FG001|Overall Study|Met discontinuation criteria|0
4603481|NCT01638013|7456494|FG002|Overall Study|Met discontinuation criteria|7
4603482|NCT01638013|7456492|FG000|Overall Study|Subject Lost to Follow up|1
4603483|NCT01638013|7456493|FG001|Overall Study|Subject Lost to Follow up|0
4603484|NCT01638013|7456494|FG002|Overall Study|Subject Lost to Follow up|1
4603485|NCT01638013|7456492|FG000|Overall Study|Miscellaneous|25
4603486|NCT01638013|7456493|FG001|Overall Study|Miscellaneous|19
4603487|NCT01638013|7456494|FG002|Overall Study|Miscellaneous|23
4603488|NCT01638013|7456492|FG000|Overall Study|Withdrawal of Consent|16
4603489|NCT01638013|7456493|FG001|Overall Study|Withdrawal of Consent|12
4603490|NCT01638013|7456494|FG002|Overall Study|Withdrawal of Consent|16
4603491|NCT01638013|7456492|FG000|Overall Study|Not met inclusion or exclusion criteria|0
4603492|NCT01638013|7456493|FG001|Overall Study|Not met inclusion or exclusion criteria|0
4603493|NCT01638013|7456494|FG002|Overall Study|Not met inclusion or exclusion criteria|1
4603494|NCT01638390|7456524|FG000|Overall Study|screening failures|21
4603495|NCT01638429|7456545|FG000|Overall Study|Withdrawal by Subject|1
4603496|NCT01638546|7456565|FG000|Overall Study|Adverse Event|1
4603497|NCT01638546|7456566|FG001|Overall Study|Adverse Event|3
4603498|NCT01638559|7456574|FG000|Overall Study|Lost to Follow-up|1
4603499|NCT01638559|7456574|FG000|Overall Study|Withdrawal by Subject|1
4603500|NCT01638559|7456574|FG000|Overall Study|Subject declined to travel for biopsy|1
4603501|NCT01638819|7456591|FG000|Overall Study|Lost to Follow-up|1
4603502|NCT01638819|7456592|FG001|Overall Study|Lost to Follow-up|0
4603503|NCT01639001|7456599|FG000|Overall Study|Refused further follow-up|9
4603504|NCT01639001|7456600|FG001|Overall Study|Refused further follow-up|12
4603505|NCT01639001|7456599|FG000|Overall Study|Lost to Follow-up|3
4603506|NCT01639001|7456600|FG001|Overall Study|Lost to Follow-up|0
4603507|NCT01639001|7456599|FG000|Overall Study|Death|62
4603508|NCT01639001|7456600|FG001|Overall Study|Death|61
4603509|NCT01639001|7456599|FG000|Overall Study|Randomized but not treated|0
4603510|NCT01639001|7456600|FG001|Overall Study|Randomized but not treated|2
4603511|NCT01639001|7456599|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1
4603512|NCT01639001|7456600|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2
4603513|NCT01639040|7456610|FG000|Overall Study|Adverse Event|1
4603514|NCT01639040|7456611|FG001|Overall Study|Adverse Event|0
4603515|NCT01639144|7456622|FG000|Overall Study|Withdrawal by Subject|4
4603516|NCT01639144|7456623|FG001|Overall Study|Withdrawal by Subject|2
4603517|NCT01639144|7456622|FG000|Overall Study|Physician Decision|2
4603518|NCT01639144|7456623|FG001|Overall Study|Physician Decision|0
4603519|NCT01639144|7456622|FG000|Overall Study|Met postoperative exclusion criteria|4
4603520|NCT01639144|7456623|FG001|Overall Study|Met postoperative exclusion criteria|3
4603521|NCT01639339|7456644|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26
4603522|NCT01639339|7456645|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19
4603523|NCT01639339|7456644|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11
4603524|NCT01639339|7456645|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5
4603525|NCT01639339|7456644|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5
4603526|NCT01639339|7456645|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4
4603527|NCT01639339|7456644|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0
4603528|NCT01639339|7456645|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2
4603529|NCT01639339|7456644|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2
4603530|NCT01639339|7456645|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1
4603531|NCT01639339|7456644|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10
4603532|NCT01639339|7456645|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7
4603533|NCT01639339|7456644|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0
4603534|NCT01639339|7456645|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2
4603535|NCT01639339|7456644|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0
4603536|NCT01639339|7456645|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1
4603537|NCT01639339|7456644|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0
4636012|NCT01939158|7507989|FG001|Overall Study|No longer meets eligibility criteria|0
4636013|NCT01939158|7507990|FG002|Overall Study|No longer meets eligibility criteria|1
4636014|NCT01939158|7507991|FG003|Overall Study|No longer meets eligibility criteria|0
4636015|NCT01939158|7507988|FG000|Overall Study|Other|1
4603538|NCT01639339|7456645|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1
4603539|NCT01639339|7456644|FG000|Open-label Period (Up to Week 28)|Adverse Event|1
4603540|NCT01639339|7456645|FG001|Open-label Period (Up to Week 28)|Adverse Event|4
4603541|NCT01639469|7456670|FG000|Overall Study|Death|4
4603542|NCT01639469|7456671|FG001|Overall Study|Death|2
4603543|NCT01639469|7456670|FG000|Overall Study|Lost to Follow-up|1
4603544|NCT01639469|7456671|FG001|Overall Study|Lost to Follow-up|1
4636016|NCT01939158|7507989|FG001|Overall Study|Other|3
4603545|NCT01639495|7456677|FG000|Overall Study|Lost to Follow-up|6
4603546|NCT01639495|7456677|FG000|Overall Study|Consented but didn't have study catheter|4
4603547|NCT01639495|7456677|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4
4603548|NCT01639495|7456677|FG000|Overall Study|No radiofrequency energy applied|2
4603549|NCT01639560|7456683|FG000|Overall Study|Withdrawal by Subject|9
4603550|NCT01639560|7456684|FG001|Overall Study|Withdrawal by Subject|14
4603551|NCT01639560|7456683|FG000|Overall Study|Lack of Efficacy|1
4603552|NCT01639560|7456684|FG001|Overall Study|Lack of Efficacy|2
4603553|NCT01639560|7456683|FG000|Overall Study|Lost to Follow-up|9
4603554|NCT01639560|7456684|FG001|Overall Study|Lost to Follow-up|11
4603555|NCT01639560|7456683|FG000|Overall Study|Adverse Event|0
4603556|NCT01639560|7456684|FG001|Overall Study|Adverse Event|2
4603557|NCT01639703|7456713|FG000|Overall Study|Withdrawal by Subject|5
4603558|NCT01639703|7456713|FG000|Overall Study|Other reason|7
4603559|NCT01639729|7456729|FG000|Overall Study|Withdrawal by Subject|1
4603560|NCT01639729|7456730|FG001|Overall Study|Withdrawal by Subject|0
4603561|NCT01639729|7456731|FG002|Overall Study|Withdrawal by Subject|1
4603562|NCT01639729|7456732|FG003|Overall Study|Withdrawal by Subject|1
4603563|NCT01639729|7456733|FG004|Overall Study|Withdrawal by Subject|0
4603564|NCT01639729|7456734|FG005|Overall Study|Withdrawal by Subject|0
4603565|NCT01639742|7456744|FG000|Overall Study|Study Ongoing|17
4603566|NCT01639742|7456744|FG000|Overall Study|Lost to Follow-up|1
4603567|NCT01639755|7456748|FG000|Overall Study|Study Ongoing|15
4603568|NCT01639755|7456748|FG000|Overall Study|Patient had device explantation|4
4603569|NCT01639833|7456754|FG000|Overall Study|Death|4
4603570|NCT01639833|7456755|FG001|Overall Study|Death|2
4603571|NCT01639833|7456754|FG000|Overall Study|Withdrawal by Subject|2
4603572|NCT01639833|7456755|FG001|Overall Study|Withdrawal by Subject|2
4603573|NCT01640054|7456770|FG000|Overall Study|Study-specific disc criteria|1
4603574|NCT01640054|7456770|FG000|Overall Study|Lack of Efficacy|3
4603575|NCT01640054|7456770|FG000|Overall Study|Adverse Event|2
4603576|NCT01640184|7456782|FG000|Overall Study|Death|1
4603577|NCT01640184|7456783|FG001|Overall Study|Death|0
4603578|NCT01640184|7456784|FG002|Overall Study|Death|0
4603579|NCT01640184|7456782|FG000|Overall Study|Lost to Follow-up|4
4603580|NCT01640184|7456783|FG001|Overall Study|Lost to Follow-up|1
4603581|NCT01640184|7456784|FG002|Overall Study|Lost to Follow-up|0
4603582|NCT01640184|7456782|FG000|Overall Study|Physician Decision|3
4603583|NCT01640184|7456783|FG001|Overall Study|Physician Decision|0
4603584|NCT01640184|7456784|FG002|Overall Study|Physician Decision|0
4603585|NCT01640184|7456782|FG000|Overall Study|Withdrawal by Subject|0
4603586|NCT01640184|7456783|FG001|Overall Study|Withdrawal by Subject|1
4603587|NCT01640184|7456784|FG002|Overall Study|Withdrawal by Subject|1
4603588|NCT01640184|7456782|FG000|Overall Study|Protocol Violation|0
4603589|NCT01640184|7456783|FG001|Overall Study|Protocol Violation|0
4603590|NCT01640184|7456784|FG002|Overall Study|Protocol Violation|1
4603591|NCT01640249|7456811|FG000|Period 1|Withdrawal by Subject|1
4603592|NCT01640249|7456812|FG001|Period 1|Withdrawal by Subject|0
4603593|NCT01640249|7456813|FG002|Period 1|Withdrawal by Subject|0
4603594|NCT01640249|7456814|FG003|Period 1|Withdrawal by Subject|0
4603595|NCT01640249|7456815|FG004|Period 1|Withdrawal by Subject|0
4603596|NCT01640249|7456816|FG005|Period 1|Withdrawal by Subject|1
4603597|NCT01640249|7456817|FG006|Period 1|Withdrawal by Subject|0
4603598|NCT01640288|7456838|FG000|Overall Study|Equipment Failure or Poor Image Quality|4
4603599|NCT01640288|7456839|FG001|Overall Study|Equipment Failure or Poor Image Quality|5
4603600|NCT01640288|7456838|FG000|Overall Study|Screen Failure|20
4603601|NCT01640288|7456839|FG001|Overall Study|Screen Failure|18
4603602|NCT01640288|7456838|FG000|Overall Study|Withdrawn by PI|5
4603603|NCT01640288|7456839|FG001|Overall Study|Withdrawn by PI|0
4603604|NCT01640288|7456838|FG000|Overall Study|Withdrawal by Subject|1
4603605|NCT01640288|7456839|FG001|Overall Study|Withdrawal by Subject|0
4603606|NCT01640314|7456848|FG000|Overall Study|Protocol Violation|0
4603607|NCT01640314|7456849|FG001|Overall Study|Protocol Violation|1
4603608|NCT01640353|7456873|FG000|Overall Study|Withdrew prior to treatment|10
4603609|NCT01640353|7456873|FG000|Overall Study|Withdrawn from analysis at term site|12
4603610|NCT01640353|7456873|FG000|Overall Study|Withdrawal by Subject|5
4603611|NCT01640353|7456873|FG000|Overall Study|Death|2
4603612|NCT01640353|7456873|FG000|Overall Study|Early site termination|3
4603613|NCT01640353|7456873|FG000|Overall Study|Lost to Follow-up|12
4603614|NCT01640353|7456873|FG000|Overall Study|Physician Decision|1
4603615|NCT01640366|7456877|FG000|Overall Study|Withdrawal by Subject|1
4603616|NCT01640366|7456877|FG000|Overall Study|Protocol Violation|16
4603617|NCT01640366|7456877|FG000|Overall Study|Lost to Follow-up|5
4636017|NCT01939158|7507990|FG002|Overall Study|Other|4
4603618|NCT01640808|7456899|FG000|Overall Study|Unable to continue dynamic CT|14
4603619|NCT01640808|7456900|FG001|Overall Study|Unable to continue dynamic CT|4
4603620|NCT01640808|7456899|FG000|Overall Study|Withdrawal by Subject|12
4603621|NCT01640808|7456900|FG001|Overall Study|Withdrawal by Subject|4
4603622|NCT01640808|7456899|FG000|Overall Study|Lost to Follow-up|4
4603623|NCT01640808|7456900|FG001|Overall Study|Lost to Follow-up|0
4603624|NCT01640808|7456899|FG000|Overall Study|Start an antiviral therapy using IFN|3
4603625|NCT01640808|7456900|FG001|Overall Study|Start an antiviral therapy using IFN|0
4603626|NCT01640808|7456899|FG000|Overall Study|Administration of anticancer drugs|2
4636018|NCT01939158|7507991|FG003|Overall Study|Other|3
4603627|NCT01640808|7456900|FG001|Overall Study|Administration of anticancer drugs|1
4603628|NCT01640808|7456899|FG000|Overall Study|Physician Decision|19
4603629|NCT01640808|7456900|FG001|Overall Study|Physician Decision|5
4603630|NCT01640808|7456899|FG000|Overall Study|Randomized but not treated|4
4603631|NCT01640808|7456900|FG001|Overall Study|Randomized but not treated|2
4636019|NCT01939197|7508012|FG000|Overall Study|Withdrawal by Subject|1
4636020|NCT01939197|7508013|FG001|Overall Study|Withdrawal by Subject|0
4636021|NCT01939197|7508014|FG002|Overall Study|Withdrawal by Subject|0
4636022|NCT01939197|7508015|FG003|Overall Study|Withdrawal by Subject|0
4636023|NCT01939197|7508016|FG004|Overall Study|Withdrawal by Subject|1
4636024|NCT01939197|7508017|FG005|Overall Study|Withdrawal by Subject|0
4636025|NCT01939197|7508018|FG006|Overall Study|Withdrawal by Subject|0
4636026|NCT01939197|7508012|FG000|Overall Study|Lost to Follow-up|0
4636027|NCT01939197|7508013|FG001|Overall Study|Lost to Follow-up|1
4636028|NCT01939197|7508014|FG002|Overall Study|Lost to Follow-up|0
4636029|NCT01939197|7508015|FG003|Overall Study|Lost to Follow-up|1
4636030|NCT01939197|7508016|FG004|Overall Study|Lost to Follow-up|3
4636031|NCT01939197|7508017|FG005|Overall Study|Lost to Follow-up|1
4636032|NCT01939197|7508018|FG006|Overall Study|Lost to Follow-up|2
4636033|NCT01939314|7508067|FG000|Overall Study|Withdrawal by Subject|3
4636034|NCT01939314|7508068|FG001|Overall Study|Withdrawal by Subject|1
4636035|NCT01939314|7508067|FG000|Overall Study|Protocol Violation|1
4636036|NCT01939314|7508068|FG001|Overall Study|Protocol Violation|0
4636037|NCT01939314|7508067|FG000|Overall Study|Pregnancy|0
4636038|NCT01939314|7508068|FG001|Overall Study|Pregnancy|1
4636039|NCT01939314|7508067|FG000|Overall Study|Lost to Follow-up|5
4636040|NCT01939314|7508068|FG001|Overall Study|Lost to Follow-up|6
4636041|NCT01939353|7508076|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3
4636042|NCT01939353|7508076|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1
4636043|NCT01939353|7508076|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2
4636044|NCT01939353|7508076|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1
4636045|NCT01939353|7508076|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1
4636046|NCT01939366|7508085|FG000|Overall Study|Adverse Event|8
4636047|NCT01939366|7508086|FG001|Overall Study|Adverse Event|17
4636048|NCT01939366|7508087|FG002|Overall Study|Adverse Event|30
4636049|NCT01939366|7508088|FG003|Overall Study|Adverse Event|8
4636050|NCT01939366|7508089|FG004|Overall Study|Adverse Event|5
4636051|NCT01939366|7508085|FG000|Overall Study|Lack of Efficacy|2
4636052|NCT01939366|7508086|FG001|Overall Study|Lack of Efficacy|1
4636053|NCT01939366|7508087|FG002|Overall Study|Lack of Efficacy|1
4636054|NCT01939366|7508088|FG003|Overall Study|Lack of Efficacy|1
4636055|NCT01939366|7508089|FG004|Overall Study|Lack of Efficacy|3
4636056|NCT01939366|7508085|FG000|Overall Study|Lost to Follow-up|1
4636057|NCT01939366|7508086|FG001|Overall Study|Lost to Follow-up|1
4636058|NCT01939366|7508087|FG002|Overall Study|Lost to Follow-up|0
4636059|NCT01939366|7508088|FG003|Overall Study|Lost to Follow-up|0
4636060|NCT01939366|7508089|FG004|Overall Study|Lost to Follow-up|0
4636061|NCT01939366|7508085|FG000|Overall Study|Withdrawal by Subject|1
4636062|NCT01939366|7508086|FG001|Overall Study|Withdrawal by Subject|0
4636063|NCT01939366|7508087|FG002|Overall Study|Withdrawal by Subject|2
4636064|NCT01939366|7508088|FG003|Overall Study|Withdrawal by Subject|2
4636065|NCT01939366|7508089|FG004|Overall Study|Withdrawal by Subject|3
4636066|NCT01939366|7508085|FG000|Overall Study|Inclusion criteria not met|0
4636067|NCT01939366|7508086|FG001|Overall Study|Inclusion criteria not met|1
4636068|NCT01939366|7508087|FG002|Overall Study|Inclusion criteria not met|1
4636069|NCT01939366|7508088|FG003|Overall Study|Inclusion criteria not met|0
4636070|NCT01939366|7508089|FG004|Overall Study|Inclusion criteria not met|1
4636071|NCT01939366|7508085|FG000|Overall Study|Other|0
4636072|NCT01939366|7508086|FG001|Overall Study|Other|0
4636073|NCT01939366|7508087|FG002|Overall Study|Other|2
4636074|NCT01939366|7508088|FG003|Overall Study|Other|2
4636075|NCT01939366|7508089|FG004|Overall Study|Other|1
4636076|NCT01939366|7508085|FG000|Overall Study|Protocol Violation|0
4636077|NCT01939366|7508086|FG001|Overall Study|Protocol Violation|0
4636078|NCT01939366|7508087|FG002|Overall Study|Protocol Violation|0
4636079|NCT01939366|7508088|FG003|Overall Study|Protocol Violation|1
4636080|NCT01939366|7508089|FG004|Overall Study|Protocol Violation|0
4636081|NCT01939366|7508085|FG000|Overall Study|Sponsor decision|0
4636082|NCT01939366|7508086|FG001|Overall Study|Sponsor decision|0
4746663|NCT00577772|7718867|FG001|Overall Study|Lost to Follow-up|1
4746664|NCT00592007|7718873|FG000|Overall Study|Withdrawal by Subject|1
4746665|NCT00592007|7718873|FG000|Overall Study|patient ineligible (out of lab range)|1
4746666|NCT00595582|7718877|FG000|Overall Study|Pilot study that PI terminated|2
4636083|NCT01939366|7508087|FG002|Overall Study|Sponsor decision|0
4636084|NCT01939366|7508088|FG003|Overall Study|Sponsor decision|0
4636085|NCT01939366|7508089|FG004|Overall Study|Sponsor decision|2
4746667|NCT00595582|7718877|FG000|Overall Study|Lost to Follow-up|1
4746668|NCT00595582|7718877|FG000|Overall Study|Adverse Event|2
4746669|NCT00595582|7718877|FG000|Overall Study|Physician Decision|5
4636086|NCT01939366|7508085|FG000|Overall Study|GCP non-compliance at site|2
4636087|NCT01939366|7508086|FG001|Overall Study|GCP non-compliance at site|3
4636088|NCT01939366|7508087|FG002|Overall Study|GCP non-compliance at site|2
4636089|NCT01939366|7508088|FG003|Overall Study|GCP non-compliance at site|3
4636090|NCT01939366|7508089|FG004|Overall Study|GCP non-compliance at site|3
4636091|NCT01939496|7508113|FG000|Overall Study|Adverse Event|2
4636092|NCT01939496|7508114|FG001|Overall Study|Adverse Event|0
4636093|NCT01939496|7508115|FG002|Overall Study|Adverse Event|0
4636094|NCT01939496|7508113|FG000|Overall Study|Lost to Follow-up|1
4636095|NCT01939496|7508114|FG001|Overall Study|Lost to Follow-up|1
4636096|NCT01939496|7508115|FG002|Overall Study|Lost to Follow-up|0
4636097|NCT01939496|7508113|FG000|Overall Study|Physician Decision|1
4636098|NCT01939496|7508114|FG001|Overall Study|Physician Decision|0
4636099|NCT01939496|7508115|FG002|Overall Study|Physician Decision|0
4636100|NCT01939496|7508113|FG000|Overall Study|Protocol Violation|3
4636101|NCT01939496|7508114|FG001|Overall Study|Protocol Violation|0
4636102|NCT01939496|7508115|FG002|Overall Study|Protocol Violation|0
4636103|NCT01939496|7508113|FG000|Overall Study|Withdrawal by Subject|0
4746670|NCT00588146|7718881|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4
4746671|NCT00588146|7718882|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3
4746672|NCT00590538|7718897|FG000|Overall Study|Study terminated before completed|2
4746673|NCT00583115|7718901|FG000|Overall Study|Death|1
4746674|NCT00582712|7718905|FG000|Overall Study|Adverse Event|1
4746675|NCT00582712|7718905|FG000|Overall Study|Lack of Efficacy|1
4746676|NCT00582712|7718905|FG000|Overall Study|Withdrawal by Subject|1
4603632|NCT01640873|7456923|FG000|Overall Study|Protocol Violation|2
4603633|NCT01640873|7456924|FG001|Overall Study|Protocol Violation|1
4603634|NCT01640925|7456932|FG000|Overall Study|Withdrawal by Subject|1
4603635|NCT01640925|7456933|FG001|Overall Study|Withdrawal by Subject|0
4603636|NCT01640925|7456932|FG000|Overall Study|Previously enrolled in this trial|13
4603637|NCT01640925|7456933|FG001|Overall Study|Previously enrolled in this trial|11
4603638|NCT01640951|7456947|FG000|Overall Study|Adverse Event|8
4603639|NCT01640951|7456948|FG001|Overall Study|Adverse Event|3
4603640|NCT01640951|7456949|FG002|Overall Study|Adverse Event|10
4603641|NCT01640951|7456950|FG003|Overall Study|Adverse Event|6
4603642|NCT01640951|7456951|FG004|Overall Study|Adverse Event|1
4603643|NCT01640951|7456952|FG005|Overall Study|Adverse Event|11
4603644|NCT01640951|7456953|FG006|Overall Study|Adverse Event|1
4603645|NCT01640951|7456954|FG007|Overall Study|Adverse Event|3
4603646|NCT01640951|7456947|FG000|Overall Study|Lack of Efficacy|20
4603647|NCT01640951|7456948|FG001|Overall Study|Lack of Efficacy|1
4603648|NCT01640951|7456949|FG002|Overall Study|Lack of Efficacy|7
4603649|NCT01640951|7456950|FG003|Overall Study|Lack of Efficacy|14
4603650|NCT01640951|7456951|FG004|Overall Study|Lack of Efficacy|0
4603651|NCT01640951|7456952|FG005|Overall Study|Lack of Efficacy|6
4603652|NCT01640951|7456953|FG006|Overall Study|Lack of Efficacy|5
4603653|NCT01640951|7456954|FG007|Overall Study|Lack of Efficacy|6
4603654|NCT01640951|7456947|FG000|Overall Study|Lost to Follow-up|1
4603655|NCT01640951|7456948|FG001|Overall Study|Lost to Follow-up|0
4603656|NCT01640951|7456949|FG002|Overall Study|Lost to Follow-up|6
4603657|NCT01640951|7456950|FG003|Overall Study|Lost to Follow-up|2
4603658|NCT01640951|7456951|FG004|Overall Study|Lost to Follow-up|2
4603659|NCT01640951|7456952|FG005|Overall Study|Lost to Follow-up|3
4603660|NCT01640951|7456953|FG006|Overall Study|Lost to Follow-up|1
4603661|NCT01640951|7456954|FG007|Overall Study|Lost to Follow-up|1
4603662|NCT01640951|7456947|FG000|Overall Study|Non-compliance with study treatment|0
4603663|NCT01640951|7456948|FG001|Overall Study|Non-compliance with study treatment|0
4603664|NCT01640951|7456949|FG002|Overall Study|Non-compliance with study treatment|1
4603665|NCT01640951|7456950|FG003|Overall Study|Non-compliance with study treatment|1
4603666|NCT01640951|7456951|FG004|Overall Study|Non-compliance with study treatment|1
4603667|NCT01640951|7456952|FG005|Overall Study|Non-compliance with study treatment|4
4603668|NCT01640951|7456953|FG006|Overall Study|Non-compliance with study treatment|1
4603669|NCT01640951|7456954|FG007|Overall Study|Non-compliance with study treatment|0
4603670|NCT01640951|7456947|FG000|Overall Study|Physician Decision|2
4603671|NCT01640951|7456948|FG001|Overall Study|Physician Decision|5
4603672|NCT01640951|7456949|FG002|Overall Study|Physician Decision|2
4603673|NCT01640951|7456950|FG003|Overall Study|Physician Decision|2
4603674|NCT01640951|7456951|FG004|Overall Study|Physician Decision|2
4603675|NCT01640951|7456952|FG005|Overall Study|Physician Decision|3
4603676|NCT01640951|7456953|FG006|Overall Study|Physician Decision|3
4603677|NCT01640951|7456954|FG007|Overall Study|Physician Decision|0
4603678|NCT01640951|7456947|FG000|Overall Study|Pregnancy|3
4603679|NCT01640951|7456948|FG001|Overall Study|Pregnancy|0
4603680|NCT01640951|7456949|FG002|Overall Study|Pregnancy|0
4603681|NCT01640951|7456950|FG003|Overall Study|Pregnancy|4
4603682|NCT01640951|7456951|FG004|Overall Study|Pregnancy|0
4603683|NCT01640951|7456952|FG005|Overall Study|Pregnancy|0
4603684|NCT01640951|7456953|FG006|Overall Study|Pregnancy|2
4603685|NCT01640951|7456954|FG007|Overall Study|Pregnancy|0
4603686|NCT01640951|7456947|FG000|Overall Study|Protocol Deviation|0
4603687|NCT01640951|7456948|FG001|Overall Study|Protocol Deviation|1
4603688|NCT01640951|7456949|FG002|Overall Study|Protocol Deviation|2
4603689|NCT01640951|7456950|FG003|Overall Study|Protocol Deviation|1
4603690|NCT01640951|7456951|FG004|Overall Study|Protocol Deviation|0
4603691|NCT01640951|7456952|FG005|Overall Study|Protocol Deviation|1
4603692|NCT01640951|7456953|FG006|Overall Study|Protocol Deviation|0
4603693|NCT01640951|7456954|FG007|Overall Study|Protocol Deviation|0
4636104|NCT01939496|7508114|FG001|Overall Study|Withdrawal by Subject|1
4746677|NCT00582712|7718905|FG000|Overall Study|Complicating disease requiring treatment|1
4603694|NCT01640951|7456947|FG000|Overall Study|Subject/Guardian decision|12
4636105|NCT01939496|7508115|FG002|Overall Study|Withdrawal by Subject|1
4603695|NCT01640951|7456948|FG001|Overall Study|Subject/Guardian decision|4
4636106|NCT01939496|7508113|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0
4636107|NCT01939496|7508114|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1
4636108|NCT01939496|7508115|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0
4636109|NCT01939496|7508113|FG000|Overall Study|Other|2
4636110|NCT01939496|7508114|FG001|Overall Study|Other|0
4636111|NCT01939496|7508115|FG002|Overall Study|Other|1
4636112|NCT01939548|7508126|FG000|Overall Study|Non compliance|0
4636113|NCT01939548|7508127|FG001|Overall Study|Non compliance|2
4636114|NCT01939548|7508128|FG002|Overall Study|Non compliance|0
4636115|NCT01939548|7508126|FG000|Overall Study|Study Terminated by Sponsor|17
4636116|NCT01939548|7508127|FG001|Overall Study|Study Terminated by Sponsor|19
4636117|NCT01939548|7508128|FG002|Overall Study|Study Terminated by Sponsor|12
4636118|NCT01939548|7508126|FG000|Overall Study|Insufficient Clinical Response|1
4636119|NCT01939548|7508127|FG001|Overall Study|Insufficient Clinical Response|0
4636120|NCT01939548|7508128|FG002|Overall Study|Insufficient Clinical Response|0
4636121|NCT01939548|7508126|FG000|Overall Study|Did Not Meet Entrance Criteria|1
4636122|NCT01939548|7508127|FG001|Overall Study|Did Not Meet Entrance Criteria|0
4636123|NCT01939548|7508128|FG002|Overall Study|Did Not Meet Entrance Criteria|0
4636124|NCT01939548|7508126|FG000|Overall Study|Withdrawal by Subject|4
4636125|NCT01939548|7508127|FG001|Overall Study|Withdrawal by Subject|4
4636126|NCT01939548|7508128|FG002|Overall Study|Withdrawal by Subject|1
4636127|NCT01939548|7508126|FG000|Overall Study|Protocol Violation|7
4636128|NCT01939548|7508127|FG001|Overall Study|Protocol Violation|6
4636129|NCT01939548|7508128|FG002|Overall Study|Protocol Violation|5
4636130|NCT01939548|7508126|FG000|Overall Study|Lost to Follow-up|5
4636131|NCT01939548|7508127|FG001|Overall Study|Lost to Follow-up|5
4636132|NCT01939548|7508128|FG002|Overall Study|Lost to Follow-up|3
4636133|NCT01939548|7508126|FG000|Overall Study|Adverse Event|2
4636134|NCT01939548|7508127|FG001|Overall Study|Adverse Event|9
4636135|NCT01939548|7508128|FG002|Overall Study|Adverse Event|7
4636136|NCT01939548|7508126|FG000|Overall Study|Death|0
4636137|NCT01939548|7508127|FG001|Overall Study|Death|0
4636138|NCT01939548|7508128|FG002|Overall Study|Death|1
4636139|NCT01939548|7508126|FG000|Overall Study|Participant dropped|0
4636140|NCT01939548|7508127|FG001|Overall Study|Participant dropped|0
4636141|NCT01939548|7508128|FG002|Overall Study|Participant dropped|1
4636142|NCT01939548|7508126|FG000|Overall Study|Participant unwilling to continue|0
4636143|NCT01939548|7508127|FG001|Overall Study|Participant unwilling to continue|1
4636144|NCT01939548|7508128|FG002|Overall Study|Participant unwilling to continue|0
4636145|NCT01939548|7508126|FG000|Overall Study|Participant withdrew consent|0
4636146|NCT01939548|7508127|FG001|Overall Study|Participant withdrew consent|2
4636147|NCT01939548|7508128|FG002|Overall Study|Participant withdrew consent|0
4636148|NCT01939548|7508126|FG000|Overall Study|Did not complete follow-up|0
4636149|NCT01939548|7508127|FG001|Overall Study|Did not complete follow-up|1
4636150|NCT01939548|7508128|FG002|Overall Study|Did not complete follow-up|0
4636151|NCT01939899|7508141|FG000|Lead-in Dose Finding Phase|Death|0
4636152|NCT01939899|7508142|FG001|Lead-in Dose Finding Phase|Death|3
4636153|NCT01939899|7508143|FG002|Lead-in Dose Finding Phase|Death|1
4636154|NCT01939899|7508144|FG003|Lead-in Dose Finding Phase|Death|0
4636155|NCT01939899|7508145|FG004|Lead-in Dose Finding Phase|Death|0
4636156|NCT01939899|7508141|FG000|Lead-in Dose Finding Phase|Disease Progression|2
4636157|NCT01939899|7508142|FG001|Lead-in Dose Finding Phase|Disease Progression|4
4636158|NCT01939899|7508143|FG002|Lead-in Dose Finding Phase|Disease Progression|3
4636159|NCT01939899|7508144|FG003|Lead-in Dose Finding Phase|Disease Progression|0
4636160|NCT01939899|7508145|FG004|Lead-in Dose Finding Phase|Disease Progression|0
4636161|NCT01939899|7508141|FG000|Lead-in Dose Finding Phase|Other|0
4636162|NCT01939899|7508142|FG001|Lead-in Dose Finding Phase|Other|0
4636163|NCT01939899|7508143|FG002|Lead-in Dose Finding Phase|Other|1
4636164|NCT01939899|7508144|FG003|Lead-in Dose Finding Phase|Other|0
4636165|NCT01939899|7508145|FG004|Lead-in Dose Finding Phase|Other|0
4603696|NCT01640951|7456949|FG002|Overall Study|Subject/Guardian decision|13
4603697|NCT01640951|7456950|FG003|Overall Study|Subject/Guardian decision|15
4603698|NCT01640951|7456951|FG004|Overall Study|Subject/Guardian decision|7
4603699|NCT01640951|7456952|FG005|Overall Study|Subject/Guardian decision|19
4603700|NCT01640951|7456953|FG006|Overall Study|Subject/Guardian decision|5
4603701|NCT01640951|7456954|FG007|Overall Study|Subject/Guardian decision|4
4603702|NCT01640951|7456947|FG000|Overall Study|Death|0
4603703|NCT01640951|7456948|FG001|Overall Study|Death|1
4636166|NCT01939899|7508141|FG000|Phase 2|Withdrawal by Subject|0
4636167|NCT01939899|7508142|FG001|Phase 2|Withdrawal by Subject|0
4636168|NCT01939899|7508143|FG002|Phase 2|Withdrawal by Subject|0
4636169|NCT01939899|7508144|FG003|Phase 2|Withdrawal by Subject|2
4636170|NCT01939899|7508145|FG004|Phase 2|Withdrawal by Subject|0
4636171|NCT01939899|7508141|FG000|Phase 2|Disease Progression|0
4636172|NCT01939899|7508142|FG001|Phase 2|Disease Progression|0
4636173|NCT01939899|7508143|FG002|Phase 2|Disease Progression|0
4636174|NCT01939899|7508144|FG003|Phase 2|Disease Progression|9
4636175|NCT01939899|7508145|FG004|Phase 2|Disease Progression|1
4636176|NCT01939977|7508171|FG000|Overall Study|Adverse Event|4
4636177|NCT01939977|7508172|FG001|Overall Study|Adverse Event|3
4636178|NCT01939977|7508171|FG000|Overall Study|Lack of Efficacy|3
4636179|NCT01939977|7508172|FG001|Overall Study|Lack of Efficacy|0
4636180|NCT01939977|7508171|FG000|Overall Study|Physician Decision|1
4603704|NCT01640951|7456949|FG002|Overall Study|Death|1
4603705|NCT01640951|7456950|FG003|Overall Study|Death|0
4603706|NCT01640951|7456951|FG004|Overall Study|Death|0
4603707|NCT01640951|7456952|FG005|Overall Study|Death|0
4603708|NCT01640951|7456953|FG006|Overall Study|Death|0
4603709|NCT01640951|7456954|FG007|Overall Study|Death|2
4603710|NCT01640964|7456977|FG000|Overall Study|Lost to Follow-up|0
4603711|NCT01640964|7456978|FG001|Overall Study|Lost to Follow-up|0
4603712|NCT01640964|7456979|FG002|Overall Study|Lost to Follow-up|1
4603713|NCT01640964|7456977|FG000|Overall Study|Protocol Deviation|1
4603714|NCT01640964|7456978|FG001|Overall Study|Protocol Deviation|1
4603715|NCT01640964|7456979|FG002|Overall Study|Protocol Deviation|2
4603716|NCT01641081|7456997|FG000|Period 1|Sponsor request (potential unblinding)|0
4603717|NCT01641081|7456998|FG001|Period 1|Sponsor request (potential unblinding)|0
4603718|NCT01641081|7456999|FG002|Period 1|Sponsor request (potential unblinding)|0
4603719|NCT01641081|7457000|FG003|Period 1|Sponsor request (potential unblinding)|0
4603720|NCT01641081|7457001|FG004|Period 1|Sponsor request (potential unblinding)|0
4603721|NCT01641081|7457002|FG005|Period 1|Sponsor request (potential unblinding)|0
4603722|NCT01641081|7457003|FG006|Period 1|Sponsor request (potential unblinding)|1
4603723|NCT01641081|7457004|FG007|Period 1|Sponsor request (potential unblinding)|0
4603724|NCT01641081|7457005|FG008|Period 1|Sponsor request (potential unblinding)|0
4603725|NCT01641081|7457006|FG009|Period 1|Sponsor request (potential unblinding)|0
4603726|NCT01641081|7456997|FG000|Period 1|Protocol Violation|0
4603727|NCT01641081|7456998|FG001|Period 1|Protocol Violation|0
4603728|NCT01641081|7456999|FG002|Period 1|Protocol Violation|0
4603729|NCT01641081|7457000|FG003|Period 1|Protocol Violation|0
4603730|NCT01641081|7457001|FG004|Period 1|Protocol Violation|1
4603731|NCT01641081|7457002|FG005|Period 1|Protocol Violation|0
4603732|NCT01641081|7457003|FG006|Period 1|Protocol Violation|0
4603733|NCT01641081|7457004|FG007|Period 1|Protocol Violation|1
4603734|NCT01641081|7457005|FG008|Period 1|Protocol Violation|0
4603735|NCT01641081|7457006|FG009|Period 1|Protocol Violation|0
4603736|NCT01641081|7456997|FG000|Period 1|Adverse Event|1
4603737|NCT01641081|7456998|FG001|Period 1|Adverse Event|0
4603738|NCT01641081|7456999|FG002|Period 1|Adverse Event|0
4603739|NCT01641081|7457000|FG003|Period 1|Adverse Event|0
4603740|NCT01641081|7457001|FG004|Period 1|Adverse Event|0
4603741|NCT01641081|7457002|FG005|Period 1|Adverse Event|0
4603742|NCT01641081|7457003|FG006|Period 1|Adverse Event|0
4603743|NCT01641081|7457004|FG007|Period 1|Adverse Event|2
4603744|NCT01641081|7457005|FG008|Period 1|Adverse Event|0
4603745|NCT01641081|7457006|FG009|Period 1|Adverse Event|0
4603746|NCT01641081|7456997|FG000|Period 2|Adverse Event|0
4603747|NCT01641081|7456998|FG001|Period 2|Adverse Event|0
4603748|NCT01641081|7456999|FG002|Period 2|Adverse Event|0
4603749|NCT01641081|7457000|FG003|Period 2|Adverse Event|0
4603750|NCT01641081|7457001|FG004|Period 2|Adverse Event|0
4603751|NCT01641081|7457002|FG005|Period 2|Adverse Event|1
4603752|NCT01641081|7457003|FG006|Period 2|Adverse Event|0
4603753|NCT01641081|7457004|FG007|Period 2|Adverse Event|0
4603754|NCT01641081|7457005|FG008|Period 2|Adverse Event|0
4603755|NCT01641081|7457006|FG009|Period 2|Adverse Event|0
4603756|NCT01641081|7456997|FG000|Period 2|Withdrawal by Subject|0
4603757|NCT01641081|7456998|FG001|Period 2|Withdrawal by Subject|0
4603758|NCT01641081|7456999|FG002|Period 2|Withdrawal by Subject|0
4603759|NCT01641081|7457000|FG003|Period 2|Withdrawal by Subject|1
4603760|NCT01641081|7457001|FG004|Period 2|Withdrawal by Subject|0
4603761|NCT01641081|7457002|FG005|Period 2|Withdrawal by Subject|0
4603762|NCT01641081|7457003|FG006|Period 2|Withdrawal by Subject|2
4603763|NCT01641081|7457004|FG007|Period 2|Withdrawal by Subject|0
4603764|NCT01641081|7457005|FG008|Period 2|Withdrawal by Subject|0
4603765|NCT01641081|7457006|FG009|Period 2|Withdrawal by Subject|0
4603766|NCT01641081|7456997|FG000|Period 2|Protocol Violation|1
4603767|NCT01641081|7456998|FG001|Period 2|Protocol Violation|0
4603768|NCT01641081|7456999|FG002|Period 2|Protocol Violation|0
4603769|NCT01641081|7457000|FG003|Period 2|Protocol Violation|0
4603770|NCT01641081|7457001|FG004|Period 2|Protocol Violation|0
4603771|NCT01641081|7457002|FG005|Period 2|Protocol Violation|0
4603772|NCT01641081|7457003|FG006|Period 2|Protocol Violation|0
4603773|NCT01641081|7457004|FG007|Period 2|Protocol Violation|0
4603774|NCT01641081|7457005|FG008|Period 2|Protocol Violation|0
4603775|NCT01641081|7457006|FG009|Period 2|Protocol Violation|0
4603776|NCT01641081|7456997|FG000|Period 3|Adverse Event|0
4603777|NCT01641081|7456998|FG001|Period 3|Adverse Event|0
4603778|NCT01641081|7456999|FG002|Period 3|Adverse Event|1
4603779|NCT01641081|7457000|FG003|Period 3|Adverse Event|0
4603780|NCT01641081|7457001|FG004|Period 3|Adverse Event|0
4603781|NCT01641081|7457002|FG005|Period 3|Adverse Event|0
4603782|NCT01641081|7457003|FG006|Period 3|Adverse Event|0
4603783|NCT01641081|7457004|FG007|Period 3|Adverse Event|0
4603784|NCT01641081|7457005|FG008|Period 3|Adverse Event|0
4603785|NCT01641081|7457006|FG009|Period 3|Adverse Event|0
4603786|NCT01641081|7456997|FG000|Period 3|Withdrawal by Subject|0
4603787|NCT01641081|7456998|FG001|Period 3|Withdrawal by Subject|0
4603788|NCT01641081|7456999|FG002|Period 3|Withdrawal by Subject|0
4603789|NCT01641081|7457000|FG003|Period 3|Withdrawal by Subject|0
4603790|NCT01641081|7457001|FG004|Period 3|Withdrawal by Subject|0
4603791|NCT01641081|7457002|FG005|Period 3|Withdrawal by Subject|0
4603792|NCT01641081|7457003|FG006|Period 3|Withdrawal by Subject|0
4603793|NCT01641081|7457004|FG007|Period 3|Withdrawal by Subject|0
4603794|NCT01641081|7457005|FG008|Period 3|Withdrawal by Subject|1
4603795|NCT01641081|7457006|FG009|Period 3|Withdrawal by Subject|0
4603796|NCT01641081|7456997|FG000|Period 4|Adverse Event|0
4603797|NCT01641081|7456998|FG001|Period 4|Adverse Event|1
4603798|NCT01641081|7456999|FG002|Period 4|Adverse Event|0
4603799|NCT01641081|7457000|FG003|Period 4|Adverse Event|1
4603800|NCT01641081|7457001|FG004|Period 4|Adverse Event|0
4603801|NCT01641081|7457002|FG005|Period 4|Adverse Event|0
4603802|NCT01641081|7457003|FG006|Period 4|Adverse Event|0
4603803|NCT01641081|7457004|FG007|Period 4|Adverse Event|0
4603804|NCT01641081|7457005|FG008|Period 4|Adverse Event|0
4603805|NCT01641081|7457006|FG009|Period 4|Adverse Event|0
4603806|NCT01641081|7456997|FG000|Period 5|Adverse Event|0
4603807|NCT01641081|7456998|FG001|Period 5|Adverse Event|0
4603808|NCT01641081|7456999|FG002|Period 5|Adverse Event|2
4603809|NCT01641081|7457000|FG003|Period 5|Adverse Event|0
4603810|NCT01641081|7457001|FG004|Period 5|Adverse Event|0
4603811|NCT01641081|7457002|FG005|Period 5|Adverse Event|0
4603812|NCT01641081|7457003|FG006|Period 5|Adverse Event|0
4603813|NCT01641081|7457004|FG007|Period 5|Adverse Event|0
4603814|NCT01641081|7457005|FG008|Period 5|Adverse Event|0
4603815|NCT01641081|7457006|FG009|Period 5|Adverse Event|0
4603816|NCT01641133|7457028|FG000|Overall Study|Protocol Violation|0
4603817|NCT01641133|7457029|FG001|Overall Study|Protocol Violation|1
4603818|NCT01641133|7457030|FG002|Overall Study|Protocol Violation|1
4603819|NCT01641133|7457028|FG000|Overall Study|Migrated/moved from study area|5
4603820|NCT01641133|7457029|FG001|Overall Study|Migrated/moved from study area|3
4603821|NCT01641133|7457030|FG002|Overall Study|Migrated/moved from study area|1
4603822|NCT01641133|7457028|FG000|Overall Study|Adverse Event|0
4603823|NCT01641133|7457029|FG001|Overall Study|Adverse Event|0
4603824|NCT01641133|7457030|FG002|Overall Study|Adverse Event|1
4603825|NCT01641133|7457028|FG000|Overall Study|Withdrawal by Subject|5
4603826|NCT01641133|7457029|FG001|Overall Study|Withdrawal by Subject|3
4603827|NCT01641133|7457030|FG002|Overall Study|Withdrawal by Subject|3
4603828|NCT01641133|7457028|FG000|Overall Study|Lost to Follow-up|0
4603829|NCT01641133|7457029|FG001|Overall Study|Lost to Follow-up|2
4603830|NCT01641133|7457030|FG002|Overall Study|Lost to Follow-up|2
4603831|NCT01641159|7457040|FG000|Overall Study|Lost to Follow-up|2
4603832|NCT01641159|7457041|FG001|Overall Study|Lost to Follow-up|1
4603833|NCT01641159|7457040|FG000|Overall Study|Withdrawal by Subject|0
4603834|NCT01641159|7457041|FG001|Overall Study|Withdrawal by Subject|1
4603835|NCT01641198|7457050|FG000|After 12 Months of Function|Lost to Follow-up|3
4603836|NCT01641198|7457051|FG001|After 12 Months of Function|Lost to Follow-up|2
4603837|NCT01641198|7457052|FG002|After 12 Months of Function|Lost to Follow-up|2
4603838|NCT01641198|7457050|FG000|After 12 Months of Function|Protocol Violation|1
4603839|NCT01641198|7457051|FG001|After 12 Months of Function|Protocol Violation|0
4603840|NCT01641198|7457052|FG002|After 12 Months of Function|Protocol Violation|0
4603841|NCT01641198|7457050|FG000|After 12 Months of Function|Adverse Event|0
4603842|NCT01641198|7457051|FG001|After 12 Months of Function|Adverse Event|1
4603843|NCT01641198|7457052|FG002|After 12 Months of Function|Adverse Event|0
4603844|NCT01641198|7457050|FG000|After 24 Months of Function|Lost to Follow-up|4
4603845|NCT01641198|7457051|FG001|After 24 Months of Function|Lost to Follow-up|9
4603846|NCT01641198|7457052|FG002|After 24 Months of Function|Lost to Follow-up|6
4603847|NCT01641198|7457050|FG000|At 15-20 Years of Function|Lost to Follow-up|5
4603848|NCT01641198|7457051|FG001|At 15-20 Years of Function|Lost to Follow-up|1
4603849|NCT01641198|7457052|FG002|At 15-20 Years of Function|Lost to Follow-up|1
4603850|NCT01641198|7457050|FG000|At 15-20 Years of Function|Death|1
4603851|NCT01641198|7457051|FG001|At 15-20 Years of Function|Death|0
4603852|NCT01641198|7457052|FG002|At 15-20 Years of Function|Death|1
4603853|NCT01641237|7457061|FG000|Period II|Withdrawal by Subject|1
4603854|NCT01641237|7457062|FG001|Period II|Withdrawal by Subject|0
4603855|NCT01641237|7457063|FG002|Period II|Withdrawal by Subject|0
4603856|NCT01641237|7457064|FG003|Period II|Withdrawal by Subject|0
4603857|NCT01641237|7457061|FG000|Period III|Lost to Follow-up|1
4603858|NCT01641237|7457062|FG001|Period III|Lost to Follow-up|0
4603859|NCT01641237|7457063|FG002|Period III|Lost to Follow-up|0
4603860|NCT01641237|7457064|FG003|Period III|Lost to Follow-up|0
4603861|NCT01641367|7457080|FG000|Cohorts|Death|18
4603862|NCT01641367|7457081|FG001|Cohorts|Death|1
4603863|NCT01641367|7457082|FG002|Cohorts|Death|2
4603864|NCT01641367|7457083|FG003|Cohorts|Death|0
4603865|NCT01641367|7457084|FG004|Cohorts|Death|1
4603866|NCT01641367|7457085|FG005|Cohorts|Death|1
4603867|NCT01641367|7457086|FG006|Cohorts|Death|0
4603868|NCT01641367|7457087|FG007|Cohorts|Death|0
4603869|NCT01641367|7457080|FG000|Cohorts|Lost to Follow-up|16
4603870|NCT01641367|7457081|FG001|Cohorts|Lost to Follow-up|0
4603871|NCT01641367|7457082|FG002|Cohorts|Lost to Follow-up|2
4603872|NCT01641367|7457083|FG003|Cohorts|Lost to Follow-up|0
4603873|NCT01641367|7457084|FG004|Cohorts|Lost to Follow-up|2
4603874|NCT01641367|7457085|FG005|Cohorts|Lost to Follow-up|0
4603875|NCT01641367|7457086|FG006|Cohorts|Lost to Follow-up|0
4603876|NCT01641367|7457087|FG007|Cohorts|Lost to Follow-up|0
4603877|NCT01641367|7457080|FG000|Randomized Adherence Intervention|Death|0
4603878|NCT01641367|7457081|FG001|Randomized Adherence Intervention|Death|0
4603879|NCT01641367|7457082|FG002|Randomized Adherence Intervention|Death|0
4603880|NCT01641367|7457083|FG003|Randomized Adherence Intervention|Death|0
4603881|NCT01641367|7457084|FG004|Randomized Adherence Intervention|Death|0
4603882|NCT01641367|7457085|FG005|Randomized Adherence Intervention|Death|0
4603883|NCT01641367|7457086|FG006|Randomized Adherence Intervention|Death|11
4603884|NCT01641367|7457087|FG007|Randomized Adherence Intervention|Death|12
4603885|NCT01641367|7457080|FG000|Randomized Adherence Intervention|Lost to Follow-up|0
4603886|NCT01641367|7457081|FG001|Randomized Adherence Intervention|Lost to Follow-up|0
4603887|NCT01641367|7457082|FG002|Randomized Adherence Intervention|Lost to Follow-up|0
4603888|NCT01641367|7457083|FG003|Randomized Adherence Intervention|Lost to Follow-up|0
4603889|NCT01641367|7457084|FG004|Randomized Adherence Intervention|Lost to Follow-up|0
4603890|NCT01641367|7457085|FG005|Randomized Adherence Intervention|Lost to Follow-up|0
4603891|NCT01641367|7457086|FG006|Randomized Adherence Intervention|Lost to Follow-up|8
4603892|NCT01641367|7457087|FG007|Randomized Adherence Intervention|Lost to Follow-up|12
4603893|NCT01641471|7457131|FG000|Overall Study|Withdrawal by Subject|19
4603894|NCT01641471|7457132|FG001|Overall Study|Withdrawal by Subject|19
4603895|NCT01641471|7457131|FG000|Overall Study|Lost to Follow-up|2
4603896|NCT01641471|7457132|FG001|Overall Study|Lost to Follow-up|4
4603897|NCT01641471|7457131|FG000|Overall Study|Protocol Violation|2
4603898|NCT01641471|7457132|FG001|Overall Study|Protocol Violation|4
4603899|NCT01641640|7457138|FG000|Overall Study|Enrolled but not treated|1
4603900|NCT01641640|7457138|FG000|Overall Study|Efficacy failure|29
4603901|NCT01641640|7457138|FG000|Overall Study|Lost to Follow-up|3
4603902|NCT01641640|7457138|FG000|Overall Study|Withdrawal by Subject|2
4603903|NCT01641640|7457138|FG000|Overall Study|Adverse Event|1
4603904|NCT01641692|7457154|FG000|Treatment Period 1|Adverse Event|1
4603905|NCT01641692|7457155|FG001|Treatment Period 1|Adverse Event|0
4603906|NCT01641692|7457156|FG002|Treatment Period 1|Adverse Event|0
4603907|NCT01641692|7457157|FG003|Treatment Period 1|Adverse Event|0
4603908|NCT01641692|7457158|FG004|Treatment Period 1|Adverse Event|0
4603909|NCT01641692|7457159|FG005|Treatment Period 1|Adverse Event|0
4603910|NCT01641692|7457160|FG006|Treatment Period 1|Adverse Event|0
4603911|NCT01641692|7457161|FG007|Treatment Period 1|Adverse Event|0
4603912|NCT01641692|7457154|FG000|Treatment Period 1|Lack of Efficacy|0
4603913|NCT01641692|7457155|FG001|Treatment Period 1|Lack of Efficacy|0
4603914|NCT01641692|7457156|FG002|Treatment Period 1|Lack of Efficacy|0
4603915|NCT01641692|7457157|FG003|Treatment Period 1|Lack of Efficacy|0
4603916|NCT01641692|7457158|FG004|Treatment Period 1|Lack of Efficacy|0
4603917|NCT01641692|7457159|FG005|Treatment Period 1|Lack of Efficacy|0
4603918|NCT01641692|7457160|FG006|Treatment Period 1|Lack of Efficacy|0
4603919|NCT01641692|7457161|FG007|Treatment Period 1|Lack of Efficacy|1
4603920|NCT01641692|7457154|FG000|Treatment Period 1|Protocol Violation|1
4603921|NCT01641692|7457155|FG001|Treatment Period 1|Protocol Violation|0
4603922|NCT01641692|7457156|FG002|Treatment Period 1|Protocol Violation|0
4603923|NCT01641692|7457157|FG003|Treatment Period 1|Protocol Violation|0
4603924|NCT01641692|7457158|FG004|Treatment Period 1|Protocol Violation|2
4603925|NCT01641692|7457159|FG005|Treatment Period 1|Protocol Violation|0
4603926|NCT01641692|7457160|FG006|Treatment Period 1|Protocol Violation|0
4603927|NCT01641692|7457161|FG007|Treatment Period 1|Protocol Violation|0
4603928|NCT01641692|7457154|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0
4603929|NCT01641692|7457155|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0
4603930|NCT01641692|7457156|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0
4603931|NCT01641692|7457157|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0
4603932|NCT01641692|7457158|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1
4603933|NCT01641692|7457159|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0
4603934|NCT01641692|7457160|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0
4603935|NCT01641692|7457161|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1
4603936|NCT01641692|7457154|FG000|Treatment Period 1|Lost to Follow-up|0
4603937|NCT01641692|7457155|FG001|Treatment Period 1|Lost to Follow-up|0
4603938|NCT01641692|7457156|FG002|Treatment Period 1|Lost to Follow-up|1
4603939|NCT01641692|7457157|FG003|Treatment Period 1|Lost to Follow-up|0
4603940|NCT01641692|7457158|FG004|Treatment Period 1|Lost to Follow-up|0
4603941|NCT01641692|7457159|FG005|Treatment Period 1|Lost to Follow-up|0
4603942|NCT01641692|7457160|FG006|Treatment Period 1|Lost to Follow-up|0
4603943|NCT01641692|7457161|FG007|Treatment Period 1|Lost to Follow-up|0
4603944|NCT01641692|7457154|FG000|Treatment Period 1|Physician Decision|0
4603945|NCT01641692|7457155|FG001|Treatment Period 1|Physician Decision|0
4603946|NCT01641692|7457156|FG002|Treatment Period 1|Physician Decision|0
4603947|NCT01641692|7457157|FG003|Treatment Period 1|Physician Decision|0
4603948|NCT01641692|7457158|FG004|Treatment Period 1|Physician Decision|1
4603949|NCT01641692|7457159|FG005|Treatment Period 1|Physician Decision|0
4603950|NCT01641692|7457160|FG006|Treatment Period 1|Physician Decision|0
4603951|NCT01641692|7457161|FG007|Treatment Period 1|Physician Decision|0
4603952|NCT01641692|7457154|FG000|Treatment Period 1|Withdrawal by Subject|0
4603953|NCT01641692|7457155|FG001|Treatment Period 1|Withdrawal by Subject|0
4603954|NCT01641692|7457156|FG002|Treatment Period 1|Withdrawal by Subject|0
4603955|NCT01641692|7457157|FG003|Treatment Period 1|Withdrawal by Subject|0
4603956|NCT01641692|7457158|FG004|Treatment Period 1|Withdrawal by Subject|0
4603957|NCT01641692|7457159|FG005|Treatment Period 1|Withdrawal by Subject|2
4603958|NCT01641692|7457160|FG006|Treatment Period 1|Withdrawal by Subject|0
4603959|NCT01641692|7457161|FG007|Treatment Period 1|Withdrawal by Subject|1
4603960|NCT01641692|7457154|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2
4603961|NCT01641692|7457155|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0
4603962|NCT01641692|7457156|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0
4603963|NCT01641692|7457157|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0
4603964|NCT01641692|7457158|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0
4603965|NCT01641692|7457159|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0
4603966|NCT01641692|7457160|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0
4603967|NCT01641692|7457161|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0
4603968|NCT01641692|7457154|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0
4603969|NCT01641692|7457155|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0
4603970|NCT01641692|7457156|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0
4603971|NCT01641692|7457157|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0
4603972|NCT01641692|7457158|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0
4603973|NCT01641692|7457159|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0
4603974|NCT01641692|7457160|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1
4603975|NCT01641692|7457161|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0
4603976|NCT01641692|7457154|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
4603977|NCT01641692|7457155|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
4603978|NCT01641692|7457156|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3
4603979|NCT01641692|7457157|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
4603980|NCT01641692|7457158|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3
4603981|NCT01641692|7457159|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
4603982|NCT01641692|7457160|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
4603983|NCT01641692|7457161|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
4603984|NCT01641692|7457154|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
4603985|NCT01641692|7457155|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
4603986|NCT01641692|7457156|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
4603987|NCT01641692|7457157|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
4603988|NCT01641692|7457158|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
4603989|NCT01641692|7457159|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
4603990|NCT01641692|7457160|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
4603991|NCT01641692|7457161|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
4603992|NCT01641692|7457154|FG000|Treatment Period 2|Lack of Efficacy|1
4603993|NCT01641692|7457155|FG001|Treatment Period 2|Lack of Efficacy|0
4603994|NCT01641692|7457156|FG002|Treatment Period 2|Lack of Efficacy|0
4603995|NCT01641692|7457157|FG003|Treatment Period 2|Lack of Efficacy|0
4603996|NCT01641692|7457158|FG004|Treatment Period 2|Lack of Efficacy|0
4603997|NCT01641692|7457159|FG005|Treatment Period 2|Lack of Efficacy|0
4603998|NCT01641692|7457160|FG006|Treatment Period 2|Lack of Efficacy|0
4603999|NCT01641692|7457161|FG007|Treatment Period 2|Lack of Efficacy|0
4604000|NCT01641692|7457154|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1
4604001|NCT01641692|7457155|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0
4604002|NCT01641692|7457156|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0
4604003|NCT01641692|7457157|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0
4604004|NCT01641692|7457158|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0
4604005|NCT01641692|7457159|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0
4604006|NCT01641692|7457160|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0
4604007|NCT01641692|7457161|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0
4604008|NCT01641692|7457154|FG000|Treatment Period 2|Lost to Follow-up|0
4604009|NCT01641692|7457155|FG001|Treatment Period 2|Lost to Follow-up|0
4604010|NCT01641692|7457156|FG002|Treatment Period 2|Lost to Follow-up|0
4604011|NCT01641692|7457157|FG003|Treatment Period 2|Lost to Follow-up|0
4604012|NCT01641692|7457158|FG004|Treatment Period 2|Lost to Follow-up|0
4604013|NCT01641692|7457159|FG005|Treatment Period 2|Lost to Follow-up|1
4604014|NCT01641692|7457160|FG006|Treatment Period 2|Lost to Follow-up|0
4604015|NCT01641692|7457161|FG007|Treatment Period 2|Lost to Follow-up|0
4604016|NCT01641692|7457154|FG000|Treatment Period 2|Withdrawal by Subject|1
4604017|NCT01641692|7457155|FG001|Treatment Period 2|Withdrawal by Subject|0
4604018|NCT01641692|7457156|FG002|Treatment Period 2|Withdrawal by Subject|0
4604019|NCT01641692|7457157|FG003|Treatment Period 2|Withdrawal by Subject|0
4604020|NCT01641692|7457158|FG004|Treatment Period 2|Withdrawal by Subject|0
4604021|NCT01641692|7457159|FG005|Treatment Period 2|Withdrawal by Subject|1
4604022|NCT01641692|7457160|FG006|Treatment Period 2|Withdrawal by Subject|0
4604023|NCT01641692|7457161|FG007|Treatment Period 2|Withdrawal by Subject|1
4604024|NCT01641692|7457154|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
4604025|NCT01641692|7457155|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
4604026|NCT01641692|7457156|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
4604027|NCT01641692|7457157|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
4604028|NCT01641692|7457158|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3
4604029|NCT01641692|7457159|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
4604030|NCT01641692|7457160|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1
4604031|NCT01641692|7457161|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
4604032|NCT01641692|7457154|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
4604033|NCT01641692|7457155|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
4604034|NCT01641692|7457156|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
4604035|NCT01641692|7457157|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
4604036|NCT01641692|7457158|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
4604037|NCT01641692|7457159|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
4604038|NCT01641692|7457160|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
4604039|NCT01641692|7457161|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
4604040|NCT01641692|7457154|FG000|Treatment Period 3|Adverse Event|0
4604041|NCT01641692|7457155|FG001|Treatment Period 3|Adverse Event|0
4604042|NCT01641692|7457156|FG002|Treatment Period 3|Adverse Event|0
4604043|NCT01641692|7457157|FG003|Treatment Period 3|Adverse Event|0
4604044|NCT01641692|7457158|FG004|Treatment Period 3|Adverse Event|0
4604045|NCT01641692|7457159|FG005|Treatment Period 3|Adverse Event|0
4604046|NCT01641692|7457160|FG006|Treatment Period 3|Adverse Event|1
4604047|NCT01641692|7457161|FG007|Treatment Period 3|Adverse Event|0
4604048|NCT01641692|7457154|FG000|Treatment Period 3|Protocol Violation|0
4604049|NCT01641692|7457155|FG001|Treatment Period 3|Protocol Violation|0
4604050|NCT01641692|7457156|FG002|Treatment Period 3|Protocol Violation|1
4604051|NCT01641692|7457157|FG003|Treatment Period 3|Protocol Violation|0
4604052|NCT01641692|7457158|FG004|Treatment Period 3|Protocol Violation|0
4604053|NCT01641692|7457159|FG005|Treatment Period 3|Protocol Violation|0
4604054|NCT01641692|7457160|FG006|Treatment Period 3|Protocol Violation|0
4604055|NCT01641692|7457161|FG007|Treatment Period 3|Protocol Violation|0
4604056|NCT01641692|7457154|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0
4604057|NCT01641692|7457155|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0
4604058|NCT01641692|7457156|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0
4604059|NCT01641692|7457157|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0
4604060|NCT01641692|7457158|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0
4604061|NCT01641692|7457159|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0
4604062|NCT01641692|7457160|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1
4604063|NCT01641692|7457161|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0
4604064|NCT01641692|7457154|FG000|Treatment Period 3|Lost to Follow-up|0
4604065|NCT01641692|7457155|FG001|Treatment Period 3|Lost to Follow-up|1
4604066|NCT01641692|7457156|FG002|Treatment Period 3|Lost to Follow-up|0
4604067|NCT01641692|7457157|FG003|Treatment Period 3|Lost to Follow-up|0
4604068|NCT01641692|7457158|FG004|Treatment Period 3|Lost to Follow-up|0
4604069|NCT01641692|7457159|FG005|Treatment Period 3|Lost to Follow-up|0
4604070|NCT01641692|7457160|FG006|Treatment Period 3|Lost to Follow-up|0
4604071|NCT01641692|7457161|FG007|Treatment Period 3|Lost to Follow-up|0
4604072|NCT01641692|7457154|FG000|Washout Period 3 or Follow-up|Protocol Violation|0
4604073|NCT01641692|7457155|FG001|Washout Period 3 or Follow-up|Protocol Violation|0
4604074|NCT01641692|7457156|FG002|Washout Period 3 or Follow-up|Protocol Violation|0
4604075|NCT01641692|7457157|FG003|Washout Period 3 or Follow-up|Protocol Violation|0
4604076|NCT01641692|7457158|FG004|Washout Period 3 or Follow-up|Protocol Violation|0
4604077|NCT01641692|7457159|FG005|Washout Period 3 or Follow-up|Protocol Violation|1
4604078|NCT01641692|7457160|FG006|Washout Period 3 or Follow-up|Protocol Violation|0
4604079|NCT01641692|7457161|FG007|Washout Period 3 or Follow-up|Protocol Violation|0
4604080|NCT01641692|7457154|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
4604081|NCT01641692|7457155|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
4604082|NCT01641692|7457156|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
4604083|NCT01641692|7457157|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
4604084|NCT01641692|7457158|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
4604085|NCT01641692|7457159|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
4604086|NCT01641692|7457160|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
4604087|NCT01641692|7457161|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
4604088|NCT01641809|7457184|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1
4604089|NCT01641809|7457185|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1
4604090|NCT01641809|7457186|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0
4604091|NCT01641809|7457187|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1
4604092|NCT01641809|7457184|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0
4604093|NCT01641809|7457185|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1
4604094|NCT01641809|7457186|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0
4604095|NCT01641809|7457187|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1
4604096|NCT01641809|7457184|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1
4604097|NCT01641809|7457185|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2
4604098|NCT01641809|7457186|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0
4604099|NCT01641809|7457187|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3
4604100|NCT01641809|7457184|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2
4604101|NCT01641809|7457185|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1
4604102|NCT01641809|7457186|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1
4604103|NCT01641809|7457187|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0
4604104|NCT01641809|7457184|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4
4604105|NCT01641809|7457185|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1
4636181|NCT01939977|7508172|FG001|Overall Study|Physician Decision|1
4636182|NCT01939977|7508171|FG000|Overall Study|Withdrawal by Subject|0
4604106|NCT01641809|7457186|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2
4636183|NCT01939977|7508172|FG001|Overall Study|Withdrawal by Subject|2
4636184|NCT01939977|7508171|FG000|Overall Study|Did not meet inclusion criteria|1
4636185|NCT01939977|7508172|FG001|Overall Study|Did not meet inclusion criteria|0
4636186|NCT01939977|7508171|FG000|Overall Study|Did not receive study medication|0
4636187|NCT01939977|7508172|FG001|Overall Study|Did not receive study medication|1
4636188|NCT01940120|7508178|FG000|Overall Study|Death|40
4636189|NCT01940120|7508178|FG000|Overall Study|Withdrawal by Subject|8
4636190|NCT01940354|7508211|FG000|Overall Study|Withdrawal by Subject|4
4636191|NCT01940354|7508212|FG001|Overall Study|Withdrawal by Subject|2
4636192|NCT01940484|7508218|FG000|Overall Study|Withdrawal by Subject|3
4636193|NCT01940484|7508218|FG000|Overall Study|Underwent transplantation|4
4636194|NCT01940484|7508218|FG000|Overall Study|Death|2
4636195|NCT01940484|7508218|FG000|Overall Study|Adverse Event|1
4636196|NCT01940497|7508224|FG000|Overall Study|Adverse Event/Intercurrent Illness|11
4636197|NCT01940497|7508225|FG001|Overall Study|Adverse Event/Intercurrent Illness|8
4636198|NCT01940497|7508224|FG000|Overall Study|Recurrence of Disease Postsurgery|1
4636199|NCT01940497|7508225|FG001|Overall Study|Recurrence of Disease Postsurgery|3
4636200|NCT01940497|7508224|FG000|Overall Study|Violation of Entry Criteria|1
4636201|NCT01940497|7508225|FG001|Overall Study|Violation of Entry Criteria|1
4636202|NCT01940497|7508224|FG000|Overall Study|Refused Treatment|1
4636203|NCT01940497|7508225|FG001|Overall Study|Refused Treatment|3
4636204|NCT01940497|7508224|FG000|Overall Study|Withdrew Consent|6
4636205|NCT01940497|7508225|FG001|Overall Study|Withdrew Consent|2
4636206|NCT01940497|7508224|FG000|Overall Study|Administrative/Other|1
4636207|NCT01940497|7508225|FG001|Overall Study|Administrative/Other|1
4636208|NCT01940705|7508264|FG000|Overall Study|Lost to Follow-up|1
4636209|NCT01940705|7508265|FG001|Overall Study|Lost to Follow-up|3
4636210|NCT01940705|7508266|FG002|Overall Study|Lost to Follow-up|2
4636211|NCT01940705|7508267|FG003|Overall Study|Lost to Follow-up|2
4636212|NCT01940705|7508264|FG000|Overall Study|Withdrawal by Subject|2
4636213|NCT01940705|7508265|FG001|Overall Study|Withdrawal by Subject|2
4636214|NCT01940705|7508266|FG002|Overall Study|Withdrawal by Subject|3
4636215|NCT01940705|7508267|FG003|Overall Study|Withdrawal by Subject|2
4636216|NCT01940705|7508264|FG000|Overall Study|Intervention not given|0
4636217|NCT01940705|7508265|FG001|Overall Study|Intervention not given|3
4636218|NCT01940705|7508266|FG002|Overall Study|Intervention not given|3
4636219|NCT01940705|7508267|FG003|Overall Study|Intervention not given|0
4636220|NCT01940705|7508264|FG000|Overall Study|Withdrawal by team - hearing aid change|1
4636221|NCT01940705|7508265|FG001|Overall Study|Withdrawal by team - hearing aid change|0
4636222|NCT01940705|7508266|FG002|Overall Study|Withdrawal by team - hearing aid change|0
4636223|NCT01940705|7508267|FG003|Overall Study|Withdrawal by team - hearing aid change|0
4636224|NCT01940887|7508282|FG000|Year 1|Protocol Violation|0
4636225|NCT01940887|7508283|FG001|Year 1|Protocol Violation|1
4636226|NCT01940887|7508282|FG000|Year 1|Physician Decision|7
4636227|NCT01940887|7508283|FG001|Year 1|Physician Decision|3
4636228|NCT01940887|7508282|FG000|Year 1|Death|5
4636229|NCT01940887|7508283|FG001|Year 1|Death|3
4636230|NCT01940887|7508282|FG000|Year 1|Adverse Event|7
4636231|NCT01940887|7508283|FG001|Year 1|Adverse Event|6
4636232|NCT01940887|7508282|FG000|Year 1|Withdrawal by Subject|18
4636233|NCT01940887|7508283|FG001|Year 1|Withdrawal by Subject|9
4636234|NCT01940887|7508282|FG000|Year 1|Lost to Follow-up|2
4636235|NCT01940887|7508283|FG001|Year 1|Lost to Follow-up|1
4636236|NCT01940887|7508282|FG000|Year 2|Physician Decision|8
4636237|NCT01940887|7508283|FG001|Year 2|Physician Decision|1
4636238|NCT01940887|7508282|FG000|Year 2|Death|0
4636239|NCT01940887|7508283|FG001|Year 2|Death|2
4636240|NCT01940887|7508282|FG000|Year 2|Sponsor Decision, early termination|192
4636241|NCT01940887|7508283|FG001|Year 2|Sponsor Decision, early termination|203
4636242|NCT01940887|7508282|FG000|Year 2|Adverse Event|8
4636243|NCT01940887|7508283|FG001|Year 2|Adverse Event|2
4636244|NCT01940887|7508282|FG000|Year 2|Withdrawal by Subject|8
4636245|NCT01940887|7508283|FG001|Year 2|Withdrawal by Subject|8
4636246|NCT01940887|7508282|FG000|Year 2|Lost to Follow-up|1
4636247|NCT01940887|7508283|FG001|Year 2|Lost to Follow-up|6
4636248|NCT01940900|7508291|FG000|Overall Study|Physician Decision|4
4604107|NCT01641809|7457187|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3
4604108|NCT01641809|7457184|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0
4604109|NCT01641809|7457185|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1
4604110|NCT01641809|7457186|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3
4604111|NCT01641809|7457187|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7
4604112|NCT01641809|7457184|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2
4636249|NCT01940900|7508292|FG001|Overall Study|Physician Decision|0
4636250|NCT01940900|7508291|FG000|Overall Study|Adverse Event|10
4636251|NCT01940900|7508292|FG001|Overall Study|Adverse Event|15
4636252|NCT01940900|7508291|FG000|Overall Study|Withdrawal by Subject|11
4636253|NCT01940900|7508292|FG001|Overall Study|Withdrawal by Subject|15
4636254|NCT01940900|7508291|FG000|Overall Study|Lost to Follow-up|1
4636255|NCT01940900|7508292|FG001|Overall Study|Lost to Follow-up|0
4636256|NCT01940900|7508291|FG000|Overall Study|Sponsor Decision|1
4636257|NCT01940900|7508292|FG001|Overall Study|Sponsor Decision|0
4636258|NCT01940900|7508291|FG000|Overall Study|subject non-compliance|1
4636259|NCT01940900|7508292|FG001|Overall Study|subject non-compliance|1
4604113|NCT01641809|7457185|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3
4604114|NCT01641809|7457186|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1
4604115|NCT01641809|7457187|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0
4604116|NCT01641809|7457184|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0
4604117|NCT01641809|7457185|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1
4604118|NCT01641809|7457186|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0
4604119|NCT01641809|7457187|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0
4604120|NCT01641809|7457184|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2
4604121|NCT01641809|7457185|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0
4604122|NCT01641809|7457186|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1
4604123|NCT01641809|7457187|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2
4604124|NCT01641809|7457184|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1
4604125|NCT01641809|7457185|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1
4604126|NCT01641809|7457186|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0
4604127|NCT01641809|7457187|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2
4604128|NCT01641809|7457184|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1
4604129|NCT01641809|7457185|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0
4604130|NCT01641809|7457186|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1
4604131|NCT01641809|7457187|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2
4604132|NCT01641809|7457184|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2
4604133|NCT01641809|7457185|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3
4604134|NCT01641809|7457186|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1
4604135|NCT01641809|7457187|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0
4604136|NCT01641809|7457184|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0
4604137|NCT01641809|7457185|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1
4604138|NCT01641809|7457186|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1
4604139|NCT01641809|7457187|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0
4604140|NCT01641809|7457184|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5
4604141|NCT01641809|7457185|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4
4604142|NCT01641809|7457186|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5
4604143|NCT01641809|7457187|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0
4604144|NCT01641809|7457184|FG000|Open-label (Week 96 to Week 324)|Site closed|1
4604145|NCT01641809|7457185|FG001|Open-label (Week 96 to Week 324)|Site closed|0
4604146|NCT01641809|7457186|FG002|Open-label (Week 96 to Week 324)|Site closed|0
4604147|NCT01641809|7457187|FG003|Open-label (Week 96 to Week 324)|Site closed|0
4604148|NCT01641809|7457184|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1
4604149|NCT01641809|7457185|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1
4604150|NCT01641809|7457186|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0
4604151|NCT01641809|7457187|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0
4604152|NCT01641809|7457184|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4
4604153|NCT01641809|7457185|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1
4604154|NCT01641809|7457186|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0
4604155|NCT01641809|7457187|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0
4604156|NCT01641809|7457184|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3
4604157|NCT01641809|7457185|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2
4604158|NCT01641809|7457186|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1
4604159|NCT01641809|7457187|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0
4604160|NCT01641822|7457207|FG000|Run-in Phase|Noncompliance with study drug|1
4604161|NCT01641822|7457208|FG001|Run-in Phase|Noncompliance with study drug|0
4604162|NCT01641822|7457209|FG002|Run-in Phase|Noncompliance with study drug|0
4604163|NCT01641822|7457207|FG000|Run-in Phase|Adverse Event|3
4604164|NCT01641822|7457208|FG001|Run-in Phase|Adverse Event|0
4604165|NCT01641822|7457209|FG002|Run-in Phase|Adverse Event|0
4604166|NCT01641822|7457207|FG000|Run-in Phase|Withdrew consent|1
4604167|NCT01641822|7457208|FG001|Run-in Phase|Withdrew consent|0
4604168|NCT01641822|7457209|FG002|Run-in Phase|Withdrew consent|0
4604169|NCT01641822|7457207|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9
4604170|NCT01641822|7457208|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0
4604171|NCT01641822|7457209|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0
4604172|NCT01641822|7457207|FG000|Comparative Phase|Noncompliance with study drug|0
4604173|NCT01641822|7457208|FG001|Comparative Phase|Noncompliance with study drug|1
4604174|NCT01641822|7457209|FG002|Comparative Phase|Noncompliance with study drug|0
4604175|NCT01641822|7457207|FG000|Comparative Phase|Investigator's discretion|0
4604176|NCT01641822|7457208|FG001|Comparative Phase|Investigator's discretion|0
4604177|NCT01641822|7457209|FG002|Comparative Phase|Investigator's discretion|1
4604178|NCT01641822|7457207|FG000|Comparative Phase|Pregnancy|0
4604179|NCT01641822|7457208|FG001|Comparative Phase|Pregnancy|0
4604180|NCT01641822|7457209|FG002|Comparative Phase|Pregnancy|1
4604181|NCT01641822|7457207|FG000|Comparative Phase|Adverse event, serious fatal|0
4604182|NCT01641822|7457208|FG001|Comparative Phase|Adverse event, serious fatal|1
4604183|NCT01641822|7457209|FG002|Comparative Phase|Adverse event, serious fatal|0
4604184|NCT01641822|7457207|FG000|Comparative Phase|Withdrew consent|0
4604185|NCT01641822|7457208|FG001|Comparative Phase|Withdrew consent|3
4604186|NCT01641822|7457209|FG002|Comparative Phase|Withdrew consent|7
4604187|NCT01641822|7457207|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0
4604188|NCT01641822|7457208|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1
4604189|NCT01641822|7457209|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1
4604190|NCT01641861|7457222|FG000|Overall Study|Lost to Follow-up|21
4604191|NCT01641861|7457223|FG001|Overall Study|Lost to Follow-up|16
4604192|NCT01641861|7457222|FG000|Overall Study|Lost the tooth due to normal exfoliation|14
4604193|NCT01641861|7457223|FG001|Overall Study|Lost the tooth due to normal exfoliation|8
4604194|NCT01641861|7457222|FG000|Overall Study|Died due to drowning|0
4604195|NCT01641861|7457223|FG001|Overall Study|Died due to drowning|1
4604196|NCT01641900|7457231|FG000|Overall Study|Withdrawal by Subject|2
4604197|NCT01641900|7457232|FG001|Overall Study|Withdrawal by Subject|2
4604198|NCT01641926|7457244|FG000|Overall Study|Adverse Event|5
4604199|NCT01641926|7457245|FG001|Overall Study|Adverse Event|2
4604200|NCT01641926|7457246|FG002|Overall Study|Adverse Event|3
4604201|NCT01641926|7457247|FG003|Overall Study|Adverse Event|1
4604202|NCT01641926|7457244|FG000|Overall Study|Lost to Follow-up|2
4604203|NCT01641926|7457245|FG001|Overall Study|Lost to Follow-up|2
4604204|NCT01641926|7457246|FG002|Overall Study|Lost to Follow-up|1
4604205|NCT01641926|7457247|FG003|Overall Study|Lost to Follow-up|0
4604206|NCT01641926|7457244|FG000|Overall Study|Physician Decision|6
4604207|NCT01641926|7457245|FG001|Overall Study|Physician Decision|5
4604208|NCT01641926|7457246|FG002|Overall Study|Physician Decision|0
4604209|NCT01641926|7457247|FG003|Overall Study|Physician Decision|1
4604210|NCT01641926|7457244|FG000|Overall Study|Protocol Violation|1
4604211|NCT01641926|7457245|FG001|Overall Study|Protocol Violation|0
4604212|NCT01641926|7457246|FG002|Overall Study|Protocol Violation|0
4604213|NCT01641926|7457247|FG003|Overall Study|Protocol Violation|1
4604214|NCT01641926|7457244|FG000|Overall Study|Withdrawal by Subject|13
4604215|NCT01641926|7457245|FG001|Overall Study|Withdrawal by Subject|5
4604216|NCT01641926|7457246|FG002|Overall Study|Withdrawal by Subject|6
4604217|NCT01641926|7457247|FG003|Overall Study|Withdrawal by Subject|1
4604218|NCT01641926|7457244|FG000|Overall Study|Not Treated|1
4604219|NCT01641926|7457245|FG001|Overall Study|Not Treated|1
4604220|NCT01641926|7457246|FG002|Overall Study|Not Treated|1
4604221|NCT01641926|7457247|FG003|Overall Study|Not Treated|0
4604222|NCT01641939|7457260|FG000|Overall Study|Death|90
4604223|NCT01641939|7457261|FG001|Overall Study|Death|187
4604224|NCT01641939|7457262|FG002|Overall Study|Death|61
4604225|NCT01641939|7457260|FG000|Overall Study|Lost to Follow-up|3
4604226|NCT01641939|7457261|FG001|Overall Study|Lost to Follow-up|2
4604227|NCT01641939|7457262|FG002|Overall Study|Lost to Follow-up|1
4604228|NCT01641939|7457260|FG000|Overall Study|Withdrawal by Subject|14
4604229|NCT01641939|7457261|FG001|Overall Study|Withdrawal by Subject|11
4604230|NCT01641939|7457262|FG002|Overall Study|Withdrawal by Subject|5
4604231|NCT01641939|7457260|FG000|Overall Study|Study Terminated by Sponsor|10
4604232|NCT01641939|7457261|FG001|Overall Study|Study Terminated by Sponsor|28
4604233|NCT01641939|7457262|FG002|Overall Study|Study Terminated by Sponsor|3
4604234|NCT01641952|7457272|FG000|Overall Study|Lost to Follow-up|28
4604235|NCT01641952|7457272|FG000|Overall Study|Adverse Event|6
4604236|NCT01641991|7457288|FG000|Overall Study|Physician Decision|0
4604237|NCT01641991|7457289|FG001|Overall Study|Physician Decision|1
4604238|NCT01641991|7457290|FG002|Overall Study|Physician Decision|7
4604239|NCT01641991|7457291|FG003|Overall Study|Physician Decision|5
4604240|NCT01641991|7457288|FG000|Overall Study|Withdrawal by Subject|4
4604241|NCT01641991|7457289|FG001|Overall Study|Withdrawal by Subject|2
4604242|NCT01641991|7457290|FG002|Overall Study|Withdrawal by Subject|1
4604243|NCT01641991|7457291|FG003|Overall Study|Withdrawal by Subject|5
4604244|NCT01641991|7457288|FG000|Overall Study|Adverse Event|2
4604245|NCT01641991|7457289|FG001|Overall Study|Adverse Event|1
4604246|NCT01641991|7457290|FG002|Overall Study|Adverse Event|2
4604247|NCT01641991|7457291|FG003|Overall Study|Adverse Event|1
4604248|NCT01641991|7457288|FG000|Overall Study|Lost to Follow-up|0
4604249|NCT01641991|7457289|FG001|Overall Study|Lost to Follow-up|2
4604250|NCT01641991|7457290|FG002|Overall Study|Lost to Follow-up|3
4604251|NCT01641991|7457291|FG003|Overall Study|Lost to Follow-up|1
4604252|NCT01641991|7457288|FG000|Overall Study|Protocol Violation|1
4604253|NCT01641991|7457289|FG001|Overall Study|Protocol Violation|1
4604254|NCT01641991|7457290|FG002|Overall Study|Protocol Violation|3
4604255|NCT01641991|7457291|FG003|Overall Study|Protocol Violation|0
4604256|NCT01641991|7457288|FG000|Overall Study|Pregnancy|0
4604257|NCT01641991|7457289|FG001|Overall Study|Pregnancy|0
4604258|NCT01641991|7457290|FG002|Overall Study|Pregnancy|1
4604259|NCT01641991|7457291|FG003|Overall Study|Pregnancy|0
4604260|NCT01641991|7457288|FG000|Overall Study|no longer eligible|2
4604261|NCT01641991|7457289|FG001|Overall Study|no longer eligible|1
4604262|NCT01641991|7457290|FG002|Overall Study|no longer eligible|0
4604263|NCT01641991|7457291|FG003|Overall Study|no longer eligible|4
4604264|NCT01642212|7457335|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26
4604265|NCT01642212|7457336|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
4604266|NCT01642212|7457337|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
4604267|NCT01642212|7457338|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
4636260|NCT01940900|7508291|FG000|Overall Study|other|1
4604268|NCT01642212|7457339|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
4604269|NCT01642212|7457335|FG000|Double-blind Treatment|Other|0
4604270|NCT01642212|7457336|FG001|Double-blind Treatment|Other|2
4604271|NCT01642212|7457337|FG002|Double-blind Treatment|Other|1
4604272|NCT01642212|7457338|FG003|Double-blind Treatment|Other|0
4604273|NCT01642212|7457339|FG004|Double-blind Treatment|Other|0
4604274|NCT01642212|7457335|FG000|Double-blind Treatment|Non-compliance|0
4604275|NCT01642212|7457336|FG001|Double-blind Treatment|Non-compliance|1
4636261|NCT01940900|7508292|FG001|Overall Study|other|0
4636262|NCT01940939|7508300|FG000|Overall Study|Withdrawal by Subject|2
4636263|NCT01940939|7508301|FG001|Overall Study|Withdrawal by Subject|8
4636264|NCT01941030|7508309|FG000|Overall Study|Death|3
4636265|NCT01941030|7508310|FG001|Overall Study|Death|2
4636266|NCT01941030|7508309|FG000|Overall Study|Lost to Follow-up|6
4636267|NCT01941030|7508310|FG001|Overall Study|Lost to Follow-up|5
4636268|NCT01941030|7508309|FG000|Overall Study|Withdrawal by Subject|4
4636269|NCT01941030|7508310|FG001|Overall Study|Withdrawal by Subject|6
4636270|NCT01941095|7508316|FG000|Overall Study|Insufficient therapeutic response|13
4636271|NCT01941095|7508316|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2
4636272|NCT01941095|7508316|FG000|Overall Study|Adverse Event|11
4636273|NCT01941095|7508316|FG000|Overall Study|Physician Decision|3
4636274|NCT01941095|7508316|FG000|Overall Study|Withdrawal by Subject|17
4636275|NCT01941095|7508316|FG000|Overall Study|Lost to Follow-up|10
4636276|NCT01941186|7508323|FG000|Follow-up|Lost to Follow-up|1
4636277|NCT01941186|7508324|FG001|Follow-up|Lost to Follow-up|0
4636278|NCT01941498|7508369|FG000|Overall Study|Relocated out of state|1
4636279|NCT01941537|7508390|FG000|Overall Study|Lack of Efficacy|1
4636280|NCT01941537|7508391|FG001|Overall Study|Lack of Efficacy|2
4636281|NCT01941537|7508390|FG000|Overall Study|Lost to Follow-up|1
4636282|NCT01941537|7508391|FG001|Overall Study|Lost to Follow-up|0
4636283|NCT01941537|7508390|FG000|Overall Study|Pregnancy|1
4636284|NCT01941537|7508391|FG001|Overall Study|Pregnancy|0
4636285|NCT01941537|7508390|FG000|Overall Study|Adverse Event|1
4636286|NCT01941537|7508391|FG001|Overall Study|Adverse Event|0
4636287|NCT01941537|7508390|FG000|Overall Study|Withdrawal by Subject|0
4636288|NCT01941537|7508391|FG001|Overall Study|Withdrawal by Subject|1
4636289|NCT01941940|7508436|FG000|Overall Study|Adverse Event|11
4636290|NCT01941940|7508436|FG000|Overall Study|Lost to Follow-up|2
4636291|NCT01941940|7508436|FG000|Overall Study|Physician Decision|2
4636292|NCT01941940|7508436|FG000|Overall Study|Withdrawal by Subject|15
4636293|NCT01941940|7508436|FG000|Overall Study|Death|1
4636294|NCT01941940|7508436|FG000|Overall Study|Other|1
4636295|NCT01941940|7508436|FG000|Overall Study|Other|1
4636296|NCT01942148|7508440|FG000|Overall Study|Adverse Event|4
4636297|NCT01942148|7508440|FG000|Overall Study|Lack of Efficacy|2
4636298|NCT01942148|7508440|FG000|Overall Study|Physician Decision|11
4636299|NCT01942148|7508440|FG000|Overall Study|Protocol Violation|1
4636300|NCT01942148|7508440|FG000|Overall Study|Withdrawal by Subject|8
4636301|NCT01942148|7508440|FG000|Overall Study|Use of the prohibition medicine|1
4636302|NCT01942161|7508447|FG000|Overall Study|Adverse Event|1
4636303|NCT01942161|7508448|FG001|Overall Study|Adverse Event|2
4636304|NCT01942161|7508449|FG002|Overall Study|Adverse Event|5
4636305|NCT01942161|7508447|FG000|Overall Study|Physician Decision|3
4636306|NCT01942161|7508448|FG001|Overall Study|Physician Decision|1
4636307|NCT01942161|7508449|FG002|Overall Study|Physician Decision|0
4636308|NCT01942161|7508447|FG000|Overall Study|Protocol Violation|1
4636309|NCT01942161|7508448|FG001|Overall Study|Protocol Violation|0
4636310|NCT01942161|7508449|FG002|Overall Study|Protocol Violation|0
4636311|NCT01942161|7508447|FG000|Overall Study|Withdrawal by Subject|3
4636312|NCT01942161|7508448|FG001|Overall Study|Withdrawal by Subject|3
4636313|NCT01942161|7508449|FG002|Overall Study|Withdrawal by Subject|1
4636314|NCT01942486|7508457|FG000|Overall Study|Lost to Follow-up|27
4636315|NCT01942590|7508463|FG000|Overall Study|Withdrawal by Subject|0
4636316|NCT01942590|7508464|FG001|Overall Study|Withdrawal by Subject|1
4636317|NCT01942590|7508463|FG000|Overall Study|Adverse Event|1
4604276|NCT01642212|7457337|FG002|Double-blind Treatment|Non-compliance|0
4604277|NCT01642212|7457338|FG003|Double-blind Treatment|Non-compliance|0
4604278|NCT01642212|7457339|FG004|Double-blind Treatment|Non-compliance|0
4604279|NCT01642212|7457335|FG000|Double-blind Treatment|Adverse Event|0
4604280|NCT01642212|7457336|FG001|Double-blind Treatment|Adverse Event|0
4604281|NCT01642212|7457337|FG002|Double-blind Treatment|Adverse Event|1
4604282|NCT01642212|7457338|FG003|Double-blind Treatment|Adverse Event|0
4604283|NCT01642212|7457339|FG004|Double-blind Treatment|Adverse Event|0
4604284|NCT01642212|7457335|FG000|Open-label Extension|Adverse Event|0
4604285|NCT01642212|7457336|FG001|Open-label Extension|Adverse Event|0
4604286|NCT01642212|7457337|FG002|Open-label Extension|Adverse Event|0
4604287|NCT01642212|7457338|FG003|Open-label Extension|Adverse Event|3
4604288|NCT01642212|7457339|FG004|Open-label Extension|Adverse Event|0
4604289|NCT01642212|7457335|FG000|Open-label Extension|Sponsor Decision|0
4636318|NCT01942590|7508464|FG001|Overall Study|Adverse Event|0
4636319|NCT01942733|7508519|FG000|Overall Study|Lost to Follow-up|1
4636320|NCT01942733|7508519|FG000|Overall Study|Non-compliance with IMP|1
4636321|NCT01942733|7508519|FG000|Overall Study|Administrative|1
4636322|NCT01942785|7508523|FG000|Overall Study|Adverse Event|2
4636323|NCT01942785|7508523|FG000|Overall Study|Withdrawal by Subject|1
4636324|NCT01942785|7508523|FG000|Overall Study|Protocol Violation|1
4636325|NCT01942993|7508529|FG000|Overall Study|Lost to Follow-up|1
4604290|NCT01642212|7457336|FG001|Open-label Extension|Sponsor Decision|0
4604291|NCT01642212|7457337|FG002|Open-label Extension|Sponsor Decision|0
4604292|NCT01642212|7457338|FG003|Open-label Extension|Sponsor Decision|7
4604293|NCT01642212|7457339|FG004|Open-label Extension|Sponsor Decision|4
4604294|NCT01642212|7457335|FG000|Open-label Extension|Consent Withdrawn|0
4604295|NCT01642212|7457336|FG001|Open-label Extension|Consent Withdrawn|0
4604296|NCT01642212|7457337|FG002|Open-label Extension|Consent Withdrawn|0
4636326|NCT01942993|7508529|FG000|Overall Study|Physician Decision|1
4636327|NCT01943292|7508561|FG000|Overall Study|Withdrawal by Subject|1
4636328|NCT01943292|7508562|FG001|Overall Study|Withdrawal by Subject|0
4636329|NCT01943292|7508563|FG002|Overall Study|Withdrawal by Subject|0
4604297|NCT01642212|7457338|FG003|Open-label Extension|Consent Withdrawn|0
4604298|NCT01642212|7457339|FG004|Open-label Extension|Consent Withdrawn|2
4604299|NCT01642212|7457335|FG000|Open-label Extension|Lost to Follow-up|0
4604300|NCT01642212|7457336|FG001|Open-label Extension|Lost to Follow-up|0
4604301|NCT01642212|7457337|FG002|Open-label Extension|Lost to Follow-up|0
4604302|NCT01642212|7457338|FG003|Open-label Extension|Lost to Follow-up|0
4604303|NCT01642212|7457339|FG004|Open-label Extension|Lost to Follow-up|1
4604304|NCT01642212|7457335|FG000|Open-label Extension|Other|0
4604305|NCT01642212|7457336|FG001|Open-label Extension|Other|0
4604306|NCT01642212|7457337|FG002|Open-label Extension|Other|0
4604307|NCT01642212|7457338|FG003|Open-label Extension|Other|0
4604308|NCT01642212|7457339|FG004|Open-label Extension|Other|1
4604309|NCT01642251|7457357|FG000|Overall Study|Progressive disease|0
4604310|NCT01642251|7457358|FG001|Overall Study|Progressive disease|0
4604311|NCT01642251|7457359|FG002|Overall Study|Progressive disease|3
4604312|NCT01642251|7457360|FG003|Overall Study|Progressive disease|3
4604313|NCT01642251|7457357|FG000|Overall Study|Adverse Event|0
4604314|NCT01642251|7457358|FG001|Overall Study|Adverse Event|0
4604315|NCT01642251|7457359|FG002|Overall Study|Adverse Event|5
4604316|NCT01642251|7457360|FG003|Overall Study|Adverse Event|4
4636330|NCT01943435|7508580|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4
4636331|NCT01943435|7508581|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12
4636332|NCT01943435|7508582|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3
4636333|NCT01943435|7508580|FG000|Intervention Period|Withdrawal by Subject|3
4636334|NCT01943435|7508581|FG001|Intervention Period|Withdrawal by Subject|3
4636335|NCT01943435|7508582|FG002|Intervention Period|Withdrawal by Subject|4
4636336|NCT01943435|7508580|FG000|2 Month Follow up|Lost to Follow-up|2
4636337|NCT01943435|7508581|FG001|2 Month Follow up|Lost to Follow-up|3
4636338|NCT01943435|7508582|FG002|2 Month Follow up|Lost to Follow-up|0
4636339|NCT01943435|7508580|FG000|6 Month Follow up|Lost to Follow-up|12
4636340|NCT01943435|7508581|FG001|6 Month Follow up|Lost to Follow-up|7
4636341|NCT01943435|7508582|FG002|6 Month Follow up|Lost to Follow-up|15
4604317|NCT01642251|7457357|FG000|Overall Study|Death|0
4604318|NCT01642251|7457358|FG001|Overall Study|Death|0
4604319|NCT01642251|7457359|FG002|Overall Study|Death|1
4604320|NCT01642251|7457360|FG003|Overall Study|Death|3
4604321|NCT01642251|7457357|FG000|Overall Study|Withdrawal by Subject|0
4604322|NCT01642251|7457358|FG001|Overall Study|Withdrawal by Subject|0
4604323|NCT01642251|7457359|FG002|Overall Study|Withdrawal by Subject|1
4604324|NCT01642251|7457360|FG003|Overall Study|Withdrawal by Subject|3
4604325|NCT01642251|7457357|FG000|Overall Study|Alternative therapy|0
4604326|NCT01642251|7457358|FG001|Overall Study|Alternative therapy|0
4604327|NCT01642251|7457359|FG002|Overall Study|Alternative therapy|0
4604328|NCT01642251|7457360|FG003|Overall Study|Alternative therapy|2
4604329|NCT01642251|7457357|FG000|Overall Study|Other complicating disease|0
4604330|NCT01642251|7457358|FG001|Overall Study|Other complicating disease|0
4604331|NCT01642251|7457359|FG002|Overall Study|Other complicating disease|1
4604332|NCT01642251|7457360|FG003|Overall Study|Other complicating disease|0
4604333|NCT01642251|7457357|FG000|Overall Study|Ineligible/never start protocol therapy|0
4604334|NCT01642251|7457358|FG001|Overall Study|Ineligible/never start protocol therapy|0
4604335|NCT01642251|7457359|FG002|Overall Study|Ineligible/never start protocol therapy|11
4604336|NCT01642251|7457360|FG003|Overall Study|Ineligible/never start protocol therapy|8
4604337|NCT01642277|7457371|FG000|Overall Study|Adverse Event|10
4604338|NCT01642277|7457372|FG001|Overall Study|Adverse Event|0
4604339|NCT01642277|7457371|FG000|Overall Study|Physician Decision|2
4604340|NCT01642277|7457372|FG001|Overall Study|Physician Decision|0
4604341|NCT01642277|7457371|FG000|Overall Study|Protocol Violation|1
4604342|NCT01642277|7457372|FG001|Overall Study|Protocol Violation|0
4604343|NCT01642277|7457371|FG000|Overall Study|Withdrawal by Subject|11
4604344|NCT01642277|7457372|FG001|Overall Study|Withdrawal by Subject|0
4604345|NCT01642407|7457379|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3
4604346|NCT01642407|7457379|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1
4604347|NCT01642407|7457379|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1
4604348|NCT01642589|7457410|FG000|Overall Study|Withdrawal by Subject|1
4604349|NCT01642589|7457411|FG001|Overall Study|Withdrawal by Subject|1
4604350|NCT01642602|7457417|FG000|Overall Study|Adverse Event|2
4604351|NCT01642615|7457421|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1
4604352|NCT01642615|7457422|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0
4604353|NCT01642615|7457423|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0
4604354|NCT01642615|7457421|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1
4604355|NCT01642615|7457422|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0
4604356|NCT01642615|7457423|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0
4604357|NCT01642615|7457421|FG000|Open Label Maintenance Phase|Lost to Follow-up|1
4604358|NCT01642615|7457422|FG001|Open Label Maintenance Phase|Lost to Follow-up|0
4604359|NCT01642615|7457423|FG002|Open Label Maintenance Phase|Lost to Follow-up|0
4604360|NCT01642615|7457421|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1
4604361|NCT01642615|7457422|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0
4604362|NCT01642615|7457423|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0
4604363|NCT01642615|7457421|FG000|Open Label Maintenance Phase|Did not receive treatment|1
4604364|NCT01642615|7457422|FG001|Open Label Maintenance Phase|Did not receive treatment|0
4604365|NCT01642615|7457423|FG002|Open Label Maintenance Phase|Did not receive treatment|0
4604366|NCT01642615|7457421|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0
4604367|NCT01642615|7457422|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1
4604368|NCT01642615|7457423|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3
4604369|NCT01642615|7457421|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0
4604370|NCT01642615|7457422|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5
4604371|NCT01642615|7457423|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2
4604372|NCT01642615|7457421|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0
4604373|NCT01642615|7457422|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1
4604374|NCT01642615|7457423|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0
4604375|NCT01642615|7457421|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0
4604376|NCT01642615|7457422|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0
4604377|NCT01642615|7457423|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1
4604378|NCT01642914|7457434|FG000|Overall Study|Adverse Event|11
4604379|NCT01642914|7457435|FG001|Overall Study|Adverse Event|7
4604380|NCT01642914|7457436|FG002|Overall Study|Adverse Event|15
4604381|NCT01642914|7457434|FG000|Overall Study|Lack of Efficacy|9
4604382|NCT01642914|7457435|FG001|Overall Study|Lack of Efficacy|4
4604383|NCT01642914|7457436|FG002|Overall Study|Lack of Efficacy|2
4604384|NCT01642914|7457434|FG000|Overall Study|Protocol Violation|15
4604385|NCT01642914|7457435|FG001|Overall Study|Protocol Violation|13
4604386|NCT01642914|7457436|FG002|Overall Study|Protocol Violation|6
4604387|NCT01642914|7457434|FG000|Overall Study|Withdrawal by Subject|5
4604388|NCT01642914|7457435|FG001|Overall Study|Withdrawal by Subject|5
4604389|NCT01642914|7457436|FG002|Overall Study|Withdrawal by Subject|10
4604390|NCT01642914|7457434|FG000|Overall Study|Lost to Follow-up|5
4604391|NCT01642914|7457435|FG001|Overall Study|Lost to Follow-up|3
4604392|NCT01642914|7457436|FG002|Overall Study|Lost to Follow-up|7
4604393|NCT01642914|7457434|FG000|Overall Study|Other Reason|1
4604394|NCT01642914|7457435|FG001|Overall Study|Other Reason|0
4604395|NCT01642914|7457436|FG002|Overall Study|Other Reason|0
4604396|NCT01643044|7457448|FG000|Overall Study|Lost to Follow-up|1
4604397|NCT01643044|7457449|FG001|Overall Study|Lost to Follow-up|1
4604398|NCT01643044|7457448|FG000|Overall Study|Miscarried baby|2
4604399|NCT01643044|7457449|FG001|Overall Study|Miscarried baby|2
4604400|NCT01643044|7457448|FG000|Overall Study|Delivered outside of hospital|1
4604401|NCT01643044|7457449|FG001|Overall Study|Delivered outside of hospital|2
4604402|NCT01643408|7457473|FG000|Overall Study|Adverse Event|12
4604403|NCT01643408|7457473|FG000|Overall Study|Other|2
4604404|NCT01643473|7457479|FG000|Overall Study|Lost to Follow-up|1
4604405|NCT01643473|7457480|FG001|Overall Study|Lost to Follow-up|0
4604406|NCT01643668|7457495|FG000|Overall Study|Death|1
4604407|NCT01643772|7457515|FG000|Overall Study|Protocol Violation|0
4604408|NCT01643772|7457516|FG001|Overall Study|Protocol Violation|0
4604409|NCT01643772|7457517|FG002|Overall Study|Protocol Violation|0
4604410|NCT01643772|7457518|FG003|Overall Study|Protocol Violation|1
4604411|NCT01643772|7457515|FG000|Overall Study|Adverse Event|0
4604412|NCT01643772|7457516|FG001|Overall Study|Adverse Event|0
4604413|NCT01643772|7457517|FG002|Overall Study|Adverse Event|0
4604414|NCT01643772|7457518|FG003|Overall Study|Adverse Event|1
4604415|NCT01643798|7457530|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1
4604416|NCT01643798|7457531|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0
4604417|NCT01643850|7457551|FG000|Overall Study|Withdrawal by Subject|0
4604418|NCT01643850|7457552|FG001|Overall Study|Withdrawal by Subject|0
4604419|NCT01643850|7457553|FG002|Overall Study|Withdrawal by Subject|0
4604420|NCT01643850|7457554|FG003|Overall Study|Withdrawal by Subject|0
4604421|NCT01643850|7457555|FG004|Overall Study|Withdrawal by Subject|1
4604422|NCT01643850|7457556|FG005|Overall Study|Withdrawal by Subject|0
4604423|NCT01643850|7457557|FG006|Overall Study|Withdrawal by Subject|0
4604424|NCT01643850|7457558|FG007|Overall Study|Withdrawal by Subject|0
4604425|NCT01643850|7457559|FG008|Overall Study|Withdrawal by Subject|0
4604426|NCT01643850|7457551|FG000|Overall Study|Lost to Follow-up|0
4604427|NCT01643850|7457552|FG001|Overall Study|Lost to Follow-up|0
4604428|NCT01643850|7457553|FG002|Overall Study|Lost to Follow-up|0
4604429|NCT01643850|7457554|FG003|Overall Study|Lost to Follow-up|0
4604430|NCT01643850|7457555|FG004|Overall Study|Lost to Follow-up|0
4604431|NCT01643850|7457556|FG005|Overall Study|Lost to Follow-up|0
4604432|NCT01643850|7457557|FG006|Overall Study|Lost to Follow-up|1
4604433|NCT01643850|7457558|FG007|Overall Study|Lost to Follow-up|0
4604434|NCT01643850|7457559|FG008|Overall Study|Lost to Follow-up|1
4604435|NCT01643850|7457551|FG000|Overall Study|Adverse Event|0
4604436|NCT01643850|7457552|FG001|Overall Study|Adverse Event|0
4604437|NCT01643850|7457553|FG002|Overall Study|Adverse Event|0
4604438|NCT01643850|7457554|FG003|Overall Study|Adverse Event|0
4604439|NCT01643850|7457555|FG004|Overall Study|Adverse Event|1
4604440|NCT01643850|7457556|FG005|Overall Study|Adverse Event|0
4604441|NCT01643850|7457557|FG006|Overall Study|Adverse Event|0
4604442|NCT01643850|7457558|FG007|Overall Study|Adverse Event|0
4604443|NCT01643850|7457559|FG008|Overall Study|Adverse Event|0
4604444|NCT01643850|7457551|FG000|Overall Study|Administrative Problems|0
4604445|NCT01643850|7457552|FG001|Overall Study|Administrative Problems|0
4604446|NCT01643850|7457553|FG002|Overall Study|Administrative Problems|1
4604447|NCT01643850|7457554|FG003|Overall Study|Administrative Problems|0
4604448|NCT01643850|7457555|FG004|Overall Study|Administrative Problems|1
4604449|NCT01643850|7457556|FG005|Overall Study|Administrative Problems|0
4604450|NCT01643850|7457557|FG006|Overall Study|Administrative Problems|0
4604451|NCT01643850|7457558|FG007|Overall Study|Administrative Problems|0
4604452|NCT01643850|7457559|FG008|Overall Study|Administrative Problems|0
4604453|NCT01643928|7457639|FG000|Overall Study|Lost to Follow-up|1
4604454|NCT01643928|7457640|FG001|Overall Study|Lost to Follow-up|0
4604455|NCT01643928|7457641|FG002|Overall Study|Lost to Follow-up|2
4604456|NCT01643928|7457642|FG003|Overall Study|Lost to Follow-up|0
4604457|NCT01643928|7457643|FG004|Overall Study|Lost to Follow-up|0
4604458|NCT01643928|7457639|FG000|Overall Study|Withdrawal by Subject|2
4604459|NCT01643928|7457640|FG001|Overall Study|Withdrawal by Subject|0
4604460|NCT01643928|7457641|FG002|Overall Study|Withdrawal by Subject|0
4604461|NCT01643928|7457642|FG003|Overall Study|Withdrawal by Subject|1
4604462|NCT01643928|7457643|FG004|Overall Study|Withdrawal by Subject|0
4604463|NCT01643928|7457639|FG000|Overall Study|Pregnancy|0
4604464|NCT01643928|7457640|FG001|Overall Study|Pregnancy|0
4604465|NCT01643928|7457641|FG002|Overall Study|Pregnancy|0
4604466|NCT01643928|7457642|FG003|Overall Study|Pregnancy|1
4604467|NCT01643928|7457643|FG004|Overall Study|Pregnancy|0
4604468|NCT01643928|7457639|FG000|Overall Study|Other|5
4604469|NCT01643928|7457640|FG001|Overall Study|Other|1
4604470|NCT01643928|7457641|FG002|Overall Study|Other|1
4604471|NCT01643928|7457642|FG003|Overall Study|Other|0
4604472|NCT01643928|7457643|FG004|Overall Study|Other|0
4604473|NCT01643928|7457639|FG000|Overall Study|Adverse Event|2
4604474|NCT01643928|7457640|FG001|Overall Study|Adverse Event|1
4604475|NCT01643928|7457641|FG002|Overall Study|Adverse Event|0
4604476|NCT01643928|7457642|FG003|Overall Study|Adverse Event|1
4604477|NCT01643928|7457643|FG004|Overall Study|Adverse Event|2
4604478|NCT01644149|7457691|FG000|Overall Study|Withdrawal by Subject|1
4604479|NCT01644149|7457692|FG001|Overall Study|Withdrawal by Subject|0
4604480|NCT01644149|7457691|FG000|Overall Study|Lost to Follow-up|3
4604481|NCT01644149|7457692|FG001|Overall Study|Lost to Follow-up|1
4604482|NCT01644175|7457701|FG000|Overall Study|Randomized But Not Treated|0
4604483|NCT01644175|7457702|FG001|Overall Study|Randomized But Not Treated|2
4604484|NCT01644175|7457701|FG000|Overall Study|Adverse Event|8
4604485|NCT01644175|7457702|FG001|Overall Study|Adverse Event|13
4604486|NCT01644175|7457701|FG000|Overall Study|Death|1
4604487|NCT01644175|7457702|FG001|Overall Study|Death|2
4604488|NCT01644175|7457701|FG000|Overall Study|Poor compliance to protocol|9
4604489|NCT01644175|7457702|FG001|Overall Study|Poor compliance to protocol|10
4604490|NCT01644175|7457701|FG000|Overall Study|Physician Decision|1
4604491|NCT01644175|7457702|FG001|Overall Study|Physician Decision|2
4604492|NCT01644175|7457701|FG000|Overall Study|Participant Moved|1
4604493|NCT01644175|7457702|FG001|Overall Study|Participant Moved|2
4604494|NCT01644175|7457701|FG000|Overall Study|Consent withdrawn by participant|3
4604495|NCT01644175|7457702|FG001|Overall Study|Consent withdrawn by participant|4
4604496|NCT01644175|7457701|FG000|Overall Study|Related to Autoinjector Administration|2
4604497|NCT01644175|7457702|FG001|Overall Study|Related to Autoinjector Administration|1
4604498|NCT01644175|7457701|FG000|Overall Study|Last visit outside protocol visit window|4
4604499|NCT01644175|7457702|FG001|Overall Study|Last visit outside protocol visit window|11
4604500|NCT01644175|7457701|FG000|Overall Study|Selection criteria finally not met|0
4604501|NCT01644175|7457702|FG001|Overall Study|Selection criteria finally not met|1
4604502|NCT01644175|7457701|FG000|Overall Study|Site closure|2
4604503|NCT01644175|7457702|FG001|Overall Study|Site closure|2
4604504|NCT01644175|7457701|FG000|Overall Study|Lost to Follow-up|1
4604505|NCT01644175|7457702|FG001|Overall Study|Lost to Follow-up|0
4604506|NCT01644175|7457701|FG000|Overall Study|Other than specified above|0
4604507|NCT01644175|7457702|FG001|Overall Study|Other than specified above|3
4604508|NCT01644188|7457710|FG000|Overall Study|Adverse Event|44
4604509|NCT01644188|7457711|FG001|Overall Study|Adverse Event|20
4604510|NCT01644188|7457710|FG000|Overall Study|Poor compliance to protocol|26
4604511|NCT01644188|7457711|FG001|Overall Study|Poor compliance to protocol|14
4604512|NCT01644188|7457710|FG000|Overall Study|Physician Decision|1
4604513|NCT01644188|7457711|FG001|Overall Study|Physician Decision|3
4604514|NCT01644188|7457710|FG000|Overall Study|Participant moved|7
4604515|NCT01644188|7457711|FG001|Overall Study|Participant moved|2
4604516|NCT01644188|7457710|FG000|Overall Study|Related to auto-injector administration|2
4604517|NCT01644188|7457711|FG001|Overall Study|Related to auto-injector administration|2
4604518|NCT01644188|7457710|FG000|Overall Study|Consent withdrawn by participant|14
4746678|NCT00587795|7718936|FG000|Overall Study|Withdrawal by Subject|1
4604519|NCT01644188|7457711|FG001|Overall Study|Consent withdrawn by participant|7
4604520|NCT01644188|7457710|FG000|Overall Study|Selection criteria finally not met|2
4604521|NCT01644188|7457711|FG001|Overall Study|Selection criteria finally not met|0
4604522|NCT01644188|7457710|FG000|Overall Study|Lost to Follow-up|1
4604523|NCT01644188|7457711|FG001|Overall Study|Lost to Follow-up|0
4604524|NCT01644188|7457710|FG000|Overall Study|Death|4
4604525|NCT01644188|7457711|FG001|Overall Study|Death|3
4604526|NCT01644188|7457710|FG000|Overall Study|Last visit outside protocol visit window|14
4604527|NCT01644188|7457711|FG001|Overall Study|Last visit outside protocol visit window|16
4604528|NCT01644188|7457710|FG000|Overall Study|Site closure|1
4604529|NCT01644188|7457711|FG001|Overall Study|Site closure|1
4604530|NCT01644188|7457710|FG000|Overall Study|Other than specified above|6
4604531|NCT01644188|7457711|FG001|Overall Study|Other than specified above|7
4604532|NCT01644474|7457750|FG000|Overall Study|Poor compliance to protocol|1
4604533|NCT01644474|7457751|FG001|Overall Study|Poor compliance to protocol|0
4604534|NCT01644474|7457750|FG000|Overall Study|Consent withdrawn by participant|0
4604535|NCT01644474|7457751|FG001|Overall Study|Consent withdrawn by participant|1
4604536|NCT01644474|7457750|FG000|Overall Study|Participant moved|0
4604537|NCT01644474|7457751|FG001|Overall Study|Participant moved|1
4604538|NCT01644474|7457750|FG000|Overall Study|Adverse Event|4
4604539|NCT01644474|7457751|FG001|Overall Study|Adverse Event|5
4604540|NCT01644474|7457750|FG000|Overall Study|Site scheduling error|1
4604541|NCT01644474|7457751|FG001|Overall Study|Site scheduling error|1
4604542|NCT01644474|7457750|FG000|Overall Study|Protocol Violation|1
4604543|NCT01644474|7457751|FG001|Overall Study|Protocol Violation|0
4604544|NCT01644500|7457760|FG000|Overall Study|Adverse Event|6
4604545|NCT01644500|7457761|FG001|Overall Study|Adverse Event|1
4604546|NCT01644500|7457762|FG002|Overall Study|Adverse Event|2
4604547|NCT01644500|7457760|FG000|Overall Study|Death|0
4604548|NCT01644500|7457761|FG001|Overall Study|Death|1
4604549|NCT01644500|7457762|FG002|Overall Study|Death|0
4604550|NCT01644500|7457760|FG000|Overall Study|Lost to Follow-up|3
4604551|NCT01644500|7457761|FG001|Overall Study|Lost to Follow-up|8
4604552|NCT01644500|7457762|FG002|Overall Study|Lost to Follow-up|0
4604553|NCT01644500|7457760|FG000|Overall Study|Protocol Violation|1
4604554|NCT01644500|7457761|FG001|Overall Study|Protocol Violation|1
4604555|NCT01644500|7457762|FG002|Overall Study|Protocol Violation|0
4604556|NCT01644500|7457760|FG000|Overall Study|Withdrawal by Subject|11
4604557|NCT01644500|7457761|FG001|Overall Study|Withdrawal by Subject|12
4604558|NCT01644500|7457762|FG002|Overall Study|Withdrawal by Subject|12
4604559|NCT01644500|7457760|FG000|Overall Study|Physician Decision|1
4604560|NCT01644500|7457761|FG001|Overall Study|Physician Decision|1
4604561|NCT01644500|7457762|FG002|Overall Study|Physician Decision|1
4604562|NCT01644565|7457770|FG000|Overall Study|Undisclosed Medical History|1
4604563|NCT01644565|7457771|FG001|Overall Study|Undisclosed Medical History|0
4604564|NCT01644565|7457772|FG002|Overall Study|Undisclosed Medical History|0
4604565|NCT01644565|7457773|FG003|Overall Study|Undisclosed Medical History|0
4604566|NCT01644565|7457774|FG004|Overall Study|Undisclosed Medical History|0
4604567|NCT01644565|7457775|FG005|Overall Study|Undisclosed Medical History|0
4604568|NCT01644565|7457776|FG006|Overall Study|Undisclosed Medical History|0
4604569|NCT01644565|7457777|FG007|Overall Study|Undisclosed Medical History|0
4604570|NCT01644565|7457778|FG008|Overall Study|Undisclosed Medical History|0
4604571|NCT01644565|7457770|FG000|Overall Study|Lost to Follow-up|0
4604572|NCT01644565|7457771|FG001|Overall Study|Lost to Follow-up|0
4604573|NCT01644565|7457772|FG002|Overall Study|Lost to Follow-up|0
4604574|NCT01644565|7457773|FG003|Overall Study|Lost to Follow-up|1
4604575|NCT01644565|7457774|FG004|Overall Study|Lost to Follow-up|0
4604576|NCT01644565|7457775|FG005|Overall Study|Lost to Follow-up|0
4604577|NCT01644565|7457776|FG006|Overall Study|Lost to Follow-up|0
4604578|NCT01644565|7457777|FG007|Overall Study|Lost to Follow-up|2
4604579|NCT01644565|7457778|FG008|Overall Study|Lost to Follow-up|0
4604580|NCT01644565|7457770|FG000|Overall Study|Family emergency|0
4604581|NCT01644565|7457771|FG001|Overall Study|Family emergency|0
4604582|NCT01644565|7457772|FG002|Overall Study|Family emergency|0
4604583|NCT01644565|7457773|FG003|Overall Study|Family emergency|0
4604584|NCT01644565|7457774|FG004|Overall Study|Family emergency|1
4604585|NCT01644565|7457775|FG005|Overall Study|Family emergency|0
4604586|NCT01644565|7457776|FG006|Overall Study|Family emergency|0
4604587|NCT01644565|7457777|FG007|Overall Study|Family emergency|0
4604588|NCT01644565|7457778|FG008|Overall Study|Family emergency|0
4604589|NCT01644565|7457770|FG000|Overall Study|Relocation|0
4604590|NCT01644565|7457771|FG001|Overall Study|Relocation|0
4604591|NCT01644565|7457772|FG002|Overall Study|Relocation|0
4604592|NCT01644565|7457773|FG003|Overall Study|Relocation|0
4604593|NCT01644565|7457774|FG004|Overall Study|Relocation|0
4604594|NCT01644565|7457775|FG005|Overall Study|Relocation|0
4604595|NCT01644565|7457776|FG006|Overall Study|Relocation|0
4604596|NCT01644565|7457777|FG007|Overall Study|Relocation|0
4604597|NCT01644565|7457778|FG008|Overall Study|Relocation|1
4604598|NCT01644617|7457801|FG000|Overall Study|Withdrawal by Subject|3
4604599|NCT01644617|7457802|FG001|Overall Study|Withdrawal by Subject|4
4604600|NCT01644617|7457803|FG002|Overall Study|Withdrawal by Subject|1
4604601|NCT01644617|7457801|FG000|Overall Study|Lost to Follow-up|0
4604602|NCT01644617|7457802|FG001|Overall Study|Lost to Follow-up|1
4604603|NCT01644617|7457803|FG002|Overall Study|Lost to Follow-up|0
4604604|NCT01644617|7457801|FG000|Overall Study|Adverse Event|3
4604605|NCT01644617|7457802|FG001|Overall Study|Adverse Event|0
4604606|NCT01644617|7457803|FG002|Overall Study|Adverse Event|6
4604607|NCT01644643|7457815|FG000|Overall Study|Death|1
4604608|NCT01644643|7457816|FG001|Overall Study|Death|0
4604609|NCT01644643|7457817|FG002|Overall Study|Death|3
4604610|NCT01644643|7457818|FG003|Overall Study|Death|3
4604611|NCT01644643|7457815|FG000|Overall Study|Lost to Follow-up|0
4604612|NCT01644643|7457816|FG001|Overall Study|Lost to Follow-up|0
4604613|NCT01644643|7457817|FG002|Overall Study|Lost to Follow-up|0
4604614|NCT01644643|7457818|FG003|Overall Study|Lost to Follow-up|4
4604615|NCT01644643|7457815|FG000|Overall Study|Withdrawal by Subject|1
4604616|NCT01644643|7457816|FG001|Overall Study|Withdrawal by Subject|0
4604617|NCT01644643|7457817|FG002|Overall Study|Withdrawal by Subject|2
4604618|NCT01644643|7457818|FG003|Overall Study|Withdrawal by Subject|1
4604619|NCT01644643|7457815|FG000|Overall Study|Other Eligibility criteria|0
4604620|NCT01644643|7457816|FG001|Overall Study|Other Eligibility criteria|0
4604621|NCT01644643|7457817|FG002|Overall Study|Other Eligibility criteria|0
4604622|NCT01644643|7457818|FG003|Overall Study|Other Eligibility criteria|2
4604623|NCT01644734|7457838|FG000|Overall Study|Adverse Event|4
4604624|NCT01644734|7457838|FG000|Overall Study|Lost to Follow-up|17
4604625|NCT01644734|7457838|FG000|Overall Study|Reasons other than stated above|7
4604626|NCT01644734|7457838|FG000|Overall Study|Missing documentation|238
4604627|NCT01644890|7457844|FG000|Overall Study|Adverse Event|7
4604628|NCT01644890|7457845|FG001|Overall Study|Adverse Event|20
4604629|NCT01644890|7457844|FG000|Overall Study|Death|1
4604630|NCT01644890|7457845|FG001|Overall Study|Death|3
4604631|NCT01644890|7457844|FG000|Overall Study|Physician Decision|3
4604632|NCT01644890|7457845|FG001|Overall Study|Physician Decision|9
4604633|NCT01644890|7457844|FG000|Overall Study|Protocol Violation|6
4604634|NCT01644890|7457845|FG001|Overall Study|Protocol Violation|7
4604635|NCT01644890|7457844|FG000|Overall Study|Withdrawal by Subject|19
4604636|NCT01644890|7457845|FG001|Overall Study|Withdrawal by Subject|27
4604637|NCT01644890|7457844|FG000|Overall Study|Progression Disease|160
4604638|NCT01644890|7457845|FG001|Overall Study|Progression Disease|131
4604639|NCT01644890|7457844|FG000|Overall Study|Clinical Progression|6
4604640|NCT01644890|7457845|FG001|Overall Study|Clinical Progression|6
4604641|NCT01644890|7457844|FG000|Overall Study|> 28 days since last dose of study drug|6
4604642|NCT01644890|7457845|FG001|Overall Study|> 28 days since last dose of study drug|3
4604643|NCT01644890|7457844|FG000|Overall Study|Other|8
4604644|NCT01644890|7457845|FG001|Overall Study|Other|9
4604645|NCT01645111|7457869|FG000|Overall Study|Did not require Clevidipine|15
4604646|NCT01645176|7457873|FG000|Overall Study|Lack of Efficacy|4
4636342|NCT01943539|7508616|FG000|Overall Study|Non-compliance with at-home intervention|4
4636343|NCT01943539|7508617|FG001|Overall Study|Non-compliance with at-home intervention|0
4636344|NCT01943552|7508626|FG000|Overall Study|Adverse Event|3
4636345|NCT01943552|7508627|FG001|Overall Study|Adverse Event|2
4636346|NCT01943552|7508626|FG000|Overall Study|Withdrawal by Subject|6
4636347|NCT01943552|7508627|FG001|Overall Study|Withdrawal by Subject|6
4636348|NCT01943552|7508626|FG000|Overall Study|Other Reasons|16
4636349|NCT01943552|7508627|FG001|Overall Study|Other Reasons|17
4636350|NCT01943591|7508648|FG000|Overall Study|Lost to Follow-up|3
4636351|NCT01943591|7508649|FG001|Overall Study|Lost to Follow-up|4
4636352|NCT01943591|7508648|FG000|Overall Study|Death|2
4636353|NCT01943591|7508649|FG001|Overall Study|Death|7
4636354|NCT01943799|7508659|FG000|Overall Study|Lost to Follow-up|0
4636355|NCT01943799|7508660|FG001|Overall Study|Lost to Follow-up|1
4636356|NCT01943799|7508661|FG002|Overall Study|Lost to Follow-up|1
4636357|NCT01943799|7508662|FG003|Overall Study|Lost to Follow-up|0
4636358|NCT01943799|7508659|FG000|Overall Study|Protocol Violation|1
4636359|NCT01943799|7508660|FG001|Overall Study|Protocol Violation|0
4636360|NCT01943799|7508661|FG002|Overall Study|Protocol Violation|0
4636361|NCT01943799|7508662|FG003|Overall Study|Protocol Violation|0
4636362|NCT01943799|7508659|FG000|Overall Study|Withdrawal by Subject|4
4636363|NCT01943799|7508660|FG001|Overall Study|Withdrawal by Subject|2
4636364|NCT01943799|7508661|FG002|Overall Study|Withdrawal by Subject|1
4636365|NCT01943799|7508662|FG003|Overall Study|Withdrawal by Subject|0
4636366|NCT01943851|7508690|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
4636367|NCT01943851|7508691|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
4636368|NCT01943851|7508692|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
4636369|NCT01943851|7508693|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1
4636370|NCT01943851|7508694|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
4636371|NCT01943851|7508695|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
4636372|NCT01943851|7508696|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1
4636373|NCT01943851|7508697|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1
4636374|NCT01943851|7508698|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1
4636375|NCT01943851|7508699|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
4636376|NCT01943851|7508700|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
4604647|NCT01645176|7457873|FG000|Overall Study|did not complete final MRI|1
4636377|NCT01943851|7508701|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
4636378|NCT01943851|7508702|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
4636379|NCT01943851|7508703|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
4636380|NCT01943851|7508704|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
4636381|NCT01943851|7508705|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
4604648|NCT01645280|7457882|FG000|Overall Study|Death|0
4604649|NCT01645280|7457883|FG001|Overall Study|Death|1
4636382|NCT01943851|7508706|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
4636383|NCT01943851|7508707|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0
4636384|NCT01943851|7508690|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
4636385|NCT01943851|7508691|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
4636386|NCT01943851|7508692|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
4636387|NCT01943851|7508693|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
4636388|NCT01943851|7508694|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1
4636389|NCT01943851|7508695|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
4636390|NCT01943851|7508696|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
4636391|NCT01943851|7508697|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1
4636392|NCT01943851|7508698|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
4636393|NCT01943851|7508699|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
4636394|NCT01943851|7508700|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
4636395|NCT01943851|7508701|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
4636396|NCT01943851|7508702|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
4636397|NCT01943851|7508703|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
4636398|NCT01943851|7508704|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
4636399|NCT01943851|7508705|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
4636400|NCT01943851|7508706|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
4636401|NCT01943851|7508707|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0
4636402|NCT01943851|7508690|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
4636403|NCT01943851|7508691|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
4636404|NCT01943851|7508692|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
4636405|NCT01943851|7508693|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
4636406|NCT01943851|7508694|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
4636407|NCT01943851|7508695|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
4636408|NCT01943851|7508696|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
4636409|NCT01943851|7508697|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
4636410|NCT01943851|7508698|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
4636411|NCT01943851|7508699|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
4636412|NCT01943851|7508700|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
4636413|NCT01943851|7508701|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
4636414|NCT01943851|7508702|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
4636415|NCT01943851|7508703|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1
4636416|NCT01943851|7508704|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
4636417|NCT01943851|7508705|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
4636418|NCT01943851|7508706|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
4636419|NCT01943851|7508707|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0
4636420|NCT01943851|7508690|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
4636421|NCT01943851|7508691|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
4636422|NCT01943851|7508692|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
4636423|NCT01943851|7508693|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
4636424|NCT01943851|7508694|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
4636425|NCT01943851|7508695|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
4636426|NCT01943851|7508696|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
4636427|NCT01943851|7508697|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
4636428|NCT01943851|7508698|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
4636429|NCT01943851|7508699|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
4636430|NCT01943851|7508700|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
4636431|NCT01943851|7508701|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
4636432|NCT01943851|7508702|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
4636433|NCT01943851|7508703|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
4636434|NCT01943851|7508704|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
4636435|NCT01943851|7508705|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2
4636436|NCT01943851|7508706|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
4636437|NCT01943851|7508707|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0
4636438|NCT01943851|7508690|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
4636439|NCT01943851|7508691|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
4746679|NCT00587795|7718937|FG001|Overall Study|Withdrawal by Subject|0
4604650|NCT01645280|7457884|FG002|Overall Study|Death|0
4604651|NCT01645280|7457885|FG003|Overall Study|Death|0
4604652|NCT01645280|7457886|FG004|Overall Study|Death|0
4604653|NCT01645280|7457882|FG000|Overall Study|Withdrawal by Subject|4
4604654|NCT01645280|7457883|FG001|Overall Study|Withdrawal by Subject|0
4604655|NCT01645280|7457884|FG002|Overall Study|Withdrawal by Subject|2
4604656|NCT01645280|7457885|FG003|Overall Study|Withdrawal by Subject|4
4604657|NCT01645280|7457886|FG004|Overall Study|Withdrawal by Subject|5
4604658|NCT01645280|7457882|FG000|Overall Study|Lost to Follow-up|0
4604659|NCT01645280|7457883|FG001|Overall Study|Lost to Follow-up|0
4604660|NCT01645280|7457884|FG002|Overall Study|Lost to Follow-up|0
4604661|NCT01645280|7457885|FG003|Overall Study|Lost to Follow-up|2
4604662|NCT01645280|7457886|FG004|Overall Study|Lost to Follow-up|1
4604663|NCT01645280|7457882|FG000|Overall Study|Other|1
4604664|NCT01645280|7457883|FG001|Overall Study|Other|1
4604665|NCT01645280|7457884|FG002|Overall Study|Other|2
4604666|NCT01645280|7457885|FG003|Overall Study|Other|0
4604667|NCT01645280|7457886|FG004|Overall Study|Other|0
4604668|NCT01645280|7457882|FG000|Overall Study|Treatment not completed/Completed f/u|1
4604669|NCT01645280|7457883|FG001|Overall Study|Treatment not completed/Completed f/u|1
4604670|NCT01645280|7457884|FG002|Overall Study|Treatment not completed/Completed f/u|2
4604671|NCT01645280|7457885|FG003|Overall Study|Treatment not completed/Completed f/u|0
4604672|NCT01645280|7457886|FG004|Overall Study|Treatment not completed/Completed f/u|2
4604673|NCT01645735|7457914|FG000|Overall Study|Physician Decision|2
4604674|NCT01645735|7457915|FG001|Overall Study|Physician Decision|0
4604675|NCT01645735|7457914|FG000|Overall Study|Withdrawal by Subject|1
4604676|NCT01645735|7457915|FG001|Overall Study|Withdrawal by Subject|0
4604677|NCT01645735|7457914|FG000|Overall Study|Protocol Violation|1
4604678|NCT01645735|7457915|FG001|Overall Study|Protocol Violation|0
4604679|NCT01645735|7457914|FG000|Overall Study|Adverse Event|0
4604680|NCT01645735|7457915|FG001|Overall Study|Adverse Event|1
4636440|NCT01943851|7508692|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
4636441|NCT01943851|7508693|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
4636442|NCT01943851|7508694|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
4636443|NCT01943851|7508695|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
4636444|NCT01943851|7508696|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
4636445|NCT01943851|7508697|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
4636446|NCT01943851|7508698|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
4636447|NCT01943851|7508699|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
4636448|NCT01943851|7508700|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
4636449|NCT01943851|7508701|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
4636450|NCT01943851|7508702|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
4636451|NCT01943851|7508703|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
4636452|NCT01943851|7508704|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0
4636453|NCT01943851|7508705|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4
4636454|NCT01943851|7508706|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3
4636455|NCT01943851|7508707|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1
4636456|NCT01943916|7508752|FG000|Overall Study|Technically invalid images|10
4636457|NCT01943916|7508752|FG000|Overall Study|Enrollment Failure|23
4636458|NCT01943916|7508752|FG000|Overall Study|Pilot Phase exclusion|100
4636459|NCT01943916|7508752|FG000|Overall Study|Quality Assurance Reader Fail|130
4636460|NCT01943916|7508752|FG000|Overall Study|Technical Failure|39
4636461|NCT01943916|7508752|FG000|Overall Study|Protocol Deviation No Biopsy|25
4636462|NCT01943916|7508752|FG000|Overall Study|No Truth Panel Review|38
4636463|NCT01943916|7508752|FG000|Overall Study|Protocol Deviation|1
4636464|NCT01944046|7508763|FG000|Randomized to DB|Adverse Event|5
4636465|NCT01944046|7508764|FG001|Randomized to DB|Adverse Event|2
4636466|NCT01944046|7508763|FG000|Randomized to DB|Clinical Worsening|3
4636467|NCT01944046|7508764|FG001|Randomized to DB|Clinical Worsening|2
4636468|NCT01944046|7508763|FG000|Randomized to DB|Lost to Follow-up|3
4636469|NCT01944046|7508764|FG001|Randomized to DB|Lost to Follow-up|3
4636470|NCT01944046|7508763|FG000|Randomized to DB|Withdrawal by Subject|2
4636471|NCT01944046|7508764|FG001|Randomized to DB|Withdrawal by Subject|4
4636472|NCT01944046|7508763|FG000|Randomized to DB|Physician Decision|1
4636473|NCT01944046|7508764|FG001|Randomized to DB|Physician Decision|2
4636474|NCT01944046|7508763|FG000|Randomized to DB|Did not have baseline ABC-SW|2
4636475|NCT01944046|7508764|FG001|Randomized to DB|Did not have baseline ABC-SW|0
4636476|NCT01944046|7508763|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5
4636477|NCT01944046|7508764|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6
4636478|NCT01944046|7508763|FG000|Open Label Eligible and Consented|Lost to Follow-up|3
4636479|NCT01944046|7508764|FG001|Open Label Eligible and Consented|Lost to Follow-up|5
4636480|NCT01944046|7508763|FG000|Open Label Eligible and Consented|Adverse Event|6
4636481|NCT01944046|7508764|FG001|Open Label Eligible and Consented|Adverse Event|1
4636482|NCT01944046|7508763|FG000|Open Label Eligible and Consented|Clinical Worsening|4
4636483|NCT01944046|7508764|FG001|Open Label Eligible and Consented|Clinical Worsening|2
4636484|NCT01944046|7508763|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1
4636485|NCT01944046|7508764|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0
4636486|NCT01944098|7508776|FG000|Overall Study|Physician Decision|1
4636487|NCT01944098|7508777|FG001|Overall Study|Physician Decision|0
4746680|NCT00590135|7718943|FG000|Overall Study|Primary endpoint measure not obtainable|59
4746681|NCT00582036|7718950|FG000|Overall Study|Withdrawal by Subject|0
4746682|NCT00582036|7718951|FG001|Overall Study|Withdrawal by Subject|1
4746683|NCT00585585|7718957|FG000|Overall Study|Adverse Event|1
4746684|NCT00585221|7718961|FG000|Overall Study|Protocol Violation|8
4746685|NCT00581113|7718967|FG000|Overall Study|Withdrawal by Subject|0
4746686|NCT00581113|7718968|FG001|Overall Study|Withdrawal by Subject|1
4604681|NCT01645930|7457922|FG000|Overall Study|Participants Ongoing on Study Treatment|22
4604682|NCT01645930|7457922|FG000|Overall Study|Progressive Disease|12
4636488|NCT01944462|7508828|FG000|PPPP Educational Program|Lost to Follow-up|60
4636489|NCT01944631|7508835|FG000|Overall Study|Adverse Event|1
4636490|NCT01944631|7508836|FG001|Overall Study|Adverse Event|0
4636491|NCT01944631|7508835|FG000|Overall Study|Lost to Follow-up|3
4636492|NCT01944631|7508836|FG001|Overall Study|Lost to Follow-up|1
4636493|NCT01944631|7508835|FG000|Overall Study|Withdrawal by Subject|0
4604683|NCT01645930|7457922|FG000|Overall Study|Adverse Event|4
4604684|NCT01645930|7457922|FG000|Overall Study|Unsatisfactory Therapeutic Response|2
4604685|NCT01645930|7457922|FG000|Overall Study|Withdrawal by Participant|2
4604686|NCT01645930|7457922|FG000|Overall Study|Reason not Defined|1
4604687|NCT01646021|7457928|FG000|Overall Study|Death|77
4604688|NCT01646021|7457929|FG001|Overall Study|Death|83
4604689|NCT01646021|7457928|FG000|Overall Study|Study Terminated by Sponsor|50
4604690|NCT01646021|7457929|FG001|Overall Study|Study Terminated by Sponsor|41
4604691|NCT01646021|7457928|FG000|Overall Study|Lost to Follow-up|2
4604692|NCT01646021|7457929|FG001|Overall Study|Lost to Follow-up|2
4604693|NCT01646021|7457928|FG000|Overall Study|Withdrawal by Subject|10
4604694|NCT01646021|7457929|FG001|Overall Study|Withdrawal by Subject|15
4604695|NCT01646073|7457937|FG000|Period A (12 Weeks)|Adverse Event|0
4604696|NCT01646073|7457938|FG001|Period A (12 Weeks)|Adverse Event|2
4604697|NCT01646073|7457937|FG000|Period A (12 Weeks)|Withdrawal by Subject|1
4604698|NCT01646073|7457938|FG001|Period A (12 Weeks)|Withdrawal by Subject|1
4604699|NCT01646073|7457937|FG000|Period A (12 Weeks)|Lack of Efficacy|1
4604700|NCT01646073|7457938|FG001|Period A (12 Weeks)|Lack of Efficacy|0
4604701|NCT01646073|7457937|FG000|Period A (12 Weeks)|Protocol Violation|0
4604702|NCT01646073|7457938|FG001|Period A (12 Weeks)|Protocol Violation|1
4604703|NCT01646073|7457937|FG000|Period A (12 Weeks)|Other|0
4604704|NCT01646073|7457938|FG001|Period A (12 Weeks)|Other|1
4604705|NCT01646073|7457937|FG000|Period B (12 Weeks)|Adverse Event|0
4604706|NCT01646073|7457938|FG001|Period B (12 Weeks)|Adverse Event|7
4604707|NCT01646073|7457937|FG000|Period B (12 Weeks)|Withdrawal by Subject|1
4604708|NCT01646073|7457938|FG001|Period B (12 Weeks)|Withdrawal by Subject|5
4604709|NCT01646073|7457937|FG000|Period B (12 Weeks)|Lost to Follow-up|0
4604710|NCT01646073|7457938|FG001|Period B (12 Weeks)|Lost to Follow-up|1
4604711|NCT01646125|7457949|FG000|Overall Study|Untreated|2
4604712|NCT01646125|7457950|FG001|Overall Study|Untreated|5
4604713|NCT01646125|7457949|FG000|Overall Study|Adverse Event|2
4604714|NCT01646125|7457950|FG001|Overall Study|Adverse Event|1
4604715|NCT01646125|7457949|FG000|Overall Study|Death|1
4604716|NCT01646125|7457950|FG001|Overall Study|Death|1
4604717|NCT01646125|7457949|FG000|Overall Study|Physician Decision|1
4604718|NCT01646125|7457950|FG001|Overall Study|Physician Decision|3
4604719|NCT01646125|7457949|FG000|Overall Study|Progressive disease|22
4604720|NCT01646125|7457950|FG001|Overall Study|Progressive disease|16
4604721|NCT01646125|7457949|FG000|Overall Study|Study terminated by sponsor|2
4604722|NCT01646125|7457950|FG001|Overall Study|Study terminated by sponsor|1
4604723|NCT01646125|7457949|FG000|Overall Study|Subject/Guardian decision|1
4604724|NCT01646125|7457950|FG001|Overall Study|Subject/Guardian decision|1
4604725|NCT01646138|7457962|FG000|Overall Study|Lost to Follow-up|0
4604726|NCT01646138|7457963|FG001|Overall Study|Lost to Follow-up|0
4604727|NCT01646138|7457964|FG002|Overall Study|Lost to Follow-up|0
4604728|NCT01646138|7457965|FG003|Overall Study|Lost to Follow-up|0
4604729|NCT01646138|7457966|FG004|Overall Study|Lost to Follow-up|2
4604730|NCT01646177|7457986|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2
4604731|NCT01646177|7457987|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4
4604732|NCT01646177|7457988|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9
4604733|NCT01646177|7457989|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8
4604734|NCT01646177|7457990|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
4604735|NCT01646177|7457991|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
4604736|NCT01646177|7457992|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
4604737|NCT01646177|7457993|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
4604738|NCT01646177|7457994|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
4604739|NCT01646177|7457995|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
4604740|NCT01646177|7457996|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
4604741|NCT01646177|7457997|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
4604742|NCT01646177|7457986|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1
4604743|NCT01646177|7457987|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3
4604744|NCT01646177|7457988|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8
4604745|NCT01646177|7457989|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7
4604746|NCT01646177|7457990|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
4604747|NCT01646177|7457991|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
4604748|NCT01646177|7457992|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
4604749|NCT01646177|7457993|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
4604750|NCT01646177|7457994|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
4636494|NCT01944631|7508836|FG001|Overall Study|Withdrawal by Subject|1
4636495|NCT01944670|7508851|FG000|Overall Study|Lost to Follow-up|2
4636496|NCT01944722|7508857|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171
4636497|NCT01944722|7508857|FG000|Overall Study|Specimen Shipping Issues|34
4636498|NCT01944722|7508857|FG000|Overall Study|Improper Storage/Transport|5
4636499|NCT01944722|7508857|FG000|Overall Study|Insufficient Volume for Test|1
4636500|NCT01944722|7508857|FG000|Overall Study|Missing Specimens|3
4636501|NCT01944722|7508857|FG000|Overall Study|Specimens Mislabeled|2
4636502|NCT01944722|7508857|FG000|Overall Study|Withdrawal by Subject|8
4604751|NCT01646177|7457995|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
4604752|NCT01646177|7457996|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
4636503|NCT01944722|7508857|FG000|Overall Study|NILM Subjects <30 years old|8106
4604753|NCT01646177|7457997|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
4604754|NCT01646177|7457986|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3
4604755|NCT01646177|7457987|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2
4604756|NCT01646177|7457988|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4
4604757|NCT01646177|7457989|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4
4604758|NCT01646177|7457990|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
4604759|NCT01646177|7457991|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
4604760|NCT01646177|7457992|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
4604761|NCT01646177|7457993|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
4604762|NCT01646177|7457994|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
4604763|NCT01646177|7457995|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
4604764|NCT01646177|7457996|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
4604765|NCT01646177|7457997|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
4636504|NCT01944722|7508857|FG000|Overall Study|Unsatisfactory Cytology Result|63
4636505|NCT01944722|7508857|FG000|Overall Study|>ASCUS Cytology|1122
4636506|NCT01944774|7508869|FG000|Overall Study|Withdrawal by Subject|2
4636507|NCT01944774|7508870|FG001|Overall Study|Withdrawal by Subject|3
4636508|NCT01944774|7508871|FG002|Overall Study|Withdrawal by Subject|3
4636509|NCT01944774|7508869|FG000|Overall Study|Adverse Event|3
4636510|NCT01944774|7508870|FG001|Overall Study|Adverse Event|2
4636511|NCT01944774|7508871|FG002|Overall Study|Adverse Event|3
4636512|NCT01944774|7508869|FG000|Overall Study|Lack of Efficacy|1
4636513|NCT01944774|7508870|FG001|Overall Study|Lack of Efficacy|2
4636514|NCT01944774|7508871|FG002|Overall Study|Lack of Efficacy|2
4636515|NCT01944774|7508869|FG000|Overall Study|Lost to Follow-up|0
4636516|NCT01944774|7508870|FG001|Overall Study|Lost to Follow-up|1
4636517|NCT01944774|7508871|FG002|Overall Study|Lost to Follow-up|0
4636518|NCT01944839|7508884|FG000|Overall Study|Physician Decision|2
4636519|NCT01944839|7508885|FG001|Overall Study|Physician Decision|2
4636520|NCT01944839|7508884|FG000|Overall Study|Protocol Violation|0
4636521|NCT01944839|7508885|FG001|Overall Study|Protocol Violation|1
4636522|NCT01944839|7508884|FG000|Overall Study|Adverse Event|10
4636523|NCT01944839|7508885|FG001|Overall Study|Adverse Event|5
4636524|NCT01944839|7508884|FG000|Overall Study|Withdrawal by Subject|9
4636525|NCT01944839|7508885|FG001|Overall Study|Withdrawal by Subject|17
4636526|NCT01944839|7508884|FG000|Overall Study|Lost to Follow-up|1
4636527|NCT01944839|7508885|FG001|Overall Study|Lost to Follow-up|0
4636528|NCT01944839|7508884|FG000|Overall Study|Subject non-compliance|0
4636529|NCT01944839|7508885|FG001|Overall Study|Subject non-compliance|3
4636530|NCT01944969|7508911|FG000|Overall Study|Adverse Event|1
4636531|NCT01944969|7508911|FG000|Overall Study|Lack of Efficacy|1
4636532|NCT01944969|7508911|FG000|Overall Study|Non-compliance with IMP|1
4636533|NCT01944969|7508911|FG000|Overall Study|Administrative or other reasons|23
4636534|NCT01945034|7508920|FG000|Overall Study|Medication Error|0
4636535|NCT01945034|7508921|FG001|Overall Study|Medication Error|1
4636536|NCT01945034|7508922|FG002|Overall Study|Medication Error|0
4636537|NCT01945034|7508920|FG000|Overall Study|Withdrawal by Subject|0
4636538|NCT01945034|7508921|FG001|Overall Study|Withdrawal by Subject|3
4636539|NCT01945034|7508922|FG002|Overall Study|Withdrawal by Subject|1
4636540|NCT01945034|7508920|FG000|Overall Study|Other|0
4636541|NCT01945034|7508921|FG001|Overall Study|Other|1
4636542|NCT01945034|7508922|FG002|Overall Study|Other|3
4636543|NCT01945034|7508920|FG000|Overall Study|Lost to Follow-up|0
4636544|NCT01945034|7508921|FG001|Overall Study|Lost to Follow-up|0
4636545|NCT01945034|7508922|FG002|Overall Study|Lost to Follow-up|2
4636546|NCT01945034|7508920|FG000|Overall Study|Protocol Violation|1
4636547|NCT01945034|7508921|FG001|Overall Study|Protocol Violation|0
4636548|NCT01945034|7508922|FG002|Overall Study|Protocol Violation|1
4746687|NCT00579254|7718974|FG000|Overall Study|Lost to Follow-up|39
4746688|NCT00579254|7718974|FG000|Overall Study|Discontinued when study terminated|73
4746689|NCT00587223|7718978|FG000|Overall Study|Adverse Event|1
4746690|NCT00577395|7719009|FG000|Overall Study|Study was terminated early by Sponsor|7
4746691|NCT00577395|7719010|FG001|Overall Study|Study was terminated early by Sponsor|6
4746692|NCT00573391|7719018|FG000|Overall Study|study stopped|2
4746693|NCT00573391|7719019|FG001|Overall Study|study stopped|2
4746694|NCT00573391|7719018|FG000|Overall Study|Death|1
4746695|NCT00573391|7719019|FG001|Overall Study|Death|0
4746696|NCT00574080|7719063|FG000|Overall Study|Death|10
4746697|NCT00574080|7719064|FG001|Overall Study|Death|10
4746698|NCT00558558|7719070|FG000|Overall Study|Unable to swallow|1
4746699|NCT00558558|7719070|FG000|Overall Study|Withdrawal by Subject|1
4746700|NCT00558558|7719070|FG000|Overall Study|Lack of Efficacy|4
4746701|NCT00573937|7719080|FG000|Overall Study|Study Terminated|0
4746702|NCT00573937|7719081|FG001|Overall Study|Study Terminated|1
4746703|NCT00577317|7719089|FG000|Overall Study|Study Terminated|0
4746704|NCT00577317|7719090|FG001|Overall Study|Study Terminated|2
4746705|NCT00571922|7719098|FG000|Overall Study|Completion unknown|36
4746706|NCT00571922|7719099|FG001|Overall Study|Completion unknown|36
4746707|NCT00573157|7719111|FG000|Overall Study|Adverse Event|3
4746708|NCT00573157|7719112|FG001|Overall Study|Adverse Event|1
4746709|NCT00573157|7719111|FG000|Overall Study|Other|1
4746710|NCT00573157|7719112|FG001|Overall Study|Other|1
4604766|NCT01646177|7457986|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1
4604767|NCT01646177|7457987|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2
4604768|NCT01646177|7457988|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1
4604769|NCT01646177|7457989|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2
4604770|NCT01646177|7457990|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
4604771|NCT01646177|7457991|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
4604772|NCT01646177|7457992|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
4604773|NCT01646177|7457993|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
4604774|NCT01646177|7457994|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
4604775|NCT01646177|7457995|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
4604776|NCT01646177|7457996|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
4604777|NCT01646177|7457997|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
4604778|NCT01646177|7457986|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
4604779|NCT01646177|7457987|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
4604780|NCT01646177|7457988|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2
4604781|NCT01646177|7457989|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1
4604782|NCT01646177|7457990|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
4604783|NCT01646177|7457991|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
4604784|NCT01646177|7457992|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
4604785|NCT01646177|7457993|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
4604786|NCT01646177|7457994|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
4636549|NCT01945086|7508933|FG000|Overall Study|Withdrawal by Subject|1
4636550|NCT01945086|7508934|FG001|Overall Study|Withdrawal by Subject|0
4604787|NCT01646177|7457995|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
4604788|NCT01646177|7457996|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
4604789|NCT01646177|7457997|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
4604790|NCT01646177|7457986|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3
4604791|NCT01646177|7457987|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2
4604792|NCT01646177|7457988|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2
4604793|NCT01646177|7457989|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
4604794|NCT01646177|7457990|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
4604795|NCT01646177|7457991|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
4604796|NCT01646177|7457992|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
4604797|NCT01646177|7457993|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
4604798|NCT01646177|7457994|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
4604799|NCT01646177|7457995|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
4604800|NCT01646177|7457996|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
4604801|NCT01646177|7457997|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
4604802|NCT01646177|7457986|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0
4604803|NCT01646177|7457987|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0
4604804|NCT01646177|7457988|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0
4604805|NCT01646177|7457989|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0
4604806|NCT01646177|7457990|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16
4604807|NCT01646177|7457991|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34
4604808|NCT01646177|7457992|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43
4604809|NCT01646177|7457993|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30
4604810|NCT01646177|7457994|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0
4604811|NCT01646177|7457995|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0
4604812|NCT01646177|7457996|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0
4636551|NCT01945086|7508935|FG002|Overall Study|Withdrawal by Subject|1
4636552|NCT01945086|7508933|FG000|Overall Study|Adverse Event|0
4636553|NCT01945086|7508934|FG001|Overall Study|Adverse Event|0
4636554|NCT01945086|7508935|FG002|Overall Study|Adverse Event|1
4636555|NCT01945216|7508961|FG000|Overall Study|Case report forms (CRF) uncollected|52
4636556|NCT01945216|7508961|FG000|Overall Study|Protocol Violation|42
4636557|NCT01945216|7508961|FG000|Overall Study|CRF not assured by investigators|5
4636558|NCT01945242|7508971|FG000|Overall Study|Physician Decision|3
4636559|NCT01945242|7508972|FG001|Overall Study|Physician Decision|3
4636560|NCT01945281|7508981|FG000|Overall Study|Adverse Event|1
4636561|NCT01945281|7508982|FG001|Overall Study|Adverse Event|0
4636562|NCT01945281|7508981|FG000|Overall Study|Death|3
4636563|NCT01945281|7508982|FG001|Overall Study|Death|3
4636564|NCT01945281|7508981|FG000|Overall Study|Physician Decision|1
4636565|NCT01945281|7508982|FG001|Overall Study|Physician Decision|1
4636566|NCT01945281|7508981|FG000|Overall Study|Technical Problems|1
4636567|NCT01945281|7508982|FG001|Overall Study|Technical Problems|0
4636568|NCT01945489|7509005|FG000|Cycle 1|Adverse Event|2
4636569|NCT01945489|7509006|FG001|Cycle 1|Adverse Event|0
4636570|NCT01945489|7509005|FG000|Cycle 1|Lost to Follow-up|4
4636571|NCT01945489|7509006|FG001|Cycle 1|Lost to Follow-up|0
4636572|NCT01945489|7509005|FG000|Cycle 1|Personal Reasons|4
4636573|NCT01945489|7509006|FG001|Cycle 1|Personal Reasons|2
4636574|NCT01945489|7509005|FG000|Cycle 1|Protocol Violation|0
4636575|NCT01945489|7509006|FG001|Cycle 1|Protocol Violation|1
4636576|NCT01945489|7509005|FG000|Cycle 1|Other Miscellaneous Reasons|3
4604813|NCT01646177|7457997|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0
4604814|NCT01646177|7457986|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
4604815|NCT01646177|7457987|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
4604816|NCT01646177|7457988|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
4604817|NCT01646177|7457989|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
4604818|NCT01646177|7457990|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11
4604819|NCT01646177|7457991|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30
4604820|NCT01646177|7457992|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29
4604821|NCT01646177|7457993|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27
4604822|NCT01646177|7457994|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
4604823|NCT01646177|7457995|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
4604824|NCT01646177|7457996|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
4604825|NCT01646177|7457997|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
4604826|NCT01646177|7457986|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
4604827|NCT01646177|7457987|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
4604828|NCT01646177|7457988|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
4604829|NCT01646177|7457989|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
4604830|NCT01646177|7457990|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6
4604831|NCT01646177|7457991|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17
4604832|NCT01646177|7457992|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23
4604833|NCT01646177|7457993|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18
4604834|NCT01646177|7457994|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
4604835|NCT01646177|7457995|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
4604836|NCT01646177|7457996|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
4604837|NCT01646177|7457997|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
4604838|NCT01646177|7457986|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
4604839|NCT01646177|7457987|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
4604840|NCT01646177|7457988|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
4604841|NCT01646177|7457989|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
4604842|NCT01646177|7457990|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6
4604843|NCT01646177|7457991|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14
4604844|NCT01646177|7457992|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10
4604845|NCT01646177|7457993|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11
4604846|NCT01646177|7457994|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
4604847|NCT01646177|7457995|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
4604848|NCT01646177|7457996|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
4604849|NCT01646177|7457997|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
4604850|NCT01646177|7457986|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0
4604851|NCT01646177|7457987|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0
4604852|NCT01646177|7457988|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0
4604853|NCT01646177|7457989|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0
4604854|NCT01646177|7457990|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3
4604855|NCT01646177|7457991|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5
4604856|NCT01646177|7457992|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5
4604857|NCT01646177|7457993|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5
4604858|NCT01646177|7457994|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0
4604859|NCT01646177|7457995|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0
4604860|NCT01646177|7457996|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0
4604861|NCT01646177|7457997|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0
4604862|NCT01646177|7457986|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
4604863|NCT01646177|7457987|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
4604864|NCT01646177|7457988|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
4604865|NCT01646177|7457989|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
4604866|NCT01646177|7457990|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1
4604867|NCT01646177|7457991|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4
4604868|NCT01646177|7457992|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
4604869|NCT01646177|7457993|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5
4604870|NCT01646177|7457994|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
4604871|NCT01646177|7457995|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
4604872|NCT01646177|7457996|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
4604873|NCT01646177|7457997|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
4604874|NCT01646177|7457986|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
4604875|NCT01646177|7457987|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
4636577|NCT01945489|7509006|FG001|Cycle 1|Other Miscellaneous Reasons|1
4636578|NCT01945489|7509005|FG000|Cycle 2|Adverse Event|1
4636579|NCT01945489|7509006|FG001|Cycle 2|Adverse Event|0
4636580|NCT01945489|7509005|FG000|Cycle 2|Lost to Follow-up|0
4604876|NCT01646177|7457988|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
4604877|NCT01646177|7457989|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
4604878|NCT01646177|7457990|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3
4604879|NCT01646177|7457991|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2
4604880|NCT01646177|7457992|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2
4604881|NCT01646177|7457993|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2
4604882|NCT01646177|7457994|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
4604883|NCT01646177|7457995|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
4604884|NCT01646177|7457996|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
4604885|NCT01646177|7457997|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
4604886|NCT01646177|7457986|FG000|Long-Term Extension Period (Week 12-264)|Death|0
4604887|NCT01646177|7457987|FG001|Long-Term Extension Period (Week 12-264)|Death|0
4604888|NCT01646177|7457988|FG002|Long-Term Extension Period (Week 12-264)|Death|0
4604889|NCT01646177|7457989|FG003|Long-Term Extension Period (Week 12-264)|Death|0
4604890|NCT01646177|7457990|FG004|Long-Term Extension Period (Week 12-264)|Death|1
4604891|NCT01646177|7457991|FG005|Long-Term Extension Period (Week 12-264)|Death|3
4604892|NCT01646177|7457992|FG006|Long-Term Extension Period (Week 12-264)|Death|1
4604893|NCT01646177|7457993|FG007|Long-Term Extension Period (Week 12-264)|Death|3
4604894|NCT01646177|7457994|FG008|Long-Term Extension Period (Week 12-264)|Death|0
4604895|NCT01646177|7457995|FG009|Long-Term Extension Period (Week 12-264)|Death|0
4604896|NCT01646177|7457996|FG010|Long-Term Extension Period (Week 12-264)|Death|0
4604897|NCT01646177|7457997|FG011|Long-Term Extension Period (Week 12-264)|Death|0
4604898|NCT01646177|7457986|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
4604899|NCT01646177|7457987|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
4604900|NCT01646177|7457988|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
4604901|NCT01646177|7457989|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
4604902|NCT01646177|7457990|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1
4604903|NCT01646177|7457991|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1
4604904|NCT01646177|7457992|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1
4604905|NCT01646177|7457993|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4
4604906|NCT01646177|7457994|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
4604907|NCT01646177|7457995|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
4604908|NCT01646177|7457996|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
4604909|NCT01646177|7457997|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
4604910|NCT01646177|7457986|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
4604911|NCT01646177|7457987|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
4604912|NCT01646177|7457988|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
4604913|NCT01646177|7457989|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
4604914|NCT01646177|7457990|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
4604915|NCT01646177|7457991|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
4604916|NCT01646177|7457992|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
4604917|NCT01646177|7457993|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1
4604918|NCT01646177|7457994|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
4604919|NCT01646177|7457995|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
4604920|NCT01646177|7457996|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
4604921|NCT01646177|7457997|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
4604922|NCT01646177|7457986|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
4604923|NCT01646177|7457987|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
4604924|NCT01646177|7457988|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
4604925|NCT01646177|7457989|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
4604926|NCT01646177|7457990|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
4604927|NCT01646177|7457991|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3
4604928|NCT01646177|7457992|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2
4604929|NCT01646177|7457993|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1
4604930|NCT01646177|7457994|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
4604931|NCT01646177|7457995|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
4604932|NCT01646177|7457996|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
4604933|NCT01646177|7457997|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
4604934|NCT01646177|7457986|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
4604935|NCT01646177|7457987|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
4604936|NCT01646177|7457988|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
4604937|NCT01646177|7457989|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
4604938|NCT01646177|7457990|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
4604939|NCT01646177|7457991|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
4604940|NCT01646177|7457992|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
4604941|NCT01646177|7457993|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
4604942|NCT01646177|7457994|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13
4636581|NCT01945489|7509006|FG001|Cycle 2|Lost to Follow-up|1
4604943|NCT01646177|7457995|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28
4636582|NCT01945580|7509015|FG000|Overall Study|Withdrawal by Subject|13
4636583|NCT01945580|7509016|FG001|Overall Study|Withdrawal by Subject|35
4636584|NCT01945580|7509015|FG000|Overall Study|Physician Decision|3
4636585|NCT01945580|7509016|FG001|Overall Study|Physician Decision|2
4636586|NCT01945580|7509015|FG000|Overall Study|Lost to Follow-up|26
4636587|NCT01945580|7509016|FG001|Overall Study|Lost to Follow-up|39
4636588|NCT01945580|7509015|FG000|Overall Study|Death|7
4636589|NCT01945580|7509016|FG001|Overall Study|Death|2
4636590|NCT01945580|7509015|FG000|Overall Study|Patient moved out of state|0
4636591|NCT01945580|7509016|FG001|Overall Study|Patient moved out of state|1
4636592|NCT01945580|7509015|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1
4636593|NCT01945580|7509016|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0
4636594|NCT01945580|7509015|FG000|Overall Study|Family illness - unable to return|0
4636595|NCT01945580|7509016|FG001|Overall Study|Family illness - unable to return|1
4636596|NCT01945580|7509015|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0
4636597|NCT01945580|7509016|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1
4636598|NCT01945580|7509015|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0
4636599|NCT01945580|7509016|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1
4636600|NCT01945580|7509015|FG000|Overall Study|Noncompliance with 36 month visit|1
4636601|NCT01945580|7509016|FG001|Overall Study|Noncompliance with 36 month visit|0
4636602|NCT01945580|7509015|FG000|Overall Study|The patient moved.|1
4636603|NCT01945580|7509016|FG001|Overall Study|The patient moved.|0
4636604|NCT01945580|7509015|FG000|Overall Study|No data available|0
4636605|NCT01945580|7509016|FG001|Overall Study|No data available|2
4636606|NCT01945593|7509030|FG000|Overall Study|Adverse Event|0
4636607|NCT01945593|7509031|FG001|Overall Study|Adverse Event|0
4636608|NCT01945593|7509032|FG002|Overall Study|Adverse Event|0
4636609|NCT01945593|7509033|FG003|Overall Study|Adverse Event|5
4636610|NCT01945593|7509030|FG000|Overall Study|Physician Decision|0
4636611|NCT01945593|7509031|FG001|Overall Study|Physician Decision|0
4636612|NCT01945593|7509032|FG002|Overall Study|Physician Decision|1
4636613|NCT01945593|7509033|FG003|Overall Study|Physician Decision|1
4636614|NCT01945593|7509030|FG000|Overall Study|Withdrawal by Subject|0
4636615|NCT01945593|7509031|FG001|Overall Study|Withdrawal by Subject|2
4636616|NCT01945593|7509032|FG002|Overall Study|Withdrawal by Subject|0
4636617|NCT01945593|7509033|FG003|Overall Study|Withdrawal by Subject|4
4636618|NCT01945593|7509030|FG000|Overall Study|Protocol Violation|0
4636619|NCT01945593|7509031|FG001|Overall Study|Protocol Violation|2
4636620|NCT01945593|7509032|FG002|Overall Study|Protocol Violation|1
4636621|NCT01945593|7509033|FG003|Overall Study|Protocol Violation|3
4636622|NCT01945593|7509030|FG000|Overall Study|Death|0
4636623|NCT01945593|7509031|FG001|Overall Study|Death|0
4636624|NCT01945593|7509032|FG002|Overall Study|Death|1
4636625|NCT01945593|7509033|FG003|Overall Study|Death|0
4636626|NCT01945593|7509030|FG000|Overall Study|Other: Terminated|0
4636627|NCT01945593|7509031|FG001|Overall Study|Other: Terminated|0
4636628|NCT01945593|7509032|FG002|Overall Study|Other: Terminated|0
4636629|NCT01945593|7509033|FG003|Overall Study|Other: Terminated|1
4636630|NCT01945593|7509030|FG000|Overall Study|Other: Surgical Procedure|0
4636631|NCT01945593|7509031|FG001|Overall Study|Other: Surgical Procedure|2
4636632|NCT01945593|7509032|FG002|Overall Study|Other: Surgical Procedure|0
4636633|NCT01945593|7509033|FG003|Overall Study|Other: Surgical Procedure|6
4636634|NCT01945593|7509030|FG000|Overall Study|Other: Screen Failure|0
4636635|NCT01945593|7509031|FG001|Overall Study|Other: Screen Failure|2
4636636|NCT01945593|7509032|FG002|Overall Study|Other: Screen Failure|0
4636637|NCT01945593|7509033|FG003|Overall Study|Other: Screen Failure|0
4636638|NCT01945710|7509055|FG000|Overall Study|Progressive Disease|5
4636639|NCT01945710|7509056|FG001|Overall Study|Progressive Disease|4
4636640|NCT01945710|7509057|FG002|Overall Study|Progressive Disease|3
4604944|NCT01646177|7457996|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34
4604945|NCT01646177|7457997|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30
4604946|NCT01646177|7457986|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
4604947|NCT01646177|7457987|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
4604948|NCT01646177|7457988|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
4604949|NCT01646177|7457989|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
4604950|NCT01646177|7457990|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
4604951|NCT01646177|7457991|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
4604952|NCT01646177|7457992|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
4604953|NCT01646177|7457993|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
4604954|NCT01646177|7457994|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7
4604955|NCT01646177|7457995|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21
4604956|NCT01646177|7457996|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19
4604957|NCT01646177|7457997|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19
4604958|NCT01646177|7457986|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
4604959|NCT01646177|7457987|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
4604960|NCT01646177|7457988|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
4604961|NCT01646177|7457989|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
4604962|NCT01646177|7457990|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
4604963|NCT01646177|7457991|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
4604964|NCT01646177|7457992|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
4604965|NCT01646177|7457993|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
4604966|NCT01646177|7457994|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4
4604967|NCT01646177|7457995|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8
4636641|NCT01945710|7509058|FG003|Overall Study|Progressive Disease|2
4636642|NCT01945710|7509059|FG004|Overall Study|Progressive Disease|7
4636643|NCT01945710|7509060|FG005|Overall Study|Progressive Disease|3
4636644|NCT01945710|7509061|FG006|Overall Study|Progressive Disease|19
4636645|NCT01945710|7509055|FG000|Overall Study|Adverse Event|0
4746711|NCT00561912|7719131|FG000|Overall Study|ineligible|1
4746712|NCT00561795|7719137|FG000|Overall Study|Adverse Event|3
4746713|NCT00561795|7719138|FG001|Overall Study|Adverse Event|3
4746714|NCT00561795|7719139|FG002|Overall Study|Adverse Event|0
4746715|NCT00561795|7719140|FG003|Overall Study|Adverse Event|0
4746716|NCT00561795|7719137|FG000|Overall Study|Study Closed/Terminated|0
4746717|NCT00561795|7719138|FG001|Overall Study|Study Closed/Terminated|3
4746718|NCT00561795|7719139|FG002|Overall Study|Study Closed/Terminated|0
4746719|NCT00561795|7719140|FG003|Overall Study|Study Closed/Terminated|0
4746720|NCT00561795|7719137|FG000|Overall Study|Physician Decision|1
4746721|NCT00561795|7719138|FG001|Overall Study|Physician Decision|0
4746722|NCT00561795|7719139|FG002|Overall Study|Physician Decision|0
4746723|NCT00561795|7719140|FG003|Overall Study|Physician Decision|0
4746724|NCT00556075|7719176|FG000|Overall Study|Lost to Follow-up|3
4746725|NCT00556075|7719177|FG001|Overall Study|Lost to Follow-up|0
4746726|NCT00556075|7719178|FG002|Overall Study|Lost to Follow-up|3
4746727|NCT00556075|7719176|FG000|Overall Study|Withdrawal by Subject|3
4746728|NCT00556075|7719177|FG001|Overall Study|Withdrawal by Subject|3
4746729|NCT00556075|7719178|FG002|Overall Study|Withdrawal by Subject|0
4746730|NCT00556075|7719176|FG000|Overall Study|Protocol Violation|1
4746731|NCT00556075|7719177|FG001|Overall Study|Protocol Violation|1
4746732|NCT00556075|7719178|FG002|Overall Study|Protocol Violation|3
4746733|NCT00556075|7719176|FG000|Overall Study|Not eligible|1
4746734|NCT00556075|7719177|FG001|Overall Study|Not eligible|1
4746735|NCT00556075|7719178|FG002|Overall Study|Not eligible|2
4746736|NCT00556075|7719176|FG000|Overall Study|Adverse Event|1
4746737|NCT00556075|7719177|FG001|Overall Study|Adverse Event|2
4746738|NCT00556075|7719178|FG002|Overall Study|Adverse Event|0
4746739|NCT00556075|7719176|FG000|Overall Study|Personal issues|4
4746740|NCT00556075|7719177|FG001|Overall Study|Personal issues|1
4746741|NCT00556075|7719178|FG002|Overall Study|Personal issues|0
4746742|NCT00556075|7719176|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0
4746743|NCT00556075|7719177|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1
4746744|NCT00556075|7719178|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0
4746745|NCT00556166|7719190|FG000|Overall Study|Withdrawal by Subject|1
4746746|NCT00539838|7719214|FG000|Overall Study|Fail to return|2
4746747|NCT00539838|7719215|FG001|Overall Study|Fail to return|0
4746748|NCT00539838|7719216|FG002|Overall Study|Fail to return|0
4746749|NCT00539838|7719214|FG000|Overall Study|Withdrawal by Subject|0
4746750|NCT00539838|7719215|FG001|Overall Study|Withdrawal by Subject|4
4746751|NCT00539838|7719216|FG002|Overall Study|Withdrawal by Subject|0
4746752|NCT00539838|7719214|FG000|Overall Study|Death|0
4746753|NCT00539838|7719215|FG001|Overall Study|Death|2
4746754|NCT00539838|7719216|FG002|Overall Study|Death|0
4746755|NCT00539838|7719214|FG000|Overall Study|Did not cooperate|1
4746756|NCT00539838|7719215|FG001|Overall Study|Did not cooperate|0
4746757|NCT00539838|7719216|FG002|Overall Study|Did not cooperate|1
4746758|NCT00539838|7719214|FG000|Overall Study|Administrative|4
4746759|NCT00539838|7719215|FG001|Overall Study|Administrative|0
4746760|NCT00539838|7719216|FG002|Overall Study|Administrative|8
4746761|NCT00549328|7719226|FG000|Overall Study|Adverse Event|2
4746762|NCT00549328|7719226|FG000|Overall Study|Disease Progression|10
4746763|NCT00549328|7719226|FG000|Overall Study|Death|1
4746764|NCT00549328|7719226|FG000|Overall Study|Use of Prohibited Medication|1
4746765|NCT00548327|7719232|FG000|Overall Study|Adverse Event|0
4746766|NCT00548327|7719233|FG001|Overall Study|Adverse Event|1
4746767|NCT00547300|7719264|FG000|Overall Study|Study was Administratively Terminated|25
4746768|NCT00547300|7719265|FG001|Overall Study|Study was Administratively Terminated|24
4746769|NCT00547300|7719264|FG000|Overall Study|Did not Meet Entry Criteria|0
4746770|NCT00547300|7719265|FG001|Overall Study|Did not Meet Entry Criteria|2
4746771|NCT00535262|7719297|FG000|Overall Study|No funding|3
4746772|NCT00537199|7719314|FG000|Overall Study|Study Terminated|1
4746773|NCT00536978|7719324|FG000|Overall Study|Not eligible for Adback Infusion|22
4746774|NCT00524485|7719328|FG000|Overall Study|Withdrawal by Subject|5
4746775|NCT00524134|7719350|FG000|Overall Study|Withdrawal by Subject|1
4746776|NCT00524134|7719350|FG000|Overall Study|Physician Decision|1
4746777|NCT00527748|7719354|FG000|Overall Study|Other|3
4746778|NCT00517699|7719358|FG000|Overall Study|Withdrawal by Subject|1
4746779|NCT00517699|7719358|FG000|Overall Study|Lack of Efficacy|1
4604968|NCT01646177|7457996|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9
4604969|NCT01646177|7457997|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9
4604970|NCT01646177|7457986|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
4604971|NCT01646177|7457987|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
4604972|NCT01646177|7457988|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
4604973|NCT01646177|7457989|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
4604974|NCT01646177|7457990|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
4604975|NCT01646177|7457991|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
4604976|NCT01646177|7457992|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
4604977|NCT01646177|7457993|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
4604978|NCT01646177|7457994|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4
4604979|NCT01646177|7457995|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9
4604980|NCT01646177|7457996|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8
4604981|NCT01646177|7457997|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9
4604982|NCT01646177|7457986|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
4604983|NCT01646177|7457987|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
4604984|NCT01646177|7457988|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
4604985|NCT01646177|7457989|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
4604986|NCT01646177|7457990|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
4604987|NCT01646177|7457991|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
4604988|NCT01646177|7457992|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
4604989|NCT01646177|7457993|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
4604990|NCT01646177|7457994|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1
4604991|NCT01646177|7457995|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6
4604992|NCT01646177|7457996|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4
4604993|NCT01646177|7457997|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7
4604994|NCT01646177|7457986|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
4604995|NCT01646177|7457987|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
4604996|NCT01646177|7457988|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
4604997|NCT01646177|7457989|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
4604998|NCT01646177|7457990|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
4604999|NCT01646177|7457991|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
4605000|NCT01646177|7457992|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
4605001|NCT01646177|7457993|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
4605002|NCT01646177|7457994|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1
4605003|NCT01646177|7457995|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2
4605004|NCT01646177|7457996|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2
4605005|NCT01646177|7457997|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3
4605006|NCT01646177|7457986|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
4605007|NCT01646177|7457987|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
4605008|NCT01646177|7457988|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
4605009|NCT01646177|7457989|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
4605010|NCT01646177|7457990|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
4605011|NCT01646177|7457991|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
4605012|NCT01646177|7457992|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
4605013|NCT01646177|7457993|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
4636646|NCT01945710|7509056|FG001|Overall Study|Adverse Event|1
4636647|NCT01945710|7509057|FG002|Overall Study|Adverse Event|0
4636648|NCT01945710|7509058|FG003|Overall Study|Adverse Event|0
4636649|NCT01945710|7509059|FG004|Overall Study|Adverse Event|0
4636650|NCT01945710|7509060|FG005|Overall Study|Adverse Event|0
4636651|NCT01945710|7509061|FG006|Overall Study|Adverse Event|0
4636652|NCT01945710|7509055|FG000|Overall Study|Other|2
4636653|NCT01945710|7509056|FG001|Overall Study|Other|0
4636654|NCT01945710|7509057|FG002|Overall Study|Other|3
4636655|NCT01945710|7509058|FG003|Overall Study|Other|1
4636656|NCT01945710|7509059|FG004|Overall Study|Other|1
4636657|NCT01945710|7509060|FG005|Overall Study|Other|0
4636658|NCT01945710|7509061|FG006|Overall Study|Other|4
4636659|NCT01945710|7509055|FG000|Overall Study|Withdrawal by Subject|0
4636660|NCT01945710|7509056|FG001|Overall Study|Withdrawal by Subject|1
4636661|NCT01945710|7509057|FG002|Overall Study|Withdrawal by Subject|1
4636662|NCT01945710|7509058|FG003|Overall Study|Withdrawal by Subject|0
4636663|NCT01945710|7509059|FG004|Overall Study|Withdrawal by Subject|1
4636664|NCT01945710|7509060|FG005|Overall Study|Withdrawal by Subject|0
4636665|NCT01945710|7509061|FG006|Overall Study|Withdrawal by Subject|0
4636666|NCT01945866|7509081|FG000|Overall Study|Eyes did not complete or were dropped|2
4636667|NCT01945866|7509082|FG001|Overall Study|Eyes did not complete or were dropped|0
4636668|NCT01945944|7509091|FG000|Overall Study|Adverse Event|0
4636669|NCT01945944|7509092|FG001|Overall Study|Adverse Event|2
4636670|NCT01945944|7509091|FG000|Overall Study|Physician Decision|1
4636671|NCT01945944|7509092|FG001|Overall Study|Physician Decision|0
4636672|NCT01945944|7509091|FG000|Overall Study|Withdrawal by Subject|0
4636673|NCT01945944|7509092|FG001|Overall Study|Withdrawal by Subject|1
4636674|NCT01945996|7509117|FG000|Overall Study|Lost to Follow-up|3
4605014|NCT01646177|7457994|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
4605015|NCT01646177|7457995|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1
4605016|NCT01646177|7457996|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1
4605017|NCT01646177|7457997|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3
4605018|NCT01646177|7457986|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
4605019|NCT01646177|7457987|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
4605020|NCT01646177|7457988|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
4605021|NCT01646177|7457989|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
4605022|NCT01646177|7457990|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
4605023|NCT01646177|7457991|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
4605024|NCT01646177|7457992|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
4605025|NCT01646177|7457993|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
4605026|NCT01646177|7457994|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
4605027|NCT01646177|7457995|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1
4605028|NCT01646177|7457996|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1
4605029|NCT01646177|7457997|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1
4605030|NCT01646177|7457986|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0
4605031|NCT01646177|7457987|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0
4605032|NCT01646177|7457988|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0
4605033|NCT01646177|7457989|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0
4605034|NCT01646177|7457990|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0
4605035|NCT01646177|7457991|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0
4605036|NCT01646177|7457992|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0
4605037|NCT01646177|7457993|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0
4605038|NCT01646177|7457994|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1
4605039|NCT01646177|7457995|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0
4605040|NCT01646177|7457996|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1
4605041|NCT01646177|7457997|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1
4605042|NCT01646177|7457986|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
4605043|NCT01646177|7457987|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
4605044|NCT01646177|7457988|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
4605045|NCT01646177|7457989|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
4605046|NCT01646177|7457990|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
4605047|NCT01646177|7457991|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
4605048|NCT01646177|7457992|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
4605049|NCT01646177|7457993|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
4605050|NCT01646177|7457994|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
4605051|NCT01646177|7457995|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
4605052|NCT01646177|7457996|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1
4605053|NCT01646177|7457997|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1
4605054|NCT01646203|7458020|FG000|Overall Study|Adverse Event|2
4605055|NCT01646203|7458021|FG001|Overall Study|Adverse Event|0
4605056|NCT01646203|7458022|FG002|Overall Study|Adverse Event|1
4605057|NCT01646203|7458020|FG000|Overall Study|Withdrawal by Subject|0
4605058|NCT01646203|7458021|FG001|Overall Study|Withdrawal by Subject|1
4605059|NCT01646203|7458022|FG002|Overall Study|Withdrawal by Subject|0
4605060|NCT01646203|7458020|FG000|Overall Study|Physician's Decision|0
4605061|NCT01646203|7458021|FG001|Overall Study|Physician's Decision|1
4605062|NCT01646203|7458022|FG002|Overall Study|Physician's Decision|0
4605063|NCT01646216|7458037|FG000|Overall Study|Baseline step length difference (<5cm)|10
4636675|NCT01945996|7509118|FG001|Overall Study|Lost to Follow-up|5
4636676|NCT01946152|7509139|FG000|Overall Study|Adverse Event|1
4636677|NCT01946152|7509140|FG001|Overall Study|Adverse Event|0
4636678|NCT01946152|7509141|FG002|Overall Study|Adverse Event|0
4636679|NCT01946152|7509142|FG003|Overall Study|Adverse Event|0
4636680|NCT01946152|7509139|FG000|Overall Study|Withdrawal by Subject|0
4636681|NCT01946152|7509140|FG001|Overall Study|Withdrawal by Subject|2
4636682|NCT01946152|7509141|FG002|Overall Study|Withdrawal by Subject|0
4636683|NCT01946152|7509142|FG003|Overall Study|Withdrawal by Subject|0
4636684|NCT01946152|7509139|FG000|Overall Study|Progression|0
4636685|NCT01946152|7509140|FG001|Overall Study|Progression|1
4636686|NCT01946152|7509141|FG002|Overall Study|Progression|4
4636687|NCT01946152|7509142|FG003|Overall Study|Progression|7
4636688|NCT01946152|7509139|FG000|Overall Study|Physician Decision|0
4636689|NCT01946152|7509140|FG001|Overall Study|Physician Decision|0
4636690|NCT01946152|7509141|FG002|Overall Study|Physician Decision|1
4636691|NCT01946152|7509142|FG003|Overall Study|Physician Decision|0
4636692|NCT01946152|7509139|FG000|Overall Study|Second malignancy|0
4636693|NCT01946152|7509140|FG001|Overall Study|Second malignancy|0
4636694|NCT01946152|7509141|FG002|Overall Study|Second malignancy|1
4636695|NCT01946152|7509142|FG003|Overall Study|Second malignancy|0
4636696|NCT01946152|7509139|FG000|Overall Study|Adverse Event|0
4636697|NCT01946152|7509140|FG001|Overall Study|Adverse Event|0
4636698|NCT01946152|7509141|FG002|Overall Study|Adverse Event|0
4636699|NCT01946152|7509142|FG003|Overall Study|Adverse Event|1
4636700|NCT01946165|7509156|FG000|Overall Study|Physician Decision|2
4605064|NCT01646216|7458038|FG001|Overall Study|Baseline step length difference (<5cm)|10
4605065|NCT01646216|7458037|FG000|Overall Study|Did not complete training|0
4605066|NCT01646216|7458038|FG001|Overall Study|Did not complete training|2
4605067|NCT01646216|7458037|FG000|Overall Study|Investigator decision|1
4605068|NCT01646216|7458038|FG001|Overall Study|Investigator decision|1
4605069|NCT01646255|7458050|FG000|Overall Study|Adverse Event|7
4605070|NCT01646255|7458051|FG001|Overall Study|Adverse Event|8
4605071|NCT01646255|7458050|FG000|Overall Study|Lack of Efficacy|2
4605072|NCT01646255|7458051|FG001|Overall Study|Lack of Efficacy|0
4605073|NCT01646255|7458050|FG000|Overall Study|Withdrawal by Subject|10
4605074|NCT01646255|7458051|FG001|Overall Study|Withdrawal by Subject|6
4605075|NCT01646255|7458050|FG000|Overall Study|Compliance is not well|1
4605076|NCT01646255|7458051|FG001|Overall Study|Compliance is not well|0
4605077|NCT01646255|7458050|FG000|Overall Study|Inclusion Criteria Deviation|1
4605078|NCT01646255|7458051|FG001|Overall Study|Inclusion Criteria Deviation|0
4605079|NCT01646268|7458060|FG000|Overall Study|Adverse Event|6
4605080|NCT01646268|7458061|FG001|Overall Study|Adverse Event|7
4605081|NCT01646268|7458060|FG000|Overall Study|Lack of Efficacy|1
4605082|NCT01646268|7458061|FG001|Overall Study|Lack of Efficacy|3
4605083|NCT01646268|7458060|FG000|Overall Study|Protocol Violation|0
4605084|NCT01646268|7458061|FG001|Overall Study|Protocol Violation|1
4605085|NCT01646268|7458060|FG000|Overall Study|Withdrawal by Subject|2
4605086|NCT01646268|7458061|FG001|Overall Study|Withdrawal by Subject|5
4605087|NCT01646268|7458060|FG000|Overall Study|Other|2
4605088|NCT01646268|7458061|FG001|Overall Study|Other|0
4605089|NCT01646320|7458069|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3
4605090|NCT01646320|7458070|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0
4605091|NCT01646320|7458069|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0
4605092|NCT01646320|7458070|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1
4605093|NCT01646320|7458069|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2
4605094|NCT01646320|7458070|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2
4605095|NCT01646320|7458069|FG000|Short-term Period (Day 1 to Week 24)|Other|1
4605096|NCT01646320|7458070|FG001|Short-term Period (Day 1 to Week 24)|Other|0
4605097|NCT01646320|7458069|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
4605098|NCT01646320|7458070|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
4605099|NCT01646320|7458069|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2
4605100|NCT01646320|7458070|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0
4605101|NCT01646320|7458069|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2
4605102|NCT01646320|7458070|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0
4605103|NCT01646320|7458069|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0
4605104|NCT01646320|7458070|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2
4605105|NCT01646320|7458069|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4
4605106|NCT01646320|7458070|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2
4605107|NCT01646320|7458069|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0
4605108|NCT01646320|7458070|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1
4605109|NCT01646320|7458069|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0
4605110|NCT01646320|7458070|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2
4605111|NCT01646385|7458082|FG000|Overall Study|Death|202
4605112|NCT01646385|7458083|FG001|Overall Study|Death|222
4605113|NCT01646385|7458082|FG000|Overall Study|Switched to alternate biologic|636
4605114|NCT01646385|7458083|FG001|Overall Study|Switched to alternate biologic|649
4605115|NCT01646398|7458091|FG000|Overall Study|Withdrawal by Subject|1
4605116|NCT01646398|7458092|FG001|Overall Study|Withdrawal by Subject|0
4605117|NCT01646645|7458098|FG000|Overall Study|No Treated|1
4605118|NCT01646645|7458098|FG000|Overall Study|Inevaluable Donor|29
4605119|NCT01646827|7458132|FG000|Overall Study|Lost to Follow-up|0
4605120|NCT01646827|7458133|FG001|Overall Study|Lost to Follow-up|3
4605121|NCT01646827|7458132|FG000|Overall Study|Physician Decision|1
4605122|NCT01646827|7458133|FG001|Overall Study|Physician Decision|2
4605123|NCT01646827|7458132|FG000|Overall Study|Withdrawal by Subject|1
4605124|NCT01646827|7458133|FG001|Overall Study|Withdrawal by Subject|0
4636701|NCT01946165|7509157|FG001|Overall Study|Physician Decision|0
4636702|NCT01946165|7509156|FG000|Overall Study|Withdrawal by Subject|0
4636703|NCT01946165|7509157|FG001|Overall Study|Withdrawal by Subject|2
4636704|NCT01946178|7509164|FG000|Overall Study|Pregnancy|1
4636705|NCT01946178|7509164|FG000|Overall Study|Lost to Follow-up|1
4636706|NCT01946191|7509174|FG000|Allocation|Did not complete orientation|1
4636707|NCT01946191|7509175|FG001|Allocation|Did not complete orientation|1
4636708|NCT01946191|7509174|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4
4636709|NCT01946191|7509175|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2
4636710|NCT01946191|7509174|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0
4636711|NCT01946191|7509175|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1
4636712|NCT01946191|7509174|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13
4636713|NCT01946191|7509175|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15
4636714|NCT01946282|7509191|FG000|Year 1|Did not return FIT kit|4186
4636715|NCT01946282|7509192|FG001|Year 1|Did not return FIT kit|608
4636716|NCT01946282|7509193|FG002|Year 1|Did not return FIT kit|654
4636717|NCT01946282|7509191|FG000|Year 2|Did not return FIT kit|803
4636718|NCT01946282|7509192|FG001|Year 2|Did not return FIT kit|131
4605125|NCT01647282|7458152|FG000|Overall Study|Physician Decision|7
4605126|NCT01647282|7458153|FG001|Overall Study|Physician Decision|5
4605127|NCT01647516|7458175|FG000|Induction Period (IP)|Physician Decision|2
4605128|NCT01647516|7458176|FG001|Induction Period (IP)|Physician Decision|0
4605129|NCT01647516|7458177|FG002|Induction Period (IP)|Physician Decision|0
4605130|NCT01647516|7458178|FG003|Induction Period (IP)|Physician Decision|0
4605131|NCT01647516|7458179|FG004|Induction Period (IP)|Physician Decision|0
4605132|NCT01647516|7458180|FG005|Induction Period (IP)|Physician Decision|0
4605133|NCT01647516|7458175|FG000|Induction Period (IP)|Adverse Event|1
4605134|NCT01647516|7458176|FG001|Induction Period (IP)|Adverse Event|2
4605135|NCT01647516|7458177|FG002|Induction Period (IP)|Adverse Event|0
4605136|NCT01647516|7458178|FG003|Induction Period (IP)|Adverse Event|0
4605137|NCT01647516|7458179|FG004|Induction Period (IP)|Adverse Event|0
4605138|NCT01647516|7458180|FG005|Induction Period (IP)|Adverse Event|0
4605139|NCT01647516|7458175|FG000|Induction Period (IP)|Withdrawal by Subject|1
4605140|NCT01647516|7458176|FG001|Induction Period (IP)|Withdrawal by Subject|0
4605141|NCT01647516|7458177|FG002|Induction Period (IP)|Withdrawal by Subject|3
4605142|NCT01647516|7458178|FG003|Induction Period (IP)|Withdrawal by Subject|0
4605143|NCT01647516|7458179|FG004|Induction Period (IP)|Withdrawal by Subject|0
4605144|NCT01647516|7458180|FG005|Induction Period (IP)|Withdrawal by Subject|0
4605145|NCT01647516|7458175|FG000|Induction Period (IP)|Participant Choice|0
4605146|NCT01647516|7458176|FG001|Induction Period (IP)|Participant Choice|0
4605147|NCT01647516|7458177|FG002|Induction Period (IP)|Participant Choice|1
4605148|NCT01647516|7458178|FG003|Induction Period (IP)|Participant Choice|0
4605149|NCT01647516|7458179|FG004|Induction Period (IP)|Participant Choice|0
4605150|NCT01647516|7458180|FG005|Induction Period (IP)|Participant Choice|0
4605151|NCT01647516|7458175|FG000|Induction Period (IP)|Lack of Efficacy|1
4605152|NCT01647516|7458176|FG001|Induction Period (IP)|Lack of Efficacy|0
4605153|NCT01647516|7458177|FG002|Induction Period (IP)|Lack of Efficacy|0
4605154|NCT01647516|7458178|FG003|Induction Period (IP)|Lack of Efficacy|0
4605155|NCT01647516|7458179|FG004|Induction Period (IP)|Lack of Efficacy|0
4605156|NCT01647516|7458180|FG005|Induction Period (IP)|Lack of Efficacy|0
4605157|NCT01647516|7458175|FG000|Induction Period (IP)|No study drug received|1
4605158|NCT01647516|7458176|FG001|Induction Period (IP)|No study drug received|1
4605159|NCT01647516|7458177|FG002|Induction Period (IP)|No study drug received|0
4605160|NCT01647516|7458178|FG003|Induction Period (IP)|No study drug received|0
4605161|NCT01647516|7458179|FG004|Induction Period (IP)|No study drug received|0
4605162|NCT01647516|7458180|FG005|Induction Period (IP)|No study drug received|0
4605163|NCT01647516|7458175|FG000|Maintenance Period (MP)|Adverse Event|2
4605164|NCT01647516|7458176|FG001|Maintenance Period (MP)|Adverse Event|1
4605165|NCT01647516|7458177|FG002|Maintenance Period (MP)|Adverse Event|0
4605166|NCT01647516|7458178|FG003|Maintenance Period (MP)|Adverse Event|0
4605167|NCT01647516|7458179|FG004|Maintenance Period (MP)|Adverse Event|0
4605168|NCT01647516|7458180|FG005|Maintenance Period (MP)|Adverse Event|0
4605169|NCT01647516|7458175|FG000|Maintenance Period (MP)|Non-compliance|1
4605170|NCT01647516|7458176|FG001|Maintenance Period (MP)|Non-compliance|0
4605171|NCT01647516|7458177|FG002|Maintenance Period (MP)|Non-compliance|0
4605172|NCT01647516|7458178|FG003|Maintenance Period (MP)|Non-compliance|0
4605173|NCT01647516|7458179|FG004|Maintenance Period (MP)|Non-compliance|0
4605174|NCT01647516|7458180|FG005|Maintenance Period (MP)|Non-compliance|0
4605175|NCT01647516|7458175|FG000|Maintenance Period (MP)|Withdrawal by Subject|0
4605176|NCT01647516|7458176|FG001|Maintenance Period (MP)|Withdrawal by Subject|1
4605177|NCT01647516|7458177|FG002|Maintenance Period (MP)|Withdrawal by Subject|1
4605178|NCT01647516|7458178|FG003|Maintenance Period (MP)|Withdrawal by Subject|0
4605179|NCT01647516|7458179|FG004|Maintenance Period (MP)|Withdrawal by Subject|0
4605180|NCT01647516|7458180|FG005|Maintenance Period (MP)|Withdrawal by Subject|0
4605181|NCT01647516|7458175|FG000|Maintenance Period (MP)|Lack of Efficacy|1
4605182|NCT01647516|7458176|FG001|Maintenance Period (MP)|Lack of Efficacy|4
4605183|NCT01647516|7458177|FG002|Maintenance Period (MP)|Lack of Efficacy|1
4605184|NCT01647516|7458178|FG003|Maintenance Period (MP)|Lack of Efficacy|0
4605185|NCT01647516|7458179|FG004|Maintenance Period (MP)|Lack of Efficacy|0
4605186|NCT01647516|7458180|FG005|Maintenance Period (MP)|Lack of Efficacy|0
4605187|NCT01647516|7458175|FG000|Open-Label Period|Adverse Event|0
4605188|NCT01647516|7458176|FG001|Open-Label Period|Adverse Event|0
4605189|NCT01647516|7458177|FG002|Open-Label Period|Adverse Event|0
4605190|NCT01647516|7458178|FG003|Open-Label Period|Adverse Event|5
4605191|NCT01647516|7458179|FG004|Open-Label Period|Adverse Event|6
4605192|NCT01647516|7458180|FG005|Open-Label Period|Adverse Event|3
4605193|NCT01647516|7458175|FG000|Open-Label Period|Pregnancy|0
4605194|NCT01647516|7458176|FG001|Open-Label Period|Pregnancy|0
4605195|NCT01647516|7458177|FG002|Open-Label Period|Pregnancy|0
4605196|NCT01647516|7458178|FG003|Open-Label Period|Pregnancy|0
4605197|NCT01647516|7458179|FG004|Open-Label Period|Pregnancy|0
4605198|NCT01647516|7458180|FG005|Open-Label Period|Pregnancy|1
4605199|NCT01647516|7458175|FG000|Open-Label Period|Non-compliance|0
4605200|NCT01647516|7458176|FG001|Open-Label Period|Non-compliance|0
4605201|NCT01647516|7458177|FG002|Open-Label Period|Non-compliance|0
4605202|NCT01647516|7458178|FG003|Open-Label Period|Non-compliance|1
4605203|NCT01647516|7458179|FG004|Open-Label Period|Non-compliance|0
4605204|NCT01647516|7458180|FG005|Open-Label Period|Non-compliance|1
4605205|NCT01647516|7458175|FG000|Open-Label Period|Physician Decision|0
4605206|NCT01647516|7458176|FG001|Open-Label Period|Physician Decision|0
4605207|NCT01647516|7458177|FG002|Open-Label Period|Physician Decision|0
4636719|NCT01946282|7509193|FG002|Year 2|Did not return FIT kit|115
4636720|NCT01946282|7509191|FG000|Year 3|Did not return FIT kit|288
4636721|NCT01946282|7509192|FG001|Year 3|Did not return FIT kit|43
4636722|NCT01946282|7509193|FG002|Year 3|Did not return FIT kit|30
4636723|NCT01946412|7509203|FG000|Overall Study|Adverse Event|1
4636724|NCT01946412|7509203|FG000|Overall Study|Non-Compliance|1
4636725|NCT01946412|7509203|FG000|Overall Study|Continued with commercial Kalydeco|2
4636726|NCT01946412|7509203|FG000|Overall Study|Difficulty in swallowing|1
4605208|NCT01647516|7458178|FG003|Open-Label Period|Physician Decision|1
4605209|NCT01647516|7458179|FG004|Open-Label Period|Physician Decision|1
4605210|NCT01647516|7458180|FG005|Open-Label Period|Physician Decision|0
4605211|NCT01647516|7458175|FG000|Open-Label Period|Withdrawal by Subject|0
4605212|NCT01647516|7458176|FG001|Open-Label Period|Withdrawal by Subject|0
4605213|NCT01647516|7458177|FG002|Open-Label Period|Withdrawal by Subject|0
4605214|NCT01647516|7458178|FG003|Open-Label Period|Withdrawal by Subject|9
4605215|NCT01647516|7458179|FG004|Open-Label Period|Withdrawal by Subject|11
4605216|NCT01647516|7458180|FG005|Open-Label Period|Withdrawal by Subject|6
4605217|NCT01647516|7458175|FG000|Open-Label Period|Lost to Follow-up|0
4605218|NCT01647516|7458176|FG001|Open-Label Period|Lost to Follow-up|0
4605219|NCT01647516|7458177|FG002|Open-Label Period|Lost to Follow-up|0
4605220|NCT01647516|7458178|FG003|Open-Label Period|Lost to Follow-up|1
4605221|NCT01647516|7458179|FG004|Open-Label Period|Lost to Follow-up|0
4605222|NCT01647516|7458180|FG005|Open-Label Period|Lost to Follow-up|1
4605223|NCT01647516|7458175|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0
4605224|NCT01647516|7458176|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0
4605225|NCT01647516|7458177|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0
4636727|NCT01946425|7509211|FG000|Overall Study|Protocol Violation|1
4636728|NCT01946425|7509212|FG001|Overall Study|Protocol Violation|0
4636729|NCT01946425|7509211|FG000|Overall Study|Withdrawal by Subject|1
4636730|NCT01946425|7509212|FG001|Overall Study|Withdrawal by Subject|0
4636731|NCT01946438|7509223|FG000|Overall Study|Adverse Event|0
4636732|NCT01946438|7509224|FG001|Overall Study|Adverse Event|0
4636733|NCT01946438|7509225|FG002|Overall Study|Adverse Event|0
4636734|NCT01946438|7509226|FG003|Overall Study|Adverse Event|1
4636735|NCT01946438|7509223|FG000|Overall Study|Serious Adverse event|1
4636736|NCT01946438|7509224|FG001|Overall Study|Serious Adverse event|0
4636737|NCT01946438|7509225|FG002|Overall Study|Serious Adverse event|0
4636738|NCT01946438|7509226|FG003|Overall Study|Serious Adverse event|0
4636739|NCT01946438|7509223|FG000|Overall Study|Protocol Violation|0
4636740|NCT01946438|7509224|FG001|Overall Study|Protocol Violation|0
4636741|NCT01946438|7509225|FG002|Overall Study|Protocol Violation|1
4636742|NCT01946438|7509226|FG003|Overall Study|Protocol Violation|0
4636743|NCT01946438|7509223|FG000|Overall Study|Withdrawal by Subject|1
4636744|NCT01946438|7509224|FG001|Overall Study|Withdrawal by Subject|0
4636745|NCT01946438|7509225|FG002|Overall Study|Withdrawal by Subject|0
4636746|NCT01946438|7509226|FG003|Overall Study|Withdrawal by Subject|0
4636747|NCT01946529|7509245|FG000|End of Window Therapy (2 Courses)|Physician Decision|0
4636748|NCT01946529|7509246|FG001|End of Window Therapy (2 Courses)|Physician Decision|1
4636749|NCT01946529|7509247|FG002|End of Window Therapy (2 Courses)|Physician Decision|0
4636750|NCT01946529|7509245|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1
4636751|NCT01946529|7509246|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16
4636752|NCT01946529|7509247|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6
4636753|NCT01946802|7509254|FG000|Overall Study|Death|1
4636754|NCT01946802|7509254|FG000|Overall Study|Withdrawal by Subject|2
4636755|NCT01946802|7509254|FG000|Overall Study|Combined septic shock|1
4636756|NCT01946802|7509254|FG000|Overall Study|Protocol Violation|1
4636757|NCT01946880|7509260|FG000|Overall Study|Lost to Follow-up|1
4636758|NCT01946880|7509261|FG001|Overall Study|Lost to Follow-up|0
4636759|NCT01946880|7509260|FG000|Overall Study|Physician Decision|1
4636760|NCT01946880|7509261|FG001|Overall Study|Physician Decision|1
4636761|NCT01946880|7509260|FG000|Overall Study|Withdrawal by Subject|3
4636762|NCT01946880|7509261|FG001|Overall Study|Withdrawal by Subject|2
4636763|NCT01946880|7509260|FG000|Overall Study|Met Primary Endpoint|1
4636764|NCT01946880|7509261|FG001|Overall Study|Met Primary Endpoint|0
4636765|NCT01946880|7509260|FG000|Overall Study|Personal and Family Issues|1
4636766|NCT01946880|7509261|FG001|Overall Study|Personal and Family Issues|0
4636767|NCT01947127|7509269|FG000|Overall Study|Protocol Violation|18
4636768|NCT01947127|7509270|FG001|Overall Study|Protocol Violation|38
4636769|NCT01947127|7509269|FG000|Overall Study|Withdrawal by Subject|1
4636770|NCT01947127|7509270|FG001|Overall Study|Withdrawal by Subject|1
4636771|NCT01947127|7509269|FG000|Overall Study|Data loss|4
4636772|NCT01947127|7509270|FG001|Overall Study|Data loss|4
4636773|NCT01947283|7509290|FG000|Overall Study|Death|1
4636774|NCT01947283|7509291|FG001|Overall Study|Death|1
4636775|NCT01947283|7509292|FG002|Overall Study|Death|1
4636776|NCT01947283|7509293|FG003|Overall Study|Death|0
4636777|NCT01947283|7509294|FG004|Overall Study|Death|0
4605226|NCT01647516|7458178|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18
4605227|NCT01647516|7458179|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13
4605228|NCT01647516|7458180|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23
4605229|NCT01647516|7458175|FG000|Open-Label Period|Lack of Efficacy|0
4605230|NCT01647516|7458176|FG001|Open-Label Period|Lack of Efficacy|0
4605231|NCT01647516|7458177|FG002|Open-Label Period|Lack of Efficacy|0
4605232|NCT01647516|7458178|FG003|Open-Label Period|Lack of Efficacy|7
4605233|NCT01647516|7458179|FG004|Open-Label Period|Lack of Efficacy|9
4605234|NCT01647516|7458180|FG005|Open-Label Period|Lack of Efficacy|10
4605235|NCT01647516|7458175|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0
4605236|NCT01647516|7458176|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0
4605237|NCT01647516|7458177|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0
4605238|NCT01647516|7458178|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7
4605239|NCT01647516|7458179|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9
4605240|NCT01647516|7458180|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10
4605241|NCT01647516|7458175|FG000|Open-Label Period|No completion / discontinuation visit|0
4605242|NCT01647516|7458176|FG001|Open-Label Period|No completion / discontinuation visit|0
4605243|NCT01647516|7458177|FG002|Open-Label Period|No completion / discontinuation visit|0
4605244|NCT01647516|7458178|FG003|Open-Label Period|No completion / discontinuation visit|0
4605245|NCT01647516|7458179|FG004|Open-Label Period|No completion / discontinuation visit|2
4605246|NCT01647516|7458180|FG005|Open-Label Period|No completion / discontinuation visit|1
4605247|NCT01647542|7458198|FG000|Overall Study|Major Protocol Deviation|1
4605248|NCT01647542|7458199|FG001|Overall Study|Major Protocol Deviation|0
4605249|NCT01647542|7458200|FG002|Overall Study|Major Protocol Deviation|0
4605250|NCT01647542|7458198|FG000|Overall Study|Adverse Event|4
4605251|NCT01647542|7458199|FG001|Overall Study|Adverse Event|5
4605252|NCT01647542|7458200|FG002|Overall Study|Adverse Event|4
4605253|NCT01647542|7458198|FG000|Overall Study|Lost to Follow-up|0
4605254|NCT01647542|7458199|FG001|Overall Study|Lost to Follow-up|2
4605255|NCT01647542|7458200|FG002|Overall Study|Lost to Follow-up|2
4605256|NCT01647542|7458198|FG000|Overall Study|Withdrawal by Subject|6
4605257|NCT01647542|7458199|FG001|Overall Study|Withdrawal by Subject|4
4605258|NCT01647542|7458200|FG002|Overall Study|Withdrawal by Subject|0
4605259|NCT01647542|7458198|FG000|Overall Study|Study Termination|64
4605260|NCT01647542|7458199|FG001|Overall Study|Study Termination|61
4605261|NCT01647542|7458200|FG002|Overall Study|Study Termination|65
4605262|NCT01647542|7458198|FG000|Overall Study|Lack of Efficacy|1
4605263|NCT01647542|7458199|FG001|Overall Study|Lack of Efficacy|1
4605264|NCT01647542|7458200|FG002|Overall Study|Lack of Efficacy|0
4605265|NCT01647542|7458198|FG000|Overall Study|Death|0
4605266|NCT01647542|7458199|FG001|Overall Study|Death|0
4605267|NCT01647542|7458200|FG002|Overall Study|Death|1
4605268|NCT01647711|7458222|FG000|Overall Study|Progressive disease|6
4605269|NCT01647711|7458223|FG001|Overall Study|Progressive disease|2
4605270|NCT01647711|7458224|FG002|Overall Study|Progressive disease|6
4605271|NCT01647711|7458225|FG003|Overall Study|Progressive disease|8
4605272|NCT01647711|7458226|FG004|Overall Study|Progressive disease|2
4605273|NCT01647711|7458222|FG000|Overall Study|Other adverse event|0
4605274|NCT01647711|7458223|FG001|Overall Study|Other adverse event|0
4605275|NCT01647711|7458224|FG002|Overall Study|Other adverse event|2
4605276|NCT01647711|7458225|FG003|Overall Study|Other adverse event|0
4605277|NCT01647711|7458226|FG004|Overall Study|Other adverse event|2
4605278|NCT01647711|7458222|FG000|Overall Study|Protocol Violation|0
4605279|NCT01647711|7458223|FG001|Overall Study|Protocol Violation|0
4605280|NCT01647711|7458224|FG002|Overall Study|Protocol Violation|0
4605281|NCT01647711|7458225|FG003|Overall Study|Protocol Violation|0
4605282|NCT01647711|7458226|FG004|Overall Study|Protocol Violation|1
4605283|NCT01647711|7458222|FG000|Overall Study|Refused to continue taking medication|0
4605284|NCT01647711|7458223|FG001|Overall Study|Refused to continue taking medication|0
4605285|NCT01647711|7458224|FG002|Overall Study|Refused to continue taking medication|0
4605286|NCT01647711|7458225|FG003|Overall Study|Refused to continue taking medication|2
4605287|NCT01647711|7458226|FG004|Overall Study|Refused to continue taking medication|1
4605288|NCT01647711|7458222|FG000|Overall Study|Other reason not defined|0
4605289|NCT01647711|7458223|FG001|Overall Study|Other reason not defined|1
4605290|NCT01647711|7458224|FG002|Overall Study|Other reason not defined|1
4605291|NCT01647711|7458225|FG003|Overall Study|Other reason not defined|1
4605292|NCT01647711|7458226|FG004|Overall Study|Other reason not defined|0
4636778|NCT01947283|7509295|FG005|Overall Study|Death|0
4636779|NCT01947283|7509296|FG006|Overall Study|Death|0
4636780|NCT01947283|7509290|FG000|Overall Study|Lost to Follow-up|4
4605293|NCT01647958|7458268|FG000|Initial Study|Lost to Follow-up|2
4636781|NCT01947283|7509291|FG001|Overall Study|Lost to Follow-up|6
4636782|NCT01947283|7509292|FG002|Overall Study|Lost to Follow-up|5
4636783|NCT01947283|7509293|FG003|Overall Study|Lost to Follow-up|5
4636784|NCT01947283|7509294|FG004|Overall Study|Lost to Follow-up|0
4636785|NCT01947283|7509295|FG005|Overall Study|Lost to Follow-up|2
4636786|NCT01947283|7509296|FG006|Overall Study|Lost to Follow-up|5
4636787|NCT01947283|7509290|FG000|Overall Study|Withdrawal by Subject|10
4636788|NCT01947283|7509291|FG001|Overall Study|Withdrawal by Subject|8
4636789|NCT01947283|7509292|FG002|Overall Study|Withdrawal by Subject|4
4636790|NCT01947283|7509293|FG003|Overall Study|Withdrawal by Subject|1
4605294|NCT01647958|7458269|FG001|Initial Study|Lost to Follow-up|3
4605295|NCT01647958|7458268|FG000|Continuation Phase|treatment received during Overall Study|39
4605296|NCT01647958|7458269|FG001|Continuation Phase|treatment received during Overall Study|0
4605297|NCT01647958|7458268|FG000|Extended Follow-up Phase|Lost to Follow-up|8
4605298|NCT01647958|7458269|FG001|Extended Follow-up Phase|Lost to Follow-up|0
4605299|NCT01648101|7458287|FG000|Titration Phase (4 Weeks)|Protocol Violation|2
4605300|NCT01648101|7458288|FG001|Titration Phase (4 Weeks)|Protocol Violation|1
4605301|NCT01648101|7458289|FG002|Titration Phase (4 Weeks)|Protocol Violation|2
4605302|NCT01648101|7458287|FG000|Titration Phase (4 Weeks)|Adverse Event|0
4605303|NCT01648101|7458288|FG001|Titration Phase (4 Weeks)|Adverse Event|2
4636791|NCT01947283|7509294|FG004|Overall Study|Withdrawal by Subject|0
4636792|NCT01947283|7509295|FG005|Overall Study|Withdrawal by Subject|0
4636793|NCT01947283|7509296|FG006|Overall Study|Withdrawal by Subject|2
4636794|NCT01947283|7509290|FG000|Overall Study|No Clinical Recording|12
4636795|NCT01947283|7509291|FG001|Overall Study|No Clinical Recording|6
4636796|NCT01947283|7509292|FG002|Overall Study|No Clinical Recording|8
4636797|NCT01947283|7509293|FG003|Overall Study|No Clinical Recording|10
4636798|NCT01947283|7509294|FG004|Overall Study|No Clinical Recording|0
4636799|NCT01947283|7509295|FG005|Overall Study|No Clinical Recording|0
4636800|NCT01947283|7509296|FG006|Overall Study|No Clinical Recording|0
4636801|NCT01947283|7509290|FG000|Overall Study|Non-coding Clinical Recording language|0
4636802|NCT01947283|7509291|FG001|Overall Study|Non-coding Clinical Recording language|0
4636803|NCT01947283|7509292|FG002|Overall Study|Non-coding Clinical Recording language|0
4636804|NCT01947283|7509293|FG003|Overall Study|Non-coding Clinical Recording language|1
4636805|NCT01947283|7509294|FG004|Overall Study|Non-coding Clinical Recording language|0
4636806|NCT01947283|7509295|FG005|Overall Study|Non-coding Clinical Recording language|0
4636807|NCT01947283|7509296|FG006|Overall Study|Non-coding Clinical Recording language|0
4636808|NCT01947283|7509290|FG000|Overall Study|Missing Follow-up Assessment|2
4636809|NCT01947283|7509291|FG001|Overall Study|Missing Follow-up Assessment|2
4636810|NCT01947283|7509292|FG002|Overall Study|Missing Follow-up Assessment|3
4636811|NCT01947283|7509293|FG003|Overall Study|Missing Follow-up Assessment|0
4636812|NCT01947283|7509294|FG004|Overall Study|Missing Follow-up Assessment|0
4636813|NCT01947283|7509295|FG005|Overall Study|Missing Follow-up Assessment|2
4636814|NCT01947283|7509296|FG006|Overall Study|Missing Follow-up Assessment|0
4636815|NCT01947283|7509290|FG000|Overall Study|No patients were enrolled in study|0
4636816|NCT01947283|7509291|FG001|Overall Study|No patients were enrolled in study|0
4636817|NCT01947283|7509292|FG002|Overall Study|No patients were enrolled in study|0
4636818|NCT01947283|7509293|FG003|Overall Study|No patients were enrolled in study|0
4636819|NCT01947283|7509294|FG004|Overall Study|No patients were enrolled in study|0
4636820|NCT01947283|7509295|FG005|Overall Study|No patients were enrolled in study|3
4636821|NCT01947283|7509296|FG006|Overall Study|No patients were enrolled in study|1
4636822|NCT01947491|7509326|FG000|Overall Study|Lost to Follow-up|5
4636823|NCT01947491|7509327|FG001|Overall Study|Lost to Follow-up|3
4636824|NCT01947491|7509328|FG002|Overall Study|Lost to Follow-up|1
4636825|NCT01947491|7509329|FG003|Overall Study|Lost to Follow-up|2
4636826|NCT01947491|7509326|FG000|Overall Study|Lack of Efficacy|1
4636827|NCT01947491|7509327|FG001|Overall Study|Lack of Efficacy|0
4636828|NCT01947491|7509328|FG002|Overall Study|Lack of Efficacy|0
4636829|NCT01947491|7509329|FG003|Overall Study|Lack of Efficacy|1
4636830|NCT01947491|7509326|FG000|Overall Study|Protocol Violation|1
4636831|NCT01947491|7509327|FG001|Overall Study|Protocol Violation|0
4636832|NCT01947491|7509328|FG002|Overall Study|Protocol Violation|0
4636833|NCT01947491|7509329|FG003|Overall Study|Protocol Violation|0
4636834|NCT01947491|7509326|FG000|Overall Study|Withdrawal by Subject|1
4636835|NCT01947491|7509327|FG001|Overall Study|Withdrawal by Subject|1
4636836|NCT01947491|7509328|FG002|Overall Study|Withdrawal by Subject|1
4636837|NCT01947491|7509329|FG003|Overall Study|Withdrawal by Subject|0
4636838|NCT01947491|7509326|FG000|Overall Study|Worsening of condition|0
4636839|NCT01947491|7509327|FG001|Overall Study|Worsening of condition|1
4636840|NCT01947491|7509328|FG002|Overall Study|Worsening of condition|0
4636841|NCT01947491|7509329|FG003|Overall Study|Worsening of condition|0
4636842|NCT01947491|7509326|FG000|Overall Study|Adverse Event|0
4636843|NCT01947491|7509327|FG001|Overall Study|Adverse Event|1
4636844|NCT01947491|7509328|FG002|Overall Study|Adverse Event|0
4636845|NCT01947491|7509329|FG003|Overall Study|Adverse Event|2
4636846|NCT01947517|7509341|FG000|Overall Study|Withdrawal by Subject|1
4636847|NCT01947517|7509342|FG001|Overall Study|Withdrawal by Subject|1
4636848|NCT01947582|7509348|FG000|Overall Study|Withdrawal by Subject|1
4636849|NCT01947855|7509368|FG000|Overall Study|Withdrawal by Subject|1
4636850|NCT01947855|7509369|FG001|Overall Study|Withdrawal by Subject|0
4636851|NCT01947855|7509370|FG002|Overall Study|Withdrawal by Subject|0
4636852|NCT01947894|7509381|FG000|Overall Study|Other|3
4636853|NCT01947894|7509382|FG001|Overall Study|Other|4
4636854|NCT01947894|7509383|FG002|Overall Study|Other|3
4636855|NCT01947894|7509381|FG000|Overall Study|Withdrawal by Subject|12
4636856|NCT01947894|7509382|FG001|Overall Study|Withdrawal by Subject|4
4636857|NCT01947894|7509383|FG002|Overall Study|Withdrawal by Subject|1
4636858|NCT01947894|7509381|FG000|Overall Study|Death|12
4605304|NCT01648101|7458289|FG002|Titration Phase (4 Weeks)|Adverse Event|3
4605305|NCT01648101|7458287|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0
4605306|NCT01648101|7458288|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0
4605307|NCT01648101|7458289|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1
4605308|NCT01648101|7458287|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1
4605309|NCT01648101|7458288|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0
4605310|NCT01648101|7458289|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1
4605311|NCT01648101|7458287|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1
4605312|NCT01648101|7458288|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0
4605313|NCT01648101|7458289|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1
4605314|NCT01648101|7458287|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1
4605315|NCT01648101|7458288|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3
4605316|NCT01648101|7458289|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4
4605317|NCT01648101|7458287|FG000|Transition Phase (4 Weeks)|Adverse Event|4
4605318|NCT01648101|7458288|FG001|Transition Phase (4 Weeks)|Adverse Event|3
4605319|NCT01648101|7458289|FG002|Transition Phase (4 Weeks)|Adverse Event|2
4605320|NCT01648101|7458287|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0
4605321|NCT01648101|7458288|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2
4605322|NCT01648101|7458289|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0
4605323|NCT01648101|7458287|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0
4605324|NCT01648101|7458288|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0
4605325|NCT01648101|7458289|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2
4605326|NCT01648101|7458287|FG000|Transition Phase (4 Weeks)|Study Terminated|1
4605327|NCT01648101|7458288|FG001|Transition Phase (4 Weeks)|Study Terminated|0
4605328|NCT01648101|7458289|FG002|Transition Phase (4 Weeks)|Study Terminated|0
4605329|NCT01648101|7458287|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0
4605330|NCT01648101|7458288|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1
4605331|NCT01648101|7458289|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0
4605332|NCT01648140|7458305|FG000|Overall Study|Physician Decision|1
4605333|NCT01648140|7458306|FG001|Overall Study|Physician Decision|0
4605334|NCT01648140|7458307|FG002|Overall Study|Physician Decision|0
4605335|NCT01648140|7458308|FG003|Overall Study|Physician Decision|0
4605336|NCT01648140|7458305|FG000|Overall Study|Lack of Efficacy|4
4605337|NCT01648140|7458306|FG001|Overall Study|Lack of Efficacy|7
4605338|NCT01648140|7458307|FG002|Overall Study|Lack of Efficacy|1
4605339|NCT01648140|7458308|FG003|Overall Study|Lack of Efficacy|0
4605340|NCT01648140|7458305|FG000|Overall Study|Adverse Event|3
4605341|NCT01648140|7458306|FG001|Overall Study|Adverse Event|1
4605342|NCT01648140|7458307|FG002|Overall Study|Adverse Event|2
4605343|NCT01648140|7458308|FG003|Overall Study|Adverse Event|0
4605344|NCT01648140|7458305|FG000|Overall Study|Withdrawal by Subject|2
4605345|NCT01648140|7458306|FG001|Overall Study|Withdrawal by Subject|3
4605346|NCT01648140|7458307|FG002|Overall Study|Withdrawal by Subject|3
4636859|NCT01947894|7509382|FG001|Overall Study|Death|1
4636860|NCT01947894|7509383|FG002|Overall Study|Death|0
4636861|NCT01947894|7509381|FG000|Overall Study|Physician Decision|2
4636862|NCT01947894|7509382|FG001|Overall Study|Physician Decision|0
4636863|NCT01947894|7509383|FG002|Overall Study|Physician Decision|0
4636864|NCT01947894|7509381|FG000|Overall Study|Adverse Event|5
4636865|NCT01947894|7509382|FG001|Overall Study|Adverse Event|1
4636866|NCT01947894|7509383|FG002|Overall Study|Adverse Event|0
4636867|NCT01947894|7509381|FG000|Overall Study|Switched to other growth hormone brand|53
4636868|NCT01947894|7509382|FG001|Overall Study|Switched to other growth hormone brand|8
4636869|NCT01947894|7509383|FG002|Overall Study|Switched to other growth hormone brand|23
4636870|NCT01948050|7509423|FG000|Overall Study|Withdrawal by Subject|0
4636871|NCT01948050|7509424|FG001|Overall Study|Withdrawal by Subject|1
4636872|NCT01948063|7509432|FG000|Overall Study|Boston MCI halted research protocol|0
4636873|NCT01948063|7509433|FG001|Overall Study|Boston MCI halted research protocol|1
4636874|NCT01948063|7509432|FG000|Overall Study|Discovered an enrollment in other study|0
4636875|NCT01948063|7509433|FG001|Overall Study|Discovered an enrollment in other study|1
4636876|NCT01948063|7509432|FG000|Overall Study|Blood samples were accidentally thawed|1
4636877|NCT01948063|7509433|FG001|Overall Study|Blood samples were accidentally thawed|0
4636878|NCT01948076|7509441|FG000|Overall Study|Withdrawal by Subject|0
4636879|NCT01948076|7509442|FG001|Overall Study|Withdrawal by Subject|1
4636880|NCT01948193|7509454|FG000|Overall Study|Serious event|2
4636881|NCT01948193|7509454|FG000|Overall Study|Lost to Follow-up|7
4636882|NCT01948258|7509459|FG000|Overall Study|Pregnancy|41
4636883|NCT01948258|7509459|FG000|Overall Study|Did not complete by cut-off date|35
4636884|NCT01948258|7509459|FG000|Overall Study|Lost to Follow-up|27
4636885|NCT01948258|7509459|FG000|Overall Study|Withdrawal by SPD|8
4636886|NCT01948258|7509459|FG000|Overall Study|Withdrawal by Subject|6
4605347|NCT01648140|7458308|FG003|Overall Study|Withdrawal by Subject|2
4605348|NCT01648140|7458305|FG000|Overall Study|Lost to Follow-up|2
4605349|NCT01648140|7458306|FG001|Overall Study|Lost to Follow-up|1
4605350|NCT01648140|7458307|FG002|Overall Study|Lost to Follow-up|2
4605351|NCT01648140|7458308|FG003|Overall Study|Lost to Follow-up|0
4605352|NCT01648166|7458329|FG000|Overall Study|inadequate toenail samples|53
4605353|NCT01648166|7458330|FG001|Overall Study|inadequate toenail samples|100
4636887|NCT01948258|7509459|FG000|Overall Study|Health Care Professional|43
4636888|NCT01948258|7509459|FG000|Overall Study|Removed from statistical analysis|2
4636889|NCT01948427|7509499|FG000|Overall Study|Serious Adverse Event|3
4636890|NCT01948427|7509500|FG001|Overall Study|Serious Adverse Event|0
4605354|NCT01648283|7458336|FG000|Overall Study|Withdrawal by Subject|14
4605355|NCT01648348|7458378|FG000|Overall Study|Cancel|1
4605356|NCT01648348|7458379|FG001|Overall Study|Cancel|0
4605357|NCT01648348|7458380|FG002|Overall Study|Cancel|0
4605358|NCT01648348|7458381|FG003|Overall Study|Cancel|0
4605359|NCT01648348|7458382|FG004|Overall Study|Cancel|3
4605360|NCT01648348|7458383|FG005|Overall Study|Cancel|6
4605361|NCT01648348|7458378|FG000|Overall Study|Replaced for MTD analysis|1
4605362|NCT01648348|7458379|FG001|Overall Study|Replaced for MTD analysis|0
4605363|NCT01648348|7458380|FG002|Overall Study|Replaced for MTD analysis|1
4605364|NCT01648348|7458381|FG003|Overall Study|Replaced for MTD analysis|0
4605365|NCT01648348|7458382|FG004|Overall Study|Replaced for MTD analysis|0
4605366|NCT01648348|7458383|FG005|Overall Study|Replaced for MTD analysis|0
4605367|NCT01648582|7458416|FG000|Overall Study|Adverse Event|6
4605368|NCT01648582|7458417|FG001|Overall Study|Adverse Event|11
4605369|NCT01648582|7458418|FG002|Overall Study|Adverse Event|2
4605370|NCT01648582|7458416|FG000|Overall Study|Lost to Follow-up|9
4605371|NCT01648582|7458417|FG001|Overall Study|Lost to Follow-up|6
4605372|NCT01648582|7458418|FG002|Overall Study|Lost to Follow-up|8
4605373|NCT01648582|7458416|FG000|Overall Study|Protocol Violation|1
4605374|NCT01648582|7458417|FG001|Overall Study|Protocol Violation|2
4605375|NCT01648582|7458418|FG002|Overall Study|Protocol Violation|1
4605376|NCT01648582|7458416|FG000|Overall Study|Withdrawal by Subject|15
4605377|NCT01648582|7458417|FG001|Overall Study|Withdrawal by Subject|17
4605378|NCT01648582|7458418|FG002|Overall Study|Withdrawal by Subject|17
4605379|NCT01648582|7458416|FG000|Overall Study|Physician Decision|0
4605380|NCT01648582|7458417|FG001|Overall Study|Physician Decision|1
4605381|NCT01648582|7458418|FG002|Overall Study|Physician Decision|3
4605382|NCT01648582|7458416|FG000|Overall Study|Death|1
4605383|NCT01648582|7458417|FG001|Overall Study|Death|0
4605384|NCT01648582|7458418|FG002|Overall Study|Death|0
4605385|NCT01648582|7458416|FG000|Overall Study|Sponsor Decision|0
4605386|NCT01648582|7458417|FG001|Overall Study|Sponsor Decision|1
4605387|NCT01648582|7458418|FG002|Overall Study|Sponsor Decision|1
4605388|NCT01648699|7458429|FG000|Overall Study|Death|1
4605389|NCT01648699|7458429|FG000|Overall Study|Lost to Follow-up|2
4605390|NCT01648699|7458429|FG000|Overall Study|Unspecified/unable to complete 4 visits|2
4605391|NCT01648764|7458456|FG000|Overall Study|Progressive Disease|0
4605392|NCT01648764|7458457|FG001|Overall Study|Progressive Disease|1
4605393|NCT01648764|7458458|FG002|Overall Study|Progressive Disease|0
4605394|NCT01648764|7458459|FG003|Overall Study|Progressive Disease|0
4605395|NCT01648764|7458460|FG004|Overall Study|Progressive Disease|0
4605396|NCT01648764|7458461|FG005|Overall Study|Progressive Disease|1
4605397|NCT01648764|7458462|FG006|Overall Study|Progressive Disease|1
4605398|NCT01648764|7458463|FG007|Overall Study|Progressive Disease|0
4605399|NCT01648764|7458464|FG008|Overall Study|Progressive Disease|0
4605400|NCT01648764|7458465|FG009|Overall Study|Progressive Disease|2
4605401|NCT01648764|7458466|FG010|Overall Study|Progressive Disease|0
4605402|NCT01648764|7458467|FG011|Overall Study|Progressive Disease|1
4605403|NCT01648764|7458468|FG012|Overall Study|Progressive Disease|2
4605404|NCT01648764|7458469|FG013|Overall Study|Progressive Disease|1
4605405|NCT01648764|7458456|FG000|Overall Study|Adverse Event|0
4605406|NCT01648764|7458457|FG001|Overall Study|Adverse Event|0
4605407|NCT01648764|7458458|FG002|Overall Study|Adverse Event|0
4605408|NCT01648764|7458459|FG003|Overall Study|Adverse Event|0
4605409|NCT01648764|7458460|FG004|Overall Study|Adverse Event|0
4605410|NCT01648764|7458461|FG005|Overall Study|Adverse Event|1
4605411|NCT01648764|7458462|FG006|Overall Study|Adverse Event|0
4605412|NCT01648764|7458463|FG007|Overall Study|Adverse Event|0
4605413|NCT01648764|7458464|FG008|Overall Study|Adverse Event|0
4605414|NCT01648764|7458465|FG009|Overall Study|Adverse Event|1
4605415|NCT01648764|7458466|FG010|Overall Study|Adverse Event|0
4605416|NCT01648764|7458467|FG011|Overall Study|Adverse Event|3
4605417|NCT01648764|7458468|FG012|Overall Study|Adverse Event|1
4636891|NCT01948427|7509501|FG002|Overall Study|Serious Adverse Event|0
4636892|NCT01948427|7509502|FG003|Overall Study|Serious Adverse Event|0
4636893|NCT01948427|7509503|FG004|Overall Study|Serious Adverse Event|1
4636894|NCT01948427|7509499|FG000|Overall Study|Investigator Request|0
4605418|NCT01648764|7458469|FG013|Overall Study|Adverse Event|1
4605419|NCT01648764|7458456|FG000|Overall Study|Death|0
4605420|NCT01648764|7458457|FG001|Overall Study|Death|0
4605421|NCT01648764|7458458|FG002|Overall Study|Death|0
4605422|NCT01648764|7458459|FG003|Overall Study|Death|0
4605423|NCT01648764|7458460|FG004|Overall Study|Death|0
4605424|NCT01648764|7458461|FG005|Overall Study|Death|0
4605425|NCT01648764|7458462|FG006|Overall Study|Death|1
4605426|NCT01648764|7458463|FG007|Overall Study|Death|0
4605427|NCT01648764|7458464|FG008|Overall Study|Death|0
4605428|NCT01648764|7458465|FG009|Overall Study|Death|0
4605429|NCT01648764|7458466|FG010|Overall Study|Death|0
4636895|NCT01948427|7509500|FG001|Overall Study|Investigator Request|8
4605430|NCT01648764|7458467|FG011|Overall Study|Death|0
4605431|NCT01648764|7458468|FG012|Overall Study|Death|0
4605432|NCT01648764|7458469|FG013|Overall Study|Death|1
4605433|NCT01648764|7458456|FG000|Overall Study|Withdrawal by Subject|0
4605434|NCT01648764|7458457|FG001|Overall Study|Withdrawal by Subject|0
4605435|NCT01648764|7458458|FG002|Overall Study|Withdrawal by Subject|0
4605436|NCT01648764|7458459|FG003|Overall Study|Withdrawal by Subject|0
4605437|NCT01648764|7458460|FG004|Overall Study|Withdrawal by Subject|0
4605438|NCT01648764|7458461|FG005|Overall Study|Withdrawal by Subject|0
4605439|NCT01648764|7458462|FG006|Overall Study|Withdrawal by Subject|2
4605440|NCT01648764|7458463|FG007|Overall Study|Withdrawal by Subject|0
4605441|NCT01648764|7458464|FG008|Overall Study|Withdrawal by Subject|0
4605442|NCT01648764|7458465|FG009|Overall Study|Withdrawal by Subject|0
4605443|NCT01648764|7458466|FG010|Overall Study|Withdrawal by Subject|0
4605444|NCT01648764|7458467|FG011|Overall Study|Withdrawal by Subject|0
4605445|NCT01648764|7458468|FG012|Overall Study|Withdrawal by Subject|1
4605446|NCT01648764|7458469|FG013|Overall Study|Withdrawal by Subject|0
4605447|NCT01648764|7458456|FG000|Overall Study|Investigator Decision|0
4605448|NCT01648764|7458457|FG001|Overall Study|Investigator Decision|0
4605449|NCT01648764|7458458|FG002|Overall Study|Investigator Decision|0
4605450|NCT01648764|7458459|FG003|Overall Study|Investigator Decision|0
4605451|NCT01648764|7458460|FG004|Overall Study|Investigator Decision|0
4605452|NCT01648764|7458461|FG005|Overall Study|Investigator Decision|0
4605453|NCT01648764|7458462|FG006|Overall Study|Investigator Decision|1
4605454|NCT01648764|7458463|FG007|Overall Study|Investigator Decision|0
4605455|NCT01648764|7458464|FG008|Overall Study|Investigator Decision|0
4605456|NCT01648764|7458465|FG009|Overall Study|Investigator Decision|0
4605457|NCT01648764|7458466|FG010|Overall Study|Investigator Decision|0
4605458|NCT01648764|7458467|FG011|Overall Study|Investigator Decision|1
4605459|NCT01648764|7458468|FG012|Overall Study|Investigator Decision|0
4605460|NCT01648764|7458469|FG013|Overall Study|Investigator Decision|0
4605461|NCT01648790|7458503|FG000|Treatment 3|Withdrawal by Subject|0
4605462|NCT01648790|7458504|FG001|Treatment 3|Withdrawal by Subject|0
4605463|NCT01648790|7458505|FG002|Treatment 3|Withdrawal by Subject|0
4605464|NCT01648790|7458506|FG003|Treatment 3|Withdrawal by Subject|1
4605465|NCT01648790|7458507|FG004|Treatment 3|Withdrawal by Subject|0
4605466|NCT01649232|7458533|FG000|Overall Study|Physician Decision|2
4605467|NCT01649232|7458534|FG001|Overall Study|Physician Decision|0
4605468|NCT01649271|7458548|FG000|Overall Study|Progressive disease|4
4605469|NCT01649271|7458549|FG001|Overall Study|Progressive disease|5
4605470|NCT01649271|7458548|FG000|Overall Study|Other Adverse Event|0
4605471|NCT01649271|7458549|FG001|Overall Study|Other Adverse Event|2
4605472|NCT01649271|7458548|FG000|Overall Study|Withdrawal by Subject|1
4605473|NCT01649271|7458549|FG001|Overall Study|Withdrawal by Subject|0
4605474|NCT01649271|7458548|FG000|Overall Study|Other than stated above|1
4605475|NCT01649271|7458549|FG001|Overall Study|Other than stated above|0
4605476|NCT01649297|7458561|FG000|Overall Study|Adverse Event|5
4605477|NCT01649297|7458562|FG001|Overall Study|Adverse Event|5
4605478|NCT01649297|7458563|FG002|Overall Study|Adverse Event|4
4605479|NCT01649297|7458564|FG003|Overall Study|Adverse Event|13
4605480|NCT01649297|7458565|FG004|Overall Study|Adverse Event|1
4605481|NCT01649297|7458561|FG000|Overall Study|Lack of Efficacy|0
4605482|NCT01649297|7458562|FG001|Overall Study|Lack of Efficacy|0
4605483|NCT01649297|7458563|FG002|Overall Study|Lack of Efficacy|0
4605484|NCT01649297|7458564|FG003|Overall Study|Lack of Efficacy|0
4605485|NCT01649297|7458565|FG004|Overall Study|Lack of Efficacy|1
4605486|NCT01649297|7458561|FG000|Overall Study|Non compliant with Protocol|1
4636896|NCT01948427|7509501|FG002|Overall Study|Investigator Request|0
4636897|NCT01948427|7509502|FG003|Overall Study|Investigator Request|0
4636898|NCT01948427|7509503|FG004|Overall Study|Investigator Request|6
4636899|NCT01948427|7509499|FG000|Overall Study|Lost to Follow-up|1
4636900|NCT01948427|7509500|FG001|Overall Study|Lost to Follow-up|0
4636901|NCT01948427|7509501|FG002|Overall Study|Lost to Follow-up|0
4636902|NCT01948427|7509502|FG003|Overall Study|Lost to Follow-up|0
4636903|NCT01948427|7509503|FG004|Overall Study|Lost to Follow-up|4
4636904|NCT01948427|7509499|FG000|Overall Study|Withdrawal by Subject|2
4636905|NCT01948427|7509500|FG001|Overall Study|Withdrawal by Subject|0
4636906|NCT01948427|7509501|FG002|Overall Study|Withdrawal by Subject|0
4636907|NCT01948427|7509502|FG003|Overall Study|Withdrawal by Subject|0
4636908|NCT01948427|7509503|FG004|Overall Study|Withdrawal by Subject|1
4636909|NCT01948427|7509499|FG000|Overall Study|Other, Not Specified|1
4636910|NCT01948427|7509500|FG001|Overall Study|Other, Not Specified|9
4636911|NCT01948427|7509501|FG002|Overall Study|Other, Not Specified|0
4636912|NCT01948427|7509502|FG003|Overall Study|Other, Not Specified|0
4636913|NCT01948427|7509503|FG004|Overall Study|Other, Not Specified|2
4636914|NCT01948791|7509528|FG000|Overall Study|Adverse Event|12
4636915|NCT01948791|7509528|FG000|Overall Study|Lack of Efficacy|3
4636916|NCT01948791|7509528|FG000|Overall Study|Protocol Violation|2
4636917|NCT01948791|7509528|FG000|Overall Study|Withdrawal by Subject|5
4636918|NCT01948791|7509528|FG000|Overall Study|Lost to Follow-up|6
4636919|NCT01948791|7509528|FG000|Overall Study|Management issues|1
4636920|NCT01948791|7509528|FG000|Overall Study|Others|7
4636921|NCT01948791|7509528|FG000|Overall Study|Screening failure|35
4636922|NCT01948830|7509534|FG000|Overall Study|Physician Decision|1
4636923|NCT01948830|7509535|FG001|Overall Study|Physician Decision|3
4636924|NCT01948830|7509534|FG000|Overall Study|Protocol deviation|1
4636925|NCT01948830|7509535|FG001|Overall Study|Protocol deviation|2
4605487|NCT01649297|7458562|FG001|Overall Study|Non compliant with Protocol|0
4605488|NCT01649297|7458563|FG002|Overall Study|Non compliant with Protocol|3
4605489|NCT01649297|7458564|FG003|Overall Study|Non compliant with Protocol|2
4605490|NCT01649297|7458565|FG004|Overall Study|Non compliant with Protocol|1
4605491|NCT01649297|7458561|FG000|Overall Study|Lost to Follow-up|1
4605492|NCT01649297|7458562|FG001|Overall Study|Lost to Follow-up|1
4605493|NCT01649297|7458563|FG002|Overall Study|Lost to Follow-up|4
4605494|NCT01649297|7458564|FG003|Overall Study|Lost to Follow-up|3
4605495|NCT01649297|7458565|FG004|Overall Study|Lost to Follow-up|0
4605496|NCT01649297|7458561|FG000|Overall Study|Patient withdrawal (not due to AE)|3
4605497|NCT01649297|7458562|FG001|Overall Study|Patient withdrawal (not due to AE)|6
4605498|NCT01649297|7458563|FG002|Overall Study|Patient withdrawal (not due to AE)|4
4605499|NCT01649297|7458564|FG003|Overall Study|Patient withdrawal (not due to AE)|1
4605500|NCT01649297|7458565|FG004|Overall Study|Patient withdrawal (not due to AE)|1
4605501|NCT01649297|7458561|FG000|Overall Study|For other reason|4
4605502|NCT01649297|7458562|FG001|Overall Study|For other reason|1
4605503|NCT01649297|7458563|FG002|Overall Study|For other reason|2
4605504|NCT01649297|7458564|FG003|Overall Study|For other reason|0
4605505|NCT01649297|7458565|FG004|Overall Study|For other reason|0
4605506|NCT01649375|7458589|FG000|Up to Week 16|Adverse Event|2
4605507|NCT01649375|7458590|FG001|Up to Week 16|Adverse Event|5
4605508|NCT01649375|7458591|FG002|Up to Week 16|Adverse Event|4
4605509|NCT01649375|7458592|FG003|Up to Week 16|Adverse Event|0
4605510|NCT01649375|7458593|FG004|Up to Week 16|Adverse Event|0
4605511|NCT01649375|7458589|FG000|Up to Week 16|Lack of Efficacy|0
4605512|NCT01649375|7458590|FG001|Up to Week 16|Lack of Efficacy|0
4605513|NCT01649375|7458591|FG002|Up to Week 16|Lack of Efficacy|1
4605514|NCT01649375|7458592|FG003|Up to Week 16|Lack of Efficacy|0
4605515|NCT01649375|7458593|FG004|Up to Week 16|Lack of Efficacy|0
4636926|NCT01948830|7509534|FG000|Overall Study|Lost to Follow-up|5
4636927|NCT01948830|7509535|FG001|Overall Study|Lost to Follow-up|4
4636928|NCT01948830|7509534|FG000|Overall Study|Withdrawal by Subject|14
4636929|NCT01948830|7509535|FG001|Overall Study|Withdrawal by Subject|17
4636930|NCT01948830|7509534|FG000|Overall Study|Adverse Event|9
4636931|NCT01948830|7509535|FG001|Overall Study|Adverse Event|2
4636932|NCT01948830|7509534|FG000|Overall Study|Death|3
4636933|NCT01948830|7509535|FG001|Overall Study|Death|4
4636934|NCT01948908|7509544|FG000|Overall Study|Protocol Violation|1
4636935|NCT01948908|7509545|FG001|Overall Study|Protocol Violation|0
4636936|NCT01948908|7509546|FG002|Overall Study|Protocol Violation|2
4636937|NCT01949051|7509584|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1
4636938|NCT01949051|7509585|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0
4636939|NCT01949051|7509586|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0
4636940|NCT01949051|7509587|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1
4636941|NCT01949051|7509588|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0
4636942|NCT01949051|7509589|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0
4636943|NCT01949051|7509584|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1
4746780|NCT00517699|7719358|FG000|Overall Study|Administrative error|1
4746781|NCT00517699|7719358|FG000|Overall Study|Study terminated by Sponsor|2
4746782|NCT00528775|7719362|FG000|Overall Study|Other not specified|1
4746783|NCT00527982|7719398|FG000|Overall Study|Physician Decision|1
4746784|NCT00527982|7719399|FG001|Overall Study|Physician Decision|0
4746785|NCT00524459|7719405|FG000|Overall Study|Withdrawal by Subject|1
4746786|NCT00524459|7719405|FG000|Overall Study|Other|1
4746787|NCT00517361|7719409|FG000|Overall Study|Death|6
4746788|NCT00517361|7719409|FG000|Overall Study|The study was terminated|5
4746789|NCT00522457|7719421|FG000|Overall Study|Due to disease progression|16
4746790|NCT00522457|7719421|FG000|Overall Study|Adverse Event|2
4746791|NCT00526331|7719425|FG000|Overall Study|Sponsor Termination|55
4746792|NCT00522301|7719446|FG000|Overall Study|Withdrawal by Subject|1
4746793|NCT00522301|7719446|FG000|Overall Study|Adverse Event|5
4746794|NCT00517192|7719452|FG000|Overall Study|Adverse Event|1
4746795|NCT00517192|7719453|FG001|Overall Study|Adverse Event|1
4746796|NCT00517192|7719452|FG000|Overall Study|Lost to Follow-up|1
4746797|NCT00517192|7719453|FG001|Overall Study|Lost to Follow-up|1
4746798|NCT00517192|7719452|FG000|Overall Study|Withdrawal by Subject|1
4746799|NCT00517192|7719453|FG001|Overall Study|Withdrawal by Subject|0
4746800|NCT00517192|7719452|FG000|Overall Study|Early termination of the trial|16
4746801|NCT00517192|7719453|FG001|Overall Study|Early termination of the trial|18
4746802|NCT00503581|7719466|FG000|Overall Study|Study closed|3
4746803|NCT00503581|7719467|FG001|Overall Study|Study closed|4
4746804|NCT00503581|7719468|FG002|Overall Study|Study closed|2
4605516|NCT01649375|7458589|FG000|Up to Week 16|Physician Decision|0
4605517|NCT01649375|7458590|FG001|Up to Week 16|Physician Decision|0
4746805|NCT00509600|7719476|FG000|Overall Study|Adverse Event|1
4746806|NCT00515112|7719482|FG000|Overall Study|Death|0
4746807|NCT00515112|7719483|FG001|Overall Study|Death|1
4746808|NCT00515112|7719482|FG000|Overall Study|The study was terminated|3
4746809|NCT00515112|7719483|FG001|Overall Study|The study was terminated|2
4746810|NCT00508872|7719489|FG000|Overall Study|Lost to Follow-up|1
4746811|NCT00508872|7719489|FG000|Overall Study|Physician Decision|1
4746812|NCT00514813|7719497|FG000|Overall Study|Study terminated|14
4746813|NCT00514813|7719498|FG001|Overall Study|Study terminated|74
4746814|NCT00514813|7719499|FG002|Overall Study|Study terminated|40
4746815|NCT00514813|7719500|FG003|Overall Study|Study terminated|2
4746816|NCT00514813|7719497|FG000|Overall Study|Adverse Event|0
4746817|NCT00514813|7719498|FG001|Overall Study|Adverse Event|2
4746818|NCT00514813|7719499|FG002|Overall Study|Adverse Event|2
4746819|NCT00514813|7719500|FG003|Overall Study|Adverse Event|0
4605518|NCT01649375|7458591|FG002|Up to Week 16|Physician Decision|1
4605519|NCT01649375|7458592|FG003|Up to Week 16|Physician Decision|0
4605520|NCT01649375|7458593|FG004|Up to Week 16|Physician Decision|0
4605521|NCT01649375|7458589|FG000|Up to Week 16|Withdrawal by Subject|2
4605522|NCT01649375|7458590|FG001|Up to Week 16|Withdrawal by Subject|1
4605523|NCT01649375|7458591|FG002|Up to Week 16|Withdrawal by Subject|2
4605524|NCT01649375|7458592|FG003|Up to Week 16|Withdrawal by Subject|0
4605525|NCT01649375|7458593|FG004|Up to Week 16|Withdrawal by Subject|0
4605526|NCT01649375|7458589|FG000|Up to Week 16|Death|1
4605527|NCT01649375|7458590|FG001|Up to Week 16|Death|0
4605528|NCT01649375|7458591|FG002|Up to Week 16|Death|0
4605529|NCT01649375|7458592|FG003|Up to Week 16|Death|0
4605530|NCT01649375|7458593|FG004|Up to Week 16|Death|0
4605531|NCT01649375|7458589|FG000|Week 16 up to Week 260|Lack of Efficacy|7
4605532|NCT01649375|7458590|FG001|Week 16 up to Week 260|Lack of Efficacy|4
4605533|NCT01649375|7458591|FG002|Week 16 up to Week 260|Lack of Efficacy|0
4605534|NCT01649375|7458592|FG003|Week 16 up to Week 260|Lack of Efficacy|4
4605535|NCT01649375|7458593|FG004|Week 16 up to Week 260|Lack of Efficacy|2
4605536|NCT01649375|7458589|FG000|Week 16 up to Week 260|Non-compliance|0
4605537|NCT01649375|7458590|FG001|Week 16 up to Week 260|Non-compliance|1
4605538|NCT01649375|7458591|FG002|Week 16 up to Week 260|Non-compliance|0
4605539|NCT01649375|7458592|FG003|Week 16 up to Week 260|Non-compliance|1
4605540|NCT01649375|7458593|FG004|Week 16 up to Week 260|Non-compliance|0
4605541|NCT01649375|7458589|FG000|Week 16 up to Week 260|Physician Decision|0
4605542|NCT01649375|7458590|FG001|Week 16 up to Week 260|Physician Decision|2
4605543|NCT01649375|7458591|FG002|Week 16 up to Week 260|Physician Decision|0
4605544|NCT01649375|7458592|FG003|Week 16 up to Week 260|Physician Decision|0
4605545|NCT01649375|7458593|FG004|Week 16 up to Week 260|Physician Decision|0
4605546|NCT01649375|7458589|FG000|Week 16 up to Week 260|Technical issues|0
4605547|NCT01649375|7458590|FG001|Week 16 up to Week 260|Technical issues|1
4605548|NCT01649375|7458591|FG002|Week 16 up to Week 260|Technical issues|0
4605549|NCT01649375|7458592|FG003|Week 16 up to Week 260|Technical issues|1
4605550|NCT01649375|7458593|FG004|Week 16 up to Week 260|Technical issues|0
4605551|NCT01649375|7458589|FG000|Week 16 up to Week 260|Withdrawal by Subject|7
4605552|NCT01649375|7458590|FG001|Week 16 up to Week 260|Withdrawal by Subject|2
4605553|NCT01649375|7458591|FG002|Week 16 up to Week 260|Withdrawal by Subject|0
4605554|NCT01649375|7458592|FG003|Week 16 up to Week 260|Withdrawal by Subject|3
4605555|NCT01649375|7458593|FG004|Week 16 up to Week 260|Withdrawal by Subject|1
4605556|NCT01649375|7458589|FG000|Week 16 up to Week 260|Death|1
4605557|NCT01649375|7458590|FG001|Week 16 up to Week 260|Death|1
4605558|NCT01649375|7458591|FG002|Week 16 up to Week 260|Death|0
4605559|NCT01649375|7458592|FG003|Week 16 up to Week 260|Death|0
4605560|NCT01649375|7458593|FG004|Week 16 up to Week 260|Death|0
4605561|NCT01649375|7458589|FG000|Week 16 up to Week 260|Adverse Event|5
4605562|NCT01649375|7458590|FG001|Week 16 up to Week 260|Adverse Event|2
4605563|NCT01649375|7458591|FG002|Week 16 up to Week 260|Adverse Event|0
4605564|NCT01649375|7458592|FG003|Week 16 up to Week 260|Adverse Event|3
4605565|NCT01649375|7458593|FG004|Week 16 up to Week 260|Adverse Event|2
4605566|NCT01649427|7458603|FG000|Overall Study|Adverse Event|1
4605567|NCT01649427|7458604|FG001|Overall Study|Adverse Event|1
4605568|NCT01649427|7458603|FG000|Overall Study|Withdrawal by Subject|8
4605569|NCT01649427|7458604|FG001|Overall Study|Withdrawal by Subject|7
4605570|NCT01649427|7458603|FG000|Overall Study|Lost to Follow-up|0
4605571|NCT01649427|7458604|FG001|Overall Study|Lost to Follow-up|1
4605572|NCT01649427|7458603|FG000|Overall Study|Graft loss|0
4605573|NCT01649427|7458604|FG001|Overall Study|Graft loss|1
4605574|NCT01649427|7458603|FG000|Overall Study|Surgical problems during nephrectomy|2
4605575|NCT01649427|7458604|FG001|Overall Study|Surgical problems during nephrectomy|2
4605576|NCT01649557|7458613|FG000|Overall Study|Lost to Follow-up|5
4605577|NCT01649557|7458614|FG001|Overall Study|Lost to Follow-up|0
4605578|NCT01649557|7458615|FG002|Overall Study|Lost to Follow-up|3
4605579|NCT01649557|7458613|FG000|Overall Study|Adverse Event|7
4605580|NCT01649557|7458614|FG001|Overall Study|Adverse Event|5
4605581|NCT01649557|7458615|FG002|Overall Study|Adverse Event|1
4605582|NCT01649557|7458613|FG000|Overall Study|Met withdrawal criteria|4
4636944|NCT01949051|7509585|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0
4636945|NCT01949051|7509586|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0
4636946|NCT01949051|7509587|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0
4636947|NCT01949051|7509588|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0
4636948|NCT01949051|7509589|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0
4636949|NCT01949051|7509584|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0
4636950|NCT01949051|7509585|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0
4636951|NCT01949051|7509586|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0
4636952|NCT01949051|7509587|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0
4636953|NCT01949051|7509588|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0
4605583|NCT01649557|7458614|FG001|Overall Study|Met withdrawal criteria|0
4605584|NCT01649557|7458615|FG002|Overall Study|Met withdrawal criteria|0
4605585|NCT01649557|7458613|FG000|Overall Study|Physician Decision|8
4605586|NCT01649557|7458614|FG001|Overall Study|Physician Decision|2
4605587|NCT01649557|7458615|FG002|Overall Study|Physician Decision|1
4636954|NCT01949051|7509589|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1
4605588|NCT01649557|7458613|FG000|Overall Study|Withdrawal by Subject|15
4605589|NCT01649557|7458614|FG001|Overall Study|Withdrawal by Subject|5
4605590|NCT01649557|7458615|FG002|Overall Study|Withdrawal by Subject|4
4605591|NCT01649557|7458613|FG000|Overall Study|Protocol deviation|0
4605592|NCT01649557|7458614|FG001|Overall Study|Protocol deviation|2
4605593|NCT01649557|7458615|FG002|Overall Study|Protocol deviation|0
4605594|NCT01649557|7458613|FG000|Overall Study|Lack of Efficacy|5
4605595|NCT01649557|7458614|FG001|Overall Study|Lack of Efficacy|0
4605596|NCT01649557|7458615|FG002|Overall Study|Lack of Efficacy|0
4605597|NCT01649765|7458643|FG000|Overall Study|Adverse Event|5
4605598|NCT01649765|7458644|FG001|Overall Study|Adverse Event|3
4636955|NCT01949051|7509584|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0
4636956|NCT01949051|7509585|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1
4636957|NCT01949051|7509586|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0
4605599|NCT01649765|7458643|FG000|Overall Study|Lack of Efficacy|1
4605600|NCT01649765|7458644|FG001|Overall Study|Lack of Efficacy|1
4605601|NCT01649765|7458643|FG000|Overall Study|Physician Decision|0
4605602|NCT01649765|7458644|FG001|Overall Study|Physician Decision|3
4605603|NCT01649765|7458643|FG000|Overall Study|Protocol Violation|1
4605604|NCT01649765|7458644|FG001|Overall Study|Protocol Violation|0
4605605|NCT01649765|7458643|FG000|Overall Study|Withdrawal by Subject|2
4605606|NCT01649765|7458644|FG001|Overall Study|Withdrawal by Subject|1
4605607|NCT01649791|7458651|FG000|Overall Study|Disease Progression|2
4605608|NCT01649791|7458651|FG000|Overall Study|Adverse Event|1
4605609|NCT01649804|7458655|FG000|Overall Study|Administrative/Other|8
4605610|NCT01649856|7458661|FG000|Overall Study|Withdrawal by Subject|14
4605611|NCT01649856|7458662|FG001|Overall Study|Withdrawal by Subject|14
4605612|NCT01649856|7458661|FG000|Overall Study|Protocol Violation|4
4605613|NCT01649856|7458662|FG001|Overall Study|Protocol Violation|4
4605614|NCT01649856|7458661|FG000|Overall Study|Treatment Failure|1
4605615|NCT01649856|7458662|FG001|Overall Study|Treatment Failure|1
4605616|NCT01649856|7458661|FG000|Overall Study|Death|69
4605617|NCT01649856|7458662|FG001|Overall Study|Death|34
4605618|NCT01649856|7458661|FG000|Overall Study|Stable or Progressed Disease|5
4605619|NCT01649856|7458662|FG001|Overall Study|Stable or Progressed Disease|3
4605620|NCT01649856|7458661|FG000|Overall Study|Lost to Follow-up|20
4636958|NCT01949051|7509587|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0
4636959|NCT01949051|7509588|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0
4636960|NCT01949051|7509589|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0
4636961|NCT01949051|7509584|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
4636962|NCT01949051|7509585|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
4636963|NCT01949051|7509586|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1
4636964|NCT01949051|7509587|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
4636965|NCT01949051|7509588|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
4636966|NCT01949051|7509589|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
4636967|NCT01949090|7509602|FG000|Overall Study|Serious Adverse Event|0
4636968|NCT01949090|7509603|FG001|Overall Study|Serious Adverse Event|1
4636969|NCT01949090|7509604|FG002|Overall Study|Serious Adverse Event|2
4636970|NCT01949090|7509605|FG003|Overall Study|Serious Adverse Event|0
4636971|NCT01949090|7509606|FG004|Overall Study|Serious Adverse Event|1
4636972|NCT01949090|7509602|FG000|Overall Study|Withdrawal by Subject|2
4636973|NCT01949090|7509603|FG001|Overall Study|Withdrawal by Subject|0
4636974|NCT01949090|7509604|FG002|Overall Study|Withdrawal by Subject|0
4636975|NCT01949090|7509605|FG003|Overall Study|Withdrawal by Subject|0
4636976|NCT01949090|7509606|FG004|Overall Study|Withdrawal by Subject|1
4636977|NCT01949090|7509602|FG000|Overall Study|Protocol non-compliance|0
4636978|NCT01949090|7509603|FG001|Overall Study|Protocol non-compliance|0
4636979|NCT01949090|7509604|FG002|Overall Study|Protocol non-compliance|0
4636980|NCT01949090|7509605|FG003|Overall Study|Protocol non-compliance|0
4636981|NCT01949090|7509606|FG004|Overall Study|Protocol non-compliance|1
4636982|NCT01949090|7509602|FG000|Overall Study|Lost to Follow-up|2
4636983|NCT01949090|7509603|FG001|Overall Study|Lost to Follow-up|1
4636984|NCT01949090|7509604|FG002|Overall Study|Lost to Follow-up|0
4636985|NCT01949090|7509605|FG003|Overall Study|Lost to Follow-up|1
4636986|NCT01949090|7509606|FG004|Overall Study|Lost to Follow-up|1
4636987|NCT01949116|7509621|FG000|Overall Study|Death|2
4636988|NCT01949116|7509622|FG001|Overall Study|Death|0
4636989|NCT01949116|7509621|FG000|Overall Study|Lost to Follow-up|1
4636990|NCT01949116|7509622|FG001|Overall Study|Lost to Follow-up|3
4636991|NCT01949116|7509621|FG000|Overall Study|Withdrawal by Subject|5
4636992|NCT01949116|7509622|FG001|Overall Study|Withdrawal by Subject|3
4636993|NCT01949142|7509634|FG000|Overall Study|Withdrawal of consent|1
4636994|NCT01949142|7509635|FG001|Overall Study|Withdrawal of consent|0
4636995|NCT01949142|7509634|FG000|Overall Study|Lost to Follow-up|1
4636996|NCT01949142|7509635|FG001|Overall Study|Lost to Follow-up|1
4636997|NCT01949142|7509634|FG000|Overall Study|Parent changed their mind|1
4636998|NCT01949142|7509635|FG001|Overall Study|Parent changed their mind|0
4636999|NCT01949155|7509644|FG000|Overall Study|Lost to Follow-up|1
4637000|NCT01949155|7509645|FG001|Overall Study|Lost to Follow-up|0
4637001|NCT01949155|7509644|FG000|Overall Study|Protocol Violation|1
4637002|NCT01949155|7509645|FG001|Overall Study|Protocol Violation|0
4637003|NCT01949480|7509667|FG000|Overall Study|Physician Decision|5
4637004|NCT01949480|7509668|FG001|Overall Study|Physician Decision|8
4605621|NCT01649856|7458662|FG001|Overall Study|Lost to Follow-up|16
4605622|NCT01649856|7458661|FG000|Overall Study|Lack of Compliance|6
4605623|NCT01649856|7458662|FG001|Overall Study|Lack of Compliance|1
4605624|NCT01649856|7458661|FG000|Overall Study|Other|20
4605625|NCT01649856|7458662|FG001|Overall Study|Other|5
4605626|NCT01649869|7458670|FG000|Overall Study|Family member illness|1
4605627|NCT01649869|7458671|FG001|Overall Study|Family member illness|0
4605628|NCT01649869|7458670|FG000|Overall Study|Required treatment outside protocol|1
4605629|NCT01649869|7458671|FG001|Overall Study|Required treatment outside protocol|0
4605630|NCT01649869|7458670|FG000|Overall Study|Severe hearing loss borderline eligible|0
4605631|NCT01649869|7458671|FG001|Overall Study|Severe hearing loss borderline eligible|1
4605632|NCT01650194|7458689|FG000|Overall Study|Progressive Disease (PD)|35
4605633|NCT01650194|7458689|FG000|Overall Study|Withdrawal by Subject|2
4605634|NCT01650194|7458689|FG000|Overall Study|Miscellaneous|10
4605635|NCT01650246|7458694|FG000|Overall Study|Adverse Event|23
4605636|NCT01650246|7458694|FG000|Overall Study|Protocol Violation|5
4605637|NCT01650246|7458694|FG000|Overall Study|Sponsor terminated study|53
4605638|NCT01650246|7458694|FG000|Overall Study|Lost to Follow-up|5
4605639|NCT01650246|7458694|FG000|Overall Study|Withdrawal by Subject|26
4605640|NCT01650246|7458694|FG000|Overall Study|Death|1
4605641|NCT01650246|7458694|FG000|Overall Study|Lack of Efficacy|30
4605642|NCT01650259|7458700|FG000|Overall Study|Improvement|105
4605643|NCT01650259|7458701|FG001|Overall Study|Improvement|0
4605644|NCT01650259|7458700|FG000|Overall Study|Adverse Event|127
4605645|NCT01650259|7458701|FG001|Overall Study|Adverse Event|0
4605646|NCT01650259|7458700|FG000|Overall Study|Lack of Efficacy|143
4605647|NCT01650259|7458701|FG001|Overall Study|Lack of Efficacy|0
4605648|NCT01650259|7458700|FG000|Overall Study|Lost to Follow-up|435
4605649|NCT01650259|7458701|FG001|Overall Study|Lost to Follow-up|0
4605650|NCT01650259|7458700|FG000|Overall Study|Patients had no visit after entry|70
4605651|NCT01650259|7458701|FG001|Overall Study|Patients had no visit after entry|0
4605652|NCT01650259|7458700|FG000|Overall Study|CRF not collected|98
4605653|NCT01650259|7458701|FG001|Overall Study|CRF not collected|82
4605654|NCT01650259|7458700|FG000|Overall Study|Not treated|1
4605655|NCT01650259|7458701|FG001|Overall Study|Not treated|7
4605656|NCT01650259|7458700|FG000|Overall Study|Other than listed|64
4605657|NCT01650259|7458701|FG001|Overall Study|Other than listed|146
4605658|NCT01650519|7458751|FG000|Overall Study|Withdrawal by Subject|1
4605659|NCT01650519|7458752|FG001|Overall Study|Withdrawal by Subject|0
4605660|NCT01650558|7458772|FG000|Overall Study|Migration out of study area|61
4605661|NCT01650558|7458773|FG001|Overall Study|Migration out of study area|71
4605662|NCT01650558|7458774|FG002|Overall Study|Migration out of study area|56
4605663|NCT01650558|7458772|FG000|Overall Study|Lost to Follow-up|10
4605664|NCT01650558|7458773|FG001|Overall Study|Lost to Follow-up|13
4605665|NCT01650558|7458774|FG002|Overall Study|Lost to Follow-up|6
4605666|NCT01650558|7458772|FG000|Overall Study|Death|10
4605667|NCT01650558|7458773|FG001|Overall Study|Death|6
4605668|NCT01650558|7458774|FG002|Overall Study|Death|8
4605669|NCT01650558|7458772|FG000|Overall Study|Withdrawal by Subject|1
4605670|NCT01650558|7458773|FG001|Overall Study|Withdrawal by Subject|1
4605671|NCT01650558|7458774|FG002|Overall Study|Withdrawal by Subject|3
4605672|NCT01650558|7458772|FG000|Overall Study|Non-compliant participant|1
4605673|NCT01650558|7458773|FG001|Overall Study|Non-compliant participant|0
4605674|NCT01650558|7458774|FG002|Overall Study|Non-compliant participant|2
4605675|NCT01650558|7458772|FG000|Overall Study|Physician Decision|0
4605676|NCT01650558|7458773|FG001|Overall Study|Physician Decision|1
4637005|NCT01949532|7509676|FG000|Overall Study|On-study at the Data Cut-off Date|3
4637006|NCT01949532|7509677|FG001|Overall Study|On-study at the Data Cut-off Date|3
4605677|NCT01650558|7458774|FG002|Overall Study|Physician Decision|0
4605678|NCT01650636|7458792|FG000|Washout up to 5 Months|Withdrawal by Subject|4
4605679|NCT01650636|7458793|FG001|Washout up to 5 Months|Withdrawal by Subject|8
4605680|NCT01650636|7458792|FG000|Washout up to 5 Months|Physician Decision|2
4605681|NCT01650636|7458793|FG001|Washout up to 5 Months|Physician Decision|2
4605682|NCT01650636|7458792|FG000|Washout up to 5 Months|Death|1
4605683|NCT01650636|7458793|FG001|Washout up to 5 Months|Death|0
4605684|NCT01650636|7458792|FG000|Washout up to 5 Months|Lost to Follow-up|2
4637007|NCT01949662|7509702|FG000|Overall Study|Death|9
4637008|NCT01949662|7509703|FG001|Overall Study|Death|7
4605685|NCT01650636|7458793|FG001|Washout up to 5 Months|Lost to Follow-up|8
4605686|NCT01650636|7458792|FG000|Washout up to 9 Months|Withdrawal by Subject|4
4605687|NCT01650636|7458793|FG001|Washout up to 9 Months|Withdrawal by Subject|2
4605688|NCT01650636|7458792|FG000|Washout up to 9 Months|Lost to Follow-up|2
4605689|NCT01650636|7458793|FG001|Washout up to 9 Months|Lost to Follow-up|1
4605690|NCT01650779|7458799|FG000|Overall Study|Withdrawal by Subject|1
4605691|NCT01650805|7458805|FG000|Overall Study|Withdrawal by Subject|1
4605692|NCT01650805|7458806|FG001|Overall Study|Withdrawal by Subject|0
4605693|NCT01650831|7458812|FG000|Overall Study|Screen failure|1
4605694|NCT01651000|7458831|FG000|Overall Study|Adverse Event|2
4605695|NCT01651000|7458832|FG001|Overall Study|Adverse Event|8
4605696|NCT01651000|7458831|FG000|Overall Study|Lost to Follow-up|3
4605697|NCT01651000|7458832|FG001|Overall Study|Lost to Follow-up|2
4605698|NCT01651000|7458831|FG000|Overall Study|Protocol Violation|0
4605699|NCT01651000|7458832|FG001|Overall Study|Protocol Violation|3
4605700|NCT01651000|7458831|FG000|Overall Study|Withdrawal by Subject|2
4605701|NCT01651000|7458832|FG001|Overall Study|Withdrawal by Subject|10
4605702|NCT01651000|7458831|FG000|Overall Study|Subject noncompliance|0
4605703|NCT01651000|7458832|FG001|Overall Study|Subject noncompliance|3
4605704|NCT01651000|7458831|FG000|Overall Study|Lack of Efficacy|1
4605705|NCT01651000|7458832|FG001|Overall Study|Lack of Efficacy|1
4605706|NCT01651000|7458831|FG000|Overall Study|Physician Decision|1
4605707|NCT01651000|7458832|FG001|Overall Study|Physician Decision|0
4605708|NCT01651000|7458831|FG000|Overall Study|Administrative reason|1
4605709|NCT01651000|7458832|FG001|Overall Study|Administrative reason|0
4605710|NCT01651000|7458831|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0
4605711|NCT01651000|7458832|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1
4605712|NCT01651039|7458838|FG000|Overall Study|Non-evaluables|5
4605713|NCT01651039|7458838|FG000|Overall Study|Physician Decision|2
4605714|NCT01651039|7458838|FG000|Overall Study|Withdrawal by Subject|1
4605715|NCT01651039|7458838|FG000|Overall Study|Progressive Disease|22
4605716|NCT01651052|7458842|FG000|Overall Study|Death|21
4605717|NCT01651052|7458842|FG000|Overall Study|Explant|1
4605718|NCT01651052|7458842|FG000|Overall Study|Withdrawal by Subject|1
4637009|NCT01949662|7509702|FG000|Overall Study|Discharged before an agitation event|8
4637010|NCT01949662|7509703|FG001|Overall Study|Discharged before an agitation event|3
4637011|NCT01949662|7509702|FG000|Overall Study|Dropped out|1
4637012|NCT01949662|7509703|FG001|Overall Study|Dropped out|3
4637013|NCT01949662|7509702|FG000|Overall Study|Ineligible|0
4637014|NCT01949662|7509703|FG001|Overall Study|Ineligible|1
4637015|NCT01949870|7509717|FG000|Overall Study|Lack of Efficacy|2
4637016|NCT01949870|7509717|FG000|Overall Study|Adverse Event|1
4637017|NCT01949870|7509717|FG000|Overall Study|Study termination|1
4637018|NCT01949870|7509717|FG000|Overall Study|Eligibility requirements not fulfilled|2
4637019|NCT01950013|7509724|FG000|Overall Study|Withdrawal by Subject|0
4637020|NCT01950013|7509725|FG001|Overall Study|Withdrawal by Subject|2
4637021|NCT01950013|7509726|FG002|Overall Study|Withdrawal by Subject|0
4637022|NCT01950169|7509755|FG000|Overall Study|Withdrawal by Subject|2
4637023|NCT01950169|7509756|FG001|Overall Study|Withdrawal by Subject|8
4637024|NCT01950169|7509757|FG002|Overall Study|Withdrawal by Subject|1
4637025|NCT01950169|7509755|FG000|Overall Study|Death|1
4637026|NCT01950169|7509756|FG001|Overall Study|Death|0
4637027|NCT01950169|7509757|FG002|Overall Study|Death|0
4637028|NCT01950273|7509777|FG000|Overall Study|Protocol Violation|1
4637029|NCT01950273|7509778|FG001|Overall Study|Protocol Violation|0
4637030|NCT01950273|7509777|FG000|Overall Study|Withdrawal by Subject|2
4637031|NCT01950273|7509778|FG001|Overall Study|Withdrawal by Subject|0
4637032|NCT01950273|7509777|FG000|Overall Study|Other not defined above|1
4637033|NCT01950273|7509778|FG001|Overall Study|Other not defined above|0
4637034|NCT01950364|7509799|FG000|Overall Study|Adverse Event|3
4637035|NCT01950364|7509800|FG001|Overall Study|Adverse Event|0
4637036|NCT01950364|7509799|FG000|Overall Study|Stem Cell Transplant|2
4637037|NCT01950364|7509800|FG001|Overall Study|Stem Cell Transplant|6
4637038|NCT01950364|7509799|FG000|Overall Study|Disease Progression|5
4637039|NCT01950364|7509800|FG001|Overall Study|Disease Progression|2
4637040|NCT01950364|7509799|FG000|Overall Study|Withdrawal by Subject|0
4637041|NCT01950364|7509800|FG001|Overall Study|Withdrawal by Subject|1
4637042|NCT01950364|7509799|FG000|Overall Study|Protocol Violation|0
4637043|NCT01950364|7509800|FG001|Overall Study|Protocol Violation|1
4637044|NCT01950741|7509810|FG000|Overall Study|Lost to Follow-up|1
4637045|NCT01950741|7509810|FG000|Overall Study|Death|1
4637046|NCT01950741|7509810|FG000|Overall Study|Withdrawal by Subject|1
4637047|NCT01950819|7509821|FG000|Overall Study|Graft Loss|35
4637048|NCT01950819|7509822|FG001|Overall Study|Graft Loss|30
4637049|NCT01950819|7509821|FG000|Overall Study|Death|29
4637050|NCT01950819|7509822|FG001|Overall Study|Death|34
4637051|NCT01950819|7509821|FG000|Overall Study|Subject / Gardian decision|54
4637052|NCT01950819|7509822|FG001|Overall Study|Subject / Gardian decision|51
4637053|NCT01950819|7509821|FG000|Overall Study|technical problems|2
4637054|NCT01950819|7509822|FG001|Overall Study|technical problems|0
4637055|NCT01950819|7509821|FG000|Overall Study|Pregnancy|0
4637056|NCT01950819|7509822|FG001|Overall Study|Pregnancy|2
4637057|NCT01950819|7509821|FG000|Overall Study|Lost to Follow-up|9
4637058|NCT01950819|7509822|FG001|Overall Study|Lost to Follow-up|17
4637059|NCT01951092|7509834|FG000|Overall Study|Lost to Follow-up|10
4637060|NCT01951092|7509834|FG000|Overall Study|Incarceration|1
4637061|NCT01951092|7509834|FG000|Overall Study|Transfer of Care|1
4637062|NCT01951105|7509841|FG000|Overall Study|Adverse Event|0
4637063|NCT01951105|7509842|FG001|Overall Study|Adverse Event|5
4637064|NCT01951105|7509843|FG002|Overall Study|Adverse Event|0
4637065|NCT01951105|7509841|FG000|Overall Study|Lost to Follow-up|0
4605719|NCT01651052|7458842|FG000|Overall Study|Lost to Follow-up|3
4605720|NCT01651117|7458858|FG000|Overall Study|Death|2
4637066|NCT01951105|7509842|FG001|Overall Study|Lost to Follow-up|1
4637067|NCT01951105|7509843|FG002|Overall Study|Lost to Follow-up|0
4637068|NCT01951105|7509841|FG000|Overall Study|Protocol Violation|1
4605721|NCT01651117|7458859|FG001|Overall Study|Death|3
4605722|NCT01651117|7458860|FG002|Overall Study|Death|2
4605723|NCT01651117|7458861|FG003|Overall Study|Death|2
4605724|NCT01651208|7458897|FG000|Overall Study|Lost to Follow-up|14
4637069|NCT01951105|7509842|FG001|Overall Study|Protocol Violation|1
4637070|NCT01951105|7509843|FG002|Overall Study|Protocol Violation|1
4637071|NCT01951105|7509841|FG000|Overall Study|Withdrawal by Subject|0
4605725|NCT01651208|7458898|FG001|Overall Study|Lost to Follow-up|16
4605726|NCT01651260|7458905|FG000|Overall Study|unable to apply product|3
4605727|NCT01651780|7458941|FG000|Overall Study|Physician decision: No 30-day visit|2
4605728|NCT01651780|7458942|FG001|Overall Study|Physician decision: No 30-day visit|1
4605729|NCT01651780|7458941|FG000|Overall Study|Reason Not Specified: No 30-day visit|2
4605730|NCT01651780|7458942|FG001|Overall Study|Reason Not Specified: No 30-day visit|2
4605731|NCT01651780|7458941|FG000|Overall Study|Withdrawal by Subject|2
4605732|NCT01651780|7458942|FG001|Overall Study|Withdrawal by Subject|0
4605733|NCT01651780|7458941|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3
4605734|NCT01651780|7458942|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0
4605735|NCT01651780|7458941|FG000|Overall Study|Lost to Follow-up|1
4605736|NCT01651780|7458942|FG001|Overall Study|Lost to Follow-up|2
4605737|NCT01651780|7458941|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1
4605738|NCT01651780|7458942|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5
4605739|NCT01651936|7458993|FG000|Base Study|Adverse Event|3
4605740|NCT01651936|7458994|FG001|Base Study|Adverse Event|0
4605741|NCT01651936|7458995|FG002|Base Study|Adverse Event|0
4605742|NCT01651936|7458993|FG000|Base Study|Withdrawal by Subject|1
4605743|NCT01651936|7458994|FG001|Base Study|Withdrawal by Subject|1
4605744|NCT01651936|7458995|FG002|Base Study|Withdrawal by Subject|0
4605745|NCT01651936|7458993|FG000|Base Study|Early Escape|2
4605746|NCT01651936|7458994|FG001|Base Study|Early Escape|8
4605747|NCT01651936|7458995|FG002|Base Study|Early Escape|0
4605748|NCT01651936|7458993|FG000|Base Study|Study terminated by sponsor|21
4605749|NCT01651936|7458994|FG001|Base Study|Study terminated by sponsor|16
4605750|NCT01651936|7458995|FG002|Base Study|Study terminated by sponsor|0
4605751|NCT01651936|7458993|FG000|Extension Study|Lack of Efficacy|0
4605752|NCT01651936|7458994|FG001|Extension Study|Lack of Efficacy|0
4605753|NCT01651936|7458995|FG002|Extension Study|Lack of Efficacy|1
4605754|NCT01651936|7458993|FG000|Extension Study|Study terminated by sponsor|0
4605755|NCT01651936|7458994|FG001|Extension Study|Study terminated by sponsor|0
4605756|NCT01651936|7458995|FG002|Extension Study|Study terminated by sponsor|13
4605757|NCT01651949|7459005|FG000|Overall Study|Unknown status|4
4605758|NCT01651949|7459006|FG001|Overall Study|Unknown status|4
4605759|NCT01651949|7459007|FG002|Overall Study|Unknown status|0
4605760|NCT01651949|7459005|FG000|Overall Study|Lost to Follow-up|30
4605761|NCT01651949|7459006|FG001|Overall Study|Lost to Follow-up|56
4605762|NCT01651949|7459007|FG002|Overall Study|Lost to Follow-up|20
4605763|NCT01651949|7459005|FG000|Overall Study|Protocol Violation|0
4605764|NCT01651949|7459006|FG001|Overall Study|Protocol Violation|2
4605765|NCT01651949|7459007|FG002|Overall Study|Protocol Violation|1
4605766|NCT01651949|7459005|FG000|Overall Study|Physician Decision|0
4605767|NCT01651949|7459006|FG001|Overall Study|Physician Decision|2
4605768|NCT01651949|7459007|FG002|Overall Study|Physician Decision|0
4605769|NCT01651949|7459005|FG000|Overall Study|Adverse Event|0
4605770|NCT01651949|7459006|FG001|Overall Study|Adverse Event|2
4605771|NCT01651949|7459007|FG002|Overall Study|Adverse Event|1
4605772|NCT01651949|7459005|FG000|Overall Study|Screen failure|2
4605773|NCT01651949|7459006|FG001|Overall Study|Screen failure|2
4605774|NCT01651949|7459007|FG002|Overall Study|Screen failure|0
4605775|NCT01651949|7459005|FG000|Overall Study|Withdrawal by Subject|17
4605776|NCT01651949|7459006|FG001|Overall Study|Withdrawal by Subject|18
4605777|NCT01651949|7459007|FG002|Overall Study|Withdrawal by Subject|9
4605778|NCT01652287|7459036|FG000|Overall Study|Withdrawal by Subject|2
4605779|NCT01652287|7459037|FG001|Overall Study|Withdrawal by Subject|0
4605780|NCT01652469|7459045|FG000|Overall Study|Withdrawal by Subject|1
4605781|NCT01652469|7459046|FG001|Overall Study|Withdrawal by Subject|4
4605782|NCT01652469|7459045|FG000|Overall Study|Lost to Follow-up|0
4605783|NCT01652469|7459046|FG001|Overall Study|Lost to Follow-up|2
4605784|NCT01652573|7459065|FG000|Overall Study|Adverse Event|0
4605785|NCT01652573|7459066|FG001|Overall Study|Adverse Event|1
4605786|NCT01652664|7459074|FG000|Overall Study|Treatment Failure|5
4605787|NCT01652664|7459075|FG001|Overall Study|Treatment Failure|1
4605788|NCT01652664|7459074|FG000|Overall Study|Inadequate IOP control|1
4605789|NCT01652664|7459075|FG001|Overall Study|Inadequate IOP control|0
4605790|NCT01652690|7459084|FG000|Overall Study|Withdrawal by Subject|16
4605791|NCT01652690|7459085|FG001|Overall Study|Withdrawal by Subject|4
4605792|NCT01652690|7459084|FG000|Overall Study|Other|8
4605793|NCT01652690|7459085|FG001|Overall Study|Other|9
4605794|NCT01652690|7459084|FG000|Overall Study|Lost to Follow-up|6
4605795|NCT01652690|7459085|FG001|Overall Study|Lost to Follow-up|6
4605796|NCT01652690|7459084|FG000|Overall Study|Death|5
4605797|NCT01652690|7459085|FG001|Overall Study|Death|2
4605798|NCT01652703|7459097|FG000|Overall Study|Withdrawal by Subject|0
4605799|NCT01652703|7459098|FG001|Overall Study|Withdrawal by Subject|1
4605800|NCT01652703|7459099|FG002|Overall Study|Withdrawal by Subject|3
4605801|NCT01652703|7459100|FG003|Overall Study|Withdrawal by Subject|1
4605802|NCT01652703|7459101|FG004|Overall Study|Withdrawal by Subject|0
4605803|NCT01652703|7459102|FG005|Overall Study|Withdrawal by Subject|1
4605804|NCT01652703|7459097|FG000|Overall Study|Other|0
4605805|NCT01652703|7459098|FG001|Overall Study|Other|0
4605806|NCT01652703|7459099|FG002|Overall Study|Other|0
4605807|NCT01652703|7459100|FG003|Overall Study|Other|1
4605808|NCT01652703|7459101|FG004|Overall Study|Other|1
4605809|NCT01652703|7459102|FG005|Overall Study|Other|1
4605810|NCT01652716|7459118|FG000|Overall Study|Loss of glucose control|1
4605811|NCT01652716|7459119|FG001|Overall Study|Loss of glucose control|0
4605812|NCT01652716|7459118|FG000|Overall Study|Administrative|0
4605813|NCT01652716|7459119|FG001|Overall Study|Administrative|2
4605814|NCT01652716|7459118|FG000|Overall Study|Investigator decision|1
4605815|NCT01652716|7459119|FG001|Overall Study|Investigator decision|4
4605816|NCT01652716|7459118|FG000|Overall Study|Lost to Follow-up|12
4605817|NCT01652716|7459119|FG001|Overall Study|Lost to Follow-up|11
4605818|NCT01652716|7459118|FG000|Overall Study|Protocol Violation|2
4605819|NCT01652716|7459119|FG001|Overall Study|Protocol Violation|1
4605820|NCT01652716|7459118|FG000|Overall Study|Adverse Event|7
4605821|NCT01652716|7459119|FG001|Overall Study|Adverse Event|10
4637072|NCT01951105|7509842|FG001|Overall Study|Withdrawal by Subject|3
4637073|NCT01951105|7509843|FG002|Overall Study|Withdrawal by Subject|1
4637074|NCT01951157|7509869|FG000|Overall Study|Progressive Disease|12
4637075|NCT01951157|7509870|FG001|Overall Study|Progressive Disease|13
4637076|NCT01951157|7509871|FG002|Overall Study|Progressive Disease|10
4637077|NCT01951157|7509869|FG000|Overall Study|Treatment-unrelated AE|1
4637078|NCT01951157|7509870|FG001|Overall Study|Treatment-unrelated AE|0
4637079|NCT01951157|7509871|FG002|Overall Study|Treatment-unrelated AE|3
4637080|NCT01951157|7509869|FG000|Overall Study|Study Termination|0
4637081|NCT01951157|7509870|FG001|Overall Study|Study Termination|0
4637082|NCT01951157|7509871|FG002|Overall Study|Study Termination|1
4637083|NCT01951157|7509869|FG000|Overall Study|Physician Decision|5
4637084|NCT01951157|7509870|FG001|Overall Study|Physician Decision|3
4637085|NCT01951157|7509871|FG002|Overall Study|Physician Decision|2
4637086|NCT01951157|7509869|FG000|Overall Study|Non-treatmentrelated death|2
4637087|NCT01951157|7509870|FG001|Overall Study|Non-treatmentrelated death|2
4637088|NCT01951157|7509871|FG002|Overall Study|Non-treatmentrelated death|2
4637089|NCT01951157|7509869|FG000|Overall Study|No treated|0
4637090|NCT01951157|7509870|FG001|Overall Study|No treated|1
4637091|NCT01951157|7509871|FG002|Overall Study|No treated|0
4637092|NCT01951157|7509869|FG000|Overall Study|Treatment-related AE|2
4637093|NCT01951157|7509870|FG001|Overall Study|Treatment-related AE|0
4637094|NCT01951157|7509871|FG002|Overall Study|Treatment-related AE|4
4637095|NCT01951157|7509869|FG000|Overall Study|Consent withdrawn by subject|0
4637096|NCT01951157|7509870|FG001|Overall Study|Consent withdrawn by subject|1
4637097|NCT01951157|7509871|FG002|Overall Study|Consent withdrawn by subject|3
4637098|NCT01951157|7509869|FG000|Overall Study|Treatment-related death|0
4637099|NCT01951157|7509870|FG001|Overall Study|Treatment-related death|2
4637100|NCT01951157|7509871|FG002|Overall Study|Treatment-related death|0
4637101|NCT01951170|7509880|FG000|Overall Study|Investigator decision|1
4637102|NCT01951261|7509886|FG000|Overall Study|Death|1
4637103|NCT01951261|7509887|FG001|Overall Study|Death|0
4637104|NCT01951261|7509886|FG000|Overall Study|Lost to Follow-up|4
4637105|NCT01951261|7509887|FG001|Overall Study|Lost to Follow-up|3
4637106|NCT01951261|7509886|FG000|Overall Study|Protocol Violation|4
4637107|NCT01951261|7509887|FG001|Overall Study|Protocol Violation|3
4637108|NCT01951417|7509927|FG000|Overall Study|Withdrawal by Subject|1
4637109|NCT01951417|7509927|FG000|Overall Study|Protocol Violation|2
4637110|NCT01951417|7509927|FG000|Overall Study|Lost to Follow-up|6
4637111|NCT01951573|7509935|FG000|Washout Period|Adverse Event|0
4637112|NCT01951573|7509936|FG001|Washout Period|Adverse Event|1
4637113|NCT01951586|7509944|FG000|Overall Study|Death|61
4637114|NCT01951586|7509945|FG001|Overall Study|Death|120
4637115|NCT01951586|7509944|FG000|Overall Study|Withdrawal by Subject|8
4637116|NCT01951586|7509945|FG001|Overall Study|Withdrawal by Subject|17
4637117|NCT01951586|7509944|FG000|Overall Study|Lost to Follow-up|0
4637118|NCT01951586|7509945|FG001|Overall Study|Lost to Follow-up|1
4637119|NCT01951586|7509944|FG000|Overall Study|Sponsor Decision|9
4637120|NCT01951586|7509945|FG001|Overall Study|Sponsor Decision|10
4637121|NCT01951625|7509957|FG000|Treatment Period|Protocol Violation|2
4637122|NCT01951625|7509958|FG001|Treatment Period|Protocol Violation|0
4637123|NCT01951625|7509959|FG002|Treatment Period|Protocol Violation|1
4637124|NCT01951625|7509960|FG003|Treatment Period|Protocol Violation|3
4637125|NCT01951625|7509961|FG004|Treatment Period|Protocol Violation|2
4637126|NCT01951625|7509957|FG000|Treatment Period|Physician Decision|0
4637127|NCT01951625|7509958|FG001|Treatment Period|Physician Decision|0
4637128|NCT01951625|7509959|FG002|Treatment Period|Physician Decision|0
4637129|NCT01951625|7509960|FG003|Treatment Period|Physician Decision|0
4637130|NCT01951625|7509961|FG004|Treatment Period|Physician Decision|1
4637131|NCT01951625|7509957|FG000|Treatment Period|Protocol driven decision point|0
4637132|NCT01951625|7509958|FG001|Treatment Period|Protocol driven decision point|5
4637133|NCT01951625|7509959|FG002|Treatment Period|Protocol driven decision point|0
4637134|NCT01951625|7509960|FG003|Treatment Period|Protocol driven decision point|2
4637135|NCT01951625|7509961|FG004|Treatment Period|Protocol driven decision point|1
4637136|NCT01951625|7509957|FG000|Treatment Period|Non compliance with study drug|1
4637137|NCT01951625|7509958|FG001|Treatment Period|Non compliance with study drug|2
4637138|NCT01951625|7509959|FG002|Treatment Period|Non compliance with study drug|2
4637139|NCT01951625|7509960|FG003|Treatment Period|Non compliance with study drug|0
4637140|NCT01951625|7509961|FG004|Treatment Period|Non compliance with study drug|0
4605822|NCT01652716|7459118|FG000|Overall Study|Withdrawal by Subject|33
4605823|NCT01652716|7459119|FG001|Overall Study|Withdrawal by Subject|18
4605824|NCT01652729|7459128|FG000|Overall Study|Withdrawal by Subject|14
4605825|NCT01652729|7459129|FG001|Overall Study|Withdrawal by Subject|7
4605826|NCT01652729|7459130|FG002|Overall Study|Withdrawal by Subject|7
4605827|NCT01652729|7459128|FG000|Overall Study|Adverse Event|4
4605828|NCT01652729|7459129|FG001|Overall Study|Adverse Event|0
4605829|NCT01652729|7459130|FG002|Overall Study|Adverse Event|3
4605830|NCT01652729|7459128|FG000|Overall Study|Physician Decision|1
4605831|NCT01652729|7459129|FG001|Overall Study|Physician Decision|0
4605832|NCT01652729|7459130|FG002|Overall Study|Physician Decision|1
4605833|NCT01652729|7459128|FG000|Overall Study|Protocol Violation|1
4605834|NCT01652729|7459129|FG001|Overall Study|Protocol Violation|0
4605835|NCT01652729|7459130|FG002|Overall Study|Protocol Violation|0
4605836|NCT01652729|7459128|FG000|Overall Study|Lost to Follow-up|6
4605837|NCT01652729|7459129|FG001|Overall Study|Lost to Follow-up|6
4605838|NCT01652729|7459130|FG002|Overall Study|Lost to Follow-up|3
4605839|NCT01652729|7459128|FG000|Overall Study|Administrative|1
4605840|NCT01652729|7459129|FG001|Overall Study|Administrative|0
4605841|NCT01652729|7459130|FG002|Overall Study|Administrative|0
4605842|NCT01652872|7459140|FG000|Overall Study|Death|36
4605843|NCT01652872|7459141|FG001|Overall Study|Death|39
4605844|NCT01652872|7459140|FG000|Overall Study|Lost to Follow-up|28
4605845|NCT01652872|7459141|FG001|Overall Study|Lost to Follow-up|23
4605846|NCT01652872|7459140|FG000|Overall Study|Decision by sponsor|5
4605847|NCT01652872|7459141|FG001|Overall Study|Decision by sponsor|7
4605848|NCT01652872|7459140|FG000|Overall Study|Withdrawal by Subject|76
4605849|NCT01652872|7459141|FG001|Overall Study|Withdrawal by Subject|84
4605850|NCT01652885|7459147|FG000|Overall Study|Adverse Event|1
4605851|NCT01653132|7459176|FG000|First Intervention|Protocol Violation|1
4605852|NCT01653132|7459177|FG001|First Intervention|Protocol Violation|0
4605853|NCT01653158|7459187|FG000|Overall Study|Death|0
4605854|NCT01653158|7459188|FG001|Overall Study|Death|0
4605855|NCT01653158|7459189|FG002|Overall Study|Death|0
4605856|NCT01653158|7459190|FG003|Overall Study|Death|1
4605857|NCT01653158|7459191|FG004|Overall Study|Death|0
4605858|NCT01653158|7459192|FG005|Overall Study|Death|0
4605859|NCT01653158|7459193|FG006|Overall Study|Death|0
4605860|NCT01653158|7459194|FG007|Overall Study|Death|2
4605861|NCT01653158|7459187|FG000|Overall Study|Adverse Event|0
4605862|NCT01653158|7459188|FG001|Overall Study|Adverse Event|0
4605863|NCT01653158|7459189|FG002|Overall Study|Adverse Event|0
4605864|NCT01653158|7459190|FG003|Overall Study|Adverse Event|1
4605865|NCT01653158|7459191|FG004|Overall Study|Adverse Event|0
4605866|NCT01653158|7459192|FG005|Overall Study|Adverse Event|0
4605867|NCT01653158|7459193|FG006|Overall Study|Adverse Event|0
4605868|NCT01653158|7459194|FG007|Overall Study|Adverse Event|3
4605869|NCT01653158|7459187|FG000|Overall Study|Other|0
4605870|NCT01653158|7459188|FG001|Overall Study|Other|0
4605871|NCT01653158|7459189|FG002|Overall Study|Other|0
4605872|NCT01653158|7459190|FG003|Overall Study|Other|0
4605873|NCT01653158|7459191|FG004|Overall Study|Other|0
4605874|NCT01653158|7459192|FG005|Overall Study|Other|0
4605875|NCT01653158|7459193|FG006|Overall Study|Other|0
4605876|NCT01653158|7459194|FG007|Overall Study|Other|1
4605877|NCT01653158|7459187|FG000|Overall Study|Progressive disease|0
4605878|NCT01653158|7459188|FG001|Overall Study|Progressive disease|0
4605879|NCT01653158|7459189|FG002|Overall Study|Progressive disease|0
4605880|NCT01653158|7459190|FG003|Overall Study|Progressive disease|0
4605881|NCT01653158|7459191|FG004|Overall Study|Progressive disease|1
4605882|NCT01653158|7459192|FG005|Overall Study|Progressive disease|1
4605883|NCT01653158|7459193|FG006|Overall Study|Progressive disease|2
4605884|NCT01653158|7459194|FG007|Overall Study|Progressive disease|9
4605885|NCT01653158|7459187|FG000|Overall Study|Withdrawal by Subject|1
4637141|NCT01951625|7509957|FG000|Treatment Period|Death|3
4637142|NCT01951625|7509958|FG001|Treatment Period|Death|2
4637143|NCT01951625|7509959|FG002|Treatment Period|Death|2
4637144|NCT01951625|7509960|FG003|Treatment Period|Death|1
4637145|NCT01951625|7509961|FG004|Treatment Period|Death|2
4637146|NCT01951625|7509957|FG000|Treatment Period|Adverse Event|7
4637147|NCT01951625|7509958|FG001|Treatment Period|Adverse Event|10
4637148|NCT01951625|7509959|FG002|Treatment Period|Adverse Event|9
4637149|NCT01951625|7509960|FG003|Treatment Period|Adverse Event|8
4637150|NCT01951625|7509961|FG004|Treatment Period|Adverse Event|8
4637151|NCT01951625|7509957|FG000|Treatment Period|Withdrawal by Subject|5
4637152|NCT01951625|7509958|FG001|Treatment Period|Withdrawal by Subject|2
4637153|NCT01951625|7509959|FG002|Treatment Period|Withdrawal by Subject|1
4637154|NCT01951625|7509960|FG003|Treatment Period|Withdrawal by Subject|7
4637155|NCT01951625|7509961|FG004|Treatment Period|Withdrawal by Subject|3
4637156|NCT01951625|7509957|FG000|Treatment Period|Lost to Follow-up|1
4637157|NCT01951625|7509958|FG001|Treatment Period|Lost to Follow-up|0
4637158|NCT01951625|7509959|FG002|Treatment Period|Lost to Follow-up|0
4637159|NCT01951625|7509960|FG003|Treatment Period|Lost to Follow-up|1
4637160|NCT01951625|7509961|FG004|Treatment Period|Lost to Follow-up|0
4637161|NCT01951625|7509957|FG000|Follow Up Period|Non-compliance with study drug|1
4637162|NCT01951625|7509958|FG001|Follow Up Period|Non-compliance with study drug|0
4605886|NCT01653158|7459188|FG001|Overall Study|Withdrawal by Subject|0
4605887|NCT01653158|7459189|FG002|Overall Study|Withdrawal by Subject|0
4605888|NCT01653158|7459190|FG003|Overall Study|Withdrawal by Subject|0
4605889|NCT01653158|7459191|FG004|Overall Study|Withdrawal by Subject|0
4605890|NCT01653158|7459192|FG005|Overall Study|Withdrawal by Subject|0
4605891|NCT01653158|7459193|FG006|Overall Study|Withdrawal by Subject|0
4605892|NCT01653158|7459194|FG007|Overall Study|Withdrawal by Subject|0
4605893|NCT01653262|7459221|FG000|Overall Study|Lack of Efficacy|1
4605894|NCT01653262|7459221|FG000|Overall Study|SAE, non-fatal|1
4605895|NCT01653262|7459221|FG000|Overall Study|AE, non-serious non-fatal|1
4605896|NCT01653327|7459236|FG000|Overall Study|Withdrawal by Subject|1
4605897|NCT01653704|7459277|FG000|Overall Study|Technical failure during recording|1
4605898|NCT01653704|7459278|FG001|Overall Study|Technical failure during recording|1
4605899|NCT01653704|7459277|FG000|Overall Study|Performance not reflective of training|1
4605900|NCT01653704|7459278|FG001|Overall Study|Performance not reflective of training|0
4605901|NCT01653743|7459286|FG000|Overall Study|Withdrawal by Subject|1
4605902|NCT01653743|7459287|FG001|Overall Study|Withdrawal by Subject|0
4605903|NCT01653743|7459286|FG000|Overall Study|Investigator discretion|3
4605904|NCT01653743|7459287|FG001|Overall Study|Investigator discretion|0
4605905|NCT01653782|7459296|FG000|Overall Study|Withdrawal by Subject|9
4605906|NCT01653782|7459297|FG001|Overall Study|Withdrawal by Subject|15
4605907|NCT01653782|7459298|FG002|Overall Study|Withdrawal by Subject|4
4605908|NCT01653782|7459296|FG000|Overall Study|Lost to Follow-up|7
4605909|NCT01653782|7459297|FG001|Overall Study|Lost to Follow-up|3
4605910|NCT01653782|7459298|FG002|Overall Study|Lost to Follow-up|2
4637163|NCT01951625|7509959|FG002|Follow Up Period|Non-compliance with study drug|0
4637164|NCT01951625|7509960|FG003|Follow Up Period|Non-compliance with study drug|0
4637165|NCT01951625|7509961|FG004|Follow Up Period|Non-compliance with study drug|0
4637166|NCT01951625|7509957|FG000|Follow Up Period|Death|1
4637167|NCT01951625|7509958|FG001|Follow Up Period|Death|3
4637168|NCT01951625|7509959|FG002|Follow Up Period|Death|2
4637169|NCT01951625|7509960|FG003|Follow Up Period|Death|2
4637170|NCT01951625|7509961|FG004|Follow Up Period|Death|1
4637171|NCT01951625|7509957|FG000|Follow Up Period|Logistical difficulties|1
4637172|NCT01951625|7509958|FG001|Follow Up Period|Logistical difficulties|2
4637173|NCT01951625|7509959|FG002|Follow Up Period|Logistical difficulties|0
4637174|NCT01951625|7509960|FG003|Follow Up Period|Logistical difficulties|0
4637175|NCT01951625|7509961|FG004|Follow Up Period|Logistical difficulties|0
4637176|NCT01951625|7509957|FG000|Follow Up Period|Adverse Event|0
4637177|NCT01951625|7509958|FG001|Follow Up Period|Adverse Event|3
4637178|NCT01951625|7509959|FG002|Follow Up Period|Adverse Event|2
4637179|NCT01951625|7509960|FG003|Follow Up Period|Adverse Event|3
4637180|NCT01951625|7509961|FG004|Follow Up Period|Adverse Event|5
4637181|NCT01951625|7509957|FG000|Follow Up Period|Withdrawal by Subject|4
4637182|NCT01951625|7509958|FG001|Follow Up Period|Withdrawal by Subject|1
4637183|NCT01951625|7509959|FG002|Follow Up Period|Withdrawal by Subject|0
4637184|NCT01951625|7509960|FG003|Follow Up Period|Withdrawal by Subject|5
4637185|NCT01951625|7509961|FG004|Follow Up Period|Withdrawal by Subject|3
4637186|NCT01951625|7509957|FG000|Follow Up Period|Lost to Follow-up|1
4637187|NCT01951625|7509958|FG001|Follow Up Period|Lost to Follow-up|0
4637188|NCT01951625|7509959|FG002|Follow Up Period|Lost to Follow-up|0
4637189|NCT01951625|7509960|FG003|Follow Up Period|Lost to Follow-up|1
4637190|NCT01951625|7509961|FG004|Follow Up Period|Lost to Follow-up|1
4637191|NCT01951638|7509979|FG000|Treatment Period|Protocol Violation|0
4637192|NCT01951638|7509980|FG001|Treatment Period|Protocol Violation|0
4637193|NCT01951638|7509981|FG002|Treatment Period|Protocol Violation|0
4637194|NCT01951638|7509982|FG003|Treatment Period|Protocol Violation|2
4637195|NCT01951638|7509983|FG004|Treatment Period|Protocol Violation|0
4637196|NCT01951638|7509979|FG000|Treatment Period|Protocol-driven decision point|1
4637197|NCT01951638|7509980|FG001|Treatment Period|Protocol-driven decision point|3
4637198|NCT01951638|7509981|FG002|Treatment Period|Protocol-driven decision point|0
4637199|NCT01951638|7509982|FG003|Treatment Period|Protocol-driven decision point|0
4637200|NCT01951638|7509983|FG004|Treatment Period|Protocol-driven decision point|0
4637201|NCT01951638|7509979|FG000|Treatment Period|Logistical difficulties|0
4637202|NCT01951638|7509980|FG001|Treatment Period|Logistical difficulties|1
4637203|NCT01951638|7509981|FG002|Treatment Period|Logistical difficulties|1
4637204|NCT01951638|7509982|FG003|Treatment Period|Logistical difficulties|0
4637205|NCT01951638|7509983|FG004|Treatment Period|Logistical difficulties|0
4637206|NCT01951638|7509979|FG000|Treatment Period|Withdrawal by Subject|9
4637207|NCT01951638|7509980|FG001|Treatment Period|Withdrawal by Subject|6
4637208|NCT01951638|7509981|FG002|Treatment Period|Withdrawal by Subject|4
4637209|NCT01951638|7509982|FG003|Treatment Period|Withdrawal by Subject|5
4637210|NCT01951638|7509983|FG004|Treatment Period|Withdrawal by Subject|4
4637211|NCT01951638|7509979|FG000|Treatment Period|Death|0
4637212|NCT01951638|7509980|FG001|Treatment Period|Death|0
4637213|NCT01951638|7509981|FG002|Treatment Period|Death|0
4637214|NCT01951638|7509982|FG003|Treatment Period|Death|3
4637215|NCT01951638|7509983|FG004|Treatment Period|Death|1
4637216|NCT01951638|7509979|FG000|Treatment Period|Adverse Event|3
4637217|NCT01951638|7509980|FG001|Treatment Period|Adverse Event|4
4637218|NCT01951638|7509981|FG002|Treatment Period|Adverse Event|8
4637219|NCT01951638|7509982|FG003|Treatment Period|Adverse Event|6
4637220|NCT01951638|7509983|FG004|Treatment Period|Adverse Event|5
4637221|NCT01951638|7509979|FG000|Follow-up Period|Protocol Violation|0
4637222|NCT01951638|7509980|FG001|Follow-up Period|Protocol Violation|0
4637223|NCT01951638|7509981|FG002|Follow-up Period|Protocol Violation|0
4637224|NCT01951638|7509982|FG003|Follow-up Period|Protocol Violation|1
4605911|NCT01653847|7459308|FG000|Overall Study|Withdrawal by Subject|1
4605912|NCT01653847|7459309|FG001|Overall Study|Withdrawal by Subject|0
4605913|NCT01653912|7459317|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
4605914|NCT01653912|7459318|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1
4605915|NCT01653912|7459319|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
4605916|NCT01653912|7459320|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
4605917|NCT01653912|7459321|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
4605918|NCT01653912|7459322|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
4605919|NCT01653912|7459317|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
4605920|NCT01653912|7459318|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
4605921|NCT01653912|7459319|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2
4605922|NCT01653912|7459320|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
4605923|NCT01653912|7459321|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
4637225|NCT01951638|7509983|FG004|Follow-up Period|Protocol Violation|0
4637226|NCT01951638|7509979|FG000|Follow-up Period|Logistical difficulties|0
4637227|NCT01951638|7509980|FG001|Follow-up Period|Logistical difficulties|2
4637228|NCT01951638|7509981|FG002|Follow-up Period|Logistical difficulties|0
4637229|NCT01951638|7509982|FG003|Follow-up Period|Logistical difficulties|0
4637230|NCT01951638|7509983|FG004|Follow-up Period|Logistical difficulties|1
4637231|NCT01951638|7509979|FG000|Follow-up Period|Withdrawal by Subject|1
4637232|NCT01951638|7509980|FG001|Follow-up Period|Withdrawal by Subject|5
4637233|NCT01951638|7509981|FG002|Follow-up Period|Withdrawal by Subject|2
4637234|NCT01951638|7509982|FG003|Follow-up Period|Withdrawal by Subject|1
4637235|NCT01951638|7509983|FG004|Follow-up Period|Withdrawal by Subject|2
4637236|NCT01951638|7509979|FG000|Follow-up Period|Lost to Follow-up|0
4637237|NCT01951638|7509980|FG001|Follow-up Period|Lost to Follow-up|1
4637238|NCT01951638|7509981|FG002|Follow-up Period|Lost to Follow-up|0
4637239|NCT01951638|7509982|FG003|Follow-up Period|Lost to Follow-up|1
4637240|NCT01951638|7509983|FG004|Follow-up Period|Lost to Follow-up|0
4637241|NCT01951638|7509979|FG000|Follow-up Period|Death|1
4637242|NCT01951638|7509980|FG001|Follow-up Period|Death|0
4637243|NCT01951638|7509981|FG002|Follow-up Period|Death|1
4637244|NCT01951638|7509982|FG003|Follow-up Period|Death|4
4637245|NCT01951638|7509983|FG004|Follow-up Period|Death|1
4637246|NCT01951638|7509979|FG000|Follow-up Period|Adverse Event|0
4637247|NCT01951638|7509980|FG001|Follow-up Period|Adverse Event|1
4637248|NCT01951638|7509981|FG002|Follow-up Period|Adverse Event|2
4637249|NCT01951638|7509982|FG003|Follow-up Period|Adverse Event|1
4637250|NCT01951638|7509983|FG004|Follow-up Period|Adverse Event|1
4746820|NCT00514813|7719497|FG000|Overall Study|Protocol Violation|1
4746821|NCT00514813|7719498|FG001|Overall Study|Protocol Violation|0
4746822|NCT00514813|7719499|FG002|Overall Study|Protocol Violation|0
4746823|NCT00514813|7719500|FG003|Overall Study|Protocol Violation|0
4746824|NCT00514813|7719497|FG000|Overall Study|Withdrawal by Subject|0
4746825|NCT00514813|7719498|FG001|Overall Study|Withdrawal by Subject|1
4746826|NCT00514813|7719499|FG002|Overall Study|Withdrawal by Subject|0
4746827|NCT00514813|7719500|FG003|Overall Study|Withdrawal by Subject|0
4746828|NCT00514813|7719497|FG000|Overall Study|Lack of Efficacy|0
4746829|NCT00514813|7719498|FG001|Overall Study|Lack of Efficacy|1
4746830|NCT00514813|7719499|FG002|Overall Study|Lack of Efficacy|0
4746831|NCT00514813|7719500|FG003|Overall Study|Lack of Efficacy|0
4746832|NCT00514813|7719497|FG000|Overall Study|Kidney transplant|0
4746833|NCT00514813|7719498|FG001|Overall Study|Kidney transplant|6
4746834|NCT00514813|7719499|FG002|Overall Study|Kidney transplant|2
4746835|NCT00514813|7719500|FG003|Overall Study|Kidney transplant|0
4746836|NCT00514813|7719497|FG000|Overall Study|Death|0
4746837|NCT00514813|7719498|FG001|Overall Study|Death|2
4746838|NCT00514813|7719499|FG002|Overall Study|Death|3
4746839|NCT00514813|7719500|FG003|Overall Study|Death|2
4746840|NCT00501228|7719533|FG000|Overall Study|Withdrawal by Subject|1
4746841|NCT00496782|7719539|FG000|Overall Study|Protocol Violation|1
4746842|NCT00496782|7719540|FG001|Overall Study|Protocol Violation|2
4746843|NCT00487578|7719552|FG000|Overall Study|Adverse Event|1
4746844|NCT00487578|7719553|FG001|Overall Study|Adverse Event|2
4746845|NCT00487578|7719552|FG000|Overall Study|Lack of Efficacy|0
4746846|NCT00487578|7719553|FG001|Overall Study|Lack of Efficacy|1
4746847|NCT00487578|7719552|FG000|Overall Study|Lost to Follow-up|0
4746848|NCT00487578|7719553|FG001|Overall Study|Lost to Follow-up|1
4746849|NCT00503009|7719562|FG000|Overall Study|Protocol Violation|1
4746850|NCT00503009|7719563|FG001|Overall Study|Protocol Violation|0
4746851|NCT00503009|7719564|FG002|Overall Study|Protocol Violation|1
4746852|NCT00503009|7719562|FG000|Overall Study|Withdrawal by Subject|0
4746853|NCT00503009|7719563|FG001|Overall Study|Withdrawal by Subject|1
4746854|NCT00503009|7719564|FG002|Overall Study|Withdrawal by Subject|1
4746855|NCT00503009|7719562|FG000|Overall Study|Physician Decision|0
4746856|NCT00503009|7719563|FG001|Overall Study|Physician Decision|1
4746857|NCT00503009|7719564|FG002|Overall Study|Physician Decision|1
4746858|NCT00499590|7719579|FG000|Overall Study|Study Terminated|112
4746859|NCT00499590|7719580|FG001|Overall Study|Study Terminated|112
4746860|NCT00499590|7719581|FG002|Overall Study|Study Terminated|112
4746861|NCT00499590|7719579|FG000|Overall Study|Not treated|1
4746862|NCT00499590|7719580|FG001|Overall Study|Not treated|0
4746863|NCT00499590|7719581|FG002|Overall Study|Not treated|1
4746864|NCT00503841|7719616|FG000|Overall Study|All screen failures|44
4605924|NCT01653912|7459322|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
4605925|NCT01653912|7459317|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
4605926|NCT01653912|7459318|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
4605927|NCT01653912|7459319|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
4605928|NCT01653912|7459320|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1
4605929|NCT01653912|7459321|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
4605930|NCT01653912|7459322|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
4605931|NCT01653912|7459317|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
4605932|NCT01653912|7459318|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
4605933|NCT01653912|7459319|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
4605934|NCT01653912|7459320|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1
4637251|NCT01951703|7510006|FG000|First Intervention|Withdrawal by Subject|1
4637252|NCT01951703|7510007|FG001|First Intervention|Withdrawal by Subject|0
4637253|NCT01951703|7510006|FG000|First Intervention|Subject was not compliant|1
4637254|NCT01951703|7510007|FG001|First Intervention|Subject was not compliant|1
4637255|NCT01951703|7510006|FG000|First Intervention|Physician Decision|1
4637256|NCT01951703|7510007|FG001|First Intervention|Physician Decision|0
4637257|NCT01951703|7510006|FG000|Second Intervention|Protocol Violation|0
4637258|NCT01951703|7510007|FG001|Second Intervention|Protocol Violation|1
4637259|NCT01951703|7510006|FG000|Second Intervention|Unsatisfactory Lens fitting|0
4637260|NCT01951703|7510007|FG001|Second Intervention|Unsatisfactory Lens fitting|1
4637261|NCT01952015|7510054|FG000|Induction|Protocol Violation|1
4637262|NCT01952015|7510054|FG000|Maintenance|Adverse Event|2
4637263|NCT01952015|7510054|FG000|Treatment Period 3|Physician Decision|9
4637264|NCT01952041|7510072|FG000|Overall Study|Lost to Follow-up|9
4637265|NCT01952041|7510073|FG001|Overall Study|Lost to Follow-up|16
4637266|NCT01952041|7510072|FG000|Overall Study|Withdrawal by Subject|7
4637267|NCT01952041|7510073|FG001|Overall Study|Withdrawal by Subject|5
4637268|NCT01952041|7510072|FG000|Overall Study|Death|1
4637269|NCT01952041|7510073|FG001|Overall Study|Death|0
4637270|NCT01952054|7510079|FG000|Overall Study|Physician Decision|1
4637271|NCT01952080|7510087|FG000|Overall Study|Withdrawal by Subject|0
4637272|NCT01952080|7510088|FG001|Overall Study|Withdrawal by Subject|0
4637273|NCT01952080|7510089|FG002|Overall Study|Withdrawal by Subject|0
4637274|NCT01952080|7510090|FG003|Overall Study|Withdrawal by Subject|1
4637275|NCT01952080|7510087|FG000|Overall Study|Protocol Non-compliance|0
4637276|NCT01952080|7510088|FG001|Overall Study|Protocol Non-compliance|1
4637277|NCT01952080|7510089|FG002|Overall Study|Protocol Non-compliance|0
4637278|NCT01952080|7510090|FG003|Overall Study|Protocol Non-compliance|0
4637279|NCT01952145|7510102|FG000|Overall Study|Protocol Violation|2
4637280|NCT01952145|7510103|FG001|Overall Study|Protocol Violation|1
4637281|NCT01952145|7510102|FG000|Overall Study|Death|0
4637282|NCT01952145|7510103|FG001|Overall Study|Death|1
4637283|NCT01952145|7510102|FG000|Overall Study|Adverse Event|9
4637284|NCT01952145|7510103|FG001|Overall Study|Adverse Event|0
4637285|NCT01952145|7510102|FG000|Overall Study|Withdrawal Criteria|16
4637286|NCT01952145|7510103|FG001|Overall Study|Withdrawal Criteria|11
4637287|NCT01952145|7510102|FG000|Overall Study|Unclassified|1
4637288|NCT01952145|7510103|FG001|Overall Study|Unclassified|1
4637289|NCT01952366|7510115|FG000|Overall Study|Death|22
4637290|NCT01952366|7510115|FG000|Overall Study|Withdrawal by Subject|9
4605935|NCT01653912|7459321|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
4605936|NCT01653912|7459322|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
4605937|NCT01653912|7459317|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0
4605938|NCT01653912|7459318|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0
4605939|NCT01653912|7459319|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0
4605940|NCT01653912|7459320|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0
4605941|NCT01653912|7459321|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0
4605942|NCT01653912|7459322|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1
4605943|NCT01653912|7459317|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0
4605944|NCT01653912|7459318|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0
4605945|NCT01653912|7459319|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0
4605946|NCT01653912|7459320|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0
4605947|NCT01653912|7459321|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0
4605948|NCT01653912|7459322|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6
4605949|NCT01653912|7459317|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
4605950|NCT01653912|7459318|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
4605951|NCT01653912|7459319|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
4605952|NCT01653912|7459320|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
4605953|NCT01653912|7459321|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
4605954|NCT01653912|7459322|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1
4605955|NCT01654224|7459347|FG000|Overall Study|Lost to Follow-up|2
4605956|NCT01654224|7459348|FG001|Overall Study|Lost to Follow-up|2
4605957|NCT01654224|7459347|FG000|Overall Study|Did not receive allocation|1
4605958|NCT01654224|7459348|FG001|Overall Study|Did not receive allocation|8
4605959|NCT01654224|7459347|FG000|Overall Study|Insufficient blood sample|3
4605960|NCT01654224|7459348|FG001|Overall Study|Insufficient blood sample|2
4605961|NCT01654250|7459356|FG000|Overall Study|Lost to Follow-up|1
4605962|NCT01654250|7459357|FG001|Overall Study|Lost to Follow-up|0
4605963|NCT01654276|7459386|FG000|Overall Study|Lack of Efficacy|1
4605964|NCT01654276|7459386|FG000|Overall Study|Lost to Follow-up|4
4605965|NCT01654276|7459386|FG000|Overall Study|Withdrawal by Subject|1
4605966|NCT01654289|7459393|FG000|Overall Study|Withdrawal by Subject|10
4605967|NCT01654289|7459394|FG001|Overall Study|Withdrawal by Subject|8
4605968|NCT01654289|7459395|FG002|Overall Study|Withdrawal by Subject|5
4605969|NCT01654289|7459393|FG000|Overall Study|Withdrew from intervention only|17
4605970|NCT01654289|7459394|FG001|Overall Study|Withdrew from intervention only|20
4605971|NCT01654289|7459395|FG002|Overall Study|Withdrew from intervention only|0
4605972|NCT01654302|7459405|FG000|Second Intervention (Day 7)|Lost to Follow-up|1
4605973|NCT01654302|7459406|FG001|Second Intervention (Day 7)|Lost to Follow-up|1
4605974|NCT01654380|7459414|FG000|Part B, Period 1|Physician Decision|0
4605975|NCT01654380|7459415|FG001|Part B, Period 1|Physician Decision|0
4605976|NCT01654380|7459416|FG002|Part B, Period 1|Physician Decision|1
4605977|NCT01654380|7459417|FG003|Part B, Period 1|Physician Decision|0
4605978|NCT01654523|7459443|FG000|Overall Study|Withdrawal by Subject|1
4605979|NCT01654536|7459449|FG000|Overall Study|Lost to Follow-up|5
4605980|NCT01654536|7459450|FG001|Overall Study|Lost to Follow-up|5
4605981|NCT01654536|7459449|FG000|Overall Study|Physician Decision|12
4605982|NCT01654536|7459450|FG001|Overall Study|Physician Decision|8
4605983|NCT01654536|7459449|FG000|Overall Study|Withdrawal by Subject|27
4605984|NCT01654536|7459450|FG001|Overall Study|Withdrawal by Subject|25
4605985|NCT01654549|7459459|FG000|Overall Study|H.pylori eradication not successful|0
4605986|NCT01654549|7459460|FG001|Overall Study|H.pylori eradication not successful|1
4605987|NCT01654601|7459472|FG000|1st Administration|Withdrawal by Subject|2
4605988|NCT01654601|7459473|FG001|1st Administration|Withdrawal by Subject|0
4605989|NCT01654601|7459472|FG000|1st Administration|Protocol Violation|0
4605990|NCT01654601|7459473|FG001|1st Administration|Protocol Violation|2
4605991|NCT01654601|7459472|FG000|2nd Administration|Adverse Event|1
4605992|NCT01654601|7459473|FG001|2nd Administration|Adverse Event|0
4605993|NCT01654601|7459472|FG000|2nd Administration|Protocol Violation|0
4605994|NCT01654601|7459473|FG001|2nd Administration|Protocol Violation|1
4605995|NCT01654666|7459482|FG000|Overall Study|Protocol Violation|7
4605996|NCT01654666|7459483|FG001|Overall Study|Protocol Violation|4
4605997|NCT01654666|7459484|FG002|Overall Study|Protocol Violation|8
4605998|NCT01654666|7459482|FG000|Overall Study|Lost to Follow-up|4
4605999|NCT01654666|7459483|FG001|Overall Study|Lost to Follow-up|5
4606000|NCT01654666|7459484|FG002|Overall Study|Lost to Follow-up|5
4606001|NCT01654666|7459482|FG000|Overall Study|Withdrawal by Subject|4
4606002|NCT01654666|7459483|FG001|Overall Study|Withdrawal by Subject|4
4606003|NCT01654666|7459484|FG002|Overall Study|Withdrawal by Subject|1
4606004|NCT01655069|7459528|FG000|Overall Study|Physician Decision|0
4606005|NCT01655069|7459529|FG001|Overall Study|Physician Decision|0
4606006|NCT01655069|7459530|FG002|Overall Study|Physician Decision|0
4606007|NCT01655069|7459531|FG003|Overall Study|Physician Decision|1
4606008|NCT01655069|7459528|FG000|Overall Study|Adverse Event|6
4606009|NCT01655069|7459529|FG001|Overall Study|Adverse Event|7
4606010|NCT01655069|7459530|FG002|Overall Study|Adverse Event|2
4606011|NCT01655069|7459531|FG003|Overall Study|Adverse Event|3
4606012|NCT01655069|7459528|FG000|Overall Study|Lack of Efficacy|0
4606013|NCT01655069|7459529|FG001|Overall Study|Lack of Efficacy|1
4606014|NCT01655069|7459530|FG002|Overall Study|Lack of Efficacy|0
4606015|NCT01655069|7459531|FG003|Overall Study|Lack of Efficacy|0
4606016|NCT01655069|7459528|FG000|Overall Study|No Treatment Needed|0
4606017|NCT01655069|7459529|FG001|Overall Study|No Treatment Needed|1
4606018|NCT01655069|7459530|FG002|Overall Study|No Treatment Needed|0
4606019|NCT01655069|7459531|FG003|Overall Study|No Treatment Needed|0
4606020|NCT01655069|7459528|FG000|Overall Study|Withdrawal by Subject|2
4606021|NCT01655069|7459529|FG001|Overall Study|Withdrawal by Subject|3
4606022|NCT01655069|7459530|FG002|Overall Study|Withdrawal by Subject|0
4606023|NCT01655069|7459531|FG003|Overall Study|Withdrawal by Subject|0
4606024|NCT01655381|7459553|FG000|Overall Study|Investigator Decision|1
4606025|NCT01655381|7459553|FG000|Overall Study|Moved to Another City|1
4606026|NCT01655381|7459553|FG000|Overall Study|Insufficient Treatment Response|1
4606027|NCT01655498|7459558|FG000|Overall Study|Unrelated health issue|2
4606028|NCT01655498|7459558|FG000|Overall Study|Protocol Violation|2
4606029|NCT01655498|7459558|FG000|Overall Study|Withdrawal by Subject|1
4606030|NCT01655693|7459577|FG000|Overall Study|Progression of Disease|92
4606031|NCT01655693|7459578|FG001|Overall Study|Progression of Disease|76
4606032|NCT01655693|7459579|FG002|Overall Study|Progression of Disease|58
4606033|NCT01655693|7459577|FG000|Overall Study|Death|8
4606034|NCT01655693|7459578|FG001|Overall Study|Death|9
4606035|NCT01655693|7459579|FG002|Overall Study|Death|12
4606036|NCT01655693|7459577|FG000|Overall Study|Serious Adverse Event|3
4606037|NCT01655693|7459578|FG001|Overall Study|Serious Adverse Event|15
4606038|NCT01655693|7459579|FG002|Overall Study|Serious Adverse Event|11
4606039|NCT01655693|7459577|FG000|Overall Study|Withdrawal by Subject|3
4606040|NCT01655693|7459578|FG001|Overall Study|Withdrawal by Subject|2
4606041|NCT01655693|7459579|FG002|Overall Study|Withdrawal by Subject|20
4606042|NCT01655693|7459577|FG000|Overall Study|Adverse Event|3
4606043|NCT01655693|7459578|FG001|Overall Study|Adverse Event|11
4606044|NCT01655693|7459579|FG002|Overall Study|Adverse Event|3
4606045|NCT01655693|7459577|FG000|Overall Study|Aggravation of Liver Dysfunction|5
4606046|NCT01655693|7459578|FG001|Overall Study|Aggravation of Liver Dysfunction|4
4606047|NCT01655693|7459579|FG002|Overall Study|Aggravation of Liver Dysfunction|0
4606048|NCT01655693|7459577|FG000|Overall Study|Non-Compliance|0
4606049|NCT01655693|7459578|FG001|Overall Study|Non-Compliance|0
4606050|NCT01655693|7459579|FG002|Overall Study|Non-Compliance|7
4606051|NCT01655693|7459577|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1
4606052|NCT01655693|7459578|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3
4606053|NCT01655693|7459579|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0
4606054|NCT01655693|7459577|FG000|Overall Study|Protocol Violation|1
4606055|NCT01655693|7459578|FG001|Overall Study|Protocol Violation|0
4746865|NCT00493025|7719622|FG000|Overall Study|Physician Decision|19
4606056|NCT01655693|7459579|FG002|Overall Study|Protocol Violation|3
4606057|NCT01655693|7459577|FG000|Overall Study|Lost to Follow-up|1
4606058|NCT01655693|7459578|FG001|Overall Study|Lost to Follow-up|0
4606059|NCT01655693|7459579|FG002|Overall Study|Lost to Follow-up|1
4606060|NCT01655693|7459577|FG000|Overall Study|Screening Failure|1
4606061|NCT01655693|7459578|FG001|Overall Study|Screening Failure|0
4606062|NCT01655693|7459579|FG002|Overall Study|Screening Failure|0
4606063|NCT01655693|7459577|FG000|Overall Study|Other|8
4606064|NCT01655693|7459578|FG001|Overall Study|Other|6
4606065|NCT01655693|7459579|FG002|Overall Study|Other|15
4606066|NCT01655823|7459606|FG000|Overall Study|Lost to Follow-up|0
4637361|NCT01952665|7510204|FG000|Overall Study|Physician Decision|3
4637362|NCT01952665|7510205|FG001|Overall Study|Physician Decision|2
4637363|NCT01952665|7510204|FG000|Overall Study|Lost to Follow-up|1
4637364|NCT01952665|7510205|FG001|Overall Study|Lost to Follow-up|2
4637365|NCT01952665|7510204|FG000|Overall Study|Adverse Event|2
4637366|NCT01952665|7510205|FG001|Overall Study|Adverse Event|1
4637367|NCT01952665|7510204|FG000|Overall Study|Protocol Violation|0
4637368|NCT01952665|7510205|FG001|Overall Study|Protocol Violation|1
4637369|NCT01952691|7510233|FG000|Overall Study|Lost to Follow-up|2
4637370|NCT01952834|7510237|FG000|Overall Study|Adverse Event|1
4637371|NCT01953003|7510244|FG000|Overall Study|Not treated|0
4637372|NCT01953003|7510245|FG001|Overall Study|Not treated|1
4637373|NCT01953003|7510244|FG000|Overall Study|Progressive disease|35
4637374|NCT01953003|7510245|FG001|Overall Study|Progressive disease|45
4637375|NCT01953003|7510244|FG000|Overall Study|Related Adverse events|7
4637376|NCT01953003|7510245|FG001|Overall Study|Related Adverse events|2
4637377|NCT01953003|7510244|FG000|Overall Study|Non-related adverse events|0
4637378|NCT01953003|7510245|FG001|Overall Study|Non-related adverse events|2
4637379|NCT01953003|7510244|FG000|Overall Study|Protocol Violation|0
4637380|NCT01953003|7510245|FG001|Overall Study|Protocol Violation|1
4637381|NCT01953003|7510244|FG000|Overall Study|Withdrawal by Subject|14
4637382|NCT01953003|7510245|FG001|Overall Study|Withdrawal by Subject|4
4637383|NCT01953224|7510268|FG000|Overall Study|Lost to Follow-up|1
4637384|NCT01953224|7510269|FG001|Overall Study|Lost to Follow-up|1
4637385|NCT01953224|7510268|FG000|Overall Study|Withdrawal by Subject|1
4637386|NCT01953224|7510269|FG001|Overall Study|Withdrawal by Subject|2
4637387|NCT01953328|7510292|FG000|Overall Study|Withdrawal by Subject|0
4637388|NCT01953328|7510293|FG001|Overall Study|Withdrawal by Subject|0
4637389|NCT01953328|7510294|FG002|Overall Study|Withdrawal by Subject|0
4637390|NCT01953328|7510295|FG003|Overall Study|Withdrawal by Subject|0
4637391|NCT01953328|7510296|FG004|Overall Study|Withdrawal by Subject|1
4637392|NCT01953328|7510297|FG005|Overall Study|Withdrawal by Subject|0
4637393|NCT01953328|7510298|FG006|Overall Study|Withdrawal by Subject|0
4637394|NCT01953328|7510299|FG007|Overall Study|Withdrawal by Subject|0
4637395|NCT01953328|7510292|FG000|Overall Study|Lost to Follow-up|0
4637396|NCT01953328|7510293|FG001|Overall Study|Lost to Follow-up|0
4637397|NCT01953328|7510294|FG002|Overall Study|Lost to Follow-up|0
4637398|NCT01953328|7510295|FG003|Overall Study|Lost to Follow-up|0
4637399|NCT01953328|7510296|FG004|Overall Study|Lost to Follow-up|1
4637400|NCT01953328|7510297|FG005|Overall Study|Lost to Follow-up|0
4637401|NCT01953328|7510298|FG006|Overall Study|Lost to Follow-up|0
4637402|NCT01953328|7510299|FG007|Overall Study|Lost to Follow-up|0
4637403|NCT01953354|7510319|FG000|Overall Study|Withdrawal by Subject|0
4637404|NCT01953354|7510320|FG001|Overall Study|Withdrawal by Subject|1
4637405|NCT01953354|7510319|FG000|Overall Study|Decision of Sponsor|0
4637406|NCT01953354|7510320|FG001|Overall Study|Decision of Sponsor|1
4637407|NCT01953354|7510319|FG000|Overall Study|Disease Exacerbation|1
4637408|NCT01953354|7510320|FG001|Overall Study|Disease Exacerbation|0
4637409|NCT01953601|7510351|FG000|Part 1 (Base Study)|Adverse Event|24
4637410|NCT01953601|7510352|FG001|Part 1 (Base Study)|Adverse Event|37
4637411|NCT01953601|7510353|FG002|Part 1 (Base Study)|Adverse Event|15
4637412|NCT01953601|7510351|FG000|Part 1 (Base Study)|Death|2
4637413|NCT01953601|7510352|FG001|Part 1 (Base Study)|Death|0
4637414|NCT01953601|7510353|FG002|Part 1 (Base Study)|Death|3
4637415|NCT01953601|7510351|FG000|Part 1 (Base Study)|Lack of Efficacy|3
4637416|NCT01953601|7510352|FG001|Part 1 (Base Study)|Lack of Efficacy|1
4637417|NCT01953601|7510353|FG002|Part 1 (Base Study)|Lack of Efficacy|4
4637418|NCT01953601|7510351|FG000|Part 1 (Base Study)|Lost to Follow-up|1
4637419|NCT01953601|7510352|FG001|Part 1 (Base Study)|Lost to Follow-up|3
4637420|NCT01953601|7510353|FG002|Part 1 (Base Study)|Lost to Follow-up|6
4637421|NCT01953601|7510351|FG000|Part 1 (Base Study)|Non-compliance with study drug|0
4637422|NCT01953601|7510352|FG001|Part 1 (Base Study)|Non-compliance with study drug|3
4637423|NCT01953601|7510353|FG002|Part 1 (Base Study)|Non-compliance with study drug|1
4637424|NCT01953601|7510351|FG000|Part 1 (Base Study)|Physician Decision|3
4637425|NCT01953601|7510352|FG001|Part 1 (Base Study)|Physician Decision|7
4637426|NCT01953601|7510353|FG002|Part 1 (Base Study)|Physician Decision|4
4637427|NCT01953601|7510351|FG000|Part 1 (Base Study)|Screen failure|1
4637428|NCT01953601|7510352|FG001|Part 1 (Base Study)|Screen failure|0
4637429|NCT01953601|7510353|FG002|Part 1 (Base Study)|Screen failure|1
4637430|NCT01953601|7510351|FG000|Part 1 (Base Study)|Site discontinued study participation|2
4606067|NCT01655823|7459607|FG001|Overall Study|Lost to Follow-up|1
4606068|NCT01655823|7459608|FG002|Overall Study|Lost to Follow-up|0
4606069|NCT01655823|7459609|FG003|Overall Study|Lost to Follow-up|0
4606070|NCT01655823|7459610|FG004|Overall Study|Lost to Follow-up|1
4606071|NCT01655823|7459606|FG000|Overall Study|Withdrawal by Subject|0
4606072|NCT01655823|7459607|FG001|Overall Study|Withdrawal by Subject|1
4606073|NCT01655823|7459608|FG002|Overall Study|Withdrawal by Subject|0
4606074|NCT01655823|7459609|FG003|Overall Study|Withdrawal by Subject|1
4606075|NCT01655823|7459610|FG004|Overall Study|Withdrawal by Subject|0
4606076|NCT01655901|7459622|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1
4606077|NCT01655901|7459623|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1
4606078|NCT01655901|7459624|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1
4606079|NCT01655901|7459625|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0
4606080|NCT01655901|7459626|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1
4606081|NCT01655901|7459627|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0
4606082|NCT01656161|7459640|FG000|Overall Study|Death|3
4606083|NCT01656161|7459640|FG000|Overall Study|Adverse Event|2
4606084|NCT01656161|7459640|FG000|Overall Study|Protocol Violation|1
4606085|NCT01656161|7459640|FG000|Overall Study|Withdrawal by Subject|1
4606086|NCT01656200|7459656|FG000|Overall Study|Withdrawal by Subject|1
4606087|NCT01656304|7459666|FG000|Overall Study|Ineligible, uncontrolled hypertension|1
4606088|NCT01656395|7459676|FG000|Overall Study|Adverse Event|1
4606089|NCT01656395|7459677|FG001|Overall Study|Adverse Event|14
4606090|NCT01656395|7459678|FG002|Overall Study|Adverse Event|5
4606091|NCT01656395|7459679|FG003|Overall Study|Adverse Event|4
4606092|NCT01656395|7459680|FG004|Overall Study|Adverse Event|5
4606093|NCT01656395|7459681|FG005|Overall Study|Adverse Event|7
4606094|NCT01656395|7459682|FG006|Overall Study|Adverse Event|0
4606095|NCT01656395|7459683|FG007|Overall Study|Adverse Event|0
4606096|NCT01656395|7459676|FG000|Overall Study|Lack of Efficacy|1
4606097|NCT01656395|7459677|FG001|Overall Study|Lack of Efficacy|8
4606098|NCT01656395|7459678|FG002|Overall Study|Lack of Efficacy|6
4606099|NCT01656395|7459679|FG003|Overall Study|Lack of Efficacy|1
4606100|NCT01656395|7459680|FG004|Overall Study|Lack of Efficacy|1
4606101|NCT01656395|7459681|FG005|Overall Study|Lack of Efficacy|6
4606102|NCT01656395|7459682|FG006|Overall Study|Lack of Efficacy|0
4606103|NCT01656395|7459683|FG007|Overall Study|Lack of Efficacy|0
4606104|NCT01656395|7459676|FG000|Overall Study|Lost to Follow-up|1
4606105|NCT01656395|7459677|FG001|Overall Study|Lost to Follow-up|0
4606106|NCT01656395|7459678|FG002|Overall Study|Lost to Follow-up|0
4606107|NCT01656395|7459679|FG003|Overall Study|Lost to Follow-up|0
4606108|NCT01656395|7459680|FG004|Overall Study|Lost to Follow-up|0
4606109|NCT01656395|7459681|FG005|Overall Study|Lost to Follow-up|0
4606110|NCT01656395|7459682|FG006|Overall Study|Lost to Follow-up|0
4606111|NCT01656395|7459683|FG007|Overall Study|Lost to Follow-up|0
4606112|NCT01656395|7459676|FG000|Overall Study|Non-Compliance with Study Drug|1
4606113|NCT01656395|7459677|FG001|Overall Study|Non-Compliance with Study Drug|1
4606114|NCT01656395|7459678|FG002|Overall Study|Non-Compliance with Study Drug|0
4606115|NCT01656395|7459679|FG003|Overall Study|Non-Compliance with Study Drug|0
4606116|NCT01656395|7459680|FG004|Overall Study|Non-Compliance with Study Drug|1
4606117|NCT01656395|7459681|FG005|Overall Study|Non-Compliance with Study Drug|1
4606118|NCT01656395|7459682|FG006|Overall Study|Non-Compliance with Study Drug|0
4606119|NCT01656395|7459683|FG007|Overall Study|Non-Compliance with Study Drug|0
4606120|NCT01656395|7459676|FG000|Overall Study|Other|0
4606121|NCT01656395|7459677|FG001|Overall Study|Other|0
4606122|NCT01656395|7459678|FG002|Overall Study|Other|1
4606123|NCT01656395|7459679|FG003|Overall Study|Other|0
4606124|NCT01656395|7459680|FG004|Overall Study|Other|0
4606125|NCT01656395|7459681|FG005|Overall Study|Other|1
4606126|NCT01656395|7459682|FG006|Overall Study|Other|0
4606127|NCT01656395|7459683|FG007|Overall Study|Other|0
4606128|NCT01656395|7459676|FG000|Overall Study|Physician Decision|2
4606129|NCT01656395|7459677|FG001|Overall Study|Physician Decision|3
4606130|NCT01656395|7459678|FG002|Overall Study|Physician Decision|3
4606131|NCT01656395|7459679|FG003|Overall Study|Physician Decision|2
4606132|NCT01656395|7459680|FG004|Overall Study|Physician Decision|3
4606133|NCT01656395|7459681|FG005|Overall Study|Physician Decision|3
4606134|NCT01656395|7459682|FG006|Overall Study|Physician Decision|0
4606135|NCT01656395|7459683|FG007|Overall Study|Physician Decision|0
4606136|NCT01656395|7459676|FG000|Overall Study|Pregnancy|0
4606137|NCT01656395|7459677|FG001|Overall Study|Pregnancy|0
4606138|NCT01656395|7459678|FG002|Overall Study|Pregnancy|1
4606139|NCT01656395|7459679|FG003|Overall Study|Pregnancy|0
4606140|NCT01656395|7459680|FG004|Overall Study|Pregnancy|0
4606141|NCT01656395|7459681|FG005|Overall Study|Pregnancy|0
4606142|NCT01656395|7459682|FG006|Overall Study|Pregnancy|0
4606143|NCT01656395|7459683|FG007|Overall Study|Pregnancy|0
4606144|NCT01656395|7459676|FG000|Overall Study|Progressive Disease|0
4606145|NCT01656395|7459677|FG001|Overall Study|Progressive Disease|0
4606146|NCT01656395|7459678|FG002|Overall Study|Progressive Disease|0
4606147|NCT01656395|7459679|FG003|Overall Study|Progressive Disease|0
4606148|NCT01656395|7459680|FG004|Overall Study|Progressive Disease|0
4606149|NCT01656395|7459681|FG005|Overall Study|Progressive Disease|1
4606150|NCT01656395|7459682|FG006|Overall Study|Progressive Disease|0
4606151|NCT01656395|7459683|FG007|Overall Study|Progressive Disease|0
4606152|NCT01656395|7459676|FG000|Overall Study|Protocol Violation|6
4606153|NCT01656395|7459677|FG001|Overall Study|Protocol Violation|6
4606154|NCT01656395|7459678|FG002|Overall Study|Protocol Violation|9
4606155|NCT01656395|7459679|FG003|Overall Study|Protocol Violation|2
4606156|NCT01656395|7459680|FG004|Overall Study|Protocol Violation|4
4606157|NCT01656395|7459681|FG005|Overall Study|Protocol Violation|10
4606158|NCT01656395|7459682|FG006|Overall Study|Protocol Violation|0
4606159|NCT01656395|7459683|FG007|Overall Study|Protocol Violation|0
4606160|NCT01656395|7459676|FG000|Overall Study|Screen Failure|2
4606161|NCT01656395|7459677|FG001|Overall Study|Screen Failure|1
4606162|NCT01656395|7459678|FG002|Overall Study|Screen Failure|7
4606163|NCT01656395|7459679|FG003|Overall Study|Screen Failure|1
4637431|NCT01953601|7510352|FG001|Part 1 (Base Study)|Site discontinued study participation|0
4637432|NCT01953601|7510353|FG002|Part 1 (Base Study)|Site discontinued study participation|0
4637433|NCT01953601|7510351|FG000|Part 1 (Base Study)|Study terminated by sponsor|174
4637434|NCT01953601|7510352|FG001|Part 1 (Base Study)|Study terminated by sponsor|169
4637435|NCT01953601|7510353|FG002|Part 1 (Base Study)|Study terminated by sponsor|179
4606164|NCT01656395|7459680|FG004|Overall Study|Screen Failure|0
4606165|NCT01656395|7459681|FG005|Overall Study|Screen Failure|8
4606166|NCT01656395|7459682|FG006|Overall Study|Screen Failure|0
4637436|NCT01953601|7510351|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7
4637437|NCT01953601|7510352|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8
4637438|NCT01953601|7510353|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10
4637439|NCT01953601|7510351|FG000|Part 1 (Base Study)|Subject moved|2
4637440|NCT01953601|7510352|FG001|Part 1 (Base Study)|Subject moved|2
4637441|NCT01953601|7510353|FG002|Part 1 (Base Study)|Subject moved|1
4637442|NCT01953601|7510351|FG000|Part 1 (Base Study)|Withdrawal by Subject|32
4637443|NCT01953601|7510352|FG001|Part 1 (Base Study)|Withdrawal by Subject|23
4637444|NCT01953601|7510353|FG002|Part 1 (Base Study)|Withdrawal by Subject|22
4637445|NCT01953601|7510351|FG000|Part 2 (Extension Study)|Adverse Event|1
4637446|NCT01953601|7510352|FG001|Part 2 (Extension Study)|Adverse Event|1
4637447|NCT01953601|7510353|FG002|Part 2 (Extension Study)|Adverse Event|10
4637448|NCT01953601|7510351|FG000|Part 2 (Extension Study)|Death|0
4637449|NCT01953601|7510352|FG001|Part 2 (Extension Study)|Death|3
4637450|NCT01953601|7510353|FG002|Part 2 (Extension Study)|Death|0
4637451|NCT01953601|7510351|FG000|Part 2 (Extension Study)|Lack of Efficacy|2
4637452|NCT01953601|7510352|FG001|Part 2 (Extension Study)|Lack of Efficacy|0
4637453|NCT01953601|7510353|FG002|Part 2 (Extension Study)|Lack of Efficacy|0
4637454|NCT01953601|7510351|FG000|Part 2 (Extension Study)|Lost to Follow-up|2
4637455|NCT01953601|7510352|FG001|Part 2 (Extension Study)|Lost to Follow-up|1
4637456|NCT01953601|7510353|FG002|Part 2 (Extension Study)|Lost to Follow-up|1
4637457|NCT01953601|7510351|FG000|Part 2 (Extension Study)|Physician Decision|2
4637458|NCT01953601|7510352|FG001|Part 2 (Extension Study)|Physician Decision|0
4637459|NCT01953601|7510353|FG002|Part 2 (Extension Study)|Physician Decision|2
4637460|NCT01953601|7510351|FG000|Part 2 (Extension Study)|Site discontinued study participation|0
4637461|NCT01953601|7510352|FG001|Part 2 (Extension Study)|Site discontinued study participation|1
4637462|NCT01953601|7510353|FG002|Part 2 (Extension Study)|Site discontinued study participation|1
4637463|NCT01953601|7510351|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185
4637464|NCT01953601|7510352|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178
4637465|NCT01953601|7510353|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187
4637466|NCT01953601|7510351|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1
4637467|NCT01953601|7510352|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3
4746866|NCT00491400|7719629|FG000|Overall Study|Withdrawal by Subject|5
4746867|NCT00491400|7719630|FG001|Overall Study|Withdrawal by Subject|4
4746868|NCT00490776|7719638|FG000|Overall Study|Withdrawal by Subject|1
4746869|NCT00490776|7719638|FG000|Overall Study|Administrative Problems|1
4746870|NCT00490776|7719638|FG000|Overall Study|Death|1
4746871|NCT00490776|7719638|FG000|Overall Study|New Cancer Therapy|1
4746872|NCT00490776|7719638|FG000|Overall Study|Disease Progression|5
4746873|NCT00487162|7719644|FG000|Overall Study|Adverse Event|0
4746874|NCT00487162|7719645|FG001|Overall Study|Adverse Event|1
4606167|NCT01656395|7459683|FG007|Overall Study|Screen Failure|0
4606168|NCT01656395|7459676|FG000|Overall Study|Withdrawal by Subject|3
4606169|NCT01656395|7459677|FG001|Overall Study|Withdrawal by Subject|1
4606170|NCT01656395|7459678|FG002|Overall Study|Withdrawal by Subject|4
4606171|NCT01656395|7459679|FG003|Overall Study|Withdrawal by Subject|2
4606172|NCT01656395|7459680|FG004|Overall Study|Withdrawal by Subject|0
4606173|NCT01656395|7459681|FG005|Overall Study|Withdrawal by Subject|3
4606174|NCT01656395|7459682|FG006|Overall Study|Withdrawal by Subject|0
4606175|NCT01656395|7459683|FG007|Overall Study|Withdrawal by Subject|0
4606176|NCT01656408|7459707|FG000|Overall Study|Adverse Event|0
4606177|NCT01656408|7459708|FG001|Overall Study|Adverse Event|0
4606178|NCT01656408|7459709|FG002|Overall Study|Adverse Event|1
4606179|NCT01656408|7459710|FG003|Overall Study|Adverse Event|0
4606180|NCT01656408|7459711|FG004|Overall Study|Adverse Event|0
4606181|NCT01656408|7459712|FG005|Overall Study|Adverse Event|1
4606182|NCT01656408|7459713|FG006|Overall Study|Adverse Event|1
4606183|NCT01656408|7459714|FG007|Overall Study|Adverse Event|0
4606184|NCT01656408|7459715|FG008|Overall Study|Adverse Event|1
4606185|NCT01656408|7459716|FG009|Overall Study|Adverse Event|0
4606186|NCT01656408|7459707|FG000|Overall Study|Physician Decision|1
4606187|NCT01656408|7459708|FG001|Overall Study|Physician Decision|0
4606188|NCT01656408|7459709|FG002|Overall Study|Physician Decision|1
4606189|NCT01656408|7459710|FG003|Overall Study|Physician Decision|0
4606190|NCT01656408|7459711|FG004|Overall Study|Physician Decision|1
4606191|NCT01656408|7459712|FG005|Overall Study|Physician Decision|1
4606192|NCT01656408|7459713|FG006|Overall Study|Physician Decision|0
4606193|NCT01656408|7459714|FG007|Overall Study|Physician Decision|1
4606194|NCT01656408|7459715|FG008|Overall Study|Physician Decision|1
4606195|NCT01656408|7459716|FG009|Overall Study|Physician Decision|3
4637468|NCT01953601|7510353|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0
4637469|NCT01953601|7510351|FG000|Part 2 (Extension Study)|Subject moved|0
4637470|NCT01953601|7510352|FG001|Part 2 (Extension Study)|Subject moved|0
4637471|NCT01953601|7510353|FG002|Part 2 (Extension Study)|Subject moved|1
4637472|NCT01953601|7510351|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5
4637473|NCT01953601|7510352|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4
4637474|NCT01953601|7510353|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2
4637475|NCT01953692|7510373|FG000|Overall Study|Adverse Event|5
4637476|NCT01953692|7510374|FG001|Overall Study|Adverse Event|2
4637477|NCT01953692|7510375|FG002|Overall Study|Adverse Event|4
4637478|NCT01953692|7510376|FG003|Overall Study|Adverse Event|2
4746875|NCT00487162|7719644|FG000|Overall Study|Physician Decision|0
4746876|NCT00487162|7719645|FG001|Overall Study|Physician Decision|1
4746877|NCT00487162|7719644|FG000|Overall Study|Withdrawal by Subject|2
4746878|NCT00487162|7719645|FG001|Overall Study|Withdrawal by Subject|3
4746879|NCT00487981|7719651|FG000|Overall Study|Hypothyroidism diagnosis|1
4746880|NCT00491387|7719655|FG000|Overall Study|study terminated|20
4746881|NCT00483119|7719666|FG000|Overall Study|Adverse Event|0
4746882|NCT00483119|7719667|FG001|Overall Study|Adverse Event|1
4746883|NCT00483119|7719666|FG000|Overall Study|Physician Decision|1
4746884|NCT00483119|7719667|FG001|Overall Study|Physician Decision|0
4606196|NCT01656733|7459794|FG000|Overall Study|No permission to collect birth outcomes|0
4606197|NCT01656733|7459795|FG001|Overall Study|No permission to collect birth outcomes|1
4606198|NCT01656733|7459794|FG000|Overall Study|Delivery at another hospital|0
4606199|NCT01656733|7459795|FG001|Overall Study|Delivery at another hospital|2
4606200|NCT01656733|7459794|FG000|Overall Study|Spontaneous abortion|0
4606201|NCT01656733|7459795|FG001|Overall Study|Spontaneous abortion|1
4606202|NCT01656759|7459803|FG000|Overall Study|Protocol Violation|2
4637479|NCT01953692|7510377|FG004|Overall Study|Adverse Event|1
4637480|NCT01953692|7510378|FG005|Overall Study|Adverse Event|2
4606203|NCT01656759|7459804|FG001|Overall Study|Protocol Violation|3
4606204|NCT01656850|7459821|FG000|First Intervention (3 Months)|Withdrawal by Subject|3
4606205|NCT01656850|7459822|FG001|First Intervention (3 Months)|Withdrawal by Subject|4
4606206|NCT01656889|7459834|FG000|Treatment Period, 12 Weeks|Adverse Event|10
4606207|NCT01656889|7459835|FG001|Treatment Period, 12 Weeks|Adverse Event|4
4606208|NCT01656889|7459834|FG000|Treatment Period, 12 Weeks|Death|0
4606209|NCT01656889|7459835|FG001|Treatment Period, 12 Weeks|Death|1
4606210|NCT01656889|7459834|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1
4606211|NCT01656889|7459835|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1
4606212|NCT01656889|7459834|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1
4606213|NCT01656889|7459835|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2
4606214|NCT01656889|7459834|FG000|Treatment Period, 12 Weeks|Protocol Violation|0
4606215|NCT01656889|7459835|FG001|Treatment Period, 12 Weeks|Protocol Violation|1
4606216|NCT01656889|7459834|FG000|Treatment Period, 12 Weeks|Moved out of the area|0
4606217|NCT01656889|7459835|FG001|Treatment Period, 12 Weeks|Moved out of the area|2
4606218|NCT01656889|7459834|FG000|Post Treatment Follow-Up, 3 Months|Death|1
4606219|NCT01656889|7459835|FG001|Post Treatment Follow-Up, 3 Months|Death|5
4606220|NCT01656889|7459834|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1
4606221|NCT01656889|7459835|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2
4606222|NCT01656889|7459834|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2
4606223|NCT01656889|7459835|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1
4606224|NCT01656889|7459834|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0
4606225|NCT01656889|7459835|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1
4606226|NCT01656967|7459843|FG000|Overall Study|faulty monitor|1
4606227|NCT01656967|7459844|FG001|Overall Study|faulty monitor|0
4606228|NCT01656967|7459843|FG000|Overall Study|unsuccessful ETT insertion|3
4606229|NCT01656967|7459844|FG001|Overall Study|unsuccessful ETT insertion|2
4606230|NCT01657019|7459854|FG000|Overall Study|Withdrawal by Subject|65
4606231|NCT01657019|7459854|FG000|Overall Study|Adverse Event|55
4606232|NCT01657019|7459854|FG000|Overall Study|Lost to Follow-up|48
4606233|NCT01657019|7459854|FG000|Overall Study|Protocol Violation|6
4606234|NCT01657019|7459854|FG000|Overall Study|Lack of Efficacy|3
4606235|NCT01657019|7459854|FG000|Overall Study|Other|58
4606236|NCT01657032|7459860|FG000|Overall Study|Lost to Follow-up|0
4606237|NCT01657032|7459861|FG001|Overall Study|Lost to Follow-up|7
4606238|NCT01657162|7459869|FG000|Overall Study|Adverse Event|26
4606239|NCT01657162|7459870|FG001|Overall Study|Adverse Event|36
4606240|NCT01657162|7459869|FG000|Overall Study|Withdrawal by Subject|13
4606241|NCT01657162|7459870|FG001|Overall Study|Withdrawal by Subject|13
4606242|NCT01657162|7459869|FG000|Overall Study|Continuing Significant Deterioration|9
4606243|NCT01657162|7459870|FG001|Overall Study|Continuing Significant Deterioration|3
4606244|NCT01657162|7459869|FG000|Overall Study|Refusal of Treatment|4
4606245|NCT01657162|7459870|FG001|Overall Study|Refusal of Treatment|6
4606246|NCT01657162|7459869|FG000|Overall Study|Lost to Follow-up|3
4606247|NCT01657162|7459870|FG001|Overall Study|Lost to Follow-up|4
4606248|NCT01657162|7459869|FG000|Overall Study|Death|2
4606249|NCT01657162|7459870|FG001|Overall Study|Death|3
4606250|NCT01657162|7459869|FG000|Overall Study|Inability to Complete Study Procedures|1
4606251|NCT01657162|7459870|FG001|Overall Study|Inability to Complete Study Procedures|7
4606252|NCT01657162|7459869|FG000|Overall Study|Protocol Violation|1
4606253|NCT01657162|7459870|FG001|Overall Study|Protocol Violation|0
4606254|NCT01657162|7459869|FG000|Overall Study|Hypersensitivity to Alendronate|0
4606255|NCT01657162|7459870|FG001|Overall Study|Hypersensitivity to Alendronate|1
4606256|NCT01657162|7459869|FG000|Overall Study|Other than Specified|0
4606257|NCT01657162|7459870|FG001|Overall Study|Other than Specified|2
4606258|NCT01657253|7459878|FG000|Overall Study|Lost to Follow-up|6
4606259|NCT01657253|7459879|FG001|Overall Study|Lost to Follow-up|5
4606260|NCT01657253|7459878|FG000|Overall Study|Withdrawal by Subject|11
4606261|NCT01657253|7459879|FG001|Overall Study|Withdrawal by Subject|12
4606262|NCT01657253|7459878|FG000|Overall Study|Adverse Event|0
4606263|NCT01657253|7459879|FG001|Overall Study|Adverse Event|1
4606264|NCT01657266|7459887|FG000|Overall Study|Lost to Follow-up|2
4606265|NCT01657266|7459888|FG001|Overall Study|Lost to Follow-up|2
4606266|NCT01657266|7459887|FG000|Overall Study|Adverse Event|2
4606267|NCT01657266|7459888|FG001|Overall Study|Adverse Event|3
4606268|NCT01657292|7459894|FG000|Overall Study|Adverse Event|6
4606269|NCT01657292|7459894|FG000|Overall Study|Withdrawal by Subject|2
4606270|NCT01657292|7459894|FG000|Overall Study|Violation of eligibility criteria|1
4606271|NCT01657292|7459894|FG000|Overall Study|Change of therapy|1
4606272|NCT01657305|7459901|FG000|Overall Study|Lack of Wound Closure at Day 28|15
4606273|NCT01657305|7459901|FG000|Overall Study|Withdrawal by Subject|4
4606274|NCT01657305|7459901|FG000|Overall Study|Adverse Event|1
4606275|NCT01657305|7459901|FG000|Overall Study|Lost to Follow-up|1
4606276|NCT01657305|7459901|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4
4606277|NCT01657370|7459963|FG000|Overall Study|Withdrawal by Subject|0
4606278|NCT01657370|7459964|FG001|Overall Study|Withdrawal by Subject|0
4606279|NCT01657370|7459965|FG002|Overall Study|Withdrawal by Subject|1
4606280|NCT01657370|7459966|FG003|Overall Study|Withdrawal by Subject|0
4606281|NCT01657370|7459967|FG004|Overall Study|Withdrawal by Subject|0
4606282|NCT01657370|7459968|FG005|Overall Study|Withdrawal by Subject|1
4606283|NCT01657370|7459963|FG000|Overall Study|Physician Decision|2
4606284|NCT01657370|7459964|FG001|Overall Study|Physician Decision|3
4606285|NCT01657370|7459965|FG002|Overall Study|Physician Decision|1
4606286|NCT01657370|7459966|FG003|Overall Study|Physician Decision|2
4606287|NCT01657370|7459967|FG004|Overall Study|Physician Decision|5
4606288|NCT01657370|7459968|FG005|Overall Study|Physician Decision|0
4606289|NCT01657370|7459963|FG000|Overall Study|Lack of Qualifying Event|1
4606290|NCT01657370|7459964|FG001|Overall Study|Lack of Qualifying Event|0
4606291|NCT01657370|7459965|FG002|Overall Study|Lack of Qualifying Event|3
4606292|NCT01657370|7459966|FG003|Overall Study|Lack of Qualifying Event|2
4637481|NCT01953692|7510379|FG006|Overall Study|Adverse Event|0
4637482|NCT01953692|7510380|FG007|Overall Study|Adverse Event|0
4637483|NCT01953692|7510381|FG008|Overall Study|Adverse Event|0
4637484|NCT01953692|7510373|FG000|Overall Study|Clinical Progression|0
4637485|NCT01953692|7510374|FG001|Overall Study|Clinical Progression|15
4746885|NCT00470067|7719708|FG000|Overall Study|Death|1
4746886|NCT00470067|7719708|FG000|Overall Study|Disease Progression|6
4746887|NCT00475657|7719735|FG000|Overall Study|Death|1
4746888|NCT00475657|7719735|FG000|Overall Study|Sponsor's Decision|3
4746889|NCT00472082|7719739|FG000|Overall Study|Study prematurely terminated|5
4746890|NCT00467753|7719753|FG000|Overall Study|Lost to Follow-up|1
4746891|NCT00467753|7719754|FG001|Overall Study|Lost to Follow-up|2
4746892|NCT00467753|7719753|FG000|Overall Study|Adverse Event|2
4746893|NCT00467753|7719754|FG001|Overall Study|Adverse Event|0
4746894|NCT00456612|7719764|FG000|Overall Study|Withdrawal by Subject|3
4746895|NCT00469612|7719771|FG000|Overall Study|Study terminated before data collected|2
4746896|NCT00469612|7719772|FG001|Overall Study|Study terminated before data collected|0
4746897|NCT00461812|7719778|FG000|Overall Study|study terminated|10
4746898|NCT00461682|7719788|FG000|Overall Study|Protocol Violation|1
4746899|NCT00462904|7719794|FG000|Overall Study|Lost to Follow-up|1
4746900|NCT00450333|7719802|FG000|Overall Study|Study terminated|47
4746901|NCT00450333|7719803|FG001|Overall Study|Study terminated|54
4746902|NCT00450333|7719804|FG002|Overall Study|Study terminated|16
4746903|NCT00450333|7719805|FG003|Overall Study|Study terminated|21
4746904|NCT00450333|7719802|FG000|Overall Study|Adverse Event|1
4746905|NCT00450333|7719803|FG001|Overall Study|Adverse Event|7
4746906|NCT00450333|7719804|FG002|Overall Study|Adverse Event|2
4746907|NCT00450333|7719805|FG003|Overall Study|Adverse Event|2
4746908|NCT00450333|7719802|FG000|Overall Study|Protocol Violation|1
4746909|NCT00450333|7719803|FG001|Overall Study|Protocol Violation|0
4746910|NCT00450333|7719804|FG002|Overall Study|Protocol Violation|1
4746911|NCT00450333|7719805|FG003|Overall Study|Protocol Violation|0
4746912|NCT00450333|7719802|FG000|Overall Study|Withdrawal by Subject|1
4746913|NCT00450333|7719803|FG001|Overall Study|Withdrawal by Subject|0
4746914|NCT00450333|7719804|FG002|Overall Study|Withdrawal by Subject|3
4746915|NCT00450333|7719805|FG003|Overall Study|Withdrawal by Subject|0
4746916|NCT00450333|7719802|FG000|Overall Study|Kidney transplant|1
4746917|NCT00450333|7719803|FG001|Overall Study|Kidney transplant|0
4746918|NCT00450333|7719804|FG002|Overall Study|Kidney transplant|1
4746919|NCT00450333|7719805|FG003|Overall Study|Kidney transplant|3
4746920|NCT00450333|7719802|FG000|Overall Study|Death|3
4746921|NCT00450333|7719803|FG001|Overall Study|Death|2
4746922|NCT00450333|7719804|FG002|Overall Study|Death|2
4746923|NCT00450333|7719805|FG003|Overall Study|Death|2
4746924|NCT00455143|7719815|FG000|Overall Study|Physician Decision|1
4746925|NCT00455143|7719815|FG000|Overall Study|Withdrawal by Subject|1
4746926|NCT00455143|7719815|FG000|Overall Study|Staff was not avail to follow patient|2
4746927|NCT00455143|7719815|FG000|Overall Study|No longer met Inclusion Criteria|1
4746928|NCT00455143|7719815|FG000|Overall Study|Surgical time, staff not available|1
4746929|NCT00454571|7719831|FG000|Overall Study|Adverse Event|2
4746930|NCT00454571|7719832|FG001|Overall Study|Adverse Event|0
4746931|NCT00454571|7719831|FG000|Overall Study|Physician Decision|0
4746932|NCT00454571|7719832|FG001|Overall Study|Physician Decision|1
4746933|NCT00454571|7719831|FG000|Overall Study|Protocol Violation|1
4746934|NCT00454571|7719832|FG001|Overall Study|Protocol Violation|0
4746935|NCT00454571|7719831|FG000|Overall Study|Withdrawal by Subject|10
4746936|NCT00454571|7719832|FG001|Overall Study|Withdrawal by Subject|5
4606293|NCT01657370|7459967|FG004|Overall Study|Lack of Qualifying Event|1
4746937|NCT00452361|7719840|FG000|Overall Study|Adverse Event|8
4606294|NCT01657370|7459968|FG005|Overall Study|Lack of Qualifying Event|2
4606295|NCT01657370|7459963|FG000|Overall Study|Adverse Event|0
4606296|NCT01657370|7459964|FG001|Overall Study|Adverse Event|0
4606297|NCT01657370|7459965|FG002|Overall Study|Adverse Event|0
4606298|NCT01657370|7459966|FG003|Overall Study|Adverse Event|0
4606299|NCT01657370|7459967|FG004|Overall Study|Adverse Event|1
4606300|NCT01657370|7459968|FG005|Overall Study|Adverse Event|0
4606301|NCT01657370|7459963|FG000|Overall Study|Protocol Violation|1
4606302|NCT01657370|7459964|FG001|Overall Study|Protocol Violation|1
4606303|NCT01657370|7459965|FG002|Overall Study|Protocol Violation|1
4606304|NCT01657370|7459966|FG003|Overall Study|Protocol Violation|1
4606305|NCT01657370|7459967|FG004|Overall Study|Protocol Violation|0
4606306|NCT01657370|7459968|FG005|Overall Study|Protocol Violation|0
4606307|NCT01657370|7459963|FG000|Overall Study|Lost to Follow-up|2
4606308|NCT01657370|7459964|FG001|Overall Study|Lost to Follow-up|0
4606309|NCT01657370|7459965|FG002|Overall Study|Lost to Follow-up|1
4606310|NCT01657370|7459966|FG003|Overall Study|Lost to Follow-up|0
4606311|NCT01657370|7459967|FG004|Overall Study|Lost to Follow-up|0
4606312|NCT01657370|7459968|FG005|Overall Study|Lost to Follow-up|1
4606313|NCT01657461|7459989|FG000|Overall Study|Death|9
4637486|NCT01953692|7510375|FG002|Overall Study|Clinical Progression|7
4606314|NCT01657461|7459990|FG001|Overall Study|Death|12
4606315|NCT01657461|7459989|FG000|Overall Study|Lost to Follow-up|0
4606316|NCT01657461|7459990|FG001|Overall Study|Lost to Follow-up|3
4606317|NCT01657461|7459989|FG000|Overall Study|Physician Decision|0
4606318|NCT01657461|7459990|FG001|Overall Study|Physician Decision|2
4606319|NCT01657461|7459989|FG000|Overall Study|Withdrawal by Subject|1
4606320|NCT01657461|7459990|FG001|Overall Study|Withdrawal by Subject|3
4606321|NCT01657760|7460002|FG000|Overall Study|Withdrawal by Subject|0
4606322|NCT01657760|7460003|FG001|Overall Study|Withdrawal by Subject|0
4606323|NCT01657760|7460004|FG002|Overall Study|Withdrawal by Subject|0
4606324|NCT01657760|7460005|FG003|Overall Study|Withdrawal by Subject|1
4606325|NCT01657760|7460002|FG000|Overall Study|Physician Decision|1
4606326|NCT01657760|7460003|FG001|Overall Study|Physician Decision|1
4606327|NCT01657760|7460004|FG002|Overall Study|Physician Decision|1
4606328|NCT01657760|7460005|FG003|Overall Study|Physician Decision|2
4606329|NCT01657799|7460020|FG000|Overall Study|Adverse Event Related to progression|6
4606330|NCT01657799|7460021|FG001|Overall Study|Adverse Event Related to progression|8
4606331|NCT01657799|7460022|FG002|Overall Study|Adverse Event Related to progression|12
4606332|NCT01657799|7460020|FG000|Overall Study|Adverse Event Not Related to Progression|5
4606333|NCT01657799|7460021|FG001|Overall Study|Adverse Event Not Related to Progression|4
4606334|NCT01657799|7460022|FG002|Overall Study|Adverse Event Not Related to Progression|4
4606335|NCT01657799|7460020|FG000|Overall Study|Withdrawal by Subject|13
4606336|NCT01657799|7460021|FG001|Overall Study|Withdrawal by Subject|10
4606337|NCT01657799|7460022|FG002|Overall Study|Withdrawal by Subject|10
4606338|NCT01657799|7460020|FG000|Overall Study|Lost to Follow-up|1
4606339|NCT01657799|7460021|FG001|Overall Study|Lost to Follow-up|0
4606340|NCT01657799|7460022|FG002|Overall Study|Lost to Follow-up|1
4606341|NCT01657799|7460020|FG000|Overall Study|Disease Progression|2
4606342|NCT01657799|7460021|FG001|Overall Study|Disease Progression|4
4606343|NCT01657799|7460022|FG002|Overall Study|Disease Progression|4
4606344|NCT01657799|7460020|FG000|Overall Study|Progressive Disease Clinical|7
4606345|NCT01657799|7460021|FG001|Overall Study|Progressive Disease Clinical|4
4606346|NCT01657799|7460022|FG002|Overall Study|Progressive Disease Clinical|7
4606347|NCT01657799|7460020|FG000|Overall Study|Radiographic & Clinical Progression|16
4606348|NCT01657799|7460021|FG001|Overall Study|Radiographic & Clinical Progression|11
4606349|NCT01657799|7460022|FG002|Overall Study|Radiographic & Clinical Progression|15
4606350|NCT01657799|7460020|FG000|Overall Study|Other|52
4606351|NCT01657799|7460021|FG001|Overall Study|Other|62
4606352|NCT01657799|7460022|FG002|Overall Study|Other|49
4606353|NCT01657877|7460030|FG000|Overall Study|Withdrawal by Subject|4
4606354|NCT01657877|7460030|FG000|Overall Study|Protocol Violation|6
4606355|NCT01657877|7460030|FG000|Overall Study|Adverse Event|2
4606356|NCT01657877|7460030|FG000|Overall Study|Other Reason|2
4606357|NCT01657903|7460047|FG000|Overall Study|Lost to Follow-up|1
4606358|NCT01657903|7460047|FG000|Overall Study|Withdrawal by Subject|1
4606359|NCT01658020|7460060|FG000|Overall Study|Adverse Event|3
4606360|NCT01658020|7460061|FG001|Overall Study|Adverse Event|3
4606361|NCT01658020|7460060|FG000|Overall Study|Lost to Follow-up|1
4606362|NCT01658020|7460061|FG001|Overall Study|Lost to Follow-up|0
4606363|NCT01658020|7460060|FG000|Overall Study|Withdrawal by Subject|4
4606364|NCT01658020|7460061|FG001|Overall Study|Withdrawal by Subject|5
4606365|NCT01658020|7460060|FG000|Overall Study|Protocol Violation|0
4606366|NCT01658020|7460061|FG001|Overall Study|Protocol Violation|1
4606367|NCT01658072|7460077|FG000|Overall Study|Protocol Violation|4
4606368|NCT01658072|7460078|FG001|Overall Study|Protocol Violation|2
4606369|NCT01658150|7460084|FG000|Overall Study|Withdrawal by Subject|1
4606370|NCT01658436|7460098|FG000|Overall Study|Adverse Event|6
4606371|NCT01658436|7460099|FG001|Overall Study|Adverse Event|5
4606372|NCT01658436|7460098|FG000|Overall Study|Physician Decision|1
4606373|NCT01658436|7460099|FG001|Overall Study|Physician Decision|0
4606374|NCT01658436|7460098|FG000|Overall Study|Progressive disease|12
4606375|NCT01658436|7460099|FG001|Overall Study|Progressive disease|4
4606376|NCT01658436|7460098|FG000|Overall Study|Study terminated by sponsor|0
4606377|NCT01658436|7460099|FG001|Overall Study|Study terminated by sponsor|1
4606378|NCT01658436|7460098|FG000|Overall Study|Subject/guardian decision|0
4606379|NCT01658436|7460099|FG001|Overall Study|Subject/guardian decision|1
4606380|NCT01658436|7460098|FG000|Overall Study|Death|1
4606381|NCT01658436|7460099|FG001|Overall Study|Death|0
4606382|NCT01658514|7460108|FG000|Overall Study|Protocol Violation|1
4746938|NCT00452361|7719841|FG001|Overall Study|Adverse Event|0
4606383|NCT01658514|7460109|FG001|Overall Study|Protocol Violation|0
4606384|NCT01658514|7460110|FG002|Overall Study|Protocol Violation|2
4606385|NCT01658579|7460121|FG000|Treatment Period A|Other|0
4606386|NCT01658579|7460122|FG001|Treatment Period A|Other|0
4606387|NCT01658579|7460123|FG002|Treatment Period A|Other|1
4606388|NCT01658579|7460124|FG003|Treatment Period A|Other|1
4606389|NCT01658579|7460121|FG000|Treatment Period A|Adverse Event|1
4606390|NCT01658579|7460122|FG001|Treatment Period A|Adverse Event|0
4606391|NCT01658579|7460123|FG002|Treatment Period A|Adverse Event|0
4606392|NCT01658579|7460124|FG003|Treatment Period A|Adverse Event|0
4606393|NCT01658579|7460121|FG000|Treatment Period B|Other|0
4606394|NCT01658579|7460122|FG001|Treatment Period B|Other|0
4606395|NCT01658579|7460123|FG002|Treatment Period B|Other|0
4746939|NCT00452361|7719840|FG000|Overall Study|Withdrawal by Subject|0
4606396|NCT01658579|7460124|FG003|Treatment Period B|Other|1
4606397|NCT01658735|7460142|FG000|Overall Study|Lack of Efficacy|1
4606398|NCT01658735|7460143|FG001|Overall Study|Lack of Efficacy|0
4606399|NCT01658735|7460144|FG002|Overall Study|Lack of Efficacy|1
4606400|NCT01658735|7460142|FG000|Overall Study|Lost to Follow-up|1
4606401|NCT01658735|7460143|FG001|Overall Study|Lost to Follow-up|1
4606402|NCT01658735|7460144|FG002|Overall Study|Lost to Follow-up|0
4606403|NCT01658735|7460142|FG000|Overall Study|Protocol Violation|0
4606404|NCT01658735|7460143|FG001|Overall Study|Protocol Violation|1
4606405|NCT01658735|7460144|FG002|Overall Study|Protocol Violation|0
4606406|NCT01658735|7460142|FG000|Overall Study|Withdrawal by Subject|3
4606407|NCT01658735|7460143|FG001|Overall Study|Withdrawal by Subject|5
4606408|NCT01658735|7460144|FG002|Overall Study|Withdrawal by Subject|3
4606409|NCT01658904|7460159|FG000|Overall Study|Principal Investigator discretion|2
4606410|NCT01658904|7460160|FG001|Overall Study|Principal Investigator discretion|0
4606411|NCT01658904|7460161|FG002|Overall Study|Principal Investigator discretion|0
4606412|NCT01658943|7460174|FG000|Overall Study|Adverse Event|6
4606413|NCT01658943|7460175|FG001|Overall Study|Adverse Event|13
4606414|NCT01658943|7460174|FG000|Overall Study|Withdrawal by Subject|9
4606415|NCT01658943|7460175|FG001|Overall Study|Withdrawal by Subject|2
4606416|NCT01658943|7460174|FG000|Overall Study|Progression/Relapse|39
4606417|NCT01658943|7460175|FG001|Overall Study|Progression/Relapse|40
4606418|NCT01658943|7460174|FG000|Overall Study|Death|4
4606419|NCT01658943|7460175|FG001|Overall Study|Death|2
4606420|NCT01658943|7460174|FG000|Overall Study|not protocol specified|4
4606421|NCT01658943|7460175|FG001|Overall Study|not protocol specified|1
4606422|NCT01658943|7460174|FG000|Overall Study|Not eligible|7
4606423|NCT01658943|7460175|FG001|Overall Study|Not eligible|9
4606424|NCT01658943|7460174|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1
4606425|NCT01658943|7460175|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0
4606426|NCT01659021|7460192|FG000|Main Study|Adverse Event|2
4606427|NCT01659021|7460193|FG001|Main Study|Adverse Event|3
4606428|NCT01659021|7460192|FG000|Main Study|Lost to Follow-up|1
4606429|NCT01659021|7460193|FG001|Main Study|Lost to Follow-up|0
4606430|NCT01659021|7460192|FG000|Main Study|Unknown Reasons|2
4606431|NCT01659021|7460193|FG001|Main Study|Unknown Reasons|1
4606432|NCT01659021|7460192|FG000|Main Study|Physician Decision|34
4606433|NCT01659021|7460193|FG001|Main Study|Physician Decision|16
4606434|NCT01659021|7460192|FG000|Main Study|Withdrawal by Subject|19
4606435|NCT01659021|7460193|FG001|Main Study|Withdrawal by Subject|16
4606436|NCT01659021|7460192|FG000|Main Study|Study Terminated by Sponsor|16
4606437|NCT01659021|7460193|FG001|Main Study|Study Terminated by Sponsor|1
4606438|NCT01659021|7460192|FG000|Long-Term Follow Up|Lost to Follow-up|3
4606439|NCT01659021|7460193|FG001|Long-Term Follow Up|Lost to Follow-up|3
4606440|NCT01659021|7460192|FG000|Long-Term Follow Up|Withdrawal by Subject|2
4606441|NCT01659021|7460193|FG001|Long-Term Follow Up|Withdrawal by Subject|1
4606442|NCT01659125|7460203|FG000|Overall Study|Withdrawal by Subject|2
4606443|NCT01659125|7460203|FG000|Overall Study|Lost to Follow-up|7
4606444|NCT01659125|7460203|FG000|Overall Study|Technical Problem|1
4606445|NCT01659125|7460203|FG000|Overall Study|Time Constraints|2
4606446|NCT01659125|7460203|FG000|Overall Study|Failed to Start Treatment|2
4606447|NCT01659255|7460224|FG000|Overall Study|Adverse Event|0
4606448|NCT01659255|7460225|FG001|Overall Study|Adverse Event|0
4606449|NCT01659255|7460226|FG002|Overall Study|Adverse Event|0
4606450|NCT01659255|7460227|FG003|Overall Study|Adverse Event|0
4606451|NCT01659255|7460228|FG004|Overall Study|Adverse Event|0
4606452|NCT01659255|7460229|FG005|Overall Study|Adverse Event|1
4606453|NCT01659255|7460230|FG006|Overall Study|Adverse Event|1
4606454|NCT01659255|7460231|FG007|Overall Study|Adverse Event|0
4606455|NCT01659255|7460232|FG008|Overall Study|Adverse Event|0
4606456|NCT01659255|7460233|FG009|Overall Study|Adverse Event|1
4606457|NCT01659255|7460234|FG010|Overall Study|Adverse Event|0
4606458|NCT01659255|7460235|FG011|Overall Study|Adverse Event|1
4606459|NCT01659255|7460236|FG012|Overall Study|Adverse Event|0
4606460|NCT01659255|7460237|FG013|Overall Study|Adverse Event|2
4606461|NCT01659255|7460238|FG014|Overall Study|Adverse Event|0
4606462|NCT01659255|7460239|FG015|Overall Study|Adverse Event|1
4606463|NCT01659255|7460240|FG016|Overall Study|Adverse Event|0
4606464|NCT01659255|7460224|FG000|Overall Study|Death|0
4606465|NCT01659255|7460225|FG001|Overall Study|Death|1
4606466|NCT01659255|7460226|FG002|Overall Study|Death|0
4606467|NCT01659255|7460227|FG003|Overall Study|Death|0
4606468|NCT01659255|7460228|FG004|Overall Study|Death|0
4606469|NCT01659255|7460229|FG005|Overall Study|Death|0
4606470|NCT01659255|7460230|FG006|Overall Study|Death|0
4606471|NCT01659255|7460231|FG007|Overall Study|Death|1
4606472|NCT01659255|7460232|FG008|Overall Study|Death|1
4606473|NCT01659255|7460233|FG009|Overall Study|Death|0
4606474|NCT01659255|7460234|FG010|Overall Study|Death|0
4606475|NCT01659255|7460235|FG011|Overall Study|Death|0
4606476|NCT01659255|7460236|FG012|Overall Study|Death|1
4606477|NCT01659255|7460237|FG013|Overall Study|Death|1
4606478|NCT01659255|7460238|FG014|Overall Study|Death|2
4606479|NCT01659255|7460239|FG015|Overall Study|Death|1
4606480|NCT01659255|7460240|FG016|Overall Study|Death|0
4606481|NCT01659255|7460224|FG000|Overall Study|Progressive Disease|2
4606482|NCT01659255|7460225|FG001|Overall Study|Progressive Disease|0
4606483|NCT01659255|7460226|FG002|Overall Study|Progressive Disease|0
4606484|NCT01659255|7460227|FG003|Overall Study|Progressive Disease|0
4606485|NCT01659255|7460228|FG004|Overall Study|Progressive Disease|0
4606486|NCT01659255|7460229|FG005|Overall Study|Progressive Disease|0
4606487|NCT01659255|7460230|FG006|Overall Study|Progressive Disease|0
4606488|NCT01659255|7460231|FG007|Overall Study|Progressive Disease|1
4606489|NCT01659255|7460232|FG008|Overall Study|Progressive Disease|0
4606490|NCT01659255|7460233|FG009|Overall Study|Progressive Disease|2
4606491|NCT01659255|7460234|FG010|Overall Study|Progressive Disease|2
4606492|NCT01659255|7460235|FG011|Overall Study|Progressive Disease|3
4606493|NCT01659255|7460236|FG012|Overall Study|Progressive Disease|5
4606494|NCT01659255|7460237|FG013|Overall Study|Progressive Disease|13
4606495|NCT01659255|7460238|FG014|Overall Study|Progressive Disease|6
4606496|NCT01659255|7460239|FG015|Overall Study|Progressive Disease|2
4606497|NCT01659255|7460240|FG016|Overall Study|Progressive Disease|3
4606498|NCT01659255|7460224|FG000|Overall Study|Withdrew Consent|0
4606499|NCT01659255|7460225|FG001|Overall Study|Withdrew Consent|0
4606500|NCT01659255|7460226|FG002|Overall Study|Withdrew Consent|0
4606501|NCT01659255|7460227|FG003|Overall Study|Withdrew Consent|0
4606502|NCT01659255|7460228|FG004|Overall Study|Withdrew Consent|0
4606503|NCT01659255|7460229|FG005|Overall Study|Withdrew Consent|0
4606504|NCT01659255|7460230|FG006|Overall Study|Withdrew Consent|0
4606505|NCT01659255|7460231|FG007|Overall Study|Withdrew Consent|0
4606506|NCT01659255|7460232|FG008|Overall Study|Withdrew Consent|0
4606507|NCT01659255|7460233|FG009|Overall Study|Withdrew Consent|0
4606508|NCT01659255|7460234|FG010|Overall Study|Withdrew Consent|1
4606509|NCT01659255|7460235|FG011|Overall Study|Withdrew Consent|0
4606510|NCT01659255|7460236|FG012|Overall Study|Withdrew Consent|0
4606511|NCT01659255|7460237|FG013|Overall Study|Withdrew Consent|1
4606512|NCT01659255|7460238|FG014|Overall Study|Withdrew Consent|0
4606513|NCT01659255|7460239|FG015|Overall Study|Withdrew Consent|0
4606514|NCT01659255|7460240|FG016|Overall Study|Withdrew Consent|0
4606515|NCT01659255|7460224|FG000|Overall Study|Investigator Decision|0
4606516|NCT01659255|7460225|FG001|Overall Study|Investigator Decision|0
4606517|NCT01659255|7460226|FG002|Overall Study|Investigator Decision|0
4606518|NCT01659255|7460227|FG003|Overall Study|Investigator Decision|0
4606519|NCT01659255|7460228|FG004|Overall Study|Investigator Decision|0
4606520|NCT01659255|7460229|FG005|Overall Study|Investigator Decision|0
4606521|NCT01659255|7460230|FG006|Overall Study|Investigator Decision|0
4606522|NCT01659255|7460231|FG007|Overall Study|Investigator Decision|0
4606523|NCT01659255|7460232|FG008|Overall Study|Investigator Decision|0
4606524|NCT01659255|7460233|FG009|Overall Study|Investigator Decision|0
4606525|NCT01659255|7460234|FG010|Overall Study|Investigator Decision|0
4606526|NCT01659255|7460235|FG011|Overall Study|Investigator Decision|0
4606527|NCT01659255|7460236|FG012|Overall Study|Investigator Decision|1
4606528|NCT01659255|7460237|FG013|Overall Study|Investigator Decision|1
4606529|NCT01659255|7460238|FG014|Overall Study|Investigator Decision|0
4606530|NCT01659255|7460239|FG015|Overall Study|Investigator Decision|0
4606531|NCT01659255|7460240|FG016|Overall Study|Investigator Decision|0
4606532|NCT01659255|7460224|FG000|Overall Study|Sponsor's Decision|0
4606533|NCT01659255|7460225|FG001|Overall Study|Sponsor's Decision|0
4606534|NCT01659255|7460226|FG002|Overall Study|Sponsor's Decision|0
4606535|NCT01659255|7460227|FG003|Overall Study|Sponsor's Decision|0
4606536|NCT01659255|7460228|FG004|Overall Study|Sponsor's Decision|0
4606537|NCT01659255|7460229|FG005|Overall Study|Sponsor's Decision|0
4606538|NCT01659255|7460230|FG006|Overall Study|Sponsor's Decision|1
4606539|NCT01659255|7460231|FG007|Overall Study|Sponsor's Decision|0
4606540|NCT01659255|7460232|FG008|Overall Study|Sponsor's Decision|0
4606541|NCT01659255|7460233|FG009|Overall Study|Sponsor's Decision|0
4606542|NCT01659255|7460234|FG010|Overall Study|Sponsor's Decision|0
4606543|NCT01659255|7460235|FG011|Overall Study|Sponsor's Decision|0
4606544|NCT01659255|7460236|FG012|Overall Study|Sponsor's Decision|0
4606545|NCT01659255|7460237|FG013|Overall Study|Sponsor's Decision|0
4606546|NCT01659255|7460238|FG014|Overall Study|Sponsor's Decision|0
4606547|NCT01659255|7460239|FG015|Overall Study|Sponsor's Decision|0
4606548|NCT01659255|7460240|FG016|Overall Study|Sponsor's Decision|0
4606549|NCT01659255|7460224|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0
4606550|NCT01659255|7460225|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0
4606551|NCT01659255|7460226|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0
4606552|NCT01659255|7460227|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0
4606553|NCT01659255|7460228|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0
4606554|NCT01659255|7460229|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0
4606555|NCT01659255|7460230|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0
4606556|NCT01659255|7460231|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0
4606557|NCT01659255|7460232|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0
4606558|NCT01659255|7460233|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0
4606559|NCT01659255|7460234|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0
4606560|NCT01659255|7460235|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0
4606561|NCT01659255|7460236|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0
4606562|NCT01659255|7460237|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0
4606563|NCT01659255|7460238|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0
4606564|NCT01659255|7460239|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1
4606565|NCT01659255|7460240|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0
4606566|NCT01659255|7460224|FG000|Overall Study|Participant Went on to Have an Allograft|0
4606567|NCT01659255|7460225|FG001|Overall Study|Participant Went on to Have an Allograft|0
4606568|NCT01659255|7460226|FG002|Overall Study|Participant Went on to Have an Allograft|0
4606569|NCT01659255|7460227|FG003|Overall Study|Participant Went on to Have an Allograft|0
4637487|NCT01953692|7510376|FG003|Overall Study|Clinical Progression|5
4637488|NCT01953692|7510377|FG004|Overall Study|Clinical Progression|0
4637489|NCT01953692|7510378|FG005|Overall Study|Clinical Progression|7
4637490|NCT01953692|7510379|FG006|Overall Study|Clinical Progression|20
4637491|NCT01953692|7510380|FG007|Overall Study|Clinical Progression|3
4637492|NCT01953692|7510381|FG008|Overall Study|Clinical Progression|3
4637493|NCT01953692|7510373|FG000|Overall Study|Death|5
4637494|NCT01953692|7510374|FG001|Overall Study|Death|0
4637495|NCT01953692|7510375|FG002|Overall Study|Death|2
4637496|NCT01953692|7510376|FG003|Overall Study|Death|2
4637497|NCT01953692|7510377|FG004|Overall Study|Death|1
4637498|NCT01953692|7510378|FG005|Overall Study|Death|3
4637499|NCT01953692|7510379|FG006|Overall Study|Death|6
4637500|NCT01953692|7510380|FG007|Overall Study|Death|2
4637501|NCT01953692|7510381|FG008|Overall Study|Death|1
4637502|NCT01953692|7510373|FG000|Overall Study|Excluded Medication|1
4637503|NCT01953692|7510374|FG001|Overall Study|Excluded Medication|0
4637504|NCT01953692|7510375|FG002|Overall Study|Excluded Medication|0
4637505|NCT01953692|7510376|FG003|Overall Study|Excluded Medication|0
4637506|NCT01953692|7510377|FG004|Overall Study|Excluded Medication|0
4637507|NCT01953692|7510378|FG005|Overall Study|Excluded Medication|0
4637508|NCT01953692|7510379|FG006|Overall Study|Excluded Medication|0
4637509|NCT01953692|7510380|FG007|Overall Study|Excluded Medication|0
4637510|NCT01953692|7510381|FG008|Overall Study|Excluded Medication|0
4637511|NCT01953692|7510373|FG000|Overall Study|Lost to Follow-up|1
4637512|NCT01953692|7510374|FG001|Overall Study|Lost to Follow-up|0
4637513|NCT01953692|7510375|FG002|Overall Study|Lost to Follow-up|3
4637514|NCT01953692|7510376|FG003|Overall Study|Lost to Follow-up|1
4637515|NCT01953692|7510377|FG004|Overall Study|Lost to Follow-up|0
4637516|NCT01953692|7510378|FG005|Overall Study|Lost to Follow-up|1
4637517|NCT01953692|7510379|FG006|Overall Study|Lost to Follow-up|0
4637518|NCT01953692|7510380|FG007|Overall Study|Lost to Follow-up|0
4637519|NCT01953692|7510381|FG008|Overall Study|Lost to Follow-up|0
4637520|NCT01953692|7510373|FG000|Overall Study|Physician Decision|11
4637521|NCT01953692|7510374|FG001|Overall Study|Physician Decision|4
4637522|NCT01953692|7510375|FG002|Overall Study|Physician Decision|2
4637523|NCT01953692|7510376|FG003|Overall Study|Physician Decision|2
4637524|NCT01953692|7510377|FG004|Overall Study|Physician Decision|1
4637525|NCT01953692|7510378|FG005|Overall Study|Physician Decision|2
4637526|NCT01953692|7510379|FG006|Overall Study|Physician Decision|4
4637527|NCT01953692|7510380|FG007|Overall Study|Physician Decision|1
4637528|NCT01953692|7510381|FG008|Overall Study|Physician Decision|0
4637529|NCT01953692|7510373|FG000|Overall Study|Protocol Violation|0
4637530|NCT01953692|7510374|FG001|Overall Study|Protocol Violation|2
4637531|NCT01953692|7510375|FG002|Overall Study|Protocol Violation|1
4637532|NCT01953692|7510376|FG003|Overall Study|Protocol Violation|0
4637533|NCT01953692|7510377|FG004|Overall Study|Protocol Violation|0
4637534|NCT01953692|7510378|FG005|Overall Study|Protocol Violation|0
4637535|NCT01953692|7510379|FG006|Overall Study|Protocol Violation|0
4637536|NCT01953692|7510380|FG007|Overall Study|Protocol Violation|1
4637537|NCT01953692|7510381|FG008|Overall Study|Protocol Violation|0
4637538|NCT01953692|7510373|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0
4637539|NCT01953692|7510374|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0
4637540|NCT01953692|7510375|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0
4637541|NCT01953692|7510376|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0
4637542|NCT01953692|7510377|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0
4637543|NCT01953692|7510378|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0
4637544|NCT01953692|7510379|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0
4637545|NCT01953692|7510380|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2
4637546|NCT01953692|7510381|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0
4637547|NCT01953692|7510373|FG000|Overall Study|Withdrawal by Subject|4
4637548|NCT01953692|7510374|FG001|Overall Study|Withdrawal by Subject|2
4637549|NCT01953692|7510375|FG002|Overall Study|Withdrawal by Subject|1
4637550|NCT01953692|7510376|FG003|Overall Study|Withdrawal by Subject|2
4637551|NCT01953692|7510377|FG004|Overall Study|Withdrawal by Subject|0
4637552|NCT01953692|7510378|FG005|Overall Study|Withdrawal by Subject|3
4637553|NCT01953692|7510379|FG006|Overall Study|Withdrawal by Subject|2
4637554|NCT01953692|7510380|FG007|Overall Study|Withdrawal by Subject|1
4637555|NCT01953692|7510381|FG008|Overall Study|Withdrawal by Subject|1
4637556|NCT01953783|7510411|FG000|Overall Study|Progressive disease|2
4637557|NCT01953913|7510425|FG000|Overall Study|Disease Progression|349
4746940|NCT00452361|7719841|FG001|Overall Study|Withdrawal by Subject|1
4637558|NCT01953913|7510425|FG000|Overall Study|Worsening of underlying cancer|22
4637559|NCT01953913|7510425|FG000|Overall Study|Adverse Event|20
4637560|NCT01953913|7510425|FG000|Overall Study|Protocol Violation|6
4746941|NCT00452361|7719840|FG000|Overall Study|Premature termination|13
4606570|NCT01659255|7460228|FG004|Overall Study|Participant Went on to Have an Allograft|0
4606571|NCT01659255|7460229|FG005|Overall Study|Participant Went on to Have an Allograft|0
4606572|NCT01659255|7460230|FG006|Overall Study|Participant Went on to Have an Allograft|0
4606573|NCT01659255|7460231|FG007|Overall Study|Participant Went on to Have an Allograft|0
4606574|NCT01659255|7460232|FG008|Overall Study|Participant Went on to Have an Allograft|0
4606575|NCT01659255|7460233|FG009|Overall Study|Participant Went on to Have an Allograft|0
4606576|NCT01659255|7460234|FG010|Overall Study|Participant Went on to Have an Allograft|0
4606577|NCT01659255|7460235|FG011|Overall Study|Participant Went on to Have an Allograft|0
4606578|NCT01659255|7460236|FG012|Overall Study|Participant Went on to Have an Allograft|1
4606579|NCT01659255|7460237|FG013|Overall Study|Participant Went on to Have an Allograft|0
4606580|NCT01659255|7460238|FG014|Overall Study|Participant Went on to Have an Allograft|0
4606581|NCT01659255|7460239|FG015|Overall Study|Participant Went on to Have an Allograft|0
4606582|NCT01659255|7460240|FG016|Overall Study|Participant Went on to Have an Allograft|0
4606583|NCT01659320|7460287|FG000|Overall Study|Withdrawal by Subject|2
4606584|NCT01659320|7460287|FG000|Overall Study|Physician Decision|1
4606585|NCT01659567|7460291|FG000|Overall Study|Lack of Efficacy|22
4606586|NCT01659567|7460291|FG000|Overall Study|Switched to Pegferon|6
4606587|NCT01659567|7460291|FG000|Overall Study|Adverse Event|12
4606588|NCT01659567|7460291|FG000|Overall Study|Good result at early stage of treatment|5
4637561|NCT01953913|7510425|FG000|Overall Study|Lost to Follow-up|4
4637562|NCT01953913|7510425|FG000|Overall Study|Withdrawal by Subject|32
4637563|NCT01953913|7510425|FG000|Overall Study|Other than listed|108
4637564|NCT01953913|7510425|FG000|Overall Study|Not Treated|1
4637565|NCT01954017|7510432|FG000|Overall Study|Adverse Event|0
4637566|NCT01954017|7510433|FG001|Overall Study|Adverse Event|0
4637567|NCT01954017|7510434|FG002|Overall Study|Adverse Event|1
4637568|NCT01954017|7510432|FG000|Overall Study|Death|2
4637569|NCT01954017|7510433|FG001|Overall Study|Death|1
4637570|NCT01954017|7510434|FG002|Overall Study|Death|1
4637571|NCT01954017|7510432|FG000|Overall Study|Withdrawal by Subject|0
4637572|NCT01954017|7510433|FG001|Overall Study|Withdrawal by Subject|1
4637573|NCT01954017|7510434|FG002|Overall Study|Withdrawal by Subject|0
4637574|NCT01954017|7510432|FG000|Overall Study|Protocol Violation|0
4637575|NCT01954017|7510433|FG001|Overall Study|Protocol Violation|3
4637576|NCT01954017|7510434|FG002|Overall Study|Protocol Violation|2
4637577|NCT01954017|7510432|FG000|Overall Study|Necrotizing enterocolitis|1
4637578|NCT01954017|7510433|FG001|Overall Study|Necrotizing enterocolitis|0
4637579|NCT01954017|7510434|FG002|Overall Study|Necrotizing enterocolitis|1
4637580|NCT01954017|7510432|FG000|Overall Study|Enteral intake stopped >7 days|0
4637581|NCT01954017|7510433|FG001|Overall Study|Enteral intake stopped >7 days|1
4637582|NCT01954017|7510434|FG002|Overall Study|Enteral intake stopped >7 days|1
4637583|NCT01954017|7510432|FG000|Overall Study|All other reasons|2
4637584|NCT01954017|7510433|FG001|Overall Study|All other reasons|2
4637585|NCT01954017|7510434|FG002|Overall Study|All other reasons|7
4637586|NCT01954056|7510470|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1
4637587|NCT01954056|7510471|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0
4637588|NCT01954082|7510479|FG000|Overall Study|Study Suspension|42
4637589|NCT01954082|7510480|FG001|Overall Study|Study Suspension|36
4637590|NCT01954082|7510479|FG000|Overall Study|Adverse Event|10
4637591|NCT01954082|7510480|FG001|Overall Study|Adverse Event|4
4637592|NCT01954082|7510479|FG000|Overall Study|Intolerance|0
4637593|NCT01954082|7510480|FG001|Overall Study|Intolerance|1
4637594|NCT01954082|7510479|FG000|Overall Study|Non-compliance|6
4637595|NCT01954082|7510480|FG001|Overall Study|Non-compliance|4
4637596|NCT01954082|7510479|FG000|Overall Study|Physician Decision|2
4637597|NCT01954082|7510480|FG001|Overall Study|Physician Decision|0
4637598|NCT01954082|7510479|FG000|Overall Study|Parent Decision|1
4637599|NCT01954082|7510480|FG001|Overall Study|Parent Decision|0
4637600|NCT01954082|7510479|FG000|Overall Study|Withdrawal by Subject|0
4637601|NCT01954082|7510480|FG001|Overall Study|Withdrawal by Subject|1
4637602|NCT01954082|7510479|FG000|Overall Study|Discontinued Early Prior to Transfer|3
4637603|NCT01954082|7510480|FG001|Overall Study|Discontinued Early Prior to Transfer|2
4637604|NCT01954082|7510479|FG000|Overall Study|Redirection of Care|0
4637605|NCT01954082|7510480|FG001|Overall Study|Redirection of Care|2
4637606|NCT01954082|7510479|FG000|Overall Study|Miscalculation of Final Dose Day|0
4637607|NCT01954082|7510480|FG001|Overall Study|Miscalculation of Final Dose Day|3
4637608|NCT01954082|7510479|FG000|Overall Study|Comfort Care|0
4637609|NCT01954082|7510480|FG001|Overall Study|Comfort Care|1
4637610|NCT01954082|7510479|FG000|Overall Study|Infant Moved|0
4637611|NCT01954082|7510480|FG001|Overall Study|Infant Moved|1
4637612|NCT01954082|7510479|FG000|Overall Study|Randomized not Treated|4
4637613|NCT01954082|7510480|FG001|Overall Study|Randomized not Treated|2
4637614|NCT01954121|7510488|FG000|Overall Study|Lack of Efficacy|94
4637615|NCT01954121|7510489|FG001|Overall Study|Lack of Efficacy|41
4637616|NCT01954121|7510488|FG000|Overall Study|Protocol Violation|0
4637617|NCT01954121|7510489|FG001|Overall Study|Protocol Violation|2
4637618|NCT01954121|7510488|FG000|Overall Study|Lost to Follow-up|5
4637619|NCT01954121|7510489|FG001|Overall Study|Lost to Follow-up|6
4637620|NCT01954121|7510488|FG000|Overall Study|Withdrawal by Subject|18
4637621|NCT01954121|7510489|FG001|Overall Study|Withdrawal by Subject|12
4637622|NCT01954121|7510488|FG000|Overall Study|Pregnancy|1
4637623|NCT01954121|7510489|FG001|Overall Study|Pregnancy|1
4637624|NCT01954121|7510488|FG000|Overall Study|AE, serious fatal|1
4637625|NCT01954121|7510489|FG001|Overall Study|AE, serious fatal|0
4637626|NCT01954121|7510488|FG000|Overall Study|AE, non-serious non-fatal|5
4606589|NCT01659567|7460291|FG000|Overall Study|Withdrawal by Subject|64
4606590|NCT01659567|7460291|FG000|Overall Study|Progression of the main disease|1
4606591|NCT01659567|7460291|FG000|Overall Study|Other|13
4606592|NCT01659736|7460297|FG000|Treatment Period|Adverse Event|1
4606593|NCT01659736|7460298|FG001|Treatment Period|Adverse Event|1
4606594|NCT01659736|7460297|FG000|Treatment Period|Protocol Violation|3
4606595|NCT01659736|7460298|FG001|Treatment Period|Protocol Violation|1
4606596|NCT01659736|7460297|FG000|Treatment Period|Withdrawal by Subject|1
4606597|NCT01659736|7460298|FG001|Treatment Period|Withdrawal by Subject|0
4606598|NCT01659736|7460297|FG000|3-month Follow-up|Lost to Follow-up|0
4606599|NCT01659736|7460298|FG001|3-month Follow-up|Lost to Follow-up|1
4606600|NCT01659853|7460306|FG000|Washout , 3 to 7 Days|Adverse Event|1
4606601|NCT01659853|7460307|FG001|Washout , 3 to 7 Days|Adverse Event|0
4606602|NCT01659853|7460306|FG000|Washout , 3 to 7 Days|Protocol Violation|1
4606603|NCT01659853|7460307|FG001|Washout , 3 to 7 Days|Protocol Violation|0
4606604|NCT01659996|7460327|FG000|Overall Study|Protocol Violation|3
4606605|NCT01659996|7460328|FG001|Overall Study|Protocol Violation|3
4606606|NCT01659996|7460329|FG002|Overall Study|Protocol Violation|3
4606607|NCT01659996|7460327|FG000|Overall Study|Lost to Follow-up|1
4606608|NCT01659996|7460328|FG001|Overall Study|Lost to Follow-up|3
4606609|NCT01659996|7460329|FG002|Overall Study|Lost to Follow-up|2
4606610|NCT01659996|7460327|FG000|Overall Study|Adverse Event|0
4606611|NCT01659996|7460328|FG001|Overall Study|Adverse Event|0
4606612|NCT01659996|7460329|FG002|Overall Study|Adverse Event|1
4606613|NCT01659996|7460327|FG000|Overall Study|Withdrawal by Subject|4
4606614|NCT01659996|7460328|FG001|Overall Study|Withdrawal by Subject|1
4606615|NCT01659996|7460329|FG002|Overall Study|Withdrawal by Subject|5
4606616|NCT01660022|7460345|FG000|First Sequence (7 Days)|Withdrawal by Subject|0
4606617|NCT01660022|7460346|FG001|First Sequence (7 Days)|Withdrawal by Subject|1
4606618|NCT01660022|7460347|FG002|First Sequence (7 Days)|Withdrawal by Subject|0
4606619|NCT01660022|7460348|FG003|First Sequence (7 Days)|Withdrawal by Subject|1
4606620|NCT01660022|7460349|FG004|First Sequence (7 Days)|Withdrawal by Subject|0
4606621|NCT01660022|7460350|FG005|First Sequence (7 Days)|Withdrawal by Subject|0
4606622|NCT01660022|7460345|FG000|First Sequence (7 Days)|Adverse Event|0
4606623|NCT01660022|7460346|FG001|First Sequence (7 Days)|Adverse Event|0
4606624|NCT01660022|7460347|FG002|First Sequence (7 Days)|Adverse Event|0
4606625|NCT01660022|7460348|FG003|First Sequence (7 Days)|Adverse Event|0
4606626|NCT01660022|7460349|FG004|First Sequence (7 Days)|Adverse Event|1
4606627|NCT01660022|7460350|FG005|First Sequence (7 Days)|Adverse Event|3
4606628|NCT01660022|7460345|FG000|First Sequence (7 Days)|Protocol Violation|0
4606629|NCT01660022|7460346|FG001|First Sequence (7 Days)|Protocol Violation|0
4606630|NCT01660022|7460347|FG002|First Sequence (7 Days)|Protocol Violation|0
4606631|NCT01660022|7460348|FG003|First Sequence (7 Days)|Protocol Violation|0
4606632|NCT01660022|7460349|FG004|First Sequence (7 Days)|Protocol Violation|0
4606633|NCT01660022|7460350|FG005|First Sequence (7 Days)|Protocol Violation|1
4606634|NCT01660256|7460442|FG000|Overall Study|Adverse Event|4
4606635|NCT01660256|7460443|FG001|Overall Study|Adverse Event|0
4606636|NCT01660256|7460444|FG002|Overall Study|Adverse Event|2
4606637|NCT01660256|7460442|FG000|Overall Study|Withdrawal by Subject|1
4606638|NCT01660256|7460443|FG001|Overall Study|Withdrawal by Subject|0
4606639|NCT01660256|7460444|FG002|Overall Study|Withdrawal by Subject|2
4606640|NCT01660334|7460456|FG000|Overall Study|Lost to Follow-up|1
4606641|NCT01660412|7460460|FG000|Overall Study|Protocol Violation|0
4606642|NCT01660412|7460461|FG001|Overall Study|Protocol Violation|3
4606643|NCT01660711|7460481|FG000|Overall Study|Adverse Event|7
4606644|NCT01660711|7460481|FG000|Overall Study|Withdrawal by Subject|1
4606645|NCT01660763|7460491|FG000|Overall Study|Lack of Efficacy|45
4606646|NCT01660763|7460492|FG001|Overall Study|Lack of Efficacy|50
4606647|NCT01660763|7460491|FG000|Overall Study|Adverse Event|22
4606648|NCT01660763|7460492|FG001|Overall Study|Adverse Event|7
4606649|NCT01660763|7460491|FG000|Overall Study|Protocol Violation|1
4606650|NCT01660763|7460492|FG001|Overall Study|Protocol Violation|0
4606651|NCT01660763|7460491|FG000|Overall Study|Withdrawal by Subject|4
4606652|NCT01660763|7460492|FG001|Overall Study|Withdrawal by Subject|0
4606653|NCT01660763|7460491|FG000|Overall Study|Patient ready for early discharge|28
4606654|NCT01660763|7460492|FG001|Overall Study|Patient ready for early discharge|4
4637627|NCT01954121|7510489|FG001|Overall Study|AE, non-serious non-fatal|22
4637628|NCT01954121|7510488|FG000|Overall Study|SAE, non-fatal|1
4637629|NCT01954121|7510489|FG001|Overall Study|SAE, non-fatal|4
4637630|NCT01954121|7510488|FG000|Overall Study|Non-compliant with study procedures|1
4637631|NCT01954121|7510489|FG001|Overall Study|Non-compliant with study procedures|0
4637632|NCT01954121|7510488|FG000|Overall Study|Non-compliant patient|1
4637633|NCT01954121|7510489|FG001|Overall Study|Non-compliant patient|1
4637634|NCT01954121|7510488|FG000|Overall Study|Subject did not follow instructions|0
4637635|NCT01954121|7510489|FG001|Overall Study|Subject did not follow instructions|2
4637636|NCT01954251|7510497|FG000|Overall Study|Adverse Event|5
4637637|NCT01954251|7510498|FG001|Overall Study|Adverse Event|7
4637638|NCT01954251|7510497|FG000|Overall Study|Lost to Follow-up|6
4637639|NCT01954251|7510498|FG001|Overall Study|Lost to Follow-up|6
4637640|NCT01954251|7510497|FG000|Overall Study|Withdrawal by Subject|2
4637641|NCT01954251|7510498|FG001|Overall Study|Withdrawal by Subject|6
4637642|NCT01954342|7510526|FG000|Overall Study|Missing data from 13-16week study visit|0
4606655|NCT01660906|7460525|FG000|Overall Study|Discontinued due to study drug toxicity|3
4606656|NCT01661062|7460529|FG000|Overall Study|Completed Treatment Off Study|3
4606657|NCT01661062|7460529|FG000|Overall Study|Withdrawal by Subject|2
4606658|NCT01661140|7460541|FG000|Open-Label Period|Adverse Event|44
4606659|NCT01661140|7460542|FG001|Open-Label Period|Adverse Event|0
4606660|NCT01661140|7460543|FG002|Open-Label Period|Adverse Event|0
4606661|NCT01661140|7460541|FG000|Open-Label Period|Protocol Violation|3
4606662|NCT01661140|7460542|FG001|Open-Label Period|Protocol Violation|0
4606663|NCT01661140|7460543|FG002|Open-Label Period|Protocol Violation|0
4606664|NCT01661140|7460541|FG000|Open-Label Period|Withdrawal by Subject|5
4606665|NCT01661140|7460542|FG001|Open-Label Period|Withdrawal by Subject|0
4606666|NCT01661140|7460543|FG002|Open-Label Period|Withdrawal by Subject|0
4606667|NCT01661140|7460541|FG000|Open-Label Period|Investigator Decision|3
4606668|NCT01661140|7460542|FG001|Open-Label Period|Investigator Decision|0
4606669|NCT01661140|7460543|FG002|Open-Label Period|Investigator Decision|0
4606670|NCT01661140|7460541|FG000|Open-Label Period|Death|1
4606671|NCT01661140|7460542|FG001|Open-Label Period|Death|0
4637643|NCT01954342|7510527|FG001|Overall Study|Missing data from 13-16week study visit|0
4637644|NCT01954342|7510528|FG002|Overall Study|Missing data from 13-16week study visit|0
4637645|NCT01954342|7510529|FG003|Overall Study|Missing data from 13-16week study visit|1
4637646|NCT01954342|7510526|FG000|Overall Study|Miscarriage|0
4637647|NCT01954342|7510527|FG001|Overall Study|Miscarriage|0
4637648|NCT01954342|7510528|FG002|Overall Study|Miscarriage|0
4637649|NCT01954342|7510529|FG003|Overall Study|Miscarriage|3
4637650|NCT01954342|7510526|FG000|Overall Study|Lost to Follow-up|0
4637651|NCT01954342|7510527|FG001|Overall Study|Lost to Follow-up|0
4637652|NCT01954342|7510528|FG002|Overall Study|Lost to Follow-up|0
4637653|NCT01954342|7510529|FG003|Overall Study|Lost to Follow-up|5
4637654|NCT01954342|7510526|FG000|Overall Study|Preterm delivery|0
4637655|NCT01954342|7510527|FG001|Overall Study|Preterm delivery|0
4637656|NCT01954342|7510528|FG002|Overall Study|Preterm delivery|0
4637657|NCT01954342|7510529|FG003|Overall Study|Preterm delivery|3
4637658|NCT01954342|7510526|FG000|Overall Study|Pre-eclampsia|0
4637659|NCT01954342|7510527|FG001|Overall Study|Pre-eclampsia|0
4637660|NCT01954342|7510528|FG002|Overall Study|Pre-eclampsia|0
4637661|NCT01954342|7510529|FG003|Overall Study|Pre-eclampsia|4
4637662|NCT01954342|7510526|FG000|Overall Study|Unreliable Data|0
4637663|NCT01954342|7510527|FG001|Overall Study|Unreliable Data|0
4637664|NCT01954342|7510528|FG002|Overall Study|Unreliable Data|0
4637665|NCT01954342|7510529|FG003|Overall Study|Unreliable Data|2
4637666|NCT01954394|7510541|FG000|Overall Study|Enrolled but not treated|1
4637667|NCT01954394|7510542|FG001|Overall Study|Enrolled but not treated|0
4637668|NCT01954394|7510541|FG000|Overall Study|Adverse Event|10
4637669|NCT01954394|7510542|FG001|Overall Study|Adverse Event|23
4637670|NCT01954394|7510541|FG000|Overall Study|Poor compliance to protocol|7
4637671|NCT01954394|7510542|FG001|Overall Study|Poor compliance to protocol|7
4637672|NCT01954394|7510541|FG000|Overall Study|Participant Moved|0
4637673|NCT01954394|7510542|FG001|Overall Study|Participant Moved|4
4637674|NCT01954394|7510541|FG000|Overall Study|Related to Study Drug administration|2
4637675|NCT01954394|7510542|FG001|Overall Study|Related to Study Drug administration|2
4637676|NCT01954394|7510541|FG000|Overall Study|Other than specified above|10
4637677|NCT01954394|7510542|FG001|Overall Study|Other than specified above|21
4637678|NCT01954745|7510563|FG000|Overall Study|Radiological Progression|11
4637679|NCT01954745|7510563|FG000|Overall Study|Clinical Progression|5
4637680|NCT01954745|7510563|FG000|Overall Study|Adverse Event|2
4637681|NCT01954745|7510563|FG000|Overall Study|Death|1
4637682|NCT01954771|7510570|FG000|Overall Study|Missing HbA1c of end-point|1
4637683|NCT01954771|7510571|FG001|Overall Study|Missing HbA1c of end-point|1
4637684|NCT01954771|7510572|FG002|Overall Study|Missing HbA1c of end-point|0
4637685|NCT01954771|7510570|FG000|Overall Study|Missing CGMS of end-point|1
4637686|NCT01954771|7510571|FG001|Overall Study|Missing CGMS of end-point|1
4637687|NCT01954771|7510572|FG002|Overall Study|Missing CGMS of end-point|0
4637688|NCT01954771|7510570|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5
4637689|NCT01954771|7510571|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1
4637690|NCT01954771|7510572|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3
4637691|NCT01954927|7510585|FG000|Overall Study|Withdrawal by Subject|3
4637692|NCT01954927|7510586|FG001|Overall Study|Withdrawal by Subject|1
4637693|NCT01955005|7510594|FG000|Overall Study|Withdrawal by Subject|3
4637694|NCT01955005|7510595|FG001|Overall Study|Withdrawal by Subject|5
4637695|NCT01955044|7510604|FG000|Overall Study|Death|1
4637696|NCT01955044|7510605|FG001|Overall Study|Death|1
4637697|NCT01955044|7510606|FG002|Overall Study|Death|0
4637698|NCT01955083|7510616|FG000|Overall Study|Lost to Follow-up|1
4637699|NCT01955083|7510617|FG001|Overall Study|Lost to Follow-up|1
4637700|NCT01955122|7510649|FG000|Overall Study|Physician Decision|5
4637701|NCT01955122|7510650|FG001|Overall Study|Physician Decision|5
4606672|NCT01661140|7460543|FG002|Open-Label Period|Death|0
4606673|NCT01661140|7460541|FG000|Open-Label Period|Administrative/Other|1
4637702|NCT01955161|7510665|FG000|Overall Study|Withdrawal before treatment|2
4637703|NCT01955161|7510666|FG001|Overall Study|Withdrawal before treatment|0
4637704|NCT01955161|7510667|FG002|Overall Study|Withdrawal before treatment|1
4637705|NCT01955161|7510665|FG000|Overall Study|Adverse Event|10
4637706|NCT01955161|7510666|FG001|Overall Study|Adverse Event|14
4637707|NCT01955161|7510667|FG002|Overall Study|Adverse Event|15
4606674|NCT01661140|7460542|FG001|Open-Label Period|Administrative/Other|0
4606675|NCT01661140|7460543|FG002|Open-Label Period|Administrative/Other|0
4606676|NCT01661140|7460541|FG000|Open-Label Period|Sponsor termination|16
4606677|NCT01661140|7460542|FG001|Open-Label Period|Sponsor termination|0
4606678|NCT01661140|7460543|FG002|Open-Label Period|Sponsor termination|0
4606679|NCT01661140|7460541|FG000|Open-Label Period|Did not meet EULAR criteria|1
4606680|NCT01661140|7460542|FG001|Open-Label Period|Did not meet EULAR criteria|0
4606681|NCT01661140|7460543|FG002|Open-Label Period|Did not meet EULAR criteria|0
4606682|NCT01661140|7460541|FG000|Open-Label Period|Lost to Follow-up|2
4606683|NCT01661140|7460542|FG001|Open-Label Period|Lost to Follow-up|0
4606684|NCT01661140|7460543|FG002|Open-Label Period|Lost to Follow-up|0
4606685|NCT01661140|7460541|FG000|Double-Blind Period|Refused Treatment|0
4606686|NCT01661140|7460542|FG001|Double-Blind Period|Refused Treatment|0
4606687|NCT01661140|7460543|FG002|Double-Blind Period|Refused Treatment|1
4606688|NCT01661140|7460541|FG000|Double-Blind Period|Adverse Event|0
4606689|NCT01661140|7460542|FG001|Double-Blind Period|Adverse Event|16
4606690|NCT01661140|7460543|FG002|Double-Blind Period|Adverse Event|18
4606691|NCT01661140|7460541|FG000|Double-Blind Period|Protocol Violation|0
4606692|NCT01661140|7460542|FG001|Double-Blind Period|Protocol Violation|2
4606693|NCT01661140|7460543|FG002|Double-Blind Period|Protocol Violation|3
4606694|NCT01661140|7460541|FG000|Double-Blind Period|Withdrawal by Subject|0
4606695|NCT01661140|7460542|FG001|Double-Blind Period|Withdrawal by Subject|1
4606696|NCT01661140|7460543|FG002|Double-Blind Period|Withdrawal by Subject|3
4606697|NCT01661140|7460541|FG000|Double-Blind Period|Investigator's Decision|0
4606698|NCT01661140|7460542|FG001|Double-Blind Period|Investigator's Decision|1
4606699|NCT01661140|7460543|FG002|Double-Blind Period|Investigator's Decision|2
4606700|NCT01661140|7460541|FG000|Double-Blind Period|Sponsor Termination|0
4606701|NCT01661140|7460542|FG001|Double-Blind Period|Sponsor Termination|14
4606702|NCT01661140|7460543|FG002|Double-Blind Period|Sponsor Termination|17
4606703|NCT01661140|7460541|FG000|Double-Blind Period|Administrative/Other|0
4606704|NCT01661140|7460542|FG001|Double-Blind Period|Administrative/Other|7
4606705|NCT01661140|7460543|FG002|Double-Blind Period|Administrative/Other|6
4606706|NCT01661179|7460551|FG000|Overall Study|Death|1
4606707|NCT01661179|7460551|FG000|Overall Study|Withdrawal by Subject|1
4606708|NCT01661179|7460551|FG000|Overall Study|Other Eligibility criteria|4
4606709|NCT01661205|7460555|FG000|Overall Study|Physician Decision|2
4606710|NCT01661595|7460577|FG000|Phase 1: Week 0-4|Adverse Event|1
4606711|NCT01661595|7460578|FG001|Phase 1: Week 0-4|Adverse Event|0
4606712|NCT01661595|7460579|FG002|Phase 1: Week 0-4|Adverse Event|0
4606713|NCT01661595|7460580|FG003|Phase 1: Week 0-4|Adverse Event|0
4637708|NCT01955161|7510665|FG000|Overall Study|Death|1
4637709|NCT01955161|7510666|FG001|Overall Study|Death|1
4637710|NCT01955161|7510667|FG002|Overall Study|Death|3
4637711|NCT01955161|7510665|FG000|Overall Study|Withdrawal by Subject|9
4637712|NCT01955161|7510666|FG001|Overall Study|Withdrawal by Subject|8
4637713|NCT01955161|7510667|FG002|Overall Study|Withdrawal by Subject|12
4637714|NCT01955161|7510665|FG000|Overall Study|Protocol Violation|2
4637715|NCT01955161|7510666|FG001|Overall Study|Protocol Violation|0
4637716|NCT01955161|7510667|FG002|Overall Study|Protocol Violation|0
4637717|NCT01955161|7510665|FG000|Overall Study|Other reason: physician decision|0
4637718|NCT01955161|7510666|FG001|Overall Study|Other reason: physician decision|1
4637719|NCT01955161|7510667|FG002|Overall Study|Other reason: physician decision|1
4637720|NCT01955161|7510665|FG000|Overall Study|Other reason: disallowed medication|1
4637721|NCT01955161|7510666|FG001|Overall Study|Other reason: disallowed medication|0
4637722|NCT01955161|7510667|FG002|Overall Study|Other reason: disallowed medication|1
4637723|NCT01955161|7510665|FG000|Overall Study|Other reason: caregiver unavailable|1
4637724|NCT01955161|7510666|FG001|Overall Study|Other reason: caregiver unavailable|0
4637725|NCT01955161|7510667|FG002|Overall Study|Other reason: caregiver unavailable|0
4637726|NCT01955161|7510665|FG000|Overall Study|Other reason: moved to nursing home|0
4637727|NCT01955161|7510666|FG001|Overall Study|Other reason: moved to nursing home|1
4637728|NCT01955161|7510667|FG002|Overall Study|Other reason: moved to nursing home|0
4637729|NCT01955161|7510665|FG000|Overall Study|Other reason: insufficient compliance|0
4637730|NCT01955161|7510666|FG001|Overall Study|Other reason: insufficient compliance|0
4637731|NCT01955161|7510667|FG002|Overall Study|Other reason: insufficient compliance|1
4637732|NCT01955161|7510665|FG000|Overall Study|Other reason: primary biliary cirrhosis|1
4637733|NCT01955161|7510666|FG001|Overall Study|Other reason: primary biliary cirrhosis|0
4637734|NCT01955161|7510667|FG002|Overall Study|Other reason: primary biliary cirrhosis|0
4637735|NCT01955161|7510665|FG000|Overall Study|Other reason: patient's will|0
4746942|NCT00452361|7719841|FG001|Overall Study|Premature termination|9
4746943|NCT00443040|7719850|FG000|Overall Study|Withdrawal by Subject|1
4746944|NCT00443040|7719851|FG001|Overall Study|Withdrawal by Subject|0
4746945|NCT00443040|7719852|FG002|Overall Study|Withdrawal by Subject|0
4746946|NCT00443040|7719850|FG000|Overall Study|Converted to an open laparotomy|3
4746947|NCT00443040|7719851|FG001|Overall Study|Converted to an open laparotomy|0
4746948|NCT00443040|7719852|FG002|Overall Study|Converted to an open laparotomy|1
4746949|NCT00447421|7719860|FG000|Overall Study|Lack of Efficacy|1
4746950|NCT00447421|7719860|FG000|Overall Study|Adverse Event|3
4746951|NCT00447421|7719860|FG000|Overall Study|Sponsor Decision|2
4746952|NCT00441272|7719866|FG000|Overall Study|Study terminated prior to enrollment|25
4637736|NCT01955161|7510666|FG001|Overall Study|Other reason: patient's will|0
4606714|NCT01661595|7460577|FG000|Phase 2: Week 5-8.|Protocol Violation|0
4606715|NCT01661595|7460578|FG001|Phase 2: Week 5-8.|Protocol Violation|0
4606716|NCT01661595|7460579|FG002|Phase 2: Week 5-8.|Protocol Violation|1
4606717|NCT01661595|7460580|FG003|Phase 2: Week 5-8.|Protocol Violation|0
4606718|NCT01661686|7460608|FG000|Overall Study|Lost to Follow-up|2
4606719|NCT01661686|7460609|FG001|Overall Study|Lost to Follow-up|1
4606720|NCT01661686|7460608|FG000|Overall Study|did not receive allocated intervention|0
4606721|NCT01661686|7460609|FG001|Overall Study|did not receive allocated intervention|1
4606722|NCT01661790|7460657|FG000|Overall Study|Lost to Follow-up|0
4606723|NCT01661790|7460658|FG001|Overall Study|Lost to Follow-up|2
4606724|NCT01661881|7460664|FG000|Overall Study|Disease Progression|1
4606725|NCT01661933|7460668|FG000|Low-dose Gluten Challenge|Physician Decision|2
4606726|NCT01661933|7460668|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2
4606727|NCT01661972|7460685|FG000|Overall Study|Adverse Event|1
4606728|NCT01661972|7460686|FG001|Overall Study|Adverse Event|2
4606729|NCT01661972|7460685|FG000|Overall Study|Death during Treatment period|1
4606730|NCT01661972|7460686|FG001|Overall Study|Death during Treatment period|1
4606731|NCT01661972|7460685|FG000|Overall Study|Withdrawal by Subject|0
4606732|NCT01661972|7460686|FG001|Overall Study|Withdrawal by Subject|1
4606733|NCT01662024|7460694|FG000|Overall Study|Pregnancy|2
4606734|NCT01662024|7460694|FG000|Overall Study|Withdrawal by Subject|3
4606735|NCT01662063|7460703|FG000|Overall Study|Adverse Event or Intercurrent Illness|1
4606736|NCT01662063|7460704|FG001|Overall Study|Adverse Event or Intercurrent Illness|12
4606737|NCT01662063|7460705|FG002|Overall Study|Adverse Event or Intercurrent Illness|0
4606738|NCT01662063|7460703|FG000|Overall Study|Lack of Efficacy|1
4606739|NCT01662063|7460704|FG001|Overall Study|Lack of Efficacy|6
4606740|NCT01662063|7460705|FG002|Overall Study|Lack of Efficacy|0
4606741|NCT01662063|7460703|FG000|Overall Study|Lost to Follow-up|0
4606742|NCT01662063|7460704|FG001|Overall Study|Lost to Follow-up|4
4606743|NCT01662063|7460705|FG002|Overall Study|Lost to Follow-up|0
4606744|NCT01662063|7460703|FG000|Overall Study|Protocol Violation|1
4606745|NCT01662063|7460704|FG001|Overall Study|Protocol Violation|0
4606746|NCT01662063|7460705|FG002|Overall Study|Protocol Violation|0
4606747|NCT01662063|7460703|FG000|Overall Study|Withdrawal by Subject|2
4606748|NCT01662063|7460704|FG001|Overall Study|Withdrawal by Subject|4
4606749|NCT01662063|7460705|FG002|Overall Study|Withdrawal by Subject|1
4606750|NCT01662063|7460703|FG000|Overall Study|Physician Decision|0
4606751|NCT01662063|7460704|FG001|Overall Study|Physician Decision|2
4606752|NCT01662063|7460705|FG002|Overall Study|Physician Decision|0
4606753|NCT01662063|7460703|FG000|Overall Study|Other|0
4606754|NCT01662063|7460704|FG001|Overall Study|Other|1
4606755|NCT01662063|7460705|FG002|Overall Study|Other|0
4606756|NCT01662310|7460735|FG000|Run-In or Stabilization Phase|Adverse Event|11
4606757|NCT01662310|7460736|FG001|Run-In or Stabilization Phase|Adverse Event|0
4606758|NCT01662310|7460737|FG002|Run-In or Stabilization Phase|Adverse Event|0
4606759|NCT01662310|7460738|FG003|Run-In or Stabilization Phase|Adverse Event|0
4606760|NCT01662310|7460739|FG004|Run-In or Stabilization Phase|Adverse Event|0
4606761|NCT01662310|7460735|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9
4606762|NCT01662310|7460736|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0
4606763|NCT01662310|7460737|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0
4606764|NCT01662310|7460738|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0
4637737|NCT01955161|7510667|FG002|Overall Study|Other reason: patient's will|1
4637738|NCT01955707|7510759|FG000|Overall Study|Adverse Event|1
4637739|NCT01955707|7510760|FG001|Overall Study|Adverse Event|2
4637740|NCT01955707|7510759|FG000|Overall Study|Lost to Follow-up|2
4637741|NCT01955707|7510760|FG001|Overall Study|Lost to Follow-up|1
4637742|NCT01955707|7510759|FG000|Overall Study|Withdrawal by Subject|0
4637743|NCT01955707|7510760|FG001|Overall Study|Withdrawal by Subject|3
4637744|NCT01955707|7510759|FG000|Overall Study|Death|13
4637745|NCT01955707|7510760|FG001|Overall Study|Death|14
4637746|NCT01955707|7510759|FG000|Overall Study|Other|4
4637747|NCT01955707|7510760|FG001|Overall Study|Other|2
4637748|NCT01955733|7510820|FG000|Period 1|Lost to Follow-up|1
4637749|NCT01955733|7510821|FG001|Period 1|Lost to Follow-up|0
4637750|NCT01955733|7510822|FG002|Period 1|Lost to Follow-up|0
4637751|NCT01955733|7510820|FG000|Period 2|Adverse Event|1
4637752|NCT01955733|7510821|FG001|Period 2|Adverse Event|0
4637753|NCT01955733|7510822|FG002|Period 2|Adverse Event|0
4637754|NCT01955733|7510820|FG000|Period 2|Physician Decision|0
4637755|NCT01955733|7510821|FG001|Period 2|Physician Decision|0
4637756|NCT01955733|7510822|FG002|Period 2|Physician Decision|1
4637757|NCT01955733|7510820|FG000|Period 2|Withdrawal by Subject|1
4637758|NCT01955733|7510821|FG001|Period 2|Withdrawal by Subject|3
4637759|NCT01955733|7510822|FG002|Period 2|Withdrawal by Subject|2
4637760|NCT01955733|7510820|FG000|Period 2|Study terminated by sponsor|8
4606765|NCT01662310|7460739|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0
4606766|NCT01662310|7460735|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4
4606767|NCT01662310|7460736|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0
4606768|NCT01662310|7460737|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0
4606769|NCT01662310|7460738|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0
4637761|NCT01955733|7510821|FG001|Period 2|Study terminated by sponsor|14
4637762|NCT01955733|7510822|FG002|Period 2|Study terminated by sponsor|16
4637763|NCT01955733|7510820|FG000|Period 2|Lost to Follow-up|2
4606770|NCT01662310|7460739|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0
4606771|NCT01662310|7460735|FG000|Run-In or Stabilization Phase|Protocol Violation|15
4606772|NCT01662310|7460736|FG001|Run-In or Stabilization Phase|Protocol Violation|0
4606773|NCT01662310|7460737|FG002|Run-In or Stabilization Phase|Protocol Violation|0
4606774|NCT01662310|7460738|FG003|Run-In or Stabilization Phase|Protocol Violation|0
4606775|NCT01662310|7460739|FG004|Run-In or Stabilization Phase|Protocol Violation|0
4606776|NCT01662310|7460735|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25
4606777|NCT01662310|7460736|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0
4606778|NCT01662310|7460737|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0
4606779|NCT01662310|7460738|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0
4606780|NCT01662310|7460739|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0
4606781|NCT01662310|7460735|FG000|Run-In or Stabilization Phase|Other|1
4606782|NCT01662310|7460736|FG001|Run-In or Stabilization Phase|Other|0
4606783|NCT01662310|7460737|FG002|Run-In or Stabilization Phase|Other|0
4606784|NCT01662310|7460738|FG003|Run-In or Stabilization Phase|Other|0
4606785|NCT01662310|7460739|FG004|Run-In or Stabilization Phase|Other|0
4606786|NCT01662310|7460735|FG000|Double-Blind Phase|Adverse Event|0
4606787|NCT01662310|7460736|FG001|Double-Blind Phase|Adverse Event|0
4606788|NCT01662310|7460737|FG002|Double-Blind Phase|Adverse Event|1
4606789|NCT01662310|7460738|FG003|Double-Blind Phase|Adverse Event|0
4606790|NCT01662310|7460739|FG004|Double-Blind Phase|Adverse Event|0
4606791|NCT01662310|7460735|FG000|Double-Blind Phase|Lost to Follow-up|0
4606792|NCT01662310|7460736|FG001|Double-Blind Phase|Lost to Follow-up|3
4606793|NCT01662310|7460737|FG002|Double-Blind Phase|Lost to Follow-up|0
4606794|NCT01662310|7460738|FG003|Double-Blind Phase|Lost to Follow-up|0
4606795|NCT01662310|7460739|FG004|Double-Blind Phase|Lost to Follow-up|0
4606796|NCT01662310|7460735|FG000|Double-Blind Phase|Pregnancy|0
4606797|NCT01662310|7460736|FG001|Double-Blind Phase|Pregnancy|2
4606798|NCT01662310|7460737|FG002|Double-Blind Phase|Pregnancy|0
4606799|NCT01662310|7460738|FG003|Double-Blind Phase|Pregnancy|0
4606800|NCT01662310|7460739|FG004|Double-Blind Phase|Pregnancy|0
4606801|NCT01662310|7460735|FG000|Double-Blind Phase|Withdrawal by Subject|0
4606802|NCT01662310|7460736|FG001|Double-Blind Phase|Withdrawal by Subject|9
4606803|NCT01662310|7460737|FG002|Double-Blind Phase|Withdrawal by Subject|3
4606804|NCT01662310|7460738|FG003|Double-Blind Phase|Withdrawal by Subject|0
4606805|NCT01662310|7460739|FG004|Double-Blind Phase|Withdrawal by Subject|0
4606806|NCT01662310|7460735|FG000|Double-Blind Phase|Other|0
4606807|NCT01662310|7460736|FG001|Double-Blind Phase|Other|0
4606808|NCT01662310|7460737|FG002|Double-Blind Phase|Other|1
4606809|NCT01662310|7460738|FG003|Double-Blind Phase|Other|0
4606810|NCT01662310|7460739|FG004|Double-Blind Phase|Other|0
4606811|NCT01662310|7460735|FG000|Double-Blind Phase|Randomized but not treated|0
4606812|NCT01662310|7460736|FG001|Double-Blind Phase|Randomized but not treated|1
4606813|NCT01662310|7460737|FG002|Double-Blind Phase|Randomized but not treated|0
4606814|NCT01662310|7460738|FG003|Double-Blind Phase|Randomized but not treated|0
4606815|NCT01662310|7460739|FG004|Double-Blind Phase|Randomized but not treated|0
4606816|NCT01662310|7460735|FG000|Open-Label Extension Phase|Adverse Event|0
4606817|NCT01662310|7460736|FG001|Open-Label Extension Phase|Adverse Event|0
4606818|NCT01662310|7460737|FG002|Open-Label Extension Phase|Adverse Event|0
4606819|NCT01662310|7460738|FG003|Open-Label Extension Phase|Adverse Event|3
4606820|NCT01662310|7460739|FG004|Open-Label Extension Phase|Adverse Event|0
4606821|NCT01662310|7460735|FG000|Open-Label Extension Phase|Death|0
4606822|NCT01662310|7460736|FG001|Open-Label Extension Phase|Death|0
4606823|NCT01662310|7460737|FG002|Open-Label Extension Phase|Death|0
4606824|NCT01662310|7460738|FG003|Open-Label Extension Phase|Death|1
4606825|NCT01662310|7460739|FG004|Open-Label Extension Phase|Death|0
4606826|NCT01662310|7460735|FG000|Open-Label Extension Phase|Lack of Efficacy|0
4606827|NCT01662310|7460736|FG001|Open-Label Extension Phase|Lack of Efficacy|0
4606828|NCT01662310|7460737|FG002|Open-Label Extension Phase|Lack of Efficacy|0
4606829|NCT01662310|7460738|FG003|Open-Label Extension Phase|Lack of Efficacy|2
4606830|NCT01662310|7460739|FG004|Open-Label Extension Phase|Lack of Efficacy|2
4606831|NCT01662310|7460735|FG000|Open-Label Extension Phase|Lost to Follow-up|0
4637764|NCT01955733|7510821|FG001|Period 2|Lost to Follow-up|0
4637765|NCT01955733|7510822|FG002|Period 2|Lost to Follow-up|0
4637766|NCT01955733|7510820|FG000|Period 2|Other not defined above|0
4637767|NCT01955733|7510821|FG001|Period 2|Other not defined above|2
4637768|NCT01955733|7510822|FG002|Period 2|Other not defined above|2
4637769|NCT01956123|7510866|FG000|COS Cycle 2|Protocol Violation|8
4637770|NCT01956123|7510867|FG001|COS Cycle 2|Protocol Violation|3
4637771|NCT01956123|7510868|FG002|COS Cycle 2|Protocol Violation|0
4637772|NCT01956123|7510869|FG003|COS Cycle 2|Protocol Violation|0
4637773|NCT01956123|7510866|FG000|COS Cycle 2|Adverse Event|3
4637774|NCT01956123|7510867|FG001|COS Cycle 2|Adverse Event|4
4637775|NCT01956123|7510868|FG002|COS Cycle 2|Adverse Event|0
4637776|NCT01956123|7510869|FG003|COS Cycle 2|Adverse Event|0
4637777|NCT01956123|7510866|FG000|COS Cycle 2|Personal Reasons|2
4637778|NCT01956123|7510867|FG001|COS Cycle 2|Personal Reasons|0
4637779|NCT01956123|7510868|FG002|COS Cycle 2|Personal Reasons|0
4637780|NCT01956123|7510869|FG003|COS Cycle 2|Personal Reasons|0
4637781|NCT01956123|7510866|FG000|COS Cycle 2|Withdrawal by Subject|1
4606832|NCT01662310|7460736|FG001|Open-Label Extension Phase|Lost to Follow-up|0
4637782|NCT01956123|7510867|FG001|COS Cycle 2|Withdrawal by Subject|0
4637783|NCT01956123|7510868|FG002|COS Cycle 2|Withdrawal by Subject|0
4606833|NCT01662310|7460737|FG002|Open-Label Extension Phase|Lost to Follow-up|0
4606834|NCT01662310|7460738|FG003|Open-Label Extension Phase|Lost to Follow-up|2
4606835|NCT01662310|7460739|FG004|Open-Label Extension Phase|Lost to Follow-up|1
4606836|NCT01662310|7460735|FG000|Open-Label Extension Phase|Pregnancy|0
4606837|NCT01662310|7460736|FG001|Open-Label Extension Phase|Pregnancy|0
4606838|NCT01662310|7460737|FG002|Open-Label Extension Phase|Pregnancy|0
4606839|NCT01662310|7460738|FG003|Open-Label Extension Phase|Pregnancy|1
4606840|NCT01662310|7460739|FG004|Open-Label Extension Phase|Pregnancy|0
4606841|NCT01662310|7460735|FG000|Open-Label Extension Phase|Withdrawal by Subject|0
4606842|NCT01662310|7460736|FG001|Open-Label Extension Phase|Withdrawal by Subject|0
4606843|NCT01662310|7460737|FG002|Open-Label Extension Phase|Withdrawal by Subject|0
4606844|NCT01662310|7460738|FG003|Open-Label Extension Phase|Withdrawal by Subject|2
4606845|NCT01662310|7460739|FG004|Open-Label Extension Phase|Withdrawal by Subject|7
4606846|NCT01662336|7460751|FG000|Overall Study|Adverse Event|1
4606847|NCT01662336|7460751|FG000|Overall Study|No longer on LPV/r|30
4606848|NCT01662336|7460751|FG000|Overall Study|Other|29
4606849|NCT01662336|7460751|FG000|Overall Study|Withdrawal by Subject|6
4606850|NCT01662362|7460760|FG000|Overall Study|Lost to Follow-up|38
4606851|NCT01662440|7460769|FG000|Overall Study|Adverse Event|1
4606852|NCT01662440|7460770|FG001|Overall Study|Adverse Event|0
4606853|NCT01662440|7460771|FG002|Overall Study|Adverse Event|0
4606854|NCT01662440|7460772|FG003|Overall Study|Adverse Event|1
4606855|NCT01662440|7460769|FG000|Overall Study|Death|0
4606856|NCT01662440|7460770|FG001|Overall Study|Death|1
4606857|NCT01662440|7460771|FG002|Overall Study|Death|0
4606858|NCT01662440|7460772|FG003|Overall Study|Death|0
4606859|NCT01662440|7460769|FG000|Overall Study|Lost to Follow-up|2
4606860|NCT01662440|7460770|FG001|Overall Study|Lost to Follow-up|2
4606861|NCT01662440|7460771|FG002|Overall Study|Lost to Follow-up|4
4606862|NCT01662440|7460772|FG003|Overall Study|Lost to Follow-up|1
4606863|NCT01662440|7460769|FG000|Overall Study|Subject moved to another country.|0
4606864|NCT01662440|7460770|FG001|Overall Study|Subject moved to another country.|1
4606865|NCT01662440|7460771|FG002|Overall Study|Subject moved to another country.|0
4606866|NCT01662440|7460772|FG003|Overall Study|Subject moved to another country.|0
4606867|NCT01662440|7460769|FG000|Overall Study|Protocol Violation|1
4606868|NCT01662440|7460770|FG001|Overall Study|Protocol Violation|0
4606869|NCT01662440|7460771|FG002|Overall Study|Protocol Violation|0
4606870|NCT01662440|7460772|FG003|Overall Study|Protocol Violation|0
4606871|NCT01662440|7460769|FG000|Overall Study|Withdrawal by Subject|5
4606872|NCT01662440|7460770|FG001|Overall Study|Withdrawal by Subject|2
4606873|NCT01662440|7460771|FG002|Overall Study|Withdrawal by Subject|2
4606874|NCT01662440|7460772|FG003|Overall Study|Withdrawal by Subject|2
4606875|NCT01662492|7460795|FG000|Overall Study|Other miscellaneous reasons.|1
4606876|NCT01662492|7460796|FG001|Overall Study|Other miscellaneous reasons.|0
4606877|NCT01662492|7460797|FG002|Overall Study|Other miscellaneous reasons.|1
4606878|NCT01662492|7460795|FG000|Overall Study|Withdrawal by Subject|0
4606879|NCT01662492|7460796|FG001|Overall Study|Withdrawal by Subject|0
4606880|NCT01662492|7460797|FG002|Overall Study|Withdrawal by Subject|1
4606881|NCT01662492|7460795|FG000|Overall Study|Protocol Violation|1
4606882|NCT01662492|7460796|FG001|Overall Study|Protocol Violation|0
4606883|NCT01662492|7460797|FG002|Overall Study|Protocol Violation|0
4606884|NCT01662492|7460795|FG000|Overall Study|Lost to Follow-up|0
4606885|NCT01662492|7460796|FG001|Overall Study|Lost to Follow-up|0
4606886|NCT01662492|7460797|FG002|Overall Study|Lost to Follow-up|2
4606887|NCT01662492|7460795|FG000|Overall Study|Lack of Efficacy|1
4606888|NCT01662492|7460796|FG001|Overall Study|Lack of Efficacy|1
4606889|NCT01662492|7460797|FG002|Overall Study|Lack of Efficacy|2
4606890|NCT01662505|7460808|FG000|Overall Study|Progressive disease|6
4606891|NCT01662505|7460809|FG001|Overall Study|Progressive disease|1
4606892|NCT01662505|7460810|FG002|Overall Study|Progressive disease|5
4606893|NCT01662505|7460808|FG000|Overall Study|Refused cont. medication|0
4606894|NCT01662505|7460809|FG001|Overall Study|Refused cont. medication|0
4606895|NCT01662505|7460810|FG002|Overall Study|Refused cont. medication|1
4606896|NCT01662505|7460808|FG000|Overall Study|Not specified above|1
4606897|NCT01662505|7460809|FG001|Overall Study|Not specified above|3
4606898|NCT01662505|7460810|FG002|Overall Study|Not specified above|2
4606899|NCT01662635|7460840|FG000|Overall Study|scarce samples for evaluation|30
4606900|NCT01662648|7460848|FG000|Overall Study|Death|1
4606901|NCT01662648|7460849|FG001|Overall Study|Death|3
4606902|NCT01662648|7460848|FG000|Overall Study|Adverse Event|40
4606903|NCT01662648|7460849|FG001|Overall Study|Adverse Event|37
4606904|NCT01662648|7460848|FG000|Overall Study|Lack of Efficacy|17
4637784|NCT01956123|7510869|FG003|COS Cycle 2|Withdrawal by Subject|0
4606905|NCT01662648|7460849|FG001|Overall Study|Lack of Efficacy|16
4606906|NCT01662648|7460848|FG000|Overall Study|Participant ineligible to continue trial|1
4606907|NCT01662648|7460849|FG001|Overall Study|Participant ineligible to continue trial|1
4606908|NCT01662648|7460848|FG000|Overall Study|Lost to Follow-up|24
4606909|NCT01662648|7460849|FG001|Overall Study|Lost to Follow-up|36
4606910|NCT01662648|7460848|FG000|Overall Study|Withdrawal by Subject|36
4606911|NCT01662648|7460849|FG001|Overall Study|Withdrawal by Subject|53
4606912|NCT01662648|7460848|FG000|Overall Study|Participant non-compliant|16
4606913|NCT01662648|7460849|FG001|Overall Study|Participant non-compliant|20
4606914|NCT01662648|7460848|FG000|Overall Study|Other|8
4606915|NCT01662648|7460849|FG001|Overall Study|Other|11
4606916|NCT01662648|7460848|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3
4606917|NCT01662648|7460849|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0
4606918|NCT01662648|7460848|FG000|Overall Study|LOE and other reason unspecified|1
4606919|NCT01662648|7460849|FG001|Overall Study|LOE and other reason unspecified|0
4606920|NCT01662648|7460848|FG000|Overall Study|LOE and Participant non-compliant|0
4606921|NCT01662648|7460849|FG001|Overall Study|LOE and Participant non-compliant|1
4606922|NCT01662895|7460923|FG000|Overall Study|Lost to Follow-up|0
4606923|NCT01662895|7460924|FG001|Overall Study|Lost to Follow-up|1
4606924|NCT01662986|7460958|FG000|Overall Study|Adverse Event|5
4606925|NCT01662986|7460959|FG001|Overall Study|Adverse Event|4
4606926|NCT01662986|7460958|FG000|Overall Study|Protocol Violation|2
4606927|NCT01662986|7460959|FG001|Overall Study|Protocol Violation|3
4606928|NCT01662986|7460958|FG000|Overall Study|Lost to Follow-up|5
4606929|NCT01662986|7460959|FG001|Overall Study|Lost to Follow-up|4
4606930|NCT01662986|7460958|FG000|Overall Study|Withdrawal by Subject|2
4606931|NCT01662986|7460959|FG001|Overall Study|Withdrawal by Subject|2
4606932|NCT01662986|7460958|FG000|Overall Study|Not Treated|1
4606933|NCT01662986|7460959|FG001|Overall Study|Not Treated|0
4606934|NCT01662986|7460958|FG000|Overall Study|Other than stated above|3
4606935|NCT01662986|7460959|FG001|Overall Study|Other than stated above|0
4606936|NCT01662999|7460971|FG000|Period 3|Withdrawal by Subject|0
4606937|NCT01662999|7460972|FG001|Period 3|Withdrawal by Subject|1
4606938|NCT01662999|7460973|FG002|Period 3|Withdrawal by Subject|0
4606939|NCT01662999|7460974|FG003|Period 3|Withdrawal by Subject|0
4606940|NCT01662999|7460975|FG004|Period 3|Withdrawal by Subject|0
4606941|NCT01662999|7460976|FG005|Period 3|Withdrawal by Subject|0
4606942|NCT01663103|7461012|FG000|Overall Study|Withdrawal by Subject|1
4606943|NCT01663103|7461013|FG001|Overall Study|Withdrawal by Subject|2
4606944|NCT01663103|7461012|FG000|Overall Study|Adverse Event|1
4606945|NCT01663103|7461013|FG001|Overall Study|Adverse Event|0
4606946|NCT01663103|7461012|FG000|Overall Study|dog bite|1
4606947|NCT01663103|7461013|FG001|Overall Study|dog bite|0
4606948|NCT01663233|7461025|FG000|Overall Study|Withdrawal by Subject|3
4606949|NCT01663233|7461026|FG001|Overall Study|Withdrawal by Subject|2
4606950|NCT01663233|7461025|FG000|Overall Study|Protocol Deviation|1
4606951|NCT01663233|7461026|FG001|Overall Study|Protocol Deviation|4
4606952|NCT01663233|7461025|FG000|Overall Study|Lost to Follow-up|0
4606953|NCT01663233|7461026|FG001|Overall Study|Lost to Follow-up|1
4606954|NCT01663402|7461048|FG000|Overall Study|Randomized but not treated|19
4606955|NCT01663402|7461049|FG001|Overall Study|Randomized but not treated|11
4606956|NCT01663402|7461048|FG000|Overall Study|Adverse Event|347
4606957|NCT01663402|7461049|FG001|Overall Study|Adverse Event|362
4606958|NCT01663402|7461048|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0
4606959|NCT01663402|7461049|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730
4606960|NCT01663402|7461048|FG000|Overall Study|Poor compliance to protocol|529
4606961|NCT01663402|7461049|FG001|Overall Study|Poor compliance to protocol|454
4606962|NCT01663402|7461048|FG000|Overall Study|Physician Decision|77
4606963|NCT01663402|7461049|FG001|Overall Study|Physician Decision|62
4606964|NCT01663402|7461048|FG000|Overall Study|Site terminated by sponsor|1
4606965|NCT01663402|7461049|FG001|Overall Study|Site terminated by sponsor|3
4606966|NCT01663402|7461048|FG000|Overall Study|Participant moved|139
4606967|NCT01663402|7461049|FG001|Overall Study|Participant moved|104
4606968|NCT01663402|7461048|FG000|Overall Study|Withdrawal by Subject|118
4606969|NCT01663402|7461049|FG001|Overall Study|Withdrawal by Subject|91
4606970|NCT01663402|7461048|FG000|Overall Study|Related to study drug administration|96
4606971|NCT01663402|7461049|FG001|Overall Study|Related to study drug administration|105
4606972|NCT01663402|7461048|FG000|Overall Study|Lost to Follow-up|17
4606973|NCT01663402|7461049|FG001|Overall Study|Lost to Follow-up|15
4606974|NCT01663402|7461048|FG000|Overall Study|Other than specified above|172
4606975|NCT01663402|7461049|FG001|Overall Study|Other than specified above|147
4606976|NCT01663506|7461055|FG000|Overall Study|Lack of Efficacy|3
4606977|NCT01663506|7461055|FG000|Overall Study|Consent Withdrawal by Subject|1
4606978|NCT01663506|7461055|FG000|Overall Study|Lost to Follow-up|1
4606979|NCT01663506|7461055|FG000|Overall Study|Adverse Event|1
4606980|NCT01663506|7461055|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2
4606981|NCT01663532|7461061|FG000|Overall Study|Lost to Follow-up|9
4606982|NCT01663532|7461062|FG001|Overall Study|Lost to Follow-up|10
4606983|NCT01663532|7461061|FG000|Overall Study|Adverse Event|7
4606984|NCT01663532|7461062|FG001|Overall Study|Adverse Event|13
4606985|NCT01663532|7461061|FG000|Overall Study|Met Withdrawal Criteria|7
4606986|NCT01663532|7461062|FG001|Overall Study|Met Withdrawal Criteria|6
4606987|NCT01663532|7461061|FG000|Overall Study|Physician Decision|1
4606988|NCT01663532|7461062|FG001|Overall Study|Physician Decision|1
4606989|NCT01663532|7461061|FG000|Overall Study|Withdrawal by Subject|35
4606990|NCT01663532|7461062|FG001|Overall Study|Withdrawal by Subject|17
4606991|NCT01663532|7461061|FG000|Overall Study|Lack of Efficacy|15
4606992|NCT01663532|7461062|FG001|Overall Study|Lack of Efficacy|60
4606993|NCT01663623|7461070|FG000|Overall Study|Adverse Event|3
4606994|NCT01663623|7461071|FG001|Overall Study|Adverse Event|7
4606995|NCT01663623|7461070|FG000|Overall Study|Lack of Efficacy|5
4606996|NCT01663623|7461071|FG001|Overall Study|Lack of Efficacy|6
4606997|NCT01663623|7461070|FG000|Overall Study|Protocol Violation|0
4606998|NCT01663623|7461071|FG001|Overall Study|Protocol Violation|1
4606999|NCT01663623|7461070|FG000|Overall Study|Other-Study closed/terminated|1
4607000|NCT01663623|7461071|FG001|Overall Study|Other-Study closed/terminated|1
4607001|NCT01663623|7461070|FG000|Overall Study|Physician Decision|1
4607002|NCT01663623|7461071|FG001|Overall Study|Physician Decision|4
4607003|NCT01663623|7461070|FG000|Overall Study|Withdrawal by Subject|2
4607004|NCT01663623|7461071|FG001|Overall Study|Withdrawal by Subject|1
4607005|NCT01663636|7461079|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25
4607006|NCT01663636|7461080|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31
4607007|NCT01663714|7461086|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3
4607008|NCT01663714|7461086|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11
4607009|NCT01663714|7461086|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16
4607010|NCT01663714|7461086|FG000|Long-Term Follow-Up|Lost to Follow-up|1
4607011|NCT01663714|7461086|FG000|Long-Term Follow-Up|Death|4
4607012|NCT01663714|7461086|FG000|Long-Term Follow-Up|Non-compliance|1
4607013|NCT01663727|7461094|FG000|Overall Study|Death|161
4607014|NCT01663727|7461095|FG001|Overall Study|Death|155
4607015|NCT01663727|7461094|FG000|Overall Study|Lost to Follow-up|10
4607016|NCT01663727|7461095|FG001|Overall Study|Lost to Follow-up|8
4607017|NCT01663727|7461094|FG000|Overall Study|Withdrawal by Subject|18
4607018|NCT01663727|7461095|FG001|Overall Study|Withdrawal by Subject|25
4607019|NCT01663727|7461094|FG000|Overall Study|Study Terminated|51
4607020|NCT01663727|7461095|FG001|Overall Study|Study Terminated|50
4607021|NCT01663727|7461094|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1
4607022|NCT01663727|7461095|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0
4607023|NCT01663727|7461094|FG000|Overall Study|Withdrawal prior to dosing.|1
4607024|NCT01663727|7461095|FG001|Overall Study|Withdrawal prior to dosing.|0
4607025|NCT01663740|7461103|FG000|Overall Study|Lost to Follow-up|1
4607026|NCT01663740|7461104|FG001|Overall Study|Lost to Follow-up|4
4607027|NCT01663740|7461103|FG000|Overall Study|Other|9
4607028|NCT01663740|7461104|FG001|Overall Study|Other|2
4607029|NCT01663740|7461103|FG000|Overall Study|Inclusion/Exclusion not met|1
4607030|NCT01663740|7461104|FG001|Overall Study|Inclusion/Exclusion not met|0
4607031|NCT01663740|7461103|FG000|Overall Study|Death|0
4607032|NCT01663740|7461104|FG001|Overall Study|Death|1
4607033|NCT01663740|7461103|FG000|Overall Study|Withdrawal by Subject|2
4607034|NCT01663740|7461104|FG001|Overall Study|Withdrawal by Subject|1
4607035|NCT01663740|7461103|FG000|Overall Study|No end of study status|3
4607036|NCT01663740|7461104|FG001|Overall Study|No end of study status|0
4607037|NCT01663857|7461123|FG000|Overall Study|Withdrew Consent to Study Participation|0
4607038|NCT01663857|7461124|FG001|Overall Study|Withdrew Consent to Study Participation|1
4607039|NCT01663857|7461125|FG002|Overall Study|Withdrew Consent to Study Participation|7
4607040|NCT01663857|7461126|FG003|Overall Study|Withdrew Consent to Study Participation|3
4607041|NCT01663857|7461123|FG000|Overall Study|Lost to Follow-up|0
4607042|NCT01663857|7461124|FG001|Overall Study|Lost to Follow-up|0
4607043|NCT01663857|7461125|FG002|Overall Study|Lost to Follow-up|3
4607044|NCT01663857|7461126|FG003|Overall Study|Lost to Follow-up|1
4607045|NCT01663896|7461142|FG000|Overall Study|Various reasons|43
4607046|NCT01663987|7461159|FG000|Overall Study|Adverse Event|7
4607047|NCT01663987|7461160|FG001|Overall Study|Adverse Event|2
4607048|NCT01663987|7461159|FG000|Overall Study|Lost to Follow-up|1
4607049|NCT01663987|7461160|FG001|Overall Study|Lost to Follow-up|1
4607050|NCT01663987|7461159|FG000|Overall Study|Withdrawal by Subject|2
4607051|NCT01663987|7461160|FG001|Overall Study|Withdrawal by Subject|3
4607052|NCT01663987|7461159|FG000|Overall Study|Other reason not defined above|3
4607053|NCT01663987|7461160|FG001|Overall Study|Other reason not defined above|0
4607054|NCT01664039|7461168|FG000|Overall Study|Adverse Event|3
4607055|NCT01664039|7461169|FG001|Overall Study|Adverse Event|4
4607056|NCT01664039|7461168|FG000|Overall Study|Lost to Follow-up|1
4607057|NCT01664039|7461169|FG001|Overall Study|Lost to Follow-up|1
4607058|NCT01664039|7461168|FG000|Overall Study|Withdrawal by Subject|1
4607059|NCT01664039|7461169|FG001|Overall Study|Withdrawal by Subject|3
4607060|NCT01664039|7461168|FG000|Overall Study|Noncompliance|1
4607061|NCT01664039|7461169|FG001|Overall Study|Noncompliance|1
4607062|NCT01664052|7461177|FG000|Phase 1|No device placement|6
4607063|NCT01664052|7461178|FG001|Phase 1|No device placement|0
4607064|NCT01664052|7461177|FG000|Phase 1|No HSG 1 hr post placement|1
4607065|NCT01664052|7461178|FG001|Phase 1|No HSG 1 hr post placement|0
4607066|NCT01664052|7461177|FG000|Phase 2|No device placement|0
4607067|NCT01664052|7461178|FG001|Phase 2|No device placement|4
4607068|NCT01664078|7461185|FG000|Overall Study|Death|9
4607069|NCT01664078|7461185|FG000|Overall Study|Withdrawal by Subject|4
4607070|NCT01664078|7461185|FG000|Overall Study|Lost to Follow-up|2
4607071|NCT01664078|7461185|FG000|Overall Study|missed 5 year visit|1
4607072|NCT01664078|7461185|FG000|Overall Study|Other|53
4607073|NCT01664091|7461235|FG000|Overall Study|Death|1
4607074|NCT01664091|7461235|FG000|Overall Study|Disease Progression|2
4607075|NCT01664091|7461235|FG000|Overall Study|Lost to Follow-up|2
4607076|NCT01664091|7461235|FG000|Overall Study|Withdrawal by Subject|1
4607077|NCT01664104|7461240|FG000|Overall Study|Adverse Event|6
4607078|NCT01664104|7461240|FG000|Overall Study|Lack of Efficacy|2
4607079|NCT01664104|7461240|FG000|Overall Study|Withdrawal by Subject|1
4607080|NCT01664104|7461240|FG000|Overall Study|Lost to Follow-up|4
4607081|NCT01664104|7461240|FG000|Overall Study|Other|1
4607082|NCT01664104|7461240|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2
4607083|NCT01664130|7461253|FG000|Overall Study|competing secondary disease|2
4607084|NCT01664247|7461262|FG000|Overall Study|Adverse Event|5
4607085|NCT01664247|7461263|FG001|Overall Study|Adverse Event|3
4607086|NCT01664247|7461262|FG000|Overall Study|Protocol Violation|3
4607087|NCT01664247|7461263|FG001|Overall Study|Protocol Violation|5
4607088|NCT01664247|7461262|FG000|Overall Study|Withdrawal Criteria|1
4607089|NCT01664247|7461263|FG001|Overall Study|Withdrawal Criteria|4
4607090|NCT01664247|7461262|FG000|Overall Study|Unclassified|5
4607091|NCT01664247|7461263|FG001|Overall Study|Unclassified|29
4607092|NCT01664494|7461269|FG000|Overall Study|Withdrawal by Subject|27
4607093|NCT01664494|7461269|FG000|Overall Study|Death|18
4607094|NCT01664494|7461269|FG000|Overall Study|Other|49
4607095|NCT01664494|7461269|FG000|Overall Study|Lost to Follow-up|99
4607096|NCT01664533|7461273|FG000|Overall Study|Death|42
4607097|NCT01664533|7461273|FG000|Overall Study|Lost to Follow-up|3
4607098|NCT01664533|7461273|FG000|Overall Study|Study termination|9
4607099|NCT01664533|7461273|FG000|Overall Study|Protocol Violation|3
4607100|NCT01664624|7461291|FG000|Overall Study|Adverse Event|0
4607101|NCT01664624|7461292|FG001|Overall Study|Adverse Event|1
4607102|NCT01664624|7461293|FG002|Overall Study|Adverse Event|0
4607103|NCT01664624|7461294|FG003|Overall Study|Adverse Event|0
4607104|NCT01664923|7461358|FG000|Period1:Double Blind Phase-29 Months|Death|8
4607105|NCT01664923|7461359|FG001|Period1:Double Blind Phase-29 Months|Death|6
4607106|NCT01664923|7461358|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0
4607107|NCT01664923|7461359|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1
4607108|NCT01664923|7461358|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2
4607109|NCT01664923|7461359|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0
4607110|NCT01664923|7461358|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12
4607111|NCT01664923|7461359|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8
4607112|NCT01664923|7461358|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65
4607113|NCT01664923|7461359|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132
4607114|NCT01664923|7461358|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14
4607115|NCT01664923|7461359|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9
4607116|NCT01664923|7461358|FG000|Period1:Double Blind Phase-29 Months|Other|3
4607117|NCT01664923|7461359|FG001|Period1:Double Blind Phase-29 Months|Other|4
4607118|NCT01664923|7461358|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1
4607119|NCT01664923|7461359|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0
4607120|NCT01664923|7461358|FG000|Period 2: Open-label Phase-36 Months|Death|3
4607121|NCT01664923|7461359|FG001|Period 2: Open-label Phase-36 Months|Death|1
4607122|NCT01664923|7461358|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1
4607123|NCT01664923|7461359|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1
4607124|NCT01664923|7461358|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28
4607125|NCT01664923|7461359|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9
4607126|NCT01664923|7461358|FG000|Period 2: Open-label Phase-36 Months|Other|3
4607127|NCT01664923|7461359|FG001|Period 2: Open-label Phase-36 Months|Other|1
4607128|NCT01664923|7461358|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4
4607129|NCT01664923|7461359|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7
4607130|NCT01664923|7461358|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2
4607131|NCT01664923|7461359|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4
4607132|NCT01664949|7461371|FG000|Overall Study|Adverse Event|11
4607133|NCT01664949|7461372|FG001|Overall Study|Adverse Event|12
4607134|NCT01664949|7461371|FG000|Overall Study|Lack of Efficacy|1
4607135|NCT01664949|7461372|FG001|Overall Study|Lack of Efficacy|1
4607136|NCT01664949|7461371|FG000|Overall Study|Lost to Follow-up|1
4607137|NCT01664949|7461372|FG001|Overall Study|Lost to Follow-up|2
4607138|NCT01664949|7461371|FG000|Overall Study|Personal Reasons|3
4607139|NCT01664949|7461372|FG001|Overall Study|Personal Reasons|4
4607140|NCT01664949|7461371|FG000|Overall Study|Protocol Violation|5
4607141|NCT01664949|7461372|FG001|Overall Study|Protocol Violation|5
4607142|NCT01664949|7461371|FG000|Overall Study|Other Miscellaneous Reasons|3
4607143|NCT01664949|7461372|FG001|Overall Study|Other Miscellaneous Reasons|1
4607144|NCT01665430|7461446|FG000|Overall Study|Adverse Event|1
4607145|NCT01665430|7461446|FG000|Overall Study|Withdrawal by Subject|6
4607146|NCT01665430|7461446|FG000|Overall Study|Other Unspecified|2
4607147|NCT01665599|7461459|FG000|Overall Study|Adverse Event|1
4607148|NCT01665599|7461459|FG000|Overall Study|Consent Withdrawn|1
4607149|NCT01665599|7461459|FG000|Overall Study|Investigator/Sponsor decision|1
4607150|NCT01665599|7461459|FG000|Overall Study|Death|1
4607151|NCT01665599|7461459|FG000|Overall Study|Lost to Follow-up|2
4607152|NCT01665599|7461459|FG000|Overall Study|Participant Left for More Than 3 Months|1
4607153|NCT01665599|7461459|FG000|Overall Study|Could Not Continue Due to Time Constrain|1
4607154|NCT01665768|7461463|FG000|Overall Study|Adverse Event|3
4607155|NCT01665768|7461463|FG000|Overall Study|Lack of Efficacy|19
4607156|NCT01665768|7461463|FG000|Overall Study|Withdrawal by Subject|1
4607157|NCT01665807|7461470|FG000|Overall Study|Withdrawal by Subject|2
4607158|NCT01665807|7461471|FG001|Overall Study|Withdrawal by Subject|0
4607159|NCT01665807|7461472|FG002|Overall Study|Withdrawal by Subject|1
4607160|NCT01665911|7461489|FG000|Overall Study|Protocol Violation|4
4607161|NCT01665911|7461489|FG000|Overall Study|Withdrawal by Subject|1
4607162|NCT01665911|7461489|FG000|Overall Study|Adverse Event|1
4607163|NCT01666002|7461509|FG000|Overall Study|Lost to Follow-up|5
4607164|NCT01666002|7461510|FG001|Overall Study|Lost to Follow-up|0
4637785|NCT01956123|7510866|FG000|COS Cycle 3|Protocol Violation|0
4637786|NCT01956123|7510867|FG001|COS Cycle 3|Protocol Violation|0
4637787|NCT01956123|7510868|FG002|COS Cycle 3|Protocol Violation|2
4637788|NCT01956123|7510869|FG003|COS Cycle 3|Protocol Violation|1
4637789|NCT01956123|7510866|FG000|COS Cycle 3|Adverse Event|0
4637790|NCT01956123|7510867|FG001|COS Cycle 3|Adverse Event|0
4637791|NCT01956123|7510868|FG002|COS Cycle 3|Adverse Event|3
4637792|NCT01956123|7510869|FG003|COS Cycle 3|Adverse Event|0
4637793|NCT01956123|7510866|FG000|COS Cycle 3|Personal Reasons|0
4637794|NCT01956123|7510867|FG001|COS Cycle 3|Personal Reasons|0
4637795|NCT01956123|7510868|FG002|COS Cycle 3|Personal Reasons|1
4637796|NCT01956123|7510869|FG003|COS Cycle 3|Personal Reasons|0
4637797|NCT01956123|7510866|FG000|COS Cycle 3|Withdrawal by Subject|0
4637798|NCT01956123|7510867|FG001|COS Cycle 3|Withdrawal by Subject|0
4637799|NCT01956123|7510868|FG002|COS Cycle 3|Withdrawal by Subject|0
4637800|NCT01956123|7510869|FG003|COS Cycle 3|Withdrawal by Subject|1
4637801|NCT01956240|7510882|FG000|Overall Study|Lost to Follow-up|6
4637802|NCT01956240|7510883|FG001|Overall Study|Lost to Follow-up|20
4637803|NCT01956240|7510882|FG000|Overall Study|Adverse Event|17
4637804|NCT01956240|7510883|FG001|Overall Study|Adverse Event|4
4637805|NCT01956773|7510908|FG000|Overall Study|Lost to Follow-up|628
4637806|NCT01956773|7510909|FG001|Overall Study|Lost to Follow-up|1
4637807|NCT01957111|7510922|FG000|Overall Study|Withdrawal by Subject|1
4637808|NCT01957111|7510923|FG001|Overall Study|Withdrawal by Subject|1
4637809|NCT01957137|7510929|FG000|Randomized Portion|Adverse Event|1
4637810|NCT01957137|7510929|FG000|Randomized Portion|Withdrawal by Subject|1
4637811|NCT01957150|7510943|FG000|Overall Study|Adverse Event|23
4637812|NCT01957150|7510944|FG001|Overall Study|Adverse Event|20
4637813|NCT01957150|7510943|FG000|Overall Study|Withdrawal by Subject|13
4637814|NCT01957150|7510944|FG001|Overall Study|Withdrawal by Subject|17
4637815|NCT01957150|7510943|FG000|Overall Study|Physician Decision|3
4637816|NCT01957150|7510944|FG001|Overall Study|Physician Decision|6
4637817|NCT01957150|7510943|FG000|Overall Study|Lost to Follow-up|4
4637818|NCT01957150|7510944|FG001|Overall Study|Lost to Follow-up|4
4637819|NCT01957150|7510943|FG000|Overall Study|Protocol Violation|1
4637820|NCT01957150|7510944|FG001|Overall Study|Protocol Violation|0
4637821|NCT01957150|7510943|FG000|Overall Study|Lack of Efficacy|11
4637822|NCT01957150|7510944|FG001|Overall Study|Lack of Efficacy|11
4637823|NCT01957163|7510953|FG000|Overall Study|Adverse Event|5
4637824|NCT01957163|7510954|FG001|Overall Study|Adverse Event|2
4637825|NCT01957163|7510955|FG002|Overall Study|Adverse Event|4
4637826|NCT01957163|7510953|FG000|Overall Study|Lack of Efficacy|5
4637827|NCT01957163|7510954|FG001|Overall Study|Lack of Efficacy|4
4637828|NCT01957163|7510955|FG002|Overall Study|Lack of Efficacy|9
4637829|NCT01957163|7510953|FG000|Overall Study|Protocol Violation|1
4637830|NCT01957163|7510954|FG001|Overall Study|Protocol Violation|2
4637831|NCT01957163|7510955|FG002|Overall Study|Protocol Violation|0
4637832|NCT01957163|7510953|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0
4637833|NCT01957163|7510954|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0
4637834|NCT01957163|7510955|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1
4637835|NCT01957163|7510953|FG000|Overall Study|Lost to Follow-up|0
4637836|NCT01957163|7510954|FG001|Overall Study|Lost to Follow-up|1
4637837|NCT01957163|7510955|FG002|Overall Study|Lost to Follow-up|0
4637838|NCT01957163|7510953|FG000|Overall Study|Withdrawal by Subject|4
4637839|NCT01957163|7510954|FG001|Overall Study|Withdrawal by Subject|2
4637840|NCT01957163|7510955|FG002|Overall Study|Withdrawal by Subject|4
4637841|NCT01957202|7510963|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
4637842|NCT01957202|7510964|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1
4637843|NCT01957202|7510965|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
4637844|NCT01957202|7510966|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
4637845|NCT01957202|7510967|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
4637846|NCT01957202|7510968|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
4637847|NCT01957202|7510969|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
4637848|NCT01957202|7510970|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
4637849|NCT01957202|7510971|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
4637850|NCT01957202|7510972|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
4637851|NCT01957202|7510973|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
4637852|NCT01957202|7510974|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
4637853|NCT01957202|7510975|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
4637854|NCT01957202|7510976|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
4637855|NCT01957202|7510977|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
4637856|NCT01957202|7510978|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
4637857|NCT01957202|7510979|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1
4637858|NCT01957202|7510980|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
4637859|NCT01957202|7510963|FG000|Treatment Period 3 (8 Days)|Adverse Event|0
4637860|NCT01957202|7510964|FG001|Treatment Period 3 (8 Days)|Adverse Event|0
4637861|NCT01957202|7510965|FG002|Treatment Period 3 (8 Days)|Adverse Event|0
4637862|NCT01957202|7510966|FG003|Treatment Period 3 (8 Days)|Adverse Event|0
4637863|NCT01957202|7510967|FG004|Treatment Period 3 (8 Days)|Adverse Event|0
4637864|NCT01957202|7510968|FG005|Treatment Period 3 (8 Days)|Adverse Event|0
4637865|NCT01957202|7510969|FG006|Treatment Period 3 (8 Days)|Adverse Event|0
4607165|NCT01666119|7461517|FG000|Overall Study|Adverse Event|6
4607166|NCT01666119|7461517|FG000|Overall Study|Withdrawal by Subject|16
4607167|NCT01666119|7461517|FG000|Overall Study|Lost to Follow-up|7
4607168|NCT01666119|7461517|FG000|Overall Study|non compliance with study medication, pa|18
4607169|NCT01666119|7461517|FG000|Overall Study|Subject experiencing withdrawal symptoms|5
4607170|NCT01666314|7461547|FG000|Overall Study|Adverse Event|3
4607171|NCT01666314|7461548|FG001|Overall Study|Adverse Event|13
4607172|NCT01666314|7461549|FG002|Overall Study|Adverse Event|7
4607173|NCT01666314|7461550|FG003|Overall Study|Adverse Event|7
4607174|NCT01666314|7461547|FG000|Overall Study|Progressive Disease|11
4607175|NCT01666314|7461548|FG001|Overall Study|Progressive Disease|9
4607176|NCT01666314|7461549|FG002|Overall Study|Progressive Disease|19
4607177|NCT01666314|7461550|FG003|Overall Study|Progressive Disease|20
4607178|NCT01666314|7461547|FG000|Overall Study|Symptomatic Deterioration|1
4607179|NCT01666314|7461548|FG001|Overall Study|Symptomatic Deterioration|0
4607180|NCT01666314|7461549|FG002|Overall Study|Symptomatic Deterioration|2
4607181|NCT01666314|7461550|FG003|Overall Study|Symptomatic Deterioration|0
4607182|NCT01666314|7461547|FG000|Overall Study|Unsatisfactory Therapeutic Response|7
4607183|NCT01666314|7461548|FG001|Overall Study|Unsatisfactory Therapeutic Response|2
4607184|NCT01666314|7461549|FG002|Overall Study|Unsatisfactory Therapeutic Response|1
4607185|NCT01666314|7461550|FG003|Overall Study|Unsatisfactory Therapeutic Response|1
4607186|NCT01666314|7461547|FG000|Overall Study|Withdrawal by Subject|1
4607187|NCT01666314|7461548|FG001|Overall Study|Withdrawal by Subject|1
4607188|NCT01666314|7461549|FG002|Overall Study|Withdrawal by Subject|2
4607189|NCT01666314|7461550|FG003|Overall Study|Withdrawal by Subject|3
4607190|NCT01666314|7461547|FG000|Overall Study|Reason not Specified|10
4607191|NCT01666314|7461548|FG001|Overall Study|Reason not Specified|7
4607192|NCT01666314|7461549|FG002|Overall Study|Reason not Specified|5
4607193|NCT01666314|7461550|FG003|Overall Study|Reason not Specified|5
4607194|NCT01666444|7461573|FG000|Overall Study|Did not initiate treatment|2
4607195|NCT01666444|7461574|FG001|Overall Study|Did not initiate treatment|1
4607196|NCT01666652|7461585|FG000|Overall Study|Serious Adverse Event|0
4607197|NCT01666652|7461586|FG001|Overall Study|Serious Adverse Event|0
4607198|NCT01666652|7461587|FG002|Overall Study|Serious Adverse Event|0
4607199|NCT01666652|7461588|FG003|Overall Study|Serious Adverse Event|1
4607200|NCT01666652|7461589|FG004|Overall Study|Serious Adverse Event|0
4607201|NCT01666652|7461585|FG000|Overall Study|Withdrawal by Subject|0
4607202|NCT01666652|7461586|FG001|Overall Study|Withdrawal by Subject|0
4607203|NCT01666652|7461587|FG002|Overall Study|Withdrawal by Subject|0
4607204|NCT01666652|7461588|FG003|Overall Study|Withdrawal by Subject|0
4607205|NCT01666652|7461589|FG004|Overall Study|Withdrawal by Subject|1
4607206|NCT01666652|7461585|FG000|Overall Study|Moved from study area|1
4607207|NCT01666652|7461586|FG001|Overall Study|Moved from study area|0
4607208|NCT01666652|7461587|FG002|Overall Study|Moved from study area|0
4607209|NCT01666652|7461588|FG003|Overall Study|Moved from study area|2
4607210|NCT01666652|7461589|FG004|Overall Study|Moved from study area|0
4607211|NCT01666652|7461585|FG000|Overall Study|Lost to Follow-up|1
4607212|NCT01666652|7461586|FG001|Overall Study|Lost to Follow-up|1
4607213|NCT01666652|7461587|FG002|Overall Study|Lost to Follow-up|1
4607214|NCT01666652|7461588|FG003|Overall Study|Lost to Follow-up|1
4607215|NCT01666652|7461589|FG004|Overall Study|Lost to Follow-up|0
4607216|NCT01666730|7461601|FG000|Overall Study|Adverse Event|16
4607217|NCT01666730|7461601|FG000|Overall Study|Death|2
4607218|NCT01666730|7461601|FG000|Overall Study|Physician Decision|5
4607219|NCT01666730|7461601|FG000|Overall Study|Withdrawal by Subject|9
4607220|NCT01666730|7461601|FG000|Overall Study|Disease progression/relapse|18
4607221|NCT01666782|7461607|FG000|Overall Study|Received 2 doses of vaccine|0
4607222|NCT01666782|7461608|FG001|Overall Study|Received 2 doses of vaccine|1
4637866|NCT01957202|7510970|FG007|Treatment Period 3 (8 Days)|Adverse Event|0
4637867|NCT01957202|7510971|FG008|Treatment Period 3 (8 Days)|Adverse Event|0
4637868|NCT01957202|7510972|FG009|Treatment Period 3 (8 Days)|Adverse Event|0
4637869|NCT01957202|7510973|FG010|Treatment Period 3 (8 Days)|Adverse Event|0
4637870|NCT01957202|7510974|FG011|Treatment Period 3 (8 Days)|Adverse Event|0
4637871|NCT01957202|7510975|FG012|Treatment Period 3 (8 Days)|Adverse Event|0
4637872|NCT01957202|7510976|FG013|Treatment Period 3 (8 Days)|Adverse Event|0
4637873|NCT01957202|7510977|FG014|Treatment Period 3 (8 Days)|Adverse Event|0
4637874|NCT01957202|7510978|FG015|Treatment Period 3 (8 Days)|Adverse Event|0
4637875|NCT01957202|7510979|FG016|Treatment Period 3 (8 Days)|Adverse Event|1
4637876|NCT01957202|7510980|FG017|Treatment Period 3 (8 Days)|Adverse Event|0
4637877|NCT01957215|7510992|FG000|Overall Study|Adverse Event|2
4637878|NCT01957215|7510993|FG001|Overall Study|Adverse Event|2
4637879|NCT01957215|7510992|FG000|Overall Study|Lost to Follow-up|3
4637880|NCT01957215|7510993|FG001|Overall Study|Lost to Follow-up|3
4637881|NCT01957215|7510992|FG000|Overall Study|Protocol Violation|1
4637882|NCT01957215|7510993|FG001|Overall Study|Protocol Violation|2
4637883|NCT01957215|7510992|FG000|Overall Study|Withdrawal by Subject|7
4637884|NCT01957215|7510993|FG001|Overall Study|Withdrawal by Subject|5
4607223|NCT01666782|7461607|FG000|Overall Study|Enrolled both years; year 1 data used|4
4607224|NCT01666782|7461608|FG001|Overall Study|Enrolled both years; year 1 data used|0
4607225|NCT01666951|7461625|FG000|Overall Study|Not dosed|1
4607226|NCT01666951|7461626|FG001|Overall Study|Not dosed|1
4607227|NCT01667107|7461641|FG000|Overall Study|Adverse Event|4
4607228|NCT01667107|7461642|FG001|Overall Study|Adverse Event|3
4607229|NCT01667107|7461641|FG000|Overall Study|Tolerability issues|0
4607230|NCT01667107|7461642|FG001|Overall Study|Tolerability issues|2
4607231|NCT01667107|7461641|FG000|Overall Study|Protocol Violation|0
4607232|NCT01667107|7461642|FG001|Overall Study|Protocol Violation|1
4607233|NCT01667107|7461641|FG000|Overall Study|Lack of Efficacy|0
4607234|NCT01667107|7461642|FG001|Overall Study|Lack of Efficacy|1
4607235|NCT01667224|7461650|FG000|Overall Study|Withdrawal by Subject|3
4607236|NCT01667224|7461651|FG001|Overall Study|Withdrawal by Subject|1
4607237|NCT01667224|7461650|FG000|Overall Study|Protocol Violation|1
4607238|NCT01667224|7461651|FG001|Overall Study|Protocol Violation|1
4607239|NCT01667419|7461745|FG000|Overall Study|Reason Not Specified|1
4607240|NCT01667419|7461746|FG001|Overall Study|Reason Not Specified|0
4607241|NCT01667419|7461747|FG002|Overall Study|Reason Not Specified|0
4607242|NCT01667419|7461748|FG003|Overall Study|Reason Not Specified|0
4607243|NCT01667419|7461745|FG000|Overall Study|Withdrawal by Subject|16
4607244|NCT01667419|7461746|FG001|Overall Study|Withdrawal by Subject|8
4607245|NCT01667419|7461747|FG002|Overall Study|Withdrawal by Subject|9
4607246|NCT01667419|7461748|FG003|Overall Study|Withdrawal by Subject|8
4607247|NCT01667419|7461745|FG000|Overall Study|Non-compliance|0
4607248|NCT01667419|7461746|FG001|Overall Study|Non-compliance|0
4607249|NCT01667419|7461747|FG002|Overall Study|Non-compliance|0
4607250|NCT01667419|7461748|FG003|Overall Study|Non-compliance|1
4607251|NCT01667419|7461745|FG000|Overall Study|Protocol Violation|1
4607252|NCT01667419|7461746|FG001|Overall Study|Protocol Violation|0
4607253|NCT01667419|7461747|FG002|Overall Study|Protocol Violation|0
4607254|NCT01667419|7461748|FG003|Overall Study|Protocol Violation|0
4607255|NCT01667419|7461745|FG000|Overall Study|Lost to Follow-up|7
4607256|NCT01667419|7461746|FG001|Overall Study|Lost to Follow-up|6
4607257|NCT01667419|7461747|FG002|Overall Study|Lost to Follow-up|2
4607258|NCT01667419|7461748|FG003|Overall Study|Lost to Follow-up|4
4607259|NCT01667419|7461745|FG000|Overall Study|Death|18
4607260|NCT01667419|7461746|FG001|Overall Study|Death|33
4607261|NCT01667419|7461747|FG002|Overall Study|Death|25
4607262|NCT01667419|7461748|FG003|Overall Study|Death|26
4607263|NCT01667432|7461759|FG000|Overall Study|Premature Study Termination|26
4607264|NCT01667432|7461759|FG000|Overall Study|Failure to Return|10
4607265|NCT01667432|7461759|FG000|Overall Study|Moved to Another Center|3
4607266|NCT01667432|7461759|FG000|Overall Study|Lost to Follow-up|3
4607267|NCT01667432|7461759|FG000|Overall Study|Refused Treatment/Withdrew Consent|1
4607268|NCT01667432|7461759|FG000|Overall Study|Insufficient Therapeutic Response|4
4607269|NCT01667432|7461759|FG000|Overall Study|Adverse Event|1
4607270|NCT01667432|7461759|FG000|Overall Study|Protocol Deviation|2
4607271|NCT01667432|7461759|FG000|Overall Study|Principal Investigator Decision|1
4607272|NCT01667432|7461759|FG000|Overall Study|Reason Not Specified|2
4607273|NCT01667432|7461759|FG000|Overall Study|Missing Information|4
4607274|NCT01667549|7461780|FG000|Overall Study|Withdrawal by Subject|3
4607275|NCT01667549|7461781|FG001|Overall Study|Withdrawal by Subject|5
4607276|NCT01667549|7461782|FG002|Overall Study|Withdrawal by Subject|7
4607277|NCT01667549|7461783|FG003|Overall Study|Withdrawal by Subject|6
4607278|NCT01667549|7461784|FG004|Overall Study|Withdrawal by Subject|1
4607279|NCT01667562|7461801|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30
4607280|NCT01667562|7461802|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0
4607281|NCT01667562|7461801|FG000|Erlotinib Phase|Lost to Follow-up|0
4607282|NCT01667562|7461802|FG001|Erlotinib Phase|Lost to Follow-up|1
4607283|NCT01667562|7461801|FG000|Erlotinib Phase|Adverse Event|0
4607284|NCT01667562|7461802|FG001|Erlotinib Phase|Adverse Event|1
4607285|NCT01667562|7461801|FG000|Erlotinib Phase|Switch to Commercial Drug|0
4607286|NCT01667562|7461802|FG001|Erlotinib Phase|Switch to Commercial Drug|1
4607287|NCT01667679|7461809|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2
4607288|NCT01667679|7461810|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6
4607289|NCT01667679|7461809|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2
4607290|NCT01667679|7461810|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0
4607291|NCT01667679|7461809|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2
4607292|NCT01667679|7461810|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0
4607293|NCT01667679|7461809|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1
4607294|NCT01667679|7461810|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0
4607295|NCT01667679|7461809|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6
4607296|NCT01667679|7461810|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13
4607297|NCT01667679|7461809|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3
4607298|NCT01667679|7461810|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3
4607299|NCT01667679|7461809|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0
4607300|NCT01667679|7461810|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2
4607301|NCT01667679|7461809|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0
4607302|NCT01667679|7461810|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2
4607303|NCT01667679|7461809|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0
4607304|NCT01667679|7461810|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3
4607305|NCT01667679|7461809|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0
4607306|NCT01667679|7461810|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1
4637885|NCT01957397|7511016|FG000|Test Period 1|sudden leakage/small bag|1
4607307|NCT01667679|7461809|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6
4607308|NCT01667679|7461810|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4
4607309|NCT01667679|7461809|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2
4607310|NCT01667679|7461810|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0
4607311|NCT01667679|7461809|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8
4607312|NCT01667679|7461810|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10
4607313|NCT01667679|7461809|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3
4607314|NCT01667679|7461810|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4
4607315|NCT01667679|7461809|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1
4607316|NCT01667679|7461810|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0
4607317|NCT01667679|7461809|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1
4637886|NCT01957397|7511017|FG001|Test Period 1|sudden leakage/small bag|1
4637887|NCT01957397|7511016|FG000|Test Period 1|Withdrawal by Subject|1
4637888|NCT01957397|7511017|FG001|Test Period 1|Withdrawal by Subject|0
4637889|NCT01957397|7511016|FG000|Test Period 2|Adverse Event|0
4637890|NCT01957397|7511017|FG001|Test Period 2|Adverse Event|1
4637891|NCT01957397|7511016|FG000|Test Period 3|Adverse Event|1
4637892|NCT01957397|7511017|FG001|Test Period 3|Adverse Event|2
4637893|NCT01957397|7511016|FG000|Test Period 3|the adhesive did not work|1
4637894|NCT01957397|7511017|FG001|Test Period 3|the adhesive did not work|0
4637895|NCT01957462|7511031|FG000|Test Period 1|Withdrawal by Subject|1
4637896|NCT01957462|7511032|FG001|Test Period 1|Withdrawal by Subject|0
4637897|NCT01957462|7511031|FG000|Test Period 1|Adverse Event|1
4637898|NCT01957462|7511032|FG001|Test Period 1|Adverse Event|0
4637899|NCT01957475|7511038|FG000|Test Period 1|Withdrawal by Subject|1
4637900|NCT01957475|7511039|FG001|Test Period 1|Withdrawal by Subject|0
4637901|NCT01957475|7511038|FG000|Test Period 1|Other|1
4637902|NCT01957475|7511039|FG001|Test Period 1|Other|0
4637903|NCT01957475|7511038|FG000|Test Period 1|Lack of Efficacy|0
4637904|NCT01957475|7511039|FG001|Test Period 1|Lack of Efficacy|1
4637905|NCT01957475|7511038|FG000|Test Period 2|Adverse Event|1
4637906|NCT01957475|7511039|FG001|Test Period 2|Adverse Event|0
4637907|NCT01957488|7511045|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2
4637908|NCT01957488|7511046|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0
4637909|NCT01957488|7511047|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1
4637910|NCT01957488|7511048|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1
4637911|NCT01957488|7511049|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0
4637912|NCT01957488|7511050|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0
4637913|NCT01957488|7511045|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1
4637914|NCT01957488|7511046|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2
4637915|NCT01957488|7511047|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2
4637916|NCT01957488|7511048|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1
4637917|NCT01957488|7511049|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0
4637918|NCT01957488|7511050|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3
4637919|NCT01957488|7511045|FG000|Test Period 1 (2 Weeks)|Adverse Event|0
4637920|NCT01957488|7511046|FG001|Test Period 1 (2 Weeks)|Adverse Event|1
4637921|NCT01957488|7511047|FG002|Test Period 1 (2 Weeks)|Adverse Event|1
4637922|NCT01957488|7511048|FG003|Test Period 1 (2 Weeks)|Adverse Event|0
4637923|NCT01957488|7511049|FG004|Test Period 1 (2 Weeks)|Adverse Event|1
4637924|NCT01957488|7511050|FG005|Test Period 1 (2 Weeks)|Adverse Event|0
4637925|NCT01957488|7511045|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0
4637926|NCT01957488|7511046|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0
4637927|NCT01957488|7511047|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0
4637928|NCT01957488|7511048|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1
4637929|NCT01957488|7511049|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1
4637930|NCT01957488|7511050|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2
4637931|NCT01957488|7511045|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0
4637932|NCT01957488|7511046|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0
4637933|NCT01957488|7511047|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0
4637934|NCT01957488|7511048|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0
4637935|NCT01957488|7511049|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1
4637936|NCT01957488|7511050|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0
4637937|NCT01957488|7511045|FG000|Test Period 1 (2 Weeks)|screen failure|0
4637938|NCT01957488|7511046|FG001|Test Period 1 (2 Weeks)|screen failure|0
4637939|NCT01957488|7511047|FG002|Test Period 1 (2 Weeks)|screen failure|0
4637940|NCT01957488|7511048|FG003|Test Period 1 (2 Weeks)|screen failure|0
4637941|NCT01957488|7511049|FG004|Test Period 1 (2 Weeks)|screen failure|0
4637942|NCT01957488|7511050|FG005|Test Period 1 (2 Weeks)|screen failure|1
4637943|NCT01957488|7511045|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2
4637944|NCT01957488|7511046|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0
4637945|NCT01957488|7511047|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1
4637946|NCT01957488|7511048|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1
4637947|NCT01957488|7511049|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0
4637948|NCT01957488|7511050|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0
4607318|NCT01667679|7461810|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0
4607319|NCT01667679|7461809|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1
4607320|NCT01667679|7461810|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0
4607321|NCT01667679|7461809|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0
4607322|NCT01667679|7461810|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1
4607323|NCT01667679|7461809|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0
4607324|NCT01667679|7461810|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1
4607325|NCT01667679|7461809|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0
4607326|NCT01667679|7461810|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1
4607327|NCT01667679|7461809|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0
4607328|NCT01667679|7461810|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1
4607329|NCT01667731|7461823|FG000|Overall Study|Enrolled but not treated|0
4637949|NCT01957488|7511045|FG000|Test Period 2 (2 Weeks)|Other|1
4637950|NCT01957488|7511046|FG001|Test Period 2 (2 Weeks)|Other|0
4637951|NCT01957488|7511047|FG002|Test Period 2 (2 Weeks)|Other|0
4637952|NCT01957488|7511048|FG003|Test Period 2 (2 Weeks)|Other|0
4637953|NCT01957488|7511049|FG004|Test Period 2 (2 Weeks)|Other|0
4637954|NCT01957488|7511050|FG005|Test Period 2 (2 Weeks)|Other|0
4637955|NCT01957488|7511045|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0
4637956|NCT01957488|7511046|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1
4637957|NCT01957488|7511047|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0
4637958|NCT01957488|7511048|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0
4637959|NCT01957488|7511049|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0
4637960|NCT01957488|7511050|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0
4637961|NCT01957488|7511045|FG000|Test Period 2 (2 Weeks)|Adverse Event|0
4637962|NCT01957488|7511046|FG001|Test Period 2 (2 Weeks)|Adverse Event|0
4637963|NCT01957488|7511047|FG002|Test Period 2 (2 Weeks)|Adverse Event|0
4637964|NCT01957488|7511048|FG003|Test Period 2 (2 Weeks)|Adverse Event|0
4637965|NCT01957488|7511049|FG004|Test Period 2 (2 Weeks)|Adverse Event|2
4637966|NCT01957488|7511050|FG005|Test Period 2 (2 Weeks)|Adverse Event|0
4637967|NCT01957488|7511045|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0
4637968|NCT01957488|7511046|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0
4637969|NCT01957488|7511047|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0
4637970|NCT01957488|7511048|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0
4637971|NCT01957488|7511049|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0
4637972|NCT01957488|7511050|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1
4637973|NCT01957488|7511045|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1
4637974|NCT01957488|7511046|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0
4637975|NCT01957488|7511047|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0
4637976|NCT01957488|7511048|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0
4637977|NCT01957488|7511049|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0
4637978|NCT01957488|7511050|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0
4607330|NCT01667731|7461824|FG001|Overall Study|Enrolled but not treated|0
4607331|NCT01667731|7461825|FG002|Overall Study|Enrolled but not treated|0
4637979|NCT01957488|7511045|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0
4637980|NCT01957488|7511046|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1
4637981|NCT01957488|7511047|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0
4637982|NCT01957488|7511048|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0
4637983|NCT01957488|7511049|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0
4637984|NCT01957488|7511050|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0
4637985|NCT01957553|7511058|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2
4637986|NCT01957553|7511059|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3
4637987|NCT01957553|7511058|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2
4637988|NCT01957553|7511059|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0
4637989|NCT01957553|7511058|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2
4637990|NCT01957553|7511059|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0
4637991|NCT01957553|7511058|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1
4637992|NCT01957553|7511059|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0
4637993|NCT01957553|7511058|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1
4637994|NCT01957553|7511059|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3
4637995|NCT01957553|7511058|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1
4637996|NCT01957553|7511059|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2
4637997|NCT01957553|7511058|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0
4637998|NCT01957553|7511059|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1
4637999|NCT01957553|7511058|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0
4638000|NCT01957553|7511059|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1
4638001|NCT01957553|7511058|FG000|Test Period 2 (21 +- 1 Days)|Other|1
4638002|NCT01957553|7511059|FG001|Test Period 2 (21 +- 1 Days)|Other|0
4638003|NCT01957579|7511069|FG000|Overall Study|Withdrawal of concent|0
4638004|NCT01957579|7511070|FG001|Overall Study|Withdrawal of concent|1
4638005|NCT01957579|7511071|FG002|Overall Study|Withdrawal of concent|0
4638006|NCT01957579|7511072|FG003|Overall Study|Withdrawal of concent|0
4638007|NCT01957579|7511069|FG000|Overall Study|Death|0
4638008|NCT01957579|7511070|FG001|Overall Study|Death|0
4638009|NCT01957579|7511071|FG002|Overall Study|Death|2
4638010|NCT01957579|7511072|FG003|Overall Study|Death|0
4638011|NCT01957644|7511104|FG000|Overall Study|Adverse Event|4
4638012|NCT01957644|7511105|FG001|Overall Study|Adverse Event|2
4607332|NCT01667731|7461826|FG003|Overall Study|Enrolled but not treated|0
4607333|NCT01667731|7461827|FG004|Overall Study|Enrolled but not treated|1
4607334|NCT01667731|7461823|FG000|Overall Study|Efficacy Failure|1
4607335|NCT01667731|7461824|FG001|Overall Study|Efficacy Failure|12
4607336|NCT01667731|7461825|FG002|Overall Study|Efficacy Failure|0
4607337|NCT01667731|7461826|FG003|Overall Study|Efficacy Failure|1
4607338|NCT01667731|7461827|FG004|Overall Study|Efficacy Failure|24
4607339|NCT01667731|7461823|FG000|Overall Study|Lost to Follow-up|2
4607340|NCT01667731|7461824|FG001|Overall Study|Lost to Follow-up|3
4607341|NCT01667731|7461825|FG002|Overall Study|Lost to Follow-up|1
4607342|NCT01667731|7461826|FG003|Overall Study|Lost to Follow-up|1
4607343|NCT01667731|7461827|FG004|Overall Study|Lost to Follow-up|2
4607344|NCT01667731|7461823|FG000|Overall Study|Subject Withdrew Consent|2
4607345|NCT01667731|7461824|FG001|Overall Study|Subject Withdrew Consent|0
4607346|NCT01667731|7461825|FG002|Overall Study|Subject Withdrew Consent|1
4607347|NCT01667731|7461826|FG003|Overall Study|Subject Withdrew Consent|0
4607348|NCT01667731|7461827|FG004|Overall Study|Subject Withdrew Consent|1
4607349|NCT01667731|7461823|FG000|Overall Study|Death|0
4607350|NCT01667731|7461824|FG001|Overall Study|Death|1
4607351|NCT01667731|7461825|FG002|Overall Study|Death|0
4607352|NCT01667731|7461826|FG003|Overall Study|Death|0
4607353|NCT01667731|7461827|FG004|Overall Study|Death|0
4607354|NCT01667900|7461867|FG000|Part B|Death|0
4607355|NCT01667900|7461868|FG001|Part B|Death|0
4607356|NCT01667900|7461869|FG002|Part B|Death|0
4607357|NCT01667900|7461870|FG003|Part B|Death|0
4607358|NCT01667900|7461871|FG004|Part B|Death|0
4607359|NCT01667900|7461872|FG005|Part B|Death|0
4607360|NCT01667900|7461873|FG006|Part B|Death|0
4607361|NCT01667900|7461874|FG007|Part B|Death|0
4607362|NCT01667900|7461875|FG008|Part B|Death|0
4607363|NCT01667900|7461876|FG009|Part B|Death|0
4607364|NCT01667900|7461877|FG010|Part B|Death|0
4607365|NCT01667900|7461878|FG011|Part B|Death|0
4607366|NCT01667900|7461879|FG012|Part B|Death|0
4607367|NCT01667900|7461880|FG013|Part B|Death|0
4607368|NCT01667900|7461881|FG014|Part B|Death|0
4607369|NCT01667900|7461882|FG015|Part B|Death|0
4607370|NCT01667900|7461883|FG016|Part B|Death|1
4607371|NCT01667900|7461884|FG017|Part B|Death|0
4607372|NCT01667900|7461885|FG018|Part B|Death|0
4607373|NCT01667900|7461886|FG019|Part B|Death|0
4607374|NCT01667926|7461908|FG000|Overall Study|Withdrawal by Subject|1
4607375|NCT01667926|7461909|FG001|Overall Study|Withdrawal by Subject|2
4607376|NCT01667926|7461910|FG002|Overall Study|Withdrawal by Subject|2
4638013|NCT01957644|7511106|FG002|Overall Study|Adverse Event|0
4638014|NCT01957644|7511107|FG003|Overall Study|Adverse Event|0
4638015|NCT01957644|7511108|FG004|Overall Study|Adverse Event|1
4638016|NCT01957644|7511104|FG000|Overall Study|Progressive disease / relapse|0
4638017|NCT01957644|7511105|FG001|Overall Study|Progressive disease / relapse|1
4638018|NCT01957644|7511106|FG002|Overall Study|Progressive disease / relapse|0
4638019|NCT01957644|7511107|FG003|Overall Study|Progressive disease / relapse|1
4638020|NCT01957644|7511108|FG004|Overall Study|Progressive disease / relapse|0
4638021|NCT01957644|7511104|FG000|Overall Study|Other reason|1
4638022|NCT01957644|7511105|FG001|Overall Study|Other reason|2
4638023|NCT01957644|7511106|FG002|Overall Study|Other reason|1
4638024|NCT01957644|7511107|FG003|Overall Study|Other reason|1
4638025|NCT01957644|7511108|FG004|Overall Study|Other reason|0
4638026|NCT01957644|7511104|FG000|Overall Study|Withdrawal by Subject|1
4638027|NCT01957644|7511105|FG001|Overall Study|Withdrawal by Subject|0
4638028|NCT01957644|7511106|FG002|Overall Study|Withdrawal by Subject|0
4638029|NCT01957644|7511107|FG003|Overall Study|Withdrawal by Subject|0
4638030|NCT01957644|7511108|FG004|Overall Study|Withdrawal by Subject|0
4638031|NCT01957644|7511104|FG000|Overall Study|Protocol Violation|0
4638032|NCT01957644|7511105|FG001|Overall Study|Protocol Violation|1
4638033|NCT01957644|7511106|FG002|Overall Study|Protocol Violation|0
4638034|NCT01957644|7511107|FG003|Overall Study|Protocol Violation|0
4638035|NCT01957644|7511108|FG004|Overall Study|Protocol Violation|0
4638036|NCT01957709|7511126|FG000|Overall Study|Patient refused to complete post-tx bx|1
4638037|NCT01957787|7511134|FG000|Overall Study|Death|18
4638038|NCT01957787|7511134|FG000|Overall Study|Lost to Follow-up|3
4638039|NCT01957787|7511134|FG000|Overall Study|Withdrawal by Subject|3
4638040|NCT01957787|7511134|FG000|Overall Study|Entered Hospice or Similar Program|2
4638041|NCT01957787|7511134|FG000|Overall Study|Index Tumor(s) Resected|2
4638042|NCT01957787|7511134|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2
4638043|NCT01957787|7511134|FG000|Overall Study|Local therapy, not cryoablation|6
4607377|NCT01667926|7461908|FG000|Overall Study|Physician Decision|0
4607378|NCT01667926|7461909|FG001|Overall Study|Physician Decision|0
4607379|NCT01667926|7461910|FG002|Overall Study|Physician Decision|1
4607380|NCT01667926|7461908|FG000|Overall Study|Time committment|0
4607381|NCT01667926|7461909|FG001|Overall Study|Time committment|0
4607382|NCT01667926|7461910|FG002|Overall Study|Time committment|2
4607383|NCT01667926|7461908|FG000|Overall Study|Inclusion/Exclusion Criteria|0
4607384|NCT01667926|7461909|FG001|Overall Study|Inclusion/Exclusion Criteria|0
4607385|NCT01667926|7461910|FG002|Overall Study|Inclusion/Exclusion Criteria|5
4607386|NCT01667926|7461908|FG000|Overall Study|Lost to Follow-up|1
4607387|NCT01667926|7461909|FG001|Overall Study|Lost to Follow-up|2
4638044|NCT01957865|7511141|FG000|Overall Study|Found HIV negative|0
4638045|NCT01957865|7511142|FG001|Overall Study|Found HIV negative|0
4607388|NCT01667926|7461910|FG002|Overall Study|Lost to Follow-up|1
4607389|NCT01667926|7461908|FG000|Overall Study|Side effects|3
4607390|NCT01667926|7461909|FG001|Overall Study|Side effects|0
4607391|NCT01667926|7461910|FG002|Overall Study|Side effects|0
4607392|NCT01668004|7461925|FG000|Overall Study|Adverse Event|7
4607393|NCT01668004|7461925|FG000|Overall Study|Withdrawal by Subject|2
4607394|NCT01668004|7461925|FG000|Overall Study|Lost to Follow-up|5
4607395|NCT01668004|7461925|FG000|Overall Study|Lack of Efficacy|9
4607396|NCT01668004|7461925|FG000|Overall Study|Non-compliance with treatment|2
4607397|NCT01668173|7461973|FG000|Overall Study|Adverse Event|3
4607398|NCT01668173|7461973|FG000|Overall Study|Trial suspension|4
4607399|NCT01668355|7461979|FG000|Overall Study|Death|3
4607400|NCT01668355|7461980|FG001|Overall Study|Death|1
4607401|NCT01668355|7461979|FG000|Overall Study|Withdrawal by Subject|6
4607402|NCT01668355|7461980|FG001|Overall Study|Withdrawal by Subject|1
4607403|NCT01668537|7461989|FG000|Overall Study|Request to Discontinue Prematurely|1
4607404|NCT01668537|7461990|FG001|Overall Study|Request to Discontinue Prematurely|1
4607405|NCT01668537|7461989|FG000|Overall Study|Subject unwilling/unable to comply|5
4607406|NCT01668537|7461990|FG001|Overall Study|Subject unwilling/unable to comply|0
4607407|NCT01668537|7461989|FG000|Overall Study|Reason Precludes Participation|1
4607408|NCT01668537|7461990|FG001|Overall Study|Reason Precludes Participation|0
4607409|NCT01668537|7461989|FG000|Overall Study|Lost to Follow-up|13
4607410|NCT01668537|7461990|FG001|Overall Study|Lost to Follow-up|6
4607411|NCT01668537|7461989|FG000|Overall Study|Other|2
4607412|NCT01668537|7461990|FG001|Overall Study|Other|3
4607413|NCT01668589|7462000|FG000|Overall Study|Lost to Follow-up|29
4607414|NCT01668589|7462001|FG001|Overall Study|Lost to Follow-up|37
4607415|NCT01668589|7462002|FG002|Overall Study|Lost to Follow-up|15
4607416|NCT01668589|7462003|FG003|Overall Study|Lost to Follow-up|5
4607417|NCT01668589|7462000|FG000|Overall Study|Full Consent/Agreement Withdrawn|54
4607418|NCT01668589|7462001|FG001|Overall Study|Full Consent/Agreement Withdrawn|8
4607419|NCT01668589|7462002|FG002|Overall Study|Full Consent/Agreement Withdrawn|11
4607420|NCT01668589|7462003|FG003|Overall Study|Full Consent/Agreement Withdrawn|4
4607421|NCT01668589|7462000|FG000|Overall Study|Death|12
4607422|NCT01668589|7462001|FG001|Overall Study|Death|3
4607423|NCT01668589|7462002|FG002|Overall Study|Death|2
4607424|NCT01668589|7462003|FG003|Overall Study|Death|11
4607425|NCT01668589|7462000|FG000|Overall Study|Other|44
4607426|NCT01668589|7462001|FG001|Overall Study|Other|10
4607427|NCT01668589|7462002|FG002|Overall Study|Other|7
4607428|NCT01668589|7462003|FG003|Overall Study|Other|15
4607429|NCT01668654|7462041|FG000|Overall Study|Study Closed/Terminated|3
4607430|NCT01668654|7462041|FG000|Overall Study|Withdrawal by Subject|1
4607431|NCT01668667|7462049|FG000|Overall Study|Adverse Event|3
4607432|NCT01668667|7462050|FG001|Overall Study|Adverse Event|6
4607433|NCT01668667|7462051|FG002|Overall Study|Adverse Event|4
4607434|NCT01668667|7462052|FG003|Overall Study|Adverse Event|4
4607435|NCT01668667|7462049|FG000|Overall Study|Lack of Efficacy|3
4638046|NCT01957865|7511143|FG002|Overall Study|Found HIV negative|1
4638047|NCT01957865|7511141|FG000|Overall Study|Lost to Follow-up|0
4638048|NCT01957865|7511142|FG001|Overall Study|Lost to Follow-up|2
4638049|NCT01957865|7511143|FG002|Overall Study|Lost to Follow-up|2
4638050|NCT01958008|7511168|FG000|Overall Study|Worsening of disease under study|0
4638051|NCT01958008|7511169|FG001|Overall Study|Worsening of disease under study|0
4638052|NCT01958008|7511170|FG002|Overall Study|Worsening of disease under study|1
4638053|NCT01958008|7511171|FG003|Overall Study|Worsening of disease under study|0
4638054|NCT01958008|7511168|FG000|Overall Study|Other adverse event|1
4638055|NCT01958008|7511169|FG001|Overall Study|Other adverse event|0
4638056|NCT01958008|7511170|FG002|Overall Study|Other adverse event|0
4638057|NCT01958008|7511171|FG003|Overall Study|Other adverse event|0
4638058|NCT01958060|7511190|FG000|Overall Study|Not treated|2
4638059|NCT01958060|7511191|FG001|Overall Study|Not treated|0
4638060|NCT01958060|7511192|FG002|Overall Study|Not treated|0
4638061|NCT01958060|7511193|FG003|Overall Study|Not treated|0
4638062|NCT01958060|7511194|FG004|Overall Study|Not treated|1
4638063|NCT01958060|7511195|FG005|Overall Study|Not treated|0
4638064|NCT01958125|7511242|FG000|Overall Study|Missing diary data|2
4638065|NCT01958125|7511243|FG001|Overall Study|Missing diary data|6
4638066|NCT01958125|7511242|FG000|Overall Study|No headache attacks|0
4638067|NCT01958125|7511243|FG001|Overall Study|No headache attacks|2
4638068|NCT01958164|7511251|FG000|Overall Study|Adverse Event|0
4638069|NCT01958164|7511252|FG001|Overall Study|Adverse Event|2
4638070|NCT01958164|7511251|FG000|Overall Study|Lost to Follow-up|2
4638071|NCT01958164|7511252|FG001|Overall Study|Lost to Follow-up|3
4746953|NCT00441272|7719867|FG001|Overall Study|Study terminated prior to enrollment|25
4607436|NCT01668667|7462050|FG001|Overall Study|Lack of Efficacy|2
4607437|NCT01668667|7462051|FG002|Overall Study|Lack of Efficacy|2
4607438|NCT01668667|7462052|FG003|Overall Study|Lack of Efficacy|3
4607439|NCT01668667|7462049|FG000|Overall Study|Protocol Violation|6
4607440|NCT01668667|7462050|FG001|Overall Study|Protocol Violation|10
4746954|NCT00440271|7719879|FG000|Overall Study|Protocol Violation|1
4746955|NCT00440271|7719880|FG001|Overall Study|Protocol Violation|1
4746956|NCT00440271|7719879|FG000|Overall Study|Adverse Event|0
4746957|NCT00440271|7719880|FG001|Overall Study|Adverse Event|1
4746958|NCT00440271|7719879|FG000|Overall Study|Lost to Follow-up|1
4746959|NCT00440271|7719880|FG001|Overall Study|Lost to Follow-up|0
4607441|NCT01668667|7462051|FG002|Overall Study|Protocol Violation|12
4607442|NCT01668667|7462052|FG003|Overall Study|Protocol Violation|5
4607443|NCT01668667|7462049|FG000|Overall Study|Lost to Follow-up|9
4607444|NCT01668667|7462050|FG001|Overall Study|Lost to Follow-up|4
4607445|NCT01668667|7462051|FG002|Overall Study|Lost to Follow-up|7
4607446|NCT01668667|7462052|FG003|Overall Study|Lost to Follow-up|6
4607447|NCT01668667|7462049|FG000|Overall Study|Physician Decision|3
4607448|NCT01668667|7462050|FG001|Overall Study|Physician Decision|0
4607449|NCT01668667|7462051|FG002|Overall Study|Physician Decision|1
4607450|NCT01668667|7462052|FG003|Overall Study|Physician Decision|0
4607451|NCT01668667|7462049|FG000|Overall Study|Withdrawal by Subject|7
4607452|NCT01668667|7462050|FG001|Overall Study|Withdrawal by Subject|4
4607453|NCT01668667|7462051|FG002|Overall Study|Withdrawal by Subject|5
4607454|NCT01668667|7462052|FG003|Overall Study|Withdrawal by Subject|5
4607455|NCT01668719|7462065|FG000|Phase I|On treatment|1
4607456|NCT01668719|7462066|FG001|Phase I|On treatment|0
4607457|NCT01668719|7462067|FG002|Phase I|On treatment|0
4607458|NCT01668719|7462065|FG000|Phase I|Adverse Event|2
4607459|NCT01668719|7462066|FG001|Phase I|Adverse Event|0
4607460|NCT01668719|7462067|FG002|Phase I|Adverse Event|0
4607461|NCT01668719|7462065|FG000|Phase I|Progression/relapse|1
4607462|NCT01668719|7462066|FG001|Phase I|Progression/relapse|0
4607463|NCT01668719|7462067|FG002|Phase I|Progression/relapse|0
4607464|NCT01668719|7462065|FG000|Phase I|not protocol specified|2
4607465|NCT01668719|7462066|FG001|Phase I|not protocol specified|0
4607466|NCT01668719|7462067|FG002|Phase I|not protocol specified|0
4607467|NCT01668719|7462065|FG000|Phase II|On treatment|0
4607468|NCT01668719|7462066|FG001|Phase II|On treatment|4
4607469|NCT01668719|7462067|FG002|Phase II|On treatment|3
4607470|NCT01668719|7462065|FG000|Phase II|Adverse Event|0
4607471|NCT01668719|7462066|FG001|Phase II|Adverse Event|18
4607472|NCT01668719|7462067|FG002|Phase II|Adverse Event|18
4607473|NCT01668719|7462065|FG000|Phase II|Refusal unrelated to adverse event|0
4607474|NCT01668719|7462066|FG001|Phase II|Refusal unrelated to adverse event|4
4607475|NCT01668719|7462067|FG002|Phase II|Refusal unrelated to adverse event|1
4607476|NCT01668719|7462065|FG000|Phase II|Progression/relapse|0
4607477|NCT01668719|7462066|FG001|Phase II|Progression/relapse|13
4607478|NCT01668719|7462067|FG002|Phase II|Progression/relapse|17
4607479|NCT01668719|7462065|FG000|Phase II|Death|0
4607480|NCT01668719|7462066|FG001|Phase II|Death|0
4607481|NCT01668719|7462067|FG002|Phase II|Death|2
4607482|NCT01668719|7462065|FG000|Phase II|not protocol specified|0
4607483|NCT01668719|7462066|FG001|Phase II|not protocol specified|13
4607484|NCT01668719|7462067|FG002|Phase II|not protocol specified|7
4607485|NCT01668797|7462079|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3
4607486|NCT01668797|7462080|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0
4607487|NCT01668797|7462081|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0
4607488|NCT01668797|7462082|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0
4607489|NCT01668797|7462079|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3
4607490|NCT01668797|7462080|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
4607491|NCT01668797|7462081|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
4607492|NCT01668797|7462082|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
4607493|NCT01668797|7462079|FG000|Phase A (Conversion Phase)|Physician Decision|2
4607494|NCT01668797|7462080|FG001|Phase A (Conversion Phase)|Physician Decision|0
4607495|NCT01668797|7462081|FG002|Phase A (Conversion Phase)|Physician Decision|0
4607496|NCT01668797|7462082|FG003|Phase A (Conversion Phase)|Physician Decision|0
4607497|NCT01668797|7462079|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16
4607498|NCT01668797|7462080|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0
4607499|NCT01668797|7462081|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0
4607500|NCT01668797|7462082|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0
4607501|NCT01668797|7462079|FG000|Phase A (Conversion Phase)|Protocol Violation|2
4607502|NCT01668797|7462080|FG001|Phase A (Conversion Phase)|Protocol Violation|0
4607503|NCT01668797|7462081|FG002|Phase A (Conversion Phase)|Protocol Violation|0
4607504|NCT01668797|7462082|FG003|Phase A (Conversion Phase)|Protocol Violation|0
4607505|NCT01668797|7462079|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7
4607506|NCT01668797|7462080|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0
4607507|NCT01668797|7462081|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0
4607508|NCT01668797|7462082|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0
4607509|NCT01668797|7462079|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8
4607510|NCT01668797|7462080|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
4638072|NCT01958281|7511261|FG000|Overall Study|Lack of Efficacy|5
4638073|NCT01958281|7511262|FG001|Overall Study|Lack of Efficacy|2
4607511|NCT01668797|7462081|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
4607512|NCT01668797|7462082|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
4607513|NCT01668797|7462079|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19
4607514|NCT01668797|7462080|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
4607515|NCT01668797|7462081|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
4607516|NCT01668797|7462082|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
4607517|NCT01668797|7462079|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0
4607518|NCT01668797|7462080|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16
4638074|NCT01958281|7511263|FG002|Overall Study|Lack of Efficacy|0
4607519|NCT01668797|7462081|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0
4607520|NCT01668797|7462082|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0
4607521|NCT01668797|7462079|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
4638075|NCT01958281|7511261|FG000|Overall Study|Adverse Event|0
4638076|NCT01958281|7511262|FG001|Overall Study|Adverse Event|2
4638077|NCT01958281|7511263|FG002|Overall Study|Adverse Event|0
4638078|NCT01958281|7511261|FG000|Overall Study|Withdrew Consent|1
4638079|NCT01958281|7511262|FG001|Overall Study|Withdrew Consent|0
4638080|NCT01958281|7511263|FG002|Overall Study|Withdrew Consent|0
4638081|NCT01958294|7511272|FG000|Overall Study|Clinical Circumstances|2
4638082|NCT01958437|7511298|FG000|Overall Study|Incidental MRI findings|0
4638083|NCT01958437|7511299|FG001|Overall Study|Incidental MRI findings|0
4638084|NCT01958437|7511300|FG002|Overall Study|Incidental MRI findings|1
4638085|NCT01958437|7511301|FG003|Overall Study|Incidental MRI findings|1
4638086|NCT01958476|7511320|FG000|Overall Study|Parent requested exclusion from analysis|1
4638087|NCT01958476|7511321|FG001|Overall Study|Parent requested exclusion from analysis|0
4638088|NCT01958489|7511327|FG000|Period 2|Adverse Event|0
4638089|NCT01958489|7511328|FG001|Period 2|Adverse Event|1
4638090|NCT01958619|7511352|FG000|Overall Study|Protocol Violation|2
4638091|NCT01958619|7511353|FG001|Overall Study|Protocol Violation|0
4638092|NCT01958619|7511354|FG002|Overall Study|Protocol Violation|1
4638093|NCT01958619|7511355|FG003|Overall Study|Protocol Violation|0
4638094|NCT01958671|7511383|FG000|Overall Study|Adverse Event|1
4638095|NCT01958671|7511384|FG001|Overall Study|Adverse Event|1
4638096|NCT01958671|7511385|FG002|Overall Study|Adverse Event|5
4638097|NCT01958671|7511383|FG000|Overall Study|Death|1
4638098|NCT01958671|7511384|FG001|Overall Study|Death|0
4638099|NCT01958671|7511385|FG002|Overall Study|Death|0
4638100|NCT01958671|7511383|FG000|Overall Study|Excluded medication|0
4638101|NCT01958671|7511384|FG001|Overall Study|Excluded medication|0
4638102|NCT01958671|7511385|FG002|Overall Study|Excluded medication|1
4746960|NCT00440271|7719879|FG000|Overall Study|Withdrawal by Subject|0
4746961|NCT00440271|7719880|FG001|Overall Study|Withdrawal by Subject|2
4746962|NCT00440271|7719879|FG000|Overall Study|Lack of Efficacy|0
4746963|NCT00440271|7719880|FG001|Overall Study|Lack of Efficacy|1
4746964|NCT00440271|7719879|FG000|Overall Study|Due to closure of trial|8
4746965|NCT00440271|7719880|FG001|Overall Study|Due to closure of trial|10
4746966|NCT00440271|7719879|FG000|Overall Study|Other|2
4746967|NCT00440271|7719880|FG001|Overall Study|Other|0
4746968|NCT00429026|7719890|FG000|Overall Study|Inevaluable for response.|40
4746969|NCT00439569|7719901|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1
4746970|NCT00439569|7719901|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3
4746971|NCT00439569|7719901|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1
4746972|NCT00422669|7719908|FG000|Overall Study|The study was terminated early.|98
4746973|NCT00422669|7719909|FG001|Overall Study|The study was terminated early.|100
4746974|NCT00422669|7719910|FG002|Overall Study|The study was terminated early.|7
4746975|NCT00434590|7719922|FG000|Overall Study|Administrative problems|5
4746976|NCT00434590|7719923|FG001|Overall Study|Administrative problems|5
4746977|NCT00424645|7719931|FG000|Overall Study|Death|1
4746978|NCT00424645|7719932|FG001|Overall Study|Death|0
4746979|NCT00430027|7719938|FG000|Overall Study|Study terminated|8
4746980|NCT00429858|7719942|FG000|Overall Study|Withdrawal by Subject|1
4607522|NCT01668797|7462080|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22
4607523|NCT01668797|7462081|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
4607524|NCT01668797|7462082|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
4607525|NCT01668797|7462079|FG000|Phase B (Stabilization Phase)|Physician Decision|0
4607526|NCT01668797|7462080|FG001|Phase B (Stabilization Phase)|Physician Decision|11
4607527|NCT01668797|7462081|FG002|Phase B (Stabilization Phase)|Physician Decision|0
4607528|NCT01668797|7462082|FG003|Phase B (Stabilization Phase)|Physician Decision|0
4607529|NCT01668797|7462079|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0
4638103|NCT01958671|7511383|FG000|Overall Study|Hyperglycemia|0
4638104|NCT01958671|7511384|FG001|Overall Study|Hyperglycemia|0
4638105|NCT01958671|7511385|FG002|Overall Study|Hyperglycemia|2
4638106|NCT01958671|7511383|FG000|Overall Study|Lost to Follow-up|7
4638107|NCT01958671|7511384|FG001|Overall Study|Lost to Follow-up|11
4638108|NCT01958671|7511385|FG002|Overall Study|Lost to Follow-up|7
4638109|NCT01958671|7511383|FG000|Overall Study|Non-compliance with study drug|1
4638110|NCT01958671|7511384|FG001|Overall Study|Non-compliance with study drug|1
4638111|NCT01958671|7511385|FG002|Overall Study|Non-compliance with study drug|1
4638112|NCT01958671|7511383|FG000|Overall Study|Pregnancy|0
4638113|NCT01958671|7511384|FG001|Overall Study|Pregnancy|0
4638114|NCT01958671|7511385|FG002|Overall Study|Pregnancy|1
4638115|NCT01958671|7511383|FG000|Overall Study|Protocol Violation|0
4638116|NCT01958671|7511384|FG001|Overall Study|Protocol Violation|1
4638117|NCT01958671|7511385|FG002|Overall Study|Protocol Violation|0
4638118|NCT01958671|7511383|FG000|Overall Study|Study site terminated by sponsor|1
4638119|NCT01958671|7511384|FG001|Overall Study|Study site terminated by sponsor|0
4638120|NCT01958671|7511385|FG002|Overall Study|Study site terminated by sponsor|1
4638121|NCT01958671|7511383|FG000|Overall Study|Participant moved|0
4638122|NCT01958671|7511384|FG001|Overall Study|Participant moved|0
4638123|NCT01958671|7511385|FG002|Overall Study|Participant moved|1
4638124|NCT01958671|7511383|FG000|Overall Study|Withdrawal by Subject|8
4607530|NCT01668797|7462080|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60
4607531|NCT01668797|7462081|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0
4607532|NCT01668797|7462082|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0
4607533|NCT01668797|7462079|FG000|Phase B (Stabilization Phase)|Protocol Violation|0
4607534|NCT01668797|7462080|FG001|Phase B (Stabilization Phase)|Protocol Violation|3
4607535|NCT01668797|7462081|FG002|Phase B (Stabilization Phase)|Protocol Violation|0
4607536|NCT01668797|7462082|FG003|Phase B (Stabilization Phase)|Protocol Violation|0
4607537|NCT01668797|7462079|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0
4607538|NCT01668797|7462080|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21
4607539|NCT01668797|7462081|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0
4607540|NCT01668797|7462082|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0
4607541|NCT01668797|7462079|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
4607542|NCT01668797|7462080|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43
4607543|NCT01668797|7462081|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
4607544|NCT01668797|7462082|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
4607545|NCT01668797|7462079|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
4607546|NCT01668797|7462080|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86
4607547|NCT01668797|7462081|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
4607548|NCT01668797|7462082|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
4607549|NCT01668797|7462079|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0
4607550|NCT01668797|7462080|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0
4607551|NCT01668797|7462081|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4
4607552|NCT01668797|7462082|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6
4607553|NCT01668797|7462079|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0
4607554|NCT01668797|7462080|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0
4607555|NCT01668797|7462081|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3
4607556|NCT01668797|7462082|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3
4607557|NCT01668797|7462079|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0
4607558|NCT01668797|7462080|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0
4607559|NCT01668797|7462081|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5
4607560|NCT01668797|7462082|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2
4607561|NCT01668797|7462079|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0
4638125|NCT01958671|7511384|FG001|Overall Study|Withdrawal by Subject|10
4638126|NCT01958671|7511385|FG002|Overall Study|Withdrawal by Subject|13
4638127|NCT01958827|7511401|FG000|Overall Study|Adverse Event|3
4638128|NCT01958827|7511401|FG000|Overall Study|Lack of Efficacy|6
4638129|NCT01958827|7511401|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1
4638130|NCT01958918|7511407|FG000|Overall Study|Death|1
4638131|NCT01958918|7511408|FG001|Overall Study|Death|3
4638132|NCT01958918|7511407|FG000|Overall Study|Lost to Follow-up|4
4638133|NCT01958918|7511408|FG001|Overall Study|Lost to Follow-up|7
4638134|NCT01958918|7511407|FG000|Overall Study|Withdrawal by Subject|13
4638135|NCT01958918|7511408|FG001|Overall Study|Withdrawal by Subject|8
4638136|NCT01958918|7511407|FG000|Overall Study|Lack of Efficacy|13
4638137|NCT01958918|7511408|FG001|Overall Study|Lack of Efficacy|10
4638138|NCT01958918|7511407|FG000|Overall Study|Adverse Event|12
4638139|NCT01958918|7511408|FG001|Overall Study|Adverse Event|12
4638140|NCT01958918|7511407|FG000|Overall Study|administrative problems|0
4638141|NCT01958918|7511408|FG001|Overall Study|administrative problems|2
4638142|NCT01959035|7511414|FG000|Overall Study|Adverse Event|5
4638143|NCT01959035|7511414|FG000|Overall Study|Withdrawal by Subject|4
4638144|NCT01959035|7511414|FG000|Overall Study|Lost to Follow-up|1
4638145|NCT01959035|7511414|FG000|Overall Study|Other (no primary reason given)|1
4638146|NCT01959165|7511432|FG000|Overall Study|Adverse Event|0
4638147|NCT01959165|7511433|FG001|Overall Study|Adverse Event|0
4638148|NCT01959165|7511434|FG002|Overall Study|Adverse Event|0
4638149|NCT01959165|7511435|FG003|Overall Study|Adverse Event|1
4638150|NCT01959165|7511432|FG000|Overall Study|Lack of Efficacy|1
4638151|NCT01959165|7511433|FG001|Overall Study|Lack of Efficacy|0
4638152|NCT01959165|7511434|FG002|Overall Study|Lack of Efficacy|0
4638153|NCT01959165|7511435|FG003|Overall Study|Lack of Efficacy|0
4638154|NCT01959165|7511432|FG000|Overall Study|overdose|0
4638155|NCT01959165|7511433|FG001|Overall Study|overdose|0
4638156|NCT01959165|7511434|FG002|Overall Study|overdose|0
4638157|NCT01959165|7511435|FG003|Overall Study|overdose|1
4638158|NCT01959165|7511432|FG000|Overall Study|Welfare recipient|0
4638159|NCT01959165|7511433|FG001|Overall Study|Welfare recipient|1
4638160|NCT01959165|7511434|FG002|Overall Study|Welfare recipient|0
4638161|NCT01959165|7511435|FG003|Overall Study|Welfare recipient|0
4638162|NCT01959230|7511454|FG000|Overall Study|Failure to follow study procedures|0
4638163|NCT01959230|7511455|FG001|Overall Study|Failure to follow study procedures|1
4638164|NCT01959230|7511454|FG000|Overall Study|Administrative reasons|2
4638165|NCT01959230|7511455|FG001|Overall Study|Administrative reasons|0
4638166|NCT01959230|7511454|FG000|Overall Study|Withdrawal by Subject|2
4638167|NCT01959230|7511455|FG001|Overall Study|Withdrawal by Subject|0
4638168|NCT01959243|7511463|FG000|Overall Study|Investigator Decision|3
4607562|NCT01668797|7462080|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0
4607563|NCT01668797|7462081|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3
4607564|NCT01668797|7462082|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5
4607565|NCT01668797|7462079|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
4607566|NCT01668797|7462080|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
4607567|NCT01668797|7462081|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2
4607568|NCT01668797|7462082|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
4607569|NCT01668797|7462079|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0
4607570|NCT01668797|7462080|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0
4607571|NCT01668797|7462081|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2
4607572|NCT01668797|7462082|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10
4607573|NCT01668797|7462079|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0
4607574|NCT01668797|7462080|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0
4607575|NCT01668797|7462081|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11
4607576|NCT01668797|7462082|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30
4607577|NCT01668797|7462079|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0
4607578|NCT01668797|7462080|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0
4607579|NCT01668797|7462081|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4
4607580|NCT01668797|7462082|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2
4607581|NCT01668797|7462079|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0
4607582|NCT01668797|7462080|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0
4607583|NCT01668797|7462081|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49
4607584|NCT01668797|7462082|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38
4607585|NCT01668966|7462112|FG000|Overall Study|Withdrawal by Subject|1
4607586|NCT01668966|7462112|FG000|Overall Study|Death|1
4607587|NCT01668966|7462112|FG000|Overall Study|Not treated|2
4607588|NCT01669122|7462120|FG000|Period I|Lost to Follow-up|1
4607589|NCT01669122|7462120|FG000|Washout Period II|Protocol Violation|2
4607590|NCT01669174|7462133|FG000|Overall Study|Subject withdrew consent|2
4607591|NCT01669174|7462134|FG001|Overall Study|Subject withdrew consent|2
4607592|NCT01669174|7462133|FG000|Overall Study|Lost to Follow-up|1
4607593|NCT01669174|7462134|FG001|Overall Study|Lost to Follow-up|0
4607594|NCT01669174|7462133|FG000|Overall Study|Adverse Event|2
4607595|NCT01669174|7462134|FG001|Overall Study|Adverse Event|2
4607596|NCT01669174|7462133|FG000|Overall Study|Administrative problems|1
4607597|NCT01669174|7462134|FG001|Overall Study|Administrative problems|2
4607598|NCT01669343|7462140|FG000|Part A: All Patients|Withdrawal by Subject|7
4607599|NCT01669343|7462140|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2
4607600|NCT01669343|7462140|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13
4607601|NCT01669343|7462140|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3
4607602|NCT01669343|7462140|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1
4607603|NCT01669421|7462147|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1
4607604|NCT01669421|7462147|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1
4607605|NCT01669577|7462179|FG000|Overall Study|Death|22
4607606|NCT01669577|7462179|FG000|Overall Study|Lost to Follow-up|78
4607607|NCT01669577|7462179|FG000|Overall Study|Physician Decision|34
4607608|NCT01669629|7462192|FG000|Period 1|protocol deviation|1
4607609|NCT01669629|7462193|FG001|Period 1|protocol deviation|2
4607610|NCT01669798|7462249|FG000|Overall Study|Physician Decision|5
4607611|NCT01669811|7462255|FG000|Overall Study|Investigator decision|0
4607612|NCT01669811|7462256|FG001|Overall Study|Investigator decision|1
4607613|NCT01669811|7462255|FG000|Overall Study|Withdrawal by Subject|1
4607614|NCT01669811|7462256|FG001|Overall Study|Withdrawal by Subject|2
4607615|NCT01669811|7462255|FG000|Overall Study|Adverse Event|2
4607616|NCT01669811|7462256|FG001|Overall Study|Adverse Event|6
4607617|NCT01669811|7462255|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0
4607618|NCT01669811|7462256|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2
4607619|NCT01669902|7462267|FG000|Overall Study|Adverse Event|11
4607620|NCT01669902|7462267|FG000|Overall Study|Lack of Efficacy|10
4607621|NCT01669902|7462267|FG000|Overall Study|Other|8
4607622|NCT01669928|7462273|FG000|First Intervention|Withdrawal by Subject|3
4607623|NCT01669928|7462274|FG001|First Intervention|Withdrawal by Subject|5
4607624|NCT01670019|7462284|FG000|Overall Study|Adverse Event|3
4607625|NCT01670019|7462285|FG001|Overall Study|Adverse Event|0
4607626|NCT01670019|7462284|FG000|Overall Study|Withdrawal by Subject|6
4607627|NCT01670019|7462285|FG001|Overall Study|Withdrawal by Subject|0
4607628|NCT01670045|7462291|FG000|Overall Study|Withdrawal by Subject|3
4607629|NCT01670045|7462291|FG000|Overall Study|Adverse Event|1
4607630|NCT01670045|7462291|FG000|Overall Study|Death|1
4607631|NCT01670045|7462291|FG000|Overall Study|Lost to Follow-up|11
4607632|NCT01670097|7462297|FG000|Overall Study|Started Phase 1 cancer treatment|1
4638169|NCT01959243|7511464|FG001|Overall Study|Investigator Decision|0
4638170|NCT01959243|7511463|FG000|Overall Study|Adverse Event|5
4638171|NCT01959243|7511464|FG001|Overall Study|Adverse Event|2
4638172|NCT01959243|7511463|FG000|Overall Study|Administrative reasons|2
4607633|NCT01670097|7462298|FG001|Overall Study|Started Phase 1 cancer treatment|0
4607634|NCT01670097|7462297|FG000|Overall Study|Study burden|1
4607635|NCT01670097|7462298|FG001|Overall Study|Study burden|0
4607636|NCT01670097|7462297|FG000|Overall Study|COPD exacerbation|0
4607637|NCT01670097|7462298|FG001|Overall Study|COPD exacerbation|1
4607638|NCT01670097|7462297|FG000|Overall Study|Neutropenia|0
4607639|NCT01670097|7462298|FG001|Overall Study|Neutropenia|1
4607640|NCT01670097|7462297|FG000|Overall Study|Clinical deterioration|0
4607641|NCT01670097|7462298|FG001|Overall Study|Clinical deterioration|1
4607642|NCT01670097|7462297|FG000|Overall Study|Disease progression|0
4607643|NCT01670097|7462298|FG001|Overall Study|Disease progression|1
4607644|NCT01670188|7462315|FG000|Overall Study|Death|0
4607645|NCT01670188|7462316|FG001|Overall Study|Death|1
4607646|NCT01670279|7462329|FG000|Overall Study|Adverse Event|0
4607647|NCT01670279|7462330|FG001|Overall Study|Adverse Event|1
4607648|NCT01670279|7462331|FG002|Overall Study|Adverse Event|0
4607649|NCT01670279|7462332|FG003|Overall Study|Adverse Event|0
4607650|NCT01670279|7462329|FG000|Overall Study|Physician Decision|0
4607651|NCT01670279|7462330|FG001|Overall Study|Physician Decision|1
4607652|NCT01670279|7462331|FG002|Overall Study|Physician Decision|0
4607653|NCT01670279|7462332|FG003|Overall Study|Physician Decision|0
4607654|NCT01670279|7462329|FG000|Overall Study|Participant met withdrawal criteria|0
4607655|NCT01670279|7462330|FG001|Overall Study|Participant met withdrawal criteria|0
4607656|NCT01670279|7462331|FG002|Overall Study|Participant met withdrawal criteria|0
4607657|NCT01670279|7462332|FG003|Overall Study|Participant met withdrawal criteria|1
4607658|NCT01670292|7462340|FG000|Overall Study|Lost to Follow-up|14
4607659|NCT01670526|7462363|FG000|Overall Study|Withdrawal by Subject|3
4607660|NCT01670526|7462364|FG001|Overall Study|Withdrawal by Subject|1
4607661|NCT01670526|7462363|FG000|Overall Study|Lost to Follow-up|9
4607662|NCT01670526|7462364|FG001|Overall Study|Lost to Follow-up|5
4607663|NCT01670721|7462370|FG000|Overall Study|Participant's decision|15
4607664|NCT01670721|7462370|FG000|Overall Study|Other than specified above|38
4607665|NCT01671007|7462398|FG000|Overall Study|Other reasons than listed|166
4607666|NCT01671007|7462399|FG001|Overall Study|Other reasons than listed|373
4607667|NCT01671007|7462400|FG002|Overall Study|Other reasons than listed|197
4607668|NCT01671007|7462401|FG003|Overall Study|Other reasons than listed|228
4607669|NCT01671007|7462402|FG004|Overall Study|Other reasons than listed|14
4607670|NCT01671007|7462403|FG005|Overall Study|Other reasons than listed|71
4607671|NCT01671007|7462404|FG006|Overall Study|Other reasons than listed|17
4607672|NCT01671007|7462405|FG007|Overall Study|Other reasons than listed|66
4607673|NCT01671007|7462406|FG008|Overall Study|Other reasons than listed|0
4607674|NCT01671007|7462398|FG000|Overall Study|Withdrawal by Subject|36
4607675|NCT01671007|7462399|FG001|Overall Study|Withdrawal by Subject|59
4638173|NCT01959243|7511464|FG001|Overall Study|Administrative reasons|1
4638174|NCT01959243|7511463|FG000|Overall Study|Lost to Follow-up|3
4638175|NCT01959243|7511464|FG001|Overall Study|Lost to Follow-up|1
4638176|NCT01959334|7511472|FG000|Second Dose|Adverse Event|1
4638177|NCT01959334|7511473|FG001|Second Dose|Adverse Event|0
4638178|NCT01959334|7511472|FG000|Third Dose|Adverse Event|0
4638179|NCT01959334|7511473|FG001|Third Dose|Adverse Event|1
4638180|NCT01959347|7511481|FG000|Overall Study|Protocol Violation|9
4638181|NCT01959347|7511482|FG001|Overall Study|Protocol Violation|7
4638182|NCT01959412|7511488|FG000|Overall Study|Protocol deviation|1
4638183|NCT01959412|7511489|FG001|Overall Study|Protocol deviation|1
4638184|NCT01959412|7511490|FG002|Overall Study|Protocol deviation|0
4638185|NCT01959412|7511491|FG003|Overall Study|Protocol deviation|1
4638186|NCT01959412|7511492|FG004|Overall Study|Protocol deviation|3
4638187|NCT01959412|7511493|FG005|Overall Study|Protocol deviation|0
4746981|NCT00429858|7719942|FG000|Overall Study|Study Termination|1
4746982|NCT00425438|7719949|FG000|Overall Study|Termination by Sponsor|25
4746983|NCT00425438|7719950|FG001|Overall Study|Termination by Sponsor|27
4746984|NCT00422942|7719960|FG000|Overall Study|Study terminated by Sponsor|3
4746985|NCT00409344|7719966|FG000|Overall Study|no enrollment|0
4746986|NCT00409344|7719967|FG001|Overall Study|no enrollment|0
4746987|NCT00414453|7719973|FG000|Overall Study|Abnormal lab work|16
4746988|NCT00417248|7719983|FG000|Overall Study|Study Terminated|6
4746989|NCT00417248|7719983|FG000|Overall Study|Death|1
4746990|NCT00417248|7719983|FG000|Overall Study|Lack of Efficacy|1
4746991|NCT00418145|7719988|FG000|Overall Study|study terminated|6
4746992|NCT00409331|7719994|FG000|Overall Study|Physician Decision|1
4746993|NCT00391430|7720011|FG000|Overall Study|Withdrawal by Subject|3
4746994|NCT00391430|7720012|FG001|Overall Study|Withdrawal by Subject|0
4746995|NCT00391430|7720013|FG002|Overall Study|Withdrawal by Subject|12
4746996|NCT00384293|7720046|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120
4607676|NCT01671007|7462400|FG002|Overall Study|Withdrawal by Subject|53
4607677|NCT01671007|7462401|FG003|Overall Study|Withdrawal by Subject|58
4607678|NCT01671007|7462402|FG004|Overall Study|Withdrawal by Subject|4
4638188|NCT01959412|7511488|FG000|Overall Study|Adverse Event|0
4638189|NCT01959412|7511489|FG001|Overall Study|Adverse Event|0
4638190|NCT01959412|7511490|FG002|Overall Study|Adverse Event|0
4638191|NCT01959412|7511491|FG003|Overall Study|Adverse Event|1
4746997|NCT00384293|7720047|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0
4746998|NCT00384293|7720048|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0
4638192|NCT01959412|7511492|FG004|Overall Study|Adverse Event|0
4638193|NCT01959412|7511493|FG005|Overall Study|Adverse Event|0
4607679|NCT01671007|7462403|FG005|Overall Study|Withdrawal by Subject|15
4607680|NCT01671007|7462404|FG006|Overall Study|Withdrawal by Subject|1
4607681|NCT01671007|7462405|FG007|Overall Study|Withdrawal by Subject|19
4607682|NCT01671007|7462406|FG008|Overall Study|Withdrawal by Subject|0
4607683|NCT01671007|7462398|FG000|Overall Study|Lost to Follow-up|93
4607684|NCT01671007|7462399|FG001|Overall Study|Lost to Follow-up|142
4607685|NCT01671007|7462400|FG002|Overall Study|Lost to Follow-up|91
4607686|NCT01671007|7462401|FG003|Overall Study|Lost to Follow-up|63
4607687|NCT01671007|7462402|FG004|Overall Study|Lost to Follow-up|7
4607688|NCT01671007|7462403|FG005|Overall Study|Lost to Follow-up|20
4607689|NCT01671007|7462404|FG006|Overall Study|Lost to Follow-up|2
4607690|NCT01671007|7462405|FG007|Overall Study|Lost to Follow-up|28
4607691|NCT01671007|7462406|FG008|Overall Study|Lost to Follow-up|0
4607692|NCT01671007|7462398|FG000|Overall Study|No end of study case report form|3
4607693|NCT01671007|7462399|FG001|Overall Study|No end of study case report form|1
4607694|NCT01671007|7462400|FG002|Overall Study|No end of study case report form|0
4607695|NCT01671007|7462401|FG003|Overall Study|No end of study case report form|2
4638194|NCT01959425|7511509|FG000|Overall Study|Withdrawal by Subject|5
4638195|NCT01959425|7511510|FG001|Overall Study|Withdrawal by Subject|4
4638196|NCT01959425|7511509|FG000|Overall Study|Lost to Follow-up|1
4638197|NCT01959425|7511510|FG001|Overall Study|Lost to Follow-up|0
4638198|NCT01959425|7511509|FG000|Overall Study|Discontinued Subjects|6
4638199|NCT01959425|7511510|FG001|Overall Study|Discontinued Subjects|4
4638200|NCT01959503|7511531|FG000|Overall Study|Death|2
4638201|NCT01959503|7511532|FG001|Overall Study|Death|1
4638202|NCT01959503|7511531|FG000|Overall Study|Randomized but not treated|1
4638203|NCT01959503|7511532|FG001|Overall Study|Randomized but not treated|1
4638204|NCT01959516|7511538|FG000|Epoch 1|Adverse Event|4
4638205|NCT01959516|7511539|FG001|Epoch 1|Adverse Event|1
4638206|NCT01959516|7511538|FG000|Epoch 1|unsatisfactory therapeutic effect|1
4638207|NCT01959516|7511539|FG001|Epoch 1|unsatisfactory therapeutic effect|0
4638208|NCT01959516|7511538|FG000|Epoch 1|Subject withdrew consent|3
4638209|NCT01959516|7511539|FG001|Epoch 1|Subject withdrew consent|2
4638210|NCT01959516|7511538|FG000|Epoch 1|Administrative problems|1
4638211|NCT01959516|7511539|FG001|Epoch 1|Administrative problems|0
4638212|NCT01959516|7511538|FG000|Epoch 1|Use of prohibited treatment|1
4638213|NCT01959516|7511539|FG001|Epoch 1|Use of prohibited treatment|0
4638214|NCT01959516|7511538|FG000|Epoch 1|Moderate or severe COPD exacerbation|0
4638215|NCT01959516|7511539|FG001|Epoch 1|Moderate or severe COPD exacerbation|1
4638216|NCT01959516|7511538|FG000|Epoch 1|Protocol deviation|0
4638217|NCT01959516|7511539|FG001|Epoch 1|Protocol deviation|1
4638218|NCT01959516|7511538|FG000|Epoch 2|unsatisfactory therapeutic effect|1
4638219|NCT01959516|7511539|FG001|Epoch 2|unsatisfactory therapeutic effect|0
4638220|NCT01959516|7511538|FG000|Epoch 2|Subject withdrew consent|1
4638221|NCT01959516|7511539|FG001|Epoch 2|Subject withdrew consent|0
4638222|NCT01959516|7511538|FG000|Epoch 2|Moderate or severe COPD exacerbation|0
4638223|NCT01959516|7511539|FG001|Epoch 2|Moderate or severe COPD exacerbation|1
4638224|NCT01959529|7511547|FG000|Overall Study|Adverse event (not hypoglycaemia)|0
4638225|NCT01959529|7511548|FG001|Overall Study|Adverse event (not hypoglycaemia)|1
4638226|NCT01959529|7511547|FG000|Overall Study|Lost to Follow-up|4
4638227|NCT01959529|7511548|FG001|Overall Study|Lost to Follow-up|1
4638228|NCT01959529|7511547|FG000|Overall Study|Other|70
4638229|NCT01959529|7511548|FG001|Overall Study|Other|68
4638230|NCT01959529|7511547|FG000|Overall Study|Hypoglycaemia|1
4638231|NCT01959529|7511548|FG001|Overall Study|Hypoglycaemia|1
4638232|NCT01959529|7511547|FG000|Overall Study|Lack of glycaemic control|1
4638233|NCT01959529|7511548|FG001|Overall Study|Lack of glycaemic control|1
4638234|NCT01959581|7511559|FG000|Overall Study|Lost to Follow-up|5
4638235|NCT01959607|7511565|FG000|First Intervention (Day 1)|Withdrawal by Subject|1
4638236|NCT01959607|7511566|FG001|First Intervention (Day 1)|Withdrawal by Subject|1
4638237|NCT01959607|7511567|FG002|First Intervention (Day 1)|Withdrawal by Subject|0
4638238|NCT01959607|7511568|FG003|First Intervention (Day 1)|Withdrawal by Subject|0
4638239|NCT01959672|7511577|FG000|Overall Study|Death|1
4638240|NCT01959698|7511595|FG000|Overall Study|Adverse Event|0
4638241|NCT01959698|7511596|FG001|Overall Study|Adverse Event|0
4638242|NCT01959698|7511597|FG002|Overall Study|Adverse Event|0
4607696|NCT01671007|7462402|FG004|Overall Study|No end of study case report form|0
4607697|NCT01671007|7462403|FG005|Overall Study|No end of study case report form|0
4638243|NCT01959698|7511598|FG003|Overall Study|Adverse Event|0
4607698|NCT01671007|7462404|FG006|Overall Study|No end of study case report form|0
4607699|NCT01671007|7462405|FG007|Overall Study|No end of study case report form|0
4638244|NCT01959698|7511599|FG004|Overall Study|Adverse Event|0
4638245|NCT01959698|7511600|FG005|Overall Study|Adverse Event|0
4638246|NCT01959698|7511601|FG006|Overall Study|Adverse Event|1
4638247|NCT01959698|7511595|FG000|Overall Study|Physician Decision|1
4638248|NCT01959698|7511596|FG001|Overall Study|Physician Decision|0
4638249|NCT01959698|7511597|FG002|Overall Study|Physician Decision|1
4638250|NCT01959698|7511598|FG003|Overall Study|Physician Decision|2
4638251|NCT01959698|7511599|FG004|Overall Study|Physician Decision|0
4638252|NCT01959698|7511600|FG005|Overall Study|Physician Decision|3
4607700|NCT01671007|7462406|FG008|Overall Study|No end of study case report form|0
4607701|NCT01671007|7462398|FG000|Overall Study|Not eligible|23
4607702|NCT01671007|7462399|FG001|Overall Study|Not eligible|76
4607703|NCT01671007|7462400|FG002|Overall Study|Not eligible|25
4607704|NCT01671007|7462401|FG003|Overall Study|Not eligible|17
4607705|NCT01671007|7462402|FG004|Overall Study|Not eligible|0
4607706|NCT01671007|7462403|FG005|Overall Study|Not eligible|6
4607707|NCT01671007|7462404|FG006|Overall Study|Not eligible|1
4607708|NCT01671007|7462405|FG007|Overall Study|Not eligible|19
4607709|NCT01671007|7462406|FG008|Overall Study|Not eligible|0
4607710|NCT01671059|7462417|FG000|Overall Study|Adverse Event|4
4607711|NCT01671059|7462417|FG000|Overall Study|Lack of Efficacy|1
4607712|NCT01671085|7462424|FG000|Overall Study|Withdrawal by Subject|1
4607713|NCT01671085|7462425|FG001|Overall Study|Withdrawal by Subject|0
4607714|NCT01671111|7462432|FG000|Overall Study|Adverse Event|2
4607715|NCT01671111|7462432|FG000|Overall Study|Lack of Efficacy|1
4607716|NCT01671111|7462432|FG000|Overall Study|Withdrawal by Subject|2
4607717|NCT01671111|7462432|FG000|Overall Study|Physician Decision|1
4607718|NCT01671111|7462432|FG000|Overall Study|Other|24
4607719|NCT01671280|7462440|FG000|Overall Study|Withdrawal by Subject|2
4607720|NCT01671319|7462453|FG000|Overall Study|Withdrawal by Subject|1
4607721|NCT01671332|7462459|FG000|Overall Study|Withdrawal by Subject|1
4607722|NCT01671332|7462460|FG001|Overall Study|Withdrawal by Subject|1
4607723|NCT01671345|7462468|FG000|Overall Study|Lost to Follow-up|10
4607724|NCT01671345|7462469|FG001|Overall Study|Lost to Follow-up|6
4607725|NCT01671345|7462468|FG000|Overall Study|visit with non-participating physician|3
4607726|NCT01671345|7462469|FG001|Overall Study|visit with non-participating physician|3
4607727|NCT01671488|7462487|FG000|Overall Study|Withdrawal by Subject|1
4607728|NCT01671748|7462502|FG000|4 Week run-in Phase|Withdrawal by Subject|1
4607729|NCT01671748|7462503|FG001|4 Week run-in Phase|Withdrawal by Subject|0
4607730|NCT01671748|7462502|FG000|4 Week run-in Phase|Adverse Event|1
4638253|NCT01959698|7511601|FG006|Overall Study|Physician Decision|3
4638254|NCT01959841|7511621|FG000|Overall Study|Adverse Event|1
4638255|NCT01959841|7511622|FG001|Overall Study|Adverse Event|3
4638256|NCT01959841|7511623|FG002|Overall Study|Adverse Event|2
4638257|NCT01959841|7511621|FG000|Overall Study|Lack of Efficacy|5
4638258|NCT01959841|7511622|FG001|Overall Study|Lack of Efficacy|0
4638259|NCT01959841|7511623|FG002|Overall Study|Lack of Efficacy|0
4638260|NCT01959841|7511621|FG000|Overall Study|Lost to Follow-up|1
4638261|NCT01959841|7511622|FG001|Overall Study|Lost to Follow-up|1
4638262|NCT01959841|7511623|FG002|Overall Study|Lost to Follow-up|0
4638263|NCT01959841|7511621|FG000|Overall Study|Physician Decision|0
4638264|NCT01959841|7511622|FG001|Overall Study|Physician Decision|2
4638265|NCT01959841|7511623|FG002|Overall Study|Physician Decision|3
4638266|NCT01959841|7511621|FG000|Overall Study|Protocol Violation|16
4638267|NCT01959841|7511622|FG001|Overall Study|Protocol Violation|23
4638268|NCT01959841|7511623|FG002|Overall Study|Protocol Violation|16
4638269|NCT01959841|7511621|FG000|Overall Study|Withdrawal by Subject|7
4638270|NCT01959841|7511622|FG001|Overall Study|Withdrawal by Subject|7
4638271|NCT01959841|7511623|FG002|Overall Study|Withdrawal by Subject|5
4638272|NCT01959841|7511621|FG000|Overall Study|Clinical laboratory value|2
4638273|NCT01959841|7511622|FG001|Overall Study|Clinical laboratory value|6
4638274|NCT01959841|7511623|FG002|Overall Study|Clinical laboratory value|6
4638275|NCT01959841|7511621|FG000|Overall Study|Platelet count below on day1 or 4|11
4638276|NCT01959841|7511622|FG001|Overall Study|Platelet count below on day1 or 4|15
4638277|NCT01959841|7511623|FG002|Overall Study|Platelet count below on day1 or 4|11
4638278|NCT01959880|7511635|FG000|Overall Study|Withdrawal by Subject|11
4638279|NCT01959880|7511636|FG001|Overall Study|Withdrawal by Subject|13
4638280|NCT01959880|7511637|FG002|Overall Study|Withdrawal by Subject|8
4638281|NCT01959880|7511638|FG003|Overall Study|Withdrawal by Subject|7
4638282|NCT01959880|7511635|FG000|Overall Study|Death|1
4638283|NCT01959880|7511636|FG001|Overall Study|Death|10
4638284|NCT01959880|7511637|FG002|Overall Study|Death|1
4638285|NCT01959880|7511638|FG003|Overall Study|Death|2
4638286|NCT01959880|7511635|FG000|Overall Study|Lost to Follow-up|95
4638287|NCT01959880|7511636|FG001|Overall Study|Lost to Follow-up|18
4638288|NCT01959880|7511637|FG002|Overall Study|Lost to Follow-up|15
4638289|NCT01959880|7511638|FG003|Overall Study|Lost to Follow-up|8
4638290|NCT01959880|7511635|FG000|Overall Study|Explantation w/o study device reimplant.|22
4607731|NCT01671748|7462503|FG001|4 Week run-in Phase|Adverse Event|0
4607732|NCT01671748|7462502|FG000|4 Week run-in Phase|Not eligible|9
4607733|NCT01671748|7462503|FG001|4 Week run-in Phase|Not eligible|0
4638291|NCT01959880|7511636|FG001|Overall Study|Explantation w/o study device reimplant.|17
4607734|NCT01672294|7462520|FG000|Overall Study|Withdrawal by Subject|4
4607735|NCT01672294|7462521|FG001|Overall Study|Withdrawal by Subject|4
4607736|NCT01672294|7462522|FG002|Overall Study|Withdrawal by Subject|4
4607737|NCT01672294|7462523|FG003|Overall Study|Withdrawal by Subject|4
4607738|NCT01672294|7462520|FG000|Overall Study|Excluded by study|1
4607739|NCT01672294|7462521|FG001|Overall Study|Excluded by study|1
4607740|NCT01672294|7462522|FG002|Overall Study|Excluded by study|0
4607741|NCT01672294|7462523|FG003|Overall Study|Excluded by study|0
4607742|NCT01672294|7462520|FG000|Overall Study|Lost to Follow-up|1
4607743|NCT01672294|7462521|FG001|Overall Study|Lost to Follow-up|16
4607744|NCT01672294|7462522|FG002|Overall Study|Lost to Follow-up|7
4607745|NCT01672294|7462523|FG003|Overall Study|Lost to Follow-up|9
4607746|NCT01672710|7462544|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0
4607747|NCT01672710|7462545|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1
4607748|NCT01672710|7462544|FG000|3 Month Follow up|Lost to Follow-up|2
4607749|NCT01672710|7462545|FG001|3 Month Follow up|Lost to Follow-up|3
4607750|NCT01672710|7462544|FG000|3 Month Follow up|follow up due after termination date|4
4607751|NCT01672710|7462545|FG001|3 Month Follow up|follow up due after termination date|1
4607752|NCT01672723|7462551|FG000|First Intervention|Adverse Event|3
4607753|NCT01672723|7462552|FG001|First Intervention|Adverse Event|0
4607754|NCT01672736|7462558|FG000|Overall Study|Available drug expired on 31 May 16|3
4607755|NCT01672788|7462562|FG000|Washout Period 2 (7 Days)|Adverse Event|0
4607756|NCT01672788|7462563|FG001|Washout Period 2 (7 Days)|Adverse Event|0
4607757|NCT01672788|7462564|FG002|Washout Period 2 (7 Days)|Adverse Event|0
4638292|NCT01959880|7511637|FG002|Overall Study|Explantation w/o study device reimplant.|5
4638293|NCT01959880|7511638|FG003|Overall Study|Explantation w/o study device reimplant.|12
4638294|NCT01959880|7511635|FG000|Overall Study|Study completed early-FDA approved|1003
4638295|NCT01959880|7511636|FG001|Overall Study|Study completed early-FDA approved|311
4638296|NCT01959880|7511637|FG002|Overall Study|Study completed early-FDA approved|179
4638297|NCT01959880|7511638|FG003|Overall Study|Study completed early-FDA approved|152
4638298|NCT01959919|7511648|FG000|Overall Study|Did not meet the eligibility criteria|2
4638299|NCT01959932|7511655|FG000|Overall Study|Withdrawal by Subject|1
4638300|NCT01959932|7511656|FG001|Overall Study|Withdrawal by Subject|0
4638301|NCT01959932|7511657|FG002|Overall Study|Withdrawal by Subject|0
4638302|NCT01960114|7511700|FG000|Overall Study|Adverse Event|1
4638303|NCT01960114|7511701|FG001|Overall Study|Adverse Event|0
4638304|NCT01960114|7511700|FG000|Overall Study|Could not swallow study medication|0
4638305|NCT01960114|7511701|FG001|Overall Study|Could not swallow study medication|1
4638306|NCT01960140|7511707|FG000|Period 2 (Days 3-18)|Adverse Event|2
4638307|NCT01960257|7511715|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12
4638308|NCT01960257|7511716|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0
4638309|NCT01960257|7511717|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0
4638310|NCT01960257|7511715|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3
4638311|NCT01960257|7511716|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0
4638312|NCT01960257|7511717|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0
4638313|NCT01960257|7511715|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1
4638314|NCT01960257|7511716|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0
4638315|NCT01960257|7511717|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0
4638316|NCT01960296|7511729|FG000|Overall Study|Postponed surgery|1
4638317|NCT01960296|7511730|FG001|Overall Study|Postponed surgery|0
4638318|NCT01960296|7511729|FG000|Overall Study|Received different procedure|1
4638319|NCT01960296|7511730|FG001|Overall Study|Received different procedure|3
4638320|NCT01960348|7511738|FG000|Overall Study|Adverse event, not serious|2
4638321|NCT01960348|7511739|FG001|Overall Study|Adverse event, not serious|2
4638322|NCT01960348|7511738|FG000|Overall Study|Adverse event, serious fatal|6
4638323|NCT01960348|7511739|FG001|Overall Study|Adverse event, serious fatal|5
4638324|NCT01960348|7511738|FG000|Overall Study|Adverse event, serious non-fatal|0
4638325|NCT01960348|7511739|FG001|Overall Study|Adverse event, serious non-fatal|3
4638326|NCT01960348|7511738|FG000|Overall Study|Withdrawal by Subject|1
4638327|NCT01960348|7511739|FG001|Overall Study|Withdrawal by Subject|11
4638328|NCT01960348|7511738|FG000|Overall Study|Physician Decision|0
4638329|NCT01960348|7511739|FG001|Overall Study|Physician Decision|1
4638330|NCT01960348|7511738|FG000|Overall Study|Protocol Violation|1
4638331|NCT01960348|7511739|FG001|Overall Study|Protocol Violation|0
4638332|NCT01960413|7511760|FG000|Overall Study|Withdrawal by Subject|1
4638333|NCT01960413|7511761|FG001|Overall Study|Withdrawal by Subject|1
4638334|NCT01960413|7511760|FG000|Overall Study|Physician Decision|1
4638335|NCT01960413|7511761|FG001|Overall Study|Physician Decision|0
4638336|NCT01960413|7511760|FG000|Overall Study|Lost to Follow-up|2
4746999|NCT00384293|7720046|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1
4747000|NCT00384293|7720047|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0
4747001|NCT00384293|7720048|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0
4747002|NCT00384293|7720046|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24
4747003|NCT00384293|7720047|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0
4638337|NCT01960413|7511761|FG001|Overall Study|Lost to Follow-up|0
4638338|NCT01960725|7511778|FG000|Overall Study|Lost to Follow-up|4
4638339|NCT01960725|7511779|FG001|Overall Study|Lost to Follow-up|3
4638340|NCT01960725|7511778|FG000|Overall Study|Withdrawal by Subject|1
4607758|NCT01672788|7462565|FG003|Washout Period 2 (7 Days)|Adverse Event|1
4607759|NCT01672801|7462577|FG000|Overall Study|Screen Failure|0
4607760|NCT01672801|7462578|FG001|Overall Study|Screen Failure|1
4607761|NCT01672853|7462593|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0
4607762|NCT01672853|7462594|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4
4607763|NCT01672853|7462595|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0
4607764|NCT01672853|7462593|FG000|Overall Study|Pregnancy|0
4607765|NCT01672853|7462594|FG001|Overall Study|Pregnancy|1
4607766|NCT01672853|7462595|FG002|Overall Study|Pregnancy|0
4607767|NCT01672853|7462593|FG000|Overall Study|Investigator's Discretion|1
4607768|NCT01672853|7462594|FG001|Overall Study|Investigator's Discretion|0
4607769|NCT01672853|7462595|FG002|Overall Study|Investigator's Discretion|0
4607770|NCT01672853|7462593|FG000|Overall Study|Withdrew Consent|5
4607771|NCT01672853|7462594|FG001|Overall Study|Withdrew Consent|5
4607772|NCT01672853|7462595|FG002|Overall Study|Withdrew Consent|5
4607773|NCT01672853|7462593|FG000|Overall Study|Adverse Event|4
4607774|NCT01672853|7462594|FG001|Overall Study|Adverse Event|6
4607775|NCT01672853|7462595|FG002|Overall Study|Adverse Event|8
4607776|NCT01672853|7462593|FG000|Overall Study|Lost to Follow-up|0
4607777|NCT01672853|7462594|FG001|Overall Study|Lost to Follow-up|1
4607778|NCT01672853|7462595|FG002|Overall Study|Lost to Follow-up|0
4607779|NCT01672853|7462593|FG000|Overall Study|Randomized but Never Treated|0
4607780|NCT01672853|7462594|FG001|Overall Study|Randomized but Never Treated|0
4607781|NCT01672853|7462595|FG002|Overall Study|Randomized but Never Treated|1
4607782|NCT01672866|7462606|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40
4607783|NCT01672866|7462607|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42
4607784|NCT01672866|7462608|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35
4607785|NCT01672866|7462606|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9
4607786|NCT01672866|7462607|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8
4607787|NCT01672866|7462608|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12
4607788|NCT01672866|7462606|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3
4607789|NCT01672866|7462607|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3
4607790|NCT01672866|7462608|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5
4607791|NCT01672866|7462606|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3
4607792|NCT01672866|7462607|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3
4607793|NCT01672866|7462608|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3
4607794|NCT01672866|7462606|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3
4607795|NCT01672866|7462607|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3
4607796|NCT01672866|7462608|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2
4607797|NCT01672866|7462606|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2
4607798|NCT01672866|7462607|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0
4607799|NCT01672866|7462608|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0
4607800|NCT01672866|7462606|FG000|Blinded Phase (up to 240 Weeks)|Death|0
4607801|NCT01672866|7462607|FG001|Blinded Phase (up to 240 Weeks)|Death|0
4607802|NCT01672866|7462608|FG002|Blinded Phase (up to 240 Weeks)|Death|1
4607803|NCT01672866|7462606|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3
4607804|NCT01672866|7462607|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0
4607805|NCT01672866|7462608|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0
4607806|NCT01672866|7462606|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11
4607807|NCT01672866|7462607|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15
4607808|NCT01672866|7462608|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16
4607809|NCT01672866|7462606|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8
4607810|NCT01672866|7462607|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15
4607811|NCT01672866|7462608|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15
4607812|NCT01672866|7462606|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1
4607813|NCT01672866|7462607|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0
4607814|NCT01672866|7462608|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1
4607815|NCT01672866|7462606|FG000|Open-Label Phase (up to 240 Weeks)|Death|1
4607816|NCT01672866|7462607|FG001|Open-Label Phase (up to 240 Weeks)|Death|0
4607817|NCT01672866|7462608|FG002|Open-Label Phase (up to 240 Weeks)|Death|0
4607818|NCT01672866|7462606|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1
4607819|NCT01672866|7462607|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0
4607820|NCT01672866|7462608|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0
4607821|NCT01672879|7462621|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43
4607822|NCT01672879|7462622|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55
4607823|NCT01672879|7462623|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61
4607824|NCT01672879|7462621|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14
4607825|NCT01672879|7462622|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7
4607826|NCT01672879|7462623|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6
4607827|NCT01672879|7462621|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5
4607828|NCT01672879|7462622|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2
4607829|NCT01672879|7462623|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7
4607830|NCT01672879|7462621|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4
4607831|NCT01672879|7462622|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3
4607832|NCT01672879|7462623|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1
4607833|NCT01672879|7462621|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5
4607834|NCT01672879|7462622|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0
4607835|NCT01672879|7462623|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2
4607836|NCT01672879|7462621|FG000|Blinded Phase (Up to 240 Weeks)|Death|0
4607837|NCT01672879|7462622|FG001|Blinded Phase (Up to 240 Weeks)|Death|2
4607838|NCT01672879|7462623|FG002|Blinded Phase (Up to 240 Weeks)|Death|0
4607839|NCT01672879|7462621|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1
4607840|NCT01672879|7462622|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0
4607841|NCT01672879|7462623|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0
4607842|NCT01672879|7462621|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0
4607843|NCT01672879|7462622|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0
4607844|NCT01672879|7462623|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1
4607845|NCT01672879|7462621|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15
4607846|NCT01672879|7462622|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17
4607847|NCT01672879|7462623|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8
4607848|NCT01672879|7462621|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8
4607849|NCT01672879|7462622|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16
4607850|NCT01672879|7462623|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6
4607851|NCT01672879|7462621|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5
4607852|NCT01672879|7462622|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1
4607853|NCT01672879|7462623|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1
4607854|NCT01672879|7462621|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1
4607855|NCT01672879|7462622|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0
4607856|NCT01672879|7462623|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1
4607857|NCT01672879|7462621|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1
4607858|NCT01672879|7462622|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0
4607859|NCT01672879|7462623|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0
4638341|NCT01960725|7511779|FG001|Overall Study|Withdrawal by Subject|0
4638342|NCT01960725|7511778|FG000|Overall Study|unable to obtain blood sample|1
4638343|NCT01960725|7511779|FG001|Overall Study|unable to obtain blood sample|2
4638344|NCT01960790|7511785|FG000|Overall Study|Survey forms could not be recovered|3
4638345|NCT01960790|7511785|FG000|Overall Study|Treat with Humira outside survey period|3
4638346|NCT01960790|7511785|FG000|Overall Study|Transferred to another hospital|4
4638347|NCT01960790|7511785|FG000|Overall Study|Unevaluable for safety|1
4638348|NCT01960816|7511789|FG000|Overall Study|Lost to Follow-up|1
4638349|NCT01960842|7511793|FG000|Overall Study|Adverse Event|1
4638350|NCT01960842|7511793|FG000|Overall Study|Withdrawal by Subject|2
4638351|NCT01960855|7511802|FG000|Overall Study|Subject noncompliant|1
4638352|NCT01960855|7511803|FG001|Overall Study|Subject noncompliant|0
4638353|NCT01960855|7511804|FG002|Overall Study|Subject noncompliant|0
4638354|NCT01960855|7511805|FG003|Overall Study|Subject noncompliant|0
4638355|NCT01960855|7511806|FG004|Overall Study|Subject noncompliant|0
4638356|NCT01960855|7511802|FG000|Overall Study|Adverse Event|2
4638357|NCT01960855|7511803|FG001|Overall Study|Adverse Event|0
4638358|NCT01960855|7511804|FG002|Overall Study|Adverse Event|6
4638359|NCT01960855|7511805|FG003|Overall Study|Adverse Event|2
4638360|NCT01960855|7511806|FG004|Overall Study|Adverse Event|2
4638361|NCT01960855|7511802|FG000|Overall Study|Lack of Efficacy|1
4638362|NCT01960855|7511803|FG001|Overall Study|Lack of Efficacy|1
4638363|NCT01960855|7511804|FG002|Overall Study|Lack of Efficacy|0
4638364|NCT01960855|7511805|FG003|Overall Study|Lack of Efficacy|0
4638365|NCT01960855|7511806|FG004|Overall Study|Lack of Efficacy|0
4638366|NCT01960855|7511802|FG000|Overall Study|Other|2
4638367|NCT01960855|7511803|FG001|Overall Study|Other|1
4638368|NCT01960855|7511804|FG002|Overall Study|Other|1
4638369|NCT01960855|7511805|FG003|Overall Study|Other|1
4638370|NCT01960855|7511806|FG004|Overall Study|Other|0
4638371|NCT01960855|7511802|FG000|Overall Study|Consent withdrawn by subject|3
4638372|NCT01960855|7511803|FG001|Overall Study|Consent withdrawn by subject|1
4638373|NCT01960855|7511804|FG002|Overall Study|Consent withdrawn by subject|2
4638374|NCT01960855|7511805|FG003|Overall Study|Consent withdrawn by subject|1
4638375|NCT01960855|7511806|FG004|Overall Study|Consent withdrawn by subject|1
4638376|NCT01960855|7511802|FG000|Overall Study|Lost to Follow-up|2
4638377|NCT01960855|7511803|FG001|Overall Study|Lost to Follow-up|1
4638378|NCT01960855|7511804|FG002|Overall Study|Lost to Follow-up|0
4638379|NCT01960855|7511805|FG003|Overall Study|Lost to Follow-up|0
4638380|NCT01960855|7511806|FG004|Overall Study|Lost to Follow-up|2
4638381|NCT01960907|7511820|FG000|Overall Study|Death|4
4638382|NCT01960907|7511821|FG001|Overall Study|Death|3
4638383|NCT01960907|7511820|FG000|Overall Study|Withdrawal by Subject|32
4638384|NCT01960907|7511821|FG001|Overall Study|Withdrawal by Subject|42
4638385|NCT01960998|7511832|FG000|Overall Study|Lost to Follow-up|3
4638386|NCT01960998|7511833|FG001|Overall Study|Lost to Follow-up|7
4638387|NCT01960998|7511832|FG000|Overall Study|Death|0
4638388|NCT01960998|7511833|FG001|Overall Study|Death|1
4638389|NCT01960998|7511832|FG000|Overall Study|Withdrawal by Subject|8
4638390|NCT01960998|7511833|FG001|Overall Study|Withdrawal by Subject|2
4638391|NCT01960998|7511832|FG000|Overall Study|lost computer access|0
4607860|NCT01672892|7462634|FG000|Overall Study|Protocol Violation|7
4607861|NCT01672892|7462635|FG001|Overall Study|Protocol Violation|3
4607862|NCT01672957|7462644|FG000|Overall Study|Protocol Violation|48
4607863|NCT01672957|7462644|FG000|Overall Study|Death|2
4607864|NCT01672957|7462644|FG000|Overall Study|ICF Signed After Transplantation|5
4607865|NCT01672970|7462648|FG000|Overall Study|Lack of Efficacy|12
4607866|NCT01672970|7462648|FG000|Overall Study|Adverse Event|18
4607867|NCT01672970|7462648|FG000|Overall Study|Withdrawal by Subject|2
4607868|NCT01672970|7462648|FG000|Overall Study|Lost to Follow-up|5
4607869|NCT01672970|7462648|FG000|Overall Study|Other|9
4607870|NCT01672970|7462648|FG000|Overall Study|Enrolled but not treated|1
4607871|NCT01673009|7462710|FG000|Overall Study|Physician Decision|5
4607872|NCT01673009|7462710|FG000|Overall Study|Withdrawal by Subject|8
4607873|NCT01673126|7462730|FG000|Overall Study|change of diagnosis|4
4638392|NCT01960998|7511833|FG001|Overall Study|lost computer access|1
4638393|NCT01961115|7511848|FG000|Overall Study|Disease Progression|1
4638394|NCT01961115|7511849|FG001|Overall Study|Disease Progression|0
4638395|NCT01961115|7511850|FG002|Overall Study|Disease Progression|3
4638396|NCT01961115|7511848|FG000|Overall Study|Adverse Event|1
4638397|NCT01961115|7511849|FG001|Overall Study|Adverse Event|0
4638398|NCT01961115|7511850|FG002|Overall Study|Adverse Event|1
4638399|NCT01961297|7511868|FG000|Overall Study|unconfirmed diagnosis of SD|2
4638400|NCT01961297|7511869|FG001|Overall Study|unconfirmed diagnosis of SD|1
4638401|NCT01961323|7511875|FG000|Overall Study|Withdrawal by Subject|7
4638402|NCT01961323|7511875|FG000|Overall Study|Lost to Follow-up|8
4638403|NCT01961323|7511875|FG000|Overall Study|screen failure|34
4638404|NCT01961349|7511882|FG000|Overall Study|Withdrawal by Subject|1
4638405|NCT01961349|7511883|FG001|Overall Study|Withdrawal by Subject|4
4638406|NCT01961349|7511884|FG002|Overall Study|Withdrawal by Subject|0
4638407|NCT01961349|7511882|FG000|Overall Study|Adverse Event|0
4638408|NCT01961349|7511883|FG001|Overall Study|Adverse Event|0
4638409|NCT01961349|7511884|FG002|Overall Study|Adverse Event|1
4638410|NCT01961349|7511882|FG000|Overall Study|registration error, personal reason etc|2
4638411|NCT01961349|7511883|FG001|Overall Study|registration error, personal reason etc|2
4638412|NCT01961349|7511884|FG002|Overall Study|registration error, personal reason etc|1
4638413|NCT01961544|7511896|FG000|Overall Study|Protocol Violation|1
4638414|NCT01961544|7511896|FG000|Overall Study|Withdrawal by Subject|7
4638415|NCT01961544|7511896|FG000|Overall Study|Adverse Event|1
4638416|NCT01961544|7511896|FG000|Overall Study|Physician Decision|2
4638417|NCT01961544|7511896|FG000|Overall Study|Poor Tolerance|1
4638418|NCT01961544|7511896|FG000|Overall Study|Aggravation of Steral Pain|1
4638419|NCT01961609|7511902|FG000|Initiation|Missing|3
4638420|NCT01961609|7511903|FG001|Initiation|Missing|2
4638421|NCT01961609|7511904|FG002|Initiation|Missing|0
4638422|NCT01961609|7511905|FG003|Initiation|Missing|0
4638423|NCT01961609|7511902|FG000|Initiation|Protocol deviation|1
4638424|NCT01961609|7511903|FG001|Initiation|Protocol deviation|0
4638425|NCT01961609|7511904|FG002|Initiation|Protocol deviation|0
4638426|NCT01961609|7511905|FG003|Initiation|Protocol deviation|0
4638427|NCT01961609|7511902|FG000|Initiation|Death|0
4638428|NCT01961609|7511903|FG001|Initiation|Death|1
4638429|NCT01961609|7511904|FG002|Initiation|Death|0
4638430|NCT01961609|7511905|FG003|Initiation|Death|0
4638431|NCT01961609|7511902|FG000|Initiation|Administrative problems|1
4638432|NCT01961609|7511903|FG001|Initiation|Administrative problems|0
4638433|NCT01961609|7511904|FG002|Initiation|Administrative problems|0
4638434|NCT01961609|7511905|FG003|Initiation|Administrative problems|0
4638435|NCT01961609|7511902|FG000|Initiation|Withdrawal by Subject|1
4638436|NCT01961609|7511903|FG001|Initiation|Withdrawal by Subject|2
4638437|NCT01961609|7511904|FG002|Initiation|Withdrawal by Subject|0
4638438|NCT01961609|7511905|FG003|Initiation|Withdrawal by Subject|0
4638439|NCT01961609|7511902|FG000|Initiation|Lack of Efficacy|2
4638440|NCT01961609|7511903|FG001|Initiation|Lack of Efficacy|1
4638441|NCT01961609|7511904|FG002|Initiation|Lack of Efficacy|0
4638442|NCT01961609|7511905|FG003|Initiation|Lack of Efficacy|0
4638443|NCT01961609|7511902|FG000|Initiation|Abnormal lab values|0
4638444|NCT01961609|7511903|FG001|Initiation|Abnormal lab values|1
4638445|NCT01961609|7511904|FG002|Initiation|Abnormal lab values|0
4638446|NCT01961609|7511905|FG003|Initiation|Abnormal lab values|0
4638447|NCT01961609|7511902|FG000|Initiation|Adverse Event|3
4638448|NCT01961609|7511903|FG001|Initiation|Adverse Event|5
4638449|NCT01961609|7511904|FG002|Initiation|Adverse Event|0
4638450|NCT01961609|7511905|FG003|Initiation|Adverse Event|0
4638451|NCT01961609|7511902|FG000|Initiation|Randomized but not treated|1
4638452|NCT01961609|7511903|FG001|Initiation|Randomized but not treated|1
4638453|NCT01961609|7511904|FG002|Initiation|Randomized but not treated|0
4638454|NCT01961609|7511905|FG003|Initiation|Randomized but not treated|0
4638455|NCT01961609|7511902|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1
4638456|NCT01961609|7511903|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0
4638457|NCT01961609|7511904|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3
4638458|NCT01961609|7511905|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0
4638459|NCT01961609|7511902|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3
4607874|NCT01673126|7462731|FG001|Overall Study|change of diagnosis|3
4607875|NCT01673178|7462742|FG000|Overall Study|Lost to Follow-up|0
4638460|NCT01961609|7511903|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0
4607876|NCT01673178|7462743|FG001|Overall Study|Lost to Follow-up|1
4607877|NCT01673178|7462744|FG002|Overall Study|Lost to Follow-up|0
4607878|NCT01673178|7462745|FG003|Overall Study|Lost to Follow-up|0
4607879|NCT01673178|7462746|FG004|Overall Study|Lost to Follow-up|0
4638461|NCT01961609|7511904|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1
4638462|NCT01961609|7511905|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0
4638463|NCT01961609|7511902|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0
4638464|NCT01961609|7511903|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1
4638465|NCT01961609|7511904|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1
4638466|NCT01961609|7511905|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0
4638467|NCT01961609|7511902|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13
4638468|NCT01961609|7511903|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4
4638469|NCT01961609|7511904|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10
4638470|NCT01961609|7511905|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0
4638471|NCT01961609|7511902|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6
4638472|NCT01961609|7511903|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6
4638473|NCT01961609|7511904|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3
4638474|NCT01961609|7511905|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0
4638475|NCT01961609|7511902|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0
4638476|NCT01961609|7511903|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0
4638477|NCT01961609|7511904|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1
4638478|NCT01961609|7511905|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0
4638479|NCT01961609|7511902|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7
4638480|NCT01961609|7511903|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5
4638481|NCT01961609|7511904|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0
4638482|NCT01961609|7511905|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4
4638483|NCT01961609|7511902|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0
4638484|NCT01961609|7511903|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0
4638485|NCT01961609|7511904|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1
4638486|NCT01961609|7511905|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0
4638487|NCT01961609|7511902|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1
4638488|NCT01961609|7511903|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0
4638489|NCT01961609|7511904|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0
4638490|NCT01961609|7511905|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0
4638491|NCT01961609|7511902|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0
4638492|NCT01961609|7511903|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1
4638493|NCT01961609|7511904|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0
4638494|NCT01961609|7511905|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0
4638495|NCT01961609|7511902|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3
4638496|NCT01961609|7511903|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0
4638497|NCT01961609|7511904|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3
4638498|NCT01961609|7511905|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1
4638499|NCT01961609|7511902|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1
4607880|NCT01673178|7462742|FG000|Overall Study|Withdrawal by Subject|0
4607881|NCT01673178|7462743|FG001|Overall Study|Withdrawal by Subject|0
4607882|NCT01673178|7462744|FG002|Overall Study|Withdrawal by Subject|1
4607883|NCT01673178|7462745|FG003|Overall Study|Withdrawal by Subject|4
4607884|NCT01673178|7462746|FG004|Overall Study|Withdrawal by Subject|2
4607885|NCT01673178|7462742|FG000|Overall Study|Protocol Violation|1
4607886|NCT01673178|7462743|FG001|Overall Study|Protocol Violation|1
4607887|NCT01673178|7462744|FG002|Overall Study|Protocol Violation|0
4607888|NCT01673178|7462745|FG003|Overall Study|Protocol Violation|1
4607889|NCT01673178|7462746|FG004|Overall Study|Protocol Violation|0
4607890|NCT01673178|7462742|FG000|Overall Study|Adverse Event|1
4607891|NCT01673178|7462743|FG001|Overall Study|Adverse Event|0
4607892|NCT01673178|7462744|FG002|Overall Study|Adverse Event|0
4607893|NCT01673178|7462745|FG003|Overall Study|Adverse Event|2
4607894|NCT01673178|7462746|FG004|Overall Study|Adverse Event|0
4607895|NCT01673178|7462742|FG000|Overall Study|Other|1
4607896|NCT01673178|7462743|FG001|Overall Study|Other|0
4607897|NCT01673178|7462744|FG002|Overall Study|Other|2
4607898|NCT01673178|7462745|FG003|Overall Study|Other|1
4607899|NCT01673178|7462746|FG004|Overall Study|Other|0
4607900|NCT01673282|7462777|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9
4607901|NCT01673282|7462778|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5
4607902|NCT01673282|7462777|FG000|Overall Study|Lack of Efficacy|9
4607903|NCT01673282|7462778|FG001|Overall Study|Lack of Efficacy|2
4607904|NCT01673282|7462777|FG000|Overall Study|Lost to Follow-up|11
4607905|NCT01673282|7462778|FG001|Overall Study|Lost to Follow-up|10
4607906|NCT01673282|7462777|FG000|Overall Study|Withdrawal by Subject|3
4607907|NCT01673282|7462778|FG001|Overall Study|Withdrawal by Subject|3
4607908|NCT01673282|7462777|FG000|Overall Study|Other|1
4607909|NCT01673282|7462778|FG001|Overall Study|Other|6
4607910|NCT01673347|7462784|FG000|Overall Study|failure of allograft|7
4607911|NCT01673373|7462788|FG000|Overall Study|Death|2
4607912|NCT01673386|7462792|FG000|Overall Study|Study terminated by sponsor|16
4607913|NCT01673386|7462793|FG001|Overall Study|Study terminated by sponsor|22
4607914|NCT01673386|7462792|FG000|Overall Study|Adverse Event|5
4607915|NCT01673386|7462793|FG001|Overall Study|Adverse Event|2
4607916|NCT01673386|7462792|FG000|Overall Study|Progressive disease|4
4607917|NCT01673386|7462793|FG001|Overall Study|Progressive disease|1
4607918|NCT01673386|7462792|FG000|Overall Study|Withdrawal by Subject|0
4607919|NCT01673386|7462793|FG001|Overall Study|Withdrawal by Subject|2
4607920|NCT01673490|7462799|FG000|Overall Study|Lost to Follow-up|1
4638500|NCT01961609|7511903|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0
4638501|NCT01961609|7511904|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0
4638502|NCT01961609|7511905|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2
4638503|NCT01961687|7511922|FG000|Overall Study|Lost to Follow-up|19
4638504|NCT01961687|7511922|FG000|Overall Study|Re-operation|17
4638505|NCT01961687|7511922|FG000|Overall Study|Death|7
4638506|NCT01961687|7511922|FG000|Overall Study|Withdrawal by Subject|6
4638507|NCT01961687|7511922|FG000|Overall Study|Adverse Event|6
4638508|NCT01961687|7511922|FG000|Overall Study|Moved to area without study site|2
4638509|NCT01961687|7511922|FG000|Overall Study|Sponsor decision|2
4638510|NCT01961687|7511922|FG000|Overall Study|Physician Decision|1
4638511|NCT01961687|7511922|FG000|Overall Study|Unable to meet follow-up requirements|1
4638512|NCT01961882|7511928|FG000|Overall Study|Adverse Event|3
4638513|NCT01961882|7511929|FG001|Overall Study|Adverse Event|2
4638514|NCT01961882|7511928|FG000|Overall Study|Physician Decision|1
4638515|NCT01961882|7511929|FG001|Overall Study|Physician Decision|0
4638516|NCT01961882|7511928|FG000|Overall Study|Withdrawal by Subject|4
4638517|NCT01961882|7511929|FG001|Overall Study|Withdrawal by Subject|1
4638518|NCT01961882|7511928|FG000|Overall Study|Relapse of AML|39
4638519|NCT01961882|7511929|FG001|Overall Study|Relapse of AML|37
4638520|NCT01961882|7511928|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2
4638521|NCT01961882|7511929|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2
4638522|NCT01961882|7511928|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1
4638523|NCT01961882|7511929|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0
4638524|NCT01962103|7511959|FG000|Phase 1|Adverse Event|4
4638525|NCT01962103|7511960|FG001|Phase 1|Adverse Event|0
4638526|NCT01962103|7511961|FG002|Phase 1|Adverse Event|2
4638527|NCT01962103|7511962|FG003|Phase 1|Adverse Event|1
4638528|NCT01962103|7511963|FG004|Phase 1|Adverse Event|2
4638529|NCT01962103|7511964|FG005|Phase 1|Adverse Event|2
4638530|NCT01962103|7511965|FG006|Phase 1|Adverse Event|0
4638531|NCT01962103|7511966|FG007|Phase 1|Adverse Event|0
4638532|NCT01962103|7511967|FG008|Phase 1|Adverse Event|0
4638533|NCT01962103|7511959|FG000|Phase 1|Progressive Disease|8
4638534|NCT01962103|7511960|FG001|Phase 1|Progressive Disease|6
4638535|NCT01962103|7511961|FG002|Phase 1|Progressive Disease|8
4638536|NCT01962103|7511962|FG003|Phase 1|Progressive Disease|4
4638537|NCT01962103|7511963|FG004|Phase 1|Progressive Disease|5
4638538|NCT01962103|7511964|FG005|Phase 1|Progressive Disease|4
4638539|NCT01962103|7511965|FG006|Phase 1|Progressive Disease|0
4638540|NCT01962103|7511966|FG007|Phase 1|Progressive Disease|0
4638541|NCT01962103|7511967|FG008|Phase 1|Progressive Disease|0
4638542|NCT01962103|7511959|FG000|Phase 1|Withdrawal by Subject|0
4638543|NCT01962103|7511960|FG001|Phase 1|Withdrawal by Subject|0
4638544|NCT01962103|7511961|FG002|Phase 1|Withdrawal by Subject|0
4638545|NCT01962103|7511962|FG003|Phase 1|Withdrawal by Subject|2
4638546|NCT01962103|7511963|FG004|Phase 1|Withdrawal by Subject|0
4638547|NCT01962103|7511964|FG005|Phase 1|Withdrawal by Subject|0
4638548|NCT01962103|7511965|FG006|Phase 1|Withdrawal by Subject|0
4638549|NCT01962103|7511966|FG007|Phase 1|Withdrawal by Subject|0
4638550|NCT01962103|7511967|FG008|Phase 1|Withdrawal by Subject|0
4638551|NCT01962103|7511959|FG000|Phase 1|Withdrawal by Parent/Guardian|0
4638552|NCT01962103|7511960|FG001|Phase 1|Withdrawal by Parent/Guardian|0
4638553|NCT01962103|7511961|FG002|Phase 1|Withdrawal by Parent/Guardian|2
4638554|NCT01962103|7511962|FG003|Phase 1|Withdrawal by Parent/Guardian|1
4638555|NCT01962103|7511963|FG004|Phase 1|Withdrawal by Parent/Guardian|0
4638556|NCT01962103|7511964|FG005|Phase 1|Withdrawal by Parent/Guardian|0
4638557|NCT01962103|7511965|FG006|Phase 1|Withdrawal by Parent/Guardian|0
4638558|NCT01962103|7511966|FG007|Phase 1|Withdrawal by Parent/Guardian|0
4638559|NCT01962103|7511967|FG008|Phase 1|Withdrawal by Parent/Guardian|0
4638560|NCT01962103|7511959|FG000|Phase 1|Physician Decision|0
4638561|NCT01962103|7511960|FG001|Phase 1|Physician Decision|0
4607921|NCT01673490|7462799|FG000|Overall Study|Adverse Event|3
4638562|NCT01962103|7511961|FG002|Phase 1|Physician Decision|0
4638563|NCT01962103|7511962|FG003|Phase 1|Physician Decision|1
4638564|NCT01962103|7511963|FG004|Phase 1|Physician Decision|0
4638565|NCT01962103|7511964|FG005|Phase 1|Physician Decision|0
4638566|NCT01962103|7511965|FG006|Phase 1|Physician Decision|0
4638567|NCT01962103|7511966|FG007|Phase 1|Physician Decision|0
4638568|NCT01962103|7511967|FG008|Phase 1|Physician Decision|0
4638569|NCT01962103|7511959|FG000|Phase 1|Symptomatic Deterioration|3
4638570|NCT01962103|7511960|FG001|Phase 1|Symptomatic Deterioration|2
4638571|NCT01962103|7511961|FG002|Phase 1|Symptomatic Deterioration|2
4638572|NCT01962103|7511962|FG003|Phase 1|Symptomatic Deterioration|2
4638573|NCT01962103|7511963|FG004|Phase 1|Symptomatic Deterioration|1
4638574|NCT01962103|7511964|FG005|Phase 1|Symptomatic Deterioration|1
4607922|NCT01673490|7462799|FG000|Overall Study|Withdrawal by Subject|3
4638575|NCT01962103|7511965|FG006|Phase 1|Symptomatic Deterioration|0
4607923|NCT01673594|7462814|FG000|Overall Study|Adverse Event|3
4607924|NCT01673594|7462815|FG001|Overall Study|Adverse Event|1
4607925|NCT01673594|7462814|FG000|Overall Study|Lost to Follow-up|1
4607926|NCT01673594|7462815|FG001|Overall Study|Lost to Follow-up|0
4607927|NCT01673594|7462814|FG000|Overall Study|Physician Decision|2
4607928|NCT01673594|7462815|FG001|Overall Study|Physician Decision|4
4607929|NCT01673594|7462814|FG000|Overall Study|Withdrawal by Subject|0
4607930|NCT01673594|7462815|FG001|Overall Study|Withdrawal by Subject|1
4607931|NCT01673646|7462824|FG000|Overall Study|Adverse Event|2
4607932|NCT01673646|7462825|FG001|Overall Study|Adverse Event|1
4638576|NCT01962103|7511966|FG007|Phase 1|Symptomatic Deterioration|0
4638577|NCT01962103|7511967|FG008|Phase 1|Symptomatic Deterioration|0
4638578|NCT01962103|7511959|FG000|Phase 1|Miscellaneous|1
4638579|NCT01962103|7511960|FG001|Phase 1|Miscellaneous|0
4638580|NCT01962103|7511961|FG002|Phase 1|Miscellaneous|0
4638581|NCT01962103|7511962|FG003|Phase 1|Miscellaneous|0
4638582|NCT01962103|7511963|FG004|Phase 1|Miscellaneous|0
4638583|NCT01962103|7511964|FG005|Phase 1|Miscellaneous|0
4638584|NCT01962103|7511965|FG006|Phase 1|Miscellaneous|0
4638585|NCT01962103|7511966|FG007|Phase 1|Miscellaneous|0
4638586|NCT01962103|7511967|FG008|Phase 1|Miscellaneous|0
4638587|NCT01962103|7511959|FG000|Phase 2|Adverse Event|0
4638588|NCT01962103|7511960|FG001|Phase 2|Adverse Event|0
4638589|NCT01962103|7511961|FG002|Phase 2|Adverse Event|0
4638590|NCT01962103|7511962|FG003|Phase 2|Adverse Event|0
4638591|NCT01962103|7511963|FG004|Phase 2|Adverse Event|0
4638592|NCT01962103|7511964|FG005|Phase 2|Adverse Event|0
4638593|NCT01962103|7511965|FG006|Phase 2|Adverse Event|1
4638594|NCT01962103|7511966|FG007|Phase 2|Adverse Event|0
4638595|NCT01962103|7511967|FG008|Phase 2|Adverse Event|3
4638596|NCT01962103|7511959|FG000|Phase 2|Progressive Disease|0
4638597|NCT01962103|7511960|FG001|Phase 2|Progressive Disease|0
4638598|NCT01962103|7511961|FG002|Phase 2|Progressive Disease|0
4638599|NCT01962103|7511962|FG003|Phase 2|Progressive Disease|0
4638600|NCT01962103|7511963|FG004|Phase 2|Progressive Disease|0
4638601|NCT01962103|7511964|FG005|Phase 2|Progressive Disease|0
4638602|NCT01962103|7511965|FG006|Phase 2|Progressive Disease|11
4638603|NCT01962103|7511966|FG007|Phase 2|Progressive Disease|12
4638604|NCT01962103|7511967|FG008|Phase 2|Progressive Disease|11
4638605|NCT01962103|7511959|FG000|Phase 2|Symptomatic Deterioration|0
4638606|NCT01962103|7511960|FG001|Phase 2|Symptomatic Deterioration|0
4638607|NCT01962103|7511961|FG002|Phase 2|Symptomatic Deterioration|0
4638608|NCT01962103|7511962|FG003|Phase 2|Symptomatic Deterioration|0
4638609|NCT01962103|7511963|FG004|Phase 2|Symptomatic Deterioration|0
4638610|NCT01962103|7511964|FG005|Phase 2|Symptomatic Deterioration|0
4638611|NCT01962103|7511965|FG006|Phase 2|Symptomatic Deterioration|2
4638612|NCT01962103|7511966|FG007|Phase 2|Symptomatic Deterioration|2
4638613|NCT01962103|7511967|FG008|Phase 2|Symptomatic Deterioration|0
4638614|NCT01962207|7511991|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2
4638615|NCT01962207|7511992|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1
4638616|NCT01962207|7511993|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5
4638617|NCT01962207|7511994|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2
4638618|NCT01962207|7511991|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2
4638619|NCT01962207|7511992|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0
4638620|NCT01962207|7511993|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4
4638621|NCT01962207|7511994|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0
4638622|NCT01962207|7511991|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4
4638623|NCT01962207|7511992|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5
4638624|NCT01962207|7511993|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18
4638625|NCT01962207|7511994|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4
4638626|NCT01962207|7511991|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0
4638627|NCT01962207|7511992|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0
4638628|NCT01962207|7511993|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3
4638629|NCT01962207|7511994|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1
4638630|NCT01962207|7511991|FG000|Persistence Phase (5 Years)|Adverse Event|0
4638631|NCT01962207|7511992|FG001|Persistence Phase (5 Years)|Adverse Event|0
4638632|NCT01962207|7511993|FG002|Persistence Phase (5 Years)|Adverse Event|1
4638633|NCT01962207|7511994|FG003|Persistence Phase (5 Years)|Adverse Event|0
4638634|NCT01962207|7511991|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21
4638635|NCT01962207|7511992|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7
4638636|NCT01962207|7511993|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13
4638637|NCT01962207|7511994|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5
4638638|NCT01962298|7512013|FG000|Overall Study|Protocol Violation|1
4638639|NCT01962298|7512014|FG001|Overall Study|Protocol Violation|0
4638640|NCT01962298|7512015|FG002|Overall Study|Protocol Violation|1
4638641|NCT01962298|7512016|FG003|Overall Study|Protocol Violation|1
4638642|NCT01962298|7512017|FG004|Overall Study|Protocol Violation|0
4638643|NCT01962298|7512013|FG000|Overall Study|Data quality insufficient|2
4638644|NCT01962298|7512014|FG001|Overall Study|Data quality insufficient|0
4638645|NCT01962298|7512015|FG002|Overall Study|Data quality insufficient|3
4638646|NCT01962298|7512016|FG003|Overall Study|Data quality insufficient|1
4638647|NCT01962298|7512017|FG004|Overall Study|Data quality insufficient|4
4607933|NCT01673646|7462826|FG002|Overall Study|Adverse Event|1
4607934|NCT01673646|7462824|FG000|Overall Study|Unsatisfactory therapeutic effect|0
4607935|NCT01673646|7462825|FG001|Overall Study|Unsatisfactory therapeutic effect|2
4607936|NCT01673646|7462826|FG002|Overall Study|Unsatisfactory therapeutic effect|0
4607937|NCT01673646|7462824|FG000|Overall Study|Condition no longer requires study drug|0
4607938|NCT01673646|7462825|FG001|Overall Study|Condition no longer requires study drug|1
4607939|NCT01673646|7462826|FG002|Overall Study|Condition no longer requires study drug|0
4607940|NCT01673646|7462824|FG000|Overall Study|Withdrawal by Subject|0
4607941|NCT01673646|7462825|FG001|Overall Study|Withdrawal by Subject|2
4607942|NCT01673646|7462826|FG002|Overall Study|Withdrawal by Subject|2
4607943|NCT01673646|7462824|FG000|Overall Study|Completed Core/did not enter Ext.|2
4607944|NCT01673646|7462825|FG001|Overall Study|Completed Core/did not enter Ext.|1
4638648|NCT01962298|7512013|FG000|Overall Study|Insufficient data|0
4638649|NCT01962298|7512014|FG001|Overall Study|Insufficient data|2
4638650|NCT01962298|7512015|FG002|Overall Study|Insufficient data|1
4638651|NCT01962298|7512016|FG003|Overall Study|Insufficient data|0
4638652|NCT01962298|7512017|FG004|Overall Study|Insufficient data|1
4638653|NCT01962298|7512013|FG000|Overall Study|Incorrect data recorded|0
4638654|NCT01962298|7512014|FG001|Overall Study|Incorrect data recorded|1
4638655|NCT01962298|7512015|FG002|Overall Study|Incorrect data recorded|0
4638656|NCT01962298|7512016|FG003|Overall Study|Incorrect data recorded|0
4638657|NCT01962298|7512017|FG004|Overall Study|Incorrect data recorded|0
4638658|NCT01962298|7512013|FG000|Overall Study|Physician Decision|0
4638659|NCT01962298|7512014|FG001|Overall Study|Physician Decision|1
4638660|NCT01962298|7512015|FG002|Overall Study|Physician Decision|0
4638661|NCT01962298|7512016|FG003|Overall Study|Physician Decision|0
4638662|NCT01962298|7512017|FG004|Overall Study|Physician Decision|1
4638663|NCT01962441|7512041|FG000|Randomized Period|Randomized but Never Treated|4
4638664|NCT01962441|7512042|FG001|Randomized Period|Randomized but Never Treated|2
4638665|NCT01962441|7512043|FG002|Randomized Period|Randomized but Never Treated|3
4638666|NCT01962441|7512041|FG000|Randomized Period|Lost to Follow-up|2
4638667|NCT01962441|7512042|FG001|Randomized Period|Lost to Follow-up|4
4638668|NCT01962441|7512043|FG002|Randomized Period|Lost to Follow-up|4
4638669|NCT01962441|7512041|FG000|Randomized Period|Withdrew Consent|3
4638670|NCT01962441|7512042|FG001|Randomized Period|Withdrew Consent|3
4638671|NCT01962441|7512043|FG002|Randomized Period|Withdrew Consent|2
4638672|NCT01962441|7512041|FG000|Randomized Period|Adverse Event|1
4638673|NCT01962441|7512042|FG001|Randomized Period|Adverse Event|1
4638674|NCT01962441|7512043|FG002|Randomized Period|Adverse Event|0
4638675|NCT01962441|7512041|FG000|Randomized Period|Death|0
4638676|NCT01962441|7512042|FG001|Randomized Period|Death|0
4638677|NCT01962441|7512043|FG002|Randomized Period|Death|2
4638678|NCT01962441|7512041|FG000|Randomized Period|Protocol Violation|0
4638679|NCT01962441|7512042|FG001|Randomized Period|Protocol Violation|1
4638680|NCT01962441|7512043|FG002|Randomized Period|Protocol Violation|0
4638681|NCT01962441|7512041|FG000|Retreatment Substudy|Lack of Efficacy|1
4638682|NCT01962441|7512042|FG001|Retreatment Substudy|Lack of Efficacy|0
4638683|NCT01962441|7512043|FG002|Retreatment Substudy|Lack of Efficacy|0
4638684|NCT01962441|7512041|FG000|Retreatment Substudy|Lost to Follow-up|1
4638685|NCT01962441|7512042|FG001|Retreatment Substudy|Lost to Follow-up|0
4638686|NCT01962441|7512043|FG002|Retreatment Substudy|Lost to Follow-up|0
4638687|NCT01962493|7512054|FG000|Overall Study|Adverse Event|1
4638688|NCT01962493|7512055|FG001|Overall Study|Adverse Event|2
4638689|NCT01962493|7512054|FG000|Overall Study|Protocol Violation|0
4638690|NCT01962493|7512055|FG001|Overall Study|Protocol Violation|1
4638691|NCT01962493|7512054|FG000|Overall Study|Withdrawal by Subject|4
4638692|NCT01962493|7512055|FG001|Overall Study|Withdrawal by Subject|2
4638693|NCT01962896|7512097|FG000|Overall Study|Lack of Efficacy|4
4638694|NCT01962922|7512104|FG000|PK Portion Day 7|Withdrawal by Subject|3
4638695|NCT01962922|7512105|FG001|PK Portion Day 7|Withdrawal by Subject|0
4638696|NCT01962922|7512104|FG000|PK Portion Day 7|non-compliance|1
4638697|NCT01962922|7512105|FG001|PK Portion Day 7|non-compliance|0
4638698|NCT01962922|7512104|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4
4638699|NCT01962922|7512105|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3
4638700|NCT01962922|7512104|FG000|Extendion Portion (up to Month 6)|Physician Decision|1
4638701|NCT01962922|7512105|FG001|Extendion Portion (up to Month 6)|Physician Decision|0
4638702|NCT01962987|7512127|FG000|Overall Study|Adverse Event|4
4638703|NCT01962987|7512128|FG001|Overall Study|Adverse Event|4
4638704|NCT01962987|7512129|FG002|Overall Study|Adverse Event|0
4638705|NCT01962987|7512127|FG000|Overall Study|Lost to Follow-up|0
4638706|NCT01962987|7512128|FG001|Overall Study|Lost to Follow-up|0
4638707|NCT01962987|7512129|FG002|Overall Study|Lost to Follow-up|1
4638708|NCT01962987|7512127|FG000|Overall Study|Non compliance with dosing requirements|4
4638709|NCT01962987|7512128|FG001|Overall Study|Non compliance with dosing requirements|2
4638710|NCT01962987|7512129|FG002|Overall Study|Non compliance with dosing requirements|0
4638711|NCT01962987|7512127|FG000|Overall Study|Miscellaneous|1
4607945|NCT01673646|7462826|FG002|Overall Study|Completed Core/did not enter Ext.|1
4638712|NCT01962987|7512128|FG001|Overall Study|Miscellaneous|9
4638713|NCT01962987|7512129|FG002|Overall Study|Miscellaneous|2
4638714|NCT01962987|7512127|FG000|Overall Study|Restricted medication|5
4638715|NCT01962987|7512128|FG001|Overall Study|Restricted medication|1
4638716|NCT01962987|7512129|FG002|Overall Study|Restricted medication|1
4607946|NCT01673698|7462840|FG000|Overall Study|Lost to Follow-up|51
4607947|NCT01673698|7462841|FG001|Overall Study|Lost to Follow-up|13
4607948|NCT01673854|7462861|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7
4607949|NCT01673854|7462861|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6
4607950|NCT01673854|7462861|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2
4607951|NCT01673854|7462861|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1
4607952|NCT01673854|7462861|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1
4607953|NCT01673854|7462861|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1
4607954|NCT01673854|7462861|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2
4607955|NCT01673854|7462861|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7
4607956|NCT01673854|7462861|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12
4607957|NCT01673854|7462861|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5
4607958|NCT01673854|7462861|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1
4607959|NCT01673854|7462861|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1
4607960|NCT01673984|7462879|FG000|Overall Study|Adverse Event|1
4607961|NCT01673984|7462880|FG001|Overall Study|Adverse Event|0
4607962|NCT01673984|7462879|FG000|Overall Study|Study termination|9
4607963|NCT01673984|7462880|FG001|Overall Study|Study termination|6
4607964|NCT01674010|7462886|FG000|Open Treatment Phase 1|Adverse Event|10
4607965|NCT01674010|7462887|FG001|Open Treatment Phase 1|Adverse Event|0
4607966|NCT01674010|7462888|FG002|Open Treatment Phase 1|Adverse Event|0
4607967|NCT01674010|7462886|FG000|Open Treatment Phase 1|Death|1
4607968|NCT01674010|7462887|FG001|Open Treatment Phase 1|Death|0
4607969|NCT01674010|7462888|FG002|Open Treatment Phase 1|Death|0
4607970|NCT01674010|7462886|FG000|Open Treatment Phase 1|Lost to Follow-up|19
4607971|NCT01674010|7462887|FG001|Open Treatment Phase 1|Lost to Follow-up|0
4607972|NCT01674010|7462888|FG002|Open Treatment Phase 1|Lost to Follow-up|0
4607973|NCT01674010|7462886|FG000|Open Treatment Phase 1|Physician Decision|9
4607974|NCT01674010|7462887|FG001|Open Treatment Phase 1|Physician Decision|0
4607975|NCT01674010|7462888|FG002|Open Treatment Phase 1|Physician Decision|0
4607976|NCT01674010|7462886|FG000|Open Treatment Phase 1|Protocol Violation|7
4607977|NCT01674010|7462887|FG001|Open Treatment Phase 1|Protocol Violation|0
4607978|NCT01674010|7462888|FG002|Open Treatment Phase 1|Protocol Violation|0
4607979|NCT01674010|7462886|FG000|Open Treatment Phase 1|Sponsor Decision|79
4607980|NCT01674010|7462887|FG001|Open Treatment Phase 1|Sponsor Decision|0
4607981|NCT01674010|7462888|FG002|Open Treatment Phase 1|Sponsor Decision|0
4638717|NCT01962987|7512127|FG000|Overall Study|Serious Adverse Event|1
4638718|NCT01962987|7512128|FG001|Overall Study|Serious Adverse Event|0
4638719|NCT01962987|7512129|FG002|Overall Study|Serious Adverse Event|0
4638720|NCT01962987|7512127|FG000|Overall Study|Withdrawal by Subject|11
4638721|NCT01962987|7512128|FG001|Overall Study|Withdrawal by Subject|10
4638722|NCT01962987|7512129|FG002|Overall Study|Withdrawal by Subject|6
4638723|NCT01962987|7512127|FG000|Overall Study|Randomized in Error|4
4638724|NCT01962987|7512128|FG001|Overall Study|Randomized in Error|2
4638725|NCT01962987|7512129|FG002|Overall Study|Randomized in Error|2
4638726|NCT01963117|7512163|FG000|Overall Study|Death|1
4638727|NCT01963260|7512217|FG000|Overall Study|Withdrawal by Subject|2
4638728|NCT01963260|7512218|FG001|Overall Study|Withdrawal by Subject|0
4638729|NCT01963260|7512219|FG002|Overall Study|Withdrawal by Subject|0
4638730|NCT01963260|7512220|FG003|Overall Study|Withdrawal by Subject|1
4638731|NCT01963260|7512221|FG004|Overall Study|Withdrawal by Subject|2
4638732|NCT01963260|7512222|FG005|Overall Study|Withdrawal by Subject|0
4638733|NCT01963260|7512223|FG006|Overall Study|Withdrawal by Subject|0
4638734|NCT01963260|7512224|FG007|Overall Study|Withdrawal by Subject|0
4638735|NCT01963260|7512225|FG008|Overall Study|Withdrawal by Subject|0
4638736|NCT01963260|7512226|FG009|Overall Study|Withdrawal by Subject|0
4638737|NCT01963403|7512257|FG000|Overall Study|Lost to Follow-up|2
4638738|NCT01963403|7512258|FG001|Overall Study|Lost to Follow-up|3
4638739|NCT01963403|7512257|FG000|Overall Study|Implant removal|0
4638740|NCT01963403|7512258|FG001|Overall Study|Implant removal|1
4638741|NCT01963611|7512275|FG000|Overall Study|Adverse Event|1
4638742|NCT01963611|7512276|FG001|Overall Study|Adverse Event|1
4638743|NCT01963611|7512277|FG002|Overall Study|Adverse Event|3
4638744|NCT01963611|7512278|FG003|Overall Study|Adverse Event|4
4638745|NCT01963611|7512279|FG004|Overall Study|Adverse Event|3
4638746|NCT01963611|7512275|FG000|Overall Study|Protocol Violation|0
4638747|NCT01963611|7512276|FG001|Overall Study|Protocol Violation|0
4638748|NCT01963611|7512277|FG002|Overall Study|Protocol Violation|0
4638749|NCT01963611|7512278|FG003|Overall Study|Protocol Violation|1
4638750|NCT01963611|7512279|FG004|Overall Study|Protocol Violation|0
4607982|NCT01674010|7462886|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30
4607983|NCT01674010|7462887|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0
4607984|NCT01674010|7462888|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0
4607985|NCT01674010|7462886|FG000|Open Treatment Phase 1|Withdrawal by Subject|25
4638751|NCT01963611|7512275|FG000|Overall Study|Lack of Efficacy|0
4638752|NCT01963611|7512276|FG001|Overall Study|Lack of Efficacy|0
4638753|NCT01963611|7512277|FG002|Overall Study|Lack of Efficacy|0
4638754|NCT01963611|7512278|FG003|Overall Study|Lack of Efficacy|1
4638755|NCT01963611|7512279|FG004|Overall Study|Lack of Efficacy|0
4638756|NCT01963611|7512275|FG000|Overall Study|Withdrawal by Subject|3
4607986|NCT01674010|7462887|FG001|Open Treatment Phase 1|Withdrawal by Subject|0
4607987|NCT01674010|7462888|FG002|Open Treatment Phase 1|Withdrawal by Subject|0
4607988|NCT01674010|7462886|FG000|Randomization Phase 2|Adverse Event|0
4607989|NCT01674010|7462887|FG001|Randomization Phase 2|Adverse Event|1
4607990|NCT01674010|7462888|FG002|Randomization Phase 2|Adverse Event|1
4607991|NCT01674010|7462886|FG000|Randomization Phase 2|Lost to Follow-up|0
4607992|NCT01674010|7462887|FG001|Randomization Phase 2|Lost to Follow-up|1
4607993|NCT01674010|7462888|FG002|Randomization Phase 2|Lost to Follow-up|2
4607994|NCT01674010|7462886|FG000|Randomization Phase 2|Mood episode recurrence|0
4607995|NCT01674010|7462887|FG001|Randomization Phase 2|Mood episode recurrence|8
4607996|NCT01674010|7462888|FG002|Randomization Phase 2|Mood episode recurrence|2
4607997|NCT01674010|7462886|FG000|Randomization Phase 2|Physician Decision|0
4607998|NCT01674010|7462887|FG001|Randomization Phase 2|Physician Decision|0
4607999|NCT01674010|7462888|FG002|Randomization Phase 2|Physician Decision|2
4608000|NCT01674010|7462886|FG000|Randomization Phase 2|Pregnancy|0
4608001|NCT01674010|7462887|FG001|Randomization Phase 2|Pregnancy|1
4608002|NCT01674010|7462888|FG002|Randomization Phase 2|Pregnancy|1
4608003|NCT01674010|7462886|FG000|Randomization Phase 2|Protocol Violation|0
4608004|NCT01674010|7462887|FG001|Randomization Phase 2|Protocol Violation|1
4608005|NCT01674010|7462888|FG002|Randomization Phase 2|Protocol Violation|1
4608006|NCT01674010|7462886|FG000|Randomization Phase 2|Sponsor Decision|0
4638757|NCT01963611|7512276|FG001|Overall Study|Withdrawal by Subject|2
4638758|NCT01963611|7512277|FG002|Overall Study|Withdrawal by Subject|1
4638759|NCT01963611|7512278|FG003|Overall Study|Withdrawal by Subject|1
4638760|NCT01963611|7512279|FG004|Overall Study|Withdrawal by Subject|3
4638761|NCT01963611|7512275|FG000|Overall Study|Other|47
4638762|NCT01963611|7512276|FG001|Overall Study|Other|46
4638763|NCT01963611|7512277|FG002|Overall Study|Other|48
4638764|NCT01963611|7512278|FG003|Overall Study|Other|45
4638765|NCT01963611|7512279|FG004|Overall Study|Other|45
4638766|NCT01963676|7512294|FG000|Overall Study|Withdrawal by Subject|1
4638767|NCT01963676|7512295|FG001|Overall Study|Withdrawal by Subject|0
4638768|NCT01963767|7512303|FG000|Overall Study|Withdrawal by Subject|4
4638769|NCT01963767|7512304|FG001|Overall Study|Withdrawal by Subject|2
4638770|NCT01963767|7512303|FG000|Overall Study|Adverse Event|2
4638771|NCT01963767|7512304|FG001|Overall Study|Adverse Event|0
4747004|NCT00384293|7720048|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0
4747005|NCT00384293|7720046|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340
4747006|NCT00384293|7720047|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0
4747007|NCT00384293|7720048|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0
4747008|NCT00384293|7720046|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16
4747009|NCT00384293|7720047|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0
4747010|NCT00384293|7720048|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0
4747011|NCT00384293|7720046|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2
4747012|NCT00384293|7720047|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0
4747013|NCT00384293|7720048|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0
4747014|NCT00384293|7720046|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1
4747015|NCT00384293|7720047|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0
4747016|NCT00384293|7720048|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0
4747017|NCT00384293|7720046|FG000|Post-randomization Period|Adverse Event|0
4747018|NCT00384293|7720047|FG001|Post-randomization Period|Adverse Event|23
4747019|NCT00384293|7720048|FG002|Post-randomization Period|Adverse Event|7
4747020|NCT00384293|7720046|FG000|Post-randomization Period|Lost to Follow-up|0
4747021|NCT00384293|7720047|FG001|Post-randomization Period|Lost to Follow-up|2
4747022|NCT00384293|7720048|FG002|Post-randomization Period|Lost to Follow-up|1
4747023|NCT00384293|7720046|FG000|Post-randomization Period|Protocol Violation|0
4747024|NCT00384293|7720047|FG001|Post-randomization Period|Protocol Violation|1
4747025|NCT00384293|7720048|FG002|Post-randomization Period|Protocol Violation|0
4747026|NCT00384293|7720046|FG000|Post-randomization Period|Withdrawal by Subject|0
4747027|NCT00384293|7720047|FG001|Post-randomization Period|Withdrawal by Subject|8
4747028|NCT00384293|7720048|FG002|Post-randomization Period|Withdrawal by Subject|6
4747029|NCT00384293|7720046|FG000|Post-randomization Period|Trial Termination|0
4747030|NCT00384293|7720047|FG001|Post-randomization Period|Trial Termination|180
4747031|NCT00384293|7720048|FG002|Post-randomization Period|Trial Termination|204
4747032|NCT00384293|7720046|FG000|Post-randomization Period|Patient Randomized in Error|0
4747033|NCT00384293|7720047|FG001|Post-randomization Period|Patient Randomized in Error|0
4747034|NCT00384293|7720048|FG002|Post-randomization Period|Patient Randomized in Error|1
4747035|NCT00377455|7720069|FG000|Overall Study|Withdrawal by Subject|1
4747036|NCT00371462|7720075|FG000|Overall Study|Withdrawal by Subject|1
4747037|NCT00371462|7720076|FG001|Overall Study|Withdrawal by Subject|0
4747038|NCT00371462|7720075|FG000|Overall Study|Other|7
4747039|NCT00371462|7720076|FG001|Overall Study|Other|8
4608007|NCT01674010|7462887|FG001|Randomization Phase 2|Sponsor Decision|42
4608008|NCT01674010|7462888|FG002|Randomization Phase 2|Sponsor Decision|45
4608009|NCT01674010|7462886|FG000|Randomization Phase 2|Withdrawal by Subject|0
4608010|NCT01674010|7462887|FG001|Randomization Phase 2|Withdrawal by Subject|8
4608011|NCT01674010|7462888|FG002|Randomization Phase 2|Withdrawal by Subject|7
4608012|NCT01674062|7462898|FG000|Overall Study|Insufficient Therapeutic Response|56
4608013|NCT01674062|7462899|FG001|Overall Study|Insufficient Therapeutic Response|26
4608014|NCT01674062|7462898|FG000|Overall Study|Other|8
4608015|NCT01674062|7462899|FG001|Overall Study|Other|1
4608016|NCT01674062|7462898|FG000|Overall Study|Adverse Event|1
4608017|NCT01674062|7462899|FG001|Overall Study|Adverse Event|1
4608018|NCT01674062|7462898|FG000|Overall Study|Death|0
4608019|NCT01674062|7462899|FG001|Overall Study|Death|1
4608020|NCT01674062|7462898|FG000|Overall Study|Programming Error|1
4608021|NCT01674062|7462899|FG001|Overall Study|Programming Error|0
4608022|NCT01674569|7462914|FG000|Overall Study|Adverse Event|0
4608023|NCT01674569|7462915|FG001|Overall Study|Adverse Event|2
4608024|NCT01674569|7462916|FG002|Overall Study|Adverse Event|0
4608025|NCT01674569|7462917|FG003|Overall Study|Adverse Event|1
4608026|NCT01674569|7462918|FG004|Overall Study|Adverse Event|2
4608027|NCT01674569|7462919|FG005|Overall Study|Adverse Event|2
4608028|NCT01674569|7462914|FG000|Overall Study|Protocol Violation|0
4608029|NCT01674569|7462915|FG001|Overall Study|Protocol Violation|1
4608030|NCT01674569|7462916|FG002|Overall Study|Protocol Violation|1
4608031|NCT01674569|7462917|FG003|Overall Study|Protocol Violation|0
4608032|NCT01674569|7462918|FG004|Overall Study|Protocol Violation|0
4608033|NCT01674569|7462919|FG005|Overall Study|Protocol Violation|0
4608034|NCT01674569|7462914|FG000|Overall Study|Withdrawal by Subject|0
4608035|NCT01674569|7462915|FG001|Overall Study|Withdrawal by Subject|0
4608036|NCT01674569|7462916|FG002|Overall Study|Withdrawal by Subject|1
4608037|NCT01674569|7462917|FG003|Overall Study|Withdrawal by Subject|0
4608038|NCT01674569|7462918|FG004|Overall Study|Withdrawal by Subject|0
4608039|NCT01674569|7462919|FG005|Overall Study|Withdrawal by Subject|0
4608040|NCT01674621|7462928|FG000|Overall Study|Adverse Event|3
4608041|NCT01674621|7462929|FG001|Overall Study|Adverse Event|2
4608042|NCT01674621|7462930|FG002|Overall Study|Adverse Event|5
4608043|NCT01674621|7462931|FG003|Overall Study|Adverse Event|5
4608044|NCT01674621|7462932|FG004|Overall Study|Adverse Event|1
4608045|NCT01674621|7462928|FG000|Overall Study|Inability to Complete Study Procedures|0
4608046|NCT01674621|7462929|FG001|Overall Study|Inability to Complete Study Procedures|0
4608047|NCT01674621|7462930|FG002|Overall Study|Inability to Complete Study Procedures|0
4608048|NCT01674621|7462931|FG003|Overall Study|Inability to Complete Study Procedures|0
4608049|NCT01674621|7462932|FG004|Overall Study|Inability to Complete Study Procedures|2
4608050|NCT01674621|7462928|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0
4608051|NCT01674621|7462929|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0
4608052|NCT01674621|7462930|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0
4608053|NCT01674621|7462931|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1
4608054|NCT01674621|7462932|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0
4608055|NCT01674621|7462928|FG000|Overall Study|Withdrawal by Subject|2
4608056|NCT01674621|7462929|FG001|Overall Study|Withdrawal by Subject|5
4608057|NCT01674621|7462930|FG002|Overall Study|Withdrawal by Subject|2
4608058|NCT01674621|7462931|FG003|Overall Study|Withdrawal by Subject|0
4608059|NCT01674621|7462932|FG004|Overall Study|Withdrawal by Subject|1
4638772|NCT01964105|7512362|FG000|Overall Study|Lost to Follow-up|2
4638773|NCT01964105|7512363|FG001|Overall Study|Lost to Follow-up|13
4608060|NCT01674621|7462928|FG000|Overall Study|Other than specified|0
4608061|NCT01674621|7462929|FG001|Overall Study|Other than specified|1
4608062|NCT01674621|7462930|FG002|Overall Study|Other than specified|0
4638774|NCT01964105|7512364|FG002|Overall Study|Lost to Follow-up|0
4638775|NCT01964222|7512374|FG000|Overall Study|Lost to Follow-up|7
4638776|NCT01964222|7512375|FG001|Overall Study|Lost to Follow-up|5
4638777|NCT01964222|7512374|FG000|Overall Study|Withdrawal by Subject|6
4638778|NCT01964222|7512375|FG001|Overall Study|Withdrawal by Subject|6
4638779|NCT01964222|7512374|FG000|Overall Study|Screening Failure|2
4638780|NCT01964222|7512375|FG001|Overall Study|Screening Failure|0
4638781|NCT01964300|7512383|FG000|Overall Study|Ineligible after enrollment|0
4638782|NCT01964300|7512384|FG001|Overall Study|Ineligible after enrollment|1
4638783|NCT01964300|7512383|FG000|Overall Study|Adverse Event|1
4638784|NCT01964300|7512384|FG001|Overall Study|Adverse Event|1
4638785|NCT01964300|7512383|FG000|Overall Study|Lack of Efficacy|3
4638786|NCT01964300|7512384|FG001|Overall Study|Lack of Efficacy|5
4638787|NCT01964300|7512383|FG000|Overall Study|Withdrawal by Subject|0
4638788|NCT01964300|7512384|FG001|Overall Study|Withdrawal by Subject|1
4747040|NCT00369265|7720084|FG000|Overall Study|Study terminated|4
4608063|NCT01674621|7462931|FG003|Overall Study|Other than specified|0
4608064|NCT01674621|7462932|FG004|Overall Study|Other than specified|2
4608065|NCT01674634|7462945|FG000|Overall Study|Withdrawal by Subject|3
4608066|NCT01674634|7462945|FG000|Overall Study|Lost to Follow-up|3
4608067|NCT01674647|7462955|FG000|Treatment Period|Death|4
4608068|NCT01674647|7462956|FG001|Treatment Period|Death|1
4608069|NCT01674647|7462955|FG000|Treatment Period|Efficacy outcome reached|0
4608070|NCT01674647|7462956|FG001|Treatment Period|Efficacy outcome reached|1
4638789|NCT01964300|7512383|FG000|Overall Study|To receive alternative therapy|1
4638790|NCT01964300|7512384|FG001|Overall Study|To receive alternative therapy|2
4638791|NCT01964300|7512383|FG000|Overall Study|Enlargement of cyst requiring drainage|1
4638792|NCT01964300|7512384|FG001|Overall Study|Enlargement of cyst requiring drainage|0
4608071|NCT01674647|7462955|FG000|Treatment Period|Physician Decision|3
4608072|NCT01674647|7462956|FG001|Treatment Period|Physician Decision|1
4608073|NCT01674647|7462955|FG000|Treatment Period|Adverse Event|60
4608074|NCT01674647|7462956|FG001|Treatment Period|Adverse Event|22
4608075|NCT01674647|7462955|FG000|Treatment Period|Non-compliance with study drug|3
4608076|NCT01674647|7462956|FG001|Treatment Period|Non-compliance with study drug|0
4608077|NCT01674647|7462955|FG000|Treatment Period|Lost to Follow-up|1
4608078|NCT01674647|7462956|FG001|Treatment Period|Lost to Follow-up|1
4608079|NCT01674647|7462955|FG000|Treatment Period|Withdrawal by Subject|19
4608080|NCT01674647|7462956|FG001|Treatment Period|Withdrawal by Subject|16
4608081|NCT01674647|7462955|FG000|Treatment Period|Switching to other therapy|5
4608082|NCT01674647|7462956|FG001|Treatment Period|Switching to other therapy|2
4608083|NCT01674647|7462955|FG000|Treatment Period|Logistical difficulties|5
4608084|NCT01674647|7462956|FG001|Treatment Period|Logistical difficulties|8
4608085|NCT01674647|7462955|FG000|Treatment Period|Treatment failure|0
4608086|NCT01674647|7462956|FG001|Treatment Period|Treatment failure|14
4608087|NCT01674647|7462955|FG000|Treatment Period|Protocol Violation|56
4608088|NCT01674647|7462956|FG001|Treatment Period|Protocol Violation|36
4608089|NCT01674647|7462955|FG000|30-day Safety Follow-up Period|Death|3
4608090|NCT01674647|7462956|FG001|30-day Safety Follow-up Period|Death|2
4608091|NCT01674647|7462955|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0
4608092|NCT01674647|7462956|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1
4608093|NCT01674647|7462955|FG000|30-day Safety Follow-up Period|Protocol Violation|39
4608094|NCT01674647|7462956|FG001|30-day Safety Follow-up Period|Protocol Violation|22
4608095|NCT01674647|7462955|FG000|30-day Safety Follow-up Period|Logistical difficulties|1
4608096|NCT01674647|7462956|FG001|30-day Safety Follow-up Period|Logistical difficulties|3
4608097|NCT01674647|7462955|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7
4608098|NCT01674647|7462956|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8
4608099|NCT01674647|7462955|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8
4608100|NCT01674647|7462956|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5
4608101|NCT01674712|7462967|FG000|Overall Study|Adverse Event|5
4608102|NCT01674712|7462968|FG001|Overall Study|Adverse Event|6
4608103|NCT01674712|7462969|FG002|Overall Study|Adverse Event|3
4608104|NCT01674712|7462970|FG003|Overall Study|Adverse Event|4
4608105|NCT01674712|7462971|FG004|Overall Study|Adverse Event|6
4608106|NCT01674712|7462967|FG000|Overall Study|Lost to Follow-up|1
4608107|NCT01674712|7462968|FG001|Overall Study|Lost to Follow-up|0
4608108|NCT01674712|7462969|FG002|Overall Study|Lost to Follow-up|0
4608109|NCT01674712|7462970|FG003|Overall Study|Lost to Follow-up|0
4608110|NCT01674712|7462971|FG004|Overall Study|Lost to Follow-up|0
4608111|NCT01674712|7462967|FG000|Overall Study|Protocol Violation|2
4608112|NCT01674712|7462968|FG001|Overall Study|Protocol Violation|0
4638793|NCT01964300|7512383|FG000|Overall Study|Weight criteria not met|0
4638794|NCT01964300|7512384|FG001|Overall Study|Weight criteria not met|1
4638795|NCT01964326|7512390|FG000|Overall Study|Adverse Event|48
4638796|NCT01964326|7512390|FG000|Overall Study|Death|2
4638797|NCT01964326|7512390|FG000|Overall Study|Protocol Violation|4
4638798|NCT01964326|7512390|FG000|Overall Study|Lost to Follow-up|88
4638799|NCT01964326|7512390|FG000|Overall Study|Withdrawal by Subject|87
4638800|NCT01964326|7512390|FG000|Overall Study|Pregnancy|1
4638801|NCT01964326|7512390|FG000|Overall Study|No Longer Meets Eligibility Criteria|1
4638802|NCT01964326|7512390|FG000|Overall Study|Physician Decision|55
4638803|NCT01964326|7512390|FG000|Overall Study|Investigator Discretion|1
4638804|NCT01964326|7512390|FG000|Overall Study|Other|9
4638805|NCT01964326|7512390|FG000|Overall Study|Did not meet eligibility criteria|1
4638806|NCT01964352|7512398|FG000|Overall Study|Adverse Event|13
4638807|NCT01964352|7512399|FG001|Overall Study|Adverse Event|3
4638808|NCT01964352|7512400|FG002|Overall Study|Adverse Event|4
4638809|NCT01964352|7512401|FG003|Overall Study|Adverse Event|3
4638810|NCT01964352|7512398|FG000|Overall Study|Lack of Efficacy|6
4638811|NCT01964352|7512399|FG001|Overall Study|Lack of Efficacy|0
4638812|NCT01964352|7512400|FG002|Overall Study|Lack of Efficacy|0
4638813|NCT01964352|7512401|FG003|Overall Study|Lack of Efficacy|0
4638814|NCT01964352|7512398|FG000|Overall Study|Protocol Violation|2
4638815|NCT01964352|7512399|FG001|Overall Study|Protocol Violation|4
4638816|NCT01964352|7512400|FG002|Overall Study|Protocol Violation|0
4638817|NCT01964352|7512401|FG003|Overall Study|Protocol Violation|2
4638818|NCT01964352|7512398|FG000|Overall Study|Lost to Follow-up|1
4638819|NCT01964352|7512399|FG001|Overall Study|Lost to Follow-up|0
4638820|NCT01964352|7512400|FG002|Overall Study|Lost to Follow-up|0
4638821|NCT01964352|7512401|FG003|Overall Study|Lost to Follow-up|1
4638822|NCT01964352|7512398|FG000|Overall Study|Withdrawal by Subject|4
4638823|NCT01964352|7512399|FG001|Overall Study|Withdrawal by Subject|2
4638824|NCT01964352|7512400|FG002|Overall Study|Withdrawal by Subject|1
4638825|NCT01964352|7512401|FG003|Overall Study|Withdrawal by Subject|0
4638826|NCT01964352|7512398|FG000|Overall Study|Other than stated above|0
4638827|NCT01964352|7512399|FG001|Overall Study|Other than stated above|2
4638828|NCT01964352|7512400|FG002|Overall Study|Other than stated above|1
4608113|NCT01674712|7462969|FG002|Overall Study|Protocol Violation|0
4608114|NCT01674712|7462970|FG003|Overall Study|Protocol Violation|0
4638829|NCT01964352|7512401|FG003|Overall Study|Other than stated above|2
4638830|NCT01964378|7512413|FG000|Overall Study|Disc. due to death before first dosing|0
4608115|NCT01674712|7462971|FG004|Overall Study|Protocol Violation|0
4608116|NCT01674712|7462967|FG000|Overall Study|Withdrawal by Subject|2
4608117|NCT01674712|7462968|FG001|Overall Study|Withdrawal by Subject|2
4608118|NCT01674712|7462969|FG002|Overall Study|Withdrawal by Subject|5
4608119|NCT01674712|7462970|FG003|Overall Study|Withdrawal by Subject|4
4608120|NCT01674712|7462971|FG004|Overall Study|Withdrawal by Subject|3
4608121|NCT01674712|7462967|FG000|Overall Study|Administrative|0
4608122|NCT01674712|7462968|FG001|Overall Study|Administrative|1
4608123|NCT01674712|7462969|FG002|Overall Study|Administrative|0
4608124|NCT01674712|7462970|FG003|Overall Study|Administrative|0
4608125|NCT01674712|7462971|FG004|Overall Study|Administrative|1
4608126|NCT01674712|7462967|FG000|Overall Study|Lack of Efficacy|0
4608127|NCT01674712|7462968|FG001|Overall Study|Lack of Efficacy|0
4608128|NCT01674712|7462969|FG002|Overall Study|Lack of Efficacy|1
4608129|NCT01674712|7462970|FG003|Overall Study|Lack of Efficacy|0
4608130|NCT01674712|7462971|FG004|Overall Study|Lack of Efficacy|1
4608131|NCT01674725|7462985|FG000|Overall Study|Adverse Event|1
4608132|NCT01674725|7462986|FG001|Overall Study|Adverse Event|0
4608133|NCT01674725|7462985|FG000|Overall Study|Did not receive study drug|1
4608134|NCT01674725|7462986|FG001|Overall Study|Did not receive study drug|0
4608135|NCT01674725|7462985|FG000|Overall Study|Withdrawal by Subject|1
4608136|NCT01674725|7462986|FG001|Overall Study|Withdrawal by Subject|0
4608137|NCT01674725|7462985|FG000|Overall Study|Lost to Follow-up|0
4747041|NCT00369265|7720085|FG001|Overall Study|Study terminated|7
4747042|NCT00364689|7720098|FG000|Overall Study|Lost to Follow-up|1
4747043|NCT00352118|7720104|FG000|Overall Study|Physician Decision|4
4747044|NCT00356421|7720127|FG000|Overall Study|Lack of Efficacy|3
4747045|NCT00356421|7720128|FG001|Overall Study|Lack of Efficacy|0
4747046|NCT00356421|7720127|FG000|Overall Study|Withdrawal by Subject|9
4747047|NCT00356421|7720128|FG001|Overall Study|Withdrawal by Subject|2
4747048|NCT00356421|7720127|FG000|Overall Study|Related to study drug|15
4747049|NCT00356421|7720128|FG001|Overall Study|Related to study drug|12
4747050|NCT00356421|7720127|FG000|Overall Study|Not related to study drug|5
4747051|NCT00356421|7720128|FG001|Overall Study|Not related to study drug|3
4747052|NCT00350623|7720137|FG000|Overall Study|Lost to Follow-up|8
4747053|NCT00350623|7720138|FG001|Overall Study|Lost to Follow-up|3
4747054|NCT00350623|7720139|FG002|Overall Study|Lost to Follow-up|4
4747055|NCT00350623|7720137|FG000|Overall Study|Withdrawal by Subject|0
4747056|NCT00350623|7720138|FG001|Overall Study|Withdrawal by Subject|1
4747057|NCT00350623|7720139|FG002|Overall Study|Withdrawal by Subject|1
4747058|NCT00350623|7720137|FG000|Overall Study|patient traveling outside the country|0
4747059|NCT00350623|7720138|FG001|Overall Study|patient traveling outside the country|0
4747060|NCT00350623|7720139|FG002|Overall Study|patient traveling outside the country|1
4747061|NCT00350844|7720167|FG000|Overall Study|Lost to Follow-up|1
4747062|NCT00348556|7720171|FG000|Overall Study|Adverse Event|1
4747063|NCT00319839|7720175|FG000|Overall Study|Adverse Event|5
4747064|NCT00319839|7720175|FG000|Overall Study|Withdrawal by Subject|1
4747065|NCT00344019|7720182|FG000|Overall Study|did not meet final inclusion criteria|0
4747066|NCT00344019|7720183|FG001|Overall Study|did not meet final inclusion criteria|0
4747067|NCT00344019|7720184|FG002|Overall Study|did not meet final inclusion criteria|74
4747068|NCT00338455|7720197|FG000|Overall Study|Death|2
4747069|NCT00338455|7720198|FG001|Overall Study|Death|1
4747070|NCT00338455|7720197|FG000|Overall Study|Physician Decision|1
4747071|NCT00338455|7720198|FG001|Overall Study|Physician Decision|0
4747072|NCT00329108|7720206|FG000|Overall Study|Adverse Event|2
4747073|NCT00329108|7720207|FG001|Overall Study|Adverse Event|2
4747074|NCT00329108|7720206|FG000|Overall Study|Lack of Efficacy|3
4747075|NCT00329108|7720207|FG001|Overall Study|Lack of Efficacy|3
4608138|NCT01674725|7462986|FG001|Overall Study|Lost to Follow-up|1
4608139|NCT01675050|7462994|FG000|Period One Treatment|Withdrawal by Subject|1
4747076|NCT00329108|7720206|FG000|Overall Study|Withdrawal by Subject|0
4747077|NCT00329108|7720207|FG001|Overall Study|Withdrawal by Subject|2
4747078|NCT00329108|7720206|FG000|Overall Study|symptomatic deterioration|1
4608140|NCT01675050|7462995|FG001|Period One Treatment|Withdrawal by Subject|0
4608141|NCT01675128|7463008|FG000|Overall Study|Disease progression on study|1
4608142|NCT01675128|7463009|FG001|Overall Study|Disease progression on study|1
4608143|NCT01675128|7463010|FG002|Overall Study|Disease progression on study|1
4608144|NCT01675128|7463008|FG000|Overall Study|Refused further treatment|1
4608145|NCT01675128|7463009|FG001|Overall Study|Refused further treatment|0
4608146|NCT01675128|7463010|FG002|Overall Study|Refused further treatment|0
4608147|NCT01675128|7463008|FG000|Overall Study|Pulmonary complication; off study|0
4608148|NCT01675128|7463009|FG001|Overall Study|Pulmonary complication; off study|1
4608149|NCT01675128|7463010|FG002|Overall Study|Pulmonary complication; off study|0
4608150|NCT01675141|7463025|FG000|Overall Study|Lenalidomide outside NIH|3
4608151|NCT01675141|7463025|FG000|Overall Study|Withdrawal by Subject|3
4608152|NCT01675141|7463025|FG000|Overall Study|Physician Decision|4
4608153|NCT01675141|7463025|FG000|Overall Study|No treatment, per protocol|1
4608154|NCT01675154|7463033|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0
4608155|NCT01675154|7463034|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1
4608156|NCT01675154|7463035|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0
4608157|NCT01675154|7463036|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0
4608158|NCT01675167|7463060|FG000|Open-label Titration Phase|Adverse Event|81
4608159|NCT01675167|7463061|FG001|Open-label Titration Phase|Adverse Event|0
4608160|NCT01675167|7463062|FG002|Open-label Titration Phase|Adverse Event|0
4608161|NCT01675167|7463060|FG000|Open-label Titration Phase|Lack of Efficacy|63
4608162|NCT01675167|7463061|FG001|Open-label Titration Phase|Lack of Efficacy|0
4608163|NCT01675167|7463062|FG002|Open-label Titration Phase|Lack of Efficacy|0
4608164|NCT01675167|7463060|FG000|Open-label Titration Phase|Withdrawal by Subject|46
4608165|NCT01675167|7463061|FG001|Open-label Titration Phase|Withdrawal by Subject|0
4608166|NCT01675167|7463062|FG002|Open-label Titration Phase|Withdrawal by Subject|0
4608167|NCT01675167|7463060|FG000|Open-label Titration Phase|Protocol Violation|43
4608168|NCT01675167|7463061|FG001|Open-label Titration Phase|Protocol Violation|0
4608169|NCT01675167|7463062|FG002|Open-label Titration Phase|Protocol Violation|0
4608170|NCT01675167|7463060|FG000|Open-label Titration Phase|Lost to Follow-up|15
4608171|NCT01675167|7463061|FG001|Open-label Titration Phase|Lost to Follow-up|0
4608172|NCT01675167|7463062|FG002|Open-label Titration Phase|Lost to Follow-up|0
4608173|NCT01675167|7463060|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1
4608174|NCT01675167|7463061|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0
4608175|NCT01675167|7463062|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0
4608176|NCT01675167|7463060|FG000|Open-label Titration Phase|Other|55
4608177|NCT01675167|7463061|FG001|Open-label Titration Phase|Other|0
4608178|NCT01675167|7463062|FG002|Open-label Titration Phase|Other|0
4608179|NCT01675167|7463060|FG000|Double-blind Treatment Phase|Lack of Efficacy|0
4608180|NCT01675167|7463061|FG001|Double-blind Treatment Phase|Lack of Efficacy|19
4608181|NCT01675167|7463062|FG002|Double-blind Treatment Phase|Lack of Efficacy|61
4608182|NCT01675167|7463060|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0
4608183|NCT01675167|7463061|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11
4608184|NCT01675167|7463062|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6
4608185|NCT01675167|7463060|FG000|Double-blind Treatment Phase|Adverse Event|0
4608186|NCT01675167|7463061|FG001|Double-blind Treatment Phase|Adverse Event|5
4608187|NCT01675167|7463062|FG002|Double-blind Treatment Phase|Adverse Event|13
4608188|NCT01675167|7463060|FG000|Double-blind Treatment Phase|Protocol Violation|0
4608189|NCT01675167|7463061|FG001|Double-blind Treatment Phase|Protocol Violation|4
4608190|NCT01675167|7463062|FG002|Double-blind Treatment Phase|Protocol Violation|11
4608191|NCT01675167|7463060|FG000|Double-blind Treatment Phase|Lost to Follow-up|0
4608192|NCT01675167|7463061|FG001|Double-blind Treatment Phase|Lost to Follow-up|1
4608193|NCT01675167|7463062|FG002|Double-blind Treatment Phase|Lost to Follow-up|5
4608194|NCT01675167|7463060|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0
4608195|NCT01675167|7463061|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1
4608196|NCT01675167|7463062|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9
4608197|NCT01675167|7463060|FG000|Double-blind Treatment Phase|Other|0
4608198|NCT01675167|7463061|FG001|Double-blind Treatment Phase|Other|7
4608199|NCT01675167|7463062|FG002|Double-blind Treatment Phase|Other|5
4608200|NCT01675427|7463079|FG000|Overall Study|Withdrawal by Subject|7
4608201|NCT01675427|7463079|FG000|Overall Study|Participant Refused Sample Collection|18
4608202|NCT01675427|7463079|FG000|Overall Study|Sample not Collected by Mistake|2
4608203|NCT01675427|7463079|FG000|Overall Study|Lost to Follow-up|5
4608204|NCT01675427|7463079|FG000|Overall Study|Other|2
4608205|NCT01675492|7463122|FG000|Overall Study|study completed early - product approval|42
4608206|NCT01675531|7463127|FG000|Overall Study|Adverse Event|9
4608207|NCT01675531|7463127|FG000|Overall Study|Withdrawal by Subject|7
4608208|NCT01675531|7463127|FG000|Overall Study|Lack of Efficacy|1
4608209|NCT01675531|7463127|FG000|Overall Study|Protocol Violation|8
4608210|NCT01675544|7463132|FG000|Overall Study|Withdrawal by Subject|2
4608211|NCT01675596|7463136|FG000|Overall Study|Death|6
4608212|NCT01675596|7463136|FG000|Overall Study|Exit with other reason|1
4608213|NCT01675596|7463136|FG000|Overall Study|Missed Visit|1
4608214|NCT01675622|7463142|FG000|Overall Study|Withdrawal by Subject|2
4608215|NCT01675622|7463143|FG001|Overall Study|Withdrawal by Subject|2
4608216|NCT01675622|7463142|FG000|Overall Study|Adverse Event|12
4608217|NCT01675622|7463143|FG001|Overall Study|Adverse Event|10
4608218|NCT01675622|7463142|FG000|Overall Study|Protocol Violation|4
4608219|NCT01675622|7463143|FG001|Overall Study|Protocol Violation|1
4608220|NCT01675622|7463142|FG000|Overall Study|Lack of Efficacy|2
4608221|NCT01675622|7463143|FG001|Overall Study|Lack of Efficacy|4
4608222|NCT01675622|7463142|FG000|Overall Study|Lost to Follow-up|1
4608223|NCT01675622|7463143|FG001|Overall Study|Lost to Follow-up|3
4608224|NCT01675622|7463142|FG000|Overall Study|Other|5
4608225|NCT01675622|7463143|FG001|Overall Study|Other|4
4608226|NCT01675661|7463165|FG000|Overall Study|Lost to Follow-up|22
4608227|NCT01675661|7463166|FG001|Overall Study|Lost to Follow-up|23
4608228|NCT01675661|7463165|FG000|Overall Study|Practical problems|9
4608229|NCT01675661|7463166|FG001|Overall Study|Practical problems|5
4608230|NCT01675661|7463165|FG000|Overall Study|Moved away|5
4608231|NCT01675661|7463166|FG001|Overall Study|Moved away|6
4608232|NCT01675661|7463165|FG000|Overall Study|Withdrawal by Subject|3
4608233|NCT01675661|7463166|FG001|Overall Study|Withdrawal by Subject|7
4608234|NCT01675661|7463165|FG000|Overall Study|Physician Decision|0
4608235|NCT01675661|7463166|FG001|Overall Study|Physician Decision|2
4608236|NCT01675661|7463165|FG000|Overall Study|Death|0
4608237|NCT01675661|7463166|FG001|Overall Study|Death|1
4608238|NCT01675661|7463165|FG000|Overall Study|Other reason|1
4608239|NCT01675661|7463166|FG001|Overall Study|Other reason|2
4608240|NCT01675765|7463174|FG000|Overall Study|Progressive disease|4
4608241|NCT01675765|7463175|FG001|Overall Study|Progressive disease|4
4608242|NCT01675765|7463174|FG000|Overall Study|Adverse Event|1
4608243|NCT01675765|7463175|FG001|Overall Study|Adverse Event|2
4608244|NCT01675765|7463174|FG000|Overall Study|Withdrawal by Subject|2
4608245|NCT01675765|7463175|FG001|Overall Study|Withdrawal by Subject|0
4608246|NCT01675765|7463174|FG000|Overall Study|Death|1
4608247|NCT01675765|7463175|FG001|Overall Study|Death|0
4608248|NCT01675765|7463174|FG000|Overall Study|Clinical progression|3
4608249|NCT01675765|7463175|FG001|Overall Study|Clinical progression|2
4608250|NCT01675882|7463194|FG000|Overall Study|Adverse Event|0
4608251|NCT01675882|7463195|FG001|Overall Study|Adverse Event|2
4608252|NCT01675882|7463196|FG002|Overall Study|Adverse Event|1
4608253|NCT01675882|7463197|FG003|Overall Study|Adverse Event|0
4608254|NCT01675882|7463194|FG000|Overall Study|Participant unwilling to continue|2
4608255|NCT01675882|7463195|FG001|Overall Study|Participant unwilling to continue|4
4608256|NCT01675882|7463196|FG002|Overall Study|Participant unwilling to continue|2
4608257|NCT01675882|7463197|FG003|Overall Study|Participant unwilling to continue|1
4608258|NCT01675882|7463194|FG000|Overall Study|Lost to Follow-up|0
4608259|NCT01675882|7463195|FG001|Overall Study|Lost to Follow-up|1
4608260|NCT01675882|7463196|FG002|Overall Study|Lost to Follow-up|0
4608261|NCT01675882|7463197|FG003|Overall Study|Lost to Follow-up|0
4608262|NCT01675882|7463194|FG000|Overall Study|Non-compliance|0
4608263|NCT01675882|7463195|FG001|Overall Study|Non-compliance|0
4608264|NCT01675882|7463196|FG002|Overall Study|Non-compliance|0
4608265|NCT01675882|7463197|FG003|Overall Study|Non-compliance|1
4608266|NCT01676012|7463207|FG000|Overall Study|Adverse Event|2
4608267|NCT01676012|7463207|FG000|Overall Study|incomplete set of videos|1
4608268|NCT01676116|7463213|FG000|Overall Study|Withdrawal criteria|2
4608269|NCT01676116|7463214|FG001|Overall Study|Withdrawal criteria|14
4608270|NCT01676116|7463213|FG000|Overall Study|Adverse Event|1
4608271|NCT01676116|7463214|FG001|Overall Study|Adverse Event|2
4608272|NCT01676116|7463213|FG000|Overall Study|Unclassified|4
4608273|NCT01676116|7463214|FG001|Overall Study|Unclassified|10
4608274|NCT01676116|7463213|FG000|Overall Study|Protocol Violation|9
4608275|NCT01676116|7463214|FG001|Overall Study|Protocol Violation|3
4608276|NCT01676220|7463222|FG000|Overall Study|Randomized But Not Treated|4
4608277|NCT01676220|7463223|FG001|Overall Study|Randomized But Not Treated|1
4608278|NCT01676220|7463222|FG000|Overall Study|Adverse Event|10
4608279|NCT01676220|7463223|FG001|Overall Study|Adverse Event|8
4608280|NCT01676220|7463222|FG000|Overall Study|Lack of Efficacy|2
4608281|NCT01676220|7463223|FG001|Overall Study|Lack of Efficacy|5
4608282|NCT01676220|7463222|FG000|Overall Study|Protocol Violation|11
4608283|NCT01676220|7463223|FG001|Overall Study|Protocol Violation|12
4608284|NCT01676220|7463222|FG000|Overall Study|Received Rescue Therapy|14
4608285|NCT01676220|7463223|FG001|Overall Study|Received Rescue Therapy|22
4608286|NCT01676220|7463222|FG000|Overall Study|Personal Reason|34
4608287|NCT01676220|7463223|FG001|Overall Study|Personal Reason|45
4608288|NCT01676220|7463222|FG000|Overall Study|Lost to Follow-up|11
4608289|NCT01676220|7463223|FG001|Overall Study|Lost to Follow-up|18
4608290|NCT01676220|7463222|FG000|Overall Study|Selection Criterion/Protocol Violation|9
4608291|NCT01676220|7463223|FG001|Overall Study|Selection Criterion/Protocol Violation|9
4608292|NCT01676220|7463222|FG000|Overall Study|Site Closure/Site Withdrawal|1
4608293|NCT01676220|7463223|FG001|Overall Study|Site Closure/Site Withdrawal|4
4608294|NCT01676220|7463222|FG000|Overall Study|Perceived Lack of Efficacy|3
4608295|NCT01676220|7463223|FG001|Overall Study|Perceived Lack of Efficacy|1
4608296|NCT01676220|7463222|FG000|Overall Study|Non Serious Hypoglycemia|2
4608297|NCT01676220|7463223|FG001|Overall Study|Non Serious Hypoglycemia|0
4608298|NCT01676220|7463222|FG000|Overall Study|No More Need of Insulin|1
4608299|NCT01676220|7463223|FG001|Overall Study|No More Need of Insulin|0
4608300|NCT01676727|7463296|FG000|Overall Study|Death|18
4608301|NCT01676727|7463296|FG000|Overall Study|Withdrawal by Subject|6
4608302|NCT01676727|7463296|FG000|Overall Study|Screening failure|5
4608303|NCT01676727|7463296|FG000|Overall Study|Not willing to attend 1-year visit|2
4608304|NCT01676727|7463296|FG000|Overall Study|Valve explanted|1
4608305|NCT01676896|7463313|FG000|Overall Study|Withdrawal by Subject|12
4608306|NCT01676896|7463314|FG001|Overall Study|Withdrawal by Subject|7
4608307|NCT01676896|7463315|FG002|Overall Study|Withdrawal by Subject|19
4608308|NCT01676909|7463325|FG000|Overall Study|Withdrawal by Subject|3
4608309|NCT01676909|7463326|FG001|Overall Study|Withdrawal by Subject|5
4608310|NCT01676909|7463325|FG000|Overall Study|Lost to Follow-up|15
4608311|NCT01676909|7463326|FG001|Overall Study|Lost to Follow-up|9
4608312|NCT01677182|7463337|FG000|Overall Study|Adverse Event|2
4608313|NCT01677182|7463338|FG001|Overall Study|Adverse Event|1
4608314|NCT01677182|7463339|FG002|Overall Study|Adverse Event|8
4638831|NCT01964378|7512414|FG001|Overall Study|Disc. due to death before first dosing|1
4608315|NCT01677182|7463337|FG000|Overall Study|Protocol Violation|5
4608316|NCT01677182|7463338|FG001|Overall Study|Protocol Violation|1
4608317|NCT01677182|7463339|FG002|Overall Study|Protocol Violation|4
4608318|NCT01677182|7463337|FG000|Overall Study|Lost to Follow-up|4
4608319|NCT01677182|7463338|FG001|Overall Study|Lost to Follow-up|0
4608320|NCT01677182|7463339|FG002|Overall Study|Lost to Follow-up|3
4608321|NCT01677182|7463337|FG000|Overall Study|Withdrawal by Subject|7
4608322|NCT01677182|7463338|FG001|Overall Study|Withdrawal by Subject|12
4608323|NCT01677182|7463339|FG002|Overall Study|Withdrawal by Subject|10
4608324|NCT01677182|7463337|FG000|Overall Study|Study termination|12
4608325|NCT01677182|7463338|FG001|Overall Study|Study termination|9
4608326|NCT01677182|7463339|FG002|Overall Study|Study termination|11
4608327|NCT01677182|7463337|FG000|Overall Study|Lack of Efficacy|3
4608328|NCT01677182|7463338|FG001|Overall Study|Lack of Efficacy|0
4608329|NCT01677182|7463339|FG002|Overall Study|Lack of Efficacy|1
4608330|NCT01677182|7463337|FG000|Overall Study|Other reasons|1
4608331|NCT01677182|7463338|FG001|Overall Study|Other reasons|5
4608332|NCT01677182|7463339|FG002|Overall Study|Other reasons|2
4608333|NCT01677195|7463350|FG000|Overall Study|Lost to Follow-up|14
4608334|NCT01677195|7463351|FG001|Overall Study|Lost to Follow-up|22
4608335|NCT01677195|7463352|FG002|Overall Study|Lost to Follow-up|22
4608336|NCT01677195|7463350|FG000|Overall Study|Withdrawal by Subject|1
4608337|NCT01677195|7463351|FG001|Overall Study|Withdrawal by Subject|0
4608338|NCT01677195|7463352|FG002|Overall Study|Withdrawal by Subject|1
4608339|NCT01677195|7463350|FG000|Overall Study|Adverse Event|6
4608340|NCT01677195|7463351|FG001|Overall Study|Adverse Event|4
4608341|NCT01677195|7463352|FG002|Overall Study|Adverse Event|1
4608342|NCT01677195|7463350|FG000|Overall Study|Physician Decision|1
4608343|NCT01677195|7463351|FG001|Overall Study|Physician Decision|2
4608344|NCT01677195|7463352|FG002|Overall Study|Physician Decision|2
4608345|NCT01677195|7463350|FG000|Overall Study|Pregnancy|0
4608346|NCT01677195|7463351|FG001|Overall Study|Pregnancy|1
4608347|NCT01677195|7463352|FG002|Overall Study|Pregnancy|0
4608348|NCT01677195|7463350|FG000|Overall Study|Protocol Violation|7
4608349|NCT01677195|7463351|FG001|Overall Study|Protocol Violation|3
4608350|NCT01677195|7463352|FG002|Overall Study|Protocol Violation|4
4608351|NCT01677299|7463370|FG000|Overall Study|Adverse Event|0
4608352|NCT01677299|7463371|FG001|Overall Study|Adverse Event|2
4608353|NCT01677299|7463372|FG002|Overall Study|Adverse Event|1
4608354|NCT01677299|7463373|FG003|Overall Study|Adverse Event|0
4608355|NCT01677299|7463370|FG000|Overall Study|Withdrawal by Subject|0
4608356|NCT01677299|7463371|FG001|Overall Study|Withdrawal by Subject|1
4608357|NCT01677299|7463372|FG002|Overall Study|Withdrawal by Subject|0
4608358|NCT01677299|7463373|FG003|Overall Study|Withdrawal by Subject|1
4608359|NCT01677377|7463399|FG000|Overall Study|Protocol Violation|1
4608360|NCT01677377|7463400|FG001|Overall Study|Protocol Violation|0
4608361|NCT01677377|7463401|FG002|Overall Study|Protocol Violation|0
4608362|NCT01677377|7463399|FG000|Overall Study|Lost to Follow-up|0
4608363|NCT01677377|7463400|FG001|Overall Study|Lost to Follow-up|1
4608364|NCT01677377|7463401|FG002|Overall Study|Lost to Follow-up|1
4608365|NCT01677377|7463399|FG000|Overall Study|Withdrawal by Subject|0
4608366|NCT01677377|7463400|FG001|Overall Study|Withdrawal by Subject|0
4608367|NCT01677377|7463401|FG002|Overall Study|Withdrawal by Subject|3
4608368|NCT01677377|7463399|FG000|Overall Study|Lack of Efficacy|0
4608369|NCT01677377|7463400|FG001|Overall Study|Lack of Efficacy|0
4608370|NCT01677377|7463401|FG002|Overall Study|Lack of Efficacy|1
4608371|NCT01677377|7463399|FG000|Overall Study|Pregnancy|0
4608372|NCT01677377|7463400|FG001|Overall Study|Pregnancy|0
4608373|NCT01677377|7463401|FG002|Overall Study|Pregnancy|1
4608374|NCT01677507|7463409|FG000|Initial Assignment|Adverse Event|0
4608375|NCT01677507|7463410|FG001|Initial Assignment|Adverse Event|1
4608376|NCT01677507|7463409|FG000|Initial Assignment|Protocol Violation|0
4608377|NCT01677507|7463410|FG001|Initial Assignment|Protocol Violation|1
4608378|NCT01677507|7463409|FG000|Second Assigment|Withdrawal by Subject|2
4608379|NCT01677507|7463410|FG001|Second Assigment|Withdrawal by Subject|2
4608380|NCT01677507|7463409|FG000|Second Assigment|Adverse Event|1
4608381|NCT01677507|7463410|FG001|Second Assigment|Adverse Event|3
4608382|NCT01677624|7463418|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1
4608383|NCT01677741|7463430|FG000|Overall Study|Death|0
4608384|NCT01677741|7463431|FG001|Overall Study|Death|0
4608385|NCT01677741|7463432|FG002|Overall Study|Death|0
4608386|NCT01677741|7463433|FG003|Overall Study|Death|1
4608387|NCT01677741|7463434|FG004|Overall Study|Death|0
4608388|NCT01677741|7463435|FG005|Overall Study|Death|1
4608389|NCT01677741|7463436|FG006|Overall Study|Death|0
4608390|NCT01677741|7463437|FG007|Overall Study|Death|0
4608391|NCT01677741|7463430|FG000|Overall Study|Withdrawal by Subject|2
4608392|NCT01677741|7463431|FG001|Overall Study|Withdrawal by Subject|7
4608393|NCT01677741|7463432|FG002|Overall Study|Withdrawal by Subject|5
4638832|NCT01964378|7512413|FG000|Overall Study|Disc. due to AE before first dosing|1
4638833|NCT01964378|7512414|FG001|Overall Study|Disc. due to AE before first dosing|0
4608394|NCT01677741|7463433|FG003|Overall Study|Withdrawal by Subject|4
4608395|NCT01677741|7463434|FG004|Overall Study|Withdrawal by Subject|11
4608396|NCT01677741|7463435|FG005|Overall Study|Withdrawal by Subject|20
4608397|NCT01677741|7463436|FG006|Overall Study|Withdrawal by Subject|4
4608398|NCT01677741|7463437|FG007|Overall Study|Withdrawal by Subject|2
4608399|NCT01677741|7463430|FG000|Overall Study|Enrolled in a rollover study|0
4608400|NCT01677741|7463431|FG001|Overall Study|Enrolled in a rollover study|3
4608401|NCT01677741|7463432|FG002|Overall Study|Enrolled in a rollover study|2
4608402|NCT01677741|7463433|FG003|Overall Study|Enrolled in a rollover study|1
4608403|NCT01677741|7463434|FG004|Overall Study|Enrolled in a rollover study|6
4608404|NCT01677741|7463435|FG005|Overall Study|Enrolled in a rollover study|6
4608405|NCT01677741|7463436|FG006|Overall Study|Enrolled in a rollover study|7
4608406|NCT01677741|7463437|FG007|Overall Study|Enrolled in a rollover study|0
4608407|NCT01677741|7463430|FG000|Overall Study|Progressive disease|1
4608408|NCT01677741|7463431|FG001|Overall Study|Progressive disease|0
4608409|NCT01677741|7463432|FG002|Overall Study|Progressive disease|1
4608410|NCT01677741|7463433|FG003|Overall Study|Progressive disease|0
4608411|NCT01677741|7463434|FG004|Overall Study|Progressive disease|0
4608412|NCT01677741|7463435|FG005|Overall Study|Progressive disease|1
4608413|NCT01677741|7463436|FG006|Overall Study|Progressive disease|0
4608414|NCT01677741|7463437|FG007|Overall Study|Progressive disease|0
4608415|NCT01677767|7463471|FG000|Overall Study|Adverse Event|1
4608416|NCT01677767|7463471|FG000|Overall Study|Death|4
4608417|NCT01677767|7463471|FG000|Overall Study|Protocol Violation|4
4608418|NCT01677767|7463471|FG000|Overall Study|Withdrawal by Subject|10
4608419|NCT01677767|7463471|FG000|Overall Study|Non-compliance by the participants|3
4608420|NCT01677858|7463482|FG000|Overall Study|Adverse Event|0
4608421|NCT01677858|7463483|FG001|Overall Study|Adverse Event|0
4608422|NCT01677858|7463484|FG002|Overall Study|Adverse Event|2
4608423|NCT01677858|7463485|FG003|Overall Study|Adverse Event|3
4608424|NCT01677858|7463486|FG004|Overall Study|Adverse Event|13
4608425|NCT01677858|7463482|FG000|Overall Study|Death|0
4608426|NCT01677858|7463483|FG001|Overall Study|Death|0
4608427|NCT01677858|7463484|FG002|Overall Study|Death|0
4608428|NCT01677858|7463485|FG003|Overall Study|Death|0
4608429|NCT01677858|7463486|FG004|Overall Study|Death|1
4608430|NCT01677858|7463482|FG000|Overall Study|Physician Decision|1
4608431|NCT01677858|7463483|FG001|Overall Study|Physician Decision|0
4608432|NCT01677858|7463484|FG002|Overall Study|Physician Decision|2
4608433|NCT01677858|7463485|FG003|Overall Study|Physician Decision|0
4608434|NCT01677858|7463486|FG004|Overall Study|Physician Decision|12
4608435|NCT01677858|7463482|FG000|Overall Study|Progressive Disease|2
4608436|NCT01677858|7463483|FG001|Overall Study|Progressive Disease|1
4608437|NCT01677858|7463484|FG002|Overall Study|Progressive Disease|9
4608438|NCT01677858|7463485|FG003|Overall Study|Progressive Disease|3
4608439|NCT01677858|7463486|FG004|Overall Study|Progressive Disease|43
4608440|NCT01677858|7463482|FG000|Overall Study|Withdrawal by Subject|0
4608441|NCT01677858|7463483|FG001|Overall Study|Withdrawal by Subject|1
4608442|NCT01677858|7463484|FG002|Overall Study|Withdrawal by Subject|1
4608443|NCT01677858|7463485|FG003|Overall Study|Withdrawal by Subject|0
4608444|NCT01677858|7463486|FG004|Overall Study|Withdrawal by Subject|15
4608445|NCT01677858|7463482|FG000|Overall Study|Lost to Follow-up|0
4608446|NCT01677858|7463483|FG001|Overall Study|Lost to Follow-up|0
4608447|NCT01677858|7463484|FG002|Overall Study|Lost to Follow-up|0
4638834|NCT01964378|7512413|FG000|Overall Study|Death|3
4638835|NCT01964378|7512414|FG001|Overall Study|Death|2
4638836|NCT01964378|7512413|FG000|Overall Study|Adverse Event|12
4638837|NCT01964378|7512414|FG001|Overall Study|Adverse Event|5
4638838|NCT01964378|7512413|FG000|Overall Study|Lack of Efficacy|0
4638839|NCT01964378|7512414|FG001|Overall Study|Lack of Efficacy|1
4638840|NCT01964378|7512413|FG000|Overall Study|Protocol Violation|0
4638841|NCT01964378|7512414|FG001|Overall Study|Protocol Violation|1
4638842|NCT01964378|7512413|FG000|Overall Study|Lost to Follow-up|0
4638843|NCT01964378|7512414|FG001|Overall Study|Lost to Follow-up|1
4638844|NCT01964378|7512413|FG000|Overall Study|Withdrawal by Subject|7
4638845|NCT01964378|7512414|FG001|Overall Study|Withdrawal by Subject|5
4638846|NCT01964378|7512413|FG000|Overall Study|Inclusion/exclusion criteria not met|1
4638847|NCT01964378|7512414|FG001|Overall Study|Inclusion/exclusion criteria not met|3
4638848|NCT01964378|7512413|FG000|Overall Study|Other|1
4638849|NCT01964378|7512414|FG001|Overall Study|Other|2
4638850|NCT01964430|7512422|FG000|Overall Study|Adverse Event|71
4638851|NCT01964430|7512423|FG001|Overall Study|Adverse Event|37
4638852|NCT01964430|7512422|FG000|Overall Study|Withdrawal by Subject|36
4638853|NCT01964430|7512423|FG001|Overall Study|Withdrawal by Subject|27
4638854|NCT01964430|7512422|FG000|Overall Study|Death|1
4638855|NCT01964430|7512423|FG001|Overall Study|Death|3
4638856|NCT01964430|7512422|FG000|Overall Study|Protocol Deviation|0
4638857|NCT01964430|7512423|FG001|Overall Study|Protocol Deviation|1
4638858|NCT01964430|7512422|FG000|Overall Study|Physician Decision|5
4638859|NCT01964430|7512423|FG001|Overall Study|Physician Decision|4
4638860|NCT01964430|7512422|FG000|Overall Study|Disease Relapse|28
4638861|NCT01964430|7512423|FG001|Overall Study|Disease Relapse|38
4638862|NCT01964430|7512422|FG000|Overall Study|Miscellaneous|1
4638863|NCT01964430|7512423|FG001|Overall Study|Miscellaneous|3
4638864|NCT01964430|7512422|FG000|Overall Study|Randomized but not Treated|3
4638865|NCT01964430|7512423|FG001|Overall Study|Randomized but not Treated|11
4638866|NCT01964521|7512429|FG000|Overall Study|Lost to Follow-up|4
4638867|NCT01964547|7512436|FG000|Overall Study|Adverse Event|8
4638868|NCT01964547|7512437|FG001|Overall Study|Adverse Event|2
4638869|NCT01964547|7512436|FG000|Overall Study|Withdrawal by Subject|4
4638870|NCT01964547|7512437|FG001|Overall Study|Withdrawal by Subject|7
4608448|NCT01677858|7463485|FG003|Overall Study|Lost to Follow-up|0
4608449|NCT01677858|7463486|FG004|Overall Study|Lost to Follow-up|1
4608450|NCT01677910|7463506|FG000|Double-Blind Treatment Period|Adverse Event|6
4608451|NCT01677910|7463507|FG001|Double-Blind Treatment Period|Adverse Event|2
4638871|NCT01964547|7512436|FG000|Overall Study|Lost to Follow-up|0
4638872|NCT01964547|7512437|FG001|Overall Study|Lost to Follow-up|1
4638873|NCT01964547|7512436|FG000|Overall Study|Withdrawal by Investigator|0
4608452|NCT01677910|7463508|FG002|Double-Blind Treatment Period|Adverse Event|3
4608453|NCT01677910|7463509|FG003|Double-Blind Treatment Period|Adverse Event|0
4608454|NCT01677910|7463506|FG000|Double-Blind Treatment Period|Physician Decision|0
4608455|NCT01677910|7463507|FG001|Double-Blind Treatment Period|Physician Decision|0
4608456|NCT01677910|7463508|FG002|Double-Blind Treatment Period|Physician Decision|1
4608457|NCT01677910|7463509|FG003|Double-Blind Treatment Period|Physician Decision|0
4608458|NCT01677910|7463506|FG000|Double-Blind Treatment Period|Withdrawal of consent|1
4608459|NCT01677910|7463507|FG001|Double-Blind Treatment Period|Withdrawal of consent|0
4608460|NCT01677910|7463508|FG002|Double-Blind Treatment Period|Withdrawal of consent|3
4608461|NCT01677910|7463509|FG003|Double-Blind Treatment Period|Withdrawal of consent|0
4608462|NCT01677910|7463506|FG000|Double-Blind Treatment Period|Reason Not Specified|0
4608463|NCT01677910|7463507|FG001|Double-Blind Treatment Period|Reason Not Specified|1
4608464|NCT01677910|7463508|FG002|Double-Blind Treatment Period|Reason Not Specified|0
4608465|NCT01677910|7463509|FG003|Double-Blind Treatment Period|Reason Not Specified|0
4608466|NCT01677910|7463506|FG000|Open-Label Extension Period (OLE)|Physician Decision|0
4608467|NCT01677910|7463507|FG001|Open-Label Extension Period (OLE)|Physician Decision|0
4608468|NCT01677910|7463508|FG002|Open-Label Extension Period (OLE)|Physician Decision|0
4608469|NCT01677910|7463509|FG003|Open-Label Extension Period (OLE)|Physician Decision|4
4608470|NCT01677910|7463506|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0
4608471|NCT01677910|7463507|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0
4608472|NCT01677910|7463508|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0
4608473|NCT01677910|7463509|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2
4608474|NCT01677910|7463506|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
4608475|NCT01677910|7463507|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
4638874|NCT01964547|7512437|FG001|Overall Study|Withdrawal by Investigator|1
4608476|NCT01677910|7463508|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
4608477|NCT01677910|7463509|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9
4608478|NCT01677910|7463506|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0
4608479|NCT01677910|7463507|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0
4608480|NCT01677910|7463508|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0
4608481|NCT01677910|7463509|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5
4608482|NCT01677910|7463506|FG000|Open-Label Extension Period (OLE)|Adverse Event|0
4608483|NCT01677910|7463507|FG001|Open-Label Extension Period (OLE)|Adverse Event|0
4608484|NCT01677910|7463508|FG002|Open-Label Extension Period (OLE)|Adverse Event|0
4608485|NCT01677910|7463509|FG003|Open-Label Extension Period (OLE)|Adverse Event|15
4608486|NCT01677910|7463506|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0
4608487|NCT01677910|7463507|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0
4608488|NCT01677910|7463508|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0
4608489|NCT01677910|7463509|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1
4608490|NCT01677936|7463521|FG000|Overall Study|Lost to Follow-up|4
4608491|NCT01677936|7463522|FG001|Overall Study|Lost to Follow-up|1
4608492|NCT01677936|7463521|FG000|Overall Study|Protocol Violation|3
4608493|NCT01677936|7463522|FG001|Overall Study|Protocol Violation|0
4608494|NCT01677936|7463521|FG000|Overall Study|Adverse Event|1
4608495|NCT01677936|7463522|FG001|Overall Study|Adverse Event|0
4638875|NCT01964716|7512445|FG000|Overall Study|Withdrawal by Subject|2
4638876|NCT01964716|7512446|FG001|Overall Study|Withdrawal by Subject|3
4638877|NCT01964716|7512445|FG000|Overall Study|Lost to Follow-up|1
4638878|NCT01964716|7512446|FG001|Overall Study|Lost to Follow-up|2
4638879|NCT01964716|7512445|FG000|Overall Study|No longer met eligibility criteria|1
4638880|NCT01964716|7512446|FG001|Overall Study|No longer met eligibility criteria|1
4638881|NCT01964716|7512445|FG000|Overall Study|Death|1
4638882|NCT01964716|7512446|FG001|Overall Study|Death|0
4638883|NCT01964755|7512460|FG000|Overall Study|Death|2
4638884|NCT01964898|7512466|FG000|Overall Study|ineligible post-randomization|1
4638885|NCT01964898|7512467|FG001|Overall Study|ineligible post-randomization|1
4638886|NCT01964898|7512466|FG000|Overall Study|did not receive the allocated interventi|2
4638887|NCT01964898|7512467|FG001|Overall Study|did not receive the allocated interventi|1
4638888|NCT01964898|7512466|FG000|Overall Study|Lost to Follow-up|3
4638889|NCT01964898|7512467|FG001|Overall Study|Lost to Follow-up|5
4638890|NCT01964898|7512466|FG000|Overall Study|Withdrawal by Subject|1
4638891|NCT01964898|7512467|FG001|Overall Study|Withdrawal by Subject|0
4638892|NCT01964924|7512473|FG000|Trametinib Monotherapy|Progression|19
4638893|NCT01964924|7512474|FG001|Trametinib Monotherapy|Progression|0
4638894|NCT01964950|7512485|FG000|Overall Study|Protocol Violation|25
4638895|NCT01964963|7512492|FG000|Overall Study|Case Report Forms Uncollected|888
4638896|NCT01964963|7512492|FG000|Overall Study|Protocol Deviation|50
4638897|NCT01964963|7512492|FG000|Overall Study|Data Reliability was not Assured|5
4638898|NCT01964976|7512498|FG000|Overall Study|Protocol Violation|31
4638899|NCT01965158|7512522|FG000|Overall Study|Adverse Event|14
4638900|NCT01965158|7512523|FG001|Overall Study|Adverse Event|5
4638901|NCT01965158|7512522|FG000|Overall Study|Withdrawal by Subject|16
4638902|NCT01965158|7512523|FG001|Overall Study|Withdrawal by Subject|24
4608496|NCT01677936|7463521|FG000|Overall Study|Lost to Follow-up|1
4608497|NCT01677936|7463522|FG001|Overall Study|Lost to Follow-up|0
4608498|NCT01677936|7463521|FG000|Overall Study|Protocol Violation|0
4608499|NCT01677936|7463522|FG001|Overall Study|Protocol Violation|4
4608500|NCT01677988|7463528|FG000|Overall Study|Lack of Efficacy|2
4608501|NCT01678131|7463536|FG000|Overall Study|Adverse Event|0
4608502|NCT01678131|7463537|FG001|Overall Study|Adverse Event|1
4608503|NCT01678131|7463538|FG002|Overall Study|Adverse Event|0
4747079|NCT00329108|7720207|FG001|Overall Study|symptomatic deterioration|1
4747080|NCT00329108|7720206|FG000|Overall Study|Subject no longer willing to participate|2
4747081|NCT00329108|7720207|FG001|Overall Study|Subject no longer willing to participate|2
4608504|NCT01678131|7463536|FG000|Overall Study|Withdrawal by Subject|0
4608505|NCT01678131|7463537|FG001|Overall Study|Withdrawal by Subject|0
4608506|NCT01678131|7463538|FG002|Overall Study|Withdrawal by Subject|2
4608507|NCT01678144|7463546|FG000|Stage 1: MAR Classic|Adverse Event|1
4608508|NCT01678209|7463562|FG000|Overall Study|could not scan twice|1
4608509|NCT01678209|7463563|FG001|Overall Study|could not scan twice|1
4608510|NCT01678209|7463564|FG002|Overall Study|could not scan twice|1
4608511|NCT01678209|7463562|FG000|Overall Study|scheduling conflicts|0
4608512|NCT01678209|7463563|FG001|Overall Study|scheduling conflicts|0
4608513|NCT01678209|7463564|FG002|Overall Study|scheduling conflicts|1
4608514|NCT01678209|7463562|FG000|Overall Study|screen fail|16
4608515|NCT01678209|7463563|FG001|Overall Study|screen fail|17
4608516|NCT01678209|7463564|FG002|Overall Study|screen fail|16
4608517|NCT01678313|7463574|FG000|Completed the 3-month Therapy|Lost to Follow-up|3
4608518|NCT01678313|7463575|FG001|Completed the 3-month Therapy|Lost to Follow-up|8
4608519|NCT01678313|7463574|FG000|Completed the 3-month Therapy|Physician Decision|3
4608520|NCT01678313|7463575|FG001|Completed the 3-month Therapy|Physician Decision|4
4608521|NCT01678313|7463574|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8
4608522|NCT01678313|7463575|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9
4608523|NCT01678313|7463574|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11
4608524|NCT01678313|7463575|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12
4608525|NCT01678560|7463587|FG000|Overall Study|Physician Decision|4
4608526|NCT01678560|7463588|FG001|Overall Study|Physician Decision|4
4608527|NCT01678560|7463587|FG000|Overall Study|Death|0
4608528|NCT01678560|7463588|FG001|Overall Study|Death|1
4608529|NCT01678560|7463587|FG000|Overall Study|Withdrawal by Subject|0
4608530|NCT01678560|7463588|FG001|Overall Study|Withdrawal by Subject|1
4608531|NCT01678807|7463610|FG000|Overall Study|Adverse Event|4
4608532|NCT01678807|7463611|FG001|Overall Study|Adverse Event|4
4608533|NCT01678807|7463612|FG002|Overall Study|Adverse Event|0
4608534|NCT01678807|7463610|FG000|Overall Study|Withdrawn by Parent/Guardian|0
4608535|NCT01678807|7463611|FG001|Overall Study|Withdrawn by Parent/Guardian|1
4638903|NCT01965158|7512522|FG000|Overall Study|Lost to Follow-up|7
4638904|NCT01965158|7512523|FG001|Overall Study|Lost to Follow-up|5
4638905|NCT01965158|7512522|FG000|Overall Study|Protocol Violation|1
4638906|NCT01965158|7512523|FG001|Overall Study|Protocol Violation|1
4638907|NCT01965158|7512522|FG000|Overall Study|Other - Miscellaneous|3
4638908|NCT01965158|7512523|FG001|Overall Study|Other - Miscellaneous|0
4638909|NCT01965262|7512529|FG000|Second Intervention (7 Days)|Discontinued|0
4638910|NCT01965262|7512530|FG001|Second Intervention (7 Days)|Discontinued|1
4638911|NCT01965262|7512529|FG000|Second Intervention (7 Days)|Poor lens fit|0
4638912|NCT01965262|7512530|FG001|Second Intervention (7 Days)|Poor lens fit|9
4638913|NCT01965262|7512529|FG000|Second Intervention (7 Days)|Poor visual acuity|1
4638914|NCT01965262|7512530|FG001|Second Intervention (7 Days)|Poor visual acuity|0
4638915|NCT01965327|7512557|FG000|Overall Study|Physician Decision|2
4638916|NCT01965431|7512570|FG000|Overall Study|Adverse Event|0
4638917|NCT01965431|7512571|FG001|Overall Study|Adverse Event|1
4608536|NCT01678807|7463612|FG002|Overall Study|Withdrawn by Parent/Guardian|0
4608537|NCT01678820|7463623|FG000|Overall Study|Study Terminated by Sponsor|45
4608538|NCT01678820|7463624|FG001|Overall Study|Study Terminated by Sponsor|43
4608539|NCT01678820|7463625|FG002|Overall Study|Study Terminated by Sponsor|43
4608540|NCT01678820|7463623|FG000|Overall Study|Withdrawal by Subject|2
4608541|NCT01678820|7463624|FG001|Overall Study|Withdrawal by Subject|5
4608542|NCT01678820|7463625|FG002|Overall Study|Withdrawal by Subject|2
4608543|NCT01678820|7463623|FG000|Overall Study|Protocol Specified Criteria|2
4608544|NCT01678820|7463624|FG001|Overall Study|Protocol Specified Criteria|3
4608545|NCT01678820|7463625|FG002|Overall Study|Protocol Specified Criteria|1
4638918|NCT01965431|7512572|FG002|Overall Study|Adverse Event|0
4638919|NCT01965431|7512573|FG003|Overall Study|Adverse Event|0
4638920|NCT01965431|7512574|FG004|Overall Study|Adverse Event|0
4747082|NCT00329108|7720206|FG000|Overall Study|study terminated by sponsor|1
4608546|NCT01678820|7463623|FG000|Overall Study|Adverse Event|2
4608547|NCT01678820|7463624|FG001|Overall Study|Adverse Event|2
4608548|NCT01678820|7463625|FG002|Overall Study|Adverse Event|2
4608549|NCT01678820|7463623|FG000|Overall Study|Lost to Follow-up|7
4608550|NCT01678820|7463624|FG001|Overall Study|Lost to Follow-up|2
4608551|NCT01678820|7463625|FG002|Overall Study|Lost to Follow-up|2
4608552|NCT01678820|7463623|FG000|Overall Study|Non-compliance with study drug|0
4608553|NCT01678820|7463624|FG001|Overall Study|Non-compliance with study drug|1
4608554|NCT01678820|7463625|FG002|Overall Study|Non-compliance with study drug|0
4608555|NCT01678820|7463623|FG000|Overall Study|Physician Decision|0
4608556|NCT01678820|7463624|FG001|Overall Study|Physician Decision|0
4608557|NCT01678820|7463625|FG002|Overall Study|Physician Decision|1
4608558|NCT01678820|7463623|FG000|Overall Study|Protocol Violation|4
4608559|NCT01678820|7463624|FG001|Overall Study|Protocol Violation|5
4608560|NCT01678820|7463625|FG002|Overall Study|Protocol Violation|4
4608561|NCT01678820|7463623|FG000|Overall Study|Not treated with double-blind study drug|0
4608562|NCT01678820|7463624|FG001|Overall Study|Not treated with double-blind study drug|2
4608563|NCT01678820|7463625|FG002|Overall Study|Not treated with double-blind study drug|2
4608564|NCT01678898|7463660|FG000|PB-102-F01|Adverse Event|0
4608565|NCT01678898|7463661|FG001|PB-102-F01|Adverse Event|1
4608566|NCT01678898|7463662|FG002|PB-102-F01|Adverse Event|0
4608567|NCT01678898|7463660|FG000|PB-102-F01|Physician Decision|0
4608568|NCT01678898|7463661|FG001|PB-102-F01|Physician Decision|1
4608569|NCT01678898|7463662|FG002|PB-102-F01|Physician Decision|0
4608570|NCT01678911|7463679|FG000|Second Intervention|Lost to Follow-up|2
4608571|NCT01678911|7463680|FG001|Second Intervention|Lost to Follow-up|0
4608572|NCT01678924|7463690|FG000|Overall Study|Adverse Event|1
4608573|NCT01678924|7463691|FG001|Overall Study|Adverse Event|1
4608574|NCT01678924|7463692|FG002|Overall Study|Adverse Event|0
4608575|NCT01678924|7463693|FG003|Overall Study|Adverse Event|1
4608576|NCT01678924|7463690|FG000|Overall Study|Lack of Efficacy|7
4608577|NCT01678924|7463691|FG001|Overall Study|Lack of Efficacy|2
4608578|NCT01678924|7463692|FG002|Overall Study|Lack of Efficacy|0
4608579|NCT01678924|7463693|FG003|Overall Study|Lack of Efficacy|5
4608580|NCT01678924|7463690|FG000|Overall Study|Lost to Follow-up|0
4608581|NCT01678924|7463691|FG001|Overall Study|Lost to Follow-up|4
4608582|NCT01678924|7463692|FG002|Overall Study|Lost to Follow-up|0
4608583|NCT01678924|7463693|FG003|Overall Study|Lost to Follow-up|2
4608584|NCT01678924|7463690|FG000|Overall Study|Personal Reasons|2
4608585|NCT01678924|7463691|FG001|Overall Study|Personal Reasons|2
4608586|NCT01678924|7463692|FG002|Overall Study|Personal Reasons|2
4608587|NCT01678924|7463693|FG003|Overall Study|Personal Reasons|7
4608588|NCT01678924|7463690|FG000|Overall Study|Withdrawal by Subject|0
4608589|NCT01678924|7463691|FG001|Overall Study|Withdrawal by Subject|3
4608590|NCT01678924|7463692|FG002|Overall Study|Withdrawal by Subject|0
4608591|NCT01678924|7463693|FG003|Overall Study|Withdrawal by Subject|2
4608592|NCT01678924|7463690|FG000|Overall Study|Unable to attend scheduled visits|0
4608593|NCT01678924|7463691|FG001|Overall Study|Unable to attend scheduled visits|0
4608594|NCT01678924|7463692|FG002|Overall Study|Unable to attend scheduled visits|0
4608595|NCT01678924|7463693|FG003|Overall Study|Unable to attend scheduled visits|1
4608596|NCT01679002|7463719|FG000|Overall Study|Adverse Event|1
4608597|NCT01679002|7463720|FG001|Overall Study|Adverse Event|1
4608598|NCT01679002|7463721|FG002|Overall Study|Adverse Event|0
4638921|NCT01965431|7512575|FG005|Overall Study|Adverse Event|0
4638922|NCT01965431|7512570|FG000|Overall Study|Other than stated above|6
4638923|NCT01965431|7512571|FG001|Overall Study|Other than stated above|5
4638924|NCT01965431|7512572|FG002|Overall Study|Other than stated above|6
4638925|NCT01965431|7512573|FG003|Overall Study|Other than stated above|6
4638926|NCT01965431|7512574|FG004|Overall Study|Other than stated above|6
4638927|NCT01965431|7512575|FG005|Overall Study|Other than stated above|6
4638928|NCT01965535|7512587|FG000|Overall Study|Lack of Efficacy|2
4638929|NCT01965535|7512588|FG001|Overall Study|Lack of Efficacy|1
4638930|NCT01965600|7512601|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1
4638931|NCT01965600|7512602|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3
4638932|NCT01965600|7512603|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2
4638933|NCT01965600|7512604|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1
4638934|NCT01965600|7512601|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
4638935|NCT01965600|7512602|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1
4638936|NCT01965600|7512603|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
4638937|NCT01965600|7512604|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
4638938|NCT01965600|7512601|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1
4638939|NCT01965600|7512602|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
4638940|NCT01965600|7512603|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
4638941|NCT01965600|7512604|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
4638942|NCT01965600|7512601|FG000|Washout Period of Approximately 15 Days|Adverse Event|0
4638943|NCT01965600|7512602|FG001|Washout Period of Approximately 15 Days|Adverse Event|0
4638944|NCT01965600|7512603|FG002|Washout Period of Approximately 15 Days|Adverse Event|0
4638945|NCT01965600|7512604|FG003|Washout Period of Approximately 15 Days|Adverse Event|1
4638946|NCT01965600|7512601|FG000|Second Intervention|Study terminated by Sponsor|0
4638947|NCT01965600|7512602|FG001|Second Intervention|Study terminated by Sponsor|0
4638948|NCT01965600|7512603|FG002|Second Intervention|Study terminated by Sponsor|2
4608599|NCT01679236|7463766|FG000|Overall Study|Lost to Follow-up|15
4608600|NCT01679236|7463767|FG001|Overall Study|Lost to Follow-up|15
4608601|NCT01679301|7463773|FG000|Screening Period|screen failure|3
4608602|NCT01679301|7463774|FG001|Screening Period|screen failure|0
4608603|NCT01679301|7463775|FG002|Screening Period|screen failure|0
4608604|NCT01679405|7463796|FG000|Overall Study|Death|2
4608605|NCT01679405|7463797|FG001|Overall Study|Death|5
4608606|NCT01679613|7463812|FG000|Overall Study|other than stated above|0
4608607|NCT01679613|7463813|FG001|Overall Study|other than stated above|1
4608608|NCT01679613|7463814|FG002|Overall Study|other than stated above|2
4608609|NCT01679613|7463815|FG003|Overall Study|other than stated above|2
4638949|NCT01965600|7512604|FG003|Second Intervention|Study terminated by Sponsor|2
4638950|NCT01965652|7512614|FG000|Overall Study|Adverse Event|40
4638951|NCT01965652|7512615|FG001|Overall Study|Adverse Event|37
4638952|NCT01965652|7512614|FG000|Overall Study|Withdrawal by Subject|62
4638953|NCT01965652|7512615|FG001|Overall Study|Withdrawal by Subject|69
4638954|NCT01965652|7512614|FG000|Overall Study|Lost to Follow-up|53
4638955|NCT01965652|7512615|FG001|Overall Study|Lost to Follow-up|40
4638956|NCT01965652|7512614|FG000|Overall Study|Protocol Violation|34
4638957|NCT01965652|7512615|FG001|Overall Study|Protocol Violation|38
4638958|NCT01965652|7512614|FG000|Overall Study|Death|3
4638959|NCT01965652|7512615|FG001|Overall Study|Death|4
4638960|NCT01965652|7512614|FG000|Overall Study|Other - Miscellaneous|18
4638961|NCT01965652|7512615|FG001|Overall Study|Other - Miscellaneous|21
4638962|NCT01965652|7512614|FG000|Overall Study|Pregnancy|0
4638963|NCT01965652|7512615|FG001|Overall Study|Pregnancy|1
4638964|NCT01965834|7512638|FG000|Overall Study|Lack of Efficacy|4
4638965|NCT01965860|7512645|FG000|Overall Study|Pregnancy|1
4638966|NCT01965860|7512646|FG001|Overall Study|Pregnancy|0
4638967|NCT01965860|7512647|FG002|Overall Study|Pregnancy|1
4638968|NCT01965860|7512645|FG000|Overall Study|Logistics|1
4638969|NCT01965860|7512646|FG001|Overall Study|Logistics|0
4638970|NCT01965860|7512647|FG002|Overall Study|Logistics|0
4638971|NCT01965938|7512662|FG000|Overall Study|Withdrawal by Subject|1
4638972|NCT01965938|7512663|FG001|Overall Study|Withdrawal by Subject|0
4638973|NCT01966003|7512673|FG000|Overall Study|Death|43
4638974|NCT01966003|7512674|FG001|Overall Study|Death|36
4638975|NCT01966003|7512673|FG000|Overall Study|Protocol Violation|6
4638976|NCT01966003|7512674|FG001|Overall Study|Protocol Violation|4
4638977|NCT01966003|7512673|FG000|Overall Study|Lost to Follow-up|4
4638978|NCT01966003|7512674|FG001|Overall Study|Lost to Follow-up|3
4638979|NCT01966003|7512673|FG000|Overall Study|Physician Decision|12
4638980|NCT01966003|7512674|FG001|Overall Study|Physician Decision|13
4638981|NCT01966003|7512673|FG000|Overall Study|Withdrawal by Subject|29
4638982|NCT01966003|7512674|FG001|Overall Study|Withdrawal by Subject|19
4638983|NCT01966003|7512673|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131
4638984|NCT01966003|7512674|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127
4638985|NCT01966003|7512673|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44
4638986|NCT01966003|7512674|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67
4638987|NCT01966003|7512673|FG000|Overall Study|Other|1
4638988|NCT01966003|7512674|FG001|Overall Study|Other|1
4638989|NCT01966042|7512680|FG000|Overall Study|Death|2
4638990|NCT01966068|7512686|FG000|Overall Study|Withdrawal by Subject|57
4638991|NCT01966068|7512686|FG000|Overall Study|Lost to Follow-up|81
4638992|NCT01966107|7512693|FG000|Overall Study|excluded from FAS|21
4638993|NCT01966107|7512694|FG001|Overall Study|excluded from FAS|20
4638994|NCT01966107|7512693|FG000|Overall Study|discontinued treatment|345
4638995|NCT01966107|7512694|FG001|Overall Study|discontinued treatment|372
4638996|NCT01966107|7512693|FG000|Overall Study|due to study closure|164
4638997|NCT01966107|7512694|FG001|Overall Study|due to study closure|186
4638998|NCT01966107|7512693|FG000|Overall Study|withdrew from the study|272
4638999|NCT01966107|7512694|FG001|Overall Study|withdrew from the study|303
4639000|NCT01966120|7512702|FG000|Overall Study|Withdrawal by Subject|0
4639001|NCT01966120|7512703|FG001|Overall Study|Withdrawal by Subject|5
4639002|NCT01966120|7512702|FG000|Overall Study|Lost to Follow-up|1
4639003|NCT01966120|7512703|FG001|Overall Study|Lost to Follow-up|1
4639004|NCT01966432|7512750|FG000|Overall Study|Lost to Follow-up|3
4639005|NCT01966432|7512751|FG001|Overall Study|Lost to Follow-up|2
4639006|NCT01966432|7512752|FG002|Overall Study|Lost to Follow-up|5
4639007|NCT01966432|7512750|FG000|Overall Study|Withdrawal by Subject|1
4639008|NCT01966432|7512751|FG001|Overall Study|Withdrawal by Subject|3
4639009|NCT01966432|7512752|FG002|Overall Study|Withdrawal by Subject|0
4639010|NCT01966432|7512750|FG000|Overall Study|Subject Incarcerated|0
4639011|NCT01966432|7512751|FG001|Overall Study|Subject Incarcerated|0
4639012|NCT01966432|7512752|FG002|Overall Study|Subject Incarcerated|1
4639013|NCT01966432|7512750|FG000|Overall Study|SBIRT program ended|1
4608610|NCT01680016|7463824|FG000|Overall Study|Adverse Event|0
4608611|NCT01680016|7463825|FG001|Overall Study|Adverse Event|0
4639014|NCT01966432|7512751|FG001|Overall Study|SBIRT program ended|8
4639015|NCT01966432|7512752|FG002|Overall Study|SBIRT program ended|20
4639016|NCT01966445|7512768|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
4639017|NCT01966445|7512769|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
4639018|NCT01966445|7512770|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
4639019|NCT01966445|7512771|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2
4639020|NCT01966445|7512772|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
4608612|NCT01680016|7463826|FG002|Overall Study|Adverse Event|1
4608613|NCT01680016|7463827|FG003|Overall Study|Adverse Event|4
4608614|NCT01680016|7463824|FG000|Overall Study|The Subject went out of The Trial|1
4608615|NCT01680016|7463825|FG001|Overall Study|The Subject went out of The Trial|0
4608616|NCT01680016|7463826|FG002|Overall Study|The Subject went out of The Trial|3
4608617|NCT01680016|7463827|FG003|Overall Study|The Subject went out of The Trial|0
4608618|NCT01680016|7463824|FG000|Overall Study|Protocol Violation|0
4608619|NCT01680016|7463825|FG001|Overall Study|Protocol Violation|1
4608620|NCT01680016|7463826|FG002|Overall Study|Protocol Violation|0
4608621|NCT01680016|7463827|FG003|Overall Study|Protocol Violation|0
4608622|NCT01680016|7463824|FG000|Overall Study|Withdrawal by Subject|5
4608623|NCT01680016|7463825|FG001|Overall Study|Withdrawal by Subject|7
4608624|NCT01680016|7463826|FG002|Overall Study|Withdrawal by Subject|1
4608625|NCT01680016|7463827|FG003|Overall Study|Withdrawal by Subject|1
4608626|NCT01680159|7463853|FG000|Screening Period|Not meet criteria for dose-up period|7
4608627|NCT01680159|7463853|FG000|Increased Dose Period|Adverse Event|6
4608628|NCT01680159|7463853|FG000|Increased Dose Period|Withdrawal by Subject|2
4608629|NCT01680341|7463919|FG000|Overall Study|Adverse Event|3
4608630|NCT01680341|7463920|FG001|Overall Study|Adverse Event|2
4608631|NCT01680341|7463919|FG000|Overall Study|Unclassified|18
4608632|NCT01680341|7463920|FG001|Overall Study|Unclassified|15
4608633|NCT01680458|7463926|FG000|Overall Study|Protocol Violation|3
4608634|NCT01680497|7463930|FG000|Overall Study|Lost to Follow-up|2
4608635|NCT01680861|7463997|FG000|Early Post-transplant Period|Protocol Violation|1
4608636|NCT01680861|7463998|FG001|Early Post-transplant Period|Protocol Violation|1
4608637|NCT01680991|7464027|FG000|Overall Study|Adverse Event|1
4608638|NCT01680991|7464028|FG001|Overall Study|Adverse Event|0
4608639|NCT01680991|7464029|FG002|Overall Study|Adverse Event|0
4608640|NCT01680991|7464027|FG000|Overall Study|Death|1
4608641|NCT01680991|7464028|FG001|Overall Study|Death|0
4608642|NCT01680991|7464029|FG002|Overall Study|Death|1
4608643|NCT01680991|7464027|FG000|Overall Study|Protocol Violation|0
4608644|NCT01680991|7464028|FG001|Overall Study|Protocol Violation|1
4608645|NCT01680991|7464029|FG002|Overall Study|Protocol Violation|0
4608646|NCT01680991|7464027|FG000|Overall Study|Withdrawal by Subject|5
4608647|NCT01680991|7464028|FG001|Overall Study|Withdrawal by Subject|1
4608648|NCT01680991|7464029|FG002|Overall Study|Withdrawal by Subject|0
4608649|NCT01680991|7464027|FG000|Overall Study|Progressive disease (PD)|0
4608650|NCT01680991|7464028|FG001|Overall Study|Progressive disease (PD)|10
4608651|NCT01680991|7464029|FG002|Overall Study|Progressive disease (PD)|0
4608652|NCT01680991|7464027|FG000|Overall Study|Physician Decision|0
4608653|NCT01680991|7464028|FG001|Overall Study|Physician Decision|7
4608654|NCT01680991|7464029|FG002|Overall Study|Physician Decision|2
4608655|NCT01680991|7464027|FG000|Overall Study|Bad physical condition|0
4608656|NCT01680991|7464028|FG001|Overall Study|Bad physical condition|0
4608657|NCT01680991|7464029|FG002|Overall Study|Bad physical condition|1
4608658|NCT01680991|7464027|FG000|Overall Study|PD confirmed in other hospital|1
4608659|NCT01680991|7464028|FG001|Overall Study|PD confirmed in other hospital|0
4608660|NCT01680991|7464029|FG002|Overall Study|PD confirmed in other hospital|0
4608661|NCT01681004|7464041|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1
4608662|NCT01681004|7464042|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2
4608663|NCT01681004|7464041|FG000|Study Completion|Lost to Follow-up|8
4608664|NCT01681004|7464042|FG001|Study Completion|Lost to Follow-up|3
4608665|NCT01681004|7464041|FG000|Study Completion|Physician Decision|1
4608666|NCT01681004|7464042|FG001|Study Completion|Physician Decision|3
4608667|NCT01681004|7464041|FG000|Study Completion|Site Termination|2
4608668|NCT01681004|7464042|FG001|Study Completion|Site Termination|1
4608669|NCT01681004|7464041|FG000|Study Completion|Death|1
4639021|NCT01966445|7512773|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1
4639022|NCT01966445|7512774|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
4639023|NCT01966445|7512768|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
4639024|NCT01966445|7512769|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1
4639025|NCT01966445|7512770|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
4639026|NCT01966445|7512771|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1
4639027|NCT01966445|7512772|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1
4639028|NCT01966445|7512773|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
4639029|NCT01966445|7512774|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
4639030|NCT01966445|7512768|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
4639031|NCT01966445|7512769|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1
4639032|NCT01966445|7512770|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1
4639033|NCT01966445|7512771|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
4639034|NCT01966445|7512772|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2
4639035|NCT01966445|7512773|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
4608670|NCT01681004|7464042|FG001|Study Completion|Death|1
4608671|NCT01681069|7464067|FG000|Overall Study|Withdrawal by Subject|4
4608672|NCT01681069|7464068|FG001|Overall Study|Withdrawal by Subject|5
4608673|NCT01681069|7464067|FG000|Overall Study|Protocol Violation|1
4639036|NCT01966445|7512774|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
4639037|NCT01966445|7512768|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
4608674|NCT01681069|7464068|FG001|Overall Study|Protocol Violation|1
4608675|NCT01681069|7464067|FG000|Overall Study|Adverse Event|0
4608676|NCT01681069|7464068|FG001|Overall Study|Adverse Event|1
4608677|NCT01681186|7464102|FG000|Washout Period From Second Intervention|Adverse Event|0
4608678|NCT01681186|7464103|FG001|Washout Period From Second Intervention|Adverse Event|0
4608679|NCT01681186|7464104|FG002|Washout Period From Second Intervention|Adverse Event|0
4608680|NCT01681186|7464105|FG003|Washout Period From Second Intervention|Adverse Event|0
4608681|NCT01681186|7464106|FG004|Washout Period From Second Intervention|Adverse Event|0
4608682|NCT01681186|7464107|FG005|Washout Period From Second Intervention|Adverse Event|0
4608683|NCT01681186|7464108|FG006|Washout Period From Second Intervention|Adverse Event|1
4608684|NCT01681186|7464109|FG007|Washout Period From Second Intervention|Adverse Event|0
4608685|NCT01681186|7464102|FG000|Washout Period From Second Intervention|Protocol Violation|0
4608686|NCT01681186|7464103|FG001|Washout Period From Second Intervention|Protocol Violation|0
4608687|NCT01681186|7464104|FG002|Washout Period From Second Intervention|Protocol Violation|0
4608688|NCT01681186|7464105|FG003|Washout Period From Second Intervention|Protocol Violation|0
4608689|NCT01681186|7464106|FG004|Washout Period From Second Intervention|Protocol Violation|0
4608690|NCT01681186|7464107|FG005|Washout Period From Second Intervention|Protocol Violation|0
4608691|NCT01681186|7464108|FG006|Washout Period From Second Intervention|Protocol Violation|0
4608692|NCT01681186|7464109|FG007|Washout Period From Second Intervention|Protocol Violation|1
4608693|NCT01681186|7464102|FG000|Washout Period From Third Intervention|Lost to Follow-up|0
4608694|NCT01681186|7464103|FG001|Washout Period From Third Intervention|Lost to Follow-up|0
4608695|NCT01681186|7464104|FG002|Washout Period From Third Intervention|Lost to Follow-up|0
4608696|NCT01681186|7464105|FG003|Washout Period From Third Intervention|Lost to Follow-up|0
4608697|NCT01681186|7464106|FG004|Washout Period From Third Intervention|Lost to Follow-up|0
4608698|NCT01681186|7464107|FG005|Washout Period From Third Intervention|Lost to Follow-up|0
4608699|NCT01681186|7464108|FG006|Washout Period From Third Intervention|Lost to Follow-up|1
4608700|NCT01681186|7464109|FG007|Washout Period From Third Intervention|Lost to Follow-up|0
4608701|NCT01681186|7464102|FG000|Fourth Intervention|Protocol Violation|0
4608702|NCT01681186|7464103|FG001|Fourth Intervention|Protocol Violation|0
4608703|NCT01681186|7464104|FG002|Fourth Intervention|Protocol Violation|0
4608704|NCT01681186|7464105|FG003|Fourth Intervention|Protocol Violation|0
4608705|NCT01681186|7464106|FG004|Fourth Intervention|Protocol Violation|0
4608706|NCT01681186|7464107|FG005|Fourth Intervention|Protocol Violation|0
4608707|NCT01681186|7464108|FG006|Fourth Intervention|Protocol Violation|0
4608708|NCT01681186|7464109|FG007|Fourth Intervention|Protocol Violation|1
4608709|NCT01681212|7464139|FG000|Overall Study|No longer met study criteria|5
4608710|NCT01681212|7464139|FG000|Overall Study|Administrative reason by sponsor|1
4608711|NCT01681277|7464148|FG000|Overall Study|Adverse Event|1
4608712|NCT01681277|7464149|FG001|Overall Study|Adverse Event|0
4608713|NCT01681277|7464150|FG002|Overall Study|Adverse Event|0
4608714|NCT01681277|7464151|FG003|Overall Study|Adverse Event|0
4608715|NCT01681277|7464152|FG004|Overall Study|Adverse Event|0
4608716|NCT01681368|7464168|FG000|Overall Study|Refused further treatment|1
4608717|NCT01681368|7464168|FG000|Overall Study|Refused further follow up|1
4608718|NCT01681433|7464174|FG000|Overall Study|Lack of Efficacy|23
4608719|NCT01681433|7464175|FG001|Overall Study|Lack of Efficacy|23
4608720|NCT01681433|7464174|FG000|Overall Study|Withdrawal by Subject|5
4639038|NCT01966445|7512769|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
4639039|NCT01966445|7512770|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
4639040|NCT01966445|7512771|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
4639041|NCT01966445|7512772|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
4639042|NCT01966445|7512773|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
4639043|NCT01966445|7512774|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3
4639044|NCT01966445|7512768|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
4639045|NCT01966445|7512769|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
4639046|NCT01966445|7512770|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
4747083|NCT00329108|7720207|FG001|Overall Study|study terminated by sponsor|0
4747084|NCT00329108|7720206|FG000|Overall Study|withdrew patient after SAE resolved|1
4747085|NCT00329108|7720207|FG001|Overall Study|withdrew patient after SAE resolved|0
4747086|NCT00329108|7720206|FG000|Overall Study|Protocol Violation|0
4747087|NCT00329108|7720207|FG001|Overall Study|Protocol Violation|2
4747088|NCT00333229|7720228|FG000|Overall Study|Lack of Efficacy|0
4747089|NCT00333229|7720229|FG001|Overall Study|Lack of Efficacy|1
4747090|NCT00314327|7720275|FG000|Overall Study|Withdrawal by Subject|1
4747091|NCT00308113|7720283|FG000|Overall Study|Protocol closure|0
4747092|NCT00308113|7720284|FG001|Overall Study|Protocol closure|0
4747093|NCT00308113|7720285|FG002|Overall Study|Protocol closure|0
4747094|NCT00308113|7720286|FG003|Overall Study|Protocol closure|1
4747095|NCT00298740|7720306|FG000|Overall Study|Lack of Efficacy|6
4747096|NCT00298740|7720306|FG000|Overall Study|Withdrawal by Subject|3
4747097|NCT00301080|7720310|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1
4747098|NCT00301080|7720311|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0
4747099|NCT00301080|7720312|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0
4639047|NCT01966445|7512771|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
4639048|NCT01966445|7512772|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
4608721|NCT01681433|7464175|FG001|Overall Study|Withdrawal by Subject|5
4608722|NCT01681433|7464174|FG000|Overall Study|Protocol Violation|2
4608723|NCT01681433|7464175|FG001|Overall Study|Protocol Violation|0
4608724|NCT01681433|7464174|FG000|Overall Study|Adverse Event|2
4608725|NCT01681433|7464175|FG001|Overall Study|Adverse Event|4
4608726|NCT01681433|7464174|FG000|Overall Study|Lost to Follow-up|0
4608727|NCT01681433|7464175|FG001|Overall Study|Lost to Follow-up|1
4608728|NCT01681472|7464185|FG000|Overall Study|Adverse Event|0
4608729|NCT01681472|7464186|FG001|Overall Study|Adverse Event|1
4608730|NCT01681472|7464187|FG002|Overall Study|Adverse Event|0
4608731|NCT01681472|7464188|FG003|Overall Study|Adverse Event|0
4608732|NCT01681511|7464209|FG000|Overall Study|No Treatment Received|1
4608733|NCT01681511|7464210|FG001|Overall Study|No Treatment Received|3
4608734|NCT01681511|7464209|FG000|Overall Study|Failed Inclusion/Exclusion|3
4608735|NCT01681511|7464210|FG001|Overall Study|Failed Inclusion/Exclusion|0
4608736|NCT01681511|7464209|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3
4608737|NCT01681511|7464210|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6
4608738|NCT01681511|7464209|FG000|Overall Study|No Daily Urine Sample Collected|0
4608739|NCT01681511|7464210|FG001|Overall Study|No Daily Urine Sample Collected|1
4608740|NCT01681511|7464209|FG000|Overall Study|No post-catheter sample collected|11
4608741|NCT01681511|7464210|FG001|Overall Study|No post-catheter sample collected|4
4608742|NCT01681576|7464218|FG000|Period 1|Adverse Event|1
4608743|NCT01681576|7464219|FG001|Period 1|Adverse Event|0
4608744|NCT01681576|7464218|FG000|Period 1|Protocol Deviation|1
4608745|NCT01681576|7464219|FG001|Period 1|Protocol Deviation|0
4608746|NCT01681576|7464218|FG000|Period 2|subject/guardian decision|3
4608747|NCT01681576|7464219|FG001|Period 2|subject/guardian decision|1
4608748|NCT01681576|7464218|FG000|Period 2|Non-compliance with study treatment|1
4608749|NCT01681576|7464219|FG001|Period 2|Non-compliance with study treatment|0
4608750|NCT01681628|7464229|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14
4608751|NCT01681628|7464230|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6
4608752|NCT01681628|7464229|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0
4608753|NCT01681628|7464230|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15
4608754|NCT01681628|7464229|FG000|19 Months Follow-up|Death|1
4608755|NCT01681628|7464230|FG001|19 Months Follow-up|Death|0
4608756|NCT01681628|7464229|FG000|19 Months Follow-up|Lost to Follow-up|61
4608757|NCT01681628|7464230|FG001|19 Months Follow-up|Lost to Follow-up|43
4608758|NCT01681771|7464241|FG000|Overall Study|Lost to Follow-up|4
4608759|NCT01681771|7464242|FG001|Overall Study|Lost to Follow-up|2
4608760|NCT01681836|7464252|FG000|Second Intervention|Withdrawal by Subject|0
4608761|NCT01681836|7464253|FG001|Second Intervention|Withdrawal by Subject|1
4608762|NCT01681849|7464262|FG000|Overall Study|Protocol Violation|2
4608763|NCT01681849|7464263|FG001|Overall Study|Protocol Violation|0
4608764|NCT01681849|7464264|FG002|Overall Study|Protocol Violation|0
4608765|NCT01681849|7464262|FG000|Overall Study|Withdrawal by Subject|3
4608766|NCT01681849|7464263|FG001|Overall Study|Withdrawal by Subject|5
4639049|NCT01966445|7512773|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
4639050|NCT01966445|7512774|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2
4639051|NCT01967069|7512893|FG000|Overall Study|Adverse Event|2
4639052|NCT01967069|7512894|FG001|Overall Study|Adverse Event|2
4639053|NCT01967069|7512893|FG000|Overall Study|Lost to Follow-up|5
4639054|NCT01967069|7512894|FG001|Overall Study|Lost to Follow-up|2
4639055|NCT01967069|7512893|FG000|Overall Study|Withdrawal by Subject|1
4639056|NCT01967069|7512894|FG001|Overall Study|Withdrawal by Subject|3
4639057|NCT01967069|7512893|FG000|Overall Study|Lack of Efficacy|0
4639058|NCT01967069|7512894|FG001|Overall Study|Lack of Efficacy|1
4639059|NCT01967134|7512916|FG000|Overall Study|Lost to Follow-up|0
4639060|NCT01967134|7512917|FG001|Overall Study|Lost to Follow-up|1
4639061|NCT01967134|7512918|FG002|Overall Study|Lost to Follow-up|0
4639062|NCT01967147|7512928|FG000|Overall Study|Adverse Event|5
4639063|NCT01967147|7512929|FG001|Overall Study|Adverse Event|2
4639064|NCT01967147|7512928|FG000|Overall Study|Lack of Efficacy|1
4639065|NCT01967147|7512929|FG001|Overall Study|Lack of Efficacy|4
4639066|NCT01967147|7512928|FG000|Overall Study|Lost to Follow-up|1
4639067|NCT01967147|7512929|FG001|Overall Study|Lost to Follow-up|2
4639068|NCT01967147|7512928|FG000|Overall Study|Withdrawal by Subject|2
4639069|NCT01967147|7512929|FG001|Overall Study|Withdrawal by Subject|4
4639070|NCT01967147|7512928|FG000|Overall Study|Non-compliance with Study Drug|0
4639071|NCT01967147|7512929|FG001|Overall Study|Non-compliance with Study Drug|3
4639072|NCT01967147|7512928|FG000|Overall Study|Other|4
4639073|NCT01967147|7512929|FG001|Overall Study|Other|5
4608767|NCT01681849|7464264|FG002|Overall Study|Withdrawal by Subject|33
4639074|NCT01967173|7512944|FG000|Overall Study|Lost to Follow-up|5
4639075|NCT01967173|7512945|FG001|Overall Study|Lost to Follow-up|3
4639076|NCT01967173|7512946|FG002|Overall Study|Lost to Follow-up|2
4639077|NCT01967173|7512947|FG003|Overall Study|Lost to Follow-up|4
4639078|NCT01967173|7512948|FG004|Overall Study|Lost to Follow-up|8
4639079|NCT01967173|7512949|FG005|Overall Study|Lost to Follow-up|12
4639080|NCT01967173|7512950|FG006|Overall Study|Lost to Follow-up|6
4639081|NCT01967173|7512951|FG007|Overall Study|Lost to Follow-up|8
4639082|NCT01967173|7512944|FG000|Overall Study|Physician Decision|2
4639083|NCT01967173|7512945|FG001|Overall Study|Physician Decision|0
4639084|NCT01967173|7512946|FG002|Overall Study|Physician Decision|2
4608768|NCT01681849|7464262|FG000|Overall Study|Lost to Follow-up|3
4608769|NCT01681849|7464263|FG001|Overall Study|Lost to Follow-up|2
4608770|NCT01681849|7464264|FG002|Overall Study|Lost to Follow-up|6
4608771|NCT01681992|7464274|FG000|Overall Study|Adverse Event|3
4608772|NCT01681992|7464275|FG001|Overall Study|Adverse Event|2
4608773|NCT01681992|7464276|FG002|Overall Study|Adverse Event|3
4608774|NCT01681992|7464274|FG000|Overall Study|Lost to Follow-up|36
4608775|NCT01681992|7464275|FG001|Overall Study|Lost to Follow-up|38
4608776|NCT01681992|7464276|FG002|Overall Study|Lost to Follow-up|53
4608777|NCT01681992|7464274|FG000|Overall Study|As Per Sponsor Decision|0
4639085|NCT01967173|7512947|FG003|Overall Study|Physician Decision|1
4639086|NCT01967173|7512948|FG004|Overall Study|Physician Decision|1
4639087|NCT01967173|7512949|FG005|Overall Study|Physician Decision|1
4639088|NCT01967173|7512950|FG006|Overall Study|Physician Decision|1
4639089|NCT01967173|7512951|FG007|Overall Study|Physician Decision|0
4639090|NCT01967173|7512944|FG000|Overall Study|Lack of Efficacy|2
4639091|NCT01967173|7512945|FG001|Overall Study|Lack of Efficacy|0
4639092|NCT01967173|7512946|FG002|Overall Study|Lack of Efficacy|2
4639093|NCT01967173|7512947|FG003|Overall Study|Lack of Efficacy|2
4639094|NCT01967173|7512948|FG004|Overall Study|Lack of Efficacy|0
4639095|NCT01967173|7512949|FG005|Overall Study|Lack of Efficacy|1
4639096|NCT01967173|7512950|FG006|Overall Study|Lack of Efficacy|0
4639097|NCT01967173|7512951|FG007|Overall Study|Lack of Efficacy|2
4639098|NCT01967173|7512944|FG000|Overall Study|Pregnancy|0
4639099|NCT01967173|7512945|FG001|Overall Study|Pregnancy|0
4639100|NCT01967173|7512946|FG002|Overall Study|Pregnancy|0
4639101|NCT01967173|7512947|FG003|Overall Study|Pregnancy|0
4639102|NCT01967173|7512948|FG004|Overall Study|Pregnancy|0
4639103|NCT01967173|7512949|FG005|Overall Study|Pregnancy|0
4639104|NCT01967173|7512950|FG006|Overall Study|Pregnancy|1
4639105|NCT01967173|7512951|FG007|Overall Study|Pregnancy|1
4639106|NCT01967173|7512944|FG000|Overall Study|Adverse Event|0
4639107|NCT01967173|7512945|FG001|Overall Study|Adverse Event|0
4639108|NCT01967173|7512946|FG002|Overall Study|Adverse Event|0
4639109|NCT01967173|7512947|FG003|Overall Study|Adverse Event|0
4639110|NCT01967173|7512948|FG004|Overall Study|Adverse Event|0
4639111|NCT01967173|7512949|FG005|Overall Study|Adverse Event|0
4639112|NCT01967173|7512950|FG006|Overall Study|Adverse Event|0
4639113|NCT01967173|7512951|FG007|Overall Study|Adverse Event|1
4639114|NCT01967173|7512944|FG000|Overall Study|Withdrawal by Subject|15
4639115|NCT01967173|7512945|FG001|Overall Study|Withdrawal by Subject|14
4639116|NCT01967173|7512946|FG002|Overall Study|Withdrawal by Subject|10
4639117|NCT01967173|7512947|FG003|Overall Study|Withdrawal by Subject|7
4639118|NCT01967173|7512948|FG004|Overall Study|Withdrawal by Subject|8
4639119|NCT01967173|7512949|FG005|Overall Study|Withdrawal by Subject|9
4639120|NCT01967173|7512950|FG006|Overall Study|Withdrawal by Subject|10
4639121|NCT01967173|7512951|FG007|Overall Study|Withdrawal by Subject|12
4639122|NCT01967225|7512967|FG000|Overall Study|Adverse Event|3
4639123|NCT01967225|7512968|FG001|Overall Study|Adverse Event|1
4639124|NCT01967225|7512967|FG000|Overall Study|Withdrawal by Subject|2
4639125|NCT01967225|7512968|FG001|Overall Study|Withdrawal by Subject|1
4639126|NCT01967225|7512967|FG000|Overall Study|Lack of Efficacy|1
4639127|NCT01967225|7512968|FG001|Overall Study|Lack of Efficacy|1
4639128|NCT01967225|7512967|FG000|Overall Study|Switching to other therapy|2
4639129|NCT01967225|7512968|FG001|Overall Study|Switching to other therapy|0
4639130|NCT01967225|7512967|FG000|Overall Study|Protocol driven decision point|1
4639131|NCT01967225|7512968|FG001|Overall Study|Protocol driven decision point|0
4639132|NCT01967225|7512967|FG000|Overall Study|Logistical difficulties|1
4639133|NCT01967225|7512968|FG001|Overall Study|Logistical difficulties|0
4639134|NCT01967225|7512967|FG000|Overall Study|Protocol Violation|2
4639135|NCT01967225|7512968|FG001|Overall Study|Protocol Violation|0
4639136|NCT01967277|7512978|FG000|Overall Study|Lost to Follow-up|1
4639137|NCT01967277|7512979|FG001|Overall Study|Lost to Follow-up|2
4639138|NCT01967277|7512978|FG000|Overall Study|Unrelated illness|0
4639139|NCT01967277|7512979|FG001|Overall Study|Unrelated illness|1
4639140|NCT01967537|7513013|FG000|Overall Study|Withdrawal by Subject|52
4639141|NCT01967537|7513013|FG000|Overall Study|Refuse treatment|2
4639142|NCT01967537|7513013|FG000|Overall Study|Lost to Follow-up|6
4639143|NCT01967550|7513019|FG000|Overall Study|Withdrawal by Subject|1
4639144|NCT01967550|7513020|FG001|Overall Study|Withdrawal by Subject|0
4639145|NCT01967550|7513019|FG000|Overall Study|Adverse Event|2
4639146|NCT01967550|7513020|FG001|Overall Study|Adverse Event|0
4639147|NCT01967550|7513019|FG000|Overall Study|Protocol Violation|2
4639148|NCT01967550|7513020|FG001|Overall Study|Protocol Violation|1
4639149|NCT01967550|7513019|FG000|Overall Study|Non Compliance|0
4639150|NCT01967550|7513020|FG001|Overall Study|Non Compliance|1
4639151|NCT01967576|7513026|FG000|Overall Study|Withdrawal by Subject|3
4608778|NCT01681992|7464275|FG001|Overall Study|As Per Sponsor Decision|0
4639152|NCT01967576|7513026|FG000|Overall Study|Progressed/Removed from treatment|1
4639153|NCT01967576|7513026|FG000|Overall Study|Study closing at site|1
4639154|NCT01967576|7513026|FG000|Overall Study|Adverse Event|1
4639155|NCT01967576|7513026|FG000|Overall Study|Refused further treatment|1
4639156|NCT01967628|7513032|FG000|Overall Study|Withdrawal by Subject|2
4639157|NCT01967628|7513033|FG001|Overall Study|Withdrawal by Subject|0
4639158|NCT01967628|7513032|FG000|Overall Study|Unable to complete bronchoscopy|4
4639159|NCT01967628|7513033|FG001|Overall Study|Unable to complete bronchoscopy|6
4608779|NCT01681992|7464276|FG002|Overall Study|As Per Sponsor Decision|1
4608780|NCT01681992|7464274|FG000|Overall Study|Protocol Violation|0
4608781|NCT01681992|7464275|FG001|Overall Study|Protocol Violation|0
4608782|NCT01681992|7464276|FG002|Overall Study|Protocol Violation|1
4608783|NCT01681992|7464274|FG000|Overall Study|Withdrawal by Subject|27
4608784|NCT01681992|7464275|FG001|Overall Study|Withdrawal by Subject|30
4608785|NCT01681992|7464276|FG002|Overall Study|Withdrawal by Subject|25
4608786|NCT01682031|7464286|FG000|Overall Study|Withdrawal by Subject|0
4608787|NCT01682031|7464287|FG001|Overall Study|Withdrawal by Subject|1
4608788|NCT01682031|7464286|FG000|Overall Study|Adverse Event|0
4608789|NCT01682031|7464287|FG001|Overall Study|Adverse Event|2
4608790|NCT01682031|7464286|FG000|Overall Study|MRI results indicate increased nodul|0
4608791|NCT01682031|7464287|FG001|Overall Study|MRI results indicate increased nodul|1
4608792|NCT01682031|7464286|FG000|Overall Study|Patient could not swallow tablets|1
4608793|NCT01682031|7464287|FG001|Overall Study|Patient could not swallow tablets|0
4608794|NCT01682031|7464286|FG000|Overall Study|Patient stopped selenium on his own|0
4608795|NCT01682031|7464287|FG001|Overall Study|Patient stopped selenium on his own|1
4608796|NCT01682044|7464293|FG000|Overall Study|Death|1
4608797|NCT01682044|7464293|FG000|Overall Study|Progression|3
4608798|NCT01682083|7464299|FG000|Overall Study|Lost to Follow-up|11
4608799|NCT01682083|7464300|FG001|Overall Study|Lost to Follow-up|18
4608800|NCT01682083|7464299|FG000|Overall Study|Withdrawal by Subject|31
4608801|NCT01682083|7464300|FG001|Overall Study|Withdrawal by Subject|40
4608802|NCT01682083|7464299|FG000|Overall Study|Death|60
4608803|NCT01682083|7464300|FG001|Overall Study|Death|93
4608804|NCT01682083|7464299|FG000|Overall Study|Physician Decision|5
4639160|NCT01967628|7513032|FG000|Overall Study|Lost to Follow-up|1
4639161|NCT01967628|7513033|FG001|Overall Study|Lost to Follow-up|0
4639162|NCT01967628|7513032|FG000|Overall Study|Low protein concentration in sample|20
4639163|NCT01967628|7513033|FG001|Overall Study|Low protein concentration in sample|25
4639164|NCT01967706|7513046|FG000|First Intervention (Day 1)|Withdrawal by Subject|1
4639165|NCT01967706|7513047|FG001|First Intervention (Day 1)|Withdrawal by Subject|0
4639166|NCT01967706|7513048|FG002|First Intervention (Day 1)|Withdrawal by Subject|0
4639167|NCT01967706|7513049|FG003|First Intervention (Day 1)|Withdrawal by Subject|0
4639168|NCT01967719|7513060|FG000|First Intervention (Day 1)|Withdrawal by Subject|0
4639169|NCT01967719|7513061|FG001|First Intervention (Day 1)|Withdrawal by Subject|1
4639170|NCT01967719|7513062|FG002|First Intervention (Day 1)|Withdrawal by Subject|0
4639171|NCT01967719|7513063|FG003|First Intervention (Day 1)|Withdrawal by Subject|1
4639172|NCT01967719|7513060|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0
4639173|NCT01967719|7513061|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1
4639174|NCT01967719|7513062|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0
4639175|NCT01967719|7513063|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0
4639176|NCT01967732|7513075|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
4639177|NCT01967732|7513076|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1
4639178|NCT01967732|7513077|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
4639179|NCT01967732|7513078|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
4639180|NCT01967732|7513075|FG000|First Intervention (Day 1)|Poor venous access|0
4639181|NCT01967732|7513076|FG001|First Intervention (Day 1)|Poor venous access|1
4639182|NCT01967732|7513077|FG002|First Intervention (Day 1)|Poor venous access|0
4639183|NCT01967732|7513078|FG003|First Intervention (Day 1)|Poor venous access|0
4639184|NCT01967888|7513101|FG000|Overall Study|Lost to Follow-up|6
4639185|NCT01967888|7513102|FG001|Overall Study|Lost to Follow-up|4
4639186|NCT01967888|7513101|FG000|Overall Study|Withdrawal by Subject|1
4639187|NCT01967888|7513102|FG001|Overall Study|Withdrawal by Subject|1
4639188|NCT01967888|7513101|FG000|Overall Study|Did Not Have Transplant|1
4639189|NCT01967888|7513102|FG001|Overall Study|Did Not Have Transplant|0
4639190|NCT01967888|7513101|FG000|Overall Study|Research visit not done, data recorded|1
4639191|NCT01967888|7513102|FG001|Overall Study|Research visit not done, data recorded|0
4639192|NCT01967888|7513101|FG000|Overall Study|Subject excluded after randomization|1
4639193|NCT01967888|7513102|FG001|Overall Study|Subject excluded after randomization|0
4639194|NCT01967888|7513101|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0
4639195|NCT01967888|7513102|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1
4639196|NCT01967888|7513101|FG000|Overall Study|Subject Unable To Comply With Final Day|0
4639197|NCT01967888|7513102|FG001|Overall Study|Subject Unable To Comply With Final Day|1
4639198|NCT01967940|7513111|FG000|Part 2|Enrolled in Part 2 and Never Treated|0
4639199|NCT01967940|7513112|FG001|Part 2|Enrolled in Part 2 and Never Treated|0
4639200|NCT01967940|7513113|FG002|Part 2|Enrolled in Part 2 and Never Treated|0
4639201|NCT01967940|7513114|FG003|Part 2|Enrolled in Part 2 and Never Treated|1
4639202|NCT01967940|7513111|FG000|Part 2|Adverse Event|0
4639203|NCT01967940|7513112|FG001|Part 2|Adverse Event|0
4639204|NCT01967940|7513113|FG002|Part 2|Adverse Event|0
4639205|NCT01967940|7513114|FG003|Part 2|Adverse Event|1
4639206|NCT01967940|7513111|FG000|Part 2|Unknown Reason|0
4639207|NCT01967940|7513112|FG001|Part 2|Unknown Reason|0
4639208|NCT01967940|7513113|FG002|Part 2|Unknown Reason|0
4639209|NCT01967940|7513114|FG003|Part 2|Unknown Reason|1
4639210|NCT01968031|7513127|FG000|Overall Study|Adverse Event|13
4639211|NCT01968031|7513128|FG001|Overall Study|Adverse Event|10
4639212|NCT01968031|7513129|FG002|Overall Study|Adverse Event|22
4608805|NCT01682083|7464300|FG001|Overall Study|Physician Decision|4
4608806|NCT01682148|7464323|FG000|Overall Study|Withdrawal by Subject|2
4608807|NCT01682148|7464324|FG001|Overall Study|Withdrawal by Subject|0
4608808|NCT01682148|7464323|FG000|Overall Study|Lost to Follow-up|1
4608809|NCT01682148|7464324|FG001|Overall Study|Lost to Follow-up|2
4608810|NCT01682148|7464323|FG000|Overall Study|Protocol Violation|1
4639213|NCT01968031|7513127|FG000|Overall Study|Withdrawal by Subject|3
4639214|NCT01968031|7513128|FG001|Overall Study|Withdrawal by Subject|7
4639215|NCT01968031|7513129|FG002|Overall Study|Withdrawal by Subject|3
4639216|NCT01968031|7513127|FG000|Overall Study|Did not meet entry criteria|1
4639217|NCT01968031|7513128|FG001|Overall Study|Did not meet entry criteria|1
4639218|NCT01968031|7513129|FG002|Overall Study|Did not meet entry criteria|1
4639219|NCT01968031|7513127|FG000|Overall Study|Noncompliance|0
4639220|NCT01968031|7513128|FG001|Overall Study|Noncompliance|0
4639221|NCT01968031|7513129|FG002|Overall Study|Noncompliance|2
4639222|NCT01968031|7513127|FG000|Overall Study|Failed inclusion criteria|0
4639223|NCT01968031|7513128|FG001|Overall Study|Failed inclusion criteria|2
4639224|NCT01968031|7513129|FG002|Overall Study|Failed inclusion criteria|0
4639225|NCT01968031|7513127|FG000|Overall Study|Death|0
4639226|NCT01968031|7513128|FG001|Overall Study|Death|0
4639227|NCT01968031|7513129|FG002|Overall Study|Death|1
4639228|NCT01968031|7513127|FG000|Overall Study|Prohibited concomitant medication|1
4639229|NCT01968031|7513128|FG001|Overall Study|Prohibited concomitant medication|0
4639230|NCT01968031|7513129|FG002|Overall Study|Prohibited concomitant medication|0
4639231|NCT01968070|7513161|FG000|Period 1|Withdrawal by Subject|0
4639232|NCT01968070|7513162|FG001|Period 1|Withdrawal by Subject|1
4639233|NCT01968070|7513163|FG002|Period 1|Withdrawal by Subject|0
4639234|NCT01968070|7513164|FG003|Period 1|Withdrawal by Subject|0
4639235|NCT01968070|7513165|FG004|Period 1|Withdrawal by Subject|0
4639236|NCT01968070|7513166|FG005|Period 1|Withdrawal by Subject|0
4639237|NCT01968070|7513167|FG006|Period 1|Withdrawal by Subject|1
4639238|NCT01968070|7513168|FG007|Period 1|Withdrawal by Subject|0
4639239|NCT01968070|7513169|FG008|Period 1|Withdrawal by Subject|0
4639240|NCT01968070|7513170|FG009|Period 1|Withdrawal by Subject|0
4639241|NCT01968070|7513171|FG010|Period 1|Withdrawal by Subject|0
4639242|NCT01968070|7513172|FG011|Period 1|Withdrawal by Subject|0
4639243|NCT01968070|7513173|FG012|Period 1|Withdrawal by Subject|0
4639244|NCT01968070|7513174|FG013|Period 1|Withdrawal by Subject|0
4639245|NCT01968070|7513175|FG014|Period 1|Withdrawal by Subject|0
4639246|NCT01968070|7513176|FG015|Period 1|Withdrawal by Subject|1
4639247|NCT01968070|7513177|FG016|Period 1|Withdrawal by Subject|0
4639248|NCT01968070|7513178|FG017|Period 1|Withdrawal by Subject|0
4639249|NCT01968070|7513161|FG000|Period 1|Protocol Violation|0
4639250|NCT01968070|7513162|FG001|Period 1|Protocol Violation|0
4639251|NCT01968070|7513163|FG002|Period 1|Protocol Violation|0
4639252|NCT01968070|7513164|FG003|Period 1|Protocol Violation|1
4639253|NCT01968070|7513165|FG004|Period 1|Protocol Violation|1
4639254|NCT01968070|7513166|FG005|Period 1|Protocol Violation|0
4639255|NCT01968070|7513167|FG006|Period 1|Protocol Violation|0
4639256|NCT01968070|7513168|FG007|Period 1|Protocol Violation|0
4639257|NCT01968070|7513169|FG008|Period 1|Protocol Violation|0
4639258|NCT01968070|7513170|FG009|Period 1|Protocol Violation|0
4639259|NCT01968070|7513171|FG010|Period 1|Protocol Violation|0
4639260|NCT01968070|7513172|FG011|Period 1|Protocol Violation|0
4639261|NCT01968070|7513173|FG012|Period 1|Protocol Violation|0
4639262|NCT01968070|7513174|FG013|Period 1|Protocol Violation|0
4639263|NCT01968070|7513175|FG014|Period 1|Protocol Violation|0
4639264|NCT01968070|7513176|FG015|Period 1|Protocol Violation|0
4639265|NCT01968070|7513177|FG016|Period 1|Protocol Violation|0
4747100|NCT00301080|7720313|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0
4747101|NCT00301080|7720314|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0
4747102|NCT00290407|7720332|FG000|Overall Study|Physician Decision|2
4747103|NCT00295490|7720340|FG000|Overall Study|Protocol Violation|0
4747104|NCT00295490|7720341|FG001|Overall Study|Protocol Violation|0
4747105|NCT00295490|7720342|FG002|Overall Study|Protocol Violation|3
4747106|NCT00295490|7720343|FG003|Overall Study|Protocol Violation|3
4747107|NCT00295490|7720340|FG000|Overall Study|Withdrawal by Subject|0
4608811|NCT01682148|7464324|FG001|Overall Study|Protocol Violation|1
4608812|NCT01682213|7464335|FG000|Overall Study|Withdrawal by Subject|2
4608813|NCT01682460|7464340|FG000|Overall Study|Withdrawal by Subject|2
4608814|NCT01682460|7464340|FG000|Overall Study|Did not meet inclusion criteria|2
4608815|NCT01682512|7464347|FG000|Overall Study|Adverse Event|6
4608816|NCT01682512|7464348|FG001|Overall Study|Adverse Event|5
4608817|NCT01682512|7464349|FG002|Overall Study|Adverse Event|2
4608818|NCT01682512|7464347|FG000|Overall Study|Withdrawal by Subject|2
4608819|NCT01682512|7464348|FG001|Overall Study|Withdrawal by Subject|6
4608820|NCT01682512|7464349|FG002|Overall Study|Withdrawal by Subject|3
4608821|NCT01682512|7464347|FG000|Overall Study|Physician Decision|0
4608822|NCT01682512|7464348|FG001|Overall Study|Physician Decision|2
4608823|NCT01682512|7464349|FG002|Overall Study|Physician Decision|0
4608824|NCT01682512|7464347|FG000|Overall Study|Study terminated by sponsor|46
4639266|NCT01968070|7513178|FG017|Period 1|Protocol Violation|0
4608825|NCT01682512|7464348|FG001|Overall Study|Study terminated by sponsor|43
4639267|NCT01968070|7513161|FG000|Period 1|Lost to Follow-up|0
4639268|NCT01968070|7513162|FG001|Period 1|Lost to Follow-up|0
4608826|NCT01682512|7464349|FG002|Overall Study|Study terminated by sponsor|0
4608827|NCT01682512|7464347|FG000|Overall Study|Lost to Follow-up|3
4608828|NCT01682512|7464348|FG001|Overall Study|Lost to Follow-up|0
4608829|NCT01682512|7464349|FG002|Overall Study|Lost to Follow-up|2
4608830|NCT01682512|7464347|FG000|Overall Study|Protocol Violation|2
4608831|NCT01682512|7464348|FG001|Overall Study|Protocol Violation|3
4608832|NCT01682512|7464349|FG002|Overall Study|Protocol Violation|2
4608833|NCT01682512|7464347|FG000|Overall Study|Primary lack of efficacy|10
4608834|NCT01682512|7464348|FG001|Overall Study|Primary lack of efficacy|7
4608835|NCT01682512|7464349|FG002|Overall Study|Primary lack of efficacy|7
4608836|NCT01682512|7464347|FG000|Overall Study|Secondary lack of efficacy|1
4608837|NCT01682512|7464348|FG001|Overall Study|Secondary lack of efficacy|1
4608838|NCT01682512|7464349|FG002|Overall Study|Secondary lack of efficacy|0
4608839|NCT01682512|7464347|FG000|Overall Study|Other than stated above|2
4608840|NCT01682512|7464348|FG001|Overall Study|Other than stated above|4
4608841|NCT01682512|7464349|FG002|Overall Study|Other than stated above|2
4608842|NCT01682603|7464372|FG000|Overall Study|Lost to Follow-up|3
4608843|NCT01682681|7464393|FG000|Overall Study|Lack of Efficacy|62
4608844|NCT01682681|7464393|FG000|Overall Study|Withdrawal by Subject|1
4608845|NCT01682681|7464393|FG000|Overall Study|Moved to other hospital|10
4608846|NCT01682681|7464393|FG000|Overall Study|Lost to Follow-up|174
4608847|NCT01682681|7464393|FG000|Overall Study|Adverse Event|46
4608848|NCT01682681|7464393|FG000|Overall Study|tapering of topiramate|5
4608849|NCT01682681|7464393|FG000|Overall Study|Other|21
4608850|NCT01682681|7464393|FG000|Overall Study|Low compliance|13
4608851|NCT01682720|7464401|FG000|Overall Study|Randomized but Not Treated|0
4608852|NCT01682720|7464402|FG001|Overall Study|Randomized but Not Treated|1
4608853|NCT01682720|7464403|FG002|Overall Study|Randomized but Not Treated|1
4608854|NCT01682720|7464404|FG003|Overall Study|Randomized but Not Treated|0
4608855|NCT01682720|7464401|FG000|Overall Study|Terminated by Sponsor|83
4608856|NCT01682720|7464402|FG001|Overall Study|Terminated by Sponsor|0
4608857|NCT01682720|7464403|FG002|Overall Study|Terminated by Sponsor|0
4608858|NCT01682720|7464404|FG003|Overall Study|Terminated by Sponsor|0
4608859|NCT01682720|7464401|FG000|Overall Study|Efficacy Failure|0
4608860|NCT01682720|7464402|FG001|Overall Study|Efficacy Failure|3
4608861|NCT01682720|7464403|FG002|Overall Study|Efficacy Failure|3
4608862|NCT01682720|7464404|FG003|Overall Study|Efficacy Failure|30
4608863|NCT01682720|7464401|FG000|Overall Study|Lost to Follow-up|1
4608864|NCT01682720|7464402|FG001|Overall Study|Lost to Follow-up|1
4608865|NCT01682720|7464403|FG002|Overall Study|Lost to Follow-up|0
4608866|NCT01682720|7464404|FG003|Overall Study|Lost to Follow-up|6
4608867|NCT01682720|7464401|FG000|Overall Study|Subject Withdrew Consent|0
4608868|NCT01682720|7464402|FG001|Overall Study|Subject Withdrew Consent|0
4608869|NCT01682720|7464403|FG002|Overall Study|Subject Withdrew Consent|2
4608870|NCT01682720|7464404|FG003|Overall Study|Subject Withdrew Consent|2
4608871|NCT01682720|7464401|FG000|Overall Study|Adverse Event|1
4608872|NCT01682720|7464402|FG001|Overall Study|Adverse Event|0
4608873|NCT01682720|7464403|FG002|Overall Study|Adverse Event|1
4608874|NCT01682720|7464404|FG003|Overall Study|Adverse Event|1
4608875|NCT01682759|7464416|FG000|Overall Study|Death|2
4608876|NCT01682759|7464417|FG001|Overall Study|Death|1
4608877|NCT01682759|7464416|FG000|Overall Study|Lost to Follow-up|10
4608878|NCT01682759|7464417|FG001|Overall Study|Lost to Follow-up|13
4608879|NCT01682759|7464416|FG000|Overall Study|Physician Decision|1
4608880|NCT01682759|7464417|FG001|Overall Study|Physician Decision|1
4608881|NCT01682759|7464416|FG000|Overall Study|Withdrawal by Subject|56
4608882|NCT01682759|7464417|FG001|Overall Study|Withdrawal by Subject|55
4608883|NCT01682811|7464430|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0
4608884|NCT01682811|7464431|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0
4608885|NCT01682811|7464432|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0
4608886|NCT01682811|7464433|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0
4608887|NCT01682811|7464434|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1
4608888|NCT01682811|7464435|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0
4608889|NCT01682811|7464436|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0
4608890|NCT01682811|7464430|FG000|Part 2 Dose Level 1|Protocol Violation|0
4608891|NCT01682811|7464431|FG001|Part 2 Dose Level 1|Protocol Violation|0
4608892|NCT01682811|7464432|FG002|Part 2 Dose Level 1|Protocol Violation|0
4608893|NCT01682811|7464433|FG003|Part 2 Dose Level 1|Protocol Violation|0
4608894|NCT01682811|7464434|FG004|Part 2 Dose Level 1|Protocol Violation|4
4608895|NCT01682811|7464435|FG005|Part 2 Dose Level 1|Protocol Violation|0
4608896|NCT01682811|7464436|FG006|Part 2 Dose Level 1|Protocol Violation|0
4608897|NCT01682811|7464430|FG000|Part 2 Dose Level 1|Lost to Follow-up|0
4608898|NCT01682811|7464431|FG001|Part 2 Dose Level 1|Lost to Follow-up|0
4608899|NCT01682811|7464432|FG002|Part 2 Dose Level 1|Lost to Follow-up|0
4608900|NCT01682811|7464433|FG003|Part 2 Dose Level 1|Lost to Follow-up|0
4608901|NCT01682811|7464434|FG004|Part 2 Dose Level 1|Lost to Follow-up|6
4608902|NCT01682811|7464435|FG005|Part 2 Dose Level 1|Lost to Follow-up|0
4608903|NCT01682811|7464436|FG006|Part 2 Dose Level 1|Lost to Follow-up|0
4608904|NCT01682811|7464430|FG000|Part 2 Dose Level 2|Lost to Follow-up|0
4608905|NCT01682811|7464431|FG001|Part 2 Dose Level 2|Lost to Follow-up|0
4608906|NCT01682811|7464432|FG002|Part 2 Dose Level 2|Lost to Follow-up|0
4608907|NCT01682811|7464433|FG003|Part 2 Dose Level 2|Lost to Follow-up|0
4608908|NCT01682811|7464434|FG004|Part 2 Dose Level 2|Lost to Follow-up|0
4608909|NCT01682811|7464435|FG005|Part 2 Dose Level 2|Lost to Follow-up|3
4608910|NCT01682811|7464436|FG006|Part 2 Dose Level 2|Lost to Follow-up|0
4608911|NCT01682837|7464455|FG000|Baseline|Withdrawal by Subject|5
4608912|NCT01682863|7464468|FG000|Overall Study|Subject/guardian decision|19
4608913|NCT01682863|7464469|FG001|Overall Study|Subject/guardian decision|12
4608914|NCT01682863|7464470|FG002|Overall Study|Subject/guardian decision|10
4608915|NCT01682863|7464468|FG000|Overall Study|Lost to Follow-up|5
4608916|NCT01682863|7464469|FG001|Overall Study|Lost to Follow-up|1
4608917|NCT01682863|7464470|FG002|Overall Study|Lost to Follow-up|6
4608918|NCT01682863|7464468|FG000|Overall Study|Death|1
4608919|NCT01682863|7464469|FG001|Overall Study|Death|3
4608920|NCT01682863|7464470|FG002|Overall Study|Death|4
4608921|NCT01682863|7464468|FG000|Overall Study|Protocol deviation|1
4608922|NCT01682863|7464469|FG001|Overall Study|Protocol deviation|0
4608923|NCT01682863|7464470|FG002|Overall Study|Protocol deviation|1
4608924|NCT01682863|7464468|FG000|Overall Study|Technical problems|1
4608925|NCT01682863|7464469|FG001|Overall Study|Technical problems|0
4608926|NCT01682863|7464470|FG002|Overall Study|Technical problems|0
4608927|NCT01682863|7464468|FG000|Overall Study|Adverse Event|0
4608928|NCT01682863|7464469|FG001|Overall Study|Adverse Event|1
4608929|NCT01682863|7464470|FG002|Overall Study|Adverse Event|2
4608930|NCT01682863|7464468|FG000|Overall Study|Physician Decision|0
4608931|NCT01682863|7464469|FG001|Overall Study|Physician Decision|0
4608932|NCT01682863|7464470|FG002|Overall Study|Physician Decision|1
4608933|NCT01682876|7464482|FG000|Overall Study|Administrative reason|4
4608934|NCT01682876|7464483|FG001|Overall Study|Administrative reason|4
4608935|NCT01682876|7464484|FG002|Overall Study|Administrative reason|0
4608936|NCT01682876|7464485|FG003|Overall Study|Administrative reason|3
4608937|NCT01682876|7464482|FG000|Overall Study|Adverse Event|0
4608938|NCT01682876|7464483|FG001|Overall Study|Adverse Event|0
4608939|NCT01682876|7464484|FG002|Overall Study|Adverse Event|0
4608940|NCT01682876|7464485|FG003|Overall Study|Adverse Event|1
4608941|NCT01682876|7464482|FG000|Overall Study|Lost to Follow-up|11
4608942|NCT01682876|7464483|FG001|Overall Study|Lost to Follow-up|15
4608943|NCT01682876|7464484|FG002|Overall Study|Lost to Follow-up|9
4608944|NCT01682876|7464485|FG003|Overall Study|Lost to Follow-up|11
4608945|NCT01682876|7464482|FG000|Overall Study|Protocol Violation|1
4608946|NCT01682876|7464483|FG001|Overall Study|Protocol Violation|1
4608947|NCT01682876|7464484|FG002|Overall Study|Protocol Violation|1
4608948|NCT01682876|7464485|FG003|Overall Study|Protocol Violation|1
4608949|NCT01682876|7464482|FG000|Overall Study|Withdrawal by Subject|4
4608950|NCT01682876|7464483|FG001|Overall Study|Withdrawal by Subject|0
4608951|NCT01682876|7464484|FG002|Overall Study|Withdrawal by Subject|0
4608952|NCT01682876|7464485|FG003|Overall Study|Withdrawal by Subject|2
4608953|NCT01682876|7464482|FG000|Overall Study|Other|1
4608954|NCT01682876|7464483|FG001|Overall Study|Other|0
4608955|NCT01682876|7464484|FG002|Overall Study|Other|1
4608956|NCT01682876|7464485|FG003|Overall Study|Other|1
4608957|NCT01683019|7464510|FG000|Overall Study|Withdrawal by Subject|2
4608958|NCT01683019|7464511|FG001|Overall Study|Withdrawal by Subject|1
4608959|NCT01683019|7464512|FG002|Overall Study|Withdrawal by Subject|4
4608960|NCT01683058|7464520|FG000|Overall Study|Lost to Follow-up|9
4639269|NCT01968070|7513163|FG002|Period 1|Lost to Follow-up|0
4639270|NCT01968070|7513164|FG003|Period 1|Lost to Follow-up|1
4639271|NCT01968070|7513165|FG004|Period 1|Lost to Follow-up|0
4639272|NCT01968070|7513166|FG005|Period 1|Lost to Follow-up|0
4639273|NCT01968070|7513167|FG006|Period 1|Lost to Follow-up|0
4639274|NCT01968070|7513168|FG007|Period 1|Lost to Follow-up|0
4639275|NCT01968070|7513169|FG008|Period 1|Lost to Follow-up|0
4639276|NCT01968070|7513170|FG009|Period 1|Lost to Follow-up|0
4639277|NCT01968070|7513171|FG010|Period 1|Lost to Follow-up|0
4639278|NCT01968070|7513172|FG011|Period 1|Lost to Follow-up|0
4639279|NCT01968070|7513173|FG012|Period 1|Lost to Follow-up|0
4639280|NCT01968070|7513174|FG013|Period 1|Lost to Follow-up|0
4639281|NCT01968070|7513175|FG014|Period 1|Lost to Follow-up|0
4639282|NCT01968070|7513176|FG015|Period 1|Lost to Follow-up|0
4639283|NCT01968070|7513177|FG016|Period 1|Lost to Follow-up|0
4639284|NCT01968070|7513178|FG017|Period 1|Lost to Follow-up|0
4639285|NCT01968070|7513161|FG000|Period 1|Adverse Event|0
4639286|NCT01968070|7513162|FG001|Period 1|Adverse Event|0
4639287|NCT01968070|7513163|FG002|Period 1|Adverse Event|0
4639288|NCT01968070|7513164|FG003|Period 1|Adverse Event|0
4639289|NCT01968070|7513165|FG004|Period 1|Adverse Event|0
4639290|NCT01968070|7513166|FG005|Period 1|Adverse Event|0
4639291|NCT01968070|7513167|FG006|Period 1|Adverse Event|1
4608961|NCT01683058|7464520|FG000|Overall Study|Adverse Event|6
4608962|NCT01683058|7464520|FG000|Overall Study|Subject Met Withdrawal Criteria|5
4608963|NCT01683058|7464520|FG000|Overall Study|Withdrawal by Subject|7
4608964|NCT01683058|7464520|FG000|Overall Study|Lack of Efficacy|2
4608965|NCT01683071|7464531|FG000|Part 1|Lack of Efficacy|1
4639292|NCT01968070|7513168|FG007|Period 1|Adverse Event|0
4639293|NCT01968070|7513169|FG008|Period 1|Adverse Event|0
4608966|NCT01683071|7464532|FG001|Part 1|Lack of Efficacy|0
4608967|NCT01683071|7464533|FG002|Part 1|Lack of Efficacy|0
4608968|NCT01683071|7464534|FG003|Part 1|Lack of Efficacy|3
4608969|NCT01683071|7464535|FG004|Part 1|Lack of Efficacy|0
4608970|NCT01683071|7464536|FG005|Part 1|Lack of Efficacy|0
4639294|NCT01968070|7513170|FG009|Period 1|Adverse Event|0
4639295|NCT01968070|7513171|FG010|Period 1|Adverse Event|0
4639296|NCT01968070|7513172|FG011|Period 1|Adverse Event|0
4608971|NCT01683071|7464531|FG000|Part 1|Withdrawal by Subject|1
4608972|NCT01683071|7464532|FG001|Part 1|Withdrawal by Subject|2
4608973|NCT01683071|7464533|FG002|Part 1|Withdrawal by Subject|2
4608974|NCT01683071|7464534|FG003|Part 1|Withdrawal by Subject|1
4608975|NCT01683071|7464535|FG004|Part 1|Withdrawal by Subject|0
4608976|NCT01683071|7464536|FG005|Part 1|Withdrawal by Subject|0
4608977|NCT01683071|7464531|FG000|Part 1|Surgery Cancelled|1
4608978|NCT01683071|7464532|FG001|Part 1|Surgery Cancelled|0
4608979|NCT01683071|7464533|FG002|Part 1|Surgery Cancelled|0
4608980|NCT01683071|7464534|FG003|Part 1|Surgery Cancelled|0
4608981|NCT01683071|7464535|FG004|Part 1|Surgery Cancelled|0
4608982|NCT01683071|7464536|FG005|Part 1|Surgery Cancelled|0
4608983|NCT01683071|7464531|FG000|Part 1|Did not receive study drug|1
4608984|NCT01683071|7464532|FG001|Part 1|Did not receive study drug|0
4608985|NCT01683071|7464533|FG002|Part 1|Did not receive study drug|0
4608986|NCT01683071|7464534|FG003|Part 1|Did not receive study drug|1
4608987|NCT01683071|7464535|FG004|Part 1|Did not receive study drug|0
4608988|NCT01683071|7464536|FG005|Part 1|Did not receive study drug|0
4608989|NCT01683071|7464531|FG000|Part 1|Early termination; met exclusion criteria|0
4608990|NCT01683071|7464532|FG001|Part 1|Early termination; met exclusion criteria|2
4608991|NCT01683071|7464533|FG002|Part 1|Early termination; met exclusion criteria|1
4608992|NCT01683071|7464534|FG003|Part 1|Early termination; met exclusion criteria|0
4608993|NCT01683071|7464535|FG004|Part 1|Early termination; met exclusion criteria|0
4608994|NCT01683071|7464536|FG005|Part 1|Early termination; met exclusion criteria|0
4608995|NCT01683071|7464531|FG000|Part 2|Lack of Efficacy|0
4608996|NCT01683071|7464532|FG001|Part 2|Lack of Efficacy|0
4608997|NCT01683071|7464533|FG002|Part 2|Lack of Efficacy|0
4608998|NCT01683071|7464534|FG003|Part 2|Lack of Efficacy|0
4608999|NCT01683071|7464535|FG004|Part 2|Lack of Efficacy|3
4609000|NCT01683071|7464536|FG005|Part 2|Lack of Efficacy|4
4609001|NCT01683071|7464531|FG000|Part 2|Lost to Follow-up|0
4609002|NCT01683071|7464532|FG001|Part 2|Lost to Follow-up|0
4609003|NCT01683071|7464533|FG002|Part 2|Lost to Follow-up|0
4609004|NCT01683071|7464534|FG003|Part 2|Lost to Follow-up|0
4609005|NCT01683071|7464535|FG004|Part 2|Lost to Follow-up|2
4609006|NCT01683071|7464536|FG005|Part 2|Lost to Follow-up|0
4609007|NCT01683071|7464531|FG000|Part 2|Withdrawal by Subject|0
4609008|NCT01683071|7464532|FG001|Part 2|Withdrawal by Subject|0
4609009|NCT01683071|7464533|FG002|Part 2|Withdrawal by Subject|0
4609010|NCT01683071|7464534|FG003|Part 2|Withdrawal by Subject|0
4609011|NCT01683071|7464535|FG004|Part 2|Withdrawal by Subject|3
4609012|NCT01683071|7464536|FG005|Part 2|Withdrawal by Subject|3
4609013|NCT01683071|7464531|FG000|Part 2|Surgery cancelled|0
4609014|NCT01683071|7464532|FG001|Part 2|Surgery cancelled|0
4609015|NCT01683071|7464533|FG002|Part 2|Surgery cancelled|0
4609016|NCT01683071|7464534|FG003|Part 2|Surgery cancelled|0
4609017|NCT01683071|7464535|FG004|Part 2|Surgery cancelled|4
4609018|NCT01683071|7464536|FG005|Part 2|Surgery cancelled|2
4609019|NCT01683071|7464531|FG000|Part 2|Did not receive study drug|0
4609020|NCT01683071|7464532|FG001|Part 2|Did not receive study drug|0
4609021|NCT01683071|7464533|FG002|Part 2|Did not receive study drug|0
4609022|NCT01683071|7464534|FG003|Part 2|Did not receive study drug|0
4609023|NCT01683071|7464535|FG004|Part 2|Did not receive study drug|2
4609024|NCT01683071|7464536|FG005|Part 2|Did not receive study drug|1
4609025|NCT01683071|7464531|FG000|Part 2|Met exclusion criterion|0
4609026|NCT01683071|7464532|FG001|Part 2|Met exclusion criterion|0
4609027|NCT01683071|7464533|FG002|Part 2|Met exclusion criterion|0
4609028|NCT01683071|7464534|FG003|Part 2|Met exclusion criterion|0
4609029|NCT01683071|7464535|FG004|Part 2|Met exclusion criterion|1
4609030|NCT01683071|7464536|FG005|Part 2|Met exclusion criterion|1
4609031|NCT01683071|7464531|FG000|Part 2|Protocol deviation|0
4609032|NCT01683071|7464532|FG001|Part 2|Protocol deviation|0
4609033|NCT01683071|7464533|FG002|Part 2|Protocol deviation|0
4609034|NCT01683071|7464534|FG003|Part 2|Protocol deviation|0
4609035|NCT01683071|7464535|FG004|Part 2|Protocol deviation|1
4609036|NCT01683071|7464536|FG005|Part 2|Protocol deviation|2
4609037|NCT01683071|7464531|FG000|Part 2|Withdrawal by investigator decision|0
4609038|NCT01683071|7464532|FG001|Part 2|Withdrawal by investigator decision|0
4609039|NCT01683071|7464533|FG002|Part 2|Withdrawal by investigator decision|0
4609040|NCT01683071|7464534|FG003|Part 2|Withdrawal by investigator decision|0
4609041|NCT01683071|7464535|FG004|Part 2|Withdrawal by investigator decision|1
4609042|NCT01683071|7464536|FG005|Part 2|Withdrawal by investigator decision|2
4609043|NCT01683266|7464558|FG000|Overall Study|Adverse Event|5
4609044|NCT01683266|7464559|FG001|Overall Study|Adverse Event|4
4609045|NCT01683266|7464558|FG000|Overall Study|Lack of Efficacy|5
4609046|NCT01683266|7464559|FG001|Overall Study|Lack of Efficacy|2
4609047|NCT01683266|7464558|FG000|Overall Study|Protocol Violation|13
4609048|NCT01683266|7464559|FG001|Overall Study|Protocol Violation|6
4609049|NCT01683266|7464558|FG000|Overall Study|Personal Reason|17
4609050|NCT01683266|7464559|FG001|Overall Study|Personal Reason|25
4609051|NCT01683266|7464558|FG000|Overall Study|Selection Criterion / Protocol Violation|7
4609052|NCT01683266|7464559|FG001|Overall Study|Selection Criterion / Protocol Violation|5
4609053|NCT01683266|7464558|FG000|Overall Study|Lost to Follow-up|5
4609054|NCT01683266|7464559|FG001|Overall Study|Lost to Follow-up|0
4609055|NCT01683266|7464558|FG000|Overall Study|Site Closure / Site Withdrawal|1
4609056|NCT01683266|7464559|FG001|Overall Study|Site Closure / Site Withdrawal|3
4609057|NCT01683266|7464558|FG000|Overall Study|Nonserious Hypoglycemia|0
4609058|NCT01683266|7464559|FG001|Overall Study|Nonserious Hypoglycemia|3
4609059|NCT01683266|7464558|FG000|Overall Study|Perceived Lack of Efficacy|1
4609060|NCT01683266|7464559|FG001|Overall Study|Perceived Lack of Efficacy|1
4609061|NCT01683266|7464558|FG000|Overall Study|Possibly Hypoglycemia|1
4609062|NCT01683266|7464559|FG001|Overall Study|Possibly Hypoglycemia|0
4609063|NCT01683266|7464558|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0
4609064|NCT01683266|7464559|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1
4609065|NCT01683383|7464576|FG000|Overall Study|Infant was not transported|1
4609066|NCT01683383|7464577|FG001|Overall Study|Infant was not transported|0
4609067|NCT01683409|7464588|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
4609068|NCT01683409|7464589|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
4609069|NCT01683409|7464590|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1
4609070|NCT01683409|7464591|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
4609071|NCT01683409|7464592|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
4609072|NCT01683409|7464588|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0
4609073|NCT01683409|7464589|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3
4609074|NCT01683409|7464590|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0
4609075|NCT01683409|7464591|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1
4609076|NCT01683409|7464592|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1
4609077|NCT01683409|7464588|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
4609078|NCT01683409|7464589|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1
4609079|NCT01683409|7464590|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
4609080|NCT01683409|7464591|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
4609081|NCT01683409|7464592|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
4609082|NCT01683409|7464588|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
4609083|NCT01683409|7464589|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
4609084|NCT01683409|7464590|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
4609085|NCT01683409|7464591|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1
4609086|NCT01683409|7464592|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1
4609087|NCT01683409|7464588|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
4609088|NCT01683409|7464589|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
4609089|NCT01683409|7464590|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1
4609090|NCT01683409|7464591|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
4609091|NCT01683409|7464592|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
4609092|NCT01683409|7464588|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1
4609093|NCT01683409|7464589|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
4609094|NCT01683409|7464590|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
4609095|NCT01683409|7464591|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1
4609096|NCT01683409|7464592|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
4609097|NCT01683409|7464588|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1
4609098|NCT01683409|7464589|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
4609099|NCT01683409|7464590|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
4609100|NCT01683409|7464591|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
4609101|NCT01683409|7464592|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1
4609102|NCT01683409|7464588|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1
4609103|NCT01683409|7464589|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0
4609104|NCT01683409|7464590|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0
4609105|NCT01683409|7464591|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0
4609106|NCT01683409|7464592|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0
4609107|NCT01683409|7464588|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0
4609108|NCT01683409|7464589|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4
4609109|NCT01683409|7464590|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0
4639297|NCT01968070|7513173|FG012|Period 1|Adverse Event|0
4639298|NCT01968070|7513174|FG013|Period 1|Adverse Event|0
4639299|NCT01968070|7513175|FG014|Period 1|Adverse Event|0
4639300|NCT01968070|7513176|FG015|Period 1|Adverse Event|0
4639301|NCT01968070|7513177|FG016|Period 1|Adverse Event|0
4639302|NCT01968070|7513178|FG017|Period 1|Adverse Event|0
4639303|NCT01968070|7513161|FG000|Period 1|Physician Decision|0
4639304|NCT01968070|7513162|FG001|Period 1|Physician Decision|0
4639305|NCT01968070|7513163|FG002|Period 1|Physician Decision|0
4639306|NCT01968070|7513164|FG003|Period 1|Physician Decision|0
4639307|NCT01968070|7513165|FG004|Period 1|Physician Decision|0
4639308|NCT01968070|7513166|FG005|Period 1|Physician Decision|0
4639309|NCT01968070|7513167|FG006|Period 1|Physician Decision|0
4639310|NCT01968070|7513168|FG007|Period 1|Physician Decision|0
4639311|NCT01968070|7513169|FG008|Period 1|Physician Decision|0
4639312|NCT01968070|7513170|FG009|Period 1|Physician Decision|0
4639313|NCT01968070|7513171|FG010|Period 1|Physician Decision|0
4639314|NCT01968070|7513172|FG011|Period 1|Physician Decision|1
4609110|NCT01683409|7464591|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1
4609111|NCT01683409|7464592|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2
4609112|NCT01683409|7464588|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0
4639315|NCT01968070|7513173|FG012|Period 1|Physician Decision|0
4639316|NCT01968070|7513174|FG013|Period 1|Physician Decision|0
4639317|NCT01968070|7513175|FG014|Period 1|Physician Decision|0
4639318|NCT01968070|7513176|FG015|Period 1|Physician Decision|0
4639319|NCT01968070|7513177|FG016|Period 1|Physician Decision|0
4639320|NCT01968070|7513178|FG017|Period 1|Physician Decision|0
4609113|NCT01683409|7464589|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0
4609114|NCT01683409|7464590|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0
4609115|NCT01683409|7464591|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0
4609116|NCT01683409|7464592|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3
4609117|NCT01683409|7464588|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0
4609118|NCT01683409|7464589|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0
4609119|NCT01683409|7464590|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1
4609120|NCT01683409|7464591|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0
4609121|NCT01683409|7464592|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0
4609122|NCT01683565|7464633|FG000|Overall Study|Lost to Follow-up|2
4609123|NCT01683565|7464634|FG001|Overall Study|Lost to Follow-up|0
4609124|NCT01683565|7464633|FG000|Overall Study|Discontinued Intervention|1
4609125|NCT01683565|7464634|FG001|Overall Study|Discontinued Intervention|1
4609126|NCT01683604|7464642|FG000|Overall Study|Adverse Event|2
4609127|NCT01683604|7464642|FG000|Overall Study|Lack of Efficacy|1
4609128|NCT01683604|7464642|FG000|Overall Study|Other|2
4609129|NCT01683838|7464666|FG000|Overall Study|Adverse Event|12
4609130|NCT01683838|7464667|FG001|Overall Study|Adverse Event|2
4609131|NCT01683838|7464666|FG000|Overall Study|Protocol Violation|3
4609132|NCT01683838|7464667|FG001|Overall Study|Protocol Violation|1
4609133|NCT01683838|7464666|FG000|Overall Study|Withdrawal by Subject|6
4609134|NCT01683838|7464667|FG001|Overall Study|Withdrawal by Subject|5
4609135|NCT01683838|7464666|FG000|Overall Study|Lost to Follow-up|1
4609136|NCT01683838|7464667|FG001|Overall Study|Lost to Follow-up|1
4609137|NCT01683838|7464666|FG000|Overall Study|Other|4
4609138|NCT01683838|7464667|FG001|Overall Study|Other|3
4609139|NCT01683994|7464678|FG000|Overall Study|Withdrawal by Subject|1
4609140|NCT01683994|7464679|FG001|Overall Study|Withdrawal by Subject|0
4609141|NCT01683994|7464680|FG002|Overall Study|Withdrawal by Subject|0
4609142|NCT01683994|7464681|FG003|Overall Study|Withdrawal by Subject|1
4609143|NCT01683994|7464682|FG004|Overall Study|Withdrawal by Subject|0
4609144|NCT01683994|7464678|FG000|Overall Study|Intercurrent illness|0
4609145|NCT01683994|7464679|FG001|Overall Study|Intercurrent illness|0
4609146|NCT01683994|7464680|FG002|Overall Study|Intercurrent illness|0
4609147|NCT01683994|7464681|FG003|Overall Study|Intercurrent illness|2
4609148|NCT01683994|7464682|FG004|Overall Study|Intercurrent illness|1
4609149|NCT01684033|7464718|FG000|Period 1, First 30 Days|Adverse Event|1
4609150|NCT01684033|7464719|FG001|Period 1, First 30 Days|Adverse Event|1
4609151|NCT01684033|7464718|FG000|Period 1, First 30 Days|Noncompliance|1
4609152|NCT01684033|7464719|FG001|Period 1, First 30 Days|Noncompliance|0
4609153|NCT01684033|7464718|FG000|Period 1, First 30 Days|Withdrawal by Subject|1
4609154|NCT01684033|7464719|FG001|Period 1, First 30 Days|Withdrawal by Subject|0
4609155|NCT01684033|7464718|FG000|Period 1, First 30 Days|Lost to Follow-up|1
4609156|NCT01684033|7464719|FG001|Period 1, First 30 Days|Lost to Follow-up|0
4609157|NCT01684033|7464718|FG000|Period 2, Second 30 Days|Adverse Event|1
4609158|NCT01684033|7464719|FG001|Period 2, Second 30 Days|Adverse Event|0
4609159|NCT01684046|7464725|FG000|Period 1, First 30 Days|Adverse Event|0
4609160|NCT01684046|7464726|FG001|Period 1, First 30 Days|Adverse Event|2
4609161|NCT01684202|7464736|FG000|Dose-escalation Period|Adverse Event|0
4609162|NCT01684202|7464737|FG001|Dose-escalation Period|Adverse Event|1
4609163|NCT01684202|7464738|FG002|Dose-escalation Period|Adverse Event|0
4609164|NCT01684202|7464739|FG003|Dose-escalation Period|Adverse Event|0
4609165|NCT01684202|7464736|FG000|Dose-escalation Period|Withdrawal by Subject|1
4609166|NCT01684202|7464737|FG001|Dose-escalation Period|Withdrawal by Subject|0
4609167|NCT01684202|7464738|FG002|Dose-escalation Period|Withdrawal by Subject|0
4609168|NCT01684202|7464739|FG003|Dose-escalation Period|Withdrawal by Subject|0
4609169|NCT01684202|7464736|FG000|Maintenance Period|Adverse Event|1
4609170|NCT01684202|7464737|FG001|Maintenance Period|Adverse Event|1
4609171|NCT01684202|7464738|FG002|Maintenance Period|Adverse Event|1
4609172|NCT01684202|7464739|FG003|Maintenance Period|Adverse Event|1
4609173|NCT01684202|7464736|FG000|Maintenance Period|Physician Decision|0
4609174|NCT01684202|7464737|FG001|Maintenance Period|Physician Decision|1
4609175|NCT01684202|7464738|FG002|Maintenance Period|Physician Decision|0
4609176|NCT01684202|7464739|FG003|Maintenance Period|Physician Decision|0
4609177|NCT01684202|7464736|FG000|Maintenance Period|Withdrawal by Subject|0
4609178|NCT01684202|7464737|FG001|Maintenance Period|Withdrawal by Subject|1
4609179|NCT01684202|7464738|FG002|Maintenance Period|Withdrawal by Subject|0
4609180|NCT01684202|7464739|FG003|Maintenance Period|Withdrawal by Subject|0
4609181|NCT01684215|7464753|FG000|Phase 1, Part 1|Adverse Event|1
4609182|NCT01684215|7464754|FG001|Phase 1, Part 1|Adverse Event|0
4609183|NCT01684215|7464755|FG002|Phase 1, Part 1|Adverse Event|0
4609184|NCT01684215|7464756|FG003|Phase 1, Part 1|Adverse Event|0
4609185|NCT01684215|7464753|FG000|Phase 1, Part 1|Objective progression or relapse|5
4609186|NCT01684215|7464754|FG001|Phase 1, Part 1|Objective progression or relapse|6
4609187|NCT01684215|7464755|FG002|Phase 1, Part 1|Objective progression or relapse|0
4609188|NCT01684215|7464756|FG003|Phase 1, Part 1|Objective progression or relapse|0
4609189|NCT01684215|7464753|FG000|Phase 1, Part 2|Adverse Event|0
4609190|NCT01684215|7464754|FG001|Phase 1, Part 2|Adverse Event|0
4609191|NCT01684215|7464755|FG002|Phase 1, Part 2|Adverse Event|1
4609192|NCT01684215|7464756|FG003|Phase 1, Part 2|Adverse Event|0
4609193|NCT01684215|7464753|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0
4609194|NCT01684215|7464754|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0
4609195|NCT01684215|7464755|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4
4609196|NCT01684215|7464756|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0
4609197|NCT01684215|7464753|FG000|Phase 1, Part 2|Withdrawal by Subject|0
4609198|NCT01684215|7464754|FG001|Phase 1, Part 2|Withdrawal by Subject|0
4609199|NCT01684215|7464755|FG002|Phase 1, Part 2|Withdrawal by Subject|1
4609200|NCT01684215|7464756|FG003|Phase 1, Part 2|Withdrawal by Subject|0
4609201|NCT01684215|7464753|FG000|Phase 2|Death|0
4609202|NCT01684215|7464754|FG001|Phase 2|Death|0
4609203|NCT01684215|7464755|FG002|Phase 2|Death|0
4609204|NCT01684215|7464756|FG003|Phase 2|Death|8
4609205|NCT01684215|7464753|FG000|Phase 2|Study terminated by sponsor|0
4609206|NCT01684215|7464754|FG001|Phase 2|Study terminated by sponsor|0
4609207|NCT01684215|7464755|FG002|Phase 2|Study terminated by sponsor|0
4609208|NCT01684215|7464756|FG003|Phase 2|Study terminated by sponsor|30
4609209|NCT01684215|7464753|FG000|Phase 2|Enrolled but not treated|0
4609210|NCT01684215|7464754|FG001|Phase 2|Enrolled but not treated|0
4609211|NCT01684215|7464755|FG002|Phase 2|Enrolled but not treated|0
4609212|NCT01684215|7464756|FG003|Phase 2|Enrolled but not treated|1
4609213|NCT01684215|7464753|FG000|Phase 2|Lost to Follow-up|0
4609214|NCT01684215|7464754|FG001|Phase 2|Lost to Follow-up|0
4609215|NCT01684215|7464755|FG002|Phase 2|Lost to Follow-up|0
4609216|NCT01684215|7464756|FG003|Phase 2|Lost to Follow-up|4
4609217|NCT01684423|7464787|FG000|Overall Study|Withdrawal by Subject|0
4609218|NCT01684423|7464788|FG001|Overall Study|Withdrawal by Subject|0
4609219|NCT01684423|7464789|FG002|Overall Study|Withdrawal by Subject|1
4609220|NCT01684423|7464790|FG003|Overall Study|Withdrawal by Subject|0
4609221|NCT01684423|7464791|FG004|Overall Study|Withdrawal by Subject|0
4609222|NCT01684722|7464831|FG000|Overall Study|Lost to Follow-up|78
4609223|NCT01684722|7464832|FG001|Overall Study|Lost to Follow-up|56
4609224|NCT01684722|7464833|FG002|Overall Study|Lost to Follow-up|75
4609225|NCT01684722|7464834|FG003|Overall Study|Lost to Follow-up|89
4609226|NCT01684722|7464831|FG000|Overall Study|Death|19
4609227|NCT01684722|7464832|FG001|Overall Study|Death|21
4609228|NCT01684722|7464833|FG002|Overall Study|Death|19
4609229|NCT01684722|7464834|FG003|Overall Study|Death|21
4609230|NCT01684878|7464873|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1
4609231|NCT01684878|7464874|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1
4609232|NCT01684878|7464875|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0
4609233|NCT01684878|7464876|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0
4609234|NCT01684878|7464873|FG000|Part 1: Safety Run in Phase|Death|15
4609235|NCT01684878|7464874|FG001|Part 1: Safety Run in Phase|Death|20
4609236|NCT01684878|7464875|FG002|Part 1: Safety Run in Phase|Death|0
4609237|NCT01684878|7464876|FG003|Part 1: Safety Run in Phase|Death|0
4609238|NCT01684878|7464873|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0
4609239|NCT01684878|7464874|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2
4609240|NCT01684878|7464875|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0
4609241|NCT01684878|7464876|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0
4609242|NCT01684878|7464873|FG000|Part 2: Randomized Phase|Participant withdrew consent|0
4609243|NCT01684878|7464874|FG001|Part 2: Randomized Phase|Participant withdrew consent|0
4609244|NCT01684878|7464875|FG002|Part 2: Randomized Phase|Participant withdrew consent|1
4609245|NCT01684878|7464876|FG003|Part 2: Randomized Phase|Participant withdrew consent|2
4609246|NCT01684878|7464873|FG000|Part 2: Randomized Phase|Lost to Follow-up|0
4609247|NCT01684878|7464874|FG001|Part 2: Randomized Phase|Lost to Follow-up|0
4609248|NCT01684878|7464875|FG002|Part 2: Randomized Phase|Lost to Follow-up|2
4609249|NCT01684878|7464876|FG003|Part 2: Randomized Phase|Lost to Follow-up|0
4609250|NCT01684878|7464873|FG000|Part 2: Randomized Phase|Death|0
4609251|NCT01684878|7464874|FG001|Part 2: Randomized Phase|Death|0
4609252|NCT01684878|7464875|FG002|Part 2: Randomized Phase|Death|62
4609253|NCT01684878|7464876|FG003|Part 2: Randomized Phase|Death|68
4609254|NCT01684878|7464873|FG000|Part 2: Randomized Phase|Alive at data-cut|0
4609255|NCT01684878|7464874|FG001|Part 2: Randomized Phase|Alive at data-cut|0
4609256|NCT01684878|7464875|FG002|Part 2: Randomized Phase|Alive at data-cut|13
4609257|NCT01684878|7464876|FG003|Part 2: Randomized Phase|Alive at data-cut|7
4609258|NCT01684878|7464873|FG000|Part 2: Randomized Phase|Participant noncompliance|0
4609259|NCT01684878|7464874|FG001|Part 2: Randomized Phase|Participant noncompliance|0
4609260|NCT01684878|7464875|FG002|Part 2: Randomized Phase|Participant noncompliance|0
4609261|NCT01684878|7464876|FG003|Part 2: Randomized Phase|Participant noncompliance|1
4609262|NCT01684930|7464905|FG000|Overall Study|Withdrawal by Subject|3
4609263|NCT01684930|7464906|FG001|Overall Study|Withdrawal by Subject|1
4609264|NCT01684943|7464915|FG000|Overall Study|Inadequate Venous Access|3
4609265|NCT01684943|7464916|FG001|Overall Study|Inadequate Venous Access|0
4609266|NCT01684943|7464917|FG002|Overall Study|Inadequate Venous Access|0
4609267|NCT01684943|7464915|FG000|Overall Study|Principal Investigator Determination|1
4609268|NCT01684943|7464916|FG001|Overall Study|Principal Investigator Determination|0
4609269|NCT01684943|7464917|FG002|Overall Study|Principal Investigator Determination|0
4609270|NCT01684943|7464915|FG000|Overall Study|Excluded from Analysis|1
4609271|NCT01684943|7464916|FG001|Overall Study|Excluded from Analysis|1
4609272|NCT01684943|7464917|FG002|Overall Study|Excluded from Analysis|1
4609273|NCT01684943|7464915|FG000|Overall Study|Lost to Follow-up|3
4609274|NCT01684943|7464916|FG001|Overall Study|Lost to Follow-up|0
4609275|NCT01684943|7464917|FG002|Overall Study|Lost to Follow-up|0
4609276|NCT01684943|7464915|FG000|Overall Study|Planning Pregnancy|1
4609277|NCT01684943|7464916|FG001|Overall Study|Planning Pregnancy|0
4609278|NCT01684943|7464917|FG002|Overall Study|Planning Pregnancy|0
4609279|NCT01685047|7464934|FG000|Overall Study|Withdrawal by Subject|20
4609280|NCT01685047|7464934|FG000|Overall Study|Death|26
4609281|NCT01685047|7464934|FG000|Overall Study|Lost to Follow-up|8
4609282|NCT01685047|7464934|FG000|Overall Study|Physician Decision|25
4609283|NCT01685047|7464934|FG000|Overall Study|Adverse Event|5
4609284|NCT01685047|7464934|FG000|Overall Study|patient withdrawn by sponsor|1
4609285|NCT01685060|7464938|FG000|Overall Study|Rollover patients|16
4609286|NCT01685060|7464938|FG000|Overall Study|Adverse Event|12
4609287|NCT01685060|7464938|FG000|Overall Study|Progressive disease|69
4609288|NCT01685060|7464938|FG000|Overall Study|Physician Decision|14
4609289|NCT01685060|7464938|FG000|Overall Study|Subject/guardian decision|20
4609290|NCT01685060|7464938|FG000|Overall Study|Lost to Follow-up|1
4609291|NCT01685060|7464938|FG000|Overall Study|Death|8
4639321|NCT01968070|7513161|FG000|Period 2|Withdrawal by Subject|0
4639322|NCT01968070|7513162|FG001|Period 2|Withdrawal by Subject|0
4639323|NCT01968070|7513163|FG002|Period 2|Withdrawal by Subject|0
4639324|NCT01968070|7513164|FG003|Period 2|Withdrawal by Subject|0
4639325|NCT01968070|7513165|FG004|Period 2|Withdrawal by Subject|1
4639326|NCT01968070|7513166|FG005|Period 2|Withdrawal by Subject|0
4639327|NCT01968070|7513167|FG006|Period 2|Withdrawal by Subject|0
4639328|NCT01968070|7513168|FG007|Period 2|Withdrawal by Subject|0
4639329|NCT01968070|7513169|FG008|Period 2|Withdrawal by Subject|0
4639330|NCT01968070|7513170|FG009|Period 2|Withdrawal by Subject|0
4639331|NCT01968070|7513171|FG010|Period 2|Withdrawal by Subject|0
4639332|NCT01968070|7513172|FG011|Period 2|Withdrawal by Subject|0
4639333|NCT01968070|7513173|FG012|Period 2|Withdrawal by Subject|0
4639334|NCT01968070|7513174|FG013|Period 2|Withdrawal by Subject|0
4639335|NCT01968070|7513175|FG014|Period 2|Withdrawal by Subject|0
4639336|NCT01968070|7513176|FG015|Period 2|Withdrawal by Subject|0
4639337|NCT01968070|7513177|FG016|Period 2|Withdrawal by Subject|0
4639338|NCT01968070|7513178|FG017|Period 2|Withdrawal by Subject|0
4639339|NCT01968213|7513227|FG000|Overall Study|Ongoing|90
4639340|NCT01968213|7513228|FG001|Overall Study|Ongoing|9
4639341|NCT01968434|7513308|FG000|Overall Study|Lost to Follow-up|3
4639342|NCT01968434|7513309|FG001|Overall Study|Lost to Follow-up|6
4639343|NCT01968551|7513327|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1
4639344|NCT01968551|7513328|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1
4639345|NCT01968551|7513329|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0
4639346|NCT01968551|7513327|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0
4639347|NCT01968551|7513328|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1
4639348|NCT01968551|7513329|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0
4639349|NCT01968551|7513327|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1
4639350|NCT01968551|7513328|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1
4639351|NCT01968551|7513329|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3
4639352|NCT01968551|7513327|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0
4639353|NCT01968551|7513328|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0
4639354|NCT01968551|7513329|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2
4639355|NCT01968551|7513327|FG000|Extension Phase|Adverse Event|0
4639356|NCT01968551|7513328|FG001|Extension Phase|Adverse Event|0
4639357|NCT01968551|7513329|FG002|Extension Phase|Adverse Event|2
4639358|NCT01968551|7513327|FG000|Extension Phase|Death|0
4639359|NCT01968551|7513328|FG001|Extension Phase|Death|1
4639360|NCT01968551|7513329|FG002|Extension Phase|Death|0
4639361|NCT01968551|7513327|FG000|Extension Phase|Withdrew Consent|0
4639362|NCT01968551|7513328|FG001|Extension Phase|Withdrew Consent|0
4639363|NCT01968551|7513329|FG002|Extension Phase|Withdrew Consent|1
4639364|NCT01968551|7513327|FG000|Extension Phase|Lost to Follow-up|1
4639365|NCT01968551|7513328|FG001|Extension Phase|Lost to Follow-up|0
4639366|NCT01968551|7513329|FG002|Extension Phase|Lost to Follow-up|1
4639367|NCT01968694|7513343|FG000|Washout (1 Month)|Lost to Follow-up|0
4639368|NCT01968694|7513344|FG001|Washout (1 Month)|Lost to Follow-up|1
4639369|NCT01968707|7513360|FG000|Overall Study|Did not meet treatment day baseline|49
4639370|NCT01968707|7513361|FG001|Overall Study|Did not meet treatment day baseline|12
4639371|NCT01968707|7513362|FG002|Overall Study|Did not meet treatment day baseline|41
4639372|NCT01968707|7513363|FG003|Overall Study|Did not meet treatment day baseline|44
4639373|NCT01968707|7513364|FG004|Overall Study|Did not meet treatment day baseline|36
4639374|NCT01968707|7513365|FG005|Overall Study|Did not meet treatment day baseline|11
4639375|NCT01968707|7513366|FG006|Overall Study|Did not meet treatment day baseline|34
4639376|NCT01968707|7513367|FG007|Overall Study|Did not meet treatment day baseline|35
4639377|NCT01968811|7513400|FG000|Overall Study|Protocol Violation|4
4639378|NCT01968811|7513400|FG000|Overall Study|post op.ref. of subject to other hospita|1
4639379|NCT01968954|7513406|FG000|Overall Study|Adverse Event|6
4639380|NCT01968954|7513407|FG001|Overall Study|Adverse Event|3
4639381|NCT01968954|7513406|FG000|Overall Study|Death|1
4639382|NCT01968954|7513407|FG001|Overall Study|Death|2
4639383|NCT01968954|7513406|FG000|Overall Study|Lost to Follow-up|6
4639384|NCT01968954|7513407|FG001|Overall Study|Lost to Follow-up|4
4639385|NCT01968954|7513406|FG000|Overall Study|Withdrawal by Subject|20
4639386|NCT01968954|7513407|FG001|Overall Study|Withdrawal by Subject|23
4639387|NCT01968954|7513406|FG000|Overall Study|Other|7
4639388|NCT01968954|7513407|FG001|Overall Study|Other|8
4639389|NCT01968954|7513406|FG000|Overall Study|Protocol Violation|0
4639390|NCT01968954|7513407|FG001|Overall Study|Protocol Violation|1
4639391|NCT01968954|7513406|FG000|Overall Study|Did not met inclusion criteria|0
4639392|NCT01968954|7513407|FG001|Overall Study|Did not met inclusion criteria|2
4639393|NCT01968967|7513416|FG000|Treatment Period|Other|22
4639394|NCT01968967|7513417|FG001|Treatment Period|Other|22
4639395|NCT01968967|7513418|FG002|Treatment Period|Other|0
4639396|NCT01968967|7513419|FG003|Treatment Period|Other|0
4639397|NCT01968967|7513420|FG004|Treatment Period|Other|0
4639398|NCT01968967|7513416|FG000|Treatment Period|Withdrawal by Subject|71
4639399|NCT01968967|7513417|FG001|Treatment Period|Withdrawal by Subject|61
4639400|NCT01968967|7513418|FG002|Treatment Period|Withdrawal by Subject|0
4639401|NCT01968967|7513419|FG003|Treatment Period|Withdrawal by Subject|0
4639402|NCT01968967|7513420|FG004|Treatment Period|Withdrawal by Subject|0
4639403|NCT01968967|7513416|FG000|Treatment Period|Did Not Meet Entrance Criteria|2
4639404|NCT01968967|7513417|FG001|Treatment Period|Did Not Meet Entrance Criteria|3
4639405|NCT01968967|7513418|FG002|Treatment Period|Did Not Meet Entrance Criteria|0
4639406|NCT01968967|7513419|FG003|Treatment Period|Did Not Meet Entrance Criteria|0
4639407|NCT01968967|7513420|FG004|Treatment Period|Did Not Meet Entrance Criteria|0
4639408|NCT01968967|7513416|FG000|Treatment Period|Lost to Follow-up|26
4639409|NCT01968967|7513417|FG001|Treatment Period|Lost to Follow-up|31
4639410|NCT01968967|7513418|FG002|Treatment Period|Lost to Follow-up|0
4639411|NCT01968967|7513419|FG003|Treatment Period|Lost to Follow-up|0
4639412|NCT01968967|7513420|FG004|Treatment Period|Lost to Follow-up|0
4639413|NCT01968967|7513416|FG000|Treatment Period|Protocol Violation|1
4639414|NCT01968967|7513417|FG001|Treatment Period|Protocol Violation|2
4639415|NCT01968967|7513418|FG002|Treatment Period|Protocol Violation|0
4639416|NCT01968967|7513419|FG003|Treatment Period|Protocol Violation|0
4639417|NCT01968967|7513420|FG004|Treatment Period|Protocol Violation|0
4639418|NCT01968967|7513416|FG000|Treatment Period|Adverse Event|9
4639419|NCT01968967|7513417|FG001|Treatment Period|Adverse Event|8
4639420|NCT01968967|7513418|FG002|Treatment Period|Adverse Event|0
4639421|NCT01968967|7513419|FG003|Treatment Period|Adverse Event|0
4639422|NCT01968967|7513420|FG004|Treatment Period|Adverse Event|0
4639423|NCT01968967|7513416|FG000|Treatment Period|Death|9
4639424|NCT01968967|7513417|FG001|Treatment Period|Death|2
4639425|NCT01968967|7513418|FG002|Treatment Period|Death|0
4639426|NCT01968967|7513419|FG003|Treatment Period|Death|0
4639427|NCT01968967|7513420|FG004|Treatment Period|Death|0
4639428|NCT01968967|7513416|FG000|Treatment Period|Randomized Not Treated|6
4639429|NCT01968967|7513417|FG001|Treatment Period|Randomized Not Treated|5
4639430|NCT01968967|7513418|FG002|Treatment Period|Randomized Not Treated|0
4639431|NCT01968967|7513419|FG003|Treatment Period|Randomized Not Treated|0
4639432|NCT01968967|7513420|FG004|Treatment Period|Randomized Not Treated|0
4639433|NCT01968967|7513416|FG000|Extension Period|Withdrew Consent|0
4639434|NCT01968967|7513417|FG001|Extension Period|Withdrew Consent|0
4639435|NCT01968967|7513418|FG002|Extension Period|Withdrew Consent|2
4639436|NCT01968967|7513419|FG003|Extension Period|Withdrew Consent|0
4639437|NCT01968967|7513420|FG004|Extension Period|Withdrew Consent|5
4639438|NCT01968980|7513436|FG000|Overall Study|Death|0
4639439|NCT01968980|7513437|FG001|Overall Study|Death|1
4639440|NCT01968980|7513436|FG000|Overall Study|Adverse Event|1
4639441|NCT01968980|7513437|FG001|Overall Study|Adverse Event|3
4639442|NCT01968980|7513436|FG000|Overall Study|Does not meet entry criteria|1
4639443|NCT01968980|7513437|FG001|Overall Study|Does not meet entry criteria|3
4639444|NCT01968980|7513436|FG000|Overall Study|Withdrawal by Subject|13
4639445|NCT01968980|7513437|FG001|Overall Study|Withdrawal by Subject|5
4639446|NCT01968980|7513436|FG000|Overall Study|Other unspecified|1
4639447|NCT01968980|7513437|FG001|Overall Study|Other unspecified|2
4639448|NCT01969058|7513446|FG000|Overall Study|Withdrawal by Subject|2
4639449|NCT01969058|7513447|FG001|Overall Study|Withdrawal by Subject|0
4639450|NCT01969058|7513446|FG000|Overall Study|Adverse Event|1
4639451|NCT01969058|7513447|FG001|Overall Study|Adverse Event|0
4639452|NCT01969084|7513455|FG000|Overall Study|Adverse Event|0
4639453|NCT01969084|7513456|FG001|Overall Study|Adverse Event|1
4747108|NCT00295490|7720341|FG001|Overall Study|Withdrawal by Subject|2
4747109|NCT00295490|7720342|FG002|Overall Study|Withdrawal by Subject|0
4747110|NCT00295490|7720343|FG003|Overall Study|Withdrawal by Subject|1
4747111|NCT00295490|7720340|FG000|Overall Study|Lost to Follow-up|0
4747112|NCT00295490|7720341|FG001|Overall Study|Lost to Follow-up|0
4747113|NCT00295490|7720342|FG002|Overall Study|Lost to Follow-up|1
4747114|NCT00295490|7720343|FG003|Overall Study|Lost to Follow-up|0
4747115|NCT00295490|7720340|FG000|Overall Study|Adverse Event|1
4747116|NCT00295490|7720341|FG001|Overall Study|Adverse Event|0
4747117|NCT00295490|7720342|FG002|Overall Study|Adverse Event|0
4747118|NCT00295490|7720343|FG003|Overall Study|Adverse Event|0
4747119|NCT00295490|7720340|FG000|Overall Study|Other|0
4747120|NCT00295490|7720341|FG001|Overall Study|Other|2
4747121|NCT00295490|7720342|FG002|Overall Study|Other|0
4747122|NCT00295490|7720343|FG003|Overall Study|Other|1
4747123|NCT00268463|7720355|FG000|Overall Study|study terminated due to low accrual|10
4639454|NCT01969500|7513513|FG000|Overall Study|Death|0
4639455|NCT01969500|7513514|FG001|Overall Study|Death|1
4639456|NCT01969500|7513513|FG000|Overall Study|extended hospitalization|1
4639457|NCT01969500|7513514|FG001|Overall Study|extended hospitalization|1
4639458|NCT01969721|7513533|FG000|Overall Study|Adverse Event|3
4639459|NCT01969721|7513534|FG001|Overall Study|Adverse Event|8
4639460|NCT01969721|7513535|FG002|Overall Study|Adverse Event|3
4639461|NCT01969721|7513536|FG003|Overall Study|Adverse Event|2
4639462|NCT01969721|7513533|FG000|Overall Study|Lack of Efficacy|0
4639463|NCT01969721|7513534|FG001|Overall Study|Lack of Efficacy|0
4639464|NCT01969721|7513535|FG002|Overall Study|Lack of Efficacy|1
4639465|NCT01969721|7513536|FG003|Overall Study|Lack of Efficacy|0
4639466|NCT01969721|7513533|FG000|Overall Study|Non compliant with protocol|1
4639467|NCT01969721|7513534|FG001|Overall Study|Non compliant with protocol|1
4639468|NCT01969721|7513535|FG002|Overall Study|Non compliant with protocol|0
4639469|NCT01969721|7513536|FG003|Overall Study|Non compliant with protocol|2
4639470|NCT01969721|7513533|FG000|Overall Study|Other not defined above|0
4639471|NCT01969721|7513534|FG001|Overall Study|Other not defined above|2
4639472|NCT01969721|7513535|FG002|Overall Study|Other not defined above|0
4639473|NCT01969721|7513536|FG003|Overall Study|Other not defined above|0
4639474|NCT01969721|7513533|FG000|Overall Study|Discontinued during washout periods.|0
4639475|NCT01969721|7513534|FG001|Overall Study|Discontinued during washout periods.|1
4639476|NCT01969721|7513535|FG002|Overall Study|Discontinued during washout periods.|1
4639477|NCT01969721|7513536|FG003|Overall Study|Discontinued during washout periods.|2
4639478|NCT01969799|7513565|FG000|Overall Study|Adverse Event|0
4639479|NCT01969799|7513566|FG001|Overall Study|Adverse Event|1
4639480|NCT01969799|7513565|FG000|Overall Study|Death|16
4639481|NCT01969799|7513566|FG001|Overall Study|Death|11
4639482|NCT01969799|7513565|FG000|Overall Study|Lost to Follow-up|0
4639483|NCT01969799|7513566|FG001|Overall Study|Lost to Follow-up|2
4639484|NCT01969799|7513565|FG000|Overall Study|Physician Decision|1
4639485|NCT01969799|7513566|FG001|Overall Study|Physician Decision|0
4639486|NCT01969851|7513575|FG000|Overall Study|Adverse Event|0
4639487|NCT01969851|7513576|FG001|Overall Study|Adverse Event|0
4639488|NCT01969851|7513577|FG002|Overall Study|Adverse Event|3
4639489|NCT01969851|7513575|FG000|Overall Study|Lack of Efficacy|0
4639490|NCT01969851|7513576|FG001|Overall Study|Lack of Efficacy|3
4639491|NCT01969851|7513577|FG002|Overall Study|Lack of Efficacy|1
4639492|NCT01969851|7513575|FG000|Overall Study|Withdrawal by Subject|1
4639493|NCT01969851|7513576|FG001|Overall Study|Withdrawal by Subject|0
4639494|NCT01969851|7513577|FG002|Overall Study|Withdrawal by Subject|1
4639495|NCT01969851|7513575|FG000|Overall Study|No effective dose in Titration period|0
4639496|NCT01969851|7513576|FG001|Overall Study|No effective dose in Titration period|0
4639497|NCT01969851|7513577|FG002|Overall Study|No effective dose in Titration period|1
4639498|NCT01969851|7513575|FG000|Overall Study|Sponsor decision|0
4639499|NCT01969851|7513576|FG001|Overall Study|Sponsor decision|0
4639500|NCT01969851|7513577|FG002|Overall Study|Sponsor decision|1
4639501|NCT01970007|7513589|FG000|Overall Study|Death|5
4639502|NCT01970007|7513589|FG000|Overall Study|Withdrawal by Subject|23
4639503|NCT01970007|7513589|FG000|Overall Study|Lost to Follow-up|24
4639504|NCT01970007|7513589|FG000|Overall Study|"Other endpoint"|3
4639505|NCT01970241|7513604|FG000|Overall Study|Withdrawal by Subject|2
4639506|NCT01970241|7513605|FG001|Overall Study|Withdrawal by Subject|0
4639507|NCT01970241|7513604|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15
4639508|NCT01970241|7513605|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8
4639509|NCT01970371|7513616|FG000|Overall Study|Death|8
4639510|NCT01970371|7513617|FG001|Overall Study|Death|13
4639511|NCT01970371|7513618|FG002|Overall Study|Death|12
4639512|NCT01970371|7513616|FG000|Overall Study|Lost to Follow-up|0
4639513|NCT01970371|7513617|FG001|Overall Study|Lost to Follow-up|0
4639514|NCT01970371|7513618|FG002|Overall Study|Lost to Follow-up|1
4639515|NCT01970397|7513630|FG000|Overall Study|Adverse Event|0
4639516|NCT01970397|7513631|FG001|Overall Study|Adverse Event|1
4639517|NCT01970397|7513630|FG000|Overall Study|Lost to Follow-up|0
4639518|NCT01970397|7513631|FG001|Overall Study|Lost to Follow-up|1
4639519|NCT01970397|7513630|FG000|Overall Study|Personal Reasons|1
4639520|NCT01970397|7513631|FG001|Overall Study|Personal Reasons|2
4639521|NCT01970397|7513630|FG000|Overall Study|Protocol Violation|1
4639522|NCT01970397|7513631|FG001|Overall Study|Protocol Violation|1
4639523|NCT01970475|7513639|FG000|Overall Study|Withdrawal by Subject|11
4639524|NCT01970475|7513640|FG001|Overall Study|Withdrawal by Subject|6
4639525|NCT01970475|7513639|FG000|Overall Study|Adverse Event|7
4639526|NCT01970475|7513640|FG001|Overall Study|Adverse Event|3
4639527|NCT01970475|7513639|FG000|Overall Study|Lost to Follow-up|2
4639528|NCT01970475|7513640|FG001|Overall Study|Lost to Follow-up|2
4639529|NCT01970475|7513639|FG000|Overall Study|Protocol Violation|1
4639530|NCT01970475|7513640|FG001|Overall Study|Protocol Violation|0
4639531|NCT01970488|7513648|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1
4639532|NCT01970488|7513649|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2
4639533|NCT01970488|7513650|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0
4639534|NCT01970488|7513651|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0
4639535|NCT01970488|7513652|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0
4639536|NCT01970488|7513648|FG000|Part 1: Through Week 16|Protocol Violation|1
4639537|NCT01970488|7513649|FG001|Part 1: Through Week 16|Protocol Violation|2
4639538|NCT01970488|7513650|FG002|Part 1: Through Week 16|Protocol Violation|0
4639539|NCT01970488|7513651|FG003|Part 1: Through Week 16|Protocol Violation|0
4639540|NCT01970488|7513652|FG004|Part 1: Through Week 16|Protocol Violation|0
4639541|NCT01970488|7513648|FG000|Part 1: Through Week 16|Adverse Event|6
4639542|NCT01970488|7513649|FG001|Part 1: Through Week 16|Adverse Event|5
4639543|NCT01970488|7513650|FG002|Part 1: Through Week 16|Adverse Event|0
4639544|NCT01970488|7513651|FG003|Part 1: Through Week 16|Adverse Event|0
4639545|NCT01970488|7513652|FG004|Part 1: Through Week 16|Adverse Event|0
4639546|NCT01970488|7513648|FG000|Part 1: Through Week 16|Withdrawal by Subject|3
4639547|NCT01970488|7513649|FG001|Part 1: Through Week 16|Withdrawal by Subject|2
4639548|NCT01970488|7513650|FG002|Part 1: Through Week 16|Withdrawal by Subject|0
4639549|NCT01970488|7513651|FG003|Part 1: Through Week 16|Withdrawal by Subject|0
4639550|NCT01970488|7513652|FG004|Part 1: Through Week 16|Withdrawal by Subject|0
4639551|NCT01970488|7513648|FG000|Part 1: Through Week 16|Lost to Follow-up|0
4639552|NCT01970488|7513649|FG001|Part 1: Through Week 16|Lost to Follow-up|2
4639553|NCT01970488|7513650|FG002|Part 1: Through Week 16|Lost to Follow-up|0
4639554|NCT01970488|7513651|FG003|Part 1: Through Week 16|Lost to Follow-up|0
4639555|NCT01970488|7513652|FG004|Part 1: Through Week 16|Lost to Follow-up|0
4639556|NCT01970488|7513648|FG000|Part 2: Post Week 16|Physician Decision|0
4639557|NCT01970488|7513649|FG001|Part 2: Post Week 16|Physician Decision|0
4639558|NCT01970488|7513650|FG002|Part 2: Post Week 16|Physician Decision|0
4639559|NCT01970488|7513651|FG003|Part 2: Post Week 16|Physician Decision|0
4639560|NCT01970488|7513652|FG004|Part 2: Post Week 16|Physician Decision|1
4639561|NCT01970488|7513648|FG000|Part 2: Post Week 16|Non-compliance|0
4639562|NCT01970488|7513649|FG001|Part 2: Post Week 16|Non-compliance|0
4639563|NCT01970488|7513650|FG002|Part 2: Post Week 16|Non-compliance|1
4639564|NCT01970488|7513651|FG003|Part 2: Post Week 16|Non-compliance|0
4639565|NCT01970488|7513652|FG004|Part 2: Post Week 16|Non-compliance|0
4639566|NCT01970488|7513648|FG000|Part 2: Post Week 16|Lack of Efficacy|0
4639567|NCT01970488|7513649|FG001|Part 2: Post Week 16|Lack of Efficacy|0
4639568|NCT01970488|7513650|FG002|Part 2: Post Week 16|Lack of Efficacy|2
4639569|NCT01970488|7513651|FG003|Part 2: Post Week 16|Lack of Efficacy|3
4639570|NCT01970488|7513652|FG004|Part 2: Post Week 16|Lack of Efficacy|1
4639571|NCT01970488|7513648|FG000|Part 2: Post Week 16|Adverse Event|0
4639572|NCT01970488|7513649|FG001|Part 2: Post Week 16|Adverse Event|0
4639573|NCT01970488|7513650|FG002|Part 2: Post Week 16|Adverse Event|5
4639574|NCT01970488|7513651|FG003|Part 2: Post Week 16|Adverse Event|1
4639575|NCT01970488|7513652|FG004|Part 2: Post Week 16|Adverse Event|1
4639576|NCT01970488|7513648|FG000|Part 2: Post Week 16|Withdrawal by Subject|0
4639577|NCT01970488|7513649|FG001|Part 2: Post Week 16|Withdrawal by Subject|0
4639578|NCT01970488|7513650|FG002|Part 2: Post Week 16|Withdrawal by Subject|8
4639579|NCT01970488|7513651|FG003|Part 2: Post Week 16|Withdrawal by Subject|3
4639580|NCT01970488|7513652|FG004|Part 2: Post Week 16|Withdrawal by Subject|3
4639581|NCT01970488|7513648|FG000|Part 2: Post Week 16|Lost to Follow-up|0
4639582|NCT01970488|7513649|FG001|Part 2: Post Week 16|Lost to Follow-up|0
4639583|NCT01970488|7513650|FG002|Part 2: Post Week 16|Lost to Follow-up|1
4639584|NCT01970488|7513651|FG003|Part 2: Post Week 16|Lost to Follow-up|1
4639585|NCT01970488|7513652|FG004|Part 2: Post Week 16|Lost to Follow-up|2
4639586|NCT01970527|7513669|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1
4639587|NCT01970527|7513670|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0
4639588|NCT01970527|7513669|FG000|Treatment|Disease progression|0
4639589|NCT01970527|7513670|FG001|Treatment|Disease progression|1
4639590|NCT01970527|7513669|FG000|Treatment|Participant did not tolerate Ipilimumab|0
4639591|NCT01970527|7513670|FG001|Treatment|Participant did not tolerate Ipilimumab|1
4639592|NCT01970527|7513669|FG000|Treatment|Death|0
4639593|NCT01970527|7513670|FG001|Treatment|Death|1
4639594|NCT01970527|7513669|FG000|Follow-up Clinic Visit|Disease progression|1
4639595|NCT01970527|7513670|FG001|Follow-up Clinic Visit|Disease progression|1
4639596|NCT01970527|7513669|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0
4639597|NCT01970527|7513670|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1
4639598|NCT01970527|7513669|FG000|Follow-up Clinic Visit|Lost to Follow-up|0
4639599|NCT01970527|7513670|FG001|Follow-up Clinic Visit|Lost to Follow-up|1
4639600|NCT01970540|7513682|FG000|Overall Study|Non-treatment-related AE|0
4639601|NCT01970540|7513683|FG001|Overall Study|Non-treatment-related AE|0
4639602|NCT01970540|7513684|FG002|Overall Study|Non-treatment-related AE|1
4639603|NCT01970540|7513682|FG000|Overall Study|Progressive disease|55
4639604|NCT01970540|7513683|FG001|Overall Study|Progressive disease|23
4639605|NCT01970540|7513684|FG002|Overall Study|Progressive disease|10
4639606|NCT01970540|7513682|FG000|Overall Study|Treatment delay over protocol|0
4639607|NCT01970540|7513683|FG001|Overall Study|Treatment delay over protocol|0
4639608|NCT01970540|7513684|FG002|Overall Study|Treatment delay over protocol|1
4639609|NCT01970540|7513682|FG000|Overall Study|Physician Decision|7
4639610|NCT01970540|7513683|FG001|Overall Study|Physician Decision|2
4639611|NCT01970540|7513684|FG002|Overall Study|Physician Decision|0
4639612|NCT01970540|7513682|FG000|Overall Study|Clinical progression|0
4639613|NCT01970540|7513683|FG001|Overall Study|Clinical progression|1
4639614|NCT01970540|7513684|FG002|Overall Study|Clinical progression|1
4639615|NCT01970540|7513682|FG000|Overall Study|End of study|2
4639616|NCT01970540|7513683|FG001|Overall Study|End of study|0
4639617|NCT01970540|7513684|FG002|Overall Study|End of study|2
4639618|NCT01970540|7513682|FG000|Overall Study|Adverse Event|0
4639619|NCT01970540|7513683|FG001|Overall Study|Adverse Event|2
4639620|NCT01970540|7513684|FG002|Overall Study|Adverse Event|1
4639621|NCT01970540|7513682|FG000|Overall Study|Treatment-related AE|4
4639622|NCT01970540|7513683|FG001|Overall Study|Treatment-related AE|0
4639623|NCT01970540|7513684|FG002|Overall Study|Treatment-related AE|2
4639624|NCT01970540|7513682|FG000|Overall Study|Withdrawal by Subject|4
4639625|NCT01970540|7513683|FG001|Overall Study|Withdrawal by Subject|0
4639626|NCT01970540|7513684|FG002|Overall Study|Withdrawal by Subject|1
4639627|NCT01970540|7513682|FG000|Overall Study|Clinical deterioration|1
4639628|NCT01970540|7513683|FG001|Overall Study|Clinical deterioration|0
4639629|NCT01970540|7513684|FG002|Overall Study|Clinical deterioration|0
4639630|NCT01970592|7513703|FG000|Overall Study|Withdrawal by Subject|4
4639631|NCT01970592|7513703|FG000|Overall Study|Physician Decision|1
4639632|NCT01970592|7513703|FG000|Overall Study|Adverse Event|1
4639633|NCT01970878|7513715|FG000|Overall Study|Withdrawal by Subject|11
4639634|NCT01970878|7513716|FG001|Overall Study|Withdrawal by Subject|10
4639635|NCT01970878|7513717|FG002|Overall Study|Withdrawal by Subject|14
4639636|NCT01970878|7513718|FG003|Overall Study|Withdrawal by Subject|7
4639637|NCT01970878|7513715|FG000|Overall Study|Lost to Follow-up|1
4639638|NCT01970878|7513716|FG001|Overall Study|Lost to Follow-up|3
4639639|NCT01970878|7513717|FG002|Overall Study|Lost to Follow-up|2
4639640|NCT01970878|7513718|FG003|Overall Study|Lost to Follow-up|4
4639641|NCT01970878|7513715|FG000|Overall Study|Administrative Reasons|1
4639642|NCT01970878|7513716|FG001|Overall Study|Administrative Reasons|0
4639643|NCT01970878|7513717|FG002|Overall Study|Administrative Reasons|0
4639644|NCT01970878|7513718|FG003|Overall Study|Administrative Reasons|4
4639645|NCT01970878|7513715|FG000|Overall Study|Lack of Efficacy|2
4639646|NCT01970878|7513716|FG001|Overall Study|Lack of Efficacy|1
4639647|NCT01970878|7513717|FG002|Overall Study|Lack of Efficacy|2
4639648|NCT01970878|7513718|FG003|Overall Study|Lack of Efficacy|0
4639649|NCT01970878|7513715|FG000|Overall Study|Adverse Event|12
4639650|NCT01970878|7513716|FG001|Overall Study|Adverse Event|7
4639651|NCT01970878|7513717|FG002|Overall Study|Adverse Event|4
4639652|NCT01970878|7513718|FG003|Overall Study|Adverse Event|3
4639653|NCT01970878|7513715|FG000|Overall Study|Protocol Specified Criteria|10
4639654|NCT01970878|7513716|FG001|Overall Study|Protocol Specified Criteria|4
4639655|NCT01970878|7513717|FG002|Overall Study|Protocol Specified Criteria|3
4639656|NCT01970878|7513718|FG003|Overall Study|Protocol Specified Criteria|6
4639657|NCT01970878|7513715|FG000|Overall Study|Physician Decision|0
4639658|NCT01970878|7513716|FG001|Overall Study|Physician Decision|1
4639659|NCT01970878|7513717|FG002|Overall Study|Physician Decision|1
4639660|NCT01970878|7513718|FG003|Overall Study|Physician Decision|0
4639661|NCT01970878|7513715|FG000|Overall Study|No Completion Status|0
4639662|NCT01970878|7513716|FG001|Overall Study|No Completion Status|1
4639663|NCT01970878|7513717|FG002|Overall Study|No Completion Status|0
4639664|NCT01970878|7513718|FG003|Overall Study|No Completion Status|0
4639665|NCT01970982|7513738|FG000|Overall Study|Withdrawal by Subject|0
4639666|NCT01970982|7513739|FG001|Overall Study|Withdrawal by Subject|0
4639667|NCT01970982|7513740|FG002|Overall Study|Withdrawal by Subject|2
4639668|NCT01970995|7513752|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
4639669|NCT01970995|7513753|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
4639670|NCT01970995|7513754|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
4639671|NCT01970995|7513752|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1
4639672|NCT01970995|7513753|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0
4639673|NCT01970995|7513754|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1
4639674|NCT01971203|7513769|FG000|Overall Study|Protocol Violation|3
4639675|NCT01971203|7513770|FG001|Overall Study|Protocol Violation|2
4639676|NCT01971203|7513769|FG000|Overall Study|Withdrawal by Subject|5
4639677|NCT01971203|7513770|FG001|Overall Study|Withdrawal by Subject|6
4639678|NCT01971203|7513769|FG000|Overall Study|Adverse Event|1
4639679|NCT01971203|7513770|FG001|Overall Study|Adverse Event|0
4639680|NCT01971346|7513785|FG000|Overall Study|Protocol Violation|3
4639681|NCT01971346|7513785|FG000|Overall Study|Lost to Follow-up|2
4639682|NCT01971346|7513785|FG000|Overall Study|Withdrawal by Subject|2
4639683|NCT01971346|7513785|FG000|Overall Study|Physician Decision|1
4639684|NCT01971476|7513816|FG000|Cohort 1: 2 to <12 Years|Other not defined|3
4639685|NCT01971476|7513817|FG001|Cohort 1: 2 to <12 Years|Other not defined|3
4639686|NCT01971476|7513818|FG002|Cohort 1: 2 to <12 Years|Other not defined|6
4639687|NCT01971476|7513816|FG000|Cohort 2: 12 to <18 Years|Other not defined|6
4639688|NCT01971476|7513817|FG001|Cohort 2: 12 to <18 Years|Other not defined|3
4639689|NCT01971476|7513818|FG002|Cohort 2: 12 to <18 Years|Other not defined|0
4639690|NCT01971476|7513816|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0
4639691|NCT01971476|7513817|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1
4639692|NCT01971476|7513818|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0
4639693|NCT01971554|7513839|FG000|Overall Study|Lost to Follow-up|1
4639694|NCT01971554|7513840|FG001|Overall Study|Lost to Follow-up|0
4639695|NCT01971554|7513841|FG002|Overall Study|Lost to Follow-up|0
4639696|NCT01971554|7513842|FG003|Overall Study|Lost to Follow-up|0
4639697|NCT01971567|7513854|FG000|Overall Study|Withdrawal by Subject|3
4639698|NCT01971567|7513855|FG001|Overall Study|Withdrawal by Subject|2
4639699|NCT01971567|7513854|FG000|Overall Study|Lost to Follow-up|1
4639700|NCT01971567|7513855|FG001|Overall Study|Lost to Follow-up|0
4639701|NCT01971645|7513880|FG000|Overall Study|Adverse Event|1
4639702|NCT01971645|7513881|FG001|Overall Study|Adverse Event|0
4639703|NCT01971645|7513882|FG002|Overall Study|Adverse Event|0
4639704|NCT01971645|7513880|FG000|Overall Study|Lost to Follow-up|1
4639705|NCT01971645|7513881|FG001|Overall Study|Lost to Follow-up|0
4639706|NCT01971645|7513882|FG002|Overall Study|Lost to Follow-up|1
4639707|NCT01971645|7513880|FG000|Overall Study|Protocol Violation|0
4639708|NCT01971645|7513881|FG001|Overall Study|Protocol Violation|0
4639709|NCT01971645|7513882|FG002|Overall Study|Protocol Violation|1
4639710|NCT01971723|7513892|FG000|Overall Study|Withdrawal by Subject|1
4639711|NCT01971723|7513893|FG001|Overall Study|Withdrawal by Subject|1
4639712|NCT01971723|7513892|FG000|Overall Study|Protocol Violation|1
4639713|NCT01971723|7513893|FG001|Overall Study|Protocol Violation|2
4639714|NCT01972074|7513915|FG000|Overall Study|Adverse Event|4
4639715|NCT01972074|7513916|FG001|Overall Study|Adverse Event|1
4639716|NCT01972074|7513917|FG002|Overall Study|Adverse Event|0
4639717|NCT01972074|7513915|FG000|Overall Study|Lack of Efficacy|1
4639718|NCT01972074|7513916|FG001|Overall Study|Lack of Efficacy|1
4639719|NCT01972074|7513917|FG002|Overall Study|Lack of Efficacy|0
4639720|NCT01972074|7513915|FG000|Overall Study|Lost to Follow-up|0
4639721|NCT01972074|7513916|FG001|Overall Study|Lost to Follow-up|1
4639722|NCT01972074|7513917|FG002|Overall Study|Lost to Follow-up|1
4639723|NCT01972074|7513915|FG000|Overall Study|Withdrawal by Subject|1
4639724|NCT01972074|7513916|FG001|Overall Study|Withdrawal by Subject|1
4639725|NCT01972074|7513917|FG002|Overall Study|Withdrawal by Subject|1
4639726|NCT01972074|7513915|FG000|Overall Study|Scanner Unavailable|0
4639727|NCT01972074|7513916|FG001|Overall Study|Scanner Unavailable|0
4639728|NCT01972074|7513917|FG002|Overall Study|Scanner Unavailable|1
4639729|NCT01972152|7513924|FG000|First Treatment Visit|Lost to Follow-up|0
4639730|NCT01972152|7513925|FG001|First Treatment Visit|Lost to Follow-up|1
4639731|NCT01972152|7513926|FG002|First Treatment Visit|Lost to Follow-up|0
4639732|NCT01972152|7513927|FG003|First Treatment Visit|Lost to Follow-up|0
4639733|NCT01972152|7513928|FG004|First Treatment Visit|Lost to Follow-up|0
4639734|NCT01972152|7513929|FG005|First Treatment Visit|Lost to Follow-up|0
4639735|NCT01972152|7513924|FG000|Second Treatment Visit|Protocol Violation|0
4639736|NCT01972152|7513925|FG001|Second Treatment Visit|Protocol Violation|1
4639737|NCT01972152|7513926|FG002|Second Treatment Visit|Protocol Violation|0
4639738|NCT01972152|7513927|FG003|Second Treatment Visit|Protocol Violation|0
4639739|NCT01972152|7513928|FG004|Second Treatment Visit|Protocol Violation|0
4639740|NCT01972152|7513929|FG005|Second Treatment Visit|Protocol Violation|0
4639741|NCT01972308|7513955|FG000|Overall Study|Withdrawal by Subject|0
4639742|NCT01972308|7513956|FG001|Overall Study|Withdrawal by Subject|1
4639743|NCT01972308|7513955|FG000|Overall Study|Lost to Follow-up|4
4639744|NCT01972308|7513956|FG001|Overall Study|Lost to Follow-up|6
4639745|NCT01972308|7513955|FG000|Overall Study|Death|4
4639746|NCT01972308|7513956|FG001|Overall Study|Death|1
4639747|NCT01972438|7513966|FG000|Baseline-Month 3 Crossover Period|Death|1
4639748|NCT01972438|7513967|FG001|Baseline-Month 3 Crossover Period|Death|0
4639749|NCT01972438|7513966|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1
4639750|NCT01972438|7513967|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0
4639751|NCT01972438|7513966|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0
4639752|NCT01972438|7513967|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1
4639753|NCT01972438|7513966|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1
4639754|NCT01972438|7513967|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2
4639755|NCT01972438|7513966|FG000|Months 3-6 Crossover Period|Early Study Closure|0
4639756|NCT01972438|7513967|FG001|Months 3-6 Crossover Period|Early Study Closure|1
4639757|NCT01972438|7513966|FG000|Months 6-12 Study Period|Death|1
4639758|NCT01972438|7513967|FG001|Months 6-12 Study Period|Death|0
4639759|NCT01972438|7513966|FG000|Months 6-12 Study Period|Early Study Closure|2
4639760|NCT01972438|7513967|FG001|Months 6-12 Study Period|Early Study Closure|2
4639761|NCT01972438|7513966|FG000|Post Month 12 Study Period|Early Study Closure|3
4639762|NCT01972438|7513967|FG001|Post Month 12 Study Period|Early Study Closure|4
4639763|NCT01972464|7513977|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2
4639764|NCT01972464|7513978|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3
4639765|NCT01972464|7513977|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1
4639766|NCT01972464|7513978|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0
4639767|NCT01972464|7513977|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0
4639768|NCT01972464|7513978|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1
4639769|NCT01972464|7513977|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1
4639770|NCT01972464|7513978|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1
4639771|NCT01972529|7513998|FG000|Overall Study|Adverse Event|0
4639772|NCT01972529|7513999|FG001|Overall Study|Adverse Event|1
4639773|NCT01972529|7514000|FG002|Overall Study|Adverse Event|0
4639774|NCT01972529|7514001|FG003|Overall Study|Adverse Event|0
4639775|NCT01972529|7513998|FG000|Overall Study|Lost to Follow-up|1
4639776|NCT01972529|7513999|FG001|Overall Study|Lost to Follow-up|0
4639777|NCT01972529|7514000|FG002|Overall Study|Lost to Follow-up|0
4639778|NCT01972529|7514001|FG003|Overall Study|Lost to Follow-up|0
4639779|NCT01972529|7513998|FG000|Overall Study|Participant Choice|0
4639780|NCT01972529|7513999|FG001|Overall Study|Participant Choice|1
4639781|NCT01972529|7514000|FG002|Overall Study|Participant Choice|0
4639782|NCT01972529|7514001|FG003|Overall Study|Participant Choice|0
4639783|NCT01972529|7513998|FG000|Overall Study|Withdrawl of Consent|1
4639784|NCT01972529|7513999|FG001|Overall Study|Withdrawl of Consent|2
4639785|NCT01972529|7514000|FG002|Overall Study|Withdrawl of Consent|0
4639786|NCT01972529|7514001|FG003|Overall Study|Withdrawl of Consent|1
4639787|NCT01972529|7513998|FG000|Overall Study|Other|0
4639788|NCT01972529|7513999|FG001|Overall Study|Other|0
4639789|NCT01972529|7514000|FG002|Overall Study|Other|0
4639790|NCT01972529|7514001|FG003|Overall Study|Other|2
4639791|NCT01972529|7513998|FG000|Overall Study|Not treated|0
4639792|NCT01972529|7513999|FG001|Overall Study|Not treated|1
4639793|NCT01972529|7514000|FG002|Overall Study|Not treated|2
4639794|NCT01972529|7514001|FG003|Overall Study|Not treated|1
4639795|NCT01972568|7514015|FG000|Overall Study|Other events|3
4639796|NCT01972568|7514016|FG001|Overall Study|Other events|0
4639797|NCT01972568|7514017|FG002|Overall Study|Other events|0
4639798|NCT01972568|7514015|FG000|Overall Study|Lack of Efficacy|0
4639799|NCT01972568|7514016|FG001|Overall Study|Lack of Efficacy|1
4639800|NCT01972568|7514017|FG002|Overall Study|Lack of Efficacy|2
4639801|NCT01972568|7514015|FG000|Overall Study|Protocol Violation|1
4639802|NCT01972568|7514016|FG001|Overall Study|Protocol Violation|2
4639803|NCT01972568|7514017|FG002|Overall Study|Protocol Violation|2
4639804|NCT01972568|7514015|FG000|Overall Study|Withdrawal by Subject|6
4639805|NCT01972568|7514016|FG001|Overall Study|Withdrawal by Subject|3
4639806|NCT01972568|7514017|FG002|Overall Study|Withdrawal by Subject|7
4639807|NCT01972568|7514015|FG000|Overall Study|Lost to Follow-up|1
4639808|NCT01972568|7514016|FG001|Overall Study|Lost to Follow-up|0
4639809|NCT01972568|7514017|FG002|Overall Study|Lost to Follow-up|0
4639810|NCT01972568|7514015|FG000|Overall Study|Adverse Event|5
4639811|NCT01972568|7514016|FG001|Overall Study|Adverse Event|6
4639812|NCT01972568|7514017|FG002|Overall Study|Adverse Event|5
4639813|NCT01972659|7514027|FG000|Overall Study|Protocol Violation|2
4639814|NCT01972659|7514028|FG001|Overall Study|Protocol Violation|2
4639815|NCT01972659|7514027|FG000|Overall Study|problems realted to acceleromyograph|2
4639816|NCT01972659|7514028|FG001|Overall Study|problems realted to acceleromyograph|1
4639817|NCT01972724|7514037|FG000|Double-Blind|Rescue Criteria Met|1
4639818|NCT01972724|7514038|FG001|Double-Blind|Rescue Criteria Met|0
4639819|NCT01972724|7514039|FG002|Double-Blind|Rescue Criteria Met|0
4639820|NCT01972724|7514037|FG000|Double-Blind|Adverse Event|1
4639821|NCT01972724|7514038|FG001|Double-Blind|Adverse Event|0
4639822|NCT01972724|7514039|FG002|Double-Blind|Adverse Event|0
4639823|NCT01972724|7514037|FG000|Double-Blind|Withdrawal of Consent|2
4639824|NCT01972724|7514038|FG001|Double-Blind|Withdrawal of Consent|1
4639825|NCT01972724|7514039|FG002|Double-Blind|Withdrawal of Consent|0
4639826|NCT01972724|7514037|FG000|Double-Blind|Significant Protocol Deviation|5
4639827|NCT01972724|7514038|FG001|Double-Blind|Significant Protocol Deviation|8
4639828|NCT01972724|7514039|FG002|Double-Blind|Significant Protocol Deviation|0
4639829|NCT01972724|7514037|FG000|Open-Label|Withdrew Consent|0
4639830|NCT01972724|7514038|FG001|Open-Label|Withdrew Consent|0
4639831|NCT01972724|7514039|FG002|Open-Label|Withdrew Consent|3
4639832|NCT01972724|7514037|FG000|Open-Label|Significant Protocol Deviation|0
4639833|NCT01972724|7514038|FG001|Open-Label|Significant Protocol Deviation|0
4639834|NCT01972724|7514039|FG002|Open-Label|Significant Protocol Deviation|2
4639835|NCT01972776|7514053|FG000|Part 1|Withdrawal by Subject|0
4639836|NCT01972776|7514054|FG001|Part 1|Withdrawal by Subject|0
4639837|NCT01972776|7514055|FG002|Part 1|Withdrawal by Subject|1
4639838|NCT01972776|7514056|FG003|Part 1|Withdrawal by Subject|0
4639839|NCT01972776|7514057|FG004|Part 1|Withdrawal by Subject|0
4639840|NCT01972776|7514058|FG005|Part 1|Withdrawal by Subject|0
4639841|NCT01972776|7514053|FG000|Part 1|Adverse Event|0
4639842|NCT01972776|7514054|FG001|Part 1|Adverse Event|0
4639843|NCT01972776|7514055|FG002|Part 1|Adverse Event|1
4639844|NCT01972776|7514056|FG003|Part 1|Adverse Event|1
4639845|NCT01972776|7514057|FG004|Part 1|Adverse Event|0
4639846|NCT01972776|7514058|FG005|Part 1|Adverse Event|0
4639847|NCT01972776|7514053|FG000|Part 2|Adverse Event|0
4639848|NCT01972776|7514054|FG001|Part 2|Adverse Event|0
4639849|NCT01972776|7514055|FG002|Part 2|Adverse Event|0
4639850|NCT01972776|7514056|FG003|Part 2|Adverse Event|0
4639851|NCT01972776|7514057|FG004|Part 2|Adverse Event|3
4639852|NCT01972776|7514058|FG005|Part 2|Adverse Event|0
4639853|NCT01972776|7514053|FG000|Part 2|Administrative problems|0
4639854|NCT01972776|7514054|FG001|Part 2|Administrative problems|0
4639855|NCT01972776|7514055|FG002|Part 2|Administrative problems|0
4639856|NCT01972776|7514056|FG003|Part 2|Administrative problems|0
4639857|NCT01972776|7514057|FG004|Part 2|Administrative problems|10
4639858|NCT01972776|7514058|FG005|Part 2|Administrative problems|7
4639859|NCT01972789|7514074|FG000|Overall Study|Adverse Event|11
4639860|NCT01972789|7514075|FG001|Overall Study|Adverse Event|4
4639861|NCT01972789|7514074|FG000|Overall Study|Subject withdrew consent|14
4639862|NCT01972789|7514075|FG001|Overall Study|Subject withdrew consent|12
4639863|NCT01972789|7514074|FG000|Overall Study|Lost to Follow-up|4
4639864|NCT01972789|7514075|FG001|Overall Study|Lost to Follow-up|7
4639865|NCT01972789|7514074|FG000|Overall Study|Death|7
4639866|NCT01972789|7514075|FG001|Overall Study|Death|5
4639867|NCT01972789|7514074|FG000|Overall Study|Protocol deviation|1
4639868|NCT01972789|7514075|FG001|Overall Study|Protocol deviation|0
4639869|NCT01972789|7514074|FG000|Overall Study|Physician Decision|3
4639870|NCT01972789|7514075|FG001|Overall Study|Physician Decision|2
4639871|NCT01972841|7514087|FG000|Overall Study|Randomized but Never Received Treatment|2
4639872|NCT01972841|7514088|FG001|Overall Study|Randomized but Never Received Treatment|5
4639873|NCT01972841|7514089|FG002|Overall Study|Randomized but Never Received Treatment|4
4639874|NCT01972841|7514090|FG003|Overall Study|Randomized but Never Received Treatment|2
4639875|NCT01972841|7514091|FG004|Overall Study|Randomized but Never Received Treatment|6
4639876|NCT01972841|7514092|FG005|Overall Study|Randomized but Never Received Treatment|13
4639877|NCT01972841|7514087|FG000|Overall Study|Adverse Event|13
4639878|NCT01972841|7514088|FG001|Overall Study|Adverse Event|8
4639879|NCT01972841|7514089|FG002|Overall Study|Adverse Event|12
4639880|NCT01972841|7514090|FG003|Overall Study|Adverse Event|9
4639881|NCT01972841|7514091|FG004|Overall Study|Adverse Event|21
4639882|NCT01972841|7514092|FG005|Overall Study|Adverse Event|26
4639883|NCT01972841|7514087|FG000|Overall Study|Lack of Efficacy|1
4639884|NCT01972841|7514088|FG001|Overall Study|Lack of Efficacy|0
4639885|NCT01972841|7514089|FG002|Overall Study|Lack of Efficacy|0
4639886|NCT01972841|7514090|FG003|Overall Study|Lack of Efficacy|2
4639887|NCT01972841|7514091|FG004|Overall Study|Lack of Efficacy|4
4639888|NCT01972841|7514092|FG005|Overall Study|Lack of Efficacy|1
4639889|NCT01972841|7514087|FG000|Overall Study|Lost to Follow-up|4
4639890|NCT01972841|7514088|FG001|Overall Study|Lost to Follow-up|2
4639891|NCT01972841|7514089|FG002|Overall Study|Lost to Follow-up|4
4639892|NCT01972841|7514090|FG003|Overall Study|Lost to Follow-up|2
4639893|NCT01972841|7514091|FG004|Overall Study|Lost to Follow-up|9
4639894|NCT01972841|7514092|FG005|Overall Study|Lost to Follow-up|3
4639895|NCT01972841|7514087|FG000|Overall Study|Protocol Violation|2
4639896|NCT01972841|7514088|FG001|Overall Study|Protocol Violation|2
4639897|NCT01972841|7514089|FG002|Overall Study|Protocol Violation|3
4639898|NCT01972841|7514090|FG003|Overall Study|Protocol Violation|5
4639899|NCT01972841|7514091|FG004|Overall Study|Protocol Violation|9
4639900|NCT01972841|7514092|FG005|Overall Study|Protocol Violation|4
4639901|NCT01972841|7514087|FG000|Overall Study|Withdrawal by participants|21
4639902|NCT01972841|7514088|FG001|Overall Study|Withdrawal by participants|27
4639903|NCT01972841|7514089|FG002|Overall Study|Withdrawal by participants|23
4639904|NCT01972841|7514090|FG003|Overall Study|Withdrawal by participants|16
4639905|NCT01972841|7514091|FG004|Overall Study|Withdrawal by participants|33
4639906|NCT01972841|7514092|FG005|Overall Study|Withdrawal by participants|34
4639907|NCT01972841|7514087|FG000|Overall Study|Miscellaneous|0
4639908|NCT01972841|7514088|FG001|Overall Study|Miscellaneous|0
4639909|NCT01972841|7514089|FG002|Overall Study|Miscellaneous|4
4639910|NCT01972841|7514090|FG003|Overall Study|Miscellaneous|1
4639911|NCT01972841|7514091|FG004|Overall Study|Miscellaneous|0
4639912|NCT01972841|7514092|FG005|Overall Study|Miscellaneous|4
4639913|NCT01972841|7514087|FG000|Overall Study|Did not have end of treatment page|0
4639914|NCT01972841|7514088|FG001|Overall Study|Did not have end of treatment page|0
4639915|NCT01972841|7514089|FG002|Overall Study|Did not have end of treatment page|0
4639916|NCT01972841|7514090|FG003|Overall Study|Did not have end of treatment page|0
4639917|NCT01972841|7514091|FG004|Overall Study|Did not have end of treatment page|1
4639918|NCT01972841|7514092|FG005|Overall Study|Did not have end of treatment page|0
4639919|NCT01973218|7514127|FG000|Overall Study|Adverse Event|1
4639920|NCT01973218|7514128|FG001|Overall Study|Adverse Event|0
4639921|NCT01973218|7514127|FG000|Overall Study|Withdrawal by Subject|1
4639922|NCT01973218|7514128|FG001|Overall Study|Withdrawal by Subject|0
4639923|NCT01973231|7514138|FG000|Overall Study|Protocol Violation|1
4639924|NCT01973231|7514139|FG001|Overall Study|Protocol Violation|1
4639925|NCT01973231|7514138|FG000|Overall Study|Lost to Follow-up|1
4639926|NCT01973231|7514139|FG001|Overall Study|Lost to Follow-up|1
4639927|NCT01973231|7514138|FG000|Overall Study|unclassified|2
4639928|NCT01973231|7514139|FG001|Overall Study|unclassified|1
4639929|NCT01973231|7514138|FG000|Overall Study|Withdrawal by Subject|7
4639930|NCT01973231|7514139|FG001|Overall Study|Withdrawal by Subject|9
4639931|NCT01973283|7514145|FG000|Overall Study|Lost to Follow-up|4
4639932|NCT01973387|7514187|FG000|Overall Study|Adverse Event|14
4639933|NCT01973387|7514188|FG001|Overall Study|Adverse Event|4
4639934|NCT01973387|7514187|FG000|Overall Study|Withdrawal by Subject|7
4639935|NCT01973387|7514188|FG001|Overall Study|Withdrawal by Subject|4
4639936|NCT01973387|7514187|FG000|Overall Study|Study terminated by sponsor|63
4639937|NCT01973387|7514188|FG001|Overall Study|Study terminated by sponsor|0
4639938|NCT01973387|7514187|FG000|Overall Study|Progressive disease or relapse|16
4639939|NCT01973387|7514188|FG001|Overall Study|Progressive disease or relapse|5
4639940|NCT01973387|7514187|FG000|Overall Study|Death|4
4639941|NCT01973387|7514188|FG001|Overall Study|Death|3
4639942|NCT01973387|7514187|FG000|Overall Study|Randomized, not treated|2
4639943|NCT01973387|7514188|FG001|Overall Study|Randomized, not treated|2
4639944|NCT01973439|7514204|FG000|Overall Study|Lost samples from one PK Day|2
4639945|NCT01973439|7514204|FG000|Overall Study|Vomiting after commencing once daily|1
4639946|NCT01973439|7514204|FG000|Overall Study|PK curve incomplete|2
4639947|NCT01973491|7514208|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17
4639948|NCT01973491|7514208|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1
4639949|NCT01973491|7514208|FG000|Treatment Period (16 Weeks)|Adverse Event|1
4639950|NCT01973569|7514215|FG000|Overall Study|Adverse Event|9
4639951|NCT01973569|7514216|FG001|Overall Study|Adverse Event|2
4639952|NCT01973569|7514217|FG002|Overall Study|Adverse Event|4
4639953|NCT01973569|7514215|FG000|Overall Study|Protocol Violation|2
4639954|NCT01973569|7514216|FG001|Overall Study|Protocol Violation|1
4639955|NCT01973569|7514217|FG002|Overall Study|Protocol Violation|3
4639956|NCT01973569|7514215|FG000|Overall Study|Withdrawal by Subject|7
4639957|NCT01973569|7514216|FG001|Overall Study|Withdrawal by Subject|5
4639958|NCT01973569|7514217|FG002|Overall Study|Withdrawal by Subject|2
4639959|NCT01973569|7514215|FG000|Overall Study|Invasive dental treatment|3
4639960|NCT01973569|7514216|FG001|Overall Study|Invasive dental treatment|5
4639961|NCT01973569|7514217|FG002|Overall Study|Invasive dental treatment|6
4639962|NCT01973569|7514215|FG000|Overall Study|Prohibited concomitant d|1
4639963|NCT01973569|7514216|FG001|Overall Study|Prohibited concomitant d|5
4639964|NCT01973569|7514217|FG002|Overall Study|Prohibited concomitant d|0
4639965|NCT01973569|7514215|FG000|Overall Study|Disease progression|0
4639966|NCT01973569|7514216|FG001|Overall Study|Disease progression|3
4639967|NCT01973569|7514217|FG002|Overall Study|Disease progression|0
4639968|NCT01973569|7514215|FG000|Overall Study|Other|1
4639969|NCT01973569|7514216|FG001|Overall Study|Other|1
4747124|NCT00268463|7720356|FG001|Overall Study|study terminated due to low accrual|12
4747125|NCT00276419|7720373|FG000|First Intervention|Adverse Event|1
4639970|NCT01973569|7514217|FG002|Overall Study|Other|0
4639971|NCT01973569|7514215|FG000|Overall Study|Did not receive study drug|6
4639972|NCT01973569|7514216|FG001|Overall Study|Did not receive study drug|3
4639973|NCT01973569|7514217|FG002|Overall Study|Did not receive study drug|3
4639974|NCT01973595|7514229|FG000|Washout|Withdrawal by Subject|1
4639975|NCT01973595|7514230|FG001|Washout|Withdrawal by Subject|0
4639976|NCT01973595|7514231|FG002|Washout|Withdrawal by Subject|1
4639977|NCT01973595|7514232|FG003|Washout|Withdrawal by Subject|0
4639978|NCT01973998|7514279|FG000|Overall Study|Death|2
4639979|NCT01973998|7514280|FG001|Overall Study|Death|2
4639980|NCT01974141|7514314|FG000|Overall Study|Other Reasons|28
4639981|NCT01974141|7514315|FG001|Overall Study|Other Reasons|18
4639982|NCT01974141|7514314|FG000|Overall Study|Protocol Violation|2
4639983|NCT01974141|7514315|FG001|Overall Study|Protocol Violation|6
4639984|NCT01974141|7514314|FG000|Overall Study|Personal Reasons|21
4639985|NCT01974141|7514315|FG001|Overall Study|Personal Reasons|20
4639986|NCT01974141|7514314|FG000|Overall Study|Lost to Follow-up|38
4639987|NCT01974141|7514315|FG001|Overall Study|Lost to Follow-up|29
4639988|NCT01974141|7514314|FG000|Overall Study|Pregnancy|3
4639989|NCT01974141|7514315|FG001|Overall Study|Pregnancy|3
4639990|NCT01974141|7514314|FG000|Overall Study|Lack of Efficacy|0
4639991|NCT01974141|7514315|FG001|Overall Study|Lack of Efficacy|1
4639992|NCT01974141|7514314|FG000|Overall Study|Adverse Event|4
4639993|NCT01974141|7514315|FG001|Overall Study|Adverse Event|5
4639994|NCT01974323|7514332|FG000|Overall Study|Other Reasons|25
4639995|NCT01974323|7514333|FG001|Overall Study|Other Reasons|28
4639996|NCT01974323|7514332|FG000|Overall Study|Protocol Violation|2
4639997|NCT01974323|7514333|FG001|Overall Study|Protocol Violation|2
4639998|NCT01974323|7514332|FG000|Overall Study|Personal Reasons|15
4639999|NCT01974323|7514333|FG001|Overall Study|Personal Reasons|19
4640000|NCT01974323|7514332|FG000|Overall Study|Lost to Follow-up|45
4640001|NCT01974323|7514333|FG001|Overall Study|Lost to Follow-up|40
4640002|NCT01974323|7514332|FG000|Overall Study|Pregnancy|2
4640003|NCT01974323|7514333|FG001|Overall Study|Pregnancy|1
4640004|NCT01974323|7514332|FG000|Overall Study|Lack of Efficacy|1
4640005|NCT01974323|7514333|FG001|Overall Study|Lack of Efficacy|1
4640006|NCT01974323|7514332|FG000|Overall Study|Adverse Event|2
4640007|NCT01974323|7514333|FG001|Overall Study|Adverse Event|2
4640008|NCT01974752|7514479|FG000|Overall Study|Death|33
4640009|NCT01974752|7514480|FG001|Overall Study|Death|11
4640010|NCT01974752|7514479|FG000|Overall Study|Lost to Follow-up|2
4640011|NCT01974752|7514480|FG001|Overall Study|Lost to Follow-up|0
4640012|NCT01974752|7514479|FG000|Overall Study|Withdrawal by Subject|2
4640013|NCT01974752|7514480|FG001|Overall Study|Withdrawal by Subject|3
4640014|NCT01974752|7514479|FG000|Overall Study|Other Eligibility Criteria|0
4640015|NCT01974752|7514480|FG001|Overall Study|Other Eligibility Criteria|1
4640016|NCT01974817|7514486|FG000|Overall Study|Death|4
4640017|NCT01974817|7514486|FG000|Overall Study|Lost to Follow-up|2
4640018|NCT01974817|7514486|FG000|Overall Study|Protocol Violation|2
4640019|NCT01974895|7514492|FG000|Overall Study|Protocol Violation|1
4640020|NCT01974895|7514493|FG001|Overall Study|Protocol Violation|0
4640021|NCT01974895|7514492|FG000|Overall Study|Lost to Follow-up|4
4640022|NCT01974895|7514493|FG001|Overall Study|Lost to Follow-up|6
4640023|NCT01974895|7514492|FG000|Overall Study|Withdrawal by Subject|0
4640024|NCT01974895|7514493|FG001|Overall Study|Withdrawal by Subject|1
4640025|NCT01974895|7514492|FG000|Overall Study|Other (Missed Visit)|1
4640026|NCT01974895|7514493|FG001|Overall Study|Other (Missed Visit)|0
4640027|NCT01974895|7514492|FG000|Overall Study|Other (Reason unknown)|9
4640028|NCT01974895|7514493|FG001|Overall Study|Other (Reason unknown)|8
4640029|NCT01975220|7514512|FG000|Test Period 1|Not treated|0
4640030|NCT01975220|7514513|FG001|Test Period 1|Not treated|1
4640031|NCT01975220|7514514|FG002|Test Period 1|Not treated|0
4640032|NCT01975220|7514515|FG003|Test Period 1|Not treated|0
4640033|NCT01975220|7514516|FG004|Test Period 1|Not treated|0
4640034|NCT01975220|7514517|FG005|Test Period 1|Not treated|0
4747126|NCT00276419|7720374|FG001|First Intervention|Adverse Event|0
4640035|NCT01975246|7514534|FG000|Overall Study|Adverse Event|2
4640036|NCT01975246|7514535|FG001|Overall Study|Adverse Event|1
4640037|NCT01975246|7514534|FG000|Overall Study|Lack of Efficacy|1
4640038|NCT01975246|7514535|FG001|Overall Study|Lack of Efficacy|0
4640039|NCT01975246|7514534|FG000|Overall Study|Protocol Violation|1
4640040|NCT01975246|7514535|FG001|Overall Study|Protocol Violation|0
4640041|NCT01975246|7514534|FG000|Overall Study|Other than stated|0
4640042|NCT01975246|7514535|FG001|Overall Study|Other than stated|1
4640043|NCT01975285|7514543|FG000|Overall Study|Failed Block and follow up|2
4640044|NCT01975285|7514544|FG001|Overall Study|Failed Block and follow up|2
4640045|NCT01975376|7514552|FG000|Overall Study|Adverse Event|5
4640046|NCT01975376|7514553|FG001|Overall Study|Adverse Event|5
4640047|NCT01975376|7514552|FG000|Overall Study|Death|65
4640048|NCT01975376|7514553|FG001|Overall Study|Death|72
4640049|NCT01975376|7514552|FG000|Overall Study|Lost to Follow-up|70
4640050|NCT01975376|7514553|FG001|Overall Study|Lost to Follow-up|66
4640051|NCT01975376|7514552|FG000|Overall Study|Withdrew consent|68
4640052|NCT01975376|7514553|FG001|Overall Study|Withdrew consent|62
4640053|NCT01975376|7514552|FG000|Overall Study|Other|2
4640054|NCT01975376|7514553|FG001|Overall Study|Other|4
4640055|NCT01975376|7514552|FG000|Overall Study|Randomized, Not Treated|16
4640056|NCT01975376|7514553|FG001|Overall Study|Randomized, Not Treated|8
4640057|NCT01975389|7514561|FG000|Overall Study|Adverse Event|10
4640058|NCT01975389|7514562|FG001|Overall Study|Adverse Event|6
4640059|NCT01975389|7514561|FG000|Overall Study|Death|61
4640060|NCT01975389|7514562|FG001|Overall Study|Death|54
4640061|NCT01975389|7514561|FG000|Overall Study|Lost to Follow-up|81
4640062|NCT01975389|7514562|FG001|Overall Study|Lost to Follow-up|86
4640063|NCT01975389|7514561|FG000|Overall Study|Withdrawal by Subject|90
4640064|NCT01975389|7514562|FG001|Overall Study|Withdrawal by Subject|76
4640065|NCT01975389|7514561|FG000|Overall Study|Other|6
4640066|NCT01975389|7514562|FG001|Overall Study|Other|9
4640067|NCT01975389|7514561|FG000|Overall Study|Randomized, not treated|4
4640068|NCT01975389|7514562|FG001|Overall Study|Randomized, not treated|5
4640069|NCT01975428|7514570|FG000|Overall Study|Lost to Follow-up|17
4640070|NCT01975428|7514571|FG001|Overall Study|Lost to Follow-up|4
4640071|NCT01975428|7514570|FG000|Overall Study|Withdrawal by Subject|3
4640072|NCT01975428|7514571|FG001|Overall Study|Withdrawal by Subject|10
4640073|NCT01975675|7514598|FG000|Overall Study|Death|0
4640074|NCT01975675|7514599|FG001|Overall Study|Death|1
4640075|NCT01975675|7514600|FG002|Overall Study|Death|0
4640076|NCT01975675|7514601|FG003|Overall Study|Death|0
4640077|NCT01975701|7514611|FG000|Overall Study|Lost to Follow-up|1
4640078|NCT01975701|7514611|FG000|Overall Study|Death|23
4640079|NCT01975701|7514611|FG000|Overall Study|Physician Decision|1
4640080|NCT01975831|7514624|FG000|Overall Study|Adverse Event|1
4640081|NCT01975831|7514625|FG001|Overall Study|Adverse Event|2
4640082|NCT01975831|7514626|FG002|Overall Study|Adverse Event|2
4640083|NCT01975831|7514627|FG003|Overall Study|Adverse Event|0
4640084|NCT01975831|7514628|FG004|Overall Study|Adverse Event|1
4640085|NCT01975831|7514629|FG005|Overall Study|Adverse Event|1
4640086|NCT01975831|7514630|FG006|Overall Study|Adverse Event|3
4640087|NCT01975831|7514631|FG007|Overall Study|Adverse Event|4
4640088|NCT01975831|7514632|FG008|Overall Study|Adverse Event|1
4640089|NCT01975831|7514624|FG000|Overall Study|Death|1
4640090|NCT01975831|7514625|FG001|Overall Study|Death|1
4640091|NCT01975831|7514626|FG002|Overall Study|Death|0
4640092|NCT01975831|7514627|FG003|Overall Study|Death|0
4640093|NCT01975831|7514628|FG004|Overall Study|Death|1
4640094|NCT01975831|7514629|FG005|Overall Study|Death|0
4640095|NCT01975831|7514630|FG006|Overall Study|Death|1
4640096|NCT01975831|7514631|FG007|Overall Study|Death|0
4640097|NCT01975831|7514632|FG008|Overall Study|Death|0
4640098|NCT01975831|7514624|FG000|Overall Study|Progressive Disease|1
4640099|NCT01975831|7514625|FG001|Overall Study|Progressive Disease|3
4640100|NCT01975831|7514626|FG002|Overall Study|Progressive Disease|2
4640101|NCT01975831|7514627|FG003|Overall Study|Progressive Disease|4
4640102|NCT01975831|7514628|FG004|Overall Study|Progressive Disease|13
4640103|NCT01975831|7514629|FG005|Overall Study|Progressive Disease|9
4640104|NCT01975831|7514630|FG006|Overall Study|Progressive Disease|10
4640105|NCT01975831|7514631|FG007|Overall Study|Progressive Disease|8
4640106|NCT01975831|7514632|FG008|Overall Study|Progressive Disease|10
4640107|NCT01975831|7514624|FG000|Overall Study|Withdrawal by Subject|0
4640108|NCT01975831|7514625|FG001|Overall Study|Withdrawal by Subject|3
4640109|NCT01975831|7514626|FG002|Overall Study|Withdrawal by Subject|0
4640110|NCT01975831|7514627|FG003|Overall Study|Withdrawal by Subject|0
4640111|NCT01975831|7514628|FG004|Overall Study|Withdrawal by Subject|3
4640112|NCT01975831|7514629|FG005|Overall Study|Withdrawal by Subject|1
4640113|NCT01975831|7514630|FG006|Overall Study|Withdrawal by Subject|1
4640114|NCT01975831|7514631|FG007|Overall Study|Withdrawal by Subject|0
4640115|NCT01975831|7514632|FG008|Overall Study|Withdrawal by Subject|0
4640116|NCT01975831|7514624|FG000|Overall Study|Physician Decision|0
4640117|NCT01975831|7514625|FG001|Overall Study|Physician Decision|0
4640118|NCT01975831|7514626|FG002|Overall Study|Physician Decision|0
4640119|NCT01975831|7514627|FG003|Overall Study|Physician Decision|0
4640120|NCT01975831|7514628|FG004|Overall Study|Physician Decision|0
4640121|NCT01975831|7514629|FG005|Overall Study|Physician Decision|1
4640122|NCT01975831|7514630|FG006|Overall Study|Physician Decision|0
4640123|NCT01975831|7514631|FG007|Overall Study|Physician Decision|1
4640124|NCT01975831|7514632|FG008|Overall Study|Physician Decision|0
4640125|NCT01975831|7514624|FG000|Overall Study|Initiation of Subsequent Therapy|0
4640126|NCT01975831|7514625|FG001|Overall Study|Initiation of Subsequent Therapy|0
4640127|NCT01975831|7514626|FG002|Overall Study|Initiation of Subsequent Therapy|0
4640128|NCT01975831|7514627|FG003|Overall Study|Initiation of Subsequent Therapy|0
4640129|NCT01975831|7514628|FG004|Overall Study|Initiation of Subsequent Therapy|0
4640130|NCT01975831|7514629|FG005|Overall Study|Initiation of Subsequent Therapy|1
4640131|NCT01975831|7514630|FG006|Overall Study|Initiation of Subsequent Therapy|0
4640132|NCT01975831|7514631|FG007|Overall Study|Initiation of Subsequent Therapy|2
4640133|NCT01975831|7514632|FG008|Overall Study|Initiation of Subsequent Therapy|0
4640134|NCT01975831|7514624|FG000|Overall Study|Entered Hospice|0
4640135|NCT01975831|7514625|FG001|Overall Study|Entered Hospice|0
4640136|NCT01975831|7514626|FG002|Overall Study|Entered Hospice|0
4640137|NCT01975831|7514627|FG003|Overall Study|Entered Hospice|0
4640138|NCT01975831|7514628|FG004|Overall Study|Entered Hospice|0
4640139|NCT01975831|7514629|FG005|Overall Study|Entered Hospice|1
4640140|NCT01975831|7514630|FG006|Overall Study|Entered Hospice|0
4640141|NCT01975831|7514631|FG007|Overall Study|Entered Hospice|0
4640142|NCT01975831|7514632|FG008|Overall Study|Entered Hospice|0
4640143|NCT01975831|7514624|FG000|Overall Study|Unable to Treat Within Protocol Windows|0
4640144|NCT01975831|7514625|FG001|Overall Study|Unable to Treat Within Protocol Windows|0
4640145|NCT01975831|7514626|FG002|Overall Study|Unable to Treat Within Protocol Windows|0
4640146|NCT01975831|7514627|FG003|Overall Study|Unable to Treat Within Protocol Windows|0
4640147|NCT01975831|7514628|FG004|Overall Study|Unable to Treat Within Protocol Windows|0
4640148|NCT01975831|7514629|FG005|Overall Study|Unable to Treat Within Protocol Windows|0
4640149|NCT01975831|7514630|FG006|Overall Study|Unable to Treat Within Protocol Windows|1
4640150|NCT01975831|7514631|FG007|Overall Study|Unable to Treat Within Protocol Windows|0
4640151|NCT01975831|7514632|FG008|Overall Study|Unable to Treat Within Protocol Windows|1
4640152|NCT01975948|7514683|FG000|Overall Study|Withdrawal by Subject|17
4640153|NCT01975948|7514684|FG001|Overall Study|Withdrawal by Subject|21
4640154|NCT01975948|7514685|FG002|Overall Study|Withdrawal by Subject|7
4640155|NCT01975948|7514686|FG003|Overall Study|Withdrawal by Subject|6
4640156|NCT01976104|7514704|FG000|Overall Study|Adverse Event|0
4640157|NCT01976104|7514705|FG001|Overall Study|Adverse Event|0
4640158|NCT01976104|7514706|FG002|Overall Study|Adverse Event|1
4640159|NCT01976104|7514707|FG003|Overall Study|Adverse Event|0
4640160|NCT01976104|7514704|FG000|Overall Study|Lost to Follow-up|3
4640161|NCT01976104|7514705|FG001|Overall Study|Lost to Follow-up|0
4640162|NCT01976104|7514706|FG002|Overall Study|Lost to Follow-up|1
4640163|NCT01976104|7514707|FG003|Overall Study|Lost to Follow-up|1
4640164|NCT01976104|7514704|FG000|Overall Study|Subject Choice|0
4640165|NCT01976104|7514705|FG001|Overall Study|Subject Choice|1
4747127|NCT00276419|7720373|FG000|First Intervention|Withdrawal by Subject|0
4747128|NCT00276419|7720374|FG001|First Intervention|Withdrawal by Subject|2
4747129|NCT00271947|7720422|FG000|Overall Study|Lost to Follow-up|1
4747130|NCT00252174|7720442|FG000|Overall Study|Withdrawal by Subject|0
4747131|NCT00252174|7720443|FG001|Overall Study|Withdrawal by Subject|1
4747132|NCT00252174|7720444|FG002|Overall Study|Withdrawal by Subject|0
4747133|NCT00256295|7720452|FG000|Overall Study|Withdrawal by Subject|3
4640166|NCT01976104|7514706|FG002|Overall Study|Subject Choice|0
4640167|NCT01976104|7514707|FG003|Overall Study|Subject Choice|1
4640168|NCT01976104|7514704|FG000|Overall Study|Withdrawal by Subject|3
4640169|NCT01976104|7514705|FG001|Overall Study|Withdrawal by Subject|0
4640170|NCT01976104|7514706|FG002|Overall Study|Withdrawal by Subject|0
4640171|NCT01976104|7514707|FG003|Overall Study|Withdrawal by Subject|1
4640172|NCT01976104|7514704|FG000|Overall Study|Other|0
4640173|NCT01976104|7514705|FG001|Overall Study|Other|1
4640174|NCT01976104|7514706|FG002|Overall Study|Other|0
4640175|NCT01976104|7514707|FG003|Overall Study|Other|0
4640176|NCT01976299|7514720|FG000|Overall Study|Withdrawal by Subject|3
4640177|NCT01976299|7514721|FG001|Overall Study|Withdrawal by Subject|1
4640178|NCT01976299|7514720|FG000|Overall Study|Death|4
4640179|NCT01976299|7514721|FG001|Overall Study|Death|2
4640180|NCT01976299|7514720|FG000|Overall Study|Lost to Follow-up|7
4640181|NCT01976299|7514721|FG001|Overall Study|Lost to Follow-up|1
4640182|NCT01976299|7514720|FG000|Overall Study|See clarification above in comments|9
4747134|NCT00256295|7720452|FG000|Overall Study|Death|1
4747135|NCT00239720|7720466|FG000|Overall Study|Adverse Event|1
4640183|NCT01976299|7514721|FG001|Overall Study|See clarification above in comments|2
4747136|NCT00239720|7720467|FG001|Overall Study|Adverse Event|0
4747137|NCT00239720|7720466|FG000|Overall Study|Lost to Follow-up|0
4747138|NCT00239720|7720467|FG001|Overall Study|Lost to Follow-up|1
4747139|NCT00250718|7720473|FG000|Overall Study|Death|1
4747140|NCT00250718|7720473|FG000|Overall Study|Adverse Event|1
4747141|NCT00250718|7720473|FG000|Overall Study|Withdrawal by Subject|1
4640184|NCT01976312|7514729|FG000|Overall Study|Pregnancy|0
4640185|NCT01976312|7514730|FG001|Overall Study|Pregnancy|1
4640186|NCT01976312|7514729|FG000|Overall Study|Lost to Follow-up|2
4640187|NCT01976312|7514730|FG001|Overall Study|Lost to Follow-up|0
4640188|NCT01976312|7514729|FG000|Overall Study|Withdrawal by Subject|7
4640189|NCT01976312|7514730|FG001|Overall Study|Withdrawal by Subject|2
4640190|NCT01976312|7514729|FG000|Overall Study|Adverse Event|6
4640191|NCT01976312|7514730|FG001|Overall Study|Adverse Event|6
4640192|NCT01976312|7514729|FG000|Overall Study|Protocol Violation|2
4640193|NCT01976312|7514730|FG001|Overall Study|Protocol Violation|0
4640194|NCT01976338|7514739|FG000|Overall Study|Physician Decision|0
4640195|NCT01976338|7514740|FG001|Overall Study|Physician Decision|1
4640196|NCT01976338|7514739|FG000|Overall Study|Lost to Follow-up|3
4640197|NCT01976338|7514740|FG001|Overall Study|Lost to Follow-up|0
4640198|NCT01976338|7514739|FG000|Overall Study|Withdrawal by Subject|5
4640199|NCT01976338|7514740|FG001|Overall Study|Withdrawal by Subject|2
4640200|NCT01976338|7514739|FG000|Overall Study|Adverse Event|5
4640201|NCT01976338|7514740|FG001|Overall Study|Adverse Event|1
4640202|NCT01976364|7514747|FG000|Main Study (36 Months)|Adverse Event|63
4640203|NCT01976364|7514748|FG001|Main Study (36 Months)|Adverse Event|0
4640204|NCT01976364|7514749|FG002|Main Study (36 Months)|Adverse Event|0
4640205|NCT01976364|7514747|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5
4640206|NCT01976364|7514748|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0
4640207|NCT01976364|7514749|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0
4640208|NCT01976364|7514747|FG000|Main Study (36 Months)|Other|13
4640209|NCT01976364|7514748|FG001|Main Study (36 Months)|Other|0
4640210|NCT01976364|7514749|FG002|Main Study (36 Months)|Other|0
4640211|NCT01976364|7514747|FG000|Main Study (36 Months)|No longer met eligibility criteria|2
4640212|NCT01976364|7514748|FG001|Main Study (36 Months)|No longer met eligibility criteria|0
4640213|NCT01976364|7514749|FG002|Main Study (36 Months)|No longer met eligibility criteria|0
4640214|NCT01976364|7514747|FG000|Main Study (36 Months)|Medication error|1
4640215|NCT01976364|7514748|FG001|Main Study (36 Months)|Medication error|0
4640216|NCT01976364|7514749|FG002|Main Study (36 Months)|Medication error|0
4640217|NCT01976364|7514747|FG000|Main Study (36 Months)|Lost to Follow-up|10
4640218|NCT01976364|7514748|FG001|Main Study (36 Months)|Lost to Follow-up|0
4640219|NCT01976364|7514749|FG002|Main Study (36 Months)|Lost to Follow-up|0
4640220|NCT01976364|7514747|FG000|Main Study (36 Months)|Lack of Efficacy|40
4640221|NCT01976364|7514748|FG001|Main Study (36 Months)|Lack of Efficacy|0
4640222|NCT01976364|7514749|FG002|Main Study (36 Months)|Lack of Efficacy|0
4640223|NCT01976364|7514747|FG000|Main Study (36 Months)|Protocol Violation|13
4640224|NCT01976364|7514748|FG001|Main Study (36 Months)|Protocol Violation|0
4640225|NCT01976364|7514749|FG002|Main Study (36 Months)|Protocol Violation|0
4640226|NCT01976364|7514747|FG000|Main Study (36 Months)|Withdrawal by Subject|69
4640227|NCT01976364|7514748|FG001|Main Study (36 Months)|Withdrawal by Subject|0
4640228|NCT01976364|7514749|FG002|Main Study (36 Months)|Withdrawal by Subject|0
4640229|NCT01976364|7514747|FG000|Main Study (36 Months)|Death|5
4640230|NCT01976364|7514748|FG001|Main Study (36 Months)|Death|0
4640231|NCT01976364|7514749|FG002|Main Study (36 Months)|Death|0
4640232|NCT01976364|7514747|FG000|Sub-study (12 Months)|Lost to Follow-up|0
4640233|NCT01976364|7514748|FG001|Sub-study (12 Months)|Lost to Follow-up|1
4640234|NCT01976364|7514749|FG002|Sub-study (12 Months)|Lost to Follow-up|0
4640235|NCT01976364|7514747|FG000|Sub-study (12 Months)|Withdrawal by Subject|0
4640236|NCT01976364|7514748|FG001|Sub-study (12 Months)|Withdrawal by Subject|0
4640237|NCT01976364|7514749|FG002|Sub-study (12 Months)|Withdrawal by Subject|1
4640238|NCT01976364|7514747|FG000|Sub-study (12 Months)|Protocol Violation|0
4640239|NCT01976364|7514748|FG001|Sub-study (12 Months)|Protocol Violation|1
4640240|NCT01976364|7514749|FG002|Sub-study (12 Months)|Protocol Violation|1
4640241|NCT01976364|7514747|FG000|Sub-study (12 Months)|Adverse Event|0
4640242|NCT01976364|7514748|FG001|Sub-study (12 Months)|Adverse Event|4
4640243|NCT01976364|7514749|FG002|Sub-study (12 Months)|Adverse Event|3
4640244|NCT01976507|7514785|FG000|Overall Study|Adverse Event|6
4640245|NCT01976507|7514785|FG000|Overall Study|ablation not done, drug not given|1
4640246|NCT01976624|7514800|FG000|Overall Study|Participants contraindicated|2
4640247|NCT01976624|7514800|FG000|Overall Study|Participants age less than 19 years|12
4640248|NCT01976663|7514808|FG000|Overall Study|Completed 18 mos but no repeat treatment|24
4640249|NCT01976663|7514808|FG000|Overall Study|Personal Reasons|6
4640250|NCT01976663|7514808|FG000|Overall Study|Withdrawal by Subject|4
4640251|NCT01976663|7514808|FG000|Overall Study|Screen Failure|3
4640252|NCT01976663|7514808|FG000|Overall Study|Adverse Event|2
4640253|NCT01976663|7514808|FG000|Overall Study|Lost to Follow-up|3
4640254|NCT01976728|7514820|FG000|Overall Study|Subject missed multiple doses of IMP|1
4640255|NCT01976728|7514821|FG001|Overall Study|Subject missed multiple doses of IMP|0
4640256|NCT01976728|7514822|FG002|Overall Study|Subject missed multiple doses of IMP|0
4640257|NCT01976728|7514823|FG003|Overall Study|Subject missed multiple doses of IMP|0
4640258|NCT01976741|7514859|FG000|Overall Study|Withdrawal by Subject|1
4640259|NCT01976741|7514860|FG001|Overall Study|Withdrawal by Subject|0
4640260|NCT01976741|7514861|FG002|Overall Study|Withdrawal by Subject|1
4640261|NCT01976741|7514862|FG003|Overall Study|Withdrawal by Subject|1
4640262|NCT01976741|7514863|FG004|Overall Study|Withdrawal by Subject|0
4640263|NCT01976741|7514864|FG005|Overall Study|Withdrawal by Subject|0
4640264|NCT01976741|7514865|FG006|Overall Study|Withdrawal by Subject|1
4640265|NCT01976741|7514866|FG007|Overall Study|Withdrawal by Subject|4
4640266|NCT01976741|7514867|FG008|Overall Study|Withdrawal by Subject|0
4640267|NCT01976741|7514868|FG009|Overall Study|Withdrawal by Subject|0
4640268|NCT01976741|7514859|FG000|Overall Study|Adverse Event|0
4640269|NCT01976741|7514860|FG001|Overall Study|Adverse Event|0
4640270|NCT01976741|7514861|FG002|Overall Study|Adverse Event|2
4640271|NCT01976741|7514862|FG003|Overall Study|Adverse Event|0
4640272|NCT01976741|7514863|FG004|Overall Study|Adverse Event|0
4640273|NCT01976741|7514864|FG005|Overall Study|Adverse Event|0
4640274|NCT01976741|7514865|FG006|Overall Study|Adverse Event|3
4640275|NCT01976741|7514866|FG007|Overall Study|Adverse Event|8
4640276|NCT01976741|7514867|FG008|Overall Study|Adverse Event|1
4640277|NCT01976741|7514868|FG009|Overall Study|Adverse Event|4
4640278|NCT01976806|7514904|FG000|Overall Study|Lost to Follow-up|1
4640279|NCT01976806|7514905|FG001|Overall Study|Lost to Follow-up|4
4640280|NCT01976806|7514904|FG000|Overall Study|Adverse Event|1
4640281|NCT01976806|7514905|FG001|Overall Study|Adverse Event|1
4640282|NCT01976806|7514904|FG000|Overall Study|Withdrawal by Subject|1
4640283|NCT01976806|7514905|FG001|Overall Study|Withdrawal by Subject|1
4640284|NCT01976845|7514923|FG000|Overall Study|Physician Decision|8
4640285|NCT01976845|7514924|FG001|Overall Study|Physician Decision|8
4640286|NCT01976845|7514925|FG002|Overall Study|Physician Decision|3
4640287|NCT01977040|7514957|FG000|Overall Study|Vasa previa not confirmed|2
4640288|NCT01977092|7514967|FG000|Overall Study|Death|3
4640289|NCT01977092|7514968|FG001|Overall Study|Death|4
4640290|NCT01977092|7514967|FG000|Overall Study|Lost to Follow-up|23
4640291|NCT01977092|7514968|FG001|Overall Study|Lost to Follow-up|14
4640292|NCT01977092|7514967|FG000|Overall Study|Withdrawal by Subject|2
4640293|NCT01977092|7514968|FG001|Overall Study|Withdrawal by Subject|1
4640294|NCT01977092|7514967|FG000|Overall Study|In prison|3
4640295|NCT01977092|7514968|FG001|Overall Study|In prison|11
4640296|NCT01977222|7514974|FG000|Overall Study|Withdrawal by Subject|1
4640297|NCT01977352|7514980|FG000|Overall Study|Lost to Follow-up|1
4640298|NCT01977352|7514981|FG001|Overall Study|Lost to Follow-up|2
4640299|NCT01977456|7514987|FG000|Overall Study|Death|5
4640300|NCT01977482|7514997|FG000|Overall Study|Adverse Event|0
4640301|NCT01977482|7514998|FG001|Overall Study|Adverse Event|1
4640302|NCT01977482|7514999|FG002|Overall Study|Adverse Event|1
4640303|NCT01977482|7515000|FG003|Overall Study|Adverse Event|0
4640304|NCT01977482|7515001|FG004|Overall Study|Adverse Event|2
4640305|NCT01977482|7515002|FG005|Overall Study|Adverse Event|0
4640306|NCT01977482|7514997|FG000|Overall Study|Lost to Follow-up|1
4640307|NCT01977482|7514998|FG001|Overall Study|Lost to Follow-up|0
4640308|NCT01977482|7514999|FG002|Overall Study|Lost to Follow-up|0
4640309|NCT01977482|7515000|FG003|Overall Study|Lost to Follow-up|0
4640310|NCT01977482|7515001|FG004|Overall Study|Lost to Follow-up|0
4640311|NCT01977482|7515002|FG005|Overall Study|Lost to Follow-up|0
4640312|NCT01977482|7514997|FG000|Overall Study|Physician Decision|0
4640313|NCT01977482|7514998|FG001|Overall Study|Physician Decision|1
4640314|NCT01977482|7514999|FG002|Overall Study|Physician Decision|0
4640315|NCT01977482|7515000|FG003|Overall Study|Physician Decision|0
4640316|NCT01977482|7515001|FG004|Overall Study|Physician Decision|0
4640317|NCT01977482|7515002|FG005|Overall Study|Physician Decision|0
4640318|NCT01977482|7514997|FG000|Overall Study|Protocol Violation|0
4640319|NCT01977482|7514998|FG001|Overall Study|Protocol Violation|0
4640320|NCT01977482|7514999|FG002|Overall Study|Protocol Violation|1
4640321|NCT01977482|7515000|FG003|Overall Study|Protocol Violation|0
4640322|NCT01977482|7515001|FG004|Overall Study|Protocol Violation|0
4640323|NCT01977482|7515002|FG005|Overall Study|Protocol Violation|0
4640324|NCT01977482|7514997|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0
4640325|NCT01977482|7514998|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3
4640326|NCT01977482|7514999|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2
4640327|NCT01977482|7515000|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1
4640328|NCT01977482|7515001|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0
4640329|NCT01977482|7515002|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0
4640330|NCT01977482|7514997|FG000|Overall Study|Withdrawal by Subject|2
4640331|NCT01977482|7514998|FG001|Overall Study|Withdrawal by Subject|4
4640332|NCT01977482|7514999|FG002|Overall Study|Withdrawal by Subject|1
4640333|NCT01977482|7515000|FG003|Overall Study|Withdrawal by Subject|3
4640334|NCT01977482|7515001|FG004|Overall Study|Withdrawal by Subject|1
4640335|NCT01977482|7515002|FG005|Overall Study|Withdrawal by Subject|5
4640336|NCT01977573|7515034|FG000|Overall Study|Adverse Event|7
4640337|NCT01977573|7515035|FG001|Overall Study|Adverse Event|0
4640338|NCT01977573|7515036|FG002|Overall Study|Adverse Event|2
4640339|NCT01977573|7515037|FG003|Overall Study|Adverse Event|1
4640340|NCT01977573|7515034|FG000|Overall Study|Lost to Follow-up|1
4640341|NCT01977573|7515035|FG001|Overall Study|Lost to Follow-up|0
4640342|NCT01977573|7515036|FG002|Overall Study|Lost to Follow-up|0
4640343|NCT01977573|7515037|FG003|Overall Study|Lost to Follow-up|1
4640344|NCT01977573|7515034|FG000|Overall Study|Physician Decision|1
4640345|NCT01977573|7515035|FG001|Overall Study|Physician Decision|0
4640346|NCT01977573|7515036|FG002|Overall Study|Physician Decision|0
4640347|NCT01977573|7515037|FG003|Overall Study|Physician Decision|0
4640348|NCT01977573|7515034|FG000|Overall Study|Protocol Violation|3
4640349|NCT01977573|7515035|FG001|Overall Study|Protocol Violation|1
4640350|NCT01977573|7515036|FG002|Overall Study|Protocol Violation|0
4640351|NCT01977573|7515037|FG003|Overall Study|Protocol Violation|0
4640352|NCT01977573|7515034|FG000|Overall Study|Reached Defined Stopping Criteria|2
4640353|NCT01977573|7515035|FG001|Overall Study|Reached Defined Stopping Criteria|1
4640354|NCT01977573|7515036|FG002|Overall Study|Reached Defined Stopping Criteria|1
4640355|NCT01977573|7515037|FG003|Overall Study|Reached Defined Stopping Criteria|0
4640356|NCT01977573|7515034|FG000|Overall Study|Withdrawal by Subject|6
4640357|NCT01977573|7515035|FG001|Overall Study|Withdrawal by Subject|1
4640358|NCT01977573|7515036|FG002|Overall Study|Withdrawal by Subject|1
4640359|NCT01977573|7515037|FG003|Overall Study|Withdrawal by Subject|1
4640360|NCT01977612|7515059|FG000|Overall Study|Lost to Follow-up|1
4640361|NCT01977612|7515060|FG001|Overall Study|Lost to Follow-up|1
4640362|NCT01977625|7515066|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3
4640363|NCT01977625|7515067|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0
4640364|NCT01977625|7515066|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1
4640365|NCT01977625|7515067|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0
4640366|NCT01977651|7515075|FG000|4 Month Treatment Period|Adverse Event|34
4640367|NCT01977651|7515075|FG000|4 Month Treatment Period|Death|3
4640368|NCT01977651|7515075|FG000|4 Month Treatment Period|Progressive Disease|43
4640369|NCT01977651|7515075|FG000|4 Month Treatment Period|Withdrawal by Subject|17
4640370|NCT01977651|7515075|FG000|4 Month Treatment Period|Physician Decision|4
4640371|NCT01977651|7515075|FG000|1 Year Extension Period|Adverse Event|14
4640372|NCT01977651|7515075|FG000|1 Year Extension Period|Death|10
4640373|NCT01977651|7515075|FG000|1 Year Extension Period|Lost to Follow-up|2
4640374|NCT01977651|7515075|FG000|1 Year Extension Period|Progressive Disease|86
4640375|NCT01977651|7515075|FG000|1 Year Extension Period|Withdrawal by Subject|11
4640376|NCT01977651|7515075|FG000|1 Year Extension Period|Physician Decision|6
4640377|NCT01977651|7515075|FG000|1 Year Extension Period|Miscellaneous|1
4640378|NCT01977651|7515075|FG000|Post 1 Year Extension Period|Adverse Event|5
4640379|NCT01977651|7515075|FG000|Post 1 Year Extension Period|Death|13
4640380|NCT01977651|7515075|FG000|Post 1 Year Extension Period|Progressive Disease|60
4640381|NCT01977651|7515075|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13
4640382|NCT01977651|7515075|FG000|Post 1 Year Extension Period|Physician Decision|4
4640383|NCT01977651|7515075|FG000|Post 1 Year Extension Period|Miscellaneous|49
4640384|NCT01977677|7515082|FG000|Overall Study|Unrelated Adverse Event|0
4640385|NCT01977677|7515083|FG001|Overall Study|Unrelated Adverse Event|0
4747142|NCT00206375|7720521|FG000|Overall Study|Lost to Follow-up|1
4747143|NCT00206375|7720522|FG001|Overall Study|Lost to Follow-up|0
4747144|NCT00206375|7720523|FG002|Overall Study|Lost to Follow-up|0
4747145|NCT00206375|7720521|FG000|Overall Study|Withdrawal by Subject|2
4747146|NCT00206375|7720522|FG001|Overall Study|Withdrawal by Subject|1
4747147|NCT00206375|7720523|FG002|Overall Study|Withdrawal by Subject|3
4747148|NCT00206375|7720521|FG000|Overall Study|Study terminated due to lack of funds|0
4747149|NCT00206375|7720522|FG001|Overall Study|Study terminated due to lack of funds|1
4747150|NCT00206375|7720523|FG002|Overall Study|Study terminated due to lack of funds|1
4747151|NCT00229931|7720533|FG000|Overall Study|Death|1
4747152|NCT00229931|7720534|FG001|Overall Study|Death|0
4747153|NCT00229931|7720533|FG000|Overall Study|Lost to Follow-up|3
4747154|NCT00229931|7720534|FG001|Overall Study|Lost to Follow-up|2
4747155|NCT00209131|7720542|FG000|Overall Study|Lack of personnel due to turnovers.|15
4747156|NCT00209131|7720543|FG001|Overall Study|Lack of personnel due to turnovers.|11
4747157|NCT00209027|7720573|FG000|Overall Study|study terminated|10
4747158|NCT00209027|7720574|FG001|Overall Study|study terminated|0
4747159|NCT00182637|7720580|FG000|Overall Study|Adverse Event|2
4747160|NCT00182637|7720580|FG000|Overall Study|Disease Progression|1
4747161|NCT00176488|7720585|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1
4640386|NCT01977677|7515084|FG002|Overall Study|Unrelated Adverse Event|1
4640387|NCT01977690|7515094|FG000|Overall Study|Withdrawal by Subject|0
4640388|NCT01977690|7515095|FG001|Overall Study|Withdrawal by Subject|4
4640389|NCT01977794|7515112|FG000|Overall Study|Adverse Event|2
4640390|NCT01977794|7515113|FG001|Overall Study|Adverse Event|2
4640391|NCT01977794|7515112|FG000|Overall Study|Lost to Follow-up|2
4640392|NCT01977794|7515113|FG001|Overall Study|Lost to Follow-up|1
4640393|NCT01977794|7515112|FG000|Overall Study|Protocol Violation|1
4640394|NCT01977794|7515113|FG001|Overall Study|Protocol Violation|0
4640395|NCT01977794|7515112|FG000|Overall Study|Death|1
4640396|NCT01977794|7515113|FG001|Overall Study|Death|1
4640397|NCT01977794|7515112|FG000|Overall Study|Withdrew consent|2
4640398|NCT01977794|7515113|FG001|Overall Study|Withdrew consent|1
4640399|NCT01977794|7515112|FG000|Overall Study|Other|0
4640400|NCT01977794|7515113|FG001|Overall Study|Other|1
4640401|NCT01977820|7515121|FG000|Overall Study|Sponsor terminated the study|1
4640402|NCT01977820|7515122|FG001|Overall Study|Sponsor terminated the study|1
4640403|NCT01977846|7515130|FG000|Total Study - Prospective|Death|0
4640404|NCT01977846|7515131|FG001|Total Study - Prospective|Death|1
4640405|NCT01977846|7515130|FG000|Total Study - Prospective|Lost to Follow-up|0
4640406|NCT01977846|7515131|FG001|Total Study - Prospective|Lost to Follow-up|8
4640407|NCT01977846|7515130|FG000|Total Study - Prospective|Withdrawal by Subject|0
4640408|NCT01977846|7515131|FG001|Total Study - Prospective|Withdrawal by Subject|13
4640409|NCT01977846|7515130|FG000|Total Study - Prospective|Not available at time of visit|0
4640410|NCT01977846|7515131|FG001|Total Study - Prospective|Not available at time of visit|5
4640411|NCT01977846|7515130|FG000|Total Study - Prospective|No show|0
4640412|NCT01977846|7515131|FG001|Total Study - Prospective|No show|1
4640413|NCT01977846|7515130|FG000|Total Study - Prospective|Protocol Violation|0
4640414|NCT01977846|7515131|FG001|Total Study - Prospective|Protocol Violation|1
4640415|NCT01977898|7515140|FG000|Overall Study|Non functioning catheter|1
4640416|NCT01977898|7515141|FG001|Overall Study|Non functioning catheter|1
4640417|NCT01977937|7515149|FG000|Overall Study|Withdrawal by Subject|2
4640418|NCT01977937|7515150|FG001|Overall Study|Withdrawal by Subject|1
4640419|NCT01977937|7515149|FG000|Overall Study|Adverse Event|1
4640420|NCT01977937|7515150|FG001|Overall Study|Adverse Event|0
4640421|NCT01977937|7515149|FG000|Overall Study|Physician Decision|0
4640422|NCT01977937|7515150|FG001|Overall Study|Physician Decision|1
4640423|NCT01978093|7515158|FG000|Overall Study|Death|1
4640424|NCT01978093|7515159|FG001|Overall Study|Death|0
4640425|NCT01978093|7515158|FG000|Overall Study|Adverse Event|0
4640426|NCT01978093|7515159|FG001|Overall Study|Adverse Event|5
4640427|NCT01978093|7515158|FG000|Overall Study|Protocol Violation|8
4640428|NCT01978093|7515159|FG001|Overall Study|Protocol Violation|2
4640429|NCT01978093|7515158|FG000|Overall Study|Withdrawal by Subject|29
4640430|NCT01978093|7515159|FG001|Overall Study|Withdrawal by Subject|25
4640431|NCT01978093|7515158|FG000|Overall Study|Lost to Follow-up|11
4640432|NCT01978093|7515159|FG001|Overall Study|Lost to Follow-up|15
4640433|NCT01978093|7515158|FG000|Overall Study|Migrated/moved from study area|11
4640434|NCT01978093|7515159|FG001|Overall Study|Migrated/moved from study area|13
4640435|NCT01978093|7515158|FG000|Overall Study|Loss of kaiser coverage|4
4640436|NCT01978093|7515159|FG001|Overall Study|Loss of kaiser coverage|10
4640437|NCT01978093|7515158|FG000|Overall Study|Lost kaiser health plan unable to contac|1
4640438|NCT01978093|7515159|FG001|Overall Study|Lost kaiser health plan unable to contac|0
4640439|NCT01978093|7515158|FG000|Overall Study|Mother lost custody of child|0
4640440|NCT01978093|7515159|FG001|Overall Study|Mother lost custody of child|1
4640441|NCT01978093|7515158|FG000|Overall Study|Child was in care of grandmother|0
4640442|NCT01978093|7515159|FG001|Overall Study|Child was in care of grandmother|1
4640443|NCT01978093|7515158|FG000|Overall Study|N/A for vaccine administration|0
4640444|NCT01978093|7515159|FG001|Overall Study|N/A for vaccine administration|1
4640445|NCT01978119|7515168|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1
4640446|NCT01978119|7515169|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0
4640447|NCT01978119|7515168|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
4640448|NCT01978119|7515169|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
4640449|NCT01978119|7515168|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
4640450|NCT01978119|7515169|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2
4640451|NCT01978145|7515175|FG000|Treatment Period 1|Adverse Event|1
4640452|NCT01978145|7515176|FG001|Treatment Period 1|Adverse Event|9
4640453|NCT01978145|7515175|FG000|Treatment Period 1|Physician Decision|1
4640454|NCT01978145|7515176|FG001|Treatment Period 1|Physician Decision|0
4640455|NCT01978145|7515175|FG000|Treatment Period 1|Withdrawal by Subject|5
4640456|NCT01978145|7515176|FG001|Treatment Period 1|Withdrawal by Subject|4
4640457|NCT01978145|7515175|FG000|Treatment Period 1|Par. reached defined stopping criteria|2
4640458|NCT01978145|7515176|FG001|Treatment Period 1|Par. reached defined stopping criteria|3
4640459|NCT01978145|7515175|FG000|Washout Period 1|Adverse Event|0
4640460|NCT01978145|7515176|FG001|Washout Period 1|Adverse Event|1
4640461|NCT01978145|7515175|FG000|Washout Period 1|Withdrawal by Subject|1
4640462|NCT01978145|7515176|FG001|Washout Period 1|Withdrawal by Subject|1
4640463|NCT01978145|7515175|FG000|Washout Period 1|Par. reached defined stopping criteria|0
4640464|NCT01978145|7515176|FG001|Washout Period 1|Par. reached defined stopping criteria|1
4640465|NCT01978145|7515175|FG000|Treatment Period 2|Adverse Event|3
4640466|NCT01978145|7515176|FG001|Treatment Period 2|Adverse Event|3
4640467|NCT01978145|7515175|FG000|Treatment Period 2|Protocol Violation|0
4640468|NCT01978145|7515176|FG001|Treatment Period 2|Protocol Violation|1
4640469|NCT01978145|7515175|FG000|Treatment Period 2|Lost to Follow-up|1
4640470|NCT01978145|7515176|FG001|Treatment Period 2|Lost to Follow-up|1
4640471|NCT01978145|7515175|FG000|Treatment Period 2|Withdrawal by Subject|7
4640472|NCT01978145|7515176|FG001|Treatment Period 2|Withdrawal by Subject|4
4640473|NCT01978145|7515175|FG000|Treatment Period 2|Par. reached defined stopping criteria|8
4640474|NCT01978145|7515176|FG001|Treatment Period 2|Par. reached defined stopping criteria|5
4640475|NCT01978184|7515184|FG000|Overall Study|Progressive disease|5
4640476|NCT01978184|7515185|FG001|Overall Study|Progressive disease|5
4640477|NCT01978184|7515184|FG000|Overall Study|Other than PDA|2
4640478|NCT01978184|7515185|FG001|Overall Study|Other than PDA|2
4640479|NCT01978184|7515184|FG000|Overall Study|Physician Decision|0
4640480|NCT01978184|7515185|FG001|Overall Study|Physician Decision|3
4640481|NCT01978184|7515184|FG000|Overall Study|Noncompliance|1
4640482|NCT01978184|7515185|FG001|Overall Study|Noncompliance|2
4640483|NCT01978184|7515184|FG000|Overall Study|Death|1
4640484|NCT01978184|7515185|FG001|Overall Study|Death|0
4640485|NCT01978184|7515184|FG000|Overall Study|Withdrew- toxicities or physical decline|4
4640486|NCT01978184|7515185|FG001|Overall Study|Withdrew- toxicities or physical decline|8
4640487|NCT01978236|7515191|FG000|Overall Study|Discontinued due to study close|2
4640488|NCT01978262|7515195|FG000|Overall Study|Withdrawal by Subject|9
4640489|NCT01978262|7515195|FG000|Overall Study|Lost to Follow-up|2
4640490|NCT01978912|7515263|FG000|Overall Study|Adverse Event|0
4640491|NCT01978912|7515264|FG001|Overall Study|Adverse Event|1
4640492|NCT01978912|7515265|FG002|Overall Study|Adverse Event|0
4640493|NCT01978912|7515266|FG003|Overall Study|Adverse Event|0
4640494|NCT01978912|7515263|FG000|Overall Study|Lost to Follow-up|1
4640495|NCT01978912|7515264|FG001|Overall Study|Lost to Follow-up|1
4640496|NCT01978912|7515265|FG002|Overall Study|Lost to Follow-up|0
4640497|NCT01978912|7515266|FG003|Overall Study|Lost to Follow-up|1
4640498|NCT01978912|7515263|FG000|Overall Study|Withdrawal by Subject|1
4640499|NCT01978912|7515264|FG001|Overall Study|Withdrawal by Subject|0
4640500|NCT01978912|7515265|FG002|Overall Study|Withdrawal by Subject|2
4640501|NCT01978912|7515266|FG003|Overall Study|Withdrawal by Subject|2
4640502|NCT01978912|7515263|FG000|Overall Study|Lumbar Surgery|1
4640503|NCT01978912|7515264|FG001|Overall Study|Lumbar Surgery|0
4640504|NCT01978912|7515265|FG002|Overall Study|Lumbar Surgery|1
4640505|NCT01978912|7515266|FG003|Overall Study|Lumbar Surgery|0
4640506|NCT01978912|7515263|FG000|Overall Study|Intradiscal Steroid Injection|0
4640507|NCT01978912|7515264|FG001|Overall Study|Intradiscal Steroid Injection|1
4640508|NCT01978912|7515265|FG002|Overall Study|Intradiscal Steroid Injection|0
4640509|NCT01978912|7515266|FG003|Overall Study|Intradiscal Steroid Injection|0
4640510|NCT01979016|7515278|FG000|Overall Study|Withdrawal by Subject|2
4640511|NCT01979016|7515279|FG001|Overall Study|Withdrawal by Subject|0
4640512|NCT01979016|7515278|FG000|Overall Study|Adverse Event|0
4640513|NCT01979016|7515279|FG001|Overall Study|Adverse Event|1
4640514|NCT01979185|7515319|FG000|Period 2|Other|0
4640515|NCT01979185|7515320|FG001|Period 2|Other|1
4640516|NCT01979523|7515355|FG000|Overall Study|Withdrawal by Subject|1
4640517|NCT01979523|7515356|FG001|Overall Study|Withdrawal by Subject|0
4640518|NCT01979614|7515365|FG000|Overall Study|Adverse Event|1
4640519|NCT01979614|7515366|FG001|Overall Study|Adverse Event|1
4640520|NCT01979835|7515372|FG000|Primary Outcome SA Measurment|failed insertion|18
4640521|NCT01979835|7515372|FG000|Follow-up|Lost to Follow-up|32
4640522|NCT01979952|7515378|FG000|Overall Study|Adverse Event|4
4640523|NCT01979952|7515379|FG001|Overall Study|Adverse Event|5
4640524|NCT01979952|7515378|FG000|Overall Study|Protocol Violation|1
4640525|NCT01979952|7515379|FG001|Overall Study|Protocol Violation|0
4640526|NCT01979952|7515378|FG000|Overall Study|Withdrawal by Subject|2
4640527|NCT01979952|7515379|FG001|Overall Study|Withdrawal by Subject|1
4640528|NCT01979952|7515378|FG000|Overall Study|Other than specified above|1
4640529|NCT01979952|7515379|FG001|Overall Study|Other than specified above|0
4640530|NCT01980056|7515388|FG000|Overall Study|Death|1
4640531|NCT01980056|7515389|FG001|Overall Study|Death|1
4640532|NCT01980056|7515390|FG002|Overall Study|Death|0
4640533|NCT01980095|7515404|FG000|Overall Study|Lost to Follow-up|6
4640534|NCT01980095|7515405|FG001|Overall Study|Lost to Follow-up|7
4640535|NCT01980095|7515404|FG000|Overall Study|Withdrawal by Subject|2
4640536|NCT01980095|7515405|FG001|Overall Study|Withdrawal by Subject|3
4640537|NCT01980095|7515404|FG000|Overall Study|Poor compliance|5
4640538|NCT01980095|7515405|FG001|Overall Study|Poor compliance|0
4640539|NCT01980095|7515404|FG000|Overall Study|Safety issue|0
4640540|NCT01980095|7515405|FG001|Overall Study|Safety issue|1
4640541|NCT01980095|7515404|FG000|Overall Study|Study drug discontinued|1
4640542|NCT01980095|7515405|FG001|Overall Study|Study drug discontinued|0
4640543|NCT01980095|7515404|FG000|Overall Study|Randomized by mistake|1
4640544|NCT01980095|7515405|FG001|Overall Study|Randomized by mistake|0
4640545|NCT01980628|7515444|FG000|Overall Study|Adverse Event|12
4640546|NCT01980628|7515444|FG000|Overall Study|Physician Decision|5
4640547|NCT01980628|7515444|FG000|Overall Study|Withdrawal by Subject|4
4640548|NCT01980628|7515444|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42
4640549|NCT01980706|7515461|FG000|Overall Study|Withdrawal by Subject|9
4640550|NCT01980706|7515462|FG001|Overall Study|Withdrawal by Subject|6
4640551|NCT01980706|7515463|FG002|Overall Study|Withdrawal by Subject|2
4640552|NCT01980706|7515461|FG000|Overall Study|Adverse Event|1
4640553|NCT01980706|7515462|FG001|Overall Study|Adverse Event|2
4640554|NCT01980706|7515463|FG002|Overall Study|Adverse Event|5
4640555|NCT01980706|7515461|FG000|Overall Study|Lost to Follow-up|3
4640556|NCT01980706|7515462|FG001|Overall Study|Lost to Follow-up|4
4640557|NCT01980706|7515463|FG002|Overall Study|Lost to Follow-up|3
4640558|NCT01980706|7515461|FG000|Overall Study|miscellaneous|4
4640559|NCT01980706|7515462|FG001|Overall Study|miscellaneous|5
4640560|NCT01980706|7515463|FG002|Overall Study|miscellaneous|3
4640561|NCT01980888|7515482|FG000|Overall Study|Study Terminated by Sponsor|116
4640562|NCT01980888|7515483|FG001|Overall Study|Study Terminated by Sponsor|122
4640563|NCT01980888|7515482|FG000|Overall Study|Withdrew Consent|17
4640564|NCT01980888|7515483|FG001|Overall Study|Withdrew Consent|6
4640565|NCT01980888|7515482|FG000|Overall Study|Investigator's Discretion|8
4640566|NCT01980888|7515483|FG001|Overall Study|Investigator's Discretion|3
4640567|NCT01980888|7515482|FG000|Overall Study|Non-Compliance with Study Drug|3
4640568|NCT01980888|7515483|FG001|Overall Study|Non-Compliance with Study Drug|2
4640569|NCT01980992|7515496|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0
4640570|NCT01980992|7515497|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3
4640571|NCT01980992|7515496|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1
4640572|NCT01980992|7515497|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1
4640573|NCT01980992|7515496|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1
4640574|NCT01980992|7515497|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0
4640575|NCT01980992|7515496|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2
4640576|NCT01980992|7515497|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0
4640577|NCT01980992|7515496|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1
4640578|NCT01980992|7515497|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0
4640579|NCT01980992|7515496|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0
4640580|NCT01980992|7515497|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1
4640581|NCT01981109|7515519|FG000|Overall Study|Death|36
4640582|NCT01981109|7515519|FG000|Overall Study|Withdrawal by Subject|40
4640583|NCT01981109|7515519|FG000|Overall Study|Lost to Follow-up|9
4640584|NCT01981109|7515519|FG000|Overall Study|No Discontinuation Documentation|37
4640585|NCT01981109|7515519|FG000|Overall Study|Study Termination|100
4640586|NCT01981109|7515519|FG000|Overall Study|No data available|2
4640587|NCT01981122|7515526|FG000|Overall Study|Withdrawal by Subject|0
4640588|NCT01981122|7515527|FG001|Overall Study|Withdrawal by Subject|2
4640589|NCT01981122|7515526|FG000|Overall Study|Protocol Violation|0
4640590|NCT01981122|7515527|FG001|Overall Study|Protocol Violation|1
4640591|NCT01981122|7515526|FG000|Overall Study|Lost to Follow-up|0
4640592|NCT01981122|7515527|FG001|Overall Study|Lost to Follow-up|1
4640593|NCT01981122|7515526|FG000|Overall Study|Investigator Or Dendreon Discretion|0
4640594|NCT01981122|7515527|FG001|Overall Study|Investigator Or Dendreon Discretion|1
4640595|NCT01981122|7515526|FG000|Overall Study|Death|14
4640596|NCT01981122|7515527|FG001|Overall Study|Death|15
4640597|NCT01981187|7515533|FG000|Overall Study|Participant/guardian decision|2
4640598|NCT01981187|7515533|FG000|Overall Study|Physician Decision|1
4640599|NCT01981187|7515533|FG000|Overall Study|Disease progression|2
4640600|NCT01981187|7515533|FG000|Overall Study|Adverse Event|7
4640601|NCT01981356|7515539|FG000|Overall Study|Lost to Follow-up|4
4640602|NCT01981356|7515540|FG001|Overall Study|Lost to Follow-up|1
4640603|NCT01981356|7515539|FG000|Overall Study|Withdrawal by Subject|1
4640604|NCT01981356|7515540|FG001|Overall Study|Withdrawal by Subject|1
4640605|NCT01981356|7515539|FG000|Overall Study|Protocol Violation|2
4640606|NCT01981356|7515540|FG001|Overall Study|Protocol Violation|0
4640607|NCT01981473|7515550|FG000|Overall Study|Incorrect diagnosis of RA|0
4640608|NCT01981473|7515551|FG001|Overall Study|Incorrect diagnosis of RA|0
4640609|NCT01981473|7515552|FG002|Overall Study|Incorrect diagnosis of RA|1
4640610|NCT01981473|7515550|FG000|Overall Study|Received treatment for < 6 months|0
4640611|NCT01981473|7515551|FG001|Overall Study|Received treatment for < 6 months|0
4640612|NCT01981473|7515552|FG002|Overall Study|Received treatment for < 6 months|1
4640613|NCT01981473|7515550|FG000|Overall Study|Received treatment for >24 months|2
4640614|NCT01981473|7515551|FG001|Overall Study|Received treatment for >24 months|0
4640615|NCT01981473|7515552|FG002|Overall Study|Received treatment for >24 months|6
4640616|NCT01981616|7515580|FG000|Overall Study|Adverse Event|0
4640617|NCT01981616|7515581|FG001|Overall Study|Adverse Event|1
4640618|NCT01981616|7515580|FG000|Overall Study|Protocol Violation|1
4640619|NCT01981616|7515581|FG001|Overall Study|Protocol Violation|0
4640620|NCT01981954|7515614|FG000|Titration Period|Protocol Deviation|1
4640621|NCT01981954|7515614|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1
4640622|NCT01982292|7515650|FG000|Overall Study|Adverse Event|2
4640623|NCT01982292|7515651|FG001|Overall Study|Adverse Event|0
4640624|NCT01982292|7515650|FG000|Overall Study|Death|1
4640625|NCT01982292|7515651|FG001|Overall Study|Death|0
4640626|NCT01982292|7515650|FG000|Overall Study|Lost to Follow-up|2
4640627|NCT01982292|7515651|FG001|Overall Study|Lost to Follow-up|0
4640628|NCT01982292|7515650|FG000|Overall Study|Non-Compliance With Study Treatment|1
4640629|NCT01982292|7515651|FG001|Overall Study|Non-Compliance With Study Treatment|0
4640630|NCT01982292|7515650|FG000|Overall Study|Protocol Deviation|1
4640631|NCT01982292|7515651|FG001|Overall Study|Protocol Deviation|0
4640632|NCT01982292|7515650|FG000|Overall Study|Patient/Guardian Decision|3
4640633|NCT01982292|7515651|FG001|Overall Study|Patient/Guardian Decision|1
4640634|NCT01982292|7515650|FG000|Overall Study|Technical Problems|2
4640635|NCT01982292|7515651|FG001|Overall Study|Technical Problems|0
4640636|NCT01982331|7515659|FG000|Received Vaccination 2|Adverse Event|1
4640637|NCT01982331|7515660|FG001|Received Vaccination 2|Adverse Event|2
4640638|NCT01982331|7515659|FG000|Received Vaccination 2|Withdrawal by Subject|0
4640639|NCT01982331|7515660|FG001|Received Vaccination 2|Withdrawal by Subject|1
4640640|NCT01982331|7515659|FG000|Completed Study (Day 112)|Withdrawal by Subject|2
4640641|NCT01982331|7515660|FG001|Completed Study (Day 112)|Withdrawal by Subject|0
4640642|NCT01982435|7515668|FG000|Overall Study|Adverse Event|1
4640643|NCT01982435|7515669|FG001|Overall Study|Adverse Event|0
4640644|NCT01982682|7515683|FG000|Overall Study|Physician Decision|1
4640645|NCT01982773|7515699|FG000|Overall Study|Withdrawal by Subject|1
4640646|NCT01982773|7515700|FG001|Overall Study|Withdrawal by Subject|3
4640647|NCT01982773|7515699|FG000|Overall Study|Lost to Follow-up|7
4640648|NCT01982773|7515700|FG001|Overall Study|Lost to Follow-up|1
4640649|NCT01982812|7515717|FG000|Overall Study|Death|1
4640650|NCT01982812|7515718|FG001|Overall Study|Death|5
4640651|NCT01982812|7515717|FG000|Overall Study|Adverse Event|0
4640652|NCT01982812|7515718|FG001|Overall Study|Adverse Event|5
4640653|NCT01982942|7515726|FG000|Overall Study|Adverse Event|10
4640654|NCT01982942|7515727|FG001|Overall Study|Adverse Event|5
4640655|NCT01982942|7515726|FG000|Overall Study|Lost to Follow-up|4
4640656|NCT01982942|7515727|FG001|Overall Study|Lost to Follow-up|3
4640657|NCT01982942|7515726|FG000|Overall Study|Multiple sclerosis progression|3
4640658|NCT01982942|7515727|FG001|Overall Study|Multiple sclerosis progression|2
4640659|NCT01982942|7515726|FG000|Overall Study|Wanted to try therapy not permitted|1
4640660|NCT01982942|7515727|FG001|Overall Study|Wanted to try therapy not permitted|0
4640661|NCT01982942|7515726|FG000|Overall Study|Subject declined future visits|0
4640662|NCT01982942|7515727|FG001|Overall Study|Subject declined future visits|1
4640663|NCT01982942|7515726|FG000|Overall Study|Left geographical area|2
4640664|NCT01982942|7515727|FG001|Overall Study|Left geographical area|0
4640665|NCT01982942|7515726|FG000|Overall Study|Too many pills|1
4640666|NCT01982942|7515727|FG001|Overall Study|Too many pills|0
4640667|NCT01982942|7515726|FG000|Overall Study|MS Relapse|0
4640668|NCT01982942|7515727|FG001|Overall Study|MS Relapse|1
4640669|NCT01982942|7515726|FG000|Overall Study|Chose to join a stem cell trial|0
4640670|NCT01982942|7515727|FG001|Overall Study|Chose to join a stem cell trial|1
4640671|NCT01982942|7515726|FG000|Overall Study|Subject bedridden, rapidly declining|0
4640672|NCT01982942|7515727|FG001|Overall Study|Subject bedridden, rapidly declining|1
4747162|NCT00162773|7720622|FG000|Overall Study|P.I, Left institution. Study terminated|22
4747163|NCT00147238|7720652|FG000|Overall Study|Inevaluable|8
4747164|NCT00165503|7720656|FG000|Overall Study|Death|1
4747165|NCT00165503|7720656|FG000|Overall Study|Lost to Follow-up|12
4747166|NCT00165503|7720656|FG000|Overall Study|Unresectable|3
4747167|NCT00160563|7720663|FG000|Overall Study|Adverse Event|1
4747168|NCT00160563|7720664|FG001|Overall Study|Adverse Event|1
4747169|NCT00160563|7720665|FG002|Overall Study|Adverse Event|1
4747170|NCT00160563|7720663|FG000|Overall Study|Lost to Follow-up|1
4747171|NCT00160563|7720664|FG001|Overall Study|Lost to Follow-up|1
4747172|NCT00160563|7720665|FG002|Overall Study|Lost to Follow-up|2
4747173|NCT00160563|7720663|FG000|Overall Study|Protocol Violation|0
4747174|NCT00160563|7720664|FG001|Overall Study|Protocol Violation|0
4747175|NCT00160563|7720665|FG002|Overall Study|Protocol Violation|3
4747176|NCT00160563|7720663|FG000|Overall Study|Withdrawal by Subject|1
4747177|NCT00160563|7720664|FG001|Overall Study|Withdrawal by Subject|2
4747178|NCT00160563|7720665|FG002|Overall Study|Withdrawal by Subject|3
4747179|NCT00160563|7720663|FG000|Overall Study|Other (listed in the study report)|48
4747180|NCT00160563|7720664|FG001|Overall Study|Other (listed in the study report)|40
4747181|NCT00160563|7720665|FG002|Overall Study|Other (listed in the study report)|81
4747182|NCT00160563|7720663|FG000|Overall Study|Missing reason|0
4747183|NCT00160563|7720664|FG001|Overall Study|Missing reason|1
4747184|NCT00160563|7720665|FG002|Overall Study|Missing reason|0
4747185|NCT00142519|7720676|FG000|Overall Study|Not Treated|7
4747186|NCT00142519|7720677|FG001|Overall Study|Not Treated|9
4747187|NCT00142519|7720676|FG000|Overall Study|Protocol Violation|1
4747188|NCT00142519|7720677|FG001|Overall Study|Protocol Violation|0
4747189|NCT00142519|7720676|FG000|Overall Study|Withdrawal by Subject|10
4747190|NCT00142519|7720677|FG001|Overall Study|Withdrawal by Subject|7
4747191|NCT00138073|7720692|FG000|Overall Study|lack of resources|55
4747192|NCT00113386|7720698|FG000|Overall Study|Withdrawal by Subject|1
4747193|NCT00113386|7720699|FG001|Overall Study|Withdrawal by Subject|0
4747194|NCT00113386|7720698|FG000|Overall Study|Physician Decision|0
4747195|NCT00113386|7720699|FG001|Overall Study|Physician Decision|1
4747196|NCT00113386|7720698|FG000|Overall Study|Toxicity|3
4747197|NCT00113386|7720699|FG001|Overall Study|Toxicity|0
4747198|NCT00113386|7720698|FG000|Overall Study|Ineligible|1
4747199|NCT00113386|7720699|FG001|Overall Study|Ineligible|2
4747200|NCT00113386|7720698|FG000|Overall Study|Unknown - Lost to Follow-Up|2
4747201|NCT00113386|7720699|FG001|Overall Study|Unknown - Lost to Follow-Up|1
4747202|NCT00138151|7720705|FG000|Overall Study|Withdrawal by Subject|3
4747203|NCT00138151|7720705|FG000|Overall Study|Physician Decision|1
4747204|NCT00129974|7720709|FG000|Overall Study|Other|1
4747205|NCT00126659|7720716|FG000|Overall Study|Adverse Event|0
4747206|NCT00126659|7720717|FG001|Overall Study|Adverse Event|0
4747207|NCT00126659|7720718|FG002|Overall Study|Adverse Event|2
4747208|NCT00125268|7720735|FG000|Overall Study|Withdrawal by Subject|1
4747209|NCT00125268|7720736|FG001|Overall Study|Withdrawal by Subject|1
4747210|NCT00113399|7720744|FG000|Overall Study|Death|1
4747211|NCT00113399|7720745|FG001|Overall Study|Death|1
4747212|NCT00113399|7720744|FG000|Overall Study|Withdrawal by Subject|1
4747213|NCT00113399|7720745|FG001|Overall Study|Withdrawal by Subject|2
4747214|NCT00113399|7720744|FG000|Overall Study|Complete Response|0
4747215|NCT00113399|7720745|FG001|Overall Study|Complete Response|1
4747216|NCT00113399|7720744|FG000|Overall Study|Other|0
4747217|NCT00113399|7720745|FG001|Overall Study|Other|1
4747218|NCT00107614|7720755|FG000|Overall Study|Physician Decision|10
4747219|NCT00107614|7720755|FG000|Overall Study|Death|2
4747220|NCT00107315|7720759|FG000|Overall Study|Disease Progression|9
4747221|NCT00107315|7720759|FG000|Overall Study|Adverse Event|4
4747222|NCT00107315|7720759|FG000|Overall Study|Withdrawal by Subject|2
4747223|NCT00108433|7720765|FG000|Overall Study|Lack of Efficacy|1
4747224|NCT00108433|7720766|FG001|Overall Study|Lack of Efficacy|2
4747225|NCT00108433|7720765|FG000|Overall Study|Death|3
4747226|NCT00108433|7720766|FG001|Overall Study|Death|0
4747227|NCT00108433|7720765|FG000|Overall Study|Adverse Event|3
4640673|NCT01982955|7515738|FG000|Overall Study|Randomized but not treated|0
4640674|NCT01982955|7515739|FG001|Overall Study|Randomized but not treated|0
4640675|NCT01982955|7515740|FG002|Overall Study|Randomized but not treated|0
4640676|NCT01982955|7515741|FG003|Overall Study|Randomized but not treated|1
4640677|NCT01982955|7515742|FG004|Overall Study|Randomized but not treated|0
4640678|NCT01982955|7515738|FG000|Overall Study|Ongoing|0
4640679|NCT01982955|7515739|FG001|Overall Study|Ongoing|0
4640680|NCT01982955|7515740|FG002|Overall Study|Ongoing|4
4640681|NCT01982955|7515741|FG003|Overall Study|Ongoing|0
4640682|NCT01982955|7515742|FG004|Overall Study|Ongoing|0
4640683|NCT01983111|7515783|FG000|Overall Study|Withdrawal by Subject|8
4640684|NCT01983111|7515784|FG001|Overall Study|Withdrawal by Subject|6
4640685|NCT01983111|7515783|FG000|Overall Study|Adverse Event|4
4640686|NCT01983111|7515784|FG001|Overall Study|Adverse Event|0
4640687|NCT01983111|7515783|FG000|Overall Study|Protocol Violation|0
4640688|NCT01983111|7515784|FG001|Overall Study|Protocol Violation|1
4640689|NCT01983254|7515803|FG000|Overall Study|Death|6
4640690|NCT01983254|7515804|FG001|Overall Study|Death|6
4640691|NCT01983254|7515803|FG000|Overall Study|Lost to Follow-up|17
4640692|NCT01983254|7515804|FG001|Overall Study|Lost to Follow-up|16
4640693|NCT01983254|7515803|FG000|Overall Study|too ill|11
4640694|NCT01983254|7515804|FG001|Overall Study|too ill|8
4640695|NCT01983293|7515812|FG000|Overall Study|Withdrawal by Subject|29
4640696|NCT01983293|7515813|FG001|Overall Study|Withdrawal by Subject|15
4640697|NCT01983293|7515812|FG000|Overall Study|Missing 12-month visit|3
4640698|NCT01983293|7515813|FG001|Overall Study|Missing 12-month visit|3
4640699|NCT01983293|7515812|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1
4640700|NCT01983293|7515813|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1
4640701|NCT01983683|7515839|FG000|Overall Study|Withdrawal by Subject|14
4640702|NCT01983683|7515840|FG001|Overall Study|Withdrawal by Subject|18
4640703|NCT01983683|7515839|FG000|Overall Study|Death|11
4640704|NCT01983683|7515840|FG001|Overall Study|Death|15
4640705|NCT01983683|7515839|FG000|Overall Study|Physician Decision|8
4640706|NCT01983683|7515840|FG001|Overall Study|Physician Decision|9
4640707|NCT01983683|7515839|FG000|Overall Study|Lost to Follow-up|4
4640708|NCT01983683|7515840|FG001|Overall Study|Lost to Follow-up|8
4640709|NCT01983683|7515839|FG000|Overall Study|Sponsor Decision|1
4640710|NCT01983683|7515840|FG001|Overall Study|Sponsor Decision|1
4640711|NCT01983930|7515893|FG000|Overall Study|Withdrawal by Subject|9
4640712|NCT01983930|7515894|FG001|Overall Study|Withdrawal by Subject|8
4640713|NCT01983930|7515893|FG000|Overall Study|Adverse Event|0
4640714|NCT01983930|7515894|FG001|Overall Study|Adverse Event|1
4640715|NCT01983969|7515904|FG000|Overall Study|Disease Progression|0
4640716|NCT01983969|7515905|FG001|Overall Study|Disease Progression|1
4640717|NCT01983969|7515906|FG002|Overall Study|Disease Progression|0
4640718|NCT01984164|7515920|FG000|Overall Study|Withdrawal by Subject|4
4640719|NCT01984164|7515921|FG001|Overall Study|Withdrawal by Subject|3
4640720|NCT01984164|7515920|FG000|Overall Study|Adverse Event|5
4640721|NCT01984164|7515921|FG001|Overall Study|Adverse Event|19
4640722|NCT01984164|7515920|FG000|Overall Study|Lost to Follow-up|1
4640723|NCT01984164|7515921|FG001|Overall Study|Lost to Follow-up|3
4640724|NCT01984229|7515929|FG000|Safety Follow-up Period|Adverse Event|1
4640725|NCT01984229|7515930|FG001|Safety Follow-up Period|Adverse Event|1
4640726|NCT01984229|7515929|FG000|Safety Follow-up Period|Lost to Follow-up|1
4640727|NCT01984229|7515930|FG001|Safety Follow-up Period|Lost to Follow-up|0
4640728|NCT01984242|7515945|FG000|Overall Study|Death|52
4640729|NCT01984242|7515946|FG001|Overall Study|Death|50
4640730|NCT01984242|7515947|FG002|Overall Study|Death|52
4640731|NCT01984242|7515945|FG000|Overall Study|Withdrawal by Subject|5
4640732|NCT01984242|7515946|FG001|Overall Study|Withdrawal by Subject|3
4640733|NCT01984242|7515947|FG002|Overall Study|Withdrawal by Subject|10
4640734|NCT01984242|7515945|FG000|Overall Study|Physician Decision|0
4640735|NCT01984242|7515946|FG001|Overall Study|Physician Decision|0
4640736|NCT01984242|7515947|FG002|Overall Study|Physician Decision|1
4640737|NCT01984242|7515945|FG000|Overall Study|Lost to Follow-up|4
4640738|NCT01984242|7515946|FG001|Overall Study|Lost to Follow-up|0
4640739|NCT01984242|7515947|FG002|Overall Study|Lost to Follow-up|3
4640740|NCT01984242|7515945|FG000|Overall Study|Sponsor Decision|1
4640741|NCT01984242|7515946|FG001|Overall Study|Sponsor Decision|0
4640742|NCT01984242|7515947|FG002|Overall Study|Sponsor Decision|0
4640743|NCT01984242|7515945|FG000|Overall Study|Non-Compliance|1
4640744|NCT01984242|7515946|FG001|Overall Study|Non-Compliance|0
4640745|NCT01984242|7515947|FG002|Overall Study|Non-Compliance|0
4640746|NCT01984242|7515945|FG000|Overall Study|Study terminated by Sponsor|38
4640747|NCT01984242|7515946|FG001|Overall Study|Study terminated by Sponsor|50
4640748|NCT01984242|7515947|FG002|Overall Study|Study terminated by Sponsor|34
4640749|NCT01984242|7515945|FG000|Overall Study|Disease Progression|0
4640750|NCT01984242|7515946|FG001|Overall Study|Disease Progression|0
4640751|NCT01984242|7515947|FG002|Overall Study|Disease Progression|1
4640752|NCT01984294|7515966|FG000|Overall Study|Randomized but Never Treated|0
4640753|NCT01984294|7515967|FG001|Overall Study|Randomized but Never Treated|0
4640754|NCT01984294|7515968|FG002|Overall Study|Randomized but Never Treated|1
4640755|NCT01984294|7515966|FG000|Overall Study|Lack of Efficacy|4
4640756|NCT01984294|7515967|FG001|Overall Study|Lack of Efficacy|2
4640757|NCT01984294|7515968|FG002|Overall Study|Lack of Efficacy|6
4640758|NCT01984294|7515966|FG000|Overall Study|Adverse Event|0
4640759|NCT01984294|7515967|FG001|Overall Study|Adverse Event|1
4640760|NCT01984294|7515968|FG002|Overall Study|Adverse Event|0
4640761|NCT01984424|7515993|FG000|Overall Study|Withdrawal by Subject|3
4640762|NCT01984424|7515994|FG001|Overall Study|Withdrawal by Subject|5
4640763|NCT01984424|7515993|FG000|Overall Study|Sponsor Decision|0
4640764|NCT01984424|7515994|FG001|Overall Study|Sponsor Decision|1
4640765|NCT01984424|7515993|FG000|Overall Study|Lost to Follow-up|0
4640766|NCT01984424|7515994|FG001|Overall Study|Lost to Follow-up|1
4640767|NCT01984684|7516006|FG000|Overall Study|Lost to Follow-up|25
4640768|NCT01984684|7516007|FG001|Overall Study|Lost to Follow-up|24
4640769|NCT01984684|7516006|FG000|Overall Study|Adverse Event|8
4640770|NCT01984684|7516007|FG001|Overall Study|Adverse Event|12
4640771|NCT01984684|7516006|FG000|Overall Study|Withdrawal by Subject|9
4640772|NCT01984684|7516007|FG001|Overall Study|Withdrawal by Subject|9
4640773|NCT01984684|7516006|FG000|Overall Study|Lack of Efficacy|3
4640774|NCT01984684|7516007|FG001|Overall Study|Lack of Efficacy|6
4640775|NCT01984684|7516006|FG000|Overall Study|Physician Decision|4
4640776|NCT01984684|7516007|FG001|Overall Study|Physician Decision|2
4640777|NCT01984684|7516006|FG000|Overall Study|Protocol Violation|4
4640778|NCT01984684|7516007|FG001|Overall Study|Protocol Violation|2
4640779|NCT01984684|7516006|FG000|Overall Study|Death|0
4640780|NCT01984684|7516007|FG001|Overall Study|Death|1
4640781|NCT01984684|7516006|FG000|Overall Study|Noncompliance with study drug|2
4640782|NCT01984684|7516007|FG001|Overall Study|Noncompliance with study drug|1
4640783|NCT01984684|7516006|FG000|Overall Study|Subject incarcerated|1
4640784|NCT01984684|7516007|FG001|Overall Study|Subject incarcerated|0
4640785|NCT01984684|7516006|FG000|Overall Study|Study drug not available at site|1
4640786|NCT01984684|7516007|FG001|Overall Study|Study drug not available at site|1
4640787|NCT01984684|7516006|FG000|Overall Study|Subject had inadequate IV access|0
4640788|NCT01984684|7516007|FG001|Overall Study|Subject had inadequate IV access|1
4640789|NCT01984697|7516018|FG000|Overall Study|Adverse Event|0
4640790|NCT01984697|7516019|FG001|Overall Study|Adverse Event|0
4640791|NCT01984697|7516020|FG002|Overall Study|Adverse Event|2
4640792|NCT01984697|7516021|FG003|Overall Study|Adverse Event|0
4640793|NCT01984697|7516022|FG004|Overall Study|Adverse Event|0
4640794|NCT01984697|7516018|FG000|Overall Study|Lost to Follow-up|14
4640795|NCT01984697|7516019|FG001|Overall Study|Lost to Follow-up|5
4640796|NCT01984697|7516020|FG002|Overall Study|Lost to Follow-up|10
4640797|NCT01984697|7516021|FG003|Overall Study|Lost to Follow-up|6
4640798|NCT01984697|7516022|FG004|Overall Study|Lost to Follow-up|21
4640799|NCT01984697|7516018|FG000|Overall Study|Physician Decision|3
4640800|NCT01984697|7516019|FG001|Overall Study|Physician Decision|0
4640801|NCT01984697|7516020|FG002|Overall Study|Physician Decision|0
4640802|NCT01984697|7516021|FG003|Overall Study|Physician Decision|1
4640803|NCT01984697|7516022|FG004|Overall Study|Physician Decision|0
4640804|NCT01984697|7516018|FG000|Overall Study|Protocol Violation|8
4640805|NCT01984697|7516019|FG001|Overall Study|Protocol Violation|5
4640806|NCT01984697|7516020|FG002|Overall Study|Protocol Violation|3
4640807|NCT01984697|7516021|FG003|Overall Study|Protocol Violation|2
4640808|NCT01984697|7516022|FG004|Overall Study|Protocol Violation|0
4640809|NCT01984697|7516018|FG000|Overall Study|Withdrawal by Subject|15
4640810|NCT01984697|7516019|FG001|Overall Study|Withdrawal by Subject|21
4640811|NCT01984697|7516020|FG002|Overall Study|Withdrawal by Subject|13
4640812|NCT01984697|7516021|FG003|Overall Study|Withdrawal by Subject|11
4640813|NCT01984697|7516022|FG004|Overall Study|Withdrawal by Subject|13
4640814|NCT01984697|7516018|FG000|Overall Study|Missed last follow-up visit|1
4640815|NCT01984697|7516019|FG001|Overall Study|Missed last follow-up visit|0
4640816|NCT01984697|7516020|FG002|Overall Study|Missed last follow-up visit|0
4640817|NCT01984697|7516021|FG003|Overall Study|Missed last follow-up visit|0
4640818|NCT01984697|7516022|FG004|Overall Study|Missed last follow-up visit|0
4640819|NCT01984697|7516018|FG000|Overall Study|Death|0
4640820|NCT01984697|7516019|FG001|Overall Study|Death|0
4640821|NCT01984697|7516020|FG002|Overall Study|Death|0
4640822|NCT01984697|7516021|FG003|Overall Study|Death|1
4640823|NCT01984697|7516022|FG004|Overall Study|Death|0
4640824|NCT01984697|7516018|FG000|Overall Study|Pregnancy|2
4640825|NCT01984697|7516019|FG001|Overall Study|Pregnancy|0
4640826|NCT01984697|7516020|FG002|Overall Study|Pregnancy|1
4640827|NCT01984697|7516021|FG003|Overall Study|Pregnancy|0
4640828|NCT01984697|7516022|FG004|Overall Study|Pregnancy|1
4640829|NCT01984892|7516034|FG000|Overall Study|Progressive disease|7
4640830|NCT01985126|7516040|FG000|Overall Study|Death|15
4640831|NCT01985126|7516041|FG001|Overall Study|Death|69
4640832|NCT01985126|7516040|FG000|Overall Study|Lost to Follow-up|0
4640833|NCT01985126|7516041|FG001|Overall Study|Lost to Follow-up|8
4640834|NCT01985126|7516040|FG000|Overall Study|Study Terminated By Sponsor|1
4640835|NCT01985126|7516041|FG001|Overall Study|Study Terminated By Sponsor|22
4640836|NCT01985126|7516040|FG000|Overall Study|Withdrawal by Subject|2
4640837|NCT01985126|7516041|FG001|Overall Study|Withdrawal by Subject|7
4640838|NCT01985321|7516049|FG000|Overall Study|Protocol Violation|4
4640839|NCT01985321|7516050|FG001|Overall Study|Protocol Violation|3
4640840|NCT01985321|7516049|FG000|Overall Study|Withdrawal by Subject|1
4640841|NCT01985321|7516050|FG001|Overall Study|Withdrawal by Subject|0
4640842|NCT01985321|7516049|FG000|Overall Study|Lost to Follow-up|5
4640843|NCT01985321|7516050|FG001|Overall Study|Lost to Follow-up|2
4640844|NCT01985321|7516049|FG000|Overall Study|Subject treated wrong type of sore|1
4640845|NCT01985321|7516050|FG001|Overall Study|Subject treated wrong type of sore|0
4640846|NCT01985334|7516064|FG000|Overall Study|Administrative problems|1
4640847|NCT01985334|7516065|FG001|Overall Study|Administrative problems|1
4640848|NCT01985334|7516066|FG002|Overall Study|Administrative problems|0
4640849|NCT01985334|7516067|FG003|Overall Study|Administrative problems|2
4640850|NCT01985334|7516068|FG004|Overall Study|Administrative problems|0
4640851|NCT01985334|7516069|FG005|Overall Study|Administrative problems|1
4640852|NCT01985334|7516070|FG006|Overall Study|Administrative problems|1
4640853|NCT01985334|7516071|FG007|Overall Study|Administrative problems|3
4640854|NCT01985334|7516064|FG000|Overall Study|Death|1
4640855|NCT01985334|7516065|FG001|Overall Study|Death|0
4640856|NCT01985334|7516066|FG002|Overall Study|Death|0
4640857|NCT01985334|7516067|FG003|Overall Study|Death|3
4640858|NCT01985334|7516068|FG004|Overall Study|Death|0
4640859|NCT01985334|7516069|FG005|Overall Study|Death|0
4640860|NCT01985334|7516070|FG006|Overall Study|Death|1
4640861|NCT01985334|7516071|FG007|Overall Study|Death|2
4640862|NCT01985334|7516064|FG000|Overall Study|Worsening of disease|0
4640863|NCT01985334|7516065|FG001|Overall Study|Worsening of disease|0
4640864|NCT01985334|7516066|FG002|Overall Study|Worsening of disease|0
4640865|NCT01985334|7516067|FG003|Overall Study|Worsening of disease|1
4640866|NCT01985334|7516068|FG004|Overall Study|Worsening of disease|0
4640867|NCT01985334|7516069|FG005|Overall Study|Worsening of disease|3
4640868|NCT01985334|7516070|FG006|Overall Study|Worsening of disease|0
4640869|NCT01985334|7516071|FG007|Overall Study|Worsening of disease|1
4640870|NCT01985334|7516064|FG000|Overall Study|Other|2
4640871|NCT01985334|7516065|FG001|Overall Study|Other|9
4640872|NCT01985334|7516066|FG002|Overall Study|Other|7
4640873|NCT01985334|7516067|FG003|Overall Study|Other|17
4640874|NCT01985334|7516068|FG004|Overall Study|Other|4
4640875|NCT01985334|7516069|FG005|Overall Study|Other|8
4640876|NCT01985334|7516070|FG006|Overall Study|Other|4
4640877|NCT01985334|7516071|FG007|Overall Study|Other|7
4640878|NCT01985334|7516064|FG000|Overall Study|Protocol deviation|6
4640879|NCT01985334|7516065|FG001|Overall Study|Protocol deviation|31
4640880|NCT01985334|7516066|FG002|Overall Study|Protocol deviation|25
4640881|NCT01985334|7516067|FG003|Overall Study|Protocol deviation|84
4640882|NCT01985334|7516068|FG004|Overall Study|Protocol deviation|17
4640883|NCT01985334|7516069|FG005|Overall Study|Protocol deviation|47
4640884|NCT01985334|7516070|FG006|Overall Study|Protocol deviation|15
4640885|NCT01985334|7516071|FG007|Overall Study|Protocol deviation|42
4640886|NCT01985334|7516064|FG000|Overall Study|Moderate / severe COPD exacerbation|5
4640887|NCT01985334|7516065|FG001|Overall Study|Moderate / severe COPD exacerbation|14
4747228|NCT00108433|7720766|FG001|Overall Study|Adverse Event|1
4747229|NCT00108433|7720765|FG000|Overall Study|Other|14
4747230|NCT00108433|7720766|FG001|Overall Study|Other|14
4747231|NCT00113919|7720772|FG000|Overall Study|Physician Decision|8
4747232|NCT00113919|7720772|FG000|Overall Study|Death|6
4747233|NCT00100828|7720785|FG000|Overall Study|Physician Decision|6
4747234|NCT00104728|7720789|FG000|Overall Study|screen failures|19
4747235|NCT00083915|7720808|FG000|Overall Study|Death|6
4747236|NCT00083915|7720809|FG001|Overall Study|Death|3
4747237|NCT00083915|7720808|FG000|Overall Study|Physician Decision|11
4747238|NCT00083915|7720809|FG001|Overall Study|Physician Decision|6
4747239|NCT00083915|7720808|FG000|Overall Study|Withdrawal by Subject|8
4747240|NCT00083915|7720809|FG001|Overall Study|Withdrawal by Subject|3
4747241|NCT00083915|7720808|FG000|Overall Study|disease progression|18
4747242|NCT00083915|7720809|FG001|Overall Study|disease progression|23
4747243|NCT00083915|7720808|FG000|Overall Study|Failure to collect|3
4747244|NCT00083915|7720809|FG001|Overall Study|Failure to collect|0
4747245|NCT00083915|7720808|FG000|Overall Study|No response|3
4747246|NCT00083915|7720809|FG001|Overall Study|No response|1
4747247|NCT00083915|7720808|FG000|Overall Study|Insurance issues|1
4747248|NCT00083915|7720809|FG001|Overall Study|Insurance issues|1
4747249|NCT00088829|7720828|FG000|Overall Study|PI left institution and study was close|22
4747250|NCT00085631|7720851|FG000|Overall Study|Missing Data|4
4747251|NCT00085631|7720852|FG001|Overall Study|Missing Data|11
4747252|NCT00085631|7720853|FG002|Overall Study|Missing Data|7
4747253|NCT00062751|7720865|FG000|Overall Study|Disease progression|24
4747254|NCT00062751|7720866|FG001|Overall Study|Disease progression|17
4747255|NCT00062751|7720867|FG002|Overall Study|Disease progression|24
4747256|NCT00062751|7720868|FG003|Overall Study|Disease progression|2
4747257|NCT00062751|7720869|FG004|Overall Study|Disease progression|2
4747258|NCT00062751|7720865|FG000|Overall Study|Adverse Event|4
4747259|NCT00062751|7720866|FG001|Overall Study|Adverse Event|7
4747260|NCT00062751|7720867|FG002|Overall Study|Adverse Event|2
4747261|NCT00062751|7720868|FG003|Overall Study|Adverse Event|2
4640888|NCT01985334|7516066|FG002|Overall Study|Moderate / severe COPD exacerbation|12
4640889|NCT01985334|7516067|FG003|Overall Study|Moderate / severe COPD exacerbation|40
4640890|NCT01985334|7516068|FG004|Overall Study|Moderate / severe COPD exacerbation|6
4640891|NCT01985334|7516069|FG005|Overall Study|Moderate / severe COPD exacerbation|40
4640892|NCT01985334|7516070|FG006|Overall Study|Moderate / severe COPD exacerbation|8
4747262|NCT00062751|7720869|FG004|Overall Study|Adverse Event|2
4747263|NCT00062751|7720865|FG000|Overall Study|Other|2
4640893|NCT01985334|7516071|FG007|Overall Study|Moderate / severe COPD exacerbation|19
4747264|NCT00062751|7720866|FG001|Overall Study|Other|3
4747265|NCT00062751|7720867|FG002|Overall Study|Other|1
4640894|NCT01985334|7516064|FG000|Overall Study|Subject withdrawal of consent|3
4640895|NCT01985334|7516065|FG001|Overall Study|Subject withdrawal of consent|6
4640896|NCT01985334|7516066|FG002|Overall Study|Subject withdrawal of consent|2
4640897|NCT01985334|7516067|FG003|Overall Study|Subject withdrawal of consent|28
4640898|NCT01985334|7516068|FG004|Overall Study|Subject withdrawal of consent|4
4640899|NCT01985334|7516069|FG005|Overall Study|Subject withdrawal of consent|19
4640900|NCT01985334|7516070|FG006|Overall Study|Subject withdrawal of consent|0
4640901|NCT01985334|7516071|FG007|Overall Study|Subject withdrawal of consent|20
4640902|NCT01985334|7516064|FG000|Overall Study|Adverse Event|0
4640903|NCT01985334|7516065|FG001|Overall Study|Adverse Event|8
4640904|NCT01985334|7516066|FG002|Overall Study|Adverse Event|2
4640905|NCT01985334|7516067|FG003|Overall Study|Adverse Event|26
4640906|NCT01985334|7516068|FG004|Overall Study|Adverse Event|3
4640907|NCT01985334|7516069|FG005|Overall Study|Adverse Event|18
4640908|NCT01985334|7516070|FG006|Overall Study|Adverse Event|3
4640909|NCT01985334|7516071|FG007|Overall Study|Adverse Event|15
4640910|NCT01985334|7516064|FG000|Overall Study|Other|4
4640911|NCT01985334|7516065|FG001|Overall Study|Other|2
4640912|NCT01985334|7516066|FG002|Overall Study|Other|3
4640913|NCT01985334|7516067|FG003|Overall Study|Other|10
4640914|NCT01985334|7516068|FG004|Overall Study|Other|1
4640915|NCT01985334|7516069|FG005|Overall Study|Other|6
4640916|NCT01985334|7516070|FG006|Overall Study|Other|2
4640917|NCT01985334|7516071|FG007|Overall Study|Other|2
4640918|NCT01985334|7516064|FG000|Overall Study|Medication non-compliance|0
4640919|NCT01985334|7516065|FG001|Overall Study|Medication non-compliance|4
4640920|NCT01985334|7516066|FG002|Overall Study|Medication non-compliance|1
4640921|NCT01985334|7516067|FG003|Overall Study|Medication non-compliance|6
4640922|NCT01985334|7516068|FG004|Overall Study|Medication non-compliance|2
4640923|NCT01985334|7516069|FG005|Overall Study|Medication non-compliance|3
4640924|NCT01985334|7516070|FG006|Overall Study|Medication non-compliance|1
4640925|NCT01985334|7516071|FG007|Overall Study|Medication non-compliance|3
4640926|NCT01985334|7516064|FG000|Overall Study|Use of prohibited treatment|1
4640927|NCT01985334|7516065|FG001|Overall Study|Use of prohibited treatment|4
4640928|NCT01985334|7516066|FG002|Overall Study|Use of prohibited treatment|1
4640929|NCT01985334|7516067|FG003|Overall Study|Use of prohibited treatment|2
4640930|NCT01985334|7516068|FG004|Overall Study|Use of prohibited treatment|1
4640931|NCT01985334|7516069|FG005|Overall Study|Use of prohibited treatment|6
4640932|NCT01985334|7516070|FG006|Overall Study|Use of prohibited treatment|2
4640933|NCT01985334|7516071|FG007|Overall Study|Use of prohibited treatment|0
4640934|NCT01985334|7516064|FG000|Overall Study|Investigator decision|0
4640935|NCT01985334|7516065|FG001|Overall Study|Investigator decision|3
4640936|NCT01985334|7516066|FG002|Overall Study|Investigator decision|0
4640937|NCT01985334|7516067|FG003|Overall Study|Investigator decision|7
4640938|NCT01985334|7516068|FG004|Overall Study|Investigator decision|1
4640939|NCT01985334|7516069|FG005|Overall Study|Investigator decision|1
4640940|NCT01985334|7516070|FG006|Overall Study|Investigator decision|0
4640941|NCT01985334|7516071|FG007|Overall Study|Investigator decision|4
4640942|NCT01985334|7516064|FG000|Overall Study|Lost to Follow-up|0
4640943|NCT01985334|7516065|FG001|Overall Study|Lost to Follow-up|2
4640944|NCT01985334|7516066|FG002|Overall Study|Lost to Follow-up|0
4640945|NCT01985334|7516067|FG003|Overall Study|Lost to Follow-up|3
4640946|NCT01985334|7516068|FG004|Overall Study|Lost to Follow-up|1
4640947|NCT01985334|7516069|FG005|Overall Study|Lost to Follow-up|4
4640948|NCT01985334|7516070|FG006|Overall Study|Lost to Follow-up|0
4640949|NCT01985334|7516071|FG007|Overall Study|Lost to Follow-up|3
4640950|NCT01985360|7516105|FG000|Overall Study|Withdrawal by Subject|4
4640951|NCT01985360|7516106|FG001|Overall Study|Withdrawal by Subject|0
4640952|NCT01985360|7516105|FG000|Overall Study|Lost to Follow-up|5
4640953|NCT01985360|7516106|FG001|Overall Study|Lost to Follow-up|3
4640954|NCT01986010|7516194|FG000|Overall Study|Adverse Event|0
4640955|NCT01986010|7516195|FG001|Overall Study|Adverse Event|1
4640956|NCT01986010|7516196|FG002|Overall Study|Adverse Event|0
4640957|NCT01986010|7516197|FG003|Overall Study|Adverse Event|0
4640958|NCT01986010|7516198|FG004|Overall Study|Adverse Event|0
4640959|NCT01986010|7516199|FG005|Overall Study|Adverse Event|0
4640960|NCT01986010|7516200|FG006|Overall Study|Adverse Event|0
4640961|NCT01986010|7516201|FG007|Overall Study|Adverse Event|0
4640962|NCT01986010|7516202|FG008|Overall Study|Adverse Event|0
4640963|NCT01986010|7516203|FG009|Overall Study|Adverse Event|0
4640964|NCT01986010|7516204|FG010|Overall Study|Adverse Event|0
4640965|NCT01986010|7516205|FG011|Overall Study|Adverse Event|0
4640966|NCT01986010|7516206|FG012|Overall Study|Adverse Event|0
4640967|NCT01986010|7516207|FG013|Overall Study|Adverse Event|0
4640968|NCT01986010|7516208|FG014|Overall Study|Adverse Event|0
4640969|NCT01986010|7516209|FG015|Overall Study|Adverse Event|1
4640970|NCT01986010|7516210|FG016|Overall Study|Adverse Event|0
4640971|NCT01986010|7516194|FG000|Overall Study|Lost to Follow-up|2
4640972|NCT01986010|7516195|FG001|Overall Study|Lost to Follow-up|1
4640973|NCT01986010|7516196|FG002|Overall Study|Lost to Follow-up|2
4640974|NCT01986010|7516197|FG003|Overall Study|Lost to Follow-up|2
4640975|NCT01986010|7516198|FG004|Overall Study|Lost to Follow-up|2
4640976|NCT01986010|7516199|FG005|Overall Study|Lost to Follow-up|2
4640977|NCT01986010|7516200|FG006|Overall Study|Lost to Follow-up|0
4640978|NCT01986010|7516201|FG007|Overall Study|Lost to Follow-up|0
4640979|NCT01986010|7516202|FG008|Overall Study|Lost to Follow-up|4
4640980|NCT01986010|7516203|FG009|Overall Study|Lost to Follow-up|2
4640981|NCT01986010|7516204|FG010|Overall Study|Lost to Follow-up|0
4640982|NCT01986010|7516205|FG011|Overall Study|Lost to Follow-up|1
4640983|NCT01986010|7516206|FG012|Overall Study|Lost to Follow-up|1
4640984|NCT01986010|7516207|FG013|Overall Study|Lost to Follow-up|1
4640985|NCT01986010|7516208|FG014|Overall Study|Lost to Follow-up|2
4640986|NCT01986010|7516209|FG015|Overall Study|Lost to Follow-up|0
4640987|NCT01986010|7516210|FG016|Overall Study|Lost to Follow-up|0
4640988|NCT01986010|7516194|FG000|Overall Study|Physician Decision|0
4640989|NCT01986010|7516195|FG001|Overall Study|Physician Decision|0
4640990|NCT01986010|7516196|FG002|Overall Study|Physician Decision|0
4640991|NCT01986010|7516197|FG003|Overall Study|Physician Decision|0
4640992|NCT01986010|7516198|FG004|Overall Study|Physician Decision|0
4640993|NCT01986010|7516199|FG005|Overall Study|Physician Decision|0
4640994|NCT01986010|7516200|FG006|Overall Study|Physician Decision|0
4640995|NCT01986010|7516201|FG007|Overall Study|Physician Decision|0
4640996|NCT01986010|7516202|FG008|Overall Study|Physician Decision|0
4640997|NCT01986010|7516203|FG009|Overall Study|Physician Decision|0
4640998|NCT01986010|7516204|FG010|Overall Study|Physician Decision|0
4640999|NCT01986010|7516205|FG011|Overall Study|Physician Decision|0
4641000|NCT01986010|7516206|FG012|Overall Study|Physician Decision|0
4641001|NCT01986010|7516207|FG013|Overall Study|Physician Decision|0
4641002|NCT01986010|7516208|FG014|Overall Study|Physician Decision|1
4641003|NCT01986010|7516209|FG015|Overall Study|Physician Decision|0
4641004|NCT01986010|7516210|FG016|Overall Study|Physician Decision|0
4641005|NCT01986010|7516194|FG000|Overall Study|Withdrawal by Subject|2
4641006|NCT01986010|7516195|FG001|Overall Study|Withdrawal by Subject|2
4641007|NCT01986010|7516196|FG002|Overall Study|Withdrawal by Subject|3
4641008|NCT01986010|7516197|FG003|Overall Study|Withdrawal by Subject|0
4641009|NCT01986010|7516198|FG004|Overall Study|Withdrawal by Subject|2
4641010|NCT01986010|7516199|FG005|Overall Study|Withdrawal by Subject|4
4641011|NCT01986010|7516200|FG006|Overall Study|Withdrawal by Subject|0
4641012|NCT01986010|7516201|FG007|Overall Study|Withdrawal by Subject|0
4641013|NCT01986010|7516202|FG008|Overall Study|Withdrawal by Subject|0
4641014|NCT01986010|7516203|FG009|Overall Study|Withdrawal by Subject|0
4641015|NCT01986010|7516204|FG010|Overall Study|Withdrawal by Subject|0
4641016|NCT01986010|7516205|FG011|Overall Study|Withdrawal by Subject|2
4641017|NCT01986010|7516206|FG012|Overall Study|Withdrawal by Subject|0
4641018|NCT01986010|7516207|FG013|Overall Study|Withdrawal by Subject|1
4641019|NCT01986010|7516208|FG014|Overall Study|Withdrawal by Subject|2
4641020|NCT01986010|7516209|FG015|Overall Study|Withdrawal by Subject|0
4641021|NCT01986010|7516210|FG016|Overall Study|Withdrawal by Subject|0
4641022|NCT01986010|7516194|FG000|Overall Study|Status Not Recorded|2
4641023|NCT01986010|7516195|FG001|Overall Study|Status Not Recorded|4
4641024|NCT01986010|7516196|FG002|Overall Study|Status Not Recorded|2
4641025|NCT01986010|7516197|FG003|Overall Study|Status Not Recorded|0
4641026|NCT01986010|7516198|FG004|Overall Study|Status Not Recorded|1
4641027|NCT01986010|7516199|FG005|Overall Study|Status Not Recorded|2
4641028|NCT01986010|7516200|FG006|Overall Study|Status Not Recorded|0
4641029|NCT01986010|7516201|FG007|Overall Study|Status Not Recorded|0
4641030|NCT01986010|7516202|FG008|Overall Study|Status Not Recorded|2
4641031|NCT01986010|7516203|FG009|Overall Study|Status Not Recorded|1
4641032|NCT01986010|7516204|FG010|Overall Study|Status Not Recorded|7
4641033|NCT01986010|7516205|FG011|Overall Study|Status Not Recorded|7
4641034|NCT01986010|7516206|FG012|Overall Study|Status Not Recorded|9
4641035|NCT01986010|7516207|FG013|Overall Study|Status Not Recorded|9
4641036|NCT01986010|7516208|FG014|Overall Study|Status Not Recorded|5
4641037|NCT01986010|7516209|FG015|Overall Study|Status Not Recorded|10
4641038|NCT01986010|7516210|FG016|Overall Study|Status Not Recorded|4
4641039|NCT01986062|7516258|FG000|Overall Study|Lost to Follow-up|1
4641040|NCT01986062|7516259|FG001|Overall Study|Lost to Follow-up|0
4641041|NCT01986062|7516258|FG000|Overall Study|Withdrawal by Subject|0
4641042|NCT01986062|7516259|FG001|Overall Study|Withdrawal by Subject|1
4641043|NCT01986140|7516267|FG000|Overall Study|Withdrawal by Subject|31
4641044|NCT01986140|7516268|FG001|Overall Study|Withdrawal by Subject|25
4641045|NCT01986140|7516267|FG000|Overall Study|alternative treatment|1
4641046|NCT01986140|7516268|FG001|Overall Study|alternative treatment|1
4641047|NCT01986140|7516267|FG000|Overall Study|found not eligible|3
4641048|NCT01986140|7516268|FG001|Overall Study|found not eligible|0
4641049|NCT01986140|7516267|FG000|Overall Study|Adverse Event|0
4747266|NCT00062751|7720868|FG003|Overall Study|Other|0
4641050|NCT01986140|7516268|FG001|Overall Study|Adverse Event|1
4641051|NCT01986140|7516267|FG000|Overall Study|progression disease|0
4641052|NCT01986140|7516268|FG001|Overall Study|progression disease|1
4641053|NCT01986231|7516274|FG000|Overall Study|Adverse Event|1
4641054|NCT01986348|7516282|FG000|Overall Study|Death|8
4641055|NCT01986348|7516283|FG001|Overall Study|Death|22
4641056|NCT01986348|7516284|FG002|Overall Study|Death|10
4641057|NCT01986348|7516285|FG003|Overall Study|Death|21
4641058|NCT01986348|7516282|FG000|Overall Study|Lost to Follow-up|0
4641059|NCT01986348|7516283|FG001|Overall Study|Lost to Follow-up|0
4641060|NCT01986348|7516284|FG002|Overall Study|Lost to Follow-up|0
4641061|NCT01986348|7516285|FG003|Overall Study|Lost to Follow-up|2
4641062|NCT01986348|7516282|FG000|Overall Study|Physician Decision|0
4641063|NCT01986348|7516283|FG001|Overall Study|Physician Decision|0
4641064|NCT01986348|7516284|FG002|Overall Study|Physician Decision|0
4641065|NCT01986348|7516285|FG003|Overall Study|Physician Decision|1
4641066|NCT01986348|7516282|FG000|Overall Study|Progressive Disease|0
4641067|NCT01986348|7516283|FG001|Overall Study|Progressive Disease|0
4641068|NCT01986348|7516284|FG002|Overall Study|Progressive Disease|2
4641069|NCT01986348|7516285|FG003|Overall Study|Progressive Disease|0
4641070|NCT01986348|7516282|FG000|Overall Study|Withdrawal by Participant|0
4641071|NCT01986348|7516283|FG001|Overall Study|Withdrawal by Participant|1
4641072|NCT01986348|7516284|FG002|Overall Study|Withdrawal by Participant|2
4641073|NCT01986348|7516285|FG003|Overall Study|Withdrawal by Participant|1
4641074|NCT01986348|7516282|FG000|Overall Study|Study Terminated by Sponsor|0
4641075|NCT01986348|7516283|FG001|Overall Study|Study Terminated by Sponsor|0
4641076|NCT01986348|7516284|FG002|Overall Study|Study Terminated by Sponsor|0
4641077|NCT01986348|7516285|FG003|Overall Study|Study Terminated by Sponsor|3
4641078|NCT01986348|7516282|FG000|Overall Study|Other-unspecified|0
4641079|NCT01986348|7516283|FG001|Overall Study|Other-unspecified|1
4641080|NCT01986348|7516284|FG002|Overall Study|Other-unspecified|0
4641081|NCT01986348|7516285|FG003|Overall Study|Other-unspecified|2
4641082|NCT01986647|7516311|FG000|Overall Study|Lost to Follow-up|4
4641083|NCT01986647|7516312|FG001|Overall Study|Lost to Follow-up|1
4641084|NCT01986647|7516313|FG002|Overall Study|Lost to Follow-up|4
4641085|NCT01986647|7516314|FG003|Overall Study|Lost to Follow-up|4
4641086|NCT01986647|7516311|FG000|Overall Study|Withdrawal by Subject|1
4641087|NCT01986647|7516312|FG001|Overall Study|Withdrawal by Subject|3
4641088|NCT01986647|7516313|FG002|Overall Study|Withdrawal by Subject|2
4641089|NCT01986647|7516314|FG003|Overall Study|Withdrawal by Subject|3
4641090|NCT01986647|7516311|FG000|Overall Study|Health|5
4641091|NCT01986647|7516312|FG001|Overall Study|Health|3
4641092|NCT01986647|7516313|FG002|Overall Study|Health|6
4641093|NCT01986647|7516314|FG003|Overall Study|Health|4
4641094|NCT01986829|7516350|FG000|Overall Study|Death|1
4641095|NCT01986855|7516360|FG000|Overall Study|Adverse Event|1
4641096|NCT01986855|7516361|FG001|Overall Study|Adverse Event|0
4641097|NCT01986855|7516362|FG002|Overall Study|Adverse Event|0
4641098|NCT01986855|7516360|FG000|Overall Study|Death|3
4641099|NCT01986855|7516361|FG001|Overall Study|Death|4
4641100|NCT01986855|7516362|FG002|Overall Study|Death|4
4641101|NCT01986855|7516360|FG000|Overall Study|Lost to Follow-up|2
4641102|NCT01986855|7516361|FG001|Overall Study|Lost to Follow-up|1
4641103|NCT01986855|7516362|FG002|Overall Study|Lost to Follow-up|0
4641104|NCT01986855|7516360|FG000|Overall Study|Screen Failure|0
4641105|NCT01986855|7516361|FG001|Overall Study|Screen Failure|1
4641106|NCT01986855|7516362|FG002|Overall Study|Screen Failure|0
4641107|NCT01986855|7516360|FG000|Overall Study|Participant Moved|0
4641108|NCT01986855|7516361|FG001|Overall Study|Participant Moved|0
4641109|NCT01986855|7516362|FG002|Overall Study|Participant Moved|2
4641110|NCT01986855|7516360|FG000|Overall Study|Withdrawal by Subject|7
4641111|NCT01986855|7516361|FG001|Overall Study|Withdrawal by Subject|8
4641112|NCT01986855|7516362|FG002|Overall Study|Withdrawal by Subject|5
4641113|NCT01986881|7516373|FG000|Overall Study|Death|228
4641114|NCT01986881|7516374|FG001|Overall Study|Death|233
4641115|NCT01986881|7516375|FG002|Overall Study|Death|247
4641116|NCT01986881|7516373|FG000|Overall Study|Lost to Follow-up|51
4641117|NCT01986881|7516374|FG001|Overall Study|Lost to Follow-up|44
4641118|NCT01986881|7516375|FG002|Overall Study|Lost to Follow-up|55
4641119|NCT01986881|7516373|FG000|Overall Study|Physician Decision|7
4641120|NCT01986881|7516374|FG001|Overall Study|Physician Decision|4
4641121|NCT01986881|7516375|FG002|Overall Study|Physician Decision|6
4641122|NCT01986881|7516373|FG000|Overall Study|Study Site Terminated by Sponsor|2
4641123|NCT01986881|7516374|FG001|Overall Study|Study Site Terminated by Sponsor|2
4641124|NCT01986881|7516375|FG002|Overall Study|Study Site Terminated by Sponsor|3
4641125|NCT01986881|7516373|FG000|Overall Study|Withdrawal by Subject|41
4641126|NCT01986881|7516374|FG001|Overall Study|Withdrawal by Subject|60
4641127|NCT01986881|7516375|FG002|Overall Study|Withdrawal by Subject|45
4641128|NCT01986881|7516373|FG000|Overall Study|Subject Moved|0
4641129|NCT01986881|7516374|FG001|Overall Study|Subject Moved|1
4641130|NCT01986881|7516375|FG002|Overall Study|Subject Moved|0
4641131|NCT01986881|7516373|FG000|Overall Study|Other|1
4641132|NCT01986881|7516374|FG001|Overall Study|Other|2
4641133|NCT01986881|7516375|FG002|Overall Study|Other|2
4641134|NCT01986907|7516406|FG000|Overall Study|Adverse Event|11
4641135|NCT01986907|7516406|FG000|Overall Study|Unsatisfactory therapeutic effect|24
4641136|NCT01986907|7516406|FG000|Overall Study|Protocol Violation|4
4641137|NCT01986907|7516406|FG000|Overall Study|Withdrawal by Subject|76
4641138|NCT01986907|7516406|FG000|Overall Study|Lost to Follow-up|38
4641139|NCT01986907|7516406|FG000|Overall Study|Death|9
4641140|NCT01986920|7516413|FG000|A- 101 25%|Withdrawal by Subject|1
4641141|NCT01986920|7516414|FG001|A- 101 25%|Withdrawal by Subject|0
4641142|NCT01986920|7516415|FG002|A- 101 25%|Withdrawal by Subject|0
4641143|NCT01986920|7516416|FG003|A- 101 25%|Withdrawal by Subject|0
4641144|NCT01986920|7516413|FG000|A-101 32.5%|Withdrawal by Subject|0
4641145|NCT01986920|7516414|FG001|A-101 32.5%|Withdrawal by Subject|1
4641146|NCT01986920|7516415|FG002|A-101 32.5%|Withdrawal by Subject|0
4641147|NCT01986920|7516416|FG003|A-101 32.5%|Withdrawal by Subject|0
4641148|NCT01986920|7516413|FG000|A-101 40%|Withdrawal by Subject|0
4641149|NCT01986920|7516414|FG001|A-101 40%|Withdrawal by Subject|0
4641150|NCT01986920|7516415|FG002|A-101 40%|Withdrawal by Subject|1
4641151|NCT01986920|7516416|FG003|A-101 40%|Withdrawal by Subject|0
4641152|NCT01986920|7516413|FG000|Placebo|Withdrawal by Subject|0
4641153|NCT01986920|7516414|FG001|Placebo|Withdrawal by Subject|0
4641154|NCT01986920|7516415|FG002|Placebo|Withdrawal by Subject|0
4641155|NCT01986920|7516416|FG003|Placebo|Withdrawal by Subject|1
4641156|NCT01986985|7516435|FG000|Overall Study|Withdrawal by Subject|4
4641157|NCT01986985|7516435|FG000|Overall Study|Scan not completed due to malfunction|3
4641158|NCT01987102|7516450|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2
4641159|NCT01987102|7516451|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2
4641160|NCT01987102|7516450|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1
4641161|NCT01987102|7516451|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2
4641162|NCT01987102|7516450|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1
4641163|NCT01987102|7516451|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0
4641164|NCT01987102|7516450|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0
4641165|NCT01987102|7516451|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1
4641166|NCT01987102|7516450|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0
4641167|NCT01987102|7516451|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1
4641168|NCT01987102|7516450|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0
4641169|NCT01987102|7516451|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1
4641170|NCT01987232|7516482|FG000|Overall Study|Ongoing in Study|0
4641171|NCT01987232|7516483|FG001|Overall Study|Ongoing in Study|0
4641172|NCT01987232|7516484|FG002|Overall Study|Ongoing in Study|0
4641173|NCT01987232|7516485|FG003|Overall Study|Ongoing in Study|1
4641174|NCT01987232|7516486|FG004|Overall Study|Ongoing in Study|0
4641175|NCT01987427|7516562|FG000|Overall Study|Adverse Event|4
4641176|NCT01987427|7516563|FG001|Overall Study|Adverse Event|2
4641177|NCT01987427|7516564|FG002|Overall Study|Adverse Event|8
4641178|NCT01987427|7516562|FG000|Overall Study|Lost to Follow-up|6
4641179|NCT01987427|7516563|FG001|Overall Study|Lost to Follow-up|6
4641180|NCT01987427|7516564|FG002|Overall Study|Lost to Follow-up|9
4641181|NCT01987427|7516562|FG000|Overall Study|Withdrawal by Subject|2
4641182|NCT01987427|7516563|FG001|Overall Study|Withdrawal by Subject|1
4641183|NCT01987427|7516564|FG002|Overall Study|Withdrawal by Subject|3
4641184|NCT01987427|7516562|FG000|Overall Study|Lack of Efficacy|1
4641185|NCT01987427|7516563|FG001|Overall Study|Lack of Efficacy|0
4641186|NCT01987427|7516564|FG002|Overall Study|Lack of Efficacy|0
4641187|NCT01987427|7516562|FG000|Overall Study|Other|1
4641188|NCT01987427|7516563|FG001|Overall Study|Other|1
4641189|NCT01987427|7516564|FG002|Overall Study|Other|0
4641190|NCT01987453|7516575|FG000|Overall Study|Death|0
4641191|NCT01987453|7516576|FG001|Overall Study|Death|0
4641192|NCT01987453|7516577|FG002|Overall Study|Death|1
4641193|NCT01987453|7516575|FG000|Overall Study|Lack of Efficacy|1
4641194|NCT01987453|7516576|FG001|Overall Study|Lack of Efficacy|12
4641195|NCT01987453|7516577|FG002|Overall Study|Lack of Efficacy|0
4641196|NCT01987479|7516589|FG000|Overall Study|Protocol Violation|1
4641197|NCT01987479|7516589|FG000|Overall Study|Physician Decision|2
4641198|NCT01987479|7516589|FG000|Overall Study|Participant/legal guardian decision|1
4641199|NCT01987479|7516589|FG000|Overall Study|Other|5
4641200|NCT01987479|7516589|FG000|Overall Study|Lost to Follow-up|1
4641201|NCT01987479|7516589|FG000|Overall Study|Adverse Event|7
4641202|NCT01987505|7516595|FG000|Overall Study|Other|9
4641203|NCT01987505|7516595|FG000|Overall Study|Withdrawal by Subject|2
4641204|NCT01987505|7516595|FG000|Overall Study|Other Reason|2
4641205|NCT01987505|7516595|FG000|Overall Study|Lost to Follow-up|15
4641206|NCT01987505|7516595|FG000|Overall Study|Investigator Decision|2
4641207|NCT01987505|7516595|FG000|Overall Study|Death|4
4641208|NCT01987557|7516604|FG000|Overall Study|Protocol Violation|1
4641209|NCT01987557|7516605|FG001|Overall Study|Protocol Violation|0
4641210|NCT01987557|7516606|FG002|Overall Study|Protocol Violation|1
4641211|NCT01987557|7516604|FG000|Overall Study|Withdrawal by Subject|2
4641212|NCT01987557|7516605|FG001|Overall Study|Withdrawal by Subject|1
4641213|NCT01987557|7516606|FG002|Overall Study|Withdrawal by Subject|2
4641214|NCT01987557|7516604|FG000|Overall Study|Adverse Event|0
4641215|NCT01987557|7516605|FG001|Overall Study|Adverse Event|2
4641216|NCT01987557|7516606|FG002|Overall Study|Adverse Event|0
4641217|NCT01987596|7516625|FG000|Overall Study|Physician Decision|1
4641218|NCT01987596|7516626|FG001|Overall Study|Physician Decision|0
4641219|NCT01987596|7516625|FG000|Overall Study|Progressive Disease; missing all period|0
4641220|NCT01987596|7516626|FG001|Overall Study|Progressive Disease; missing all period|1
4641221|NCT01987609|7516638|FG000|Overall Study|Adverse Event|1
4641222|NCT01987765|7516656|FG000|Overall Study|Protocol Violation|65
4641223|NCT01987765|7516656|FG000|Overall Study|Lost to Follow-up|37
4641224|NCT01987817|7516662|FG000|Overall Study|Adverse Event|4
4641225|NCT01987817|7516663|FG001|Overall Study|Adverse Event|0
4641226|NCT01987817|7516662|FG000|Overall Study|Withdrawal by Subject|1
4641227|NCT01987817|7516663|FG001|Overall Study|Withdrawal by Subject|1
4641228|NCT01987817|7516662|FG000|Overall Study|Physician Decision|1
4641229|NCT01987817|7516663|FG001|Overall Study|Physician Decision|0
4641230|NCT01987830|7516670|FG000|Overall Study|Never received baseline scan|1
4641231|NCT01987895|7516676|FG000|Overall Study|Withdrawal by Subject|12
4641232|NCT01987895|7516677|FG001|Overall Study|Withdrawal by Subject|7
4641233|NCT01987895|7516676|FG000|Overall Study|Physician Decision|8
4641234|NCT01987895|7516677|FG001|Overall Study|Physician Decision|10
4641235|NCT01987895|7516676|FG000|Overall Study|Death|7
4641236|NCT01987895|7516677|FG001|Overall Study|Death|7
4641237|NCT01987895|7516676|FG000|Overall Study|Lost to Follow-up|3
4641238|NCT01987895|7516677|FG001|Overall Study|Lost to Follow-up|5
4641239|NCT01987895|7516676|FG000|Overall Study|randomized before giving IC|0
4641240|NCT01987895|7516677|FG001|Overall Study|randomized before giving IC|1
4641241|NCT01987908|7516683|FG000|Placebo Lead-in Period|Adverse Event|2
4641242|NCT01987908|7516684|FG001|Placebo Lead-in Period|Adverse Event|0
4641243|NCT01987908|7516685|FG002|Placebo Lead-in Period|Adverse Event|0
4641244|NCT01987908|7516683|FG000|Placebo Lead-in Period|Physician Decision|2
4641245|NCT01987908|7516684|FG001|Placebo Lead-in Period|Physician Decision|0
4641246|NCT01987908|7516685|FG002|Placebo Lead-in Period|Physician Decision|0
4641247|NCT01987908|7516683|FG000|Placebo Lead-in Period|Withdrawal by Subject|1
4641248|NCT01987908|7516684|FG001|Placebo Lead-in Period|Withdrawal by Subject|0
4641249|NCT01987908|7516685|FG002|Placebo Lead-in Period|Withdrawal by Subject|0
4641250|NCT01987908|7516683|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4
4641251|NCT01987908|7516684|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0
4641252|NCT01987908|7516685|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0
4641253|NCT01987908|7516683|FG000|Treatment Period|Adverse Event|0
4641254|NCT01987908|7516684|FG001|Treatment Period|Adverse Event|1
4641255|NCT01987908|7516685|FG002|Treatment Period|Adverse Event|1
4641256|NCT01987908|7516683|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0
4641257|NCT01987908|7516684|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2
4641258|NCT01987908|7516685|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0
4641259|NCT01987908|7516683|FG000|Post-Treatment Observation Period|Other: Bad Veins|0
4641260|NCT01987908|7516684|FG001|Post-Treatment Observation Period|Other: Bad Veins|1
4641261|NCT01987908|7516685|FG002|Post-Treatment Observation Period|Other: Bad Veins|0
4641262|NCT01987960|7516711|FG000|Period 1|Adverse Event|24
4641263|NCT01987960|7516712|FG001|Period 1|Adverse Event|0
4641264|NCT01987960|7516713|FG002|Period 1|Adverse Event|0
4641265|NCT01987960|7516714|FG003|Period 1|Adverse Event|0
4641266|NCT01987960|7516711|FG000|Period 1|Lack of Efficacy|4
4641267|NCT01987960|7516712|FG001|Period 1|Lack of Efficacy|0
4641268|NCT01987960|7516713|FG002|Period 1|Lack of Efficacy|0
4641269|NCT01987960|7516714|FG003|Period 1|Lack of Efficacy|0
4641270|NCT01987960|7516711|FG000|Period 1|Non-compliance with IMP|6
4641271|NCT01987960|7516712|FG001|Period 1|Non-compliance with IMP|0
4641272|NCT01987960|7516713|FG002|Period 1|Non-compliance with IMP|0
4641273|NCT01987960|7516714|FG003|Period 1|Non-compliance with IMP|0
4641274|NCT01987960|7516711|FG000|Period 1|Protocol Violation|12
4641275|NCT01987960|7516712|FG001|Period 1|Protocol Violation|0
4641276|NCT01987960|7516713|FG002|Period 1|Protocol Violation|0
4641277|NCT01987960|7516714|FG003|Period 1|Protocol Violation|0
4641278|NCT01987960|7516711|FG000|Period 1|Withdrawal by Subject|21
4641279|NCT01987960|7516712|FG001|Period 1|Withdrawal by Subject|0
4641280|NCT01987960|7516713|FG002|Period 1|Withdrawal by Subject|0
4641281|NCT01987960|7516714|FG003|Period 1|Withdrawal by Subject|0
4641282|NCT01987960|7516711|FG000|Period 1|Lost to Follow-up|40
4641283|NCT01987960|7516712|FG001|Period 1|Lost to Follow-up|0
4641284|NCT01987960|7516713|FG002|Period 1|Lost to Follow-up|0
4641285|NCT01987960|7516714|FG003|Period 1|Lost to Follow-up|0
4641286|NCT01987960|7516711|FG000|Period 1|administrative or other reason|75
4641287|NCT01987960|7516712|FG001|Period 1|administrative or other reason|0
4641288|NCT01987960|7516713|FG002|Period 1|administrative or other reason|0
4641289|NCT01987960|7516714|FG003|Period 1|administrative or other reason|0
4641290|NCT01987960|7516711|FG000|Period 1|Withdrawal of consent before treatment|4
4641291|NCT01987960|7516712|FG001|Period 1|Withdrawal of consent before treatment|0
4641292|NCT01987960|7516713|FG002|Period 1|Withdrawal of consent before treatment|0
4641293|NCT01987960|7516714|FG003|Period 1|Withdrawal of consent before treatment|0
4641294|NCT01987960|7516711|FG000|Period 2|Adverse Event|0
4641295|NCT01987960|7516712|FG001|Period 2|Adverse Event|0
4641296|NCT01987960|7516713|FG002|Period 2|Adverse Event|1
4641297|NCT01987960|7516714|FG003|Period 2|Adverse Event|0
4641298|NCT01987960|7516711|FG000|Period 2|Withdrawal by Subject|0
4641299|NCT01987960|7516712|FG001|Period 2|Withdrawal by Subject|0
4641300|NCT01987960|7516713|FG002|Period 2|Withdrawal by Subject|1
4641301|NCT01987960|7516714|FG003|Period 2|Withdrawal by Subject|0
4641302|NCT01987960|7516711|FG000|Period 2|Administrative or other reason|0
4641303|NCT01987960|7516712|FG001|Period 2|Administrative or other reason|5
4641304|NCT01987960|7516713|FG002|Period 2|Administrative or other reason|7
4641305|NCT01987960|7516714|FG003|Period 2|Administrative or other reason|0
4641306|NCT01987960|7516711|FG000|Period 3|Adverse Event|0
4641307|NCT01987960|7516712|FG001|Period 3|Adverse Event|0
4641308|NCT01987960|7516713|FG002|Period 3|Adverse Event|0
4641309|NCT01987960|7516714|FG003|Period 3|Adverse Event|7
4641310|NCT01987960|7516711|FG000|Period 3|Non-compliance with IMP|0
4641311|NCT01987960|7516712|FG001|Period 3|Non-compliance with IMP|0
4641312|NCT01987960|7516713|FG002|Period 3|Non-compliance with IMP|0
4641313|NCT01987960|7516714|FG003|Period 3|Non-compliance with IMP|1
4641314|NCT01987960|7516711|FG000|Period 3|Protocol Violation|0
4641315|NCT01987960|7516712|FG001|Period 3|Protocol Violation|0
4641316|NCT01987960|7516713|FG002|Period 3|Protocol Violation|0
4641317|NCT01987960|7516714|FG003|Period 3|Protocol Violation|6
4641318|NCT01987960|7516711|FG000|Period 3|Withdrawal by Subject|0
4641319|NCT01987960|7516712|FG001|Period 3|Withdrawal by Subject|0
4641320|NCT01987960|7516713|FG002|Period 3|Withdrawal by Subject|0
4641321|NCT01987960|7516714|FG003|Period 3|Withdrawal by Subject|9
4641322|NCT01987960|7516711|FG000|Period 3|Lost to Follow-up|0
4641323|NCT01987960|7516712|FG001|Period 3|Lost to Follow-up|0
4641324|NCT01987960|7516713|FG002|Period 3|Lost to Follow-up|0
4641325|NCT01987960|7516714|FG003|Period 3|Lost to Follow-up|5
4641326|NCT01987960|7516711|FG000|Period 3|Administrative or other reason|0
4641327|NCT01987960|7516712|FG001|Period 3|Administrative or other reason|0
4641328|NCT01987960|7516713|FG002|Period 3|Administrative or other reason|0
4641329|NCT01987960|7516714|FG003|Period 3|Administrative or other reason|43
4641330|NCT01987986|7516728|FG000|Overall Study|Lost to Follow-up|1
4641331|NCT01987986|7516729|FG001|Overall Study|Lost to Follow-up|0
4641332|NCT01987986|7516730|FG002|Overall Study|Lost to Follow-up|0
4641333|NCT01987986|7516731|FG003|Overall Study|Lost to Follow-up|0
4641334|NCT01987986|7516728|FG000|Overall Study|Adverse Event|1
4641335|NCT01987986|7516729|FG001|Overall Study|Adverse Event|0
4641336|NCT01987986|7516730|FG002|Overall Study|Adverse Event|2
4641337|NCT01987986|7516731|FG003|Overall Study|Adverse Event|0
4641338|NCT01988012|7516741|FG000|Overall Study|Adverse Event|5
4641339|NCT01988012|7516741|FG000|Overall Study|Insufficient Therapeutic Response|3
4641340|NCT01988012|7516741|FG000|Overall Study|Patient Withdrawal of Consent|4
4641341|NCT01988012|7516741|FG000|Overall Study|Lost to Follow-up|1
4641342|NCT01988012|7516741|FG000|Overall Study|Physician Decision|1
4641343|NCT01988012|7516741|FG000|Overall Study|Protocol Violation|1
4641344|NCT01988090|7516747|FG000|Start Treament After Randomization|Withdrawal by Subject|2
4641345|NCT01988090|7516748|FG001|Start Treament After Randomization|Withdrawal by Subject|3
4641346|NCT01988090|7516747|FG000|Start Treament After Randomization|Protocol Violation|0
4641347|NCT01988090|7516748|FG001|Start Treament After Randomization|Protocol Violation|1
4641348|NCT01988090|7516747|FG000|Complete Study After Start|Withdrawal by Subject|2
4641349|NCT01988090|7516748|FG001|Complete Study After Start|Withdrawal by Subject|0
4641350|NCT01988090|7516747|FG000|Complete Study After Start|Protocol Violation|1
4641351|NCT01988090|7516748|FG001|Complete Study After Start|Protocol Violation|1
4641352|NCT01988103|7516757|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3
4641353|NCT01988103|7516758|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10
4641354|NCT01988103|7516759|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6
4641355|NCT01988103|7516760|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0
4641356|NCT01988103|7516761|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0
4641357|NCT01988103|7516757|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1
4641358|NCT01988103|7516758|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2
4641359|NCT01988103|7516759|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2
4641360|NCT01988103|7516760|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0
4641361|NCT01988103|7516761|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0
4641362|NCT01988103|7516757|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8
4641363|NCT01988103|7516758|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4
4641364|NCT01988103|7516759|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1
4641365|NCT01988103|7516760|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0
4641366|NCT01988103|7516761|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0
4641367|NCT01988103|7516757|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0
4641368|NCT01988103|7516758|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6
4641369|NCT01988103|7516759|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3
4641370|NCT01988103|7516760|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3
4641371|NCT01988103|7516761|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2
4641372|NCT01988103|7516757|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0
4641373|NCT01988103|7516758|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1
4641374|NCT01988103|7516759|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2
4641375|NCT01988103|7516760|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0
4641376|NCT01988103|7516761|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0
4641377|NCT01988103|7516757|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0
4641378|NCT01988103|7516758|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5
4641379|NCT01988103|7516759|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4
4641380|NCT01988103|7516760|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0
4641381|NCT01988103|7516761|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1
4641382|NCT01988103|7516757|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0
4641383|NCT01988103|7516758|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1
4641384|NCT01988103|7516759|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2
4641385|NCT01988103|7516760|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0
4641386|NCT01988103|7516761|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2
4641387|NCT01988402|7516808|FG000|Overall Study|Adverse Event|1
4641388|NCT01988402|7516809|FG001|Overall Study|Adverse Event|2
4641389|NCT01988402|7516808|FG000|Overall Study|Withdrawal by Subject|1
4641390|NCT01988402|7516809|FG001|Overall Study|Withdrawal by Subject|0
4641391|NCT01988662|7516823|FG000|Overall Study|Subject/guardian decision|1
4641392|NCT01988662|7516824|FG001|Overall Study|Subject/guardian decision|1
4641393|NCT01988662|7516823|FG000|Overall Study|Adverse Event|3
4641394|NCT01988662|7516824|FG001|Overall Study|Adverse Event|1
4641395|NCT01988779|7516833|FG000|Overall Study|Withdrawal by Subject|2
4641396|NCT01988779|7516834|FG001|Overall Study|Withdrawal by Subject|2
4641397|NCT01988779|7516833|FG000|Overall Study|Protocol Violation|1
4641398|NCT01988779|7516834|FG001|Overall Study|Protocol Violation|0
4641399|NCT01989156|7516872|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0
4641400|NCT01989156|7516873|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
4641401|NCT01989156|7516874|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3
4641402|NCT01989156|7516872|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0
4641403|NCT01989156|7516873|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0
4641404|NCT01989156|7516874|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1
4641405|NCT01989156|7516872|FG000|Confinement Period (Population at Day 5)|Adverse Event|0
4641406|NCT01989156|7516873|FG001|Confinement Period (Population at Day 5)|Adverse Event|0
4641407|NCT01989156|7516874|FG002|Confinement Period (Population at Day 5)|Adverse Event|1
4641408|NCT01989156|7516872|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2
4641409|NCT01989156|7516873|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2
4641410|NCT01989156|7516874|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2
4641411|NCT01989156|7516872|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3
4641412|NCT01989156|7516873|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2
4641413|NCT01989156|7516874|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0
4641414|NCT01989156|7516872|FG000|End of Study (Population at Day 90)|Physician Decision|1
4641415|NCT01989156|7516873|FG001|End of Study (Population at Day 90)|Physician Decision|0
4641416|NCT01989156|7516874|FG002|End of Study (Population at Day 90)|Physician Decision|1
4641417|NCT01989156|7516872|FG000|End of Study (Population at Day 90)|Moved out of state|1
4641418|NCT01989156|7516873|FG001|End of Study (Population at Day 90)|Moved out of state|0
4641419|NCT01989156|7516874|FG002|End of Study (Population at Day 90)|Moved out of state|0
4641420|NCT01989156|7516872|FG000|End of Study (Population at Day 90)|Employment Conflict|0
4641421|NCT01989156|7516873|FG001|End of Study (Population at Day 90)|Employment Conflict|1
4641422|NCT01989156|7516874|FG002|End of Study (Population at Day 90)|Employment Conflict|0
4641423|NCT01989169|7516884|FG000|Period 2|Adverse Event|0
4641424|NCT01989169|7516885|FG001|Period 2|Adverse Event|1
4641425|NCT01989208|7516900|FG000|200 mg (7 Days)|Protocol Violation|0
4641426|NCT01989208|7516901|FG001|200 mg (7 Days)|Protocol Violation|1
4641427|NCT01989455|7516928|FG000|Overall Study|Adverse Event|0
4641428|NCT01989455|7516929|FG001|Overall Study|Adverse Event|1
4641429|NCT01989455|7516930|FG002|Overall Study|Adverse Event|0
4641430|NCT01989455|7516931|FG003|Overall Study|Adverse Event|0
4641431|NCT01989455|7516932|FG004|Overall Study|Adverse Event|0
4641432|NCT01989455|7516928|FG000|Overall Study|Withdrawal by Subject|0
4641433|NCT01989455|7516929|FG001|Overall Study|Withdrawal by Subject|1
4641434|NCT01989455|7516930|FG002|Overall Study|Withdrawal by Subject|0
4641435|NCT01989455|7516931|FG003|Overall Study|Withdrawal by Subject|0
4641436|NCT01989455|7516932|FG004|Overall Study|Withdrawal by Subject|0
4641437|NCT01989455|7516928|FG000|Overall Study|Technical problems with infusion|0
4641438|NCT01989455|7516929|FG001|Overall Study|Technical problems with infusion|0
4641439|NCT01989455|7516930|FG002|Overall Study|Technical problems with infusion|1
4641440|NCT01989455|7516931|FG003|Overall Study|Technical problems with infusion|0
4641441|NCT01989455|7516932|FG004|Overall Study|Technical problems with infusion|1
4641442|NCT01989468|7516951|FG000|Overall Study|Adverse Event|10
4641443|NCT01989468|7516952|FG001|Overall Study|Adverse Event|15
4641444|NCT01989468|7516953|FG002|Overall Study|Adverse Event|4
4641445|NCT01989468|7516954|FG003|Overall Study|Adverse Event|5
4641446|NCT01989468|7516955|FG004|Overall Study|Adverse Event|4
4641447|NCT01989468|7516951|FG000|Overall Study|Lack of Efficacy|11
4641448|NCT01989468|7516952|FG001|Overall Study|Lack of Efficacy|11
4641449|NCT01989468|7516953|FG002|Overall Study|Lack of Efficacy|7
4641450|NCT01989468|7516954|FG003|Overall Study|Lack of Efficacy|4
4641451|NCT01989468|7516955|FG004|Overall Study|Lack of Efficacy|2
4641452|NCT01989468|7516951|FG000|Overall Study|Lost to Follow-up|5
4641453|NCT01989468|7516952|FG001|Overall Study|Lost to Follow-up|2
4641454|NCT01989468|7516953|FG002|Overall Study|Lost to Follow-up|0
4641455|NCT01989468|7516954|FG003|Overall Study|Lost to Follow-up|1
4641456|NCT01989468|7516955|FG004|Overall Study|Lost to Follow-up|1
4641457|NCT01989468|7516951|FG000|Overall Study|Physician Decision|4
4641458|NCT01989468|7516952|FG001|Overall Study|Physician Decision|1
4641459|NCT01989468|7516953|FG002|Overall Study|Physician Decision|0
4641460|NCT01989468|7516954|FG003|Overall Study|Physician Decision|1
4641461|NCT01989468|7516955|FG004|Overall Study|Physician Decision|0
4641462|NCT01989468|7516951|FG000|Overall Study|Pregnancy|0
4641463|NCT01989468|7516952|FG001|Overall Study|Pregnancy|1
4641464|NCT01989468|7516953|FG002|Overall Study|Pregnancy|0
4641465|NCT01989468|7516954|FG003|Overall Study|Pregnancy|0
4641466|NCT01989468|7516955|FG004|Overall Study|Pregnancy|0
4641467|NCT01989468|7516951|FG000|Overall Study|Technical Problems|3
4641468|NCT01989468|7516952|FG001|Overall Study|Technical Problems|1
4641469|NCT01989468|7516953|FG002|Overall Study|Technical Problems|3
4641470|NCT01989468|7516954|FG003|Overall Study|Technical Problems|1
4641471|NCT01989468|7516955|FG004|Overall Study|Technical Problems|0
4641472|NCT01989468|7516951|FG000|Overall Study|Subject Guardian Decision|11
4641473|NCT01989468|7516952|FG001|Overall Study|Subject Guardian Decision|6
4641474|NCT01989468|7516953|FG002|Overall Study|Subject Guardian Decision|4
4641475|NCT01989468|7516954|FG003|Overall Study|Subject Guardian Decision|4
4641476|NCT01989468|7516955|FG004|Overall Study|Subject Guardian Decision|1
4641477|NCT01989468|7516951|FG000|Overall Study|Death|3
4641478|NCT01989468|7516952|FG001|Overall Study|Death|0
4641479|NCT01989468|7516953|FG002|Overall Study|Death|1
4641480|NCT01989468|7516954|FG003|Overall Study|Death|0
4641481|NCT01989468|7516955|FG004|Overall Study|Death|0
4641482|NCT01989546|7516968|FG000|Overall Study|Clinical Progression|1
4641483|NCT01989546|7516968|FG000|Overall Study|Disease progression on study|8
4641484|NCT01989572|7516978|FG000|Overall Study|Lack of Efficacy|35
4641485|NCT01989572|7516979|FG001|Overall Study|Lack of Efficacy|48
4641486|NCT01989572|7516980|FG002|Overall Study|Lack of Efficacy|48
4641487|NCT01989572|7516981|FG003|Overall Study|Lack of Efficacy|43
4641488|NCT01989572|7516982|FG004|Overall Study|Lack of Efficacy|71
4641489|NCT01989572|7516983|FG005|Overall Study|Lack of Efficacy|79
4641490|NCT01989572|7516978|FG000|Overall Study|Adverse Event|2
4641491|NCT01989572|7516979|FG001|Overall Study|Adverse Event|1
4641492|NCT01989572|7516980|FG002|Overall Study|Adverse Event|3
4641493|NCT01989572|7516981|FG003|Overall Study|Adverse Event|0
4641494|NCT01989572|7516982|FG004|Overall Study|Adverse Event|3
4641495|NCT01989572|7516983|FG005|Overall Study|Adverse Event|0
4641496|NCT01989572|7516978|FG000|Overall Study|Death|0
4641497|NCT01989572|7516979|FG001|Overall Study|Death|0
4641498|NCT01989572|7516980|FG002|Overall Study|Death|0
4641499|NCT01989572|7516981|FG003|Overall Study|Death|0
4641500|NCT01989572|7516982|FG004|Overall Study|Death|1
4641501|NCT01989572|7516983|FG005|Overall Study|Death|0
4641502|NCT01989572|7516978|FG000|Overall Study|Withdrawal by Subject|4
4641503|NCT01989572|7516979|FG001|Overall Study|Withdrawal by Subject|1
4641504|NCT01989572|7516980|FG002|Overall Study|Withdrawal by Subject|5
4641505|NCT01989572|7516981|FG003|Overall Study|Withdrawal by Subject|1
4641506|NCT01989572|7516982|FG004|Overall Study|Withdrawal by Subject|12
4641507|NCT01989572|7516983|FG005|Overall Study|Withdrawal by Subject|4
4641508|NCT01989572|7516978|FG000|Overall Study|complicating disease|1
4641509|NCT01989572|7516979|FG001|Overall Study|complicating disease|1
4641510|NCT01989572|7516980|FG002|Overall Study|complicating disease|2
4641511|NCT01989572|7516981|FG003|Overall Study|complicating disease|0
4641512|NCT01989572|7516982|FG004|Overall Study|complicating disease|1
4641513|NCT01989572|7516983|FG005|Overall Study|complicating disease|0
4641514|NCT01989572|7516978|FG000|Overall Study|error|2
4641515|NCT01989572|7516979|FG001|Overall Study|error|1
4641516|NCT01989572|7516980|FG002|Overall Study|error|1
4641517|NCT01989572|7516981|FG003|Overall Study|error|1
4641518|NCT01989572|7516982|FG004|Overall Study|error|1
4641519|NCT01989572|7516983|FG005|Overall Study|error|1
4641520|NCT01989572|7516978|FG000|Overall Study|maximum dose reached|0
4641521|NCT01989572|7516979|FG001|Overall Study|maximum dose reached|1
4641522|NCT01989572|7516980|FG002|Overall Study|maximum dose reached|0
4641523|NCT01989572|7516981|FG003|Overall Study|maximum dose reached|0
4641524|NCT01989572|7516982|FG004|Overall Study|maximum dose reached|1
4641525|NCT01989572|7516983|FG005|Overall Study|maximum dose reached|0
4641526|NCT01989572|7516978|FG000|Overall Study|unknown/not specify|3
4641527|NCT01989572|7516979|FG001|Overall Study|unknown/not specify|4
4641528|NCT01989572|7516980|FG002|Overall Study|unknown/not specify|1
4641529|NCT01989572|7516981|FG003|Overall Study|unknown/not specify|3
4641530|NCT01989572|7516982|FG004|Overall Study|unknown/not specify|3
4641531|NCT01989572|7516983|FG005|Overall Study|unknown/not specify|5
4641532|NCT01989572|7516978|FG000|Overall Study|not start protocol therapy|5
4641533|NCT01989572|7516979|FG001|Overall Study|not start protocol therapy|1
4641534|NCT01989572|7516980|FG002|Overall Study|not start protocol therapy|2
4641535|NCT01989572|7516981|FG003|Overall Study|not start protocol therapy|3
4641536|NCT01989572|7516982|FG004|Overall Study|not start protocol therapy|4
4641537|NCT01989572|7516983|FG005|Overall Study|not start protocol therapy|18
4641538|NCT01989572|7516978|FG000|Overall Study|alternative therapy|3
4641539|NCT01989572|7516979|FG001|Overall Study|alternative therapy|0
4641540|NCT01989572|7516980|FG002|Overall Study|alternative therapy|0
4641541|NCT01989572|7516981|FG003|Overall Study|alternative therapy|0
4641542|NCT01989572|7516982|FG004|Overall Study|alternative therapy|1
4641543|NCT01989572|7516983|FG005|Overall Study|alternative therapy|3
4641544|NCT01989689|7517003|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0
4641545|NCT01989689|7517004|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2
4641546|NCT01989689|7517003|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0
4641547|NCT01989689|7517004|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1
4641548|NCT01989754|7517014|FG000|Overall Study|Withdrawal by Subject|10
4641549|NCT01989754|7517015|FG001|Overall Study|Withdrawal by Subject|14
4641550|NCT01989754|7517014|FG000|Overall Study|Lost to Follow-up|28
4641551|NCT01989754|7517015|FG001|Overall Study|Lost to Follow-up|20
4641552|NCT01989754|7517014|FG000|Overall Study|Closed Site|1
4641553|NCT01989754|7517015|FG001|Overall Study|Closed Site|1
4747267|NCT00062751|7720869|FG004|Overall Study|Other|1
4747268|NCT00062751|7720865|FG000|Overall Study|Withdrawal by Subject|1
4747269|NCT00062751|7720866|FG001|Overall Study|Withdrawal by Subject|2
4747270|NCT00062751|7720867|FG002|Overall Study|Withdrawal by Subject|2
4747271|NCT00062751|7720868|FG003|Overall Study|Withdrawal by Subject|1
4747272|NCT00062751|7720869|FG004|Overall Study|Withdrawal by Subject|0
4641554|NCT01990261|7517043|FG000|Overall Study|Death Before Treatment Start|2
4641555|NCT01990261|7517043|FG000|Overall Study|Death due to Disease Progression (PD)|10
4641556|NCT01990261|7517043|FG000|Overall Study|Death From other Causes|1
4641557|NCT01990261|7517043|FG000|Overall Study|Disease Progression (PD)|8
4641558|NCT01990261|7517043|FG000|Overall Study|PD Before Treatment Start|1
4641559|NCT01990261|7517043|FG000|Overall Study|Dossier not Approved|1
4641560|NCT01990261|7517043|FG000|Overall Study|Lost to Follow-up|2
4641561|NCT01990300|7517047|FG000|Overall Study|Case Report Forms Uncollected|89
4641562|NCT01990300|7517047|FG000|Overall Study|Protocol Deviation|53
4641563|NCT01990313|7517051|FG000|Overall Study|Lost to Follow-up|1
4641564|NCT01990339|7517055|FG000|Overall Study|Data Not Available|49
4641565|NCT01990339|7517055|FG000|Overall Study|Voluntary Withdrawal|1402
4641566|NCT01990339|7517055|FG000|Overall Study|Lost to Follow-up|861
4641567|NCT01990495|7517061|FG000|Overall Study|Physician Decision|5
4641568|NCT01990495|7517062|FG001|Overall Study|Physician Decision|4
4641569|NCT01990534|7517070|FG000|Overall Study|Death|22
4641570|NCT01990534|7517070|FG000|Overall Study|Progressive disease|3
4641571|NCT01990534|7517070|FG000|Overall Study|Protocol Violation|1
4641572|NCT01990534|7517070|FG000|Overall Study|Withdrawal of Informed Consent|2
4641573|NCT01990534|7517070|FG000|Overall Study|Symptomatic Deterioration|1
4641574|NCT01990534|7517070|FG000|Overall Study|Withdrawal by Subject|3
4641575|NCT01990534|7517070|FG000|Overall Study|Reason not Specified|2
4641576|NCT01990534|7517070|FG000|Overall Study|Lost to Follow-up|1
4641577|NCT01990560|7517074|FG000|Overall Study|Withdrawal by Subject|1
4641578|NCT01990573|7517081|FG000|Overall Study|Physician Decision|0
4641579|NCT01990573|7517082|FG001|Overall Study|Physician Decision|0
4641580|NCT01990573|7517083|FG002|Overall Study|Physician Decision|1
4747273|NCT00062751|7720865|FG000|Overall Study|Symptomatic deterioration|1
4747274|NCT00062751|7720866|FG001|Overall Study|Symptomatic deterioration|1
4747275|NCT00062751|7720867|FG002|Overall Study|Symptomatic deterioration|0
4747276|NCT00062751|7720868|FG003|Overall Study|Symptomatic deterioration|0
4747277|NCT00062751|7720869|FG004|Overall Study|Symptomatic deterioration|1
4747278|NCT00062751|7720865|FG000|Overall Study|Death|1
4641581|NCT01990612|7517093|FG000|Overall Study|Lost to Follow-up|2
4641582|NCT01990612|7517094|FG001|Overall Study|Lost to Follow-up|1
4641583|NCT01990612|7517093|FG000|Overall Study|Withdrawal by Subject|5
4641584|NCT01990612|7517094|FG001|Overall Study|Withdrawal by Subject|2
4641585|NCT01990664|7517102|FG000|Overall Study|Lost to Follow-up|2
4641586|NCT01990664|7517103|FG001|Overall Study|Lost to Follow-up|6
4641587|NCT01990664|7517102|FG000|Overall Study|Withdrawal by Subject|2
4641588|NCT01990664|7517103|FG001|Overall Study|Withdrawal by Subject|3
4641589|NCT01990664|7517102|FG000|Overall Study|Protocol Violation|1
4641590|NCT01990664|7517103|FG001|Overall Study|Protocol Violation|0
4641591|NCT01990664|7517102|FG000|Overall Study|Lens Discomfort|1
4641592|NCT01990664|7517103|FG001|Overall Study|Lens Discomfort|1
4641593|NCT01990664|7517102|FG000|Overall Study|Lens Handling Difficulties|1
4641594|NCT01990664|7517103|FG001|Overall Study|Lens Handling Difficulties|0
4641595|NCT01990664|7517102|FG000|Overall Study|Unsatisfactory Visual Response|0
4641596|NCT01990664|7517103|FG001|Overall Study|Unsatisfactory Visual Response|1
4641597|NCT01990742|7517129|FG000|Overall Study|Withdrawal by facility|407
4641598|NCT01990742|7517130|FG001|Overall Study|Withdrawal by facility|1083
4641599|NCT01990742|7517129|FG000|Overall Study|Facility closed|0
4641600|NCT01990742|7517130|FG001|Overall Study|Facility closed|270
4641601|NCT01990768|7517139|FG000|Intervention Started|Found to be ineligible|14
4641602|NCT01990768|7517140|FG001|Intervention Started|Found to be ineligible|13
4641603|NCT01990768|7517141|FG002|Intervention Started|Found to be ineligible|11
4641604|NCT01990768|7517139|FG000|Intervention Started|Study drug issue or kit malfunction|9
4641605|NCT01990768|7517140|FG001|Intervention Started|Study drug issue or kit malfunction|6
4641606|NCT01990768|7517141|FG002|Intervention Started|Study drug issue or kit malfunction|7
4641607|NCT01990768|7517139|FG000|Intervention Started|Patient became ineligible due to vitals|5
4641608|NCT01990768|7517140|FG001|Intervention Started|Patient became ineligible due to vitals|5
4641609|NCT01990768|7517141|FG002|Intervention Started|Patient became ineligible due to vitals|2
4641610|NCT01990768|7517139|FG000|Intervention Started|Not enough time for EMS to enroll|4
4641611|NCT01990768|7517140|FG001|Intervention Started|Not enough time for EMS to enroll|3
4641612|NCT01990768|7517141|FG002|Intervention Started|Not enough time for EMS to enroll|0
4641613|NCT01990768|7517139|FG000|Intervention Started|Patient care priority|1
4641614|NCT01990768|7517140|FG001|Intervention Started|Patient care priority|2
4641615|NCT01990768|7517141|FG002|Intervention Started|Patient care priority|3
4641616|NCT01990768|7517139|FG000|Intervention Started|IV lost|2
4641617|NCT01990768|7517140|FG001|Intervention Started|IV lost|2
4641618|NCT01990768|7517141|FG002|Intervention Started|IV lost|2
4641619|NCT01990768|7517139|FG000|Intervention Started|Required CPR|1
4641620|NCT01990768|7517140|FG001|Intervention Started|Required CPR|1
4641621|NCT01990768|7517141|FG002|Intervention Started|Required CPR|0
4641622|NCT01990768|7517139|FG000|Intervention Started|Seizure or hx of seizure|0
4641623|NCT01990768|7517140|FG001|Intervention Started|Seizure or hx of seizure|0
4641624|NCT01990768|7517141|FG002|Intervention Started|Seizure or hx of seizure|2
4641625|NCT01990768|7517139|FG000|Intervention Started|Discovered to be pregnant|0
4641626|NCT01990768|7517140|FG001|Intervention Started|Discovered to be pregnant|1
4641627|NCT01990768|7517141|FG002|Intervention Started|Discovered to be pregnant|0
4641628|NCT01990768|7517139|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4
4641629|NCT01990768|7517140|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11
4641630|NCT01990768|7517141|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10
4641631|NCT01990768|7517139|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4
4641632|NCT01990768|7517140|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3
4641633|NCT01990768|7517141|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4
4641634|NCT01990768|7517139|FG000|Prehospital Study Drug Infusion|Required CPR|2
4641635|NCT01990768|7517140|FG001|Prehospital Study Drug Infusion|Required CPR|6
4641636|NCT01990768|7517141|FG002|Prehospital Study Drug Infusion|Required CPR|0
4641637|NCT01990768|7517139|FG000|Prehospital Study Drug Infusion|Other safety concern|2
4641638|NCT01990768|7517140|FG001|Prehospital Study Drug Infusion|Other safety concern|1
4641639|NCT01990768|7517141|FG002|Prehospital Study Drug Infusion|Other safety concern|1
4641640|NCT01990768|7517139|FG000|Prehospital Study Drug Infusion|Death|3
4641641|NCT01990768|7517140|FG001|Prehospital Study Drug Infusion|Death|1
4641642|NCT01990768|7517141|FG002|Prehospital Study Drug Infusion|Death|1
4641643|NCT01990768|7517139|FG000|Prehospital Study Drug Infusion|Discharged|2
4641644|NCT01990768|7517140|FG001|Prehospital Study Drug Infusion|Discharged|1
4641645|NCT01990768|7517141|FG002|Prehospital Study Drug Infusion|Discharged|0
4641646|NCT01990768|7517139|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1
4641647|NCT01990768|7517140|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0
4641648|NCT01990768|7517141|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0
4641649|NCT01990768|7517139|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0
4641650|NCT01990768|7517140|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0
4641651|NCT01990768|7517141|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1
4641652|NCT01990768|7517139|FG000|Prehospital Study Drug Infusion|Unknown if completed|1
4641653|NCT01990768|7517140|FG001|Prehospital Study Drug Infusion|Unknown if completed|4
4641654|NCT01990768|7517141|FG002|Prehospital Study Drug Infusion|Unknown if completed|2
4641655|NCT01990768|7517139|FG000|In-Hospital Study Drug Infusion|Discharged|19
4641656|NCT01990768|7517140|FG001|In-Hospital Study Drug Infusion|Discharged|18
4641657|NCT01990768|7517141|FG002|In-Hospital Study Drug Infusion|Discharged|13
4641658|NCT01990768|7517139|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14
4641659|NCT01990768|7517140|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17
4641660|NCT01990768|7517141|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10
4641661|NCT01990768|7517139|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13
4641662|NCT01990768|7517140|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7
4641663|NCT01990768|7517141|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12
4641664|NCT01990768|7517139|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12
4641665|NCT01990768|7517140|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11
4641666|NCT01990768|7517141|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6
4641667|NCT01990768|7517139|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11
4641668|NCT01990768|7517140|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4
4641669|NCT01990768|7517141|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7
4641670|NCT01990768|7517139|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8
4641671|NCT01990768|7517140|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9
4641672|NCT01990768|7517141|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17
4641673|NCT01990768|7517139|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5
4641674|NCT01990768|7517140|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5
4641675|NCT01990768|7517141|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4
4641676|NCT01990768|7517139|FG000|In-Hospital Study Drug Infusion|Required CPR|3
4641677|NCT01990768|7517140|FG001|In-Hospital Study Drug Infusion|Required CPR|7
4641678|NCT01990768|7517141|FG002|In-Hospital Study Drug Infusion|Required CPR|1
4641679|NCT01990768|7517139|FG000|In-Hospital Study Drug Infusion|Other safety concern|4
4641680|NCT01990768|7517140|FG001|In-Hospital Study Drug Infusion|Other safety concern|2
4641681|NCT01990768|7517141|FG002|In-Hospital Study Drug Infusion|Other safety concern|3
4641682|NCT01990768|7517139|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4
4641683|NCT01990768|7517140|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0
4641684|NCT01990768|7517141|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3
4641685|NCT01990768|7517139|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1
4641686|NCT01990768|7517140|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1
4641687|NCT01990768|7517141|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1
4641688|NCT01990768|7517139|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1
4641689|NCT01990768|7517140|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1
4641690|NCT01990768|7517141|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0
4641691|NCT01990768|7517139|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0
4641692|NCT01990768|7517140|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1
4641693|NCT01990768|7517141|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2
4641694|NCT01990768|7517139|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0
4641695|NCT01990768|7517140|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0
4641696|NCT01990768|7517141|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1
4641697|NCT01990768|7517139|FG000|6-Month Follow-up|Withdrawal by Subject|25
4641698|NCT01990768|7517140|FG001|6-Month Follow-up|Withdrawal by Subject|25
4641699|NCT01990768|7517141|FG002|6-Month Follow-up|Withdrawal by Subject|26
4641700|NCT01990768|7517139|FG000|6-Month Follow-up|Calls unreturned or refused contact|4
4641701|NCT01990768|7517140|FG001|6-Month Follow-up|Calls unreturned or refused contact|15
4641702|NCT01990768|7517141|FG002|6-Month Follow-up|Calls unreturned or refused contact|20
4641703|NCT01990768|7517139|FG000|6-Month Follow-up|No contact information|5
4641704|NCT01990768|7517140|FG001|6-Month Follow-up|No contact information|6
4641705|NCT01990768|7517141|FG002|6-Month Follow-up|No contact information|5
4641706|NCT01990768|7517139|FG000|6-Month Follow-up|Homeless|4
4641707|NCT01990768|7517140|FG001|6-Month Follow-up|Homeless|3
4641708|NCT01990768|7517141|FG002|6-Month Follow-up|Homeless|6
4641709|NCT01990768|7517139|FG000|6-Month Follow-up|Prisoner at time of enrollment|0
4641710|NCT01990768|7517140|FG001|6-Month Follow-up|Prisoner at time of enrollment|0
4641711|NCT01990768|7517141|FG002|6-Month Follow-up|Prisoner at time of enrollment|1
4641712|NCT01990768|7517139|FG000|6-Month Follow-up|Prisoner at time of follow-up|0
4641713|NCT01990768|7517140|FG001|6-Month Follow-up|Prisoner at time of follow-up|2
4641714|NCT01990768|7517141|FG002|6-Month Follow-up|Prisoner at time of follow-up|0
4641715|NCT01990768|7517139|FG000|6-Month Follow-up|Patient at psychiatric hospital|1
4641716|NCT01990768|7517140|FG001|6-Month Follow-up|Patient at psychiatric hospital|0
4641717|NCT01990768|7517141|FG002|6-Month Follow-up|Patient at psychiatric hospital|0
4641718|NCT01990859|7517246|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5
4641719|NCT01990859|7517246|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17
4641720|NCT01990950|7517255|FG000|Overall Study|Death|3
4641721|NCT01990950|7517255|FG000|Overall Study|Lost to Follow-up|2
4641722|NCT01990950|7517255|FG000|Overall Study|Withdrawal by Subject|6
4641723|NCT01991197|7517261|FG000|Overall Study|Lost to Follow-up|1
4641724|NCT01991197|7517262|FG001|Overall Study|Lost to Follow-up|1
4641725|NCT01991197|7517261|FG000|Overall Study|Physician Decision|0
4641726|NCT01991197|7517262|FG001|Overall Study|Physician Decision|2
4641727|NCT01991197|7517261|FG000|Overall Study|Withdrawal by Subject|2
4641728|NCT01991197|7517262|FG001|Overall Study|Withdrawal by Subject|0
4641729|NCT01991314|7517275|FG000|Overall Study|Adverse Event|5
4641730|NCT01991314|7517276|FG001|Overall Study|Adverse Event|1
4641731|NCT01991314|7517275|FG000|Overall Study|Lost to Follow-up|6
4641732|NCT01991314|7517276|FG001|Overall Study|Lost to Follow-up|10
4641733|NCT01991470|7517282|FG000|Enlite 1 Period|Withdrawal by Subject|18
4641734|NCT01991470|7517282|FG000|Enlite 1 Period|Adverse Event|1
4641735|NCT01991470|7517282|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1
4641736|NCT01991470|7517282|FG000|Enlite 3 Period|Lost to Follow-up|1
4641737|NCT01991470|7517282|FG000|Enlite 3 Period|Physician Decision|2
4641738|NCT01991470|7517282|FG000|Enlite 3 Period|Physician Decision|8
4641739|NCT01991470|7517282|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1
4641740|NCT01991483|7517298|FG000|Dose Level 600 mg|Withdrawal by Subject|0
4641741|NCT01991483|7517299|FG001|Dose Level 600 mg|Withdrawal by Subject|0
4641742|NCT01991483|7517300|FG002|Dose Level 600 mg|Withdrawal by Subject|1
4641743|NCT01991483|7517301|FG003|Dose Level 600 mg|Withdrawal by Subject|0
4641744|NCT01991483|7517298|FG000|Dose Level 600 mg|Physician Decision|0
4641745|NCT01991483|7517299|FG001|Dose Level 600 mg|Physician Decision|0
4641746|NCT01991483|7517300|FG002|Dose Level 600 mg|Physician Decision|1
4641747|NCT01991483|7517301|FG003|Dose Level 600 mg|Physician Decision|0
4641748|NCT01991483|7517298|FG000|Dose Level 1000 mg|Protocol Violation|0
4641749|NCT01991483|7517299|FG001|Dose Level 1000 mg|Protocol Violation|0
4641750|NCT01991483|7517300|FG002|Dose Level 1000 mg|Protocol Violation|0
4641751|NCT01991483|7517301|FG003|Dose Level 1000 mg|Protocol Violation|1
4641752|NCT01991743|7517331|FG000|Overall Study|external cephalic version not performed|0
4641753|NCT01991743|7517332|FG001|Overall Study|external cephalic version not performed|0
4641754|NCT01991743|7517333|FG002|Overall Study|external cephalic version not performed|1
4641755|NCT01991743|7517334|FG003|Overall Study|external cephalic version not performed|0
4641756|NCT01991795|7517346|FG000|Overall Study|Lost to Follow-up|6
4641757|NCT01991795|7517347|FG001|Overall Study|Lost to Follow-up|4
4641758|NCT01991795|7517346|FG000|Overall Study|Withdrawal by Subject|117
4641759|NCT01991795|7517347|FG001|Overall Study|Withdrawal by Subject|94
4641760|NCT01991795|7517346|FG000|Overall Study|Site prematurely closed by sponsor|26
4641761|NCT01991795|7517347|FG001|Overall Study|Site prematurely closed by sponsor|25
4641762|NCT01991977|7517377|FG000|Overall Study|Withdrew prior to receiving treatment|7
4641763|NCT01991977|7517377|FG000|Overall Study|Withdrew after start of treatment|5
4641764|NCT01992094|7517406|FG000|Overall Study|ADMINISTRATIVE REASON|6
4641765|NCT01992094|7517407|FG001|Overall Study|ADMINISTRATIVE REASON|7
4641766|NCT01992094|7517408|FG002|Overall Study|ADMINISTRATIVE REASON|1
4641767|NCT01992094|7517406|FG000|Overall Study|Adverse Event|1
4641768|NCT01992094|7517407|FG001|Overall Study|Adverse Event|0
4641769|NCT01992094|7517408|FG002|Overall Study|Adverse Event|0
4641770|NCT01992094|7517406|FG000|Overall Study|Death|5
4641771|NCT01992094|7517407|FG001|Overall Study|Death|5
4641772|NCT01992094|7517408|FG002|Overall Study|Death|2
4641773|NCT01992094|7517406|FG000|Overall Study|Lost to Follow-up|26
4641774|NCT01992094|7517407|FG001|Overall Study|Lost to Follow-up|9
4641775|NCT01992094|7517408|FG002|Overall Study|Lost to Follow-up|13
4641776|NCT01992094|7517406|FG000|Overall Study|OTHER|4
4641777|NCT01992094|7517407|FG001|Overall Study|OTHER|0
4641778|NCT01992094|7517408|FG002|Overall Study|OTHER|0
4641779|NCT01992094|7517406|FG000|Overall Study|Protocol Violation|1
4641780|NCT01992094|7517407|FG001|Overall Study|Protocol Violation|0
4641781|NCT01992094|7517408|FG002|Overall Study|Protocol Violation|1
4641782|NCT01992094|7517406|FG000|Overall Study|Withdrawal by Subject|7
4641783|NCT01992094|7517407|FG001|Overall Study|Withdrawal by Subject|3
4641784|NCT01992094|7517408|FG002|Overall Study|Withdrawal by Subject|4
4641785|NCT01992107|7517435|FG000|Overall Study|Administrative reasons|2
4641786|NCT01992107|7517436|FG001|Overall Study|Administrative reasons|0
4641787|NCT01992107|7517437|FG002|Overall Study|Administrative reasons|0
4641788|NCT01992107|7517435|FG000|Overall Study|Adverse Event|0
4641789|NCT01992107|7517436|FG001|Overall Study|Adverse Event|1
4641790|NCT01992107|7517437|FG002|Overall Study|Adverse Event|0
4641791|NCT01992107|7517435|FG000|Overall Study|Lost to Follow-up|46
4641792|NCT01992107|7517436|FG001|Overall Study|Lost to Follow-up|22
4641793|NCT01992107|7517437|FG002|Overall Study|Lost to Follow-up|26
4641794|NCT01992107|7517435|FG000|Overall Study|noncompliance and were unavailable|7
4641795|NCT01992107|7517436|FG001|Overall Study|noncompliance and were unavailable|3
4641796|NCT01992107|7517437|FG002|Overall Study|noncompliance and were unavailable|2
4641797|NCT01992107|7517435|FG000|Overall Study|Withdrawal by Subject|13
4641798|NCT01992107|7517436|FG001|Overall Study|Withdrawal by Subject|7
4641799|NCT01992107|7517437|FG002|Overall Study|Withdrawal by Subject|8
4641800|NCT01992159|7517466|FG000|Overall Study|Withdrawal by Subject|4
4641801|NCT01992159|7517467|FG001|Overall Study|Withdrawal by Subject|7
4641802|NCT01992159|7517468|FG002|Overall Study|Withdrawal by Subject|0
4641803|NCT01992159|7517469|FG003|Overall Study|Withdrawal by Subject|3
4641804|NCT01992159|7517466|FG000|Overall Study|Adverse Event|0
4641805|NCT01992159|7517467|FG001|Overall Study|Adverse Event|1
4641806|NCT01992159|7517468|FG002|Overall Study|Adverse Event|0
4641807|NCT01992159|7517469|FG003|Overall Study|Adverse Event|1
4641808|NCT01992159|7517466|FG000|Overall Study|Death|0
4641809|NCT01992159|7517467|FG001|Overall Study|Death|0
4641810|NCT01992159|7517468|FG002|Overall Study|Death|1
4641811|NCT01992159|7517469|FG003|Overall Study|Death|0
4641812|NCT01992536|7517534|FG000|Overall Study|Administrative Reason|0
4641813|NCT01992536|7517535|FG001|Overall Study|Administrative Reason|0
4641814|NCT01992536|7517536|FG002|Overall Study|Administrative Reason|0
4641815|NCT01992536|7517537|FG003|Overall Study|Administrative Reason|0
4641816|NCT01992536|7517538|FG004|Overall Study|Administrative Reason|0
4641817|NCT01992536|7517539|FG005|Overall Study|Administrative Reason|0
4641818|NCT01992536|7517540|FG006|Overall Study|Administrative Reason|7
4641819|NCT01992536|7517541|FG007|Overall Study|Administrative Reason|0
4641820|NCT01992536|7517542|FG008|Overall Study|Administrative Reason|0
4641821|NCT01992536|7517543|FG009|Overall Study|Administrative Reason|0
4641822|NCT01992536|7517534|FG000|Overall Study|Lost to Follow-up|4
4641823|NCT01992536|7517535|FG001|Overall Study|Lost to Follow-up|2
4641824|NCT01992536|7517536|FG002|Overall Study|Lost to Follow-up|1
4641825|NCT01992536|7517537|FG003|Overall Study|Lost to Follow-up|0
4641826|NCT01992536|7517538|FG004|Overall Study|Lost to Follow-up|0
4641827|NCT01992536|7517539|FG005|Overall Study|Lost to Follow-up|1
4641828|NCT01992536|7517540|FG006|Overall Study|Lost to Follow-up|0
4641829|NCT01992536|7517541|FG007|Overall Study|Lost to Follow-up|0
4641830|NCT01992536|7517542|FG008|Overall Study|Lost to Follow-up|1
4641831|NCT01992536|7517543|FG009|Overall Study|Lost to Follow-up|1
4641832|NCT01992536|7517534|FG000|Overall Study|Withdrawal by Subject|0
4641833|NCT01992536|7517535|FG001|Overall Study|Withdrawal by Subject|1
4641834|NCT01992536|7517536|FG002|Overall Study|Withdrawal by Subject|0
4641835|NCT01992536|7517537|FG003|Overall Study|Withdrawal by Subject|2
4641836|NCT01992536|7517538|FG004|Overall Study|Withdrawal by Subject|0
4641837|NCT01992536|7517539|FG005|Overall Study|Withdrawal by Subject|0
4641838|NCT01992536|7517540|FG006|Overall Study|Withdrawal by Subject|0
4641839|NCT01992536|7517541|FG007|Overall Study|Withdrawal by Subject|0
4641840|NCT01992536|7517542|FG008|Overall Study|Withdrawal by Subject|0
4641841|NCT01992536|7517543|FG009|Overall Study|Withdrawal by Subject|0
4641842|NCT01992549|7517585|FG000|Overall Study|Lost to Follow-up|2
4641843|NCT01992549|7517585|FG000|Overall Study|Serious Adverse Event|1
4641844|NCT01992549|7517585|FG000|Overall Study|Product Switch to Extend Half Life|1
4641845|NCT01992757|7517595|FG000|Overall Study|2 patients excluded due to FFP given.|2
4641846|NCT01993017|7517615|FG000|Overall Study|Death|23
4641847|NCT01993017|7517616|FG001|Overall Study|Death|26
4641848|NCT01993017|7517617|FG002|Overall Study|Death|18
4641849|NCT01993017|7517615|FG000|Overall Study|Could not be contacted|43
4641850|NCT01993017|7517616|FG001|Overall Study|Could not be contacted|42
4641851|NCT01993017|7517617|FG002|Overall Study|Could not be contacted|38
4641852|NCT01993017|7517615|FG000|Overall Study|Dropped out|19
4641853|NCT01993017|7517616|FG001|Overall Study|Dropped out|6
4641854|NCT01993017|7517617|FG002|Overall Study|Dropped out|11
4641855|NCT01993017|7517615|FG000|Overall Study|Other reasons|17
4641856|NCT01993017|7517616|FG001|Overall Study|Other reasons|11
4641857|NCT01993017|7517617|FG002|Overall Study|Other reasons|7
4641858|NCT01993017|7517615|FG000|Overall Study|Ineligible after randomization|4
4641859|NCT01993017|7517616|FG001|Overall Study|Ineligible after randomization|5
4641860|NCT01993017|7517617|FG002|Overall Study|Ineligible after randomization|5
4641861|NCT01993030|7517628|FG000|Overall Study|Adverse Event|0
4641862|NCT01993030|7517629|FG001|Overall Study|Adverse Event|4
4641863|NCT01993186|7517658|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1
4641864|NCT01993186|7517659|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0
4641865|NCT01993186|7517658|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1
4641866|NCT01993186|7517659|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0
4641867|NCT01993186|7517658|FG000|Open-Label Extension Period|Other, Not Specified|0
4641868|NCT01993186|7517659|FG001|Open-Label Extension Period|Other, Not Specified|1
4641869|NCT01993186|7517658|FG000|Open-Label Extension Period|Adverse Event|1
4641870|NCT01993186|7517659|FG001|Open-Label Extension Period|Adverse Event|0
4641871|NCT01993186|7517658|FG000|Open-Label Extension Period|Principal Investigator Decision|1
4641872|NCT01993186|7517659|FG001|Open-Label Extension Period|Principal Investigator Decision|0
4641873|NCT01993186|7517658|FG000|Open-Label Extension Period|Withdrawal by Subject|4
4641874|NCT01993186|7517659|FG001|Open-Label Extension Period|Withdrawal by Subject|5
4641875|NCT01993186|7517658|FG000|Open-Label Extension Period|Subject Non-Compliance|1
4641876|NCT01993186|7517659|FG001|Open-Label Extension Period|Subject Non-Compliance|0
4641877|NCT01993329|7517676|FG000|Period 2|Adverse Event|0
4641878|NCT01993329|7517677|FG001|Period 2|Adverse Event|0
4641879|NCT01993329|7517678|FG002|Period 2|Adverse Event|0
4641880|NCT01993329|7517679|FG003|Period 2|Adverse Event|0
4641881|NCT01993329|7517680|FG004|Period 2|Adverse Event|0
4641882|NCT01993329|7517681|FG005|Period 2|Adverse Event|1
4641883|NCT01993329|7517676|FG000|Wash-out|Personal reasons|0
4641884|NCT01993329|7517677|FG001|Wash-out|Personal reasons|1
4641885|NCT01993329|7517678|FG002|Wash-out|Personal reasons|0
4641886|NCT01993329|7517679|FG003|Wash-out|Personal reasons|0
4641887|NCT01993329|7517680|FG004|Wash-out|Personal reasons|0
4641888|NCT01993329|7517681|FG005|Wash-out|Personal reasons|0
4641889|NCT01993615|7517695|FG000|Overall Study|Death|1
4641890|NCT01993615|7517696|FG001|Overall Study|Death|0
4641891|NCT01993667|7517704|FG000|Overall Study|Insufficient data to analyze|16
4641892|NCT01993667|7517705|FG001|Overall Study|Insufficient data to analyze|16
4641893|NCT01993667|7517704|FG000|Overall Study|Insufficient altitude reached|3
4641894|NCT01993667|7517705|FG001|Overall Study|Insufficient altitude reached|1
4641895|NCT01993667|7517704|FG000|Overall Study|Lost to Follow-up|2
4641896|NCT01993667|7517705|FG001|Overall Study|Lost to Follow-up|2
4641897|NCT01993823|7517713|FG000|Overall Study|Requested by the patient|6
4641898|NCT01993823|7517714|FG001|Overall Study|Requested by the patient|11
4641899|NCT01993823|7517713|FG000|Overall Study|Protocol Violation|0
4641900|NCT01993823|7517714|FG001|Overall Study|Protocol Violation|1
4641901|NCT01993823|7517713|FG000|Overall Study|Lost to Follow-up|1
4641902|NCT01993823|7517714|FG001|Overall Study|Lost to Follow-up|4
4641903|NCT01993836|7517723|FG000|Overall Study|Surgery Cancelled|3
4641904|NCT01993836|7517724|FG001|Overall Study|Surgery Cancelled|0
4641905|NCT01993836|7517725|FG002|Overall Study|Surgery Cancelled|0
4641906|NCT01993836|7517723|FG000|Overall Study|Physician Decision|2
4641907|NCT01993836|7517724|FG001|Overall Study|Physician Decision|1
4641908|NCT01993836|7517725|FG002|Overall Study|Physician Decision|0
4641909|NCT01993836|7517723|FG000|Overall Study|Death|0
4641910|NCT01993836|7517724|FG001|Overall Study|Death|2
4641911|NCT01993836|7517725|FG002|Overall Study|Death|0
4641912|NCT01993836|7517723|FG000|Overall Study|Withdrawal by Subject|12
4641913|NCT01993836|7517724|FG001|Overall Study|Withdrawal by Subject|10
4641914|NCT01993836|7517725|FG002|Overall Study|Withdrawal by Subject|5
4641915|NCT01993888|7517756|FG000|Overall Study|Death|1
4641916|NCT01993888|7517757|FG001|Overall Study|Death|1
4641917|NCT01993888|7517756|FG000|Overall Study|Lost to Follow-up|1
4641918|NCT01993888|7517757|FG001|Overall Study|Lost to Follow-up|1
4641919|NCT01993888|7517756|FG000|Overall Study|Withdrawal by Subject|0
4641920|NCT01993888|7517757|FG001|Overall Study|Withdrawal by Subject|1
4641921|NCT01993927|7517763|FG000|Overall Study|Case Report Forms Uncollected|18
4641922|NCT01993927|7517763|FG000|Overall Study|Protocol Violation|11
4641923|NCT01993940|7517769|FG000|Overall Study|Adverse Event|16
4641924|NCT01993940|7517770|FG001|Overall Study|Adverse Event|11
4641925|NCT01993940|7517769|FG000|Overall Study|Withdrawal by Subject|15
4641926|NCT01993940|7517770|FG001|Overall Study|Withdrawal by Subject|19
4641927|NCT01993940|7517769|FG000|Overall Study|Lost to Follow-up|2
4641928|NCT01993940|7517770|FG001|Overall Study|Lost to Follow-up|5
4641929|NCT01993940|7517769|FG000|Overall Study|Protocol Violation|5
4641930|NCT01993940|7517770|FG001|Overall Study|Protocol Violation|8
4641931|NCT01993940|7517769|FG000|Overall Study|Death|1
4641932|NCT01993940|7517770|FG001|Overall Study|Death|0
4641933|NCT01993940|7517769|FG000|Overall Study|Other - Miscellaneous|1
4641934|NCT01993940|7517770|FG001|Overall Study|Other - Miscellaneous|1
4641935|NCT01994226|7517794|FG000|Overall Study|Protocol Violation|13
4641936|NCT01994226|7517795|FG001|Overall Study|Protocol Violation|10
4641937|NCT01994226|7517794|FG000|Overall Study|Early Cessation of treatment|6
4641938|NCT01994226|7517795|FG001|Overall Study|Early Cessation of treatment|11
4641939|NCT01994291|7517804|FG000|Overall Study|Adverse Event|4
4641940|NCT01994291|7517805|FG001|Overall Study|Adverse Event|1
4641941|NCT01994291|7517806|FG002|Overall Study|Adverse Event|3
4641942|NCT01994291|7517804|FG000|Overall Study|Lost to Follow-up|1
4641943|NCT01994291|7517805|FG001|Overall Study|Lost to Follow-up|1
4641944|NCT01994291|7517806|FG002|Overall Study|Lost to Follow-up|0
4641945|NCT01994291|7517804|FG000|Overall Study|Does not meet entrance criteria|1
4641946|NCT01994291|7517805|FG001|Overall Study|Does not meet entrance criteria|0
4641947|NCT01994291|7517806|FG002|Overall Study|Does not meet entrance criteria|0
4641948|NCT01994291|7517804|FG000|Overall Study|Medication error without associated AE|1
4641949|NCT01994291|7517805|FG001|Overall Study|Medication error without associated AE|0
4641950|NCT01994291|7517806|FG002|Overall Study|Medication error without associated AE|1
4641951|NCT01994291|7517804|FG000|Overall Study|Protocol Violation|1
4641952|NCT01994291|7517805|FG001|Overall Study|Protocol Violation|0
4641953|NCT01994291|7517806|FG002|Overall Study|Protocol Violation|0
4641954|NCT01994291|7517804|FG000|Overall Study|Withdrawal by Subject|6
4641955|NCT01994291|7517805|FG001|Overall Study|Withdrawal by Subject|3
4641956|NCT01994291|7517806|FG002|Overall Study|Withdrawal by Subject|5
4641957|NCT01994291|7517804|FG000|Overall Study|Other|1
4641958|NCT01994291|7517805|FG001|Overall Study|Other|2
4641959|NCT01994291|7517806|FG002|Overall Study|Other|0
4641960|NCT01994395|7517817|FG000|Overall Study|Withdrawal by Subject|1
4641961|NCT01994395|7517818|FG001|Overall Study|Withdrawal by Subject|2
4641962|NCT01994590|7517839|FG000|Overall Study|Adverse Event|1
4641963|NCT01994590|7517839|FG000|Overall Study|Trial Terminated|1
4641964|NCT01994629|7517845|FG000|Overall Study|Withdrawal by Subject|1
4641965|NCT01994629|7517846|FG001|Overall Study|Withdrawal by Subject|0
4641966|NCT01994629|7517845|FG000|Overall Study|Lost to Follow-up|0
4641967|NCT01994629|7517846|FG001|Overall Study|Lost to Follow-up|3
4641968|NCT01994720|7517854|FG000|Overall Study|Withdrawal by Subject|46
4641969|NCT01994720|7517855|FG001|Overall Study|Withdrawal by Subject|56
4641970|NCT01994837|7517885|FG000|Overall Study|Progressive disease per protocol|23
4641971|NCT01994837|7517885|FG000|Overall Study|Adv event related to progressive disease|3
4641972|NCT01994837|7517885|FG000|Overall Study|Fatal progressive disease|2
4641973|NCT01994837|7517885|FG000|Overall Study|Adverse event not related to progression|1
4641974|NCT01994837|7517885|FG000|Overall Study|Chose palliative care|1
4641975|NCT01994837|7517885|FG000|Overall Study|Proceeded to transplant|1
4641976|NCT01994837|7517885|FG000|Overall Study|Removed from study due to no response|1
4641977|NCT01994850|7517889|FG000|Overall Study|Physician Decision|1
4641978|NCT01994850|7517889|FG000|Overall Study|Withdrawal by Subject|1
4641979|NCT01994863|7517893|FG000|Period 1|Adverse Event|4
4641980|NCT01994863|7517894|FG001|Period 1|Adverse Event|0
4641981|NCT01994863|7517893|FG000|Period 1|Withdrawal by Subject|1
4641982|NCT01994863|7517894|FG001|Period 1|Withdrawal by Subject|0
4641983|NCT01994863|7517893|FG000|Period 1|Trial stopped by sponsor|1
4641984|NCT01994863|7517894|FG001|Period 1|Trial stopped by sponsor|3
4641985|NCT01994863|7517893|FG000|Period 1|Lack of Efficacy|1
4641986|NCT01994863|7517894|FG001|Period 1|Lack of Efficacy|0
4641987|NCT01994863|7517893|FG000|Period 2|Adverse Event|0
4641988|NCT01994863|7517894|FG001|Period 2|Adverse Event|1
4641989|NCT01994863|7517893|FG000|Period 2|Lack of Efficacy|0
4641990|NCT01994863|7517894|FG001|Period 2|Lack of Efficacy|2
4641991|NCT01994863|7517893|FG000|Period 2|Withdrawal by Subject|1
4641992|NCT01994863|7517894|FG001|Period 2|Withdrawal by Subject|1
4641993|NCT01994876|7517900|FG000|Test Period 1|Withdrawal by Subject|0
4641994|NCT01994876|7517901|FG001|Test Period 1|Withdrawal by Subject|1
4641995|NCT01994876|7517900|FG000|Test Period 1|Adverse Event|0
4641996|NCT01994876|7517901|FG001|Test Period 1|Adverse Event|1
4641997|NCT01994876|7517900|FG000|Test Period 2|Adverse Event|1
4641998|NCT01994876|7517901|FG001|Test Period 2|Adverse Event|0
4641999|NCT01994876|7517900|FG000|Test Period 2|Protocol Violation|0
4642000|NCT01994876|7517901|FG001|Test Period 2|Protocol Violation|1
4642001|NCT01994889|7517912|FG000|Overall Study|Adverse Event|5
4642002|NCT01994889|7517913|FG001|Overall Study|Adverse Event|12
4642003|NCT01994889|7517914|FG002|Overall Study|Adverse Event|11
4642004|NCT01994889|7517912|FG000|Overall Study|Cardiac Device Implantation|0
4642005|NCT01994889|7517913|FG001|Overall Study|Cardiac Device Implantation|2
4642006|NCT01994889|7517914|FG002|Overall Study|Cardiac Device Implantation|0
4642007|NCT01994889|7517912|FG000|Overall Study|Organ Transplantation|1
4642008|NCT01994889|7517913|FG001|Overall Study|Organ Transplantation|5
4642009|NCT01994889|7517914|FG002|Overall Study|Organ Transplantation|5
4642010|NCT01994889|7517912|FG000|Overall Study|No longer willing to participate|8
4642011|NCT01994889|7517913|FG001|Overall Study|No longer willing to participate|17
4642012|NCT01994889|7517914|FG002|Overall Study|No longer willing to participate|37
4642013|NCT01994889|7517912|FG000|Overall Study|Lost to Follow-up|0
4642014|NCT01994889|7517913|FG001|Overall Study|Lost to Follow-up|1
4642015|NCT01994889|7517914|FG002|Overall Study|Lost to Follow-up|0
4642016|NCT01994889|7517912|FG000|Overall Study|Protocol Violation|0
4642017|NCT01994889|7517913|FG001|Overall Study|Protocol Violation|1
4642018|NCT01994889|7517914|FG002|Overall Study|Protocol Violation|1
4642019|NCT01994889|7517912|FG000|Overall Study|Death|14
4642020|NCT01994889|7517913|FG001|Overall Study|Death|25
4642021|NCT01994889|7517914|FG002|Overall Study|Death|38
4642022|NCT01994902|7517921|FG000|Test Period 1|Withdrawal by Subject|3
4642023|NCT01994902|7517922|FG001|Test Period 1|Withdrawal by Subject|0
4642024|NCT01994902|7517921|FG000|Test Period 1|device deficiency with adverse event|0
4642025|NCT01994902|7517922|FG001|Test Period 1|device deficiency with adverse event|1
4642026|NCT01994902|7517921|FG000|Test Period 1|Adverse Event|2
4642027|NCT01994902|7517922|FG001|Test Period 1|Adverse Event|1
4642028|NCT01994902|7517921|FG000|Test Period 1|Lack of Efficacy|0
4642029|NCT01994902|7517922|FG001|Test Period 1|Lack of Efficacy|1
4642030|NCT01994902|7517921|FG000|Test Period 1|bag too small|1
4642031|NCT01994902|7517922|FG001|Test Period 1|bag too small|0
4642032|NCT01994902|7517921|FG000|Test Period 2|Withdrawal by Subject|0
4642033|NCT01994902|7517922|FG001|Test Period 2|Withdrawal by Subject|2
4642034|NCT01994902|7517921|FG000|Test Period 2|Lack of Efficacy|0
4642035|NCT01994902|7517922|FG001|Test Period 2|Lack of Efficacy|1
4642036|NCT01994902|7517921|FG000|Test Period 2|Other|0
4642037|NCT01994902|7517922|FG001|Test Period 2|Other|3
4642038|NCT01994954|7517930|FG000|Overall Study|Death|1
4642039|NCT01994954|7517931|FG001|Overall Study|Death|0
4642040|NCT01994954|7517930|FG000|Overall Study|Withdrawal by Subject|9
4642041|NCT01994954|7517931|FG001|Overall Study|Withdrawal by Subject|14
4642042|NCT01994954|7517930|FG000|Overall Study|Physician Decision|2
4642043|NCT01994954|7517931|FG001|Overall Study|Physician Decision|2
4642044|NCT01994954|7517930|FG000|Overall Study|Lost to Follow-up|8
4642045|NCT01994954|7517931|FG001|Overall Study|Lost to Follow-up|10
4642046|NCT01994954|7517930|FG000|Overall Study|6 Month Follow-up Not Complete|5
4642047|NCT01994954|7517931|FG001|Overall Study|6 Month Follow-up Not Complete|4
4642048|NCT01995071|7517985|FG000|Overall Study|Adverse Event|0
4642049|NCT01995071|7517986|FG001|Overall Study|Adverse Event|0
4642050|NCT01995071|7517987|FG002|Overall Study|Adverse Event|0
4642051|NCT01995071|7517988|FG003|Overall Study|Adverse Event|0
4642052|NCT01995071|7517989|FG004|Overall Study|Adverse Event|0
4642053|NCT01995071|7517990|FG005|Overall Study|Adverse Event|0
4642054|NCT01995071|7517991|FG006|Overall Study|Adverse Event|1
4642055|NCT01995071|7517992|FG007|Overall Study|Adverse Event|0
4642056|NCT01995071|7517993|FG008|Overall Study|Adverse Event|0
4642057|NCT01995071|7517994|FG009|Overall Study|Adverse Event|0
4642058|NCT01995071|7517995|FG010|Overall Study|Adverse Event|0
4642059|NCT01995071|7517996|FG011|Overall Study|Adverse Event|0
4642060|NCT01995071|7517985|FG000|Overall Study|Moved|0
4642061|NCT01995071|7517986|FG001|Overall Study|Moved|0
4642062|NCT01995071|7517987|FG002|Overall Study|Moved|1
4642063|NCT01995071|7517988|FG003|Overall Study|Moved|0
4642064|NCT01995071|7517989|FG004|Overall Study|Moved|1
4642065|NCT01995071|7517990|FG005|Overall Study|Moved|0
4642066|NCT01995071|7517991|FG006|Overall Study|Moved|0
4642067|NCT01995071|7517992|FG007|Overall Study|Moved|0
4642068|NCT01995071|7517993|FG008|Overall Study|Moved|0
4642069|NCT01995071|7517994|FG009|Overall Study|Moved|0
4642070|NCT01995071|7517995|FG010|Overall Study|Moved|1
4642071|NCT01995071|7517996|FG011|Overall Study|Moved|0
4642072|NCT01995071|7517985|FG000|Overall Study|Lost to Follow-up|1
4642073|NCT01995071|7517986|FG001|Overall Study|Lost to Follow-up|0
4642074|NCT01995071|7517987|FG002|Overall Study|Lost to Follow-up|0
4642075|NCT01995071|7517988|FG003|Overall Study|Lost to Follow-up|0
4642076|NCT01995071|7517989|FG004|Overall Study|Lost to Follow-up|0
4642077|NCT01995071|7517990|FG005|Overall Study|Lost to Follow-up|0
4642078|NCT01995071|7517991|FG006|Overall Study|Lost to Follow-up|0
4642079|NCT01995071|7517992|FG007|Overall Study|Lost to Follow-up|1
4642080|NCT01995071|7517993|FG008|Overall Study|Lost to Follow-up|1
4642081|NCT01995071|7517994|FG009|Overall Study|Lost to Follow-up|0
4642082|NCT01995071|7517995|FG010|Overall Study|Lost to Follow-up|0
4642083|NCT01995071|7517996|FG011|Overall Study|Lost to Follow-up|0
4642084|NCT01995071|7517985|FG000|Overall Study|Incarcerated|0
4642085|NCT01995071|7517986|FG001|Overall Study|Incarcerated|0
4642086|NCT01995071|7517987|FG002|Overall Study|Incarcerated|0
4642087|NCT01995071|7517988|FG003|Overall Study|Incarcerated|0
4642088|NCT01995071|7517989|FG004|Overall Study|Incarcerated|0
4642089|NCT01995071|7517990|FG005|Overall Study|Incarcerated|0
4642090|NCT01995071|7517991|FG006|Overall Study|Incarcerated|0
4642091|NCT01995071|7517992|FG007|Overall Study|Incarcerated|1
4642092|NCT01995071|7517993|FG008|Overall Study|Incarcerated|0
4642093|NCT01995071|7517994|FG009|Overall Study|Incarcerated|0
4642094|NCT01995071|7517995|FG010|Overall Study|Incarcerated|0
4642095|NCT01995071|7517996|FG011|Overall Study|Incarcerated|0
4642096|NCT01995136|7518037|FG000|Overall Study|Change in residence|1
4642097|NCT01995201|7518043|FG000|From Baseline Until Week 24|Adverse Event|4
4642098|NCT01995201|7518044|FG001|From Baseline Until Week 24|Adverse Event|15
4642099|NCT01995201|7518045|FG002|From Baseline Until Week 24|Adverse Event|0
4642100|NCT01995201|7518046|FG003|From Baseline Until Week 24|Adverse Event|0
4642101|NCT01995201|7518047|FG004|From Baseline Until Week 24|Adverse Event|0
4642102|NCT01995201|7518048|FG005|From Baseline Until Week 24|Adverse Event|0
4642103|NCT01995201|7518049|FG006|From Baseline Until Week 24|Adverse Event|0
4642104|NCT01995201|7518043|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
4642105|NCT01995201|7518044|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3
4642106|NCT01995201|7518045|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
4642107|NCT01995201|7518046|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
4642108|NCT01995201|7518047|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
4642109|NCT01995201|7518048|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
4642110|NCT01995201|7518049|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
4642111|NCT01995201|7518043|FG000|From Baseline Until Week 24|Death|0
4642112|NCT01995201|7518044|FG001|From Baseline Until Week 24|Death|1
4642113|NCT01995201|7518045|FG002|From Baseline Until Week 24|Death|0
4642114|NCT01995201|7518046|FG003|From Baseline Until Week 24|Death|0
4642115|NCT01995201|7518047|FG004|From Baseline Until Week 24|Death|0
4642116|NCT01995201|7518048|FG005|From Baseline Until Week 24|Death|0
4642117|NCT01995201|7518049|FG006|From Baseline Until Week 24|Death|0
4642118|NCT01995201|7518043|FG000|From Baseline Until Week 24|Lack of Efficacy|2
4642119|NCT01995201|7518044|FG001|From Baseline Until Week 24|Lack of Efficacy|5
4642120|NCT01995201|7518045|FG002|From Baseline Until Week 24|Lack of Efficacy|0
4642121|NCT01995201|7518046|FG003|From Baseline Until Week 24|Lack of Efficacy|0
4642122|NCT01995201|7518047|FG004|From Baseline Until Week 24|Lack of Efficacy|0
4642123|NCT01995201|7518048|FG005|From Baseline Until Week 24|Lack of Efficacy|0
4642124|NCT01995201|7518049|FG006|From Baseline Until Week 24|Lack of Efficacy|0
4642125|NCT01995201|7518043|FG000|From Baseline Until Week 24|Lost to Follow-up|2
4642126|NCT01995201|7518044|FG001|From Baseline Until Week 24|Lost to Follow-up|3
4642127|NCT01995201|7518045|FG002|From Baseline Until Week 24|Lost to Follow-up|0
4642128|NCT01995201|7518046|FG003|From Baseline Until Week 24|Lost to Follow-up|0
4642129|NCT01995201|7518047|FG004|From Baseline Until Week 24|Lost to Follow-up|0
4642130|NCT01995201|7518048|FG005|From Baseline Until Week 24|Lost to Follow-up|0
4642131|NCT01995201|7518049|FG006|From Baseline Until Week 24|Lost to Follow-up|0
4642132|NCT01995201|7518043|FG000|From Baseline Until Week 24|Withdrawal by Subject|2
4642133|NCT01995201|7518044|FG001|From Baseline Until Week 24|Withdrawal by Subject|8
4642134|NCT01995201|7518045|FG002|From Baseline Until Week 24|Withdrawal by Subject|0
4642135|NCT01995201|7518046|FG003|From Baseline Until Week 24|Withdrawal by Subject|0
4642136|NCT01995201|7518047|FG004|From Baseline Until Week 24|Withdrawal by Subject|0
4642137|NCT01995201|7518048|FG005|From Baseline Until Week 24|Withdrawal by Subject|0
4642138|NCT01995201|7518049|FG006|From Baseline Until Week 24|Withdrawal by Subject|0
4642139|NCT01995201|7518043|FG000|From Baseline Until Week 24|Physician Decision|0
4642140|NCT01995201|7518044|FG001|From Baseline Until Week 24|Physician Decision|2
4642141|NCT01995201|7518045|FG002|From Baseline Until Week 24|Physician Decision|0
4642142|NCT01995201|7518046|FG003|From Baseline Until Week 24|Physician Decision|0
4642143|NCT01995201|7518047|FG004|From Baseline Until Week 24|Physician Decision|0
4642144|NCT01995201|7518048|FG005|From Baseline Until Week 24|Physician Decision|0
4642145|NCT01995201|7518049|FG006|From Baseline Until Week 24|Physician Decision|0
4642146|NCT01995201|7518043|FG000|From Baseline Until Week 24|Protocol Violation|0
4642147|NCT01995201|7518044|FG001|From Baseline Until Week 24|Protocol Violation|9
4642148|NCT01995201|7518045|FG002|From Baseline Until Week 24|Protocol Violation|0
4642149|NCT01995201|7518046|FG003|From Baseline Until Week 24|Protocol Violation|0
4642150|NCT01995201|7518047|FG004|From Baseline Until Week 24|Protocol Violation|0
4642151|NCT01995201|7518048|FG005|From Baseline Until Week 24|Protocol Violation|0
4642152|NCT01995201|7518049|FG006|From Baseline Until Week 24|Protocol Violation|0
4642153|NCT01995201|7518043|FG000|From Week 24 Until Week 48|Adverse Event|0
4642154|NCT01995201|7518044|FG001|From Week 24 Until Week 48|Adverse Event|0
4642155|NCT01995201|7518045|FG002|From Week 24 Until Week 48|Adverse Event|2
4642156|NCT01995201|7518046|FG003|From Week 24 Until Week 48|Adverse Event|1
4642157|NCT01995201|7518047|FG004|From Week 24 Until Week 48|Adverse Event|1
4642158|NCT01995201|7518048|FG005|From Week 24 Until Week 48|Adverse Event|3
4642159|NCT01995201|7518049|FG006|From Week 24 Until Week 48|Adverse Event|1
4642160|NCT01995201|7518043|FG000|From Week 24 Until Week 48|Death|0
4642161|NCT01995201|7518044|FG001|From Week 24 Until Week 48|Death|0
4642162|NCT01995201|7518045|FG002|From Week 24 Until Week 48|Death|0
4642163|NCT01995201|7518046|FG003|From Week 24 Until Week 48|Death|0
4642164|NCT01995201|7518047|FG004|From Week 24 Until Week 48|Death|0
4642165|NCT01995201|7518048|FG005|From Week 24 Until Week 48|Death|2
4642166|NCT01995201|7518049|FG006|From Week 24 Until Week 48|Death|0
4642167|NCT01995201|7518043|FG000|From Week 24 Until Week 48|Lack of Efficacy|0
4642168|NCT01995201|7518044|FG001|From Week 24 Until Week 48|Lack of Efficacy|0
4642169|NCT01995201|7518045|FG002|From Week 24 Until Week 48|Lack of Efficacy|1
4642170|NCT01995201|7518046|FG003|From Week 24 Until Week 48|Lack of Efficacy|0
4642171|NCT01995201|7518047|FG004|From Week 24 Until Week 48|Lack of Efficacy|0
4642172|NCT01995201|7518048|FG005|From Week 24 Until Week 48|Lack of Efficacy|2
4642173|NCT01995201|7518049|FG006|From Week 24 Until Week 48|Lack of Efficacy|1
4642174|NCT01995201|7518043|FG000|From Week 24 Until Week 48|Lost to Follow-up|0
4642175|NCT01995201|7518044|FG001|From Week 24 Until Week 48|Lost to Follow-up|0
4642176|NCT01995201|7518045|FG002|From Week 24 Until Week 48|Lost to Follow-up|0
4642177|NCT01995201|7518046|FG003|From Week 24 Until Week 48|Lost to Follow-up|0
4642178|NCT01995201|7518047|FG004|From Week 24 Until Week 48|Lost to Follow-up|1
4642179|NCT01995201|7518048|FG005|From Week 24 Until Week 48|Lost to Follow-up|1
4642180|NCT01995201|7518049|FG006|From Week 24 Until Week 48|Lost to Follow-up|0
4642181|NCT01995201|7518043|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0
4642182|NCT01995201|7518044|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0
4642183|NCT01995201|7518045|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1
4642184|NCT01995201|7518046|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0
4642185|NCT01995201|7518047|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1
4642186|NCT01995201|7518048|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0
4642187|NCT01995201|7518049|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0
4642188|NCT01995201|7518043|FG000|From Week 24 Until Week 48|Physician Decision|0
4642189|NCT01995201|7518044|FG001|From Week 24 Until Week 48|Physician Decision|0
4642190|NCT01995201|7518045|FG002|From Week 24 Until Week 48|Physician Decision|0
4642191|NCT01995201|7518046|FG003|From Week 24 Until Week 48|Physician Decision|0
4642192|NCT01995201|7518047|FG004|From Week 24 Until Week 48|Physician Decision|1
4642193|NCT01995201|7518048|FG005|From Week 24 Until Week 48|Physician Decision|0
4642194|NCT01995201|7518049|FG006|From Week 24 Until Week 48|Physician Decision|0
4642195|NCT01995201|7518043|FG000|From Week 24 Until Week 48|Protocol Violation|0
4642196|NCT01995201|7518044|FG001|From Week 24 Until Week 48|Protocol Violation|0
4642197|NCT01995201|7518045|FG002|From Week 24 Until Week 48|Protocol Violation|1
4642198|NCT01995201|7518046|FG003|From Week 24 Until Week 48|Protocol Violation|0
4642199|NCT01995201|7518047|FG004|From Week 24 Until Week 48|Protocol Violation|2
4642200|NCT01995201|7518048|FG005|From Week 24 Until Week 48|Protocol Violation|0
4642201|NCT01995201|7518049|FG006|From Week 24 Until Week 48|Protocol Violation|0
4642202|NCT01995266|7518070|FG000|Overall Study|Death|1
4642203|NCT01995266|7518070|FG000|Overall Study|Lack of Efficacy|6
4642204|NCT01995266|7518070|FG000|Overall Study|Adverse Event|2
4642205|NCT01995357|7518074|FG000|Period 5|Lack of Efficacy|1
4642206|NCT01995357|7518075|FG001|Period 5|Lack of Efficacy|0
4642207|NCT01995357|7518076|FG002|Period 5|Lack of Efficacy|0
4642208|NCT01995357|7518077|FG003|Period 5|Lack of Efficacy|0
4642209|NCT01995357|7518078|FG004|Period 5|Lack of Efficacy|0
4642210|NCT01995357|7518079|FG005|Period 5|Lack of Efficacy|0
4642211|NCT01995357|7518074|FG000|Period 5|Adverse Event|1
4642212|NCT01995357|7518075|FG001|Period 5|Adverse Event|0
4642213|NCT01995357|7518076|FG002|Period 5|Adverse Event|1
4642214|NCT01995357|7518077|FG003|Period 5|Adverse Event|0
4642215|NCT01995357|7518078|FG004|Period 5|Adverse Event|0
4642216|NCT01995357|7518079|FG005|Period 5|Adverse Event|0
4642217|NCT01995461|7518095|FG000|Overall Study|Death|1
4642218|NCT01995461|7518095|FG000|Overall Study|Lost to Follow-up|2
4642219|NCT01995461|7518095|FG000|Overall Study|Withdrawal by Subject|2
4642220|NCT01995513|7518108|FG000|Open Label Treatment Period|Other|9
4642221|NCT01995513|7518109|FG001|Open Label Treatment Period|Other|0
4642222|NCT01995513|7518110|FG002|Open Label Treatment Period|Other|0
4642223|NCT01995513|7518108|FG000|Open Label Treatment Period|Withdrawal by Subject|14
4642224|NCT01995513|7518109|FG001|Open Label Treatment Period|Withdrawal by Subject|0
4642225|NCT01995513|7518110|FG002|Open Label Treatment Period|Withdrawal by Subject|0
4642226|NCT01995513|7518108|FG000|Open Label Treatment Period|Protocol Violation|1
4642227|NCT01995513|7518109|FG001|Open Label Treatment Period|Protocol Violation|0
4642228|NCT01995513|7518110|FG002|Open Label Treatment Period|Protocol Violation|0
4642229|NCT01995513|7518108|FG000|Open Label Treatment Period|Disease Progression|64
4642230|NCT01995513|7518109|FG001|Open Label Treatment Period|Disease Progression|0
4642231|NCT01995513|7518110|FG002|Open Label Treatment Period|Disease Progression|0
4642232|NCT01995513|7518108|FG000|Open Label Treatment Period|No PSA response at week 13|43
4642233|NCT01995513|7518109|FG001|Open Label Treatment Period|No PSA response at week 13|0
4642234|NCT01995513|7518110|FG002|Open Label Treatment Period|No PSA response at week 13|0
4642235|NCT01995513|7518108|FG000|Open Label Treatment Period|Adverse Event|35
4642236|NCT01995513|7518109|FG001|Open Label Treatment Period|Adverse Event|0
4642237|NCT01995513|7518110|FG002|Open Label Treatment Period|Adverse Event|0
4642238|NCT01995513|7518108|FG000|Open Label Treatment Period|Death|8
4642239|NCT01995513|7518109|FG001|Open Label Treatment Period|Death|0
4642240|NCT01995513|7518110|FG002|Open Label Treatment Period|Death|0
4642241|NCT01995513|7518108|FG000|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|84
4642242|NCT01995513|7518109|FG001|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
4642243|NCT01995513|7518110|FG002|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
4642244|NCT01995513|7518108|FG000|Double Blind Treatment Period|Adverse Event|0
4642245|NCT01995513|7518109|FG001|Double Blind Treatment Period|Adverse Event|12
4642246|NCT01995513|7518110|FG002|Double Blind Treatment Period|Adverse Event|5
4642247|NCT01995513|7518108|FG000|Double Blind Treatment Period|Other|0
4642248|NCT01995513|7518109|FG001|Double Blind Treatment Period|Other|1
4642249|NCT01995513|7518110|FG002|Double Blind Treatment Period|Other|2
4642250|NCT01995513|7518108|FG000|Double Blind Treatment Period|Withdrawal by Subject|0
4642251|NCT01995513|7518109|FG001|Double Blind Treatment Period|Withdrawal by Subject|4
4642252|NCT01995513|7518110|FG002|Double Blind Treatment Period|Withdrawal by Subject|6
4642253|NCT01995513|7518108|FG000|Double Blind Treatment Period|Death|0
4642254|NCT01995513|7518109|FG001|Double Blind Treatment Period|Death|0
4642255|NCT01995513|7518110|FG002|Double Blind Treatment Period|Death|1
4642256|NCT01995513|7518108|FG000|Double Blind Treatment Period|Disease Progression|0
4642257|NCT01995513|7518109|FG001|Double Blind Treatment Period|Disease Progression|82
4642258|NCT01995513|7518110|FG002|Double Blind Treatment Period|Disease Progression|93
4642259|NCT01995513|7518108|FG000|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
4642260|NCT01995513|7518109|FG001|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|27
4642261|NCT01995513|7518110|FG002|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|18
4642262|NCT01995526|7518120|FG000|Overall Study|Physician Decision|1
4642263|NCT01995539|7518124|FG000|Overall Study|Screening Failure|1
4642264|NCT01995539|7518124|FG000|Overall Study|Withdrawal by Investigator|15
4642265|NCT01995539|7518124|FG000|Overall Study|Withdrawal by Subject|11
4642266|NCT01995539|7518124|FG000|Overall Study|Lost to Follow-up|5
4642267|NCT01995539|7518124|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1
4642268|NCT01995552|7518128|FG000|Overall Study|Protocol Violation|1
4642269|NCT01995552|7518128|FG000|Overall Study|Lack of Efficacy|15
4642270|NCT01995552|7518128|FG000|Overall Study|Death|1
4642271|NCT01995825|7518136|FG000|Overall Study|Withdrawal by Subject|1
4642272|NCT01995825|7518137|FG001|Overall Study|Withdrawal by Subject|0
4642273|NCT01995838|7518150|FG000|Overall Study|Lost to Follow-up|0
4642274|NCT01995838|7518151|FG001|Overall Study|Lost to Follow-up|1
4642275|NCT01995838|7518152|FG002|Overall Study|Lost to Follow-up|0
4642276|NCT01995838|7518153|FG003|Overall Study|Lost to Follow-up|0
4642277|NCT01995838|7518154|FG004|Overall Study|Lost to Follow-up|0
4642278|NCT01995838|7518155|FG005|Overall Study|Lost to Follow-up|0
4642279|NCT01995838|7518156|FG006|Overall Study|Lost to Follow-up|1
4642280|NCT01995838|7518150|FG000|Overall Study|Participant choice|2
4747279|NCT00062751|7720866|FG001|Overall Study|Death|0
4747280|NCT00062751|7720867|FG002|Overall Study|Death|1
4747281|NCT00062751|7720868|FG003|Overall Study|Death|0
4747282|NCT00062751|7720869|FG004|Overall Study|Death|0
4747283|NCT00066807|7720884|FG000|Overall Study|Study was terminated early|14
4747284|NCT00066807|7720885|FG001|Overall Study|Study was terminated early|15
4747285|NCT00038142|7720906|FG000|Overall Study|Ineligible|1
4747286|NCT00038142|7720907|FG001|Overall Study|Ineligible|0
4747287|NCT00038142|7720906|FG000|Overall Study|Progressive Disease|11
4642281|NCT01995838|7518151|FG001|Overall Study|Participant choice|0
4642282|NCT01995838|7518152|FG002|Overall Study|Participant choice|0
4642283|NCT01995838|7518153|FG003|Overall Study|Participant choice|0
4642284|NCT01995838|7518154|FG004|Overall Study|Participant choice|0
4642285|NCT01995838|7518155|FG005|Overall Study|Participant choice|1
4642286|NCT01995838|7518156|FG006|Overall Study|Participant choice|1
4642287|NCT01995838|7518150|FG000|Overall Study|Adverse Event|0
4642288|NCT01995838|7518151|FG001|Overall Study|Adverse Event|0
4642289|NCT01995838|7518152|FG002|Overall Study|Adverse Event|0
4642290|NCT01995838|7518153|FG003|Overall Study|Adverse Event|0
4642291|NCT01995838|7518154|FG004|Overall Study|Adverse Event|0
4642292|NCT01995838|7518155|FG005|Overall Study|Adverse Event|0
4642293|NCT01995838|7518156|FG006|Overall Study|Adverse Event|1
4642294|NCT01995838|7518150|FG000|Overall Study|Withdrawal by Subject|0
4642295|NCT01995838|7518151|FG001|Overall Study|Withdrawal by Subject|0
4642296|NCT01995838|7518152|FG002|Overall Study|Withdrawal by Subject|0
4642297|NCT01995838|7518153|FG003|Overall Study|Withdrawal by Subject|0
4642298|NCT01995838|7518154|FG004|Overall Study|Withdrawal by Subject|1
4642299|NCT01995838|7518155|FG005|Overall Study|Withdrawal by Subject|0
4642300|NCT01995838|7518156|FG006|Overall Study|Withdrawal by Subject|0
4642301|NCT01995838|7518150|FG000|Overall Study|Other|3
4642302|NCT01995838|7518151|FG001|Overall Study|Other|1
4642303|NCT01995838|7518152|FG002|Overall Study|Other|0
4642304|NCT01995838|7518153|FG003|Overall Study|Other|2
4642305|NCT01995838|7518154|FG004|Overall Study|Other|1
4642306|NCT01995838|7518155|FG005|Overall Study|Other|1
4747288|NCT00038142|7720907|FG001|Overall Study|Progressive Disease|7
4747289|NCT00038142|7720906|FG000|Overall Study|Death|1
4747290|NCT00038142|7720907|FG001|Overall Study|Death|0
4747291|NCT00038142|7720906|FG000|Overall Study|Adverse Event|1
4747292|NCT00038142|7720907|FG001|Overall Study|Adverse Event|0
4747293|NCT00038142|7720906|FG000|Overall Study|Unknown Reason|8
4747294|NCT00038142|7720907|FG001|Overall Study|Unknown Reason|0
4747295|NCT00006478|7720922|FG000|Overall Study|Vaccine could not be produced|1
4747296|NCT00006478|7720922|FG000|Overall Study|Physician Decision|6
4747297|NCT00006916|7720935|FG000|Overall Study|Device not inserted|4
4642307|NCT01995838|7518156|FG006|Overall Study|Other|2
4642308|NCT01996033|7518173|FG000|Overall Study|Death|1
4642309|NCT01996033|7518173|FG000|Overall Study|Physician Decision|1
4642310|NCT01996033|7518173|FG000|Overall Study|Withdrawal by Subject|4
4642311|NCT01996033|7518173|FG000|Overall Study|Lost to Follow-up|3
4642312|NCT01996241|7518179|FG000|Overall Study|Lost to Follow-up|252
4642313|NCT01996241|7518180|FG001|Overall Study|Lost to Follow-up|235
4642314|NCT01996254|7518190|FG000|Overall Study|Change in Eligibility|0
4747298|NCT00006916|7720935|FG000|Overall Study|Complication of device insertion|1
4747299|NCT02009384|7721009|FG000|Overall Study|Death|2
4747300|NCT04558125|7721013|FG000|Overall Study|Death|1
4747301|NCT02401308|7721019|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0
4747302|NCT02401308|7721020|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1
4747303|NCT04381988|7721028|FG000|Overall Study|The study was terminated|4
4747304|NCT04381988|7721029|FG001|Overall Study|The study was terminated|0
4747305|NCT00479167|7721057|FG000|Overall Study|Withdrawal by Subject|1
4747306|NCT03998189|7721064|FG000|Overall Study|Lack of Efficacy|0
4747307|NCT03998189|7721065|FG001|Overall Study|Lack of Efficacy|1
4747308|NCT02934503|7721179|FG000|Overall Study|progression of disease|3
4747309|NCT02934503|7721179|FG000|Overall Study|Withdrawal by Subject|1
4642315|NCT01996254|7518191|FG001|Overall Study|Change in Eligibility|2
4642316|NCT01996254|7518192|FG002|Overall Study|Change in Eligibility|0
4642317|NCT01996254|7518190|FG000|Overall Study|Withdrawal by Subject|0
4642318|NCT01996254|7518191|FG001|Overall Study|Withdrawal by Subject|3
4642319|NCT01996254|7518192|FG002|Overall Study|Withdrawal by Subject|4
4642320|NCT01996254|7518190|FG000|Overall Study|Lost to Follow-up|1
4642321|NCT01996254|7518191|FG001|Overall Study|Lost to Follow-up|0
4747310|NCT02137252|7721185|FG000|Overall Study|trial terminated early|2
4747311|NCT02137252|7721186|FG001|Overall Study|trial terminated early|1
4747312|NCT01294670|7721201|FG000|Overall Study|Not treated|1
4642322|NCT01996254|7518192|FG002|Overall Study|Lost to Follow-up|4
4747313|NCT01294670|7721202|FG001|Overall Study|Not treated|0
4747314|NCT01294670|7721203|FG002|Overall Study|Not treated|0
4747315|NCT01294670|7721204|FG003|Overall Study|Not treated|0
4747316|NCT01294670|7721205|FG004|Overall Study|Not treated|0
4747317|NCT03095287|7721217|FG000|Overall Study|Treatment Failure|1
4747318|NCT03095287|7721217|FG000|Overall Study|Adverse Event|1
4747319|NCT02930122|7721227|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3
4747320|NCT02930122|7721228|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3
4747321|NCT04144166|7721248|FG000|Overall Study|Discharged before study start|1
4747322|NCT04144166|7721248|FG000|Overall Study|Pregnancy|1
4747323|NCT04144166|7721248|FG000|Overall Study|Nail polish could not be removed from finger|1
4747324|NCT04090164|7721259|FG000|Overall Study|incomplete data on file|245
4747325|NCT04090164|7721260|FG001|Overall Study|incomplete data on file|0
4642323|NCT01996319|7518204|FG000|Overall Study|Protocol Violation|1
4642324|NCT01996319|7518205|FG001|Overall Study|Protocol Violation|0
4642325|NCT01996319|7518204|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5
4642326|NCT01996319|7518205|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1
4642327|NCT01996319|7518204|FG000|Overall Study|Adverse Event|2
4642328|NCT01996319|7518205|FG001|Overall Study|Adverse Event|2
4642329|NCT01996332|7518211|FG000|Overall Study|Adverse Event|117
4642330|NCT01996332|7518211|FG000|Overall Study|Lack of Efficacy|1245
4642331|NCT01996332|7518211|FG000|Overall Study|Death|264
4642332|NCT01996332|7518211|FG000|Overall Study|Protocol Violation|9
4642333|NCT01996332|7518211|FG000|Overall Study|Withdrawal by Subject|71
4642334|NCT01996332|7518211|FG000|Overall Study|Other|20
4642335|NCT01996332|7518211|FG000|Overall Study|Clinical Deterioration|28
4642336|NCT01996332|7518211|FG000|Overall Study|Physician Decision|17
4642337|NCT01996332|7518211|FG000|Overall Study|Lost to Follow-up|34
4642338|NCT01996592|7518215|FG000|Overall Study|no response to text/no diary entry|32
4642339|NCT01996592|7518215|FG000|Overall Study|change in surgical date|4
4642340|NCT01996592|7518215|FG000|Overall Study|Withdrawal by Subject|5
4642341|NCT01996592|7518215|FG000|Overall Study|change in mode of delivery|4
4642342|NCT01996709|7518251|FG000|Overall Study|Withdrawal by Subject|1
4642343|NCT01996709|7518252|FG001|Overall Study|Withdrawal by Subject|0
4642344|NCT01996709|7518251|FG000|Overall Study|Lost to Follow-up|3
4642345|NCT01996709|7518252|FG001|Overall Study|Lost to Follow-up|0
4642346|NCT01996709|7518251|FG000|Overall Study|Subject Non-Compliant|1
4642347|NCT01996709|7518252|FG001|Overall Study|Subject Non-Compliant|0
4642348|NCT01996709|7518251|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0
4642349|NCT01996709|7518252|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1
4642350|NCT01996748|7518264|FG000|Overall Study|Personal reason|1
4642351|NCT01996748|7518265|FG001|Overall Study|Personal reason|0
4642352|NCT01996748|7518264|FG000|Overall Study|Physician Decision|2
4642353|NCT01996748|7518265|FG001|Overall Study|Physician Decision|0
4642354|NCT01996748|7518264|FG000|Overall Study|Adverse Event|1
4642355|NCT01996748|7518265|FG001|Overall Study|Adverse Event|4
4642356|NCT01996748|7518264|FG000|Overall Study|Withdrawal by Subject|0
4642357|NCT01996748|7518265|FG001|Overall Study|Withdrawal by Subject|1
4642358|NCT01996748|7518264|FG000|Overall Study|Lost to Follow-up|4
4642359|NCT01996748|7518265|FG001|Overall Study|Lost to Follow-up|1
4642360|NCT01996826|7518284|FG000|Overall Study|Lost to Follow-up|6
4642361|NCT01996826|7518285|FG001|Overall Study|Lost to Follow-up|2
4642362|NCT01996826|7518284|FG000|Overall Study|Physician Decision|1
4642363|NCT01996826|7518285|FG001|Overall Study|Physician Decision|1
4642364|NCT01996904|7518306|FG000|Overall Study|Lost to Follow-up|38
4642365|NCT01996904|7518307|FG001|Overall Study|Lost to Follow-up|27
4642366|NCT01997281|7518349|FG000|Overall Study|Withdrawal by Subject|1
4642367|NCT01997281|7518350|FG001|Overall Study|Withdrawal by Subject|0
4642368|NCT01997333|7518358|FG000|Randomization and Treatment|Disease Progression|70
4642369|NCT01997333|7518359|FG001|Randomization and Treatment|Disease Progression|159
4642370|NCT01997333|7518358|FG000|Randomization and Treatment|Adverse Event|10
4642371|NCT01997333|7518359|FG001|Randomization and Treatment|Adverse Event|32
4642372|NCT01997333|7518358|FG000|Randomization and Treatment|Physician Decision|0
4642373|NCT01997333|7518359|FG001|Randomization and Treatment|Physician Decision|4
4642374|NCT01997333|7518358|FG000|Randomization and Treatment|Withdrawal by Subject|6
4642375|NCT01997333|7518359|FG001|Randomization and Treatment|Withdrawal by Subject|3
4642376|NCT01997333|7518358|FG000|Randomization and Treatment|Did not receive treatment|17
4642377|NCT01997333|7518359|FG001|Randomization and Treatment|Did not receive treatment|5
4642378|NCT01997333|7518358|FG000|Survival Follow up|Withdrawal by Subject|15
4642379|NCT01997333|7518359|FG001|Survival Follow up|Withdrawal by Subject|6
4642380|NCT01997333|7518358|FG000|Survival Follow up|Lost to Follow-up|0
4642381|NCT01997333|7518359|FG001|Survival Follow up|Lost to Follow-up|6
4642382|NCT01997333|7518358|FG000|Survival Follow up|Various|1
4642383|NCT01997333|7518359|FG001|Survival Follow up|Various|2
4642384|NCT01997892|7518423|FG000|Overall Study|Physician Decision|2
4642385|NCT01997892|7518423|FG000|Overall Study|Lost to Follow-up|6
4642386|NCT01997892|7518423|FG000|Overall Study|Death|14
4642387|NCT01997892|7518423|FG000|Overall Study|Renal transplant|8
4642388|NCT01997892|7518423|FG000|Overall Study|Other|3
4642389|NCT01997892|7518423|FG000|Overall Study|Study completion data not recorded|35
4642390|NCT01998243|7518438|FG000|Overall Study|Pregnancy|0
4642391|NCT01998243|7518439|FG001|Overall Study|Pregnancy|1
4642392|NCT01998243|7518438|FG000|Overall Study|Protocol Violation|5
4642393|NCT01998243|7518439|FG001|Overall Study|Protocol Violation|2
4642394|NCT01998243|7518438|FG000|Overall Study|Withdrawal by Subject|3
4642395|NCT01998243|7518439|FG001|Overall Study|Withdrawal by Subject|4
4642396|NCT01998399|7518462|FG000|Overall Study|Lost to Follow-up|1
4642397|NCT01998399|7518463|FG001|Overall Study|Lost to Follow-up|3
4642398|NCT01998399|7518462|FG000|Overall Study|Death|4
4642399|NCT01998399|7518463|FG001|Overall Study|Death|2
4642400|NCT01998399|7518462|FG000|Overall Study|Study stopped before dosing completed|3
4642401|NCT01998399|7518463|FG001|Overall Study|Study stopped before dosing completed|3
4642402|NCT01998399|7518462|FG000|Overall Study|Withdrawal by Subject|0
4642403|NCT01998399|7518463|FG001|Overall Study|Withdrawal by Subject|1
4642404|NCT01998477|7518484|FG000|Overall Study|Lost to Follow-up|4
4642405|NCT01998477|7518485|FG001|Overall Study|Lost to Follow-up|5
4642406|NCT01998477|7518484|FG000|Overall Study|Withdrawal by Subject|6
4642407|NCT01998477|7518485|FG001|Overall Study|Withdrawal by Subject|0
4642408|NCT01998581|7518518|FG000|Overall Study|Refused repeat treatment|20
4642409|NCT01998581|7518519|FG001|Overall Study|Refused repeat treatment|4
4642410|NCT01998581|7518518|FG000|Overall Study|Protocol Violation|1
4642411|NCT01998581|7518519|FG001|Overall Study|Protocol Violation|0
4642412|NCT01998581|7518518|FG000|Overall Study|Withdrawal by Subject|8
4642413|NCT01998581|7518519|FG001|Overall Study|Withdrawal by Subject|1
4642414|NCT01998581|7518518|FG000|Overall Study|Lost to Follow-up|12
4642415|NCT01998581|7518519|FG001|Overall Study|Lost to Follow-up|4
4642416|NCT01998581|7518518|FG000|Overall Study|Adverse Event|1
4642417|NCT01998581|7518519|FG001|Overall Study|Adverse Event|1
4642418|NCT01998581|7518518|FG000|Overall Study|Other reasons|3
4642419|NCT01998581|7518519|FG001|Overall Study|Other reasons|2
4642420|NCT01998581|7518518|FG000|Overall Study|Randomized but withdrew before treatment|1
4642421|NCT01998581|7518519|FG001|Overall Study|Randomized but withdrew before treatment|0
4642422|NCT01998633|7518528|FG000|Overall Study|Death|1
4642423|NCT01998737|7518538|FG000|Overall Study|Corrupted database|23
4642424|NCT01998737|7518539|FG001|Overall Study|Corrupted database|0
4642425|NCT01998880|7518547|FG000|Overall Study|Adverse Events or Intercurrent Illness|16
4642426|NCT01998880|7518548|FG001|Overall Study|Adverse Events or Intercurrent Illness|16
4642427|NCT01998880|7518547|FG000|Overall Study|Disease Progression|1
4642428|NCT01998880|7518548|FG001|Overall Study|Disease Progression|8
4642429|NCT01998880|7518547|FG000|Overall Study|Withdrew Consent|2
4642430|NCT01998880|7518548|FG001|Overall Study|Withdrew Consent|1
4642431|NCT01998880|7518547|FG000|Overall Study|Death|3
4642432|NCT01998880|7518548|FG001|Overall Study|Death|6
4642433|NCT01998880|7518547|FG000|Overall Study|Insufficient Therapeutic Response|1
4642434|NCT01998880|7518548|FG001|Overall Study|Insufficient Therapeutic Response|5
4642435|NCT01998880|7518547|FG000|Overall Study|Administrative/Other|1
4642436|NCT01998880|7518548|FG001|Overall Study|Administrative/Other|1
4642437|NCT01998880|7518547|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1
4642438|NCT01998880|7518548|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0
4642439|NCT01998880|7518547|FG000|Overall Study|Violation of Selection Criteria at Entry|0
4642440|NCT01998880|7518548|FG001|Overall Study|Violation of Selection Criteria at Entry|1
4642441|NCT01998880|7518547|FG000|Overall Study|Did Not Receive Treatment|3
4642442|NCT01998880|7518548|FG001|Overall Study|Did Not Receive Treatment|2
4642443|NCT01998893|7518554|FG000|Overall Study|Adverse Event|2
4642444|NCT01998893|7518554|FG000|Overall Study|Death|1
4642445|NCT01998893|7518554|FG000|Overall Study|Lost to Follow-up|8
4642446|NCT01998893|7518554|FG000|Overall Study|Physician Decision|2
4642447|NCT01998893|7518554|FG000|Overall Study|Protocol Violation|2
4642448|NCT01998893|7518554|FG000|Overall Study|Withdrawal by Subject|1
4642449|NCT01998893|7518554|FG000|Overall Study|Transformation to high-grade lymphoma|1
4642450|NCT01998906|7518561|FG000|Overall Study|Participants ongoing in follow-up|77
4642451|NCT01998906|7518562|FG001|Overall Study|Participants ongoing in follow-up|60
4642452|NCT01998906|7518563|FG002|Overall Study|Participants ongoing in follow-up|58
4642453|NCT01998906|7518561|FG000|Overall Study|Death|21
4642454|NCT01998906|7518562|FG001|Overall Study|Death|30
4642455|NCT01998906|7518563|FG002|Overall Study|Death|17
4642456|NCT01998906|7518561|FG000|Overall Study|Lack of Efficacy|10
4642457|NCT01998906|7518562|FG001|Overall Study|Lack of Efficacy|9
4642458|NCT01998906|7518563|FG002|Overall Study|Lack of Efficacy|8
4642459|NCT01998906|7518561|FG000|Overall Study|Failure to return|0
4642460|NCT01998906|7518562|FG001|Overall Study|Failure to return|2
4642461|NCT01998906|7518563|FG002|Overall Study|Failure to return|4
4642462|NCT01998906|7518561|FG000|Overall Study|Violation of Selection Criteria|0
4642463|NCT01998906|7518562|FG001|Overall Study|Violation of Selection Criteria|0
4642464|NCT01998906|7518563|FG002|Overall Study|Violation of Selection Criteria|1
4642465|NCT01998906|7518561|FG000|Overall Study|Withdrawal by Subject|1
4642466|NCT01998906|7518562|FG001|Overall Study|Withdrawal by Subject|4
4642467|NCT01998906|7518563|FG002|Overall Study|Withdrawal by Subject|3
4642468|NCT01998906|7518561|FG000|Overall Study|Administrative/Other|2
4642469|NCT01998906|7518562|FG001|Overall Study|Administrative/Other|1
4642470|NCT01998906|7518563|FG002|Overall Study|Administrative/Other|3
4642471|NCT01998906|7518561|FG000|Overall Study|Other|3
4642472|NCT01998906|7518562|FG001|Overall Study|Other|8
4642473|NCT01998906|7518563|FG002|Overall Study|Other|4
4642474|NCT01998919|7518576|FG000|Overall Study|Death|2
4642475|NCT01998919|7518577|FG001|Overall Study|Death|2
4642476|NCT01998919|7518576|FG000|Overall Study|Adverse Event|0
4642477|NCT01998919|7518577|FG001|Overall Study|Adverse Event|5
4642478|NCT01998919|7518576|FG000|Overall Study|Disease progression|31
4642479|NCT01998919|7518577|FG001|Overall Study|Disease progression|22
4642480|NCT01998919|7518576|FG000|Overall Study|Withdrawal by Subject|2
4642481|NCT01998919|7518577|FG001|Overall Study|Withdrawal by Subject|4
4642482|NCT01998919|7518576|FG000|Overall Study|Lost to Follow-up|2
4642483|NCT01998919|7518577|FG001|Overall Study|Lost to Follow-up|0
4642484|NCT01998919|7518576|FG000|Overall Study|Other|5
4642485|NCT01998919|7518577|FG001|Overall Study|Other|2
4642486|NCT01998958|7518590|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0
4642487|NCT01998958|7518591|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1
4642488|NCT01998958|7518592|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0
4642489|NCT01998958|7518593|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0
4642490|NCT01998958|7518594|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0
4642491|NCT01998958|7518595|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0
4642492|NCT01998958|7518596|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0
4642493|NCT01998958|7518597|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0
4642494|NCT01998958|7518598|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0
4642495|NCT01998958|7518599|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0
4642496|NCT01998958|7518600|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0
4642497|NCT01998958|7518601|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0
4642498|NCT01998958|7518602|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0
4642499|NCT01998958|7518603|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0
4642500|NCT01998958|7518604|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0
4642501|NCT01998958|7518605|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0
4642502|NCT01998958|7518606|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0
4642503|NCT01998958|7518607|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0
4642504|NCT01998958|7518608|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0
4642505|NCT01998958|7518609|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0
4642506|NCT01998958|7518610|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0
4642507|NCT01998958|7518611|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0
4642508|NCT01998958|7518612|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0
4747326|NCT03997825|7721353|FG000|Overall Study|Death|3
4747327|NCT03997825|7721353|FG000|Overall Study|Lost to Follow-up|10
4642509|NCT01998958|7518613|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0
4642510|NCT01998958|7518614|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0
4642511|NCT01998958|7518615|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0
4642512|NCT01998958|7518616|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0
4642513|NCT01998958|7518617|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0
4642514|NCT01998958|7518618|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0
4642515|NCT01998958|7518619|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0
4642516|NCT01998958|7518620|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0
4642517|NCT01998958|7518621|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0
4642518|NCT01998958|7518590|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0
4642519|NCT01998958|7518591|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1
4642520|NCT01998958|7518592|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0
4642521|NCT01998958|7518593|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0
4642522|NCT01998958|7518594|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0
4642523|NCT01998958|7518595|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0
4642524|NCT01998958|7518596|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0
4642525|NCT01998958|7518597|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0
4642526|NCT01998958|7518598|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0
4642527|NCT01998958|7518599|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0
4642528|NCT01998958|7518600|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0
4642529|NCT01998958|7518601|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0
4642530|NCT01998958|7518602|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0
4642531|NCT01998958|7518603|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0
4642532|NCT01998958|7518604|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0
4642533|NCT01998958|7518605|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0
4642534|NCT01998958|7518606|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0
4642535|NCT01998958|7518607|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0
4642536|NCT01998958|7518608|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0
4642537|NCT01998958|7518609|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0
4642538|NCT01998958|7518610|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0
4642539|NCT01998958|7518611|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0
4642540|NCT01998958|7518612|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0
4642541|NCT01998958|7518613|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0
4642542|NCT01998958|7518614|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0
4642543|NCT01998958|7518615|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0
4642544|NCT01998958|7518616|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0
4642545|NCT01998958|7518617|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0
4642546|NCT01998958|7518618|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0
4747328|NCT03997825|7721353|FG000|Overall Study|Withdrawal by Subject|3
4747329|NCT03997825|7721353|FG000|Overall Study|Refused participation|1
4747330|NCT03764813|7721390|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0
4747331|NCT03764813|7721391|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1
4747332|NCT03764813|7721392|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1
4747333|NCT03764813|7721393|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0
4642547|NCT01998958|7518619|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0
4642548|NCT01998958|7518620|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0
4642549|NCT01998958|7518621|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0
4642550|NCT01998958|7518590|FG000|Period 1 (Panel A and B)|Adverse Event|0
4642551|NCT01998958|7518591|FG001|Period 1 (Panel A and B)|Adverse Event|1
4642552|NCT01998958|7518592|FG002|Period 1 (Panel A and B)|Adverse Event|0
4642553|NCT01998958|7518593|FG003|Period 1 (Panel A and B)|Adverse Event|0
4642554|NCT01998958|7518594|FG004|Period 1 (Panel A and B)|Adverse Event|0
4642555|NCT01998958|7518595|FG005|Period 1 (Panel A and B)|Adverse Event|0
4642556|NCT01998958|7518596|FG006|Period 1 (Panel A and B)|Adverse Event|0
4642557|NCT01998958|7518597|FG007|Period 1 (Panel A and B)|Adverse Event|0
4642558|NCT01998958|7518598|FG008|Period 1 (Panel A and B)|Adverse Event|0
4642559|NCT01998958|7518599|FG009|Period 1 (Panel A and B)|Adverse Event|0
4642560|NCT01998958|7518600|FG010|Period 1 (Panel A and B)|Adverse Event|0
4642561|NCT01998958|7518601|FG011|Period 1 (Panel A and B)|Adverse Event|0
4642562|NCT01998958|7518602|FG012|Period 1 (Panel A and B)|Adverse Event|0
4642563|NCT01998958|7518603|FG013|Period 1 (Panel A and B)|Adverse Event|0
4642564|NCT01998958|7518604|FG014|Period 1 (Panel A and B)|Adverse Event|0
4642565|NCT01998958|7518605|FG015|Period 1 (Panel A and B)|Adverse Event|0
4642566|NCT01998958|7518606|FG016|Period 1 (Panel A and B)|Adverse Event|0
4642567|NCT01998958|7518607|FG017|Period 1 (Panel A and B)|Adverse Event|0
4642568|NCT01998958|7518608|FG018|Period 1 (Panel A and B)|Adverse Event|0
4642569|NCT01998958|7518609|FG019|Period 1 (Panel A and B)|Adverse Event|0
4642570|NCT01998958|7518610|FG020|Period 1 (Panel A and B)|Adverse Event|0
4642571|NCT01998958|7518611|FG021|Period 1 (Panel A and B)|Adverse Event|0
4642572|NCT01998958|7518612|FG022|Period 1 (Panel A and B)|Adverse Event|0
4642573|NCT01998958|7518613|FG023|Period 1 (Panel A and B)|Adverse Event|0
4642574|NCT01998958|7518614|FG024|Period 1 (Panel A and B)|Adverse Event|0
4642575|NCT01998958|7518615|FG025|Period 1 (Panel A and B)|Adverse Event|0
4642576|NCT01998958|7518616|FG026|Period 1 (Panel A and B)|Adverse Event|0
4642577|NCT01998958|7518617|FG027|Period 1 (Panel A and B)|Adverse Event|0
4642578|NCT01998958|7518618|FG028|Period 1 (Panel A and B)|Adverse Event|0
4642579|NCT01998958|7518619|FG029|Period 1 (Panel A and B)|Adverse Event|0
4642580|NCT01998958|7518620|FG030|Period 1 (Panel A and B)|Adverse Event|0
4642581|NCT01998958|7518621|FG031|Period 1 (Panel A and B)|Adverse Event|0
4642582|NCT01998958|7518590|FG000|Period 1 (Panel A and B)|Other|1
4642583|NCT01998958|7518591|FG001|Period 1 (Panel A and B)|Other|0
4642584|NCT01998958|7518592|FG002|Period 1 (Panel A and B)|Other|0
4642585|NCT01998958|7518593|FG003|Period 1 (Panel A and B)|Other|0
4642586|NCT01998958|7518594|FG004|Period 1 (Panel A and B)|Other|0
4642587|NCT01998958|7518595|FG005|Period 1 (Panel A and B)|Other|0
4642588|NCT01998958|7518596|FG006|Period 1 (Panel A and B)|Other|0
4642589|NCT01998958|7518597|FG007|Period 1 (Panel A and B)|Other|0
4642590|NCT01998958|7518598|FG008|Period 1 (Panel A and B)|Other|0
4642591|NCT01998958|7518599|FG009|Period 1 (Panel A and B)|Other|0
4642592|NCT01998958|7518600|FG010|Period 1 (Panel A and B)|Other|0
4642593|NCT01998958|7518601|FG011|Period 1 (Panel A and B)|Other|0
4642594|NCT01998958|7518602|FG012|Period 1 (Panel A and B)|Other|0
4642595|NCT01998958|7518603|FG013|Period 1 (Panel A and B)|Other|0
4642596|NCT01998958|7518604|FG014|Period 1 (Panel A and B)|Other|0
4642597|NCT01998958|7518605|FG015|Period 1 (Panel A and B)|Other|0
4642598|NCT01998958|7518606|FG016|Period 1 (Panel A and B)|Other|0
4642599|NCT01998958|7518607|FG017|Period 1 (Panel A and B)|Other|0
4642600|NCT01998958|7518608|FG018|Period 1 (Panel A and B)|Other|0
4642601|NCT01998958|7518609|FG019|Period 1 (Panel A and B)|Other|0
4642602|NCT01998958|7518610|FG020|Period 1 (Panel A and B)|Other|0
4642603|NCT01998958|7518611|FG021|Period 1 (Panel A and B)|Other|0
4642604|NCT01998958|7518612|FG022|Period 1 (Panel A and B)|Other|0
4642605|NCT01998958|7518613|FG023|Period 1 (Panel A and B)|Other|0
4642606|NCT01998958|7518614|FG024|Period 1 (Panel A and B)|Other|0
4642607|NCT01998958|7518615|FG025|Period 1 (Panel A and B)|Other|0
4642608|NCT01998958|7518616|FG026|Period 1 (Panel A and B)|Other|0
4642609|NCT01998958|7518617|FG027|Period 1 (Panel A and B)|Other|0
4642610|NCT01998958|7518618|FG028|Period 1 (Panel A and B)|Other|0
4642611|NCT01998958|7518619|FG029|Period 1 (Panel A and B)|Other|0
4642612|NCT01998958|7518620|FG030|Period 1 (Panel A and B)|Other|0
4642613|NCT01998958|7518621|FG031|Period 1 (Panel A and B)|Other|0
4642614|NCT01998958|7518590|FG000|Period 2 (Panel A and B)|Adverse Event|0
4642615|NCT01998958|7518591|FG001|Period 2 (Panel A and B)|Adverse Event|0
4642616|NCT01998958|7518592|FG002|Period 2 (Panel A and B)|Adverse Event|0
4642617|NCT01998958|7518593|FG003|Period 2 (Panel A and B)|Adverse Event|0
4642618|NCT01998958|7518594|FG004|Period 2 (Panel A and B)|Adverse Event|0
4642619|NCT01998958|7518595|FG005|Period 2 (Panel A and B)|Adverse Event|0
4642620|NCT01998958|7518596|FG006|Period 2 (Panel A and B)|Adverse Event|0
4642621|NCT01998958|7518597|FG007|Period 2 (Panel A and B)|Adverse Event|0
4642622|NCT01998958|7518598|FG008|Period 2 (Panel A and B)|Adverse Event|0
4642623|NCT01998958|7518599|FG009|Period 2 (Panel A and B)|Adverse Event|0
4642624|NCT01998958|7518600|FG010|Period 2 (Panel A and B)|Adverse Event|1
4642625|NCT01998958|7518601|FG011|Period 2 (Panel A and B)|Adverse Event|0
4642626|NCT01998958|7518602|FG012|Period 2 (Panel A and B)|Adverse Event|0
4642627|NCT01998958|7518603|FG013|Period 2 (Panel A and B)|Adverse Event|0
4642628|NCT01998958|7518604|FG014|Period 2 (Panel A and B)|Adverse Event|1
4642629|NCT01998958|7518605|FG015|Period 2 (Panel A and B)|Adverse Event|0
4642630|NCT01998958|7518606|FG016|Period 2 (Panel A and B)|Adverse Event|0
4642631|NCT01998958|7518607|FG017|Period 2 (Panel A and B)|Adverse Event|0
4642632|NCT01998958|7518608|FG018|Period 2 (Panel A and B)|Adverse Event|0
4642633|NCT01998958|7518609|FG019|Period 2 (Panel A and B)|Adverse Event|0
4642634|NCT01998958|7518610|FG020|Period 2 (Panel A and B)|Adverse Event|0
4642635|NCT01998958|7518611|FG021|Period 2 (Panel A and B)|Adverse Event|0
4642636|NCT01998958|7518612|FG022|Period 2 (Panel A and B)|Adverse Event|0
4642637|NCT01998958|7518613|FG023|Period 2 (Panel A and B)|Adverse Event|0
4642638|NCT01998958|7518614|FG024|Period 2 (Panel A and B)|Adverse Event|0
4642639|NCT01998958|7518615|FG025|Period 2 (Panel A and B)|Adverse Event|0
4642640|NCT01998958|7518616|FG026|Period 2 (Panel A and B)|Adverse Event|0
4642641|NCT01998958|7518617|FG027|Period 2 (Panel A and B)|Adverse Event|0
4642642|NCT01998958|7518618|FG028|Period 2 (Panel A and B)|Adverse Event|0
4642643|NCT01998958|7518619|FG029|Period 2 (Panel A and B)|Adverse Event|0
4642644|NCT01998958|7518620|FG030|Period 2 (Panel A and B)|Adverse Event|0
4642645|NCT01998958|7518621|FG031|Period 2 (Panel A and B)|Adverse Event|0
4642646|NCT01998958|7518590|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0
4642647|NCT01998958|7518591|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0
4642648|NCT01998958|7518592|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0
4642649|NCT01998958|7518593|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0
4642650|NCT01998958|7518594|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0
4642651|NCT01998958|7518595|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0
4642652|NCT01998958|7518596|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0
4642653|NCT01998958|7518597|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0
4642654|NCT01998958|7518598|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0
4642655|NCT01998958|7518599|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0
4642656|NCT01998958|7518600|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0
4642657|NCT01998958|7518601|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0
4642658|NCT01998958|7518602|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0
4642659|NCT01998958|7518603|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0
4642660|NCT01998958|7518604|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1
4642661|NCT01998958|7518605|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0
4642662|NCT01998958|7518606|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0
4642663|NCT01998958|7518607|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0
4642664|NCT01998958|7518608|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1
4642665|NCT01998958|7518609|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0
4642666|NCT01998958|7518610|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0
4642667|NCT01998958|7518611|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0
4642668|NCT01998958|7518612|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0
4642669|NCT01998958|7518613|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0
4642670|NCT01998958|7518614|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0
4642671|NCT01998958|7518615|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0
4642672|NCT01998958|7518616|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0
4642673|NCT01998958|7518617|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0
4642674|NCT01998958|7518618|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0
4642675|NCT01998958|7518619|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0
4642676|NCT01998958|7518620|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0
4642677|NCT01998958|7518621|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0
4642678|NCT01998958|7518590|FG000|Open Label Phase (Optional)|Adverse Event|0
4642679|NCT01998958|7518591|FG001|Open Label Phase (Optional)|Adverse Event|0
4642680|NCT01998958|7518592|FG002|Open Label Phase (Optional)|Adverse Event|0
4642681|NCT01998958|7518593|FG003|Open Label Phase (Optional)|Adverse Event|0
4642682|NCT01998958|7518594|FG004|Open Label Phase (Optional)|Adverse Event|0
4642683|NCT01998958|7518595|FG005|Open Label Phase (Optional)|Adverse Event|0
4642684|NCT01998958|7518596|FG006|Open Label Phase (Optional)|Adverse Event|0
4642685|NCT01998958|7518597|FG007|Open Label Phase (Optional)|Adverse Event|0
4642686|NCT01998958|7518598|FG008|Open Label Phase (Optional)|Adverse Event|0
4642687|NCT01998958|7518599|FG009|Open Label Phase (Optional)|Adverse Event|0
4642688|NCT01998958|7518600|FG010|Open Label Phase (Optional)|Adverse Event|0
4642689|NCT01998958|7518601|FG011|Open Label Phase (Optional)|Adverse Event|0
4642690|NCT01998958|7518602|FG012|Open Label Phase (Optional)|Adverse Event|0
4642691|NCT01998958|7518603|FG013|Open Label Phase (Optional)|Adverse Event|0
4642692|NCT01998958|7518604|FG014|Open Label Phase (Optional)|Adverse Event|0
4642693|NCT01998958|7518605|FG015|Open Label Phase (Optional)|Adverse Event|0
4642694|NCT01998958|7518606|FG016|Open Label Phase (Optional)|Adverse Event|0
4642695|NCT01998958|7518607|FG017|Open Label Phase (Optional)|Adverse Event|0
4642696|NCT01998958|7518608|FG018|Open Label Phase (Optional)|Adverse Event|0
4642697|NCT01998958|7518609|FG019|Open Label Phase (Optional)|Adverse Event|0
4642698|NCT01998958|7518610|FG020|Open Label Phase (Optional)|Adverse Event|0
4642699|NCT01998958|7518611|FG021|Open Label Phase (Optional)|Adverse Event|0
4642700|NCT01998958|7518612|FG022|Open Label Phase (Optional)|Adverse Event|0
4642701|NCT01998958|7518613|FG023|Open Label Phase (Optional)|Adverse Event|1
4642702|NCT01998958|7518614|FG024|Open Label Phase (Optional)|Adverse Event|0
4642703|NCT01998958|7518615|FG025|Open Label Phase (Optional)|Adverse Event|0
4642704|NCT01998958|7518616|FG026|Open Label Phase (Optional)|Adverse Event|0
4642705|NCT01998958|7518617|FG027|Open Label Phase (Optional)|Adverse Event|0
4642706|NCT01998958|7518618|FG028|Open Label Phase (Optional)|Adverse Event|0
4642707|NCT01998958|7518619|FG029|Open Label Phase (Optional)|Adverse Event|0
4642708|NCT01998958|7518620|FG030|Open Label Phase (Optional)|Adverse Event|0
4642709|NCT01998958|7518621|FG031|Open Label Phase (Optional)|Adverse Event|0
4642710|NCT01998958|7518590|FG000|Open Label Phase (Optional)|Other|0
4642711|NCT01998958|7518591|FG001|Open Label Phase (Optional)|Other|0
4642712|NCT01998958|7518592|FG002|Open Label Phase (Optional)|Other|0
4642713|NCT01998958|7518593|FG003|Open Label Phase (Optional)|Other|0
4642714|NCT01998958|7518594|FG004|Open Label Phase (Optional)|Other|0
4642715|NCT01998958|7518595|FG005|Open Label Phase (Optional)|Other|0
4642716|NCT01998958|7518596|FG006|Open Label Phase (Optional)|Other|0
4642717|NCT01998958|7518597|FG007|Open Label Phase (Optional)|Other|0
4642718|NCT01998958|7518598|FG008|Open Label Phase (Optional)|Other|0
4642719|NCT01998958|7518599|FG009|Open Label Phase (Optional)|Other|0
4642720|NCT01998958|7518600|FG010|Open Label Phase (Optional)|Other|0
4642721|NCT01998958|7518601|FG011|Open Label Phase (Optional)|Other|0
4642722|NCT01998958|7518602|FG012|Open Label Phase (Optional)|Other|0
4642723|NCT01998958|7518603|FG013|Open Label Phase (Optional)|Other|0
4642724|NCT01998958|7518604|FG014|Open Label Phase (Optional)|Other|0
4642725|NCT01998958|7518605|FG015|Open Label Phase (Optional)|Other|0
4642726|NCT01998958|7518606|FG016|Open Label Phase (Optional)|Other|0
4642727|NCT01998958|7518607|FG017|Open Label Phase (Optional)|Other|0
4642728|NCT01998958|7518608|FG018|Open Label Phase (Optional)|Other|0
4642729|NCT01998958|7518609|FG019|Open Label Phase (Optional)|Other|0
4642730|NCT01998958|7518610|FG020|Open Label Phase (Optional)|Other|0
4642731|NCT01998958|7518611|FG021|Open Label Phase (Optional)|Other|0
4642732|NCT01998958|7518612|FG022|Open Label Phase (Optional)|Other|5
4642733|NCT01998958|7518613|FG023|Open Label Phase (Optional)|Other|1
4642734|NCT01998958|7518614|FG024|Open Label Phase (Optional)|Other|0
4642735|NCT01998958|7518615|FG025|Open Label Phase (Optional)|Other|0
4642736|NCT01998958|7518616|FG026|Open Label Phase (Optional)|Other|0
4642737|NCT01998958|7518617|FG027|Open Label Phase (Optional)|Other|0
4642738|NCT01998958|7518618|FG028|Open Label Phase (Optional)|Other|0
4642739|NCT01998958|7518619|FG029|Open Label Phase (Optional)|Other|0
4642740|NCT01998958|7518620|FG030|Open Label Phase (Optional)|Other|0
4642741|NCT01998958|7518621|FG031|Open Label Phase (Optional)|Other|0
4642742|NCT01998958|7518590|FG000|Open Label Phase (Optional)|Lost to Follow-up|0
4642743|NCT01998958|7518591|FG001|Open Label Phase (Optional)|Lost to Follow-up|0
4642744|NCT01998958|7518592|FG002|Open Label Phase (Optional)|Lost to Follow-up|0
4642745|NCT01998958|7518593|FG003|Open Label Phase (Optional)|Lost to Follow-up|0
4642746|NCT01998958|7518594|FG004|Open Label Phase (Optional)|Lost to Follow-up|0
4642747|NCT01998958|7518595|FG005|Open Label Phase (Optional)|Lost to Follow-up|0
4642748|NCT01998958|7518596|FG006|Open Label Phase (Optional)|Lost to Follow-up|0
4642749|NCT01998958|7518597|FG007|Open Label Phase (Optional)|Lost to Follow-up|0
4642750|NCT01998958|7518598|FG008|Open Label Phase (Optional)|Lost to Follow-up|0
4642751|NCT01998958|7518599|FG009|Open Label Phase (Optional)|Lost to Follow-up|0
4642752|NCT01998958|7518600|FG010|Open Label Phase (Optional)|Lost to Follow-up|0
4642753|NCT01998958|7518601|FG011|Open Label Phase (Optional)|Lost to Follow-up|0
4642754|NCT01998958|7518602|FG012|Open Label Phase (Optional)|Lost to Follow-up|0
4642755|NCT01998958|7518603|FG013|Open Label Phase (Optional)|Lost to Follow-up|0
4642756|NCT01998958|7518604|FG014|Open Label Phase (Optional)|Lost to Follow-up|0
4642757|NCT01998958|7518605|FG015|Open Label Phase (Optional)|Lost to Follow-up|0
4642758|NCT01998958|7518606|FG016|Open Label Phase (Optional)|Lost to Follow-up|0
4642759|NCT01998958|7518607|FG017|Open Label Phase (Optional)|Lost to Follow-up|0
4642760|NCT01998958|7518608|FG018|Open Label Phase (Optional)|Lost to Follow-up|0
4642761|NCT01998958|7518609|FG019|Open Label Phase (Optional)|Lost to Follow-up|0
4642762|NCT01998958|7518610|FG020|Open Label Phase (Optional)|Lost to Follow-up|0
4642763|NCT01998958|7518611|FG021|Open Label Phase (Optional)|Lost to Follow-up|0
4642764|NCT01998958|7518612|FG022|Open Label Phase (Optional)|Lost to Follow-up|1
4642765|NCT01998958|7518613|FG023|Open Label Phase (Optional)|Lost to Follow-up|0
4642766|NCT01998958|7518614|FG024|Open Label Phase (Optional)|Lost to Follow-up|0
4642767|NCT01998958|7518615|FG025|Open Label Phase (Optional)|Lost to Follow-up|0
4642768|NCT01998958|7518616|FG026|Open Label Phase (Optional)|Lost to Follow-up|0
4642769|NCT01998958|7518617|FG027|Open Label Phase (Optional)|Lost to Follow-up|0
4642770|NCT01998958|7518618|FG028|Open Label Phase (Optional)|Lost to Follow-up|0
4642771|NCT01998958|7518619|FG029|Open Label Phase (Optional)|Lost to Follow-up|0
4642772|NCT01998958|7518620|FG030|Open Label Phase (Optional)|Lost to Follow-up|0
4642773|NCT01998958|7518621|FG031|Open Label Phase (Optional)|Lost to Follow-up|0
4642774|NCT01998958|7518590|FG000|Open Label Phase (Optional)|Lack of Efficacy|0
4642775|NCT01998958|7518591|FG001|Open Label Phase (Optional)|Lack of Efficacy|0
4642776|NCT01998958|7518592|FG002|Open Label Phase (Optional)|Lack of Efficacy|0
4747334|NCT00078806|7721409|FG000|Part 1A|Adverse Event|2
4642777|NCT01998958|7518593|FG003|Open Label Phase (Optional)|Lack of Efficacy|0
4642778|NCT01998958|7518594|FG004|Open Label Phase (Optional)|Lack of Efficacy|0
4642779|NCT01998958|7518595|FG005|Open Label Phase (Optional)|Lack of Efficacy|0
4642780|NCT01998958|7518596|FG006|Open Label Phase (Optional)|Lack of Efficacy|0
4642781|NCT01998958|7518597|FG007|Open Label Phase (Optional)|Lack of Efficacy|0
4642782|NCT01998958|7518598|FG008|Open Label Phase (Optional)|Lack of Efficacy|0
4642783|NCT01998958|7518599|FG009|Open Label Phase (Optional)|Lack of Efficacy|0
4642784|NCT01998958|7518600|FG010|Open Label Phase (Optional)|Lack of Efficacy|0
4642785|NCT01998958|7518601|FG011|Open Label Phase (Optional)|Lack of Efficacy|0
4642786|NCT01998958|7518602|FG012|Open Label Phase (Optional)|Lack of Efficacy|0
4642787|NCT01998958|7518603|FG013|Open Label Phase (Optional)|Lack of Efficacy|0
4642788|NCT01998958|7518604|FG014|Open Label Phase (Optional)|Lack of Efficacy|0
4642789|NCT01998958|7518605|FG015|Open Label Phase (Optional)|Lack of Efficacy|0
4642790|NCT01998958|7518606|FG016|Open Label Phase (Optional)|Lack of Efficacy|0
4642791|NCT01998958|7518607|FG017|Open Label Phase (Optional)|Lack of Efficacy|0
4642792|NCT01998958|7518608|FG018|Open Label Phase (Optional)|Lack of Efficacy|0
4747335|NCT00078806|7721410|FG001|Part 1A|Adverse Event|0
4642793|NCT01998958|7518609|FG019|Open Label Phase (Optional)|Lack of Efficacy|0
4642794|NCT01998958|7518610|FG020|Open Label Phase (Optional)|Lack of Efficacy|0
4642795|NCT01998958|7518611|FG021|Open Label Phase (Optional)|Lack of Efficacy|1
4642796|NCT01998958|7518612|FG022|Open Label Phase (Optional)|Lack of Efficacy|2
4642797|NCT01998958|7518613|FG023|Open Label Phase (Optional)|Lack of Efficacy|0
4642798|NCT01998958|7518614|FG024|Open Label Phase (Optional)|Lack of Efficacy|0
4642799|NCT01998958|7518615|FG025|Open Label Phase (Optional)|Lack of Efficacy|0
4642800|NCT01998958|7518616|FG026|Open Label Phase (Optional)|Lack of Efficacy|0
4642801|NCT01998958|7518617|FG027|Open Label Phase (Optional)|Lack of Efficacy|0
4642802|NCT01998958|7518618|FG028|Open Label Phase (Optional)|Lack of Efficacy|0
4642803|NCT01998958|7518619|FG029|Open Label Phase (Optional)|Lack of Efficacy|0
4642804|NCT01998958|7518620|FG030|Open Label Phase (Optional)|Lack of Efficacy|0
4642805|NCT01998958|7518621|FG031|Open Label Phase (Optional)|Lack of Efficacy|0
4642806|NCT01998958|7518590|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0
4642807|NCT01998958|7518591|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0
4642808|NCT01998958|7518592|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0
4642809|NCT01998958|7518593|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0
4642810|NCT01998958|7518594|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0
4642811|NCT01998958|7518595|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0
4642812|NCT01998958|7518596|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0
4642813|NCT01998958|7518597|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0
4642814|NCT01998958|7518598|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0
4642815|NCT01998958|7518599|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0
4642816|NCT01998958|7518600|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0
4642817|NCT01998958|7518601|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0
4642818|NCT01998958|7518602|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0
4642819|NCT01998958|7518603|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0
4642820|NCT01998958|7518604|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0
4642821|NCT01998958|7518605|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0
4642822|NCT01998958|7518606|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0
4642823|NCT01998958|7518607|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0
4642824|NCT01998958|7518608|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0
4642825|NCT01998958|7518609|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0
4642826|NCT01998958|7518610|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0
4642827|NCT01998958|7518611|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2
4642828|NCT01998958|7518612|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1
4642829|NCT01998958|7518613|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2
4642830|NCT01998958|7518614|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0
4642831|NCT01998958|7518615|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0
4642832|NCT01998958|7518616|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0
4642833|NCT01998958|7518617|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0
4642834|NCT01998958|7518618|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0
4642835|NCT01998958|7518619|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0
4642836|NCT01998958|7518620|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0
4642837|NCT01998958|7518621|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0
4642838|NCT01998984|7518675|FG000|Overall Study|Adverse Event|0
4642839|NCT01998984|7518676|FG001|Overall Study|Adverse Event|0
4642840|NCT01998984|7518677|FG002|Overall Study|Adverse Event|0
4642841|NCT01998984|7518678|FG003|Overall Study|Adverse Event|1
4642842|NCT01998984|7518675|FG000|Overall Study|Lost to Follow-up|0
4642843|NCT01998984|7518676|FG001|Overall Study|Lost to Follow-up|1
4642844|NCT01998984|7518677|FG002|Overall Study|Lost to Follow-up|0
4642845|NCT01998984|7518678|FG003|Overall Study|Lost to Follow-up|1
4642846|NCT01998984|7518675|FG000|Overall Study|Withdrawal by Subject|0
4642847|NCT01998984|7518676|FG001|Overall Study|Withdrawal by Subject|0
4642848|NCT01998984|7518677|FG002|Overall Study|Withdrawal by Subject|1
4642849|NCT01998984|7518678|FG003|Overall Study|Withdrawal by Subject|0
4642850|NCT01998984|7518675|FG000|Overall Study|Other|0
4642851|NCT01998984|7518676|FG001|Overall Study|Other|0
4642852|NCT01998984|7518677|FG002|Overall Study|Other|0
4642853|NCT01998984|7518678|FG003|Overall Study|Other|1
4642854|NCT01999114|7518693|FG000|Overall Study|Adverse Event|8
4642855|NCT01999114|7518694|FG001|Overall Study|Adverse Event|7
4642856|NCT01999114|7518695|FG002|Overall Study|Adverse Event|2
4642857|NCT01999114|7518696|FG003|Overall Study|Adverse Event|2
4642858|NCT01999114|7518697|FG004|Overall Study|Adverse Event|1
4642859|NCT01999114|7518693|FG000|Overall Study|Withdrawal by Subject|0
4642860|NCT01999114|7518694|FG001|Overall Study|Withdrawal by Subject|0
4642861|NCT01999114|7518695|FG002|Overall Study|Withdrawal by Subject|1
4642862|NCT01999114|7518696|FG003|Overall Study|Withdrawal by Subject|0
4642863|NCT01999114|7518697|FG004|Overall Study|Withdrawal by Subject|1
4642864|NCT01999114|7518693|FG000|Overall Study|Lost to Follow-up|0
4642865|NCT01999114|7518694|FG001|Overall Study|Lost to Follow-up|0
4642866|NCT01999114|7518695|FG002|Overall Study|Lost to Follow-up|1
4642867|NCT01999114|7518696|FG003|Overall Study|Lost to Follow-up|0
4642868|NCT01999114|7518697|FG004|Overall Study|Lost to Follow-up|0
4642869|NCT01999114|7518693|FG000|Overall Study|Administrative|0
4642870|NCT01999114|7518694|FG001|Overall Study|Administrative|0
4642871|NCT01999114|7518695|FG002|Overall Study|Administrative|1
4642872|NCT01999114|7518696|FG003|Overall Study|Administrative|1
4642873|NCT01999114|7518697|FG004|Overall Study|Administrative|2
4642874|NCT01999218|7518743|FG000|Overall Study|Hyperglycemia|18
4642875|NCT01999218|7518744|FG001|Overall Study|Hyperglycemia|17
4642876|NCT01999218|7518745|FG002|Overall Study|Hyperglycemia|17
4642877|NCT01999218|7518743|FG000|Overall Study|Lack of Efficacy|1
4642878|NCT01999218|7518744|FG001|Overall Study|Lack of Efficacy|0
4642879|NCT01999218|7518745|FG002|Overall Study|Lack of Efficacy|1
4642880|NCT01999218|7518743|FG000|Overall Study|Lost to Follow-up|22
4642881|NCT01999218|7518744|FG001|Overall Study|Lost to Follow-up|17
4642882|NCT01999218|7518745|FG002|Overall Study|Lost to Follow-up|18
4642883|NCT01999218|7518743|FG000|Overall Study|Non-Compliance With Study Drug|6
4642884|NCT01999218|7518744|FG001|Overall Study|Non-Compliance With Study Drug|4
4642885|NCT01999218|7518745|FG002|Overall Study|Non-Compliance With Study Drug|1
4642886|NCT01999218|7518743|FG000|Overall Study|Physician Decision|1
4642887|NCT01999218|7518744|FG001|Overall Study|Physician Decision|4
4642888|NCT01999218|7518745|FG002|Overall Study|Physician Decision|6
4642889|NCT01999218|7518743|FG000|Overall Study|Protocol Violation|4
4642890|NCT01999218|7518744|FG001|Overall Study|Protocol Violation|5
4642891|NCT01999218|7518745|FG002|Overall Study|Protocol Violation|4
4642892|NCT01999218|7518743|FG000|Overall Study|Screen failure|0
4642893|NCT01999218|7518744|FG001|Overall Study|Screen failure|1
4642894|NCT01999218|7518745|FG002|Overall Study|Screen failure|0
4642895|NCT01999218|7518743|FG000|Overall Study|Study Terminated By Sponsor|7
4642896|NCT01999218|7518744|FG001|Overall Study|Study Terminated By Sponsor|5
4642897|NCT01999218|7518745|FG002|Overall Study|Study Terminated By Sponsor|12
4642898|NCT01999218|7518743|FG000|Overall Study|Participant moves|2
4642899|NCT01999218|7518744|FG001|Overall Study|Participant moves|5
4642900|NCT01999218|7518745|FG002|Overall Study|Participant moves|3
4642901|NCT01999218|7518743|FG000|Overall Study|Withdrawal by Subject|28
4642902|NCT01999218|7518744|FG001|Overall Study|Withdrawal by Subject|29
4642903|NCT01999218|7518745|FG002|Overall Study|Withdrawal by Subject|34
4642904|NCT01999218|7518743|FG000|Overall Study|Creatinine/eGFR|0
4642905|NCT01999218|7518744|FG001|Overall Study|Creatinine/eGFR|0
4642906|NCT01999218|7518745|FG002|Overall Study|Creatinine/eGFR|1
4642907|NCT01999218|7518743|FG000|Overall Study|Death|7
4642908|NCT01999218|7518744|FG001|Overall Study|Death|1
4642909|NCT01999218|7518745|FG002|Overall Study|Death|2
4642910|NCT01999218|7518743|FG000|Overall Study|Excluded Medication|1
4642911|NCT01999218|7518744|FG001|Overall Study|Excluded Medication|1
4642912|NCT01999218|7518745|FG002|Overall Study|Excluded Medication|2
4642913|NCT01999218|7518743|FG000|Overall Study|Adverse Event|9
4642914|NCT01999218|7518744|FG001|Overall Study|Adverse Event|7
4642915|NCT01999218|7518745|FG002|Overall Study|Adverse Event|7
4642916|NCT01999218|7518743|FG000|Overall Study|Treated but excluded at 1 trial site|3
4642917|NCT01999218|7518744|FG001|Overall Study|Treated but excluded at 1 trial site|5
4642918|NCT01999218|7518745|FG002|Overall Study|Treated but excluded at 1 trial site|2
4642919|NCT01999322|7518774|FG000|Overall Study|Adverse Event|1
4642920|NCT01999322|7518775|FG001|Overall Study|Adverse Event|0
4642921|NCT01999335|7518786|FG000|Overall Study|Discontinued before receiving treatment|0
4642922|NCT01999335|7518787|FG001|Overall Study|Discontinued before receiving treatment|0
4642923|NCT01999335|7518788|FG002|Overall Study|Discontinued before receiving treatment|0
4642924|NCT01999335|7518789|FG003|Overall Study|Discontinued before receiving treatment|0
4642925|NCT01999335|7518790|FG004|Overall Study|Discontinued before receiving treatment|2
4642926|NCT01999465|7518826|FG000|Overall Study|Lost to Follow-up|0
4642927|NCT01999465|7518827|FG001|Overall Study|Lost to Follow-up|2
4642928|NCT01999465|7518826|FG000|Overall Study|Protocol Violation|0
4642929|NCT01999465|7518827|FG001|Overall Study|Protocol Violation|1
4642930|NCT01999868|7518858|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0
4642931|NCT01999868|7518859|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0
4642932|NCT01999868|7518860|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5
4642933|NCT01999868|7518858|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1
4747336|NCT00078806|7721411|FG002|Part 1A|Adverse Event|0
4747337|NCT00078806|7721412|FG003|Part 1A|Adverse Event|0
4747338|NCT00078806|7721409|FG000|Part 1A|Lack of Efficacy|7
4747339|NCT00078806|7721410|FG001|Part 1A|Lack of Efficacy|0
4747340|NCT00078806|7721411|FG002|Part 1A|Lack of Efficacy|0
4747341|NCT00078806|7721412|FG003|Part 1A|Lack of Efficacy|0
4747342|NCT00078806|7721409|FG000|Part 1A|Other|1
4747343|NCT00078806|7721410|FG001|Part 1A|Other|0
4747344|NCT00078806|7721411|FG002|Part 1A|Other|0
4747345|NCT00078806|7721412|FG003|Part 1A|Other|0
4747346|NCT00078806|7721409|FG000|Part 1B|Adverse Event|1
4642934|NCT01999868|7518859|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1
4642935|NCT01999868|7518860|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0
4642936|NCT01999868|7518858|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3
4642937|NCT01999868|7518859|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4
4642938|NCT01999868|7518860|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0
4642939|NCT01999868|7518858|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0
4642940|NCT01999868|7518859|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1
4642941|NCT01999868|7518860|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0
4642942|NCT01999868|7518858|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0
4747347|NCT00078806|7721410|FG001|Part 1B|Adverse Event|0
4747348|NCT00078806|7721411|FG002|Part 1B|Adverse Event|0
4747349|NCT00078806|7721412|FG003|Part 1B|Adverse Event|0
4642943|NCT01999868|7518859|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2
4642944|NCT01999868|7518860|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0
4642945|NCT01999868|7518858|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1
4642946|NCT01999868|7518859|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2
4642947|NCT01999868|7518860|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0
4642948|NCT01999868|7518858|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8
4642949|NCT01999868|7518859|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1
4642950|NCT01999868|7518860|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0
4642951|NCT01999868|7518858|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1
4642952|NCT01999868|7518859|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0
4642953|NCT01999868|7518860|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0
4642954|NCT01999868|7518858|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4
4642955|NCT01999868|7518859|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0
4642956|NCT01999868|7518860|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0
4642957|NCT01999868|7518858|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0
4642958|NCT01999868|7518859|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1
4642959|NCT01999868|7518860|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0
4642960|NCT01999868|7518858|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0
4642961|NCT01999868|7518859|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1
4642962|NCT01999868|7518860|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0
4642963|NCT01999868|7518858|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1
4642964|NCT01999868|7518859|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2
4642965|NCT01999868|7518860|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0
4642966|NCT01999868|7518858|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10
4642967|NCT01999868|7518859|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19
4642968|NCT01999868|7518860|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0
4642969|NCT01999868|7518858|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0
4642970|NCT01999868|7518859|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2
4642971|NCT01999868|7518860|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0
4642972|NCT01999868|7518858|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12
4642973|NCT01999868|7518859|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4
4642974|NCT01999868|7518860|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0
4642975|NCT01999894|7518868|FG000|Overall Study|Adverse Event|9
4642976|NCT01999894|7518868|FG000|Overall Study|Lack of Efficacy|5
4642977|NCT01999894|7518868|FG000|Overall Study|Protocol Violation|1
4642978|NCT01999894|7518868|FG000|Overall Study|Withdrawal by Subject|7
4642979|NCT01999894|7518868|FG000|Overall Study|Lost to Follow-up|10
4642980|NCT01999894|7518868|FG000|Overall Study|Other Reason|3
4642981|NCT01999894|7518868|FG000|Overall Study|Inclusion/exclusion criteria not met|1
4642982|NCT01999946|7518885|FG000|Overall Study|Participant not released from jail|2
4642983|NCT01999946|7518886|FG001|Overall Study|Participant not released from jail|2
4642984|NCT01999946|7518887|FG002|Overall Study|Participant not released from jail|0
4642985|NCT01999946|7518885|FG000|Overall Study|Not included in primary outcome analysis|0
4642986|NCT01999946|7518886|FG001|Overall Study|Not included in primary outcome analysis|0
4642987|NCT01999946|7518887|FG002|Overall Study|Not included in primary outcome analysis|79
4642988|NCT01999972|7518900|FG000|Dose Escalation Part|Participant refused further follow-up|1
4642989|NCT01999972|7518901|FG001|Dose Escalation Part|Participant refused further follow-up|0
4642990|NCT01999972|7518902|FG002|Dose Escalation Part|Participant refused further follow-up|1
4642991|NCT01999972|7518903|FG003|Dose Escalation Part|Participant refused further follow-up|1
4642992|NCT01999972|7518904|FG004|Dose Escalation Part|Participant refused further follow-up|0
4642993|NCT01999972|7518905|FG005|Dose Escalation Part|Participant refused further follow-up|0
4642994|NCT01999972|7518900|FG000|Dose Escalation Part|Death|0
4642995|NCT01999972|7518901|FG001|Dose Escalation Part|Death|1
4642996|NCT01999972|7518902|FG002|Dose Escalation Part|Death|0
4642997|NCT01999972|7518903|FG003|Dose Escalation Part|Death|0
4642998|NCT01999972|7518904|FG004|Dose Escalation Part|Death|0
4642999|NCT01999972|7518905|FG005|Dose Escalation Part|Death|0
4643000|NCT01999972|7518900|FG000|Dose Escalation Part|Enrolled but not treated|0
4643001|NCT01999972|7518901|FG001|Dose Escalation Part|Enrolled but not treated|0
4643002|NCT01999972|7518902|FG002|Dose Escalation Part|Enrolled but not treated|1
4643003|NCT01999972|7518903|FG003|Dose Escalation Part|Enrolled but not treated|1
4643004|NCT01999972|7518904|FG004|Dose Escalation Part|Enrolled but not treated|0
4643005|NCT01999972|7518905|FG005|Dose Escalation Part|Enrolled but not treated|0
4643006|NCT01999972|7518900|FG000|Dose Escalation Part|Disease progression|3
4643007|NCT01999972|7518901|FG001|Dose Escalation Part|Disease progression|2
4643008|NCT01999972|7518902|FG002|Dose Escalation Part|Disease progression|3
4643009|NCT01999972|7518903|FG003|Dose Escalation Part|Disease progression|6
4643010|NCT01999972|7518904|FG004|Dose Escalation Part|Disease progression|0
4643011|NCT01999972|7518905|FG005|Dose Escalation Part|Disease progression|0
4643012|NCT01999972|7518900|FG000|Dose Escalation Part|Adverse Event|0
4643013|NCT01999972|7518901|FG001|Dose Escalation Part|Adverse Event|0
4643014|NCT01999972|7518902|FG002|Dose Escalation Part|Adverse Event|0
4643015|NCT01999972|7518903|FG003|Dose Escalation Part|Adverse Event|2
4643016|NCT01999972|7518904|FG004|Dose Escalation Part|Adverse Event|0
4643017|NCT01999972|7518905|FG005|Dose Escalation Part|Adverse Event|0
4643018|NCT01999972|7518900|FG000|Dose Escalation Part|Global deterioration of health status|1
4643019|NCT01999972|7518901|FG001|Dose Escalation Part|Global deterioration of health status|0
4643020|NCT01999972|7518902|FG002|Dose Escalation Part|Global deterioration of health status|0
4643021|NCT01999972|7518903|FG003|Dose Escalation Part|Global deterioration of health status|1
4643022|NCT01999972|7518904|FG004|Dose Escalation Part|Global deterioration of health status|0
4643023|NCT01999972|7518905|FG005|Dose Escalation Part|Global deterioration of health status|0
4643024|NCT01999972|7518900|FG000|Dose Expansion Part|Death|0
4643025|NCT01999972|7518901|FG001|Dose Expansion Part|Death|0
4643026|NCT01999972|7518902|FG002|Dose Expansion Part|Death|0
4643027|NCT01999972|7518903|FG003|Dose Expansion Part|Death|0
4643028|NCT01999972|7518904|FG004|Dose Expansion Part|Death|2
4643029|NCT01999972|7518905|FG005|Dose Expansion Part|Death|1
4643030|NCT01999972|7518900|FG000|Dose Expansion Part|Disease progression|0
4643031|NCT01999972|7518901|FG001|Dose Expansion Part|Disease progression|0
4643032|NCT01999972|7518902|FG002|Dose Expansion Part|Disease progression|0
4643033|NCT01999972|7518903|FG003|Dose Expansion Part|Disease progression|0
4643034|NCT01999972|7518904|FG004|Dose Expansion Part|Disease progression|9
4643035|NCT01999972|7518905|FG005|Dose Expansion Part|Disease progression|3
4643036|NCT01999972|7518900|FG000|Dose Expansion Part|Sponsor decision|0
4643037|NCT01999972|7518901|FG001|Dose Expansion Part|Sponsor decision|0
4643038|NCT01999972|7518902|FG002|Dose Expansion Part|Sponsor decision|0
4643039|NCT01999972|7518903|FG003|Dose Expansion Part|Sponsor decision|0
4643040|NCT01999972|7518904|FG004|Dose Expansion Part|Sponsor decision|1
4643041|NCT01999972|7518905|FG005|Dose Expansion Part|Sponsor decision|0
4643042|NCT01999972|7518900|FG000|Dose Expansion Part|Adverse Event|0
4643043|NCT01999972|7518901|FG001|Dose Expansion Part|Adverse Event|0
4643044|NCT01999972|7518902|FG002|Dose Expansion Part|Adverse Event|0
4643045|NCT01999972|7518903|FG003|Dose Expansion Part|Adverse Event|0
4643046|NCT01999972|7518904|FG004|Dose Expansion Part|Adverse Event|4
4643047|NCT01999972|7518905|FG005|Dose Expansion Part|Adverse Event|2
4643048|NCT01999972|7518900|FG000|Dose Expansion Part|Participant's non-compliance|0
4643049|NCT01999972|7518901|FG001|Dose Expansion Part|Participant's non-compliance|0
4643050|NCT01999972|7518902|FG002|Dose Expansion Part|Participant's non-compliance|0
4643051|NCT01999972|7518903|FG003|Dose Expansion Part|Participant's non-compliance|0
4643052|NCT01999972|7518904|FG004|Dose Expansion Part|Participant's non-compliance|0
4643053|NCT01999972|7518905|FG005|Dose Expansion Part|Participant's non-compliance|1
4643054|NCT01999972|7518900|FG000|Dose Expansion Part|Participant refused further follow-up|0
4643055|NCT01999972|7518901|FG001|Dose Expansion Part|Participant refused further follow-up|0
4643056|NCT01999972|7518902|FG002|Dose Expansion Part|Participant refused further follow-up|0
4643057|NCT01999972|7518903|FG003|Dose Expansion Part|Participant refused further follow-up|0
4643058|NCT01999972|7518904|FG004|Dose Expansion Part|Participant refused further follow-up|4
4643059|NCT01999972|7518905|FG005|Dose Expansion Part|Participant refused further follow-up|0
4643060|NCT01999972|7518900|FG000|Dose Expansion Part|Changed to standard of care|0
4643061|NCT01999972|7518901|FG001|Dose Expansion Part|Changed to standard of care|0
4643062|NCT01999972|7518902|FG002|Dose Expansion Part|Changed to standard of care|0
4643063|NCT01999972|7518903|FG003|Dose Expansion Part|Changed to standard of care|0
4643064|NCT01999972|7518904|FG004|Dose Expansion Part|Changed to standard of care|1
4643065|NCT01999972|7518905|FG005|Dose Expansion Part|Changed to standard of care|0
4643066|NCT02000440|7518942|FG000|Overall Study|Adverse Event|3
4643067|NCT02000440|7518942|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1
4643068|NCT02000531|7518948|FG000|Overall Study|Lost to Follow-up|1
4643069|NCT02000531|7518949|FG001|Overall Study|Lost to Follow-up|0
4643070|NCT02000531|7518948|FG000|Overall Study|Discontinued due to data cut-off|3
4643071|NCT02000531|7518949|FG001|Overall Study|Discontinued due to data cut-off|8
4643072|NCT02000752|7518966|FG000|Overall Study|Dystocic delivery|19
4643073|NCT02000752|7518967|FG001|Overall Study|Dystocic delivery|8
4643074|NCT02000752|7518966|FG000|Overall Study|Shift Changes|12
4643075|NCT02000752|7518967|FG001|Overall Study|Shift Changes|5
4643076|NCT02000817|7518977|FG000|Overall Study|Withdrawal by Subject|2
4643077|NCT02000817|7518978|FG001|Overall Study|Withdrawal by Subject|0
4643078|NCT02000817|7518979|FG002|Overall Study|Withdrawal by Subject|0
4643079|NCT02000817|7518980|FG003|Overall Study|Withdrawal by Subject|0
4643080|NCT02000817|7518977|FG000|Overall Study|Adverse Event|0
4643081|NCT02000817|7518978|FG001|Overall Study|Adverse Event|1
4643082|NCT02000817|7518979|FG002|Overall Study|Adverse Event|0
4643083|NCT02000817|7518980|FG003|Overall Study|Adverse Event|0
4643084|NCT02000817|7518977|FG000|Overall Study|Lost to Follow-up|0
4643085|NCT02000817|7518978|FG001|Overall Study|Lost to Follow-up|0
4643086|NCT02000817|7518979|FG002|Overall Study|Lost to Follow-up|1
4643087|NCT02000817|7518980|FG003|Overall Study|Lost to Follow-up|0
4643088|NCT02000921|7519005|FG000|Overall Study|Withdrawal by Subject|3
4643089|NCT02000921|7519006|FG001|Overall Study|Withdrawal by Subject|10
4643090|NCT02000921|7519007|FG002|Overall Study|Withdrawal by Subject|5
4643091|NCT02000921|7519005|FG000|Overall Study|Lost to Follow-up|2
4643092|NCT02000921|7519006|FG001|Overall Study|Lost to Follow-up|4
4643093|NCT02000921|7519007|FG002|Overall Study|Lost to Follow-up|5
4643094|NCT02000921|7519005|FG000|Overall Study|Physician Decision|0
4643095|NCT02000921|7519006|FG001|Overall Study|Physician Decision|2
4643096|NCT02000921|7519007|FG002|Overall Study|Physician Decision|0
4643097|NCT02001051|7519034|FG000|Overall Study|Deemed not eligible following enrollment|0
4643098|NCT02001051|7519035|FG001|Overall Study|Deemed not eligible following enrollment|1
4643099|NCT02001064|7519043|FG000|Overall Study|Withdrawal by Subject|2
4643100|NCT02001064|7519044|FG001|Overall Study|Withdrawal by Subject|1
4643101|NCT02001181|7519052|FG000|Overall Study|Adverse Event|0
4643102|NCT02001181|7519053|FG001|Overall Study|Adverse Event|2
4643103|NCT02001181|7519052|FG000|Overall Study|Lost to Follow-up|1
4643104|NCT02001181|7519053|FG001|Overall Study|Lost to Follow-up|0
4643105|NCT02001181|7519052|FG000|Overall Study|Withdrawal by Subject|0
4643106|NCT02001181|7519053|FG001|Overall Study|Withdrawal by Subject|1
4643107|NCT02001194|7519063|FG000|Intervention Period (13 Weeks)|No longer interested|1
4643108|NCT02001194|7519064|FG001|Intervention Period (13 Weeks)|No longer interested|0
4643109|NCT02001194|7519065|FG002|Intervention Period (13 Weeks)|No longer interested|2
4643110|NCT02001194|7519066|FG003|Intervention Period (13 Weeks)|No longer interested|2
4643111|NCT02001194|7519063|FG000|Follow-Up Period (13 Weeks)|No longer interested|3
4643112|NCT02001194|7519064|FG001|Follow-Up Period (13 Weeks)|No longer interested|2
4643113|NCT02001194|7519065|FG002|Follow-Up Period (13 Weeks)|No longer interested|1
4643114|NCT02001194|7519066|FG003|Follow-Up Period (13 Weeks)|No longer interested|0
4643115|NCT02001558|7519078|FG000|Overall Study|Lost to Follow-up|8
4643116|NCT02001558|7519079|FG001|Overall Study|Lost to Follow-up|14
4643117|NCT02001688|7519088|FG000|Overall Study|Withdrawal by Subject|0
4643118|NCT02001688|7519089|FG001|Overall Study|Withdrawal by Subject|0
4643119|NCT02001688|7519090|FG002|Overall Study|Withdrawal by Subject|1
4643120|NCT02001688|7519088|FG000|Overall Study|Adverse Event|0
4643121|NCT02001688|7519089|FG001|Overall Study|Adverse Event|1
4643122|NCT02001688|7519090|FG002|Overall Study|Adverse Event|0
4643123|NCT02001987|7519108|FG000|Core Study Period (24 Weeks)|Adverse Event|9
4643124|NCT02001987|7519108|FG000|Core Study Period (24 Weeks)|Death|1
4643125|NCT02001987|7519108|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2
4643126|NCT02001987|7519108|FG000|Core Study Period (24 Weeks)|Physician Decision|1
4643127|NCT02001987|7519108|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4
4643128|NCT02001987|7519108|FG000|Core Study Period (24 Weeks)|Protocol Violation|3
4643129|NCT02001987|7519108|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3
4643130|NCT02001987|7519108|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2
4643131|NCT02001987|7519108|FG000|LTE Period (52 Weeks)|Physician Decision|2
4643132|NCT02001987|7519108|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1
4643133|NCT02001987|7519108|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1
4643134|NCT02001987|7519108|FG000|LTE Period (52 Weeks)|Other|3
4643135|NCT02002091|7519119|FG000|Screening|Lost to Follow-up|10
4643136|NCT02002091|7519120|FG001|Screening|Lost to Follow-up|12
4643137|NCT02002091|7519119|FG000|Screening|Death|3
4643138|NCT02002091|7519120|FG001|Screening|Death|2
4643139|NCT02002182|7519157|FG000|Overall Study|Withdraw from study|3
4643140|NCT02002182|7519158|FG001|Overall Study|Withdraw from study|1
4643141|NCT02002182|7519157|FG000|Overall Study|Health Reasons|1
4643142|NCT02002182|7519158|FG001|Overall Study|Health Reasons|0
4643143|NCT02002182|7519157|FG000|Overall Study|Death|1
4643144|NCT02002182|7519158|FG001|Overall Study|Death|0
4643145|NCT02002221|7519175|FG000|Overall Study|Adverse Event|2
4643146|NCT02002221|7519176|FG001|Overall Study|Adverse Event|1
4643147|NCT02002221|7519175|FG000|Overall Study|Unsatisfactory therapeutic effect|0
4643148|NCT02002221|7519176|FG001|Overall Study|Unsatisfactory therapeutic effect|1
4643149|NCT02002221|7519175|FG000|Overall Study|Patient withdrew consent|0
4643150|NCT02002221|7519176|FG001|Overall Study|Patient withdrew consent|1
4643151|NCT02002533|7519199|FG000|Overall Study|Withdrawal by Subject|6
4643152|NCT02002533|7519200|FG001|Overall Study|Withdrawal by Subject|13
4643153|NCT02002533|7519199|FG000|Overall Study|Protocol Violation|0
4643154|NCT02002533|7519200|FG001|Overall Study|Protocol Violation|1
4643155|NCT02002533|7519199|FG000|Overall Study|Adverse Event|0
4643156|NCT02002533|7519200|FG001|Overall Study|Adverse Event|3
4643157|NCT02002533|7519199|FG000|Overall Study|Lost to Follow-up|0
4643158|NCT02002533|7519200|FG001|Overall Study|Lost to Follow-up|1
4643159|NCT02002689|7519217|FG000|Overall Study|Disease Progression|7
4643160|NCT02002689|7519217|FG000|Overall Study|Adverse Event|3
4643161|NCT02002884|7519261|FG000|Main Period (MP)|Other|0
4643162|NCT02002884|7519262|FG001|Main Period (MP)|Other|3
4643163|NCT02002884|7519263|FG002|Main Period (MP)|Other|3
4643164|NCT02002884|7519264|FG003|Main Period (MP)|Other|0
4643165|NCT02002884|7519261|FG000|Main Period (MP)|Adverse Event|0
4643166|NCT02002884|7519262|FG001|Main Period (MP)|Adverse Event|1
4643167|NCT02002884|7519263|FG002|Main Period (MP)|Adverse Event|1
4643168|NCT02002884|7519264|FG003|Main Period (MP)|Adverse Event|0
4643169|NCT02002884|7519261|FG000|Main Period (MP)|Withdrawal by Subject|6
4643170|NCT02002884|7519262|FG001|Main Period (MP)|Withdrawal by Subject|2
4643171|NCT02002884|7519263|FG002|Main Period (MP)|Withdrawal by Subject|2
4643172|NCT02002884|7519264|FG003|Main Period (MP)|Withdrawal by Subject|0
4643173|NCT02002884|7519261|FG000|Main Period (MP)|Lost to Follow-up|0
4643174|NCT02002884|7519262|FG001|Main Period (MP)|Lost to Follow-up|0
4643175|NCT02002884|7519263|FG002|Main Period (MP)|Lost to Follow-up|2
4643176|NCT02002884|7519264|FG003|Main Period (MP)|Lost to Follow-up|0
4643177|NCT02002884|7519261|FG000|Open-Label Extension Period (OLEX)|Other|0
4643178|NCT02002884|7519262|FG001|Open-Label Extension Period (OLEX)|Other|0
4643179|NCT02002884|7519263|FG002|Open-Label Extension Period (OLEX)|Other|0
4643180|NCT02002884|7519264|FG003|Open-Label Extension Period (OLEX)|Other|24
4643181|NCT02002884|7519261|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0
4643182|NCT02002884|7519262|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0
4643183|NCT02002884|7519263|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0
4643184|NCT02002884|7519264|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1
4643185|NCT02002884|7519261|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0
4643186|NCT02002884|7519262|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0
4643187|NCT02002884|7519263|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0
4643188|NCT02002884|7519264|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5
4643189|NCT02002884|7519261|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0
4643190|NCT02002884|7519262|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0
4643191|NCT02002884|7519263|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0
4643192|NCT02002884|7519264|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10
4643193|NCT02002884|7519261|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0
4643194|NCT02002884|7519262|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0
4643195|NCT02002884|7519263|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0
4643196|NCT02002884|7519264|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10
4643197|NCT02002975|7519278|FG000|Overall Study|Case Report Forms Uncollected|135
4643198|NCT02002975|7519278|FG000|Overall Study|Protocol Deviation|437
4643199|NCT02003014|7519282|FG000|Overall Study|Case report forms uncollected|9
4643200|NCT02003014|7519282|FG000|Overall Study|Treatment started after contract period|1
4643201|NCT02003014|7519282|FG000|Overall Study|Patient did not visit the study site|5
4643202|NCT02003014|7519282|FG000|Overall Study|Investigator's transfer|4
4643203|NCT02003183|7519297|FG000|Overall Study|Lost to Follow-up|0
4643204|NCT02003183|7519298|FG001|Overall Study|Lost to Follow-up|2
4643205|NCT02003365|7519311|FG000|Overall Study|Lost to Follow-up|0
4643206|NCT02003365|7519312|FG001|Overall Study|Lost to Follow-up|0
4643207|NCT02003365|7519313|FG002|Overall Study|Lost to Follow-up|1
4643208|NCT02003391|7519323|FG000|Overall Study|Withdrawal by Subject|2
4643209|NCT02003391|7519324|FG001|Overall Study|Withdrawal by Subject|1
4643210|NCT02003391|7519323|FG000|Overall Study|Protocol Violation|0
4643211|NCT02003391|7519324|FG001|Overall Study|Protocol Violation|1
4643212|NCT02003391|7519323|FG000|Overall Study|Adverse Event|1
4643213|NCT02003391|7519324|FG001|Overall Study|Adverse Event|0
4643214|NCT02003534|7519345|FG000|Overall Study|Lost to Follow-up|47
4747350|NCT00078806|7721409|FG000|Part 1B|Lack of Efficacy|7
4747351|NCT00078806|7721410|FG001|Part 1B|Lack of Efficacy|0
4747352|NCT00078806|7721411|FG002|Part 1B|Lack of Efficacy|0
4747353|NCT00078806|7721412|FG003|Part 1B|Lack of Efficacy|0
4747354|NCT00078806|7721409|FG000|Part 2|Adverse Event|0
4747355|NCT00078806|7721410|FG001|Part 2|Adverse Event|1
4747356|NCT00078806|7721411|FG002|Part 2|Adverse Event|0
4747357|NCT00078806|7721412|FG003|Part 2|Adverse Event|0
4643215|NCT02003573|7519352|FG000|Overall Study|Progressive disease|2
4643216|NCT02003573|7519353|FG001|Overall Study|Progressive disease|0
4643217|NCT02003573|7519354|FG002|Overall Study|Progressive disease|1
4643218|NCT02003573|7519352|FG000|Overall Study|Other Adverse event|0
4643219|NCT02003573|7519353|FG001|Overall Study|Other Adverse event|1
4643220|NCT02003573|7519354|FG002|Overall Study|Other Adverse event|1
4643221|NCT02003573|7519352|FG000|Overall Study|Refuse to take trial medication|0
4643222|NCT02003573|7519353|FG001|Overall Study|Refuse to take trial medication|1
4643223|NCT02003573|7519354|FG002|Overall Study|Refuse to take trial medication|1
4643224|NCT02003573|7519352|FG000|Overall Study|Other than specified|1
4643225|NCT02003573|7519353|FG001|Overall Study|Other than specified|2
4643226|NCT02003573|7519354|FG002|Overall Study|Other than specified|3
4643227|NCT02003638|7519375|FG000|Overall Study|Withdrawal by Subject|1
4643228|NCT02003638|7519376|FG001|Overall Study|Withdrawal by Subject|0
4643229|NCT02003898|7519382|FG000|Overall Study|Death|3
4643230|NCT02003898|7519382|FG000|Overall Study|Lost to Follow-up|12
4643231|NCT02003898|7519382|FG000|Overall Study|Withdrawal by Subject|52
4643232|NCT02003963|7519397|FG000|Overall Study|Lost to Follow-up|2
4643233|NCT02003963|7519398|FG001|Overall Study|Lost to Follow-up|1
4643234|NCT02004093|7519408|FG000|Overall Study|Death|2
4643235|NCT02004093|7519409|FG001|Overall Study|Death|1
4643236|NCT02004093|7519408|FG000|Overall Study|Lack of Efficacy|66
4643237|NCT02004093|7519409|FG001|Overall Study|Lack of Efficacy|62
4643238|NCT02004093|7519408|FG000|Overall Study|Protocol Violation|0
4643239|NCT02004093|7519409|FG001|Overall Study|Protocol Violation|1
4643240|NCT02004093|7519408|FG000|Overall Study|Lost to Follow-up|0
4643241|NCT02004093|7519409|FG001|Overall Study|Lost to Follow-up|1
4643242|NCT02004093|7519408|FG000|Overall Study|Withdrawal by Subject|3
4643243|NCT02004093|7519409|FG001|Overall Study|Withdrawal by Subject|7
4643244|NCT02004093|7519408|FG000|Overall Study|Other|3
4643245|NCT02004093|7519409|FG001|Overall Study|Other|1
4643246|NCT02004236|7519431|FG000|Overall Study|Lack of Efficacy|0
4643247|NCT02004236|7519432|FG001|Overall Study|Lack of Efficacy|0
4643248|NCT02004236|7519433|FG002|Overall Study|Lack of Efficacy|16
4643249|NCT02004262|7519448|FG000|Overall Study|Death|67
4643250|NCT02004262|7519449|FG001|Overall Study|Death|64
4643251|NCT02004262|7519450|FG002|Overall Study|Death|66
4643252|NCT02004262|7519451|FG003|Overall Study|Death|28
4643253|NCT02004262|7519452|FG004|Overall Study|Death|29
4643254|NCT02004262|7519453|FG005|Overall Study|Death|22
4643255|NCT02004262|7519448|FG000|Overall Study|Withdrawal by Subject|1
4643256|NCT02004262|7519449|FG001|Overall Study|Withdrawal by Subject|0
4643257|NCT02004262|7519450|FG002|Overall Study|Withdrawal by Subject|4
4643258|NCT02004262|7519451|FG003|Overall Study|Withdrawal by Subject|0
4643259|NCT02004262|7519452|FG004|Overall Study|Withdrawal by Subject|1
4643260|NCT02004262|7519453|FG005|Overall Study|Withdrawal by Subject|3
4643261|NCT02004262|7519448|FG000|Overall Study|Lost to Follow-up|1
4643262|NCT02004262|7519449|FG001|Overall Study|Lost to Follow-up|1
4643263|NCT02004262|7519450|FG002|Overall Study|Lost to Follow-up|0
4643264|NCT02004262|7519451|FG003|Overall Study|Lost to Follow-up|0
4643265|NCT02004262|7519452|FG004|Overall Study|Lost to Follow-up|0
4643266|NCT02004262|7519453|FG005|Overall Study|Lost to Follow-up|0
4643267|NCT02004262|7519448|FG000|Overall Study|Study Terminated by Sponsor|4
4643268|NCT02004262|7519449|FG001|Overall Study|Study Terminated by Sponsor|3
4643269|NCT02004262|7519450|FG002|Overall Study|Study Terminated by Sponsor|2
4643270|NCT02004262|7519451|FG003|Overall Study|Study Terminated by Sponsor|1
4643271|NCT02004262|7519452|FG004|Overall Study|Study Terminated by Sponsor|1
4643272|NCT02004262|7519453|FG005|Overall Study|Study Terminated by Sponsor|5
4643273|NCT02004353|7519476|FG000|Overall Study|Voluntary participation|1334
4643274|NCT02004847|7519513|FG000|Overall Study|Protocol Violation|1
4643275|NCT02004847|7519514|FG001|Overall Study|Protocol Violation|1
4643276|NCT02004873|7519529|FG000|Overall Study|Implant unsuccessful|6
4643277|NCT02004873|7519529|FG000|Overall Study|Awaiting 6-month visit|390
4643278|NCT02004873|7519529|FG000|Overall Study|Missed 6-month visit|4
4643279|NCT02004873|7519529|FG000|Overall Study|Death|23
4643280|NCT02004873|7519529|FG000|Overall Study|Withdrawal by Subject|1
4643281|NCT02004886|7519540|FG000|Overall Study|Adverse Event|0
4643282|NCT02004886|7519541|FG001|Overall Study|Adverse Event|1
4643283|NCT02004886|7519542|FG002|Overall Study|Adverse Event|0
4643284|NCT02004886|7519543|FG003|Overall Study|Adverse Event|0
4643285|NCT02004886|7519540|FG000|Overall Study|Unable to attend future visits|1
4643286|NCT02004886|7519541|FG001|Overall Study|Unable to attend future visits|0
4643287|NCT02004886|7519542|FG002|Overall Study|Unable to attend future visits|0
4643288|NCT02004886|7519543|FG003|Overall Study|Unable to attend future visits|0
4643289|NCT02005029|7519572|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1
4643290|NCT02005029|7519573|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0
4643291|NCT02005211|7519604|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
4643292|NCT02005211|7519605|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
4643293|NCT02005211|7519606|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
4643294|NCT02005211|7519607|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
4643295|NCT02005211|7519608|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1
4643296|NCT02005211|7519609|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
4747358|NCT00162370|7721427|FG000|Efficacy Population|Lost to Follow-up|51
4643297|NCT02005211|7519610|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
4643298|NCT02005250|7519635|FG000|Overall Study|Lost to Follow-up|15
4643299|NCT02005250|7519636|FG001|Overall Study|Lost to Follow-up|5
4643300|NCT02005276|7519646|FG000|Overall Study|No longer interested|5
4643301|NCT02005276|7519647|FG001|Overall Study|No longer interested|2
4643302|NCT02005276|7519648|FG002|Overall Study|No longer interested|3
4643303|NCT02005276|7519649|FG003|Overall Study|No longer interested|3
4643304|NCT02005484|7519674|FG000|Overall Study|Death|1
4643305|NCT02005484|7519674|FG000|Overall Study|Disease progression|1
4643306|NCT02005484|7519674|FG000|Overall Study|Changed to a Different Study|1
4643307|NCT02005484|7519674|FG000|Overall Study|Sponsor decision|1
4643308|NCT02005562|7519697|FG000|Overall Study|Death|2
4643309|NCT02005562|7519698|FG001|Overall Study|Death|2
4643310|NCT02005562|7519697|FG000|Overall Study|Graft loss|7
4643311|NCT02005562|7519698|FG001|Overall Study|Graft loss|6
4643312|NCT02005562|7519697|FG000|Overall Study|Withdrawal by Subject|2
4643313|NCT02005562|7519698|FG001|Overall Study|Withdrawal by Subject|2
4643314|NCT02005562|7519697|FG000|Overall Study|No transplant|1
4643315|NCT02005562|7519698|FG001|Overall Study|No transplant|4
4643316|NCT02005562|7519697|FG000|Overall Study|Physician Decision|0
4643317|NCT02005562|7519698|FG001|Overall Study|Physician Decision|1
4643318|NCT02005627|7519715|FG000|Overall Study|Lost to Follow-up|1
4643319|NCT02005627|7519716|FG001|Overall Study|Lost to Follow-up|2
4643320|NCT02005627|7519715|FG000|Overall Study|Withdrawal by Subject|1
4643321|NCT02005627|7519716|FG001|Overall Study|Withdrawal by Subject|2
4643322|NCT02005692|7519736|FG000|Overall Study|Protocol Violation|1
4643323|NCT02005692|7519736|FG000|Overall Study|Withdrawal by Subject|1
4643324|NCT02005692|7519736|FG000|Overall Study|Discharged earlier than anticipated|5
4643325|NCT02005887|7519743|FG000|Overall Study|Protocol Violation|0
4643326|NCT02005887|7519744|FG001|Overall Study|Protocol Violation|2
4643327|NCT02006121|7519765|FG000|Double Blind Phase|Adverse Event|6
4643328|NCT02006121|7519766|FG001|Double Blind Phase|Adverse Event|0
4643329|NCT02006121|7519765|FG000|Double Blind Phase|Lack of Efficacy|1
4643330|NCT02006121|7519766|FG001|Double Blind Phase|Lack of Efficacy|16
4643331|NCT02006121|7519765|FG000|Double Blind Phase|Withdrawal by Subject|3
4643332|NCT02006121|7519766|FG001|Double Blind Phase|Withdrawal by Subject|4
4643333|NCT02006121|7519765|FG000|Double Blind Phase|Non-compliance with study drug|1
4643334|NCT02006121|7519766|FG001|Double Blind Phase|Non-compliance with study drug|3
4643335|NCT02006121|7519765|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1
4643336|NCT02006121|7519766|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0
4643337|NCT02006121|7519765|FG000|Double Blind Phase|Inconvenience of infusion system|0
4643338|NCT02006121|7519766|FG001|Double Blind Phase|Inconvenience of infusion system|1
4643339|NCT02006121|7519765|FG000|Open Label Phase|Adverse Event|15
4643340|NCT02006121|7519766|FG001|Open Label Phase|Adverse Event|0
4643341|NCT02006121|7519765|FG000|Open Label Phase|Lack of Efficacy|2
4643342|NCT02006121|7519766|FG001|Open Label Phase|Lack of Efficacy|0
4643343|NCT02006121|7519765|FG000|Open Label Phase|Protocol Violation|2
4643344|NCT02006121|7519766|FG001|Open Label Phase|Protocol Violation|0
4643345|NCT02006121|7519765|FG000|Open Label Phase|Withdrawal by Subject|3
4643346|NCT02006121|7519766|FG001|Open Label Phase|Withdrawal by Subject|0
4643347|NCT02006121|7519765|FG000|Open Label Phase|Non-compliance with study drug|3
4643348|NCT02006121|7519766|FG001|Open Label Phase|Non-compliance with study drug|0
4643349|NCT02006472|7519823|FG000|Period 1 (Through Week 26)|Protocol Violation|1
4643350|NCT02006472|7519824|FG001|Period 1 (Through Week 26)|Protocol Violation|1
4643351|NCT02006472|7519825|FG002|Period 1 (Through Week 26)|Protocol Violation|1
4643352|NCT02006472|7519826|FG003|Period 1 (Through Week 26)|Protocol Violation|1
4643353|NCT02006472|7519827|FG004|Period 1 (Through Week 26)|Protocol Violation|0
4643354|NCT02006472|7519823|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0
4643355|NCT02006472|7519824|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0
4643356|NCT02006472|7519825|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1
4643357|NCT02006472|7519826|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0
4643358|NCT02006472|7519827|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0
4643359|NCT02006472|7519823|FG000|Period 1 (Through Week 26)|Noncompliance|2
4643360|NCT02006472|7519824|FG001|Period 1 (Through Week 26)|Noncompliance|1
4643361|NCT02006472|7519825|FG002|Period 1 (Through Week 26)|Noncompliance|1
4643362|NCT02006472|7519826|FG003|Period 1 (Through Week 26)|Noncompliance|0
4643363|NCT02006472|7519827|FG004|Period 1 (Through Week 26)|Noncompliance|0
4643364|NCT02006472|7519823|FG000|Period 1 (Through Week 26)|Other|1
4643365|NCT02006472|7519824|FG001|Period 1 (Through Week 26)|Other|5
4643366|NCT02006472|7519825|FG002|Period 1 (Through Week 26)|Other|0
4643367|NCT02006472|7519826|FG003|Period 1 (Through Week 26)|Other|2
4643368|NCT02006472|7519827|FG004|Period 1 (Through Week 26)|Other|3
4643369|NCT02006472|7519823|FG000|Period 1 (Through Week 26)|Adverse Event|5
4643370|NCT02006472|7519824|FG001|Period 1 (Through Week 26)|Adverse Event|6
4643371|NCT02006472|7519825|FG002|Period 1 (Through Week 26)|Adverse Event|11
4643372|NCT02006472|7519826|FG003|Period 1 (Through Week 26)|Adverse Event|11
4643373|NCT02006472|7519827|FG004|Period 1 (Through Week 26)|Adverse Event|14
4643374|NCT02006472|7519823|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3
4643375|NCT02006472|7519824|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9
4643376|NCT02006472|7519825|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3
4643377|NCT02006472|7519826|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0
4643378|NCT02006472|7519827|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3
4643379|NCT02006472|7519823|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1
4643380|NCT02006472|7519824|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0
4643381|NCT02006472|7519825|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0
4643382|NCT02006472|7519826|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1
4643383|NCT02006472|7519827|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1
4643384|NCT02006472|7519823|FG000|Period 2 (Through Week 52)|Noncompliance|1
4643385|NCT02006472|7519824|FG001|Period 2 (Through Week 52)|Noncompliance|0
4643386|NCT02006472|7519825|FG002|Period 2 (Through Week 52)|Noncompliance|0
4643387|NCT02006472|7519826|FG003|Period 2 (Through Week 52)|Noncompliance|0
4643388|NCT02006472|7519827|FG004|Period 2 (Through Week 52)|Noncompliance|0
4643389|NCT02006472|7519823|FG000|Period 2 (Through Week 52)|Adverse Event|1
4643390|NCT02006472|7519824|FG001|Period 2 (Through Week 52)|Adverse Event|4
4643391|NCT02006472|7519825|FG002|Period 2 (Through Week 52)|Adverse Event|5
4643392|NCT02006472|7519826|FG003|Period 2 (Through Week 52)|Adverse Event|1
4643393|NCT02006472|7519827|FG004|Period 2 (Through Week 52)|Adverse Event|1
4643394|NCT02006472|7519823|FG000|Period 2 (Through Week 52)|Other|0
4643395|NCT02006472|7519824|FG001|Period 2 (Through Week 52)|Other|1
4643396|NCT02006472|7519825|FG002|Period 2 (Through Week 52)|Other|0
4643397|NCT02006472|7519826|FG003|Period 2 (Through Week 52)|Other|1
4643398|NCT02006472|7519827|FG004|Period 2 (Through Week 52)|Other|0
4643399|NCT02006472|7519823|FG000|Period 2 (Through Week 52)|Not treated|0
4643400|NCT02006472|7519824|FG001|Period 2 (Through Week 52)|Not treated|0
4643401|NCT02006472|7519825|FG002|Period 2 (Through Week 52)|Not treated|2
4643402|NCT02006472|7519826|FG003|Period 2 (Through Week 52)|Not treated|0
4643403|NCT02006472|7519827|FG004|Period 2 (Through Week 52)|Not treated|0
4643404|NCT02006472|7519823|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2
4643405|NCT02006472|7519824|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1
4643406|NCT02006472|7519825|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2
4643407|NCT02006472|7519826|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0
4643408|NCT02006472|7519827|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0
4643409|NCT02006472|7519823|FG000|Period 2 (Through Week 52)|Sponsor decision|0
4643410|NCT02006472|7519824|FG001|Period 2 (Through Week 52)|Sponsor decision|0
4643411|NCT02006472|7519825|FG002|Period 2 (Through Week 52)|Sponsor decision|1
4643412|NCT02006472|7519826|FG003|Period 2 (Through Week 52)|Sponsor decision|0
4643413|NCT02006472|7519827|FG004|Period 2 (Through Week 52)|Sponsor decision|0
4643414|NCT02006576|7519847|FG000|Overall Study|Withdrawal by Subject|4
4643415|NCT02006576|7519848|FG001|Overall Study|Withdrawal by Subject|6
4643416|NCT02006576|7519849|FG002|Overall Study|Withdrawal by Subject|2
4643417|NCT02006576|7519847|FG000|Overall Study|Death|0
4643418|NCT02006576|7519848|FG001|Overall Study|Death|0
4643419|NCT02006576|7519849|FG002|Overall Study|Death|1
4643420|NCT02006576|7519847|FG000|Overall Study|Lost to Follow-up|1
4643421|NCT02006576|7519848|FG001|Overall Study|Lost to Follow-up|0
4643422|NCT02006576|7519849|FG002|Overall Study|Lost to Follow-up|1
4643423|NCT02006576|7519847|FG000|Overall Study|Screen Failure, too sick, other|13
4643424|NCT02006576|7519848|FG001|Overall Study|Screen Failure, too sick, other|1
4643425|NCT02006576|7519849|FG002|Overall Study|Screen Failure, too sick, other|13
4643426|NCT02006628|7519859|FG000|Overall Study|Adverse Event|1
4643427|NCT02006628|7519860|FG001|Overall Study|Adverse Event|1
4643428|NCT02006628|7519859|FG000|Overall Study|Withdrawal by Subject|2
4643429|NCT02006628|7519860|FG001|Overall Study|Withdrawal by Subject|1
4643430|NCT02006641|7519869|FG000|Overall Study|Withdrawal before treatment|2
4643431|NCT02006641|7519870|FG001|Overall Study|Withdrawal before treatment|5
4643432|NCT02006641|7519871|FG002|Overall Study|Withdrawal before treatment|3
4643433|NCT02006641|7519869|FG000|Overall Study|Adverse Event|15
4643434|NCT02006641|7519870|FG001|Overall Study|Adverse Event|11
4643435|NCT02006641|7519871|FG002|Overall Study|Adverse Event|15
4643436|NCT02006641|7519869|FG000|Overall Study|Protocol Violation|0
4643437|NCT02006641|7519870|FG001|Overall Study|Protocol Violation|2
4643438|NCT02006641|7519871|FG002|Overall Study|Protocol Violation|2
4643439|NCT02006641|7519869|FG000|Overall Study|Lost to Follow-up|0
4643440|NCT02006641|7519870|FG001|Overall Study|Lost to Follow-up|1
4643441|NCT02006641|7519871|FG002|Overall Study|Lost to Follow-up|0
4643442|NCT02006641|7519869|FG000|Overall Study|Withdrawal by Subject|7
4643443|NCT02006641|7519870|FG001|Overall Study|Withdrawal by Subject|12
4643444|NCT02006641|7519871|FG002|Overall Study|Withdrawal by Subject|11
4643445|NCT02006641|7519869|FG000|Overall Study|Other reason: patient didn't show up|1
4643446|NCT02006641|7519870|FG001|Overall Study|Other reason: patient didn't show up|0
4643447|NCT02006641|7519871|FG002|Overall Study|Other reason: patient didn't show up|0
4643448|NCT02006641|7519869|FG000|Overall Study|Other reason:patient didn't want to come|0
4643449|NCT02006641|7519870|FG001|Overall Study|Other reason:patient didn't want to come|0
4643450|NCT02006641|7519871|FG002|Overall Study|Other reason:patient didn't want to come|1
4643451|NCT02006641|7519869|FG000|Overall Study|Other reason: patient has moved|1
4643452|NCT02006641|7519870|FG001|Overall Study|Other reason: patient has moved|0
4643453|NCT02006641|7519871|FG002|Overall Study|Other reason: patient has moved|1
4643454|NCT02006641|7519869|FG000|Overall Study|Other reason: caregiver in hospital|0
4643455|NCT02006641|7519870|FG001|Overall Study|Other reason: caregiver in hospital|1
4643456|NCT02006641|7519871|FG002|Overall Study|Other reason: caregiver in hospital|0
4643457|NCT02006641|7519869|FG000|Overall Study|Other reason: patient's wife has died|0
4643458|NCT02006641|7519870|FG001|Overall Study|Other reason: patient's wife has died|0
4643459|NCT02006641|7519871|FG002|Overall Study|Other reason: patient's wife has died|1
4643460|NCT02006641|7519869|FG000|Overall Study|Other reason: hospitalisation|0
4643461|NCT02006641|7519870|FG001|Overall Study|Other reason: hospitalisation|1
4643462|NCT02006641|7519871|FG002|Overall Study|Other reason: hospitalisation|0
4643463|NCT02006641|7519869|FG000|Overall Study|Other reason: caregiver impossibility|0
4643464|NCT02006641|7519870|FG001|Overall Study|Other reason: caregiver impossibility|0
4643465|NCT02006641|7519871|FG002|Overall Study|Other reason: caregiver impossibility|1
4643466|NCT02006641|7519869|FG000|Overall Study|Other reason: protocol non-compliance|0
4643467|NCT02006641|7519870|FG001|Overall Study|Other reason: protocol non-compliance|0
4643468|NCT02006641|7519871|FG002|Overall Study|Other reason: protocol non-compliance|1
4643469|NCT02006654|7519881|FG000|Overall Study|Withdrawal before treatment|4
4643470|NCT02006654|7519882|FG001|Overall Study|Withdrawal before treatment|2
4643471|NCT02006654|7519881|FG000|Overall Study|Adverse Event|16
4643472|NCT02006654|7519882|FG001|Overall Study|Adverse Event|17
4643473|NCT02006654|7519881|FG000|Overall Study|Death|1
4643474|NCT02006654|7519882|FG001|Overall Study|Death|0
4643475|NCT02006654|7519881|FG000|Overall Study|Withdrawal by Subject|14
4643476|NCT02006654|7519882|FG001|Overall Study|Withdrawal by Subject|12
4643477|NCT02006654|7519881|FG000|Overall Study|Protocol Violation|5
4643478|NCT02006654|7519882|FG001|Overall Study|Protocol Violation|8
4643479|NCT02006654|7519881|FG000|Overall Study|Lost to Follow-up|1
4643480|NCT02006654|7519882|FG001|Overall Study|Lost to Follow-up|0
4643481|NCT02006654|7519881|FG000|Overall Study|patient's will|2
4643482|NCT02006654|7519882|FG001|Overall Study|patient's will|1
4643483|NCT02006654|7519881|FG000|Overall Study|insufficient compliance|1
4643484|NCT02006654|7519882|FG001|Overall Study|insufficient compliance|0
4643485|NCT02006654|7519881|FG000|Overall Study|worsening cognitive condition|0
4643486|NCT02006654|7519882|FG001|Overall Study|worsening cognitive condition|1
4643487|NCT02006654|7519881|FG000|Overall Study|faecal incontinence|0
4643488|NCT02006654|7519882|FG001|Overall Study|faecal incontinence|1
4643489|NCT02006654|7519881|FG000|Overall Study|mood disorder|0
4643490|NCT02006654|7519882|FG001|Overall Study|mood disorder|1
4643491|NCT02006654|7519881|FG000|Overall Study|disallowed medication|1
4643492|NCT02006654|7519882|FG001|Overall Study|disallowed medication|0
4643493|NCT02006654|7519881|FG000|Overall Study|moving out of state|0
4643494|NCT02006654|7519882|FG001|Overall Study|moving out of state|1
4643495|NCT02006667|7519889|FG000|Overall Study|Adverse Event|3
4643496|NCT02006667|7519889|FG000|Overall Study|Death|2
4643497|NCT02006667|7519889|FG000|Overall Study|Withdrawal by Subject|1
4643498|NCT02006693|7519895|FG000|Overall Study|No Reason Specified|6
4643499|NCT02006693|7519896|FG001|Overall Study|No Reason Specified|8
4643500|NCT02006693|7519895|FG000|Overall Study|Another Glaucoma-related Surgery|12
4643501|NCT02006693|7519896|FG001|Overall Study|Another Glaucoma-related Surgery|1
4643502|NCT02006693|7519895|FG000|Overall Study|XEN Implant Explantation|0
4643503|NCT02006693|7519896|FG001|Overall Study|XEN Implant Explantation|1
4643504|NCT02006693|7519895|FG000|Overall Study|Death|2
4643505|NCT02006693|7519896|FG001|Overall Study|Death|2
4643506|NCT02006693|7519895|FG000|Overall Study|Lost to Follow-up|4
4643507|NCT02006693|7519896|FG001|Overall Study|Lost to Follow-up|1
4643508|NCT02006693|7519895|FG000|Overall Study|Patient Decision|4
4643509|NCT02006693|7519896|FG001|Overall Study|Patient Decision|0
4643510|NCT02006706|7519902|FG000|Overall Study|Lost to Follow-up|1
4643511|NCT02006719|7519908|FG000|Overall Study|Withdrawal by Subject|10
4643512|NCT02006719|7519909|FG001|Overall Study|Withdrawal by Subject|2
4643513|NCT02006719|7519908|FG000|Overall Study|Lost to Follow-up|5
4643514|NCT02006719|7519909|FG001|Overall Study|Lost to Follow-up|1
4643515|NCT02006719|7519908|FG000|Overall Study|Protocol Violation|2
4643516|NCT02006719|7519909|FG001|Overall Study|Protocol Violation|0
4643517|NCT02006719|7519908|FG000|Overall Study|Adverse Event|1
4643518|NCT02006719|7519909|FG001|Overall Study|Adverse Event|1
4643519|NCT02006719|7519908|FG000|Overall Study|Other/Unknown|0
4643520|NCT02006719|7519909|FG001|Overall Study|Other/Unknown|1
4643521|NCT02006732|7519919|FG000|Overall Study|Adverse Event|10
4643522|NCT02006732|7519920|FG001|Overall Study|Adverse Event|7
4643523|NCT02006732|7519921|FG002|Overall Study|Adverse Event|4
4643524|NCT02006732|7519922|FG003|Overall Study|Adverse Event|2
4643525|NCT02006732|7519919|FG000|Overall Study|Lack of Efficacy|6
4643526|NCT02006732|7519920|FG001|Overall Study|Lack of Efficacy|3
4643527|NCT02006732|7519921|FG002|Overall Study|Lack of Efficacy|1
4643528|NCT02006732|7519922|FG003|Overall Study|Lack of Efficacy|1
4643529|NCT02006732|7519919|FG000|Overall Study|Protocol Violation|1
4643530|NCT02006732|7519920|FG001|Overall Study|Protocol Violation|1
4643531|NCT02006732|7519921|FG002|Overall Study|Protocol Violation|0
4643532|NCT02006732|7519922|FG003|Overall Study|Protocol Violation|0
4643533|NCT02006732|7519919|FG000|Overall Study|Lost to Follow-up|0
4643534|NCT02006732|7519920|FG001|Overall Study|Lost to Follow-up|1
4643535|NCT02006732|7519921|FG002|Overall Study|Lost to Follow-up|0
4643536|NCT02006732|7519922|FG003|Overall Study|Lost to Follow-up|0
4643537|NCT02006732|7519919|FG000|Overall Study|Withdrawal by Subject|3
4643538|NCT02006732|7519920|FG001|Overall Study|Withdrawal by Subject|0
4643539|NCT02006732|7519921|FG002|Overall Study|Withdrawal by Subject|4
4643540|NCT02006732|7519922|FG003|Overall Study|Withdrawal by Subject|1
4643541|NCT02006758|7519932|FG000|Overall Study|Protocol Violation|1
4643542|NCT02006758|7519932|FG000|Overall Study|Death|1
4643543|NCT02006758|7519932|FG000|Overall Study|Lost to Follow-up|4
4643544|NCT02006758|7519932|FG000|Overall Study|Withdrawal by Subject|4
4643545|NCT02006758|7519932|FG000|Overall Study|Procedurally excluded|1
4643546|NCT02006758|7519932|FG000|Overall Study|Other|2
4643547|NCT02006979|7519967|FG000|Overall Study|Withdrawal by Subject|1
4643548|NCT02006979|7519968|FG001|Overall Study|Withdrawal by Subject|1
4643549|NCT02006979|7519967|FG000|Overall Study|Protocol Violation|0
4643550|NCT02006979|7519968|FG001|Overall Study|Protocol Violation|1
4643551|NCT02007070|7519974|FG000|Overall Study|Adverse Event|4
4643552|NCT02007070|7519974|FG000|Overall Study|Clinical Progression|4
4643553|NCT02007070|7519974|FG000|Overall Study|Death|1
4643554|NCT02007070|7519974|FG000|Overall Study|Protocol Violation|2
4643555|NCT02007070|7519974|FG000|Overall Study|Physician Decision|1
4643556|NCT02007070|7519974|FG000|Overall Study|Progressive Disease|21
4643557|NCT02007096|7519980|FG000|Overall Study|medication not available|2
4643558|NCT02007096|7519981|FG001|Overall Study|medication not available|0
4643559|NCT02007096|7519980|FG000|Overall Study|did not inject saline|0
4643560|NCT02007096|7519981|FG001|Overall Study|did not inject saline|3
4643561|NCT02007096|7519980|FG000|Overall Study|did not follow postoperative protocol|8
4643562|NCT02007096|7519981|FG001|Overall Study|did not follow postoperative protocol|11
4643563|NCT02007096|7519980|FG000|Overall Study|converted to open surgery|1
4643564|NCT02007096|7519981|FG001|Overall Study|converted to open surgery|1
4643565|NCT02007096|7519980|FG000|Overall Study|no mesh placed|0
4643566|NCT02007096|7519981|FG001|Overall Study|no mesh placed|1
4643567|NCT02007109|7519987|FG000|Overall Study|Diary not returned or excluded|102
4643568|NCT02007109|7519987|FG000|Overall Study|Excluded - Age<7yo|9
4643569|NCT02007252|7520000|FG000|Overall Study|Administrative problems|3
4643570|NCT02007252|7520001|FG001|Overall Study|Administrative problems|7
4643571|NCT02007252|7520000|FG000|Overall Study|Abnormal laboratory value(s)|1
4643572|NCT02007252|7520001|FG001|Overall Study|Abnormal laboratory value(s)|0
4643573|NCT02007252|7520000|FG000|Overall Study|Adverse Event|7
4643574|NCT02007252|7520001|FG001|Overall Study|Adverse Event|4
4643575|NCT02007278|7520009|FG000|Overall Study|Failure to comply with an eligibility|0
4643576|NCT02007278|7520010|FG001|Overall Study|Failure to comply with an eligibility|1
4643577|NCT02007278|7520009|FG000|Overall Study|Ingestion of drugs not allowed in study|0
4643578|NCT02007278|7520010|FG001|Overall Study|Ingestion of drugs not allowed in study|1
4643579|NCT02007278|7520009|FG000|Overall Study|Incorrect medication administration|1
4643580|NCT02007278|7520010|FG001|Overall Study|Incorrect medication administration|0
4643581|NCT02007278|7520009|FG000|Overall Study|Mis-randomization|1
4643582|NCT02007278|7520010|FG001|Overall Study|Mis-randomization|1
4643583|NCT02007434|7520044|FG000|Overall Study|Lost to Follow-up|0
4643584|NCT02007434|7520045|FG001|Overall Study|Lost to Follow-up|1
4643585|NCT02007434|7520046|FG002|Overall Study|Lost to Follow-up|0
4643586|NCT02007434|7520047|FG003|Overall Study|Lost to Follow-up|0
4643587|NCT02007434|7520048|FG004|Overall Study|Lost to Follow-up|0
4643588|NCT02007434|7520049|FG005|Overall Study|Lost to Follow-up|0
4643589|NCT02007434|7520050|FG006|Overall Study|Lost to Follow-up|0
4643590|NCT02007434|7520051|FG007|Overall Study|Lost to Follow-up|0
4643591|NCT02007434|7520044|FG000|Overall Study|Non-compliance|1
4643592|NCT02007434|7520045|FG001|Overall Study|Non-compliance|0
4643593|NCT02007434|7520046|FG002|Overall Study|Non-compliance|1
4643594|NCT02007434|7520047|FG003|Overall Study|Non-compliance|0
4643595|NCT02007434|7520048|FG004|Overall Study|Non-compliance|0
4643596|NCT02007434|7520049|FG005|Overall Study|Non-compliance|0
4643597|NCT02007434|7520050|FG006|Overall Study|Non-compliance|0
4643598|NCT02007434|7520051|FG007|Overall Study|Non-compliance|0
4643599|NCT02007512|7520074|FG000|Double Blind Treatment Period|Adverse Event|4
4643600|NCT02007512|7520075|FG001|Double Blind Treatment Period|Adverse Event|2
4643601|NCT02007512|7520076|FG002|Double Blind Treatment Period|Adverse Event|6
4643602|NCT02007512|7520077|FG003|Double Blind Treatment Period|Adverse Event|2
4643603|NCT02007512|7520074|FG000|Double Blind Treatment Period|Death|1
4643604|NCT02007512|7520075|FG001|Double Blind Treatment Period|Death|0
4643605|NCT02007512|7520076|FG002|Double Blind Treatment Period|Death|0
4643606|NCT02007512|7520077|FG003|Double Blind Treatment Period|Death|0
4643607|NCT02007512|7520074|FG000|Double Blind Treatment Period|Disease progression|44
4643608|NCT02007512|7520075|FG001|Double Blind Treatment Period|Disease progression|49
4643609|NCT02007512|7520076|FG002|Double Blind Treatment Period|Disease progression|45
4643610|NCT02007512|7520077|FG003|Double Blind Treatment Period|Disease progression|51
4643611|NCT02007512|7520074|FG000|Double Blind Treatment Period|Withdrawal by Subject|4
4643612|NCT02007512|7520075|FG001|Double Blind Treatment Period|Withdrawal by Subject|2
4643613|NCT02007512|7520076|FG002|Double Blind Treatment Period|Withdrawal by Subject|3
4643614|NCT02007512|7520077|FG003|Double Blind Treatment Period|Withdrawal by Subject|3
4643615|NCT02007512|7520074|FG000|Double Blind Treatment Period|Protocol Violation|0
4643616|NCT02007512|7520075|FG001|Double Blind Treatment Period|Protocol Violation|0
4643617|NCT02007512|7520076|FG002|Double Blind Treatment Period|Protocol Violation|0
4643618|NCT02007512|7520077|FG003|Double Blind Treatment Period|Protocol Violation|1
4643619|NCT02007512|7520074|FG000|Double Blind Treatment Period|Other|0
4643620|NCT02007512|7520075|FG001|Double Blind Treatment Period|Other|0
4643621|NCT02007512|7520076|FG002|Double Blind Treatment Period|Other|1
4643622|NCT02007512|7520077|FG003|Double Blind Treatment Period|Other|2
4643623|NCT02007512|7520074|FG000|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|10
4643624|NCT02007512|7520075|FG001|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|11
4643625|NCT02007512|7520076|FG002|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|5
4643626|NCT02007512|7520077|FG003|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|1
4643627|NCT02007512|7520074|FG000|Open Label Treatment Period|Adverse Event|0
4643628|NCT02007512|7520075|FG001|Open Label Treatment Period|Adverse Event|1
4643629|NCT02007512|7520076|FG002|Open Label Treatment Period|Adverse Event|0
4643630|NCT02007512|7520077|FG003|Open Label Treatment Period|Adverse Event|0
4643631|NCT02007512|7520074|FG000|Open Label Treatment Period|Other|0
4643632|NCT02007512|7520075|FG001|Open Label Treatment Period|Other|0
4643633|NCT02007512|7520076|FG002|Open Label Treatment Period|Other|0
4643634|NCT02007512|7520077|FG003|Open Label Treatment Period|Other|1
4643635|NCT02007512|7520074|FG000|Open Label Treatment Period|Disease progression|0
4643636|NCT02007512|7520075|FG001|Open Label Treatment Period|Disease progression|17
4643637|NCT02007512|7520076|FG002|Open Label Treatment Period|Disease progression|0
4643638|NCT02007512|7520077|FG003|Open Label Treatment Period|Disease progression|11
4643639|NCT02007512|7520074|FG000|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0
4643640|NCT02007512|7520075|FG001|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|3
4643641|NCT02007512|7520076|FG002|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0
4643642|NCT02007512|7520077|FG003|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0
4643643|NCT02007577|7520092|FG000|Overall Study|Adverse Event|1
4643644|NCT02007577|7520093|FG001|Overall Study|Adverse Event|0
4643645|NCT02007577|7520092|FG000|Overall Study|Withdrawal by Subject|0
4643646|NCT02007577|7520093|FG001|Overall Study|Withdrawal by Subject|1
4643647|NCT02007720|7520101|FG000|Overall Study|Withdrawal by Subject|9
4643648|NCT02007720|7520102|FG001|Overall Study|Withdrawal by Subject|11
4643649|NCT02007720|7520101|FG000|Overall Study|study terminated by sponsor|58
4643650|NCT02007720|7520102|FG001|Overall Study|study terminated by sponsor|54
4643651|NCT02007720|7520101|FG000|Overall Study|technical problem|4
4643652|NCT02007720|7520102|FG001|Overall Study|technical problem|2
4643653|NCT02007720|7520101|FG000|Overall Study|patient followd less than 165 days|11
4643654|NCT02007720|7520102|FG001|Overall Study|patient followd less than 165 days|5
4643655|NCT02007954|7520113|FG000|Overall Study|Received liver transplant|3
4643656|NCT02007954|7520113|FG000|Overall Study|Switch in treatment modality|2
4643657|NCT02007954|7520113|FG000|Overall Study|Disease progression and unrelated AE|1
4643658|NCT02007954|7520113|FG000|Overall Study|Death|1
4643659|NCT02008227|7520132|FG000|Overall Study|Lost to Follow-up|7
4643660|NCT02008227|7520133|FG001|Overall Study|Lost to Follow-up|9
4643661|NCT02008227|7520132|FG000|Overall Study|Death|494
4643662|NCT02008227|7520133|FG001|Overall Study|Death|485
4643663|NCT02008227|7520132|FG000|Overall Study|Withdrawal by Subject|67
4643664|NCT02008227|7520133|FG001|Overall Study|Withdrawal by Subject|36
4643665|NCT02008227|7520132|FG000|Overall Study|Study Terminated By Sponsor|44
4643666|NCT02008227|7520133|FG001|Overall Study|Study Terminated By Sponsor|83
4643667|NCT02008318|7520142|FG000|Overall Study|Adverse Event|4
4643668|NCT02008318|7520143|FG001|Overall Study|Adverse Event|0
4643669|NCT02008318|7520142|FG000|Overall Study|Physician Decision|2
4643670|NCT02008318|7520143|FG001|Overall Study|Physician Decision|0
4643671|NCT02008318|7520142|FG000|Overall Study|Progressive Disease|2
4643672|NCT02008318|7520143|FG001|Overall Study|Progressive Disease|0
4643673|NCT02008318|7520142|FG000|Overall Study|Protocol Violation|1
4643674|NCT02008318|7520143|FG001|Overall Study|Protocol Violation|1
4643675|NCT02008318|7520142|FG000|Overall Study|Withdrawal by Subject|3
4643676|NCT02008318|7520143|FG001|Overall Study|Withdrawal by Subject|0
4643677|NCT02008526|7520155|FG000|Overall Study|Death|0
4643678|NCT02008526|7520156|FG001|Overall Study|Death|2
4643679|NCT02008526|7520157|FG002|Overall Study|Death|1
4643680|NCT02008526|7520155|FG000|Overall Study|Withdrawal by Subject|3
4643681|NCT02008526|7520156|FG001|Overall Study|Withdrawal by Subject|3
4643682|NCT02008526|7520157|FG002|Overall Study|Withdrawal by Subject|2
4643683|NCT02008526|7520155|FG000|Overall Study|Lost to Follow-up|5
4643684|NCT02008526|7520156|FG001|Overall Study|Lost to Follow-up|9
4643685|NCT02008526|7520157|FG002|Overall Study|Lost to Follow-up|6
4643686|NCT02008565|7520169|FG000|Overall Study|Protocol Violation|1
4643687|NCT02008565|7520170|FG001|Overall Study|Protocol Violation|1
4643688|NCT02008565|7520171|FG002|Overall Study|Protocol Violation|2
4643689|NCT02008565|7520172|FG003|Overall Study|Protocol Violation|0
4643690|NCT02008773|7520206|FG000|Overall Study|Adverse Event|3
4643691|NCT02008773|7520207|FG001|Overall Study|Adverse Event|3
4643692|NCT02008773|7520208|FG002|Overall Study|Adverse Event|1
4643693|NCT02008773|7520209|FG003|Overall Study|Adverse Event|2
4643694|NCT02008773|7520206|FG000|Overall Study|Medication Non-compliance|2
4747359|NCT00214500|7721443|FG000|Treatment Period|Adverse Event|1
4747360|NCT00214500|7721443|FG000|Extension Period|Withdrawal by Subject|2
4643695|NCT02008773|7520207|FG001|Overall Study|Medication Non-compliance|1
4643696|NCT02008773|7520208|FG002|Overall Study|Medication Non-compliance|3
4643697|NCT02008773|7520209|FG003|Overall Study|Medication Non-compliance|2
4643698|NCT02008773|7520206|FG000|Overall Study|Withdrawal by Subject|8
4643699|NCT02008773|7520207|FG001|Overall Study|Withdrawal by Subject|4
4643700|NCT02008773|7520208|FG002|Overall Study|Withdrawal by Subject|7
4643701|NCT02008773|7520209|FG003|Overall Study|Withdrawal by Subject|6
4643702|NCT02008773|7520206|FG000|Overall Study|Lost to Follow-up|0
4643703|NCT02008773|7520207|FG001|Overall Study|Lost to Follow-up|1
4643704|NCT02008773|7520208|FG002|Overall Study|Lost to Follow-up|3
4643705|NCT02008773|7520209|FG003|Overall Study|Lost to Follow-up|2
4643706|NCT02008877|7520217|FG000|Overall Study|Inevaluable|0
4643707|NCT02008877|7520218|FG001|Overall Study|Inevaluable|1
4643708|NCT02008877|7520219|FG002|Overall Study|Inevaluable|0
4643709|NCT02008890|7520231|FG000|Period 1|Withdrawal by Subject|7
4643710|NCT02008890|7520232|FG001|Period 1|Withdrawal by Subject|7
4643711|NCT02008890|7520233|FG002|Period 1|Withdrawal by Subject|5
4643712|NCT02008890|7520234|FG003|Period 1|Withdrawal by Subject|0
4643713|NCT02008890|7520235|FG004|Period 1|Withdrawal by Subject|0
4643714|NCT02008890|7520231|FG000|Period 1|Pregnancy|1
4643715|NCT02008890|7520232|FG001|Period 1|Pregnancy|0
4643716|NCT02008890|7520233|FG002|Period 1|Pregnancy|0
4643717|NCT02008890|7520234|FG003|Period 1|Pregnancy|0
4643718|NCT02008890|7520235|FG004|Period 1|Pregnancy|0
4643719|NCT02008890|7520231|FG000|Period 1|Physician Decision|1
4643720|NCT02008890|7520232|FG001|Period 1|Physician Decision|0
4643721|NCT02008890|7520233|FG002|Period 1|Physician Decision|1
4643722|NCT02008890|7520234|FG003|Period 1|Physician Decision|0
4643723|NCT02008890|7520235|FG004|Period 1|Physician Decision|0
4643724|NCT02008890|7520231|FG000|Period 1|Adverse Event|6
4643725|NCT02008890|7520232|FG001|Period 1|Adverse Event|8
4643726|NCT02008890|7520233|FG002|Period 1|Adverse Event|6
4643727|NCT02008890|7520234|FG003|Period 1|Adverse Event|0
4643728|NCT02008890|7520235|FG004|Period 1|Adverse Event|0
4643729|NCT02008890|7520231|FG000|Period 2|Adverse Event|12
4643730|NCT02008890|7520232|FG001|Period 2|Adverse Event|7
4643731|NCT02008890|7520233|FG002|Period 2|Adverse Event|0
4643732|NCT02008890|7520234|FG003|Period 2|Adverse Event|5
4643733|NCT02008890|7520235|FG004|Period 2|Adverse Event|5
4643734|NCT02008890|7520231|FG000|Period 2|Withdrawal by Subject|11
4643735|NCT02008890|7520232|FG001|Period 2|Withdrawal by Subject|8
4643736|NCT02008890|7520233|FG002|Period 2|Withdrawal by Subject|0
4643737|NCT02008890|7520234|FG003|Period 2|Withdrawal by Subject|7
4643738|NCT02008890|7520235|FG004|Period 2|Withdrawal by Subject|2
4643739|NCT02008890|7520231|FG000|Period 2|Physician Decision|4
4643740|NCT02008890|7520232|FG001|Period 2|Physician Decision|0
4643741|NCT02008890|7520233|FG002|Period 2|Physician Decision|0
4643742|NCT02008890|7520234|FG003|Period 2|Physician Decision|2
4643743|NCT02008890|7520235|FG004|Period 2|Physician Decision|1
4643744|NCT02008890|7520231|FG000|Period 2|Lost to Follow-up|0
4643745|NCT02008890|7520232|FG001|Period 2|Lost to Follow-up|0
4643746|NCT02008890|7520233|FG002|Period 2|Lost to Follow-up|1
4643747|NCT02008890|7520234|FG003|Period 2|Lost to Follow-up|0
4643748|NCT02008890|7520235|FG004|Period 2|Lost to Follow-up|0
4643749|NCT02008890|7520231|FG000|Extension Period|Withdrawal by Subject|3
4643750|NCT02008890|7520232|FG001|Extension Period|Withdrawal by Subject|2
4643751|NCT02008890|7520233|FG002|Extension Period|Withdrawal by Subject|0
4643752|NCT02008890|7520234|FG003|Extension Period|Withdrawal by Subject|4
4643753|NCT02008890|7520235|FG004|Extension Period|Withdrawal by Subject|2
4643754|NCT02008890|7520231|FG000|Extension Period|Lost to Follow-up|1
4643755|NCT02008890|7520232|FG001|Extension Period|Lost to Follow-up|0
4643756|NCT02008890|7520233|FG002|Extension Period|Lost to Follow-up|0
4643757|NCT02008890|7520234|FG003|Extension Period|Lost to Follow-up|0
4643758|NCT02008890|7520235|FG004|Extension Period|Lost to Follow-up|0
4643759|NCT02008890|7520231|FG000|Extension Period|Adverse Event|1
4643760|NCT02008890|7520232|FG001|Extension Period|Adverse Event|3
4643761|NCT02008890|7520233|FG002|Extension Period|Adverse Event|0
4643762|NCT02008890|7520234|FG003|Extension Period|Adverse Event|0
4643763|NCT02008890|7520235|FG004|Extension Period|Adverse Event|2
4643764|NCT02008916|7520253|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0
4643765|NCT02008916|7520254|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1
4643766|NCT02008916|7520255|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3
4643767|NCT02008916|7520253|FG000|Week 16 - 156|Adverse Event|4
4643768|NCT02008916|7520254|FG001|Week 16 - 156|Adverse Event|2
4643769|NCT02008916|7520255|FG002|Week 16 - 156|Adverse Event|3
4643770|NCT02008916|7520253|FG000|Week 16 - 156|Withdrawal by Subject|7
4643771|NCT02008916|7520254|FG001|Week 16 - 156|Withdrawal by Subject|3
4643772|NCT02008916|7520255|FG002|Week 16 - 156|Withdrawal by Subject|5
4643773|NCT02008916|7520253|FG000|Week 16 - 156|No longer requires treatment|0
4643774|NCT02008916|7520254|FG001|Week 16 - 156|No longer requires treatment|1
4643775|NCT02008916|7520255|FG002|Week 16 - 156|No longer requires treatment|0
4643776|NCT02008916|7520253|FG000|Week 16 - 156|Lost to Follow-up|5
4643777|NCT02008916|7520254|FG001|Week 16 - 156|Lost to Follow-up|0
4643778|NCT02008916|7520255|FG002|Week 16 - 156|Lost to Follow-up|0
4643779|NCT02008916|7520253|FG000|Week 16 - 156|Lack of Efficacy|3
4643780|NCT02008916|7520254|FG001|Week 16 - 156|Lack of Efficacy|5
4643781|NCT02008916|7520255|FG002|Week 16 - 156|Lack of Efficacy|2
4643782|NCT02008916|7520253|FG000|Week 16 - 156|Pregnancy|0
4643783|NCT02008916|7520254|FG001|Week 16 - 156|Pregnancy|1
4643784|NCT02008916|7520255|FG002|Week 16 - 156|Pregnancy|0
4643785|NCT02008916|7520253|FG000|Week 16 - 156|Physician Decision|0
4643786|NCT02008916|7520254|FG001|Week 16 - 156|Physician Decision|1
4643787|NCT02008916|7520255|FG002|Week 16 - 156|Physician Decision|0
4643788|NCT02009046|7520273|FG000|Overall Study|Lost to Follow-up|256
4643789|NCT02009046|7520274|FG001|Overall Study|Lost to Follow-up|206
4643790|NCT02009163|7520288|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48
4643791|NCT02009163|7520289|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0
4643792|NCT02009163|7520290|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0
4643793|NCT02009163|7520288|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29
4643794|NCT02009163|7520289|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0
4643795|NCT02009163|7520290|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0
4643796|NCT02009163|7520288|FG000|Open-label Period (Non-randomized)|Adverse Event|22
4643797|NCT02009163|7520289|FG001|Open-label Period (Non-randomized)|Adverse Event|0
4643798|NCT02009163|7520290|FG002|Open-label Period (Non-randomized)|Adverse Event|0
4643799|NCT02009163|7520288|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20
4643800|NCT02009163|7520289|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0
4643801|NCT02009163|7520290|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0
4643802|NCT02009163|7520288|FG000|Open-label Period (Non-randomized)|Protocol Violation|10
4643803|NCT02009163|7520289|FG001|Open-label Period (Non-randomized)|Protocol Violation|0
4643804|NCT02009163|7520290|FG002|Open-label Period (Non-randomized)|Protocol Violation|0
4643805|NCT02009163|7520288|FG000|Open-label Period (Non-randomized)|Pregnancy|1
4643806|NCT02009163|7520289|FG001|Open-label Period (Non-randomized)|Pregnancy|0
4643807|NCT02009163|7520290|FG002|Open-label Period (Non-randomized)|Pregnancy|0
4643808|NCT02009163|7520288|FG000|Open-label Period (Non-randomized)|Other|13
4643809|NCT02009163|7520289|FG001|Open-label Period (Non-randomized)|Other|0
4643810|NCT02009163|7520290|FG002|Open-label Period (Non-randomized)|Other|0
4643811|NCT02009163|7520288|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0
4643812|NCT02009163|7520289|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25
4643813|NCT02009163|7520290|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9
4643814|NCT02009163|7520288|FG000|Randomized-withdrawal Period|Lost to Follow-up|0
4643815|NCT02009163|7520289|FG001|Randomized-withdrawal Period|Lost to Follow-up|13
4643816|NCT02009163|7520290|FG002|Randomized-withdrawal Period|Lost to Follow-up|6
4643817|NCT02009163|7520288|FG000|Randomized-withdrawal Period|Adverse Event|0
4643818|NCT02009163|7520289|FG001|Randomized-withdrawal Period|Adverse Event|0
4643819|NCT02009163|7520290|FG002|Randomized-withdrawal Period|Adverse Event|6
4643820|NCT02009163|7520288|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0
4643821|NCT02009163|7520289|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40
4643822|NCT02009163|7520290|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5
4643823|NCT02009163|7520288|FG000|Randomized-withdrawal Period|Protocol Violation|0
4643824|NCT02009163|7520289|FG001|Randomized-withdrawal Period|Protocol Violation|1
4643825|NCT02009163|7520290|FG002|Randomized-withdrawal Period|Protocol Violation|2
4643826|NCT02009163|7520288|FG000|Randomized-withdrawal Period|Pregnancy|0
4643827|NCT02009163|7520289|FG001|Randomized-withdrawal Period|Pregnancy|0
4643828|NCT02009163|7520290|FG002|Randomized-withdrawal Period|Pregnancy|2
4643829|NCT02009163|7520288|FG000|Randomized-withdrawal Period|Other|0
4643830|NCT02009163|7520289|FG001|Randomized-withdrawal Period|Other|9
4643831|NCT02009163|7520290|FG002|Randomized-withdrawal Period|Other|5
4643832|NCT02009332|7520306|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0
4643833|NCT02009332|7520307|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1
4643834|NCT02009332|7520308|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0
4643835|NCT02009332|7520309|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0
4643836|NCT02009332|7520310|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0
4643837|NCT02009332|7520311|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0
4643838|NCT02009332|7520306|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0
4643839|NCT02009332|7520307|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0
4643840|NCT02009332|7520308|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0
4643841|NCT02009332|7520309|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0
4643842|NCT02009332|7520310|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1
4643843|NCT02009332|7520311|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0
4643844|NCT02009332|7520306|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0
4643845|NCT02009332|7520307|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0
4643846|NCT02009332|7520308|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0
4643847|NCT02009332|7520309|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0
4643848|NCT02009332|7520310|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0
4643849|NCT02009332|7520311|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1
4643850|NCT02009397|7520325|FG000|Overall Study|Protocol Violation|6
4643851|NCT02009397|7520325|FG000|Overall Study|Death|8
4643852|NCT02009397|7520325|FG000|Overall Study|Lost to Follow-up|6
4643853|NCT02009696|7520338|FG000|Overall Study|Withdrawal by Subject|2
4643854|NCT02009722|7520344|FG000|Overall Study|Protocol Violation|1
4643855|NCT02009722|7520345|FG001|Overall Study|Protocol Violation|2
4643856|NCT02009722|7520344|FG000|Overall Study|Did not receive intervention|0
4643857|NCT02009722|7520345|FG001|Overall Study|Did not receive intervention|1
4643858|NCT02009865|7520353|FG000|Overall Study|Adverse Event|0
4643859|NCT02009865|7520354|FG001|Overall Study|Adverse Event|2
4643860|NCT02009865|7520353|FG000|Overall Study|Protocol Violation|0
4643861|NCT02009865|7520354|FG001|Overall Study|Protocol Violation|2
4643862|NCT02009865|7520353|FG000|Overall Study|Withdrawal by Subject|1
4643863|NCT02009865|7520354|FG001|Overall Study|Withdrawal by Subject|1
4643864|NCT02009878|7520363|FG000|Overall Study|Participant Met Withdrawal Criteria|0
4643865|NCT02009878|7520364|FG001|Overall Study|Participant Met Withdrawal Criteria|1
4643866|NCT02009878|7520365|FG002|Overall Study|Participant Met Withdrawal Criteria|0
4643867|NCT02009930|7520373|FG000|Overall Study|withdrawn|5
4643868|NCT02010255|7520441|FG000|Overall Study|Death|0
4643869|NCT02010255|7520442|FG001|Overall Study|Death|1
4643870|NCT02010255|7520443|FG002|Overall Study|Death|4
4643871|NCT02010255|7520444|FG003|Overall Study|Death|4
4643872|NCT02010255|7520445|FG004|Overall Study|Death|2
4643873|NCT02010255|7520446|FG005|Overall Study|Death|0
4643874|NCT02010255|7520447|FG006|Overall Study|Death|1
4643875|NCT02010255|7520448|FG007|Overall Study|Death|1
4643876|NCT02010255|7520449|FG008|Overall Study|Death|1
4643877|NCT02010255|7520450|FG009|Overall Study|Death|0
4643878|NCT02010255|7520451|FG010|Overall Study|Death|1
4643879|NCT02010255|7520452|FG011|Overall Study|Death|1
4643880|NCT02010255|7520453|FG012|Overall Study|Death|0
4643881|NCT02010255|7520454|FG013|Overall Study|Death|0
4643882|NCT02010255|7520441|FG000|Overall Study|Lack of Efficacy|4
4643883|NCT02010255|7520442|FG001|Overall Study|Lack of Efficacy|1
4643884|NCT02010255|7520443|FG002|Overall Study|Lack of Efficacy|2
4643885|NCT02010255|7520444|FG003|Overall Study|Lack of Efficacy|1
4643886|NCT02010255|7520445|FG004|Overall Study|Lack of Efficacy|1
4643887|NCT02010255|7520446|FG005|Overall Study|Lack of Efficacy|0
4643888|NCT02010255|7520447|FG006|Overall Study|Lack of Efficacy|0
4643889|NCT02010255|7520448|FG007|Overall Study|Lack of Efficacy|0
4643890|NCT02010255|7520449|FG008|Overall Study|Lack of Efficacy|0
4643891|NCT02010255|7520450|FG009|Overall Study|Lack of Efficacy|0
4643892|NCT02010255|7520451|FG010|Overall Study|Lack of Efficacy|1
4643893|NCT02010255|7520452|FG011|Overall Study|Lack of Efficacy|0
4643894|NCT02010255|7520453|FG012|Overall Study|Lack of Efficacy|0
4643895|NCT02010255|7520454|FG013|Overall Study|Lack of Efficacy|0
4643896|NCT02010255|7520441|FG000|Overall Study|Withdrew Consent|1
4643897|NCT02010255|7520442|FG001|Overall Study|Withdrew Consent|0
4643898|NCT02010255|7520443|FG002|Overall Study|Withdrew Consent|0
4643899|NCT02010255|7520444|FG003|Overall Study|Withdrew Consent|1
4643900|NCT02010255|7520445|FG004|Overall Study|Withdrew Consent|0
4643901|NCT02010255|7520446|FG005|Overall Study|Withdrew Consent|0
4643902|NCT02010255|7520447|FG006|Overall Study|Withdrew Consent|0
4643903|NCT02010255|7520448|FG007|Overall Study|Withdrew Consent|0
4643904|NCT02010255|7520449|FG008|Overall Study|Withdrew Consent|0
4643905|NCT02010255|7520450|FG009|Overall Study|Withdrew Consent|0
4643906|NCT02010255|7520451|FG010|Overall Study|Withdrew Consent|0
4643907|NCT02010255|7520452|FG011|Overall Study|Withdrew Consent|0
4643908|NCT02010255|7520453|FG012|Overall Study|Withdrew Consent|0
4643909|NCT02010255|7520454|FG013|Overall Study|Withdrew Consent|0
4643910|NCT02010255|7520441|FG000|Overall Study|Adverse Event|1
4643911|NCT02010255|7520442|FG001|Overall Study|Adverse Event|0
4643912|NCT02010255|7520443|FG002|Overall Study|Adverse Event|0
4643913|NCT02010255|7520444|FG003|Overall Study|Adverse Event|0
4643914|NCT02010255|7520445|FG004|Overall Study|Adverse Event|0
4643915|NCT02010255|7520446|FG005|Overall Study|Adverse Event|0
4643916|NCT02010255|7520447|FG006|Overall Study|Adverse Event|0
4643917|NCT02010255|7520448|FG007|Overall Study|Adverse Event|0
4643918|NCT02010255|7520449|FG008|Overall Study|Adverse Event|0
4643919|NCT02010255|7520450|FG009|Overall Study|Adverse Event|0
4643920|NCT02010255|7520451|FG010|Overall Study|Adverse Event|0
4643921|NCT02010255|7520452|FG011|Overall Study|Adverse Event|0
4643922|NCT02010255|7520453|FG012|Overall Study|Adverse Event|0
4643923|NCT02010255|7520454|FG013|Overall Study|Adverse Event|0
4643924|NCT02010255|7520441|FG000|Overall Study|Lost to Follow-up|0
4643925|NCT02010255|7520442|FG001|Overall Study|Lost to Follow-up|0
4643926|NCT02010255|7520443|FG002|Overall Study|Lost to Follow-up|1
4643927|NCT02010255|7520444|FG003|Overall Study|Lost to Follow-up|0
4643928|NCT02010255|7520445|FG004|Overall Study|Lost to Follow-up|1
4643929|NCT02010255|7520446|FG005|Overall Study|Lost to Follow-up|0
4643930|NCT02010255|7520447|FG006|Overall Study|Lost to Follow-up|0
4643931|NCT02010255|7520448|FG007|Overall Study|Lost to Follow-up|0
4643932|NCT02010255|7520449|FG008|Overall Study|Lost to Follow-up|0
4643933|NCT02010255|7520450|FG009|Overall Study|Lost to Follow-up|0
4643934|NCT02010255|7520451|FG010|Overall Study|Lost to Follow-up|0
4643935|NCT02010255|7520452|FG011|Overall Study|Lost to Follow-up|0
4643936|NCT02010255|7520453|FG012|Overall Study|Lost to Follow-up|0
4643937|NCT02010255|7520454|FG013|Overall Study|Lost to Follow-up|0
4643938|NCT02010255|7520441|FG000|Overall Study|Randomized but Not Treated|0
4643939|NCT02010255|7520442|FG001|Overall Study|Randomized but Not Treated|0
4643940|NCT02010255|7520443|FG002|Overall Study|Randomized but Not Treated|0
4643941|NCT02010255|7520444|FG003|Overall Study|Randomized but Not Treated|0
4643942|NCT02010255|7520445|FG004|Overall Study|Randomized but Not Treated|0
4643943|NCT02010255|7520446|FG005|Overall Study|Randomized but Not Treated|0
4643944|NCT02010255|7520447|FG006|Overall Study|Randomized but Not Treated|0
4643945|NCT02010255|7520448|FG007|Overall Study|Randomized but Not Treated|0
4643946|NCT02010255|7520449|FG008|Overall Study|Randomized but Not Treated|0
4643947|NCT02010255|7520450|FG009|Overall Study|Randomized but Not Treated|0
4643948|NCT02010255|7520451|FG010|Overall Study|Randomized but Not Treated|0
4643949|NCT02010255|7520452|FG011|Overall Study|Randomized but Not Treated|0
4643950|NCT02010255|7520453|FG012|Overall Study|Randomized but Not Treated|0
4643951|NCT02010255|7520454|FG013|Overall Study|Randomized but Not Treated|1
4747361|NCT00283959|7721455|FG000|Extension Period|Low Compliance|1
4747362|NCT00290758|7721461|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1
4747363|NCT00290758|7721462|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2
4747364|NCT00290758|7721461|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1
4747365|NCT00290758|7721462|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0
4747366|NCT00290758|7721461|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3
4747367|NCT00290758|7721462|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1
4747368|NCT00290758|7721461|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1
4747369|NCT00290758|7721462|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1
4747370|NCT00290758|7721461|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0
4747371|NCT00290758|7721462|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5
4747372|NCT00290758|7721461|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1
4747373|NCT00290758|7721462|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0
4747374|NCT00290758|7721461|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0
4747375|NCT00290758|7721462|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1
4747376|NCT00290758|7721461|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6
4747377|NCT00290758|7721462|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5
4747378|NCT00310388|7721472|FG000|Primary Reporting Phase|Adverse Event|101
4747379|NCT00310388|7721473|FG001|Primary Reporting Phase|Adverse Event|0
4747380|NCT00310388|7721472|FG000|Primary Reporting Phase|Lack of Efficacy|56
4747381|NCT00310388|7721473|FG001|Primary Reporting Phase|Lack of Efficacy|0
4747382|NCT00310388|7721472|FG000|Primary Reporting Phase|Withdrawal by Subject|97
4747383|NCT00310388|7721473|FG001|Primary Reporting Phase|Withdrawal by Subject|0
4747384|NCT00310388|7721472|FG000|Primary Reporting Phase|Protocol Violation|10
4747385|NCT00310388|7721473|FG001|Primary Reporting Phase|Protocol Violation|0
4747386|NCT00310388|7721472|FG000|Primary Reporting Phase|Pregnancy|3
4747387|NCT00310388|7721473|FG001|Primary Reporting Phase|Pregnancy|0
4747388|NCT00310388|7721472|FG000|Primary Reporting Phase|Change in participant medical condition|3
4747389|NCT00310388|7721473|FG001|Primary Reporting Phase|Change in participant medical condition|0
4747390|NCT00310388|7721472|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3
4747391|NCT00310388|7721473|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0
4747392|NCT00310388|7721472|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3
4747393|NCT00310388|7721473|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0
4747394|NCT00310388|7721472|FG000|Primary Reporting Phase|Physician Decision|2
4747395|NCT00310388|7721473|FG001|Primary Reporting Phase|Physician Decision|0
4747396|NCT00310388|7721472|FG000|Primary Reporting Phase|Request of the sponsor|19
4747397|NCT00310388|7721473|FG001|Primary Reporting Phase|Request of the sponsor|0
4747398|NCT00310388|7721472|FG000|Primary Reporting Phase|Failed to return|8
4747399|NCT00310388|7721473|FG001|Primary Reporting Phase|Failed to return|0
4747400|NCT00310388|7721472|FG000|Primary Reporting Phase|Participant request unrelated to study|2
4747401|NCT00310388|7721473|FG001|Primary Reporting Phase|Participant request unrelated to study|0
4747402|NCT00310388|7721472|FG000|Primary Reporting Phase|Participant request|2
4747403|NCT00310388|7721473|FG001|Primary Reporting Phase|Participant request|0
4747404|NCT00310388|7721472|FG000|Primary Reporting Phase|Ministry of Health decision|25
4747405|NCT00310388|7721473|FG001|Primary Reporting Phase|Ministry of Health decision|0
4747406|NCT00310388|7721472|FG000|Primary Reporting Phase|Discontinuation of study|1
4747407|NCT00310388|7721473|FG001|Primary Reporting Phase|Discontinuation of study|0
4747408|NCT00310388|7721472|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1
4747409|NCT00310388|7721473|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0
4747410|NCT00310388|7721472|FG000|Primary Reporting Phase|Termination of study at sponsor request|3
4747411|NCT00310388|7721473|FG001|Primary Reporting Phase|Termination of study at sponsor request|0
4747412|NCT00310388|7721472|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1
4747413|NCT00310388|7721473|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0
4747414|NCT00310388|7721472|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2
4747415|NCT00310388|7721473|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0
4747416|NCT00310388|7721472|FG000|Primary Reporting Phase|Participant passed away|1
4747417|NCT00310388|7721473|FG001|Primary Reporting Phase|Participant passed away|0
4747418|NCT00310388|7721472|FG000|Primary Reporting Phase|Participant retired the informed consent|1
4747419|NCT00310388|7721473|FG001|Primary Reporting Phase|Participant retired the informed consent|0
4747420|NCT00310388|7721472|FG000|Primary Reporting Phase|Missing|1
4747421|NCT00310388|7721473|FG001|Primary Reporting Phase|Missing|0
4747422|NCT00310388|7721472|FG000|Primary Reporting Phase|Other|1
4747423|NCT00310388|7721473|FG001|Primary Reporting Phase|Other|0
4747424|NCT00310388|7721472|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0
4747425|NCT00310388|7721473|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5
4747426|NCT00310388|7721472|FG000|Safety Follow-up Continuation Phase|Adverse Event|0
4747427|NCT00310388|7721473|FG001|Safety Follow-up Continuation Phase|Adverse Event|1
4747428|NCT00310388|7721472|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0
4747429|NCT00310388|7721473|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5
4747430|NCT00310388|7721472|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0
4643952|NCT02010567|7520523|FG000|Overall Study|Adverse Event|0
4643953|NCT02010567|7520524|FG001|Overall Study|Adverse Event|0
4643954|NCT02010567|7520525|FG002|Overall Study|Adverse Event|1
4643955|NCT02010567|7520526|FG003|Overall Study|Adverse Event|0
4643956|NCT02010567|7520527|FG004|Overall Study|Adverse Event|1
4643957|NCT02010632|7520537|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1
4643958|NCT02010632|7520538|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0
4643959|NCT02010684|7520550|FG000|Overall Study|Lost to Follow-up|8
4643960|NCT02010684|7520551|FG001|Overall Study|Lost to Follow-up|18
4643961|NCT02010684|7520550|FG000|Overall Study|Withdrawal by Subject|4
4643962|NCT02010684|7520551|FG001|Overall Study|Withdrawal by Subject|5
4643963|NCT02010775|7520575|FG000|Overall Study|Adverse Event|0
4643964|NCT02010775|7520576|FG001|Overall Study|Adverse Event|0
4643965|NCT02010775|7520577|FG002|Overall Study|Adverse Event|0
4643966|NCT02010775|7520578|FG003|Overall Study|Adverse Event|0
4643967|NCT02010775|7520579|FG004|Overall Study|Adverse Event|1
4643968|NCT02010775|7520575|FG000|Overall Study|Pregnancy|0
4643969|NCT02010775|7520576|FG001|Overall Study|Pregnancy|0
4643970|NCT02010775|7520577|FG002|Overall Study|Pregnancy|2
4643971|NCT02010775|7520578|FG003|Overall Study|Pregnancy|0
4643972|NCT02010775|7520579|FG004|Overall Study|Pregnancy|0
4643973|NCT02010775|7520575|FG000|Overall Study|Lost to Follow-up|2
4643974|NCT02010775|7520576|FG001|Overall Study|Lost to Follow-up|0
4643975|NCT02010775|7520577|FG002|Overall Study|Lost to Follow-up|0
4643976|NCT02010775|7520578|FG003|Overall Study|Lost to Follow-up|1
4643977|NCT02010775|7520579|FG004|Overall Study|Lost to Follow-up|1
4643978|NCT02010775|7520575|FG000|Overall Study|Personal Reasons|3
4643979|NCT02010775|7520576|FG001|Overall Study|Personal Reasons|3
4643980|NCT02010775|7520577|FG002|Overall Study|Personal Reasons|1
4643981|NCT02010775|7520578|FG003|Overall Study|Personal Reasons|2
4643982|NCT02010775|7520579|FG004|Overall Study|Personal Reasons|4
4643983|NCT02011113|7520604|FG000|Overall Study|Adverse Event|4
4643984|NCT02011113|7520604|FG000|Overall Study|Disease Progression (DP)|16
4643985|NCT02011113|7520604|FG000|Overall Study|Death|1
4643986|NCT02011113|7520604|FG000|Overall Study|Insufficient effect of Pomalidomide|1
4643987|NCT02011113|7520604|FG000|Overall Study|Investigator's judgement- DP|3
4643988|NCT02011113|7520604|FG000|Overall Study|Study terminated by sponsor|11
4643989|NCT02011386|7520609|FG000|Overall Study|Non-compliance|2
4643990|NCT02011386|7520609|FG000|Overall Study|Lack of Efficacy|3
4643991|NCT02011893|7520665|FG000|Enrollment to Randomization|Adverse Event|2
4643992|NCT02011893|7520666|FG001|Enrollment to Randomization|Adverse Event|0
4643993|NCT02011893|7520667|FG002|Enrollment to Randomization|Adverse Event|0
4643994|NCT02011893|7520665|FG000|Enrollment to Randomization|Physician Decision|10
4643995|NCT02011893|7520666|FG001|Enrollment to Randomization|Physician Decision|0
4643996|NCT02011893|7520667|FG002|Enrollment to Randomization|Physician Decision|0
4643997|NCT02011893|7520665|FG000|Enrollment to Randomization|Withdrawal by Subject|21
4643998|NCT02011893|7520666|FG001|Enrollment to Randomization|Withdrawal by Subject|0
4643999|NCT02011893|7520667|FG002|Enrollment to Randomization|Withdrawal by Subject|0
4644000|NCT02011893|7520665|FG000|Enrollment to Randomization|Screening Failure|29
4644001|NCT02011893|7520666|FG001|Enrollment to Randomization|Screening Failure|0
4644002|NCT02011893|7520667|FG002|Enrollment to Randomization|Screening Failure|0
4644003|NCT02011893|7520665|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9
4644004|NCT02011893|7520666|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0
4644005|NCT02011893|7520667|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0
4644006|NCT02011893|7520665|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2
4644007|NCT02011893|7520666|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0
4644008|NCT02011893|7520667|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0
4644009|NCT02011893|7520665|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0
4644010|NCT02011893|7520666|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0
4644011|NCT02011893|7520667|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1
4644012|NCT02011893|7520665|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0
4644013|NCT02011893|7520666|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0
4644014|NCT02011893|7520667|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2
4644015|NCT02011893|7520665|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0
4644016|NCT02011893|7520666|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0
4644017|NCT02011893|7520667|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1
4644018|NCT02011945|7520675|FG000|Overall Study|Participant requested to Discontinue|0
4644019|NCT02011945|7520676|FG001|Overall Study|Participant requested to Discontinue|1
4644020|NCT02011945|7520677|FG002|Overall Study|Participant requested to Discontinue|1
4644021|NCT02011945|7520675|FG000|Overall Study|Adverse Event unrelated to Drug|0
4644022|NCT02011945|7520676|FG001|Overall Study|Adverse Event unrelated to Drug|2
4644023|NCT02011945|7520677|FG002|Overall Study|Adverse Event unrelated to Drug|1
4644024|NCT02011945|7520675|FG000|Overall Study|Study Drug Toxicity|0
4644025|NCT02011945|7520676|FG001|Overall Study|Study Drug Toxicity|0
4644026|NCT02011945|7520677|FG002|Overall Study|Study Drug Toxicity|1
4644027|NCT02011945|7520675|FG000|Overall Study|Treatment Failure|0
4644028|NCT02011945|7520676|FG001|Overall Study|Treatment Failure|7
4644029|NCT02011945|7520677|FG002|Overall Study|Treatment Failure|6
4644030|NCT02011945|7520675|FG000|Overall Study|No Longer Meets Study Criteria|1
4644031|NCT02011945|7520676|FG001|Overall Study|No Longer Meets Study Criteria|0
4644032|NCT02011945|7520677|FG002|Overall Study|No Longer Meets Study Criteria|0
4644033|NCT02011945|7520675|FG000|Overall Study|Proceeded to stem cell transplant|0
4644034|NCT02011945|7520676|FG001|Overall Study|Proceeded to stem cell transplant|0
4644035|NCT02011945|7520677|FG002|Overall Study|Proceeded to stem cell transplant|1
4644036|NCT02011945|7520675|FG000|Overall Study|Sub-Optimal Response to dasatinib|1
4644037|NCT02011945|7520676|FG001|Overall Study|Sub-Optimal Response to dasatinib|0
4644038|NCT02011945|7520677|FG002|Overall Study|Sub-Optimal Response to dasatinib|0
4644039|NCT02012218|7520699|FG000|Overall Study|Withdrawal by Subject|1
4644040|NCT02012218|7520700|FG001|Overall Study|Withdrawal by Subject|0
4644041|NCT02012218|7520701|FG002|Overall Study|Withdrawal by Subject|1
4644042|NCT02012218|7520702|FG003|Overall Study|Withdrawal by Subject|1
4644043|NCT02012218|7520703|FG004|Overall Study|Withdrawal by Subject|1
4644044|NCT02012218|7520699|FG000|Overall Study|Adverse Event|1
4644045|NCT02012218|7520700|FG001|Overall Study|Adverse Event|0
4644046|NCT02012218|7520701|FG002|Overall Study|Adverse Event|0
4644047|NCT02012218|7520702|FG003|Overall Study|Adverse Event|1
4644048|NCT02012218|7520703|FG004|Overall Study|Adverse Event|0
4644049|NCT02012218|7520699|FG000|Overall Study|Lost to Follow-up|0
4644050|NCT02012218|7520700|FG001|Overall Study|Lost to Follow-up|1
4644051|NCT02012218|7520701|FG002|Overall Study|Lost to Follow-up|1
4644052|NCT02012218|7520702|FG003|Overall Study|Lost to Follow-up|0
4644053|NCT02012218|7520703|FG004|Overall Study|Lost to Follow-up|0
4644054|NCT02012218|7520699|FG000|Overall Study|Protocol Specified|1
4644055|NCT02012218|7520700|FG001|Overall Study|Protocol Specified|0
4644056|NCT02012218|7520701|FG002|Overall Study|Protocol Specified|0
4644057|NCT02012218|7520702|FG003|Overall Study|Protocol Specified|0
4644058|NCT02012218|7520703|FG004|Overall Study|Protocol Specified|0
4644059|NCT02012218|7520699|FG000|Overall Study|Protocol Deviation|1
4644060|NCT02012218|7520700|FG001|Overall Study|Protocol Deviation|0
4644061|NCT02012218|7520701|FG002|Overall Study|Protocol Deviation|0
4644062|NCT02012218|7520702|FG003|Overall Study|Protocol Deviation|0
4644063|NCT02012218|7520703|FG004|Overall Study|Protocol Deviation|0
4644064|NCT02012452|7520744|FG000|Overall Study|Lost to Follow-up|2
4644065|NCT02012452|7520745|FG001|Overall Study|Lost to Follow-up|1
4644066|NCT02012452|7520744|FG000|Overall Study|Withdrawal by Subject|4
4644067|NCT02012452|7520745|FG001|Overall Study|Withdrawal by Subject|0
4644068|NCT02012491|7520753|FG000|Overall Study|Lost to Follow-up|1
4644069|NCT02012491|7520754|FG001|Overall Study|Lost to Follow-up|0
4644070|NCT02012491|7520753|FG000|Overall Study|Protocol Violation|0
4644071|NCT02012491|7520754|FG001|Overall Study|Protocol Violation|1
4644072|NCT02012491|7520753|FG000|Overall Study|Withdrawal by Subject|1
4644073|NCT02012491|7520754|FG001|Overall Study|Withdrawal by Subject|0
4644074|NCT02012686|7520783|FG000|Overall Study|muscle contraction|0
4644075|NCT02012686|7520784|FG001|Overall Study|muscle contraction|1
4644076|NCT02012686|7520783|FG000|Overall Study|electrocardiography monitoring noise|0
4644077|NCT02012686|7520784|FG001|Overall Study|electrocardiography monitoring noise|1
4644078|NCT02012959|7520790|FG000|Treatment Phase A|Adverse Event|2
4644079|NCT02012959|7520791|FG001|Treatment Phase A|Adverse Event|0
4644080|NCT02012959|7520792|FG002|Treatment Phase A|Adverse Event|0
4644081|NCT02012959|7520793|FG003|Treatment Phase A|Adverse Event|0
4644082|NCT02012959|7520794|FG004|Treatment Phase A|Adverse Event|0
4644083|NCT02013037|7520804|FG000|Overall Study|Death|6
4644084|NCT02013037|7520804|FG000|Overall Study|Withdrawal by Subject|1
4644085|NCT02013037|7520804|FG000|Overall Study|Awaiting Transplantation|7
4747431|NCT00310388|7721473|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2
4644086|NCT02013037|7520804|FG000|Overall Study|Transplanted without DSA|2
4644087|NCT02013206|7520837|FG000|Overall Study|Progressive disease (PD)|14
4644088|NCT02013206|7520838|FG001|Overall Study|Progressive disease (PD)|17
4644089|NCT02013206|7520837|FG000|Overall Study|Symptomatic deterioration|3
4644090|NCT02013206|7520838|FG001|Overall Study|Symptomatic deterioration|1
4644091|NCT02013206|7520837|FG000|Overall Study|Adverse Event|1
4644092|NCT02013206|7520838|FG001|Overall Study|Adverse Event|0
4644093|NCT02013206|7520837|FG000|Overall Study|Patient refusal|2
4644094|NCT02013206|7520838|FG001|Overall Study|Patient refusal|0
4644095|NCT02013206|7520837|FG000|Overall Study|Patient non-compliance|1
4644096|NCT02013206|7520838|FG001|Overall Study|Patient non-compliance|0
4644097|NCT02013206|7520837|FG000|Overall Study|Death|1
4644098|NCT02013206|7520838|FG001|Overall Study|Death|2
4644099|NCT02013206|7520837|FG000|Overall Study|Other reasons off treatment|5
4644100|NCT02013206|7520838|FG001|Overall Study|Other reasons off treatment|2
4644101|NCT02013375|7520861|FG000|Overall Study|Did not engraft|1
4644102|NCT02013375|7520861|FG000|Overall Study|Did not engraft|1
4644103|NCT02013388|7520874|FG000|Overall Study|work emergency|1
4644104|NCT02013388|7520875|FG001|Overall Study|work emergency|0
4644105|NCT02013388|7520876|FG002|Overall Study|work emergency|0
4644106|NCT02013388|7520877|FG003|Overall Study|work emergency|0
4644107|NCT02013388|7520878|FG004|Overall Study|work emergency|1
4644108|NCT02013388|7520879|FG005|Overall Study|work emergency|0
4644109|NCT02013388|7520880|FG006|Overall Study|work emergency|0
4644110|NCT02013388|7520881|FG007|Overall Study|work emergency|0
4644111|NCT02013531|7520903|FG000|Overall Study|Lost to Follow-up|3
4644112|NCT02013531|7520903|FG000|Overall Study|Met Withdrawal Criteria|1
4644113|NCT02013531|7520903|FG000|Overall Study|Withdrawal by Subject|1
4644114|NCT02013544|7520909|FG000|Overall Study|Adverse Event|5
4644115|NCT02013544|7520910|FG001|Overall Study|Adverse Event|5
4644116|NCT02013544|7520909|FG000|Overall Study|Lost to Follow-up|2
4644117|NCT02013544|7520910|FG001|Overall Study|Lost to Follow-up|3
4644118|NCT02013544|7520909|FG000|Overall Study|Withdrawal by Subject|2
4644119|NCT02013544|7520910|FG001|Overall Study|Withdrawal by Subject|8
4644120|NCT02013544|7520909|FG000|Overall Study|Physician Decision|0
4644121|NCT02013544|7520910|FG001|Overall Study|Physician Decision|1
4644122|NCT02013544|7520909|FG000|Overall Study|Entry criteria not met/non-compliance|2
4644123|NCT02013544|7520910|FG001|Overall Study|Entry criteria not met/non-compliance|3
4644124|NCT02013609|7520916|FG000|Overall Study|Withdrawal by Subject|9
4644125|NCT02013609|7520916|FG000|Overall Study|Lost to Follow-up|3
4644126|NCT02013609|7520916|FG000|Overall Study|Adverse Event|3
4644127|NCT02013609|7520916|FG000|Overall Study|Met Withdrawal Criteria|3
4644128|NCT02013622|7520920|FG000|Overall Study|Lost to Follow-up|10
4644129|NCT02013622|7520920|FG000|Overall Study|Adverse Event|3
4644130|NCT02013622|7520920|FG000|Overall Study|Met Withdrawal Criteria|3
4644131|NCT02013622|7520920|FG000|Overall Study|Withdrawal by Subject|6
4644132|NCT02013622|7520920|FG000|Overall Study|Protocol Deviation|1
4644133|NCT02013622|7520920|FG000|Overall Study|Lack of Efficacy|1
4644134|NCT02013674|7520926|FG000|Overall Study|Death|0
4644135|NCT02013674|7520927|FG001|Overall Study|Death|1
4644136|NCT02013674|7520926|FG000|Overall Study|Lost to Follow-up|1
4644137|NCT02013674|7520927|FG001|Overall Study|Lost to Follow-up|0
4644138|NCT02013687|7520937|FG000|Overall Study|Lost to Follow-up|0
4644139|NCT02013687|7520938|FG001|Overall Study|Lost to Follow-up|0
4644140|NCT02013687|7520939|FG002|Overall Study|Lost to Follow-up|1
4644141|NCT02013687|7520940|FG003|Overall Study|Lost to Follow-up|0
4644142|NCT02013687|7520937|FG000|Overall Study|Protocol Violation|0
4644143|NCT02013687|7520938|FG001|Overall Study|Protocol Violation|0
4644144|NCT02013687|7520939|FG002|Overall Study|Protocol Violation|0
4644145|NCT02013687|7520940|FG003|Overall Study|Protocol Violation|1
4644146|NCT02013687|7520937|FG000|Overall Study|Withdrawal by Subject|0
4644147|NCT02013687|7520938|FG001|Overall Study|Withdrawal by Subject|0
4644148|NCT02013687|7520939|FG002|Overall Study|Withdrawal by Subject|0
4644149|NCT02013687|7520940|FG003|Overall Study|Withdrawal by Subject|1
4644150|NCT02013687|7520937|FG000|Overall Study|Missed visits due to patient travel|0
4644151|NCT02013687|7520938|FG001|Overall Study|Missed visits due to patient travel|0
4644152|NCT02013687|7520939|FG002|Overall Study|Missed visits due to patient travel|1
4644153|NCT02013687|7520940|FG003|Overall Study|Missed visits due to patient travel|0
4747432|NCT00345358|7721482|FG000|Primary Vaccination Phase|Other|0
4747433|NCT00345358|7721483|FG001|Primary Vaccination Phase|Other|1
4747434|NCT00345358|7721484|FG002|Primary Vaccination Phase|Other|1
4747435|NCT00345358|7721485|FG003|Primary Vaccination Phase|Other|0
4747436|NCT00345358|7721482|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3
4747437|NCT00345358|7721483|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1
4747438|NCT00345358|7721484|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1
4747439|NCT00345358|7721485|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0
4747440|NCT00345358|7721482|FG000|Primary Vaccination Phase|Withdrawal by Subject|1
4747441|NCT00345358|7721483|FG001|Primary Vaccination Phase|Withdrawal by Subject|2
4644154|NCT02013765|7520954|FG000|Overall Study|Trial was terminated by sponsor|1
4644155|NCT02013778|7520958|FG000|Overall Study|Death|4
4644156|NCT02013778|7520958|FG000|Overall Study|Withdrawal by Subject|1
4644157|NCT02013778|7520958|FG000|Overall Study|Physician Decision|1
4644158|NCT02013778|7520958|FG000|Overall Study|Adverse Event|1
4644159|NCT02013791|7520971|FG000|Period 1|Lost to Follow-up|0
4747442|NCT00345358|7721484|FG002|Primary Vaccination Phase|Withdrawal by Subject|4
4747443|NCT00345358|7721485|FG003|Primary Vaccination Phase|Withdrawal by Subject|0
4747444|NCT00345358|7721482|FG000|Primary Vaccination Phase|Lost to Follow-up|1
4747445|NCT00345358|7721483|FG001|Primary Vaccination Phase|Lost to Follow-up|0
4747446|NCT00345358|7721484|FG002|Primary Vaccination Phase|Lost to Follow-up|2
4644160|NCT02013791|7520972|FG001|Period 1|Lost to Follow-up|0
4644161|NCT02013791|7520973|FG002|Period 1|Lost to Follow-up|0
4644162|NCT02013791|7520974|FG003|Period 1|Lost to Follow-up|1
4644163|NCT02013791|7520975|FG004|Period 1|Lost to Follow-up|0
4644164|NCT02013791|7520976|FG005|Period 1|Lost to Follow-up|0
4644165|NCT02013791|7520977|FG006|Period 1|Lost to Follow-up|1
4644166|NCT02013791|7520978|FG007|Period 1|Lost to Follow-up|1
4644167|NCT02013791|7520979|FG008|Period 1|Lost to Follow-up|0
4644168|NCT02013791|7520971|FG000|Period 1|Other Miscellaneous Reasons|0
4644169|NCT02013791|7520972|FG001|Period 1|Other Miscellaneous Reasons|2
4644170|NCT02013791|7520973|FG002|Period 1|Other Miscellaneous Reasons|0
4644171|NCT02013791|7520974|FG003|Period 1|Other Miscellaneous Reasons|0
4644172|NCT02013791|7520975|FG004|Period 1|Other Miscellaneous Reasons|0
4644173|NCT02013791|7520976|FG005|Period 1|Other Miscellaneous Reasons|0
4644174|NCT02013791|7520977|FG006|Period 1|Other Miscellaneous Reasons|0
4644175|NCT02013791|7520978|FG007|Period 1|Other Miscellaneous Reasons|0
4644176|NCT02013791|7520979|FG008|Period 1|Other Miscellaneous Reasons|0
4644177|NCT02013817|7521000|FG000|Overall Study|Adverse Event|12
4644178|NCT02013817|7521000|FG000|Overall Study|Withdrawal by Subject|4
4644179|NCT02013817|7521000|FG000|Overall Study|Death|2
4644180|NCT02013817|7521000|FG000|Overall Study|Other|9
4644181|NCT02013830|7521004|FG000|Overall Study|Adverse Event|3
4644182|NCT02013830|7521004|FG000|Overall Study|Death|1
4644183|NCT02013830|7521004|FG000|Overall Study|Insufficient therapeutic response|25
4644184|NCT02013830|7521004|FG000|Overall Study|Refused treatment|1
4644185|NCT02014116|7521025|FG000|Overall Study|Progressive Disease|3
4644186|NCT02014116|7521026|FG001|Overall Study|Progressive Disease|4
4644187|NCT02014116|7521027|FG002|Overall Study|Progressive Disease|2
4644188|NCT02014116|7521028|FG003|Overall Study|Progressive Disease|6
4644189|NCT02014116|7521029|FG004|Overall Study|Progressive Disease|1
4644190|NCT02014116|7521030|FG005|Overall Study|Progressive Disease|13
4644191|NCT02014116|7521031|FG006|Overall Study|Progressive Disease|1
4644192|NCT02014116|7521032|FG007|Overall Study|Progressive Disease|3
4644193|NCT02014116|7521033|FG008|Overall Study|Progressive Disease|7
4644194|NCT02014116|7521025|FG000|Overall Study|Adverse Event|0
4644195|NCT02014116|7521026|FG001|Overall Study|Adverse Event|0
4644196|NCT02014116|7521027|FG002|Overall Study|Adverse Event|0
4644197|NCT02014116|7521028|FG003|Overall Study|Adverse Event|0
4644198|NCT02014116|7521029|FG004|Overall Study|Adverse Event|1
4644199|NCT02014116|7521030|FG005|Overall Study|Adverse Event|0
4644200|NCT02014116|7521031|FG006|Overall Study|Adverse Event|0
4644201|NCT02014116|7521032|FG007|Overall Study|Adverse Event|1
4644202|NCT02014116|7521033|FG008|Overall Study|Adverse Event|0
4644203|NCT02014116|7521025|FG000|Overall Study|Lost to Follow-up|0
4644204|NCT02014116|7521026|FG001|Overall Study|Lost to Follow-up|0
4644205|NCT02014116|7521027|FG002|Overall Study|Lost to Follow-up|0
4644206|NCT02014116|7521028|FG003|Overall Study|Lost to Follow-up|0
4644207|NCT02014116|7521029|FG004|Overall Study|Lost to Follow-up|0
4644208|NCT02014116|7521030|FG005|Overall Study|Lost to Follow-up|1
4644209|NCT02014116|7521031|FG006|Overall Study|Lost to Follow-up|0
4644210|NCT02014116|7521032|FG007|Overall Study|Lost to Follow-up|0
4644211|NCT02014116|7521033|FG008|Overall Study|Lost to Follow-up|1
4644212|NCT02014116|7521025|FG000|Overall Study|Death|0
4644213|NCT02014116|7521026|FG001|Overall Study|Death|0
4644214|NCT02014116|7521027|FG002|Overall Study|Death|0
4644215|NCT02014116|7521028|FG003|Overall Study|Death|0
4644216|NCT02014116|7521029|FG004|Overall Study|Death|0
4644217|NCT02014116|7521030|FG005|Overall Study|Death|0
4644218|NCT02014116|7521031|FG006|Overall Study|Death|0
4644219|NCT02014116|7521032|FG007|Overall Study|Death|1
4644220|NCT02014116|7521033|FG008|Overall Study|Death|1
4644221|NCT02014116|7521025|FG000|Overall Study|Withdrawal by Subject|0
4644222|NCT02014116|7521026|FG001|Overall Study|Withdrawal by Subject|0
4644223|NCT02014116|7521027|FG002|Overall Study|Withdrawal by Subject|1
4644224|NCT02014116|7521028|FG003|Overall Study|Withdrawal by Subject|1
4644225|NCT02014116|7521029|FG004|Overall Study|Withdrawal by Subject|0
4644226|NCT02014116|7521030|FG005|Overall Study|Withdrawal by Subject|1
4644227|NCT02014116|7521031|FG006|Overall Study|Withdrawal by Subject|0
4644228|NCT02014116|7521032|FG007|Overall Study|Withdrawal by Subject|0
4644229|NCT02014116|7521033|FG008|Overall Study|Withdrawal by Subject|0
4644230|NCT02014116|7521025|FG000|Overall Study|Withdrawal Caregiver Decision|0
4644231|NCT02014116|7521026|FG001|Overall Study|Withdrawal Caregiver Decision|0
4644232|NCT02014116|7521027|FG002|Overall Study|Withdrawal Caregiver Decision|0
4644233|NCT02014116|7521028|FG003|Overall Study|Withdrawal Caregiver Decision|0
4644234|NCT02014116|7521029|FG004|Overall Study|Withdrawal Caregiver Decision|0
4644235|NCT02014116|7521030|FG005|Overall Study|Withdrawal Caregiver Decision|1
4644236|NCT02014116|7521031|FG006|Overall Study|Withdrawal Caregiver Decision|0
4644237|NCT02014116|7521032|FG007|Overall Study|Withdrawal Caregiver Decision|0
4644238|NCT02014116|7521033|FG008|Overall Study|Withdrawal Caregiver Decision|0
4644239|NCT02014116|7521025|FG000|Overall Study|Physician Decision|0
4644240|NCT02014116|7521026|FG001|Overall Study|Physician Decision|0
4644241|NCT02014116|7521027|FG002|Overall Study|Physician Decision|0
4644242|NCT02014116|7521028|FG003|Overall Study|Physician Decision|0
4644243|NCT02014116|7521029|FG004|Overall Study|Physician Decision|0
4644244|NCT02014116|7521030|FG005|Overall Study|Physician Decision|0
4644245|NCT02014116|7521031|FG006|Overall Study|Physician Decision|0
4644246|NCT02014116|7521032|FG007|Overall Study|Physician Decision|0
4644247|NCT02014116|7521033|FG008|Overall Study|Physician Decision|1
4644248|NCT02014272|7521069|FG000|Intervention Period 1|Withdrawal by Subject|1
4644249|NCT02014272|7521070|FG001|Intervention Period 1|Withdrawal by Subject|0
4644250|NCT02014272|7521069|FG000|Intervention Period 1|Adverse Event|0
4644251|NCT02014272|7521070|FG001|Intervention Period 1|Adverse Event|1
4644252|NCT02014376|7521092|FG000|Overall Study|Adverse Event|1
4644253|NCT02014376|7521093|FG001|Overall Study|Adverse Event|1
4644254|NCT02014376|7521094|FG002|Overall Study|Adverse Event|0
4644255|NCT02014376|7521092|FG000|Overall Study|Lost to Follow-up|2
4644256|NCT02014376|7521093|FG001|Overall Study|Lost to Follow-up|0
4644257|NCT02014376|7521094|FG002|Overall Study|Lost to Follow-up|0
4644258|NCT02014402|7521106|FG000|Overall Study|Adverse Event|1
4644259|NCT02014402|7521107|FG001|Overall Study|Adverse Event|0
4644260|NCT02014402|7521108|FG002|Overall Study|Adverse Event|0
4644261|NCT02014402|7521109|FG003|Overall Study|Adverse Event|0
4644262|NCT02014402|7521106|FG000|Overall Study|Withdrawal by Subject|1
4644263|NCT02014402|7521107|FG001|Overall Study|Withdrawal by Subject|2
4644264|NCT02014402|7521108|FG002|Overall Study|Withdrawal by Subject|2
4644265|NCT02014402|7521109|FG003|Overall Study|Withdrawal by Subject|1
4644266|NCT02014402|7521106|FG000|Overall Study|Subject did not have transportation|0
4644267|NCT02014402|7521107|FG001|Overall Study|Subject did not have transportation|1
4644268|NCT02014402|7521108|FG002|Overall Study|Subject did not have transportation|0
4644269|NCT02014402|7521109|FG003|Overall Study|Subject did not have transportation|0
4644270|NCT02014402|7521106|FG000|Overall Study|Lost to Follow-up|0
4644271|NCT02014402|7521107|FG001|Overall Study|Lost to Follow-up|0
4644272|NCT02014402|7521108|FG002|Overall Study|Lost to Follow-up|1
4644273|NCT02014402|7521109|FG003|Overall Study|Lost to Follow-up|2
4644274|NCT02014441|7521126|FG000|Overall Study|Withdrawal by Subject|12
4644275|NCT02014467|7521134|FG000|Overall Study|Adverse Event|4
4644276|NCT02014467|7521135|FG001|Overall Study|Adverse Event|0
4644277|NCT02014467|7521134|FG000|Overall Study|Protocol Violation|3
4644278|NCT02014467|7521135|FG001|Overall Study|Protocol Violation|0
4644279|NCT02014467|7521134|FG000|Overall Study|Physician Decision|2
4644280|NCT02014467|7521135|FG001|Overall Study|Physician Decision|3
4644281|NCT02014467|7521134|FG000|Overall Study|Withdrawal by Subject|16
4644282|NCT02014467|7521135|FG001|Overall Study|Withdrawal by Subject|4
4644283|NCT02014480|7521141|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0
4644284|NCT02014480|7521142|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0
4644285|NCT02014480|7521143|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1
4644286|NCT02014480|7521144|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0
4644287|NCT02014480|7521145|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0
4644288|NCT02014480|7521146|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0
4644289|NCT02014480|7521141|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
4644290|NCT02014480|7521142|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
4644291|NCT02014480|7521143|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
4644292|NCT02014480|7521144|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2
4644293|NCT02014480|7521145|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
4644294|NCT02014480|7521146|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
4644295|NCT02014480|7521141|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
4644296|NCT02014480|7521142|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
4644297|NCT02014480|7521143|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1
4644298|NCT02014480|7521144|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
4644299|NCT02014480|7521145|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
4644300|NCT02014480|7521146|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
4644301|NCT02014480|7521141|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1
4644302|NCT02014480|7521142|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1
4644303|NCT02014480|7521143|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2
4644304|NCT02014480|7521144|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1
4644305|NCT02014480|7521145|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0
4644306|NCT02014480|7521146|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0
4644307|NCT02014480|7521141|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
4644308|NCT02014480|7521142|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1
4644309|NCT02014480|7521143|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
4644310|NCT02014480|7521144|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
4644311|NCT02014480|7521145|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
4644312|NCT02014480|7521146|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
4644313|NCT02014480|7521141|FG000|Treatment Period 3 (14 Days)|Adverse Event|0
4644314|NCT02014480|7521142|FG001|Treatment Period 3 (14 Days)|Adverse Event|0
4644315|NCT02014480|7521143|FG002|Treatment Period 3 (14 Days)|Adverse Event|1
4644316|NCT02014480|7521144|FG003|Treatment Period 3 (14 Days)|Adverse Event|0
4644317|NCT02014480|7521145|FG004|Treatment Period 3 (14 Days)|Adverse Event|0
4644318|NCT02014480|7521146|FG005|Treatment Period 3 (14 Days)|Adverse Event|1
4644319|NCT02014480|7521141|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0
4644320|NCT02014480|7521142|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0
4644321|NCT02014480|7521143|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0
4644322|NCT02014480|7521144|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0
4644323|NCT02014480|7521145|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0
4644324|NCT02014480|7521146|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1
4644325|NCT02014584|7521168|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0
4644326|NCT02014584|7521169|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1
4644327|NCT02014584|7521170|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0
4644328|NCT02014584|7521171|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0
4644329|NCT02014584|7521172|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0
4644330|NCT02014584|7521173|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0
4644331|NCT02014584|7521168|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2
4644332|NCT02014584|7521169|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5
4644333|NCT02014584|7521170|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
4644334|NCT02014584|7521171|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
4644335|NCT02014584|7521172|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
4644336|NCT02014584|7521173|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
4644337|NCT02014584|7521168|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0
4644338|NCT02014584|7521169|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0
4644339|NCT02014584|7521170|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2
4644340|NCT02014584|7521171|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0
4644341|NCT02014584|7521172|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0
4644342|NCT02014584|7521173|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0
4644343|NCT02014584|7521168|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
4644344|NCT02014584|7521169|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
4644345|NCT02014584|7521170|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3
4644346|NCT02014584|7521171|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1
4644347|NCT02014584|7521172|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
4644348|NCT02014584|7521173|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
4644349|NCT02014584|7521168|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
4644350|NCT02014584|7521169|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
4644351|NCT02014584|7521170|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
4644352|NCT02014584|7521171|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
4644353|NCT02014584|7521172|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1
4644354|NCT02014584|7521173|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
4644355|NCT02014597|7521187|FG000|Overall Study|Unable to record log contrast sensitivity|2
4644356|NCT02014597|7521188|FG001|Overall Study|Unable to record log contrast sensitivity|1
4644357|NCT02014740|7521196|FG000|Overall Study|Lost to Follow-up|4
4644358|NCT02014740|7521197|FG001|Overall Study|Lost to Follow-up|4
4644359|NCT02014740|7521196|FG000|Overall Study|Withdrawal by Subject|2
4644360|NCT02014740|7521197|FG001|Overall Study|Withdrawal by Subject|1
4644361|NCT02015039|7521205|FG000|Overall Study|Not eligible|0
4644362|NCT02015039|7521206|FG001|Overall Study|Not eligible|1
4644363|NCT02015065|7521215|FG000|Overall Study|Death on study|1
4644364|NCT02015065|7521216|FG001|Overall Study|Death on study|2
4644365|NCT02015065|7521217|FG002|Overall Study|Death on study|1
4644366|NCT02015104|7521227|FG000|Overall Study|Withdrew consent after first dose drug|1
4644367|NCT02015104|7521228|FG001|Overall Study|Withdrew consent after first dose drug|0
4644368|NCT02015104|7521227|FG000|Overall Study|Withdrew consent prior to treatment|0
4644369|NCT02015104|7521228|FG001|Overall Study|Withdrew consent prior to treatment|1
4644370|NCT02015195|7521244|FG000|Overall Study|Adverse Event|0
4644371|NCT02015195|7521245|FG001|Overall Study|Adverse Event|0
4644372|NCT02015195|7521246|FG002|Overall Study|Adverse Event|0
4644373|NCT02015195|7521247|FG003|Overall Study|Adverse Event|1
4644374|NCT02015195|7521248|FG004|Overall Study|Adverse Event|0
4644375|NCT02015195|7521249|FG005|Overall Study|Adverse Event|0
4644376|NCT02015195|7521250|FG006|Overall Study|Adverse Event|0
4644377|NCT02015221|7521267|FG000|Overall Study|Withdrawal by Subject|8
4644378|NCT02015221|7521268|FG001|Overall Study|Withdrawal by Subject|6
4644379|NCT02015221|7521267|FG000|Overall Study|Lost to Follow-up|1
4644380|NCT02015221|7521268|FG001|Overall Study|Lost to Follow-up|0
4644381|NCT02015390|7521287|FG000|Overall Study|Lost to Follow-up|1
4644382|NCT02015390|7521288|FG001|Overall Study|Lost to Follow-up|0
4644383|NCT02015390|7521287|FG000|Overall Study|Adverse Event|0
4644384|NCT02015390|7521288|FG001|Overall Study|Adverse Event|3
4644385|NCT02015390|7521287|FG000|Overall Study|Physician Decision|0
4644386|NCT02015390|7521288|FG001|Overall Study|Physician Decision|1
4644387|NCT02015481|7521302|FG000|Overall Study|Death|1
4644388|NCT02015520|7521311|FG000|Overall Study|Lack of Efficacy|1
4644389|NCT02015520|7521312|FG001|Overall Study|Lack of Efficacy|0
4644390|NCT02015520|7521313|FG002|Overall Study|Lack of Efficacy|3
4644391|NCT02015520|7521314|FG003|Overall Study|Lack of Efficacy|2
4644392|NCT02015520|7521311|FG000|Overall Study|Adverse Event|0
4644393|NCT02015520|7521312|FG001|Overall Study|Adverse Event|0
4644394|NCT02015520|7521313|FG002|Overall Study|Adverse Event|0
4644395|NCT02015520|7521314|FG003|Overall Study|Adverse Event|1
4644396|NCT02015520|7521311|FG000|Overall Study|Withdrawal by Subject|2
4644397|NCT02015520|7521312|FG001|Overall Study|Withdrawal by Subject|2
4644398|NCT02015520|7521313|FG002|Overall Study|Withdrawal by Subject|1
4644399|NCT02015520|7521314|FG003|Overall Study|Withdrawal by Subject|0
4644400|NCT02015520|7521311|FG000|Overall Study|Death|1
4644401|NCT02015520|7521312|FG001|Overall Study|Death|0
4644402|NCT02015520|7521313|FG002|Overall Study|Death|0
4644403|NCT02015520|7521314|FG003|Overall Study|Death|0
4644404|NCT02015520|7521311|FG000|Overall Study|Lost to Follow-up|0
4644405|NCT02015520|7521312|FG001|Overall Study|Lost to Follow-up|0
4644406|NCT02015520|7521313|FG002|Overall Study|Lost to Follow-up|1
4644407|NCT02015520|7521314|FG003|Overall Study|Lost to Follow-up|0
4644408|NCT02015520|7521311|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1
4644409|NCT02015520|7521312|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1
4644410|NCT02015520|7521313|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2
4644411|NCT02015520|7521314|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1
4644412|NCT02015520|7521311|FG000|Overall Study|Subject no Longer Meets Study Criteria|0
4644413|NCT02015520|7521312|FG001|Overall Study|Subject no Longer Meets Study Criteria|1
4644414|NCT02015520|7521313|FG002|Overall Study|Subject no Longer Meets Study Criteria|0
4644415|NCT02015520|7521314|FG003|Overall Study|Subject no Longer Meets Study Criteria|0
4644416|NCT02015546|7521327|FG000|Overall Study|Withdrawal by Subject|1
4644417|NCT02015546|7521328|FG001|Overall Study|Withdrawal by Subject|1
4644418|NCT02015546|7521329|FG002|Overall Study|Withdrawal by Subject|1
4644419|NCT02015546|7521327|FG000|Overall Study|Screem Failure|2
4644420|NCT02015546|7521328|FG001|Overall Study|Screem Failure|1
4644421|NCT02015546|7521329|FG002|Overall Study|Screem Failure|3
4644422|NCT02015637|7521339|FG000|Overall Study|Lost to Follow-up|3
4644423|NCT02015637|7521340|FG001|Overall Study|Lost to Follow-up|5
4644424|NCT02015637|7521339|FG000|Overall Study|Adverse Event|3
4644425|NCT02015637|7521340|FG001|Overall Study|Adverse Event|0
4644426|NCT02015637|7521339|FG000|Overall Study|Did not take study drug|2
4644427|NCT02015637|7521340|FG001|Overall Study|Did not take study drug|0
4644428|NCT02015676|7521349|FG000|Overall Study|Adverse Event|2
4644429|NCT02015676|7521350|FG001|Overall Study|Adverse Event|18
4644430|NCT02015676|7521351|FG002|Overall Study|Adverse Event|0
4644431|NCT02015676|7521349|FG000|Overall Study|Lack of Efficacy|2
4644432|NCT02015676|7521350|FG001|Overall Study|Lack of Efficacy|4
4644433|NCT02015676|7521351|FG002|Overall Study|Lack of Efficacy|0
4644434|NCT02015676|7521349|FG000|Overall Study|Protocol Violation|1
4644435|NCT02015676|7521350|FG001|Overall Study|Protocol Violation|0
4644436|NCT02015676|7521351|FG002|Overall Study|Protocol Violation|0
4644437|NCT02015676|7521349|FG000|Overall Study|Withdrawal by Subject|1
4644438|NCT02015676|7521350|FG001|Overall Study|Withdrawal by Subject|7
4644439|NCT02015676|7521351|FG002|Overall Study|Withdrawal by Subject|1
4644440|NCT02015676|7521349|FG000|Overall Study|Administrative reasons|0
4644441|NCT02015676|7521350|FG001|Overall Study|Administrative reasons|3
4644442|NCT02015676|7521351|FG002|Overall Study|Administrative reasons|1
4644443|NCT02015676|7521349|FG000|Overall Study|Death|0
4644444|NCT02015676|7521350|FG001|Overall Study|Death|1
4644445|NCT02015676|7521351|FG002|Overall Study|Death|0
4644446|NCT02015676|7521349|FG000|Overall Study|Disease progression|3
4644447|NCT02015676|7521350|FG001|Overall Study|Disease progression|1
4644448|NCT02015676|7521351|FG002|Overall Study|Disease progression|1
4644449|NCT02015754|7521355|FG000|Overall Study|Disease progression|5
4644450|NCT02015754|7521355|FG000|Overall Study|Change in treatment modality|5
4644451|NCT02015754|7521355|FG000|Overall Study|Lost to Follow-up|1
4644452|NCT02015793|7521361|FG000|Overall Study|Adverse Event|3
4644453|NCT02015793|7521362|FG001|Overall Study|Adverse Event|3
4644454|NCT02015793|7521361|FG000|Overall Study|Withdrawal by Subject|1
4644455|NCT02015793|7521362|FG001|Overall Study|Withdrawal by Subject|1
4644456|NCT02015819|7521378|FG000|Overall Study|Rickham catheter was misaligned|0
4644457|NCT02015819|7521379|FG001|Overall Study|Rickham catheter was misaligned|0
4644458|NCT02015819|7521380|FG002|Overall Study|Rickham catheter was misaligned|0
4644459|NCT02015819|7521381|FG003|Overall Study|Rickham catheter was misaligned|1
4644460|NCT02016105|7521397|FG000|TREATMENT PERIOD 1|Protocol Violation|2
4644461|NCT02016105|7521398|FG001|TREATMENT PERIOD 1|Protocol Violation|8
4644462|NCT02016105|7521399|FG002|TREATMENT PERIOD 1|Protocol Violation|0
4644463|NCT02016105|7521400|FG003|TREATMENT PERIOD 1|Protocol Violation|0
4644464|NCT02016105|7521401|FG004|TREATMENT PERIOD 1|Protocol Violation|0
4644465|NCT02016105|7521402|FG005|TREATMENT PERIOD 1|Protocol Violation|0
4644466|NCT02016105|7521397|FG000|TREATMENT PERIOD 1|Physician Decision|0
4644467|NCT02016105|7521398|FG001|TREATMENT PERIOD 1|Physician Decision|2
4644468|NCT02016105|7521399|FG002|TREATMENT PERIOD 1|Physician Decision|0
4644469|NCT02016105|7521400|FG003|TREATMENT PERIOD 1|Physician Decision|0
4644470|NCT02016105|7521401|FG004|TREATMENT PERIOD 1|Physician Decision|0
4644471|NCT02016105|7521402|FG005|TREATMENT PERIOD 1|Physician Decision|0
4644472|NCT02016105|7521397|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4
4644473|NCT02016105|7521398|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2
4644474|NCT02016105|7521399|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0
4644475|NCT02016105|7521400|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0
4644476|NCT02016105|7521401|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0
4644477|NCT02016105|7521402|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0
4644478|NCT02016105|7521397|FG000|TREATMENT PERIOD 1|Pregnancy|0
4644479|NCT02016105|7521398|FG001|TREATMENT PERIOD 1|Pregnancy|1
4644480|NCT02016105|7521399|FG002|TREATMENT PERIOD 1|Pregnancy|0
4644481|NCT02016105|7521400|FG003|TREATMENT PERIOD 1|Pregnancy|0
4644482|NCT02016105|7521401|FG004|TREATMENT PERIOD 1|Pregnancy|0
4644483|NCT02016105|7521402|FG005|TREATMENT PERIOD 1|Pregnancy|0
4644484|NCT02016105|7521397|FG000|TREATMENT PERIOD 1|Adverse Event|3
4644485|NCT02016105|7521398|FG001|TREATMENT PERIOD 1|Adverse Event|5
4644486|NCT02016105|7521399|FG002|TREATMENT PERIOD 1|Adverse Event|0
4644487|NCT02016105|7521400|FG003|TREATMENT PERIOD 1|Adverse Event|0
4644488|NCT02016105|7521401|FG004|TREATMENT PERIOD 1|Adverse Event|0
4644489|NCT02016105|7521402|FG005|TREATMENT PERIOD 1|Adverse Event|0
4644490|NCT02016105|7521397|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15
4644491|NCT02016105|7521398|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11
4644492|NCT02016105|7521399|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0
4644493|NCT02016105|7521400|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0
4644494|NCT02016105|7521401|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0
4644495|NCT02016105|7521402|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0
4644496|NCT02016105|7521397|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6
4644497|NCT02016105|7521398|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4
4644498|NCT02016105|7521399|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0
4644499|NCT02016105|7521400|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0
4644500|NCT02016105|7521401|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0
4644501|NCT02016105|7521402|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0
4644502|NCT02016105|7521397|FG000|TREATMENT PERIOD 2|Non compliance study medication|0
4644503|NCT02016105|7521398|FG001|TREATMENT PERIOD 2|Non compliance study medication|0
4644504|NCT02016105|7521399|FG002|TREATMENT PERIOD 2|Non compliance study medication|0
4644505|NCT02016105|7521400|FG003|TREATMENT PERIOD 2|Non compliance study medication|0
4644506|NCT02016105|7521401|FG004|TREATMENT PERIOD 2|Non compliance study medication|0
4644507|NCT02016105|7521402|FG005|TREATMENT PERIOD 2|Non compliance study medication|1
4644508|NCT02016105|7521397|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0
4644509|NCT02016105|7521398|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0
4644510|NCT02016105|7521399|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2
4644511|NCT02016105|7521400|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6
4644512|NCT02016105|7521401|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3
4644513|NCT02016105|7521402|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2
4644514|NCT02016105|7521397|FG000|TREATMENT PERIOD 2|Pregnancy|0
4644515|NCT02016105|7521398|FG001|TREATMENT PERIOD 2|Pregnancy|0
4644516|NCT02016105|7521399|FG002|TREATMENT PERIOD 2|Pregnancy|0
4644517|NCT02016105|7521400|FG003|TREATMENT PERIOD 2|Pregnancy|0
4644518|NCT02016105|7521401|FG004|TREATMENT PERIOD 2|Pregnancy|0
4644519|NCT02016105|7521402|FG005|TREATMENT PERIOD 2|Pregnancy|1
4644520|NCT02016105|7521397|FG000|TREATMENT PERIOD 2|Death|0
4644521|NCT02016105|7521398|FG001|TREATMENT PERIOD 2|Death|0
4644522|NCT02016105|7521399|FG002|TREATMENT PERIOD 2|Death|0
4644523|NCT02016105|7521400|FG003|TREATMENT PERIOD 2|Death|0
4644524|NCT02016105|7521401|FG004|TREATMENT PERIOD 2|Death|0
4644525|NCT02016105|7521402|FG005|TREATMENT PERIOD 2|Death|1
4644526|NCT02016105|7521397|FG000|TREATMENT PERIOD 2|Adverse Event|0
4644527|NCT02016105|7521398|FG001|TREATMENT PERIOD 2|Adverse Event|0
4644528|NCT02016105|7521399|FG002|TREATMENT PERIOD 2|Adverse Event|0
4644529|NCT02016105|7521400|FG003|TREATMENT PERIOD 2|Adverse Event|4
4644530|NCT02016105|7521401|FG004|TREATMENT PERIOD 2|Adverse Event|0
4644531|NCT02016105|7521402|FG005|TREATMENT PERIOD 2|Adverse Event|1
4644532|NCT02016105|7521397|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0
4644533|NCT02016105|7521398|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0
4644534|NCT02016105|7521399|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3
4644535|NCT02016105|7521400|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1
4644536|NCT02016105|7521401|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1
4644537|NCT02016105|7521402|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7
4644538|NCT02016105|7521397|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0
4644539|NCT02016105|7521398|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0
4644540|NCT02016105|7521399|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1
4644541|NCT02016105|7521400|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0
4644542|NCT02016105|7521401|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0
4644543|NCT02016105|7521402|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1
4644544|NCT02016105|7521397|FG000|EXTENSION PERIOD|New therapy for study indication|0
4644545|NCT02016105|7521398|FG001|EXTENSION PERIOD|New therapy for study indication|0
4644546|NCT02016105|7521399|FG002|EXTENSION PERIOD|New therapy for study indication|0
4644547|NCT02016105|7521400|FG003|EXTENSION PERIOD|New therapy for study indication|0
4644548|NCT02016105|7521401|FG004|EXTENSION PERIOD|New therapy for study indication|1
4644549|NCT02016105|7521402|FG005|EXTENSION PERIOD|New therapy for study indication|1
4644550|NCT02016105|7521397|FG000|EXTENSION PERIOD|Lack of Efficacy|0
4644551|NCT02016105|7521398|FG001|EXTENSION PERIOD|Lack of Efficacy|0
4644552|NCT02016105|7521399|FG002|EXTENSION PERIOD|Lack of Efficacy|1
4644553|NCT02016105|7521400|FG003|EXTENSION PERIOD|Lack of Efficacy|3
4644554|NCT02016105|7521401|FG004|EXTENSION PERIOD|Lack of Efficacy|1
4644555|NCT02016105|7521402|FG005|EXTENSION PERIOD|Lack of Efficacy|1
4644556|NCT02016105|7521397|FG000|EXTENSION PERIOD|Adverse Event|0
4644557|NCT02016105|7521398|FG001|EXTENSION PERIOD|Adverse Event|0
4644558|NCT02016105|7521399|FG002|EXTENSION PERIOD|Adverse Event|2
4644559|NCT02016105|7521400|FG003|EXTENSION PERIOD|Adverse Event|0
4644560|NCT02016105|7521401|FG004|EXTENSION PERIOD|Adverse Event|1
4644561|NCT02016105|7521402|FG005|EXTENSION PERIOD|Adverse Event|0
4644562|NCT02016105|7521397|FG000|EXTENSION PERIOD|Withdrawal by Subject|0
4644563|NCT02016105|7521398|FG001|EXTENSION PERIOD|Withdrawal by Subject|0
4644564|NCT02016105|7521399|FG002|EXTENSION PERIOD|Withdrawal by Subject|2
4644565|NCT02016105|7521400|FG003|EXTENSION PERIOD|Withdrawal by Subject|2
4644566|NCT02016105|7521401|FG004|EXTENSION PERIOD|Withdrawal by Subject|2
4644567|NCT02016105|7521402|FG005|EXTENSION PERIOD|Withdrawal by Subject|2
4644568|NCT02016105|7521397|FG000|EXTENSION PERIOD|Non-compliance with study indication|0
4644569|NCT02016105|7521398|FG001|EXTENSION PERIOD|Non-compliance with study indication|0
4644570|NCT02016105|7521399|FG002|EXTENSION PERIOD|Non-compliance with study indication|0
4644571|NCT02016105|7521400|FG003|EXTENSION PERIOD|Non-compliance with study indication|0
4644572|NCT02016105|7521401|FG004|EXTENSION PERIOD|Non-compliance with study indication|1
4644573|NCT02016105|7521402|FG005|EXTENSION PERIOD|Non-compliance with study indication|0
4644574|NCT02016105|7521397|FG000|EXTENSION PERIOD|Lost to Follow-up|0
4644575|NCT02016105|7521398|FG001|EXTENSION PERIOD|Lost to Follow-up|0
4644576|NCT02016105|7521399|FG002|EXTENSION PERIOD|Lost to Follow-up|0
4644577|NCT02016105|7521400|FG003|EXTENSION PERIOD|Lost to Follow-up|0
4644578|NCT02016105|7521401|FG004|EXTENSION PERIOD|Lost to Follow-up|0
4644579|NCT02016105|7521402|FG005|EXTENSION PERIOD|Lost to Follow-up|2
4644580|NCT02016170|7521419|FG000|Overall Study|Adverse Event|1
4644581|NCT02016170|7521420|FG001|Overall Study|Adverse Event|1
4644582|NCT02016170|7521421|FG002|Overall Study|Adverse Event|0
4644583|NCT02016170|7521419|FG000|Overall Study|Protocol Violation|1
4644584|NCT02016170|7521420|FG001|Overall Study|Protocol Violation|0
4644585|NCT02016170|7521421|FG002|Overall Study|Protocol Violation|0
4644586|NCT02016183|7521428|FG000|Overall Study|Case Report Forms Uncollected|13
4644587|NCT02016183|7521428|FG000|Overall Study|Protocol Violation|52
4644588|NCT02016300|7521447|FG000|Overall Study|Lost to Follow-up|0
4644589|NCT02016300|7521448|FG001|Overall Study|Lost to Follow-up|3
4644590|NCT02016482|7521456|FG000|Period A|Adverse Event|3
4644591|NCT02016482|7521457|FG001|Period A|Adverse Event|5
4644592|NCT02016482|7521456|FG000|Period A|Withdrawal by Subject|3
4644593|NCT02016482|7521457|FG001|Period A|Withdrawal by Subject|4
4644594|NCT02016482|7521456|FG000|Period A|Lost to Follow-up|3
4644595|NCT02016482|7521457|FG001|Period A|Lost to Follow-up|3
4644596|NCT02016482|7521456|FG000|Period A|Lack of Efficacy|2
4644597|NCT02016482|7521457|FG001|Period A|Lack of Efficacy|1
4644598|NCT02016482|7521456|FG000|Period A|Other|3
4644599|NCT02016482|7521457|FG001|Period A|Other|0
4644600|NCT02016482|7521456|FG000|Period A|Protocol Violation|0
4644601|NCT02016482|7521457|FG001|Period A|Protocol Violation|1
4644602|NCT02016482|7521456|FG000|Period A|Required Alternative/Prohibited Therapy|0
4644603|NCT02016482|7521457|FG001|Period A|Required Alternative/Prohibited Therapy|1
4644604|NCT02016482|7521456|FG000|Period B|Withdrawal by Subject|1
4644605|NCT02016482|7521457|FG001|Period B|Withdrawal by Subject|1
4644606|NCT02016482|7521456|FG000|Period B|Lost to Follow-up|2
4644607|NCT02016482|7521457|FG001|Period B|Lost to Follow-up|0
4644608|NCT02016482|7521456|FG000|Period B|Lack of Efficacy|6
4644609|NCT02016482|7521457|FG001|Period B|Lack of Efficacy|4
4644610|NCT02016482|7521456|FG000|Period B|Other|4
4644611|NCT02016482|7521457|FG001|Period B|Other|0
4644612|NCT02016482|7521456|FG000|Period B|Required Alternative/Prohibited Therapy|0
4644613|NCT02016482|7521457|FG001|Period B|Required Alternative/Prohibited Therapy|2
4644614|NCT02016625|7521517|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0
4644615|NCT02016625|7521518|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1
4644616|NCT02016625|7521517|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1
4644617|NCT02016625|7521518|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0
4644618|NCT02016625|7521517|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2
4644619|NCT02016625|7521518|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0
4644620|NCT02016690|7521534|FG000|Overall Study|Excluded from SAS: Enrollment violation|2
4644621|NCT02016690|7521534|FG000|Overall Study|Excluded from SAS: Duplication|2
4644622|NCT02016690|7521534|FG000|Overall Study|Excluded from SAS: Early treatment|2
4644623|NCT02016690|7521534|FG000|Overall Study|Excluded from SAS: Ineligible for study|2
4644624|NCT02016690|7521534|FG000|Overall Study|Did not meet inclusion criteria|13
4644625|NCT02016690|7521534|FG000|Overall Study|Hospitalized for RSV at study start|3
4644626|NCT02016716|7521541|FG000|Overall Study|Withdrawal by Subject|5
4644627|NCT02016716|7521542|FG001|Overall Study|Withdrawal by Subject|5
4644628|NCT02016716|7521543|FG002|Overall Study|Withdrawal by Subject|5
4644629|NCT02016716|7521541|FG000|Overall Study|Protocol-specified Criteria|0
4644630|NCT02016716|7521542|FG001|Overall Study|Protocol-specified Criteria|1
4644631|NCT02016716|7521543|FG002|Overall Study|Protocol-specified Criteria|0
4644632|NCT02016716|7521541|FG000|Overall Study|Lost to Follow-up|1
4644633|NCT02016716|7521542|FG001|Overall Study|Lost to Follow-up|2
4644634|NCT02016716|7521543|FG002|Overall Study|Lost to Follow-up|1
4644635|NCT02016755|7521552|FG000|Overall Study|Major amputation of index limb|2
4644636|NCT02016755|7521552|FG000|Overall Study|Adverse Event|2
4644637|NCT02016755|7521552|FG000|Overall Study|Physician Decision|1
4644638|NCT02016755|7521552|FG000|Overall Study|Death|2
4644639|NCT02016898|7521579|FG000|Overall Study|Death|1
4644640|NCT02016898|7521580|FG001|Overall Study|Death|1
4644641|NCT02016898|7521579|FG000|Overall Study|Lost to Follow-up|4
4644642|NCT02016898|7521580|FG001|Overall Study|Lost to Follow-up|4
4644643|NCT02017015|7521591|FG000|Overall Study|Adverse Event|9
4644644|NCT02017015|7521591|FG000|Overall Study|Withdrawal by Subject|21
4644645|NCT02017015|7521591|FG000|Overall Study|Death|4
4644646|NCT02017015|7521591|FG000|Overall Study|Progressive Disease|31
4644647|NCT02017015|7521591|FG000|Overall Study|Non-compliance with study drug|2
4644648|NCT02017015|7521591|FG000|Overall Study|Physician Decision|2
4644649|NCT02017171|7521609|FG000|Overall Study|Death|10
4644650|NCT02017171|7521610|FG001|Overall Study|Death|4
4644651|NCT02017171|7521609|FG000|Overall Study|Withdrawal by Subject|23
4644652|NCT02017171|7521610|FG001|Overall Study|Withdrawal by Subject|17
4644653|NCT02017171|7521609|FG000|Overall Study|Lost to Follow-up|21
4644654|NCT02017171|7521610|FG001|Overall Study|Lost to Follow-up|20
4644655|NCT02017171|7521609|FG000|Overall Study|ESKD|6
4644656|NCT02017171|7521610|FG001|Overall Study|ESKD|2
4644657|NCT02017171|7521609|FG000|Overall Study|Miscellaneous|2
4644658|NCT02017171|7521610|FG001|Overall Study|Miscellaneous|3
4644659|NCT02017223|7521633|FG000|Overall Study|Algorithm problems|2
4644660|NCT02017444|7521652|FG000|Overall Study|Physician Decision|1
4644661|NCT02017444|7521653|FG001|Overall Study|Physician Decision|0
4644662|NCT02017444|7521652|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1
4644663|NCT02017444|7521653|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0
4644664|NCT02017535|7521663|FG000|Overall Study|Withdrawal by Subject|1
4644665|NCT02017535|7521664|FG001|Overall Study|Withdrawal by Subject|0
4644666|NCT02017535|7521665|FG002|Overall Study|Withdrawal by Subject|0
4644667|NCT02017535|7521666|FG003|Overall Study|Withdrawal by Subject|0
4644668|NCT02017860|7521685|FG000|Overall Study|Adverse Event|1
4644669|NCT02017860|7521685|FG000|Overall Study|Withdrawal by Subject|1
4644670|NCT02017899|7521695|FG000|Overall Study|Withdrawal by Subject|0
4644671|NCT02017899|7521696|FG001|Overall Study|Withdrawal by Subject|0
4644672|NCT02017899|7521697|FG002|Overall Study|Withdrawal by Subject|0
4644673|NCT02017899|7521698|FG003|Overall Study|Withdrawal by Subject|1
4644674|NCT02017899|7521699|FG004|Overall Study|Withdrawal by Subject|1
4644675|NCT02017899|7521700|FG005|Overall Study|Withdrawal by Subject|0
4644676|NCT02018042|7521714|FG000|Overall Study|Withdrawal by Subject|1
4747447|NCT00345358|7721485|FG003|Primary Vaccination Phase|Lost to Follow-up|2
4747448|NCT00345358|7721482|FG000|Booster Vaccination Phase|Withdrawal by Subject|1
4747449|NCT00345358|7721483|FG001|Booster Vaccination Phase|Withdrawal by Subject|0
4747450|NCT00345358|7721484|FG002|Booster Vaccination Phase|Withdrawal by Subject|0
4747451|NCT00345358|7721485|FG003|Booster Vaccination Phase|Withdrawal by Subject|0
4747452|NCT00345358|7721482|FG000|Booster Vaccination Phase|Lost to Follow-up|3
4747453|NCT00345358|7721483|FG001|Booster Vaccination Phase|Lost to Follow-up|0
4747454|NCT00345358|7721484|FG002|Booster Vaccination Phase|Lost to Follow-up|0
4747455|NCT00345358|7721485|FG003|Booster Vaccination Phase|Lost to Follow-up|0
4644677|NCT02018458|7521733|FG000|Overall Study|Death|4
4644678|NCT02018562|7521739|FG000|Overall Study|Withdrawal by Subject|2
4644679|NCT02018562|7521740|FG001|Overall Study|Withdrawal by Subject|0
4644680|NCT02018562|7521739|FG000|Overall Study|Discharged prior to study completion|1
4644681|NCT02018562|7521740|FG001|Overall Study|Discharged prior to study completion|0
4644682|NCT02018822|7521783|FG000|Overall Study|filling replaced by crown|0
4644683|NCT02018822|7521784|FG001|Overall Study|filling replaced by crown|1
4644684|NCT02018822|7521785|FG002|Overall Study|filling replaced by crown|0
4644685|NCT02018822|7521783|FG000|Overall Study|Physician Decision|0
4644686|NCT02018822|7521784|FG001|Overall Study|Physician Decision|1
4644687|NCT02018822|7521785|FG002|Overall Study|Physician Decision|1
4644688|NCT02018822|7521783|FG000|Overall Study|Lost to Follow-up|6
4644689|NCT02018822|7521784|FG001|Overall Study|Lost to Follow-up|6
4644690|NCT02018822|7521785|FG002|Overall Study|Lost to Follow-up|5
4644691|NCT02018887|7521804|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1
4644692|NCT02018887|7521805|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0
4644693|NCT02018887|7521806|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0
4644694|NCT02018887|7521807|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0
4644695|NCT02018887|7521808|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0
4644696|NCT02018887|7521809|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0
4644697|NCT02018887|7521810|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0
4644698|NCT02018887|7521811|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0
4644699|NCT02018887|7521812|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0
4644700|NCT02018887|7521813|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0
4644701|NCT02018887|7521814|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0
4644702|NCT02018887|7521804|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0
4644703|NCT02018887|7521805|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0
4644704|NCT02018887|7521806|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0
4644705|NCT02018887|7521807|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0
4644706|NCT02018887|7521808|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1
4644707|NCT02018887|7521809|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0
4747456|NCT00372229|7721501|FG000|Study Phase|Graft loss|0
4747457|NCT00372229|7721502|FG001|Study Phase|Graft loss|3
4747458|NCT00372229|7721501|FG000|Study Phase|Protocol Violation|3
4747459|NCT00372229|7721502|FG001|Study Phase|Protocol Violation|4
4747460|NCT00372229|7721501|FG000|Study Phase|Consent withdrawn|16
4747461|NCT00372229|7721502|FG001|Study Phase|Consent withdrawn|14
4747462|NCT00372229|7721501|FG000|Study Phase|Refused treatment/did not cooperate|3
4747463|NCT00372229|7721502|FG001|Study Phase|Refused treatment/did not cooperate|1
4747464|NCT00372229|7721501|FG000|Study Phase|Death|3
4747465|NCT00372229|7721502|FG001|Study Phase|Death|2
4747466|NCT00372229|7721501|FG000|Study Phase|Reason not specified|3
4747467|NCT00372229|7721502|FG001|Study Phase|Reason not specified|2
4747468|NCT00372229|7721501|FG000|Study Phase|Lost to Follow-up|3
4747469|NCT00372229|7721502|FG001|Study Phase|Lost to Follow-up|3
4747470|NCT00372229|7721501|FG000|Follow-Up Phase|Graft loss|8
4747471|NCT00372229|7721502|FG001|Follow-Up Phase|Graft loss|7
4747472|NCT00372229|7721501|FG000|Follow-Up Phase|Consent withdrawn|13
4747473|NCT00372229|7721502|FG001|Follow-Up Phase|Consent withdrawn|19
4747474|NCT00372229|7721501|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0
4747475|NCT00372229|7721502|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1
4747476|NCT00372229|7721501|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1
4747477|NCT00372229|7721502|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0
4747478|NCT00372229|7721501|FG000|Follow-Up Phase|Death|9
4747479|NCT00372229|7721502|FG001|Follow-Up Phase|Death|12
4747480|NCT00372229|7721501|FG000|Follow-Up Phase|Administrative|1
4747481|NCT00372229|7721502|FG001|Follow-Up Phase|Administrative|0
4747482|NCT00372229|7721501|FG000|Follow-Up Phase|Reason not specified|2
4747483|NCT00372229|7721502|FG001|Follow-Up Phase|Reason not specified|3
4747484|NCT00372229|7721501|FG000|Follow-Up Phase|Lost to Follow-up|12
4747485|NCT00372229|7721502|FG001|Follow-Up Phase|Lost to Follow-up|10
4747486|NCT00383708|7721512|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1
4747487|NCT00383708|7721512|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32
4747488|NCT00383708|7721512|FG000|Run-in Period|Protocol Violation|4
4747489|NCT00383708|7721512|FG000|Run-in Period|Adverse Event|2
4747490|NCT00383708|7721512|FG000|Run-in Period|Claustrophobia|1
4747491|NCT00383708|7721512|FG000|Co-administration Period|Adverse Event|5
4747492|NCT00413699|7721519|FG000|Initial Period|Death|25
4747493|NCT00413699|7721520|FG001|Initial Period|Death|30
4747494|NCT00413699|7721521|FG002|Initial Period|Death|0
4747495|NCT00413699|7721519|FG000|Initial Period|Lack of Efficacy|59
4747496|NCT00413699|7721520|FG001|Initial Period|Lack of Efficacy|115
4747497|NCT00413699|7721521|FG002|Initial Period|Lack of Efficacy|0
4747498|NCT00413699|7721519|FG000|Initial Period|Lost to Follow-up|31
4747499|NCT00413699|7721520|FG001|Initial Period|Lost to Follow-up|101
4747500|NCT00413699|7721521|FG002|Initial Period|Lost to Follow-up|0
4747501|NCT00413699|7721519|FG000|Initial Period|Protocol Violation|38
4747502|NCT00413699|7721520|FG001|Initial Period|Protocol Violation|89
4644708|NCT02018887|7521810|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1
4644709|NCT02018887|7521811|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4
4644710|NCT02018887|7521812|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0
4644711|NCT02018887|7521813|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0
4747503|NCT00413699|7721521|FG002|Initial Period|Protocol Violation|0
4644712|NCT02018887|7521814|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0
4644713|NCT02018887|7521804|FG000|Part C: Cohort 8 Overall|Adverse Event|0
4644714|NCT02018887|7521805|FG001|Part C: Cohort 8 Overall|Adverse Event|0
4644715|NCT02018887|7521806|FG002|Part C: Cohort 8 Overall|Adverse Event|0
4644716|NCT02018887|7521807|FG003|Part C: Cohort 8 Overall|Adverse Event|0
4644717|NCT02018887|7521808|FG004|Part C: Cohort 8 Overall|Adverse Event|0
4644718|NCT02018887|7521809|FG005|Part C: Cohort 8 Overall|Adverse Event|0
4644719|NCT02018887|7521810|FG006|Part C: Cohort 8 Overall|Adverse Event|0
4644720|NCT02018887|7521811|FG007|Part C: Cohort 8 Overall|Adverse Event|0
4644721|NCT02018887|7521812|FG008|Part C: Cohort 8 Overall|Adverse Event|1
4644722|NCT02018887|7521813|FG009|Part C: Cohort 8 Overall|Adverse Event|3
4644723|NCT02018887|7521814|FG010|Part C: Cohort 8 Overall|Adverse Event|0
4644724|NCT02018887|7521804|FG000|Part C: Cohort 8 Overall|Physician Decision|0
4644725|NCT02018887|7521805|FG001|Part C: Cohort 8 Overall|Physician Decision|0
4644726|NCT02018887|7521806|FG002|Part C: Cohort 8 Overall|Physician Decision|0
4644727|NCT02018887|7521807|FG003|Part C: Cohort 8 Overall|Physician Decision|0
4644728|NCT02018887|7521808|FG004|Part C: Cohort 8 Overall|Physician Decision|0
4644729|NCT02018887|7521809|FG005|Part C: Cohort 8 Overall|Physician Decision|0
4644730|NCT02018887|7521810|FG006|Part C: Cohort 8 Overall|Physician Decision|0
4644731|NCT02018887|7521811|FG007|Part C: Cohort 8 Overall|Physician Decision|0
4644732|NCT02018887|7521812|FG008|Part C: Cohort 8 Overall|Physician Decision|2
4644733|NCT02018887|7521813|FG009|Part C: Cohort 8 Overall|Physician Decision|0
4644734|NCT02018887|7521814|FG010|Part C: Cohort 8 Overall|Physician Decision|1
4644735|NCT02019108|7521886|FG000|Overall Study|Lost to Follow-up|5
4644736|NCT02019108|7521887|FG001|Overall Study|Lost to Follow-up|7
4644737|NCT02019264|7521895|FG000|Overall Study|Not treated|6
4644738|NCT02019264|7521896|FG001|Overall Study|Not treated|4
4644739|NCT02019264|7521895|FG000|Overall Study|Lost to Follow-up|50
4644740|NCT02019264|7521896|FG001|Overall Study|Lost to Follow-up|47
4644741|NCT02019264|7521895|FG000|Overall Study|Withdrawal by Subject|142
4644742|NCT02019264|7521896|FG001|Overall Study|Withdrawal by Subject|117
4644743|NCT02019264|7521895|FG000|Overall Study|Administrative reason|36
4644744|NCT02019264|7521896|FG001|Overall Study|Administrative reason|28
4644745|NCT02019264|7521895|FG000|Overall Study|Missing|14
4644746|NCT02019264|7521896|FG001|Overall Study|Missing|11
4644747|NCT02019277|7521902|FG000|Overall Study|Withdrawal by Subject|3
4644748|NCT02019277|7521902|FG000|Overall Study|Death|7
4644749|NCT02019277|7521902|FG000|Overall Study|Did no Cooperate|1
4644750|NCT02019277|7521902|FG000|Overall Study|Adverse Event|1
4644751|NCT02019420|7521908|FG000|Overall Study|Did not receive study drug|2
4644752|NCT02019420|7521909|FG001|Overall Study|Did not receive study drug|2
4644753|NCT02019420|7521908|FG000|Overall Study|Withdrawal by Subject|1
4644754|NCT02019420|7521909|FG001|Overall Study|Withdrawal by Subject|3
4644755|NCT02019420|7521908|FG000|Overall Study|At request of sponsor or investigator|0
4644756|NCT02019420|7521909|FG001|Overall Study|At request of sponsor or investigator|1
4644757|NCT02019420|7521908|FG000|Overall Study|Death|104
4644758|NCT02019420|7521909|FG001|Overall Study|Death|99
4644759|NCT02019420|7521908|FG000|Overall Study|Transferred to other care facility|1
4644760|NCT02019420|7521909|FG001|Overall Study|Transferred to other care facility|1
4644761|NCT02019472|7521918|FG000|Overall Study|Adverse Event|14
4644762|NCT02019472|7521919|FG001|Overall Study|Adverse Event|23
4644763|NCT02019472|7521920|FG002|Overall Study|Adverse Event|17
4644764|NCT02019472|7521918|FG000|Overall Study|Death|0
4644765|NCT02019472|7521919|FG001|Overall Study|Death|1
4644766|NCT02019472|7521920|FG002|Overall Study|Death|1
4644767|NCT02019472|7521918|FG000|Overall Study|Lack of Efficacy|7
4644768|NCT02019472|7521919|FG001|Overall Study|Lack of Efficacy|4
4644769|NCT02019472|7521920|FG002|Overall Study|Lack of Efficacy|4
4644770|NCT02019472|7521918|FG000|Overall Study|Lost to Follow-up|0
4644771|NCT02019472|7521919|FG001|Overall Study|Lost to Follow-up|2
4644772|NCT02019472|7521920|FG002|Overall Study|Lost to Follow-up|1
4644773|NCT02019472|7521918|FG000|Overall Study|Physician Decision|1
4644774|NCT02019472|7521919|FG001|Overall Study|Physician Decision|2
4644775|NCT02019472|7521920|FG002|Overall Study|Physician Decision|0
4644776|NCT02019472|7521918|FG000|Overall Study|Pregnancy|1
4644777|NCT02019472|7521919|FG001|Overall Study|Pregnancy|2
4644778|NCT02019472|7521920|FG002|Overall Study|Pregnancy|2
4644779|NCT02019472|7521918|FG000|Overall Study|Withdrawal by Subject|11
4644780|NCT02019472|7521919|FG001|Overall Study|Withdrawal by Subject|10
4644781|NCT02019472|7521920|FG002|Overall Study|Withdrawal by Subject|11
4644782|NCT02019472|7521918|FG000|Overall Study|Other|3
4644783|NCT02019472|7521919|FG001|Overall Study|Other|8
4644784|NCT02019472|7521920|FG002|Overall Study|Other|6
4644785|NCT02019550|7521934|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0
4644786|NCT02019550|7521935|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1
4644787|NCT02019602|7521956|FG000|Screening Period|Ineligibility|4
4644788|NCT02019602|7521957|FG001|Screening Period|Ineligibility|0
4644789|NCT02019602|7521956|FG000|Screening Period|Adverse Event|1
4644790|NCT02019602|7521957|FG001|Screening Period|Adverse Event|0
4644791|NCT02019667|7521964|FG000|First Intervention (6 Months)|Adverse Event|0
4644792|NCT02019667|7521965|FG001|First Intervention (6 Months)|Adverse Event|1
4644793|NCT02019667|7521964|FG000|2nd Intervention (6 Months)|Adverse Event|0
4644794|NCT02019667|7521965|FG001|2nd Intervention (6 Months)|Adverse Event|1
4644795|NCT02019667|7521964|FG000|2nd Intervention (6 Months)|Physician Decision|0
4644796|NCT02019667|7521965|FG001|2nd Intervention (6 Months)|Physician Decision|1
4644797|NCT02019719|7521978|FG000|Overall Study|Adverse Event|1
4644798|NCT02019719|7521979|FG001|Overall Study|Adverse Event|0
4644799|NCT02019719|7521980|FG002|Overall Study|Adverse Event|0
4644800|NCT02019719|7521981|FG003|Overall Study|Adverse Event|1
4644801|NCT02019719|7521982|FG004|Overall Study|Adverse Event|1
4644802|NCT02019719|7521978|FG000|Overall Study|Protocol Violation|1
4644803|NCT02019719|7521979|FG001|Overall Study|Protocol Violation|1
4644804|NCT02019719|7521980|FG002|Overall Study|Protocol Violation|0
4644805|NCT02019719|7521981|FG003|Overall Study|Protocol Violation|0
4644806|NCT02019719|7521982|FG004|Overall Study|Protocol Violation|0
4644807|NCT02019719|7521978|FG000|Overall Study|Protocol defined stopping criteria|2
4644808|NCT02019719|7521979|FG001|Overall Study|Protocol defined stopping criteria|0
4644809|NCT02019719|7521980|FG002|Overall Study|Protocol defined stopping criteria|0
4644810|NCT02019719|7521981|FG003|Overall Study|Protocol defined stopping criteria|1
4644811|NCT02019719|7521982|FG004|Overall Study|Protocol defined stopping criteria|1
4644812|NCT02019719|7521978|FG000|Overall Study|Physician Decision|2
4644813|NCT02019719|7521979|FG001|Overall Study|Physician Decision|0
4644814|NCT02019719|7521980|FG002|Overall Study|Physician Decision|0
4644815|NCT02019719|7521981|FG003|Overall Study|Physician Decision|0
4644816|NCT02019719|7521982|FG004|Overall Study|Physician Decision|0
4644817|NCT02019927|7522029|FG000|Overall Study|Lost to Follow-up|2
4644818|NCT02019927|7522030|FG001|Overall Study|Lost to Follow-up|4
4644819|NCT02019927|7522031|FG002|Overall Study|Lost to Follow-up|1
4644820|NCT02019927|7522032|FG003|Overall Study|Lost to Follow-up|2
4644821|NCT02019927|7522033|FG004|Overall Study|Lost to Follow-up|3
4644822|NCT02019927|7522034|FG005|Overall Study|Lost to Follow-up|1
4747504|NCT00413699|7721519|FG000|Initial Period|Pregnancy|10
4747505|NCT00413699|7721520|FG001|Initial Period|Pregnancy|8
4747506|NCT00413699|7721521|FG002|Initial Period|Pregnancy|0
4747507|NCT00413699|7721519|FG000|Initial Period|Did not meet entrance criteria|2
4747508|NCT00413699|7721520|FG001|Initial Period|Did not meet entrance criteria|2
4747509|NCT00413699|7721521|FG002|Initial Period|Did not meet entrance criteria|0
4747510|NCT00413699|7721519|FG000|Initial Period|Medication error without adverse event|0
4747511|NCT00413699|7721520|FG001|Initial Period|Medication error without adverse event|1
4747512|NCT00413699|7721521|FG002|Initial Period|Medication error without adverse event|0
4747513|NCT00413699|7721519|FG000|Initial Period|Study terminated by Sponsor|0
4747514|NCT00413699|7721520|FG001|Initial Period|Study terminated by Sponsor|1
4747515|NCT00413699|7721521|FG002|Initial Period|Study terminated by Sponsor|0
4747516|NCT00413699|7721519|FG000|Initial Period|Other|67
4747517|NCT00413699|7721520|FG001|Initial Period|Other|211
4747518|NCT00413699|7721521|FG002|Initial Period|Other|0
4747519|NCT00413699|7721519|FG000|Initial Period|Adverse event related to study drug|178
4747520|NCT00413699|7721520|FG001|Initial Period|Adverse event related to study drug|527
4747521|NCT00413699|7721521|FG002|Initial Period|Adverse event related to study drug|0
4747522|NCT00413699|7721519|FG000|Initial Period|Adverse event not related to study drug|113
4747523|NCT00413699|7721520|FG001|Initial Period|Adverse event not related to study drug|248
4747524|NCT00413699|7721521|FG002|Initial Period|Adverse event not related to study drug|0
4747525|NCT00413699|7721519|FG000|Initial Period|Missing end of study page|0
4747526|NCT00413699|7721520|FG001|Initial Period|Missing end of study page|4
4747527|NCT00413699|7721521|FG002|Initial Period|Missing end of study page|0
4747528|NCT00413699|7721519|FG000|Initial Period|No longer willing to participate|116
4747529|NCT00413699|7721520|FG001|Initial Period|No longer willing to participate|368
4747530|NCT00413699|7721521|FG002|Initial Period|No longer willing to participate|0
4747531|NCT00413699|7721519|FG000|Extension Period|No Longer Willing to Participate|0
4747532|NCT00413699|7721520|FG001|Extension Period|No Longer Willing to Participate|0
4747533|NCT00413699|7721521|FG002|Extension Period|No Longer Willing to Participate|2
4747534|NCT00413699|7721519|FG000|Extension Period|Protocol Violation|0
4747535|NCT00413699|7721520|FG001|Extension Period|Protocol Violation|0
4747536|NCT00413699|7721521|FG002|Extension Period|Protocol Violation|1
4747537|NCT00413699|7721519|FG000|Extension Period|Adverse Event|0
4747538|NCT00413699|7721520|FG001|Extension Period|Adverse Event|0
4747539|NCT00413699|7721521|FG002|Extension Period|Adverse Event|2
4644823|NCT02019979|7522056|FG000|Overall Study|study terminated|14
4644824|NCT02020031|7522071|FG000|Overall Study|Physician Decision|1
4644825|NCT02020031|7522072|FG001|Overall Study|Physician Decision|1
4644826|NCT02020512|7522127|FG000|Overall Study|Adverse Event|1
4644827|NCT02020512|7522127|FG000|Overall Study|Lost to Follow-up|3
4644828|NCT02020512|7522127|FG000|Overall Study|Protocol Violation|4
4644829|NCT02020577|7522133|FG000|Overall Study|Progressive disease|3
4644830|NCT02020577|7522134|FG001|Overall Study|Progressive disease|38
4644831|NCT02020577|7522133|FG000|Overall Study|Other AE or clinical progression|0
4644832|NCT02020577|7522134|FG001|Overall Study|Other AE or clinical progression|15
4644833|NCT02020577|7522133|FG000|Overall Study|Withdrawal by Subject|0
4644834|NCT02020577|7522134|FG001|Overall Study|Withdrawal by Subject|1
4644835|NCT02020577|7522133|FG000|Overall Study|Other than stated above|0
4644836|NCT02020577|7522134|FG001|Overall Study|Other than stated above|1
4644837|NCT02020616|7522153|FG000|Overall Study|Adverse Event|0
4644838|NCT02020616|7522154|FG001|Overall Study|Adverse Event|0
4644839|NCT02020616|7522155|FG002|Overall Study|Adverse Event|0
4644840|NCT02020616|7522156|FG003|Overall Study|Adverse Event|0
4644841|NCT02020616|7522157|FG004|Overall Study|Adverse Event|0
4644842|NCT02020616|7522158|FG005|Overall Study|Adverse Event|1
4644843|NCT02020616|7522159|FG006|Overall Study|Adverse Event|1
4644844|NCT02020616|7522153|FG000|Overall Study|Physician Decision|0
4644845|NCT02020616|7522154|FG001|Overall Study|Physician Decision|0
4644846|NCT02020616|7522155|FG002|Overall Study|Physician Decision|0
4644847|NCT02020616|7522156|FG003|Overall Study|Physician Decision|0
4644848|NCT02020616|7522157|FG004|Overall Study|Physician Decision|0
4644849|NCT02020616|7522158|FG005|Overall Study|Physician Decision|1
4644850|NCT02020616|7522159|FG006|Overall Study|Physician Decision|2
4644851|NCT02020616|7522153|FG000|Overall Study|Withdrawal by Subject|0
4644852|NCT02020616|7522154|FG001|Overall Study|Withdrawal by Subject|0
4644853|NCT02020616|7522155|FG002|Overall Study|Withdrawal by Subject|1
4644854|NCT02020616|7522156|FG003|Overall Study|Withdrawal by Subject|0
4644855|NCT02020616|7522157|FG004|Overall Study|Withdrawal by Subject|0
4644856|NCT02020616|7522158|FG005|Overall Study|Withdrawal by Subject|1
4644857|NCT02020616|7522159|FG006|Overall Study|Withdrawal by Subject|1
4644858|NCT02020616|7522153|FG000|Overall Study|Lost to Follow-up|0
4644859|NCT02020616|7522154|FG001|Overall Study|Lost to Follow-up|1
4644860|NCT02020616|7522155|FG002|Overall Study|Lost to Follow-up|0
4644861|NCT02020616|7522156|FG003|Overall Study|Lost to Follow-up|1
4644862|NCT02020616|7522157|FG004|Overall Study|Lost to Follow-up|1
4644863|NCT02020616|7522158|FG005|Overall Study|Lost to Follow-up|1
4644864|NCT02020616|7522159|FG006|Overall Study|Lost to Follow-up|0
4644865|NCT02020616|7522153|FG000|Overall Study|Early Termination Criteria Met|0
4644866|NCT02020616|7522154|FG001|Overall Study|Early Termination Criteria Met|0
4644867|NCT02020616|7522155|FG002|Overall Study|Early Termination Criteria Met|1
4644868|NCT02020616|7522156|FG003|Overall Study|Early Termination Criteria Met|0
4644869|NCT02020616|7522157|FG004|Overall Study|Early Termination Criteria Met|0
4644870|NCT02020616|7522158|FG005|Overall Study|Early Termination Criteria Met|1
4644871|NCT02020616|7522159|FG006|Overall Study|Early Termination Criteria Met|0
4644872|NCT02020616|7522153|FG000|Overall Study|Randomized in Error|0
4644873|NCT02020616|7522154|FG001|Overall Study|Randomized in Error|0
4644874|NCT02020616|7522155|FG002|Overall Study|Randomized in Error|0
4644875|NCT02020616|7522156|FG003|Overall Study|Randomized in Error|1
4644876|NCT02020616|7522157|FG004|Overall Study|Randomized in Error|0
4644877|NCT02020616|7522158|FG005|Overall Study|Randomized in Error|0
4644878|NCT02020616|7522159|FG006|Overall Study|Randomized in Error|0
4644879|NCT02020616|7522153|FG000|Overall Study|Lack of Efficacy|0
4644880|NCT02020616|7522154|FG001|Overall Study|Lack of Efficacy|0
4644881|NCT02020616|7522155|FG002|Overall Study|Lack of Efficacy|0
4644882|NCT02020616|7522156|FG003|Overall Study|Lack of Efficacy|0
4644883|NCT02020616|7522157|FG004|Overall Study|Lack of Efficacy|1
4644884|NCT02020616|7522158|FG005|Overall Study|Lack of Efficacy|0
4644885|NCT02020616|7522159|FG006|Overall Study|Lack of Efficacy|0
4644886|NCT02020863|7522198|FG000|Overall Study|Discovery of Metastatic disease|4
4644887|NCT02020863|7522198|FG000|Overall Study|Team chose not to place an a line|1
4644888|NCT02020889|7522204|FG000|Overall Study|Adverse Event|0
4644889|NCT02020889|7522205|FG001|Overall Study|Adverse Event|1
4644890|NCT02020889|7522204|FG000|Overall Study|Lack of Efficacy|1
4644891|NCT02020889|7522205|FG001|Overall Study|Lack of Efficacy|0
4644892|NCT02020889|7522204|FG000|Overall Study|Lost to Follow-up|1
4644893|NCT02020889|7522205|FG001|Overall Study|Lost to Follow-up|0
4644894|NCT02020889|7522204|FG000|Overall Study|Physician Decision|2
4644895|NCT02020889|7522205|FG001|Overall Study|Physician Decision|0
4644896|NCT02020889|7522204|FG000|Overall Study|Withdrawal by Subject|3
4644897|NCT02020889|7522205|FG001|Overall Study|Withdrawal by Subject|2
4644898|NCT02020941|7522211|FG000|Overall Study|Adverse Event|1
4644899|NCT02020941|7522211|FG000|Overall Study|Physician Decision|2
4644900|NCT02020941|7522211|FG000|Overall Study|Withdrawal by Subject|1
4644901|NCT02020941|7522211|FG000|Overall Study|Disease Progression|4
4644902|NCT02020967|7522217|FG000|Overall Study|Withdrawal by Subject|51
4644903|NCT02021292|7522225|FG000|Overall Study|Physician Decision|0
4644904|NCT02021292|7522226|FG001|Overall Study|Physician Decision|1
4644905|NCT02021292|7522225|FG000|Overall Study|Lost to Follow-up|0
4644906|NCT02021292|7522226|FG001|Overall Study|Lost to Follow-up|1
4644907|NCT02021292|7522225|FG000|Overall Study|Death|0
4644908|NCT02021292|7522226|FG001|Overall Study|Death|1
4644909|NCT02021318|7522236|FG000|Overall Study|Adverse Event|2
4644910|NCT02021318|7522237|FG001|Overall Study|Adverse Event|1
4644911|NCT02021318|7522236|FG000|Overall Study|Death|33
4644912|NCT02021318|7522237|FG001|Overall Study|Death|34
4644913|NCT02021318|7522236|FG000|Overall Study|Lost to Follow-up|3
4644914|NCT02021318|7522237|FG001|Overall Study|Lost to Follow-up|3
4644915|NCT02021318|7522236|FG000|Overall Study|Progressive Disease|0
4644916|NCT02021318|7522237|FG001|Overall Study|Progressive Disease|1
4644917|NCT02021318|7522236|FG000|Overall Study|Withdrawal by Subject|30
4644918|NCT02021318|7522237|FG001|Overall Study|Withdrawal by Subject|18
4644919|NCT02021318|7522236|FG000|Overall Study|Physician Decision|3
4644920|NCT02021318|7522237|FG001|Overall Study|Physician Decision|3
4644921|NCT02021318|7522236|FG000|Overall Study|Miscellaneous|2
4644922|NCT02021318|7522237|FG001|Overall Study|Miscellaneous|3
4644923|NCT02021331|7522246|FG000|Overall Study|Adverse Event|0
4644924|NCT02021331|7522247|FG001|Overall Study|Adverse Event|2
4644925|NCT02021565|7522261|FG000|Baseline Through Intervention|Death|0
4644926|NCT02021565|7522262|FG001|Baseline Through Intervention|Death|1
4644927|NCT02021565|7522261|FG000|Baseline Through Intervention|Withdrawal by Subject|8
4644928|NCT02021565|7522262|FG001|Baseline Through Intervention|Withdrawal by Subject|8
4644929|NCT02021565|7522261|FG000|Baseline Through Intervention|Protocol Violation|0
4644930|NCT02021565|7522262|FG001|Baseline Through Intervention|Protocol Violation|7
4644931|NCT02021565|7522261|FG000|Baseline Through Intervention|Lost to Follow-up|4
4644932|NCT02021565|7522262|FG001|Baseline Through Intervention|Lost to Follow-up|2
4644933|NCT02021565|7522261|FG000|3-month Follow-up|Death|3
4644934|NCT02021565|7522262|FG001|3-month Follow-up|Death|0
4644935|NCT02021565|7522261|FG000|3-month Follow-up|Withdrawal by Subject|4
4644936|NCT02021565|7522262|FG001|3-month Follow-up|Withdrawal by Subject|0
4644937|NCT02021565|7522261|FG000|3-month Follow-up|Protocol Violation|3
4644938|NCT02021565|7522262|FG001|3-month Follow-up|Protocol Violation|2
4644939|NCT02021643|7522276|FG000|Overall Study|Enrolled but Never Treated|1
4644940|NCT02021643|7522277|FG001|Overall Study|Enrolled but Never Treated|0
4644941|NCT02021643|7522278|FG002|Overall Study|Enrolled but Never Treated|0
4644942|NCT02021643|7522279|FG003|Overall Study|Enrolled but Never Treated|0
4644943|NCT02021643|7522276|FG000|Overall Study|Adverse Event|0
4644944|NCT02021643|7522277|FG001|Overall Study|Adverse Event|1
4644945|NCT02021643|7522278|FG002|Overall Study|Adverse Event|0
4644946|NCT02021643|7522279|FG003|Overall Study|Adverse Event|0
4644947|NCT02021643|7522276|FG000|Overall Study|Death|0
4644948|NCT02021643|7522277|FG001|Overall Study|Death|1
4644949|NCT02021643|7522278|FG002|Overall Study|Death|0
4644950|NCT02021643|7522279|FG003|Overall Study|Death|0
4644951|NCT02021643|7522276|FG000|Overall Study|Investigator's Discretion|1
4644952|NCT02021643|7522277|FG001|Overall Study|Investigator's Discretion|0
4644953|NCT02021643|7522278|FG002|Overall Study|Investigator's Discretion|0
4644954|NCT02021643|7522279|FG003|Overall Study|Investigator's Discretion|0
4644955|NCT02021643|7522276|FG000|Overall Study|Lack of Efficacy|7
4644956|NCT02021643|7522277|FG001|Overall Study|Lack of Efficacy|6
4644957|NCT02021643|7522278|FG002|Overall Study|Lack of Efficacy|0
4644958|NCT02021643|7522279|FG003|Overall Study|Lack of Efficacy|12
4644959|NCT02021643|7522276|FG000|Overall Study|Lost to Follow-up|0
4644960|NCT02021643|7522277|FG001|Overall Study|Lost to Follow-up|1
4644961|NCT02021643|7522278|FG002|Overall Study|Lost to Follow-up|0
4644962|NCT02021643|7522279|FG003|Overall Study|Lost to Follow-up|0
4644963|NCT02021643|7522276|FG000|Overall Study|Withdrew Consent|0
4644964|NCT02021643|7522277|FG001|Overall Study|Withdrew Consent|1
4644965|NCT02021643|7522278|FG002|Overall Study|Withdrew Consent|0
4644966|NCT02021643|7522279|FG003|Overall Study|Withdrew Consent|0
4644967|NCT02021656|7522295|FG000|Overall Study|Adverse Event|1
4644968|NCT02021656|7522295|FG000|Overall Study|Lack of Efficacy|2
4644969|NCT02021656|7522295|FG000|Overall Study|Lost to Follow-up|1
4644970|NCT02021656|7522295|FG000|Overall Study|Withdrew Consent|2
4644971|NCT02021812|7522312|FG000|Overall Study|Death|8
4644972|NCT02021812|7522312|FG000|Overall Study|Withdrawal by Subject|3
4644973|NCT02021812|7522312|FG000|Overall Study|Lost to Follow-up|1
4644974|NCT02021812|7522312|FG000|Overall Study|Refuse to return, COVD 19, in hospice, and didn't return for visit|4
4644975|NCT02021812|7522312|FG000|Overall Study|Still in study|6
4644976|NCT02022007|7522342|FG000|Overall Study|Withdrawal by Subject|1
4644977|NCT02022007|7522343|FG001|Overall Study|Withdrawal by Subject|1
4644978|NCT02022007|7522344|FG002|Overall Study|Withdrawal by Subject|1
4644979|NCT02022007|7522342|FG000|Overall Study|Noncompliant|0
4644980|NCT02022007|7522343|FG001|Overall Study|Noncompliant|0
4644981|NCT02022007|7522344|FG002|Overall Study|Noncompliant|1
4644982|NCT02022033|7522356|FG000|Overall Study|Physician Decision|1
4644983|NCT02022657|7522375|FG000|Overall Study|Withdrawal by Subject|2
4644984|NCT02022657|7522376|FG001|Overall Study|Withdrawal by Subject|0
4644985|NCT02022657|7522377|FG002|Overall Study|Withdrawal by Subject|1
4644986|NCT02022657|7522378|FG003|Overall Study|Withdrawal by Subject|0
4644987|NCT02022657|7522379|FG004|Overall Study|Withdrawal by Subject|0
4644988|NCT02022657|7522380|FG005|Overall Study|Withdrawal by Subject|0
4644989|NCT02022657|7522375|FG000|Overall Study|Physician Decision|0
4644990|NCT02022657|7522376|FG001|Overall Study|Physician Decision|0
4644991|NCT02022657|7522377|FG002|Overall Study|Physician Decision|0
4644992|NCT02022657|7522378|FG003|Overall Study|Physician Decision|0
4644993|NCT02022657|7522379|FG004|Overall Study|Physician Decision|0
4644994|NCT02022657|7522380|FG005|Overall Study|Physician Decision|1
4644995|NCT02022670|7522389|FG000|Overall Study|Adverse Event|1
4644996|NCT02022670|7522390|FG001|Overall Study|Adverse Event|0
4644997|NCT02022670|7522391|FG002|Overall Study|Adverse Event|1
4644998|NCT02022748|7522412|FG000|Overall Study|Adverse Event|1
4644999|NCT02022748|7522413|FG001|Overall Study|Adverse Event|1
4645000|NCT02022748|7522414|FG002|Overall Study|Adverse Event|0
4645001|NCT02022748|7522412|FG000|Overall Study|Withdrawal by Subject|0
4645002|NCT02022748|7522413|FG001|Overall Study|Withdrawal by Subject|1
4645003|NCT02022748|7522414|FG002|Overall Study|Withdrawal by Subject|0
4645004|NCT02023099|7522429|FG000|Overall Study|Non-fatal Adverse Event (AE)|0
4645005|NCT02023099|7522430|FG001|Overall Study|Non-fatal Adverse Event (AE)|0
4645006|NCT02023099|7522431|FG002|Overall Study|Non-fatal Adverse Event (AE)|1
4645007|NCT02023099|7522429|FG000|Overall Study|Withdrawn Consent|3
4645008|NCT02023099|7522430|FG001|Overall Study|Withdrawn Consent|0
4645009|NCT02023099|7522431|FG002|Overall Study|Withdrawn Consent|1
4645010|NCT02023099|7522429|FG000|Overall Study|Non-treatment-emergent Fatal AE|0
4645011|NCT02023099|7522430|FG001|Overall Study|Non-treatment-emergent Fatal AE|0
4645012|NCT02023099|7522431|FG002|Overall Study|Non-treatment-emergent Fatal AE|1
4645013|NCT02023112|7522441|FG000|Overall Study|Withdrawal by Subject|2
4645014|NCT02023112|7522442|FG001|Overall Study|Withdrawal by Subject|1
4645015|NCT02023151|7522466|FG000|Overall Study|Lost to Follow-up|4
4645016|NCT02023242|7522472|FG000|Overall Study|Lost to Follow-up|3
4645017|NCT02023242|7522473|FG001|Overall Study|Lost to Follow-up|1
4645018|NCT02023242|7522472|FG000|Overall Study|Death|0
4645019|NCT02023242|7522473|FG001|Overall Study|Death|1
4645020|NCT02023268|7522481|FG000|Overall Study|Lack of Efficacy|0
4645021|NCT02023268|7522482|FG001|Overall Study|Lack of Efficacy|1
4645022|NCT02023268|7522481|FG000|Overall Study|Adverse Event|0
4645023|NCT02023268|7522482|FG001|Overall Study|Adverse Event|2
4645024|NCT02023268|7522481|FG000|Overall Study|Withdrawal by Subject|0
4645025|NCT02023268|7522482|FG001|Overall Study|Withdrawal by Subject|1
4645026|NCT02023697|7522510|FG000|Treatment Period|Radiological progression|13
4645027|NCT02023697|7522511|FG001|Treatment Period|Radiological progression|17
4645028|NCT02023697|7522512|FG002|Treatment Period|Radiological progression|26
4645029|NCT02023697|7522510|FG000|Treatment Period|Never Treated|5
4645030|NCT02023697|7522511|FG001|Treatment Period|Never Treated|6
4645031|NCT02023697|7522512|FG002|Treatment Period|Never Treated|10
4645032|NCT02023697|7522510|FG000|Treatment Period|Adverse Event|13
4645033|NCT02023697|7522511|FG001|Treatment Period|Adverse Event|25
4645034|NCT02023697|7522512|FG002|Treatment Period|Adverse Event|23
4645035|NCT02023697|7522510|FG000|Treatment Period|Logistical difficulties|1
4645036|NCT02023697|7522511|FG001|Treatment Period|Logistical difficulties|1
4645037|NCT02023697|7522512|FG002|Treatment Period|Logistical difficulties|1
4645038|NCT02023697|7522510|FG000|Treatment Period|Clinical progression|10
4645039|NCT02023697|7522511|FG001|Treatment Period|Clinical progression|8
4645040|NCT02023697|7522512|FG002|Treatment Period|Clinical progression|28
4645041|NCT02023697|7522510|FG000|Treatment Period|Withdrawal by Subject|4
4645042|NCT02023697|7522511|FG001|Treatment Period|Withdrawal by Subject|5
4645043|NCT02023697|7522512|FG002|Treatment Period|Withdrawal by Subject|13
4645044|NCT02023697|7522510|FG000|Treatment Period|Safety outcome reached|0
4645045|NCT02023697|7522511|FG001|Treatment Period|Safety outcome reached|1
4645046|NCT02023697|7522512|FG002|Treatment Period|Safety outcome reached|0
4645047|NCT02023697|7522510|FG000|Treatment Period|Physician Decision|0
4645048|NCT02023697|7522511|FG001|Treatment Period|Physician Decision|0
4645049|NCT02023697|7522512|FG002|Treatment Period|Physician Decision|1
4645050|NCT02023697|7522510|FG000|Active Follow-up Period|Withdrawal by Subject|5
4645051|NCT02023697|7522511|FG001|Active Follow-up Period|Withdrawal by Subject|13
4645052|NCT02023697|7522512|FG002|Active Follow-up Period|Withdrawal by Subject|7
4645053|NCT02023697|7522510|FG000|Active Follow-up Period|Lost to Follow-up|1
4645054|NCT02023697|7522511|FG001|Active Follow-up Period|Lost to Follow-up|1
4645055|NCT02023697|7522512|FG002|Active Follow-up Period|Lost to Follow-up|1
4645056|NCT02023697|7522510|FG000|Active Follow-up Period|Deterioration of general condition|1
4645057|NCT02023697|7522511|FG001|Active Follow-up Period|Deterioration of general condition|1
4645058|NCT02023697|7522512|FG002|Active Follow-up Period|Deterioration of general condition|1
4645059|NCT02023697|7522510|FG000|Active Follow-up Period|Other unspecified|2
4645060|NCT02023697|7522511|FG001|Active Follow-up Period|Other unspecified|0
4645061|NCT02023697|7522512|FG002|Active Follow-up Period|Other unspecified|1
4645062|NCT02023697|7522510|FG000|Active Follow-up Period|Clinical progression|0
4645063|NCT02023697|7522511|FG001|Active Follow-up Period|Clinical progression|2
4645064|NCT02023697|7522512|FG002|Active Follow-up Period|Clinical progression|1
4645065|NCT02023697|7522510|FG000|Active Follow-up Period|Radiological progression|0
4645066|NCT02023697|7522511|FG001|Active Follow-up Period|Radiological progression|0
4645067|NCT02023697|7522512|FG002|Active Follow-up Period|Radiological progression|1
4645068|NCT02023697|7522510|FG000|Active Follow-up Period|Death|83
4645069|NCT02023697|7522511|FG001|Active Follow-up Period|Death|82
4645070|NCT02023697|7522512|FG002|Active Follow-up Period|Death|87
4645071|NCT02023697|7522510|FG000|Long-term Follow-up Period|Death|9
4645072|NCT02023697|7522511|FG001|Long-term Follow-up Period|Death|6
4645073|NCT02023697|7522512|FG002|Long-term Follow-up Period|Death|4
4645074|NCT02023697|7522510|FG000|Long-term Follow-up Period|Withdrawal by Subject|6
4645075|NCT02023697|7522511|FG001|Long-term Follow-up Period|Withdrawal by Subject|3
4645076|NCT02023697|7522512|FG002|Long-term Follow-up Period|Withdrawal by Subject|0
4645077|NCT02023697|7522510|FG000|Long-term Follow-up Period|Lost to Follow-up|1
4645078|NCT02023697|7522511|FG001|Long-term Follow-up Period|Lost to Follow-up|0
4645079|NCT02023697|7522512|FG002|Long-term Follow-up Period|Lost to Follow-up|1
4645080|NCT02023697|7522510|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6
4645081|NCT02023697|7522511|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9
4645082|NCT02023697|7522512|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6
4645083|NCT02023697|7522510|FG000|Long-term Follow-up Period|Technical problems|0
4645084|NCT02023697|7522511|FG001|Long-term Follow-up Period|Technical problems|0
4645085|NCT02023697|7522512|FG002|Long-term Follow-up Period|Technical problems|1
4645086|NCT02023697|7522510|FG000|Long-term Follow-up Period|Other unspecified|6
4645087|NCT02023697|7522511|FG001|Long-term Follow-up Period|Other unspecified|3
4645088|NCT02023697|7522512|FG002|Long-term Follow-up Period|Other unspecified|5
4645089|NCT02023866|7522531|FG000|Overall Study|Non-compliance|2
4645090|NCT02023866|7522531|FG000|Overall Study|Adverse Event|3
4645091|NCT02023866|7522531|FG000|Overall Study|Withdrawal by Subject|1
4645092|NCT02023879|7522538|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2
4645093|NCT02023879|7522539|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2
4645094|NCT02023879|7522540|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5
4645095|NCT02023879|7522538|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0
4645096|NCT02023879|7522539|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2
4645097|NCT02023879|7522540|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1
4645098|NCT02023879|7522538|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0
4645099|NCT02023879|7522539|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1
4645100|NCT02023879|7522540|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0
4645101|NCT02023879|7522538|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1
4645102|NCT02023879|7522539|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0
4645103|NCT02023879|7522540|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1
4645104|NCT02023879|7522538|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0
4645105|NCT02023879|7522539|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1
4645106|NCT02023879|7522540|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1
4645107|NCT02023879|7522538|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1
4645108|NCT02023879|7522539|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3
4645109|NCT02023879|7522540|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1
4645110|NCT02023879|7522538|FG000|Extension Open Label Treatment|Adverse Event|1
4645111|NCT02023879|7522539|FG001|Extension Open Label Treatment|Adverse Event|7
4645112|NCT02023879|7522540|FG002|Extension Open Label Treatment|Adverse Event|3
4645113|NCT02023879|7522538|FG000|Extension Open Label Treatment|Poor compliance to protocol|1
4645114|NCT02023879|7522539|FG001|Extension Open Label Treatment|Poor compliance to protocol|1
4645115|NCT02023879|7522540|FG002|Extension Open Label Treatment|Poor compliance to protocol|0
4645116|NCT02023879|7522538|FG000|Extension Open Label Treatment|Participant moved|1
4645117|NCT02023879|7522539|FG001|Extension Open Label Treatment|Participant moved|2
4645118|NCT02023879|7522540|FG002|Extension Open Label Treatment|Participant moved|0
4645119|NCT02023879|7522538|FG000|Extension Open Label Treatment|Other than specified above|2
4645120|NCT02023879|7522539|FG001|Extension Open Label Treatment|Other than specified above|7
4645121|NCT02023879|7522540|FG002|Extension Open Label Treatment|Other than specified above|2
4645122|NCT02024698|7522638|FG000|First Intervention (7 Days)|Withdrawal by Subject|0
4645123|NCT02024698|7522639|FG001|First Intervention (7 Days)|Withdrawal by Subject|1
4645124|NCT02024750|7522665|FG000|Overall Study|Withdrawal by Subject|2
4645125|NCT02024750|7522666|FG001|Overall Study|Withdrawal by Subject|1
4645126|NCT02024867|7522674|FG000|Overall Study|Protocol Violation|3
4645127|NCT02024867|7522675|FG001|Overall Study|Protocol Violation|3
4645128|NCT02024867|7522674|FG000|Overall Study|Lost to Follow-up|6
4645129|NCT02024867|7522675|FG001|Overall Study|Lost to Follow-up|4
4645130|NCT02024932|7522687|FG000|Overall Study|Adverse Event|2
4645131|NCT02024932|7522688|FG001|Overall Study|Adverse Event|3
4645132|NCT02024932|7522689|FG002|Overall Study|Adverse Event|0
4645133|NCT02024932|7522690|FG003|Overall Study|Adverse Event|0
4645134|NCT02024932|7522691|FG004|Overall Study|Adverse Event|2
4645135|NCT02024932|7522692|FG005|Overall Study|Adverse Event|0
4645136|NCT02024932|7522687|FG000|Overall Study|Abnormal laboratory value|0
4645137|NCT02024932|7522688|FG001|Overall Study|Abnormal laboratory value|0
4645138|NCT02024932|7522689|FG002|Overall Study|Abnormal laboratory value|0
4645139|NCT02024932|7522690|FG003|Overall Study|Abnormal laboratory value|2
4645140|NCT02024932|7522691|FG004|Overall Study|Abnormal laboratory value|0
4645141|NCT02024932|7522692|FG005|Overall Study|Abnormal laboratory value|0
4645142|NCT02024971|7522712|FG000|Overall Study|Data Not Available|30
4645143|NCT02024971|7522712|FG000|Overall Study|Lost to Follow-up|6
4645144|NCT02025179|7522734|FG000|Overall Study|Lost to Follow-up|0
4645145|NCT02025179|7522735|FG001|Overall Study|Lost to Follow-up|0
4645146|NCT02025179|7522736|FG002|Overall Study|Lost to Follow-up|1
4645147|NCT02025205|7522746|FG000|Overall Study|Withdrawal by Subject|1
4645148|NCT02025205|7522747|FG001|Overall Study|Withdrawal by Subject|1
4645149|NCT02025205|7522746|FG000|Overall Study|Protocol Violation|2
4645150|NCT02025205|7522747|FG001|Overall Study|Protocol Violation|1
4645151|NCT02025205|7522746|FG000|Overall Study|Death|0
4645152|NCT02025205|7522747|FG001|Overall Study|Death|1
4645153|NCT02025530|7522775|FG000|Overall Study|No longer met elligibility criteria|5
4645154|NCT02025530|7522776|FG001|Overall Study|No longer met elligibility criteria|1
4645155|NCT02025621|7522784|FG000|Overall Study|Withdrawal by Subject|1
4645156|NCT02025621|7522785|FG001|Overall Study|Withdrawal by Subject|0
4645157|NCT02025621|7522784|FG000|Overall Study|Death|0
4645158|NCT02025621|7522785|FG001|Overall Study|Death|1
4645159|NCT02025621|7522784|FG000|Overall Study|No longer eligible|10
4645160|NCT02025621|7522785|FG001|Overall Study|No longer eligible|15
4645161|NCT02025621|7522784|FG000|Overall Study|Surgery initiated before infusion|3
4645162|NCT02025621|7522785|FG001|Overall Study|Surgery initiated before infusion|3
4747540|NCT00436826|7721559|FG000|Double Blind Period (DBP)|Adverse Event|2
4747541|NCT00436826|7721560|FG001|Double Blind Period (DBP)|Adverse Event|0
4747542|NCT00436826|7721561|FG002|Double Blind Period (DBP)|Adverse Event|0
4747543|NCT00436826|7721562|FG003|Double Blind Period (DBP)|Adverse Event|0
4747544|NCT00436826|7721563|FG004|Double Blind Period (DBP)|Adverse Event|0
4747545|NCT00436826|7721564|FG005|Double Blind Period (DBP)|Adverse Event|0
4747546|NCT00436826|7721559|FG000|Double Blind Period (DBP)|Protocol Violation|1
4747547|NCT00436826|7721560|FG001|Double Blind Period (DBP)|Protocol Violation|0
4747548|NCT00436826|7721561|FG002|Double Blind Period (DBP)|Protocol Violation|0
4747549|NCT00436826|7721562|FG003|Double Blind Period (DBP)|Protocol Violation|0
4747550|NCT00436826|7721563|FG004|Double Blind Period (DBP)|Protocol Violation|0
4747551|NCT00436826|7721564|FG005|Double Blind Period (DBP)|Protocol Violation|0
4747552|NCT00436826|7721559|FG000|Double Blind Period (DBP)|Other|10
4747553|NCT00436826|7721560|FG001|Double Blind Period (DBP)|Other|11
4747554|NCT00436826|7721561|FG002|Double Blind Period (DBP)|Other|0
4747555|NCT00436826|7721562|FG003|Double Blind Period (DBP)|Other|0
4747556|NCT00436826|7721563|FG004|Double Blind Period (DBP)|Other|0
4747557|NCT00436826|7721564|FG005|Double Blind Period (DBP)|Other|0
4747558|NCT00436826|7721559|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0
4747559|NCT00436826|7721560|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0
4747560|NCT00436826|7721561|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0
4747561|NCT00436826|7721562|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1
4747562|NCT00436826|7721563|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0
4747563|NCT00436826|7721564|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0
4747564|NCT00436826|7721559|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0
4747565|NCT00436826|7721560|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0
4747566|NCT00436826|7721561|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46
4747567|NCT00436826|7721562|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25
4747568|NCT00436826|7721563|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0
4747569|NCT00436826|7721564|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0
4747570|NCT00436826|7721559|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
4747571|NCT00436826|7721560|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
4747572|NCT00436826|7721561|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
4747573|NCT00436826|7721562|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
4747574|NCT00436826|7721563|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51
4747575|NCT00436826|7721564|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7
4747576|NCT00442546|7721583|FG000|Overall Study|Adverse Event|11
4747577|NCT00442546|7721584|FG001|Overall Study|Adverse Event|17
4747578|NCT00442546|7721585|FG002|Overall Study|Adverse Event|13
4747579|NCT00442546|7721583|FG000|Overall Study|Lost to Follow-up|1
4747580|NCT00442546|7721584|FG001|Overall Study|Lost to Follow-up|2
4747581|NCT00442546|7721585|FG002|Overall Study|Lost to Follow-up|1
4747582|NCT00442546|7721583|FG000|Overall Study|Other|4
4747583|NCT00442546|7721584|FG001|Overall Study|Other|9
4747584|NCT00442546|7721585|FG002|Overall Study|Other|6
4747585|NCT00442546|7721583|FG000|Overall Study|Withdrawal by Subject|5
4747586|NCT00442546|7721584|FG001|Overall Study|Withdrawal by Subject|5
4747587|NCT00442546|7721585|FG002|Overall Study|Withdrawal by Subject|7
4747588|NCT00442546|7721583|FG000|Overall Study|Randomized But Not Treated|5
4747589|NCT00442546|7721584|FG001|Overall Study|Randomized But Not Treated|4
4747590|NCT00442546|7721585|FG002|Overall Study|Randomized But Not Treated|6
4747591|NCT04715932|7721597|FG000|Overall Study|Lost to Follow-up|1
4747592|NCT04715932|7721598|FG001|Overall Study|Lost to Follow-up|0
4747593|NCT04666441|7721612|FG000|Overall Study|Lost to Follow-up|1
4747594|NCT04666441|7721613|FG001|Overall Study|Lost to Follow-up|4
4747595|NCT04666441|7721614|FG002|Overall Study|Lost to Follow-up|1
4747596|NCT04666441|7721615|FG003|Overall Study|Lost to Follow-up|3
4747597|NCT04666441|7721616|FG004|Overall Study|Lost to Follow-up|0
4747598|NCT04666441|7721617|FG005|Overall Study|Lost to Follow-up|2
4747599|NCT04666441|7721618|FG006|Overall Study|Lost to Follow-up|2
4747600|NCT04666441|7721619|FG007|Overall Study|Lost to Follow-up|2
4747601|NCT04666441|7721612|FG000|Overall Study|Subject Decision|1
4747602|NCT04666441|7721613|FG001|Overall Study|Subject Decision|1
4747603|NCT04666441|7721614|FG002|Overall Study|Subject Decision|3
4747604|NCT04666441|7721615|FG003|Overall Study|Subject Decision|1
4747605|NCT04666441|7721616|FG004|Overall Study|Subject Decision|0
4747606|NCT04666441|7721617|FG005|Overall Study|Subject Decision|1
4747607|NCT04666441|7721618|FG006|Overall Study|Subject Decision|3
4747608|NCT04666441|7721619|FG007|Overall Study|Subject Decision|2
4747609|NCT04274192|7721673|FG000|Overall Study|Protocol Violation|1
4747610|NCT04274192|7721674|FG001|Overall Study|Protocol Violation|0
4747611|NCT04259346|7721684|FG000|Overall Study|Lost to Follow-up|1
4747612|NCT04259346|7721685|FG001|Overall Study|Lost to Follow-up|3
4747613|NCT04259346|7721684|FG000|Overall Study|Protocol Violation|1
4747614|NCT04259346|7721685|FG001|Overall Study|Protocol Violation|0
4645163|NCT02025725|7522806|FG000|Overall Study|Adverse Event|5
4645164|NCT02025725|7522807|FG001|Overall Study|Adverse Event|0
4645165|NCT02025725|7522806|FG000|Overall Study|Lost to Follow-up|2
4645166|NCT02025725|7522807|FG001|Overall Study|Lost to Follow-up|0
4645167|NCT02025725|7522806|FG000|Overall Study|Protocol Violation|1
4645168|NCT02025725|7522807|FG001|Overall Study|Protocol Violation|1
4645169|NCT02025725|7522806|FG000|Overall Study|Withdrawal by Subject|3
4645170|NCT02025725|7522807|FG001|Overall Study|Withdrawal by Subject|2
4645171|NCT02025725|7522806|FG000|Overall Study|Post-dose QTcB > 270 msec|0
4645172|NCT02025725|7522807|FG001|Overall Study|Post-dose QTcB > 270 msec|1
4645173|NCT02025751|7522817|FG000|Overall Study|Lost to Follow-up|1
4645174|NCT02025751|7522818|FG001|Overall Study|Lost to Follow-up|0
4645175|NCT02025751|7522817|FG000|Overall Study|Adverse Event|0
4645176|NCT02025751|7522818|FG001|Overall Study|Adverse Event|1
4645177|NCT02025751|7522817|FG000|Overall Study|Physician Decision|0
4645178|NCT02025751|7522818|FG001|Overall Study|Physician Decision|1
4645179|NCT02025751|7522817|FG000|Overall Study|Withdrawal by Subject|0
4645180|NCT02025751|7522818|FG001|Overall Study|Withdrawal by Subject|1
4645181|NCT02025907|7522836|FG000|Overall Study|Lack of Efficacy|1
4645182|NCT02025907|7522837|FG001|Overall Study|Lack of Efficacy|0
4645183|NCT02025907|7522836|FG000|Overall Study|Withdrawal by Subject|15
4645184|NCT02025907|7522837|FG001|Overall Study|Withdrawal by Subject|8
4645185|NCT02025907|7522836|FG000|Overall Study|Protocol Violation|2
4645186|NCT02025907|7522837|FG001|Overall Study|Protocol Violation|0
4645187|NCT02025907|7522836|FG000|Overall Study|Physician Decision|2
4645188|NCT02025907|7522837|FG001|Overall Study|Physician Decision|0
4645189|NCT02025907|7522836|FG000|Overall Study|Lost to Follow-up|2
4645190|NCT02025907|7522837|FG001|Overall Study|Lost to Follow-up|2
4645191|NCT02025907|7522836|FG000|Overall Study|Adverse Event|3
4645192|NCT02025907|7522837|FG001|Overall Study|Adverse Event|1
4645193|NCT02025907|7522836|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2
4645194|NCT02025907|7522837|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1
4645195|NCT02025985|7522848|FG000|Overall Study|Consent withdrawn|0
4645196|NCT02025985|7522849|FG001|Overall Study|Consent withdrawn|0
4645197|NCT02025985|7522850|FG002|Overall Study|Consent withdrawn|1
4645198|NCT02025985|7522851|FG003|Overall Study|Consent withdrawn|0
4645199|NCT02025985|7522852|FG004|Overall Study|Consent withdrawn|0
4645200|NCT02025985|7522848|FG000|Overall Study|Termination of study by Sponsor|4
4645201|NCT02025985|7522849|FG001|Overall Study|Termination of study by Sponsor|3
4645202|NCT02025985|7522850|FG002|Overall Study|Termination of study by Sponsor|1
4645203|NCT02025985|7522851|FG003|Overall Study|Termination of study by Sponsor|1
4645204|NCT02025985|7522852|FG004|Overall Study|Termination of study by Sponsor|3
4645205|NCT02025985|7522848|FG000|Overall Study|Death|21
4645206|NCT02025985|7522849|FG001|Overall Study|Death|20
4645207|NCT02025985|7522850|FG002|Overall Study|Death|23
4645208|NCT02025985|7522851|FG003|Overall Study|Death|20
4645209|NCT02025985|7522852|FG004|Overall Study|Death|17
4645210|NCT02026011|7522868|FG000|Allocation 1 (First Set of Medication)|Side Effects|6
4645211|NCT02026011|7522869|FG001|Allocation 1 (First Set of Medication)|Side Effects|0
4645212|NCT02026011|7522868|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1
4645213|NCT02026011|7522869|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2
4645214|NCT02026011|7522868|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1
4645215|NCT02026011|7522869|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0
4645216|NCT02026011|7522868|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1
4645217|NCT02026011|7522869|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2
4747615|NCT04259346|7721684|FG000|Overall Study|Withdrawal by Subject|1
4747616|NCT04259346|7721685|FG001|Overall Study|Withdrawal by Subject|0
4747617|NCT04259346|7721684|FG000|Overall Study|Adverse Event|1
4747618|NCT04259346|7721685|FG001|Overall Study|Adverse Event|1
4645218|NCT02026063|7522880|FG000|Overall Study|Physician Decision|0
4645219|NCT02026063|7522881|FG001|Overall Study|Physician Decision|10
4645220|NCT02026063|7522880|FG000|Overall Study|Noncompliance with Study Drug|1
4645221|NCT02026063|7522881|FG001|Overall Study|Noncompliance with Study Drug|1
4645222|NCT02026063|7522880|FG000|Overall Study|Withdrawal of Consent|1
4645223|NCT02026063|7522881|FG001|Overall Study|Withdrawal of Consent|6
4645224|NCT02026063|7522880|FG000|Overall Study|Adverse Event|5
4645225|NCT02026063|7522881|FG001|Overall Study|Adverse Event|20
4645226|NCT02026063|7522880|FG000|Overall Study|Lack of Efficacy|0
4645227|NCT02026063|7522881|FG001|Overall Study|Lack of Efficacy|4
4645228|NCT02026063|7522880|FG000|Overall Study|Lost to Follow-up|0
4645229|NCT02026063|7522881|FG001|Overall Study|Lost to Follow-up|1
4645230|NCT02026063|7522880|FG000|Overall Study|Reason not Specified|2
4645231|NCT02026063|7522881|FG001|Overall Study|Reason not Specified|7
4645232|NCT02026141|7522890|FG000|Overall Study|Protocol Violation|0
4645233|NCT02026141|7522891|FG001|Overall Study|Protocol Violation|1
4645234|NCT02026258|7522917|FG000|Randomized|Did not start treatment|2
4645235|NCT02026258|7522918|FG001|Randomized|Did not start treatment|1
4645236|NCT02026258|7522917|FG000|Randomized|Change in treatment plan|1
4645237|NCT02026258|7522918|FG001|Randomized|Change in treatment plan|0
4645238|NCT02026258|7522917|FG000|Randomized|Presence of periodontal disease|1
4645239|NCT02026258|7522918|FG001|Randomized|Presence of periodontal disease|1
4645240|NCT02026258|7522917|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1
4645241|NCT02026258|7522918|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1
4645242|NCT02026258|7522917|FG000|Recieved Allocated Intervention|Lost to Follow-up|0
4645243|NCT02026258|7522918|FG001|Recieved Allocated Intervention|Lost to Follow-up|1
4645244|NCT02027025|7522959|FG000|Overall Study|Adverse Event|0
4645245|NCT02027025|7522960|FG001|Overall Study|Adverse Event|1
4645246|NCT02027025|7522961|FG002|Overall Study|Adverse Event|1
4645247|NCT02027025|7522959|FG000|Overall Study|Protocol Violation|1
4645248|NCT02027025|7522960|FG001|Overall Study|Protocol Violation|0
4645249|NCT02027025|7522961|FG002|Overall Study|Protocol Violation|0
4645250|NCT02027025|7522959|FG000|Overall Study|Lost to Follow-up|0
4645251|NCT02027025|7522960|FG001|Overall Study|Lost to Follow-up|2
4645252|NCT02027025|7522961|FG002|Overall Study|Lost to Follow-up|0
4645253|NCT02027025|7522959|FG000|Overall Study|Withdrawal by Subject|0
4645254|NCT02027025|7522960|FG001|Overall Study|Withdrawal by Subject|1
4645255|NCT02027025|7522961|FG002|Overall Study|Withdrawal by Subject|0
4645256|NCT02027025|7522959|FG000|Overall Study|Sponsor's decision|0
4645257|NCT02027025|7522960|FG001|Overall Study|Sponsor's decision|1
4645258|NCT02027025|7522961|FG002|Overall Study|Sponsor's decision|0
4645259|NCT02027311|7522982|FG000|Overall Study|Protocol Violation|3
4645260|NCT02027311|7522983|FG001|Overall Study|Protocol Violation|2
4645261|NCT02027376|7522991|FG000|Overall Study|Death|1
4645262|NCT02027376|7522992|FG001|Overall Study|Death|0
4645263|NCT02027376|7522993|FG002|Overall Study|Death|0
4645264|NCT02027402|7523005|FG000|Overall Study|Withdrawal by Subject|4
4645265|NCT02027402|7523006|FG001|Overall Study|Withdrawal by Subject|1
4645266|NCT02027428|7523016|FG000|Induction|Never treated|7
4645267|NCT02027428|7523017|FG001|Induction|Never treated|0
4645268|NCT02027428|7523018|FG002|Induction|Never treated|0
4645269|NCT02027428|7523016|FG000|Induction|Progressive disease|77
4645270|NCT02027428|7523017|FG001|Induction|Progressive disease|0
4645271|NCT02027428|7523018|FG002|Induction|Progressive disease|0
4645272|NCT02027428|7523016|FG000|Induction|Adverse Event|51
4645273|NCT02027428|7523017|FG001|Induction|Adverse Event|0
4645274|NCT02027428|7523018|FG002|Induction|Adverse Event|0
4645275|NCT02027428|7523016|FG000|Induction|Withdrawal by Subject|22
4645276|NCT02027428|7523017|FG001|Induction|Withdrawal by Subject|0
4645277|NCT02027428|7523018|FG002|Induction|Withdrawal by Subject|0
4645278|NCT02027428|7523016|FG000|Induction|Death|21
4645279|NCT02027428|7523017|FG001|Induction|Death|0
4645280|NCT02027428|7523018|FG002|Induction|Death|0
4645281|NCT02027428|7523016|FG000|Induction|Symptomatic deterioration|16
4645282|NCT02027428|7523017|FG001|Induction|Symptomatic deterioration|0
4645283|NCT02027428|7523018|FG002|Induction|Symptomatic deterioration|0
4645284|NCT02027428|7523016|FG000|Induction|Study terminated by sponsor|12
4645285|NCT02027428|7523017|FG001|Induction|Study terminated by sponsor|0
4645286|NCT02027428|7523018|FG002|Induction|Study terminated by sponsor|0
4645287|NCT02027428|7523016|FG000|Induction|Protocol Violation|1
4645288|NCT02027428|7523017|FG001|Induction|Protocol Violation|0
4645289|NCT02027428|7523018|FG002|Induction|Protocol Violation|0
4645290|NCT02027428|7523016|FG000|Induction|Miscellaneous|14
4645291|NCT02027428|7523017|FG001|Induction|Miscellaneous|0
4645292|NCT02027428|7523018|FG002|Induction|Miscellaneous|0
4645293|NCT02027428|7523016|FG000|Induction|Induction Treatment Ongoing|4
4645294|NCT02027428|7523017|FG001|Induction|Induction Treatment Ongoing|0
4645295|NCT02027428|7523018|FG002|Induction|Induction Treatment Ongoing|0
4645296|NCT02027428|7523016|FG000|Maintenance|Death|0
4645297|NCT02027428|7523017|FG001|Maintenance|Death|3
4645298|NCT02027428|7523018|FG002|Maintenance|Death|2
4645299|NCT02027428|7523016|FG000|Maintenance|Adverse Event|0
4645300|NCT02027428|7523017|FG001|Maintenance|Adverse Event|21
4645301|NCT02027428|7523018|FG002|Maintenance|Adverse Event|1
4645302|NCT02027428|7523016|FG000|Maintenance|Progressive disease|0
4645303|NCT02027428|7523017|FG001|Maintenance|Progressive disease|84
4645304|NCT02027428|7523018|FG002|Maintenance|Progressive disease|47
4645305|NCT02027428|7523016|FG000|Maintenance|Symptomatic deterioration|0
4645306|NCT02027428|7523017|FG001|Maintenance|Symptomatic deterioration|4
4645307|NCT02027428|7523018|FG002|Maintenance|Symptomatic deterioration|1
4645308|NCT02027428|7523016|FG000|Maintenance|Withdrawal by Subject|0
4645309|NCT02027428|7523017|FG001|Maintenance|Withdrawal by Subject|6
4645310|NCT02027428|7523018|FG002|Maintenance|Withdrawal by Subject|5
4645311|NCT02027428|7523016|FG000|Maintenance|Protocol Violation|0
4645312|NCT02027428|7523017|FG001|Maintenance|Protocol Violation|0
4645313|NCT02027428|7523018|FG002|Maintenance|Protocol Violation|1
4645314|NCT02027428|7523016|FG000|Maintenance|Other|0
4645315|NCT02027428|7523017|FG001|Maintenance|Other|6
4645316|NCT02027428|7523018|FG002|Maintenance|Other|3
4645317|NCT02027428|7523016|FG000|Survival Follow-up|Death|0
4645318|NCT02027428|7523017|FG001|Survival Follow-up|Death|78
4645319|NCT02027428|7523018|FG002|Survival Follow-up|Death|45
4645320|NCT02027428|7523016|FG000|Survival Follow-up|Lost to Follow-up|0
4645321|NCT02027428|7523017|FG001|Survival Follow-up|Lost to Follow-up|1
4645322|NCT02027428|7523018|FG002|Survival Follow-up|Lost to Follow-up|1
4645323|NCT02027545|7523043|FG000|Overall Study|Failed to sign HIPAA|0
4645324|NCT02027545|7523044|FG001|Overall Study|Failed to sign HIPAA|2
4645325|NCT02027545|7523043|FG000|Overall Study|Failed to attend study visit|2
4645326|NCT02027545|7523044|FG001|Overall Study|Failed to attend study visit|0
4645327|NCT02027558|7523052|FG000|Overall Study|Death|0
4645328|NCT02027558|7523053|FG001|Overall Study|Death|1
4645329|NCT02027558|7523052|FG000|Overall Study|Withdrawal by Subject|2
4645330|NCT02027558|7523053|FG001|Overall Study|Withdrawal by Subject|0
4645331|NCT02027558|7523052|FG000|Overall Study|Lost to Follow-up|4
4645332|NCT02027558|7523053|FG001|Overall Study|Lost to Follow-up|1
4645333|NCT02027558|7523052|FG000|Overall Study|Refused assessment|3
4645334|NCT02027558|7523053|FG001|Overall Study|Refused assessment|0
4645335|NCT02027623|7523063|FG000|Overall Study|Lost to Follow-up|3
4645336|NCT02027623|7523064|FG001|Overall Study|Lost to Follow-up|3
4645337|NCT02027623|7523063|FG000|Overall Study|Withdrawal by Subject|6
4645338|NCT02027623|7523064|FG001|Overall Study|Withdrawal by Subject|9
4645339|NCT02027701|7523071|FG000|Overall Study|Adverse Event|3
4645340|NCT02027701|7523071|FG000|Overall Study|Lack of Efficacy|8
4645341|NCT02027701|7523071|FG000|Overall Study|Physician Decision|2
4645342|NCT02027701|7523071|FG000|Overall Study|Withdrawal by Subject|3
4645343|NCT02027844|7523080|FG000|Overall Study|Withdrawal by Subject|3
4645344|NCT02027844|7523081|FG001|Overall Study|Withdrawal by Subject|2
4645345|NCT02027844|7523082|FG002|Overall Study|Withdrawal by Subject|1
4645346|NCT02027844|7523080|FG000|Overall Study|Lost to Follow-up|0
4645347|NCT02027844|7523081|FG001|Overall Study|Lost to Follow-up|2
4645348|NCT02027844|7523082|FG002|Overall Study|Lost to Follow-up|1
4645349|NCT02027844|7523080|FG000|Overall Study|Protocol Violation|0
4645350|NCT02027844|7523081|FG001|Overall Study|Protocol Violation|2
4645351|NCT02027844|7523082|FG002|Overall Study|Protocol Violation|0
4645352|NCT02027844|7523080|FG000|Overall Study|Incomlete data|2
4645353|NCT02027844|7523081|FG001|Overall Study|Incomlete data|0
4645354|NCT02027844|7523082|FG002|Overall Study|Incomlete data|0
4645355|NCT02028065|7523106|FG000|Randomization Through Start Treatment|Not treated|1
4645356|NCT02028065|7523107|FG001|Randomization Through Start Treatment|Not treated|3
4645357|NCT02028065|7523108|FG002|Randomization Through Start Treatment|Not treated|3
4645358|NCT02028065|7523106|FG000|Treatment Through Study Completion|Lost to Follow-up|2
4645359|NCT02028065|7523107|FG001|Treatment Through Study Completion|Lost to Follow-up|4
4645360|NCT02028065|7523108|FG002|Treatment Through Study Completion|Lost to Follow-up|6
4645361|NCT02028065|7523106|FG000|Treatment Through Study Completion|Physician Decision|1
4645362|NCT02028065|7523107|FG001|Treatment Through Study Completion|Physician Decision|0
4645363|NCT02028065|7523108|FG002|Treatment Through Study Completion|Physician Decision|0
4645364|NCT02028065|7523106|FG000|Treatment Through Study Completion|Protocol Violation|1
4645365|NCT02028065|7523107|FG001|Treatment Through Study Completion|Protocol Violation|4
4645366|NCT02028065|7523108|FG002|Treatment Through Study Completion|Protocol Violation|0
4645367|NCT02028065|7523106|FG000|Treatment Through Study Completion|Withdrawal by Subject|5
4645368|NCT02028065|7523107|FG001|Treatment Through Study Completion|Withdrawal by Subject|4
4645369|NCT02028065|7523108|FG002|Treatment Through Study Completion|Withdrawal by Subject|3
4645370|NCT02028065|7523106|FG000|Treatment Through Study Completion|Adverse Event|3
4645371|NCT02028065|7523107|FG001|Treatment Through Study Completion|Adverse Event|3
4645372|NCT02028065|7523108|FG002|Treatment Through Study Completion|Adverse Event|5
4645373|NCT02028169|7523116|FG000|Overall Study|Lost to Follow-up|21
4645374|NCT02028169|7523116|FG000|Overall Study|Lack of Efficacy|2
4645375|NCT02028169|7523116|FG000|Overall Study|Withdrawal by Subject|2
4645376|NCT02028169|7523116|FG000|Overall Study|Adverse Event|1
4645377|NCT02028169|7523116|FG000|Overall Study|Cessation of Drug|1
4645378|NCT02028169|7523116|FG000|Overall Study|Concomitant Medication Usage|1
4645379|NCT02028182|7523120|FG000|Overall Study|Protocol Violation|2
4645380|NCT02028715|7523207|FG000|Overall Study|Adverse Event|2
4645381|NCT02028715|7523208|FG001|Overall Study|Adverse Event|2
4645382|NCT02028715|7523207|FG000|Overall Study|Physician Decision|1
4645383|NCT02028715|7523208|FG001|Overall Study|Physician Decision|0
4645384|NCT02028715|7523207|FG000|Overall Study|Did not complete satisfaction surveys|2
4645385|NCT02028715|7523208|FG001|Overall Study|Did not complete satisfaction surveys|2
4645386|NCT02028767|7523223|FG000|Treatment Period 2|Non compliant with protocol|1
4645387|NCT02028767|7523224|FG001|Treatment Period 2|Non compliant with protocol|0
4645388|NCT02028767|7523223|FG000|Treatment Period 2|Reason other than those specified above|1
4645389|NCT02028767|7523224|FG001|Treatment Period 2|Reason other than those specified above|0
4645390|NCT02028871|7523299|FG000|Overall Study|Positive urine drug screen|1
4645391|NCT02028871|7523300|FG001|Overall Study|Positive urine drug screen|1
4645392|NCT02028871|7523299|FG000|Overall Study|Withdrawal by Subject|1
4645393|NCT02028871|7523300|FG001|Overall Study|Withdrawal by Subject|2
4645394|NCT02028871|7523299|FG000|Overall Study|IV placement difficulty|1
4645395|NCT02028871|7523300|FG001|Overall Study|IV placement difficulty|0
4645396|NCT02028871|7523299|FG000|Overall Study|Current Illness|1
4645397|NCT02028871|7523300|FG001|Overall Study|Current Illness|0
4645398|NCT02029235|7523329|FG000|Overall Study|Non-compliance with study meds or diary|4
4645399|NCT02029235|7523330|FG001|Overall Study|Non-compliance with study meds or diary|1
4645400|NCT02029274|7523340|FG000|Overall Study|Adverse Event|1
4645401|NCT02029274|7523341|FG001|Overall Study|Adverse Event|0
4645402|NCT02029274|7523342|FG002|Overall Study|Adverse Event|2
4645403|NCT02029274|7523343|FG003|Overall Study|Adverse Event|2
4645404|NCT02029417|7523357|FG000|Overall Study|Death|1
4645405|NCT02029417|7523357|FG000|Overall Study|Adverse Event|1
4645406|NCT02029521|7523376|FG000|Overall Study|Protocol Violation|1
4645407|NCT02029521|7523377|FG001|Overall Study|Protocol Violation|0
4645408|NCT02029521|7523376|FG000|Overall Study|Withdrawal by Subject|1
4645409|NCT02029521|7523377|FG001|Overall Study|Withdrawal by Subject|1
4645410|NCT02029638|7523389|FG000|Overall Study|Death|0
4645411|NCT02029638|7523390|FG001|Overall Study|Death|0
4645412|NCT02029638|7523391|FG002|Overall Study|Death|1
4645413|NCT02029638|7523389|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2
4645414|NCT02029638|7523390|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0
4645415|NCT02029638|7523391|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0
4645416|NCT02029976|7523436|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12
4645417|NCT02029976|7523437|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8
4645418|NCT02029976|7523436|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8
4645419|NCT02029976|7523437|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4
4645420|NCT02029976|7523436|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2
4645421|NCT02029976|7523437|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2
4645422|NCT02029976|7523436|FG000|YR-2 Follow Up vs Baseline|Moved from area|0
4645423|NCT02029976|7523437|FG001|YR-2 Follow Up vs Baseline|Moved from area|2
4645424|NCT02029989|7523445|FG000|Overall Study|Withdrawal by Subject|1
4645425|NCT02029989|7523446|FG001|Overall Study|Withdrawal by Subject|0
4645426|NCT02029989|7523445|FG000|Overall Study|Withdrawal: Fear of needles|1
4645427|NCT02029989|7523446|FG001|Overall Study|Withdrawal: Fear of needles|0
4645428|NCT02029989|7523445|FG000|Overall Study|Change of location|2
4645429|NCT02029989|7523446|FG001|Overall Study|Change of location|3
4645430|NCT02029989|7523445|FG000|Overall Study|Physician Decision|2
4645431|NCT02029989|7523446|FG001|Overall Study|Physician Decision|0
4645432|NCT02029989|7523445|FG000|Overall Study|Lost to Follow-up|9
4645433|NCT02029989|7523446|FG001|Overall Study|Lost to Follow-up|7
4645434|NCT02029989|7523445|FG000|Overall Study|Death|0
4645435|NCT02029989|7523446|FG001|Overall Study|Death|1
4645436|NCT02029989|7523445|FG000|Overall Study|Protocol Violation|1
4645437|NCT02029989|7523446|FG001|Overall Study|Protocol Violation|0
4645438|NCT02030002|7523452|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1
4645439|NCT02030002|7523452|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4
4645440|NCT02030002|7523452|FG000|Follow-up|Lost to Follow-up|2
4645441|NCT02030041|7523461|FG000|Overall Study|Withdrawal by Subject|2
4645442|NCT02030041|7523462|FG001|Overall Study|Withdrawal by Subject|2
4645443|NCT02030041|7523463|FG002|Overall Study|Withdrawal by Subject|1
4645444|NCT02030119|7523492|FG000|Overall Study|Withdrawal by Subject|3
4645445|NCT02030119|7523493|FG001|Overall Study|Withdrawal by Subject|1
4645446|NCT02030119|7523494|FG002|Overall Study|Withdrawal by Subject|5
4645447|NCT02030119|7523495|FG003|Overall Study|Withdrawal by Subject|3
4645448|NCT02030119|7523492|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0
4645449|NCT02030119|7523493|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1
4645450|NCT02030119|7523494|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1
4645451|NCT02030119|7523495|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0
4645452|NCT02030405|7523518|FG000|Overall Study|Withdrawal by Subject|1
4645453|NCT02030405|7523518|FG000|Overall Study|Lost to Follow-up|1
4645454|NCT02030535|7523523|FG000|Washout Period 1 (21 Days)|Adverse Event|1
4645455|NCT02030600|7523543|FG000|Treatment Period 1|Adverse Event|5
4645456|NCT02030600|7523544|FG001|Treatment Period 1|Adverse Event|7
4645457|NCT02030600|7523543|FG000|Treatment Period 1|Lack of Efficacy|0
4645458|NCT02030600|7523544|FG001|Treatment Period 1|Lack of Efficacy|1
4645459|NCT02030600|7523543|FG000|Treatment Period 1|Lost to Follow-up|11
4645460|NCT02030600|7523544|FG001|Treatment Period 1|Lost to Follow-up|3
4645461|NCT02030600|7523543|FG000|Treatment Period 1|Protocol Violation|22
4645462|NCT02030600|7523544|FG001|Treatment Period 1|Protocol Violation|17
4645463|NCT02030600|7523543|FG000|Treatment Period 1|Withdrawal by Subject|13
4645464|NCT02030600|7523544|FG001|Treatment Period 1|Withdrawal by Subject|17
4645465|NCT02030600|7523543|FG000|Treatment Period 1|Casebook Unsigned|1
4645466|NCT02030600|7523544|FG001|Treatment Period 1|Casebook Unsigned|0
4645467|NCT02030600|7523543|FG000|Treatment Period 1|Unclassified|1
4645468|NCT02030600|7523544|FG001|Treatment Period 1|Unclassified|0
4645469|NCT02030600|7523543|FG000|Treatment Period 2|Adverse Event|4
4645470|NCT02030600|7523544|FG001|Treatment Period 2|Adverse Event|4
4645471|NCT02030600|7523543|FG000|Treatment Period 2|Lack of Efficacy|2
4645472|NCT02030600|7523544|FG001|Treatment Period 2|Lack of Efficacy|1
4645473|NCT02030600|7523543|FG000|Treatment Period 2|Lost to Follow-up|4
4645474|NCT02030600|7523544|FG001|Treatment Period 2|Lost to Follow-up|2
4645475|NCT02030600|7523543|FG000|Treatment Period 2|Protocol Violation|1
4645476|NCT02030600|7523544|FG001|Treatment Period 2|Protocol Violation|2
4645477|NCT02030600|7523543|FG000|Treatment Period 2|Withdrawal by Subject|13
4645478|NCT02030600|7523544|FG001|Treatment Period 2|Withdrawal by Subject|9
4645479|NCT02030600|7523543|FG000|Treatment Period 2|Unclassified|1
4645480|NCT02030600|7523544|FG001|Treatment Period 2|Unclassified|0
4645481|NCT02030821|7523556|FG000|Overall Study|Physician Decision|2
4645482|NCT02030821|7523557|FG001|Overall Study|Physician Decision|2
4645483|NCT02030821|7523558|FG002|Overall Study|Physician Decision|5
4645484|NCT02030821|7523559|FG003|Overall Study|Physician Decision|2
4645485|NCT02030834|7523572|FG000|Overall Study|Death|4
4645486|NCT02030834|7523573|FG001|Overall Study|Death|0
4645487|NCT02030834|7523574|FG002|Overall Study|Death|0
4645488|NCT02030834|7523572|FG000|Overall Study|Manufacturing failure|2
4645489|NCT02030834|7523573|FG001|Overall Study|Manufacturing failure|0
4645490|NCT02030834|7523574|FG002|Overall Study|Manufacturing failure|1
4645491|NCT02030834|7523572|FG000|Overall Study|Disease progression|2
4645492|NCT02030834|7523573|FG001|Overall Study|Disease progression|0
4645493|NCT02030834|7523574|FG002|Overall Study|Disease progression|2
4645494|NCT02030834|7523572|FG000|Overall Study|Lost to Follow-up|1
4645495|NCT02030834|7523573|FG001|Overall Study|Lost to Follow-up|0
4645496|NCT02030834|7523574|FG002|Overall Study|Lost to Follow-up|0
4645497|NCT02030834|7523572|FG000|Overall Study|Withdrawal by Subject|1
4645498|NCT02030834|7523573|FG001|Overall Study|Withdrawal by Subject|0
4645499|NCT02030834|7523574|FG002|Overall Study|Withdrawal by Subject|0
4645500|NCT02030834|7523572|FG000|Overall Study|Lack of funding|1
4645501|NCT02030834|7523573|FG001|Overall Study|Lack of funding|0
4645502|NCT02030834|7523574|FG002|Overall Study|Lack of funding|0
4645503|NCT02030847|7523582|FG000|Overall Study|Death|10
4645504|NCT02030847|7523582|FG000|Overall Study|Disease Progression|15
4645505|NCT02030847|7523582|FG000|Overall Study|New Cancer Therapy|8
4645506|NCT02030847|7523582|FG000|Overall Study|Physician Decision|3
4645507|NCT02030847|7523582|FG000|Overall Study|Withdrawal by Subject|1
4645508|NCT02031146|7523600|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0
4645509|NCT02031146|7523601|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0
4645510|NCT02031146|7523602|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0
4645511|NCT02031146|7523603|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100
4645512|NCT02031146|7523604|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26
4645513|NCT02031146|7523605|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4
4645514|NCT02031146|7523606|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5
4645515|NCT02031237|7523618|FG000|Overall Study|Death|1
4645516|NCT02031237|7523619|FG001|Overall Study|Death|5
4645517|NCT02031237|7523620|FG002|Overall Study|Death|0
4645518|NCT02031237|7523618|FG000|Overall Study|Physician Decision|0
4645519|NCT02031237|7523619|FG001|Overall Study|Physician Decision|1
4645520|NCT02031237|7523620|FG002|Overall Study|Physician Decision|0
4645521|NCT02031237|7523618|FG000|Overall Study|Withdrawal by Subject|2
4645522|NCT02031237|7523619|FG001|Overall Study|Withdrawal by Subject|2
4645523|NCT02031237|7523620|FG002|Overall Study|Withdrawal by Subject|0
4645524|NCT02031237|7523618|FG000|Overall Study|Protocol Violation|2
4645525|NCT02031237|7523619|FG001|Overall Study|Protocol Violation|6
4645526|NCT02031237|7523620|FG002|Overall Study|Protocol Violation|0
4645527|NCT02031237|7523618|FG000|Overall Study|Alternate Treatment Given|0
4645528|NCT02031237|7523619|FG001|Overall Study|Alternate Treatment Given|0
4645529|NCT02031237|7523620|FG002|Overall Study|Alternate Treatment Given|3
4645530|NCT02031276|7523630|FG000|Period 1 Double-blind IV|Adverse Event|6
4645531|NCT02031276|7523631|FG001|Period 1 Double-blind IV|Adverse Event|5
4645532|NCT02031276|7523632|FG002|Period 1 Double-blind IV|Adverse Event|1
4645533|NCT02031276|7523630|FG000|Period 1 Double-blind IV|Other|0
4645534|NCT02031276|7523631|FG001|Period 1 Double-blind IV|Other|1
4645535|NCT02031276|7523632|FG002|Period 1 Double-blind IV|Other|0
4645536|NCT02031276|7523630|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1
4645537|NCT02031276|7523631|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0
4645538|NCT02031276|7523632|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0
4645539|NCT02031276|7523630|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3
4645540|NCT02031276|7523631|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0
4645541|NCT02031276|7523632|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0
4645542|NCT02031276|7523630|FG000|Period 2 Open-label Risankizumab IV|Other|0
4645543|NCT02031276|7523631|FG001|Period 2 Open-label Risankizumab IV|Other|2
4645544|NCT02031276|7523632|FG002|Period 2 Open-label Risankizumab IV|Other|1
4645545|NCT02031276|7523630|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0
4645546|NCT02031276|7523631|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2
4645547|NCT02031276|7523632|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0
4645548|NCT02031276|7523630|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2
4645549|NCT02031276|7523631|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0
4645550|NCT02031276|7523632|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0
4645551|NCT02031276|7523630|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1
4645552|NCT02031276|7523631|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1
4645553|NCT02031276|7523632|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1
4645554|NCT02031276|7523630|FG000|Period 3 Open-label Risankizumab SC|Other|0
4645555|NCT02031276|7523631|FG001|Period 3 Open-label Risankizumab SC|Other|0
4645556|NCT02031276|7523632|FG002|Period 3 Open-label Risankizumab SC|Other|1
4645557|NCT02031302|7523646|FG000|Overall Study|Death|115
4645558|NCT02031302|7523647|FG001|Overall Study|Death|0
4645559|NCT02031302|7523646|FG000|Overall Study|Not treated with study valve system|18
4645560|NCT02031302|7523647|FG001|Overall Study|Not treated with study valve system|0
4645561|NCT02031302|7523646|FG000|Overall Study|Missed Follow Up|27
4645562|NCT02031302|7523647|FG001|Overall Study|Missed Follow Up|0
4645563|NCT02031302|7523646|FG000|Overall Study|Lost to Follow-up|4
4645564|NCT02031302|7523647|FG001|Overall Study|Lost to Follow-up|0
4645565|NCT02031432|7523654|FG000|Overall Study|Protocol Violation|1
4645566|NCT02031432|7523654|FG000|Overall Study|Lack of Efficacy|5
4645567|NCT02031432|7523654|FG000|Overall Study|Cancer Progression|2
4645568|NCT02031432|7523654|FG000|Overall Study|Withdrawn as forbidden meds required|1
4645569|NCT02031432|7523654|FG000|Overall Study|Adverse Event|8
4645570|NCT02031432|7523654|FG000|Overall Study|Withdrawal by Subject|5
4645571|NCT02031432|7523654|FG000|Overall Study|Lost to Follow-up|1
4645572|NCT02031432|7523654|FG000|Overall Study|Inclusion/Exclusion criteria not met|5
4645573|NCT02031432|7523654|FG000|Overall Study|Death|10
4645574|NCT02031458|7523661|FG000|May 8, 2015 to January 11, 2019|Death|89
4645575|NCT02031458|7523662|FG001|May 8, 2015 to January 11, 2019|Death|193
4645576|NCT02031458|7523663|FG002|May 8, 2015 to January 11, 2019|Death|198
4645577|NCT02031458|7523661|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2
4645578|NCT02031458|7523662|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5
4645579|NCT02031458|7523663|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8
4645580|NCT02031458|7523661|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1
4645581|NCT02031458|7523662|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6
4645582|NCT02031458|7523663|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6
4645583|NCT02031458|7523661|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2
4645584|NCT02031458|7523662|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3
4645585|NCT02031458|7523663|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3
4645586|NCT02031458|7523661|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7
4645587|NCT02031458|7523662|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4
4645588|NCT02031458|7523663|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0
4645589|NCT02031458|7523661|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24
4645590|NCT02031458|7523662|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42
4645591|NCT02031458|7523663|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23
4645592|NCT02031458|7523661|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13
4645593|NCT02031458|7523662|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16
4645594|NCT02031458|7523663|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14
4645595|NCT02031458|7523661|FG000|Baseline to May 8, 2015|Death|36
4645596|NCT02031458|7523662|FG001|Baseline to May 8, 2015|Death|87
4645597|NCT02031458|7523663|FG002|Baseline to May 8, 2015|Death|100
4645598|NCT02031458|7523661|FG000|Baseline to May 8, 2015|Protocol Violation|7
4645599|NCT02031458|7523662|FG001|Baseline to May 8, 2015|Protocol Violation|4
4645600|NCT02031458|7523663|FG002|Baseline to May 8, 2015|Protocol Violation|0
4645601|NCT02031458|7523661|FG000|Baseline to May 8, 2015|Physician Decision|0
4645602|NCT02031458|7523662|FG001|Baseline to May 8, 2015|Physician Decision|1
4645603|NCT02031458|7523663|FG002|Baseline to May 8, 2015|Physician Decision|0
4645604|NCT02031458|7523661|FG000|Baseline to May 8, 2015|Unknown Reason|0
4645605|NCT02031458|7523662|FG001|Baseline to May 8, 2015|Unknown Reason|1
4645606|NCT02031458|7523663|FG002|Baseline to May 8, 2015|Unknown Reason|2
4645607|NCT02031458|7523661|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6
4645608|NCT02031458|7523662|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9
4645609|NCT02031458|7523663|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3
4645610|NCT02031458|7523661|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46
4645611|NCT02031458|7523662|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83
4645612|NCT02031458|7523663|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73
4645613|NCT02031458|7523661|FG000|Baseline to May 8, 2015|On Treatment|43
4645614|NCT02031458|7523662|FG001|Baseline to May 8, 2015|On Treatment|81
4645615|NCT02031458|7523663|FG002|Baseline to May 8, 2015|On Treatment|73
4645616|NCT02031458|7523661|FG000|Baseline to May 8, 2015|Lost to Follow-up|1
4645617|NCT02031458|7523662|FG001|Baseline to May 8, 2015|Lost to Follow-up|1
4645618|NCT02031458|7523663|FG002|Baseline to May 8, 2015|Lost to Follow-up|2
4645619|NCT02031471|7523673|FG000|24 Week Treatment Period|Adverse Event|6
4645620|NCT02031471|7523673|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2
4645621|NCT02031471|7523673|FG000|24 Week Treatment Period|Protocol Violation|1
4645622|NCT02031471|7523673|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1
4645623|NCT02031471|7523673|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1
4645624|NCT02031471|7523673|FG000|Long Term Extension (LTE) Period|Adverse Event|1
4645625|NCT02031471|7523673|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1
4645626|NCT02031536|7523679|FG000|Overall Study|ineligible|1
4645627|NCT02031536|7523680|FG001|Overall Study|ineligible|0
4645628|NCT02031640|7523704|FG000|Screening Period|Adverse Event|1
4645629|NCT02031640|7523705|FG001|Screening Period|Adverse Event|0
4645630|NCT02031640|7523706|FG002|Screening Period|Adverse Event|0
4645631|NCT02031640|7523707|FG003|Screening Period|Adverse Event|0
4645632|NCT02031640|7523708|FG004|Screening Period|Adverse Event|0
4645633|NCT02031640|7523709|FG005|Screening Period|Adverse Event|0
4645634|NCT02031640|7523704|FG000|Screening Period|Withdrawal by Subject|29
4645635|NCT02031640|7523705|FG001|Screening Period|Withdrawal by Subject|0
4645636|NCT02031640|7523706|FG002|Screening Period|Withdrawal by Subject|0
4645637|NCT02031640|7523707|FG003|Screening Period|Withdrawal by Subject|0
4645638|NCT02031640|7523708|FG004|Screening Period|Withdrawal by Subject|0
4645639|NCT02031640|7523709|FG005|Screening Period|Withdrawal by Subject|0
4645640|NCT02031640|7523704|FG000|Screening Period|Inclusion criteria not met|312
4645641|NCT02031640|7523705|FG001|Screening Period|Inclusion criteria not met|0
4645642|NCT02031640|7523706|FG002|Screening Period|Inclusion criteria not met|0
4645643|NCT02031640|7523707|FG003|Screening Period|Inclusion criteria not met|0
4645644|NCT02031640|7523708|FG004|Screening Period|Inclusion criteria not met|0
4645645|NCT02031640|7523709|FG005|Screening Period|Inclusion criteria not met|0
4645646|NCT02031640|7523704|FG000|Screening Period|Exclusion criteria met|30
4645647|NCT02031640|7523705|FG001|Screening Period|Exclusion criteria met|0
4645648|NCT02031640|7523706|FG002|Screening Period|Exclusion criteria met|0
4645649|NCT02031640|7523707|FG003|Screening Period|Exclusion criteria met|0
4645650|NCT02031640|7523708|FG004|Screening Period|Exclusion criteria met|0
4645651|NCT02031640|7523709|FG005|Screening Period|Exclusion criteria met|0
4645652|NCT02031640|7523704|FG000|Screening Period|Lost to Follow-up|14
4645653|NCT02031640|7523705|FG001|Screening Period|Lost to Follow-up|0
4645654|NCT02031640|7523706|FG002|Screening Period|Lost to Follow-up|0
4645655|NCT02031640|7523707|FG003|Screening Period|Lost to Follow-up|0
4645656|NCT02031640|7523708|FG004|Screening Period|Lost to Follow-up|0
4645657|NCT02031640|7523709|FG005|Screening Period|Lost to Follow-up|0
4645658|NCT02031640|7523704|FG000|Screening Period|Enrollment closed|26
4645659|NCT02031640|7523705|FG001|Screening Period|Enrollment closed|0
4645660|NCT02031640|7523706|FG002|Screening Period|Enrollment closed|0
4645661|NCT02031640|7523707|FG003|Screening Period|Enrollment closed|0
4645662|NCT02031640|7523708|FG004|Screening Period|Enrollment closed|0
4645663|NCT02031640|7523709|FG005|Screening Period|Enrollment closed|0
4645664|NCT02031640|7523704|FG000|Run-In Period|Adverse Event|4
4645665|NCT02031640|7523705|FG001|Run-In Period|Adverse Event|0
4645666|NCT02031640|7523706|FG002|Run-In Period|Adverse Event|0
4645667|NCT02031640|7523707|FG003|Run-In Period|Adverse Event|0
4645668|NCT02031640|7523708|FG004|Run-In Period|Adverse Event|0
4645669|NCT02031640|7523709|FG005|Run-In Period|Adverse Event|0
4645670|NCT02031640|7523704|FG000|Run-In Period|Withdrawal by Subject|17
4645671|NCT02031640|7523705|FG001|Run-In Period|Withdrawal by Subject|0
4645672|NCT02031640|7523706|FG002|Run-In Period|Withdrawal by Subject|0
4645673|NCT02031640|7523707|FG003|Run-In Period|Withdrawal by Subject|0
4645674|NCT02031640|7523708|FG004|Run-In Period|Withdrawal by Subject|0
4645675|NCT02031640|7523709|FG005|Run-In Period|Withdrawal by Subject|0
4645676|NCT02031640|7523704|FG000|Run-In Period|Inclusion criteria not met|38
4645677|NCT02031640|7523705|FG001|Run-In Period|Inclusion criteria not met|0
4645678|NCT02031640|7523706|FG002|Run-In Period|Inclusion criteria not met|0
4645679|NCT02031640|7523707|FG003|Run-In Period|Inclusion criteria not met|0
4645680|NCT02031640|7523708|FG004|Run-In Period|Inclusion criteria not met|0
4645681|NCT02031640|7523709|FG005|Run-In Period|Inclusion criteria not met|0
4645682|NCT02031640|7523704|FG000|Run-In Period|Exclusion criteria met|8
4645683|NCT02031640|7523705|FG001|Run-In Period|Exclusion criteria met|0
4645684|NCT02031640|7523706|FG002|Run-In Period|Exclusion criteria met|0
4645685|NCT02031640|7523707|FG003|Run-In Period|Exclusion criteria met|0
4645686|NCT02031640|7523708|FG004|Run-In Period|Exclusion criteria met|0
4645687|NCT02031640|7523709|FG005|Run-In Period|Exclusion criteria met|0
4645688|NCT02031640|7523704|FG000|Run-In Period|Randomization criteria not met|85
4645689|NCT02031640|7523705|FG001|Run-In Period|Randomization criteria not met|0
4645690|NCT02031640|7523706|FG002|Run-In Period|Randomization criteria not met|0
4645691|NCT02031640|7523707|FG003|Run-In Period|Randomization criteria not met|0
4645692|NCT02031640|7523708|FG004|Run-In Period|Randomization criteria not met|0
4645693|NCT02031640|7523709|FG005|Run-In Period|Randomization criteria not met|0
4645694|NCT02031640|7523704|FG000|Run-In Period|Various administrative reasons|17
4645695|NCT02031640|7523705|FG001|Run-In Period|Various administrative reasons|0
4645696|NCT02031640|7523706|FG002|Run-In Period|Various administrative reasons|0
4645697|NCT02031640|7523707|FG003|Run-In Period|Various administrative reasons|0
4645698|NCT02031640|7523708|FG004|Run-In Period|Various administrative reasons|0
4645699|NCT02031640|7523709|FG005|Run-In Period|Various administrative reasons|0
4645700|NCT02031640|7523704|FG000|Double-blind Treatment Period|Protocol deviation|0
4645701|NCT02031640|7523705|FG001|Double-blind Treatment Period|Protocol deviation|2
4645702|NCT02031640|7523706|FG002|Double-blind Treatment Period|Protocol deviation|0
4645703|NCT02031640|7523707|FG003|Double-blind Treatment Period|Protocol deviation|1
4645704|NCT02031640|7523708|FG004|Double-blind Treatment Period|Protocol deviation|3
4645705|NCT02031640|7523709|FG005|Double-blind Treatment Period|Protocol deviation|1
4645706|NCT02031640|7523704|FG000|Double-blind Treatment Period|Lack of Efficacy|0
4645707|NCT02031640|7523705|FG001|Double-blind Treatment Period|Lack of Efficacy|14
4645708|NCT02031640|7523706|FG002|Double-blind Treatment Period|Lack of Efficacy|3
4645709|NCT02031640|7523707|FG003|Double-blind Treatment Period|Lack of Efficacy|2
4645710|NCT02031640|7523708|FG004|Double-blind Treatment Period|Lack of Efficacy|5
4645711|NCT02031640|7523709|FG005|Double-blind Treatment Period|Lack of Efficacy|1
4645712|NCT02031640|7523704|FG000|Double-blind Treatment Period|Non-compliance|0
4645713|NCT02031640|7523705|FG001|Double-blind Treatment Period|Non-compliance|1
4645714|NCT02031640|7523706|FG002|Double-blind Treatment Period|Non-compliance|0
4645715|NCT02031640|7523707|FG003|Double-blind Treatment Period|Non-compliance|1
4645716|NCT02031640|7523708|FG004|Double-blind Treatment Period|Non-compliance|1
4645717|NCT02031640|7523709|FG005|Double-blind Treatment Period|Non-compliance|0
4645718|NCT02031640|7523704|FG000|Double-blind Treatment Period|Adverse Event|0
4645719|NCT02031640|7523705|FG001|Double-blind Treatment Period|Adverse Event|0
4645720|NCT02031640|7523706|FG002|Double-blind Treatment Period|Adverse Event|0
4645721|NCT02031640|7523707|FG003|Double-blind Treatment Period|Adverse Event|2
4645722|NCT02031640|7523708|FG004|Double-blind Treatment Period|Adverse Event|0
4645723|NCT02031640|7523709|FG005|Double-blind Treatment Period|Adverse Event|0
4645724|NCT02031640|7523704|FG000|Double-blind Treatment Period|Withdrawal by Subject|0
4645725|NCT02031640|7523705|FG001|Double-blind Treatment Period|Withdrawal by Subject|2
4645726|NCT02031640|7523706|FG002|Double-blind Treatment Period|Withdrawal by Subject|3
4645727|NCT02031640|7523707|FG003|Double-blind Treatment Period|Withdrawal by Subject|1
4645728|NCT02031640|7523708|FG004|Double-blind Treatment Period|Withdrawal by Subject|1
4645729|NCT02031640|7523709|FG005|Double-blind Treatment Period|Withdrawal by Subject|1
4645730|NCT02031640|7523704|FG000|Double-blind Treatment Period|Lost to Follow-up|0
4645731|NCT02031640|7523705|FG001|Double-blind Treatment Period|Lost to Follow-up|3
4645732|NCT02031640|7523706|FG002|Double-blind Treatment Period|Lost to Follow-up|0
4645733|NCT02031640|7523707|FG003|Double-blind Treatment Period|Lost to Follow-up|0
4645734|NCT02031640|7523708|FG004|Double-blind Treatment Period|Lost to Follow-up|1
4645735|NCT02031640|7523709|FG005|Double-blind Treatment Period|Lost to Follow-up|0
4645736|NCT02031679|7523730|FG000|Overall Study|Protocol Violation|0
4645737|NCT02031679|7523731|FG001|Overall Study|Protocol Violation|1
4645738|NCT02031679|7523730|FG000|Overall Study|Lack of Efficacy|0
4645739|NCT02031679|7523731|FG001|Overall Study|Lack of Efficacy|1
4645740|NCT02032173|7523748|FG000|Overall Study|Discontinuation due to sponsor decision|31
4645741|NCT02032238|7523771|FG000|Overall Study|Lost to Follow-up|2
4645742|NCT02032238|7523772|FG001|Overall Study|Lost to Follow-up|0
4645743|NCT02032407|7523778|FG000|Overall Study|Lost to Follow-up|2
4645744|NCT02032407|7523778|FG000|Overall Study|Pregnancy|1
4645745|NCT02032407|7523778|FG000|Overall Study|Other Miscellaneous Reasons|2
4645746|NCT02032706|7523824|FG000|Overall Study|Did not qualify|5
4645747|NCT02032706|7523824|FG000|Overall Study|Protocol Violation|1
4645748|NCT02032875|7523852|FG000|Treatment Period|Adverse Event|1
4645749|NCT02032875|7523853|FG001|Treatment Period|Adverse Event|0
4645750|NCT02032875|7523852|FG000|Treatment Period|Liver transplant, No extension needed|0
4645751|NCT02032875|7523853|FG001|Treatment Period|Liver transplant, No extension needed|1
4645752|NCT02032875|7523852|FG000|Treatment Period|Liver transplant, Treatment extension|0
4645753|NCT02032875|7523853|FG001|Treatment Period|Liver transplant, Treatment extension|3
4645754|NCT02032875|7523852|FG000|Follow-up Period|Death|0
4645755|NCT02032875|7523853|FG001|Follow-up Period|Death|1
4645756|NCT02032875|7523852|FG000|Follow-up Period|Virologic Relapse|3
4645757|NCT02032875|7523853|FG001|Follow-up Period|Virologic Relapse|10
4645758|NCT02032888|7523863|FG000|Treatment Period|Poor compliance/noncompliance|1
4645759|NCT02032888|7523864|FG001|Treatment Period|Poor compliance/noncompliance|1
4645760|NCT02032888|7523865|FG002|Treatment Period|Poor compliance/noncompliance|0
4645761|NCT02032888|7523863|FG000|Treatment Period|Other|1
4645762|NCT02032888|7523864|FG001|Treatment Period|Other|1
4645763|NCT02032888|7523865|FG002|Treatment Period|Other|0
4645764|NCT02032888|7523863|FG000|Follow-up Period|Lost to Follow-up|1
4645765|NCT02032888|7523864|FG001|Follow-up Period|Lost to Follow-up|1
4645766|NCT02032888|7523865|FG002|Follow-up Period|Lost to Follow-up|0
4645767|NCT02032888|7523863|FG000|Follow-up Period|Death|1
4645768|NCT02032888|7523864|FG001|Follow-up Period|Death|1
4645769|NCT02032888|7523865|FG002|Follow-up Period|Death|0
4645770|NCT02032888|7523863|FG000|Follow-up Period|Other|1
4645771|NCT02032888|7523864|FG001|Follow-up Period|Other|0
4645772|NCT02032888|7523865|FG002|Follow-up Period|Other|0
4645773|NCT02032901|7523884|FG000|Treatment Period (12 Weeks)|Pregnancy|1
4645774|NCT02032901|7523885|FG001|Treatment Period (12 Weeks)|Pregnancy|0
4645775|NCT02032901|7523884|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0
4645776|NCT02032901|7523885|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1
4747619|NCT03959423|7721693|FG000|Overall Study|Withdrawal by Subject|2
4747620|NCT03959423|7721694|FG001|Overall Study|Withdrawal by Subject|3
4747621|NCT03959423|7721693|FG000|Overall Study|Physician Decision|0
4747622|NCT03959423|7721694|FG001|Overall Study|Physician Decision|1
4747623|NCT03959423|7721693|FG000|Overall Study|Lost to Follow-up|1
4747624|NCT03959423|7721694|FG001|Overall Study|Lost to Follow-up|0
4747625|NCT03959423|7721693|FG000|Overall Study|Withdrawal by Parent/Guardian|6
4645777|NCT02033369|7523949|FG000|Overall Study|Physician Decision|1
4645778|NCT02033369|7523950|FG001|Overall Study|Physician Decision|2
4645779|NCT02033369|7523949|FG000|Overall Study|Not a good demographic match|0
4645780|NCT02033369|7523950|FG001|Overall Study|Not a good demographic match|2
4645781|NCT02033369|7523949|FG000|Overall Study|Withdrawal by Subject|1
4645782|NCT02033369|7523950|FG001|Overall Study|Withdrawal by Subject|1
4645783|NCT02033369|7523949|FG000|Overall Study|Lost to Follow-up|1
4645784|NCT02033369|7523950|FG001|Overall Study|Lost to Follow-up|0
4645785|NCT02033369|7523949|FG000|Overall Study|Protocol Violation|2
4645786|NCT02033369|7523950|FG001|Overall Study|Protocol Violation|0
4645787|NCT02033759|7523988|FG000|Overall Study|Withdrawal by Subject|2
4645788|NCT02033759|7523989|FG001|Overall Study|Withdrawal by Subject|1
4645789|NCT02033759|7523988|FG000|Overall Study|Protocol Violation|1
4645790|NCT02033759|7523989|FG001|Overall Study|Protocol Violation|1
4645791|NCT02033850|7523997|FG000|Overall Study|Death|1
4645792|NCT02033850|7523998|FG001|Overall Study|Death|0
4645793|NCT02033850|7523997|FG000|Overall Study|unrelated medical reason|1
4645794|NCT02033850|7523998|FG001|Overall Study|unrelated medical reason|1
4645795|NCT02033889|7524016|FG000|Overall Study|Adverse Event|3
4645796|NCT02033889|7524017|FG001|Overall Study|Adverse Event|1
4645797|NCT02033889|7524018|FG002|Overall Study|Adverse Event|3
4645798|NCT02033889|7524016|FG000|Overall Study|Death|3
4645799|NCT02033889|7524017|FG001|Overall Study|Death|1
4645800|NCT02033889|7524018|FG002|Overall Study|Death|2
4645801|NCT02033889|7524016|FG000|Overall Study|Excluded Medication|1
4645802|NCT02033889|7524017|FG001|Overall Study|Excluded Medication|1
4645803|NCT02033889|7524018|FG002|Overall Study|Excluded Medication|0
4645804|NCT02033889|7524016|FG000|Overall Study|Lost to Follow-up|8
4645805|NCT02033889|7524017|FG001|Overall Study|Lost to Follow-up|5
4645806|NCT02033889|7524018|FG002|Overall Study|Lost to Follow-up|6
4747626|NCT03959423|7721694|FG001|Overall Study|Withdrawal by Parent/Guardian|0
4645807|NCT02033889|7524016|FG000|Overall Study|Non-Compliance With Study Drug|1
4645808|NCT02033889|7524017|FG001|Overall Study|Non-Compliance With Study Drug|0
4645809|NCT02033889|7524018|FG002|Overall Study|Non-Compliance With Study Drug|0
4645810|NCT02033889|7524016|FG000|Overall Study|Physician Decision|0
4645811|NCT02033889|7524017|FG001|Overall Study|Physician Decision|1
4645812|NCT02033889|7524018|FG002|Overall Study|Physician Decision|1
4645813|NCT02033889|7524016|FG000|Overall Study|Participant moved|0
4645814|NCT02033889|7524017|FG001|Overall Study|Participant moved|1
4645815|NCT02033889|7524018|FG002|Overall Study|Participant moved|0
4645816|NCT02033889|7524016|FG000|Overall Study|Withdrawal by Subject|18
4645817|NCT02033889|7524017|FG001|Overall Study|Withdrawal by Subject|10
4645818|NCT02033889|7524018|FG002|Overall Study|Withdrawal by Subject|13
4645819|NCT02034006|7524037|FG000|Overall Study|Withdrawal by Subject|7
4645820|NCT02034006|7524037|FG000|Overall Study|Lost to Follow-up|5
4645821|NCT02034006|7524037|FG000|Overall Study|Death|1
4645822|NCT02034006|7524037|FG000|Overall Study|Pregnancy|1
4645823|NCT02034058|7524053|FG000|Overall Study|Death|3
4645824|NCT02034162|7524059|FG000|Double-blind|Lost to Follow-up|3
4645825|NCT02034162|7524060|FG001|Double-blind|Lost to Follow-up|0
4645826|NCT02034162|7524061|FG002|Double-blind|Lost to Follow-up|0
4645827|NCT02034162|7524059|FG000|Double-blind|Physician Decision|1
4645828|NCT02034162|7524060|FG001|Double-blind|Physician Decision|0
4645829|NCT02034162|7524061|FG002|Double-blind|Physician Decision|0
4645830|NCT02034162|7524059|FG000|Double-blind|Protocol Violation|0
4645831|NCT02034162|7524060|FG001|Double-blind|Protocol Violation|1
4645832|NCT02034162|7524061|FG002|Double-blind|Protocol Violation|0
4645833|NCT02034162|7524059|FG000|Double-blind|Withdrawal by Subject|5
4645834|NCT02034162|7524060|FG001|Double-blind|Withdrawal by Subject|7
4645835|NCT02034162|7524061|FG002|Double-blind|Withdrawal by Subject|0
4645836|NCT02034409|7524078|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4
4645837|NCT02034409|7524079|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0
4645838|NCT02034409|7524078|FG000|Sham-Controlled Treatment Period|Adverse Event|1
4645839|NCT02034409|7524079|FG001|Sham-Controlled Treatment Period|Adverse Event|1
4645840|NCT02034409|7524078|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0
4645841|NCT02034409|7524079|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1
4645842|NCT02034409|7524078|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8
4645843|NCT02034409|7524079|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8
4645844|NCT02034409|7524078|FG000|Sham-Controlled Treatment Period|Physician Decision|1
4645845|NCT02034409|7524079|FG001|Sham-Controlled Treatment Period|Physician Decision|3
4645846|NCT02034409|7524078|FG000|Sham-Controlled Treatment Period|misrandomized|2
4645847|NCT02034409|7524079|FG001|Sham-Controlled Treatment Period|misrandomized|2
4645848|NCT02034435|7524087|FG000|Overall Study|Withdrawal by Subject|1
4645849|NCT02034435|7524088|FG001|Overall Study|Withdrawal by Subject|0
4645850|NCT02034435|7524089|FG002|Overall Study|Withdrawal by Subject|0
4645851|NCT02034435|7524090|FG003|Overall Study|Withdrawal by Subject|0
4645852|NCT02034435|7524087|FG000|Overall Study|Illness|0
4645853|NCT02034435|7524088|FG001|Overall Study|Illness|2
4645854|NCT02034435|7524089|FG002|Overall Study|Illness|0
4645855|NCT02034435|7524090|FG003|Overall Study|Illness|0
4645856|NCT02034435|7524087|FG000|Overall Study|Inadequate IV access|1
4645857|NCT02034435|7524088|FG001|Overall Study|Inadequate IV access|0
4645858|NCT02034435|7524089|FG002|Overall Study|Inadequate IV access|0
4645859|NCT02034435|7524090|FG003|Overall Study|Inadequate IV access|1
4645860|NCT02034474|7524102|FG000|Overall Study|Adverse Event|3
4645861|NCT02034474|7524103|FG001|Overall Study|Adverse Event|2
4645862|NCT02034474|7524102|FG000|Overall Study|Withdrawal by Subject|1
4645863|NCT02034474|7524103|FG001|Overall Study|Withdrawal by Subject|2
4645864|NCT02034513|7524113|FG000|Overall Study|Adverse Event|11
4645865|NCT02034513|7524114|FG001|Overall Study|Adverse Event|10
4645866|NCT02034513|7524113|FG000|Overall Study|Lack of Efficacy|0
4645867|NCT02034513|7524114|FG001|Overall Study|Lack of Efficacy|1
4645868|NCT02034513|7524113|FG000|Overall Study|Lost to Follow-up|6
4645869|NCT02034513|7524114|FG001|Overall Study|Lost to Follow-up|7
4645870|NCT02034513|7524113|FG000|Overall Study|Pregnancy|0
4645871|NCT02034513|7524114|FG001|Overall Study|Pregnancy|3
4645872|NCT02034513|7524113|FG000|Overall Study|Protocol Violation|7
4645873|NCT02034513|7524114|FG001|Overall Study|Protocol Violation|10
4645874|NCT02034513|7524113|FG000|Overall Study|Withdrawal by Subject|25
4645875|NCT02034513|7524114|FG001|Overall Study|Withdrawal by Subject|25
4645876|NCT02034513|7524113|FG000|Overall Study|Unclassified|0
4645877|NCT02034513|7524114|FG001|Overall Study|Unclassified|1
4645878|NCT02034552|7524125|FG000|Overall Study|Never treated|3
4645879|NCT02034552|7524126|FG001|Overall Study|Never treated|2
4645880|NCT02034552|7524127|FG002|Overall Study|Never treated|0
4645881|NCT02034552|7524125|FG000|Overall Study|Radiological progression|3
4645882|NCT02034552|7524126|FG001|Overall Study|Radiological progression|5
4645883|NCT02034552|7524127|FG002|Overall Study|Radiological progression|4
4645884|NCT02034552|7524125|FG000|Overall Study|AE not assoc. with disease progression|1
4645885|NCT02034552|7524126|FG001|Overall Study|AE not assoc. with disease progression|4
4645886|NCT02034552|7524127|FG002|Overall Study|AE not assoc. with disease progression|2
4645887|NCT02034552|7524125|FG000|Overall Study|AE associated with disease progression|0
4645888|NCT02034552|7524126|FG001|Overall Study|AE associated with disease progression|1
4645889|NCT02034552|7524127|FG002|Overall Study|AE associated with disease progression|0
4645890|NCT02034552|7524125|FG000|Overall Study|Withdrawal by Subject|2
4645891|NCT02034552|7524126|FG001|Overall Study|Withdrawal by Subject|1
4645892|NCT02034552|7524127|FG002|Overall Study|Withdrawal by Subject|1
4645893|NCT02034552|7524125|FG000|Overall Study|Non-compliance with study drug|0
4645894|NCT02034552|7524126|FG001|Overall Study|Non-compliance with study drug|0
4645895|NCT02034552|7524127|FG002|Overall Study|Non-compliance with study drug|1
4645896|NCT02034552|7524125|FG000|Overall Study|Clinical progression|5
4645897|NCT02034552|7524126|FG001|Overall Study|Clinical progression|7
4645898|NCT02034552|7524127|FG002|Overall Study|Clinical progression|9
4645899|NCT02034565|7524135|FG000|Overall Study|Adverse Event|1
4645900|NCT02034565|7524136|FG001|Overall Study|Adverse Event|0
4645901|NCT02034591|7524158|FG000|Overall Study|Withdrawal by Subject|0
4645902|NCT02034591|7524159|FG001|Overall Study|Withdrawal by Subject|0
4645903|NCT02034591|7524160|FG002|Overall Study|Withdrawal by Subject|0
4645904|NCT02034591|7524161|FG003|Overall Study|Withdrawal by Subject|0
4645905|NCT02034591|7524162|FG004|Overall Study|Withdrawal by Subject|1
4645906|NCT02034591|7524163|FG005|Overall Study|Withdrawal by Subject|0
4645907|NCT02034708|7524174|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2
4645908|NCT02034708|7524175|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5
4645909|NCT02034708|7524174|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1
4645910|NCT02034708|7524175|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0
4645911|NCT02034708|7524174|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3
4645912|NCT02034708|7524175|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3
4645913|NCT02034708|7524174|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3
4645914|NCT02034708|7524175|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2
4645915|NCT02034799|7524188|FG000|Overall Study|Withdrawal by Subject|0
4645916|NCT02034799|7524189|FG001|Overall Study|Withdrawal by Subject|2
4645917|NCT02034799|7524188|FG000|Overall Study|Lost to Follow-up|0
4645918|NCT02034799|7524189|FG001|Overall Study|Lost to Follow-up|1
4645919|NCT02034799|7524188|FG000|Overall Study|Death|2
4645920|NCT02034799|7524189|FG001|Overall Study|Death|1
4645921|NCT02034877|7524197|FG000|Overall Study|Lost to Follow-up|0
4645922|NCT02034877|7524198|FG001|Overall Study|Lost to Follow-up|3
4645923|NCT02034877|7524197|FG000|Overall Study|No Longer Willing to Participate|0
4645924|NCT02034877|7524198|FG001|Overall Study|No Longer Willing to Participate|3
4645925|NCT02034916|7524206|FG000|Overall Study|Death|39
4645926|NCT02034916|7524207|FG001|Overall Study|Death|28
4645927|NCT02034916|7524206|FG000|Overall Study|Withdrawal by Subject|2
4645928|NCT02034916|7524207|FG001|Overall Study|Withdrawal by Subject|1
4645929|NCT02034916|7524206|FG000|Overall Study|Lost to Follow-up|4
4645930|NCT02034916|7524207|FG001|Overall Study|Lost to Follow-up|1
4645931|NCT02034916|7524206|FG000|Overall Study|Study terminated by sponsor|4
4645932|NCT02034916|7524207|FG001|Overall Study|Study terminated by sponsor|5
4645933|NCT02035202|7524217|FG000|Overall Study|Lost to Follow-up|8
4645934|NCT02035202|7524218|FG001|Overall Study|Lost to Follow-up|16
4645935|NCT02035202|7524219|FG002|Overall Study|Lost to Follow-up|2
4645936|NCT02035267|7524231|FG000|Overall Study|Withdrawal consent-subject convenience|0
4645937|NCT02035267|7524232|FG001|Overall Study|Withdrawal consent-subject convenience|0
4645938|NCT02035267|7524233|FG002|Overall Study|Withdrawal consent-subject convenience|1
4645939|NCT02035267|7524234|FG003|Overall Study|Withdrawal consent-subject convenience|0
4645940|NCT02035267|7524231|FG000|Overall Study|Adverse Event|0
4645941|NCT02035267|7524232|FG001|Overall Study|Adverse Event|0
4645942|NCT02035267|7524233|FG002|Overall Study|Adverse Event|1
4645943|NCT02035267|7524234|FG003|Overall Study|Adverse Event|0
4645944|NCT02035267|7524231|FG000|Overall Study|Lost to Follow-up|0
4645945|NCT02035267|7524232|FG001|Overall Study|Lost to Follow-up|0
4645946|NCT02035267|7524233|FG002|Overall Study|Lost to Follow-up|0
4645947|NCT02035267|7524234|FG003|Overall Study|Lost to Follow-up|1
4645948|NCT02035267|7524231|FG000|Overall Study|Other unspecified|0
4645949|NCT02035267|7524232|FG001|Overall Study|Other unspecified|1
4645950|NCT02035267|7524233|FG002|Overall Study|Other unspecified|0
4645951|NCT02035267|7524234|FG003|Overall Study|Other unspecified|0
4645952|NCT02035332|7524246|FG000|Overall Study|Procedure Aborted due to Uterine Width|1
4645953|NCT02035475|7524255|FG000|Overall Study|Withdrawal by Subject|4
4645954|NCT02035475|7524255|FG000|Overall Study|Physician Decision|1
4645955|NCT02035475|7524255|FG000|Overall Study|Equipment Error|1
4645956|NCT02035553|7524263|FG000|Overall Study|Death (See All-Cause Mortality Table)|0
4645957|NCT02035553|7524264|FG001|Overall Study|Death (See All-Cause Mortality Table)|1
4645958|NCT02035553|7524263|FG000|Overall Study|Adverse Event|10
4645959|NCT02035553|7524264|FG001|Overall Study|Adverse Event|6
4645960|NCT02035553|7524263|FG000|Overall Study|Physician Decision|3
4645961|NCT02035553|7524264|FG001|Overall Study|Physician Decision|2
4645962|NCT02035553|7524263|FG000|Overall Study|Lack of Efficacy|1
4645963|NCT02035553|7524264|FG001|Overall Study|Lack of Efficacy|1
4645964|NCT02035553|7524263|FG000|Overall Study|Withdrawal by Subject|4
4645965|NCT02035553|7524264|FG001|Overall Study|Withdrawal by Subject|7
4645966|NCT02035553|7524263|FG000|Overall Study|Non-compliance with Study Drug|0
4645967|NCT02035553|7524264|FG001|Overall Study|Non-compliance with Study Drug|1
4645968|NCT02035553|7524263|FG000|Overall Study|Lost to Follow-up|0
4645969|NCT02035553|7524264|FG001|Overall Study|Lost to Follow-up|1
4645970|NCT02035553|7524263|FG000|Overall Study|Other Reason|0
4645971|NCT02035553|7524264|FG001|Overall Study|Other Reason|4
4645972|NCT02035696|7524274|FG000|Overall Study|Lost to Follow-up|0
4645973|NCT02035696|7524275|FG001|Overall Study|Lost to Follow-up|3
4645974|NCT02035696|7524276|FG002|Overall Study|Lost to Follow-up|1
4645975|NCT02035696|7524277|FG003|Overall Study|Lost to Follow-up|2
4645976|NCT02035696|7524274|FG000|Overall Study|Withdrawal by Subject|3
4645977|NCT02035696|7524275|FG001|Overall Study|Withdrawal by Subject|0
4645978|NCT02035696|7524276|FG002|Overall Study|Withdrawal by Subject|2
4645979|NCT02035696|7524277|FG003|Overall Study|Withdrawal by Subject|1
4645980|NCT02035748|7524291|FG000|Overall Study|Adverse Event|5
4645981|NCT02035748|7524291|FG000|Overall Study|Death|3
4645982|NCT02035748|7524291|FG000|Overall Study|Lost to Follow-up|2
4645983|NCT02035748|7524291|FG000|Overall Study|Physician Decision|3
4645984|NCT02035748|7524291|FG000|Overall Study|Withdrawal by Subject|6
4645985|NCT02035748|7524291|FG000|Overall Study|Progressive Disease|1
4645986|NCT02036294|7524298|FG000|Overall Study|Death|7
4645987|NCT02036294|7524299|FG001|Overall Study|Death|8
4645988|NCT02036294|7524298|FG000|Overall Study|Withdrawal by Subject|2
4645989|NCT02036294|7524299|FG001|Overall Study|Withdrawal by Subject|3
4645990|NCT02036502|7524329|FG000|Part 1:Dose Determination/Escalation|Death|3
4645991|NCT02036502|7524330|FG001|Part 1:Dose Determination/Escalation|Death|2
4645992|NCT02036502|7524331|FG002|Part 1:Dose Determination/Escalation|Death|0
4645993|NCT02036502|7524332|FG003|Part 1:Dose Determination/Escalation|Death|0
4645994|NCT02036502|7524333|FG004|Part 1:Dose Determination/Escalation|Death|0
4645995|NCT02036502|7524334|FG005|Part 1:Dose Determination/Escalation|Death|0
4645996|NCT02036502|7524335|FG006|Part 1:Dose Determination/Escalation|Death|0
4645997|NCT02036502|7524336|FG007|Part 1:Dose Determination/Escalation|Death|0
4645998|NCT02036502|7524329|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3
4645999|NCT02036502|7524330|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0
4646000|NCT02036502|7524331|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0
4646001|NCT02036502|7524332|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0
4646002|NCT02036502|7524333|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0
4646003|NCT02036502|7524334|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0
4646004|NCT02036502|7524335|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0
4646005|NCT02036502|7524336|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0
4646006|NCT02036502|7524329|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0
4646007|NCT02036502|7524330|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1
4646008|NCT02036502|7524331|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0
4646009|NCT02036502|7524332|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0
4646010|NCT02036502|7524333|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0
4646011|NCT02036502|7524334|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0
4646012|NCT02036502|7524335|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0
4646013|NCT02036502|7524336|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0
4646014|NCT02036502|7524329|FG000|Part 1:Dose Determination/Escalation|Not treated|0
4646015|NCT02036502|7524330|FG001|Part 1:Dose Determination/Escalation|Not treated|1
4646016|NCT02036502|7524331|FG002|Part 1:Dose Determination/Escalation|Not treated|0
4646017|NCT02036502|7524332|FG003|Part 1:Dose Determination/Escalation|Not treated|0
4646018|NCT02036502|7524333|FG004|Part 1:Dose Determination/Escalation|Not treated|0
4646019|NCT02036502|7524334|FG005|Part 1:Dose Determination/Escalation|Not treated|0
4646020|NCT02036502|7524335|FG006|Part 1:Dose Determination/Escalation|Not treated|0
4646021|NCT02036502|7524336|FG007|Part 1:Dose Determination/Escalation|Not treated|0
4646022|NCT02036502|7524329|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0
4646023|NCT02036502|7524330|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0
4646024|NCT02036502|7524331|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2
4646025|NCT02036502|7524332|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1
4646026|NCT02036502|7524333|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1
4646027|NCT02036502|7524334|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0
4646028|NCT02036502|7524335|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0
4646029|NCT02036502|7524336|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0
4646030|NCT02036502|7524329|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0
4646031|NCT02036502|7524330|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0
4646032|NCT02036502|7524331|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3
4646033|NCT02036502|7524332|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0
4646034|NCT02036502|7524333|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0
4646035|NCT02036502|7524334|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0
4646036|NCT02036502|7524335|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0
4646037|NCT02036502|7524336|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0
4646038|NCT02036502|7524329|FG000|Part 2:Dose Confirmation|Death|0
4646039|NCT02036502|7524330|FG001|Part 2:Dose Confirmation|Death|0
4646040|NCT02036502|7524331|FG002|Part 2:Dose Confirmation|Death|1
4646041|NCT02036502|7524332|FG003|Part 2:Dose Confirmation|Death|0
4646042|NCT02036502|7524333|FG004|Part 2:Dose Confirmation|Death|0
4646043|NCT02036502|7524334|FG005|Part 2:Dose Confirmation|Death|0
4646044|NCT02036502|7524335|FG006|Part 2:Dose Confirmation|Death|0
4646045|NCT02036502|7524336|FG007|Part 2:Dose Confirmation|Death|0
4646046|NCT02036502|7524329|FG000|Part 2:Dose Confirmation|Not treated|0
4646047|NCT02036502|7524330|FG001|Part 2:Dose Confirmation|Not treated|0
4646048|NCT02036502|7524331|FG002|Part 2:Dose Confirmation|Not treated|0
4646049|NCT02036502|7524332|FG003|Part 2:Dose Confirmation|Not treated|1
4646050|NCT02036502|7524333|FG004|Part 2:Dose Confirmation|Not treated|0
4646051|NCT02036502|7524334|FG005|Part 2:Dose Confirmation|Not treated|0
4646052|NCT02036502|7524335|FG006|Part 2:Dose Confirmation|Not treated|0
4646053|NCT02036502|7524336|FG007|Part 2:Dose Confirmation|Not treated|0
4646054|NCT02036502|7524329|FG000|Part 3:Dose Expansion|Adverse Event|0
4646055|NCT02036502|7524330|FG001|Part 3:Dose Expansion|Adverse Event|0
4646056|NCT02036502|7524331|FG002|Part 3:Dose Expansion|Adverse Event|0
4646057|NCT02036502|7524332|FG003|Part 3:Dose Expansion|Adverse Event|0
4646058|NCT02036502|7524333|FG004|Part 3:Dose Expansion|Adverse Event|0
4646059|NCT02036502|7524334|FG005|Part 3:Dose Expansion|Adverse Event|4
4646060|NCT02036502|7524335|FG006|Part 3:Dose Expansion|Adverse Event|0
4646061|NCT02036502|7524336|FG007|Part 3:Dose Expansion|Adverse Event|2
4646062|NCT02036502|7524329|FG000|Part 3:Dose Expansion|Death|0
4646063|NCT02036502|7524330|FG001|Part 3:Dose Expansion|Death|0
4646064|NCT02036502|7524331|FG002|Part 3:Dose Expansion|Death|0
4646065|NCT02036502|7524332|FG003|Part 3:Dose Expansion|Death|0
4646066|NCT02036502|7524333|FG004|Part 3:Dose Expansion|Death|0
4646067|NCT02036502|7524334|FG005|Part 3:Dose Expansion|Death|24
4646068|NCT02036502|7524335|FG006|Part 3:Dose Expansion|Death|0
4646069|NCT02036502|7524336|FG007|Part 3:Dose Expansion|Death|3
4646070|NCT02036502|7524329|FG000|Part 3:Dose Expansion|Lost to Follow-up|0
4646071|NCT02036502|7524330|FG001|Part 3:Dose Expansion|Lost to Follow-up|0
4646072|NCT02036502|7524331|FG002|Part 3:Dose Expansion|Lost to Follow-up|0
4646073|NCT02036502|7524332|FG003|Part 3:Dose Expansion|Lost to Follow-up|0
4646074|NCT02036502|7524333|FG004|Part 3:Dose Expansion|Lost to Follow-up|0
4646075|NCT02036502|7524334|FG005|Part 3:Dose Expansion|Lost to Follow-up|0
4646076|NCT02036502|7524335|FG006|Part 3:Dose Expansion|Lost to Follow-up|0
4646077|NCT02036502|7524336|FG007|Part 3:Dose Expansion|Lost to Follow-up|1
4646078|NCT02036502|7524329|FG000|Part 3:Dose Expansion|Physician Decision|0
4646079|NCT02036502|7524330|FG001|Part 3:Dose Expansion|Physician Decision|0
4646080|NCT02036502|7524331|FG002|Part 3:Dose Expansion|Physician Decision|0
4646081|NCT02036502|7524332|FG003|Part 3:Dose Expansion|Physician Decision|0
4646082|NCT02036502|7524333|FG004|Part 3:Dose Expansion|Physician Decision|0
4646083|NCT02036502|7524334|FG005|Part 3:Dose Expansion|Physician Decision|1
4646084|NCT02036502|7524335|FG006|Part 3:Dose Expansion|Physician Decision|0
4646085|NCT02036502|7524336|FG007|Part 3:Dose Expansion|Physician Decision|0
4646086|NCT02036502|7524329|FG000|Part 3:Dose Expansion|Progressive Disease|0
4646087|NCT02036502|7524330|FG001|Part 3:Dose Expansion|Progressive Disease|0
4646088|NCT02036502|7524331|FG002|Part 3:Dose Expansion|Progressive Disease|0
4646089|NCT02036502|7524332|FG003|Part 3:Dose Expansion|Progressive Disease|0
4646090|NCT02036502|7524333|FG004|Part 3:Dose Expansion|Progressive Disease|0
4646091|NCT02036502|7524334|FG005|Part 3:Dose Expansion|Progressive Disease|1
4646092|NCT02036502|7524335|FG006|Part 3:Dose Expansion|Progressive Disease|0
4646093|NCT02036502|7524336|FG007|Part 3:Dose Expansion|Progressive Disease|0
4646094|NCT02036502|7524329|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0
4646095|NCT02036502|7524330|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0
4646096|NCT02036502|7524331|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0
4646097|NCT02036502|7524332|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0
4646098|NCT02036502|7524333|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0
4646099|NCT02036502|7524334|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11
4646100|NCT02036502|7524335|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0
4646101|NCT02036502|7524336|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2
4646102|NCT02036502|7524329|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0
4646103|NCT02036502|7524330|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0
4646104|NCT02036502|7524331|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0
4646105|NCT02036502|7524332|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0
4646106|NCT02036502|7524333|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0
4646107|NCT02036502|7524334|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4
4646108|NCT02036502|7524335|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1
4646109|NCT02036502|7524336|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2
4646110|NCT02036502|7524329|FG000|Part 3:Dose Expansion|Not Treated|0
4646111|NCT02036502|7524330|FG001|Part 3:Dose Expansion|Not Treated|0
4646112|NCT02036502|7524331|FG002|Part 3:Dose Expansion|Not Treated|0
4646113|NCT02036502|7524332|FG003|Part 3:Dose Expansion|Not Treated|0
4747627|NCT03713320|7721702|FG000|Randomized Period|Adverse Event|1
4747628|NCT03713320|7721703|FG001|Randomized Period|Adverse Event|5
4747629|NCT03713320|7721704|FG002|Randomized Period|Adverse Event|0
4747630|NCT03713320|7721702|FG000|Randomized Period|Physician Decision|1
4747631|NCT03713320|7721703|FG001|Randomized Period|Physician Decision|1
4747632|NCT03713320|7721704|FG002|Randomized Period|Physician Decision|0
4747633|NCT03713320|7721702|FG000|Randomized Period|Withdrawal by Subject|4
4747634|NCT03713320|7721703|FG001|Randomized Period|Withdrawal by Subject|0
4747635|NCT03713320|7721704|FG002|Randomized Period|Withdrawal by Subject|0
4747636|NCT03713320|7721702|FG000|Randomized Period|Participant decision|3
4747637|NCT03713320|7721703|FG001|Randomized Period|Participant decision|1
4747638|NCT03713320|7721704|FG002|Randomized Period|Participant decision|0
4747639|NCT03713320|7721702|FG000|Randomized Period|Study terminated by sponsor|6
4646114|NCT02036502|7524333|FG004|Part 3:Dose Expansion|Not Treated|0
4747640|NCT03713320|7721703|FG001|Randomized Period|Study terminated by sponsor|3
4747641|NCT03713320|7721704|FG002|Randomized Period|Study terminated by sponsor|0
4646115|NCT02036502|7524334|FG005|Part 3:Dose Expansion|Not Treated|2
4646116|NCT02036502|7524335|FG006|Part 3:Dose Expansion|Not Treated|0
4646117|NCT02036502|7524336|FG007|Part 3:Dose Expansion|Not Treated|0
4646118|NCT02036515|7524359|FG000|Overall Study|Adverse Event|1
4646119|NCT02036515|7524360|FG001|Overall Study|Adverse Event|1
4646120|NCT02036515|7524361|FG002|Overall Study|Adverse Event|2
4646121|NCT02036515|7524359|FG000|Overall Study|Lost to Follow-up|0
4646122|NCT02036515|7524360|FG001|Overall Study|Lost to Follow-up|2
4646123|NCT02036515|7524361|FG002|Overall Study|Lost to Follow-up|0
4646124|NCT02036515|7524359|FG000|Overall Study|Non-compliance with study drug|0
4646125|NCT02036515|7524360|FG001|Overall Study|Non-compliance with study drug|0
4646126|NCT02036515|7524361|FG002|Overall Study|Non-compliance with study drug|2
4646127|NCT02036515|7524359|FG000|Overall Study|Screen failure|0
4646128|NCT02036515|7524360|FG001|Overall Study|Screen failure|2
4646129|NCT02036515|7524361|FG002|Overall Study|Screen failure|0
4646130|NCT02036515|7524359|FG000|Overall Study|Withdrawal by Subject|4
4646131|NCT02036515|7524360|FG001|Overall Study|Withdrawal by Subject|7
4646132|NCT02036515|7524361|FG002|Overall Study|Withdrawal by Subject|9
4646133|NCT02036515|7524359|FG000|Overall Study|Hyperglycemia|0
4646134|NCT02036515|7524360|FG001|Overall Study|Hyperglycemia|0
4646135|NCT02036515|7524361|FG002|Overall Study|Hyperglycemia|1
4646136|NCT02036580|7524376|FG000|Overall Study|Withdrawal by Subject|0
4646137|NCT02036580|7524377|FG001|Overall Study|Withdrawal by Subject|1
4646138|NCT02036580|7524378|FG002|Overall Study|Withdrawal by Subject|0
4646139|NCT02036580|7524376|FG000|Overall Study|Adverse Event|1
4646140|NCT02036580|7524377|FG001|Overall Study|Adverse Event|0
4646141|NCT02036580|7524378|FG002|Overall Study|Adverse Event|0
4646142|NCT02036645|7524398|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0
4646143|NCT02036645|7524399|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0
4646144|NCT02036645|7524400|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0
4646145|NCT02036645|7524401|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0
4646146|NCT02036645|7524402|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0
4646147|NCT02036645|7524403|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0
4646148|NCT02036645|7524404|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1
4646149|NCT02036645|7524405|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0
4646150|NCT02036645|7524406|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0
4646151|NCT02036645|7524407|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0
4646152|NCT02036645|7524408|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0
4646153|NCT02036645|7524409|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0
4646154|NCT02036645|7524398|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
4646155|NCT02036645|7524399|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
4646156|NCT02036645|7524400|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
4646157|NCT02036645|7524401|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1
4646158|NCT02036645|7524402|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
4646159|NCT02036645|7524403|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
4646160|NCT02036645|7524404|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
4646161|NCT02036645|7524405|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
4646162|NCT02036645|7524406|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
4646163|NCT02036645|7524407|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
4646164|NCT02036645|7524408|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
4646165|NCT02036645|7524409|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
4646166|NCT02036775|7524447|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
4646167|NCT02036775|7524448|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
4646168|NCT02036775|7524449|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
4646169|NCT02036775|7524450|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
4646170|NCT02036775|7524451|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
4646171|NCT02036775|7524452|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1
4646172|NCT02036853|7524466|FG000|Overall Study|Adverse Event|0
4646173|NCT02036853|7524467|FG001|Overall Study|Adverse Event|2
4646174|NCT02036853|7524466|FG000|Overall Study|Lack of Efficacy|0
4646175|NCT02036853|7524467|FG001|Overall Study|Lack of Efficacy|2
4646176|NCT02036853|7524466|FG000|Overall Study|Physician Decision|0
4646177|NCT02036853|7524467|FG001|Overall Study|Physician Decision|1
4646178|NCT02036853|7524466|FG000|Overall Study|Withdrawal by Subject|0
4646179|NCT02036853|7524467|FG001|Overall Study|Withdrawal by Subject|1
4646180|NCT02037165|7524489|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0
4646181|NCT02037165|7524490|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0
4646182|NCT02037165|7524491|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0
4646183|NCT02037165|7524492|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0
4646184|NCT02037165|7524493|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1
4646185|NCT02037256|7524534|FG000|Overall Study|Protocol Violation|0
4646186|NCT02037256|7524535|FG001|Overall Study|Protocol Violation|1
4646187|NCT02037256|7524534|FG000|Overall Study|Withdrawn prior to Velcade|0
4646188|NCT02037256|7524535|FG001|Overall Study|Withdrawn prior to Velcade|2
4646189|NCT02037295|7524547|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1
4646190|NCT02037295|7524548|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0
4646191|NCT02037295|7524549|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0
4646192|NCT02037295|7524550|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1
4646193|NCT02037477|7524585|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0
4646194|NCT02037477|7524586|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0
4646195|NCT02037477|7524587|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1
4646196|NCT02037477|7524588|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0
4646197|NCT02037568|7524609|FG000|Overall Study|Withdrawal by Subject|17
4646198|NCT02037568|7524610|FG001|Overall Study|Withdrawal by Subject|24
4646199|NCT02037568|7524609|FG000|Overall Study|Lost to Follow-up|16
4646200|NCT02037568|7524610|FG001|Overall Study|Lost to Follow-up|13
4646201|NCT02037568|7524609|FG000|Overall Study|Screen Failure|3
4646202|NCT02037568|7524610|FG001|Overall Study|Screen Failure|1
4646203|NCT02037568|7524609|FG000|Overall Study|Patient did not receive transplant|0
4646204|NCT02037568|7524610|FG001|Overall Study|Patient did not receive transplant|1
4646205|NCT02037984|7524654|FG000|Overall Study|Lack of Efficacy|0
4646206|NCT02037984|7524655|FG001|Overall Study|Lack of Efficacy|0
4646207|NCT02037984|7524656|FG002|Overall Study|Lack of Efficacy|3
4646208|NCT02037984|7524657|FG003|Overall Study|Lack of Efficacy|10
4646209|NCT02037984|7524658|FG004|Overall Study|Lack of Efficacy|2
4646210|NCT02037984|7524659|FG005|Overall Study|Lack of Efficacy|2
4646211|NCT02037984|7524660|FG006|Overall Study|Lack of Efficacy|4
4646212|NCT02037984|7524661|FG007|Overall Study|Lack of Efficacy|3
4646213|NCT02037984|7524654|FG000|Overall Study|Lost to Follow-up|1
4646214|NCT02037984|7524655|FG001|Overall Study|Lost to Follow-up|0
4646215|NCT02037984|7524656|FG002|Overall Study|Lost to Follow-up|3
4646216|NCT02037984|7524657|FG003|Overall Study|Lost to Follow-up|5
4646217|NCT02037984|7524658|FG004|Overall Study|Lost to Follow-up|2
4646218|NCT02037984|7524659|FG005|Overall Study|Lost to Follow-up|2
4646219|NCT02037984|7524660|FG006|Overall Study|Lost to Follow-up|2
4646220|NCT02037984|7524661|FG007|Overall Study|Lost to Follow-up|4
4646221|NCT02037984|7524654|FG000|Overall Study|Physician Decision|0
4646222|NCT02037984|7524655|FG001|Overall Study|Physician Decision|0
4646223|NCT02037984|7524656|FG002|Overall Study|Physician Decision|0
4646224|NCT02037984|7524657|FG003|Overall Study|Physician Decision|0
4646225|NCT02037984|7524658|FG004|Overall Study|Physician Decision|0
4646226|NCT02037984|7524659|FG005|Overall Study|Physician Decision|0
4646227|NCT02037984|7524660|FG006|Overall Study|Physician Decision|1
4646228|NCT02037984|7524661|FG007|Overall Study|Physician Decision|0
4646229|NCT02037984|7524654|FG000|Overall Study|Protocol Violation|0
4646230|NCT02037984|7524655|FG001|Overall Study|Protocol Violation|0
4646231|NCT02037984|7524656|FG002|Overall Study|Protocol Violation|0
4646232|NCT02037984|7524657|FG003|Overall Study|Protocol Violation|0
4646233|NCT02037984|7524658|FG004|Overall Study|Protocol Violation|0
4646234|NCT02037984|7524659|FG005|Overall Study|Protocol Violation|1
4646235|NCT02037984|7524660|FG006|Overall Study|Protocol Violation|2
4646236|NCT02037984|7524661|FG007|Overall Study|Protocol Violation|0
4646237|NCT02037984|7524654|FG000|Overall Study|Technical Problems|0
4646238|NCT02037984|7524655|FG001|Overall Study|Technical Problems|0
4646239|NCT02037984|7524656|FG002|Overall Study|Technical Problems|3
4646240|NCT02037984|7524657|FG003|Overall Study|Technical Problems|3
4646241|NCT02037984|7524658|FG004|Overall Study|Technical Problems|2
4646242|NCT02037984|7524659|FG005|Overall Study|Technical Problems|3
4646243|NCT02037984|7524660|FG006|Overall Study|Technical Problems|4
4646244|NCT02037984|7524661|FG007|Overall Study|Technical Problems|2
4646245|NCT02037984|7524654|FG000|Overall Study|Withdrawal by Parent/Guardian|0
4646246|NCT02037984|7524655|FG001|Overall Study|Withdrawal by Parent/Guardian|0
4646247|NCT02037984|7524656|FG002|Overall Study|Withdrawal by Parent/Guardian|3
4646248|NCT02037984|7524657|FG003|Overall Study|Withdrawal by Parent/Guardian|2
4646249|NCT02037984|7524658|FG004|Overall Study|Withdrawal by Parent/Guardian|5
4646250|NCT02037984|7524659|FG005|Overall Study|Withdrawal by Parent/Guardian|1
4646251|NCT02037984|7524660|FG006|Overall Study|Withdrawal by Parent/Guardian|4
4646252|NCT02037984|7524661|FG007|Overall Study|Withdrawal by Parent/Guardian|2
4646253|NCT02037984|7524654|FG000|Overall Study|Withdrawal by Subject|0
4646254|NCT02037984|7524655|FG001|Overall Study|Withdrawal by Subject|0
4646255|NCT02037984|7524656|FG002|Overall Study|Withdrawal by Subject|0
4646256|NCT02037984|7524657|FG003|Overall Study|Withdrawal by Subject|1
4646257|NCT02037984|7524658|FG004|Overall Study|Withdrawal by Subject|1
4646258|NCT02037984|7524659|FG005|Overall Study|Withdrawal by Subject|3
4646259|NCT02037984|7524660|FG006|Overall Study|Withdrawal by Subject|0
4646260|NCT02037984|7524661|FG007|Overall Study|Withdrawal by Subject|1
4646261|NCT02038010|7524689|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0
4646262|NCT02038010|7524690|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1
4646263|NCT02038010|7524691|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0
4646264|NCT02038010|7524692|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0
4646265|NCT02038010|7524689|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1
4646266|NCT02038010|7524690|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0
4646267|NCT02038010|7524691|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0
4646268|NCT02038010|7524692|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0
4646269|NCT02038010|7524689|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0
4646270|NCT02038010|7524690|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1
4646271|NCT02038010|7524691|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0
4646272|NCT02038010|7524692|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0
4646273|NCT02038010|7524689|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1
4646274|NCT02038010|7524690|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1
4646275|NCT02038010|7524691|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0
4646276|NCT02038010|7524692|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0
4646277|NCT02038010|7524689|FG000|Follow Up|Death|4
4646278|NCT02038010|7524690|FG001|Follow Up|Death|3
4646279|NCT02038010|7524691|FG002|Follow Up|Death|0
4646280|NCT02038010|7524692|FG003|Follow Up|Death|0
4646281|NCT02038010|7524689|FG000|Follow Up|Other|3
4646282|NCT02038010|7524690|FG001|Follow Up|Other|0
4646283|NCT02038010|7524691|FG002|Follow Up|Other|0
4646284|NCT02038010|7524692|FG003|Follow Up|Other|0
4646285|NCT02038036|7524708|FG000|Core Study|Adverse Event|7
4646286|NCT02038036|7524709|FG001|Core Study|Adverse Event|7
4646287|NCT02038036|7524708|FG000|Core Study|Death|1
4646288|NCT02038036|7524709|FG001|Core Study|Death|1
4646289|NCT02038036|7524708|FG000|Core Study|Disease progression|2
4646290|NCT02038036|7524709|FG001|Core Study|Disease progression|2
4646291|NCT02038036|7524708|FG000|Core Study|Lost to Follow-up|0
4646292|NCT02038036|7524709|FG001|Core Study|Lost to Follow-up|1
4646293|NCT02038036|7524708|FG000|Core Study|Physician Decision|2
4646294|NCT02038036|7524709|FG001|Core Study|Physician Decision|1
4646295|NCT02038036|7524708|FG000|Core Study|Subject/guardian decision|0
4646296|NCT02038036|7524709|FG001|Core Study|Subject/guardian decision|1
4646297|NCT02038036|7524708|FG000|Core Study|Withdrawal by Subject|3
4646298|NCT02038036|7524709|FG001|Core Study|Withdrawal by Subject|1
4646299|NCT02038036|7524708|FG000|Crossover Period|Withdrawal by Subject|0
4646300|NCT02038036|7524709|FG001|Crossover Period|Withdrawal by Subject|3
4646301|NCT02038036|7524708|FG000|Crossover Period|Adverse Event|0
4646302|NCT02038036|7524709|FG001|Crossover Period|Adverse Event|9
4646303|NCT02038036|7524708|FG000|Crossover Period|Death|0
4646304|NCT02038036|7524709|FG001|Crossover Period|Death|2
4646305|NCT02038036|7524708|FG000|Crossover Period|Disease progression|0
4646306|NCT02038036|7524709|FG001|Crossover Period|Disease progression|3
4646307|NCT02038036|7524708|FG000|Crossover Period|Lost to Follow-up|0
4646308|NCT02038036|7524709|FG001|Crossover Period|Lost to Follow-up|1
4646309|NCT02038036|7524708|FG000|Crossover Period|Physician Decision|0
4646310|NCT02038036|7524709|FG001|Crossover Period|Physician Decision|2
4646311|NCT02038049|7524720|FG000|Overall Study|Lost to Follow-up|1
4646312|NCT02038049|7524721|FG001|Overall Study|Lost to Follow-up|0
4646313|NCT02038075|7524733|FG000|Overall Study|Withdrawal by Subject|3
4646314|NCT02038075|7524734|FG001|Overall Study|Withdrawal by Subject|0
4646315|NCT02038543|7524760|FG000|Overall Study|Screen Failure|0
4646316|NCT02038543|7524761|FG001|Overall Study|Screen Failure|0
4646317|NCT02038543|7524762|FG002|Overall Study|Screen Failure|0
4646318|NCT02038543|7524763|FG003|Overall Study|Screen Failure|1
4646319|NCT02038543|7524760|FG000|Overall Study|Withdrawal by Subject|0
4646320|NCT02038543|7524761|FG001|Overall Study|Withdrawal by Subject|0
4646321|NCT02038543|7524762|FG002|Overall Study|Withdrawal by Subject|0
4646322|NCT02038543|7524763|FG003|Overall Study|Withdrawal by Subject|1
4646323|NCT02038647|7524780|FG000|Overall Study|Progressive Disease|50
4646324|NCT02038647|7524781|FG001|Overall Study|Progressive Disease|59
4646325|NCT02038647|7524780|FG000|Overall Study|Adverse Event|18
4646326|NCT02038647|7524781|FG001|Overall Study|Adverse Event|10
4646327|NCT02038647|7524780|FG000|Overall Study|Symptomatic Deterioration|7
4646328|NCT02038647|7524781|FG001|Overall Study|Symptomatic Deterioration|7
4646329|NCT02038647|7524780|FG000|Overall Study|Withdrawal by Subject|5
4646330|NCT02038647|7524781|FG001|Overall Study|Withdrawal by Subject|2
4646331|NCT02038647|7524780|FG000|Overall Study|Not Reported|0
4646332|NCT02038647|7524781|FG001|Overall Study|Not Reported|1
4646333|NCT02038647|7524780|FG000|Overall Study|Ongoing at Datacut|9
4646334|NCT02038647|7524781|FG001|Overall Study|Ongoing at Datacut|10
4646335|NCT02038764|7524792|FG000|Overall Study|Adverse Event|0
4646336|NCT02038764|7524793|FG001|Overall Study|Adverse Event|0
4646337|NCT02038764|7524794|FG002|Overall Study|Adverse Event|1
4646338|NCT02038764|7524795|FG003|Overall Study|Adverse Event|0
4646339|NCT02038764|7524796|FG004|Overall Study|Adverse Event|0
4646340|NCT02038764|7524792|FG000|Overall Study|Lost to Follow-up|0
4646341|NCT02038764|7524793|FG001|Overall Study|Lost to Follow-up|1
4646342|NCT02038764|7524794|FG002|Overall Study|Lost to Follow-up|0
4646343|NCT02038764|7524795|FG003|Overall Study|Lost to Follow-up|0
4646344|NCT02038764|7524796|FG004|Overall Study|Lost to Follow-up|0
4646345|NCT02038764|7524792|FG000|Overall Study|Withdrawal by Subject|0
4646346|NCT02038764|7524793|FG001|Overall Study|Withdrawal by Subject|0
4646347|NCT02038764|7524794|FG002|Overall Study|Withdrawal by Subject|0
4646348|NCT02038764|7524795|FG003|Overall Study|Withdrawal by Subject|0
4646349|NCT02038764|7524796|FG004|Overall Study|Withdrawal by Subject|1
4646350|NCT02038764|7524792|FG000|Overall Study|Other|1
4646351|NCT02038764|7524793|FG001|Overall Study|Other|0
4646352|NCT02038764|7524794|FG002|Overall Study|Other|1
4646353|NCT02038764|7524795|FG003|Overall Study|Other|0
4646354|NCT02038764|7524796|FG004|Overall Study|Other|0
4646355|NCT02038790|7524812|FG000|Day 0 - First Treatment|Withdrawal by Subject|1
4646356|NCT02038790|7524813|FG001|Day 0 - First Treatment|Withdrawal by Subject|1
4646357|NCT02038829|7524820|FG000|Washout Period 1|Death|0
4646358|NCT02038829|7524821|FG001|Washout Period 1|Death|0
4646359|NCT02038829|7524822|FG002|Washout Period 1|Death|0
4646360|NCT02038829|7524823|FG003|Washout Period 1|Death|0
4646361|NCT02038829|7524824|FG004|Washout Period 1|Death|1
4646362|NCT02038829|7524825|FG005|Washout Period 1|Death|0
4646363|NCT02038829|7524826|FG006|Washout Period 1|Death|0
4646364|NCT02038829|7524827|FG007|Washout Period 1|Death|0
4646365|NCT02038829|7524828|FG008|Washout Period 1|Death|0
4646366|NCT02038829|7524829|FG009|Washout Period 1|Death|0
4646367|NCT02038829|7524830|FG010|Washout Period 1|Death|0
4646368|NCT02038829|7524831|FG011|Washout Period 1|Death|0
4646369|NCT02038829|7524820|FG000|Treatment Period 2|Adverse Event|0
4646370|NCT02038829|7524821|FG001|Treatment Period 2|Adverse Event|0
4646371|NCT02038829|7524822|FG002|Treatment Period 2|Adverse Event|0
4646372|NCT02038829|7524823|FG003|Treatment Period 2|Adverse Event|0
4646373|NCT02038829|7524824|FG004|Treatment Period 2|Adverse Event|0
4646374|NCT02038829|7524825|FG005|Treatment Period 2|Adverse Event|0
4646375|NCT02038829|7524826|FG006|Treatment Period 2|Adverse Event|0
4646376|NCT02038829|7524827|FG007|Treatment Period 2|Adverse Event|0
4646377|NCT02038829|7524828|FG008|Treatment Period 2|Adverse Event|0
4646378|NCT02038829|7524829|FG009|Treatment Period 2|Adverse Event|0
4646379|NCT02038829|7524830|FG010|Treatment Period 2|Adverse Event|1
4646380|NCT02038829|7524831|FG011|Treatment Period 2|Adverse Event|0
4646381|NCT02038829|7524820|FG000|Treatment Period 2|Withdrawal by Subject|1
4646382|NCT02038829|7524821|FG001|Treatment Period 2|Withdrawal by Subject|0
4646383|NCT02038829|7524822|FG002|Treatment Period 2|Withdrawal by Subject|0
4646384|NCT02038829|7524823|FG003|Treatment Period 2|Withdrawal by Subject|0
4646385|NCT02038829|7524824|FG004|Treatment Period 2|Withdrawal by Subject|0
4646386|NCT02038829|7524825|FG005|Treatment Period 2|Withdrawal by Subject|0
4646387|NCT02038829|7524826|FG006|Treatment Period 2|Withdrawal by Subject|0
4646388|NCT02038829|7524827|FG007|Treatment Period 2|Withdrawal by Subject|0
4646389|NCT02038829|7524828|FG008|Treatment Period 2|Withdrawal by Subject|0
4646390|NCT02038829|7524829|FG009|Treatment Period 2|Withdrawal by Subject|0
4646391|NCT02038829|7524830|FG010|Treatment Period 2|Withdrawal by Subject|0
4646392|NCT02038829|7524831|FG011|Treatment Period 2|Withdrawal by Subject|0
4646393|NCT02038829|7524820|FG000|Washout Period 2|Adverse Event|0
4646394|NCT02038829|7524821|FG001|Washout Period 2|Adverse Event|0
4646395|NCT02038829|7524822|FG002|Washout Period 2|Adverse Event|0
4646396|NCT02038829|7524823|FG003|Washout Period 2|Adverse Event|0
4646397|NCT02038829|7524824|FG004|Washout Period 2|Adverse Event|0
4646398|NCT02038829|7524825|FG005|Washout Period 2|Adverse Event|0
4646399|NCT02038829|7524826|FG006|Washout Period 2|Adverse Event|0
4646400|NCT02038829|7524827|FG007|Washout Period 2|Adverse Event|0
4646401|NCT02038829|7524828|FG008|Washout Period 2|Adverse Event|1
4646402|NCT02038829|7524829|FG009|Washout Period 2|Adverse Event|0
4646403|NCT02038829|7524830|FG010|Washout Period 2|Adverse Event|0
4646404|NCT02038829|7524831|FG011|Washout Period 2|Adverse Event|0
4646405|NCT02038829|7524820|FG000|Washout Period 2|Withdrawal by Subject|0
4646406|NCT02038829|7524821|FG001|Washout Period 2|Withdrawal by Subject|0
4646407|NCT02038829|7524822|FG002|Washout Period 2|Withdrawal by Subject|0
4646408|NCT02038829|7524823|FG003|Washout Period 2|Withdrawal by Subject|0
4646409|NCT02038829|7524824|FG004|Washout Period 2|Withdrawal by Subject|0
4646410|NCT02038829|7524825|FG005|Washout Period 2|Withdrawal by Subject|1
4646411|NCT02038829|7524826|FG006|Washout Period 2|Withdrawal by Subject|0
4646412|NCT02038829|7524827|FG007|Washout Period 2|Withdrawal by Subject|0
4646413|NCT02038829|7524828|FG008|Washout Period 2|Withdrawal by Subject|0
4646414|NCT02038829|7524829|FG009|Washout Period 2|Withdrawal by Subject|0
4646415|NCT02038829|7524830|FG010|Washout Period 2|Withdrawal by Subject|0
4646416|NCT02038829|7524831|FG011|Washout Period 2|Withdrawal by Subject|0
4646417|NCT02038829|7524820|FG000|Treatment Period 4|Adverse Event|0
4646418|NCT02038829|7524821|FG001|Treatment Period 4|Adverse Event|1
4646419|NCT02038829|7524822|FG002|Treatment Period 4|Adverse Event|0
4646420|NCT02038829|7524823|FG003|Treatment Period 4|Adverse Event|0
4646421|NCT02038829|7524824|FG004|Treatment Period 4|Adverse Event|0
4646422|NCT02038829|7524825|FG005|Treatment Period 4|Adverse Event|0
4646423|NCT02038829|7524826|FG006|Treatment Period 4|Adverse Event|0
4646424|NCT02038829|7524827|FG007|Treatment Period 4|Adverse Event|0
4646425|NCT02038829|7524828|FG008|Treatment Period 4|Adverse Event|0
4646426|NCT02038829|7524829|FG009|Treatment Period 4|Adverse Event|0
4646427|NCT02038829|7524830|FG010|Treatment Period 4|Adverse Event|0
4646428|NCT02038829|7524831|FG011|Treatment Period 4|Adverse Event|0
4646429|NCT02038829|7524820|FG000|Washout Period 4|Adverse Event|0
4646430|NCT02038829|7524821|FG001|Washout Period 4|Adverse Event|0
4646431|NCT02038829|7524822|FG002|Washout Period 4|Adverse Event|0
4646432|NCT02038829|7524823|FG003|Washout Period 4|Adverse Event|0
4646433|NCT02038829|7524824|FG004|Washout Period 4|Adverse Event|0
4646434|NCT02038829|7524825|FG005|Washout Period 4|Adverse Event|0
4646435|NCT02038829|7524826|FG006|Washout Period 4|Adverse Event|1
4646436|NCT02038829|7524827|FG007|Washout Period 4|Adverse Event|0
4646437|NCT02038829|7524828|FG008|Washout Period 4|Adverse Event|0
4646438|NCT02038829|7524829|FG009|Washout Period 4|Adverse Event|0
4646439|NCT02038829|7524830|FG010|Washout Period 4|Adverse Event|0
4646440|NCT02038829|7524831|FG011|Washout Period 4|Adverse Event|0
4646441|NCT02038829|7524820|FG000|Treatment Period 6|Adverse Event|0
4646442|NCT02038829|7524821|FG001|Treatment Period 6|Adverse Event|0
4646443|NCT02038829|7524822|FG002|Treatment Period 6|Adverse Event|1
4646444|NCT02038829|7524823|FG003|Treatment Period 6|Adverse Event|0
4646445|NCT02038829|7524824|FG004|Treatment Period 6|Adverse Event|0
4646446|NCT02038829|7524825|FG005|Treatment Period 6|Adverse Event|0
4646447|NCT02038829|7524826|FG006|Treatment Period 6|Adverse Event|0
4646448|NCT02038829|7524827|FG007|Treatment Period 6|Adverse Event|0
4646449|NCT02038829|7524828|FG008|Treatment Period 6|Adverse Event|0
4646450|NCT02038829|7524829|FG009|Treatment Period 6|Adverse Event|0
4646451|NCT02038829|7524830|FG010|Treatment Period 6|Adverse Event|0
4646452|NCT02038829|7524831|FG011|Treatment Period 6|Adverse Event|0
4646453|NCT02038881|7524849|FG000|Overall Study|Withdrawal by Subject|0
4646454|NCT02038881|7524850|FG001|Overall Study|Withdrawal by Subject|0
4646455|NCT02038881|7524851|FG002|Overall Study|Withdrawal by Subject|1
4646456|NCT02038881|7524849|FG000|Overall Study|Lost to Follow-up|2
4646457|NCT02038881|7524850|FG001|Overall Study|Lost to Follow-up|0
4646458|NCT02038881|7524851|FG002|Overall Study|Lost to Follow-up|0
4646459|NCT02038881|7524849|FG000|Overall Study|incarcerated|1
4646460|NCT02038881|7524850|FG001|Overall Study|incarcerated|0
4646461|NCT02038881|7524851|FG002|Overall Study|incarcerated|0
4646462|NCT02038907|7524892|FG000|Overall Study|Protocol Violation|0
4646463|NCT02038907|7524893|FG001|Overall Study|Protocol Violation|0
4646464|NCT02038907|7524894|FG002|Overall Study|Protocol Violation|0
4646465|NCT02038907|7524895|FG003|Overall Study|Protocol Violation|0
4646466|NCT02038907|7524896|FG004|Overall Study|Protocol Violation|0
4646467|NCT02038907|7524897|FG005|Overall Study|Protocol Violation|0
4646468|NCT02038907|7524898|FG006|Overall Study|Protocol Violation|0
4646469|NCT02038907|7524899|FG007|Overall Study|Protocol Violation|0
4646470|NCT02038907|7524900|FG008|Overall Study|Protocol Violation|0
4646471|NCT02038907|7524901|FG009|Overall Study|Protocol Violation|0
4646472|NCT02038907|7524902|FG010|Overall Study|Protocol Violation|1
4646473|NCT02038907|7524903|FG011|Overall Study|Protocol Violation|0
4646474|NCT02038907|7524904|FG012|Overall Study|Protocol Violation|0
4646475|NCT02038907|7524905|FG013|Overall Study|Protocol Violation|0
4646476|NCT02038907|7524892|FG000|Overall Study|Withdrawal by Subject|0
4646477|NCT02038907|7524893|FG001|Overall Study|Withdrawal by Subject|0
4646478|NCT02038907|7524894|FG002|Overall Study|Withdrawal by Subject|0
4646479|NCT02038907|7524895|FG003|Overall Study|Withdrawal by Subject|0
4646480|NCT02038907|7524896|FG004|Overall Study|Withdrawal by Subject|0
4646481|NCT02038907|7524897|FG005|Overall Study|Withdrawal by Subject|0
4646482|NCT02038907|7524898|FG006|Overall Study|Withdrawal by Subject|0
4646483|NCT02038907|7524899|FG007|Overall Study|Withdrawal by Subject|0
4646484|NCT02038907|7524900|FG008|Overall Study|Withdrawal by Subject|0
4646485|NCT02038907|7524901|FG009|Overall Study|Withdrawal by Subject|0
4646486|NCT02038907|7524902|FG010|Overall Study|Withdrawal by Subject|1
4646487|NCT02038907|7524903|FG011|Overall Study|Withdrawal by Subject|0
4646488|NCT02038907|7524904|FG012|Overall Study|Withdrawal by Subject|0
4646489|NCT02038907|7524905|FG013|Overall Study|Withdrawal by Subject|0
4646490|NCT02038920|7524939|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3
4646491|NCT02038920|7524940|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11
4646492|NCT02038920|7524941|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0
4646493|NCT02038920|7524942|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0
4646494|NCT02038920|7524943|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0
4646495|NCT02038920|7524944|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0
4646496|NCT02038920|7524939|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2
4646497|NCT02038920|7524940|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
4646498|NCT02038920|7524941|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
4646499|NCT02038920|7524942|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
4646500|NCT02038920|7524943|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
4646501|NCT02038920|7524944|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
4646502|NCT02038920|7524939|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1
4646503|NCT02038920|7524940|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1
4646504|NCT02038920|7524941|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0
4646505|NCT02038920|7524942|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0
4646506|NCT02038920|7524943|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0
4646507|NCT02038920|7524944|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0
4646508|NCT02038920|7524939|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0
4646509|NCT02038920|7524940|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0
4646510|NCT02038920|7524941|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2
4646511|NCT02038920|7524942|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4
4646512|NCT02038920|7524943|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2
4646513|NCT02038920|7524944|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0
4646514|NCT02038920|7524939|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
4646515|NCT02038920|7524940|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
4646516|NCT02038920|7524941|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1
4646517|NCT02038920|7524942|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
4646518|NCT02038920|7524943|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
4646519|NCT02038920|7524944|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
4646520|NCT02038920|7524939|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0
4646521|NCT02038920|7524940|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0
4646522|NCT02038920|7524941|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2
4646523|NCT02038920|7524942|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4
4646524|NCT02038920|7524943|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10
4646525|NCT02038920|7524944|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0
4646526|NCT02038920|7524939|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
4646527|NCT02038920|7524940|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
4646528|NCT02038920|7524941|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
4646529|NCT02038920|7524942|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
4646530|NCT02038920|7524943|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
4646531|NCT02038920|7524944|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43
4646532|NCT02038920|7524939|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
4646533|NCT02038920|7524940|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
4646534|NCT02038920|7524941|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
4646535|NCT02038920|7524942|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
4646536|NCT02038920|7524943|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
4646537|NCT02038920|7524944|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1
4646538|NCT02038920|7524939|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
4646539|NCT02038920|7524940|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
4646540|NCT02038920|7524941|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
4646541|NCT02038920|7524942|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
4646542|NCT02038920|7524943|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
4646543|NCT02038920|7524944|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7
4646544|NCT02038920|7524939|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0
4646545|NCT02038920|7524940|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0
4646546|NCT02038920|7524941|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0
4646547|NCT02038920|7524942|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0
4646548|NCT02038920|7524943|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0
4646549|NCT02038920|7524944|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1
4646550|NCT02038920|7524939|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
4646551|NCT02038920|7524940|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
4646552|NCT02038920|7524941|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
4646553|NCT02038920|7524942|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
4646554|NCT02038920|7524943|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
4646555|NCT02038920|7524944|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23
4646556|NCT02038920|7524939|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
4646557|NCT02038920|7524940|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
4646558|NCT02038920|7524941|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
4646559|NCT02038920|7524942|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
4646560|NCT02038920|7524943|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
4646561|NCT02038920|7524944|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2
4646562|NCT02038933|7524963|FG000|Overall Study|Disease progression|104
4646563|NCT02038933|7524963|FG000|Overall Study|Study drug toxicity|6
4646564|NCT02038933|7524963|FG000|Overall Study|Adverse event unrelated to study drug|6
4646565|NCT02038933|7524963|FG000|Overall Study|Participant request to discontinue treatment|2
4646566|NCT02038933|7524963|FG000|Overall Study|Lost to Follow-up|1
4646567|NCT02038933|7524963|FG000|Overall Study|Other reasons|2
4646568|NCT02038959|7524970|FG000|Overall Study|Withdrawal by Subject|6
4646569|NCT02038959|7524971|FG001|Overall Study|Withdrawal by Subject|8
4646570|NCT02039219|7524988|FG000|Treatment|Withdrawal by Subject|1
4646571|NCT02039219|7524989|FG001|Treatment|Withdrawal by Subject|0
4646572|NCT02039219|7524988|FG000|Treatment|Adverse Event|0
4646573|NCT02039219|7524989|FG001|Treatment|Adverse Event|1
4646574|NCT02039219|7524988|FG000|Treatment|Physician Decision|1
4646575|NCT02039219|7524989|FG001|Treatment|Physician Decision|0
4646576|NCT02039219|7524988|FG000|Treatment|Lost to Follow-up|0
4646577|NCT02039219|7524989|FG001|Treatment|Lost to Follow-up|1
4646578|NCT02039219|7524988|FG000|Treatment|Protocol Violation|1
4646579|NCT02039219|7524989|FG001|Treatment|Protocol Violation|0
4646580|NCT02039219|7524988|FG000|Treatment|Death|1
4646581|NCT02039219|7524989|FG001|Treatment|Death|0
4646582|NCT02039219|7524988|FG000|Follow up|Adverse Event|0
4646583|NCT02039219|7524989|FG001|Follow up|Adverse Event|1
4646584|NCT02039375|7524995|FG000|Overall Study|Lost to Follow-up|2
4646585|NCT02039414|7525001|FG000|Overall Study|Delivered|1
4646586|NCT02039414|7525002|FG001|Overall Study|Delivered|1
4646587|NCT02039414|7525001|FG000|Overall Study|Lost to Follow-up|2
4646588|NCT02039414|7525002|FG001|Overall Study|Lost to Follow-up|0
4646589|NCT02039414|7525001|FG000|Overall Study|Protocol Violation|3
4646590|NCT02039414|7525002|FG001|Overall Study|Protocol Violation|1
4646591|NCT02039427|7525012|FG000|Overall Study|Duration of surgery > 3h|1
4646592|NCT02039427|7525013|FG001|Overall Study|Duration of surgery > 3h|1
4646593|NCT02039427|7525014|FG002|Overall Study|Duration of surgery > 3h|0
4646594|NCT02039427|7525015|FG003|Overall Study|Duration of surgery > 3h|0
4646595|NCT02039427|7525012|FG000|Overall Study|Withdrawal on concent|0
4646596|NCT02039427|7525013|FG001|Overall Study|Withdrawal on concent|0
4646597|NCT02039427|7525014|FG002|Overall Study|Withdrawal on concent|0
4646598|NCT02039427|7525015|FG003|Overall Study|Withdrawal on concent|1
4646599|NCT02039427|7525012|FG000|Overall Study|Cancellation of surgery|0
4646600|NCT02039427|7525013|FG001|Overall Study|Cancellation of surgery|0
4646601|NCT02039427|7525014|FG002|Overall Study|Cancellation of surgery|1
4646602|NCT02039427|7525015|FG003|Overall Study|Cancellation of surgery|0
4646603|NCT02039427|7525012|FG000|Overall Study|Loss of follow - up|1
4646604|NCT02039427|7525013|FG001|Overall Study|Loss of follow - up|0
4646605|NCT02039427|7525014|FG002|Overall Study|Loss of follow - up|2
4646606|NCT02039427|7525015|FG003|Overall Study|Loss of follow - up|4
4646607|NCT02039427|7525012|FG000|Overall Study|Steroid Use|1
4646608|NCT02039427|7525013|FG001|Overall Study|Steroid Use|0
4646609|NCT02039427|7525014|FG002|Overall Study|Steroid Use|0
4646610|NCT02039427|7525015|FG003|Overall Study|Steroid Use|0
4646611|NCT02039505|7525032|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2
4646612|NCT02039505|7525033|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8
4646613|NCT02039505|7525034|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7
4646614|NCT02039505|7525035|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
4646615|NCT02039505|7525036|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
4646616|NCT02039505|7525037|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
4646617|NCT02039505|7525038|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
4646618|NCT02039505|7525032|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1
4646619|NCT02039505|7525033|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1
4646620|NCT02039505|7525034|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3
4646621|NCT02039505|7525035|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
4646622|NCT02039505|7525036|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
4646623|NCT02039505|7525037|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
4646624|NCT02039505|7525038|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
4646625|NCT02039505|7525032|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1
4646626|NCT02039505|7525033|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
4646627|NCT02039505|7525034|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
4646628|NCT02039505|7525035|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
4646629|NCT02039505|7525036|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
4646630|NCT02039505|7525037|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
4646631|NCT02039505|7525038|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
4646632|NCT02039505|7525032|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
4646633|NCT02039505|7525033|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
4646634|NCT02039505|7525034|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
4646635|NCT02039505|7525035|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13
4646636|NCT02039505|7525036|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8
4646637|NCT02039505|7525037|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12
4646638|NCT02039505|7525038|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
4646639|NCT02039505|7525032|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
4646640|NCT02039505|7525033|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
4646641|NCT02039505|7525034|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
4646642|NCT02039505|7525035|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6
4646643|NCT02039505|7525036|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1
4646644|NCT02039505|7525037|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1
4646645|NCT02039505|7525038|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
4646646|NCT02039505|7525032|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
4646647|NCT02039505|7525033|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
4646648|NCT02039505|7525034|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
4646649|NCT02039505|7525035|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3
4646650|NCT02039505|7525036|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2
4646651|NCT02039505|7525037|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1
4646652|NCT02039505|7525038|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
4646653|NCT02039505|7525032|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
4646654|NCT02039505|7525033|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
4646655|NCT02039505|7525034|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
4646656|NCT02039505|7525035|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2
4646657|NCT02039505|7525036|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
4646658|NCT02039505|7525037|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
4646659|NCT02039505|7525038|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
4646660|NCT02039505|7525032|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
4646661|NCT02039505|7525033|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
4646662|NCT02039505|7525034|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
4646663|NCT02039505|7525035|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
4646664|NCT02039505|7525036|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
4646665|NCT02039505|7525037|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
4646666|NCT02039505|7525038|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44
4646667|NCT02039505|7525032|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
4646668|NCT02039505|7525033|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
4646669|NCT02039505|7525034|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
4646670|NCT02039505|7525035|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
4646671|NCT02039505|7525036|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
4646672|NCT02039505|7525037|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
4646673|NCT02039505|7525038|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19
4646674|NCT02039505|7525032|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
4646675|NCT02039505|7525033|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
4646676|NCT02039505|7525034|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
4646677|NCT02039505|7525035|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
4646678|NCT02039505|7525036|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
4646679|NCT02039505|7525037|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
4646680|NCT02039505|7525038|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7
4646681|NCT02039505|7525032|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
4646682|NCT02039505|7525033|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
4646683|NCT02039505|7525034|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
4646684|NCT02039505|7525035|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
4646685|NCT02039505|7525036|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
4646686|NCT02039505|7525037|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
4646687|NCT02039505|7525038|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1
4646688|NCT02039674|7525072|FG000|Overall Study|Adverse Event|0
4646689|NCT02039674|7525073|FG001|Overall Study|Adverse Event|0
4646690|NCT02039674|7525074|FG002|Overall Study|Adverse Event|1
4646691|NCT02039674|7525075|FG003|Overall Study|Adverse Event|1
4646692|NCT02039674|7525076|FG004|Overall Study|Adverse Event|0
4646693|NCT02039674|7525077|FG005|Overall Study|Adverse Event|0
4646694|NCT02039674|7525078|FG006|Overall Study|Adverse Event|0
4646695|NCT02039674|7525079|FG007|Overall Study|Adverse Event|0
4646696|NCT02039674|7525080|FG008|Overall Study|Adverse Event|2
4646697|NCT02039674|7525081|FG009|Overall Study|Adverse Event|0
4646698|NCT02039674|7525082|FG010|Overall Study|Adverse Event|0
4646699|NCT02039674|7525083|FG011|Overall Study|Adverse Event|2
4646700|NCT02039674|7525084|FG012|Overall Study|Adverse Event|2
4646701|NCT02039674|7525085|FG013|Overall Study|Adverse Event|1
4646702|NCT02039674|7525072|FG000|Overall Study|Death|0
4646703|NCT02039674|7525073|FG001|Overall Study|Death|0
4646704|NCT02039674|7525074|FG002|Overall Study|Death|1
4646705|NCT02039674|7525075|FG003|Overall Study|Death|2
4646706|NCT02039674|7525076|FG004|Overall Study|Death|0
4646707|NCT02039674|7525077|FG005|Overall Study|Death|0
4646708|NCT02039674|7525078|FG006|Overall Study|Death|0
4646709|NCT02039674|7525079|FG007|Overall Study|Death|0
4646710|NCT02039674|7525080|FG008|Overall Study|Death|0
4646711|NCT02039674|7525081|FG009|Overall Study|Death|0
4646712|NCT02039674|7525082|FG010|Overall Study|Death|1
4646713|NCT02039674|7525083|FG011|Overall Study|Death|1
4646714|NCT02039674|7525084|FG012|Overall Study|Death|0
4646715|NCT02039674|7525085|FG013|Overall Study|Death|8
4646716|NCT02039674|7525072|FG000|Overall Study|Excluded Medication|1
4646717|NCT02039674|7525073|FG001|Overall Study|Excluded Medication|1
4646718|NCT02039674|7525074|FG002|Overall Study|Excluded Medication|0
4646719|NCT02039674|7525075|FG003|Overall Study|Excluded Medication|1
4646720|NCT02039674|7525076|FG004|Overall Study|Excluded Medication|0
4646721|NCT02039674|7525077|FG005|Overall Study|Excluded Medication|1
4646722|NCT02039674|7525078|FG006|Overall Study|Excluded Medication|0
4646723|NCT02039674|7525079|FG007|Overall Study|Excluded Medication|0
4646724|NCT02039674|7525080|FG008|Overall Study|Excluded Medication|2
4646725|NCT02039674|7525081|FG009|Overall Study|Excluded Medication|2
4646726|NCT02039674|7525082|FG010|Overall Study|Excluded Medication|4
4646727|NCT02039674|7525083|FG011|Overall Study|Excluded Medication|2
4646728|NCT02039674|7525084|FG012|Overall Study|Excluded Medication|4
4646729|NCT02039674|7525085|FG013|Overall Study|Excluded Medication|3
4646730|NCT02039674|7525072|FG000|Overall Study|Lost to Follow-up|0
4646731|NCT02039674|7525073|FG001|Overall Study|Lost to Follow-up|0
4646732|NCT02039674|7525074|FG002|Overall Study|Lost to Follow-up|0
4646733|NCT02039674|7525075|FG003|Overall Study|Lost to Follow-up|0
4646734|NCT02039674|7525076|FG004|Overall Study|Lost to Follow-up|0
4646735|NCT02039674|7525077|FG005|Overall Study|Lost to Follow-up|0
4646736|NCT02039674|7525078|FG006|Overall Study|Lost to Follow-up|0
4646737|NCT02039674|7525079|FG007|Overall Study|Lost to Follow-up|0
4646738|NCT02039674|7525080|FG008|Overall Study|Lost to Follow-up|0
4646739|NCT02039674|7525081|FG009|Overall Study|Lost to Follow-up|0
4646740|NCT02039674|7525082|FG010|Overall Study|Lost to Follow-up|0
4646741|NCT02039674|7525083|FG011|Overall Study|Lost to Follow-up|0
4646742|NCT02039674|7525084|FG012|Overall Study|Lost to Follow-up|1
4646743|NCT02039674|7525085|FG013|Overall Study|Lost to Follow-up|0
4747642|NCT03713320|7721702|FG000|Cobomarsen Crossover Period|Physician Decision|0
4747643|NCT03713320|7721703|FG001|Cobomarsen Crossover Period|Physician Decision|0
4747644|NCT03713320|7721704|FG002|Cobomarsen Crossover Period|Physician Decision|2
4747645|NCT03713320|7721702|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0
4747646|NCT03713320|7721703|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0
4646744|NCT02039674|7525072|FG000|Overall Study|Physician Decision|0
4646745|NCT02039674|7525073|FG001|Overall Study|Physician Decision|0
4646746|NCT02039674|7525074|FG002|Overall Study|Physician Decision|0
4646747|NCT02039674|7525075|FG003|Overall Study|Physician Decision|0
4646748|NCT02039674|7525076|FG004|Overall Study|Physician Decision|0
4646749|NCT02039674|7525077|FG005|Overall Study|Physician Decision|0
4646750|NCT02039674|7525078|FG006|Overall Study|Physician Decision|0
4646751|NCT02039674|7525079|FG007|Overall Study|Physician Decision|0
4646752|NCT02039674|7525080|FG008|Overall Study|Physician Decision|0
4646753|NCT02039674|7525081|FG009|Overall Study|Physician Decision|0
4646754|NCT02039674|7525082|FG010|Overall Study|Physician Decision|0
4646755|NCT02039674|7525083|FG011|Overall Study|Physician Decision|1
4646756|NCT02039674|7525084|FG012|Overall Study|Physician Decision|0
4646757|NCT02039674|7525085|FG013|Overall Study|Physician Decision|0
4646758|NCT02039674|7525072|FG000|Overall Study|Progressive Disease|6
4646759|NCT02039674|7525073|FG001|Overall Study|Progressive Disease|7
4646760|NCT02039674|7525074|FG002|Overall Study|Progressive Disease|6
4646761|NCT02039674|7525075|FG003|Overall Study|Progressive Disease|7
4646762|NCT02039674|7525076|FG004|Overall Study|Progressive Disease|8
4646763|NCT02039674|7525077|FG005|Overall Study|Progressive Disease|10
4646764|NCT02039674|7525078|FG006|Overall Study|Progressive Disease|1
4646765|NCT02039674|7525079|FG007|Overall Study|Progressive Disease|3
4646766|NCT02039674|7525080|FG008|Overall Study|Progressive Disease|7
4646767|NCT02039674|7525081|FG009|Overall Study|Progressive Disease|2
4646768|NCT02039674|7525082|FG010|Overall Study|Progressive Disease|0
4646769|NCT02039674|7525083|FG011|Overall Study|Progressive Disease|17
4646770|NCT02039674|7525084|FG012|Overall Study|Progressive Disease|18
4646771|NCT02039674|7525085|FG013|Overall Study|Progressive Disease|16
4646772|NCT02039674|7525072|FG000|Overall Study|Withdrawal by Subject|0
4646773|NCT02039674|7525073|FG001|Overall Study|Withdrawal by Subject|2
4646774|NCT02039674|7525074|FG002|Overall Study|Withdrawal by Subject|1
4646775|NCT02039674|7525075|FG003|Overall Study|Withdrawal by Subject|0
4646776|NCT02039674|7525076|FG004|Overall Study|Withdrawal by Subject|1
4646777|NCT02039674|7525077|FG005|Overall Study|Withdrawal by Subject|0
4646778|NCT02039674|7525078|FG006|Overall Study|Withdrawal by Subject|0
4646779|NCT02039674|7525079|FG007|Overall Study|Withdrawal by Subject|0
4646780|NCT02039674|7525080|FG008|Overall Study|Withdrawal by Subject|0
4646781|NCT02039674|7525081|FG009|Overall Study|Withdrawal by Subject|2
4646782|NCT02039674|7525082|FG010|Overall Study|Withdrawal by Subject|1
4646783|NCT02039674|7525083|FG011|Overall Study|Withdrawal by Subject|3
4646784|NCT02039674|7525084|FG012|Overall Study|Withdrawal by Subject|5
4646785|NCT02039674|7525085|FG013|Overall Study|Withdrawal by Subject|2
4646786|NCT02039674|7525072|FG000|Overall Study|Ongoing in Study|5
4646787|NCT02039674|7525073|FG001|Overall Study|Ongoing in Study|2
4646788|NCT02039674|7525074|FG002|Overall Study|Ongoing in Study|3
4646789|NCT02039674|7525075|FG003|Overall Study|Ongoing in Study|2
4646790|NCT02039674|7525076|FG004|Overall Study|Ongoing in Study|3
4646791|NCT02039674|7525077|FG005|Overall Study|Ongoing in Study|1
4646792|NCT02039674|7525078|FG006|Overall Study|Ongoing in Study|2
4646793|NCT02039674|7525079|FG007|Overall Study|Ongoing in Study|0
4646794|NCT02039674|7525080|FG008|Overall Study|Ongoing in Study|1
4646795|NCT02039674|7525081|FG009|Overall Study|Ongoing in Study|6
4646796|NCT02039674|7525082|FG010|Overall Study|Ongoing in Study|1
4646797|NCT02039674|7525083|FG011|Overall Study|Ongoing in Study|34
4646798|NCT02039674|7525084|FG012|Overall Study|Ongoing in Study|33
4646799|NCT02039674|7525085|FG013|Overall Study|Ongoing in Study|3
4646800|NCT02039687|7525122|FG000|Overall Study|Adverse Event|0
4646801|NCT02039687|7525123|FG001|Overall Study|Adverse Event|0
4646802|NCT02039687|7525124|FG002|Overall Study|Adverse Event|1
4646803|NCT02039687|7525125|FG003|Overall Study|Adverse Event|0
4646804|NCT02039687|7525122|FG000|Overall Study|Withdrawal by Subject|0
4646805|NCT02039687|7525123|FG001|Overall Study|Withdrawal by Subject|1
4646806|NCT02039687|7525124|FG002|Overall Study|Withdrawal by Subject|0
4646807|NCT02039687|7525125|FG003|Overall Study|Withdrawal by Subject|0
4646808|NCT02039687|7525122|FG000|Overall Study|treatment assignment could not be confir|0
4646809|NCT02039687|7525123|FG001|Overall Study|treatment assignment could not be confir|0
4646810|NCT02039687|7525124|FG002|Overall Study|treatment assignment could not be confir|2
4646811|NCT02039687|7525125|FG003|Overall Study|treatment assignment could not be confir|0
4646812|NCT02039778|7525144|FG000|Overall Study|Death|2
4646813|NCT02039778|7525144|FG000|Overall Study|Withdrawal by Subject|1
4646814|NCT02039778|7525144|FG000|Overall Study|Never started the protocol treatment|1
4646815|NCT02039856|7525158|FG000|Overall Study|Death|5
4646816|NCT02039856|7525159|FG001|Overall Study|Death|3
4646817|NCT02039856|7525158|FG000|Overall Study|Partial survey completion|61
4646818|NCT02039856|7525159|FG001|Overall Study|Partial survey completion|26
4646819|NCT02039856|7525158|FG000|Overall Study|Lost to Follow-up|388
4646820|NCT02039856|7525159|FG001|Overall Study|Lost to Follow-up|206
4646821|NCT02039856|7525158|FG000|Overall Study|Withdrawal by Subject|1573
4646822|NCT02039856|7525159|FG001|Overall Study|Withdrawal by Subject|618
4646823|NCT02039908|7525167|FG000|Phase 1-Summer|Withdrawal by Subject|7
4646824|NCT02039908|7525168|FG001|Phase 1-Summer|Withdrawal by Subject|6
4646825|NCT02039908|7525169|FG002|Phase 1-Summer|Withdrawal by Subject|0
4646826|NCT02039908|7525170|FG003|Phase 1-Summer|Withdrawal by Subject|0
4646827|NCT02039908|7525167|FG000|Phase 1-Summer|Protocol Violation|6
4646828|NCT02039908|7525168|FG001|Phase 1-Summer|Protocol Violation|0
4646829|NCT02039908|7525169|FG002|Phase 1-Summer|Protocol Violation|0
4646830|NCT02039908|7525170|FG003|Phase 1-Summer|Protocol Violation|0
4646831|NCT02039908|7525167|FG000|Phase 2-School Year|Lost to Follow-up|0
4646832|NCT02039908|7525168|FG001|Phase 2-School Year|Lost to Follow-up|0
4646833|NCT02039908|7525169|FG002|Phase 2-School Year|Lost to Follow-up|1
4646834|NCT02039908|7525170|FG003|Phase 2-School Year|Lost to Follow-up|3
4646835|NCT02039908|7525167|FG000|Phase 2-School Year|Protocol Violation|0
4646836|NCT02039908|7525168|FG001|Phase 2-School Year|Protocol Violation|0
4646837|NCT02039908|7525169|FG002|Phase 2-School Year|Protocol Violation|3
4646838|NCT02039908|7525170|FG003|Phase 2-School Year|Protocol Violation|0
4646839|NCT02039908|7525167|FG000|Phase 2-School Year|Withdrawal by Subject|0
4646840|NCT02039908|7525168|FG001|Phase 2-School Year|Withdrawal by Subject|0
4646841|NCT02039908|7525169|FG002|Phase 2-School Year|Withdrawal by Subject|8
4646842|NCT02039908|7525170|FG003|Phase 2-School Year|Withdrawal by Subject|5
4646843|NCT02040090|7525215|FG000|Overall Study|Adverse Event|2
4646844|NCT02040090|7525216|FG001|Overall Study|Adverse Event|0
4646845|NCT02040090|7525215|FG000|Overall Study|Physician Decision|1
4646846|NCT02040090|7525216|FG001|Overall Study|Physician Decision|0
4646847|NCT02040090|7525215|FG000|Overall Study|Withdrawal by Subject|0
4646848|NCT02040090|7525216|FG001|Overall Study|Withdrawal by Subject|1
4646849|NCT02040090|7525215|FG000|Overall Study|Lost to Follow-up|0
4646850|NCT02040090|7525216|FG001|Overall Study|Lost to Follow-up|1
4646851|NCT02040259|7525230|FG000|Overall Study|Death|280
4646852|NCT02040259|7525230|FG000|Overall Study|Lost to Follow-up|76
4646853|NCT02040259|7525230|FG000|Overall Study|Assessment not completed|3
4646854|NCT02040259|7525230|FG000|Overall Study|Withdrawal by Subject|4
4646855|NCT02040428|7525253|FG000|Overall Study|Death|4
4646856|NCT02040428|7525254|FG001|Overall Study|Death|3
4646857|NCT02040428|7525253|FG000|Overall Study|Withdrawal by Subject|1
4646858|NCT02040428|7525254|FG001|Overall Study|Withdrawal by Subject|1
4747647|NCT03713320|7721704|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5
4747648|NCT03429049|7721713|FG000|Overall Study|Adverse Event|2
4747649|NCT03429049|7721714|FG001|Overall Study|Adverse Event|3
4747650|NCT03429049|7721713|FG000|Overall Study|Death|0
4747651|NCT03429049|7721714|FG001|Overall Study|Death|1
4747652|NCT03429049|7721713|FG000|Overall Study|Lack of Efficacy|4
4747653|NCT03429049|7721714|FG001|Overall Study|Lack of Efficacy|2
4747654|NCT03429049|7721713|FG000|Overall Study|Lost to Follow-up|9
4747655|NCT03429049|7721714|FG001|Overall Study|Lost to Follow-up|8
4747656|NCT03429049|7721713|FG000|Overall Study|Physician Decision|1
4747657|NCT03429049|7721714|FG001|Overall Study|Physician Decision|0
4747658|NCT03429049|7721713|FG000|Overall Study|Protocol Violation|3
4747659|NCT03429049|7721714|FG001|Overall Study|Protocol Violation|0
4747660|NCT03429049|7721713|FG000|Overall Study|Sponsor Decision|2
4747661|NCT03429049|7721714|FG001|Overall Study|Sponsor Decision|0
4747662|NCT03429049|7721713|FG000|Overall Study|Withdrawal by Subject|4
4747663|NCT03429049|7721714|FG001|Overall Study|Withdrawal by Subject|20
4747664|NCT03429049|7721713|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3
4747665|NCT03429049|7721714|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8
4747666|NCT03409731|7721720|FG000|Overall Study|Withdrawal by Subject|1
4747667|NCT03409731|7721720|FG000|Overall Study|Death|2
4646859|NCT02040532|7525260|FG000|Overall Study|Lost to Follow-up|1
4646860|NCT02040532|7525260|FG000|Overall Study|Physician Decision|4
4646861|NCT02040532|7525260|FG000|Overall Study|Adverse Event|4
4646862|NCT02040532|7525260|FG000|Overall Study|Withdrawal by Subject|3
4646863|NCT02040766|7525282|FG000|Overall Study|Adverse Event|1
4646864|NCT02040766|7525283|FG001|Overall Study|Adverse Event|1
4646865|NCT02040766|7525284|FG002|Overall Study|Adverse Event|1
4646866|NCT02040766|7525285|FG003|Overall Study|Adverse Event|0
4646867|NCT02040766|7525286|FG004|Overall Study|Adverse Event|2
4646868|NCT02040766|7525282|FG000|Overall Study|Withdrawal by Subject|4
4646869|NCT02040766|7525283|FG001|Overall Study|Withdrawal by Subject|3
4646870|NCT02040766|7525284|FG002|Overall Study|Withdrawal by Subject|2
4646871|NCT02040766|7525285|FG003|Overall Study|Withdrawal by Subject|3
4646872|NCT02040766|7525286|FG004|Overall Study|Withdrawal by Subject|2
4646873|NCT02040766|7525282|FG000|Overall Study|Non-compliance|0
4646874|NCT02040766|7525283|FG001|Overall Study|Non-compliance|1
4646875|NCT02040766|7525284|FG002|Overall Study|Non-compliance|0
4646876|NCT02040766|7525285|FG003|Overall Study|Non-compliance|0
4646877|NCT02040766|7525286|FG004|Overall Study|Non-compliance|0
4646878|NCT02040766|7525282|FG000|Overall Study|Protocol Violation|2
4646879|NCT02040766|7525283|FG001|Overall Study|Protocol Violation|1
4646880|NCT02040766|7525284|FG002|Overall Study|Protocol Violation|2
4646881|NCT02040766|7525285|FG003|Overall Study|Protocol Violation|3
4646882|NCT02040766|7525286|FG004|Overall Study|Protocol Violation|0
4646883|NCT02040766|7525282|FG000|Overall Study|Lost to Follow-up|4
4646884|NCT02040766|7525283|FG001|Overall Study|Lost to Follow-up|1
4646885|NCT02040766|7525284|FG002|Overall Study|Lost to Follow-up|3
4646886|NCT02040766|7525285|FG003|Overall Study|Lost to Follow-up|1
4646887|NCT02040766|7525286|FG004|Overall Study|Lost to Follow-up|4
4646888|NCT02040766|7525282|FG000|Overall Study|Not reported|1
4646889|NCT02040766|7525283|FG001|Overall Study|Not reported|0
4646890|NCT02040766|7525284|FG002|Overall Study|Not reported|0
4646891|NCT02040766|7525285|FG003|Overall Study|Not reported|0
4646892|NCT02040766|7525286|FG004|Overall Study|Not reported|0
4646893|NCT02040766|7525282|FG000|Overall Study|Lack of Efficacy|6
4646894|NCT02040766|7525283|FG001|Overall Study|Lack of Efficacy|3
4646895|NCT02040766|7525284|FG002|Overall Study|Lack of Efficacy|4
4646896|NCT02040766|7525285|FG003|Overall Study|Lack of Efficacy|6
4646897|NCT02040766|7525286|FG004|Overall Study|Lack of Efficacy|5
4646898|NCT02040779|7525302|FG000|Overall Study|Adverse Event|1
4646899|NCT02040779|7525303|FG001|Overall Study|Adverse Event|0
4646900|NCT02040779|7525304|FG002|Overall Study|Adverse Event|0
4646901|NCT02040779|7525302|FG000|Overall Study|Withdrawal by Subject|4
4646902|NCT02040779|7525303|FG001|Overall Study|Withdrawal by Subject|1
4646903|NCT02040779|7525304|FG002|Overall Study|Withdrawal by Subject|3
4646904|NCT02040779|7525302|FG000|Overall Study|Non-compliance|0
4646905|NCT02040779|7525303|FG001|Overall Study|Non-compliance|1
4646906|NCT02040779|7525304|FG002|Overall Study|Non-compliance|0
4646907|NCT02040779|7525302|FG000|Overall Study|Protocol Violation|2
4646908|NCT02040779|7525303|FG001|Overall Study|Protocol Violation|1
4646909|NCT02040779|7525304|FG002|Overall Study|Protocol Violation|0
4646910|NCT02040779|7525302|FG000|Overall Study|Lost to Follow-up|1
4646911|NCT02040779|7525303|FG001|Overall Study|Lost to Follow-up|2
4646912|NCT02040779|7525304|FG002|Overall Study|Lost to Follow-up|1
4646913|NCT02040779|7525302|FG000|Overall Study|Lack of Efficacy|4
4646914|NCT02040779|7525303|FG001|Overall Study|Lack of Efficacy|2
4646915|NCT02040779|7525304|FG002|Overall Study|Lack of Efficacy|0
4646916|NCT02040805|7525314|FG000|Overall Study|Lost to Follow-up|14
4646917|NCT02040805|7525315|FG001|Overall Study|Lost to Follow-up|9
4646918|NCT02040805|7525314|FG000|Overall Study|Withdrawal by Subject|28
4646919|NCT02040805|7525315|FG001|Overall Study|Withdrawal by Subject|41
4646920|NCT02040844|7525324|FG000|Overall Study|Adverse Event|0
4646921|NCT02040844|7525325|FG001|Overall Study|Adverse Event|0
4646922|NCT02040844|7525326|FG002|Overall Study|Adverse Event|1
4646923|NCT02040844|7525324|FG000|Overall Study|Withdrawal by Subject|16
4646924|NCT02040844|7525325|FG001|Overall Study|Withdrawal by Subject|22
4646925|NCT02040844|7525326|FG002|Overall Study|Withdrawal by Subject|25
4646926|NCT02040844|7525324|FG000|Overall Study|Lost to Follow-up|12
4646927|NCT02040844|7525325|FG001|Overall Study|Lost to Follow-up|9
4646928|NCT02040844|7525326|FG002|Overall Study|Lost to Follow-up|13
4646929|NCT02040844|7525324|FG000|Overall Study|Missing|13
4646930|NCT02040844|7525325|FG001|Overall Study|Missing|3
4646931|NCT02040844|7525326|FG002|Overall Study|Missing|2
4646932|NCT02040844|7525324|FG000|Overall Study|Non-specified|8
4646933|NCT02040844|7525325|FG001|Overall Study|Non-specified|2
4646934|NCT02040844|7525326|FG002|Overall Study|Non-specified|5
4646935|NCT02040844|7525324|FG000|Overall Study|Concomitant medication|1
4646936|NCT02040844|7525325|FG001|Overall Study|Concomitant medication|3
4646937|NCT02040844|7525326|FG002|Overall Study|Concomitant medication|1
4646938|NCT02040870|7525334|FG000|Overall Study|Completed treatment phase|6
4646939|NCT02040870|7525334|FG000|Overall Study|Adverse Event|7
4646940|NCT02040870|7525334|FG000|Overall Study|Progressive disease|58
4646941|NCT02040870|7525334|FG000|Overall Study|Physician Decision|6
4646942|NCT02040870|7525334|FG000|Overall Study|Subject/guardian decision|10
4646943|NCT02040870|7525334|FG000|Overall Study|Lost to Follow-up|3
4646944|NCT02040870|7525334|FG000|Overall Study|Death|13
4646945|NCT02041091|7525340|FG000|Treatment|Adverse Event|3
4646946|NCT02041091|7525341|FG001|Treatment|Adverse Event|3
4646947|NCT02041091|7525340|FG000|Treatment|Withdrawal by Subject|2
4646948|NCT02041091|7525341|FG001|Treatment|Withdrawal by Subject|4
4646949|NCT02041091|7525340|FG000|Treatment|Physician Decision|1
4646950|NCT02041091|7525341|FG001|Treatment|Physician Decision|0
4646951|NCT02041091|7525340|FG000|Treatment|Sponsor Decision|15
4646952|NCT02041091|7525341|FG001|Treatment|Sponsor Decision|16
4646953|NCT02041091|7525340|FG000|Treatment|Lost to Follow-up|1
4646954|NCT02041091|7525341|FG001|Treatment|Lost to Follow-up|0
4646955|NCT02041091|7525340|FG000|Optional Safety Extension Period|Adverse Event|4
4646956|NCT02041091|7525341|FG001|Optional Safety Extension Period|Adverse Event|2
4646957|NCT02041091|7525340|FG000|Optional Safety Extension Period|Withdrawal by Subject|5
4646958|NCT02041091|7525341|FG001|Optional Safety Extension Period|Withdrawal by Subject|2
4646959|NCT02041091|7525340|FG000|Optional Safety Extension Period|Protocol Violation|2
4646960|NCT02041091|7525341|FG001|Optional Safety Extension Period|Protocol Violation|0
4646961|NCT02041091|7525340|FG000|Optional Safety Extension Period|Physician Decision|2
4646962|NCT02041091|7525341|FG001|Optional Safety Extension Period|Physician Decision|1
4646963|NCT02041091|7525340|FG000|Optional Safety Extension Period|Sponsor Decision|70
4646964|NCT02041091|7525341|FG001|Optional Safety Extension Period|Sponsor Decision|74
4646965|NCT02041091|7525340|FG000|Optional Safety Extension Period|Lost to Follow-up|2
4646966|NCT02041091|7525341|FG001|Optional Safety Extension Period|Lost to Follow-up|3
4646967|NCT02041104|7525355|FG000|Overall Study|Lost to Follow-up|1
4646968|NCT02041104|7525356|FG001|Overall Study|Lost to Follow-up|4
4646969|NCT02041104|7525355|FG000|Overall Study|discomfort during OGTT|0
4646970|NCT02041104|7525356|FG001|Overall Study|discomfort during OGTT|3
4646971|NCT02041286|7525389|FG000|Overall Study|Adverse Event|1
4646972|NCT02041299|7525397|FG000|Overall Study|Adverse Event|9
4646973|NCT02041299|7525398|FG001|Overall Study|Adverse Event|3
4646974|NCT02041299|7525397|FG000|Overall Study|Lost to Follow-up|4
4646975|NCT02041299|7525398|FG001|Overall Study|Lost to Follow-up|1
4646976|NCT02041299|7525397|FG000|Overall Study|Physician Decision|1
4646977|NCT02041299|7525398|FG001|Overall Study|Physician Decision|1
4646978|NCT02041299|7525397|FG000|Overall Study|Withdrawal by Subject|13
4646979|NCT02041299|7525398|FG001|Overall Study|Withdrawal by Subject|7
4646980|NCT02041299|7525397|FG000|Overall Study|Protocol Violation|11
4646981|NCT02041299|7525398|FG001|Overall Study|Protocol Violation|4
4646982|NCT02041299|7525397|FG000|Overall Study|Termination of the study|7
4646983|NCT02041299|7525398|FG001|Overall Study|Termination of the study|3
4646984|NCT02041299|7525397|FG000|Overall Study|Required bone marrow transplant|0
4646985|NCT02041299|7525398|FG001|Overall Study|Required bone marrow transplant|1
4646986|NCT02041299|7525397|FG000|Overall Study|Patient stopped dosing on unknown date|1
4646987|NCT02041299|7525398|FG001|Overall Study|Patient stopped dosing on unknown date|0
4646988|NCT02041429|7525429|FG000|Overall Study|Progressive Disease|2
4646989|NCT02041429|7525430|FG001|Overall Study|Progressive Disease|2
4646990|NCT02041429|7525431|FG002|Overall Study|Progressive Disease|3
4646991|NCT02041429|7525432|FG003|Overall Study|Progressive Disease|2
4646992|NCT02041429|7525429|FG000|Overall Study|Toxicity|0
4646993|NCT02041429|7525430|FG001|Overall Study|Toxicity|1
4646994|NCT02041429|7525431|FG002|Overall Study|Toxicity|4
4646995|NCT02041429|7525432|FG003|Overall Study|Toxicity|2
4646996|NCT02041429|7525429|FG000|Overall Study|Withdrawal by Subject|0
4646997|NCT02041429|7525430|FG001|Overall Study|Withdrawal by Subject|1
4646998|NCT02041429|7525431|FG002|Overall Study|Withdrawal by Subject|0
4646999|NCT02041429|7525432|FG003|Overall Study|Withdrawal by Subject|0
4647000|NCT02041429|7525429|FG000|Overall Study|On Maintenance Therapy|1
4647001|NCT02041429|7525430|FG001|Overall Study|On Maintenance Therapy|0
4647002|NCT02041429|7525431|FG002|Overall Study|On Maintenance Therapy|0
4647003|NCT02041429|7525432|FG003|Overall Study|On Maintenance Therapy|2
4647004|NCT02041494|7525449|FG000|Overall Study|Death|1
4647005|NCT02041494|7525450|FG001|Overall Study|Death|3
4647006|NCT02041494|7525449|FG000|Overall Study|Lost to Follow-up|2
4647007|NCT02041494|7525450|FG001|Overall Study|Lost to Follow-up|6
4647008|NCT02041494|7525449|FG000|Overall Study|study terminated|16
4647009|NCT02041494|7525450|FG001|Overall Study|study terminated|11
4647010|NCT02041520|7525459|FG000|Overall Study|Adverse Event|2
4647011|NCT02041520|7525460|FG001|Overall Study|Adverse Event|1
4647012|NCT02041520|7525459|FG000|Overall Study|Withdrawal by Subject|3
4647013|NCT02041520|7525460|FG001|Overall Study|Withdrawal by Subject|4
4647014|NCT02041520|7525459|FG000|Overall Study|Protocol Violation|1
4647015|NCT02041520|7525460|FG001|Overall Study|Protocol Violation|0
4647016|NCT02041520|7525459|FG000|Overall Study|Lost to Follow-up|0
4647017|NCT02041520|7525460|FG001|Overall Study|Lost to Follow-up|1
4647018|NCT02041520|7525459|FG000|Overall Study|Hypothiroidism identified during follow-|0
4647019|NCT02041520|7525460|FG001|Overall Study|Hypothiroidism identified during follow-|1
4647020|NCT02041702|7525470|FG000|Overall Study|Lost to Follow-up|1
4647021|NCT02041702|7525471|FG001|Overall Study|Lost to Follow-up|6
4647022|NCT02041702|7525470|FG000|Overall Study|Death|4
4647023|NCT02041702|7525471|FG001|Overall Study|Death|0
4647024|NCT02041702|7525470|FG000|Overall Study|Withdrawal by Subject|4
4647025|NCT02041702|7525471|FG001|Overall Study|Withdrawal by Subject|3
4647026|NCT02041702|7525470|FG000|Overall Study|Patient not confirmed as MRI compatible|1
4647027|NCT02041702|7525471|FG001|Overall Study|Patient not confirmed as MRI compatible|0
4647028|NCT02041702|7525470|FG000|Overall Study|Cardiac Resynchronization Therapy|1
4647029|NCT02041702|7525471|FG001|Overall Study|Cardiac Resynchronization Therapy|0
4647030|NCT02041923|7525479|FG000|Overall Study|Lost to Follow-up|26
4647031|NCT02041923|7525480|FG001|Overall Study|Lost to Follow-up|30
4647032|NCT02041962|7525490|FG000|Overall Study|Lost Aetna Coverage|43
4647033|NCT02041962|7525491|FG001|Overall Study|Lost Aetna Coverage|40
4647034|NCT02041962|7525490|FG000|Overall Study|Death|1
4647035|NCT02041962|7525491|FG001|Overall Study|Death|1
4647036|NCT02041962|7525490|FG000|Overall Study|Lost to Follow-up|37
4647037|NCT02041962|7525491|FG001|Overall Study|Lost to Follow-up|32
4647038|NCT02041962|7525490|FG000|Overall Study|Withdrawal by Subject|0
4647039|NCT02041962|7525491|FG001|Overall Study|Withdrawal by Subject|11
4647040|NCT02042014|7525497|FG000|Overall Study|Adverse Event|1
4647041|NCT02042014|7525497|FG000|Overall Study|Physician Decision|7
4647042|NCT02042183|7525518|FG000|Overall Study|Physician Decision|7
4647043|NCT02042183|7525519|FG001|Overall Study|Physician Decision|2
4647044|NCT02042183|7525518|FG000|Overall Study|Lack of Efficacy|4
4647045|NCT02042183|7525519|FG001|Overall Study|Lack of Efficacy|3
4647046|NCT02042183|7525518|FG000|Overall Study|Non-compliance with Study Drug|2
4647047|NCT02042183|7525519|FG001|Overall Study|Non-compliance with Study Drug|3
4647048|NCT02042183|7525518|FG000|Overall Study|Adverse Event|17
4647049|NCT02042183|7525519|FG001|Overall Study|Adverse Event|6
4647050|NCT02042183|7525518|FG000|Overall Study|Other|3
4647051|NCT02042183|7525519|FG001|Overall Study|Other|3
4647052|NCT02042183|7525518|FG000|Overall Study|Withdrawal by Subject|21
4647053|NCT02042183|7525519|FG001|Overall Study|Withdrawal by Subject|16
4647054|NCT02042183|7525518|FG000|Overall Study|Site Terminated by Sponsor|2
4647055|NCT02042183|7525519|FG001|Overall Study|Site Terminated by Sponsor|1
4647056|NCT02042183|7525518|FG000|Overall Study|Lost to Follow-up|9
4647057|NCT02042183|7525519|FG001|Overall Study|Lost to Follow-up|2
4647058|NCT02042404|7525531|FG000|Overall Study|Death|1
4647059|NCT02042404|7525532|FG001|Overall Study|Death|0
4647060|NCT02042404|7525531|FG000|Overall Study|Unrelated Adverse Event|3
4647061|NCT02042404|7525532|FG001|Overall Study|Unrelated Adverse Event|0
4647062|NCT02042404|7525531|FG000|Overall Study|Inability to meet time requirements|1
4647063|NCT02042404|7525532|FG001|Overall Study|Inability to meet time requirements|0
4647064|NCT02042443|7525541|FG000|Overall Study|Adverse Event|2
4647065|NCT02042443|7525542|FG001|Overall Study|Adverse Event|1
4647066|NCT02042443|7525541|FG000|Overall Study|Withdrawal by Subject|0
4647067|NCT02042443|7525542|FG001|Overall Study|Withdrawal by Subject|1
4647068|NCT02042443|7525541|FG000|Overall Study|Progression|21
4647069|NCT02042443|7525542|FG001|Overall Study|Progression|17
4647070|NCT02042443|7525541|FG000|Overall Study|not protocol specified|1
4647071|NCT02042443|7525542|FG001|Overall Study|not protocol specified|1
4647072|NCT02042443|7525541|FG000|Overall Study|Not eligible/not analyzable|3
4647073|NCT02042443|7525542|FG001|Overall Study|Not eligible/not analyzable|6
4647074|NCT02043015|7525571|FG000|Overall Study|Lost to Follow-up|4
4647075|NCT02043015|7525571|FG000|Overall Study|Withdrawal by Subject|4
4647076|NCT02043015|7525571|FG000|Overall Study|Removed once target enrollment reached|15
4647077|NCT02043015|7525571|FG000|Overall Study|Participant moved away from study city|4
4647078|NCT02043015|7525571|FG000|Overall Study|Incarceration|1
4647079|NCT02043132|7525579|FG000|Overall Study|Lost to Follow-up|1
4647080|NCT02043132|7525580|FG001|Overall Study|Lost to Follow-up|1
4647081|NCT02043132|7525579|FG000|Overall Study|screen failures|4
4647082|NCT02043132|7525580|FG001|Overall Study|screen failures|8
4647083|NCT02043301|7525608|FG000|Overall Study|Discontinued|0
4647084|NCT02043301|7525609|FG001|Overall Study|Discontinued|1
4647085|NCT02043301|7525610|FG002|Overall Study|Discontinued|0
4647086|NCT02043366|7525624|FG000|Overall Study|Lost to Follow-up|2
4647087|NCT02043366|7525625|FG001|Overall Study|Lost to Follow-up|2
4647088|NCT02043366|7525626|FG002|Overall Study|Lost to Follow-up|2
4647089|NCT02043366|7525627|FG003|Overall Study|Lost to Follow-up|2
4647090|NCT02043366|7525628|FG004|Overall Study|Lost to Follow-up|2
4647091|NCT02043366|7525629|FG005|Overall Study|Lost to Follow-up|2
4647092|NCT02043509|7525656|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61
4647093|NCT02043509|7525657|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47
4647094|NCT02043509|7525656|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4
4647095|NCT02043509|7525657|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0
4647096|NCT02043509|7525656|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67
4647097|NCT02043509|7525657|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67
4647098|NCT02043509|7525656|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7
4647099|NCT02043509|7525657|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5
4647100|NCT02043548|7525665|FG000|Overall Study|Lack of Efficacy|1
4647101|NCT02043548|7525666|FG001|Overall Study|Lack of Efficacy|0
4647102|NCT02043548|7525665|FG000|Overall Study|Adverse Event|0
4647103|NCT02043548|7525666|FG001|Overall Study|Adverse Event|1
4647104|NCT02043782|7525695|FG000|Period 1|Adverse Event|0
4647105|NCT02043782|7525696|FG001|Period 1|Adverse Event|0
4647106|NCT02043782|7525697|FG002|Period 1|Adverse Event|1
4647107|NCT02043782|7525698|FG003|Period 1|Adverse Event|0
4647108|NCT02043782|7525699|FG004|Period 1|Adverse Event|0
4647109|NCT02043782|7525700|FG005|Period 1|Adverse Event|0
4647110|NCT02043899|7525717|FG000|Overall Study|Adverse Event|3
4647111|NCT02043899|7525717|FG000|Overall Study|Physician Decision|1
4647112|NCT02043899|7525717|FG000|Overall Study|Withdrawal by Subject|2
4647113|NCT02043899|7525717|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5
4647114|NCT02043899|7525717|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12
4647115|NCT02043899|7525717|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2
4647116|NCT02043899|7525717|FG000|Overall Study|Clinical progression necessitating urgent treatment|1
4647117|NCT02043899|7525717|FG000|Overall Study|Treatment delayed|1
4647118|NCT02043938|7525721|FG000|Overall Study|Withdrawal by Subject|7
4647119|NCT02043938|7525721|FG000|Overall Study|Unable to place EEG sensors on patient|1
4647120|NCT02043938|7525721|FG000|Overall Study|No show by subject|1
4647121|NCT02043938|7525721|FG000|Overall Study|Investigator decision|1
4647122|NCT02044094|7525728|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3
4647123|NCT02044094|7525728|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3
4647124|NCT02044094|7525728|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3
4647125|NCT02044094|7525728|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4
4647126|NCT02044094|7525728|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5
4647127|NCT02044094|7525728|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2
4647128|NCT02044094|7525728|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1
4647129|NCT02044094|7525728|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1
4647130|NCT02044159|7525745|FG000|Overall Study|Consent declined (deferred consent)|2
4647131|NCT02044159|7525746|FG001|Overall Study|Consent declined (deferred consent)|4
4647132|NCT02044159|7525745|FG000|Overall Study|No longer eligible, drug not given|1
4647133|NCT02044159|7525746|FG001|Overall Study|No longer eligible, drug not given|0
4647134|NCT02044159|7525745|FG000|Overall Study|Nurse declined to give study drug|1
4647135|NCT02044159|7525746|FG001|Overall Study|Nurse declined to give study drug|0
4647136|NCT02044458|7525804|FG000|Overall Study|Protocol Violation|3
4647137|NCT02044458|7525805|FG001|Overall Study|Protocol Violation|8
4647138|NCT02044510|7525813|FG000|Overall Study|Adverse Event|1
4647139|NCT02044510|7525814|FG001|Overall Study|Adverse Event|2
4647140|NCT02044874|7525852|FG000|Overall Study|Adverse Event|5
4647141|NCT02044874|7525853|FG001|Overall Study|Adverse Event|6
4647142|NCT02044874|7525854|FG002|Overall Study|Adverse Event|6
4647143|NCT02044874|7525852|FG000|Overall Study|Withdrawal by Subject|8
4647144|NCT02044874|7525853|FG001|Overall Study|Withdrawal by Subject|16
4647145|NCT02044874|7525854|FG002|Overall Study|Withdrawal by Subject|23
4647146|NCT02044874|7525852|FG000|Overall Study|Physician Decision|0
4647147|NCT02044874|7525853|FG001|Overall Study|Physician Decision|2
4647148|NCT02044874|7525854|FG002|Overall Study|Physician Decision|1
4647149|NCT02044874|7525852|FG000|Overall Study|Lost to Follow-up|10
4647150|NCT02044874|7525853|FG001|Overall Study|Lost to Follow-up|27
4647151|NCT02044874|7525854|FG002|Overall Study|Lost to Follow-up|21
4647152|NCT02044874|7525852|FG000|Overall Study|Sponsor Decision|0
4647153|NCT02044874|7525853|FG001|Overall Study|Sponsor Decision|1
4647154|NCT02044874|7525854|FG002|Overall Study|Sponsor Decision|1
4647155|NCT02044874|7525852|FG000|Overall Study|Other|7
4647156|NCT02044874|7525853|FG001|Overall Study|Other|3
4647157|NCT02044874|7525854|FG002|Overall Study|Other|8
4647158|NCT02045095|7525873|FG000|Overall Study|Other|0
4647159|NCT02045095|7525874|FG001|Overall Study|Other|0
4647160|NCT02045095|7525875|FG002|Overall Study|Other|1
4647161|NCT02045095|7525876|FG003|Overall Study|Other|0
4647162|NCT02045095|7525877|FG004|Overall Study|Other|0
4647163|NCT02045095|7525878|FG005|Overall Study|Other|2
4647164|NCT02045095|7525879|FG006|Overall Study|Other|0
4647165|NCT02045095|7525873|FG000|Overall Study|Progressive Disease|3
4647166|NCT02045095|7525874|FG001|Overall Study|Progressive Disease|3
4647167|NCT02045095|7525875|FG002|Overall Study|Progressive Disease|2
4647168|NCT02045095|7525876|FG003|Overall Study|Progressive Disease|4
4647169|NCT02045095|7525877|FG004|Overall Study|Progressive Disease|2
4647170|NCT02045095|7525878|FG005|Overall Study|Progressive Disease|4
4647171|NCT02045095|7525879|FG006|Overall Study|Progressive Disease|1
4647172|NCT02045095|7525873|FG000|Overall Study|Withdrawal by Subject|0
4647173|NCT02045095|7525874|FG001|Overall Study|Withdrawal by Subject|0
4647174|NCT02045095|7525875|FG002|Overall Study|Withdrawal by Subject|0
4647175|NCT02045095|7525876|FG003|Overall Study|Withdrawal by Subject|0
4647176|NCT02045095|7525877|FG004|Overall Study|Withdrawal by Subject|3
4647177|NCT02045095|7525878|FG005|Overall Study|Withdrawal by Subject|0
4647178|NCT02045095|7525879|FG006|Overall Study|Withdrawal by Subject|0
4647179|NCT02045095|7525873|FG000|Overall Study|Adverse Event|0
4647180|NCT02045095|7525874|FG001|Overall Study|Adverse Event|1
4647181|NCT02045095|7525875|FG002|Overall Study|Adverse Event|1
4647182|NCT02045095|7525876|FG003|Overall Study|Adverse Event|0
4647183|NCT02045095|7525877|FG004|Overall Study|Adverse Event|0
4647184|NCT02045095|7525878|FG005|Overall Study|Adverse Event|2
4647185|NCT02045095|7525879|FG006|Overall Study|Adverse Event|0
4647186|NCT02045212|7525914|FG000|Overall Study|Adverse Event|0
4647187|NCT02045212|7525915|FG001|Overall Study|Adverse Event|1
4647188|NCT02045212|7525914|FG000|Overall Study|Withdrawal by Subject|1
4647189|NCT02045212|7525915|FG001|Overall Study|Withdrawal by Subject|0
4647190|NCT02045212|7525914|FG000|Overall Study|Finished 13 weeks, chose not to extend|1
4647191|NCT02045212|7525915|FG001|Overall Study|Finished 13 weeks, chose not to extend|0
4647192|NCT02045433|7525955|FG000|Overall Study|Withdrawal by Subject|1
4647193|NCT02045732|7525970|FG000|Overall Study|At the discretion of the investigator|1
4647194|NCT02045732|7525971|FG001|Overall Study|At the discretion of the investigator|1
4647195|NCT02045836|7525979|FG000|Overall Study|Adverse Event|4
4647196|NCT02045836|7525980|FG001|Overall Study|Adverse Event|4
4647197|NCT02045836|7525979|FG000|Overall Study|Withdrawal by Subject|1
4647198|NCT02045836|7525980|FG001|Overall Study|Withdrawal by Subject|1
4647199|NCT02045836|7525979|FG000|Overall Study|Lost to Follow-up|4
4647200|NCT02045836|7525980|FG001|Overall Study|Lost to Follow-up|7
4647201|NCT02045836|7525979|FG000|Overall Study|Migrated from study area|0
4647202|NCT02045836|7525980|FG001|Overall Study|Migrated from study area|2
4647203|NCT02045862|7525990|FG000|Overall Study|Death|0
4647204|NCT02045862|7525991|FG001|Overall Study|Death|0
4647205|NCT02045862|7525992|FG002|Overall Study|Death|1
4647206|NCT02045862|7525990|FG000|Overall Study|Miscellaneous|5
4647207|NCT02045862|7525991|FG001|Overall Study|Miscellaneous|0
4647208|NCT02045862|7525992|FG002|Overall Study|Miscellaneous|8
4647209|NCT02045862|7525990|FG000|Overall Study|Withdrawal by Patient|18
4647210|NCT02045862|7525991|FG001|Overall Study|Withdrawal by Patient|27
4647211|NCT02045862|7525992|FG002|Overall Study|Withdrawal by Patient|57
4647212|NCT02045862|7525990|FG000|Overall Study|Protocol Violation|0
4647213|NCT02045862|7525991|FG001|Overall Study|Protocol Violation|0
4647214|NCT02045862|7525992|FG002|Overall Study|Protocol Violation|6
4647215|NCT02045862|7525990|FG000|Overall Study|Lack of Efficacy|8
4647216|NCT02045862|7525991|FG001|Overall Study|Lack of Efficacy|4
4647217|NCT02045862|7525992|FG002|Overall Study|Lack of Efficacy|13
4647218|NCT02045862|7525990|FG000|Overall Study|Randomized but not Received Study Drug|0
4647219|NCT02045862|7525991|FG001|Overall Study|Randomized but not Received Study Drug|2
4647220|NCT02045862|7525992|FG002|Overall Study|Randomized but not Received Study Drug|8
4647221|NCT02045862|7525990|FG000|Overall Study|Adverse Event|7
4647222|NCT02045862|7525991|FG001|Overall Study|Adverse Event|5
4647223|NCT02045862|7525992|FG002|Overall Study|Adverse Event|27
4647224|NCT02045862|7525990|FG000|Overall Study|Lost to Follow-up|1
4647225|NCT02045862|7525991|FG001|Overall Study|Lost to Follow-up|2
4647226|NCT02045862|7525992|FG002|Overall Study|Lost to Follow-up|6
4647227|NCT02045875|7526002|FG000|Overall Study|Lost to Follow-up|3
4647228|NCT02045875|7526003|FG001|Overall Study|Lost to Follow-up|0
4647229|NCT02045875|7526002|FG000|Overall Study|Withdrawal by Subject|4
4647230|NCT02045875|7526003|FG001|Overall Study|Withdrawal by Subject|3
4647231|NCT02045979|7526012|FG000|Overall Study|Informed Consent Withdrawn|2
4647232|NCT02045979|7526013|FG001|Overall Study|Informed Consent Withdrawn|0
4647233|NCT02045979|7526014|FG002|Overall Study|Informed Consent Withdrawn|1
4647234|NCT02045979|7526012|FG000|Overall Study|not specified above|0
4647235|NCT02045979|7526013|FG001|Overall Study|not specified above|1
4647236|NCT02045979|7526014|FG002|Overall Study|not specified above|0
4647237|NCT02046070|7526038|FG000|Overall Study|Progressive Disease|18
4647238|NCT02046070|7526039|FG001|Overall Study|Progressive Disease|11
4647239|NCT02046070|7526040|FG002|Overall Study|Progressive Disease|40
4647240|NCT02046070|7526038|FG000|Overall Study|Adverse Event|8
4647241|NCT02046070|7526039|FG001|Overall Study|Adverse Event|10
4647242|NCT02046070|7526040|FG002|Overall Study|Adverse Event|17
4647243|NCT02046070|7526038|FG000|Overall Study|Withdrawal by Subject|1
4647244|NCT02046070|7526039|FG001|Overall Study|Withdrawal by Subject|2
4647245|NCT02046070|7526040|FG002|Overall Study|Withdrawal by Subject|6
4647246|NCT02046070|7526038|FG000|Overall Study|Study Terminated by Sponsor|1
4647247|NCT02046070|7526039|FG001|Overall Study|Study Terminated by Sponsor|1
4647248|NCT02046070|7526040|FG002|Overall Study|Study Terminated by Sponsor|1
4647249|NCT02046070|7526038|FG000|Overall Study|Reason not Specified|4
4647250|NCT02046070|7526039|FG001|Overall Study|Reason not Specified|4
4647251|NCT02046070|7526040|FG002|Overall Study|Reason not Specified|6
4647252|NCT02046122|7526048|FG000|Overall Study|Physician Decision|8
4647253|NCT02046122|7526048|FG000|Overall Study|Withdrawal by Subject|1
4647254|NCT02046148|7526063|FG000|Overall Study|Lost to Follow-up|1
4647255|NCT02046148|7526064|FG001|Overall Study|Lost to Follow-up|1
4647256|NCT02046148|7526063|FG000|Overall Study|Withdrawal by Subject|0
4647257|NCT02046148|7526064|FG001|Overall Study|Withdrawal by Subject|2
4647258|NCT02046174|7526070|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1
4647259|NCT02046174|7526071|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0
4647260|NCT02046369|7526199|FG000|Overall Study|Adverse Event|3
4647261|NCT02046369|7526200|FG001|Overall Study|Adverse Event|3
4647262|NCT02046369|7526199|FG000|Overall Study|Lack of Efficacy|3
4647263|NCT02046369|7526200|FG001|Overall Study|Lack of Efficacy|3
4647264|NCT02046369|7526199|FG000|Overall Study|Lost to Follow-up|3
4647265|NCT02046369|7526200|FG001|Overall Study|Lost to Follow-up|3
4647266|NCT02046369|7526199|FG000|Overall Study|Protocol Violation|1
4647267|NCT02046369|7526200|FG001|Overall Study|Protocol Violation|2
4647268|NCT02046369|7526199|FG000|Overall Study|Withdrawal by Subject|3
4647269|NCT02046369|7526200|FG001|Overall Study|Withdrawal by Subject|6
4647270|NCT02046369|7526199|FG000|Overall Study|never received study drug|0
4647271|NCT02046369|7526200|FG001|Overall Study|never received study drug|1
4647272|NCT02046369|7526199|FG000|Overall Study|non compliance|1
4647273|NCT02046369|7526200|FG001|Overall Study|non compliance|0
4647274|NCT02046564|7526226|FG000|Overall Study|Adverse Event|6
4647275|NCT02046564|7526227|FG001|Overall Study|Adverse Event|3
4647276|NCT02046564|7526226|FG000|Overall Study|Physician Decision|0
4647277|NCT02046564|7526227|FG001|Overall Study|Physician Decision|1
4647278|NCT02046564|7526226|FG000|Overall Study|Protocol Violation|3
4647279|NCT02046564|7526227|FG001|Overall Study|Protocol Violation|1
4647280|NCT02046564|7526226|FG000|Overall Study|Withdrawal by Subject|4
4647281|NCT02046564|7526227|FG001|Overall Study|Withdrawal by Subject|10
4647282|NCT02046564|7526226|FG000|Overall Study|Subject met withdrawal criteria|2
4647283|NCT02046564|7526227|FG001|Overall Study|Subject met withdrawal criteria|5
4647284|NCT02046603|7526235|FG000|Overall Study|Other|11
4647285|NCT02046603|7526236|FG001|Overall Study|Other|66
4647286|NCT02046603|7526235|FG000|Overall Study|Protocol Violation|0
4647287|NCT02046603|7526236|FG001|Overall Study|Protocol Violation|1
4647288|NCT02046603|7526235|FG000|Overall Study|Participant/legal guardian decision|1
4647289|NCT02046603|7526236|FG001|Overall Study|Participant/legal guardian decision|3
4647290|NCT02046603|7526235|FG000|Overall Study|Physician Decision|2
4647291|NCT02046603|7526236|FG001|Overall Study|Physician Decision|1
4647292|NCT02046603|7526235|FG000|Overall Study|Lost to Follow-up|1
4647293|NCT02046603|7526236|FG001|Overall Study|Lost to Follow-up|2
4647294|NCT02046603|7526235|FG000|Overall Study|Death|0
4647295|NCT02046603|7526236|FG001|Overall Study|Death|1
4647296|NCT02046603|7526235|FG000|Overall Study|Adverse Event|0
4647297|NCT02046603|7526236|FG001|Overall Study|Adverse Event|1
4647298|NCT02046616|7526243|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1
4647299|NCT02046616|7526243|FG000|24-Week Treatment Period|Any Other Adverse Event|13
4647300|NCT02046616|7526243|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1
4647301|NCT02046616|7526243|FG000|24-Week Treatment Period|Physician Decision|3
4647302|NCT02046616|7526243|FG000|24-Week Treatment Period|Other|1
4647303|NCT02046616|7526243|FG000|8-Week FU Period|Lost to Follow-up|1
4647304|NCT02046993|7526292|FG000|Overall Study|Withdrawal by Subject|2
4647305|NCT02046993|7526293|FG001|Overall Study|Withdrawal by Subject|10
4647306|NCT02046993|7526292|FG000|Overall Study|Lost to Follow-up|1
4647307|NCT02046993|7526293|FG001|Overall Study|Lost to Follow-up|1
4647308|NCT02047045|7526314|FG000|Baseline|Withdrawal by Subject|3
4647309|NCT02047045|7526315|FG001|Baseline|Withdrawal by Subject|2
4647310|NCT02047045|7526314|FG000|Treatment Period (8 Weeks )|Adverse Event|3
4647311|NCT02047045|7526315|FG001|Treatment Period (8 Weeks )|Adverse Event|1
4647312|NCT02047045|7526314|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1
4647313|NCT02047045|7526315|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3
4647314|NCT02047045|7526314|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3
4647315|NCT02047045|7526315|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5
4647316|NCT02047045|7526314|FG000|Treatment Period (8 Weeks )|moved far away out of work|3
4647317|NCT02047045|7526315|FG001|Treatment Period (8 Weeks )|moved far away out of work|0
4647318|NCT02047045|7526314|FG000|Treatment Period (8 Weeks )|no reason was given|1
4647319|NCT02047045|7526315|FG001|Treatment Period (8 Weeks )|no reason was given|0
4647320|NCT02047045|7526314|FG000|Treatment Period (8 Weeks )|refused to take drugs|0
4647321|NCT02047045|7526315|FG001|Treatment Period (8 Weeks )|refused to take drugs|5
4647322|NCT02047045|7526314|FG000|Treatment Period (8 Weeks )|for safety considerations|0
4647323|NCT02047045|7526315|FG001|Treatment Period (8 Weeks )|for safety considerations|1
4647324|NCT02047045|7526314|FG000|Follow-up Period (24 Weeks)|Adverse Event|1
4647325|NCT02047045|7526315|FG001|Follow-up Period (24 Weeks)|Adverse Event|1
4647326|NCT02047110|7526325|FG000|DB Treatment Period up to Week 24|Adverse Event|1
4647327|NCT02047110|7526326|FG001|DB Treatment Period up to Week 24|Adverse Event|0
4647328|NCT02047110|7526327|FG002|DB Treatment Period up to Week 24|Adverse Event|0
4647329|NCT02047110|7526328|FG003|DB Treatment Period up to Week 24|Adverse Event|0
4647330|NCT02047110|7526325|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1
4647331|NCT02047110|7526326|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0
4647332|NCT02047110|7526327|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0
4647333|NCT02047110|7526328|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0
4647334|NCT02047110|7526325|FG000|DB Treatment Period up to Week 24|Protocol Violation|1
4647335|NCT02047110|7526326|FG001|DB Treatment Period up to Week 24|Protocol Violation|0
4647336|NCT02047110|7526327|FG002|DB Treatment Period up to Week 24|Protocol Violation|0
4647337|NCT02047110|7526328|FG003|DB Treatment Period up to Week 24|Protocol Violation|0
4647338|NCT02047110|7526325|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1
4647339|NCT02047110|7526326|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0
4647340|NCT02047110|7526327|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0
4647341|NCT02047110|7526328|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1
4647342|NCT02047110|7526325|FG000|DB Treatment Period up to Week 24|Other than specified|1
4647343|NCT02047110|7526326|FG001|DB Treatment Period up to Week 24|Other than specified|2
4647344|NCT02047110|7526327|FG002|DB Treatment Period up to Week 24|Other than specified|3
4647345|NCT02047110|7526328|FG003|DB Treatment Period up to Week 24|Other than specified|1
4647346|NCT02047110|7526325|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0
4647347|NCT02047110|7526326|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1
4647348|NCT02047110|7526327|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0
4647349|NCT02047110|7526328|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0
4647350|NCT02047110|7526325|FG000|DB (Week 12 up to Week 24)|Other than specified|0
4647351|NCT02047110|7526326|FG001|DB (Week 12 up to Week 24)|Other than specified|1
4647352|NCT02047110|7526327|FG002|DB (Week 12 up to Week 24)|Other than specified|1
4647353|NCT02047110|7526328|FG003|DB (Week 12 up to Week 24)|Other than specified|0
4647354|NCT02047110|7526325|FG000|Escape Treatment Period|Withdrawal by Subject|1
4647355|NCT02047110|7526326|FG001|Escape Treatment Period|Withdrawal by Subject|2
4647356|NCT02047110|7526327|FG002|Escape Treatment Period|Withdrawal by Subject|1
4647357|NCT02047110|7526328|FG003|Escape Treatment Period|Withdrawal by Subject|1
4647358|NCT02047110|7526325|FG000|Escape Treatment Period|Adverse Event|1
4647359|NCT02047110|7526326|FG001|Escape Treatment Period|Adverse Event|2
4647360|NCT02047110|7526327|FG002|Escape Treatment Period|Adverse Event|2
4647361|NCT02047110|7526328|FG003|Escape Treatment Period|Adverse Event|0
4647362|NCT02047110|7526325|FG000|Escape Treatment Period|Other than specified|1
4647363|NCT02047110|7526326|FG001|Escape Treatment Period|Other than specified|2
4647364|NCT02047110|7526327|FG002|Escape Treatment Period|Other than specified|0
4647365|NCT02047110|7526328|FG003|Escape Treatment Period|Other than specified|1
4647366|NCT02047110|7526325|FG000|OLE Treatment Period|Other than specified|0
4647367|NCT02047110|7526326|FG001|OLE Treatment Period|Other than specified|0
4647368|NCT02047110|7526327|FG002|OLE Treatment Period|Other than specified|1
4647369|NCT02047110|7526328|FG003|OLE Treatment Period|Other than specified|0
4647370|NCT02047227|7526347|FG000|Overall Study|Adverse Event|2
4647371|NCT02047227|7526348|FG001|Overall Study|Adverse Event|4
4647372|NCT02047227|7526347|FG000|Overall Study|Lost to Follow-up|0
4647373|NCT02047227|7526348|FG001|Overall Study|Lost to Follow-up|3
4647374|NCT02047227|7526347|FG000|Overall Study|Protocol Violation|1
4647375|NCT02047227|7526348|FG001|Overall Study|Protocol Violation|0
4647376|NCT02047227|7526347|FG000|Overall Study|Spontaneous pregnancy|1
4647377|NCT02047227|7526348|FG001|Overall Study|Spontaneous pregnancy|0
4647378|NCT02047227|7526347|FG000|Overall Study|Lack of ovarian response to stimulation|35
4647379|NCT02047227|7526348|FG001|Overall Study|Lack of ovarian response to stimulation|32
4647380|NCT02047227|7526347|FG000|Overall Study|No oocytes retrieved|21
4647381|NCT02047227|7526348|FG001|Overall Study|No oocytes retrieved|20
4647382|NCT02047227|7526347|FG000|Overall Study|No fertilization|61
4647383|NCT02047227|7526348|FG001|Overall Study|No fertilization|51
4647384|NCT02047227|7526347|FG000|Overall Study|Intention to freeze all embryos|1
4647385|NCT02047227|7526348|FG001|Overall Study|Intention to freeze all embryos|0
4647386|NCT02047227|7526347|FG000|Overall Study|All embryos discarded|12
4647387|NCT02047227|7526348|FG001|Overall Study|All embryos discarded|11
4647388|NCT02047227|7526347|FG000|Overall Study|Other|10
4647389|NCT02047227|7526348|FG001|Overall Study|Other|9
4647390|NCT02047253|7526354|FG000|Overall Study|Lost to Follow-up|8
4647391|NCT02047318|7526362|FG000|Core Study Period|Did not consent to 52-week follow- up|8
4647392|NCT02047318|7526362|FG000|Core Study Period|Adverse Event|1
4647393|NCT02047318|7526362|FG000|Core Study Period|Withdrawal by caregiver|3
4647394|NCT02047318|7526362|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1
4647395|NCT02047604|7526402|FG000|Overall Study|Withdrawal by Subject|0
4647396|NCT02047604|7526403|FG001|Overall Study|Withdrawal by Subject|0
4647397|NCT02047604|7526404|FG002|Overall Study|Withdrawal by Subject|0
4647398|NCT02047604|7526405|FG003|Overall Study|Withdrawal by Subject|0
4647399|NCT02047604|7526406|FG004|Overall Study|Withdrawal by Subject|1
4647400|NCT02047604|7526407|FG005|Overall Study|Withdrawal by Subject|1
4747732|NCT03283566|7721740|FG000|Overall Study|Lost to Follow-up|1
4747733|NCT03283566|7721741|FG001|Overall Study|Lost to Follow-up|2
4647401|NCT02047734|7526431|FG000|Overall Study|Adverse Event|18
4647402|NCT02047734|7526432|FG001|Overall Study|Adverse Event|13
4647403|NCT02047734|7526433|FG002|Overall Study|Adverse Event|13
4647404|NCT02047734|7526431|FG000|Overall Study|Lack of Efficacy|4
4647405|NCT02047734|7526432|FG001|Overall Study|Lack of Efficacy|5
4647406|NCT02047734|7526433|FG002|Overall Study|Lack of Efficacy|1
4647407|NCT02047734|7526431|FG000|Overall Study|Protocol Violation|3
4647408|NCT02047734|7526432|FG001|Overall Study|Protocol Violation|1
4647409|NCT02047734|7526433|FG002|Overall Study|Protocol Violation|1
4647410|NCT02047734|7526431|FG000|Overall Study|Lost to Follow-up|1
4647411|NCT02047734|7526432|FG001|Overall Study|Lost to Follow-up|4
4647412|NCT02047734|7526433|FG002|Overall Study|Lost to Follow-up|0
4647413|NCT02047734|7526431|FG000|Overall Study|Death|0
4647414|NCT02047734|7526432|FG001|Overall Study|Death|1
4647415|NCT02047734|7526433|FG002|Overall Study|Death|0
4647416|NCT02047734|7526431|FG000|Overall Study|Withdrawal by Subject|30
4647417|NCT02047734|7526432|FG001|Overall Study|Withdrawal by Subject|31
4647418|NCT02047734|7526433|FG002|Overall Study|Withdrawal by Subject|19
4647419|NCT02047734|7526431|FG000|Overall Study|Physician Decision|7
4647420|NCT02047734|7526432|FG001|Overall Study|Physician Decision|6
4647421|NCT02047734|7526433|FG002|Overall Study|Physician Decision|5
4647422|NCT02047734|7526431|FG000|Overall Study|Miscellaneous|2
4647423|NCT02047734|7526432|FG001|Overall Study|Miscellaneous|4
4647424|NCT02047734|7526433|FG002|Overall Study|Miscellaneous|6
4647425|NCT02047734|7526431|FG000|Overall Study|Did Not Receive Study Drug|2
4647426|NCT02047734|7526432|FG001|Overall Study|Did Not Receive Study Drug|4
4647427|NCT02047734|7526433|FG002|Overall Study|Did Not Receive Study Drug|1
4647428|NCT02047903|7526441|FG000|Overall Study|Adverse Event|14
4647429|NCT02047903|7526441|FG000|Overall Study|Serious adverse event|10
4647430|NCT02047903|7526441|FG000|Overall Study|Withdrawal by Subject|16
4647431|NCT02047903|7526441|FG000|Overall Study|Lost to Follow-up|4
4647432|NCT02047903|7526441|FG000|Overall Study|Reason not listed|6
4647433|NCT02047903|7526441|FG000|Overall Study|Not Treated|9
4647434|NCT02048072|7526454|FG000|Overall Study|Adverse Event|3
4647435|NCT02048072|7526454|FG000|Overall Study|Lost to Follow-up|1
4647436|NCT02048241|7526460|FG000|Overall Study|Withdrawal by Subject|0
4647437|NCT02048241|7526461|FG001|Overall Study|Withdrawal by Subject|1
4647438|NCT02048826|7526478|FG000|Overall Study|Withdrawal by Subject|1
4647439|NCT02048826|7526479|FG001|Overall Study|Withdrawal by Subject|0
4647440|NCT02049437|7526532|FG000|Period 1|Adverse Event|1
4647441|NCT02049437|7526533|FG001|Period 1|Adverse Event|1
4647442|NCT02049437|7526532|FG000|Period 1|Adverse Event|1
4647443|NCT02049437|7526533|FG001|Period 1|Adverse Event|0
4647444|NCT02049450|7526539|FG000|Overall Study|Adverse Event|2
4647445|NCT02049450|7526539|FG000|Overall Study|Withdrawal by Subject|1
4647446|NCT02049450|7526539|FG000|Overall Study|Patients/guardian decision|1
4647447|NCT02049814|7526570|FG000|Overall Study|Reason not Specified|4
4647448|NCT02049814|7526571|FG001|Overall Study|Reason not Specified|3
4647449|NCT02049814|7526570|FG000|Overall Study|Pregnancy|1
4647450|NCT02049814|7526571|FG001|Overall Study|Pregnancy|0
4647451|NCT02049814|7526570|FG000|Overall Study|Lost to Follow-up|2
4647452|NCT02049814|7526571|FG001|Overall Study|Lost to Follow-up|3
4647453|NCT02049814|7526570|FG000|Overall Study|Serious Protocol Violation|5
4647454|NCT02049814|7526571|FG001|Overall Study|Serious Protocol Violation|7
4647455|NCT02049814|7526570|FG000|Overall Study|Study Termination|0
4647456|NCT02049814|7526571|FG001|Overall Study|Study Termination|1
4647457|NCT02049814|7526570|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8
4647458|NCT02049814|7526571|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5
4647459|NCT02049814|7526570|FG000|Overall Study|Voluntary withdrawal|9
4647460|NCT02049814|7526571|FG001|Overall Study|Voluntary withdrawal|8
4647461|NCT02049866|7526577|FG000|Overall Study|Withdrawal by Subject|1
4647462|NCT02049944|7526594|FG000|Overall Study|Protocol Violation|2
4647463|NCT02049957|7526607|FG000|Overall Study|Progressive Disease|5
4647464|NCT02049957|7526608|FG001|Overall Study|Progressive Disease|4
4647465|NCT02049957|7526609|FG002|Overall Study|Progressive Disease|2
4647466|NCT02049957|7526610|FG003|Overall Study|Progressive Disease|2
4647467|NCT02049957|7526611|FG004|Overall Study|Progressive Disease|6
4647468|NCT02049957|7526612|FG005|Overall Study|Progressive Disease|35
4647469|NCT02049957|7526613|FG006|Overall Study|Progressive Disease|7
4647470|NCT02049957|7526614|FG007|Overall Study|Progressive Disease|26
4647471|NCT02049957|7526615|FG008|Overall Study|Progressive Disease|6
4647472|NCT02049957|7526607|FG000|Overall Study|Adverse Event|1
4647473|NCT02049957|7526608|FG001|Overall Study|Adverse Event|1
4647474|NCT02049957|7526609|FG002|Overall Study|Adverse Event|1
4647475|NCT02049957|7526610|FG003|Overall Study|Adverse Event|0
4647476|NCT02049957|7526611|FG004|Overall Study|Adverse Event|0
4647477|NCT02049957|7526612|FG005|Overall Study|Adverse Event|5
4647478|NCT02049957|7526613|FG006|Overall Study|Adverse Event|0
4647479|NCT02049957|7526614|FG007|Overall Study|Adverse Event|6
4647480|NCT02049957|7526615|FG008|Overall Study|Adverse Event|1
4647481|NCT02049957|7526607|FG000|Overall Study|Study Terminated by Sponsor|0
4647482|NCT02049957|7526608|FG001|Overall Study|Study Terminated by Sponsor|1
4647483|NCT02049957|7526609|FG002|Overall Study|Study Terminated by Sponsor|0
4647484|NCT02049957|7526610|FG003|Overall Study|Study Terminated by Sponsor|0
4647485|NCT02049957|7526611|FG004|Overall Study|Study Terminated by Sponsor|0
4647486|NCT02049957|7526612|FG005|Overall Study|Study Terminated by Sponsor|0
4647487|NCT02049957|7526613|FG006|Overall Study|Study Terminated by Sponsor|1
4647488|NCT02049957|7526614|FG007|Overall Study|Study Terminated by Sponsor|0
4647489|NCT02049957|7526615|FG008|Overall Study|Study Terminated by Sponsor|0
4647490|NCT02049957|7526607|FG000|Overall Study|Withdrawal by Subject|0
4647491|NCT02049957|7526608|FG001|Overall Study|Withdrawal by Subject|0
4647492|NCT02049957|7526609|FG002|Overall Study|Withdrawal by Subject|0
4647493|NCT02049957|7526610|FG003|Overall Study|Withdrawal by Subject|1
4647494|NCT02049957|7526611|FG004|Overall Study|Withdrawal by Subject|0
4647495|NCT02049957|7526612|FG005|Overall Study|Withdrawal by Subject|2
4647496|NCT02049957|7526613|FG006|Overall Study|Withdrawal by Subject|0
4647497|NCT02049957|7526614|FG007|Overall Study|Withdrawal by Subject|3
4647498|NCT02049957|7526615|FG008|Overall Study|Withdrawal by Subject|1
4647499|NCT02049957|7526607|FG000|Overall Study|Physician Decision|0
4647500|NCT02049957|7526608|FG001|Overall Study|Physician Decision|0
4647501|NCT02049957|7526609|FG002|Overall Study|Physician Decision|0
4647502|NCT02049957|7526610|FG003|Overall Study|Physician Decision|0
4647503|NCT02049957|7526611|FG004|Overall Study|Physician Decision|0
4647504|NCT02049957|7526612|FG005|Overall Study|Physician Decision|1
4647505|NCT02049957|7526613|FG006|Overall Study|Physician Decision|0
4647506|NCT02049957|7526614|FG007|Overall Study|Physician Decision|0
4647507|NCT02049957|7526615|FG008|Overall Study|Physician Decision|0
4647508|NCT02050048|7526637|FG000|Overall Study|Lost to Follow-up|0
4647509|NCT02050048|7526638|FG001|Overall Study|Lost to Follow-up|1
4647510|NCT02050048|7526637|FG000|Overall Study|Death|1
4647511|NCT02050048|7526638|FG001|Overall Study|Death|0
4647512|NCT02050048|7526637|FG000|Overall Study|Ineligible after ERCP|4
4647513|NCT02050048|7526638|FG001|Overall Study|Ineligible after ERCP|1
4647514|NCT02050321|7526644|FG000|Overall Study|Withdrawal by Subject|1
4647515|NCT02050321|7526644|FG000|Overall Study|Adverse Event|1
4647516|NCT02050373|7526660|FG000|Overall Study|Adverse Event|4
4647517|NCT02050373|7526661|FG001|Overall Study|Adverse Event|7
4647518|NCT02050373|7526660|FG000|Overall Study|Death|3
4647519|NCT02050373|7526661|FG001|Overall Study|Death|3
4647520|NCT02051296|7526680|FG000|Overall Study|Lost to Follow-up|1
4647521|NCT02051296|7526681|FG001|Overall Study|Lost to Follow-up|2
4647522|NCT02051296|7526680|FG000|Overall Study|withdraw prior to treatment|7
4647523|NCT02051296|7526681|FG001|Overall Study|withdraw prior to treatment|7
4647524|NCT02051764|7526737|FG000|Overall Study|Study terminated by sponsor|0
4647525|NCT02051764|7526738|FG001|Overall Study|Study terminated by sponsor|7
4647526|NCT02052011|7526771|FG000|Overall Study|Lost to Follow-up|3
4647527|NCT02052011|7526772|FG001|Overall Study|Lost to Follow-up|0
4647528|NCT02052011|7526771|FG000|Overall Study|Withdrawal by Subject|1
4647529|NCT02052011|7526772|FG001|Overall Study|Withdrawal by Subject|2
4647530|NCT02052310|7526789|FG000|Overall Study|Death|64
4647531|NCT02052310|7526790|FG001|Overall Study|Death|54
4647532|NCT02052310|7526789|FG000|Overall Study|Withdrawal by Subject|37
4647533|NCT02052310|7526790|FG001|Overall Study|Withdrawal by Subject|49
4647534|NCT02052310|7526789|FG000|Overall Study|Other than specified|32
4647535|NCT02052310|7526790|FG001|Overall Study|Other than specified|29
4647536|NCT02052310|7526789|FG000|Overall Study|Adverse Event|29
4647537|NCT02052310|7526790|FG001|Overall Study|Adverse Event|22
4647538|NCT02052310|7526789|FG000|Overall Study|Kidney Transplant|23
4647539|NCT02052310|7526790|FG001|Overall Study|Kidney Transplant|29
4647540|NCT02052310|7526789|FG000|Overall Study|Physician Decision|14
4647541|NCT02052310|7526790|FG001|Overall Study|Physician Decision|7
4647542|NCT02052310|7526789|FG000|Overall Study|Lack of Efficacy|6
4647543|NCT02052310|7526790|FG001|Overall Study|Lack of Efficacy|1
4647544|NCT02052310|7526789|FG000|Overall Study|Site Terminated by Sponsor|5
4647545|NCT02052310|7526790|FG001|Overall Study|Site Terminated by Sponsor|13
4647546|NCT02052310|7526789|FG000|Overall Study|Lost to Follow-up|4
4647547|NCT02052310|7526790|FG001|Overall Study|Lost to Follow-up|2
4647548|NCT02052310|7526789|FG000|Overall Study|Protocol Violation|1
4647549|NCT02052310|7526790|FG001|Overall Study|Protocol Violation|6
4647550|NCT02052414|7526796|FG000|Overall Study|Adverse Event|12
4647551|NCT02052414|7526796|FG000|Overall Study|Lack of Efficacy|2
4647552|NCT02052414|7526796|FG000|Overall Study|Withdrawal by Subject|3
4647553|NCT02052440|7526803|FG000|Overall Study|Withdrawal by Subject|0
4647554|NCT02052440|7526804|FG001|Overall Study|Withdrawal by Subject|1
4647555|NCT02052466|7526810|FG000|Overall Study|Withdrawal by Subject|1
4647556|NCT02052466|7526810|FG000|Overall Study|Acromial fracture|1
4647557|NCT02052596|7526832|FG000|Active Phase|Adverse Event|3
4647558|NCT02052596|7526833|FG001|Active Phase|Adverse Event|2
4647559|NCT02052596|7526832|FG000|Active Phase|Lost to Follow-up|8
4647560|NCT02052596|7526833|FG001|Active Phase|Lost to Follow-up|11
4647561|NCT02052596|7526832|FG000|Active Phase|Protocol Violation|1
4647562|NCT02052596|7526833|FG001|Active Phase|Protocol Violation|2
4647563|NCT02052596|7526832|FG000|Active Phase|Withdrawal by Subject|3
4647564|NCT02052596|7526833|FG001|Active Phase|Withdrawal by Subject|4
4647565|NCT02052596|7526832|FG000|Active Phase|Enrolled in error|1
4647566|NCT02052596|7526833|FG001|Active Phase|Enrolled in error|0
4647567|NCT02052596|7526832|FG000|Active Phase|Lost due to Crohn's disease|0
4647568|NCT02052596|7526833|FG001|Active Phase|Lost due to Crohn's disease|1
4647569|NCT02052596|7526832|FG000|Safety Phase|Adverse Event|6
4647570|NCT02052596|7526833|FG001|Safety Phase|Adverse Event|3
4647571|NCT02052596|7526832|FG000|Safety Phase|Lost to Follow-up|11
4647572|NCT02052596|7526833|FG001|Safety Phase|Lost to Follow-up|18
4647573|NCT02052596|7526832|FG000|Safety Phase|Protocol Violation|1
4647574|NCT02052596|7526833|FG001|Safety Phase|Protocol Violation|2
4647575|NCT02052596|7526832|FG000|Safety Phase|Withdrawal by Subject|8
4647576|NCT02052596|7526833|FG001|Safety Phase|Withdrawal by Subject|11
4647577|NCT02052596|7526832|FG000|Safety Phase|Enrolled in error|1
4647578|NCT02052596|7526833|FG001|Safety Phase|Enrolled in error|0
4647579|NCT02052596|7526832|FG000|Safety Phase|Lost due to Crohn's disease|0
4647580|NCT02052596|7526833|FG001|Safety Phase|Lost due to Crohn's disease|1
4647581|NCT02052960|7526880|FG000|Overall Study|Adverse Event|19
4647582|NCT02052960|7526881|FG001|Overall Study|Adverse Event|17
4647583|NCT02052960|7526880|FG000|Overall Study|Protocol Violation|4
4647584|NCT02052960|7526881|FG001|Overall Study|Protocol Violation|3
4647585|NCT02052960|7526880|FG000|Overall Study|Withdrawal by Subject|6
4647586|NCT02052960|7526881|FG001|Overall Study|Withdrawal by Subject|11
4647587|NCT02052960|7526880|FG000|Overall Study|Other|25
4647588|NCT02052960|7526881|FG001|Overall Study|Other|15
4647589|NCT02053168|7526894|FG000|Overall Study|Withdrawal by Subject|1
4647590|NCT02053168|7526894|FG000|Overall Study|Physician Decision|1
4647591|NCT02053168|7526894|FG000|Overall Study|Lost to Follow-up|1
4647592|NCT02053493|7526921|FG000|Overall Study|Withdrawal by Subject|1
4647593|NCT02053493|7526922|FG001|Overall Study|Withdrawal by Subject|1
4647594|NCT02053610|7526930|FG000|Overall Study|Adverse Event/Intercurrent Illness|25
4647595|NCT02053610|7526931|FG001|Overall Study|Adverse Event/Intercurrent Illness|43
4647596|NCT02053610|7526930|FG000|Overall Study|Withdrew Consent|2
4647597|NCT02053610|7526931|FG001|Overall Study|Withdrew Consent|9
4647598|NCT02053610|7526930|FG000|Overall Study|Death|5
4647599|NCT02053610|7526931|FG001|Overall Study|Death|5
4647600|NCT02053610|7526930|FG000|Overall Study|Administrative/Other|1
4647601|NCT02053610|7526931|FG001|Overall Study|Administrative/Other|1
4647602|NCT02053610|7526930|FG000|Overall Study|Disease Progression|2
4647603|NCT02053610|7526931|FG001|Overall Study|Disease Progression|3
4647604|NCT02053610|7526930|FG000|Overall Study|Refused treatment/Did not cooperate|1
4647605|NCT02053610|7526931|FG001|Overall Study|Refused treatment/Did not cooperate|3
4647606|NCT02053610|7526930|FG000|Overall Study|Did not Receive Treatment|4
4647607|NCT02053610|7526931|FG001|Overall Study|Did not Receive Treatment|2
4647608|NCT02053610|7526930|FG000|Overall Study|Insufficient Therapeutic Response|1
4647609|NCT02053610|7526931|FG001|Overall Study|Insufficient Therapeutic Response|1
4647610|NCT02053610|7526930|FG000|Overall Study|Violation of Selection Criteria|1
4647611|NCT02053610|7526931|FG001|Overall Study|Violation of Selection Criteria|0
4647612|NCT02053753|7526939|FG000|Overall Study|Withdrawal by Subject|2
4647613|NCT02053753|7526940|FG001|Overall Study|Withdrawal by Subject|4
4647614|NCT02053753|7526939|FG000|Overall Study|Decision by Sponsor|1
4647615|NCT02053753|7526940|FG001|Overall Study|Decision by Sponsor|1
4647616|NCT02053753|7526939|FG000|Overall Study|Lost to Follow-up|4
4647617|NCT02053753|7526940|FG001|Overall Study|Lost to Follow-up|3
4647618|NCT02054130|7526950|FG000|Overall Study|Withdrawal by Subject|4
4647619|NCT02054130|7526951|FG001|Overall Study|Withdrawal by Subject|4
4647620|NCT02054130|7526952|FG002|Overall Study|Withdrawal by Subject|7
4647621|NCT02054130|7526953|FG003|Overall Study|Withdrawal by Subject|10
4647622|NCT02054130|7526950|FG000|Overall Study|Death|0
4647623|NCT02054130|7526951|FG001|Overall Study|Death|1
4647624|NCT02054130|7526952|FG002|Overall Study|Death|0
4647625|NCT02054130|7526953|FG003|Overall Study|Death|0
4647626|NCT02054130|7526950|FG000|Overall Study|Lost to Follow-up|0
4647627|NCT02054130|7526951|FG001|Overall Study|Lost to Follow-up|0
4647628|NCT02054130|7526952|FG002|Overall Study|Lost to Follow-up|1
4647629|NCT02054130|7526953|FG003|Overall Study|Lost to Follow-up|2
4647630|NCT02054130|7526950|FG000|Overall Study|Missed dose|4
4647631|NCT02054130|7526951|FG001|Overall Study|Missed dose|6
4647632|NCT02054130|7526952|FG002|Overall Study|Missed dose|7
4647633|NCT02054130|7526953|FG003|Overall Study|Missed dose|10
4747734|NCT03077412|7721750|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1
4747735|NCT03077412|7721751|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5
4747736|NCT03077412|7721752|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3
4747737|NCT03077412|7721750|FG000|Overall Study|Protocol-Specified Disease Worsening|1
4747738|NCT03077412|7721751|FG001|Overall Study|Protocol-Specified Disease Worsening|3
4747739|NCT03077412|7721752|FG002|Overall Study|Protocol-Specified Disease Worsening|3
4747740|NCT03077412|7721750|FG000|Overall Study|Adverse Event|1
4747741|NCT03077412|7721751|FG001|Overall Study|Adverse Event|2
4747742|NCT03077412|7721752|FG002|Overall Study|Adverse Event|2
4747743|NCT03077412|7721750|FG000|Overall Study|Investigator's Discretion|0
4747744|NCT03077412|7721751|FG001|Overall Study|Investigator's Discretion|1
4747745|NCT03077412|7721752|FG002|Overall Study|Investigator's Discretion|1
4747746|NCT03077412|7721750|FG000|Overall Study|Withdrew Consent|0
4747747|NCT03077412|7721751|FG001|Overall Study|Withdrew Consent|2
4747748|NCT03077412|7721752|FG002|Overall Study|Withdrew Consent|0
4647634|NCT02054325|7526977|FG000|Overall Study|Lost to Follow-up|8
4647635|NCT02054325|7526978|FG001|Overall Study|Lost to Follow-up|5
4647636|NCT02054481|7526997|FG000|Overall Study|Adverse Event|1
4647637|NCT02054481|7526998|FG001|Overall Study|Adverse Event|1
4647638|NCT02054481|7526999|FG002|Overall Study|Adverse Event|0
4647639|NCT02054481|7527000|FG003|Overall Study|Adverse Event|1
4647640|NCT02054481|7526997|FG000|Overall Study|Lost to Follow-up|1
4647641|NCT02054481|7526998|FG001|Overall Study|Lost to Follow-up|0
4647642|NCT02054481|7526999|FG002|Overall Study|Lost to Follow-up|0
4647643|NCT02054481|7527000|FG003|Overall Study|Lost to Follow-up|0
4647644|NCT02054481|7526997|FG000|Overall Study|Other reason|2
4647645|NCT02054481|7526998|FG001|Overall Study|Other reason|1
4647646|NCT02054481|7526999|FG002|Overall Study|Other reason|2
4647647|NCT02054481|7527000|FG003|Overall Study|Other reason|0
4647648|NCT02054520|7527017|FG000|Overall Study|Adverse Event|1
4647649|NCT02054520|7527018|FG001|Overall Study|Adverse Event|4
4647650|NCT02054520|7527019|FG002|Overall Study|Adverse Event|2
4647651|NCT02054520|7527020|FG003|Overall Study|Adverse Event|1
4647652|NCT02054520|7527021|FG004|Overall Study|Adverse Event|1
4647653|NCT02054520|7527022|FG005|Overall Study|Adverse Event|0
4647654|NCT02054520|7527017|FG000|Overall Study|Lack of Efficacy|7
4647655|NCT02054520|7527018|FG001|Overall Study|Lack of Efficacy|0
4647656|NCT02054520|7527019|FG002|Overall Study|Lack of Efficacy|2
4647657|NCT02054520|7527020|FG003|Overall Study|Lack of Efficacy|1
4647658|NCT02054520|7527021|FG004|Overall Study|Lack of Efficacy|3
4647659|NCT02054520|7527022|FG005|Overall Study|Lack of Efficacy|2
4647660|NCT02054520|7527017|FG000|Overall Study|Withdrawal by Subject|1
4647661|NCT02054520|7527018|FG001|Overall Study|Withdrawal by Subject|0
4647662|NCT02054520|7527019|FG002|Overall Study|Withdrawal by Subject|0
4647663|NCT02054520|7527020|FG003|Overall Study|Withdrawal by Subject|2
4647664|NCT02054520|7527021|FG004|Overall Study|Withdrawal by Subject|1
4647665|NCT02054520|7527022|FG005|Overall Study|Withdrawal by Subject|0
4647666|NCT02054520|7527017|FG000|Overall Study|Physician Decision|0
4647667|NCT02054520|7527018|FG001|Overall Study|Physician Decision|1
4647668|NCT02054520|7527019|FG002|Overall Study|Physician Decision|0
4647669|NCT02054520|7527020|FG003|Overall Study|Physician Decision|1
4647670|NCT02054520|7527021|FG004|Overall Study|Physician Decision|0
4647671|NCT02054520|7527022|FG005|Overall Study|Physician Decision|1
4647672|NCT02054520|7527017|FG000|Overall Study|Study terminated by Sponsor|0
4647673|NCT02054520|7527018|FG001|Overall Study|Study terminated by Sponsor|0
4647674|NCT02054520|7527019|FG002|Overall Study|Study terminated by Sponsor|2
4647675|NCT02054520|7527020|FG003|Overall Study|Study terminated by Sponsor|1
4647676|NCT02054520|7527021|FG004|Overall Study|Study terminated by Sponsor|0
4647677|NCT02054520|7527022|FG005|Overall Study|Study terminated by Sponsor|0
4647678|NCT02054702|7527042|FG000|Overall Study|Lost to Follow-up|3
4647679|NCT02054702|7527043|FG001|Overall Study|Lost to Follow-up|5
4647680|NCT02054702|7527042|FG000|Overall Study|Adverse Event|3
4647681|NCT02054702|7527043|FG001|Overall Study|Adverse Event|1
4647682|NCT02054702|7527042|FG000|Overall Study|Met Withdrawal Criteria|4
4647683|NCT02054702|7527043|FG001|Overall Study|Met Withdrawal Criteria|1
4647684|NCT02054702|7527042|FG000|Overall Study|Physician Decision|0
4647685|NCT02054702|7527043|FG001|Overall Study|Physician Decision|1
4647686|NCT02054702|7527042|FG000|Overall Study|Withdrawal by Subject|14
4647687|NCT02054702|7527043|FG001|Overall Study|Withdrawal by Subject|4
4647688|NCT02054715|7527051|FG000|Baseline/Follow-up 1|Refused|1
4647689|NCT02054715|7527052|FG001|Baseline/Follow-up 1|Refused|3
4647690|NCT02054715|7527051|FG000|Baseline/Follow-up 1|Medical|0
4647691|NCT02054715|7527052|FG001|Baseline/Follow-up 1|Medical|1
4647692|NCT02054715|7527051|FG000|Baseline/Follow-up 1|Changed MD/Facility|0
4647693|NCT02054715|7527052|FG001|Baseline/Follow-up 1|Changed MD/Facility|1
4647694|NCT02054715|7527051|FG000|Baseline/Follow-up 1|Disliked Procedure|0
4647695|NCT02054715|7527052|FG001|Baseline/Follow-up 1|Disliked Procedure|1
4647696|NCT02054715|7527051|FG000|Baseline/Follow-up 1|No Reason|0
4647697|NCT02054715|7527052|FG001|Baseline/Follow-up 1|No Reason|1
4647698|NCT02054715|7527051|FG000|Baseline/Follow-up 1|Overwhelmed|2
4647699|NCT02054715|7527052|FG001|Baseline/Follow-up 1|Overwhelmed|0
4647700|NCT02054715|7527051|FG000|Baseline/Follow-up 1|Ineligible|3
4647701|NCT02054715|7527052|FG001|Baseline/Follow-up 1|Ineligible|0
4647702|NCT02054715|7527051|FG000|Baseline/Follow-up 1|Hospitalization|1
4647703|NCT02054715|7527052|FG001|Baseline/Follow-up 1|Hospitalization|0
4647704|NCT02054715|7527051|FG000|Baseline/Follow-up 1|Changed Mind|1
4647705|NCT02054715|7527052|FG001|Baseline/Follow-up 1|Changed Mind|0
4647706|NCT02054715|7527051|FG000|Follow-up 2|Lost to Followup|3
4647707|NCT02054715|7527052|FG001|Follow-up 2|Lost to Followup|1
4647708|NCT02054715|7527051|FG000|Follow-up 2|Refused|3
4647709|NCT02054715|7527052|FG001|Follow-up 2|Refused|2
4647710|NCT02054715|7527051|FG000|Follow-up 2|Followup Not Completed|3
4647711|NCT02054715|7527052|FG001|Follow-up 2|Followup Not Completed|4
4647712|NCT02054715|7527051|FG000|Follow-up 2|Ineligible|4
4647713|NCT02054715|7527052|FG001|Follow-up 2|Ineligible|5
4647714|NCT02054715|7527051|FG000|Follow-up 2|Death|3
4647715|NCT02054715|7527052|FG001|Follow-up 2|Death|3
4647716|NCT02054715|7527051|FG000|Follow-up 2|Hospitalization|0
4647717|NCT02054715|7527052|FG001|Follow-up 2|Hospitalization|2
4647718|NCT02054715|7527051|FG000|Follow-up 2|Changed MD/Facility|0
4647719|NCT02054715|7527052|FG001|Follow-up 2|Changed MD/Facility|1
4647720|NCT02054715|7527051|FG000|Follow-up 2|Changed Mind|0
4647721|NCT02054715|7527052|FG001|Follow-up 2|Changed Mind|1
4647722|NCT02054715|7527051|FG000|Follow-up 2|No Reason|2
4647723|NCT02054715|7527052|FG001|Follow-up 2|No Reason|0
4647724|NCT02054715|7527051|FG000|Follow-up 2|Treatment Change or Delay|1
4647725|NCT02054715|7527052|FG001|Follow-up 2|Treatment Change or Delay|0
4647726|NCT02054897|7527083|FG000|Overall Study|Withdrawal by Subject|2
4647727|NCT02054897|7527084|FG001|Overall Study|Withdrawal by Subject|0
4647728|NCT02054897|7527085|FG002|Overall Study|Withdrawal by Subject|2
4647729|NCT02054897|7527083|FG000|Overall Study|Missing follow-up information|3
4647730|NCT02054897|7527084|FG001|Overall Study|Missing follow-up information|5
4647731|NCT02054897|7527085|FG002|Overall Study|Missing follow-up information|3
4647732|NCT02054897|7527083|FG000|Overall Study|Lost to Follow-up|4
4647733|NCT02054897|7527084|FG001|Overall Study|Lost to Follow-up|2
4647734|NCT02054897|7527085|FG002|Overall Study|Lost to Follow-up|7
4647735|NCT02054897|7527083|FG000|Overall Study|Randomized but not exposed|1
4647736|NCT02054897|7527084|FG001|Overall Study|Randomized but not exposed|0
4647737|NCT02054897|7527085|FG002|Overall Study|Randomized but not exposed|0
4647738|NCT02055118|7527096|FG000|Overall Study|Withdrawal by Subject|0
4647739|NCT02055118|7527097|FG001|Overall Study|Withdrawal by Subject|2
4647740|NCT02055118|7527098|FG002|Overall Study|Withdrawal by Subject|0
4647741|NCT02055157|7527111|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0
4647742|NCT02055157|7527112|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1
4647743|NCT02055157|7527113|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0
4647744|NCT02055157|7527114|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0
4647745|NCT02055157|7527111|FG000|Initial 6 Months|Adverse Event|0
4647746|NCT02055157|7527112|FG001|Initial 6 Months|Adverse Event|0
4647747|NCT02055157|7527113|FG002|Initial 6 Months|Adverse Event|0
4647748|NCT02055157|7527114|FG003|Initial 6 Months|Adverse Event|1
4647749|NCT02055157|7527111|FG000|Initial 6 Months|Consent withdrawn by subject|1
4647750|NCT02055157|7527112|FG001|Initial 6 Months|Consent withdrawn by subject|0
4647751|NCT02055157|7527113|FG002|Initial 6 Months|Consent withdrawn by subject|0
4647752|NCT02055157|7527114|FG003|Initial 6 Months|Consent withdrawn by subject|0
4647753|NCT02055157|7527111|FG000|18-month Extension|Investigator decision|0
4647754|NCT02055157|7527112|FG001|18-month Extension|Investigator decision|1
4647755|NCT02055157|7527113|FG002|18-month Extension|Investigator decision|0
4647756|NCT02055157|7527114|FG003|18-month Extension|Investigator decision|0
4647757|NCT02055157|7527111|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1
4647758|NCT02055157|7527112|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0
4647759|NCT02055157|7527113|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0
4647760|NCT02055157|7527114|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0
4647761|NCT02055352|7527137|FG000|Overall Study|Adverse Event|0
4647762|NCT02055352|7527138|FG001|Overall Study|Adverse Event|1
4647763|NCT02055352|7527137|FG000|Overall Study|Non-eligible|0
4647764|NCT02055352|7527138|FG001|Overall Study|Non-eligible|1
4647765|NCT02055352|7527137|FG000|Overall Study|Poor compliance|1
4647766|NCT02055352|7527138|FG001|Overall Study|Poor compliance|1
4647767|NCT02055352|7527137|FG000|Overall Study|Death|1
4647768|NCT02055352|7527138|FG001|Overall Study|Death|2
4647769|NCT02055352|7527137|FG000|Overall Study|Patient decision|1
4647770|NCT02055352|7527138|FG001|Overall Study|Patient decision|1
4647771|NCT02055352|7527137|FG000|Overall Study|Use of prohibited treatment|0
4647772|NCT02055352|7527138|FG001|Overall Study|Use of prohibited treatment|3
4647773|NCT02055352|7527137|FG000|Overall Study|AE, study drug would be detrimental|1
4647774|NCT02055352|7527138|FG001|Overall Study|AE, study drug would be detrimental|3
4647775|NCT02055352|7527137|FG000|Overall Study|Withdrawal of informed consent|1
4647776|NCT02055352|7527138|FG001|Overall Study|Withdrawal of informed consent|0
4747749|NCT02886572|7721777|FG000|Baseline Through Follow up MRI|Death|8
4747750|NCT02384850|7721810|FG000|Overall Study|Withdrawal by Subject|2
4747751|NCT02384850|7721811|FG001|Overall Study|Withdrawal by Subject|2
4747752|NCT02352090|7721820|FG000|Overall Study|general malaise|1
4747753|NCT02352090|7721821|FG001|Overall Study|general malaise|0
4747754|NCT02352090|7721822|FG002|Overall Study|general malaise|0
4747755|NCT02352090|7721820|FG000|Overall Study|non-specified mild side-effects|0
4747756|NCT02352090|7721821|FG001|Overall Study|non-specified mild side-effects|0
4747757|NCT02352090|7721822|FG002|Overall Study|non-specified mild side-effects|2
4747758|NCT01078662|7721857|FG000|Overall Study|Death|41
4747759|NCT01078662|7721858|FG001|Overall Study|Death|103
4747760|NCT01078662|7721859|FG002|Overall Study|Death|18
4747761|NCT01078662|7721860|FG003|Overall Study|Death|5
4747762|NCT01078662|7721861|FG004|Overall Study|Death|8
4747763|NCT01078662|7721857|FG000|Overall Study|Patients reached data cut-off|12
4747764|NCT01078662|7721858|FG001|Overall Study|Patients reached data cut-off|53
4747765|NCT01078662|7721859|FG002|Overall Study|Patients reached data cut-off|2
4747766|NCT01078662|7721860|FG003|Overall Study|Patients reached data cut-off|2
4747767|NCT01078662|7721861|FG004|Overall Study|Patients reached data cut-off|3
4747768|NCT01078662|7721857|FG000|Overall Study|Withdrawal by Subject|4
4747769|NCT01078662|7721858|FG001|Overall Study|Withdrawal by Subject|11
4747770|NCT01078662|7721859|FG002|Overall Study|Withdrawal by Subject|1
4747771|NCT01078662|7721860|FG003|Overall Study|Withdrawal by Subject|0
4747772|NCT01078662|7721861|FG004|Overall Study|Withdrawal by Subject|0
4747773|NCT01078662|7721857|FG000|Overall Study|Protocol Violation|0
4747774|NCT01078662|7721858|FG001|Overall Study|Protocol Violation|1
4747775|NCT01078662|7721859|FG002|Overall Study|Protocol Violation|0
4747776|NCT01078662|7721860|FG003|Overall Study|Protocol Violation|0
4747777|NCT01078662|7721861|FG004|Overall Study|Protocol Violation|0
4747778|NCT01078662|7721857|FG000|Overall Study|Lost to Follow-up|1
4647777|NCT02055352|7527137|FG000|Overall Study|Reason unknown|1
4647778|NCT02055352|7527138|FG001|Overall Study|Reason unknown|5
4647779|NCT02055365|7527144|FG000|Overall Study|Prematurely Withdrawn|1
4647780|NCT02055820|7527209|FG000|Phase I: Dose-Finding|Death|1
4647781|NCT02055820|7527210|FG001|Phase I: Dose-Finding|Death|0
4647782|NCT02055820|7527211|FG002|Phase I: Dose-Finding|Death|1
4647783|NCT02055820|7527212|FG003|Phase I: Dose-Finding|Death|2
4647784|NCT02055820|7527213|FG004|Phase I: Dose-Finding|Death|0
4647785|NCT02055820|7527214|FG005|Phase I: Dose-Finding|Death|1
4647786|NCT02055820|7527215|FG006|Phase I: Dose-Finding|Death|1
4647787|NCT02055820|7527216|FG007|Phase I: Dose-Finding|Death|0
4647788|NCT02055820|7527217|FG008|Phase I: Dose-Finding|Death|0
4647789|NCT02055820|7527218|FG009|Phase I: Dose-Finding|Death|0
4647790|NCT02055820|7527209|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0
4647791|NCT02055820|7527210|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0
4647792|NCT02055820|7527211|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0
4647793|NCT02055820|7527212|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0
4647794|NCT02055820|7527213|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0
4647795|NCT02055820|7527214|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1
4647796|NCT02055820|7527215|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0
4647797|NCT02055820|7527216|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0
4647798|NCT02055820|7527217|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0
4647799|NCT02055820|7527218|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0
4647800|NCT02055820|7527209|FG000|Phase I: Dose-Finding|Lost to Follow-up|0
4647801|NCT02055820|7527210|FG001|Phase I: Dose-Finding|Lost to Follow-up|0
4647802|NCT02055820|7527211|FG002|Phase I: Dose-Finding|Lost to Follow-up|0
4647803|NCT02055820|7527212|FG003|Phase I: Dose-Finding|Lost to Follow-up|1
4647804|NCT02055820|7527213|FG004|Phase I: Dose-Finding|Lost to Follow-up|0
4647805|NCT02055820|7527214|FG005|Phase I: Dose-Finding|Lost to Follow-up|0
4647806|NCT02055820|7527215|FG006|Phase I: Dose-Finding|Lost to Follow-up|1
4647807|NCT02055820|7527216|FG007|Phase I: Dose-Finding|Lost to Follow-up|0
4647808|NCT02055820|7527217|FG008|Phase I: Dose-Finding|Lost to Follow-up|0
4647809|NCT02055820|7527218|FG009|Phase I: Dose-Finding|Lost to Follow-up|0
4647810|NCT02055820|7527209|FG000|Phase II: Expansion|Death|0
4647811|NCT02055820|7527210|FG001|Phase II: Expansion|Death|0
4647812|NCT02055820|7527211|FG002|Phase II: Expansion|Death|0
4647813|NCT02055820|7527212|FG003|Phase II: Expansion|Death|0
4647814|NCT02055820|7527213|FG004|Phase II: Expansion|Death|33
4647815|NCT02055820|7527214|FG005|Phase II: Expansion|Death|0
4647816|NCT02055820|7527215|FG006|Phase II: Expansion|Death|0
4647817|NCT02055820|7527216|FG007|Phase II: Expansion|Death|0
4647818|NCT02055820|7527217|FG008|Phase II: Expansion|Death|0
4647819|NCT02055820|7527218|FG009|Phase II: Expansion|Death|0
4647820|NCT02055820|7527209|FG000|Phase II: Expansion|Lost to Follow-up|0
4647821|NCT02055820|7527210|FG001|Phase II: Expansion|Lost to Follow-up|0
4647822|NCT02055820|7527211|FG002|Phase II: Expansion|Lost to Follow-up|0
4647823|NCT02055820|7527212|FG003|Phase II: Expansion|Lost to Follow-up|0
4647824|NCT02055820|7527213|FG004|Phase II: Expansion|Lost to Follow-up|4
4647825|NCT02055820|7527214|FG005|Phase II: Expansion|Lost to Follow-up|0
4647826|NCT02055820|7527215|FG006|Phase II: Expansion|Lost to Follow-up|0
4647827|NCT02055820|7527216|FG007|Phase II: Expansion|Lost to Follow-up|0
4647828|NCT02055820|7527217|FG008|Phase II: Expansion|Lost to Follow-up|0
4647829|NCT02055820|7527218|FG009|Phase II: Expansion|Lost to Follow-up|0
4647830|NCT02055820|7527209|FG000|Phase II: Expansion|Withdrawal by Subject|0
4647831|NCT02055820|7527210|FG001|Phase II: Expansion|Withdrawal by Subject|0
4647832|NCT02055820|7527211|FG002|Phase II: Expansion|Withdrawal by Subject|0
4647833|NCT02055820|7527212|FG003|Phase II: Expansion|Withdrawal by Subject|0
4647834|NCT02055820|7527213|FG004|Phase II: Expansion|Withdrawal by Subject|12
4647835|NCT02055820|7527214|FG005|Phase II: Expansion|Withdrawal by Subject|0
4647836|NCT02055820|7527215|FG006|Phase II: Expansion|Withdrawal by Subject|0
4647837|NCT02055820|7527216|FG007|Phase II: Expansion|Withdrawal by Subject|0
4647838|NCT02055820|7527217|FG008|Phase II: Expansion|Withdrawal by Subject|0
4647839|NCT02055820|7527218|FG009|Phase II: Expansion|Withdrawal by Subject|0
4647840|NCT02055898|7527262|FG000|First Intervention (5 Days)|Physician Decision|2
4647841|NCT02055898|7527263|FG001|First Intervention (5 Days)|Physician Decision|0
4647842|NCT02055898|7527262|FG000|First Intervention (5 Days)|Withdrawal by Subject|0
4647843|NCT02055898|7527263|FG001|First Intervention (5 Days)|Withdrawal by Subject|1
4647844|NCT02055976|7527278|FG000|Overall Study|Other|0
4647845|NCT02055976|7527279|FG001|Overall Study|Other|0
4647846|NCT02055976|7527280|FG002|Overall Study|Other|1
4647847|NCT02055976|7527281|FG003|Overall Study|Other|0
4647848|NCT02055976|7527282|FG004|Overall Study|Other|0
4647849|NCT02055976|7527283|FG005|Overall Study|Other|0
4647850|NCT02055976|7527284|FG006|Overall Study|Other|0
4647851|NCT02055976|7527285|FG007|Overall Study|Other|0
4647852|NCT02055976|7527286|FG008|Overall Study|Other|0
4647853|NCT02055976|7527278|FG000|Overall Study|Adverse Event|0
4647854|NCT02055976|7527279|FG001|Overall Study|Adverse Event|0
4647855|NCT02055976|7527280|FG002|Overall Study|Adverse Event|0
4647856|NCT02055976|7527281|FG003|Overall Study|Adverse Event|0
4647857|NCT02055976|7527282|FG004|Overall Study|Adverse Event|0
4647858|NCT02055976|7527283|FG005|Overall Study|Adverse Event|1
4647859|NCT02055976|7527284|FG006|Overall Study|Adverse Event|1
4647860|NCT02055976|7527285|FG007|Overall Study|Adverse Event|0
4647861|NCT02055976|7527286|FG008|Overall Study|Adverse Event|0
4647862|NCT02055976|7527278|FG000|Overall Study|Does not meet entrance criteria|0
4647863|NCT02055976|7527279|FG001|Overall Study|Does not meet entrance criteria|0
4647864|NCT02055976|7527280|FG002|Overall Study|Does not meet entrance criteria|0
4647865|NCT02055976|7527281|FG003|Overall Study|Does not meet entrance criteria|0
4647866|NCT02055976|7527282|FG004|Overall Study|Does not meet entrance criteria|0
4647867|NCT02055976|7527283|FG005|Overall Study|Does not meet entrance criteria|0
4647868|NCT02055976|7527284|FG006|Overall Study|Does not meet entrance criteria|1
4647869|NCT02055976|7527285|FG007|Overall Study|Does not meet entrance criteria|0
4647870|NCT02055976|7527286|FG008|Overall Study|Does not meet entrance criteria|0
4647871|NCT02055976|7527278|FG000|Overall Study|Lost to Follow-up|0
4647872|NCT02055976|7527279|FG001|Overall Study|Lost to Follow-up|0
4647873|NCT02055976|7527280|FG002|Overall Study|Lost to Follow-up|0
4647874|NCT02055976|7527281|FG003|Overall Study|Lost to Follow-up|1
4647875|NCT02055976|7527282|FG004|Overall Study|Lost to Follow-up|0
4647876|NCT02055976|7527283|FG005|Overall Study|Lost to Follow-up|0
4647877|NCT02055976|7527284|FG006|Overall Study|Lost to Follow-up|0
4647878|NCT02055976|7527285|FG007|Overall Study|Lost to Follow-up|0
4647879|NCT02055976|7527286|FG008|Overall Study|Lost to Follow-up|0
4647880|NCT02056288|7527324|FG000|In-Hospital Data|Surgery cancelled|1
4647881|NCT02056288|7527325|FG001|In-Hospital Data|Surgery cancelled|0
4647882|NCT02056288|7527324|FG000|In-Hospital Data|Protocol Violation|3
4647883|NCT02056288|7527325|FG001|In-Hospital Data|Protocol Violation|0
4647884|NCT02056288|7527324|FG000|In-Hospital Data|Physician Decision|1
4647885|NCT02056288|7527325|FG001|In-Hospital Data|Physician Decision|0
4647886|NCT02056288|7527324|FG000|48-Hour Post-Discharge Data|Did not return diary|14
4647887|NCT02056288|7527325|FG001|48-Hour Post-Discharge Data|Did not return diary|20
4647888|NCT02056301|7527333|FG000|Overall Study|Protocol Violation|1
4647889|NCT02056301|7527334|FG001|Overall Study|Protocol Violation|2
4647890|NCT02056301|7527333|FG000|Overall Study|Surgical complications req. 2nd surgery|1
4647891|NCT02056301|7527334|FG001|Overall Study|Surgical complications req. 2nd surgery|0
4647892|NCT02056301|7527333|FG000|Overall Study|Withdrawal by Subject|0
4647893|NCT02056301|7527334|FG001|Overall Study|Withdrawal by Subject|1
4647894|NCT02056301|7527333|FG000|Overall Study|Issues with epidural|0
4647895|NCT02056301|7527334|FG001|Overall Study|Issues with epidural|3
4647896|NCT02056340|7527342|FG000|Overall Study|Lost to Follow-up|5
4647897|NCT02056340|7527343|FG001|Overall Study|Lost to Follow-up|5
4647898|NCT02056340|7527342|FG000|Overall Study|Withdrawal by Subject|2
4647899|NCT02056340|7527343|FG001|Overall Study|Withdrawal by Subject|6
4647900|NCT02056392|7527355|FG000|Overall Study|Lost to Follow-up|0
4647901|NCT02056392|7527356|FG001|Overall Study|Lost to Follow-up|1
4647902|NCT02056392|7527357|FG002|Overall Study|Lost to Follow-up|2
4647903|NCT02056392|7527358|FG003|Overall Study|Lost to Follow-up|0
4647904|NCT02056392|7527359|FG004|Overall Study|Lost to Follow-up|0
4647905|NCT02056392|7527360|FG005|Overall Study|Lost to Follow-up|0
4647906|NCT02056392|7527355|FG000|Overall Study|Protocol Violation|1
4647907|NCT02056392|7527356|FG001|Overall Study|Protocol Violation|0
4647908|NCT02056392|7527357|FG002|Overall Study|Protocol Violation|1
4647909|NCT02056392|7527358|FG003|Overall Study|Protocol Violation|0
4647910|NCT02056392|7527359|FG004|Overall Study|Protocol Violation|0
4647911|NCT02056392|7527360|FG005|Overall Study|Protocol Violation|0
4647912|NCT02056392|7527355|FG000|Overall Study|Withdrawal by Subject|1
4647913|NCT02056392|7527356|FG001|Overall Study|Withdrawal by Subject|0
4647914|NCT02056392|7527357|FG002|Overall Study|Withdrawal by Subject|0
4647915|NCT02056392|7527358|FG003|Overall Study|Withdrawal by Subject|0
4647916|NCT02056392|7527359|FG004|Overall Study|Withdrawal by Subject|1
4647917|NCT02056392|7527360|FG005|Overall Study|Withdrawal by Subject|0
4647918|NCT02056626|7527383|FG000|Overall Study|patient did not follow directions|3
4647919|NCT02056626|7527384|FG001|Overall Study|patient did not follow directions|1
4647920|NCT02056626|7527385|FG002|Overall Study|patient did not follow directions|0
4647921|NCT02056626|7527386|FG003|Overall Study|patient did not follow directions|0
4647922|NCT02056652|7527409|FG000|Overall Study|Withdrawal by Subject|1
4647923|NCT02056652|7527410|FG001|Overall Study|Withdrawal by Subject|0
4647924|NCT02056652|7527409|FG000|Overall Study|Lost to Follow-up|0
4647925|NCT02056652|7527410|FG001|Overall Study|Lost to Follow-up|3
4647926|NCT02056834|7527416|FG000|Overall Study|Lost to Follow-up|7
4647927|NCT02057068|7527432|FG000|Overall Study|Withdrawal by Subject|2
4647928|NCT02057068|7527433|FG001|Overall Study|Withdrawal by Subject|2
4647929|NCT02057068|7527432|FG000|Overall Study|Caregiver (CG) Health|0
4647930|NCT02057068|7527433|FG001|Overall Study|Caregiver (CG) Health|2
4647931|NCT02057068|7527432|FG000|Overall Study|Carepartner (CP) Health|4
4647932|NCT02057068|7527433|FG001|Overall Study|Carepartner (CP) Health|2
4647933|NCT02057068|7527432|FG000|Overall Study|Lost to Follow-up|2
4647934|NCT02057068|7527433|FG001|Overall Study|Lost to Follow-up|2
4647935|NCT02057198|7527453|FG000|Overall Study|Death|0
4647936|NCT02057198|7527454|FG001|Overall Study|Death|0
4647937|NCT02057198|7527455|FG002|Overall Study|Death|1
4647938|NCT02057198|7527453|FG000|Overall Study|Discharged early; lost to followup|0
4647939|NCT02057198|7527454|FG001|Overall Study|Discharged early; lost to followup|1
4647940|NCT02057198|7527455|FG002|Overall Study|Discharged early; lost to followup|0
4647941|NCT02057250|7527467|FG000|AID Assessment Phase|Adverse Event|3
4647942|NCT02057250|7527468|FG001|AID Assessment Phase|Adverse Event|2
4647943|NCT02057250|7527469|FG002|AID Assessment Phase|Adverse Event|6
4647944|NCT02057250|7527470|FG003|AID Assessment Phase|Adverse Event|1
4647945|NCT02057250|7527471|FG004|AID Assessment Phase|Adverse Event|0
4647946|NCT02057250|7527467|FG000|AID Assessment Phase|Other than specified above|1
4647947|NCT02057250|7527468|FG001|AID Assessment Phase|Other than specified above|1
4647948|NCT02057250|7527469|FG002|AID Assessment Phase|Other than specified above|1
4647949|NCT02057250|7527470|FG003|AID Assessment Phase|Other than specified above|1
4647950|NCT02057250|7527471|FG004|AID Assessment Phase|Other than specified above|0
4647951|NCT02057250|7527467|FG000|Extension Phase|Adverse Event|0
4647952|NCT02057250|7527468|FG001|Extension Phase|Adverse Event|0
4647953|NCT02057250|7527469|FG002|Extension Phase|Adverse Event|0
4647954|NCT02057250|7527470|FG003|Extension Phase|Adverse Event|0
4647955|NCT02057250|7527471|FG004|Extension Phase|Adverse Event|15
4647956|NCT02057250|7527467|FG000|Extension Phase|Lack of Efficacy|0
4647957|NCT02057250|7527468|FG001|Extension Phase|Lack of Efficacy|0
4647958|NCT02057250|7527469|FG002|Extension Phase|Lack of Efficacy|0
4647959|NCT02057250|7527470|FG003|Extension Phase|Lack of Efficacy|0
4647960|NCT02057250|7527471|FG004|Extension Phase|Lack of Efficacy|10
4647961|NCT02057250|7527467|FG000|Extension Phase|Entered in this period but not treated|0
4647962|NCT02057250|7527468|FG001|Extension Phase|Entered in this period but not treated|0
4647963|NCT02057250|7527469|FG002|Extension Phase|Entered in this period but not treated|0
4647964|NCT02057250|7527470|FG003|Extension Phase|Entered in this period but not treated|0
4647965|NCT02057250|7527471|FG004|Extension Phase|Entered in this period but not treated|4
4647966|NCT02057250|7527467|FG000|Extension Phase|Other than specified above|0
4647967|NCT02057250|7527468|FG001|Extension Phase|Other than specified above|0
4647968|NCT02057250|7527469|FG002|Extension Phase|Other than specified above|0
4647969|NCT02057250|7527470|FG003|Extension Phase|Other than specified above|0
4647970|NCT02057250|7527471|FG004|Extension Phase|Other than specified above|7
4647971|NCT02057393|7527483|FG000|Overall Study|Withdrawal by Subject|1
4647972|NCT02057393|7527483|FG000|Overall Study|Patient did not meet criteria|1
4647973|NCT02057406|7527490|FG000|Overall Study|Physician Decision|0
4647974|NCT02057406|7527491|FG001|Overall Study|Physician Decision|0
4647975|NCT02057406|7527492|FG002|Overall Study|Physician Decision|2
4647976|NCT02057406|7527490|FG000|Overall Study|Withdrawal by Subject|0
4647977|NCT02057406|7527491|FG001|Overall Study|Withdrawal by Subject|2
4647978|NCT02057406|7527492|FG002|Overall Study|Withdrawal by Subject|0
4647979|NCT02057406|7527490|FG000|Overall Study|Lost to Follow-up|0
4647980|NCT02057406|7527491|FG001|Overall Study|Lost to Follow-up|0
4647981|NCT02057406|7527492|FG002|Overall Study|Lost to Follow-up|1
4647982|NCT02057406|7527490|FG000|Overall Study|Death|1
4647983|NCT02057406|7527491|FG001|Overall Study|Death|0
4647984|NCT02057406|7527492|FG002|Overall Study|Death|0
4647985|NCT02057406|7527490|FG000|Overall Study|Protocol Violation|0
4647986|NCT02057406|7527491|FG001|Overall Study|Protocol Violation|1
4647987|NCT02057406|7527492|FG002|Overall Study|Protocol Violation|0
4647988|NCT02057406|7527490|FG000|Overall Study|Patient transportation issues|0
4647989|NCT02057406|7527491|FG001|Overall Study|Patient transportation issues|0
4647990|NCT02057406|7527492|FG002|Overall Study|Patient transportation issues|1
4647991|NCT02057458|7527500|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0
4647992|NCT02057458|7527501|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1
4647993|NCT02057458|7527502|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0
4647994|NCT02057458|7527500|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2
4647995|NCT02057458|7527501|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0
4647996|NCT02057458|7527502|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0
4647997|NCT02057458|7527500|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1
4647998|NCT02057458|7527501|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0
4647999|NCT02057458|7527502|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0
4648000|NCT02057523|7527532|FG000|Overall Study|Withdrawal by Subject|1
4648001|NCT02057523|7527532|FG000|Overall Study|Lack of Efficacy|1
4648002|NCT02057549|7527538|FG000|Overall Study|Lost to Follow-up|1
4648003|NCT02057549|7527539|FG001|Overall Study|Lost to Follow-up|0
4648004|NCT02057549|7527538|FG000|Overall Study|Physician Decision|1
4648005|NCT02057549|7527539|FG001|Overall Study|Physician Decision|0
4648006|NCT02057549|7527538|FG000|Overall Study|Withdrawal by Subject|1
4648007|NCT02057549|7527539|FG001|Overall Study|Withdrawal by Subject|0
4747779|NCT01078662|7721858|FG001|Overall Study|Lost to Follow-up|0
4747780|NCT01078662|7721859|FG002|Overall Study|Lost to Follow-up|0
4747781|NCT01078662|7721860|FG003|Overall Study|Lost to Follow-up|0
4747782|NCT01078662|7721861|FG004|Overall Study|Lost to Follow-up|0
4747783|NCT00971867|7721870|FG000|Overall Study|Adverse Event|4
4747784|NCT00971867|7721870|FG000|Overall Study|Participant Withdrew Consent|1
4747785|NCT00971867|7721870|FG000|Overall Study|Disease Progression|6
4648008|NCT02057575|7527549|FG000|Overall Study|Adverse Event|0
4648009|NCT02057575|7527550|FG001|Overall Study|Adverse Event|2
4648010|NCT02057575|7527551|FG002|Overall Study|Adverse Event|0
4648011|NCT02057575|7527552|FG003|Overall Study|Adverse Event|1
4648012|NCT02057575|7527549|FG000|Overall Study|Withdrawal by Subject|1
4648013|NCT02057575|7527550|FG001|Overall Study|Withdrawal by Subject|0
4648014|NCT02057575|7527551|FG002|Overall Study|Withdrawal by Subject|0
4648015|NCT02057575|7527552|FG003|Overall Study|Withdrawal by Subject|0
4648016|NCT02057575|7527549|FG000|Overall Study|Dissallowed Concurrent Medication|0
4648017|NCT02057575|7527550|FG001|Overall Study|Dissallowed Concurrent Medication|1
4648018|NCT02057575|7527551|FG002|Overall Study|Dissallowed Concurrent Medication|0
4648019|NCT02057575|7527552|FG003|Overall Study|Dissallowed Concurrent Medication|0
4648020|NCT02057575|7527549|FG000|Overall Study|Protocol Violation|0
4648021|NCT02057575|7527550|FG001|Overall Study|Protocol Violation|1
4648022|NCT02057575|7527551|FG002|Overall Study|Protocol Violation|0
4648023|NCT02057575|7527552|FG003|Overall Study|Protocol Violation|0
4648024|NCT02057666|7527574|FG000|Double Blind Treatment Period|Withdrawal by Subject|8
4648025|NCT02057666|7527575|FG001|Double Blind Treatment Period|Withdrawal by Subject|5
4648026|NCT02057666|7527574|FG000|Double Blind Treatment Period|Poor tolerability|7
4648027|NCT02057666|7527575|FG001|Double Blind Treatment Period|Poor tolerability|2
4648028|NCT02057666|7527574|FG000|Double Blind Treatment Period|Symptomatic disease progression|8
4648029|NCT02057666|7527575|FG001|Double Blind Treatment Period|Symptomatic disease progression|3
4648030|NCT02057666|7527574|FG000|Double Blind Treatment Period|Physician Decision|1
4648031|NCT02057666|7527575|FG001|Double Blind Treatment Period|Physician Decision|0
4648032|NCT02057666|7527574|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1
4648033|NCT02057666|7527575|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0
4648034|NCT02057666|7527574|FG000|Double Blind Treatment Period|Subject planning to withdraw|1
4648035|NCT02057666|7527575|FG001|Double Blind Treatment Period|Subject planning to withdraw|0
4648036|NCT02057666|7527574|FG000|Double Blind Treatment Period|Sponsor's request|70
4648037|NCT02057666|7527575|FG001|Double Blind Treatment Period|Sponsor's request|34
4648038|NCT02057666|7527574|FG000|Open-Label Treatment Period|Poor tolerability|0
4648039|NCT02057666|7527575|FG001|Open-Label Treatment Period|Poor tolerability|1
4648040|NCT02057666|7527574|FG000|Open-Label Treatment Period|Symptomatic disease progression|0
4648041|NCT02057666|7527575|FG001|Open-Label Treatment Period|Symptomatic disease progression|1
4648042|NCT02057666|7527574|FG000|Open-Label Treatment Period|Sponsor's request|0
4648043|NCT02057666|7527575|FG001|Open-Label Treatment Period|Sponsor's request|4
4648044|NCT02057692|7527585|FG000|Overall Study|Adverse Event|1
4648045|NCT02057692|7527586|FG001|Overall Study|Adverse Event|0
4648046|NCT02057692|7527587|FG002|Overall Study|Adverse Event|0
4648047|NCT02057692|7527588|FG003|Overall Study|Adverse Event|0
4648048|NCT02057692|7527585|FG000|Overall Study|Lost to Follow-up|0
4648049|NCT02057692|7527586|FG001|Overall Study|Lost to Follow-up|0
4648050|NCT02057692|7527587|FG002|Overall Study|Lost to Follow-up|0
4648051|NCT02057692|7527588|FG003|Overall Study|Lost to Follow-up|1
4648052|NCT02057718|7527606|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0
4648053|NCT02057718|7527607|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2
4648054|NCT02057718|7527606|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1
4648055|NCT02057718|7527607|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0
4648056|NCT02057718|7527606|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0
4648057|NCT02057718|7527607|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1
4648058|NCT02057718|7527606|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0
4648059|NCT02057718|7527607|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3
4648060|NCT02057718|7527606|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1
4648061|NCT02057718|7527607|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1
4648062|NCT02057718|7527606|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0
4648063|NCT02057718|7527607|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1
4648064|NCT02057718|7527606|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0
4648065|NCT02057718|7527607|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1
4648066|NCT02057718|7527606|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1
4648067|NCT02057718|7527607|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3
4648068|NCT02057718|7527606|FG000|Optional Follow-up Treatment Period|Progressive disease|0
4648069|NCT02057718|7527607|FG001|Optional Follow-up Treatment Period|Progressive disease|1
4648070|NCT02057718|7527606|FG000|Optional Follow-up Treatment Period|Adverse Event|1
4648071|NCT02057718|7527607|FG001|Optional Follow-up Treatment Period|Adverse Event|2
4648072|NCT02057718|7527606|FG000|Optional Follow-up Treatment Period|Liver Transplant|0
4648073|NCT02057718|7527607|FG001|Optional Follow-up Treatment Period|Liver Transplant|2
4648074|NCT02057757|7527615|FG000|Overall Study|Withdrawal by Subject|3
4648075|NCT02057757|7527616|FG001|Overall Study|Withdrawal by Subject|5
4648076|NCT02057757|7527615|FG000|Overall Study|Death|2
4648077|NCT02057757|7527616|FG001|Overall Study|Death|0
4648078|NCT02057757|7527615|FG000|Overall Study|Lost to Follow-up|8
4648079|NCT02057757|7527616|FG001|Overall Study|Lost to Follow-up|3
4648080|NCT02057757|7527615|FG000|Overall Study|Non-compliance|1
4648081|NCT02057757|7527616|FG001|Overall Study|Non-compliance|0
4648082|NCT02057835|7527636|FG000|Overall Study|Withdrawal by Subject|0
4648083|NCT02057835|7527637|FG001|Overall Study|Withdrawal by Subject|2
4648084|NCT02057835|7527638|FG002|Overall Study|Withdrawal by Subject|0
4648085|NCT02057835|7527639|FG003|Overall Study|Withdrawal by Subject|0
4648086|NCT02057835|7527640|FG004|Overall Study|Withdrawal by Subject|0
4648087|NCT02057835|7527641|FG005|Overall Study|Withdrawal by Subject|0
4648088|NCT02057835|7527642|FG006|Overall Study|Withdrawal by Subject|0
4648089|NCT02057835|7527643|FG007|Overall Study|Withdrawal by Subject|0
4648090|NCT02057835|7527644|FG008|Overall Study|Withdrawal by Subject|0
4648091|NCT02057835|7527645|FG009|Overall Study|Withdrawal by Subject|0
4648092|NCT02058069|7527691|FG000|Overall Study|Exclusion due to implant size|5
4648093|NCT02058069|7527691|FG000|Overall Study|Withdrawal by Subject|6
4648094|NCT02058095|7527697|FG000|Overall Study|Adverse Event|1
4648095|NCT02058095|7527698|FG001|Overall Study|Adverse Event|0
4648096|NCT02058108|7527706|FG000|Overall Study|Abnormal Laboratory Values|0
4648097|NCT02058108|7527707|FG001|Overall Study|Abnormal Laboratory Values|1
4648098|NCT02058108|7527706|FG000|Overall Study|Unsatisfactory therapeutic effect|37
4648099|NCT02058108|7527707|FG001|Overall Study|Unsatisfactory therapeutic effect|4
4648100|NCT02058108|7527706|FG000|Overall Study|No longer requires study drug|0
4648101|NCT02058108|7527707|FG001|Overall Study|No longer requires study drug|1
4648102|NCT02058108|7527706|FG000|Overall Study|Withdrawal by Subject|1
4648103|NCT02058108|7527707|FG001|Overall Study|Withdrawal by Subject|0
4648104|NCT02058108|7527706|FG000|Overall Study|Administrative problems|3
4648105|NCT02058108|7527707|FG001|Overall Study|Administrative problems|3
4648106|NCT02058108|7527706|FG000|Overall Study|Protocol Violation|0
4648107|NCT02058108|7527707|FG001|Overall Study|Protocol Violation|1
4648108|NCT02058147|7527718|FG000|Overall Study|Randomized but not treated|0
4648109|NCT02058147|7527719|FG001|Overall Study|Randomized but not treated|0
4648110|NCT02058147|7527720|FG002|Overall Study|Randomized but not treated|1
4648111|NCT02058147|7527718|FG000|Overall Study|Adverse Event|12
4648112|NCT02058147|7527719|FG001|Overall Study|Adverse Event|9
4648113|NCT02058147|7527720|FG002|Overall Study|Adverse Event|21
4648114|NCT02058147|7527718|FG000|Overall Study|Lack of Efficacy|1
4648115|NCT02058147|7527719|FG001|Overall Study|Lack of Efficacy|0
4648116|NCT02058147|7527720|FG002|Overall Study|Lack of Efficacy|3
4648117|NCT02058147|7527718|FG000|Overall Study|Poor compliance to protocol|8
4648118|NCT02058147|7527719|FG001|Overall Study|Poor compliance to protocol|9
4648119|NCT02058147|7527720|FG002|Overall Study|Poor compliance to protocol|4
4648120|NCT02058147|7527718|FG000|Overall Study|Other than specified|8
4648121|NCT02058147|7527719|FG001|Overall Study|Other than specified|9
4648122|NCT02058147|7527720|FG002|Overall Study|Other than specified|0
4648123|NCT02058160|7527730|FG000|Overall Study|Randomized but not treated|2
4648124|NCT02058160|7527731|FG001|Overall Study|Randomized but not treated|4
4648125|NCT02058160|7527730|FG000|Overall Study|Poor compliance to protocol|4
4648126|NCT02058160|7527731|FG001|Overall Study|Poor compliance to protocol|1
4648127|NCT02058160|7527730|FG000|Overall Study|Adverse Event|12
4648128|NCT02058160|7527731|FG001|Overall Study|Adverse Event|3
4648129|NCT02058160|7527730|FG000|Overall Study|Lost to Follow-up|1
4648130|NCT02058160|7527731|FG001|Overall Study|Lost to Follow-up|0
4648131|NCT02058160|7527730|FG000|Overall Study|Other than specified above|12
4648132|NCT02058160|7527731|FG001|Overall Study|Other than specified above|6
4648133|NCT02058290|7527748|FG000|Overall Study|Protocol Violation|2
4648134|NCT02058290|7527749|FG001|Overall Study|Protocol Violation|1
4648135|NCT02058290|7527748|FG000|Overall Study|Physician Decision|1
4648136|NCT02058290|7527749|FG001|Overall Study|Physician Decision|0
4648137|NCT02058290|7527748|FG000|Overall Study|Didn't meet intraoperative criteria|8
4648138|NCT02058290|7527749|FG001|Overall Study|Didn't meet intraoperative criteria|7
4648139|NCT02058290|7527748|FG000|Overall Study|Withdrawal by Subject|0
4648140|NCT02058290|7527749|FG001|Overall Study|Withdrawal by Subject|1
4648141|NCT02058368|7527757|FG000|Overall Study|Adverse Event|15
4648142|NCT02058368|7527758|FG001|Overall Study|Adverse Event|20
4648143|NCT02058368|7527757|FG000|Overall Study|Lack of Efficacy|0
4648144|NCT02058368|7527758|FG001|Overall Study|Lack of Efficacy|1
4648145|NCT02058368|7527757|FG000|Overall Study|Protocol Violation|0
4648146|NCT02058368|7527758|FG001|Overall Study|Protocol Violation|4
4648147|NCT02058368|7527757|FG000|Overall Study|Lost to Follow-up|2
4648148|NCT02058368|7527758|FG001|Overall Study|Lost to Follow-up|0
4648149|NCT02058368|7527757|FG000|Overall Study|Physician Decision|2
4648150|NCT02058368|7527758|FG001|Overall Study|Physician Decision|3
4648151|NCT02058368|7527757|FG000|Overall Study|Withdrawal by Subject|22
4648152|NCT02058368|7527758|FG001|Overall Study|Withdrawal by Subject|26
4648153|NCT02058498|7527764|FG000|Overall Study|Withdrawal by Subject|4
4648154|NCT02058563|7527774|FG000|Overall Study|Lost to Follow-up|26
4648155|NCT02058563|7527775|FG001|Overall Study|Lost to Follow-up|22
4648156|NCT02058563|7527774|FG000|Overall Study|Other (vaccinated later as new subject)|1
4648157|NCT02058563|7527775|FG001|Overall Study|Other (vaccinated later as new subject)|0
4648158|NCT02058563|7527774|FG000|Overall Study|Consent Withdrawal|1
4648159|NCT02058563|7527775|FG001|Overall Study|Consent Withdrawal|1
4648160|NCT02058563|7527774|FG000|Overall Study|Other (patient incarcerated)|0
4648161|NCT02058563|7527775|FG001|Overall Study|Other (patient incarcerated)|1
4648162|NCT02058589|7527783|FG000|Overall Study|Serious Adverse Event|1
4648163|NCT02058589|7527784|FG001|Overall Study|Serious Adverse Event|1
4648164|NCT02058589|7527783|FG000|Overall Study|Non-Serious Adverse Event|1
4648165|NCT02058589|7527784|FG001|Overall Study|Non-Serious Adverse Event|0
4648166|NCT02058589|7527783|FG000|Overall Study|Withdrawal by Subject|0
4648167|NCT02058589|7527784|FG001|Overall Study|Withdrawal by Subject|1
4648168|NCT02058628|7527794|FG000|Overall Study|Adverse Event|1
4648169|NCT02058628|7527795|FG001|Overall Study|Adverse Event|0
4648170|NCT02058628|7527794|FG000|Overall Study|Withdrawal by Subject|2
4648171|NCT02058628|7527795|FG001|Overall Study|Withdrawal by Subject|2
4648172|NCT02058628|7527794|FG000|Overall Study|Lost to Follow-up|2
4648173|NCT02058628|7527795|FG001|Overall Study|Lost to Follow-up|4
4648174|NCT02058628|7527794|FG000|Overall Study|Not in time schedule|0
4648175|NCT02058628|7527795|FG001|Overall Study|Not in time schedule|1
4648176|NCT02058628|7527794|FG000|Overall Study|The visit date was not in timeline|0
4648177|NCT02058628|7527795|FG001|Overall Study|The visit date was not in timeline|1
4648178|NCT02058628|7527794|FG000|Overall Study|A lot of time for study for participant|1
4648179|NCT02058628|7527795|FG001|Overall Study|A lot of time for study for participant|0
4648180|NCT02058628|7527794|FG000|Overall Study|Non compliance|1
4648181|NCT02058628|7527795|FG001|Overall Study|Non compliance|0
4648182|NCT02058836|7527806|FG000|Overall Study|Withdrawal by Subject|1
4648183|NCT02058836|7527807|FG001|Overall Study|Withdrawal by Subject|1
4648184|NCT02058849|7527815|FG000|Overall Study|Hospitalization|1
4648185|NCT02058849|7527816|FG001|Overall Study|Hospitalization|1
4648186|NCT02058849|7527815|FG000|Overall Study|Death|1
4648187|NCT02058849|7527816|FG001|Overall Study|Death|0
4648188|NCT02058849|7527815|FG000|Overall Study|Lost to Follow-up|1
4648189|NCT02058849|7527816|FG001|Overall Study|Lost to Follow-up|0
4648190|NCT02058849|7527815|FG000|Overall Study|Withdrawal by Subject|4
4648191|NCT02058849|7527816|FG001|Overall Study|Withdrawal by Subject|0
4648192|NCT02058940|7527822|FG000|Overall Study|Discharged from Critical Care Unit|1
4648193|NCT02058966|7527826|FG000|Open-Label Methamphetamine|Adverse Event|1
4648194|NCT02058966|7527826|FG000|First Intervention|Withdrawal by Subject|1
4648195|NCT02058992|7527838|FG000|Overall Study|Lost to Follow-up|4
4648196|NCT02058992|7527838|FG000|Overall Study|Protocol Violation|92
4648197|NCT02058992|7527838|FG000|Overall Study|CRF Uncollected|20
4648198|NCT02059005|7527844|FG000|Overall Study|Death|1
4648199|NCT02059005|7527845|FG001|Overall Study|Death|3
4648200|NCT02059005|7527844|FG000|Overall Study|Lost to Follow-up|19
4648201|NCT02059005|7527845|FG001|Overall Study|Lost to Follow-up|19
4648202|NCT02059005|7527844|FG000|Overall Study|Incarceration|0
4648203|NCT02059005|7527845|FG001|Overall Study|Incarceration|1
4648204|NCT02059005|7527844|FG000|Overall Study|Inpatient|0
4648205|NCT02059005|7527845|FG001|Overall Study|Inpatient|1
4648206|NCT02059135|7527869|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3
4648207|NCT02059135|7527870|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2
4648208|NCT02059135|7527869|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0
4648209|NCT02059135|7527870|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3
4648210|NCT02059135|7527869|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0
4648211|NCT02059135|7527870|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1
4648212|NCT02059135|7527869|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0
4648213|NCT02059135|7527870|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1
4648214|NCT02059135|7527869|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1
4648215|NCT02059135|7527870|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0
4648216|NCT02059135|7527869|FG000|Neonatal Follow-up (Safety Population)|Death|3
4648217|NCT02059135|7527870|FG001|Neonatal Follow-up (Safety Population)|Death|2
4648218|NCT02059135|7527869|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0
4648219|NCT02059135|7527870|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1
4648220|NCT02059135|7527869|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0
4648221|NCT02059135|7527870|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1
4648222|NCT02059148|7527878|FG000|Treatment 1|Protocol Violation|0
4648223|NCT02059148|7527879|FG001|Treatment 1|Protocol Violation|0
4648224|NCT02059148|7527880|FG002|Treatment 1|Protocol Violation|0
4648225|NCT02059148|7527881|FG003|Treatment 1|Protocol Violation|0
4648226|NCT02059148|7527882|FG004|Treatment 1|Protocol Violation|0
4648227|NCT02059148|7527883|FG005|Treatment 1|Protocol Violation|1
4648228|NCT02059161|7527896|FG000|Overall Study|Pregnancy|0
4648229|NCT02059161|7527897|FG001|Overall Study|Pregnancy|2
4648230|NCT02059161|7527896|FG000|Overall Study|Adverse Event|2
4648231|NCT02059161|7527897|FG001|Overall Study|Adverse Event|6
4648232|NCT02059161|7527896|FG000|Overall Study|Lost to Follow-up|20
4648233|NCT02059161|7527897|FG001|Overall Study|Lost to Follow-up|12
4648234|NCT02059161|7527896|FG000|Overall Study|Physician Decision|4
4648235|NCT02059161|7527897|FG001|Overall Study|Physician Decision|4
4648236|NCT02059161|7527896|FG000|Overall Study|Protocol Violation|1
4648237|NCT02059161|7527897|FG001|Overall Study|Protocol Violation|1
4648238|NCT02059161|7527896|FG000|Overall Study|Withdrawal by Subject|16
4648239|NCT02059161|7527897|FG001|Overall Study|Withdrawal by Subject|13
4648240|NCT02059161|7527896|FG000|Overall Study|Randomized in error, no study drug|0
4648241|NCT02059161|7527897|FG001|Overall Study|Randomized in error, no study drug|1
4648242|NCT02059161|7527896|FG000|Overall Study|Non-compliance with study drug|6
4747786|NCT00853307|7721876|FG000|Overall Study|Adverse Event|1
4648243|NCT02059161|7527897|FG001|Overall Study|Non-compliance with study drug|2
4648244|NCT02059174|7527903|FG000|Period 1|Withdrawal by Subject|0
4648245|NCT02059174|7527904|FG001|Period 1|Withdrawal by Subject|2
4648246|NCT02059174|7527903|FG000|Period 2|Withdrawal by Subject|0
4648247|NCT02059174|7527904|FG001|Period 2|Withdrawal by Subject|2
4648248|NCT02059174|7527903|FG000|Period 2|Protocol Violation|1
4648249|NCT02059174|7527904|FG001|Period 2|Protocol Violation|0
4648250|NCT02059174|7527903|FG000|Period 3|Physician Decision|1
4648251|NCT02059174|7527904|FG001|Period 3|Physician Decision|0
4648252|NCT02059187|7527912|FG000|Overall Study|Adverse Event|0
4648253|NCT02059187|7527913|FG001|Overall Study|Adverse Event|3
4648254|NCT02059187|7527912|FG000|Overall Study|Death|1
4648255|NCT02059187|7527913|FG001|Overall Study|Death|1
4648256|NCT02059187|7527912|FG000|Overall Study|Lost to Follow-up|9
4648257|NCT02059187|7527913|FG001|Overall Study|Lost to Follow-up|8
4648258|NCT02059187|7527912|FG000|Overall Study|Non-compliance with study drug|1
4648259|NCT02059187|7527913|FG001|Overall Study|Non-compliance with study drug|0
4648260|NCT02059187|7527912|FG000|Overall Study|Physician Decision|1
4648261|NCT02059187|7527913|FG001|Overall Study|Physician Decision|2
4648262|NCT02059187|7527912|FG000|Overall Study|Protocol Violation|1
4648263|NCT02059187|7527913|FG001|Overall Study|Protocol Violation|0
4648264|NCT02059187|7527912|FG000|Overall Study|Withdrawal by Subject|12
4648265|NCT02059187|7527913|FG001|Overall Study|Withdrawal by Subject|8
4648266|NCT02059239|7527933|FG000|Overall Study|Progressive Disease after Bendamustine|1
4648267|NCT02059239|7527934|FG001|Overall Study|Progressive Disease after Bendamustine|3
4648268|NCT02059239|7527933|FG000|Overall Study|Physician Decision|1
4648269|NCT02059239|7527934|FG001|Overall Study|Physician Decision|0
4648270|NCT02059278|7527943|FG000|Overall Study|Adverse Event|1
4648271|NCT02059278|7527944|FG001|Overall Study|Adverse Event|1
4648272|NCT02059278|7527943|FG000|Overall Study|Lost to Follow-up|1
4648273|NCT02059278|7527944|FG001|Overall Study|Lost to Follow-up|0
4648274|NCT02059278|7527943|FG000|Overall Study|Withdrawal by Subject|0
4648275|NCT02059278|7527944|FG001|Overall Study|Withdrawal by Subject|3
4648276|NCT02059278|7527943|FG000|Overall Study|Ran out of IP and decided to discontinue|1
4648277|NCT02059278|7527944|FG001|Overall Study|Ran out of IP and decided to discontinue|0
4648278|NCT02059291|7527959|FG000|Epoch 2|Lack of Efficacy|0
4648279|NCT02059291|7527960|FG001|Epoch 2|Lack of Efficacy|0
4648280|NCT02059291|7527961|FG002|Epoch 2|Lack of Efficacy|0
4648281|NCT02059291|7527962|FG003|Epoch 2|Lack of Efficacy|1
4648282|NCT02059291|7527963|FG004|Epoch 2|Lack of Efficacy|0
4648283|NCT02059291|7527964|FG005|Epoch 2|Lack of Efficacy|1
4648284|NCT02059291|7527965|FG006|Epoch 2|Lack of Efficacy|0
4648285|NCT02059291|7527966|FG007|Epoch 2|Lack of Efficacy|0
4648286|NCT02059291|7527967|FG008|Epoch 2|Lack of Efficacy|0
4648287|NCT02059291|7527968|FG009|Epoch 2|Lack of Efficacy|0
4648288|NCT02059291|7527969|FG010|Epoch 2|Lack of Efficacy|0
4648289|NCT02059291|7527970|FG011|Epoch 2|Lack of Efficacy|0
4648290|NCT02059291|7527971|FG012|Epoch 2|Lack of Efficacy|0
4648291|NCT02059291|7527972|FG013|Epoch 2|Lack of Efficacy|0
4648292|NCT02059291|7527973|FG014|Epoch 2|Lack of Efficacy|0
4648293|NCT02059291|7527974|FG015|Epoch 2|Lack of Efficacy|0
4648294|NCT02059291|7527975|FG016|Epoch 2|Lack of Efficacy|0
4648295|NCT02059291|7527976|FG017|Epoch 2|Lack of Efficacy|0
4648296|NCT02059291|7527977|FG018|Epoch 2|Lack of Efficacy|0
4648297|NCT02059291|7527978|FG019|Epoch 2|Lack of Efficacy|0
4648298|NCT02059291|7527979|FG020|Epoch 2|Lack of Efficacy|0
4648299|NCT02059291|7527980|FG021|Epoch 2|Lack of Efficacy|0
4648300|NCT02059291|7527981|FG022|Epoch 2|Lack of Efficacy|0
4648301|NCT02059291|7527982|FG023|Epoch 2|Lack of Efficacy|0
4648302|NCT02059291|7527983|FG024|Epoch 2|Lack of Efficacy|0
4648303|NCT02059291|7527959|FG000|Epoch 2|Adverse Event|0
4648304|NCT02059291|7527960|FG001|Epoch 2|Adverse Event|0
4648305|NCT02059291|7527961|FG002|Epoch 2|Adverse Event|1
4648306|NCT02059291|7527962|FG003|Epoch 2|Adverse Event|1
4648307|NCT02059291|7527963|FG004|Epoch 2|Adverse Event|0
4648308|NCT02059291|7527964|FG005|Epoch 2|Adverse Event|0
4648309|NCT02059291|7527965|FG006|Epoch 2|Adverse Event|0
4648310|NCT02059291|7527966|FG007|Epoch 2|Adverse Event|1
4648311|NCT02059291|7527967|FG008|Epoch 2|Adverse Event|1
4648312|NCT02059291|7527968|FG009|Epoch 2|Adverse Event|0
4648313|NCT02059291|7527969|FG010|Epoch 2|Adverse Event|0
4648314|NCT02059291|7527970|FG011|Epoch 2|Adverse Event|0
4648315|NCT02059291|7527971|FG012|Epoch 2|Adverse Event|0
4648316|NCT02059291|7527972|FG013|Epoch 2|Adverse Event|0
4648317|NCT02059291|7527973|FG014|Epoch 2|Adverse Event|0
4648318|NCT02059291|7527974|FG015|Epoch 2|Adverse Event|0
4648319|NCT02059291|7527975|FG016|Epoch 2|Adverse Event|0
4648320|NCT02059291|7527976|FG017|Epoch 2|Adverse Event|0
4648321|NCT02059291|7527977|FG018|Epoch 2|Adverse Event|0
4648322|NCT02059291|7527978|FG019|Epoch 2|Adverse Event|0
4648323|NCT02059291|7527979|FG020|Epoch 2|Adverse Event|0
4648324|NCT02059291|7527980|FG021|Epoch 2|Adverse Event|0
4648325|NCT02059291|7527981|FG022|Epoch 2|Adverse Event|0
4648326|NCT02059291|7527982|FG023|Epoch 2|Adverse Event|0
4648327|NCT02059291|7527983|FG024|Epoch 2|Adverse Event|0
4648328|NCT02059291|7527959|FG000|Epoch 2|Withdrawal by Subject|0
4648329|NCT02059291|7527960|FG001|Epoch 2|Withdrawal by Subject|1
4648330|NCT02059291|7527961|FG002|Epoch 2|Withdrawal by Subject|0
4648331|NCT02059291|7527962|FG003|Epoch 2|Withdrawal by Subject|0
4648332|NCT02059291|7527963|FG004|Epoch 2|Withdrawal by Subject|0
4648333|NCT02059291|7527964|FG005|Epoch 2|Withdrawal by Subject|1
4648334|NCT02059291|7527965|FG006|Epoch 2|Withdrawal by Subject|0
4648335|NCT02059291|7527966|FG007|Epoch 2|Withdrawal by Subject|0
4648336|NCT02059291|7527967|FG008|Epoch 2|Withdrawal by Subject|1
4648337|NCT02059291|7527968|FG009|Epoch 2|Withdrawal by Subject|0
4648338|NCT02059291|7527969|FG010|Epoch 2|Withdrawal by Subject|0
4648339|NCT02059291|7527970|FG011|Epoch 2|Withdrawal by Subject|0
4648340|NCT02059291|7527971|FG012|Epoch 2|Withdrawal by Subject|0
4648341|NCT02059291|7527972|FG013|Epoch 2|Withdrawal by Subject|0
4648342|NCT02059291|7527973|FG014|Epoch 2|Withdrawal by Subject|0
4648343|NCT02059291|7527974|FG015|Epoch 2|Withdrawal by Subject|0
4648344|NCT02059291|7527975|FG016|Epoch 2|Withdrawal by Subject|0
4648345|NCT02059291|7527976|FG017|Epoch 2|Withdrawal by Subject|0
4648346|NCT02059291|7527977|FG018|Epoch 2|Withdrawal by Subject|0
4648347|NCT02059291|7527978|FG019|Epoch 2|Withdrawal by Subject|0
4648348|NCT02059291|7527979|FG020|Epoch 2|Withdrawal by Subject|0
4648349|NCT02059291|7527980|FG021|Epoch 2|Withdrawal by Subject|0
4648350|NCT02059291|7527981|FG022|Epoch 2|Withdrawal by Subject|0
4648351|NCT02059291|7527982|FG023|Epoch 2|Withdrawal by Subject|0
4648352|NCT02059291|7527983|FG024|Epoch 2|Withdrawal by Subject|0
4648353|NCT02059291|7527959|FG000|Epoch 3|Physician Decision|0
4648354|NCT02059291|7527960|FG001|Epoch 3|Physician Decision|0
4648355|NCT02059291|7527961|FG002|Epoch 3|Physician Decision|0
4648356|NCT02059291|7527962|FG003|Epoch 3|Physician Decision|0
4648357|NCT02059291|7527963|FG004|Epoch 3|Physician Decision|0
4648358|NCT02059291|7527964|FG005|Epoch 3|Physician Decision|0
4648359|NCT02059291|7527965|FG006|Epoch 3|Physician Decision|0
4648360|NCT02059291|7527966|FG007|Epoch 3|Physician Decision|0
4648361|NCT02059291|7527967|FG008|Epoch 3|Physician Decision|0
4648362|NCT02059291|7527968|FG009|Epoch 3|Physician Decision|0
4648363|NCT02059291|7527969|FG010|Epoch 3|Physician Decision|0
4648364|NCT02059291|7527970|FG011|Epoch 3|Physician Decision|0
4648365|NCT02059291|7527971|FG012|Epoch 3|Physician Decision|0
4648366|NCT02059291|7527972|FG013|Epoch 3|Physician Decision|1
4648367|NCT02059291|7527973|FG014|Epoch 3|Physician Decision|0
4648368|NCT02059291|7527974|FG015|Epoch 3|Physician Decision|1
4648369|NCT02059291|7527975|FG016|Epoch 3|Physician Decision|0
4648370|NCT02059291|7527976|FG017|Epoch 3|Physician Decision|0
4648371|NCT02059291|7527977|FG018|Epoch 3|Physician Decision|0
4648372|NCT02059291|7527978|FG019|Epoch 3|Physician Decision|0
4648373|NCT02059291|7527979|FG020|Epoch 3|Physician Decision|0
4648374|NCT02059291|7527980|FG021|Epoch 3|Physician Decision|0
4648375|NCT02059291|7527981|FG022|Epoch 3|Physician Decision|0
4648376|NCT02059291|7527982|FG023|Epoch 3|Physician Decision|0
4648377|NCT02059291|7527983|FG024|Epoch 3|Physician Decision|0
4648378|NCT02059291|7527959|FG000|Epoch 3|Adverse Event|0
4648379|NCT02059291|7527960|FG001|Epoch 3|Adverse Event|0
4648380|NCT02059291|7527961|FG002|Epoch 3|Adverse Event|0
4648381|NCT02059291|7527962|FG003|Epoch 3|Adverse Event|0
4648382|NCT02059291|7527963|FG004|Epoch 3|Adverse Event|0
4648383|NCT02059291|7527964|FG005|Epoch 3|Adverse Event|0
4648384|NCT02059291|7527965|FG006|Epoch 3|Adverse Event|0
4648385|NCT02059291|7527966|FG007|Epoch 3|Adverse Event|0
4648386|NCT02059291|7527967|FG008|Epoch 3|Adverse Event|0
4648387|NCT02059291|7527968|FG009|Epoch 3|Adverse Event|0
4648388|NCT02059291|7527969|FG010|Epoch 3|Adverse Event|0
4648389|NCT02059291|7527970|FG011|Epoch 3|Adverse Event|0
4648390|NCT02059291|7527971|FG012|Epoch 3|Adverse Event|0
4648391|NCT02059291|7527972|FG013|Epoch 3|Adverse Event|0
4648392|NCT02059291|7527973|FG014|Epoch 3|Adverse Event|0
4648393|NCT02059291|7527974|FG015|Epoch 3|Adverse Event|1
4648394|NCT02059291|7527975|FG016|Epoch 3|Adverse Event|0
4648395|NCT02059291|7527976|FG017|Epoch 3|Adverse Event|0
4648396|NCT02059291|7527977|FG018|Epoch 3|Adverse Event|0
4648397|NCT02059291|7527978|FG019|Epoch 3|Adverse Event|0
4648398|NCT02059291|7527979|FG020|Epoch 3|Adverse Event|0
4648399|NCT02059291|7527980|FG021|Epoch 3|Adverse Event|0
4648400|NCT02059291|7527981|FG022|Epoch 3|Adverse Event|0
4648401|NCT02059291|7527982|FG023|Epoch 3|Adverse Event|0
4648402|NCT02059291|7527983|FG024|Epoch 3|Adverse Event|0
4648403|NCT02059291|7527959|FG000|Epoch 3|Lack of Efficacy|0
4648404|NCT02059291|7527960|FG001|Epoch 3|Lack of Efficacy|0
4648405|NCT02059291|7527961|FG002|Epoch 3|Lack of Efficacy|0
4648406|NCT02059291|7527962|FG003|Epoch 3|Lack of Efficacy|0
4648407|NCT02059291|7527963|FG004|Epoch 3|Lack of Efficacy|0
4648408|NCT02059291|7527964|FG005|Epoch 3|Lack of Efficacy|0
4648409|NCT02059291|7527965|FG006|Epoch 3|Lack of Efficacy|0
4648410|NCT02059291|7527966|FG007|Epoch 3|Lack of Efficacy|0
4648411|NCT02059291|7527967|FG008|Epoch 3|Lack of Efficacy|0
4648412|NCT02059291|7527968|FG009|Epoch 3|Lack of Efficacy|0
4648413|NCT02059291|7527969|FG010|Epoch 3|Lack of Efficacy|0
4648414|NCT02059291|7527970|FG011|Epoch 3|Lack of Efficacy|0
4648415|NCT02059291|7527971|FG012|Epoch 3|Lack of Efficacy|0
4648416|NCT02059291|7527972|FG013|Epoch 3|Lack of Efficacy|0
4648417|NCT02059291|7527973|FG014|Epoch 3|Lack of Efficacy|0
4648418|NCT02059291|7527974|FG015|Epoch 3|Lack of Efficacy|3
4648419|NCT02059291|7527975|FG016|Epoch 3|Lack of Efficacy|0
4648420|NCT02059291|7527976|FG017|Epoch 3|Lack of Efficacy|0
4648421|NCT02059291|7527977|FG018|Epoch 3|Lack of Efficacy|0
4648422|NCT02059291|7527978|FG019|Epoch 3|Lack of Efficacy|0
4648423|NCT02059291|7527979|FG020|Epoch 3|Lack of Efficacy|0
4648424|NCT02059291|7527980|FG021|Epoch 3|Lack of Efficacy|0
4648425|NCT02059291|7527981|FG022|Epoch 3|Lack of Efficacy|0
4648426|NCT02059291|7527982|FG023|Epoch 3|Lack of Efficacy|0
4648427|NCT02059291|7527983|FG024|Epoch 3|Lack of Efficacy|0
4648428|NCT02059291|7527959|FG000|Epoch 3|Withdrawal by Subject|0
4648429|NCT02059291|7527960|FG001|Epoch 3|Withdrawal by Subject|0
4648430|NCT02059291|7527961|FG002|Epoch 3|Withdrawal by Subject|0
4648431|NCT02059291|7527962|FG003|Epoch 3|Withdrawal by Subject|0
4648432|NCT02059291|7527963|FG004|Epoch 3|Withdrawal by Subject|0
4648433|NCT02059291|7527964|FG005|Epoch 3|Withdrawal by Subject|0
4648434|NCT02059291|7527965|FG006|Epoch 3|Withdrawal by Subject|0
4648435|NCT02059291|7527966|FG007|Epoch 3|Withdrawal by Subject|0
4648436|NCT02059291|7527967|FG008|Epoch 3|Withdrawal by Subject|0
4648437|NCT02059291|7527968|FG009|Epoch 3|Withdrawal by Subject|0
4648438|NCT02059291|7527969|FG010|Epoch 3|Withdrawal by Subject|0
4648439|NCT02059291|7527970|FG011|Epoch 3|Withdrawal by Subject|0
4648440|NCT02059291|7527971|FG012|Epoch 3|Withdrawal by Subject|0
4648441|NCT02059291|7527972|FG013|Epoch 3|Withdrawal by Subject|0
4648442|NCT02059291|7527973|FG014|Epoch 3|Withdrawal by Subject|0
4648443|NCT02059291|7527974|FG015|Epoch 3|Withdrawal by Subject|1
4648444|NCT02059291|7527975|FG016|Epoch 3|Withdrawal by Subject|0
4648445|NCT02059291|7527976|FG017|Epoch 3|Withdrawal by Subject|0
4648446|NCT02059291|7527977|FG018|Epoch 3|Withdrawal by Subject|0
4648447|NCT02059291|7527978|FG019|Epoch 3|Withdrawal by Subject|0
4648448|NCT02059291|7527979|FG020|Epoch 3|Withdrawal by Subject|0
4648449|NCT02059291|7527980|FG021|Epoch 3|Withdrawal by Subject|0
4648450|NCT02059291|7527981|FG022|Epoch 3|Withdrawal by Subject|0
4648451|NCT02059291|7527982|FG023|Epoch 3|Withdrawal by Subject|0
4648452|NCT02059291|7527983|FG024|Epoch 3|Withdrawal by Subject|0
4648453|NCT02059291|7527959|FG000|Epoch 4|Adverse Event|0
4648454|NCT02059291|7527960|FG001|Epoch 4|Adverse Event|0
4648455|NCT02059291|7527961|FG002|Epoch 4|Adverse Event|0
4648456|NCT02059291|7527962|FG003|Epoch 4|Adverse Event|0
4648457|NCT02059291|7527963|FG004|Epoch 4|Adverse Event|0
4648458|NCT02059291|7527964|FG005|Epoch 4|Adverse Event|0
4648459|NCT02059291|7527965|FG006|Epoch 4|Adverse Event|0
4648460|NCT02059291|7527966|FG007|Epoch 4|Adverse Event|0
4648461|NCT02059291|7527967|FG008|Epoch 4|Adverse Event|0
4648462|NCT02059291|7527968|FG009|Epoch 4|Adverse Event|0
4648463|NCT02059291|7527969|FG010|Epoch 4|Adverse Event|0
4648464|NCT02059291|7527970|FG011|Epoch 4|Adverse Event|0
4648465|NCT02059291|7527971|FG012|Epoch 4|Adverse Event|0
4648466|NCT02059291|7527972|FG013|Epoch 4|Adverse Event|0
4648467|NCT02059291|7527973|FG014|Epoch 4|Adverse Event|0
4648468|NCT02059291|7527974|FG015|Epoch 4|Adverse Event|0
4648469|NCT02059291|7527975|FG016|Epoch 4|Adverse Event|1
4648470|NCT02059291|7527976|FG017|Epoch 4|Adverse Event|0
4648471|NCT02059291|7527977|FG018|Epoch 4|Adverse Event|0
4648472|NCT02059291|7527978|FG019|Epoch 4|Adverse Event|0
4648473|NCT02059291|7527979|FG020|Epoch 4|Adverse Event|0
4648474|NCT02059291|7527980|FG021|Epoch 4|Adverse Event|0
4648475|NCT02059291|7527981|FG022|Epoch 4|Adverse Event|1
4648476|NCT02059291|7527982|FG023|Epoch 4|Adverse Event|0
4648477|NCT02059291|7527983|FG024|Epoch 4|Adverse Event|0
4648478|NCT02059291|7527959|FG000|Epoch 4|Pregnancy|0
4648479|NCT02059291|7527960|FG001|Epoch 4|Pregnancy|0
4648480|NCT02059291|7527961|FG002|Epoch 4|Pregnancy|0
4648481|NCT02059291|7527962|FG003|Epoch 4|Pregnancy|0
4648482|NCT02059291|7527963|FG004|Epoch 4|Pregnancy|0
4648483|NCT02059291|7527964|FG005|Epoch 4|Pregnancy|0
4648484|NCT02059291|7527965|FG006|Epoch 4|Pregnancy|0
4648485|NCT02059291|7527966|FG007|Epoch 4|Pregnancy|0
4648486|NCT02059291|7527967|FG008|Epoch 4|Pregnancy|0
4648487|NCT02059291|7527968|FG009|Epoch 4|Pregnancy|0
4648488|NCT02059291|7527969|FG010|Epoch 4|Pregnancy|0
4648489|NCT02059291|7527970|FG011|Epoch 4|Pregnancy|0
4648490|NCT02059291|7527971|FG012|Epoch 4|Pregnancy|0
4648491|NCT02059291|7527972|FG013|Epoch 4|Pregnancy|0
4648492|NCT02059291|7527973|FG014|Epoch 4|Pregnancy|0
4648493|NCT02059291|7527974|FG015|Epoch 4|Pregnancy|0
4648494|NCT02059291|7527975|FG016|Epoch 4|Pregnancy|1
4648495|NCT02059291|7527976|FG017|Epoch 4|Pregnancy|0
4648496|NCT02059291|7527977|FG018|Epoch 4|Pregnancy|0
4648497|NCT02059291|7527978|FG019|Epoch 4|Pregnancy|0
4648498|NCT02059291|7527979|FG020|Epoch 4|Pregnancy|0
4648499|NCT02059291|7527980|FG021|Epoch 4|Pregnancy|0
4648500|NCT02059291|7527981|FG022|Epoch 4|Pregnancy|0
4648501|NCT02059291|7527982|FG023|Epoch 4|Pregnancy|0
4648502|NCT02059291|7527983|FG024|Epoch 4|Pregnancy|0
4648503|NCT02059291|7527959|FG000|Epoch 4|Withdrawal by Subject|0
4648504|NCT02059291|7527960|FG001|Epoch 4|Withdrawal by Subject|0
4648505|NCT02059291|7527961|FG002|Epoch 4|Withdrawal by Subject|0
4648506|NCT02059291|7527962|FG003|Epoch 4|Withdrawal by Subject|0
4648507|NCT02059291|7527963|FG004|Epoch 4|Withdrawal by Subject|0
4648508|NCT02059291|7527964|FG005|Epoch 4|Withdrawal by Subject|0
4648509|NCT02059291|7527965|FG006|Epoch 4|Withdrawal by Subject|0
4648510|NCT02059291|7527966|FG007|Epoch 4|Withdrawal by Subject|0
4648511|NCT02059291|7527967|FG008|Epoch 4|Withdrawal by Subject|0
4648512|NCT02059291|7527968|FG009|Epoch 4|Withdrawal by Subject|0
4648513|NCT02059291|7527969|FG010|Epoch 4|Withdrawal by Subject|0
4648514|NCT02059291|7527970|FG011|Epoch 4|Withdrawal by Subject|0
4648515|NCT02059291|7527971|FG012|Epoch 4|Withdrawal by Subject|0
4648516|NCT02059291|7527972|FG013|Epoch 4|Withdrawal by Subject|0
4648517|NCT02059291|7527973|FG014|Epoch 4|Withdrawal by Subject|0
4648518|NCT02059291|7527974|FG015|Epoch 4|Withdrawal by Subject|0
4648519|NCT02059291|7527975|FG016|Epoch 4|Withdrawal by Subject|0
4648520|NCT02059291|7527976|FG017|Epoch 4|Withdrawal by Subject|0
4648521|NCT02059291|7527977|FG018|Epoch 4|Withdrawal by Subject|0
4648522|NCT02059291|7527978|FG019|Epoch 4|Withdrawal by Subject|0
4648523|NCT02059291|7527979|FG020|Epoch 4|Withdrawal by Subject|1
4648524|NCT02059291|7527980|FG021|Epoch 4|Withdrawal by Subject|0
4648525|NCT02059291|7527981|FG022|Epoch 4|Withdrawal by Subject|0
4648526|NCT02059291|7527982|FG023|Epoch 4|Withdrawal by Subject|0
4648527|NCT02059291|7527983|FG024|Epoch 4|Withdrawal by Subject|0
4648528|NCT02059291|7527959|FG000|Epoch 4|Lack of Efficacy|0
4648529|NCT02059291|7527960|FG001|Epoch 4|Lack of Efficacy|0
4648530|NCT02059291|7527961|FG002|Epoch 4|Lack of Efficacy|0
4648531|NCT02059291|7527962|FG003|Epoch 4|Lack of Efficacy|0
4648532|NCT02059291|7527963|FG004|Epoch 4|Lack of Efficacy|0
4648533|NCT02059291|7527964|FG005|Epoch 4|Lack of Efficacy|0
4648534|NCT02059291|7527965|FG006|Epoch 4|Lack of Efficacy|0
4648535|NCT02059291|7527966|FG007|Epoch 4|Lack of Efficacy|0
4648536|NCT02059291|7527967|FG008|Epoch 4|Lack of Efficacy|0
4648537|NCT02059291|7527968|FG009|Epoch 4|Lack of Efficacy|0
4648538|NCT02059291|7527969|FG010|Epoch 4|Lack of Efficacy|0
4648539|NCT02059291|7527970|FG011|Epoch 4|Lack of Efficacy|0
4648540|NCT02059291|7527971|FG012|Epoch 4|Lack of Efficacy|0
4648541|NCT02059291|7527972|FG013|Epoch 4|Lack of Efficacy|0
4648542|NCT02059291|7527973|FG014|Epoch 4|Lack of Efficacy|0
4648543|NCT02059291|7527974|FG015|Epoch 4|Lack of Efficacy|0
4648544|NCT02059291|7527975|FG016|Epoch 4|Lack of Efficacy|0
4648545|NCT02059291|7527976|FG017|Epoch 4|Lack of Efficacy|0
4648546|NCT02059291|7527977|FG018|Epoch 4|Lack of Efficacy|0
4648547|NCT02059291|7527978|FG019|Epoch 4|Lack of Efficacy|0
4648548|NCT02059291|7527979|FG020|Epoch 4|Lack of Efficacy|0
4648549|NCT02059291|7527980|FG021|Epoch 4|Lack of Efficacy|0
4648550|NCT02059291|7527981|FG022|Epoch 4|Lack of Efficacy|0
4648551|NCT02059291|7527982|FG023|Epoch 4|Lack of Efficacy|1
4648552|NCT02059291|7527983|FG024|Epoch 4|Lack of Efficacy|0
4648553|NCT02059395|7528013|FG000|Overall Study|Lost to Follow-up|2
4648554|NCT02059395|7528014|FG001|Overall Study|Lost to Follow-up|4
4648555|NCT02059408|7528023|FG000|Overall Study|Did not get tested|0
4648556|NCT02059408|7528024|FG001|Overall Study|Did not get tested|330
4648557|NCT02059408|7528025|FG002|Overall Study|Did not get tested|358
4648558|NCT02059434|7528044|FG000|Washout Between Periods 1 and 2|Physician Decision|0
4648559|NCT02059434|7528045|FG001|Washout Between Periods 1 and 2|Physician Decision|0
4648560|NCT02059434|7528046|FG002|Washout Between Periods 1 and 2|Physician Decision|0
4648561|NCT02059434|7528047|FG003|Washout Between Periods 1 and 2|Physician Decision|0
4648562|NCT02059434|7528048|FG004|Washout Between Periods 1 and 2|Physician Decision|0
4648563|NCT02059434|7528049|FG005|Washout Between Periods 1 and 2|Physician Decision|0
4648564|NCT02059434|7528050|FG006|Washout Between Periods 1 and 2|Physician Decision|0
4648565|NCT02059434|7528051|FG007|Washout Between Periods 1 and 2|Physician Decision|1
4648566|NCT02059434|7528052|FG008|Washout Between Periods 1 and 2|Physician Decision|0
4648567|NCT02059434|7528044|FG000|Washout Between Periods 4 and 5|Adverse Event|0
4648568|NCT02059434|7528045|FG001|Washout Between Periods 4 and 5|Adverse Event|0
4648569|NCT02059434|7528046|FG002|Washout Between Periods 4 and 5|Adverse Event|0
4648570|NCT02059434|7528047|FG003|Washout Between Periods 4 and 5|Adverse Event|0
4648571|NCT02059434|7528048|FG004|Washout Between Periods 4 and 5|Adverse Event|0
4648572|NCT02059434|7528049|FG005|Washout Between Periods 4 and 5|Adverse Event|0
4648573|NCT02059434|7528050|FG006|Washout Between Periods 4 and 5|Adverse Event|0
4648574|NCT02059434|7528051|FG007|Washout Between Periods 4 and 5|Adverse Event|0
4648575|NCT02059434|7528052|FG008|Washout Between Periods 4 and 5|Adverse Event|1
4648576|NCT02059434|7528044|FG000|Washout Between Periods 6 and 7|Physician Decision|0
4648577|NCT02059434|7528045|FG001|Washout Between Periods 6 and 7|Physician Decision|0
4648578|NCT02059434|7528046|FG002|Washout Between Periods 6 and 7|Physician Decision|0
4648579|NCT02059434|7528047|FG003|Washout Between Periods 6 and 7|Physician Decision|0
4648580|NCT02059434|7528048|FG004|Washout Between Periods 6 and 7|Physician Decision|0
4648581|NCT02059434|7528049|FG005|Washout Between Periods 6 and 7|Physician Decision|0
4648582|NCT02059434|7528050|FG006|Washout Between Periods 6 and 7|Physician Decision|0
4648583|NCT02059434|7528051|FG007|Washout Between Periods 6 and 7|Physician Decision|0
4648584|NCT02059434|7528052|FG008|Washout Between Periods 6 and 7|Physician Decision|1
4648585|NCT02059434|7528044|FG000|Washout Between Periods 7 and 8|Adverse Event|0
4648586|NCT02059434|7528045|FG001|Washout Between Periods 7 and 8|Adverse Event|0
4648587|NCT02059434|7528046|FG002|Washout Between Periods 7 and 8|Adverse Event|0
4648588|NCT02059434|7528047|FG003|Washout Between Periods 7 and 8|Adverse Event|0
4648589|NCT02059434|7528048|FG004|Washout Between Periods 7 and 8|Adverse Event|0
4648590|NCT02059434|7528049|FG005|Washout Between Periods 7 and 8|Adverse Event|0
4648591|NCT02059434|7528050|FG006|Washout Between Periods 7 and 8|Adverse Event|0
4648592|NCT02059434|7528051|FG007|Washout Between Periods 7 and 8|Adverse Event|0
4648593|NCT02059434|7528052|FG008|Washout Between Periods 7 and 8|Adverse Event|1
4648594|NCT02059434|7528044|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0
4648595|NCT02059434|7528045|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0
4648596|NCT02059434|7528046|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0
4648597|NCT02059434|7528047|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0
4648598|NCT02059434|7528048|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0
4648599|NCT02059434|7528049|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0
4648600|NCT02059434|7528050|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0
4648601|NCT02059434|7528051|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0
4648602|NCT02059434|7528052|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1
4648603|NCT02059980|7528133|FG000|Overall Study|Lost to Follow-up|2
4648604|NCT02059980|7528134|FG001|Overall Study|Lost to Follow-up|1
4648605|NCT02060370|7528163|FG000|Overall Study|Physician Decision|1
4648606|NCT02060383|7528172|FG000|Core Phase|Unsatisfactory therapeutic effect|1
4648607|NCT02060383|7528173|FG001|Core Phase|Unsatisfactory therapeutic effect|5
4648608|NCT02060383|7528174|FG002|Core Phase|Unsatisfactory therapeutic effect|0
4648609|NCT02060383|7528175|FG003|Core Phase|Unsatisfactory therapeutic effect|0
4648610|NCT02060383|7528176|FG004|Core Phase|Unsatisfactory therapeutic effect|0
4648611|NCT02060383|7528172|FG000|Core Phase|Adverse Event|2
4648612|NCT02060383|7528173|FG001|Core Phase|Adverse Event|0
4648613|NCT02060383|7528174|FG002|Core Phase|Adverse Event|0
4648614|NCT02060383|7528175|FG003|Core Phase|Adverse Event|2
4648615|NCT02060383|7528176|FG004|Core Phase|Adverse Event|6
4648616|NCT02060383|7528172|FG000|Core Phase|Administrative problems|0
4648617|NCT02060383|7528173|FG001|Core Phase|Administrative problems|1
4648618|NCT02060383|7528174|FG002|Core Phase|Administrative problems|0
4648619|NCT02060383|7528175|FG003|Core Phase|Administrative problems|0
4648620|NCT02060383|7528176|FG004|Core Phase|Administrative problems|0
4648621|NCT02060383|7528172|FG000|Core Phase|Protocol Violation|0
4648622|NCT02060383|7528173|FG001|Core Phase|Protocol Violation|0
4648623|NCT02060383|7528174|FG002|Core Phase|Protocol Violation|0
4648624|NCT02060383|7528175|FG003|Core Phase|Protocol Violation|1
4648625|NCT02060383|7528176|FG004|Core Phase|Protocol Violation|0
4648626|NCT02060383|7528172|FG000|Core Phase|Withdrawal by Subject|0
4648627|NCT02060383|7528173|FG001|Core Phase|Withdrawal by Subject|0
4648628|NCT02060383|7528174|FG002|Core Phase|Withdrawal by Subject|0
4648629|NCT02060383|7528175|FG003|Core Phase|Withdrawal by Subject|4
4648630|NCT02060383|7528176|FG004|Core Phase|Withdrawal by Subject|2
4648631|NCT02060383|7528172|FG000|Extension Phase|Unsatisfactory therapeutic effect|1
4648632|NCT02060383|7528173|FG001|Extension Phase|Unsatisfactory therapeutic effect|1
4648633|NCT02060383|7528174|FG002|Extension Phase|Unsatisfactory therapeutic effect|0
4648634|NCT02060383|7528175|FG003|Extension Phase|Unsatisfactory therapeutic effect|2
4648635|NCT02060383|7528176|FG004|Extension Phase|Unsatisfactory therapeutic effect|2
4648636|NCT02060383|7528172|FG000|Extension Phase|Adverse Event|1
4648637|NCT02060383|7528173|FG001|Extension Phase|Adverse Event|1
4648638|NCT02060383|7528174|FG002|Extension Phase|Adverse Event|2
4648639|NCT02060383|7528175|FG003|Extension Phase|Adverse Event|0
4648640|NCT02060383|7528176|FG004|Extension Phase|Adverse Event|1
4648641|NCT02060383|7528172|FG000|Extension Phase|Withdrawal by Subject|0
4648642|NCT02060383|7528173|FG001|Extension Phase|Withdrawal by Subject|1
4648643|NCT02060383|7528174|FG002|Extension Phase|Withdrawal by Subject|0
4648644|NCT02060383|7528175|FG003|Extension Phase|Withdrawal by Subject|0
4648645|NCT02060383|7528176|FG004|Extension Phase|Withdrawal by Subject|2
4648646|NCT02060383|7528172|FG000|Extension Phase|Administrative problems|1
4648647|NCT02060383|7528173|FG001|Extension Phase|Administrative problems|0
4648648|NCT02060383|7528174|FG002|Extension Phase|Administrative problems|0
4648649|NCT02060383|7528175|FG003|Extension Phase|Administrative problems|0
4648650|NCT02060383|7528176|FG004|Extension Phase|Administrative problems|0
4648651|NCT02060383|7528172|FG000|Extension Phase|Death|0
4648652|NCT02060383|7528173|FG001|Extension Phase|Death|0
4648653|NCT02060383|7528174|FG002|Extension Phase|Death|1
4648654|NCT02060383|7528175|FG003|Extension Phase|Death|0
4648655|NCT02060383|7528176|FG004|Extension Phase|Death|1
4648656|NCT02060383|7528172|FG000|Extension Phase|Protocol Violation|0
4648657|NCT02060383|7528173|FG001|Extension Phase|Protocol Violation|0
4648658|NCT02060383|7528174|FG002|Extension Phase|Protocol Violation|0
4648659|NCT02060383|7528175|FG003|Extension Phase|Protocol Violation|0
4648660|NCT02060383|7528176|FG004|Extension Phase|Protocol Violation|1
4648661|NCT02060903|7528229|FG000|Overall Study|Lost to Follow-up|4
4648662|NCT02060903|7528230|FG001|Overall Study|Lost to Follow-up|0
4648663|NCT02060903|7528229|FG000|Overall Study|Withdrawal by Subject|0
4648664|NCT02060903|7528230|FG001|Overall Study|Withdrawal by Subject|7
4648665|NCT02061202|7528238|FG000|Overall Study|Lost to Follow-up|1
4648666|NCT02061202|7528239|FG001|Overall Study|Lost to Follow-up|1
4648667|NCT02061280|7528247|FG000|Overall Study|Protocol Violation|12
4648668|NCT02061280|7528248|FG001|Overall Study|Protocol Violation|8
4648669|NCT02061280|7528247|FG000|Overall Study|moved out of state|0
4648670|NCT02061280|7528248|FG001|Overall Study|moved out of state|1
4648671|NCT02061280|7528247|FG000|Overall Study|Withdrawal by Subject|1
4648672|NCT02061280|7528248|FG001|Overall Study|Withdrawal by Subject|2
4648673|NCT02061280|7528247|FG000|Overall Study|Lost to Follow-up|5
4648674|NCT02061280|7528248|FG001|Overall Study|Lost to Follow-up|1
4648675|NCT02061540|7528307|FG000|Overall Study|Adverse Event|2
4648676|NCT02061540|7528307|FG000|Overall Study|Withdrawal by Subject|2
4648677|NCT02061592|7528318|FG000|Period 1|Withdrawal by Subject|1
4648678|NCT02061592|7528319|FG001|Period 1|Withdrawal by Subject|0
4648679|NCT02061592|7528318|FG000|Period 1|Protocol Violation|1
4648680|NCT02061592|7528319|FG001|Period 1|Protocol Violation|0
4648681|NCT02061592|7528318|FG000|Period 2|Lost to Follow-up|0
4648682|NCT02061592|7528319|FG001|Period 2|Lost to Follow-up|1
4648683|NCT02061813|7528358|FG000|Overall Study|Withdrawal by Subject|1
4648684|NCT02061813|7528358|FG000|Overall Study|Protocol Violation|2
4648685|NCT02062151|7528378|FG000|Overall Study|screen failure|1
4648686|NCT02062385|7528403|FG000|Overall Study|Adverse Event|19
4648687|NCT02062385|7528404|FG001|Overall Study|Adverse Event|13
4648688|NCT02062385|7528405|FG002|Overall Study|Adverse Event|1
4648689|NCT02062385|7528406|FG003|Overall Study|Adverse Event|0
4747787|NCT00853307|7721877|FG001|Overall Study|Adverse Event|2
4747788|NCT00853307|7721876|FG000|Overall Study|Withdrawal by Subject|1
4747789|NCT00853307|7721877|FG001|Overall Study|Withdrawal by Subject|2
4747790|NCT00853307|7721876|FG000|Overall Study|Reason Not Specified|0
4747791|NCT00853307|7721877|FG001|Overall Study|Reason Not Specified|1
4648690|NCT02062385|7528403|FG000|Overall Study|Protocol Violation|1
4648691|NCT02062385|7528404|FG001|Overall Study|Protocol Violation|0
4648692|NCT02062385|7528405|FG002|Overall Study|Protocol Violation|0
4648693|NCT02062385|7528406|FG003|Overall Study|Protocol Violation|0
4648694|NCT02062385|7528403|FG000|Overall Study|Incomplete EPI by database lock|2
4648695|NCT02062385|7528404|FG001|Overall Study|Incomplete EPI by database lock|0
4648696|NCT02062385|7528405|FG002|Overall Study|Incomplete EPI by database lock|0
4648697|NCT02062385|7528406|FG003|Overall Study|Incomplete EPI by database lock|0
4648698|NCT02062385|7528403|FG000|Overall Study|Moved|10
4648699|NCT02062385|7528404|FG001|Overall Study|Moved|11
4648700|NCT02062385|7528405|FG002|Overall Study|Moved|1
4648701|NCT02062385|7528406|FG003|Overall Study|Moved|0
4648702|NCT02062385|7528403|FG000|Overall Study|Withdrawn by parent/guardian|46
4648703|NCT02062385|7528404|FG001|Overall Study|Withdrawn by parent/guardian|41
4648704|NCT02062385|7528405|FG002|Overall Study|Withdrawn by parent/guardian|9
4648705|NCT02062385|7528406|FG003|Overall Study|Withdrawn by parent/guardian|8
4648706|NCT02062385|7528403|FG000|Overall Study|Death|0
4648707|NCT02062385|7528404|FG001|Overall Study|Death|0
4648708|NCT02062385|7528405|FG002|Overall Study|Death|0
4648709|NCT02062385|7528406|FG003|Overall Study|Death|1
4648710|NCT02062385|7528403|FG000|Overall Study|Lost to Follow-up|0
4648711|NCT02062385|7528404|FG001|Overall Study|Lost to Follow-up|0
4648712|NCT02062385|7528405|FG002|Overall Study|Lost to Follow-up|1
4648713|NCT02062385|7528406|FG003|Overall Study|Lost to Follow-up|0
4648714|NCT02062398|7528414|FG000|Overall Study|Implant removal|1
4648715|NCT02062437|7528418|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31
4648716|NCT02062437|7528418|FG000|Overall Study|Patient not available for the 2y visit|18
4648717|NCT02062437|7528418|FG000|Overall Study|Death|2
4648718|NCT02062437|7528418|FG000|Overall Study|Pt. couldn't come due to med. condition|1
4648719|NCT02062450|7528424|FG000|Overall Study|No follow-up visit|124
4648720|NCT02062632|7528492|FG000|Overall Study|No treatment data|1
4648721|NCT02062645|7528496|FG000|Overall Study|Adverse Event|2
4648722|NCT02062645|7528496|FG000|Overall Study|Protocol Violation|8
4648723|NCT02062645|7528496|FG000|Overall Study|Lost to Follow-up|5
4648724|NCT02062658|7528500|FG000|Overall Study|Withdrawal by Subject|1
4648725|NCT02062658|7528500|FG000|Overall Study|Lack of Efficacy|1
4648726|NCT02062879|7528528|FG000|Overall Study|Withdrawal by Subject|4
4648727|NCT02062879|7528529|FG001|Overall Study|Withdrawal by Subject|1
4648728|NCT02063217|7528578|FG000|Overall Study|Withdrawal by Subject|1
4648729|NCT02063217|7528579|FG001|Overall Study|Withdrawal by Subject|0
4648730|NCT02063217|7528580|FG002|Overall Study|Withdrawal by Subject|0
4648731|NCT02063659|7528617|FG000|Double-Blind Treatment Period|Adverse Event|1
4648732|NCT02063659|7528618|FG001|Double-Blind Treatment Period|Adverse Event|2
4648733|NCT02063659|7528619|FG002|Double-Blind Treatment Period|Adverse Event|0
4648734|NCT02063659|7528620|FG003|Double-Blind Treatment Period|Adverse Event|0
4648735|NCT02063659|7528617|FG000|Double-Blind Treatment Period|Physician Decision|1
4648736|NCT02063659|7528618|FG001|Double-Blind Treatment Period|Physician Decision|0
4648737|NCT02063659|7528619|FG002|Double-Blind Treatment Period|Physician Decision|0
4648738|NCT02063659|7528620|FG003|Double-Blind Treatment Period|Physician Decision|0
4648739|NCT02063659|7528617|FG000|Double-Blind Treatment Period|Withdrawal of consent|0
4648740|NCT02063659|7528618|FG001|Double-Blind Treatment Period|Withdrawal of consent|1
4648741|NCT02063659|7528619|FG002|Double-Blind Treatment Period|Withdrawal of consent|3
4648742|NCT02063659|7528620|FG003|Double-Blind Treatment Period|Withdrawal of consent|0
4648743|NCT02063659|7528617|FG000|Open-Label Extension Period (OLE)|Physician Decision|0
4648744|NCT02063659|7528618|FG001|Open-Label Extension Period (OLE)|Physician Decision|0
4648745|NCT02063659|7528619|FG002|Open-Label Extension Period (OLE)|Physician Decision|0
4648746|NCT02063659|7528620|FG003|Open-Label Extension Period (OLE)|Physician Decision|1
4648747|NCT02063659|7528617|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
4648748|NCT02063659|7528618|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
4648749|NCT02063659|7528619|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
4648750|NCT02063659|7528620|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9
4648751|NCT02063659|7528617|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0
4648752|NCT02063659|7528618|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0
4648753|NCT02063659|7528619|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0
4648754|NCT02063659|7528620|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1
4648755|NCT02063659|7528617|FG000|Open-Label Extension Period (OLE)|Adverse Event|0
4648756|NCT02063659|7528618|FG001|Open-Label Extension Period (OLE)|Adverse Event|0
4648757|NCT02063659|7528619|FG002|Open-Label Extension Period (OLE)|Adverse Event|0
4648758|NCT02063659|7528620|FG003|Open-Label Extension Period (OLE)|Adverse Event|7
4648759|NCT02063659|7528617|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0
4648760|NCT02063659|7528618|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0
4648761|NCT02063659|7528619|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0
4648762|NCT02063659|7528620|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2
4648763|NCT02063672|7528636|FG000|Overall Study|Ongoing Follow-up|27
4648764|NCT02063672|7528637|FG001|Overall Study|Ongoing Follow-up|14
4648765|NCT02063672|7528636|FG000|Overall Study|Death|5
4648766|NCT02063672|7528637|FG001|Overall Study|Death|3
4648767|NCT02063672|7528636|FG000|Overall Study|Lost to Follow-up|1
4648768|NCT02063672|7528637|FG001|Overall Study|Lost to Follow-up|3
4648769|NCT02063672|7528636|FG000|Overall Study|Withdrawal by Subject|2
4648770|NCT02063672|7528637|FG001|Overall Study|Withdrawal by Subject|2
4648771|NCT02063698|7528645|FG000|Overall Study|did not complete booklet for days 2-8|1
4648772|NCT02063698|7528646|FG001|Overall Study|did not complete booklet for days 2-8|2
4648773|NCT02063737|7528654|FG000|Overall Study|Lost to Follow-up|11
4648774|NCT02063737|7528655|FG001|Overall Study|Lost to Follow-up|4
4747792|NCT00545129|7721891|FG000|Overall Study|Lack of Efficacy|2
4747793|NCT00545129|7721892|FG001|Overall Study|Lack of Efficacy|5
4747794|NCT00545129|7721891|FG000|Overall Study|Death|2
4747795|NCT00545129|7721892|FG001|Overall Study|Death|1
4747796|NCT00545129|7721891|FG000|Overall Study|Adverse Event|1
4747797|NCT00545129|7721892|FG001|Overall Study|Adverse Event|1
4747798|NCT00545129|7721891|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9
4648775|NCT02063828|7528664|FG000|Overall Study|Withdrawal by Subject|4
4648776|NCT02063828|7528665|FG001|Overall Study|Withdrawal by Subject|6
4648777|NCT02063828|7528666|FG002|Overall Study|Withdrawal by Subject|3
4648778|NCT02063828|7528664|FG000|Overall Study|Death|0
4648779|NCT02063828|7528665|FG001|Overall Study|Death|0
4648780|NCT02063828|7528666|FG002|Overall Study|Death|1
4648781|NCT02063854|7528681|FG000|Overall Study|Pretreatment Event/Adverse Event|13
4648782|NCT02063854|7528682|FG001|Overall Study|Pretreatment Event/Adverse Event|10
4648783|NCT02063854|7528683|FG002|Overall Study|Pretreatment Event/Adverse Event|13
4648784|NCT02063854|7528684|FG003|Overall Study|Pretreatment Event/Adverse Event|8
4648785|NCT02063854|7528685|FG004|Overall Study|Pretreatment Event/Adverse Event|7
4648786|NCT02063854|7528686|FG005|Overall Study|Pretreatment Event/Adverse Event|18
4648787|NCT02063854|7528687|FG006|Overall Study|Pretreatment Event/Adverse Event|4
4648788|NCT02063854|7528681|FG000|Overall Study|Major Protocol Deviation|0
4648789|NCT02063854|7528682|FG001|Overall Study|Major Protocol Deviation|0
4648790|NCT02063854|7528683|FG002|Overall Study|Major Protocol Deviation|3
4648791|NCT02063854|7528684|FG003|Overall Study|Major Protocol Deviation|0
4648792|NCT02063854|7528685|FG004|Overall Study|Major Protocol Deviation|0
4648793|NCT02063854|7528686|FG005|Overall Study|Major Protocol Deviation|0
4648794|NCT02063854|7528687|FG006|Overall Study|Major Protocol Deviation|0
4648795|NCT02063854|7528681|FG000|Overall Study|Voluntary Withdrawal|2
4648796|NCT02063854|7528682|FG001|Overall Study|Voluntary Withdrawal|0
4648797|NCT02063854|7528683|FG002|Overall Study|Voluntary Withdrawal|8
4648798|NCT02063854|7528684|FG003|Overall Study|Voluntary Withdrawal|1
4648799|NCT02063854|7528685|FG004|Overall Study|Voluntary Withdrawal|3
4648800|NCT02063854|7528686|FG005|Overall Study|Voluntary Withdrawal|6
4648801|NCT02063854|7528687|FG006|Overall Study|Voluntary Withdrawal|1
4648802|NCT02063854|7528681|FG000|Overall Study|Surgical Dental Work Performed/Planned|5
4648803|NCT02063854|7528682|FG001|Overall Study|Surgical Dental Work Performed/Planned|2
4648804|NCT02063854|7528683|FG002|Overall Study|Surgical Dental Work Performed/Planned|6
4648805|NCT02063854|7528684|FG003|Overall Study|Surgical Dental Work Performed/Planned|1
4648806|NCT02063854|7528685|FG004|Overall Study|Surgical Dental Work Performed/Planned|1
4648807|NCT02063854|7528686|FG005|Overall Study|Surgical Dental Work Performed/Planned|6
4648808|NCT02063854|7528687|FG006|Overall Study|Surgical Dental Work Performed/Planned|1
4648809|NCT02063854|7528681|FG000|Overall Study|Reason Not Specified|1
4648810|NCT02063854|7528682|FG001|Overall Study|Reason Not Specified|0
4648811|NCT02063854|7528683|FG002|Overall Study|Reason Not Specified|0
4648812|NCT02063854|7528684|FG003|Overall Study|Reason Not Specified|0
4648813|NCT02063854|7528685|FG004|Overall Study|Reason Not Specified|0
4648814|NCT02063854|7528686|FG005|Overall Study|Reason Not Specified|0
4648815|NCT02063854|7528687|FG006|Overall Study|Reason Not Specified|0
4648816|NCT02063854|7528681|FG000|Overall Study|Did Not Receive Study Drug|0
4648817|NCT02063854|7528682|FG001|Overall Study|Did Not Receive Study Drug|0
4648818|NCT02063854|7528683|FG002|Overall Study|Did Not Receive Study Drug|0
4648819|NCT02063854|7528684|FG003|Overall Study|Did Not Receive Study Drug|0
4648820|NCT02063854|7528685|FG004|Overall Study|Did Not Receive Study Drug|0
4648821|NCT02063854|7528686|FG005|Overall Study|Did Not Receive Study Drug|1
4648822|NCT02063854|7528687|FG006|Overall Study|Did Not Receive Study Drug|0
4648823|NCT02063880|7528716|FG000|Overall Study|Death|21
4648824|NCT02063880|7528717|FG001|Overall Study|Death|18
4648825|NCT02063880|7528716|FG000|Overall Study|Lost to Follow-up|7
4648826|NCT02063880|7528717|FG001|Overall Study|Lost to Follow-up|7
4648827|NCT02063880|7528716|FG000|Overall Study|Ineligible|0
4648828|NCT02063880|7528717|FG001|Overall Study|Ineligible|2
4648829|NCT02063984|7528725|FG000|Overall Study|Lost to Follow-up|6
4648830|NCT02063984|7528726|FG001|Overall Study|Lost to Follow-up|5
4648831|NCT02064166|7528738|FG000|Overall Study|Adverse Event|1
4648832|NCT02064166|7528739|FG001|Overall Study|Adverse Event|0
4648833|NCT02064205|7528767|FG000|Overall Study|Withdrawal by Subject|1
4648834|NCT02064231|7528783|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5
4648835|NCT02064231|7528784|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3
4648836|NCT02064231|7528785|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0
4648837|NCT02064231|7528786|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0
4648838|NCT02064231|7528783|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1
4648839|NCT02064231|7528784|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1
4648840|NCT02064231|7528785|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0
4648841|NCT02064231|7528786|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0
4648842|NCT02064231|7528783|FG000|First Test Period (Test A or Test C)|Adverse Event|1
4648843|NCT02064231|7528784|FG001|First Test Period (Test A or Test C)|Adverse Event|0
4648844|NCT02064231|7528785|FG002|First Test Period (Test A or Test C)|Adverse Event|1
4648845|NCT02064231|7528786|FG003|First Test Period (Test A or Test C)|Adverse Event|0
4648846|NCT02064231|7528783|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1
4648847|NCT02064231|7528784|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1
4648848|NCT02064231|7528785|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0
4648849|NCT02064231|7528786|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0
4648850|NCT02064439|7528810|FG000|Overall Study|Adverse Event|51
4648851|NCT02064439|7528811|FG001|Overall Study|Adverse Event|47
4648852|NCT02064439|7528812|FG002|Overall Study|Adverse Event|46
4648853|NCT02064439|7528810|FG000|Overall Study|Death|0
4648854|NCT02064439|7528811|FG001|Overall Study|Death|2
4648855|NCT02064439|7528812|FG002|Overall Study|Death|3
4648856|NCT02064439|7528810|FG000|Overall Study|Withdrawal by Subject|29
4648857|NCT02064439|7528811|FG001|Overall Study|Withdrawal by Subject|18
4648858|NCT02064439|7528812|FG002|Overall Study|Withdrawal by Subject|26
4648859|NCT02064439|7528810|FG000|Overall Study|Protocol Violation|3
4648860|NCT02064439|7528811|FG001|Overall Study|Protocol Violation|5
4648861|NCT02064439|7528812|FG002|Overall Study|Protocol Violation|3
4648862|NCT02064439|7528810|FG000|Overall Study|Lost to Follow-up|1
4648863|NCT02064439|7528811|FG001|Overall Study|Lost to Follow-up|3
4648864|NCT02064439|7528812|FG002|Overall Study|Lost to Follow-up|4
4648865|NCT02064439|7528810|FG000|Overall Study|Non-compliance with study medication|21
4648866|NCT02064439|7528811|FG001|Overall Study|Non-compliance with study medication|19
4648867|NCT02064439|7528812|FG002|Overall Study|Non-compliance with study medication|23
4648868|NCT02064439|7528810|FG000|Overall Study|Physician Decision|0
4648869|NCT02064439|7528811|FG001|Overall Study|Physician Decision|1
4648870|NCT02064439|7528812|FG002|Overall Study|Physician Decision|1
4648871|NCT02064439|7528810|FG000|Overall Study|Logistical difficulties|6
4648872|NCT02064439|7528811|FG001|Overall Study|Logistical difficulties|5
4648873|NCT02064439|7528812|FG002|Overall Study|Logistical difficulties|2
4648874|NCT02064439|7528810|FG000|Overall Study|Efficacy outcome reached|18
4648875|NCT02064439|7528811|FG001|Overall Study|Efficacy outcome reached|16
4648876|NCT02064439|7528812|FG002|Overall Study|Efficacy outcome reached|57
4648877|NCT02064439|7528810|FG000|Overall Study|Safety outcome reached|12
4648878|NCT02064439|7528811|FG001|Overall Study|Safety outcome reached|20
4648879|NCT02064439|7528812|FG002|Overall Study|Safety outcome reached|10
4648880|NCT02064439|7528810|FG000|Overall Study|Other|2
4648881|NCT02064439|7528811|FG001|Overall Study|Other|2
4648882|NCT02064439|7528812|FG002|Overall Study|Other|7
4648883|NCT02064816|7528826|FG000|Overall Study|Adverse Event|3
4648884|NCT02064816|7528827|FG001|Overall Study|Adverse Event|2
4648885|NCT02064816|7528826|FG000|Overall Study|Withdrawal by Subject|2
4648886|NCT02064816|7528827|FG001|Overall Study|Withdrawal by Subject|1
4648887|NCT02064816|7528826|FG000|Overall Study|Lost to Follow-up|2
4648888|NCT02064816|7528827|FG001|Overall Study|Lost to Follow-up|1
4648889|NCT02064816|7528826|FG000|Overall Study|Therapeutic failure|0
4648890|NCT02064816|7528827|FG001|Overall Study|Therapeutic failure|1
4648891|NCT02064816|7528826|FG000|Overall Study|Other|1
4648892|NCT02064816|7528827|FG001|Overall Study|Other|3
4648893|NCT02064868|7528882|FG000|Overall Study|Lost to Follow-up|14
4648894|NCT02064868|7528883|FG001|Overall Study|Lost to Follow-up|8
4648895|NCT02064868|7528882|FG000|Overall Study|Physician Decision|1
4648896|NCT02064868|7528883|FG001|Overall Study|Physician Decision|0
4648897|NCT02064868|7528882|FG000|Overall Study|Withdrawal by Subject|14
4648898|NCT02064868|7528883|FG001|Overall Study|Withdrawal by Subject|3
4648899|NCT02064868|7528882|FG000|Overall Study|Technical Problems or Missing|5
4648900|NCT02064868|7528883|FG001|Overall Study|Technical Problems or Missing|2
4648901|NCT02064894|7528892|FG000|Overall Study|Withdrawal by Subject|43
4648902|NCT02064894|7528893|FG001|Overall Study|Withdrawal by Subject|102
4648903|NCT02064894|7528894|FG002|Overall Study|Withdrawal by Subject|115
4648904|NCT02064920|7528913|FG000|Overall Study|Adverse Event|0
4648905|NCT02064920|7528914|FG001|Overall Study|Adverse Event|4
4648906|NCT02064920|7528913|FG000|Overall Study|Physician Decision|0
4648907|NCT02064920|7528914|FG001|Overall Study|Physician Decision|1
4648908|NCT02064920|7528913|FG000|Overall Study|Technical Problems|0
4648909|NCT02064920|7528914|FG001|Overall Study|Technical Problems|1
4648910|NCT02064920|7528913|FG000|Overall Study|Withdrawal by Subject|1
4648911|NCT02064920|7528914|FG001|Overall Study|Withdrawal by Subject|3
4648912|NCT02065245|7528949|FG000|Infusion 1|Lost to Follow-up|0
4648913|NCT02065245|7528950|FG001|Infusion 1|Lost to Follow-up|0
4648914|NCT02065245|7528951|FG002|Infusion 1|Lost to Follow-up|0
4648915|NCT02065245|7528952|FG003|Infusion 1|Lost to Follow-up|0
4648916|NCT02065245|7528953|FG004|Infusion 1|Lost to Follow-up|0
4648917|NCT02065245|7528954|FG005|Infusion 1|Lost to Follow-up|0
4648918|NCT02065245|7528955|FG006|Infusion 1|Lost to Follow-up|1
4648919|NCT02065245|7528949|FG000|Infusion 1|Death|0
4648920|NCT02065245|7528950|FG001|Infusion 1|Death|0
4648921|NCT02065245|7528951|FG002|Infusion 1|Death|1
4648922|NCT02065245|7528952|FG003|Infusion 1|Death|0
4648923|NCT02065245|7528953|FG004|Infusion 1|Death|1
4648924|NCT02065245|7528954|FG005|Infusion 1|Death|0
4648925|NCT02065245|7528955|FG006|Infusion 1|Death|0
4648926|NCT02065245|7528949|FG000|Infusion 2|Death|0
4648927|NCT02065245|7528950|FG001|Infusion 2|Death|0
4648928|NCT02065245|7528951|FG002|Infusion 2|Death|0
4648929|NCT02065245|7528952|FG003|Infusion 2|Death|0
4648930|NCT02065245|7528953|FG004|Infusion 2|Death|0
4648931|NCT02065245|7528954|FG005|Infusion 2|Death|0
4648932|NCT02065245|7528955|FG006|Infusion 2|Death|1
4648933|NCT02065245|7528949|FG000|Infusion 3|Lost to Follow-up|1
4648934|NCT02065245|7528950|FG001|Infusion 3|Lost to Follow-up|1
4648935|NCT02065245|7528951|FG002|Infusion 3|Lost to Follow-up|0
4648936|NCT02065245|7528952|FG003|Infusion 3|Lost to Follow-up|0
4648937|NCT02065245|7528953|FG004|Infusion 3|Lost to Follow-up|0
4648938|NCT02065245|7528954|FG005|Infusion 3|Lost to Follow-up|0
4648939|NCT02065245|7528955|FG006|Infusion 3|Lost to Follow-up|0
4648940|NCT02065336|7528979|FG000|Extension Phase|Study Terminated by Sponsor|0
4648941|NCT02065336|7528980|FG001|Extension Phase|Study Terminated by Sponsor|0
4648942|NCT02065336|7528981|FG002|Extension Phase|Study Terminated by Sponsor|0
4648943|NCT02065336|7528982|FG003|Extension Phase|Study Terminated by Sponsor|0
4648944|NCT02065336|7528983|FG004|Extension Phase|Study Terminated by Sponsor|0
4648945|NCT02065336|7528984|FG005|Extension Phase|Study Terminated by Sponsor|0
4648946|NCT02065336|7528985|FG006|Extension Phase|Study Terminated by Sponsor|0
4648947|NCT02065336|7528986|FG007|Extension Phase|Study Terminated by Sponsor|0
4648948|NCT02065336|7528987|FG008|Extension Phase|Study Terminated by Sponsor|2
4648949|NCT02065336|7528988|FG009|Extension Phase|Study Terminated by Sponsor|8
4648950|NCT02065518|7529040|FG000|Overall Study|Lost to Follow-up|3
4648951|NCT02065518|7529041|FG001|Overall Study|Lost to Follow-up|4
4648952|NCT02065518|7529042|FG002|Overall Study|Lost to Follow-up|0
4648953|NCT02065518|7529043|FG003|Overall Study|Lost to Follow-up|3
4648954|NCT02065518|7529040|FG000|Overall Study|Withdrawal by Subject|3
4648955|NCT02065518|7529041|FG001|Overall Study|Withdrawal by Subject|4
4648956|NCT02065518|7529042|FG002|Overall Study|Withdrawal by Subject|9
4648957|NCT02065518|7529043|FG003|Overall Study|Withdrawal by Subject|2
4648958|NCT02065557|7529056|FG000|Induction Period|Withdrawal by Subject|2
4648959|NCT02065557|7529057|FG001|Induction Period|Withdrawal by Subject|1
4648960|NCT02065557|7529058|FG002|Induction Period|Withdrawal by Subject|0
4648961|NCT02065557|7529059|FG003|Induction Period|Withdrawal by Subject|0
4648962|NCT02065557|7529060|FG004|Induction Period|Withdrawal by Subject|0
4648963|NCT02065557|7529061|FG005|Induction Period|Withdrawal by Subject|0
4648964|NCT02065557|7529056|FG000|Induction Period|Lack of Efficacy|2
4648965|NCT02065557|7529057|FG001|Induction Period|Lack of Efficacy|1
4648966|NCT02065557|7529058|FG002|Induction Period|Lack of Efficacy|1
4648967|NCT02065557|7529059|FG003|Induction Period|Lack of Efficacy|0
4648968|NCT02065557|7529060|FG004|Induction Period|Lack of Efficacy|0
4648969|NCT02065557|7529061|FG005|Induction Period|Lack of Efficacy|0
4648970|NCT02065557|7529056|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1
4648971|NCT02065557|7529057|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1
4648972|NCT02065557|7529058|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1
4648973|NCT02065557|7529059|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0
4648974|NCT02065557|7529060|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0
4648975|NCT02065557|7529061|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0
4648976|NCT02065557|7529056|FG000|Induction Period|Non-Responder at Week 8|4
4648977|NCT02065557|7529057|FG001|Induction Period|Non-Responder at Week 8|4
4648978|NCT02065557|7529058|FG002|Induction Period|Non-Responder at Week 8|0
4648979|NCT02065557|7529059|FG003|Induction Period|Non-Responder at Week 8|0
4648980|NCT02065557|7529060|FG004|Induction Period|Non-Responder at Week 8|0
4648981|NCT02065557|7529061|FG005|Induction Period|Non-Responder at Week 8|0
4648982|NCT02065557|7529056|FG000|Induction Period|Adverse Event|1
4648983|NCT02065557|7529057|FG001|Induction Period|Adverse Event|1
4648984|NCT02065557|7529058|FG002|Induction Period|Adverse Event|0
4648985|NCT02065557|7529059|FG003|Induction Period|Adverse Event|0
4648986|NCT02065557|7529060|FG004|Induction Period|Adverse Event|0
4648987|NCT02065557|7529061|FG005|Induction Period|Adverse Event|0
4648988|NCT02065557|7529056|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0
4648989|NCT02065557|7529057|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0
4648990|NCT02065557|7529058|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0
4648991|NCT02065557|7529059|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1
4648992|NCT02065557|7529060|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1
4648993|NCT02065557|7529061|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0
4648994|NCT02065557|7529056|FG000|Maintenance Period|Withdrawal by Subject|0
4648995|NCT02065557|7529057|FG001|Maintenance Period|Withdrawal by Subject|0
4648996|NCT02065557|7529058|FG002|Maintenance Period|Withdrawal by Subject|0
4648997|NCT02065557|7529059|FG003|Maintenance Period|Withdrawal by Subject|0
4648998|NCT02065557|7529060|FG004|Maintenance Period|Withdrawal by Subject|2
4648999|NCT02065557|7529061|FG005|Maintenance Period|Withdrawal by Subject|1
4649000|NCT02065557|7529056|FG000|Maintenance Period|Lack of Efficacy|0
4649001|NCT02065557|7529057|FG001|Maintenance Period|Lack of Efficacy|0
4649002|NCT02065557|7529058|FG002|Maintenance Period|Lack of Efficacy|0
4649003|NCT02065557|7529059|FG003|Maintenance Period|Lack of Efficacy|0
4649004|NCT02065557|7529060|FG004|Maintenance Period|Lack of Efficacy|5
4649005|NCT02065557|7529061|FG005|Maintenance Period|Lack of Efficacy|2
4649006|NCT02065557|7529056|FG000|Maintenance Period|Subject Non-Compliance|0
4649007|NCT02065557|7529057|FG001|Maintenance Period|Subject Non-Compliance|0
4649008|NCT02065557|7529058|FG002|Maintenance Period|Subject Non-Compliance|0
4649009|NCT02065557|7529059|FG003|Maintenance Period|Subject Non-Compliance|0
4649010|NCT02065557|7529060|FG004|Maintenance Period|Subject Non-Compliance|0
4649011|NCT02065557|7529061|FG005|Maintenance Period|Subject Non-Compliance|1
4649012|NCT02065570|7529088|FG000|Induction Study|Adverse Event|5
4649013|NCT02065570|7529089|FG001|Induction Study|Adverse Event|12
4649014|NCT02065570|7529090|FG002|Induction Study|Adverse Event|0
4649015|NCT02065570|7529091|FG003|Induction Study|Adverse Event|0
4649016|NCT02065570|7529088|FG000|Induction Study|Withdrawal by Subject|2
4649017|NCT02065570|7529089|FG001|Induction Study|Withdrawal by Subject|3
4649018|NCT02065570|7529090|FG002|Induction Study|Withdrawal by Subject|0
4649019|NCT02065570|7529091|FG003|Induction Study|Withdrawal by Subject|0
4649020|NCT02065570|7529088|FG000|Induction Study|Lost to Follow-up|1
4649021|NCT02065570|7529089|FG001|Induction Study|Lost to Follow-up|1
4649022|NCT02065570|7529090|FG002|Induction Study|Lost to Follow-up|0
4649023|NCT02065570|7529091|FG003|Induction Study|Lost to Follow-up|0
4649024|NCT02065570|7529088|FG000|Induction Study|Other, Not Specified|6
4649025|NCT02065570|7529089|FG001|Induction Study|Other, Not Specified|5
4649026|NCT02065570|7529090|FG002|Induction Study|Other, Not Specified|0
4649027|NCT02065570|7529091|FG003|Induction Study|Other, Not Specified|0
4649028|NCT02065570|7529088|FG000|Maintenance Study|Adverse Event|0
4649029|NCT02065570|7529089|FG001|Maintenance Study|Adverse Event|0
4649030|NCT02065570|7529090|FG002|Maintenance Study|Adverse Event|8
4649031|NCT02065570|7529091|FG003|Maintenance Study|Adverse Event|8
4649032|NCT02065570|7529088|FG000|Maintenance Study|Withdrawal by Subject|0
4649033|NCT02065570|7529089|FG001|Maintenance Study|Withdrawal by Subject|0
4649034|NCT02065570|7529090|FG002|Maintenance Study|Withdrawal by Subject|1
4649035|NCT02065570|7529091|FG003|Maintenance Study|Withdrawal by Subject|4
4649036|NCT02065570|7529088|FG000|Maintenance Study|Lost to Follow-up|0
4649037|NCT02065570|7529089|FG001|Maintenance Study|Lost to Follow-up|0
4649038|NCT02065570|7529090|FG002|Maintenance Study|Lost to Follow-up|2
4649039|NCT02065570|7529091|FG003|Maintenance Study|Lost to Follow-up|2
4649040|NCT02065570|7529088|FG000|Maintenance Study|Other, Not Specified|0
4649041|NCT02065570|7529089|FG001|Maintenance Study|Other, Not Specified|0
4649042|NCT02065570|7529090|FG002|Maintenance Study|Other, Not Specified|11
4649043|NCT02065570|7529091|FG003|Maintenance Study|Other, Not Specified|5
4649044|NCT02065622|7529104|FG000|Induction Study|Adverse Event|13
4649045|NCT02065622|7529105|FG001|Induction Study|Adverse Event|19
4649046|NCT02065622|7529106|FG002|Induction Study|Adverse Event|0
4649047|NCT02065622|7529107|FG003|Induction Study|Adverse Event|0
4649048|NCT02065622|7529108|FG004|Induction Study|Adverse Event|0
4649049|NCT02065622|7529104|FG000|Induction Study|Withdrawal by Subject|3
4649050|NCT02065622|7529105|FG001|Induction Study|Withdrawal by Subject|5
4649051|NCT02065622|7529106|FG002|Induction Study|Withdrawal by Subject|0
4649052|NCT02065622|7529107|FG003|Induction Study|Withdrawal by Subject|0
4649053|NCT02065622|7529108|FG004|Induction Study|Withdrawal by Subject|0
4649054|NCT02065622|7529104|FG000|Induction Study|Lost to Follow-up|1
4649055|NCT02065622|7529105|FG001|Induction Study|Lost to Follow-up|0
4649056|NCT02065622|7529106|FG002|Induction Study|Lost to Follow-up|0
4649057|NCT02065622|7529107|FG003|Induction Study|Lost to Follow-up|0
4649058|NCT02065622|7529108|FG004|Induction Study|Lost to Follow-up|0
4649059|NCT02065622|7529104|FG000|Induction Study|Lack of Efficacy|22
4649060|NCT02065622|7529105|FG001|Induction Study|Lack of Efficacy|27
4649061|NCT02065622|7529106|FG002|Induction Study|Lack of Efficacy|0
4649062|NCT02065622|7529107|FG003|Induction Study|Lack of Efficacy|0
4649063|NCT02065622|7529108|FG004|Induction Study|Lack of Efficacy|0
4649064|NCT02065622|7529104|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4
4649065|NCT02065622|7529105|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5
4649066|NCT02065622|7529106|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0
4649067|NCT02065622|7529107|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0
4649068|NCT02065622|7529108|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0
4649069|NCT02065622|7529104|FG000|Induction Study|Subject Noncompliance|1
4649070|NCT02065622|7529105|FG001|Induction Study|Subject Noncompliance|1
4649071|NCT02065622|7529106|FG002|Induction Study|Subject Noncompliance|0
4649072|NCT02065622|7529107|FG003|Induction Study|Subject Noncompliance|0
4649073|NCT02065622|7529108|FG004|Induction Study|Subject Noncompliance|0
4649074|NCT02065622|7529104|FG000|Induction Study|Other, Not Specified|3
4649075|NCT02065622|7529105|FG001|Induction Study|Other, Not Specified|2
4649076|NCT02065622|7529106|FG002|Induction Study|Other, Not Specified|0
4649077|NCT02065622|7529107|FG003|Induction Study|Other, Not Specified|0
4649078|NCT02065622|7529108|FG004|Induction Study|Other, Not Specified|0
4649079|NCT02065622|7529104|FG000|Maintenance Study|Adverse Event|0
4649080|NCT02065622|7529105|FG001|Maintenance Study|Adverse Event|0
4649081|NCT02065622|7529106|FG002|Maintenance Study|Adverse Event|25
4649082|NCT02065622|7529107|FG003|Maintenance Study|Adverse Event|22
4649083|NCT02065622|7529108|FG004|Maintenance Study|Adverse Event|11
4649084|NCT02065622|7529104|FG000|Maintenance Study|Withdrawal by Subject|0
4649085|NCT02065622|7529105|FG001|Maintenance Study|Withdrawal by Subject|0
4649086|NCT02065622|7529106|FG002|Maintenance Study|Withdrawal by Subject|11
4649087|NCT02065622|7529107|FG003|Maintenance Study|Withdrawal by Subject|5
4649088|NCT02065622|7529108|FG004|Maintenance Study|Withdrawal by Subject|7
4649089|NCT02065622|7529104|FG000|Maintenance Study|Lost to Follow-up|0
4649090|NCT02065622|7529105|FG001|Maintenance Study|Lost to Follow-up|0
4649091|NCT02065622|7529106|FG002|Maintenance Study|Lost to Follow-up|4
4649092|NCT02065622|7529107|FG003|Maintenance Study|Lost to Follow-up|1
4649093|NCT02065622|7529108|FG004|Maintenance Study|Lost to Follow-up|1
4649094|NCT02065622|7529104|FG000|Maintenance Study|Lack of Efficacy|0
4649095|NCT02065622|7529105|FG001|Maintenance Study|Lack of Efficacy|0
4649096|NCT02065622|7529106|FG002|Maintenance Study|Lack of Efficacy|70
4649097|NCT02065622|7529107|FG003|Maintenance Study|Lack of Efficacy|55
4649098|NCT02065622|7529108|FG004|Maintenance Study|Lack of Efficacy|19
4649099|NCT02065622|7529104|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0
4649100|NCT02065622|7529105|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0
4649101|NCT02065622|7529106|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7
4649102|NCT02065622|7529107|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3
4649103|NCT02065622|7529108|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4
4649104|NCT02065622|7529104|FG000|Maintenance Study|Subject Non-Compliance|0
4649105|NCT02065622|7529105|FG001|Maintenance Study|Subject Non-Compliance|0
4649106|NCT02065622|7529106|FG002|Maintenance Study|Subject Non-Compliance|1
4649107|NCT02065622|7529107|FG003|Maintenance Study|Subject Non-Compliance|3
4649108|NCT02065622|7529108|FG004|Maintenance Study|Subject Non-Compliance|2
4649109|NCT02065622|7529104|FG000|Maintenance Study|Other, Not Specified|0
4649110|NCT02065622|7529105|FG001|Maintenance Study|Other, Not Specified|0
4649111|NCT02065622|7529106|FG002|Maintenance Study|Other, Not Specified|6
4649112|NCT02065622|7529107|FG003|Maintenance Study|Other, Not Specified|14
4649113|NCT02065622|7529108|FG004|Maintenance Study|Other, Not Specified|2
4649114|NCT02065622|7529104|FG000|Maintenance Study|Unknown Reason|0
4649115|NCT02065622|7529105|FG001|Maintenance Study|Unknown Reason|0
4649116|NCT02065622|7529106|FG002|Maintenance Study|Unknown Reason|0
4649117|NCT02065622|7529107|FG003|Maintenance Study|Unknown Reason|1
4649118|NCT02065622|7529108|FG004|Maintenance Study|Unknown Reason|0
4649119|NCT02065713|7529134|FG000|Overall Study|Adverse Event|0
4649120|NCT02065713|7529135|FG001|Overall Study|Adverse Event|1
4649121|NCT02065713|7529134|FG000|Overall Study|Unsatisfactory therapeutic effect|1
4649122|NCT02065713|7529135|FG001|Overall Study|Unsatisfactory therapeutic effect|0
4649123|NCT02065791|7529143|FG000|Overall Study|Closed Site|1
4649124|NCT02065791|7529144|FG001|Overall Study|Closed Site|1
4649125|NCT02065791|7529143|FG000|Overall Study|Withdrawal by Subject|11
4649126|NCT02065791|7529144|FG001|Overall Study|Withdrawal by Subject|5
4649127|NCT02065791|7529143|FG000|Overall Study|Lost to Follow-up|13
4649128|NCT02065791|7529144|FG001|Overall Study|Lost to Follow-up|9
4649129|NCT02065895|7529150|FG000|Overall Study|Protocol Violation|1
4649130|NCT02065895|7529151|FG001|Overall Study|Protocol Violation|0
4649131|NCT02065895|7529152|FG002|Overall Study|Protocol Violation|0
4649132|NCT02065895|7529153|FG003|Overall Study|Protocol Violation|1
4649133|NCT02065895|7529154|FG004|Overall Study|Protocol Violation|0
4649134|NCT02065895|7529155|FG005|Overall Study|Protocol Violation|0
4649135|NCT02065895|7529150|FG000|Overall Study|Scheduling conflicts|0
4649136|NCT02065895|7529151|FG001|Overall Study|Scheduling conflicts|1
4649137|NCT02065895|7529152|FG002|Overall Study|Scheduling conflicts|0
4649138|NCT02065895|7529153|FG003|Overall Study|Scheduling conflicts|0
4649139|NCT02065895|7529154|FG004|Overall Study|Scheduling conflicts|0
4649140|NCT02065895|7529155|FG005|Overall Study|Scheduling conflicts|0
4649141|NCT02066051|7529172|FG000|Overall Study|Subject developed active GVHD|1
4649142|NCT02066129|7529178|FG000|Overall Study|Lost to Follow-up|13
4649143|NCT02066129|7529179|FG001|Overall Study|Lost to Follow-up|12
4649144|NCT02066129|7529178|FG000|Overall Study|Withdrawal by Subject|7
4649145|NCT02066129|7529179|FG001|Overall Study|Withdrawal by Subject|10
4649146|NCT02066129|7529178|FG000|Overall Study|Lack of Efficacy|8
4649147|NCT02066129|7529179|FG001|Overall Study|Lack of Efficacy|10
4649148|NCT02066129|7529178|FG000|Overall Study|Physician Decision|1
4649149|NCT02066129|7529179|FG001|Overall Study|Physician Decision|1
4649150|NCT02066233|7529187|FG000|EG Scan II (Day 1)|difficulty intubating subject|6
4649151|NCT02066233|7529188|FG001|EG Scan II (Day 1)|difficulty intubating subject|6
4649152|NCT02066298|7529200|FG000|Overall Study|Lost to Follow-up|3
4649153|NCT02066298|7529201|FG001|Overall Study|Lost to Follow-up|2
4649154|NCT02066298|7529202|FG002|Overall Study|Lost to Follow-up|3
4649155|NCT02066298|7529203|FG003|Overall Study|Lost to Follow-up|2
4649156|NCT02066298|7529204|FG004|Overall Study|Lost to Follow-up|3
4649157|NCT02066298|7529205|FG005|Overall Study|Lost to Follow-up|4
4649158|NCT02066298|7529200|FG000|Overall Study|Withdrawal by Subject|6
4649159|NCT02066298|7529201|FG001|Overall Study|Withdrawal by Subject|6
4649160|NCT02066298|7529202|FG002|Overall Study|Withdrawal by Subject|6
4649161|NCT02066298|7529203|FG003|Overall Study|Withdrawal by Subject|4
4649162|NCT02066298|7529204|FG004|Overall Study|Withdrawal by Subject|5
4649163|NCT02066298|7529205|FG005|Overall Study|Withdrawal by Subject|8
4649164|NCT02066298|7529200|FG000|Overall Study|Physician Decision|0
4649165|NCT02066298|7529201|FG001|Overall Study|Physician Decision|0
4649166|NCT02066298|7529202|FG002|Overall Study|Physician Decision|1
4649167|NCT02066298|7529203|FG003|Overall Study|Physician Decision|0
4649168|NCT02066298|7529204|FG004|Overall Study|Physician Decision|1
4649169|NCT02066298|7529205|FG005|Overall Study|Physician Decision|0
4649170|NCT02066311|7529217|FG000|Overall Study|Adverse Event|4
4649171|NCT02066311|7529217|FG000|Overall Study|Withdrawal by Subject|1
4649172|NCT02066389|7529227|FG000|Overall Study|Adverse Event|1
4649173|NCT02066389|7529228|FG001|Overall Study|Adverse Event|1
4649174|NCT02066389|7529229|FG002|Overall Study|Adverse Event|1
4649175|NCT02066389|7529230|FG003|Overall Study|Adverse Event|1
4649176|NCT02066389|7529231|FG004|Overall Study|Adverse Event|5
4649177|NCT02066389|7529232|FG005|Overall Study|Adverse Event|1
4649178|NCT02066389|7529227|FG000|Overall Study|Withdrawal by Subject|4
4649179|NCT02066389|7529228|FG001|Overall Study|Withdrawal by Subject|0
4649180|NCT02066389|7529229|FG002|Overall Study|Withdrawal by Subject|5
4649181|NCT02066389|7529230|FG003|Overall Study|Withdrawal by Subject|1
4649182|NCT02066389|7529231|FG004|Overall Study|Withdrawal by Subject|1
4649183|NCT02066389|7529232|FG005|Overall Study|Withdrawal by Subject|2
4649184|NCT02066389|7529227|FG000|Overall Study|Lost to Follow-up|0
4649185|NCT02066389|7529228|FG001|Overall Study|Lost to Follow-up|0
4649186|NCT02066389|7529229|FG002|Overall Study|Lost to Follow-up|0
4649187|NCT02066389|7529230|FG003|Overall Study|Lost to Follow-up|1
4649188|NCT02066389|7529231|FG004|Overall Study|Lost to Follow-up|1
4649189|NCT02066389|7529232|FG005|Overall Study|Lost to Follow-up|1
4649190|NCT02066389|7529227|FG000|Overall Study|Randomized in Error|0
4649191|NCT02066389|7529228|FG001|Overall Study|Randomized in Error|0
4649192|NCT02066389|7529229|FG002|Overall Study|Randomized in Error|0
4649193|NCT02066389|7529230|FG003|Overall Study|Randomized in Error|0
4649194|NCT02066389|7529231|FG004|Overall Study|Randomized in Error|0
4649195|NCT02066389|7529232|FG005|Overall Study|Randomized in Error|1
4649196|NCT02066402|7529248|FG000|Overall Study|Adverse Event|1
4649197|NCT02066402|7529249|FG001|Overall Study|Adverse Event|2
4649198|NCT02066402|7529248|FG000|Overall Study|Lost to Follow-up|11
4649199|NCT02066402|7529249|FG001|Overall Study|Lost to Follow-up|8
4649200|NCT02066402|7529248|FG000|Overall Study|Withdrawal by Subject|14
4649201|NCT02066402|7529249|FG001|Overall Study|Withdrawal by Subject|11
4649202|NCT02066402|7529248|FG000|Overall Study|Progressive disease-clinical progression|0
4649203|NCT02066402|7529249|FG001|Overall Study|Progressive disease-clinical progression|1
4649204|NCT02066402|7529248|FG000|Overall Study|Protocol driven decision point|0
4649205|NCT02066402|7529249|FG001|Overall Study|Protocol driven decision point|1
4649215|NCT02066467|7529268|FG000|Overall Study|Did not undergo implant procedure|24
4649216|NCT02066467|7529268|FG000|Overall Study|Attempted to implant withoput success|43
4649217|NCT02066467|7529268|FG000|Overall Study|Consent ineligible|1
4649218|NCT02066467|7529268|FG000|Overall Study|Death|54
4649219|NCT02066467|7529268|FG000|Overall Study|Lost to Follow-up|51
4649220|NCT02066467|7529268|FG000|Overall Study|Adverse Event|20
4649221|NCT02066467|7529268|FG000|Overall Study|Withdrawal by Subject|16
4649222|NCT02066467|7529268|FG000|Overall Study|Physician Decision|2
4649223|NCT02066467|7529268|FG000|Overall Study|Not defined|4
4649224|NCT02066922|7529321|FG000|Overall Study|Adverse Event|1
4649225|NCT02067533|7529367|FG000|Overall Study|Lost to Follow-up|4
4649226|NCT02067533|7529368|FG001|Overall Study|Lost to Follow-up|2
4649227|NCT02067663|7529389|FG000|Overall Study|Lost to Follow-up|13
4649228|NCT02067663|7529390|FG001|Overall Study|Lost to Follow-up|14
4649229|NCT02067676|7529402|FG000|Overall Study|Withdrawal by Subject|1
4649230|NCT02067676|7529403|FG001|Overall Study|Withdrawal by Subject|0
4649231|NCT02067676|7529404|FG002|Overall Study|Withdrawal by Subject|0
4649232|NCT02067676|7529405|FG003|Overall Study|Withdrawal by Subject|0
4649233|NCT02067676|7529406|FG004|Overall Study|Withdrawal by Subject|0
4649234|NCT02067676|7529407|FG005|Overall Study|Withdrawal by Subject|0
4649235|NCT02067728|7529428|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7
4649236|NCT02067728|7529429|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28
4649237|NCT02067728|7529428|FG000|6 Month Follow up Survey|Lost to Follow-up|48
4649238|NCT02067728|7529429|FG001|6 Month Follow up Survey|Lost to Follow-up|60
4649239|NCT02067728|7529428|FG000|6 Month Measurements|Unable to attend|114
4649240|NCT02067728|7529429|FG001|6 Month Measurements|Unable to attend|97
4649241|NCT02068118|7529455|FG000|18-month Comparative Study Period|Death|90
4649242|NCT02068118|7529456|FG001|18-month Comparative Study Period|Death|97
4649243|NCT02068118|7529455|FG000|18-month Comparative Study Period|Withdrawal by Subject|23
4649244|NCT02068118|7529456|FG001|18-month Comparative Study Period|Withdrawal by Subject|52
4649245|NCT02068118|7529455|FG000|18-month Comparative Study Period|Lost to Follow-up|6
4649246|NCT02068118|7529456|FG001|18-month Comparative Study Period|Lost to Follow-up|7
4649247|NCT02068118|7529455|FG000|18-month Comparative Study Period|Heart transplant|9
4649248|NCT02068118|7529456|FG001|18-month Comparative Study Period|Heart transplant|15
4649249|NCT02068118|7529455|FG000|18-month Comparative Study Period|Inclusion in another protocol|0
4649250|NCT02068118|7529456|FG001|18-month Comparative Study Period|Inclusion in another protocol|2
4649251|NCT02068118|7529455|FG000|18-month Comparative Study Period|Hemiplegia|0
4649252|NCT02068118|7529456|FG001|18-month Comparative Study Period|Hemiplegia|1
4649253|NCT02068118|7529455|FG000|18-month Comparative Study Period|Alzheimer's disease|0
4649254|NCT02068118|7529456|FG001|18-month Comparative Study Period|Alzheimer's disease|1
4649255|NCT02068118|7529455|FG000|18-month Comparative Study Period|Move|0
4649256|NCT02068118|7529456|FG001|18-month Comparative Study Period|Move|1
4649257|NCT02068118|7529455|FG000|18-month Comparative Study Period|Hearing loss|0
4649258|NCT02068118|7529456|FG001|18-month Comparative Study Period|Hearing loss|1
4649259|NCT02068118|7529455|FG000|Extension Period|Death|0
4649260|NCT02068118|7529456|FG001|Extension Period|Death|2
4649261|NCT02068118|7529455|FG000|Extension Period|Withdrawal by Subject|1
4649262|NCT02068118|7529456|FG001|Extension Period|Withdrawal by Subject|0
4649263|NCT02068118|7529455|FG000|Extension Period|Heart transplant|1
4649264|NCT02068118|7529456|FG001|Extension Period|Heart transplant|0
4649265|NCT02068118|7529455|FG000|Extension Period|Wrong device use|0
4649266|NCT02068118|7529456|FG001|Extension Period|Wrong device use|1
4649267|NCT02068222|7529468|FG000|Overall Study|Lost to Follow-up|1
4649268|NCT02068352|7529475|FG000|Overall Study|Lost to Follow-up|0
4649269|NCT02068352|7529476|FG001|Overall Study|Lost to Follow-up|2
4649270|NCT02068352|7529477|FG002|Overall Study|Lost to Follow-up|0
4649271|NCT02068352|7529475|FG000|Overall Study|Adverse Event|4
4649272|NCT02068352|7529476|FG001|Overall Study|Adverse Event|2
4649273|NCT02068352|7529477|FG002|Overall Study|Adverse Event|7
4649274|NCT02068352|7529475|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0
4649275|NCT02068352|7529476|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1
4649276|NCT02068352|7529477|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0
4649277|NCT02068352|7529475|FG000|Overall Study|Participant Withdrew Consent to Participate|6
4649278|NCT02068352|7529476|FG001|Overall Study|Participant Withdrew Consent to Participate|3
4649279|NCT02068352|7529477|FG002|Overall Study|Participant Withdrew Consent to Participate|1
4649280|NCT02068352|7529475|FG000|Overall Study|Protocol Deviation|0
4649281|NCT02068352|7529476|FG001|Overall Study|Protocol Deviation|0
4649282|NCT02068352|7529477|FG002|Overall Study|Protocol Deviation|1
4649283|NCT02068443|7529488|FG000|Overall Study|Pretreatment Event/Adverse Event|0
4649284|NCT02068443|7529489|FG001|Overall Study|Pretreatment Event/Adverse Event|5
4649285|NCT02068443|7529490|FG002|Overall Study|Pretreatment Event/Adverse Event|2
4649286|NCT02068443|7529488|FG000|Overall Study|Voluntary Withdrawal|4
4649287|NCT02068443|7529489|FG001|Overall Study|Voluntary Withdrawal|0
4649288|NCT02068443|7529490|FG002|Overall Study|Voluntary Withdrawal|1
4649289|NCT02068443|7529488|FG000|Overall Study|Lack of Efficacy|2
4649290|NCT02068443|7529489|FG001|Overall Study|Lack of Efficacy|1
4649291|NCT02068443|7529490|FG002|Overall Study|Lack of Efficacy|0
4649292|NCT02068443|7529488|FG000|Overall Study|Other Reason Not Specified|1
4649293|NCT02068443|7529489|FG001|Overall Study|Other Reason Not Specified|0
4649294|NCT02068443|7529490|FG002|Overall Study|Other Reason Not Specified|0
4649295|NCT02068495|7529498|FG000|Overall Study|Case Report Forms Uncollected|60
4649296|NCT02068495|7529498|FG000|Overall Study|Protocol Deviation|49
4649297|NCT02068508|7529502|FG000|Overall Study|Case report forms uncollected|27
4649298|NCT02068508|7529502|FG000|Overall Study|Patient did not visit the study site|1
4649299|NCT02068508|7529502|FG000|Overall Study|Protocol Violation|4
4649300|NCT02068599|7529509|FG000|Overall Study|Adverse Event|4
4649301|NCT02068599|7529510|FG001|Overall Study|Adverse Event|1
4649302|NCT02068599|7529511|FG002|Overall Study|Adverse Event|1
4649303|NCT02068599|7529509|FG000|Overall Study|Withdrawal by Subject|2
4649304|NCT02068599|7529510|FG001|Overall Study|Withdrawal by Subject|7
4649305|NCT02068599|7529511|FG002|Overall Study|Withdrawal by Subject|5
4649306|NCT02068599|7529509|FG000|Overall Study|Protocol Violation|4
4649307|NCT02068599|7529510|FG001|Overall Study|Protocol Violation|2
4649308|NCT02068599|7529511|FG002|Overall Study|Protocol Violation|3
4649309|NCT02068599|7529509|FG000|Overall Study|Lost to Follow-up|1
4649310|NCT02068599|7529510|FG001|Overall Study|Lost to Follow-up|0
4649311|NCT02068599|7529511|FG002|Overall Study|Lost to Follow-up|0
4649312|NCT02068599|7529509|FG000|Overall Study|Lack of Efficacy|0
4649313|NCT02068599|7529510|FG001|Overall Study|Lack of Efficacy|0
4649314|NCT02068599|7529511|FG002|Overall Study|Lack of Efficacy|3
4649315|NCT02068599|7529509|FG000|Overall Study|Noncompliance|0
4649316|NCT02068599|7529510|FG001|Overall Study|Noncompliance|0
4649317|NCT02068599|7529511|FG002|Overall Study|Noncompliance|1
4649318|NCT02068768|7529578|FG000|Overall Study|Lost to Follow-up|5
4649319|NCT02068768|7529578|FG000|Overall Study|Early Termination by Sponsor|2
4649320|NCT02068885|7529608|FG000|Overall Study|Withdrew|3
4649321|NCT02068885|7529609|FG001|Overall Study|Withdrew|5
4649322|NCT02068885|7529610|FG002|Overall Study|Withdrew|8
4649323|NCT02069015|7529621|FG000|Overall Study|Lost to Follow-up|39
4649324|NCT02069015|7529622|FG001|Overall Study|Lost to Follow-up|32
4649325|NCT02069015|7529621|FG000|Overall Study|Withdrawal by Subject|1
4649326|NCT02069015|7529622|FG001|Overall Study|Withdrawal by Subject|1
4649327|NCT02069093|7529633|FG000|Overall Study|Disease progression|14
4649328|NCT02069093|7529633|FG000|Overall Study|New cancer therapy|1
4649329|NCT02069093|7529633|FG000|Overall Study|Death|1
4649330|NCT02069093|7529633|FG000|Overall Study|Administrative problems|1
4649331|NCT02069093|7529633|FG000|Overall Study|Withdrawal by Subject|2
4649332|NCT02069093|7529633|FG000|Overall Study|Abnormal laboratory values|1
4649333|NCT02069093|7529633|FG000|Overall Study|Adverse Event|10
4649334|NCT02069379|7529671|FG000|Baseline Measurements|Lost to Follow-up|1
4649335|NCT02069379|7529672|FG001|Baseline Measurements|Lost to Follow-up|0
4649336|NCT02069379|7529673|FG002|Baseline Measurements|Lost to Follow-up|0
4649337|NCT02069379|7529674|FG003|Baseline Measurements|Lost to Follow-up|0
4649338|NCT02069379|7529671|FG000|Baseline Measurements|Ineligible based on initial assessments|2
4649339|NCT02069379|7529672|FG001|Baseline Measurements|Ineligible based on initial assessments|0
4649340|NCT02069379|7529673|FG002|Baseline Measurements|Ineligible based on initial assessments|0
4649341|NCT02069379|7529674|FG003|Baseline Measurements|Ineligible based on initial assessments|2
4649342|NCT02069379|7529671|FG000|First Treatment Arm|Lost to Follow-up|0
4649343|NCT02069379|7529672|FG001|First Treatment Arm|Lost to Follow-up|1
4649344|NCT02069379|7529673|FG002|First Treatment Arm|Lost to Follow-up|1
4649345|NCT02069379|7529674|FG003|First Treatment Arm|Lost to Follow-up|0
4649346|NCT02069379|7529671|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0
4649347|NCT02069379|7529672|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1
4649348|NCT02069379|7529673|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0
4649349|NCT02069379|7529674|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0
4649350|NCT02069379|7529671|FG000|Washout Period (4 Weeks)|Unrelated event|0
4649351|NCT02069379|7529672|FG001|Washout Period (4 Weeks)|Unrelated event|1
4649352|NCT02069379|7529673|FG002|Washout Period (4 Weeks)|Unrelated event|0
4649353|NCT02069379|7529674|FG003|Washout Period (4 Weeks)|Unrelated event|0
4649354|NCT02069379|7529671|FG000|Second Treatment Arm|Lost to Follow-up|0
4649355|NCT02069379|7529672|FG001|Second Treatment Arm|Lost to Follow-up|0
4649356|NCT02069379|7529673|FG002|Second Treatment Arm|Lost to Follow-up|1
4649357|NCT02069379|7529674|FG003|Second Treatment Arm|Lost to Follow-up|0
4649358|NCT02069392|7529686|FG000|Overall Study|Withdrawal by Subject|4
4649359|NCT02069392|7529687|FG001|Overall Study|Withdrawal by Subject|2
4649360|NCT02070380|7529754|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0
4649361|NCT02070380|7529755|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5
4649362|NCT02070380|7529756|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2
4649363|NCT02070380|7529757|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3
4649364|NCT02070380|7529754|FG000|Second Injection|Image sets missing or technically inadeq|0
4649365|NCT02070380|7529755|FG001|Second Injection|Image sets missing or technically inadeq|1
4649366|NCT02070380|7529756|FG002|Second Injection|Image sets missing or technically inadeq|0
4649367|NCT02070380|7529757|FG003|Second Injection|Image sets missing or technically inadeq|0
4649368|NCT02070380|7529754|FG000|Second Injection|Protocol Violation|0
4649369|NCT02070380|7529755|FG001|Second Injection|Protocol Violation|1
4649370|NCT02070380|7529756|FG002|Second Injection|Protocol Violation|1
4649371|NCT02070380|7529757|FG003|Second Injection|Protocol Violation|5
4649372|NCT02070484|7529771|FG000|Overall Study|Withdrawal by Subject|1
4649373|NCT02070484|7529772|FG001|Overall Study|Withdrawal by Subject|0
4649374|NCT02070588|7529781|FG000|Overall Study|Withdrawal by Subject|29
4649375|NCT02070588|7529782|FG001|Overall Study|Withdrawal by Subject|1
4649376|NCT02070588|7529783|FG002|Overall Study|Withdrawal by Subject|0
4649377|NCT02070588|7529781|FG000|Overall Study|Writhdrawal due to early termination|9
4649378|NCT02070588|7529782|FG001|Overall Study|Writhdrawal due to early termination|0
4649379|NCT02070588|7529783|FG002|Overall Study|Writhdrawal due to early termination|0
4649380|NCT02070588|7529781|FG000|Overall Study|Adverse Event|1
4649381|NCT02070588|7529782|FG001|Overall Study|Adverse Event|0
4649382|NCT02070588|7529783|FG002|Overall Study|Adverse Event|0
4649383|NCT02070744|7529814|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0
4649384|NCT02070744|7529815|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0
4649385|NCT02070744|7529816|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0
4649386|NCT02070744|7529817|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1
4649387|NCT02070744|7529818|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0
4649388|NCT02070744|7529814|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0
4649389|NCT02070744|7529815|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0
4649390|NCT02070744|7529816|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0
4649391|NCT02070744|7529817|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0
4649392|NCT02070744|7529818|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2
4649393|NCT02070744|7529814|FG000|OLE Phase (48 Weeks)|Other|0
4649394|NCT02070744|7529815|FG001|OLE Phase (48 Weeks)|Other|0
4649395|NCT02070744|7529816|FG002|OLE Phase (48 Weeks)|Other|0
4649396|NCT02070744|7529817|FG003|OLE Phase (48 Weeks)|Other|0
4649397|NCT02070744|7529818|FG004|OLE Phase (48 Weeks)|Other|1
4649398|NCT02070757|7529835|FG000|Overall Study|Adverse Event|107
4649399|NCT02070757|7529836|FG001|Overall Study|Adverse Event|99
4649400|NCT02070757|7529835|FG000|Overall Study|Lost to Follow-up|7
4649401|NCT02070757|7529836|FG001|Overall Study|Lost to Follow-up|4
4649402|NCT02070757|7529835|FG000|Overall Study|Protocol Violation|0
4649403|NCT02070757|7529836|FG001|Overall Study|Protocol Violation|4
4649404|NCT02070757|7529835|FG000|Overall Study|Withdrawal by Subject|1
4649405|NCT02070757|7529836|FG001|Overall Study|Withdrawal by Subject|3
4649406|NCT02070757|7529835|FG000|Overall Study|Investigator Decision|0
4649407|NCT02070757|7529836|FG001|Overall Study|Investigator Decision|2
4649408|NCT02070757|7529835|FG000|Overall Study|Discharged from Study Hospital|2
4649409|NCT02070757|7529836|FG001|Overall Study|Discharged from Study Hospital|2
4649410|NCT02070965|7529845|FG000|Overall Study|Lost to Follow-up|0
4747799|NCT00545129|7721892|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14
4747800|NCT00545129|7721891|FG000|Overall Study|Other|3
4747801|NCT00545129|7721892|FG001|Overall Study|Other|3
4649411|NCT02070965|7529846|FG001|Overall Study|Lost to Follow-up|1
4649412|NCT02070965|7529847|FG002|Overall Study|Lost to Follow-up|0
4649413|NCT02070965|7529845|FG000|Overall Study|Withdrawal by Subject|1
4649414|NCT02070965|7529846|FG001|Overall Study|Withdrawal by Subject|1
4649415|NCT02070965|7529847|FG002|Overall Study|Withdrawal by Subject|1
4649416|NCT02070965|7529845|FG000|Overall Study|Subject moved|1
4649417|NCT02070965|7529846|FG001|Overall Study|Subject moved|0
4649418|NCT02070965|7529847|FG002|Overall Study|Subject moved|0
4649419|NCT02070978|7529858|FG000|Overall Study|Adverse Event|6
4649420|NCT02070978|7529859|FG001|Overall Study|Adverse Event|2
4649421|NCT02070978|7529860|FG002|Overall Study|Adverse Event|0
4649422|NCT02070978|7529858|FG000|Overall Study|Lost to Follow-up|1
4649423|NCT02070978|7529859|FG001|Overall Study|Lost to Follow-up|3
4649424|NCT02070978|7529860|FG002|Overall Study|Lost to Follow-up|4
4649425|NCT02070978|7529858|FG000|Overall Study|Withdrawal by Subject|3
4649426|NCT02070978|7529859|FG001|Overall Study|Withdrawal by Subject|5
4649427|NCT02070978|7529860|FG002|Overall Study|Withdrawal by Subject|3
4649428|NCT02070978|7529858|FG000|Overall Study|Protocol Violation|1
4649429|NCT02070978|7529859|FG001|Overall Study|Protocol Violation|0
4649430|NCT02070978|7529860|FG002|Overall Study|Protocol Violation|3
4649431|NCT02070978|7529858|FG000|Overall Study|Lack of Efficacy|0
4649432|NCT02070978|7529859|FG001|Overall Study|Lack of Efficacy|1
4649433|NCT02070978|7529860|FG002|Overall Study|Lack of Efficacy|0
4649434|NCT02070978|7529858|FG000|Overall Study|Death|0
4649435|NCT02070978|7529859|FG001|Overall Study|Death|0
4649436|NCT02070978|7529860|FG002|Overall Study|Death|2
4649437|NCT02070978|7529858|FG000|Overall Study|Un-specified|3
4649438|NCT02070978|7529859|FG001|Overall Study|Un-specified|2
4649439|NCT02070978|7529860|FG002|Overall Study|Un-specified|2
4649440|NCT02070978|7529858|FG000|Overall Study|Terminated by Sponsor|33
4649441|NCT02070978|7529859|FG001|Overall Study|Terminated by Sponsor|40
4649442|NCT02070978|7529860|FG002|Overall Study|Terminated by Sponsor|39
4649443|NCT02070991|7529870|FG000|Overall Study|Death|2
4649444|NCT02070991|7529871|FG001|Overall Study|Death|0
4649445|NCT02070991|7529870|FG000|Overall Study|Withdrawal by Subject|1
4649446|NCT02070991|7529871|FG001|Overall Study|Withdrawal by Subject|0
4649447|NCT02071082|7529879|FG000|Overall Study|Enrolled and Never Treated|1
4649448|NCT02071082|7529880|FG001|Overall Study|Enrolled and Never Treated|1
4649449|NCT02071082|7529879|FG000|Overall Study|Adverse Event|0
4649450|NCT02071082|7529880|FG001|Overall Study|Adverse Event|1
4649451|NCT02071082|7529879|FG000|Overall Study|Withdrew Consent|0
4649452|NCT02071082|7529880|FG001|Overall Study|Withdrew Consent|4
4649453|NCT02071082|7529879|FG000|Overall Study|Lost to Follow-up|1
4649454|NCT02071082|7529880|FG001|Overall Study|Lost to Follow-up|1
4649455|NCT02071225|7529904|FG000|Overall Study|Withdrawal of Consent|2
4649456|NCT02071225|7529904|FG000|Overall Study|Protocol Deviation|1
4649457|NCT02071225|7529904|FG000|Overall Study|Lost to Follow-up|2
4649458|NCT02071225|7529904|FG000|Overall Study|Death|25
4649459|NCT02071290|7529910|FG000|Overall Study|Death|1
4649460|NCT02071290|7529911|FG001|Overall Study|Death|0
4649461|NCT02071290|7529910|FG000|Overall Study|Withdrawal by Subject|0
4649462|NCT02071290|7529911|FG001|Overall Study|Withdrawal by Subject|1
4649463|NCT02071290|7529910|FG000|Overall Study|Protocol Violation|3
4649464|NCT02071290|7529911|FG001|Overall Study|Protocol Violation|5
4649465|NCT02071290|7529910|FG000|Overall Study|Physician Decision|0
4649466|NCT02071290|7529911|FG001|Overall Study|Physician Decision|1
4747802|NCT00548093|7721900|FG000|Overall Study|Death|33
4747803|NCT00548093|7721901|FG001|Overall Study|Death|13
4747804|NCT00548093|7721900|FG000|Overall Study|Lost to Follow-up|3
4747805|NCT00548093|7721901|FG001|Overall Study|Lost to Follow-up|1
4747806|NCT00548093|7721900|FG000|Overall Study|Objective progression or relapse|1
4747807|NCT00548093|7721901|FG001|Overall Study|Objective progression or relapse|1
4747808|NCT00548093|7721900|FG000|Overall Study|Other|11
4747809|NCT00548093|7721901|FG001|Overall Study|Other|1
4747810|NCT00548093|7721900|FG000|Overall Study|Withdrawal by Subject|1
4747811|NCT00548093|7721901|FG001|Overall Study|Withdrawal by Subject|0
4747812|NCT00548093|7721900|FG000|Overall Study|Completed post-treatment follow-up|1
4747813|NCT00548093|7721901|FG001|Overall Study|Completed post-treatment follow-up|0
4649467|NCT02071706|7529926|FG000|Overall Study|Adverse Event|1
4649468|NCT02071706|7529926|FG000|Overall Study|Withdrawal by Subject|2
4649469|NCT02071771|7529930|FG000|Period 1: First 10 Days|Unacceptable lens fit|1
4649470|NCT02071771|7529931|FG001|Period 1: First 10 Days|Unacceptable lens fit|0
4649471|NCT02071771|7529930|FG000|Period 1: First 10 Days|Unavailable lens power|1
4649472|NCT02071771|7529931|FG001|Period 1: First 10 Days|Unavailable lens power|0
4649473|NCT02071849|7529969|FG000|6-month Primary Endpoint|Did not receive device|4
4649474|NCT02071849|7529969|FG000|6-month Primary Endpoint|Adverse Event|1
4649475|NCT02071849|7529969|FG000|2-year Extended Follow-up|Adverse Event|1
4649476|NCT02072096|7529988|FG000|Overall Study|Lack of Efficacy|18
4649477|NCT02072096|7529989|FG001|Overall Study|Lack of Efficacy|29
4649478|NCT02072096|7529988|FG000|Overall Study|Protocol Violation|7
4649479|NCT02072096|7529989|FG001|Overall Study|Protocol Violation|7
4649480|NCT02072096|7529988|FG000|Overall Study|Withdrawal by Subject|5
4649481|NCT02072096|7529989|FG001|Overall Study|Withdrawal by Subject|7
4649482|NCT02072096|7529988|FG000|Overall Study|Adverse Event|5
4649483|NCT02072096|7529989|FG001|Overall Study|Adverse Event|2
4649484|NCT02072096|7529988|FG000|Overall Study|No Reason Provided|4
4649485|NCT02072096|7529989|FG001|Overall Study|No Reason Provided|2
4649486|NCT02072096|7529988|FG000|Overall Study|Death|2
4649487|NCT02072096|7529989|FG001|Overall Study|Death|0
4649488|NCT02072096|7529988|FG000|Overall Study|Physician Decision|0
4649489|NCT02072096|7529989|FG001|Overall Study|Physician Decision|1
4649490|NCT02072096|7529988|FG000|Overall Study|Study Terminated by Sponsor|43
4649491|NCT02072096|7529989|FG001|Overall Study|Study Terminated by Sponsor|30
4649492|NCT02072096|7529988|FG000|Overall Study|Lost to Follow-up|1
4649493|NCT02072096|7529989|FG001|Overall Study|Lost to Follow-up|0
4649494|NCT02072174|7529998|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14
4649495|NCT02072174|7529999|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15
4649496|NCT02072174|7529998|FG000|Overall Study|Protocol Violation|16
4649497|NCT02072174|7529999|FG001|Overall Study|Protocol Violation|23
4649498|NCT02072174|7529998|FG000|Overall Study|Physician Decision|0
4649499|NCT02072174|7529999|FG001|Overall Study|Physician Decision|1
4649500|NCT02072174|7529998|FG000|Overall Study|Non-compliance with protocol requirement|2
4649501|NCT02072174|7529999|FG001|Overall Study|Non-compliance with protocol requirement|0
4649502|NCT02072226|7530013|FG000|Overall Study|Lost to Follow-up|11
4649503|NCT02072226|7530014|FG001|Overall Study|Lost to Follow-up|7
4649504|NCT02072226|7530013|FG000|Overall Study|Patient Non-compliance|2
4649505|NCT02072226|7530014|FG001|Overall Study|Patient Non-compliance|3
4649506|NCT02072226|7530013|FG000|Overall Study|Death|1
4649507|NCT02072226|7530014|FG001|Overall Study|Death|0
4649508|NCT02072226|7530013|FG000|Overall Study|Patient Withdrawal of Consent|1
4649509|NCT02072226|7530014|FG001|Overall Study|Patient Withdrawal of Consent|0
4649510|NCT02072434|7530027|FG000|Overall Study|Protocol Violation|10
4649511|NCT02072434|7530028|FG001|Overall Study|Protocol Violation|9
4649512|NCT02072434|7530027|FG000|Overall Study|Physician Decision|5
4649513|NCT02072434|7530028|FG001|Overall Study|Physician Decision|10
4649514|NCT02072434|7530027|FG000|Overall Study|Adverse event, serious fatal|1
4649515|NCT02072434|7530028|FG001|Overall Study|Adverse event, serious fatal|6
4649516|NCT02072434|7530027|FG000|Overall Study|Adverse Event|7
4649517|NCT02072434|7530028|FG001|Overall Study|Adverse Event|6
4649518|NCT02072434|7530027|FG000|Overall Study|Withdrawal by Subject|17
4649519|NCT02072434|7530028|FG001|Overall Study|Withdrawal by Subject|29
4649520|NCT02072434|7530027|FG000|Overall Study|Other|14
4649521|NCT02072434|7530028|FG001|Overall Study|Other|29
4649522|NCT02072434|7530027|FG000|Overall Study|Lost to Follow-up|0
4649523|NCT02072434|7530028|FG001|Overall Study|Lost to Follow-up|1
4649524|NCT02072668|7530034|FG000|Second Intervention|Lost to Follow-up|1
4649525|NCT02072668|7530035|FG001|Second Intervention|Lost to Follow-up|0
4649526|NCT02072824|7530046|FG000|Overall Study|Insufficient clinical response|1
4649527|NCT02072824|7530047|FG001|Overall Study|Insufficient clinical response|0
4649528|NCT02072824|7530048|FG002|Overall Study|Insufficient clinical response|1
4649529|NCT02072824|7530046|FG000|Overall Study|No longer willing to participate|1
4649530|NCT02072824|7530047|FG001|Overall Study|No longer willing to participate|0
4649531|NCT02072824|7530048|FG002|Overall Study|No longer willing to participate|1
4649532|NCT02072824|7530046|FG000|Overall Study|Medication error|0
4649533|NCT02072824|7530047|FG001|Overall Study|Medication error|1
4649534|NCT02072824|7530048|FG002|Overall Study|Medication error|0
4649535|NCT02072824|7530046|FG000|Overall Study|Adverse Event|0
4649536|NCT02072824|7530047|FG001|Overall Study|Adverse Event|0
4649537|NCT02072824|7530048|FG002|Overall Study|Adverse Event|1
4649538|NCT02072941|7530062|FG000|Overall Study|Withdrawal by Subject|29
4649539|NCT02072941|7530063|FG001|Overall Study|Withdrawal by Subject|21
4649540|NCT02072941|7530062|FG000|Overall Study|Lost to Follow-up|4
4649541|NCT02072941|7530063|FG001|Overall Study|Lost to Follow-up|4
4649542|NCT02072941|7530062|FG000|Overall Study|Death|3
4649543|NCT02072941|7530063|FG001|Overall Study|Death|2
4649544|NCT02072941|7530062|FG000|Overall Study|Removed by Study Staff|2
4649545|NCT02072941|7530063|FG001|Overall Study|Removed by Study Staff|2
4649546|NCT02072980|7530069|FG000|Period 2, Second Wear|Adverse Event|0
4649547|NCT02072980|7530070|FG001|Period 2, Second Wear|Adverse Event|1
4649548|NCT02073565|7530138|FG000|Cohort A|Withdrawal by Subject|1
4649549|NCT02073565|7530139|FG001|Cohort A|Withdrawal by Subject|0
4649550|NCT02073565|7530138|FG000|Cohort B|Withdrawal by Subject|1
4649551|NCT02073565|7530139|FG001|Cohort B|Withdrawal by Subject|2
4649552|NCT02073565|7530138|FG000|Cohort C|Withdrawal by Subject|0
4649553|NCT02073565|7530139|FG001|Cohort C|Withdrawal by Subject|2
4649554|NCT02073565|7530138|FG000|Cohort C|Lost to Follow-up|0
4649555|NCT02073565|7530139|FG001|Cohort C|Lost to Follow-up|2
4649556|NCT02073643|7530145|FG000|Overall Study|Lost to Follow-up|24
4649557|NCT02073656|7530149|FG000|Primary Study|Lost to Follow-up|6
4649558|NCT02073656|7530149|FG000|Primary Study|Death|1
4649559|NCT02073656|7530149|FG000|Primary Study|Withdrew Consent|1
4649560|NCT02073682|7530157|FG000|Overall Study|Low Creatinine Clearance|1
4649561|NCT02073682|7530158|FG001|Overall Study|Low Creatinine Clearance|2
4649562|NCT02073682|7530157|FG000|Overall Study|Death|86
4649563|NCT02073682|7530158|FG001|Overall Study|Death|100
4649564|NCT02073682|7530157|FG000|Overall Study|Cancer Cured|10
4649565|NCT02073682|7530158|FG001|Overall Study|Cancer Cured|15
4649566|NCT02073682|7530157|FG000|Overall Study|ID: Patient Noncompliance|1
4649567|NCT02073682|7530158|FG001|Overall Study|ID: Patient Noncompliance|2
4649568|NCT02073682|7530157|FG000|Overall Study|ID: Palliative Treatment Only|10
4649569|NCT02073682|7530158|FG001|Overall Study|ID: Palliative Treatment Only|7
4649570|NCT02073682|7530157|FG000|Overall Study|Prohibited Concomitant Medication Use|0
4649571|NCT02073682|7530158|FG001|Overall Study|Prohibited Concomitant Medication Use|1
4649572|NCT02073682|7530157|FG000|Overall Study|Platelet Count <50,000/mL|1
4649573|NCT02073682|7530158|FG001|Overall Study|Platelet Count <50,000/mL|2
4649574|NCT02073682|7530157|FG000|Overall Study|Surgery/Medical Procedure|3
4649575|NCT02073682|7530158|FG001|Overall Study|Surgery/Medical Procedure|1
4649576|NCT02073682|7530157|FG000|Overall Study|Withdrawal by Subject|6
4649577|NCT02073682|7530158|FG001|Overall Study|Withdrawal by Subject|8
4649578|NCT02073682|7530157|FG000|Overall Study|Start of New Chemotherapy Regimen|6
4649579|NCT02073682|7530158|FG001|Overall Study|Start of New Chemotherapy Regimen|3
4649580|NCT02073682|7530157|FG000|Overall Study|Cancer Progression|53
4649581|NCT02073682|7530158|FG001|Overall Study|Cancer Progression|33
4649582|NCT02073682|7530157|FG000|Overall Study|Protocol Violation|1
4649583|NCT02073682|7530158|FG001|Overall Study|Protocol Violation|0
4649584|NCT02073682|7530157|FG000|Overall Study|Adverse Event|79
4649585|NCT02073682|7530158|FG001|Overall Study|Adverse Event|62
4649586|NCT02073682|7530157|FG000|Overall Study|No reason provided|11
4649587|NCT02073682|7530158|FG001|Overall Study|No reason provided|9
4649588|NCT02073682|7530157|FG000|Overall Study|PD: Inconvenience of Dosing|21
4649589|NCT02073682|7530158|FG001|Overall Study|PD: Inconvenience of Dosing|78
4649590|NCT02073682|7530157|FG000|Overall Study|Lost to Follow-up|1
4649591|NCT02073682|7530158|FG001|Overall Study|Lost to Follow-up|1
4649592|NCT02073682|7530157|FG000|Overall Study|ID: Benefit/Risk Judgment|32
4649593|NCT02073682|7530158|FG001|Overall Study|ID: Benefit/Risk Judgment|46
4649594|NCT02073929|7530175|FG000|Overall Study|Lost to Follow-up|2
4649595|NCT02073929|7530176|FG001|Overall Study|Lost to Follow-up|1
4649596|NCT02073929|7530175|FG000|Overall Study|Adverse Event|2
4649597|NCT02073929|7530176|FG001|Overall Study|Adverse Event|1
4649598|NCT02073929|7530175|FG000|Overall Study|Withdrawal by Subject|0
4649599|NCT02073929|7530176|FG001|Overall Study|Withdrawal by Subject|1
4649600|NCT02074059|7530188|FG000|Overall Study|Death|0
4649601|NCT02074059|7530189|FG001|Overall Study|Death|0
4649602|NCT02074059|7530190|FG002|Overall Study|Death|0
4649603|NCT02074059|7530191|FG003|Overall Study|Death|0
4649604|NCT02074059|7530192|FG004|Overall Study|Death|1
4649605|NCT02074059|7530193|FG005|Overall Study|Death|1
4649606|NCT02074514|7530242|FG000|Overall Study|Lack of Efficacy|3
4649607|NCT02074514|7530243|FG001|Overall Study|Lack of Efficacy|2
4649608|NCT02074514|7530242|FG000|Overall Study|Lost to Follow-up|0
4649609|NCT02074514|7530243|FG001|Overall Study|Lost to Follow-up|1
4649610|NCT02074514|7530242|FG000|Overall Study|Withdrew Consent|0
4649611|NCT02074514|7530243|FG001|Overall Study|Withdrew Consent|1
4649612|NCT02074553|7530255|FG000|Intervention Period 1|Family Emergency|0
4649613|NCT02074553|7530256|FG001|Intervention Period 1|Family Emergency|0
4649614|NCT02074553|7530257|FG002|Intervention Period 1|Family Emergency|0
4649615|NCT02074553|7530258|FG003|Intervention Period 1|Family Emergency|1
4649616|NCT02074553|7530259|FG004|Intervention Period 1|Family Emergency|0
4649617|NCT02074553|7530260|FG005|Intervention Period 1|Family Emergency|0
4649618|NCT02074553|7530261|FG006|Intervention Period 1|Family Emergency|0
4649619|NCT02074553|7530262|FG007|Intervention Period 1|Family Emergency|0
4649620|NCT02074553|7530255|FG000|Washout Period 1|Adverse Event|1
4649621|NCT02074553|7530256|FG001|Washout Period 1|Adverse Event|0
4649622|NCT02074553|7530257|FG002|Washout Period 1|Adverse Event|0
4649623|NCT02074553|7530258|FG003|Washout Period 1|Adverse Event|0
4649624|NCT02074553|7530259|FG004|Washout Period 1|Adverse Event|0
4649625|NCT02074553|7530260|FG005|Washout Period 1|Adverse Event|0
4649626|NCT02074553|7530261|FG006|Washout Period 1|Adverse Event|0
4649627|NCT02074553|7530262|FG007|Washout Period 1|Adverse Event|0
4649628|NCT02074553|7530255|FG000|Washout Period 1|Physician Decision|0
4649629|NCT02074553|7530256|FG001|Washout Period 1|Physician Decision|0
4649630|NCT02074553|7530257|FG002|Washout Period 1|Physician Decision|0
4649631|NCT02074553|7530258|FG003|Washout Period 1|Physician Decision|1
4649632|NCT02074553|7530259|FG004|Washout Period 1|Physician Decision|0
4649633|NCT02074553|7530260|FG005|Washout Period 1|Physician Decision|0
4649634|NCT02074553|7530261|FG006|Washout Period 1|Physician Decision|0
4649635|NCT02074553|7530262|FG007|Washout Period 1|Physician Decision|0
4649636|NCT02074553|7530255|FG000|Washout Period 1|Other|0
4649637|NCT02074553|7530256|FG001|Washout Period 1|Other|0
4649638|NCT02074553|7530257|FG002|Washout Period 1|Other|0
4649639|NCT02074553|7530258|FG003|Washout Period 1|Other|0
4649640|NCT02074553|7530259|FG004|Washout Period 1|Other|0
4649641|NCT02074553|7530260|FG005|Washout Period 1|Other|1
4649642|NCT02074553|7530261|FG006|Washout Period 1|Other|0
4649643|NCT02074553|7530262|FG007|Washout Period 1|Other|0
4649644|NCT02074553|7530255|FG000|Washout Period 2|Adverse Event|0
4649645|NCT02074553|7530256|FG001|Washout Period 2|Adverse Event|0
4649646|NCT02074553|7530257|FG002|Washout Period 2|Adverse Event|0
4649647|NCT02074553|7530258|FG003|Washout Period 2|Adverse Event|0
4649648|NCT02074553|7530259|FG004|Washout Period 2|Adverse Event|0
4649649|NCT02074553|7530260|FG005|Washout Period 2|Adverse Event|0
4649650|NCT02074553|7530261|FG006|Washout Period 2|Adverse Event|1
4649651|NCT02074553|7530262|FG007|Washout Period 2|Adverse Event|0
4649652|NCT02074553|7530255|FG000|Washout Period 2|Physician Decision|0
4649653|NCT02074553|7530256|FG001|Washout Period 2|Physician Decision|0
4649654|NCT02074553|7530257|FG002|Washout Period 2|Physician Decision|0
4649655|NCT02074553|7530258|FG003|Washout Period 2|Physician Decision|0
4649656|NCT02074553|7530259|FG004|Washout Period 2|Physician Decision|0
4649657|NCT02074553|7530260|FG005|Washout Period 2|Physician Decision|1
4649658|NCT02074553|7530261|FG006|Washout Period 2|Physician Decision|0
4649659|NCT02074553|7530262|FG007|Washout Period 2|Physician Decision|0
4649660|NCT02074553|7530255|FG000|Washout Period 2|Lost to Follow-up|0
4649661|NCT02074553|7530256|FG001|Washout Period 2|Lost to Follow-up|0
4649662|NCT02074553|7530257|FG002|Washout Period 2|Lost to Follow-up|1
4649663|NCT02074553|7530258|FG003|Washout Period 2|Lost to Follow-up|0
4649664|NCT02074553|7530259|FG004|Washout Period 2|Lost to Follow-up|0
4649665|NCT02074553|7530260|FG005|Washout Period 2|Lost to Follow-up|0
4649666|NCT02074553|7530261|FG006|Washout Period 2|Lost to Follow-up|0
4649667|NCT02074553|7530262|FG007|Washout Period 2|Lost to Follow-up|0
4649668|NCT02074553|7530255|FG000|Washout Period 3|Physician Decision|0
4649669|NCT02074553|7530256|FG001|Washout Period 3|Physician Decision|0
4649670|NCT02074553|7530257|FG002|Washout Period 3|Physician Decision|0
4649671|NCT02074553|7530258|FG003|Washout Period 3|Physician Decision|0
4649672|NCT02074553|7530259|FG004|Washout Period 3|Physician Decision|0
4649673|NCT02074553|7530260|FG005|Washout Period 3|Physician Decision|0
4649674|NCT02074553|7530261|FG006|Washout Period 3|Physician Decision|0
4649675|NCT02074553|7530262|FG007|Washout Period 3|Physician Decision|1
4649676|NCT02074982|7530300|FG000|Overall Study|Adverse Event|15
4649677|NCT02074982|7530301|FG001|Overall Study|Adverse Event|7
4649678|NCT02074982|7530300|FG000|Overall Study|Lack of Efficacy|6
4649679|NCT02074982|7530301|FG001|Overall Study|Lack of Efficacy|1
4649680|NCT02074982|7530300|FG000|Overall Study|Lost to Follow-up|9
4649681|NCT02074982|7530301|FG001|Overall Study|Lost to Follow-up|10
4649682|NCT02074982|7530300|FG000|Overall Study|Non-compliance with study treatment|0
4649683|NCT02074982|7530301|FG001|Overall Study|Non-compliance with study treatment|2
4649684|NCT02074982|7530300|FG000|Overall Study|Physician Decision|1
4649685|NCT02074982|7530301|FG001|Overall Study|Physician Decision|1
4649686|NCT02074982|7530300|FG000|Overall Study|Pregnancy|1
4649687|NCT02074982|7530301|FG001|Overall Study|Pregnancy|2
4649688|NCT02074982|7530300|FG000|Overall Study|Protocol deviation|4
4649689|NCT02074982|7530301|FG001|Overall Study|Protocol deviation|3
4649690|NCT02074982|7530300|FG000|Overall Study|Technical problems|0
4649691|NCT02074982|7530301|FG001|Overall Study|Technical problems|2
4649692|NCT02074982|7530300|FG000|Overall Study|Subject/guardian decision|15
4649693|NCT02074982|7530301|FG001|Overall Study|Subject/guardian decision|24
4649694|NCT02074982|7530300|FG000|Overall Study|Death|0
4649695|NCT02074982|7530301|FG001|Overall Study|Death|2
4649696|NCT02075008|7530313|FG000|Overall Study|Technical problems|1
4649697|NCT02075008|7530313|FG000|Overall Study|Pregnancy|1
4649698|NCT02075008|7530313|FG000|Overall Study|Physician Decision|1
4649699|NCT02075008|7530313|FG000|Overall Study|Lost to Follow-up|1
4649700|NCT02075008|7530313|FG000|Overall Study|Lack of Efficacy|1
4649701|NCT02075008|7530313|FG000|Overall Study|Death|1
4649702|NCT02075008|7530313|FG000|Overall Study|Adverse Event|5
4649703|NCT02075008|7530313|FG000|Overall Study|Withdrawal by Subject|6
4649704|NCT02075008|7530313|FG000|Overall Study|Study terminated by Sponsor|159
4649705|NCT02075047|7530319|FG000|Treatment Phase (4 Weeks)|Adverse Event|14
4649706|NCT02075047|7530320|FG001|Treatment Phase (4 Weeks)|Adverse Event|4
4649707|NCT02075047|7530319|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2
4649708|NCT02075047|7530320|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2
4649709|NCT02075047|7530319|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0
4649710|NCT02075047|7530320|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1
4649711|NCT02075047|7530319|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1
4649712|NCT02075047|7530320|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0
4649713|NCT02075047|7530319|FG000|Treatment Phase (4 Weeks)|Screen Failure|1
4649714|NCT02075047|7530320|FG001|Treatment Phase (4 Weeks)|Screen Failure|0
4649715|NCT02075047|7530319|FG000|Treatment Phase (4 Weeks)|Other|1
4649716|NCT02075047|7530320|FG001|Treatment Phase (4 Weeks)|Other|1
4649717|NCT02075047|7530319|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4
4649718|NCT02075047|7530320|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2
4649719|NCT02075047|7530319|FG000|Follow up Phase (5 Weeks)|Adverse Event|14
4649720|NCT02075047|7530320|FG001|Follow up Phase (5 Weeks)|Adverse Event|4
4649721|NCT02075047|7530319|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2
4649722|NCT02075047|7530320|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2
4649723|NCT02075047|7530319|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0
4649724|NCT02075047|7530320|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1
4649725|NCT02075047|7530319|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1
4649726|NCT02075047|7530320|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0
4649727|NCT02075047|7530319|FG000|Follow up Phase (5 Weeks)|Screen Failure|1
4649728|NCT02075047|7530320|FG001|Follow up Phase (5 Weeks)|Screen Failure|0
4649729|NCT02075047|7530319|FG000|Follow up Phase (5 Weeks)|Other|1
4649730|NCT02075047|7530320|FG001|Follow up Phase (5 Weeks)|Other|2
4649731|NCT02075047|7530319|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7
4649732|NCT02075047|7530320|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4
4649733|NCT02075073|7530329|FG000|Overall Study|Withdrawal by Subject|0
4649734|NCT02075073|7530330|FG001|Overall Study|Withdrawal by Subject|1
4649735|NCT02075073|7530331|FG002|Overall Study|Withdrawal by Subject|0
4649736|NCT02075203|7530351|FG000|Overall Study|Withdrawal by Subject|1
4649737|NCT02075203|7530352|FG001|Overall Study|Withdrawal by Subject|0
4649738|NCT02075203|7530353|FG002|Overall Study|Withdrawal by Subject|1
4649739|NCT02075203|7530351|FG000|Overall Study|Adverse Event|1
4649740|NCT02075203|7530352|FG001|Overall Study|Adverse Event|0
4649741|NCT02075203|7530353|FG002|Overall Study|Adverse Event|0
4649742|NCT02075203|7530351|FG000|Overall Study|participant refused to use contraception|1
4649743|NCT02075203|7530352|FG001|Overall Study|participant refused to use contraception|0
4649744|NCT02075203|7530353|FG002|Overall Study|participant refused to use contraception|0
4649745|NCT02075255|7530364|FG000|Overall Study|Study specific withdrawal criteria|0
4649746|NCT02075255|7530365|FG001|Overall Study|Study specific withdrawal criteria|1
4649747|NCT02075255|7530366|FG002|Overall Study|Study specific withdrawal criteria|1
4649748|NCT02075255|7530364|FG000|Overall Study|Withdrawal by Subject|4
4649749|NCT02075255|7530365|FG001|Overall Study|Withdrawal by Subject|1
4649750|NCT02075255|7530366|FG002|Overall Study|Withdrawal by Subject|0
4649751|NCT02075255|7530364|FG000|Overall Study|Lost to Follow-up|0
4649752|NCT02075255|7530365|FG001|Overall Study|Lost to Follow-up|0
4649753|NCT02075255|7530366|FG002|Overall Study|Lost to Follow-up|1
4649754|NCT02075255|7530364|FG000|Overall Study|Adverse Event|0
4649755|NCT02075255|7530365|FG001|Overall Study|Adverse Event|0
4649756|NCT02075255|7530366|FG002|Overall Study|Adverse Event|1
4649757|NCT02075255|7530364|FG000|Overall Study|Death|0
4649758|NCT02075255|7530365|FG001|Overall Study|Death|2
4649759|NCT02075255|7530366|FG002|Overall Study|Death|0
4649760|NCT02075320|7530374|FG000|Overall Study|Withdrawal by Subject|2
4649761|NCT02075463|7530378|FG000|Overall Study|Adverse Event|3
4649762|NCT02075463|7530378|FG000|Overall Study|Par. reached stopping criteria|4
4649763|NCT02075463|7530378|FG000|Overall Study|Withdrawal by Subject|1
4649764|NCT02075476|7530385|FG000|Overall Study|Death|2
4649765|NCT02075476|7530386|FG001|Overall Study|Death|2
4649766|NCT02075476|7530385|FG000|Overall Study|Lost to Follow-up|1
4649767|NCT02075476|7530386|FG001|Overall Study|Lost to Follow-up|3
4649768|NCT02075515|7530395|FG000|Overall Study|Serious Adverse Event|1
4649769|NCT02075515|7530396|FG001|Overall Study|Serious Adverse Event|1
4649770|NCT02075515|7530397|FG002|Overall Study|Serious Adverse Event|1
4649771|NCT02075515|7530395|FG000|Overall Study|Non-Serious Adverse Event|0
4649772|NCT02075515|7530396|FG001|Overall Study|Non-Serious Adverse Event|1
4649773|NCT02075515|7530397|FG002|Overall Study|Non-Serious Adverse Event|0
4649774|NCT02075515|7530395|FG000|Overall Study|Withdrawal by Subject|2
4649775|NCT02075515|7530396|FG001|Overall Study|Withdrawal by Subject|0
4649776|NCT02075515|7530397|FG002|Overall Study|Withdrawal by Subject|1
4649777|NCT02075515|7530395|FG000|Overall Study|Lost to Follow-up|1
4649778|NCT02075515|7530396|FG001|Overall Study|Lost to Follow-up|3
4649779|NCT02075515|7530397|FG002|Overall Study|Lost to Follow-up|6
4649780|NCT02075541|7530408|FG000|Overall Study|Serious Adverse Event|1
4649781|NCT02075541|7530409|FG001|Overall Study|Serious Adverse Event|4
4649782|NCT02075541|7530408|FG000|Overall Study|Protocol Violation|1
4649783|NCT02075541|7530409|FG001|Overall Study|Protocol Violation|0
4649784|NCT02075541|7530408|FG000|Overall Study|Withdrawal by Subject|1
4649785|NCT02075541|7530409|FG001|Overall Study|Withdrawal by Subject|3
4649786|NCT02075541|7530408|FG000|Overall Study|Sponsor study termination|0
4649787|NCT02075541|7530409|FG001|Overall Study|Sponsor study termination|1
4649788|NCT02075541|7530408|FG000|Overall Study|Other- unable to perform study procedure|1
4649789|NCT02075541|7530409|FG001|Overall Study|Other- unable to perform study procedure|0
4649790|NCT02075554|7530415|FG000|Overall Study|Lost to Follow-up|7
4649791|NCT02075554|7530415|FG000|Overall Study|Withdrawal by Subject|5
4649792|NCT02075554|7530415|FG000|Overall Study|Physician Decision|3
4649793|NCT02075606|7530419|FG000|Overall Study|Adverse Event|5
4649794|NCT02075606|7530419|FG000|Overall Study|Withdrawal by Subject|1
4649795|NCT02075606|7530419|FG000|Overall Study|Death|1
4649796|NCT02075606|7530419|FG000|Overall Study|Investigator's decision|1
4649797|NCT02075606|7530419|FG000|Overall Study|Symptom management|1
4649798|NCT02075606|7530419|FG000|Overall Study|Increasing Symptoms|1
4649799|NCT02075632|7530430|FG000|Overall Study|Adverse Event|1
4649800|NCT02075632|7530431|FG001|Overall Study|Adverse Event|1
4649801|NCT02075632|7530430|FG000|Overall Study|Lost to Follow-up|0
4649802|NCT02075632|7530431|FG001|Overall Study|Lost to Follow-up|3
4649803|NCT02075632|7530430|FG000|Overall Study|Withdrawal by Subject|0
4649804|NCT02075632|7530431|FG001|Overall Study|Withdrawal by Subject|1
4649805|NCT02075658|7530439|FG000|Overall Study|Physician Decision|2
4649806|NCT02075658|7530440|FG001|Overall Study|Physician Decision|2
4649807|NCT02076022|7530448|FG000|Overall Study|Withdrawal by Subject|2
4649808|NCT02076022|7530449|FG001|Overall Study|Withdrawal by Subject|0
4649809|NCT02076113|7530490|FG000|Overall Study|Lost to Follow-up|4
4649810|NCT02076113|7530491|FG001|Overall Study|Lost to Follow-up|1
4649811|NCT02076113|7530490|FG000|Overall Study|Withdrawal by Subject|2
4649812|NCT02076113|7530491|FG001|Overall Study|Withdrawal by Subject|3
4649813|NCT02076113|7530490|FG000|Overall Study|Death|1
4649814|NCT02076113|7530491|FG001|Overall Study|Death|3
4649815|NCT02076165|7530510|FG000|Overall Study|Lost to Follow-up|7
4649816|NCT02076165|7530511|FG001|Overall Study|Lost to Follow-up|5
4649817|NCT02076165|7530510|FG000|Overall Study|Refused follow-up assessment|1
4649818|NCT02076165|7530511|FG001|Overall Study|Refused follow-up assessment|1
4649819|NCT02076334|7530534|FG000|Overall Study|Protocol Violation|1
4649820|NCT02076334|7530535|FG001|Overall Study|Protocol Violation|0
4649821|NCT02076334|7530536|FG002|Overall Study|Protocol Violation|0
4649822|NCT02076334|7530537|FG003|Overall Study|Protocol Violation|0
4649823|NCT02076334|7530534|FG000|Overall Study|Lost to Follow-up|0
4649824|NCT02076334|7530535|FG001|Overall Study|Lost to Follow-up|1
4649825|NCT02076334|7530536|FG002|Overall Study|Lost to Follow-up|1
4649826|NCT02076334|7530537|FG003|Overall Study|Lost to Follow-up|0
4649827|NCT02076334|7530534|FG000|Overall Study|muscle soreness|0
4649828|NCT02076334|7530535|FG001|Overall Study|muscle soreness|0
4649829|NCT02076334|7530536|FG002|Overall Study|muscle soreness|0
4649830|NCT02076334|7530537|FG003|Overall Study|muscle soreness|1
4649831|NCT02077140|7530638|FG000|Overall Study|Lost to Follow-up|4
4649832|NCT02077140|7530639|FG001|Overall Study|Lost to Follow-up|1
4649833|NCT02077140|7530640|FG002|Overall Study|Lost to Follow-up|2
4649834|NCT02077140|7530641|FG003|Overall Study|Lost to Follow-up|2
4649835|NCT02077140|7530642|FG004|Overall Study|Lost to Follow-up|3
4649836|NCT02077140|7530638|FG000|Overall Study|Withdrawal by Subject|0
4649837|NCT02077140|7530639|FG001|Overall Study|Withdrawal by Subject|1
4649838|NCT02077140|7530640|FG002|Overall Study|Withdrawal by Subject|0
4649839|NCT02077140|7530641|FG003|Overall Study|Withdrawal by Subject|2
4649840|NCT02077140|7530642|FG004|Overall Study|Withdrawal by Subject|2
4649841|NCT02077374|7530659|FG000|Overall Study|Withdrawal by Subject|0
4649842|NCT02077374|7530660|FG001|Overall Study|Withdrawal by Subject|1
4649843|NCT02077374|7530659|FG000|Overall Study|Protocol Violation|0
4649844|NCT02077374|7530660|FG001|Overall Study|Protocol Violation|1
4649845|NCT02077465|7530671|FG000|Overall Study|Withdrew Consent|0
4649846|NCT02077465|7530672|FG001|Overall Study|Withdrew Consent|1
4649847|NCT02077465|7530671|FG000|Overall Study|Lost to Follow-up|1
4649848|NCT02077465|7530672|FG001|Overall Study|Lost to Follow-up|0
4649849|NCT02078102|7530680|FG000|Overall Study|Adverse Event|1
4649850|NCT02078102|7530681|FG001|Overall Study|Adverse Event|0
4649851|NCT02078102|7530680|FG000|Overall Study|Withdrawal by Subject|1
4649852|NCT02078102|7530681|FG001|Overall Study|Withdrawal by Subject|0
4649853|NCT02078102|7530680|FG000|Overall Study|Physician Decision|0
4649854|NCT02078102|7530681|FG001|Overall Study|Physician Decision|1
4649855|NCT02078219|7530707|FG000|Overall Study|Other|2
4649856|NCT02078219|7530708|FG001|Overall Study|Other|2
4649857|NCT02078219|7530709|FG002|Overall Study|Other|3
4649858|NCT02078219|7530710|FG003|Overall Study|Other|0
4649859|NCT02078219|7530711|FG004|Overall Study|Other|1
4649860|NCT02078219|7530707|FG000|Overall Study|Withdrawal by Subject|0
4649861|NCT02078219|7530708|FG001|Overall Study|Withdrawal by Subject|1
4649862|NCT02078219|7530709|FG002|Overall Study|Withdrawal by Subject|0
4649863|NCT02078219|7530710|FG003|Overall Study|Withdrawal by Subject|1
4649864|NCT02078219|7530711|FG004|Overall Study|Withdrawal by Subject|1
4649865|NCT02078219|7530707|FG000|Overall Study|Protocol Violation|0
4649866|NCT02078219|7530708|FG001|Overall Study|Protocol Violation|0
4649867|NCT02078219|7530709|FG002|Overall Study|Protocol Violation|0
4649868|NCT02078219|7530710|FG003|Overall Study|Protocol Violation|1
4649869|NCT02078219|7530711|FG004|Overall Study|Protocol Violation|0
4649870|NCT02078219|7530707|FG000|Overall Study|Death|0
4649871|NCT02078219|7530708|FG001|Overall Study|Death|0
4649872|NCT02078219|7530709|FG002|Overall Study|Death|0
4649873|NCT02078219|7530710|FG003|Overall Study|Death|1
4649874|NCT02078219|7530711|FG004|Overall Study|Death|0
4649875|NCT02078219|7530707|FG000|Overall Study|Adverse Event|1
4649876|NCT02078219|7530708|FG001|Overall Study|Adverse Event|1
4649877|NCT02078219|7530709|FG002|Overall Study|Adverse Event|3
4649878|NCT02078219|7530710|FG003|Overall Study|Adverse Event|1
4649879|NCT02078219|7530711|FG004|Overall Study|Adverse Event|0
4649880|NCT02078713|7530765|FG000|Overall Study|Lost to Follow-up|49
4649881|NCT02078713|7530766|FG001|Overall Study|Lost to Follow-up|55
4649882|NCT02078713|7530767|FG002|Overall Study|Lost to Follow-up|0
4649883|NCT02078713|7530768|FG003|Overall Study|Lost to Follow-up|0
4649884|NCT02078713|7530765|FG000|Overall Study|Pregnant at baseline|3
4649885|NCT02078713|7530766|FG001|Overall Study|Pregnant at baseline|5
4649886|NCT02078713|7530767|FG002|Overall Study|Pregnant at baseline|0
4649887|NCT02078713|7530768|FG003|Overall Study|Pregnant at baseline|0
4649888|NCT02078713|7530765|FG000|Overall Study|Enrolled twice|0
4649889|NCT02078713|7530766|FG001|Overall Study|Enrolled twice|1
4649890|NCT02078713|7530767|FG002|Overall Study|Enrolled twice|0
4649891|NCT02078713|7530768|FG003|Overall Study|Enrolled twice|0
4747814|NCT00554606|7721910|FG000|Overall Study|Adverse Event|3
4747815|NCT00554606|7721910|FG000|Overall Study|Abnormal laboratory values|1
4747816|NCT00554606|7721910|FG000|Overall Study|Unsatisfactory therapeutic effect|14
4747817|NCT00554606|7721910|FG000|Overall Study|Subject withdrew consent|2
4747818|NCT00554606|7721910|FG000|Overall Study|Lost to Follow-up|2
4649892|NCT02078752|7530799|FG000|Overall Study|Death|0
4649893|NCT02078752|7530800|FG001|Overall Study|Death|3
4649894|NCT02078752|7530801|FG002|Overall Study|Death|0
4649895|NCT02078752|7530802|FG003|Overall Study|Death|0
4649896|NCT02078752|7530803|FG004|Overall Study|Death|0
4649897|NCT02078752|7530804|FG005|Overall Study|Death|1
4649898|NCT02078752|7530805|FG006|Overall Study|Death|0
4649899|NCT02078752|7530806|FG007|Overall Study|Death|1
4649900|NCT02078752|7530807|FG008|Overall Study|Death|0
4649901|NCT02078752|7530808|FG009|Overall Study|Death|4
4649902|NCT02078752|7530799|FG000|Overall Study|Lost to Follow-up|1
4649903|NCT02078752|7530800|FG001|Overall Study|Lost to Follow-up|0
4649904|NCT02078752|7530801|FG002|Overall Study|Lost to Follow-up|0
4649905|NCT02078752|7530802|FG003|Overall Study|Lost to Follow-up|1
4649906|NCT02078752|7530803|FG004|Overall Study|Lost to Follow-up|0
4649907|NCT02078752|7530804|FG005|Overall Study|Lost to Follow-up|0
4649908|NCT02078752|7530805|FG006|Overall Study|Lost to Follow-up|0
4649909|NCT02078752|7530806|FG007|Overall Study|Lost to Follow-up|0
4649910|NCT02078752|7530807|FG008|Overall Study|Lost to Follow-up|0
4649911|NCT02078752|7530808|FG009|Overall Study|Lost to Follow-up|0
4649912|NCT02078752|7530799|FG000|Overall Study|Withdrawal by Subject|1
4649913|NCT02078752|7530800|FG001|Overall Study|Withdrawal by Subject|1
4649914|NCT02078752|7530801|FG002|Overall Study|Withdrawal by Subject|1
4649915|NCT02078752|7530802|FG003|Overall Study|Withdrawal by Subject|1
4649916|NCT02078752|7530803|FG004|Overall Study|Withdrawal by Subject|0
4649917|NCT02078752|7530804|FG005|Overall Study|Withdrawal by Subject|3
4649918|NCT02078752|7530805|FG006|Overall Study|Withdrawal by Subject|2
4649919|NCT02078752|7530806|FG007|Overall Study|Withdrawal by Subject|1
4649920|NCT02078752|7530807|FG008|Overall Study|Withdrawal by Subject|0
4649921|NCT02078752|7530808|FG009|Overall Study|Withdrawal by Subject|1
4649922|NCT02078752|7530799|FG000|Overall Study|Other|0
4649923|NCT02078752|7530800|FG001|Overall Study|Other|3
4649924|NCT02078752|7530801|FG002|Overall Study|Other|0
4649925|NCT02078752|7530802|FG003|Overall Study|Other|0
4649926|NCT02078752|7530803|FG004|Overall Study|Other|1
4649927|NCT02078752|7530804|FG005|Overall Study|Other|0
4649928|NCT02078752|7530805|FG006|Overall Study|Other|0
4649929|NCT02078752|7530806|FG007|Overall Study|Other|1
4649930|NCT02078752|7530807|FG008|Overall Study|Other|0
4649931|NCT02078752|7530808|FG009|Overall Study|Other|0
4649932|NCT02078752|7530799|FG000|Overall Study|Study terminated by sponsor|0
4649933|NCT02078752|7530800|FG001|Overall Study|Study terminated by sponsor|0
4649934|NCT02078752|7530801|FG002|Overall Study|Study terminated by sponsor|0
4649935|NCT02078752|7530802|FG003|Overall Study|Study terminated by sponsor|0
4649936|NCT02078752|7530803|FG004|Overall Study|Study terminated by sponsor|0
4649937|NCT02078752|7530804|FG005|Overall Study|Study terminated by sponsor|0
4649938|NCT02078752|7530805|FG006|Overall Study|Study terminated by sponsor|0
4649939|NCT02078752|7530806|FG007|Overall Study|Study terminated by sponsor|0
4649940|NCT02078752|7530807|FG008|Overall Study|Study terminated by sponsor|0
4649941|NCT02078752|7530808|FG009|Overall Study|Study terminated by sponsor|5
4649942|NCT02078817|7530839|FG000|Overall Study|Withdrawal by Subject|1
4649943|NCT02078960|7530850|FG000|Treatment Period|Other|0
4649944|NCT02078960|7530851|FG001|Treatment Period|Other|0
4649945|NCT02078960|7530852|FG002|Treatment Period|Other|1
4649946|NCT02078960|7530850|FG000|Treatment Period|Lack of Efficacy|0
4649947|NCT02078960|7530851|FG001|Treatment Period|Lack of Efficacy|1
4649948|NCT02078960|7530852|FG002|Treatment Period|Lack of Efficacy|0
4649949|NCT02078960|7530850|FG000|Treatment Period|Disease progression - accelerated phase|0
4649950|NCT02078960|7530851|FG001|Treatment Period|Disease progression - accelerated phase|1
4649951|NCT02078960|7530852|FG002|Treatment Period|Disease progression - accelerated phase|0
4649952|NCT02078960|7530850|FG000|Treatment Period|Disease progression - blast phase|1
4649953|NCT02078960|7530851|FG001|Treatment Period|Disease progression - blast phase|0
4649954|NCT02078960|7530852|FG002|Treatment Period|Disease progression - blast phase|0
4649955|NCT02078960|7530850|FG000|Treatment Period|Withdrawal by Subject|0
4649956|NCT02078960|7530851|FG001|Treatment Period|Withdrawal by Subject|1
4649957|NCT02078960|7530852|FG002|Treatment Period|Withdrawal by Subject|1
4649958|NCT02078960|7530850|FG000|Treatment Period|Adverse Event|1
4649959|NCT02078960|7530851|FG001|Treatment Period|Adverse Event|0
4649960|NCT02078960|7530852|FG002|Treatment Period|Adverse Event|0
4649961|NCT02078960|7530850|FG000|Treatment Period|Death|0
4649962|NCT02078960|7530851|FG001|Treatment Period|Death|0
4649963|NCT02078960|7530852|FG002|Treatment Period|Death|1
4649964|NCT02078960|7530850|FG000|Follow-up Period|Death|2
4649965|NCT02078960|7530851|FG001|Follow-up Period|Death|0
4649966|NCT02078960|7530852|FG002|Follow-up Period|Death|0
4649967|NCT02078960|7530850|FG000|Follow-up Period|Lost to Follow-up|0
4649968|NCT02078960|7530851|FG001|Follow-up Period|Lost to Follow-up|1
4649969|NCT02078960|7530852|FG002|Follow-up Period|Lost to Follow-up|0
4649970|NCT02079038|7530874|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6
4649971|NCT02079038|7530875|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5
4649972|NCT02079038|7530874|FG000|Modified Intent to Treat Population|Death|1
4649973|NCT02079038|7530875|FG001|Modified Intent to Treat Population|Death|0
4649974|NCT02079038|7530874|FG000|Completed 6 Months|Lost to Follow-up|2
4649975|NCT02079038|7530875|FG001|Completed 6 Months|Lost to Follow-up|1
4649976|NCT02079077|7530883|FG000|Overall Study|Lost to Follow-up|5
4649977|NCT02079077|7530884|FG001|Overall Study|Lost to Follow-up|7
4649978|NCT02079077|7530883|FG000|Overall Study|Became STIs Positive|1
4649979|NCT02079077|7530884|FG001|Overall Study|Became STIs Positive|2
4649980|NCT02079246|7530890|FG000|OLEX|Withdrawal before treatment|1
4649981|NCT02079246|7530891|FG001|OLEX|Withdrawal before treatment|0
4649982|NCT02079246|7530890|FG000|OLEX|Death|11
4649983|NCT02079246|7530891|FG001|OLEX|Death|0
4649984|NCT02079246|7530890|FG000|OLEX|Adverse Event|66
4649985|NCT02079246|7530891|FG001|OLEX|Adverse Event|0
4649986|NCT02079246|7530890|FG000|OLEX|Withdrawal by Subject|60
4649987|NCT02079246|7530891|FG001|OLEX|Withdrawal by Subject|0
4649988|NCT02079246|7530890|FG000|OLEX|Lost to Follow-up|6
4649989|NCT02079246|7530891|FG001|OLEX|Lost to Follow-up|0
4649990|NCT02079246|7530890|FG000|OLEX|Protocol Violation|6
4649991|NCT02079246|7530891|FG001|OLEX|Protocol Violation|0
4649992|NCT02079246|7530890|FG000|OLEX|Lack of Efficacy|3
4649993|NCT02079246|7530891|FG001|OLEX|Lack of Efficacy|0
4649994|NCT02079246|7530890|FG000|OLEX|Results of the lead-in studies|58
4649995|NCT02079246|7530891|FG001|OLEX|Results of the lead-in studies|0
4649996|NCT02079246|7530890|FG000|OLEX|Other: Disallowed medication|8
4649997|NCT02079246|7530891|FG001|OLEX|Other: Disallowed medication|0
4649998|NCT02079246|7530890|FG000|OLEX|Other: Insufficient compliance|2
4649999|NCT02079246|7530891|FG001|OLEX|Other: Insufficient compliance|0
4650000|NCT02079246|7530890|FG000|OLEX|Other: Caregiver unavailable|3
4650001|NCT02079246|7530891|FG001|OLEX|Other: Caregiver unavailable|0
4650002|NCT02079246|7530890|FG000|OLEX|Other: Coordinator decision|1
4650003|NCT02079246|7530891|FG001|OLEX|Other: Coordinator decision|0
4650004|NCT02079246|7530890|FG000|OLEX|Other: Worsening of condition|1
4650005|NCT02079246|7530891|FG001|OLEX|Other: Worsening of condition|0
4650006|NCT02079246|7530890|FG000|OLEX|Other: Moved to nursing home|1
4650007|NCT02079246|7530891|FG001|OLEX|Other: Moved to nursing home|0
4650008|NCT02079246|7530890|FG000|OLEX|Other: Withdrawal of caregiver consent|1
4650009|NCT02079246|7530891|FG001|OLEX|Other: Withdrawal of caregiver consent|0
4650010|NCT02079246|7530890|FG000|OLEX-MEM|Adverse Event|0
4650011|NCT02079246|7530891|FG001|OLEX-MEM|Adverse Event|6
4650012|NCT02079246|7530890|FG000|OLEX-MEM|Withdrawal by Subject|0
4650013|NCT02079246|7530891|FG001|OLEX-MEM|Withdrawal by Subject|7
4650014|NCT02079246|7530890|FG000|OLEX-MEM|Protocol Violation|0
4650015|NCT02079246|7530891|FG001|OLEX-MEM|Protocol Violation|2
4650016|NCT02079246|7530890|FG000|OLEX-MEM|Lost to Follow-up|0
4650017|NCT02079246|7530891|FG001|OLEX-MEM|Lost to Follow-up|1
4650018|NCT02079246|7530890|FG000|OLEX-MEM|Other: Moved to nursing home|0
4650019|NCT02079246|7530891|FG001|OLEX-MEM|Other: Moved to nursing home|3
4650020|NCT02079519|7530909|FG000|Overall Study|Disease Progression|9
4650021|NCT02079519|7530909|FG000|Overall Study|Adverse Event|1
4650022|NCT02079532|7530913|FG000|Overall Study|Adverse Event|7
4650023|NCT02079532|7530913|FG000|Overall Study|Additional or changed therapy|2
4650024|NCT02079532|7530913|FG000|Overall Study|Lack of Efficacy|9
4650025|NCT02079532|7530913|FG000|Overall Study|Protocol Violation|3
4650026|NCT02079532|7530913|FG000|Overall Study|Withdrawal by Subject|1
4650027|NCT02079532|7530913|FG000|Overall Study|Administrative problems|1
4650028|NCT02079532|7530913|FG000|Overall Study|Inclusion into ReFIRST|3
4650029|NCT02079532|7530913|FG000|Overall Study|Other|3
4650030|NCT02079610|7530919|FG000|Overall Study|Withdrawal by Subject|1
4650031|NCT02079610|7530920|FG001|Overall Study|Withdrawal by Subject|1
4650032|NCT02079636|7530941|FG000|Overall Study|Death|2
4650033|NCT02079636|7530942|FG001|Overall Study|Death|1
4650034|NCT02079636|7530943|FG002|Overall Study|Death|0
4650035|NCT02079636|7530944|FG003|Overall Study|Death|5
4650036|NCT02079636|7530945|FG004|Overall Study|Death|1
4650037|NCT02079636|7530946|FG005|Overall Study|Death|2
4650038|NCT02079636|7530947|FG006|Overall Study|Death|1
4650039|NCT02079636|7530948|FG007|Overall Study|Death|0
4650040|NCT02079636|7530949|FG008|Overall Study|Death|0
4650041|NCT02079636|7530950|FG009|Overall Study|Death|0
4650042|NCT02079636|7530951|FG010|Overall Study|Death|0
4747819|NCT00554606|7721910|FG000|Overall Study|Administrative problems|60
4650043|NCT02079636|7530952|FG011|Overall Study|Death|1
4650044|NCT02079636|7530953|FG012|Overall Study|Death|1
4650045|NCT02079636|7530954|FG013|Overall Study|Death|0
4650046|NCT02079636|7530955|FG014|Overall Study|Death|2
4650047|NCT02079636|7530941|FG000|Overall Study|Adverse Event|1
4650048|NCT02079636|7530942|FG001|Overall Study|Adverse Event|1
4650049|NCT02079636|7530943|FG002|Overall Study|Adverse Event|0
4650050|NCT02079636|7530944|FG003|Overall Study|Adverse Event|1
4650051|NCT02079636|7530945|FG004|Overall Study|Adverse Event|1
4650052|NCT02079636|7530946|FG005|Overall Study|Adverse Event|2
4650053|NCT02079636|7530947|FG006|Overall Study|Adverse Event|0
4650054|NCT02079636|7530948|FG007|Overall Study|Adverse Event|0
4650055|NCT02079636|7530949|FG008|Overall Study|Adverse Event|0
4650056|NCT02079636|7530950|FG009|Overall Study|Adverse Event|0
4650057|NCT02079636|7530951|FG010|Overall Study|Adverse Event|0
4650058|NCT02079636|7530952|FG011|Overall Study|Adverse Event|0
4650059|NCT02079636|7530953|FG012|Overall Study|Adverse Event|0
4650060|NCT02079636|7530954|FG013|Overall Study|Adverse Event|0
4650061|NCT02079636|7530955|FG014|Overall Study|Adverse Event|0
4650062|NCT02079636|7530941|FG000|Overall Study|Progressive disease|0
4650063|NCT02079636|7530942|FG001|Overall Study|Progressive disease|0
4650064|NCT02079636|7530943|FG002|Overall Study|Progressive disease|0
4650065|NCT02079636|7530944|FG003|Overall Study|Progressive disease|2
4650066|NCT02079636|7530945|FG004|Overall Study|Progressive disease|0
4650067|NCT02079636|7530946|FG005|Overall Study|Progressive disease|0
4650068|NCT02079636|7530947|FG006|Overall Study|Progressive disease|0
4650069|NCT02079636|7530948|FG007|Overall Study|Progressive disease|0
4650070|NCT02079636|7530949|FG008|Overall Study|Progressive disease|0
4650071|NCT02079636|7530950|FG009|Overall Study|Progressive disease|0
4650072|NCT02079636|7530951|FG010|Overall Study|Progressive disease|0
4650073|NCT02079636|7530952|FG011|Overall Study|Progressive disease|0
4650074|NCT02079636|7530953|FG012|Overall Study|Progressive disease|1
4650075|NCT02079636|7530954|FG013|Overall Study|Progressive disease|0
4650076|NCT02079636|7530955|FG014|Overall Study|Progressive disease|0
4650077|NCT02079636|7530941|FG000|Overall Study|Withdrawal by Subject|0
4650078|NCT02079636|7530942|FG001|Overall Study|Withdrawal by Subject|0
4650079|NCT02079636|7530943|FG002|Overall Study|Withdrawal by Subject|0
4650080|NCT02079636|7530944|FG003|Overall Study|Withdrawal by Subject|4
4650081|NCT02079636|7530945|FG004|Overall Study|Withdrawal by Subject|0
4650082|NCT02079636|7530946|FG005|Overall Study|Withdrawal by Subject|1
4650083|NCT02079636|7530947|FG006|Overall Study|Withdrawal by Subject|0
4650084|NCT02079636|7530948|FG007|Overall Study|Withdrawal by Subject|0
4650085|NCT02079636|7530949|FG008|Overall Study|Withdrawal by Subject|0
4650086|NCT02079636|7530950|FG009|Overall Study|Withdrawal by Subject|2
4650087|NCT02079636|7530951|FG010|Overall Study|Withdrawal by Subject|1
4650088|NCT02079636|7530952|FG011|Overall Study|Withdrawal by Subject|1
4650089|NCT02079636|7530953|FG012|Overall Study|Withdrawal by Subject|1
4650090|NCT02079636|7530954|FG013|Overall Study|Withdrawal by Subject|0
4650091|NCT02079636|7530955|FG014|Overall Study|Withdrawal by Subject|2
4650092|NCT02079636|7530941|FG000|Overall Study|Physician Decision|0
4650093|NCT02079636|7530942|FG001|Overall Study|Physician Decision|0
4650094|NCT02079636|7530943|FG002|Overall Study|Physician Decision|0
4650095|NCT02079636|7530944|FG003|Overall Study|Physician Decision|0
4650096|NCT02079636|7530945|FG004|Overall Study|Physician Decision|0
4650097|NCT02079636|7530946|FG005|Overall Study|Physician Decision|1
4650098|NCT02079636|7530947|FG006|Overall Study|Physician Decision|0
4650099|NCT02079636|7530948|FG007|Overall Study|Physician Decision|0
4650100|NCT02079636|7530949|FG008|Overall Study|Physician Decision|0
4650101|NCT02079636|7530950|FG009|Overall Study|Physician Decision|1
4650102|NCT02079636|7530951|FG010|Overall Study|Physician Decision|1
4650103|NCT02079636|7530952|FG011|Overall Study|Physician Decision|0
4650104|NCT02079636|7530953|FG012|Overall Study|Physician Decision|0
4650105|NCT02079636|7530954|FG013|Overall Study|Physician Decision|0
4650106|NCT02079636|7530955|FG014|Overall Study|Physician Decision|1
4650107|NCT02079636|7530941|FG000|Overall Study|Lost to Follow-up|0
4650108|NCT02079636|7530942|FG001|Overall Study|Lost to Follow-up|0
4650109|NCT02079636|7530943|FG002|Overall Study|Lost to Follow-up|0
4650110|NCT02079636|7530944|FG003|Overall Study|Lost to Follow-up|0
4650111|NCT02079636|7530945|FG004|Overall Study|Lost to Follow-up|0
4650112|NCT02079636|7530946|FG005|Overall Study|Lost to Follow-up|0
4650113|NCT02079636|7530947|FG006|Overall Study|Lost to Follow-up|0
4650114|NCT02079636|7530948|FG007|Overall Study|Lost to Follow-up|1
4650115|NCT02079636|7530949|FG008|Overall Study|Lost to Follow-up|0
4650116|NCT02079636|7530950|FG009|Overall Study|Lost to Follow-up|0
4650117|NCT02079636|7530951|FG010|Overall Study|Lost to Follow-up|0
4650118|NCT02079636|7530952|FG011|Overall Study|Lost to Follow-up|0
4650119|NCT02079636|7530953|FG012|Overall Study|Lost to Follow-up|0
4650120|NCT02079636|7530954|FG013|Overall Study|Lost to Follow-up|0
4650121|NCT02079636|7530955|FG014|Overall Study|Lost to Follow-up|0
4650122|NCT02079649|7531023|FG000|Overall Study|Lost to Follow-up|0
4650123|NCT02079649|7531024|FG001|Overall Study|Lost to Follow-up|0
4650124|NCT02079649|7531025|FG002|Overall Study|Lost to Follow-up|0
4650125|NCT02079649|7531026|FG003|Overall Study|Lost to Follow-up|1
4650126|NCT02079649|7531023|FG000|Overall Study|Withdrawal by Subject|0
4650127|NCT02079649|7531024|FG001|Overall Study|Withdrawal by Subject|0
4650128|NCT02079649|7531025|FG002|Overall Study|Withdrawal by Subject|0
4650129|NCT02079649|7531026|FG003|Overall Study|Withdrawal by Subject|1
4650130|NCT02079649|7531023|FG000|Overall Study|Randomization error (prior to treatment)|1
4650131|NCT02079649|7531024|FG001|Overall Study|Randomization error (prior to treatment)|0
4650132|NCT02079649|7531025|FG002|Overall Study|Randomization error (prior to treatment)|1
4650133|NCT02079649|7531026|FG003|Overall Study|Randomization error (prior to treatment)|0
4650134|NCT02079805|7531039|FG000|Overall Study|Pretreatment Event/Adverse Event|0
4650135|NCT02079805|7531040|FG001|Overall Study|Pretreatment Event/Adverse Event|1
4650136|NCT02079805|7531039|FG000|Overall Study|Voluntary Withdrawal|0
4650137|NCT02079805|7531040|FG001|Overall Study|Voluntary Withdrawal|1
4650138|NCT02079844|7531049|FG000|Treatment Period 1|Voluntary Withdrawal|0
4650139|NCT02079844|7531050|FG001|Treatment Period 1|Voluntary Withdrawal|0
4650140|NCT02079844|7531051|FG002|Treatment Period 1|Voluntary Withdrawal|2
4650141|NCT02079844|7531049|FG000|Treatment Period 2|Voluntary Withdrawal|0
4650142|NCT02079844|7531050|FG001|Treatment Period 2|Voluntary Withdrawal|1
4650143|NCT02079844|7531051|FG002|Treatment Period 2|Voluntary Withdrawal|0
4650144|NCT02079909|7531065|FG000|Overall Study|Adverse Event|23
4650145|NCT02079909|7531066|FG001|Overall Study|Adverse Event|23
4650146|NCT02079909|7531067|FG002|Overall Study|Adverse Event|7
4650147|NCT02079909|7531065|FG000|Overall Study|Withdrawal by Subject|9
4650148|NCT02079909|7531066|FG001|Overall Study|Withdrawal by Subject|17
4650149|NCT02079909|7531067|FG002|Overall Study|Withdrawal by Subject|4
4650150|NCT02079909|7531065|FG000|Overall Study|Lost to Follow-up|2
4650151|NCT02079909|7531066|FG001|Overall Study|Lost to Follow-up|3
4650152|NCT02079909|7531067|FG002|Overall Study|Lost to Follow-up|1
4650153|NCT02079909|7531065|FG000|Overall Study|Death|2
4650154|NCT02079909|7531066|FG001|Overall Study|Death|2
4650155|NCT02079909|7531067|FG002|Overall Study|Death|0
4650156|NCT02079909|7531065|FG000|Overall Study|Lack of Efficacy|0
4650157|NCT02079909|7531066|FG001|Overall Study|Lack of Efficacy|0
4650158|NCT02079909|7531067|FG002|Overall Study|Lack of Efficacy|1
4650159|NCT02079909|7531065|FG000|Overall Study|Protocol Violation|0
4650160|NCT02079909|7531066|FG001|Overall Study|Protocol Violation|1
4650161|NCT02079909|7531067|FG002|Overall Study|Protocol Violation|1
4650162|NCT02079909|7531065|FG000|Overall Study|Physician Decision|0
4650163|NCT02079909|7531066|FG001|Overall Study|Physician Decision|1
4650164|NCT02079909|7531067|FG002|Overall Study|Physician Decision|1
4650165|NCT02079909|7531065|FG000|Overall Study|Relocation etc.|2
4650166|NCT02079909|7531066|FG001|Overall Study|Relocation etc.|2
4650167|NCT02079909|7531067|FG002|Overall Study|Relocation etc.|3
4650168|NCT02080091|7531085|FG000|Overall Study|Study Terminated|22
4650169|NCT02080091|7531085|FG000|Overall Study|Death|1
4650170|NCT02080091|7531085|FG000|Overall Study|Withdrawal by Subject|1
4650171|NCT02080091|7531085|FG000|Overall Study|Other|1
4747820|NCT00554606|7721910|FG000|Overall Study|Death|1
4747821|NCT00554606|7721910|FG000|Overall Study|Protocol deviation|2
4650172|NCT02080221|7531093|FG000|Overall Study|Withdrawal by Subject|1
4650173|NCT02080221|7531093|FG000|Overall Study|Clinical Progression of Disease|1
4650174|NCT02080364|7531119|FG000|Baseline Period|Protocol Violation|2
4650175|NCT02080364|7531120|FG001|Baseline Period|Protocol Violation|1
4650176|NCT02080364|7531121|FG002|Baseline Period|Protocol Violation|0
4650177|NCT02080364|7531122|FG003|Baseline Period|Protocol Violation|0
4650178|NCT02080364|7531119|FG000|Baseline Period|Other|0
4650179|NCT02080364|7531120|FG001|Baseline Period|Other|1
4650180|NCT02080364|7531121|FG002|Baseline Period|Other|1
4650181|NCT02080364|7531122|FG003|Baseline Period|Other|0
4650182|NCT02080364|7531119|FG000|Treatment Period|Adverse Event|10
4650183|NCT02080364|7531120|FG001|Treatment Period|Adverse Event|15
4650184|NCT02080364|7531121|FG002|Treatment Period|Adverse Event|11
4650185|NCT02080364|7531122|FG003|Treatment Period|Adverse Event|14
4650186|NCT02080364|7531119|FG000|Treatment Period|Lost to Follow-up|2
4650187|NCT02080364|7531120|FG001|Treatment Period|Lost to Follow-up|3
4650188|NCT02080364|7531121|FG002|Treatment Period|Lost to Follow-up|5
4650189|NCT02080364|7531122|FG003|Treatment Period|Lost to Follow-up|0
4650190|NCT02080364|7531119|FG000|Treatment Period|Protocol Violation|5
4650191|NCT02080364|7531120|FG001|Treatment Period|Protocol Violation|3
4650192|NCT02080364|7531121|FG002|Treatment Period|Protocol Violation|5
4650193|NCT02080364|7531122|FG003|Treatment Period|Protocol Violation|1
4650194|NCT02080364|7531119|FG000|Treatment Period|Withdrawal by Subject|16
4650195|NCT02080364|7531120|FG001|Treatment Period|Withdrawal by Subject|16
4650196|NCT02080364|7531121|FG002|Treatment Period|Withdrawal by Subject|15
4650197|NCT02080364|7531122|FG003|Treatment Period|Withdrawal by Subject|10
4650198|NCT02080364|7531119|FG000|Treatment Period|Study Terminated by Sponsor|0
4650199|NCT02080364|7531120|FG001|Treatment Period|Study Terminated by Sponsor|0
4650200|NCT02080364|7531121|FG002|Treatment Period|Study Terminated by Sponsor|180
4650201|NCT02080364|7531122|FG003|Treatment Period|Study Terminated by Sponsor|183
4650202|NCT02080364|7531119|FG000|Treatment Period|Other|14
4650203|NCT02080364|7531120|FG001|Treatment Period|Other|12
4650204|NCT02080364|7531121|FG002|Treatment Period|Other|21
4650205|NCT02080364|7531122|FG003|Treatment Period|Other|16
4650206|NCT02080403|7531134|FG000|Overall Study|Adverse Event|5
4650207|NCT02080403|7531135|FG001|Overall Study|Adverse Event|1
4650208|NCT02080403|7531134|FG000|Overall Study|Death|0
4650209|NCT02080403|7531135|FG001|Overall Study|Death|2
4650210|NCT02080403|7531134|FG000|Overall Study|Lost to Follow-up|2
4650211|NCT02080403|7531135|FG001|Overall Study|Lost to Follow-up|0
4650212|NCT02080403|7531134|FG000|Overall Study|Pregnancy|0
4650213|NCT02080403|7531135|FG001|Overall Study|Pregnancy|1
4650214|NCT02080403|7531134|FG000|Overall Study|Protocol Violation|3
4650215|NCT02080403|7531135|FG001|Overall Study|Protocol Violation|7
4650216|NCT02080403|7531134|FG000|Overall Study|Withdrawal by Subject|5
4650217|NCT02080403|7531135|FG001|Overall Study|Withdrawal by Subject|1
4650218|NCT02080481|7531176|FG000|Overall Study|Never received a block.|1
4650219|NCT02080481|7531177|FG001|Overall Study|Never received a block.|0
4650220|NCT02080832|7531233|FG000|Overall Study|Excluded from analysis by MRI|9
4650221|NCT02080832|7531234|FG001|Overall Study|Excluded from analysis by MRI|10
4650222|NCT02080832|7531235|FG002|Overall Study|Excluded from analysis by MRI|14
4650223|NCT02080832|7531233|FG000|Overall Study|Lost to Follow-up|0
4650224|NCT02080832|7531234|FG001|Overall Study|Lost to Follow-up|2
4650225|NCT02080832|7531235|FG002|Overall Study|Lost to Follow-up|2
4650226|NCT02080871|7531245|FG000|Overall Study|Death|1
4650227|NCT02080871|7531245|FG000|Overall Study|Lost to Follow-up|1
4650228|NCT02081001|7531251|FG000|Overall Study|Adverse Event|0
4650229|NCT02081001|7531252|FG001|Overall Study|Adverse Event|0
4650230|NCT02081001|7531253|FG002|Overall Study|Adverse Event|0
4650231|NCT02081001|7531254|FG003|Overall Study|Adverse Event|0
4650232|NCT02081001|7531255|FG004|Overall Study|Adverse Event|1
4650233|NCT02081001|7531256|FG005|Overall Study|Adverse Event|0
4650234|NCT02081001|7531257|FG006|Overall Study|Adverse Event|0
4650235|NCT02081001|7531258|FG007|Overall Study|Adverse Event|0
4650236|NCT02081001|7531259|FG008|Overall Study|Adverse Event|0
4650237|NCT02081001|7531260|FG009|Overall Study|Adverse Event|0
4650238|NCT02081001|7531261|FG010|Overall Study|Adverse Event|0
4650239|NCT02081001|7531262|FG011|Overall Study|Adverse Event|0
4650240|NCT02081079|7531299|FG000|Overall Study|Lack of Efficacy|3
4650241|NCT02081079|7531300|FG001|Overall Study|Lack of Efficacy|2
4650242|NCT02081079|7531299|FG000|Overall Study|Lost to Follow-up|1
4650243|NCT02081079|7531300|FG001|Overall Study|Lost to Follow-up|0
4650244|NCT02081196|7531310|FG000|Overall Study|Lost to Follow-up|1
4650245|NCT02081417|7531336|FG000|Overall Study|Lost to Follow-up|26
4650246|NCT02081417|7531337|FG001|Overall Study|Lost to Follow-up|23
4650247|NCT02081417|7531336|FG000|Overall Study|Moved Away|1
4650248|NCT02081417|7531337|FG001|Overall Study|Moved Away|2
4650249|NCT02081417|7531336|FG000|Overall Study|Incarcerated|2
4650250|NCT02081417|7531337|FG001|Overall Study|Incarcerated|2
4650251|NCT02081417|7531336|FG000|Overall Study|Death|4
4650252|NCT02081417|7531337|FG001|Overall Study|Death|3
4650253|NCT02081417|7531336|FG000|Overall Study|Withdrawal by Subject|4
4650254|NCT02081417|7531337|FG001|Overall Study|Withdrawal by Subject|0
4650255|NCT02081417|7531336|FG000|Overall Study|Admitted to Residential Treatment|2
4650256|NCT02081417|7531337|FG001|Overall Study|Admitted to Residential Treatment|0
4650257|NCT02081417|7531336|FG000|Overall Study|Did not start treatment|17
4650258|NCT02081417|7531337|FG001|Overall Study|Did not start treatment|21
4650259|NCT02081534|7531368|FG000|Overall Study|Adverse Event|5
4650260|NCT02081534|7531369|FG001|Overall Study|Adverse Event|4
4650261|NCT02081534|7531370|FG002|Overall Study|Adverse Event|3
4650262|NCT02081534|7531371|FG003|Overall Study|Adverse Event|10
4650263|NCT02081534|7531372|FG004|Overall Study|Adverse Event|2
4650264|NCT02081534|7531373|FG005|Overall Study|Adverse Event|8
4650265|NCT02081534|7531374|FG006|Overall Study|Adverse Event|2
4650266|NCT02081534|7531368|FG000|Overall Study|Withdrawal by Subject|0
4650267|NCT02081534|7531369|FG001|Overall Study|Withdrawal by Subject|1
4650268|NCT02081534|7531370|FG002|Overall Study|Withdrawal by Subject|1
4650269|NCT02081534|7531371|FG003|Overall Study|Withdrawal by Subject|1
4650270|NCT02081534|7531372|FG004|Overall Study|Withdrawal by Subject|1
4650271|NCT02081534|7531373|FG005|Overall Study|Withdrawal by Subject|0
4650272|NCT02081534|7531374|FG006|Overall Study|Withdrawal by Subject|1
4650273|NCT02081534|7531368|FG000|Overall Study|Protocol Violation|0
4650274|NCT02081534|7531369|FG001|Overall Study|Protocol Violation|3
4650275|NCT02081534|7531370|FG002|Overall Study|Protocol Violation|0
4650276|NCT02081534|7531371|FG003|Overall Study|Protocol Violation|0
4650277|NCT02081534|7531372|FG004|Overall Study|Protocol Violation|0
4650278|NCT02081534|7531373|FG005|Overall Study|Protocol Violation|0
4650279|NCT02081534|7531374|FG006|Overall Study|Protocol Violation|1
4650280|NCT02081534|7531368|FG000|Overall Study|Lost to Follow-up|0
4650281|NCT02081534|7531369|FG001|Overall Study|Lost to Follow-up|0
4650282|NCT02081534|7531370|FG002|Overall Study|Lost to Follow-up|0
4650283|NCT02081534|7531371|FG003|Overall Study|Lost to Follow-up|2
4650284|NCT02081534|7531372|FG004|Overall Study|Lost to Follow-up|1
4650285|NCT02081534|7531373|FG005|Overall Study|Lost to Follow-up|1
4650286|NCT02081534|7531374|FG006|Overall Study|Lost to Follow-up|0
4650287|NCT02081586|7531398|FG000|Overall Study|Lost to Follow-up|0
4650288|NCT02081586|7531399|FG001|Overall Study|Lost to Follow-up|1
4650289|NCT02081586|7531400|FG002|Overall Study|Lost to Follow-up|0
4650290|NCT02081586|7531401|FG003|Overall Study|Lost to Follow-up|1
4650291|NCT02081586|7531398|FG000|Overall Study|Head injury not related to study|0
4650292|NCT02081586|7531399|FG001|Overall Study|Head injury not related to study|0
4650293|NCT02081586|7531400|FG002|Overall Study|Head injury not related to study|1
4650294|NCT02081586|7531401|FG003|Overall Study|Head injury not related to study|0
4650295|NCT02081599|7531415|FG000|Period 1：Double-blind Period|Adverse Event|3
4650296|NCT02081599|7531416|FG001|Period 1：Double-blind Period|Adverse Event|0
4650297|NCT02081599|7531415|FG000|Period 1：Double-blind Period|Lack of Efficacy|2
4650298|NCT02081599|7531416|FG001|Period 1：Double-blind Period|Lack of Efficacy|1
4650299|NCT02081599|7531415|FG000|Period 1：Double-blind Period|Physician Decision|1
4650300|NCT02081599|7531416|FG001|Period 1：Double-blind Period|Physician Decision|0
4650301|NCT02081599|7531415|FG000|Period 1：Double-blind Period|Protocol Violation|0
4650302|NCT02081599|7531416|FG001|Period 1：Double-blind Period|Protocol Violation|1
4650303|NCT02081599|7531415|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1
4650304|NCT02081599|7531416|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0
4650305|NCT02081599|7531415|FG000|Period 1：Double-blind Period|stopping criteria|1
4650306|NCT02081599|7531416|FG001|Period 1：Double-blind Period|stopping criteria|0
4650307|NCT02081599|7531415|FG000|Period 2：Open-label Period|Adverse Event|1
4650308|NCT02081599|7531416|FG001|Period 2：Open-label Period|Adverse Event|0
4650309|NCT02081599|7531415|FG000|Period 2：Open-label Period|Lack of Efficacy|2
4650310|NCT02081599|7531416|FG001|Period 2：Open-label Period|Lack of Efficacy|4
4650311|NCT02081599|7531415|FG000|Period 2：Open-label Period|Physician Decision|1
4650312|NCT02081599|7531416|FG001|Period 2：Open-label Period|Physician Decision|0
4650313|NCT02081599|7531415|FG000|Period 2：Open-label Period|Withdrawal by Subject|2
4650314|NCT02081599|7531416|FG001|Period 2：Open-label Period|Withdrawal by Subject|0
4650315|NCT02081677|7531441|FG000|Overall Study|Adverse Event|0
4650316|NCT02081677|7531442|FG001|Overall Study|Adverse Event|0
4650317|NCT02081677|7531443|FG002|Overall Study|Adverse Event|1
4650318|NCT02081677|7531444|FG003|Overall Study|Adverse Event|0
4650319|NCT02081677|7531441|FG000|Overall Study|No Longer Meets Eligibility Criteria|0
4650320|NCT02081677|7531442|FG001|Overall Study|No Longer Meets Eligibility Criteria|0
4650321|NCT02081677|7531443|FG002|Overall Study|No Longer Meets Eligibility Criteria|1
4650322|NCT02081677|7531444|FG003|Overall Study|No Longer Meets Eligibility Criteria|0
4650323|NCT02081677|7531441|FG000|Overall Study|Not comfortable with lens care system|1
4650324|NCT02081677|7531442|FG001|Overall Study|Not comfortable with lens care system|0
4650325|NCT02081677|7531443|FG002|Overall Study|Not comfortable with lens care system|0
4650326|NCT02081677|7531444|FG003|Overall Study|Not comfortable with lens care system|0
4650327|NCT02081677|7531441|FG000|Overall Study|Unsatisfactory Lens Fitting|0
4650328|NCT02081677|7531442|FG001|Overall Study|Unsatisfactory Lens Fitting|1
4650329|NCT02081677|7531443|FG002|Overall Study|Unsatisfactory Lens Fitting|0
4650330|NCT02081677|7531444|FG003|Overall Study|Unsatisfactory Lens Fitting|0
4650331|NCT02081690|7531454|FG000|Overall Study|Death|3
4650332|NCT02081690|7531454|FG000|Overall Study|Physician Decision|3
4650333|NCT02081690|7531454|FG000|Overall Study|Withdrawal by Subject|1
4650334|NCT02081846|7531503|FG000|Overall Study|Withdrawal by Subject|1
4650335|NCT02081846|7531504|FG001|Overall Study|Withdrawal by Subject|0
4650336|NCT02081846|7531503|FG000|Overall Study|invalid consent|1
4747822|NCT00555009|7721918|FG000|Overall Study|Withdrawal by Subject|0
4650337|NCT02081846|7531504|FG001|Overall Study|invalid consent|0
4650338|NCT02081859|7531512|FG000|Overall Study|No fertilization|2
4650339|NCT02081859|7531513|FG001|Overall Study|No fertilization|2
4650340|NCT02081859|7531512|FG000|Overall Study|No sperm|1
4650341|NCT02081859|7531513|FG001|Overall Study|No sperm|0
4650342|NCT02081859|7531512|FG000|Overall Study|Unanticipated freeze all cycle|2
4650343|NCT02081859|7531513|FG001|Overall Study|Unanticipated freeze all cycle|6
4650344|NCT02081859|7531512|FG000|Overall Study|< 4 embryos|27
4650345|NCT02081859|7531513|FG001|Overall Study|< 4 embryos|23
4650346|NCT02081859|7531512|FG000|Overall Study|Other reasons|2
4650347|NCT02081859|7531513|FG001|Overall Study|Other reasons|0
4650348|NCT02082158|7531555|FG000|Overall Study|Withdrawal by Subject|0
4650349|NCT02082158|7531556|FG001|Overall Study|Withdrawal by Subject|0
4650350|NCT02082158|7531557|FG002|Overall Study|Withdrawal by Subject|0
4650351|NCT02082158|7531558|FG003|Overall Study|Withdrawal by Subject|0
4650352|NCT02082158|7531559|FG004|Overall Study|Withdrawal by Subject|1
4650353|NCT02082158|7531560|FG005|Overall Study|Withdrawal by Subject|0
4650354|NCT02082158|7531555|FG000|Overall Study|Failed Fit-testing|8
4650355|NCT02082158|7531556|FG001|Overall Study|Failed Fit-testing|8
4650356|NCT02082158|7531557|FG002|Overall Study|Failed Fit-testing|14
4650357|NCT02082158|7531558|FG003|Overall Study|Failed Fit-testing|4
4650358|NCT02082158|7531559|FG004|Overall Study|Failed Fit-testing|3
4650359|NCT02082158|7531560|FG005|Overall Study|Failed Fit-testing|7
4650360|NCT02082184|7531582|FG000|Overall Study|Adverse Event|1
4650361|NCT02082184|7531583|FG001|Overall Study|Adverse Event|0
4650362|NCT02082184|7531582|FG000|Overall Study|Medical diagnosis|1
4650363|NCT02082184|7531583|FG001|Overall Study|Medical diagnosis|2
4650364|NCT02082184|7531582|FG000|Overall Study|Device associated symptoms|5
4650365|NCT02082184|7531583|FG001|Overall Study|Device associated symptoms|0
4650366|NCT02082184|7531582|FG000|Overall Study|Withdrawal by Subject|3
4650367|NCT02082184|7531583|FG001|Overall Study|Withdrawal by Subject|2
4650368|NCT02082184|7531582|FG000|Overall Study|Protocol Violation|0
4650369|NCT02082184|7531583|FG001|Overall Study|Protocol Violation|6
4650370|NCT02082184|7531582|FG000|Overall Study|Lost to Follow-up|0
4650371|NCT02082184|7531583|FG001|Overall Study|Lost to Follow-up|2
4650372|NCT02082184|7531582|FG000|Overall Study|Subject non-compliance|0
4650373|NCT02082184|7531583|FG001|Overall Study|Subject non-compliance|1
4650374|NCT02082210|7531595|FG000|Overall Study|Death|0
4650375|NCT02082210|7531596|FG001|Overall Study|Death|0
4650376|NCT02082210|7531597|FG002|Overall Study|Death|1
4650377|NCT02082210|7531598|FG003|Overall Study|Death|1
4650378|NCT02082210|7531599|FG004|Overall Study|Death|1
4650379|NCT02082210|7531600|FG005|Overall Study|Death|0
4650380|NCT02082210|7531595|FG000|Overall Study|Withdrawal by Subject|0
4650381|NCT02082210|7531596|FG001|Overall Study|Withdrawal by Subject|0
4650382|NCT02082210|7531597|FG002|Overall Study|Withdrawal by Subject|0
4650383|NCT02082210|7531598|FG003|Overall Study|Withdrawal by Subject|1
4650384|NCT02082210|7531599|FG004|Overall Study|Withdrawal by Subject|2
4650385|NCT02082210|7531600|FG005|Overall Study|Withdrawal by Subject|2
4650386|NCT02082210|7531595|FG000|Overall Study|Clinical Progression|0
4650387|NCT02082210|7531596|FG001|Overall Study|Clinical Progression|0
4650388|NCT02082210|7531597|FG002|Overall Study|Clinical Progression|0
4650389|NCT02082210|7531598|FG003|Overall Study|Clinical Progression|1
4650390|NCT02082210|7531599|FG004|Overall Study|Clinical Progression|0
4650391|NCT02082210|7531600|FG005|Overall Study|Clinical Progression|0
4650392|NCT02082210|7531595|FG000|Overall Study|No Post-Baseline Tumor Assesment|0
4650393|NCT02082210|7531596|FG001|Overall Study|No Post-Baseline Tumor Assesment|0
4650394|NCT02082210|7531597|FG002|Overall Study|No Post-Baseline Tumor Assesment|1
4650395|NCT02082210|7531598|FG003|Overall Study|No Post-Baseline Tumor Assesment|2
4650396|NCT02082210|7531599|FG004|Overall Study|No Post-Baseline Tumor Assesment|0
4650397|NCT02082210|7531600|FG005|Overall Study|No Post-Baseline Tumor Assesment|0
4650398|NCT02082210|7531595|FG000|Overall Study|Physician Decision|0
4650399|NCT02082210|7531596|FG001|Overall Study|Physician Decision|0
4650400|NCT02082210|7531597|FG002|Overall Study|Physician Decision|1
4650401|NCT02082210|7531598|FG003|Overall Study|Physician Decision|1
4650402|NCT02082210|7531599|FG004|Overall Study|Physician Decision|0
4650403|NCT02082210|7531600|FG005|Overall Study|Physician Decision|0
4650404|NCT02082262|7531626|FG000|Overall Study|Withdrawal by Subject|3
4650405|NCT02082262|7531626|FG000|Overall Study|Adverse Event|48
4650406|NCT02082340|7531636|FG000|Overall Study|Lost to Follow-up|1
4650407|NCT02082340|7531637|FG001|Overall Study|Lost to Follow-up|1
4650408|NCT02082483|7531654|FG000|Overall Study|Lost to Follow-up|1
4650409|NCT02082483|7531655|FG001|Overall Study|Lost to Follow-up|1
4650410|NCT02082483|7531654|FG000|Overall Study|Withdrawal by Subject|2
4650411|NCT02082483|7531655|FG001|Overall Study|Withdrawal by Subject|1
4650412|NCT02082483|7531654|FG000|Overall Study|Physician Decision|1
4650413|NCT02082483|7531655|FG001|Overall Study|Physician Decision|1
4650414|NCT02082483|7531654|FG000|Overall Study|Death|2
4650415|NCT02082483|7531655|FG001|Overall Study|Death|3
4650416|NCT02082522|7531664|FG000|Overall Study|Sponsor termination|5
4650417|NCT02082522|7531665|FG001|Overall Study|Sponsor termination|3
4650418|NCT02082522|7531664|FG000|Overall Study|Withdrawal by Subject|2
4650419|NCT02082522|7531665|FG001|Overall Study|Withdrawal by Subject|4
4650420|NCT02082522|7531664|FG000|Overall Study|Death|1
4650421|NCT02082522|7531665|FG001|Overall Study|Death|0
4650422|NCT02082522|7531664|FG000|Overall Study|Lost to Follow-up|1
4650423|NCT02082522|7531665|FG001|Overall Study|Lost to Follow-up|0
4650424|NCT02082522|7531664|FG000|Overall Study|Physician Decision|3
4650425|NCT02082522|7531665|FG001|Overall Study|Physician Decision|1
4650426|NCT02082522|7531664|FG000|Overall Study|Disease progression|2
4650427|NCT02082522|7531665|FG001|Overall Study|Disease progression|2
4650428|NCT02082522|7531664|FG000|Overall Study|Chemotherapy change|1
4650429|NCT02082522|7531665|FG001|Overall Study|Chemotherapy change|3
4650430|NCT02082912|7531708|FG000|Overall Study|Physician Decision|0
4650431|NCT02082912|7531709|FG001|Overall Study|Physician Decision|1
4650432|NCT02082977|7531725|FG000|Part 1 (Up to 3.2 Years)|Death|1
4650433|NCT02082977|7531726|FG001|Part 1 (Up to 3.2 Years)|Death|0
4650434|NCT02082977|7531727|FG002|Part 1 (Up to 3.2 Years)|Death|0
4650435|NCT02082977|7531728|FG003|Part 1 (Up to 3.2 Years)|Death|0
4650436|NCT02082977|7531729|FG004|Part 1 (Up to 3.2 Years)|Death|0
4650437|NCT02082977|7531730|FG005|Part 1 (Up to 3.2 Years)|Death|1
4650438|NCT02082977|7531731|FG006|Part 1 (Up to 3.2 Years)|Death|2
4650439|NCT02082977|7531732|FG007|Part 1 (Up to 3.2 Years)|Death|0
4650440|NCT02082977|7531733|FG008|Part 1 (Up to 3.2 Years)|Death|1
4650441|NCT02082977|7531734|FG009|Part 1 (Up to 3.2 Years)|Death|0
4650442|NCT02082977|7531725|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
4650443|NCT02082977|7531726|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
4650444|NCT02082977|7531727|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
4650445|NCT02082977|7531728|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
4650446|NCT02082977|7531729|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
4650447|NCT02082977|7531730|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
4650448|NCT02082977|7531731|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
4650449|NCT02082977|7531732|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2
4650450|NCT02082977|7531733|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
4650451|NCT02082977|7531734|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
4650452|NCT02082977|7531725|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
4650453|NCT02082977|7531726|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
4650454|NCT02082977|7531727|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
4650455|NCT02082977|7531728|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
4650456|NCT02082977|7531729|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
4650457|NCT02082977|7531730|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1
4650458|NCT02082977|7531731|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
4650459|NCT02082977|7531732|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
4650460|NCT02082977|7531733|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
4650461|NCT02082977|7531734|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
4650462|NCT02082977|7531725|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0
4650463|NCT02082977|7531726|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0
4650464|NCT02082977|7531727|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0
4650465|NCT02082977|7531728|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0
4650466|NCT02082977|7531729|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1
4650467|NCT02082977|7531730|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1
4650468|NCT02082977|7531731|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4
4650469|NCT02082977|7531732|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1
4650470|NCT02082977|7531733|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2
4650471|NCT02082977|7531734|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0
4650472|NCT02082977|7531725|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
4650473|NCT02082977|7531726|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
4650474|NCT02082977|7531727|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
4650475|NCT02082977|7531728|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
4650476|NCT02082977|7531729|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
4650477|NCT02082977|7531730|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
4650478|NCT02082977|7531731|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
4650479|NCT02082977|7531732|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2
4650480|NCT02082977|7531733|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
4650481|NCT02082977|7531734|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
4650482|NCT02083185|7531782|FG000|Overall Study|Lost to Follow-up|0
4650483|NCT02083185|7531783|FG001|Overall Study|Lost to Follow-up|3
4650484|NCT02083185|7531784|FG002|Overall Study|Lost to Follow-up|0
4650485|NCT02083185|7531782|FG000|Overall Study|Withdrawal by Subject|9
4650486|NCT02083185|7531783|FG001|Overall Study|Withdrawal by Subject|15
4650487|NCT02083185|7531784|FG002|Overall Study|Withdrawal by Subject|1
4650488|NCT02083185|7531782|FG000|Overall Study|Death|2
4650489|NCT02083185|7531783|FG001|Overall Study|Death|2
4650490|NCT02083185|7531784|FG002|Overall Study|Death|1
4650491|NCT02083185|7531782|FG000|Overall Study|Reason not Specified|9
4650492|NCT02083185|7531783|FG001|Overall Study|Reason not Specified|6
4650493|NCT02083185|7531784|FG002|Overall Study|Reason not Specified|5
4747823|NCT00555009|7721919|FG001|Overall Study|Withdrawal by Subject|1
4650494|NCT02083185|7531782|FG000|Overall Study|Study Terminated by Sponsor|0
4650495|NCT02083185|7531783|FG001|Overall Study|Study Terminated by Sponsor|1
4650496|NCT02083185|7531784|FG002|Overall Study|Study Terminated by Sponsor|0
4650497|NCT02083185|7531782|FG000|Overall Study|Did not Receive Study Drug|0
4650498|NCT02083185|7531783|FG001|Overall Study|Did not Receive Study Drug|2
4650499|NCT02083185|7531784|FG002|Overall Study|Did not Receive Study Drug|0
4650500|NCT02083380|7531804|FG000|Overall Study|Lack of Efficacy|68
4650501|NCT02083380|7531805|FG001|Overall Study|Lack of Efficacy|79
4650502|NCT02083380|7531806|FG002|Overall Study|Lack of Efficacy|64
4650503|NCT02083380|7531804|FG000|Overall Study|Withdrawal by Subject|9
4650504|NCT02083380|7531805|FG001|Overall Study|Withdrawal by Subject|3
4650505|NCT02083380|7531806|FG002|Overall Study|Withdrawal by Subject|7
4650506|NCT02083380|7531804|FG000|Overall Study|Physician Decision|1
4650507|NCT02083380|7531805|FG001|Overall Study|Physician Decision|6
4650508|NCT02083380|7531806|FG002|Overall Study|Physician Decision|3
4650509|NCT02083380|7531804|FG000|Overall Study|Adverse Event|0
4650510|NCT02083380|7531805|FG001|Overall Study|Adverse Event|0
4650511|NCT02083380|7531806|FG002|Overall Study|Adverse Event|1
4650512|NCT02083380|7531804|FG000|Overall Study|Lost to Follow-up|5
4650513|NCT02083380|7531805|FG001|Overall Study|Lost to Follow-up|3
4650514|NCT02083380|7531806|FG002|Overall Study|Lost to Follow-up|3
4650515|NCT02083380|7531804|FG000|Overall Study|Other|8
4650516|NCT02083380|7531805|FG001|Overall Study|Other|4
4650517|NCT02083380|7531806|FG002|Overall Study|Other|6
4650518|NCT02083653|7531835|FG000|Overall Study|Randomized but not Treated|0
4650519|NCT02083653|7531836|FG001|Overall Study|Randomized but not Treated|2
4650520|NCT02083653|7531837|FG002|Overall Study|Randomized but not Treated|7
4650521|NCT02083653|7531835|FG000|Overall Study|Adverse Event|12
4650522|NCT02083653|7531836|FG001|Overall Study|Adverse Event|5
4650523|NCT02083653|7531837|FG002|Overall Study|Adverse Event|4
4650524|NCT02083653|7531835|FG000|Overall Study|Lost to Follow-up|1
4650525|NCT02083653|7531836|FG001|Overall Study|Lost to Follow-up|0
4650526|NCT02083653|7531837|FG002|Overall Study|Lost to Follow-up|0
4650527|NCT02083653|7531835|FG000|Overall Study|Death|2
4650528|NCT02083653|7531836|FG001|Overall Study|Death|2
4650529|NCT02083653|7531837|FG002|Overall Study|Death|2
4650530|NCT02083653|7531835|FG000|Overall Study|Progressive Disease|65
4650531|NCT02083653|7531836|FG001|Overall Study|Progressive Disease|73
4650532|NCT02083653|7531837|FG002|Overall Study|Progressive Disease|63
4650533|NCT02083653|7531835|FG000|Overall Study|Withdrawal by Subject|2
4650534|NCT02083653|7531836|FG001|Overall Study|Withdrawal by Subject|1
4650535|NCT02083653|7531837|FG002|Overall Study|Withdrawal by Subject|2
4650536|NCT02083653|7531835|FG000|Overall Study|Other Events|0
4650537|NCT02083653|7531836|FG001|Overall Study|Other Events|2
4650538|NCT02083653|7531837|FG002|Overall Study|Other Events|2
4650539|NCT02083653|7531835|FG000|Overall Study|Reason Missing|0
4650540|NCT02083653|7531836|FG001|Overall Study|Reason Missing|0
4650541|NCT02083653|7531837|FG002|Overall Study|Reason Missing|4
4650542|NCT02083783|7531864|FG000|Overall Study|Withdrawal by Subject|1
4650543|NCT02083783|7531865|FG001|Overall Study|Withdrawal by Subject|0
4650544|NCT02083926|7531895|FG000|Overall Study|Withdrawal by Subject|1
4650545|NCT02083926|7531896|FG001|Overall Study|Withdrawal by Subject|0
4650546|NCT02083965|7531905|FG000|Treatment Period|Other|1
4650547|NCT02083965|7531906|FG001|Treatment Period|Other|0
4650548|NCT02084056|7531916|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
4650549|NCT02084056|7531917|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
4650550|NCT02084056|7531918|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
4650551|NCT02084056|7531919|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
4650552|NCT02084056|7531916|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1
4650553|NCT02084056|7531917|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0
4650554|NCT02084056|7531918|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0
4650555|NCT02084056|7531919|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0
4650556|NCT02084082|7531940|FG000|Washout Period 1 (35 Days)|Adverse Event|0
4650557|NCT02084082|7531941|FG001|Washout Period 1 (35 Days)|Adverse Event|0
4650558|NCT02084082|7531942|FG002|Washout Period 1 (35 Days)|Adverse Event|1
4650559|NCT02084082|7531943|FG003|Washout Period 1 (35 Days)|Adverse Event|1
4650560|NCT02084082|7531940|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0
4650561|NCT02084082|7531941|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0
4650562|NCT02084082|7531942|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0
4650563|NCT02084082|7531943|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1
4650564|NCT02084134|7531955|FG000|Overall Study|Protocol Violation|4
4650565|NCT02084134|7531956|FG001|Overall Study|Protocol Violation|2
4650566|NCT02084134|7531955|FG000|Overall Study|Death|0
4650567|NCT02084134|7531956|FG001|Overall Study|Death|1
4650568|NCT02084238|7531966|FG000|Overall Study|Lost to Follow-up|2
4650569|NCT02085135|7532022|FG000|Overall Study|Adverse Event|4
4650570|NCT02085135|7532023|FG001|Overall Study|Adverse Event|7
4650571|NCT02085135|7532022|FG000|Overall Study|Lost to Follow-up|2
4650572|NCT02085135|7532023|FG001|Overall Study|Lost to Follow-up|2
4650573|NCT02085135|7532022|FG000|Overall Study|Withdrawal by Subject|3
4650574|NCT02085135|7532023|FG001|Overall Study|Withdrawal by Subject|0
4650575|NCT02085135|7532022|FG000|Overall Study|Lack of Efficacy|2
4650576|NCT02085135|7532023|FG001|Overall Study|Lack of Efficacy|0
4650577|NCT02085161|7532033|FG000|Overall Study|Not Treated|1
4650578|NCT02085161|7532034|FG001|Overall Study|Not Treated|0
4650579|NCT02085161|7532035|FG002|Overall Study|Not Treated|0
4650580|NCT02085161|7532036|FG003|Overall Study|Not Treated|0
4650581|NCT02085161|7532033|FG000|Overall Study|Adverse Event|8
4650582|NCT02085161|7532034|FG001|Overall Study|Adverse Event|5
4650583|NCT02085161|7532035|FG002|Overall Study|Adverse Event|4
4650584|NCT02085161|7532036|FG003|Overall Study|Adverse Event|5
4650585|NCT02085161|7532033|FG000|Overall Study|Protocol Violation|0
4650586|NCT02085161|7532034|FG001|Overall Study|Protocol Violation|1
4650587|NCT02085161|7532035|FG002|Overall Study|Protocol Violation|0
4650588|NCT02085161|7532036|FG003|Overall Study|Protocol Violation|1
4650589|NCT02085161|7532033|FG000|Overall Study|Withdrawal by Subject|2
4650590|NCT02085161|7532034|FG001|Overall Study|Withdrawal by Subject|4
4650591|NCT02085161|7532035|FG002|Overall Study|Withdrawal by Subject|0
4650592|NCT02085161|7532036|FG003|Overall Study|Withdrawal by Subject|3
4650593|NCT02085161|7532033|FG000|Overall Study|Other Reason|1
4650594|NCT02085161|7532034|FG001|Overall Study|Other Reason|0
4650595|NCT02085161|7532035|FG002|Overall Study|Other Reason|1
4650596|NCT02085161|7532036|FG003|Overall Study|Other Reason|1
4650597|NCT02085252|7532049|FG000|Overall Study|Withdrawal of Consent|1
4650598|NCT02085252|7532050|FG001|Overall Study|Withdrawal of Consent|0
4650599|NCT02085252|7532049|FG000|Overall Study|Adverse Event|0
4650600|NCT02085252|7532050|FG001|Overall Study|Adverse Event|1
4650601|NCT02085252|7532049|FG000|Overall Study|Discontinuation Due to Patient Decision|0
4650602|NCT02085252|7532050|FG001|Overall Study|Discontinuation Due to Patient Decision|1
4650603|NCT02085252|7532049|FG000|Overall Study|Reason Not Specified|0
4650604|NCT02085252|7532050|FG001|Overall Study|Reason Not Specified|1
4650605|NCT02085252|7532049|FG000|Overall Study|Reason Unknown|0
4650606|NCT02085252|7532050|FG001|Overall Study|Reason Unknown|1
4650607|NCT02085460|7532081|FG000|Overall Study|Adverse Event|2
4650608|NCT02085460|7532082|FG001|Overall Study|Adverse Event|2
4650609|NCT02085460|7532083|FG002|Overall Study|Adverse Event|1
4650610|NCT02085460|7532081|FG000|Overall Study|Physician Decision|1
4650611|NCT02085460|7532082|FG001|Overall Study|Physician Decision|1
4650612|NCT02085460|7532083|FG002|Overall Study|Physician Decision|2
4650613|NCT02085460|7532081|FG000|Overall Study|Withdrawal by Subject|11
4650614|NCT02085460|7532082|FG001|Overall Study|Withdrawal by Subject|5
4650615|NCT02085460|7532083|FG002|Overall Study|Withdrawal by Subject|7
4650616|NCT02085785|7532122|FG000|Overall Study|Withdrawal by Subject|2
4650617|NCT02085785|7532123|FG001|Overall Study|Withdrawal by Subject|1
4650618|NCT02085785|7532122|FG000|Overall Study|Lost to Follow-up|0
4650619|NCT02085785|7532123|FG001|Overall Study|Lost to Follow-up|1
4650620|NCT02086110|7532137|FG000|Overall Study|Withdrawal by Subject|1
4650621|NCT02086110|7532138|FG001|Overall Study|Withdrawal by Subject|1
4650622|NCT02086162|7532147|FG000|Overall Study|Withdrawal by Subject|4
4650623|NCT02086162|7532148|FG001|Overall Study|Withdrawal by Subject|4
4650624|NCT02086162|7532147|FG000|Overall Study|moved|1
4650625|NCT02086162|7532148|FG001|Overall Study|moved|1
4650626|NCT02086162|7532147|FG000|Overall Study|Lost to Follow-up|4
4650627|NCT02086162|7532148|FG001|Overall Study|Lost to Follow-up|2
4650628|NCT02086162|7532147|FG000|Overall Study|Death|1
4650629|NCT02086162|7532148|FG001|Overall Study|Death|0
4650630|NCT02086565|7532182|FG000|Overall Study|Lost to Follow-up|9
4650631|NCT02086565|7532183|FG001|Overall Study|Lost to Follow-up|7
4650632|NCT02086565|7532182|FG000|Overall Study|Withdrawal by Subject|2
4650633|NCT02086565|7532183|FG001|Overall Study|Withdrawal by Subject|1
4650634|NCT02086565|7532182|FG000|Overall Study|Death|3
4650635|NCT02086565|7532183|FG001|Overall Study|Death|2
4650636|NCT02086565|7532182|FG000|Overall Study|withdrawn by research team|2
4650637|NCT02086565|7532183|FG001|Overall Study|withdrawn by research team|2
4650638|NCT02086591|7532189|FG000|Overall Study|Adverse Event|1
4650639|NCT02086591|7532189|FG000|Overall Study|Withdrawal by Subject|1
4650640|NCT02086591|7532189|FG000|Overall Study|protocol terminated|3
4650641|NCT02086968|7532227|FG000|Overall Study|Adverse Event|1
4650642|NCT02086968|7532228|FG001|Overall Study|Adverse Event|5
4650643|NCT02086968|7532227|FG000|Overall Study|Lost to Follow-up|2
4650644|NCT02086968|7532228|FG001|Overall Study|Lost to Follow-up|3
4650645|NCT02086968|7532227|FG000|Overall Study|Study drug received outside protocol|0
4650646|NCT02086968|7532228|FG001|Overall Study|Study drug received outside protocol|1
4650647|NCT02086968|7532227|FG000|Overall Study|Physician Decision|4
4650648|NCT02086968|7532228|FG001|Overall Study|Physician Decision|0
4650649|NCT02086968|7532227|FG000|Overall Study|Withdrawal by Subject|1
4650650|NCT02086968|7532228|FG001|Overall Study|Withdrawal by Subject|4
4650651|NCT02087046|7532234|FG000|Overall Study|Adverse Event|4
4650652|NCT02087046|7532234|FG000|Overall Study|Death|1
4650653|NCT02087046|7532234|FG000|Overall Study|Lost to Follow-up|3
4650654|NCT02087046|7532234|FG000|Overall Study|Withdrawal by Subject|2
4650655|NCT02087046|7532234|FG000|Overall Study|Physician Decision|1
4650656|NCT02087059|7532239|FG000|Overall Study|Disease Progression|1
4650657|NCT02087059|7532239|FG000|Overall Study|Adverse Event|5
4650658|NCT02087059|7532239|FG000|Overall Study|Lost to Follow-up|1
4650659|NCT02087085|7532245|FG000|Overall Study|Adverse Event|10
4650660|NCT02087085|7532246|FG001|Overall Study|Adverse Event|14
4650661|NCT02087085|7532245|FG000|Overall Study|Lack of Efficacy|4
4650662|NCT02087085|7532246|FG001|Overall Study|Lack of Efficacy|3
4650663|NCT02087085|7532245|FG000|Overall Study|Lost to Follow-up|6
4650664|NCT02087085|7532246|FG001|Overall Study|Lost to Follow-up|4
4650665|NCT02087085|7532245|FG000|Overall Study|Withdrawal by Subject|9
4650666|NCT02087085|7532246|FG001|Overall Study|Withdrawal by Subject|11
4650667|NCT02087085|7532245|FG000|Overall Study|Protocol Violation|1
4650668|NCT02087085|7532246|FG001|Overall Study|Protocol Violation|0
4650669|NCT02087085|7532245|FG000|Overall Study|Study Terminated by Sponsor|87
4650670|NCT02087085|7532246|FG001|Overall Study|Study Terminated by Sponsor|80
4650671|NCT02087085|7532245|FG000|Overall Study|Other Miscellaneous Reasons|3
4650672|NCT02087085|7532246|FG001|Overall Study|Other Miscellaneous Reasons|4
4747824|NCT00555009|7721918|FG000|Overall Study|Terminated by Sponsor|2
4747825|NCT00555009|7721919|FG001|Overall Study|Terminated by Sponsor|5
4650673|NCT02087150|7532255|FG000|Overall Study|Death|0
4650674|NCT02087150|7532256|FG001|Overall Study|Death|1
4650675|NCT02087150|7532257|FG002|Overall Study|Death|0
4650676|NCT02087150|7532255|FG000|Overall Study|Lost to Follow-up|6
4650677|NCT02087150|7532256|FG001|Overall Study|Lost to Follow-up|13
4650678|NCT02087150|7532257|FG002|Overall Study|Lost to Follow-up|7
4650679|NCT02087150|7532255|FG000|Overall Study|Withdrawal by Subject|2
4650680|NCT02087150|7532256|FG001|Overall Study|Withdrawal by Subject|5
4650681|NCT02087150|7532257|FG002|Overall Study|Withdrawal by Subject|3
4650682|NCT02087150|7532255|FG000|Overall Study|Physician Decision|0
4650683|NCT02087150|7532256|FG001|Overall Study|Physician Decision|1
4650684|NCT02087150|7532257|FG002|Overall Study|Physician Decision|0
4650685|NCT02087150|7532255|FG000|Overall Study|Procedure not done|1
4650686|NCT02087150|7532256|FG001|Overall Study|Procedure not done|13
4650687|NCT02087150|7532257|FG002|Overall Study|Procedure not done|0
4650688|NCT02087150|7532255|FG000|Overall Study|F/U not completed w/in study window|0
4650689|NCT02087150|7532256|FG001|Overall Study|F/U not completed w/in study window|0
4650690|NCT02087150|7532257|FG002|Overall Study|F/U not completed w/in study window|1
4650691|NCT02087150|7532255|FG000|Overall Study|Other|1
4650692|NCT02087150|7532256|FG001|Overall Study|Other|0
4650693|NCT02087150|7532257|FG002|Overall Study|Other|0
4650694|NCT02087150|7532255|FG000|Overall Study|Pt moved out of town|0
4650695|NCT02087150|7532256|FG001|Overall Study|Pt moved out of town|1
4650696|NCT02087150|7532257|FG002|Overall Study|Pt moved out of town|0
4650697|NCT02087176|7532270|FG000|Overall Study|Withdrawal by Subject|1
4650698|NCT02087176|7532270|FG000|Overall Study|Death|10
4650699|NCT02087176|7532270|FG000|Overall Study|Censored|19
4650700|NCT02087176|7532270|FG000|Overall Study|Study Terminated by Sponsor|2
4650701|NCT02087241|7532278|FG000|Overall Study|Death|2
4650702|NCT02087241|7532279|FG001|Overall Study|Death|1
4650703|NCT02087241|7532280|FG002|Overall Study|Death|1
4650704|NCT02087241|7532281|FG003|Overall Study|Death|1
4650705|NCT02087241|7532278|FG000|Overall Study|Withdrawal by Subject|1
4650706|NCT02087241|7532279|FG001|Overall Study|Withdrawal by Subject|0
4650707|NCT02087241|7532280|FG002|Overall Study|Withdrawal by Subject|0
4650708|NCT02087241|7532281|FG003|Overall Study|Withdrawal by Subject|1
4650709|NCT02087241|7532278|FG000|Overall Study|Progressive Disease|0
4650710|NCT02087241|7532279|FG001|Overall Study|Progressive Disease|0
4650711|NCT02087241|7532280|FG002|Overall Study|Progressive Disease|0
4650712|NCT02087241|7532281|FG003|Overall Study|Progressive Disease|1
4650713|NCT02087241|7532278|FG000|Overall Study|Study Terminated by Sponsor|0
4650714|NCT02087241|7532279|FG001|Overall Study|Study Terminated by Sponsor|2
4650715|NCT02087241|7532280|FG002|Overall Study|Study Terminated by Sponsor|0
4650716|NCT02087241|7532281|FG003|Overall Study|Study Terminated by Sponsor|4
4650717|NCT02087670|7532334|FG000|Overall Study|Withdrawal by Subject|3
4650718|NCT02087670|7532335|FG001|Overall Study|Withdrawal by Subject|2
4650719|NCT02087774|7532351|FG000|Overall Study|Were absent day of data collection|8
4650720|NCT02087774|7532352|FG001|Overall Study|Were absent day of data collection|20
4650721|NCT02087904|7532362|FG000|Overall Study|Did Not Receive Study Drug|0
4650722|NCT02087904|7532363|FG001|Overall Study|Did Not Receive Study Drug|0
4650723|NCT02087904|7532364|FG002|Overall Study|Did Not Receive Study Drug|2
4650724|NCT02087904|7532365|FG003|Overall Study|Did Not Receive Study Drug|1
4650725|NCT02087904|7532362|FG000|Overall Study|Adverse Event|8
4650726|NCT02087904|7532363|FG001|Overall Study|Adverse Event|4
4650727|NCT02087904|7532364|FG002|Overall Study|Adverse Event|4
4650728|NCT02087904|7532365|FG003|Overall Study|Adverse Event|12
4650729|NCT02087904|7532362|FG000|Overall Study|Lack of Efficacy|3
4650730|NCT02087904|7532363|FG001|Overall Study|Lack of Efficacy|6
4650731|NCT02087904|7532364|FG002|Overall Study|Lack of Efficacy|3
4650732|NCT02087904|7532365|FG003|Overall Study|Lack of Efficacy|2
4650733|NCT02087904|7532362|FG000|Overall Study|Other|6
4650734|NCT02087904|7532363|FG001|Overall Study|Other|2
4650735|NCT02087904|7532364|FG002|Overall Study|Other|4
4650736|NCT02087904|7532365|FG003|Overall Study|Other|4
4650737|NCT02087904|7532362|FG000|Overall Study|Withdrawal by Subject|8
4650738|NCT02087904|7532363|FG001|Overall Study|Withdrawal by Subject|3
4650739|NCT02087904|7532364|FG002|Overall Study|Withdrawal by Subject|7
4650740|NCT02087904|7532365|FG003|Overall Study|Withdrawal by Subject|4
4650741|NCT02087904|7532362|FG000|Overall Study|Lost to Follow-up|0
4650742|NCT02087904|7532363|FG001|Overall Study|Lost to Follow-up|4
4650743|NCT02087904|7532364|FG002|Overall Study|Lost to Follow-up|2
4650744|NCT02087904|7532365|FG003|Overall Study|Lost to Follow-up|2
4650745|NCT02087943|7532378|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1
4650746|NCT02087943|7532379|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2
4650747|NCT02087943|7532380|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6
4650748|NCT02087943|7532381|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0
4650749|NCT02087943|7532382|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0
4650750|NCT02087943|7532378|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8
4650751|NCT02087943|7532379|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7
4650752|NCT02087943|7532380|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4
4650753|NCT02087943|7532381|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0
4650754|NCT02087943|7532382|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0
4650755|NCT02087943|7532378|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4
4650756|NCT02087943|7532379|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2
4650757|NCT02087943|7532380|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2
4650758|NCT02087943|7532381|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0
4650759|NCT02087943|7532382|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0
4650760|NCT02087943|7532378|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1
4650761|NCT02087943|7532379|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
4650762|NCT02087943|7532380|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1
4650763|NCT02087943|7532381|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
4650764|NCT02087943|7532382|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
4650765|NCT02087943|7532378|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
4650766|NCT02087943|7532379|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1
4650767|NCT02087943|7532380|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
4650768|NCT02087943|7532381|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
4650769|NCT02087943|7532382|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
4650770|NCT02087943|7532378|FG000|Active Treatment Phase Week 12-24|Adverse Event|0
4650771|NCT02087943|7532379|FG001|Active Treatment Phase Week 12-24|Adverse Event|1
4650772|NCT02087943|7532380|FG002|Active Treatment Phase Week 12-24|Adverse Event|2
4650773|NCT02087943|7532381|FG003|Active Treatment Phase Week 12-24|Adverse Event|0
4650774|NCT02087943|7532382|FG004|Active Treatment Phase Week 12-24|Adverse Event|1
4650775|NCT02087943|7532378|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0
4650776|NCT02087943|7532379|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3
4650777|NCT02087943|7532380|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1
4650778|NCT02087943|7532381|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1
4650779|NCT02087943|7532382|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0
4650780|NCT02087943|7532378|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
4650781|NCT02087943|7532379|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
4650782|NCT02087943|7532380|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1
4650783|NCT02087943|7532381|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
4650784|NCT02087943|7532382|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
4650785|NCT02087943|7532378|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0
4650786|NCT02087943|7532379|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0
4650787|NCT02087943|7532380|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0
4650788|NCT02087943|7532381|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0
4650789|NCT02087943|7532382|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1
4650790|NCT02087943|7532378|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0
4650791|NCT02087943|7532379|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0
4650792|NCT02087943|7532380|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1
4650793|NCT02087943|7532381|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1
4650794|NCT02087943|7532382|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0
4650795|NCT02088034|7532412|FG000|Overall Study|Lost to Follow-up|1
4650796|NCT02088034|7532413|FG001|Overall Study|Lost to Follow-up|1
4650797|NCT02088034|7532414|FG002|Overall Study|Lost to Follow-up|0
4650798|NCT02088034|7532412|FG000|Overall Study|Pregnancy|2
4650799|NCT02088034|7532413|FG001|Overall Study|Pregnancy|1
4650800|NCT02088034|7532414|FG002|Overall Study|Pregnancy|2
4650801|NCT02088047|7532424|FG000|Overall Study|Withdrawal by Subject|1
4650802|NCT02088047|7532425|FG001|Overall Study|Withdrawal by Subject|0
4650803|NCT02088073|7532436|FG000|Acute Phase|Withdrawal by Subject|5
4650804|NCT02088073|7532437|FG001|Acute Phase|Withdrawal by Subject|0
4650805|NCT02088073|7532438|FG002|Acute Phase|Withdrawal by Subject|0
4650806|NCT02088073|7532439|FG003|Acute Phase|Withdrawal by Subject|0
4650807|NCT02088073|7532440|FG004|Acute Phase|Withdrawal by Subject|0
4650808|NCT02088073|7532436|FG000|Acute Phase|Hyperkalemia|2
4650809|NCT02088073|7532437|FG001|Acute Phase|Hyperkalemia|0
4650810|NCT02088073|7532438|FG002|Acute Phase|Hyperkalemia|0
4650811|NCT02088073|7532439|FG003|Acute Phase|Hyperkalemia|0
4650812|NCT02088073|7532440|FG004|Acute Phase|Hyperkalemia|0
4650813|NCT02088073|7532436|FG000|Maintanance Phase|Withdrawal by Subject|0
4650814|NCT02088073|7532437|FG001|Maintanance Phase|Withdrawal by Subject|2
4650815|NCT02088073|7532438|FG002|Maintanance Phase|Withdrawal by Subject|0
4650816|NCT02088073|7532439|FG003|Maintanance Phase|Withdrawal by Subject|0
4650817|NCT02088073|7532440|FG004|Maintanance Phase|Withdrawal by Subject|0
4650818|NCT02088073|7532436|FG000|Maintanance Phase|Adverse Event|0
4650819|NCT02088073|7532437|FG001|Maintanance Phase|Adverse Event|0
4650820|NCT02088073|7532438|FG002|Maintanance Phase|Adverse Event|3
4650821|NCT02088073|7532439|FG003|Maintanance Phase|Adverse Event|0
4650822|NCT02088073|7532440|FG004|Maintanance Phase|Adverse Event|1
4650823|NCT02088073|7532436|FG000|Maintanance Phase|Physician Decision|0
4650824|NCT02088073|7532437|FG001|Maintanance Phase|Physician Decision|0
4650825|NCT02088073|7532438|FG002|Maintanance Phase|Physician Decision|0
4650826|NCT02088073|7532439|FG003|Maintanance Phase|Physician Decision|0
4650827|NCT02088073|7532440|FG004|Maintanance Phase|Physician Decision|1
4650828|NCT02088073|7532436|FG000|Maintanance Phase|Sponsor's decision|0
4650829|NCT02088073|7532437|FG001|Maintanance Phase|Sponsor's decision|2
4650830|NCT02088073|7532438|FG002|Maintanance Phase|Sponsor's decision|0
4650831|NCT02088073|7532439|FG003|Maintanance Phase|Sponsor's decision|2
4650832|NCT02088073|7532440|FG004|Maintanance Phase|Sponsor's decision|1
4650833|NCT02088073|7532436|FG000|Maintanance Phase|Hypo- or hyperkalemia|0
4650834|NCT02088073|7532437|FG001|Maintanance Phase|Hypo- or hyperkalemia|3
4650835|NCT02088073|7532438|FG002|Maintanance Phase|Hypo- or hyperkalemia|0
4650836|NCT02088073|7532439|FG003|Maintanance Phase|Hypo- or hyperkalemia|3
4650837|NCT02088073|7532440|FG004|Maintanance Phase|Hypo- or hyperkalemia|1
4650838|NCT02088073|7532436|FG000|Maintanance Phase|Miscellaneous|0
4650839|NCT02088073|7532437|FG001|Maintanance Phase|Miscellaneous|2
4650840|NCT02088073|7532438|FG002|Maintanance Phase|Miscellaneous|1
4650841|NCT02088073|7532439|FG003|Maintanance Phase|Miscellaneous|2
4650842|NCT02088073|7532440|FG004|Maintanance Phase|Miscellaneous|1
4650843|NCT02088073|7532436|FG000|Maintanance Phase|Met ECG withdrawal criteria|0
4650844|NCT02088073|7532437|FG001|Maintanance Phase|Met ECG withdrawal criteria|0
4650845|NCT02088073|7532438|FG002|Maintanance Phase|Met ECG withdrawal criteria|1
4650846|NCT02088073|7532439|FG003|Maintanance Phase|Met ECG withdrawal criteria|0
4650847|NCT02088073|7532440|FG004|Maintanance Phase|Met ECG withdrawal criteria|2
4650848|NCT02088073|7532436|FG000|Maintanance Phase|Subject compliance|0
4650849|NCT02088073|7532437|FG001|Maintanance Phase|Subject compliance|1
4650850|NCT02088073|7532438|FG002|Maintanance Phase|Subject compliance|0
4650851|NCT02088073|7532439|FG003|Maintanance Phase|Subject compliance|0
4650852|NCT02088073|7532440|FG004|Maintanance Phase|Subject compliance|0
4747826|NCT00566995|7721948|FG000|Overall Study|Toxicity|4
4747827|NCT00566995|7721948|FG000|Overall Study|Withdrew consent|3
4747828|NCT00586924|7721958|FG000|Overall Study|Adverse event/serious adverse event|0
4747829|NCT00586924|7721959|FG001|Overall Study|Adverse event/serious adverse event|0
4747830|NCT00586924|7721960|FG002|Overall Study|Adverse event/serious adverse event|0
4747831|NCT00586924|7721961|FG003|Overall Study|Adverse event/serious adverse event|1
4747832|NCT00586924|7721962|FG004|Overall Study|Adverse event/serious adverse event|0
4747833|NCT00586924|7721963|FG005|Overall Study|Adverse event/serious adverse event|2
4747834|NCT00586924|7721958|FG000|Overall Study|Initiation of alternative cancer therapy|0
4747835|NCT00586924|7721959|FG001|Overall Study|Initiation of alternative cancer therapy|0
4747836|NCT00586924|7721960|FG002|Overall Study|Initiation of alternative cancer therapy|0
4747837|NCT00586924|7721961|FG003|Overall Study|Initiation of alternative cancer therapy|0
4747838|NCT00586924|7721962|FG004|Overall Study|Initiation of alternative cancer therapy|0
4747839|NCT00586924|7721963|FG005|Overall Study|Initiation of alternative cancer therapy|1
4747840|NCT00586924|7721958|FG000|Overall Study|Disease progression|0
4747841|NCT00586924|7721959|FG001|Overall Study|Disease progression|0
4747842|NCT00586924|7721960|FG002|Overall Study|Disease progression|0
4747843|NCT00586924|7721961|FG003|Overall Study|Disease progression|1
4747844|NCT00586924|7721962|FG004|Overall Study|Disease progression|1
4747845|NCT00586924|7721963|FG005|Overall Study|Disease progression|0
4747846|NCT00586924|7721958|FG000|Overall Study|Development of neutralizing antibodies|2
4747847|NCT00586924|7721959|FG001|Overall Study|Development of neutralizing antibodies|2
4747848|NCT00586924|7721960|FG002|Overall Study|Development of neutralizing antibodies|2
4747849|NCT00586924|7721961|FG003|Overall Study|Development of neutralizing antibodies|0
4747850|NCT00586924|7721962|FG004|Overall Study|Development of neutralizing antibodies|0
4747851|NCT00586924|7721963|FG005|Overall Study|Development of neutralizing antibodies|22
4747852|NCT00586924|7721958|FG000|Overall Study|Complete response|0
4747853|NCT00586924|7721959|FG001|Overall Study|Complete response|1
4747854|NCT00586924|7721960|FG002|Overall Study|Complete response|0
4747855|NCT00586924|7721961|FG003|Overall Study|Complete response|0
4747856|NCT00586924|7721962|FG004|Overall Study|Complete response|2
4747857|NCT00586924|7721963|FG005|Overall Study|Complete response|2
4747858|NCT00586924|7721958|FG000|Overall Study|Other|1
4747859|NCT00586924|7721959|FG001|Overall Study|Other|0
4747860|NCT00586924|7721960|FG002|Overall Study|Other|1
4747861|NCT00586924|7721961|FG003|Overall Study|Other|1
4747862|NCT00586924|7721962|FG004|Overall Study|Other|1
4747863|NCT00586924|7721963|FG005|Overall Study|Other|6
4650853|NCT02088177|7532453|FG000|Overall Study|Lost to Follow-up|3
4650854|NCT02088541|7532480|FG000|Overall Study|Adverse Event|3
4650855|NCT02088541|7532481|FG001|Overall Study|Adverse Event|0
4650856|NCT02088541|7532482|FG002|Overall Study|Adverse Event|3
4650857|NCT02088541|7532483|FG003|Overall Study|Adverse Event|3
4650858|NCT02088541|7532484|FG004|Overall Study|Adverse Event|0
4650859|NCT02088541|7532480|FG000|Overall Study|Death|51
4650860|NCT02088541|7532481|FG001|Overall Study|Death|21
4650861|NCT02088541|7532482|FG002|Overall Study|Death|85
4650862|NCT02088541|7532483|FG003|Overall Study|Death|28
4650863|NCT02088541|7532484|FG004|Overall Study|Death|38
4650864|NCT02088541|7532480|FG000|Overall Study|Lost to Follow-up|2
4650865|NCT02088541|7532481|FG001|Overall Study|Lost to Follow-up|0
4650866|NCT02088541|7532482|FG002|Overall Study|Lost to Follow-up|1
4650867|NCT02088541|7532483|FG003|Overall Study|Lost to Follow-up|0
4650868|NCT02088541|7532484|FG004|Overall Study|Lost to Follow-up|0
4650869|NCT02088541|7532480|FG000|Overall Study|Physician Decision|2
4650870|NCT02088541|7532481|FG001|Overall Study|Physician Decision|1
4650871|NCT02088541|7532482|FG002|Overall Study|Physician Decision|2
4650872|NCT02088541|7532483|FG003|Overall Study|Physician Decision|0
4650873|NCT02088541|7532484|FG004|Overall Study|Physician Decision|2
4650874|NCT02088541|7532480|FG000|Overall Study|Disease progression|7
4650875|NCT02088541|7532481|FG001|Overall Study|Disease progression|1
4650876|NCT02088541|7532482|FG002|Overall Study|Disease progression|2
4650877|NCT02088541|7532483|FG003|Overall Study|Disease progression|3
4650878|NCT02088541|7532484|FG004|Overall Study|Disease progression|1
4650879|NCT02088541|7532480|FG000|Overall Study|Study terminated by sponsor|1
4650880|NCT02088541|7532481|FG001|Overall Study|Study terminated by sponsor|1
4650881|NCT02088541|7532482|FG002|Overall Study|Study terminated by sponsor|12
4650882|NCT02088541|7532483|FG003|Overall Study|Study terminated by sponsor|2
4650883|NCT02088541|7532484|FG004|Overall Study|Study terminated by sponsor|6
4650884|NCT02088541|7532480|FG000|Overall Study|Withdrawal by Subject|3
4650885|NCT02088541|7532481|FG001|Overall Study|Withdrawal by Subject|2
4650886|NCT02088541|7532482|FG002|Overall Study|Withdrawal by Subject|9
4650887|NCT02088541|7532483|FG003|Overall Study|Withdrawal by Subject|7
4650888|NCT02088541|7532484|FG004|Overall Study|Withdrawal by Subject|10
4650889|NCT02088541|7532480|FG000|Overall Study|Other|2
4650890|NCT02088541|7532481|FG001|Overall Study|Other|1
4650891|NCT02088541|7532482|FG002|Overall Study|Other|3
4650892|NCT02088541|7532483|FG003|Overall Study|Other|1
4650893|NCT02088541|7532484|FG004|Overall Study|Other|1
4650894|NCT02088697|7532496|FG000|Period I|Physician Decision|1
4650895|NCT02088697|7532497|FG001|Period I|Physician Decision|4
4650896|NCT02088697|7532496|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1
4650897|NCT02088697|7532497|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0
4650898|NCT02088905|7532514|FG000|Overall Study|Withdrawal by Subject|5
4650899|NCT02088905|7532515|FG001|Overall Study|Withdrawal by Subject|1
4650900|NCT02089230|7532540|FG000|Overall Study|Death|0
4650901|NCT02089230|7532541|FG001|Overall Study|Death|0
4650902|NCT02089230|7532542|FG002|Overall Study|Death|2
4650903|NCT02089230|7532540|FG000|Overall Study|Seeking Alternative Therapy|0
4650904|NCT02089230|7532541|FG001|Overall Study|Seeking Alternative Therapy|0
4650905|NCT02089230|7532542|FG002|Overall Study|Seeking Alternative Therapy|4
4650906|NCT02089334|7532554|FG000|Overall Study|Withdrawal by Subject|0
4650907|NCT02089334|7532555|FG001|Overall Study|Withdrawal by Subject|0
4650908|NCT02089334|7532556|FG002|Overall Study|Withdrawal by Subject|0
4650909|NCT02089334|7532557|FG003|Overall Study|Withdrawal by Subject|2
4650910|NCT02089334|7532554|FG000|Overall Study|Adverse Event|0
4650911|NCT02089334|7532555|FG001|Overall Study|Adverse Event|0
4650912|NCT02089334|7532556|FG002|Overall Study|Adverse Event|0
4650913|NCT02089334|7532557|FG003|Overall Study|Adverse Event|2
4650914|NCT02089334|7532554|FG000|Overall Study|Progressive disease|0
4650915|NCT02089334|7532555|FG001|Overall Study|Progressive disease|0
4650916|NCT02089334|7532556|FG002|Overall Study|Progressive disease|0
4650917|NCT02089334|7532557|FG003|Overall Study|Progressive disease|2
4650918|NCT02089334|7532554|FG000|Overall Study|Physician Decision|0
4650919|NCT02089334|7532555|FG001|Overall Study|Physician Decision|0
4650920|NCT02089334|7532556|FG002|Overall Study|Physician Decision|1
4650921|NCT02089334|7532557|FG003|Overall Study|Physician Decision|1
4650922|NCT02089347|7532572|FG000|Overall Study|Protocol Violation|1
4650923|NCT02089347|7532573|FG001|Overall Study|Protocol Violation|0
4650924|NCT02089737|7532598|FG000|Overall Study|Survey form not completed|5
4650925|NCT02089737|7532598|FG000|Overall Study|Not treated|1
4650926|NCT02089997|7532603|FG000|Overall Study|Case report forms uncollected|99
4650927|NCT02089997|7532603|FG000|Overall Study|Protocol Violation|147
4650928|NCT02090283|7532624|FG000|Overall Study|Withdrawal by Subject|6
4650929|NCT02090283|7532625|FG001|Overall Study|Withdrawal by Subject|6
4650930|NCT02090283|7532626|FG002|Overall Study|Withdrawal by Subject|6
4650931|NCT02090283|7532624|FG000|Overall Study|Sponsor Terminated Study|6
4650932|NCT02090283|7532625|FG001|Overall Study|Sponsor Terminated Study|6
4650933|NCT02090283|7532626|FG002|Overall Study|Sponsor Terminated Study|1
4650934|NCT02090283|7532624|FG000|Overall Study|Lost to Follow-up|2
4650935|NCT02090283|7532625|FG001|Overall Study|Lost to Follow-up|2
4650936|NCT02090283|7532626|FG002|Overall Study|Lost to Follow-up|3
4650937|NCT02090283|7532624|FG000|Overall Study|Adverse Event|1
4650938|NCT02090283|7532625|FG001|Overall Study|Adverse Event|1
4650939|NCT02090283|7532626|FG002|Overall Study|Adverse Event|0
4650940|NCT02090283|7532624|FG000|Overall Study|Protocol Violation|2
4650941|NCT02090283|7532625|FG001|Overall Study|Protocol Violation|0
4650942|NCT02090283|7532626|FG002|Overall Study|Protocol Violation|0
4650943|NCT02090413|7532670|FG000|Overall Study|Adverse Event|11
4650944|NCT02090413|7532671|FG001|Overall Study|Adverse Event|15
4650945|NCT02090413|7532672|FG002|Overall Study|Adverse Event|20
4650946|NCT02090413|7532670|FG000|Overall Study|Flushing event|2
4650947|NCT02090413|7532671|FG001|Overall Study|Flushing event|0
4650948|NCT02090413|7532672|FG002|Overall Study|Flushing event|1
4650949|NCT02090413|7532670|FG000|Overall Study|Withdrawal by Subject|2
4650950|NCT02090413|7532671|FG001|Overall Study|Withdrawal by Subject|2
4650951|NCT02090413|7532672|FG002|Overall Study|Withdrawal by Subject|2
4650952|NCT02090413|7532670|FG000|Overall Study|Investigator Decision|1
4650953|NCT02090413|7532671|FG001|Overall Study|Investigator Decision|1
4650954|NCT02090413|7532672|FG002|Overall Study|Investigator Decision|0
4650955|NCT02090413|7532670|FG000|Overall Study|Other|2
4650956|NCT02090413|7532671|FG001|Overall Study|Other|1
4650957|NCT02090413|7532672|FG002|Overall Study|Other|0
4650958|NCT02090413|7532670|FG000|Overall Study|Lost to Follow-up|1
4650959|NCT02090413|7532671|FG001|Overall Study|Lost to Follow-up|1
4650960|NCT02090413|7532672|FG002|Overall Study|Lost to Follow-up|0
4650961|NCT02090426|7532683|FG000|Overall Study|Lost to Follow-up|12
4650962|NCT02090426|7532684|FG001|Overall Study|Lost to Follow-up|6
4650963|NCT02090634|7532692|FG000|Overall Study|Lost to Follow-up|0
4650964|NCT02090634|7532693|FG001|Overall Study|Lost to Follow-up|1
4650965|NCT02090634|7532692|FG000|Overall Study|Death|0
4650966|NCT02090634|7532693|FG001|Overall Study|Death|1
4650967|NCT02090634|7532692|FG000|Overall Study|Protocol Violation|3
4650968|NCT02090634|7532693|FG001|Overall Study|Protocol Violation|1
4650969|NCT02090634|7532692|FG000|Overall Study|Adverse Event|2
4650970|NCT02090634|7532693|FG001|Overall Study|Adverse Event|0
4650971|NCT02090725|7532699|FG000|Overall Study|Withdrawal by Subject|1
4650972|NCT02090725|7532699|FG000|Overall Study|participants moved from area|3
4650973|NCT02090764|7532705|FG000|Overall Study|Adverse Event|1
4650974|NCT02090764|7532706|FG001|Overall Study|Adverse Event|3
4650975|NCT02090764|7532705|FG000|Overall Study|Lack of Efficacy|0
4650976|NCT02090764|7532706|FG001|Overall Study|Lack of Efficacy|13
4650977|NCT02090764|7532705|FG000|Overall Study|Withdrawal by Subject|2
4650978|NCT02090764|7532706|FG001|Overall Study|Withdrawal by Subject|1
4650979|NCT02090764|7532705|FG000|Overall Study|Intercurrent illness and other|1
4650980|NCT02090764|7532706|FG001|Overall Study|Intercurrent illness and other|1
4650981|NCT02090764|7532705|FG000|Overall Study|Lost to Follow-up|2
4650982|NCT02090764|7532706|FG001|Overall Study|Lost to Follow-up|2
4650983|NCT02090855|7532716|FG000|Overall Study|no evaluable Standard of Truth results|2
4650984|NCT02090959|7532727|FG000|Overall Study|Withdrawal by Subject|10
4650985|NCT02090959|7532727|FG000|Overall Study|Adverse Event|1
4650986|NCT02090959|7532727|FG000|Overall Study|Investigator decision|2
4650987|NCT02090959|7532727|FG000|Overall Study|Study termination|6
4650988|NCT02090959|7532727|FG000|Overall Study|Enrolled but not treated|1
4650989|NCT02090959|7532727|FG000|Overall Study|Transfer for compassionate use medicine|4
4650990|NCT02090959|7532727|FG000|Overall Study|Move to medical need program|3
4650991|NCT02090959|7532727|FG000|Overall Study|Entered in to other study|34
4650992|NCT02090959|7532727|FG000|Overall Study|Switched to commercial supply|88
4650993|NCT02090959|7532727|FG000|Overall Study|Other than specified|2
4650994|NCT02091089|7532731|FG000|Overall Study|Lost to Follow-up|2
4650995|NCT02091167|7532741|FG000|Overall Study|Lost to Follow-up|0
4650996|NCT02091167|7532742|FG001|Overall Study|Lost to Follow-up|2
4650997|NCT02091206|7532752|FG000|Treatment Period|Adverse Event|0
4650998|NCT02091206|7532753|FG001|Treatment Period|Adverse Event|1
4650999|NCT02091206|7532754|FG002|Treatment Period|Adverse Event|0
4651000|NCT02091206|7532755|FG003|Treatment Period|Adverse Event|0
4651001|NCT02091206|7532752|FG000|Treatment Period|Met withdrawal criteria|0
4651002|NCT02091206|7532753|FG001|Treatment Period|Met withdrawal criteria|0
4651003|NCT02091206|7532754|FG002|Treatment Period|Met withdrawal criteria|1
4747864|NCT00588861|7721979|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95
4747865|NCT00588861|7721980|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86
4747866|NCT00588861|7721979|FG000|6 Months|Patients did not return for follow-up|98
4747867|NCT00588861|7721980|FG001|6 Months|Patients did not return for follow-up|73
4651004|NCT02091206|7532755|FG003|Treatment Period|Met withdrawal criteria|0
4651005|NCT02091206|7532752|FG000|Taper Period|Participant refused study drug|1
4651006|NCT02091206|7532753|FG001|Taper Period|Participant refused study drug|0
4651007|NCT02091206|7532754|FG002|Taper Period|Participant refused study drug|0
4651008|NCT02091206|7532755|FG003|Taper Period|Participant refused study drug|1
4651009|NCT02091206|7532752|FG000|Taper Period|Lost to Follow-up|0
4651010|NCT02091206|7532753|FG001|Taper Period|Lost to Follow-up|0
4651011|NCT02091206|7532754|FG002|Taper Period|Lost to Follow-up|0
4651012|NCT02091206|7532755|FG003|Taper Period|Lost to Follow-up|1
4651013|NCT02091284|7532767|FG000|Overall Study|Withdrawal by Subject|2
4651014|NCT02091284|7532768|FG001|Overall Study|Withdrawal by Subject|1
4651015|NCT02091284|7532767|FG000|Overall Study|unreliable data|1
4651016|NCT02091284|7532768|FG001|Overall Study|unreliable data|0
4651017|NCT02091362|7532778|FG000|Period 1|Protocol Violation|1
4651018|NCT02091362|7532779|FG001|Period 1|Protocol Violation|0
4651019|NCT02091362|7532778|FG000|Period 1|Withdrawal by Subject|2
4651020|NCT02091362|7532779|FG001|Period 1|Withdrawal by Subject|3
4651021|NCT02091362|7532778|FG000|Period 1|Lost to Follow-up|0
4651022|NCT02091362|7532779|FG001|Period 1|Lost to Follow-up|1
4651023|NCT02091362|7532778|FG000|Period 1|Adverse Event|2
4651024|NCT02091362|7532779|FG001|Period 1|Adverse Event|0
4651025|NCT02091362|7532778|FG000|Wash-out|Lost to Follow-up|1
4651026|NCT02091362|7532779|FG001|Wash-out|Lost to Follow-up|1
4651027|NCT02091362|7532778|FG000|Wash-out|Withdrawal by Subject|0
4651028|NCT02091362|7532779|FG001|Wash-out|Withdrawal by Subject|2
4651029|NCT02091362|7532778|FG000|Period 2|Adverse Event|1
4651030|NCT02091362|7532779|FG001|Period 2|Adverse Event|0
4651031|NCT02091362|7532778|FG000|Period 2|Lost to Follow-up|0
4651032|NCT02091362|7532779|FG001|Period 2|Lost to Follow-up|1
4651033|NCT02091362|7532778|FG000|Period 2|Withdrawal by Subject|1
4651034|NCT02091362|7532779|FG001|Period 2|Withdrawal by Subject|1
4651035|NCT02091375|7532791|FG000|Overall Study|Adverse Event|8
4747868|NCT00588861|7721979|FG000|1 Year|Patients did not return for follow-up|89
4747869|NCT00588861|7721980|FG001|1 Year|Patients did not return for follow-up|82
4747870|NCT00588861|7721979|FG000|2 Years|Patients did not return for follow-up|92
4747871|NCT00588861|7721980|FG001|2 Years|Patients did not return for follow-up|87
4747872|NCT00588861|7721979|FG000|4 Years|Patients did not return for follow-up|91
4747873|NCT00588861|7721980|FG001|4 Years|Patients did not return for follow-up|103
4747874|NCT00588861|7721979|FG000|6 Years|Patients did not return for follow-up|104
4747875|NCT00588861|7721980|FG001|6 Years|Patients did not return for follow-up|109
4747876|NCT00588861|7721979|FG000|8 Years|Patients did not return for follow-up|105
4747877|NCT00588861|7721980|FG001|8 Years|Patients did not return for follow-up|114
4747878|NCT00588861|7721979|FG000|10 Years|Incomplete due to study termination|107
4747879|NCT00588861|7721980|FG001|10 Years|Incomplete due to study termination|114
4651036|NCT02091375|7532792|FG001|Overall Study|Adverse Event|1
4651037|NCT02091375|7532791|FG000|Overall Study|Lost to Follow-up|0
4651038|NCT02091375|7532792|FG001|Overall Study|Lost to Follow-up|1
4651039|NCT02091375|7532791|FG000|Overall Study|Withdrawal by Subject|0
4651040|NCT02091375|7532792|FG001|Overall Study|Withdrawal by Subject|1
4651041|NCT02091375|7532791|FG000|Overall Study|Withdrawn by the investigator|1
4651042|NCT02091375|7532792|FG001|Overall Study|Withdrawn by the investigator|0
4651043|NCT02091414|7532798|FG000|Overall Study|Withdrawal by Subject|2
4651044|NCT02091414|7532798|FG000|Overall Study|Death|2
4651045|NCT02091440|7532802|FG000|Overall Study|Death|2
4651046|NCT02091726|7532819|FG000|Overall Study|Lost to Follow-up|6
4651047|NCT02091739|7532826|FG000|MP: 16 Weeks|Adverse Event|1
4651048|NCT02091739|7532827|FG001|MP: 16 Weeks|Adverse Event|1
4651049|NCT02091739|7532828|FG002|MP: 16 Weeks|Adverse Event|1
4651050|NCT02091739|7532829|FG003|MP: 16 Weeks|Adverse Event|0
4651051|NCT02091739|7532830|FG004|MP: 16 Weeks|Adverse Event|0
4651052|NCT02091739|7532826|FG000|MP: 16 Weeks|Withdrawal by Subject|3
4651053|NCT02091739|7532827|FG001|MP: 16 Weeks|Withdrawal by Subject|4
4651054|NCT02091739|7532828|FG002|MP: 16 Weeks|Withdrawal by Subject|0
4651055|NCT02091739|7532829|FG003|MP: 16 Weeks|Withdrawal by Subject|0
4651056|NCT02091739|7532830|FG004|MP: 16 Weeks|Withdrawal by Subject|0
4651057|NCT02091739|7532826|FG000|MP: 16 Weeks|Lost to Follow-up|0
4651058|NCT02091739|7532827|FG001|MP: 16 Weeks|Lost to Follow-up|0
4651059|NCT02091739|7532828|FG002|MP: 16 Weeks|Lost to Follow-up|1
4651060|NCT02091739|7532829|FG003|MP: 16 Weeks|Lost to Follow-up|0
4651061|NCT02091739|7532830|FG004|MP: 16 Weeks|Lost to Follow-up|0
4651062|NCT02091739|7532826|FG000|EP: 48 Weeks|Other|0
4651063|NCT02091739|7532827|FG001|EP: 48 Weeks|Other|0
4651064|NCT02091739|7532828|FG002|EP: 48 Weeks|Other|0
4651065|NCT02091739|7532829|FG003|EP: 48 Weeks|Other|1
4651066|NCT02091739|7532830|FG004|EP: 48 Weeks|Other|0
4651067|NCT02091739|7532826|FG000|EP: 48 Weeks|Death|0
4651068|NCT02091739|7532827|FG001|EP: 48 Weeks|Death|0
4651069|NCT02091739|7532828|FG002|EP: 48 Weeks|Death|0
4651070|NCT02091739|7532829|FG003|EP: 48 Weeks|Death|3
4651071|NCT02091739|7532830|FG004|EP: 48 Weeks|Death|2
4651072|NCT02091739|7532826|FG000|EP: 48 Weeks|Adverse Event|0
4651073|NCT02091739|7532827|FG001|EP: 48 Weeks|Adverse Event|0
4651074|NCT02091739|7532828|FG002|EP: 48 Weeks|Adverse Event|0
4651075|NCT02091739|7532829|FG003|EP: 48 Weeks|Adverse Event|2
4651076|NCT02091739|7532830|FG004|EP: 48 Weeks|Adverse Event|6
4651077|NCT02091739|7532826|FG000|EP: 48 Weeks|Withdrawal by Subject|0
4651078|NCT02091739|7532827|FG001|EP: 48 Weeks|Withdrawal by Subject|0
4651079|NCT02091739|7532828|FG002|EP: 48 Weeks|Withdrawal by Subject|0
4651080|NCT02091739|7532829|FG003|EP: 48 Weeks|Withdrawal by Subject|2
4651081|NCT02091739|7532830|FG004|EP: 48 Weeks|Withdrawal by Subject|6
4747880|NCT04505722|7721988|FG000|Overall Study|Adverse Event|1
4747881|NCT04505722|7721989|FG001|Overall Study|Adverse Event|2
4747882|NCT04505722|7721988|FG000|Overall Study|Death|34
4747883|NCT04505722|7721989|FG001|Overall Study|Death|63
4747884|NCT04505722|7721988|FG000|Overall Study|Lost to Follow-up|271
4747885|NCT04505722|7721989|FG001|Overall Study|Lost to Follow-up|333
4747886|NCT04505722|7721988|FG000|Overall Study|Physician Decision|17
4747887|NCT04505722|7721989|FG001|Overall Study|Physician Decision|17
4747888|NCT04505722|7721988|FG000|Overall Study|Protocol Violation|0
4747889|NCT04505722|7721989|FG001|Overall Study|Protocol Violation|1
4747890|NCT04505722|7721988|FG000|Overall Study|Withdrawal by Subject|376
4747891|NCT04505722|7721989|FG001|Overall Study|Withdrawal by Subject|714
4747892|NCT04505722|7721988|FG000|Overall Study|Other|61
4747893|NCT04505722|7721989|FG001|Overall Study|Other|98
4747894|NCT04505722|7721988|FG000|Overall Study|Still ongoing|21138
4747895|NCT04505722|7721989|FG001|Overall Study|Still ongoing|20662
4747896|NCT04505722|7721988|FG000|Overall Study|Randomized not vaccinated|276
4747897|NCT04505722|7721989|FG001|Overall Study|Randomized not vaccinated|260
4747898|NCT03400943|7721999|FG000|Treatment Period 1|Adverse Event|0
4747899|NCT03400943|7722000|FG001|Treatment Period 1|Adverse Event|0
4747900|NCT03400943|7722001|FG002|Treatment Period 1|Adverse Event|0
4747901|NCT03400943|7722002|FG003|Treatment Period 1|Adverse Event|1
4747902|NCT03400943|7721999|FG000|Treatment Period 1|Lost to Follow-up|1
4747903|NCT03400943|7722000|FG001|Treatment Period 1|Lost to Follow-up|0
4747904|NCT03400943|7722001|FG002|Treatment Period 1|Lost to Follow-up|0
4747905|NCT03400943|7722002|FG003|Treatment Period 1|Lost to Follow-up|0
4747906|NCT03400943|7721999|FG000|Treatment Period 1|Protocol Violation|0
4747907|NCT03400943|7722000|FG001|Treatment Period 1|Protocol Violation|1
4747908|NCT03400943|7722001|FG002|Treatment Period 1|Protocol Violation|1
4747909|NCT03400943|7722002|FG003|Treatment Period 1|Protocol Violation|0
4651082|NCT02091869|7532859|FG000|Overall Study|Withdrawal by Subject|0
4651083|NCT02091869|7532860|FG001|Overall Study|Withdrawal by Subject|3
4747910|NCT03400943|7721999|FG000|Treatment Period 1|Study terminated by sponsor|2
4747911|NCT03400943|7722000|FG001|Treatment Period 1|Study terminated by sponsor|0
4747912|NCT03400943|7722001|FG002|Treatment Period 1|Study terminated by sponsor|0
4747913|NCT03400943|7722002|FG003|Treatment Period 1|Study terminated by sponsor|1
4747914|NCT03400943|7721999|FG000|Treatment Period 1|Withdrawal by Subject|0
4651084|NCT02091921|7532870|FG000|Overall Study|Adverse Event|3
4651085|NCT02091986|7532880|FG000|Overall Study|7 rand in error 1 patient decision|2
4651086|NCT02091986|7532881|FG001|Overall Study|7 rand in error 1 patient decision|3
4651087|NCT02091986|7532882|FG002|Overall Study|7 rand in error 1 patient decision|3
4651088|NCT02091986|7532880|FG000|Overall Study|Lost to Follow-up|1
4651089|NCT02091986|7532881|FG001|Overall Study|Lost to Follow-up|0
4651090|NCT02091986|7532882|FG002|Overall Study|Lost to Follow-up|0
4651091|NCT02091986|7532880|FG000|Overall Study|Withdrawal by Subject|4
4651092|NCT02091986|7532881|FG001|Overall Study|Withdrawal by Subject|8
4651093|NCT02091986|7532882|FG002|Overall Study|Withdrawal by Subject|3
4651094|NCT02091986|7532880|FG000|Overall Study|Adverse Event|0
4651095|NCT02091986|7532881|FG001|Overall Study|Adverse Event|0
4651096|NCT02091986|7532882|FG002|Overall Study|Adverse Event|2
4651097|NCT02092025|7532890|FG000|Overall Study|Case Report Forms Uncollected|44
4651098|NCT02092025|7532890|FG000|Overall Study|Protocol Deviation|24
4651099|NCT02092116|7532896|FG000|Overall Study|Withdrawal by Subject|0
4651100|NCT02092116|7532897|FG001|Overall Study|Withdrawal by Subject|3
4651101|NCT02092116|7532896|FG000|Overall Study|Adverse Event|0
4651102|NCT02092116|7532897|FG001|Overall Study|Adverse Event|1
4651103|NCT02092220|7532921|FG000|Period 1|Unrelated Illness|0
4651104|NCT02092220|7532922|FG001|Period 1|Unrelated Illness|2
4651105|NCT02092220|7532921|FG000|Period 2|Severe Hypoglycaemia|1
4651106|NCT02092220|7532922|FG001|Period 2|Severe Hypoglycaemia|0
4651107|NCT02092220|7532921|FG000|Period 2|Nausea, Anxiety, Inconvenience|0
4651108|NCT02092220|7532922|FG001|Period 2|Nausea, Anxiety, Inconvenience|1
4651109|NCT02092285|7532930|FG000|Induction Phase|Adverse Event|7
4651110|NCT02092285|7532930|FG000|Induction Phase|Physician Decision|4
4651111|NCT02092285|7532930|FG000|Induction Phase|Pregnancy|1
4651112|NCT02092285|7532930|FG000|Induction Phase|Relapse/Recurrence|7
4651113|NCT02092285|7532930|FG000|Induction Phase|Withdrawal by Subject|2
4651114|NCT02092285|7532930|FG000|Induction Phase|Lack of Efficacy|14
4651115|NCT02092285|7532930|FG000|Maintenance Phase & Follow-up|Adverse Event|22
4651116|NCT02092285|7532930|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1
4651117|NCT02092285|7532930|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2
4651118|NCT02092285|7532930|FG000|Maintenance Phase & Follow-up|Physician Decision|10
4651119|NCT02092285|7532930|FG000|Maintenance Phase & Follow-up|Pregnancy|1
4651120|NCT02092285|7532930|FG000|Maintenance Phase & Follow-up|Protocol Violation|11
4651121|NCT02092285|7532930|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29
4651122|NCT02092285|7532930|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11
4651123|NCT02092285|7532930|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23
4651124|NCT02092324|7532949|FG000|Overall Study|Adverse Event|1
4651125|NCT02092324|7532949|FG000|Overall Study|Lack of Efficacy|6
4651126|NCT02092324|7532949|FG000|Overall Study|Proceed to Transplant|3
4651127|NCT02092324|7532949|FG000|Overall Study|Physician Decision|7
4651128|NCT02092324|7532949|FG000|Overall Study|Misdiagnosis|2
4651129|NCT02092350|7532958|FG000|Overall Study|Adverse Event|0
4651130|NCT02092350|7532959|FG001|Overall Study|Adverse Event|3
4651131|NCT02092350|7532958|FG000|Overall Study|Death|2
4651132|NCT02092350|7532959|FG001|Overall Study|Death|5
4651133|NCT02092350|7532958|FG000|Overall Study|Lost to Follow-up|3
4651134|NCT02092350|7532959|FG001|Overall Study|Lost to Follow-up|1
4651135|NCT02092350|7532958|FG000|Overall Study|Protocol Violation|1
4651136|NCT02092350|7532959|FG001|Overall Study|Protocol Violation|0
4651137|NCT02092350|7532958|FG000|Overall Study|Physician Decision|1
4651138|NCT02092350|7532959|FG001|Overall Study|Physician Decision|1
4651139|NCT02092350|7532958|FG000|Overall Study|Screen Failure|1
4651140|NCT02092350|7532959|FG001|Overall Study|Screen Failure|0
4651141|NCT02092350|7532958|FG000|Overall Study|Withdrawal by Subject|2
4651142|NCT02092350|7532959|FG001|Overall Study|Withdrawal by Subject|2
4651143|NCT02092389|7532967|FG000|Overall Study|Adverse Event|1
4651144|NCT02092389|7532967|FG000|Overall Study|Other|5
4651145|NCT02092467|7532988|FG000|Overall Study|Death|49
4651146|NCT02092467|7532989|FG001|Overall Study|Death|66
4651147|NCT02092467|7532990|FG002|Overall Study|Death|38
4651148|NCT02092467|7532988|FG000|Overall Study|Lost to Follow-up|38
4651149|NCT02092467|7532989|FG001|Overall Study|Lost to Follow-up|35
4651150|NCT02092467|7532990|FG002|Overall Study|Lost to Follow-up|40
4651151|NCT02092467|7532988|FG000|Overall Study|Global Deterioration of Health Status|1
4651152|NCT02092467|7532989|FG001|Overall Study|Global Deterioration of Health Status|0
4651153|NCT02092467|7532990|FG002|Overall Study|Global Deterioration of Health Status|0
4651154|NCT02092467|7532988|FG000|Overall Study|Other|32
4651155|NCT02092467|7532989|FG001|Overall Study|Other|30
4651156|NCT02092467|7532990|FG002|Overall Study|Other|24
4651157|NCT02092467|7532988|FG000|Overall Study|Withdrawal by Subject|282
4651158|NCT02092467|7532989|FG001|Overall Study|Withdrawal by Subject|327
4651159|NCT02092467|7532990|FG002|Overall Study|Withdrawal by Subject|289
4651160|NCT02092467|7532988|FG000|Overall Study|Randomized but not treated|2
4651161|NCT02092467|7532989|FG001|Overall Study|Randomized but not treated|1
4651162|NCT02092467|7532990|FG002|Overall Study|Randomized but not treated|7
4651163|NCT02092662|7533020|FG000|Overall Study|Lost to Follow-up|13
4651164|NCT02092662|7533021|FG001|Overall Study|Lost to Follow-up|0
4651165|NCT02092909|7533045|FG000|Overall Study|Adverse Event|0
4651166|NCT02092909|7533046|FG001|Overall Study|Adverse Event|0
4651167|NCT02092909|7533047|FG002|Overall Study|Adverse Event|4
4651168|NCT02092909|7533048|FG003|Overall Study|Adverse Event|2
4651169|NCT02092909|7533045|FG000|Overall Study|Lack of Efficacy|0
4651170|NCT02092909|7533046|FG001|Overall Study|Lack of Efficacy|2
4651171|NCT02092909|7533047|FG002|Overall Study|Lack of Efficacy|1
4651172|NCT02092909|7533048|FG003|Overall Study|Lack of Efficacy|0
4651173|NCT02092909|7533045|FG000|Overall Study|Withdrawal by Subject|0
4651174|NCT02092909|7533046|FG001|Overall Study|Withdrawal by Subject|0
4651175|NCT02092909|7533047|FG002|Overall Study|Withdrawal by Subject|2
4651176|NCT02092909|7533048|FG003|Overall Study|Withdrawal by Subject|1
4651177|NCT02092909|7533045|FG000|Overall Study|Study terminated by Sponsor|0
4651178|NCT02092909|7533046|FG001|Overall Study|Study terminated by Sponsor|0
4651179|NCT02092909|7533047|FG002|Overall Study|Study terminated by Sponsor|0
4651180|NCT02092909|7533048|FG003|Overall Study|Study terminated by Sponsor|2
4651181|NCT02092909|7533045|FG000|Overall Study|Miscellaneous|1
4651182|NCT02092909|7533046|FG001|Overall Study|Miscellaneous|1
4651183|NCT02092909|7533047|FG002|Overall Study|Miscellaneous|2
4651184|NCT02092909|7533048|FG003|Overall Study|Miscellaneous|1
4651185|NCT02092961|7533061|FG000|Overall Study|Not reported|1
4651186|NCT02092961|7533062|FG001|Overall Study|Not reported|0
4651187|NCT02092961|7533063|FG002|Overall Study|Not reported|1
4651188|NCT02092961|7533061|FG000|Overall Study|Study stopped|13
4651189|NCT02092961|7533062|FG001|Overall Study|Study stopped|9
4651190|NCT02092961|7533063|FG002|Overall Study|Study stopped|12
4651191|NCT02092961|7533061|FG000|Overall Study|Lack of therapeutic response|2
4651192|NCT02092961|7533062|FG001|Overall Study|Lack of therapeutic response|1
4651193|NCT02092961|7533063|FG002|Overall Study|Lack of therapeutic response|3
4651194|NCT02092961|7533061|FG000|Overall Study|Dev. of study specific discont. criteria|3
4651195|NCT02092961|7533062|FG001|Overall Study|Dev. of study specific discont. criteria|0
4651196|NCT02092961|7533063|FG002|Overall Study|Dev. of study specific discont. criteria|0
4651197|NCT02092961|7533061|FG000|Overall Study|Adverse Event|2
4651198|NCT02092961|7533062|FG001|Overall Study|Adverse Event|4
4651199|NCT02092961|7533063|FG002|Overall Study|Adverse Event|0
4651200|NCT02093026|7533084|FG000|Overall Study|Adverse Event|26
4651201|NCT02093026|7533084|FG000|Overall Study|Death|10
4651202|NCT02093026|7533084|FG000|Overall Study|Other|157
4651203|NCT02093221|7533094|FG000|Overall Study|Adverse Event|1
4651204|NCT02093221|7533095|FG001|Overall Study|Adverse Event|0
4651205|NCT02093221|7533096|FG002|Overall Study|Adverse Event|0
4651206|NCT02093221|7533097|FG003|Overall Study|Adverse Event|0
4651207|NCT02093221|7533098|FG004|Overall Study|Adverse Event|0
4651208|NCT02093221|7533094|FG000|Overall Study|Withdrawal by Subject|1
4651209|NCT02093221|7533095|FG001|Overall Study|Withdrawal by Subject|1
4651210|NCT02093221|7533096|FG002|Overall Study|Withdrawal by Subject|4
4651211|NCT02093221|7533097|FG003|Overall Study|Withdrawal by Subject|1
4651212|NCT02093221|7533098|FG004|Overall Study|Withdrawal by Subject|1
4651213|NCT02093221|7533094|FG000|Overall Study|Lost to Follow-up|2
4651214|NCT02093221|7533095|FG001|Overall Study|Lost to Follow-up|0
4651215|NCT02093221|7533096|FG002|Overall Study|Lost to Follow-up|1
4651216|NCT02093221|7533097|FG003|Overall Study|Lost to Follow-up|1
4651217|NCT02093221|7533098|FG004|Overall Study|Lost to Follow-up|0
4651218|NCT02093221|7533094|FG000|Overall Study|Death|0
4651219|NCT02093221|7533095|FG001|Overall Study|Death|1
4651220|NCT02093221|7533096|FG002|Overall Study|Death|0
4651221|NCT02093221|7533097|FG003|Overall Study|Death|0
4651222|NCT02093221|7533098|FG004|Overall Study|Death|0
4651223|NCT02093221|7533094|FG000|Overall Study|Protocol Violation|0
4651224|NCT02093221|7533095|FG001|Overall Study|Protocol Violation|1
4651225|NCT02093221|7533096|FG002|Overall Study|Protocol Violation|0
4651226|NCT02093221|7533097|FG003|Overall Study|Protocol Violation|0
4651227|NCT02093221|7533098|FG004|Overall Study|Protocol Violation|0
4651228|NCT02093221|7533094|FG000|Overall Study|Study termination|6
4651229|NCT02093221|7533095|FG001|Overall Study|Study termination|5
4651230|NCT02093221|7533096|FG002|Overall Study|Study termination|4
4651231|NCT02093221|7533097|FG003|Overall Study|Study termination|6
4651232|NCT02093221|7533098|FG004|Overall Study|Study termination|7
4651233|NCT02093351|7533126|FG000|Part A|Adverse Event|0
4651234|NCT02093351|7533127|FG001|Part A|Adverse Event|1
4651235|NCT02093351|7533128|FG002|Part A|Adverse Event|1
4651236|NCT02093351|7533129|FG003|Part A|Adverse Event|0
4651237|NCT02093351|7533126|FG000|Part A|Condition under investigation worsened|2
4651238|NCT02093351|7533127|FG001|Part A|Condition under investigation worsened|0
4651239|NCT02093351|7533128|FG002|Part A|Condition under investigation worsened|2
4651240|NCT02093351|7533129|FG003|Part A|Condition under investigation worsened|0
4747915|NCT03400943|7722000|FG001|Treatment Period 1|Withdrawal by Subject|0
4747916|NCT03400943|7722001|FG002|Treatment Period 1|Withdrawal by Subject|3
4747917|NCT03400943|7722002|FG003|Treatment Period 1|Withdrawal by Subject|1
4651241|NCT02093351|7533126|FG000|Part A|Death|0
4651242|NCT02093351|7533127|FG001|Part A|Death|1
4651243|NCT02093351|7533128|FG002|Part A|Death|0
4651244|NCT02093351|7533129|FG003|Part A|Death|0
4651245|NCT02093351|7533126|FG000|Part B|Patient decision|0
4651246|NCT02093351|7533127|FG001|Part B|Patient decision|0
4651247|NCT02093351|7533128|FG002|Part B|Patient decision|0
4651248|NCT02093351|7533129|FG003|Part B|Patient decision|3
4651249|NCT02093351|7533126|FG000|Part B|Disease progression|0
4651250|NCT02093351|7533127|FG001|Part B|Disease progression|0
4651251|NCT02093351|7533128|FG002|Part B|Disease progression|0
4651252|NCT02093351|7533129|FG003|Part B|Disease progression|4
4747918|NCT03400943|7721999|FG000|Treatment Period 1|Other|2
4747919|NCT03400943|7722000|FG001|Treatment Period 1|Other|1
4747920|NCT03400943|7722001|FG002|Treatment Period 1|Other|2
4747921|NCT03400943|7722002|FG003|Treatment Period 1|Other|2
4747922|NCT03400943|7721999|FG000|Post-treatment Period 1|Adverse Event|2
4651253|NCT02093351|7533126|FG000|Part B|Complete response|0
4651254|NCT02093351|7533127|FG001|Part B|Complete response|0
4651255|NCT02093351|7533128|FG002|Part B|Complete response|0
4651256|NCT02093351|7533129|FG003|Part B|Complete response|1
4651257|NCT02093351|7533126|FG000|Part B|Adverse event + disease progression|0
4651258|NCT02093351|7533127|FG001|Part B|Adverse event + disease progression|0
4651259|NCT02093351|7533128|FG002|Part B|Adverse event + disease progression|0
4651260|NCT02093351|7533129|FG003|Part B|Adverse event + disease progression|1
4651261|NCT02093351|7533126|FG000|Part B|Lack of therapeutic response|0
4651262|NCT02093351|7533127|FG001|Part B|Lack of therapeutic response|0
4651263|NCT02093351|7533128|FG002|Part B|Lack of therapeutic response|0
4651264|NCT02093351|7533129|FG003|Part B|Lack of therapeutic response|12
4651265|NCT02093351|7533126|FG000|Part B|Condition under investigation worsened|0
4651266|NCT02093351|7533127|FG001|Part B|Condition under investigation worsened|0
4651267|NCT02093351|7533128|FG002|Part B|Condition under investigation worsened|0
4651268|NCT02093351|7533129|FG003|Part B|Condition under investigation worsened|39
4651269|NCT02093351|7533126|FG000|Part B|Adverse Event|0
4651270|NCT02093351|7533127|FG001|Part B|Adverse Event|0
4651271|NCT02093351|7533128|FG002|Part B|Adverse Event|0
4651272|NCT02093351|7533129|FG003|Part B|Adverse Event|2
4651273|NCT02093351|7533126|FG000|Part B|Death|0
4651274|NCT02093351|7533127|FG001|Part B|Death|0
4651275|NCT02093351|7533128|FG002|Part B|Death|0
4651276|NCT02093351|7533129|FG003|Part B|Death|1
4651277|NCT02093390|7533146|FG000|Overall Study|Withdrawal by Subject|0
4651278|NCT02093390|7533147|FG001|Overall Study|Withdrawal by Subject|1
4651279|NCT02093520|7533156|FG000|Overall Study|Not treated|6
4651280|NCT02093520|7533157|FG001|Overall Study|Not treated|22
4651281|NCT02093663|7533163|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1
4651282|NCT02093663|7533164|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0
4651283|NCT02093663|7533165|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0
4651284|NCT02093663|7533166|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0
4651285|NCT02093663|7533167|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0
4651286|NCT02093663|7533163|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5
4651287|NCT02093663|7533164|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0
4651288|NCT02093663|7533165|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0
4651289|NCT02093663|7533166|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0
4651290|NCT02093663|7533167|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0
4651291|NCT02093663|7533163|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2
4651292|NCT02093663|7533164|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4
4651293|NCT02093663|7533165|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0
4651294|NCT02093663|7533166|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0
4651295|NCT02093663|7533167|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0
4651296|NCT02093663|7533163|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0
4651297|NCT02093663|7533164|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0
4651298|NCT02093663|7533165|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1
4651299|NCT02093663|7533166|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0
4651300|NCT02093663|7533167|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0
4651301|NCT02093663|7533163|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0
4651302|NCT02093663|7533164|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0
4651303|NCT02093663|7533165|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5
4651304|NCT02093663|7533166|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0
4651305|NCT02093663|7533167|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0
4651306|NCT02093663|7533163|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0
4651307|NCT02093663|7533164|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0
4651308|NCT02093663|7533165|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0
4651309|NCT02093663|7533166|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3
4651310|NCT02093663|7533167|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2
4651311|NCT02093663|7533163|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0
4651312|NCT02093663|7533164|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0
4651313|NCT02093663|7533165|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0
4651314|NCT02093663|7533166|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6
4651315|NCT02093663|7533167|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7
4651316|NCT02093663|7533163|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0
4651317|NCT02093663|7533164|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0
4651318|NCT02093663|7533165|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0
4651319|NCT02093663|7533166|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1
4651320|NCT02093663|7533167|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1
4651321|NCT02093663|7533163|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0
4651322|NCT02093663|7533164|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0
4651323|NCT02093663|7533165|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0
4651324|NCT02093663|7533166|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0
4651325|NCT02093663|7533167|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1
4651326|NCT02093897|7533249|FG000|Overall Study|Physician Decision|1
4651327|NCT02093897|7533249|FG000|Overall Study|Planned age group closure - no's reached|17
4651328|NCT02093897|7533249|FG000|Overall Study|Adverse event, non-fatal|1
4651329|NCT02093923|7533265|FG000|Overall Study|Lost to Follow-up|0
4651330|NCT02093923|7533266|FG001|Overall Study|Lost to Follow-up|0
4651331|NCT02093923|7533267|FG002|Overall Study|Lost to Follow-up|0
4651332|NCT02093923|7533268|FG003|Overall Study|Lost to Follow-up|1
4651333|NCT02093923|7533269|FG004|Overall Study|Lost to Follow-up|0
4651334|NCT02093923|7533265|FG000|Overall Study|Screen failure after randomization|0
4651335|NCT02093923|7533266|FG001|Overall Study|Screen failure after randomization|0
4651336|NCT02093923|7533267|FG002|Overall Study|Screen failure after randomization|0
4651337|NCT02093923|7533268|FG003|Overall Study|Screen failure after randomization|1
4651338|NCT02093923|7533269|FG004|Overall Study|Screen failure after randomization|0
4747923|NCT03400943|7722000|FG001|Post-treatment Period 1|Adverse Event|0
4747924|NCT03400943|7722001|FG002|Post-treatment Period 1|Adverse Event|0
4747925|NCT03400943|7722002|FG003|Post-treatment Period 1|Adverse Event|0
4747926|NCT03400943|7721999|FG000|Post-treatment Period 1|Protocol Violation|1
4747927|NCT03400943|7722000|FG001|Post-treatment Period 1|Protocol Violation|0
4747928|NCT03400943|7722001|FG002|Post-treatment Period 1|Protocol Violation|0
4747929|NCT03400943|7722002|FG003|Post-treatment Period 1|Protocol Violation|0
4747930|NCT03400943|7721999|FG000|Post-treatment Period 1|Study terminated by sponsor|5
4747931|NCT03400943|7722000|FG001|Post-treatment Period 1|Study terminated by sponsor|0
4747932|NCT03400943|7722001|FG002|Post-treatment Period 1|Study terminated by sponsor|5
4747933|NCT03400943|7722002|FG003|Post-treatment Period 1|Study terminated by sponsor|6
4747934|NCT03400943|7721999|FG000|Post-treatment Period 1|Withdrawal by Subject|1
4747935|NCT03400943|7722000|FG001|Post-treatment Period 1|Withdrawal by Subject|0
4747936|NCT03400943|7722001|FG002|Post-treatment Period 1|Withdrawal by Subject|2
4747937|NCT03400943|7722002|FG003|Post-treatment Period 1|Withdrawal by Subject|2
4747938|NCT03400943|7721999|FG000|Post-treatment Period 1|Other|2
4747939|NCT03400943|7722000|FG001|Post-treatment Period 1|Other|0
4747940|NCT03400943|7722001|FG002|Post-treatment Period 1|Other|4
4747941|NCT03400943|7722002|FG003|Post-treatment Period 1|Other|5
4747942|NCT03400943|7721999|FG000|Treatment Period 2|Study terminated by sponsor|0
4747943|NCT03400943|7722000|FG001|Treatment Period 2|Study terminated by sponsor|1
4747944|NCT03400943|7722001|FG002|Treatment Period 2|Study terminated by sponsor|0
4747945|NCT03400943|7722002|FG003|Treatment Period 2|Study terminated by sponsor|0
4747946|NCT03400943|7721999|FG000|Treatment Period 2|Withdrawal by Subject|0
4747947|NCT03400943|7722000|FG001|Treatment Period 2|Withdrawal by Subject|1
4747948|NCT03400943|7722001|FG002|Treatment Period 2|Withdrawal by Subject|0
4747949|NCT03400943|7722002|FG003|Treatment Period 2|Withdrawal by Subject|0
4747950|NCT03400943|7721999|FG000|Treatment Period 2|Other|1
4747951|NCT03400943|7722000|FG001|Treatment Period 2|Other|6
4747952|NCT03400943|7722001|FG002|Treatment Period 2|Other|0
4747953|NCT03400943|7722002|FG003|Treatment Period 2|Other|0
4747954|NCT03400943|7721999|FG000|Follow-up Period|Withdrawal by Subject|1
4747955|NCT03400943|7722000|FG001|Follow-up Period|Withdrawal by Subject|0
4747956|NCT03400943|7722001|FG002|Follow-up Period|Withdrawal by Subject|0
4747957|NCT03400943|7722002|FG003|Follow-up Period|Withdrawal by Subject|0
4747958|NCT03288142|7722016|FG000|Overall Study|Lost to Follow-up|22
4747959|NCT03288142|7722017|FG001|Overall Study|Lost to Follow-up|15
4747960|NCT03112603|7722027|FG000|End of Randomization Period|Lost to Follow-up|1
4747961|NCT03112603|7722028|FG001|End of Randomization Period|Lost to Follow-up|0
4747962|NCT03112603|7722029|FG002|End of Randomization Period|Lost to Follow-up|0
4747963|NCT03112603|7722027|FG000|End of Randomization Period|Subject/Guardian Decision|4
4747964|NCT03112603|7722028|FG001|End of Randomization Period|Subject/Guardian Decision|11
4747965|NCT03112603|7722029|FG002|End of Randomization Period|Subject/Guardian Decision|0
4747966|NCT03112603|7722027|FG000|End of Randomization Period|Physician Decision|4
4747967|NCT03112603|7722028|FG001|End of Randomization Period|Physician Decision|14
4747968|NCT03112603|7722029|FG002|End of Randomization Period|Physician Decision|0
4747969|NCT03112603|7722027|FG000|End of Randomization Period|Failure to meet protocol continuation criteria|4
4747970|NCT03112603|7722028|FG001|End of Randomization Period|Failure to meet protocol continuation criteria|5
4747971|NCT03112603|7722029|FG002|End of Randomization Period|Failure to meet protocol continuation criteria|0
4747972|NCT03112603|7722027|FG000|End of Randomization Period|Death|8
4747973|NCT03112603|7722028|FG001|End of Randomization Period|Death|7
4747974|NCT03112603|7722029|FG002|End of Randomization Period|Death|0
4747975|NCT03112603|7722027|FG000|End of Randomization Period|Disease Relapse|9
4747976|NCT03112603|7722028|FG001|End of Randomization Period|Disease Relapse|7
4747977|NCT03112603|7722029|FG002|End of Randomization Period|Disease Relapse|0
4747978|NCT03112603|7722027|FG000|End of Randomization Period|Lack of Efficacy|24
4747979|NCT03112603|7722028|FG001|End of Randomization Period|Lack of Efficacy|70
4747980|NCT03112603|7722029|FG002|End of Randomization Period|Lack of Efficacy|0
4747981|NCT03112603|7722027|FG000|End of Randomization Period|Adverse Event|28
4747982|NCT03112603|7722028|FG001|End of Randomization Period|Adverse Event|8
4747983|NCT03112603|7722029|FG002|End of Randomization Period|Adverse Event|0
4747984|NCT03112603|7722027|FG000|End of Randomization Period|Ongoing Treatment|83
4747985|NCT03112603|7722028|FG001|End of Randomization Period|Ongoing Treatment|42
4747986|NCT03112603|7722029|FG002|End of Randomization Period|Ongoing Treatment|0
4747987|NCT03112603|7722027|FG000|End of Cross Over Period|Death|0
4747988|NCT03112603|7722028|FG001|End of Cross Over Period|Death|0
4747989|NCT03112603|7722029|FG002|End of Cross Over Period|Death|1
4651339|NCT02094300|7533324|FG000|Overall Study|Death|7
4651340|NCT02094300|7533324|FG000|Overall Study|Lost to Follow-up|10
4651341|NCT02094300|7533324|FG000|Overall Study|Still be eligible for follow-up|3
4651342|NCT02094417|7533337|FG000|Overall Study|Adverse Event|0
4651343|NCT02094417|7533338|FG001|Overall Study|Adverse Event|0
4651344|NCT02094417|7533339|FG002|Overall Study|Adverse Event|0
4651345|NCT02094417|7533340|FG003|Overall Study|Adverse Event|1
4651346|NCT02094417|7533337|FG000|Overall Study|Eligibility criteria|0
4651347|NCT02094417|7533338|FG001|Overall Study|Eligibility criteria|1
4651348|NCT02094417|7533339|FG002|Overall Study|Eligibility criteria|0
4651349|NCT02094417|7533340|FG003|Overall Study|Eligibility criteria|0
4651350|NCT02094417|7533337|FG000|Overall Study|No responder|4
4651351|NCT02094417|7533338|FG001|Overall Study|No responder|4
4651352|NCT02094417|7533339|FG002|Overall Study|No responder|4
4651353|NCT02094417|7533340|FG003|Overall Study|No responder|3
4651354|NCT02094417|7533337|FG000|Overall Study|Unable to conduct observations or assess|0
4651355|NCT02094417|7533338|FG001|Overall Study|Unable to conduct observations or assess|1
4651356|NCT02094417|7533339|FG002|Overall Study|Unable to conduct observations or assess|0
4651357|NCT02094417|7533340|FG003|Overall Study|Unable to conduct observations or assess|0
4651358|NCT02094417|7533337|FG000|Overall Study|Withdrawal by Subject|1
4651359|NCT02094417|7533338|FG001|Overall Study|Withdrawal by Subject|2
4651360|NCT02094417|7533339|FG002|Overall Study|Withdrawal by Subject|1
4651361|NCT02094417|7533340|FG003|Overall Study|Withdrawal by Subject|3
4651362|NCT02094573|7533370|FG000|Overall Study|Adverse Event|4
4651363|NCT02094573|7533371|FG001|Overall Study|Adverse Event|14
4651364|NCT02094573|7533370|FG000|Overall Study|Clinical Progressive Disease|9
4651365|NCT02094573|7533371|FG001|Overall Study|Clinical Progressive Disease|13
4651366|NCT02094573|7533370|FG000|Overall Study|Death|11
4651367|NCT02094573|7533371|FG001|Overall Study|Death|3
4651368|NCT02094573|7533370|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63
4651369|NCT02094573|7533371|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50
4747990|NCT03112603|7722027|FG000|End of Cross Over Period|Subject/Guardian Decision|0
4747991|NCT03112603|7722028|FG001|End of Cross Over Period|Subject/Guardian Decision|0
4747992|NCT03112603|7722029|FG002|End of Cross Over Period|Subject/Guardian Decision|3
4747993|NCT03112603|7722027|FG000|End of Cross Over Period|Physician Decision|0
4747994|NCT03112603|7722028|FG001|End of Cross Over Period|Physician Decision|0
4747995|NCT03112603|7722029|FG002|End of Cross Over Period|Physician Decision|3
4747996|NCT03112603|7722027|FG000|End of Cross Over Period|Lack of Efficacy|0
4747997|NCT03112603|7722028|FG001|End of Cross Over Period|Lack of Efficacy|0
4747998|NCT03112603|7722029|FG002|End of Cross Over Period|Lack of Efficacy|4
4747999|NCT03112603|7722027|FG000|End of Cross Over Period|Adverse Event|0
4748000|NCT03112603|7722028|FG001|End of Cross Over Period|Adverse Event|0
4748001|NCT03112603|7722029|FG002|End of Cross Over Period|Adverse Event|4
4748002|NCT03112603|7722027|FG000|End of Cross Over Period|Treatment Ongoing|0
4748003|NCT03112603|7722028|FG001|End of Cross Over Period|Treatment Ongoing|0
4748004|NCT03112603|7722029|FG002|End of Cross Over Period|Treatment Ongoing|46
4748005|NCT02949934|7722041|FG000|Natural Drinking Period|Adverse Event|1
4748006|NCT02949934|7722042|FG001|Natural Drinking Period|Adverse Event|0
4748007|NCT02949934|7722043|FG002|Natural Drinking Period|Adverse Event|0
4748008|NCT02949934|7722044|FG003|Natural Drinking Period|Adverse Event|1
4748009|NCT02949934|7722045|FG004|Natural Drinking Period|Adverse Event|0
4748010|NCT02949934|7722046|FG005|Natural Drinking Period|Adverse Event|0
4748011|NCT02949934|7722041|FG000|Natural Drinking Period|Lost to Follow-up|0
4748012|NCT02949934|7722042|FG001|Natural Drinking Period|Lost to Follow-up|0
4748013|NCT02949934|7722043|FG002|Natural Drinking Period|Lost to Follow-up|0
4748014|NCT02949934|7722044|FG003|Natural Drinking Period|Lost to Follow-up|0
4748015|NCT02949934|7722045|FG004|Natural Drinking Period|Lost to Follow-up|1
4748016|NCT02949934|7722046|FG005|Natural Drinking Period|Lost to Follow-up|0
4748017|NCT02949934|7722041|FG000|Neuroimaging|Protocol Violation|2
4748018|NCT02949934|7722042|FG001|Neuroimaging|Protocol Violation|0
4748019|NCT02949934|7722043|FG002|Neuroimaging|Protocol Violation|0
4748020|NCT02949934|7722044|FG003|Neuroimaging|Protocol Violation|0
4748021|NCT02949934|7722045|FG004|Neuroimaging|Protocol Violation|1
4748022|NCT02949934|7722046|FG005|Neuroimaging|Protocol Violation|0
4748023|NCT02949934|7722041|FG000|Neuroimaging|Motion artifacts in imaging data|1
4748024|NCT02949934|7722042|FG001|Neuroimaging|Motion artifacts in imaging data|0
4748025|NCT02949934|7722043|FG002|Neuroimaging|Motion artifacts in imaging data|1
4748026|NCT02949934|7722044|FG003|Neuroimaging|Motion artifacts in imaging data|0
4748027|NCT02949934|7722045|FG004|Neuroimaging|Motion artifacts in imaging data|1
4748028|NCT02949934|7722046|FG005|Neuroimaging|Motion artifacts in imaging data|0
4748029|NCT02949934|7722041|FG000|Neuroimaging|Not scanned|0
4748030|NCT02949934|7722042|FG001|Neuroimaging|Not scanned|0
4748031|NCT02949934|7722043|FG002|Neuroimaging|Not scanned|1
4748032|NCT02949934|7722044|FG003|Neuroimaging|Not scanned|0
4748033|NCT02949934|7722045|FG004|Neuroimaging|Not scanned|0
4748034|NCT02949934|7722046|FG005|Neuroimaging|Not scanned|2
4748035|NCT02949934|7722041|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0
4748036|NCT02949934|7722042|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5
4748037|NCT02949934|7722043|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5
4748038|NCT02949934|7722044|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3
4651370|NCT02094573|7533370|FG000|Overall Study|Non-compliance with Study Drug|1
4651371|NCT02094573|7533371|FG001|Overall Study|Non-compliance with Study Drug|1
4651372|NCT02094573|7533370|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1
4651373|NCT02094573|7533371|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0
4651374|NCT02094573|7533370|FG000|Overall Study|Physician Decision|4
4651375|NCT02094573|7533371|FG001|Overall Study|Physician Decision|4
4651376|NCT02094573|7533370|FG000|Overall Study|Site Terminated by Sponsor|10
4651377|NCT02094573|7533371|FG001|Overall Study|Site Terminated by Sponsor|17
4651378|NCT02094573|7533370|FG000|Overall Study|Withdrawal by Subject|6
4651379|NCT02094573|7533371|FG001|Overall Study|Withdrawal by Subject|8
4651380|NCT02094573|7533370|FG000|Overall Study|Randomized but not Treated|3
4651381|NCT02094573|7533371|FG001|Overall Study|Randomized but not Treated|0
4651382|NCT02094612|7533408|FG000|Overall Study|Lost to Follow-up|47
4651383|NCT02094612|7533409|FG001|Overall Study|Lost to Follow-up|47
4651384|NCT02094612|7533408|FG000|Overall Study|Never started ADHD medication|32
4651385|NCT02094612|7533409|FG001|Overall Study|Never started ADHD medication|23
4651386|NCT02094677|7533426|FG000|Overall Study|Screening|3
4651387|NCT02094677|7533427|FG001|Overall Study|Screening|1
4651388|NCT02094885|7533450|FG000|Overall Study|Death|1
4651389|NCT02094885|7533451|FG001|Overall Study|Death|5
4651390|NCT02094885|7533450|FG000|Overall Study|Withdrawn due to age|1
4651391|NCT02094885|7533451|FG001|Overall Study|Withdrawn due to age|0
4651392|NCT02094898|7533457|FG000|Overall Study|Clinical Worsening|2
4651393|NCT02094898|7533457|FG000|Overall Study|Adverse Event|2
4651394|NCT02094898|7533457|FG000|Overall Study|Lack of Efficacy|1
4651395|NCT02094937|7533463|FG000|8 Weeks in Period 1|Adverse Event|9
4651396|NCT02094937|7533464|FG001|8 Weeks in Period 1|Adverse Event|0
4651397|NCT02094937|7533465|FG002|8 Weeks in Period 1|Adverse Event|0
4651398|NCT02094937|7533466|FG003|8 Weeks in Period 1|Adverse Event|0
4651399|NCT02094937|7533463|FG000|8 Weeks in Period 1|Lack of Efficacy|3
4651400|NCT02094937|7533464|FG001|8 Weeks in Period 1|Lack of Efficacy|0
4651401|NCT02094937|7533465|FG002|8 Weeks in Period 1|Lack of Efficacy|0
4651402|NCT02094937|7533466|FG003|8 Weeks in Period 1|Lack of Efficacy|0
4651403|NCT02094937|7533463|FG000|8 Weeks in Period 1|Protocol Violation|2
4651404|NCT02094937|7533464|FG001|8 Weeks in Period 1|Protocol Violation|0
4651405|NCT02094937|7533465|FG002|8 Weeks in Period 1|Protocol Violation|0
4651406|NCT02094937|7533466|FG003|8 Weeks in Period 1|Protocol Violation|0
4651407|NCT02094937|7533463|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41
4651408|NCT02094937|7533464|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0
4651409|NCT02094937|7533465|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0
4651410|NCT02094937|7533466|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0
4651411|NCT02094937|7533463|FG000|8 Weeks in Period 1|Physician Decision|1
4651412|NCT02094937|7533464|FG001|8 Weeks in Period 1|Physician Decision|0
4651413|NCT02094937|7533465|FG002|8 Weeks in Period 1|Physician Decision|0
4651414|NCT02094937|7533466|FG003|8 Weeks in Period 1|Physician Decision|0
4651415|NCT02094937|7533463|FG000|8 Weeks in Period 1|Withdrawal by Subject|4
4651416|NCT02094937|7533464|FG001|8 Weeks in Period 1|Withdrawal by Subject|0
4651417|NCT02094937|7533465|FG002|8 Weeks in Period 1|Withdrawal by Subject|0
4651418|NCT02094937|7533466|FG003|8 Weeks in Period 1|Withdrawal by Subject|0
4651419|NCT02094937|7533463|FG000|12 Weeks in Period 2|Adverse Event|0
4651420|NCT02094937|7533464|FG001|12 Weeks in Period 2|Adverse Event|2
4651421|NCT02094937|7533465|FG002|12 Weeks in Period 2|Adverse Event|4
4651422|NCT02094937|7533466|FG003|12 Weeks in Period 2|Adverse Event|1
4651423|NCT02094937|7533463|FG000|12 Weeks in Period 2|Lack of Efficacy|0
4651424|NCT02094937|7533464|FG001|12 Weeks in Period 2|Lack of Efficacy|1
4651425|NCT02094937|7533465|FG002|12 Weeks in Period 2|Lack of Efficacy|0
4651426|NCT02094937|7533466|FG003|12 Weeks in Period 2|Lack of Efficacy|0
4651427|NCT02094937|7533463|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0
4651428|NCT02094937|7533464|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5
4651429|NCT02094937|7533465|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6
4651430|NCT02094937|7533466|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11
4651431|NCT02094937|7533463|FG000|12 Weeks in Period 2|Withdrawal by Subject|0
4651432|NCT02094937|7533464|FG001|12 Weeks in Period 2|Withdrawal by Subject|2
4651433|NCT02094937|7533465|FG002|12 Weeks in Period 2|Withdrawal by Subject|2
4651434|NCT02094937|7533466|FG003|12 Weeks in Period 2|Withdrawal by Subject|0
4651435|NCT02094937|7533463|FG000|12 Weeks in Period 2|Randomized incorrectly|0
4651436|NCT02094937|7533464|FG001|12 Weeks in Period 2|Randomized incorrectly|1
4651437|NCT02094937|7533465|FG002|12 Weeks in Period 2|Randomized incorrectly|0
4651438|NCT02094937|7533466|FG003|12 Weeks in Period 2|Randomized incorrectly|0
4651439|NCT02095106|7533477|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0
4651440|NCT02095106|7533478|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1
4651441|NCT02095145|7533490|FG000|Overall Study|Withdrawal by Subject|1
4651442|NCT02095145|7533491|FG001|Overall Study|Withdrawal by Subject|0
4651443|NCT02095158|7533499|FG000|Overall Study|Adverse Event|14
4651444|NCT02095158|7533499|FG000|Overall Study|Lack of Efficacy|3
4651445|NCT02095158|7533499|FG000|Overall Study|Pregnancy|1
4651446|NCT02095158|7533499|FG000|Overall Study|Lost to Follow-up|20
4651447|NCT02095158|7533499|FG000|Overall Study|Personal Reasons|35
4651448|NCT02095158|7533499|FG000|Overall Study|Protocol Violation|1
4651449|NCT02095158|7533499|FG000|Overall Study|Other Miscellaneous Reasons|1
4651450|NCT02095197|7533505|FG000|Overall Study|Lost to Follow-up|0
4651451|NCT02095197|7533506|FG001|Overall Study|Lost to Follow-up|3
4651452|NCT02095223|7533514|FG000|Overall Study|Withdrawal by Subject|1
4651453|NCT02095223|7533515|FG001|Overall Study|Withdrawal by Subject|0
4651454|NCT02095535|7533535|FG000|Recruitment|Protocol Violation|2
4651455|NCT02095678|7533550|FG000|Overall Study|Withdrawal by Subject|0
4651456|NCT02095678|7533551|FG001|Overall Study|Withdrawal by Subject|1
4651457|NCT02095678|7533550|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11
4651458|NCT02095678|7533551|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12
4651459|NCT02095678|7533550|FG000|Overall Study|lesion impacted by previous treatment|1
4651460|NCT02095678|7533551|FG001|Overall Study|lesion impacted by previous treatment|1
4651461|NCT02095678|7533550|FG000|Overall Study|No Confirmed Diagnosis|0
4651462|NCT02095678|7533551|FG001|Overall Study|No Confirmed Diagnosis|3
4651463|NCT02095678|7533550|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1
4651464|NCT02095678|7533551|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1
4651465|NCT02095678|7533550|FG000|Overall Study|No Visible Lesion or Pathological Finding|4
4651466|NCT02095678|7533551|FG001|Overall Study|No Visible Lesion or Pathological Finding|0
4651467|NCT02095691|7533560|FG000|Overall Study|Physician Decision|1
4651468|NCT02095873|7533578|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1
4651469|NCT02095873|7533579|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0
4651470|NCT02095873|7533578|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1
4651471|NCT02095873|7533579|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0
4651472|NCT02095873|7533578|FG000|Second Intervention (8 Weeks)|Protocol Violation|1
4651473|NCT02095873|7533579|FG001|Second Intervention (8 Weeks)|Protocol Violation|0
4651474|NCT02095951|7533589|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9
4651475|NCT02095951|7533590|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6
4651476|NCT02096003|7533602|FG000|Overall Study|Protocol Violation|0
4651477|NCT02096003|7533603|FG001|Overall Study|Protocol Violation|2
4651478|NCT02096003|7533602|FG000|Overall Study|additional surgery|2
4651479|NCT02096003|7533603|FG001|Overall Study|additional surgery|1
4651480|NCT02096263|7533639|FG000|Overall Study|Adverse Event|1
4651481|NCT02096263|7533640|FG001|Overall Study|Adverse Event|0
4651482|NCT02096263|7533641|FG002|Overall Study|Adverse Event|1
4651483|NCT02096263|7533639|FG000|Overall Study|Lost to Follow-up|14
4651484|NCT02096263|7533640|FG001|Overall Study|Lost to Follow-up|18
4651485|NCT02096263|7533641|FG002|Overall Study|Lost to Follow-up|15
4651486|NCT02096263|7533639|FG000|Overall Study|Other|7
4651487|NCT02096263|7533640|FG001|Overall Study|Other|9
4651488|NCT02096263|7533641|FG002|Overall Study|Other|6
4651489|NCT02096263|7533639|FG000|Overall Study|Sponsor study termination|0
4651490|NCT02096263|7533640|FG001|Overall Study|Sponsor study termination|0
4651491|NCT02096263|7533641|FG002|Overall Study|Sponsor study termination|1
4651492|NCT02096263|7533639|FG000|Overall Study|Protocol Violation|7
4651493|NCT02096263|7533640|FG001|Overall Study|Protocol Violation|2
4651494|NCT02096263|7533641|FG002|Overall Study|Protocol Violation|8
4651495|NCT02096263|7533639|FG000|Overall Study|Withdrawal by Subject|5
4651496|NCT02096263|7533640|FG001|Overall Study|Withdrawal by Subject|7
4651497|NCT02096263|7533641|FG002|Overall Study|Withdrawal by Subject|8
4651498|NCT02096471|7533662|FG000|Overall Study|Adverse Event|1
4651499|NCT02096471|7533662|FG000|Overall Study|Lack of Efficacy|7
4651500|NCT02096471|7533662|FG000|Overall Study|Withdrawal by Subject|3
4651501|NCT02096471|7533662|FG000|Overall Study|Non-Compliant|2
4651502|NCT02096588|7533679|FG000|Overall Study|Lack of Efficacy|2
4651503|NCT02096588|7533680|FG001|Overall Study|Lack of Efficacy|0
4651504|NCT02096588|7533679|FG000|Overall Study|Withdrawal by Subject|0
4651505|NCT02096588|7533680|FG001|Overall Study|Withdrawal by Subject|1
4651506|NCT02096705|7533696|FG000|Treatment|Adverse Event|6
4651507|NCT02096705|7533697|FG001|Treatment|Adverse Event|3
4651508|NCT02096705|7533696|FG000|Treatment|Subject request to discontinue treatment|1
4651509|NCT02096705|7533697|FG001|Treatment|Subject request to discontinue treatment|1
4651510|NCT02096705|7533696|FG000|Treatment|Withdrawal by Subject|1
4651511|NCT02096705|7533697|FG001|Treatment|Withdrawal by Subject|0
4651512|NCT02096705|7533696|FG000|Treatment|Other|1
4651513|NCT02096705|7533697|FG001|Treatment|Other|1
4651514|NCT02096705|7533696|FG000|Follow-up|Withdrawal by Subject|1
4651515|NCT02096705|7533697|FG001|Follow-up|Withdrawal by Subject|0
4651516|NCT02096705|7533696|FG000|Follow-up|Adverse Event|2
4651517|NCT02096705|7533697|FG001|Follow-up|Adverse Event|2
4651518|NCT02096705|7533696|FG000|Follow-up|Subjects not reporting status|1
4651519|NCT02096705|7533697|FG001|Follow-up|Subjects not reporting status|2
4651520|NCT02096744|7533729|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0
4651521|NCT02096744|7533730|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1
4651522|NCT02096744|7533729|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1
4651523|NCT02096744|7533730|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0
4651524|NCT02096744|7533729|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0
4651525|NCT02096744|7533730|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1
4651526|NCT02096835|7533741|FG000|Overall Study|Withdrawal by Subject|1
4651527|NCT02096835|7533742|FG001|Overall Study|Withdrawal by Subject|0
4651528|NCT02096835|7533743|FG002|Overall Study|Withdrawal by Subject|0
4651529|NCT02096835|7533741|FG000|Overall Study|converted to open procedures|1
4651530|NCT02096835|7533742|FG001|Overall Study|converted to open procedures|0
4651531|NCT02096835|7533743|FG002|Overall Study|converted to open procedures|0
4651532|NCT02096835|7533741|FG000|Overall Study|Lost to Follow-up|1
4651533|NCT02096835|7533742|FG001|Overall Study|Lost to Follow-up|0
4651534|NCT02096835|7533743|FG002|Overall Study|Lost to Follow-up|1
4651535|NCT02096900|7533772|FG000|Overall Study|Did not receive medication|3
4651536|NCT02096900|7533773|FG001|Overall Study|Did not receive medication|1
4651537|NCT02096900|7533772|FG000|Overall Study|Surgery cancelled- medication received|1
4651538|NCT02096900|7533773|FG001|Overall Study|Surgery cancelled- medication received|1
4651539|NCT02096952|7533779|FG000|Overall Study|Adverse Event|1
4651540|NCT02097030|7533785|FG000|First Intervention (3 Days)|Lost to Follow-up|1
4651541|NCT02097030|7533786|FG001|First Intervention (3 Days)|Lost to Follow-up|0
4651542|NCT02097030|7533785|FG000|First Intervention (3 Days)|Visual Acuity|0
4651543|NCT02097030|7533786|FG001|First Intervention (3 Days)|Visual Acuity|1
4651544|NCT02097056|7533796|FG000|Overall Study|Protocol Violation|2
4651545|NCT02097056|7533796|FG000|Overall Study|Withdrawal by Subject|15
4651546|NCT02097056|7533796|FG000|Overall Study|Lost to Follow-up|2
4651547|NCT02097056|7533796|FG000|Overall Study|Adverse Event|37
4651548|NCT02097056|7533796|FG000|Overall Study|Other|2
4651549|NCT02097108|7533800|FG000|Overall Study|Adverse Event|1
4651550|NCT02097108|7533800|FG000|Overall Study|patient was abroad for 6 months|1
4651551|NCT02097238|7533804|FG000|Overall Study|Death|1
4651552|NCT02097238|7533804|FG000|Overall Study|Physician Decision|1
4651553|NCT02097238|7533804|FG000|Overall Study|Progressive Disease|17
4651554|NCT02097277|7533814|FG000|Overall Study|Subject no longer meets study criteria|0
4651555|NCT02097277|7533815|FG001|Overall Study|Subject no longer meets study criteria|1
4651556|NCT02097277|7533816|FG002|Overall Study|Subject no longer meets study criteria|0
4651557|NCT02097277|7533817|FG003|Overall Study|Subject no longer meets study criteria|1
4651558|NCT02097277|7533818|FG004|Overall Study|Subject no longer meets study criteria|0
4651559|NCT02097277|7533814|FG000|Overall Study|Subject request to discontinue treatment|0
4651560|NCT02097277|7533815|FG001|Overall Study|Subject request to discontinue treatment|0
4651561|NCT02097277|7533816|FG002|Overall Study|Subject request to discontinue treatment|0
4651562|NCT02097277|7533817|FG003|Overall Study|Subject request to discontinue treatment|0
4651563|NCT02097277|7533818|FG004|Overall Study|Subject request to discontinue treatment|1
4651564|NCT02097277|7533814|FG000|Overall Study|Lost to Follow-up|0
4651565|NCT02097277|7533815|FG001|Overall Study|Lost to Follow-up|1
4651566|NCT02097277|7533816|FG002|Overall Study|Lost to Follow-up|1
4651567|NCT02097277|7533817|FG003|Overall Study|Lost to Follow-up|0
4651568|NCT02097277|7533818|FG004|Overall Study|Lost to Follow-up|0
4651569|NCT02097277|7533814|FG000|Overall Study|Withdrawal by Subject|2
4651570|NCT02097277|7533815|FG001|Overall Study|Withdrawal by Subject|1
4651571|NCT02097277|7533816|FG002|Overall Study|Withdrawal by Subject|0
4651572|NCT02097277|7533817|FG003|Overall Study|Withdrawal by Subject|1
4651573|NCT02097277|7533818|FG004|Overall Study|Withdrawal by Subject|0
4651574|NCT02097277|7533814|FG000|Overall Study|Adverse Event|0
4651575|NCT02097277|7533815|FG001|Overall Study|Adverse Event|0
4651576|NCT02097277|7533816|FG002|Overall Study|Adverse Event|1
4651577|NCT02097277|7533817|FG003|Overall Study|Adverse Event|2
4651578|NCT02097277|7533818|FG004|Overall Study|Adverse Event|0
4651579|NCT02097290|7533834|FG000|Overall Study|Death|6
4651580|NCT02097290|7533834|FG000|Overall Study|Total Withdrawals|3
4651581|NCT02097290|7533834|FG000|Overall Study|Attempt|8
4651582|NCT02097472|7533850|FG000|Received Vaccination 2|Adverse Event|0
4651583|NCT02097472|7533851|FG001|Received Vaccination 2|Adverse Event|0
4651584|NCT02097472|7533852|FG002|Received Vaccination 2|Adverse Event|0
4651585|NCT02097472|7533853|FG003|Received Vaccination 2|Adverse Event|0
4651586|NCT02097472|7533854|FG004|Received Vaccination 2|Adverse Event|0
4651587|NCT02097472|7533855|FG005|Received Vaccination 2|Adverse Event|0
4651588|NCT02097472|7533856|FG006|Received Vaccination 2|Adverse Event|1
4651589|NCT02097472|7533857|FG007|Received Vaccination 2|Adverse Event|0
4651590|NCT02097719|7533967|FG000|Overall Study|Subject Withdrew Consent|1
4651591|NCT02097719|7533968|FG001|Overall Study|Subject Withdrew Consent|0
4651592|NCT02097719|7533967|FG000|Overall Study|Lost to Follow-up|0
4651593|NCT02097719|7533968|FG001|Overall Study|Lost to Follow-up|1
4651594|NCT02097719|7533967|FG000|Overall Study|Adverse Event|2
4651595|NCT02097719|7533968|FG001|Overall Study|Adverse Event|0
4651596|NCT02097745|7533984|FG000|Overall Study|Adverse Event|25
4651597|NCT02097745|7533984|FG000|Overall Study|Death|16
4651598|NCT02097745|7533984|FG000|Overall Study|Failure to Return|14
4651599|NCT02097745|7533984|FG000|Overall Study|Administrative/Other|27
4651600|NCT02097745|7533984|FG000|Overall Study|Reason Not Specified|96
4651601|NCT02097823|7533993|FG000|Overall Study|Withdrawal by Subject|1
4651602|NCT02097823|7533994|FG001|Overall Study|Withdrawal by Subject|1
4651603|NCT02098109|7534027|FG000|Overall Study|Protocol Violation|3
4651604|NCT02098109|7534028|FG001|Overall Study|Protocol Violation|0
4651605|NCT02098369|7534043|FG000|Overall Study|Withdrawal by Subject|1
4651606|NCT02098369|7534044|FG001|Overall Study|Withdrawal by Subject|5
4651607|NCT02098369|7534045|FG002|Overall Study|Withdrawal by Subject|0
4651608|NCT02098369|7534043|FG000|Overall Study|Lost to Follow-up|5
4651609|NCT02098369|7534044|FG001|Overall Study|Lost to Follow-up|1
4651610|NCT02098369|7534045|FG002|Overall Study|Lost to Follow-up|3
4651611|NCT02098369|7534043|FG000|Overall Study|Death|1
4651612|NCT02098369|7534044|FG001|Overall Study|Death|1
4651613|NCT02098369|7534045|FG002|Overall Study|Death|1
4651614|NCT02098369|7534043|FG000|Overall Study|Other|0
4651615|NCT02098369|7534044|FG001|Overall Study|Other|2
4651616|NCT02098369|7534045|FG002|Overall Study|Other|1
4651617|NCT02098395|7534057|FG000|Overall Study|Protocol Violation|2
4651618|NCT02098395|7534058|FG001|Overall Study|Protocol Violation|2
4651619|NCT02098395|7534059|FG002|Overall Study|Protocol Violation|0
4651620|NCT02098395|7534060|FG003|Overall Study|Protocol Violation|7
4651621|NCT02098395|7534057|FG000|Overall Study|Withdrawal by Subject|10
4651622|NCT02098395|7534058|FG001|Overall Study|Withdrawal by Subject|10
4651623|NCT02098395|7534059|FG002|Overall Study|Withdrawal by Subject|5
4651624|NCT02098395|7534060|FG003|Overall Study|Withdrawal by Subject|13
4651625|NCT02098395|7534057|FG000|Overall Study|Adverse Event|12
4651626|NCT02098395|7534058|FG001|Overall Study|Adverse Event|19
4651627|NCT02098395|7534059|FG002|Overall Study|Adverse Event|34
4651628|NCT02098395|7534060|FG003|Overall Study|Adverse Event|2
4651629|NCT02098395|7534057|FG000|Overall Study|Lost to Follow-up|2
4651630|NCT02098395|7534058|FG001|Overall Study|Lost to Follow-up|1
4651631|NCT02098395|7534059|FG002|Overall Study|Lost to Follow-up|0
4651632|NCT02098395|7534060|FG003|Overall Study|Lost to Follow-up|3
4651633|NCT02098395|7534057|FG000|Overall Study|Unclassified|0
4651634|NCT02098395|7534058|FG001|Overall Study|Unclassified|0
4651635|NCT02098395|7534059|FG002|Overall Study|Unclassified|3
4651636|NCT02098395|7534060|FG003|Overall Study|Unclassified|2
4651637|NCT02098733|7534070|FG000|Overall Study|Data Not Available|5
4651638|NCT02098733|7534070|FG000|Overall Study|Lost to Follow-up|5
4651639|NCT02098746|7534074|FG000|Overall Study|Changes of Investigator|2
4651640|NCT02098746|7534074|FG000|Overall Study|Other Miscellaneous Reasons|1
4651641|NCT02098746|7534074|FG000|Overall Study|Enrolled 15 Days After the First Dose|1
4651642|NCT02098746|7534074|FG000|Overall Study|Data Not Available After Treatment|1
4651643|NCT02099110|7534105|FG000|Overall Study|Protocol Violation|2
4651644|NCT02099110|7534106|FG001|Overall Study|Protocol Violation|1
4651645|NCT02099110|7534107|FG002|Overall Study|Protocol Violation|0
4651646|NCT02099110|7534108|FG003|Overall Study|Protocol Violation|3
4651647|NCT02099110|7534109|FG004|Overall Study|Protocol Violation|1
4651648|NCT02099110|7534105|FG000|Overall Study|Participant moved|1
4651649|NCT02099110|7534106|FG001|Overall Study|Participant moved|1
4651650|NCT02099110|7534107|FG002|Overall Study|Participant moved|1
4651651|NCT02099110|7534108|FG003|Overall Study|Participant moved|0
4651652|NCT02099110|7534109|FG004|Overall Study|Participant moved|2
4651653|NCT02099110|7534105|FG000|Overall Study|Withdrawal by Subject|7
4651654|NCT02099110|7534106|FG001|Overall Study|Withdrawal by Subject|11
4651655|NCT02099110|7534107|FG002|Overall Study|Withdrawal by Subject|13
4651656|NCT02099110|7534108|FG003|Overall Study|Withdrawal by Subject|9
4651657|NCT02099110|7534109|FG004|Overall Study|Withdrawal by Subject|13
4651658|NCT02099110|7534105|FG000|Overall Study|Adverse Event|3
4651659|NCT02099110|7534106|FG001|Overall Study|Adverse Event|5
4651660|NCT02099110|7534107|FG002|Overall Study|Adverse Event|2
4651661|NCT02099110|7534108|FG003|Overall Study|Adverse Event|3
4651662|NCT02099110|7534109|FG004|Overall Study|Adverse Event|2
4651663|NCT02099110|7534105|FG000|Overall Study|Lost to Follow-up|6
4651664|NCT02099110|7534106|FG001|Overall Study|Lost to Follow-up|12
4651665|NCT02099110|7534107|FG002|Overall Study|Lost to Follow-up|11
4651666|NCT02099110|7534108|FG003|Overall Study|Lost to Follow-up|5
4651667|NCT02099110|7534109|FG004|Overall Study|Lost to Follow-up|6
4651668|NCT02099110|7534105|FG000|Overall Study|Death|0
4651669|NCT02099110|7534106|FG001|Overall Study|Death|1
4651670|NCT02099110|7534107|FG002|Overall Study|Death|0
4651671|NCT02099110|7534108|FG003|Overall Study|Death|0
4651672|NCT02099110|7534109|FG004|Overall Study|Death|0
4651673|NCT02099110|7534105|FG000|Overall Study|Screen failure|0
4651674|NCT02099110|7534106|FG001|Overall Study|Screen failure|0
4651675|NCT02099110|7534107|FG002|Overall Study|Screen failure|0
4651676|NCT02099110|7534108|FG003|Overall Study|Screen failure|0
4651677|NCT02099110|7534109|FG004|Overall Study|Screen failure|1
4651678|NCT02099110|7534105|FG000|Overall Study|Non-compliance with study drug|2
4651679|NCT02099110|7534106|FG001|Overall Study|Non-compliance with study drug|0
4651680|NCT02099110|7534107|FG002|Overall Study|Non-compliance with study drug|0
4651681|NCT02099110|7534108|FG003|Overall Study|Non-compliance with study drug|0
4651682|NCT02099110|7534109|FG004|Overall Study|Non-compliance with study drug|1
4651683|NCT02099110|7534105|FG000|Overall Study|Physician Decision|3
4651684|NCT02099110|7534106|FG001|Overall Study|Physician Decision|0
4651685|NCT02099110|7534107|FG002|Overall Study|Physician Decision|1
4651686|NCT02099110|7534108|FG003|Overall Study|Physician Decision|2
4651687|NCT02099110|7534109|FG004|Overall Study|Physician Decision|1
4651688|NCT02099682|7534141|FG000|Overall Study|Data Not Available|51
4651689|NCT02099682|7534141|FG000|Overall Study|Lost to Follow-up|31
4651690|NCT02099682|7534141|FG000|Overall Study|Other|29
4651691|NCT02099708|7534145|FG000|Overall Study|Data Not Available|30
4651692|NCT02099708|7534145|FG000|Overall Study|Lost to Follow-up|141
4651693|NCT02099708|7534145|FG000|Overall Study|Other|29
4651694|NCT02099838|7534195|FG000|Overall Study|Death|1
4651695|NCT02099838|7534196|FG001|Overall Study|Death|0
4651696|NCT02099838|7534195|FG000|Overall Study|Lost to Follow-up|3
4651697|NCT02099838|7534196|FG001|Overall Study|Lost to Follow-up|1
4651698|NCT02099838|7534195|FG000|Overall Study|Withdrawal by Subject|0
4651699|NCT02099838|7534196|FG001|Overall Study|Withdrawal by Subject|1
4651700|NCT02100124|7534222|FG000|Overall Study|Lost to Follow-up|5
4651701|NCT02100124|7534223|FG001|Overall Study|Lost to Follow-up|11
4651702|NCT02100124|7534224|FG002|Overall Study|Lost to Follow-up|3
4651703|NCT02100124|7534222|FG000|Overall Study|Withdrawal by Subject|1
4651704|NCT02100124|7534223|FG001|Overall Study|Withdrawal by Subject|0
4651705|NCT02100124|7534224|FG002|Overall Study|Withdrawal by Subject|0
4651706|NCT02100228|7534238|FG000|Overall Study|Other|19
4651707|NCT02100228|7534239|FG001|Overall Study|Other|19
4651708|NCT02100228|7534238|FG000|Overall Study|Administrative reason|0
4651709|NCT02100228|7534239|FG001|Overall Study|Administrative reason|1
4651710|NCT02100228|7534238|FG000|Overall Study|Inclusion/Exclusion criteria not met|12
4651711|NCT02100228|7534239|FG001|Overall Study|Inclusion/Exclusion criteria not met|16
4651712|NCT02100228|7534238|FG000|Overall Study|Non-compliance|0
4651713|NCT02100228|7534239|FG001|Overall Study|Non-compliance|3
4651714|NCT02100228|7534238|FG000|Overall Study|Lost to Follow-up|0
4651715|NCT02100228|7534239|FG001|Overall Study|Lost to Follow-up|1
4651716|NCT02100228|7534238|FG000|Overall Study|Withdrawal by Subject|27
4651717|NCT02100228|7534239|FG001|Overall Study|Withdrawal by Subject|37
4651718|NCT02100228|7534238|FG000|Overall Study|Adverse Event|16
4651719|NCT02100228|7534239|FG001|Overall Study|Adverse Event|12
4651720|NCT02100228|7534238|FG000|Overall Study|Death|1
4651721|NCT02100228|7534239|FG001|Overall Study|Death|1
4651722|NCT02100319|7534256|FG000|Overall Study|Case Report Forms Uncollected|11
4651723|NCT02100319|7534256|FG000|Overall Study|Protocol Deviation|5
4651724|NCT02100475|7534279|FG000|Overall Study|Unclassified|1
4651725|NCT02100475|7534280|FG001|Overall Study|Unclassified|2
4651726|NCT02100475|7534279|FG000|Overall Study|Withdrawal criteria|1
4651727|NCT02100475|7534280|FG001|Overall Study|Withdrawal criteria|0
4651728|NCT02100514|7534288|FG000|Treatment Period|Adverse Event|0
4651729|NCT02100514|7534289|FG001|Treatment Period|Adverse Event|5
4651730|NCT02100514|7534290|FG002|Treatment Period|Adverse Event|0
4651731|NCT02100514|7534291|FG003|Treatment Period|Adverse Event|0
4651732|NCT02100514|7534292|FG004|Treatment Period|Adverse Event|0
4651733|NCT02100514|7534288|FG000|Treatment Period|Death|2
4651734|NCT02100514|7534289|FG001|Treatment Period|Death|2
4651735|NCT02100514|7534290|FG002|Treatment Period|Death|0
4651736|NCT02100514|7534291|FG003|Treatment Period|Death|0
4651737|NCT02100514|7534292|FG004|Treatment Period|Death|0
4651738|NCT02100514|7534288|FG000|Treatment Period|Lost to Follow-up|5
4651739|NCT02100514|7534289|FG001|Treatment Period|Lost to Follow-up|17
4651740|NCT02100514|7534290|FG002|Treatment Period|Lost to Follow-up|0
4651741|NCT02100514|7534291|FG003|Treatment Period|Lost to Follow-up|0
4651742|NCT02100514|7534292|FG004|Treatment Period|Lost to Follow-up|0
4651743|NCT02100514|7534288|FG000|Treatment Period|Did Not Meet Entrance Criteria|0
4651744|NCT02100514|7534289|FG001|Treatment Period|Did Not Meet Entrance Criteria|1
4651745|NCT02100514|7534290|FG002|Treatment Period|Did Not Meet Entrance Criteria|0
4651746|NCT02100514|7534291|FG003|Treatment Period|Did Not Meet Entrance Criteria|0
4651747|NCT02100514|7534292|FG004|Treatment Period|Did Not Meet Entrance Criteria|0
4651748|NCT02100514|7534288|FG000|Treatment Period|Protocol Violation|1
4651749|NCT02100514|7534289|FG001|Treatment Period|Protocol Violation|1
4651750|NCT02100514|7534290|FG002|Treatment Period|Protocol Violation|0
4651751|NCT02100514|7534291|FG003|Treatment Period|Protocol Violation|0
4651752|NCT02100514|7534292|FG004|Treatment Period|Protocol Violation|0
4651753|NCT02100514|7534288|FG000|Treatment Period|Withdrawal by Subject|12
4651754|NCT02100514|7534289|FG001|Treatment Period|Withdrawal by Subject|37
4651755|NCT02100514|7534290|FG002|Treatment Period|Withdrawal by Subject|0
4651756|NCT02100514|7534291|FG003|Treatment Period|Withdrawal by Subject|0
4651757|NCT02100514|7534292|FG004|Treatment Period|Withdrawal by Subject|0
4651758|NCT02100514|7534288|FG000|Treatment Period|Other|9
4651759|NCT02100514|7534289|FG001|Treatment Period|Other|11
4651760|NCT02100514|7534290|FG002|Treatment Period|Other|0
4651761|NCT02100514|7534291|FG003|Treatment Period|Other|0
4651762|NCT02100514|7534292|FG004|Treatment Period|Other|0
4651763|NCT02100514|7534288|FG000|Extension Period|Withdrew consent|0
4651764|NCT02100514|7534289|FG001|Extension Period|Withdrew consent|0
4651765|NCT02100514|7534290|FG002|Extension Period|Withdrew consent|2
4651766|NCT02100514|7534291|FG003|Extension Period|Withdrew consent|0
4651767|NCT02100514|7534292|FG004|Extension Period|Withdrew consent|0
4748039|NCT02949934|7722045|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5
4748040|NCT02949934|7722046|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1
4748041|NCT02949934|7722041|FG000|Bar Laboratory|Adverse Event|1
4748042|NCT02949934|7722042|FG001|Bar Laboratory|Adverse Event|0
4748043|NCT02949934|7722043|FG002|Bar Laboratory|Adverse Event|2
4748044|NCT02949934|7722044|FG003|Bar Laboratory|Adverse Event|0
4748045|NCT02949934|7722045|FG004|Bar Laboratory|Adverse Event|1
4748046|NCT02949934|7722046|FG005|Bar Laboratory|Adverse Event|0
4748047|NCT02949934|7722041|FG000|Bar Laboratory|Protocol Violation|0
4748048|NCT02949934|7722042|FG001|Bar Laboratory|Protocol Violation|0
4748049|NCT02949934|7722043|FG002|Bar Laboratory|Protocol Violation|0
4748050|NCT02949934|7722044|FG003|Bar Laboratory|Protocol Violation|1
4651768|NCT02100631|7534318|FG000|Overall Study|Withdrawal by Subject|1
4651769|NCT02100631|7534319|FG001|Overall Study|Withdrawal by Subject|0
4651770|NCT02100631|7534320|FG002|Overall Study|Withdrawal by Subject|0
4748051|NCT02949934|7722045|FG004|Bar Laboratory|Protocol Violation|0
4748052|NCT02949934|7722046|FG005|Bar Laboratory|Protocol Violation|0
4748053|NCT02908672|7722062|FG000|Overall Study|Death|112
4651771|NCT02100631|7534318|FG000|Overall Study|Lost to Follow-up|3
4651772|NCT02100631|7534319|FG001|Overall Study|Lost to Follow-up|4
4651773|NCT02100631|7534320|FG002|Overall Study|Lost to Follow-up|0
4651774|NCT02100631|7534318|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3
4651775|NCT02100631|7534319|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0
4651776|NCT02100631|7534320|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0
4651777|NCT02100644|7534328|FG000|LTG Escalation Phase|Adverse Event|9
4651778|NCT02100644|7534329|FG001|LTG Escalation Phase|Adverse Event|0
4651779|NCT02100644|7534330|FG002|LTG Escalation Phase|Adverse Event|0
4651780|NCT02100644|7534328|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1
4651781|NCT02100644|7534329|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0
4651782|NCT02100644|7534330|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0
4651783|NCT02100644|7534328|FG000|LTG Escalation Phase|Withdrawal by Subject|3
4651784|NCT02100644|7534329|FG001|LTG Escalation Phase|Withdrawal by Subject|0
4651785|NCT02100644|7534330|FG002|LTG Escalation Phase|Withdrawal by Subject|0
4651786|NCT02100657|7534337|FG000|Cohort 1: Dose Level 1|Progressive disease|6
4651787|NCT02100657|7534338|FG001|Cohort 1: Dose Level 1|Progressive disease|0
4651788|NCT02100657|7534339|FG002|Cohort 1: Dose Level 1|Progressive disease|0
4651789|NCT02100657|7534337|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1
4651790|NCT02100657|7534338|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0
4651791|NCT02100657|7534339|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0
4651792|NCT02100657|7534337|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1
4651793|NCT02100657|7534338|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0
4651794|NCT02100657|7534339|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0
4651795|NCT02100657|7534337|FG000|Cohort 2: Dose Level 2|Progressive disease|0
4651796|NCT02100657|7534338|FG001|Cohort 2: Dose Level 2|Progressive disease|2
4651797|NCT02100657|7534339|FG002|Cohort 2: Dose Level 2|Progressive disease|0
4651798|NCT02100657|7534337|FG000|Cohort 2: Dose Level 2|Physician Decision|0
4651799|NCT02100657|7534338|FG001|Cohort 2: Dose Level 2|Physician Decision|1
4651800|NCT02100657|7534339|FG002|Cohort 2: Dose Level 2|Physician Decision|0
4651801|NCT02100657|7534337|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0
4651802|NCT02100657|7534338|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1
4651803|NCT02100657|7534339|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0
4651804|NCT02100657|7534337|FG000|Cohort 3: Dose Level 3|Progressive disease|0
4651805|NCT02100657|7534338|FG001|Cohort 3: Dose Level 3|Progressive disease|0
4651806|NCT02100657|7534339|FG002|Cohort 3: Dose Level 3|Progressive disease|15
4651807|NCT02100657|7534337|FG000|Cohort 3: Dose Level 3|Death|0
4651808|NCT02100657|7534338|FG001|Cohort 3: Dose Level 3|Death|0
4651809|NCT02100657|7534339|FG002|Cohort 3: Dose Level 3|Death|1
4651810|NCT02100657|7534337|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0
4651811|NCT02100657|7534338|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0
4651812|NCT02100657|7534339|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1
4651813|NCT02100657|7534337|FG000|Cohort 3: Dose Level 3|Physician Decision|0
4651814|NCT02100657|7534338|FG001|Cohort 3: Dose Level 3|Physician Decision|0
4651815|NCT02100657|7534339|FG002|Cohort 3: Dose Level 3|Physician Decision|1
4651816|NCT02100657|7534337|FG000|Cohort 3: Dose Level 3|Never were treated|0
4651817|NCT02100657|7534338|FG001|Cohort 3: Dose Level 3|Never were treated|0
4651818|NCT02100657|7534339|FG002|Cohort 3: Dose Level 3|Never were treated|3
4651819|NCT02100657|7534337|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0
4651820|NCT02100657|7534338|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0
4651821|NCT02100657|7534339|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3
4651822|NCT02100657|7534337|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0
4651823|NCT02100657|7534338|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0
4651824|NCT02100657|7534339|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3
4651825|NCT02100670|7534352|FG000|Overall Study|Adverse Event|10
4651826|NCT02100670|7534353|FG001|Overall Study|Adverse Event|3
4651827|NCT02100670|7534354|FG002|Overall Study|Adverse Event|3
4651828|NCT02100670|7534355|FG003|Overall Study|Adverse Event|0
4651829|NCT02100670|7534352|FG000|Overall Study|Lost to Follow-up|1
4651830|NCT02100670|7534353|FG001|Overall Study|Lost to Follow-up|0
4651831|NCT02100670|7534354|FG002|Overall Study|Lost to Follow-up|0
4651832|NCT02100670|7534355|FG003|Overall Study|Lost to Follow-up|0
4651833|NCT02100670|7534352|FG000|Overall Study|Protocol Violation|0
4651834|NCT02100670|7534353|FG001|Overall Study|Protocol Violation|1
4651835|NCT02100670|7534354|FG002|Overall Study|Protocol Violation|0
4651836|NCT02100670|7534355|FG003|Overall Study|Protocol Violation|1
4651837|NCT02100670|7534352|FG000|Overall Study|Withdrawal of Consent|0
4651838|NCT02100670|7534353|FG001|Overall Study|Withdrawal of Consent|1
4651839|NCT02100670|7534354|FG002|Overall Study|Withdrawal of Consent|1
4651840|NCT02100670|7534355|FG003|Overall Study|Withdrawal of Consent|0
4651841|NCT02100670|7534352|FG000|Overall Study|No swelling no pain|1
4651842|NCT02100670|7534353|FG001|Overall Study|No swelling no pain|0
4651843|NCT02100670|7534354|FG002|Overall Study|No swelling no pain|0
4651844|NCT02100670|7534355|FG003|Overall Study|No swelling no pain|0
4651845|NCT02100670|7534352|FG000|Overall Study|Poor Efficacy|0
4651846|NCT02100670|7534353|FG001|Overall Study|Poor Efficacy|1
4651847|NCT02100670|7534354|FG002|Overall Study|Poor Efficacy|0
4651848|NCT02100670|7534355|FG003|Overall Study|Poor Efficacy|0
4651849|NCT02100670|7534352|FG000|Overall Study|Physician Decision|0
4651850|NCT02100670|7534353|FG001|Overall Study|Physician Decision|1
4651851|NCT02100670|7534354|FG002|Overall Study|Physician Decision|0
4651852|NCT02100670|7534355|FG003|Overall Study|Physician Decision|0
4651853|NCT02100670|7534352|FG000|Overall Study|Withdrawal by Subject|1
4651854|NCT02100670|7534353|FG001|Overall Study|Withdrawal by Subject|0
4651855|NCT02100670|7534354|FG002|Overall Study|Withdrawal by Subject|0
4651856|NCT02100670|7534355|FG003|Overall Study|Withdrawal by Subject|0
4651857|NCT02100696|7534378|FG000|Induction Phase|Adverse Event|0
4651858|NCT02100696|7534379|FG001|Induction Phase|Adverse Event|0
4651859|NCT02100696|7534380|FG002|Induction Phase|Adverse Event|1
4651860|NCT02100696|7534381|FG003|Induction Phase|Adverse Event|0
4651861|NCT02100696|7534382|FG004|Induction Phase|Adverse Event|0
4651862|NCT02100696|7534383|FG005|Induction Phase|Adverse Event|0
4651863|NCT02100696|7534378|FG000|Induction Phase|Lost to Follow-up|1
4651864|NCT02100696|7534379|FG001|Induction Phase|Lost to Follow-up|0
4651865|NCT02100696|7534380|FG002|Induction Phase|Lost to Follow-up|1
4651866|NCT02100696|7534381|FG003|Induction Phase|Lost to Follow-up|0
4651867|NCT02100696|7534382|FG004|Induction Phase|Lost to Follow-up|0
4651868|NCT02100696|7534383|FG005|Induction Phase|Lost to Follow-up|0
4651869|NCT02100696|7534378|FG000|Induction Phase|Protocol Violation|0
4651870|NCT02100696|7534379|FG001|Induction Phase|Protocol Violation|1
4651871|NCT02100696|7534380|FG002|Induction Phase|Protocol Violation|1
4651872|NCT02100696|7534381|FG003|Induction Phase|Protocol Violation|0
4651873|NCT02100696|7534382|FG004|Induction Phase|Protocol Violation|0
4651874|NCT02100696|7534383|FG005|Induction Phase|Protocol Violation|0
4651875|NCT02100696|7534378|FG000|Induction Phase|Withdrawal by Subject|8
4651876|NCT02100696|7534379|FG001|Induction Phase|Withdrawal by Subject|2
4651877|NCT02100696|7534380|FG002|Induction Phase|Withdrawal by Subject|13
4651878|NCT02100696|7534381|FG003|Induction Phase|Withdrawal by Subject|0
4651879|NCT02100696|7534382|FG004|Induction Phase|Withdrawal by Subject|0
4651880|NCT02100696|7534383|FG005|Induction Phase|Withdrawal by Subject|0
4651881|NCT02100696|7534378|FG000|Induction Phase|Physician Decision|1
4651882|NCT02100696|7534379|FG001|Induction Phase|Physician Decision|0
4651883|NCT02100696|7534380|FG002|Induction Phase|Physician Decision|2
4651884|NCT02100696|7534381|FG003|Induction Phase|Physician Decision|0
4651885|NCT02100696|7534382|FG004|Induction Phase|Physician Decision|0
4651886|NCT02100696|7534383|FG005|Induction Phase|Physician Decision|0
4651887|NCT02100696|7534378|FG000|Induction Phase|Multiple Reasons|5
4651888|NCT02100696|7534379|FG001|Induction Phase|Multiple Reasons|2
4651889|NCT02100696|7534380|FG002|Induction Phase|Multiple Reasons|8
4651890|NCT02100696|7534381|FG003|Induction Phase|Multiple Reasons|0
4651891|NCT02100696|7534382|FG004|Induction Phase|Multiple Reasons|0
4651892|NCT02100696|7534383|FG005|Induction Phase|Multiple Reasons|0
4651893|NCT02100696|7534378|FG000|Maintenance Phase|Adverse Event|0
4651894|NCT02100696|7534379|FG001|Maintenance Phase|Adverse Event|0
4651895|NCT02100696|7534380|FG002|Maintenance Phase|Adverse Event|0
4651896|NCT02100696|7534381|FG003|Maintenance Phase|Adverse Event|0
4651897|NCT02100696|7534382|FG004|Maintenance Phase|Adverse Event|0
4651898|NCT02100696|7534383|FG005|Maintenance Phase|Adverse Event|2
4651899|NCT02100696|7534378|FG000|Maintenance Phase|Lost to Follow-up|0
4651900|NCT02100696|7534379|FG001|Maintenance Phase|Lost to Follow-up|0
4651901|NCT02100696|7534380|FG002|Maintenance Phase|Lost to Follow-up|0
4651902|NCT02100696|7534381|FG003|Maintenance Phase|Lost to Follow-up|0
4651903|NCT02100696|7534382|FG004|Maintenance Phase|Lost to Follow-up|1
4651904|NCT02100696|7534383|FG005|Maintenance Phase|Lost to Follow-up|0
4651905|NCT02100696|7534378|FG000|Maintenance Phase|Protocol Violation|0
4651906|NCT02100696|7534379|FG001|Maintenance Phase|Protocol Violation|0
4651907|NCT02100696|7534380|FG002|Maintenance Phase|Protocol Violation|0
4651908|NCT02100696|7534381|FG003|Maintenance Phase|Protocol Violation|0
4651909|NCT02100696|7534382|FG004|Maintenance Phase|Protocol Violation|1
4651910|NCT02100696|7534383|FG005|Maintenance Phase|Protocol Violation|0
4651911|NCT02100696|7534378|FG000|Maintenance Phase|Withdrawal by Subject|0
4651912|NCT02100696|7534379|FG001|Maintenance Phase|Withdrawal by Subject|0
4651913|NCT02100696|7534380|FG002|Maintenance Phase|Withdrawal by Subject|0
4651914|NCT02100696|7534381|FG003|Maintenance Phase|Withdrawal by Subject|1
4651915|NCT02100696|7534382|FG004|Maintenance Phase|Withdrawal by Subject|4
4651916|NCT02100696|7534383|FG005|Maintenance Phase|Withdrawal by Subject|2
4651917|NCT02100696|7534378|FG000|Maintenance Phase|Physician Decision|0
4651918|NCT02100696|7534379|FG001|Maintenance Phase|Physician Decision|0
4651919|NCT02100696|7534380|FG002|Maintenance Phase|Physician Decision|0
4651920|NCT02100696|7534381|FG003|Maintenance Phase|Physician Decision|0
4651921|NCT02100696|7534382|FG004|Maintenance Phase|Physician Decision|1
4651922|NCT02100696|7534383|FG005|Maintenance Phase|Physician Decision|0
4651923|NCT02100696|7534378|FG000|Maintenance Phase|Multiple Reasons|0
4651924|NCT02100696|7534379|FG001|Maintenance Phase|Multiple Reasons|0
4651925|NCT02100696|7534380|FG002|Maintenance Phase|Multiple Reasons|0
4651926|NCT02100696|7534381|FG003|Maintenance Phase|Multiple Reasons|0
4651927|NCT02100696|7534382|FG004|Maintenance Phase|Multiple Reasons|2
4651928|NCT02100696|7534383|FG005|Maintenance Phase|Multiple Reasons|1
4748054|NCT02908672|7722063|FG001|Overall Study|Death|93
4748055|NCT02908672|7722062|FG000|Overall Study|Lost to Follow-up|3
4651929|NCT02100813|7534461|FG000|Overall Study|Adverse Event|0
4651930|NCT02100813|7534462|FG001|Overall Study|Adverse Event|0
4651931|NCT02100813|7534463|FG002|Overall Study|Adverse Event|0
4651932|NCT02100813|7534464|FG003|Overall Study|Adverse Event|0
4651933|NCT02100813|7534465|FG004|Overall Study|Adverse Event|0
4651934|NCT02100813|7534466|FG005|Overall Study|Adverse Event|0
4651935|NCT02100813|7534467|FG006|Overall Study|Adverse Event|0
4651936|NCT02100813|7534468|FG007|Overall Study|Adverse Event|1
4651937|NCT02100839|7534495|FG000|Multiple Ascending Dose|Adverse Event|2
4651938|NCT02100839|7534496|FG001|Multiple Ascending Dose|Adverse Event|0
4651939|NCT02100839|7534495|FG000|Multiple Ascending Dose|Withdrawal by Subject|2
4651940|NCT02100839|7534496|FG001|Multiple Ascending Dose|Withdrawal by Subject|0
4651941|NCT02100969|7534506|FG000|Overall Study|Did not pass screening phase|1
4651942|NCT02101021|7534520|FG000|Overall Study|Death|4
4651943|NCT02101021|7534521|FG001|Overall Study|Death|3
4651944|NCT02101021|7534522|FG002|Overall Study|Death|6
4651945|NCT02101021|7534523|FG003|Overall Study|Death|0
4651946|NCT02101021|7534524|FG004|Overall Study|Death|3
4651947|NCT02101021|7534520|FG000|Overall Study|Withdrew Consent from study|1
4651948|NCT02101021|7534521|FG001|Overall Study|Withdrew Consent from study|1
4651949|NCT02101021|7534522|FG002|Overall Study|Withdrew Consent from study|0
4651950|NCT02101021|7534523|FG003|Overall Study|Withdrew Consent from study|2
4651951|NCT02101021|7534524|FG004|Overall Study|Withdrew Consent from study|0
4651952|NCT02101021|7534520|FG000|Overall Study|Lost to Follow-up|1
4651953|NCT02101021|7534521|FG001|Overall Study|Lost to Follow-up|0
4651954|NCT02101021|7534522|FG002|Overall Study|Lost to Follow-up|0
4651955|NCT02101021|7534523|FG003|Overall Study|Lost to Follow-up|0
4651956|NCT02101021|7534524|FG004|Overall Study|Lost to Follow-up|0
4651957|NCT02101021|7534520|FG000|Overall Study|Study Terminated by Sponsor|1
4651958|NCT02101021|7534521|FG001|Overall Study|Study Terminated by Sponsor|0
4651959|NCT02101021|7534522|FG002|Overall Study|Study Terminated by Sponsor|1
4651960|NCT02101021|7534523|FG003|Overall Study|Study Terminated by Sponsor|1
4651961|NCT02101021|7534524|FG004|Overall Study|Study Terminated by Sponsor|1
4651962|NCT02101034|7534541|FG000|Overall Study|Enrolled but did not start treatment|0
4651963|NCT02101034|7534542|FG001|Overall Study|Enrolled but did not start treatment|0
4651964|NCT02101034|7534543|FG002|Overall Study|Enrolled but did not start treatment|1
4651965|NCT02101034|7534544|FG003|Overall Study|Enrolled but did not start treatment|0
4651966|NCT02101034|7534545|FG004|Overall Study|Enrolled but did not start treatment|0
4651967|NCT02101060|7534565|FG000|Overall Study|Adverse Event|1
4651968|NCT02101060|7534566|FG001|Overall Study|Adverse Event|0
4651969|NCT02101060|7534565|FG000|Overall Study|Withdrawal by Subject|1
4651970|NCT02101060|7534566|FG001|Overall Study|Withdrawal by Subject|1
4651971|NCT02101060|7534565|FG000|Overall Study|Lost to Follow-up|3
4651972|NCT02101060|7534566|FG001|Overall Study|Lost to Follow-up|3
4651973|NCT02101112|7534572|FG000|Overall Study|Adverse Event|0
4651974|NCT02101112|7534573|FG001|Overall Study|Adverse Event|0
4651975|NCT02101112|7534574|FG002|Overall Study|Adverse Event|1
4651976|NCT02101112|7534575|FG003|Overall Study|Adverse Event|0
4651977|NCT02101112|7534576|FG004|Overall Study|Adverse Event|0
4651978|NCT02101112|7534577|FG005|Overall Study|Adverse Event|0
4651979|NCT02101112|7534572|FG000|Overall Study|Withdrawal by Subject|0
4651980|NCT02101112|7534573|FG001|Overall Study|Withdrawal by Subject|0
4651981|NCT02101112|7534574|FG002|Overall Study|Withdrawal by Subject|0
4651982|NCT02101112|7534575|FG003|Overall Study|Withdrawal by Subject|0
4651983|NCT02101112|7534576|FG004|Overall Study|Withdrawal by Subject|1
4651984|NCT02101112|7534577|FG005|Overall Study|Withdrawal by Subject|0
4651985|NCT02101281|7534598|FG000|Overall Study|Adverse Event|0
4651986|NCT02101281|7534599|FG001|Overall Study|Adverse Event|1
4651987|NCT02101294|7534611|FG000|Overall Study|Withdrawal by Subject|5
4651988|NCT02101294|7534611|FG000|Overall Study|Lost to Follow-up|6
4651989|NCT02101359|7534620|FG000|Overall Study|Not included|23
4651990|NCT02101359|7534621|FG001|Overall Study|Not included|13
4651991|NCT02101359|7534620|FG000|Overall Study|Withdrawal by Subject|5
4651992|NCT02101359|7534621|FG001|Overall Study|Withdrawal by Subject|4
4651993|NCT02101359|7534620|FG000|Overall Study|Lost to Follow-up|1
4651994|NCT02101359|7534621|FG001|Overall Study|Lost to Follow-up|0
4651995|NCT02101359|7534620|FG000|Overall Study|Protocol Violation|0
4651996|NCT02101359|7534621|FG001|Overall Study|Protocol Violation|2
4651997|NCT02101554|7534669|FG000|Overall Study|Protocol Violation|0
4651998|NCT02101554|7534670|FG001|Overall Study|Protocol Violation|1
4651999|NCT02101554|7534671|FG002|Overall Study|Protocol Violation|0
4652000|NCT02101554|7534669|FG000|Overall Study|Insufficient Clinical Response|0
4652001|NCT02101554|7534670|FG001|Overall Study|Insufficient Clinical Response|2
4652002|NCT02101554|7534671|FG002|Overall Study|Insufficient Clinical Response|0
4652003|NCT02101554|7534669|FG000|Overall Study|Adverse Event|2
4652004|NCT02101554|7534670|FG001|Overall Study|Adverse Event|1
4652005|NCT02101554|7534671|FG002|Overall Study|Adverse Event|1
4652006|NCT02101554|7534669|FG000|Overall Study|Lost to Follow-up|0
4652007|NCT02101554|7534670|FG001|Overall Study|Lost to Follow-up|1
4652008|NCT02101554|7534671|FG002|Overall Study|Lost to Follow-up|0
4652009|NCT02101554|7534669|FG000|Overall Study|Withdrawl by Parents/Guardians|1
4652010|NCT02101554|7534670|FG001|Overall Study|Withdrawl by Parents/Guardians|0
4652011|NCT02101554|7534671|FG002|Overall Study|Withdrawl by Parents/Guardians|0
4652012|NCT02101983|7534685|FG000|Overall Study|Physician Decision|1
4652013|NCT02101983|7534686|FG001|Overall Study|Physician Decision|0
4652014|NCT02102204|7534701|FG000|Overall Study|Withdrawal by Subject|137
4652015|NCT02102204|7534701|FG000|Overall Study|Death|92
4652016|NCT02102204|7534701|FG000|Overall Study|Lost to Follow-up|65
4652017|NCT02102204|7534701|FG000|Overall Study|Sponsor Decision|5
4652018|NCT02102204|7534701|FG000|Overall Study|Ongoing|5
4652019|NCT02102399|7534721|FG000|Overall Study|Withdrawal by Subject|6
4652020|NCT02102399|7534722|FG001|Overall Study|Withdrawal by Subject|4
4652021|NCT02102464|7534735|FG000|Randomized Study|Withdrawal by Subject|0
4652022|NCT02102464|7534736|FG001|Randomized Study|Withdrawal by Subject|1
4652023|NCT02102464|7534737|FG002|Randomized Study|Withdrawal by Subject|0
4652024|NCT02102490|7534746|FG000|Overall Study|Death|6
4652025|NCT02102490|7534746|FG000|Overall Study|Lost to Follow-up|1
4652026|NCT02102724|7534752|FG000|Overall Study|Lost to Follow-up|1
4652027|NCT02102724|7534753|FG001|Overall Study|Lost to Follow-up|0
4652028|NCT02102724|7534752|FG000|Overall Study|surgery for brain aneurysm|1
4652029|NCT02102724|7534753|FG001|Overall Study|surgery for brain aneurysm|1
4652030|NCT02103062|7534794|FG000|Overall Study|Adverse Event|1
4652031|NCT02103062|7534795|FG001|Overall Study|Adverse Event|2
4652032|NCT02103062|7534794|FG000|Overall Study|Progressive Disease|17
4652033|NCT02103062|7534795|FG001|Overall Study|Progressive Disease|20
4652034|NCT02103062|7534794|FG000|Overall Study|Death|0
4652035|NCT02103062|7534795|FG001|Overall Study|Death|1
4652036|NCT02103439|7534864|FG000|Overall Study|Adverse Event|0
4652037|NCT02103439|7534865|FG001|Overall Study|Adverse Event|2
4652038|NCT02103439|7534864|FG000|Overall Study|Withdrawal by Subject|3
4652039|NCT02103439|7534865|FG001|Overall Study|Withdrawal by Subject|1
4652040|NCT02103478|7534882|FG000|Overall Study|Adverse Event|0
4652041|NCT02103478|7534883|FG001|Overall Study|Adverse Event|0
4652042|NCT02103478|7534884|FG002|Overall Study|Adverse Event|1
4652043|NCT02103478|7534885|FG003|Overall Study|Adverse Event|1
4652044|NCT02103478|7534886|FG004|Overall Study|Adverse Event|2
4652045|NCT02103478|7534887|FG005|Overall Study|Adverse Event|1
4652046|NCT02103478|7534888|FG006|Overall Study|Adverse Event|0
4652047|NCT02103478|7534889|FG007|Overall Study|Adverse Event|0
4652048|NCT02103478|7534890|FG008|Overall Study|Adverse Event|0
4652049|NCT02103478|7534882|FG000|Overall Study|Death|2
4652050|NCT02103478|7534883|FG001|Overall Study|Death|2
4652051|NCT02103478|7534884|FG002|Overall Study|Death|1
4652052|NCT02103478|7534885|FG003|Overall Study|Death|1
4652053|NCT02103478|7534886|FG004|Overall Study|Death|5
4652054|NCT02103478|7534887|FG005|Overall Study|Death|15
4652055|NCT02103478|7534888|FG006|Overall Study|Death|14
4652056|NCT02103478|7534889|FG007|Overall Study|Death|10
4652057|NCT02103478|7534890|FG008|Overall Study|Death|11
4652058|NCT02103478|7534882|FG000|Overall Study|Progressive Disease|2
4652059|NCT02103478|7534883|FG001|Overall Study|Progressive Disease|1
4652060|NCT02103478|7534884|FG002|Overall Study|Progressive Disease|2
4652061|NCT02103478|7534885|FG003|Overall Study|Progressive Disease|0
4652062|NCT02103478|7534886|FG004|Overall Study|Progressive Disease|9
4652063|NCT02103478|7534887|FG005|Overall Study|Progressive Disease|1
4652064|NCT02103478|7534888|FG006|Overall Study|Progressive Disease|2
4652065|NCT02103478|7534889|FG007|Overall Study|Progressive Disease|0
4652066|NCT02103478|7534890|FG008|Overall Study|Progressive Disease|1
4652067|NCT02103478|7534882|FG000|Overall Study|Withdrawal by Subject|2
4652068|NCT02103478|7534883|FG001|Overall Study|Withdrawal by Subject|0
4652069|NCT02103478|7534884|FG002|Overall Study|Withdrawal by Subject|0
4652070|NCT02103478|7534885|FG003|Overall Study|Withdrawal by Subject|4
4652071|NCT02103478|7534886|FG004|Overall Study|Withdrawal by Subject|0
4652072|NCT02103478|7534887|FG005|Overall Study|Withdrawal by Subject|0
4652073|NCT02103478|7534888|FG006|Overall Study|Withdrawal by Subject|1
4652074|NCT02103478|7534889|FG007|Overall Study|Withdrawal by Subject|1
4652075|NCT02103478|7534890|FG008|Overall Study|Withdrawal by Subject|0
4652076|NCT02103478|7534882|FG000|Overall Study|Lost to Follow-up|0
4652077|NCT02103478|7534883|FG001|Overall Study|Lost to Follow-up|0
4652078|NCT02103478|7534884|FG002|Overall Study|Lost to Follow-up|0
4652079|NCT02103478|7534885|FG003|Overall Study|Lost to Follow-up|0
4652080|NCT02103478|7534886|FG004|Overall Study|Lost to Follow-up|0
4652081|NCT02103478|7534887|FG005|Overall Study|Lost to Follow-up|0
4652082|NCT02103478|7534888|FG006|Overall Study|Lost to Follow-up|0
4652083|NCT02103478|7534889|FG007|Overall Study|Lost to Follow-up|1
4652084|NCT02103478|7534890|FG008|Overall Study|Lost to Follow-up|0
4652085|NCT02103478|7534882|FG000|Overall Study|Other|1
4652086|NCT02103478|7534883|FG001|Overall Study|Other|3
4652087|NCT02103478|7534884|FG002|Overall Study|Other|2
4652088|NCT02103478|7534885|FG003|Overall Study|Other|0
4652089|NCT02103478|7534886|FG004|Overall Study|Other|3
4652090|NCT02103478|7534887|FG005|Overall Study|Other|8
4748056|NCT02908672|7722063|FG001|Overall Study|Lost to Follow-up|3
4652091|NCT02103478|7534888|FG006|Overall Study|Other|8
4652092|NCT02103478|7534889|FG007|Overall Study|Other|4
4652093|NCT02103478|7534890|FG008|Overall Study|Other|2
4652094|NCT02104505|7534981|FG000|First Intervention (14 Days)|Adverse Event|2
4652095|NCT02104505|7534982|FG001|First Intervention (14 Days)|Adverse Event|0
4652096|NCT02104505|7534981|FG000|First Intervention (14 Days)|Withdrawal by Subject|0
4652097|NCT02104505|7534982|FG001|First Intervention (14 Days)|Withdrawal by Subject|1
4652098|NCT02104505|7534981|FG000|First Intervention (14 Days)|Lost to Follow-up|0
4748057|NCT02908672|7722062|FG000|Overall Study|Other|2
4652099|NCT02104505|7534982|FG001|First Intervention (14 Days)|Lost to Follow-up|1
4652100|NCT02104505|7534981|FG000|First Intervention (14 Days)|exclusionary condition|0
4652101|NCT02104505|7534982|FG001|First Intervention (14 Days)|exclusionary condition|1
4652102|NCT02104505|7534981|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0
4652103|NCT02104505|7534982|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1
4652104|NCT02104505|7534981|FG000|Second Intervention (14 Days)|Adverse Event|2
4652105|NCT02104505|7534982|FG001|Second Intervention (14 Days)|Adverse Event|0
4652106|NCT02104557|7534989|FG000|Overall Study|Adverse Event|24
4652107|NCT02104557|7534989|FG000|Overall Study|Lost to Follow-up|34
4652108|NCT02104557|7534989|FG000|Overall Study|Violated the usage and dosage|14
4652109|NCT02104557|7534989|FG000|Overall Study|No longer met inclusion/exclusion criteria|1
4652110|NCT02104557|7534989|FG000|Overall Study|Administered Sayana prior to the contract|1
4652111|NCT02104557|7534989|FG000|Overall Study|Other|17
4652112|NCT02104557|7534989|FG000|Overall Study|Change to other contraception methods|5
4652113|NCT02104557|7534989|FG000|Overall Study|Discontinuation due to no pain|1
4652114|NCT02104557|7534989|FG000|Overall Study|Withdrawal consent|2
4652115|NCT02104557|7534989|FG000|Overall Study|Refusal of administration due to unknown reasons|69
4652116|NCT02104557|7534989|FG000|Overall Study|Discontinuation of contraception|9
4652117|NCT02104583|7534998|FG000|Overall Study|New ICD or CRT-D implanted|2
4652118|NCT02104583|7534999|FG001|Overall Study|New ICD or CRT-D implanted|0
4652119|NCT02104583|7535000|FG002|Overall Study|New ICD or CRT-D implanted|1
4652120|NCT02104583|7535001|FG003|Overall Study|New ICD or CRT-D implanted|0
4652121|NCT02104583|7535002|FG004|Overall Study|New ICD or CRT-D implanted|0
4652122|NCT02104583|7534998|FG000|Overall Study|Death|2
4652123|NCT02104583|7534999|FG001|Overall Study|Death|1
4652124|NCT02104583|7535000|FG002|Overall Study|Death|3
4652125|NCT02104583|7535001|FG003|Overall Study|Death|3
4652126|NCT02104583|7535002|FG004|Overall Study|Death|5
4652127|NCT02104583|7534998|FG000|Overall Study|Subject required cardiac ablation|6
4652128|NCT02104583|7534999|FG001|Overall Study|Subject required cardiac ablation|4
4652129|NCT02104583|7535000|FG002|Overall Study|Subject required cardiac ablation|4
4652130|NCT02104583|7535001|FG003|Overall Study|Subject required cardiac ablation|5
4652131|NCT02104583|7535002|FG004|Overall Study|Subject required cardiac ablation|4
4652132|NCT02104583|7534998|FG000|Overall Study|Subject required prohibited medication|0
4652133|NCT02104583|7534999|FG001|Overall Study|Subject required prohibited medication|1
4652134|NCT02104583|7535000|FG002|Overall Study|Subject required prohibited medication|1
4652135|NCT02104583|7535001|FG003|Overall Study|Subject required prohibited medication|0
4652136|NCT02104583|7535002|FG004|Overall Study|Subject required prohibited medication|1
4652137|NCT02104583|7534998|FG000|Overall Study|Withdrew Consent|3
4652138|NCT02104583|7534999|FG001|Overall Study|Withdrew Consent|2
4652139|NCT02104583|7535000|FG002|Overall Study|Withdrew Consent|0
4652140|NCT02104583|7535001|FG003|Overall Study|Withdrew Consent|2
4652141|NCT02104583|7535002|FG004|Overall Study|Withdrew Consent|1
4652142|NCT02104583|7534998|FG000|Overall Study|Investigator's Discretion|1
4652143|NCT02104583|7534999|FG001|Overall Study|Investigator's Discretion|0
4652144|NCT02104583|7535000|FG002|Overall Study|Investigator's Discretion|0
4652145|NCT02104583|7535001|FG003|Overall Study|Investigator's Discretion|0
4652146|NCT02104583|7535002|FG004|Overall Study|Investigator's Discretion|0
4652147|NCT02104583|7534998|FG000|Overall Study|Protocol Violation|0
4652148|NCT02104583|7534999|FG001|Overall Study|Protocol Violation|0
4652149|NCT02104583|7535000|FG002|Overall Study|Protocol Violation|1
4652150|NCT02104583|7535001|FG003|Overall Study|Protocol Violation|0
4652151|NCT02104583|7535002|FG004|Overall Study|Protocol Violation|0
4652152|NCT02104583|7534998|FG000|Overall Study|Adverse Event|3
4652153|NCT02104583|7534999|FG001|Overall Study|Adverse Event|3
4652154|NCT02104583|7535000|FG002|Overall Study|Adverse Event|6
4652155|NCT02104583|7535001|FG003|Overall Study|Adverse Event|6
4652156|NCT02104583|7535002|FG004|Overall Study|Adverse Event|1
4652157|NCT02104583|7534998|FG000|Overall Study|Lost to Follow-up|1
4652158|NCT02104583|7534999|FG001|Overall Study|Lost to Follow-up|0
4652159|NCT02104583|7535000|FG002|Overall Study|Lost to Follow-up|0
4652160|NCT02104583|7535001|FG003|Overall Study|Lost to Follow-up|0
4652161|NCT02104583|7535002|FG004|Overall Study|Lost to Follow-up|0
4652162|NCT02104583|7534998|FG000|Overall Study|Randomized but Never Treated|0
4652163|NCT02104583|7534999|FG001|Overall Study|Randomized but Never Treated|0
4652164|NCT02104583|7535000|FG002|Overall Study|Randomized but Never Treated|0
4652165|NCT02104583|7535001|FG003|Overall Study|Randomized but Never Treated|1
4652166|NCT02104583|7535002|FG004|Overall Study|Randomized but Never Treated|0
4652167|NCT02104752|7535041|FG000|Overall Study|Withdrawal by Subject|1
4652168|NCT02104752|7535042|FG001|Overall Study|Withdrawal by Subject|0
4652169|NCT02104752|7535041|FG000|Overall Study|Weight gain; unrelated anxiety|0
4652170|NCT02104752|7535042|FG001|Overall Study|Weight gain; unrelated anxiety|2
4652171|NCT02104765|7535055|FG000|Overall Study|Lost to Follow-up|0
4652172|NCT02104765|7535056|FG001|Overall Study|Lost to Follow-up|0
4652173|NCT02104765|7535057|FG002|Overall Study|Lost to Follow-up|1
4652174|NCT02104765|7535058|FG003|Overall Study|Lost to Follow-up|0
4652175|NCT02104765|7535059|FG004|Overall Study|Lost to Follow-up|0
4652176|NCT02104765|7535060|FG005|Overall Study|Lost to Follow-up|0
4652177|NCT02104765|7535061|FG006|Overall Study|Lost to Follow-up|0
4652178|NCT02104765|7535055|FG000|Overall Study|Withdrawal by Subject|0
4652179|NCT02104765|7535056|FG001|Overall Study|Withdrawal by Subject|0
4652180|NCT02104765|7535057|FG002|Overall Study|Withdrawal by Subject|0
4748058|NCT02908672|7722063|FG001|Overall Study|Other|0
4748059|NCT02908672|7722062|FG000|Overall Study|Protocol Violation|1
4748060|NCT02908672|7722063|FG001|Overall Study|Protocol Violation|1
4748061|NCT02908672|7722062|FG000|Overall Study|Withdrawal by Subject|13
4748062|NCT02908672|7722063|FG001|Overall Study|Withdrawal by Subject|18
4748063|NCT02908672|7722062|FG000|Overall Study|Study is ongoing|124
4748064|NCT02908672|7722063|FG001|Overall Study|Study is ongoing|141
4748065|NCT02908672|7722062|FG000|Overall Study|Discontinued the study during run-in|3
4748066|NCT02908672|7722063|FG001|Overall Study|Discontinued the study during run-in|0
4748067|NCT02767570|7722071|FG000|Overall Study|Lost to Follow-up|3
4652181|NCT02104765|7535058|FG003|Overall Study|Withdrawal by Subject|1
4748068|NCT02767570|7722072|FG001|Overall Study|Lost to Follow-up|0
4748069|NCT02767570|7722071|FG000|Overall Study|COVID shutdown|2
4748070|NCT02767570|7722072|FG001|Overall Study|COVID shutdown|5
4748071|NCT02767570|7722071|FG000|Overall Study|Increased pain|2
4748072|NCT02767570|7722072|FG001|Overall Study|Increased pain|0
4652182|NCT02104765|7535059|FG004|Overall Study|Withdrawal by Subject|1
4652183|NCT02104765|7535060|FG005|Overall Study|Withdrawal by Subject|0
4652184|NCT02104765|7535061|FG006|Overall Study|Withdrawal by Subject|1
4652185|NCT02104804|7535085|FG000|Overall Study|Did not take study medication|0
4652186|NCT02104804|7535086|FG001|Overall Study|Did not take study medication|1
4652187|NCT02104804|7535085|FG000|Overall Study|Study specific discontinuation criteria|6
4652188|NCT02104804|7535086|FG001|Overall Study|Study specific discontinuation criteria|1
4652189|NCT02104804|7535085|FG000|Overall Study|Other listed|2
4652190|NCT02104804|7535086|FG001|Overall Study|Other listed|1
4652191|NCT02104804|7535085|FG000|Overall Study|Protocol Violation|0
4652192|NCT02104804|7535086|FG001|Overall Study|Protocol Violation|1
4652193|NCT02104804|7535085|FG000|Overall Study|Adverse Event|4
4652194|NCT02104804|7535086|FG001|Overall Study|Adverse Event|3
4652195|NCT02104804|7535085|FG000|Overall Study|Withdrawal by Subject|4
4652196|NCT02104804|7535086|FG001|Overall Study|Withdrawal by Subject|12
4652197|NCT02104817|7535094|FG000|Overall Study|Death|363
4652198|NCT02104817|7535095|FG001|Overall Study|Death|330
4652199|NCT02104817|7535094|FG000|Overall Study|Lost to Follow-up|3
4652200|NCT02104817|7535095|FG001|Overall Study|Lost to Follow-up|2
4652201|NCT02104817|7535094|FG000|Overall Study|Protocol Violation|0
4652202|NCT02104817|7535095|FG001|Overall Study|Protocol Violation|1
4652203|NCT02104817|7535094|FG000|Overall Study|Study terminated by sponsor|5854
4652204|NCT02104817|7535095|FG001|Overall Study|Study terminated by sponsor|5901
4652205|NCT02104817|7535094|FG000|Overall Study|Withdrawal by Subject|111
4652206|NCT02104817|7535095|FG001|Overall Study|Withdrawal by Subject|78
4652207|NCT02104817|7535094|FG000|Overall Study|Other reasons|128
4652208|NCT02104817|7535095|FG001|Overall Study|Other reasons|135
4652209|NCT02104895|7535116|FG000|Overall Study|Withdrawal by Subject|0
4652210|NCT02104895|7535117|FG001|Overall Study|Withdrawal by Subject|14
4652211|NCT02104947|7535125|FG000|Overall Study|Withdrawal by Subject|10
4652212|NCT02104947|7535126|FG001|Overall Study|Withdrawal by Subject|3
4652213|NCT02104947|7535125|FG000|Overall Study|Lost to Follow-up|4
4652214|NCT02104947|7535126|FG001|Overall Study|Lost to Follow-up|4
4652215|NCT02104947|7535125|FG000|Overall Study|Protocol Violation|6
4652216|NCT02104947|7535126|FG001|Overall Study|Protocol Violation|8
4652217|NCT02104947|7535125|FG000|Overall Study|Adverse Event|57
4652218|NCT02104947|7535126|FG001|Overall Study|Adverse Event|38
4652219|NCT02104947|7535125|FG000|Overall Study|Other than stated above|2
4652220|NCT02104947|7535126|FG001|Overall Study|Other than stated above|3
4652221|NCT02105012|7535136|FG000|Overall Study|Withdrawal by Subject|11
4652222|NCT02105012|7535136|FG000|Overall Study|Protocol Specified Criteria|9
4652223|NCT02105012|7535136|FG000|Overall Study|Lost to Follow-up|4
4652224|NCT02105012|7535136|FG000|Overall Study|Protocol Violation|4
4652225|NCT02105012|7535136|FG000|Overall Study|Physician Decision|3
4652226|NCT02105012|7535136|FG000|Overall Study|Adverse Event|1
4652227|NCT02105012|7535136|FG000|Overall Study|Lack of Efficacy|1
4652228|NCT02105272|7535163|FG000|Overall Study|Adverse Event|1
4652229|NCT02105272|7535164|FG001|Overall Study|Adverse Event|2
4652230|NCT02105272|7535163|FG000|Overall Study|Physician Decision|0
4652231|NCT02105272|7535164|FG001|Overall Study|Physician Decision|1
4652232|NCT02105272|7535163|FG000|Overall Study|Protocol Violation|2
4652233|NCT02105272|7535164|FG001|Overall Study|Protocol Violation|0
4652234|NCT02105272|7535163|FG000|Overall Study|Withdrawal by Subject|2
4652235|NCT02105272|7535164|FG001|Overall Study|Withdrawal by Subject|0
4652236|NCT02105285|7535173|FG000|Overall Study|Adverse Event|1
4652237|NCT02105285|7535174|FG001|Overall Study|Adverse Event|1
4652238|NCT02105285|7535175|FG002|Overall Study|Adverse Event|0
4652239|NCT02105285|7535173|FG000|Overall Study|Protocol Violation|0
4652240|NCT02105285|7535174|FG001|Overall Study|Protocol Violation|1
4652241|NCT02105285|7535175|FG002|Overall Study|Protocol Violation|0
4652242|NCT02105285|7535173|FG000|Overall Study|Withdrawal by Subject|1
4652243|NCT02105285|7535174|FG001|Overall Study|Withdrawal by Subject|0
4652244|NCT02105285|7535175|FG002|Overall Study|Withdrawal by Subject|0
4652245|NCT02105454|7535206|FG000|Overall Study|Withdrawal by Subject|1
4652246|NCT02105467|7535212|FG000|Period 1|Lost to Follow-up|1
4652247|NCT02105467|7535213|FG001|Period 1|Lost to Follow-up|0
4652248|NCT02105467|7535212|FG000|Period 1|Death|1
4652249|NCT02105467|7535213|FG001|Period 1|Death|0
4652250|NCT02105467|7535212|FG000|Period 2|Lost to Follow-up|1
4652251|NCT02105467|7535213|FG001|Period 2|Lost to Follow-up|0
4652252|NCT02105467|7535212|FG000|Period 2|Death|1
4652253|NCT02105467|7535213|FG001|Period 2|Death|0
4652254|NCT02105467|7535212|FG000|Period 2|Withdrawal by Subject|0
4652255|NCT02105467|7535213|FG001|Period 2|Withdrawal by Subject|2
4652256|NCT02105467|7535212|FG000|Period 3|Lost to Follow-up|0
4652257|NCT02105467|7535213|FG001|Period 3|Lost to Follow-up|1
4652258|NCT02105662|7535229|FG000|Overall Study|Lost to Follow-up|5
4652259|NCT02105662|7535229|FG000|Overall Study|Withdrawal by Subject|1
4652260|NCT02105688|7535235|FG000|Part A: Double-Blind|Adverse Event|1
4652261|NCT02105688|7535236|FG001|Part A: Double-Blind|Adverse Event|0
4652262|NCT02105688|7535235|FG000|Part A: Double-Blind|Death|0
4652263|NCT02105688|7535236|FG001|Part A: Double-Blind|Death|1
4652264|NCT02105688|7535235|FG000|Part A: Double-Blind|Lost to Follow-up|15
4652265|NCT02105688|7535236|FG001|Part A: Double-Blind|Lost to Follow-up|11
4652266|NCT02105688|7535235|FG000|Part A: Double-Blind|Physician Decision|0
4652267|NCT02105688|7535236|FG001|Part A: Double-Blind|Physician Decision|1
4652268|NCT02105688|7535235|FG000|Part A: Double-Blind|Status Unknown|0
4652269|NCT02105688|7535236|FG001|Part A: Double-Blind|Status Unknown|2
4652270|NCT02105688|7535235|FG000|Part A: Double-Blind|Withdrawal by Subject|4
4652271|NCT02105688|7535236|FG001|Part A: Double-Blind|Withdrawal by Subject|2
4652272|NCT02105688|7535235|FG000|Part B: Observational Follow-up|Death|2
4652273|NCT02105688|7535236|FG001|Part B: Observational Follow-up|Death|1
4652274|NCT02105688|7535235|FG000|Part B: Observational Follow-up|Lost to Follow-up|23
4652275|NCT02105688|7535236|FG001|Part B: Observational Follow-up|Lost to Follow-up|15
4652276|NCT02105688|7535235|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9
4652277|NCT02105688|7535236|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3
4652278|NCT02105688|7535235|FG000|Part B: Observational Follow-up|Physician Decision|3
4652279|NCT02105688|7535236|FG001|Part B: Observational Follow-up|Physician Decision|1
4652280|NCT02105701|7535247|FG000|Overall Study|Lost to Follow-up|1
4652281|NCT02105701|7535248|FG001|Overall Study|Lost to Follow-up|0
4652282|NCT02105701|7535249|FG002|Overall Study|Lost to Follow-up|2
4652283|NCT02105701|7535250|FG003|Overall Study|Lost to Follow-up|1
4652284|NCT02105701|7535247|FG000|Overall Study|Protocol Violation|0
4652285|NCT02105701|7535248|FG001|Overall Study|Protocol Violation|0
4652286|NCT02105701|7535249|FG002|Overall Study|Protocol Violation|1
4652287|NCT02105701|7535250|FG003|Overall Study|Protocol Violation|0
4652288|NCT02105701|7535247|FG000|Overall Study|Withdrawal by Subject|2
4652289|NCT02105701|7535248|FG001|Overall Study|Withdrawal by Subject|1
4652290|NCT02105701|7535249|FG002|Overall Study|Withdrawal by Subject|0
4652291|NCT02105701|7535250|FG003|Overall Study|Withdrawal by Subject|1
4652292|NCT02105701|7535247|FG000|Overall Study|Death|1
4652293|NCT02105701|7535248|FG001|Overall Study|Death|0
4652294|NCT02105701|7535249|FG002|Overall Study|Death|0
4652295|NCT02105701|7535250|FG003|Overall Study|Death|0
4652296|NCT02105948|7535275|FG000|Overall Study|Adverse Event|10
4652297|NCT02105948|7535276|FG001|Overall Study|Adverse Event|7
4652298|NCT02105948|7535277|FG002|Overall Study|Adverse Event|11
4652299|NCT02105948|7535278|FG003|Overall Study|Adverse Event|11
4652300|NCT02105948|7535275|FG000|Overall Study|Lack of Efficacy|0
4652301|NCT02105948|7535276|FG001|Overall Study|Lack of Efficacy|1
4652302|NCT02105948|7535277|FG002|Overall Study|Lack of Efficacy|3
4748073|NCT02767570|7722071|FG000|Overall Study|Withdrawal by Subject|1
4748074|NCT02767570|7722072|FG001|Overall Study|Withdrawal by Subject|3
4748075|NCT02767570|7722071|FG000|Overall Study|Unrelated medical issue|1
4748076|NCT02767570|7722072|FG001|Overall Study|Unrelated medical issue|1
4748077|NCT02767570|7722071|FG000|Overall Study|Received intra-articular injection|0
4748078|NCT02767570|7722072|FG001|Overall Study|Received intra-articular injection|1
4748079|NCT02743494|7722080|FG000|Pre-treatment Period|Participant request to discontinue treatment|0
4748080|NCT02743494|7722081|FG001|Pre-treatment Period|Participant request to discontinue treatment|1
4748081|NCT02743494|7722080|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0
4748082|NCT02743494|7722081|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1
4748083|NCT02743494|7722080|FG000|Treatment Period|Completed treatment|229
4748084|NCT02743494|7722081|FG001|Treatment Period|Completed treatment|99
4748085|NCT02743494|7722080|FG000|Treatment Period|Disease recurrence|149
4748086|NCT02743494|7722081|FG001|Treatment Period|Disease recurrence|113
4748087|NCT02743494|7722080|FG000|Treatment Period|Study drug toxicity|57
4748088|NCT02743494|7722081|FG001|Treatment Period|Study drug toxicity|8
4748089|NCT02743494|7722080|FG000|Treatment Period|Death|1
4748090|NCT02743494|7722081|FG001|Treatment Period|Death|0
4748091|NCT02743494|7722080|FG000|Treatment Period|Adverse event unrelated to study drug|15
4748092|NCT02743494|7722081|FG001|Treatment Period|Adverse event unrelated to study drug|9
4748093|NCT02743494|7722080|FG000|Treatment Period|Participant request to discontinue treatment|30
4748094|NCT02743494|7722081|FG001|Treatment Period|Participant request to discontinue treatment|5
4748095|NCT02743494|7722080|FG000|Treatment Period|Participant withdrew consent|12
4748096|NCT02743494|7722081|FG001|Treatment Period|Participant withdrew consent|4
4652303|NCT02105948|7535278|FG003|Overall Study|Lack of Efficacy|2
4652304|NCT02105948|7535275|FG000|Overall Study|Lost to Follow-up|0
4652305|NCT02105948|7535276|FG001|Overall Study|Lost to Follow-up|0
4652306|NCT02105948|7535277|FG002|Overall Study|Lost to Follow-up|2
4652307|NCT02105948|7535278|FG003|Overall Study|Lost to Follow-up|1
4652308|NCT02105948|7535275|FG000|Overall Study|Physician Decision|2
4652309|NCT02105948|7535276|FG001|Overall Study|Physician Decision|2
4652310|NCT02105948|7535277|FG002|Overall Study|Physician Decision|2
4652311|NCT02105948|7535278|FG003|Overall Study|Physician Decision|2
4652312|NCT02105948|7535275|FG000|Overall Study|Withdrawal by Subject|15
4652313|NCT02105948|7535276|FG001|Overall Study|Withdrawal by Subject|10
4652314|NCT02105948|7535277|FG002|Overall Study|Withdrawal by Subject|10
4652315|NCT02105948|7535278|FG003|Overall Study|Withdrawal by Subject|11
4652316|NCT02105961|7535292|FG000|Overall Study|Adverse Event|18
4652317|NCT02105961|7535293|FG001|Overall Study|Adverse Event|7
4652318|NCT02105961|7535294|FG002|Overall Study|Adverse Event|13
4652319|NCT02105961|7535292|FG000|Overall Study|Lack of Efficacy|3
4652320|NCT02105961|7535293|FG001|Overall Study|Lack of Efficacy|0
4652321|NCT02105961|7535294|FG002|Overall Study|Lack of Efficacy|3
4652322|NCT02105961|7535292|FG000|Overall Study|Lost to Follow-up|2
4652323|NCT02105961|7535293|FG001|Overall Study|Lost to Follow-up|0
4652324|NCT02105961|7535294|FG002|Overall Study|Lost to Follow-up|1
4652325|NCT02105961|7535292|FG000|Overall Study|Physician Decision|3
4652326|NCT02105961|7535293|FG001|Overall Study|Physician Decision|3
4652327|NCT02105961|7535294|FG002|Overall Study|Physician Decision|2
4652328|NCT02105961|7535292|FG000|Overall Study|Withdrawal by Subject|15
4652329|NCT02105961|7535293|FG001|Overall Study|Withdrawal by Subject|7
4652330|NCT02105961|7535294|FG002|Overall Study|Withdrawal by Subject|11
4652331|NCT02105974|7535305|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158
4652332|NCT02105974|7535306|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0
4652333|NCT02105974|7535307|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0
4652334|NCT02105974|7535305|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603
4652335|NCT02105974|7535306|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0
4652336|NCT02105974|7535307|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0
4652337|NCT02105974|7535305|FG000|2 Week Run-in Period|Adverse Event|6
4652338|NCT02105974|7535306|FG001|2 Week Run-in Period|Adverse Event|0
4652339|NCT02105974|7535307|FG002|2 Week Run-in Period|Adverse Event|0
4652340|NCT02105974|7535305|FG000|2 Week Run-in Period|Study closed/terminated|1
4652341|NCT02105974|7535306|FG001|2 Week Run-in Period|Study closed/terminated|0
4652342|NCT02105974|7535307|FG002|2 Week Run-in Period|Study closed/terminated|0
4652343|NCT02105974|7535305|FG000|2 Week Run-in Period|Lost to Follow-up|2
4652344|NCT02105974|7535306|FG001|2 Week Run-in Period|Lost to Follow-up|0
4652345|NCT02105974|7535307|FG002|2 Week Run-in Period|Lost to Follow-up|0
4652346|NCT02105974|7535305|FG000|2 Week Run-in Period|Withdrew consent|23
4652347|NCT02105974|7535306|FG001|2 Week Run-in Period|Withdrew consent|0
4652348|NCT02105974|7535307|FG002|2 Week Run-in Period|Withdrew consent|0
4652349|NCT02105974|7535305|FG000|2 Week Run-in Period|Investigator discretion|8
4652350|NCT02105974|7535306|FG001|2 Week Run-in Period|Investigator discretion|0
4652351|NCT02105974|7535307|FG002|2 Week Run-in Period|Investigator discretion|0
4652352|NCT02105974|7535305|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0
4652353|NCT02105974|7535306|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14
4652354|NCT02105974|7535307|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18
4652355|NCT02105974|7535305|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0
4652356|NCT02105974|7535306|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6
4652357|NCT02105974|7535307|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9
4652358|NCT02105974|7535305|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0
4652359|NCT02105974|7535306|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2
4652360|NCT02105974|7535307|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6
4652361|NCT02105974|7535305|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0
4652362|NCT02105974|7535306|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1
4652363|NCT02105974|7535307|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2
4652364|NCT02105974|7535305|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0
4652365|NCT02105974|7535306|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0
4652366|NCT02105974|7535307|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1
4652367|NCT02105974|7535305|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0
4652368|NCT02105974|7535306|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7
4652369|NCT02105974|7535307|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4
4652370|NCT02105974|7535305|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0
4652371|NCT02105974|7535306|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12
4652372|NCT02105974|7535307|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18
4652373|NCT02105987|7535315|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10
4652374|NCT02105987|7535316|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0
4652375|NCT02105987|7535317|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0
4652376|NCT02105987|7535318|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0
4652377|NCT02105987|7535319|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0
4652378|NCT02105987|7535320|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0
4652379|NCT02105987|7535315|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15
4652380|NCT02105987|7535316|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17
4652381|NCT02105987|7535317|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0
4652382|NCT02105987|7535318|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0
4652383|NCT02105987|7535319|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0
4652384|NCT02105987|7535320|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0
4652385|NCT02105987|7535315|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4
4652386|NCT02105987|7535316|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10
4652387|NCT02105987|7535317|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
4652388|NCT02105987|7535318|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
4652389|NCT02105987|7535319|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
4652390|NCT02105987|7535320|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
4652391|NCT02105987|7535315|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3
4652392|NCT02105987|7535316|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3
4652393|NCT02105987|7535317|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
4652394|NCT02105987|7535318|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
4652395|NCT02105987|7535319|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
4652396|NCT02105987|7535320|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
4652397|NCT02105987|7535315|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4
4652398|NCT02105987|7535316|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3
4652399|NCT02105987|7535317|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0
4652400|NCT02105987|7535318|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0
4652401|NCT02105987|7535319|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0
4652402|NCT02105987|7535320|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0
4652403|NCT02105987|7535315|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
4652404|NCT02105987|7535316|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1
4652405|NCT02105987|7535317|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
4652406|NCT02105987|7535318|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
4652407|NCT02105987|7535319|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
4652408|NCT02105987|7535320|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
4652409|NCT02105987|7535315|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0
4652410|NCT02105987|7535316|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0
4652411|NCT02105987|7535317|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10
4652412|NCT02105987|7535318|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4
4652413|NCT02105987|7535319|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0
4652414|NCT02105987|7535320|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0
4652415|NCT02105987|7535315|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0
4652416|NCT02105987|7535316|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0
4652417|NCT02105987|7535317|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15
4652418|NCT02105987|7535318|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1
4652419|NCT02105987|7535319|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0
4652420|NCT02105987|7535320|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0
4652421|NCT02105987|7535315|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
4652422|NCT02105987|7535316|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
4652423|NCT02105987|7535317|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6
4652424|NCT02105987|7535318|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5
4652425|NCT02105987|7535319|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
4652426|NCT02105987|7535320|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
4652427|NCT02105987|7535315|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
4652428|NCT02105987|7535316|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
4652429|NCT02105987|7535317|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8
4652430|NCT02105987|7535318|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3
4652431|NCT02105987|7535319|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
4652432|NCT02105987|7535320|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
4652433|NCT02105987|7535315|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0
4652434|NCT02105987|7535316|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0
4652435|NCT02105987|7535317|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5
4652436|NCT02105987|7535318|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0
4652437|NCT02105987|7535319|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0
4652438|NCT02105987|7535320|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0
4652439|NCT02105987|7535315|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
4652440|NCT02105987|7535316|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
4652441|NCT02105987|7535317|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
4652442|NCT02105987|7535318|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1
4652443|NCT02105987|7535319|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
4652444|NCT02105987|7535320|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
4652445|NCT02105987|7535315|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0
4652446|NCT02105987|7535316|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0
4652447|NCT02105987|7535317|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1
4652448|NCT02105987|7535318|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0
4652449|NCT02105987|7535319|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0
4652450|NCT02105987|7535320|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0
4652451|NCT02105987|7535315|FG000|Continuation Phase|Protocol Violation|0
4652452|NCT02105987|7535316|FG001|Continuation Phase|Protocol Violation|0
4652453|NCT02105987|7535317|FG002|Continuation Phase|Protocol Violation|0
4652454|NCT02105987|7535318|FG003|Continuation Phase|Protocol Violation|0
4652455|NCT02105987|7535319|FG004|Continuation Phase|Protocol Violation|1
4652456|NCT02105987|7535320|FG005|Continuation Phase|Protocol Violation|0
4652457|NCT02106156|7535342|FG000|Overall Study|Patient Died|19
4652458|NCT02106156|7535343|FG001|Overall Study|Patient Died|0
4652459|NCT02106156|7535344|FG002|Overall Study|Patient Died|0
4652460|NCT02106156|7535342|FG000|Overall Study|Lack of Tolerability|305
4652461|NCT02106156|7535343|FG001|Overall Study|Lack of Tolerability|3
4652462|NCT02106156|7535344|FG002|Overall Study|Lack of Tolerability|0
4652463|NCT02106156|7535342|FG000|Overall Study|Lack of Virological Response|1044
4652464|NCT02106156|7535343|FG001|Overall Study|Lack of Virological Response|8
4652465|NCT02106156|7535344|FG002|Overall Study|Lack of Virological Response|0
4652466|NCT02106156|7535342|FG000|Overall Study|Concomitant Disease|74
4652467|NCT02106156|7535343|FG001|Overall Study|Concomitant Disease|2
4652468|NCT02106156|7535344|FG002|Overall Study|Concomitant Disease|0
4652469|NCT02106156|7535342|FG000|Overall Study|Lack of Compliance|211
4652470|NCT02106156|7535343|FG001|Overall Study|Lack of Compliance|7
4652471|NCT02106156|7535344|FG002|Overall Study|Lack of Compliance|0
4652472|NCT02106156|7535342|FG000|Overall Study|Patients Request|307
4652473|NCT02106156|7535343|FG001|Overall Study|Patients Request|9
4652474|NCT02106156|7535344|FG002|Overall Study|Patients Request|0
4652475|NCT02106156|7535342|FG000|Overall Study|Lost to Follow-up|451
4652476|NCT02106156|7535343|FG001|Overall Study|Lost to Follow-up|8
4652477|NCT02106156|7535344|FG002|Overall Study|Lost to Follow-up|0
4652478|NCT02106156|7535342|FG000|Overall Study|Unplanned Event|82
4652479|NCT02106156|7535343|FG001|Overall Study|Unplanned Event|2
4652480|NCT02106156|7535344|FG002|Overall Study|Unplanned Event|0
4652481|NCT02106156|7535342|FG000|Overall Study|Change of Laboratory Parameter|10
4652482|NCT02106156|7535343|FG001|Overall Study|Change of Laboratory Parameter|0
4652483|NCT02106156|7535344|FG002|Overall Study|Change of Laboratory Parameter|0
4652484|NCT02106156|7535342|FG000|Overall Study|Hospitalization/Surgical Intervention|6
4652485|NCT02106156|7535343|FG001|Overall Study|Hospitalization/Surgical Intervention|0
4652486|NCT02106156|7535344|FG002|Overall Study|Hospitalization/Surgical Intervention|0
4652487|NCT02106156|7535342|FG000|Overall Study|Relocation/Change of Physician|40
4652488|NCT02106156|7535343|FG001|Overall Study|Relocation/Change of Physician|1
4652489|NCT02106156|7535344|FG002|Overall Study|Relocation/Change of Physician|0
4652490|NCT02106325|7535353|FG000|Phase 1|Lost to Follow-up|2
4652491|NCT02106325|7535354|FG001|Phase 1|Lost to Follow-up|2
4652492|NCT02106325|7535353|FG000|Phase 2|Lost to Follow-up|2
4652493|NCT02106325|7535354|FG001|Phase 2|Lost to Follow-up|3
4652494|NCT02106325|7535353|FG000|Phase 3|Lost to Follow-up|2
4652495|NCT02106325|7535354|FG001|Phase 3|Lost to Follow-up|1
4652496|NCT02106351|7535363|FG000|Treatment Cycle 1|Adverse Event|2
4652497|NCT02106351|7535364|FG001|Treatment Cycle 1|Adverse Event|0
4652498|NCT02106351|7535365|FG002|Treatment Cycle 1|Adverse Event|0
4652499|NCT02106351|7535363|FG000|Treatment Cycle 1|Consent withdrawn|1
4652500|NCT02106351|7535364|FG001|Treatment Cycle 1|Consent withdrawn|0
4652501|NCT02106351|7535365|FG002|Treatment Cycle 1|Consent withdrawn|2
4652502|NCT02106351|7535363|FG000|Treatment Cycle 1|Lost to Follow-up|1
4652503|NCT02106351|7535364|FG001|Treatment Cycle 1|Lost to Follow-up|0
4652504|NCT02106351|7535365|FG002|Treatment Cycle 1|Lost to Follow-up|0
4652505|NCT02106351|7535363|FG000|Treatment Cycle 1|Other|0
4652506|NCT02106351|7535364|FG001|Treatment Cycle 1|Other|3
4652507|NCT02106351|7535365|FG002|Treatment Cycle 1|Other|1
4652508|NCT02106351|7535363|FG000|Treatment Cycle 1|Randomised but not treated|1
4652509|NCT02106351|7535364|FG001|Treatment Cycle 1|Randomised but not treated|0
4652510|NCT02106351|7535365|FG002|Treatment Cycle 1|Randomised but not treated|1
4652511|NCT02106351|7535363|FG000|Treatment Cycle 2|Adverse Event|0
4652512|NCT02106351|7535364|FG001|Treatment Cycle 2|Adverse Event|2
4652513|NCT02106351|7535365|FG002|Treatment Cycle 2|Adverse Event|0
4652514|NCT02106351|7535363|FG000|Treatment Cycle 2|Consent withdrawn|0
4652515|NCT02106351|7535364|FG001|Treatment Cycle 2|Consent withdrawn|1
4652516|NCT02106351|7535365|FG002|Treatment Cycle 2|Consent withdrawn|1
4652517|NCT02106351|7535363|FG000|Treatment Cycle 2|Other|0
4652518|NCT02106351|7535364|FG001|Treatment Cycle 2|Other|2
4652519|NCT02106351|7535365|FG002|Treatment Cycle 2|Other|2
4652520|NCT02106351|7535363|FG000|Treatment Cycle 3|Adverse Event|0
4652521|NCT02106351|7535364|FG001|Treatment Cycle 3|Adverse Event|1
4652522|NCT02106351|7535365|FG002|Treatment Cycle 3|Adverse Event|0
4652523|NCT02106351|7535363|FG000|Treatment Cycle 3|Consent withdrawn|0
4652524|NCT02106351|7535364|FG001|Treatment Cycle 3|Consent withdrawn|0
4652525|NCT02106351|7535365|FG002|Treatment Cycle 3|Consent withdrawn|2
4652526|NCT02106351|7535363|FG000|Treatment Cycle 3|Lost to Follow-up|0
4652527|NCT02106351|7535364|FG001|Treatment Cycle 3|Lost to Follow-up|1
4748097|NCT02743494|7722080|FG000|Treatment Period|Lost to Follow-up|0
4748098|NCT02743494|7722081|FG001|Treatment Period|Lost to Follow-up|1
4748099|NCT02743494|7722080|FG000|Treatment Period|Poor/Non-compliance|1
4748100|NCT02743494|7722081|FG001|Treatment Period|Poor/Non-compliance|0
4748101|NCT02743494|7722080|FG000|Treatment Period|Other reasons|7
4748102|NCT02743494|7722081|FG001|Treatment Period|Other reasons|2
4652528|NCT02106351|7535365|FG002|Treatment Cycle 3|Lost to Follow-up|0
4652529|NCT02106351|7535363|FG000|Treatment Cycle 3|Other|0
4652530|NCT02106351|7535364|FG001|Treatment Cycle 3|Other|2
4652531|NCT02106351|7535365|FG002|Treatment Cycle 3|Other|3
4652532|NCT02106351|7535363|FG000|Treatment Cycle 4|Consent withdrawn|0
4652533|NCT02106351|7535364|FG001|Treatment Cycle 4|Consent withdrawn|0
4652534|NCT02106351|7535365|FG002|Treatment Cycle 4|Consent withdrawn|2
4652535|NCT02106351|7535363|FG000|Treatment Cycle 4|Other|0
4652536|NCT02106351|7535364|FG001|Treatment Cycle 4|Other|1
4652537|NCT02106351|7535365|FG002|Treatment Cycle 4|Other|0
4652538|NCT02106390|7535382|FG000|Overall Study|Withdrawal by Subject|15
4652539|NCT02106390|7535383|FG001|Overall Study|Withdrawal by Subject|16
4652540|NCT02106390|7535384|FG002|Overall Study|Withdrawal by Subject|15
4652541|NCT02106390|7535382|FG000|Overall Study|Lost to Follow-up|25
4652542|NCT02106390|7535383|FG001|Overall Study|Lost to Follow-up|20
4652543|NCT02106390|7535384|FG002|Overall Study|Lost to Follow-up|13
4652544|NCT02106390|7535382|FG000|Overall Study|Other: Administrative Reason|8
4652545|NCT02106390|7535383|FG001|Overall Study|Other: Administrative Reason|5
4652546|NCT02106390|7535384|FG002|Overall Study|Other: Administrative Reason|12
4652547|NCT02106390|7535382|FG000|Overall Study|Other: Unspecified|1
4652548|NCT02106390|7535383|FG001|Overall Study|Other: Unspecified|4
4652549|NCT02106390|7535384|FG002|Overall Study|Other: Unspecified|2
4652550|NCT02106390|7535382|FG000|Overall Study|Adverse Event|0
4652551|NCT02106390|7535383|FG001|Overall Study|Adverse Event|2
4652552|NCT02106390|7535384|FG002|Overall Study|Adverse Event|1
4652553|NCT02106390|7535382|FG000|Overall Study|Protocol Violation|0
4652554|NCT02106390|7535383|FG001|Overall Study|Protocol Violation|1
4652555|NCT02106390|7535384|FG002|Overall Study|Protocol Violation|0
4652556|NCT02106403|7535395|FG000|Follow-Up Visit 3|Other Reason|0
4652557|NCT02106403|7535396|FG001|Follow-Up Visit 3|Other Reason|0
4652558|NCT02106403|7535397|FG002|Follow-Up Visit 3|Other Reason|0
4652559|NCT02106403|7535398|FG003|Follow-Up Visit 3|Other Reason|0
4652560|NCT02106403|7535399|FG004|Follow-Up Visit 3|Other Reason|0
4652561|NCT02106403|7535400|FG005|Follow-Up Visit 3|Other Reason|1
4652562|NCT02106442|7535410|FG000|Overall Study|Case Report Forms Uncollected|7
4652563|NCT02106442|7535410|FG000|Overall Study|Protocol Deviation|30
4652564|NCT02106455|7535414|FG000|Overall Study|Case Report Form Uncollected|6
4652565|NCT02106455|7535414|FG000|Overall Study|Protocol Deviation|2
4652566|NCT02106832|7535448|FG000|Overall Study|Adverse Event|1
4652567|NCT02106832|7535449|FG001|Overall Study|Adverse Event|2
4652568|NCT02106832|7535450|FG002|Overall Study|Adverse Event|3
4652569|NCT02106832|7535451|FG003|Overall Study|Adverse Event|0
4652570|NCT02106832|7535448|FG000|Overall Study|Death|4
4652571|NCT02106832|7535449|FG001|Overall Study|Death|4
4652572|NCT02106832|7535450|FG002|Overall Study|Death|1
4652573|NCT02106832|7535451|FG003|Overall Study|Death|4
4652574|NCT02106832|7535448|FG000|Overall Study|Deterioration of general conditions|0
4652575|NCT02106832|7535449|FG001|Overall Study|Deterioration of general conditions|0
4652576|NCT02106832|7535450|FG002|Overall Study|Deterioration of general conditions|1
4652577|NCT02106832|7535451|FG003|Overall Study|Deterioration of general conditions|0
4652578|NCT02106832|7535448|FG000|Overall Study|Lost to Follow-up|0
4652579|NCT02106832|7535449|FG001|Overall Study|Lost to Follow-up|1
4652580|NCT02106832|7535450|FG002|Overall Study|Lost to Follow-up|1
4652581|NCT02106832|7535451|FG003|Overall Study|Lost to Follow-up|3
4652582|NCT02106832|7535448|FG000|Overall Study|Physician Decision|1
4652583|NCT02106832|7535449|FG001|Overall Study|Physician Decision|0
4652584|NCT02106832|7535450|FG002|Overall Study|Physician Decision|0
4652585|NCT02106832|7535451|FG003|Overall Study|Physician Decision|0
4652586|NCT02106832|7535448|FG000|Overall Study|Protocol Violation|0
4652587|NCT02106832|7535449|FG001|Overall Study|Protocol Violation|0
4652588|NCT02106832|7535450|FG002|Overall Study|Protocol Violation|0
4652589|NCT02106832|7535451|FG003|Overall Study|Protocol Violation|1
4652590|NCT02106832|7535448|FG000|Overall Study|Withdrawal by Subject|17
4652591|NCT02106832|7535449|FG001|Overall Study|Withdrawal by Subject|17
4652592|NCT02106832|7535450|FG002|Overall Study|Withdrawal by Subject|10
4652593|NCT02106832|7535451|FG003|Overall Study|Withdrawal by Subject|7
4652594|NCT02106832|7535448|FG000|Overall Study|Technical problems|0
4652595|NCT02106832|7535449|FG001|Overall Study|Technical problems|1
4652596|NCT02106832|7535450|FG002|Overall Study|Technical problems|0
4652597|NCT02106832|7535451|FG003|Overall Study|Technical problems|0
4652598|NCT02106884|7535465|FG000|Overall Study|Change of diagnosis/exclusion|0
4652599|NCT02106884|7535466|FG001|Overall Study|Change of diagnosis/exclusion|1
4652600|NCT02106910|7535477|FG000|Overall Study|Lost to Follow-up|1
4652601|NCT02106910|7535478|FG001|Overall Study|Lost to Follow-up|1
4652602|NCT02106923|7535488|FG000|Overall Study|Protocol Violation|0
4652603|NCT02106923|7535489|FG001|Overall Study|Protocol Violation|0
4652604|NCT02106923|7535490|FG002|Overall Study|Protocol Violation|0
4652605|NCT02106923|7535491|FG003|Overall Study|Protocol Violation|0
4652606|NCT02106923|7535492|FG004|Overall Study|Protocol Violation|0
4652607|NCT02106923|7535493|FG005|Overall Study|Protocol Violation|1
4652608|NCT02106975|7535520|FG000|Overall Study|Death|25
4652609|NCT02106975|7535521|FG001|Overall Study|Death|39
4652610|NCT02107014|7535527|FG000|Overall Study|Withdrew before drug: moving interstate|1
4652611|NCT02107092|7535531|FG000|Overall Study|Miscellaneous|3
4652612|NCT02107092|7535531|FG000|Overall Study|Subject compliance|3
4652613|NCT02107092|7535531|FG000|Overall Study|Hypo-or hyperkalemia|2
4652614|NCT02107092|7535531|FG000|Overall Study|Met ECG withdrawal criteria|3
4652615|NCT02107092|7535531|FG000|Overall Study|Physician Decision|3
4652616|NCT02107092|7535531|FG000|Overall Study|Lost to Follow-up|2
4652617|NCT02107092|7535531|FG000|Overall Study|Withdrawal by Subject|9
4652618|NCT02107092|7535531|FG000|Overall Study|Adverse Event|7
4652619|NCT02107092|7535531|FG000|Overall Study|Expected progression of CKD|12
4652620|NCT02107131|7535537|FG000|Overall Study|Lost to Follow-up|4
4652621|NCT02107131|7535538|FG001|Overall Study|Lost to Follow-up|4
4652622|NCT02107131|7535537|FG000|Overall Study|Physician Decision|1
4652623|NCT02107131|7535538|FG001|Overall Study|Physician Decision|0
4652624|NCT02107131|7535537|FG000|Overall Study|Withdrawal by Subject|2
4652625|NCT02107131|7535538|FG001|Overall Study|Withdrawal by Subject|0
4652626|NCT02107131|7535537|FG000|Overall Study|mental instability|1
4652627|NCT02107131|7535538|FG001|Overall Study|mental instability|0
4652628|NCT02107131|7535537|FG000|Overall Study|Death|0
4652629|NCT02107131|7535538|FG001|Overall Study|Death|1
4652630|NCT02107131|7535537|FG000|Overall Study|Protocol Violation|0
4652631|NCT02107131|7535538|FG001|Overall Study|Protocol Violation|4
4652632|NCT02107196|7535561|FG000|12-week Treatment Period|Adverse Event|6
4652633|NCT02107196|7535562|FG001|12-week Treatment Period|Adverse Event|3
4652634|NCT02107196|7535561|FG000|12-week Treatment Period|Lack of Efficacy|2
4652635|NCT02107196|7535562|FG001|12-week Treatment Period|Lack of Efficacy|1
4652636|NCT02107196|7535561|FG000|12-week Treatment Period|Lost to Follow-up|3
4652637|NCT02107196|7535562|FG001|12-week Treatment Period|Lost to Follow-up|6
4652638|NCT02107196|7535561|FG000|12-week Treatment Period|Physician Decision|0
4652639|NCT02107196|7535562|FG001|12-week Treatment Period|Physician Decision|1
4652640|NCT02107196|7535561|FG000|12-week Treatment Period|Withdrawal by Subject|15
4652641|NCT02107196|7535562|FG001|12-week Treatment Period|Withdrawal by Subject|12
4652642|NCT02107196|7535561|FG000|12-week Treatment Period|Protocol Violation|7
4652643|NCT02107196|7535562|FG001|12-week Treatment Period|Protocol Violation|8
4652644|NCT02107196|7535561|FG000|12-week Treatment Period|Reason Missing|11
4652645|NCT02107196|7535562|FG001|12-week Treatment Period|Reason Missing|8
4652646|NCT02107196|7535561|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2
4652647|NCT02107196|7535562|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0
4652648|NCT02107196|7535561|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1
4652649|NCT02107196|7535562|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0
4652650|NCT02107196|7535561|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2
4652651|NCT02107196|7535562|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0
4748103|NCT02702180|7722090|FG000|Double-blind Treatment Period|Withdrawal by Subject|1
4748104|NCT02702180|7722091|FG001|Double-blind Treatment Period|Withdrawal by Subject|1
4748105|NCT02702180|7722092|FG002|Double-blind Treatment Period|Withdrawal by Subject|0
4748106|NCT02702180|7722090|FG000|Double-blind Treatment Period|Adverse Event|0
4748107|NCT02702180|7722091|FG001|Double-blind Treatment Period|Adverse Event|0
4748108|NCT02702180|7722092|FG002|Double-blind Treatment Period|Adverse Event|1
4748109|NCT02702180|7722090|FG000|Double-blind Treatment Period|Lack of Efficacy|0
4748110|NCT02702180|7722091|FG001|Double-blind Treatment Period|Lack of Efficacy|0
4748111|NCT02702180|7722092|FG002|Double-blind Treatment Period|Lack of Efficacy|1
4748112|NCT02702180|7722090|FG000|Double-blind Treatment Period|Protocol Violation|0
4748113|NCT02702180|7722091|FG001|Double-blind Treatment Period|Protocol Violation|0
4748114|NCT02702180|7722092|FG002|Double-blind Treatment Period|Protocol Violation|2
4748115|NCT02702180|7722090|FG000|Open-label Treatment Period|Withdrawal by Subject|0
4748116|NCT02702180|7722091|FG001|Open-label Treatment Period|Withdrawal by Subject|1
4748117|NCT02702180|7722092|FG002|Open-label Treatment Period|Withdrawal by Subject|1
4748118|NCT02702180|7722090|FG000|Open-label Treatment Period|Withdrawn in error|0
4748119|NCT02702180|7722091|FG001|Open-label Treatment Period|Withdrawn in error|0
4748120|NCT02702180|7722092|FG002|Open-label Treatment Period|Withdrawn in error|1
4748121|NCT02545049|7722103|FG000|Overall Study|Withdrawal by Subject|1
4748122|NCT02545049|7722104|FG001|Overall Study|Withdrawal by Subject|7
4748123|NCT02545049|7722103|FG000|Overall Study|Lost to Follow-up|4
4748124|NCT02545049|7722104|FG001|Overall Study|Lost to Follow-up|6
4748125|NCT02545049|7722103|FG000|Overall Study|GCP violations|37
4652652|NCT02107196|7535561|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18
4652653|NCT02107196|7535562|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5
4652654|NCT02107274|7535570|FG000|Treatment vs. Placebo|Adverse Event|3
4652655|NCT02107274|7535571|FG001|Treatment vs. Placebo|Adverse Event|0
4652656|NCT02107274|7535570|FG000|Treatment vs. Placebo|Lost to Follow-up|0
4652657|NCT02107274|7535571|FG001|Treatment vs. Placebo|Lost to Follow-up|2
4652658|NCT02107274|7535570|FG000|Control Phase|Lost to Follow-up|1
4652659|NCT02107274|7535571|FG001|Control Phase|Lost to Follow-up|1
4652660|NCT02107274|7535570|FG000|Control Phase|Death|2
4652661|NCT02107274|7535571|FG001|Control Phase|Death|0
4652662|NCT02107274|7535570|FG000|Control Phase|Adverse Event|0
4652663|NCT02107274|7535571|FG001|Control Phase|Adverse Event|1
4652664|NCT02107313|7535586|FG000|Overall Study|One participant did not do the FED cohor|0
4652665|NCT02107313|7535587|FG001|Overall Study|One participant did not do the FED cohor|1
4652666|NCT02107443|7535604|FG000|Overall Study|Death|42
4652667|NCT02107443|7535605|FG001|Overall Study|Death|30
4652668|NCT02107443|7535604|FG000|Overall Study|Study Protocol Violation|3
4652669|NCT02107443|7535605|FG001|Overall Study|Study Protocol Violation|1
4652670|NCT02107443|7535604|FG000|Overall Study|Registered but Not Eligible|0
4652671|NCT02107443|7535605|FG001|Overall Study|Registered but Not Eligible|1
4652672|NCT02107443|7535604|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28
4652673|NCT02107443|7535605|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28
4652674|NCT02107443|7535604|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1
4652675|NCT02107443|7535605|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2
4652676|NCT02107443|7535604|FG000|Overall Study|Withdrawal: Changed Mind|2
4652677|NCT02107443|7535605|FG001|Overall Study|Withdrawal: Changed Mind|0
4652678|NCT02107443|7535604|FG000|Overall Study|Withdrawal: Changed MD/Facility|1
4652679|NCT02107443|7535605|FG001|Overall Study|Withdrawal: Changed MD/Facility|3
4652680|NCT02107443|7535604|FG000|Overall Study|Withdrawal: Too Many Forms|3
4652681|NCT02107443|7535605|FG001|Overall Study|Withdrawal: Too Many Forms|1
4652682|NCT02107443|7535604|FG000|Overall Study|Withdrawal: Too Time Consuming|3
4652683|NCT02107443|7535605|FG001|Overall Study|Withdrawal: Too Time Consuming|6
4652684|NCT02107443|7535604|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2
4652685|NCT02107443|7535605|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1
4652686|NCT02107443|7535604|FG000|Overall Study|Withdrawal: Other Medical|9
4652687|NCT02107443|7535605|FG001|Overall Study|Withdrawal: Other Medical|5
4652688|NCT02107443|7535604|FG000|Overall Study|Withdrawal: Disease Progression|4
4652689|NCT02107443|7535605|FG001|Overall Study|Withdrawal: Disease Progression|2
4652690|NCT02107443|7535604|FG000|Overall Study|Withdrawal: Personal Issues|0
4652691|NCT02107443|7535605|FG001|Overall Study|Withdrawal: Personal Issues|3
4652692|NCT02107482|7535612|FG000|Overall Study|inconveinence|2
4652693|NCT02107482|7535612|FG000|Overall Study|Lost to Follow-up|1
4652694|NCT02107482|7535612|FG000|Overall Study|Lack of Efficacy|1
4748126|NCT02545049|7722104|FG001|Overall Study|GCP violations|48
4652695|NCT02107703|7535625|FG000|Overall Study|Withdrawal by Subject|36
4652696|NCT02107703|7535626|FG001|Overall Study|Withdrawal by Subject|19
4652697|NCT02107703|7535625|FG000|Overall Study|Lost to Follow-up|6
4652698|NCT02107703|7535626|FG001|Overall Study|Lost to Follow-up|4
4652699|NCT02107703|7535625|FG000|Overall Study|On study treatment/follow up|319
4652700|NCT02107703|7535626|FG001|Overall Study|On study treatment/follow up|152
4652701|NCT02107859|7535635|FG000|Overall Study|Withdrawal by Subject|14
4652702|NCT02107859|7535635|FG000|Overall Study|Adverse Event|3
4652703|NCT02107859|7535635|FG000|Overall Study|Study closure|41
4652704|NCT02107859|7535635|FG000|Overall Study|Other than specified|3
4652705|NCT02107898|7535641|FG000|Overall Study|Adverse Event|4
4652706|NCT02107898|7535642|FG001|Overall Study|Adverse Event|7
4652707|NCT02107898|7535641|FG000|Overall Study|Poor compliance to protocol|0
4652708|NCT02107898|7535642|FG001|Overall Study|Poor compliance to protocol|1
4652709|NCT02107898|7535641|FG000|Overall Study|Participant moved|0
4652710|NCT02107898|7535642|FG001|Overall Study|Participant moved|2
4652711|NCT02107898|7535641|FG000|Overall Study|Consent withdrawn by participant|2
4652712|NCT02107898|7535642|FG001|Overall Study|Consent withdrawn by participant|1
4652713|NCT02107898|7535641|FG000|Overall Study|Randomized but not treated|0
4652714|NCT02107898|7535642|FG001|Overall Study|Randomized but not treated|1
4652715|NCT02108262|7535678|FG000|Overall Study|Non-compliance|0
4652716|NCT02108262|7535679|FG001|Overall Study|Non-compliance|2
4652717|NCT02108262|7535680|FG002|Overall Study|Non-compliance|1
4652718|NCT02108262|7535681|FG003|Overall Study|Non-compliance|1
4652719|NCT02108262|7535678|FG000|Overall Study|Randomized by error/screen failure|0
4652720|NCT02108262|7535679|FG001|Overall Study|Randomized by error/screen failure|0
4652721|NCT02108262|7535680|FG002|Overall Study|Randomized by error/screen failure|1
4652722|NCT02108262|7535681|FG003|Overall Study|Randomized by error/screen failure|0
4652723|NCT02108262|7535678|FG000|Overall Study|Distance to center|0
4652724|NCT02108262|7535679|FG001|Overall Study|Distance to center|1
4652725|NCT02108262|7535680|FG002|Overall Study|Distance to center|1
4652726|NCT02108262|7535681|FG003|Overall Study|Distance to center|0
4652727|NCT02108262|7535678|FG000|Overall Study|Adverse Event|0
4652728|NCT02108262|7535679|FG001|Overall Study|Adverse Event|11
4652729|NCT02108262|7535680|FG002|Overall Study|Adverse Event|6
4652730|NCT02108262|7535681|FG003|Overall Study|Adverse Event|12
4652731|NCT02108262|7535678|FG000|Overall Study|Death|0
4652732|NCT02108262|7535679|FG001|Overall Study|Death|2
4652733|NCT02108262|7535680|FG002|Overall Study|Death|2
4652734|NCT02108262|7535681|FG003|Overall Study|Death|1
4652735|NCT02108262|7535678|FG000|Overall Study|Lost to Follow-up|0
4652736|NCT02108262|7535679|FG001|Overall Study|Lost to Follow-up|0
4652737|NCT02108262|7535680|FG002|Overall Study|Lost to Follow-up|1
4652738|NCT02108262|7535681|FG003|Overall Study|Lost to Follow-up|0
4652739|NCT02108262|7535678|FG000|Overall Study|Physician Decision|0
4652740|NCT02108262|7535679|FG001|Overall Study|Physician Decision|0
4652741|NCT02108262|7535680|FG002|Overall Study|Physician Decision|2
4652742|NCT02108262|7535681|FG003|Overall Study|Physician Decision|0
4652743|NCT02108262|7535678|FG000|Overall Study|Withdrawal by Subject|0
4652744|NCT02108262|7535679|FG001|Overall Study|Withdrawal by Subject|7
4652745|NCT02108262|7535680|FG002|Overall Study|Withdrawal by Subject|3
4652746|NCT02108262|7535681|FG003|Overall Study|Withdrawal by Subject|4
4652747|NCT02108262|7535678|FG000|Overall Study|Due to key hepatic values|0
4652748|NCT02108262|7535679|FG001|Overall Study|Due to key hepatic values|1
4652749|NCT02108262|7535680|FG002|Overall Study|Due to key hepatic values|0
4652750|NCT02108262|7535681|FG003|Overall Study|Due to key hepatic values|0
4652751|NCT02108262|7535678|FG000|Overall Study|Unable to contact patient|0
4652752|NCT02108262|7535679|FG001|Overall Study|Unable to contact patient|3
4652753|NCT02108262|7535680|FG002|Overall Study|Unable to contact patient|1
4652754|NCT02108262|7535681|FG003|Overall Study|Unable to contact patient|2
4652755|NCT02108262|7535678|FG000|Overall Study|Patient unable to come to site/attend visit|0
4652756|NCT02108262|7535679|FG001|Overall Study|Patient unable to come to site/attend visit|6
4652757|NCT02108262|7535680|FG002|Overall Study|Patient unable to come to site/attend visit|11
4652758|NCT02108262|7535681|FG003|Overall Study|Patient unable to come to site/attend visit|6
4652759|NCT02108262|7535678|FG000|Overall Study|Patient did not want another infusion|0
4652760|NCT02108262|7535679|FG001|Overall Study|Patient did not want another infusion|3
4652761|NCT02108262|7535680|FG002|Overall Study|Patient did not want another infusion|3
4652762|NCT02108262|7535681|FG003|Overall Study|Patient did not want another infusion|2
4652763|NCT02108262|7535678|FG000|Overall Study|Vacation|0
4652764|NCT02108262|7535679|FG001|Overall Study|Vacation|1
4652765|NCT02108262|7535680|FG002|Overall Study|Vacation|0
4652766|NCT02108262|7535681|FG003|Overall Study|Vacation|0
4652767|NCT02108262|7535678|FG000|Overall Study|Patient decision|0
4652768|NCT02108262|7535679|FG001|Overall Study|Patient decision|7
4652769|NCT02108262|7535680|FG002|Overall Study|Patient decision|9
4652770|NCT02108262|7535681|FG003|Overall Study|Patient decision|14
4652771|NCT02108262|7535678|FG000|Overall Study|Missed IV due to pharmacy error|0
4652772|NCT02108262|7535679|FG001|Overall Study|Missed IV due to pharmacy error|0
4652773|NCT02108262|7535680|FG002|Overall Study|Missed IV due to pharmacy error|1
4652774|NCT02108262|7535681|FG003|Overall Study|Missed IV due to pharmacy error|0
4652775|NCT02108600|7535718|FG000|Overall Study|Withdrawal by Subject|2
4652776|NCT02108600|7535719|FG001|Overall Study|Withdrawal by Subject|0
4652777|NCT02108600|7535718|FG000|Overall Study|Lost to Follow-up|1
4652778|NCT02108600|7535719|FG001|Overall Study|Lost to Follow-up|1
4652779|NCT02108912|7535742|FG000|Overall Study|Lost to Follow-up|1
4652780|NCT02108912|7535743|FG001|Overall Study|Lost to Follow-up|1
4652781|NCT02108912|7535742|FG000|Overall Study|lack of transportation|1
4652782|NCT02108912|7535743|FG001|Overall Study|lack of transportation|0
4652783|NCT02108912|7535742|FG000|Overall Study|high blood pressure|1
4652784|NCT02108912|7535743|FG001|Overall Study|high blood pressure|0
4652785|NCT02108951|7535749|FG000|Overall Study|Lost to Follow-up|1
4652786|NCT02108951|7535749|FG000|Overall Study|Patient's/guardian's decision|1
4652787|NCT02108951|7535749|FG000|Overall Study|Study Terminated by Sponsor|14
4652788|NCT02109029|7535767|FG000|Part B|Adverse Event|0
4652789|NCT02109029|7535768|FG001|Part B|Adverse Event|0
4652790|NCT02109029|7535769|FG002|Part B|Adverse Event|0
4652791|NCT02109029|7535770|FG003|Part B|Adverse Event|0
4652792|NCT02109029|7535771|FG004|Part B|Adverse Event|1
4652793|NCT02109029|7535772|FG005|Part B|Adverse Event|1
4652794|NCT02109042|7535783|FG000|Overall Study|Sponsor Decision|15
4652795|NCT02109107|7535788|FG000|Overall Study|Lost to Follow-up|2
4652796|NCT02109133|7535794|FG000|Overall Study|Lost to Follow-up|1
4652797|NCT02109133|7535795|FG001|Overall Study|Lost to Follow-up|0
4652798|NCT02109432|7535818|FG000|Overall Study|Withdrawal by Subject|1
4652799|NCT02109445|7535822|FG000|Overall Study|Symptomatic deterioration|2
4652800|NCT02109445|7535822|FG000|Overall Study|Adverse Event|1
4652801|NCT02109484|7535838|FG000|Overall Study|Lost to Follow-up|0
4652802|NCT02109484|7535839|FG001|Overall Study|Lost to Follow-up|0
4652803|NCT02109484|7535840|FG002|Overall Study|Lost to Follow-up|0
4652804|NCT02109484|7535841|FG003|Overall Study|Lost to Follow-up|1
4652805|NCT02109484|7535842|FG004|Overall Study|Lost to Follow-up|1
4652806|NCT02109484|7535843|FG005|Overall Study|Lost to Follow-up|0
4652807|NCT02109484|7535844|FG006|Overall Study|Lost to Follow-up|1
4652808|NCT02109484|7535845|FG007|Overall Study|Lost to Follow-up|0
4652809|NCT02109484|7535838|FG000|Overall Study|Withdrawal by Subject|0
4652810|NCT02109484|7535839|FG001|Overall Study|Withdrawal by Subject|0
4652811|NCT02109484|7535840|FG002|Overall Study|Withdrawal by Subject|0
4652812|NCT02109484|7535841|FG003|Overall Study|Withdrawal by Subject|0
4652813|NCT02109484|7535842|FG004|Overall Study|Withdrawal by Subject|1
4652814|NCT02109484|7535843|FG005|Overall Study|Withdrawal by Subject|1
4652815|NCT02109484|7535844|FG006|Overall Study|Withdrawal by Subject|1
4652816|NCT02109484|7535845|FG007|Overall Study|Withdrawal by Subject|0
4652817|NCT02109484|7535838|FG000|Overall Study|Physician Decision|0
4652818|NCT02109484|7535839|FG001|Overall Study|Physician Decision|0
4652819|NCT02109484|7535840|FG002|Overall Study|Physician Decision|0
4652820|NCT02109484|7535841|FG003|Overall Study|Physician Decision|0
4652821|NCT02109484|7535842|FG004|Overall Study|Physician Decision|2
4652822|NCT02109484|7535843|FG005|Overall Study|Physician Decision|0
4652823|NCT02109484|7535844|FG006|Overall Study|Physician Decision|0
4652824|NCT02109484|7535845|FG007|Overall Study|Physician Decision|0
4652825|NCT02109484|7535838|FG000|Overall Study|Death|0
4652826|NCT02109484|7535839|FG001|Overall Study|Death|0
4652827|NCT02109484|7535840|FG002|Overall Study|Death|0
4652828|NCT02109484|7535841|FG003|Overall Study|Death|0
4652829|NCT02109484|7535842|FG004|Overall Study|Death|0
4652830|NCT02109484|7535843|FG005|Overall Study|Death|0
4652831|NCT02109484|7535844|FG006|Overall Study|Death|0
4652832|NCT02109484|7535845|FG007|Overall Study|Death|2
4652833|NCT02109484|7535838|FG000|Overall Study|Moved away from study area|0
4652834|NCT02109484|7535839|FG001|Overall Study|Moved away from study area|0
4652835|NCT02109484|7535840|FG002|Overall Study|Moved away from study area|0
4652836|NCT02109484|7535841|FG003|Overall Study|Moved away from study area|0
4652837|NCT02109484|7535842|FG004|Overall Study|Moved away from study area|0
4652838|NCT02109484|7535843|FG005|Overall Study|Moved away from study area|0
4652839|NCT02109484|7535844|FG006|Overall Study|Moved away from study area|1
4652840|NCT02109484|7535845|FG007|Overall Study|Moved away from study area|1
4652841|NCT02109562|7535887|FG000|Overall Study|Insufficient clinical response|2
4652842|NCT02109562|7535888|FG001|Overall Study|Insufficient clinical response|0
4652843|NCT02109562|7535889|FG002|Overall Study|Insufficient clinical response|4
4652844|NCT02109562|7535887|FG000|Overall Study|Adverse Event|0
4652845|NCT02109562|7535888|FG001|Overall Study|Adverse Event|2
4652846|NCT02109562|7535889|FG002|Overall Study|Adverse Event|3
4652847|NCT02109562|7535887|FG000|Overall Study|Lost to Follow-up|1
4652848|NCT02109562|7535888|FG001|Overall Study|Lost to Follow-up|0
4652849|NCT02109562|7535889|FG002|Overall Study|Lost to Follow-up|1
4652850|NCT02109562|7535887|FG000|Overall Study|Protocol Violation|0
4652851|NCT02109562|7535888|FG001|Overall Study|Protocol Violation|3
4652852|NCT02109562|7535889|FG002|Overall Study|Protocol Violation|1
4652853|NCT02109562|7535887|FG000|Overall Study|Withdrawal by Subject|20
4652854|NCT02109562|7535888|FG001|Overall Study|Withdrawal by Subject|25
4652855|NCT02109562|7535889|FG002|Overall Study|Withdrawal by Subject|21
4652856|NCT02109562|7535887|FG000|Overall Study|Physician Decision|3
4652857|NCT02109562|7535888|FG001|Overall Study|Physician Decision|4
4652858|NCT02109562|7535889|FG002|Overall Study|Physician Decision|5
4652859|NCT02110225|7535951|FG000|Overall Study|Lost to Follow-up|0
4652860|NCT02110225|7535952|FG001|Overall Study|Lost to Follow-up|1
4652861|NCT02110225|7535953|FG002|Overall Study|Lost to Follow-up|0
4652862|NCT02110238|7535964|FG000|12 Week Pivotal Phase|Adverse Event|3
4652863|NCT02110238|7535965|FG001|12 Week Pivotal Phase|Adverse Event|0
4652864|NCT02110238|7535964|FG000|12 Week Pivotal Phase|Lack of Efficacy|2
4652865|NCT02110238|7535965|FG001|12 Week Pivotal Phase|Lack of Efficacy|3
4652866|NCT02110238|7535964|FG000|12 Week Pivotal Phase|Lost to Follow-up|2
4652867|NCT02110238|7535965|FG001|12 Week Pivotal Phase|Lost to Follow-up|0
4652868|NCT02110238|7535964|FG000|12 Week Pivotal Phase|Physician Decision|0
4652869|NCT02110238|7535965|FG001|12 Week Pivotal Phase|Physician Decision|2
4652870|NCT02110238|7535964|FG000|12 Week Pivotal Phase|Protocol Violation|0
4652871|NCT02110238|7535965|FG001|12 Week Pivotal Phase|Protocol Violation|1
4652872|NCT02110238|7535964|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3
4652873|NCT02110238|7535965|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3
4652874|NCT02110238|7535964|FG000|14 Week Blinded Extension Phase|Adverse Event|1
4652875|NCT02110238|7535965|FG001|14 Week Blinded Extension Phase|Adverse Event|1
4652876|NCT02110238|7535964|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2
4652877|NCT02110238|7535965|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4
4652878|NCT02110238|7535964|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3
4652879|NCT02110238|7535965|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1
4652880|NCT02110238|7535964|FG000|14 Week Blinded Extension Phase|Protocol Violation|2
4652881|NCT02110238|7535965|FG001|14 Week Blinded Extension Phase|Protocol Violation|3
4652882|NCT02110238|7535964|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4
4652883|NCT02110238|7535965|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3
4652884|NCT02110693|7536003|FG000|Overall Study|Withdrawal by Subject|6
4652885|NCT02110693|7536004|FG001|Overall Study|Withdrawal by Subject|7
4652886|NCT02110693|7536003|FG000|Overall Study|skipped assessment|15
4652887|NCT02110693|7536004|FG001|Overall Study|skipped assessment|18
4652888|NCT02110693|7536003|FG000|Overall Study|technical difficulties|6
4652889|NCT02110693|7536004|FG001|Overall Study|technical difficulties|4
4652890|NCT02110693|7536003|FG000|Overall Study|Other|1
4652891|NCT02110693|7536004|FG001|Overall Study|Other|0
4652892|NCT02110706|7536026|FG000|Overall Study|Adverse Event|2
4652893|NCT02110706|7536027|FG001|Overall Study|Adverse Event|3
4652894|NCT02110706|7536026|FG000|Overall Study|Patients who didn't receive 2nd infusion|3
4652895|NCT02110706|7536027|FG001|Overall Study|Patients who didn't receive 2nd infusion|1
4652896|NCT02110732|7536037|FG000|Overall Study|Physician Decision|5
4652897|NCT02110732|7536038|FG001|Overall Study|Physician Decision|2
4652898|NCT02110732|7536037|FG000|Overall Study|Lost to Follow-up|1
4652899|NCT02110732|7536038|FG001|Overall Study|Lost to Follow-up|1
4652900|NCT02110901|7536067|FG000|Overall Study|Death|6
4652901|NCT02110901|7536068|FG001|Overall Study|Death|3
4652902|NCT02110901|7536067|FG000|Overall Study|Lost to Follow-up|12
4652903|NCT02110901|7536068|FG001|Overall Study|Lost to Follow-up|8
4652904|NCT02110901|7536067|FG000|Overall Study|Withdrawal by Subject|7
4652905|NCT02110901|7536068|FG001|Overall Study|Withdrawal by Subject|3
4652906|NCT02110901|7536067|FG000|Overall Study|received a kidney transplant|5
4652907|NCT02110901|7536068|FG001|Overall Study|received a kidney transplant|0
4652908|NCT02111083|7536077|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1
4652909|NCT02111083|7536078|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1
4652910|NCT02111096|7536087|FG000|Overall Study|Adverse Event|4
4652911|NCT02111096|7536088|FG001|Overall Study|Adverse Event|1
4652912|NCT02111096|7536089|FG002|Overall Study|Adverse Event|2
4652913|NCT02111096|7536087|FG000|Overall Study|Non-Compliance with Study Drug|1
4652914|NCT02111096|7536088|FG001|Overall Study|Non-Compliance with Study Drug|1
4652915|NCT02111096|7536089|FG002|Overall Study|Non-Compliance with Study Drug|0
4652916|NCT02111096|7536087|FG000|Overall Study|Lost to Follow Up|1
4652917|NCT02111096|7536088|FG001|Overall Study|Lost to Follow Up|1
4652918|NCT02111096|7536089|FG002|Overall Study|Lost to Follow Up|1
4652919|NCT02111096|7536087|FG000|Overall Study|Physician Decision|0
4652920|NCT02111096|7536088|FG001|Overall Study|Physician Decision|1
4652921|NCT02111096|7536089|FG002|Overall Study|Physician Decision|0
4652922|NCT02111096|7536087|FG000|Overall Study|Protocol Violation|1
4652923|NCT02111096|7536088|FG001|Overall Study|Protocol Violation|0
4652924|NCT02111096|7536089|FG002|Overall Study|Protocol Violation|1
4652925|NCT02111096|7536087|FG000|Overall Study|Terminated by Sponsor|53
4652926|NCT02111096|7536088|FG001|Overall Study|Terminated by Sponsor|35
4652927|NCT02111096|7536089|FG002|Overall Study|Terminated by Sponsor|54
4652928|NCT02111096|7536087|FG000|Overall Study|Withdrawal by Subject|4
4652929|NCT02111096|7536088|FG001|Overall Study|Withdrawal by Subject|2
4652930|NCT02111096|7536089|FG002|Overall Study|Withdrawal by Subject|8
4652931|NCT02111174|7536102|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1
4652932|NCT02111174|7536103|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0
4652933|NCT02111174|7536102|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2
4652934|NCT02111174|7536103|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2
4652935|NCT02111174|7536102|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8
4652936|NCT02111174|7536103|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6
4652937|NCT02111174|7536102|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0
4652938|NCT02111174|7536103|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1
4652939|NCT02111213|7536135|FG000|Overall Study|Withdrawal by Subject|3
4652940|NCT02111213|7536136|FG001|Overall Study|Withdrawal by Subject|2
4652941|NCT02111213|7536135|FG000|Overall Study|Lost to Follow-up|3
4652942|NCT02111213|7536136|FG001|Overall Study|Lost to Follow-up|4
4652943|NCT02111369|7536146|FG000|Overall Study|Lost to Follow-up|2
4652944|NCT02111369|7536146|FG000|Overall Study|Withdrawal by Subject|1
4652945|NCT02111564|7536169|FG000|Overall Study|Death|109
4652946|NCT02111564|7536170|FG001|Overall Study|Death|120
4652947|NCT02111564|7536169|FG000|Overall Study|Lost to Follow-up|2
4652948|NCT02111564|7536170|FG001|Overall Study|Lost to Follow-up|3
4652949|NCT02111564|7536169|FG000|Overall Study|Withdrawal by Subject|20
4652950|NCT02111564|7536170|FG001|Overall Study|Withdrawal by Subject|20
4652951|NCT02111577|7536178|FG000|Overall Study|Protocol Violation|2
4652952|NCT02111577|7536179|FG001|Overall Study|Protocol Violation|0
4652953|NCT02111577|7536178|FG000|Overall Study|Unable to tolerate leukapheresis|1
4652954|NCT02111577|7536179|FG001|Overall Study|Unable to tolerate leukapheresis|0
4652955|NCT02111577|7536178|FG000|Overall Study|Failure to produce study treatment|6
4652956|NCT02111577|7536179|FG001|Overall Study|Failure to produce study treatment|0
4652957|NCT02111577|7536178|FG000|Overall Study|Death|518
4652958|NCT02111577|7536179|FG001|Overall Study|Death|254
4652959|NCT02111577|7536178|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1
4652960|NCT02111577|7536179|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0
4652961|NCT02111577|7536178|FG000|Overall Study|Adverse Event|1
4652962|NCT02111577|7536179|FG001|Overall Study|Adverse Event|1
4652963|NCT02111577|7536178|FG000|Overall Study|Withdrawal by Subject|51
4652964|NCT02111577|7536179|FG001|Overall Study|Withdrawal by Subject|23
4652965|NCT02111577|7536178|FG000|Overall Study|Disease progression|0
4652966|NCT02111577|7536179|FG001|Overall Study|Disease progression|1
4652967|NCT02111577|7536178|FG000|Overall Study|Lost to Follow-up|19
4652968|NCT02111577|7536179|FG001|Overall Study|Lost to Follow-up|10
4652969|NCT02111603|7536187|FG000|Overall Study|Withdrawal by Subject|1
4652970|NCT02111785|7536213|FG000|Overall Study|Death|0
4652971|NCT02111785|7536214|FG001|Overall Study|Death|1
4652972|NCT02111785|7536215|FG002|Overall Study|Death|0
4652973|NCT02111785|7536216|FG003|Overall Study|Death|0
4652974|NCT02111811|7536250|FG000|Treatment Phase|Lost to Follow-up|22
4652975|NCT02111811|7536251|FG001|Treatment Phase|Lost to Follow-up|18
4652976|NCT02111811|7536250|FG000|Treatment Phase|Death|2
4652977|NCT02111811|7536251|FG001|Treatment Phase|Death|0
4652978|NCT02111811|7536250|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26
4652979|NCT02111811|7536251|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17
4652980|NCT02111811|7536250|FG000|Follow up Period (Aim 2)|Death|2
4652981|NCT02111811|7536251|FG001|Follow up Period (Aim 2)|Death|0
4652982|NCT02111993|7536270|FG000|Overall Study|Physician Decision|5
4652983|NCT02111993|7536271|FG001|Overall Study|Physician Decision|4
4652984|NCT02112045|7536281|FG000|Overall Study|Withdrawal by Subject|1
4652985|NCT02112045|7536282|FG001|Overall Study|Withdrawal by Subject|0
4652986|NCT02112448|7536299|FG000|Overall Study|lab values precluding use of ketorolac|2
4652987|NCT02112448|7536300|FG001|Overall Study|lab values precluding use of ketorolac|2
4652988|NCT02112448|7536299|FG000|Overall Study|Protocol Violation|1
4652989|NCT02112448|7536300|FG001|Overall Study|Protocol Violation|2
4652990|NCT02112448|7536299|FG000|Overall Study|Physician Decision|4
4652991|NCT02112448|7536300|FG001|Overall Study|Physician Decision|6
4652992|NCT02112448|7536299|FG000|Overall Study|required heparin so could not use ketoro|1
4652993|NCT02112448|7536300|FG001|Overall Study|required heparin so could not use ketoro|0
4652994|NCT02112877|7536323|FG000|Overall Study|Withdrawal by Subject|1
4652995|NCT02112877|7536324|FG001|Overall Study|Withdrawal by Subject|7
4652996|NCT02112877|7536323|FG000|Overall Study|Visit Missed|1
4652997|NCT02112877|7536324|FG001|Overall Study|Visit Missed|6
4652998|NCT02112994|7536332|FG000|Overall Study|Progressive Disease|0
4652999|NCT02112994|7536333|FG001|Overall Study|Progressive Disease|0
4653000|NCT02112994|7536334|FG002|Overall Study|Progressive Disease|1
4653001|NCT02112994|7536332|FG000|Overall Study|Pregnancy|0
4653002|NCT02112994|7536333|FG001|Overall Study|Pregnancy|1
4653003|NCT02112994|7536334|FG002|Overall Study|Pregnancy|1
4653004|NCT02112994|7536332|FG000|Overall Study|Liver Transplant|0
4653005|NCT02112994|7536333|FG001|Overall Study|Liver Transplant|1
4653006|NCT02112994|7536334|FG002|Overall Study|Liver Transplant|0
4653007|NCT02112994|7536332|FG000|Overall Study|Withdrawal by Subject|0
4653008|NCT02112994|7536333|FG001|Overall Study|Withdrawal by Subject|0
4653009|NCT02112994|7536334|FG002|Overall Study|Withdrawal by Subject|1
4653010|NCT02113007|7536346|FG000|Overall Study|Progressive disease|2
4653011|NCT02113124|7536352|FG000|Overall Study|Unable to retrieve blood sample|1
4653012|NCT02113124|7536353|FG001|Overall Study|Unable to retrieve blood sample|1
4653013|NCT02113189|7536362|FG000|Overall Study|Lost to follow up|2
4653014|NCT02113189|7536363|FG001|Overall Study|Lost to follow up|1
4653015|NCT02113189|7536364|FG002|Overall Study|Lost to follow up|3
4653016|NCT02113436|7536397|FG000|Period 1: 8 Weeks|Adverse Event|1
4653017|NCT02113436|7536398|FG001|Period 1: 8 Weeks|Adverse Event|0
4653018|NCT02113436|7536399|FG002|Period 1: 8 Weeks|Adverse Event|0
4653019|NCT02113436|7536400|FG003|Period 1: 8 Weeks|Adverse Event|0
4653020|NCT02113436|7536397|FG000|Period 1: 8 Weeks|Protocol Violation|1
4653021|NCT02113436|7536398|FG001|Period 1: 8 Weeks|Protocol Violation|0
4653022|NCT02113436|7536399|FG002|Period 1: 8 Weeks|Protocol Violation|0
4653023|NCT02113436|7536400|FG003|Period 1: 8 Weeks|Protocol Violation|0
4653024|NCT02113436|7536397|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5
4653025|NCT02113436|7536398|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2
4653026|NCT02113436|7536399|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0
4653027|NCT02113436|7536400|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0
4653028|NCT02113436|7536397|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1
4653029|NCT02113436|7536398|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0
4653030|NCT02113436|7536399|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0
4653031|NCT02113436|7536400|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0
4653032|NCT02113436|7536397|FG000|Period 2: 16 Weeks|Adverse Event|0
4653033|NCT02113436|7536398|FG001|Period 2: 16 Weeks|Adverse Event|0
4653034|NCT02113436|7536399|FG002|Period 2: 16 Weeks|Adverse Event|4
4653035|NCT02113436|7536400|FG003|Period 2: 16 Weeks|Adverse Event|5
4653036|NCT02113436|7536397|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0
4653037|NCT02113436|7536398|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0
4653038|NCT02113436|7536399|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2
4653039|NCT02113436|7536400|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5
4653040|NCT02113436|7536397|FG000|Period 2: 16 Weeks|Physician Decision|0
4653041|NCT02113436|7536398|FG001|Period 2: 16 Weeks|Physician Decision|0
4653042|NCT02113436|7536399|FG002|Period 2: 16 Weeks|Physician Decision|2
4653043|NCT02113436|7536400|FG003|Period 2: 16 Weeks|Physician Decision|0
4653044|NCT02113436|7536397|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0
4653045|NCT02113436|7536398|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0
4653046|NCT02113436|7536399|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1
4653047|NCT02113436|7536400|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1
4653048|NCT02113449|7536409|FG000|Overall Study|Adverse Event|4
4653049|NCT02113579|7536419|FG000|Overall Study|Adverse Event|1
4653050|NCT02113579|7536420|FG001|Overall Study|Adverse Event|0
4653051|NCT02113579|7536419|FG000|Overall Study|Withdrawal by Subject|3
4653052|NCT02113579|7536420|FG001|Overall Study|Withdrawal by Subject|2
4653053|NCT02113579|7536419|FG000|Overall Study|Lost to Follow-up|6
4653054|NCT02113579|7536420|FG001|Overall Study|Lost to Follow-up|2
4653055|NCT02113956|7536428|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5
4653056|NCT02113956|7536429|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1
4653057|NCT02113956|7536428|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4
4653058|NCT02113956|7536429|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3
4653059|NCT02113956|7536428|FG000|3 Month Post-intervention|Lost to Follow-up|4
4653060|NCT02113956|7536429|FG001|3 Month Post-intervention|Lost to Follow-up|2
4653061|NCT02114151|7536435|FG000|Overall Study|Death|1
4653062|NCT02114151|7536435|FG000|Overall Study|Lost to Follow-up|1
4653063|NCT02114151|7536435|FG000|Overall Study|Withdrawal by Subject|5
4653064|NCT02114177|7536450|FG000|Overall Study|Lost to Follow-up|1
4653065|NCT02114177|7536451|FG001|Overall Study|Lost to Follow-up|2
4653066|NCT02114177|7536450|FG000|Overall Study|Withdrawal by Subject|6
4653067|NCT02114177|7536451|FG001|Overall Study|Withdrawal by Subject|1
4653068|NCT02114177|7536450|FG000|Overall Study|Other|2
4653069|NCT02114177|7536451|FG001|Overall Study|Other|1
4653070|NCT02114203|7536460|FG000|Overall Study|Adverse Event|0
4653071|NCT02114203|7536461|FG001|Overall Study|Adverse Event|1
4653072|NCT02114203|7536462|FG002|Overall Study|Adverse Event|0
4653073|NCT02114203|7536460|FG000|Overall Study|Withdrawal by Subject|0
4653074|NCT02114203|7536461|FG001|Overall Study|Withdrawal by Subject|1
4653075|NCT02114203|7536462|FG002|Overall Study|Withdrawal by Subject|0
4653076|NCT02114268|7536492|FG000|Overall Study|Lost to Follow-up|4
4653077|NCT02114268|7536493|FG001|Overall Study|Lost to Follow-up|1
4653078|NCT02114268|7536494|FG002|Overall Study|Lost to Follow-up|1
4653079|NCT02114268|7536495|FG003|Overall Study|Lost to Follow-up|0
4653080|NCT02114268|7536496|FG004|Overall Study|Lost to Follow-up|0
4653081|NCT02114268|7536497|FG005|Overall Study|Lost to Follow-up|2
4653082|NCT02114268|7536492|FG000|Overall Study|Withdrawal by Subject|1
4653083|NCT02114268|7536493|FG001|Overall Study|Withdrawal by Subject|0
4653084|NCT02114268|7536494|FG002|Overall Study|Withdrawal by Subject|0
4653085|NCT02114268|7536495|FG003|Overall Study|Withdrawal by Subject|0
4653086|NCT02114268|7536496|FG004|Overall Study|Withdrawal by Subject|0
4653087|NCT02114268|7536497|FG005|Overall Study|Withdrawal by Subject|1
4653088|NCT02114268|7536492|FG000|Overall Study|Withdrawn by site due to noncompliance|1
4653089|NCT02114268|7536493|FG001|Overall Study|Withdrawn by site due to noncompliance|0
4653090|NCT02114268|7536494|FG002|Overall Study|Withdrawn by site due to noncompliance|0
4653091|NCT02114268|7536495|FG003|Overall Study|Withdrawn by site due to noncompliance|0
4653092|NCT02114268|7536496|FG004|Overall Study|Withdrawn by site due to noncompliance|0
4653093|NCT02114268|7536497|FG005|Overall Study|Withdrawn by site due to noncompliance|0
4653094|NCT02114385|7536529|FG000|Overall Study|Withdrawal by Subject|3
4653095|NCT02114385|7536530|FG001|Overall Study|Withdrawal by Subject|2
4653096|NCT02114385|7536529|FG000|Overall Study|Lost to Follow-up|0
4653097|NCT02114385|7536530|FG001|Overall Study|Lost to Follow-up|6
4653098|NCT02114515|7536538|FG000|Overall Study|Lost to Follow-up|52
4653099|NCT02114515|7536539|FG001|Overall Study|Lost to Follow-up|55
4653100|NCT02114515|7536538|FG000|Overall Study|Death|12
4653101|NCT02114515|7536539|FG001|Overall Study|Death|12
4653102|NCT02114515|7536538|FG000|Overall Study|Withdrawal by Subject|4
4653103|NCT02114515|7536539|FG001|Overall Study|Withdrawal by Subject|22
4653104|NCT02114515|7536538|FG000|Overall Study|Other|65
4653105|NCT02114515|7536539|FG001|Overall Study|Other|61
4653106|NCT02114606|7536545|FG000|Overall Study|Unable to swallow Cytosponge|6
4653107|NCT02114684|7536551|FG000|Overall Study|Death|6
4653108|NCT02114684|7536552|FG001|Overall Study|Death|4
4653109|NCT02114684|7536551|FG000|Overall Study|Lost to Follow-up|1
4653110|NCT02114684|7536552|FG001|Overall Study|Lost to Follow-up|2
4653111|NCT02114684|7536551|FG000|Overall Study|Withdrawal by Subject|1
4653112|NCT02114684|7536552|FG001|Overall Study|Withdrawal by Subject|2
4653113|NCT02114684|7536551|FG000|Overall Study|Relocation|3
4653114|NCT02114684|7536552|FG001|Overall Study|Relocation|1
4653115|NCT02114684|7536551|FG000|Overall Study|Rifampicin resistant on culture|0
4653116|NCT02114684|7536552|FG001|Overall Study|Rifampicin resistant on culture|1
4653117|NCT02114684|7536551|FG000|Overall Study|Patient Incarcerated|1
4653118|NCT02114684|7536552|FG001|Overall Study|Patient Incarcerated|0
4653119|NCT02114879|7536577|FG000|Overall Study|Withdrawal by Subject|9
4653120|NCT02114879|7536578|FG001|Overall Study|Withdrawal by Subject|5
4653121|NCT02114879|7536577|FG000|Overall Study|Death|6
4653122|NCT02114879|7536578|FG001|Overall Study|Death|11
4653123|NCT02114879|7536577|FG000|Overall Study|Lost to Follow-up|4
4653124|NCT02114879|7536578|FG001|Overall Study|Lost to Follow-up|6
4653125|NCT02114879|7536577|FG000|Overall Study|Physician Decision|0
4653126|NCT02114879|7536578|FG001|Overall Study|Physician Decision|2
4653127|NCT02114892|7536586|FG000|Overall Study|Lost to Follow-up|1
4653128|NCT02114892|7536587|FG001|Overall Study|Lost to Follow-up|2
4653129|NCT02114931|7536595|FG000|Overall Study|Withdrawal by Subject|15
4653130|NCT02114931|7536596|FG001|Overall Study|Withdrawal by Subject|18
4653131|NCT02114931|7536595|FG000|Overall Study|Adverse Event|4
4653132|NCT02114931|7536596|FG001|Overall Study|Adverse Event|6
4653133|NCT02114931|7536595|FG000|Overall Study|Lost to Follow-up|3
4653134|NCT02114931|7536596|FG001|Overall Study|Lost to Follow-up|3
4653135|NCT02114931|7536595|FG000|Overall Study|Physician Decision|1
4653136|NCT02114931|7536596|FG001|Overall Study|Physician Decision|2
4653137|NCT02114931|7536595|FG000|Overall Study|Other|2
4653138|NCT02114931|7536596|FG001|Overall Study|Other|1
4653139|NCT02115113|7536611|FG000|Participants in Run-in Period|Death|0
4653140|NCT02115113|7536612|FG001|Participants in Run-in Period|Death|0
4653141|NCT02115113|7536613|FG002|Participants in Run-in Period|Death|1
4653142|NCT02115113|7536611|FG000|Participants in Run-in Period|Administrative problems|0
4653143|NCT02115113|7536612|FG001|Participants in Run-in Period|Administrative problems|0
4653144|NCT02115113|7536613|FG002|Participants in Run-in Period|Administrative problems|1
4653145|NCT02115113|7536611|FG000|Participants in Run-in Period|Lost to Follow-up|0
4653146|NCT02115113|7536612|FG001|Participants in Run-in Period|Lost to Follow-up|0
4653147|NCT02115113|7536613|FG002|Participants in Run-in Period|Lost to Follow-up|5
4653148|NCT02115113|7536611|FG000|Participants in Run-in Period|Withdrawal by Subject|0
4653149|NCT02115113|7536612|FG001|Participants in Run-in Period|Withdrawal by Subject|0
4653150|NCT02115113|7536613|FG002|Participants in Run-in Period|Withdrawal by Subject|3
4653151|NCT02115113|7536611|FG000|Participants Randomized|Lost to Follow-up|1
4653152|NCT02115113|7536612|FG001|Participants Randomized|Lost to Follow-up|0
4653153|NCT02115113|7536613|FG002|Participants Randomized|Lost to Follow-up|0
4653154|NCT02115113|7536611|FG000|Participants Randomized|Death|1
4653155|NCT02115113|7536612|FG001|Participants Randomized|Death|0
4653156|NCT02115113|7536613|FG002|Participants Randomized|Death|0
4653157|NCT02115139|7536622|FG000|Overall Study|Protocol Violation|1
4653158|NCT02115139|7536622|FG000|Overall Study|treatment discontinuation|6
4653159|NCT02115256|7536628|FG000|Overall Study|Withdrawal by Subject|0
4653160|NCT02115256|7536629|FG001|Overall Study|Withdrawal by Subject|1
4653161|NCT02115269|7536635|FG000|Overall Study|Lost to Follow-up|43
4653162|NCT02115269|7536635|FG000|Overall Study|Did not complete patient diary|3
4653163|NCT02115269|7536635|FG000|Overall Study|Moved to another city|7
4653164|NCT02115269|7536635|FG000|Overall Study|Withdrawal by Subject|2
4653165|NCT02115269|7536635|FG000|Overall Study|Didn't take study drug|2
4748127|NCT02488759|7722116|FG000|Overall Study|Disease progression|74
4748128|NCT02488759|7722117|FG001|Overall Study|Disease progression|110
4748129|NCT02488759|7722118|FG002|Overall Study|Disease progression|62
4748130|NCT02488759|7722119|FG003|Overall Study|Disease progression|7
4748131|NCT02488759|7722120|FG004|Overall Study|Disease progression|4
4748132|NCT02488759|7722121|FG005|Overall Study|Disease progression|2
4748133|NCT02488759|7722116|FG000|Overall Study|Study drug toxicity|11
4748134|NCT02488759|7722117|FG001|Overall Study|Study drug toxicity|33
4748135|NCT02488759|7722118|FG002|Overall Study|Study drug toxicity|31
4748136|NCT02488759|7722119|FG003|Overall Study|Study drug toxicity|0
4748137|NCT02488759|7722120|FG004|Overall Study|Study drug toxicity|0
4748138|NCT02488759|7722121|FG005|Overall Study|Study drug toxicity|2
4748139|NCT02488759|7722116|FG000|Overall Study|Adverse event unrelated to study drug|9
4748140|NCT02488759|7722117|FG001|Overall Study|Adverse event unrelated to study drug|11
4748141|NCT02488759|7722118|FG002|Overall Study|Adverse event unrelated to study drug|7
4748142|NCT02488759|7722119|FG003|Overall Study|Adverse event unrelated to study drug|0
4748143|NCT02488759|7722120|FG004|Overall Study|Adverse event unrelated to study drug|1
4748144|NCT02488759|7722121|FG005|Overall Study|Adverse event unrelated to study drug|0
4653166|NCT02115282|7536652|FG000|Overall Study|Disease progression during treatment|216
4653167|NCT02115282|7536653|FG001|Overall Study|Disease progression during treatment|229
4653168|NCT02115282|7536652|FG000|Overall Study|Adverse Event|49
4653169|NCT02115282|7536653|FG001|Overall Study|Adverse Event|23
4653170|NCT02115282|7536652|FG000|Overall Study|Death|1
4653171|NCT02115282|7536653|FG001|Overall Study|Death|3
4653172|NCT02115282|7536652|FG000|Overall Study|Alternative therapy|1
4653173|NCT02115282|7536653|FG001|Overall Study|Alternative therapy|1
4653174|NCT02115282|7536652|FG000|Overall Study|Complicating disease|0
4653175|NCT02115282|7536653|FG001|Overall Study|Complicating disease|3
4653176|NCT02115282|7536652|FG000|Overall Study|Withdrawal by Subject|12
4653177|NCT02115282|7536653|FG001|Overall Study|Withdrawal by Subject|10
4653178|NCT02115282|7536652|FG000|Overall Study|Symptomatic progression/deterioration|7
4653179|NCT02115282|7536653|FG001|Overall Study|Symptomatic progression/deterioration|18
4653180|NCT02115282|7536652|FG000|Overall Study|Non-compliance|5
4653181|NCT02115282|7536653|FG001|Overall Study|Non-compliance|1
4653182|NCT02115282|7536652|FG000|Overall Study|Protocol Violation|2
4653183|NCT02115282|7536653|FG001|Overall Study|Protocol Violation|2
4653184|NCT02115282|7536652|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3
4653185|NCT02115282|7536653|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3
4653186|NCT02115282|7536652|FG000|Overall Study|Not start protocol therapy|9
4653187|NCT02115282|7536653|FG001|Overall Study|Not start protocol therapy|10
4653188|NCT02115308|7536663|FG000|Overall Study|Safety Screening|2
4653189|NCT02115308|7536664|FG001|Overall Study|Safety Screening|2
4653190|NCT02115321|7536676|FG000|Overall Study|Death|1
4653191|NCT02115321|7536677|FG001|Overall Study|Death|0
4653192|NCT02115386|7536713|FG000|Overall Study|Protocol Violation|1
4653193|NCT02115386|7536713|FG000|Overall Study|Administrative - trial was terminated|6
4653194|NCT02115607|7536730|FG000|Overall Study|Withdrawal by Subject|1
4653195|NCT02115815|7536773|FG000|Overall Study|Withdrawal by Subject|2
4653196|NCT02115815|7536774|FG001|Overall Study|Withdrawal by Subject|0
4653197|NCT02115815|7536775|FG002|Overall Study|Withdrawal by Subject|0
4653198|NCT02115815|7536776|FG003|Overall Study|Withdrawal by Subject|0
4653199|NCT02115815|7536777|FG004|Overall Study|Withdrawal by Subject|0
4653200|NCT02115815|7536778|FG005|Overall Study|Withdrawal by Subject|0
4653201|NCT02115815|7536779|FG006|Overall Study|Withdrawal by Subject|0
4653202|NCT02115815|7536773|FG000|Overall Study|Not enough drug to dose participant|0
4653203|NCT02115815|7536774|FG001|Overall Study|Not enough drug to dose participant|0
4653204|NCT02115815|7536775|FG002|Overall Study|Not enough drug to dose participant|0
4653205|NCT02115815|7536776|FG003|Overall Study|Not enough drug to dose participant|0
4653206|NCT02115815|7536777|FG004|Overall Study|Not enough drug to dose participant|0
4653207|NCT02115815|7536778|FG005|Overall Study|Not enough drug to dose participant|1
4653208|NCT02115815|7536779|FG006|Overall Study|Not enough drug to dose participant|0
4653209|NCT02115815|7536773|FG000|Overall Study|Missed appointment, randomized in error|0
4653210|NCT02115815|7536774|FG001|Overall Study|Missed appointment, randomized in error|0
4653211|NCT02115815|7536775|FG002|Overall Study|Missed appointment, randomized in error|0
4653212|NCT02115815|7536776|FG003|Overall Study|Missed appointment, randomized in error|0
4653213|NCT02115815|7536777|FG004|Overall Study|Missed appointment, randomized in error|0
4653214|NCT02115815|7536778|FG005|Overall Study|Missed appointment, randomized in error|1
4653215|NCT02115815|7536779|FG006|Overall Study|Missed appointment, randomized in error|0
4653216|NCT02116205|7536812|FG000|Overall Study|Withdrawal by Subject|2
4653217|NCT02116205|7536813|FG001|Overall Study|Withdrawal by Subject|4
4653218|NCT02116205|7536814|FG002|Overall Study|Withdrawal by Subject|1
4653219|NCT02116205|7536815|FG003|Overall Study|Withdrawal by Subject|3
4653220|NCT02116205|7536812|FG000|Overall Study|Lost to Follow-up|0
4653221|NCT02116205|7536813|FG001|Overall Study|Lost to Follow-up|2
4653222|NCT02116205|7536814|FG002|Overall Study|Lost to Follow-up|1
4653223|NCT02116205|7536815|FG003|Overall Study|Lost to Follow-up|2
4653224|NCT02116205|7536812|FG000|Overall Study|Physician Decision|0
4653225|NCT02116205|7536813|FG001|Overall Study|Physician Decision|1
4653226|NCT02116205|7536814|FG002|Overall Study|Physician Decision|1
4653227|NCT02116205|7536815|FG003|Overall Study|Physician Decision|1
4653228|NCT02116205|7536812|FG000|Overall Study|Exclusion criteria|0
4653229|NCT02116205|7536813|FG001|Overall Study|Exclusion criteria|0
4653230|NCT02116205|7536814|FG002|Overall Study|Exclusion criteria|1
4653231|NCT02116205|7536815|FG003|Overall Study|Exclusion criteria|0
4653232|NCT02116309|7536827|FG000|Overall Study|Lost to Follow-up|0
4653233|NCT02116309|7536828|FG001|Overall Study|Lost to Follow-up|1
4653234|NCT02116361|7536842|FG000|Overall Study|Pregnancy|0
4653235|NCT02116361|7536843|FG001|Overall Study|Pregnancy|0
4653236|NCT02116361|7536844|FG002|Overall Study|Pregnancy|0
4653237|NCT02116361|7536845|FG003|Overall Study|Pregnancy|1
4653238|NCT02116361|7536842|FG000|Overall Study|Protocol Violation|1
4653239|NCT02116361|7536843|FG001|Overall Study|Protocol Violation|0
4653240|NCT02116361|7536844|FG002|Overall Study|Protocol Violation|0
4653241|NCT02116361|7536845|FG003|Overall Study|Protocol Violation|2
4653242|NCT02116361|7536842|FG000|Overall Study|Physician Decision|2
4653243|NCT02116361|7536843|FG001|Overall Study|Physician Decision|3
4653244|NCT02116361|7536844|FG002|Overall Study|Physician Decision|0
4653245|NCT02116361|7536845|FG003|Overall Study|Physician Decision|0
4653246|NCT02116361|7536842|FG000|Overall Study|Adverse Event|1
4653247|NCT02116361|7536843|FG001|Overall Study|Adverse Event|0
4653248|NCT02116361|7536844|FG002|Overall Study|Adverse Event|0
4653249|NCT02116361|7536845|FG003|Overall Study|Adverse Event|3
4653250|NCT02116361|7536842|FG000|Overall Study|Other Reasons|3
4653251|NCT02116361|7536843|FG001|Overall Study|Other Reasons|3
4653252|NCT02116361|7536844|FG002|Overall Study|Other Reasons|3
4653253|NCT02116361|7536845|FG003|Overall Study|Other Reasons|3
4653254|NCT02116361|7536842|FG000|Overall Study|Lack of Efficacy|5
4653255|NCT02116361|7536843|FG001|Overall Study|Lack of Efficacy|7
4653256|NCT02116361|7536844|FG002|Overall Study|Lack of Efficacy|4
4653257|NCT02116361|7536845|FG003|Overall Study|Lack of Efficacy|3
4653258|NCT02116361|7536842|FG000|Overall Study|Lost to Follow-up|4
4653259|NCT02116361|7536843|FG001|Overall Study|Lost to Follow-up|5
4653260|NCT02116361|7536844|FG002|Overall Study|Lost to Follow-up|7
4653261|NCT02116361|7536845|FG003|Overall Study|Lost to Follow-up|5
4653262|NCT02116361|7536842|FG000|Overall Study|Personal Reasons|6
4653263|NCT02116361|7536843|FG001|Overall Study|Personal Reasons|6
4653264|NCT02116361|7536844|FG002|Overall Study|Personal Reasons|4
4653265|NCT02116361|7536845|FG003|Overall Study|Personal Reasons|9
4653266|NCT02116361|7536842|FG000|Overall Study|Investigator Decision - Relapse|9
4653267|NCT02116361|7536843|FG001|Overall Study|Investigator Decision - Relapse|7
4653268|NCT02116361|7536844|FG002|Overall Study|Investigator Decision - Relapse|8
4653269|NCT02116361|7536845|FG003|Overall Study|Investigator Decision - Relapse|5
4653270|NCT02116530|7536857|FG000|Overall Study|Withdrawal by Subject|1
4653271|NCT02116530|7536858|FG001|Overall Study|Withdrawal by Subject|2
4653272|NCT02116530|7536857|FG000|Overall Study|Adverse Event|4
4653273|NCT02116530|7536858|FG001|Overall Study|Adverse Event|0
4653274|NCT02116530|7536857|FG000|Overall Study|Physician Decision|1
4653275|NCT02116530|7536858|FG001|Overall Study|Physician Decision|0
4653276|NCT02116530|7536857|FG000|Overall Study|Lost to Follow-up|1
4653277|NCT02116530|7536858|FG001|Overall Study|Lost to Follow-up|0
4653278|NCT02116530|7536857|FG000|Overall Study|Other Medical Problems|2
4653279|NCT02116530|7536858|FG001|Overall Study|Other Medical Problems|2
4653280|NCT02116582|7536864|FG000|Overall Study|Enrolled but Never Received Study Drug|1
4653281|NCT02116582|7536864|FG000|Overall Study|Adverse Event|22
4653282|NCT02116582|7536864|FG000|Overall Study|Death|9
4653283|NCT02116582|7536864|FG000|Overall Study|Progressive Disease|148
4653284|NCT02116582|7536864|FG000|Overall Study|Protocol Violation|3
4653285|NCT02116582|7536864|FG000|Overall Study|Withdrawal by Subject|8
4653286|NCT02116582|7536864|FG000|Overall Study|Other: Miscellaneous|11
4653287|NCT02116582|7536864|FG000|Overall Study|Lost to Follow-up|1
4653288|NCT02116582|7536864|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12
4653289|NCT02116608|7536871|FG000|Overall Study|Lost to Follow-up|0
4653290|NCT02116608|7536872|FG001|Overall Study|Lost to Follow-up|0
4653291|NCT02116608|7536873|FG002|Overall Study|Lost to Follow-up|1
4653292|NCT02116608|7536871|FG000|Overall Study|Physician Decision|0
4653293|NCT02116608|7536872|FG001|Overall Study|Physician Decision|1
4653294|NCT02116608|7536873|FG002|Overall Study|Physician Decision|0
4653295|NCT02116608|7536871|FG000|Overall Study|Death|0
4653296|NCT02116608|7536872|FG001|Overall Study|Death|1
4653297|NCT02116608|7536873|FG002|Overall Study|Death|0
4653298|NCT02116621|7536883|FG000|Baseline|Withdrawal by Subject|0
4653299|NCT02116621|7536884|FG001|Baseline|Withdrawal by Subject|4
4653300|NCT02116621|7536883|FG000|Three Month Follow-up|Death|1
4653301|NCT02116621|7536884|FG001|Three Month Follow-up|Death|1
4653302|NCT02116621|7536883|FG000|Three Month Follow-up|Withdrawal by Subject|4
4653303|NCT02116621|7536884|FG001|Three Month Follow-up|Withdrawal by Subject|1
4653304|NCT02116621|7536883|FG000|Three Month Follow-up|Lost to Follow-up|0
4653305|NCT02116621|7536884|FG001|Three Month Follow-up|Lost to Follow-up|1
4653306|NCT02116621|7536883|FG000|Three Month Follow-up|Did not complete follow-up survey|14
4653307|NCT02116621|7536884|FG001|Three Month Follow-up|Did not complete follow-up survey|4
4653308|NCT02116621|7536883|FG000|Six Month Follow-up|Withdrawal by Subject|1
4653309|NCT02116621|7536884|FG001|Six Month Follow-up|Withdrawal by Subject|1
4653310|NCT02116621|7536883|FG000|Six Month Follow-up|Lost to Follow-up|2
4653311|NCT02116621|7536884|FG001|Six Month Follow-up|Lost to Follow-up|1
4653312|NCT02116621|7536883|FG000|Six Month Follow-up|Did not complete follow-up survey|1
4653313|NCT02116621|7536884|FG001|Six Month Follow-up|Did not complete follow-up survey|1
4653314|NCT02116621|7536883|FG000|Twelve Month Follow-up|Withdrawal by Subject|1
4653315|NCT02116621|7536884|FG001|Twelve Month Follow-up|Withdrawal by Subject|0
4653316|NCT02116621|7536883|FG000|Twelve Month Follow-up|Lost to Follow-up|0
4653317|NCT02116621|7536884|FG001|Twelve Month Follow-up|Lost to Follow-up|1
4653318|NCT02116621|7536883|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1
4653319|NCT02116621|7536884|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3
4653320|NCT02116621|7536883|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14
4653321|NCT02116621|7536884|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8
4653322|NCT02116660|7536892|FG000|Overall Study|Deteriorating renal function|0
4653323|NCT02116660|7536893|FG001|Overall Study|Deteriorating renal function|1
4653324|NCT02116660|7536892|FG000|Overall Study|Adverse Event|1
4653325|NCT02116660|7536893|FG001|Overall Study|Adverse Event|1
4653326|NCT02116660|7536892|FG000|Overall Study|Withdrawal by Subject|0
4653327|NCT02116660|7536893|FG001|Overall Study|Withdrawal by Subject|2
4653328|NCT02116660|7536892|FG000|Overall Study|Organization reason|1
4653329|NCT02116660|7536893|FG001|Overall Study|Organization reason|0
4653330|NCT02116777|7536908|FG000|Overall Study|Adverse Event|0
4653331|NCT02116777|7536909|FG001|Overall Study|Adverse Event|0
4653332|NCT02116777|7536910|FG002|Overall Study|Adverse Event|0
4653333|NCT02116777|7536911|FG003|Overall Study|Adverse Event|0
4653334|NCT02116777|7536912|FG004|Overall Study|Adverse Event|2
4653335|NCT02116777|7536913|FG005|Overall Study|Adverse Event|2
4653336|NCT02116777|7536914|FG006|Overall Study|Adverse Event|0
4653337|NCT02116777|7536908|FG000|Overall Study|Death|0
4653338|NCT02116777|7536909|FG001|Overall Study|Death|0
4653339|NCT02116777|7536910|FG002|Overall Study|Death|0
4653340|NCT02116777|7536911|FG003|Overall Study|Death|1
4653341|NCT02116777|7536912|FG004|Overall Study|Death|0
4653342|NCT02116777|7536913|FG005|Overall Study|Death|0
4748145|NCT02488759|7722116|FG000|Overall Study|Participant request to discontinue study treatment|7
4748146|NCT02488759|7722117|FG001|Overall Study|Participant request to discontinue study treatment|8
4748147|NCT02488759|7722118|FG002|Overall Study|Participant request to discontinue study treatment|4
4748148|NCT02488759|7722119|FG003|Overall Study|Participant request to discontinue study treatment|0
4748149|NCT02488759|7722120|FG004|Overall Study|Participant request to discontinue study treatment|0
4748150|NCT02488759|7722121|FG005|Overall Study|Participant request to discontinue study treatment|0
4748151|NCT02488759|7722116|FG000|Overall Study|Withdrawal by Subject|2
4748152|NCT02488759|7722117|FG001|Overall Study|Withdrawal by Subject|0
4748153|NCT02488759|7722118|FG002|Overall Study|Withdrawal by Subject|3
4748154|NCT02488759|7722119|FG003|Overall Study|Withdrawal by Subject|0
4748155|NCT02488759|7722120|FG004|Overall Study|Withdrawal by Subject|0
4748156|NCT02488759|7722121|FG005|Overall Study|Withdrawal by Subject|2
4748157|NCT02488759|7722116|FG000|Overall Study|Lost to Follow-up|0
4748158|NCT02488759|7722117|FG001|Overall Study|Lost to Follow-up|1
4748159|NCT02488759|7722118|FG002|Overall Study|Lost to Follow-up|2
4748160|NCT02488759|7722119|FG003|Overall Study|Lost to Follow-up|0
4748161|NCT02488759|7722120|FG004|Overall Study|Lost to Follow-up|0
4748162|NCT02488759|7722121|FG005|Overall Study|Lost to Follow-up|0
4748163|NCT02488759|7722116|FG000|Overall Study|Maximum clinical benefit|3
4748164|NCT02488759|7722117|FG001|Overall Study|Maximum clinical benefit|0
4748165|NCT02488759|7722118|FG002|Overall Study|Maximum clinical benefit|1
4748166|NCT02488759|7722119|FG003|Overall Study|Maximum clinical benefit|0
4748167|NCT02488759|7722120|FG004|Overall Study|Maximum clinical benefit|0
4748168|NCT02488759|7722121|FG005|Overall Study|Maximum clinical benefit|0
4748169|NCT02488759|7722116|FG000|Overall Study|Completed treatment|0
4748170|NCT02488759|7722117|FG001|Overall Study|Completed treatment|0
4748171|NCT02488759|7722118|FG002|Overall Study|Completed treatment|0
4748172|NCT02488759|7722119|FG003|Overall Study|Completed treatment|0
4748173|NCT02488759|7722120|FG004|Overall Study|Completed treatment|0
4748174|NCT02488759|7722121|FG005|Overall Study|Completed treatment|116
4748175|NCT02488759|7722116|FG000|Overall Study|Other reasons|5
4748176|NCT02488759|7722117|FG001|Overall Study|Other reasons|32
4748177|NCT02488759|7722118|FG002|Overall Study|Other reasons|21
4748178|NCT02488759|7722119|FG003|Overall Study|Other reasons|1
4748179|NCT02488759|7722120|FG004|Overall Study|Other reasons|1
4748180|NCT02488759|7722121|FG005|Overall Study|Other reasons|1
4748181|NCT02448381|7722137|FG000|Overall Study|Adverse Event|2
4748182|NCT02448381|7722138|FG001|Overall Study|Adverse Event|0
4748183|NCT02448381|7722137|FG000|Overall Study|Lost to Follow-up|16
4748184|NCT02448381|7722138|FG001|Overall Study|Lost to Follow-up|9
4748185|NCT02448381|7722137|FG000|Overall Study|Physician Decision|1
4748186|NCT02448381|7722138|FG001|Overall Study|Physician Decision|1
4748187|NCT02448381|7722137|FG000|Overall Study|Pregnancy|1
4748188|NCT02448381|7722138|FG001|Overall Study|Pregnancy|0
4748189|NCT02448381|7722137|FG000|Overall Study|Withdrawal by Subject|13
4748190|NCT02448381|7722138|FG001|Overall Study|Withdrawal by Subject|9
4748191|NCT02448381|7722137|FG000|Overall Study|Noncompliance with Study Procedures|2
4748192|NCT02448381|7722138|FG001|Overall Study|Noncompliance with Study Procedures|0
4748193|NCT02151981|7722152|FG000|Overall Study|Death|184
4748194|NCT02151981|7722153|FG001|Overall Study|Death|88
4748195|NCT02151981|7722152|FG000|Overall Study|Lost to Follow-up|7
4748196|NCT02151981|7722153|FG001|Overall Study|Lost to Follow-up|1
4748197|NCT02151981|7722152|FG000|Overall Study|Withdrawal by Subject|27
4748198|NCT02151981|7722153|FG001|Overall Study|Withdrawal by Subject|21
4748199|NCT02151981|7722152|FG000|Overall Study|Ongoing Study at Data Cut-off|60
4748200|NCT02151981|7722153|FG001|Overall Study|Ongoing Study at Data Cut-off|27
4748201|NCT02151981|7722152|FG000|Overall Study|Eligibility criteria not fulfilled|0
4748202|NCT02151981|7722153|FG001|Overall Study|Eligibility criteria not fulfilled|1
4748203|NCT02151981|7722152|FG000|Overall Study|Patient had no clinical benefit|1
4748204|NCT02151981|7722153|FG001|Overall Study|Patient had no clinical benefit|0
4748205|NCT02151981|7722152|FG000|Overall Study|Unwilling to continue to follow up visit|0
4748206|NCT02151981|7722153|FG001|Overall Study|Unwilling to continue to follow up visit|1
4748207|NCT02151981|7722152|FG000|Overall Study|Study terminated|0
4748208|NCT02151981|7722153|FG001|Overall Study|Study terminated|1
4748209|NCT01972217|7722163|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0
4748210|NCT01972217|7722164|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1
4748211|NCT01972217|7722165|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0
4748212|NCT01972217|7722166|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0
4748213|NCT01972217|7722163|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1
4653343|NCT02116777|7536914|FG006|Overall Study|Death|0
4653344|NCT02116777|7536908|FG000|Overall Study|Lack of Efficacy|3
4653345|NCT02116777|7536909|FG001|Overall Study|Lack of Efficacy|3
4653346|NCT02116777|7536910|FG002|Overall Study|Lack of Efficacy|3
4653347|NCT02116777|7536911|FG003|Overall Study|Lack of Efficacy|8
4653348|NCT02116777|7536912|FG004|Overall Study|Lack of Efficacy|4
4653349|NCT02116777|7536913|FG005|Overall Study|Lack of Efficacy|1
4653350|NCT02116777|7536914|FG006|Overall Study|Lack of Efficacy|9
4653351|NCT02116777|7536908|FG000|Overall Study|Physician Decision|0
4653352|NCT02116777|7536909|FG001|Overall Study|Physician Decision|0
4653353|NCT02116777|7536910|FG002|Overall Study|Physician Decision|0
4653354|NCT02116777|7536911|FG003|Overall Study|Physician Decision|2
4653355|NCT02116777|7536912|FG004|Overall Study|Physician Decision|0
4653356|NCT02116777|7536913|FG005|Overall Study|Physician Decision|0
4653357|NCT02116777|7536914|FG006|Overall Study|Physician Decision|0
4653358|NCT02116777|7536908|FG000|Overall Study|Protocol Violation|0
4653359|NCT02116777|7536909|FG001|Overall Study|Protocol Violation|0
4653360|NCT02116777|7536910|FG002|Overall Study|Protocol Violation|0
4653361|NCT02116777|7536911|FG003|Overall Study|Protocol Violation|1
4653362|NCT02116777|7536912|FG004|Overall Study|Protocol Violation|0
4653363|NCT02116777|7536913|FG005|Overall Study|Protocol Violation|0
4653364|NCT02116777|7536914|FG006|Overall Study|Protocol Violation|0
4653365|NCT02116777|7536908|FG000|Overall Study|Withdrawal by Subject|0
4653366|NCT02116777|7536909|FG001|Overall Study|Withdrawal by Subject|0
4653367|NCT02116777|7536910|FG002|Overall Study|Withdrawal by Subject|0
4653368|NCT02116777|7536911|FG003|Overall Study|Withdrawal by Subject|1
4653369|NCT02116777|7536912|FG004|Overall Study|Withdrawal by Subject|0
4653370|NCT02116777|7536913|FG005|Overall Study|Withdrawal by Subject|0
4653371|NCT02116777|7536914|FG006|Overall Study|Withdrawal by Subject|0
4653372|NCT02116803|7536935|FG000|Overall Study|Adverse Event|2
4653373|NCT02116803|7536936|FG001|Overall Study|Adverse Event|1
4653374|NCT02116803|7536935|FG000|Overall Study|Physician Decision|1
4653375|NCT02116803|7536936|FG001|Overall Study|Physician Decision|0
4653376|NCT02116803|7536935|FG000|Overall Study|Progressive disease|4
4653377|NCT02116803|7536936|FG001|Overall Study|Progressive disease|0
4653378|NCT02116803|7536935|FG000|Overall Study|Study terminated by sponsor|2
4653379|NCT02116803|7536936|FG001|Overall Study|Study terminated by sponsor|1
4653380|NCT02116803|7536935|FG000|Overall Study|Death|1
4653381|NCT02116803|7536936|FG001|Overall Study|Death|0
4653382|NCT02116972|7536945|FG000|Overall Study|Adverse Event|4
4653383|NCT02116972|7536946|FG001|Overall Study|Adverse Event|4
4653384|NCT02116972|7536947|FG002|Overall Study|Adverse Event|1
4653385|NCT02116972|7536945|FG000|Overall Study|Withdrawal by Subject|1
4653386|NCT02116972|7536946|FG001|Overall Study|Withdrawal by Subject|1
4653387|NCT02116972|7536947|FG002|Overall Study|Withdrawal by Subject|5
4653388|NCT02116972|7536945|FG000|Overall Study|Protocol Violation|1
4653389|NCT02116972|7536946|FG001|Overall Study|Protocol Violation|0
4653390|NCT02116972|7536947|FG002|Overall Study|Protocol Violation|1
4653391|NCT02116972|7536945|FG000|Overall Study|Lost to Follow-up|4
4653392|NCT02116972|7536946|FG001|Overall Study|Lost to Follow-up|3
4653393|NCT02116972|7536947|FG002|Overall Study|Lost to Follow-up|1
4653394|NCT02116972|7536945|FG000|Overall Study|Lack of Efficacy|6
4653395|NCT02116972|7536946|FG001|Overall Study|Lack of Efficacy|6
4653396|NCT02116972|7536947|FG002|Overall Study|Lack of Efficacy|5
4653397|NCT02116972|7536945|FG000|Overall Study|scheduling conflicts and relocation|3
4653398|NCT02116972|7536946|FG001|Overall Study|scheduling conflicts and relocation|3
4653399|NCT02116972|7536947|FG002|Overall Study|scheduling conflicts and relocation|6
4653400|NCT02117024|7536959|FG000|Overall Study|Progressive Disease|26
4653401|NCT02117024|7536960|FG001|Overall Study|Progressive Disease|9
4653402|NCT02117024|7536959|FG000|Overall Study|Significant Clinical Progression|7
4653403|NCT02117024|7536960|FG001|Overall Study|Significant Clinical Progression|4
4653404|NCT02117024|7536959|FG000|Overall Study|Death|5
4653405|NCT02117024|7536960|FG001|Overall Study|Death|0
4653406|NCT02117024|7536959|FG000|Overall Study|Withdrawal by Subject|3
4653407|NCT02117024|7536960|FG001|Overall Study|Withdrawal by Subject|1
4653408|NCT02117024|7536959|FG000|Overall Study|Protocol Violation|1
4653409|NCT02117024|7536960|FG001|Overall Study|Protocol Violation|0
4653410|NCT02117024|7536959|FG000|Overall Study|Adverse Event|1
4653411|NCT02117024|7536960|FG001|Overall Study|Adverse Event|2
4653412|NCT02117024|7536959|FG000|Overall Study|Randomized in Error|1
4653413|NCT02117024|7536960|FG001|Overall Study|Randomized in Error|0
4653414|NCT02117024|7536959|FG000|Overall Study|Patient returned to primary oncologist|0
4653415|NCT02117024|7536960|FG001|Overall Study|Patient returned to primary oncologist|1
4653416|NCT02117024|7536959|FG000|Overall Study|Patient took treatment break|0
4653417|NCT02117024|7536960|FG001|Overall Study|Patient took treatment break|1
4653418|NCT02117024|7536959|FG000|Overall Study|Physician Decision|0
4653419|NCT02117024|7536960|FG001|Overall Study|Physician Decision|2
4653420|NCT02117349|7536991|FG000|Overall Study|Withdrawal by Subject|1
4653421|NCT02117349|7536992|FG001|Overall Study|Withdrawal by Subject|0
4653422|NCT02117349|7536991|FG000|Overall Study|Lost to Follow-up|1
4653423|NCT02117349|7536992|FG001|Overall Study|Lost to Follow-up|1
4653424|NCT02117349|7536991|FG000|Overall Study|Death|1
4653425|NCT02117349|7536992|FG001|Overall Study|Death|0
4653426|NCT02117414|7537000|FG000|Overall Study|Death|5
4653427|NCT02117414|7537001|FG001|Overall Study|Death|2
4653428|NCT02117414|7537000|FG000|Overall Study|Withdrawal by Subject|10
4653429|NCT02117414|7537001|FG001|Overall Study|Withdrawal by Subject|4
4653430|NCT02117427|7537012|FG000|Overall Study|Permanent need for exogenous EPO Tx|2
4653431|NCT02117427|7537013|FG001|Overall Study|Permanent need for exogenous EPO Tx|0
4653432|NCT02117427|7537014|FG002|Overall Study|Permanent need for exogenous EPO Tx|0
4653433|NCT02117427|7537012|FG000|Overall Study|Permanent need for exogenous ESA Tx|3
4653434|NCT02117427|7537013|FG001|Overall Study|Permanent need for exogenous ESA Tx|1
4653435|NCT02117427|7537014|FG002|Overall Study|Permanent need for exogenous ESA Tx|0
4653436|NCT02117427|7537012|FG000|Overall Study|Physician Decision|0
4653437|NCT02117427|7537013|FG001|Overall Study|Physician Decision|2
4653438|NCT02117427|7537014|FG002|Overall Study|Physician Decision|0
4653439|NCT02117427|7537012|FG000|Overall Study|No longer meets inclusion criteria|0
4653440|NCT02117427|7537013|FG001|Overall Study|No longer meets inclusion criteria|1
4653441|NCT02117427|7537014|FG002|Overall Study|No longer meets inclusion criteria|0
4653442|NCT02117427|7537012|FG000|Overall Study|Death|0
4653443|NCT02117427|7537013|FG001|Overall Study|Death|1
4653444|NCT02117427|7537014|FG002|Overall Study|Death|0
4653445|NCT02117479|7537022|FG000|Overall Study|Death|13
4653446|NCT02117479|7537023|FG001|Overall Study|Death|8
4653447|NCT02117479|7537022|FG000|Overall Study|Adverse Event|8
4653448|NCT02117479|7537023|FG001|Overall Study|Adverse Event|16
4653449|NCT02117479|7537022|FG000|Overall Study|Subject decision|8
4653450|NCT02117479|7537023|FG001|Overall Study|Subject decision|9
4653451|NCT02117479|7537022|FG000|Overall Study|Disease progression|104
4653452|NCT02117479|7537023|FG001|Overall Study|Disease progression|108
4653453|NCT02117479|7537022|FG000|Overall Study|Noncompliance with study treatment|1
4653454|NCT02117479|7537023|FG001|Overall Study|Noncompliance with study treatment|0
4653455|NCT02117479|7537022|FG000|Overall Study|Study terminated by the sponsor|4
4653456|NCT02117479|7537023|FG001|Overall Study|Study terminated by the sponsor|6
4653457|NCT02117479|7537022|FG000|Overall Study|Physician Decision|7
4653458|NCT02117479|7537023|FG001|Overall Study|Physician Decision|2
4653459|NCT02117479|7537022|FG000|Overall Study|Other unspecified|11
4653460|NCT02117479|7537023|FG001|Overall Study|Other unspecified|7
4653461|NCT02117544|7537029|FG000|Period 1|Lost to follow-up (prior to treatment)|2
4653462|NCT02117544|7537030|FG001|Period 1|Lost to follow-up (prior to treatment)|0
4653463|NCT02117570|7537040|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0
4653464|NCT02117570|7537041|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2
4653465|NCT02117570|7537042|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1
4653466|NCT02117570|7537040|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1
4653467|NCT02117570|7537041|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1
4653468|NCT02117570|7537042|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0
4653469|NCT02117570|7537040|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0
4653470|NCT02117570|7537041|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0
4653471|NCT02117570|7537042|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2
4653472|NCT02117570|7537040|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0
4653473|NCT02117570|7537041|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0
4653474|NCT02117570|7537042|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1
4653475|NCT02117570|7537040|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0
4653476|NCT02117570|7537041|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0
4653477|NCT02117570|7537042|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1
4653478|NCT02117570|7537040|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1
4653479|NCT02117570|7537041|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2
4653480|NCT02117570|7537042|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2
4653481|NCT02117570|7537040|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0
4653482|NCT02117570|7537041|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1
4653483|NCT02117570|7537042|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0
4653484|NCT02117648|7537053|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1
4653485|NCT02117648|7537053|FG000|Abemaciclib Alone Period 1|Adverse Event|1
4653486|NCT02117648|7537053|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1
4653487|NCT02117648|7537053|FG000|Abemaciclib + Clarithromycin Period 2|Death|1
4653488|NCT02117648|7537053|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1
4653489|NCT02117648|7537053|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1
4653490|NCT02117648|7537053|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12
4653491|NCT02117648|7537053|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1
4653492|NCT02117648|7537053|FG000|Abemaciclib Safety-Extension Phase|Death|3
4653493|NCT02117648|7537053|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2
4653494|NCT02117648|7537053|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2
4653495|NCT02117687|7537063|FG000|Overall Study|Lost to Follow-up|0
4653496|NCT02117687|7537064|FG001|Overall Study|Lost to Follow-up|1
4653497|NCT02117687|7537063|FG000|Overall Study|Adverse Event|0
4653498|NCT02117687|7537064|FG001|Overall Study|Adverse Event|2
4653499|NCT02117687|7537063|FG000|Overall Study|Other Reasons|1
4653500|NCT02117687|7537064|FG001|Overall Study|Other Reasons|1
4653501|NCT02117713|7537070|FG000|Week 48|Adverse Event|4
4653502|NCT02117713|7537070|FG000|Week 48|Withdrawal by caregiver|2
4653503|NCT02117713|7537070|FG000|Week 48|Did not consent to Protocol Amendment 4|2
4653504|NCT02117713|7537070|FG000|Long Term Follow-up Treatment|Adverse Event|3
4653505|NCT02117713|7537070|FG000|Long Term Follow-up Treatment|Progressive Disease|2
4653506|NCT02117713|7537070|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1
4653507|NCT02118012|7537104|FG000|Overall Study|Adverse Event|0
4653508|NCT02118012|7537105|FG001|Overall Study|Adverse Event|1
4653509|NCT02118012|7537104|FG000|Overall Study|Physician Decision|0
4653510|NCT02118012|7537105|FG001|Overall Study|Physician Decision|1
4653511|NCT02118337|7537120|FG000|Overall Study|Other|1
4653512|NCT02118337|7537121|FG001|Overall Study|Other|0
4653513|NCT02118337|7537122|FG002|Overall Study|Other|0
4653514|NCT02118337|7537123|FG003|Overall Study|Other|0
4653515|NCT02118337|7537124|FG004|Overall Study|Other|2
4653516|NCT02118337|7537125|FG005|Overall Study|Other|3
4653517|NCT02118337|7537126|FG006|Overall Study|Other|1
4653518|NCT02118337|7537127|FG007|Overall Study|Other|28
4653519|NCT02118337|7537128|FG008|Overall Study|Other|15
4653520|NCT02118337|7537120|FG000|Overall Study|Lost to Follow-up|0
4653521|NCT02118337|7537121|FG001|Overall Study|Lost to Follow-up|0
4653522|NCT02118337|7537122|FG002|Overall Study|Lost to Follow-up|0
4653523|NCT02118337|7537123|FG003|Overall Study|Lost to Follow-up|0
4653524|NCT02118337|7537124|FG004|Overall Study|Lost to Follow-up|0
4653525|NCT02118337|7537125|FG005|Overall Study|Lost to Follow-up|0
4653526|NCT02118337|7537126|FG006|Overall Study|Lost to Follow-up|0
4653527|NCT02118337|7537127|FG007|Overall Study|Lost to Follow-up|1
4653528|NCT02118337|7537128|FG008|Overall Study|Lost to Follow-up|0
4653529|NCT02118337|7537120|FG000|Overall Study|Withdrawal by Subject|1
4653530|NCT02118337|7537121|FG001|Overall Study|Withdrawal by Subject|3
4653531|NCT02118337|7537122|FG002|Overall Study|Withdrawal by Subject|2
4653532|NCT02118337|7537123|FG003|Overall Study|Withdrawal by Subject|1
4653533|NCT02118337|7537124|FG004|Overall Study|Withdrawal by Subject|2
4653534|NCT02118337|7537125|FG005|Overall Study|Withdrawal by Subject|2
4653535|NCT02118337|7537126|FG006|Overall Study|Withdrawal by Subject|1
4653536|NCT02118337|7537127|FG007|Overall Study|Withdrawal by Subject|4
4653537|NCT02118337|7537128|FG008|Overall Study|Withdrawal by Subject|2
4653538|NCT02118337|7537120|FG000|Overall Study|Death|2
4653539|NCT02118337|7537121|FG001|Overall Study|Death|2
4653540|NCT02118337|7537122|FG002|Overall Study|Death|1
4653541|NCT02118337|7537123|FG003|Overall Study|Death|2
4653542|NCT02118337|7537124|FG004|Overall Study|Death|5
4653543|NCT02118337|7537125|FG005|Overall Study|Death|1
4653544|NCT02118337|7537126|FG006|Overall Study|Death|2
4653545|NCT02118337|7537127|FG007|Overall Study|Death|9
4653546|NCT02118337|7537128|FG008|Overall Study|Death|4
4653547|NCT02118428|7537154|FG000|Overall Study|Physician Decision|0
4653548|NCT02118428|7537155|FG001|Overall Study|Physician Decision|1
4653549|NCT02118428|7537156|FG002|Overall Study|Physician Decision|0
4653550|NCT02118428|7537154|FG000|Overall Study|Withdrawal by Subject|2
4653551|NCT02118428|7537155|FG001|Overall Study|Withdrawal by Subject|2
4653552|NCT02118428|7537156|FG002|Overall Study|Withdrawal by Subject|0
4653553|NCT02118428|7537154|FG000|Overall Study|Death|7
4653554|NCT02118428|7537155|FG001|Overall Study|Death|5
4653555|NCT02118428|7537156|FG002|Overall Study|Death|0
4653556|NCT02118428|7537154|FG000|Overall Study|Lost to Follow-up|3
4653557|NCT02118428|7537155|FG001|Overall Study|Lost to Follow-up|1
4653558|NCT02118428|7537156|FG002|Overall Study|Lost to Follow-up|0
4653559|NCT02118428|7537154|FG000|Overall Study|Screen Failure or Became Inelegible|1
4653560|NCT02118428|7537155|FG001|Overall Study|Screen Failure or Became Inelegible|0
4653561|NCT02118428|7537156|FG002|Overall Study|Screen Failure or Became Inelegible|1
4653562|NCT02118597|7537172|FG000|Overall Study|Sponsor terminated the study|14
4653563|NCT02118597|7537172|FG000|Overall Study|Serious Adverse Event|1
4653564|NCT02118597|7537172|FG000|Overall Study|Investigator's decision|1
4653565|NCT02118714|7537176|FG000|Overall Study|Lost to Follow-up|2
4653566|NCT02118714|7537176|FG000|Overall Study|Protocol Violation|1
4653567|NCT02118766|7537182|FG000|Overall Study|Adverse Event|7
4653568|NCT02118766|7537183|FG001|Overall Study|Adverse Event|2
4653569|NCT02118766|7537182|FG000|Overall Study|Withdrawal by Subject|3
4653570|NCT02118766|7537183|FG001|Overall Study|Withdrawal by Subject|6
4653571|NCT02118766|7537182|FG000|Overall Study|Lost to Follow-up|5
4653572|NCT02118766|7537183|FG001|Overall Study|Lost to Follow-up|4
4653573|NCT02118766|7537182|FG000|Overall Study|Withdrawal by parent/guardian|12
4653574|NCT02118766|7537183|FG001|Overall Study|Withdrawal by parent/guardian|18
4653575|NCT02118766|7537182|FG000|Overall Study|Other|3
4653576|NCT02118766|7537183|FG001|Overall Study|Other|1
4653577|NCT02118792|7537191|FG000|Overall Study|Withdrawal by Subject|6
4653578|NCT02118792|7537192|FG001|Overall Study|Withdrawal by Subject|3
4653579|NCT02118792|7537191|FG000|Overall Study|Lost to Follow-up|4
4653580|NCT02118792|7537192|FG001|Overall Study|Lost to Follow-up|4
4653581|NCT02118792|7537191|FG000|Overall Study|Adverse Event|5
4653582|NCT02118792|7537192|FG001|Overall Study|Adverse Event|4
4653583|NCT02118792|7537191|FG000|Overall Study|Withdrawal by parent/guardian|14
4653584|NCT02118792|7537192|FG001|Overall Study|Withdrawal by parent/guardian|20
4653585|NCT02118792|7537191|FG000|Overall Study|Other|1
4653586|NCT02118792|7537192|FG001|Overall Study|Other|6
4653587|NCT02118792|7537191|FG000|Overall Study|Randomised but not treated|1
4653588|NCT02118792|7537192|FG001|Overall Study|Randomised but not treated|0
4653589|NCT02118896|7537223|FG000|Overall Study|Death|4
4653590|NCT02118896|7537224|FG001|Overall Study|Death|0
4653591|NCT02118896|7537225|FG002|Overall Study|Death|4
4653592|NCT02118896|7537226|FG003|Overall Study|Death|6
4653593|NCT02118896|7537227|FG004|Overall Study|Death|3
4653594|NCT02118896|7537228|FG005|Overall Study|Death|1
4653595|NCT02118896|7537229|FG006|Overall Study|Death|0
4653596|NCT02118896|7537230|FG007|Overall Study|Death|0
4653597|NCT02118896|7537231|FG008|Overall Study|Death|0
4653598|NCT02118896|7537232|FG009|Overall Study|Death|0
4653599|NCT02118896|7537223|FG000|Overall Study|Adverse Event|5
4653600|NCT02118896|7537224|FG001|Overall Study|Adverse Event|4
4653601|NCT02118896|7537225|FG002|Overall Study|Adverse Event|4
4653602|NCT02118896|7537226|FG003|Overall Study|Adverse Event|5
4653603|NCT02118896|7537227|FG004|Overall Study|Adverse Event|5
4653604|NCT02118896|7537228|FG005|Overall Study|Adverse Event|9
4653605|NCT02118896|7537229|FG006|Overall Study|Adverse Event|1
4653606|NCT02118896|7537230|FG007|Overall Study|Adverse Event|1
4653607|NCT02118896|7537231|FG008|Overall Study|Adverse Event|4
4653608|NCT02118896|7537232|FG009|Overall Study|Adverse Event|0
4653609|NCT02118896|7537223|FG000|Overall Study|Consent withdrawn|2
4653610|NCT02118896|7537224|FG001|Overall Study|Consent withdrawn|0
4653611|NCT02118896|7537225|FG002|Overall Study|Consent withdrawn|3
4653612|NCT02118896|7537226|FG003|Overall Study|Consent withdrawn|4
4653613|NCT02118896|7537227|FG004|Overall Study|Consent withdrawn|1
4653614|NCT02118896|7537228|FG005|Overall Study|Consent withdrawn|4
4653615|NCT02118896|7537229|FG006|Overall Study|Consent withdrawn|0
4653616|NCT02118896|7537230|FG007|Overall Study|Consent withdrawn|0
4653617|NCT02118896|7537231|FG008|Overall Study|Consent withdrawn|0
4653618|NCT02118896|7537232|FG009|Overall Study|Consent withdrawn|0
4653619|NCT02118896|7537223|FG000|Overall Study|Non-compliance|2
4653620|NCT02118896|7537224|FG001|Overall Study|Non-compliance|1
4653621|NCT02118896|7537225|FG002|Overall Study|Non-compliance|1
4653622|NCT02118896|7537226|FG003|Overall Study|Non-compliance|5
4653623|NCT02118896|7537227|FG004|Overall Study|Non-compliance|0
4653624|NCT02118896|7537228|FG005|Overall Study|Non-compliance|1
4653625|NCT02118896|7537229|FG006|Overall Study|Non-compliance|0
4653626|NCT02118896|7537230|FG007|Overall Study|Non-compliance|1
4653627|NCT02118896|7537231|FG008|Overall Study|Non-compliance|0
4653628|NCT02118896|7537232|FG009|Overall Study|Non-compliance|0
4653629|NCT02118896|7537223|FG000|Overall Study|Pregnancy|1
4653630|NCT02118896|7537224|FG001|Overall Study|Pregnancy|1
4653631|NCT02118896|7537225|FG002|Overall Study|Pregnancy|0
4653632|NCT02118896|7537226|FG003|Overall Study|Pregnancy|0
4653633|NCT02118896|7537227|FG004|Overall Study|Pregnancy|1
4653634|NCT02118896|7537228|FG005|Overall Study|Pregnancy|3
4653635|NCT02118896|7537229|FG006|Overall Study|Pregnancy|1
4653636|NCT02118896|7537230|FG007|Overall Study|Pregnancy|0
4653637|NCT02118896|7537231|FG008|Overall Study|Pregnancy|0
4653638|NCT02118896|7537232|FG009|Overall Study|Pregnancy|0
4653639|NCT02118896|7537223|FG000|Overall Study|Lost to Follow-up|1
4653640|NCT02118896|7537224|FG001|Overall Study|Lost to Follow-up|2
4653641|NCT02118896|7537225|FG002|Overall Study|Lost to Follow-up|1
4653642|NCT02118896|7537226|FG003|Overall Study|Lost to Follow-up|0
4653643|NCT02118896|7537227|FG004|Overall Study|Lost to Follow-up|2
4653644|NCT02118896|7537228|FG005|Overall Study|Lost to Follow-up|1
4653645|NCT02118896|7537229|FG006|Overall Study|Lost to Follow-up|0
4653646|NCT02118896|7537230|FG007|Overall Study|Lost to Follow-up|0
4653647|NCT02118896|7537231|FG008|Overall Study|Lost to Follow-up|0
4653648|NCT02118896|7537232|FG009|Overall Study|Lost to Follow-up|0
4653649|NCT02118896|7537223|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1
4653650|NCT02118896|7537224|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5
4653651|NCT02118896|7537225|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1
4653652|NCT02118896|7537226|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2
4653653|NCT02118896|7537227|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4
4653654|NCT02118896|7537228|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2
4653655|NCT02118896|7537229|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0
4653656|NCT02118896|7537230|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0
4653657|NCT02118896|7537231|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0
4653658|NCT02118896|7537232|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2
4653659|NCT02118896|7537223|FG000|Overall Study|Prohibited medication|0
4653660|NCT02118896|7537224|FG001|Overall Study|Prohibited medication|0
4653661|NCT02118896|7537225|FG002|Overall Study|Prohibited medication|0
4653662|NCT02118896|7537226|FG003|Overall Study|Prohibited medication|0
4653663|NCT02118896|7537227|FG004|Overall Study|Prohibited medication|1
4653664|NCT02118896|7537228|FG005|Overall Study|Prohibited medication|3
4653665|NCT02118896|7537229|FG006|Overall Study|Prohibited medication|0
4653666|NCT02118896|7537230|FG007|Overall Study|Prohibited medication|0
4653667|NCT02118896|7537231|FG008|Overall Study|Prohibited medication|0
4653668|NCT02118896|7537232|FG009|Overall Study|Prohibited medication|0
4653669|NCT02118896|7537223|FG000|Overall Study|Miscellaneous|1
4653670|NCT02118896|7537224|FG001|Overall Study|Miscellaneous|2
4653671|NCT02118896|7537225|FG002|Overall Study|Miscellaneous|0
4653672|NCT02118896|7537226|FG003|Overall Study|Miscellaneous|2
4653673|NCT02118896|7537227|FG004|Overall Study|Miscellaneous|0
4653674|NCT02118896|7537228|FG005|Overall Study|Miscellaneous|4
4653675|NCT02118896|7537229|FG006|Overall Study|Miscellaneous|0
4653676|NCT02118896|7537230|FG007|Overall Study|Miscellaneous|0
4653677|NCT02118896|7537231|FG008|Overall Study|Miscellaneous|0
4653678|NCT02118896|7537232|FG009|Overall Study|Miscellaneous|0
4653679|NCT02118961|7537257|FG000|Overall Study|Withdrawal by Subject|1
4653680|NCT02118961|7537258|FG001|Overall Study|Withdrawal by Subject|0
4653681|NCT02119026|7537266|FG000|1st-line Treatment|Adverse Event|9
4653682|NCT02119026|7537267|FG001|1st-line Treatment|Adverse Event|14
4653683|NCT02119026|7537266|FG000|1st-line Treatment|Physician Decision|3
4653684|NCT02119026|7537267|FG001|1st-line Treatment|Physician Decision|8
4653685|NCT02119026|7537266|FG000|1st-line Treatment|Withdrawal by Subject|4
4653686|NCT02119026|7537267|FG001|1st-line Treatment|Withdrawal by Subject|10
4653687|NCT02119026|7537266|FG000|1st-line Treatment|Patient condition or compliance|6
4653688|NCT02119026|7537267|FG001|1st-line Treatment|Patient condition or compliance|4
4653689|NCT02119026|7537266|FG000|1st-line Treatment|Surgery of metastases|2
4653690|NCT02119026|7537267|FG001|1st-line Treatment|Surgery of metastases|1
4653691|NCT02119026|7537266|FG000|1st-line Treatment|Death|2
4653692|NCT02119026|7537267|FG001|1st-line Treatment|Death|1
4653693|NCT02119026|7537266|FG000|2nd-line Treatment|Lost to Follow-up|2
4653694|NCT02119026|7537267|FG001|2nd-line Treatment|Lost to Follow-up|0
4653695|NCT02119026|7537266|FG000|2nd-line Treatment|Withdrawal by Subject|3
4653696|NCT02119026|7537267|FG001|2nd-line Treatment|Withdrawal by Subject|1
4653697|NCT02119026|7537266|FG000|2nd-line Treatment|Adverse Event|4
4653698|NCT02119026|7537267|FG001|2nd-line Treatment|Adverse Event|1
4653699|NCT02119104|7537273|FG000|Overall Study|Protocol Violation|16
4653700|NCT02119156|7537280|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0
4653701|NCT02119156|7537281|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0
4653702|NCT02119156|7537282|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1
4653703|NCT02119156|7537280|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4
4653704|NCT02119156|7537281|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0
4653705|NCT02119156|7537282|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0
4653706|NCT02119156|7537280|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1
4653707|NCT02119156|7537281|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2
4653708|NCT02119156|7537282|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0
4653709|NCT02119156|7537280|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1
4653710|NCT02119156|7537281|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0
4653711|NCT02119156|7537282|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0
4653712|NCT02119156|7537280|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0
4653713|NCT02119156|7537281|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10
4653714|NCT02119156|7537282|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7
4653715|NCT02119260|7537304|FG000|Overall Study|Adverse Event|1
4653716|NCT02119260|7537305|FG001|Overall Study|Adverse Event|0
4653717|NCT02119260|7537306|FG002|Overall Study|Adverse Event|0
4653718|NCT02119260|7537307|FG003|Overall Study|Adverse Event|0
4653719|NCT02119260|7537308|FG004|Overall Study|Adverse Event|0
4653720|NCT02119260|7537309|FG005|Overall Study|Adverse Event|0
4653721|NCT02119260|7537310|FG006|Overall Study|Adverse Event|0
4653722|NCT02119260|7537304|FG000|Overall Study|Withdrew consent|0
4653723|NCT02119260|7537305|FG001|Overall Study|Withdrew consent|1
4653724|NCT02119260|7537306|FG002|Overall Study|Withdrew consent|1
4653725|NCT02119260|7537307|FG003|Overall Study|Withdrew consent|0
4653726|NCT02119260|7537308|FG004|Overall Study|Withdrew consent|0
4653727|NCT02119260|7537309|FG005|Overall Study|Withdrew consent|0
4653728|NCT02119260|7537310|FG006|Overall Study|Withdrew consent|0
4653729|NCT02119286|7537338|FG000|Overall Study|Adverse Event|9
4653730|NCT02119286|7537339|FG001|Overall Study|Adverse Event|7
4653731|NCT02119286|7537340|FG002|Overall Study|Adverse Event|2
4653732|NCT02119286|7537338|FG000|Overall Study|Lack of Efficacy|11
4653733|NCT02119286|7537339|FG001|Overall Study|Lack of Efficacy|3
4653734|NCT02119286|7537340|FG002|Overall Study|Lack of Efficacy|4
4653735|NCT02119286|7537338|FG000|Overall Study|Lost to Follow-up|2
4653736|NCT02119286|7537339|FG001|Overall Study|Lost to Follow-up|0
4653737|NCT02119286|7537340|FG002|Overall Study|Lost to Follow-up|1
4653738|NCT02119286|7537338|FG000|Overall Study|Withdrawal by Subject|4
4653739|NCT02119286|7537339|FG001|Overall Study|Withdrawal by Subject|1
4653740|NCT02119286|7537340|FG002|Overall Study|Withdrawal by Subject|0
4653741|NCT02119299|7537348|FG000|Overall Study|Withdrawal by Subject|7
4653742|NCT02119299|7537348|FG000|Overall Study|Lack of Efficacy|1
4653743|NCT02119299|7537348|FG000|Overall Study|Pregnancy|1
4653744|NCT02119325|7537352|FG000|Washout Period 1|Adverse Event|0
4653745|NCT02119325|7537353|FG001|Washout Period 1|Adverse Event|1
4653746|NCT02119650|7537376|FG000|Overall Study|Adverse Event|3
4653747|NCT02119650|7537377|FG001|Overall Study|Adverse Event|4
4653748|NCT02119650|7537376|FG000|Overall Study|Subject decision|2
4653749|NCT02119650|7537377|FG001|Overall Study|Subject decision|3
4653750|NCT02119650|7537376|FG000|Overall Study|Disease progression|11
4653751|NCT02119650|7537377|FG001|Overall Study|Disease progression|14
4653752|NCT02119650|7537376|FG000|Overall Study|Death|5
4653753|NCT02119650|7537377|FG001|Overall Study|Death|1
4653754|NCT02119650|7537376|FG000|Overall Study|Noncompliance with study treatment|1
4653755|NCT02119650|7537377|FG001|Overall Study|Noncompliance with study treatment|1
4653756|NCT02119650|7537376|FG000|Overall Study|Study terminated by the sponsor|1
4653757|NCT02119650|7537377|FG001|Overall Study|Study terminated by the sponsor|0
4653758|NCT02119650|7537376|FG000|Overall Study|Physician Decision|0
4653759|NCT02119650|7537377|FG001|Overall Study|Physician Decision|2
4653760|NCT02119650|7537376|FG000|Overall Study|Multiple reasons for termination|2
4653761|NCT02119650|7537377|FG001|Overall Study|Multiple reasons for termination|1
4653762|NCT02119663|7537385|FG000|Overall Study|Disease progression|26
4653763|NCT02119663|7537386|FG001|Overall Study|Disease progression|27
4653764|NCT02119663|7537385|FG000|Overall Study|Adverse Event|5
4653765|NCT02119663|7537386|FG001|Overall Study|Adverse Event|5
4653766|NCT02119663|7537385|FG000|Overall Study|Death|3
4653767|NCT02119663|7537386|FG001|Overall Study|Death|2
4653768|NCT02119663|7537385|FG000|Overall Study|Physician Decision|1
4653769|NCT02119663|7537386|FG001|Overall Study|Physician Decision|2
4653770|NCT02119663|7537385|FG000|Overall Study|Other unspecified|2
4653771|NCT02119663|7537386|FG001|Overall Study|Other unspecified|0
4653772|NCT02119663|7537385|FG000|Overall Study|Subject decision|0
4653773|NCT02119663|7537386|FG001|Overall Study|Subject decision|1
4653774|NCT02119663|7537385|FG000|Overall Study|Study Terminated by the Sponsor|3
4653775|NCT02119663|7537386|FG001|Overall Study|Study Terminated by the Sponsor|4
4653776|NCT02119676|7537396|FG000|Overall Study|Adverse Event|9
4653777|NCT02119676|7537397|FG001|Overall Study|Adverse Event|17
4653778|NCT02119676|7537398|FG002|Overall Study|Adverse Event|10
4653779|NCT02119676|7537399|FG003|Overall Study|Adverse Event|10
4653780|NCT02119676|7537396|FG000|Overall Study|Disease progression|53
4653781|NCT02119676|7537397|FG001|Overall Study|Disease progression|55
4653782|NCT02119676|7537398|FG002|Overall Study|Disease progression|68
4653783|NCT02119676|7537399|FG003|Overall Study|Disease progression|73
4653784|NCT02119676|7537396|FG000|Overall Study|Patient decision, inc. consent withdrawn|4
4653785|NCT02119676|7537397|FG001|Overall Study|Patient decision, inc. consent withdrawn|5
4653786|NCT02119676|7537398|FG002|Overall Study|Patient decision, inc. consent withdrawn|5
4653787|NCT02119676|7537399|FG003|Overall Study|Patient decision, inc. consent withdrawn|6
4653788|NCT02119676|7537396|FG000|Overall Study|Physician Decision|4
4653789|NCT02119676|7537397|FG001|Overall Study|Physician Decision|2
4653790|NCT02119676|7537398|FG002|Overall Study|Physician Decision|3
4653791|NCT02119676|7537399|FG003|Overall Study|Physician Decision|2
4653792|NCT02119676|7537396|FG000|Overall Study|Death|9
4653793|NCT02119676|7537397|FG001|Overall Study|Death|3
4653794|NCT02119676|7537398|FG002|Overall Study|Death|2
4653795|NCT02119676|7537399|FG003|Overall Study|Death|1
4653796|NCT02119676|7537396|FG000|Overall Study|Noncompliance|0
4653797|NCT02119676|7537397|FG001|Overall Study|Noncompliance|1
4653798|NCT02119676|7537398|FG002|Overall Study|Noncompliance|0
4653799|NCT02119676|7537399|FG003|Overall Study|Noncompliance|0
4653800|NCT02119676|7537396|FG000|Overall Study|Lost to Follow-up|0
4653801|NCT02119676|7537397|FG001|Overall Study|Lost to Follow-up|0
4653802|NCT02119676|7537398|FG002|Overall Study|Lost to Follow-up|1
4653803|NCT02119676|7537399|FG003|Overall Study|Lost to Follow-up|0
4653804|NCT02119676|7537396|FG000|Overall Study|Protocol deviation|0
4653805|NCT02119676|7537397|FG001|Overall Study|Protocol deviation|0
4653806|NCT02119676|7537398|FG002|Overall Study|Protocol deviation|1
4653807|NCT02119676|7537399|FG003|Overall Study|Protocol deviation|0
4653808|NCT02119676|7537396|FG000|Overall Study|Other, unspecified|2
4653809|NCT02119676|7537397|FG001|Overall Study|Other, unspecified|1
4653810|NCT02119676|7537398|FG002|Overall Study|Other, unspecified|3
4653811|NCT02119676|7537399|FG003|Overall Study|Other, unspecified|4
4653812|NCT02119676|7537396|FG000|Overall Study|Did not receive study med|2
4653813|NCT02119676|7537397|FG001|Overall Study|Did not receive study med|2
4653814|NCT02119676|7537398|FG002|Overall Study|Did not receive study med|4
4653815|NCT02119676|7537399|FG003|Overall Study|Did not receive study med|5
4653816|NCT02119819|7537415|FG000|Overall Study|Adverse Event|3
4653817|NCT02119819|7537416|FG001|Overall Study|Adverse Event|1
4653818|NCT02119819|7537417|FG002|Overall Study|Adverse Event|2
4653819|NCT02119819|7537418|FG003|Overall Study|Adverse Event|3
4653820|NCT02119819|7537419|FG004|Overall Study|Adverse Event|0
4653821|NCT02119819|7537420|FG005|Overall Study|Adverse Event|1
4653822|NCT02119819|7537415|FG000|Overall Study|Lack of Efficacy|0
4653823|NCT02119819|7537416|FG001|Overall Study|Lack of Efficacy|0
4653824|NCT02119819|7537417|FG002|Overall Study|Lack of Efficacy|0
4653825|NCT02119819|7537418|FG003|Overall Study|Lack of Efficacy|0
4653826|NCT02119819|7537419|FG004|Overall Study|Lack of Efficacy|0
4653827|NCT02119819|7537420|FG005|Overall Study|Lack of Efficacy|1
4653828|NCT02119819|7537415|FG000|Overall Study|Lost to Follow-up|0
4653829|NCT02119819|7537416|FG001|Overall Study|Lost to Follow-up|0
4653830|NCT02119819|7537417|FG002|Overall Study|Lost to Follow-up|1
4653831|NCT02119819|7537418|FG003|Overall Study|Lost to Follow-up|2
4653832|NCT02119819|7537419|FG004|Overall Study|Lost to Follow-up|1
4653833|NCT02119819|7537420|FG005|Overall Study|Lost to Follow-up|2
4653834|NCT02119819|7537415|FG000|Overall Study|Physician Decision|1
4653835|NCT02119819|7537416|FG001|Overall Study|Physician Decision|1
4653836|NCT02119819|7537417|FG002|Overall Study|Physician Decision|0
4653837|NCT02119819|7537418|FG003|Overall Study|Physician Decision|0
4653838|NCT02119819|7537419|FG004|Overall Study|Physician Decision|0
4653839|NCT02119819|7537420|FG005|Overall Study|Physician Decision|1
4653840|NCT02119819|7537415|FG000|Overall Study|Withdrawal by Subject|5
4653841|NCT02119819|7537416|FG001|Overall Study|Withdrawal by Subject|3
4653842|NCT02119819|7537417|FG002|Overall Study|Withdrawal by Subject|0
4653843|NCT02119819|7537418|FG003|Overall Study|Withdrawal by Subject|0
4653844|NCT02119819|7537419|FG004|Overall Study|Withdrawal by Subject|6
4653845|NCT02119819|7537420|FG005|Overall Study|Withdrawal by Subject|10
4653846|NCT02119819|7537415|FG000|Overall Study|Jury Duty|0
4653847|NCT02119819|7537416|FG001|Overall Study|Jury Duty|0
4653848|NCT02119819|7537417|FG002|Overall Study|Jury Duty|1
4653849|NCT02119819|7537418|FG003|Overall Study|Jury Duty|0
4653850|NCT02119819|7537419|FG004|Overall Study|Jury Duty|0
4653851|NCT02119819|7537420|FG005|Overall Study|Jury Duty|0
4653852|NCT02119819|7537415|FG000|Overall Study|Protocol Violation|0
4653853|NCT02119819|7537416|FG001|Overall Study|Protocol Violation|0
4653854|NCT02119819|7537417|FG002|Overall Study|Protocol Violation|0
4653855|NCT02119819|7537418|FG003|Overall Study|Protocol Violation|1
4653856|NCT02119819|7537419|FG004|Overall Study|Protocol Violation|0
4653857|NCT02119819|7537420|FG005|Overall Study|Protocol Violation|0
4653858|NCT02119819|7537415|FG000|Overall Study|Left the city to get a job|0
4653859|NCT02119819|7537416|FG001|Overall Study|Left the city to get a job|0
4653860|NCT02119819|7537417|FG002|Overall Study|Left the city to get a job|0
4653861|NCT02119819|7537418|FG003|Overall Study|Left the city to get a job|1
4653862|NCT02119819|7537419|FG004|Overall Study|Left the city to get a job|0
4653863|NCT02119819|7537420|FG005|Overall Study|Left the city to get a job|0
4653864|NCT02119936|7537443|FG000|Overall Study|Lost to Follow-up|10
4653865|NCT02120027|7537458|FG000|Overall Study|Adverse Event|4
4653866|NCT02120027|7537459|FG001|Overall Study|Adverse Event|5
4653867|NCT02120027|7537458|FG000|Overall Study|Lack of Efficacy|3
4653868|NCT02120027|7537459|FG001|Overall Study|Lack of Efficacy|5
4653869|NCT02120027|7537458|FG000|Overall Study|Lost to Follow-up|5
4653870|NCT02120027|7537459|FG001|Overall Study|Lost to Follow-up|13
4653871|NCT02120027|7537458|FG000|Overall Study|Other|4
4653872|NCT02120027|7537459|FG001|Overall Study|Other|0
4653873|NCT02120027|7537458|FG000|Overall Study|Physician Decision|4
4653874|NCT02120027|7537459|FG001|Overall Study|Physician Decision|3
4653875|NCT02120027|7537458|FG000|Overall Study|Protocol Violation|18
4653876|NCT02120027|7537459|FG001|Overall Study|Protocol Violation|21
4653877|NCT02120027|7537458|FG000|Overall Study|Study terminated by Sponsor|45
4653878|NCT02120027|7537459|FG001|Overall Study|Study terminated by Sponsor|47
4653879|NCT02120027|7537458|FG000|Overall Study|Withdrawal by Subject|33
4653880|NCT02120027|7537459|FG001|Overall Study|Withdrawal by Subject|25
4653881|NCT02120157|7537465|FG000|Overall Study|Death|8
4653882|NCT02120300|7537488|FG000|Overall Study|Enrolled but Never Treated|2
4653883|NCT02120300|7537489|FG001|Overall Study|Enrolled but Never Treated|0
4653884|NCT02120300|7537490|FG002|Overall Study|Enrolled but Never Treated|0
4653885|NCT02120300|7537491|FG003|Overall Study|Enrolled but Never Treated|0
4653886|NCT02120300|7537488|FG000|Overall Study|Lack of Efficacy|0
4653887|NCT02120300|7537489|FG001|Overall Study|Lack of Efficacy|0
4653888|NCT02120300|7537490|FG002|Overall Study|Lack of Efficacy|0
4653889|NCT02120300|7537491|FG003|Overall Study|Lack of Efficacy|1
4653890|NCT02120300|7537488|FG000|Overall Study|Lost to Follow-up|1
4653891|NCT02120300|7537489|FG001|Overall Study|Lost to Follow-up|0
4653892|NCT02120300|7537490|FG002|Overall Study|Lost to Follow-up|0
4653893|NCT02120300|7537491|FG003|Overall Study|Lost to Follow-up|0
4653894|NCT02120352|7537503|FG000|Induction Period (20 Weeks)|Adverse Event|3
4653895|NCT02120352|7537504|FG001|Induction Period (20 Weeks)|Adverse Event|0
4653896|NCT02120352|7537505|FG002|Induction Period (20 Weeks)|Adverse Event|0
4653897|NCT02120352|7537506|FG003|Induction Period (20 Weeks)|Adverse Event|0
4653898|NCT02120352|7537503|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5
4653899|NCT02120352|7537504|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0
4653900|NCT02120352|7537505|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0
4653901|NCT02120352|7537506|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0
4653902|NCT02120352|7537503|FG000|Induction Period (20 Weeks)|Protocol Violation|2
4653903|NCT02120352|7537504|FG001|Induction Period (20 Weeks)|Protocol Violation|0
4653904|NCT02120352|7537505|FG002|Induction Period (20 Weeks)|Protocol Violation|0
4653905|NCT02120352|7537506|FG003|Induction Period (20 Weeks)|Protocol Violation|0
4653906|NCT02120352|7537503|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3
4653907|NCT02120352|7537504|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0
4653908|NCT02120352|7537505|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0
4653909|NCT02120352|7537506|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0
4653910|NCT02120352|7537503|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2
4653911|NCT02120352|7537504|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0
4653912|NCT02120352|7537505|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0
4653913|NCT02120352|7537506|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0
4653914|NCT02120352|7537503|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5
4653915|NCT02120352|7537504|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0
4653916|NCT02120352|7537505|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0
4653917|NCT02120352|7537506|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0
4653918|NCT02120352|7537503|FG000|Induction Period (20 Weeks)|Physician Decision|1
4653919|NCT02120352|7537504|FG001|Induction Period (20 Weeks)|Physician Decision|0
4653920|NCT02120352|7537505|FG002|Induction Period (20 Weeks)|Physician Decision|0
4653921|NCT02120352|7537506|FG003|Induction Period (20 Weeks)|Physician Decision|0
4653922|NCT02120352|7537503|FG000|Maintenance Period (32 Weeks)|Adverse Event|0
4653923|NCT02120352|7537504|FG001|Maintenance Period (32 Weeks)|Adverse Event|0
4653924|NCT02120352|7537505|FG002|Maintenance Period (32 Weeks)|Adverse Event|6
4653925|NCT02120352|7537506|FG003|Maintenance Period (32 Weeks)|Adverse Event|1
4653926|NCT02120352|7537503|FG000|Maintenance Period (32 Weeks)|Lack of Efficacy|0
4653927|NCT02120352|7537504|FG001|Maintenance Period (32 Weeks)|Lack of Efficacy|1
4653928|NCT02120352|7537505|FG002|Maintenance Period (32 Weeks)|Lack of Efficacy|0
4653929|NCT02120352|7537506|FG003|Maintenance Period (32 Weeks)|Lack of Efficacy|1
4653930|NCT02120352|7537503|FG000|Maintenance Period (32 Weeks)|Protocol Violation|0
4653931|NCT02120352|7537504|FG001|Maintenance Period (32 Weeks)|Protocol Violation|0
4653932|NCT02120352|7537505|FG002|Maintenance Period (32 Weeks)|Protocol Violation|2
4653933|NCT02120352|7537506|FG003|Maintenance Period (32 Weeks)|Protocol Violation|0
4653934|NCT02120352|7537503|FG000|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|0
4653935|NCT02120352|7537504|FG001|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|0
4653936|NCT02120352|7537505|FG002|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|1
4653937|NCT02120352|7537506|FG003|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|1
4653938|NCT02120352|7537503|FG000|Maintenance Period (32 Weeks)|Lost to Follow-up|0
4653939|NCT02120352|7537504|FG001|Maintenance Period (32 Weeks)|Lost to Follow-up|0
4653940|NCT02120352|7537505|FG002|Maintenance Period (32 Weeks)|Lost to Follow-up|0
4653941|NCT02120352|7537506|FG003|Maintenance Period (32 Weeks)|Lost to Follow-up|1
4653942|NCT02120352|7537503|FG000|Maintenance Period (32 Weeks)|Withdrawal by Subject|0
4653943|NCT02120352|7537504|FG001|Maintenance Period (32 Weeks)|Withdrawal by Subject|2
4653944|NCT02120352|7537505|FG002|Maintenance Period (32 Weeks)|Withdrawal by Subject|1
4653945|NCT02120352|7537506|FG003|Maintenance Period (32 Weeks)|Withdrawal by Subject|2
4653946|NCT02120352|7537503|FG000|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|0
4653947|NCT02120352|7537504|FG001|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|112
4653948|NCT02120352|7537505|FG002|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|105
4653949|NCT02120352|7537506|FG003|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|50
4653950|NCT02120417|7537522|FG000|Overall Study|Death|5
4653951|NCT02120417|7537523|FG001|Overall Study|Death|1
4653952|NCT02120417|7537522|FG000|Overall Study|Adverse Event|3
4653953|NCT02120417|7537523|FG001|Overall Study|Adverse Event|9
4653954|NCT02120417|7537522|FG000|Overall Study|Participant decision|4
4653955|NCT02120417|7537523|FG001|Overall Study|Participant decision|4
4653956|NCT02120417|7537522|FG000|Overall Study|Disease progression|41
4653957|NCT02120417|7537523|FG001|Overall Study|Disease progression|45
4653958|NCT02120417|7537522|FG000|Overall Study|Noncompliance with study treatment|0
4653959|NCT02120417|7537523|FG001|Overall Study|Noncompliance with study treatment|2
4653960|NCT02120417|7537522|FG000|Overall Study|Physician Decision|2
4653961|NCT02120417|7537523|FG001|Overall Study|Physician Decision|3
4653962|NCT02120417|7537522|FG000|Overall Study|Other unspecified|5
4653963|NCT02120417|7537523|FG001|Overall Study|Other unspecified|4
4653964|NCT02120456|7537542|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0
4653965|NCT02120456|7537543|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0
4653966|NCT02120456|7537544|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0
4653967|NCT02120456|7537545|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0
4653968|NCT02120456|7537546|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0
4653969|NCT02120456|7537547|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0
4653970|NCT02120456|7537548|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1
4653971|NCT02120456|7537549|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0
4653972|NCT02120456|7537550|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0
4653973|NCT02120456|7537542|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0
4653974|NCT02120456|7537543|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0
4653975|NCT02120456|7537544|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0
4653976|NCT02120456|7537545|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0
4653977|NCT02120456|7537546|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0
4653978|NCT02120456|7537547|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0
4653979|NCT02120456|7537548|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1
4653980|NCT02120456|7537549|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0
4653981|NCT02120456|7537550|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0
4653982|NCT02120456|7537542|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0
4653983|NCT02120456|7537543|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0
4653984|NCT02120456|7537544|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0
4653985|NCT02120456|7537545|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0
4653986|NCT02120456|7537546|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0
4653987|NCT02120456|7537547|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0
4653988|NCT02120456|7537548|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0
4653989|NCT02120456|7537549|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0
4653990|NCT02120456|7537550|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1
4653991|NCT02120625|7537570|FG000|Overall Study|Physician Decision|2
4653992|NCT02120664|7537579|FG000|Overall Study|Withdrawal by Subject|0
4653993|NCT02120664|7537580|FG001|Overall Study|Withdrawal by Subject|0
4653994|NCT02120664|7537581|FG002|Overall Study|Withdrawal by Subject|0
4653995|NCT02120664|7537582|FG003|Overall Study|Withdrawal by Subject|1
4653996|NCT02120664|7537583|FG004|Overall Study|Withdrawal by Subject|0
4653997|NCT02120781|7537607|FG000|Overall Study|Physician Decision|2
4653998|NCT02120781|7537608|FG001|Overall Study|Physician Decision|0
4653999|NCT02120781|7537607|FG000|Overall Study|Completion not documented|2
4654000|NCT02120781|7537608|FG001|Overall Study|Completion not documented|1
4654001|NCT02120794|7537614|FG000|Overall Study|Withdrawal by Subject|43
4654002|NCT02120794|7537614|FG000|Overall Study|Adverse Event|10
4654003|NCT02120794|7537614|FG000|Overall Study|Physician Decision|4
4654004|NCT02120794|7537614|FG000|Overall Study|Due to insurance coverage|1
4654005|NCT02120833|7537620|FG000|Overall Study|Adverse Event|1
4654006|NCT02120833|7537621|FG001|Overall Study|Adverse Event|0
4654007|NCT02120833|7537620|FG000|Overall Study|Withdrawal by Subject|2
4654008|NCT02120833|7537621|FG001|Overall Study|Withdrawal by Subject|0
4654009|NCT02120833|7537620|FG000|Overall Study|Lost to Follow-up|1
4654010|NCT02120833|7537621|FG001|Overall Study|Lost to Follow-up|1
4654011|NCT02120898|7537630|FG000|Overall Study|Withdrawal by Subject|4
4654012|NCT02120898|7537631|FG001|Overall Study|Withdrawal by Subject|2
4654013|NCT02120898|7537632|FG002|Overall Study|Withdrawal by Subject|2
4654014|NCT02120898|7537630|FG000|Overall Study|Non-compliance with study drug|3
4654015|NCT02120898|7537631|FG001|Overall Study|Non-compliance with study drug|0
4654016|NCT02120898|7537632|FG002|Overall Study|Non-compliance with study drug|0
4654017|NCT02120898|7537630|FG000|Overall Study|Adverse Event|1
4654018|NCT02120898|7537631|FG001|Overall Study|Adverse Event|2
4654019|NCT02120898|7537632|FG002|Overall Study|Adverse Event|1
4654020|NCT02120898|7537630|FG000|Overall Study|Protocol Violation|1
4654021|NCT02120898|7537631|FG001|Overall Study|Protocol Violation|2
4654022|NCT02120898|7537632|FG002|Overall Study|Protocol Violation|0
4654023|NCT02120898|7537630|FG000|Overall Study|Lost to Follow-up|0
4654024|NCT02120898|7537631|FG001|Overall Study|Lost to Follow-up|0
4654025|NCT02120898|7537632|FG002|Overall Study|Lost to Follow-up|1
4654026|NCT02120924|7537643|FG000|Overall Study|Lack of Efficacy|1
4654027|NCT02120924|7537644|FG001|Overall Study|Lack of Efficacy|2
4654028|NCT02120924|7537645|FG002|Overall Study|Lack of Efficacy|3
4654029|NCT02120924|7537643|FG000|Overall Study|Adverse Event|0
4654030|NCT02120924|7537644|FG001|Overall Study|Adverse Event|1
4654031|NCT02120924|7537645|FG002|Overall Study|Adverse Event|3
4654032|NCT02120924|7537643|FG000|Overall Study|Withdrawal by Subject|16
4654033|NCT02120924|7537644|FG001|Overall Study|Withdrawal by Subject|20
4654034|NCT02120924|7537645|FG002|Overall Study|Withdrawal by Subject|8
4654035|NCT02120924|7537643|FG000|Overall Study|Lost to Follow-up|14
4654036|NCT02120924|7537644|FG001|Overall Study|Lost to Follow-up|14
4654037|NCT02120924|7537645|FG002|Overall Study|Lost to Follow-up|11
4654038|NCT02120924|7537643|FG000|Overall Study|Pregnancy|2
4748214|NCT01972217|7722164|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9
4748215|NCT01972217|7722165|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0
4748216|NCT01972217|7722166|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0
4748217|NCT01972217|7722163|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0
4748218|NCT01972217|7722164|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1
4748219|NCT01972217|7722165|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0
4748220|NCT01972217|7722166|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0
4748221|NCT01972217|7722163|FG000|Part A: Open-label Safety Run-in Period|Death|0
4748222|NCT01972217|7722164|FG001|Part A: Open-label Safety Run-in Period|Death|1
4748223|NCT01972217|7722165|FG002|Part A: Open-label Safety Run-in Period|Death|0
4748224|NCT01972217|7722166|FG003|Part A: Open-label Safety Run-in Period|Death|0
4748225|NCT01972217|7722163|FG000|Part B Double-blind, Randomised Period|Death|0
4748226|NCT01972217|7722164|FG001|Part B Double-blind, Randomised Period|Death|0
4748227|NCT01972217|7722165|FG002|Part B Double-blind, Randomised Period|Death|43
4748228|NCT01972217|7722166|FG003|Part B Double-blind, Randomised Period|Death|44
4748229|NCT01972217|7722163|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0
4748230|NCT01972217|7722164|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0
4748231|NCT01972217|7722165|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1
4748232|NCT01972217|7722166|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0
4748233|NCT01972217|7722163|FG000|Part B Double-blind, Randomised Period|Screen failure|0
4748234|NCT01972217|7722164|FG001|Part B Double-blind, Randomised Period|Screen failure|0
4748235|NCT01972217|7722165|FG002|Part B Double-blind, Randomised Period|Screen failure|0
4748236|NCT01972217|7722166|FG003|Part B Double-blind, Randomised Period|Screen failure|1
4748237|NCT01972217|7722163|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0
4748238|NCT01972217|7722164|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0
4748239|NCT01972217|7722165|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2
4748240|NCT01972217|7722166|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1
4748241|NCT01972217|7722163|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0
4748242|NCT01972217|7722164|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0
4748243|NCT01972217|7722165|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0
4748244|NCT01972217|7722166|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1
4748245|NCT01849874|7722180|FG000|Overall Study|Death|34
4654039|NCT02120924|7537644|FG001|Overall Study|Pregnancy|0
4654040|NCT02120924|7537645|FG002|Overall Study|Pregnancy|0
4654041|NCT02120924|7537643|FG000|Overall Study|Protocol Violation|3
4654042|NCT02120924|7537644|FG001|Overall Study|Protocol Violation|7
4654043|NCT02120924|7537645|FG002|Overall Study|Protocol Violation|2
4654044|NCT02120924|7537643|FG000|Overall Study|Physician Decision|0
4654045|NCT02120924|7537644|FG001|Overall Study|Physician Decision|1
4654046|NCT02120924|7537645|FG002|Overall Study|Physician Decision|1
4748246|NCT01849874|7722181|FG001|Overall Study|Death|16
4654047|NCT02120924|7537643|FG000|Overall Study|Death|1
4654048|NCT02120924|7537644|FG001|Overall Study|Death|0
4654049|NCT02120924|7537645|FG002|Overall Study|Death|0
4654050|NCT02120924|7537643|FG000|Overall Study|Compliance with IP|5
4654051|NCT02120924|7537644|FG001|Overall Study|Compliance with IP|1
4654052|NCT02120924|7537645|FG002|Overall Study|Compliance with IP|1
4654053|NCT02120950|7537656|FG000|Overall Study|Adverse Event|5
4654054|NCT02120950|7537657|FG001|Overall Study|Adverse Event|4
4654055|NCT02120950|7537658|FG002|Overall Study|Adverse Event|3
4654056|NCT02120950|7537656|FG000|Overall Study|Death|3
4654057|NCT02120950|7537657|FG001|Overall Study|Death|0
4654058|NCT02120950|7537658|FG002|Overall Study|Death|1
4654059|NCT02120950|7537656|FG000|Overall Study|Withdrawal by Subject|6
4654060|NCT02120950|7537657|FG001|Overall Study|Withdrawal by Subject|3
4654061|NCT02120950|7537658|FG002|Overall Study|Withdrawal by Subject|2
4654062|NCT02120950|7537656|FG000|Overall Study|Protocol Violation|1
4654063|NCT02120950|7537657|FG001|Overall Study|Protocol Violation|1
4654064|NCT02120950|7537658|FG002|Overall Study|Protocol Violation|7
4654065|NCT02120950|7537656|FG000|Overall Study|Other reasons|5
4654066|NCT02120950|7537657|FG001|Overall Study|Other reasons|4
4654067|NCT02120950|7537658|FG002|Overall Study|Other reasons|1
4654068|NCT02120950|7537656|FG000|Overall Study|Lost to Follow-up|0
4654069|NCT02120950|7537657|FG001|Overall Study|Lost to Follow-up|2
4654070|NCT02120950|7537658|FG002|Overall Study|Lost to Follow-up|1
4654071|NCT02121002|7537668|FG000|Overall Study|Physician Decision|2
4654072|NCT02121002|7537669|FG001|Overall Study|Physician Decision|0
4654073|NCT02121002|7537670|FG002|Overall Study|Physician Decision|0
4654074|NCT02121002|7537668|FG000|Overall Study|Withdrawal by Subject|3
4654075|NCT02121002|7537669|FG001|Overall Study|Withdrawal by Subject|1
4654076|NCT02121002|7537670|FG002|Overall Study|Withdrawal by Subject|4
4654077|NCT02121002|7537668|FG000|Overall Study|Protocol Violation|1
4654078|NCT02121002|7537669|FG001|Overall Study|Protocol Violation|2
4654079|NCT02121002|7537670|FG002|Overall Study|Protocol Violation|4
4654080|NCT02121002|7537668|FG000|Overall Study|Concomitant therapy|0
4654081|NCT02121002|7537669|FG001|Overall Study|Concomitant therapy|1
4748247|NCT01849874|7722180|FG000|Overall Study|Withdrawal by Subject|4
4748248|NCT01849874|7722181|FG001|Overall Study|Withdrawal by Subject|8
4748249|NCT01849874|7722180|FG000|Overall Study|Lost to Follow-up|0
4748250|NCT01849874|7722181|FG001|Overall Study|Lost to Follow-up|1
4748251|NCT01849874|7722180|FG000|Overall Study|Randomized but Never Treated|1
4748252|NCT01849874|7722181|FG001|Overall Study|Randomized but Never Treated|8
4748253|NCT01849874|7722180|FG000|Overall Study|Ongoing|162
4748254|NCT01849874|7722181|FG001|Overall Study|Ongoing|69
4748255|NCT01724866|7722191|FG000|Overall Study|Adverse Event|0
4748256|NCT01724866|7722192|FG001|Overall Study|Adverse Event|0
4748257|NCT01724866|7722193|FG002|Overall Study|Adverse Event|1
4748258|NCT01724866|7722194|FG003|Overall Study|Adverse Event|1
4748259|NCT01724866|7722191|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0
4748260|NCT01724866|7722192|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2
4748261|NCT01724866|7722193|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0
4748262|NCT01724866|7722194|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0
4748263|NCT01724866|7722191|FG000|Overall Study|Investigator's Discretion|0
4748264|NCT01724866|7722192|FG001|Overall Study|Investigator's Discretion|1
4748265|NCT01724866|7722193|FG002|Overall Study|Investigator's Discretion|1
4748266|NCT01724866|7722194|FG003|Overall Study|Investigator's Discretion|0
4748267|NCT01724866|7722191|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1
4748268|NCT01724866|7722192|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0
4748269|NCT01724866|7722193|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0
4748270|NCT01724866|7722194|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0
4748271|NCT01724866|7722191|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0
4748272|NCT01724866|7722192|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2
4748273|NCT01724866|7722193|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1
4748274|NCT01724866|7722194|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0
4748275|NCT01670877|7722208|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0
4748276|NCT01670877|7722209|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1
4748277|NCT01670877|7722210|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0
4654082|NCT02121002|7537670|FG002|Overall Study|Concomitant therapy|1
4654083|NCT02121002|7537668|FG000|Overall Study|Others|1
4654084|NCT02121002|7537669|FG001|Overall Study|Others|0
4654085|NCT02121002|7537670|FG002|Overall Study|Others|1
4654086|NCT02121210|7537694|FG000|Overall Study|Adverse Event|5
4654087|NCT02121210|7537695|FG001|Overall Study|Adverse Event|7
4654088|NCT02121210|7537694|FG000|Overall Study|Lack of Efficacy|2
4654089|NCT02121210|7537695|FG001|Overall Study|Lack of Efficacy|0
4654090|NCT02121210|7537694|FG000|Overall Study|Other than specified above|0
4654091|NCT02121210|7537695|FG001|Overall Study|Other than specified above|2
4654092|NCT02121262|7537703|FG000|Overall Study|Adverse Event|6
4654093|NCT02121262|7537704|FG001|Overall Study|Adverse Event|3
4654094|NCT02121262|7537703|FG000|Overall Study|Lack of Efficacy|3
4654095|NCT02121262|7537704|FG001|Overall Study|Lack of Efficacy|0
4654096|NCT02121262|7537703|FG000|Overall Study|Personal Reasons|19
4654097|NCT02121262|7537704|FG001|Overall Study|Personal Reasons|5
4654098|NCT02121262|7537703|FG000|Overall Study|Protocol Violation|1
4654099|NCT02121262|7537704|FG001|Overall Study|Protocol Violation|1
4654100|NCT02121262|7537703|FG000|Overall Study|Participant Dropped-out|0
4654101|NCT02121262|7537704|FG001|Overall Study|Participant Dropped-out|1
4654102|NCT02121262|7537703|FG000|Overall Study|Participant was Deemed Unsuitable|1
4654103|NCT02121262|7537704|FG001|Overall Study|Participant was Deemed Unsuitable|0
4654104|NCT02121262|7537703|FG000|Overall Study|Consent Withdrawn|1
4654105|NCT02121262|7537704|FG001|Overall Study|Consent Withdrawn|0
4654106|NCT02121301|7537713|FG000|Overall Study|Protocol Violation|1
4654107|NCT02121301|7537714|FG001|Overall Study|Protocol Violation|4
4654108|NCT02121301|7537715|FG002|Overall Study|Protocol Violation|1
4654109|NCT02121392|7537725|FG000|Prior to Intervention|Protocol Violation|40
4654110|NCT02121392|7537726|FG001|Prior to Intervention|Protocol Violation|35
4654111|NCT02121392|7537725|FG000|Prior to Intervention|Withdrawal by Subject|8
4654112|NCT02121392|7537726|FG001|Prior to Intervention|Withdrawal by Subject|6
4654113|NCT02121392|7537725|FG000|After Placement of AC Block vs Sham|Protocol Violation|3
4654114|NCT02121392|7537726|FG001|After Placement of AC Block vs Sham|Protocol Violation|2
4654115|NCT02121392|7537725|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0
4654116|NCT02121392|7537726|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1
4654117|NCT02121509|7537751|FG000|Washout Period (35 Days)|Adverse Event|1
4654118|NCT02121509|7537752|FG001|Washout Period (35 Days)|Adverse Event|1
4654119|NCT02121509|7537753|FG002|Washout Period (35 Days)|Adverse Event|0
4654120|NCT02121509|7537754|FG003|Washout Period (35 Days)|Adverse Event|0
4654121|NCT02121509|7537751|FG000|Washout Period (35 Days)|Withdrawal by Subject|0
4654122|NCT02121509|7537752|FG001|Washout Period (35 Days)|Withdrawal by Subject|3
4654123|NCT02121509|7537753|FG002|Washout Period (35 Days)|Withdrawal by Subject|0
4654124|NCT02121509|7537754|FG003|Washout Period (35 Days)|Withdrawal by Subject|0
4654125|NCT02121509|7537751|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1
4654126|NCT02121509|7537752|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0
4654127|NCT02121509|7537753|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0
4654128|NCT02121509|7537754|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0
4654129|NCT02121522|7537764|FG000|Overall Study|Adverse Event|1
4654130|NCT02121535|7537770|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0
4654131|NCT02121535|7537771|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1
4654132|NCT02121535|7537770|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1
4654133|NCT02121535|7537771|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0
4654134|NCT02121756|7537780|FG000|Overall Study|Adverse Event|3
4654135|NCT02121756|7537781|FG001|Overall Study|Adverse Event|0
4654136|NCT02121756|7537780|FG000|Overall Study|Protocol Violation|1
4654137|NCT02121756|7537781|FG001|Overall Study|Protocol Violation|1
4654138|NCT02121756|7537780|FG000|Overall Study|Physician Decision|2
4654139|NCT02121756|7537781|FG001|Overall Study|Physician Decision|1
4654140|NCT02121795|7537792|FG000|Double-Blind Phase|Randomized but Never Treated|1
4654141|NCT02121795|7537793|FG001|Double-Blind Phase|Randomized but Never Treated|4
4654142|NCT02121795|7537792|FG000|Double-Blind Phase|Withdrawal by Subject|19
4654143|NCT02121795|7537793|FG001|Double-Blind Phase|Withdrawal by Subject|16
4654144|NCT02121795|7537792|FG000|Double-Blind Phase|Lost to Follow-up|7
4654145|NCT02121795|7537793|FG001|Double-Blind Phase|Lost to Follow-up|4
4654146|NCT02121795|7537792|FG000|Double-Blind Phase|Physician Decision|2
4654147|NCT02121795|7537793|FG001|Double-Blind Phase|Physician Decision|5
4654148|NCT02121795|7537792|FG000|Double-Blind Phase|Adverse Event|5
4654149|NCT02121795|7537793|FG001|Double-Blind Phase|Adverse Event|0
4654150|NCT02121795|7537792|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3
4654151|NCT02121795|7537793|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1
4654152|NCT02121795|7537792|FG000|Double-Blind Phase|Protocol Violation|0
4654153|NCT02121795|7537793|FG001|Double-Blind Phase|Protocol Violation|3
4654154|NCT02121795|7537792|FG000|Double-Blind Phase|Death|1
4654155|NCT02121795|7537793|FG001|Double-Blind Phase|Death|1
4654156|NCT02121795|7537792|FG000|Open-Label Phase|Physician Decision|8
4654157|NCT02121795|7537793|FG001|Open-Label Phase|Physician Decision|8
4654158|NCT02121795|7537792|FG000|Open-Label Phase|Withdrawal by Subject|3
4654159|NCT02121795|7537793|FG001|Open-Label Phase|Withdrawal by Subject|2
4654160|NCT02121795|7537792|FG000|Open-Label Phase|Lost to Follow-up|1
4654161|NCT02121795|7537793|FG001|Open-Label Phase|Lost to Follow-up|0
4748278|NCT01670877|7722211|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0
4748279|NCT01670877|7722212|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0
4748280|NCT01670877|7722213|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0
4748281|NCT01670877|7722208|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0
4748282|NCT01670877|7722209|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0
4748283|NCT01670877|7722210|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1
4748284|NCT01670877|7722211|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0
4748285|NCT01670877|7722212|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0
4748286|NCT01670877|7722213|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0
4748287|NCT01670877|7722208|FG000|Part I and Part 2|Grade 2 vomiting|0
4654162|NCT02121808|7537801|FG000|Overall Study|Technical problem|3
4654163|NCT02121834|7537817|FG000|Overall Study|Protocol Violation|0
4654164|NCT02121834|7537818|FG001|Overall Study|Protocol Violation|1
4654165|NCT02121834|7537819|FG002|Overall Study|Protocol Violation|0
4654166|NCT02121834|7537820|FG003|Overall Study|Protocol Violation|0
4654167|NCT02121834|7537821|FG004|Overall Study|Protocol Violation|0
4654168|NCT02121834|7537822|FG005|Overall Study|Protocol Violation|0
4654169|NCT02121834|7537823|FG006|Overall Study|Protocol Violation|0
4654170|NCT02121834|7537817|FG000|Overall Study|Withdrawal by Subject|0
4654171|NCT02121834|7537818|FG001|Overall Study|Withdrawal by Subject|1
4654172|NCT02121834|7537819|FG002|Overall Study|Withdrawal by Subject|1
4654173|NCT02121834|7537820|FG003|Overall Study|Withdrawal by Subject|0
4654174|NCT02121834|7537821|FG004|Overall Study|Withdrawal by Subject|0
4654175|NCT02121834|7537822|FG005|Overall Study|Withdrawal by Subject|0
4654176|NCT02121834|7537823|FG006|Overall Study|Withdrawal by Subject|0
4654177|NCT02121834|7537817|FG000|Overall Study|Lost to Follow-up|0
4654178|NCT02121834|7537818|FG001|Overall Study|Lost to Follow-up|0
4654179|NCT02121834|7537819|FG002|Overall Study|Lost to Follow-up|1
4654180|NCT02121834|7537820|FG003|Overall Study|Lost to Follow-up|0
4654181|NCT02121834|7537821|FG004|Overall Study|Lost to Follow-up|0
4654182|NCT02121834|7537822|FG005|Overall Study|Lost to Follow-up|0
4654183|NCT02121834|7537823|FG006|Overall Study|Lost to Follow-up|0
4654184|NCT02121847|7537849|FG000|Overall Study|Administrative Reasons|1
4654185|NCT02121847|7537849|FG000|Overall Study|Adverse Event|2
4654186|NCT02122146|7537884|FG000|Part 1: Dose Escalation|Death|0
4654187|NCT02122146|7537885|FG001|Part 1: Dose Escalation|Death|1
4654188|NCT02122146|7537886|FG002|Part 1: Dose Escalation|Death|1
4654189|NCT02122146|7537887|FG003|Part 1: Dose Escalation|Death|0
4654190|NCT02122146|7537888|FG004|Part 1: Dose Escalation|Death|0
4654191|NCT02122146|7537889|FG005|Part 1: Dose Escalation|Death|0
4654192|NCT02122146|7537890|FG006|Part 1: Dose Escalation|Death|0
4654193|NCT02122146|7537891|FG007|Part 1: Dose Escalation|Death|0
4654194|NCT02122146|7537884|FG000|Part 1: Dose Escalation|Lost to Follow-up|0
4654195|NCT02122146|7537885|FG001|Part 1: Dose Escalation|Lost to Follow-up|0
4654196|NCT02122146|7537886|FG002|Part 1: Dose Escalation|Lost to Follow-up|1
4654197|NCT02122146|7537887|FG003|Part 1: Dose Escalation|Lost to Follow-up|0
4654198|NCT02122146|7537888|FG004|Part 1: Dose Escalation|Lost to Follow-up|1
4654199|NCT02122146|7537889|FG005|Part 1: Dose Escalation|Lost to Follow-up|0
4654200|NCT02122146|7537890|FG006|Part 1: Dose Escalation|Lost to Follow-up|0
4654201|NCT02122146|7537891|FG007|Part 1: Dose Escalation|Lost to Follow-up|0
4654202|NCT02122146|7537884|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0
4654203|NCT02122146|7537885|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0
4654204|NCT02122146|7537886|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0
4654205|NCT02122146|7537887|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1
4654206|NCT02122146|7537888|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0
4654207|NCT02122146|7537889|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0
4654208|NCT02122146|7537890|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0
4654209|NCT02122146|7537891|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0
4654210|NCT02122146|7537884|FG000|Part 1: Dose Escalation|Other|1
4654211|NCT02122146|7537885|FG001|Part 1: Dose Escalation|Other|0
4654212|NCT02122146|7537886|FG002|Part 1: Dose Escalation|Other|0
4654213|NCT02122146|7537887|FG003|Part 1: Dose Escalation|Other|0
4654214|NCT02122146|7537888|FG004|Part 1: Dose Escalation|Other|0
4654215|NCT02122146|7537889|FG005|Part 1: Dose Escalation|Other|1
4654216|NCT02122146|7537890|FG006|Part 1: Dose Escalation|Other|1
4654217|NCT02122146|7537891|FG007|Part 1: Dose Escalation|Other|2
4654218|NCT02122380|7537921|FG000|First Intervention (30 Days)|Adverse Event|1
4654219|NCT02122380|7537922|FG001|First Intervention (30 Days)|Adverse Event|0
4654220|NCT02122380|7537921|FG000|First Intervention (30 Days)|Physician Decision|0
4654221|NCT02122380|7537922|FG001|First Intervention (30 Days)|Physician Decision|1
4654222|NCT02122380|7537921|FG000|Washout (8 Weeks)|Lost to Follow-up|1
4654223|NCT02122380|7537922|FG001|Washout (8 Weeks)|Lost to Follow-up|0
4654224|NCT02122380|7537921|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0
4654225|NCT02122380|7537922|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2
4654226|NCT02122380|7537921|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0
4654227|NCT02122380|7537922|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2
4654228|NCT02122770|7537959|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3
4654229|NCT02122770|7537960|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0
4654230|NCT02122770|7537961|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1
4654231|NCT02122770|7537962|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2
4654232|NCT02122770|7537963|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0
4654233|NCT02122770|7537964|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0
4654234|NCT02122770|7537959|FG000|Part A: Drug-drug Interaction 2|Other|0
4654235|NCT02122770|7537960|FG001|Part A: Drug-drug Interaction 2|Other|0
4654236|NCT02122770|7537961|FG002|Part A: Drug-drug Interaction 2|Other|1
4654237|NCT02122770|7537962|FG003|Part A: Drug-drug Interaction 2|Other|0
4654238|NCT02122770|7537963|FG004|Part A: Drug-drug Interaction 2|Other|0
4654239|NCT02122770|7537964|FG005|Part A: Drug-drug Interaction 2|Other|0
4654240|NCT02122770|7537959|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
4654241|NCT02122770|7537960|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1
4654242|NCT02122770|7537961|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
4654243|NCT02122770|7537962|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
4654244|NCT02122770|7537963|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
4654245|NCT02122770|7537964|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
4654246|NCT02122770|7537959|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1
4654247|NCT02122770|7537960|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5
4654248|NCT02122770|7537961|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0
4654249|NCT02122770|7537962|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1
4654250|NCT02122770|7537963|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0
4654251|NCT02122770|7537964|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0
4654252|NCT02122770|7537959|FG000|Part B: Standard of Care|Adverse Event|0
4654253|NCT02122770|7537960|FG001|Part B: Standard of Care|Adverse Event|0
4654254|NCT02122770|7537961|FG002|Part B: Standard of Care|Adverse Event|0
4654255|NCT02122770|7537962|FG003|Part B: Standard of Care|Adverse Event|0
4654256|NCT02122770|7537963|FG004|Part B: Standard of Care|Adverse Event|4
4654257|NCT02122770|7537964|FG005|Part B: Standard of Care|Adverse Event|1
4654258|NCT02122770|7537959|FG000|Part B: Standard of Care|Other|0
4654259|NCT02122770|7537960|FG001|Part B: Standard of Care|Other|0
4654260|NCT02122770|7537961|FG002|Part B: Standard of Care|Other|0
4654261|NCT02122770|7537962|FG003|Part B: Standard of Care|Other|0
4654262|NCT02122770|7537963|FG004|Part B: Standard of Care|Other|0
4654263|NCT02122770|7537964|FG005|Part B: Standard of Care|Other|2
4654264|NCT02122770|7537959|FG000|Part B: Standard of Care|Withdrawal by Subject|0
4654265|NCT02122770|7537960|FG001|Part B: Standard of Care|Withdrawal by Subject|0
4654266|NCT02122770|7537961|FG002|Part B: Standard of Care|Withdrawal by Subject|0
4654267|NCT02122770|7537962|FG003|Part B: Standard of Care|Withdrawal by Subject|0
4654268|NCT02122770|7537963|FG004|Part B: Standard of Care|Withdrawal by Subject|4
4654269|NCT02122770|7537964|FG005|Part B: Standard of Care|Withdrawal by Subject|2
4654270|NCT02122770|7537959|FG000|Part B: Standard of Care|Symptomatic Deterioration|0
4654271|NCT02122770|7537960|FG001|Part B: Standard of Care|Symptomatic Deterioration|0
4654272|NCT02122770|7537961|FG002|Part B: Standard of Care|Symptomatic Deterioration|0
4654273|NCT02122770|7537962|FG003|Part B: Standard of Care|Symptomatic Deterioration|0
4654274|NCT02122770|7537963|FG004|Part B: Standard of Care|Symptomatic Deterioration|5
4654275|NCT02122770|7537964|FG005|Part B: Standard of Care|Symptomatic Deterioration|0
4654276|NCT02122770|7537959|FG000|Part B: Standard of Care|Progressive Disease|0
4654277|NCT02122770|7537960|FG001|Part B: Standard of Care|Progressive Disease|0
4654278|NCT02122770|7537961|FG002|Part B: Standard of Care|Progressive Disease|0
4654279|NCT02122770|7537962|FG003|Part B: Standard of Care|Progressive Disease|0
4654280|NCT02122770|7537963|FG004|Part B: Standard of Care|Progressive Disease|10
4654281|NCT02122770|7537964|FG005|Part B: Standard of Care|Progressive Disease|8
4654282|NCT02122783|7537989|FG000|Overall Study|Adverse Event|0
4654283|NCT02122783|7537990|FG001|Overall Study|Adverse Event|1
4654284|NCT02122887|7538011|FG000|Overall Study|Withdrawal by Subject|20
4654285|NCT02122887|7538012|FG001|Overall Study|Withdrawal by Subject|2
4654286|NCT02123134|7538042|FG000|Overall Study|Withdrawal of consent|3
4654287|NCT02123134|7538043|FG001|Overall Study|Withdrawal of consent|2
4654288|NCT02123134|7538042|FG000|Overall Study|Administrative decision|0
4654289|NCT02123134|7538043|FG001|Overall Study|Administrative decision|1
4654290|NCT02123251|7538051|FG000|Overall Study|Death|1
4654291|NCT02123251|7538052|FG001|Overall Study|Death|1
4654292|NCT02123251|7538051|FG000|Overall Study|Withdrawal by Subject|0
4654293|NCT02123251|7538052|FG001|Overall Study|Withdrawal by Subject|3
4654294|NCT02123251|7538051|FG000|Overall Study|Lost Medicaid eligibility|29
4654295|NCT02123251|7538052|FG001|Overall Study|Lost Medicaid eligibility|22
4654296|NCT02123251|7538051|FG000|Overall Study|Switched Managed Care Organization (MCO)|4
4654297|NCT02123251|7538052|FG001|Overall Study|Switched Managed Care Organization (MCO)|4
4654298|NCT02123446|7538068|FG000|Washout Period (1 Day)|Physician Decision|1
4654299|NCT02123446|7538069|FG001|Washout Period (1 Day)|Physician Decision|0
4654300|NCT02123459|7538075|FG000|Washout Period (1 Day)|Adverse Event|1
4654301|NCT02123459|7538076|FG001|Washout Period (1 Day)|Adverse Event|0
4654302|NCT02123472|7538082|FG000|Period 2 (7 Days)|Withdrawal by Subject|0
4654303|NCT02123472|7538083|FG001|Period 2 (7 Days)|Withdrawal by Subject|1
4654304|NCT02123511|7538100|FG000|Overall Study|Cancelled treatment|1
4654305|NCT02123511|7538101|FG001|Overall Study|Cancelled treatment|0
4654306|NCT02123511|7538100|FG000|Overall Study|Incomplete data|1
4654307|NCT02123511|7538101|FG001|Overall Study|Incomplete data|3
4654308|NCT02123511|7538100|FG000|Overall Study|Ineligible|0
4654309|NCT02123511|7538101|FG001|Overall Study|Ineligible|1
4654310|NCT02123576|7538109|FG000|Overall Study|Adverse Event|1
4654311|NCT02123576|7538110|FG001|Overall Study|Adverse Event|0
4654312|NCT02123797|7538122|FG000|Baseline Intervention|Death|9
4654313|NCT02123797|7538123|FG001|Baseline Intervention|Death|16
4654314|NCT02123797|7538124|FG002|Baseline Intervention|Death|0
4654315|NCT02123797|7538125|FG003|Baseline Intervention|Death|0
4654316|NCT02123797|7538126|FG004|Baseline Intervention|Death|0
4654317|NCT02123797|7538122|FG000|Baseline Intervention|Withdrawal by Subject|2
4654318|NCT02123797|7538123|FG001|Baseline Intervention|Withdrawal by Subject|8
4654319|NCT02123797|7538124|FG002|Baseline Intervention|Withdrawal by Subject|0
4654320|NCT02123797|7538125|FG003|Baseline Intervention|Withdrawal by Subject|0
4654321|NCT02123797|7538126|FG004|Baseline Intervention|Withdrawal by Subject|0
4654322|NCT02123797|7538122|FG000|Baseline Intervention|Relocation|2
4654323|NCT02123797|7538123|FG001|Baseline Intervention|Relocation|0
4654324|NCT02123797|7538124|FG002|Baseline Intervention|Relocation|0
4654325|NCT02123797|7538125|FG003|Baseline Intervention|Relocation|0
4654326|NCT02123797|7538126|FG004|Baseline Intervention|Relocation|0
4654327|NCT02123797|7538122|FG000|Baseline Intervention|Out of window for initial survey|6
4654328|NCT02123797|7538123|FG001|Baseline Intervention|Out of window for initial survey|13
4654329|NCT02123797|7538124|FG002|Baseline Intervention|Out of window for initial survey|0
4654330|NCT02123797|7538125|FG003|Baseline Intervention|Out of window for initial survey|0
4654331|NCT02123797|7538126|FG004|Baseline Intervention|Out of window for initial survey|0
4654332|NCT02123797|7538122|FG000|Baseline Intervention|Lost to Follow-up|0
4654333|NCT02123797|7538123|FG001|Baseline Intervention|Lost to Follow-up|5
4654334|NCT02123797|7538124|FG002|Baseline Intervention|Lost to Follow-up|0
4654335|NCT02123797|7538125|FG003|Baseline Intervention|Lost to Follow-up|0
4654336|NCT02123797|7538126|FG004|Baseline Intervention|Lost to Follow-up|0
4654337|NCT02123797|7538122|FG000|Baseline Intervention|Other Disease|3
4654338|NCT02123797|7538123|FG001|Baseline Intervention|Other Disease|0
4654339|NCT02123797|7538124|FG002|Baseline Intervention|Other Disease|0
4654340|NCT02123797|7538125|FG003|Baseline Intervention|Other Disease|0
4654341|NCT02123797|7538126|FG004|Baseline Intervention|Other Disease|0
4654342|NCT02123797|7538122|FG000|3-month Follow up (Cumulative Counts)|Death|33
4654343|NCT02123797|7538123|FG001|3-month Follow up (Cumulative Counts)|Death|57
4654344|NCT02123797|7538124|FG002|3-month Follow up (Cumulative Counts)|Death|0
4654345|NCT02123797|7538125|FG003|3-month Follow up (Cumulative Counts)|Death|0
4654346|NCT02123797|7538126|FG004|3-month Follow up (Cumulative Counts)|Death|0
4654347|NCT02123797|7538122|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2
4654348|NCT02123797|7538123|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7
4654349|NCT02123797|7538124|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50
4654350|NCT02123797|7538125|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82
4654351|NCT02123797|7538126|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3
4654352|NCT02123797|7538122|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6
4654353|NCT02123797|7538123|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16
4654354|NCT02123797|7538124|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
4654355|NCT02123797|7538125|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
4654356|NCT02123797|7538126|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
4654357|NCT02123797|7538122|FG000|3-month Follow up (Cumulative Counts)|Relocation|0
4654358|NCT02123797|7538123|FG001|3-month Follow up (Cumulative Counts)|Relocation|1
4654359|NCT02123797|7538124|FG002|3-month Follow up (Cumulative Counts)|Relocation|0
4654360|NCT02123797|7538125|FG003|3-month Follow up (Cumulative Counts)|Relocation|0
4654361|NCT02123797|7538126|FG004|3-month Follow up (Cumulative Counts)|Relocation|0
4654362|NCT02123797|7538122|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16
4654363|NCT02123797|7538123|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36
4654364|NCT02123797|7538124|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0
4654365|NCT02123797|7538125|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0
4654366|NCT02123797|7538126|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0
4654367|NCT02123797|7538122|FG000|6-month Follow up (Cumulative Counts)|Death|51
4654368|NCT02123797|7538123|FG001|6-month Follow up (Cumulative Counts)|Death|97
4654369|NCT02123797|7538124|FG002|6-month Follow up (Cumulative Counts)|Death|0
4654370|NCT02123797|7538125|FG003|6-month Follow up (Cumulative Counts)|Death|0
4654371|NCT02123797|7538126|FG004|6-month Follow up (Cumulative Counts)|Death|0
4654372|NCT02123797|7538122|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3
4654373|NCT02123797|7538123|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20
4654374|NCT02123797|7538124|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66
4654375|NCT02123797|7538125|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113
4654376|NCT02123797|7538126|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3
4654377|NCT02123797|7538122|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1
4654378|NCT02123797|7538123|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9
4654379|NCT02123797|7538124|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
4654380|NCT02123797|7538125|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
4654381|NCT02123797|7538126|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
4654382|NCT02123797|7538122|FG000|6-month Follow up (Cumulative Counts)|Relocation|0
4654383|NCT02123797|7538123|FG001|6-month Follow up (Cumulative Counts)|Relocation|2
4654384|NCT02123797|7538124|FG002|6-month Follow up (Cumulative Counts)|Relocation|0
4654385|NCT02123797|7538125|FG003|6-month Follow up (Cumulative Counts)|Relocation|0
4654386|NCT02123797|7538126|FG004|6-month Follow up (Cumulative Counts)|Relocation|0
4654387|NCT02123966|7538157|FG000|Overall Study|Intercurrent Illness|1
4654388|NCT02124161|7538201|FG000|Overall Study|Other unspecified|0
4654389|NCT02124161|7538202|FG001|Overall Study|Other unspecified|1
4654390|NCT02124161|7538201|FG000|Overall Study|Death|1
4654391|NCT02124161|7538202|FG001|Overall Study|Death|0
4654392|NCT02124161|7538201|FG000|Overall Study|Protocol Violation|2
4654393|NCT02124161|7538202|FG001|Overall Study|Protocol Violation|1
4654394|NCT02124161|7538201|FG000|Overall Study|Withdrawal by Subject|1
4654395|NCT02124161|7538202|FG001|Overall Study|Withdrawal by Subject|2
4654396|NCT02124161|7538201|FG000|Overall Study|Adverse Event|2
4654397|NCT02124161|7538202|FG001|Overall Study|Adverse Event|0
4654398|NCT02124161|7538201|FG000|Overall Study|Does not meet entrance criteria|2
4654399|NCT02124161|7538202|FG001|Overall Study|Does not meet entrance criteria|3
4654400|NCT02124161|7538201|FG000|Overall Study|No longer meets eligibility criteria|5
4654401|NCT02124161|7538202|FG001|Overall Study|No longer meets eligibility criteria|4
4654402|NCT02124161|7538201|FG000|Overall Study|Lost to Follow-up|3
4654403|NCT02124161|7538202|FG001|Overall Study|Lost to Follow-up|4
4654404|NCT02124265|7538215|FG000|Overall Study|Adverse Event|1
4654405|NCT02124564|7538247|FG000|Treatment Period|Adverse Event|2
4654406|NCT02124564|7538247|FG000|Treatment Period|Lack of Efficacy|3
4654407|NCT02124564|7538247|FG000|Treatment Period|Withdrawal by Subject|2
4654408|NCT02124707|7538257|FG000|Overall Study|Adverse Event|5
4654409|NCT02124707|7538257|FG000|Overall Study|Physician Decision|1
4654410|NCT02124707|7538257|FG000|Overall Study|Death|1
4654411|NCT02124746|7538265|FG000|Overall Study|Adverse Event|2
4654412|NCT02124746|7538266|FG001|Overall Study|Adverse Event|1
4654413|NCT02124746|7538267|FG002|Overall Study|Adverse Event|2
4654414|NCT02124746|7538265|FG000|Overall Study|Death|2
4654415|NCT02124746|7538266|FG001|Overall Study|Death|1
4654416|NCT02124746|7538267|FG002|Overall Study|Death|3
4654417|NCT02124746|7538265|FG000|Overall Study|Lack of Efficacy|3
4654418|NCT02124746|7538266|FG001|Overall Study|Lack of Efficacy|2
4654419|NCT02124746|7538267|FG002|Overall Study|Lack of Efficacy|2
4654420|NCT02124746|7538265|FG000|Overall Study|Physician Decision|6
4654421|NCT02124746|7538266|FG001|Overall Study|Physician Decision|4
4654422|NCT02124746|7538267|FG002|Overall Study|Physician Decision|5
4654423|NCT02124746|7538265|FG000|Overall Study|Non-Compliance with Study Drug|0
4654424|NCT02124746|7538266|FG001|Overall Study|Non-Compliance with Study Drug|1
4654425|NCT02124746|7538267|FG002|Overall Study|Non-Compliance with Study Drug|0
4654426|NCT02124746|7538265|FG000|Overall Study|Withdrawal by Subject|3
4654427|NCT02124746|7538266|FG001|Overall Study|Withdrawal by Subject|3
4654428|NCT02124746|7538267|FG002|Overall Study|Withdrawal by Subject|0
4654429|NCT02124746|7538265|FG000|Overall Study|Study Terminated by Sponsor|0
4654430|NCT02124746|7538266|FG001|Overall Study|Study Terminated by Sponsor|0
4654431|NCT02124746|7538267|FG002|Overall Study|Study Terminated by Sponsor|6
4654432|NCT02124746|7538265|FG000|Overall Study|Disease Progression|3
4654433|NCT02124746|7538266|FG001|Overall Study|Disease Progression|6
4654434|NCT02124746|7538267|FG002|Overall Study|Disease Progression|4
4654435|NCT02124759|7538278|FG000|Overall Study|Withdrawal by Subject|3
4654436|NCT02124759|7538279|FG001|Overall Study|Withdrawal by Subject|1
4654437|NCT02124759|7538280|FG002|Overall Study|Withdrawal by Subject|1
4654438|NCT02124759|7538278|FG000|Overall Study|Screen Fail|2
4654439|NCT02124759|7538279|FG001|Overall Study|Screen Fail|2
4654440|NCT02124759|7538280|FG002|Overall Study|Screen Fail|3
4654441|NCT02124772|7538306|FG000|Overall Study|Lack of Efficacy|2
4654442|NCT02124772|7538307|FG001|Overall Study|Lack of Efficacy|0
4654443|NCT02124772|7538308|FG002|Overall Study|Lack of Efficacy|0
4654444|NCT02124772|7538309|FG003|Overall Study|Lack of Efficacy|1
4654445|NCT02124772|7538310|FG004|Overall Study|Lack of Efficacy|2
4654446|NCT02124772|7538311|FG005|Overall Study|Lack of Efficacy|3
4654447|NCT02124772|7538312|FG006|Overall Study|Lack of Efficacy|0
4654448|NCT02124772|7538313|FG007|Overall Study|Lack of Efficacy|2
4654449|NCT02124772|7538314|FG008|Overall Study|Lack of Efficacy|0
4654450|NCT02124772|7538315|FG009|Overall Study|Lack of Efficacy|1
4654451|NCT02124772|7538316|FG010|Overall Study|Lack of Efficacy|0
4654452|NCT02124772|7538317|FG011|Overall Study|Lack of Efficacy|0
4654453|NCT02124772|7538318|FG012|Overall Study|Lack of Efficacy|1
4654454|NCT02124772|7538306|FG000|Overall Study|Adverse Event|1
4654455|NCT02124772|7538307|FG001|Overall Study|Adverse Event|4
4654456|NCT02124772|7538308|FG002|Overall Study|Adverse Event|1
4654457|NCT02124772|7538309|FG003|Overall Study|Adverse Event|5
4654458|NCT02124772|7538310|FG004|Overall Study|Adverse Event|2
4654459|NCT02124772|7538311|FG005|Overall Study|Adverse Event|1
4654460|NCT02124772|7538312|FG006|Overall Study|Adverse Event|1
4654461|NCT02124772|7538313|FG007|Overall Study|Adverse Event|5
4654462|NCT02124772|7538314|FG008|Overall Study|Adverse Event|0
4654463|NCT02124772|7538315|FG009|Overall Study|Adverse Event|3
4654464|NCT02124772|7538316|FG010|Overall Study|Adverse Event|1
4654465|NCT02124772|7538317|FG011|Overall Study|Adverse Event|3
4654466|NCT02124772|7538318|FG012|Overall Study|Adverse Event|1
4748288|NCT01670877|7722209|FG001|Part I and Part 2|Grade 2 vomiting|0
4654467|NCT02124772|7538306|FG000|Overall Study|Withdrawal consent|0
4654468|NCT02124772|7538307|FG001|Overall Study|Withdrawal consent|1
4654469|NCT02124772|7538308|FG002|Overall Study|Withdrawal consent|1
4654470|NCT02124772|7538309|FG003|Overall Study|Withdrawal consent|1
4654471|NCT02124772|7538310|FG004|Overall Study|Withdrawal consent|0
4654472|NCT02124772|7538311|FG005|Overall Study|Withdrawal consent|1
4654473|NCT02124772|7538312|FG006|Overall Study|Withdrawal consent|1
4654474|NCT02124772|7538313|FG007|Overall Study|Withdrawal consent|0
4654475|NCT02124772|7538314|FG008|Overall Study|Withdrawal consent|0
4654476|NCT02124772|7538315|FG009|Overall Study|Withdrawal consent|1
4654477|NCT02124772|7538316|FG010|Overall Study|Withdrawal consent|0
4654478|NCT02124772|7538317|FG011|Overall Study|Withdrawal consent|1
4654479|NCT02124772|7538318|FG012|Overall Study|Withdrawal consent|0
4654480|NCT02124772|7538306|FG000|Overall Study|Investigator discretion|0
4654481|NCT02124772|7538307|FG001|Overall Study|Investigator discretion|2
4654482|NCT02124772|7538308|FG002|Overall Study|Investigator discretion|2
4654483|NCT02124772|7538309|FG003|Overall Study|Investigator discretion|1
4654484|NCT02124772|7538310|FG004|Overall Study|Investigator discretion|1
4654485|NCT02124772|7538311|FG005|Overall Study|Investigator discretion|0
4654486|NCT02124772|7538312|FG006|Overall Study|Investigator discretion|1
4654487|NCT02124772|7538313|FG007|Overall Study|Investigator discretion|0
4654488|NCT02124772|7538314|FG008|Overall Study|Investigator discretion|0
4654489|NCT02124772|7538315|FG009|Overall Study|Investigator discretion|1
4654490|NCT02124772|7538316|FG010|Overall Study|Investigator discretion|0
4654491|NCT02124772|7538317|FG011|Overall Study|Investigator discretion|1
4654492|NCT02124772|7538318|FG012|Overall Study|Investigator discretion|0
4654493|NCT02124772|7538306|FG000|Overall Study|Progressive disease|0
4654494|NCT02124772|7538307|FG001|Overall Study|Progressive disease|0
4654495|NCT02124772|7538308|FG002|Overall Study|Progressive disease|0
4654496|NCT02124772|7538309|FG003|Overall Study|Progressive disease|0
4654497|NCT02124772|7538310|FG004|Overall Study|Progressive disease|0
4654498|NCT02124772|7538311|FG005|Overall Study|Progressive disease|0
4654499|NCT02124772|7538312|FG006|Overall Study|Progressive disease|1
4654500|NCT02124772|7538313|FG007|Overall Study|Progressive disease|1
4654501|NCT02124772|7538314|FG008|Overall Study|Progressive disease|0
4654502|NCT02124772|7538315|FG009|Overall Study|Progressive disease|0
4654503|NCT02124772|7538316|FG010|Overall Study|Progressive disease|0
4654504|NCT02124772|7538317|FG011|Overall Study|Progressive disease|0
4654505|NCT02124772|7538318|FG012|Overall Study|Progressive disease|0
4654506|NCT02124772|7538306|FG000|Overall Study|Other|0
4654507|NCT02124772|7538307|FG001|Overall Study|Other|7
4654508|NCT02124772|7538308|FG002|Overall Study|Other|2
4654509|NCT02124772|7538309|FG003|Overall Study|Other|5
4654510|NCT02124772|7538310|FG004|Overall Study|Other|4
4654511|NCT02124772|7538311|FG005|Overall Study|Other|3
4654512|NCT02124772|7538312|FG006|Overall Study|Other|4
4654513|NCT02124772|7538313|FG007|Overall Study|Other|1
4654514|NCT02124772|7538314|FG008|Overall Study|Other|1
4654515|NCT02124772|7538315|FG009|Overall Study|Other|1
4654516|NCT02124772|7538316|FG010|Overall Study|Other|1
4654517|NCT02124772|7538317|FG011|Overall Study|Other|1
4654518|NCT02124772|7538318|FG012|Overall Study|Other|0
4654519|NCT02124798|7538370|FG000|Overall Study|Adverse Event|3
4654520|NCT02124798|7538370|FG000|Overall Study|Lost to Follow-up|1
4654521|NCT02124811|7538376|FG000|Overall Study|Early termination|2
4654522|NCT02124811|7538377|FG001|Overall Study|Early termination|2
4654523|NCT02124811|7538376|FG000|Overall Study|Withdrawal by Subject|1
4654524|NCT02124811|7538377|FG001|Overall Study|Withdrawal by Subject|0
4654525|NCT02125279|7538398|FG000|Overall Study|Lack of Efficacy|2
4654526|NCT02125279|7538398|FG000|Overall Study|Withdrawal by Subject|6
4654527|NCT02125279|7538398|FG000|Overall Study|Protocol Violation|1
4654528|NCT02125279|7538398|FG000|Overall Study|Lost to Follow-up|4
4654529|NCT02125331|7538420|FG000|Overall Study|Protocol Violation|1
4654530|NCT02125331|7538421|FG001|Overall Study|Protocol Violation|0
4654531|NCT02125331|7538420|FG000|Overall Study|technical problem|2
4654532|NCT02125331|7538421|FG001|Overall Study|technical problem|0
4654533|NCT02125331|7538420|FG000|Overall Study|screen failure|2
4654534|NCT02125331|7538421|FG001|Overall Study|screen failure|0
4654535|NCT02125604|7538427|FG000|Overall Study|Other|4
4654536|NCT02125604|7538427|FG000|Overall Study|Investigator Decision|1
4654537|NCT02125604|7538427|FG000|Overall Study|Lost to Follow-up|2
4654538|NCT02125604|7538427|FG000|Overall Study|Consent Withdrawn|4
4654539|NCT02125604|7538427|FG000|Overall Study|Adverse Event|20
4654540|NCT02125734|7538437|FG000|Period 2|Adverse Event|0
4654541|NCT02125734|7538438|FG001|Period 2|Adverse Event|1
4654542|NCT02125838|7538446|FG000|Overall Study|Lost to Follow-up|4
4654543|NCT02125838|7538447|FG001|Overall Study|Lost to Follow-up|4
4654544|NCT02125877|7538455|FG000|Overall Study|Physician Decision|1
4654545|NCT02125877|7538456|FG001|Overall Study|Physician Decision|0
4654546|NCT02125877|7538455|FG000|Overall Study|Death|0
4654547|NCT02125877|7538456|FG001|Overall Study|Death|1
4654548|NCT02125877|7538455|FG000|Overall Study|Administrative problems|0
4654549|NCT02125877|7538456|FG001|Overall Study|Administrative problems|1
4654550|NCT02125877|7538455|FG000|Overall Study|Participant/guardian decision|0
4654551|NCT02125877|7538456|FG001|Overall Study|Participant/guardian decision|2
4748289|NCT01670877|7722210|FG002|Part I and Part 2|Grade 2 vomiting|0
4654552|NCT02125877|7538455|FG000|Overall Study|Withdrawal by Subject|2
4654553|NCT02125877|7538456|FG001|Overall Study|Withdrawal by Subject|1
4654554|NCT02125877|7538455|FG000|Overall Study|Protocol deviation|4
4654555|NCT02125877|7538456|FG001|Overall Study|Protocol deviation|1
4654556|NCT02125877|7538455|FG000|Overall Study|Adverse Event|6
4654557|NCT02125877|7538456|FG001|Overall Study|Adverse Event|4
4654558|NCT02126670|7538486|FG000|Overall Study|Withdrawal by Subject|1
4654559|NCT02126670|7538487|FG001|Overall Study|Withdrawal by Subject|0
4654560|NCT02126670|7538488|FG002|Overall Study|Withdrawal by Subject|0
4654561|NCT02126670|7538489|FG003|Overall Study|Withdrawal by Subject|1
4654562|NCT02126826|7538519|FG000|Overall Study|Withdrawal by Subject|0
4654563|NCT02126826|7538520|FG001|Overall Study|Withdrawal by Subject|0
4654564|NCT02126826|7538521|FG002|Overall Study|Withdrawal by Subject|0
4654565|NCT02126826|7538522|FG003|Overall Study|Withdrawal by Subject|1
4654566|NCT02126826|7538523|FG004|Overall Study|Withdrawal by Subject|0
4654567|NCT02126826|7538524|FG005|Overall Study|Withdrawal by Subject|0
4654568|NCT02126826|7538525|FG006|Overall Study|Withdrawal by Subject|0
4654569|NCT02126839|7538548|FG000|Overall Study|Adverse Event|0
4654570|NCT02126839|7538549|FG001|Overall Study|Adverse Event|1
4654571|NCT02126839|7538548|FG000|Overall Study|Withdrawal by Subject|1
4654572|NCT02126839|7538549|FG001|Overall Study|Withdrawal by Subject|0
4654573|NCT02126839|7538548|FG000|Overall Study|Withdrawal by parent/guardian|1
4654574|NCT02126839|7538549|FG001|Overall Study|Withdrawal by parent/guardian|0
4654575|NCT02126839|7538548|FG000|Overall Study|Protocol Violation|2
4654576|NCT02126839|7538549|FG001|Overall Study|Protocol Violation|3
4654577|NCT02126839|7538548|FG000|Overall Study|Sponsor request|0
4654578|NCT02126839|7538549|FG001|Overall Study|Sponsor request|1
4654579|NCT02126839|7538548|FG000|Overall Study|Lost to Follow-up|1
4654580|NCT02126839|7538549|FG001|Overall Study|Lost to Follow-up|4
4654581|NCT02126839|7538548|FG000|Overall Study|Other|5
4654582|NCT02126839|7538549|FG001|Overall Study|Other|5
4654583|NCT02126969|7538557|FG000|Overall Study|Withdrawal by Subject|1
4654584|NCT02126969|7538558|FG001|Overall Study|Withdrawal by Subject|2
4654585|NCT02127125|7538573|FG000|Overall Study|Lost to Follow-up|0
4654586|NCT02127125|7538574|FG001|Overall Study|Lost to Follow-up|0
4654587|NCT02127125|7538575|FG002|Overall Study|Lost to Follow-up|0
4654588|NCT02127125|7538576|FG003|Overall Study|Lost to Follow-up|0
4654589|NCT02127125|7538577|FG004|Overall Study|Lost to Follow-up|2
4654590|NCT02127125|7538578|FG005|Overall Study|Lost to Follow-up|1
4654591|NCT02127125|7538579|FG006|Overall Study|Lost to Follow-up|0
4654592|NCT02127125|7538580|FG007|Overall Study|Lost to Follow-up|0
4654593|NCT02127125|7538581|FG008|Overall Study|Lost to Follow-up|0
4654594|NCT02127125|7538573|FG000|Overall Study|Withdrawal by Subject|0
4654595|NCT02127125|7538574|FG001|Overall Study|Withdrawal by Subject|0
4654596|NCT02127125|7538575|FG002|Overall Study|Withdrawal by Subject|0
4654597|NCT02127125|7538576|FG003|Overall Study|Withdrawal by Subject|1
4654598|NCT02127125|7538577|FG004|Overall Study|Withdrawal by Subject|0
4654599|NCT02127125|7538578|FG005|Overall Study|Withdrawal by Subject|0
4654600|NCT02127125|7538579|FG006|Overall Study|Withdrawal by Subject|0
4654601|NCT02127125|7538580|FG007|Overall Study|Withdrawal by Subject|0
4654602|NCT02127125|7538581|FG008|Overall Study|Withdrawal by Subject|0
4654603|NCT02127125|7538573|FG000|Overall Study|Physician Decision|0
4654604|NCT02127125|7538574|FG001|Overall Study|Physician Decision|0
4654605|NCT02127125|7538575|FG002|Overall Study|Physician Decision|1
4654606|NCT02127125|7538576|FG003|Overall Study|Physician Decision|0
4654607|NCT02127125|7538577|FG004|Overall Study|Physician Decision|1
4654608|NCT02127125|7538578|FG005|Overall Study|Physician Decision|2
4654609|NCT02127125|7538579|FG006|Overall Study|Physician Decision|0
4654610|NCT02127125|7538580|FG007|Overall Study|Physician Decision|0
4654611|NCT02127125|7538581|FG008|Overall Study|Physician Decision|0
4654612|NCT02127281|7538603|FG000|Overall Study|Lost to Follow-up|1
4654613|NCT02127281|7538604|FG001|Overall Study|Lost to Follow-up|0
4654614|NCT02127307|7538610|FG000|Overall Study|Protocol Violation|36
4654615|NCT02127307|7538610|FG000|Overall Study|Lost to Follow-up|2
4654616|NCT02127307|7538610|FG000|Overall Study|Death|101
4654617|NCT02127307|7538610|FG000|Overall Study|Other than specified above|169
4654618|NCT02127372|7538616|FG000|Overall Study|Withdrawal by Subject|1
4654619|NCT02127372|7538617|FG001|Overall Study|Withdrawal by Subject|0
4654620|NCT02127931|7538678|FG000|Overall Study|Glitch in Game|1
4654621|NCT02127970|7538685|FG000|Overall Study|Adverse Event|2
4654622|NCT02127970|7538686|FG001|Overall Study|Adverse Event|1
4654623|NCT02127970|7538685|FG000|Overall Study|Death|1
4654624|NCT02127970|7538686|FG001|Overall Study|Death|1
4654625|NCT02127970|7538685|FG000|Overall Study|Lost to Follow-up|14
4654626|NCT02127970|7538686|FG001|Overall Study|Lost to Follow-up|14
4654627|NCT02127970|7538685|FG000|Overall Study|Reason not Specified|4
4654628|NCT02127970|7538686|FG001|Overall Study|Reason not Specified|7
4654629|NCT02127970|7538685|FG000|Overall Study|Pregnancy|0
4654630|NCT02127970|7538686|FG001|Overall Study|Pregnancy|1
4654631|NCT02127970|7538685|FG000|Overall Study|Subject Withdrew Consent|5
4654632|NCT02127970|7538686|FG001|Overall Study|Subject Withdrew Consent|3
4654633|NCT02128217|7538698|FG000|Overall Study|Lost to Follow-up|0
4654634|NCT02128217|7538699|FG001|Overall Study|Lost to Follow-up|1
4654635|NCT02128269|7538714|FG000|Treatment Period|Adverse Event|1
4654636|NCT02128269|7538714|FG000|Treatment Period|Physician Decision|1
4654637|NCT02128490|7538723|FG000|Overall Study|Pretreatment Event/Adverse Event|1
4654638|NCT02128490|7538724|FG001|Overall Study|Pretreatment Event/Adverse Event|0
4654639|NCT02128490|7538725|FG002|Overall Study|Pretreatment Event/Adverse Event|1
4654640|NCT02128490|7538726|FG003|Overall Study|Pretreatment Event/Adverse Event|1
4654641|NCT02128490|7538727|FG004|Overall Study|Pretreatment Event/Adverse Event|0
4654642|NCT02128490|7538723|FG000|Overall Study|Major Protocol Deviation|1
4654643|NCT02128490|7538724|FG001|Overall Study|Major Protocol Deviation|2
4654644|NCT02128490|7538725|FG002|Overall Study|Major Protocol Deviation|0
4654645|NCT02128490|7538726|FG003|Overall Study|Major Protocol Deviation|2
4654646|NCT02128490|7538727|FG004|Overall Study|Major Protocol Deviation|2
4654647|NCT02128490|7538723|FG000|Overall Study|Lost to Follow-up|0
4654648|NCT02128490|7538724|FG001|Overall Study|Lost to Follow-up|0
4654649|NCT02128490|7538725|FG002|Overall Study|Lost to Follow-up|1
4654650|NCT02128490|7538726|FG003|Overall Study|Lost to Follow-up|1
4654651|NCT02128490|7538727|FG004|Overall Study|Lost to Follow-up|1
4654652|NCT02128490|7538723|FG000|Overall Study|Voluntary Withdrawal|3
4654653|NCT02128490|7538724|FG001|Overall Study|Voluntary Withdrawal|3
4654654|NCT02128490|7538725|FG002|Overall Study|Voluntary Withdrawal|1
4654655|NCT02128490|7538726|FG003|Overall Study|Voluntary Withdrawal|1
4654656|NCT02128490|7538727|FG004|Overall Study|Voluntary Withdrawal|2
4654657|NCT02128490|7538723|FG000|Overall Study|Lack of Efficacy|0
4654658|NCT02128490|7538724|FG001|Overall Study|Lack of Efficacy|1
4654659|NCT02128490|7538725|FG002|Overall Study|Lack of Efficacy|0
4654660|NCT02128490|7538726|FG003|Overall Study|Lack of Efficacy|0
4654661|NCT02128490|7538727|FG004|Overall Study|Lack of Efficacy|0
4654662|NCT02128490|7538723|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0
4654663|NCT02128490|7538724|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0
4654664|NCT02128490|7538725|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0
4654665|NCT02128490|7538726|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0
4654666|NCT02128490|7538727|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1
4654667|NCT02128490|7538723|FG000|Overall Study|Other Miscellaneous Reasons|0
4654668|NCT02128490|7538724|FG001|Overall Study|Other Miscellaneous Reasons|0
4654669|NCT02128490|7538725|FG002|Overall Study|Other Miscellaneous Reasons|2
4654670|NCT02128490|7538726|FG003|Overall Study|Other Miscellaneous Reasons|1
4654671|NCT02128490|7538727|FG004|Overall Study|Other Miscellaneous Reasons|1
4654672|NCT02128542|7538741|FG000|Overall Study|Lost to Follow-up|3
4654673|NCT02128542|7538742|FG001|Overall Study|Lost to Follow-up|0
4654674|NCT02128542|7538741|FG000|Overall Study|Withdrew Consent|1
4654675|NCT02128542|7538742|FG001|Overall Study|Withdrew Consent|0
4654676|NCT02128724|7538754|FG000|Overall Study|Death|1
4654677|NCT02128724|7538755|FG001|Overall Study|Death|0
4654678|NCT02128724|7538756|FG002|Overall Study|Death|0
4654679|NCT02128724|7538757|FG003|Overall Study|Death|0
4654680|NCT02128724|7538754|FG000|Overall Study|Adverse Event|0
4654681|NCT02128724|7538755|FG001|Overall Study|Adverse Event|1
4654682|NCT02128724|7538756|FG002|Overall Study|Adverse Event|0
4654683|NCT02128724|7538757|FG003|Overall Study|Adverse Event|0
4654684|NCT02128724|7538754|FG000|Overall Study|Physician Decision|0
4654685|NCT02128724|7538755|FG001|Overall Study|Physician Decision|0
4654686|NCT02128724|7538756|FG002|Overall Study|Physician Decision|0
4654687|NCT02128724|7538757|FG003|Overall Study|Physician Decision|2
4654688|NCT02128724|7538754|FG000|Overall Study|Withdrawal by Subject|0
4654689|NCT02128724|7538755|FG001|Overall Study|Withdrawal by Subject|0
4654690|NCT02128724|7538756|FG002|Overall Study|Withdrawal by Subject|0
4654691|NCT02128724|7538757|FG003|Overall Study|Withdrawal by Subject|1
4654692|NCT02128763|7538768|FG000|Overall Study|Death|1
4654693|NCT02128763|7538769|FG001|Overall Study|Death|0
4654694|NCT02128763|7538768|FG000|Overall Study|Lost to Follow-up|19
4654695|NCT02128763|7538769|FG001|Overall Study|Lost to Follow-up|16
4654696|NCT02128932|7538808|FG000|Overall Study|Withdrawal by Subject|11
4654697|NCT02128932|7538809|FG001|Overall Study|Withdrawal by Subject|7
4654698|NCT02128932|7538810|FG002|Overall Study|Withdrawal by Subject|8
4654699|NCT02128932|7538808|FG000|Overall Study|Death|2
4654700|NCT02128932|7538809|FG001|Overall Study|Death|0
4654701|NCT02128932|7538810|FG002|Overall Study|Death|2
4654702|NCT02128932|7538808|FG000|Overall Study|Lost to Follow-up|2
4654703|NCT02128932|7538809|FG001|Overall Study|Lost to Follow-up|1
4654704|NCT02128932|7538810|FG002|Overall Study|Lost to Follow-up|1
4654705|NCT02128932|7538808|FG000|Overall Study|No reason for withdrawal|12
4654706|NCT02128932|7538809|FG001|Overall Study|No reason for withdrawal|11
4654707|NCT02128932|7538810|FG002|Overall Study|No reason for withdrawal|7
4654708|NCT02128997|7538820|FG000|Overall Study|Lost to Follow-up|6
4654709|NCT02128997|7538821|FG001|Overall Study|Lost to Follow-up|11
4654710|NCT02129062|7538827|FG000|Overall Study|Death|1
4654711|NCT02129062|7538827|FG000|Overall Study|Disease Progression|2
4654712|NCT02129192|7538844|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0
4654713|NCT02129192|7538845|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1
4654714|NCT02129205|7538864|FG000|Overall Study|Withdrawal by Subject|0
4654715|NCT02129205|7538865|FG001|Overall Study|Withdrawal by Subject|0
4654716|NCT02129205|7538866|FG002|Overall Study|Withdrawal by Subject|0
4654717|NCT02129205|7538867|FG003|Overall Study|Withdrawal by Subject|0
4654718|NCT02129205|7538868|FG004|Overall Study|Withdrawal by Subject|1
4654719|NCT02129205|7538869|FG005|Overall Study|Withdrawal by Subject|1
4654720|NCT02129205|7538870|FG006|Overall Study|Withdrawal by Subject|1
4654721|NCT02129205|7538871|FG007|Overall Study|Withdrawal by Subject|0
4654722|NCT02129205|7538872|FG008|Overall Study|Withdrawal by Subject|1
4654723|NCT02129205|7538873|FG009|Overall Study|Withdrawal by Subject|0
4654724|NCT02129205|7538864|FG000|Overall Study|Other|1
4654725|NCT02129205|7538865|FG001|Overall Study|Other|0
4654726|NCT02129205|7538866|FG002|Overall Study|Other|0
4654727|NCT02129205|7538867|FG003|Overall Study|Other|0
4654728|NCT02129205|7538868|FG004|Overall Study|Other|2
4654729|NCT02129205|7538869|FG005|Overall Study|Other|3
4654730|NCT02129205|7538870|FG006|Overall Study|Other|3
4654731|NCT02129205|7538871|FG007|Overall Study|Other|2
4654732|NCT02129205|7538872|FG008|Overall Study|Other|1
4654733|NCT02129205|7538873|FG009|Overall Study|Other|0
4654734|NCT02129608|7538928|FG000|Overall Study|Lost to Follow-up|0
4654735|NCT02129608|7538929|FG001|Overall Study|Lost to Follow-up|1
4654736|NCT02129608|7538930|FG002|Overall Study|Lost to Follow-up|1
4654737|NCT02129608|7538928|FG000|Overall Study|Withdrawal by Subject|0
4654738|NCT02129608|7538929|FG001|Overall Study|Withdrawal by Subject|0
4654739|NCT02129608|7538930|FG002|Overall Study|Withdrawal by Subject|2
4654740|NCT02129777|7538974|FG000|Double-Blind Period|Adverse Event|0
4654741|NCT02129777|7538975|FG001|Double-Blind Period|Adverse Event|0
4654742|NCT02129777|7538976|FG002|Double-Blind Period|Adverse Event|0
4654743|NCT02129777|7538977|FG003|Double-Blind Period|Adverse Event|0
4654744|NCT02129777|7538978|FG004|Double-Blind Period|Adverse Event|1
4654745|NCT02129777|7538979|FG005|Double-Blind Period|Adverse Event|0
4654746|NCT02129777|7538980|FG006|Double-Blind Period|Adverse Event|0
4654747|NCT02129777|7538974|FG000|Double-Blind Period|Lost to Follow-up|1
4654748|NCT02129777|7538975|FG001|Double-Blind Period|Lost to Follow-up|1
4654749|NCT02129777|7538976|FG002|Double-Blind Period|Lost to Follow-up|1
4654750|NCT02129777|7538977|FG003|Double-Blind Period|Lost to Follow-up|2
4654751|NCT02129777|7538978|FG004|Double-Blind Period|Lost to Follow-up|0
4654752|NCT02129777|7538979|FG005|Double-Blind Period|Lost to Follow-up|0
4654753|NCT02129777|7538980|FG006|Double-Blind Period|Lost to Follow-up|0
4654754|NCT02129777|7538974|FG000|Double-Blind Period|Withdrawal by Subject|2
4654755|NCT02129777|7538975|FG001|Double-Blind Period|Withdrawal by Subject|4
4654756|NCT02129777|7538976|FG002|Double-Blind Period|Withdrawal by Subject|3
4654757|NCT02129777|7538977|FG003|Double-Blind Period|Withdrawal by Subject|2
4654758|NCT02129777|7538978|FG004|Double-Blind Period|Withdrawal by Subject|3
4654759|NCT02129777|7538979|FG005|Double-Blind Period|Withdrawal by Subject|0
4654760|NCT02129777|7538980|FG006|Double-Blind Period|Withdrawal by Subject|0
4654761|NCT02129777|7538974|FG000|Double-Blind Period|Pregnancy|0
4654762|NCT02129777|7538975|FG001|Double-Blind Period|Pregnancy|0
4654763|NCT02129777|7538976|FG002|Double-Blind Period|Pregnancy|0
4654764|NCT02129777|7538977|FG003|Double-Blind Period|Pregnancy|0
4654765|NCT02129777|7538978|FG004|Double-Blind Period|Pregnancy|1
4654766|NCT02129777|7538979|FG005|Double-Blind Period|Pregnancy|0
4654767|NCT02129777|7538980|FG006|Double-Blind Period|Pregnancy|0
4654768|NCT02129777|7538974|FG000|Double-Blind Period|Lack of Efficacy|3
4654769|NCT02129777|7538975|FG001|Double-Blind Period|Lack of Efficacy|1
4654770|NCT02129777|7538976|FG002|Double-Blind Period|Lack of Efficacy|0
4654771|NCT02129777|7538977|FG003|Double-Blind Period|Lack of Efficacy|3
4654772|NCT02129777|7538978|FG004|Double-Blind Period|Lack of Efficacy|2
4654773|NCT02129777|7538979|FG005|Double-Blind Period|Lack of Efficacy|0
4654774|NCT02129777|7538980|FG006|Double-Blind Period|Lack of Efficacy|0
4654775|NCT02129777|7538974|FG000|Double-Blind Period|Other|1
4654776|NCT02129777|7538975|FG001|Double-Blind Period|Other|2
4654777|NCT02129777|7538976|FG002|Double-Blind Period|Other|0
4654778|NCT02129777|7538977|FG003|Double-Blind Period|Other|0
4654779|NCT02129777|7538978|FG004|Double-Blind Period|Other|0
4654780|NCT02129777|7538979|FG005|Double-Blind Period|Other|0
4654781|NCT02129777|7538980|FG006|Double-Blind Period|Other|0
4654782|NCT02129777|7538974|FG000|Open-Label Period|Lack of Efficacy|0
4654783|NCT02129777|7538975|FG001|Open-Label Period|Lack of Efficacy|0
4654784|NCT02129777|7538976|FG002|Open-Label Period|Lack of Efficacy|0
4654785|NCT02129777|7538977|FG003|Open-Label Period|Lack of Efficacy|0
4654786|NCT02129777|7538978|FG004|Open-Label Period|Lack of Efficacy|0
4654787|NCT02129777|7538979|FG005|Open-Label Period|Lack of Efficacy|0
4654788|NCT02129777|7538980|FG006|Open-Label Period|Lack of Efficacy|5
4654789|NCT02129777|7538974|FG000|Open-Label Period|Lost to Follow-up|0
4654790|NCT02129777|7538975|FG001|Open-Label Period|Lost to Follow-up|0
4654791|NCT02129777|7538976|FG002|Open-Label Period|Lost to Follow-up|0
4654792|NCT02129777|7538977|FG003|Open-Label Period|Lost to Follow-up|0
4654793|NCT02129777|7538978|FG004|Open-Label Period|Lost to Follow-up|0
4654794|NCT02129777|7538979|FG005|Open-Label Period|Lost to Follow-up|1
4654795|NCT02129777|7538980|FG006|Open-Label Period|Lost to Follow-up|1
4654796|NCT02129777|7538974|FG000|Open-Label Period|Withdrawal by Subject|0
4654797|NCT02129777|7538975|FG001|Open-Label Period|Withdrawal by Subject|0
4654798|NCT02129777|7538976|FG002|Open-Label Period|Withdrawal by Subject|0
4654799|NCT02129777|7538977|FG003|Open-Label Period|Withdrawal by Subject|0
4654800|NCT02129777|7538978|FG004|Open-Label Period|Withdrawal by Subject|0
4654801|NCT02129777|7538979|FG005|Open-Label Period|Withdrawal by Subject|1
4654802|NCT02129777|7538980|FG006|Open-Label Period|Withdrawal by Subject|3
4654803|NCT02129777|7538974|FG000|Open-Label Period|Study Termination|0
4654804|NCT02129777|7538975|FG001|Open-Label Period|Study Termination|0
4654805|NCT02129777|7538976|FG002|Open-Label Period|Study Termination|0
4654806|NCT02129777|7538977|FG003|Open-Label Period|Study Termination|0
4654807|NCT02129777|7538978|FG004|Open-Label Period|Study Termination|0
4654808|NCT02129777|7538979|FG005|Open-Label Period|Study Termination|10
4654809|NCT02129777|7538980|FG006|Open-Label Period|Study Termination|39
4748290|NCT01670877|7722211|FG003|Part I and Part 2|Grade 2 vomiting|1
4748291|NCT01670877|7722212|FG004|Part I and Part 2|Grade 2 vomiting|0
4748292|NCT01670877|7722213|FG005|Part I and Part 2|Grade 2 vomiting|0
4748293|NCT01670877|7722208|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0
4748294|NCT01670877|7722209|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0
4748295|NCT01670877|7722210|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0
4748296|NCT01670877|7722211|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1
4654810|NCT02129803|7539001|FG000|Overall Study|Protocol Violation|4
4654811|NCT02129803|7539002|FG001|Overall Study|Protocol Violation|0
4654812|NCT02129803|7539001|FG000|Overall Study|Physician Decision|0
4654813|NCT02129803|7539002|FG001|Overall Study|Physician Decision|1
4654814|NCT02129803|7539001|FG000|Overall Study|Difficulty sleeping|1
4654815|NCT02129803|7539002|FG001|Overall Study|Difficulty sleeping|0
4654816|NCT02129803|7539001|FG000|Overall Study|Morning headache|0
4654817|NCT02129803|7539002|FG001|Overall Study|Morning headache|1
4654818|NCT02129803|7539001|FG000|Overall Study|Withdrawal by Subject|1
4654819|NCT02129803|7539002|FG001|Overall Study|Withdrawal by Subject|1
4654820|NCT02130024|7539010|FG000|Overall Study|Adverse Event|10
4654821|NCT02130024|7539011|FG001|Overall Study|Adverse Event|11
4654822|NCT02130024|7539010|FG000|Overall Study|Death|2
4654823|NCT02130024|7539011|FG001|Overall Study|Death|2
4654824|NCT02130024|7539010|FG000|Overall Study|Lost to Follow-up|1
4654825|NCT02130024|7539011|FG001|Overall Study|Lost to Follow-up|1
4654826|NCT02130024|7539010|FG000|Overall Study|Physician Decision|1
4654827|NCT02130024|7539011|FG001|Overall Study|Physician Decision|3
4654828|NCT02130024|7539010|FG000|Overall Study|Protocol Deviation|4
4654829|NCT02130024|7539011|FG001|Overall Study|Protocol Deviation|0
4654830|NCT02130024|7539010|FG000|Overall Study|Site Administration Problems|1
4654831|NCT02130024|7539011|FG001|Overall Study|Site Administration Problems|0
4654832|NCT02130024|7539010|FG000|Overall Study|Subject Withdrew Consent|6
4654833|NCT02130024|7539011|FG001|Overall Study|Subject Withdrew Consent|14
4654834|NCT02130193|7539028|FG000|Part B: 52-week Double-blind Period|Adverse Event|0
4654835|NCT02130193|7539029|FG001|Part B: 52-week Double-blind Period|Adverse Event|5
4654836|NCT02130193|7539030|FG002|Part B: 52-week Double-blind Period|Adverse Event|3
4654837|NCT02130193|7539028|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0
4654838|NCT02130193|7539029|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2
4654839|NCT02130193|7539030|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1
4654840|NCT02130193|7539028|FG000|Part B: 52-week Double-blind Period|Physician Decision|0
4654841|NCT02130193|7539029|FG001|Part B: 52-week Double-blind Period|Physician Decision|0
4654842|NCT02130193|7539030|FG002|Part B: 52-week Double-blind Period|Physician Decision|1
4654843|NCT02130193|7539028|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0
4654844|NCT02130193|7539029|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3
4654845|NCT02130193|7539030|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3
4748297|NCT01670877|7722212|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0
4748298|NCT01670877|7722213|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0
4748299|NCT01670877|7722208|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0
4748300|NCT01670877|7722209|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0
4748301|NCT01670877|7722210|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0
4748302|NCT01670877|7722211|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1
4748303|NCT01670877|7722212|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0
4748304|NCT01670877|7722213|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0
4748305|NCT01602380|7722229|FG000|Overall Study|Death|63
4748306|NCT01602380|7722230|FG001|Overall Study|Death|68
4748307|NCT01602380|7722229|FG000|Overall Study|Withdrawal by Subject|22
4748308|NCT01602380|7722230|FG001|Overall Study|Withdrawal by Subject|29
4748309|NCT01602380|7722229|FG000|Overall Study|Lost to Follow-up|6
4748310|NCT01602380|7722230|FG001|Overall Study|Lost to Follow-up|1
4748311|NCT01602380|7722229|FG000|Overall Study|Eligibility criteria not fulfilled|2
4748312|NCT01602380|7722230|FG001|Overall Study|Eligibility criteria not fulfilled|3
4748313|NCT01412333|7722238|FG000|Overall Study|Death|1
4748314|NCT01412333|7722239|FG001|Overall Study|Death|1
4748315|NCT01412333|7722238|FG000|Overall Study|Physician Decision|0
4748316|NCT01412333|7722239|FG001|Overall Study|Physician Decision|1
4748317|NCT01412333|7722238|FG000|Overall Study|Reason not specified|16
4748318|NCT01412333|7722239|FG001|Overall Study|Reason not specified|10
4748319|NCT01412333|7722238|FG000|Overall Study|Non-compliance with study drug|1
4748320|NCT01412333|7722239|FG001|Overall Study|Non-compliance with study drug|1
4748321|NCT01412333|7722238|FG000|Overall Study|Protocol Violation|1
4748322|NCT01412333|7722239|FG001|Overall Study|Protocol Violation|1
4748323|NCT01412333|7722238|FG000|Overall Study|Non-compliance|1
4748324|NCT01412333|7722239|FG001|Overall Study|Non-compliance|3
4748325|NCT01412333|7722238|FG000|Overall Study|Lack of Efficacy|15
4748326|NCT01412333|7722239|FG001|Overall Study|Lack of Efficacy|6
4748327|NCT01412333|7722238|FG000|Overall Study|Pregnancy|3
4748328|NCT01412333|7722239|FG001|Overall Study|Pregnancy|0
4748329|NCT01412333|7722238|FG000|Overall Study|Consent withdrawn by participant|25
4748330|NCT01412333|7722239|FG001|Overall Study|Consent withdrawn by participant|12
4748331|NCT01412333|7722238|FG000|Overall Study|Adverse Event|25
4748332|NCT01412333|7722239|FG001|Overall Study|Adverse Event|16
4748333|NCT01412333|7722238|FG000|Overall Study|Lost to Follow-up|10
4748334|NCT01412333|7722239|FG001|Overall Study|Lost to Follow-up|6
4748335|NCT01247324|7722248|FG000|Overall Study|Death|1
4748336|NCT01247324|7722249|FG001|Overall Study|Death|0
4748337|NCT01247324|7722248|FG000|Overall Study|Physician Decision|0
4748338|NCT01247324|7722249|FG001|Overall Study|Physician Decision|1
4748339|NCT01247324|7722248|FG000|Overall Study|Non-compliance with study drug|3
4748340|NCT01247324|7722249|FG001|Overall Study|Non-compliance with study drug|0
4748341|NCT01247324|7722248|FG000|Overall Study|Lack of Efficacy|12
4654846|NCT02130284|7539048|FG000|Overall Study|Withdrawal by Subject|3
4654847|NCT02130284|7539048|FG000|Overall Study|Subject Withdrew Consent|1
4654848|NCT02130284|7539048|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1
4654849|NCT02130284|7539048|FG000|Overall Study|Subject was screened as backup for study|3
4654850|NCT02130284|7539048|FG000|Overall Study|Screen Failure|1
4654851|NCT02130297|7539052|FG000|Overall Study|Lost to Follow-up|4
4654852|NCT02130427|7539056|FG000|Overall Study|Imaging results not interpretable|30
4654853|NCT02130557|7539062|FG000|Overall Study|Withdrawal by Subject|12
4654854|NCT02130557|7539063|FG001|Overall Study|Withdrawal by Subject|12
4654855|NCT02130557|7539062|FG000|Overall Study|Investigator Request|0
4654856|NCT02130557|7539063|FG001|Overall Study|Investigator Request|2
4748342|NCT01247324|7722249|FG001|Overall Study|Lack of Efficacy|8
4748343|NCT01247324|7722248|FG000|Overall Study|Non-compliance|2
4748344|NCT01247324|7722249|FG001|Overall Study|Non-compliance|0
4748345|NCT01247324|7722248|FG000|Overall Study|Pregnancy|2
4748346|NCT01247324|7722249|FG001|Overall Study|Pregnancy|3
4748347|NCT01247324|7722248|FG000|Overall Study|Protocol Violation|1
4748348|NCT01247324|7722249|FG001|Overall Study|Protocol Violation|2
4748349|NCT01247324|7722248|FG000|Overall Study|Reason not specified|11
4748350|NCT01247324|7722249|FG001|Overall Study|Reason not specified|8
4748351|NCT01247324|7722248|FG000|Overall Study|Consent withdrawn by participant|13
4748352|NCT01247324|7722249|FG001|Overall Study|Consent withdrawn by participant|8
4748353|NCT01247324|7722248|FG000|Overall Study|Adverse Event|25
4748354|NCT01247324|7722249|FG001|Overall Study|Adverse Event|13
4748355|NCT01247324|7722248|FG000|Overall Study|Lost to Follow-up|1
4748356|NCT01247324|7722249|FG001|Overall Study|Lost to Follow-up|1
4748357|NCT00667628|7722258|FG000|Overall Study|Lost to Follow-up|1
4748358|NCT00667628|7722259|FG001|Overall Study|Lost to Follow-up|0
4748359|NCT00667628|7722258|FG000|Overall Study|Death|6
4748360|NCT00667628|7722259|FG001|Overall Study|Death|6
4748361|NCT00667628|7722258|FG000|Overall Study|Investigator Considers in Best Interest|1
4748362|NCT00667628|7722259|FG001|Overall Study|Investigator Considers in Best Interest|0
4748363|NCT00667628|7722258|FG000|Overall Study|Sponsor Terminated Study|17
4748364|NCT00667628|7722259|FG001|Overall Study|Sponsor Terminated Study|21
4654857|NCT02130557|7539062|FG000|Overall Study|Deceased|14
4654858|NCT02130557|7539063|FG001|Overall Study|Deceased|14
4654859|NCT02130557|7539062|FG000|Overall Study|Lost to Follow-up|6
4654860|NCT02130557|7539063|FG001|Overall Study|Lost to Follow-up|7
4654861|NCT02130557|7539062|FG000|Overall Study|Other|2
4654862|NCT02130557|7539063|FG001|Overall Study|Other|1
4654863|NCT02130557|7539062|FG000|Overall Study|Missing|2
4654864|NCT02130557|7539063|FG001|Overall Study|Missing|1
4654865|NCT02130570|7539071|FG000|Overall Study|Death|3
4654866|NCT02130570|7539072|FG001|Overall Study|Death|5
4654867|NCT02130570|7539071|FG000|Overall Study|Withdrawal by Subject|6
4654868|NCT02130570|7539072|FG001|Overall Study|Withdrawal by Subject|3
4654869|NCT02130570|7539071|FG000|Overall Study|Part of practice that discontinued study|0
4654870|NCT02130570|7539072|FG001|Overall Study|Part of practice that discontinued study|5
4654871|NCT02130765|7539136|FG000|Overall Study|Did not receive treatment|4
4654872|NCT02130765|7539137|FG001|Overall Study|Did not receive treatment|0
4654873|NCT02130765|7539138|FG002|Overall Study|Did not receive treatment|0
4654874|NCT02130765|7539139|FG003|Overall Study|Did not receive treatment|0
4654875|NCT02130986|7539153|FG000|Overall Study|Withdrawal by Subject|4
4654876|NCT02130986|7539154|FG001|Overall Study|Withdrawal by Subject|4
4654877|NCT02130986|7539153|FG000|Overall Study|Lost to Follow-up|151
4654878|NCT02130986|7539154|FG001|Overall Study|Lost to Follow-up|160
4654879|NCT02131064|7539176|FG000|Overall Study|Death|5
4654880|NCT02131064|7539177|FG001|Overall Study|Death|6
4654881|NCT02131064|7539176|FG000|Overall Study|Lost to Follow-up|4
4654882|NCT02131064|7539177|FG001|Overall Study|Lost to Follow-up|8
4654883|NCT02131064|7539176|FG000|Overall Study|Withdrawal by Subject|14
4654884|NCT02131064|7539177|FG001|Overall Study|Withdrawal by Subject|18
4654885|NCT02131064|7539176|FG000|Overall Study|Other|2
4654886|NCT02131064|7539177|FG001|Overall Study|Other|2
4654887|NCT02131129|7539186|FG000|Overall Study|Withdrawal by Subject|1
4654888|NCT02131129|7539187|FG001|Overall Study|Withdrawal by Subject|0
4654889|NCT02131233|7539195|FG000|Overall Study|Not Treated|2
4654890|NCT02131233|7539196|FG001|Overall Study|Not Treated|3
4654891|NCT02131233|7539195|FG000|Overall Study|Adverse Event|7
4654892|NCT02131233|7539196|FG001|Overall Study|Adverse Event|6
4654893|NCT02131233|7539195|FG000|Overall Study|Death|0
4654894|NCT02131233|7539196|FG001|Overall Study|Death|1
4654895|NCT02131233|7539195|FG000|Overall Study|Lack of Efficacy|6
4654896|NCT02131233|7539196|FG001|Overall Study|Lack of Efficacy|3
4654897|NCT02131233|7539195|FG000|Overall Study|Lost to Follow-up|14
4654898|NCT02131233|7539196|FG001|Overall Study|Lost to Follow-up|13
4654899|NCT02131233|7539195|FG000|Overall Study|Non-Compliance With Study Drug|8
4654900|NCT02131233|7539196|FG001|Overall Study|Non-Compliance With Study Drug|5
4654901|NCT02131233|7539195|FG000|Overall Study|Physician Decision|7
4654902|NCT02131233|7539196|FG001|Overall Study|Physician Decision|0
4654903|NCT02131233|7539195|FG000|Overall Study|Pregnancy|4
4654904|NCT02131233|7539196|FG001|Overall Study|Pregnancy|0
4654905|NCT02131233|7539195|FG000|Overall Study|Withdrawal by Subject|18
4654906|NCT02131233|7539196|FG001|Overall Study|Withdrawal by Subject|11
4654907|NCT02131259|7539202|FG000|Overall Study|Progressive disease|751
4654908|NCT02131259|7539202|FG000|Overall Study|Adverse Event|341
4654909|NCT02131259|7539202|FG000|Overall Study|Lost to Follow-up|7
4654910|NCT02131259|7539202|FG000|Overall Study|Relocation|32
4654911|NCT02131259|7539202|FG000|Overall Study|Other|63
4654912|NCT02131259|7539202|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22
4654913|NCT02131259|7539202|FG000|Overall Study|Progressive disease/relocation|1
4654914|NCT02131259|7539202|FG000|Overall Study|Progressive disease/other|2
4654915|NCT02131259|7539202|FG000|Overall Study|AE/lost to follow-up|1
4654916|NCT02131259|7539202|FG000|Overall Study|AE/other|1
4654917|NCT02131259|7539202|FG000|Overall Study|Progressive disease/AE/other|1
4654918|NCT02131259|7539202|FG000|Overall Study|Missing|3
4654919|NCT02131272|7539208|FG000|Overall Study|Withdrawal by parent|0
4654920|NCT02131272|7539209|FG001|Overall Study|Withdrawal by parent|1
4654921|NCT02131272|7539208|FG000|Overall Study|Withdrawal by Subject|0
4654922|NCT02131272|7539209|FG001|Overall Study|Withdrawal by Subject|1
4654923|NCT02131272|7539208|FG000|Overall Study|Withdrawal Criteria|1
4654924|NCT02131272|7539209|FG001|Overall Study|Withdrawal Criteria|0
4654925|NCT02131311|7539215|FG000|Overall Study|Adverse Event|2
4654926|NCT02131311|7539215|FG000|Overall Study|Protocol Violation|1
4654927|NCT02131311|7539215|FG000|Overall Study|Lost to Follow-up|1
4654928|NCT02131324|7539222|FG000|Overall Study|Withdrawal by Subject|1
4654929|NCT02131324|7539223|FG001|Overall Study|Withdrawal by Subject|2
4654930|NCT02131324|7539222|FG000|Overall Study|Lost to Follow-up|1
4654931|NCT02131324|7539223|FG001|Overall Study|Lost to Follow-up|1
4654932|NCT02131532|7539292|FG000|Overall Study|Withdrawal by Subject|1
4654933|NCT02131532|7539292|FG000|Overall Study|Physician Decision|1
4654934|NCT02131532|7539292|FG000|Overall Study|Other health conditions|2
4654935|NCT02131636|7539299|FG000|Overall Study|Personal Reasons|4
4654936|NCT02131636|7539300|FG001|Overall Study|Personal Reasons|4
4654937|NCT02131636|7539299|FG000|Overall Study|Lost to Follow-up|4
4654938|NCT02131636|7539300|FG001|Overall Study|Lost to Follow-up|0
4654939|NCT02131636|7539299|FG000|Overall Study|Adverse Event|4
4654940|NCT02131636|7539300|FG001|Overall Study|Adverse Event|1
4654941|NCT02131662|7539311|FG000|Overall Study|Protocol Violation|1
4654942|NCT02131662|7539312|FG001|Overall Study|Protocol Violation|0
4654943|NCT02131662|7539313|FG002|Overall Study|Protocol Violation|0
4654944|NCT02131662|7539314|FG003|Overall Study|Protocol Violation|0
4654945|NCT02131662|7539315|FG004|Overall Study|Protocol Violation|0
4654946|NCT02131662|7539311|FG000|Overall Study|Other|2
4654947|NCT02131662|7539312|FG001|Overall Study|Other|4
4654948|NCT02131662|7539313|FG002|Overall Study|Other|3
4654949|NCT02131662|7539314|FG003|Overall Study|Other|3
4654950|NCT02131662|7539315|FG004|Overall Study|Other|4
4654951|NCT02131662|7539311|FG000|Overall Study|Adverse Event|0
4654952|NCT02131662|7539312|FG001|Overall Study|Adverse Event|1
4654953|NCT02131662|7539313|FG002|Overall Study|Adverse Event|1
4654954|NCT02131662|7539314|FG003|Overall Study|Adverse Event|1
4654955|NCT02131662|7539315|FG004|Overall Study|Adverse Event|3
4654956|NCT02131662|7539311|FG000|Overall Study|Pregnancy|0
4654957|NCT02131662|7539312|FG001|Overall Study|Pregnancy|1
4654958|NCT02131662|7539313|FG002|Overall Study|Pregnancy|0
4654959|NCT02131662|7539314|FG003|Overall Study|Pregnancy|1
4654960|NCT02131662|7539315|FG004|Overall Study|Pregnancy|0
4654961|NCT02131662|7539311|FG000|Overall Study|Wish for pregnancy|0
4654962|NCT02131662|7539312|FG001|Overall Study|Wish for pregnancy|0
4654963|NCT02131662|7539313|FG002|Overall Study|Wish for pregnancy|0
4654964|NCT02131662|7539314|FG003|Overall Study|Wish for pregnancy|0
4654965|NCT02131662|7539315|FG004|Overall Study|Wish for pregnancy|1
4654966|NCT02131662|7539311|FG000|Overall Study|Lack of Efficacy|1
4654967|NCT02131662|7539312|FG001|Overall Study|Lack of Efficacy|0
4654968|NCT02131662|7539313|FG002|Overall Study|Lack of Efficacy|0
4654969|NCT02131662|7539314|FG003|Overall Study|Lack of Efficacy|0
4654970|NCT02131662|7539315|FG004|Overall Study|Lack of Efficacy|1
4654971|NCT02131662|7539311|FG000|Overall Study|Withdrawal by Subject|1
4654972|NCT02131662|7539312|FG001|Overall Study|Withdrawal by Subject|5
4654973|NCT02131662|7539313|FG002|Overall Study|Withdrawal by Subject|1
4654974|NCT02131662|7539314|FG003|Overall Study|Withdrawal by Subject|5
4654975|NCT02131662|7539315|FG004|Overall Study|Withdrawal by Subject|6
4654976|NCT02131662|7539311|FG000|Overall Study|Lost to Follow-up|1
4654977|NCT02131662|7539312|FG001|Overall Study|Lost to Follow-up|3
4748365|NCT03581786|7722284|FG000|Overall Study|Death|17
4748366|NCT03581786|7722285|FG001|Overall Study|Death|12
4748367|NCT03581786|7722284|FG000|Overall Study|Withdrawal by Subject|2
4748368|NCT03581786|7722285|FG001|Overall Study|Withdrawal by Subject|4
4748369|NCT03581786|7722284|FG000|Overall Study|Lost to Follow-up|1
4748370|NCT03581786|7722285|FG001|Overall Study|Lost to Follow-up|0
4748371|NCT03581786|7722284|FG000|Overall Study|reason other than specified above|0
4748372|NCT03581786|7722285|FG001|Overall Study|reason other than specified above|1
4748373|NCT03581786|7722284|FG000|Overall Study|Ongoing in the study|123
4748374|NCT03581786|7722285|FG001|Overall Study|Ongoing in the study|129
4654978|NCT02131662|7539313|FG002|Overall Study|Lost to Follow-up|0
4654979|NCT02131662|7539314|FG003|Overall Study|Lost to Follow-up|9
4654980|NCT02131662|7539315|FG004|Overall Study|Lost to Follow-up|0
4654981|NCT02131662|7539311|FG000|Overall Study|Not treated|2
4654982|NCT02131662|7539312|FG001|Overall Study|Not treated|0
4654983|NCT02131662|7539313|FG002|Overall Study|Not treated|2
4654984|NCT02131662|7539314|FG003|Overall Study|Not treated|2
4654985|NCT02131662|7539315|FG004|Overall Study|Not treated|3
4654986|NCT02131766|7539331|FG000|Overall Study|Withdrawal by Subject|4
4654987|NCT02132117|7539340|FG000|Overall Study|Adverse Event|6
4654988|NCT02132117|7539341|FG001|Overall Study|Adverse Event|1
4654989|NCT02132117|7539340|FG000|Overall Study|Lost to Follow-up|2
4654990|NCT02132117|7539341|FG001|Overall Study|Lost to Follow-up|2
4654991|NCT02132117|7539340|FG000|Overall Study|Personal Reasons|1
4654992|NCT02132117|7539341|FG001|Overall Study|Personal Reasons|2
4654993|NCT02132117|7539340|FG000|Overall Study|Other Miscellaneous Reasons|2
4654994|NCT02132117|7539341|FG001|Overall Study|Other Miscellaneous Reasons|0
4654995|NCT02132130|7539351|FG000|Overall Study|Lost to Follow-up|0
4654996|NCT02132130|7539352|FG001|Overall Study|Lost to Follow-up|2
4654997|NCT02132130|7539353|FG002|Overall Study|Lost to Follow-up|0
4654998|NCT02132130|7539354|FG003|Overall Study|Lost to Follow-up|0
4654999|NCT02132130|7539351|FG000|Overall Study|Withdrawal by Subject|0
4655000|NCT02132130|7539352|FG001|Overall Study|Withdrawal by Subject|0
4655001|NCT02132130|7539353|FG002|Overall Study|Withdrawal by Subject|0
4655002|NCT02132130|7539354|FG003|Overall Study|Withdrawal by Subject|1
4655003|NCT02132195|7539380|FG000|Initial Assignment|Relapsed|14
4655004|NCT02132195|7539381|FG001|Initial Assignment|Relapsed|0
4655005|NCT02132195|7539382|FG002|Initial Assignment|Relapsed|0
4655006|NCT02132195|7539380|FG000|Rescue Therapy|Relapsed|0
4655007|NCT02132195|7539381|FG001|Rescue Therapy|Relapsed|0
4655008|NCT02132195|7539382|FG002|Rescue Therapy|Relapsed|7
4655009|NCT02132195|7539380|FG000|Rescue Therapy|Physician Decision|0
4655010|NCT02132195|7539381|FG001|Rescue Therapy|Physician Decision|0
4655011|NCT02132195|7539382|FG002|Rescue Therapy|Physician Decision|1
4655012|NCT02132195|7539380|FG000|Rescue Therapy|Withdrawal by Subject|0
4655013|NCT02132195|7539381|FG001|Rescue Therapy|Withdrawal by Subject|0
4655014|NCT02132195|7539382|FG002|Rescue Therapy|Withdrawal by Subject|1
4655015|NCT02132195|7539380|FG000|Rescue Therapy|Adverse Event|0
4655016|NCT02132195|7539381|FG001|Rescue Therapy|Adverse Event|0
4655017|NCT02132195|7539382|FG002|Rescue Therapy|Adverse Event|2
4655018|NCT02132247|7539392|FG000|Overall Study|Protocol Violation|1
4655019|NCT02132247|7539393|FG001|Overall Study|Protocol Violation|0
4655020|NCT02132312|7539401|FG000|Overall Study|Adverse Event|2
4655021|NCT02132312|7539402|FG001|Overall Study|Adverse Event|0
4655022|NCT02132312|7539401|FG000|Overall Study|Physician Decision|1
4655023|NCT02132312|7539402|FG001|Overall Study|Physician Decision|1
4655024|NCT02132312|7539401|FG000|Overall Study|Protocol Violation|0
4655025|NCT02132312|7539402|FG001|Overall Study|Protocol Violation|1
4655026|NCT02132312|7539401|FG000|Overall Study|Withdrawal by Subject|1
4655027|NCT02132312|7539402|FG001|Overall Study|Withdrawal by Subject|0
4655028|NCT02132312|7539401|FG000|Overall Study|Lost to Follow-up|2
4655029|NCT02132312|7539402|FG001|Overall Study|Lost to Follow-up|1
4655030|NCT02132637|7539443|FG000|Study Period 1|Withdrawal by Subject|0
4655031|NCT02132637|7539444|FG001|Study Period 1|Withdrawal by Subject|4
4655032|NCT02132637|7539443|FG000|Study Period 1|Physician Decision|1
4655033|NCT02132637|7539444|FG001|Study Period 1|Physician Decision|0
4655034|NCT02132637|7539443|FG000|Study Period 2 (Crossover)|Adverse Event|0
4655035|NCT02132637|7539444|FG001|Study Period 2 (Crossover)|Adverse Event|1
4655036|NCT02132637|7539443|FG000|Study Period 2 (Crossover)|Physician Decision|2
4655037|NCT02132637|7539444|FG001|Study Period 2 (Crossover)|Physician Decision|0
4655038|NCT02132754|7539503|FG000|Overall Study|Adverse Event|0
4655039|NCT02132754|7539504|FG001|Overall Study|Adverse Event|0
4655040|NCT02132754|7539505|FG002|Overall Study|Adverse Event|0
4655041|NCT02132754|7539506|FG003|Overall Study|Adverse Event|0
4655042|NCT02132754|7539507|FG004|Overall Study|Adverse Event|0
4655043|NCT02132754|7539508|FG005|Overall Study|Adverse Event|0
4655044|NCT02132754|7539509|FG006|Overall Study|Adverse Event|0
4655045|NCT02132754|7539510|FG007|Overall Study|Adverse Event|0
4655046|NCT02132754|7539511|FG008|Overall Study|Adverse Event|0
4655047|NCT02132754|7539512|FG009|Overall Study|Adverse Event|0
4655048|NCT02132754|7539513|FG010|Overall Study|Adverse Event|0
4655049|NCT02132754|7539514|FG011|Overall Study|Adverse Event|0
4655050|NCT02132754|7539515|FG012|Overall Study|Adverse Event|0
4655051|NCT02132754|7539516|FG013|Overall Study|Adverse Event|0
4655052|NCT02132754|7539517|FG014|Overall Study|Adverse Event|0
4655053|NCT02132754|7539518|FG015|Overall Study|Adverse Event|0
4655054|NCT02132754|7539519|FG016|Overall Study|Adverse Event|0
4655055|NCT02132754|7539520|FG017|Overall Study|Adverse Event|1
4655056|NCT02132754|7539521|FG018|Overall Study|Adverse Event|0
4655057|NCT02132754|7539522|FG019|Overall Study|Adverse Event|0
4655058|NCT02132754|7539523|FG020|Overall Study|Adverse Event|0
4655059|NCT02132754|7539524|FG021|Overall Study|Adverse Event|0
4655060|NCT02132754|7539525|FG022|Overall Study|Adverse Event|0
4655061|NCT02132754|7539526|FG023|Overall Study|Adverse Event|0
4655062|NCT02132754|7539527|FG024|Overall Study|Adverse Event|0
4655063|NCT02132754|7539528|FG025|Overall Study|Adverse Event|1
4655064|NCT02132754|7539529|FG026|Overall Study|Adverse Event|1
4655065|NCT02132754|7539530|FG027|Overall Study|Adverse Event|0
4655066|NCT02132754|7539531|FG028|Overall Study|Adverse Event|0
4655067|NCT02132754|7539532|FG029|Overall Study|Adverse Event|0
4655068|NCT02132754|7539533|FG030|Overall Study|Adverse Event|1
4655069|NCT02132754|7539534|FG031|Overall Study|Adverse Event|0
4655070|NCT02132754|7539535|FG032|Overall Study|Adverse Event|1
4655071|NCT02132754|7539536|FG033|Overall Study|Adverse Event|1
4655072|NCT02132754|7539503|FG000|Overall Study|Clinical Progression|0
4655073|NCT02132754|7539504|FG001|Overall Study|Clinical Progression|0
4655074|NCT02132754|7539505|FG002|Overall Study|Clinical Progression|0
4655075|NCT02132754|7539506|FG003|Overall Study|Clinical Progression|0
4655076|NCT02132754|7539507|FG004|Overall Study|Clinical Progression|0
4655077|NCT02132754|7539508|FG005|Overall Study|Clinical Progression|0
4655078|NCT02132754|7539509|FG006|Overall Study|Clinical Progression|0
4655079|NCT02132754|7539510|FG007|Overall Study|Clinical Progression|0
4655080|NCT02132754|7539511|FG008|Overall Study|Clinical Progression|0
4655081|NCT02132754|7539512|FG009|Overall Study|Clinical Progression|1
4655082|NCT02132754|7539513|FG010|Overall Study|Clinical Progression|0
4655083|NCT02132754|7539514|FG011|Overall Study|Clinical Progression|0
4655084|NCT02132754|7539515|FG012|Overall Study|Clinical Progression|0
4655085|NCT02132754|7539516|FG013|Overall Study|Clinical Progression|0
4655086|NCT02132754|7539517|FG014|Overall Study|Clinical Progression|0
4655087|NCT02132754|7539518|FG015|Overall Study|Clinical Progression|0
4655088|NCT02132754|7539519|FG016|Overall Study|Clinical Progression|1
4655089|NCT02132754|7539520|FG017|Overall Study|Clinical Progression|1
4655090|NCT02132754|7539521|FG018|Overall Study|Clinical Progression|0
4655091|NCT02132754|7539522|FG019|Overall Study|Clinical Progression|1
4655092|NCT02132754|7539523|FG020|Overall Study|Clinical Progression|0
4655093|NCT02132754|7539524|FG021|Overall Study|Clinical Progression|0
4655094|NCT02132754|7539525|FG022|Overall Study|Clinical Progression|1
4655095|NCT02132754|7539526|FG023|Overall Study|Clinical Progression|0
4655096|NCT02132754|7539527|FG024|Overall Study|Clinical Progression|1
4655097|NCT02132754|7539528|FG025|Overall Study|Clinical Progression|1
4655098|NCT02132754|7539529|FG026|Overall Study|Clinical Progression|0
4655099|NCT02132754|7539530|FG027|Overall Study|Clinical Progression|1
4655100|NCT02132754|7539531|FG028|Overall Study|Clinical Progression|1
4655101|NCT02132754|7539532|FG029|Overall Study|Clinical Progression|0
4655102|NCT02132754|7539533|FG030|Overall Study|Clinical Progression|1
4655103|NCT02132754|7539534|FG031|Overall Study|Clinical Progression|0
4655104|NCT02132754|7539535|FG032|Overall Study|Clinical Progression|0
4655105|NCT02132754|7539536|FG033|Overall Study|Clinical Progression|2
4655106|NCT02132754|7539503|FG000|Overall Study|Death|0
4655107|NCT02132754|7539504|FG001|Overall Study|Death|0
4655108|NCT02132754|7539505|FG002|Overall Study|Death|0
4655109|NCT02132754|7539506|FG003|Overall Study|Death|0
4655110|NCT02132754|7539507|FG004|Overall Study|Death|0
4655111|NCT02132754|7539508|FG005|Overall Study|Death|0
4655112|NCT02132754|7539509|FG006|Overall Study|Death|0
4655113|NCT02132754|7539510|FG007|Overall Study|Death|0
4655114|NCT02132754|7539511|FG008|Overall Study|Death|0
4655115|NCT02132754|7539512|FG009|Overall Study|Death|0
4655116|NCT02132754|7539513|FG010|Overall Study|Death|0
4655117|NCT02132754|7539514|FG011|Overall Study|Death|0
4655118|NCT02132754|7539515|FG012|Overall Study|Death|0
4655119|NCT02132754|7539516|FG013|Overall Study|Death|0
4655120|NCT02132754|7539517|FG014|Overall Study|Death|0
4655121|NCT02132754|7539518|FG015|Overall Study|Death|1
4655122|NCT02132754|7539519|FG016|Overall Study|Death|0
4655123|NCT02132754|7539520|FG017|Overall Study|Death|0
4655124|NCT02132754|7539521|FG018|Overall Study|Death|0
4655125|NCT02132754|7539522|FG019|Overall Study|Death|1
4655126|NCT02132754|7539523|FG020|Overall Study|Death|0
4655127|NCT02132754|7539524|FG021|Overall Study|Death|1
4655128|NCT02132754|7539525|FG022|Overall Study|Death|0
4655129|NCT02132754|7539526|FG023|Overall Study|Death|0
4655130|NCT02132754|7539527|FG024|Overall Study|Death|0
4655131|NCT02132754|7539528|FG025|Overall Study|Death|0
4655132|NCT02132754|7539529|FG026|Overall Study|Death|1
4655133|NCT02132754|7539530|FG027|Overall Study|Death|0
4655134|NCT02132754|7539531|FG028|Overall Study|Death|0
4655135|NCT02132754|7539532|FG029|Overall Study|Death|0
4655136|NCT02132754|7539533|FG030|Overall Study|Death|0
4655137|NCT02132754|7539534|FG031|Overall Study|Death|0
4655138|NCT02132754|7539535|FG032|Overall Study|Death|0
4655139|NCT02132754|7539536|FG033|Overall Study|Death|2
4655140|NCT02132754|7539503|FG000|Overall Study|Excluded Medication|0
4655141|NCT02132754|7539504|FG001|Overall Study|Excluded Medication|0
4655142|NCT02132754|7539505|FG002|Overall Study|Excluded Medication|0
4655143|NCT02132754|7539506|FG003|Overall Study|Excluded Medication|0
4655144|NCT02132754|7539507|FG004|Overall Study|Excluded Medication|0
4655145|NCT02132754|7539508|FG005|Overall Study|Excluded Medication|0
4655146|NCT02132754|7539509|FG006|Overall Study|Excluded Medication|0
4655147|NCT02132754|7539510|FG007|Overall Study|Excluded Medication|0
4655148|NCT02132754|7539511|FG008|Overall Study|Excluded Medication|0
4655149|NCT02132754|7539512|FG009|Overall Study|Excluded Medication|0
4655150|NCT02132754|7539513|FG010|Overall Study|Excluded Medication|0
4655151|NCT02132754|7539514|FG011|Overall Study|Excluded Medication|0
4655152|NCT02132754|7539515|FG012|Overall Study|Excluded Medication|0
4655153|NCT02132754|7539516|FG013|Overall Study|Excluded Medication|0
4655154|NCT02132754|7539517|FG014|Overall Study|Excluded Medication|0
4655155|NCT02132754|7539518|FG015|Overall Study|Excluded Medication|0
4655156|NCT02132754|7539519|FG016|Overall Study|Excluded Medication|0
4655157|NCT02132754|7539520|FG017|Overall Study|Excluded Medication|0
4655158|NCT02132754|7539521|FG018|Overall Study|Excluded Medication|0
4655159|NCT02132754|7539522|FG019|Overall Study|Excluded Medication|0
4655160|NCT02132754|7539523|FG020|Overall Study|Excluded Medication|1
4655161|NCT02132754|7539524|FG021|Overall Study|Excluded Medication|0
4655162|NCT02132754|7539525|FG022|Overall Study|Excluded Medication|0
4655163|NCT02132754|7539526|FG023|Overall Study|Excluded Medication|0
4655164|NCT02132754|7539527|FG024|Overall Study|Excluded Medication|0
4655165|NCT02132754|7539528|FG025|Overall Study|Excluded Medication|0
4655166|NCT02132754|7539529|FG026|Overall Study|Excluded Medication|0
4655167|NCT02132754|7539530|FG027|Overall Study|Excluded Medication|0
4655168|NCT02132754|7539531|FG028|Overall Study|Excluded Medication|0
4655169|NCT02132754|7539532|FG029|Overall Study|Excluded Medication|0
4655170|NCT02132754|7539533|FG030|Overall Study|Excluded Medication|0
4655171|NCT02132754|7539534|FG031|Overall Study|Excluded Medication|0
4655172|NCT02132754|7539535|FG032|Overall Study|Excluded Medication|0
4655173|NCT02132754|7539536|FG033|Overall Study|Excluded Medication|1
4655174|NCT02132754|7539503|FG000|Overall Study|Physician Decision|0
4655175|NCT02132754|7539504|FG001|Overall Study|Physician Decision|0
4655176|NCT02132754|7539505|FG002|Overall Study|Physician Decision|0
4655177|NCT02132754|7539506|FG003|Overall Study|Physician Decision|0
4655178|NCT02132754|7539507|FG004|Overall Study|Physician Decision|0
4655179|NCT02132754|7539508|FG005|Overall Study|Physician Decision|0
4655180|NCT02132754|7539509|FG006|Overall Study|Physician Decision|0
4655181|NCT02132754|7539510|FG007|Overall Study|Physician Decision|0
4655182|NCT02132754|7539511|FG008|Overall Study|Physician Decision|0
4655183|NCT02132754|7539512|FG009|Overall Study|Physician Decision|1
4655184|NCT02132754|7539513|FG010|Overall Study|Physician Decision|0
4655185|NCT02132754|7539514|FG011|Overall Study|Physician Decision|1
4655186|NCT02132754|7539515|FG012|Overall Study|Physician Decision|1
4655187|NCT02132754|7539516|FG013|Overall Study|Physician Decision|0
4655188|NCT02132754|7539517|FG014|Overall Study|Physician Decision|0
4655189|NCT02132754|7539518|FG015|Overall Study|Physician Decision|1
4655190|NCT02132754|7539519|FG016|Overall Study|Physician Decision|0
4655191|NCT02132754|7539520|FG017|Overall Study|Physician Decision|0
4655192|NCT02132754|7539521|FG018|Overall Study|Physician Decision|0
4655193|NCT02132754|7539522|FG019|Overall Study|Physician Decision|0
4655194|NCT02132754|7539523|FG020|Overall Study|Physician Decision|0
4655195|NCT02132754|7539524|FG021|Overall Study|Physician Decision|0
4655196|NCT02132754|7539525|FG022|Overall Study|Physician Decision|0
4655197|NCT02132754|7539526|FG023|Overall Study|Physician Decision|0
4655198|NCT02132754|7539527|FG024|Overall Study|Physician Decision|1
4655199|NCT02132754|7539528|FG025|Overall Study|Physician Decision|0
4655200|NCT02132754|7539529|FG026|Overall Study|Physician Decision|0
4655201|NCT02132754|7539530|FG027|Overall Study|Physician Decision|0
4655202|NCT02132754|7539531|FG028|Overall Study|Physician Decision|0
4655203|NCT02132754|7539532|FG029|Overall Study|Physician Decision|0
4655204|NCT02132754|7539533|FG030|Overall Study|Physician Decision|0
4655205|NCT02132754|7539534|FG031|Overall Study|Physician Decision|1
4655206|NCT02132754|7539535|FG032|Overall Study|Physician Decision|0
4655207|NCT02132754|7539536|FG033|Overall Study|Physician Decision|3
4655208|NCT02132754|7539503|FG000|Overall Study|Progressive Disease|1
4655209|NCT02132754|7539504|FG001|Overall Study|Progressive Disease|1
4655210|NCT02132754|7539505|FG002|Overall Study|Progressive Disease|1
4655211|NCT02132754|7539506|FG003|Overall Study|Progressive Disease|1
4655212|NCT02132754|7539507|FG004|Overall Study|Progressive Disease|1
4655213|NCT02132754|7539508|FG005|Overall Study|Progressive Disease|1
4655214|NCT02132754|7539509|FG006|Overall Study|Progressive Disease|1
4655215|NCT02132754|7539510|FG007|Overall Study|Progressive Disease|1
4655216|NCT02132754|7539511|FG008|Overall Study|Progressive Disease|1
4655217|NCT02132754|7539512|FG009|Overall Study|Progressive Disease|3
4655218|NCT02132754|7539513|FG010|Overall Study|Progressive Disease|3
4655219|NCT02132754|7539514|FG011|Overall Study|Progressive Disease|2
4655220|NCT02132754|7539515|FG012|Overall Study|Progressive Disease|2
4655221|NCT02132754|7539516|FG013|Overall Study|Progressive Disease|3
4655222|NCT02132754|7539517|FG014|Overall Study|Progressive Disease|2
4655223|NCT02132754|7539518|FG015|Overall Study|Progressive Disease|1
4655224|NCT02132754|7539519|FG016|Overall Study|Progressive Disease|2
4655225|NCT02132754|7539520|FG017|Overall Study|Progressive Disease|1
4655226|NCT02132754|7539521|FG018|Overall Study|Progressive Disease|3
4655227|NCT02132754|7539522|FG019|Overall Study|Progressive Disease|1
4655228|NCT02132754|7539523|FG020|Overall Study|Progressive Disease|1
4655229|NCT02132754|7539524|FG021|Overall Study|Progressive Disease|3
4655230|NCT02132754|7539525|FG022|Overall Study|Progressive Disease|2
4655231|NCT02132754|7539526|FG023|Overall Study|Progressive Disease|3
4655232|NCT02132754|7539527|FG024|Overall Study|Progressive Disease|0
4655233|NCT02132754|7539528|FG025|Overall Study|Progressive Disease|1
4655234|NCT02132754|7539529|FG026|Overall Study|Progressive Disease|2
4655235|NCT02132754|7539530|FG027|Overall Study|Progressive Disease|1
4655236|NCT02132754|7539531|FG028|Overall Study|Progressive Disease|2
4655237|NCT02132754|7539532|FG029|Overall Study|Progressive Disease|3
4655238|NCT02132754|7539533|FG030|Overall Study|Progressive Disease|1
4655239|NCT02132754|7539534|FG031|Overall Study|Progressive Disease|1
4655240|NCT02132754|7539535|FG032|Overall Study|Progressive Disease|3
4655241|NCT02132754|7539536|FG033|Overall Study|Progressive Disease|6
4655242|NCT02132754|7539503|FG000|Overall Study|Screen Failure|0
4655243|NCT02132754|7539504|FG001|Overall Study|Screen Failure|0
4655244|NCT02132754|7539505|FG002|Overall Study|Screen Failure|0
4655245|NCT02132754|7539506|FG003|Overall Study|Screen Failure|0
4655246|NCT02132754|7539507|FG004|Overall Study|Screen Failure|0
4655247|NCT02132754|7539508|FG005|Overall Study|Screen Failure|0
4655248|NCT02132754|7539509|FG006|Overall Study|Screen Failure|0
4655249|NCT02132754|7539510|FG007|Overall Study|Screen Failure|0
4655250|NCT02132754|7539511|FG008|Overall Study|Screen Failure|0
4655251|NCT02132754|7539512|FG009|Overall Study|Screen Failure|0
4655252|NCT02132754|7539513|FG010|Overall Study|Screen Failure|0
4655253|NCT02132754|7539514|FG011|Overall Study|Screen Failure|0
4655254|NCT02132754|7539515|FG012|Overall Study|Screen Failure|0
4655255|NCT02132754|7539516|FG013|Overall Study|Screen Failure|0
4655256|NCT02132754|7539517|FG014|Overall Study|Screen Failure|0
4655257|NCT02132754|7539518|FG015|Overall Study|Screen Failure|0
4655258|NCT02132754|7539519|FG016|Overall Study|Screen Failure|0
4655259|NCT02132754|7539520|FG017|Overall Study|Screen Failure|0
4655260|NCT02132754|7539521|FG018|Overall Study|Screen Failure|0
4655261|NCT02132754|7539522|FG019|Overall Study|Screen Failure|1
4655262|NCT02132754|7539523|FG020|Overall Study|Screen Failure|0
4655263|NCT02132754|7539524|FG021|Overall Study|Screen Failure|1
4655264|NCT02132754|7539525|FG022|Overall Study|Screen Failure|0
4655265|NCT02132754|7539526|FG023|Overall Study|Screen Failure|0
4655266|NCT02132754|7539527|FG024|Overall Study|Screen Failure|0
4655267|NCT02132754|7539528|FG025|Overall Study|Screen Failure|0
4655268|NCT02132754|7539529|FG026|Overall Study|Screen Failure|0
4655269|NCT02132754|7539530|FG027|Overall Study|Screen Failure|0
4655270|NCT02132754|7539531|FG028|Overall Study|Screen Failure|0
4655271|NCT02132754|7539532|FG029|Overall Study|Screen Failure|0
4655272|NCT02132754|7539533|FG030|Overall Study|Screen Failure|0
4655273|NCT02132754|7539534|FG031|Overall Study|Screen Failure|0
4655274|NCT02132754|7539535|FG032|Overall Study|Screen Failure|0
4655275|NCT02132754|7539536|FG033|Overall Study|Screen Failure|0
4655276|NCT02132754|7539503|FG000|Overall Study|Transferred to Extension Study|0
4655277|NCT02132754|7539504|FG001|Overall Study|Transferred to Extension Study|0
4655278|NCT02132754|7539505|FG002|Overall Study|Transferred to Extension Study|0
4655279|NCT02132754|7539506|FG003|Overall Study|Transferred to Extension Study|0
4655280|NCT02132754|7539507|FG004|Overall Study|Transferred to Extension Study|0
4655281|NCT02132754|7539508|FG005|Overall Study|Transferred to Extension Study|0
4655282|NCT02132754|7539509|FG006|Overall Study|Transferred to Extension Study|0
4655283|NCT02132754|7539510|FG007|Overall Study|Transferred to Extension Study|0
4655284|NCT02132754|7539511|FG008|Overall Study|Transferred to Extension Study|0
4655285|NCT02132754|7539512|FG009|Overall Study|Transferred to Extension Study|0
4655286|NCT02132754|7539513|FG010|Overall Study|Transferred to Extension Study|0
4655287|NCT02132754|7539514|FG011|Overall Study|Transferred to Extension Study|0
4655288|NCT02132754|7539515|FG012|Overall Study|Transferred to Extension Study|0
4655289|NCT02132754|7539516|FG013|Overall Study|Transferred to Extension Study|0
4655290|NCT02132754|7539517|FG014|Overall Study|Transferred to Extension Study|0
4655291|NCT02132754|7539518|FG015|Overall Study|Transferred to Extension Study|0
4655292|NCT02132754|7539519|FG016|Overall Study|Transferred to Extension Study|0
4655293|NCT02132754|7539520|FG017|Overall Study|Transferred to Extension Study|0
4655294|NCT02132754|7539521|FG018|Overall Study|Transferred to Extension Study|0
4655295|NCT02132754|7539522|FG019|Overall Study|Transferred to Extension Study|0
4655296|NCT02132754|7539523|FG020|Overall Study|Transferred to Extension Study|0
4655297|NCT02132754|7539524|FG021|Overall Study|Transferred to Extension Study|0
4655298|NCT02132754|7539525|FG022|Overall Study|Transferred to Extension Study|0
4655299|NCT02132754|7539526|FG023|Overall Study|Transferred to Extension Study|0
4655300|NCT02132754|7539527|FG024|Overall Study|Transferred to Extension Study|0
4655301|NCT02132754|7539528|FG025|Overall Study|Transferred to Extension Study|0
4655302|NCT02132754|7539529|FG026|Overall Study|Transferred to Extension Study|0
4655303|NCT02132754|7539530|FG027|Overall Study|Transferred to Extension Study|0
4655304|NCT02132754|7539531|FG028|Overall Study|Transferred to Extension Study|0
4655305|NCT02132754|7539532|FG029|Overall Study|Transferred to Extension Study|0
4655306|NCT02132754|7539533|FG030|Overall Study|Transferred to Extension Study|0
4655307|NCT02132754|7539534|FG031|Overall Study|Transferred to Extension Study|0
4655308|NCT02132754|7539535|FG032|Overall Study|Transferred to Extension Study|0
4655309|NCT02132754|7539536|FG033|Overall Study|Transferred to Extension Study|6
4655310|NCT02132754|7539503|FG000|Overall Study|Withdrawal by Subject|0
4655311|NCT02132754|7539504|FG001|Overall Study|Withdrawal by Subject|0
4655312|NCT02132754|7539505|FG002|Overall Study|Withdrawal by Subject|0
4655313|NCT02132754|7539506|FG003|Overall Study|Withdrawal by Subject|0
4655314|NCT02132754|7539507|FG004|Overall Study|Withdrawal by Subject|0
4655315|NCT02132754|7539508|FG005|Overall Study|Withdrawal by Subject|0
4655316|NCT02132754|7539509|FG006|Overall Study|Withdrawal by Subject|0
4655317|NCT02132754|7539510|FG007|Overall Study|Withdrawal by Subject|0
4655318|NCT02132754|7539511|FG008|Overall Study|Withdrawal by Subject|0
4655319|NCT02132754|7539512|FG009|Overall Study|Withdrawal by Subject|1
4655320|NCT02132754|7539513|FG010|Overall Study|Withdrawal by Subject|0
4655321|NCT02132754|7539514|FG011|Overall Study|Withdrawal by Subject|0
4655322|NCT02132754|7539515|FG012|Overall Study|Withdrawal by Subject|1
4655323|NCT02132754|7539516|FG013|Overall Study|Withdrawal by Subject|0
4655324|NCT02132754|7539517|FG014|Overall Study|Withdrawal by Subject|1
4655325|NCT02132754|7539518|FG015|Overall Study|Withdrawal by Subject|2
4655326|NCT02132754|7539519|FG016|Overall Study|Withdrawal by Subject|1
4655327|NCT02132754|7539520|FG017|Overall Study|Withdrawal by Subject|0
4655328|NCT02132754|7539521|FG018|Overall Study|Withdrawal by Subject|0
4655329|NCT02132754|7539522|FG019|Overall Study|Withdrawal by Subject|0
4655330|NCT02132754|7539523|FG020|Overall Study|Withdrawal by Subject|1
4655331|NCT02132754|7539524|FG021|Overall Study|Withdrawal by Subject|0
4655332|NCT02132754|7539525|FG022|Overall Study|Withdrawal by Subject|0
4655333|NCT02132754|7539526|FG023|Overall Study|Withdrawal by Subject|0
4655334|NCT02132754|7539527|FG024|Overall Study|Withdrawal by Subject|1
4655335|NCT02132754|7539528|FG025|Overall Study|Withdrawal by Subject|0
4655336|NCT02132754|7539529|FG026|Overall Study|Withdrawal by Subject|0
4655337|NCT02132754|7539530|FG027|Overall Study|Withdrawal by Subject|1
4655338|NCT02132754|7539531|FG028|Overall Study|Withdrawal by Subject|0
4655339|NCT02132754|7539532|FG029|Overall Study|Withdrawal by Subject|0
4655340|NCT02132754|7539533|FG030|Overall Study|Withdrawal by Subject|0
4655341|NCT02132754|7539534|FG031|Overall Study|Withdrawal by Subject|1
4655342|NCT02132754|7539535|FG032|Overall Study|Withdrawal by Subject|0
4655343|NCT02132754|7539536|FG033|Overall Study|Withdrawal by Subject|2
4655344|NCT02132767|7539648|FG000|Overall Study|Death|3
4655345|NCT02132767|7539649|FG001|Overall Study|Death|2
4655346|NCT02132767|7539648|FG000|Overall Study|Withdrawal by Subject|10
4655347|NCT02132767|7539649|FG001|Overall Study|Withdrawal by Subject|9
4655348|NCT02132767|7539648|FG000|Overall Study|Lost to Follow-up|4
4655349|NCT02132767|7539649|FG001|Overall Study|Lost to Follow-up|4
4655350|NCT02132949|7539693|FG000|Overall Study|Death|7
4655351|NCT02132949|7539694|FG001|Overall Study|Death|13
4655352|NCT02132949|7539693|FG000|Overall Study|Lost to Follow-up|14
4655353|NCT02132949|7539694|FG001|Overall Study|Lost to Follow-up|4
4655354|NCT02132949|7539693|FG000|Overall Study|Withdrawal by Subject|6
4655355|NCT02132949|7539694|FG001|Overall Study|Withdrawal by Subject|5
4655356|NCT02132949|7539693|FG000|Overall Study|Noncompliance|5
4655357|NCT02132949|7539694|FG001|Overall Study|Noncompliance|1
4655358|NCT02132949|7539693|FG000|Overall Study|Physician Decision|3
4655359|NCT02132949|7539694|FG001|Overall Study|Physician Decision|1
4655360|NCT02132949|7539693|FG000|Overall Study|Disease Progression|3
4655361|NCT02132949|7539694|FG001|Overall Study|Disease Progression|0
4655362|NCT02132949|7539693|FG000|Overall Study|Adverse Event|2
4655363|NCT02132949|7539694|FG001|Overall Study|Adverse Event|1
4655364|NCT02132949|7539693|FG000|Overall Study|Withdrew Prior to Treatment|1
4655365|NCT02132949|7539694|FG001|Overall Study|Withdrew Prior to Treatment|2
4655366|NCT02132949|7539693|FG000|Overall Study|Reason Unspecified|0
4655367|NCT02132949|7539694|FG001|Overall Study|Reason Unspecified|1
4655368|NCT02133001|7539702|FG000|Double Blind (Day 1-25)|Adverse Event|1
4655369|NCT02133001|7539703|FG001|Double Blind (Day 1-25)|Adverse Event|5
4655370|NCT02133001|7539702|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4
4655371|NCT02133001|7539703|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1
4655372|NCT02133001|7539702|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2
4655373|NCT02133001|7539703|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0
4655374|NCT02133001|7539702|FG000|Double Blind (Day 1-25)|Other|2
4655375|NCT02133001|7539703|FG001|Double Blind (Day 1-25)|Other|2
4655376|NCT02133001|7539702|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1
4655377|NCT02133001|7539703|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1
4655378|NCT02133001|7539702|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1
4655379|NCT02133001|7539703|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1
4655380|NCT02133001|7539702|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1
4655381|NCT02133001|7539703|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1
4655382|NCT02133001|7539702|FG000|Follow-Up Phase (Day 26-81)|Other|0
4655383|NCT02133001|7539703|FG001|Follow-Up Phase (Day 26-81)|Other|1
4655384|NCT02133131|7539727|FG000|Overall Study|Adverse Event|0
4655385|NCT02133131|7539728|FG001|Overall Study|Adverse Event|0
4655386|NCT02133131|7539729|FG002|Overall Study|Adverse Event|0
4655387|NCT02133131|7539730|FG003|Overall Study|Adverse Event|1
4655388|NCT02133131|7539731|FG004|Overall Study|Adverse Event|0
4655389|NCT02133131|7539732|FG005|Overall Study|Adverse Event|0
4655390|NCT02133131|7539733|FG006|Overall Study|Adverse Event|0
4655391|NCT02133131|7539727|FG000|Overall Study|Lost to Follow-up|1
4655392|NCT02133131|7539728|FG001|Overall Study|Lost to Follow-up|0
4655393|NCT02133131|7539729|FG002|Overall Study|Lost to Follow-up|0
4655394|NCT02133131|7539730|FG003|Overall Study|Lost to Follow-up|1
4655395|NCT02133131|7539731|FG004|Overall Study|Lost to Follow-up|0
4655396|NCT02133131|7539732|FG005|Overall Study|Lost to Follow-up|0
4655397|NCT02133131|7539733|FG006|Overall Study|Lost to Follow-up|0
4655398|NCT02133131|7539727|FG000|Overall Study|Status not recorded|4
4655399|NCT02133131|7539728|FG001|Overall Study|Status not recorded|5
4655400|NCT02133131|7539729|FG002|Overall Study|Status not recorded|1
4655401|NCT02133131|7539730|FG003|Overall Study|Status not recorded|4
4655402|NCT02133131|7539731|FG004|Overall Study|Status not recorded|0
4655403|NCT02133131|7539732|FG005|Overall Study|Status not recorded|0
4655404|NCT02133131|7539733|FG006|Overall Study|Status not recorded|0
4748375|NCT03486314|7722308|FG000|Part A|Adverse Event|1
4748376|NCT03486314|7722309|FG001|Part A|Adverse Event|0
4655405|NCT02133131|7539727|FG000|Overall Study|Ongoing in study|0
4655406|NCT02133131|7539728|FG001|Overall Study|Ongoing in study|0
4655407|NCT02133131|7539729|FG002|Overall Study|Ongoing in study|0
4655408|NCT02133131|7539730|FG003|Overall Study|Ongoing in study|0
4655409|NCT02133131|7539731|FG004|Overall Study|Ongoing in study|15
4748377|NCT03486314|7722310|FG002|Part A|Adverse Event|0
4748378|NCT03486314|7722308|FG000|Part A|Symptomatic Deterioration|2
4655410|NCT02133131|7539732|FG005|Overall Study|Ongoing in study|14
4655411|NCT02133131|7539733|FG006|Overall Study|Ongoing in study|11
4655412|NCT02133131|7539727|FG000|Overall Study|Protocol Violation|0
4655413|NCT02133131|7539728|FG001|Overall Study|Protocol Violation|0
4655414|NCT02133131|7539729|FG002|Overall Study|Protocol Violation|0
4655415|NCT02133131|7539730|FG003|Overall Study|Protocol Violation|0
4655416|NCT02133131|7539731|FG004|Overall Study|Protocol Violation|0
4655417|NCT02133131|7539732|FG005|Overall Study|Protocol Violation|0
4655418|NCT02133131|7539733|FG006|Overall Study|Protocol Violation|1
4655419|NCT02133352|7539764|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6
4655420|NCT02133508|7539768|FG000|Overall Study|Decision of Investigator or Sponsor|1
4655421|NCT02133508|7539768|FG000|Overall Study|Death|12
4655422|NCT02133508|7539768|FG000|Overall Study|Lost to Follow-up|2
4655423|NCT02133664|7539774|FG000|Overall Study|Lost to Follow-up|2
4655424|NCT02133664|7539775|FG001|Overall Study|Lost to Follow-up|1
4655425|NCT02133664|7539774|FG000|Overall Study|Adverse Event|3
4655426|NCT02133664|7539775|FG001|Overall Study|Adverse Event|6
4655427|NCT02133742|7539781|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2
4655428|NCT02133742|7539781|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31
4655429|NCT02133742|7539781|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13
4655430|NCT02133742|7539781|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5
4655431|NCT02133742|7539781|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1
4655432|NCT02134015|7539802|FG000|Overall Study|Protocol Violation|0
4655433|NCT02134015|7539803|FG001|Overall Study|Protocol Violation|1
4655434|NCT02134015|7539802|FG000|Overall Study|Death|2
4655435|NCT02134015|7539803|FG001|Overall Study|Death|1
4655436|NCT02134015|7539802|FG000|Overall Study|Reason not provided|1
4655437|NCT02134015|7539803|FG001|Overall Study|Reason not provided|2
4655438|NCT02134015|7539802|FG000|Overall Study|Clinical progression|14
4655439|NCT02134015|7539803|FG001|Overall Study|Clinical progression|7
4655440|NCT02134015|7539802|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40
4655441|NCT02134015|7539803|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43
4655442|NCT02134015|7539802|FG000|Overall Study|Study terminated by sponsor|2
4655443|NCT02134015|7539803|FG001|Overall Study|Study terminated by sponsor|3
4655444|NCT02134015|7539802|FG000|Overall Study|Adverse Event|9
4655445|NCT02134015|7539803|FG001|Overall Study|Adverse Event|10
4655446|NCT02134015|7539802|FG000|Overall Study|Withdrawal by Subject|3
4655447|NCT02134015|7539803|FG001|Overall Study|Withdrawal by Subject|7
4655448|NCT02134353|7539852|FG000|Overall Study|Adverse Event|10
4655449|NCT02134353|7539853|FG001|Overall Study|Adverse Event|6
4655450|NCT02134353|7539852|FG000|Overall Study|Lost to Follow-up|1
4655451|NCT02134353|7539853|FG001|Overall Study|Lost to Follow-up|1
4655452|NCT02134353|7539852|FG000|Overall Study|Lack of Efficacy|2
4655453|NCT02134353|7539853|FG001|Overall Study|Lack of Efficacy|1
4655454|NCT02134353|7539852|FG000|Overall Study|Withdrawal by Subject|12
4655455|NCT02134353|7539853|FG001|Overall Study|Withdrawal by Subject|13
4655456|NCT02134353|7539852|FG000|Overall Study|Death|0
4655457|NCT02134353|7539853|FG001|Overall Study|Death|1
4655458|NCT02134353|7539852|FG000|Overall Study|Pregnancy|0
4655459|NCT02134353|7539853|FG001|Overall Study|Pregnancy|1
4655460|NCT02134353|7539852|FG000|Overall Study|Relocation|1
4655461|NCT02134353|7539853|FG001|Overall Study|Relocation|0
4655462|NCT02134353|7539852|FG000|Overall Study|Other - Patient's Choice|0
4655463|NCT02134353|7539853|FG001|Overall Study|Other - Patient's Choice|1
4655464|NCT02134587|7539863|FG000|Overall Study|Did not completed all meetings|30
4655465|NCT02134977|7539890|FG000|Overall Study|Protocol Deviation|102
4655466|NCT02135107|7539918|FG000|Treatment Period|Withdrawal by Subject|11
4655467|NCT02135107|7539919|FG001|Treatment Period|Withdrawal by Subject|0
4655468|NCT02135107|7539920|FG002|Treatment Period|Withdrawal by Subject|0
4655469|NCT02135107|7539921|FG003|Treatment Period|Withdrawal by Subject|0
4655470|NCT02135107|7539918|FG000|Treatment Period|Adverse Event|5
4655471|NCT02135107|7539919|FG001|Treatment Period|Adverse Event|2
4655472|NCT02135107|7539920|FG002|Treatment Period|Adverse Event|0
4655473|NCT02135107|7539921|FG003|Treatment Period|Adverse Event|0
4655474|NCT02135107|7539918|FG000|Treatment Period|Pregnancy|1
4655475|NCT02135107|7539919|FG001|Treatment Period|Pregnancy|0
4655476|NCT02135107|7539920|FG002|Treatment Period|Pregnancy|0
4655477|NCT02135107|7539921|FG003|Treatment Period|Pregnancy|0
4655478|NCT02135107|7539918|FG000|Treatment Period|Other|115
4655479|NCT02135107|7539919|FG001|Treatment Period|Other|24
4655480|NCT02135107|7539920|FG002|Treatment Period|Other|0
4655481|NCT02135107|7539921|FG003|Treatment Period|Other|0
4655482|NCT02135107|7539918|FG000|Maintenance Therapy Period|Adverse Event|0
4655483|NCT02135107|7539919|FG001|Maintenance Therapy Period|Adverse Event|0
4655484|NCT02135107|7539920|FG002|Maintenance Therapy Period|Adverse Event|3
4655485|NCT02135107|7539921|FG003|Maintenance Therapy Period|Adverse Event|7
4655486|NCT02135107|7539918|FG000|Maintenance Therapy Period|Withdrawal by Subject|0
4655487|NCT02135107|7539919|FG001|Maintenance Therapy Period|Withdrawal by Subject|0
4655488|NCT02135107|7539920|FG002|Maintenance Therapy Period|Withdrawal by Subject|5
4655489|NCT02135107|7539921|FG003|Maintenance Therapy Period|Withdrawal by Subject|4
4655490|NCT02135107|7539918|FG000|Maintenance Therapy Period|Pregnancy|0
4655491|NCT02135107|7539919|FG001|Maintenance Therapy Period|Pregnancy|0
4655492|NCT02135107|7539920|FG002|Maintenance Therapy Period|Pregnancy|0
4655493|NCT02135107|7539921|FG003|Maintenance Therapy Period|Pregnancy|1
4655494|NCT02135107|7539918|FG000|Maintenance Therapy Period|Other|0
4655495|NCT02135107|7539919|FG001|Maintenance Therapy Period|Other|0
4655496|NCT02135107|7539920|FG002|Maintenance Therapy Period|Other|7
4655497|NCT02135107|7539921|FG003|Maintenance Therapy Period|Other|8
4655498|NCT02135445|7539954|FG000|Overall Study|Lost to Follow-up|1
4655499|NCT02135445|7539955|FG001|Overall Study|Lost to Follow-up|0
4655500|NCT02135445|7539954|FG000|Overall Study|Withdrawal by Subject|1
4655501|NCT02135445|7539955|FG001|Overall Study|Withdrawal by Subject|0
4655502|NCT02135614|7539963|FG000|Overall Study|Randomized but Not Treated|2
4655503|NCT02135614|7539964|FG001|Overall Study|Randomized but Not Treated|1
4655504|NCT02135614|7539963|FG000|Overall Study|Adverse Event|0
4655505|NCT02135614|7539964|FG001|Overall Study|Adverse Event|1
4655506|NCT02135614|7539963|FG000|Overall Study|Death|1
4655507|NCT02135614|7539964|FG001|Overall Study|Death|0
4655508|NCT02135614|7539963|FG000|Overall Study|Investigator's Discretion|0
4655509|NCT02135614|7539964|FG001|Overall Study|Investigator's Discretion|1
4655510|NCT02135614|7539963|FG000|Overall Study|Withdrew Consent|2
4655511|NCT02135614|7539964|FG001|Overall Study|Withdrew Consent|2
4655512|NCT02135614|7539963|FG000|Overall Study|Lost to Follow-up|3
4655513|NCT02135614|7539964|FG001|Overall Study|Lost to Follow-up|0
4655514|NCT02135692|7539981|FG000|Overall Study|Adverse Event|3
4655515|NCT02135692|7539981|FG000|Overall Study|Lack of Efficacy|2
4655516|NCT02135692|7539981|FG000|Overall Study|Protocol Violation|2
4655517|NCT02135692|7539981|FG000|Overall Study|Subject met Liver Stopping Criteria|1
4655518|NCT02135692|7539981|FG000|Overall Study|Product commercially available|159
4655519|NCT02135692|7539981|FG000|Overall Study|Study closed/terminated|153
4655520|NCT02135692|7539981|FG000|Overall Study|Lost to Follow-up|4
4655521|NCT02135692|7539981|FG000|Overall Study|Withdrawal by Subject|15
4655522|NCT02135848|7539987|FG000|Overall Study|Adverse Event|2
4655523|NCT02135848|7539988|FG001|Overall Study|Adverse Event|0
4655524|NCT02135848|7539987|FG000|Overall Study|Withdrawal by Subject|1
4655525|NCT02135848|7539988|FG001|Overall Study|Withdrawal by Subject|1
4655526|NCT02136576|7540081|FG000|Overall Study|Lost to Follow-up|2
4655527|NCT02136576|7540082|FG001|Overall Study|Lost to Follow-up|0
4655528|NCT02136576|7540083|FG002|Overall Study|Lost to Follow-up|0
4655529|NCT02136680|7540093|FG000|Overall Study|No Longer Interested|1
4655530|NCT02136680|7540094|FG001|Overall Study|No Longer Interested|1
4655531|NCT02136680|7540093|FG000|Overall Study|No longer receiving care at clinic|3
4655532|NCT02136680|7540094|FG001|Overall Study|No longer receiving care at clinic|5
4655533|NCT02136680|7540093|FG000|Overall Study|Moved away|5
4655534|NCT02136680|7540094|FG001|Overall Study|Moved away|4
4655535|NCT02136680|7540093|FG000|Overall Study|Unable to schedule|17
4655536|NCT02136680|7540094|FG001|Overall Study|Unable to schedule|16
4655537|NCT02136680|7540093|FG000|Overall Study|Study ended before interview due|6
4655538|NCT02136680|7540094|FG001|Overall Study|Study ended before interview due|3
4655539|NCT02136914|7540106|FG000|Overall Study|Sponsor's Decision to Stop the Study|7
4655540|NCT02136914|7540107|FG001|Overall Study|Sponsor's Decision to Stop the Study|7
4655541|NCT02136914|7540106|FG000|Overall Study|Withdrawal by Subject|3
4655542|NCT02136914|7540107|FG001|Overall Study|Withdrawal by Subject|10
4655543|NCT02136914|7540106|FG000|Overall Study|Subject Unwilling to Proceed|7
4655544|NCT02136914|7540107|FG001|Overall Study|Subject Unwilling to Proceed|2
4655545|NCT02136914|7540106|FG000|Overall Study|Lost to Follow-up|1
4655546|NCT02136914|7540107|FG001|Overall Study|Lost to Follow-up|1
4655547|NCT02136914|7540106|FG000|Overall Study|Did Not Receive Study Drug|2
4655548|NCT02136914|7540107|FG001|Overall Study|Did Not Receive Study Drug|0
4655549|NCT02136914|7540106|FG000|Overall Study|Lack of Efficacy|1
4655550|NCT02136914|7540107|FG001|Overall Study|Lack of Efficacy|0
4655551|NCT02136914|7540106|FG000|Overall Study|Death|0
4655552|NCT02136914|7540107|FG001|Overall Study|Death|1
4655553|NCT02137226|7540115|FG000|Period 1 (Initial Randomization)|Adverse Event|3
4655554|NCT02137226|7540116|FG001|Period 1 (Initial Randomization)|Adverse Event|3
4655555|NCT02137226|7540117|FG002|Period 1 (Initial Randomization)|Adverse Event|0
4655556|NCT02137226|7540118|FG003|Period 1 (Initial Randomization)|Adverse Event|0
4655557|NCT02137226|7540119|FG004|Period 1 (Initial Randomization)|Adverse Event|0
4655558|NCT02137226|7540115|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11
4655559|NCT02137226|7540116|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5
4655560|NCT02137226|7540117|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0
4655561|NCT02137226|7540118|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0
4655562|NCT02137226|7540119|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0
4655563|NCT02137226|7540115|FG000|Period 1 (Initial Randomization)|Physician Decision|1
4655564|NCT02137226|7540116|FG001|Period 1 (Initial Randomization)|Physician Decision|3
4655565|NCT02137226|7540117|FG002|Period 1 (Initial Randomization)|Physician Decision|0
4655566|NCT02137226|7540118|FG003|Period 1 (Initial Randomization)|Physician Decision|0
4655567|NCT02137226|7540119|FG004|Period 1 (Initial Randomization)|Physician Decision|0
4655568|NCT02137226|7540115|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3
4655569|NCT02137226|7540116|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2
4655570|NCT02137226|7540117|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0
4655571|NCT02137226|7540118|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0
4655572|NCT02137226|7540119|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0
4655573|NCT02137226|7540115|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1
4655574|NCT02137226|7540116|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0
4655575|NCT02137226|7540117|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0
4655576|NCT02137226|7540118|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0
4655577|NCT02137226|7540119|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0
4655578|NCT02137226|7540115|FG000|Period 1 (Initial Randomization)|Other Reason|1
4655579|NCT02137226|7540116|FG001|Period 1 (Initial Randomization)|Other Reason|3
4655580|NCT02137226|7540117|FG002|Period 1 (Initial Randomization)|Other Reason|0
4655581|NCT02137226|7540118|FG003|Period 1 (Initial Randomization)|Other Reason|0
4655582|NCT02137226|7540119|FG004|Period 1 (Initial Randomization)|Other Reason|0
4655583|NCT02137226|7540115|FG000|Period 2 (Re - Randomization)|Adverse Event|0
4655584|NCT02137226|7540116|FG001|Period 2 (Re - Randomization)|Adverse Event|0
4655585|NCT02137226|7540117|FG002|Period 2 (Re - Randomization)|Adverse Event|3
4655586|NCT02137226|7540118|FG003|Period 2 (Re - Randomization)|Adverse Event|1
4655587|NCT02137226|7540119|FG004|Period 2 (Re - Randomization)|Adverse Event|4
4655588|NCT02137226|7540115|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0
4655589|NCT02137226|7540116|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0
4655590|NCT02137226|7540117|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8
4655591|NCT02137226|7540118|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5
4655592|NCT02137226|7540119|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4
4655593|NCT02137226|7540115|FG000|Period 2 (Re - Randomization)|Physician Decision|0
4655594|NCT02137226|7540116|FG001|Period 2 (Re - Randomization)|Physician Decision|0
4655595|NCT02137226|7540117|FG002|Period 2 (Re - Randomization)|Physician Decision|0
4655596|NCT02137226|7540118|FG003|Period 2 (Re - Randomization)|Physician Decision|1
4655597|NCT02137226|7540119|FG004|Period 2 (Re - Randomization)|Physician Decision|0
4655598|NCT02137226|7540115|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0
4655599|NCT02137226|7540116|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0
4655600|NCT02137226|7540117|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3
4655601|NCT02137226|7540118|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0
4655602|NCT02137226|7540119|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0
4655603|NCT02137226|7540115|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0
4655604|NCT02137226|7540116|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0
4655605|NCT02137226|7540117|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2
4655606|NCT02137226|7540118|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0
4655607|NCT02137226|7540119|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0
4655608|NCT02137226|7540115|FG000|Period 2 (Re - Randomization)|Other Reason|0
4655609|NCT02137226|7540116|FG001|Period 2 (Re - Randomization)|Other Reason|0
4655610|NCT02137226|7540117|FG002|Period 2 (Re - Randomization)|Other Reason|1
4655611|NCT02137226|7540118|FG003|Period 2 (Re - Randomization)|Other Reason|1
4655612|NCT02137226|7540119|FG004|Period 2 (Re - Randomization)|Other Reason|1
4655613|NCT02137369|7540129|FG000|Overall Study|Withdrawal by Subject|3
4655614|NCT02137369|7540130|FG001|Overall Study|Withdrawal by Subject|2
4655615|NCT02137369|7540129|FG000|Overall Study|Adverse Event|2
4655616|NCT02137369|7540130|FG001|Overall Study|Adverse Event|0
4655617|NCT02137369|7540129|FG000|Overall Study|Lost to Follow-up|1
4655618|NCT02137369|7540130|FG001|Overall Study|Lost to Follow-up|0
4655619|NCT02137369|7540129|FG000|Overall Study|Moved away|2
4655620|NCT02137369|7540130|FG001|Overall Study|Moved away|0
4655621|NCT02137772|7540207|FG000|Overall Study|Adverse Event|6
4655622|NCT02137772|7540208|FG001|Overall Study|Adverse Event|3
4655623|NCT02137772|7540207|FG000|Overall Study|Death|71
4655624|NCT02137772|7540208|FG001|Overall Study|Death|44
4655625|NCT02137772|7540207|FG000|Overall Study|Lost to Follow-up|8
4655626|NCT02137772|7540208|FG001|Overall Study|Lost to Follow-up|4
4748379|NCT03486314|7722309|FG001|Part A|Symptomatic Deterioration|0
4748380|NCT03486314|7722310|FG002|Part A|Symptomatic Deterioration|0
4748381|NCT02988713|7722318|FG000|Overall Study|Withdrawal by Subject|1
4748382|NCT02988713|7722318|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2
4748383|NCT02879448|7722324|FG000|Overall Study|No implant attempt|17
4748384|NCT02879448|7722325|FG001|Overall Study|No implant attempt|28
4748385|NCT02879448|7722324|FG000|Overall Study|Withdrawal by Subject|20
4748386|NCT02879448|7722325|FG001|Overall Study|Withdrawal by Subject|46
4748387|NCT02879448|7722324|FG000|Overall Study|Death|63
4748388|NCT02879448|7722325|FG001|Overall Study|Death|85
4748389|NCT02879448|7722324|FG000|Overall Study|Lost to Follow-up|3
4748390|NCT02879448|7722325|FG001|Overall Study|Lost to Follow-up|4
4748391|NCT02879448|7722324|FG000|Overall Study|Missing visit|34
4748392|NCT02879448|7722325|FG001|Overall Study|Missing visit|39
4748393|NCT02879448|7722324|FG000|Overall Study|Pending evaluation|1
4748394|NCT02879448|7722325|FG001|Overall Study|Pending evaluation|0
4748395|NCT02794883|7722343|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0
4748396|NCT02794883|7722344|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0
4748397|NCT02794883|7722345|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1
4748398|NCT02794883|7722343|FG000|Pre-Surgical Treatment|Progressive Disease|0
4748399|NCT02794883|7722344|FG001|Pre-Surgical Treatment|Progressive Disease|1
4748400|NCT02794883|7722345|FG002|Pre-Surgical Treatment|Progressive Disease|0
4748401|NCT02794883|7722343|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1
4748402|NCT02794883|7722344|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4
4748403|NCT02794883|7722345|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0
4748404|NCT02794883|7722343|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1
4748405|NCT02794883|7722344|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0
4748406|NCT02794883|7722345|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0
4748407|NCT02794883|7722343|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10
4748408|NCT02794883|7722344|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6
4748409|NCT02794883|7722345|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10
4748410|NCT02794883|7722343|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0
4748411|NCT02794883|7722344|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1
4748412|NCT02794883|7722345|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1
4748413|NCT02794883|7722343|FG000|Follow-up Period (up to 2 Years)|Death|12
4748414|NCT02794883|7722344|FG001|Follow-up Period (up to 2 Years)|Death|10
4748415|NCT02794883|7722345|FG002|Follow-up Period (up to 2 Years)|Death|10
4748416|NCT02677987|7722355|FG000|Overall Study|Withdrawal by Subject|3
4748417|NCT02677987|7722356|FG001|Overall Study|Withdrawal by Subject|0
4748418|NCT02677987|7722355|FG000|Overall Study|Lost to Follow-up|1
4748419|NCT02677987|7722356|FG001|Overall Study|Lost to Follow-up|0
4748420|NCT02659059|7722368|FG000|Overall Study|Completed|1
4748421|NCT02659059|7722369|FG001|Overall Study|Completed|0
4748422|NCT02659059|7722368|FG000|Overall Study|Other reasons|8
4748423|NCT02659059|7722369|FG001|Overall Study|Other reasons|2
4748424|NCT02659059|7722368|FG000|Overall Study|Disease Progression|120
4655627|NCT02137772|7540207|FG000|Overall Study|Physician Decision|15
4655628|NCT02137772|7540208|FG001|Overall Study|Physician Decision|5
4655629|NCT02137772|7540207|FG000|Overall Study|Withdrawal by Subject|28
4655630|NCT02137772|7540208|FG001|Overall Study|Withdrawal by Subject|17
4655631|NCT02137772|7540207|FG000|Overall Study|Non-compliance with study drug|1
4655632|NCT02137772|7540208|FG001|Overall Study|Non-compliance with study drug|0
4655633|NCT02137772|7540207|FG000|Overall Study|Not treated|3
4655634|NCT02137772|7540208|FG001|Overall Study|Not treated|2
4655635|NCT02137785|7540216|FG000|Overall Study|Lost to Follow-up|1
4655636|NCT02137785|7540217|FG001|Overall Study|Lost to Follow-up|0
4655637|NCT02137785|7540216|FG000|Overall Study|Withdrawal by Subject|1
4655638|NCT02137785|7540217|FG001|Overall Study|Withdrawal by Subject|4
4655639|NCT02137785|7540216|FG000|Overall Study|subject moved out of state|1
4655640|NCT02137785|7540217|FG001|Overall Study|subject moved out of state|0
4655641|NCT02137837|7540226|FG000|Overall Study|Adverse Event|0
4655642|NCT02137837|7540227|FG001|Overall Study|Adverse Event|2
4655643|NCT02137837|7540228|FG002|Overall Study|Adverse Event|1
4655644|NCT02137837|7540226|FG000|Overall Study|Refusal unrelated to adverse event|2
4655645|NCT02137837|7540227|FG001|Overall Study|Refusal unrelated to adverse event|2
4655646|NCT02137837|7540228|FG002|Overall Study|Refusal unrelated to adverse event|1
4655647|NCT02137837|7540226|FG000|Overall Study|Progression/relapse|9
4655648|NCT02137837|7540227|FG001|Overall Study|Progression/relapse|7
4655649|NCT02137837|7540228|FG002|Overall Study|Progression/relapse|7
4655650|NCT02137837|7540226|FG000|Overall Study|Not protocol specified|2
4655651|NCT02137837|7540227|FG001|Overall Study|Not protocol specified|1
4655652|NCT02137837|7540228|FG002|Overall Study|Not protocol specified|3
4748425|NCT02659059|7722369|FG001|Overall Study|Disease Progression|16
4748426|NCT02659059|7722368|FG000|Overall Study|Study Drug toxicity|37
4748427|NCT02659059|7722369|FG001|Overall Study|Study Drug toxicity|9
4748428|NCT02659059|7722368|FG000|Overall Study|Death|2
4748429|NCT02659059|7722369|FG001|Overall Study|Death|1
4748430|NCT02659059|7722368|FG000|Overall Study|Adverse Event unrelated to Study drug|22
4748431|NCT02659059|7722369|FG001|Overall Study|Adverse Event unrelated to Study drug|4
4748432|NCT02659059|7722368|FG000|Overall Study|Participant request to discontinue study treatment|5
4748433|NCT02659059|7722369|FG001|Overall Study|Participant request to discontinue study treatment|0
4748434|NCT02659059|7722368|FG000|Overall Study|Participant withdrew consent|4
4748435|NCT02659059|7722369|FG001|Overall Study|Participant withdrew consent|0
4748436|NCT02659059|7722368|FG000|Overall Study|Lost to Follow-up|1
4748437|NCT02659059|7722369|FG001|Overall Study|Lost to Follow-up|0
4748438|NCT02337829|7722380|FG000|Overall Study|Death|0
4748439|NCT02337829|7722381|FG001|Overall Study|Death|1
4748440|NCT02337829|7722382|FG002|Overall Study|Death|0
4748441|NCT02337829|7722383|FG003|Overall Study|Death|0
4748442|NCT02337829|7722380|FG000|Overall Study|Study terminated by sponsor|12
4748443|NCT02337829|7722381|FG001|Overall Study|Study terminated by sponsor|10
4748444|NCT02337829|7722382|FG002|Overall Study|Study terminated by sponsor|5
4748445|NCT02337829|7722383|FG003|Overall Study|Study terminated by sponsor|6
4748446|NCT02337829|7722380|FG000|Overall Study|discontinued for other reasons|6
4748447|NCT02337829|7722381|FG001|Overall Study|discontinued for other reasons|3
4748448|NCT02337829|7722382|FG002|Overall Study|discontinued for other reasons|1
4748449|NCT02337829|7722383|FG003|Overall Study|discontinued for other reasons|4
4748450|NCT02258451|7722397|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|88
4748451|NCT02258451|7722398|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|95
4748452|NCT02258451|7722397|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|6
4748453|NCT02258451|7722398|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7
4748454|NCT02258451|7722397|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8
4748455|NCT02258451|7722398|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1
4748456|NCT02258451|7722397|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8
4748457|NCT02258451|7722398|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6
4748458|NCT02258451|7722397|FG000|Overall Study|Death|4
4748459|NCT02258451|7722398|FG001|Overall Study|Death|3
4748460|NCT02258451|7722397|FG000|Overall Study|Withdrawal by Subject|21
4748461|NCT02258451|7722398|FG001|Overall Study|Withdrawal by Subject|12
4748462|NCT02258451|7722397|FG000|Overall Study|Discontinuation all treatment due to TS-1 started|1
4748463|NCT02258451|7722398|FG001|Overall Study|Discontinuation all treatment due to TS-1 started|0
4748464|NCT02258451|7722397|FG000|Overall Study|Discontinuation all treatment due to event point reached|1
4748465|NCT02258451|7722398|FG001|Overall Study|Discontinuation all treatment due to event point reached|1
4748466|NCT02258451|7722397|FG000|Overall Study|Physician Decision|0
4748467|NCT02258451|7722398|FG001|Overall Study|Physician Decision|2
4748468|NCT02258451|7722397|FG000|Overall Study|Never treated|2
4748469|NCT02258451|7722398|FG001|Overall Study|Never treated|3
4748470|NCT02258451|7722397|FG000|Overall Study|Ongoing with any Treatment of radium 223 or placebo, exemestane, or everolimus|3
4748471|NCT02258451|7722398|FG001|Overall Study|Ongoing with any Treatment of radium 223 or placebo, exemestane, or everolimus|11
4748472|NCT01928394|7722429|FG000|Treatment Period|Disease progression|17
4748473|NCT01928394|7722430|FG001|Treatment Period|Disease progression|2
4655653|NCT02138110|7540293|FG000|Enrolled for Scaffold Implantation|Physician Decision|1
4655654|NCT02138110|7540293|FG000|Overall Scaffold Implantation|Death|3
4655655|NCT02138136|7540297|FG000|Overall Study|Protocol Violation|4
4655656|NCT02138136|7540297|FG000|Overall Study|Physician Decision|7
4655657|NCT02138136|7540297|FG000|Overall Study|Lack of Efficacy|35
4655658|NCT02138136|7540297|FG000|Overall Study|Pregnancy|2
4655659|NCT02138136|7540297|FG000|Overall Study|Adverse Event|18
4655660|NCT02138136|7540297|FG000|Overall Study|Withdrawal by Subject|36
4655661|NCT02138136|7540297|FG000|Overall Study|Lost to Follow-up|32
4655662|NCT02138136|7540297|FG000|Overall Study|Withdrawn by Sponsor|5
4655663|NCT02138214|7540305|FG000|Overall Study|Withdrawal by Subject|0
4655664|NCT02138214|7540306|FG001|Overall Study|Withdrawal by Subject|1
4655665|NCT02138214|7540307|FG002|Overall Study|Withdrawal by Subject|0
4655666|NCT02138214|7540305|FG000|Overall Study|Lost to Follow-up|0
4655667|NCT02138214|7540306|FG001|Overall Study|Lost to Follow-up|2
4655668|NCT02138214|7540307|FG002|Overall Study|Lost to Follow-up|4
4655669|NCT02138214|7540305|FG000|Overall Study|Screen Failure|0
4655670|NCT02138214|7540306|FG001|Overall Study|Screen Failure|1
4655671|NCT02138214|7540307|FG002|Overall Study|Screen Failure|0
4655672|NCT02138253|7540354|FG000|Overall Study|Adverse Event|3
4655673|NCT02138253|7540355|FG001|Overall Study|Adverse Event|3
4655674|NCT02138253|7540354|FG000|Overall Study|Lost to Follow-up|2
4655675|NCT02138253|7540355|FG001|Overall Study|Lost to Follow-up|1
4655676|NCT02138253|7540354|FG000|Overall Study|Physician Decision|2
4655677|NCT02138253|7540355|FG001|Overall Study|Physician Decision|0
4655678|NCT02138253|7540354|FG000|Overall Study|Non compliance|1
4655679|NCT02138253|7540355|FG001|Overall Study|Non compliance|0
4655680|NCT02138253|7540354|FG000|Overall Study|Withdrawal by Subject|1
4655681|NCT02138253|7540355|FG001|Overall Study|Withdrawal by Subject|0
4655682|NCT02138747|7540387|FG000|Treatment Period 1|Adverse Event|10
4655683|NCT02138747|7540388|FG001|Treatment Period 1|Adverse Event|14
4655684|NCT02138747|7540389|FG002|Treatment Period 1|Adverse Event|2
4655685|NCT02138747|7540390|FG003|Treatment Period 1|Adverse Event|1
4655686|NCT02138747|7540387|FG000|Treatment Period 1|Lost to Follow-up|0
4655687|NCT02138747|7540388|FG001|Treatment Period 1|Lost to Follow-up|1
4655688|NCT02138747|7540389|FG002|Treatment Period 1|Lost to Follow-up|1
4655689|NCT02138747|7540390|FG003|Treatment Period 1|Lost to Follow-up|0
4655690|NCT02138747|7540387|FG000|Treatment Period 1|Protocol Violation|0
4655691|NCT02138747|7540388|FG001|Treatment Period 1|Protocol Violation|2
4655692|NCT02138747|7540389|FG002|Treatment Period 1|Protocol Violation|0
4655693|NCT02138747|7540390|FG003|Treatment Period 1|Protocol Violation|0
4655694|NCT02138747|7540387|FG000|Treatment Period 1|Withdrawal by Subject|8
4655695|NCT02138747|7540388|FG001|Treatment Period 1|Withdrawal by Subject|4
4655696|NCT02138747|7540389|FG002|Treatment Period 1|Withdrawal by Subject|1
4655697|NCT02138747|7540390|FG003|Treatment Period 1|Withdrawal by Subject|3
4655698|NCT02138747|7540387|FG000|Treatment Period 1|Other - Miscellaneous|2
4655699|NCT02138747|7540388|FG001|Treatment Period 1|Other - Miscellaneous|4
4655700|NCT02138747|7540389|FG002|Treatment Period 1|Other - Miscellaneous|0
4655701|NCT02138747|7540390|FG003|Treatment Period 1|Other - Miscellaneous|0
4655702|NCT02138747|7540387|FG000|Treatment Period 2|Adverse Event|6
4655703|NCT02138747|7540388|FG001|Treatment Period 2|Adverse Event|3
4655704|NCT02138747|7540389|FG002|Treatment Period 2|Adverse Event|1
4655705|NCT02138747|7540390|FG003|Treatment Period 2|Adverse Event|1
4655706|NCT02138747|7540387|FG000|Treatment Period 2|Lost to Follow-up|2
4655707|NCT02138747|7540388|FG001|Treatment Period 2|Lost to Follow-up|0
4655708|NCT02138747|7540389|FG002|Treatment Period 2|Lost to Follow-up|0
4655709|NCT02138747|7540390|FG003|Treatment Period 2|Lost to Follow-up|0
4655710|NCT02138747|7540387|FG000|Treatment Period 2|Protocol Violation|1
4655711|NCT02138747|7540388|FG001|Treatment Period 2|Protocol Violation|0
4655712|NCT02138747|7540389|FG002|Treatment Period 2|Protocol Violation|0
4655713|NCT02138747|7540390|FG003|Treatment Period 2|Protocol Violation|0
4655714|NCT02138747|7540387|FG000|Treatment Period 2|Withdrawal by Subject|5
4655715|NCT02138747|7540388|FG001|Treatment Period 2|Withdrawal by Subject|4
4655716|NCT02138747|7540389|FG002|Treatment Period 2|Withdrawal by Subject|1
4655717|NCT02138747|7540390|FG003|Treatment Period 2|Withdrawal by Subject|2
4655718|NCT02138747|7540387|FG000|Treatment Period 2|Other - Miscellaneous|3
4748474|NCT01928394|7722431|FG002|Treatment Period|Disease progression|12
4748475|NCT01928394|7722432|FG003|Treatment Period|Disease progression|48
4748476|NCT01928394|7722433|FG004|Treatment Period|Disease progression|3
4748477|NCT01928394|7722434|FG005|Treatment Period|Disease progression|25
4748478|NCT01928394|7722435|FG006|Treatment Period|Disease progression|38
4748479|NCT01928394|7722436|FG007|Treatment Period|Disease progression|16
4748480|NCT01928394|7722437|FG008|Treatment Period|Disease progression|3
4748481|NCT01928394|7722438|FG009|Treatment Period|Disease progression|11
4748482|NCT01928394|7722439|FG010|Treatment Period|Disease progression|22
4748483|NCT01928394|7722440|FG011|Treatment Period|Disease progression|73
4748484|NCT01928394|7722441|FG012|Treatment Period|Disease progression|38
4748485|NCT01928394|7722442|FG013|Treatment Period|Disease progression|118
4655719|NCT02138747|7540388|FG001|Treatment Period 2|Other - Miscellaneous|0
4655720|NCT02138747|7540389|FG002|Treatment Period 2|Other - Miscellaneous|0
4655721|NCT02138747|7540390|FG003|Treatment Period 2|Other - Miscellaneous|0
4655722|NCT02138786|7540403|FG000|Overall Study|Adverse Event|0
4655723|NCT02138786|7540404|FG001|Overall Study|Adverse Event|2
4655724|NCT02138786|7540405|FG002|Overall Study|Adverse Event|1
4655725|NCT02138786|7540403|FG000|Overall Study|Death|1
4655726|NCT02138786|7540404|FG001|Overall Study|Death|7
4655727|NCT02138786|7540405|FG002|Overall Study|Death|2
4655728|NCT02138786|7540403|FG000|Overall Study|Disease Progression|1
4655729|NCT02138786|7540404|FG001|Overall Study|Disease Progression|1
4655730|NCT02138786|7540405|FG002|Overall Study|Disease Progression|3
4655731|NCT02138786|7540403|FG000|Overall Study|Withdrawal by Subject|1
4655732|NCT02138786|7540404|FG001|Overall Study|Withdrawal by Subject|2
4655733|NCT02138786|7540405|FG002|Overall Study|Withdrawal by Subject|0
4655734|NCT02138786|7540403|FG000|Overall Study|Patient's Wish|0
4655735|NCT02138786|7540404|FG001|Overall Study|Patient's Wish|2
4655736|NCT02138786|7540405|FG002|Overall Study|Patient's Wish|0
4655737|NCT02138786|7540403|FG000|Overall Study|Sponsor Terminated Study|0
4655738|NCT02138786|7540404|FG001|Overall Study|Sponsor Terminated Study|1
4655739|NCT02138786|7540405|FG002|Overall Study|Sponsor Terminated Study|1
4655740|NCT02138786|7540403|FG000|Overall Study|Non-Compliance|0
4655741|NCT02138786|7540404|FG001|Overall Study|Non-Compliance|0
4655742|NCT02138786|7540405|FG002|Overall Study|Non-Compliance|1
4655743|NCT02138825|7540413|FG000|Main Study Treatment|Adverse Event|11
4655744|NCT02138825|7540414|FG001|Main Study Treatment|Adverse Event|3
4655745|NCT02138825|7540413|FG000|Main Study Treatment|Death|1
4655746|NCT02138825|7540414|FG001|Main Study Treatment|Death|2
4655747|NCT02138825|7540413|FG000|Main Study Treatment|Protocol Violation|2
4655748|NCT02138825|7540414|FG001|Main Study Treatment|Protocol Violation|2
4655749|NCT02138825|7540413|FG000|Main Study Treatment|Sponsor decision|12
4655750|NCT02138825|7540414|FG001|Main Study Treatment|Sponsor decision|18
4655751|NCT02138825|7540413|FG000|Main Study Treatment|Study terminated by sponsor|10
4655752|NCT02138825|7540414|FG001|Main Study Treatment|Study terminated by sponsor|9
4655753|NCT02138825|7540413|FG000|Main Study Treatment|Withdrawal by Subject|3
4655754|NCT02138825|7540414|FG001|Main Study Treatment|Withdrawal by Subject|1
4655755|NCT02138825|7540413|FG000|Main Study Treatment|Medical decision|1
4655756|NCT02138825|7540414|FG001|Main Study Treatment|Medical decision|0
4655757|NCT02138825|7540413|FG000|Long-term Extension|Study termination by sponsor|32
4655758|NCT02138825|7540414|FG001|Long-term Extension|Study termination by sponsor|38
4655759|NCT02138825|7540413|FG000|Safety Follow-up|Adverse Event|4
4655760|NCT02138825|7540414|FG001|Safety Follow-up|Adverse Event|3
4655761|NCT02138825|7540413|FG000|Safety Follow-up|Death|11
4655762|NCT02138825|7540414|FG001|Safety Follow-up|Death|5
4655763|NCT02138825|7540413|FG000|Safety Follow-up|Withdrawal by Subject|5
4655764|NCT02138825|7540414|FG001|Safety Follow-up|Withdrawal by Subject|3
4655765|NCT02138825|7540413|FG000|Safety Follow-up|clinic worsening|1
4655766|NCT02138825|7540414|FG001|Safety Follow-up|clinic worsening|0
4655767|NCT02138825|7540413|FG000|Safety Follow-up|withdrawal by PI|1
4655768|NCT02138825|7540414|FG001|Safety Follow-up|withdrawal by PI|0
4655769|NCT02138825|7540413|FG000|Safety Follow-up|logistical difficulties|0
4655770|NCT02138825|7540414|FG001|Safety Follow-up|logistical difficulties|1
4655771|NCT02138825|7540413|FG000|Safety Follow-up|progressive disease|0
4655772|NCT02138825|7540414|FG001|Safety Follow-up|progressive disease|2
4655773|NCT02138825|7540413|FG000|Safety Follow-up|too unwell to attend the visit|0
4655774|NCT02138825|7540414|FG001|Safety Follow-up|too unwell to attend the visit|1
4655775|NCT02138825|7540413|FG000|Safety Follow-up|treatment unblinded|0
4655776|NCT02138825|7540414|FG001|Safety Follow-up|treatment unblinded|1
4655777|NCT02138825|7540413|FG000|Safety Follow-up|withdrawn due to lung transplant|0
4655778|NCT02138825|7540414|FG001|Safety Follow-up|withdrawn due to lung transplant|1
4655779|NCT02138838|7540427|FG000|Overall Study|Study Closure|7
4655780|NCT02138838|7540428|FG001|Overall Study|Study Closure|6
4655781|NCT02138838|7540427|FG000|Overall Study|Withdrawal by Subject|1
4655782|NCT02138838|7540428|FG001|Overall Study|Withdrawal by Subject|5
4655783|NCT02138890|7540436|FG000|Overall Study|Adverse Event|1
4655784|NCT02138890|7540437|FG001|Overall Study|Adverse Event|0
4655785|NCT02138916|7540447|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6
4655786|NCT02138916|7540448|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9
4655787|NCT02138916|7540449|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7
4655788|NCT02138916|7540447|FG000|Overall Study|Death|14
4655789|NCT02138916|7540448|FG001|Overall Study|Death|11
4655790|NCT02138916|7540449|FG002|Overall Study|Death|12
4655791|NCT02138916|7540447|FG000|Overall Study|Withdrawal by Subject|27
4655792|NCT02138916|7540448|FG001|Overall Study|Withdrawal by Subject|31
4655793|NCT02138916|7540449|FG002|Overall Study|Withdrawal by Subject|32
4655794|NCT02138916|7540447|FG000|Overall Study|Study specific withdrawal criteria|0
4655795|NCT02138916|7540448|FG001|Overall Study|Study specific withdrawal criteria|0
4655796|NCT02138916|7540449|FG002|Overall Study|Study specific withdrawal criteria|1
4655797|NCT02138916|7540447|FG000|Overall Study|incorrect enrolment|1
4655798|NCT02138916|7540448|FG001|Overall Study|incorrect enrolment|1
4655799|NCT02138916|7540449|FG002|Overall Study|incorrect enrolment|0
4655800|NCT02138916|7540447|FG000|Overall Study|Severe non-compliance|1
4655801|NCT02138916|7540448|FG001|Overall Study|Severe non-compliance|2
4655802|NCT02138916|7540449|FG002|Overall Study|Severe non-compliance|1
4655803|NCT02138916|7540447|FG000|Overall Study|Lost to Follow-up|4
4655804|NCT02138916|7540448|FG001|Overall Study|Lost to Follow-up|2
4655805|NCT02138916|7540449|FG002|Overall Study|Lost to Follow-up|3
4655806|NCT02138916|7540447|FG000|Overall Study|Adverse Event|4
4655807|NCT02138916|7540448|FG001|Overall Study|Adverse Event|4
4655808|NCT02138916|7540449|FG002|Overall Study|Adverse Event|3
4655809|NCT02139046|7540474|FG000|Overall Study|Pretreatment Event/Adverse Event|9
4655810|NCT02139046|7540475|FG001|Overall Study|Pretreatment Event/Adverse Event|9
4655811|NCT02139046|7540476|FG002|Overall Study|Pretreatment Event/Adverse Event|10
4655812|NCT02139046|7540477|FG003|Overall Study|Pretreatment Event/Adverse Event|13
4655813|NCT02139046|7540478|FG004|Overall Study|Pretreatment Event/Adverse Event|7
4655814|NCT02139046|7540474|FG000|Overall Study|Major Protocol Deviation|9
4655815|NCT02139046|7540475|FG001|Overall Study|Major Protocol Deviation|10
4655816|NCT02139046|7540476|FG002|Overall Study|Major Protocol Deviation|16
4655817|NCT02139046|7540477|FG003|Overall Study|Major Protocol Deviation|12
4655818|NCT02139046|7540478|FG004|Overall Study|Major Protocol Deviation|6
4655819|NCT02139046|7540474|FG000|Overall Study|Lost to Follow-up|13
4655820|NCT02139046|7540475|FG001|Overall Study|Lost to Follow-up|16
4655821|NCT02139046|7540476|FG002|Overall Study|Lost to Follow-up|16
4655822|NCT02139046|7540477|FG003|Overall Study|Lost to Follow-up|18
4655823|NCT02139046|7540478|FG004|Overall Study|Lost to Follow-up|13
4655824|NCT02139046|7540474|FG000|Overall Study|Voluntary Withdrawal|20
4655825|NCT02139046|7540475|FG001|Overall Study|Voluntary Withdrawal|8
4655826|NCT02139046|7540476|FG002|Overall Study|Voluntary Withdrawal|10
4655827|NCT02139046|7540477|FG003|Overall Study|Voluntary Withdrawal|15
4655828|NCT02139046|7540478|FG004|Overall Study|Voluntary Withdrawal|16
4655829|NCT02139046|7540474|FG000|Overall Study|Lack of Efficacy|0
4655830|NCT02139046|7540475|FG001|Overall Study|Lack of Efficacy|1
4655831|NCT02139046|7540476|FG002|Overall Study|Lack of Efficacy|2
4655832|NCT02139046|7540477|FG003|Overall Study|Lack of Efficacy|1
4655833|NCT02139046|7540478|FG004|Overall Study|Lack of Efficacy|2
4655834|NCT02139046|7540474|FG000|Overall Study|Withdrawal due to a Gout Flare|1
4655835|NCT02139046|7540475|FG001|Overall Study|Withdrawal due to a Gout Flare|1
4655836|NCT02139046|7540476|FG002|Overall Study|Withdrawal due to a Gout Flare|1
4655837|NCT02139046|7540477|FG003|Overall Study|Withdrawal due to a Gout Flare|0
4655838|NCT02139046|7540478|FG004|Overall Study|Withdrawal due to a Gout Flare|1
4655839|NCT02139046|7540474|FG000|Overall Study|Other Miscellaneous Reasons|10
4655840|NCT02139046|7540475|FG001|Overall Study|Other Miscellaneous Reasons|9
4655841|NCT02139046|7540476|FG002|Overall Study|Other Miscellaneous Reasons|4
4655842|NCT02139046|7540477|FG003|Overall Study|Other Miscellaneous Reasons|9
4655843|NCT02139046|7540478|FG004|Overall Study|Other Miscellaneous Reasons|12
4655844|NCT02139124|7540495|FG000|Overall Study|Adverse Event|2
4655845|NCT02139124|7540496|FG001|Overall Study|Adverse Event|0
4655846|NCT02139124|7540497|FG002|Overall Study|Adverse Event|1
4655847|NCT02139124|7540498|FG003|Overall Study|Adverse Event|2
4655848|NCT02139124|7540499|FG004|Overall Study|Adverse Event|5
4655849|NCT02139124|7540495|FG000|Overall Study|Withdrawal by Subject|2
4655850|NCT02139124|7540496|FG001|Overall Study|Withdrawal by Subject|2
4655851|NCT02139124|7540497|FG002|Overall Study|Withdrawal by Subject|2
4655852|NCT02139124|7540498|FG003|Overall Study|Withdrawal by Subject|2
4655853|NCT02139124|7540499|FG004|Overall Study|Withdrawal by Subject|3
4655854|NCT02139124|7540495|FG000|Overall Study|Protocol Violation|0
4655855|NCT02139124|7540496|FG001|Overall Study|Protocol Violation|0
4655856|NCT02139124|7540497|FG002|Overall Study|Protocol Violation|0
4655857|NCT02139124|7540498|FG003|Overall Study|Protocol Violation|1
4655858|NCT02139124|7540499|FG004|Overall Study|Protocol Violation|1
4655859|NCT02139124|7540495|FG000|Overall Study|non-compliant|1
4655860|NCT02139124|7540496|FG001|Overall Study|non-compliant|0
4655861|NCT02139124|7540497|FG002|Overall Study|non-compliant|0
4655862|NCT02139124|7540498|FG003|Overall Study|non-compliant|2
4655863|NCT02139124|7540499|FG004|Overall Study|non-compliant|0
4655864|NCT02139124|7540495|FG000|Overall Study|incarceration|0
4655865|NCT02139124|7540496|FG001|Overall Study|incarceration|0
4748486|NCT01928394|7722443|FG014|Treatment Period|Disease progression|59
4748487|NCT01928394|7722444|FG015|Treatment Period|Disease progression|1
4748488|NCT01928394|7722445|FG016|Treatment Period|Disease progression|43
4748489|NCT01928394|7722446|FG017|Treatment Period|Disease progression|56
4748490|NCT01928394|7722447|FG018|Treatment Period|Disease progression|50
4748491|NCT01928394|7722448|FG019|Treatment Period|Disease progression|71
4748492|NCT01928394|7722449|FG020|Treatment Period|Disease progression|30
4655866|NCT02139124|7540497|FG002|Overall Study|incarceration|1
4655867|NCT02139124|7540498|FG003|Overall Study|incarceration|0
4655868|NCT02139124|7540499|FG004|Overall Study|incarceration|0
4655869|NCT02139124|7540495|FG000|Overall Study|subject moved|1
4655870|NCT02139124|7540496|FG001|Overall Study|subject moved|0
4655871|NCT02139124|7540497|FG002|Overall Study|subject moved|0
4655872|NCT02139124|7540498|FG003|Overall Study|subject moved|0
4655873|NCT02139124|7540499|FG004|Overall Study|subject moved|0
4655874|NCT02139124|7540495|FG000|Overall Study|Lost to Follow-up|3
4655875|NCT02139124|7540496|FG001|Overall Study|Lost to Follow-up|2
4655876|NCT02139124|7540497|FG002|Overall Study|Lost to Follow-up|0
4748493|NCT01928394|7722450|FG021|Treatment Period|Disease progression|31
4655877|NCT02139124|7540498|FG003|Overall Study|Lost to Follow-up|5
4655878|NCT02139124|7540499|FG004|Overall Study|Lost to Follow-up|4
4655879|NCT02139280|7540541|FG000|Overall Study|No longer eligible|2
4655880|NCT02139280|7540542|FG001|Overall Study|No longer eligible|0
4655881|NCT02139306|7540550|FG000|Overall Study|Withdrawal by Subject|4
4655882|NCT02139306|7540551|FG001|Overall Study|Withdrawal by Subject|6
4655883|NCT02139306|7540550|FG000|Overall Study|Adverse Event|3
4655884|NCT02139306|7540551|FG001|Overall Study|Adverse Event|4
4655885|NCT02139306|7540550|FG000|Overall Study|Physician Decision|0
4655886|NCT02139306|7540551|FG001|Overall Study|Physician Decision|1
4655887|NCT02139306|7540550|FG000|Overall Study|Other Unspecified|2
4655888|NCT02139306|7540551|FG001|Overall Study|Other Unspecified|3
4655889|NCT02139306|7540550|FG000|Overall Study|Protocol Violation|4
4655890|NCT02139306|7540551|FG001|Overall Study|Protocol Violation|0
4655891|NCT02139592|7540571|FG000|Overall Study|Case Report Forms Uncollected|8
4655892|NCT02139644|7540580|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70
4655893|NCT02139644|7540581|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0
4655894|NCT02139644|7540582|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0
4655895|NCT02139644|7540583|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0
4655896|NCT02139644|7540584|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0
4655897|NCT02139644|7540585|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0
4655898|NCT02139644|7540580|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30
4655899|NCT02139644|7540581|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
4655900|NCT02139644|7540582|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
4655901|NCT02139644|7540583|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
4655902|NCT02139644|7540584|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
4655903|NCT02139644|7540585|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
4655904|NCT02139644|7540580|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12
4655905|NCT02139644|7540581|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
4655906|NCT02139644|7540582|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
4655907|NCT02139644|7540583|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
4655908|NCT02139644|7540584|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
4655909|NCT02139644|7540585|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
4655910|NCT02139644|7540580|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11
4655911|NCT02139644|7540581|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0
4655912|NCT02139644|7540582|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0
4655913|NCT02139644|7540583|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0
4655914|NCT02139644|7540584|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0
4655915|NCT02139644|7540585|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0
4655916|NCT02139644|7540580|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8
4655917|NCT02139644|7540581|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0
4655918|NCT02139644|7540582|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0
4655919|NCT02139644|7540583|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0
4655920|NCT02139644|7540584|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0
4655921|NCT02139644|7540585|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0
4655922|NCT02139644|7540580|FG000|Run-In Period (Pre-assignment)|Adverse Event|3
4655923|NCT02139644|7540581|FG001|Run-In Period (Pre-assignment)|Adverse Event|0
4655924|NCT02139644|7540582|FG002|Run-In Period (Pre-assignment)|Adverse Event|0
4655925|NCT02139644|7540583|FG003|Run-In Period (Pre-assignment)|Adverse Event|0
4655926|NCT02139644|7540584|FG004|Run-In Period (Pre-assignment)|Adverse Event|0
4655927|NCT02139644|7540585|FG005|Run-In Period (Pre-assignment)|Adverse Event|0
4655928|NCT02139644|7540580|FG000|Run-In Period (Pre-assignment)|Other|6
4655929|NCT02139644|7540581|FG001|Run-In Period (Pre-assignment)|Other|0
4655930|NCT02139644|7540582|FG002|Run-In Period (Pre-assignment)|Other|0
4655931|NCT02139644|7540583|FG003|Run-In Period (Pre-assignment)|Other|0
4655932|NCT02139644|7540584|FG004|Run-In Period (Pre-assignment)|Other|0
4655933|NCT02139644|7540585|FG005|Run-In Period (Pre-assignment)|Other|0
4655934|NCT02139644|7540580|FG000|Treatment Period|Adverse Event|0
4655935|NCT02139644|7540581|FG001|Treatment Period|Adverse Event|0
4655936|NCT02139644|7540582|FG002|Treatment Period|Adverse Event|3
4655937|NCT02139644|7540583|FG003|Treatment Period|Adverse Event|2
4655938|NCT02139644|7540584|FG004|Treatment Period|Adverse Event|1
4655939|NCT02139644|7540585|FG005|Treatment Period|Adverse Event|6
4655940|NCT02139644|7540580|FG000|Treatment Period|Withdrawal by Subject|0
4655941|NCT02139644|7540581|FG001|Treatment Period|Withdrawal by Subject|0
4655942|NCT02139644|7540582|FG002|Treatment Period|Withdrawal by Subject|2
4655943|NCT02139644|7540583|FG003|Treatment Period|Withdrawal by Subject|2
4655944|NCT02139644|7540584|FG004|Treatment Period|Withdrawal by Subject|3
4655945|NCT02139644|7540585|FG005|Treatment Period|Withdrawal by Subject|2
4655946|NCT02139644|7540580|FG000|Treatment Period|Non-compliance|0
4655947|NCT02139644|7540581|FG001|Treatment Period|Non-compliance|0
4655948|NCT02139644|7540582|FG002|Treatment Period|Non-compliance|0
4655949|NCT02139644|7540583|FG003|Treatment Period|Non-compliance|1
4655950|NCT02139644|7540584|FG004|Treatment Period|Non-compliance|0
4655951|NCT02139644|7540585|FG005|Treatment Period|Non-compliance|0
4748494|NCT01928394|7722451|FG022|Treatment Period|Disease progression|31
4655952|NCT02139644|7540580|FG000|Treatment Period|Protocol Violation|0
4655953|NCT02139644|7540581|FG001|Treatment Period|Protocol Violation|0
4655954|NCT02139644|7540582|FG002|Treatment Period|Protocol Violation|0
4655955|NCT02139644|7540583|FG003|Treatment Period|Protocol Violation|1
4655956|NCT02139644|7540584|FG004|Treatment Period|Protocol Violation|1
4655957|NCT02139644|7540585|FG005|Treatment Period|Protocol Violation|1
4655958|NCT02139644|7540580|FG000|Treatment Period|Disease progression|0
4655959|NCT02139644|7540581|FG001|Treatment Period|Disease progression|0
4655960|NCT02139644|7540582|FG002|Treatment Period|Disease progression|0
4655961|NCT02139644|7540583|FG003|Treatment Period|Disease progression|1
4655962|NCT02139644|7540584|FG004|Treatment Period|Disease progression|1
4655963|NCT02139644|7540585|FG005|Treatment Period|Disease progression|2
4655964|NCT02139644|7540580|FG000|Treatment Period|Lost to Follow-up|0
4655965|NCT02139644|7540581|FG001|Treatment Period|Lost to Follow-up|0
4655966|NCT02139644|7540582|FG002|Treatment Period|Lost to Follow-up|1
4655967|NCT02139644|7540583|FG003|Treatment Period|Lost to Follow-up|1
4655968|NCT02139644|7540584|FG004|Treatment Period|Lost to Follow-up|1
4655969|NCT02139644|7540585|FG005|Treatment Period|Lost to Follow-up|1
4655970|NCT02139644|7540580|FG000|Treatment Period|Lack of Efficacy|0
4655971|NCT02139644|7540581|FG001|Treatment Period|Lack of Efficacy|0
4655972|NCT02139644|7540582|FG002|Treatment Period|Lack of Efficacy|1
4655973|NCT02139644|7540583|FG003|Treatment Period|Lack of Efficacy|0
4655974|NCT02139644|7540584|FG004|Treatment Period|Lack of Efficacy|1
4655975|NCT02139644|7540585|FG005|Treatment Period|Lack of Efficacy|4
4655976|NCT02139644|7540580|FG000|Treatment Period|Other|0
4655977|NCT02139644|7540581|FG001|Treatment Period|Other|3
4655978|NCT02139644|7540582|FG002|Treatment Period|Other|1
4655979|NCT02139644|7540583|FG003|Treatment Period|Other|1
4655980|NCT02139644|7540584|FG004|Treatment Period|Other|0
4655981|NCT02139644|7540585|FG005|Treatment Period|Other|1
4655982|NCT02139826|7540606|FG000|Overall Study|Adverse Event|1
4655983|NCT02139943|7540626|FG000|Overall Study|Adverse Event|0
4655984|NCT02139943|7540627|FG001|Overall Study|Adverse Event|1
4655985|NCT02139943|7540628|FG002|Overall Study|Adverse Event|2
4655986|NCT02139943|7540626|FG000|Overall Study|Lost to Follow-up|3
4655987|NCT02139943|7540627|FG001|Overall Study|Lost to Follow-up|2
4655988|NCT02139943|7540628|FG002|Overall Study|Lost to Follow-up|2
4655989|NCT02139943|7540626|FG000|Overall Study|Withdrawal by Subject|4
4655990|NCT02139943|7540627|FG001|Overall Study|Withdrawal by Subject|3
4655991|NCT02139943|7540628|FG002|Overall Study|Withdrawal by Subject|0
4655992|NCT02139943|7540626|FG000|Overall Study|Other|0
4655993|NCT02139943|7540627|FG001|Overall Study|Other|0
4655994|NCT02139943|7540628|FG002|Overall Study|Other|1
4655995|NCT02139943|7540626|FG000|Overall Study|Participant wishes to discontinue|2
4655996|NCT02139943|7540627|FG001|Overall Study|Participant wishes to discontinue|0
4655997|NCT02139943|7540628|FG002|Overall Study|Participant wishes to discontinue|0
4655998|NCT02139943|7540626|FG000|Overall Study|Participant in Poor Compliance|1
4655999|NCT02139943|7540627|FG001|Overall Study|Participant in Poor Compliance|0
4656000|NCT02139943|7540628|FG002|Overall Study|Participant in Poor Compliance|1
4656001|NCT02139943|7540626|FG000|Overall Study|eGFR Withdrawal Criteria|0
4656002|NCT02139943|7540627|FG001|Overall Study|eGFR Withdrawal Criteria|0
4656003|NCT02139943|7540628|FG002|Overall Study|eGFR Withdrawal Criteria|1
4656004|NCT02139982|7540650|FG000|Overall Study|Lack of Efficacy|0
4656005|NCT02139982|7540651|FG001|Overall Study|Lack of Efficacy|1
4656006|NCT02139982|7540652|FG002|Overall Study|Lack of Efficacy|0
4656007|NCT02139982|7540653|FG003|Overall Study|Lack of Efficacy|1
4656008|NCT02139982|7540654|FG004|Overall Study|Lack of Efficacy|0
4656009|NCT02139982|7540655|FG005|Overall Study|Lack of Efficacy|0
4656010|NCT02139982|7540656|FG006|Overall Study|Lack of Efficacy|0
4656011|NCT02139982|7540657|FG007|Overall Study|Lack of Efficacy|0
4656012|NCT02139982|7540658|FG008|Overall Study|Lack of Efficacy|0
4656013|NCT02139982|7540659|FG009|Overall Study|Lack of Efficacy|0
4656014|NCT02140060|7540687|FG000|Overall Study|Adverse Event|0
4656015|NCT02140060|7540688|FG001|Overall Study|Adverse Event|0
4656016|NCT02140060|7540689|FG002|Overall Study|Adverse Event|0
4656017|NCT02140060|7540690|FG003|Overall Study|Adverse Event|1
4656018|NCT02140060|7540691|FG004|Overall Study|Adverse Event|1
4656019|NCT02140060|7540692|FG005|Overall Study|Adverse Event|1
4656020|NCT02140060|7540687|FG000|Overall Study|Lack of Efficacy|0
4656021|NCT02140060|7540688|FG001|Overall Study|Lack of Efficacy|0
4656022|NCT02140060|7540689|FG002|Overall Study|Lack of Efficacy|0
4656023|NCT02140060|7540690|FG003|Overall Study|Lack of Efficacy|1
4656024|NCT02140060|7540691|FG004|Overall Study|Lack of Efficacy|0
4656025|NCT02140060|7540692|FG005|Overall Study|Lack of Efficacy|0
4656026|NCT02140164|7540707|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2
4656027|NCT02140411|7540715|FG000|Overall Study|Adverse Event|1
4656028|NCT02140567|7540719|FG000|Overall Study|Problems with recording equipment|6
4656029|NCT02140645|7540739|FG000|Overall Study|Not linked|5489
4656030|NCT02140645|7540740|FG001|Overall Study|Not linked|61654
4656031|NCT02140645|7540741|FG002|Overall Study|Not linked|4236
4656032|NCT02140645|7540742|FG003|Overall Study|Not linked|13833
4656033|NCT02140645|7540743|FG004|Overall Study|Not linked|3286
4656034|NCT02140645|7540744|FG005|Overall Study|Not linked|70896
4656035|NCT02140762|7540755|FG000|Overall Study|Adverse Event|1
4656036|NCT02140762|7540756|FG001|Overall Study|Adverse Event|1
4656037|NCT02140762|7540755|FG000|Overall Study|Lost to Follow-up|9
4656038|NCT02140762|7540756|FG001|Overall Study|Lost to Follow-up|5
4656039|NCT02140762|7540755|FG000|Overall Study|Protocol Violation|1
4656040|NCT02140762|7540756|FG001|Overall Study|Protocol Violation|1
4656041|NCT02140762|7540755|FG000|Overall Study|Withdrawal by Subject|6
4656042|NCT02140762|7540756|FG001|Overall Study|Withdrawal by Subject|4
4656043|NCT02140762|7540755|FG000|Overall Study|Other|0
4656044|NCT02140762|7540756|FG001|Overall Study|Other|1
4656045|NCT02140775|7540769|FG000|Overall Study|Withdrawal by Subject|30
4656046|NCT02140775|7540770|FG001|Overall Study|Withdrawal by Subject|7
4656047|NCT02140970|7540789|FG000|Overall Study|Lost to Follow-up|1
4656048|NCT02140970|7540790|FG001|Overall Study|Lost to Follow-up|2
4656049|NCT02140970|7540789|FG000|Overall Study|Misplaced consent, subject withdrawn|1
4656050|NCT02140970|7540790|FG001|Overall Study|Misplaced consent, subject withdrawn|0
4656051|NCT02140970|7540789|FG000|Overall Study|Did not meet inclusion criteria|0
4656052|NCT02140970|7540790|FG001|Overall Study|Did not meet inclusion criteria|1
4656053|NCT02141204|7540798|FG000|Overall Study|Lost to Follow-up|2
4656054|NCT02141204|7540799|FG001|Overall Study|Lost to Follow-up|1
4656055|NCT02141204|7540798|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1
4656056|NCT02141204|7540799|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2
4656057|NCT02141204|7540798|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3
4656058|NCT02141204|7540799|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5
4656059|NCT02141204|7540798|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9
4656060|NCT02141204|7540799|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7
4656061|NCT02141217|7540807|FG000|Overall Study|Adverse Event|1
4656062|NCT02141217|7540808|FG001|Overall Study|Adverse Event|2
4656063|NCT02141217|7540807|FG000|Overall Study|Protocol Violation|1
4656064|NCT02141217|7540808|FG001|Overall Study|Protocol Violation|4
4656065|NCT02141217|7540807|FG000|Overall Study|Withdrawal by Subject|6
4656066|NCT02141217|7540808|FG001|Overall Study|Withdrawal by Subject|0
4656067|NCT02141217|7540807|FG000|Overall Study|Lost to Follow-up|1
4656068|NCT02141217|7540808|FG001|Overall Study|Lost to Follow-up|1
4656069|NCT02141217|7540807|FG000|Overall Study|Physician Decision|1
4656070|NCT02141217|7540808|FG001|Overall Study|Physician Decision|0
4656071|NCT02141217|7540807|FG000|Overall Study|Surgical Intervention|1
4656072|NCT02141217|7540808|FG001|Overall Study|Surgical Intervention|1
4656073|NCT02141295|7540820|FG000|Overall Study|Adverse Event|1
4656074|NCT02141295|7540821|FG001|Overall Study|Adverse Event|18
4656075|NCT02141295|7540822|FG002|Overall Study|Adverse Event|11
4656076|NCT02141295|7540820|FG000|Overall Study|Physician Decision|2
4748495|NCT01928394|7722429|FG000|Treatment Period|Study drug toxicity|1
4748496|NCT01928394|7722430|FG001|Treatment Period|Study drug toxicity|1
4748497|NCT01928394|7722431|FG002|Treatment Period|Study drug toxicity|3
4748498|NCT01928394|7722432|FG003|Treatment Period|Study drug toxicity|3
4748499|NCT01928394|7722433|FG004|Treatment Period|Study drug toxicity|0
4748500|NCT01928394|7722434|FG005|Treatment Period|Study drug toxicity|9
4748501|NCT01928394|7722435|FG006|Treatment Period|Study drug toxicity|7
4748502|NCT01928394|7722436|FG007|Treatment Period|Study drug toxicity|1
4748503|NCT01928394|7722437|FG008|Treatment Period|Study drug toxicity|0
4748504|NCT01928394|7722438|FG009|Treatment Period|Study drug toxicity|5
4748505|NCT01928394|7722439|FG010|Treatment Period|Study drug toxicity|2
4748506|NCT01928394|7722440|FG011|Treatment Period|Study drug toxicity|3
4748507|NCT01928394|7722441|FG012|Treatment Period|Study drug toxicity|7
4748508|NCT01928394|7722442|FG013|Treatment Period|Study drug toxicity|5
4748509|NCT01928394|7722443|FG014|Treatment Period|Study drug toxicity|12
4748510|NCT01928394|7722444|FG015|Treatment Period|Study drug toxicity|0
4748511|NCT01928394|7722445|FG016|Treatment Period|Study drug toxicity|3
4748512|NCT01928394|7722446|FG017|Treatment Period|Study drug toxicity|3
4748513|NCT01928394|7722447|FG018|Treatment Period|Study drug toxicity|12
4748514|NCT01928394|7722448|FG019|Treatment Period|Study drug toxicity|15
4748515|NCT01928394|7722449|FG020|Treatment Period|Study drug toxicity|4
4748516|NCT01928394|7722450|FG021|Treatment Period|Study drug toxicity|7
4748517|NCT01928394|7722451|FG022|Treatment Period|Study drug toxicity|4
4748518|NCT01928394|7722429|FG000|Treatment Period|AE unrelated to study drug|0
4748519|NCT01928394|7722430|FG001|Treatment Period|AE unrelated to study drug|0
4748520|NCT01928394|7722431|FG002|Treatment Period|AE unrelated to study drug|2
4748521|NCT01928394|7722432|FG003|Treatment Period|AE unrelated to study drug|3
4748522|NCT01928394|7722433|FG004|Treatment Period|AE unrelated to study drug|0
4748523|NCT01928394|7722434|FG005|Treatment Period|AE unrelated to study drug|5
4748524|NCT01928394|7722435|FG006|Treatment Period|AE unrelated to study drug|1
4748525|NCT01928394|7722436|FG007|Treatment Period|AE unrelated to study drug|0
4748526|NCT01928394|7722437|FG008|Treatment Period|AE unrelated to study drug|0
4748527|NCT01928394|7722438|FG009|Treatment Period|AE unrelated to study drug|2
4748528|NCT01928394|7722439|FG010|Treatment Period|AE unrelated to study drug|0
4656077|NCT02141295|7540821|FG001|Overall Study|Physician Decision|19
4656078|NCT02141295|7540822|FG002|Overall Study|Physician Decision|14
4656079|NCT02141295|7540820|FG000|Overall Study|Study terminated by sponsor|0
4656080|NCT02141295|7540821|FG001|Overall Study|Study terminated by sponsor|6
4656081|NCT02141295|7540822|FG002|Overall Study|Study terminated by sponsor|6
4656082|NCT02141295|7540820|FG000|Overall Study|Non-compliance|0
4748529|NCT01928394|7722440|FG011|Treatment Period|AE unrelated to study drug|12
4656083|NCT02141295|7540821|FG001|Overall Study|Non-compliance|1
4656084|NCT02141295|7540822|FG002|Overall Study|Non-compliance|0
4656085|NCT02141295|7540820|FG000|Overall Study|Progressive disease|3
4656086|NCT02141295|7540821|FG001|Overall Study|Progressive disease|32
4656087|NCT02141295|7540822|FG002|Overall Study|Progressive disease|50
4748530|NCT01928394|7722441|FG012|Treatment Period|AE unrelated to study drug|6
4748531|NCT01928394|7722442|FG013|Treatment Period|AE unrelated to study drug|13
4656088|NCT02141295|7540820|FG000|Overall Study|Reason not specified|0
4656089|NCT02141295|7540821|FG001|Overall Study|Reason not specified|9
4656090|NCT02141295|7540822|FG002|Overall Study|Reason not specified|10
4656091|NCT02141295|7540820|FG000|Overall Study|Withdrawal by Subject|0
4656092|NCT02141295|7540821|FG001|Overall Study|Withdrawal by Subject|9
4656093|NCT02141295|7540822|FG002|Overall Study|Withdrawal by Subject|4
4656094|NCT02141360|7540834|FG000|Overall Study|Withdrawal by Subject|6
4656095|NCT02141360|7540835|FG001|Overall Study|Withdrawal by Subject|0
4656096|NCT02141360|7540836|FG002|Overall Study|Withdrawal by Subject|0
4656097|NCT02141360|7540834|FG000|Overall Study|Study Terminated before Visit|1
4656098|NCT02141360|7540835|FG001|Overall Study|Study Terminated before Visit|0
4656099|NCT02141360|7540836|FG002|Overall Study|Study Terminated before Visit|0
4656100|NCT02141399|7540844|FG000|Overall Study|Adverse Event|158
4656101|NCT02141399|7540844|FG000|Overall Study|Lack of Efficacy|62
4656102|NCT02141399|7540844|FG000|Overall Study|Lost to Follow-up|151
4656103|NCT02141399|7540844|FG000|Overall Study|Non-compliance with study drug|18
4656104|NCT02141399|7540844|FG000|Overall Study|Other|45
4656105|NCT02141399|7540844|FG000|Overall Study|Physician Decision|17
4656106|NCT02141399|7540844|FG000|Overall Study|Pregnancy|3
4656107|NCT02141399|7540844|FG000|Overall Study|Protocol Violation|38
4656108|NCT02141399|7540844|FG000|Overall Study|Withdrawal by Subject|238
4656109|NCT02141399|7540844|FG000|Overall Study|Failure to meet eligibility criteria|14
4656110|NCT02141490|7540871|FG000|Overall Study|Screening failures|4
4656111|NCT02141490|7540872|FG001|Overall Study|Screening failures|0
4656112|NCT02141490|7540873|FG002|Overall Study|Screening failures|0
4656113|NCT02141516|7540886|FG000|Overall Study|Adverse Event|0
4656114|NCT02141516|7540887|FG001|Overall Study|Adverse Event|1
4656115|NCT02141516|7540888|FG002|Overall Study|Adverse Event|0
4656116|NCT02141516|7540886|FG000|Overall Study|Lost to Follow-up|0
4656117|NCT02141516|7540887|FG001|Overall Study|Lost to Follow-up|1
4656118|NCT02141516|7540888|FG002|Overall Study|Lost to Follow-up|0
4656119|NCT02141516|7540886|FG000|Overall Study|Other|0
4656120|NCT02141516|7540887|FG001|Overall Study|Other|3
4656121|NCT02141516|7540888|FG002|Overall Study|Other|0
4656122|NCT02141620|7540922|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1
4656123|NCT02141620|7540923|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0
4656124|NCT02141633|7540931|FG000|Overall Study|Physician Decision|1
4656125|NCT02141633|7540932|FG001|Overall Study|Physician Decision|0
4656126|NCT02141659|7540944|FG000|Overall Study|Major Protocol Deviation|0
4656127|NCT02141659|7540945|FG001|Overall Study|Major Protocol Deviation|1
4656128|NCT02141659|7540946|FG002|Overall Study|Major Protocol Deviation|0
4656129|NCT02141659|7540947|FG003|Overall Study|Major Protocol Deviation|0
4656130|NCT02141659|7540948|FG004|Overall Study|Major Protocol Deviation|0
4656131|NCT02141659|7540949|FG005|Overall Study|Major Protocol Deviation|0
4656132|NCT02141659|7540944|FG000|Overall Study|Lack of Efficacy|0
4656133|NCT02141659|7540945|FG001|Overall Study|Lack of Efficacy|0
4656134|NCT02141659|7540946|FG002|Overall Study|Lack of Efficacy|0
4656135|NCT02141659|7540947|FG003|Overall Study|Lack of Efficacy|0
4656136|NCT02141659|7540948|FG004|Overall Study|Lack of Efficacy|0
4656137|NCT02141659|7540949|FG005|Overall Study|Lack of Efficacy|1
4656138|NCT02141659|7540944|FG000|Overall Study|Pretreatment Event/ Adverse Event|0
4656139|NCT02141659|7540945|FG001|Overall Study|Pretreatment Event/ Adverse Event|0
4656140|NCT02141659|7540946|FG002|Overall Study|Pretreatment Event/ Adverse Event|0
4656141|NCT02141659|7540947|FG003|Overall Study|Pretreatment Event/ Adverse Event|0
4656142|NCT02141659|7540948|FG004|Overall Study|Pretreatment Event/ Adverse Event|2
4656143|NCT02141659|7540949|FG005|Overall Study|Pretreatment Event/ Adverse Event|1
4656144|NCT02141672|7540966|FG000|Overall Study|Adverse Event|0
4656145|NCT02141672|7540967|FG001|Overall Study|Adverse Event|1
4656146|NCT02141672|7540968|FG002|Overall Study|Adverse Event|0
4656147|NCT02141672|7540966|FG000|Overall Study|Death|10
4656148|NCT02141672|7540967|FG001|Overall Study|Death|2
4656149|NCT02141672|7540968|FG002|Overall Study|Death|1
4656150|NCT02141672|7540966|FG000|Overall Study|Lack of Efficacy|0
4656151|NCT02141672|7540967|FG001|Overall Study|Lack of Efficacy|0
4656152|NCT02141672|7540968|FG002|Overall Study|Lack of Efficacy|2
4656153|NCT02141672|7540966|FG000|Overall Study|Lost to Follow-up|1
4656154|NCT02141672|7540967|FG001|Overall Study|Lost to Follow-up|1
4656155|NCT02141672|7540968|FG002|Overall Study|Lost to Follow-up|3
4656156|NCT02141672|7540966|FG000|Overall Study|Physician Decision|1
4656157|NCT02141672|7540967|FG001|Overall Study|Physician Decision|2
4656158|NCT02141672|7540968|FG002|Overall Study|Physician Decision|5
4656159|NCT02141672|7540966|FG000|Overall Study|Protocol Violation|0
4656160|NCT02141672|7540967|FG001|Overall Study|Protocol Violation|0
4656161|NCT02141672|7540968|FG002|Overall Study|Protocol Violation|1
4656162|NCT02141672|7540966|FG000|Overall Study|Withdrawal by Subject|3
4656163|NCT02141672|7540967|FG001|Overall Study|Withdrawal by Subject|2
4656164|NCT02141672|7540968|FG002|Overall Study|Withdrawal by Subject|5
4656165|NCT02141672|7540966|FG000|Overall Study|refused to follow-up|1
4656166|NCT02141672|7540967|FG001|Overall Study|refused to follow-up|0
4656167|NCT02141672|7540968|FG002|Overall Study|refused to follow-up|1
4656168|NCT02141854|7540981|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25
4656169|NCT02141854|7540982|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
4656170|NCT02141854|7540983|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
4656171|NCT02141854|7540984|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
4656172|NCT02141854|7540985|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
4656173|NCT02141854|7540986|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
4656174|NCT02141854|7540981|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76
4656175|NCT02141854|7540982|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0
4656176|NCT02141854|7540983|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0
4656177|NCT02141854|7540984|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0
4656178|NCT02141854|7540985|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0
4656179|NCT02141854|7540986|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0
4656180|NCT02141854|7540981|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14
4656181|NCT02141854|7540982|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0
4656182|NCT02141854|7540983|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0
4656183|NCT02141854|7540984|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0
4656184|NCT02141854|7540985|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0
4656185|NCT02141854|7540986|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0
4656186|NCT02141854|7540981|FG000|Run-In Period (Pre-assignment)|Other|14
4656187|NCT02141854|7540982|FG001|Run-In Period (Pre-assignment)|Other|0
4656188|NCT02141854|7540983|FG002|Run-In Period (Pre-assignment)|Other|0
4656189|NCT02141854|7540984|FG003|Run-In Period (Pre-assignment)|Other|0
4656190|NCT02141854|7540985|FG004|Run-In Period (Pre-assignment)|Other|0
4656191|NCT02141854|7540986|FG005|Run-In Period (Pre-assignment)|Other|0
4656192|NCT02141854|7540981|FG000|Run-In Period (Pre-assignment)|Adverse Event|10
4656193|NCT02141854|7540982|FG001|Run-In Period (Pre-assignment)|Adverse Event|0
4656194|NCT02141854|7540983|FG002|Run-In Period (Pre-assignment)|Adverse Event|0
4656195|NCT02141854|7540984|FG003|Run-In Period (Pre-assignment)|Adverse Event|0
4656196|NCT02141854|7540985|FG004|Run-In Period (Pre-assignment)|Adverse Event|0
4656197|NCT02141854|7540986|FG005|Run-In Period (Pre-assignment)|Adverse Event|0
4656198|NCT02141854|7540981|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9
4656199|NCT02141854|7540982|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
4656200|NCT02141854|7540983|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
4656201|NCT02141854|7540984|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
4656202|NCT02141854|7540985|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
4656203|NCT02141854|7540986|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
4656204|NCT02141854|7540981|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6
4656205|NCT02141854|7540982|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0
4656206|NCT02141854|7540983|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0
4656207|NCT02141854|7540984|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0
4656208|NCT02141854|7540985|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0
4656209|NCT02141854|7540986|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0
4656210|NCT02141854|7540981|FG000|Treatment Period|Protocol Violation|0
4656211|NCT02141854|7540982|FG001|Treatment Period|Protocol Violation|1
4656212|NCT02141854|7540983|FG002|Treatment Period|Protocol Violation|0
4656213|NCT02141854|7540984|FG003|Treatment Period|Protocol Violation|2
4656214|NCT02141854|7540985|FG004|Treatment Period|Protocol Violation|2
4656215|NCT02141854|7540986|FG005|Treatment Period|Protocol Violation|1
4656216|NCT02141854|7540981|FG000|Treatment Period|Noncompliance|0
4656217|NCT02141854|7540982|FG001|Treatment Period|Noncompliance|0
4656218|NCT02141854|7540983|FG002|Treatment Period|Noncompliance|0
4656219|NCT02141854|7540984|FG003|Treatment Period|Noncompliance|1
4656220|NCT02141854|7540985|FG004|Treatment Period|Noncompliance|0
4656221|NCT02141854|7540986|FG005|Treatment Period|Noncompliance|0
4656222|NCT02141854|7540981|FG000|Treatment Period|Lack of Efficacy|0
4656223|NCT02141854|7540982|FG001|Treatment Period|Lack of Efficacy|0
4656224|NCT02141854|7540983|FG002|Treatment Period|Lack of Efficacy|0
4656225|NCT02141854|7540984|FG003|Treatment Period|Lack of Efficacy|1
4656226|NCT02141854|7540985|FG004|Treatment Period|Lack of Efficacy|1
4656227|NCT02141854|7540986|FG005|Treatment Period|Lack of Efficacy|7
4656228|NCT02141854|7540981|FG000|Treatment Period|Pregnancy|0
4656229|NCT02141854|7540982|FG001|Treatment Period|Pregnancy|1
4656230|NCT02141854|7540983|FG002|Treatment Period|Pregnancy|0
4656231|NCT02141854|7540984|FG003|Treatment Period|Pregnancy|0
4656232|NCT02141854|7540985|FG004|Treatment Period|Pregnancy|0
4656233|NCT02141854|7540986|FG005|Treatment Period|Pregnancy|0
4656234|NCT02141854|7540981|FG000|Treatment Period|Other|0
4656235|NCT02141854|7540982|FG001|Treatment Period|Other|1
4656236|NCT02141854|7540983|FG002|Treatment Period|Other|2
4656237|NCT02141854|7540984|FG003|Treatment Period|Other|0
4656238|NCT02141854|7540985|FG004|Treatment Period|Other|1
4656239|NCT02141854|7540986|FG005|Treatment Period|Other|2
4656240|NCT02141854|7540981|FG000|Treatment Period|Adverse Event|0
4656241|NCT02141854|7540982|FG001|Treatment Period|Adverse Event|2
4656242|NCT02141854|7540983|FG002|Treatment Period|Adverse Event|2
4656243|NCT02141854|7540984|FG003|Treatment Period|Adverse Event|0
4656244|NCT02141854|7540985|FG004|Treatment Period|Adverse Event|2
4656245|NCT02141854|7540986|FG005|Treatment Period|Adverse Event|2
4656246|NCT02141854|7540981|FG000|Treatment Period|Withdrawal by Subject|0
4656247|NCT02141854|7540982|FG001|Treatment Period|Withdrawal by Subject|2
4656248|NCT02141854|7540983|FG002|Treatment Period|Withdrawal by Subject|3
4656249|NCT02141854|7540984|FG003|Treatment Period|Withdrawal by Subject|3
4656250|NCT02141854|7540985|FG004|Treatment Period|Withdrawal by Subject|4
4656251|NCT02141854|7540986|FG005|Treatment Period|Withdrawal by Subject|7
4656252|NCT02141854|7540981|FG000|Treatment Period|Disease progression|0
4656253|NCT02141854|7540982|FG001|Treatment Period|Disease progression|2
4656254|NCT02141854|7540983|FG002|Treatment Period|Disease progression|1
4656255|NCT02141854|7540984|FG003|Treatment Period|Disease progression|3
4656256|NCT02141854|7540985|FG004|Treatment Period|Disease progression|0
4656257|NCT02141854|7540986|FG005|Treatment Period|Disease progression|18
4656258|NCT02141854|7540981|FG000|Treatment Period|Lost to Follow-up|0
4656259|NCT02141854|7540982|FG001|Treatment Period|Lost to Follow-up|1
4656260|NCT02141854|7540983|FG002|Treatment Period|Lost to Follow-up|1
4656261|NCT02141854|7540984|FG003|Treatment Period|Lost to Follow-up|1
4656262|NCT02141854|7540985|FG004|Treatment Period|Lost to Follow-up|0
4656263|NCT02141854|7540986|FG005|Treatment Period|Lost to Follow-up|1
4656264|NCT02141984|7541002|FG000|Overall Study|Lack of Efficacy|2
4656265|NCT02141997|7541010|FG000|Overall Study|Adverse Event|0
4656266|NCT02141997|7541011|FG001|Overall Study|Adverse Event|2
4656267|NCT02141997|7541012|FG002|Overall Study|Adverse Event|0
4656268|NCT02141997|7541013|FG003|Overall Study|Adverse Event|1
4656269|NCT02141997|7541010|FG000|Overall Study|Participant noncompliance|1
4656270|NCT02141997|7541011|FG001|Overall Study|Participant noncompliance|0
4656271|NCT02141997|7541012|FG002|Overall Study|Participant noncompliance|0
4656272|NCT02141997|7541013|FG003|Overall Study|Participant noncompliance|0
4656273|NCT02141997|7541010|FG000|Overall Study|Withdrew consent|1
4656274|NCT02141997|7541011|FG001|Overall Study|Withdrew consent|0
4656275|NCT02141997|7541012|FG002|Overall Study|Withdrew consent|3
4656276|NCT02141997|7541013|FG003|Overall Study|Withdrew consent|0
4656277|NCT02141997|7541010|FG000|Overall Study|Other|1
4656278|NCT02141997|7541011|FG001|Overall Study|Other|4
4748532|NCT01928394|7722443|FG014|Treatment Period|AE unrelated to study drug|6
4748533|NCT01928394|7722444|FG015|Treatment Period|AE unrelated to study drug|1
4748534|NCT01928394|7722445|FG016|Treatment Period|AE unrelated to study drug|1
4748535|NCT01928394|7722446|FG017|Treatment Period|AE unrelated to study drug|6
4748536|NCT01928394|7722447|FG018|Treatment Period|AE unrelated to study drug|3
4748537|NCT01928394|7722448|FG019|Treatment Period|AE unrelated to study drug|5
4748538|NCT01928394|7722449|FG020|Treatment Period|AE unrelated to study drug|1
4748539|NCT01928394|7722450|FG021|Treatment Period|AE unrelated to study drug|1
4748540|NCT01928394|7722451|FG022|Treatment Period|AE unrelated to study drug|0
4748541|NCT01928394|7722429|FG000|Treatment Period|Participant request to stop therapy|0
4748542|NCT01928394|7722430|FG001|Treatment Period|Participant request to stop therapy|0
4748543|NCT01928394|7722431|FG002|Treatment Period|Participant request to stop therapy|0
4748544|NCT01928394|7722432|FG003|Treatment Period|Participant request to stop therapy|0
4748545|NCT01928394|7722433|FG004|Treatment Period|Participant request to stop therapy|0
4748546|NCT01928394|7722434|FG005|Treatment Period|Participant request to stop therapy|3
4748547|NCT01928394|7722435|FG006|Treatment Period|Participant request to stop therapy|3
4748548|NCT01928394|7722436|FG007|Treatment Period|Participant request to stop therapy|0
4748549|NCT01928394|7722437|FG008|Treatment Period|Participant request to stop therapy|0
4748550|NCT01928394|7722438|FG009|Treatment Period|Participant request to stop therapy|0
4748551|NCT01928394|7722439|FG010|Treatment Period|Participant request to stop therapy|3
4748552|NCT01928394|7722440|FG011|Treatment Period|Participant request to stop therapy|2
4748553|NCT01928394|7722441|FG012|Treatment Period|Participant request to stop therapy|1
4748554|NCT01928394|7722442|FG013|Treatment Period|Participant request to stop therapy|2
4748555|NCT01928394|7722443|FG014|Treatment Period|Participant request to stop therapy|4
4748556|NCT01928394|7722444|FG015|Treatment Period|Participant request to stop therapy|0
4748557|NCT01928394|7722445|FG016|Treatment Period|Participant request to stop therapy|1
4748558|NCT01928394|7722446|FG017|Treatment Period|Participant request to stop therapy|3
4748559|NCT01928394|7722447|FG018|Treatment Period|Participant request to stop therapy|1
4748560|NCT01928394|7722448|FG019|Treatment Period|Participant request to stop therapy|1
4748561|NCT01928394|7722449|FG020|Treatment Period|Participant request to stop therapy|3
4748562|NCT01928394|7722450|FG021|Treatment Period|Participant request to stop therapy|1
4748563|NCT01928394|7722451|FG022|Treatment Period|Participant request to stop therapy|3
4748564|NCT01928394|7722429|FG000|Treatment Period|Participant withdrew consent|0
4748565|NCT01928394|7722430|FG001|Treatment Period|Participant withdrew consent|0
4748566|NCT01928394|7722431|FG002|Treatment Period|Participant withdrew consent|1
4748567|NCT01928394|7722432|FG003|Treatment Period|Participant withdrew consent|1
4748568|NCT01928394|7722433|FG004|Treatment Period|Participant withdrew consent|0
4748569|NCT01928394|7722434|FG005|Treatment Period|Participant withdrew consent|1
4748570|NCT01928394|7722435|FG006|Treatment Period|Participant withdrew consent|0
4748571|NCT01928394|7722436|FG007|Treatment Period|Participant withdrew consent|1
4748572|NCT01928394|7722437|FG008|Treatment Period|Participant withdrew consent|0
4656279|NCT02141997|7541012|FG002|Overall Study|Other|0
4656280|NCT02141997|7541013|FG003|Overall Study|Other|0
4656281|NCT02142283|7541102|FG000|Overall Study|Death|20
4656282|NCT02142283|7541103|FG001|Overall Study|Death|18
4656283|NCT02142283|7541102|FG000|Overall Study|Withdrawal by Subject|1
4656284|NCT02142283|7541103|FG001|Overall Study|Withdrawal by Subject|3
4656285|NCT02142387|7541124|FG000|Overall Study|<19 years old|49
4656286|NCT02142387|7541125|FG001|Overall Study|<19 years old|326
4656287|NCT02142387|7541124|FG000|Overall Study|non-cardiac etiology|504
4656288|NCT02142387|7541125|FG001|Overall Study|non-cardiac etiology|3431
4656289|NCT02142387|7541124|FG000|Overall Study|CPR not performed|74
4656290|NCT02142387|7541125|FG001|Overall Study|CPR not performed|473
4656291|NCT02142387|7541124|FG000|Overall Study|witnessed by paramedic|139
4656292|NCT02142387|7541125|FG001|Overall Study|witnessed by paramedic|917
4656293|NCT02142387|7541124|FG000|Overall Study|incomplete data|1
4656294|NCT02142387|7541125|FG001|Overall Study|incomplete data|9
4656295|NCT02142387|7541124|FG000|Overall Study|occurred not at home|298
4656296|NCT02142387|7541125|FG001|Overall Study|occurred not at home|2474
4656297|NCT02142504|7541134|FG000|Overall Study|Protocol Violation|2
4656298|NCT02142504|7541135|FG001|Overall Study|Protocol Violation|1
4656299|NCT02142504|7541136|FG002|Overall Study|Protocol Violation|2
4656300|NCT02142504|7541134|FG000|Overall Study|Adverse Event|2
4656301|NCT02142504|7541135|FG001|Overall Study|Adverse Event|3
4656302|NCT02142504|7541136|FG002|Overall Study|Adverse Event|4
4656303|NCT02142504|7541134|FG000|Overall Study|Lost to Follow-up|12
4656304|NCT02142504|7541135|FG001|Overall Study|Lost to Follow-up|19
4656305|NCT02142504|7541136|FG002|Overall Study|Lost to Follow-up|17
4656306|NCT02142504|7541134|FG000|Overall Study|Withdrawal by Subject|7
4656307|NCT02142504|7541135|FG001|Overall Study|Withdrawal by Subject|9
4656308|NCT02142504|7541136|FG002|Overall Study|Withdrawal by Subject|11
4656309|NCT02142504|7541134|FG000|Overall Study|Pregnancy|4
4656310|NCT02142504|7541135|FG001|Overall Study|Pregnancy|4
4656311|NCT02142504|7541136|FG002|Overall Study|Pregnancy|2
4656312|NCT02142504|7541134|FG000|Overall Study|Physician Decision|0
4656313|NCT02142504|7541135|FG001|Overall Study|Physician Decision|1
4656314|NCT02142504|7541136|FG002|Overall Study|Physician Decision|3
4656315|NCT02142504|7541134|FG000|Overall Study|Reason Not Specified|4
4656316|NCT02142504|7541135|FG001|Overall Study|Reason Not Specified|5
4656317|NCT02142504|7541136|FG002|Overall Study|Reason Not Specified|4
4656318|NCT02142712|7541152|FG000|Overall Study|Lost to Follow-up|1
4656319|NCT02142712|7541153|FG001|Overall Study|Lost to Follow-up|1
4656320|NCT02142712|7541154|FG002|Overall Study|Lost to Follow-up|1
4656321|NCT02142712|7541155|FG003|Overall Study|Lost to Follow-up|0
4656322|NCT02142738|7541166|FG000|Overall Study|Adverse Event|9
4656323|NCT02142738|7541167|FG001|Overall Study|Adverse Event|8
4656324|NCT02142738|7541166|FG000|Overall Study|Death|33
4656325|NCT02142738|7541167|FG001|Overall Study|Death|55
4656326|NCT02142738|7541166|FG000|Overall Study|Progressive Disease|0
4656327|NCT02142738|7541167|FG001|Overall Study|Progressive Disease|1
4656328|NCT02142738|7541166|FG000|Overall Study|Withdrawal by Subject|5
4656329|NCT02142738|7541167|FG001|Overall Study|Withdrawal by Subject|5
4656330|NCT02142738|7541166|FG000|Overall Study|Ongoing in Study|107
4656331|NCT02142738|7541167|FG001|Overall Study|Ongoing in Study|82
4656332|NCT02142894|7541173|FG000|Overall Study|Protocol Violation|8
4656333|NCT02143024|7541179|FG000|Overall Study|Lost to Follow-up|1
4656334|NCT02143024|7541180|FG001|Overall Study|Lost to Follow-up|1
4656335|NCT02143024|7541179|FG000|Overall Study|Withdrawal by Subject|1
4656336|NCT02143024|7541180|FG001|Overall Study|Withdrawal by Subject|0
4656337|NCT02143102|7541188|FG000|Overall Study|Lost to Follow-up|11
4656338|NCT02143102|7541189|FG001|Overall Study|Lost to Follow-up|0
4656339|NCT02143141|7541197|FG000|Overall Study|pain scores at 24 hours not collected|1
4656340|NCT02143141|7541198|FG001|Overall Study|pain scores at 24 hours not collected|0
4656341|NCT02143583|7541211|FG000|Overall Study|Withdrawal by Subject|1
4656342|NCT02143583|7541212|FG001|Overall Study|Withdrawal by Subject|0
4656343|NCT02143583|7541213|FG002|Overall Study|Withdrawal by Subject|1
4656344|NCT02143583|7541211|FG000|Overall Study|husband illness|0
4656345|NCT02143583|7541212|FG001|Overall Study|husband illness|0
4656346|NCT02143583|7541213|FG002|Overall Study|husband illness|1
4656347|NCT02143713|7541238|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1
4656348|NCT02143713|7541239|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2
4656349|NCT02143713|7541240|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5
4656350|NCT02143713|7541241|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4
4656351|NCT02143713|7541238|FG000|Treatment Period (6 Months)|Adverse Event|7
4656352|NCT02143713|7541239|FG001|Treatment Period (6 Months)|Adverse Event|8
4656353|NCT02143713|7541240|FG002|Treatment Period (6 Months)|Adverse Event|8
4656354|NCT02143713|7541241|FG003|Treatment Period (6 Months)|Adverse Event|9
4656355|NCT02143713|7541238|FG000|Treatment Period (6 Months)|Lost to Follow-up|3
4656356|NCT02143713|7541239|FG001|Treatment Period (6 Months)|Lost to Follow-up|0
4656357|NCT02143713|7541240|FG002|Treatment Period (6 Months)|Lost to Follow-up|4
4656358|NCT02143713|7541241|FG003|Treatment Period (6 Months)|Lost to Follow-up|3
4656359|NCT02143713|7541238|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2
4656360|NCT02143713|7541239|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0
4656361|NCT02143713|7541240|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0
4656362|NCT02143713|7541241|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2
4656363|NCT02143713|7541238|FG000|Treatment Period (6 Months)|Pregnancy|0
4656364|NCT02143713|7541239|FG001|Treatment Period (6 Months)|Pregnancy|2
4656365|NCT02143713|7541240|FG002|Treatment Period (6 Months)|Pregnancy|2
4656366|NCT02143713|7541241|FG003|Treatment Period (6 Months)|Pregnancy|0
4656367|NCT02143713|7541238|FG000|Treatment Period (6 Months)|Non-compliance|1
4656368|NCT02143713|7541239|FG001|Treatment Period (6 Months)|Non-compliance|0
4656369|NCT02143713|7541240|FG002|Treatment Period (6 Months)|Non-compliance|0
4656370|NCT02143713|7541241|FG003|Treatment Period (6 Months)|Non-compliance|3
4656371|NCT02143713|7541238|FG000|Treatment Period (6 Months)|Other|3
4656372|NCT02143713|7541239|FG001|Treatment Period (6 Months)|Other|0
4656373|NCT02143713|7541240|FG002|Treatment Period (6 Months)|Other|3
4656374|NCT02143713|7541241|FG003|Treatment Period (6 Months)|Other|2
4656375|NCT02143713|7541238|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0
4656376|NCT02143713|7541239|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0
4656377|NCT02143713|7541240|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0
4656378|NCT02143713|7541241|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4
4656379|NCT02143713|7541238|FG000|Treatment Period (6 Months)|Exclusionary Medication|2
4656380|NCT02143713|7541239|FG001|Treatment Period (6 Months)|Exclusionary Medication|0
4656381|NCT02143713|7541240|FG002|Treatment Period (6 Months)|Exclusionary Medication|0
4656382|NCT02143713|7541241|FG003|Treatment Period (6 Months)|Exclusionary Medication|0
4656383|NCT02143713|7541238|FG000|Treatment Period (6 Months)|Lack of Efficacy|1
4656384|NCT02143713|7541239|FG001|Treatment Period (6 Months)|Lack of Efficacy|0
4656385|NCT02143713|7541240|FG002|Treatment Period (6 Months)|Lack of Efficacy|0
4656386|NCT02143713|7541241|FG003|Treatment Period (6 Months)|Lack of Efficacy|1
4656387|NCT02143713|7541238|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4
4656388|NCT02143713|7541239|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7
4656389|NCT02143713|7541240|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6
4656390|NCT02143713|7541241|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10
4656391|NCT02143713|7541238|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0
4656392|NCT02143713|7541239|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0
4656393|NCT02143713|7541240|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1
4656394|NCT02143713|7541241|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0
4656395|NCT02143713|7541238|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3
4656396|NCT02143713|7541239|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8
4656397|NCT02143713|7541240|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11
4656398|NCT02143713|7541241|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8
4656399|NCT02143713|7541238|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2
4656400|NCT02143713|7541239|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4
4656401|NCT02143713|7541240|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4
4656402|NCT02143713|7541241|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1
4656403|NCT02143713|7541238|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0
4656404|NCT02143713|7541239|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1
4656405|NCT02143713|7541240|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0
4656406|NCT02143713|7541241|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1
4656407|NCT02143713|7541238|FG000|Post-treatment Follow-up (12 Months)|Other|3
4656408|NCT02143713|7541239|FG001|Post-treatment Follow-up (12 Months)|Other|4
4656409|NCT02143713|7541240|FG002|Post-treatment Follow-up (12 Months)|Other|7
4656410|NCT02143713|7541241|FG003|Post-treatment Follow-up (12 Months)|Other|7
4656411|NCT02143778|7541252|FG000|Overall Study|Withdrawal by Subject|2
4656412|NCT02143778|7541252|FG000|Overall Study|Device malfunction|1
4656413|NCT02143843|7541257|FG000|Overall Study|Adverse Event|8
4656414|NCT02143843|7541257|FG000|Overall Study|Lack of Efficacy|2
4656415|NCT02143843|7541257|FG000|Overall Study|Withdrawal by Subject|2
4656416|NCT02143947|7541263|FG000|Overall Study|Lost to Follow-up|4
4656417|NCT02143947|7541264|FG001|Overall Study|Lost to Follow-up|2
4656418|NCT02144012|7541278|FG000|Overall Study|Adverse Event|1
4656419|NCT02144012|7541279|FG001|Overall Study|Adverse Event|0
4656420|NCT02144012|7541278|FG000|Overall Study|Death|1
4656421|NCT02144012|7541279|FG001|Overall Study|Death|0
4656422|NCT02144012|7541278|FG000|Overall Study|Withdrawal by Subject|11
4656423|NCT02144012|7541279|FG001|Overall Study|Withdrawal by Subject|3
4656424|NCT02144012|7541278|FG000|Overall Study|Study Terminated by Sponsor|18
4656425|NCT02144012|7541279|FG001|Overall Study|Study Terminated by Sponsor|12
4656426|NCT02144012|7541278|FG000|Overall Study|Other|3
4656427|NCT02144012|7541279|FG001|Overall Study|Other|0
4656428|NCT02144077|7541287|FG000|Overall Study|Withdrawal by Subject|3
4656429|NCT02144077|7541288|FG001|Overall Study|Withdrawal by Subject|3
4656430|NCT02144077|7541287|FG000|Overall Study|Adverse Event|2
4656431|NCT02144077|7541288|FG001|Overall Study|Adverse Event|3
4656432|NCT02144077|7541287|FG000|Overall Study|Lost to Follow-up|2
4656433|NCT02144077|7541288|FG001|Overall Study|Lost to Follow-up|2
4656434|NCT02144077|7541287|FG000|Overall Study|Protocol Violation|1
4656435|NCT02144077|7541288|FG001|Overall Study|Protocol Violation|2
4656436|NCT02144077|7541287|FG000|Overall Study|Death|0
4656437|NCT02144077|7541288|FG001|Overall Study|Death|1
4656438|NCT02144077|7541287|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2
4656439|NCT02144077|7541288|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0
4656440|NCT02144220|7541294|FG000|Overall Study|technology incompatibility|9
4656441|NCT02144220|7541294|FG000|Overall Study|Lack of Efficacy|4
4656442|NCT02144220|7541294|FG000|Overall Study|Physician Decision|3
4656443|NCT02144220|7541294|FG000|Overall Study|Withdrawal by Subject|2
4656444|NCT02144220|7541294|FG000|Overall Study|Protocol Violation|1
4656445|NCT02144285|7541330|FG000|Overall Study|Withdrawal by Subject|0
4656446|NCT02144285|7541331|FG001|Overall Study|Withdrawal by Subject|0
4656447|NCT02144285|7541332|FG002|Overall Study|Withdrawal by Subject|0
4656448|NCT02144285|7541333|FG003|Overall Study|Withdrawal by Subject|0
4656449|NCT02144285|7541334|FG004|Overall Study|Withdrawal by Subject|1
4656450|NCT02144285|7541335|FG005|Overall Study|Withdrawal by Subject|0
4656451|NCT02144285|7541336|FG006|Overall Study|Withdrawal by Subject|0
4656452|NCT02144285|7541337|FG007|Overall Study|Withdrawal by Subject|0
4656453|NCT02144285|7541338|FG008|Overall Study|Withdrawal by Subject|0
4656454|NCT02144285|7541339|FG009|Overall Study|Withdrawal by Subject|0
4656455|NCT02144337|7541377|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1
4656456|NCT02144337|7541378|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1
4656457|NCT02144337|7541377|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2
4656458|NCT02144337|7541378|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0
4656459|NCT02144337|7541377|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1
4656460|NCT02144337|7541378|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0
4656461|NCT02144337|7541377|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2
4656462|NCT02144337|7541378|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0
4656463|NCT02144337|7541377|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1
4656464|NCT02144337|7541378|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0
4656465|NCT02144610|7541409|FG000|Overall Study|Physician Decision|1
4656466|NCT02144610|7541410|FG001|Overall Study|Physician Decision|0
4656467|NCT02144610|7541409|FG000|Overall Study|Withdrawal by Subject|1
4656468|NCT02144610|7541410|FG001|Overall Study|Withdrawal by Subject|5
4656469|NCT02144610|7541409|FG000|Overall Study|Death|2
4656470|NCT02144610|7541410|FG001|Overall Study|Death|2
4656471|NCT02144610|7541409|FG000|Overall Study|Study Discontinuation by Sponsor|19
4656472|NCT02144610|7541410|FG001|Overall Study|Study Discontinuation by Sponsor|14
4656473|NCT02144610|7541409|FG000|Overall Study|Other|0
4656474|NCT02144610|7541410|FG001|Overall Study|Other|1
4656475|NCT02144701|7541427|FG000|Overall Study|development of relapse, GVHD or death|9
4748573|NCT01928394|7722438|FG009|Treatment Period|Participant withdrew consent|0
4748574|NCT01928394|7722439|FG010|Treatment Period|Participant withdrew consent|1
4748575|NCT01928394|7722440|FG011|Treatment Period|Participant withdrew consent|1
4748576|NCT01928394|7722441|FG012|Treatment Period|Participant withdrew consent|1
4748577|NCT01928394|7722442|FG013|Treatment Period|Participant withdrew consent|0
4748578|NCT01928394|7722443|FG014|Treatment Period|Participant withdrew consent|2
4748579|NCT01928394|7722444|FG015|Treatment Period|Participant withdrew consent|0
4748580|NCT01928394|7722445|FG016|Treatment Period|Participant withdrew consent|2
4748581|NCT01928394|7722446|FG017|Treatment Period|Participant withdrew consent|1
4748582|NCT01928394|7722447|FG018|Treatment Period|Participant withdrew consent|1
4748583|NCT01928394|7722448|FG019|Treatment Period|Participant withdrew consent|1
4748584|NCT01928394|7722449|FG020|Treatment Period|Participant withdrew consent|0
4748585|NCT01928394|7722450|FG021|Treatment Period|Participant withdrew consent|2
4748586|NCT01928394|7722451|FG022|Treatment Period|Participant withdrew consent|0
4748587|NCT01928394|7722429|FG000|Treatment Period|Poor/non-compliance|0
4748588|NCT01928394|7722430|FG001|Treatment Period|Poor/non-compliance|0
4748589|NCT01928394|7722431|FG002|Treatment Period|Poor/non-compliance|0
4748590|NCT01928394|7722432|FG003|Treatment Period|Poor/non-compliance|1
4748591|NCT01928394|7722433|FG004|Treatment Period|Poor/non-compliance|0
4748592|NCT01928394|7722434|FG005|Treatment Period|Poor/non-compliance|0
4748593|NCT01928394|7722435|FG006|Treatment Period|Poor/non-compliance|0
4748594|NCT01928394|7722436|FG007|Treatment Period|Poor/non-compliance|0
4748595|NCT01928394|7722437|FG008|Treatment Period|Poor/non-compliance|0
4748596|NCT01928394|7722438|FG009|Treatment Period|Poor/non-compliance|0
4748597|NCT01928394|7722439|FG010|Treatment Period|Poor/non-compliance|0
4748598|NCT01928394|7722440|FG011|Treatment Period|Poor/non-compliance|0
4748599|NCT01928394|7722441|FG012|Treatment Period|Poor/non-compliance|1
4748600|NCT01928394|7722442|FG013|Treatment Period|Poor/non-compliance|0
4748601|NCT01928394|7722443|FG014|Treatment Period|Poor/non-compliance|1
4748602|NCT01928394|7722444|FG015|Treatment Period|Poor/non-compliance|0
4748603|NCT01928394|7722445|FG016|Treatment Period|Poor/non-compliance|0
4748604|NCT01928394|7722446|FG017|Treatment Period|Poor/non-compliance|1
4748605|NCT01928394|7722447|FG018|Treatment Period|Poor/non-compliance|0
4748606|NCT01928394|7722448|FG019|Treatment Period|Poor/non-compliance|1
4748607|NCT01928394|7722449|FG020|Treatment Period|Poor/non-compliance|0
4748608|NCT01928394|7722450|FG021|Treatment Period|Poor/non-compliance|0
4748609|NCT01928394|7722451|FG022|Treatment Period|Poor/non-compliance|0
4748610|NCT01928394|7722429|FG000|Treatment Period|other reason|0
4748611|NCT01928394|7722430|FG001|Treatment Period|other reason|0
4748612|NCT01928394|7722431|FG002|Treatment Period|other reason|0
4748613|NCT01928394|7722432|FG003|Treatment Period|other reason|0
4748614|NCT01928394|7722433|FG004|Treatment Period|other reason|0
4748615|NCT01928394|7722434|FG005|Treatment Period|other reason|0
4656476|NCT02144701|7541428|FG001|Overall Study|development of relapse, GVHD or death|3
4656477|NCT02145026|7541447|FG000|Overall Study|Adverse Event|2
4656478|NCT02145026|7541447|FG000|Overall Study|Death|4
4656479|NCT02145026|7541447|FG000|Overall Study|Withdrawal by Subject|2
4656480|NCT02145026|7541447|FG000|Overall Study|Physician Decision|4
4656481|NCT02145078|7541455|FG000|Overall Study|Death|1
4656482|NCT02145078|7541455|FG000|Overall Study|Reason not given|3
4656483|NCT02145156|7541462|FG000|Overall Study|No match to vaccination records|60
4656484|NCT02145156|7541463|FG001|Overall Study|No match to vaccination records|52
4656485|NCT02145156|7541464|FG002|Overall Study|No match to vaccination records|41
4748616|NCT01928394|7722435|FG006|Treatment Period|other reason|0
4748617|NCT01928394|7722436|FG007|Treatment Period|other reason|0
4748618|NCT01928394|7722437|FG008|Treatment Period|other reason|0
4748619|NCT01928394|7722438|FG009|Treatment Period|other reason|0
4748620|NCT01928394|7722439|FG010|Treatment Period|other reason|1
4748621|NCT01928394|7722440|FG011|Treatment Period|other reason|1
4748622|NCT01928394|7722441|FG012|Treatment Period|other reason|1
4748623|NCT01928394|7722442|FG013|Treatment Period|other reason|0
4748624|NCT01928394|7722443|FG014|Treatment Period|other reason|1
4748625|NCT01928394|7722444|FG015|Treatment Period|other reason|0
4748626|NCT01928394|7722445|FG016|Treatment Period|other reason|0
4748627|NCT01928394|7722446|FG017|Treatment Period|other reason|0
4748628|NCT01928394|7722447|FG018|Treatment Period|other reason|2
4748629|NCT01928394|7722448|FG019|Treatment Period|other reason|2
4748630|NCT01928394|7722449|FG020|Treatment Period|other reason|0
4748631|NCT01928394|7722450|FG021|Treatment Period|other reason|0
4748632|NCT01928394|7722451|FG022|Treatment Period|other reason|0
4748633|NCT01928394|7722429|FG000|Treatment Period|Maximum clinical benefit|0
4748634|NCT01928394|7722430|FG001|Treatment Period|Maximum clinical benefit|0
4748635|NCT01928394|7722431|FG002|Treatment Period|Maximum clinical benefit|0
4748636|NCT01928394|7722432|FG003|Treatment Period|Maximum clinical benefit|0
4748637|NCT01928394|7722433|FG004|Treatment Period|Maximum clinical benefit|0
4748638|NCT01928394|7722434|FG005|Treatment Period|Maximum clinical benefit|0
4748639|NCT01928394|7722435|FG006|Treatment Period|Maximum clinical benefit|0
4748640|NCT01928394|7722436|FG007|Treatment Period|Maximum clinical benefit|0
4748641|NCT01928394|7722437|FG008|Treatment Period|Maximum clinical benefit|0
4748642|NCT01928394|7722438|FG009|Treatment Period|Maximum clinical benefit|0
4748643|NCT01928394|7722439|FG010|Treatment Period|Maximum clinical benefit|1
4748644|NCT01928394|7722440|FG011|Treatment Period|Maximum clinical benefit|1
4748645|NCT01928394|7722441|FG012|Treatment Period|Maximum clinical benefit|0
4748646|NCT01928394|7722442|FG013|Treatment Period|Maximum clinical benefit|0
4748647|NCT01928394|7722443|FG014|Treatment Period|Maximum clinical benefit|1
4748648|NCT01928394|7722444|FG015|Treatment Period|Maximum clinical benefit|0
4748649|NCT01928394|7722445|FG016|Treatment Period|Maximum clinical benefit|0
4748650|NCT01928394|7722446|FG017|Treatment Period|Maximum clinical benefit|1
4748651|NCT01928394|7722447|FG018|Treatment Period|Maximum clinical benefit|1
4748652|NCT01928394|7722448|FG019|Treatment Period|Maximum clinical benefit|0
4748653|NCT01928394|7722449|FG020|Treatment Period|Maximum clinical benefit|2
4748654|NCT01928394|7722450|FG021|Treatment Period|Maximum clinical benefit|0
4748655|NCT01928394|7722451|FG022|Treatment Period|Maximum clinical benefit|0
4748656|NCT01928394|7722429|FG000|Treatment Period|Lost to Follow-up|0
4748657|NCT01928394|7722430|FG001|Treatment Period|Lost to Follow-up|0
4748658|NCT01928394|7722431|FG002|Treatment Period|Lost to Follow-up|0
4748659|NCT01928394|7722432|FG003|Treatment Period|Lost to Follow-up|0
4748660|NCT01928394|7722433|FG004|Treatment Period|Lost to Follow-up|0
4748661|NCT01928394|7722434|FG005|Treatment Period|Lost to Follow-up|0
4748662|NCT01928394|7722435|FG006|Treatment Period|Lost to Follow-up|0
4748663|NCT01928394|7722436|FG007|Treatment Period|Lost to Follow-up|0
4748664|NCT01928394|7722437|FG008|Treatment Period|Lost to Follow-up|0
4748665|NCT01928394|7722438|FG009|Treatment Period|Lost to Follow-up|0
4748666|NCT01928394|7722439|FG010|Treatment Period|Lost to Follow-up|0
4748667|NCT01928394|7722440|FG011|Treatment Period|Lost to Follow-up|0
4748668|NCT01928394|7722441|FG012|Treatment Period|Lost to Follow-up|0
4748669|NCT01928394|7722442|FG013|Treatment Period|Lost to Follow-up|0
4748670|NCT01928394|7722443|FG014|Treatment Period|Lost to Follow-up|0
4748671|NCT01928394|7722444|FG015|Treatment Period|Lost to Follow-up|0
4748672|NCT01928394|7722445|FG016|Treatment Period|Lost to Follow-up|0
4748673|NCT01928394|7722446|FG017|Treatment Period|Lost to Follow-up|0
4748674|NCT01928394|7722447|FG018|Treatment Period|Lost to Follow-up|0
4748675|NCT01928394|7722448|FG019|Treatment Period|Lost to Follow-up|0
4748676|NCT01928394|7722449|FG020|Treatment Period|Lost to Follow-up|0
4748677|NCT01928394|7722450|FG021|Treatment Period|Lost to Follow-up|0
4748678|NCT01928394|7722451|FG022|Treatment Period|Lost to Follow-up|1
4748679|NCT01928394|7722429|FG000|Treatment Period|Death|0
4748680|NCT01928394|7722430|FG001|Treatment Period|Death|0
4748681|NCT01928394|7722431|FG002|Treatment Period|Death|0
4748682|NCT01928394|7722432|FG003|Treatment Period|Death|0
4748683|NCT01928394|7722433|FG004|Treatment Period|Death|0
4748684|NCT01928394|7722434|FG005|Treatment Period|Death|0
4748685|NCT01928394|7722435|FG006|Treatment Period|Death|0
4748686|NCT01928394|7722436|FG007|Treatment Period|Death|0
4748687|NCT01928394|7722437|FG008|Treatment Period|Death|0
4748688|NCT01928394|7722438|FG009|Treatment Period|Death|0
4748689|NCT01928394|7722439|FG010|Treatment Period|Death|0
4748690|NCT01928394|7722440|FG011|Treatment Period|Death|0
4748691|NCT01928394|7722441|FG012|Treatment Period|Death|0
4748692|NCT01928394|7722442|FG013|Treatment Period|Death|1
4748693|NCT01928394|7722443|FG014|Treatment Period|Death|2
4748694|NCT01928394|7722444|FG015|Treatment Period|Death|0
4656486|NCT02145182|7541474|FG000|Overall Study|Adverse Event|4
4656487|NCT02145182|7541475|FG001|Overall Study|Adverse Event|1
4656488|NCT02145182|7541474|FG000|Overall Study|Death|7
4656489|NCT02145182|7541475|FG001|Overall Study|Death|7
4656490|NCT02145182|7541474|FG000|Overall Study|Lost to Follow-up|2
4656491|NCT02145182|7541475|FG001|Overall Study|Lost to Follow-up|2
4656492|NCT02145182|7541474|FG000|Overall Study|Pre-transplant Withdrawal|0
4656493|NCT02145182|7541475|FG001|Overall Study|Pre-transplant Withdrawal|2
4656494|NCT02145182|7541474|FG000|Overall Study|Withdrawal by Subject|5
4656495|NCT02145182|7541475|FG001|Overall Study|Withdrawal by Subject|4
4656496|NCT02145429|7541501|FG000|Overall Study|Death|4
4656497|NCT02145429|7541502|FG001|Overall Study|Death|5
4656498|NCT02145429|7541501|FG000|Overall Study|Lost to Follow-up|4
4656499|NCT02145429|7541502|FG001|Overall Study|Lost to Follow-up|3
4656500|NCT02145429|7541501|FG000|Overall Study|Withdrawal by Subject|8
4656501|NCT02145429|7541502|FG001|Overall Study|Withdrawal by Subject|3
4656502|NCT02145468|7541510|FG000|Overall Study|Withdrawal by Subject|5
4656503|NCT02145468|7541511|FG001|Overall Study|Withdrawal by Subject|8
4656504|NCT02146105|7541543|FG000|Overall Study|Adverse Event|1
4656505|NCT02146105|7541543|FG000|Overall Study|Withdrawal by Subject|5
4656506|NCT02146131|7541549|FG000|Overall Study|Physician Decision|61
4656507|NCT02146131|7541550|FG001|Overall Study|Physician Decision|56
4656508|NCT02146248|7541556|FG000|Overall Study|Withdrawal by Subject|2
4656509|NCT02146274|7541564|FG000|Overall Study|Protocol Violation|73
4656510|NCT02146326|7541575|FG000|Overall Study|Lost to Follow-up|3
4656511|NCT02146326|7541576|FG001|Overall Study|Lost to Follow-up|3
4656512|NCT02146326|7541577|FG002|Overall Study|Lost to Follow-up|11
4656513|NCT02146326|7541578|FG003|Overall Study|Lost to Follow-up|19
4656514|NCT02146326|7541575|FG000|Overall Study|Withdrawal by Subject|2
4656515|NCT02146326|7541576|FG001|Overall Study|Withdrawal by Subject|1
4656516|NCT02146326|7541577|FG002|Overall Study|Withdrawal by Subject|15
4656517|NCT02146326|7541578|FG003|Overall Study|Withdrawal by Subject|11
4656518|NCT02146326|7541575|FG000|Overall Study|Separated from mental health center|23
4656519|NCT02146326|7541576|FG001|Overall Study|Separated from mental health center|33
4656520|NCT02146326|7541577|FG002|Overall Study|Separated from mental health center|0
4656521|NCT02146326|7541578|FG003|Overall Study|Separated from mental health center|0
4656522|NCT02146326|7541575|FG000|Overall Study|Incarcerated|0
4656523|NCT02146326|7541576|FG001|Overall Study|Incarcerated|0
4656524|NCT02146326|7541577|FG002|Overall Study|Incarcerated|3
4656525|NCT02146326|7541578|FG003|Overall Study|Incarcerated|8
4656526|NCT02146326|7541575|FG000|Overall Study|Death|0
4656527|NCT02146326|7541576|FG001|Overall Study|Death|0
4656528|NCT02146326|7541577|FG002|Overall Study|Death|4
4656529|NCT02146326|7541578|FG003|Overall Study|Death|4
4656530|NCT02146326|7541575|FG000|Overall Study|Unable to complete interview|0
4656531|NCT02146326|7541576|FG001|Overall Study|Unable to complete interview|0
4656532|NCT02146326|7541577|FG002|Overall Study|Unable to complete interview|10
4656533|NCT02146326|7541578|FG003|Overall Study|Unable to complete interview|6
4656534|NCT02146352|7541594|FG000|Overall Study|Death|1
4656535|NCT02146352|7541594|FG000|Overall Study|Patient entered hospice care|1
4656536|NCT02146365|7541604|FG000|Overall Study|Lost to Follow-up|2
4656537|NCT02146365|7541605|FG001|Overall Study|Lost to Follow-up|1
4656538|NCT02146365|7541606|FG002|Overall Study|Lost to Follow-up|3
4656539|NCT02146365|7541607|FG003|Overall Study|Lost to Follow-up|3
4656540|NCT02146365|7541608|FG004|Overall Study|Lost to Follow-up|1
4656541|NCT02146365|7541609|FG005|Overall Study|Lost to Follow-up|1
4656542|NCT02146365|7541610|FG006|Overall Study|Lost to Follow-up|0
4656543|NCT02146365|7541611|FG007|Overall Study|Lost to Follow-up|1
4656544|NCT02146365|7541604|FG000|Overall Study|Withdrawal by Subject|1
4656545|NCT02146365|7541605|FG001|Overall Study|Withdrawal by Subject|2
4656546|NCT02146365|7541606|FG002|Overall Study|Withdrawal by Subject|1
4656547|NCT02146365|7541607|FG003|Overall Study|Withdrawal by Subject|5
4656548|NCT02146365|7541608|FG004|Overall Study|Withdrawal by Subject|1
4656549|NCT02146365|7541609|FG005|Overall Study|Withdrawal by Subject|0
4656550|NCT02146365|7541610|FG006|Overall Study|Withdrawal by Subject|0
4656551|NCT02146365|7541611|FG007|Overall Study|Withdrawal by Subject|0
4656552|NCT02146365|7541604|FG000|Overall Study|Unable to Comply with Protocol|0
4656553|NCT02146365|7541605|FG001|Overall Study|Unable to Comply with Protocol|1
4656554|NCT02146365|7541606|FG002|Overall Study|Unable to Comply with Protocol|1
4656555|NCT02146365|7541607|FG003|Overall Study|Unable to Comply with Protocol|0
4656556|NCT02146365|7541608|FG004|Overall Study|Unable to Comply with Protocol|0
4656557|NCT02146365|7541609|FG005|Overall Study|Unable to Comply with Protocol|0
4656558|NCT02146365|7541610|FG006|Overall Study|Unable to Comply with Protocol|0
4656559|NCT02146365|7541611|FG007|Overall Study|Unable to Comply with Protocol|0
4656560|NCT02146365|7541604|FG000|Overall Study|Other|1
4656561|NCT02146365|7541605|FG001|Overall Study|Other|0
4656562|NCT02146365|7541606|FG002|Overall Study|Other|2
4656563|NCT02146365|7541607|FG003|Overall Study|Other|1
4656564|NCT02146365|7541608|FG004|Overall Study|Other|0
4656565|NCT02146365|7541609|FG005|Overall Study|Other|0
4656566|NCT02146365|7541610|FG006|Overall Study|Other|0
4656567|NCT02146365|7541611|FG007|Overall Study|Other|0
4656568|NCT02146430|7541633|FG000|Overall Study|Protocol Violation|5
4656569|NCT02146430|7541634|FG001|Overall Study|Protocol Violation|4
4656570|NCT02146430|7541635|FG002|Overall Study|Protocol Violation|8
4656571|NCT02146430|7541636|FG003|Overall Study|Protocol Violation|6
4656572|NCT02146430|7541633|FG000|Overall Study|Lack of Efficacy|13
4656573|NCT02146430|7541634|FG001|Overall Study|Lack of Efficacy|11
4656574|NCT02146430|7541635|FG002|Overall Study|Lack of Efficacy|8
4656575|NCT02146430|7541636|FG003|Overall Study|Lack of Efficacy|5
4656576|NCT02146430|7541633|FG000|Overall Study|Adverse Event|20
4656577|NCT02146430|7541634|FG001|Overall Study|Adverse Event|40
4656578|NCT02146430|7541635|FG002|Overall Study|Adverse Event|32
4656579|NCT02146430|7541636|FG003|Overall Study|Adverse Event|49
4656580|NCT02146430|7541633|FG000|Overall Study|Reason missing or not reported|2
4656581|NCT02146430|7541634|FG001|Overall Study|Reason missing or not reported|3
4656582|NCT02146430|7541635|FG002|Overall Study|Reason missing or not reported|4
4656583|NCT02146430|7541636|FG003|Overall Study|Reason missing or not reported|5
4656584|NCT02146430|7541633|FG000|Overall Study|Withdrawal by Subject|27
4656585|NCT02146430|7541634|FG001|Overall Study|Withdrawal by Subject|29
4656586|NCT02146430|7541635|FG002|Overall Study|Withdrawal by Subject|30
4656587|NCT02146430|7541636|FG003|Overall Study|Withdrawal by Subject|34
4656588|NCT02146599|7541659|FG000|Overall Study|Failed to meet inclusion criteria|5
4656589|NCT02146833|7541663|FG000|Overall Study|Death|10
4656590|NCT02146833|7541663|FG000|Overall Study|No longer consented to study treatment|1
4656591|NCT02147067|7541669|FG000|Overall Study|Withdrawal by Subject|2
4656592|NCT02147067|7541670|FG001|Overall Study|Withdrawal by Subject|2
4656593|NCT02147093|7541678|FG000|Period 1|Lost to Follow-up|0
4656594|NCT02147093|7541679|FG001|Period 1|Lost to Follow-up|1
4656595|NCT02147093|7541678|FG000|Period 2|Protocol Violation|2
4656596|NCT02147093|7541679|FG001|Period 2|Protocol Violation|0
4656597|NCT02147132|7541685|FG000|Overall Study|Lost to Follow-up|1
4656598|NCT02147132|7541686|FG001|Overall Study|Lost to Follow-up|0
4656599|NCT02147132|7541687|FG002|Overall Study|Lost to Follow-up|0
4656600|NCT02147132|7541688|FG003|Overall Study|Lost to Follow-up|0
4656601|NCT02147158|7541704|FG000|Treatment Course 1|Adverse Event|1
4656602|NCT02147158|7541705|FG001|Treatment Course 1|Adverse Event|4
4656603|NCT02147158|7541706|FG002|Treatment Course 1|Adverse Event|3
4656604|NCT02147158|7541707|FG003|Treatment Course 1|Adverse Event|4
4656605|NCT02147158|7541708|FG004|Treatment Course 1|Adverse Event|1
4656606|NCT02147158|7541709|FG005|Treatment Course 1|Adverse Event|2
4656607|NCT02147158|7541704|FG000|Treatment Course 1|Lost to Follow-up|2
4656608|NCT02147158|7541705|FG001|Treatment Course 1|Lost to Follow-up|4
4656609|NCT02147158|7541706|FG002|Treatment Course 1|Lost to Follow-up|3
4656610|NCT02147158|7541707|FG003|Treatment Course 1|Lost to Follow-up|3
4656611|NCT02147158|7541708|FG004|Treatment Course 1|Lost to Follow-up|2
4656612|NCT02147158|7541709|FG005|Treatment Course 1|Lost to Follow-up|4
4656613|NCT02147158|7541704|FG000|Treatment Course 1|Protocol Violation|0
4656614|NCT02147158|7541705|FG001|Treatment Course 1|Protocol Violation|0
4656615|NCT02147158|7541706|FG002|Treatment Course 1|Protocol Violation|1
4656616|NCT02147158|7541707|FG003|Treatment Course 1|Protocol Violation|1
4748695|NCT01928394|7722445|FG016|Treatment Period|Death|0
4748696|NCT01928394|7722446|FG017|Treatment Period|Death|0
4748697|NCT01928394|7722447|FG018|Treatment Period|Death|0
4748698|NCT01928394|7722448|FG019|Treatment Period|Death|0
4748699|NCT01928394|7722449|FG020|Treatment Period|Death|0
4748700|NCT01928394|7722450|FG021|Treatment Period|Death|0
4748701|NCT01928394|7722451|FG022|Treatment Period|Death|0
4748702|NCT01928394|7722429|FG000|Follow-up Period|Participant withdrew consent|3
4748703|NCT01928394|7722430|FG001|Follow-up Period|Participant withdrew consent|0
4748704|NCT01928394|7722431|FG002|Follow-up Period|Participant withdrew consent|1
4748705|NCT01928394|7722432|FG003|Follow-up Period|Participant withdrew consent|4
4748706|NCT01928394|7722433|FG004|Follow-up Period|Participant withdrew consent|0
4748707|NCT01928394|7722434|FG005|Follow-up Period|Participant withdrew consent|2
4748708|NCT01928394|7722435|FG006|Follow-up Period|Participant withdrew consent|5
4748709|NCT01928394|7722436|FG007|Follow-up Period|Participant withdrew consent|1
4748710|NCT01928394|7722437|FG008|Follow-up Period|Participant withdrew consent|0
4748711|NCT01928394|7722438|FG009|Follow-up Period|Participant withdrew consent|0
4748712|NCT01928394|7722439|FG010|Follow-up Period|Participant withdrew consent|5
4748713|NCT01928394|7722440|FG011|Follow-up Period|Participant withdrew consent|8
4748714|NCT01928394|7722441|FG012|Follow-up Period|Participant withdrew consent|2
4748715|NCT01928394|7722442|FG013|Follow-up Period|Participant withdrew consent|12
4748716|NCT01928394|7722443|FG014|Follow-up Period|Participant withdrew consent|7
4748717|NCT01928394|7722444|FG015|Follow-up Period|Participant withdrew consent|0
4748718|NCT01928394|7722445|FG016|Follow-up Period|Participant withdrew consent|5
4748719|NCT01928394|7722446|FG017|Follow-up Period|Participant withdrew consent|3
4748720|NCT01928394|7722447|FG018|Follow-up Period|Participant withdrew consent|2
4656617|NCT02147158|7541708|FG004|Treatment Course 1|Protocol Violation|0
4656618|NCT02147158|7541709|FG005|Treatment Course 1|Protocol Violation|0
4656619|NCT02147158|7541704|FG000|Treatment Course 1|Withdrawal of Consent|1
4656620|NCT02147158|7541705|FG001|Treatment Course 1|Withdrawal of Consent|1
4656621|NCT02147158|7541706|FG002|Treatment Course 1|Withdrawal of Consent|1
4656622|NCT02147158|7541707|FG003|Treatment Course 1|Withdrawal of Consent|5
4656623|NCT02147158|7541708|FG004|Treatment Course 1|Withdrawal of Consent|3
4656624|NCT02147158|7541709|FG005|Treatment Course 1|Withdrawal of Consent|2
4656625|NCT02147158|7541704|FG000|Off-Treatment Interval 1|Adverse Event|1
4656626|NCT02147158|7541705|FG001|Off-Treatment Interval 1|Adverse Event|0
4656627|NCT02147158|7541706|FG002|Off-Treatment Interval 1|Adverse Event|0
4656628|NCT02147158|7541707|FG003|Off-Treatment Interval 1|Adverse Event|1
4656629|NCT02147158|7541708|FG004|Off-Treatment Interval 1|Adverse Event|0
4656630|NCT02147158|7541709|FG005|Off-Treatment Interval 1|Adverse Event|0
4656631|NCT02147158|7541704|FG000|Off-Treatment Interval 1|Lost to Follow-up|2
4656632|NCT02147158|7541705|FG001|Off-Treatment Interval 1|Lost to Follow-up|1
4656633|NCT02147158|7541706|FG002|Off-Treatment Interval 1|Lost to Follow-up|3
4656634|NCT02147158|7541707|FG003|Off-Treatment Interval 1|Lost to Follow-up|2
4656635|NCT02147158|7541708|FG004|Off-Treatment Interval 1|Lost to Follow-up|4
4656636|NCT02147158|7541709|FG005|Off-Treatment Interval 1|Lost to Follow-up|2
4656637|NCT02147158|7541704|FG000|Off-Treatment Interval 1|Protocol Violation|1
4656638|NCT02147158|7541705|FG001|Off-Treatment Interval 1|Protocol Violation|0
4656639|NCT02147158|7541706|FG002|Off-Treatment Interval 1|Protocol Violation|2
4656640|NCT02147158|7541707|FG003|Off-Treatment Interval 1|Protocol Violation|0
4656641|NCT02147158|7541708|FG004|Off-Treatment Interval 1|Protocol Violation|1
4656642|NCT02147158|7541709|FG005|Off-Treatment Interval 1|Protocol Violation|0
4656643|NCT02147158|7541704|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4
4656644|NCT02147158|7541705|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3
4656645|NCT02147158|7541706|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5
4656646|NCT02147158|7541707|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10
4656647|NCT02147158|7541708|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2
4656648|NCT02147158|7541709|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3
4656649|NCT02147158|7541704|FG000|Off-Treatment Interval 1|Lack of Efficacy|0
4656650|NCT02147158|7541705|FG001|Off-Treatment Interval 1|Lack of Efficacy|0
4656651|NCT02147158|7541706|FG002|Off-Treatment Interval 1|Lack of Efficacy|2
4656652|NCT02147158|7541707|FG003|Off-Treatment Interval 1|Lack of Efficacy|0
4656653|NCT02147158|7541708|FG004|Off-Treatment Interval 1|Lack of Efficacy|1
4656654|NCT02147158|7541709|FG005|Off-Treatment Interval 1|Lack of Efficacy|0
4656655|NCT02147158|7541704|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2
4656656|NCT02147158|7541705|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0
4656657|NCT02147158|7541706|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3
4656658|NCT02147158|7541707|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2
4656659|NCT02147158|7541708|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0
4656660|NCT02147158|7541709|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0
4656661|NCT02147158|7541704|FG000|Treatment Course 2|Adverse Event|0
4656662|NCT02147158|7541705|FG001|Treatment Course 2|Adverse Event|4
4656663|NCT02147158|7541706|FG002|Treatment Course 2|Adverse Event|2
4656664|NCT02147158|7541707|FG003|Treatment Course 2|Adverse Event|1
4656665|NCT02147158|7541708|FG004|Treatment Course 2|Adverse Event|0
4656666|NCT02147158|7541709|FG005|Treatment Course 2|Adverse Event|1
4656667|NCT02147158|7541704|FG000|Treatment Course 2|Withdrawal of Consent|0
4656668|NCT02147158|7541705|FG001|Treatment Course 2|Withdrawal of Consent|1
4656669|NCT02147158|7541706|FG002|Treatment Course 2|Withdrawal of Consent|2
4656670|NCT02147158|7541707|FG003|Treatment Course 2|Withdrawal of Consent|3
4656671|NCT02147158|7541708|FG004|Treatment Course 2|Withdrawal of Consent|0
4656672|NCT02147158|7541709|FG005|Treatment Course 2|Withdrawal of Consent|0
4656673|NCT02147158|7541704|FG000|Treatment Course 2|Lost to Follow-up|1
4656674|NCT02147158|7541705|FG001|Treatment Course 2|Lost to Follow-up|0
4656675|NCT02147158|7541706|FG002|Treatment Course 2|Lost to Follow-up|1
4656676|NCT02147158|7541707|FG003|Treatment Course 2|Lost to Follow-up|1
4656677|NCT02147158|7541708|FG004|Treatment Course 2|Lost to Follow-up|0
4656678|NCT02147158|7541709|FG005|Treatment Course 2|Lost to Follow-up|1
4656679|NCT02147158|7541704|FG000|Off-Treatment Interval 2|Lack of Efficacy|0
4656680|NCT02147158|7541705|FG001|Off-Treatment Interval 2|Lack of Efficacy|1
4656681|NCT02147158|7541706|FG002|Off-Treatment Interval 2|Lack of Efficacy|1
4656682|NCT02147158|7541707|FG003|Off-Treatment Interval 2|Lack of Efficacy|0
4656683|NCT02147158|7541708|FG004|Off-Treatment Interval 2|Lack of Efficacy|0
4656684|NCT02147158|7541709|FG005|Off-Treatment Interval 2|Lack of Efficacy|0
4656685|NCT02147158|7541704|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4
4656686|NCT02147158|7541705|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0
4656687|NCT02147158|7541706|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5
4656688|NCT02147158|7541707|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4
4656689|NCT02147158|7541708|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0
4656690|NCT02147158|7541709|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1
4656691|NCT02147158|7541704|FG000|Off-Treatment Interval 2|Lost to Follow-up|0
4656692|NCT02147158|7541705|FG001|Off-Treatment Interval 2|Lost to Follow-up|0
4656693|NCT02147158|7541706|FG002|Off-Treatment Interval 2|Lost to Follow-up|3
4656694|NCT02147158|7541707|FG003|Off-Treatment Interval 2|Lost to Follow-up|2
4656695|NCT02147158|7541708|FG004|Off-Treatment Interval 2|Lost to Follow-up|2
4656696|NCT02147158|7541709|FG005|Off-Treatment Interval 2|Lost to Follow-up|2
4656697|NCT02147158|7541704|FG000|Off-Treatment Interval 2|Protocol Violation|0
4656698|NCT02147158|7541705|FG001|Off-Treatment Interval 2|Protocol Violation|0
4656699|NCT02147158|7541706|FG002|Off-Treatment Interval 2|Protocol Violation|0
4656700|NCT02147158|7541707|FG003|Off-Treatment Interval 2|Protocol Violation|1
4656701|NCT02147158|7541708|FG004|Off-Treatment Interval 2|Protocol Violation|0
4656702|NCT02147158|7541709|FG005|Off-Treatment Interval 2|Protocol Violation|0
4656703|NCT02147158|7541704|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0
4656704|NCT02147158|7541705|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3
4656705|NCT02147158|7541706|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1
4656706|NCT02147158|7541707|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4
4656707|NCT02147158|7541708|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0
4656708|NCT02147158|7541709|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1
4656709|NCT02147197|7541729|FG000|Overall Study|Adverse Event|1
4656710|NCT02147197|7541730|FG001|Overall Study|Adverse Event|0
4656711|NCT02147197|7541731|FG002|Overall Study|Adverse Event|0
4656712|NCT02147197|7541729|FG000|Overall Study|Withdrawal of Consent|4
4656713|NCT02147197|7541730|FG001|Overall Study|Withdrawal of Consent|3
4656714|NCT02147197|7541731|FG002|Overall Study|Withdrawal of Consent|2
4656715|NCT02147197|7541729|FG000|Overall Study|Lost to Follow-up|2
4656716|NCT02147197|7541730|FG001|Overall Study|Lost to Follow-up|3
4656717|NCT02147197|7541731|FG002|Overall Study|Lost to Follow-up|1
4656718|NCT02147197|7541729|FG000|Overall Study|Protocol Violation|1
4656719|NCT02147197|7541730|FG001|Overall Study|Protocol Violation|0
4656720|NCT02147197|7541731|FG002|Overall Study|Protocol Violation|3
4656721|NCT02147197|7541729|FG000|Overall Study|Other Miscellaneous Reasons|1
4656722|NCT02147197|7541730|FG001|Overall Study|Other Miscellaneous Reasons|0
4656723|NCT02147197|7541731|FG002|Overall Study|Other Miscellaneous Reasons|3
4656724|NCT02147288|7541741|FG000|Overall Study|post-operative hematoma|1
4656725|NCT02147288|7541742|FG001|Overall Study|post-operative hematoma|1
4656726|NCT02147288|7541743|FG002|Overall Study|post-operative hematoma|0
4656727|NCT02147288|7541744|FG003|Overall Study|post-operative hematoma|0
4656728|NCT02147288|7541745|FG004|Overall Study|post-operative hematoma|0
4656729|NCT02147288|7541746|FG005|Overall Study|post-operative hematoma|0
4656730|NCT02147288|7541747|FG006|Overall Study|post-operative hematoma|0
4656731|NCT02147288|7541748|FG007|Overall Study|post-operative hematoma|0
4656732|NCT02147288|7541749|FG008|Overall Study|post-operative hematoma|0
4656733|NCT02147288|7541750|FG009|Overall Study|post-operative hematoma|0
4656734|NCT02147288|7541741|FG000|Overall Study|complications from concurrent hernia rep|0
4656735|NCT02147288|7541742|FG001|Overall Study|complications from concurrent hernia rep|1
4656736|NCT02147288|7541743|FG002|Overall Study|complications from concurrent hernia rep|0
4656737|NCT02147288|7541744|FG003|Overall Study|complications from concurrent hernia rep|0
4656738|NCT02147288|7541745|FG004|Overall Study|complications from concurrent hernia rep|0
4656739|NCT02147288|7541746|FG005|Overall Study|complications from concurrent hernia rep|0
4656740|NCT02147288|7541747|FG006|Overall Study|complications from concurrent hernia rep|0
4656741|NCT02147288|7541748|FG007|Overall Study|complications from concurrent hernia rep|0
4656742|NCT02147288|7541749|FG008|Overall Study|complications from concurrent hernia rep|0
4656743|NCT02147288|7541750|FG009|Overall Study|complications from concurrent hernia rep|0
4656744|NCT02147353|7541762|FG000|Overall Study|Lost to Follow-up|2
4656745|NCT02147353|7541763|FG001|Overall Study|Lost to Follow-up|0
4656746|NCT02147353|7541762|FG000|Overall Study|unable to make visits|4
4656747|NCT02147353|7541763|FG001|Overall Study|unable to make visits|0
4656748|NCT02147353|7541762|FG000|Overall Study|medication noncompliance|3
4656749|NCT02147353|7541763|FG001|Overall Study|medication noncompliance|0
4656750|NCT02147561|7541778|FG000|Overall Study|Lost to Follow-up|3
4656751|NCT02147561|7541778|FG000|Overall Study|Subjects who didn't receive BOTOX|1
4656752|NCT02147587|7541784|FG000|Overall Study|Adverse Event|9
4656753|NCT02147587|7541785|FG001|Overall Study|Adverse Event|4
4656754|NCT02147587|7541784|FG000|Overall Study|Lack of Efficacy|2
4656755|NCT02147587|7541785|FG001|Overall Study|Lack of Efficacy|1
4656756|NCT02147626|7541802|FG000|Overall Study|Lost to Follow-up|4
4656757|NCT02147626|7541803|FG001|Overall Study|Lost to Follow-up|4
4656758|NCT02147626|7541802|FG000|Overall Study|Pregnancy|1
4656759|NCT02147626|7541803|FG001|Overall Study|Pregnancy|2
4656760|NCT02147626|7541802|FG000|Overall Study|Withdrawal by Subject|0
4656761|NCT02147626|7541803|FG001|Overall Study|Withdrawal by Subject|1
4656762|NCT02147691|7541811|FG000|Overall Study|Withdrawal by Subject|2
4656763|NCT02147691|7541812|FG001|Overall Study|Withdrawal by Subject|0
4656764|NCT02147691|7541811|FG000|Overall Study|Adverse Event|2
4656765|NCT02147691|7541812|FG001|Overall Study|Adverse Event|0
4656766|NCT02147691|7541811|FG000|Overall Study|Lost to Follow-up|0
4656767|NCT02147691|7541812|FG001|Overall Study|Lost to Follow-up|1
4656768|NCT02148211|7541862|FG000|Overall Study|Lost to Follow-up|352
4656769|NCT02148250|7541866|FG000|Screening|Withdrawal by Subject|5
4656770|NCT02148250|7541867|FG001|Screening|Withdrawal by Subject|0
4656771|NCT02148445|7541885|FG000|Overall Study|Death|1
4656772|NCT02148445|7541886|FG001|Overall Study|Death|3
4656773|NCT02148718|7541911|FG000|Overall Study|Protocol Violation|26
4656774|NCT02148718|7541911|FG000|Overall Study|Discontinued Study Prematurely|5
4656775|NCT02148952|7541940|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241
4656776|NCT02148952|7541941|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591
4656777|NCT02148952|7541940|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862
4656778|NCT02148952|7541941|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556
4656779|NCT02148952|7541940|FG000|Follow-Up|Lost to Follow-up|219
4656780|NCT02148952|7541941|FG001|Follow-Up|Lost to Follow-up|231
4656781|NCT02148952|7541940|FG000|Follow-Up|Withdrawal by Subject|46
4656782|NCT02148952|7541941|FG001|Follow-Up|Withdrawal by Subject|48
4656783|NCT02149108|7541957|FG000|Overall Study|Not treated|1
4656784|NCT02149108|7541958|FG001|Overall Study|Not treated|2
4656785|NCT02149108|7541957|FG000|Overall Study|Progressive Disease (PD)|324
4656786|NCT02149108|7541958|FG001|Overall Study|Progressive Disease (PD)|318
4656787|NCT02149108|7541957|FG000|Overall Study|Worsening/adverse event cancer disease|31
4656788|NCT02149108|7541958|FG001|Overall Study|Worsening/adverse event cancer disease|32
4656789|NCT02149108|7541957|FG000|Overall Study|Other Adverse Event (AE)|8
4656790|NCT02149108|7541958|FG001|Overall Study|Other Adverse Event (AE)|18
4656791|NCT02149108|7541957|FG000|Overall Study|Other not defined above|0
4656792|NCT02149108|7541958|FG001|Overall Study|Other not defined above|2
4656793|NCT02149108|7541957|FG000|Overall Study|Refusal to continue trial medication|15
4656794|NCT02149108|7541958|FG001|Overall Study|Refusal to continue trial medication|11
4656795|NCT02149108|7541957|FG000|Overall Study|Lost to Follow-up|1
4656796|NCT02149108|7541958|FG001|Overall Study|Lost to Follow-up|0
4656797|NCT02149199|7541977|FG000|Overall Study|Study specific withdrawal criteria|4
4656798|NCT02149199|7541978|FG001|Overall Study|Study specific withdrawal criteria|21
4656799|NCT02149199|7541979|FG002|Overall Study|Study specific withdrawal criteria|6
4656800|NCT02149199|7541977|FG000|Overall Study|Other|20
4656801|NCT02149199|7541978|FG001|Overall Study|Other|25
4656802|NCT02149199|7541979|FG002|Overall Study|Other|20
4656803|NCT02149199|7541977|FG000|Overall Study|Eligibility criteria not fulfilled|9
4656804|NCT02149199|7541978|FG001|Overall Study|Eligibility criteria not fulfilled|14
4656805|NCT02149199|7541979|FG002|Overall Study|Eligibility criteria not fulfilled|8
4656806|NCT02149199|7541977|FG000|Overall Study|Withdrawal by Subject|75
4656807|NCT02149199|7541978|FG001|Overall Study|Withdrawal by Subject|93
4656808|NCT02149199|7541979|FG002|Overall Study|Withdrawal by Subject|77
4656809|NCT02149199|7541977|FG000|Overall Study|Protocol Violation|16
4656810|NCT02149199|7541978|FG001|Overall Study|Protocol Violation|13
4748721|NCT01928394|7722448|FG019|Follow-up Period|Participant withdrew consent|7
4748722|NCT01928394|7722449|FG020|Follow-up Period|Participant withdrew consent|4
4748723|NCT01928394|7722450|FG021|Follow-up Period|Participant withdrew consent|6
4748724|NCT01928394|7722451|FG022|Follow-up Period|Participant withdrew consent|2
4748725|NCT01928394|7722429|FG000|Follow-up Period|Death|0
4748726|NCT01928394|7722430|FG001|Follow-up Period|Death|0
4748727|NCT01928394|7722431|FG002|Follow-up Period|Death|2
4748728|NCT01928394|7722432|FG003|Follow-up Period|Death|6
4656811|NCT02149199|7541979|FG002|Overall Study|Protocol Violation|15
4656812|NCT02149199|7541977|FG000|Overall Study|Lost to Follow-up|3
4656813|NCT02149199|7541978|FG001|Overall Study|Lost to Follow-up|12
4656814|NCT02149199|7541979|FG002|Overall Study|Lost to Follow-up|11
4656815|NCT02149199|7541977|FG000|Overall Study|Death|0
4656816|NCT02149199|7541978|FG001|Overall Study|Death|0
4656817|NCT02149199|7541979|FG002|Overall Study|Death|1
4656818|NCT02149199|7541977|FG000|Overall Study|Adverse Event|6
4656819|NCT02149199|7541978|FG001|Overall Study|Adverse Event|15
4656820|NCT02149199|7541979|FG002|Overall Study|Adverse Event|9
4656821|NCT02149264|7541987|FG000|Overall Study|Withdrawal by Subject|9
4656822|NCT02149264|7541987|FG000|Overall Study|Adverse Event|7
4656823|NCT02149264|7541987|FG000|Overall Study|Physician Decision|3
4656824|NCT02149264|7541987|FG000|Overall Study|Protocol Violation|1
4656825|NCT02149420|7542011|FG000|Core Study|Administrative problems|0
4656826|NCT02149420|7542012|FG001|Core Study|Administrative problems|1
4656827|NCT02149420|7542013|FG002|Core Study|Administrative problems|2
4656828|NCT02149420|7542011|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1
4656829|NCT02149420|7542012|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0
4656830|NCT02149420|7542013|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0
4656831|NCT02149810|7542037|FG000|Overall Study|Physician Decision|1
4656832|NCT02149810|7542038|FG001|Overall Study|Physician Decision|2
4656833|NCT02149810|7542037|FG000|Overall Study|Lost to Follow-up|2
4656834|NCT02149810|7542038|FG001|Overall Study|Lost to Follow-up|1
4656835|NCT02149810|7542037|FG000|Overall Study|Withdrawal by Subject|5
4656836|NCT02149810|7542038|FG001|Overall Study|Withdrawal by Subject|1
4656837|NCT02149836|7542044|FG000|Overall Study|Withdrawal by Subject|1
4656838|NCT02149875|7542051|FG000|Overall Study|Lost to Follow-up|3
4656839|NCT02149875|7542052|FG001|Overall Study|Lost to Follow-up|4
4656840|NCT02149875|7542053|FG002|Overall Study|Lost to Follow-up|5
4656841|NCT02149875|7542051|FG000|Overall Study|Withdrawal by Subject|3
4656842|NCT02149875|7542052|FG001|Overall Study|Withdrawal by Subject|2
4656843|NCT02149875|7542053|FG002|Overall Study|Withdrawal by Subject|2
4656844|NCT02149875|7542051|FG000|Overall Study|Physician Decision|1
4656845|NCT02149875|7542052|FG001|Overall Study|Physician Decision|2
4656846|NCT02149875|7542053|FG002|Overall Study|Physician Decision|2
4656847|NCT02150057|7542067|FG000|Overall Study|Lost to Follow-up|6
4656848|NCT02150057|7542068|FG001|Overall Study|Lost to Follow-up|4
4748729|NCT01928394|7722433|FG004|Follow-up Period|Death|0
4748730|NCT01928394|7722434|FG005|Follow-up Period|Death|6
4656849|NCT02150213|7542084|FG000|Overall Study|Lost to Follow-up|1
4656850|NCT02150213|7542084|FG000|Overall Study|Withdrawal by Subject|1
4656851|NCT02150343|7542092|FG000|Overall Study|Adverse Event|2
4656852|NCT02150343|7542093|FG001|Overall Study|Adverse Event|0
4656853|NCT02150343|7542094|FG002|Overall Study|Adverse Event|1
4656854|NCT02150343|7542095|FG003|Overall Study|Adverse Event|1
4656855|NCT02150343|7542092|FG000|Overall Study|Withdrawal by Subject|13
4656856|NCT02150343|7542093|FG001|Overall Study|Withdrawal by Subject|10
4656857|NCT02150343|7542094|FG002|Overall Study|Withdrawal by Subject|9
4656858|NCT02150343|7542095|FG003|Overall Study|Withdrawal by Subject|4
4656859|NCT02150343|7542092|FG000|Overall Study|Lost to Follow-up|4
4656860|NCT02150343|7542093|FG001|Overall Study|Lost to Follow-up|4
4656861|NCT02150343|7542094|FG002|Overall Study|Lost to Follow-up|2
4656862|NCT02150343|7542095|FG003|Overall Study|Lost to Follow-up|3
4656863|NCT02150343|7542092|FG000|Overall Study|Other|2
4656864|NCT02150343|7542093|FG001|Overall Study|Other|6
4656865|NCT02150343|7542094|FG002|Overall Study|Other|0
4656866|NCT02150343|7542095|FG003|Overall Study|Other|2
4656867|NCT02150954|7542143|FG000|Overall Study|Protocol Violation|1
4656868|NCT02150954|7542144|FG001|Overall Study|Protocol Violation|0
4656869|NCT02151058|7542153|FG000|Overall Study|Withdrawal by Subject|1
4656870|NCT02151058|7542154|FG001|Overall Study|Withdrawal by Subject|1
4656871|NCT02151058|7542155|FG002|Overall Study|Withdrawal by Subject|3
4656872|NCT02151058|7542153|FG000|Overall Study|Lost to Follow-up|1
4656873|NCT02151058|7542154|FG001|Overall Study|Lost to Follow-up|0
4656874|NCT02151058|7542155|FG002|Overall Study|Lost to Follow-up|2
4656875|NCT02151110|7542171|FG000|Overall Study|Withdrawal by Subject|0
4656876|NCT02151110|7542172|FG001|Overall Study|Withdrawal by Subject|0
4656877|NCT02151110|7542173|FG002|Overall Study|Withdrawal by Subject|0
4656878|NCT02151110|7542174|FG003|Overall Study|Withdrawal by Subject|0
4656879|NCT02151110|7542175|FG004|Overall Study|Withdrawal by Subject|0
4656880|NCT02151110|7542176|FG005|Overall Study|Withdrawal by Subject|0
4656881|NCT02151110|7542177|FG006|Overall Study|Withdrawal by Subject|0
4656882|NCT02151110|7542178|FG007|Overall Study|Withdrawal by Subject|1
4656883|NCT02151110|7542171|FG000|Overall Study|Lost to Follow-up|0
4656884|NCT02151110|7542172|FG001|Overall Study|Lost to Follow-up|0
4656885|NCT02151110|7542173|FG002|Overall Study|Lost to Follow-up|0
4656886|NCT02151110|7542174|FG003|Overall Study|Lost to Follow-up|0
4656887|NCT02151110|7542175|FG004|Overall Study|Lost to Follow-up|0
4656888|NCT02151110|7542176|FG005|Overall Study|Lost to Follow-up|0
4656889|NCT02151110|7542177|FG006|Overall Study|Lost to Follow-up|0
4656890|NCT02151110|7542178|FG007|Overall Study|Lost to Follow-up|2
4656891|NCT02151149|7542205|FG000|Treatment Period|Death|2
4656892|NCT02151149|7542206|FG001|Treatment Period|Death|3
4656893|NCT02151149|7542205|FG000|Treatment Period|Adverse Event|17
4656894|NCT02151149|7542206|FG001|Treatment Period|Adverse Event|14
4656895|NCT02151149|7542205|FG000|Treatment Period|Progressive Disease|25
4656896|NCT02151149|7542206|FG001|Treatment Period|Progressive Disease|24
4656897|NCT02151149|7542205|FG000|Treatment Period|Symptomatic Deterioration|2
4656898|NCT02151149|7542206|FG001|Treatment Period|Symptomatic Deterioration|10
4656899|NCT02151149|7542205|FG000|Treatment Period|Withdrawal by Subject|13
4656900|NCT02151149|7542206|FG001|Treatment Period|Withdrawal by Subject|11
4656901|NCT02151149|7542205|FG000|Treatment Period|Miscellaneous|8
4656902|NCT02151149|7542206|FG001|Treatment Period|Miscellaneous|7
4656903|NCT02151149|7542205|FG000|Treatment Period|Participants randomized but not treated|3
4656904|NCT02151149|7542206|FG001|Treatment Period|Participants randomized but not treated|2
4656905|NCT02151149|7542205|FG000|Follow-Up Period|Lost to Follow-up|2
4656906|NCT02151149|7542206|FG001|Follow-Up Period|Lost to Follow-up|3
4656907|NCT02151149|7542205|FG000|Follow-Up Period|Death|37
4656908|NCT02151149|7542206|FG001|Follow-Up Period|Death|34
4656909|NCT02151266|7542222|FG000|Overall Study|Lost to Follow-up|1
4656910|NCT02151266|7542223|FG001|Overall Study|Lost to Follow-up|4
4656911|NCT02151266|7542224|FG002|Overall Study|Lost to Follow-up|1
4656912|NCT02151266|7542222|FG000|Overall Study|Did NOT receive intervention|3
4656913|NCT02151266|7542223|FG001|Overall Study|Did NOT receive intervention|6
4656914|NCT02151266|7542224|FG002|Overall Study|Did NOT receive intervention|2
4656915|NCT02151266|7542222|FG000|Overall Study|Not able to exercise|4
4656916|NCT02151266|7542223|FG001|Overall Study|Not able to exercise|5
4656917|NCT02151266|7542224|FG002|Overall Study|Not able to exercise|4
4656918|NCT02151461|7542253|FG000|Overall Study|Adverse Event|5
4656919|NCT02151461|7542254|FG001|Overall Study|Adverse Event|1
4656920|NCT02151461|7542255|FG002|Overall Study|Adverse Event|0
4656921|NCT02151461|7542256|FG003|Overall Study|Adverse Event|2
4656922|NCT02151461|7542253|FG000|Overall Study|Lost to Follow-up|0
4656923|NCT02151461|7542254|FG001|Overall Study|Lost to Follow-up|0
4656924|NCT02151461|7542255|FG002|Overall Study|Lost to Follow-up|1
4656925|NCT02151461|7542256|FG003|Overall Study|Lost to Follow-up|1
4656926|NCT02151461|7542253|FG000|Overall Study|Withdrawal by Subject|1
4656927|NCT02151461|7542254|FG001|Overall Study|Withdrawal by Subject|0
4656928|NCT02151461|7542255|FG002|Overall Study|Withdrawal by Subject|1
4656929|NCT02151461|7542256|FG003|Overall Study|Withdrawal by Subject|1
4656930|NCT02151461|7542253|FG000|Overall Study|Treatment discontinuation|0
4656931|NCT02151461|7542254|FG001|Overall Study|Treatment discontinuation|0
4656932|NCT02151461|7542255|FG002|Overall Study|Treatment discontinuation|1
4656933|NCT02151461|7542256|FG003|Overall Study|Treatment discontinuation|0
4656934|NCT02151591|7542285|FG000|Overall Study|Lost to Follow-up|6
4656935|NCT02151591|7542286|FG001|Overall Study|Lost to Follow-up|3
4656936|NCT02151643|7542297|FG000|Overall Study|Adverse Event|2
4656937|NCT02151643|7542298|FG001|Overall Study|Adverse Event|0
4656938|NCT02151643|7542299|FG002|Overall Study|Adverse Event|1
4656939|NCT02151643|7542300|FG003|Overall Study|Adverse Event|4
4656940|NCT02151643|7542301|FG004|Overall Study|Adverse Event|0
4656941|NCT02151643|7542297|FG000|Overall Study|Withdrawal by Subject|0
4656942|NCT02151643|7542298|FG001|Overall Study|Withdrawal by Subject|1
4656943|NCT02151643|7542299|FG002|Overall Study|Withdrawal by Subject|1
4656944|NCT02151643|7542300|FG003|Overall Study|Withdrawal by Subject|1
4656945|NCT02151643|7542301|FG004|Overall Study|Withdrawal by Subject|1
4656946|NCT02151643|7542297|FG000|Overall Study|Hyperphosphataemia|1
4656947|NCT02151643|7542298|FG001|Overall Study|Hyperphosphataemia|0
4656948|NCT02151643|7542299|FG002|Overall Study|Hyperphosphataemia|0
4656949|NCT02151643|7542300|FG003|Overall Study|Hyperphosphataemia|0
4656950|NCT02151643|7542301|FG004|Overall Study|Hyperphosphataemia|1
4656951|NCT02151643|7542297|FG000|Overall Study|High Ferritin levels|3
4656952|NCT02151643|7542298|FG001|Overall Study|High Ferritin levels|3
4656953|NCT02151643|7542299|FG002|Overall Study|High Ferritin levels|2
4656954|NCT02151643|7542300|FG003|Overall Study|High Ferritin levels|2
4656955|NCT02151643|7542301|FG004|Overall Study|High Ferritin levels|1
4656956|NCT02151682|7542315|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
4656957|NCT02151682|7542316|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2
4656958|NCT02151682|7542317|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
4656959|NCT02151682|7542318|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
4656960|NCT02151682|7542319|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
4656961|NCT02151682|7542320|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
4656962|NCT02151682|7542315|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
4656963|NCT02151682|7542316|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1
4656964|NCT02151682|7542317|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
4656965|NCT02151682|7542318|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
4656966|NCT02151682|7542319|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
4656967|NCT02151682|7542320|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
4656968|NCT02151682|7542315|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
4656969|NCT02151682|7542316|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1
4656970|NCT02151682|7542317|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
4656971|NCT02151682|7542318|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
4656972|NCT02151682|7542319|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
4656973|NCT02151682|7542320|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
4656974|NCT02151682|7542315|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1
4656975|NCT02151682|7542316|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1
4748731|NCT01928394|7722435|FG006|Follow-up Period|Death|6
4748732|NCT01928394|7722436|FG007|Follow-up Period|Death|2
4748733|NCT01928394|7722437|FG008|Follow-up Period|Death|1
4748734|NCT01928394|7722438|FG009|Follow-up Period|Death|2
4748735|NCT01928394|7722439|FG010|Follow-up Period|Death|4
4748736|NCT01928394|7722440|FG011|Follow-up Period|Death|12
4748737|NCT01928394|7722441|FG012|Follow-up Period|Death|11
4748738|NCT01928394|7722442|FG013|Follow-up Period|Death|25
4748739|NCT01928394|7722443|FG014|Follow-up Period|Death|18
4748740|NCT01928394|7722444|FG015|Follow-up Period|Death|0
4748741|NCT01928394|7722445|FG016|Follow-up Period|Death|6
4748742|NCT01928394|7722446|FG017|Follow-up Period|Death|5
4748743|NCT01928394|7722447|FG018|Follow-up Period|Death|13
4748744|NCT01928394|7722448|FG019|Follow-up Period|Death|13
4748745|NCT01928394|7722449|FG020|Follow-up Period|Death|5
4748746|NCT01928394|7722450|FG021|Follow-up Period|Death|3
4748747|NCT01928394|7722451|FG022|Follow-up Period|Death|2
4748748|NCT01928394|7722429|FG000|Follow-up Period|other reason|0
4748749|NCT01928394|7722430|FG001|Follow-up Period|other reason|0
4748750|NCT01928394|7722431|FG002|Follow-up Period|other reason|0
4748751|NCT01928394|7722432|FG003|Follow-up Period|other reason|0
4748752|NCT01928394|7722433|FG004|Follow-up Period|other reason|0
4748753|NCT01928394|7722434|FG005|Follow-up Period|other reason|0
4748754|NCT01928394|7722435|FG006|Follow-up Period|other reason|1
4748755|NCT01928394|7722436|FG007|Follow-up Period|other reason|3
4748756|NCT01928394|7722437|FG008|Follow-up Period|other reason|0
4748757|NCT01928394|7722438|FG009|Follow-up Period|other reason|0
4748758|NCT01928394|7722439|FG010|Follow-up Period|other reason|2
4748759|NCT01928394|7722440|FG011|Follow-up Period|other reason|1
4748760|NCT01928394|7722441|FG012|Follow-up Period|other reason|0
4748761|NCT01928394|7722442|FG013|Follow-up Period|other reason|1
4748762|NCT01928394|7722443|FG014|Follow-up Period|other reason|4
4748763|NCT01928394|7722444|FG015|Follow-up Period|other reason|0
4748764|NCT01928394|7722445|FG016|Follow-up Period|other reason|2
4748765|NCT01928394|7722446|FG017|Follow-up Period|other reason|0
4748766|NCT01928394|7722447|FG018|Follow-up Period|other reason|1
4748767|NCT01928394|7722448|FG019|Follow-up Period|other reason|1
4748768|NCT01928394|7722449|FG020|Follow-up Period|other reason|0
4748769|NCT01928394|7722450|FG021|Follow-up Period|other reason|0
4748770|NCT01928394|7722451|FG022|Follow-up Period|other reason|1
4656976|NCT02151682|7542317|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
4656977|NCT02151682|7542318|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
4656978|NCT02151682|7542319|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
4656979|NCT02151682|7542320|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
4656980|NCT02151682|7542315|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1
4656981|NCT02151682|7542316|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0
4656982|NCT02151682|7542317|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0
4656983|NCT02151682|7542318|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0
4656984|NCT02151682|7542319|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0
4656985|NCT02151682|7542320|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0
4656986|NCT02151682|7542315|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0
4656987|NCT02151682|7542316|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0
4656988|NCT02151682|7542317|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3
4656989|NCT02151682|7542318|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0
4656990|NCT02151682|7542319|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0
4656991|NCT02151682|7542320|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0
4656992|NCT02151682|7542315|FG000|Part 2: Tapent. Extension or Observation|Death|0
4656993|NCT02151682|7542316|FG001|Part 2: Tapent. Extension or Observation|Death|0
4656994|NCT02151682|7542317|FG002|Part 2: Tapent. Extension or Observation|Death|0
4656995|NCT02151682|7542318|FG003|Part 2: Tapent. Extension or Observation|Death|2
4656996|NCT02151682|7542319|FG004|Part 2: Tapent. Extension or Observation|Death|0
4656997|NCT02151682|7542320|FG005|Part 2: Tapent. Extension or Observation|Death|0
4656998|NCT02151682|7542315|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
4656999|NCT02151682|7542316|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
4657000|NCT02151682|7542317|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1
4657001|NCT02151682|7542318|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1
4748771|NCT01928394|7722429|FG000|Follow-up Period|Lost to Follow-up|0
4748772|NCT01928394|7722430|FG001|Follow-up Period|Lost to Follow-up|0
4748773|NCT01928394|7722431|FG002|Follow-up Period|Lost to Follow-up|0
4748774|NCT01928394|7722432|FG003|Follow-up Period|Lost to Follow-up|0
4748775|NCT01928394|7722433|FG004|Follow-up Period|Lost to Follow-up|0
4748776|NCT01928394|7722434|FG005|Follow-up Period|Lost to Follow-up|0
4748777|NCT01928394|7722435|FG006|Follow-up Period|Lost to Follow-up|0
4748778|NCT01928394|7722436|FG007|Follow-up Period|Lost to Follow-up|0
4748779|NCT01928394|7722437|FG008|Follow-up Period|Lost to Follow-up|0
4748780|NCT01928394|7722438|FG009|Follow-up Period|Lost to Follow-up|0
4748781|NCT01928394|7722439|FG010|Follow-up Period|Lost to Follow-up|0
4748782|NCT01928394|7722440|FG011|Follow-up Period|Lost to Follow-up|1
4748783|NCT01928394|7722441|FG012|Follow-up Period|Lost to Follow-up|1
4748784|NCT01928394|7722442|FG013|Follow-up Period|Lost to Follow-up|0
4748785|NCT01928394|7722443|FG014|Follow-up Period|Lost to Follow-up|1
4748786|NCT01928394|7722444|FG015|Follow-up Period|Lost to Follow-up|0
4748787|NCT01928394|7722445|FG016|Follow-up Period|Lost to Follow-up|1
4748788|NCT01928394|7722446|FG017|Follow-up Period|Lost to Follow-up|0
4748789|NCT01928394|7722447|FG018|Follow-up Period|Lost to Follow-up|0
4748790|NCT01928394|7722448|FG019|Follow-up Period|Lost to Follow-up|0
4748791|NCT01928394|7722449|FG020|Follow-up Period|Lost to Follow-up|0
4748792|NCT01928394|7722450|FG021|Follow-up Period|Lost to Follow-up|0
4748793|NCT01928394|7722451|FG022|Follow-up Period|Lost to Follow-up|1
4748794|NCT01657500|7722501|FG000|Overall Study|set impropperly matched|3
4748795|NCT01657500|7722502|FG001|Overall Study|set impropperly matched|3
4748796|NCT01657500|7722501|FG000|Overall Study|Lost to Follow-up|2
4748797|NCT01657500|7722502|FG001|Overall Study|Lost to Follow-up|2
4657002|NCT02151682|7542319|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
4657003|NCT02151682|7542320|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
4657004|NCT02151682|7542315|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
4657005|NCT02151682|7542316|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
4657006|NCT02151682|7542317|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3
4657007|NCT02151682|7542318|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
4657008|NCT02151682|7542319|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
4657009|NCT02151682|7542320|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
4657010|NCT02151682|7542315|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0
4657011|NCT02151682|7542316|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0
4657012|NCT02151682|7542317|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1
4657013|NCT02151682|7542318|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0
4657014|NCT02151682|7542319|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0
4657015|NCT02151682|7542320|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0
4657016|NCT02151682|7542315|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0
4657017|NCT02151682|7542316|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0
4657018|NCT02151682|7542317|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13
4657019|NCT02151682|7542318|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0
4657020|NCT02151682|7542319|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0
4657021|NCT02151682|7542320|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0
4657022|NCT02151682|7542315|FG000|Part 2: Tapent. Extension or Observation|Missing|0
4657023|NCT02151682|7542316|FG001|Part 2: Tapent. Extension or Observation|Missing|0
4657024|NCT02151682|7542317|FG002|Part 2: Tapent. Extension or Observation|Missing|0
4657025|NCT02151682|7542318|FG003|Part 2: Tapent. Extension or Observation|Missing|1
4657026|NCT02151682|7542319|FG004|Part 2: Tapent. Extension or Observation|Missing|0
4657027|NCT02151682|7542320|FG005|Part 2: Tapent. Extension or Observation|Missing|0
4657028|NCT02151682|7542315|FG000|Part 2: Tapent. Extension or Observation|Various other|0
4657029|NCT02151682|7542316|FG001|Part 2: Tapent. Extension or Observation|Various other|0
4657030|NCT02151682|7542317|FG002|Part 2: Tapent. Extension or Observation|Various other|6
4657031|NCT02151682|7542318|FG003|Part 2: Tapent. Extension or Observation|Various other|0
4657032|NCT02151682|7542319|FG004|Part 2: Tapent. Extension or Observation|Various other|0
4657033|NCT02151682|7542320|FG005|Part 2: Tapent. Extension or Observation|Various other|0
4657034|NCT02151682|7542315|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
4657035|NCT02151682|7542316|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
4657036|NCT02151682|7542317|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1
4748798|NCT04810221|7722508|FG000|Overall Study|Physician Decision|3
4657037|NCT02151682|7542318|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
4657038|NCT02151682|7542319|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
4657039|NCT02151682|7542320|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
4657040|NCT02151682|7542315|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
4748799|NCT04575038|7722514|FG000|Overall Study|Withdrawal by Subject|1
4748800|NCT04575038|7722515|FG001|Overall Study|Withdrawal by Subject|1
4748819|NCT04112303|7722593|FG000|Overall Study|Death|1
4748820|NCT03896477|7722600|FG000|Overall Study|Met Ineligibility Criteria During the Study|1
4748821|NCT03896477|7722601|FG001|Overall Study|Met Ineligibility Criteria During the Study|1
4748822|NCT03896477|7722602|FG002|Overall Study|Met Ineligibility Criteria During the Study|2
4748823|NCT03896477|7722600|FG000|Overall Study|Parent Requested Withdrawal|8
4748824|NCT03896477|7722601|FG001|Overall Study|Parent Requested Withdrawal|12
4657041|NCT02151682|7542316|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
4657042|NCT02151682|7542317|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
4657043|NCT02151682|7542318|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
4657044|NCT02151682|7542319|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
4657045|NCT02151682|7542320|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1
4657046|NCT02151682|7542315|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0
4657047|NCT02151682|7542316|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0
4657048|NCT02151682|7542317|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0
4657049|NCT02151682|7542318|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0
4657050|NCT02151682|7542319|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0
4657051|NCT02151682|7542320|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1
4657052|NCT02151682|7542315|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0
4657053|NCT02151682|7542316|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0
4657054|NCT02151682|7542317|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0
4657055|NCT02151682|7542318|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0
4657056|NCT02151682|7542319|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0
4657057|NCT02151682|7542320|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3
4657058|NCT02151682|7542315|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0
4657059|NCT02151682|7542316|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0
4657060|NCT02151682|7542317|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0
4657061|NCT02151682|7542318|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0
4657062|NCT02151682|7542319|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0
4657063|NCT02151682|7542320|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2
4657064|NCT02151773|7542338|FG000|Overall Study|Protocol Deviation|64
4657065|NCT02151786|7542342|FG000|Overall Study|Unavailability of Case Report Form|26
4657066|NCT02151786|7542342|FG000|Overall Study|Outside the Contract Period|1
4657067|NCT02151786|7542342|FG000|Overall Study|Randomized, not Treated|1
4657068|NCT02151786|7542342|FG000|Overall Study|Unavailability of Information|8
4657069|NCT02151851|7542348|FG000|Overall Study|Lack of Efficacy|67
4657070|NCT02151851|7542349|FG001|Overall Study|Lack of Efficacy|94
4657071|NCT02151851|7542348|FG000|Overall Study|Protocol Violation|0
4657072|NCT02151851|7542349|FG001|Overall Study|Protocol Violation|1
4748801|NCT04545567|7722523|FG000|Overall Study|tested positive for SARS-co-V2|1
4748802|NCT04545567|7722524|FG001|Overall Study|tested positive for SARS-co-V2|1
4748803|NCT04545567|7722523|FG000|Overall Study|Withdrawal by Subject|0
4748804|NCT04545567|7722524|FG001|Overall Study|Withdrawal by Subject|1
4748805|NCT04397757|7722536|FG000|Overall Study|Death|3
4748806|NCT04397757|7722537|FG001|Overall Study|Death|11
4748807|NCT04397757|7722536|FG000|Overall Study|Withdrawal by Subject|2
4748808|NCT04397757|7722537|FG001|Overall Study|Withdrawal by Subject|0
4748809|NCT04397757|7722536|FG000|Overall Study|Lost to Follow-up|4
4748810|NCT04397757|7722537|FG001|Overall Study|Lost to Follow-up|3
4748811|NCT04382651|7722559|FG000|Overall Study|Death|26
4748812|NCT04382651|7722560|FG001|Overall Study|Death|23
4748813|NCT04382651|7722559|FG000|Overall Study|Lost to Follow-up|3
4748814|NCT04382651|7722560|FG001|Overall Study|Lost to Follow-up|4
4748815|NCT04382651|7722559|FG000|Overall Study|Withdrawal by Subject|2
4748816|NCT04382651|7722560|FG001|Overall Study|Withdrawal by Subject|0
4748817|NCT04382651|7722559|FG000|Overall Study|Physician Decision|0
4748818|NCT04382651|7722560|FG001|Overall Study|Physician Decision|1
4748825|NCT03896477|7722602|FG002|Overall Study|Parent Requested Withdrawal|9
4748826|NCT03896477|7722600|FG000|Overall Study|Adverse Event|0
4748827|NCT03896477|7722601|FG001|Overall Study|Adverse Event|0
4748828|NCT03896477|7722602|FG002|Overall Study|Adverse Event|1
4748829|NCT03896477|7722600|FG000|Overall Study|Death|1
4748830|NCT03896477|7722601|FG001|Overall Study|Death|0
4748831|NCT03896477|7722602|FG002|Overall Study|Death|0
4748832|NCT03896477|7722600|FG000|Overall Study|Other|5
4748833|NCT03896477|7722601|FG001|Overall Study|Other|6
4748834|NCT03896477|7722602|FG002|Overall Study|Other|7
4748835|NCT03896477|7722600|FG000|Overall Study|Lost to Follow-up|2
4748836|NCT03896477|7722601|FG001|Overall Study|Lost to Follow-up|1
4748837|NCT03896477|7722602|FG002|Overall Study|Lost to Follow-up|1
4657073|NCT02151851|7542348|FG000|Overall Study|Withdrawal by Subject|2
4657074|NCT02151851|7542349|FG001|Overall Study|Withdrawal by Subject|5
4657075|NCT02151851|7542348|FG000|Overall Study|Medical impairment|1
4657076|NCT02151851|7542349|FG001|Overall Study|Medical impairment|0
4657077|NCT02151851|7542348|FG000|Overall Study|Low compliance to study visits|0
4657078|NCT02151851|7542349|FG001|Overall Study|Low compliance to study visits|1
4657079|NCT02151851|7542348|FG000|Overall Study|Subject entered into study in error|0
4657080|NCT02151851|7542349|FG001|Overall Study|Subject entered into study in error|1
4657081|NCT02151851|7542348|FG000|Overall Study|Adverse Event|6
4657082|NCT02151851|7542349|FG001|Overall Study|Adverse Event|28
4657083|NCT02151903|7542368|FG000|Overall Study|Withdrawal by Subject|1
4657084|NCT02151903|7542369|FG001|Overall Study|Withdrawal by Subject|0
4657085|NCT02151903|7542368|FG000|Overall Study|Progressive disease|2
4657086|NCT02151903|7542369|FG001|Overall Study|Progressive disease|1
4657087|NCT02152007|7542427|FG000|Overall Study|Withdrawal by Subject|1
4748838|NCT03760185|7722613|FG000|Overall Study|Lost to Follow-up|1
4748839|NCT03760185|7722614|FG001|Overall Study|Lost to Follow-up|1
4748840|NCT03732534|7722622|FG000|Overall Study|Study terminated by Sponsor|6
4748841|NCT03721705|7722628|FG000|Overall Study|Adverse Event|2
4748842|NCT03721705|7722629|FG001|Overall Study|Adverse Event|0
4748843|NCT03721705|7722628|FG000|Overall Study|Withdrawal by Subject|4
4748844|NCT03721705|7722629|FG001|Overall Study|Withdrawal by Subject|10
4748845|NCT03721705|7722628|FG000|Overall Study|No Suitable Study Partner|1
4748846|NCT03721705|7722629|FG001|Overall Study|No Suitable Study Partner|0
4748847|NCT03721705|7722628|FG000|Overall Study|Early Termination Due to COVID-19|3
4748848|NCT03721705|7722629|FG001|Overall Study|Early Termination Due to COVID-19|7
4748849|NCT03721705|7722628|FG000|Overall Study|Death|0
4748850|NCT03721705|7722629|FG001|Overall Study|Death|1
4748851|NCT03692910|7722635|FG000|Overall Study|Lost to Follow-up|4
4748852|NCT03692910|7722636|FG001|Overall Study|Lost to Follow-up|0
4748853|NCT03692910|7722637|FG002|Overall Study|Lost to Follow-up|0
4748854|NCT03692910|7722635|FG000|Overall Study|Withdrawal by Subject|2
4748855|NCT03692910|7722636|FG001|Overall Study|Withdrawal by Subject|0
4748856|NCT03692910|7722637|FG002|Overall Study|Withdrawal by Subject|0
4748857|NCT03673956|7722647|FG000|Overall Study|Lost to Follow-up|1
4748858|NCT03673956|7722648|FG001|Overall Study|Lost to Follow-up|0
4748859|NCT03673956|7722649|FG002|Overall Study|Lost to Follow-up|0
4748860|NCT03673956|7722650|FG003|Overall Study|Lost to Follow-up|0
4748861|NCT03673956|7722647|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1
4748862|NCT03673956|7722648|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0
4748863|NCT03673956|7722649|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0
4748864|NCT03673956|7722650|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0
4748865|NCT03474107|7722699|FG000|Overall Study|Adverse Event|42
4748866|NCT03474107|7722700|FG001|Overall Study|Adverse Event|46
4748867|NCT03474107|7722699|FG000|Overall Study|Death|2
4748868|NCT03474107|7722700|FG001|Overall Study|Death|2
4748869|NCT03474107|7722699|FG000|Overall Study|Lost to Follow-up|0
4748870|NCT03474107|7722700|FG001|Overall Study|Lost to Follow-up|1
4748871|NCT03474107|7722699|FG000|Overall Study|Progressive Disease|177
4748872|NCT03474107|7722700|FG001|Overall Study|Progressive Disease|180
4748873|NCT03474107|7722699|FG000|Overall Study|Protocol Violation|1
4748874|NCT03474107|7722700|FG001|Overall Study|Protocol Violation|1
4748875|NCT03474107|7722699|FG000|Overall Study|Withdrawal by Subject|15
4748876|NCT03474107|7722700|FG001|Overall Study|Withdrawal by Subject|27
4748877|NCT03474107|7722699|FG000|Overall Study|Physician Decision|7
4748878|NCT03474107|7722700|FG001|Overall Study|Physician Decision|22
4748879|NCT03474107|7722699|FG000|Overall Study|Miscellaneous|1
4748880|NCT03474107|7722700|FG001|Overall Study|Miscellaneous|6
4748881|NCT03463993|7722708|FG000|Overall Study|Lost to Follow-up|7
4748882|NCT03463993|7722709|FG001|Overall Study|Lost to Follow-up|8
4748883|NCT03463993|7722708|FG000|Overall Study|Withdrawal by Subject|2
4748884|NCT03463993|7722709|FG001|Overall Study|Withdrawal by Subject|0
4748885|NCT03463993|7722708|FG000|Overall Study|Protocol Violation|4
4748886|NCT03463993|7722709|FG001|Overall Study|Protocol Violation|1
4748887|NCT03463993|7722708|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9
4748888|NCT03463993|7722709|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11
4748889|NCT03463993|7722708|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7
4748890|NCT03463993|7722709|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6
4748891|NCT03364036|7722737|FG000|Overall Study|Adverse Event|1
4748892|NCT03364036|7722737|FG000|Overall Study|Lost to Follow-up|1
4748893|NCT03364036|7722737|FG000|Overall Study|Withdrew Consent|1
4748894|NCT03364036|7722737|FG000|Overall Study|Protocol Non-Compliance|1
4748895|NCT03364036|7722737|FG000|Overall Study|Other|2
4748896|NCT03205163|7722743|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1
4748897|NCT03205163|7722744|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0
4657088|NCT02152137|7542441|FG000|Overall Study|Withdrawal by Subject|1
4748898|NCT03178045|7722761|FG000|Overall Study|Withdrawal by Subject|5
4657089|NCT02152137|7542441|FG000|Overall Study|Originally assigned to Arm B|3
4657090|NCT02152163|7542447|FG000|Overall Study|Physician Decision|12
4657091|NCT02152163|7542448|FG001|Overall Study|Physician Decision|13
4657092|NCT02152345|7542456|FG000|Overall Study|Case Cancellations|2
4657093|NCT02152345|7542457|FG001|Overall Study|Case Cancellations|4
4657094|NCT02152345|7542456|FG000|Overall Study|Withdrawal by Subject|2
4657095|NCT02152345|7542457|FG001|Overall Study|Withdrawal by Subject|1
4657096|NCT02152371|7542465|FG000|Overall Study|Adverse Event|6
4657097|NCT02152371|7542466|FG001|Overall Study|Adverse Event|2
4657098|NCT02152371|7542465|FG000|Overall Study|Withdrawal by Subject|3
4657099|NCT02152371|7542466|FG001|Overall Study|Withdrawal by Subject|7
4657100|NCT02152371|7542465|FG000|Overall Study|Protocol Violation|2
4657101|NCT02152371|7542466|FG001|Overall Study|Protocol Violation|3
4657102|NCT02152371|7542465|FG000|Overall Study|Lost to Follow-up|1
4657103|NCT02152371|7542466|FG001|Overall Study|Lost to Follow-up|0
4657104|NCT02152371|7542465|FG000|Overall Study|Lack of Efficacy|0
4657105|NCT02152371|7542466|FG001|Overall Study|Lack of Efficacy|1
4657106|NCT02152371|7542465|FG000|Overall Study|Physician Decision|0
4657107|NCT02152371|7542466|FG001|Overall Study|Physician Decision|2
4657108|NCT02152371|7542465|FG000|Overall Study|Reason Not Given|0
4657109|NCT02152371|7542466|FG001|Overall Study|Reason Not Given|1
4657110|NCT02152384|7542472|FG000|Period 1|Withdrawal by Subject|0
4657111|NCT02152384|7542473|FG001|Period 1|Withdrawal by Subject|1
4657112|NCT02152384|7542472|FG000|Period 1|Adverse Event|1
4657113|NCT02152384|7542473|FG001|Period 1|Adverse Event|1
4657114|NCT02152605|7542501|FG000|Overall Study|Adverse Event|6
4657115|NCT02152605|7542502|FG001|Overall Study|Adverse Event|8
4657116|NCT02152605|7542501|FG000|Overall Study|Lack of Efficacy|7
4657117|NCT02152605|7542502|FG001|Overall Study|Lack of Efficacy|4
4657118|NCT02152605|7542501|FG000|Overall Study|Protocol deviation|1
4657119|NCT02152605|7542502|FG001|Overall Study|Protocol deviation|4
4657120|NCT02152605|7542501|FG000|Overall Study|Lost to Follow-up|1
4657121|NCT02152605|7542502|FG001|Overall Study|Lost to Follow-up|0
4657122|NCT02152605|7542501|FG000|Overall Study|Withdrew consent|4
4657123|NCT02152605|7542502|FG001|Overall Study|Withdrew consent|2
4657124|NCT02152631|7542511|FG000|Overall Study|Adverse Event|32
4657125|NCT02152631|7542512|FG001|Overall Study|Adverse Event|4
4657126|NCT02152631|7542511|FG000|Overall Study|Withdrawal by Subject|13
4657127|NCT02152631|7542512|FG001|Overall Study|Withdrawal by Subject|16
4657128|NCT02152631|7542511|FG000|Overall Study|Noncompliance with study drug|1
4657129|NCT02152631|7542512|FG001|Overall Study|Noncompliance with study drug|0
4657130|NCT02152631|7542511|FG000|Overall Study|Physician Decision|1
4657131|NCT02152631|7542512|FG001|Overall Study|Physician Decision|2
4657132|NCT02152631|7542511|FG000|Overall Study|Lost to Follow-up|0
4657133|NCT02152631|7542512|FG001|Overall Study|Lost to Follow-up|1
4657134|NCT02152631|7542511|FG000|Overall Study|On Treatment|19
4657135|NCT02152631|7542512|FG001|Overall Study|On Treatment|3
4657136|NCT02152761|7542535|FG000|Epoch: Treatment Epoch|Technical problems|0
4657137|NCT02152761|7542536|FG001|Epoch: Treatment Epoch|Technical problems|0
4657138|NCT02152761|7542537|FG002|Epoch: Treatment Epoch|Technical problems|0
4657139|NCT02152761|7542538|FG003|Epoch: Treatment Epoch|Technical problems|1
4657140|NCT02152761|7542535|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0
4657141|NCT02152761|7542536|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2
4657142|NCT02152761|7542537|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0
4657143|NCT02152761|7542538|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0
4657144|NCT02152761|7542535|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7
4657145|NCT02152761|7542536|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8
4657146|NCT02152761|7542537|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3
4657147|NCT02152761|7542538|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5
4657148|NCT02152761|7542535|FG000|Epoch: Treatment Epoch|Adverse Event|3
4657149|NCT02152761|7542536|FG001|Epoch: Treatment Epoch|Adverse Event|6
4657150|NCT02152761|7542537|FG002|Epoch: Treatment Epoch|Adverse Event|1
4657151|NCT02152761|7542538|FG003|Epoch: Treatment Epoch|Adverse Event|2
4657152|NCT02152761|7542535|FG000|Epoch: Treatment Epoch|Death|0
4657153|NCT02152761|7542536|FG001|Epoch: Treatment Epoch|Death|3
4657154|NCT02152761|7542537|FG002|Epoch: Treatment Epoch|Death|1
4657155|NCT02152761|7542538|FG003|Epoch: Treatment Epoch|Death|0
4657156|NCT02152761|7542535|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1
4657157|NCT02152761|7542536|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1
4657158|NCT02152761|7542537|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0
4657159|NCT02152761|7542538|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0
4657160|NCT02152761|7542535|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1
4657161|NCT02152761|7542536|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3
4657162|NCT02152761|7542537|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0
4657163|NCT02152761|7542538|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1
4657164|NCT02152761|7542535|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1
4657165|NCT02152761|7542536|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4
4657166|NCT02152761|7542537|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0
4657167|NCT02152761|7542538|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0
4657168|NCT02152761|7542535|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1
4657169|NCT02152761|7542536|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0
4657170|NCT02152761|7542537|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0
4657171|NCT02152761|7542538|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0
4748899|NCT03178045|7722762|FG001|Overall Study|Withdrawal by Subject|7
4748900|NCT03178045|7722761|FG000|Overall Study|Surgery Cancelled/Relocated|34
4748901|NCT03178045|7722762|FG001|Overall Study|Surgery Cancelled/Relocated|30
4748902|NCT03178045|7722761|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47
4748903|NCT03178045|7722762|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46
4748904|NCT03145766|7722774|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1
4748905|NCT03145766|7722775|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1
4748906|NCT03145766|7722776|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0
4748907|NCT03145766|7722777|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1
4748908|NCT03145766|7722778|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2
4748909|NCT03145766|7722774|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0
4748910|NCT03145766|7722775|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0
4748911|NCT03145766|7722776|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1
4748912|NCT03145766|7722777|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2
4748913|NCT03145766|7722778|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1
4748914|NCT03145766|7722774|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1
4748915|NCT03145766|7722775|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1
4748916|NCT03145766|7722776|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0
4657172|NCT02152761|7542535|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1
4657173|NCT02152761|7542536|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0
4657174|NCT02152761|7542537|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0
4657175|NCT02152761|7542538|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1
4657176|NCT02153073|7542563|FG000|Overall Study|Case Report Forms Uncollected|230
4657177|NCT02153073|7542563|FG000|Overall Study|Protocol Deviation|68
4657178|NCT02153086|7542567|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2
4657179|NCT02153086|7542567|FG000|Overall Study|Other|2
4657180|NCT02153112|7542610|FG000|Overall Study|Adverse Event|0
4657181|NCT02153112|7542611|FG001|Overall Study|Adverse Event|0
4657182|NCT02153112|7542612|FG002|Overall Study|Adverse Event|1
4657183|NCT02153112|7542613|FG003|Overall Study|Adverse Event|0
4657184|NCT02153112|7542614|FG004|Overall Study|Adverse Event|0
4657185|NCT02153112|7542615|FG005|Overall Study|Adverse Event|0
4657186|NCT02153112|7542616|FG006|Overall Study|Adverse Event|0
4657187|NCT02153112|7542617|FG007|Overall Study|Adverse Event|0
4657188|NCT02153112|7542618|FG008|Overall Study|Adverse Event|0
4657189|NCT02153112|7542619|FG009|Overall Study|Adverse Event|0
4657190|NCT02153112|7542610|FG000|Overall Study|Lost to Follow-up|1
4657191|NCT02153112|7542611|FG001|Overall Study|Lost to Follow-up|1
4657192|NCT02153112|7542612|FG002|Overall Study|Lost to Follow-up|0
4657193|NCT02153112|7542613|FG003|Overall Study|Lost to Follow-up|0
4657194|NCT02153112|7542614|FG004|Overall Study|Lost to Follow-up|2
4657195|NCT02153112|7542615|FG005|Overall Study|Lost to Follow-up|1
4657196|NCT02153112|7542616|FG006|Overall Study|Lost to Follow-up|1
4657197|NCT02153112|7542617|FG007|Overall Study|Lost to Follow-up|0
4657198|NCT02153112|7542618|FG008|Overall Study|Lost to Follow-up|1
4657199|NCT02153112|7542619|FG009|Overall Study|Lost to Follow-up|1
4657200|NCT02153112|7542610|FG000|Overall Study|Withdrawal by Subject|3
4657201|NCT02153112|7542611|FG001|Overall Study|Withdrawal by Subject|1
4657202|NCT02153112|7542612|FG002|Overall Study|Withdrawal by Subject|2
4657203|NCT02153112|7542613|FG003|Overall Study|Withdrawal by Subject|2
4657204|NCT02153112|7542614|FG004|Overall Study|Withdrawal by Subject|1
4657205|NCT02153112|7542615|FG005|Overall Study|Withdrawal by Subject|1
4657206|NCT02153112|7542616|FG006|Overall Study|Withdrawal by Subject|7
4657207|NCT02153112|7542617|FG007|Overall Study|Withdrawal by Subject|2
4657208|NCT02153112|7542618|FG008|Overall Study|Withdrawal by Subject|13
4657209|NCT02153112|7542619|FG009|Overall Study|Withdrawal by Subject|12
4657210|NCT02153112|7542610|FG000|Overall Study|Reason not Specified|0
4657211|NCT02153112|7542611|FG001|Overall Study|Reason not Specified|0
4657212|NCT02153112|7542612|FG002|Overall Study|Reason not Specified|0
4657213|NCT02153112|7542613|FG003|Overall Study|Reason not Specified|0
4657214|NCT02153112|7542614|FG004|Overall Study|Reason not Specified|0
4657215|NCT02153112|7542615|FG005|Overall Study|Reason not Specified|0
4657216|NCT02153112|7542616|FG006|Overall Study|Reason not Specified|0
4657217|NCT02153112|7542617|FG007|Overall Study|Reason not Specified|0
4657218|NCT02153112|7542618|FG008|Overall Study|Reason not Specified|1
4657219|NCT02153112|7542619|FG009|Overall Study|Reason not Specified|1
4657220|NCT02153346|7542643|FG000|Overall Study|Lost to Follow-up|11
4657221|NCT02153359|7542648|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0
4657222|NCT02153359|7542649|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2
4657223|NCT02153398|7542663|FG000|Overall Study|Withdrawal by Subject|1
4657224|NCT02153398|7542664|FG001|Overall Study|Withdrawal by Subject|0
4657225|NCT02153398|7542665|FG002|Overall Study|Withdrawal by Subject|0
4657226|NCT02153398|7542666|FG003|Overall Study|Withdrawal by Subject|0
4657227|NCT02153398|7542667|FG004|Overall Study|Withdrawal by Subject|0
4657228|NCT02153398|7542663|FG000|Overall Study|Adverse Event|0
4657229|NCT02153398|7542664|FG001|Overall Study|Adverse Event|0
4657230|NCT02153398|7542665|FG002|Overall Study|Adverse Event|1
4657231|NCT02153398|7542666|FG003|Overall Study|Adverse Event|1
4657232|NCT02153398|7542667|FG004|Overall Study|Adverse Event|0
4657233|NCT02153736|7542730|FG000|Overall Study|Lost to Follow-up|1
4657234|NCT02153736|7542731|FG001|Overall Study|Lost to Follow-up|0
4657235|NCT02153736|7542730|FG000|Overall Study|Medical status change made ineligible|1
4657236|NCT02153736|7542731|FG001|Overall Study|Medical status change made ineligible|0
4657237|NCT02153736|7542730|FG000|Overall Study|Death|0
4657238|NCT02153736|7542731|FG001|Overall Study|Death|1
4657239|NCT02153736|7542730|FG000|Overall Study|Withdrawal by Subject|0
4657240|NCT02153736|7542731|FG001|Overall Study|Withdrawal by Subject|1
4657241|NCT02153788|7542739|FG000|Overall Study|Physician Decision|2
4657242|NCT02153788|7542740|FG001|Overall Study|Physician Decision|1
4657243|NCT02153827|7542748|FG000|Overall Study|Lost to Follow-up|3
4657244|NCT02153827|7542749|FG001|Overall Study|Lost to Follow-up|9
4657245|NCT02153905|7542757|FG000|Overall Study|Death|1
4657246|NCT02153905|7542758|FG001|Overall Study|Death|0
4657247|NCT02153918|7542764|FG000|Overall Study|Refused further treatment|1
4657248|NCT02154061|7542808|FG000|Overall Study|Pregnancy|1
4657249|NCT02154061|7542809|FG001|Overall Study|Pregnancy|0
4657250|NCT02154061|7542808|FG000|Overall Study|enrolled but not vaccinated|1
4657251|NCT02154061|7542809|FG001|Overall Study|enrolled but not vaccinated|0
4657252|NCT02154139|7542815|FG000|Overall Study|Injection not administered|2
4657253|NCT02154139|7542815|FG000|Overall Study|Other|2
4657254|NCT02154139|7542815|FG000|Overall Study|Investigator transferred|3
4657255|NCT02154347|7542834|FG000|Double-blind Period|Adverse Event|1
4657256|NCT02154347|7542835|FG001|Double-blind Period|Adverse Event|2
4657257|NCT02154347|7542834|FG000|Double-blind Period|Lack of Efficacy|1
4657258|NCT02154347|7542835|FG001|Double-blind Period|Lack of Efficacy|0
4657259|NCT02154347|7542834|FG000|Double-blind Period|Physician Decision|0
4657260|NCT02154347|7542835|FG001|Double-blind Period|Physician Decision|1
4657261|NCT02154347|7542834|FG000|Double-blind Period|Withdrawal by Subject|1
4657262|NCT02154347|7542835|FG001|Double-blind Period|Withdrawal by Subject|1
4657263|NCT02154347|7542834|FG000|Open-label Period|Adverse Event|3
4657264|NCT02154347|7542835|FG001|Open-label Period|Adverse Event|4
4657265|NCT02154347|7542834|FG000|Open-label Period|Lack of Efficacy|4
4657266|NCT02154347|7542835|FG001|Open-label Period|Lack of Efficacy|19
4657267|NCT02154347|7542834|FG000|Open-label Period|Protocol Violation|0
4657268|NCT02154347|7542835|FG001|Open-label Period|Protocol Violation|1
4657269|NCT02154347|7542834|FG000|Open-label Period|Withdrawal by Subject|0
4657270|NCT02154347|7542835|FG001|Open-label Period|Withdrawal by Subject|1
4657271|NCT02154425|7542851|FG000|Screening Period|Adverse Event|1
4657272|NCT02154581|7542870|FG000|Overall Study|Lost to Follow-up|7
4657273|NCT02154581|7542871|FG001|Overall Study|Lost to Follow-up|8
4657274|NCT02155283|7542934|FG000|Overall Study|Lost to Follow-up|3
4657275|NCT02155283|7542934|FG000|Overall Study|Withdrawal by Subject|1
4657276|NCT02155283|7542934|FG000|Overall Study|Protocol Violation|3
4657277|NCT02155309|7542940|FG000|Overall Study|Protocol Violation|0
4657278|NCT02155309|7542941|FG001|Overall Study|Protocol Violation|0
4657279|NCT02155309|7542942|FG002|Overall Study|Protocol Violation|1
4657280|NCT02155322|7542949|FG000|Overall Study|Adverse Event|1
4657281|NCT02155322|7542949|FG000|Overall Study|Physician Decision|1
4657282|NCT02155322|7542949|FG000|Overall Study|Relapse/Recurrence|8
4657283|NCT02155322|7542949|FG000|Overall Study|Withdrawal by Subject|4
4657284|NCT02155608|7543018|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0
4657285|NCT02155608|7543019|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1
4657286|NCT02155608|7543018|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1
4657287|NCT02155608|7543019|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1
4657288|NCT02155647|7543033|FG000|Overall Study|Still on Treatment|26
4657289|NCT02155647|7543034|FG001|Overall Study|Still on Treatment|26
4657290|NCT02155647|7543033|FG000|Overall Study|Off-Treatment, but follow up ongoing|15
4657291|NCT02155647|7543034|FG001|Overall Study|Off-Treatment, but follow up ongoing|26
4657292|NCT02155660|7543044|FG000|Overall Study|Other Reason|8
4657293|NCT02155660|7543045|FG001|Overall Study|Other Reason|6
4657294|NCT02155660|7543046|FG002|Overall Study|Other Reason|10
4657295|NCT02155660|7543047|FG003|Overall Study|Other Reason|10
4657296|NCT02155660|7543044|FG000|Overall Study|Study-specific withdrawal criteria|0
4657297|NCT02155660|7543045|FG001|Overall Study|Study-specific withdrawal criteria|1
4657298|NCT02155660|7543046|FG002|Overall Study|Study-specific withdrawal criteria|1
4657299|NCT02155660|7543047|FG003|Overall Study|Study-specific withdrawal criteria|1
4657300|NCT02155660|7543044|FG000|Overall Study|Severe non-compliance|0
4657301|NCT02155660|7543045|FG001|Overall Study|Severe non-compliance|4
4657302|NCT02155660|7543046|FG002|Overall Study|Severe non-compliance|0
4657303|NCT02155660|7543047|FG003|Overall Study|Severe non-compliance|1
4657304|NCT02155660|7543044|FG000|Overall Study|Adverse Event|2
4657305|NCT02155660|7543045|FG001|Overall Study|Adverse Event|6
4657306|NCT02155660|7543046|FG002|Overall Study|Adverse Event|3
4657307|NCT02155660|7543047|FG003|Overall Study|Adverse Event|1
4657308|NCT02155660|7543044|FG000|Overall Study|Lost to Follow-up|3
4657309|NCT02155660|7543045|FG001|Overall Study|Lost to Follow-up|6
4657310|NCT02155660|7543046|FG002|Overall Study|Lost to Follow-up|5
4657311|NCT02155660|7543047|FG003|Overall Study|Lost to Follow-up|8
4657312|NCT02155660|7543044|FG000|Overall Study|Death|17
4657313|NCT02155660|7543045|FG001|Overall Study|Death|19
4657314|NCT02155660|7543046|FG002|Overall Study|Death|17
4657315|NCT02155660|7543047|FG003|Overall Study|Death|19
4657316|NCT02155660|7543044|FG000|Overall Study|Withdrawal by Subject|28
4657317|NCT02155660|7543045|FG001|Overall Study|Withdrawal by Subject|31
4657318|NCT02155660|7543046|FG002|Overall Study|Withdrawal by Subject|24
4657319|NCT02155660|7543047|FG003|Overall Study|Withdrawal by Subject|21
4657320|NCT02155712|7543059|FG000|Primary Objective|Death|3
4657321|NCT02155712|7543060|FG001|Primary Objective|Death|0
4657322|NCT02155712|7543059|FG000|Primary Objective|Lost to Follow-up|22
4657323|NCT02155712|7543060|FG001|Primary Objective|Lost to Follow-up|0
4657324|NCT02155712|7543059|FG000|Primary Objective|No 2-Year Forms but not Terminated|13
4657325|NCT02155712|7543060|FG001|Primary Objective|No 2-Year Forms but not Terminated|0
4657326|NCT02155712|7543059|FG000|Primary Objective|Revision/Removal of Tibial Baseplate|1
4657327|NCT02155712|7543060|FG001|Primary Objective|Revision/Removal of Tibial Baseplate|0
4657328|NCT02155712|7543059|FG000|Primary Objective|Withdrawal by Subject|21
4657329|NCT02155712|7543060|FG001|Primary Objective|Withdrawal by Subject|0
4657330|NCT02155738|7543085|FG000|Overall Study|Missing critical information|1
4657331|NCT02155738|7543086|FG001|Overall Study|Missing critical information|0
4657332|NCT02155738|7543087|FG002|Overall Study|Missing critical information|0
4657333|NCT02155738|7543088|FG003|Overall Study|Missing critical information|1
4657334|NCT02155829|7543100|FG000|Overall Study|Adverse Event|1
4657335|NCT02155829|7543101|FG001|Overall Study|Adverse Event|0
4657336|NCT02155829|7543100|FG000|Overall Study|Withdrawal by Subject|3
4657337|NCT02155829|7543101|FG001|Overall Study|Withdrawal by Subject|3
4657338|NCT02155829|7543100|FG000|Overall Study|Protocol Violation|2
4657339|NCT02155829|7543101|FG001|Overall Study|Protocol Violation|0
4657340|NCT02155881|7543110|FG000|Overall Study|Withdrawal by Subject|0
4657341|NCT02155881|7543111|FG001|Overall Study|Withdrawal by Subject|2
4657342|NCT02155881|7543110|FG000|Overall Study|Inappropriately randomized|2
4657343|NCT02155881|7543111|FG001|Overall Study|Inappropriately randomized|2
4657344|NCT02155985|7543120|FG000|Overall Study|Withdrawal by Subject|0
4657345|NCT02155985|7543121|FG001|Overall Study|Withdrawal by Subject|0
4657346|NCT02155985|7543122|FG002|Overall Study|Withdrawal by Subject|1
4657347|NCT02155985|7543120|FG000|Overall Study|Lost to Follow-up|1
4657348|NCT02155985|7543121|FG001|Overall Study|Lost to Follow-up|0
4657349|NCT02155985|7543122|FG002|Overall Study|Lost to Follow-up|0
4657350|NCT02156076|7543134|FG000|Treatment Period|no longer meets study criteria|0
4657351|NCT02156076|7543135|FG001|Treatment Period|no longer meets study criteria|0
4657352|NCT02156076|7543136|FG002|Treatment Period|no longer meets study criteria|1
4657353|NCT02156076|7543137|FG003|Treatment Period|no longer meets study criteria|0
4657354|NCT02156076|7543134|FG000|Treatment Period|Poor/non-compliance|0
4657355|NCT02156076|7543135|FG001|Treatment Period|Poor/non-compliance|1
4657356|NCT02156076|7543136|FG002|Treatment Period|Poor/non-compliance|0
4657357|NCT02156076|7543137|FG003|Treatment Period|Poor/non-compliance|0
4657358|NCT02156076|7543134|FG000|Treatment Period|Lost to Follow-up|0
4657359|NCT02156076|7543135|FG001|Treatment Period|Lost to Follow-up|0
4657360|NCT02156076|7543136|FG002|Treatment Period|Lost to Follow-up|0
4657361|NCT02156076|7543137|FG003|Treatment Period|Lost to Follow-up|1
4657362|NCT02156076|7543134|FG000|Treatment Period|Withdrawal by Subject|0
4657363|NCT02156076|7543135|FG001|Treatment Period|Withdrawal by Subject|0
4657364|NCT02156076|7543136|FG002|Treatment Period|Withdrawal by Subject|1
4657365|NCT02156076|7543137|FG003|Treatment Period|Withdrawal by Subject|0
4657366|NCT02156076|7543134|FG000|Treatment Period|Subject request to discontinue treatment|0
4657367|NCT02156076|7543135|FG001|Treatment Period|Subject request to discontinue treatment|1
4657368|NCT02156076|7543136|FG002|Treatment Period|Subject request to discontinue treatment|0
4657369|NCT02156076|7543137|FG003|Treatment Period|Subject request to discontinue treatment|0
4748917|NCT03145766|7722777|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3
4748918|NCT03145766|7722778|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0
4748919|NCT03145766|7722774|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4
4748920|NCT03145766|7722775|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1
4748921|NCT03145766|7722776|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1
4748922|NCT03145766|7722777|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1
4748923|NCT03145766|7722778|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0
4748924|NCT03145766|7722774|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2
4748925|NCT03145766|7722775|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0
4748926|NCT03145766|7722776|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0
4748927|NCT03145766|7722777|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1
4748928|NCT03145766|7722778|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0
4748929|NCT03145766|7722774|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4
4748930|NCT03145766|7722775|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1
4748931|NCT03145766|7722776|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4
4748932|NCT03145766|7722777|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2
4748933|NCT03145766|7722778|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3
4748934|NCT03145766|7722774|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1
4748935|NCT03145766|7722775|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1
4748936|NCT03145766|7722776|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1
4748937|NCT03145766|7722777|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0
4748938|NCT03145766|7722778|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0
4748939|NCT03106987|7722795|FG000|Overall Study|Death|37
4748940|NCT03106987|7722796|FG001|Overall Study|Death|22
4748941|NCT03106987|7722797|FG002|Overall Study|Death|12
4748942|NCT03106987|7722798|FG003|Overall Study|Death|8
4748943|NCT03106987|7722795|FG000|Overall Study|Lost to Follow-up|2
4748944|NCT03106987|7722796|FG001|Overall Study|Lost to Follow-up|0
4748945|NCT03106987|7722797|FG002|Overall Study|Lost to Follow-up|2
4748946|NCT03106987|7722798|FG003|Overall Study|Lost to Follow-up|2
4748947|NCT03106987|7722795|FG000|Overall Study|Withdrawal by Subject|5
4748948|NCT03106987|7722796|FG001|Overall Study|Withdrawal by Subject|1
4748949|NCT03106987|7722797|FG002|Overall Study|Withdrawal by Subject|4
4748950|NCT03106987|7722798|FG003|Overall Study|Withdrawal by Subject|1
4748951|NCT03103087|7722811|FG000|Overall Study|Did not receive any study drug|1
4748952|NCT03103087|7722812|FG001|Overall Study|Did not receive any study drug|0
4748953|NCT03103087|7722813|FG002|Overall Study|Did not receive any study drug|0
4748954|NCT03103087|7722811|FG000|Overall Study|Protocol Violation|1
4748955|NCT03103087|7722812|FG001|Overall Study|Protocol Violation|2
4748956|NCT03103087|7722813|FG002|Overall Study|Protocol Violation|1
4748957|NCT03103087|7722811|FG000|Overall Study|Lack of Efficacy|2
4748958|NCT03103087|7722812|FG001|Overall Study|Lack of Efficacy|1
4748959|NCT03103087|7722813|FG002|Overall Study|Lack of Efficacy|1
4748960|NCT03103087|7722811|FG000|Overall Study|Pregnancy|0
4748961|NCT03103087|7722812|FG001|Overall Study|Pregnancy|0
4748962|NCT03103087|7722813|FG002|Overall Study|Pregnancy|1
4748963|NCT03103087|7722811|FG000|Overall Study|Adverse Event|2
4748964|NCT03103087|7722812|FG001|Overall Study|Adverse Event|15
4657370|NCT02156076|7543134|FG000|Treatment Period|Adverse Event|0
4657371|NCT02156076|7543135|FG001|Treatment Period|Adverse Event|0
4657372|NCT02156076|7543136|FG002|Treatment Period|Adverse Event|0
4657373|NCT02156076|7543137|FG003|Treatment Period|Adverse Event|1
4657374|NCT02156076|7543134|FG000|Follow-up Period|Withdrawal by Subject|1
4657375|NCT02156076|7543135|FG001|Follow-up Period|Withdrawal by Subject|0
4657376|NCT02156076|7543136|FG002|Follow-up Period|Withdrawal by Subject|0
4657377|NCT02156076|7543137|FG003|Follow-up Period|Withdrawal by Subject|0
4657378|NCT02156271|7543175|FG000|Overall Study|Physician Decision|4
4657379|NCT02156271|7543176|FG001|Overall Study|Physician Decision|3
4657380|NCT02156466|7543187|FG000|Overall Study|Adverse Event|0
4657381|NCT02156466|7543188|FG001|Overall Study|Adverse Event|0
4657382|NCT02156466|7543189|FG002|Overall Study|Adverse Event|1
4657383|NCT02156466|7543190|FG003|Overall Study|Adverse Event|1
4657384|NCT02156466|7543191|FG004|Overall Study|Adverse Event|0
4657385|NCT02156466|7543187|FG000|Overall Study|Quantiferon Positivity|0
4657386|NCT02156466|7543188|FG001|Overall Study|Quantiferon Positivity|0
4657387|NCT02156466|7543189|FG002|Overall Study|Quantiferon Positivity|0
4657388|NCT02156466|7543190|FG003|Overall Study|Quantiferon Positivity|1
4657389|NCT02156466|7543191|FG004|Overall Study|Quantiferon Positivity|0
4657390|NCT02156492|7543215|FG000|Period 1|No Reason Given|0
4657391|NCT02156492|7543216|FG001|Period 1|No Reason Given|1
4657392|NCT02156492|7543217|FG002|Period 1|No Reason Given|0
4657393|NCT02156492|7543215|FG000|Period 3|Adverse Event|0
4657394|NCT02156492|7543216|FG001|Period 3|Adverse Event|1
4657395|NCT02156492|7543217|FG002|Period 3|Adverse Event|0
4657396|NCT02156804|7543248|FG000|Overall Study|Withdrawal by Subject|1
4657397|NCT02157298|7543284|FG000|Overall Study|Adverse Event|1
4657398|NCT02157298|7543285|FG001|Overall Study|Adverse Event|0
4657399|NCT02157298|7543284|FG000|Overall Study|Subject no longer meets study criteria|1
4657400|NCT02157298|7543285|FG001|Overall Study|Subject no longer meets study criteria|2
4657401|NCT02157298|7543284|FG000|Overall Study|Poor/Non-compliance|1
4657402|NCT02157298|7543285|FG001|Overall Study|Poor/Non-compliance|0
4657403|NCT02157298|7543284|FG000|Overall Study|Withdrawal by Subject|1
4657404|NCT02157298|7543285|FG001|Overall Study|Withdrawal by Subject|0
4657405|NCT02157376|7543293|FG000|Overall Study|Death|10
4657406|NCT02157376|7543294|FG001|Overall Study|Death|4
4657407|NCT02157376|7543293|FG000|Overall Study|Eligibility criteria not fulfilled|0
4657408|NCT02157376|7543294|FG001|Overall Study|Eligibility criteria not fulfilled|1
4657409|NCT02157376|7543293|FG000|Overall Study|Withdrawal by Subject|3
4657410|NCT02157376|7543294|FG001|Overall Study|Withdrawal by Subject|8
4657411|NCT02157376|7543293|FG000|Overall Study|Not treated|8
4657412|NCT02157376|7543294|FG001|Overall Study|Not treated|3
4657413|NCT02157376|7543293|FG000|Overall Study|Investigator's misjudgement|1
4657414|NCT02157376|7543294|FG001|Overall Study|Investigator's misjudgement|2
4657415|NCT02157506|7543305|FG000|Overall Study|Adverse Event|0
4657416|NCT02157506|7543306|FG001|Overall Study|Adverse Event|1
4657417|NCT02157506|7543307|FG002|Overall Study|Adverse Event|0
4657418|NCT02157506|7543308|FG003|Overall Study|Adverse Event|0
4657419|NCT02157506|7543309|FG004|Overall Study|Adverse Event|0
4657420|NCT02157506|7543305|FG000|Overall Study|Lost to Follow-up|0
4657421|NCT02157506|7543306|FG001|Overall Study|Lost to Follow-up|0
4657422|NCT02157506|7543307|FG002|Overall Study|Lost to Follow-up|1
4657423|NCT02157506|7543308|FG003|Overall Study|Lost to Follow-up|0
4657424|NCT02157506|7543309|FG004|Overall Study|Lost to Follow-up|0
4657425|NCT02157519|7543323|FG000|Overall Study|Death|3
4657426|NCT02157519|7543324|FG001|Overall Study|Death|1
4657427|NCT02157519|7543323|FG000|Overall Study|Withdrawal by Subject|7
4657428|NCT02157519|7543324|FG001|Overall Study|Withdrawal by Subject|0
4657429|NCT02157519|7543323|FG000|Overall Study|Lost to Follow-up|1
4657430|NCT02157519|7543324|FG001|Overall Study|Lost to Follow-up|0
4657431|NCT02157779|7543342|FG000|Overall Study|Logistical|9
4657432|NCT02157779|7543343|FG001|Overall Study|Logistical|3
4657433|NCT02157779|7543342|FG000|Overall Study|Stopped attending, reason unknown|11
4657434|NCT02157779|7543343|FG001|Overall Study|Stopped attending, reason unknown|7
4657435|NCT02157779|7543342|FG000|Overall Study|No response to outreach after Baseline|1
4657436|NCT02157779|7543343|FG001|Overall Study|No response to outreach after Baseline|1
4657437|NCT02157779|7543342|FG000|Overall Study|Moved|1
4657438|NCT02157779|7543343|FG001|Overall Study|Moved|0
4657439|NCT02157779|7543342|FG000|Overall Study|Medical|1
4657440|NCT02157779|7543343|FG001|Overall Study|Medical|0
4657441|NCT02157779|7543342|FG000|Overall Study|Legal issue|1
4657442|NCT02157779|7543343|FG001|Overall Study|Legal issue|0
4657443|NCT02157935|7543364|FG000|Overall Study|Withdrawal by Subject|25
4657444|NCT02157935|7543365|FG001|Overall Study|Withdrawal by Subject|39
4657445|NCT02157935|7543364|FG000|Overall Study|Screen failure|1
4657446|NCT02157935|7543365|FG001|Overall Study|Screen failure|2
4657447|NCT02157935|7543364|FG000|Overall Study|Protocol Violation|1
4657448|NCT02157935|7543365|FG001|Overall Study|Protocol Violation|0
4657449|NCT02157935|7543364|FG000|Overall Study|Progressive disease|0
4657450|NCT02157935|7543365|FG001|Overall Study|Progressive disease|2
4657451|NCT02157935|7543364|FG000|Overall Study|Other|5
4657452|NCT02157935|7543365|FG001|Overall Study|Other|12
4657453|NCT02157935|7543364|FG000|Overall Study|Lack of Efficacy|0
4657454|NCT02157935|7543365|FG001|Overall Study|Lack of Efficacy|1
4657455|NCT02157935|7543364|FG000|Overall Study|Death|4
4657456|NCT02157935|7543365|FG001|Overall Study|Death|4
4657457|NCT02157935|7543364|FG000|Overall Study|Adverse Event|3
4657458|NCT02157935|7543365|FG001|Overall Study|Adverse Event|5
4748965|NCT03103087|7722813|FG002|Overall Study|Adverse Event|6
4748966|NCT03103087|7722811|FG000|Overall Study|Withdrawal by Subject|13
4748967|NCT03103087|7722812|FG001|Overall Study|Withdrawal by Subject|6
4748968|NCT03103087|7722813|FG002|Overall Study|Withdrawal by Subject|6
4748969|NCT03103087|7722811|FG000|Overall Study|Lost to Follow-up|4
4748970|NCT03103087|7722812|FG001|Overall Study|Lost to Follow-up|2
4748971|NCT03103087|7722813|FG002|Overall Study|Lost to Follow-up|7
4748972|NCT03103087|7722811|FG000|Overall Study|Other reason not reported|1
4748973|NCT03103087|7722812|FG001|Overall Study|Other reason not reported|3
4748974|NCT03103087|7722813|FG002|Overall Study|Other reason not reported|5
4657459|NCT02157948|7543373|FG000|Overall Study|Withdrawal by Subject|4
4657460|NCT02157948|7543374|FG001|Overall Study|Withdrawal by Subject|5
4657461|NCT02157948|7543373|FG000|Overall Study|Lost to Follow-up|3
4657462|NCT02157948|7543374|FG001|Overall Study|Lost to Follow-up|2
4657463|NCT02157948|7543373|FG000|Overall Study|Protocol Specified Criteria|2
4657464|NCT02157948|7543374|FG001|Overall Study|Protocol Specified Criteria|1
4657465|NCT02157948|7543373|FG000|Overall Study|Decision by Sponsor|0
4657466|NCT02157948|7543374|FG001|Overall Study|Decision by Sponsor|1
4657467|NCT02158039|7543380|FG000|Overall Study|Withdrawal by Subject|1
4657468|NCT02158039|7543380|FG000|Overall Study|Screen Failure|9
4657469|NCT02158247|7543386|FG000|Overall Study|Invisible vocal cords|5
4657470|NCT02158364|7543411|FG000|Overall Study|Case report forms uncollected|10
4657471|NCT02158364|7543411|FG000|Overall Study|Protocol Deviation|50
4657472|NCT02158442|7543417|FG000|Overall Study|Withdrawal by Subject|1
4657473|NCT02158442|7543418|FG001|Overall Study|Withdrawal by Subject|0
4657474|NCT02158442|7543417|FG000|Overall Study|Perfusion staff not available|1
4657475|NCT02158442|7543418|FG001|Overall Study|Perfusion staff not available|0
4657476|NCT02158533|7543452|FG000|Stage 1|Adverse Event|6
4657477|NCT02158533|7543453|FG001|Stage 1|Adverse Event|4
4657478|NCT02158533|7543454|FG002|Stage 1|Adverse Event|7
4657479|NCT02158533|7543455|FG003|Stage 1|Adverse Event|0
4657480|NCT02158533|7543456|FG004|Stage 1|Adverse Event|0
4657481|NCT02158533|7543457|FG005|Stage 1|Adverse Event|0
4657482|NCT02158533|7543452|FG000|Stage 1|Withdrawal by Subject|3
4657483|NCT02158533|7543453|FG001|Stage 1|Withdrawal by Subject|2
4657484|NCT02158533|7543454|FG002|Stage 1|Withdrawal by Subject|1
4657485|NCT02158533|7543455|FG003|Stage 1|Withdrawal by Subject|0
4657486|NCT02158533|7543456|FG004|Stage 1|Withdrawal by Subject|0
4657487|NCT02158533|7543457|FG005|Stage 1|Withdrawal by Subject|0
4657488|NCT02158533|7543452|FG000|Stage 1|Lack of Efficacy|1
4657489|NCT02158533|7543453|FG001|Stage 1|Lack of Efficacy|0
4657490|NCT02158533|7543454|FG002|Stage 1|Lack of Efficacy|0
4657491|NCT02158533|7543455|FG003|Stage 1|Lack of Efficacy|0
4657492|NCT02158533|7543456|FG004|Stage 1|Lack of Efficacy|0
4657493|NCT02158533|7543457|FG005|Stage 1|Lack of Efficacy|0
4657494|NCT02158533|7543452|FG000|Stage 1|Lost to Follow-up|3
4657495|NCT02158533|7543453|FG001|Stage 1|Lost to Follow-up|1
4657496|NCT02158533|7543454|FG002|Stage 1|Lost to Follow-up|0
4657497|NCT02158533|7543455|FG003|Stage 1|Lost to Follow-up|0
4657498|NCT02158533|7543456|FG004|Stage 1|Lost to Follow-up|0
4657499|NCT02158533|7543457|FG005|Stage 1|Lost to Follow-up|0
4657500|NCT02158533|7543452|FG000|Stage 1|Failure to Meet Eligibility Criteria|0
4657501|NCT02158533|7543453|FG001|Stage 1|Failure to Meet Eligibility Criteria|1
4657502|NCT02158533|7543454|FG002|Stage 1|Failure to Meet Eligibility Criteria|0
4657503|NCT02158533|7543455|FG003|Stage 1|Failure to Meet Eligibility Criteria|0
4657504|NCT02158533|7543456|FG004|Stage 1|Failure to Meet Eligibility Criteria|0
4657505|NCT02158533|7543457|FG005|Stage 1|Failure to Meet Eligibility Criteria|0
4657506|NCT02158533|7543452|FG000|Stage 1|Non-compliance with study visits|1
4657507|NCT02158533|7543453|FG001|Stage 1|Non-compliance with study visits|0
4657508|NCT02158533|7543454|FG002|Stage 1|Non-compliance with study visits|0
4657509|NCT02158533|7543455|FG003|Stage 1|Non-compliance with study visits|0
4657510|NCT02158533|7543456|FG004|Stage 1|Non-compliance with study visits|0
4657511|NCT02158533|7543457|FG005|Stage 1|Non-compliance with study visits|0
4657512|NCT02158533|7543452|FG000|Stage 2|Adverse Event|0
4657513|NCT02158533|7543453|FG001|Stage 2|Adverse Event|0
4657514|NCT02158533|7543454|FG002|Stage 2|Adverse Event|0
4657515|NCT02158533|7543455|FG003|Stage 2|Adverse Event|0
4657516|NCT02158533|7543456|FG004|Stage 2|Adverse Event|0
4657517|NCT02158533|7543457|FG005|Stage 2|Adverse Event|1
4657518|NCT02158533|7543452|FG000|Stage 2|Lack of Efficacy|0
4657519|NCT02158533|7543453|FG001|Stage 2|Lack of Efficacy|0
4657520|NCT02158533|7543454|FG002|Stage 2|Lack of Efficacy|0
4657521|NCT02158533|7543455|FG003|Stage 2|Lack of Efficacy|0
4657522|NCT02158533|7543456|FG004|Stage 2|Lack of Efficacy|1
4657523|NCT02158533|7543457|FG005|Stage 2|Lack of Efficacy|0
4657524|NCT02158533|7543452|FG000|Stage 2|Lost to Follow-up|0
4657525|NCT02158533|7543453|FG001|Stage 2|Lost to Follow-up|0
4657526|NCT02158533|7543454|FG002|Stage 2|Lost to Follow-up|0
4657527|NCT02158533|7543455|FG003|Stage 2|Lost to Follow-up|1
4657528|NCT02158533|7543456|FG004|Stage 2|Lost to Follow-up|1
4657529|NCT02158533|7543457|FG005|Stage 2|Lost to Follow-up|2
4657530|NCT02158533|7543452|FG000|Stage 2|Withdrawal by Subject|0
4657531|NCT02158533|7543453|FG001|Stage 2|Withdrawal by Subject|0
4657532|NCT02158533|7543454|FG002|Stage 2|Withdrawal by Subject|0
4657533|NCT02158533|7543455|FG003|Stage 2|Withdrawal by Subject|0
4657534|NCT02158533|7543456|FG004|Stage 2|Withdrawal by Subject|1
4657535|NCT02158533|7543457|FG005|Stage 2|Withdrawal by Subject|2
4657536|NCT02158533|7543452|FG000|Stage 2|Physician Decision|0
4657537|NCT02158533|7543453|FG001|Stage 2|Physician Decision|0
4657538|NCT02158533|7543454|FG002|Stage 2|Physician Decision|0
4657539|NCT02158533|7543455|FG003|Stage 2|Physician Decision|0
4657540|NCT02158533|7543456|FG004|Stage 2|Physician Decision|1
4657541|NCT02158533|7543457|FG005|Stage 2|Physician Decision|0
4657542|NCT02158533|7543452|FG000|Stage 2|Pregnancy|0
4657543|NCT02158533|7543453|FG001|Stage 2|Pregnancy|0
4657544|NCT02158533|7543454|FG002|Stage 2|Pregnancy|0
4657545|NCT02158533|7543455|FG003|Stage 2|Pregnancy|1
4657546|NCT02158533|7543456|FG004|Stage 2|Pregnancy|0
4657547|NCT02158533|7543457|FG005|Stage 2|Pregnancy|0
4657548|NCT02158533|7543452|FG000|Stage 2|Psychiatrist decision to try new tx|0
4657549|NCT02158533|7543453|FG001|Stage 2|Psychiatrist decision to try new tx|0
4657550|NCT02158533|7543454|FG002|Stage 2|Psychiatrist decision to try new tx|0
4657551|NCT02158533|7543455|FG003|Stage 2|Psychiatrist decision to try new tx|1
4748975|NCT03073980|7722826|FG000|Overall Study|Lost to Follow-up|10
4748976|NCT03073980|7722827|FG001|Overall Study|Lost to Follow-up|2
4748977|NCT03073980|7722828|FG002|Overall Study|Lost to Follow-up|9
4748978|NCT03073980|7722826|FG000|Overall Study|No post-procedure data|0
4748979|NCT03073980|7722827|FG001|Overall Study|No post-procedure data|0
4748980|NCT03073980|7722828|FG002|Overall Study|No post-procedure data|2
4748981|NCT03049735|7722843|FG000|Overall Study|Discontinued due to AE (not dosed)|0
4748982|NCT03049735|7722844|FG001|Overall Study|Discontinued due to AE (not dosed)|0
4748983|NCT03049735|7722845|FG002|Overall Study|Discontinued due to AE (not dosed)|1
4748984|NCT03049735|7722843|FG000|Overall Study|Other|5
4748985|NCT03049735|7722844|FG001|Overall Study|Other|3
4657552|NCT02158533|7543456|FG004|Stage 2|Psychiatrist decision to try new tx|0
4657553|NCT02158533|7543457|FG005|Stage 2|Psychiatrist decision to try new tx|0
4657554|NCT02158533|7543452|FG000|Stage 2|Non-adherence with study visits|0
4657555|NCT02158533|7543453|FG001|Stage 2|Non-adherence with study visits|0
4657556|NCT02158533|7543454|FG002|Stage 2|Non-adherence with study visits|0
4657557|NCT02158533|7543455|FG003|Stage 2|Non-adherence with study visits|0
4657558|NCT02158533|7543456|FG004|Stage 2|Non-adherence with study visits|0
4657559|NCT02158533|7543457|FG005|Stage 2|Non-adherence with study visits|1
4657560|NCT02158546|7543475|FG000|Overall Study|Physician Decision|0
4657561|NCT02158546|7543476|FG001|Overall Study|Physician Decision|1
4657562|NCT02158546|7543477|FG002|Overall Study|Physician Decision|0
4657563|NCT02158546|7543478|FG003|Overall Study|Physician Decision|0
4748986|NCT03049735|7722845|FG002|Overall Study|Other|1
4748987|NCT03049735|7722843|FG000|Overall Study|Lack of Efficacy|4
4748988|NCT03049735|7722844|FG001|Overall Study|Lack of Efficacy|0
4657564|NCT02158546|7543475|FG000|Overall Study|Non-compliance|0
4657565|NCT02158546|7543476|FG001|Overall Study|Non-compliance|1
4657566|NCT02158546|7543477|FG002|Overall Study|Non-compliance|0
4657567|NCT02158546|7543478|FG003|Overall Study|Non-compliance|1
4657568|NCT02158546|7543475|FG000|Overall Study|Failure to meet eligibility criteria|0
4657569|NCT02158546|7543476|FG001|Overall Study|Failure to meet eligibility criteria|1
4657570|NCT02158546|7543477|FG002|Overall Study|Failure to meet eligibility criteria|0
4657571|NCT02158546|7543478|FG003|Overall Study|Failure to meet eligibility criteria|0
4657572|NCT02158546|7543475|FG000|Overall Study|Lack of Efficacy|1
4657573|NCT02158546|7543476|FG001|Overall Study|Lack of Efficacy|1
4657574|NCT02158546|7543477|FG002|Overall Study|Lack of Efficacy|0
4657575|NCT02158546|7543478|FG003|Overall Study|Lack of Efficacy|0
4657576|NCT02158546|7543475|FG000|Overall Study|Adverse Event|2
4657577|NCT02158546|7543476|FG001|Overall Study|Adverse Event|2
4657578|NCT02158546|7543477|FG002|Overall Study|Adverse Event|0
4657579|NCT02158546|7543478|FG003|Overall Study|Adverse Event|0
4657580|NCT02158546|7543475|FG000|Overall Study|Withdrawal by Subject|6
4657581|NCT02158546|7543476|FG001|Overall Study|Withdrawal by Subject|2
4657582|NCT02158546|7543477|FG002|Overall Study|Withdrawal by Subject|1
4657583|NCT02158546|7543478|FG003|Overall Study|Withdrawal by Subject|0
4657584|NCT02158546|7543475|FG000|Overall Study|Lost to Follow-up|5
4657585|NCT02158546|7543476|FG001|Overall Study|Lost to Follow-up|4
4657586|NCT02158546|7543477|FG002|Overall Study|Lost to Follow-up|0
4748989|NCT03049735|7722845|FG002|Overall Study|Lack of Efficacy|3
4748990|NCT03049735|7722843|FG000|Overall Study|Protocol deviation|1
4748991|NCT03049735|7722844|FG001|Overall Study|Protocol deviation|0
4748992|NCT03049735|7722845|FG002|Overall Study|Protocol deviation|0
4748993|NCT03049735|7722843|FG000|Overall Study|Pregnancy|0
4748994|NCT03049735|7722844|FG001|Overall Study|Pregnancy|0
4748995|NCT03049735|7722845|FG002|Overall Study|Pregnancy|1
4748996|NCT03049735|7722843|FG000|Overall Study|Adverse Event|7
4748997|NCT03049735|7722844|FG001|Overall Study|Adverse Event|18
4748998|NCT03049735|7722845|FG002|Overall Study|Adverse Event|5
4748999|NCT03049735|7722843|FG000|Overall Study|Withdrawal by Subject|10
4749000|NCT03049735|7722844|FG001|Overall Study|Withdrawal by Subject|3
4749001|NCT03049735|7722845|FG002|Overall Study|Withdrawal by Subject|7
4749002|NCT03049735|7722843|FG000|Overall Study|Lost to Follow-up|1
4749003|NCT03049735|7722844|FG001|Overall Study|Lost to Follow-up|5
4749004|NCT03049735|7722845|FG002|Overall Study|Lost to Follow-up|5
4749005|NCT03021551|7722853|FG000|Overall Study|Equipment Issues|2
4749006|NCT03021551|7722853|FG000|Overall Study|Protocol Violation|1
4749007|NCT02990338|7722859|FG000|Overall Study|Adverse Event|19
4749008|NCT02990338|7722860|FG001|Overall Study|Adverse Event|11
4749009|NCT02990338|7722859|FG000|Overall Study|Progressive disease|88
4749010|NCT02990338|7722860|FG001|Overall Study|Progressive disease|66
4749011|NCT02990338|7722859|FG000|Overall Study|Poor compliance to protocol|0
4749012|NCT02990338|7722860|FG001|Overall Study|Poor compliance to protocol|1
4749013|NCT02990338|7722859|FG000|Overall Study|Withdrawal by Subject|6
4749014|NCT02990338|7722860|FG001|Overall Study|Withdrawal by Subject|5
4749015|NCT02990338|7722859|FG000|Overall Study|Other|1
4749016|NCT02990338|7722860|FG001|Overall Study|Other|4
4749017|NCT02990338|7722859|FG000|Overall Study|Randomized but not treated|4
4749018|NCT02990338|7722860|FG001|Overall Study|Randomized but not treated|2
4749019|NCT02932332|7722880|FG000|Overall Study|Withdrawal by Subject|1
4749020|NCT02932332|7722881|FG001|Overall Study|Withdrawal by Subject|1
4749021|NCT02932332|7722882|FG002|Overall Study|Withdrawal by Subject|0
4749022|NCT02932332|7722883|FG003|Overall Study|Withdrawal by Subject|1
4657587|NCT02158546|7543478|FG003|Overall Study|Lost to Follow-up|1
4657588|NCT02158546|7543475|FG000|Overall Study|Site Excluded|5
4657589|NCT02158546|7543476|FG001|Overall Study|Site Excluded|5
4657590|NCT02158546|7543477|FG002|Overall Study|Site Excluded|3
4749023|NCT02932332|7722880|FG000|Overall Study|Chest pain|0
4749024|NCT02932332|7722881|FG001|Overall Study|Chest pain|0
4749025|NCT02932332|7722882|FG002|Overall Study|Chest pain|0
4657591|NCT02158546|7543478|FG003|Overall Study|Site Excluded|4
4749026|NCT02932332|7722883|FG003|Overall Study|Chest pain|1
4749027|NCT02932332|7722880|FG000|Overall Study|Not Dyspneic cough|1
4657592|NCT02158663|7543494|FG000|Overall Study|Withdrawal by Subject|5
4657593|NCT02158663|7543495|FG001|Overall Study|Withdrawal by Subject|4
4657594|NCT02158728|7543503|FG000|Overall Study|no procedure according to CIP done|3
4657595|NCT02158728|7543503|FG000|Overall Study|no qualified dataset|24
4657596|NCT02158806|7543509|FG000|Overall Study|Death|2
4657597|NCT02158806|7543510|FG001|Overall Study|Death|0
4657598|NCT02158806|7543509|FG000|Overall Study|Withdrawal by Subject|2
4657599|NCT02158806|7543510|FG001|Overall Study|Withdrawal by Subject|0
4657600|NCT02158806|7543509|FG000|Overall Study|Lost to Follow-up|0
4657601|NCT02158806|7543510|FG001|Overall Study|Lost to Follow-up|3
4657602|NCT02158806|7543509|FG000|Overall Study|Moved out of area|0
4657603|NCT02158806|7543510|FG001|Overall Study|Moved out of area|1
4657604|NCT02158806|7543509|FG000|Overall Study|Transferred to palliative care|0
4657605|NCT02158806|7543510|FG001|Overall Study|Transferred to palliative care|1
4657606|NCT02158884|7543516|FG000|Baseline Assessment|Missed performance assessment|3
4657607|NCT02158884|7543516|FG000|Baseline Assessment|Missed SMFA|1
4657608|NCT02158884|7543516|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6
4657609|NCT02158884|7543516|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10
4657610|NCT02158884|7543516|FG000|6 Month Assessment|Missed SMFA|20
4657611|NCT02158884|7543516|FG000|12 Month Assessment|Missed SMFA|17
4657612|NCT02158936|7543523|FG000|Overall Study|Study closed/ terminated|57
4657613|NCT02158936|7543524|FG001|Overall Study|Study closed/ terminated|77
4657614|NCT02158936|7543523|FG000|Overall Study|Azacitidine tx discontinued|53
4657615|NCT02158936|7543524|FG001|Overall Study|Azacitidine tx discontinued|46
4657616|NCT02158936|7543523|FG000|Overall Study|Adverse Event|39
4657617|NCT02158936|7543524|FG001|Overall Study|Adverse Event|24
4657618|NCT02158936|7543523|FG000|Overall Study|Withdrawal by Subject|15
4657619|NCT02158936|7543524|FG001|Overall Study|Withdrawal by Subject|16
4657620|NCT02158936|7543523|FG000|Overall Study|Physician Decision|15
4657621|NCT02158936|7543524|FG001|Overall Study|Physician Decision|13
4657622|NCT02158936|7543523|FG000|Overall Study|Lost to Follow-up|0
4657623|NCT02158936|7543524|FG001|Overall Study|Lost to Follow-up|1
4657624|NCT02158949|7543532|FG000|Overall Study|Withdrawal by Subject|1
4657625|NCT02158949|7543533|FG001|Overall Study|Withdrawal by Subject|0
4657626|NCT02158949|7543532|FG000|Overall Study|Lost to Follow-up|5
4657627|NCT02158949|7543533|FG001|Overall Study|Lost to Follow-up|11
4749028|NCT02932332|7722881|FG001|Overall Study|Not Dyspneic cough|2
4749029|NCT02932332|7722882|FG002|Overall Study|Not Dyspneic cough|1
4749030|NCT02932332|7722883|FG003|Overall Study|Not Dyspneic cough|0
4749031|NCT02588248|7722926|FG000|Overall Study|Physician Decision|4
4749032|NCT02588248|7722927|FG001|Overall Study|Physician Decision|3
4749033|NCT02535065|7722938|FG000|Overall Study|Death|13
4749034|NCT02535065|7722938|FG000|Overall Study|Lost to Follow-up|1
4749035|NCT02535065|7722938|FG000|Overall Study|Withdrawal by Subject|6
4749036|NCT02451358|7722950|FG000|Overall Study|Withdrawal by Subject|1
4749037|NCT02451358|7722951|FG001|Overall Study|Withdrawal by Subject|1
4749038|NCT02451358|7722952|FG002|Overall Study|Withdrawal by Subject|0
4749039|NCT02451358|7722953|FG003|Overall Study|Withdrawal by Subject|0
4749040|NCT02451358|7722950|FG000|Overall Study|Protocol Violation|0
4749041|NCT02451358|7722951|FG001|Overall Study|Protocol Violation|1
4749042|NCT02451358|7722952|FG002|Overall Study|Protocol Violation|1
4749043|NCT02451358|7722953|FG003|Overall Study|Protocol Violation|0
4657628|NCT02158975|7543539|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1
4657629|NCT02159053|7543547|FG000|Overall Study|Death|2
4657630|NCT02159053|7543548|FG001|Overall Study|Death|0
4657631|NCT02159053|7543549|FG002|Overall Study|Death|1
4657632|NCT02159053|7543547|FG000|Overall Study|Physician Decision|0
4657633|NCT02159053|7543548|FG001|Overall Study|Physician Decision|1
4657634|NCT02159053|7543549|FG002|Overall Study|Physician Decision|1
4657635|NCT02159053|7543547|FG000|Overall Study|Lack of Efficacy|3
4657636|NCT02159053|7543548|FG001|Overall Study|Lack of Efficacy|4
4657637|NCT02159053|7543549|FG002|Overall Study|Lack of Efficacy|7
4657638|NCT02159053|7543547|FG000|Overall Study|Adverse Event|7
4657639|NCT02159053|7543548|FG001|Overall Study|Adverse Event|6
4657640|NCT02159053|7543549|FG002|Overall Study|Adverse Event|5
4657641|NCT02159053|7543547|FG000|Overall Study|Participants/guardian decision|8
4657642|NCT02159053|7543548|FG001|Overall Study|Participants/guardian decision|10
4657643|NCT02159053|7543549|FG002|Overall Study|Participants/guardian decision|6
4657644|NCT02159183|7543579|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2
4657645|NCT02159183|7543580|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1
4657646|NCT02159183|7543579|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1
4657647|NCT02159183|7543580|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0
4657648|NCT02159183|7543579|FG000|Analysis After the 36 Months Follow-up|Death|0
4657649|NCT02159183|7543580|FG001|Analysis After the 36 Months Follow-up|Death|1
4657650|NCT02159183|7543579|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1
4657651|NCT02159183|7543580|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0
4657652|NCT02159183|7543579|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2
4657653|NCT02159183|7543580|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1
4657654|NCT02159352|7543588|FG000|Overall Study|Adverse Event|3
4657655|NCT02159352|7543589|FG001|Overall Study|Adverse Event|1
4657656|NCT02159352|7543588|FG000|Overall Study|Withdrawal by Subject|0
4657657|NCT02159352|7543589|FG001|Overall Study|Withdrawal by Subject|1
4657658|NCT02159365|7543614|FG000|Overall Study|Disease Progression|23
4657659|NCT02159365|7543614|FG000|Overall Study|Other reasons|11
4657660|NCT02159365|7543614|FG000|Overall Study|Administrative reason by Sponsor|9
4657661|NCT02159365|7543614|FG000|Overall Study|Adverse Event unrelated to study drug|9
4657662|NCT02159365|7543614|FG000|Overall Study|Study drug toxicity|7
4657663|NCT02159365|7543614|FG000|Overall Study|Maximum clinical benefit|3
4657664|NCT02159365|7543614|FG000|Overall Study|Subject request to discontinue treatment|3
4657665|NCT02159365|7543614|FG000|Overall Study|Subject withdrew consent|3
4657666|NCT02159365|7543614|FG000|Overall Study|Death|1
4657667|NCT02159365|7543614|FG000|Overall Study|Lost to Follow-up|1
4657668|NCT02159469|7543618|FG000|Overall Study|Missing Completion status|1
4657669|NCT02159469|7543618|FG000|Overall Study|Adverse Event|5
4657670|NCT02159469|7543618|FG000|Overall Study|Non-compliance|2
4657671|NCT02159469|7543618|FG000|Overall Study|Withdrawal by Subject|9
4657672|NCT02159469|7543618|FG000|Overall Study|Lost to Follow-up|1
4657673|NCT02159469|7543618|FG000|Overall Study|Sponsor's request|2
4657674|NCT02159469|7543618|FG000|Overall Study|Met Stopping Criteria|3
4657675|NCT02159469|7543618|FG000|Overall Study|Other|1
4657676|NCT02159469|7543618|FG000|Overall Study|Multiple|29
4657677|NCT02159482|7543623|FG000|Overall Study|Withdrawal by Subject|2
4657678|NCT02159482|7543623|FG000|Overall Study|Physician Decision|3
4657679|NCT02159521|7543627|FG000|Overall Study|Enrolled but not treated|3
4657680|NCT02159521|7543627|FG000|Overall Study|Withdrawal by Subject|7
4657681|NCT02159521|7543627|FG000|Overall Study|Lost to Follow-up|6
4657682|NCT02159521|7543627|FG000|Overall Study|Death|1
4657683|NCT02159521|7543627|FG000|Overall Study|Other than specified|1
4749044|NCT02178709|7722972|FG000|Overall Study|Adverse Event|5
4749045|NCT02178709|7722972|FG000|Overall Study|Death|2
4749046|NCT02178709|7722972|FG000|Overall Study|Withdrawal by Subject|2
4749047|NCT02178709|7722972|FG000|Overall Study|Physician Decision|2
4749048|NCT02178709|7722972|FG000|Overall Study|Disease Progression|5
4749049|NCT01980017|7722982|FG000|Overall Study|Lost to Follow-up|30
4749050|NCT01980017|7722983|FG001|Overall Study|Lost to Follow-up|21
4749051|NCT01980017|7722982|FG000|Overall Study|Death|0
4749052|NCT01980017|7722983|FG001|Overall Study|Death|1
4749053|NCT01890759|7722994|FG000|Overall Study|Protocol Violation|0
4749054|NCT01890759|7722995|FG001|Overall Study|Protocol Violation|2
4749055|NCT01890759|7722994|FG000|Overall Study|Lost to Follow-up|0
4749056|NCT01890759|7722995|FG001|Overall Study|Lost to Follow-up|2
4749057|NCT01890759|7722994|FG000|Overall Study|Withdrawal by Subject|2
4749058|NCT01890759|7722995|FG001|Overall Study|Withdrawal by Subject|8
4749059|NCT01721746|7723008|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0
4749060|NCT01721746|7723009|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13
4749061|NCT01721746|7723008|FG000|Pre-Treatment|Withdrawal by Subject|1
4749062|NCT01721746|7723009|FG001|Pre-Treatment|Withdrawal by Subject|16
4749063|NCT01721746|7723008|FG000|Pre-Treatment|Poor/Non-compliance|1
4749064|NCT01721746|7723009|FG001|Pre-Treatment|Poor/Non-compliance|0
4749065|NCT01721746|7723008|FG000|Pre-Treatment|Participant no longer met study criteria|2
4749066|NCT01721746|7723009|FG001|Pre-Treatment|Participant no longer met study criteria|2
4749067|NCT01721746|7723008|FG000|Treatment|Disease Progression|192
4749068|NCT01721746|7723009|FG001|Treatment|Disease Progression|74
4749069|NCT01721746|7723008|FG000|Treatment|Study Drug Toxicity|19
4657684|NCT02159729|7543647|FG000|Overall Study|Adverse Event|0
4657685|NCT02159729|7543648|FG001|Overall Study|Adverse Event|1
4657686|NCT02159729|7543647|FG000|Overall Study|Subject's Request|13
4657687|NCT02159729|7543648|FG001|Overall Study|Subject's Request|10
4657688|NCT02159729|7543647|FG000|Overall Study|Lost to Follow-up|24
4657689|NCT02159729|7543648|FG001|Overall Study|Lost to Follow-up|9
4657690|NCT02159729|7543647|FG000|Overall Study|Non compliance|2
4657691|NCT02159729|7543648|FG001|Overall Study|Non compliance|0
4657692|NCT02159729|7543647|FG000|Overall Study|Other Unspecified|3
4657693|NCT02159729|7543648|FG001|Overall Study|Other Unspecified|1
4749070|NCT01721746|7723009|FG001|Treatment|Study Drug Toxicity|11
4749071|NCT01721746|7723008|FG000|Treatment|Adverse Event unrelated to Study Drug|6
4749072|NCT01721746|7723009|FG001|Treatment|Adverse Event unrelated to Study Drug|3
4749073|NCT01721746|7723008|FG000|Treatment|Participant request to discontinue Study treatment|26
4749074|NCT01721746|7723009|FG001|Treatment|Participant request to discontinue Study treatment|7
4749075|NCT01721746|7723008|FG000|Treatment|Participant withdrew consent|4
4749076|NCT01721746|7723009|FG001|Treatment|Participant withdrew consent|2
4749077|NCT01721746|7723008|FG000|Treatment|Maximum Clinical Benefit|9
4749078|NCT01721746|7723009|FG001|Treatment|Maximum Clinical Benefit|3
4749079|NCT01721746|7723008|FG000|Treatment|Poor/Non-compliance|2
4749080|NCT01721746|7723009|FG001|Treatment|Poor/Non-compliance|0
4749081|NCT01721746|7723008|FG000|Treatment|Participant no longer met Study criteria|4
4749082|NCT01721746|7723009|FG001|Treatment|Participant no longer met Study criteria|0
4749083|NCT01721746|7723008|FG000|Treatment|Other reasons|6
4749084|NCT01721746|7723009|FG001|Treatment|Other reasons|2
4749085|NCT01705977|7723018|FG000|Overall Study|Withdrawal by Subject|128
4749086|NCT01705977|7723019|FG001|Overall Study|Withdrawal by Subject|128
4749087|NCT01705977|7723018|FG000|Overall Study|Adverse Event|57
4749088|NCT01705977|7723019|FG001|Overall Study|Adverse Event|49
4749089|NCT01705977|7723018|FG000|Overall Study|Protocol Violation|2
4749090|NCT01705977|7723019|FG001|Overall Study|Protocol Violation|4
4749091|NCT01705977|7723018|FG000|Overall Study|Site closure|3
4749092|NCT01705977|7723019|FG001|Overall Study|Site closure|2
4749093|NCT01705977|7723018|FG000|Overall Study|Lost to Follow-up|33
4749094|NCT01705977|7723019|FG001|Overall Study|Lost to Follow-up|37
4749095|NCT01705977|7723018|FG000|Overall Study|Physician Decision|48
4749096|NCT01705977|7723019|FG001|Overall Study|Physician Decision|38
4749097|NCT01705977|7723018|FG000|Overall Study|Missing study conclusion form|2
4749098|NCT01705977|7723019|FG001|Overall Study|Missing study conclusion form|2
4749099|NCT01587040|7723029|FG000|Overall Study|Protocol Violation|0
4749100|NCT01587040|7723030|FG001|Overall Study|Protocol Violation|0
4749101|NCT01587040|7723031|FG002|Overall Study|Protocol Violation|1
4749102|NCT01587040|7723032|FG003|Overall Study|Protocol Violation|0
4749103|NCT01587040|7723029|FG000|Overall Study|Adverse Event|0
4749104|NCT01587040|7723030|FG001|Overall Study|Adverse Event|1
4749105|NCT01587040|7723031|FG002|Overall Study|Adverse Event|10
4749106|NCT01587040|7723032|FG003|Overall Study|Adverse Event|0
4657694|NCT02159807|7543661|FG000|Overall Study|Adverse Event|0
4657695|NCT02159807|7543662|FG001|Overall Study|Adverse Event|0
4657696|NCT02159807|7543663|FG002|Overall Study|Adverse Event|1
4657697|NCT02159807|7543661|FG000|Overall Study|No CSF|1
4657698|NCT02159807|7543662|FG001|Overall Study|No CSF|1
4657699|NCT02159807|7543663|FG002|Overall Study|No CSF|1
4657700|NCT02159807|7543661|FG000|Overall Study|elevated blood pressure|0
4657701|NCT02159807|7543662|FG001|Overall Study|elevated blood pressure|0
4657702|NCT02159807|7543663|FG002|Overall Study|elevated blood pressure|1
4657703|NCT02159950|7543692|FG000|Overall Study|Adverse Event|0
4657704|NCT02159950|7543693|FG001|Overall Study|Adverse Event|1
4657705|NCT02159950|7543692|FG000|Overall Study|Progression|0
4657706|NCT02159950|7543693|FG001|Overall Study|Progression|1
4657707|NCT02160002|7543712|FG000|Overall Study|Withdrawal by Subject|2
4657708|NCT02160002|7543713|FG001|Overall Study|Withdrawal by Subject|1
4657709|NCT02160041|7543719|FG000|Overall Study|Adverse Event|11
4657710|NCT02160041|7543719|FG000|Overall Study|Death|2
4657711|NCT02160041|7543719|FG000|Overall Study|disease progression|57
4657712|NCT02160041|7543719|FG000|Overall Study|Protocol Violation|1
4657713|NCT02160041|7543719|FG000|Overall Study|non-compliance with study|1
4657714|NCT02160041|7543719|FG000|Overall Study|Physician Decision|3
4657715|NCT02160041|7543719|FG000|Overall Study|Withdrawal by Subject|8
4657716|NCT02160041|7543719|FG000|Overall Study|study terminated by by sponsor|1
4657717|NCT02160145|7543725|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23
4657718|NCT02160145|7543726|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0
4657719|NCT02160145|7543727|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0
4657720|NCT02160145|7543725|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126
4657721|NCT02160145|7543726|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0
4657722|NCT02160145|7543727|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0
4749107|NCT01587040|7723029|FG000|Overall Study|Disease progression|12
4749108|NCT01587040|7723030|FG001|Overall Study|Disease progression|1
4749109|NCT01587040|7723031|FG002|Overall Study|Disease progression|15
4749110|NCT01587040|7723032|FG003|Overall Study|Disease progression|3
4749111|NCT01587040|7723029|FG000|Overall Study|Other than specified|5
4749112|NCT01587040|7723030|FG001|Overall Study|Other than specified|1
4657723|NCT02160145|7543725|FG000|Randomized Double-blind Period|Subject decision|0
4657724|NCT02160145|7543726|FG001|Randomized Double-blind Period|Subject decision|21
4657725|NCT02160145|7543727|FG002|Randomized Double-blind Period|Subject decision|20
4657726|NCT02160145|7543725|FG000|Randomized Double-blind Period|Lost to Follow-up|0
4657727|NCT02160145|7543726|FG001|Randomized Double-blind Period|Lost to Follow-up|1
4657728|NCT02160145|7543727|FG002|Randomized Double-blind Period|Lost to Follow-up|3
4657729|NCT02160145|7543725|FG000|Randomized Double-blind Period|Physician Decision|0
4657730|NCT02160145|7543726|FG001|Randomized Double-blind Period|Physician Decision|7
4657731|NCT02160145|7543727|FG002|Randomized Double-blind Period|Physician Decision|5
4657732|NCT02160314|7543745|FG000|Overall Study|Adverse Event|0
4657733|NCT02160314|7543746|FG001|Overall Study|Adverse Event|6
4657734|NCT02160314|7543745|FG000|Overall Study|Protocol Violation|0
4657735|NCT02160314|7543746|FG001|Overall Study|Protocol Violation|4
4657736|NCT02160314|7543745|FG000|Overall Study|Withdrawal by Subject|1
4657737|NCT02160314|7543746|FG001|Overall Study|Withdrawal by Subject|2
4657738|NCT02160314|7543745|FG000|Overall Study|Lost to Follow-up|0
4657739|NCT02160314|7543746|FG001|Overall Study|Lost to Follow-up|1
4657740|NCT02160626|7543759|FG000|Overall Study|Adverse Event|1
4657741|NCT02160626|7543760|FG001|Overall Study|Adverse Event|0
4657742|NCT02160626|7543761|FG002|Overall Study|Adverse Event|0
4657743|NCT02160626|7543759|FG000|Overall Study|Schedule not conducive to study visits|0
4657744|NCT02160626|7543760|FG001|Overall Study|Schedule not conducive to study visits|0
4657745|NCT02160626|7543761|FG002|Overall Study|Schedule not conducive to study visits|1
4657746|NCT02160626|7543759|FG000|Overall Study|Withdrawal by Subject|0
4657747|NCT02160626|7543760|FG001|Overall Study|Withdrawal by Subject|1
4657748|NCT02160626|7543761|FG002|Overall Study|Withdrawal by Subject|0
4657749|NCT02160782|7543776|FG000|Open-label Period: Maralixibat|Adverse Event|2
4657750|NCT02160782|7543777|FG001|Open-label Period: Maralixibat|Adverse Event|0
4657751|NCT02160782|7543778|FG002|Open-label Period: Maralixibat|Adverse Event|0
4657752|NCT02160782|7543779|FG003|Open-label Period: Maralixibat|Adverse Event|0
4657753|NCT02160782|7543780|FG004|Open-label Period: Maralixibat|Adverse Event|0
4657754|NCT02160782|7543776|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0
4657755|NCT02160782|7543777|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0
4657756|NCT02160782|7543778|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0
4657757|NCT02160782|7543779|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1
4657758|NCT02160782|7543780|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0
4657759|NCT02160782|7543776|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0
4657760|NCT02160782|7543777|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0
4657761|NCT02160782|7543778|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0
4657762|NCT02160782|7543779|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5
4657763|NCT02160782|7543780|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0
4657764|NCT02160782|7543776|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0
4657765|NCT02160782|7543777|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0
4657766|NCT02160782|7543778|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0
4657767|NCT02160782|7543779|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0
4657768|NCT02160782|7543780|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4
4657769|NCT02160782|7543776|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0
4657770|NCT02160782|7543777|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0
4657771|NCT02160782|7543778|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0
4657772|NCT02160782|7543779|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0
4657773|NCT02160782|7543780|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1
4657774|NCT02160782|7543776|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0
4657775|NCT02160782|7543777|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0
4657776|NCT02160782|7543778|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0
4657777|NCT02160782|7543779|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0
4657778|NCT02160782|7543780|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3
4657779|NCT02160782|7543776|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0
4657780|NCT02160782|7543777|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0
4657781|NCT02160782|7543778|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0
4657782|NCT02160782|7543779|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0
4657783|NCT02160782|7543780|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1
4657784|NCT02160899|7543843|FG000|Overall Study|Adverse Event or Serious Adverse Event|0
4657785|NCT02160899|7543844|FG001|Overall Study|Adverse Event or Serious Adverse Event|1
4657786|NCT02160899|7543845|FG002|Overall Study|Adverse Event or Serious Adverse Event|0
4657787|NCT02160899|7543846|FG003|Overall Study|Adverse Event or Serious Adverse Event|1
4657788|NCT02160899|7543847|FG004|Overall Study|Adverse Event or Serious Adverse Event|2
4657789|NCT02160899|7543848|FG005|Overall Study|Adverse Event or Serious Adverse Event|0
4657790|NCT02160977|7543864|FG000|Six Weeks After Surgery|Lost to Follow-up|1
4657791|NCT02160977|7543865|FG001|Six Weeks After Surgery|Lost to Follow-up|0
4657792|NCT02160977|7543864|FG000|Three Months After Surgery|Lost to Follow-up|0
4657793|NCT02160977|7543865|FG001|Three Months After Surgery|Lost to Follow-up|2
4657794|NCT02160977|7543864|FG000|Six Months After Surgery|Lost to Follow-up|2
4657795|NCT02160977|7543865|FG001|Six Months After Surgery|Lost to Follow-up|1
4657796|NCT02161146|7543894|FG000|Overall Study|Adverse Event|1
4657797|NCT02161146|7543895|FG001|Overall Study|Adverse Event|1
4657798|NCT02161146|7543896|FG002|Overall Study|Adverse Event|0
4657799|NCT02161146|7543897|FG003|Overall Study|Adverse Event|1
4749113|NCT01587040|7723031|FG002|Overall Study|Other than specified|11
4749114|NCT01587040|7723032|FG003|Overall Study|Other than specified|1
4749115|NCT01254409|7723050|FG000|Overall Study|Adverse Event|0
4749116|NCT01254409|7723051|FG001|Overall Study|Adverse Event|1
4749117|NCT01254409|7723052|FG002|Overall Study|Adverse Event|0
4749118|NCT01254409|7723053|FG003|Overall Study|Adverse Event|0
4749119|NCT01253161|7723066|FG000|Overall Study|Adverse Event|1
4749120|NCT01084252|7723084|FG000|Phase 1 (120 Weeks)|Adverse Event|0
4749121|NCT01084252|7723085|FG001|Phase 1 (120 Weeks)|Adverse Event|0
4749122|NCT01084252|7723086|FG002|Phase 1 (120 Weeks)|Adverse Event|1
4749123|NCT01084252|7723087|FG003|Phase 1 (120 Weeks)|Adverse Event|1
4749124|NCT01084252|7723088|FG004|Phase 1 (120 Weeks)|Adverse Event|1
4749125|NCT01084252|7723089|FG005|Phase 1 (120 Weeks)|Adverse Event|0
4749126|NCT01084252|7723090|FG006|Phase 1 (120 Weeks)|Adverse Event|1
4749127|NCT01084252|7723091|FG007|Phase 1 (120 Weeks)|Adverse Event|0
4749128|NCT01084252|7723092|FG008|Phase 1 (120 Weeks)|Adverse Event|0
4749129|NCT01084252|7723093|FG009|Phase 1 (120 Weeks)|Adverse Event|0
4749130|NCT01084252|7723094|FG010|Phase 1 (120 Weeks)|Adverse Event|0
4749131|NCT01084252|7723095|FG011|Phase 1 (120 Weeks)|Adverse Event|0
4749132|NCT01084252|7723096|FG012|Phase 1 (120 Weeks)|Adverse Event|0
4749133|NCT01084252|7723097|FG013|Phase 1 (120 Weeks)|Adverse Event|0
4749134|NCT01084252|7723084|FG000|Phase 1 (120 Weeks)|Progressive disease|15
4749135|NCT01084252|7723085|FG001|Phase 1 (120 Weeks)|Progressive disease|5
4749136|NCT01084252|7723086|FG002|Phase 1 (120 Weeks)|Progressive disease|2
4749137|NCT01084252|7723087|FG003|Phase 1 (120 Weeks)|Progressive disease|22
4749138|NCT01084252|7723088|FG004|Phase 1 (120 Weeks)|Progressive disease|16
4749139|NCT01084252|7723089|FG005|Phase 1 (120 Weeks)|Progressive disease|6
4749140|NCT01084252|7723090|FG006|Phase 1 (120 Weeks)|Progressive disease|5
4749141|NCT01084252|7723091|FG007|Phase 1 (120 Weeks)|Progressive disease|6
4749142|NCT01084252|7723092|FG008|Phase 1 (120 Weeks)|Progressive disease|0
4749143|NCT01084252|7723093|FG009|Phase 1 (120 Weeks)|Progressive disease|0
4749144|NCT01084252|7723094|FG010|Phase 1 (120 Weeks)|Progressive disease|0
4749145|NCT01084252|7723095|FG011|Phase 1 (120 Weeks)|Progressive disease|0
4749146|NCT01084252|7723096|FG012|Phase 1 (120 Weeks)|Progressive disease|0
4749147|NCT01084252|7723097|FG013|Phase 1 (120 Weeks)|Progressive disease|0
4749148|NCT01084252|7723084|FG000|Phase 1 (120 Weeks)|Other than specified above|1
4749149|NCT01084252|7723085|FG001|Phase 1 (120 Weeks)|Other than specified above|1
4749150|NCT01084252|7723086|FG002|Phase 1 (120 Weeks)|Other than specified above|0
4749151|NCT01084252|7723087|FG003|Phase 1 (120 Weeks)|Other than specified above|3
4749152|NCT01084252|7723088|FG004|Phase 1 (120 Weeks)|Other than specified above|1
4749153|NCT01084252|7723089|FG005|Phase 1 (120 Weeks)|Other than specified above|0
4749154|NCT01084252|7723090|FG006|Phase 1 (120 Weeks)|Other than specified above|1
4749155|NCT01084252|7723091|FG007|Phase 1 (120 Weeks)|Other than specified above|1
4749156|NCT01084252|7723092|FG008|Phase 1 (120 Weeks)|Other than specified above|0
4749157|NCT01084252|7723093|FG009|Phase 1 (120 Weeks)|Other than specified above|0
4749158|NCT01084252|7723094|FG010|Phase 1 (120 Weeks)|Other than specified above|0
4749159|NCT01084252|7723095|FG011|Phase 1 (120 Weeks)|Other than specified above|0
4749160|NCT01084252|7723096|FG012|Phase 1 (120 Weeks)|Other than specified above|0
4749161|NCT01084252|7723097|FG013|Phase 1 (120 Weeks)|Other than specified above|0
4749162|NCT01084252|7723084|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
4749163|NCT01084252|7723085|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
4749164|NCT01084252|7723086|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
4749165|NCT01084252|7723087|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
4749166|NCT01084252|7723088|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
4749167|NCT01084252|7723089|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
4657800|NCT02161146|7543898|FG004|Overall Study|Adverse Event|0
4657801|NCT02161146|7543894|FG000|Overall Study|Lost to Follow-up|0
4657802|NCT02161146|7543895|FG001|Overall Study|Lost to Follow-up|1
4657803|NCT02161146|7543896|FG002|Overall Study|Lost to Follow-up|0
4657804|NCT02161146|7543897|FG003|Overall Study|Lost to Follow-up|0
4657805|NCT02161146|7543898|FG004|Overall Study|Lost to Follow-up|0
4657806|NCT02161146|7543894|FG000|Overall Study|Personal Reasons|0
4657807|NCT02161146|7543895|FG001|Overall Study|Personal Reasons|1
4657808|NCT02161146|7543896|FG002|Overall Study|Personal Reasons|0
4657809|NCT02161146|7543897|FG003|Overall Study|Personal Reasons|2
4657810|NCT02161146|7543898|FG004|Overall Study|Personal Reasons|1
4657811|NCT02161146|7543894|FG000|Overall Study|Other Miscellaneous Reasons|0
4657812|NCT02161146|7543895|FG001|Overall Study|Other Miscellaneous Reasons|1
4749168|NCT01084252|7723090|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
4749169|NCT01084252|7723091|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
4749170|NCT01084252|7723092|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
4749171|NCT01084252|7723093|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|2
4657813|NCT02161146|7543896|FG002|Overall Study|Other Miscellaneous Reasons|0
4657814|NCT02161146|7543897|FG003|Overall Study|Other Miscellaneous Reasons|0
4657815|NCT02161146|7543898|FG004|Overall Study|Other Miscellaneous Reasons|0
4657816|NCT02161185|7543908|FG000|Treatment Phase|Administrative/Other|7
4657817|NCT02161406|7543914|FG000|Overall Study|Death|2
4657818|NCT02161406|7543915|FG001|Overall Study|Death|1
4657819|NCT02161406|7543914|FG000|Overall Study|Lost to Follow-up|2
4657820|NCT02161406|7543915|FG001|Overall Study|Lost to Follow-up|1
4657821|NCT02161406|7543914|FG000|Overall Study|Withdrawal by Subject|2
4657822|NCT02161406|7543915|FG001|Overall Study|Withdrawal by Subject|4
4657823|NCT02161406|7543914|FG000|Overall Study|investigator withdrew subject|3
4657824|NCT02161406|7543915|FG001|Overall Study|investigator withdrew subject|1
4657825|NCT02161406|7543914|FG000|Overall Study|Lack of Efficacy|1
4657826|NCT02161406|7543915|FG001|Overall Study|Lack of Efficacy|1
4657827|NCT02161406|7543914|FG000|Overall Study|relocation|0
4657828|NCT02161406|7543915|FG001|Overall Study|relocation|1
4657829|NCT02161458|7543925|FG000|Overall Study|Withdrawal by Subject|0
4657830|NCT02161458|7543926|FG001|Overall Study|Withdrawal by Subject|4
4657831|NCT02161458|7543927|FG002|Overall Study|Withdrawal by Subject|4
4657832|NCT02161458|7543928|FG003|Overall Study|Withdrawal by Subject|0
4657833|NCT02161458|7543925|FG000|Overall Study|Lost to Follow-up|0
4657834|NCT02161458|7543926|FG001|Overall Study|Lost to Follow-up|2
4657835|NCT02161458|7543927|FG002|Overall Study|Lost to Follow-up|1
4657836|NCT02161458|7543928|FG003|Overall Study|Lost to Follow-up|0
4657837|NCT02161549|7543962|FG000|Overall Study|Physician Decision|6
4657838|NCT02161549|7543963|FG001|Overall Study|Physician Decision|2
4657839|NCT02161562|7543971|FG000|Overall Study|Withdrawal by Subject|5
4657840|NCT02161562|7543972|FG001|Overall Study|Withdrawal by Subject|8
4657841|NCT02161562|7543971|FG000|Overall Study|Protocol Violation|9
4657842|NCT02161562|7543972|FG001|Overall Study|Protocol Violation|4
4657843|NCT02161562|7543971|FG000|Overall Study|Pregnancy|1
4657844|NCT02161562|7543972|FG001|Overall Study|Pregnancy|2
4657845|NCT02161562|7543971|FG000|Overall Study|Lost to Follow-up|3
4657846|NCT02161562|7543972|FG001|Overall Study|Lost to Follow-up|1
4657847|NCT02161562|7543971|FG000|Overall Study|Lack of Efficacy|4
4657848|NCT02161562|7543972|FG001|Overall Study|Lack of Efficacy|1
4657849|NCT02161562|7543971|FG000|Overall Study|Adverse Event|1
4657850|NCT02161562|7543972|FG001|Overall Study|Adverse Event|1
4657851|NCT02161562|7543971|FG000|Overall Study|Participant moved back to home country|1
4657852|NCT02161562|7543972|FG001|Overall Study|Participant moved back to home country|0
4657853|NCT02161562|7543971|FG000|Overall Study|Withdrew due to being out of the country|1
4657854|NCT02161562|7543972|FG001|Overall Study|Withdrew due to being out of the country|0
4657855|NCT02161562|7543971|FG000|Overall Study|Participant moved out of province|1
4657856|NCT02161562|7543972|FG001|Overall Study|Participant moved out of province|0
4657857|NCT02161575|7543991|FG000|Overall Study|Protocol Violation|8
4657858|NCT02161575|7543991|FG000|Overall Study|Lack of Efficacy|1
4657859|NCT02161575|7543991|FG000|Overall Study|Adverse Event|2
4657860|NCT02161718|7544006|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2
4657861|NCT02161718|7544007|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0
4657862|NCT02161718|7544008|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0
4657863|NCT02161718|7544006|FG000|Open-Label ALKS 3831 Period|Physician Decision|1
4657864|NCT02161718|7544007|FG001|Open-Label ALKS 3831 Period|Physician Decision|0
4657865|NCT02161718|7544008|FG002|Open-Label ALKS 3831 Period|Physician Decision|0
4657866|NCT02161718|7544006|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1
4657867|NCT02161718|7544007|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0
4657868|NCT02161718|7544008|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0
4749172|NCT01084252|7723094|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|2
4749173|NCT01084252|7723095|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|1
4749174|NCT01084252|7723096|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
4749175|NCT01084252|7723097|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
4749176|NCT01084252|7723084|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
4749177|NCT01084252|7723085|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
4749178|NCT01084252|7723086|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
4749179|NCT01084252|7723087|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
4749180|NCT01084252|7723088|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
4749181|NCT01084252|7723089|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
4749182|NCT01084252|7723090|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
4749183|NCT01084252|7723091|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
4749184|NCT01084252|7723092|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|20
4749185|NCT01084252|7723093|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|18
4749186|NCT01084252|7723094|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|17
4749187|NCT01084252|7723095|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|19
4657869|NCT02161718|7544006|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1
4657870|NCT02161718|7544007|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0
4657871|NCT02161718|7544008|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0
4657872|NCT02161718|7544006|FG000|Open-Label ALKS 3831 Period|Adverse Event|3
4657873|NCT02161718|7544007|FG001|Open-Label ALKS 3831 Period|Adverse Event|0
4657874|NCT02161718|7544008|FG002|Open-Label ALKS 3831 Period|Adverse Event|0
4657875|NCT02161718|7544006|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4
4657876|NCT02161718|7544007|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0
4657877|NCT02161718|7544008|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0
4657878|NCT02161718|7544006|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3
4657879|NCT02161718|7544007|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0
4657880|NCT02161718|7544008|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0
4657881|NCT02161718|7544006|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6
4657882|NCT02161718|7544007|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0
4657883|NCT02161718|7544008|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0
4657884|NCT02161718|7544006|FG000|Post- Randomization Period|Withdrawal by Subject|0
4657885|NCT02161718|7544007|FG001|Post- Randomization Period|Withdrawal by Subject|23
4657886|NCT02161718|7544008|FG002|Post- Randomization Period|Withdrawal by Subject|18
4657887|NCT02161718|7544006|FG000|Post- Randomization Period|Lost to Follow-up|0
4657888|NCT02161718|7544007|FG001|Post- Randomization Period|Lost to Follow-up|9
4657889|NCT02161718|7544008|FG002|Post- Randomization Period|Lost to Follow-up|15
4657890|NCT02161718|7544006|FG000|Post- Randomization Period|Adverse Event|0
4657891|NCT02161718|7544007|FG001|Post- Randomization Period|Adverse Event|9
4657892|NCT02161718|7544008|FG002|Post- Randomization Period|Adverse Event|10
4657893|NCT02161718|7544006|FG000|Post- Randomization Period|Non- compliance with study drug|0
4657894|NCT02161718|7544007|FG001|Post- Randomization Period|Non- compliance with study drug|8
4657895|NCT02161718|7544008|FG002|Post- Randomization Period|Non- compliance with study drug|2
4657896|NCT02161718|7544006|FG000|Post- Randomization Period|Physician Decision|0
4657897|NCT02161718|7544007|FG001|Post- Randomization Period|Physician Decision|2
4657898|NCT02161718|7544008|FG002|Post- Randomization Period|Physician Decision|4
4657899|NCT02161718|7544006|FG000|Post- Randomization Period|Protocol Violation|0
4657900|NCT02161718|7544007|FG001|Post- Randomization Period|Protocol Violation|2
4657901|NCT02161718|7544008|FG002|Post- Randomization Period|Protocol Violation|3
4657902|NCT02161718|7544006|FG000|Post- Randomization Period|Lack of Efficacy|0
4657903|NCT02161718|7544007|FG001|Post- Randomization Period|Lack of Efficacy|0
4657904|NCT02161718|7544008|FG002|Post- Randomization Period|Lack of Efficacy|1
4657905|NCT02161718|7544006|FG000|Post- Randomization Period|Non-compliance with study procedures|0
4657906|NCT02161718|7544007|FG001|Post- Randomization Period|Non-compliance with study procedures|2
4657907|NCT02161718|7544008|FG002|Post- Randomization Period|Non-compliance with study procedures|4
4657908|NCT02161718|7544006|FG000|Post- Randomization Period|Received prohibitive treatment|0
4657909|NCT02161718|7544007|FG001|Post- Randomization Period|Received prohibitive treatment|1
4657910|NCT02161718|7544008|FG002|Post- Randomization Period|Received prohibitive treatment|2
4749188|NCT01084252|7723096|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
4749189|NCT01084252|7723097|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
4749190|NCT01084252|7723084|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
4749191|NCT01084252|7723085|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
4749192|NCT01084252|7723086|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
4749193|NCT01084252|7723087|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
4749194|NCT01084252|7723088|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
4749195|NCT01084252|7723089|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
4749196|NCT01084252|7723090|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
4749197|NCT01084252|7723091|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
4749198|NCT01084252|7723092|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|2
4749199|NCT01084252|7723093|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
4749200|NCT01084252|7723094|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|4
4749201|NCT01084252|7723095|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|3
4749202|NCT01084252|7723096|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
4749203|NCT01084252|7723097|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
4749204|NCT01084252|7723084|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
4749205|NCT01084252|7723085|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
4749206|NCT01084252|7723086|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
4749207|NCT01084252|7723087|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
4749208|NCT01084252|7723088|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
4749209|NCT01084252|7723089|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
4749210|NCT01084252|7723090|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
4749211|NCT01084252|7723091|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
4749212|NCT01084252|7723092|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|1
4749213|NCT01084252|7723093|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|4
4749214|NCT01084252|7723094|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|2
4749215|NCT01084252|7723095|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|2
4749216|NCT01084252|7723096|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
4749217|NCT01084252|7723097|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
4749218|NCT01084252|7723084|FG000|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
4749219|NCT01084252|7723085|FG001|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
4657911|NCT02161718|7544006|FG000|Post- Randomization Period|Relocation|0
4657912|NCT02161718|7544007|FG001|Post- Randomization Period|Relocation|3
4657913|NCT02161718|7544008|FG002|Post- Randomization Period|Relocation|0
4657914|NCT02161731|7544015|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0
4657915|NCT02161731|7544016|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1
4657916|NCT02161731|7544015|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0
4657917|NCT02161731|7544016|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1
4657918|NCT02161757|7544026|FG000|Randomised Through Start Treatment|Did not receive treatment|3
4657919|NCT02161757|7544027|FG001|Randomised Through Start Treatment|Did not receive treatment|2
4657920|NCT02161757|7544028|FG002|Randomised Through Start Treatment|Did not receive treatment|0
4657921|NCT02161757|7544026|FG000|Treatment Through Study Completion|Adverse Event|1
4657922|NCT02161757|7544027|FG001|Treatment Through Study Completion|Adverse Event|1
4657923|NCT02161757|7544028|FG002|Treatment Through Study Completion|Adverse Event|0
4657924|NCT02161757|7544026|FG000|Treatment Through Study Completion|Protocol Violation|0
4657925|NCT02161757|7544027|FG001|Treatment Through Study Completion|Protocol Violation|1
4657926|NCT02161757|7544028|FG002|Treatment Through Study Completion|Protocol Violation|2
4657927|NCT02161757|7544026|FG000|Treatment Through Study Completion|Withdrawal by Subject|27
4657928|NCT02161757|7544027|FG001|Treatment Through Study Completion|Withdrawal by Subject|19
4657929|NCT02161757|7544028|FG002|Treatment Through Study Completion|Withdrawal by Subject|20
4657930|NCT02161757|7544026|FG000|Treatment Through Study Completion|Lost to Follow-up|7
4657931|NCT02161757|7544027|FG001|Treatment Through Study Completion|Lost to Follow-up|2
4657932|NCT02161757|7544028|FG002|Treatment Through Study Completion|Lost to Follow-up|4
4657933|NCT02161757|7544026|FG000|Treatment Through Study Completion|Other|20
4657934|NCT02161757|7544027|FG001|Treatment Through Study Completion|Other|19
4657935|NCT02161757|7544028|FG002|Treatment Through Study Completion|Other|12
4657936|NCT02161757|7544026|FG000|Treatment Through Study Completion|Death|2
4657937|NCT02161757|7544027|FG001|Treatment Through Study Completion|Death|1
4657938|NCT02161757|7544028|FG002|Treatment Through Study Completion|Death|1
4657939|NCT02162719|7544095|FG000|Overall Study|Death|41
4657940|NCT02162719|7544096|FG001|Overall Study|Death|46
4657941|NCT02162719|7544095|FG000|Overall Study|Lost to Follow-up|1
4657942|NCT02162719|7544096|FG001|Overall Study|Lost to Follow-up|3
4657943|NCT02162719|7544095|FG000|Overall Study|Disease Progression|2
4657944|NCT02162719|7544096|FG001|Overall Study|Disease Progression|1
4657945|NCT02162719|7544095|FG000|Overall Study|Withdrawal by Subject|8
4657946|NCT02162719|7544096|FG001|Overall Study|Withdrawal by Subject|2
4657947|NCT02162719|7544095|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10
4657948|NCT02162719|7544096|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10
4657949|NCT02162758|7544104|FG000|Overall Study|Study termination|0
4657950|NCT02162758|7544105|FG001|Overall Study|Study termination|1
4657951|NCT02162771|7544113|FG000|Core Study Period (Part 2)|Progressive Disease|2
4657952|NCT02162771|7544114|FG001|Core Study Period (Part 2)|Progressive Disease|3
4657953|NCT02162771|7544113|FG000|Core Study Period (Part 2)|Adverse Event|4
4657954|NCT02162771|7544114|FG001|Core Study Period (Part 2)|Adverse Event|1
4657955|NCT02162771|7544113|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1
4657956|NCT02162771|7544114|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2
4657957|NCT02162771|7544113|FG000|Core Study Period (Part 2)|Physician Decision|0
4657958|NCT02162771|7544114|FG001|Core Study Period (Part 2)|Physician Decision|2
4657959|NCT02162771|7544113|FG000|Core Study Period (Part 2)|Death|1
4657960|NCT02162771|7544114|FG001|Core Study Period (Part 2)|Death|0
4657961|NCT02162771|7544113|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11
4657962|NCT02162771|7544114|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13
4657963|NCT02162771|7544113|FG000|Maintenance Study Period (Part 2)|Adverse Event|3
4749220|NCT01084252|7723086|FG002|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
4749221|NCT01084252|7723087|FG003|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
4749222|NCT01084252|7723088|FG004|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
4749223|NCT01084252|7723089|FG005|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
4749224|NCT01084252|7723090|FG006|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
4749225|NCT01084252|7723091|FG007|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
4749226|NCT01084252|7723092|FG008|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
4749227|NCT01084252|7723093|FG009|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
4749228|NCT01084252|7723094|FG010|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
4749229|NCT01084252|7723095|FG011|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
4749230|NCT01084252|7723096|FG012|Phase 2 Stage 2 (97 Weeks)|Adverse Event|13
4749231|NCT01084252|7723097|FG013|Phase 2 Stage 2 (97 Weeks)|Adverse Event|5
4749232|NCT01084252|7723084|FG000|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
4749233|NCT01084252|7723085|FG001|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
4749234|NCT01084252|7723086|FG002|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
4749235|NCT01084252|7723087|FG003|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
4749236|NCT01084252|7723088|FG004|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
4749237|NCT01084252|7723089|FG005|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
4749238|NCT01084252|7723090|FG006|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
4749239|NCT01084252|7723091|FG007|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
4749240|NCT01084252|7723092|FG008|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
4749241|NCT01084252|7723093|FG009|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
4749242|NCT01084252|7723094|FG010|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
4657964|NCT02162771|7544114|FG001|Maintenance Study Period (Part 2)|Adverse Event|3
4657965|NCT02162771|7544113|FG000|Maintenance Study Period (Part 2)|Death|2
4657966|NCT02162771|7544114|FG001|Maintenance Study Period (Part 2)|Death|1
4657967|NCT02162771|7544113|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0
4657968|NCT02162771|7544114|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3
4657969|NCT02162771|7544113|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0
4657970|NCT02162771|7544114|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1
4657971|NCT02162771|7544113|FG000|Maintenance Study Period (Part 2)|Stable Disease|0
4657972|NCT02162771|7544114|FG001|Maintenance Study Period (Part 2)|Stable Disease|1
4657973|NCT02162862|7544123|FG000|Overall Study|Lost to Follow-up|0
4657974|NCT02162862|7544124|FG001|Overall Study|Lost to Follow-up|11
4657975|NCT02162862|7544125|FG002|Overall Study|Lost to Follow-up|0
4657976|NCT02162862|7544123|FG000|Overall Study|Subject did not feel the med was needed|0
4657977|NCT02162862|7544124|FG001|Overall Study|Subject did not feel the med was needed|0
4657978|NCT02162862|7544125|FG002|Overall Study|Subject did not feel the med was needed|4
4657979|NCT02163057|7544146|FG000|Overall Study|Participant Refusal to Continue|2
4657980|NCT02163057|7544147|FG001|Overall Study|Participant Refusal to Continue|2
4657981|NCT02163057|7544146|FG000|Overall Study|Participant Significant Noncompliance|0
4657982|NCT02163057|7544147|FG001|Overall Study|Participant Significant Noncompliance|1
4657983|NCT02163057|7544146|FG000|Overall Study|Progression of Disease|1
4657984|NCT02163057|7544147|FG001|Overall Study|Progression of Disease|2
4657985|NCT02163226|7544157|FG000|Overall Study|Death|2
4657986|NCT02163226|7544158|FG001|Overall Study|Death|1
4657987|NCT02163226|7544157|FG000|Overall Study|Withdrawal by Subject|5
4657988|NCT02163226|7544158|FG001|Overall Study|Withdrawal by Subject|2
4657989|NCT02163226|7544157|FG000|Overall Study|Returned home, local radiotherapy|3
4657990|NCT02163226|7544158|FG001|Overall Study|Returned home, local radiotherapy|0
4657991|NCT02163226|7544157|FG000|Overall Study|Repeat imaging showed no disease|2
4657992|NCT02163226|7544158|FG001|Overall Study|Repeat imaging showed no disease|0
4657993|NCT02163226|7544157|FG000|Overall Study|Incomplete radiotherapy|3
4657994|NCT02163226|7544158|FG001|Overall Study|Incomplete radiotherapy|0
4657995|NCT02163226|7544157|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1
4657996|NCT02163226|7544158|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0
4657997|NCT02163226|7544157|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0
4657998|NCT02163226|7544158|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5
4657999|NCT02163226|7544157|FG000|Overall Study|ineligible|0
4658000|NCT02163226|7544158|FG001|Overall Study|ineligible|3
4658001|NCT02163395|7544164|FG000|Overall Study|Withdrawal by Subject|1
4658002|NCT02163395|7544164|FG000|Overall Study|Lost to Follow-up|3
4658003|NCT02163395|7544164|FG000|Overall Study|Adverse Event|1
4658004|NCT02163447|7544194|FG000|Overall Study|Withdrawal by Subject|2
4658005|NCT02163447|7544195|FG001|Overall Study|Withdrawal by Subject|0
4658006|NCT02163447|7544196|FG002|Overall Study|Withdrawal by Subject|1
4658007|NCT02163447|7544194|FG000|Overall Study|Lost to Follow-up|1
4658008|NCT02163447|7544195|FG001|Overall Study|Lost to Follow-up|3
4658009|NCT02163447|7544196|FG002|Overall Study|Lost to Follow-up|0
4658010|NCT02163447|7544194|FG000|Overall Study|Moved out of study area|2
4658011|NCT02163447|7544195|FG001|Overall Study|Moved out of study area|3
4658012|NCT02163447|7544196|FG002|Overall Study|Moved out of study area|2
4658013|NCT02163447|7544194|FG000|Overall Study|Became HIV infected at time of delivery|1
4658014|NCT02163447|7544195|FG001|Overall Study|Became HIV infected at time of delivery|0
4658015|NCT02163447|7544196|FG002|Overall Study|Became HIV infected at time of delivery|0
4658016|NCT02163499|7544223|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1
4658017|NCT02163499|7544223|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1
4658018|NCT02163499|7544223|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1
4658019|NCT02163499|7544223|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1
4658020|NCT02163499|7544223|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1
4658021|NCT02163499|7544223|FG000|Extended Dosing Phase: ZS|Adverse Event|51
4658022|NCT02163499|7544223|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40
4658023|NCT02163499|7544223|FG000|Extended Dosing Phase: ZS|Hypokalemia|9
4658024|NCT02163499|7544223|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5
4658025|NCT02163499|7544223|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7
4658026|NCT02163499|7544223|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81
4749243|NCT01084252|7723095|FG011|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
4749244|NCT01084252|7723096|FG012|Phase 2 Stage 2 (97 Weeks)|Progressive disease|70
4749245|NCT01084252|7723097|FG013|Phase 2 Stage 2 (97 Weeks)|Progressive disease|33
4749246|NCT01084252|7723084|FG000|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
4749247|NCT01084252|7723085|FG001|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
4749248|NCT01084252|7723086|FG002|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
4749249|NCT01084252|7723087|FG003|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
4749250|NCT01084252|7723088|FG004|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
4749251|NCT01084252|7723089|FG005|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
4749252|NCT01084252|7723090|FG006|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
4749253|NCT01084252|7723091|FG007|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
4749254|NCT01084252|7723092|FG008|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
4749255|NCT01084252|7723093|FG009|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
4658027|NCT02163499|7544223|FG000|Extended Dosing Phase: ZS|Physician Decision|8
4658028|NCT02163499|7544223|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31
4658029|NCT02163499|7544223|FG000|Extended Dosing Phase: ZS|Protocol Violation|2
4658030|NCT02163499|7544223|FG000|Extended Dosing Phase: ZS|Death|8
4658031|NCT02163499|7544223|FG000|Extended Dosing Phase: ZS|Subject Compliance|17
4658032|NCT02163499|7544223|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5
4658033|NCT02163499|7544223|FG000|Extended Dosing Phase: ZS|Various reasons|16
4658034|NCT02163538|7544233|FG000|Overall Study|Protocol Violation|1
4658035|NCT02163538|7544234|FG001|Overall Study|Protocol Violation|0
4658036|NCT02163538|7544233|FG000|Overall Study|Physician Decision|0
4658037|NCT02163538|7544234|FG001|Overall Study|Physician Decision|1
4658038|NCT02163759|7544252|FG000|Overall Study|Withdrawal by Subject|1
4658039|NCT02163759|7544253|FG001|Overall Study|Withdrawal by Subject|5
4658040|NCT02163759|7544254|FG002|Overall Study|Withdrawal by Subject|1
4658041|NCT02163759|7544252|FG000|Overall Study|Adverse Event|0
4658042|NCT02163759|7544253|FG001|Overall Study|Adverse Event|0
4658043|NCT02163759|7544254|FG002|Overall Study|Adverse Event|1
4658044|NCT02163759|7544252|FG000|Overall Study|Death|0
4658045|NCT02163759|7544253|FG001|Overall Study|Death|0
4658046|NCT02163759|7544254|FG002|Overall Study|Death|1
4658047|NCT02163902|7544293|FG000|Overall Study|Subject's Request|3
4658048|NCT02163902|7544294|FG001|Overall Study|Subject's Request|4
4658049|NCT02163902|7544293|FG000|Overall Study|Lost to Follow-up|6
4658050|NCT02163902|7544294|FG001|Overall Study|Lost to Follow-up|7
4658051|NCT02163902|7544293|FG000|Overall Study|Administrative Decision|2
4658052|NCT02163902|7544294|FG001|Overall Study|Administrative Decision|2
4658053|NCT02163915|7544305|FG000|Overall Study|Withdrawal by Subject|2
4658054|NCT02163915|7544306|FG001|Overall Study|Withdrawal by Subject|0
4658055|NCT02163915|7544307|FG002|Overall Study|Withdrawal by Subject|2
4658056|NCT02163915|7544308|FG003|Overall Study|Withdrawal by Subject|2
4658057|NCT02163915|7544309|FG004|Overall Study|Withdrawal by Subject|2
4658058|NCT02163915|7544305|FG000|Overall Study|Study termination|1
4658059|NCT02163915|7544306|FG001|Overall Study|Study termination|0
4658060|NCT02163915|7544307|FG002|Overall Study|Study termination|0
4658061|NCT02163915|7544308|FG003|Overall Study|Study termination|0
4658062|NCT02163915|7544309|FG004|Overall Study|Study termination|2
4658063|NCT02163915|7544305|FG000|Overall Study|Physician Decision|0
4658064|NCT02163915|7544306|FG001|Overall Study|Physician Decision|0
4658065|NCT02163915|7544307|FG002|Overall Study|Physician Decision|0
4658066|NCT02163915|7544308|FG003|Overall Study|Physician Decision|1
4658067|NCT02163915|7544309|FG004|Overall Study|Physician Decision|0
4658068|NCT02163993|7544346|FG000|Treatment Period|Adverse Event|0
4658069|NCT02163993|7544347|FG001|Treatment Period|Adverse Event|1
4658070|NCT02163993|7544348|FG002|Treatment Period|Adverse Event|0
4658071|NCT02163993|7544349|FG003|Treatment Period|Adverse Event|0
4658072|NCT02163993|7544350|FG004|Treatment Period|Adverse Event|1
4658073|NCT02163993|7544346|FG000|Treatment Period|Lost to Follow-up|2
4658074|NCT02163993|7544347|FG001|Treatment Period|Lost to Follow-up|3
4658075|NCT02163993|7544348|FG002|Treatment Period|Lost to Follow-up|1
4658076|NCT02163993|7544349|FG003|Treatment Period|Lost to Follow-up|3
4658077|NCT02163993|7544350|FG004|Treatment Period|Lost to Follow-up|1
4658078|NCT02163993|7544346|FG000|Treatment Period|Physician Decision|1
4658079|NCT02163993|7544347|FG001|Treatment Period|Physician Decision|0
4658080|NCT02163993|7544348|FG002|Treatment Period|Physician Decision|0
4658081|NCT02163993|7544349|FG003|Treatment Period|Physician Decision|0
4658082|NCT02163993|7544350|FG004|Treatment Period|Physician Decision|0
4658083|NCT02163993|7544346|FG000|Treatment Period|Protocol Violation|2
4658084|NCT02163993|7544347|FG001|Treatment Period|Protocol Violation|1
4658085|NCT02163993|7544348|FG002|Treatment Period|Protocol Violation|0
4658086|NCT02163993|7544349|FG003|Treatment Period|Protocol Violation|1
4658087|NCT02163993|7544350|FG004|Treatment Period|Protocol Violation|2
4658088|NCT02163993|7544346|FG000|Treatment Period|Withdrawal by Subject|6
4658089|NCT02163993|7544347|FG001|Treatment Period|Withdrawal by Subject|4
4658090|NCT02163993|7544348|FG002|Treatment Period|Withdrawal by Subject|1
4658091|NCT02163993|7544349|FG003|Treatment Period|Withdrawal by Subject|4
4658092|NCT02163993|7544350|FG004|Treatment Period|Withdrawal by Subject|1
4658093|NCT02163993|7544346|FG000|Treatment Period|Not treated|1
4658094|NCT02163993|7544347|FG001|Treatment Period|Not treated|0
4658095|NCT02163993|7544348|FG002|Treatment Period|Not treated|0
4658096|NCT02163993|7544349|FG003|Treatment Period|Not treated|1
4658097|NCT02163993|7544350|FG004|Treatment Period|Not treated|2
4658098|NCT02163993|7544346|FG000|Post-treatment Period|Adverse Event|0
4658099|NCT02163993|7544347|FG001|Post-treatment Period|Adverse Event|0
4658100|NCT02163993|7544348|FG002|Post-treatment Period|Adverse Event|1
4658101|NCT02163993|7544349|FG003|Post-treatment Period|Adverse Event|0
4658102|NCT02163993|7544350|FG004|Post-treatment Period|Adverse Event|0
4658103|NCT02163993|7544346|FG000|Post-treatment Period|Lost to Follow-up|2
4658104|NCT02163993|7544347|FG001|Post-treatment Period|Lost to Follow-up|2
4658105|NCT02163993|7544348|FG002|Post-treatment Period|Lost to Follow-up|3
4658106|NCT02163993|7544349|FG003|Post-treatment Period|Lost to Follow-up|1
4658107|NCT02163993|7544350|FG004|Post-treatment Period|Lost to Follow-up|0
4658108|NCT02163993|7544346|FG000|Post-treatment Period|Protocol Violation|0
4658109|NCT02163993|7544347|FG001|Post-treatment Period|Protocol Violation|0
4658110|NCT02163993|7544348|FG002|Post-treatment Period|Protocol Violation|0
4658111|NCT02163993|7544349|FG003|Post-treatment Period|Protocol Violation|0
4658112|NCT02163993|7544350|FG004|Post-treatment Period|Protocol Violation|1
4658113|NCT02163993|7544346|FG000|Post-treatment Period|Withdrawal by Subject|2
4658114|NCT02163993|7544347|FG001|Post-treatment Period|Withdrawal by Subject|4
4658115|NCT02163993|7544348|FG002|Post-treatment Period|Withdrawal by Subject|0
4658116|NCT02163993|7544349|FG003|Post-treatment Period|Withdrawal by Subject|1
4658117|NCT02163993|7544350|FG004|Post-treatment Period|Withdrawal by Subject|2
4658118|NCT02164318|7544386|FG000|Overall Study|Withdrawal by Subject|0
4658119|NCT02164318|7544387|FG001|Overall Study|Withdrawal by Subject|1
4658120|NCT02164318|7544388|FG002|Overall Study|Withdrawal by Subject|0
4658121|NCT02164318|7544389|FG003|Overall Study|Withdrawal by Subject|1
4658122|NCT02164383|7544401|FG000|Overall Study|Lost to Follow-up|1
4658123|NCT02164383|7544402|FG001|Overall Study|Lost to Follow-up|0
4658124|NCT02164513|7544437|FG000|Overall Study|Adverse Event|162
4658125|NCT02164513|7544438|FG001|Overall Study|Adverse Event|180
4658126|NCT02164513|7544439|FG002|Overall Study|Adverse Event|111
4658127|NCT02164513|7544437|FG000|Overall Study|Other: Study Closed or terminated|5
4658128|NCT02164513|7544438|FG001|Overall Study|Other: Study Closed or terminated|2
4658129|NCT02164513|7544439|FG002|Overall Study|Other: Study Closed or terminated|4
4658130|NCT02164513|7544437|FG000|Overall Study|Lost to Follow-up|30
4658131|NCT02164513|7544438|FG001|Overall Study|Lost to Follow-up|36
4658132|NCT02164513|7544439|FG002|Overall Study|Lost to Follow-up|22
4658133|NCT02164513|7544437|FG000|Overall Study|Physician Decision|47
4658134|NCT02164513|7544438|FG001|Overall Study|Physician Decision|57
4658135|NCT02164513|7544439|FG002|Overall Study|Physician Decision|28
4658136|NCT02164513|7544437|FG000|Overall Study|Withdrawal by Subject|192
4658137|NCT02164513|7544438|FG001|Overall Study|Withdrawal by Subject|261
4749256|NCT01084252|7723094|FG010|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
4749257|NCT01084252|7723095|FG011|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
4749258|NCT01084252|7723096|FG012|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|1
4749259|NCT01084252|7723097|FG013|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
4749260|NCT01084252|7723084|FG000|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
4749261|NCT01084252|7723085|FG001|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
4749262|NCT01084252|7723086|FG002|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
4749263|NCT01084252|7723087|FG003|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
4749264|NCT01084252|7723088|FG004|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
4749265|NCT01084252|7723089|FG005|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
4749266|NCT01084252|7723090|FG006|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
4749267|NCT01084252|7723091|FG007|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
4749268|NCT01084252|7723092|FG008|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
4749269|NCT01084252|7723093|FG009|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
4749270|NCT01084252|7723094|FG010|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
4749271|NCT01084252|7723095|FG011|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
4749272|NCT01084252|7723096|FG012|Phase 2 Stage 2 (97 Weeks)|Other than specified above|12
4749273|NCT01084252|7723097|FG013|Phase 2 Stage 2 (97 Weeks)|Other than specified above|2
4749274|NCT01084252|7723084|FG000|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
4749275|NCT01084252|7723085|FG001|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
4749276|NCT01084252|7723086|FG002|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
4749277|NCT01084252|7723087|FG003|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
4749278|NCT01084252|7723088|FG004|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
4749279|NCT01084252|7723089|FG005|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
4749280|NCT01084252|7723090|FG006|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
4749281|NCT01084252|7723091|FG007|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
4749282|NCT01084252|7723092|FG008|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
4749283|NCT01084252|7723093|FG009|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
4749284|NCT01084252|7723094|FG010|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
4749285|NCT01084252|7723095|FG011|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
4749286|NCT01084252|7723096|FG012|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|13
4749287|NCT01084252|7723097|FG013|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|15
4749288|NCT01084252|7723084|FG000|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
4749289|NCT01084252|7723085|FG001|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
4749290|NCT01084252|7723086|FG002|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
4749291|NCT01084252|7723087|FG003|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
4749292|NCT01084252|7723088|FG004|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
4749293|NCT01084252|7723089|FG005|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
4749294|NCT01084252|7723090|FG006|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
4749295|NCT01084252|7723091|FG007|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
4658138|NCT02164513|7544439|FG002|Overall Study|Withdrawal by Subject|130
4658139|NCT02164513|7544437|FG000|Overall Study|Other: Reason not provided by site|1
4658140|NCT02164513|7544438|FG001|Overall Study|Other: Reason not provided by site|0
4658141|NCT02164513|7544439|FG002|Overall Study|Other: Reason not provided by site|0
4658142|NCT02164539|7544454|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2
4658143|NCT02164539|7544455|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0
4658144|NCT02164539|7544456|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1
4749296|NCT01084252|7723092|FG008|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
4749297|NCT01084252|7723093|FG009|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
4749298|NCT01084252|7723094|FG010|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
4749299|NCT01084252|7723095|FG011|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
4749300|NCT01084252|7723096|FG012|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|1
4749301|NCT01084252|7723097|FG013|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
4749302|NCT00728962|7723184|FG000|Implant Placement Surgery|Adverse Event|8
4749303|NCT00728962|7723184|FG000|Implant Placement Surgery|Lost to Follow-up|1
4749304|NCT00728962|7723184|FG000|Implant Placement Surgery|Protocol Violation|1
4749305|NCT00728962|7723184|FG000|Permanent Prosthesis Placement|Adverse Event|3
4749306|NCT00728962|7723184|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3
4749307|NCT00728754|7723190|FG000|Permanent Prosthesis Placement|Adverse Event|1
4749308|NCT00728754|7723191|FG001|Permanent Prosthesis Placement|Adverse Event|1
4749309|NCT00728754|7723190|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3
4749310|NCT00728754|7723191|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3
4749311|NCT00728754|7723190|FG000|One Year Post Placement Follow-up|Adverse Event|1
4749312|NCT00728754|7723191|FG001|One Year Post Placement Follow-up|Adverse Event|0
4749313|NCT00723944|7723199|FG000|Permanent Prosthesis Placement|Adverse Event|1
4749314|NCT00723944|7723200|FG001|Permanent Prosthesis Placement|Adverse Event|7
4749315|NCT00723944|7723199|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2
4749316|NCT00723944|7723200|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2
4749317|NCT00723944|7723199|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1
4749318|NCT00723944|7723200|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4
4749319|NCT00565851|7723214|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9
4749320|NCT00565851|7723215|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9
4749321|NCT00565851|7723216|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3
4749322|NCT00565851|7723217|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18
4749323|NCT00565851|7723218|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0
4749324|NCT00565851|7723219|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2
4749325|NCT00565851|7723220|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0
4749326|NCT00565851|7723221|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2
4749327|NCT00565851|7723214|FG000|Chemotherapy Assignment|Still On Chemotherapy|0
4749328|NCT00565851|7723215|FG001|Chemotherapy Assignment|Still On Chemotherapy|14
4749329|NCT00565851|7723216|FG002|Chemotherapy Assignment|Still On Chemotherapy|0
4749330|NCT00565851|7723217|FG003|Chemotherapy Assignment|Still On Chemotherapy|18
4749331|NCT00565851|7723218|FG004|Chemotherapy Assignment|Still On Chemotherapy|0
4749332|NCT00565851|7723219|FG005|Chemotherapy Assignment|Still On Chemotherapy|1
4749333|NCT00565851|7723220|FG006|Chemotherapy Assignment|Still On Chemotherapy|0
4749334|NCT00565851|7723221|FG007|Chemotherapy Assignment|Still On Chemotherapy|1
4749335|NCT00467142|7723243|FG000|Overall Study|Withdrawal by Subject|1
4749336|NCT00467142|7723243|FG000|Overall Study|Adverse Event|1
4749337|NCT00467142|7723243|FG000|Overall Study|Protocol Violation|1
4658145|NCT02164539|7544457|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2
4658146|NCT02164539|7544458|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3
4658147|NCT02164539|7544459|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1
4658148|NCT02164539|7544460|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0
4658149|NCT02164539|7544454|FG000|Treatment Phase B (1 Week)|Adverse Event|0
4658150|NCT02164539|7544455|FG001|Treatment Phase B (1 Week)|Adverse Event|0
4658151|NCT02164539|7544456|FG002|Treatment Phase B (1 Week)|Adverse Event|0
4658152|NCT02164539|7544457|FG003|Treatment Phase B (1 Week)|Adverse Event|0
4658153|NCT02164539|7544458|FG004|Treatment Phase B (1 Week)|Adverse Event|2
4658154|NCT02164539|7544459|FG005|Treatment Phase B (1 Week)|Adverse Event|0
4658155|NCT02164539|7544460|FG006|Treatment Phase B (1 Week)|Adverse Event|0
4658156|NCT02164539|7544454|FG000|Treatment Phase B (1 Week)|Physician Decision|0
4658157|NCT02164539|7544455|FG001|Treatment Phase B (1 Week)|Physician Decision|0
4658158|NCT02164539|7544456|FG002|Treatment Phase B (1 Week)|Physician Decision|0
4658159|NCT02164539|7544457|FG003|Treatment Phase B (1 Week)|Physician Decision|0
4658160|NCT02164539|7544458|FG004|Treatment Phase B (1 Week)|Physician Decision|1
4658161|NCT02164539|7544459|FG005|Treatment Phase B (1 Week)|Physician Decision|0
4658162|NCT02164539|7544460|FG006|Treatment Phase B (1 Week)|Physician Decision|1
4658163|NCT02164539|7544454|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1
4658164|NCT02164539|7544455|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0
4658165|NCT02164539|7544456|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0
4658166|NCT02164539|7544457|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0
4658167|NCT02164539|7544458|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0
4658168|NCT02164539|7544459|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0
4658169|NCT02164539|7544460|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0
4658170|NCT02164539|7544454|FG000|Treatment Phase C (1 Week)|Adverse Event|0
4658171|NCT02164539|7544455|FG001|Treatment Phase C (1 Week)|Adverse Event|0
4658172|NCT02164539|7544456|FG002|Treatment Phase C (1 Week)|Adverse Event|0
4658173|NCT02164539|7544457|FG003|Treatment Phase C (1 Week)|Adverse Event|0
4658174|NCT02164539|7544458|FG004|Treatment Phase C (1 Week)|Adverse Event|0
4658175|NCT02164539|7544459|FG005|Treatment Phase C (1 Week)|Adverse Event|0
4658176|NCT02164539|7544460|FG006|Treatment Phase C (1 Week)|Adverse Event|1
4658177|NCT02164539|7544454|FG000|Treatment Phase C (1 Week)|Physician Decision|0
4658178|NCT02164539|7544455|FG001|Treatment Phase C (1 Week)|Physician Decision|0
4658179|NCT02164539|7544456|FG002|Treatment Phase C (1 Week)|Physician Decision|0
4658180|NCT02164539|7544457|FG003|Treatment Phase C (1 Week)|Physician Decision|0
4658181|NCT02164539|7544458|FG004|Treatment Phase C (1 Week)|Physician Decision|0
4658182|NCT02164539|7544459|FG005|Treatment Phase C (1 Week)|Physician Decision|0
4658183|NCT02164539|7544460|FG006|Treatment Phase C (1 Week)|Physician Decision|1
4658184|NCT02164864|7544483|FG000|Overall Study|Trial disease worsening|7
4658185|NCT02164864|7544484|FG001|Overall Study|Trial disease worsening|5
4658186|NCT02164864|7544485|FG002|Overall Study|Trial disease worsening|1
4658187|NCT02164864|7544483|FG000|Overall Study|Other pre-existing disease worsening|6
4658188|NCT02164864|7544484|FG001|Overall Study|Other pre-existing disease worsening|4
4658189|NCT02164864|7544485|FG002|Overall Study|Other pre-existing disease worsening|9
4658190|NCT02164864|7544483|FG000|Overall Study|Other Adverse Event (AE)|52
4658191|NCT02164864|7544484|FG001|Overall Study|Other Adverse Event (AE)|32
4658192|NCT02164864|7544485|FG002|Overall Study|Other Adverse Event (AE)|49
4658193|NCT02164864|7544483|FG000|Overall Study|Protocol Violation|2
4658194|NCT02164864|7544484|FG001|Overall Study|Protocol Violation|4
4658195|NCT02164864|7544485|FG002|Overall Study|Protocol Violation|1
4658196|NCT02164864|7544483|FG000|Overall Study|Lost to Follow-up|4
4658197|NCT02164864|7544484|FG001|Overall Study|Lost to Follow-up|3
4658198|NCT02164864|7544485|FG002|Overall Study|Lost to Follow-up|2
4658199|NCT02164864|7544483|FG000|Overall Study|Consent withdrawn, not due to AE|21
4658200|NCT02164864|7544484|FG001|Overall Study|Consent withdrawn, not due to AE|8
4658201|NCT02164864|7544485|FG002|Overall Study|Consent withdrawn, not due to AE|56
4658202|NCT02164864|7544483|FG000|Overall Study|Other than stated|3
4658203|NCT02164864|7544484|FG001|Overall Study|Other than stated|4
4658204|NCT02164864|7544485|FG002|Overall Study|Other than stated|14
4749338|NCT04557371|7723280|FG000|Overall Study|Covid-19-related|0
4749339|NCT04557371|7723281|FG001|Overall Study|Covid-19-related|1
4749340|NCT04557371|7723282|FG002|Overall Study|Covid-19-related|0
4749341|NCT04557371|7723280|FG000|Overall Study|Withdrawal by Subject|0
4749342|NCT04557371|7723281|FG001|Overall Study|Withdrawal by Subject|1
4749343|NCT04557371|7723282|FG002|Overall Study|Withdrawal by Subject|0
4749344|NCT04557371|7723280|FG000|Overall Study|Adverse Event|1
4749345|NCT04557371|7723281|FG001|Overall Study|Adverse Event|0
4749346|NCT04557371|7723282|FG002|Overall Study|Adverse Event|0
4749347|NCT04369742|7723303|FG000|Overall Study|Lost to Follow-Up (Day 14)|7
4749348|NCT04369742|7723304|FG001|Overall Study|Lost to Follow-Up (Day 14)|4
4749349|NCT04369742|7723303|FG000|Overall Study|Lost to Follow-Up (Day 30)|7
4658205|NCT02164916|7544498|FG000|Overall Study|Adverse Event|3
4658206|NCT02164916|7544499|FG001|Overall Study|Adverse Event|8
4658207|NCT02164916|7544498|FG000|Overall Study|Death|1
4658208|NCT02164916|7544499|FG001|Overall Study|Death|1
4658209|NCT02164916|7544498|FG000|Overall Study|Refusal unrelated to adverse event|3
4658210|NCT02164916|7544499|FG001|Overall Study|Refusal unrelated to adverse event|7
4658211|NCT02164916|7544498|FG000|Overall Study|Progression|37
4658212|NCT02164916|7544499|FG001|Overall Study|Progression|26
4658213|NCT02164916|7544498|FG000|Overall Study|Not protocol specified|5
4658214|NCT02164916|7544499|FG001|Overall Study|Not protocol specified|1
4658215|NCT02164916|7544498|FG000|Overall Study|Reason under review|1
4658216|NCT02164916|7544499|FG001|Overall Study|Reason under review|6
4658217|NCT02164916|7544498|FG000|Overall Study|Not eligible|2
4658218|NCT02164916|7544499|FG001|Overall Study|Not eligible|5
4658219|NCT02164929|7544514|FG000|Overall Study|Converted to open procedure|1
4658220|NCT02164929|7544515|FG001|Overall Study|Converted to open procedure|0
4658221|NCT02164929|7544516|FG002|Overall Study|Converted to open procedure|0
4658222|NCT02164929|7544517|FG003|Overall Study|Converted to open procedure|2
4658223|NCT02164929|7544514|FG000|Overall Study|Failed regional block|0
4658224|NCT02164929|7544515|FG001|Overall Study|Failed regional block|0
4658225|NCT02164929|7544516|FG002|Overall Study|Failed regional block|1
4658226|NCT02164929|7544517|FG003|Overall Study|Failed regional block|0
4658227|NCT02164981|7544530|FG000|Started|Withdrawal by Subject|2
4658228|NCT02164981|7544531|FG001|Started|Withdrawal by Subject|1
4658229|NCT02164981|7544532|FG002|Started|Withdrawal by Subject|0
4658230|NCT02164981|7544530|FG000|Started|Protocol Violation|2
4658231|NCT02164981|7544531|FG001|Started|Protocol Violation|0
4658232|NCT02164981|7544532|FG002|Started|Protocol Violation|0
4658233|NCT02164981|7544530|FG000|Started|Adverse Event|1
4658234|NCT02164981|7544531|FG001|Started|Adverse Event|2
4658235|NCT02164981|7544532|FG002|Started|Adverse Event|0
4658236|NCT02164981|7544530|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0
4658237|NCT02164981|7544531|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2
4658238|NCT02164981|7544532|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0
4658239|NCT02164981|7544530|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2
4658240|NCT02164981|7544531|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1
4658241|NCT02164981|7544532|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0
4658242|NCT02164981|7544530|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0
4658243|NCT02164981|7544531|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1
4658244|NCT02164981|7544532|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0
4749350|NCT04369742|7723304|FG001|Overall Study|Lost to Follow-Up (Day 30)|7
4749351|NCT04346628|7723312|FG000|Overall Study|Lost to Follow-up|4
4749352|NCT04346628|7723313|FG001|Overall Study|Lost to Follow-up|4
4749353|NCT04346628|7723312|FG000|Overall Study|Withdrew (had personal reasons)|2
4749354|NCT04346628|7723313|FG001|Overall Study|Withdrew (had personal reasons)|5
4749355|NCT04346628|7723312|FG000|Overall Study|Withdrew (medication intolerant)|0
4749356|NCT04346628|7723313|FG001|Overall Study|Withdrew (medication intolerant)|3
4749357|NCT04346628|7723312|FG000|Overall Study|Withdrew (declined intervention)|0
4749358|NCT04346628|7723313|FG001|Overall Study|Withdrew (declined intervention)|1
4658245|NCT02165202|7544574|FG000|Oral Phase|Refused further participation|5
4658246|NCT02165202|7544575|FG001|Oral Phase|Refused further participation|1
4658247|NCT02165202|7544574|FG000|Oral Phase|Study product Related Toxicity|1
4658248|NCT02165202|7544575|FG001|Oral Phase|Study product Related Toxicity|0
4658249|NCT02165202|7544574|FG000|Oral Phase|Unable to contact Participant|1
4658250|NCT02165202|7544575|FG001|Oral Phase|Unable to contact Participant|1
4658251|NCT02165202|7544574|FG000|Oral Phase|Clinical reasons|1
4658252|NCT02165202|7544575|FG001|Oral Phase|Clinical reasons|0
4658253|NCT02165202|7544574|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1
4658254|NCT02165202|7544575|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0
4658255|NCT02165202|7544574|FG000|Oral Phase|CMC advised termination|1
4658256|NCT02165202|7544575|FG001|Oral Phase|CMC advised termination|0
4658257|NCT02165202|7544574|FG000|Oral Phase|Relocated, no follow-up planned|1
4658258|NCT02165202|7544575|FG001|Oral Phase|Relocated, no follow-up planned|0
4658259|NCT02165202|7544574|FG000|Oral Phase|Abnormal EKG|0
4658260|NCT02165202|7544575|FG001|Oral Phase|Abnormal EKG|1
4658261|NCT02165202|7544574|FG000|Injection Phase|Abnormal Lab Value|5
4658262|NCT02165202|7544575|FG001|Injection Phase|Abnormal Lab Value|1
4658263|NCT02165202|7544574|FG000|Injection Phase|Reactive HIV or HIV Suspected|0
4658264|NCT02165202|7544575|FG001|Injection Phase|Reactive HIV or HIV Suspected|2
4658265|NCT02165202|7544574|FG000|Injection Phase|Unable to attend within Visit Window|1
4658266|NCT02165202|7544575|FG001|Injection Phase|Unable to attend within Visit Window|0
4658267|NCT02165202|7544574|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0
4658268|NCT02165202|7544575|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1
4658269|NCT02165202|7544574|FG000|Injection Phase|End of Study|2
4658270|NCT02165202|7544575|FG001|Injection Phase|End of Study|1
4658271|NCT02165202|7544574|FG000|Injection Phase|Study Product related Toxicity|1
4658272|NCT02165202|7544575|FG001|Injection Phase|Study Product related Toxicity|0
4658273|NCT02165202|7544574|FG000|Injection Phase|No longer interested|0
4658274|NCT02165202|7544575|FG001|Injection Phase|No longer interested|1
4658275|NCT02165202|7544574|FG000|Injection Phase|Participant unwilling to comply|1
4658276|NCT02165202|7544575|FG001|Injection Phase|Participant unwilling to comply|0
4658277|NCT02165397|7544588|FG000|Overall Study|Death|7
4658278|NCT02165397|7544589|FG001|Overall Study|Death|10
4658279|NCT02165397|7544590|FG002|Overall Study|Death|8
4658280|NCT02165397|7544588|FG000|Overall Study|Lost to Follow-up|1
4658281|NCT02165397|7544589|FG001|Overall Study|Lost to Follow-up|3
4658282|NCT02165397|7544590|FG002|Overall Study|Lost to Follow-up|0
4658283|NCT02165397|7544588|FG000|Overall Study|Withdrawal by Subject|6
4658284|NCT02165397|7544589|FG001|Overall Study|Withdrawal by Subject|6
4658285|NCT02165397|7544590|FG002|Overall Study|Withdrawal by Subject|1
4658286|NCT02165397|7544588|FG000|Overall Study|Other, Not Specified|0
4658287|NCT02165397|7544589|FG001|Overall Study|Other, Not Specified|0
4658288|NCT02165397|7544590|FG002|Overall Study|Other, Not Specified|1
4658289|NCT02165735|7544628|FG000|Overall Study|Lost to Follow-up|12
4658290|NCT02165735|7544629|FG001|Overall Study|Lost to Follow-up|10
4658291|NCT02165735|7544628|FG000|Overall Study|Withdrawal by Subject|3
4658292|NCT02165735|7544629|FG001|Overall Study|Withdrawal by Subject|0
4658293|NCT02165735|7544628|FG000|Overall Study|Participant indicated lack of time|1
4658294|NCT02165735|7544629|FG001|Overall Study|Participant indicated lack of time|3
4658295|NCT02165735|7544628|FG000|Overall Study|Protocol Violation|0
4658296|NCT02165735|7544629|FG001|Overall Study|Protocol Violation|1
4658297|NCT02165826|7544647|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44
4658298|NCT02165826|7544648|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57
4658299|NCT02165826|7544649|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68
4658300|NCT02165826|7544647|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0
4658301|NCT02165826|7544648|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1
4658302|NCT02165826|7544649|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3
4658303|NCT02165826|7544647|FG000|Main Treatment Period|Lost to Follow-up|4
4658304|NCT02165826|7544648|FG001|Main Treatment Period|Lost to Follow-up|2
4658305|NCT02165826|7544649|FG002|Main Treatment Period|Lost to Follow-up|1
4658306|NCT02165826|7544647|FG000|Main Treatment Period|Voluntary Withdrawal|23
4658307|NCT02165826|7544648|FG001|Main Treatment Period|Voluntary Withdrawal|23
4658308|NCT02165826|7544649|FG002|Main Treatment Period|Voluntary Withdrawal|21
4658309|NCT02165826|7544647|FG000|Main Treatment Period|Lack of Efficacy|2
4658310|NCT02165826|7544648|FG001|Main Treatment Period|Lack of Efficacy|0
4658311|NCT02165826|7544649|FG002|Main Treatment Period|Lack of Efficacy|0
4658312|NCT02165826|7544647|FG000|Main Treatment Period|Reason Not Specified|8
4658313|NCT02165826|7544648|FG001|Main Treatment Period|Reason Not Specified|5
4658314|NCT02165826|7544649|FG002|Main Treatment Period|Reason Not Specified|16
4658315|NCT02165826|7544647|FG000|Main Treatment Period|Did Not Receive Study Drug|0
4658316|NCT02165826|7544648|FG001|Main Treatment Period|Did Not Receive Study Drug|2
4658317|NCT02165826|7544649|FG002|Main Treatment Period|Did Not Receive Study Drug|0
4658318|NCT02165826|7544647|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4
4658319|NCT02165826|7544648|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10
4658320|NCT02165826|7544649|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3
4658321|NCT02165826|7544647|FG000|Down-Titration Period|Voluntary Withdrawal|2
4658322|NCT02165826|7544648|FG001|Down-Titration Period|Voluntary Withdrawal|1
4658323|NCT02165826|7544649|FG002|Down-Titration Period|Voluntary Withdrawal|2
4658324|NCT02165826|7544647|FG000|Down-Titration Period|Reason Not Specified|1
4658325|NCT02165826|7544648|FG001|Down-Titration Period|Reason Not Specified|0
4658326|NCT02165826|7544649|FG002|Down-Titration Period|Reason Not Specified|2
4658327|NCT02166047|7544700|FG000|Overall Study|Withdrawal by Participant|0
4658328|NCT02166047|7544701|FG001|Overall Study|Withdrawal by Participant|1
4658329|NCT02166047|7544702|FG002|Overall Study|Withdrawal by Participant|2
4658330|NCT02166047|7544703|FG003|Overall Study|Withdrawal by Participant|0
4658331|NCT02166047|7544704|FG004|Overall Study|Withdrawal by Participant|0
4658332|NCT02166047|7544705|FG005|Overall Study|Withdrawal by Participant|0
4658333|NCT02166047|7544706|FG006|Overall Study|Withdrawal by Participant|1
4658334|NCT02166047|7544707|FG007|Overall Study|Withdrawal by Participant|0
4658335|NCT02166047|7544708|FG008|Overall Study|Withdrawal by Participant|0
4658336|NCT02166047|7544709|FG009|Overall Study|Withdrawal by Participant|0
4658337|NCT02166047|7544710|FG010|Overall Study|Withdrawal by Participant|0
4658338|NCT02166047|7544711|FG011|Overall Study|Withdrawal by Participant|0
4658339|NCT02166047|7544700|FG000|Overall Study|Adverse Event|0
4658340|NCT02166047|7544701|FG001|Overall Study|Adverse Event|0
4658341|NCT02166047|7544702|FG002|Overall Study|Adverse Event|0
4658342|NCT02166047|7544703|FG003|Overall Study|Adverse Event|0
4658343|NCT02166047|7544704|FG004|Overall Study|Adverse Event|1
4658344|NCT02166047|7544705|FG005|Overall Study|Adverse Event|0
4658345|NCT02166047|7544706|FG006|Overall Study|Adverse Event|1
4658346|NCT02166047|7544707|FG007|Overall Study|Adverse Event|0
4658347|NCT02166047|7544708|FG008|Overall Study|Adverse Event|0
4658348|NCT02166047|7544709|FG009|Overall Study|Adverse Event|0
4658349|NCT02166047|7544710|FG010|Overall Study|Adverse Event|2
4658350|NCT02166047|7544711|FG011|Overall Study|Adverse Event|0
4658351|NCT02166333|7544741|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4
4658352|NCT02166333|7544742|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0
4749359|NCT04003623|7723343|FG000|Overall Study|Withdrawal by Subject|1
4749360|NCT04003623|7723344|FG001|Overall Study|Withdrawal by Subject|0
4749361|NCT03969589|7723352|FG000|Overall Study|Lost to Follow-up|3
4749362|NCT03969589|7723353|FG001|Overall Study|Lost to Follow-up|2
4749363|NCT03969589|7723352|FG000|Overall Study|Declined Follow-Up|0
4749364|NCT03969589|7723353|FG001|Overall Study|Declined Follow-Up|1
4749365|NCT03917472|7723361|FG000|Overall Study|Physician Decision|4
4749366|NCT03917472|7723362|FG001|Overall Study|Physician Decision|0
4749367|NCT03917472|7723361|FG000|Overall Study|Adverse Event|3
4749368|NCT03917472|7723362|FG001|Overall Study|Adverse Event|1
4749369|NCT03917472|7723361|FG000|Overall Study|Death|7
4749370|NCT03917472|7723362|FG001|Overall Study|Death|5
4749371|NCT03917472|7723361|FG000|Overall Study|Withdrawal by Subject|11
4749372|NCT03917472|7723362|FG001|Overall Study|Withdrawal by Subject|4
4749373|NCT03917472|7723361|FG000|Overall Study|Lost to Follow-up|10
4749374|NCT03917472|7723362|FG001|Overall Study|Lost to Follow-up|5
4749375|NCT03655691|7723406|FG000|Overall Study|Adverse Event|0
4749376|NCT03655691|7723407|FG001|Overall Study|Adverse Event|0
4749377|NCT03655691|7723408|FG002|Overall Study|Adverse Event|1
4749378|NCT03655691|7723406|FG000|Overall Study|Lost to Follow-up|1
4749379|NCT03655691|7723407|FG001|Overall Study|Lost to Follow-up|1
4749380|NCT03655691|7723408|FG002|Overall Study|Lost to Follow-up|2
4749381|NCT03655691|7723406|FG000|Overall Study|Protocol Violation|0
4749382|NCT03655691|7723407|FG001|Overall Study|Protocol Violation|1
4749383|NCT03655691|7723408|FG002|Overall Study|Protocol Violation|0
4749384|NCT03655691|7723406|FG000|Overall Study|Withdrawal by Subject|1
4749385|NCT03655691|7723407|FG001|Overall Study|Withdrawal by Subject|1
4749386|NCT03655691|7723408|FG002|Overall Study|Withdrawal by Subject|0
4749387|NCT03462719|7723422|FG000|Overall Study|Withdrawal by Subject|2
4749388|NCT03462719|7723423|FG001|Overall Study|Withdrawal by Subject|3
4749389|NCT03462719|7723422|FG000|Overall Study|Ongoing|93
4749390|NCT03462719|7723423|FG001|Overall Study|Ongoing|91
4749391|NCT03412565|7723433|FG000|Overall Study|Other|0
4749392|NCT03412565|7723434|FG001|Overall Study|Other|0
4749393|NCT03412565|7723435|FG002|Overall Study|Other|0
4749394|NCT03412565|7723436|FG003|Overall Study|Other|3
4749395|NCT03412565|7723433|FG000|Overall Study|Withdrawal by Subject|0
4749396|NCT03412565|7723434|FG001|Overall Study|Withdrawal by Subject|0
4749397|NCT03412565|7723435|FG002|Overall Study|Withdrawal by Subject|1
4749398|NCT03412565|7723436|FG003|Overall Study|Withdrawal by Subject|5
4749399|NCT03412565|7723433|FG000|Overall Study|Physician Decision|0
4749400|NCT03412565|7723434|FG001|Overall Study|Physician Decision|1
4749401|NCT03412565|7723435|FG002|Overall Study|Physician Decision|0
4749402|NCT03412565|7723436|FG003|Overall Study|Physician Decision|1
4749403|NCT03412565|7723433|FG000|Overall Study|Death|1
4749404|NCT03412565|7723434|FG001|Overall Study|Death|2
4749405|NCT03412565|7723435|FG002|Overall Study|Death|2
4749406|NCT03412565|7723436|FG003|Overall Study|Death|4
4749407|NCT03412565|7723433|FG000|Overall Study|Still ongoing|0
4749408|NCT03412565|7723434|FG001|Overall Study|Still ongoing|62
4749409|NCT03412565|7723435|FG002|Overall Study|Still ongoing|59
4749410|NCT03412565|7723436|FG003|Overall Study|Still ongoing|41
4749411|NCT03364686|7723451|FG000|Overall Study|Physician Decision|2
4749412|NCT03326856|7723469|FG000|Overall Study|Lost to Follow-up|1
4749413|NCT03326856|7723470|FG001|Overall Study|Lost to Follow-up|1
4749414|NCT03326856|7723471|FG002|Overall Study|Lost to Follow-up|0
4749415|NCT03326856|7723472|FG003|Overall Study|Lost to Follow-up|0
4749416|NCT03326856|7723473|FG004|Overall Study|Lost to Follow-up|0
4749417|NCT03287089|7723491|FG000|Overall Study|Lost to Follow-up|0
4749418|NCT03287089|7723492|FG001|Overall Study|Lost to Follow-up|2
4658353|NCT02166333|7544743|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0
4658354|NCT02166333|7544744|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0
4658355|NCT02166333|7544745|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3
4658356|NCT02166333|7544746|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1
4658357|NCT02166333|7544741|FG000|Stage 1|Death|4
4658358|NCT02166333|7544742|FG001|Stage 1|Death|0
4658359|NCT02166333|7544743|FG002|Stage 1|Death|2
4658360|NCT02166333|7544744|FG003|Stage 1|Death|0
4658361|NCT02166333|7544745|FG004|Stage 1|Death|3
4658362|NCT02166333|7544746|FG005|Stage 1|Death|2
4658363|NCT02166333|7544741|FG000|Stage 1|Lost to Follow-up|12
4658364|NCT02166333|7544742|FG001|Stage 1|Lost to Follow-up|0
4658365|NCT02166333|7544743|FG002|Stage 1|Lost to Follow-up|6
4658366|NCT02166333|7544744|FG003|Stage 1|Lost to Follow-up|0
4658367|NCT02166333|7544745|FG004|Stage 1|Lost to Follow-up|3
4658368|NCT02166333|7544746|FG005|Stage 1|Lost to Follow-up|3
4658369|NCT02166333|7544741|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180
4658370|NCT02166333|7544742|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0
4658371|NCT02166333|7544743|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63
4658372|NCT02166333|7544744|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0
4658373|NCT02166333|7544745|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54
4658374|NCT02166333|7544746|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52
4658375|NCT02166333|7544741|FG000|Stage 2|Death|4
4658376|NCT02166333|7544742|FG001|Stage 2|Death|2
4658377|NCT02166333|7544743|FG002|Stage 2|Death|1
4658378|NCT02166333|7544744|FG003|Stage 2|Death|0
4749419|NCT03287089|7723491|FG000|Overall Study|Physician Decision|0
4749420|NCT03287089|7723492|FG001|Overall Study|Physician Decision|2
4749421|NCT03287089|7723491|FG000|Overall Study|Withdrawal by Subject|0
4749422|NCT03287089|7723492|FG001|Overall Study|Withdrawal by Subject|2
4749423|NCT03277105|7723500|FG000|Overall Study|Death|77
4749424|NCT03277105|7723501|FG001|Overall Study|Death|73
4749425|NCT03277105|7723500|FG000|Overall Study|Lost to Follow-up|0
4749426|NCT03277105|7723501|FG001|Overall Study|Lost to Follow-up|3
4749427|NCT03277105|7723500|FG000|Overall Study|Withdrawal by Subject|10
4749428|NCT03277105|7723501|FG001|Overall Study|Withdrawal by Subject|9
4749429|NCT03277105|7723500|FG000|Overall Study|Other|1
4749430|NCT03277105|7723501|FG001|Overall Study|Other|3
4749431|NCT03277105|7723500|FG000|Overall Study|Ongoing|171
4749432|NCT03277105|7723501|FG001|Overall Study|Ongoing|175
4749433|NCT03240692|7723507|FG000|Overall Study|Physician Decision|1
4749434|NCT03240692|7723507|FG000|Overall Study|Withdrawal by Subject|1
4749435|NCT03227029|7723514|FG000|Overall Study|Child Wheezed (no treatment)|0
4749436|NCT03227029|7723515|FG001|Overall Study|Child Wheezed (no treatment)|1
4749437|NCT03227029|7723516|FG002|Overall Study|Child Wheezed (no treatment)|0
4749438|NCT03227029|7723514|FG000|Overall Study|No post RSV season visit due to COVID|3
4749439|NCT03227029|7723515|FG001|Overall Study|No post RSV season visit due to COVID|3
4749440|NCT03227029|7723516|FG002|Overall Study|No post RSV season visit due to COVID|2
4749441|NCT03227029|7723514|FG000|Overall Study|Not able to get to clinic|0
4749442|NCT03227029|7723515|FG001|Overall Study|Not able to get to clinic|0
4749443|NCT03227029|7723516|FG002|Overall Study|Not able to get to clinic|1
4749444|NCT03227029|7723514|FG000|Overall Study|Withdrawal by Subject|1
4749445|NCT03227029|7723515|FG001|Overall Study|Withdrawal by Subject|0
4749446|NCT03227029|7723516|FG002|Overall Study|Withdrawal by Subject|0
4749447|NCT03227029|7723514|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0
4749448|NCT03227029|7723515|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0
4749449|NCT03227029|7723516|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1
4749450|NCT03201965|7723545|FG000|Overall Study|Death|5
4749451|NCT03201965|7723546|FG001|Overall Study|Death|27
4749452|NCT03201965|7723547|FG002|Overall Study|Death|27
4749453|NCT03201965|7723545|FG000|Overall Study|Lost to Follow-up|0
4749454|NCT03201965|7723546|FG001|Overall Study|Lost to Follow-up|1
4749455|NCT03201965|7723547|FG002|Overall Study|Lost to Follow-up|0
4749456|NCT03201965|7723545|FG000|Overall Study|Withdrawal by Subject|3
4749457|NCT03201965|7723546|FG001|Overall Study|Withdrawal by Subject|13
4749458|NCT03201965|7723547|FG002|Overall Study|Withdrawal by Subject|4
4749459|NCT03201965|7723545|FG000|Overall Study|Ongoing|20
4749460|NCT03201965|7723546|FG001|Overall Study|Ongoing|152
4749461|NCT03201965|7723547|FG002|Overall Study|Ongoing|164
4749462|NCT03182829|7723556|FG000|Overall Study|Protocol Violation|12
4749463|NCT03182829|7723557|FG001|Overall Study|Protocol Violation|12
4749464|NCT03182829|7723556|FG000|Overall Study|Other|4
4749465|NCT03182829|7723557|FG001|Overall Study|Other|3
4749466|NCT03181789|7723567|FG000|Overall Study|Withdrawal by Subject|0
4749467|NCT03181789|7723568|FG001|Overall Study|Withdrawal by Subject|1
4749468|NCT03181789|7723569|FG002|Overall Study|Withdrawal by Subject|1
4749469|NCT03181789|7723570|FG003|Overall Study|Withdrawal by Subject|0
4749470|NCT03181789|7723567|FG000|Overall Study|Lost to Follow-up|7
4749471|NCT03181789|7723568|FG001|Overall Study|Lost to Follow-up|1
4749472|NCT03181789|7723569|FG002|Overall Study|Lost to Follow-up|0
4658379|NCT02166333|7544745|FG004|Stage 2|Death|0
4658380|NCT02166333|7544746|FG005|Stage 2|Death|1
4658381|NCT02166333|7544741|FG000|Stage 2|Lost to Follow-up|23
4658382|NCT02166333|7544742|FG001|Stage 2|Lost to Follow-up|4
4658383|NCT02166333|7544743|FG002|Stage 2|Lost to Follow-up|11
4658384|NCT02166333|7544744|FG003|Stage 2|Lost to Follow-up|9
4658385|NCT02166333|7544745|FG004|Stage 2|Lost to Follow-up|3
4658386|NCT02166333|7544746|FG005|Stage 2|Lost to Follow-up|6
4658387|NCT02166476|7544767|FG000|Overall Study|Withdrawal by Subject|5
4658388|NCT02166476|7544768|FG001|Overall Study|Withdrawal by Subject|7
4658389|NCT02166476|7544767|FG000|Overall Study|Adverse Event|3
4658390|NCT02166476|7544768|FG001|Overall Study|Adverse Event|3
4658391|NCT02166476|7544767|FG000|Overall Study|Lost to Follow-up|5
4658392|NCT02166476|7544768|FG001|Overall Study|Lost to Follow-up|10
4658393|NCT02166476|7544767|FG000|Overall Study|Physician Decision|1
4658394|NCT02166476|7544768|FG001|Overall Study|Physician Decision|0
4658395|NCT02166476|7544767|FG000|Overall Study|Unable to Come for Visit|0
4658396|NCT02166476|7544768|FG001|Overall Study|Unable to Come for Visit|3
4658397|NCT02166606|7544777|FG000|Overall Study|Adverse Event|3
4658398|NCT02166606|7544777|FG000|Overall Study|Death|31
4658399|NCT02166606|7544777|FG000|Overall Study|Protocol Violation|7
4658400|NCT02166606|7544777|FG000|Overall Study|Lost to Follow-up|30
4658401|NCT02166606|7544777|FG000|Overall Study|Withdrawal by Subject|1
4658402|NCT02166606|7544777|FG000|Overall Study|Physician Decision|1
4658403|NCT02166606|7544777|FG000|Overall Study|Device upgrade|1
4658404|NCT02166606|7544777|FG000|Overall Study|Enrolled after End of Enrollment|4
4658405|NCT02166697|7544781|FG000|Overall Study|Protocol Violation|347
4658406|NCT02167035|7544787|FG000|Overall Study|Adverse Event|2
4658407|NCT02167035|7544788|FG001|Overall Study|Adverse Event|2
4658408|NCT02167035|7544787|FG000|Overall Study|Lost to Follow-up|3
4658409|NCT02167035|7544788|FG001|Overall Study|Lost to Follow-up|3
4658410|NCT02167035|7544787|FG000|Overall Study|Randomized to incorrect Study Medication|0
4658411|NCT02167035|7544788|FG001|Overall Study|Randomized to incorrect Study Medication|1
4658412|NCT02167139|7544807|FG000|Randomised, Double-blind|Withdrawal by Subject|11
4658413|NCT02167139|7544808|FG001|Randomised, Double-blind|Withdrawal by Subject|8
4658414|NCT02167139|7544809|FG002|Randomised, Double-blind|Withdrawal by Subject|0
4658415|NCT02167139|7544810|FG003|Randomised, Double-blind|Withdrawal by Subject|0
4658416|NCT02167139|7544807|FG000|Randomised, Double-blind|Adverse Event|2
4658417|NCT02167139|7544808|FG001|Randomised, Double-blind|Adverse Event|9
4658418|NCT02167139|7544809|FG002|Randomised, Double-blind|Adverse Event|0
4658419|NCT02167139|7544810|FG003|Randomised, Double-blind|Adverse Event|0
4658420|NCT02167139|7544807|FG000|Randomised, Double-blind|Lack of Efficacy|1
4658421|NCT02167139|7544808|FG001|Randomised, Double-blind|Lack of Efficacy|2
4658422|NCT02167139|7544809|FG002|Randomised, Double-blind|Lack of Efficacy|0
4658423|NCT02167139|7544810|FG003|Randomised, Double-blind|Lack of Efficacy|0
4658424|NCT02167139|7544807|FG000|Randomised, Double-blind|Other|3
4658425|NCT02167139|7544808|FG001|Randomised, Double-blind|Other|0
4658426|NCT02167139|7544809|FG002|Randomised, Double-blind|Other|0
4658427|NCT02167139|7544810|FG003|Randomised, Double-blind|Other|0
4658428|NCT02167139|7544807|FG000|Transition-extension|Adverse Event|2
4658429|NCT02167139|7544808|FG001|Transition-extension|Adverse Event|0
4658430|NCT02167139|7544809|FG002|Transition-extension|Adverse Event|2
4658431|NCT02167139|7544810|FG003|Transition-extension|Adverse Event|3
4658432|NCT02167139|7544807|FG000|Transition-extension|Withdrawal by Subject|2
4658433|NCT02167139|7544808|FG001|Transition-extension|Withdrawal by Subject|0
4658434|NCT02167139|7544809|FG002|Transition-extension|Withdrawal by Subject|4
4658435|NCT02167139|7544810|FG003|Transition-extension|Withdrawal by Subject|1
4658436|NCT02167139|7544807|FG000|Transition-extension|Lack of Efficacy|0
4658437|NCT02167139|7544808|FG001|Transition-extension|Lack of Efficacy|0
4658438|NCT02167139|7544809|FG002|Transition-extension|Lack of Efficacy|1
4658439|NCT02167139|7544810|FG003|Transition-extension|Lack of Efficacy|1
4658440|NCT02167139|7544807|FG000|Transition-extension|Other|1
4658441|NCT02167139|7544808|FG001|Transition-extension|Other|0
4658442|NCT02167139|7544809|FG002|Transition-extension|Other|1
4658443|NCT02167139|7544810|FG003|Transition-extension|Other|0
4658444|NCT02167139|7544807|FG000|Transition-extension|Lost to Follow-up|1
4658445|NCT02167139|7544808|FG001|Transition-extension|Lost to Follow-up|0
4658446|NCT02167139|7544809|FG002|Transition-extension|Lost to Follow-up|0
4749473|NCT03181789|7723570|FG003|Overall Study|Lost to Follow-up|0
4658447|NCT02167139|7544810|FG003|Transition-extension|Lost to Follow-up|0
4749474|NCT03181789|7723567|FG000|Overall Study|Participant unable to adhere to visit|0
4749475|NCT03181789|7723568|FG001|Overall Study|Participant unable to adhere to visit|1
4749476|NCT03181789|7723569|FG002|Overall Study|Participant unable to adhere to visit|0
4749477|NCT03181789|7723570|FG003|Overall Study|Participant unable to adhere to visit|0
4749478|NCT03164356|7723585|FG000|Overall Study|Lost to Follow-up|1
4749479|NCT03164356|7723586|FG001|Overall Study|Lost to Follow-up|1
4749480|NCT03164356|7723587|FG002|Overall Study|Lost to Follow-up|2
4749481|NCT03164356|7723588|FG003|Overall Study|Lost to Follow-up|1
4749482|NCT03164356|7723585|FG000|Overall Study|Physician Decision|0
4749483|NCT03164356|7723586|FG001|Overall Study|Physician Decision|0
4749484|NCT03164356|7723587|FG002|Overall Study|Physician Decision|3
4749485|NCT03164356|7723588|FG003|Overall Study|Physician Decision|0
4749486|NCT03164356|7723585|FG000|Overall Study|Protocol Violation|2
4749487|NCT03164356|7723586|FG001|Overall Study|Protocol Violation|1
4658448|NCT02167256|7544840|FG000|Overall Study|Adverse Event|13
4658449|NCT02167256|7544841|FG001|Overall Study|Adverse Event|6
4658450|NCT02167256|7544840|FG000|Overall Study|Withdrawal by Subject|4
4658451|NCT02167256|7544841|FG001|Overall Study|Withdrawal by Subject|4
4658452|NCT02167256|7544840|FG000|Overall Study|non-compliance|3
4658453|NCT02167256|7544841|FG001|Overall Study|non-compliance|0
4749488|NCT03164356|7723587|FG002|Overall Study|Protocol Violation|0
4749489|NCT03164356|7723588|FG003|Overall Study|Protocol Violation|0
4749490|NCT03164356|7723585|FG000|Overall Study|Withdrawal by Subject|1
4749491|NCT03164356|7723586|FG001|Overall Study|Withdrawal by Subject|0
4749492|NCT03164356|7723587|FG002|Overall Study|Withdrawal by Subject|0
4749493|NCT03164356|7723588|FG003|Overall Study|Withdrawal by Subject|0
4749494|NCT03164356|7723585|FG000|Overall Study|Study timeframe interrupted by COVID-19|1
4658454|NCT02167256|7544840|FG000|Overall Study|Study partner unable to participate|1
4658455|NCT02167256|7544841|FG001|Overall Study|Study partner unable to participate|0
4658456|NCT02167451|7544847|FG000|Overall Study|Withdrawal by Subject|1
4658457|NCT02167594|7544854|FG000|Overall Study|Withdrawal by Subject|2
4658458|NCT02167594|7544855|FG001|Overall Study|Withdrawal by Subject|0
4658459|NCT02167594|7544856|FG002|Overall Study|Withdrawal by Subject|0
4658460|NCT02167594|7544854|FG000|Overall Study|Death|0
4658461|NCT02167594|7544855|FG001|Overall Study|Death|1
4658462|NCT02167594|7544856|FG002|Overall Study|Death|0
4658463|NCT02167893|7544884|FG000|Overall Study|Investigator transferred|85
4658464|NCT02167893|7544884|FG000|Overall Study|Investigator health reasons|10
4658465|NCT02167893|7544884|FG000|Overall Study|Case report forms not collected|68
4658466|NCT02168101|7544906|FG000|Overall Study|Death|2
4658467|NCT02168101|7544907|FG001|Overall Study|Death|2
4658468|NCT02168101|7544908|FG002|Overall Study|Death|1
4658469|NCT02168387|7544946|FG000|Overall Study|Planned exubation|6
4658470|NCT02168387|7544947|FG001|Overall Study|Planned exubation|3
4658471|NCT02168387|7544946|FG000|Overall Study|Death|1
4658472|NCT02168387|7544947|FG001|Overall Study|Death|0
4658473|NCT02168439|7544955|FG000|Overall Study|Protocol Violation|0
4658474|NCT02168439|7544956|FG001|Overall Study|Protocol Violation|2
4658475|NCT02168478|7544962|FG000|Overall Study|Withdrawal by Subject|1
4658476|NCT02168478|7544962|FG000|Overall Study|Did Not Consent to Participation|2
4658477|NCT02168478|7544962|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1
4658478|NCT02168491|7544966|FG000|Overall Study|Withdrawal by Subject|1
4658479|NCT02168777|7544989|FG000|Overall Study|Withdrawal by Subject|1
4658480|NCT02168777|7544990|FG001|Overall Study|Withdrawal by Subject|0
4658481|NCT02168777|7544991|FG002|Overall Study|Withdrawal by Subject|2
4658482|NCT02168777|7544989|FG000|Overall Study|Adverse Event|1
4658483|NCT02168777|7544990|FG001|Overall Study|Adverse Event|0
4658484|NCT02168777|7544991|FG002|Overall Study|Adverse Event|1
4658485|NCT02168777|7544989|FG000|Overall Study|Disease recurrence|0
4658486|NCT02168777|7544990|FG001|Overall Study|Disease recurrence|0
4658487|NCT02168777|7544991|FG002|Overall Study|Disease recurrence|1
4658488|NCT02168777|7544989|FG000|Overall Study|Radiological disease progression|0
4658489|NCT02168777|7544990|FG001|Overall Study|Radiological disease progression|5
4658490|NCT02168777|7544991|FG002|Overall Study|Radiological disease progression|5
4658491|NCT02168777|7544989|FG000|Overall Study|Clinical disease progression|0
4658492|NCT02168777|7544990|FG001|Overall Study|Clinical disease progression|1
4658493|NCT02168777|7544991|FG002|Overall Study|Clinical disease progression|2
4658494|NCT02168777|7544989|FG000|Overall Study|Other reason|0
4658495|NCT02168777|7544990|FG001|Overall Study|Other reason|1
4658496|NCT02168777|7544991|FG002|Overall Study|Other reason|0
4658497|NCT02168803|7545005|FG000|Overall Study|Lost to Follow-up|1
4658498|NCT02168803|7545006|FG001|Overall Study|Lost to Follow-up|0
4658499|NCT02168803|7545007|FG002|Overall Study|Lost to Follow-up|1
4658500|NCT02168803|7545005|FG000|Overall Study|Withdrawal by Subject|1
4658501|NCT02168803|7545006|FG001|Overall Study|Withdrawal by Subject|1
4658502|NCT02168803|7545007|FG002|Overall Study|Withdrawal by Subject|2
4658503|NCT02168803|7545005|FG000|Overall Study|Physician Decision|0
4658504|NCT02168803|7545006|FG001|Overall Study|Physician Decision|1
4658505|NCT02168803|7545007|FG002|Overall Study|Physician Decision|0
4658506|NCT02168803|7545005|FG000|Overall Study|Adverse Event|0
4658507|NCT02168803|7545006|FG001|Overall Study|Adverse Event|1
4658508|NCT02168803|7545007|FG002|Overall Study|Adverse Event|1
4658509|NCT02168803|7545005|FG000|Overall Study|Death|0
4658510|NCT02168803|7545006|FG001|Overall Study|Death|0
4658511|NCT02168803|7545007|FG002|Overall Study|Death|1
4658512|NCT02168803|7545005|FG000|Overall Study|Sponsor Decision|0
4658513|NCT02168803|7545006|FG001|Overall Study|Sponsor Decision|0
4658514|NCT02168803|7545007|FG002|Overall Study|Sponsor Decision|1
4658515|NCT02168816|7545024|FG000|Overall Study|Lost to Follow-up|2
4658516|NCT02168816|7545025|FG001|Overall Study|Lost to Follow-up|2
4658517|NCT02168842|7545033|FG000|Overall Study|Withdrawal by Subject|5
4658518|NCT02168842|7545034|FG001|Overall Study|Withdrawal by Subject|3
4658519|NCT02168842|7545033|FG000|Overall Study|Lost to Follow-up|0
4658520|NCT02168842|7545034|FG001|Overall Study|Lost to Follow-up|2
4658521|NCT02168842|7545033|FG000|Overall Study|Death|2
4658522|NCT02168842|7545034|FG001|Overall Study|Death|1
4658523|NCT02168842|7545033|FG000|Overall Study|Physician Decision|1
4749495|NCT03164356|7723586|FG001|Overall Study|Study timeframe interrupted by COVID-19|0
4658524|NCT02168842|7545034|FG001|Overall Study|Physician Decision|2
4658525|NCT02168946|7545063|FG000|Overall Study|Adverse Event|8
4658526|NCT02168946|7545064|FG001|Overall Study|Adverse Event|5
4658527|NCT02168946|7545063|FG000|Overall Study|Lost to Follow-up|3
4658528|NCT02168946|7545064|FG001|Overall Study|Lost to Follow-up|0
4658529|NCT02168946|7545063|FG000|Overall Study|Subject unable to come back for visits|1
4658530|NCT02168946|7545064|FG001|Overall Study|Subject unable to come back for visits|0
4658531|NCT02169219|7545084|FG000|Overall Study|Lack of Efficacy|6
4658532|NCT02169271|7545095|FG000|Overall Study|Protocol Violation|1
4658533|NCT02169271|7545096|FG001|Overall Study|Protocol Violation|2
4658534|NCT02169284|7545104|FG000|Overall Study|Physician Decision|0
4658535|NCT02169284|7545105|FG001|Overall Study|Physician Decision|1
4749496|NCT03164356|7723587|FG002|Overall Study|Study timeframe interrupted by COVID-19|0
4749497|NCT03164356|7723588|FG003|Overall Study|Study timeframe interrupted by COVID-19|1
4749498|NCT03164356|7723585|FG000|Overall Study|Subject Incarcerated|0
4749499|NCT03164356|7723586|FG001|Overall Study|Subject Incarcerated|1
4749500|NCT03164356|7723587|FG002|Overall Study|Subject Incarcerated|0
4749501|NCT03164356|7723588|FG003|Overall Study|Subject Incarcerated|0
4749502|NCT03164356|7723585|FG000|Overall Study|Prosthetist unable to participate|0
4749503|NCT03164356|7723586|FG001|Overall Study|Prosthetist unable to participate|2
4749504|NCT03164356|7723587|FG002|Overall Study|Prosthetist unable to participate|1
4749505|NCT03164356|7723588|FG003|Overall Study|Prosthetist unable to participate|0
4749506|NCT02975700|7723608|FG000|Overall Study|Adverse Event|1
4749507|NCT02975700|7723608|FG000|Overall Study|Progressive disease|3
4749508|NCT02975700|7723608|FG000|Overall Study|Failed screening criteria|2
4749509|NCT02941549|7723615|FG000|Overall Study|Adverse Event|1
4749510|NCT02941549|7723616|FG001|Overall Study|Adverse Event|0
4749511|NCT02941549|7723617|FG002|Overall Study|Adverse Event|0
4749512|NCT02941549|7723615|FG000|Overall Study|Withdrawal by Subject|2
4749513|NCT02941549|7723616|FG001|Overall Study|Withdrawal by Subject|1
4749514|NCT02941549|7723617|FG002|Overall Study|Withdrawal by Subject|2
4749515|NCT02927938|7723641|FG000|Overall Study|Death|0
4749516|NCT02927938|7723642|FG001|Overall Study|Death|1
4749517|NCT02927938|7723643|FG002|Overall Study|Death|0
4749518|NCT02927938|7723644|FG003|Overall Study|Death|4
4749519|NCT02927938|7723641|FG000|Overall Study|Early Study Termination|1
4749520|NCT02927938|7723642|FG001|Overall Study|Early Study Termination|5
4749521|NCT02927938|7723643|FG002|Overall Study|Early Study Termination|4
4749522|NCT02927938|7723644|FG003|Overall Study|Early Study Termination|3
4658536|NCT02169336|7545116|FG000|Overall Study|Lack of Efficacy|1
4658537|NCT02169336|7545117|FG001|Overall Study|Lack of Efficacy|1
4658538|NCT02169336|7545118|FG002|Overall Study|Lack of Efficacy|0
4658539|NCT02169336|7545116|FG000|Overall Study|Adverse Event|2
4658540|NCT02169336|7545117|FG001|Overall Study|Adverse Event|3
4658541|NCT02169336|7545118|FG002|Overall Study|Adverse Event|1
4658542|NCT02169336|7545116|FG000|Overall Study|Withdrawal by Subject|1
4658543|NCT02169336|7545117|FG001|Overall Study|Withdrawal by Subject|0
4658544|NCT02169336|7545118|FG002|Overall Study|Withdrawal by Subject|0
4658545|NCT02169336|7545116|FG000|Overall Study|Physician Decision|0
4658546|NCT02169336|7545117|FG001|Overall Study|Physician Decision|0
4658547|NCT02169336|7545118|FG002|Overall Study|Physician Decision|1
4658548|NCT02169336|7545116|FG000|Overall Study|Subject declined to continue dosing|0
4658549|NCT02169336|7545117|FG001|Overall Study|Subject declined to continue dosing|0
4658550|NCT02169336|7545118|FG002|Overall Study|Subject declined to continue dosing|1
4658551|NCT02169414|7545130|FG000|Overall Study|Withdrawal by Subject|1
4658552|NCT02169414|7545131|FG001|Overall Study|Withdrawal by Subject|0
4658553|NCT02169414|7545132|FG002|Overall Study|Withdrawal by Subject|0
4658554|NCT02169414|7545133|FG003|Overall Study|Withdrawal by Subject|0
4658555|NCT02169414|7545130|FG000|Overall Study|Adverse Event|0
4658556|NCT02169414|7545131|FG001|Overall Study|Adverse Event|1
4658557|NCT02169414|7545132|FG002|Overall Study|Adverse Event|0
4658558|NCT02169414|7545133|FG003|Overall Study|Adverse Event|0
4658559|NCT02169505|7545216|FG000|Overall Study|Withdrawal by Subject|1
4658560|NCT02169674|7545222|FG000|Overall Study|Withdrawal by Subject|2
4658561|NCT02169674|7545223|FG001|Overall Study|Withdrawal by Subject|1
4658562|NCT02169674|7545222|FG000|Overall Study|Seroprotected|30
4658563|NCT02169674|7545223|FG001|Overall Study|Seroprotected|76
4658564|NCT02169674|7545222|FG000|Overall Study|Lost to Follow-up|0
4658565|NCT02169674|7545223|FG001|Overall Study|Lost to Follow-up|1
4658566|NCT02169739|7545231|FG000|Overall Study|Lost to Follow-up|0
4658567|NCT02169739|7545232|FG001|Overall Study|Lost to Follow-up|4
4658568|NCT02169791|7545239|FG000|Overall Study|Death|6
4658569|NCT02169791|7545239|FG000|Overall Study|patient withdrew consent|1
4658570|NCT02170025|7545271|FG000|Overall Study|Adverse Event|2
4658571|NCT02170025|7545272|FG001|Overall Study|Adverse Event|0
4658572|NCT02170051|7545280|FG000|Overall Study|Withdrawal by Subject|10
4658573|NCT02170051|7545281|FG001|Overall Study|Withdrawal by Subject|10
4658574|NCT02170051|7545280|FG000|Overall Study|Lost to Follow-up|1
4658575|NCT02170051|7545281|FG001|Overall Study|Lost to Follow-up|3
4658576|NCT02170064|7545290|FG000|Overall Study|Withdrawal by Subject|5
4658577|NCT02170064|7545291|FG001|Overall Study|Withdrawal by Subject|1
4658578|NCT02170064|7545292|FG002|Overall Study|Withdrawal by Subject|1
4658579|NCT02170064|7545290|FG000|Overall Study|Physician Decision|1
4658580|NCT02170064|7545291|FG001|Overall Study|Physician Decision|1
4658581|NCT02170064|7545292|FG002|Overall Study|Physician Decision|0
4658582|NCT02170077|7545303|FG000|Overall Study|Withdrawal by Subject|3
4658583|NCT02170077|7545304|FG001|Overall Study|Withdrawal by Subject|4
4658584|NCT02170077|7545305|FG002|Overall Study|Withdrawal by Subject|2
4658585|NCT02170077|7545303|FG000|Overall Study|Adverse Event|4
4658586|NCT02170077|7545304|FG001|Overall Study|Adverse Event|4
4658587|NCT02170077|7545305|FG002|Overall Study|Adverse Event|4
4658588|NCT02170077|7545303|FG000|Overall Study|Lost to Follow-up|0
4658589|NCT02170077|7545304|FG001|Overall Study|Lost to Follow-up|1
4658590|NCT02170077|7545305|FG002|Overall Study|Lost to Follow-up|0
4658591|NCT02170077|7545303|FG000|Overall Study|Exclusion criteria|2
4658592|NCT02170077|7545304|FG001|Overall Study|Exclusion criteria|2
4658593|NCT02170077|7545305|FG002|Overall Study|Exclusion criteria|5
4658594|NCT02170077|7545303|FG000|Overall Study|Exacerbation of seizures|0
4658595|NCT02170077|7545304|FG001|Overall Study|Exacerbation of seizures|2
4658596|NCT02170077|7545305|FG002|Overall Study|Exacerbation of seizures|1
4658597|NCT02170207|7545313|FG000|Overall Study|Case report forms unavailable|5
4658598|NCT02170389|7545353|FG000|Overall Study|Study terminated prior to start of treat|1
4658599|NCT02170688|7545396|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4
4658600|NCT02170688|7545397|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2
4658601|NCT02170688|7545398|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3
4658602|NCT02170688|7545399|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2
4658603|NCT02170688|7545400|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0
4658604|NCT02170688|7545396|FG000|Overall Study|Full dose not received|0
4658605|NCT02170688|7545397|FG001|Overall Study|Full dose not received|1
4658606|NCT02170688|7545398|FG002|Overall Study|Full dose not received|0
4658607|NCT02170688|7545399|FG003|Overall Study|Full dose not received|0
4658608|NCT02170688|7545400|FG004|Overall Study|Full dose not received|0
4658609|NCT02170688|7545396|FG000|Overall Study|Physician Decision|0
4658610|NCT02170688|7545397|FG001|Overall Study|Physician Decision|0
4658611|NCT02170688|7545398|FG002|Overall Study|Physician Decision|1
4658612|NCT02170688|7545399|FG003|Overall Study|Physician Decision|0
4658613|NCT02170688|7545400|FG004|Overall Study|Physician Decision|0
4658614|NCT02170727|7545414|FG000|Overall Study|Lost to Follow-up|1
4658615|NCT02170727|7545415|FG001|Overall Study|Lost to Follow-up|0
4658616|NCT02170727|7545414|FG000|Overall Study|Withdrawal by Subject|2
4658617|NCT02170727|7545415|FG001|Overall Study|Withdrawal by Subject|0
4658618|NCT02170779|7545426|FG000|Overall Study|Withdrawal by Subject|1
4658619|NCT02170779|7545427|FG001|Overall Study|Withdrawal by Subject|0
4658620|NCT02170779|7545426|FG000|Overall Study|Lost to Follow-up|0
4658621|NCT02170779|7545427|FG001|Overall Study|Lost to Follow-up|1
4658622|NCT02171065|7545464|FG000|Overall Study|Withdrawal by Subject|1
4658623|NCT02171065|7545465|FG001|Overall Study|Withdrawal by Subject|0
4658624|NCT02171065|7545466|FG002|Overall Study|Withdrawal by Subject|0
4658625|NCT02171065|7545464|FG000|Overall Study|Lost to Follow-up|0
4658626|NCT02171065|7545465|FG001|Overall Study|Lost to Follow-up|0
4658627|NCT02171065|7545466|FG002|Overall Study|Lost to Follow-up|1
4658628|NCT02171130|7545476|FG000|Overall Study|Death|1
4658629|NCT02171130|7545476|FG000|Overall Study|Discontinued; Clinical Material Issue|16
4658630|NCT02171130|7545476|FG000|Overall Study|Discontinued; Site Termination|5
4658631|NCT02171130|7545476|FG000|Overall Study|Withdrawal by Subject|3
4658632|NCT02171130|7545476|FG000|Overall Study|Physician Decision|1
4658633|NCT02171130|7545476|FG000|Overall Study|Lost to Follow-up|1
4658634|NCT02171130|7545476|FG000|Overall Study|Met Exclusion Criteria|1
4658635|NCT02171260|7545551|FG000|Overall Study|Death|0
4658636|NCT02171260|7545552|FG001|Overall Study|Death|0
4658637|NCT02171260|7545553|FG002|Overall Study|Death|0
4658638|NCT02171260|7545554|FG003|Overall Study|Death|1
4658639|NCT02171260|7545551|FG000|Overall Study|Physician Decision|1
4658640|NCT02171260|7545552|FG001|Overall Study|Physician Decision|0
4658641|NCT02171260|7545553|FG002|Overall Study|Physician Decision|1
4658642|NCT02171260|7545554|FG003|Overall Study|Physician Decision|0
4658643|NCT02171260|7545551|FG000|Overall Study|Withdrawal by Subject|1
4749523|NCT02823574|7723684|FG000|Pre-Treatment Period|Adverse Event Unrelated to Study drug|1
4749524|NCT02823574|7723685|FG001|Pre-Treatment Period|Adverse Event Unrelated to Study drug|0
4749525|NCT02823574|7723686|FG002|Pre-Treatment Period|Adverse Event Unrelated to Study drug|0
4749526|NCT02823574|7723687|FG003|Pre-Treatment Period|Adverse Event Unrelated to Study drug|0
4749527|NCT02823574|7723684|FG000|Pre-Treatment Period|Disease progression|0
4749528|NCT02823574|7723685|FG001|Pre-Treatment Period|Disease progression|0
4749529|NCT02823574|7723686|FG002|Pre-Treatment Period|Disease progression|1
4749530|NCT02823574|7723687|FG003|Pre-Treatment Period|Disease progression|0
4749531|NCT02823574|7723684|FG000|Treatment Period|Poor/Non Compliance|1
4749532|NCT02823574|7723685|FG001|Treatment Period|Poor/Non Compliance|0
4749533|NCT02823574|7723686|FG002|Treatment Period|Poor/Non Compliance|0
4749534|NCT02823574|7723687|FG003|Treatment Period|Poor/Non Compliance|1
4749535|NCT02823574|7723684|FG000|Treatment Period|Maximum Clinical Benefit|1
4749536|NCT02823574|7723685|FG001|Treatment Period|Maximum Clinical Benefit|0
4749537|NCT02823574|7723686|FG002|Treatment Period|Maximum Clinical Benefit|2
4749538|NCT02823574|7723687|FG003|Treatment Period|Maximum Clinical Benefit|0
4749539|NCT02823574|7723684|FG000|Treatment Period|Lost to Follow-up|1
4749540|NCT02823574|7723685|FG001|Treatment Period|Lost to Follow-up|0
4749541|NCT02823574|7723686|FG002|Treatment Period|Lost to Follow-up|0
4749542|NCT02823574|7723687|FG003|Treatment Period|Lost to Follow-up|0
4749543|NCT02823574|7723684|FG000|Treatment Period|Participant withdrew consent|2
4749544|NCT02823574|7723685|FG001|Treatment Period|Participant withdrew consent|0
4749545|NCT02823574|7723686|FG002|Treatment Period|Participant withdrew consent|0
4749546|NCT02823574|7723687|FG003|Treatment Period|Participant withdrew consent|0
4749547|NCT02823574|7723684|FG000|Treatment Period|Participant request to discontinue|4
4749548|NCT02823574|7723685|FG001|Treatment Period|Participant request to discontinue|0
4749549|NCT02823574|7723686|FG002|Treatment Period|Participant request to discontinue|2
4749550|NCT02823574|7723687|FG003|Treatment Period|Participant request to discontinue|3
4749551|NCT02823574|7723684|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10
4749552|NCT02823574|7723685|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2
4749553|NCT02823574|7723686|FG002|Treatment Period|Adverse Event unrelated to to study Drug|8
4749554|NCT02823574|7723687|FG003|Treatment Period|Adverse Event unrelated to to study Drug|1
4749555|NCT02823574|7723684|FG000|Treatment Period|Study Drug Toxicity|7
4749556|NCT02823574|7723685|FG001|Treatment Period|Study Drug Toxicity|2
4749557|NCT02823574|7723686|FG002|Treatment Period|Study Drug Toxicity|13
4749558|NCT02823574|7723687|FG003|Treatment Period|Study Drug Toxicity|3
4749559|NCT02823574|7723684|FG000|Treatment Period|Disease Progression|112
4749560|NCT02823574|7723685|FG001|Treatment Period|Disease Progression|60
4749561|NCT02823574|7723686|FG002|Treatment Period|Disease Progression|80
4749562|NCT02823574|7723687|FG003|Treatment Period|Disease Progression|41
4749563|NCT02823574|7723684|FG000|Treatment Period|participant no longer meets study criteria|0
4749564|NCT02823574|7723685|FG001|Treatment Period|participant no longer meets study criteria|0
4749565|NCT02823574|7723686|FG002|Treatment Period|participant no longer meets study criteria|1
4749566|NCT02823574|7723687|FG003|Treatment Period|participant no longer meets study criteria|0
4749567|NCT02823574|7723684|FG000|Treatment Period|Death|0
4749568|NCT02823574|7723685|FG001|Treatment Period|Death|0
4749569|NCT02823574|7723686|FG002|Treatment Period|Death|2
4749570|NCT02823574|7723687|FG003|Treatment Period|Death|1
4749571|NCT02823574|7723684|FG000|Treatment Period|Other reasons|1
4749572|NCT02823574|7723685|FG001|Treatment Period|Other reasons|2
4658644|NCT02171260|7545552|FG001|Overall Study|Withdrawal by Subject|0
4658645|NCT02171260|7545553|FG002|Overall Study|Withdrawal by Subject|0
4658646|NCT02171260|7545554|FG003|Overall Study|Withdrawal by Subject|0
4658647|NCT02171260|7545551|FG000|Overall Study|Evidence of progressive disease|4
4749573|NCT02823574|7723686|FG002|Treatment Period|Other reasons|0
4749574|NCT02823574|7723687|FG003|Treatment Period|Other reasons|1
4749575|NCT02743819|7723709|FG000|Overall Study|Lack of Efficacy|5
4658648|NCT02171260|7545552|FG001|Overall Study|Evidence of progressive disease|6
4658649|NCT02171260|7545553|FG002|Overall Study|Evidence of progressive disease|4
4658650|NCT02171260|7545554|FG003|Overall Study|Evidence of progressive disease|4
4658651|NCT02171429|7545573|FG000|Overall Study|Other|0
4658652|NCT02171429|7545574|FG001|Overall Study|Other|1
4658653|NCT02171429|7545575|FG002|Overall Study|Other|1
4658654|NCT02171429|7545573|FG000|Overall Study|Non-Compliance|0
4658655|NCT02171429|7545574|FG001|Overall Study|Non-Compliance|0
4658656|NCT02171429|7545575|FG002|Overall Study|Non-Compliance|1
4658657|NCT02171429|7545573|FG000|Overall Study|Physician Decision|0
4658658|NCT02171429|7545574|FG001|Overall Study|Physician Decision|0
4658659|NCT02171429|7545575|FG002|Overall Study|Physician Decision|1
4658660|NCT02171429|7545573|FG000|Overall Study|Withdrawal by Subject|1
4658661|NCT02171429|7545574|FG001|Overall Study|Withdrawal by Subject|1
4658662|NCT02171429|7545575|FG002|Overall Study|Withdrawal by Subject|1
4658663|NCT02171429|7545573|FG000|Overall Study|Lost to Follow-up|0
4658664|NCT02171429|7545574|FG001|Overall Study|Lost to Follow-up|1
4658665|NCT02171429|7545575|FG002|Overall Study|Lost to Follow-up|0
4658666|NCT02171429|7545573|FG000|Overall Study|Death|0
4658667|NCT02171429|7545574|FG001|Overall Study|Death|0
4658668|NCT02171429|7545575|FG002|Overall Study|Death|1
4658669|NCT02172040|7545620|FG000|Overall Study|Adverse Event|0
4658670|NCT02172040|7545621|FG001|Overall Study|Adverse Event|2
4658671|NCT02172040|7545622|FG002|Overall Study|Adverse Event|0
4658672|NCT02172040|7545623|FG003|Overall Study|Adverse Event|0
4658673|NCT02172040|7545620|FG000|Overall Study|Protocol Violation|0
4658674|NCT02172040|7545621|FG001|Overall Study|Protocol Violation|1
4658675|NCT02172040|7545622|FG002|Overall Study|Protocol Violation|0
4658676|NCT02172040|7545623|FG003|Overall Study|Protocol Violation|0
4658677|NCT02172040|7545620|FG000|Overall Study|Withdrawal by Subject|0
4658678|NCT02172040|7545621|FG001|Overall Study|Withdrawal by Subject|0
4658679|NCT02172040|7545622|FG002|Overall Study|Withdrawal by Subject|1
4658680|NCT02172040|7545623|FG003|Overall Study|Withdrawal by Subject|0
4658681|NCT02172040|7545620|FG000|Overall Study|Not available for Day 13 & 14 visits|0
4658682|NCT02172040|7545621|FG001|Overall Study|Not available for Day 13 & 14 visits|0
4658683|NCT02172040|7545622|FG002|Overall Study|Not available for Day 13 & 14 visits|1
4658684|NCT02172040|7545623|FG003|Overall Study|Not available for Day 13 & 14 visits|0
4658685|NCT02172040|7545620|FG000|Overall Study|Family emergency abroad|0
4658686|NCT02172040|7545621|FG001|Overall Study|Family emergency abroad|0
4658687|NCT02172040|7545622|FG002|Overall Study|Family emergency abroad|0
4658688|NCT02172040|7545623|FG003|Overall Study|Family emergency abroad|1
4658689|NCT02172625|7545636|FG000|Overall Study|Adverse Event|0
4658690|NCT02172625|7545637|FG001|Overall Study|Adverse Event|1
4658691|NCT02172625|7545636|FG000|Overall Study|Pregnancy|0
4658692|NCT02172625|7545637|FG001|Overall Study|Pregnancy|1
4658693|NCT02172625|7545636|FG000|Overall Study|car accident|0
4658694|NCT02172625|7545637|FG001|Overall Study|car accident|1
4658695|NCT02172664|7545647|FG000|Overall Study|Lost to Follow-up|4
4658696|NCT02172664|7545648|FG001|Overall Study|Lost to Follow-up|4
4658697|NCT02172664|7545647|FG000|Overall Study|Death|1
4658698|NCT02172664|7545648|FG001|Overall Study|Death|1
4658699|NCT02172664|7545647|FG000|Overall Study|Moved out of area|1
4658700|NCT02172664|7545648|FG001|Overall Study|Moved out of area|1
4658701|NCT02172911|7545681|FG000|Overall Study|Serious Adverse Event|0
4658702|NCT02172911|7545682|FG001|Overall Study|Serious Adverse Event|1
4749576|NCT02743819|7723709|FG000|Overall Study|Death|2
4749577|NCT02743819|7723709|FG000|Overall Study|Adverse Event|1
4749578|NCT02729753|7723715|FG000|Overall Study|Device Malfunction. No units in stock.|0
4749579|NCT02729753|7723716|FG001|Overall Study|Device Malfunction. No units in stock.|1
4749580|NCT02704130|7723727|FG000|Overall Study|Physician Decision|5
4749581|NCT02704130|7723728|FG001|Overall Study|Physician Decision|3
4749582|NCT02701192|7723734|FG000|Overall Study|Protocol Violation|2
4749583|NCT02701192|7723734|FG000|Overall Study|Lost to Follow-up|4
4749584|NCT02653482|7723768|FG000|Overall Study|Death|1
4749585|NCT02653482|7723769|FG001|Overall Study|Death|1
4749586|NCT02632409|7723777|FG000|Randomized|AE unrelated to study Drug|0
4749587|NCT02632409|7723778|FG001|Randomized|AE unrelated to study Drug|1
4749588|NCT02632409|7723777|FG000|Randomized|Participant withdrew consent|2
4749589|NCT02632409|7723778|FG001|Randomized|Participant withdrew consent|1
4749590|NCT02632409|7723777|FG000|Randomized|No Longer meets study criteria|5
4749591|NCT02632409|7723778|FG001|Randomized|No Longer meets study criteria|0
4658703|NCT02172911|7545681|FG000|Overall Study|Progression of Disease|0
4658704|NCT02172911|7545682|FG001|Overall Study|Progression of Disease|1
4658705|NCT02172911|7545681|FG000|Overall Study|Loss of insurance coverage|1
4658706|NCT02172911|7545682|FG001|Overall Study|Loss of insurance coverage|0
4658707|NCT02172950|7545690|FG000|Overall Study|Physician Decision|3
4658708|NCT02172950|7545691|FG001|Overall Study|Physician Decision|3
4658709|NCT02172950|7545690|FG000|Overall Study|Lack of Efficacy|1
4658710|NCT02172950|7545691|FG001|Overall Study|Lack of Efficacy|0
4658711|NCT02172950|7545690|FG000|Overall Study|Adverse Event|4
4658712|NCT02172950|7545691|FG001|Overall Study|Adverse Event|1
4658713|NCT02172950|7545690|FG000|Overall Study|Withdrawal by Subject|10
4658714|NCT02172950|7545691|FG001|Overall Study|Withdrawal by Subject|0
4749592|NCT02632409|7723777|FG000|Randomized|other reasons|1
4658715|NCT02172950|7545690|FG000|Overall Study|Protocol Violation|1
4658716|NCT02172950|7545691|FG001|Overall Study|Protocol Violation|0
4658717|NCT02172950|7545690|FG000|Overall Study|Lost to Follow-up|1
4658718|NCT02172950|7545691|FG001|Overall Study|Lost to Follow-up|0
4658719|NCT02172950|7545690|FG000|Overall Study|Death|1
4658720|NCT02172950|7545691|FG001|Overall Study|Death|0
4658721|NCT02172950|7545690|FG000|Overall Study|Patient traveling|1
4658722|NCT02172950|7545691|FG001|Overall Study|Patient traveling|0
4658723|NCT02172950|7545690|FG000|Overall Study|Patient went to other country|1
4658724|NCT02172950|7545691|FG001|Overall Study|Patient went to other country|0
4658725|NCT02172950|7545690|FG000|Overall Study|Patient relocated overseas|1
4658726|NCT02172950|7545691|FG001|Overall Study|Patient relocated overseas|1
4658727|NCT02172950|7545690|FG000|Overall Study|Patient moving|1
4658728|NCT02172950|7545691|FG001|Overall Study|Patient moving|0
4658729|NCT02173054|7545701|FG000|Overall Study|lack of compliance|1
4658730|NCT02173054|7545702|FG001|Overall Study|lack of compliance|0
4658731|NCT02173054|7545703|FG002|Overall Study|lack of compliance|0
4658732|NCT02173054|7545701|FG000|Overall Study|Withdrawal by Subject|0
4658733|NCT02173054|7545702|FG001|Overall Study|Withdrawal by Subject|0
4658734|NCT02173054|7545703|FG002|Overall Study|Withdrawal by Subject|1
4658735|NCT02173158|7545711|FG000|Efficacy Phase|Adverse Event|1
4658736|NCT02173548|7545802|FG000|Overall Study|Lost to Follow-up|0
4658737|NCT02173548|7545803|FG001|Overall Study|Lost to Follow-up|2
4658738|NCT02173548|7545802|FG000|Overall Study|Withdrawal by Subject|1
4658739|NCT02173548|7545803|FG001|Overall Study|Withdrawal by Subject|0
4658740|NCT02173704|7545811|FG000|Overall Study|Adverse Event|1
4658741|NCT02173704|7545812|FG001|Overall Study|Adverse Event|0
4658742|NCT02173704|7545811|FG000|Overall Study|Lost to Follow-up|1
4658743|NCT02173704|7545812|FG001|Overall Study|Lost to Follow-up|0
4658744|NCT02173704|7545811|FG000|Overall Study|Other|1
4658745|NCT02173704|7545812|FG001|Overall Study|Other|0
4658746|NCT02173704|7545811|FG000|Overall Study|Protocol Violation|1
4658747|NCT02173704|7545812|FG001|Overall Study|Protocol Violation|0
4658748|NCT02173704|7545811|FG000|Overall Study|Withdrawal by Subject|9
4658749|NCT02173704|7545812|FG001|Overall Study|Withdrawal by Subject|4
4658750|NCT02173769|7545818|FG000|Overall Study|Protocol Violation|4
4658751|NCT02174276|7545836|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1
4658752|NCT02174276|7545837|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0
4658753|NCT02174276|7545838|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0
4658754|NCT02174276|7545839|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0
4658755|NCT02174276|7545836|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0
4658756|NCT02174276|7545837|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0
4658757|NCT02174276|7545838|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1
4658758|NCT02174276|7545839|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0
4658759|NCT02174276|7545836|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0
4658760|NCT02174276|7545837|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1
4658761|NCT02174276|7545838|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2
4749593|NCT02632409|7723778|FG001|Randomized|other reasons|0
4749594|NCT02632409|7723777|FG000|Treatment Period|Ongoing Treatment|20
4749595|NCT02632409|7723778|FG001|Treatment Period|Ongoing Treatment|21
4749596|NCT02632409|7723777|FG000|Treatment Period|Disease Recurrence|147
4749597|NCT02632409|7723778|FG001|Treatment Period|Disease Recurrence|90
4749598|NCT02632409|7723777|FG000|Treatment Period|Study Drug Toxicity|8
4749599|NCT02632409|7723778|FG001|Treatment Period|Study Drug Toxicity|49
4749600|NCT02632409|7723777|FG000|Treatment Period|Death|1
4749601|NCT02632409|7723778|FG001|Treatment Period|Death|0
4749602|NCT02632409|7723777|FG000|Treatment Period|AE unrelated to study drug|15
4749603|NCT02632409|7723778|FG001|Treatment Period|AE unrelated to study drug|16
4749604|NCT02632409|7723777|FG000|Treatment Period|Request to discontinue treatment|4
4749605|NCT02632409|7723778|FG001|Treatment Period|Request to discontinue treatment|19
4749606|NCT02632409|7723777|FG000|Treatment Period|Participant withdrew consent|7
4749607|NCT02632409|7723778|FG001|Treatment Period|Participant withdrew consent|5
4749608|NCT02632409|7723777|FG000|Treatment Period|Lost to Follow-up|0
4749609|NCT02632409|7723778|FG001|Treatment Period|Lost to Follow-up|1
4749610|NCT02632409|7723777|FG000|Treatment Period|Maximum clinical benefit|1
4749611|NCT02632409|7723778|FG001|Treatment Period|Maximum clinical benefit|0
4749612|NCT02632409|7723777|FG000|Treatment Period|No longer meets study criteria|3
4749613|NCT02632409|7723778|FG001|Treatment Period|No longer meets study criteria|0
4749614|NCT02632409|7723777|FG000|Treatment Period|Administrative Reason by sponsor|0
4749615|NCT02632409|7723778|FG001|Treatment Period|Administrative Reason by sponsor|1
4749616|NCT02632409|7723777|FG000|Treatment Period|Other Reasons|10
4749617|NCT02632409|7723778|FG001|Treatment Period|Other Reasons|6
4658762|NCT02174276|7545839|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0
4658763|NCT02174276|7545836|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0
4658764|NCT02174276|7545837|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0
4658765|NCT02174276|7545838|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1
4658766|NCT02174276|7545839|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0
4658767|NCT02174276|7545836|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0
4658768|NCT02174276|7545837|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0
4658769|NCT02174276|7545838|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1
4749618|NCT02612194|7723787|FG000|Overall Study|Death|5
4749619|NCT02612194|7723788|FG001|Overall Study|Death|0
4749620|NCT02612194|7723789|FG002|Overall Study|Death|2
4749621|NCT02612194|7723787|FG000|Overall Study|Early Study Termination|1
4658770|NCT02174276|7545839|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0
4658771|NCT02174276|7545836|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1
4658772|NCT02174276|7545837|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0
4658773|NCT02174276|7545838|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1
4658774|NCT02174276|7545839|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2
4658775|NCT02174523|7545884|FG000|Overall Study|Withdrawal by Subject|1
4658776|NCT02174523|7545885|FG001|Overall Study|Withdrawal by Subject|0
4658777|NCT02174562|7545892|FG000|Overall Study|Withdrawal by Subject|7
4658778|NCT02174562|7545893|FG001|Overall Study|Withdrawal by Subject|2
4658779|NCT02174562|7545892|FG000|Overall Study|Death|2
4658780|NCT02174562|7545893|FG001|Overall Study|Death|0
4658781|NCT02174562|7545892|FG000|Overall Study|Lost to Follow-up|0
4658782|NCT02174562|7545893|FG001|Overall Study|Lost to Follow-up|3
4658783|NCT02174627|7545901|FG000|Overall Study|Missing|0
4658784|NCT02174627|7545902|FG001|Overall Study|Missing|1
4658785|NCT02174627|7545901|FG000|Overall Study|Incorrect enrolment before randomization|0
4658786|NCT02174627|7545902|FG001|Overall Study|Incorrect enrolment before randomization|1
4658787|NCT02174627|7545901|FG000|Overall Study|Participant decision|84
4658788|NCT02174627|7545902|FG001|Overall Study|Participant decision|128
4658789|NCT02174731|7545910|FG000|Overall Study|Participant decision|67
4658790|NCT02174731|7545911|FG001|Overall Study|Participant decision|64
4658791|NCT02174731|7545910|FG000|Overall Study|Incorrect enrolment before randomization|0
4658792|NCT02174731|7545911|FG001|Overall Study|Incorrect enrolment before randomization|1
4658793|NCT02174731|7545910|FG000|Overall Study|Missing|2
4658794|NCT02174731|7545911|FG001|Overall Study|Missing|0
4658795|NCT02174848|7545919|FG000|Overall Study|Adverse Event|2
4658796|NCT02174848|7545920|FG001|Overall Study|Adverse Event|1
4658797|NCT02174848|7545919|FG000|Overall Study|Withdrawal by Subject|3
4658798|NCT02174848|7545920|FG001|Overall Study|Withdrawal by Subject|3
4658799|NCT02174848|7545919|FG000|Overall Study|Lost to Follow-up|0
4658800|NCT02174848|7545920|FG001|Overall Study|Lost to Follow-up|1
4658801|NCT02174848|7545919|FG000|Overall Study|Worsening of disease|1
4658802|NCT02174848|7545920|FG001|Overall Study|Worsening of disease|1
4658803|NCT02174848|7545919|FG000|Overall Study|Unable to comply with study requirements|1
4658804|NCT02174848|7545920|FG001|Overall Study|Unable to comply with study requirements|0
4658805|NCT02174861|7545931|FG000|Overall Study|Decision by sponsor|8
4658806|NCT02174861|7545931|FG000|Overall Study|Withdrawal by Subject|124
4658807|NCT02174861|7545931|FG000|Overall Study|Lost to Follow-up|26
4658808|NCT02175121|7545951|FG000|Overall Study|Lack of Efficacy|1
4658809|NCT02175121|7545952|FG001|Overall Study|Lack of Efficacy|0
4658810|NCT02175121|7545953|FG002|Overall Study|Lack of Efficacy|0
4658811|NCT02175121|7545954|FG003|Overall Study|Lack of Efficacy|0
4658812|NCT02175121|7545955|FG004|Overall Study|Lack of Efficacy|0
4658813|NCT02175121|7545951|FG000|Overall Study|Lost to Follow-up|0
4658814|NCT02175121|7545952|FG001|Overall Study|Lost to Follow-up|1
4658815|NCT02175121|7545953|FG002|Overall Study|Lost to Follow-up|0
4658816|NCT02175121|7545954|FG003|Overall Study|Lost to Follow-up|1
4658817|NCT02175121|7545955|FG004|Overall Study|Lost to Follow-up|0
4658818|NCT02175121|7545951|FG000|Overall Study|Personal emergency|0
4658819|NCT02175121|7545952|FG001|Overall Study|Personal emergency|0
4658820|NCT02175121|7545953|FG002|Overall Study|Personal emergency|0
4658821|NCT02175121|7545954|FG003|Overall Study|Personal emergency|0
4658822|NCT02175121|7545955|FG004|Overall Study|Personal emergency|1
4658823|NCT02175121|7545951|FG000|Overall Study|Schedule conflict|0
4658824|NCT02175121|7545952|FG001|Overall Study|Schedule conflict|0
4658825|NCT02175121|7545953|FG002|Overall Study|Schedule conflict|1
4658826|NCT02175121|7545954|FG003|Overall Study|Schedule conflict|0
4658827|NCT02175121|7545955|FG004|Overall Study|Schedule conflict|0
4658828|NCT02175121|7545951|FG000|Overall Study|Time issues|0
4658829|NCT02175121|7545952|FG001|Overall Study|Time issues|0
4658830|NCT02175121|7545953|FG002|Overall Study|Time issues|1
4658831|NCT02175121|7545954|FG003|Overall Study|Time issues|0
4658832|NCT02175121|7545955|FG004|Overall Study|Time issues|0
4658833|NCT02175199|7545973|FG000|Overall Study|Withdrawal by Subject|1
4658834|NCT02175199|7545974|FG001|Overall Study|Withdrawal by Subject|5
4658835|NCT02175199|7545973|FG000|Overall Study|Randomized in Error|1
4658836|NCT02175199|7545974|FG001|Overall Study|Randomized in Error|0
4658837|NCT02175199|7545973|FG000|Overall Study|Sponsor Decision|1
4658838|NCT02175199|7545974|FG001|Overall Study|Sponsor Decision|0
4658839|NCT02175225|7545992|FG000|Overall Study|Withdrawal by Subject|1
4658840|NCT02175225|7545993|FG001|Overall Study|Withdrawal by Subject|2
4658841|NCT02175225|7545992|FG000|Overall Study|Lost to Follow-up|6
4658842|NCT02175225|7545993|FG001|Overall Study|Lost to Follow-up|7
4658843|NCT02175225|7545992|FG000|Overall Study|Study drug not administered|1
4658844|NCT02175225|7545993|FG001|Overall Study|Study drug not administered|2
4749622|NCT02612194|7723788|FG001|Overall Study|Early Study Termination|0
4749623|NCT02612194|7723789|FG002|Overall Study|Early Study Termination|0
4749624|NCT02586207|7723796|FG000|Overall Study|Physician Decision|1
4749625|NCT02586207|7723796|FG000|Overall Study|Withdrawal by Subject|1
4749626|NCT02542397|7723800|FG000|Overall Study|Death|2
4749627|NCT02542397|7723800|FG000|Overall Study|Physician Decision|6
4749628|NCT02542397|7723800|FG000|Overall Study|Withdrawal by Subject|6
4749629|NCT02542397|7723800|FG000|Overall Study|Lost to Follow-up|2
4749630|NCT02536794|7723805|FG000|Reached 1st Response Assessment|Adverse Event|2
4658845|NCT02175277|7545999|FG000|Overall Study|Protocol-specified Criteria|1
4658846|NCT02175368|7546003|FG000|Overall Study|Lost to Follow-up|1
4658847|NCT02175641|7546018|FG000|Overall Study|Death|3
4658848|NCT02175641|7546019|FG001|Overall Study|Death|4
4658849|NCT02175641|7546018|FG000|Overall Study|Lost to Follow-up|4
4658850|NCT02175641|7546019|FG001|Overall Study|Lost to Follow-up|4
4658851|NCT02175641|7546018|FG000|Overall Study|Withdrawal by Subject|7
4658852|NCT02175641|7546019|FG001|Overall Study|Withdrawal by Subject|4
4658853|NCT02175641|7546018|FG000|Overall Study|Discharged from Supportive Housing Agenc|13
4658854|NCT02175641|7546019|FG001|Overall Study|Discharged from Supportive Housing Agenc|15
4658855|NCT02175641|7546018|FG000|Overall Study|Developed Contraindicated Condition|8
4658856|NCT02175641|7546019|FG001|Overall Study|Developed Contraindicated Condition|0
4658857|NCT02175745|7546025|FG000|Overall Study|Not Eligible|1
4658858|NCT02175758|7546035|FG000|Treatment Phase|Lost to Follow-up|0
4658859|NCT02175758|7546036|FG001|Treatment Phase|Lost to Follow-up|1
4658860|NCT02175758|7546037|FG002|Treatment Phase|Lost to Follow-up|0
4658861|NCT02175758|7546038|FG003|Treatment Phase|Lost to Follow-up|0
4658862|NCT02175758|7546039|FG004|Treatment Phase|Lost to Follow-up|0
4658863|NCT02175758|7546040|FG005|Treatment Phase|Lost to Follow-up|0
4658864|NCT02175758|7546035|FG000|Treatment Phase|Adverse Event|0
4658865|NCT02175758|7546036|FG001|Treatment Phase|Adverse Event|0
4658866|NCT02175758|7546037|FG002|Treatment Phase|Adverse Event|0
4658867|NCT02175758|7546038|FG003|Treatment Phase|Adverse Event|0
4658868|NCT02175758|7546039|FG004|Treatment Phase|Adverse Event|1
4658869|NCT02175758|7546040|FG005|Treatment Phase|Adverse Event|0
4658870|NCT02175771|7546088|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23
4658871|NCT02175771|7546089|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0
4658872|NCT02175771|7546090|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0
4658873|NCT02175771|7546091|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0
4658874|NCT02175771|7546092|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0
4658875|NCT02175771|7546093|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0
4658876|NCT02175771|7546094|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0
4658877|NCT02175771|7546095|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0
4658878|NCT02175771|7546096|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0
4658879|NCT02175771|7546088|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20
4658880|NCT02175771|7546089|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0
4658881|NCT02175771|7546090|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0
4658882|NCT02175771|7546091|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0
4658883|NCT02175771|7546092|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0
4658884|NCT02175771|7546093|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0
4658885|NCT02175771|7546094|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0
4658886|NCT02175771|7546095|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0
4658887|NCT02175771|7546096|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0
4658888|NCT02175771|7546088|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11
4658889|NCT02175771|7546089|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
4658890|NCT02175771|7546090|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
4658891|NCT02175771|7546091|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
4658892|NCT02175771|7546092|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
4658893|NCT02175771|7546093|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
4658894|NCT02175771|7546094|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
4658895|NCT02175771|7546095|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
4658896|NCT02175771|7546096|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
4658897|NCT02175771|7546088|FG000|Run-In Period (Pre-assignment)|Adverse Event|9
4658898|NCT02175771|7546089|FG001|Run-In Period (Pre-assignment)|Adverse Event|0
4658899|NCT02175771|7546090|FG002|Run-In Period (Pre-assignment)|Adverse Event|0
4658900|NCT02175771|7546091|FG003|Run-In Period (Pre-assignment)|Adverse Event|0
4658901|NCT02175771|7546092|FG004|Run-In Period (Pre-assignment)|Adverse Event|0
4658902|NCT02175771|7546093|FG005|Run-In Period (Pre-assignment)|Adverse Event|0
4658903|NCT02175771|7546094|FG006|Run-In Period (Pre-assignment)|Adverse Event|0
4658904|NCT02175771|7546095|FG007|Run-In Period (Pre-assignment)|Adverse Event|0
4658905|NCT02175771|7546096|FG008|Run-In Period (Pre-assignment)|Adverse Event|0
4658906|NCT02175771|7546088|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7
4658907|NCT02175771|7546089|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
4658908|NCT02175771|7546090|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
4658909|NCT02175771|7546091|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
4658910|NCT02175771|7546092|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
4658911|NCT02175771|7546093|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
4749631|NCT02536794|7723805|FG000|Reached 1st Response Assessment|Progressive Disease|2
4749632|NCT02536794|7723805|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1
4749633|NCT02536794|7723805|FG000|Reached 1st Response Assessment|Protocol Violation|1
4749634|NCT02536794|7723805|FG000|Continued Treatment After 1st Response|Progressive disease|7
4658912|NCT02175771|7546094|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
4658913|NCT02175771|7546095|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
4658914|NCT02175771|7546096|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
4658915|NCT02175771|7546088|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6
4658916|NCT02175771|7546089|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0
4658917|NCT02175771|7546090|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0
4658918|NCT02175771|7546091|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0
4658919|NCT02175771|7546092|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0
4658920|NCT02175771|7546093|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0
4658921|NCT02175771|7546094|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0
4658922|NCT02175771|7546095|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0
4658923|NCT02175771|7546096|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0
4658924|NCT02175771|7546088|FG000|Run-In Period (Pre-assignment)|Other|8
4658925|NCT02175771|7546089|FG001|Run-In Period (Pre-assignment)|Other|0
4658926|NCT02175771|7546090|FG002|Run-In Period (Pre-assignment)|Other|0
4658927|NCT02175771|7546091|FG003|Run-In Period (Pre-assignment)|Other|0
4658928|NCT02175771|7546092|FG004|Run-In Period (Pre-assignment)|Other|0
4658929|NCT02175771|7546093|FG005|Run-In Period (Pre-assignment)|Other|0
4658930|NCT02175771|7546094|FG006|Run-In Period (Pre-assignment)|Other|0
4658931|NCT02175771|7546095|FG007|Run-In Period (Pre-assignment)|Other|0
4658932|NCT02175771|7546096|FG008|Run-In Period (Pre-assignment)|Other|0
4658933|NCT02175771|7546088|FG000|Treatment Period|Adverse Event|0
4658934|NCT02175771|7546089|FG001|Treatment Period|Adverse Event|2
4658935|NCT02175771|7546090|FG002|Treatment Period|Adverse Event|1
4658936|NCT02175771|7546091|FG003|Treatment Period|Adverse Event|1
4658937|NCT02175771|7546092|FG004|Treatment Period|Adverse Event|1
4658938|NCT02175771|7546093|FG005|Treatment Period|Adverse Event|3
4658939|NCT02175771|7546094|FG006|Treatment Period|Adverse Event|2
4658940|NCT02175771|7546095|FG007|Treatment Period|Adverse Event|0
4658941|NCT02175771|7546096|FG008|Treatment Period|Adverse Event|1
4658942|NCT02175771|7546088|FG000|Treatment Period|Withdrawal by Subject|0
4658943|NCT02175771|7546089|FG001|Treatment Period|Withdrawal by Subject|9
4658944|NCT02175771|7546090|FG002|Treatment Period|Withdrawal by Subject|3
4658945|NCT02175771|7546091|FG003|Treatment Period|Withdrawal by Subject|6
4658946|NCT02175771|7546092|FG004|Treatment Period|Withdrawal by Subject|2
4658947|NCT02175771|7546093|FG005|Treatment Period|Withdrawal by Subject|4
4658948|NCT02175771|7546094|FG006|Treatment Period|Withdrawal by Subject|2
4658949|NCT02175771|7546095|FG007|Treatment Period|Withdrawal by Subject|9
4658950|NCT02175771|7546096|FG008|Treatment Period|Withdrawal by Subject|2
4658951|NCT02175771|7546088|FG000|Treatment Period|Noncompliance|0
4658952|NCT02175771|7546089|FG001|Treatment Period|Noncompliance|1
4658953|NCT02175771|7546090|FG002|Treatment Period|Noncompliance|2
4658954|NCT02175771|7546091|FG003|Treatment Period|Noncompliance|0
4658955|NCT02175771|7546092|FG004|Treatment Period|Noncompliance|0
4658956|NCT02175771|7546093|FG005|Treatment Period|Noncompliance|0
4658957|NCT02175771|7546094|FG006|Treatment Period|Noncompliance|0
4658958|NCT02175771|7546095|FG007|Treatment Period|Noncompliance|0
4658959|NCT02175771|7546096|FG008|Treatment Period|Noncompliance|1
4658960|NCT02175771|7546088|FG000|Treatment Period|Protocol Violation|0
4658961|NCT02175771|7546089|FG001|Treatment Period|Protocol Violation|0
4658962|NCT02175771|7546090|FG002|Treatment Period|Protocol Violation|0
4658963|NCT02175771|7546091|FG003|Treatment Period|Protocol Violation|0
4658964|NCT02175771|7546092|FG004|Treatment Period|Protocol Violation|0
4658965|NCT02175771|7546093|FG005|Treatment Period|Protocol Violation|0
4658966|NCT02175771|7546094|FG006|Treatment Period|Protocol Violation|0
4658967|NCT02175771|7546095|FG007|Treatment Period|Protocol Violation|1
4658968|NCT02175771|7546096|FG008|Treatment Period|Protocol Violation|0
4658969|NCT02175771|7546088|FG000|Treatment Period|Disease progression|0
4658970|NCT02175771|7546089|FG001|Treatment Period|Disease progression|0
4658971|NCT02175771|7546090|FG002|Treatment Period|Disease progression|0
4658972|NCT02175771|7546091|FG003|Treatment Period|Disease progression|0
4658973|NCT02175771|7546092|FG004|Treatment Period|Disease progression|0
4658974|NCT02175771|7546093|FG005|Treatment Period|Disease progression|0
4658975|NCT02175771|7546094|FG006|Treatment Period|Disease progression|0
4658976|NCT02175771|7546095|FG007|Treatment Period|Disease progression|2
4658977|NCT02175771|7546096|FG008|Treatment Period|Disease progression|0
4658978|NCT02175771|7546088|FG000|Treatment Period|Lost to Follow-up|0
4658979|NCT02175771|7546089|FG001|Treatment Period|Lost to Follow-up|3
4658980|NCT02175771|7546090|FG002|Treatment Period|Lost to Follow-up|1
4658981|NCT02175771|7546091|FG003|Treatment Period|Lost to Follow-up|3
4658982|NCT02175771|7546092|FG004|Treatment Period|Lost to Follow-up|1
4658983|NCT02175771|7546093|FG005|Treatment Period|Lost to Follow-up|2
4658984|NCT02175771|7546094|FG006|Treatment Period|Lost to Follow-up|1
4658985|NCT02175771|7546095|FG007|Treatment Period|Lost to Follow-up|2
4658986|NCT02175771|7546096|FG008|Treatment Period|Lost to Follow-up|2
4658987|NCT02175771|7546088|FG000|Treatment Period|Lack of Efficacy|0
4658988|NCT02175771|7546089|FG001|Treatment Period|Lack of Efficacy|0
4658989|NCT02175771|7546090|FG002|Treatment Period|Lack of Efficacy|0
4658990|NCT02175771|7546091|FG003|Treatment Period|Lack of Efficacy|0
4658991|NCT02175771|7546092|FG004|Treatment Period|Lack of Efficacy|0
4658992|NCT02175771|7546093|FG005|Treatment Period|Lack of Efficacy|1
4658993|NCT02175771|7546094|FG006|Treatment Period|Lack of Efficacy|0
4658994|NCT02175771|7546095|FG007|Treatment Period|Lack of Efficacy|1
4658995|NCT02175771|7546096|FG008|Treatment Period|Lack of Efficacy|0
4658996|NCT02175771|7546088|FG000|Treatment Period|Other|0
4658997|NCT02175771|7546089|FG001|Treatment Period|Other|1
4658998|NCT02175771|7546090|FG002|Treatment Period|Other|0
4658999|NCT02175771|7546091|FG003|Treatment Period|Other|3
4659000|NCT02175771|7546092|FG004|Treatment Period|Other|1
4659001|NCT02175771|7546093|FG005|Treatment Period|Other|0
4659002|NCT02175771|7546094|FG006|Treatment Period|Other|0
4659003|NCT02175771|7546095|FG007|Treatment Period|Other|2
4659004|NCT02175771|7546096|FG008|Treatment Period|Other|0
4659005|NCT02175966|7546116|FG000|Follow-up Period|Lack of Efficacy|10
4659006|NCT02175966|7546117|FG001|Follow-up Period|Lack of Efficacy|6
4659007|NCT02176018|7546151|FG000|Overall Study|Adverse Event|0
4659008|NCT02176018|7546152|FG001|Overall Study|Adverse Event|2
4659009|NCT02176018|7546151|FG000|Overall Study|Lost to Follow-up|3
4659010|NCT02176018|7546152|FG001|Overall Study|Lost to Follow-up|1
4659011|NCT02176018|7546151|FG000|Overall Study|Protocol Violation|1
4659012|NCT02176018|7546152|FG001|Overall Study|Protocol Violation|1
4659013|NCT02176018|7546151|FG000|Overall Study|Withdrawal by Subject|1
4659014|NCT02176018|7546152|FG001|Overall Study|Withdrawal by Subject|2
4659015|NCT02176226|7546172|FG000|Overall Study|Lost to Follow-up|3
4659016|NCT02176226|7546172|FG000|Overall Study|Withdrew prior to treatment|6
4659017|NCT02176291|7546178|FG000|Overall Study|Death|1
4659018|NCT02176291|7546179|FG001|Overall Study|Death|0
4659019|NCT02176291|7546178|FG000|Overall Study|non compliance with protocol|2
4659020|NCT02176291|7546179|FG001|Overall Study|non compliance with protocol|0
4659021|NCT02176291|7546178|FG000|Overall Study|Withdrawal by Subject|2
4659022|NCT02176291|7546179|FG001|Overall Study|Withdrawal by Subject|0
4659023|NCT02176356|7546189|FG000|Overall Study|Screen Failure|14
4659024|NCT02176356|7546189|FG000|Overall Study|Lost to Follow-up|4
4659025|NCT02176356|7546189|FG000|Overall Study|Personal Reasons|3
4659026|NCT02176356|7546189|FG000|Overall Study|Other Miscellaneous Reasons|2
4659027|NCT02176421|7546211|FG000|Overall Study|Lost to Follow-up|4
4659028|NCT02176421|7546211|FG000|Overall Study|Adverse Event|1
4659029|NCT02176525|7546238|FG000|Overall Study|Adverse Event|0
4659030|NCT02176525|7546239|FG001|Overall Study|Adverse Event|0
4659031|NCT02176525|7546240|FG002|Overall Study|Adverse Event|0
4659032|NCT02176525|7546241|FG003|Overall Study|Adverse Event|1
4659033|NCT02176525|7546242|FG004|Overall Study|Adverse Event|1
4659034|NCT02176525|7546243|FG005|Overall Study|Adverse Event|0
4659035|NCT02176525|7546244|FG006|Overall Study|Adverse Event|1
4659036|NCT02176525|7546245|FG007|Overall Study|Adverse Event|0
4659037|NCT02176525|7546238|FG000|Overall Study|not treated|1
4659038|NCT02176525|7546239|FG001|Overall Study|not treated|0
4659039|NCT02176525|7546240|FG002|Overall Study|not treated|0
4659040|NCT02176525|7546241|FG003|Overall Study|not treated|0
4659041|NCT02176525|7546242|FG004|Overall Study|not treated|0
4659042|NCT02176525|7546243|FG005|Overall Study|not treated|1
4659043|NCT02176525|7546244|FG006|Overall Study|not treated|0
4659044|NCT02176525|7546245|FG007|Overall Study|not treated|0
4659045|NCT02176642|7546273|FG000|Overall Study|Withdrawal by Subject|0
4659046|NCT02176642|7546274|FG001|Overall Study|Withdrawal by Subject|1
4659047|NCT02176655|7546280|FG000|Overall Study|Subjects did not treat|6
4659048|NCT02176928|7546291|FG000|Overall Study|Lost to Follow-up|2
4659049|NCT02176928|7546292|FG001|Overall Study|Lost to Follow-up|4
4659050|NCT02177032|7546302|FG000|Overall Study|ADMINISTRATIVE REASON|2
4659051|NCT02177032|7546303|FG001|Overall Study|ADMINISTRATIVE REASON|0
4659052|NCT02177032|7546304|FG002|Overall Study|ADMINISTRATIVE REASON|1
4659053|NCT02177032|7546305|FG003|Overall Study|ADMINISTRATIVE REASON|0
4659054|NCT02177032|7546302|FG000|Overall Study|Lost to Follow-up|0
4659055|NCT02177032|7546303|FG001|Overall Study|Lost to Follow-up|2
4659056|NCT02177032|7546304|FG002|Overall Study|Lost to Follow-up|0
4659057|NCT02177032|7546305|FG003|Overall Study|Lost to Follow-up|0
4749635|NCT02536794|7723805|FG000|Continued Treatment After 1st Response|Adverse Event|1
4749636|NCT02519777|7723812|FG000|Overall Study|Death|1
4749637|NCT02519777|7723813|FG001|Overall Study|Death|0
4749638|NCT02519777|7723814|FG002|Overall Study|Death|0
4749639|NCT02519777|7723812|FG000|Overall Study|Lost to Follow-up|0
4749640|NCT02519777|7723813|FG001|Overall Study|Lost to Follow-up|4
4749641|NCT02519777|7723814|FG002|Overall Study|Lost to Follow-up|2
4749642|NCT02519777|7723812|FG000|Overall Study|Withdrawal by Subject|3
4749643|NCT02519777|7723813|FG001|Overall Study|Withdrawal by Subject|1
4749644|NCT02519777|7723814|FG002|Overall Study|Withdrawal by Subject|0
4749645|NCT02519777|7723812|FG000|Overall Study|Severe Debilitation|1
4749646|NCT02519777|7723813|FG001|Overall Study|Severe Debilitation|1
4749647|NCT02519777|7723814|FG002|Overall Study|Severe Debilitation|1
4749648|NCT02519777|7723812|FG000|Overall Study|Not able to get to clinic|1
4659058|NCT02177032|7546302|FG000|Overall Study|OTHER|2
4659059|NCT02177032|7546303|FG001|Overall Study|OTHER|0
4659060|NCT02177032|7546304|FG002|Overall Study|OTHER|1
4659061|NCT02177032|7546305|FG003|Overall Study|OTHER|0
4659062|NCT02177032|7546302|FG000|Overall Study|Withdrawal by Subject|1
4659063|NCT02177032|7546303|FG001|Overall Study|Withdrawal by Subject|0
4659064|NCT02177032|7546304|FG002|Overall Study|Withdrawal by Subject|1
4749649|NCT02519777|7723813|FG001|Overall Study|Not able to get to clinic|2
4749650|NCT02519777|7723814|FG002|Overall Study|Not able to get to clinic|1
4659065|NCT02177032|7546305|FG003|Overall Study|Withdrawal by Subject|0
4659066|NCT02177123|7546326|FG000|Overall Study|Lost to Follow-up|6
4659067|NCT02177123|7546326|FG000|Overall Study|Withdrawal by Subject|4
4659068|NCT02177123|7546326|FG000|Overall Study|Adverse Event|4
4659069|NCT02177123|7546326|FG000|Overall Study|Physician Decision|3
4659070|NCT02177123|7546326|FG000|Overall Study|Excluded by Sponsor - other reason|2
4659071|NCT02177123|7546326|FG000|Overall Study|Excluded for medical reasons|2
4659072|NCT02177123|7546326|FG000|Overall Study|Death|1
4659073|NCT02177123|7546326|FG000|Overall Study|Other|1
4659074|NCT02177123|7546326|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1
4659075|NCT02177136|7546336|FG000|DB Phase|Withdrawal by Subject|2
4659076|NCT02177136|7546337|FG001|DB Phase|Withdrawal by Subject|0
4659077|NCT02177136|7546338|FG002|DB Phase|Withdrawal by Subject|0
4659078|NCT02177136|7546339|FG003|DB Phase|Withdrawal by Subject|0
4659079|NCT02177136|7546336|FG000|DB Phase|Discontinued Due to Pruritus|1
4659080|NCT02177136|7546337|FG001|DB Phase|Discontinued Due to Pruritus|3
4659081|NCT02177136|7546338|FG002|DB Phase|Discontinued Due to Pruritus|0
4659082|NCT02177136|7546339|FG003|DB Phase|Discontinued Due to Pruritus|0
4659083|NCT02177136|7546336|FG000|DB Phase|Adverse Event|3
4659084|NCT02177136|7546337|FG001|DB Phase|Adverse Event|2
4659085|NCT02177136|7546338|FG002|DB Phase|Adverse Event|3
4659086|NCT02177136|7546339|FG003|DB Phase|Adverse Event|0
4659087|NCT02177136|7546336|FG000|DB Phase|Protocol Violation|0
4659088|NCT02177136|7546337|FG001|DB Phase|Protocol Violation|0
4659089|NCT02177136|7546338|FG002|DB Phase|Protocol Violation|1
4659090|NCT02177136|7546339|FG003|DB Phase|Protocol Violation|0
4659091|NCT02177136|7546336|FG000|DB Phase|Withdrew Consent Prior to Dosing|1
4659092|NCT02177136|7546337|FG001|DB Phase|Withdrew Consent Prior to Dosing|0
4659093|NCT02177136|7546338|FG002|DB Phase|Withdrew Consent Prior to Dosing|0
4659094|NCT02177136|7546339|FG003|DB Phase|Withdrew Consent Prior to Dosing|0
4659095|NCT02177136|7546336|FG000|LTSE Phase|Withdrawal by Subject|0
4659096|NCT02177136|7546337|FG001|LTSE Phase|Withdrawal by Subject|0
4659097|NCT02177136|7546338|FG002|LTSE Phase|Withdrawal by Subject|0
4659098|NCT02177136|7546339|FG003|LTSE Phase|Withdrawal by Subject|6
4659099|NCT02177136|7546336|FG000|LTSE Phase|Adverse Event|0
4749651|NCT02489318|7723824|FG000|Randomized|Withdrawal by Subject|0
4749652|NCT02489318|7723825|FG001|Randomized|Withdrawal by Subject|1
4749653|NCT02489318|7723824|FG000|Treated|Adverse Event|19
4749654|NCT02489318|7723825|FG001|Treated|Adverse Event|62
4749655|NCT02489318|7723824|FG000|Treated|Death|13
4749656|NCT02489318|7723825|FG001|Treated|Death|11
4749657|NCT02489318|7723824|FG000|Treated|Physician Decision|4
4749658|NCT02489318|7723825|FG001|Treated|Physician Decision|6
4749659|NCT02489318|7723824|FG000|Treated|Protocol Violation|1
4659100|NCT02177136|7546337|FG001|LTSE Phase|Adverse Event|0
4659101|NCT02177136|7546338|FG002|LTSE Phase|Adverse Event|0
4659102|NCT02177136|7546339|FG003|LTSE Phase|Adverse Event|10
4659103|NCT02177136|7546336|FG000|LTSE Phase|Discontinued Due to Pruritus|0
4659104|NCT02177136|7546337|FG001|LTSE Phase|Discontinued Due to Pruritus|0
4659105|NCT02177136|7546338|FG002|LTSE Phase|Discontinued Due to Pruritus|0
4659106|NCT02177136|7546339|FG003|LTSE Phase|Discontinued Due to Pruritus|4
4659107|NCT02177136|7546336|FG000|LTSE Phase|Physician Decision|0
4659108|NCT02177136|7546337|FG001|LTSE Phase|Physician Decision|0
4659109|NCT02177136|7546338|FG002|LTSE Phase|Physician Decision|0
4659110|NCT02177136|7546339|FG003|LTSE Phase|Physician Decision|2
4659111|NCT02177136|7546336|FG000|LTSE Phase|Lost to Follow-up|0
4659112|NCT02177136|7546337|FG001|LTSE Phase|Lost to Follow-up|0
4659113|NCT02177136|7546338|FG002|LTSE Phase|Lost to Follow-up|0
4749660|NCT02489318|7723825|FG001|Treated|Protocol Violation|2
4749661|NCT02489318|7723824|FG000|Treated|Withdrawal by Subject|37
4749662|NCT02489318|7723825|FG001|Treated|Withdrawal by Subject|36
4749663|NCT02489318|7723824|FG000|Treated|Other: Progressive Disease|245
4749664|NCT02489318|7723825|FG001|Treated|Other: Progressive Disease|138
4749665|NCT02489318|7723824|FG000|Treated|Other|0
4749666|NCT02489318|7723825|FG001|Treated|Other|2
4749667|NCT02489318|7723824|FG000|Treated|Ongoing|0
4749668|NCT02489318|7723825|FG001|Treated|Ongoing|267
4749669|NCT02484443|7723832|FG000|Overall Study|Lack of Efficacy|28
4749670|NCT02484443|7723832|FG000|Overall Study|Physician Decision|2
4749671|NCT02484443|7723832|FG000|Overall Study|Ineligible|2
4749672|NCT02395666|7723838|FG000|Overall Study|Physician Decision|3
4749673|NCT02395666|7723839|FG001|Overall Study|Physician Decision|0
4749674|NCT02395666|7723838|FG000|Overall Study|Lost to Follow-up|1
4749675|NCT02395666|7723839|FG001|Overall Study|Lost to Follow-up|0
4749676|NCT02395666|7723838|FG000|Overall Study|Withdrawal by Subject|2
4749677|NCT02395666|7723839|FG001|Overall Study|Withdrawal by Subject|1
4749678|NCT02357810|7723849|FG000|Registered and Started Treatment|Withdrawal by Subject|1
4749679|NCT02357810|7723849|FG000|Registered and Started Treatment|Found not to be eligible for the study|26
4749680|NCT02357810|7723849|FG000|Reached 12 Weeks Response|Adverse Event|5
4749681|NCT02357810|7723849|FG000|Reached 12 Weeks Response|Progressive Disease|39
4749682|NCT02357810|7723849|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8
4749683|NCT02357810|7723849|FG000|Reached 12 Weeks Response|Protocol Violation|1
4749684|NCT02357810|7723849|FG000|Reached 12 Weeks Response|Death|1
4749685|NCT02357810|7723849|FG000|Reached 12 Weeks Response|Physician Decision|1
4749686|NCT02357810|7723849|FG000|Reached 12 Weeks Response|Other|1
4749687|NCT02357810|7723849|FG000|12 Week Response and Further Treatment|Adverse Event|5
4749688|NCT02357810|7723849|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1
4749689|NCT02357810|7723849|FG000|12 Week Response and Further Treatment|Progressive Disease|15
4749690|NCT02357810|7723849|FG000|12 Week Response and Further Treatment|Wound Complications|1
4659114|NCT02177136|7546339|FG003|LTSE Phase|Lost to Follow-up|1
4659115|NCT02177136|7546336|FG000|LTSE Phase|Participant Moved|0
4659116|NCT02177136|7546337|FG001|LTSE Phase|Participant Moved|0
4659117|NCT02177136|7546338|FG002|LTSE Phase|Participant Moved|0
4659118|NCT02177136|7546339|FG003|LTSE Phase|Participant Moved|1
4659119|NCT02177786|7546363|FG000|Overall Study|Withdrew Consent|2
4659120|NCT02177786|7546364|FG001|Overall Study|Withdrew Consent|6
4659121|NCT02177786|7546365|FG002|Overall Study|Withdrew Consent|9
4659122|NCT02177786|7546366|FG003|Overall Study|Withdrew Consent|5
4659123|NCT02177786|7546363|FG000|Overall Study|Progression to End Stage Renal Disease|2
4659124|NCT02177786|7546364|FG001|Overall Study|Progression to End Stage Renal Disease|3
4659125|NCT02177786|7546365|FG002|Overall Study|Progression to End Stage Renal Disease|2
4659126|NCT02177786|7546366|FG003|Overall Study|Progression to End Stage Renal Disease|1
4659127|NCT02177786|7546363|FG000|Overall Study|Adverse Event|1
4659128|NCT02177786|7546364|FG001|Overall Study|Adverse Event|1
4659129|NCT02177786|7546365|FG002|Overall Study|Adverse Event|2
4659130|NCT02177786|7546366|FG003|Overall Study|Adverse Event|3
4659131|NCT02177786|7546363|FG000|Overall Study|Death|1
4659132|NCT02177786|7546364|FG001|Overall Study|Death|1
4659133|NCT02177786|7546365|FG002|Overall Study|Death|1
4659134|NCT02177786|7546366|FG003|Overall Study|Death|1
4659135|NCT02177786|7546363|FG000|Overall Study|Lost to Follow-up|0
4659136|NCT02177786|7546364|FG001|Overall Study|Lost to Follow-up|0
4659137|NCT02177786|7546365|FG002|Overall Study|Lost to Follow-up|2
4659138|NCT02177786|7546366|FG003|Overall Study|Lost to Follow-up|2
4659139|NCT02177786|7546363|FG000|Overall Study|Non-Compliance with Study Drug|0
4659140|NCT02177786|7546364|FG001|Overall Study|Non-Compliance with Study Drug|1
4659141|NCT02177786|7546365|FG002|Overall Study|Non-Compliance with Study Drug|0
4659142|NCT02177786|7546366|FG003|Overall Study|Non-Compliance with Study Drug|1
4659143|NCT02177786|7546363|FG000|Overall Study|Protocol Violation|0
4659144|NCT02177786|7546364|FG001|Overall Study|Protocol Violation|0
4659145|NCT02177786|7546365|FG002|Overall Study|Protocol Violation|2
4659146|NCT02177786|7546366|FG003|Overall Study|Protocol Violation|0
4659147|NCT02177786|7546363|FG000|Overall Study|Progressive Disease|0
4659148|NCT02177786|7546364|FG001|Overall Study|Progressive Disease|1
4659149|NCT02177786|7546365|FG002|Overall Study|Progressive Disease|0
4659150|NCT02177786|7546366|FG003|Overall Study|Progressive Disease|0
4659151|NCT02177786|7546363|FG000|Overall Study|Missing study completion status|0
4659152|NCT02177786|7546364|FG001|Overall Study|Missing study completion status|1
4659153|NCT02177786|7546365|FG002|Overall Study|Missing study completion status|0
4659154|NCT02177786|7546366|FG003|Overall Study|Missing study completion status|0
4659155|NCT02177812|7546385|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
4659156|NCT02177812|7546386|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
4659157|NCT02177812|7546387|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
4659158|NCT02177812|7546388|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
4659159|NCT02177812|7546389|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
4659160|NCT02177812|7546390|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1
4659161|NCT02177812|7546391|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2
4659162|NCT02177812|7546392|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1
4659163|NCT02177812|7546393|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
4659164|NCT02177812|7546385|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0
4659165|NCT02177812|7546386|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0
4659166|NCT02177812|7546387|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0
4659167|NCT02177812|7546388|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0
4659168|NCT02177812|7546389|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0
4659169|NCT02177812|7546390|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1
4659170|NCT02177812|7546391|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1
4659171|NCT02177812|7546392|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0
4659172|NCT02177812|7546393|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0
4659173|NCT02177812|7546385|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0
4659174|NCT02177812|7546386|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0
4659175|NCT02177812|7546387|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0
4659176|NCT02177812|7546388|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1
4659177|NCT02177812|7546389|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1
4659178|NCT02177812|7546390|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1
4659179|NCT02177812|7546391|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6
4659180|NCT02177812|7546392|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1
4659181|NCT02177812|7546393|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0
4659182|NCT02177838|7546422|FG000|Overall Study|Withdrawal by Subject|1
4659183|NCT02177838|7546422|FG000|Overall Study|Physician Decision|1
4659184|NCT02177838|7546422|FG000|Overall Study|Death|1
4659185|NCT02177942|7546428|FG000|Overall Study|Adverse Event|1
4659186|NCT02177942|7546429|FG001|Overall Study|Adverse Event|0
4659187|NCT02177942|7546428|FG000|Overall Study|Lost to Follow-up|1
4659188|NCT02177942|7546429|FG001|Overall Study|Lost to Follow-up|1
4659189|NCT02177942|7546428|FG000|Overall Study|Protocol Violation|4
4659190|NCT02177942|7546429|FG001|Overall Study|Protocol Violation|6
4659191|NCT02177942|7546428|FG000|Overall Study|Withdrawal by Subject|71
4659192|NCT02177942|7546429|FG001|Overall Study|Withdrawal by Subject|81
4659193|NCT02178059|7546439|FG000|Washout|Physician Decision|1
4659194|NCT02178059|7546440|FG001|Washout|Physician Decision|0
4659195|NCT02178475|7546450|FG000|Overall Study|Withdrawal by Subject|7
4659196|NCT02178475|7546450|FG000|Overall Study|Lost to Follow-up|10
4659197|NCT02178475|7546450|FG000|Overall Study|Death|13
4659198|NCT02178475|7546450|FG000|Overall Study|Protocol-specified Criteria|99
4659199|NCT02178553|7546463|FG000|Overall Study|Did not proceed to open thoracotomy|7
4659200|NCT02178553|7546464|FG001|Overall Study|Did not proceed to open thoracotomy|3
4659201|NCT02178553|7546463|FG000|Overall Study|Physician Decision|0
4659202|NCT02178553|7546464|FG001|Overall Study|Physician Decision|4
4659203|NCT02178553|7546463|FG000|Overall Study|Technical problem with injection|1
4659204|NCT02178553|7546464|FG001|Overall Study|Technical problem with injection|3
4659205|NCT02178592|7546472|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0
4659206|NCT02178592|7546473|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2
4659207|NCT02178592|7546472|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1
4659208|NCT02178592|7546473|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1
4659209|NCT02178592|7546472|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3
4659210|NCT02178592|7546473|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2
4659211|NCT02178592|7546472|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3
4659212|NCT02178592|7546473|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1
4659213|NCT02178592|7546472|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11
4659214|NCT02178592|7546473|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3
4659215|NCT02178592|7546472|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1
4659216|NCT02178592|7546473|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0
4659217|NCT02178592|7546472|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1
4659218|NCT02178592|7546473|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0
4659219|NCT02178592|7546472|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0
4659220|NCT02178592|7546473|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1
4659221|NCT02178592|7546472|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2
4659222|NCT02178592|7546473|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0
4659223|NCT02178592|7546472|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4
4659224|NCT02178592|7546473|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1
4659225|NCT02178592|7546472|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2
4659226|NCT02178592|7546473|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0
4659227|NCT02178592|7546472|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3
4659228|NCT02178592|7546473|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1
4659229|NCT02178787|7546496|FG000|Overall Study|Lost to Follow-up|1
4659230|NCT02178787|7546497|FG001|Overall Study|Lost to Follow-up|0
4749691|NCT02357810|7723849|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4
4749692|NCT02357810|7723849|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3
4749693|NCT02343549|7723853|FG000|Overall Study|Death|11
4749694|NCT02343549|7723853|FG000|Overall Study|Withdrawal by Subject|2
4749695|NCT02328105|7723861|FG000|Overall Study|Death|6
4749696|NCT02328105|7723861|FG000|Overall Study|Withdrawal by Subject|1
4749697|NCT02328105|7723861|FG000|Overall Study|Still On Study in Follow-Up|4
4749698|NCT02315066|7723888|FG000|Overall Study|Lost to Follow-up|0
4749699|NCT02315066|7723889|FG001|Overall Study|Lost to Follow-up|1
4749700|NCT02315066|7723890|FG002|Overall Study|Lost to Follow-up|1
4749701|NCT02315066|7723891|FG003|Overall Study|Lost to Follow-up|0
4749702|NCT02315066|7723892|FG004|Overall Study|Lost to Follow-up|1
4749703|NCT02315066|7723893|FG005|Overall Study|Lost to Follow-up|0
4749704|NCT02315066|7723894|FG006|Overall Study|Lost to Follow-up|2
4749705|NCT02315066|7723895|FG007|Overall Study|Lost to Follow-up|1
4749706|NCT02315066|7723896|FG008|Overall Study|Lost to Follow-up|0
4749707|NCT02315066|7723897|FG009|Overall Study|Lost to Follow-up|0
4749708|NCT02315066|7723898|FG010|Overall Study|Lost to Follow-up|1
4749709|NCT02315066|7723899|FG011|Overall Study|Lost to Follow-up|2
4749710|NCT02315066|7723900|FG012|Overall Study|Lost to Follow-up|0
4749711|NCT02315066|7723901|FG013|Overall Study|Lost to Follow-up|4
4749712|NCT02315066|7723888|FG000|Overall Study|Death|2
4749713|NCT02315066|7723889|FG001|Overall Study|Death|7
4749714|NCT02315066|7723890|FG002|Overall Study|Death|6
4749715|NCT02315066|7723891|FG003|Overall Study|Death|11
4749716|NCT02315066|7723892|FG004|Overall Study|Death|10
4749717|NCT02315066|7723893|FG005|Overall Study|Death|3
4749718|NCT02315066|7723894|FG006|Overall Study|Death|9
4749719|NCT02315066|7723895|FG007|Overall Study|Death|9
4749720|NCT02315066|7723896|FG008|Overall Study|Death|10
4749721|NCT02315066|7723897|FG009|Overall Study|Death|8
4749722|NCT02315066|7723898|FG010|Overall Study|Death|10
4749723|NCT02315066|7723899|FG011|Overall Study|Death|7
4749724|NCT02315066|7723900|FG012|Overall Study|Death|8
4749725|NCT02315066|7723901|FG013|Overall Study|Death|21
4749726|NCT02315066|7723888|FG000|Overall Study|Other|0
4749727|NCT02315066|7723889|FG001|Overall Study|Other|0
4749728|NCT02315066|7723890|FG002|Overall Study|Other|0
4749729|NCT02315066|7723891|FG003|Overall Study|Other|0
4749730|NCT02315066|7723892|FG004|Overall Study|Other|0
4749731|NCT02315066|7723893|FG005|Overall Study|Other|0
4749732|NCT02315066|7723894|FG006|Overall Study|Other|0
4749733|NCT02315066|7723895|FG007|Overall Study|Other|1
4749734|NCT02315066|7723896|FG008|Overall Study|Other|1
4749735|NCT02315066|7723897|FG009|Overall Study|Other|2
4749736|NCT02315066|7723898|FG010|Overall Study|Other|0
4749737|NCT02315066|7723899|FG011|Overall Study|Other|0
4749738|NCT02315066|7723900|FG012|Overall Study|Other|0
4659231|NCT02178787|7546496|FG000|Overall Study|Withdrawal by Subject|0
4659232|NCT02178787|7546497|FG001|Overall Study|Withdrawal by Subject|2
4659233|NCT02178787|7546496|FG000|Overall Study|No TCD window|3
4659234|NCT02178787|7546497|FG001|Overall Study|No TCD window|7
4659235|NCT02178787|7546496|FG000|Overall Study|Physician Decision|1
4659236|NCT02178787|7546497|FG001|Overall Study|Physician Decision|0
4659237|NCT02178995|7546524|FG000|Double Blind|Adverse Event|0
4659238|NCT02178995|7546525|FG001|Double Blind|Adverse Event|0
4659239|NCT02178995|7546526|FG002|Double Blind|Adverse Event|0
4659240|NCT02178995|7546527|FG003|Double Blind|Adverse Event|0
4659241|NCT02178995|7546528|FG004|Double Blind|Adverse Event|0
4659242|NCT02178995|7546529|FG005|Double Blind|Adverse Event|1
4659243|NCT02178995|7546530|FG006|Double Blind|Adverse Event|0
4659244|NCT02178995|7546531|FG007|Double Blind|Adverse Event|1
4659245|NCT02178995|7546532|FG008|Double Blind|Adverse Event|1
4659246|NCT02178995|7546524|FG000|Double Blind|Lost to Follow-up|0
4659247|NCT02178995|7546525|FG001|Double Blind|Lost to Follow-up|1
4659248|NCT02178995|7546526|FG002|Double Blind|Lost to Follow-up|0
4659249|NCT02178995|7546527|FG003|Double Blind|Lost to Follow-up|0
4659250|NCT02178995|7546528|FG004|Double Blind|Lost to Follow-up|0
4659251|NCT02178995|7546529|FG005|Double Blind|Lost to Follow-up|0
4659252|NCT02178995|7546530|FG006|Double Blind|Lost to Follow-up|0
4659253|NCT02178995|7546531|FG007|Double Blind|Lost to Follow-up|1
4659254|NCT02178995|7546532|FG008|Double Blind|Lost to Follow-up|0
4659255|NCT02178995|7546524|FG000|Open Label|Adverse Event|2
4659256|NCT02178995|7546525|FG001|Open Label|Adverse Event|0
4659257|NCT02178995|7546526|FG002|Open Label|Adverse Event|0
4659258|NCT02178995|7546527|FG003|Open Label|Adverse Event|0
4659259|NCT02178995|7546528|FG004|Open Label|Adverse Event|0
4659260|NCT02178995|7546529|FG005|Open Label|Adverse Event|0
4659261|NCT02178995|7546530|FG006|Open Label|Adverse Event|0
4659262|NCT02178995|7546531|FG007|Open Label|Adverse Event|0
4659263|NCT02178995|7546532|FG008|Open Label|Adverse Event|0
4659264|NCT02179177|7546578|FG000|Overall Study|Lost to Follow-up|1
4659265|NCT02179177|7546579|FG001|Overall Study|Lost to Follow-up|1
4659266|NCT02179177|7546578|FG000|Overall Study|Withdrawal by Subject|1
4659267|NCT02179177|7546579|FG001|Overall Study|Withdrawal by Subject|1
4659268|NCT02179190|7546585|FG000|Enrollment|Exit Prior to Device Attempt|11
4659269|NCT02179190|7546585|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7
4659270|NCT02179190|7546585|FG000|Follow-Up Post Barrel VRD Implanted|Death|3
4659271|NCT02179190|7546585|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3
4659272|NCT02179190|7546585|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2
4659273|NCT02179190|7546585|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1
4659274|NCT02179398|7546591|FG000|Overall Study|Lack of obligatory data|3
4659275|NCT02179398|7546592|FG001|Overall Study|Lack of obligatory data|3
4659276|NCT02179398|7546591|FG000|Overall Study|Lost to Follow-up|0
4659277|NCT02179398|7546592|FG001|Overall Study|Lost to Follow-up|1
4659278|NCT02179515|7546623|FG000|Overall Study|switched to alternative treatment|0
4659279|NCT02179515|7546624|FG001|Overall Study|switched to alternative treatment|1
4659280|NCT02179515|7546625|FG002|Overall Study|switched to alternative treatment|1
4659281|NCT02179515|7546623|FG000|Overall Study|Death|0
4659282|NCT02179515|7546624|FG001|Overall Study|Death|1
4659283|NCT02179515|7546625|FG002|Overall Study|Death|1
4659284|NCT02179515|7546623|FG000|Overall Study|refused further treatment|0
4659285|NCT02179515|7546624|FG001|Overall Study|refused further treatment|3
4659286|NCT02179515|7546625|FG002|Overall Study|refused further treatment|4
4659287|NCT02179515|7546623|FG000|Overall Study|Disease progression on study|2
4659288|NCT02179515|7546624|FG001|Overall Study|Disease progression on study|11
4659289|NCT02179515|7546625|FG002|Overall Study|Disease progression on study|8
4659290|NCT02179918|7546681|FG000|Overall Study|Death|0
4659291|NCT02179918|7546682|FG001|Overall Study|Death|0
4659292|NCT02179918|7546683|FG002|Overall Study|Death|0
4659293|NCT02179918|7546684|FG003|Overall Study|Death|1
4659294|NCT02179918|7546685|FG004|Overall Study|Death|0
4659295|NCT02179918|7546681|FG000|Overall Study|Lost to Follow-up|0
4659296|NCT02179918|7546682|FG001|Overall Study|Lost to Follow-up|0
4749739|NCT02315066|7723901|FG013|Overall Study|Other|0
4749740|NCT02315066|7723888|FG000|Overall Study|Subject refused further follow-up|0
4749741|NCT02315066|7723889|FG001|Overall Study|Subject refused further follow-up|2
4749742|NCT02315066|7723890|FG002|Overall Study|Subject refused further follow-up|2
4659297|NCT02179918|7546683|FG002|Overall Study|Lost to Follow-up|1
4659298|NCT02179918|7546684|FG003|Overall Study|Lost to Follow-up|0
4659299|NCT02179918|7546685|FG004|Overall Study|Lost to Follow-up|0
4659300|NCT02179918|7546681|FG000|Overall Study|Progressive Disease|4
4659301|NCT02179918|7546682|FG001|Overall Study|Progressive Disease|1
4659302|NCT02179918|7546683|FG002|Overall Study|Progressive Disease|1
4659303|NCT02179918|7546684|FG003|Overall Study|Progressive Disease|2
4659304|NCT02179918|7546685|FG004|Overall Study|Progressive Disease|6
4659305|NCT02179918|7546681|FG000|Overall Study|Other|0
4659306|NCT02179918|7546682|FG001|Overall Study|Other|1
4659307|NCT02179918|7546683|FG002|Overall Study|Other|0
4659308|NCT02179918|7546684|FG003|Overall Study|Other|0
4659309|NCT02179918|7546685|FG004|Overall Study|Other|1
4659310|NCT02179918|7546681|FG000|Overall Study|Subject refused further follow-up|0
4659311|NCT02179918|7546682|FG001|Overall Study|Subject refused further follow-up|1
4659312|NCT02179918|7546683|FG002|Overall Study|Subject refused further follow-up|0
4659313|NCT02179918|7546684|FG003|Overall Study|Subject refused further follow-up|0
4659314|NCT02179918|7546685|FG004|Overall Study|Subject refused further follow-up|1
4659315|NCT02180061|7546700|FG000|Overall Study|Adverse Event|4
4659316|NCT02180061|7546701|FG001|Overall Study|Adverse Event|2
4659317|NCT02180061|7546700|FG000|Overall Study|Clinical Progression|5
4659318|NCT02180061|7546701|FG001|Overall Study|Clinical Progression|1
4659319|NCT02180061|7546700|FG000|Overall Study|Progressive Disease|15
4659320|NCT02180061|7546701|FG001|Overall Study|Progressive Disease|5
4659321|NCT02180061|7546700|FG000|Overall Study|Physician Decision|1
4659322|NCT02180061|7546701|FG001|Overall Study|Physician Decision|0
4659323|NCT02180165|7546720|FG000|Overall Study|Not Treated|0
4659324|NCT02180165|7546721|FG001|Overall Study|Not Treated|0
4659325|NCT02180165|7546722|FG002|Overall Study|Not Treated|1
4659326|NCT02180165|7546723|FG003|Overall Study|Not Treated|0
4659327|NCT02180165|7546720|FG000|Overall Study|Adverse Event|7
4659328|NCT02180165|7546721|FG001|Overall Study|Adverse Event|0
4659329|NCT02180165|7546722|FG002|Overall Study|Adverse Event|18
4659330|NCT02180165|7546723|FG003|Overall Study|Adverse Event|3
4659331|NCT02180165|7546720|FG000|Overall Study|Lack of Efficacy|0
4659332|NCT02180165|7546721|FG001|Overall Study|Lack of Efficacy|1
4659333|NCT02180165|7546722|FG002|Overall Study|Lack of Efficacy|3
4659334|NCT02180165|7546723|FG003|Overall Study|Lack of Efficacy|2
4659335|NCT02180165|7546720|FG000|Overall Study|Physician Decision|1
4659336|NCT02180165|7546721|FG001|Overall Study|Physician Decision|0
4659337|NCT02180165|7546722|FG002|Overall Study|Physician Decision|5
4659338|NCT02180165|7546723|FG003|Overall Study|Physician Decision|0
4659339|NCT02180165|7546720|FG000|Overall Study|Withdrawal by Subject|3
4659340|NCT02180165|7546721|FG001|Overall Study|Withdrawal by Subject|0
4659341|NCT02180165|7546722|FG002|Overall Study|Withdrawal by Subject|2
4659342|NCT02180165|7546723|FG003|Overall Study|Withdrawal by Subject|1
4659343|NCT02180438|7546739|FG000|Overall Study|Lost to Follow-up|1
4659344|NCT02180659|7546756|FG000|Overall Study|Adverse Event|1
4659345|NCT02180659|7546757|FG001|Overall Study|Adverse Event|0
4659346|NCT02180659|7546756|FG000|Overall Study|Lost to Follow-up|4
4659347|NCT02180659|7546757|FG001|Overall Study|Lost to Follow-up|2
4659348|NCT02180659|7546756|FG000|Overall Study|Subject incarcerated during conduct|1
4659349|NCT02180659|7546757|FG001|Overall Study|Subject incarcerated during conduct|0
4659350|NCT02180659|7546756|FG000|Overall Study|Withdrawal by Subject|0
4659351|NCT02180659|7546757|FG001|Overall Study|Withdrawal by Subject|2
4659352|NCT02180659|7546756|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0
4659353|NCT02180659|7546757|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1
4659354|NCT02180672|7546765|FG000|Overall Study|Lost to Follow-up|5
4659355|NCT02180672|7546766|FG001|Overall Study|Lost to Follow-up|7
4659356|NCT02181296|7546827|FG000|Overall Study|Lost to Follow-up|7
4659357|NCT02181296|7546828|FG001|Overall Study|Lost to Follow-up|6
4749743|NCT02315066|7723891|FG003|Overall Study|Subject refused further follow-up|0
4749744|NCT02315066|7723892|FG004|Overall Study|Subject refused further follow-up|0
4749745|NCT02315066|7723893|FG005|Overall Study|Subject refused further follow-up|0
4749746|NCT02315066|7723894|FG006|Overall Study|Subject refused further follow-up|2
4749747|NCT02315066|7723895|FG007|Overall Study|Subject refused further follow-up|3
4749748|NCT02315066|7723896|FG008|Overall Study|Subject refused further follow-up|0
4749749|NCT02315066|7723897|FG009|Overall Study|Subject refused further follow-up|1
4749750|NCT02315066|7723898|FG010|Overall Study|Subject refused further follow-up|1
4749751|NCT02315066|7723899|FG011|Overall Study|Subject refused further follow-up|2
4749752|NCT02315066|7723900|FG012|Overall Study|Subject refused further follow-up|2
4749753|NCT02315066|7723901|FG013|Overall Study|Subject refused further follow-up|4
4749754|NCT02315066|7723888|FG000|Overall Study|Study ongoing at date of cut-off|0
4749755|NCT02315066|7723889|FG001|Overall Study|Study ongoing at date of cut-off|0
4749756|NCT02315066|7723890|FG002|Overall Study|Study ongoing at date of cut-off|0
4749757|NCT02315066|7723891|FG003|Overall Study|Study ongoing at date of cut-off|0
4749758|NCT02315066|7723892|FG004|Overall Study|Study ongoing at date of cut-off|0
4749759|NCT02315066|7723893|FG005|Overall Study|Study ongoing at date of cut-off|0
4749760|NCT02315066|7723894|FG006|Overall Study|Study ongoing at date of cut-off|0
4749761|NCT02315066|7723895|FG007|Overall Study|Study ongoing at date of cut-off|0
4749762|NCT02315066|7723896|FG008|Overall Study|Study ongoing at date of cut-off|0
4749763|NCT02315066|7723897|FG009|Overall Study|Study ongoing at date of cut-off|0
4749764|NCT02315066|7723898|FG010|Overall Study|Study ongoing at date of cut-off|0
4749765|NCT02315066|7723899|FG011|Overall Study|Study ongoing at date of cut-off|0
4749766|NCT02315066|7723900|FG012|Overall Study|Study ongoing at date of cut-off|0
4749767|NCT02315066|7723901|FG013|Overall Study|Study ongoing at date of cut-off|1
4659358|NCT02181413|7546858|FG000|Overall Study|Adverse Event|7
4659359|NCT02181413|7546859|FG001|Overall Study|Adverse Event|24
4659360|NCT02181413|7546858|FG000|Overall Study|Progressive Disease|121
4659361|NCT02181413|7546859|FG001|Overall Study|Progressive Disease|143
4659362|NCT02181413|7546858|FG000|Overall Study|Withdrawal by Subject|5
4659363|NCT02181413|7546859|FG001|Overall Study|Withdrawal by Subject|8
4749768|NCT02277444|7723931|FG000|Overall Study|Adverse Event|10
4749769|NCT02277444|7723931|FG000|Overall Study|Withdrawal by Subject|3
4749770|NCT02277444|7723931|FG000|Overall Study|Other|1
4659364|NCT02181413|7546858|FG000|Overall Study|Reason Not Specified|19
4659365|NCT02181413|7546859|FG001|Overall Study|Reason Not Specified|20
4659366|NCT02181413|7546858|FG000|Overall Study|Ongoing Study Treatment|0
4659367|NCT02181413|7546859|FG001|Overall Study|Ongoing Study Treatment|1
4659368|NCT02181413|7546858|FG000|Overall Study|Lost to Follow-up|0
4659369|NCT02181413|7546859|FG001|Overall Study|Lost to Follow-up|1
4659370|NCT02181504|7546885|FG000|Overall Study|Adverse Event|1
4659371|NCT02181504|7546886|FG001|Overall Study|Adverse Event|1
4659372|NCT02181504|7546887|FG002|Overall Study|Adverse Event|1
4659373|NCT02181556|7546913|FG000|Overall Study|Withdrawal by Subject|1
4659374|NCT02181634|7546917|FG000|Overall Study|Lack of Efficacy|33
4659375|NCT02181634|7546917|FG000|Overall Study|Adverse Event|17
4659376|NCT02181634|7546917|FG000|Overall Study|Physician Decision|8
4659377|NCT02181634|7546917|FG000|Overall Study|Withdrawal by Subject|5
4659378|NCT02181634|7546917|FG000|Overall Study|Death|2
4659379|NCT02181634|7546917|FG000|Overall Study|Treatment delayed greater than 4 weeks|3
4659380|NCT02181634|7546917|FG000|Overall Study|Ineligible|1
4659381|NCT02181634|7546917|FG000|Overall Study|Max number of dose reduction|1
4659382|NCT02181634|7546917|FG000|Overall Study|Symptomatic progression|1
4659383|NCT02181634|7546917|FG000|Overall Study|Patient opted to proceed to surgery|1
4659384|NCT02181673|7546923|FG000|Up to Week 24|Adverse Event|2
4659385|NCT02181673|7546924|FG001|Up to Week 24|Adverse Event|0
4659386|NCT02181673|7546925|FG002|Up to Week 24|Adverse Event|3
4659387|NCT02181673|7546923|FG000|Up to Week 24|Death|1
4659388|NCT02181673|7546924|FG001|Up to Week 24|Death|0
4659389|NCT02181673|7546925|FG002|Up to Week 24|Death|0
4659390|NCT02181673|7546923|FG000|Up to Week 24|Lack of Efficacy|1
4659391|NCT02181673|7546924|FG001|Up to Week 24|Lack of Efficacy|0
4659392|NCT02181673|7546925|FG002|Up to Week 24|Lack of Efficacy|0
4659393|NCT02181673|7546923|FG000|Up to Week 24|Lost to Follow-up|1
4659394|NCT02181673|7546924|FG001|Up to Week 24|Lost to Follow-up|0
4659395|NCT02181673|7546925|FG002|Up to Week 24|Lost to Follow-up|0
4659396|NCT02181673|7546923|FG000|Up to Week 24|Physician Decision|0
4659397|NCT02181673|7546924|FG001|Up to Week 24|Physician Decision|0
4659398|NCT02181673|7546925|FG002|Up to Week 24|Physician Decision|3
4659399|NCT02181673|7546923|FG000|Up to Week 24|Withdrawal by Subject|10
4659400|NCT02181673|7546924|FG001|Up to Week 24|Withdrawal by Subject|0
4659401|NCT02181673|7546925|FG002|Up to Week 24|Withdrawal by Subject|1
4659402|NCT02181673|7546923|FG000|Up to Week 24|Other|2
4659403|NCT02181673|7546924|FG001|Up to Week 24|Other|0
4659404|NCT02181673|7546925|FG002|Up to Week 24|Other|3
4659405|NCT02181673|7546923|FG000|Up to Week 24|Randomized not Treated|0
4659406|NCT02181673|7546924|FG001|Up to Week 24|Randomized not Treated|0
4659407|NCT02181673|7546925|FG002|Up to Week 24|Randomized not Treated|1
4659408|NCT02181673|7546923|FG000|Week 24-Week 60|Adverse Event|0
4659409|NCT02181673|7546924|FG001|Week 24-Week 60|Adverse Event|4
4659410|NCT02181673|7546925|FG002|Week 24-Week 60|Adverse Event|10
4659411|NCT02181673|7546923|FG000|Week 24-Week 60|Other|0
4659412|NCT02181673|7546924|FG001|Week 24-Week 60|Other|2
4659413|NCT02181673|7546925|FG002|Week 24-Week 60|Other|1
4749771|NCT02277444|7723931|FG000|Overall Study|Enrolled and not Treated|3
4749772|NCT02277444|7723931|FG000|Overall Study|Ongoing|113
4749773|NCT02257736|7723946|FG000|Overall Study|Progressive disease|365
4749774|NCT02257736|7723947|FG001|Overall Study|Progressive disease|327
4749775|NCT02257736|7723946|FG000|Overall Study|Adverse Event|45
4749776|NCT02257736|7723947|FG001|Overall Study|Adverse Event|56
4749777|NCT02257736|7723946|FG000|Overall Study|Withdrawal by Subject|21
4749778|NCT02257736|7723947|FG001|Overall Study|Withdrawal by Subject|38
4749779|NCT02257736|7723946|FG000|Overall Study|Death|11
4749780|NCT02257736|7723947|FG001|Overall Study|Death|6
4749781|NCT02257736|7723946|FG000|Overall Study|Physician Decision|5
4749782|NCT02257736|7723947|FG001|Overall Study|Physician Decision|9
4749783|NCT02257736|7723946|FG000|Overall Study|Non-Compliance with study drug|1
4749784|NCT02257736|7723947|FG001|Overall Study|Non-Compliance with study drug|2
4749785|NCT02257736|7723946|FG000|Overall Study|Protocol Violation|1
4749786|NCT02257736|7723947|FG001|Overall Study|Protocol Violation|0
4659414|NCT02181673|7546923|FG000|Week 24-Week 60|Withdrawal by Subject|0
4659415|NCT02181673|7546924|FG001|Week 24-Week 60|Withdrawal by Subject|2
4659416|NCT02181673|7546925|FG002|Week 24-Week 60|Withdrawal by Subject|2
4659417|NCT02181673|7546923|FG000|Week 24-Week 60|Pregnancy|0
4659418|NCT02181673|7546924|FG001|Week 24-Week 60|Pregnancy|0
4659419|NCT02181673|7546925|FG002|Week 24-Week 60|Pregnancy|1
4659420|NCT02181673|7546923|FG000|Week 24-Week 60|Lack of Efficacy|0
4659421|NCT02181673|7546924|FG001|Week 24-Week 60|Lack of Efficacy|0
4659422|NCT02181673|7546925|FG002|Week 24-Week 60|Lack of Efficacy|1
4659423|NCT02181673|7546923|FG000|Week 24-Week 60|Lost to Follow-up|0
4659424|NCT02181673|7546924|FG001|Week 24-Week 60|Lost to Follow-up|0
4659425|NCT02181673|7546925|FG002|Week 24-Week 60|Lost to Follow-up|1
4659426|NCT02181673|7546923|FG000|Week 24-Week 60|Physician Decision|0
4659427|NCT02181673|7546924|FG001|Week 24-Week 60|Physician Decision|0
4659428|NCT02181673|7546925|FG002|Week 24-Week 60|Physician Decision|1
4659429|NCT02181738|7546936|FG000|Overall Study|Death|1
4659430|NCT02181738|7546937|FG001|Overall Study|Death|1
4659431|NCT02181738|7546938|FG002|Overall Study|Death|6
4749787|NCT02257736|7723946|FG000|Overall Study|Other|1
4749788|NCT02257736|7723947|FG001|Overall Study|Other|7
4749789|NCT02257736|7723946|FG000|Overall Study|Randomized, not treated|1
4659432|NCT02181738|7546939|FG003|Overall Study|Death|1
4659433|NCT02181738|7546936|FG000|Overall Study|Subject Withdrew Consent|1
4749790|NCT02257736|7723947|FG001|Overall Study|Randomized, not treated|2
4659434|NCT02181738|7546937|FG001|Overall Study|Subject Withdrew Consent|3
4659435|NCT02181738|7546938|FG002|Overall Study|Subject Withdrew Consent|2
4659436|NCT02181738|7546939|FG003|Overall Study|Subject Withdrew Consent|1
4659437|NCT02181738|7546936|FG000|Overall Study|Lost to Follow-up|0
4659438|NCT02181738|7546937|FG001|Overall Study|Lost to Follow-up|4
4659439|NCT02181738|7546938|FG002|Overall Study|Lost to Follow-up|2
4659440|NCT02181738|7546939|FG003|Overall Study|Lost to Follow-up|0
4659441|NCT02181738|7546936|FG000|Overall Study|Patient Return to Home Country|0
4659442|NCT02181738|7546937|FG001|Overall Study|Patient Return to Home Country|1
4659443|NCT02181738|7546938|FG002|Overall Study|Patient Return to Home Country|0
4659444|NCT02181738|7546939|FG003|Overall Study|Patient Return to Home Country|0
4659445|NCT02181803|7546958|FG000|Overall Study|Withdrawal by Subject|0
4659446|NCT02181803|7546959|FG001|Overall Study|Withdrawal by Subject|2
4659447|NCT02181803|7546960|FG002|Overall Study|Withdrawal by Subject|0
4659448|NCT02181803|7546961|FG003|Overall Study|Withdrawal by Subject|0
4659449|NCT02181803|7546962|FG004|Overall Study|Withdrawal by Subject|0
4659450|NCT02181803|7546963|FG005|Overall Study|Withdrawal by Subject|0
4659451|NCT02181803|7546964|FG006|Overall Study|Withdrawal by Subject|0
4659452|NCT02181803|7546965|FG007|Overall Study|Withdrawal by Subject|0
4659453|NCT02181803|7546966|FG008|Overall Study|Withdrawal by Subject|0
4659454|NCT02181803|7546958|FG000|Overall Study|Physician Decision|0
4659455|NCT02181803|7546959|FG001|Overall Study|Physician Decision|0
4659456|NCT02181803|7546960|FG002|Overall Study|Physician Decision|0
4659457|NCT02181803|7546961|FG003|Overall Study|Physician Decision|1
4659458|NCT02181803|7546962|FG004|Overall Study|Physician Decision|0
4659459|NCT02181803|7546963|FG005|Overall Study|Physician Decision|0
4659460|NCT02181803|7546964|FG006|Overall Study|Physician Decision|0
4659461|NCT02181803|7546965|FG007|Overall Study|Physician Decision|1
4659462|NCT02181803|7546966|FG008|Overall Study|Physician Decision|0
4749791|NCT02256631|7723960|FG000|Overall Study|Lost to Follow-up|1
4749792|NCT02256631|7723961|FG001|Overall Study|Lost to Follow-up|1
4749793|NCT02256631|7723962|FG002|Overall Study|Lost to Follow-up|0
4749794|NCT02256631|7723963|FG003|Overall Study|Lost to Follow-up|2
4749795|NCT02256631|7723964|FG004|Overall Study|Lost to Follow-up|0
4749796|NCT02256631|7723965|FG005|Overall Study|Lost to Follow-up|1
4749797|NCT02256631|7723966|FG006|Overall Study|Lost to Follow-up|1
4749798|NCT02256631|7723960|FG000|Overall Study|Withdrawal by Subject|0
4749799|NCT02256631|7723961|FG001|Overall Study|Withdrawal by Subject|0
4749800|NCT02256631|7723962|FG002|Overall Study|Withdrawal by Subject|0
4749801|NCT02256631|7723963|FG003|Overall Study|Withdrawal by Subject|1
4749802|NCT02256631|7723964|FG004|Overall Study|Withdrawal by Subject|1
4749803|NCT02256631|7723965|FG005|Overall Study|Withdrawal by Subject|0
4749804|NCT02256631|7723966|FG006|Overall Study|Withdrawal by Subject|1
4749805|NCT02256631|7723960|FG000|Overall Study|Unable to get to clinic|0
4749806|NCT02256631|7723961|FG001|Overall Study|Unable to get to clinic|2
4749807|NCT02256631|7723962|FG002|Overall Study|Unable to get to clinic|0
4749808|NCT02256631|7723963|FG003|Overall Study|Unable to get to clinic|1
4749809|NCT02256631|7723964|FG004|Overall Study|Unable to get to clinic|0
4749810|NCT02256631|7723965|FG005|Overall Study|Unable to get to clinic|1
4749811|NCT02256631|7723966|FG006|Overall Study|Unable to get to clinic|2
4749812|NCT02252172|7723984|FG000|Overall Study|Lost to Follow-up|3
4749813|NCT02252172|7723985|FG001|Overall Study|Lost to Follow-up|1
4749814|NCT02252172|7723984|FG000|Overall Study|Ongoing|276
4749815|NCT02252172|7723985|FG001|Overall Study|Ongoing|298
4659463|NCT02181803|7546958|FG000|Overall Study|Adverse Event|0
4659464|NCT02181803|7546959|FG001|Overall Study|Adverse Event|2
4659465|NCT02181803|7546960|FG002|Overall Study|Adverse Event|0
4659466|NCT02181803|7546961|FG003|Overall Study|Adverse Event|1
4659467|NCT02181803|7546962|FG004|Overall Study|Adverse Event|0
4659468|NCT02181803|7546963|FG005|Overall Study|Adverse Event|0
4659469|NCT02181803|7546964|FG006|Overall Study|Adverse Event|1
4659470|NCT02181803|7546965|FG007|Overall Study|Adverse Event|0
4659471|NCT02181803|7546966|FG008|Overall Study|Adverse Event|0
4659472|NCT02181816|7547011|FG000|Overall Study|Case Report Forms Uncollected|38
4659473|NCT02181816|7547011|FG000|Overall Study|Protocol Deviation|21
4659474|NCT02181842|7547019|FG000|Overall Study|Case Report Forms Uncollected|2
4659475|NCT02182440|7547036|FG000|Overall Study|Adverse Event|0
4659476|NCT02182440|7547037|FG001|Overall Study|Adverse Event|1
4659477|NCT02182440|7547038|FG002|Overall Study|Adverse Event|0
4659478|NCT02182440|7547039|FG003|Overall Study|Adverse Event|0
4659479|NCT02182440|7547036|FG000|Overall Study|Death|31
4659480|NCT02182440|7547037|FG001|Overall Study|Death|8
4659481|NCT02182440|7547038|FG002|Overall Study|Death|5
4659482|NCT02182440|7547039|FG003|Overall Study|Death|16
4659483|NCT02182440|7547036|FG000|Overall Study|Protocol Violation|0
4659484|NCT02182440|7547037|FG001|Overall Study|Protocol Violation|1
4659485|NCT02182440|7547038|FG002|Overall Study|Protocol Violation|0
4659486|NCT02182440|7547039|FG003|Overall Study|Protocol Violation|0
4659487|NCT02182440|7547036|FG000|Overall Study|Physician Decision|1
4659488|NCT02182440|7547037|FG001|Overall Study|Physician Decision|0
4659489|NCT02182440|7547038|FG002|Overall Study|Physician Decision|0
4659490|NCT02182440|7547039|FG003|Overall Study|Physician Decision|0
4659491|NCT02182440|7547036|FG000|Overall Study|Withdrawal by Subject|1
4659492|NCT02182440|7547037|FG001|Overall Study|Withdrawal by Subject|1
4659493|NCT02182440|7547038|FG002|Overall Study|Withdrawal by Subject|3
4659494|NCT02182440|7547039|FG003|Overall Study|Withdrawal by Subject|4
4659495|NCT02182440|7547036|FG000|Overall Study|different, e.g adm other hospital|12
4659496|NCT02182440|7547037|FG001|Overall Study|different, e.g adm other hospital|3
4659497|NCT02182440|7547038|FG002|Overall Study|different, e.g adm other hospital|3
4659498|NCT02182440|7547039|FG003|Overall Study|different, e.g adm other hospital|10
4659499|NCT02182830|7547066|FG000|Overall Study|Not Treated|1
4659500|NCT02182830|7547067|FG001|Overall Study|Not Treated|1
4659501|NCT02182830|7547066|FG000|Overall Study|Trial stopped, reason missing|3
4659502|NCT02182830|7547067|FG001|Overall Study|Trial stopped, reason missing|3
4659503|NCT02182830|7547066|FG000|Overall Study|Consent withdrawn|8
4659504|NCT02182830|7547067|FG001|Overall Study|Consent withdrawn|8
4659505|NCT02182830|7547066|FG000|Overall Study|Lost to Follow-up|3
4659506|NCT02182830|7547067|FG001|Overall Study|Lost to Follow-up|3
4659507|NCT02182843|7547073|FG000|Overall Study|Withdrawal by Subject|7
4749816|NCT02195479|7723993|FG000|Overall Study|Lost to Follow-up|3
4749817|NCT02195479|7723994|FG001|Overall Study|Lost to Follow-up|0
4749818|NCT02195479|7723993|FG000|Overall Study|Death|48
4749819|NCT02195479|7723994|FG001|Overall Study|Death|45
4749820|NCT02195479|7723993|FG000|Overall Study|Physician Decision|1
4749821|NCT02195479|7723994|FG001|Overall Study|Physician Decision|0
4749822|NCT02195479|7723993|FG000|Overall Study|Withdrawal by Subject|11
4749823|NCT02195479|7723994|FG001|Overall Study|Withdrawal by Subject|6
4749824|NCT02195479|7723993|FG000|Overall Study|Other|2
4749825|NCT02195479|7723994|FG001|Overall Study|Other|2
4749826|NCT02195479|7723993|FG000|Overall Study|Ongoing|291
4749827|NCT02195479|7723994|FG001|Overall Study|Ongoing|297
4749828|NCT02173379|7724002|FG000|Overall Study|Lost to Follow-up|48
4749829|NCT02173379|7724003|FG001|Overall Study|Lost to Follow-up|34
4749830|NCT02173379|7724002|FG000|Overall Study|Withdrawal by Subject|14
4749831|NCT02173379|7724003|FG001|Overall Study|Withdrawal by Subject|17
4749832|NCT02173379|7724002|FG000|Overall Study|Physician Decision|7
4749833|NCT02173379|7724003|FG001|Overall Study|Physician Decision|4
4749834|NCT02173379|7724002|FG000|Overall Study|Death|22
4749835|NCT02173379|7724003|FG001|Overall Study|Death|22
4749836|NCT02136134|7724012|FG000|Overall Study|Death|35
4749837|NCT02136134|7724013|FG001|Overall Study|Death|29
4749838|NCT02136134|7724012|FG000|Overall Study|Withdrawal by Subject|14
4749839|NCT02136134|7724013|FG001|Overall Study|Withdrawal by Subject|4
4749840|NCT02136134|7724012|FG000|Overall Study|Other|3
4749841|NCT02136134|7724013|FG001|Overall Study|Other|3
4749842|NCT02136134|7724012|FG000|Overall Study|Ongoing|185
4749843|NCT02136134|7724013|FG001|Overall Study|Ongoing|207
4749844|NCT02136134|7724012|FG000|Overall Study|Subjects randomized but not treated|10
4749845|NCT02136134|7724013|FG001|Overall Study|Subjects randomized but not treated|8
4749846|NCT02080260|7724028|FG000|Overall Study|Death|18
4749847|NCT02080260|7724028|FG000|Overall Study|Withdrawal by Subject|1
4749848|NCT02076009|7724034|FG000|Overall Study|Death|44
4749849|NCT02076009|7724035|FG001|Overall Study|Death|30
4749850|NCT02076009|7724034|FG000|Overall Study|Withdrawal by Subject|9
4659508|NCT02182843|7547073|FG000|Overall Study|Lost to Follow-up|2
4659509|NCT02182843|7547073|FG000|Overall Study|Adverse Event|1
4659510|NCT02182895|7547079|FG000|Overall Study|Discharged from hospital within 24 hours|2
4659511|NCT02182895|7547080|FG001|Overall Study|Discharged from hospital within 24 hours|4
4659512|NCT02182947|7547086|FG000|Overall Study|Withdrawal by Subject|7
4659513|NCT02182947|7547086|FG000|Overall Study|Lost to Follow-up|3
4659514|NCT02182947|7547086|FG000|Overall Study|Failed screening activities|8
4659515|NCT02182973|7547092|FG000|Overall Study|Withdrawal by Subject|3
4749851|NCT02076009|7724035|FG001|Overall Study|Withdrawal by Subject|3
4659516|NCT02182973|7547093|FG001|Overall Study|Withdrawal by Subject|0
4659517|NCT02182999|7547102|FG000|Overall Study|Adverse Event|4
4659518|NCT02182999|7547103|FG001|Overall Study|Adverse Event|3
4659519|NCT02182999|7547102|FG000|Overall Study|Physician Decision|1
4659520|NCT02182999|7547103|FG001|Overall Study|Physician Decision|0
4659521|NCT02183519|7547111|FG000|Overall Study|computer error|3
4659522|NCT02183519|7547112|FG001|Overall Study|computer error|0
4659523|NCT02183519|7547111|FG000|Overall Study|Did not respond to cough inducter|0
4659524|NCT02183519|7547112|FG001|Overall Study|Did not respond to cough inducter|3
4659525|NCT02183675|7547124|FG000|Treatment Period 2 (10 Days)|Adverse Event|0
4659526|NCT02183675|7547125|FG001|Treatment Period 2 (10 Days)|Adverse Event|0
4659527|NCT02183675|7547126|FG002|Treatment Period 2 (10 Days)|Adverse Event|0
4659528|NCT02183675|7547127|FG003|Treatment Period 2 (10 Days)|Adverse Event|0
4659529|NCT02183675|7547128|FG004|Treatment Period 2 (10 Days)|Adverse Event|0
4659530|NCT02183675|7547129|FG005|Treatment Period 2 (10 Days)|Adverse Event|2
4659531|NCT02184143|7547150|FG000|Overall Study|Withdrawal by Subject|4
4659532|NCT02184143|7547151|FG001|Overall Study|Withdrawal by Subject|4
4659533|NCT02184143|7547150|FG000|Overall Study|Lost to Follow-up|5
4659534|NCT02184143|7547151|FG001|Overall Study|Lost to Follow-up|3
4659535|NCT02184143|7547150|FG000|Overall Study|Death|1
4659536|NCT02184143|7547151|FG001|Overall Study|Death|0
4749852|NCT02076009|7724034|FG000|Overall Study|Lost to Follow-up|1
4749853|NCT02076009|7724035|FG001|Overall Study|Lost to Follow-up|1
4749854|NCT02076009|7724034|FG000|Overall Study|Progressive disease|1
4749855|NCT02076009|7724035|FG001|Overall Study|Progressive disease|0
4749856|NCT02076009|7724034|FG000|Overall Study|Ongoing|226
4749857|NCT02076009|7724035|FG001|Overall Study|Ongoing|249
4749858|NCT02076009|7724034|FG000|Overall Study|Subjects randomized but not treated|2
4749859|NCT02076009|7724035|FG001|Overall Study|Subjects randomized but not treated|3
4749860|NCT02051933|7724043|FG000|Overall Study|Physician Decision|0
4749861|NCT02051933|7724044|FG001|Overall Study|Physician Decision|1
4749862|NCT01946204|7724098|FG000|Overall Study|Death|38
4749863|NCT01946204|7724099|FG001|Overall Study|Death|59
4749864|NCT01946204|7724098|FG000|Overall Study|Withdrawal by Subject|37
4749865|NCT01946204|7724099|FG001|Overall Study|Withdrawal by Subject|50
4749866|NCT01946204|7724098|FG000|Overall Study|Lost to Follow-up|3
4749867|NCT01946204|7724099|FG001|Overall Study|Lost to Follow-up|7
4749868|NCT01946204|7724098|FG000|Overall Study|Ongoing|316
4749869|NCT01946204|7724099|FG001|Overall Study|Ongoing|687
4749870|NCT01946204|7724098|FG000|Overall Study|Other|7
4749871|NCT01946204|7724099|FG001|Overall Study|Other|3
4749872|NCT01802281|7724125|FG000|Overall Study|Death|1
4749873|NCT01802281|7724126|FG001|Overall Study|Death|2
4749874|NCT01802281|7724125|FG000|Overall Study|Withdrawal by Subject|2
4749875|NCT01802281|7724126|FG001|Overall Study|Withdrawal by Subject|1
4749876|NCT01802281|7724125|FG000|Overall Study|Ineligible|5
4749877|NCT01802281|7724126|FG001|Overall Study|Ineligible|3
4749878|NCT01774253|7724132|FG000|Overall Study|Lack of Efficacy|4
4749879|NCT01774253|7724132|FG000|Overall Study|Physician Decision|2
4749880|NCT01774253|7724132|FG000|Overall Study|Withdrawal by Subject|2
4749881|NCT01774253|7724132|FG000|Overall Study|Death|1
4659537|NCT02184442|7547178|FG000|Overall Study|Death|61
4659538|NCT02184442|7547179|FG001|Overall Study|Death|65
4659539|NCT02184442|7547178|FG000|Overall Study|Withdrawal by Subject|3
4659540|NCT02184442|7547179|FG001|Overall Study|Withdrawal by Subject|11
4659541|NCT02184455|7547185|FG000|Overall Study|Lost to Follow-up|1
4659542|NCT02184572|7547204|FG000|Overall Study|Lost to Follow-up|29
4659543|NCT02184572|7547205|FG001|Overall Study|Lost to Follow-up|21
4659544|NCT02184572|7547204|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1
4659545|NCT02184572|7547205|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0
4659546|NCT02184572|7547204|FG000|Overall Study|Loss Of Kaiser Insurance|1
4659547|NCT02184572|7547205|FG001|Overall Study|Loss Of Kaiser Insurance|0
4659548|NCT02184572|7547204|FG000|Overall Study|2nd blooddraw & diary card incomplete|1
4659549|NCT02184572|7547205|FG001|Overall Study|2nd blooddraw & diary card incomplete|0
4659550|NCT02184572|7547204|FG000|Overall Study|Traveling Outside The Country|1
4659551|NCT02184572|7547205|FG001|Overall Study|Traveling Outside The Country|0
4659552|NCT02184572|7547204|FG000|Overall Study|Withdrawal by Subject|14
4659553|NCT02184572|7547205|FG001|Overall Study|Withdrawal by Subject|9
4659554|NCT02184611|7547215|FG000|Overall Study|Lack of Efficacy|11
4659555|NCT02184611|7547216|FG001|Overall Study|Lack of Efficacy|15
4659556|NCT02184611|7547215|FG000|Overall Study|Withdrawal by Subject|5
4659557|NCT02184611|7547216|FG001|Overall Study|Withdrawal by Subject|6
4659558|NCT02184611|7547215|FG000|Overall Study|Adverse Event|4
4659559|NCT02184611|7547216|FG001|Overall Study|Adverse Event|5
4659560|NCT02184611|7547215|FG000|Overall Study|Protocol Violation|1
4659561|NCT02184611|7547216|FG001|Overall Study|Protocol Violation|1
4659562|NCT02184611|7547215|FG000|Overall Study|Protocol defined stopping criteria|0
4659563|NCT02184611|7547216|FG001|Overall Study|Protocol defined stopping criteria|1
4659564|NCT02184988|7547243|FG000|Overall Study|Pregnancy|2
4659565|NCT02184988|7547243|FG000|Overall Study|Adverse Event|2
4659566|NCT02184988|7547243|FG000|Overall Study|moving away/travelling/unable to complet|6
4659567|NCT02184988|7547243|FG000|Overall Study|work scheduling issues|4
4659568|NCT02184988|7547243|FG000|Overall Study|various other reasons|9
4659569|NCT02184988|7547243|FG000|Overall Study|Lost to Follow-up|32
4659570|NCT02185014|7547247|FG000|Overall Study|Adverse Event|18
4659571|NCT02185014|7547247|FG000|Overall Study|Withdrew Consent|8
4659572|NCT02185014|7547247|FG000|Overall Study|Lost to Follow-up|4
4659573|NCT02185014|7547247|FG000|Overall Study|Lack of Efficacy|14
4659574|NCT02185014|7547247|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5
4659575|NCT02185014|7547247|FG000|Overall Study|Subject Noncompliance|1
4659576|NCT02185014|7547247|FG000|Overall Study|Other|4
4659577|NCT02185040|7547256|FG000|Part 1 Treatment Phase|Miscellaneous|0
4659578|NCT02185040|7547257|FG001|Part 1 Treatment Phase|Miscellaneous|0
4659579|NCT02185040|7547258|FG002|Part 1 Treatment Phase|Miscellaneous|1
4659580|NCT02185040|7547259|FG003|Part 1 Treatment Phase|Miscellaneous|0
4659581|NCT02185040|7547260|FG004|Part 1 Treatment Phase|Miscellaneous|0
4659582|NCT02185040|7547261|FG005|Part 1 Treatment Phase|Miscellaneous|0
4659583|NCT02185040|7547262|FG006|Part 1 Treatment Phase|Miscellaneous|0
4659584|NCT02185040|7547256|FG000|Part 1 Treatment Phase|Adverse Event|1
4659585|NCT02185040|7547257|FG001|Part 1 Treatment Phase|Adverse Event|0
4659586|NCT02185040|7547258|FG002|Part 1 Treatment Phase|Adverse Event|0
4659587|NCT02185040|7547259|FG003|Part 1 Treatment Phase|Adverse Event|2
4659588|NCT02185040|7547260|FG004|Part 1 Treatment Phase|Adverse Event|3
4659589|NCT02185040|7547261|FG005|Part 1 Treatment Phase|Adverse Event|0
4659590|NCT02185040|7547262|FG006|Part 1 Treatment Phase|Adverse Event|0
4659591|NCT02185040|7547256|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0
4659592|NCT02185040|7547257|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1
4659593|NCT02185040|7547258|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0
4659594|NCT02185040|7547259|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0
4659595|NCT02185040|7547260|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0
4659596|NCT02185040|7547261|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0
4659597|NCT02185040|7547262|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0
4659598|NCT02185040|7547256|FG000|Part 1 Treatment Phase|Lost to Follow-up|0
4659599|NCT02185040|7547257|FG001|Part 1 Treatment Phase|Lost to Follow-up|1
4659600|NCT02185040|7547258|FG002|Part 1 Treatment Phase|Lost to Follow-up|0
4659601|NCT02185040|7547259|FG003|Part 1 Treatment Phase|Lost to Follow-up|0
4659602|NCT02185040|7547260|FG004|Part 1 Treatment Phase|Lost to Follow-up|0
4659603|NCT02185040|7547261|FG005|Part 1 Treatment Phase|Lost to Follow-up|0
4659604|NCT02185040|7547262|FG006|Part 1 Treatment Phase|Lost to Follow-up|0
4659605|NCT02185040|7547256|FG000|Active Treatment Extension Phase|Miscellaneous|0
4659606|NCT02185040|7547257|FG001|Active Treatment Extension Phase|Miscellaneous|0
4659607|NCT02185040|7547258|FG002|Active Treatment Extension Phase|Miscellaneous|0
4659608|NCT02185040|7547259|FG003|Active Treatment Extension Phase|Miscellaneous|0
4659609|NCT02185040|7547260|FG004|Active Treatment Extension Phase|Miscellaneous|0
4659610|NCT02185040|7547261|FG005|Active Treatment Extension Phase|Miscellaneous|1
4659611|NCT02185040|7547262|FG006|Active Treatment Extension Phase|Miscellaneous|0
4659612|NCT02185040|7547256|FG000|Active Treatment Extension Phase|Adverse Event|0
4659613|NCT02185040|7547257|FG001|Active Treatment Extension Phase|Adverse Event|0
4659614|NCT02185040|7547258|FG002|Active Treatment Extension Phase|Adverse Event|0
4659615|NCT02185040|7547259|FG003|Active Treatment Extension Phase|Adverse Event|0
4659616|NCT02185040|7547260|FG004|Active Treatment Extension Phase|Adverse Event|0
4659617|NCT02185040|7547261|FG005|Active Treatment Extension Phase|Adverse Event|1
4659618|NCT02185040|7547262|FG006|Active Treatment Extension Phase|Adverse Event|4
4659619|NCT02185040|7547256|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0
4659620|NCT02185040|7547257|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0
4659621|NCT02185040|7547258|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0
4659622|NCT02185040|7547259|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0
4659623|NCT02185040|7547260|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0
4659624|NCT02185040|7547261|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1
4659625|NCT02185040|7547262|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1
4659626|NCT02185040|7547256|FG000|Active Treatment Extension Phase|Lost to Follow-up|0
4749918|NCT01615029|7724159|FG000|Overall Study|Adverse Event|0
4749919|NCT01615029|7724160|FG001|Overall Study|Adverse Event|0
4749920|NCT01615029|7724161|FG002|Overall Study|Adverse Event|0
4749921|NCT01615029|7724162|FG003|Overall Study|Adverse Event|0
4749922|NCT01615029|7724163|FG004|Overall Study|Adverse Event|1
4749923|NCT01615029|7724159|FG000|Overall Study|Death|0
4749924|NCT01615029|7724160|FG001|Overall Study|Death|0
4749925|NCT01615029|7724161|FG002|Overall Study|Death|0
4749926|NCT01615029|7724162|FG003|Overall Study|Death|0
4749927|NCT01615029|7724163|FG004|Overall Study|Death|1
4749928|NCT01615029|7724159|FG000|Overall Study|Lost to Follow-up|0
4749929|NCT01615029|7724160|FG001|Overall Study|Lost to Follow-up|0
4749930|NCT01615029|7724161|FG002|Overall Study|Lost to Follow-up|0
4749931|NCT01615029|7724162|FG003|Overall Study|Lost to Follow-up|0
4749932|NCT01615029|7724163|FG004|Overall Study|Lost to Follow-up|1
4749933|NCT01615029|7724159|FG000|Overall Study|Progressive disease|2
4749934|NCT01615029|7724160|FG001|Overall Study|Progressive disease|1
4749935|NCT01615029|7724161|FG002|Overall Study|Progressive disease|1
4749936|NCT01615029|7724162|FG003|Overall Study|Progressive disease|1
4749937|NCT01615029|7724163|FG004|Overall Study|Progressive disease|5
4749938|NCT01615029|7724159|FG000|Overall Study|Physician Decision|0
4749939|NCT01615029|7724160|FG001|Overall Study|Physician Decision|0
4749940|NCT01615029|7724161|FG002|Overall Study|Physician Decision|0
4749941|NCT01615029|7724162|FG003|Overall Study|Physician Decision|0
4749942|NCT01615029|7724163|FG004|Overall Study|Physician Decision|1
4749943|NCT01615029|7724159|FG000|Overall Study|Ongoing|1
4749944|NCT01615029|7724160|FG001|Overall Study|Ongoing|2
4749945|NCT01615029|7724161|FG002|Overall Study|Ongoing|3
4749946|NCT01615029|7724162|FG003|Overall Study|Ongoing|2
4749947|NCT01615029|7724163|FG004|Overall Study|Ongoing|23
4749948|NCT01505608|7724177|FG000|Phase I|Lack of Efficacy|0
4749949|NCT01505608|7724178|FG001|Phase I|Lack of Efficacy|4
4749950|NCT01505608|7724177|FG000|Phase I|Adverse Event|0
4749951|NCT01505608|7724178|FG001|Phase I|Adverse Event|1
4749952|NCT01505608|7724177|FG000|Phase I|Withdrawal by Subject|0
4749953|NCT01505608|7724178|FG001|Phase I|Withdrawal by Subject|1
4749954|NCT01505608|7724177|FG000|Phase II|Lack of Efficacy|2
4749955|NCT01505608|7724178|FG001|Phase II|Lack of Efficacy|1
4749956|NCT01505608|7724177|FG000|Phase II|Protocol Violation|0
4749957|NCT01505608|7724178|FG001|Phase II|Protocol Violation|1
4749958|NCT01483820|7724187|FG000|Overall Study|Lack of Efficacy|6
4749959|NCT01483820|7724187|FG000|Overall Study|Adverse Event|1
4749960|NCT01483820|7724187|FG000|Overall Study|Death|1
4749961|NCT01355679|7724191|FG000|Overall Study|benign tumor types found at biopsy|2
4749962|NCT01314118|7724196|FG000|Overall Study|Adverse Event|9
4749963|NCT01314118|7724196|FG000|Overall Study|Progressive disease|27
4749964|NCT01314118|7724196|FG000|Overall Study|Physician Decision|11
4749965|NCT01314118|7724196|FG000|Overall Study|Death|4
4749966|NCT01314118|7724196|FG000|Overall Study|Protocol Violation|5
4749967|NCT01314118|7724196|FG000|Overall Study|Withdrawal by Subject|11
4749968|NCT01314118|7724196|FG000|Overall Study|Other|2
4749969|NCT01314118|7724196|FG000|Overall Study|Ongoing|62
4749975|NCT01171898|7724244|FG000|Overall Study|Death|0
4749976|NCT01171898|7724245|FG001|Overall Study|Death|0
4749977|NCT01171898|7724246|FG002|Overall Study|Death|2
4749978|NCT01171898|7724247|FG003|Overall Study|Death|0
4749979|NCT01171898|7724244|FG000|Overall Study|Lost to Follow-up|0
4749980|NCT01171898|7724245|FG001|Overall Study|Lost to Follow-up|1
4749981|NCT01171898|7724246|FG002|Overall Study|Lost to Follow-up|1
4749982|NCT01171898|7724247|FG003|Overall Study|Lost to Follow-up|1
4749983|NCT01171898|7724244|FG000|Overall Study|Withdrawal by Subject|1
4749984|NCT01171898|7724245|FG001|Overall Study|Withdrawal by Subject|4
4749985|NCT01171898|7724246|FG002|Overall Study|Withdrawal by Subject|6
4749986|NCT01171898|7724247|FG003|Overall Study|Withdrawal by Subject|3
4749987|NCT01171898|7724244|FG000|Overall Study|Terminated by Sponsor|1
4749988|NCT01171898|7724245|FG001|Overall Study|Terminated by Sponsor|0
4749989|NCT01171898|7724246|FG002|Overall Study|Terminated by Sponsor|0
4749990|NCT01171898|7724247|FG003|Overall Study|Terminated by Sponsor|0
4749991|NCT01171898|7724244|FG000|Overall Study|Ongoing|1
4749992|NCT01171898|7724245|FG001|Overall Study|Ongoing|9
4749993|NCT01171898|7724246|FG002|Overall Study|Ongoing|3
4749994|NCT01171898|7724247|FG003|Overall Study|Ongoing|0
4659627|NCT02185040|7547257|FG001|Active Treatment Extension Phase|Lost to Follow-up|0
4659628|NCT02185040|7547258|FG002|Active Treatment Extension Phase|Lost to Follow-up|0
4659629|NCT02185040|7547259|FG003|Active Treatment Extension Phase|Lost to Follow-up|0
4659630|NCT02185040|7547260|FG004|Active Treatment Extension Phase|Lost to Follow-up|0
4659631|NCT02185040|7547261|FG005|Active Treatment Extension Phase|Lost to Follow-up|0
4659632|NCT02185040|7547262|FG006|Active Treatment Extension Phase|Lost to Follow-up|2
4659633|NCT02185053|7547282|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1
4659634|NCT02185053|7547283|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0
4659635|NCT02185053|7547284|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0
4659636|NCT02185053|7547282|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2
4659637|NCT02185053|7547283|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0
4659638|NCT02185053|7547284|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0
4659639|NCT02185053|7547282|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0
4659640|NCT02185053|7547283|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1
4659641|NCT02185053|7547284|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0
4659642|NCT02185053|7547282|FG000|Donepezil Dose Escalation Phase|Adverse Event|0
4659643|NCT02185053|7547283|FG001|Donepezil Dose Escalation Phase|Adverse Event|1
4659644|NCT02185053|7547284|FG002|Donepezil Dose Escalation Phase|Adverse Event|0
4659645|NCT02185053|7547282|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0
4659646|NCT02185053|7547283|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2
4659647|NCT02185053|7547284|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0
4659648|NCT02185053|7547282|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0
4659649|NCT02185053|7547283|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1
4659650|NCT02185053|7547284|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0
4659651|NCT02185053|7547282|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0
4659652|NCT02185053|7547283|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0
4659653|NCT02185053|7547284|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1
4659654|NCT02185053|7547282|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0
4659655|NCT02185053|7547283|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0
4659656|NCT02185053|7547284|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2
4659657|NCT02185521|7547330|FG000|Overall Study|Withdrawal by Subject|1
4659658|NCT02185521|7547330|FG000|Overall Study|Protocol Violation|1
4659659|NCT02185534|7547341|FG000|First Period|Withdrawal by Subject|0
4659660|NCT02185534|7547342|FG001|First Period|Withdrawal by Subject|0
4659661|NCT02185534|7547343|FG002|First Period|Withdrawal by Subject|0
4659662|NCT02185534|7547344|FG003|First Period|Withdrawal by Subject|1
4659663|NCT02185534|7547345|FG004|First Period|Withdrawal by Subject|0
4659664|NCT02185534|7547346|FG005|First Period|Withdrawal by Subject|0
4659665|NCT02185534|7547341|FG000|First Washout Period|Withdrawal by Subject|1
4659666|NCT02185534|7547342|FG001|First Washout Period|Withdrawal by Subject|0
4659667|NCT02185534|7547343|FG002|First Washout Period|Withdrawal by Subject|0
4659668|NCT02185534|7547344|FG003|First Washout Period|Withdrawal by Subject|0
4659669|NCT02185534|7547345|FG004|First Washout Period|Withdrawal by Subject|1
4659670|NCT02185534|7547346|FG005|First Washout Period|Withdrawal by Subject|0
4659671|NCT02185534|7547341|FG000|First Washout Period|Protocol Violation|0
4659672|NCT02185534|7547342|FG001|First Washout Period|Protocol Violation|0
4659673|NCT02185534|7547343|FG002|First Washout Period|Protocol Violation|0
4659674|NCT02185534|7547344|FG003|First Washout Period|Protocol Violation|0
4659675|NCT02185534|7547345|FG004|First Washout Period|Protocol Violation|0
4659676|NCT02185534|7547346|FG005|First Washout Period|Protocol Violation|1
4659677|NCT02185794|7547368|FG000|Overall Study|Enrolled but Never Dosed|1
4659678|NCT02185794|7547369|FG001|Overall Study|Enrolled but Never Dosed|6
4659679|NCT02185794|7547370|FG002|Overall Study|Enrolled but Never Dosed|3
4659680|NCT02185794|7547371|FG003|Overall Study|Enrolled but Never Dosed|1
4659681|NCT02185794|7547372|FG004|Overall Study|Enrolled but Never Dosed|1
4659682|NCT02185794|7547373|FG005|Overall Study|Enrolled but Never Dosed|0
4659683|NCT02185794|7547368|FG000|Overall Study|Investigator's Discretion|1
4659684|NCT02185794|7547369|FG001|Overall Study|Investigator's Discretion|0
4659685|NCT02185794|7547370|FG002|Overall Study|Investigator's Discretion|1
4659686|NCT02185794|7547371|FG003|Overall Study|Investigator's Discretion|2
4659687|NCT02185794|7547372|FG004|Overall Study|Investigator's Discretion|2
4659688|NCT02185794|7547373|FG005|Overall Study|Investigator's Discretion|15
4659689|NCT02185794|7547368|FG000|Overall Study|Withdrew Consent|2
4659690|NCT02185794|7547369|FG001|Overall Study|Withdrew Consent|5
4659691|NCT02185794|7547370|FG002|Overall Study|Withdrew Consent|10
4659692|NCT02185794|7547371|FG003|Overall Study|Withdrew Consent|2
4659693|NCT02185794|7547372|FG004|Overall Study|Withdrew Consent|0
4659694|NCT02185794|7547373|FG005|Overall Study|Withdrew Consent|0
4659695|NCT02185794|7547368|FG000|Overall Study|Lost to Follow-up|1
4659696|NCT02185794|7547369|FG001|Overall Study|Lost to Follow-up|2
4659697|NCT02185794|7547370|FG002|Overall Study|Lost to Follow-up|2
4659698|NCT02185794|7547371|FG003|Overall Study|Lost to Follow-up|3
4659699|NCT02185794|7547372|FG004|Overall Study|Lost to Follow-up|0
4659700|NCT02185794|7547373|FG005|Overall Study|Lost to Follow-up|1
4659701|NCT02186015|7547403|FG000|Overall Study|Physician Decision|1
4659702|NCT02186015|7547404|FG001|Overall Study|Physician Decision|0
4659703|NCT02186171|7547413|FG000|Overall Study|Withdrawal by Subject|1
4659704|NCT02186171|7547414|FG001|Overall Study|Withdrawal by Subject|9
4659705|NCT02186171|7547413|FG000|Overall Study|Lost to Follow-up|2
4659706|NCT02186171|7547414|FG001|Overall Study|Lost to Follow-up|2
4659707|NCT02186171|7547413|FG000|Overall Study|Death|1
4659708|NCT02186171|7547414|FG001|Overall Study|Death|2
4659709|NCT02186171|7547413|FG000|Overall Study|Protocol-specified Criteria|0
4659710|NCT02186171|7547414|FG001|Overall Study|Protocol-specified Criteria|2
4659711|NCT02186223|7547431|FG000|Overall Study|Not eligible for device placement|6
4659712|NCT02186223|7547431|FG000|Overall Study|Unable to obtain femoral access|3
4659713|NCT02186223|7547431|FG000|Overall Study|Death|3
4659714|NCT02186223|7547431|FG000|Overall Study|Device in place less than 48 hours|9
4659715|NCT02186301|7547439|FG000|Overall Study|Progressive Disease|7
4659716|NCT02186301|7547440|FG001|Overall Study|Progressive Disease|22
4659717|NCT02186301|7547441|FG002|Overall Study|Progressive Disease|27
4659718|NCT02186301|7547439|FG000|Overall Study|Adverse Event|5
4659719|NCT02186301|7547440|FG001|Overall Study|Adverse Event|5
4659720|NCT02186301|7547441|FG002|Overall Study|Adverse Event|5
4659721|NCT02186301|7547439|FG000|Overall Study|Death|1
4659722|NCT02186301|7547440|FG001|Overall Study|Death|0
4659723|NCT02186301|7547441|FG002|Overall Study|Death|0
4659724|NCT02186301|7547439|FG000|Overall Study|Withdrawal by Subject|5
4659725|NCT02186301|7547440|FG001|Overall Study|Withdrawal by Subject|1
4659726|NCT02186301|7547441|FG002|Overall Study|Withdrawal by Subject|3
4659727|NCT02186301|7547439|FG000|Overall Study|Physician Decision|1
4659728|NCT02186301|7547440|FG001|Overall Study|Physician Decision|0
4659729|NCT02186301|7547441|FG002|Overall Study|Physician Decision|1
4659730|NCT02186301|7547439|FG000|Overall Study|Study Terminated by Sponsor|1
4659731|NCT02186301|7547440|FG001|Overall Study|Study Terminated by Sponsor|0
4749995|NCT01171898|7724244|FG000|Overall Study|Other|1
4749996|NCT01171898|7724245|FG001|Overall Study|Other|5
4749997|NCT01171898|7724246|FG002|Overall Study|Other|0
4749998|NCT01171898|7724247|FG003|Overall Study|Other|2
4749999|NCT01166386|7724262|FG000|Overall Study|Withdrawal by Subject|3
4750000|NCT01166386|7724263|FG001|Overall Study|Withdrawal by Subject|5
4750017|NCT01114217|7724280|FG000|Overall Study|Adverse Event|5
4659732|NCT02186301|7547441|FG002|Overall Study|Study Terminated by Sponsor|11
4659733|NCT02186301|7547439|FG000|Overall Study|Protocol Deviation|0
4659734|NCT02186301|7547440|FG001|Overall Study|Protocol Deviation|2
4659735|NCT02186301|7547441|FG002|Overall Study|Protocol Deviation|0
4659736|NCT02186301|7547439|FG000|Overall Study|Missing|0
4659737|NCT02186301|7547440|FG001|Overall Study|Missing|0
4659738|NCT02186301|7547441|FG002|Overall Study|Missing|2
4659739|NCT02186301|7547439|FG000|Overall Study|Other|0
4659740|NCT02186301|7547440|FG001|Overall Study|Other|0
4659741|NCT02186301|7547441|FG002|Overall Study|Other|1
4659742|NCT02186561|7547455|FG000|Enrollment|Did Not Meet Inclusion Criteria|46
4659743|NCT02186561|7547455|FG000|Enrollment|Enrollment Cap Reached|5
4659744|NCT02186561|7547455|FG000|Enrollment|Insurance Denial|2
4659745|NCT02186561|7547455|FG000|Enrollment|Withdrawal by Subject|2
4659746|NCT02186561|7547455|FG000|Enrollment|Investigator Withdrew Consent|1
4750018|NCT01114217|7724281|FG001|Overall Study|Adverse Event|3
4750019|NCT01114217|7724280|FG000|Overall Study|Lost to Follow-up|17
4750020|NCT01114217|7724281|FG001|Overall Study|Lost to Follow-up|33
4659747|NCT02186561|7547455|FG000|30-Day Post Index Procedure Visit|Death|1
4659748|NCT02186561|7547455|FG000|1- Year Post Index Procedure Visit|Death|1
4659749|NCT02186561|7547455|FG000|1- Year Post Index Procedure Visit|Missed|1
4659750|NCT02186652|7547471|FG000|Overall Study|Lost to Follow-up|2
4659751|NCT02186652|7547472|FG001|Overall Study|Lost to Follow-up|0
4659752|NCT02186821|7547507|FG000|Overall Study|Adverse Event|9
4659753|NCT02186821|7547507|FG000|Overall Study|Death|2
4659754|NCT02186821|7547507|FG000|Overall Study|Disease progression|32
4659755|NCT02186821|7547507|FG000|Overall Study|Protocol Violation|1
4659756|NCT02186821|7547507|FG000|Overall Study|Physician Decision|1
4659757|NCT02186821|7547507|FG000|Overall Study|Study terminated by sponsor|2
4659758|NCT02186847|7547513|FG000|Overall Study|Protocol Violation|3
4659759|NCT02186847|7547514|FG001|Overall Study|Protocol Violation|0
4659760|NCT02186873|7547522|FG000|Overall Study|Adverse Event|1
4659761|NCT02186873|7547523|FG001|Overall Study|Adverse Event|3
4659762|NCT02186873|7547522|FG000|Overall Study|Lack of Efficacy|0
4659763|NCT02186873|7547523|FG001|Overall Study|Lack of Efficacy|1
4659764|NCT02186873|7547522|FG000|Overall Study|Lost to Follow-up|1
4659765|NCT02186873|7547523|FG001|Overall Study|Lost to Follow-up|2
4659766|NCT02186873|7547522|FG000|Overall Study|Withdrawal by Subject|7
4659767|NCT02186873|7547523|FG001|Overall Study|Withdrawal by Subject|2
4659768|NCT02187029|7547560|FG000|Overall Study|Adverse Event|0
4659769|NCT02187029|7547561|FG001|Overall Study|Adverse Event|1
4659770|NCT02187029|7547562|FG002|Overall Study|Adverse Event|1
4659771|NCT02187029|7547563|FG003|Overall Study|Adverse Event|0
4659772|NCT02187029|7547560|FG000|Overall Study|Study Terminated by Sponsor|0
4659773|NCT02187029|7547561|FG001|Overall Study|Study Terminated by Sponsor|0
4659774|NCT02187029|7547562|FG002|Overall Study|Study Terminated by Sponsor|10
4659775|NCT02187029|7547563|FG003|Overall Study|Study Terminated by Sponsor|3
4659776|NCT02187029|7547560|FG000|Overall Study|Withdrawal by Subject|1
4659777|NCT02187029|7547561|FG001|Overall Study|Withdrawal by Subject|0
4659778|NCT02187029|7547562|FG002|Overall Study|Withdrawal by Subject|0
4659779|NCT02187029|7547563|FG003|Overall Study|Withdrawal by Subject|0
4659780|NCT02187042|7547575|FG000|Overall Study|Death|1
4659781|NCT02187042|7547576|FG001|Overall Study|Death|1
4659782|NCT02187042|7547575|FG000|Overall Study|Toxicity|6
4659783|NCT02187042|7547576|FG001|Overall Study|Toxicity|5
4659784|NCT02187042|7547575|FG000|Overall Study|Participant choice|1
4659785|NCT02187042|7547576|FG001|Overall Study|Participant choice|0
4659786|NCT02187042|7547575|FG000|Overall Study|Doctor choice|1
4659787|NCT02187042|7547576|FG001|Overall Study|Doctor choice|0
4659788|NCT02187042|7547575|FG000|Overall Study|Progressive disease|4
4659789|NCT02187042|7547576|FG001|Overall Study|Progressive disease|8
4659790|NCT02187055|7547586|FG000|Overall Study|Lack of Efficacy|10
4659791|NCT02187055|7547587|FG001|Overall Study|Lack of Efficacy|3
4659792|NCT02187055|7547588|FG002|Overall Study|Lack of Efficacy|7
4659793|NCT02187055|7547586|FG000|Overall Study|Lost to Follow-up|2
4659794|NCT02187055|7547587|FG001|Overall Study|Lost to Follow-up|7
4659795|NCT02187055|7547588|FG002|Overall Study|Lost to Follow-up|3
4659796|NCT02187055|7547586|FG000|Overall Study|No longer meets eligibility criteria|0
4659797|NCT02187055|7547587|FG001|Overall Study|No longer meets eligibility criteria|2
4659798|NCT02187055|7547588|FG002|Overall Study|No longer meets eligibility criteria|0
4659799|NCT02187055|7547586|FG000|Overall Study|No longer willing to participate|6
4659800|NCT02187055|7547587|FG001|Overall Study|No longer willing to participate|8
4659801|NCT02187055|7547588|FG002|Overall Study|No longer willing to participate|10
4659802|NCT02187055|7547586|FG000|Overall Study|Other|5
4659803|NCT02187055|7547587|FG001|Overall Study|Other|6
4659804|NCT02187055|7547588|FG002|Overall Study|Other|3
4659805|NCT02187055|7547586|FG000|Overall Study|Protocol Violation|9
4659806|NCT02187055|7547587|FG001|Overall Study|Protocol Violation|9
4659807|NCT02187055|7547588|FG002|Overall Study|Protocol Violation|4
4659808|NCT02187055|7547586|FG000|Overall Study|Pregnancy|3
4750021|NCT01114217|7724280|FG000|Overall Study|Withdrawal by Subject|21
4750022|NCT01114217|7724281|FG001|Overall Study|Withdrawal by Subject|28
4750023|NCT01114217|7724280|FG000|Overall Study|Other-Clerical Error|3
4750024|NCT01114217|7724281|FG001|Overall Study|Other-Clerical Error|0
4750025|NCT01114217|7724280|FG000|Overall Study|Other-Early termination|6
4750026|NCT01114217|7724281|FG001|Overall Study|Other-Early termination|10
4750027|NCT01114217|7724280|FG000|Overall Study|Other-Procedure|1
4750028|NCT01114217|7724281|FG001|Overall Study|Other-Procedure|1
4750029|NCT01114217|7724280|FG000|Overall Study|Other-Pregnancy|2
4750030|NCT01114217|7724281|FG001|Overall Study|Other-Pregnancy|4
4750031|NCT01114217|7724280|FG000|Overall Study|Other-Protocol Violation|1
4750032|NCT01114217|7724281|FG001|Overall Study|Other-Protocol Violation|3
4750033|NCT01114217|7724280|FG000|Overall Study|Other-Lack of Efficacy|1
4659809|NCT02187055|7547587|FG001|Overall Study|Pregnancy|1
4659810|NCT02187055|7547588|FG002|Overall Study|Pregnancy|0
4659811|NCT02187055|7547586|FG000|Overall Study|Withdrawal by Subject|11
4659812|NCT02187055|7547587|FG001|Overall Study|Withdrawal by Subject|11
4659813|NCT02187055|7547588|FG002|Overall Study|Withdrawal by Subject|11
4659814|NCT02187055|7547586|FG000|Overall Study|Adverse Event|21
4659815|NCT02187055|7547587|FG001|Overall Study|Adverse Event|26
4659816|NCT02187055|7547588|FG002|Overall Study|Adverse Event|36
4659817|NCT02187055|7547586|FG000|Overall Study|Death|2
4659818|NCT02187055|7547587|FG001|Overall Study|Death|0
4659819|NCT02187055|7547588|FG002|Overall Study|Death|0
4659820|NCT02187159|7547600|FG000|Overall Study|Protocol Violation|4
4659821|NCT02187159|7547601|FG001|Overall Study|Protocol Violation|6
4659822|NCT02187159|7547602|FG002|Overall Study|Protocol Violation|3
4659823|NCT02187159|7547603|FG003|Overall Study|Protocol Violation|4
4659824|NCT02187159|7547600|FG000|Overall Study|Lack of Efficacy|10
4659825|NCT02187159|7547601|FG001|Overall Study|Lack of Efficacy|5
4659826|NCT02187159|7547602|FG002|Overall Study|Lack of Efficacy|4
4659827|NCT02187159|7547603|FG003|Overall Study|Lack of Efficacy|7
4659828|NCT02187159|7547600|FG000|Overall Study|Adverse Event|28
4659829|NCT02187159|7547601|FG001|Overall Study|Adverse Event|33
4659830|NCT02187159|7547602|FG002|Overall Study|Adverse Event|42
4659831|NCT02187159|7547603|FG003|Overall Study|Adverse Event|50
4659832|NCT02187159|7547600|FG000|Overall Study|Withdrawal by Subject|24
4659833|NCT02187159|7547601|FG001|Overall Study|Withdrawal by Subject|28
4659834|NCT02187159|7547602|FG002|Overall Study|Withdrawal by Subject|25
4659835|NCT02187159|7547603|FG003|Overall Study|Withdrawal by Subject|26
4659836|NCT02187159|7547600|FG000|Overall Study|Other|3
4659837|NCT02187159|7547601|FG001|Overall Study|Other|7
4659838|NCT02187159|7547602|FG002|Overall Study|Other|3
4659839|NCT02187159|7547603|FG003|Overall Study|Other|9
4659840|NCT02187172|7547615|FG000|Overall Study|Lost to Follow-up|1
4659841|NCT02187172|7547616|FG001|Overall Study|Lost to Follow-up|2
4659842|NCT02187172|7547615|FG000|Overall Study|Lack of Efficacy|1
4659843|NCT02187172|7547616|FG001|Overall Study|Lack of Efficacy|2
4659844|NCT02187172|7547615|FG000|Overall Study|Adverse Event|0
4659845|NCT02187172|7547616|FG001|Overall Study|Adverse Event|1
4659846|NCT02187172|7547615|FG000|Overall Study|Physician Decision|1
4659847|NCT02187172|7547616|FG001|Overall Study|Physician Decision|1
4659848|NCT02187471|7547628|FG000|Overall Study|Protocol Violation|4
4659849|NCT02187471|7547629|FG001|Overall Study|Protocol Violation|5
4659850|NCT02187471|7547630|FG002|Overall Study|Protocol Violation|4
4659851|NCT02187471|7547631|FG003|Overall Study|Protocol Violation|4
4659852|NCT02187471|7547628|FG000|Overall Study|Missing|0
4659853|NCT02187471|7547629|FG001|Overall Study|Missing|0
4659854|NCT02187471|7547630|FG002|Overall Study|Missing|0
4659855|NCT02187471|7547631|FG003|Overall Study|Missing|1
4659856|NCT02187471|7547628|FG000|Overall Study|Lack of Efficacy|18
4659857|NCT02187471|7547629|FG001|Overall Study|Lack of Efficacy|9
4659858|NCT02187471|7547630|FG002|Overall Study|Lack of Efficacy|13
4750034|NCT01114217|7724281|FG001|Overall Study|Other-Lack of Efficacy|0
4750035|NCT01114217|7724280|FG000|Overall Study|Other-Non Compliance|2
4750036|NCT01114217|7724281|FG001|Overall Study|Other-Non Compliance|0
4750037|NCT01114217|7724280|FG000|Overall Study|Other-Physician Decision|1
4750038|NCT01114217|7724281|FG001|Overall Study|Other-Physician Decision|1
4750039|NCT01114217|7724280|FG000|Overall Study|Other-Sponsor Decision|10
4750040|NCT01114217|7724281|FG001|Overall Study|Other-Sponsor Decision|12
4750041|NCT01114217|7724280|FG000|Overall Study|Other-Study Termination|0
4750042|NCT01114217|7724281|FG001|Overall Study|Other-Study Termination|1
4750043|NCT01114217|7724280|FG000|Overall Study|Other-Study Withdrawn|1
4750044|NCT01114217|7724281|FG001|Overall Study|Other-Study Withdrawn|1
4750045|NCT01114217|7724280|FG000|Overall Study|Other-Site Stopped Communicating|2
4750046|NCT01114217|7724281|FG001|Overall Study|Other-Site Stopped Communicating|0
4750047|NCT01114217|7724280|FG000|Overall Study|Other-Lost to Follow-up|1
4750048|NCT01114217|7724281|FG001|Overall Study|Other-Lost to Follow-up|0
4750049|NCT01114217|7724280|FG000|Overall Study|Other-Withdrawal by Subject|1
4659859|NCT02187471|7547631|FG003|Overall Study|Lack of Efficacy|11
4659860|NCT02187471|7547628|FG000|Overall Study|Adverse Event|24
4659861|NCT02187471|7547629|FG001|Overall Study|Adverse Event|34
4659862|NCT02187471|7547630|FG002|Overall Study|Adverse Event|44
4659863|NCT02187471|7547631|FG003|Overall Study|Adverse Event|36
4659864|NCT02187471|7547628|FG000|Overall Study|Withdrawal by Subject|23
4659865|NCT02187471|7547629|FG001|Overall Study|Withdrawal by Subject|29
4659866|NCT02187471|7547630|FG002|Overall Study|Withdrawal by Subject|22
4659867|NCT02187471|7547631|FG003|Overall Study|Withdrawal by Subject|24
4659868|NCT02187471|7547628|FG000|Overall Study|Other|7
4659869|NCT02187471|7547629|FG001|Overall Study|Other|5
4659870|NCT02187471|7547630|FG002|Overall Study|Other|3
4750050|NCT01114217|7724281|FG001|Overall Study|Other-Withdrawal by Subject|1
4750051|NCT01114204|7724287|FG000|Overall Study|Adverse Event|3
4750052|NCT01114204|7724288|FG001|Overall Study|Adverse Event|2
4750053|NCT01114204|7724287|FG000|Overall Study|Lost to Follow-up|1
4750054|NCT01114204|7724288|FG001|Overall Study|Lost to Follow-up|0
4750055|NCT01114204|7724287|FG000|Overall Study|Withdrawal by Subject|10
4750056|NCT01114204|7724288|FG001|Overall Study|Withdrawal by Subject|6
4750057|NCT01114204|7724287|FG000|Overall Study|Death|1
4750058|NCT01114204|7724288|FG001|Overall Study|Death|0
4659871|NCT02187471|7547631|FG003|Overall Study|Other|4
4659872|NCT02187744|7547644|FG000|Study|Participant refused further follow-up|1
4659873|NCT02187744|7547645|FG001|Study|Participant refused further follow-up|0
4659874|NCT02187744|7547644|FG000|Study|Other|2
4659875|NCT02187744|7547645|FG001|Study|Other|1
4659876|NCT02187744|7547644|FG000|Study|Lost to Follow-up|0
4659877|NCT02187744|7547645|FG001|Study|Lost to Follow-up|2
4659878|NCT02187744|7547644|FG000|Study|Related adverse event, not serious|0
4659879|NCT02187744|7547645|FG001|Study|Related adverse event, not serious|2
4659880|NCT02187744|7547644|FG000|Study|Death|1
4659881|NCT02187744|7547645|FG001|Study|Death|0
4659882|NCT02187744|7547644|FG000|Study|Related adverse event, serious non-fatal|0
4659883|NCT02187744|7547645|FG001|Study|Related adverse event, serious non-fatal|1
4659884|NCT02187744|7547644|FG000|Treatment|Death|1
4659885|NCT02187744|7547645|FG001|Treatment|Death|0
4659886|NCT02187744|7547644|FG000|Treatment|Related adverse event, serious non-fatal|0
4659887|NCT02187744|7547645|FG001|Treatment|Related adverse event, serious non-fatal|1
4659888|NCT02187744|7547644|FG000|Treatment|Related adverse event, not serious|0
4659889|NCT02187744|7547645|FG001|Treatment|Related adverse event, not serious|2
4659890|NCT02187744|7547644|FG000|Treatment|Lost to Follow-up|0
4659891|NCT02187744|7547645|FG001|Treatment|Lost to Follow-up|1
4750059|NCT01114204|7724287|FG000|Overall Study|Other-Personal reasons|2
4750060|NCT01114204|7724288|FG001|Overall Study|Other-Personal reasons|0
4750061|NCT01114204|7724287|FG000|Overall Study|Other-Medical monitor request|1
4750062|NCT01114204|7724288|FG001|Overall Study|Other-Medical monitor request|0
4750063|NCT01114204|7724287|FG000|Overall Study|Other-Participant request|2
4750064|NCT01114204|7724288|FG001|Overall Study|Other-Participant request|0
4750065|NCT01114204|7724287|FG000|Overall Study|Other-Protocol Violation|1
4750066|NCT01114204|7724288|FG001|Overall Study|Other-Protocol Violation|0
4750067|NCT01114139|7724296|FG000|Overall Study|Adverse Event|3
4750068|NCT01114139|7724297|FG001|Overall Study|Adverse Event|2
4750069|NCT01114139|7724296|FG000|Overall Study|Lost to Follow-up|15
4750070|NCT01114139|7724297|FG001|Overall Study|Lost to Follow-up|3
4750071|NCT01114139|7724296|FG000|Overall Study|Withdrawal by Subject|17
4750072|NCT01114139|7724297|FG001|Overall Study|Withdrawal by Subject|6
4750073|NCT01114139|7724296|FG000|Overall Study|Other-Missed 1 visit|1
4750074|NCT01114139|7724297|FG001|Overall Study|Other-Missed 1 visit|0
4750075|NCT01114139|7724296|FG000|Overall Study|Other-Protocol Violation|1
4750076|NCT01114139|7724297|FG001|Overall Study|Other-Protocol Violation|0
4750077|NCT01114139|7724296|FG000|Overall Study|Other-Out of window for study drug dose|1
4750078|NCT01114139|7724297|FG001|Overall Study|Other-Out of window for study drug dose|0
4750079|NCT01114139|7724296|FG000|Overall Study|Other-Participant falsified records|0
4750080|NCT01114139|7724297|FG001|Overall Study|Other-Participant falsified records|1
4750081|NCT01114139|7724296|FG000|Overall Study|Other-Participant went on hospice|0
4750082|NCT01114139|7724297|FG001|Overall Study|Other-Participant went on hospice|1
4750083|NCT01114139|7724296|FG000|Overall Study|Other-Physician changed treatment|1
4750084|NCT01114139|7724297|FG001|Overall Study|Other-Physician changed treatment|0
4750085|NCT01114139|7724296|FG000|Overall Study|Other-Withdrew prior to receiving dose|1
4750086|NCT01114139|7724297|FG001|Overall Study|Other-Withdrew prior to receiving dose|3
4750087|NCT01059071|7724303|FG000|Overall Study|Lack of Efficacy|1
4750088|NCT01059071|7724304|FG001|Overall Study|Lack of Efficacy|4
4750089|NCT01059071|7724305|FG002|Overall Study|Lack of Efficacy|2
4750090|NCT01059071|7724306|FG003|Overall Study|Lack of Efficacy|3
4750091|NCT01059071|7724303|FG000|Overall Study|Withdrawal by Subject|1
4750092|NCT01059071|7724304|FG001|Overall Study|Withdrawal by Subject|0
4750093|NCT01059071|7724305|FG002|Overall Study|Withdrawal by Subject|0
4750094|NCT01059071|7724306|FG003|Overall Study|Withdrawal by Subject|2
4750095|NCT01059071|7724303|FG000|Overall Study|Physician Decision|0
4750096|NCT01059071|7724304|FG001|Overall Study|Physician Decision|0
4750097|NCT01059071|7724305|FG002|Overall Study|Physician Decision|0
4750098|NCT01059071|7724306|FG003|Overall Study|Physician Decision|1
4750099|NCT01027702|7724314|FG000|Overall Study|Received subsequent therapy|1
4750100|NCT01027702|7724315|FG001|Overall Study|Received subsequent therapy|2
4750101|NCT01027702|7724316|FG002|Overall Study|Received subsequent therapy|0
4750102|NCT01027702|7724317|FG003|Overall Study|Received subsequent therapy|4
4659892|NCT02187744|7547644|FG000|Treatment|Other|2
4659893|NCT02187744|7547645|FG001|Treatment|Other|0
4659894|NCT02187744|7547644|FG000|Treatment|Participant refused continued treatment|1
4659895|NCT02187744|7547645|FG001|Treatment|Participant refused continued treatment|1
4659896|NCT02187783|7547651|FG000|Overall Study|Adverse Event|8
4659897|NCT02187783|7547651|FG000|Overall Study|Death|3
4659898|NCT02187783|7547651|FG000|Overall Study|Progressive disease|80
4659899|NCT02187783|7547651|FG000|Overall Study|Protocol Violation|3
4659900|NCT02187783|7547651|FG000|Overall Study|Physician Decision|2
4659901|NCT02187783|7547651|FG000|Overall Study|Withdrawal by Subject|9
4659902|NCT02187783|7547651|FG000|Overall Study|Study terminated by sponsor|1
4659903|NCT02187809|7547655|FG000|Overall Study|The study was terminated|3
4659904|NCT02187861|7547663|FG000|Overall Study|Adverse Event|2
4659905|NCT02187861|7547664|FG001|Overall Study|Adverse Event|1
4659906|NCT02187861|7547665|FG002|Overall Study|Adverse Event|2
4659907|NCT02187861|7547666|FG003|Overall Study|Adverse Event|1
4659908|NCT02187861|7547663|FG000|Overall Study|Death|0
4659909|NCT02187861|7547664|FG001|Overall Study|Death|3
4750103|NCT01027702|7724318|FG004|Overall Study|Received subsequent therapy|1
4750104|NCT01027702|7724319|FG005|Overall Study|Received subsequent therapy|0
4750105|NCT01027702|7724320|FG006|Overall Study|Received subsequent therapy|1
4750106|NCT01027702|7724314|FG000|Overall Study|Death|0
4750107|NCT01027702|7724315|FG001|Overall Study|Death|0
4750108|NCT01027702|7724316|FG002|Overall Study|Death|1
4659910|NCT02187861|7547665|FG002|Overall Study|Death|1
4659911|NCT02187861|7547666|FG003|Overall Study|Death|2
4659912|NCT02187861|7547663|FG000|Overall Study|Physician Decision|0
4659913|NCT02187861|7547664|FG001|Overall Study|Physician Decision|1
4659914|NCT02187861|7547665|FG002|Overall Study|Physician Decision|0
4659915|NCT02187861|7547666|FG003|Overall Study|Physician Decision|3
4659916|NCT02187861|7547663|FG000|Overall Study|Progressive Disease|4
4659917|NCT02187861|7547664|FG001|Overall Study|Progressive Disease|42
4659918|NCT02187861|7547665|FG002|Overall Study|Progressive Disease|19
4659919|NCT02187861|7547666|FG003|Overall Study|Progressive Disease|22
4659920|NCT02187861|7547663|FG000|Overall Study|Withdrawal by Subject|0
4659921|NCT02187861|7547664|FG001|Overall Study|Withdrawal by Subject|0
4659922|NCT02187861|7547665|FG002|Overall Study|Withdrawal by Subject|3
4659923|NCT02187861|7547666|FG003|Overall Study|Withdrawal by Subject|3
4659924|NCT02187861|7547663|FG000|Overall Study|Other|0
4659925|NCT02187861|7547664|FG001|Overall Study|Other|1
4659926|NCT02187861|7547665|FG002|Overall Study|Other|7
4659927|NCT02187861|7547666|FG003|Overall Study|Other|1
4659928|NCT02188160|7547687|FG000|Overall Study|Adverse Event|1
4659929|NCT02188160|7547688|FG001|Overall Study|Adverse Event|0
4659930|NCT02188160|7547687|FG000|Overall Study|Use of an excluded medication|0
4659931|NCT02188160|7547688|FG001|Overall Study|Use of an excluded medication|1
4659932|NCT02188303|7547702|FG000|Overall Study|Adverse Event|0
4659933|NCT02188303|7547703|FG001|Overall Study|Adverse Event|0
4659934|NCT02188303|7547704|FG002|Overall Study|Adverse Event|0
4659935|NCT02188303|7547705|FG003|Overall Study|Adverse Event|0
4659936|NCT02188303|7547706|FG004|Overall Study|Adverse Event|0
4659937|NCT02188303|7547707|FG005|Overall Study|Adverse Event|2
4659938|NCT02188303|7547708|FG006|Overall Study|Adverse Event|0
4659939|NCT02188303|7547709|FG007|Overall Study|Adverse Event|2
4659940|NCT02188303|7547702|FG000|Overall Study|Dose Termination Criteria Met|0
4659941|NCT02188303|7547703|FG001|Overall Study|Dose Termination Criteria Met|0
4659942|NCT02188303|7547704|FG002|Overall Study|Dose Termination Criteria Met|0
4659943|NCT02188303|7547705|FG003|Overall Study|Dose Termination Criteria Met|0
4659944|NCT02188303|7547706|FG004|Overall Study|Dose Termination Criteria Met|0
4659945|NCT02188303|7547707|FG005|Overall Study|Dose Termination Criteria Met|0
4659946|NCT02188303|7547708|FG006|Overall Study|Dose Termination Criteria Met|2
4659947|NCT02188303|7547709|FG007|Overall Study|Dose Termination Criteria Met|4
4659948|NCT02188459|7547735|FG000|Overall Study|Lost to Follow-up|3
4659949|NCT02188459|7547736|FG001|Overall Study|Lost to Follow-up|4
4659950|NCT02188459|7547735|FG000|Overall Study|Early Termination|0
4659951|NCT02188459|7547736|FG001|Overall Study|Early Termination|3
4659952|NCT02188485|7547748|FG000|Overall Study|Withdrawal by Subject|2
4659953|NCT02188485|7547749|FG001|Overall Study|Withdrawal by Subject|1
4659954|NCT02188485|7547748|FG000|Overall Study|PI withdrew, lack of capacity|0
4659955|NCT02188485|7547749|FG001|Overall Study|PI withdrew, lack of capacity|2
4659956|NCT02188589|7547764|FG000|Overall Study|Withdrawal by Subject|5
4659957|NCT02188719|7547773|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0
4659958|NCT02188719|7547774|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1
4659959|NCT02188719|7547775|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0
4659960|NCT02188719|7547776|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0
4659961|NCT02188784|7547786|FG000|Overall Study|Death|3
4659962|NCT02188784|7547787|FG001|Overall Study|Death|1
4659963|NCT02188784|7547786|FG000|Overall Study|Lost to Follow-up|1
4659964|NCT02188784|7547787|FG001|Overall Study|Lost to Follow-up|0
4659965|NCT02188784|7547786|FG000|Overall Study|Withdrawal by Subject|3
4659966|NCT02188784|7547787|FG001|Overall Study|Withdrawal by Subject|9
4659967|NCT02188784|7547786|FG000|Overall Study|Physician Decision|2
4659968|NCT02188784|7547787|FG001|Overall Study|Physician Decision|3
4659969|NCT02188849|7547795|FG000|Overall Study|Lost to Follow-up|3
4659970|NCT02188849|7547796|FG001|Overall Study|Lost to Follow-up|8
4659971|NCT02189252|7547830|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
4659972|NCT02189252|7547831|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1
4659973|NCT02189252|7547832|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
4659974|NCT02189252|7547833|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
4659975|NCT02189252|7547830|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0
4659976|NCT02189252|7547831|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1
4659977|NCT02189252|7547832|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0
4659978|NCT02189252|7547833|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0
4659979|NCT02189473|7547864|FG000|Overall Study|Death|22
4659980|NCT02189473|7547865|FG001|Overall Study|Death|23
4659981|NCT02189473|7547864|FG000|Overall Study|Lost to Follow-up|1
4659982|NCT02189473|7547865|FG001|Overall Study|Lost to Follow-up|2
4659983|NCT02189759|7547888|FG000|Overall Study|Lost to Follow-up|0
4659984|NCT02189759|7547889|FG001|Overall Study|Lost to Follow-up|0
4659985|NCT02189759|7547890|FG002|Overall Study|Lost to Follow-up|2
4659986|NCT02189759|7547891|FG003|Overall Study|Lost to Follow-up|5
4659987|NCT02189837|7547907|FG000|Overall Study|Withdrawal by Subject|2
4659988|NCT02189837|7547908|FG001|Overall Study|Withdrawal by Subject|1
4659989|NCT02189837|7547909|FG002|Overall Study|Withdrawal by Subject|3
4659990|NCT02189837|7547910|FG003|Overall Study|Withdrawal by Subject|1
4659991|NCT02189837|7547907|FG000|Overall Study|Sponsor Decision|0
4659992|NCT02189837|7547908|FG001|Overall Study|Sponsor Decision|0
4659993|NCT02189837|7547909|FG002|Overall Study|Sponsor Decision|0
4659994|NCT02189837|7547910|FG003|Overall Study|Sponsor Decision|1
4659995|NCT02189863|7547929|FG000|First 2 Weeks|Motion Sickness|4
4659996|NCT02189863|7547930|FG001|First 2 Weeks|Motion Sickness|2
4659997|NCT02189941|7547952|FG000|Overall Study|Non-compliance|0
4659998|NCT02189941|7547953|FG001|Overall Study|Non-compliance|0
4659999|NCT02189941|7547954|FG002|Overall Study|Non-compliance|1
4660000|NCT02190279|7547983|FG000|Overall Study|Withdrawal consent|1
4660001|NCT02190279|7547984|FG001|Overall Study|Withdrawal consent|0
4660002|NCT02190279|7547985|FG002|Overall Study|Withdrawal consent|1
4750109|NCT01027702|7724317|FG003|Overall Study|Death|0
4750110|NCT01027702|7724318|FG004|Overall Study|Death|0
4750111|NCT01027702|7724319|FG005|Overall Study|Death|0
4750112|NCT01027702|7724320|FG006|Overall Study|Death|0
4750113|NCT00991887|7724333|FG000|Overall Study|Lost to Follow-up|2
4750114|NCT00991887|7724334|FG001|Overall Study|Lost to Follow-up|1
4750115|NCT00968864|7724340|FG000|Overall Study|Protocol exception/ not evaluable|1
4750116|NCT00934700|7724351|FG000|Overall Study|missing scan|5
4750117|NCT00934700|7724352|FG001|Overall Study|missing scan|9
4750118|NCT00934700|7724351|FG000|Overall Study|Death|8
4750119|NCT00934700|7724352|FG001|Overall Study|Death|3
4750120|NCT00867568|7724359|FG000|Overall Study|Lack of Efficacy|10
4750121|NCT00867568|7724359|FG000|Overall Study|Adverse Event|4
4750122|NCT00867568|7724359|FG000|Overall Study|Withdrawal by Subject|1
4750123|NCT00785291|7724366|FG000|Overall Study|Never began treatment|8
4750124|NCT00785291|7724367|FG001|Overall Study|Never began treatment|4
4750125|NCT00785291|7724368|FG002|Overall Study|Never began treatment|4
4750126|NCT00785291|7724366|FG000|Overall Study|Adverse Event|39
4750127|NCT00785291|7724367|FG001|Overall Study|Adverse Event|70
4750128|NCT00785291|7724368|FG002|Overall Study|Adverse Event|56
4750129|NCT00785291|7724366|FG000|Overall Study|Death|7
4750130|NCT00785291|7724367|FG001|Overall Study|Death|4
4750131|NCT00785291|7724368|FG002|Overall Study|Death|3
4750132|NCT00785291|7724366|FG000|Overall Study|Withdrawal by Subject|35
4750133|NCT00785291|7724367|FG001|Overall Study|Withdrawal by Subject|36
4750134|NCT00785291|7724368|FG002|Overall Study|Withdrawal by Subject|17
4750135|NCT00785291|7724366|FG000|Overall Study|Alternative Therapy|12
4750136|NCT00785291|7724367|FG001|Overall Study|Alternative Therapy|6
4750137|NCT00785291|7724368|FG002|Overall Study|Alternative Therapy|7
4750138|NCT00785291|7724366|FG000|Overall Study|Complicating illness|6
4750139|NCT00785291|7724367|FG001|Overall Study|Complicating illness|4
4750140|NCT00785291|7724368|FG002|Overall Study|Complicating illness|4
4750141|NCT00785291|7724366|FG000|Overall Study|Other Medical Reasons|29
4750142|NCT00785291|7724367|FG001|Overall Study|Other Medical Reasons|25
4750143|NCT00785291|7724368|FG002|Overall Study|Other Medical Reasons|15
4750144|NCT00777036|7724394|FG000|On Treatment|Reason Not Specified|4
4750145|NCT00777036|7724395|FG001|On Treatment|Reason Not Specified|7
4750146|NCT00777036|7724396|FG002|On Treatment|Reason Not Specified|12
4750147|NCT00777036|7724394|FG000|On Treatment|Failure to Meet Study Criteria|0
4750148|NCT00777036|7724395|FG001|On Treatment|Failure to Meet Study Criteria|1
4750149|NCT00777036|7724396|FG002|On Treatment|Failure to Meet Study Criteria|0
4750150|NCT00777036|7724394|FG000|On Treatment|Non-compliance with Study Drug|1
4750151|NCT00777036|7724395|FG001|On Treatment|Non-compliance with Study Drug|0
4750152|NCT00777036|7724396|FG002|On Treatment|Non-compliance with Study Drug|0
4750153|NCT00777036|7724394|FG000|On Treatment|Maximum Clinical Benefit|2
4750154|NCT00777036|7724395|FG001|On Treatment|Maximum Clinical Benefit|0
4750155|NCT00777036|7724396|FG002|On Treatment|Maximum Clinical Benefit|1
4750156|NCT00777036|7724394|FG000|On Treatment|Withdrawal by Subject|3
4750157|NCT00777036|7724395|FG001|On Treatment|Withdrawal by Subject|2
4750158|NCT00777036|7724396|FG002|On Treatment|Withdrawal by Subject|3
4750159|NCT00777036|7724394|FG000|On Treatment|Death|0
4750160|NCT00777036|7724395|FG001|On Treatment|Death|2
4750161|NCT00777036|7724396|FG002|On Treatment|Death|0
4750162|NCT00777036|7724394|FG000|On Treatment|Study Drug Toxicity|0
4750163|NCT00777036|7724395|FG001|On Treatment|Study Drug Toxicity|0
4750164|NCT00777036|7724396|FG002|On Treatment|Study Drug Toxicity|1
4750165|NCT00777036|7724394|FG000|On Treatment|Progressive Disease|5
4660003|NCT02190279|7547983|FG000|Overall Study|Lost to Follow-up|2
4660004|NCT02190279|7547984|FG001|Overall Study|Lost to Follow-up|0
4660005|NCT02190279|7547985|FG002|Overall Study|Lost to Follow-up|0
4660006|NCT02190279|7547983|FG000|Overall Study|Refused further treatment|0
4660007|NCT02190279|7547984|FG001|Overall Study|Refused further treatment|0
4660008|NCT02190279|7547985|FG002|Overall Study|Refused further treatment|1
4660009|NCT02190279|7547983|FG000|Overall Study|Screening failure|0
4660010|NCT02190279|7547984|FG001|Overall Study|Screening failure|0
4660011|NCT02190279|7547985|FG002|Overall Study|Screening failure|1
4750166|NCT00777036|7724395|FG001|On Treatment|Progressive Disease|4
4750167|NCT00777036|7724396|FG002|On Treatment|Progressive Disease|6
4750168|NCT00777036|7724394|FG000|Follow-Up|Lost to Follow-up|1
4750169|NCT00777036|7724395|FG001|Follow-Up|Lost to Follow-up|0
4750170|NCT00777036|7724396|FG002|Follow-Up|Lost to Follow-up|0
4750171|NCT00777036|7724394|FG000|Follow-Up|Reason Not Specified|2
4660012|NCT02190435|7547997|FG000|Overall Study|First 12 patients were lead-ins|12
4750172|NCT00777036|7724395|FG001|Follow-Up|Reason Not Specified|0
4750173|NCT00777036|7724396|FG002|Follow-Up|Reason Not Specified|0
4750174|NCT00777036|7724394|FG000|Follow-Up|Withdrawal by Subject|1
4750175|NCT00777036|7724395|FG001|Follow-Up|Withdrawal by Subject|0
4660013|NCT02190435|7547998|FG001|Overall Study|First 12 patients were lead-ins|0
4660014|NCT02190435|7547997|FG000|Overall Study|3 consented screen fails|3
4660015|NCT02190435|7547998|FG001|Overall Study|3 consented screen fails|0
4660016|NCT02190591|7548011|FG000|Overall Study|Withdrawal by Subject|1
4660017|NCT02190591|7548012|FG001|Overall Study|Withdrawal by Subject|8
4750176|NCT00777036|7724396|FG002|Follow-Up|Withdrawal by Subject|4
4750177|NCT00777036|7724394|FG000|Follow-Up|Death|1
4750178|NCT00777036|7724395|FG001|Follow-Up|Death|8
4750179|NCT00777036|7724396|FG002|Follow-Up|Death|0
4750180|NCT00770809|7724414|FG000|Overall Study|Adverse Event|9
4750181|NCT00770809|7724415|FG001|Overall Study|Adverse Event|1
4750182|NCT00770809|7724416|FG002|Overall Study|Adverse Event|12
4750183|NCT00770809|7724414|FG000|Overall Study|Death|1
4750184|NCT00770809|7724415|FG001|Overall Study|Death|0
4750185|NCT00770809|7724416|FG002|Overall Study|Death|0
4750186|NCT00770809|7724414|FG000|Overall Study|Withdrawal by Subject|3
4750187|NCT00770809|7724415|FG001|Overall Study|Withdrawal by Subject|3
4750188|NCT00770809|7724416|FG002|Overall Study|Withdrawal by Subject|7
4750189|NCT00770809|7724414|FG000|Overall Study|Progression|2
4750190|NCT00770809|7724415|FG001|Overall Study|Progression|2
4750191|NCT00770809|7724416|FG002|Overall Study|Progression|0
4660018|NCT02190591|7548011|FG000|Overall Study|Protocol Violation|1
4660019|NCT02190591|7548012|FG001|Overall Study|Protocol Violation|0
4660020|NCT02190591|7548011|FG000|Overall Study|did not use peanut ball as instructed|0
4660021|NCT02190591|7548012|FG001|Overall Study|did not use peanut ball as instructed|2
4660022|NCT02190591|7548011|FG000|Overall Study|face presentation so she was ineligible|0
4660023|NCT02190591|7548012|FG001|Overall Study|face presentation so she was ineligible|1
4660024|NCT02190604|7548037|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
4660025|NCT02190604|7548038|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
4660026|NCT02190604|7548039|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
4660027|NCT02190604|7548040|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
4660028|NCT02190604|7548041|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
4660029|NCT02190604|7548042|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
4660030|NCT02190604|7548043|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
4660031|NCT02190604|7548044|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
4660032|NCT02190604|7548045|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
4660033|NCT02190604|7548046|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
4660034|NCT02190604|7548047|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
4660035|NCT02190604|7548048|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
4660036|NCT02190604|7548049|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
4660037|NCT02190604|7548050|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
4660038|NCT02190604|7548051|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2
4660039|NCT02190604|7548052|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
4660040|NCT02190604|7548053|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
4660041|NCT02190604|7548054|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
4660042|NCT02190604|7548055|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
4660043|NCT02190604|7548037|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
4660044|NCT02190604|7548038|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
4660045|NCT02190604|7548039|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
4660046|NCT02190604|7548040|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
4660047|NCT02190604|7548041|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
4660048|NCT02190604|7548042|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
4660049|NCT02190604|7548043|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
4660050|NCT02190604|7548044|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
4660051|NCT02190604|7548045|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
4660052|NCT02190604|7548046|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
4660053|NCT02190604|7548047|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
4660054|NCT02190604|7548048|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
4660055|NCT02190604|7548049|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
4660056|NCT02190604|7548050|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1
4660057|NCT02190604|7548051|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
4660058|NCT02190604|7548052|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
4660059|NCT02190604|7548053|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
4660060|NCT02190604|7548054|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
4660061|NCT02190604|7548055|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
4660062|NCT02191046|7548145|FG000|Overall Study|low compliance|5
4660063|NCT02191046|7548146|FG001|Overall Study|low compliance|1
4660064|NCT02191137|7548152|FG000|Treatment|Death|4
4660065|NCT02191137|7548152|FG000|Treatment|Withdrawal by Subject|3
4660066|NCT02191137|7548152|FG000|Treatment|Adverse Event|2
4660067|NCT02191137|7548152|FG000|Treatment|Other|1
4660068|NCT02191137|7548152|FG000|Follow-up|Lost to Follow-up|2
4660069|NCT02191137|7548152|FG000|Follow-up|Ongoing/unknown|2
4660070|NCT02191137|7548152|FG000|Follow-up|Adverse Event|1
4660071|NCT02191267|7548159|FG000|Overall Study|Withdrawal by Subject|1
4660072|NCT02191267|7548160|FG001|Overall Study|Withdrawal by Subject|0
4660073|NCT02191267|7548161|FG002|Overall Study|Withdrawal by Subject|0
4660074|NCT02191397|7548171|FG000|Overall Study|Adverse Event|28
4660075|NCT02191397|7548172|FG001|Overall Study|Adverse Event|17
4660076|NCT02191397|7548171|FG000|Overall Study|Lack of Efficacy|10
4660077|NCT02191397|7548172|FG001|Overall Study|Lack of Efficacy|5
4660078|NCT02191397|7548171|FG000|Overall Study|Protocol Violation|0
4660079|NCT02191397|7548172|FG001|Overall Study|Protocol Violation|3
4660080|NCT02191397|7548171|FG000|Overall Study|Met protocol-defined stopping criteria|5
4660081|NCT02191397|7548172|FG001|Overall Study|Met protocol-defined stopping criteria|4
4660082|NCT02191397|7548171|FG000|Overall Study|Lost to Follow-up|10
4660083|NCT02191397|7548172|FG001|Overall Study|Lost to Follow-up|11
4660084|NCT02191397|7548171|FG000|Overall Study|Physician Decision|8
4660085|NCT02191397|7548172|FG001|Overall Study|Physician Decision|3
4660086|NCT02191397|7548171|FG000|Overall Study|Withdrawal by Subject|22
4660087|NCT02191397|7548172|FG001|Overall Study|Withdrawal by Subject|27
4750192|NCT00770809|7724414|FG000|Overall Study|Complicating illness|0
4750193|NCT00770809|7724415|FG001|Overall Study|Complicating illness|0
4750194|NCT00770809|7724416|FG002|Overall Study|Complicating illness|1
4750195|NCT00770809|7724414|FG000|Overall Study|Other Medical Reasons|2
4750196|NCT00770809|7724415|FG001|Overall Study|Other Medical Reasons|4
4750197|NCT00770809|7724416|FG002|Overall Study|Other Medical Reasons|3
4750198|NCT00628446|7724429|FG000|Overall Study|Lost to Follow-up|3
4750199|NCT00628446|7724429|FG000|Overall Study|Withdrawal by Subject|1
4750200|NCT00628446|7724429|FG000|Overall Study|Protocol Violation|3
4750201|NCT00621751|7724436|FG000|Overall Study|Adverse Event|0
4750202|NCT00621751|7724437|FG001|Overall Study|Adverse Event|1
4750203|NCT00605215|7724446|FG000|Overall Study|Death|0
4750204|NCT00605215|7724447|FG001|Overall Study|Death|0
4660088|NCT02191579|7548180|FG000|Treatment 1|Multiple Reasons Specified|27
4750205|NCT00605215|7724448|FG002|Overall Study|Death|1
4660089|NCT02191579|7548181|FG001|Treatment 1|Multiple Reasons Specified|58
4660090|NCT02191579|7548180|FG000|Treatment 2|Multiple Reasons Specified|0
4750206|NCT00605215|7724446|FG000|Overall Study|Adverse Event|19
4660091|NCT02191579|7548181|FG001|Treatment 2|Multiple Reasons Specified|25
4660092|NCT02191605|7548192|FG000|Overall Study|Lost to Follow-up|9
4660093|NCT02191605|7548193|FG001|Overall Study|Lost to Follow-up|4
4660094|NCT02191605|7548194|FG002|Overall Study|Lost to Follow-up|7
4660095|NCT02191605|7548195|FG003|Overall Study|Lost to Follow-up|3
4660096|NCT02191605|7548196|FG004|Overall Study|Lost to Follow-up|4
4660097|NCT02191618|7548208|FG000|Overall Study|Withdrawal by Subject|3
4660098|NCT02191618|7548208|FG000|Overall Study|Missed Visit|4
4660099|NCT02192099|7548228|FG000|Overall Study|Adverse Event|1
4660100|NCT02192099|7548228|FG000|Overall Study|Lost to Follow-up|2
4660101|NCT02192099|7548228|FG000|Overall Study|Physician Decision|1
4660102|NCT02192099|7548228|FG000|Overall Study|Pregnancy|1
4660103|NCT02192099|7548228|FG000|Overall Study|Protocol Violation|8
4660104|NCT02192099|7548228|FG000|Overall Study|Study Terminated by Sponsor|32
4660105|NCT02192099|7548228|FG000|Overall Study|Withdrawal by Subject|11
4660106|NCT02192099|7548228|FG000|Overall Study|Miscellaneous Reasons|5
4660107|NCT02192164|7548232|FG000|Overall Study|Other|8
4660108|NCT02192164|7548232|FG000|Overall Study|Withdrawal by Subject|1
4660109|NCT02192164|7548232|FG000|Overall Study|Physician Decision|4
4660110|NCT02192164|7548232|FG000|Overall Study|Did not meet the exclusion criteria|1
4660111|NCT02192190|7548245|FG000|Overall Study|Adverse Event|1
4660112|NCT02192190|7548246|FG001|Overall Study|Adverse Event|1
4660113|NCT02192190|7548247|FG002|Overall Study|Adverse Event|0
4660114|NCT02192190|7548248|FG003|Overall Study|Adverse Event|0
4660115|NCT02192190|7548249|FG004|Overall Study|Adverse Event|0
4660116|NCT02192190|7548250|FG005|Overall Study|Adverse Event|0
4660117|NCT02192190|7548245|FG000|Overall Study|Lost to Follow-up|3
4660118|NCT02192190|7548246|FG001|Overall Study|Lost to Follow-up|3
4660119|NCT02192190|7548247|FG002|Overall Study|Lost to Follow-up|2
4660120|NCT02192190|7548248|FG003|Overall Study|Lost to Follow-up|1
4660121|NCT02192190|7548249|FG004|Overall Study|Lost to Follow-up|4
4660122|NCT02192190|7548250|FG005|Overall Study|Lost to Follow-up|3
4660123|NCT02192190|7548245|FG000|Overall Study|Physician Decision|2
4660124|NCT02192190|7548246|FG001|Overall Study|Physician Decision|0
4660125|NCT02192190|7548247|FG002|Overall Study|Physician Decision|0
4660126|NCT02192190|7548248|FG003|Overall Study|Physician Decision|0
4660127|NCT02192190|7548249|FG004|Overall Study|Physician Decision|0
4660128|NCT02192190|7548250|FG005|Overall Study|Physician Decision|0
4660129|NCT02192190|7548245|FG000|Overall Study|Terminated by Sponsor|43
4660130|NCT02192190|7548246|FG001|Overall Study|Terminated by Sponsor|23
4660131|NCT02192190|7548247|FG002|Overall Study|Terminated by Sponsor|20
4660132|NCT02192190|7548248|FG003|Overall Study|Terminated by Sponsor|23
4660133|NCT02192190|7548249|FG004|Overall Study|Terminated by Sponsor|21
4660134|NCT02192190|7548250|FG005|Overall Study|Terminated by Sponsor|23
4660135|NCT02192190|7548245|FG000|Overall Study|Withdrawal by Subject|4
4660136|NCT02192190|7548246|FG001|Overall Study|Withdrawal by Subject|1
4660137|NCT02192190|7548247|FG002|Overall Study|Withdrawal by Subject|2
4660138|NCT02192190|7548248|FG003|Overall Study|Withdrawal by Subject|1
4660139|NCT02192190|7548249|FG004|Overall Study|Withdrawal by Subject|5
4660140|NCT02192190|7548250|FG005|Overall Study|Withdrawal by Subject|3
4660141|NCT02192190|7548245|FG000|Overall Study|Could not Keep Visit Schedule|1
4660142|NCT02192190|7548246|FG001|Overall Study|Could not Keep Visit Schedule|0
4660143|NCT02192190|7548247|FG002|Overall Study|Could not Keep Visit Schedule|0
4660144|NCT02192190|7548248|FG003|Overall Study|Could not Keep Visit Schedule|0
4660145|NCT02192190|7548249|FG004|Overall Study|Could not Keep Visit Schedule|0
4660146|NCT02192190|7548250|FG005|Overall Study|Could not Keep Visit Schedule|0
4660147|NCT02192190|7548245|FG000|Overall Study|Positive Drug Screen|0
4660148|NCT02192190|7548246|FG001|Overall Study|Positive Drug Screen|0
4660149|NCT02192190|7548247|FG002|Overall Study|Positive Drug Screen|0
4660150|NCT02192190|7548248|FG003|Overall Study|Positive Drug Screen|1
4660151|NCT02192190|7548249|FG004|Overall Study|Positive Drug Screen|0
4660152|NCT02192190|7548250|FG005|Overall Study|Positive Drug Screen|0
4660153|NCT02192190|7548245|FG000|Overall Study|Inadequate Pain Relief|0
4660154|NCT02192190|7548246|FG001|Overall Study|Inadequate Pain Relief|1
4660155|NCT02192190|7548247|FG002|Overall Study|Inadequate Pain Relief|1
4660156|NCT02192190|7548248|FG003|Overall Study|Inadequate Pain Relief|0
4660157|NCT02192190|7548249|FG004|Overall Study|Inadequate Pain Relief|0
4660158|NCT02192190|7548250|FG005|Overall Study|Inadequate Pain Relief|0
4660159|NCT02192606|7548286|FG000|Overall Study|surgery type was changed|1
4660160|NCT02192606|7548287|FG001|Overall Study|surgery type was changed|1
4660161|NCT02192606|7548286|FG000|Overall Study|Physician Decision|1
4660162|NCT02192606|7548287|FG001|Overall Study|Physician Decision|2
4660163|NCT02192606|7548286|FG000|Overall Study|3D equipment rep unable to join|0
4660164|NCT02192606|7548287|FG001|Overall Study|3D equipment rep unable to join|1
4660165|NCT02192905|7548319|FG000|Overall Study|Lost to Follow-up|1
4750207|NCT00605215|7724447|FG001|Overall Study|Adverse Event|21
4750208|NCT00605215|7724448|FG002|Overall Study|Adverse Event|26
4750209|NCT00605215|7724446|FG000|Overall Study|Refusal to sign the re-consent form|8
4750210|NCT00605215|7724447|FG001|Overall Study|Refusal to sign the re-consent form|3
4750211|NCT00605215|7724448|FG002|Overall Study|Refusal to sign the re-consent form|3
4750212|NCT00605215|7724446|FG000|Overall Study|Withdrawal by Subject|39
4750213|NCT00605215|7724447|FG001|Overall Study|Withdrawal by Subject|37
4750214|NCT00605215|7724448|FG002|Overall Study|Withdrawal by Subject|27
4660166|NCT02192970|7548326|FG000|Overall Study|Lost to Follow-up|6
4660167|NCT02192970|7548327|FG001|Overall Study|Lost to Follow-up|0
4660168|NCT02193074|7548335|FG000|Overall Study|Withdrawal by Subject|1
4660169|NCT02193074|7548336|FG001|Overall Study|Withdrawal by Subject|2
4660170|NCT02193074|7548335|FG000|Overall Study|Adverse Event|16
4660171|NCT02193074|7548336|FG001|Overall Study|Adverse Event|13
4660172|NCT02193087|7548346|FG000|Overall Study|Adverse Event|2
4660173|NCT02193087|7548347|FG001|Overall Study|Adverse Event|0
4660174|NCT02193087|7548348|FG002|Overall Study|Adverse Event|0
4660175|NCT02193087|7548349|FG003|Overall Study|Adverse Event|11
4660176|NCT02193087|7548346|FG000|Overall Study|Lost to Follow-up|14
4660177|NCT02193087|7548347|FG001|Overall Study|Lost to Follow-up|6
4660178|NCT02193087|7548348|FG002|Overall Study|Lost to Follow-up|4
4660179|NCT02193087|7548349|FG003|Overall Study|Lost to Follow-up|37
4660180|NCT02193087|7548346|FG000|Overall Study|Protocol Violation|2
4660181|NCT02193087|7548347|FG001|Overall Study|Protocol Violation|0
4660182|NCT02193087|7548348|FG002|Overall Study|Protocol Violation|1
4660183|NCT02193087|7548349|FG003|Overall Study|Protocol Violation|2
4660184|NCT02193087|7548346|FG000|Overall Study|Withdrawal by Subject|10
4660185|NCT02193087|7548347|FG001|Overall Study|Withdrawal by Subject|3
4660186|NCT02193087|7548348|FG002|Overall Study|Withdrawal by Subject|1
4660187|NCT02193087|7548349|FG003|Overall Study|Withdrawal by Subject|19
4660188|NCT02193087|7548346|FG000|Overall Study|Other Reason Not Specified|7
4660189|NCT02193087|7548347|FG001|Overall Study|Other Reason Not Specified|2
4660190|NCT02193087|7548348|FG002|Overall Study|Other Reason Not Specified|1
4660191|NCT02193087|7548349|FG003|Overall Study|Other Reason Not Specified|9
4660192|NCT02193087|7548346|FG000|Overall Study|Did Not Receive Any Vaccination|2
4660193|NCT02193087|7548347|FG001|Overall Study|Did Not Receive Any Vaccination|3
4660194|NCT02193087|7548348|FG002|Overall Study|Did Not Receive Any Vaccination|0
4660195|NCT02193087|7548349|FG003|Overall Study|Did Not Receive Any Vaccination|1
4660196|NCT02193165|7548373|FG000|4 Week Product Use|Lost to Follow-up|1
4660197|NCT02193165|7548374|FG001|4 Week Product Use|Lost to Follow-up|1
4660198|NCT02193165|7548375|FG002|4 Week Product Use|Lost to Follow-up|1
4660199|NCT02193165|7548373|FG000|6 Week Product Use|Lost to Follow-up|0
4660200|NCT02193165|7548374|FG001|6 Week Product Use|Lost to Follow-up|1
4660201|NCT02193165|7548375|FG002|6 Week Product Use|Lost to Follow-up|0
4660202|NCT02193178|7548383|FG000|Overall Study|Lost to Follow-up|1
4660203|NCT02193178|7548383|FG000|Overall Study|Dry eyes|1
4660204|NCT02193776|7548418|FG000|Overall Study|Consent withdrawn|1
4660205|NCT02193776|7548419|FG001|Overall Study|Consent withdrawn|0
4660206|NCT02193776|7548420|FG002|Overall Study|Consent withdrawn|0
4660207|NCT02193776|7548421|FG003|Overall Study|Consent withdrawn|0
4660208|NCT02193776|7548418|FG000|Overall Study|Failure to comply with protocol|0
4660209|NCT02193776|7548419|FG001|Overall Study|Failure to comply with protocol|1
4660210|NCT02193776|7548420|FG002|Overall Study|Failure to comply with protocol|0
4660211|NCT02193776|7548421|FG003|Overall Study|Failure to comply with protocol|0
4660212|NCT02193776|7548418|FG000|Overall Study|Investigator/Sponsor decision|1
4660213|NCT02193776|7548419|FG001|Overall Study|Investigator/Sponsor decision|1
4660214|NCT02193776|7548420|FG002|Overall Study|Investigator/Sponsor decision|0
4660215|NCT02193776|7548421|FG003|Overall Study|Investigator/Sponsor decision|0
4660216|NCT02193776|7548418|FG000|Overall Study|Death|1
4660217|NCT02193776|7548419|FG001|Overall Study|Death|0
4660218|NCT02193776|7548420|FG002|Overall Study|Death|0
4660219|NCT02193776|7548421|FG003|Overall Study|Death|0
4660220|NCT02193776|7548418|FG000|Overall Study|Adverse event/Specific toxicity|5
4660221|NCT02193776|7548419|FG001|Overall Study|Adverse event/Specific toxicity|5
4660222|NCT02193776|7548420|FG002|Overall Study|Adverse event/Specific toxicity|2
4660223|NCT02193776|7548421|FG003|Overall Study|Adverse event/Specific toxicity|2
4660224|NCT02193828|7548449|FG000|Overall Study|Withdrawal by Subject|0
4660225|NCT02193828|7548450|FG001|Overall Study|Withdrawal by Subject|0
4660226|NCT02193828|7548451|FG002|Overall Study|Withdrawal by Subject|1
4660227|NCT02193828|7548452|FG003|Overall Study|Withdrawal by Subject|1
4660228|NCT02193880|7548462|FG000|Overall Study|patients did not collect enough HPC|3
4660229|NCT02194062|7548469|FG000|Overall Study|Lost to Follow-up|2
4660230|NCT02194062|7548470|FG001|Overall Study|Lost to Follow-up|2
4660231|NCT02194062|7548471|FG002|Overall Study|Lost to Follow-up|5
4660232|NCT02194465|7548501|FG000|Overall Study|Adverse Event|6
4660233|NCT02194465|7548502|FG001|Overall Study|Adverse Event|1
4660234|NCT02194465|7548503|FG002|Overall Study|Adverse Event|4
4660235|NCT02194465|7548504|FG003|Overall Study|Adverse Event|4
4660236|NCT02194465|7548505|FG004|Overall Study|Adverse Event|4
4660237|NCT02194465|7548506|FG005|Overall Study|Adverse Event|2
4660238|NCT02194465|7548507|FG006|Overall Study|Adverse Event|0
4660239|NCT02194465|7548501|FG000|Overall Study|Lost to Follow-up|0
4660240|NCT02194465|7548502|FG001|Overall Study|Lost to Follow-up|0
4660241|NCT02194465|7548503|FG002|Overall Study|Lost to Follow-up|0
4660242|NCT02194465|7548504|FG003|Overall Study|Lost to Follow-up|1
4660243|NCT02194465|7548505|FG004|Overall Study|Lost to Follow-up|0
4660244|NCT02194465|7548506|FG005|Overall Study|Lost to Follow-up|1
4660245|NCT02194465|7548507|FG006|Overall Study|Lost to Follow-up|0
4660246|NCT02194465|7548501|FG000|Overall Study|Physician Decision|1
4660247|NCT02194465|7548502|FG001|Overall Study|Physician Decision|0
4660248|NCT02194465|7548503|FG002|Overall Study|Physician Decision|0
4660249|NCT02194465|7548504|FG003|Overall Study|Physician Decision|0
4660250|NCT02194465|7548505|FG004|Overall Study|Physician Decision|0
4660251|NCT02194465|7548506|FG005|Overall Study|Physician Decision|0
4660252|NCT02194465|7548507|FG006|Overall Study|Physician Decision|0
4660253|NCT02194465|7548501|FG000|Overall Study|Protocol Violation|1
4660254|NCT02194465|7548502|FG001|Overall Study|Protocol Violation|1
4660255|NCT02194465|7548503|FG002|Overall Study|Protocol Violation|2
4660256|NCT02194465|7548504|FG003|Overall Study|Protocol Violation|1
4660257|NCT02194465|7548505|FG004|Overall Study|Protocol Violation|1
4660258|NCT02194465|7548506|FG005|Overall Study|Protocol Violation|0
4660259|NCT02194465|7548507|FG006|Overall Study|Protocol Violation|0
4660260|NCT02194465|7548501|FG000|Overall Study|Withdrawal by Subject|1
4660261|NCT02194465|7548502|FG001|Overall Study|Withdrawal by Subject|3
4660262|NCT02194465|7548503|FG002|Overall Study|Withdrawal by Subject|1
4660263|NCT02194465|7548504|FG003|Overall Study|Withdrawal by Subject|2
4660264|NCT02194465|7548505|FG004|Overall Study|Withdrawal by Subject|2
4660265|NCT02194465|7548506|FG005|Overall Study|Withdrawal by Subject|1
4660266|NCT02194465|7548507|FG006|Overall Study|Withdrawal by Subject|2
4660267|NCT02194465|7548501|FG000|Overall Study|Discontinued follow-up period|0
4660268|NCT02194465|7548502|FG001|Overall Study|Discontinued follow-up period|2
4660269|NCT02194465|7548503|FG002|Overall Study|Discontinued follow-up period|1
4660270|NCT02194465|7548504|FG003|Overall Study|Discontinued follow-up period|0
4660271|NCT02194465|7548505|FG004|Overall Study|Discontinued follow-up period|2
4660272|NCT02194465|7548506|FG005|Overall Study|Discontinued follow-up period|0
4660273|NCT02194465|7548507|FG006|Overall Study|Discontinued follow-up period|0
4660274|NCT02194621|7548530|FG000|Overall Study|6 withdrew prior to randomization|2
4660275|NCT02194621|7548531|FG001|Overall Study|6 withdrew prior to randomization|2
4660276|NCT02194621|7548532|FG002|Overall Study|6 withdrew prior to randomization|2
4660277|NCT02194621|7548530|FG000|Overall Study|Withdrawal by Subject|4
4660278|NCT02194621|7548531|FG001|Overall Study|Withdrawal by Subject|4
4660279|NCT02194621|7548532|FG002|Overall Study|Withdrawal by Subject|7
4660280|NCT02194699|7548542|FG000|Randomised|Did not receive treatment|1
4660281|NCT02194699|7548543|FG001|Randomised|Did not receive treatment|5
4660282|NCT02194699|7548542|FG000|Randomised|Without potential for 52 weeks of IP|5
4660283|NCT02194699|7548543|FG001|Randomised|Without potential for 52 weeks of IP|5
4660284|NCT02194699|7548542|FG000|Randomised|Duplicate patient|2
4660285|NCT02194699|7548543|FG001|Randomised|Duplicate patient|1
4660286|NCT02194699|7548542|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4
4660287|NCT02194699|7548543|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3
4660288|NCT02194699|7548542|FG000|With Potential to Receive 52 Weeks of IP|Death|1
4660289|NCT02194699|7548543|FG001|With Potential to Receive 52 Weeks of IP|Death|3
4660290|NCT02194699|7548542|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5
4660291|NCT02194699|7548543|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8
4660292|NCT02194699|7548542|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2
4660293|NCT02194699|7548543|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2
4660294|NCT02194699|7548542|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14
4660295|NCT02194699|7548543|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20
4660296|NCT02194699|7548542|FG000|With Potential to Receive 52 Weeks of IP|Other|24
4660297|NCT02194699|7548543|FG001|With Potential to Receive 52 Weeks of IP|Other|16
4660298|NCT02194933|7548559|FG000|Overall Study|Lost to Follow-up|1
4660299|NCT02194933|7548560|FG001|Overall Study|Lost to Follow-up|2
4660300|NCT02194933|7548559|FG000|Overall Study|Participant met withdrawal criteria|1
4660301|NCT02194933|7548560|FG001|Overall Study|Participant met withdrawal criteria|3
4660302|NCT02194933|7548559|FG000|Overall Study|Withdrawal by Subject|0
4660303|NCT02194933|7548560|FG001|Overall Study|Withdrawal by Subject|2
4660304|NCT02194933|7548559|FG000|Overall Study|Lack of Efficacy|1
4660305|NCT02194933|7548560|FG001|Overall Study|Lack of Efficacy|2
4660306|NCT02194985|7548568|FG000|Overall Study|Adverse Event|1
4660307|NCT02194985|7548568|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3
4660308|NCT02194985|7548568|FG000|Overall Study|Physician Decision|4
4660309|NCT02194985|7548568|FG000|Overall Study|Lost to Follow-up|1
4660310|NCT02194985|7548568|FG000|Overall Study|Withdrawal by Subject|2
4660311|NCT02194998|7548576|FG000|On-HCV Treatment|Did not pick up study medication|0
4660312|NCT02194998|7548577|FG001|On-HCV Treatment|Did not pick up study medication|1
4660313|NCT02194998|7548578|FG002|On-HCV Treatment|Did not pick up study medication|0
4660314|NCT02194998|7548579|FG003|On-HCV Treatment|Did not pick up study medication|0
4660315|NCT02194998|7548576|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1
4660316|NCT02194998|7548577|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0
4660317|NCT02194998|7548578|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1
4660318|NCT02194998|7548579|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0
4660319|NCT02195011|7548591|FG000|Overall Study|Adverse Event|4
4660320|NCT02195011|7548592|FG001|Overall Study|Adverse Event|0
4660321|NCT02195011|7548591|FG000|Overall Study|Progressive Disease|18
4660322|NCT02195011|7548592|FG001|Overall Study|Progressive Disease|1
4660323|NCT02195011|7548591|FG000|Overall Study|Withdrawal by Subject|3
4660324|NCT02195011|7548592|FG001|Overall Study|Withdrawal by Subject|0
4660325|NCT02195427|7548687|FG000|Overall Study|Did not consent to study extension|13
4660326|NCT02195427|7548688|FG001|Overall Study|Did not consent to study extension|9
4660327|NCT02195427|7548687|FG000|Overall Study|Withdrawal by Subject|4
4660328|NCT02195427|7548688|FG001|Overall Study|Withdrawal by Subject|2
4660329|NCT02195427|7548687|FG000|Overall Study|Lost to Follow-up|0
4660330|NCT02195427|7548688|FG001|Overall Study|Lost to Follow-up|1
4660331|NCT02195427|7548687|FG000|Overall Study|Protocol Violation|7
4660332|NCT02195427|7548688|FG001|Overall Study|Protocol Violation|14
4660333|NCT02195427|7548687|FG000|Overall Study|Conditional re-treatment at W52|2
4660334|NCT02195427|7548688|FG001|Overall Study|Conditional re-treatment at W52|1
4660335|NCT02195518|7548698|FG000|Overall Study|Adverse Event|1
4660336|NCT02195518|7548698|FG000|Overall Study|Protocol Violation|4
4660337|NCT02195518|7548698|FG000|Overall Study|Pregnancy|2
4660338|NCT02195518|7548698|FG000|Overall Study|Withdrawal by Subject|1
4660339|NCT02195518|7548698|FG000|Overall Study|Lost to Follow-up|1
4660340|NCT02195531|7548705|FG000|Overall Study|Withdrawal by Subject|1
4660341|NCT02195531|7548706|FG001|Overall Study|Withdrawal by Subject|1
4660342|NCT02195531|7548707|FG002|Overall Study|Withdrawal by Subject|1
4660343|NCT02195583|7548715|FG000|Overall Study|Lost to Follow-up|1
4660344|NCT02195583|7548715|FG000|Overall Study|Withdrawal by Subject|4
4660345|NCT02195583|7548715|FG000|Overall Study|Adverse Event|2
4660346|NCT02195583|7548715|FG000|Overall Study|Other Reason|2
4660347|NCT02195687|7548741|FG000|Overall Study|Personal Reasons|1
4750215|NCT00605215|7724446|FG000|Overall Study|Request of Primary Care Physician or Investigator|6
4750216|NCT00605215|7724447|FG001|Overall Study|Request of Primary Care Physician or Investigator|4
4750217|NCT00605215|7724448|FG002|Overall Study|Request of Primary Care Physician or Investigator|4
4750218|NCT00605215|7724446|FG000|Overall Study|Protocol Violation|3
4750219|NCT00605215|7724447|FG001|Overall Study|Protocol Violation|4
4750220|NCT00605215|7724448|FG002|Overall Study|Protocol Violation|1
4750221|NCT00605215|7724446|FG000|Overall Study|Pregnancy|8
4750222|NCT00605215|7724447|FG001|Overall Study|Pregnancy|5
4750223|NCT00605215|7724448|FG002|Overall Study|Pregnancy|4
4750224|NCT00605215|7724446|FG000|Overall Study|Lost to Follow-up|8
4750225|NCT00605215|7724447|FG001|Overall Study|Lost to Follow-up|5
4750226|NCT00605215|7724448|FG002|Overall Study|Lost to Follow-up|2
4750227|NCT00605215|7724446|FG000|Overall Study|Other than specified|0
4750228|NCT00605215|7724447|FG001|Overall Study|Other than specified|2
4750229|NCT00605215|7724448|FG002|Overall Study|Other than specified|1
4660348|NCT02195687|7548742|FG001|Overall Study|Personal Reasons|1
4660349|NCT02195687|7548741|FG000|Overall Study|Lost to Follow-up|4
4660350|NCT02195687|7548742|FG001|Overall Study|Lost to Follow-up|1
4660351|NCT02195700|7548750|FG000|Overall Study|Protocol Violation|0
4660352|NCT02195700|7548751|FG001|Overall Study|Protocol Violation|2
4660353|NCT02195700|7548750|FG000|Overall Study|Noncompliance|1
4660354|NCT02195700|7548751|FG001|Overall Study|Noncompliance|0
4660355|NCT02195700|7548750|FG000|Overall Study|Adverse Event|1
4660356|NCT02195700|7548751|FG001|Overall Study|Adverse Event|2
4660357|NCT02195700|7548750|FG000|Overall Study|Withdrawal by Subject|3
4660358|NCT02195700|7548751|FG001|Overall Study|Withdrawal by Subject|2
4660359|NCT02195700|7548750|FG000|Overall Study|Lost to Follow-up|1
4660360|NCT02195700|7548751|FG001|Overall Study|Lost to Follow-up|1
4660361|NCT02195869|7548766|FG000|Overall Study|cGVHD Progression|5
4660362|NCT02195869|7548766|FG000|Overall Study|Malignancy Progression/relapse|2
4660363|NCT02195869|7548766|FG000|Overall Study|Adverse Event|15
4660364|NCT02195869|7548766|FG000|Overall Study|Withdrawal by Subject|7
4660365|NCT02195869|7548766|FG000|Overall Study|Physician Decision|4
4660366|NCT02195869|7548766|FG000|Overall Study|Study Terminated by Sponsor|7
4660367|NCT02195869|7548766|FG000|Overall Study|Noncompliance with study drug|2
4660368|NCT02196038|7548801|FG000|Overall Study|Death|16
4660369|NCT02196038|7548802|FG001|Overall Study|Death|21
4660370|NCT02196038|7548801|FG000|Overall Study|Withdrawal by Subject|0
4660371|NCT02196038|7548802|FG001|Overall Study|Withdrawal by Subject|1
4660372|NCT02196038|7548801|FG000|Overall Study|Lost to Follow-up|1
4660373|NCT02196038|7548802|FG001|Overall Study|Lost to Follow-up|0
4660374|NCT02196077|7548808|FG000|Overall Study|Adverse Event|4
4660375|NCT02196077|7548808|FG000|Overall Study|Lack of Efficacy|1
4660376|NCT02196077|7548808|FG000|Overall Study|Withdrawal by Subject|14
4660377|NCT02196077|7548808|FG000|Overall Study|Physician Decision|1
4660378|NCT02196077|7548808|FG000|Overall Study|Lost to Follow-up|3
4660379|NCT02196077|7548808|FG000|Overall Study|Protocol Violation|24
4660380|NCT02196259|7548832|FG000|Overall Study|Researcher choice|0
4660381|NCT02196259|7548833|FG001|Overall Study|Researcher choice|0
4660382|NCT02196259|7548834|FG002|Overall Study|Researcher choice|1
4660383|NCT02196259|7548832|FG000|Overall Study|Partial data analysis|0
4660384|NCT02196259|7548833|FG001|Overall Study|Partial data analysis|3
4660385|NCT02196259|7548834|FG002|Overall Study|Partial data analysis|0
4660386|NCT02196324|7548843|FG000|Overall Study|Withdrawal by Subject|8
4660387|NCT02196324|7548844|FG001|Overall Study|Withdrawal by Subject|4
4660388|NCT02196324|7548843|FG000|Overall Study|Adverse Event or Serious Adverse Event|6
4660389|NCT02196324|7548844|FG001|Overall Study|Adverse Event or Serious Adverse Event|3
4660390|NCT02196324|7548843|FG000|Overall Study|Occurrence of an Exclusion Criterion|0
4660391|NCT02196324|7548844|FG001|Overall Study|Occurrence of an Exclusion Criterion|1
4660392|NCT02196324|7548843|FG000|Overall Study|Other|1
4660393|NCT02196324|7548844|FG001|Overall Study|Other|0
4660394|NCT02196506|7548852|FG000|Phase A|Participant Met Withdrawal Criteria|34
4660395|NCT02196506|7548853|FG001|Phase A|Participant Met Withdrawal Criteria|0
4660396|NCT02196506|7548854|FG002|Phase A|Participant Met Withdrawal Criteria|0
4660397|NCT02196506|7548855|FG003|Phase A|Participant Met Withdrawal Criteria|0
4660398|NCT02196506|7548852|FG000|Phase A|Withdrawal by Subject|34
4660399|NCT02196506|7548853|FG001|Phase A|Withdrawal by Subject|0
4750230|NCT00552513|7724462|FG000|Overall Study|Lost to Follow-up|5
4750231|NCT00552513|7724463|FG001|Overall Study|Lost to Follow-up|1
4750232|NCT00368836|7724473|FG000|Phase II|Screen Failure|1
4750233|NCT00368836|7724473|FG000|Phase II|Withdrawal by Subject|1
4750234|NCT00368836|7724473|FG000|Phase II|unable to collect blood and/or breath|17
4750235|NCT00368836|7724473|FG000|Phase II|Protocol Violation|2
4660400|NCT02196506|7548854|FG002|Phase A|Withdrawal by Subject|0
4660401|NCT02196506|7548855|FG003|Phase A|Withdrawal by Subject|0
4660402|NCT02196506|7548852|FG000|Phase A|Adverse Event|22
4660403|NCT02196506|7548853|FG001|Phase A|Adverse Event|0
4660404|NCT02196506|7548854|FG002|Phase A|Adverse Event|0
4660405|NCT02196506|7548855|FG003|Phase A|Adverse Event|0
4660406|NCT02196506|7548852|FG000|Phase A|Lost to Follow-up|9
4660407|NCT02196506|7548853|FG001|Phase A|Lost to Follow-up|0
4660408|NCT02196506|7548854|FG002|Phase A|Lost to Follow-up|0
4660409|NCT02196506|7548855|FG003|Phase A|Lost to Follow-up|0
4660410|NCT02196506|7548852|FG000|Phase A|Protocol deviation|12
4660411|NCT02196506|7548853|FG001|Phase A|Protocol deviation|0
4660412|NCT02196506|7548854|FG002|Phase A|Protocol deviation|0
4660413|NCT02196506|7548855|FG003|Phase A|Protocol deviation|0
4660414|NCT02196506|7548852|FG000|Phase A|Participant withdrawn by investigator|10
4660415|NCT02196506|7548853|FG001|Phase A|Participant withdrawn by investigator|0
4660416|NCT02196506|7548854|FG002|Phase A|Participant withdrawn by investigator|0
4660417|NCT02196506|7548855|FG003|Phase A|Participant withdrawn by investigator|0
4660418|NCT02196506|7548852|FG000|Phase B|Participant Met Withdrawal Criteria|0
4660419|NCT02196506|7548853|FG001|Phase B|Participant Met Withdrawal Criteria|0
4660420|NCT02196506|7548854|FG002|Phase B|Participant Met Withdrawal Criteria|1
4660421|NCT02196506|7548855|FG003|Phase B|Participant Met Withdrawal Criteria|0
4660422|NCT02196506|7548852|FG000|Phase B|Lack of Efficacy|0
4660423|NCT02196506|7548853|FG001|Phase B|Lack of Efficacy|1
4660424|NCT02196506|7548854|FG002|Phase B|Lack of Efficacy|2
4660425|NCT02196506|7548855|FG003|Phase B|Lack of Efficacy|0
4660426|NCT02196506|7548852|FG000|Phase B|Withdrawal by Participant|0
4660427|NCT02196506|7548853|FG001|Phase B|Withdrawal by Participant|8
4660428|NCT02196506|7548854|FG002|Phase B|Withdrawal by Participant|1
4750236|NCT00290511|7724480|FG000|Overall Study|Adverse Event|1
4660429|NCT02196506|7548855|FG003|Phase B|Withdrawal by Participant|0
4660430|NCT02196506|7548852|FG000|Phase B|Adverse Event|0
4660431|NCT02196506|7548853|FG001|Phase B|Adverse Event|4
4660432|NCT02196506|7548854|FG002|Phase B|Adverse Event|1
4660433|NCT02196506|7548855|FG003|Phase B|Adverse Event|0
4660434|NCT02196506|7548852|FG000|Phase B|Lost to Follow-up|0
4660435|NCT02196506|7548853|FG001|Phase B|Lost to Follow-up|2
4660436|NCT02196506|7548854|FG002|Phase B|Lost to Follow-up|1
4660437|NCT02196506|7548855|FG003|Phase B|Lost to Follow-up|0
4660438|NCT02196506|7548852|FG000|Phase A+|Participant Met Withdrawal Criteria|0
4660439|NCT02196506|7548853|FG001|Phase A+|Participant Met Withdrawal Criteria|0
4660440|NCT02196506|7548854|FG002|Phase A+|Participant Met Withdrawal Criteria|0
4660441|NCT02196506|7548855|FG003|Phase A+|Participant Met Withdrawal Criteria|1
4660442|NCT02196506|7548852|FG000|Phase A+|Withdrawal by Participant|0
4660443|NCT02196506|7548853|FG001|Phase A+|Withdrawal by Participant|0
4660444|NCT02196506|7548854|FG002|Phase A+|Withdrawal by Participant|0
4660445|NCT02196506|7548855|FG003|Phase A+|Withdrawal by Participant|5
4660446|NCT02196506|7548852|FG000|Phase A+|Adverse Event|0
4660447|NCT02196506|7548853|FG001|Phase A+|Adverse Event|0
4660448|NCT02196506|7548854|FG002|Phase A+|Adverse Event|0
4660449|NCT02196506|7548855|FG003|Phase A+|Adverse Event|1
4660450|NCT02196506|7548852|FG000|Phase A+|Lost to Follow-up|0
4660451|NCT02196506|7548853|FG001|Phase A+|Lost to Follow-up|0
4750237|NCT00290511|7724480|FG000|Overall Study|Death|1
4750238|NCT00290511|7724480|FG000|Overall Study|Physician Decision|1
4750239|NCT00290511|7724480|FG000|Overall Study|Withdrawal by Subject|1
4660452|NCT02196506|7548854|FG002|Phase A+|Lost to Follow-up|0
4660453|NCT02196506|7548855|FG003|Phase A+|Lost to Follow-up|6
4660454|NCT02196506|7548852|FG000|Phase A+|Participant withdrawn by investigator|0
4660455|NCT02196506|7548853|FG001|Phase A+|Participant withdrawn by investigator|0
4660456|NCT02196506|7548854|FG002|Phase A+|Participant withdrawn by investigator|0
4660457|NCT02196506|7548855|FG003|Phase A+|Participant withdrawn by investigator|1
4660458|NCT02196558|7548864|FG000|Treatment Phase (12 Weeks)|Adverse Event|0
4660459|NCT02196558|7548865|FG001|Treatment Phase (12 Weeks)|Adverse Event|2
4660460|NCT02196558|7548866|FG002|Treatment Phase (12 Weeks)|Adverse Event|0
4660461|NCT02196558|7548864|FG000|Treatment Phase (12 Weeks)|Participant Choice|0
4660462|NCT02196558|7548865|FG001|Treatment Phase (12 Weeks)|Participant Choice|1
4660463|NCT02196558|7548866|FG002|Treatment Phase (12 Weeks)|Participant Choice|1
4660464|NCT02196558|7548864|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0
4660465|NCT02196558|7548865|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0
4660466|NCT02196558|7548866|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1
4660467|NCT02196558|7548864|FG000|Extension Phase (40 Weeks)|Adverse Event|1
4660468|NCT02196558|7548865|FG001|Extension Phase (40 Weeks)|Adverse Event|2
4660469|NCT02196558|7548866|FG002|Extension Phase (40 Weeks)|Adverse Event|0
4660470|NCT02196558|7548864|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1
4660471|NCT02196558|7548865|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1
4660472|NCT02196558|7548866|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1
4660473|NCT02196675|7548877|FG000|Overall Study|Withdrawal by Subject|1
4660474|NCT02196675|7548878|FG001|Overall Study|Withdrawal by Subject|0
4660475|NCT02196675|7548879|FG002|Overall Study|Withdrawal by Subject|0
4660476|NCT02196675|7548877|FG000|Overall Study|Intra-operative surgical exclusion|1
4660477|NCT02196675|7548878|FG001|Overall Study|Intra-operative surgical exclusion|1
4660478|NCT02196675|7548879|FG002|Overall Study|Intra-operative surgical exclusion|0
4660479|NCT02196675|7548877|FG000|Overall Study|Protocol Violation|0
4660480|NCT02196675|7548878|FG001|Overall Study|Protocol Violation|1
4660481|NCT02196675|7548879|FG002|Overall Study|Protocol Violation|0
4660482|NCT02196675|7548877|FG000|Overall Study|Death|0
4660483|NCT02196675|7548878|FG001|Overall Study|Death|0
4660484|NCT02196675|7548879|FG002|Overall Study|Death|1
4660485|NCT02196701|7548898|FG000|Overall Study|Adverse Event|1
4660486|NCT02196701|7548898|FG000|Overall Study|Lost to Follow-up|1
4660487|NCT02196701|7548898|FG000|Overall Study|Non-adherence to Protocol|1
4660488|NCT02196714|7548905|FG000|Overall Study|Protocol Violation|0
4660489|NCT02196714|7548906|FG001|Overall Study|Protocol Violation|0
4660490|NCT02196714|7548907|FG002|Overall Study|Protocol Violation|1
4660491|NCT02196714|7548908|FG003|Overall Study|Protocol Violation|0
4660492|NCT02197130|7549016|FG000|Overall Study|Adverse Event|13
4660493|NCT02197130|7549017|FG001|Overall Study|Adverse Event|4
4660494|NCT02197130|7549018|FG002|Overall Study|Adverse Event|23
4660495|NCT02197130|7549016|FG000|Overall Study|Death|0
4660496|NCT02197130|7549017|FG001|Overall Study|Death|1
4660497|NCT02197130|7549018|FG002|Overall Study|Death|0
4660498|NCT02197130|7549016|FG000|Overall Study|Lost to Follow-up|2
4660499|NCT02197130|7549017|FG001|Overall Study|Lost to Follow-up|0
4660500|NCT02197130|7549018|FG002|Overall Study|Lost to Follow-up|1
4660501|NCT02197130|7549016|FG000|Overall Study|Does not meet entrance criteria|0
4660502|NCT02197130|7549017|FG001|Overall Study|Does not meet entrance criteria|0
4750240|NCT00641537|7724493|FG000|96-week Period|Adverse Event|0
4750241|NCT00641537|7724494|FG001|96-week Period|Adverse Event|1
4750242|NCT00641537|7724495|FG002|96-week Period|Adverse Event|3
4750243|NCT00641537|7724496|FG003|96-week Period|Adverse Event|0
4750244|NCT00641537|7724497|FG004|96-week Period|Adverse Event|2
4750245|NCT00641537|7724498|FG005|96-week Period|Adverse Event|0
4750246|NCT00641537|7724499|FG006|96-week Period|Adverse Event|0
4750247|NCT00641537|7724500|FG007|96-week Period|Adverse Event|0
4750248|NCT00641537|7724493|FG000|96-week Period|Lost to Follow-up|3
4750249|NCT00641537|7724494|FG001|96-week Period|Lost to Follow-up|1
4750250|NCT00641537|7724495|FG002|96-week Period|Lost to Follow-up|2
4750251|NCT00641537|7724496|FG003|96-week Period|Lost to Follow-up|2
4750252|NCT00641537|7724497|FG004|96-week Period|Lost to Follow-up|4
4750253|NCT00641537|7724498|FG005|96-week Period|Lost to Follow-up|0
4750254|NCT00641537|7724499|FG006|96-week Period|Lost to Follow-up|1
4750255|NCT00641537|7724500|FG007|96-week Period|Lost to Follow-up|0
4750256|NCT00641537|7724493|FG000|96-week Period|Protocol Violation|0
4750257|NCT00641537|7724494|FG001|96-week Period|Protocol Violation|1
4750258|NCT00641537|7724495|FG002|96-week Period|Protocol Violation|0
4750259|NCT00641537|7724496|FG003|96-week Period|Protocol Violation|1
4750260|NCT00641537|7724497|FG004|96-week Period|Protocol Violation|0
4750261|NCT00641537|7724498|FG005|96-week Period|Protocol Violation|1
4750262|NCT00641537|7724499|FG006|96-week Period|Protocol Violation|0
4750263|NCT00641537|7724500|FG007|96-week Period|Protocol Violation|0
4750264|NCT00641537|7724493|FG000|96-week Period|Death|2
4750265|NCT00641537|7724494|FG001|96-week Period|Death|0
4750266|NCT00641537|7724495|FG002|96-week Period|Death|1
4750267|NCT00641537|7724496|FG003|96-week Period|Death|0
4750268|NCT00641537|7724497|FG004|96-week Period|Death|0
4750269|NCT00641537|7724498|FG005|96-week Period|Death|0
4750270|NCT00641537|7724499|FG006|96-week Period|Death|0
4750271|NCT00641537|7724500|FG007|96-week Period|Death|0
4750272|NCT00641537|7724493|FG000|96-week Period|Other|4
4750273|NCT00641537|7724494|FG001|96-week Period|Other|7
4750274|NCT00641537|7724495|FG002|96-week Period|Other|14
4750275|NCT00641537|7724496|FG003|96-week Period|Other|9
4750276|NCT00641537|7724497|FG004|96-week Period|Other|11
4750277|NCT00641537|7724498|FG005|96-week Period|Other|6
4750278|NCT00641537|7724499|FG006|96-week Period|Other|4
4750279|NCT00641537|7724500|FG007|96-week Period|Other|6
4750280|NCT00641537|7724493|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
4750281|NCT00641537|7724494|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
4750282|NCT00641537|7724495|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
4750283|NCT00641537|7724496|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3
4660503|NCT02197130|7549018|FG002|Overall Study|Does not meet entrance criteria|1
4660504|NCT02197130|7549016|FG000|Overall Study|Withdrawal by Subject|0
4660505|NCT02197130|7549017|FG001|Overall Study|Withdrawal by Subject|3
4660506|NCT02197130|7549018|FG002|Overall Study|Withdrawal by Subject|4
4660507|NCT02197130|7549016|FG000|Overall Study|Other|1
4660508|NCT02197130|7549017|FG001|Overall Study|Other|0
4660509|NCT02197130|7549018|FG002|Overall Study|Other|3
4660510|NCT02197247|7549026|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2
4660511|NCT02197247|7549026|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2
4660512|NCT02197247|7549026|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5
4660513|NCT02197247|7549026|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2
4660514|NCT02197247|7549026|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2
4660515|NCT02197247|7549026|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1
4660516|NCT02197247|7549026|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1
4660517|NCT02197247|7549026|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9
4660518|NCT02197377|7549047|FG000|Overall Study|Insertion Failure|0
4660519|NCT02197377|7549048|FG001|Overall Study|Insertion Failure|3
4660520|NCT02197416|7549057|FG000|Overall Study|Other reasons|0
4660521|NCT02197416|7549058|FG001|Overall Study|Other reasons|2
4660522|NCT02197416|7549059|FG002|Overall Study|Other reasons|5
4660523|NCT02197416|7549057|FG000|Overall Study|Withdrawal by Subject|0
4750284|NCT00641537|7724497|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2
4750285|NCT00641537|7724498|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
4750286|NCT00641537|7724499|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
4750287|NCT00641537|7724500|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
4750288|NCT00641537|7724493|FG000|24-Week Supplemental Follow-up Period|Other|0
4750289|NCT00641537|7724494|FG001|24-Week Supplemental Follow-up Period|Other|2
4750290|NCT00641537|7724495|FG002|24-Week Supplemental Follow-up Period|Other|2
4750291|NCT00641537|7724496|FG003|24-Week Supplemental Follow-up Period|Other|1
4750292|NCT00641537|7724497|FG004|24-Week Supplemental Follow-up Period|Other|3
4750293|NCT00641537|7724498|FG005|24-Week Supplemental Follow-up Period|Other|0
4750294|NCT00641537|7724499|FG006|24-Week Supplemental Follow-up Period|Other|1
4750295|NCT00641537|7724500|FG007|24-Week Supplemental Follow-up Period|Other|1
4660524|NCT02197416|7549058|FG001|Overall Study|Withdrawal by Subject|2
4660525|NCT02197416|7549059|FG002|Overall Study|Withdrawal by Subject|1
4660526|NCT02197416|7549057|FG000|Overall Study|Protocol Violation|1
4660527|NCT02197416|7549058|FG001|Overall Study|Protocol Violation|0
4660528|NCT02197416|7549059|FG002|Overall Study|Protocol Violation|1
4660529|NCT02197416|7549057|FG000|Overall Study|Adverse Event|0
4660530|NCT02197416|7549058|FG001|Overall Study|Adverse Event|0
4660531|NCT02197416|7549059|FG002|Overall Study|Adverse Event|1
4660532|NCT02197520|7549078|FG000|Period 1|Withdrawal by Subject|1
4660533|NCT02197520|7549079|FG001|Period 1|Withdrawal by Subject|0
4660534|NCT02197520|7549078|FG000|Period 2|Adverse Event|0
4660535|NCT02197520|7549079|FG001|Period 2|Adverse Event|2
4660536|NCT02197520|7549078|FG000|Period 2|Withdrawal by Subject|1
4660537|NCT02197520|7549079|FG001|Period 2|Withdrawal by Subject|0
4660538|NCT02197572|7549087|FG000|Overall Study|Progressive Disease|28
4750296|NCT00655824|7724518|FG000|Overall Study|Adverse Event|3
4750297|NCT00655824|7724518|FG000|Overall Study|Early Termination of Study by Sponsor|74
4750298|NCT00655824|7724518|FG000|Overall Study|Protocol Violation|1
4750299|NCT00655824|7724518|FG000|Overall Study|Withdrawal by Subject|4
4750300|NCT00655824|7724518|FG000|Overall Study|Deterioration of Trial Disease|2
4750301|NCT00663052|7724524|FG000|Overall Study|Adverse Event|6
4750302|NCT00663052|7724525|FG001|Overall Study|Adverse Event|3
4750303|NCT00663052|7724524|FG000|Overall Study|Discontinuation of Study by Sponsor|2
4750304|NCT00663052|7724525|FG001|Overall Study|Discontinuation of Study by Sponsor|0
4750305|NCT00663052|7724524|FG000|Overall Study|Protocol Violation|1
4750306|NCT00663052|7724525|FG001|Overall Study|Protocol Violation|0
4750307|NCT00663052|7724524|FG000|Overall Study|Withdrawal by Subject|2
4750308|NCT00663052|7724525|FG001|Overall Study|Withdrawal by Subject|5
4750309|NCT00663052|7724524|FG000|Overall Study|Unsatisfactory Response - Efficacy|1
4750310|NCT00663052|7724525|FG001|Overall Study|Unsatisfactory Response - Efficacy|1
4750311|NCT00663052|7724524|FG000|Overall Study|Other|0
4750312|NCT00663052|7724525|FG001|Overall Study|Other|1
4750313|NCT00686374|7724531|FG000|Overall Study|Lack of Efficacy|10
4750314|NCT00686374|7724531|FG000|Overall Study|Adverse Event|8
4750315|NCT00686374|7724531|FG000|Overall Study|Withdrew consent|5
4750316|NCT00686374|7724531|FG000|Overall Study|Lost to Follow-up|1
4750317|NCT00686374|7724531|FG000|Overall Study|Missing reason|33
4750318|NCT00686374|7724531|FG000|Overall Study|Other, not specified|4
4750319|NCT00698828|7724538|FG000|Overall Study|Adverse Event|3
4750320|NCT00698828|7724539|FG001|Overall Study|Adverse Event|4
4750321|NCT00698828|7724540|FG002|Overall Study|Adverse Event|4
4750322|NCT00698828|7724538|FG000|Overall Study|Death|0
4750323|NCT00698828|7724539|FG001|Overall Study|Death|0
4750324|NCT00698828|7724540|FG002|Overall Study|Death|1
4750325|NCT00698828|7724538|FG000|Overall Study|Exacerbation of COPD|1
4750326|NCT00698828|7724539|FG001|Overall Study|Exacerbation of COPD|3
4750327|NCT00698828|7724540|FG002|Overall Study|Exacerbation of COPD|0
4750328|NCT00698828|7724538|FG000|Overall Study|Exacerbation of COPD (Not treated)|1
4750329|NCT00698828|7724539|FG001|Overall Study|Exacerbation of COPD (Not treated)|0
4750330|NCT00698828|7724540|FG002|Overall Study|Exacerbation of COPD (Not treated)|0
4750331|NCT00698828|7724538|FG000|Overall Study|Investigator/Sponsor decision|1
4750332|NCT00698828|7724539|FG001|Overall Study|Investigator/Sponsor decision|0
4750333|NCT00698828|7724540|FG002|Overall Study|Investigator/Sponsor decision|2
4750334|NCT00698828|7724538|FG000|Overall Study|Lost to Follow-up|1
4750335|NCT00698828|7724539|FG001|Overall Study|Lost to Follow-up|1
4750336|NCT00698828|7724540|FG002|Overall Study|Lost to Follow-up|0
4750337|NCT00698828|7724538|FG000|Overall Study|Withdrew consent|0
4750338|NCT00698828|7724539|FG001|Overall Study|Withdrew consent|7
4750339|NCT00698828|7724540|FG002|Overall Study|Withdrew consent|4
4750340|NCT00698828|7724538|FG000|Overall Study|Withdrew consent (not treated)|2
4750341|NCT00698828|7724539|FG001|Overall Study|Withdrew consent (not treated)|0
4750342|NCT00698828|7724540|FG002|Overall Study|Withdrew consent (not treated)|0
4750343|NCT00712933|7724548|FG000|Overall Study|Adverse Event|69
4750344|NCT00712933|7724548|FG000|Overall Study|Lack of Efficacy|6
4750345|NCT00712933|7724548|FG000|Overall Study|Lost to Follow-up|22
4750346|NCT00712933|7724548|FG000|Overall Study|Non-compliance with study drug|13
4750347|NCT00712933|7724548|FG000|Overall Study|Other Pregnancy|37
4750348|NCT00712933|7724548|FG000|Overall Study|Sponsor decision|14
4750349|NCT00712933|7724548|FG000|Overall Study|Withdrew consent|4
4750350|NCT00712933|7724548|FG000|Overall Study|Hip replacement surgery|1
4750351|NCT00712933|7724548|FG000|Overall Study|Involved in Clinical research|3
4750352|NCT00712933|7724548|FG000|Overall Study|Participant hospitalized|1
4750353|NCT00712933|7724548|FG000|Overall Study|Participant travelled overseas|2
4750354|NCT00712933|7724548|FG000|Overall Study|Death of patient|1
4750355|NCT00712933|7724548|FG000|Overall Study|Other Physician decision|1
4750356|NCT00712933|7724548|FG000|Overall Study|Not committed to contraception|1
4750357|NCT00712933|7724548|FG000|Overall Study|Participant received medication|1
4750358|NCT00712933|7724548|FG000|Overall Study|Physician Decision|36
4750359|NCT00712933|7724548|FG000|Overall Study|Protocol Violation|4
4750360|NCT00712933|7724548|FG000|Overall Study|Withdrawal by Subject|151
4750361|NCT00725985|7724559|FG000|ITP- Treatment Disposition|Adverse Event|20
4660539|NCT02197572|7549087|FG000|Overall Study|Withdrawal by Subject|9
4660540|NCT02197572|7549087|FG000|Overall Study|Adverse Event|3
4660541|NCT02197572|7549087|FG000|Overall Study|Reason Not Specified|4
4660542|NCT02197806|7549099|FG000|Overall Study|Adverse Event|0
4660543|NCT02197806|7549100|FG001|Overall Study|Adverse Event|1
4660544|NCT02197806|7549101|FG002|Overall Study|Adverse Event|0
4660545|NCT02197806|7549102|FG003|Overall Study|Adverse Event|1
4660546|NCT02197897|7549112|FG000|Overall Study|not eligible|1
4660547|NCT02198040|7549119|FG000|Overall Study|Work reasons|0
4660548|NCT02198040|7549120|FG001|Overall Study|Work reasons|1
4660549|NCT02198040|7549121|FG002|Overall Study|Work reasons|0
4660550|NCT02198040|7549119|FG000|Overall Study|Withdrawal by Subject|0
4660551|NCT02198040|7549120|FG001|Overall Study|Withdrawal by Subject|0
4660552|NCT02198040|7549121|FG002|Overall Study|Withdrawal by Subject|1
4660553|NCT02198235|7549134|FG000|Overall Study|Lost to Follow-up|3
4660554|NCT02198235|7549135|FG001|Overall Study|Lost to Follow-up|2
4660555|NCT02198235|7549136|FG002|Overall Study|Lost to Follow-up|2
4660556|NCT02198651|7549153|FG000|Lead-in Period|Withdrew consent|13
4660557|NCT02198651|7549154|FG001|Lead-in Period|Withdrew consent|0
4660558|NCT02198651|7549155|FG002|Lead-in Period|Withdrew consent|0
4660559|NCT02198651|7549156|FG003|Lead-in Period|Withdrew consent|0
4660560|NCT02198651|7549157|FG004|Lead-in Period|Withdrew consent|0
4660561|NCT02198651|7549153|FG000|Lead-in Period|Adverse Event|2
4660562|NCT02198651|7549154|FG001|Lead-in Period|Adverse Event|0
4660563|NCT02198651|7549155|FG002|Lead-in Period|Adverse Event|0
4660564|NCT02198651|7549156|FG003|Lead-in Period|Adverse Event|0
4660565|NCT02198651|7549157|FG004|Lead-in Period|Adverse Event|0
4660566|NCT02198651|7549153|FG000|Lead-in Period|Other, not specified|22
4660567|NCT02198651|7549154|FG001|Lead-in Period|Other, not specified|0
4660568|NCT02198651|7549155|FG002|Lead-in Period|Other, not specified|0
4660569|NCT02198651|7549156|FG003|Lead-in Period|Other, not specified|0
4660570|NCT02198651|7549157|FG004|Lead-in Period|Other, not specified|0
4660571|NCT02198651|7549153|FG000|Double-blind Period|Withdrew consent|0
4750362|NCT00725985|7724560|FG001|ITP- Treatment Disposition|Adverse Event|10
4750363|NCT00725985|7724561|FG002|ITP- Treatment Disposition|Adverse Event|5
4750364|NCT00725985|7724562|FG003|ITP- Treatment Disposition|Adverse Event|0
4750365|NCT00725985|7724563|FG004|ITP- Treatment Disposition|Adverse Event|0
4750366|NCT00725985|7724564|FG005|ITP- Treatment Disposition|Adverse Event|0
4750367|NCT00725985|7724565|FG006|ITP- Treatment Disposition|Adverse Event|0
4750368|NCT00725985|7724566|FG007|ITP- Treatment Disposition|Adverse Event|0
4750369|NCT00725985|7724567|FG008|ITP- Treatment Disposition|Adverse Event|0
4750370|NCT00725985|7724568|FG009|ITP- Treatment Disposition|Adverse Event|0
4750371|NCT00725985|7724569|FG010|ITP- Treatment Disposition|Adverse Event|0
4750372|NCT00725985|7724570|FG011|ITP- Treatment Disposition|Adverse Event|0
4750373|NCT00725985|7724559|FG000|ITP- Treatment Disposition|Lost to Follow-up|0
4750374|NCT00725985|7724560|FG001|ITP- Treatment Disposition|Lost to Follow-up|0
4750375|NCT00725985|7724561|FG002|ITP- Treatment Disposition|Lost to Follow-up|2
4750376|NCT00725985|7724562|FG003|ITP- Treatment Disposition|Lost to Follow-up|0
4750377|NCT00725985|7724563|FG004|ITP- Treatment Disposition|Lost to Follow-up|0
4750378|NCT00725985|7724564|FG005|ITP- Treatment Disposition|Lost to Follow-up|0
4750379|NCT00725985|7724565|FG006|ITP- Treatment Disposition|Lost to Follow-up|0
4750380|NCT00725985|7724566|FG007|ITP- Treatment Disposition|Lost to Follow-up|0
4750381|NCT00725985|7724567|FG008|ITP- Treatment Disposition|Lost to Follow-up|0
4750382|NCT00725985|7724568|FG009|ITP- Treatment Disposition|Lost to Follow-up|0
4750383|NCT00725985|7724569|FG010|ITP- Treatment Disposition|Lost to Follow-up|0
4750384|NCT00725985|7724570|FG011|ITP- Treatment Disposition|Lost to Follow-up|0
4750385|NCT00725985|7724559|FG000|ITP- Treatment Disposition|Randomized but not treated|1
4750386|NCT00725985|7724560|FG001|ITP- Treatment Disposition|Randomized but not treated|0
4750387|NCT00725985|7724561|FG002|ITP- Treatment Disposition|Randomized but not treated|0
4750388|NCT00725985|7724562|FG003|ITP- Treatment Disposition|Randomized but not treated|0
4750389|NCT00725985|7724563|FG004|ITP- Treatment Disposition|Randomized but not treated|0
4750390|NCT00725985|7724564|FG005|ITP- Treatment Disposition|Randomized but not treated|0
4750391|NCT00725985|7724565|FG006|ITP- Treatment Disposition|Randomized but not treated|0
4750392|NCT00725985|7724566|FG007|ITP- Treatment Disposition|Randomized but not treated|0
4750393|NCT00725985|7724567|FG008|ITP- Treatment Disposition|Randomized but not treated|0
4750394|NCT00725985|7724568|FG009|ITP- Treatment Disposition|Randomized but not treated|0
4750395|NCT00725985|7724569|FG010|ITP- Treatment Disposition|Randomized but not treated|0
4750396|NCT00725985|7724570|FG011|ITP- Treatment Disposition|Randomized but not treated|0
4750397|NCT00725985|7724559|FG000|ITP- Treatment Disposition|Converted to CDMS|30
4750398|NCT00725985|7724560|FG001|ITP- Treatment Disposition|Converted to CDMS|27
4750399|NCT00725985|7724561|FG002|ITP- Treatment Disposition|Converted to CDMS|71
4750400|NCT00725985|7724562|FG003|ITP- Treatment Disposition|Converted to CDMS|0
4750401|NCT00725985|7724563|FG004|ITP- Treatment Disposition|Converted to CDMS|0
4750402|NCT00725985|7724564|FG005|ITP- Treatment Disposition|Converted to CDMS|0
4750403|NCT00725985|7724565|FG006|ITP- Treatment Disposition|Converted to CDMS|0
4750404|NCT00725985|7724566|FG007|ITP- Treatment Disposition|Converted to CDMS|0
4750405|NCT00725985|7724567|FG008|ITP- Treatment Disposition|Converted to CDMS|0
4660572|NCT02198651|7549154|FG001|Double-blind Period|Withdrew consent|4
4660573|NCT02198651|7549155|FG002|Double-blind Period|Withdrew consent|0
4660574|NCT02198651|7549156|FG003|Double-blind Period|Withdrew consent|0
4660575|NCT02198651|7549157|FG004|Double-blind Period|Withdrew consent|0
4660576|NCT02198651|7549153|FG000|Double-blind Period|Adverse Event|0
4660577|NCT02198651|7549154|FG001|Double-blind Period|Adverse Event|1
4660578|NCT02198651|7549155|FG002|Double-blind Period|Adverse Event|0
4660579|NCT02198651|7549156|FG003|Double-blind Period|Adverse Event|0
4660580|NCT02198651|7549157|FG004|Double-blind Period|Adverse Event|0
4660581|NCT02198651|7549153|FG000|Double-blind Period|Other, not specified|0
4660582|NCT02198651|7549154|FG001|Double-blind Period|Other, not specified|4
4660583|NCT02198651|7549155|FG002|Double-blind Period|Other, not specified|1
4660584|NCT02198651|7549156|FG003|Double-blind Period|Other, not specified|0
4660585|NCT02198651|7549157|FG004|Double-blind Period|Other, not specified|0
4660586|NCT02198651|7549153|FG000|Open-label Rescue Period|Withdrew consent|0
4660587|NCT02198651|7549154|FG001|Open-label Rescue Period|Withdrew consent|0
4660588|NCT02198651|7549155|FG002|Open-label Rescue Period|Withdrew consent|0
4660589|NCT02198651|7549156|FG003|Open-label Rescue Period|Withdrew consent|2
4660590|NCT02198651|7549157|FG004|Open-label Rescue Period|Withdrew consent|0
4660591|NCT02198651|7549153|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
4660592|NCT02198651|7549154|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
4660593|NCT02198651|7549155|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
4660594|NCT02198651|7549156|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1
4660595|NCT02198651|7549157|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
4660596|NCT02198664|7549172|FG000|Overall Study|Adverse Event|2
4660597|NCT02198664|7549173|FG001|Overall Study|Adverse Event|0
4660598|NCT02198664|7549172|FG000|Overall Study|Withdrawal by Subject|11
4660599|NCT02198664|7549173|FG001|Overall Study|Withdrawal by Subject|8
4660600|NCT02198664|7549172|FG000|Overall Study|Failure to tolerate|2
4660601|NCT02198664|7549173|FG001|Overall Study|Failure to tolerate|0
4660602|NCT02198664|7549172|FG000|Overall Study|Not stated|1
4660603|NCT02198664|7549173|FG001|Overall Study|Not stated|0
4660604|NCT02198963|7549181|FG000|Overall Study|Adverse Event|1
4660605|NCT02198963|7549181|FG000|Overall Study|Withdrawal by Subject|6
4660606|NCT02199028|7549192|FG000|Week 1|Adverse Event|1
4660607|NCT02199028|7549193|FG001|Week 1|Adverse Event|0
4660608|NCT02199028|7549192|FG000|Week 3|Adverse Event|1
4660609|NCT02199028|7549193|FG001|Week 3|Adverse Event|0
4660610|NCT02199080|7549205|FG000|Overall Study|Protocol Violation|12
4660611|NCT02199314|7549221|FG000|Overall Study|Withdrawal by Subject|6
4660612|NCT02199314|7549221|FG000|Overall Study|Physician Decision|10
4660613|NCT02199509|7549236|FG000|Overall Study|Suicidal Ideation|0
4660614|NCT02199509|7549237|FG001|Overall Study|Suicidal Ideation|1
4660615|NCT02199509|7549236|FG000|Overall Study|Misunderstood titration schedule|1
4660616|NCT02199509|7549237|FG001|Overall Study|Misunderstood titration schedule|0
4660617|NCT02199795|7549280|FG000|Overall Study|no longer met inclusion criteria|1
4660618|NCT02199795|7549281|FG001|Overall Study|no longer met inclusion criteria|0
4660619|NCT02199795|7549280|FG000|Overall Study|withdrew due to shoulder pain|1
4660620|NCT02199795|7549281|FG001|Overall Study|withdrew due to shoulder pain|0
4660621|NCT02200211|7549306|FG000|Overall Study|Lost to Follow-up|7
4660622|NCT02200211|7549307|FG001|Overall Study|Lost to Follow-up|7
4660623|NCT02200211|7549308|FG002|Overall Study|Lost to Follow-up|1
4660624|NCT02200211|7549309|FG003|Overall Study|Lost to Follow-up|2
4660625|NCT02200211|7549306|FG000|Overall Study|Withdrawal by Subject|1
4660626|NCT02200211|7549307|FG001|Overall Study|Withdrawal by Subject|0
4660627|NCT02200211|7549308|FG002|Overall Study|Withdrawal by Subject|0
4660628|NCT02200211|7549309|FG003|Overall Study|Withdrawal by Subject|0
4660629|NCT02200445|7549330|FG000|Overall Study|Lack of Efficacy|1
4660630|NCT02200445|7549331|FG001|Overall Study|Lack of Efficacy|2
4660631|NCT02200445|7549332|FG002|Overall Study|Lack of Efficacy|2
4660632|NCT02200445|7549330|FG000|Overall Study|Adverse Event|0
4660633|NCT02200445|7549331|FG001|Overall Study|Adverse Event|2
4660634|NCT02200445|7549332|FG002|Overall Study|Adverse Event|0
4660635|NCT02200510|7549346|FG000|Overall Study|Death|1
4660636|NCT02200510|7549347|FG001|Overall Study|Death|1
4660637|NCT02200510|7549346|FG000|Overall Study|Protocol Violation|0
4660638|NCT02200510|7549347|FG001|Overall Study|Protocol Violation|1
4660639|NCT02200510|7549346|FG000|Overall Study|Lost to Follow-up|7
4750406|NCT00725985|7724568|FG009|ITP- Treatment Disposition|Converted to CDMS|0
4750407|NCT00725985|7724569|FG010|ITP- Treatment Disposition|Converted to CDMS|0
4750408|NCT00725985|7724570|FG011|ITP- Treatment Disposition|Converted to CDMS|0
4660640|NCT02200510|7549347|FG001|Overall Study|Lost to Follow-up|1
4660641|NCT02200510|7549346|FG000|Overall Study|potential COI - joined study team|1
4660642|NCT02200510|7549347|FG001|Overall Study|potential COI - joined study team|0
4660643|NCT02200614|7549377|FG000|Double Blind Treatment|Adverse Event|86
4660644|NCT02200614|7549378|FG001|Double Blind Treatment|Adverse Event|48
4660645|NCT02200614|7549377|FG000|Double Blind Treatment|Confirmed metastasis|119
4660646|NCT02200614|7549378|FG001|Double Blind Treatment|Confirmed metastasis|140
4660647|NCT02200614|7549377|FG000|Double Blind Treatment|Judgment of the investigator|60
4660648|NCT02200614|7549378|FG001|Double Blind Treatment|Judgment of the investigator|99
4750409|NCT00725985|7724559|FG000|ITP- Treatment Disposition|Other|50
4750410|NCT00725985|7724560|FG001|ITP- Treatment Disposition|Other|38
4660649|NCT02200614|7549377|FG000|Double Blind Treatment|Metastasis by local reading|1
4660650|NCT02200614|7549378|FG001|Double Blind Treatment|Metastasis by local reading|3
4660651|NCT02200614|7549377|FG000|Double Blind Treatment|Other reason|6
4660652|NCT02200614|7549378|FG001|Double Blind Treatment|Other reason|2
4750411|NCT00725985|7724561|FG002|ITP- Treatment Disposition|Other|24
4660653|NCT02200614|7549377|FG000|Double Blind Treatment|Personal reason|77
4660654|NCT02200614|7549378|FG001|Double Blind Treatment|Personal reason|85
4660655|NCT02200614|7549377|FG000|Double Blind Treatment|Protocol deviation|14
4660656|NCT02200614|7549378|FG001|Double Blind Treatment|Protocol deviation|7
4660657|NCT02200614|7549377|FG000|Double Blind Treatment|Not treated|1
4660658|NCT02200614|7549378|FG001|Double Blind Treatment|Not treated|0
4660659|NCT02200614|7549377|FG000|Open Label|Adverse Event|15
4660660|NCT02200614|7549378|FG001|Open Label|Adverse Event|8
4660661|NCT02200614|7549377|FG000|Open Label|Confirmed metastasis|1
4660662|NCT02200614|7549378|FG001|Open Label|Confirmed metastasis|0
4660663|NCT02200614|7549377|FG000|Open Label|Judgment of the investigator|15
4660664|NCT02200614|7549378|FG001|Open Label|Judgment of the investigator|0
4660665|NCT02200614|7549377|FG000|Open Label|Metastasis by local reading|58
4660666|NCT02200614|7549378|FG001|Open Label|Metastasis by local reading|10
4660667|NCT02200614|7549377|FG000|Open Label|Other reason|6
4660668|NCT02200614|7549378|FG001|Open Label|Other reason|1
4660669|NCT02200614|7549377|FG000|Open Label|Personal reason|29
4660670|NCT02200614|7549378|FG001|Open Label|Personal reason|3
4660671|NCT02200614|7549377|FG000|Open Label|Protocol deviation|1
4660672|NCT02200614|7549378|FG001|Open Label|Protocol deviation|1
4660673|NCT02201108|7549423|FG000|Overall Study|Adverse Event|0
4660674|NCT02201108|7549424|FG001|Overall Study|Adverse Event|6
4660675|NCT02201108|7549423|FG000|Overall Study|Lack of Efficacy|2
4660676|NCT02201108|7549424|FG001|Overall Study|Lack of Efficacy|1
4660677|NCT02201108|7549423|FG000|Overall Study|Withdrawal by Subject|2
4660678|NCT02201108|7549424|FG001|Overall Study|Withdrawal by Subject|0
4660679|NCT02201251|7549439|FG000|Overall Study|Adverse Event|1
4660680|NCT02201251|7549440|FG001|Overall Study|Adverse Event|1
4660681|NCT02201251|7549439|FG000|Overall Study|Protocol Violation|1
4660682|NCT02201251|7549440|FG001|Overall Study|Protocol Violation|0
4660683|NCT02201251|7549439|FG000|Overall Study|Noncompliance with Study Drug|0
4660684|NCT02201251|7549440|FG001|Overall Study|Noncompliance with Study Drug|1
4750412|NCT00725985|7724562|FG003|ITP- Treatment Disposition|Other|0
4750413|NCT00725985|7724563|FG004|ITP- Treatment Disposition|Other|0
4750414|NCT00725985|7724564|FG005|ITP- Treatment Disposition|Other|0
4750415|NCT00725985|7724565|FG006|ITP- Treatment Disposition|Other|0
4750416|NCT00725985|7724566|FG007|ITP- Treatment Disposition|Other|0
4750417|NCT00725985|7724567|FG008|ITP- Treatment Disposition|Other|0
4750418|NCT00725985|7724568|FG009|ITP- Treatment Disposition|Other|0
4750419|NCT00725985|7724569|FG010|ITP- Treatment Disposition|Other|0
4750420|NCT00725985|7724570|FG011|ITP- Treatment Disposition|Other|0
4750421|NCT00725985|7724559|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0
4750422|NCT00725985|7724560|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0
4750423|NCT00725985|7724561|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0
4750424|NCT00725985|7724562|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2
4750425|NCT00725985|7724563|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2
4750426|NCT00725985|7724564|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5
4750427|NCT00725985|7724565|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0
4750428|NCT00725985|7724566|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0
4750429|NCT00725985|7724567|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0
4660685|NCT02201251|7549439|FG000|Overall Study|Withdrawal by Subject|2
4750430|NCT00725985|7724568|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0
4750431|NCT00725985|7724569|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0
4750432|NCT00725985|7724570|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0
4750433|NCT00725985|7724559|FG000|OLMP (Up to 96 Weeks)|Death|0
4750434|NCT00725985|7724560|FG001|OLMP (Up to 96 Weeks)|Death|0
4750435|NCT00725985|7724561|FG002|OLMP (Up to 96 Weeks)|Death|0
4750436|NCT00725985|7724562|FG003|OLMP (Up to 96 Weeks)|Death|0
4750437|NCT00725985|7724563|FG004|OLMP (Up to 96 Weeks)|Death|1
4750438|NCT00725985|7724564|FG005|OLMP (Up to 96 Weeks)|Death|0
4750439|NCT00725985|7724565|FG006|OLMP (Up to 96 Weeks)|Death|0
4750440|NCT00725985|7724566|FG007|OLMP (Up to 96 Weeks)|Death|0
4750441|NCT00725985|7724567|FG008|OLMP (Up to 96 Weeks)|Death|0
4750442|NCT00725985|7724568|FG009|OLMP (Up to 96 Weeks)|Death|0
4750443|NCT00725985|7724569|FG010|OLMP (Up to 96 Weeks)|Death|0
4750444|NCT00725985|7724570|FG011|OLMP (Up to 96 Weeks)|Death|0
4750445|NCT00725985|7724559|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
4750446|NCT00725985|7724560|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
4750447|NCT00725985|7724561|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
4750448|NCT00725985|7724562|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1
4750449|NCT00725985|7724563|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
4660686|NCT02201251|7549440|FG001|Overall Study|Withdrawal by Subject|1
4660687|NCT02201277|7549448|FG000|Overall Study|Death|3
4660688|NCT02201277|7549449|FG001|Overall Study|Death|4
4660689|NCT02201277|7549448|FG000|Overall Study|Lost to Follow-up|2
4660690|NCT02201277|7549449|FG001|Overall Study|Lost to Follow-up|1
4660691|NCT02201277|7549448|FG000|Overall Study|Failed retrieval|1
4660692|NCT02201277|7549449|FG001|Overall Study|Failed retrieval|0
4660693|NCT02201277|7549448|FG000|Overall Study|Physician Decision|1
4750450|NCT00725985|7724564|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
4750451|NCT00725985|7724565|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
4750452|NCT00725985|7724566|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
4750453|NCT00725985|7724567|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
4750454|NCT00725985|7724568|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
4660694|NCT02201277|7549449|FG001|Overall Study|Physician Decision|0
4660695|NCT02201290|7549459|FG000|Overall Study|Withdrawal by Subject|2
4660696|NCT02201290|7549459|FG000|Overall Study|Lack of Efficacy|2
4660697|NCT02201290|7549459|FG000|Overall Study|Adverse Event|1
4660698|NCT02201329|7549463|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3
4660699|NCT02201329|7549463|FG000|Overall Study|Withdrawal by Subject|2
4750455|NCT00725985|7724569|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
4750456|NCT00725985|7724570|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0
4750457|NCT00725985|7724559|FG000|OLMP (Up to 96 Weeks)|Disease progression|0
4750458|NCT00725985|7724560|FG001|OLMP (Up to 96 Weeks)|Disease progression|0
4750459|NCT00725985|7724561|FG002|OLMP (Up to 96 Weeks)|Disease progression|0
4750460|NCT00725985|7724562|FG003|OLMP (Up to 96 Weeks)|Disease progression|0
4750461|NCT00725985|7724563|FG004|OLMP (Up to 96 Weeks)|Disease progression|0
4750462|NCT00725985|7724564|FG005|OLMP (Up to 96 Weeks)|Disease progression|4
4750463|NCT00725985|7724565|FG006|OLMP (Up to 96 Weeks)|Disease progression|0
4750464|NCT00725985|7724566|FG007|OLMP (Up to 96 Weeks)|Disease progression|0
4750465|NCT00725985|7724567|FG008|OLMP (Up to 96 Weeks)|Disease progression|0
4750466|NCT00725985|7724568|FG009|OLMP (Up to 96 Weeks)|Disease progression|0
4750467|NCT00725985|7724569|FG010|OLMP (Up to 96 Weeks)|Disease progression|0
4750468|NCT00725985|7724570|FG011|OLMP (Up to 96 Weeks)|Disease progression|0
4750469|NCT00725985|7724559|FG000|OLMP (Up to 96 Weeks)|Other|0
4750470|NCT00725985|7724560|FG001|OLMP (Up to 96 Weeks)|Other|0
4750471|NCT00725985|7724561|FG002|OLMP (Up to 96 Weeks)|Other|0
4750472|NCT00725985|7724562|FG003|OLMP (Up to 96 Weeks)|Other|15
4750473|NCT00725985|7724563|FG004|OLMP (Up to 96 Weeks)|Other|20
4750474|NCT00725985|7724564|FG005|OLMP (Up to 96 Weeks)|Other|44
4750475|NCT00725985|7724565|FG006|OLMP (Up to 96 Weeks)|Other|0
4750476|NCT00725985|7724566|FG007|OLMP (Up to 96 Weeks)|Other|0
4750477|NCT00725985|7724567|FG008|OLMP (Up to 96 Weeks)|Other|0
4750478|NCT00725985|7724568|FG009|OLMP (Up to 96 Weeks)|Other|0
4750479|NCT00725985|7724569|FG010|OLMP (Up to 96 Weeks)|Other|0
4750480|NCT00725985|7724570|FG011|OLMP (Up to 96 Weeks)|Other|0
4750481|NCT00725985|7724559|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
4750482|NCT00725985|7724560|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
4750483|NCT00725985|7724561|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
4750484|NCT00725985|7724562|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
4750485|NCT00725985|7724563|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
4750486|NCT00725985|7724564|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
4750487|NCT00725985|7724565|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
4750488|NCT00725985|7724566|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1
4750489|NCT00725985|7724567|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
4750490|NCT00725985|7724568|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
4750491|NCT00725985|7724569|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
4750492|NCT00725985|7724570|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0
4750493|NCT00725985|7724559|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
4750494|NCT00725985|7724560|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
4750495|NCT00725985|7724561|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
4750496|NCT00725985|7724562|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
4750497|NCT00725985|7724563|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
4750498|NCT00725985|7724564|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
4750499|NCT00725985|7724565|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
4750500|NCT00725985|7724566|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
4750501|NCT00725985|7724567|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1
4750502|NCT00725985|7724568|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
4750503|NCT00725985|7724569|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
4750504|NCT00725985|7724570|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0
4750505|NCT00725985|7724559|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0
4750506|NCT00725985|7724560|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0
4750507|NCT00725985|7724561|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0
4750508|NCT00725985|7724562|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0
4750509|NCT00725985|7724563|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0
4750510|NCT00725985|7724564|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0
4750511|NCT00725985|7724565|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9
4750512|NCT00725985|7724566|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8
4750513|NCT00725985|7724567|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16
4750514|NCT00725985|7724568|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0
4750515|NCT00725985|7724569|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0
4750516|NCT00725985|7724570|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0
4750517|NCT00725985|7724559|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0
4750518|NCT00725985|7724560|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0
4750519|NCT00725985|7724561|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0
4750520|NCT00725985|7724562|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0
4750521|NCT00725985|7724563|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0
4750522|NCT00725985|7724564|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0
4750523|NCT00725985|7724565|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0
4750524|NCT00725985|7724566|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0
4750525|NCT00725985|7724567|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0
4660700|NCT02201524|7549489|FG000|Overall Study|Adverse Event|0
4660701|NCT02201524|7549490|FG001|Overall Study|Adverse Event|2
4660702|NCT02201524|7549491|FG002|Overall Study|Adverse Event|1
4660703|NCT02201524|7549492|FG003|Overall Study|Adverse Event|0
4660704|NCT02201524|7549489|FG000|Overall Study|Insufficient clinical response|1
4660705|NCT02201524|7549490|FG001|Overall Study|Insufficient clinical response|0
4660706|NCT02201524|7549491|FG002|Overall Study|Insufficient clinical response|0
4660707|NCT02201524|7549492|FG003|Overall Study|Insufficient clinical response|0
4660708|NCT02201524|7549489|FG000|Overall Study|Lost to Follow-up|0
4660709|NCT02201524|7549490|FG001|Overall Study|Lost to Follow-up|0
4660710|NCT02201524|7549491|FG002|Overall Study|Lost to Follow-up|2
4660711|NCT02201524|7549492|FG003|Overall Study|Lost to Follow-up|0
4660712|NCT02201524|7549489|FG000|Overall Study|No longer meets eligibility criteria|0
4660713|NCT02201524|7549490|FG001|Overall Study|No longer meets eligibility criteria|0
4660714|NCT02201524|7549491|FG002|Overall Study|No longer meets eligibility criteria|0
4660715|NCT02201524|7549492|FG003|Overall Study|No longer meets eligibility criteria|2
4660716|NCT02201524|7549489|FG000|Overall Study|Protocol Violation|0
4660717|NCT02201524|7549490|FG001|Overall Study|Protocol Violation|0
4660718|NCT02201524|7549491|FG002|Overall Study|Protocol Violation|0
4660719|NCT02201524|7549492|FG003|Overall Study|Protocol Violation|1
4660720|NCT02201524|7549489|FG000|Overall Study|Withdrawal by Subject|0
4660721|NCT02201524|7549490|FG001|Overall Study|Withdrawal by Subject|0
4750526|NCT00725985|7724568|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34
4750527|NCT00725985|7724569|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36
4750528|NCT00725985|7724570|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14
4660722|NCT02201524|7549491|FG002|Overall Study|Withdrawal by Subject|1
4660723|NCT02201524|7549492|FG003|Overall Study|Withdrawal by Subject|1
4660724|NCT02201524|7549489|FG000|Overall Study|Other|1
4660725|NCT02201524|7549490|FG001|Overall Study|Other|1
4660726|NCT02201524|7549491|FG002|Overall Study|Other|0
4660727|NCT02201524|7549492|FG003|Overall Study|Other|0
4660728|NCT02201771|7549505|FG000|Overall Study|Death|3
4660729|NCT02201771|7549506|FG001|Overall Study|Death|2
4660730|NCT02201771|7549507|FG002|Overall Study|Death|0
4660731|NCT02201771|7549505|FG000|Overall Study|Protocol Violation|10
4660732|NCT02201771|7549506|FG001|Overall Study|Protocol Violation|8
4660733|NCT02201771|7549507|FG002|Overall Study|Protocol Violation|10
4660734|NCT02201784|7549517|FG000|Overall Study|Failure to achieve adequate block|2
4660735|NCT02201784|7549518|FG001|Overall Study|Failure to achieve adequate block|0
4660736|NCT02201901|7549527|FG000|Overall Study|Randomized but never treated|0
4660737|NCT02201901|7549528|FG001|Overall Study|Randomized but never treated|1
4660738|NCT02201901|7549529|FG002|Overall Study|Randomized but never treated|0
4660739|NCT02201901|7549527|FG000|Overall Study|Lack of Efficacy|7
4660740|NCT02201901|7549528|FG001|Overall Study|Lack of Efficacy|1
4660741|NCT02201901|7549529|FG002|Overall Study|Lack of Efficacy|6
4660742|NCT02201901|7549527|FG000|Overall Study|Death|3
4660743|NCT02201901|7549528|FG001|Overall Study|Death|3
4660744|NCT02201901|7549529|FG002|Overall Study|Death|3
4660745|NCT02201901|7549527|FG000|Overall Study|Lost to Follow-up|2
4660746|NCT02201901|7549528|FG001|Overall Study|Lost to Follow-up|3
4660747|NCT02201901|7549529|FG002|Overall Study|Lost to Follow-up|2
4660748|NCT02201901|7549527|FG000|Overall Study|Withdrew Consent|2
4660749|NCT02201901|7549528|FG001|Overall Study|Withdrew Consent|0
4660750|NCT02201901|7549529|FG002|Overall Study|Withdrew Consent|2
4660751|NCT02201901|7549527|FG000|Overall Study|Adverse Event|1
4660752|NCT02201901|7549528|FG001|Overall Study|Adverse Event|1
4660753|NCT02201901|7549529|FG002|Overall Study|Adverse Event|0
4660754|NCT02201940|7549540|FG000|Overall Study|Randomized/Enrolled but Never Treated|1
4660755|NCT02201940|7549541|FG001|Overall Study|Randomized/Enrolled but Never Treated|0
4660756|NCT02201940|7549540|FG000|Overall Study|Lack of Efficacy|2
4660757|NCT02201940|7549541|FG001|Overall Study|Lack of Efficacy|113
4660758|NCT02201940|7549540|FG000|Overall Study|Lost to Follow-up|5
4660759|NCT02201940|7549541|FG001|Overall Study|Lost to Follow-up|0
4660760|NCT02201940|7549540|FG000|Overall Study|Withdrew Consent|2
4660761|NCT02201940|7549541|FG001|Overall Study|Withdrew Consent|1
4660762|NCT02201940|7549540|FG000|Overall Study|Investigator's Discretion|1
4660763|NCT02201940|7549541|FG001|Overall Study|Investigator's Discretion|1
4660764|NCT02201940|7549540|FG000|Overall Study|Death|1
4660765|NCT02201940|7549541|FG001|Overall Study|Death|0
4660766|NCT02201940|7549540|FG000|Overall Study|Adverse Event|0
4660767|NCT02201940|7549541|FG001|Overall Study|Adverse Event|1
4660768|NCT02201953|7549549|FG000|Overall Study|Randomized but Never Treated|1
4660769|NCT02201953|7549550|FG001|Overall Study|Randomized but Never Treated|5
4660770|NCT02201953|7549549|FG000|Overall Study|Lack of Efficacy|9
4660771|NCT02201953|7549550|FG001|Overall Study|Lack of Efficacy|30
4660772|NCT02201953|7549549|FG000|Overall Study|Lost to Follow-up|8
4660773|NCT02201953|7549550|FG001|Overall Study|Lost to Follow-up|8
4660774|NCT02201953|7549549|FG000|Overall Study|Withdrew Consent|2
4660775|NCT02201953|7549550|FG001|Overall Study|Withdrew Consent|5
4660776|NCT02201953|7549549|FG000|Overall Study|Adverse Event|0
4660777|NCT02201953|7549550|FG001|Overall Study|Adverse Event|5
4660778|NCT02201953|7549549|FG000|Overall Study|Death|0
4660779|NCT02201953|7549550|FG001|Overall Study|Death|3
4660780|NCT02202031|7549558|FG000|Overall Study|Lost to Follow-up|1
4660781|NCT02202031|7549559|FG001|Overall Study|Lost to Follow-up|0
4660782|NCT02202031|7549558|FG000|Overall Study|Too Busy|1
4750529|NCT00788671|7724596|FG000|Overall Study|Death|2
4750530|NCT00788671|7724596|FG000|Overall Study|Unable to biopsy|1
4750531|NCT00788671|7724596|FG000|Overall Study|Withdrawal by Subject|4
4750532|NCT00788671|7724596|FG000|Overall Study|IUD expulsed|1
4750533|NCT00788671|7724596|FG000|Overall Study|Lost to follow up|2
4750534|NCT00799266|7724602|FG000|Overall Study|Adverse Event|0
4750535|NCT00799266|7724603|FG001|Overall Study|Adverse Event|1
4750536|NCT00799266|7724602|FG000|Overall Study|Subject withdrew consent|3
4750537|NCT00799266|7724603|FG001|Overall Study|Subject withdrew consent|0
4750538|NCT00844480|7724615|FG000|Overall Study|Withdrawal by Subject|2
4750539|NCT00844480|7724616|FG001|Overall Study|Withdrawal by Subject|3
4750540|NCT00873366|7724626|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1
4750541|NCT00873366|7724626|FG000|Overall Study|Off tamoxifen due to side effects|2
4750542|NCT00873366|7724626|FG000|Overall Study|Refused to continue DM-BT testing|3
4750543|NCT00930722|7724662|FG000|Overall Study|Lost to Follow-up|16
4750544|NCT00930722|7724662|FG000|Overall Study|No longer willing to participate|9
4750545|NCT00930722|7724662|FG000|Overall Study|Study terminated by sponsor|2
4750546|NCT00940498|7724674|FG000|Overall Study|Death|2
4750547|NCT00940498|7724675|FG001|Overall Study|Death|0
4750548|NCT00940498|7724676|FG002|Overall Study|Death|0
4750549|NCT00940498|7724677|FG003|Overall Study|Death|1
4660783|NCT02202031|7549559|FG001|Overall Study|Too Busy|3
4660784|NCT02202031|7549558|FG000|Overall Study|Illness/Medical Reason|0
4660785|NCT02202031|7549559|FG001|Overall Study|Illness/Medical Reason|2
4660786|NCT02202031|7549558|FG000|Overall Study|Intolerance/Lack of Improvement|3
4660787|NCT02202031|7549559|FG001|Overall Study|Intolerance/Lack of Improvement|0
4660788|NCT02202109|7549567|FG000|Overall Study|Lost to Follow-up|88
4660789|NCT02202109|7549568|FG001|Overall Study|Lost to Follow-up|87
4660790|NCT02202109|7549567|FG000|Overall Study|Withdrawal by Subject|2
4660791|NCT02202109|7549568|FG001|Overall Study|Withdrawal by Subject|0
4660792|NCT02202161|7549586|FG000|Overall Study|Adverse Event|1
4660793|NCT02202161|7549587|FG001|Overall Study|Adverse Event|1
4660794|NCT02202161|7549588|FG002|Overall Study|Adverse Event|0
4660795|NCT02202161|7549589|FG003|Overall Study|Adverse Event|0
4660796|NCT02202161|7549590|FG004|Overall Study|Adverse Event|0
4660797|NCT02202161|7549591|FG005|Overall Study|Adverse Event|1
4660798|NCT02202161|7549592|FG006|Overall Study|Adverse Event|0
4660799|NCT02202161|7549593|FG007|Overall Study|Adverse Event|0
4660800|NCT02202161|7549586|FG000|Overall Study|Did not meet continuation criteria|0
4660801|NCT02202161|7549587|FG001|Overall Study|Did not meet continuation criteria|0
4660802|NCT02202161|7549588|FG002|Overall Study|Did not meet continuation criteria|0
4660803|NCT02202161|7549589|FG003|Overall Study|Did not meet continuation criteria|0
4660804|NCT02202161|7549590|FG004|Overall Study|Did not meet continuation criteria|0
4660805|NCT02202161|7549591|FG005|Overall Study|Did not meet continuation criteria|0
4660806|NCT02202161|7549592|FG006|Overall Study|Did not meet continuation criteria|0
4660807|NCT02202161|7549593|FG007|Overall Study|Did not meet continuation criteria|3
4660808|NCT02202161|7549586|FG000|Overall Study|Physician Decision|0
4660809|NCT02202161|7549587|FG001|Overall Study|Physician Decision|0
4660810|NCT02202161|7549588|FG002|Overall Study|Physician Decision|0
4660811|NCT02202161|7549589|FG003|Overall Study|Physician Decision|0
4660812|NCT02202161|7549590|FG004|Overall Study|Physician Decision|0
4660813|NCT02202161|7549591|FG005|Overall Study|Physician Decision|0
4660814|NCT02202161|7549592|FG006|Overall Study|Physician Decision|0
4660815|NCT02202161|7549593|FG007|Overall Study|Physician Decision|3
4660816|NCT02202161|7549586|FG000|Overall Study|Withdrawal by Subject|0
4660817|NCT02202161|7549587|FG001|Overall Study|Withdrawal by Subject|0
4660818|NCT02202161|7549588|FG002|Overall Study|Withdrawal by Subject|0
4660819|NCT02202161|7549589|FG003|Overall Study|Withdrawal by Subject|0
4660820|NCT02202161|7549590|FG004|Overall Study|Withdrawal by Subject|1
4660821|NCT02202161|7549591|FG005|Overall Study|Withdrawal by Subject|0
4660822|NCT02202161|7549592|FG006|Overall Study|Withdrawal by Subject|0
4660823|NCT02202161|7549593|FG007|Overall Study|Withdrawal by Subject|0
4660824|NCT02202317|7549621|FG000|Overall Study|Lost to Follow-up|1
4660825|NCT02202499|7549628|FG000|Overall Study|Cancer diagnosis|0
4660826|NCT02202499|7549629|FG001|Overall Study|Cancer diagnosis|0
4660827|NCT02202499|7549630|FG002|Overall Study|Cancer diagnosis|1
4660828|NCT02202499|7549628|FG000|Overall Study|Moved from area|0
4660829|NCT02202499|7549629|FG001|Overall Study|Moved from area|0
4660830|NCT02202499|7549630|FG002|Overall Study|Moved from area|1
4660831|NCT02202499|7549628|FG000|Overall Study|Declined before randomization|1
4660832|NCT02202499|7549629|FG001|Overall Study|Declined before randomization|0
4660833|NCT02202499|7549630|FG002|Overall Study|Declined before randomization|0
4660834|NCT02202499|7549628|FG000|Overall Study|Auto accident|1
4660835|NCT02202499|7549629|FG001|Overall Study|Auto accident|0
4660836|NCT02202499|7549630|FG002|Overall Study|Auto accident|0
4660837|NCT02202538|7549643|FG000|Overall Study|Withdrawal by Subject|5
4660838|NCT02202538|7549643|FG000|Overall Study|Did not meet all inclusion criteria|2
4660839|NCT02202538|7549643|FG000|Overall Study|Investigator Decision|1
4660840|NCT02202551|7549651|FG000|Overall Study|Adverse Event|8
4660841|NCT02202551|7549652|FG001|Overall Study|Adverse Event|19
4660842|NCT02202551|7549653|FG002|Overall Study|Adverse Event|5
4660843|NCT02202551|7549654|FG003|Overall Study|Adverse Event|9
4660844|NCT02202551|7549651|FG000|Overall Study|Death|3
4660845|NCT02202551|7549652|FG001|Overall Study|Death|2
4660846|NCT02202551|7549653|FG002|Overall Study|Death|1
4660847|NCT02202551|7549654|FG003|Overall Study|Death|1
4660848|NCT02202551|7549651|FG000|Overall Study|Lost to Follow-up|0
4660849|NCT02202551|7549652|FG001|Overall Study|Lost to Follow-up|1
4660850|NCT02202551|7549653|FG002|Overall Study|Lost to Follow-up|0
4660851|NCT02202551|7549654|FG003|Overall Study|Lost to Follow-up|1
4660852|NCT02202551|7549651|FG000|Overall Study|Needed to take excluded medication|0
4660853|NCT02202551|7549652|FG001|Overall Study|Needed to take excluded medication|2
4660854|NCT02202551|7549653|FG002|Overall Study|Needed to take excluded medication|0
4660855|NCT02202551|7549654|FG003|Overall Study|Needed to take excluded medication|1
4660856|NCT02202551|7549651|FG000|Overall Study|Subject moved away|0
4660857|NCT02202551|7549652|FG001|Overall Study|Subject moved away|1
4660858|NCT02202551|7549653|FG002|Overall Study|Subject moved away|0
4660859|NCT02202551|7549654|FG003|Overall Study|Subject moved away|0
4660860|NCT02202551|7549651|FG000|Overall Study|DBS surgery|3
4660861|NCT02202551|7549652|FG001|Overall Study|DBS surgery|0
4660862|NCT02202551|7549653|FG002|Overall Study|DBS surgery|0
4660863|NCT02202551|7549654|FG003|Overall Study|DBS surgery|0
4660864|NCT02202551|7549651|FG000|Overall Study|Dyskinesia upon taper|1
4660865|NCT02202551|7549652|FG001|Overall Study|Dyskinesia upon taper|0
4660866|NCT02202551|7549653|FG002|Overall Study|Dyskinesia upon taper|0
4660867|NCT02202551|7549654|FG003|Overall Study|Dyskinesia upon taper|0
4660868|NCT02202551|7549651|FG000|Overall Study|Lack of Efficacy|0
4660869|NCT02202551|7549652|FG001|Overall Study|Lack of Efficacy|1
4660870|NCT02202551|7549653|FG002|Overall Study|Lack of Efficacy|0
4660871|NCT02202551|7549654|FG003|Overall Study|Lack of Efficacy|0
4660872|NCT02202551|7549651|FG000|Overall Study|Physician Decision|1
4660873|NCT02202551|7549652|FG001|Overall Study|Physician Decision|0
4660874|NCT02202551|7549653|FG002|Overall Study|Physician Decision|0
4660875|NCT02202551|7549654|FG003|Overall Study|Physician Decision|0
4660876|NCT02202551|7549651|FG000|Overall Study|Site closure|3
4660877|NCT02202551|7549652|FG001|Overall Study|Site closure|0
4660878|NCT02202551|7549653|FG002|Overall Study|Site closure|0
4660879|NCT02202551|7549654|FG003|Overall Study|Site closure|1
4660880|NCT02202551|7549651|FG000|Overall Study|Unable to complete visits per protocol|1
4660881|NCT02202551|7549652|FG001|Overall Study|Unable to complete visits per protocol|0
4660882|NCT02202551|7549653|FG002|Overall Study|Unable to complete visits per protocol|0
4660883|NCT02202551|7549654|FG003|Overall Study|Unable to complete visits per protocol|0
4660884|NCT02202551|7549651|FG000|Overall Study|Worsening Dyskinesia|0
4660885|NCT02202551|7549652|FG001|Overall Study|Worsening Dyskinesia|0
4660886|NCT02202551|7549653|FG002|Overall Study|Worsening Dyskinesia|0
4660887|NCT02202551|7549654|FG003|Overall Study|Worsening Dyskinesia|1
4660888|NCT02202551|7549651|FG000|Overall Study|Protocol Violation|0
4660889|NCT02202551|7549652|FG001|Overall Study|Protocol Violation|1
4660890|NCT02202551|7549653|FG002|Overall Study|Protocol Violation|0
4660891|NCT02202551|7549654|FG003|Overall Study|Protocol Violation|0
4660892|NCT02202551|7549651|FG000|Overall Study|Sponsor's decision|2
4660893|NCT02202551|7549652|FG001|Overall Study|Sponsor's decision|0
4660894|NCT02202551|7549653|FG002|Overall Study|Sponsor's decision|0
4660895|NCT02202551|7549654|FG003|Overall Study|Sponsor's decision|0
4660896|NCT02202551|7549651|FG000|Overall Study|Subject unwilling to proceed|1
4660897|NCT02202551|7549652|FG001|Overall Study|Subject unwilling to proceed|5
4660898|NCT02202551|7549653|FG002|Overall Study|Subject unwilling to proceed|3
4660899|NCT02202551|7549654|FG003|Overall Study|Subject unwilling to proceed|5
4660900|NCT02202551|7549651|FG000|Overall Study|Subject consent withdrawn|0
4660901|NCT02202551|7549652|FG001|Overall Study|Subject consent withdrawn|3
4660902|NCT02202551|7549653|FG002|Overall Study|Subject consent withdrawn|1
4660903|NCT02202551|7549654|FG003|Overall Study|Subject consent withdrawn|2
4660904|NCT02202551|7549651|FG000|Overall Study|eGFR<50mL/min/m2|2
4660905|NCT02202551|7549652|FG001|Overall Study|eGFR<50mL/min/m2|2
4660906|NCT02202551|7549653|FG002|Overall Study|eGFR<50mL/min/m2|0
4660907|NCT02202551|7549654|FG003|Overall Study|eGFR<50mL/min/m2|1
4660908|NCT02202616|7549668|FG000|Overall Study|Screen failed|24
4660909|NCT02202616|7549668|FG000|Overall Study|Adverse Event|32
4660910|NCT02202616|7549668|FG000|Overall Study|Protocol deviation|18
4660911|NCT02202616|7549668|FG000|Overall Study|Patient withdrew consent|12
4660912|NCT02202616|7549668|FG000|Overall Study|Lost to Follow-up|6
4660913|NCT02202616|7549668|FG000|Overall Study|Administrative problems|6
4660914|NCT02202616|7549668|FG000|Overall Study|Abnormal test procedure result|1
4660915|NCT02202616|7549668|FG000|Overall Study|Unsatisfactory therapeutic effect|1
4660916|NCT02202759|7549688|FG000|Overall Study|Study Terminated by Sponsor|3
4660917|NCT02202759|7549689|FG001|Overall Study|Study Terminated by Sponsor|3
4660918|NCT02202759|7549690|FG002|Overall Study|Study Terminated by Sponsor|3
4660919|NCT02202759|7549688|FG000|Overall Study|Withdrawal by Subject|2
4660920|NCT02202759|7549689|FG001|Overall Study|Withdrawal by Subject|1
4660921|NCT02202759|7549690|FG002|Overall Study|Withdrawal by Subject|1
4660922|NCT02202759|7549688|FG000|Overall Study|Reason not Specified|4
4660923|NCT02202759|7549689|FG001|Overall Study|Reason not Specified|11
4660924|NCT02202759|7549690|FG002|Overall Study|Reason not Specified|10
4660925|NCT02202785|7549700|FG000|Overall Study|Study Terminated by Sponsor|1
4660926|NCT02202785|7549701|FG001|Overall Study|Study Terminated by Sponsor|6
4660927|NCT02202785|7549702|FG002|Overall Study|Study Terminated by Sponsor|4
4660928|NCT02202785|7549700|FG000|Overall Study|Withdrawal by Subject|0
4660929|NCT02202785|7549701|FG001|Overall Study|Withdrawal by Subject|1
4660930|NCT02202785|7549702|FG002|Overall Study|Withdrawal by Subject|0
4660931|NCT02202785|7549700|FG000|Overall Study|Lost to Follow-up|0
4660932|NCT02202785|7549701|FG001|Overall Study|Lost to Follow-up|1
4660933|NCT02202785|7549702|FG002|Overall Study|Lost to Follow-up|0
4750550|NCT00940498|7724678|FG004|Overall Study|Death|5
4750551|NCT00940498|7724679|FG005|Overall Study|Death|0
4750552|NCT00940498|7724680|FG006|Overall Study|Death|1
4750553|NCT00940498|7724681|FG007|Overall Study|Death|0
4750554|NCT00940498|7724674|FG000|Overall Study|Lost to Follow-up|1
4750555|NCT00940498|7724675|FG001|Overall Study|Lost to Follow-up|1
4750556|NCT00940498|7724676|FG002|Overall Study|Lost to Follow-up|2
4660934|NCT02202785|7549700|FG000|Overall Study|Reason not Specified|10
4660935|NCT02202785|7549701|FG001|Overall Study|Reason not Specified|7
4660936|NCT02202785|7549702|FG002|Overall Study|Reason not Specified|13
4660937|NCT02202837|7549712|FG000|Overall Study|Enbrel treatment discontinued|36
4660938|NCT02202837|7549713|FG001|Overall Study|Enbrel treatment discontinued|4
4660939|NCT02202837|7549712|FG000|Overall Study|Other|10
4750557|NCT00940498|7724677|FG003|Overall Study|Lost to Follow-up|0
4750558|NCT00940498|7724678|FG004|Overall Study|Lost to Follow-up|1
4750559|NCT00940498|7724679|FG005|Overall Study|Lost to Follow-up|0
4750560|NCT00940498|7724680|FG006|Overall Study|Lost to Follow-up|0
4750561|NCT00940498|7724681|FG007|Overall Study|Lost to Follow-up|1
4750562|NCT00940498|7724674|FG000|Overall Study|Disease Progression|0
4750563|NCT00940498|7724675|FG001|Overall Study|Disease Progression|0
4750564|NCT00940498|7724676|FG002|Overall Study|Disease Progression|1
4750565|NCT00940498|7724677|FG003|Overall Study|Disease Progression|1
4750566|NCT00940498|7724678|FG004|Overall Study|Disease Progression|0
4750567|NCT00940498|7724679|FG005|Overall Study|Disease Progression|1
4750568|NCT00940498|7724680|FG006|Overall Study|Disease Progression|0
4750569|NCT00940498|7724681|FG007|Overall Study|Disease Progression|0
4660940|NCT02202837|7549713|FG001|Overall Study|Other|0
4660941|NCT02202837|7549712|FG000|Overall Study|Lost to Follow-up|7
4660942|NCT02202837|7549713|FG001|Overall Study|Lost to Follow-up|1
4660943|NCT02202850|7549721|FG000|Overall Study|Other|2
4660944|NCT02202850|7549722|FG001|Overall Study|Other|2
4660945|NCT02202850|7549721|FG000|Overall Study|Enbrel treatment discontinued|15
4660946|NCT02202850|7549722|FG001|Overall Study|Enbrel treatment discontinued|3
4750570|NCT00940498|7724674|FG000|Overall Study|Physician Decision|0
4660947|NCT02202850|7549721|FG000|Overall Study|Lost to Follow-up|7
4750571|NCT00940498|7724675|FG001|Overall Study|Physician Decision|0
4750572|NCT00940498|7724676|FG002|Overall Study|Physician Decision|0
4750573|NCT00940498|7724677|FG003|Overall Study|Physician Decision|0
4660948|NCT02202850|7549722|FG001|Overall Study|Lost to Follow-up|1
4660949|NCT02202980|7549742|FG000|Overall Study|Lack of Efficacy|1
4660950|NCT02202980|7549743|FG001|Overall Study|Lack of Efficacy|0
4660951|NCT02202980|7549744|FG002|Overall Study|Lack of Efficacy|7
4660952|NCT02202980|7549745|FG003|Overall Study|Lack of Efficacy|0
4660953|NCT02202980|7549746|FG004|Overall Study|Lack of Efficacy|3
4660954|NCT02202980|7549747|FG005|Overall Study|Lack of Efficacy|1
4660955|NCT02202980|7549748|FG006|Overall Study|Lack of Efficacy|11
4660956|NCT02202980|7549749|FG007|Overall Study|Lack of Efficacy|2
4660957|NCT02202980|7549750|FG008|Overall Study|Lack of Efficacy|2
4660958|NCT02202980|7549751|FG009|Overall Study|Lack of Efficacy|0
4660959|NCT02202980|7549752|FG010|Overall Study|Lack of Efficacy|0
4660960|NCT02202980|7549753|FG011|Overall Study|Lack of Efficacy|3
4660961|NCT02202980|7549754|FG012|Overall Study|Lack of Efficacy|10
4660962|NCT02202980|7549755|FG013|Overall Study|Lack of Efficacy|0
4660963|NCT02202980|7549742|FG000|Overall Study|Protocol Violation|0
4660964|NCT02202980|7549743|FG001|Overall Study|Protocol Violation|0
4660965|NCT02202980|7549744|FG002|Overall Study|Protocol Violation|0
4660966|NCT02202980|7549745|FG003|Overall Study|Protocol Violation|3
4660967|NCT02202980|7549746|FG004|Overall Study|Protocol Violation|3
4660968|NCT02202980|7549747|FG005|Overall Study|Protocol Violation|0
4660969|NCT02202980|7549748|FG006|Overall Study|Protocol Violation|0
4660970|NCT02202980|7549749|FG007|Overall Study|Protocol Violation|0
4660971|NCT02202980|7549750|FG008|Overall Study|Protocol Violation|0
4660972|NCT02202980|7549751|FG009|Overall Study|Protocol Violation|0
4660973|NCT02202980|7549752|FG010|Overall Study|Protocol Violation|0
4660974|NCT02202980|7549753|FG011|Overall Study|Protocol Violation|0
4660975|NCT02202980|7549754|FG012|Overall Study|Protocol Violation|0
4660976|NCT02202980|7549755|FG013|Overall Study|Protocol Violation|0
4660977|NCT02202980|7549742|FG000|Overall Study|Lost to Follow-up|0
4660978|NCT02202980|7549743|FG001|Overall Study|Lost to Follow-up|1
4660979|NCT02202980|7549744|FG002|Overall Study|Lost to Follow-up|1
4660980|NCT02202980|7549745|FG003|Overall Study|Lost to Follow-up|1
4660981|NCT02202980|7549746|FG004|Overall Study|Lost to Follow-up|0
4660982|NCT02202980|7549747|FG005|Overall Study|Lost to Follow-up|0
4660983|NCT02202980|7549748|FG006|Overall Study|Lost to Follow-up|0
4660984|NCT02202980|7549749|FG007|Overall Study|Lost to Follow-up|1
4660985|NCT02202980|7549750|FG008|Overall Study|Lost to Follow-up|1
4660986|NCT02202980|7549751|FG009|Overall Study|Lost to Follow-up|0
4660987|NCT02202980|7549752|FG010|Overall Study|Lost to Follow-up|0
4660988|NCT02202980|7549753|FG011|Overall Study|Lost to Follow-up|0
4660989|NCT02202980|7549754|FG012|Overall Study|Lost to Follow-up|1
4660990|NCT02202980|7549755|FG013|Overall Study|Lost to Follow-up|0
4660991|NCT02202980|7549742|FG000|Overall Study|Withdrew Consent|0
4660992|NCT02202980|7549743|FG001|Overall Study|Withdrew Consent|1
4660993|NCT02202980|7549744|FG002|Overall Study|Withdrew Consent|2
4660994|NCT02202980|7549745|FG003|Overall Study|Withdrew Consent|0
4660995|NCT02202980|7549746|FG004|Overall Study|Withdrew Consent|0
4660996|NCT02202980|7549747|FG005|Overall Study|Withdrew Consent|0
4660997|NCT02202980|7549748|FG006|Overall Study|Withdrew Consent|0
4660998|NCT02202980|7549749|FG007|Overall Study|Withdrew Consent|0
4660999|NCT02202980|7549750|FG008|Overall Study|Withdrew Consent|1
4661000|NCT02202980|7549751|FG009|Overall Study|Withdrew Consent|0
4661001|NCT02202980|7549752|FG010|Overall Study|Withdrew Consent|0
4661002|NCT02202980|7549753|FG011|Overall Study|Withdrew Consent|0
4661003|NCT02202980|7549754|FG012|Overall Study|Withdrew Consent|0
4661004|NCT02202980|7549755|FG013|Overall Study|Withdrew Consent|0
4661005|NCT02203032|7549794|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2
4661006|NCT02203032|7549795|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
4661007|NCT02203032|7549796|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
4661008|NCT02203032|7549797|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
4661009|NCT02203032|7549794|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1
4661010|NCT02203032|7549795|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
4661011|NCT02203032|7549796|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
4661012|NCT02203032|7549797|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
4661013|NCT02203032|7549794|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3
4661014|NCT02203032|7549795|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
4661015|NCT02203032|7549796|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
4661016|NCT02203032|7549797|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
4661017|NCT02203032|7549794|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6
4661018|NCT02203032|7549795|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
4661019|NCT02203032|7549796|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
4750574|NCT00940498|7724678|FG004|Overall Study|Physician Decision|2
4750575|NCT00940498|7724679|FG005|Overall Study|Physician Decision|0
4750576|NCT00940498|7724680|FG006|Overall Study|Physician Decision|0
4661020|NCT02203032|7549797|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
4661021|NCT02203032|7549794|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4
4661022|NCT02203032|7549795|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
4661023|NCT02203032|7549796|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
4661024|NCT02203032|7549797|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
4661025|NCT02203032|7549794|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2
4661026|NCT02203032|7549795|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0
4661027|NCT02203032|7549796|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0
4750577|NCT00940498|7724681|FG007|Overall Study|Physician Decision|0
4661028|NCT02203032|7549797|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0
4661029|NCT02203032|7549794|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1
4661030|NCT02203032|7549795|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
4661031|NCT02203032|7549796|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
4661032|NCT02203032|7549797|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
4661033|NCT02203032|7549794|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0
4661034|NCT02203032|7549795|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2
4661035|NCT02203032|7549796|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3
4661036|NCT02203032|7549797|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8
4661037|NCT02203032|7549794|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0
4661038|NCT02203032|7549795|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8
4661039|NCT02203032|7549796|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19
4661040|NCT02203032|7549797|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20
4661041|NCT02203032|7549794|FG000|Blinded Phase (Week 16 to Week 44)|Other|0
4661042|NCT02203032|7549795|FG001|Blinded Phase (Week 16 to Week 44)|Other|4
4661043|NCT02203032|7549796|FG002|Blinded Phase (Week 16 to Week 44)|Other|1
4661044|NCT02203032|7549797|FG003|Blinded Phase (Week 16 to Week 44)|Other|15
4661045|NCT02203032|7549794|FG000|Blinded Phase (Week 16 to Week 44)|Death|0
4661046|NCT02203032|7549795|FG001|Blinded Phase (Week 16 to Week 44)|Death|0
4661047|NCT02203032|7549796|FG002|Blinded Phase (Week 16 to Week 44)|Death|0
4661048|NCT02203032|7549797|FG003|Blinded Phase (Week 16 to Week 44)|Death|1
4661049|NCT02203032|7549794|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0
4661050|NCT02203032|7549795|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1
4661051|NCT02203032|7549796|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3
4661052|NCT02203032|7549797|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2
4661053|NCT02203071|7549807|FG000|Overall Study|Lost to Follow-up|3
4661054|NCT02203071|7549808|FG001|Overall Study|Lost to Follow-up|1
4661055|NCT02203149|7549819|FG000|Part 1|Adverse Event|0
4661056|NCT02203149|7549820|FG001|Part 1|Adverse Event|1
4661057|NCT02203149|7549821|FG002|Part 1|Adverse Event|0
4661058|NCT02203149|7549822|FG003|Part 1|Adverse Event|0
4661059|NCT02203149|7549823|FG004|Part 1|Adverse Event|0
4661060|NCT02203149|7549819|FG000|Part 2|Death|0
4661061|NCT02203149|7549820|FG001|Part 2|Death|0
4661062|NCT02203149|7549821|FG002|Part 2|Death|1
4750578|NCT00940498|7724674|FG000|Overall Study|Not treated due to disease related pain|0
4750579|NCT00940498|7724675|FG001|Overall Study|Not treated due to disease related pain|0
4750580|NCT00940498|7724676|FG002|Overall Study|Not treated due to disease related pain|0
4750581|NCT00940498|7724677|FG003|Overall Study|Not treated due to disease related pain|0
4750582|NCT00940498|7724678|FG004|Overall Study|Not treated due to disease related pain|1
4750583|NCT00940498|7724679|FG005|Overall Study|Not treated due to disease related pain|0
4750584|NCT00940498|7724680|FG006|Overall Study|Not treated due to disease related pain|0
4750585|NCT00940498|7724681|FG007|Overall Study|Not treated due to disease related pain|0
4661063|NCT02203149|7549822|FG003|Part 2|Death|1
4661064|NCT02203149|7549823|FG004|Part 2|Death|0
4661065|NCT02203149|7549819|FG000|Part 2|Withdrawal by Subject|0
4661066|NCT02203149|7549820|FG001|Part 2|Withdrawal by Subject|0
4661067|NCT02203149|7549821|FG002|Part 2|Withdrawal by Subject|0
4661068|NCT02203149|7549822|FG003|Part 2|Withdrawal by Subject|1
4661069|NCT02203149|7549823|FG004|Part 2|Withdrawal by Subject|0
4661070|NCT02203149|7549819|FG000|Part 2|Adverse Event|0
4661071|NCT02203149|7549820|FG001|Part 2|Adverse Event|0
4661072|NCT02203149|7549821|FG002|Part 2|Adverse Event|0
4661073|NCT02203149|7549822|FG003|Part 2|Adverse Event|1
4661074|NCT02203149|7549823|FG004|Part 2|Adverse Event|1
4661075|NCT02203331|7549855|FG000|Overall Study|Pregnancy|1
4661076|NCT02203331|7549856|FG001|Overall Study|Pregnancy|0
4661077|NCT02203331|7549857|FG002|Overall Study|Pregnancy|0
4661078|NCT02203331|7549858|FG003|Overall Study|Pregnancy|0
4661079|NCT02203331|7549859|FG004|Overall Study|Pregnancy|2
4661080|NCT02203331|7549860|FG005|Overall Study|Pregnancy|0
4661081|NCT02203331|7549855|FG000|Overall Study|Withdrawal by Subject|1
4661082|NCT02203331|7549856|FG001|Overall Study|Withdrawal by Subject|0
4661083|NCT02203331|7549857|FG002|Overall Study|Withdrawal by Subject|1
4661084|NCT02203331|7549858|FG003|Overall Study|Withdrawal by Subject|0
4661085|NCT02203331|7549859|FG004|Overall Study|Withdrawal by Subject|0
4661086|NCT02203331|7549860|FG005|Overall Study|Withdrawal by Subject|3
4661087|NCT02203331|7549855|FG000|Overall Study|Adverse Event|4
4661088|NCT02203331|7549856|FG001|Overall Study|Adverse Event|8
4661089|NCT02203331|7549857|FG002|Overall Study|Adverse Event|3
4661090|NCT02203331|7549858|FG003|Overall Study|Adverse Event|4
4661091|NCT02203331|7549859|FG004|Overall Study|Adverse Event|3
4661092|NCT02203331|7549860|FG005|Overall Study|Adverse Event|3
4661093|NCT02203331|7549855|FG000|Overall Study|Other Reasons|1
4661094|NCT02203331|7549856|FG001|Overall Study|Other Reasons|2
4661095|NCT02203331|7549857|FG002|Overall Study|Other Reasons|0
4661096|NCT02203331|7549858|FG003|Overall Study|Other Reasons|2
4661097|NCT02203331|7549859|FG004|Overall Study|Other Reasons|0
4661098|NCT02203331|7549860|FG005|Overall Study|Other Reasons|0
4661099|NCT02203331|7549855|FG000|Overall Study|Lack of Efficacy|0
4661100|NCT02203331|7549856|FG001|Overall Study|Lack of Efficacy|2
4661101|NCT02203331|7549857|FG002|Overall Study|Lack of Efficacy|1
4661102|NCT02203331|7549858|FG003|Overall Study|Lack of Efficacy|0
4661103|NCT02203331|7549859|FG004|Overall Study|Lack of Efficacy|0
4661104|NCT02203331|7549860|FG005|Overall Study|Lack of Efficacy|1
4661105|NCT02203331|7549855|FG000|Overall Study|Protocol Violation|0
4661106|NCT02203331|7549856|FG001|Overall Study|Protocol Violation|2
4661107|NCT02203331|7549857|FG002|Overall Study|Protocol Violation|0
4661108|NCT02203331|7549858|FG003|Overall Study|Protocol Violation|1
4661109|NCT02203331|7549859|FG004|Overall Study|Protocol Violation|1
4661110|NCT02203331|7549860|FG005|Overall Study|Protocol Violation|0
4661111|NCT02203331|7549855|FG000|Overall Study|Lost to Follow-up|0
4661112|NCT02203331|7549856|FG001|Overall Study|Lost to Follow-up|0
4661113|NCT02203331|7549857|FG002|Overall Study|Lost to Follow-up|0
4661114|NCT02203331|7549858|FG003|Overall Study|Lost to Follow-up|0
4661115|NCT02203331|7549859|FG004|Overall Study|Lost to Follow-up|1
4661116|NCT02203331|7549860|FG005|Overall Study|Lost to Follow-up|0
4661117|NCT02203357|7549877|FG000|Overall Study|Lost to Follow-up|58
4661118|NCT02203357|7549878|FG001|Overall Study|Lost to Follow-up|66
4661119|NCT02203357|7549879|FG002|Overall Study|Lost to Follow-up|70
4661120|NCT02203591|7549906|FG000|Overall Study|Did not meet treatment day baseline|147
4661121|NCT02203591|7549907|FG001|Overall Study|Did not meet treatment day baseline|141
4661122|NCT02203591|7549908|FG002|Overall Study|Did not meet treatment day baseline|150
4661123|NCT02203591|7549909|FG003|Overall Study|Did not meet treatment day baseline|45
4661124|NCT02203591|7549910|FG004|Overall Study|Did not meet treatment day baseline|33
4661125|NCT02203591|7549911|FG005|Overall Study|Did not meet treatment day baseline|35
4661126|NCT02203591|7549912|FG006|Overall Study|Did not meet treatment day baseline|29
4661127|NCT02203591|7549913|FG007|Overall Study|Did not meet treatment day baseline|12
4661128|NCT02203591|7549906|FG000|Overall Study|Discontinued early due to compromised test sites|0
4661129|NCT02203591|7549907|FG001|Overall Study|Discontinued early due to compromised test sites|1
4661130|NCT02203591|7549908|FG002|Overall Study|Discontinued early due to compromised test sites|1
4661131|NCT02203591|7549909|FG003|Overall Study|Discontinued early due to compromised test sites|0
4661132|NCT02203591|7549910|FG004|Overall Study|Discontinued early due to compromised test sites|1
4661133|NCT02203591|7549911|FG005|Overall Study|Discontinued early due to compromised test sites|0
4661134|NCT02203591|7549912|FG006|Overall Study|Discontinued early due to compromised test sites|0
4661135|NCT02203591|7549913|FG007|Overall Study|Discontinued early due to compromised test sites|1
4661136|NCT02203721|7549946|FG000|Overall Study|Lost to Follow-up|1
4661137|NCT02203721|7549947|FG001|Overall Study|Lost to Follow-up|0
4661138|NCT02203721|7549946|FG000|Overall Study|Death|0
4661139|NCT02203721|7549947|FG001|Overall Study|Death|2
4661140|NCT02203721|7549946|FG000|Overall Study|Illness|0
4661141|NCT02203721|7549947|FG001|Overall Study|Illness|1
4661142|NCT02203838|7549985|FG000|Overall Study|Lack of Efficacy|7
4661143|NCT02203838|7549986|FG001|Overall Study|Lack of Efficacy|0
4661144|NCT02203838|7549987|FG002|Overall Study|Lack of Efficacy|1
4661145|NCT02203838|7549988|FG003|Overall Study|Lack of Efficacy|1
4661146|NCT02203838|7549985|FG000|Overall Study|Adverse Event|46
4661147|NCT02203838|7549986|FG001|Overall Study|Adverse Event|6
4661148|NCT02203838|7549987|FG002|Overall Study|Adverse Event|3
4661149|NCT02203838|7549988|FG003|Overall Study|Adverse Event|2
4661150|NCT02203838|7549985|FG000|Overall Study|Lost to Follow-up|39
4661151|NCT02203838|7549986|FG001|Overall Study|Lost to Follow-up|3
4661152|NCT02203838|7549987|FG002|Overall Study|Lost to Follow-up|2
4661153|NCT02203838|7549988|FG003|Overall Study|Lost to Follow-up|1
4661154|NCT02203838|7549985|FG000|Overall Study|Protocol Violation|7
4661155|NCT02203838|7549986|FG001|Overall Study|Protocol Violation|3
4661156|NCT02203838|7549987|FG002|Overall Study|Protocol Violation|0
4661157|NCT02203838|7549988|FG003|Overall Study|Protocol Violation|0
4661158|NCT02203838|7549985|FG000|Overall Study|Withdrawal by Subject|83
4661159|NCT02203838|7549986|FG001|Overall Study|Withdrawal by Subject|10
4661160|NCT02203838|7549987|FG002|Overall Study|Withdrawal by Subject|8
4661161|NCT02203838|7549988|FG003|Overall Study|Withdrawal by Subject|11
4661162|NCT02203838|7549985|FG000|Overall Study|Physician Decision|27
4661163|NCT02203838|7549986|FG001|Overall Study|Physician Decision|0
4661164|NCT02203838|7549987|FG002|Overall Study|Physician Decision|2
4661165|NCT02203838|7549988|FG003|Overall Study|Physician Decision|3
4661166|NCT02203838|7549985|FG000|Overall Study|Other|1
4661167|NCT02203838|7549986|FG001|Overall Study|Other|0
4661168|NCT02203838|7549987|FG002|Overall Study|Other|0
4661169|NCT02203838|7549988|FG003|Overall Study|Other|0
4661170|NCT02203851|7549998|FG000|Overall Study|Lost to Follow-up|4
4661171|NCT02203851|7549998|FG000|Overall Study|Withdrawal by Subject|6
4661172|NCT02203851|7549998|FG000|Overall Study|Other|1
4661173|NCT02203916|7550012|FG000|Overall Study|Pretreatment Event/Adverse Event|1
4661174|NCT02203916|7550013|FG001|Overall Study|Pretreatment Event/Adverse Event|3
4661175|NCT02203916|7550014|FG002|Overall Study|Pretreatment Event/Adverse Event|2
4661176|NCT02203916|7550012|FG000|Overall Study|Major Protocol Deviation|1
4661177|NCT02203916|7550013|FG001|Overall Study|Major Protocol Deviation|1
4750586|NCT04553913|7724714|FG000|Overall Study|patient's block resolved prior to PACU|1
4750587|NCT04553913|7724714|FG000|Overall Study|did not use the device properly|5
4750588|NCT04009824|7724729|FG000|Overall Study|COVID-19 pandemic restriction/closure|2
4750589|NCT04009824|7724730|FG001|Overall Study|COVID-19 pandemic restriction/closure|3
4661178|NCT02203916|7550014|FG002|Overall Study|Major Protocol Deviation|0
4661179|NCT02203916|7550012|FG000|Overall Study|Lost to Follow-up|0
4661180|NCT02203916|7550013|FG001|Overall Study|Lost to Follow-up|1
4750590|NCT04009824|7724731|FG002|Overall Study|COVID-19 pandemic restriction/closure|5
4750591|NCT04009824|7724732|FG003|Overall Study|COVID-19 pandemic restriction/closure|2
4661181|NCT02203916|7550014|FG002|Overall Study|Lost to Follow-up|0
4661182|NCT02203916|7550012|FG000|Overall Study|Voluntary Withdrawal|3
4661183|NCT02203916|7550013|FG001|Overall Study|Voluntary Withdrawal|3
4750592|NCT04009824|7724733|FG004|Overall Study|COVID-19 pandemic restriction/closure|3
4750593|NCT03449758|7724755|FG000|Overall Study|Major protocol deviation|1
4750594|NCT03449758|7724755|FG000|Overall Study|Treatment inefficacy|5
4661184|NCT02203916|7550014|FG002|Overall Study|Voluntary Withdrawal|8
4661185|NCT02203916|7550012|FG000|Overall Study|Lack of Efficacy|3
4661186|NCT02203916|7550013|FG001|Overall Study|Lack of Efficacy|0
4661187|NCT02203916|7550014|FG002|Overall Study|Lack of Efficacy|0
4661188|NCT02203916|7550012|FG000|Overall Study|Reason Not Specified|0
4661189|NCT02203916|7550013|FG001|Overall Study|Reason Not Specified|2
4661190|NCT02203916|7550014|FG002|Overall Study|Reason Not Specified|1
4661191|NCT02204007|7550024|FG000|Overall Study|Surgery Canceled|1
4661192|NCT02204007|7550025|FG001|Overall Study|Surgery Canceled|1
4661193|NCT02204293|7550059|FG000|Core Study Part I|Met one or more exclusion criteria|1
4661194|NCT02204293|7550060|FG001|Core Study Part I|Met one or more exclusion criteria|0
4661195|NCT02204293|7550061|FG002|Core Study Part I|Met one or more exclusion criteria|0
4661196|NCT02204293|7550062|FG003|Core Study Part I|Met one or more exclusion criteria|0
4661197|NCT02204293|7550063|FG004|Core Study Part I|Met one or more exclusion criteria|0
4750595|NCT03449758|7724755|FG000|Overall Study|Adverse Event|9
4750596|NCT03449758|7724755|FG000|Overall Study|Consent withdrawal|1
4750597|NCT03449758|7724755|FG000|Overall Study|Other unspecified reason|3
4750598|NCT03222973|7724762|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3
4750599|NCT03222973|7724763|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0
4750600|NCT03222973|7724764|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0
4750601|NCT03222973|7724765|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0
4750602|NCT03222973|7724762|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1
4750603|NCT03222973|7724763|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1
4750604|NCT03222973|7724764|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0
4750605|NCT03222973|7724765|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0
4750606|NCT03222973|7724762|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12
4750607|NCT03222973|7724763|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9
4750608|NCT03222973|7724764|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0
4750609|NCT03222973|7724765|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0
4750610|NCT03222973|7724762|FG000|Part 1 (Week 0 to Week 72)|Death|0
4750611|NCT03222973|7724763|FG001|Part 1 (Week 0 to Week 72)|Death|1
4750612|NCT03222973|7724764|FG002|Part 1 (Week 0 to Week 72)|Death|0
4750613|NCT03222973|7724765|FG003|Part 1 (Week 0 to Week 72)|Death|0
4750614|NCT03222973|7724762|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0
4750615|NCT03222973|7724763|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1
4750616|NCT03222973|7724764|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0
4750617|NCT03222973|7724765|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0
4750618|NCT03222973|7724762|FG000|Part 1 (Week 0 to Week 72)|Other|8
4750619|NCT03222973|7724763|FG001|Part 1 (Week 0 to Week 72)|Other|2
4750620|NCT03222973|7724764|FG002|Part 1 (Week 0 to Week 72)|Other|0
4750621|NCT03222973|7724765|FG003|Part 1 (Week 0 to Week 72)|Other|0
4750622|NCT03222973|7724762|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0
4750623|NCT03222973|7724763|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0
4750624|NCT03222973|7724764|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2
4750625|NCT03222973|7724765|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0
4750626|NCT03222973|7724762|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0
4750627|NCT03222973|7724763|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0
4750628|NCT03222973|7724764|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10
4750629|NCT03222973|7724765|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11
4750630|NCT03222973|7724762|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0
4750631|NCT03222973|7724763|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0
4750632|NCT03222973|7724764|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2
4750633|NCT03222973|7724765|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1
4750634|NCT03222973|7724762|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0
4750635|NCT03222973|7724763|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0
4750636|NCT03222973|7724764|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2
4750637|NCT03222973|7724765|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1
4750638|NCT03222973|7724762|FG000|Part 2 (Week 73 to Week 168)|Other|0
4750639|NCT03222973|7724763|FG001|Part 2 (Week 73 to Week 168)|Other|0
4750640|NCT03222973|7724764|FG002|Part 2 (Week 73 to Week 168)|Other|84
4750641|NCT03222973|7724765|FG003|Part 2 (Week 73 to Week 168)|Other|100
4750642|NCT03222973|7724762|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0
4750643|NCT03222973|7724763|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0
4750644|NCT03222973|7724764|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1
4750645|NCT03222973|7724765|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0
4750646|NCT03187262|7724775|FG000|Induction|Lack of Efficacy|2
4750647|NCT03187262|7724775|FG000|Induction|Progressive Disease|4
4750648|NCT03187262|7724775|FG000|Consolidation|Progressive Disease|5
4750649|NCT02987959|7724783|FG000|Overall Study|Grantor stopped supply of drugs|6
4750650|NCT02985541|7724787|FG000|Overall Study|Withdrawal by Subject|33
4750651|NCT02985541|7724787|FG000|Overall Study|Lost to Follow-up|26
4750652|NCT02985541|7724787|FG000|Overall Study|Adverse Event|27
4750653|NCT02985541|7724787|FG000|Overall Study|Physician Decision|2
4750654|NCT02985541|7724787|FG000|Overall Study|Pregnancy|2
4750655|NCT02985541|7724787|FG000|Overall Study|Wish for pregnancy|44
4750656|NCT02985541|7724787|FG000|Overall Study|Other reason|5
4750657|NCT02985541|7724787|FG000|Overall Study|Not valid for analysis|2
4750658|NCT02960893|7724793|FG000|Randomization Phase (8-week)|Adverse Event|5
4750659|NCT02960893|7724794|FG001|Randomization Phase (8-week)|Adverse Event|0
4661198|NCT02204293|7550064|FG005|Core Study Part I|Met one or more exclusion criteria|0
4661199|NCT02204293|7550059|FG000|Core Study Part I|Adverse Event|1
4661200|NCT02204293|7550060|FG001|Core Study Part I|Adverse Event|0
4661201|NCT02204293|7550061|FG002|Core Study Part I|Adverse Event|0
4661202|NCT02204293|7550062|FG003|Core Study Part I|Adverse Event|0
4661203|NCT02204293|7550063|FG004|Core Study Part I|Adverse Event|0
4661204|NCT02204293|7550064|FG005|Core Study Part I|Adverse Event|0
4661205|NCT02204293|7550059|FG000|Core Study Part I|Physician Decision|0
4661206|NCT02204293|7550060|FG001|Core Study Part I|Physician Decision|3
4661207|NCT02204293|7550061|FG002|Core Study Part I|Physician Decision|0
4661208|NCT02204293|7550062|FG003|Core Study Part I|Physician Decision|0
4661209|NCT02204293|7550063|FG004|Core Study Part I|Physician Decision|0
4661210|NCT02204293|7550064|FG005|Core Study Part I|Physician Decision|0
4661211|NCT02204293|7550059|FG000|LTE Phase|Study Suspended|0
4661212|NCT02204293|7550060|FG001|LTE Phase|Study Suspended|0
4661213|NCT02204293|7550061|FG002|LTE Phase|Study Suspended|0
4661214|NCT02204293|7550062|FG003|LTE Phase|Study Suspended|0
4661215|NCT02204293|7550063|FG004|LTE Phase|Study Suspended|0
4661216|NCT02204293|7550064|FG005|LTE Phase|Study Suspended|7
4661217|NCT02204319|7550078|FG000|Overall Study|Pregnancy|1
4661218|NCT02204319|7550078|FG000|Overall Study|Withdrawal by Subject|2
4661219|NCT02204371|7550083|FG000|Overall Study|Adverse Event|1
4661220|NCT02204410|7550087|FG000|Overall Study|Lost to Follow-up|5
4661221|NCT02204410|7550087|FG000|Overall Study|Physician Decision|2
4661222|NCT02204410|7550087|FG000|Overall Study|Protocol Violation|1
4661223|NCT02204410|7550087|FG000|Overall Study|Withdrawal by Subject|3
4661224|NCT02204449|7550093|FG000|Overall Study|Lost to Follow-up|7
4661225|NCT02204449|7550094|FG001|Overall Study|Lost to Follow-up|9
4661226|NCT02204449|7550093|FG000|Overall Study|Death|0
4661227|NCT02204449|7550094|FG001|Overall Study|Death|1
4661228|NCT02204449|7550093|FG000|Overall Study|Withdrawal by Subject|0
4661229|NCT02204449|7550094|FG001|Overall Study|Withdrawal by Subject|1
4661230|NCT02204579|7550104|FG000|Overall Study|Screen failures|2
4661231|NCT02204917|7550130|FG000|Overall Study|Protocol Violation|1
4661232|NCT02204982|7550139|FG000|Overall Study|Patient ineligible-medical monitor|1
4661233|NCT02204982|7550140|FG001|Overall Study|Patient ineligible-medical monitor|0
4661234|NCT02204982|7550139|FG000|Overall Study|Withdrawal by Subject|1
4661235|NCT02204982|7550140|FG001|Overall Study|Withdrawal by Subject|0
4661236|NCT02204982|7550139|FG000|Overall Study|Adverse Event|1
4661237|NCT02204982|7550140|FG001|Overall Study|Adverse Event|0
4661238|NCT02204982|7550139|FG000|Overall Study|Adverse Event and Investigator decision|1
4661239|NCT02204982|7550140|FG001|Overall Study|Adverse Event and Investigator decision|0
4661240|NCT02204982|7550139|FG000|Overall Study|Physician Decision|0
4661241|NCT02204982|7550140|FG001|Overall Study|Physician Decision|2
4661242|NCT02204982|7550139|FG000|Overall Study|Protocol-Specified Disease Progression|0
4661243|NCT02204982|7550140|FG001|Overall Study|Protocol-Specified Disease Progression|4
4661244|NCT02204982|7550139|FG000|Overall Study|Termination of Study bySponsor|0
4661245|NCT02204982|7550140|FG001|Overall Study|Termination of Study bySponsor|1
4661246|NCT02205333|7550174|FG000|Overall Study|Death|5
4661247|NCT02205333|7550175|FG001|Overall Study|Death|6
4661248|NCT02205333|7550176|FG002|Overall Study|Death|2
4661249|NCT02205333|7550177|FG003|Overall Study|Death|6
4661250|NCT02205333|7550178|FG004|Overall Study|Death|5
4661251|NCT02205333|7550179|FG005|Overall Study|Death|3
4661252|NCT02205333|7550180|FG006|Overall Study|Death|3
4661253|NCT02205333|7550181|FG007|Overall Study|Death|2
4661254|NCT02205333|7550182|FG008|Overall Study|Death|0
4661255|NCT02205333|7550174|FG000|Overall Study|Withdrawal by Subject|1
4661256|NCT02205333|7550175|FG001|Overall Study|Withdrawal by Subject|0
4661257|NCT02205333|7550176|FG002|Overall Study|Withdrawal by Subject|0
4661258|NCT02205333|7550177|FG003|Overall Study|Withdrawal by Subject|1
4661259|NCT02205333|7550178|FG004|Overall Study|Withdrawal by Subject|0
4661260|NCT02205333|7550179|FG005|Overall Study|Withdrawal by Subject|0
4661261|NCT02205333|7550180|FG006|Overall Study|Withdrawal by Subject|2
4661262|NCT02205333|7550181|FG007|Overall Study|Withdrawal by Subject|0
4661263|NCT02205333|7550182|FG008|Overall Study|Withdrawal by Subject|0
4661264|NCT02205476|7550204|FG000|Overall Study|Study termination by Sponsor|7
4661265|NCT02205476|7550205|FG001|Overall Study|Study termination by Sponsor|3
4661266|NCT02205814|7550238|FG000|Overall Study|Lost to Follow-up|0
4661267|NCT02205814|7550239|FG001|Overall Study|Lost to Follow-up|0
4661268|NCT02205814|7550240|FG002|Overall Study|Lost to Follow-up|0
4661269|NCT02205814|7550241|FG003|Overall Study|Lost to Follow-up|1
4661270|NCT02205814|7550238|FG000|Overall Study|Lack of Efficacy|1
4661271|NCT02205814|7550239|FG001|Overall Study|Lack of Efficacy|0
4661272|NCT02205814|7550240|FG002|Overall Study|Lack of Efficacy|1
4661273|NCT02205814|7550241|FG003|Overall Study|Lack of Efficacy|1
4661274|NCT02205814|7550238|FG000|Overall Study|Physician Decision|0
4661275|NCT02205814|7550239|FG001|Overall Study|Physician Decision|0
4661276|NCT02205814|7550240|FG002|Overall Study|Physician Decision|1
4661277|NCT02205814|7550241|FG003|Overall Study|Physician Decision|0
4661278|NCT02205814|7550238|FG000|Overall Study|Protocol Violation|1
4661279|NCT02205814|7550239|FG001|Overall Study|Protocol Violation|0
4661280|NCT02205814|7550240|FG002|Overall Study|Protocol Violation|0
4661281|NCT02205814|7550241|FG003|Overall Study|Protocol Violation|1
4661282|NCT02205814|7550238|FG000|Overall Study|Withdrawal by Subject|0
4661283|NCT02205814|7550239|FG001|Overall Study|Withdrawal by Subject|1
4661284|NCT02205814|7550240|FG002|Overall Study|Withdrawal by Subject|2
4661285|NCT02205814|7550241|FG003|Overall Study|Withdrawal by Subject|1
4661286|NCT02205814|7550238|FG000|Overall Study|not compliant with study procedures|0
4661287|NCT02205814|7550239|FG001|Overall Study|not compliant with study procedures|0
4661288|NCT02205814|7550240|FG002|Overall Study|not compliant with study procedures|1
4661289|NCT02205814|7550241|FG003|Overall Study|not compliant with study procedures|0
4661290|NCT02206061|7550271|FG000|Overall Study|Withdrawal by Subject|4
4661291|NCT02206061|7550272|FG001|Overall Study|Withdrawal by Subject|7
4661292|NCT02206061|7550273|FG002|Overall Study|Withdrawal by Subject|1
4661293|NCT02206061|7550271|FG000|Overall Study|Lost to Follow-up|14
4661294|NCT02206061|7550272|FG001|Overall Study|Lost to Follow-up|7
4661295|NCT02206061|7550273|FG002|Overall Study|Lost to Follow-up|20
4661296|NCT02206152|7550281|FG000|Pre-Randomization|Withdrawal by Subject|2
4661297|NCT02206607|7550296|FG000|Open-Label Run-In|Withdrawal by Subject|3
4661298|NCT02206607|7550297|FG001|Open-Label Run-In|Withdrawal by Subject|0
4661299|NCT02206607|7550298|FG002|Open-Label Run-In|Withdrawal by Subject|0
4661300|NCT02206607|7550299|FG003|Open-Label Run-In|Withdrawal by Subject|0
4661301|NCT02206607|7550300|FG004|Open-Label Run-In|Withdrawal by Subject|0
4661302|NCT02206607|7550296|FG000|Second Intervention Period|Insufficient Clinical Response|0
4661303|NCT02206607|7550297|FG001|Second Intervention Period|Insufficient Clinical Response|0
4661304|NCT02206607|7550298|FG002|Second Intervention Period|Insufficient Clinical Response|0
4661305|NCT02206607|7550299|FG003|Second Intervention Period|Insufficient Clinical Response|1
4661306|NCT02206607|7550300|FG004|Second Intervention Period|Insufficient Clinical Response|0
4661307|NCT02206620|7550316|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1
4661308|NCT02206620|7550317|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1
4661309|NCT02206620|7550316|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0
4661310|NCT02206620|7550317|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2
4661311|NCT02206685|7550331|FG000|Overall Study|Surgery cancelled/changed|2
4661312|NCT02206685|7550332|FG001|Overall Study|Surgery cancelled/changed|3
4661313|NCT02206685|7550331|FG000|Overall Study|Withdrawal by Subject|1
4661314|NCT02206685|7550332|FG001|Overall Study|Withdrawal by Subject|2
4661315|NCT02206685|7550331|FG000|Overall Study|Protocol Violation|2
4661316|NCT02206685|7550332|FG001|Overall Study|Protocol Violation|2
4750660|NCT02960893|7724793|FG000|Randomization Phase (8-week)|Withdrawal by Subject|2
4750661|NCT02960893|7724794|FG001|Randomization Phase (8-week)|Withdrawal by Subject|1
4750662|NCT02960893|7724793|FG000|Randomization Phase (8-week)|Reason Not Specified|0
4750663|NCT02960893|7724794|FG001|Randomization Phase (8-week)|Reason Not Specified|1
4750664|NCT02960893|7724793|FG000|Extension Phase (48-week)|Adverse Event|2
4750665|NCT02960893|7724794|FG001|Extension Phase (48-week)|Adverse Event|3
4750666|NCT02960893|7724793|FG000|Extension Phase (48-week)|Withdrawal by Subject|8
4750667|NCT02960893|7724794|FG001|Extension Phase (48-week)|Withdrawal by Subject|8
4750668|NCT02960893|7724793|FG000|Extension Phase (48-week)|Other Reason|2
4750669|NCT02960893|7724794|FG001|Extension Phase (48-week)|Other Reason|1
4750670|NCT02960893|7724793|FG000|Extension Phase (48-week)|Lost to Follow-up|1
4750671|NCT02960893|7724794|FG001|Extension Phase (48-week)|Lost to Follow-up|1
4750672|NCT02960893|7724793|FG000|Extension Phase (48-week)|Sponsors Decision|1
4750673|NCT02960893|7724794|FG001|Extension Phase (48-week)|Sponsors Decision|0
4750674|NCT02940522|7724809|FG000|Overall Study|Lost to Follow-up|1
4750675|NCT02940522|7724810|FG001|Overall Study|Lost to Follow-up|2
4750676|NCT02940522|7724809|FG000|Overall Study|Withdrawal by Subject|1
4750677|NCT02940522|7724810|FG001|Overall Study|Withdrawal by Subject|0
4750678|NCT02789657|7724820|FG000|Overall Study|Withdrawal by Subject|2
4750679|NCT02789657|7724821|FG001|Overall Study|Withdrawal by Subject|0
4750680|NCT02789657|7724822|FG002|Overall Study|Withdrawal by Subject|0
4750681|NCT02789657|7724823|FG003|Overall Study|Withdrawal by Subject|0
4750682|NCT02711137|7724847|FG000|Overall Study|Death|1
4750683|NCT02711137|7724848|FG001|Overall Study|Death|4
4750684|NCT02711137|7724849|FG002|Overall Study|Death|5
4750685|NCT02711137|7724850|FG003|Overall Study|Death|5
4750686|NCT02711137|7724851|FG004|Overall Study|Death|3
4750687|NCT02711137|7724852|FG005|Overall Study|Death|1
4750688|NCT02711137|7724853|FG006|Overall Study|Death|61
4750689|NCT02711137|7724854|FG007|Overall Study|Death|3
4750690|NCT02711137|7724855|FG008|Overall Study|Death|0
4661317|NCT02206828|7550347|FG000|Overall Study|Lost to Follow-up|7
4661318|NCT02207088|7550374|FG000|Overall Study|Adverse Event|2
4661319|NCT02207231|7550381|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2
4661320|NCT02207231|7550382|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4
4661321|NCT02207231|7550383|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2
4661322|NCT02207231|7550384|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
4661323|NCT02207231|7550381|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2
4661324|NCT02207231|7550382|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
4661325|NCT02207231|7550383|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1
4661326|NCT02207231|7550384|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
4661327|NCT02207231|7550381|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
4661328|NCT02207231|7550382|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
4661329|NCT02207231|7550383|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
4661330|NCT02207231|7550384|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
4661331|NCT02207231|7550381|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2
4661332|NCT02207231|7550382|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
4661333|NCT02207231|7550383|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4
4661334|NCT02207231|7550384|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
4661335|NCT02207231|7550381|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
4661336|NCT02207231|7550382|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
4661337|NCT02207231|7550383|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1
4661338|NCT02207231|7550384|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
4661339|NCT02207231|7550381|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0
4661340|NCT02207231|7550382|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2
4661341|NCT02207231|7550383|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1
4661342|NCT02207231|7550384|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0
4661343|NCT02207231|7550381|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1
4661344|NCT02207231|7550382|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6
4661345|NCT02207231|7550383|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10
4661346|NCT02207231|7550384|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0
4661347|NCT02207231|7550381|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0
4661348|NCT02207231|7550382|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0
4750691|NCT02711137|7724856|FG009|Overall Study|Death|1
4750692|NCT02711137|7724857|FG010|Overall Study|Death|1
4750693|NCT02711137|7724858|FG011|Overall Study|Death|1
4750694|NCT02711137|7724859|FG012|Overall Study|Death|0
4750695|NCT02711137|7724860|FG013|Overall Study|Death|0
4750696|NCT02711137|7724861|FG014|Overall Study|Death|0
4750697|NCT02711137|7724847|FG000|Overall Study|Study Terminated by Sponsor|0
4750698|NCT02711137|7724848|FG001|Overall Study|Study Terminated by Sponsor|0
4750699|NCT02711137|7724849|FG002|Overall Study|Study Terminated by Sponsor|1
4750700|NCT02711137|7724850|FG003|Overall Study|Study Terminated by Sponsor|0
4750701|NCT02711137|7724851|FG004|Overall Study|Study Terminated by Sponsor|0
4750702|NCT02711137|7724852|FG005|Overall Study|Study Terminated by Sponsor|0
4750703|NCT02711137|7724853|FG006|Overall Study|Study Terminated by Sponsor|1
4750704|NCT02711137|7724854|FG007|Overall Study|Study Terminated by Sponsor|0
4750705|NCT02711137|7724855|FG008|Overall Study|Study Terminated by Sponsor|0
4750706|NCT02711137|7724856|FG009|Overall Study|Study Terminated by Sponsor|0
4750707|NCT02711137|7724857|FG010|Overall Study|Study Terminated by Sponsor|0
4750708|NCT02711137|7724858|FG011|Overall Study|Study Terminated by Sponsor|0
4750709|NCT02711137|7724859|FG012|Overall Study|Study Terminated by Sponsor|0
4750710|NCT02711137|7724860|FG013|Overall Study|Study Terminated by Sponsor|0
4750711|NCT02711137|7724861|FG014|Overall Study|Study Terminated by Sponsor|0
4750712|NCT02711137|7724847|FG000|Overall Study|Physician Decision|1
4750713|NCT02711137|7724848|FG001|Overall Study|Physician Decision|0
4750714|NCT02711137|7724849|FG002|Overall Study|Physician Decision|2
4750715|NCT02711137|7724850|FG003|Overall Study|Physician Decision|1
4750716|NCT02711137|7724851|FG004|Overall Study|Physician Decision|1
4750717|NCT02711137|7724852|FG005|Overall Study|Physician Decision|0
4750718|NCT02711137|7724853|FG006|Overall Study|Physician Decision|12
4750719|NCT02711137|7724854|FG007|Overall Study|Physician Decision|2
4750720|NCT02711137|7724855|FG008|Overall Study|Physician Decision|1
4750721|NCT02711137|7724856|FG009|Overall Study|Physician Decision|1
4750722|NCT02711137|7724857|FG010|Overall Study|Physician Decision|3
4750723|NCT02711137|7724858|FG011|Overall Study|Physician Decision|2
4750724|NCT02711137|7724859|FG012|Overall Study|Physician Decision|1
4750725|NCT02711137|7724860|FG013|Overall Study|Physician Decision|1
4750726|NCT02711137|7724861|FG014|Overall Study|Physician Decision|2
4750727|NCT02711137|7724847|FG000|Overall Study|Other|0
4750728|NCT02711137|7724848|FG001|Overall Study|Other|1
4750729|NCT02711137|7724849|FG002|Overall Study|Other|0
4750730|NCT02711137|7724850|FG003|Overall Study|Other|0
4750731|NCT02711137|7724851|FG004|Overall Study|Other|0
4750732|NCT02711137|7724852|FG005|Overall Study|Other|0
4750733|NCT02711137|7724853|FG006|Overall Study|Other|3
4750734|NCT02711137|7724854|FG007|Overall Study|Other|0
4750735|NCT02711137|7724855|FG008|Overall Study|Other|0
4750736|NCT02711137|7724856|FG009|Overall Study|Other|0
4750737|NCT02711137|7724857|FG010|Overall Study|Other|0
4750738|NCT02711137|7724858|FG011|Overall Study|Other|0
4750739|NCT02711137|7724859|FG012|Overall Study|Other|0
4750740|NCT02711137|7724860|FG013|Overall Study|Other|0
4750741|NCT02711137|7724861|FG014|Overall Study|Other|1
4750742|NCT02711137|7724847|FG000|Overall Study|Withdrawal by Subject|1
4750743|NCT02711137|7724848|FG001|Overall Study|Withdrawal by Subject|0
4750744|NCT02711137|7724849|FG002|Overall Study|Withdrawal by Subject|0
4750745|NCT02711137|7724850|FG003|Overall Study|Withdrawal by Subject|1
4750746|NCT02711137|7724851|FG004|Overall Study|Withdrawal by Subject|1
4750747|NCT02711137|7724852|FG005|Overall Study|Withdrawal by Subject|0
4750748|NCT02711137|7724853|FG006|Overall Study|Withdrawal by Subject|7
4750749|NCT02711137|7724854|FG007|Overall Study|Withdrawal by Subject|0
4750750|NCT02711137|7724855|FG008|Overall Study|Withdrawal by Subject|0
4750751|NCT02711137|7724856|FG009|Overall Study|Withdrawal by Subject|0
4750752|NCT02711137|7724857|FG010|Overall Study|Withdrawal by Subject|0
4750753|NCT02711137|7724858|FG011|Overall Study|Withdrawal by Subject|0
4661349|NCT02207231|7550383|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1
4661350|NCT02207231|7550384|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0
4661351|NCT02207231|7550381|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0
4661352|NCT02207231|7550382|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3
4661353|NCT02207231|7550383|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11
4661354|NCT02207231|7550384|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0
4661355|NCT02207231|7550381|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1
4661356|NCT02207231|7550382|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2
4661357|NCT02207231|7550383|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5
4661358|NCT02207231|7550384|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0
4661359|NCT02207231|7550381|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1
4661360|NCT02207231|7550382|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4
4661361|NCT02207231|7550383|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10
4661362|NCT02207231|7550384|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0
4661363|NCT02207231|7550381|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0
4661364|NCT02207231|7550382|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1
4661365|NCT02207231|7550383|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0
4661366|NCT02207231|7550384|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0
4661367|NCT02207231|7550381|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0
4661368|NCT02207231|7550382|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3
4661369|NCT02207231|7550383|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3
4661370|NCT02207231|7550384|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0
4661371|NCT02207231|7550381|FG000|Active Controlled Period: Week 16 - 48|Other|0
4661372|NCT02207231|7550382|FG001|Active Controlled Period: Week 16 - 48|Other|2
4661373|NCT02207231|7550383|FG002|Active Controlled Period: Week 16 - 48|Other|3
4661374|NCT02207231|7550384|FG003|Active Controlled Period: Week 16 - 48|Other|0
4661375|NCT02207231|7550381|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0
4661376|NCT02207231|7550382|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0
4661377|NCT02207231|7550383|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12
4661378|NCT02207231|7550384|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19
4661379|NCT02207231|7550381|FG000|Open-label Guselkumab: Week 48 - 264|Death|0
4661380|NCT02207231|7550382|FG001|Open-label Guselkumab: Week 48 - 264|Death|0
4661381|NCT02207231|7550383|FG002|Open-label Guselkumab: Week 48 - 264|Death|1
4661382|NCT02207231|7550384|FG003|Open-label Guselkumab: Week 48 - 264|Death|3
4661383|NCT02207231|7550381|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0
4661384|NCT02207231|7550382|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0
4661385|NCT02207231|7550383|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3
4661386|NCT02207231|7550384|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7
4661387|NCT02207231|7550381|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0
4661388|NCT02207231|7550382|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0
4661389|NCT02207231|7550383|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2
4661390|NCT02207231|7550384|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4
4661391|NCT02207231|7550381|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0
4661392|NCT02207231|7550382|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0
4661393|NCT02207231|7550383|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6
4661394|NCT02207231|7550384|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11
4661395|NCT02207231|7550381|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0
4661396|NCT02207231|7550382|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0
4661397|NCT02207231|7550383|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10
4661398|NCT02207231|7550384|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28
4661399|NCT02207231|7550381|FG000|Open-label Guselkumab: Week 48 - 264|Other|0
4661400|NCT02207231|7550382|FG001|Open-label Guselkumab: Week 48 - 264|Other|0
4661401|NCT02207231|7550383|FG002|Open-label Guselkumab: Week 48 - 264|Other|4
4661402|NCT02207231|7550384|FG003|Open-label Guselkumab: Week 48 - 264|Other|11
4661403|NCT02207244|7550405|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2
4661404|NCT02207244|7550406|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9
4661405|NCT02207244|7550407|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4
4661406|NCT02207244|7550408|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0
4661407|NCT02207244|7550409|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0
4661408|NCT02207244|7550410|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0
4661409|NCT02207244|7550411|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0
4661410|NCT02207244|7550412|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0
4661411|NCT02207244|7550413|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0
4661412|NCT02207244|7550414|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0
4661413|NCT02207244|7550415|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0
4661414|NCT02207244|7550405|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4
4661415|NCT02207244|7550406|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
4661416|NCT02207244|7550407|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2
4661417|NCT02207244|7550408|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
4661418|NCT02207244|7550409|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
4750754|NCT02711137|7724859|FG012|Overall Study|Withdrawal by Subject|0
4750755|NCT02711137|7724860|FG013|Overall Study|Withdrawal by Subject|1
4750756|NCT02711137|7724861|FG014|Overall Study|Withdrawal by Subject|0
4750757|NCT02711137|7724847|FG000|Overall Study|Lost to Follow-up|1
4750758|NCT02711137|7724848|FG001|Overall Study|Lost to Follow-up|0
4750759|NCT02711137|7724849|FG002|Overall Study|Lost to Follow-up|0
4750760|NCT02711137|7724850|FG003|Overall Study|Lost to Follow-up|0
4750761|NCT02711137|7724851|FG004|Overall Study|Lost to Follow-up|0
4750762|NCT02711137|7724852|FG005|Overall Study|Lost to Follow-up|0
4750763|NCT02711137|7724853|FG006|Overall Study|Lost to Follow-up|2
4750764|NCT02711137|7724854|FG007|Overall Study|Lost to Follow-up|0
4750765|NCT02711137|7724855|FG008|Overall Study|Lost to Follow-up|0
4750766|NCT02711137|7724856|FG009|Overall Study|Lost to Follow-up|0
4750767|NCT02711137|7724857|FG010|Overall Study|Lost to Follow-up|0
4750768|NCT02711137|7724858|FG011|Overall Study|Lost to Follow-up|0
4750769|NCT02711137|7724859|FG012|Overall Study|Lost to Follow-up|0
4750770|NCT02711137|7724860|FG013|Overall Study|Lost to Follow-up|0
4750771|NCT02711137|7724861|FG014|Overall Study|Lost to Follow-up|0
4750772|NCT02630459|7724902|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
4750773|NCT02630459|7724903|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1
4750774|NCT02630459|7724904|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
4750775|NCT02630459|7724905|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2
4750776|NCT02630459|7724906|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
4750777|NCT02630459|7724907|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
4750778|NCT02630459|7724908|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
4661419|NCT02207244|7550410|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
4661420|NCT02207244|7550411|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
4661421|NCT02207244|7550412|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
4661422|NCT02207244|7550413|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
4661423|NCT02207244|7550414|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
4661424|NCT02207244|7550415|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0
4661425|NCT02207244|7550405|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1
4661426|NCT02207244|7550406|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3
4661427|NCT02207244|7550407|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2
4661428|NCT02207244|7550408|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0
4661429|NCT02207244|7550409|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0
4661430|NCT02207244|7550410|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0
4661431|NCT02207244|7550411|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0
4661432|NCT02207244|7550412|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0
4661433|NCT02207244|7550413|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0
4661434|NCT02207244|7550414|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0
4661435|NCT02207244|7550415|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0
4661436|NCT02207244|7550405|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7
4661437|NCT02207244|7550406|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1
4661438|NCT02207244|7550407|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
4661439|NCT02207244|7550408|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
4661440|NCT02207244|7550409|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
4661441|NCT02207244|7550410|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
4661442|NCT02207244|7550411|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
4661443|NCT02207244|7550412|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
4661444|NCT02207244|7550413|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
4661445|NCT02207244|7550414|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
4661446|NCT02207244|7550415|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0
4661447|NCT02207244|7550405|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1
4661448|NCT02207244|7550406|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3
4661449|NCT02207244|7550407|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1
4661450|NCT02207244|7550408|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0
4661451|NCT02207244|7550409|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0
4661452|NCT02207244|7550410|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0
4661453|NCT02207244|7550411|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0
4661454|NCT02207244|7550412|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0
4661455|NCT02207244|7550413|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0
4661456|NCT02207244|7550414|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0
4661457|NCT02207244|7550415|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0
4661458|NCT02207244|7550405|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0
4661459|NCT02207244|7550406|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1
4661460|NCT02207244|7550407|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2
4661461|NCT02207244|7550408|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0
4661462|NCT02207244|7550409|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0
4661463|NCT02207244|7550410|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0
4661464|NCT02207244|7550411|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0
4661465|NCT02207244|7550412|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0
4661466|NCT02207244|7550413|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0
4661467|NCT02207244|7550414|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0
4661468|NCT02207244|7550415|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0
4661469|NCT02207244|7550405|FG000|Placebo Controlled Period: Week 0-16|OTHER|0
4661470|NCT02207244|7550406|FG001|Placebo Controlled Period: Week 0-16|OTHER|1
4661471|NCT02207244|7550407|FG002|Placebo Controlled Period: Week 0-16|OTHER|0
4661472|NCT02207244|7550408|FG003|Placebo Controlled Period: Week 0-16|OTHER|0
4661473|NCT02207244|7550409|FG004|Placebo Controlled Period: Week 0-16|OTHER|0
4661474|NCT02207244|7550410|FG005|Placebo Controlled Period: Week 0-16|OTHER|0
4661475|NCT02207244|7550411|FG006|Placebo Controlled Period: Week 0-16|OTHER|0
4661476|NCT02207244|7550412|FG007|Placebo Controlled Period: Week 0-16|OTHER|0
4661477|NCT02207244|7550413|FG008|Placebo Controlled Period: Week 0-16|OTHER|0
4661478|NCT02207244|7550414|FG009|Placebo Controlled Period: Week 0-16|OTHER|0
4661479|NCT02207244|7550415|FG010|Placebo Controlled Period: Week 0-16|OTHER|0
4661480|NCT02207244|7550405|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
4661481|NCT02207244|7550406|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
4661482|NCT02207244|7550407|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
4661483|NCT02207244|7550408|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
4661484|NCT02207244|7550409|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3
4661485|NCT02207244|7550410|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2
4661486|NCT02207244|7550411|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
4661487|NCT02207244|7550412|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
4661488|NCT02207244|7550413|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
4661489|NCT02207244|7550414|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
4661490|NCT02207244|7550415|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0
4661491|NCT02207244|7550405|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
4661492|NCT02207244|7550406|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
4661493|NCT02207244|7550407|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
4661494|NCT02207244|7550408|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
4661495|NCT02207244|7550409|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
4661496|NCT02207244|7550410|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2
4661497|NCT02207244|7550411|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
4661498|NCT02207244|7550412|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
4661499|NCT02207244|7550413|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
4661500|NCT02207244|7550414|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
4661501|NCT02207244|7550415|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0
4661502|NCT02207244|7550405|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0
4661503|NCT02207244|7550406|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0
4661504|NCT02207244|7550407|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0
4661505|NCT02207244|7550408|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1
4661506|NCT02207244|7550409|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2
4661507|NCT02207244|7550410|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2
4661508|NCT02207244|7550411|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0
4661509|NCT02207244|7550412|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0
4661510|NCT02207244|7550413|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0
4661511|NCT02207244|7550414|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0
4661512|NCT02207244|7550415|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0
4661513|NCT02207244|7550405|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0
4661514|NCT02207244|7550406|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0
4661515|NCT02207244|7550407|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0
4661516|NCT02207244|7550408|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3
4661517|NCT02207244|7550409|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3
4661518|NCT02207244|7550410|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2
4661519|NCT02207244|7550411|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0
4661520|NCT02207244|7550412|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0
4661521|NCT02207244|7550413|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0
4661522|NCT02207244|7550414|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0
4661523|NCT02207244|7550415|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0
4661524|NCT02207244|7550405|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
4661525|NCT02207244|7550406|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
4661526|NCT02207244|7550407|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
4661527|NCT02207244|7550408|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1
4661528|NCT02207244|7550409|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
4661529|NCT02207244|7550410|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1
4661530|NCT02207244|7550411|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
4661531|NCT02207244|7550412|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
4661532|NCT02207244|7550413|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
4661533|NCT02207244|7550414|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
4661534|NCT02207244|7550415|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0
4661535|NCT02207244|7550405|FG000|Placebo Crossover and ACP: Week 16-28|Other|0
4661536|NCT02207244|7550406|FG001|Placebo Crossover and ACP: Week 16-28|Other|0
4661537|NCT02207244|7550407|FG002|Placebo Crossover and ACP: Week 16-28|Other|0
4661538|NCT02207244|7550408|FG003|Placebo Crossover and ACP: Week 16-28|Other|1
4661539|NCT02207244|7550409|FG004|Placebo Crossover and ACP: Week 16-28|Other|0
4661540|NCT02207244|7550410|FG005|Placebo Crossover and ACP: Week 16-28|Other|0
4661541|NCT02207244|7550411|FG006|Placebo Crossover and ACP: Week 16-28|Other|0
4661542|NCT02207244|7550412|FG007|Placebo Crossover and ACP: Week 16-28|Other|0
4661543|NCT02207244|7550413|FG008|Placebo Crossover and ACP: Week 16-28|Other|0
4661544|NCT02207244|7550414|FG009|Placebo Crossover and ACP: Week 16-28|Other|0
4661545|NCT02207244|7550415|FG010|Placebo Crossover and ACP: Week 16-28|Other|0
4661546|NCT02207244|7550405|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0
4661547|NCT02207244|7550406|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0
4661548|NCT02207244|7550407|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0
4661549|NCT02207244|7550408|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0
4661550|NCT02207244|7550409|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0
4661551|NCT02207244|7550410|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0
4661552|NCT02207244|7550411|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1
4661553|NCT02207244|7550412|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5
4661554|NCT02207244|7550413|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3
4661555|NCT02207244|7550414|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2
4661556|NCT02207244|7550415|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0
4661557|NCT02207244|7550405|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
4661558|NCT02207244|7550406|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
4661559|NCT02207244|7550407|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
4661560|NCT02207244|7550408|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
4661561|NCT02207244|7550409|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
4661562|NCT02207244|7550410|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
4661563|NCT02207244|7550411|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
4661564|NCT02207244|7550412|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2
4661565|NCT02207244|7550413|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
4661566|NCT02207244|7550414|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
4661567|NCT02207244|7550415|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0
4661568|NCT02207244|7550405|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0
4661569|NCT02207244|7550406|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0
4661570|NCT02207244|7550407|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0
4661571|NCT02207244|7550408|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0
4661572|NCT02207244|7550409|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0
4661573|NCT02207244|7550410|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0
4661574|NCT02207244|7550411|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1
4661575|NCT02207244|7550412|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3
4661576|NCT02207244|7550413|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2
4661577|NCT02207244|7550414|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2
4661578|NCT02207244|7550415|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0
4661579|NCT02207244|7550405|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0
4661580|NCT02207244|7550406|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0
4661581|NCT02207244|7550407|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0
4661582|NCT02207244|7550408|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0
4661583|NCT02207244|7550409|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0
4661584|NCT02207244|7550410|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0
4661585|NCT02207244|7550411|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2
4661586|NCT02207244|7550412|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7
4661587|NCT02207244|7550413|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0
4661588|NCT02207244|7550414|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2
4661589|NCT02207244|7550415|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0
4661590|NCT02207244|7550405|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0
4661591|NCT02207244|7550406|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0
4661592|NCT02207244|7550407|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0
4661593|NCT02207244|7550408|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0
4661594|NCT02207244|7550409|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0
4661595|NCT02207244|7550410|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0
4661596|NCT02207244|7550411|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2
4661597|NCT02207244|7550412|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7
4661598|NCT02207244|7550413|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2
4661599|NCT02207244|7550414|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2
4661600|NCT02207244|7550415|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0
4661601|NCT02207244|7550405|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
4661602|NCT02207244|7550406|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
4661603|NCT02207244|7550407|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
4661604|NCT02207244|7550408|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
4661605|NCT02207244|7550409|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
4661606|NCT02207244|7550410|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
4661607|NCT02207244|7550411|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
4661608|NCT02207244|7550412|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1
4661609|NCT02207244|7550413|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1
4661610|NCT02207244|7550414|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
4661611|NCT02207244|7550415|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0
4661612|NCT02207244|7550405|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
4661613|NCT02207244|7550406|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
4661614|NCT02207244|7550407|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
4661615|NCT02207244|7550408|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
4661616|NCT02207244|7550409|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
4661617|NCT02207244|7550410|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
4661618|NCT02207244|7550411|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
4661619|NCT02207244|7550412|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
4661620|NCT02207244|7550413|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1
4661621|NCT02207244|7550414|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
4750779|NCT02630459|7724909|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0
4750780|NCT02630459|7724902|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
4750781|NCT02630459|7724903|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
4750782|NCT02630459|7724904|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1
4750783|NCT02630459|7724905|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
4750784|NCT02630459|7724906|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
4750785|NCT02630459|7724907|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
4750786|NCT02630459|7724908|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
4661622|NCT02207244|7550415|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0
4661623|NCT02207244|7550405|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0
4661624|NCT02207244|7550406|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0
4661625|NCT02207244|7550407|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0
4661626|NCT02207244|7550408|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0
4661627|NCT02207244|7550409|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0
4661628|NCT02207244|7550410|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0
4661629|NCT02207244|7550411|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0
4661630|NCT02207244|7550412|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2
4661631|NCT02207244|7550413|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0
4661632|NCT02207244|7550414|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0
4661633|NCT02207244|7550415|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0
4661634|NCT02207244|7550405|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
4661635|NCT02207244|7550406|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
4661636|NCT02207244|7550407|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
4661637|NCT02207244|7550408|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
4661638|NCT02207244|7550409|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
4661639|NCT02207244|7550410|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
4661640|NCT02207244|7550411|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8
4661641|NCT02207244|7550412|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
4661642|NCT02207244|7550413|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
4661643|NCT02207244|7550414|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
4661644|NCT02207244|7550415|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0
4661645|NCT02207244|7550405|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
4661646|NCT02207244|7550406|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
4661647|NCT02207244|7550407|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
4661648|NCT02207244|7550408|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
4661649|NCT02207244|7550409|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
4661650|NCT02207244|7550410|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
4661651|NCT02207244|7550411|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
4661652|NCT02207244|7550412|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
4661653|NCT02207244|7550413|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10
4661654|NCT02207244|7550414|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0
4661655|NCT02207244|7550415|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30
4661656|NCT02207244|7550405|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
4661657|NCT02207244|7550406|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
4661658|NCT02207244|7550407|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
4661659|NCT02207244|7550408|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
4661660|NCT02207244|7550409|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
4661661|NCT02207244|7550410|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
4661662|NCT02207244|7550411|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
4661663|NCT02207244|7550412|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
4661664|NCT02207244|7550413|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2
4661665|NCT02207244|7550414|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0
4661666|NCT02207244|7550415|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3
4661667|NCT02207244|7550405|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
4661668|NCT02207244|7550406|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
4661669|NCT02207244|7550407|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
4661670|NCT02207244|7550408|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
4661671|NCT02207244|7550409|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
4661672|NCT02207244|7550410|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
4661673|NCT02207244|7550411|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
4661674|NCT02207244|7550412|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
4661675|NCT02207244|7550413|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5
4661676|NCT02207244|7550414|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0
4661677|NCT02207244|7550415|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26
4661678|NCT02207244|7550405|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0
4661679|NCT02207244|7550406|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0
4661680|NCT02207244|7550407|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0
4750787|NCT02630459|7724909|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0
4750788|NCT02630459|7724902|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2
4750789|NCT02630459|7724903|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1
4750790|NCT02630459|7724904|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4
4750791|NCT02630459|7724905|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1
4750792|NCT02630459|7724906|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0
4750793|NCT02630459|7724907|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0
4750794|NCT02630459|7724908|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0
4750795|NCT02630459|7724909|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0
4750796|NCT02630459|7724902|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1
4750797|NCT02630459|7724903|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
4750798|NCT02630459|7724904|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
4750799|NCT02630459|7724905|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
4750800|NCT02630459|7724906|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
4750801|NCT02630459|7724907|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
4750802|NCT02630459|7724908|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
4750803|NCT02630459|7724909|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0
4750804|NCT02630459|7724902|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
4750805|NCT02630459|7724903|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
4750806|NCT02630459|7724904|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
4750807|NCT02630459|7724905|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
4750808|NCT02630459|7724906|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4
4750809|NCT02630459|7724907|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1
4750810|NCT02630459|7724908|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
4750811|NCT02630459|7724909|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0
4750812|NCT02630459|7724902|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0
4750813|NCT02630459|7724903|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0
4750814|NCT02630459|7724904|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0
4750815|NCT02630459|7724905|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0
4750816|NCT02630459|7724906|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24
4750817|NCT02630459|7724907|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3
4750818|NCT02630459|7724908|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0
4750819|NCT02630459|7724909|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0
4750820|NCT02630459|7724902|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
4750821|NCT02630459|7724903|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
4750822|NCT02630459|7724904|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
4750823|NCT02630459|7724905|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
4750824|NCT02630459|7724906|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1
4750825|NCT02630459|7724907|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
4750826|NCT02630459|7724908|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
4750827|NCT02630459|7724909|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0
4750828|NCT02545868|7724959|FG000|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|33
4750829|NCT02545868|7724960|FG001|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|35
4750830|NCT02545868|7724961|FG002|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|34
4750831|NCT02470091|7724976|FG000|Overall Study|Withdrawal by Subject|1
4750832|NCT02470091|7724977|FG001|Overall Study|Withdrawal by Subject|0
4661681|NCT02207244|7550408|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0
4661682|NCT02207244|7550409|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0
4661683|NCT02207244|7550410|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0
4661684|NCT02207244|7550411|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0
4661685|NCT02207244|7550412|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0
4661686|NCT02207244|7550413|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12
4661687|NCT02207244|7550414|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0
4661688|NCT02207244|7550415|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21
4661689|NCT02207244|7550405|FG000|Open-label Guselkumab: Week 72-264|Death|0
4661690|NCT02207244|7550406|FG001|Open-label Guselkumab: Week 72-264|Death|0
4661691|NCT02207244|7550407|FG002|Open-label Guselkumab: Week 72-264|Death|0
4661692|NCT02207244|7550408|FG003|Open-label Guselkumab: Week 72-264|Death|0
4661693|NCT02207244|7550409|FG004|Open-label Guselkumab: Week 72-264|Death|0
4661694|NCT02207244|7550410|FG005|Open-label Guselkumab: Week 72-264|Death|0
4661695|NCT02207244|7550411|FG006|Open-label Guselkumab: Week 72-264|Death|0
4661696|NCT02207244|7550412|FG007|Open-label Guselkumab: Week 72-264|Death|0
4661697|NCT02207244|7550413|FG008|Open-label Guselkumab: Week 72-264|Death|1
4661698|NCT02207244|7550414|FG009|Open-label Guselkumab: Week 72-264|Death|0
4661699|NCT02207244|7550415|FG010|Open-label Guselkumab: Week 72-264|Death|1
4661700|NCT02207244|7550405|FG000|Open-label Guselkumab: Week 72-264|Other|0
4661701|NCT02207244|7550406|FG001|Open-label Guselkumab: Week 72-264|Other|0
4661702|NCT02207244|7550407|FG002|Open-label Guselkumab: Week 72-264|Other|0
4750833|NCT02470091|7724976|FG000|Overall Study|Ineligible|0
4750834|NCT02470091|7724977|FG001|Overall Study|Ineligible|2
4750835|NCT02440425|7724985|FG000|Overall Study|Death likely due to disease progression|1
4750836|NCT02440425|7724985|FG000|Overall Study|Withdrawal by Subject|2
4750837|NCT02440425|7724985|FG000|Overall Study|Adverse Event|1
4750838|NCT02440425|7724985|FG000|Overall Study|Adverse Event/Ineligible|1
4750839|NCT02343120|7724994|FG000|Part 1: Dose Escalation|Sponsor decision|1
4750840|NCT02343120|7724995|FG001|Part 1: Dose Escalation|Sponsor decision|2
4750841|NCT02343120|7724996|FG002|Part 1: Dose Escalation|Sponsor decision|3
4750842|NCT02343120|7724997|FG003|Part 1: Dose Escalation|Sponsor decision|2
4750843|NCT02343120|7724998|FG004|Part 1: Dose Escalation|Sponsor decision|0
4750844|NCT02343120|7724994|FG000|Part 1: Dose Escalation|Death|1
4750845|NCT02343120|7724995|FG001|Part 1: Dose Escalation|Death|2
4750846|NCT02343120|7724996|FG002|Part 1: Dose Escalation|Death|2
4750847|NCT02343120|7724997|FG003|Part 1: Dose Escalation|Death|2
4750848|NCT02343120|7724998|FG004|Part 1: Dose Escalation|Death|1
4750849|NCT02343120|7724994|FG000|Part 1: Dose Escalation|Lost to Follow-up|1
4750850|NCT02343120|7724995|FG001|Part 1: Dose Escalation|Lost to Follow-up|0
4750851|NCT02343120|7724996|FG002|Part 1: Dose Escalation|Lost to Follow-up|0
4750852|NCT02343120|7724997|FG003|Part 1: Dose Escalation|Lost to Follow-up|0
4661703|NCT02207244|7550408|FG003|Open-label Guselkumab: Week 72-264|Other|0
4661704|NCT02207244|7550409|FG004|Open-label Guselkumab: Week 72-264|Other|0
4661705|NCT02207244|7550410|FG005|Open-label Guselkumab: Week 72-264|Other|0
4661706|NCT02207244|7550411|FG006|Open-label Guselkumab: Week 72-264|Other|0
4661707|NCT02207244|7550412|FG007|Open-label Guselkumab: Week 72-264|Other|0
4661708|NCT02207244|7550413|FG008|Open-label Guselkumab: Week 72-264|Other|8
4661709|NCT02207244|7550414|FG009|Open-label Guselkumab: Week 72-264|Other|0
4661710|NCT02207244|7550415|FG010|Open-label Guselkumab: Week 72-264|Other|19
4661711|NCT02207244|7550405|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0
4661712|NCT02207244|7550406|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0
4661713|NCT02207244|7550407|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0
4661714|NCT02207244|7550408|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0
4661715|NCT02207244|7550409|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0
4661716|NCT02207244|7550410|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0
4661717|NCT02207244|7550411|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0
4661718|NCT02207244|7550412|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0
4661719|NCT02207244|7550413|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0
4661720|NCT02207244|7550414|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0
4661721|NCT02207244|7550415|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2
4661722|NCT02207374|7550456|FG000|Overall Study|Withdrawal by Subject|5
4661723|NCT02207374|7550457|FG001|Overall Study|Withdrawal by Subject|9
4661724|NCT02207374|7550458|FG002|Overall Study|Withdrawal by Subject|4
4661725|NCT02207374|7550456|FG000|Overall Study|Death|1
4661726|NCT02207374|7550457|FG001|Overall Study|Death|0
4661727|NCT02207374|7550458|FG002|Overall Study|Death|1
4661728|NCT02207374|7550456|FG000|Overall Study|Missing follow-up information|0
4661729|NCT02207374|7550457|FG001|Overall Study|Missing follow-up information|1
4661730|NCT02207374|7550458|FG002|Overall Study|Missing follow-up information|1
4661731|NCT02207400|7550468|FG000|Overall Study|Adverse Event|1
4661732|NCT02207400|7550469|FG001|Overall Study|Adverse Event|1
4661733|NCT02207400|7550468|FG000|Overall Study|Lost to Follow-up|6
4661734|NCT02207400|7550469|FG001|Overall Study|Lost to Follow-up|7
4661735|NCT02207400|7550468|FG000|Overall Study|Protocol Violation|1
4661736|NCT02207400|7550469|FG001|Overall Study|Protocol Violation|1
4661737|NCT02207400|7550468|FG000|Overall Study|Withdrawal by Subject|8
4750853|NCT02343120|7724998|FG004|Part 1: Dose Escalation|Lost to Follow-up|0
4750854|NCT02343120|7724994|FG000|Part 2: Expansion|Sponsor decision|0
4750855|NCT02343120|7724995|FG001|Part 2: Expansion|Sponsor decision|0
4750856|NCT02343120|7724996|FG002|Part 2: Expansion|Sponsor decision|0
4661738|NCT02207400|7550469|FG001|Overall Study|Withdrawal by Subject|4
4661739|NCT02207400|7550468|FG000|Overall Study|Positive Urine Pregnancy Test|0
4661740|NCT02207400|7550469|FG001|Overall Study|Positive Urine Pregnancy Test|1
4661741|NCT02207413|7550484|FG000|Overall Study|Withdrawal by Subject|1
4661742|NCT02207413|7550485|FG001|Overall Study|Withdrawal by Subject|0
4661743|NCT02207413|7550486|FG002|Overall Study|Withdrawal by Subject|0
4661744|NCT02207413|7550487|FG003|Overall Study|Withdrawal by Subject|0
4661745|NCT02207413|7550488|FG004|Overall Study|Withdrawal by Subject|3
4661746|NCT02207413|7550489|FG005|Overall Study|Withdrawal by Subject|7
4661747|NCT02207413|7550484|FG000|Overall Study|Lost to Follow-up|0
4661748|NCT02207413|7550485|FG001|Overall Study|Lost to Follow-up|0
4661749|NCT02207413|7550486|FG002|Overall Study|Lost to Follow-up|0
4661750|NCT02207413|7550487|FG003|Overall Study|Lost to Follow-up|1
4661751|NCT02207413|7550488|FG004|Overall Study|Lost to Follow-up|1
4661752|NCT02207413|7550489|FG005|Overall Study|Lost to Follow-up|5
4661753|NCT02207413|7550484|FG000|Overall Study|Adverse Event|0
4661754|NCT02207413|7550485|FG001|Overall Study|Adverse Event|0
4661755|NCT02207413|7550486|FG002|Overall Study|Adverse Event|0
4661756|NCT02207413|7550487|FG003|Overall Study|Adverse Event|0
4661757|NCT02207413|7550488|FG004|Overall Study|Adverse Event|2
4661758|NCT02207413|7550489|FG005|Overall Study|Adverse Event|1
4661759|NCT02207413|7550484|FG000|Overall Study|Migrated/moved from study area|0
4661760|NCT02207413|7550485|FG001|Overall Study|Migrated/moved from study area|0
4661761|NCT02207413|7550486|FG002|Overall Study|Migrated/moved from study area|0
4661762|NCT02207413|7550487|FG003|Overall Study|Migrated/moved from study area|0
4661763|NCT02207413|7550488|FG004|Overall Study|Migrated/moved from study area|1
4661764|NCT02207413|7550489|FG005|Overall Study|Migrated/moved from study area|0
4661765|NCT02207491|7550520|FG000|Overall Study|Adverse Event|20
4661766|NCT02207491|7550521|FG001|Overall Study|Adverse Event|4
4661767|NCT02207491|7550520|FG000|Overall Study|Withdrawal by Subject|3
4661768|NCT02207491|7550521|FG001|Overall Study|Withdrawal by Subject|2
4661769|NCT02207491|7550520|FG000|Overall Study|Non-compliant|0
4661770|NCT02207491|7550521|FG001|Overall Study|Non-compliant|1
4661771|NCT02207491|7550520|FG000|Overall Study|Lost to Follow-up|0
4661772|NCT02207491|7550521|FG001|Overall Study|Lost to Follow-up|1
4661773|NCT02207491|7550520|FG000|Overall Study|Lack of Efficacy|3
4661774|NCT02207491|7550521|FG001|Overall Study|Lack of Efficacy|0
4661775|NCT02207491|7550520|FG000|Overall Study|Physician Decision|2
4661776|NCT02207491|7550521|FG001|Overall Study|Physician Decision|0
4661777|NCT02207491|7550520|FG000|Overall Study|Protocol Violation|3
4661778|NCT02207491|7550521|FG001|Overall Study|Protocol Violation|5
4661779|NCT02207530|7550527|FG000|Overall Study|Worsening condition under investigation|78
4661780|NCT02207530|7550527|FG000|Overall Study|Patient decision to stop study treatment|5
4661781|NCT02207530|7550527|FG000|Overall Study|Adverse Event|8
4661782|NCT02207556|7550533|FG000|Overall Study|Physician Decision|1
4661783|NCT02207556|7550534|FG001|Overall Study|Physician Decision|0
4661784|NCT02207556|7550533|FG000|Overall Study|Withdrawal by Subject|1
4661785|NCT02207556|7550534|FG001|Overall Study|Withdrawal by Subject|0
4661786|NCT02207556|7550533|FG000|Overall Study|Death|0
4661787|NCT02207556|7550534|FG001|Overall Study|Death|5
4661788|NCT02207569|7550543|FG000|Implant to 1-Month|Death|6
4661789|NCT02207569|7550543|FG000|Implant to 1-Month|Withdrawal by Subject|2
4661790|NCT02207569|7550543|FG000|Implant to 1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1
4661791|NCT02207569|7550543|FG000|1-Month to 6-Month|Death|8
4661792|NCT02207569|7550543|FG000|1-Month to 6-Month|Withdrawal by Subject|2
4661793|NCT02207569|7550543|FG000|12-Month|Death|8
4661794|NCT02207569|7550543|FG000|12-Month|Withdrawal by Subject|1
4661795|NCT02207569|7550543|FG000|6-Month to 12-Month|Death|14
4661796|NCT02207569|7550543|FG000|6-Month to 12-Month|Withdrawal by Subject|2
4661797|NCT02207569|7550543|FG000|12-Month to 24 Month|Death|23
4661798|NCT02207569|7550543|FG000|12-Month to 24 Month|Withdrawal by Subject|3
4661799|NCT02207569|7550543|FG000|24-Month to 36-Month|Death|23
4661800|NCT02207569|7550543|FG000|24-Month to 36-Month|Withdrawal by Subject|4
4661801|NCT02207569|7550543|FG000|36-Month to 48-Month|Death|25
4661802|NCT02207569|7550543|FG000|36-Month to 48-Month|Withdrawal by Subject|2
4661803|NCT02207569|7550543|FG000|36-Month to 48-Month|Lost to Follow-up|4
4661804|NCT02207569|7550543|FG000|48-Month to 60-Month|Death|1
4661805|NCT02207569|7550543|FG000|48-Month to 60-Month|Lost to Follow-up|1
4661806|NCT02207569|7550543|FG000|48-Month to 60-Month|pt 103 years old no longer traveling for MD visits|1
4661807|NCT02207569|7550543|FG000|48-Month to 60-Month|Covid-19 pt not willing to be seen|1
4661808|NCT02207608|7550549|FG000|Overall Study|Adverse Event|1
4661809|NCT02207608|7550550|FG001|Overall Study|Adverse Event|0
4661810|NCT02207621|7550559|FG000|Overall Study|Adverse Event|71
4661811|NCT02207621|7550560|FG001|Overall Study|Adverse Event|15
4661812|NCT02207621|7550561|FG002|Overall Study|Adverse Event|132
4661813|NCT02207621|7550559|FG000|Overall Study|Withdrawal by Subject|9
4661814|NCT02207621|7550560|FG001|Overall Study|Withdrawal by Subject|9
4661815|NCT02207621|7550561|FG002|Overall Study|Withdrawal by Subject|13
4661816|NCT02207621|7550559|FG000|Overall Study|Non-Compliant|3
4661817|NCT02207621|7550560|FG001|Overall Study|Non-Compliant|3
4661818|NCT02207621|7550561|FG002|Overall Study|Non-Compliant|1
4661819|NCT02207621|7550559|FG000|Overall Study|Lost to Follow-up|1
4661820|NCT02207621|7550560|FG001|Overall Study|Lost to Follow-up|0
4661821|NCT02207621|7550561|FG002|Overall Study|Lost to Follow-up|3
4661822|NCT02207621|7550559|FG000|Overall Study|Lack of Efficacy|10
4661823|NCT02207621|7550560|FG001|Overall Study|Lack of Efficacy|2
4661824|NCT02207621|7550561|FG002|Overall Study|Lack of Efficacy|4
4661825|NCT02207621|7550559|FG000|Overall Study|Disallowed Concurrent Medication|2
4661826|NCT02207621|7550560|FG001|Overall Study|Disallowed Concurrent Medication|5
4661827|NCT02207621|7550561|FG002|Overall Study|Disallowed Concurrent Medication|2
4661828|NCT02207621|7550559|FG000|Overall Study|Physician Decision|1
4661829|NCT02207621|7550560|FG001|Overall Study|Physician Decision|2
4661830|NCT02207621|7550561|FG002|Overall Study|Physician Decision|2
4661831|NCT02207621|7550559|FG000|Overall Study|Protocol Violation|4
4661832|NCT02207621|7550560|FG001|Overall Study|Protocol Violation|10
4661833|NCT02207621|7550561|FG002|Overall Study|Protocol Violation|6
4661834|NCT02207621|7550559|FG000|Overall Study|Death|2
4661835|NCT02207621|7550560|FG001|Overall Study|Death|0
4661836|NCT02207621|7550561|FG002|Overall Study|Death|0
4661837|NCT02207621|7550559|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2
4661838|NCT02207621|7550560|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1
4661839|NCT02207621|7550561|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5
4661840|NCT02207634|7550572|FG000|Overall Study|Withdrawal by Subject|21
4661841|NCT02207634|7550573|FG001|Overall Study|Withdrawal by Subject|31
4661842|NCT02207634|7550572|FG000|Overall Study|Lost to Follow-up|1
4661843|NCT02207634|7550573|FG001|Overall Study|Lost to Follow-up|0
4661844|NCT02207725|7550583|FG000|Overall Study|Did Not Receive Treatment|0
4661845|NCT02207725|7550584|FG001|Overall Study|Did Not Receive Treatment|1
4661846|NCT02207725|7550585|FG002|Overall Study|Did Not Receive Treatment|1
4661847|NCT02207725|7550586|FG003|Overall Study|Did Not Receive Treatment|1
4661848|NCT02207816|7550610|FG000|Overall Study|Serious Adverse Event|0
4661849|NCT02207816|7550611|FG001|Overall Study|Serious Adverse Event|5
4661850|NCT02207816|7550612|FG002|Overall Study|Serious Adverse Event|2
4661851|NCT02207816|7550610|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2
4661852|NCT02207816|7550611|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1
4661853|NCT02207816|7550612|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2
4661854|NCT02207816|7550610|FG000|Overall Study|Withdrawal by Subject|4
4661855|NCT02207816|7550611|FG001|Overall Study|Withdrawal by Subject|9
4661856|NCT02207816|7550612|FG002|Overall Study|Withdrawal by Subject|7
4661857|NCT02207816|7550610|FG000|Overall Study|Migrated/Moved From Study Area|41
4661858|NCT02207816|7550611|FG001|Overall Study|Migrated/Moved From Study Area|60
4661859|NCT02207816|7550612|FG002|Overall Study|Migrated/Moved From Study Area|51
4661860|NCT02207816|7550610|FG000|Overall Study|Lost to Follow-up|3
4661861|NCT02207816|7550611|FG001|Overall Study|Lost to Follow-up|9
4661862|NCT02207816|7550612|FG002|Overall Study|Lost to Follow-up|1
4661863|NCT02207816|7550610|FG000|Overall Study|Other|1
4661864|NCT02207816|7550611|FG001|Overall Study|Other|2
4661865|NCT02207816|7550612|FG002|Overall Study|Other|4
4661866|NCT02207829|7550625|FG000|Overall Study|Adverse Event|10
4661867|NCT02207829|7550626|FG001|Overall Study|Adverse Event|9
4661868|NCT02207829|7550625|FG000|Overall Study|Lack of Efficacy|7
4661869|NCT02207829|7550626|FG001|Overall Study|Lack of Efficacy|5
4661870|NCT02207829|7550625|FG000|Overall Study|Lost to Follow-up|2
4750857|NCT02343120|7724997|FG003|Part 2: Expansion|Sponsor decision|165
4750858|NCT02343120|7724998|FG004|Part 2: Expansion|Sponsor decision|67
4750859|NCT02343120|7724994|FG000|Part 2: Expansion|Death|0
4750860|NCT02343120|7724995|FG001|Part 2: Expansion|Death|0
4750861|NCT02343120|7724996|FG002|Part 2: Expansion|Death|0
4750862|NCT02343120|7724997|FG003|Part 2: Expansion|Death|74
4750863|NCT02343120|7724998|FG004|Part 2: Expansion|Death|17
4750864|NCT02343120|7724994|FG000|Part 2: Expansion|Withdrawal by Subject|0
4750865|NCT02343120|7724995|FG001|Part 2: Expansion|Withdrawal by Subject|0
4750866|NCT02343120|7724996|FG002|Part 2: Expansion|Withdrawal by Subject|0
4750867|NCT02343120|7724997|FG003|Part 2: Expansion|Withdrawal by Subject|28
4750868|NCT02343120|7724998|FG004|Part 2: Expansion|Withdrawal by Subject|2
4750869|NCT02343120|7724994|FG000|Part 2: Expansion|Lost to Follow-up|0
4750870|NCT02343120|7724995|FG001|Part 2: Expansion|Lost to Follow-up|0
4750871|NCT02343120|7724996|FG002|Part 2: Expansion|Lost to Follow-up|0
4750872|NCT02343120|7724997|FG003|Part 2: Expansion|Lost to Follow-up|5
4750873|NCT02343120|7724998|FG004|Part 2: Expansion|Lost to Follow-up|2
4750874|NCT02343120|7724994|FG000|Part 2: Expansion|Other|0
4750875|NCT02343120|7724995|FG001|Part 2: Expansion|Other|0
4750876|NCT02343120|7724996|FG002|Part 2: Expansion|Other|0
4750877|NCT02343120|7724997|FG003|Part 2: Expansion|Other|1
4750878|NCT02343120|7724998|FG004|Part 2: Expansion|Other|5
4750879|NCT02343120|7724994|FG000|Part 2: Expansion|Adverse Event|0
4750880|NCT02343120|7724995|FG001|Part 2: Expansion|Adverse Event|0
4661871|NCT02207829|7550626|FG001|Overall Study|Lost to Follow-up|2
4661872|NCT02207829|7550625|FG000|Overall Study|Protocol deviation|5
4661873|NCT02207829|7550626|FG001|Overall Study|Protocol deviation|4
4661874|NCT02207829|7550625|FG000|Overall Study|Withdrew consent|18
4661875|NCT02207829|7550626|FG001|Overall Study|Withdrew consent|14
4661876|NCT02207907|7550634|FG000|Overall Study|Lost to Follow-up|3
4661877|NCT02207907|7550635|FG001|Overall Study|Lost to Follow-up|1
4661878|NCT02207907|7550634|FG000|Overall Study|Withdrawal by Subject|5
4750881|NCT02343120|7724996|FG002|Part 2: Expansion|Adverse Event|0
4750882|NCT02343120|7724997|FG003|Part 2: Expansion|Adverse Event|1
4750883|NCT02343120|7724998|FG004|Part 2: Expansion|Adverse Event|1
4661879|NCT02207907|7550635|FG001|Overall Study|Withdrawal by Subject|6
4661880|NCT02207907|7550634|FG000|Overall Study|Did not meet study criteria|3
4661881|NCT02207907|7550635|FG001|Overall Study|Did not meet study criteria|0
4661882|NCT02207907|7550634|FG000|Overall Study|Pregnancy|0
4661883|NCT02207907|7550635|FG001|Overall Study|Pregnancy|1
4661884|NCT02207946|7550644|FG000|Overall Study|Lost to Follow-up|1
4661885|NCT02207946|7550645|FG001|Overall Study|Lost to Follow-up|0
4661886|NCT02207946|7550644|FG000|Overall Study|Adverse Event|0
4661887|NCT02207946|7550645|FG001|Overall Study|Adverse Event|1
4661888|NCT02208050|7550677|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1
4661889|NCT02208050|7550678|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0
4661890|NCT02208063|7550700|FG000|Overall Study|Death|3
4661891|NCT02208063|7550701|FG001|Overall Study|Death|5
4661892|NCT02208063|7550700|FG000|Overall Study|Not Specified in report|3
4661893|NCT02208063|7550701|FG001|Overall Study|Not Specified in report|4
4661894|NCT02208063|7550700|FG000|Overall Study|Withdrawal by Subject|5
4661895|NCT02208063|7550701|FG001|Overall Study|Withdrawal by Subject|2
4661896|NCT02208063|7550700|FG000|Overall Study|Lost to Follow-up|1
4661897|NCT02208063|7550701|FG001|Overall Study|Lost to Follow-up|0
4661898|NCT02208089|7550709|FG000|Overall Study|Withdrawal by Subject|1
4661899|NCT02208089|7550710|FG001|Overall Study|Withdrawal by Subject|0
4661900|NCT02208089|7550709|FG000|Overall Study|Lost to Follow-up|6
4661901|NCT02208089|7550710|FG001|Overall Study|Lost to Follow-up|0
4750884|NCT02066415|7725020|FG000|Overall Study|Decision by Sponsor|5
4750885|NCT02066415|7725021|FG001|Overall Study|Decision by Sponsor|4
4750886|NCT02066415|7725022|FG002|Overall Study|Decision by Sponsor|2
4750887|NCT02066415|7725020|FG000|Overall Study|Withdrawal by Subject|9
4750888|NCT02066415|7725021|FG001|Overall Study|Withdrawal by Subject|1
4750889|NCT02066415|7725022|FG002|Overall Study|Withdrawal by Subject|4
4750890|NCT02066415|7725020|FG000|Overall Study|Lost to Follow-up|7
4750891|NCT02066415|7725021|FG001|Overall Study|Lost to Follow-up|2
4750892|NCT02066415|7725022|FG002|Overall Study|Lost to Follow-up|2
4750893|NCT01952574|7725034|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9
4750894|NCT01952574|7725035|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3
4750895|NCT01952574|7725036|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3
4750896|NCT01952574|7725037|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4
4750897|NCT01952574|7725038|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0
4750898|NCT01952574|7725039|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0
4750899|NCT01952574|7725040|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0
4750900|NCT01952574|7725034|FG000|Double-blind Treatment Phase|Sponsor Decision|6
4750901|NCT01952574|7725035|FG001|Double-blind Treatment Phase|Sponsor Decision|0
4750902|NCT01952574|7725036|FG002|Double-blind Treatment Phase|Sponsor Decision|5
4750903|NCT01952574|7725037|FG003|Double-blind Treatment Phase|Sponsor Decision|2
4750904|NCT01952574|7725038|FG004|Double-blind Treatment Phase|Sponsor Decision|0
4750905|NCT01952574|7725039|FG005|Double-blind Treatment Phase|Sponsor Decision|0
4750906|NCT01952574|7725040|FG006|Double-blind Treatment Phase|Sponsor Decision|0
4750907|NCT01952574|7725034|FG000|Double-blind Treatment Phase|Lost to Follow-up|2
4750908|NCT01952574|7725035|FG001|Double-blind Treatment Phase|Lost to Follow-up|0
4750909|NCT01952574|7725036|FG002|Double-blind Treatment Phase|Lost to Follow-up|1
4750910|NCT01952574|7725037|FG003|Double-blind Treatment Phase|Lost to Follow-up|0
4750911|NCT01952574|7725038|FG004|Double-blind Treatment Phase|Lost to Follow-up|0
4750912|NCT01952574|7725039|FG005|Double-blind Treatment Phase|Lost to Follow-up|0
4750913|NCT01952574|7725040|FG006|Double-blind Treatment Phase|Lost to Follow-up|0
4750914|NCT01952574|7725034|FG000|Open-label Treatment Phase|Withdrawal by Subject|0
4750915|NCT01952574|7725035|FG001|Open-label Treatment Phase|Withdrawal by Subject|0
4750916|NCT01952574|7725036|FG002|Open-label Treatment Phase|Withdrawal by Subject|0
4750917|NCT01952574|7725037|FG003|Open-label Treatment Phase|Withdrawal by Subject|0
4750918|NCT01952574|7725038|FG004|Open-label Treatment Phase|Withdrawal by Subject|121
4750919|NCT01952574|7725039|FG005|Open-label Treatment Phase|Withdrawal by Subject|0
4750920|NCT01952574|7725040|FG006|Open-label Treatment Phase|Withdrawal by Subject|0
4750921|NCT01952574|7725034|FG000|Open-label Treatment Phase|Decision by Sponsor|0
4750922|NCT01952574|7725035|FG001|Open-label Treatment Phase|Decision by Sponsor|0
4750923|NCT01952574|7725036|FG002|Open-label Treatment Phase|Decision by Sponsor|0
4750924|NCT01952574|7725037|FG003|Open-label Treatment Phase|Decision by Sponsor|0
4750925|NCT01952574|7725038|FG004|Open-label Treatment Phase|Decision by Sponsor|17
4750926|NCT01952574|7725039|FG005|Open-label Treatment Phase|Decision by Sponsor|0
4750927|NCT01952574|7725040|FG006|Open-label Treatment Phase|Decision by Sponsor|0
4750928|NCT01952574|7725034|FG000|Open-label Treatment Phase|Missing|0
4750929|NCT01952574|7725035|FG001|Open-label Treatment Phase|Missing|0
4750930|NCT01952574|7725036|FG002|Open-label Treatment Phase|Missing|0
4750931|NCT01952574|7725037|FG003|Open-label Treatment Phase|Missing|0
4750932|NCT01952574|7725038|FG004|Open-label Treatment Phase|Missing|4
4750933|NCT01952574|7725039|FG005|Open-label Treatment Phase|Missing|0
4750934|NCT01952574|7725040|FG006|Open-label Treatment Phase|Missing|0
4750935|NCT01952574|7725034|FG000|Open-label Treatment Phase|Lost to Follow-up|0
4750936|NCT01952574|7725035|FG001|Open-label Treatment Phase|Lost to Follow-up|0
4750937|NCT01952574|7725036|FG002|Open-label Treatment Phase|Lost to Follow-up|0
4750938|NCT01952574|7725037|FG003|Open-label Treatment Phase|Lost to Follow-up|0
4750939|NCT01952574|7725038|FG004|Open-label Treatment Phase|Lost to Follow-up|19
4661902|NCT02208843|7550759|FG000|Overall Study|Clinical symptoms of progression|2
4661903|NCT02208843|7550759|FG000|Overall Study|Progression disease according to RECIST|24
4750940|NCT01952574|7725039|FG005|Open-label Treatment Phase|Lost to Follow-up|0
4750941|NCT01952574|7725040|FG006|Open-label Treatment Phase|Lost to Follow-up|0
4750942|NCT01952574|7725034|FG000|Open-label Treatment Phase|Death|0
4750943|NCT01952574|7725035|FG001|Open-label Treatment Phase|Death|0
4750944|NCT01952574|7725036|FG002|Open-label Treatment Phase|Death|0
4750945|NCT01952574|7725037|FG003|Open-label Treatment Phase|Death|0
4750946|NCT01952574|7725038|FG004|Open-label Treatment Phase|Death|1
4750947|NCT01952574|7725039|FG005|Open-label Treatment Phase|Death|0
4750948|NCT01952574|7725040|FG006|Open-label Treatment Phase|Death|0
4750949|NCT01952574|7725034|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0
4750950|NCT01952574|7725035|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0
4750951|NCT01952574|7725036|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0
4750952|NCT01952574|7725037|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0
4750953|NCT01952574|7725038|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0
4750954|NCT01952574|7725039|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1
4750955|NCT01952574|7725040|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0
4750956|NCT01952574|7725034|FG000|Clinical Home Use Substudy|Decision by Sponsor|0
4750957|NCT01952574|7725035|FG001|Clinical Home Use Substudy|Decision by Sponsor|0
4750958|NCT01952574|7725036|FG002|Clinical Home Use Substudy|Decision by Sponsor|0
4750959|NCT01952574|7725037|FG003|Clinical Home Use Substudy|Decision by Sponsor|0
4750960|NCT01952574|7725038|FG004|Clinical Home Use Substudy|Decision by Sponsor|0
4750961|NCT01952574|7725039|FG005|Clinical Home Use Substudy|Decision by Sponsor|2
4750962|NCT01952574|7725040|FG006|Clinical Home Use Substudy|Decision by Sponsor|1
4750963|NCT01660451|7725068|FG000|Overall Study|Protocol Violation|0
4750964|NCT01660451|7725069|FG001|Overall Study|Protocol Violation|1
4750965|NCT01660451|7725070|FG002|Overall Study|Protocol Violation|1
4750966|NCT01660451|7725068|FG000|Overall Study|Adverse Event (AE) without Clinical PD|11
4750967|NCT01660451|7725069|FG001|Overall Study|Adverse Event (AE) without Clinical PD|8
4750968|NCT01660451|7725070|FG002|Overall Study|Adverse Event (AE) without Clinical PD|26
4750969|NCT01660451|7725068|FG000|Overall Study|AE with Clinical PD|1
4750970|NCT01660451|7725069|FG001|Overall Study|AE with Clinical PD|3
4750971|NCT01660451|7725070|FG002|Overall Study|AE with Clinical PD|9
4750972|NCT01660451|7725068|FG000|Overall Study|Sponsor Decision|0
4750973|NCT01660451|7725069|FG001|Overall Study|Sponsor Decision|0
4750974|NCT01660451|7725070|FG002|Overall Study|Sponsor Decision|1
4750975|NCT01660451|7725068|FG000|Overall Study|Protocol Deviation|0
4750976|NCT01660451|7725069|FG001|Overall Study|Protocol Deviation|0
4750977|NCT01660451|7725070|FG002|Overall Study|Protocol Deviation|1
4750978|NCT01660451|7725068|FG000|Overall Study|Physician Decision|1
4750979|NCT01660451|7725069|FG001|Overall Study|Physician Decision|2
4750980|NCT01660451|7725070|FG002|Overall Study|Physician Decision|5
4750981|NCT01660451|7725068|FG000|Overall Study|Withdrawal by Subject|1
4750982|NCT01660451|7725069|FG001|Overall Study|Withdrawal by Subject|0
4750983|NCT01660451|7725070|FG002|Overall Study|Withdrawal by Subject|16
4750984|NCT01660451|7725068|FG000|Overall Study|Ongoing with treatment|3
4750985|NCT01660451|7725069|FG001|Overall Study|Ongoing with treatment|3
4750986|NCT01660451|7725070|FG002|Overall Study|Ongoing with treatment|46
4750987|NCT01659151|7725079|FG000|Overall Study|Inadequate TIL growth|1
4750988|NCT01539863|7725094|FG000|Overall Study|Lost to Follow-up|5
4661904|NCT02208843|7550759|FG000|Overall Study|Adverse Event|12
4661905|NCT02208843|7550759|FG000|Overall Study|Protocol Violation|1
4661906|NCT02208843|7550759|FG000|Overall Study|Withdrawal by Subject|1
4661907|NCT02208843|7550759|FG000|Overall Study|Switched to commercial afatinib|20
4661908|NCT02208999|7550765|FG000|Overall Study|Lost to Follow-up|1
4661909|NCT02209181|7550793|FG000|Overall Study|Adverse Event|1
4661910|NCT02209181|7550794|FG001|Overall Study|Adverse Event|0
4661911|NCT02209181|7550795|FG002|Overall Study|Adverse Event|1
4661912|NCT02209181|7550796|FG003|Overall Study|Adverse Event|0
4661913|NCT02209181|7550793|FG000|Overall Study|Withdrawal by Subject|0
4661914|NCT02209181|7550794|FG001|Overall Study|Withdrawal by Subject|1
4661915|NCT02209181|7550795|FG002|Overall Study|Withdrawal by Subject|0
4661916|NCT02209181|7550796|FG003|Overall Study|Withdrawal by Subject|0
4661917|NCT02209454|7550828|FG000|Second Period|Adverse Event|1
4661918|NCT02209454|7550829|FG001|Second Period|Adverse Event|0
4661919|NCT02209506|7550840|FG000|Overall Study|Withdrawal by Subject|0
4661920|NCT02209506|7550841|FG001|Overall Study|Withdrawal by Subject|0
4661921|NCT02209506|7550842|FG002|Overall Study|Withdrawal by Subject|0
4661922|NCT02209506|7550843|FG003|Overall Study|Withdrawal by Subject|0
4661923|NCT02209506|7550844|FG004|Overall Study|Withdrawal by Subject|1
4661924|NCT02209597|7550879|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2
4661925|NCT02209597|7550879|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1
4661926|NCT02209597|7550879|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3
4661927|NCT02209597|7550879|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1
4661928|NCT02209766|7550903|FG000|Overall Study|Withdrawal by Subject|0
4661929|NCT02209766|7550904|FG001|Overall Study|Withdrawal by Subject|0
4661930|NCT02209766|7550905|FG002|Overall Study|Withdrawal by Subject|0
4661931|NCT02209766|7550906|FG003|Overall Study|Withdrawal by Subject|1
4661932|NCT02209766|7550907|FG004|Overall Study|Withdrawal by Subject|0
4661933|NCT02210000|7550928|FG000|Overall Study|Study Terminated|11
4661934|NCT02210000|7550929|FG001|Overall Study|Study Terminated|12
4661935|NCT02210000|7550928|FG000|Overall Study|Withdrawal by Subject|7
4661936|NCT02210000|7550929|FG001|Overall Study|Withdrawal by Subject|1
4661937|NCT02210000|7550928|FG000|Overall Study|Adverse Event|1
4661938|NCT02210000|7550929|FG001|Overall Study|Adverse Event|5
4661939|NCT02210000|7550928|FG000|Overall Study|Lost to Follow-up|0
4661940|NCT02210000|7550929|FG001|Overall Study|Lost to Follow-up|2
4661941|NCT02210000|7550928|FG000|Overall Study|Physician Decision|0
4661942|NCT02210000|7550929|FG001|Overall Study|Physician Decision|1
4661943|NCT02210091|7550949|FG000|Overall Study|Physician Decision|0
4661944|NCT02210091|7550950|FG001|Overall Study|Physician Decision|1
4661945|NCT02210091|7550949|FG000|Overall Study|Withdrawal by Sponsor|0
4661946|NCT02210091|7550950|FG001|Overall Study|Withdrawal by Sponsor|1
4661947|NCT02210208|7550981|FG000|Period A (Graft Site)|Withdrawal by Subject|1
4661948|NCT02210208|7550981|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1
4661949|NCT02210208|7550981|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7
4661950|NCT02210221|7550987|FG000|Overall Study|Lack of Efficacy|7
4661951|NCT02210221|7550987|FG000|Overall Study|Withdrawal by Subject|43
4661952|NCT02210689|7551033|FG000|Overall Study|Withdrawal by Subject|7
4661953|NCT02210689|7551034|FG001|Overall Study|Withdrawal by Subject|4
4661954|NCT02210689|7551035|FG002|Overall Study|Withdrawal by Subject|2
4661955|NCT02210689|7551033|FG000|Overall Study|Adverse Event|0
4661956|NCT02210689|7551034|FG001|Overall Study|Adverse Event|1
4750989|NCT01539863|7725095|FG001|Overall Study|Lost to Follow-up|4
4750990|NCT01439165|7725116|FG000|Overall Study|Protocol Violation|3
4750991|NCT01439165|7725117|FG001|Overall Study|Protocol Violation|0
4750992|NCT01439165|7725116|FG000|Overall Study|Lost to Follow-up|11
4750993|NCT01439165|7725117|FG001|Overall Study|Lost to Follow-up|1
4750994|NCT01439165|7725116|FG000|Overall Study|Withdrawal by Subject|7
4750995|NCT01439165|7725117|FG001|Overall Study|Withdrawal by Subject|1
4750996|NCT01264679|7725123|FG000|Overall Study|Participation in Another Clinical Trial|1
4750997|NCT01264679|7725123|FG000|Overall Study|Physician Decision|1
4750998|NCT01264679|7725123|FG000|Overall Study|Sponsor's Suspension of Dosing|2
4750999|NCT01264679|7725123|FG000|Overall Study|Withdrawal by Subject|1
4751000|NCT01155388|7725130|FG000|Overall Study|Adverse Event|1
4751001|NCT01155388|7725131|FG001|Overall Study|Adverse Event|0
4751002|NCT01137435|7725138|FG000|Overall Study|Lost to Follow-up|24
4751003|NCT01137435|7725138|FG000|Overall Study|Off label usage|4
4751004|NCT01064817|7725155|FG000|Study Completion|Physician Decision|1
4751005|NCT01064817|7725156|FG001|Study Completion|Physician Decision|0
4751006|NCT01064817|7725155|FG000|Study Completion|Withdrawal by Subject|1
4751007|NCT01064817|7725156|FG001|Study Completion|Withdrawal by Subject|0
4751008|NCT01026220|7725162|FG000|Induction|Death|1
4751009|NCT01026220|7725163|FG001|Induction|Death|0
4751010|NCT01026220|7725164|FG002|Induction|Death|0
4751011|NCT01026220|7725162|FG000|Induction|Lack of Efficacy|2
4751012|NCT01026220|7725163|FG001|Induction|Lack of Efficacy|0
4751013|NCT01026220|7725164|FG002|Induction|Lack of Efficacy|0
4751014|NCT01026220|7725162|FG000|Induction|Physician Decision|12
4751015|NCT01026220|7725163|FG001|Induction|Physician Decision|0
4751016|NCT01026220|7725164|FG002|Induction|Physician Decision|0
4751017|NCT01026220|7725162|FG000|Induction|Withdrawal by Subject|9
4751018|NCT01026220|7725163|FG001|Induction|Withdrawal by Subject|0
4751019|NCT01026220|7725164|FG002|Induction|Withdrawal by Subject|0
4751020|NCT01026220|7725162|FG000|Induction|Ineligible|1
4751021|NCT01026220|7725163|FG001|Induction|Ineligible|0
4751022|NCT01026220|7725164|FG002|Induction|Ineligible|0
4751023|NCT01026220|7725162|FG000|Consolidation Maintenance|Death|0
4751024|NCT01026220|7725163|FG001|Consolidation Maintenance|Death|1
4751025|NCT01026220|7725164|FG002|Consolidation Maintenance|Death|0
4751026|NCT01026220|7725162|FG000|Consolidation Maintenance|Lack of Efficacy|0
4751027|NCT01026220|7725163|FG001|Consolidation Maintenance|Lack of Efficacy|1
4751028|NCT01026220|7725164|FG002|Consolidation Maintenance|Lack of Efficacy|1
4751029|NCT01026220|7725162|FG000|Consolidation Maintenance|Physician Decision|0
4751030|NCT01026220|7725163|FG001|Consolidation Maintenance|Physician Decision|2
4751031|NCT01026220|7725164|FG002|Consolidation Maintenance|Physician Decision|7
4751032|NCT01026220|7725162|FG000|Consolidation Maintenance|Withdrawal by Subject|0
4751033|NCT01026220|7725163|FG001|Consolidation Maintenance|Withdrawal by Subject|2
4751034|NCT01026220|7725164|FG002|Consolidation Maintenance|Withdrawal by Subject|6
4751035|NCT00567567|7725186|FG000|Overall Study|Adverse Event|0
4751036|NCT00567567|7725187|FG001|Overall Study|Adverse Event|2
4751037|NCT00567567|7725188|FG002|Overall Study|Adverse Event|5
4661957|NCT02210689|7551035|FG002|Overall Study|Adverse Event|0
4661958|NCT02210689|7551033|FG000|Overall Study|Protocol Violation|1
4661959|NCT02210689|7551034|FG001|Overall Study|Protocol Violation|0
4751038|NCT00567567|7725186|FG000|Overall Study|Death|8
4751039|NCT00567567|7725187|FG001|Overall Study|Death|1
4751040|NCT00567567|7725188|FG002|Overall Study|Death|5
4751041|NCT00567567|7725186|FG000|Overall Study|Lack of Efficacy|16
4751042|NCT00567567|7725187|FG001|Overall Study|Lack of Efficacy|17
4751043|NCT00567567|7725188|FG002|Overall Study|Lack of Efficacy|48
4751044|NCT00567567|7725186|FG000|Overall Study|Lost to Follow-up|0
4751045|NCT00567567|7725187|FG001|Overall Study|Lost to Follow-up|0
4661960|NCT02210689|7551035|FG002|Overall Study|Protocol Violation|0
4661961|NCT02210689|7551033|FG000|Overall Study|Lost to Follow-up|11
4661962|NCT02210689|7551034|FG001|Overall Study|Lost to Follow-up|9
4751046|NCT00567567|7725188|FG002|Overall Study|Lost to Follow-up|1
4751047|NCT00567567|7725186|FG000|Overall Study|Physician Decision|16
4751048|NCT00567567|7725187|FG001|Overall Study|Physician Decision|18
4751049|NCT00567567|7725188|FG002|Overall Study|Physician Decision|84
4751050|NCT00567567|7725186|FG000|Overall Study|Withdrawal by Subject|0
4751051|NCT00567567|7725187|FG001|Overall Study|Withdrawal by Subject|0
4751052|NCT00567567|7725188|FG002|Overall Study|Withdrawal by Subject|2
4751053|NCT00567567|7725186|FG000|Overall Study|Ineligible|4
4751054|NCT00567567|7725187|FG001|Overall Study|Ineligible|0
4751055|NCT00567567|7725188|FG002|Overall Study|Ineligible|9
4751056|NCT00567567|7725186|FG000|Overall Study|Refusal by patient/parent/guardian|9
4751057|NCT00567567|7725187|FG001|Overall Study|Refusal by patient/parent/guardian|16
4751058|NCT00567567|7725188|FG002|Overall Study|Refusal by patient/parent/guardian|122
4751059|NCT00567567|7725186|FG000|Overall Study|Enrolled another COG therapeutic study|99
4751060|NCT00567567|7725187|FG001|Overall Study|Enrolled another COG therapeutic study|80
4751061|NCT00567567|7725188|FG002|Overall Study|Enrolled another COG therapeutic study|0
4751062|NCT00567567|7725186|FG000|Overall Study|Unable adequate stem cell for transplant|0
4751063|NCT00567567|7725187|FG001|Overall Study|Unable adequate stem cell for transplant|0
4751064|NCT00567567|7725188|FG002|Overall Study|Unable adequate stem cell for transplant|2
4751065|NCT00450450|7725200|FG000|Overall Study|Death|1
4751066|NCT00450450|7725201|FG001|Overall Study|Death|3
4751067|NCT00450450|7725200|FG000|Overall Study|Relapse|2
4751068|NCT00450450|7725201|FG001|Overall Study|Relapse|0
4751069|NCT00450450|7725200|FG000|Overall Study|Missing Data|2
4751070|NCT00450450|7725201|FG001|Overall Study|Missing Data|0
4751071|NCT00346164|7725222|FG000|Overall Study|Adverse Event|0
4751072|NCT00346164|7725223|FG001|Overall Study|Adverse Event|0
4751073|NCT00346164|7725224|FG002|Overall Study|Adverse Event|0
4751074|NCT00346164|7725225|FG003|Overall Study|Adverse Event|1
4751075|NCT00346164|7725222|FG000|Overall Study|Lack of Efficacy|0
4751076|NCT00346164|7725223|FG001|Overall Study|Lack of Efficacy|1
4751077|NCT00346164|7725224|FG002|Overall Study|Lack of Efficacy|7
4751078|NCT00346164|7725225|FG003|Overall Study|Lack of Efficacy|25
4751079|NCT00346164|7725222|FG000|Overall Study|Physician Decision|0
4751080|NCT00346164|7725223|FG001|Overall Study|Physician Decision|1
4751081|NCT00346164|7725224|FG002|Overall Study|Physician Decision|2
4751082|NCT00346164|7725225|FG003|Overall Study|Physician Decision|27
4751083|NCT00346164|7725222|FG000|Overall Study|Protocol Violation|6
4751084|NCT00346164|7725223|FG001|Overall Study|Protocol Violation|2
4751085|NCT00346164|7725224|FG002|Overall Study|Protocol Violation|10
4751086|NCT00346164|7725225|FG003|Overall Study|Protocol Violation|4
4751087|NCT00346164|7725222|FG000|Overall Study|Withdrawal by Subject|0
4751088|NCT00346164|7725223|FG001|Overall Study|Withdrawal by Subject|0
4751089|NCT00346164|7725224|FG002|Overall Study|Withdrawal by Subject|2
4751090|NCT00346164|7725225|FG003|Overall Study|Withdrawal by Subject|0
4751091|NCT00346164|7725222|FG000|Overall Study|Ineligible|11
4751092|NCT00346164|7725223|FG001|Overall Study|Ineligible|2
4751093|NCT00346164|7725224|FG002|Overall Study|Ineligible|2
4751094|NCT00346164|7725225|FG003|Overall Study|Ineligible|23
4751095|NCT00346164|7725222|FG000|Overall Study|Refusal of further protocol therapy|0
4661963|NCT02210689|7551035|FG002|Overall Study|Lost to Follow-up|5
4661964|NCT02210689|7551033|FG000|Overall Study|Pregnancy|0
4661965|NCT02210689|7551034|FG001|Overall Study|Pregnancy|1
4661966|NCT02210689|7551035|FG002|Overall Study|Pregnancy|0
4661967|NCT02210689|7551033|FG000|Overall Study|Lack of Efficacy|0
4661968|NCT02210689|7551034|FG001|Overall Study|Lack of Efficacy|1
4661969|NCT02210689|7551035|FG002|Overall Study|Lack of Efficacy|5
4661970|NCT02210689|7551033|FG000|Overall Study|Prohibited medication|2
4661971|NCT02210689|7551034|FG001|Overall Study|Prohibited medication|8
4661972|NCT02210689|7551035|FG002|Overall Study|Prohibited medication|1
4661973|NCT02210689|7551033|FG000|Overall Study|Negative Nugent score at baseline|6
4661974|NCT02210689|7551034|FG001|Overall Study|Negative Nugent score at baseline|2
4661975|NCT02210689|7551035|FG002|Overall Study|Negative Nugent score at baseline|2
4661976|NCT02210689|7551033|FG000|Overall Study|Other|25
4661977|NCT02210689|7551034|FG001|Overall Study|Other|21
4661978|NCT02210689|7551035|FG002|Overall Study|Other|8
4661979|NCT02210780|7551045|FG000|Overall Study|Adverse Event|0
4661980|NCT02210780|7551046|FG001|Overall Study|Adverse Event|5
4661981|NCT02210780|7551045|FG000|Overall Study|Lost to Follow-up|2
4661982|NCT02210780|7551046|FG001|Overall Study|Lost to Follow-up|1
4661983|NCT02210780|7551045|FG000|Overall Study|Withdrawal by Subject|1
4661984|NCT02210780|7551046|FG001|Overall Study|Withdrawal by Subject|1
4661985|NCT02210780|7551045|FG000|Overall Study|Physician Decision|1
4661986|NCT02210780|7551046|FG001|Overall Study|Physician Decision|0
4661987|NCT02210780|7551045|FG000|Overall Study|Protocol Violation|1
4661988|NCT02210780|7551046|FG001|Overall Study|Protocol Violation|0
4661989|NCT02210780|7551045|FG000|Overall Study|Other than specified above|0
4661990|NCT02210780|7551046|FG001|Overall Study|Other than specified above|1
4661991|NCT02211014|7551054|FG000|Overall Study|Adverse Event|0
4751096|NCT00346164|7725223|FG001|Overall Study|Refusal of further protocol therapy|1
4751097|NCT00346164|7725224|FG002|Overall Study|Refusal of further protocol therapy|3
4751098|NCT00346164|7725225|FG003|Overall Study|Refusal of further protocol therapy|15
4661992|NCT02211014|7551055|FG001|Overall Study|Adverse Event|2
4661993|NCT02211014|7551054|FG000|Overall Study|Physician Decision|1
4661994|NCT02211014|7551055|FG001|Overall Study|Physician Decision|2
4661995|NCT02211014|7551054|FG000|Overall Study|Started another cancer therapy|1
4661996|NCT02211014|7551055|FG001|Overall Study|Started another cancer therapy|0
4661997|NCT02211014|7551054|FG000|Overall Study|Withdrawal by Subject|0
4661998|NCT02211014|7551055|FG001|Overall Study|Withdrawal by Subject|1
4661999|NCT02211014|7551054|FG000|Overall Study|In agreement with patient, no benefit|0
4662000|NCT02211014|7551055|FG001|Overall Study|In agreement with patient, no benefit|1
4662001|NCT02211261|7551088|FG000|Overall Study|Withdrawal by Subject|0
4662002|NCT02211261|7551089|FG001|Overall Study|Withdrawal by Subject|0
4662003|NCT02211261|7551090|FG002|Overall Study|Withdrawal by Subject|1
4662004|NCT02211261|7551091|FG003|Overall Study|Withdrawal by Subject|0
4662005|NCT02211261|7551092|FG004|Overall Study|Withdrawal by Subject|2
4662006|NCT02211261|7551093|FG005|Overall Study|Withdrawal by Subject|0
4662007|NCT02211261|7551094|FG006|Overall Study|Withdrawal by Subject|0
4662008|NCT02211261|7551095|FG007|Overall Study|Withdrawal by Subject|0
4662009|NCT02211261|7551096|FG008|Overall Study|Withdrawal by Subject|0
4662010|NCT02211261|7551097|FG009|Overall Study|Withdrawal by Subject|0
4662011|NCT02211261|7551098|FG010|Overall Study|Withdrawal by Subject|0
4662012|NCT02211261|7551088|FG000|Overall Study|Other|0
4662013|NCT02211261|7551089|FG001|Overall Study|Other|0
4662014|NCT02211261|7551090|FG002|Overall Study|Other|0
4662015|NCT02211261|7551091|FG003|Overall Study|Other|0
4662016|NCT02211261|7551092|FG004|Overall Study|Other|0
4662017|NCT02211261|7551093|FG005|Overall Study|Other|1
4662018|NCT02211261|7551094|FG006|Overall Study|Other|0
4662019|NCT02211261|7551095|FG007|Overall Study|Other|0
4662020|NCT02211261|7551096|FG008|Overall Study|Other|0
4662021|NCT02211261|7551097|FG009|Overall Study|Other|2
4662022|NCT02211261|7551098|FG010|Overall Study|Other|0
4662023|NCT02211261|7551088|FG000|Overall Study|Lost to Follow-up|0
4662024|NCT02211261|7551089|FG001|Overall Study|Lost to Follow-up|0
4662025|NCT02211261|7551090|FG002|Overall Study|Lost to Follow-up|0
4662026|NCT02211261|7551091|FG003|Overall Study|Lost to Follow-up|0
4662027|NCT02211261|7551092|FG004|Overall Study|Lost to Follow-up|0
4662028|NCT02211261|7551093|FG005|Overall Study|Lost to Follow-up|0
4662029|NCT02211261|7551094|FG006|Overall Study|Lost to Follow-up|0
4662030|NCT02211261|7551095|FG007|Overall Study|Lost to Follow-up|1
4662031|NCT02211261|7551096|FG008|Overall Study|Lost to Follow-up|0
4662032|NCT02211261|7551097|FG009|Overall Study|Lost to Follow-up|0
4662033|NCT02211261|7551098|FG010|Overall Study|Lost to Follow-up|0
4662034|NCT02211313|7551133|FG000|Overall Study|Treatment Failure|5
4662035|NCT02211313|7551134|FG001|Overall Study|Treatment Failure|2
4662036|NCT02211313|7551133|FG000|Overall Study|No Follow up Questionnaires|1
4662037|NCT02211313|7551134|FG001|Overall Study|No Follow up Questionnaires|1
4662038|NCT02211638|7551166|FG000|Overall Study|Case Report Forms Uncollected|291
4662039|NCT02211638|7551166|FG000|Overall Study|Protocol Violation|692
4662040|NCT02212197|7551192|FG000|Overall Study|Need for radiotherapy|1
4662041|NCT02212197|7551193|FG001|Overall Study|Need for radiotherapy|0
4662042|NCT02212197|7551194|FG002|Overall Study|Need for radiotherapy|0
4662043|NCT02212301|7551202|FG000|Period 1|Lost to Follow-up|0
4662044|NCT02212301|7551203|FG001|Period 1|Lost to Follow-up|1
4662045|NCT02212379|7551210|FG000|From Baseline to Week 48|Lack of Efficacy|1
4662046|NCT02212379|7551210|FG000|From Baseline to Week 48|Adverse Event|7
4662047|NCT02212379|7551210|FG000|From Baseline to Week 48|Withdrawal by Subject|1
4662048|NCT02212379|7551210|FG000|From Week 48 to Week 96|Lack of Efficacy|1
4662049|NCT02212379|7551210|FG000|From Week 48 to Week 96|Adverse Event|1
4662050|NCT02212379|7551210|FG000|From Week 48 to Week 96|Withdrawal by Subject|2
4662051|NCT02212457|7551223|FG000|Overall Study|Adverse Event|1
4662052|NCT02212457|7551224|FG001|Overall Study|Adverse Event|2
4662053|NCT02212457|7551225|FG002|Overall Study|Adverse Event|2
4662054|NCT02212457|7551226|FG003|Overall Study|Adverse Event|2
4662055|NCT02212457|7551227|FG004|Overall Study|Adverse Event|0
4662056|NCT02212457|7551228|FG005|Overall Study|Adverse Event|1
4662057|NCT02212457|7551223|FG000|Overall Study|Withdrawal by Subject|8
4662058|NCT02212457|7551224|FG001|Overall Study|Withdrawal by Subject|10
4662059|NCT02212457|7551225|FG002|Overall Study|Withdrawal by Subject|8
4662060|NCT02212457|7551226|FG003|Overall Study|Withdrawal by Subject|6
4662061|NCT02212457|7551227|FG004|Overall Study|Withdrawal by Subject|5
4662062|NCT02212457|7551228|FG005|Overall Study|Withdrawal by Subject|4
4662063|NCT02212457|7551223|FG000|Overall Study|Lost to Follow-up|6
4662064|NCT02212457|7551224|FG001|Overall Study|Lost to Follow-up|7
4662065|NCT02212457|7551225|FG002|Overall Study|Lost to Follow-up|4
4662066|NCT02212457|7551226|FG003|Overall Study|Lost to Follow-up|1
4662067|NCT02212457|7551227|FG004|Overall Study|Lost to Follow-up|8
4662068|NCT02212457|7551228|FG005|Overall Study|Lost to Follow-up|4
4662069|NCT02212457|7551223|FG000|Overall Study|Protocol Violation|2
4662070|NCT02212457|7551224|FG001|Overall Study|Protocol Violation|1
4662071|NCT02212457|7551225|FG002|Overall Study|Protocol Violation|0
4662072|NCT02212457|7551226|FG003|Overall Study|Protocol Violation|1
4662073|NCT02212457|7551227|FG004|Overall Study|Protocol Violation|2
4662074|NCT02212457|7551228|FG005|Overall Study|Protocol Violation|3
4662075|NCT02212457|7551223|FG000|Overall Study|Other|2
4662076|NCT02212457|7551224|FG001|Overall Study|Other|1
4662077|NCT02212457|7551225|FG002|Overall Study|Other|2
4662078|NCT02212457|7551226|FG003|Overall Study|Other|1
4662079|NCT02212457|7551227|FG004|Overall Study|Other|0
4662080|NCT02212457|7551228|FG005|Overall Study|Other|1
4662081|NCT02212678|7551253|FG000|Overall Study|Adverse Event|1
4662082|NCT02212730|7551259|FG000|Overall Study|Tumor not of the required cell histology|1
4662083|NCT02212730|7551260|FG001|Overall Study|Tumor not of the required cell histology|0
4662084|NCT02212730|7551259|FG000|Overall Study|Withdrawal by Subject|1
4662085|NCT02212730|7551260|FG001|Overall Study|Withdrawal by Subject|0
4662086|NCT02212730|7551259|FG000|Overall Study|Disease progression prior to RCC surgery|0
4662087|NCT02212730|7551260|FG001|Overall Study|Disease progression prior to RCC surgery|1
4662088|NCT02213042|7551289|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14
4662089|NCT02213042|7551290|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13
4662090|NCT02213042|7551291|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8
4751099|NCT00346164|7725222|FG000|Overall Study|Inability to start week 16 tx on time|0
4751100|NCT00346164|7725223|FG001|Overall Study|Inability to start week 16 tx on time|0
4751101|NCT00346164|7725224|FG002|Overall Study|Inability to start week 16 tx on time|0
4751102|NCT00346164|7725225|FG003|Overall Study|Inability to start week 16 tx on time|11
4662091|NCT02213042|7551289|FG000|Overall Study|Adverse Event|2
4662092|NCT02213042|7551290|FG001|Overall Study|Adverse Event|1
4662093|NCT02213042|7551291|FG002|Overall Study|Adverse Event|0
4662094|NCT02213042|7551289|FG000|Overall Study|Withdrawal by Subject|0
4662095|NCT02213042|7551290|FG001|Overall Study|Withdrawal by Subject|1
4662096|NCT02213042|7551291|FG002|Overall Study|Withdrawal by Subject|1
4662097|NCT02213042|7551289|FG000|Overall Study|Protocol Violation|1
4662098|NCT02213042|7551290|FG001|Overall Study|Protocol Violation|0
4662099|NCT02213042|7551291|FG002|Overall Study|Protocol Violation|0
4662100|NCT02213042|7551289|FG000|Overall Study|Investigator discretion|0
4662101|NCT02213042|7551290|FG001|Overall Study|Investigator discretion|0
4662102|NCT02213042|7551291|FG002|Overall Study|Investigator discretion|1
4662103|NCT02213055|7551303|FG000|Overall Study|Protocol was not Followed at Enrollment|5
4662104|NCT02213055|7551304|FG001|Overall Study|Protocol was not Followed at Enrollment|0
4662105|NCT02213055|7551303|FG000|Overall Study|Protocol was not Followed during Study|1
4662106|NCT02213055|7551304|FG001|Overall Study|Protocol was not Followed during Study|0
4662107|NCT02213055|7551303|FG000|Overall Study|Documentation Issue at Enrollment|1
4662108|NCT02213055|7551304|FG001|Overall Study|Documentation Issue at Enrollment|0
4662109|NCT02213055|7551303|FG000|Overall Study|Documentation Issue during Study|10
4662110|NCT02213055|7551304|FG001|Overall Study|Documentation Issue during Study|0
4662111|NCT02213055|7551303|FG000|Overall Study|Did not have Live Lice|8
4662112|NCT02213055|7551304|FG001|Overall Study|Did not have Live Lice|0
4662113|NCT02213055|7551303|FG000|Overall Study|Had another Treatment during the Study|3
4662114|NCT02213055|7551304|FG001|Overall Study|Had another Treatment during the Study|0
4662115|NCT02213055|7551303|FG000|Overall Study|Did not meet Inclusion Criteria|6
4662116|NCT02213055|7551304|FG001|Overall Study|Did not meet Inclusion Criteria|0
4662117|NCT02213055|7551303|FG000|Overall Study|Did not Return to School|5
4662118|NCT02213055|7551304|FG001|Overall Study|Did not Return to School|0
4662119|NCT02213094|7551325|FG000|Overall Study|Adverse Event|1
4662120|NCT02213094|7551326|FG001|Overall Study|Adverse Event|0
4662121|NCT02213133|7551335|FG000|Overall Study|Participant discontinued study therapy|2
4662122|NCT02213133|7551336|FG001|Overall Study|Participant discontinued study therapy|0
4662123|NCT02213133|7551337|FG002|Overall Study|Participant discontinued study therapy|0
4662124|NCT02213133|7551335|FG000|Overall Study|Participant withdrew informed consent|2
4662125|NCT02213133|7551336|FG001|Overall Study|Participant withdrew informed consent|1
4662126|NCT02213133|7551337|FG002|Overall Study|Participant withdrew informed consent|2
4662127|NCT02213133|7551335|FG000|Overall Study|Disease progression|11
4662128|NCT02213133|7551336|FG001|Overall Study|Disease progression|2
4662129|NCT02213133|7551337|FG002|Overall Study|Disease progression|0
4662130|NCT02213133|7551335|FG000|Overall Study|Adverse Event (AE)|1
4662131|NCT02213133|7551336|FG001|Overall Study|Adverse Event (AE)|0
4662132|NCT02213133|7551337|FG002|Overall Study|Adverse Event (AE)|0
4662133|NCT02213133|7551335|FG000|Overall Study|Death|16
4662134|NCT02213133|7551336|FG001|Overall Study|Death|2
4662135|NCT02213133|7551337|FG002|Overall Study|Death|1
4662136|NCT02213133|7551335|FG000|Overall Study|Other|5
4662137|NCT02213133|7551336|FG001|Overall Study|Other|0
4662138|NCT02213133|7551337|FG002|Overall Study|Other|0
4662139|NCT02213198|7551348|FG000|Baseline|No show for intake|7
4662140|NCT02213198|7551349|FG001|Baseline|No show for intake|9
4662141|NCT02213198|7551348|FG000|Baseline|Withdrawal by Subject|34
4662142|NCT02213198|7551349|FG001|Baseline|Withdrawal by Subject|11
4662143|NCT02213198|7551348|FG000|Baseline|transferred out of clinic|7
4662144|NCT02213198|7551349|FG001|Baseline|transferred out of clinic|9
4662145|NCT02213198|7551348|FG000|Baseline|Lost to Follow-up|40
4662146|NCT02213198|7551349|FG001|Baseline|Lost to Follow-up|21
4662147|NCT02213198|7551348|FG000|Baseline|incarcerated,violent|0
4662148|NCT02213198|7551349|FG001|Baseline|incarcerated,violent|1
4662149|NCT02213198|7551348|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4
4662150|NCT02213198|7551349|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4
4662151|NCT02213198|7551348|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3
4662152|NCT02213198|7551349|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2
4662153|NCT02213198|7551348|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1
4662154|NCT02213198|7551349|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0
4662155|NCT02213198|7551348|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68
4662156|NCT02213198|7551349|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25
4662157|NCT02213198|7551348|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17
4662158|NCT02213198|7551349|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10
4662159|NCT02213198|7551348|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23
4662160|NCT02213198|7551349|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7
4662161|NCT02213263|7551365|FG000|Overall Study|Insufficient clinical response|4
4662162|NCT02213263|7551366|FG001|Overall Study|Insufficient clinical response|3
4662163|NCT02213263|7551365|FG000|Overall Study|Lost to Follow-up|0
4662164|NCT02213263|7551366|FG001|Overall Study|Lost to Follow-up|1
4662165|NCT02213263|7551365|FG000|Overall Study|No longer willing to participate|3
4662166|NCT02213263|7551366|FG001|Overall Study|No longer willing to participate|4
4662167|NCT02213263|7551365|FG000|Overall Study|Progressive disease|20
4662168|NCT02213263|7551366|FG001|Overall Study|Progressive disease|14
4662169|NCT02213263|7551365|FG000|Overall Study|Protocol Violation|0
4662170|NCT02213263|7551366|FG001|Overall Study|Protocol Violation|1
4662171|NCT02213263|7551365|FG000|Overall Study|Adverse Event|1
4662172|NCT02213263|7551366|FG001|Overall Study|Adverse Event|3
4662173|NCT02213380|7551387|FG000|Underwent Randomization|Withdrawal by Subject|2
4662174|NCT02213380|7551388|FG001|Underwent Randomization|Withdrawal by Subject|0
4662175|NCT02213380|7551387|FG000|Underwent Randomization|Not treated|3
4662176|NCT02213380|7551388|FG001|Underwent Randomization|Not treated|3
4662177|NCT02213380|7551387|FG000|Per-protocol Analysis|Protocol Violation|32
4662178|NCT02213380|7551388|FG001|Per-protocol Analysis|Protocol Violation|36
4662179|NCT02213458|7551396|FG000|Overall Study|No longer meets criteria: caregiver deceased|4
4662180|NCT02213458|7551397|FG001|Overall Study|No longer meets criteria: caregiver deceased|0
4662181|NCT02213458|7551396|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4
4662182|NCT02213458|7551397|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0
4662183|NCT02213458|7551396|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2
4662184|NCT02213458|7551397|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0
4662185|NCT02213458|7551396|FG000|Overall Study|No longer meets criteria: patient moved out of state|10
4662186|NCT02213458|7551397|FG001|Overall Study|No longer meets criteria: patient moved out of state|0
4662187|NCT02213458|7551396|FG000|Overall Study|Refused re-consent|6
4662188|NCT02213458|7551397|FG001|Overall Study|Refused re-consent|0
4662189|NCT02213458|7551396|FG000|Overall Study|Lost to Follow-up|2
4662190|NCT02213458|7551397|FG001|Overall Study|Lost to Follow-up|2
4662191|NCT02213458|7551396|FG000|Overall Study|Withdrawal by Subject|26
4662192|NCT02213458|7551397|FG001|Overall Study|Withdrawal by Subject|8
4662193|NCT02213510|7551405|FG000|Overall Study|Death|0
4662194|NCT02213510|7551406|FG001|Overall Study|Death|1
4662195|NCT02213510|7551405|FG000|Overall Study|Lost to Follow-up|1
4662196|NCT02213510|7551406|FG001|Overall Study|Lost to Follow-up|0
4662197|NCT02213666|7551412|FG000|Overall Study|Withdrawal by Subject|1
4662198|NCT02214121|7551437|FG000|Part A|Patient decision|2
4662199|NCT02214121|7551438|FG001|Part A|Patient decision|0
4662200|NCT02214121|7551439|FG002|Part A|Patient decision|0
4662201|NCT02214121|7551437|FG000|Part A|Dev. of study-specific withdrawal crit.|4
4662202|NCT02214121|7551438|FG001|Part A|Dev. of study-specific withdrawal crit.|0
4662203|NCT02214121|7551439|FG002|Part A|Dev. of study-specific withdrawal crit.|0
4662204|NCT02214121|7551437|FG000|Part A|Other|1
4662205|NCT02214121|7551438|FG001|Part A|Other|0
4662206|NCT02214121|7551439|FG002|Part A|Other|0
4662207|NCT02214121|7551437|FG000|Part B|Patient decision|0
4662208|NCT02214121|7551438|FG001|Part B|Patient decision|1
4662209|NCT02214121|7551439|FG002|Part B|Patient decision|0
4662210|NCT02214121|7551437|FG000|Part B|Dev. of study-specific withdrawal crit.|0
4662211|NCT02214121|7551438|FG001|Part B|Dev. of study-specific withdrawal crit.|2
4662212|NCT02214121|7551439|FG002|Part B|Dev. of study-specific withdrawal crit.|0
4662213|NCT02214121|7551437|FG000|Part B|Lost to Follow-up|0
4662214|NCT02214121|7551438|FG001|Part B|Lost to Follow-up|0
4662215|NCT02214121|7551439|FG002|Part B|Lost to Follow-up|1
4662216|NCT02214186|7551474|FG000|Overall Study|Lost to Follow-up|1
4662217|NCT02214186|7551475|FG001|Overall Study|Lost to Follow-up|1
4662218|NCT02214186|7551474|FG000|Overall Study|Protocol Violation|1
4662219|NCT02214186|7551475|FG001|Overall Study|Protocol Violation|1
4662220|NCT02214225|7551498|FG000|Overall Study|Lost to Follow-up|46
4662221|NCT02214225|7551499|FG001|Overall Study|Lost to Follow-up|18
4662222|NCT02214225|7551500|FG002|Overall Study|Lost to Follow-up|18
4662223|NCT02214225|7551498|FG000|Overall Study|Withdrawal by Subject|2
4662224|NCT02214225|7551499|FG001|Overall Study|Withdrawal by Subject|0
4662225|NCT02214225|7551500|FG002|Overall Study|Withdrawal by Subject|2
4662226|NCT02214225|7551498|FG000|Overall Study|Death|5
4662227|NCT02214225|7551499|FG001|Overall Study|Death|0
4751103|NCT01009294|7725251|FG000|Overall Study|Study discontinued by Sponsor|6
4751104|NCT01072175|7725276|FG000|Part A (Drug-Drug Interaction)|Death|1
4751105|NCT01072175|7725277|FG001|Part A (Drug-Drug Interaction)|Death|0
4751106|NCT01072175|7725278|FG002|Part A (Drug-Drug Interaction)|Death|0
4751107|NCT01072175|7725279|FG003|Part A (Drug-Drug Interaction)|Death|0
4751108|NCT01072175|7725280|FG004|Part A (Drug-Drug Interaction)|Death|0
4751109|NCT01072175|7725281|FG005|Part A (Drug-Drug Interaction)|Death|0
4751110|NCT01072175|7725282|FG006|Part A (Drug-Drug Interaction)|Death|0
4751111|NCT01072175|7725283|FG007|Part A (Drug-Drug Interaction)|Death|0
4751112|NCT01072175|7725284|FG008|Part A (Drug-Drug Interaction)|Death|0
4751113|NCT01072175|7725285|FG009|Part A (Drug-Drug Interaction)|Death|0
4751114|NCT01072175|7725286|FG010|Part A (Drug-Drug Interaction)|Death|0
4751115|NCT01072175|7725287|FG011|Part A (Drug-Drug Interaction)|Death|0
4751116|NCT01072175|7725288|FG012|Part A (Drug-Drug Interaction)|Death|0
4751117|NCT01072175|7725276|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6
4751118|NCT01072175|7725277|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0
4751119|NCT01072175|7725278|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0
4751120|NCT01072175|7725279|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0
4751121|NCT01072175|7725280|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0
4662228|NCT02214225|7551500|FG002|Overall Study|Death|1
4662229|NCT02214225|7551498|FG000|Overall Study|randomized in error, not vaccinated|2
4662230|NCT02214225|7551499|FG001|Overall Study|randomized in error, not vaccinated|1
4662231|NCT02214225|7551500|FG002|Overall Study|randomized in error, not vaccinated|1
4662232|NCT02215252|7551628|FG000|Overall Study|Adverse Event|1
4662233|NCT02215252|7551629|FG001|Overall Study|Adverse Event|5
4662234|NCT02215252|7551630|FG002|Overall Study|Adverse Event|2
4662235|NCT02215252|7551628|FG000|Overall Study|Lost to Follow-up|0
4662236|NCT02215252|7551629|FG001|Overall Study|Lost to Follow-up|0
4662237|NCT02215252|7551630|FG002|Overall Study|Lost to Follow-up|1
4662238|NCT02215252|7551628|FG000|Overall Study|Does not Meet Entrance Criteria|0
4662239|NCT02215252|7551629|FG001|Overall Study|Does not Meet Entrance Criteria|1
4662240|NCT02215252|7551630|FG002|Overall Study|Does not Meet Entrance Criteria|0
4662241|NCT02215252|7551628|FG000|Overall Study|Protocol Violation|0
4662242|NCT02215252|7551629|FG001|Overall Study|Protocol Violation|1
4662243|NCT02215252|7551630|FG002|Overall Study|Protocol Violation|0
4662244|NCT02215252|7551628|FG000|Overall Study|Withdrawal by Subject|1
4662245|NCT02215252|7551629|FG001|Overall Study|Withdrawal by Subject|0
4662246|NCT02215252|7551630|FG002|Overall Study|Withdrawal by Subject|0
4662247|NCT02215252|7551628|FG000|Overall Study|Other|0
4662248|NCT02215252|7551629|FG001|Overall Study|Other|1
4662249|NCT02215252|7551630|FG002|Overall Study|Other|1
4662250|NCT02215616|7551646|FG000|Overall Study|Sponsor requested to stop study drug|0
4662251|NCT02215616|7551647|FG001|Overall Study|Sponsor requested to stop study drug|0
4662252|NCT02215616|7551648|FG002|Overall Study|Sponsor requested to stop study drug|1
4662253|NCT02215616|7551649|FG003|Overall Study|Sponsor requested to stop study drug|4
4662254|NCT02215616|7551646|FG000|Overall Study|Death|1
4662255|NCT02215616|7551647|FG001|Overall Study|Death|0
4662256|NCT02215616|7551648|FG002|Overall Study|Death|0
4662257|NCT02215616|7551649|FG003|Overall Study|Death|0
4662258|NCT02215616|7551646|FG000|Overall Study|Adverse Event|7
4662259|NCT02215616|7551647|FG001|Overall Study|Adverse Event|4
4662260|NCT02215616|7551648|FG002|Overall Study|Adverse Event|9
4662261|NCT02215616|7551649|FG003|Overall Study|Adverse Event|2
4662262|NCT02215616|7551646|FG000|Overall Study|Withdrawal by Subject|1
4662263|NCT02215616|7551647|FG001|Overall Study|Withdrawal by Subject|8
4662264|NCT02215616|7551648|FG002|Overall Study|Withdrawal by Subject|2
4662265|NCT02215616|7551649|FG003|Overall Study|Withdrawal by Subject|5
4662266|NCT02215616|7551646|FG000|Overall Study|Non-compliance|0
4662267|NCT02215616|7551647|FG001|Overall Study|Non-compliance|2
4662268|NCT02215616|7551648|FG002|Overall Study|Non-compliance|1
4662269|NCT02215616|7551649|FG003|Overall Study|Non-compliance|0
4662270|NCT02215616|7551646|FG000|Overall Study|Protocol Violation|0
4662271|NCT02215616|7551647|FG001|Overall Study|Protocol Violation|2
4662272|NCT02215616|7551648|FG002|Overall Study|Protocol Violation|0
4662273|NCT02215616|7551649|FG003|Overall Study|Protocol Violation|0
4662274|NCT02215616|7551646|FG000|Overall Study|Lost to Follow-up|1
4662275|NCT02215616|7551647|FG001|Overall Study|Lost to Follow-up|1
4662276|NCT02215616|7551648|FG002|Overall Study|Lost to Follow-up|0
4662277|NCT02215616|7551649|FG003|Overall Study|Lost to Follow-up|1
4662278|NCT02215616|7551646|FG000|Overall Study|Other than specified|1
4662279|NCT02215616|7551647|FG001|Overall Study|Other than specified|0
4662280|NCT02215616|7551648|FG002|Overall Study|Other than specified|1
4662281|NCT02215616|7551649|FG003|Overall Study|Other than specified|1
4662282|NCT02215954|7551662|FG000|Overall Study|Adverse Event|0
4662283|NCT02215954|7551663|FG001|Overall Study|Adverse Event|0
4751122|NCT01072175|7725281|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0
4751123|NCT01072175|7725282|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0
4751124|NCT01072175|7725283|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0
4751125|NCT01072175|7725284|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0
4751126|NCT01072175|7725285|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0
4751127|NCT01072175|7725286|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0
4751128|NCT01072175|7725287|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0
4751129|NCT01072175|7725288|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0
4751130|NCT01072175|7725276|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1
4751131|NCT01072175|7725277|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
4662284|NCT02215954|7551664|FG002|Overall Study|Adverse Event|1
4662285|NCT02215954|7551662|FG000|Overall Study|Withdrawal by Subject|0
4662286|NCT02215954|7551663|FG001|Overall Study|Withdrawal by Subject|0
4662287|NCT02215954|7551664|FG002|Overall Study|Withdrawal by Subject|2
4662288|NCT02215954|7551662|FG000|Overall Study|Not exposed|1
4662289|NCT02215954|7551663|FG001|Overall Study|Not exposed|1
4662290|NCT02215954|7551664|FG002|Overall Study|Not exposed|3
4662291|NCT02215967|7551677|FG000|Overall Study|Patient became ineligible for treatment|0
4662292|NCT02215967|7551678|FG001|Overall Study|Patient became ineligible for treatment|0
4662293|NCT02215967|7551679|FG002|Overall Study|Patient became ineligible for treatment|0
4662294|NCT02215967|7551680|FG003|Overall Study|Patient became ineligible for treatment|3
4662295|NCT02215967|7551677|FG000|Overall Study|Patient did not get CAR T-Cells|0
4662296|NCT02215967|7551678|FG001|Overall Study|Patient did not get CAR T-Cells|0
4662297|NCT02215967|7551679|FG002|Overall Study|Patient did not get CAR T-Cells|1
4662298|NCT02215967|7551680|FG003|Overall Study|Patient did not get CAR T-Cells|0
4662299|NCT02216071|7551692|FG000|Overall Study|Withdrawal by Subject|7
4662300|NCT02216071|7551693|FG001|Overall Study|Withdrawal by Subject|2
4662301|NCT02216071|7551692|FG000|Overall Study|Lost to Follow-up|3
4662302|NCT02216071|7551693|FG001|Overall Study|Lost to Follow-up|3
4662303|NCT02216071|7551692|FG000|Overall Study|Protocol Violation|3
4662304|NCT02216071|7551693|FG001|Overall Study|Protocol Violation|5
4662305|NCT02216071|7551692|FG000|Overall Study|Other|2
4662306|NCT02216071|7551693|FG001|Overall Study|Other|2
4662307|NCT02216123|7551710|FG000|Overall Study|Lost to Follow-up|4
4662308|NCT02216123|7551711|FG001|Overall Study|Lost to Follow-up|2
4662309|NCT02216123|7551710|FG000|Overall Study|Withdrawal by Subject|2
4662310|NCT02216123|7551711|FG001|Overall Study|Withdrawal by Subject|0
4662311|NCT02216214|7551736|FG000|Overall Study|Randomized Never Received Study Drug|1
4662312|NCT02216214|7551737|FG001|Overall Study|Randomized Never Received Study Drug|0
4662313|NCT02216214|7551736|FG000|Overall Study|Adverse Event|10
4662314|NCT02216214|7551737|FG001|Overall Study|Adverse Event|8
4662315|NCT02216214|7551736|FG000|Overall Study|Lack of Efficacy|2
4662316|NCT02216214|7551737|FG001|Overall Study|Lack of Efficacy|2
4662317|NCT02216214|7551736|FG000|Overall Study|Lost to Follow-up|3
4662318|NCT02216214|7551737|FG001|Overall Study|Lost to Follow-up|2
4662319|NCT02216214|7551736|FG000|Overall Study|Protocol Violation|4
4662320|NCT02216214|7551737|FG001|Overall Study|Protocol Violation|2
4662321|NCT02216214|7551736|FG000|Overall Study|Withdrawal by Subject|22
4751132|NCT01072175|7725278|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
4751133|NCT01072175|7725279|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
4751134|NCT01072175|7725280|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
4751135|NCT01072175|7725281|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
4751136|NCT01072175|7725282|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
4751137|NCT01072175|7725283|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
4751138|NCT01072175|7725284|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
4751139|NCT01072175|7725285|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
4751140|NCT01072175|7725286|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
4751141|NCT01072175|7725287|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
4751142|NCT01072175|7725288|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
4751143|NCT01072175|7725276|FG000|Part B (Dose Escalation and Expansion)|Death|0
4751144|NCT01072175|7725277|FG001|Part B (Dose Escalation and Expansion)|Death|4
4751145|NCT01072175|7725278|FG002|Part B (Dose Escalation and Expansion)|Death|18
4751146|NCT01072175|7725279|FG003|Part B (Dose Escalation and Expansion)|Death|21
4751147|NCT01072175|7725280|FG004|Part B (Dose Escalation and Expansion)|Death|68
4751148|NCT01072175|7725281|FG005|Part B (Dose Escalation and Expansion)|Death|0
4751149|NCT01072175|7725282|FG006|Part B (Dose Escalation and Expansion)|Death|0
4751150|NCT01072175|7725283|FG007|Part B (Dose Escalation and Expansion)|Death|0
4751151|NCT01072175|7725284|FG008|Part B (Dose Escalation and Expansion)|Death|0
4751152|NCT01072175|7725285|FG009|Part B (Dose Escalation and Expansion)|Death|0
4751153|NCT01072175|7725286|FG010|Part B (Dose Escalation and Expansion)|Death|0
4751154|NCT01072175|7725287|FG011|Part B (Dose Escalation and Expansion)|Death|0
4751155|NCT01072175|7725288|FG012|Part B (Dose Escalation and Expansion)|Death|0
4751156|NCT01072175|7725276|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0
4751157|NCT01072175|7725277|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0
4751158|NCT01072175|7725278|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2
4751159|NCT01072175|7725279|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0
4751160|NCT01072175|7725280|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4
4751161|NCT01072175|7725281|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0
4751162|NCT01072175|7725282|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0
4751163|NCT01072175|7725283|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0
4751164|NCT01072175|7725284|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0
4751165|NCT01072175|7725285|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0
4751166|NCT01072175|7725286|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0
4751167|NCT01072175|7725287|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0
4751168|NCT01072175|7725288|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0
4751169|NCT01072175|7725276|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
4751170|NCT01072175|7725277|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1
4751171|NCT01072175|7725278|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
4751172|NCT01072175|7725279|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1
4751173|NCT01072175|7725280|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6
4751174|NCT01072175|7725281|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
4751175|NCT01072175|7725282|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
4751176|NCT01072175|7725283|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
4751177|NCT01072175|7725284|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
4751178|NCT01072175|7725285|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
4751179|NCT01072175|7725286|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
4751180|NCT01072175|7725287|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
4751181|NCT01072175|7725288|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
4751182|NCT01072175|7725276|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
4751183|NCT01072175|7725277|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
4662322|NCT02216214|7551737|FG001|Overall Study|Withdrawal by Subject|20
4662323|NCT02216214|7551736|FG000|Overall Study|Study Terminated By Sponsor|0
4662324|NCT02216214|7551737|FG001|Overall Study|Study Terminated By Sponsor|1
4662325|NCT02216214|7551736|FG000|Overall Study|Miscellaneous|1
4662326|NCT02216214|7551737|FG001|Overall Study|Miscellaneous|1
4662327|NCT02216357|7551745|FG000|Overall Study|Inclusion or exclusion criteria not met|2
4662328|NCT02216357|7551746|FG001|Overall Study|Inclusion or exclusion criteria not met|1
4662329|NCT02216526|7551759|FG000|Overall Study|Adverse Event|1
4662330|NCT02216526|7551760|FG001|Overall Study|Adverse Event|1
4662331|NCT02216526|7551761|FG002|Overall Study|Adverse Event|0
4662332|NCT02216526|7551759|FG000|Overall Study|Death|0
4662333|NCT02216526|7551760|FG001|Overall Study|Death|1
4662334|NCT02216526|7551761|FG002|Overall Study|Death|3
4662335|NCT02216526|7551759|FG000|Overall Study|Protocol Violation|2
4662336|NCT02216526|7551760|FG001|Overall Study|Protocol Violation|0
4662337|NCT02216526|7551761|FG002|Overall Study|Protocol Violation|2
4662338|NCT02216526|7551759|FG000|Overall Study|Hospitalization|2
4662339|NCT02216526|7551760|FG001|Overall Study|Hospitalization|1
4662340|NCT02216526|7551761|FG002|Overall Study|Hospitalization|3
4662341|NCT02216591|7551771|FG000|Overall Study|Lost to Follow-up|0
4662342|NCT02216591|7551772|FG001|Overall Study|Lost to Follow-up|1
4662343|NCT02216773|7551789|FG000|Overall Study|Disease progression|4
4662344|NCT02216773|7551790|FG001|Overall Study|Disease progression|2
4662345|NCT02216773|7551789|FG000|Overall Study|Insufficient FLRV|4
4662346|NCT02216773|7551790|FG001|Overall Study|Insufficient FLRV|0
4662347|NCT02216773|7551789|FG000|Overall Study|Abandoned|4
4662348|NCT02216773|7551790|FG001|Overall Study|Abandoned|3
4662349|NCT02216812|7551798|FG000|Overall Study|Lost to Follow-up|10
4662350|NCT02216812|7551799|FG001|Overall Study|Lost to Follow-up|5
4662351|NCT02217280|7551814|FG000|Overall Study|Withdrawal by Subject|2
4662352|NCT02217280|7551814|FG000|Overall Study|Post-consent sceen fail|2
4662353|NCT02217332|7551819|FG000|Overall Study|Adverse Event|3
4662354|NCT02217332|7551819|FG000|Overall Study|Dose interruption >1 month|1
4662355|NCT02217332|7551819|FG000|Overall Study|Protocol Violation (eligibility)|1
4662356|NCT02217332|7551819|FG000|Overall Study|Withdrawal by Subject|1
4662357|NCT02217332|7551819|FG000|Overall Study|Lost to Follow-up|1
4662358|NCT02217410|7551826|FG000|Overall Study|Graft Loss|0
4662359|NCT02217410|7551827|FG001|Overall Study|Graft Loss|0
4662360|NCT02217410|7551828|FG002|Overall Study|Graft Loss|2
4662361|NCT02217410|7551826|FG000|Overall Study|Withdrawal by Subject|0
4662362|NCT02217410|7551827|FG001|Overall Study|Withdrawal by Subject|0
4662363|NCT02217410|7551828|FG002|Overall Study|Withdrawal by Subject|2
4662364|NCT02217410|7551826|FG000|Overall Study|Lost to Follow-up|0
4662365|NCT02217410|7551827|FG001|Overall Study|Lost to Follow-up|0
4662366|NCT02217410|7551828|FG002|Overall Study|Lost to Follow-up|1
4662367|NCT02217410|7551826|FG000|Overall Study|Lack of Efficacy|0
4662368|NCT02217410|7551827|FG001|Overall Study|Lack of Efficacy|1
4662369|NCT02217410|7551828|FG002|Overall Study|Lack of Efficacy|0
4662370|NCT02217410|7551826|FG000|Overall Study|Physician Decision|1
4662371|NCT02217410|7551827|FG001|Overall Study|Physician Decision|3
4662372|NCT02217410|7551828|FG002|Overall Study|Physician Decision|0
4662373|NCT02217436|7551843|FG000|Overall Study|Protocol Violation|1
4662374|NCT02217436|7551844|FG001|Overall Study|Protocol Violation|1
4662375|NCT02217436|7551843|FG000|Overall Study|Incomplete data|0
4662376|NCT02217436|7551844|FG001|Overall Study|Incomplete data|1
4662377|NCT02217475|7551853|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0
4662378|NCT02217475|7551854|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1
4662379|NCT02217475|7551855|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0
4662380|NCT02217475|7551853|FG000|Treatment Period 1 (Year 1)|Adverse Event|4
4662381|NCT02217475|7551854|FG001|Treatment Period 1 (Year 1)|Adverse Event|5
4662382|NCT02217475|7551855|FG002|Treatment Period 1 (Year 1)|Adverse Event|9
4662383|NCT02217475|7551853|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1
4662384|NCT02217475|7551854|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0
4662385|NCT02217475|7551855|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0
4662386|NCT02217475|7551853|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5
4662387|NCT02217475|7551854|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2
4662388|NCT02217475|7551855|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11
4662389|NCT02217475|7551853|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0
4662390|NCT02217475|7551854|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0
4662391|NCT02217475|7551855|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1
4662392|NCT02217475|7551853|FG000|Discontinued After Period 1|Adverse Event|1
4662393|NCT02217475|7551854|FG001|Discontinued After Period 1|Adverse Event|2
4662394|NCT02217475|7551855|FG002|Discontinued After Period 1|Adverse Event|0
4662395|NCT02217475|7551853|FG000|Discontinued After Period 1|Participant Withdrew Consent|1
4662396|NCT02217475|7551854|FG001|Discontinued After Period 1|Participant Withdrew Consent|1
4662397|NCT02217475|7551855|FG002|Discontinued After Period 1|Participant Withdrew Consent|2
4662398|NCT02217475|7551853|FG000|Discontinued After Period 1|Physician Decision|0
4662399|NCT02217475|7551854|FG001|Discontinued After Period 1|Physician Decision|0
4662400|NCT02217475|7551855|FG002|Discontinued After Period 1|Physician Decision|1
4662401|NCT02217475|7551853|FG000|Treatment Period 2 (Year 2)|Adverse Event|0
4662402|NCT02217475|7551854|FG001|Treatment Period 2 (Year 2)|Adverse Event|1
4662403|NCT02217475|7551855|FG002|Treatment Period 2 (Year 2)|Adverse Event|5
4662404|NCT02217475|7551853|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0
4662405|NCT02217475|7551854|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1
4662406|NCT02217475|7551855|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2
4662407|NCT02217475|7551853|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2
4662408|NCT02217475|7551854|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0
4662409|NCT02217475|7551855|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2
4662410|NCT02217475|7551853|FG000|Treatment Period 2 (Year 2)|Physician Decision|0
4662411|NCT02217475|7551854|FG001|Treatment Period 2 (Year 2)|Physician Decision|0
4662412|NCT02217475|7551855|FG002|Treatment Period 2 (Year 2)|Physician Decision|2
4662413|NCT02217475|7551853|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0
4662414|NCT02217475|7551854|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0
4662415|NCT02217475|7551855|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1
4662416|NCT02217501|7551874|FG000|Overall Study|Death|3
4662417|NCT02217501|7551875|FG001|Overall Study|Death|4
4751184|NCT01072175|7725278|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3
4751185|NCT01072175|7725279|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2
4751186|NCT01072175|7725280|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10
4751187|NCT01072175|7725281|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
4751188|NCT01072175|7725282|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
4751189|NCT01072175|7725283|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
4751190|NCT01072175|7725284|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
4751191|NCT01072175|7725285|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
4751192|NCT01072175|7725286|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
4751193|NCT01072175|7725287|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
4751194|NCT01072175|7725288|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
4751195|NCT01072175|7725276|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
4751196|NCT01072175|7725277|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1
4751197|NCT01072175|7725278|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
4751198|NCT01072175|7725279|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3
4751199|NCT01072175|7725280|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6
4751200|NCT01072175|7725281|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
4751201|NCT01072175|7725282|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
4751202|NCT01072175|7725283|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
4751203|NCT01072175|7725284|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
4751204|NCT01072175|7725285|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
4751205|NCT01072175|7725286|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
4751206|NCT01072175|7725287|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
4751207|NCT01072175|7725288|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
4751208|NCT01072175|7725276|FG000|Part C (Phase II: Randomized Phase)|Death|0
4751209|NCT01072175|7725277|FG001|Part C (Phase II: Randomized Phase)|Death|0
4751210|NCT01072175|7725278|FG002|Part C (Phase II: Randomized Phase)|Death|0
4751211|NCT01072175|7725279|FG003|Part C (Phase II: Randomized Phase)|Death|0
4751212|NCT01072175|7725280|FG004|Part C (Phase II: Randomized Phase)|Death|0
4751213|NCT01072175|7725281|FG005|Part C (Phase II: Randomized Phase)|Death|44
4751214|NCT01072175|7725282|FG006|Part C (Phase II: Randomized Phase)|Death|34
4751215|NCT01072175|7725283|FG007|Part C (Phase II: Randomized Phase)|Death|39
4751216|NCT01072175|7725284|FG008|Part C (Phase II: Randomized Phase)|Death|0
4751217|NCT01072175|7725285|FG009|Part C (Phase II: Randomized Phase)|Death|0
4751218|NCT01072175|7725286|FG010|Part C (Phase II: Randomized Phase)|Death|0
4751219|NCT01072175|7725287|FG011|Part C (Phase II: Randomized Phase)|Death|0
4751220|NCT01072175|7725288|FG012|Part C (Phase II: Randomized Phase)|Death|0
4751221|NCT01072175|7725276|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0
4751222|NCT01072175|7725277|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0
4751223|NCT01072175|7725278|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0
4751224|NCT01072175|7725279|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0
4751225|NCT01072175|7725280|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0
4751226|NCT01072175|7725281|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1
4751227|NCT01072175|7725282|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1
4751228|NCT01072175|7725283|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1
4751229|NCT01072175|7725284|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0
4751230|NCT01072175|7725285|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0
4751231|NCT01072175|7725286|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0
4751232|NCT01072175|7725287|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0
4751233|NCT01072175|7725288|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0
4751234|NCT01072175|7725276|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
4751235|NCT01072175|7725277|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
4751236|NCT01072175|7725278|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
4751237|NCT01072175|7725279|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
4751238|NCT01072175|7725280|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
4751239|NCT01072175|7725281|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
4751240|NCT01072175|7725282|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3
4751241|NCT01072175|7725283|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3
4751242|NCT01072175|7725284|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
4751243|NCT01072175|7725285|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
4662418|NCT02217527|7551883|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1
4662419|NCT02217527|7551884|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3
4662420|NCT02217527|7551883|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0
4662421|NCT02217527|7551884|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1
4662422|NCT02217566|7551890|FG000|Overall Study|Lost to Follow-up|2
4662423|NCT02217566|7551890|FG000|Overall Study|Death|3
4662424|NCT02217566|7551890|FG000|Overall Study|Early study termination|6
4662425|NCT02217878|7551912|FG000|Overall Study|required morphine due to chest pain|1
4662426|NCT02217878|7551913|FG001|Overall Study|required morphine due to chest pain|2
4662427|NCT02217878|7551912|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1
4662428|NCT02217878|7551913|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0
4662429|NCT02217982|7551944|FG000|Overall Study|Trial discontinued|1
4662430|NCT02217982|7551945|FG001|Overall Study|Trial discontinued|0
4662431|NCT02217982|7551944|FG000|Overall Study|Adverse Event|0
4662432|NCT02217982|7551945|FG001|Overall Study|Adverse Event|1
4662433|NCT02218008|7551954|FG000|Stage 1 (S1)|Adverse Event|6
4662434|NCT02218008|7551955|FG001|Stage 1 (S1)|Adverse Event|5
4662435|NCT02218008|7551956|FG002|Stage 1 (S1)|Adverse Event|11
4662436|NCT02218008|7551957|FG003|Stage 1 (S1)|Adverse Event|0
4662437|NCT02218008|7551958|FG004|Stage 1 (S1)|Adverse Event|0
4662438|NCT02218008|7551959|FG005|Stage 1 (S1)|Adverse Event|0
4662439|NCT02218008|7551954|FG000|Stage 1 (S1)|Withdrawal by Subject|6
4662440|NCT02218008|7551955|FG001|Stage 1 (S1)|Withdrawal by Subject|1
4662441|NCT02218008|7551956|FG002|Stage 1 (S1)|Withdrawal by Subject|1
4662442|NCT02218008|7551957|FG003|Stage 1 (S1)|Withdrawal by Subject|0
4662443|NCT02218008|7551958|FG004|Stage 1 (S1)|Withdrawal by Subject|0
4662444|NCT02218008|7551959|FG005|Stage 1 (S1)|Withdrawal by Subject|0
4751244|NCT01072175|7725286|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
4751245|NCT01072175|7725287|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
4751246|NCT01072175|7725288|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
4751247|NCT01072175|7725276|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
4751248|NCT01072175|7725277|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
4751249|NCT01072175|7725278|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
4751250|NCT01072175|7725279|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
4751251|NCT01072175|7725280|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
4751252|NCT01072175|7725281|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6
4751253|NCT01072175|7725282|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9
4751254|NCT01072175|7725283|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11
4751255|NCT01072175|7725284|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
4751256|NCT01072175|7725285|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
4751257|NCT01072175|7725286|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
4751258|NCT01072175|7725287|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
4751259|NCT01072175|7725288|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
4751260|NCT01072175|7725276|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
4751261|NCT01072175|7725277|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
4751262|NCT01072175|7725278|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
4751263|NCT01072175|7725279|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
4751264|NCT01072175|7725280|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
4751265|NCT01072175|7725281|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3
4751266|NCT01072175|7725282|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7
4662445|NCT02218008|7551954|FG000|Stage 1 (S1)|Lack of Efficacy|3
4662446|NCT02218008|7551955|FG001|Stage 1 (S1)|Lack of Efficacy|0
4662447|NCT02218008|7551956|FG002|Stage 1 (S1)|Lack of Efficacy|0
4662448|NCT02218008|7551957|FG003|Stage 1 (S1)|Lack of Efficacy|0
4662449|NCT02218008|7551958|FG004|Stage 1 (S1)|Lack of Efficacy|0
4662450|NCT02218008|7551959|FG005|Stage 1 (S1)|Lack of Efficacy|0
4662451|NCT02218008|7551954|FG000|Stage 1 (S1)|Lost to Follow-up|3
4662452|NCT02218008|7551955|FG001|Stage 1 (S1)|Lost to Follow-up|0
4662453|NCT02218008|7551956|FG002|Stage 1 (S1)|Lost to Follow-up|1
4662454|NCT02218008|7551957|FG003|Stage 1 (S1)|Lost to Follow-up|0
4662455|NCT02218008|7551958|FG004|Stage 1 (S1)|Lost to Follow-up|0
4662456|NCT02218008|7551959|FG005|Stage 1 (S1)|Lost to Follow-up|0
4662457|NCT02218008|7551954|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2
4662458|NCT02218008|7551955|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1
4662459|NCT02218008|7551956|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0
4662460|NCT02218008|7551957|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0
4662461|NCT02218008|7551958|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0
4662462|NCT02218008|7551959|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0
4662463|NCT02218008|7551954|FG000|Stage 1 (S1)|Non-compliance; drug use|1
4662464|NCT02218008|7551955|FG001|Stage 1 (S1)|Non-compliance; drug use|0
4662465|NCT02218008|7551956|FG002|Stage 1 (S1)|Non-compliance; drug use|0
4662466|NCT02218008|7551957|FG003|Stage 1 (S1)|Non-compliance; drug use|0
4662467|NCT02218008|7551958|FG004|Stage 1 (S1)|Non-compliance; drug use|0
4662468|NCT02218008|7551959|FG005|Stage 1 (S1)|Non-compliance; drug use|0
4662469|NCT02218008|7551954|FG000|Stage 1 (S1)|Pregnancy|0
4662470|NCT02218008|7551955|FG001|Stage 1 (S1)|Pregnancy|0
4662471|NCT02218008|7551956|FG002|Stage 1 (S1)|Pregnancy|1
4662472|NCT02218008|7551957|FG003|Stage 1 (S1)|Pregnancy|0
4662473|NCT02218008|7551958|FG004|Stage 1 (S1)|Pregnancy|0
4662474|NCT02218008|7551959|FG005|Stage 1 (S1)|Pregnancy|0
4662475|NCT02218008|7551954|FG000|Stage 1 (S1)|Protocol Violation|0
4662476|NCT02218008|7551955|FG001|Stage 1 (S1)|Protocol Violation|0
4662477|NCT02218008|7551956|FG002|Stage 1 (S1)|Protocol Violation|1
4662478|NCT02218008|7551957|FG003|Stage 1 (S1)|Protocol Violation|0
4662479|NCT02218008|7551958|FG004|Stage 1 (S1)|Protocol Violation|0
4662480|NCT02218008|7551959|FG005|Stage 1 (S1)|Protocol Violation|0
4662481|NCT02218008|7551954|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1
4662482|NCT02218008|7551955|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
4662483|NCT02218008|7551956|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
4662484|NCT02218008|7551957|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
4662485|NCT02218008|7551958|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
4662486|NCT02218008|7551959|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
4662487|NCT02218008|7551954|FG000|Stage 2 (S2)|Adverse Event|0
4662488|NCT02218008|7551955|FG001|Stage 2 (S2)|Adverse Event|0
4662489|NCT02218008|7551956|FG002|Stage 2 (S2)|Adverse Event|0
4662490|NCT02218008|7551957|FG003|Stage 2 (S2)|Adverse Event|2
4662491|NCT02218008|7551958|FG004|Stage 2 (S2)|Adverse Event|3
4662492|NCT02218008|7551959|FG005|Stage 2 (S2)|Adverse Event|3
4662493|NCT02218008|7551954|FG000|Stage 2 (S2)|Withdrawal by Subject|0
4662494|NCT02218008|7551955|FG001|Stage 2 (S2)|Withdrawal by Subject|0
4662495|NCT02218008|7551956|FG002|Stage 2 (S2)|Withdrawal by Subject|0
4662496|NCT02218008|7551957|FG003|Stage 2 (S2)|Withdrawal by Subject|1
4662497|NCT02218008|7551958|FG004|Stage 2 (S2)|Withdrawal by Subject|1
4662498|NCT02218008|7551959|FG005|Stage 2 (S2)|Withdrawal by Subject|0
4662499|NCT02218008|7551954|FG000|Stage 2 (S2)|Lack of Efficacy|0
4662500|NCT02218008|7551955|FG001|Stage 2 (S2)|Lack of Efficacy|0
4662501|NCT02218008|7551956|FG002|Stage 2 (S2)|Lack of Efficacy|0
4662502|NCT02218008|7551957|FG003|Stage 2 (S2)|Lack of Efficacy|0
4662503|NCT02218008|7551958|FG004|Stage 2 (S2)|Lack of Efficacy|0
4662504|NCT02218008|7551959|FG005|Stage 2 (S2)|Lack of Efficacy|2
4662505|NCT02218008|7551954|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
4662506|NCT02218008|7551955|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
4662507|NCT02218008|7551956|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
4662508|NCT02218008|7551957|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1
4662509|NCT02218008|7551958|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
4662510|NCT02218008|7551959|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
4662511|NCT02218008|7551954|FG000|Stage 2 (S2)|Lost to Follow-up|0
4662512|NCT02218008|7551955|FG001|Stage 2 (S2)|Lost to Follow-up|0
4662513|NCT02218008|7551956|FG002|Stage 2 (S2)|Lost to Follow-up|0
4662514|NCT02218008|7551957|FG003|Stage 2 (S2)|Lost to Follow-up|0
4662515|NCT02218008|7551958|FG004|Stage 2 (S2)|Lost to Follow-up|0
4662516|NCT02218008|7551959|FG005|Stage 2 (S2)|Lost to Follow-up|1
4662517|NCT02218216|7552010|FG000|Overall Study|Study terminated before completed|6
4751267|NCT01072175|7725283|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
4751268|NCT01072175|7725284|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
4751269|NCT01072175|7725285|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
4751270|NCT01072175|7725286|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
4751271|NCT01072175|7725287|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
4751272|NCT01072175|7725288|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
4751273|NCT01072175|7725276|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0
4751274|NCT01072175|7725277|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0
4751275|NCT01072175|7725278|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0
4751276|NCT01072175|7725279|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0
4751277|NCT01072175|7725280|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0
4751278|NCT01072175|7725281|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0
4751279|NCT01072175|7725282|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0
4751280|NCT01072175|7725283|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0
4751281|NCT01072175|7725284|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37
4751282|NCT01072175|7725285|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0
4751283|NCT01072175|7725286|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0
4751284|NCT01072175|7725287|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0
4751285|NCT01072175|7725288|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0
4751286|NCT01072175|7725276|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
4751287|NCT01072175|7725277|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
4751288|NCT01072175|7725278|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
4751289|NCT01072175|7725279|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
4751290|NCT01072175|7725280|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
4751291|NCT01072175|7725281|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
4751292|NCT01072175|7725282|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
4751293|NCT01072175|7725283|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
4751294|NCT01072175|7725284|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1
4662518|NCT02218216|7552011|FG001|Overall Study|Study terminated before completed|0
4662519|NCT02218216|7552012|FG002|Overall Study|Study terminated before completed|0
4662520|NCT02218268|7552024|FG000|24 Hour Washout|Physician Decision|11
4662521|NCT02218268|7552025|FG001|24 Hour Washout|Physician Decision|9
4662522|NCT02218372|7552051|FG000|Overall Study|Adverse Event|1
4662523|NCT02218372|7552052|FG001|Overall Study|Adverse Event|1
4662524|NCT02218372|7552051|FG000|Overall Study|Miscellaneous|2
4662525|NCT02218372|7552052|FG001|Overall Study|Miscellaneous|1
4662526|NCT02218372|7552051|FG000|Overall Study|Randomized but did not receive treatment|2
4662527|NCT02218372|7552052|FG001|Overall Study|Randomized but did not receive treatment|3
4662528|NCT02218372|7552051|FG000|Overall Study|Withdrawal by Parent/Guardian|0
4662529|NCT02218372|7552052|FG001|Overall Study|Withdrawal by Parent/Guardian|1
4662530|NCT02218489|7552083|FG000|Overall Study|Withdrawal by Subject|4
4662531|NCT02218489|7552084|FG001|Overall Study|Withdrawal by Subject|3
4662532|NCT02218489|7552083|FG000|Overall Study|Lost to Follow-up|1
4662533|NCT02218489|7552084|FG001|Overall Study|Lost to Follow-up|0
4662534|NCT02218541|7552093|FG000|Overall Study|Lost to Follow-up|2
4662535|NCT02218541|7552094|FG001|Overall Study|Lost to Follow-up|1
4662536|NCT02218541|7552093|FG000|Overall Study|Implant Failure|4
4662537|NCT02218541|7552094|FG001|Overall Study|Implant Failure|1
4662538|NCT02218736|7552103|FG000|Overall Study|Withdrawal by Subject|10
4662539|NCT02218736|7552104|FG001|Overall Study|Withdrawal by Subject|9
4662540|NCT02218736|7552103|FG000|Overall Study|Protocol Violation|2
4662541|NCT02218736|7552104|FG001|Overall Study|Protocol Violation|0
4662542|NCT02219009|7552112|FG000|Overall Study|Withdrawal by Subject|5
4662543|NCT02219009|7552113|FG001|Overall Study|Withdrawal by Subject|1
4751295|NCT01072175|7725285|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
4751296|NCT01072175|7725286|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
4751297|NCT01072175|7725287|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
4751298|NCT01072175|7725288|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
4751299|NCT01072175|7725276|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
4751300|NCT01072175|7725277|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
4751301|NCT01072175|7725278|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
4751302|NCT01072175|7725279|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
4751303|NCT01072175|7725280|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
4751304|NCT01072175|7725281|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
4751305|NCT01072175|7725282|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
4751306|NCT01072175|7725283|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
4751307|NCT01072175|7725284|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4
4751308|NCT01072175|7725285|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
4751309|NCT01072175|7725286|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
4751310|NCT01072175|7725287|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
4751311|NCT01072175|7725288|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
4751312|NCT01072175|7725276|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
4751313|NCT01072175|7725277|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
4751314|NCT01072175|7725278|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
4751315|NCT01072175|7725279|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
4751316|NCT01072175|7725280|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
4751317|NCT01072175|7725281|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
4751318|NCT01072175|7725282|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
4751319|NCT01072175|7725283|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
4751320|NCT01072175|7725284|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3
4751321|NCT01072175|7725285|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
4751322|NCT01072175|7725286|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
4751323|NCT01072175|7725287|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
4751324|NCT01072175|7725288|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
4751325|NCT01072175|7725276|FG000|Part D (HPMC Capsules)|Death|0
4751326|NCT01072175|7725277|FG001|Part D (HPMC Capsules)|Death|0
4751327|NCT01072175|7725278|FG002|Part D (HPMC Capsules)|Death|0
4751328|NCT01072175|7725279|FG003|Part D (HPMC Capsules)|Death|0
4751329|NCT01072175|7725280|FG004|Part D (HPMC Capsules)|Death|0
4751330|NCT01072175|7725281|FG005|Part D (HPMC Capsules)|Death|0
4751331|NCT01072175|7725282|FG006|Part D (HPMC Capsules)|Death|0
4751332|NCT01072175|7725283|FG007|Part D (HPMC Capsules)|Death|0
4751333|NCT01072175|7725284|FG008|Part D (HPMC Capsules)|Death|0
4751334|NCT01072175|7725285|FG009|Part D (HPMC Capsules)|Death|10
4751335|NCT01072175|7725286|FG010|Part D (HPMC Capsules)|Death|12
4751336|NCT01072175|7725287|FG011|Part D (HPMC Capsules)|Death|28
4751337|NCT01072175|7725288|FG012|Part D (HPMC Capsules)|Death|26
4751338|NCT01072175|7725276|FG000|Part D (HPMC Capsules)|Physician Decision|0
4751339|NCT01072175|7725277|FG001|Part D (HPMC Capsules)|Physician Decision|0
4751340|NCT01072175|7725278|FG002|Part D (HPMC Capsules)|Physician Decision|0
4751341|NCT01072175|7725279|FG003|Part D (HPMC Capsules)|Physician Decision|0
4751342|NCT01072175|7725280|FG004|Part D (HPMC Capsules)|Physician Decision|0
4751343|NCT01072175|7725281|FG005|Part D (HPMC Capsules)|Physician Decision|0
4751344|NCT01072175|7725282|FG006|Part D (HPMC Capsules)|Physician Decision|0
4662544|NCT02219009|7552112|FG000|Overall Study|Adverse Event|2
4662545|NCT02219009|7552113|FG001|Overall Study|Adverse Event|4
4662546|NCT02219009|7552112|FG000|Overall Study|Lost to Follow-up|2
4662547|NCT02219009|7552113|FG001|Overall Study|Lost to Follow-up|2
4662548|NCT02219009|7552112|FG000|Overall Study|Protocol deviation|1
4662549|NCT02219009|7552113|FG001|Overall Study|Protocol deviation|0
4662550|NCT02219009|7552112|FG000|Overall Study|Physician Decision|0
4662551|NCT02219009|7552113|FG001|Overall Study|Physician Decision|1
4662552|NCT02219048|7552121|FG000|Overall Study|Adverse Event|2
4662553|NCT02219048|7552122|FG001|Overall Study|Adverse Event|5
4662554|NCT02219048|7552121|FG000|Overall Study|No longer meets eligibility criteria|1
4662555|NCT02219048|7552122|FG001|Overall Study|No longer meets eligibility criteria|0
4662556|NCT02219048|7552121|FG000|Overall Study|Study terminated by sponsor|16
4662557|NCT02219048|7552122|FG001|Overall Study|Study terminated by sponsor|15
4662558|NCT02219048|7552121|FG000|Overall Study|Withdrawal by Subject|2
4662559|NCT02219048|7552122|FG001|Overall Study|Withdrawal by Subject|0
4662560|NCT02219048|7552121|FG000|Overall Study|Other|0
4662561|NCT02219048|7552122|FG001|Overall Study|Other|1
4662562|NCT02219087|7552130|FG000|Overall Study|Randomization envelope pulled out of seq|0
4662563|NCT02219087|7552131|FG001|Overall Study|Randomization envelope pulled out of seq|1
4662564|NCT02219308|7552201|FG000|Overall Study|Withdrawal by Subject|1
4662565|NCT02219308|7552202|FG001|Overall Study|Withdrawal by Subject|2
4662566|NCT02219334|7552219|FG000|Overall Study|Withdrawal by Subject|1
4662567|NCT02219334|7552220|FG001|Overall Study|Withdrawal by Subject|0
4662568|NCT02219334|7552219|FG000|Overall Study|Protocol Violation|7
4662569|NCT02219334|7552220|FG001|Overall Study|Protocol Violation|3
4662570|NCT02219464|7552239|FG000|Overall Study|Withdrawal by Subject|1
4662571|NCT02219464|7552240|FG001|Overall Study|Withdrawal by Subject|0
4662572|NCT02219464|7552239|FG000|Overall Study|case cancelled|1
4662573|NCT02219464|7552240|FG001|Overall Study|case cancelled|0
4662574|NCT02219464|7552239|FG000|Overall Study|catheter malfunction|1
4662575|NCT02219464|7552240|FG001|Overall Study|catheter malfunction|0
4662576|NCT02219477|7552249|FG000|Overall Study|Adverse Event|0
4662577|NCT02219477|7552250|FG001|Overall Study|Adverse Event|1
4662578|NCT02219477|7552251|FG002|Overall Study|Adverse Event|1
4751345|NCT01072175|7725283|FG007|Part D (HPMC Capsules)|Physician Decision|0
4751346|NCT01072175|7725284|FG008|Part D (HPMC Capsules)|Physician Decision|0
4751347|NCT01072175|7725285|FG009|Part D (HPMC Capsules)|Physician Decision|0
4751348|NCT01072175|7725286|FG010|Part D (HPMC Capsules)|Physician Decision|1
4751349|NCT01072175|7725287|FG011|Part D (HPMC Capsules)|Physician Decision|1
4751350|NCT01072175|7725288|FG012|Part D (HPMC Capsules)|Physician Decision|1
4751351|NCT01072175|7725276|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0
4751352|NCT01072175|7725277|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0
4751353|NCT01072175|7725278|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0
4751354|NCT01072175|7725279|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0
4751355|NCT01072175|7725280|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0
4751356|NCT01072175|7725281|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0
4751357|NCT01072175|7725282|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0
4751358|NCT01072175|7725283|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0
4751359|NCT01072175|7725284|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0
4751360|NCT01072175|7725285|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0
4751361|NCT01072175|7725286|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1
4751362|NCT01072175|7725287|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1
4751363|NCT01072175|7725288|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3
4751364|NCT01072175|7725276|FG000|Part D (HPMC Capsules)|Study closed/terminated|0
4751365|NCT01072175|7725277|FG001|Part D (HPMC Capsules)|Study closed/terminated|0
4751366|NCT01072175|7725278|FG002|Part D (HPMC Capsules)|Study closed/terminated|0
4751367|NCT01072175|7725279|FG003|Part D (HPMC Capsules)|Study closed/terminated|0
4751368|NCT01072175|7725280|FG004|Part D (HPMC Capsules)|Study closed/terminated|0
4751369|NCT01072175|7725281|FG005|Part D (HPMC Capsules)|Study closed/terminated|0
4751370|NCT01072175|7725282|FG006|Part D (HPMC Capsules)|Study closed/terminated|0
4751371|NCT01072175|7725283|FG007|Part D (HPMC Capsules)|Study closed/terminated|0
4751372|NCT01072175|7725284|FG008|Part D (HPMC Capsules)|Study closed/terminated|0
4751373|NCT01072175|7725285|FG009|Part D (HPMC Capsules)|Study closed/terminated|2
4662579|NCT02219477|7552249|FG000|Overall Study|Withdrawal by Subject|0
4662580|NCT02219477|7552250|FG001|Overall Study|Withdrawal by Subject|1
4662581|NCT02219477|7552251|FG002|Overall Study|Withdrawal by Subject|0
4662582|NCT02219685|7552283|FG000|Blinded Treatment Phase|Lost to Follow-up|1
4662583|NCT02219685|7552284|FG001|Blinded Treatment Phase|Lost to Follow-up|0
4662584|NCT02219685|7552283|FG000|Blinded Treatment Phase|Withdrew Consent|1
4662585|NCT02219685|7552284|FG001|Blinded Treatment Phase|Withdrew Consent|0
4662586|NCT02219932|7552303|FG000|Overall Study|Other|5
4662587|NCT02219932|7552304|FG001|Overall Study|Other|11
4662588|NCT02219932|7552303|FG000|Overall Study|Death|1
4662589|NCT02219932|7552304|FG001|Overall Study|Death|1
4662590|NCT02219932|7552303|FG000|Overall Study|Investigator Decision|0
4662591|NCT02219932|7552304|FG001|Overall Study|Investigator Decision|1
4662592|NCT02219932|7552303|FG000|Overall Study|Consent Withdrawn|11
4662593|NCT02219932|7552304|FG001|Overall Study|Consent Withdrawn|7
4662594|NCT02219932|7552303|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10
4662595|NCT02219932|7552304|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2
4662596|NCT02219932|7552303|FG000|Overall Study|Protocol Violation|10
4662597|NCT02219932|7552304|FG001|Overall Study|Protocol Violation|6
4662598|NCT02219932|7552303|FG000|Overall Study|Pregnancy|1
4662599|NCT02219932|7552304|FG001|Overall Study|Pregnancy|0
4662600|NCT02219932|7552303|FG000|Overall Study|Lost to Follow-up|4
4662601|NCT02219932|7552304|FG001|Overall Study|Lost to Follow-up|2
4662602|NCT02219932|7552303|FG000|Overall Study|Adverse Event|23
4662603|NCT02219932|7552304|FG001|Overall Study|Adverse Event|21
4662604|NCT02220205|7552327|FG000|Overall Study|Withdrawal by Subject|1
4662605|NCT02220205|7552328|FG001|Overall Study|Withdrawal by Subject|0
4662606|NCT02220712|7552334|FG000|Overall Study|Adverse Event|1
4662607|NCT02220712|7552334|FG000|Overall Study|Withdrawal by Subject|2
4751374|NCT01072175|7725286|FG010|Part D (HPMC Capsules)|Study closed/terminated|1
4751375|NCT01072175|7725287|FG011|Part D (HPMC Capsules)|Study closed/terminated|10
4751376|NCT01072175|7725288|FG012|Part D (HPMC Capsules)|Study closed/terminated|9
4751377|NCT01072175|7725276|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0
4751378|NCT01072175|7725277|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0
4751379|NCT01072175|7725278|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0
4751380|NCT01072175|7725279|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0
4751381|NCT01072175|7725280|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0
4751382|NCT01072175|7725281|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0
4751383|NCT01072175|7725282|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0
4751384|NCT01072175|7725283|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0
4751385|NCT01072175|7725284|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0
4751386|NCT01072175|7725285|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0
4751387|NCT01072175|7725286|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1
4751388|NCT01072175|7725287|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3
4751389|NCT01072175|7725288|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0
4662608|NCT02220712|7552334|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1
4662609|NCT02220725|7552346|FG000|Overall Study|Lost to Follow-up|0
4662610|NCT02220725|7552347|FG001|Overall Study|Lost to Follow-up|0
4662611|NCT02220725|7552348|FG002|Overall Study|Lost to Follow-up|0
4662612|NCT02220725|7552349|FG003|Overall Study|Lost to Follow-up|1
4662613|NCT02220725|7552346|FG000|Overall Study|Withdrawal by Subject|0
4662614|NCT02220725|7552347|FG001|Overall Study|Withdrawal by Subject|0
4662615|NCT02220725|7552348|FG002|Overall Study|Withdrawal by Subject|0
4662616|NCT02220725|7552349|FG003|Overall Study|Withdrawal by Subject|1
4662617|NCT02220764|7552364|FG000|Overall Study|Lost to Follow-up|3
4662618|NCT02220764|7552365|FG001|Overall Study|Lost to Follow-up|1
4662619|NCT02220764|7552364|FG000|Overall Study|Death|1
4662620|NCT02220764|7552365|FG001|Overall Study|Death|0
4662621|NCT02220907|7552371|FG000|Overall Study|Adverse Event|7
4662622|NCT02220907|7552371|FG000|Overall Study|Physician Decision|1
4662623|NCT02220907|7552371|FG000|Overall Study|Withdrawal by Subject|2
4662624|NCT02220907|7552371|FG000|Overall Study|Conflict with the stopping criteria|1
4662625|NCT02220920|7552377|FG000|Overall Study|Adverse Event|1
4662626|NCT02220920|7552378|FG001|Overall Study|Adverse Event|0
4662627|NCT02220920|7552377|FG000|Overall Study|Lack of Efficacy|0
4662628|NCT02220920|7552378|FG001|Overall Study|Lack of Efficacy|1
4662629|NCT02220920|7552377|FG000|Overall Study|Withdrawal by Subject|1
4662630|NCT02220920|7552378|FG001|Overall Study|Withdrawal by Subject|0
4662631|NCT02220920|7552377|FG000|Overall Study|Conflict with the stopping criteria|1
4662632|NCT02220920|7552378|FG001|Overall Study|Conflict with the stopping criteria|2
4662633|NCT02220998|7552386|FG000|Overall Study|Randomized but Never Treated|1
4662634|NCT02220998|7552387|FG001|Overall Study|Randomized but Never Treated|2
4662635|NCT02220998|7552386|FG000|Overall Study|Death|2
4662636|NCT02220998|7552387|FG001|Overall Study|Death|0
4662637|NCT02220998|7552386|FG000|Overall Study|Lack of Efficacy|0
4662638|NCT02220998|7552387|FG001|Overall Study|Lack of Efficacy|5
4662639|NCT02220998|7552386|FG000|Overall Study|Lost to Follow-up|4
4662640|NCT02220998|7552387|FG001|Overall Study|Lost to Follow-up|4
4662641|NCT02221284|7552414|FG000|Overall Study|Case Report Forms Uncollected|56
4662642|NCT02221284|7552414|FG000|Overall Study|Protocol Deviation|5
4662643|NCT02221648|7552439|FG000|Overall Study|Withdrawal by Subject|3
4662644|NCT02221648|7552440|FG001|Overall Study|Withdrawal by Subject|3
4662645|NCT02221674|7552453|FG000|Overall Study|Lost to Follow-up|1
4662646|NCT02221674|7552454|FG001|Overall Study|Lost to Follow-up|0
4662647|NCT02221674|7552455|FG002|Overall Study|Lost to Follow-up|0
4662648|NCT02221882|7552487|FG000|Overall Study|Withdrawal by Subject|0
4662649|NCT02221882|7552488|FG001|Overall Study|Withdrawal by Subject|0
4662650|NCT02221882|7552489|FG002|Overall Study|Withdrawal by Subject|4
4662651|NCT02221882|7552490|FG003|Overall Study|Withdrawal by Subject|2
4662652|NCT02221882|7552491|FG004|Overall Study|Withdrawal by Subject|2
4662653|NCT02221882|7552492|FG005|Overall Study|Withdrawal by Subject|2
4662654|NCT02221882|7552487|FG000|Overall Study|Death|0
4662655|NCT02221882|7552488|FG001|Overall Study|Death|1
4662656|NCT02221882|7552489|FG002|Overall Study|Death|0
4662657|NCT02221882|7552490|FG003|Overall Study|Death|0
4662658|NCT02221882|7552491|FG004|Overall Study|Death|0
4662659|NCT02221882|7552492|FG005|Overall Study|Death|0
4662660|NCT02222207|7552536|FG000|Overall Study|Death|1
4662661|NCT02222207|7552536|FG000|Overall Study|Other reasons|2
4662662|NCT02222207|7552536|FG000|Overall Study|Adverse Event|1
4751390|NCT01087203|7725322|FG000|Overall Study|Lost to Follow-up|2
4751391|NCT01087203|7725323|FG001|Overall Study|Lost to Follow-up|0
4751392|NCT01087203|7725322|FG000|Overall Study|Withdrawal by Subject|2
4751393|NCT01087203|7725323|FG001|Overall Study|Withdrawal by Subject|6
4751394|NCT01087203|7725322|FG000|Overall Study|Lack of Efficacy|1
4751395|NCT01087203|7725323|FG001|Overall Study|Lack of Efficacy|2
4751396|NCT01087203|7725322|FG000|Overall Study|Study terminated by sponsor|27
4751397|NCT01087203|7725323|FG001|Overall Study|Study terminated by sponsor|27
4751398|NCT01108055|7725334|FG000|Overall Study|Ineligible|11
4751399|NCT01108055|7725334|FG000|Overall Study|Not evaluable- didn't complete treatment|4
4751400|NCT01111019|7725338|FG000|Overall Study|Withdrew Prematurely|2
4751401|NCT01111019|7725338|FG000|Overall Study|Other|1
4751402|NCT01136967|7725344|FG000|Overall Study|Adverse Event|9
4751403|NCT01136967|7725345|FG001|Overall Study|Adverse Event|12
4751404|NCT01136967|7725344|FG000|Overall Study|Participant Choice|8
4751405|NCT01136967|7725345|FG001|Overall Study|Participant Choice|3
4751406|NCT01136967|7725344|FG000|Overall Study|Lost to Follow-up|0
4751407|NCT01136967|7725345|FG001|Overall Study|Lost to Follow-up|1
4751408|NCT01136967|7725344|FG000|Overall Study|Withdrawal by Subject|1
4751409|NCT01136967|7725345|FG001|Overall Study|Withdrawal by Subject|2
4751410|NCT01136967|7725344|FG000|Overall Study|Clinical Progression|3
4751411|NCT01136967|7725345|FG001|Overall Study|Clinical Progression|5
4751412|NCT01136967|7725344|FG000|Overall Study|Radiation|1
4751413|NCT01136967|7725345|FG001|Overall Study|Radiation|0
4751414|NCT01136967|7725344|FG000|Overall Study|Non-compliance|1
4751415|NCT01136967|7725345|FG001|Overall Study|Non-compliance|0
4751416|NCT01136967|7725344|FG000|Overall Study|Investigator's Choice|1
4751417|NCT01136967|7725345|FG001|Overall Study|Investigator's Choice|1
4751418|NCT01136967|7725344|FG000|Overall Study|Increase in Lesion Size|0
4751419|NCT01136967|7725345|FG001|Overall Study|Increase in Lesion Size|2
4751420|NCT01136967|7725344|FG000|Overall Study|Diagnosis of Second Primary Cancer|0
4751421|NCT01136967|7725345|FG001|Overall Study|Diagnosis of Second Primary Cancer|1
4662663|NCT02222246|7552542|FG000|Overall Study|No Emergency Department Visits|27
4662664|NCT02222246|7552543|FG001|Overall Study|No Emergency Department Visits|26
4662665|NCT02222246|7552542|FG000|Overall Study|Physician Decision|0
4662666|NCT02222246|7552543|FG001|Overall Study|Physician Decision|1
4662667|NCT02222493|7552566|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2
4751422|NCT01140451|7725362|FG000|Overall Study|Withdrawal by Subject|26
4751423|NCT01140451|7725363|FG001|Overall Study|Withdrawal by Subject|33
4751424|NCT01140451|7725362|FG000|Overall Study|Adverse Event|2
4662668|NCT02222493|7552567|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2
4662669|NCT02222493|7552566|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0
4662670|NCT02222493|7552567|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1
4662671|NCT02222493|7552566|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11
4662672|NCT02222493|7552567|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9
4662673|NCT02222493|7552566|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5
4662674|NCT02222493|7552567|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1
4662675|NCT02222493|7552566|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0
4662676|NCT02222493|7552567|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7
4662677|NCT02222493|7552566|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1
4662678|NCT02222493|7552567|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0
4662679|NCT02222493|7552566|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2
4662680|NCT02222493|7552567|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0
4662681|NCT02222493|7552566|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18
4662682|NCT02222493|7552567|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20
4751425|NCT01140451|7725363|FG001|Overall Study|Adverse Event|6
4751426|NCT01140451|7725362|FG000|Overall Study|Physician Decision|5
4751427|NCT01140451|7725363|FG001|Overall Study|Physician Decision|3
4751428|NCT01140451|7725362|FG000|Overall Study|Lost to Follow-up|2
4751429|NCT01140451|7725363|FG001|Overall Study|Lost to Follow-up|0
4751430|NCT01140451|7725362|FG000|Overall Study|Participants Planning Pregnancy|3
4751431|NCT01140451|7725363|FG001|Overall Study|Participants Planning Pregnancy|0
4662683|NCT02222493|7552566|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4
4662684|NCT02222493|7552567|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0
4662685|NCT02222493|7552566|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1
4662686|NCT02222493|7552567|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0
4662687|NCT02222493|7552566|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1
4662688|NCT02222493|7552567|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0
4751432|NCT01174563|7725370|FG000|Overall Study|Progressive Disease|45
4751433|NCT01174563|7725370|FG000|Overall Study|Death|5
4751434|NCT01174563|7725370|FG000|Overall Study|Investigator's Discretion|5
4751435|NCT01174563|7725370|FG000|Overall Study|Participant Withdrew Consent|3
4751436|NCT01174563|7725370|FG000|Overall Study|Rash Adverse Event|1
4751437|NCT01174563|7725370|FG000|Overall Study|Sponsor's decision|1
4751438|NCT01235962|7725450|FG000|Overall Study|Withdrawal by Subject|20
4751439|NCT01235962|7725451|FG001|Overall Study|Withdrawal by Subject|19
4751440|NCT01235962|7725452|FG002|Overall Study|Withdrawal by Subject|62
4751441|NCT01235962|7725453|FG003|Overall Study|Withdrawal by Subject|49
4751442|NCT01235962|7725450|FG000|Overall Study|Lost to Follow-up|21
4751443|NCT01235962|7725451|FG001|Overall Study|Lost to Follow-up|16
4751444|NCT01235962|7725452|FG002|Overall Study|Lost to Follow-up|47
4751445|NCT01235962|7725453|FG003|Overall Study|Lost to Follow-up|32
4751446|NCT01235962|7725450|FG000|Overall Study|Physician Decision|5
4751447|NCT01235962|7725451|FG001|Overall Study|Physician Decision|0
4751448|NCT01235962|7725452|FG002|Overall Study|Physician Decision|9
4751449|NCT01235962|7725453|FG003|Overall Study|Physician Decision|5
4751450|NCT01239368|7725481|FG000|Overall Study|Principal investigator discretion|1
4751451|NCT01239368|7725482|FG001|Overall Study|Principal investigator discretion|0
4751452|NCT01239368|7725483|FG002|Overall Study|Principal investigator discretion|0
4751453|NCT01239368|7725484|FG003|Overall Study|Principal investigator discretion|0
4751454|NCT01239368|7725485|FG004|Overall Study|Principal investigator discretion|1
4662689|NCT02222493|7552566|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22
4662690|NCT02222493|7552567|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9
4662691|NCT02222493|7552566|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3
4662692|NCT02222493|7552567|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0
4662693|NCT02222493|7552566|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1
4662694|NCT02222493|7552567|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0
4662695|NCT02222493|7552566|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6
4662696|NCT02222493|7552567|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4
4662697|NCT02222493|7552566|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1
4662698|NCT02222493|7552567|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1
4662699|NCT02222493|7552566|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9
4662700|NCT02222493|7552567|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3
4662701|NCT02222493|7552566|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3
4662702|NCT02222493|7552567|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0
4662703|NCT02222493|7552566|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14
4662704|NCT02222493|7552567|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0
4662705|NCT02222493|7552566|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4
4662706|NCT02222493|7552567|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0
4662707|NCT02222493|7552566|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1
4662708|NCT02222493|7552567|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0
4662709|NCT02222493|7552566|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9
4662710|NCT02222493|7552567|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0
4662711|NCT02222558|7552586|FG000|Period 1: Single Dose|Withdrawal by Subject|4
4662712|NCT02222558|7552587|FG001|Period 1: Single Dose|Withdrawal by Subject|0
4662713|NCT02222558|7552588|FG002|Period 1: Single Dose|Withdrawal by Subject|0
4662714|NCT02222558|7552589|FG003|Period 1: Single Dose|Withdrawal by Subject|0
4662715|NCT02222558|7552590|FG004|Period 1: Single Dose|Withdrawal by Subject|0
4662716|NCT02222558|7552591|FG005|Period 1: Single Dose|Withdrawal by Subject|0
4662717|NCT02222558|7552586|FG000|Period 3|Withdrawal by Subject|0
4662718|NCT02222558|7552587|FG001|Period 3|Withdrawal by Subject|0
4662719|NCT02222558|7552588|FG002|Period 3|Withdrawal by Subject|0
4662720|NCT02222558|7552589|FG003|Period 3|Withdrawal by Subject|0
4662721|NCT02222558|7552590|FG004|Period 3|Withdrawal by Subject|0
4662722|NCT02222558|7552591|FG005|Period 3|Withdrawal by Subject|1
4662723|NCT02222688|7552625|FG000|Overall Study|Withdrawal by Subject|0
4662724|NCT02222688|7552626|FG001|Overall Study|Withdrawal by Subject|0
4662725|NCT02222688|7552627|FG002|Overall Study|Withdrawal by Subject|0
4662726|NCT02222688|7552628|FG003|Overall Study|Withdrawal by Subject|2
4662727|NCT02222688|7552629|FG004|Overall Study|Withdrawal by Subject|1
4662728|NCT02222688|7552630|FG005|Overall Study|Withdrawal by Subject|0
4662729|NCT02222688|7552631|FG006|Overall Study|Withdrawal by Subject|1
4662730|NCT02222688|7552625|FG000|Overall Study|Disease progression|1
4662731|NCT02222688|7552626|FG001|Overall Study|Disease progression|0
4662732|NCT02222688|7552627|FG002|Overall Study|Disease progression|0
4662733|NCT02222688|7552628|FG003|Overall Study|Disease progression|0
4662734|NCT02222688|7552629|FG004|Overall Study|Disease progression|0
4662735|NCT02222688|7552630|FG005|Overall Study|Disease progression|0
4662736|NCT02222688|7552631|FG006|Overall Study|Disease progression|0
4662737|NCT02222714|7552654|FG000|Overall Study|Death|0
4662738|NCT02222714|7552655|FG001|Overall Study|Death|2
4662739|NCT02222714|7552656|FG002|Overall Study|Death|3
4662740|NCT02222714|7552657|FG003|Overall Study|Death|4
4662741|NCT02222714|7552658|FG004|Overall Study|Death|6
4662742|NCT02222714|7552654|FG000|Overall Study|Withdrawal by Subject|0
4662743|NCT02222714|7552655|FG001|Overall Study|Withdrawal by Subject|0
4662744|NCT02222714|7552656|FG002|Overall Study|Withdrawal by Subject|1
4662745|NCT02222714|7552657|FG003|Overall Study|Withdrawal by Subject|0
4662746|NCT02222714|7552658|FG004|Overall Study|Withdrawal by Subject|1
4662747|NCT02222818|7552675|FG000|Period 1|Eligibility criteria not met|0
4662748|NCT02222818|7552676|FG001|Period 1|Eligibility criteria not met|3
4662749|NCT02222896|7552690|FG000|Abdomen|Did not qualify|34
4662750|NCT02222896|7552691|FG001|Abdomen|Did not qualify|10
4662751|NCT02222896|7552692|FG002|Abdomen|Did not qualify|32
4662752|NCT02222896|7552690|FG000|Groin|Did not qualify|43
4662753|NCT02222896|7552691|FG001|Groin|Did not qualify|9
4662754|NCT02222896|7552692|FG002|Groin|Did not qualify|40
4662755|NCT02222922|7552712|FG000|Overall Study|Death|0
4662756|NCT02222922|7552713|FG001|Overall Study|Death|0
4662757|NCT02222922|7552714|FG002|Overall Study|Death|0
4662758|NCT02222922|7552715|FG003|Overall Study|Death|0
4662759|NCT02222922|7552716|FG004|Overall Study|Death|13
4662760|NCT02222922|7552717|FG005|Overall Study|Death|0
4662761|NCT02222922|7552718|FG006|Overall Study|Death|0
4662762|NCT02222922|7552719|FG007|Overall Study|Death|0
4662763|NCT02222922|7552720|FG008|Overall Study|Death|2
4662764|NCT02222922|7552712|FG000|Overall Study|Lost to Follow-up|0
4662765|NCT02222922|7552713|FG001|Overall Study|Lost to Follow-up|0
4662766|NCT02222922|7552714|FG002|Overall Study|Lost to Follow-up|1
4662767|NCT02222922|7552715|FG003|Overall Study|Lost to Follow-up|0
4662768|NCT02222922|7552716|FG004|Overall Study|Lost to Follow-up|9
4662769|NCT02222922|7552717|FG005|Overall Study|Lost to Follow-up|1
4662770|NCT02222922|7552718|FG006|Overall Study|Lost to Follow-up|0
4662771|NCT02222922|7552719|FG007|Overall Study|Lost to Follow-up|0
4662772|NCT02222922|7552720|FG008|Overall Study|Lost to Follow-up|0
4662773|NCT02222922|7552712|FG000|Overall Study|Other|0
4662774|NCT02222922|7552713|FG001|Overall Study|Other|0
4662775|NCT02222922|7552714|FG002|Overall Study|Other|0
4662776|NCT02222922|7552715|FG003|Overall Study|Other|2
4662777|NCT02222922|7552716|FG004|Overall Study|Other|10
4662778|NCT02222922|7552717|FG005|Overall Study|Other|2
4662779|NCT02222922|7552718|FG006|Overall Study|Other|2
4662780|NCT02222922|7552719|FG007|Overall Study|Other|4
4662781|NCT02222922|7552720|FG008|Overall Study|Other|1
4662782|NCT02222922|7552712|FG000|Overall Study|Participant refused further follow-up|1
4662783|NCT02222922|7552713|FG001|Overall Study|Participant refused further follow-up|0
4662784|NCT02222922|7552714|FG002|Overall Study|Participant refused further follow-up|0
4662785|NCT02222922|7552715|FG003|Overall Study|Participant refused further follow-up|1
4662786|NCT02222922|7552716|FG004|Overall Study|Participant refused further follow-up|6
4662787|NCT02222922|7552717|FG005|Overall Study|Participant refused further follow-up|0
4662788|NCT02222922|7552718|FG006|Overall Study|Participant refused further follow-up|0
4662789|NCT02222922|7552719|FG007|Overall Study|Participant refused further follow-up|0
4662790|NCT02222922|7552720|FG008|Overall Study|Participant refused further follow-up|3
4662791|NCT02223364|7552796|FG000|Overall Study|Protocol Violation|3
4662792|NCT02223364|7552797|FG001|Overall Study|Protocol Violation|0
4662793|NCT02223364|7552798|FG002|Overall Study|Protocol Violation|3
4662794|NCT02223364|7552796|FG000|Overall Study|subject expired before surgery|1
4662795|NCT02223364|7552797|FG001|Overall Study|subject expired before surgery|0
4662796|NCT02223364|7552798|FG002|Overall Study|subject expired before surgery|0
4662797|NCT02223364|7552796|FG000|Overall Study|Physician Decision|1
4662798|NCT02223364|7552797|FG001|Overall Study|Physician Decision|0
4662799|NCT02223364|7552798|FG002|Overall Study|Physician Decision|0
4662800|NCT02223390|7552808|FG000|Overall Study|Lost to Follow-up|9
4662801|NCT02223390|7552809|FG001|Overall Study|Lost to Follow-up|4
4662802|NCT02223715|7552884|FG000|Overall Study|Death|31
4662803|NCT02223715|7552884|FG000|Overall Study|Lost to Follow-up|73
4662804|NCT02223754|7552893|FG000|Period 1|Adverse Event|1
4662805|NCT02223754|7552894|FG001|Period 1|Adverse Event|0
4662806|NCT02223754|7552893|FG000|Period 1|Lost to Follow-up|0
4662807|NCT02223754|7552894|FG001|Period 1|Lost to Follow-up|1
4662808|NCT02223754|7552893|FG000|Period 1|Protocol Violation|2
4662809|NCT02223754|7552894|FG001|Period 1|Protocol Violation|4
4662810|NCT02223754|7552893|FG000|Period 1|Withdrawal by Subject|0
4662811|NCT02223754|7552894|FG001|Period 1|Withdrawal by Subject|4
4662812|NCT02223754|7552893|FG000|Period 1|Test Article No Longer Available|1
4662813|NCT02223754|7552894|FG001|Period 1|Test Article No Longer Available|5
4662814|NCT02223754|7552893|FG000|Period 1|Unsatisfactory Visual Response|0
4662815|NCT02223754|7552894|FG001|Period 1|Unsatisfactory Visual Response|1
4662816|NCT02223754|7552893|FG000|Period 2|Adverse Event|0
4662817|NCT02223754|7552894|FG001|Period 2|Adverse Event|1
4662818|NCT02223754|7552893|FG000|Period 2|Protocol Violation|1
4662819|NCT02223754|7552894|FG001|Period 2|Protocol Violation|0
4662820|NCT02223754|7552893|FG000|Period 2|Lens Discomfort|1
4662821|NCT02223754|7552894|FG001|Period 2|Lens Discomfort|1
4662822|NCT02223754|7552893|FG000|Period 2|Lost to Follow-up|1
4662823|NCT02223754|7552894|FG001|Period 2|Lost to Follow-up|0
4662824|NCT02223754|7552893|FG000|Period 2|Test Article No Longer Available|0
4662825|NCT02223754|7552894|FG001|Period 2|Test Article No Longer Available|1
4751455|NCT01239368|7725486|FG005|Overall Study|Principal investigator discretion|2
4751456|NCT01239368|7725487|FG006|Overall Study|Principal investigator discretion|0
4751457|NCT01239368|7725488|FG007|Overall Study|Principal investigator discretion|0
4751458|NCT01239368|7725489|FG008|Overall Study|Principal investigator discretion|0
4751459|NCT01239368|7725490|FG009|Overall Study|Principal investigator discretion|1
4751460|NCT01239368|7725481|FG000|Overall Study|Disease progression on study|1
4751461|NCT01239368|7725482|FG001|Overall Study|Disease progression on study|1
4751462|NCT01239368|7725483|FG002|Overall Study|Disease progression on study|1
4751463|NCT01239368|7725484|FG003|Overall Study|Disease progression on study|1
4751464|NCT01239368|7725485|FG004|Overall Study|Disease progression on study|4
4751465|NCT01239368|7725486|FG005|Overall Study|Disease progression on study|2
4751466|NCT01239368|7725487|FG006|Overall Study|Disease progression on study|5
4751467|NCT01239368|7725488|FG007|Overall Study|Disease progression on study|0
4751468|NCT01239368|7725489|FG008|Overall Study|Disease progression on study|0
4751469|NCT01239368|7725490|FG009|Overall Study|Disease progression on study|2
4751470|NCT01239368|7725481|FG000|Overall Study|Refused further treatment|0
4751471|NCT01239368|7725482|FG001|Overall Study|Refused further treatment|0
4751472|NCT01239368|7725483|FG002|Overall Study|Refused further treatment|0
4751473|NCT01239368|7725484|FG003|Overall Study|Refused further treatment|0
4751474|NCT01239368|7725485|FG004|Overall Study|Refused further treatment|0
4751475|NCT01239368|7725486|FG005|Overall Study|Refused further treatment|0
4751476|NCT01239368|7725487|FG006|Overall Study|Refused further treatment|0
4751477|NCT01239368|7725488|FG007|Overall Study|Refused further treatment|0
4751478|NCT01239368|7725489|FG008|Overall Study|Refused further treatment|0
4751479|NCT01239368|7725490|FG009|Overall Study|Refused further treatment|1
4751480|NCT01239368|7725481|FG000|Overall Study|Death|0
4751481|NCT01239368|7725482|FG001|Overall Study|Death|0
4751482|NCT01239368|7725483|FG002|Overall Study|Death|0
4751483|NCT01239368|7725484|FG003|Overall Study|Death|0
4751484|NCT01239368|7725485|FG004|Overall Study|Death|0
4751485|NCT01239368|7725486|FG005|Overall Study|Death|0
4751486|NCT01239368|7725487|FG006|Overall Study|Death|1
4751487|NCT01239368|7725488|FG007|Overall Study|Death|0
4751488|NCT01239368|7725489|FG008|Overall Study|Death|0
4751489|NCT01239368|7725490|FG009|Overall Study|Death|0
4662826|NCT02223793|7552904|FG000|Overall Study|Lost to Follow-up|10
4662827|NCT02223793|7552905|FG001|Overall Study|Lost to Follow-up|1
4662828|NCT02223793|7552906|FG002|Overall Study|Lost to Follow-up|2
4662829|NCT02223793|7552904|FG000|Overall Study|Withdrawal by Subject|3
4662830|NCT02223793|7552905|FG001|Overall Study|Withdrawal by Subject|2
4662831|NCT02223793|7552906|FG002|Overall Study|Withdrawal by Subject|3
4662832|NCT02223793|7552904|FG000|Overall Study|Moved/studycenter unable to participate|4
4662833|NCT02223793|7552905|FG001|Overall Study|Moved/studycenter unable to participate|6
4662834|NCT02223793|7552906|FG002|Overall Study|Moved/studycenter unable to participate|8
4662835|NCT02223858|7552916|FG000|Overall Study|Death|1
4662836|NCT02223858|7552917|FG001|Overall Study|Death|1
4662837|NCT02223858|7552916|FG000|Overall Study|Lost to Follow-up|6
4662838|NCT02223858|7552917|FG001|Overall Study|Lost to Follow-up|11
4662839|NCT02223858|7552916|FG000|Overall Study|Withdrawal by Subject|8
4662840|NCT02223858|7552917|FG001|Overall Study|Withdrawal by Subject|5
4662841|NCT02223858|7552916|FG000|Overall Study|Refused|9
4662842|NCT02223858|7552917|FG001|Overall Study|Refused|9
4662843|NCT02224053|7552927|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11
4662844|NCT02224053|7552927|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4
4662845|NCT02224053|7552927|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3
4662846|NCT02224053|7552927|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1
4662847|NCT02224053|7552927|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2
4662848|NCT02224157|7552935|FG000|Overall Study|Severe non-compliance to protocol|2
4662849|NCT02224157|7552936|FG001|Overall Study|Severe non-compliance to protocol|2
4662850|NCT02224157|7552935|FG000|Overall Study|Other|13
4662851|NCT02224157|7552936|FG001|Overall Study|Other|10
4662852|NCT02224157|7552935|FG000|Overall Study|Subject decision|58
4662853|NCT02224157|7552936|FG001|Overall Study|Subject decision|50
4662854|NCT02224157|7552935|FG000|Overall Study|Prematurely closed site|4
4662855|NCT02224157|7552936|FG001|Overall Study|Prematurely closed site|2
4662856|NCT02224157|7552935|FG000|Overall Study|Eligibility criteria not fulfilled|4
4662857|NCT02224157|7552936|FG001|Overall Study|Eligibility criteria not fulfilled|8
4662858|NCT02224157|7552935|FG000|Overall Study|Lost to Follow-up|27
4662859|NCT02224157|7552936|FG001|Overall Study|Lost to Follow-up|35
4662860|NCT02224157|7552935|FG000|Overall Study|Death|1
4662861|NCT02224157|7552936|FG001|Overall Study|Death|1
4662862|NCT02224157|7552935|FG000|Overall Study|Adverse Event|1
4662863|NCT02224157|7552936|FG001|Overall Study|Adverse Event|3
4662864|NCT02224274|7552944|FG000|Overall Study|Death|1
4662865|NCT02224274|7552945|FG001|Overall Study|Death|0
4662866|NCT02224560|7552986|FG000|Overall Study|Protocol Deviation|1
4662867|NCT02224560|7552987|FG001|Overall Study|Protocol Deviation|0
4662868|NCT02224560|7552988|FG002|Overall Study|Protocol Deviation|0
4662869|NCT02224560|7552986|FG000|Overall Study|Withdrawal by Subject|2
4662870|NCT02224560|7552987|FG001|Overall Study|Withdrawal by Subject|0
4662871|NCT02224560|7552988|FG002|Overall Study|Withdrawal by Subject|1
4662872|NCT02224560|7552986|FG000|Overall Study|Met Withdrawal Criteria|1
4662873|NCT02224560|7552987|FG001|Overall Study|Met Withdrawal Criteria|0
4662874|NCT02224560|7552988|FG002|Overall Study|Met Withdrawal Criteria|0
4662875|NCT02224560|7552986|FG000|Overall Study|Adverse Event|4
4662876|NCT02224560|7552987|FG001|Overall Study|Adverse Event|1
4662877|NCT02224560|7552988|FG002|Overall Study|Adverse Event|1
4662878|NCT02224560|7552986|FG000|Overall Study|Withdrawn by Investigator|1
4662879|NCT02224560|7552987|FG001|Overall Study|Withdrawn by Investigator|1
4662880|NCT02224560|7552988|FG002|Overall Study|Withdrawn by Investigator|0
4662881|NCT02224625|7553005|FG000|Irritation|Adverse Event|6
4662882|NCT02224625|7553005|FG000|Sensitization|Adverse Event|55
4662883|NCT02224638|7553019|FG000|Overall Study|Adverse Event|1
4662884|NCT02224638|7553020|FG001|Overall Study|Adverse Event|1
4662885|NCT02224664|7553028|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5
4662886|NCT02224664|7553029|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0
4662887|NCT02224664|7553030|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0
4662888|NCT02224664|7553031|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0
4662889|NCT02224664|7553032|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0
4662890|NCT02224664|7553028|FG000|Dose Escalation Period (21 Days)|Adverse Event|0
4662891|NCT02224664|7553029|FG001|Dose Escalation Period (21 Days)|Adverse Event|0
4662892|NCT02224664|7553030|FG002|Dose Escalation Period (21 Days)|Adverse Event|2
4662893|NCT02224664|7553031|FG003|Dose Escalation Period (21 Days)|Adverse Event|2
4662894|NCT02224664|7553032|FG004|Dose Escalation Period (21 Days)|Adverse Event|7
4662895|NCT02224664|7553028|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
4662896|NCT02224664|7553029|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
4662897|NCT02224664|7553030|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
4662898|NCT02224664|7553031|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1
4662899|NCT02224664|7553032|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4
4751490|NCT01266031|7725526|FG000|Overall Study|Not treated|0
4751491|NCT01266031|7725527|FG001|Overall Study|Not treated|3
4751492|NCT01266031|7725528|FG002|Overall Study|Not treated|2
4751493|NCT01287741|7725549|FG000|Overall Study|Withdrawal by Subject|35
4751494|NCT01287741|7725550|FG001|Overall Study|Withdrawal by Subject|38
4751495|NCT01287741|7725549|FG000|Overall Study|Protocol Violation|2
4751496|NCT01287741|7725550|FG001|Overall Study|Protocol Violation|0
4751497|NCT01287741|7725549|FG000|Overall Study|Physician Decision|15
4751498|NCT01287741|7725550|FG001|Overall Study|Physician Decision|23
4751499|NCT01287741|7725549|FG000|Overall Study|Non-compliance|8
4751500|NCT01287741|7725550|FG001|Overall Study|Non-compliance|6
4751501|NCT01287741|7725549|FG000|Overall Study|Lost to Follow-up|10
4751502|NCT01287741|7725550|FG001|Overall Study|Lost to Follow-up|8
4751503|NCT01287741|7725549|FG000|Overall Study|Death|32
4751504|NCT01287741|7725550|FG001|Overall Study|Death|44
4751505|NCT01287741|7725549|FG000|Overall Study|Adverse Event|4
4751506|NCT01287741|7725550|FG001|Overall Study|Adverse Event|6
4751507|NCT01287741|7725549|FG000|Overall Study|Study terminated by Sponsor|307
4751508|NCT01287741|7725550|FG001|Overall Study|Study terminated by Sponsor|315
4751509|NCT01287741|7725549|FG000|Overall Study|Progressive disease|190
4751510|NCT01287741|7725550|FG001|Overall Study|Progressive disease|166
4751511|NCT01287741|7725549|FG000|Overall Study|Reason not specified|23
4751512|NCT01287741|7725550|FG001|Overall Study|Reason not specified|9
4751513|NCT01313689|7725567|FG000|24-Week Randomization 1|Adverse Event|10
4751514|NCT01313689|7725568|FG001|24-Week Randomization 1|Adverse Event|5
4751515|NCT01313689|7725569|FG002|24-Week Randomization 1|Adverse Event|0
4751516|NCT01313689|7725570|FG003|24-Week Randomization 1|Adverse Event|0
4751517|NCT01313689|7725571|FG004|24-Week Randomization 1|Adverse Event|0
4751518|NCT01313689|7725567|FG000|24-Week Randomization 1|Physician Decision|4
4751519|NCT01313689|7725568|FG001|24-Week Randomization 1|Physician Decision|5
4751520|NCT01313689|7725569|FG002|24-Week Randomization 1|Physician Decision|0
4751521|NCT01313689|7725570|FG003|24-Week Randomization 1|Physician Decision|0
4751522|NCT01313689|7725571|FG004|24-Week Randomization 1|Physician Decision|0
4751523|NCT01313689|7725567|FG000|24-Week Randomization 1|Withdrawal by Subject|5
4751524|NCT01313689|7725568|FG001|24-Week Randomization 1|Withdrawal by Subject|0
4751525|NCT01313689|7725569|FG002|24-Week Randomization 1|Withdrawal by Subject|0
4751526|NCT01313689|7725570|FG003|24-Week Randomization 1|Withdrawal by Subject|0
4751527|NCT01313689|7725571|FG004|24-Week Randomization 1|Withdrawal by Subject|0
4751528|NCT01313689|7725567|FG000|24-Week Randomization 2|Adverse Event|0
4751529|NCT01313689|7725568|FG001|24-Week Randomization 2|Adverse Event|0
4751530|NCT01313689|7725569|FG002|24-Week Randomization 2|Adverse Event|2
4751531|NCT01313689|7725570|FG003|24-Week Randomization 2|Adverse Event|0
4751532|NCT01313689|7725571|FG004|24-Week Randomization 2|Adverse Event|8
4662900|NCT02224690|7553050|FG000|Overall Study|Adverse Event|8
4662901|NCT02224690|7553051|FG001|Overall Study|Adverse Event|1
4662902|NCT02224690|7553050|FG000|Overall Study|Met Withdrawal Criteria|4
4662903|NCT02224690|7553051|FG001|Overall Study|Met Withdrawal Criteria|0
4662904|NCT02224690|7553050|FG000|Overall Study|Use of G-tube|1
4662905|NCT02224690|7553051|FG001|Overall Study|Use of G-tube|0
4662906|NCT02224690|7553050|FG000|Overall Study|Did not meet eligibility criteria|1
4662907|NCT02224690|7553051|FG001|Overall Study|Did not meet eligibility criteria|0
4662908|NCT02224703|7553060|FG000|Overall Study|Adverse Event|0
4662909|NCT02224703|7553061|FG001|Overall Study|Adverse Event|5
4662910|NCT02224703|7553062|FG002|Overall Study|Adverse Event|0
4662911|NCT02224703|7553060|FG000|Overall Study|Withdrawn by investigator|1
4662912|NCT02224703|7553061|FG001|Overall Study|Withdrawn by investigator|0
4662913|NCT02224703|7553062|FG002|Overall Study|Withdrawn by investigator|0
4662914|NCT02224703|7553060|FG000|Overall Study|Advised by medical monitor|1
4662915|NCT02224703|7553061|FG001|Overall Study|Advised by medical monitor|0
4751533|NCT01313689|7725567|FG000|24-Week Randomization 2|Withdrawal by Subject|0
4751534|NCT01313689|7725568|FG001|24-Week Randomization 2|Withdrawal by Subject|0
4751535|NCT01313689|7725569|FG002|24-Week Randomization 2|Withdrawal by Subject|1
4751536|NCT01313689|7725570|FG003|24-Week Randomization 2|Withdrawal by Subject|1
4751537|NCT01313689|7725571|FG004|24-Week Randomization 2|Withdrawal by Subject|3
4751538|NCT01313689|7725567|FG000|24-Week Randomization 2|Physician Decision|0
4751539|NCT01313689|7725568|FG001|24-Week Randomization 2|Physician Decision|0
4751540|NCT01313689|7725569|FG002|24-Week Randomization 2|Physician Decision|0
4751541|NCT01313689|7725570|FG003|24-Week Randomization 2|Physician Decision|0
4751542|NCT01313689|7725571|FG004|24-Week Randomization 2|Physician Decision|4
4662916|NCT02224703|7553062|FG002|Overall Study|Advised by medical monitor|0
4662917|NCT02224703|7553060|FG000|Overall Study|Withdrawn by parent/guardian|0
4662918|NCT02224703|7553061|FG001|Overall Study|Withdrawn by parent/guardian|1
4662919|NCT02224703|7553062|FG002|Overall Study|Withdrawn by parent/guardian|0
4662920|NCT02224703|7553060|FG000|Overall Study|Lack of Efficacy|1
4662921|NCT02224703|7553061|FG001|Overall Study|Lack of Efficacy|0
4662922|NCT02224703|7553062|FG002|Overall Study|Lack of Efficacy|0
4662923|NCT02224755|7553077|FG000|Randomization to Device Implant|Withdrawn prior to implant|7
4662924|NCT02224755|7553078|FG001|Randomization to Device Implant|Withdrawn prior to implant|1
4662925|NCT02224755|7553077|FG000|Two Year Follow up Post-implant|Death|103
4662926|NCT02224755|7553078|FG001|Two Year Follow up Post-implant|Death|98
4662927|NCT02224755|7553077|FG000|Two Year Follow up Post-implant|Heart transplant|137
4662928|NCT02224755|7553078|FG001|Two Year Follow up Post-implant|Heart transplant|119
4662929|NCT02224755|7553077|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3
4662930|NCT02224755|7553078|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3
4662931|NCT02224755|7553077|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15
4662932|NCT02224755|7553078|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6
4662933|NCT02224846|7553094|FG000|Period 1 (Month 3)|Adverse Event|2
4662934|NCT02224846|7553095|FG001|Period 1 (Month 3)|Adverse Event|1
4662935|NCT02224846|7553094|FG000|Period 1 (Month 3)|Lost to Follow-up|3
4662936|NCT02224846|7553095|FG001|Period 1 (Month 3)|Lost to Follow-up|8
4662937|NCT02224846|7553094|FG000|Period 1 (Month 3)|Protocol Violation|4
4662938|NCT02224846|7553095|FG001|Period 1 (Month 3)|Protocol Violation|8
4662939|NCT02224846|7553094|FG000|Period 1 (Month 3)|Withdrawal by Subject|8
4662940|NCT02224846|7553095|FG001|Period 1 (Month 3)|Withdrawal by Subject|18
4662941|NCT02224846|7553094|FG000|Period 1 (Month 3)|Sponsor Decision|2
4662942|NCT02224846|7553095|FG001|Period 1 (Month 3)|Sponsor Decision|1
4662943|NCT02224846|7553094|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1
4662944|NCT02224846|7553095|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2
4662945|NCT02224846|7553094|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3
4662946|NCT02224846|7553095|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5
4662947|NCT02224846|7553094|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0
4662948|NCT02224846|7553095|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3
4662949|NCT02224846|7553094|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15
4662950|NCT02224846|7553095|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19
4662951|NCT02224846|7553094|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0
4751543|NCT01315353|7725593|FG000|Overall Study|Death|2
4751544|NCT01315353|7725594|FG001|Overall Study|Death|1
4751545|NCT01315353|7725595|FG002|Overall Study|Death|0
4751546|NCT01315353|7725593|FG000|Overall Study|Withdrawal by Subject|2
4751547|NCT01315353|7725594|FG001|Overall Study|Withdrawal by Subject|6
4751548|NCT01315353|7725595|FG002|Overall Study|Withdrawal by Subject|1
4751549|NCT01315353|7725593|FG000|Overall Study|Lost to Follow-up|13
4751550|NCT01315353|7725594|FG001|Overall Study|Lost to Follow-up|6
4751551|NCT01315353|7725595|FG002|Overall Study|Lost to Follow-up|6
4751552|NCT01315353|7725593|FG000|Overall Study|Unwilling to adhere to requirements|5
4751553|NCT01315353|7725594|FG001|Overall Study|Unwilling to adhere to requirements|5
4751554|NCT01315353|7725595|FG002|Overall Study|Unwilling to adhere to requirements|4
4751555|NCT01315353|7725593|FG000|Overall Study|Site closing|7
4751556|NCT01315353|7725594|FG001|Overall Study|Site closing|4
4751557|NCT01315353|7725595|FG002|Overall Study|Site closing|0
4751558|NCT01315353|7725593|FG000|Overall Study|Taken off study by site in error|0
4751559|NCT01315353|7725594|FG001|Overall Study|Taken off study by site in error|1
4751560|NCT01315353|7725595|FG002|Overall Study|Taken off study by site in error|0
4751561|NCT01315353|7725593|FG000|Overall Study|Inadvertent randomization/assignment|0
4751562|NCT01315353|7725594|FG001|Overall Study|Inadvertent randomization/assignment|0
4751563|NCT01315353|7725595|FG002|Overall Study|Inadvertent randomization/assignment|2
4662952|NCT02224846|7553095|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2
4662953|NCT02224846|7553094|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3
4662954|NCT02224846|7553095|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4
4662955|NCT02224846|7553094|FG000|Period 2 (Month 12 to Month 24)|Death|1
4662956|NCT02224846|7553095|FG001|Period 2 (Month 12 to Month 24)|Death|0
4662957|NCT02224846|7553094|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7
4662958|NCT02224846|7553095|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13
4662959|NCT02224846|7553094|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4
4662960|NCT02224846|7553095|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11
4662961|NCT02224846|7553094|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25
4662962|NCT02224846|7553095|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43
4662963|NCT02224846|7553094|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0
4662964|NCT02224846|7553095|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2
4662965|NCT02224846|7553094|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2
4662966|NCT02224846|7553095|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1
4662967|NCT02225223|7553115|FG000|Overall Study|Death|10
4662968|NCT02225223|7553116|FG001|Overall Study|Death|1
4662969|NCT02225223|7553115|FG000|Overall Study|Lost to Follow-up|5
4662970|NCT02225223|7553116|FG001|Overall Study|Lost to Follow-up|0
4662971|NCT02225223|7553115|FG000|Overall Study|Other|1
4662972|NCT02225223|7553116|FG001|Overall Study|Other|2
4662973|NCT02225223|7553115|FG000|Overall Study|Physician Decision|1
4662974|NCT02225223|7553116|FG001|Overall Study|Physician Decision|0
4662975|NCT02225223|7553115|FG000|Overall Study|Withdrawal by Subject|2
4662976|NCT02225223|7553116|FG001|Overall Study|Withdrawal by Subject|2
4662977|NCT02225353|7553125|FG000|Overall Study|Lost to Follow-up|0
4662978|NCT02225353|7553126|FG001|Overall Study|Lost to Follow-up|1
4662979|NCT02225353|7553127|FG002|Overall Study|Lost to Follow-up|3
4662980|NCT02225353|7553125|FG000|Overall Study|Protocol Violation|4
4662981|NCT02225353|7553126|FG001|Overall Study|Protocol Violation|5
4662982|NCT02225353|7553127|FG002|Overall Study|Protocol Violation|12
4662983|NCT02225587|7553140|FG000|Overall Study|Adverse Event|5
4662984|NCT02225587|7553141|FG001|Overall Study|Adverse Event|5
4662985|NCT02225587|7553140|FG000|Overall Study|Lost to Follow-up|5
4662986|NCT02225587|7553141|FG001|Overall Study|Lost to Follow-up|5
4662987|NCT02225587|7553140|FG000|Overall Study|Non-Compliance With Study Drug|1
4662988|NCT02225587|7553141|FG001|Overall Study|Non-Compliance With Study Drug|0
4662989|NCT02225587|7553140|FG000|Overall Study|Physician Decision|2
4662990|NCT02225587|7553141|FG001|Overall Study|Physician Decision|0
4662991|NCT02225587|7553140|FG000|Overall Study|Protocol Violation|1
4662992|NCT02225587|7553141|FG001|Overall Study|Protocol Violation|0
4662993|NCT02225587|7553140|FG000|Overall Study|Participant Moved|1
4662994|NCT02225587|7553141|FG001|Overall Study|Participant Moved|0
4662995|NCT02225587|7553140|FG000|Overall Study|Withdrawal by Subject|13
4662996|NCT02225587|7553141|FG001|Overall Study|Withdrawal by Subject|28
4662997|NCT02225665|7553149|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1
4662998|NCT02225665|7553150|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0
4662999|NCT02225665|7553149|FG000|Overall Study|Subject restarted HAART prior to month 18.|0
4663000|NCT02225665|7553150|FG001|Overall Study|Subject restarted HAART prior to month 18.|1
4663001|NCT02225743|7553156|FG000|Overall Study|Withdrawal by Subject|18
4663002|NCT02226003|7553177|FG000|Overall Study|Lost to Follow-up|2
4663003|NCT02226003|7553178|FG001|Overall Study|Lost to Follow-up|1
4663004|NCT02226003|7553179|FG002|Overall Study|Lost to Follow-up|3
4663005|NCT02226003|7553177|FG000|Overall Study|Withdrawal by Subject|0
4663006|NCT02226003|7553178|FG001|Overall Study|Withdrawal by Subject|0
4663007|NCT02226003|7553179|FG002|Overall Study|Withdrawal by Subject|3
4663008|NCT02226120|7553187|FG000|Overall Study|Adverse Event|60
4663009|NCT02226120|7553187|FG000|Overall Study|Death|172
4663010|NCT02226120|7553187|FG000|Overall Study|Study terminated by sponsor|1
4663011|NCT02226120|7553187|FG000|Overall Study|Technical problems|4
4663012|NCT02226120|7553187|FG000|Overall Study|Lost to Follow-up|13
4751564|NCT01318993|7725603|FG000|Overall Study|Adverse Event|53
4751565|NCT01318993|7725603|FG000|Overall Study|Lack of Efficacy|121
4751566|NCT01318993|7725603|FG000|Overall Study|Protocol Violation|3
4751567|NCT01318993|7725603|FG000|Overall Study|Protocol based stopping criteria|6
4751568|NCT01318993|7725603|FG000|Overall Study|Study closed or terminated|174
4751569|NCT01318993|7725603|FG000|Overall Study|Lost to Follow-up|4
4751570|NCT01318993|7725603|FG000|Overall Study|Physician Decision|13
4751571|NCT01318993|7725603|FG000|Overall Study|Withdrawal by Subject|24
4751572|NCT01335685|7725611|FG000|Overall Study|Study Terminated by Sponsor|2
4751573|NCT01335685|7725612|FG001|Overall Study|Study Terminated by Sponsor|1
4751574|NCT01335685|7725613|FG002|Overall Study|Study Terminated by Sponsor|1
4751575|NCT01335685|7725614|FG003|Overall Study|Study Terminated by Sponsor|10
4751576|NCT01335685|7725615|FG004|Overall Study|Study Terminated by Sponsor|0
4751577|NCT01335685|7725616|FG005|Overall Study|Study Terminated by Sponsor|4
4751578|NCT01335685|7725617|FG006|Overall Study|Study Terminated by Sponsor|2
4751579|NCT01335685|7725618|FG007|Overall Study|Study Terminated by Sponsor|3
4751580|NCT01335685|7725611|FG000|Overall Study|Withdrawal by Subject|1
4751581|NCT01335685|7725612|FG001|Overall Study|Withdrawal by Subject|0
4751582|NCT01335685|7725613|FG002|Overall Study|Withdrawal by Subject|0
4751583|NCT01335685|7725614|FG003|Overall Study|Withdrawal by Subject|1
4751584|NCT01335685|7725615|FG004|Overall Study|Withdrawal by Subject|0
4751585|NCT01335685|7725616|FG005|Overall Study|Withdrawal by Subject|0
4751586|NCT01335685|7725617|FG006|Overall Study|Withdrawal by Subject|0
4751587|NCT01335685|7725618|FG007|Overall Study|Withdrawal by Subject|0
4751588|NCT01335685|7725611|FG000|Overall Study|Reason not Specified|0
4751589|NCT01335685|7725612|FG001|Overall Study|Reason not Specified|0
4751590|NCT01335685|7725613|FG002|Overall Study|Reason not Specified|1
4751591|NCT01335685|7725614|FG003|Overall Study|Reason not Specified|0
4751592|NCT01335685|7725615|FG004|Overall Study|Reason not Specified|0
4751593|NCT01335685|7725616|FG005|Overall Study|Reason not Specified|1
4751594|NCT01335685|7725617|FG006|Overall Study|Reason not Specified|0
4751595|NCT01335685|7725618|FG007|Overall Study|Reason not Specified|0
4751610|NCT04170296|7725661|FG000|Overall Study|Adverse Event|1
4751611|NCT04170296|7725662|FG001|Overall Study|Adverse Event|0
4751612|NCT04170296|7725661|FG000|Overall Study|Withdrawal by Subject|3
4751613|NCT04170296|7725662|FG001|Overall Study|Withdrawal by Subject|2
4751614|NCT04170296|7725661|FG000|Overall Study|Lost to Follow-up|4
4751615|NCT04170296|7725662|FG001|Overall Study|Lost to Follow-up|2
4751616|NCT04039217|7725674|FG000|Overall Study|Lost to Follow-up|1
4751617|NCT03078192|7725728|FG000|Overall Study|Withdrawal by Subject|2
4751618|NCT03078192|7725729|FG001|Overall Study|Withdrawal by Subject|1
4751619|NCT03078192|7725728|FG000|Overall Study|screen failure|0
4751620|NCT03078192|7725729|FG001|Overall Study|screen failure|3
4751621|NCT02903823|7725744|FG000|Overall Study|Physician Decision|5
4751622|NCT02903823|7725744|FG000|Overall Study|Could not advance catheter|1
4663013|NCT02226120|7553187|FG000|Overall Study|Physician Decision|21
4663014|NCT02226120|7553187|FG000|Overall Study|Withdrawal by parent/guardian|36
4663015|NCT02226120|7553187|FG000|Overall Study|Non-compliance with study drug|10
4663016|NCT02226120|7553187|FG000|Overall Study|Protocol deviation|1
4663017|NCT02226120|7553187|FG000|Overall Study|missing treatment disposition pages|2
4663018|NCT02226172|7553200|FG000|Overall Study|Participant refused further follow-up|4
4663019|NCT02226172|7553200|FG000|Overall Study|Other|5
4663020|NCT02226172|7553200|FG000|Overall Study|Death|1
4663021|NCT02226172|7553200|FG000|Overall Study|Study terminated by sponsor|1
4663022|NCT02226172|7553200|FG000|Overall Study|Adverse Event|6
4663023|NCT02226198|7553204|FG000|Lead-in Phase|Protocol Violation|1
4663024|NCT02226198|7553205|FG001|Lead-in Phase|Protocol Violation|0
4663025|NCT02226198|7553206|FG002|Lead-in Phase|Protocol Violation|0
4663026|NCT02226198|7553204|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0
4663027|NCT02226198|7553205|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1
4663028|NCT02226198|7553206|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0
4663029|NCT02226549|7553234|FG000|Overall Study|Randomized but Never Treated|1
4663030|NCT02226549|7553235|FG001|Overall Study|Randomized but Never Treated|0
4663031|NCT02226549|7553234|FG000|Overall Study|Lost to Follow-up|0
4663032|NCT02226549|7553235|FG001|Overall Study|Lost to Follow-up|1
4663033|NCT02226562|7553243|FG000|Overall Study|Lost to Follow-up|0
4663034|NCT02226562|7553244|FG001|Overall Study|Lost to Follow-up|1
4663035|NCT02226653|7553252|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1
4663036|NCT02226653|7553253|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0
4663037|NCT02226653|7553252|FG000|Treatment Period 5 Fed State|Adverse Event|0
4663038|NCT02226653|7553253|FG001|Treatment Period 5 Fed State|Adverse Event|1
4663039|NCT02227108|7553277|FG000|Overall Study|Did not receive treatment|2
4663040|NCT02227108|7553277|FG000|Overall Study|Other|3
4663041|NCT02227108|7553277|FG000|Overall Study|Progressive disease|17
4663042|NCT02227108|7553277|FG000|Overall Study|Initiation of alternative therapy|2
4663043|NCT02227108|7553277|FG000|Overall Study|Investigator discretion|1
4663044|NCT02227108|7553277|FG000|Overall Study|Adverse Event|6
4663045|NCT02227368|7553313|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0
4663046|NCT02227368|7553314|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4
4663047|NCT02227368|7553313|FG000|Overall Study|Lost to Follow-up|1
4663048|NCT02227368|7553314|FG001|Overall Study|Lost to Follow-up|0
4663049|NCT02227368|7553313|FG000|Overall Study|Adverse Event|1
4663050|NCT02227368|7553314|FG001|Overall Study|Adverse Event|0
4663051|NCT02227446|7553322|FG000|Overall Study|not eligible post randomization|18
4663052|NCT02227446|7553323|FG001|Overall Study|not eligible post randomization|29
4663053|NCT02227446|7553322|FG000|Overall Study|Withdrawal by Subject|4
4663054|NCT02227446|7553323|FG001|Overall Study|Withdrawal by Subject|5
4663055|NCT02227784|7553383|FG000|Double-Blind Phase|Adverse Event|3
4663056|NCT02227784|7553384|FG001|Double-Blind Phase|Adverse Event|2
4663057|NCT02227784|7553385|FG002|Double-Blind Phase|Adverse Event|1
4751596|NCT01336621|7725641|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11
4751597|NCT01336621|7725641|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2
4751598|NCT01336621|7725641|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12
4751599|NCT01336621|7725641|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27
4751600|NCT01336621|7725641|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11
4751601|NCT01336621|7725641|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2
4751602|NCT01336621|7725641|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22
4751603|NCT01336621|7725641|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2
4751604|NCT01336621|7725641|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9
4751605|NCT01336621|7725641|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1
4751606|NCT01336621|7725641|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1
4751607|NCT01336621|7725641|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3
4751608|NCT01336621|7725641|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1
4751609|NCT01336621|7725641|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3
4751623|NCT02903823|7725744|FG000|Overall Study|Catheter dislodgement|1
4663058|NCT02227784|7553386|FG003|Double-Blind Phase|Adverse Event|3
4663059|NCT02227784|7553387|FG004|Double-Blind Phase|Adverse Event|0
4663060|NCT02227784|7553383|FG000|Double-Blind Phase|Physician Decision|1
4663061|NCT02227784|7553384|FG001|Double-Blind Phase|Physician Decision|0
4663062|NCT02227784|7553385|FG002|Double-Blind Phase|Physician Decision|0
4663063|NCT02227784|7553386|FG003|Double-Blind Phase|Physician Decision|1
4663064|NCT02227784|7553387|FG004|Double-Blind Phase|Physician Decision|0
4663065|NCT02227784|7553383|FG000|Double-Blind Phase|Protocol Violation|0
4663066|NCT02227784|7553384|FG001|Double-Blind Phase|Protocol Violation|0
4663067|NCT02227784|7553385|FG002|Double-Blind Phase|Protocol Violation|1
4663068|NCT02227784|7553386|FG003|Double-Blind Phase|Protocol Violation|1
4663069|NCT02227784|7553387|FG004|Double-Blind Phase|Protocol Violation|0
4663070|NCT02227784|7553383|FG000|Double-Blind Phase|Sponsor Decision|34
4663071|NCT02227784|7553384|FG001|Double-Blind Phase|Sponsor Decision|15
4663072|NCT02227784|7553385|FG002|Double-Blind Phase|Sponsor Decision|14
4663073|NCT02227784|7553386|FG003|Double-Blind Phase|Sponsor Decision|32
4663074|NCT02227784|7553387|FG004|Double-Blind Phase|Sponsor Decision|0
4663075|NCT02227784|7553383|FG000|Double-Blind Phase|Withdrawal by Subject|2
4663076|NCT02227784|7553384|FG001|Double-Blind Phase|Withdrawal by Subject|1
4663077|NCT02227784|7553385|FG002|Double-Blind Phase|Withdrawal by Subject|5
4663078|NCT02227784|7553386|FG003|Double-Blind Phase|Withdrawal by Subject|2
4663079|NCT02227784|7553387|FG004|Double-Blind Phase|Withdrawal by Subject|0
4663080|NCT02227784|7553383|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0
4663081|NCT02227784|7553384|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0
4663082|NCT02227784|7553385|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0
4663083|NCT02227784|7553386|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0
4663084|NCT02227784|7553387|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1
4663085|NCT02227784|7553383|FG000|Open-Label Extension Phase (OLE)|Death|0
4663086|NCT02227784|7553384|FG001|Open-Label Extension Phase (OLE)|Death|0
4663087|NCT02227784|7553385|FG002|Open-Label Extension Phase (OLE)|Death|0
4663088|NCT02227784|7553386|FG003|Open-Label Extension Phase (OLE)|Death|0
4663089|NCT02227784|7553387|FG004|Open-Label Extension Phase (OLE)|Death|1
4663090|NCT02227784|7553383|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0
4663091|NCT02227784|7553384|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0
4663092|NCT02227784|7553385|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0
4663093|NCT02227784|7553386|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0
4663094|NCT02227784|7553387|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243
4663095|NCT02227784|7553383|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
4663096|NCT02227784|7553384|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
4663097|NCT02227784|7553385|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
4663098|NCT02227784|7553386|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
4663099|NCT02227784|7553387|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3
4663100|NCT02227849|7553415|FG000|Overall Study|Adverse Event|4
4663101|NCT02227849|7553415|FG000|Overall Study|Physician Decision|1
4663102|NCT02227849|7553415|FG000|Overall Study|Withdrawal by Subject|3
4663103|NCT02228096|7553421|FG000|Overall Study|Study terminated by Sponsor|24
4663104|NCT02228096|7553421|FG000|Overall Study|Lack of Efficacy|18
4663105|NCT02228096|7553421|FG000|Overall Study|Death|12
4663106|NCT02228096|7553421|FG000|Overall Study|Physician Decision|3
4663107|NCT02228096|7553421|FG000|Overall Study|Subject/guardian decision|2
4663108|NCT02228096|7553421|FG000|Overall Study|New therapy for study indication|1
4663109|NCT02228096|7553421|FG000|Overall Study|Enrolled, not infused|11
4663110|NCT02228395|7553443|FG000|First Intervention Period|No longer willing to participate|1
4663111|NCT02228395|7553444|FG001|First Intervention Period|No longer willing to participate|0
4663112|NCT02228395|7553445|FG002|First Intervention Period|No longer willing to participate|0
4663113|NCT02228395|7553443|FG000|First Intervention Period|Unable to comply with study dates|0
4751624|NCT01547117|7725766|FG000|Overall Study|Physician Decision|0
4751625|NCT01547117|7725767|FG001|Overall Study|Physician Decision|1
4751626|NCT01547117|7725768|FG002|Overall Study|Physician Decision|1
4751627|NCT01547117|7725769|FG003|Overall Study|Physician Decision|3
4751628|NCT01547117|7725766|FG000|Overall Study|Withdrawal by Subject|1
4751629|NCT01547117|7725767|FG001|Overall Study|Withdrawal by Subject|2
4751630|NCT01547117|7725768|FG002|Overall Study|Withdrawal by Subject|1
4751631|NCT01547117|7725769|FG003|Overall Study|Withdrawal by Subject|2
4751632|NCT01431508|7725795|FG000|Overall Study|Lack of Efficacy|1
4751633|NCT01431508|7725795|FG000|Overall Study|Unable to Follow Protocol Procedures|1
4751634|NCT00871351|7725802|FG000|Overall Study|Withdrawal by Subject|1
4751635|NCT00871351|7725803|FG001|Overall Study|Withdrawal by Subject|0
4751636|NCT00871351|7725804|FG002|Overall Study|Withdrawal by Subject|0
4751637|NCT00871351|7725802|FG000|Overall Study|Adverse Event|3
4751638|NCT00871351|7725803|FG001|Overall Study|Adverse Event|1
4751639|NCT00871351|7725804|FG002|Overall Study|Adverse Event|0
4751640|NCT00832455|7725812|FG000|Overall Study|Adverse Event|13
4663114|NCT02228395|7553444|FG001|First Intervention Period|Unable to comply with study dates|1
4663115|NCT02228395|7553445|FG002|First Intervention Period|Unable to comply with study dates|1
4663116|NCT02228460|7553464|FG000|Overall Study|Adverse Event|1
4663117|NCT02228460|7553464|FG000|Overall Study|Lost to Follow-up|1
4663118|NCT02228564|7553478|FG000|Overall Study|Withdrawal by Subject|10
4663119|NCT02228564|7553478|FG000|Overall Study|Death|11
4663120|NCT02228564|7553478|FG000|Overall Study|Physician Decision|5
4663121|NCT02228564|7553478|FG000|Overall Study|Lost to Follow-up|17
4663122|NCT02228564|7553478|FG000|Overall Study|Other|6
4663123|NCT02228590|7553482|FG000|Overall Study|Withdrawal by Subject|1
4663124|NCT02228720|7553496|FG000|Open Label - Day 30|Lost to Follow-up|1
4663125|NCT02228967|7553511|FG000|Overall Study|Lost to Follow-up|146
4663126|NCT02228967|7553512|FG001|Overall Study|Lost to Follow-up|142
4663127|NCT02228967|7553511|FG000|Overall Study|Withdrawal by Subject|13
4663128|NCT02228967|7553512|FG001|Overall Study|Withdrawal by Subject|18
4663129|NCT02228980|7553522|FG000|Overall Study|Adverse Event|14
4663130|NCT02228980|7553523|FG001|Overall Study|Adverse Event|0
4663131|NCT02228980|7553524|FG002|Overall Study|Adverse Event|0
4663132|NCT02228980|7553525|FG003|Overall Study|Adverse Event|0
4663133|NCT02228980|7553522|FG000|Overall Study|Protocol Violation|7
4663134|NCT02228980|7553523|FG001|Overall Study|Protocol Violation|0
4663135|NCT02228980|7553524|FG002|Overall Study|Protocol Violation|0
4663136|NCT02228980|7553525|FG003|Overall Study|Protocol Violation|0
4663137|NCT02228980|7553522|FG000|Overall Study|Withdrawal by Subject|3
4663138|NCT02228980|7553523|FG001|Overall Study|Withdrawal by Subject|3
4663139|NCT02228980|7553524|FG002|Overall Study|Withdrawal by Subject|2
4663140|NCT02228980|7553525|FG003|Overall Study|Withdrawal by Subject|3
4663141|NCT02229214|7553541|FG000|Overall Study|Adverse Event|2
4663142|NCT02229214|7553542|FG001|Overall Study|Adverse Event|0
4663143|NCT02229214|7553541|FG000|Overall Study|Withdrawal by Subject|4
4663144|NCT02229214|7553542|FG001|Overall Study|Withdrawal by Subject|0
4663145|NCT02229227|7553552|FG000|Overall Study|Adverse Event|14
4663146|NCT02229227|7553553|FG001|Overall Study|Adverse Event|9
4663147|NCT02229227|7553552|FG000|Overall Study|Lack of Efficacy|3
4751641|NCT00832455|7725812|FG000|Overall Study|Lost to Follow-up|26
4751642|NCT00832455|7725812|FG000|Overall Study|Protocol Violation|4
4751643|NCT00832455|7725812|FG000|Overall Study|Withdrawal by Subject|17
4751644|NCT00832455|7725812|FG000|Overall Study|Screening Failure|2
4751645|NCT00832455|7725812|FG000|Overall Study|Stopped Medication|4
4751646|NCT00832455|7725812|FG000|Overall Study|Parent misunderstood study|1
4751647|NCT00832455|7725812|FG000|Overall Study|Parent dissatisfied|1
4751648|NCT00832455|7725812|FG000|Overall Study|No improvement|3
4751649|NCT00832455|7725812|FG000|Overall Study|Patient moved|1
4751650|NCT00812006|7725828|FG000|Overall Study|Lost to Follow-up|0
4751651|NCT00812006|7725829|FG001|Overall Study|Lost to Follow-up|0
4751652|NCT00812006|7725830|FG002|Overall Study|Lost to Follow-up|2
4751653|NCT00812006|7725828|FG000|Overall Study|Physician Decision|0
4751654|NCT00812006|7725829|FG001|Overall Study|Physician Decision|0
4751655|NCT00812006|7725830|FG002|Overall Study|Physician Decision|1
4751656|NCT00812006|7725828|FG000|Overall Study|Withdrawal by Subject|2
4751657|NCT00812006|7725829|FG001|Overall Study|Withdrawal by Subject|1
4751658|NCT00812006|7725830|FG002|Overall Study|Withdrawal by Subject|1
4751659|NCT00812006|7725828|FG000|Overall Study|Lack of Qualifying Event|4
4751660|NCT00812006|7725829|FG001|Overall Study|Lack of Qualifying Event|2
4751661|NCT00812006|7725830|FG002|Overall Study|Lack of Qualifying Event|2
4751662|NCT00687531|7725843|FG000|Overall Study|Did not meet protocol eligibility|104
4751663|NCT00687531|7725843|FG000|Overall Study|Adverse Event|5
4751664|NCT00687531|7725843|FG000|Overall Study|Lost to Follow-up|26
4751665|NCT00654628|7725847|FG000|6-week Active Treatment Period|Adverse Event|9
4751666|NCT00654628|7725847|FG000|6-week Active Treatment Period|Lost to Follow-up|10
4751667|NCT00654628|7725847|FG000|6-week Active Treatment Period|Transferred to branch hospital|1
4751668|NCT00654628|7725847|FG000|6-week Active Treatment Period|Out of window period|1
4751669|NCT00654628|7725847|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4
4751670|NCT00654628|7725847|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1
4751671|NCT00536380|7725873|FG000|Overall Study|Adverse Event|0
4751672|NCT00536380|7725874|FG001|Overall Study|Adverse Event|2
4751673|NCT00536380|7725875|FG002|Overall Study|Adverse Event|2
4751674|NCT00536380|7725873|FG000|Overall Study|Lost to Follow-up|0
4751675|NCT00536380|7725874|FG001|Overall Study|Lost to Follow-up|0
4751676|NCT00536380|7725875|FG002|Overall Study|Lost to Follow-up|1
4751677|NCT00536380|7725873|FG000|Overall Study|Withdrawal unrelated to study drug|2
4751678|NCT00536380|7725874|FG001|Overall Study|Withdrawal unrelated to study drug|0
4751679|NCT00536380|7725875|FG002|Overall Study|Withdrawal unrelated to study drug|1
4751680|NCT00536380|7725873|FG000|Overall Study|Withdrawal related to study drug|7
4751681|NCT00536380|7725874|FG001|Overall Study|Withdrawal related to study drug|5
4751682|NCT00536380|7725875|FG002|Overall Study|Withdrawal related to study drug|2
4751683|NCT00536380|7725873|FG000|Overall Study|Noncompliance with protocol|3
4751684|NCT00536380|7725874|FG001|Overall Study|Noncompliance with protocol|2
4751685|NCT00536380|7725875|FG002|Overall Study|Noncompliance with protocol|2
4751686|NCT00536380|7725873|FG000|Overall Study|Did not meet protocol eligibility|0
4751687|NCT00536380|7725874|FG001|Overall Study|Did not meet protocol eligibility|0
4751688|NCT00536380|7725875|FG002|Overall Study|Did not meet protocol eligibility|1
4751689|NCT00536380|7725873|FG000|Overall Study|Administrative|0
4751690|NCT00536380|7725874|FG001|Overall Study|Administrative|0
4751691|NCT00536380|7725875|FG002|Overall Study|Administrative|1
4751692|NCT00521599|7725886|FG000|Overall Study|Adverse Event|5
4751693|NCT00521599|7725887|FG001|Overall Study|Adverse Event|7
4751694|NCT00521599|7725888|FG002|Overall Study|Adverse Event|6
4751695|NCT00521599|7725886|FG000|Overall Study|Treatment Failure|8
4751696|NCT00521599|7725887|FG001|Overall Study|Treatment Failure|9
4663148|NCT02229227|7553553|FG001|Overall Study|Lack of Efficacy|3
4663149|NCT02229227|7553552|FG000|Overall Study|Protocol Violation|6
4751697|NCT00521599|7725888|FG002|Overall Study|Treatment Failure|22
4751698|NCT00521599|7725886|FG000|Overall Study|Lost to Follow-up|2
4751699|NCT00521599|7725887|FG001|Overall Study|Lost to Follow-up|1
4751700|NCT00521599|7725888|FG002|Overall Study|Lost to Follow-up|2
4751701|NCT00521599|7725886|FG000|Overall Study|Withdrawal by Subject|3
4663150|NCT02229227|7553553|FG001|Overall Study|Protocol Violation|8
4663151|NCT02229227|7553552|FG000|Overall Study|Protocol defined stopping criteria|1
4663152|NCT02229227|7553553|FG001|Overall Study|Protocol defined stopping criteria|3
4663153|NCT02229227|7553552|FG000|Overall Study|Lost to Follow-up|3
4663154|NCT02229227|7553553|FG001|Overall Study|Lost to Follow-up|3
4663155|NCT02229227|7553552|FG000|Overall Study|Study terminated by sponsor|11
4663156|NCT02229227|7553553|FG001|Overall Study|Study terminated by sponsor|11
4663157|NCT02229227|7553552|FG000|Overall Study|Withdrawal by Subject|8
4663158|NCT02229227|7553553|FG001|Overall Study|Withdrawal by Subject|12
4663159|NCT02229227|7553552|FG000|Overall Study|Other|0
4663160|NCT02229227|7553553|FG001|Overall Study|Other|1
4663161|NCT02229227|7553552|FG000|Overall Study|Physician Decision|5
4663162|NCT02229227|7553553|FG001|Overall Study|Physician Decision|12
4663163|NCT02229383|7553566|FG000|Overall Study|Adverse Event|7
4663164|NCT02229383|7553567|FG001|Overall Study|Adverse Event|4
4663165|NCT02229383|7553566|FG000|Overall Study|Death|0
4663166|NCT02229383|7553567|FG001|Overall Study|Death|1
4663167|NCT02229383|7553566|FG000|Overall Study|Lost to Follow-up|5
4663168|NCT02229383|7553567|FG001|Overall Study|Lost to Follow-up|3
4663169|NCT02229383|7553566|FG000|Overall Study|Withdrawal by Subject|4
4663170|NCT02229383|7553567|FG001|Overall Study|Withdrawal by Subject|6
4663171|NCT02229383|7553566|FG000|Overall Study|Did not receive treatment|1
4663172|NCT02229383|7553567|FG001|Overall Study|Did not receive treatment|0
4663173|NCT02229383|7553566|FG000|Overall Study|Other|3
4663174|NCT02229383|7553567|FG001|Overall Study|Other|8
4663175|NCT02229396|7553576|FG000|Overall Study|Adverse Event|6
4663176|NCT02229396|7553577|FG001|Overall Study|Adverse Event|12
4663177|NCT02229396|7553578|FG002|Overall Study|Adverse Event|12
4663178|NCT02229396|7553576|FG000|Overall Study|Death|2
4663179|NCT02229396|7553577|FG001|Overall Study|Death|3
4663180|NCT02229396|7553578|FG002|Overall Study|Death|1
4663181|NCT02229396|7553576|FG000|Overall Study|Lost to Follow-up|14
4663182|NCT02229396|7553577|FG001|Overall Study|Lost to Follow-up|14
4663183|NCT02229396|7553578|FG002|Overall Study|Lost to Follow-up|21
4663184|NCT02229396|7553576|FG000|Overall Study|Protocol Violation|2
4663185|NCT02229396|7553577|FG001|Overall Study|Protocol Violation|1
4663186|NCT02229396|7553578|FG002|Overall Study|Protocol Violation|0
4663187|NCT02229396|7553576|FG000|Overall Study|Patient Incorrectly Randomized|0
4663188|NCT02229396|7553577|FG001|Overall Study|Patient Incorrectly Randomized|0
4663189|NCT02229396|7553578|FG002|Overall Study|Patient Incorrectly Randomized|1
4663190|NCT02229396|7553576|FG000|Overall Study|Other|10
4663191|NCT02229396|7553577|FG001|Overall Study|Other|18
4663192|NCT02229396|7553578|FG002|Overall Study|Other|15
4663193|NCT02229396|7553576|FG000|Overall Study|Withdrawal by Subject|42
4663194|NCT02229396|7553577|FG001|Overall Study|Withdrawal by Subject|28
4663195|NCT02229396|7553578|FG002|Overall Study|Withdrawal by Subject|41
4663196|NCT02229396|7553576|FG000|Overall Study|Study-Specific Withdrawal Criteria|0
4663197|NCT02229396|7553577|FG001|Overall Study|Study-Specific Withdrawal Criteria|1
4663198|NCT02229396|7553578|FG002|Overall Study|Study-Specific Withdrawal Criteria|3
4663199|NCT02229396|7553576|FG000|Overall Study|Withdrew; No Record on Termination Page|2
4663200|NCT02229396|7553577|FG001|Overall Study|Withdrew; No Record on Termination Page|0
4663201|NCT02229396|7553578|FG002|Overall Study|Withdrew; No Record on Termination Page|1
4663202|NCT02229539|7553644|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0
4663203|NCT02229539|7553645|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1
4663204|NCT02229539|7553646|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0
4663205|NCT02229539|7553644|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0
4663206|NCT02229539|7553645|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0
4663207|NCT02229539|7553646|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1
4663208|NCT02229539|7553644|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0
4663209|NCT02229539|7553645|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0
4663210|NCT02229539|7553646|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1
4663211|NCT02229539|7553644|FG000|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|3
4663212|NCT02229539|7553645|FG001|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|4
4663213|NCT02229539|7553646|FG002|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|1
4663214|NCT02229539|7553644|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5
4663215|NCT02229539|7553645|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5
4663216|NCT02229539|7553646|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6
4663217|NCT02229539|7553644|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2
4663218|NCT02229539|7553645|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0
4663219|NCT02229539|7553646|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0
4663220|NCT02229539|7553644|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0
4663221|NCT02229539|7553645|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1
4663222|NCT02229539|7553646|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1
4663223|NCT02229539|7553644|FG000|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0
4663224|NCT02229539|7553645|FG001|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0
4663225|NCT02229539|7553646|FG002|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|3
4663226|NCT02229539|7553644|FG000|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|2
4663227|NCT02229539|7553645|FG001|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|1
4751702|NCT00521599|7725887|FG001|Overall Study|Withdrawal by Subject|5
4663228|NCT02229539|7553646|FG002|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|0
4663229|NCT02229552|7553654|FG000|Baseline|Withdrawal by Subject|6
4663230|NCT02229552|7553654|FG000|1-year Follow up|Withdrawal by Subject|7
4663231|NCT02229552|7553654|FG000|1-year Follow up|Lost to Follow-up|18
4663232|NCT02229552|7553654|FG000|2-Year Follow up|Withdrawal by Subject|9
4663233|NCT02229552|7553654|FG000|2-Year Follow up|Lost to Follow-up|17
4663234|NCT02229851|7553661|FG000|Main Phase (Double-blind Phase)|Unclassified|1
4663235|NCT02229851|7553662|FG001|Main Phase (Double-blind Phase)|Unclassified|2
4663236|NCT02229851|7553663|FG002|Main Phase (Double-blind Phase)|Unclassified|0
4663237|NCT02229851|7553664|FG003|Main Phase (Double-blind Phase)|Unclassified|0
4663238|NCT02229851|7553665|FG004|Main Phase (Double-blind Phase)|Unclassified|0
4663239|NCT02229851|7553666|FG005|Main Phase (Double-blind Phase)|Unclassified|0
4663240|NCT02229851|7553667|FG006|Main Phase (Double-blind Phase)|Unclassified|0
4663241|NCT02229851|7553661|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0
4751703|NCT00521599|7725888|FG002|Overall Study|Withdrawal by Subject|1
4751704|NCT00521599|7725886|FG000|Overall Study|Withdrawal by subject treatment related|3
4751705|NCT00521599|7725887|FG001|Overall Study|Withdrawal by subject treatment related|1
4751706|NCT00521599|7725888|FG002|Overall Study|Withdrawal by subject treatment related|2
4751707|NCT00521599|7725886|FG000|Overall Study|Protocol Violation|2
4751708|NCT00521599|7725887|FG001|Overall Study|Protocol Violation|4
4751709|NCT00521599|7725888|FG002|Overall Study|Protocol Violation|2
4751710|NCT00521599|7725886|FG000|Overall Study|Did not meet protocol eligibility|2
4751711|NCT00521599|7725887|FG001|Overall Study|Did not meet protocol eligibility|2
4751712|NCT00521599|7725888|FG002|Overall Study|Did not meet protocol eligibility|1
4751713|NCT00496834|7725899|FG000|Overall Study|Withdrawal by Subject|4
4751714|NCT00496834|7725900|FG001|Overall Study|Withdrawal by Subject|6
4751715|NCT00496834|7725899|FG000|Overall Study|Contraindicated medication administered|0
4751716|NCT00496834|7725900|FG001|Overall Study|Contraindicated medication administered|1
4751717|NCT00496834|7725899|FG000|Overall Study|Inclusion/exclusion criteria not met|3
4751718|NCT00496834|7725900|FG001|Overall Study|Inclusion/exclusion criteria not met|2
4751719|NCT00496834|7725899|FG000|Overall Study|Adverse Event|5
4751720|NCT00496834|7725900|FG001|Overall Study|Adverse Event|3
4751721|NCT00496834|7725899|FG000|Overall Study|IP administration violation|2
4751722|NCT00496834|7725900|FG001|Overall Study|IP administration violation|0
4751723|NCT00496834|7725899|FG000|Overall Study|Lost to Follow-up|2
4751724|NCT00496834|7725900|FG001|Overall Study|Lost to Follow-up|0
4751725|NCT00496834|7725899|FG000|Overall Study|Blood Pressure control failure|2
4751726|NCT00496834|7725900|FG001|Overall Study|Blood Pressure control failure|1
4751727|NCT00442897|7725910|FG000|Base Study (12 Week Follow-up)|Adverse Event|1
4751728|NCT00442897|7725911|FG001|Base Study (12 Week Follow-up)|Adverse Event|0
4751729|NCT00442897|7725910|FG000|Base Study (12 Week Follow-up)|Death|0
4751730|NCT00442897|7725911|FG001|Base Study (12 Week Follow-up)|Death|1
4751731|NCT00442897|7725910|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7
4751732|NCT00442897|7725911|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3
4751733|NCT00442897|7725910|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9
4751734|NCT00442897|7725911|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8
4751735|NCT00442897|7725910|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1
4751736|NCT00442897|7725911|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0
4751737|NCT00442897|7725910|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2
4751738|NCT00442897|7725911|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2
4751739|NCT00442897|7725910|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2
4751740|NCT00442897|7725911|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1
4751741|NCT00442897|7725910|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1
4751742|NCT00442897|7725911|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3
4751743|NCT00423579|7725919|FG000|Overall Study|Lost to Follow-up|3
4751744|NCT00423579|7725920|FG001|Overall Study|Lost to Follow-up|0
4751745|NCT00423579|7725919|FG000|Overall Study|Protocol Violation|1
4751746|NCT00423579|7725920|FG001|Overall Study|Protocol Violation|3
4751747|NCT00423579|7725919|FG000|Overall Study|Diagnosis of diabetes|0
4751748|NCT00423579|7725920|FG001|Overall Study|Diagnosis of diabetes|1
4751749|NCT00394355|7725930|FG000|Overall Study|Adverse Event|10
4751750|NCT00394355|7725931|FG001|Overall Study|Adverse Event|6
4751751|NCT00394355|7725932|FG002|Overall Study|Adverse Event|7
4751752|NCT00394355|7725933|FG003|Overall Study|Adverse Event|8
4751753|NCT00394355|7725930|FG000|Overall Study|Did not meet protocol eligibility|1
4751754|NCT00394355|7725931|FG001|Overall Study|Did not meet protocol eligibility|5
4751755|NCT00394355|7725932|FG002|Overall Study|Did not meet protocol eligibility|4
4751756|NCT00394355|7725933|FG003|Overall Study|Did not meet protocol eligibility|2
4751757|NCT00394355|7725930|FG000|Overall Study|Subject withdrawal - unrelated to drug|12
4751758|NCT00394355|7725931|FG001|Overall Study|Subject withdrawal - unrelated to drug|14
4751759|NCT00394355|7725932|FG002|Overall Study|Subject withdrawal - unrelated to drug|10
4751760|NCT00394355|7725933|FG003|Overall Study|Subject withdrawal - unrelated to drug|6
4751761|NCT00394355|7725930|FG000|Overall Study|Subject withdrawal - related to drug|1
4751762|NCT00394355|7725931|FG001|Overall Study|Subject withdrawal - related to drug|0
4663242|NCT02229851|7553662|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1
4663243|NCT02229851|7553663|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0
4663244|NCT02229851|7553664|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0
4663245|NCT02229851|7553665|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0
4663246|NCT02229851|7553666|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0
4663247|NCT02229851|7553667|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0
4663248|NCT02229851|7553661|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4
4663249|NCT02229851|7553662|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12
4663250|NCT02229851|7553663|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4
4663251|NCT02229851|7553664|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0
4663252|NCT02229851|7553665|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0
4663253|NCT02229851|7553666|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0
4663254|NCT02229851|7553667|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0
4663255|NCT02229851|7553661|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0
4663256|NCT02229851|7553662|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0
4663257|NCT02229851|7553663|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2
4663258|NCT02229851|7553664|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0
4663259|NCT02229851|7553665|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0
4663260|NCT02229851|7553666|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0
4663261|NCT02229851|7553667|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0
4663262|NCT02229851|7553661|FG000|Main Phase (Double-blind Phase)|Death|1
4663263|NCT02229851|7553662|FG001|Main Phase (Double-blind Phase)|Death|1
4663264|NCT02229851|7553663|FG002|Main Phase (Double-blind Phase)|Death|0
4663265|NCT02229851|7553664|FG003|Main Phase (Double-blind Phase)|Death|0
4663266|NCT02229851|7553665|FG004|Main Phase (Double-blind Phase)|Death|0
4663267|NCT02229851|7553666|FG005|Main Phase (Double-blind Phase)|Death|0
4663268|NCT02229851|7553667|FG006|Main Phase (Double-blind Phase)|Death|0
4663269|NCT02229851|7553661|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0
4663270|NCT02229851|7553662|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0
4663271|NCT02229851|7553663|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0
4663272|NCT02229851|7553664|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0
4663273|NCT02229851|7553665|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1
4663274|NCT02229851|7553666|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1
4663275|NCT02229851|7553667|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1
4663276|NCT02229851|7553661|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0
4663277|NCT02229851|7553662|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0
4663278|NCT02229851|7553663|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0
4663279|NCT02229851|7553664|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1
4663280|NCT02229851|7553665|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4
4663281|NCT02229851|7553666|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3
4663282|NCT02229851|7553667|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1
4663283|NCT02229851|7553661|FG000|Extension Phase (Open-label Phase)|Death|0
4663284|NCT02229851|7553662|FG001|Extension Phase (Open-label Phase)|Death|0
4663285|NCT02229851|7553663|FG002|Extension Phase (Open-label Phase)|Death|0
4751763|NCT00394355|7725932|FG002|Overall Study|Subject withdrawal - related to drug|0
4751764|NCT00394355|7725933|FG003|Overall Study|Subject withdrawal - related to drug|0
4751765|NCT00394355|7725930|FG000|Overall Study|Lost to Follow-up|7
4751766|NCT00394355|7725931|FG001|Overall Study|Lost to Follow-up|5
4751767|NCT00394355|7725932|FG002|Overall Study|Lost to Follow-up|4
4751768|NCT00394355|7725933|FG003|Overall Study|Lost to Follow-up|3
4751769|NCT00394355|7725930|FG000|Overall Study|Noncompliance with protocol|4
4751770|NCT00394355|7725931|FG001|Overall Study|Noncompliance with protocol|3
4751771|NCT00394355|7725932|FG002|Overall Study|Noncompliance with protocol|10
4751772|NCT00394355|7725933|FG003|Overall Study|Noncompliance with protocol|8
4751773|NCT00394355|7725930|FG000|Overall Study|Administrative|0
4751774|NCT00394355|7725931|FG001|Overall Study|Administrative|1
4751775|NCT00394355|7725932|FG002|Overall Study|Administrative|1
4751776|NCT00394355|7725933|FG003|Overall Study|Administrative|1
4751777|NCT00394355|7725930|FG000|Overall Study|Lack of Efficacy|0
4751778|NCT00394355|7725931|FG001|Overall Study|Lack of Efficacy|0
4663286|NCT02229851|7553664|FG003|Extension Phase (Open-label Phase)|Death|1
4663287|NCT02229851|7553665|FG004|Extension Phase (Open-label Phase)|Death|0
4663288|NCT02229851|7553666|FG005|Extension Phase (Open-label Phase)|Death|1
4663289|NCT02229851|7553667|FG006|Extension Phase (Open-label Phase)|Death|1
4663290|NCT02229864|7553682|FG000|Overall Study|Death|2
4663291|NCT02229864|7553682|FG000|Overall Study|Lost to Follow-up|1
4663292|NCT02230085|7553686|FG000|Overall Study|Physician Decision|1
4663293|NCT02230085|7553686|FG000|Overall Study|Withdrawal by Subject|3
4663294|NCT02230306|7553690|FG000|Overall Study|Did not receive study treatment|1
4663295|NCT02230332|7553696|FG000|Overall Study|Adverse Event|2
4663296|NCT02230332|7553697|FG001|Overall Study|Adverse Event|1
4663297|NCT02230332|7553696|FG000|Overall Study|Lost to Follow-up|1
4663298|NCT02230332|7553697|FG001|Overall Study|Lost to Follow-up|0
4663299|NCT02230332|7553696|FG000|Overall Study|Protocol Violation|1
4663300|NCT02230332|7553697|FG001|Overall Study|Protocol Violation|0
4663301|NCT02230384|7553705|FG000|Phase 1|Lost to Follow-up|1
4663302|NCT02230384|7553706|FG001|Phase 1|Lost to Follow-up|0
4751779|NCT00394355|7725932|FG002|Overall Study|Lack of Efficacy|2
4751780|NCT00394355|7725933|FG003|Overall Study|Lack of Efficacy|3
4751781|NCT00166504|7725954|FG000|Overall Study|Adverse Event|3
4663303|NCT02230384|7553705|FG000|Phase 1|Physician Decision|0
4663304|NCT02230384|7553706|FG001|Phase 1|Physician Decision|1
4663305|NCT02230384|7553705|FG000|Phase 2 - Switch|Withdrawal by Subject|0
4663306|NCT02230384|7553706|FG001|Phase 2 - Switch|Withdrawal by Subject|1
4663307|NCT02230384|7553705|FG000|Phase 2 - Switch|Lost to Follow-up|1
4663308|NCT02230384|7553706|FG001|Phase 2 - Switch|Lost to Follow-up|0
4663309|NCT02230384|7553705|FG000|Phase 2 - Switch|Adverse Event|2
4663310|NCT02230384|7553706|FG001|Phase 2 - Switch|Adverse Event|0
4663311|NCT02230527|7553722|FG000|Overall Study|Withdrawal by Subject|1
4663312|NCT02230527|7553723|FG001|Overall Study|Withdrawal by Subject|1
4663313|NCT02230527|7553722|FG000|Overall Study|Death|1
4663314|NCT02230527|7553723|FG001|Overall Study|Death|0
4663315|NCT02230527|7553722|FG000|Overall Study|Lost to Follow-up|2
4663316|NCT02230527|7553723|FG001|Overall Study|Lost to Follow-up|1
4663317|NCT02230527|7553722|FG000|Overall Study|Other|1
4663318|NCT02230527|7553723|FG001|Overall Study|Other|0
4663319|NCT02230670|7553777|FG000|Overall Study|Adverse Event|1
4663320|NCT02230670|7553778|FG001|Overall Study|Adverse Event|2
4663321|NCT02230670|7553777|FG000|Overall Study|Withdrawal by Subject|2
4663322|NCT02230670|7553778|FG001|Overall Study|Withdrawal by Subject|2
4663323|NCT02230670|7553777|FG000|Overall Study|Physician Decision|0
4663324|NCT02230670|7553778|FG001|Overall Study|Physician Decision|1
4663325|NCT02230670|7553777|FG000|Overall Study|Protocol Violation|0
4663326|NCT02230670|7553778|FG001|Overall Study|Protocol Violation|1
4663327|NCT02230670|7553777|FG000|Overall Study|Progression to Child-Pugh C|1
4663328|NCT02230670|7553778|FG001|Overall Study|Progression to Child-Pugh C|2
4663329|NCT02230683|7553784|FG000|Overall Study|Adverse Event|1
4663330|NCT02230904|7553818|FG000|Overall Study|Safety follow up could not take place|0
4663331|NCT02230904|7553819|FG001|Overall Study|Safety follow up could not take place|1
4663332|NCT02230956|7553830|FG000|Overall Study|Adverse Event|1
4663333|NCT02230956|7553831|FG001|Overall Study|Adverse Event|1
4663334|NCT02230956|7553832|FG002|Overall Study|Adverse Event|0
4663335|NCT02230956|7553830|FG000|Overall Study|Lack of Efficacy|1
4663336|NCT02230956|7553831|FG001|Overall Study|Lack of Efficacy|1
4663337|NCT02230956|7553832|FG002|Overall Study|Lack of Efficacy|1
4663338|NCT02230956|7553830|FG000|Overall Study|Lost to Follow-up|1
4663339|NCT02230956|7553831|FG001|Overall Study|Lost to Follow-up|1
4663340|NCT02230956|7553832|FG002|Overall Study|Lost to Follow-up|2
4663341|NCT02230956|7553830|FG000|Overall Study|Personal Reasons|2
4663342|NCT02230956|7553831|FG001|Overall Study|Personal Reasons|1
4663343|NCT02230956|7553832|FG002|Overall Study|Personal Reasons|1
4663344|NCT02230956|7553830|FG000|Overall Study|Protocol Violation|0
4663345|NCT02230956|7553831|FG001|Overall Study|Protocol Violation|1
4663346|NCT02230956|7553832|FG002|Overall Study|Protocol Violation|1
4663347|NCT02230956|7553830|FG000|Overall Study|Other Miscellaneous Reason|0
4663348|NCT02230956|7553831|FG001|Overall Study|Other Miscellaneous Reason|1
4663349|NCT02230956|7553832|FG002|Overall Study|Other Miscellaneous Reason|2
4663350|NCT02231164|7553860|FG000|Overall Study|Adverse Event|1
4663351|NCT02231164|7553861|FG001|Overall Study|Adverse Event|1
4663352|NCT02231164|7553860|FG000|Overall Study|Lack of Efficacy|4
4663353|NCT02231164|7553861|FG001|Overall Study|Lack of Efficacy|3
4663354|NCT02231164|7553860|FG000|Overall Study|Withdrawal by Subject|1
4663355|NCT02231164|7553861|FG001|Overall Study|Withdrawal by Subject|2
4663356|NCT02231580|7553883|FG000|Overall Study|Adverse Event|5
4663357|NCT02231580|7553884|FG001|Overall Study|Adverse Event|0
4663358|NCT02231749|7553894|FG000|Overall Study|Disease progression|229
4663359|NCT02231749|7553895|FG001|Overall Study|Disease progression|297
4663360|NCT02231749|7553894|FG000|Overall Study|Study Drug Toxicity|134
4663361|NCT02231749|7553895|FG001|Overall Study|Study Drug Toxicity|63
4663362|NCT02231749|7553894|FG000|Overall Study|Death|1
4663363|NCT02231749|7553895|FG001|Overall Study|Death|1
4663364|NCT02231749|7553894|FG000|Overall Study|AE unrelated to Study drug|32
4663365|NCT02231749|7553895|FG001|Overall Study|AE unrelated to Study drug|31
4663366|NCT02231749|7553894|FG000|Overall Study|Participant's request to discontinue|10
4663367|NCT02231749|7553895|FG001|Overall Study|Participant's request to discontinue|21
4663368|NCT02231749|7553894|FG000|Overall Study|Participant withdrew Consent|8
4663369|NCT02231749|7553895|FG001|Overall Study|Participant withdrew Consent|15
4663370|NCT02231749|7553894|FG000|Overall Study|Lost to Follow-up|1
4663371|NCT02231749|7553895|FG001|Overall Study|Lost to Follow-up|2
4663372|NCT02231749|7553894|FG000|Overall Study|Maximum Clinical Benefit|5
4663373|NCT02231749|7553895|FG001|Overall Study|Maximum Clinical Benefit|8
4663374|NCT02231749|7553894|FG000|Overall Study|Poor/Non-Compliance|0
4663375|NCT02231749|7553895|FG001|Overall Study|Poor/Non-Compliance|3
4663376|NCT02231749|7553894|FG000|Overall Study|Pregnancy|1
4663377|NCT02231749|7553895|FG001|Overall Study|Pregnancy|0
4663378|NCT02231749|7553894|FG000|Overall Study|other|0
4663379|NCT02231749|7553895|FG001|Overall Study|other|8
4663380|NCT02231749|7553894|FG000|Overall Study|No longer meets Study Criteria|1
4663381|NCT02231749|7553895|FG001|Overall Study|No longer meets Study Criteria|0
4663382|NCT02231918|7553904|FG000|Overall Study|Withdrawal by Subject|0
4663383|NCT02231918|7553905|FG001|Overall Study|Withdrawal by Subject|1
4663384|NCT02231918|7553906|FG002|Overall Study|Withdrawal by Subject|0
4663385|NCT02231918|7553904|FG000|Overall Study|Adverse Event|0
4663386|NCT02231918|7553905|FG001|Overall Study|Adverse Event|0
4663387|NCT02231918|7553906|FG002|Overall Study|Adverse Event|1
4663388|NCT02232061|7553924|FG000|Overall Study|Administrative problems|1
4663389|NCT02232061|7553924|FG000|Overall Study|Withdrawal by Subject|1
4663390|NCT02232074|7553930|FG000|Overall Study|Withdrawal by Subject|5
4663391|NCT02232074|7553931|FG001|Overall Study|Withdrawal by Subject|3
4663392|NCT02232074|7553930|FG000|Overall Study|No legal concerns at baseline|36
4663393|NCT02232074|7553931|FG001|Overall Study|No legal concerns at baseline|41
4663394|NCT02232074|7553930|FG000|Overall Study|deemed ineligible|0
4663395|NCT02232074|7553931|FG001|Overall Study|deemed ineligible|1
4663396|NCT02232087|7553943|FG000|Overall Study|Withdrawal by Subject|2
4663397|NCT02232087|7553944|FG001|Overall Study|Withdrawal by Subject|0
4663398|NCT02232087|7553945|FG002|Overall Study|Withdrawal by Subject|0
4663399|NCT02232087|7553946|FG003|Overall Study|Withdrawal by Subject|0
4663400|NCT02232087|7553947|FG004|Overall Study|Withdrawal by Subject|0
4663401|NCT02232087|7553948|FG005|Overall Study|Withdrawal by Subject|1
4663402|NCT02232087|7553943|FG000|Overall Study|poor inhalation technique|0
4663403|NCT02232087|7553944|FG001|Overall Study|poor inhalation technique|1
4663404|NCT02232087|7553945|FG002|Overall Study|poor inhalation technique|0
4663405|NCT02232087|7553946|FG003|Overall Study|poor inhalation technique|0
4663406|NCT02232087|7553947|FG004|Overall Study|poor inhalation technique|0
4663407|NCT02232087|7553948|FG005|Overall Study|poor inhalation technique|2
4663408|NCT02232087|7553943|FG000|Overall Study|protocol stop criteria|0
4663409|NCT02232087|7553944|FG001|Overall Study|protocol stop criteria|1
4663410|NCT02232087|7553945|FG002|Overall Study|protocol stop criteria|0
4663411|NCT02232087|7553946|FG003|Overall Study|protocol stop criteria|1
4663412|NCT02232087|7553947|FG004|Overall Study|protocol stop criteria|0
4663413|NCT02232087|7553948|FG005|Overall Study|protocol stop criteria|0
4663414|NCT02232087|7553943|FG000|Overall Study|Adverse Event|0
4663415|NCT02232087|7553944|FG001|Overall Study|Adverse Event|0
4663416|NCT02232087|7553945|FG002|Overall Study|Adverse Event|0
4663417|NCT02232087|7553946|FG003|Overall Study|Adverse Event|0
4663418|NCT02232087|7553947|FG004|Overall Study|Adverse Event|1
4663419|NCT02232087|7553948|FG005|Overall Study|Adverse Event|0
4663420|NCT02232178|7553981|FG000|Overall Study|Lost to Follow-up|0
4663421|NCT02232178|7553982|FG001|Overall Study|Lost to Follow-up|1
4663422|NCT02232178|7553983|FG002|Overall Study|Lost to Follow-up|0
4663423|NCT02232178|7553981|FG000|Overall Study|ineligibility|0
4663424|NCT02232178|7553982|FG001|Overall Study|ineligibility|0
4663425|NCT02232178|7553983|FG002|Overall Study|ineligibility|1
4663426|NCT02232178|7553981|FG000|Overall Study|surgical complication|1
4663427|NCT02232178|7553982|FG001|Overall Study|surgical complication|0
4663428|NCT02232178|7553983|FG002|Overall Study|surgical complication|0
4663429|NCT02232243|7553994|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0
4663430|NCT02232243|7553995|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1
4663431|NCT02232243|7553996|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0
4663432|NCT02232425|7554007|FG000|Overall Study|Lost to Follow-up|6
4663433|NCT02232425|7554008|FG001|Overall Study|Lost to Follow-up|2
4663434|NCT02232425|7554007|FG000|Overall Study|Adverse Event|2
4663435|NCT02232425|7554008|FG001|Overall Study|Adverse Event|0
4663436|NCT02232425|7554007|FG000|Overall Study|Withdrawal by Subject|5
4751782|NCT00166504|7725955|FG001|Overall Study|Adverse Event|3
4751783|NCT00166504|7725954|FG000|Overall Study|Lost to Follow-up|1
4751784|NCT00166504|7725955|FG001|Overall Study|Lost to Follow-up|1
4751785|NCT00166504|7725954|FG000|Overall Study|Withdrawal by Subject|1
4751786|NCT00166504|7725955|FG001|Overall Study|Withdrawal by Subject|0
4663437|NCT02232425|7554008|FG001|Overall Study|Withdrawal by Subject|6
4663438|NCT02232425|7554007|FG000|Overall Study|Lack of Efficacy|1
4663439|NCT02232425|7554008|FG001|Overall Study|Lack of Efficacy|0
4663440|NCT02232698|7554016|FG000|Overall Study|Pregnancy|1
4663441|NCT02232698|7554017|FG001|Overall Study|Pregnancy|1
4663442|NCT02232698|7554016|FG000|Overall Study|Met exclusion criteria|1
4663443|NCT02232698|7554017|FG001|Overall Study|Met exclusion criteria|1
4663444|NCT02232698|7554016|FG000|Overall Study|Had device-associated symptoms|7
4663445|NCT02232698|7554017|FG001|Overall Study|Had device-associated symptoms|0
4663446|NCT02232698|7554016|FG000|Overall Study|Non-compliance with study device|1
4663447|NCT02232698|7554017|FG001|Overall Study|Non-compliance with study device|4
4663448|NCT02232698|7554016|FG000|Overall Study|Allocated to control group|0
4663449|NCT02232698|7554017|FG001|Overall Study|Allocated to control group|3
4663450|NCT02232698|7554016|FG000|Overall Study|Withdrawal by Subject|0
4663451|NCT02232698|7554017|FG001|Overall Study|Withdrawal by Subject|11
4663452|NCT02232802|7554025|FG000|Period 1|Sponsor request|1
4663453|NCT02232802|7554026|FG001|Period 1|Sponsor request|0
4663454|NCT02232802|7554025|FG000|Period 1|Adverse Event|1
4663455|NCT02232802|7554026|FG001|Period 1|Adverse Event|1
4663456|NCT02232893|7554034|FG000|Overall Study|Withdrawal by Subject|4
4663457|NCT02232893|7554035|FG001|Overall Study|Withdrawal by Subject|1
4663458|NCT02232893|7554034|FG000|Overall Study|Adverse Event|0
4663459|NCT02232893|7554035|FG001|Overall Study|Adverse Event|1
4663460|NCT02232893|7554034|FG000|Overall Study|Sponsor request early termination|0
4663461|NCT02232893|7554035|FG001|Overall Study|Sponsor request early termination|1
4663462|NCT02232893|7554034|FG000|Overall Study|Developed exclusion criteria|0
4663463|NCT02232893|7554035|FG001|Overall Study|Developed exclusion criteria|1
4663464|NCT02232893|7554034|FG000|Overall Study|Other|0
4663465|NCT02232893|7554035|FG001|Overall Study|Other|3
4751787|NCT01345240|7725966|FG000|Overall Study|Adverse Event|3
4751788|NCT01345240|7725967|FG001|Overall Study|Adverse Event|5
4751789|NCT01345240|7725968|FG002|Overall Study|Adverse Event|4
4751790|NCT01345240|7725969|FG003|Overall Study|Adverse Event|2
4751791|NCT01345240|7725970|FG004|Overall Study|Adverse Event|1
4751792|NCT01345240|7725966|FG000|Overall Study|Lost to Follow-up|8
4751793|NCT01345240|7725967|FG001|Overall Study|Lost to Follow-up|9
4751794|NCT01345240|7725968|FG002|Overall Study|Lost to Follow-up|14
4751795|NCT01345240|7725969|FG003|Overall Study|Lost to Follow-up|7
4751796|NCT01345240|7725970|FG004|Overall Study|Lost to Follow-up|9
4663466|NCT02232984|7554041|FG000|Overall Study|Withdrawal by Subject|5
4663467|NCT02232984|7554041|FG000|Overall Study|Death|1
4663468|NCT02232984|7554041|FG000|Overall Study|Investigator withdrawal|10
4663469|NCT02232984|7554041|FG000|Overall Study|Device implant unsuccessful|53
4663470|NCT02232984|7554041|FG000|Overall Study|not disclosed by site|7
4751797|NCT01371305|7725997|FG000|Overall Study|Adverse Event|0
4751798|NCT01371305|7725998|FG001|Overall Study|Adverse Event|0
4751799|NCT01371305|7725999|FG002|Overall Study|Adverse Event|0
4751800|NCT01371305|7726000|FG003|Overall Study|Adverse Event|2
4751801|NCT01371305|7726001|FG004|Overall Study|Adverse Event|1
4751802|NCT01371305|7726002|FG005|Overall Study|Adverse Event|0
4751803|NCT01371305|7725997|FG000|Overall Study|Study terminated by sponsor|0
4751804|NCT01371305|7725998|FG001|Overall Study|Study terminated by sponsor|0
4751805|NCT01371305|7725999|FG002|Overall Study|Study terminated by sponsor|0
4751806|NCT01371305|7726000|FG003|Overall Study|Study terminated by sponsor|0
4751807|NCT01371305|7726001|FG004|Overall Study|Study terminated by sponsor|3
4751808|NCT01371305|7726002|FG005|Overall Study|Study terminated by sponsor|1
4751809|NCT01371305|7725997|FG000|Overall Study|Subject request|0
4751810|NCT01371305|7725998|FG001|Overall Study|Subject request|0
4751811|NCT01371305|7725999|FG002|Overall Study|Subject request|0
4751812|NCT01371305|7726000|FG003|Overall Study|Subject request|0
4751813|NCT01371305|7726001|FG004|Overall Study|Subject request|0
4663471|NCT02232984|7554041|FG000|Overall Study|Protocol Violation|1
4663472|NCT02233309|7554070|FG000|Overall Study|Physician Decision|5
4663473|NCT02233413|7554076|FG000|Overall Study|Lost to Follow-up|7
4663474|NCT02233413|7554077|FG001|Overall Study|Lost to Follow-up|9
4663475|NCT02233413|7554076|FG000|Overall Study|Withdrawal by Subject|4
4663476|NCT02233413|7554077|FG001|Overall Study|Withdrawal by Subject|5
4663477|NCT02233543|7554109|FG000|Period 1|Withdrawal by Subject|1
4663478|NCT02233543|7554110|FG001|Period 1|Withdrawal by Subject|0
4663479|NCT02233543|7554109|FG000|Period 1|Participants required other treatment.|2
4663480|NCT02233543|7554110|FG001|Period 1|Participants required other treatment.|3
4663481|NCT02233543|7554109|FG000|Period 2|Adverse Event|1
4663482|NCT02233543|7554110|FG001|Period 2|Adverse Event|0
4663483|NCT02233543|7554109|FG000|Period 2|Participant required other treatment.|0
4663484|NCT02233543|7554110|FG001|Period 2|Participant required other treatment.|1
4663485|NCT02233543|7554109|FG000|Period 2|COPD exacerbation|1
4663486|NCT02233543|7554110|FG001|Period 2|COPD exacerbation|0
4663487|NCT02233647|7554116|FG000|Overall Study|Adverse Event|1
4663488|NCT02233738|7554122|FG000|Overall Study|Lost to Follow-up|5
4663489|NCT02233738|7554123|FG001|Overall Study|Lost to Follow-up|12
4663490|NCT02233738|7554122|FG000|Overall Study|Death|0
4663491|NCT02233738|7554123|FG001|Overall Study|Death|1
4663492|NCT02233738|7554122|FG000|Overall Study|Withdrawal by Subject|0
4663493|NCT02233738|7554123|FG001|Overall Study|Withdrawal by Subject|1
4663494|NCT02233738|7554122|FG000|Overall Study|Did not return after Baseline|3
4663495|NCT02233738|7554123|FG001|Overall Study|Did not return after Baseline|2
4663496|NCT02233803|7554300|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1
4663497|NCT02233803|7554301|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0
4663498|NCT02233803|7554300|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0
4663499|NCT02233803|7554301|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1
4663500|NCT02233803|7554300|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2
4663501|NCT02233803|7554301|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2
4663502|NCT02233803|7554300|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0
4663503|NCT02233803|7554301|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1
4663504|NCT02233803|7554300|FG000|Washout Period (4-Wks)|Lost to Follow-up|0
4663505|NCT02233803|7554301|FG001|Washout Period (4-Wks)|Lost to Follow-up|1
4663506|NCT02233803|7554300|FG000|Washout Period (4-Wks)|Physician Decision|1
4663507|NCT02233803|7554301|FG001|Washout Period (4-Wks)|Physician Decision|0
4663508|NCT02233803|7554300|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1
4663509|NCT02233803|7554301|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1
4663510|NCT02233803|7554300|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1
4663511|NCT02233803|7554301|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0
4663512|NCT02233803|7554300|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1
4663513|NCT02233803|7554301|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2
4663514|NCT02233946|7554316|FG000|Baseline|Withdrawal by Subject|2
4663515|NCT02233946|7554317|FG001|Baseline|Withdrawal by Subject|0
4663516|NCT02233946|7554316|FG000|3-months Follow-up|Lost to Follow-up|53
4663517|NCT02233946|7554317|FG001|3-months Follow-up|Lost to Follow-up|29
4663518|NCT02233946|7554316|FG000|6-months Follow-up|Lost to Follow-up|21
4663519|NCT02233946|7554317|FG001|6-months Follow-up|Lost to Follow-up|2
4663520|NCT02233946|7554316|FG000|9-month Follow-up|Lost to Follow-up|20
4663521|NCT02233946|7554317|FG001|9-month Follow-up|Lost to Follow-up|11
4663522|NCT02233946|7554316|FG000|12-month Follow-up|Lost to Follow-up|28
4751814|NCT01371305|7726002|FG005|Overall Study|Subject request|1
4663523|NCT02233946|7554317|FG001|12-month Follow-up|Lost to Follow-up|11
4663524|NCT02234063|7554349|FG000|Overall Study|Lost to Follow-up|235
4663525|NCT02234063|7554350|FG001|Overall Study|Lost to Follow-up|42
4663526|NCT02234063|7554349|FG000|Overall Study|Withdrawal by Subject|20
4663527|NCT02234063|7554350|FG001|Overall Study|Withdrawal by Subject|1
4663528|NCT02234141|7554382|FG000|Treatment Period (24 Weeks)|Protocol Violation|0
4663529|NCT02234141|7554383|FG001|Treatment Period (24 Weeks)|Protocol Violation|0
4663530|NCT02234141|7554384|FG002|Treatment Period (24 Weeks)|Protocol Violation|0
4663531|NCT02234141|7554385|FG003|Treatment Period (24 Weeks)|Protocol Violation|1
4663532|NCT02234141|7554386|FG004|Treatment Period (24 Weeks)|Protocol Violation|0
4663533|NCT02234141|7554387|FG005|Treatment Period (24 Weeks)|Protocol Violation|0
4663534|NCT02234141|7554388|FG006|Treatment Period (24 Weeks)|Protocol Violation|0
4663535|NCT02234141|7554382|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0
4663536|NCT02234141|7554383|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2
4663537|NCT02234141|7554384|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0
4663538|NCT02234141|7554385|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0
4663539|NCT02234141|7554386|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0
4663540|NCT02234141|7554387|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0
4663541|NCT02234141|7554388|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0
4663542|NCT02234141|7554382|FG000|Treatment Period (24 Weeks)|Death|1
4663543|NCT02234141|7554383|FG001|Treatment Period (24 Weeks)|Death|2
4663544|NCT02234141|7554384|FG002|Treatment Period (24 Weeks)|Death|0
4663545|NCT02234141|7554385|FG003|Treatment Period (24 Weeks)|Death|1
4663546|NCT02234141|7554386|FG004|Treatment Period (24 Weeks)|Death|0
4663547|NCT02234141|7554387|FG005|Treatment Period (24 Weeks)|Death|0
4663548|NCT02234141|7554388|FG006|Treatment Period (24 Weeks)|Death|0
4663549|NCT02234141|7554382|FG000|Treatment Period (24 Weeks)|Adverse Event|3
4663550|NCT02234141|7554383|FG001|Treatment Period (24 Weeks)|Adverse Event|1
4663551|NCT02234141|7554384|FG002|Treatment Period (24 Weeks)|Adverse Event|2
4663552|NCT02234141|7554385|FG003|Treatment Period (24 Weeks)|Adverse Event|3
4663553|NCT02234141|7554386|FG004|Treatment Period (24 Weeks)|Adverse Event|0
4663554|NCT02234141|7554387|FG005|Treatment Period (24 Weeks)|Adverse Event|0
4663555|NCT02234141|7554388|FG006|Treatment Period (24 Weeks)|Adverse Event|0
4663556|NCT02234141|7554382|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0
4663557|NCT02234141|7554383|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1
4663558|NCT02234141|7554384|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0
4663559|NCT02234141|7554385|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0
4663560|NCT02234141|7554386|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0
4663561|NCT02234141|7554387|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0
4663562|NCT02234141|7554388|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0
4663563|NCT02234141|7554382|FG000|Long-Term Treatment Period|Death|0
4663564|NCT02234141|7554383|FG001|Long-Term Treatment Period|Death|0
4663565|NCT02234141|7554384|FG002|Long-Term Treatment Period|Death|0
4663566|NCT02234141|7554385|FG003|Long-Term Treatment Period|Death|0
4663567|NCT02234141|7554386|FG004|Long-Term Treatment Period|Death|0
4663568|NCT02234141|7554387|FG005|Long-Term Treatment Period|Death|1
4751815|NCT01376323|7726022|FG000|Overall Study|Adverse Event|1
4751816|NCT01376323|7726023|FG001|Overall Study|Adverse Event|0
4751817|NCT01376323|7726024|FG002|Overall Study|Adverse Event|0
4751818|NCT01376323|7726025|FG003|Overall Study|Adverse Event|2
4751819|NCT01376323|7726026|FG004|Overall Study|Adverse Event|0
4751820|NCT01376323|7726022|FG000|Overall Study|Lost to Follow-up|0
4751821|NCT01376323|7726023|FG001|Overall Study|Lost to Follow-up|0
4751822|NCT01376323|7726024|FG002|Overall Study|Lost to Follow-up|0
4751823|NCT01376323|7726025|FG003|Overall Study|Lost to Follow-up|2
4751824|NCT01376323|7726026|FG004|Overall Study|Lost to Follow-up|0
4751825|NCT01376323|7726022|FG000|Overall Study|Physician Decision|1
4751826|NCT01376323|7726023|FG001|Overall Study|Physician Decision|0
4751827|NCT01376323|7726024|FG002|Overall Study|Physician Decision|2
4751828|NCT01376323|7726025|FG003|Overall Study|Physician Decision|1
4751829|NCT01376323|7726026|FG004|Overall Study|Physician Decision|1
4751830|NCT01376323|7726022|FG000|Overall Study|Withdrawal by Subject|0
4751831|NCT01376323|7726023|FG001|Overall Study|Withdrawal by Subject|1
4751832|NCT01376323|7726024|FG002|Overall Study|Withdrawal by Subject|1
4751833|NCT01376323|7726025|FG003|Overall Study|Withdrawal by Subject|0
4751834|NCT01376323|7726026|FG004|Overall Study|Withdrawal by Subject|0
4663569|NCT02234141|7554388|FG006|Long-Term Treatment Period|Death|0
4663570|NCT02234141|7554382|FG000|Long-Term Treatment Period|Investigator's discretion|1
4663571|NCT02234141|7554383|FG001|Long-Term Treatment Period|Investigator's discretion|3
4663572|NCT02234141|7554384|FG002|Long-Term Treatment Period|Investigator's discretion|2
4663573|NCT02234141|7554385|FG003|Long-Term Treatment Period|Investigator's discretion|0
4663574|NCT02234141|7554386|FG004|Long-Term Treatment Period|Investigator's discretion|0
4663575|NCT02234141|7554387|FG005|Long-Term Treatment Period|Investigator's discretion|0
4663576|NCT02234141|7554388|FG006|Long-Term Treatment Period|Investigator's discretion|1
4663577|NCT02234141|7554382|FG000|Long-Term Treatment Period|Adverse Event|4
4663578|NCT02234141|7554383|FG001|Long-Term Treatment Period|Adverse Event|0
4663579|NCT02234141|7554384|FG002|Long-Term Treatment Period|Adverse Event|5
4663580|NCT02234141|7554385|FG003|Long-Term Treatment Period|Adverse Event|0
4663581|NCT02234141|7554386|FG004|Long-Term Treatment Period|Adverse Event|1
4663582|NCT02234141|7554387|FG005|Long-Term Treatment Period|Adverse Event|1
4663583|NCT02234141|7554388|FG006|Long-Term Treatment Period|Adverse Event|1
4663584|NCT02234141|7554382|FG000|Long-Term Treatment Period|Withdrew Consent|0
4663585|NCT02234141|7554383|FG001|Long-Term Treatment Period|Withdrew Consent|1
4663586|NCT02234141|7554384|FG002|Long-Term Treatment Period|Withdrew Consent|1
4663587|NCT02234141|7554385|FG003|Long-Term Treatment Period|Withdrew Consent|0
4663588|NCT02234141|7554386|FG004|Long-Term Treatment Period|Withdrew Consent|0
4663589|NCT02234141|7554387|FG005|Long-Term Treatment Period|Withdrew Consent|0
4663590|NCT02234141|7554388|FG006|Long-Term Treatment Period|Withdrew Consent|0
4663591|NCT02234141|7554382|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28
4663592|NCT02234141|7554383|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27
4663593|NCT02234141|7554384|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25
4663594|NCT02234141|7554385|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0
4663595|NCT02234141|7554386|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9
4663596|NCT02234141|7554387|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10
4663597|NCT02234141|7554388|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8
4663598|NCT02234284|7554406|FG000|Overall Study|Death|4
4663599|NCT02234284|7554407|FG001|Overall Study|Death|2
4663600|NCT02234284|7554406|FG000|Overall Study|Withdrawal by Subject|1
4663601|NCT02234284|7554407|FG001|Overall Study|Withdrawal by Subject|0
4663602|NCT02234284|7554406|FG000|Overall Study|Lost to Follow-up|20
4663603|NCT02234284|7554407|FG001|Overall Study|Lost to Follow-up|7
4663604|NCT02234362|7554417|FG000|Overall Study|Not eligible after first screening visit|17
4663605|NCT02234362|7554417|FG000|Overall Study|Lost to Follow-up|6
4663606|NCT02234362|7554417|FG000|Overall Study|Withdrawal by Subject|3
4663607|NCT02234479|7554427|FG000|Overall Study|Withdrawal by Subject|1
4663608|NCT02234479|7554428|FG001|Overall Study|Withdrawal by Subject|3
4663609|NCT02234583|7554469|FG000|Overall Study|Adverse Event|172
4663610|NCT02234583|7554470|FG001|Overall Study|Adverse Event|156
4663611|NCT02234583|7554469|FG000|Overall Study|Withdrawal by Subject|109
4663612|NCT02234583|7554470|FG001|Overall Study|Withdrawal by Subject|157
4663613|NCT02234583|7554469|FG000|Overall Study|Lost to Follow-up|0
4663614|NCT02234583|7554470|FG001|Overall Study|Lost to Follow-up|1
4663615|NCT02234583|7554469|FG000|Overall Study|Lack of Efficacy|58
4663616|NCT02234583|7554470|FG001|Overall Study|Lack of Efficacy|103
4663617|NCT02234583|7554469|FG000|Overall Study|Protocol Violation|35
4663618|NCT02234583|7554470|FG001|Overall Study|Protocol Violation|42
4663619|NCT02234583|7554469|FG000|Overall Study|Other|39
4663620|NCT02234583|7554470|FG001|Overall Study|Other|97
4663621|NCT02234596|7554482|FG000|Overall Study|Participant not treated|2
4663622|NCT02234622|7554488|FG000|Overall Study|Withdrawal by Subject|16
4663623|NCT02234622|7554489|FG001|Overall Study|Withdrawal by Subject|22
4663624|NCT02234622|7554488|FG000|Overall Study|Lost to Follow-up|27
4751835|NCT01386658|7726050|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0
4751836|NCT01386658|7726051|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9
4751837|NCT01386658|7726050|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0
4663625|NCT02234622|7554489|FG001|Overall Study|Lost to Follow-up|14
4663626|NCT02235077|7554525|FG000|Overall Study|Death|5
4663627|NCT02235077|7554526|FG001|Overall Study|Death|7
4663628|NCT02235077|7554525|FG000|Overall Study|Lost to Follow-up|5
4663629|NCT02235077|7554526|FG001|Overall Study|Lost to Follow-up|6
4663630|NCT02235077|7554525|FG000|Overall Study|Withdrawal by Subject|8
4663631|NCT02235077|7554526|FG001|Overall Study|Withdrawal by Subject|5
4663632|NCT02235077|7554525|FG000|Overall Study|Physician Decision|0
4663633|NCT02235077|7554526|FG001|Overall Study|Physician Decision|1
4663634|NCT02235298|7554538|FG000|Overall Study|Lost to Follow-up|6
4663635|NCT02235298|7554539|FG001|Overall Study|Lost to Follow-up|5
4663636|NCT02235298|7554538|FG000|Overall Study|Adverse Event|2
4663637|NCT02235298|7554539|FG001|Overall Study|Adverse Event|2
4663638|NCT02235298|7554538|FG000|Overall Study|Withdrawal by Subject|0
4663639|NCT02235298|7554539|FG001|Overall Study|Withdrawal by Subject|1
4663640|NCT02235311|7554547|FG000|Overall Study|Lost to Follow-up|0
4663641|NCT02235311|7554548|FG001|Overall Study|Lost to Follow-up|1
4663642|NCT02235311|7554547|FG000|Overall Study|Protocol Violation|0
4663643|NCT02235311|7554548|FG001|Overall Study|Protocol Violation|1
4663644|NCT02235454|7554554|FG000|Overall Study|Withdrawal by Subject|2
4663645|NCT02236130|7554599|FG000|Overall Study|Lost to Follow-up|7
4663646|NCT02236130|7554600|FG001|Overall Study|Lost to Follow-up|12
4663647|NCT02236520|7554619|FG000|Overall Study|Physician Decision|0
4663648|NCT02236520|7554620|FG001|Overall Study|Physician Decision|5
4663649|NCT02236520|7554621|FG002|Overall Study|Physician Decision|0
4663650|NCT02236520|7554622|FG003|Overall Study|Physician Decision|0
4663651|NCT02236520|7554619|FG000|Overall Study|Withdrawal by Subject|1
4663652|NCT02236520|7554620|FG001|Overall Study|Withdrawal by Subject|0
4663653|NCT02236520|7554621|FG002|Overall Study|Withdrawal by Subject|0
4663654|NCT02236520|7554622|FG003|Overall Study|Withdrawal by Subject|1
4663655|NCT02236520|7554619|FG000|Overall Study|Pregnancy|1
4663656|NCT02236520|7554620|FG001|Overall Study|Pregnancy|0
4663657|NCT02236520|7554621|FG002|Overall Study|Pregnancy|0
4663658|NCT02236520|7554622|FG003|Overall Study|Pregnancy|0
4663659|NCT02236559|7554634|FG000|Overall Study|Met Exclusion|3
4663660|NCT02236559|7554635|FG001|Overall Study|Met Exclusion|6
4663661|NCT02236559|7554634|FG000|Overall Study|Did not Meet Inclusion|3
4663662|NCT02236559|7554635|FG001|Overall Study|Did not Meet Inclusion|3
4663663|NCT02236559|7554634|FG000|Overall Study|Subject Did Not Consent|4
4663664|NCT02236559|7554635|FG001|Overall Study|Subject Did Not Consent|2
4663665|NCT02236559|7554634|FG000|Overall Study|Physician Decision|1
4663666|NCT02236559|7554635|FG001|Overall Study|Physician Decision|1
4663667|NCT02236559|7554634|FG000|Overall Study|Withdrawal by Subject|1
4663668|NCT02236559|7554635|FG001|Overall Study|Withdrawal by Subject|0
4663669|NCT02236598|7554643|FG000|Overall Study|Adverse Event|0
4663670|NCT02236598|7554644|FG001|Overall Study|Adverse Event|1
4663671|NCT02236598|7554643|FG000|Overall Study|Withdrawal by Subject|0
4663672|NCT02236598|7554644|FG001|Overall Study|Withdrawal by Subject|1
4663673|NCT02236611|7554652|FG000|Overall Study|Adverse Event|10
4663674|NCT02236611|7554653|FG001|Overall Study|Adverse Event|16
4663675|NCT02236611|7554652|FG000|Overall Study|Lack of Efficacy|4
4663676|NCT02236611|7554653|FG001|Overall Study|Lack of Efficacy|7
4663677|NCT02236611|7554652|FG000|Overall Study|Lost to Follow-up|0
4663678|NCT02236611|7554653|FG001|Overall Study|Lost to Follow-up|2
4663679|NCT02236611|7554652|FG000|Overall Study|Protocol deviation|3
4663680|NCT02236611|7554653|FG001|Overall Study|Protocol deviation|5
4663681|NCT02236611|7554652|FG000|Overall Study|Withdrew consent|9
4663682|NCT02236611|7554653|FG001|Overall Study|Withdrew consent|4
4663683|NCT02236988|7554667|FG000|Overall Study|Lost to Follow-up|0
4663684|NCT02236988|7554668|FG001|Overall Study|Lost to Follow-up|0
4663685|NCT02236988|7554669|FG002|Overall Study|Lost to Follow-up|0
4663686|NCT02236988|7554670|FG003|Overall Study|Lost to Follow-up|1
4663687|NCT02236988|7554667|FG000|Overall Study|Unable to Comply with Study Visits|0
4663688|NCT02236988|7554668|FG001|Overall Study|Unable to Comply with Study Visits|0
4663689|NCT02236988|7554669|FG002|Overall Study|Unable to Comply with Study Visits|0
4663690|NCT02236988|7554670|FG003|Overall Study|Unable to Comply with Study Visits|2
4663691|NCT02237001|7554721|FG000|Overall Study|Lost to Follow-up|2
4663692|NCT02237001|7554721|FG000|Overall Study|Withdrawal by Subject|1
4663693|NCT02237001|7554721|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3
4663694|NCT02237001|7554721|FG000|Overall Study|Re-operation|4
4663695|NCT02237001|7554721|FG000|Overall Study|Incarceration|1
4663696|NCT02237118|7554742|FG000|Overall Study|Protocol Violation|0
4663697|NCT02237118|7554743|FG001|Overall Study|Protocol Violation|1
4663698|NCT02237118|7554742|FG000|Overall Study|consent withdrawn|1
4663699|NCT02237118|7554743|FG001|Overall Study|consent withdrawn|0
4663700|NCT02237157|7554757|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3
4663701|NCT02237157|7554758|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0
4663702|NCT02237157|7554759|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0
4663703|NCT02237157|7554760|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0
4663704|NCT02237157|7554757|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1
4663705|NCT02237157|7554758|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0
4663706|NCT02237157|7554759|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0
4663707|NCT02237157|7554760|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0
4663708|NCT02237196|7554771|FG000|Overall Study|Adverse Event|0
4663709|NCT02237196|7554772|FG001|Overall Study|Adverse Event|1
4751838|NCT01386658|7726051|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3
4751839|NCT01386684|7726061|FG000|Overall Study|Lost to Follow-up|51
4751840|NCT01386684|7726061|FG000|Overall Study|Other|51
4751841|NCT01386684|7726061|FG000|Overall Study|Death|47
4751842|NCT01386684|7726061|FG000|Overall Study|Withdrawal of Consent|44
4663710|NCT02237196|7554773|FG002|Overall Study|Adverse Event|1
4663711|NCT02237196|7554774|FG003|Overall Study|Adverse Event|0
4663712|NCT02237196|7554771|FG000|Overall Study|Lost to Follow-up|4
4663713|NCT02237196|7554772|FG001|Overall Study|Lost to Follow-up|2
4663714|NCT02237196|7554773|FG002|Overall Study|Lost to Follow-up|4
4663715|NCT02237196|7554774|FG003|Overall Study|Lost to Follow-up|6
4663716|NCT02237196|7554771|FG000|Overall Study|Physician Decision|2
4663717|NCT02237196|7554772|FG001|Overall Study|Physician Decision|0
4663718|NCT02237196|7554773|FG002|Overall Study|Physician Decision|0
4663719|NCT02237196|7554774|FG003|Overall Study|Physician Decision|1
4663720|NCT02237196|7554771|FG000|Overall Study|Pregnancy|0
4663721|NCT02237196|7554772|FG001|Overall Study|Pregnancy|0
4663722|NCT02237196|7554773|FG002|Overall Study|Pregnancy|1
4663723|NCT02237196|7554774|FG003|Overall Study|Pregnancy|1
4663724|NCT02237196|7554771|FG000|Overall Study|Withdrawal by Subject|1
4663725|NCT02237196|7554772|FG001|Overall Study|Withdrawal by Subject|1
4663726|NCT02237196|7554773|FG002|Overall Study|Withdrawal by Subject|4
4663727|NCT02237196|7554774|FG003|Overall Study|Withdrawal by Subject|1
4663728|NCT02237196|7554771|FG000|Overall Study|Site Error|1
4663729|NCT02237196|7554772|FG001|Overall Study|Site Error|2
4663730|NCT02237196|7554773|FG002|Overall Study|Site Error|0
4663731|NCT02237196|7554774|FG003|Overall Study|Site Error|2
4663732|NCT02237911|7554811|FG000|Overall Study|Withdrawal by Subject|4
4663733|NCT02237911|7554812|FG001|Overall Study|Withdrawal by Subject|7
4663734|NCT02237911|7554813|FG002|Overall Study|Withdrawal by Subject|2
4663735|NCT02237911|7554811|FG000|Overall Study|Lost to Follow-up|3
4663736|NCT02237911|7554812|FG001|Overall Study|Lost to Follow-up|1
4663737|NCT02237911|7554813|FG002|Overall Study|Lost to Follow-up|1
4663738|NCT02238067|7554851|FG000|Overall Study|Not completed survey at Month 6|45
4663739|NCT02238080|7554855|FG000|Overall Study|Death|13
4663740|NCT02238080|7554855|FG000|Overall Study|Treatment interrupted|6
4663741|NCT02238080|7554855|FG000|Overall Study|Withdrawal by Subject|2
4663742|NCT02238080|7554855|FG000|Overall Study|Other|4
4663743|NCT02238379|7554861|FG000|Overall Study|Lost to Follow-up|1
4663744|NCT02238379|7554862|FG001|Overall Study|Lost to Follow-up|0
4663745|NCT02238483|7554870|FG000|Overall Study|Withdrawal by Subject|2
4663746|NCT02238483|7554871|FG001|Overall Study|Withdrawal by Subject|7
4663747|NCT02238483|7554870|FG000|Overall Study|Lost to Follow-up|1
4663748|NCT02238483|7554871|FG001|Overall Study|Lost to Follow-up|1
4663749|NCT02238483|7554870|FG000|Overall Study|Protocol Violation|1
4663750|NCT02238483|7554871|FG001|Overall Study|Protocol Violation|2
4663751|NCT02238483|7554870|FG000|Overall Study|Death|1
4663752|NCT02238483|7554871|FG001|Overall Study|Death|0
4663753|NCT02238483|7554870|FG000|Overall Study|Adverse Event|7
4663754|NCT02238483|7554871|FG001|Overall Study|Adverse Event|3
4663755|NCT02238483|7554870|FG000|Overall Study|Withdrawn due to physician decision|1
4663756|NCT02238483|7554871|FG001|Overall Study|Withdrawn due to physician decision|0
4663757|NCT02238483|7554870|FG000|Overall Study|Completion status not recorded|1
4751843|NCT01386684|7726061|FG000|Overall Study|Alternative Therapy Required|37
4751844|NCT01386684|7726061|FG000|Overall Study|Disease Progression|28
4751845|NCT01386684|7726061|FG000|Overall Study|Adverse Event|20
4751846|NCT01386684|7726061|FG000|Overall Study|Noncompliance|8
4751847|NCT01386684|7726061|FG000|Overall Study|Protocol Violation|4
4751848|NCT01386684|7726061|FG000|Overall Study|Missing|3
4663758|NCT02238483|7554871|FG001|Overall Study|Completion status not recorded|1
4663759|NCT02238483|7554870|FG000|Overall Study|Illness in family member|1
4663760|NCT02238483|7554871|FG001|Overall Study|Illness in family member|0
4663761|NCT02238626|7554881|FG000|Overall Study|Adverse Event|3
4663762|NCT02238626|7554882|FG001|Overall Study|Adverse Event|5
4663763|NCT02238626|7554883|FG002|Overall Study|Adverse Event|0
4663764|NCT02238626|7554884|FG003|Overall Study|Adverse Event|3
4663765|NCT02238626|7554881|FG000|Overall Study|Lost to Follow-up|2
4663766|NCT02238626|7554882|FG001|Overall Study|Lost to Follow-up|4
4663767|NCT02238626|7554883|FG002|Overall Study|Lost to Follow-up|2
4663768|NCT02238626|7554884|FG003|Overall Study|Lost to Follow-up|2
4663769|NCT02238626|7554881|FG000|Overall Study|Withdrawal by Subject|0
4663770|NCT02238626|7554882|FG001|Overall Study|Withdrawal by Subject|3
4663771|NCT02238626|7554883|FG002|Overall Study|Withdrawal by Subject|0
4663772|NCT02238626|7554884|FG003|Overall Study|Withdrawal by Subject|1
4663773|NCT02238626|7554881|FG000|Overall Study|Death|0
4663774|NCT02238626|7554882|FG001|Overall Study|Death|0
4663775|NCT02238626|7554883|FG002|Overall Study|Death|1
4663776|NCT02238626|7554884|FG003|Overall Study|Death|1
4663777|NCT02238626|7554881|FG000|Overall Study|Other|0
4663778|NCT02238626|7554882|FG001|Overall Study|Other|2
4663779|NCT02238626|7554883|FG002|Overall Study|Other|0
4663780|NCT02238626|7554884|FG003|Overall Study|Other|0
4663781|NCT02239094|7554931|FG000|Overall Study|Withdrawal by Subject|1
4663782|NCT02239094|7554931|FG000|Overall Study|Remitted before started|1
4663783|NCT02239120|7554937|FG000|Overall Study|Death|56
4663784|NCT02239120|7554938|FG001|Overall Study|Death|58
4663785|NCT02239120|7554937|FG000|Overall Study|Lost to Follow-up|19
4663786|NCT02239120|7554938|FG001|Overall Study|Lost to Follow-up|14
4663787|NCT02239224|7554948|FG000|Overall Study|Administrative|0
4663788|NCT02239224|7554949|FG001|Overall Study|Administrative|0
4663789|NCT02239224|7554950|FG002|Overall Study|Administrative|3
4663790|NCT02239224|7554951|FG003|Overall Study|Administrative|1
4663791|NCT02239263|7554961|FG000|Overall Study|Protocol Violation|6
4663792|NCT02239328|7554971|FG000|Overall Study|Benign disease noted at time of surgery|6
4663793|NCT02239328|7554971|FG000|Overall Study|Equipment or website malfunction|2
4663794|NCT02239510|7554981|FG000|Overall Study|Lost to Follow-up|2
4663795|NCT02239510|7554982|FG001|Overall Study|Lost to Follow-up|1
4663796|NCT02239536|7554990|FG000|Overall Study|Non-neoplastic polyp|23
4663797|NCT02239536|7554991|FG001|Overall Study|Non-neoplastic polyp|17
4663798|NCT02239601|7555026|FG000|Overall Study|Withdrawal by Subject|3
4663799|NCT02239601|7555027|FG001|Overall Study|Withdrawal by Subject|4
4663800|NCT02239601|7555026|FG000|Overall Study|Protocol Violation|4
4663801|NCT02239601|7555027|FG001|Overall Study|Protocol Violation|2
4663802|NCT02239640|7555038|FG000|Overall Study|Withdrawal by Subject|3
4663803|NCT02239640|7555038|FG000|Overall Study|Lost to Follow-up|72
4663804|NCT02239640|7555038|FG000|Overall Study|Death|142
4663805|NCT02239679|7555051|FG000|Overall Study|Lost to Follow-up|1
4663806|NCT02239679|7555052|FG001|Overall Study|Lost to Follow-up|0
4663807|NCT02239679|7555053|FG002|Overall Study|Lost to Follow-up|0
4663808|NCT02239679|7555051|FG000|Overall Study|Withdrawal by Subject|2
4663809|NCT02239679|7555052|FG001|Overall Study|Withdrawal by Subject|3
4663810|NCT02239679|7555053|FG002|Overall Study|Withdrawal by Subject|1
4663811|NCT02239692|7555063|FG000|Overall Study|Incomplete colonoscopy|1
4663812|NCT02239692|7555064|FG001|Overall Study|Incomplete colonoscopy|2
4663813|NCT02239692|7555063|FG000|Overall Study|Adverse Event|0
4663814|NCT02239692|7555064|FG001|Overall Study|Adverse Event|1
4663815|NCT02239692|7555063|FG000|Overall Study|Physician Decision|0
4663816|NCT02239692|7555064|FG001|Overall Study|Physician Decision|1
4663817|NCT02239692|7555063|FG000|Overall Study|Lost to Follow-up|1
4663818|NCT02239692|7555064|FG001|Overall Study|Lost to Follow-up|4
4663819|NCT02239692|7555063|FG000|Overall Study|Withdrawal by Subject|3
4663820|NCT02239692|7555064|FG001|Overall Study|Withdrawal by Subject|5
4663821|NCT02239692|7555063|FG000|Overall Study|Other reason|1
4663822|NCT02239692|7555064|FG001|Overall Study|Other reason|0
4663823|NCT02239939|7555115|FG000|Overall Study|Adverse Event|1
4663824|NCT02239939|7555116|FG001|Overall Study|Adverse Event|0
4663825|NCT02239939|7555115|FG000|Overall Study|Withdrawal by Subject|1
4663826|NCT02239939|7555116|FG001|Overall Study|Withdrawal by Subject|1
4663827|NCT02239939|7555115|FG000|Overall Study|Lost to Follow-up|0
4663828|NCT02239939|7555116|FG001|Overall Study|Lost to Follow-up|1
4663829|NCT02239978|7555126|FG000|Overall Study|Withdrawal by Subject|2
4663830|NCT02239978|7555127|FG001|Overall Study|Withdrawal by Subject|0
4663831|NCT02240108|7555152|FG000|Overall Study|Other than specified|8
4663832|NCT02240108|7555153|FG001|Overall Study|Other than specified|6
4663833|NCT02240108|7555152|FG000|Overall Study|Adverse Event|1
4663834|NCT02240108|7555153|FG001|Overall Study|Adverse Event|9
4663835|NCT02240108|7555152|FG000|Overall Study|Pregnancy|1
4663836|NCT02240108|7555153|FG001|Overall Study|Pregnancy|0
4663837|NCT02240108|7555152|FG000|Overall Study|Withdrawal by Subject|4
4663838|NCT02240108|7555153|FG001|Overall Study|Withdrawal by Subject|9
4663839|NCT02240108|7555152|FG000|Overall Study|StudyTerminated by Sponsor|0
4663840|NCT02240108|7555153|FG001|Overall Study|StudyTerminated by Sponsor|1
4663841|NCT02240121|7555161|FG000|Overall Study|Protocol Violation|1
4663842|NCT02240121|7555162|FG001|Overall Study|Protocol Violation|2
4663843|NCT02240121|7555161|FG000|Overall Study|Physician Decision|0
4663844|NCT02240121|7555162|FG001|Overall Study|Physician Decision|1
4663845|NCT02240121|7555161|FG000|Overall Study|Change in protocol interpretation|1
4663846|NCT02240121|7555162|FG001|Overall Study|Change in protocol interpretation|0
4663847|NCT02240121|7555161|FG000|Overall Study|Lack of Efficacy|2
4663848|NCT02240121|7555162|FG001|Overall Study|Lack of Efficacy|3
4663849|NCT02240121|7555161|FG000|Overall Study|Site closed|1
4663850|NCT02240121|7555162|FG001|Overall Study|Site closed|1
4663851|NCT02240121|7555161|FG000|Overall Study|Pregnancy|1
4663852|NCT02240121|7555162|FG001|Overall Study|Pregnancy|0
4663853|NCT02240121|7555161|FG000|Overall Study|Adverse Event|2
4663854|NCT02240121|7555162|FG001|Overall Study|Adverse Event|4
4663855|NCT02240121|7555161|FG000|Overall Study|Withdrawal by Subject|6
4663856|NCT02240121|7555162|FG001|Overall Study|Withdrawal by Subject|2
4663857|NCT02240121|7555161|FG000|Overall Study|Lost to Follow-up|3
4751849|NCT04980014|7726065|FG000|Overall Study|Participants who are Duplicated|1
4751850|NCT04980014|7726065|FG000|Overall Study|Follow-up Failure|13
4751851|NCT04980014|7726065|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2
4751852|NCT04980014|7726065|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2
4751853|NCT04980014|7726065|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57
4751854|NCT04427501|7726096|FG000|Overall Study|Death|0
4751855|NCT04427501|7726097|FG001|Overall Study|Death|0
4751856|NCT04427501|7726098|FG002|Overall Study|Death|0
4751857|NCT04427501|7726099|FG003|Overall Study|Death|0
4751858|NCT04427501|7726100|FG004|Overall Study|Death|0
4751859|NCT04427501|7726101|FG005|Overall Study|Death|15
4751860|NCT04427501|7726102|FG006|Overall Study|Death|0
4751861|NCT04427501|7726103|FG007|Overall Study|Death|0
4751862|NCT04427501|7726104|FG008|Overall Study|Death|0
4751863|NCT04427501|7726105|FG009|Overall Study|Death|0
4751864|NCT04427501|7726096|FG000|Overall Study|Lost to Follow-up|5
4751865|NCT04427501|7726097|FG001|Overall Study|Lost to Follow-up|1
4751866|NCT04427501|7726098|FG002|Overall Study|Lost to Follow-up|2
4751867|NCT04427501|7726099|FG003|Overall Study|Lost to Follow-up|0
4751868|NCT04427501|7726100|FG004|Overall Study|Lost to Follow-up|2
4751869|NCT04427501|7726101|FG005|Overall Study|Lost to Follow-up|11
4751870|NCT04427501|7726102|FG006|Overall Study|Lost to Follow-up|10
4751871|NCT04427501|7726103|FG007|Overall Study|Lost to Follow-up|10
4751872|NCT04427501|7726104|FG008|Overall Study|Lost to Follow-up|2
4751873|NCT04427501|7726105|FG009|Overall Study|Lost to Follow-up|5
4751874|NCT04427501|7726096|FG000|Overall Study|Physician Decision|0
4751875|NCT04427501|7726097|FG001|Overall Study|Physician Decision|3
4751876|NCT04427501|7726098|FG002|Overall Study|Physician Decision|0
4751877|NCT04427501|7726099|FG003|Overall Study|Physician Decision|0
4751878|NCT04427501|7726100|FG004|Overall Study|Physician Decision|0
4751879|NCT04427501|7726101|FG005|Overall Study|Physician Decision|0
4663858|NCT02240121|7555162|FG001|Overall Study|Lost to Follow-up|4
4663859|NCT02240121|7555161|FG000|Overall Study|Other than specified|1
4663860|NCT02240121|7555162|FG001|Overall Study|Other than specified|3
4663861|NCT02240368|7555182|FG000|Overall Study|Surgery lasted less then 20 minutes|1
4663862|NCT02240368|7555183|FG001|Overall Study|Surgery lasted less then 20 minutes|0
4663863|NCT02240368|7555184|FG002|Overall Study|Surgery lasted less then 20 minutes|0
4663864|NCT02240368|7555182|FG000|Overall Study|Entropy failed to detect more than 50%|0
4663865|NCT02240368|7555183|FG001|Overall Study|Entropy failed to detect more than 50%|0
4663866|NCT02240368|7555184|FG002|Overall Study|Entropy failed to detect more than 50%|1
4663867|NCT02240628|7555203|FG000|Overall Study|Physician Decision|6
4663868|NCT02240628|7555204|FG001|Overall Study|Physician Decision|5
4663869|NCT02240680|7555242|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6
4663870|NCT02240680|7555243|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6
4663871|NCT02240680|7555244|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0
4663872|NCT02240680|7555245|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0
4751880|NCT04427501|7726102|FG006|Overall Study|Physician Decision|2
4751881|NCT04427501|7726103|FG007|Overall Study|Physician Decision|0
4751882|NCT04427501|7726104|FG008|Overall Study|Physician Decision|0
4751883|NCT04427501|7726105|FG009|Overall Study|Physician Decision|0
4751884|NCT04427501|7726096|FG000|Overall Study|Withdrawal by Subject|9
4751885|NCT04427501|7726097|FG001|Overall Study|Withdrawal by Subject|2
4751886|NCT04427501|7726098|FG002|Overall Study|Withdrawal by Subject|2
4751887|NCT04427501|7726099|FG003|Overall Study|Withdrawal by Subject|3
4751888|NCT04427501|7726100|FG004|Overall Study|Withdrawal by Subject|7
4751889|NCT04427501|7726101|FG005|Overall Study|Withdrawal by Subject|25
4751890|NCT04427501|7726102|FG006|Overall Study|Withdrawal by Subject|15
4751891|NCT04427501|7726103|FG007|Overall Study|Withdrawal by Subject|7
4751892|NCT04427501|7726104|FG008|Overall Study|Withdrawal by Subject|4
4751893|NCT04427501|7726105|FG009|Overall Study|Withdrawal by Subject|1
4751894|NCT04427501|7726096|FG000|Overall Study|Other - as reported by the investigator|1
4751895|NCT04427501|7726097|FG001|Overall Study|Other - as reported by the investigator|0
4751896|NCT04427501|7726098|FG002|Overall Study|Other - as reported by the investigator|0
4751897|NCT04427501|7726099|FG003|Overall Study|Other - as reported by the investigator|0
4751898|NCT04427501|7726100|FG004|Overall Study|Other - as reported by the investigator|0
4751899|NCT04427501|7726101|FG005|Overall Study|Other - as reported by the investigator|6
4751900|NCT04427501|7726102|FG006|Overall Study|Other - as reported by the investigator|6
4751901|NCT04427501|7726103|FG007|Overall Study|Other - as reported by the investigator|0
4751902|NCT04427501|7726104|FG008|Overall Study|Other - as reported by the investigator|0
4751903|NCT04427501|7726105|FG009|Overall Study|Other - as reported by the investigator|0
4751904|NCT03735849|7726141|FG000|Overall Study|Lost to Follow-up|1
4751905|NCT03735849|7726142|FG001|Overall Study|Lost to Follow-up|0
4751906|NCT03735849|7726143|FG002|Overall Study|Lost to Follow-up|0
4751907|NCT03735849|7726141|FG000|Overall Study|Participant unable to adhere to visit|1
4751908|NCT03735849|7726142|FG001|Overall Study|Participant unable to adhere to visit|0
4751909|NCT03735849|7726143|FG002|Overall Study|Participant unable to adhere to visit|0
4751910|NCT03735849|7726141|FG000|Overall Study|Not Randomized|0
4663873|NCT02240680|7555242|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4
4663874|NCT02240680|7555243|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1
4663875|NCT02240680|7555244|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0
4663876|NCT02240680|7555245|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0
4663877|NCT02240680|7555242|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1
4663878|NCT02240680|7555243|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0
4663879|NCT02240680|7555244|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0
4663880|NCT02240680|7555245|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0
4663881|NCT02240680|7555242|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3
4663882|NCT02240680|7555243|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1
4663883|NCT02240680|7555244|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0
4663884|NCT02240680|7555245|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0
4663885|NCT02240680|7555242|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1
4663886|NCT02240680|7555243|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0
4663887|NCT02240680|7555244|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0
4663888|NCT02240680|7555245|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0
4663889|NCT02240680|7555242|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0
4663890|NCT02240680|7555243|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0
4663891|NCT02240680|7555244|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6
4663892|NCT02240680|7555245|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7
4663893|NCT02240680|7555242|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0
4663894|NCT02240680|7555243|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0
4663895|NCT02240680|7555244|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1
4663896|NCT02240680|7555245|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0
4663897|NCT02240680|7555242|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0
4663898|NCT02240680|7555243|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0
4663899|NCT02240680|7555244|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1
4663900|NCT02240680|7555245|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0
4663901|NCT02240693|7555258|FG000|Overall Study|Adverse Event|0
4663902|NCT02240693|7555259|FG001|Overall Study|Adverse Event|0
4663903|NCT02240693|7555260|FG002|Overall Study|Adverse Event|0
4663904|NCT02240693|7555261|FG003|Overall Study|Adverse Event|0
4663905|NCT02240693|7555262|FG004|Overall Study|Adverse Event|1
4663906|NCT02240693|7555258|FG000|Overall Study|Withdrawal by Subject|0
4663907|NCT02240693|7555259|FG001|Overall Study|Withdrawal by Subject|0
4663908|NCT02240693|7555260|FG002|Overall Study|Withdrawal by Subject|2
4663909|NCT02240693|7555261|FG003|Overall Study|Withdrawal by Subject|1
4663910|NCT02240693|7555262|FG004|Overall Study|Withdrawal by Subject|0
4663911|NCT02240693|7555258|FG000|Overall Study|Other than specified|0
4663912|NCT02240693|7555259|FG001|Overall Study|Other than specified|0
4663913|NCT02240693|7555260|FG002|Overall Study|Other than specified|2
4663914|NCT02240693|7555261|FG003|Overall Study|Other than specified|0
4663915|NCT02240693|7555262|FG004|Overall Study|Other than specified|0
4751911|NCT03735849|7726142|FG001|Overall Study|Not Randomized|0
4751912|NCT03735849|7726143|FG002|Overall Study|Not Randomized|4
4751913|NCT03552393|7726159|FG000|Core Period|Kidney Transplant|1
4751914|NCT03552393|7726159|FG000|Core Period|Prohibited Medication|1
4751915|NCT03552393|7726159|FG000|Safety Extension Period|Kidney Transplant|4
4751916|NCT03412747|7726166|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2
4751917|NCT03412747|7726167|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2
4751918|NCT03412747|7726168|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3
4751919|NCT03412747|7726166|FG000|Initial Treatment Period: Wk0-Wk16|Death|0
4751920|NCT03412747|7726167|FG001|Initial Treatment Period: Wk0-Wk16|Death|0
4751921|NCT03412747|7726168|FG002|Initial Treatment Period: Wk0-Wk16|Death|1
4751922|NCT03412747|7726166|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0
4751923|NCT03412747|7726167|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0
4751924|NCT03412747|7726168|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1
4751925|NCT03412747|7726166|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0
4751926|NCT03412747|7726167|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0
4751927|NCT03412747|7726168|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2
4751928|NCT03412747|7726166|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0
4751929|NCT03412747|7726167|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2
4751930|NCT03412747|7726168|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1
4751931|NCT03412747|7726166|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4
4751932|NCT03412747|7726167|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1
4751933|NCT03412747|7726168|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1
4751934|NCT03412747|7726166|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1
4751935|NCT03412747|7726167|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0
4751936|NCT03412747|7726168|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0
4751937|NCT03412747|7726166|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3
4751938|NCT03412747|7726167|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1
4751939|NCT03412747|7726168|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0
4751940|NCT03412747|7726166|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1
4751941|NCT03412747|7726167|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0
4663916|NCT02240706|7555281|FG000|Overall Study|Lack of Efficacy|2
4663917|NCT02240706|7555282|FG001|Overall Study|Lack of Efficacy|2
4663918|NCT02240706|7555283|FG002|Overall Study|Lack of Efficacy|2
4663919|NCT02240706|7555284|FG003|Overall Study|Lack of Efficacy|2
4663920|NCT02240706|7555285|FG004|Overall Study|Lack of Efficacy|5
4663921|NCT02240706|7555286|FG005|Overall Study|Lack of Efficacy|0
4663922|NCT02240706|7555287|FG006|Overall Study|Lack of Efficacy|0
4663923|NCT02240706|7555281|FG000|Overall Study|Adverse Event|1
4663924|NCT02240706|7555282|FG001|Overall Study|Adverse Event|0
4663925|NCT02240706|7555283|FG002|Overall Study|Adverse Event|1
4663926|NCT02240706|7555284|FG003|Overall Study|Adverse Event|0
4663927|NCT02240706|7555285|FG004|Overall Study|Adverse Event|2
4663928|NCT02240706|7555286|FG005|Overall Study|Adverse Event|0
4663929|NCT02240706|7555287|FG006|Overall Study|Adverse Event|0
4663930|NCT02240706|7555281|FG000|Overall Study|Progressive disease|0
4663931|NCT02240706|7555282|FG001|Overall Study|Progressive disease|0
4663932|NCT02240706|7555283|FG002|Overall Study|Progressive disease|0
4663933|NCT02240706|7555284|FG003|Overall Study|Progressive disease|0
4663934|NCT02240706|7555285|FG004|Overall Study|Progressive disease|1
4663935|NCT02240706|7555286|FG005|Overall Study|Progressive disease|0
4663936|NCT02240706|7555287|FG006|Overall Study|Progressive disease|0
4663937|NCT02240706|7555281|FG000|Overall Study|Dose limiting toxicity|0
4663938|NCT02240706|7555282|FG001|Overall Study|Dose limiting toxicity|0
4663939|NCT02240706|7555283|FG002|Overall Study|Dose limiting toxicity|0
4663940|NCT02240706|7555284|FG003|Overall Study|Dose limiting toxicity|0
4663941|NCT02240706|7555285|FG004|Overall Study|Dose limiting toxicity|1
4663942|NCT02240706|7555286|FG005|Overall Study|Dose limiting toxicity|0
4663943|NCT02240706|7555287|FG006|Overall Study|Dose limiting toxicity|0
4663944|NCT02240706|7555281|FG000|Overall Study|Refused to continue taking medication|0
4663945|NCT02240706|7555282|FG001|Overall Study|Refused to continue taking medication|1
4663946|NCT02240706|7555283|FG002|Overall Study|Refused to continue taking medication|3
4663947|NCT02240706|7555284|FG003|Overall Study|Refused to continue taking medication|1
4663948|NCT02240706|7555285|FG004|Overall Study|Refused to continue taking medication|2
4663949|NCT02240706|7555286|FG005|Overall Study|Refused to continue taking medication|0
4663950|NCT02240706|7555287|FG006|Overall Study|Refused to continue taking medication|0
4663951|NCT02240706|7555281|FG000|Overall Study|Insurance billing concerns|0
4663952|NCT02240706|7555282|FG001|Overall Study|Insurance billing concerns|0
4663953|NCT02240706|7555283|FG002|Overall Study|Insurance billing concerns|0
4663954|NCT02240706|7555284|FG003|Overall Study|Insurance billing concerns|1
4663955|NCT02240706|7555285|FG004|Overall Study|Insurance billing concerns|0
4663956|NCT02240706|7555286|FG005|Overall Study|Insurance billing concerns|0
4663957|NCT02240706|7555287|FG006|Overall Study|Insurance billing concerns|0
4663958|NCT02241512|7555318|FG000|Overall Study|Pump malfunction, drug not delivered|1
4663959|NCT02241512|7555319|FG001|Overall Study|Pump malfunction, drug not delivered|0
4663960|NCT02241733|7555345|FG000|Overall Study|Lost to Follow-up|9
4663961|NCT02241733|7555346|FG001|Overall Study|Lost to Follow-up|4
4663962|NCT02241733|7555345|FG000|Overall Study|Physician Decision|6
4663963|NCT02241733|7555346|FG001|Overall Study|Physician Decision|2
4663964|NCT02241733|7555345|FG000|Overall Study|Withdrawal by Subject|0
4663965|NCT02241733|7555346|FG001|Overall Study|Withdrawal by Subject|2
4663966|NCT02241733|7555345|FG000|Overall Study|Death|0
4663967|NCT02241733|7555346|FG001|Overall Study|Death|2
4663968|NCT02241785|7555352|FG000|Overall Study|Sponsor Termination|43
4663969|NCT02241785|7555352|FG000|Overall Study|Withdrawal by Subject|1
4663970|NCT02241785|7555352|FG000|Overall Study|Lost to Follow-up|2
4663971|NCT02241785|7555352|FG000|Overall Study|Adverse Event|1
4663972|NCT02241889|7555356|FG000|Overall Study|device issues|0
4663973|NCT02241889|7555357|FG001|Overall Study|device issues|0
4663974|NCT02241889|7555358|FG002|Overall Study|device issues|1
4663975|NCT02241889|7555359|FG003|Overall Study|device issues|0
4663976|NCT02241889|7555360|FG004|Overall Study|device issues|0
4663977|NCT02241889|7555361|FG005|Overall Study|device issues|0
4663978|NCT02241889|7555356|FG000|Overall Study|Withdrawal by Subject|0
4663979|NCT02241889|7555357|FG001|Overall Study|Withdrawal by Subject|0
4663980|NCT02241889|7555358|FG002|Overall Study|Withdrawal by Subject|0
4663981|NCT02241889|7555359|FG003|Overall Study|Withdrawal by Subject|0
4663982|NCT02241889|7555360|FG004|Overall Study|Withdrawal by Subject|0
4751942|NCT03412747|7726168|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0
4751943|NCT03412747|7726166|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0
4751944|NCT03412747|7726167|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0
4751945|NCT03412747|7726168|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1
4663983|NCT02241889|7555361|FG005|Overall Study|Withdrawal by Subject|1
4663984|NCT02242045|7555390|FG000|Overall Study|Investigator's Discretion|1
4663985|NCT02242045|7555390|FG000|Overall Study|Progressive Disease|2
4663986|NCT02242045|7555390|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1
4663987|NCT02242045|7555390|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2
4663988|NCT02242201|7555397|FG000|Overall Study|preoperative identified neuropathy|2
4663989|NCT02242201|7555398|FG001|Overall Study|preoperative identified neuropathy|0
4663990|NCT02242201|7555399|FG002|Overall Study|preoperative identified neuropathy|0
4663991|NCT02242201|7555397|FG000|Overall Study|planned post-op anticoagulation|1
4663992|NCT02242201|7555398|FG001|Overall Study|planned post-op anticoagulation|0
4663993|NCT02242201|7555399|FG002|Overall Study|planned post-op anticoagulation|0
4663994|NCT02242201|7555397|FG000|Overall Study|changed surgical procedure|1
4663995|NCT02242201|7555398|FG001|Overall Study|changed surgical procedure|0
4663996|NCT02242201|7555399|FG002|Overall Study|changed surgical procedure|0
4663997|NCT02242201|7555397|FG000|Overall Study|postponed surgery|0
4663998|NCT02242201|7555398|FG001|Overall Study|postponed surgery|0
4663999|NCT02242201|7555399|FG002|Overall Study|postponed surgery|1
4664000|NCT02242201|7555397|FG000|Overall Study|preoperative opioid consumption|0
4664001|NCT02242201|7555398|FG001|Overall Study|preoperative opioid consumption|1
4664002|NCT02242201|7555399|FG002|Overall Study|preoperative opioid consumption|0
4664003|NCT02242305|7555409|FG000|Overall Study|Without spasm-like pain during 3 weeks|1
4664004|NCT02242305|7555410|FG001|Overall Study|Without spasm-like pain during 3 weeks|4
4664005|NCT02242305|7555409|FG000|Overall Study|Adverse Event|1
4664006|NCT02242305|7555410|FG001|Overall Study|Adverse Event|0
4664007|NCT02242305|7555409|FG000|Overall Study|Non-compliance dosing regimen or visit|2
4664008|NCT02242305|7555410|FG001|Overall Study|Non-compliance dosing regimen or visit|2
4664009|NCT02242305|7555409|FG000|Overall Study|Subject withdraws inform consent|0
4664010|NCT02242305|7555410|FG001|Overall Study|Subject withdraws inform consent|4
4664011|NCT02242305|7555409|FG000|Overall Study|Lost to Follow-up|2
4664012|NCT02242305|7555410|FG001|Overall Study|Lost to Follow-up|0
4664013|NCT02242487|7555418|FG000|Overall Study|Adverse Event|13
4664014|NCT02242487|7555419|FG001|Overall Study|Adverse Event|15
4664015|NCT02242487|7555418|FG000|Overall Study|Lack of Efficacy|4
4664016|NCT02242487|7555419|FG001|Overall Study|Lack of Efficacy|6
4664017|NCT02242487|7555418|FG000|Overall Study|Protocol Violation|2
4664018|NCT02242487|7555419|FG001|Overall Study|Protocol Violation|0
4664019|NCT02242487|7555418|FG000|Overall Study|Lost to Follow-up|2
4664020|NCT02242487|7555419|FG001|Overall Study|Lost to Follow-up|1
4664021|NCT02242487|7555418|FG000|Overall Study|Other - Miscellaneous|4
4664022|NCT02242487|7555419|FG001|Overall Study|Other - Miscellaneous|6
4664023|NCT02242487|7555418|FG000|Overall Study|Withdrawal by Subject|37
4664024|NCT02242487|7555419|FG001|Overall Study|Withdrawal by Subject|19
4664025|NCT02242643|7555446|FG000|Overall Study|Protocol Violation|1
4664026|NCT02242643|7555447|FG001|Overall Study|Protocol Violation|2
4664027|NCT02242643|7555446|FG000|Overall Study|Withdrawal by Subject|15
4664028|NCT02242643|7555447|FG001|Overall Study|Withdrawal by Subject|10
4664029|NCT02242643|7555446|FG000|Overall Study|Migrated/moved from study area|1
4664030|NCT02242643|7555447|FG001|Overall Study|Migrated/moved from study area|3
4664031|NCT02242643|7555446|FG000|Overall Study|Lost to Follow-up|54
4664032|NCT02242643|7555447|FG001|Overall Study|Lost to Follow-up|61
4664033|NCT02242643|7555446|FG000|Overall Study|Child placed in foster care by family|0
4664034|NCT02242643|7555447|FG001|Overall Study|Child placed in foster care by family|1
4664035|NCT02242643|7555446|FG000|Overall Study|Non-compliance|1
4664036|NCT02242643|7555447|FG001|Overall Study|Non-compliance|0
4664037|NCT02242643|7555446|FG000|Overall Study|Consent withdrawal by parent|1
4664038|NCT02242643|7555447|FG001|Overall Study|Consent withdrawal by parent|0
4664039|NCT02242643|7555446|FG000|Overall Study|Protocol requirements not followed|1
4664040|NCT02242643|7555447|FG001|Overall Study|Protocol requirements not followed|0
4664041|NCT02242643|7555446|FG000|Overall Study|Language barrier|1
4664042|NCT02242643|7555447|FG001|Overall Study|Language barrier|0
4664043|NCT02242643|7555446|FG000|Overall Study|Withdrawal by subject at Visit 2|0
4664044|NCT02242643|7555447|FG001|Overall Study|Withdrawal by subject at Visit 2|1
4664045|NCT02242903|7555462|FG000|Overall Study|Withdrawal by Subject|1
4664046|NCT02242903|7555463|FG001|Overall Study|Withdrawal by Subject|0
4664047|NCT02242903|7555464|FG002|Overall Study|Withdrawal by Subject|0
4664048|NCT02242903|7555465|FG003|Overall Study|Withdrawal by Subject|0
4664049|NCT02242903|7555466|FG004|Overall Study|Withdrawal by Subject|0
4664050|NCT02242903|7555467|FG005|Overall Study|Withdrawal by Subject|0
4664051|NCT02242903|7555468|FG006|Overall Study|Withdrawal by Subject|0
4664052|NCT02242981|7555490|FG000|Overall Study|Withdrawal by Subject|1
4751946|NCT03412747|7726166|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1
4751947|NCT03412747|7726167|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0
4751948|NCT03412747|7726168|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0
4751949|NCT03412747|7726166|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3
4751950|NCT03412747|7726167|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4
4751951|NCT03412747|7726168|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6
4664053|NCT02243046|7555510|FG000|Overall Study|Lost to Follow-up|1
4664054|NCT02243046|7555511|FG001|Overall Study|Lost to Follow-up|1
4664055|NCT02243046|7555512|FG002|Overall Study|Lost to Follow-up|4
4664056|NCT02243176|7555522|FG000|Overall Study|Other reason|1
4664057|NCT02243176|7555523|FG001|Overall Study|Other reason|2
4664058|NCT02243176|7555522|FG000|Overall Study|protocol specified withdrawal critera|1
4664059|NCT02243176|7555523|FG001|Overall Study|protocol specified withdrawal critera|3
4664060|NCT02243176|7555522|FG000|Overall Study|Protocol Violation|2
4664061|NCT02243176|7555523|FG001|Overall Study|Protocol Violation|1
4664062|NCT02243176|7555522|FG000|Overall Study|Withdrawal by Subject|8
4664063|NCT02243176|7555523|FG001|Overall Study|Withdrawal by Subject|7
4664064|NCT02243176|7555522|FG000|Overall Study|Adverse Event|2
4664065|NCT02243176|7555523|FG001|Overall Study|Adverse Event|2
4664066|NCT02243202|7555533|FG000|Overall Study|Adverse Event|5
4664067|NCT02243202|7555534|FG001|Overall Study|Adverse Event|6
4664068|NCT02243202|7555535|FG002|Overall Study|Adverse Event|10
4664069|NCT02243202|7555536|FG003|Overall Study|Adverse Event|4
4664070|NCT02243202|7555533|FG000|Overall Study|Lost to Follow-up|9
4664071|NCT02243202|7555534|FG001|Overall Study|Lost to Follow-up|9
4664072|NCT02243202|7555535|FG002|Overall Study|Lost to Follow-up|14
4664073|NCT02243202|7555536|FG003|Overall Study|Lost to Follow-up|11
4664074|NCT02243202|7555533|FG000|Overall Study|Protocol Violation|3
4664075|NCT02243202|7555534|FG001|Overall Study|Protocol Violation|1
4664076|NCT02243202|7555535|FG002|Overall Study|Protocol Violation|2
4664077|NCT02243202|7555536|FG003|Overall Study|Protocol Violation|1
4664078|NCT02243202|7555533|FG000|Overall Study|Withdrawal by Subject|7
4664079|NCT02243202|7555534|FG001|Overall Study|Withdrawal by Subject|6
4664080|NCT02243202|7555535|FG002|Overall Study|Withdrawal by Subject|4
4664081|NCT02243202|7555536|FG003|Overall Study|Withdrawal by Subject|4
4664082|NCT02243202|7555533|FG000|Overall Study|Other|1
4664083|NCT02243202|7555534|FG001|Overall Study|Other|3
4664084|NCT02243202|7555535|FG002|Overall Study|Other|1
4664085|NCT02243202|7555536|FG003|Overall Study|Other|2
4664086|NCT02243202|7555533|FG000|Overall Study|Randomized but not received treatment|0
4664087|NCT02243202|7555534|FG001|Overall Study|Randomized but not received treatment|0
4664088|NCT02243202|7555535|FG002|Overall Study|Randomized but not received treatment|0
4664089|NCT02243202|7555536|FG003|Overall Study|Randomized but not received treatment|1
4664090|NCT02243280|7555557|FG000|Treated|Adverse Event|1
4664091|NCT02243280|7555558|FG001|Treated|Adverse Event|0
4664092|NCT02243280|7555559|FG002|Treated|Adverse Event|0
4664093|NCT02243280|7555560|FG003|Treated|Adverse Event|0
4664094|NCT02243280|7555561|FG004|Treated|Adverse Event|0
4664095|NCT02243280|7555562|FG005|Treated|Adverse Event|0
4664096|NCT02243280|7555563|FG006|Treated|Adverse Event|0
4664097|NCT02243280|7555564|FG007|Treated|Adverse Event|0
4664098|NCT02243280|7555565|FG008|Treated|Adverse Event|0
4664099|NCT02243280|7555566|FG009|Treated|Adverse Event|0
4664100|NCT02243280|7555567|FG010|Treated|Adverse Event|1
4664101|NCT02243280|7555557|FG000|Treated|Lost to Follow-up|0
4664102|NCT02243280|7555558|FG001|Treated|Lost to Follow-up|0
4664103|NCT02243280|7555559|FG002|Treated|Lost to Follow-up|0
4664104|NCT02243280|7555560|FG003|Treated|Lost to Follow-up|0
4664105|NCT02243280|7555561|FG004|Treated|Lost to Follow-up|0
4664106|NCT02243280|7555562|FG005|Treated|Lost to Follow-up|0
4664107|NCT02243280|7555563|FG006|Treated|Lost to Follow-up|0
4664108|NCT02243280|7555564|FG007|Treated|Lost to Follow-up|0
4664109|NCT02243280|7555565|FG008|Treated|Lost to Follow-up|1
4664110|NCT02243280|7555566|FG009|Treated|Lost to Follow-up|0
4664111|NCT02243280|7555567|FG010|Treated|Lost to Follow-up|2
4664112|NCT02243293|7555602|FG000|Overall Study|Adverse Event|1
4664113|NCT02243293|7555603|FG001|Overall Study|Adverse Event|0
4664114|NCT02243293|7555604|FG002|Overall Study|Adverse Event|0
4664115|NCT02243293|7555605|FG003|Overall Study|Adverse Event|0
4664116|NCT02243293|7555606|FG004|Overall Study|Adverse Event|0
4664117|NCT02243293|7555607|FG005|Overall Study|Adverse Event|0
4664118|NCT02243293|7555608|FG006|Overall Study|Adverse Event|0
4664119|NCT02243293|7555609|FG007|Overall Study|Adverse Event|0
4664120|NCT02243293|7555610|FG008|Overall Study|Adverse Event|0
4664121|NCT02243293|7555611|FG009|Overall Study|Adverse Event|0
4664122|NCT02243293|7555612|FG010|Overall Study|Adverse Event|0
4664123|NCT02243293|7555613|FG011|Overall Study|Adverse Event|0
4664124|NCT02243293|7555614|FG012|Overall Study|Adverse Event|0
4664125|NCT02243293|7555615|FG013|Overall Study|Adverse Event|0
4664126|NCT02243293|7555616|FG014|Overall Study|Adverse Event|0
4664127|NCT02243293|7555617|FG015|Overall Study|Adverse Event|1
4664128|NCT02243293|7555618|FG016|Overall Study|Adverse Event|0
4664129|NCT02243293|7555619|FG017|Overall Study|Adverse Event|0
4751952|NCT03412747|7726166|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0
4751953|NCT03412747|7726167|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1
4751954|NCT03412747|7726168|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1
4751955|NCT03412747|7726166|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0
4751956|NCT03412747|7726167|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2
4751957|NCT03412747|7726168|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5
4751958|NCT03412747|7726166|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3
4751959|NCT03412747|7726167|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1
4751960|NCT03412747|7726168|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4
4751961|NCT03412747|7726166|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0
4751962|NCT03412747|7726167|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1
4664130|NCT02243293|7555620|FG018|Overall Study|Adverse Event|0
4664131|NCT02243293|7555621|FG019|Overall Study|Adverse Event|0
4664132|NCT02243293|7555622|FG020|Overall Study|Adverse Event|1
4664133|NCT02243293|7555623|FG021|Overall Study|Adverse Event|0
4664134|NCT02243293|7555602|FG000|Overall Study|Withdrawal by Subject|1
4664135|NCT02243293|7555603|FG001|Overall Study|Withdrawal by Subject|0
4664136|NCT02243293|7555604|FG002|Overall Study|Withdrawal by Subject|0
4664137|NCT02243293|7555605|FG003|Overall Study|Withdrawal by Subject|0
4664138|NCT02243293|7555606|FG004|Overall Study|Withdrawal by Subject|0
4664139|NCT02243293|7555607|FG005|Overall Study|Withdrawal by Subject|0
4664140|NCT02243293|7555608|FG006|Overall Study|Withdrawal by Subject|0
4664141|NCT02243293|7555609|FG007|Overall Study|Withdrawal by Subject|0
4664142|NCT02243293|7555610|FG008|Overall Study|Withdrawal by Subject|0
4751963|NCT03412747|7726168|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0
4751964|NCT03333382|7726188|FG000|Overall Study|Lost to Follow-up|1
4751965|NCT03333382|7726189|FG001|Overall Study|Lost to Follow-up|0
4751966|NCT03107611|7726213|FG000|Overall Study|Adverse Event|1
4751967|NCT03107611|7726214|FG001|Overall Study|Adverse Event|0
4751968|NCT03107611|7726215|FG002|Overall Study|Adverse Event|2
4751969|NCT03107611|7726213|FG000|Overall Study|Lost to Follow-up|3
4751970|NCT03107611|7726214|FG001|Overall Study|Lost to Follow-up|3
4751971|NCT03107611|7726215|FG002|Overall Study|Lost to Follow-up|3
4751972|NCT03107611|7726213|FG000|Overall Study|Protocol Violation|0
4751973|NCT03107611|7726214|FG001|Overall Study|Protocol Violation|0
4751974|NCT03107611|7726215|FG002|Overall Study|Protocol Violation|1
4751975|NCT03107611|7726213|FG000|Overall Study|Withdrawal by Subject|1
4751976|NCT03107611|7726214|FG001|Overall Study|Withdrawal by Subject|0
4751977|NCT03107611|7726215|FG002|Overall Study|Withdrawal by Subject|1
4751978|NCT03107611|7726213|FG000|Overall Study|Worsening signs/symptoms|2
4751979|NCT03107611|7726214|FG001|Overall Study|Worsening signs/symptoms|1
4751980|NCT03107611|7726215|FG002|Overall Study|Worsening signs/symptoms|2
4751981|NCT02720016|7726226|FG000|Overall Study|Separation of couple|6
4751982|NCT02720016|7726227|FG001|Overall Study|Separation of couple|8
4751983|NCT02720016|7726228|FG002|Overall Study|Separation of couple|2
4751984|NCT02720016|7726226|FG000|Overall Study|Withdrawal by Subject|6
4751985|NCT02720016|7726227|FG001|Overall Study|Withdrawal by Subject|6
4751986|NCT02720016|7726228|FG002|Overall Study|Withdrawal by Subject|4
4751987|NCT02720016|7726226|FG000|Overall Study|Scheduling issues|2
4751988|NCT02720016|7726227|FG001|Overall Study|Scheduling issues|4
4751989|NCT02720016|7726228|FG002|Overall Study|Scheduling issues|7
4751990|NCT02720016|7726226|FG000|Overall Study|Childcare|2
4751991|NCT02720016|7726227|FG001|Overall Study|Childcare|0
4751992|NCT02720016|7726228|FG002|Overall Study|Childcare|2
4751993|NCT02720016|7726226|FG000|Overall Study|Withdrawal by PI|2
4751994|NCT02720016|7726227|FG001|Overall Study|Withdrawal by PI|2
4751995|NCT02720016|7726228|FG002|Overall Study|Withdrawal by PI|0
4751996|NCT02720016|7726226|FG000|Overall Study|Moved away|2
4751997|NCT02720016|7726227|FG001|Overall Study|Moved away|0
4751998|NCT02720016|7726228|FG002|Overall Study|Moved away|0
4751999|NCT02720016|7726226|FG000|Overall Study|Not Primary Health Concern|0
4752000|NCT02720016|7726227|FG001|Overall Study|Not Primary Health Concern|0
4752001|NCT02720016|7726228|FG002|Overall Study|Not Primary Health Concern|2
4752002|NCT02720016|7726226|FG000|Overall Study|Transportation issues|0
4752003|NCT02720016|7726227|FG001|Overall Study|Transportation issues|0
4752004|NCT02720016|7726228|FG002|Overall Study|Transportation issues|1
4752005|NCT02720016|7726226|FG000|Overall Study|Other|0
4752006|NCT02720016|7726227|FG001|Overall Study|Other|0
4752007|NCT02720016|7726228|FG002|Overall Study|Other|2
4664143|NCT02243293|7555611|FG009|Overall Study|Withdrawal by Subject|1
4664144|NCT02243293|7555612|FG010|Overall Study|Withdrawal by Subject|0
4664145|NCT02243293|7555613|FG011|Overall Study|Withdrawal by Subject|1
4664146|NCT02243293|7555614|FG012|Overall Study|Withdrawal by Subject|0
4664147|NCT02243293|7555615|FG013|Overall Study|Withdrawal by Subject|0
4664148|NCT02243293|7555616|FG014|Overall Study|Withdrawal by Subject|0
4664149|NCT02243293|7555617|FG015|Overall Study|Withdrawal by Subject|0
4664150|NCT02243293|7555618|FG016|Overall Study|Withdrawal by Subject|0
4664151|NCT02243293|7555619|FG017|Overall Study|Withdrawal by Subject|0
4664152|NCT02243293|7555620|FG018|Overall Study|Withdrawal by Subject|0
4664153|NCT02243293|7555621|FG019|Overall Study|Withdrawal by Subject|0
4664154|NCT02243293|7555622|FG020|Overall Study|Withdrawal by Subject|0
4664155|NCT02243293|7555623|FG021|Overall Study|Withdrawal by Subject|1
4664156|NCT02243293|7555602|FG000|Overall Study|Lost to Follow-up|0
4664157|NCT02243293|7555603|FG001|Overall Study|Lost to Follow-up|1
4664158|NCT02243293|7555604|FG002|Overall Study|Lost to Follow-up|1
4664159|NCT02243293|7555605|FG003|Overall Study|Lost to Follow-up|1
4664160|NCT02243293|7555606|FG004|Overall Study|Lost to Follow-up|0
4664161|NCT02243293|7555607|FG005|Overall Study|Lost to Follow-up|0
4664162|NCT02243293|7555608|FG006|Overall Study|Lost to Follow-up|3
4664163|NCT02243293|7555609|FG007|Overall Study|Lost to Follow-up|0
4664164|NCT02243293|7555610|FG008|Overall Study|Lost to Follow-up|0
4664165|NCT02243293|7555611|FG009|Overall Study|Lost to Follow-up|0
4664166|NCT02243293|7555612|FG010|Overall Study|Lost to Follow-up|0
4664167|NCT02243293|7555613|FG011|Overall Study|Lost to Follow-up|2
4664168|NCT02243293|7555614|FG012|Overall Study|Lost to Follow-up|0
4664169|NCT02243293|7555615|FG013|Overall Study|Lost to Follow-up|0
4664170|NCT02243293|7555616|FG014|Overall Study|Lost to Follow-up|0
4664171|NCT02243293|7555617|FG015|Overall Study|Lost to Follow-up|0
4664172|NCT02243293|7555618|FG016|Overall Study|Lost to Follow-up|3
4664173|NCT02243293|7555619|FG017|Overall Study|Lost to Follow-up|1
4664174|NCT02243293|7555620|FG018|Overall Study|Lost to Follow-up|0
4664175|NCT02243293|7555621|FG019|Overall Study|Lost to Follow-up|0
4664176|NCT02243293|7555622|FG020|Overall Study|Lost to Follow-up|1
4664177|NCT02243293|7555623|FG021|Overall Study|Lost to Follow-up|2
4664178|NCT02243293|7555602|FG000|Overall Study|Enrolled into a Re-treatment Study|0
4664179|NCT02243293|7555603|FG001|Overall Study|Enrolled into a Re-treatment Study|0
4664180|NCT02243293|7555604|FG002|Overall Study|Enrolled into a Re-treatment Study|0
4664181|NCT02243293|7555605|FG003|Overall Study|Enrolled into a Re-treatment Study|0
4664182|NCT02243293|7555606|FG004|Overall Study|Enrolled into a Re-treatment Study|0
4664183|NCT02243293|7555607|FG005|Overall Study|Enrolled into a Re-treatment Study|0
4664184|NCT02243293|7555608|FG006|Overall Study|Enrolled into a Re-treatment Study|0
4664185|NCT02243293|7555609|FG007|Overall Study|Enrolled into a Re-treatment Study|0
4664186|NCT02243293|7555610|FG008|Overall Study|Enrolled into a Re-treatment Study|0
4664187|NCT02243293|7555611|FG009|Overall Study|Enrolled into a Re-treatment Study|0
4664188|NCT02243293|7555612|FG010|Overall Study|Enrolled into a Re-treatment Study|0
4664189|NCT02243293|7555613|FG011|Overall Study|Enrolled into a Re-treatment Study|0
4664190|NCT02243293|7555614|FG012|Overall Study|Enrolled into a Re-treatment Study|0
4664191|NCT02243293|7555615|FG013|Overall Study|Enrolled into a Re-treatment Study|0
4664192|NCT02243293|7555616|FG014|Overall Study|Enrolled into a Re-treatment Study|1
4664193|NCT02243293|7555617|FG015|Overall Study|Enrolled into a Re-treatment Study|0
4664194|NCT02243293|7555618|FG016|Overall Study|Enrolled into a Re-treatment Study|0
4664195|NCT02243293|7555619|FG017|Overall Study|Enrolled into a Re-treatment Study|0
4752008|NCT02607956|7726239|FG000|Double-Blinded Phase|Withdrew Consent|17
4752009|NCT02607956|7726240|FG001|Double-Blinded Phase|Withdrew Consent|19
4752010|NCT02607956|7726241|FG002|Double-Blinded Phase|Withdrew Consent|0
4752011|NCT02607956|7726242|FG003|Double-Blinded Phase|Withdrew Consent|0
4752012|NCT02607956|7726239|FG000|Double-Blinded Phase|Lost to Follow-up|19
4752013|NCT02607956|7726240|FG001|Double-Blinded Phase|Lost to Follow-up|16
4752014|NCT02607956|7726241|FG002|Double-Blinded Phase|Lost to Follow-up|0
4752015|NCT02607956|7726242|FG003|Double-Blinded Phase|Lost to Follow-up|0
4752016|NCT02607956|7726239|FG000|Double-Blinded Phase|Randomized but never treated|7
4752017|NCT02607956|7726240|FG001|Double-Blinded Phase|Randomized but never treated|5
4752018|NCT02607956|7726241|FG002|Double-Blinded Phase|Randomized but never treated|0
4752019|NCT02607956|7726242|FG003|Double-Blinded Phase|Randomized but never treated|0
4752020|NCT02607956|7726239|FG000|Double-Blinded Phase|Investigator's Discretion|7
4752021|NCT02607956|7726240|FG001|Double-Blinded Phase|Investigator's Discretion|2
4752022|NCT02607956|7726241|FG002|Double-Blinded Phase|Investigator's Discretion|0
4752023|NCT02607956|7726242|FG003|Double-Blinded Phase|Investigator's Discretion|0
4752024|NCT02607956|7726239|FG000|Double-Blinded Phase|Death|4
4752025|NCT02607956|7726240|FG001|Double-Blinded Phase|Death|4
4752026|NCT02607956|7726241|FG002|Double-Blinded Phase|Death|0
4752027|NCT02607956|7726242|FG003|Double-Blinded Phase|Death|0
4752028|NCT02607956|7726239|FG000|Double-Blinded Phase|Adverse Event|4
4752029|NCT02607956|7726240|FG001|Double-Blinded Phase|Adverse Event|3
4752030|NCT02607956|7726241|FG002|Double-Blinded Phase|Adverse Event|0
4752031|NCT02607956|7726242|FG003|Double-Blinded Phase|Adverse Event|0
4752032|NCT02607956|7726239|FG000|Double-Blinded Phase|Protocol Violation|3
4752033|NCT02607956|7726240|FG001|Double-Blinded Phase|Protocol Violation|1
4752034|NCT02607956|7726241|FG002|Double-Blinded Phase|Protocol Violation|0
4752035|NCT02607956|7726242|FG003|Double-Blinded Phase|Protocol Violation|0
4752036|NCT02607956|7726239|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0
4752037|NCT02607956|7726240|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3
4752038|NCT02607956|7726241|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0
4752039|NCT02607956|7726242|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0
4752040|NCT02607956|7726239|FG000|Open-Label Extension Phase|Withdrew Consent|0
4752041|NCT02607956|7726240|FG001|Open-Label Extension Phase|Withdrew Consent|0
4752042|NCT02607956|7726241|FG002|Open-Label Extension Phase|Withdrew Consent|10
4752043|NCT02607956|7726242|FG003|Open-Label Extension Phase|Withdrew Consent|16
4752044|NCT02607956|7726239|FG000|Open-Label Extension Phase|Lost to Follow-up|0
4752045|NCT02607956|7726240|FG001|Open-Label Extension Phase|Lost to Follow-up|0
4752046|NCT02607956|7726241|FG002|Open-Label Extension Phase|Lost to Follow-up|14
4752047|NCT02607956|7726242|FG003|Open-Label Extension Phase|Lost to Follow-up|6
4752048|NCT02607956|7726239|FG000|Open-Label Extension Phase|Death|0
4752049|NCT02607956|7726240|FG001|Open-Label Extension Phase|Death|0
4664196|NCT02243293|7555620|FG018|Overall Study|Enrolled into a Re-treatment Study|0
4664197|NCT02243293|7555621|FG019|Overall Study|Enrolled into a Re-treatment Study|0
4664198|NCT02243293|7555622|FG020|Overall Study|Enrolled into a Re-treatment Study|0
4664199|NCT02243293|7555623|FG021|Overall Study|Enrolled into a Re-treatment Study|0
4664200|NCT02243293|7555602|FG000|Overall Study|Randomized but did'nt receive study drug|0
4664201|NCT02243293|7555603|FG001|Overall Study|Randomized but did'nt receive study drug|0
4664202|NCT02243293|7555604|FG002|Overall Study|Randomized but did'nt receive study drug|0
4664203|NCT02243293|7555605|FG003|Overall Study|Randomized but did'nt receive study drug|0
4664204|NCT02243293|7555606|FG004|Overall Study|Randomized but did'nt receive study drug|1
4664205|NCT02243293|7555607|FG005|Overall Study|Randomized but did'nt receive study drug|0
4664206|NCT02243293|7555608|FG006|Overall Study|Randomized but did'nt receive study drug|0
4664207|NCT02243293|7555609|FG007|Overall Study|Randomized but did'nt receive study drug|0
4664208|NCT02243293|7555610|FG008|Overall Study|Randomized but did'nt receive study drug|0
4664209|NCT02243293|7555611|FG009|Overall Study|Randomized but did'nt receive study drug|1
4664210|NCT02243293|7555612|FG010|Overall Study|Randomized but did'nt receive study drug|0
4664211|NCT02243293|7555613|FG011|Overall Study|Randomized but did'nt receive study drug|0
4664212|NCT02243293|7555614|FG012|Overall Study|Randomized but did'nt receive study drug|0
4664213|NCT02243293|7555615|FG013|Overall Study|Randomized but did'nt receive study drug|0
4664214|NCT02243293|7555616|FG014|Overall Study|Randomized but did'nt receive study drug|0
4664215|NCT02243293|7555617|FG015|Overall Study|Randomized but did'nt receive study drug|0
4664216|NCT02243293|7555618|FG016|Overall Study|Randomized but did'nt receive study drug|0
4664217|NCT02243293|7555619|FG017|Overall Study|Randomized but did'nt receive study drug|0
4664218|NCT02243293|7555620|FG018|Overall Study|Randomized but did'nt receive study drug|0
4664219|NCT02243293|7555621|FG019|Overall Study|Randomized but did'nt receive study drug|1
4664220|NCT02243293|7555622|FG020|Overall Study|Randomized but did'nt receive study drug|0
4664221|NCT02243293|7555623|FG021|Overall Study|Randomized but did'nt receive study drug|0
4664222|NCT02243371|7555662|FG000|Overall Study|Progressive Disease (clinic & radio)|35
4664223|NCT02243371|7555663|FG001|Overall Study|Progressive Disease (clinic & radio)|24
4664224|NCT02243371|7555662|FG000|Overall Study|Death (unrelated)|2
4664225|NCT02243371|7555663|FG001|Overall Study|Death (unrelated)|4
4664226|NCT02243371|7555662|FG000|Overall Study|Adverse Event (unrelated)|0
4664227|NCT02243371|7555663|FG001|Overall Study|Adverse Event (unrelated)|1
4664228|NCT02243371|7555662|FG000|Overall Study|Lack of Clinical Benefit|0
4664229|NCT02243371|7555663|FG001|Overall Study|Lack of Clinical Benefit|1
4664230|NCT02243371|7555662|FG000|Overall Study|Withdrawal by Subject|0
4664231|NCT02243371|7555663|FG001|Overall Study|Withdrawal by Subject|2
4664232|NCT02243605|7555684|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1
4664233|NCT02243605|7555685|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1
4664234|NCT02243605|7555684|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1
4664235|NCT02243605|7555685|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0
4664236|NCT02243605|7555684|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5
4664237|NCT02243605|7555685|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1
4664238|NCT02243605|7555684|FG000|Stage 2 - Final Analysis Population|Adverse Event|1
4664239|NCT02243605|7555685|FG001|Stage 2 - Final Analysis Population|Adverse Event|1
4664240|NCT02243605|7555684|FG000|Stage 2 - Final Analysis Population|Progression|0
4664241|NCT02243605|7555685|FG001|Stage 2 - Final Analysis Population|Progression|1
4664242|NCT02243696|7555691|FG000|Overall Study|Death|282
4664243|NCT02243696|7555691|FG000|Overall Study|Withdrawal by Subject|79
4664244|NCT02243696|7555691|FG000|Overall Study|Lost to Follow-up|57
4664245|NCT02243696|7555691|FG000|Overall Study|Subject No Longer has Study System|42
4664246|NCT02243696|7555691|FG000|Overall Study|Subject Withdrawn by Investigator|273
4664247|NCT02243696|7555691|FG000|Overall Study|Study Terminated for EP PASSION|961
4664248|NCT02243865|7555697|FG000|Overall Study|Protocol Violation|1
4664249|NCT02243865|7555698|FG001|Overall Study|Protocol Violation|3
4664250|NCT02243865|7555697|FG000|Overall Study|Lost to Follow-up|1
4664251|NCT02243865|7555698|FG001|Overall Study|Lost to Follow-up|1
4664252|NCT02243865|7555697|FG000|Overall Study|Withdrawal by Subject|1
4664253|NCT02243865|7555698|FG001|Overall Study|Withdrawal by Subject|0
4664254|NCT02243865|7555697|FG000|Overall Study|Adverse Event|1
4664255|NCT02243865|7555698|FG001|Overall Study|Adverse Event|1
4664256|NCT02244424|7555717|FG000|Overall Study|Lost to Follow-up|20
4664257|NCT02244424|7555718|FG001|Overall Study|Lost to Follow-up|10
4664258|NCT02244580|7555724|FG000|Overall Study|No cancer tissues available|241
4664259|NCT02244619|7555734|FG000|Overall Study|Did not receive study intervention|8
4664260|NCT02244619|7555735|FG001|Overall Study|Did not receive study intervention|21
4752050|NCT02607956|7726241|FG002|Open-Label Extension Phase|Death|1
4752051|NCT02607956|7726242|FG003|Open-Label Extension Phase|Death|3
4752052|NCT02607956|7726239|FG000|Open-Label Extension Phase|Investigator's Discretion|0
4752053|NCT02607956|7726240|FG001|Open-Label Extension Phase|Investigator's Discretion|0
4752054|NCT02607956|7726241|FG002|Open-Label Extension Phase|Investigator's Discretion|2
4752055|NCT02607956|7726242|FG003|Open-Label Extension Phase|Investigator's Discretion|2
4752056|NCT02607956|7726239|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0
4752057|NCT02607956|7726240|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0
4752058|NCT02607956|7726241|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2
4664261|NCT02244957|7555757|FG000|Overall Study|Lack of Efficacy|1
4664262|NCT02244957|7555758|FG001|Overall Study|Lack of Efficacy|0
4664263|NCT02244996|7555768|FG000|Overall Study|Lack of Efficacy|2
4664264|NCT02244996|7555769|FG001|Overall Study|Lack of Efficacy|6
4664265|NCT02245412|7555791|FG000|Treatment Period|Death|1
4664266|NCT02245412|7555792|FG001|Treatment Period|Death|1
4664267|NCT02245412|7555793|FG002|Treatment Period|Death|0
4664268|NCT02245412|7555791|FG000|Treatment Period|Physician Decision|1
4664269|NCT02245412|7555792|FG001|Treatment Period|Physician Decision|1
4664270|NCT02245412|7555793|FG002|Treatment Period|Physician Decision|0
4664271|NCT02245412|7555791|FG000|Treatment Period|Withdrawal by Subject|2
4664272|NCT02245412|7555792|FG001|Treatment Period|Withdrawal by Subject|1
4664273|NCT02245412|7555793|FG002|Treatment Period|Withdrawal by Subject|0
4664274|NCT02245412|7555791|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1
4664275|NCT02245412|7555792|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0
4664276|NCT02245412|7555793|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0
4664277|NCT02245412|7555791|FG000|Follow-Up Period|Death|4
4664278|NCT02245412|7555792|FG001|Follow-Up Period|Death|2
4664279|NCT02245412|7555793|FG002|Follow-Up Period|Death|1
4664280|NCT02245412|7555791|FG000|Follow-Up Period|Physician Decision|1
4664281|NCT02245412|7555792|FG001|Follow-Up Period|Physician Decision|0
4664282|NCT02245412|7555793|FG002|Follow-Up Period|Physician Decision|0
4664283|NCT02245412|7555791|FG000|Follow-Up Period|Other - Terminated by Sponsor|0
4664284|NCT02245412|7555792|FG001|Follow-Up Period|Other - Terminated by Sponsor|0
4664285|NCT02245412|7555793|FG002|Follow-Up Period|Other - Terminated by Sponsor|1
4664286|NCT02245568|7555810|FG000|Overall Study|Study terminated by Sponsor|346
4664287|NCT02245568|7555810|FG000|Overall Study|Adverse Event|144
4664288|NCT02245568|7555810|FG000|Overall Study|Lack of Efficacy|98
4664289|NCT02245568|7555810|FG000|Overall Study|Withdrawal by Caregiver|85
4664290|NCT02245568|7555810|FG000|Overall Study|Withdrawal by Subject|77
4664291|NCT02245568|7555810|FG000|Overall Study|Withdrawal by Legal Representative|31
4664292|NCT02245568|7555810|FG000|Overall Study|Missing (Site closure)|16
4664293|NCT02245568|7555810|FG000|Overall Study|Physician Decision|14
4664294|NCT02245568|7555810|FG000|Overall Study|Non-compliance with study drug|11
4664295|NCT02245568|7555810|FG000|Overall Study|Death|9
4752059|NCT02607956|7726242|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0
4752060|NCT02607956|7726239|FG000|Open-Label Extension Phase|Protocol Violation|0
4752061|NCT02607956|7726240|FG001|Open-Label Extension Phase|Protocol Violation|0
4752062|NCT02607956|7726241|FG002|Open-Label Extension Phase|Protocol Violation|0
4752063|NCT02607956|7726242|FG003|Open-Label Extension Phase|Protocol Violation|2
4752064|NCT02607956|7726239|FG000|Open-Label Extension Phase|Pregnancy|0
4752065|NCT02607956|7726240|FG001|Open-Label Extension Phase|Pregnancy|0
4752066|NCT02607956|7726241|FG002|Open-Label Extension Phase|Pregnancy|0
4752067|NCT02607956|7726242|FG003|Open-Label Extension Phase|Pregnancy|1
4752068|NCT02564523|7726272|FG000|Overall Study|Withdrawal by Subject|3
4752069|NCT02564523|7726273|FG001|Overall Study|Withdrawal by Subject|0
4752070|NCT02564523|7726274|FG002|Overall Study|Withdrawal by Subject|1
4752071|NCT02564523|7726275|FG003|Overall Study|Withdrawal by Subject|0
4752072|NCT02564523|7726276|FG004|Overall Study|Withdrawal by Subject|1
4752073|NCT02564523|7726277|FG005|Overall Study|Withdrawal by Subject|0
4752074|NCT02564523|7726278|FG006|Overall Study|Withdrawal by Subject|1
4752075|NCT02564523|7726279|FG007|Overall Study|Withdrawal by Subject|0
4752076|NCT02564523|7726280|FG008|Overall Study|Withdrawal by Subject|0
4752077|NCT02564523|7726281|FG009|Overall Study|Withdrawal by Subject|0
4752078|NCT02564523|7726282|FG010|Overall Study|Withdrawal by Subject|1
4752079|NCT02564523|7726283|FG011|Overall Study|Withdrawal by Subject|0
4752080|NCT02564523|7726284|FG012|Overall Study|Withdrawal by Subject|1
4752081|NCT02564523|7726285|FG013|Overall Study|Withdrawal by Subject|0
4752082|NCT02564523|7726286|FG014|Overall Study|Withdrawal by Subject|0
4752083|NCT02564523|7726287|FG015|Overall Study|Withdrawal by Subject|0
4664296|NCT02245568|7555810|FG000|Overall Study|Blue staining|6
4664297|NCT02245568|7555810|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6
4664298|NCT02245568|7555810|FG000|Overall Study|Intolerance/dosing issues/interruption|5
4664299|NCT02245568|7555810|FG000|Overall Study|Lost to Follow-up|5
4664300|NCT02245620|7555816|FG000|Overall Study|Physician Decision|1
4664301|NCT02245620|7555817|FG001|Overall Study|Physician Decision|1
4664302|NCT02245737|7555826|FG000|Overall Study|Adverse Event|23
4664303|NCT02245737|7555827|FG001|Overall Study|Adverse Event|26
4664304|NCT02245737|7555828|FG002|Overall Study|Adverse Event|33
4664305|NCT02245737|7555826|FG000|Overall Study|Condition Worsened|9
4664306|NCT02245737|7555827|FG001|Overall Study|Condition Worsened|10
4664307|NCT02245737|7555828|FG002|Overall Study|Condition Worsened|9
4664308|NCT02245737|7555826|FG000|Overall Study|Death|2
4664309|NCT02245737|7555827|FG001|Overall Study|Death|4
4664310|NCT02245737|7555828|FG002|Overall Study|Death|4
4664311|NCT02245737|7555826|FG000|Overall Study|Eligibility Criteria No Longer Met|2
4664312|NCT02245737|7555827|FG001|Overall Study|Eligibility Criteria No Longer Met|4
4664313|NCT02245737|7555828|FG002|Overall Study|Eligibility Criteria No Longer Met|4
4664314|NCT02245737|7555826|FG000|Overall Study|Initiation of Symptomatic AD medication|2
4664315|NCT02245737|7555827|FG001|Overall Study|Initiation of Symptomatic AD medication|0
4664316|NCT02245737|7555828|FG002|Overall Study|Initiation of Symptomatic AD medication|0
4664317|NCT02245737|7555826|FG000|Overall Study|Lost to Follow-up|2
4664318|NCT02245737|7555827|FG001|Overall Study|Lost to Follow-up|5
4664319|NCT02245737|7555828|FG002|Overall Study|Lost to Follow-up|4
4664320|NCT02245737|7555826|FG000|Overall Study|Other-determined by Investigator|9
4664321|NCT02245737|7555827|FG001|Overall Study|Other-determined by Investigator|10
4664322|NCT02245737|7555828|FG002|Overall Study|Other-determined by Investigator|10
4664323|NCT02245737|7555826|FG000|Overall Study|Physician Decision|6
4664324|NCT02245737|7555827|FG001|Overall Study|Physician Decision|3
4664325|NCT02245737|7555828|FG002|Overall Study|Physician Decision|6
4664326|NCT02245737|7555826|FG000|Overall Study|Protocol Violation|3
4664327|NCT02245737|7555827|FG001|Overall Study|Protocol Violation|2
4664328|NCT02245737|7555828|FG002|Overall Study|Protocol Violation|3
4664329|NCT02245737|7555826|FG000|Overall Study|Withdrawal by Subject|40
4664330|NCT02245737|7555827|FG001|Overall Study|Withdrawal by Subject|41
4664331|NCT02245737|7555828|FG002|Overall Study|Withdrawal by Subject|44
4664332|NCT02245737|7555826|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10
4664333|NCT02245737|7555827|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20
4664334|NCT02245737|7555828|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22
4664335|NCT02245737|7555826|FG000|Overall Study|Sponsor Decision|445
4664336|NCT02245737|7555827|FG001|Overall Study|Sponsor Decision|430
4664337|NCT02245737|7555828|FG002|Overall Study|Sponsor Decision|432
4664338|NCT02246166|7555877|FG000|Overall Study|Protocol Violation|1
4664339|NCT02246166|7555878|FG001|Overall Study|Protocol Violation|0
4664340|NCT02246218|7555886|FG000|Overall Study|Withdrawal by Parent/Guardian|0
4664341|NCT02246218|7555887|FG001|Overall Study|Withdrawal by Parent/Guardian|1
4664342|NCT02246218|7555886|FG000|Overall Study|Stopping Rule: Liver Transplant|2
4664343|NCT02246218|7555887|FG001|Overall Study|Stopping Rule: Liver Transplant|4
4664344|NCT02246218|7555886|FG000|Overall Study|Adverse Event|1
4664345|NCT02246218|7555887|FG001|Overall Study|Adverse Event|1
4664346|NCT02246218|7555886|FG000|Overall Study|Lost to Follow-up|1
4664347|NCT02246218|7555887|FG001|Overall Study|Lost to Follow-up|0
4664348|NCT02246439|7555913|FG000|Overall Study|Adverse Event|3
4664349|NCT02246439|7555914|FG001|Overall Study|Adverse Event|0
4664350|NCT02246439|7555913|FG000|Overall Study|Lost to Follow-up|7
4664351|NCT02246439|7555914|FG001|Overall Study|Lost to Follow-up|5
4664352|NCT02246439|7555913|FG000|Overall Study|Protocol Violation|0
4664353|NCT02246439|7555914|FG001|Overall Study|Protocol Violation|2
4664354|NCT02246439|7555913|FG000|Overall Study|Physician Decision|0
4664355|NCT02246439|7555914|FG001|Overall Study|Physician Decision|1
4664356|NCT02246439|7555913|FG000|Overall Study|Unkonwn|1
4664357|NCT02246439|7555914|FG001|Overall Study|Unkonwn|3
4664358|NCT02246439|7555913|FG000|Overall Study|Withdrawal by Subject|1
4664359|NCT02246439|7555914|FG001|Overall Study|Withdrawal by Subject|0
4664360|NCT02246478|7555924|FG000|Multiple-dose Phase|Protocol Violation|1
4664361|NCT02246478|7555925|FG001|Multiple-dose Phase|Protocol Violation|0
4664362|NCT02246478|7555926|FG002|Multiple-dose Phase|Protocol Violation|0
4664363|NCT02246478|7555927|FG003|Multiple-dose Phase|Protocol Violation|1
4664364|NCT02246582|7555944|FG000|Overall Study|Withdrawal by Subject|3
4664365|NCT02246582|7555945|FG001|Overall Study|Withdrawal by Subject|4
4664366|NCT02246647|7555960|FG000|Overall Study|Withdrawal by Subject|1
4664367|NCT02246647|7555961|FG001|Overall Study|Withdrawal by Subject|1
4664368|NCT02246660|7555984|FG000|Overall Study|Withdrawal by Subject|0
4664369|NCT02246660|7555985|FG001|Overall Study|Withdrawal by Subject|1
4664370|NCT02246660|7555986|FG002|Overall Study|Withdrawal by Subject|0
4664371|NCT02246660|7555984|FG000|Overall Study|Death|0
4664372|NCT02246660|7555985|FG001|Overall Study|Death|0
4664373|NCT02246660|7555986|FG002|Overall Study|Death|1
4664374|NCT02246673|7555999|FG000|Overall Study|Sponsor Decision|1
4664375|NCT02246673|7556000|FG001|Overall Study|Sponsor Decision|0
4664376|NCT02246673|7556001|FG002|Overall Study|Sponsor Decision|0
4664377|NCT02246673|7556002|FG003|Overall Study|Sponsor Decision|0
4664378|NCT02246673|7556003|FG004|Overall Study|Sponsor Decision|0
4664379|NCT02246673|7555999|FG000|Overall Study|Withdrawal by Subject|0
4664380|NCT02246673|7556000|FG001|Overall Study|Withdrawal by Subject|0
4664381|NCT02246673|7556001|FG002|Overall Study|Withdrawal by Subject|0
4664382|NCT02246673|7556002|FG003|Overall Study|Withdrawal by Subject|0
4664383|NCT02246673|7556003|FG004|Overall Study|Withdrawal by Subject|1
4664384|NCT02246673|7555999|FG000|Overall Study|Lost to Follow-up|0
4664385|NCT02246673|7556000|FG001|Overall Study|Lost to Follow-up|0
4664386|NCT02246673|7556001|FG002|Overall Study|Lost to Follow-up|0
4664387|NCT02246673|7556002|FG003|Overall Study|Lost to Follow-up|1
4664388|NCT02246673|7556003|FG004|Overall Study|Lost to Follow-up|0
4664389|NCT02246673|7555999|FG000|Overall Study|Protocol Violation|0
4664390|NCT02246673|7556000|FG001|Overall Study|Protocol Violation|0
4664391|NCT02246673|7556001|FG002|Overall Study|Protocol Violation|0
4664392|NCT02246673|7556002|FG003|Overall Study|Protocol Violation|1
4664393|NCT02246673|7556003|FG004|Overall Study|Protocol Violation|0
4664394|NCT02246764|7556048|FG000|Overall Study|Adverse Event|15
4664395|NCT02246764|7556049|FG001|Overall Study|Adverse Event|29
4664396|NCT02246764|7556050|FG002|Overall Study|Adverse Event|1
4664397|NCT02246764|7556048|FG000|Overall Study|Withdrawal by Subject|0
4664398|NCT02246764|7556049|FG001|Overall Study|Withdrawal by Subject|0
4752084|NCT02564523|7726288|FG016|Overall Study|Withdrawal by Subject|0
4664399|NCT02246764|7556050|FG002|Overall Study|Withdrawal by Subject|1
4664400|NCT02246764|7556048|FG000|Overall Study|Disallowed Concomitant Medication|1
4752085|NCT02564523|7726289|FG017|Overall Study|Withdrawal by Subject|0
4664401|NCT02246764|7556049|FG001|Overall Study|Disallowed Concomitant Medication|0
4664402|NCT02246764|7556050|FG002|Overall Study|Disallowed Concomitant Medication|0
4664403|NCT02246764|7556048|FG000|Overall Study|Physician Decision|0
4664404|NCT02246764|7556049|FG001|Overall Study|Physician Decision|2
4664405|NCT02246764|7556050|FG002|Overall Study|Physician Decision|1
4664406|NCT02246764|7556048|FG000|Overall Study|Protocol Violation|2
4664407|NCT02246764|7556049|FG001|Overall Study|Protocol Violation|1
4664408|NCT02246764|7556050|FG002|Overall Study|Protocol Violation|1
4664409|NCT02246777|7556058|FG000|Overall Study|Adverse Event|2
4664410|NCT02246777|7556058|FG000|Overall Study|Change of residence|1
4664411|NCT02246998|7556071|FG000|Overall Study|Adverse Event|0
4664412|NCT02246998|7556072|FG001|Overall Study|Adverse Event|1
4664413|NCT02246998|7556073|FG002|Overall Study|Adverse Event|1
4664414|NCT02246998|7556074|FG003|Overall Study|Adverse Event|0
4664415|NCT02246998|7556071|FG000|Overall Study|Lost to Follow-up|1
4664416|NCT02246998|7556072|FG001|Overall Study|Lost to Follow-up|0
4664417|NCT02246998|7556073|FG002|Overall Study|Lost to Follow-up|0
4664418|NCT02246998|7556074|FG003|Overall Study|Lost to Follow-up|1
4664419|NCT02246998|7556071|FG000|Overall Study|Randomized but Never Dosed|1
4664420|NCT02246998|7556072|FG001|Overall Study|Randomized but Never Dosed|2
4664421|NCT02246998|7556073|FG002|Overall Study|Randomized but Never Dosed|2
4664422|NCT02246998|7556074|FG003|Overall Study|Randomized but Never Dosed|1
4664423|NCT02247011|7556089|FG000|Overall Study|Poor quality of radiological results|125
4664424|NCT02247401|7556143|FG000|Overall Study|Adverse Event|1
4664425|NCT02247401|7556144|FG001|Overall Study|Adverse Event|0
4664426|NCT02247401|7556145|FG002|Overall Study|Adverse Event|0
4664427|NCT02247401|7556143|FG000|Overall Study|Withdrawal by Subject|4
4664428|NCT02247401|7556144|FG001|Overall Study|Withdrawal by Subject|1
4664429|NCT02247401|7556145|FG002|Overall Study|Withdrawal by Subject|1
4664430|NCT02247401|7556143|FG000|Overall Study|Lost to Follow-up|1
4664431|NCT02247401|7556144|FG001|Overall Study|Lost to Follow-up|1
4664432|NCT02247401|7556145|FG002|Overall Study|Lost to Follow-up|1
4664433|NCT02247440|7556154|FG000|Overall Study|Withdrawal by Subject|1
4664434|NCT02247440|7556154|FG000|Overall Study|Lack of Efficacy|3
4664435|NCT02247466|7556160|FG000|Overall Study|Procedure changed to open surgery|0
4664436|NCT02247466|7556161|FG001|Overall Study|Procedure changed to open surgery|3
4664437|NCT02247479|7556170|FG000|Overall Study|Adverse Event|8
4664438|NCT02247479|7556171|FG001|Overall Study|Adverse Event|9
4664439|NCT02247479|7556172|FG002|Overall Study|Adverse Event|8
4664440|NCT02247479|7556170|FG000|Overall Study|Death|5
4664441|NCT02247479|7556171|FG001|Overall Study|Death|4
4664442|NCT02247479|7556172|FG002|Overall Study|Death|6
4664443|NCT02247479|7556170|FG000|Overall Study|Lost to Follow-up|3
4664444|NCT02247479|7556171|FG001|Overall Study|Lost to Follow-up|3
4664445|NCT02247479|7556172|FG002|Overall Study|Lost to Follow-up|1
4664446|NCT02247479|7556170|FG000|Overall Study|Non-compliance|0
4664447|NCT02247479|7556171|FG001|Overall Study|Non-compliance|0
4664448|NCT02247479|7556172|FG002|Overall Study|Non-compliance|1
4664449|NCT02247479|7556170|FG000|Overall Study|Withdrawal by Subject|25
4664450|NCT02247479|7556171|FG001|Overall Study|Withdrawal by Subject|29
4664451|NCT02247479|7556172|FG002|Overall Study|Withdrawal by Subject|24
4664452|NCT02247479|7556170|FG000|Overall Study|Study Terminated by Sponsor|98
4664453|NCT02247479|7556171|FG001|Overall Study|Study Terminated by Sponsor|88
4664454|NCT02247479|7556172|FG002|Overall Study|Study Terminated by Sponsor|94
4664455|NCT02247479|7556170|FG000|Overall Study|Physician Decision|1
4664456|NCT02247479|7556171|FG001|Overall Study|Physician Decision|0
4664457|NCT02247479|7556172|FG002|Overall Study|Physician Decision|2
4664458|NCT02247479|7556170|FG000|Overall Study|Unspecified Reason|2
4664459|NCT02247479|7556171|FG001|Overall Study|Unspecified Reason|5
4664460|NCT02247479|7556172|FG002|Overall Study|Unspecified Reason|2
4664461|NCT02247531|7556183|FG000|Overall Study|Adverse Event|3
4664462|NCT02247531|7556184|FG001|Overall Study|Adverse Event|4
4664463|NCT02247531|7556185|FG002|Overall Study|Adverse Event|9
4664464|NCT02247531|7556183|FG000|Overall Study|Death|8
4664465|NCT02247531|7556184|FG001|Overall Study|Death|9
4664466|NCT02247531|7556185|FG002|Overall Study|Death|5
4664467|NCT02247531|7556183|FG000|Overall Study|Lost to Follow-up|1
4664468|NCT02247531|7556184|FG001|Overall Study|Lost to Follow-up|8
4664469|NCT02247531|7556185|FG002|Overall Study|Lost to Follow-up|3
4664470|NCT02247531|7556183|FG000|Overall Study|Non-compliance|2
4664471|NCT02247531|7556184|FG001|Overall Study|Non-compliance|2
4664472|NCT02247531|7556185|FG002|Overall Study|Non-compliance|0
4664473|NCT02247531|7556183|FG000|Overall Study|Withdrawal by Subject|26
4664474|NCT02247531|7556184|FG001|Overall Study|Withdrawal by Subject|31
4664475|NCT02247531|7556185|FG002|Overall Study|Withdrawal by Subject|25
4664476|NCT02247531|7556183|FG000|Overall Study|Study Terminated by Sponsor|64
4664477|NCT02247531|7556184|FG001|Overall Study|Study Terminated by Sponsor|66
4664478|NCT02247531|7556185|FG002|Overall Study|Study Terminated by Sponsor|62
4664479|NCT02247531|7556183|FG000|Overall Study|Physician Decision|0
4664480|NCT02247531|7556184|FG001|Overall Study|Physician Decision|2
4664481|NCT02247531|7556185|FG002|Overall Study|Physician Decision|2
4664482|NCT02247531|7556183|FG000|Overall Study|Unspecified Reason|2
4664483|NCT02247531|7556184|FG001|Overall Study|Unspecified Reason|3
4664484|NCT02247531|7556185|FG002|Overall Study|Unspecified Reason|4
4664485|NCT02247804|7556215|FG000|Treatment Period 1|Adverse Event|9
4664486|NCT02247804|7556216|FG001|Treatment Period 1|Adverse Event|2
4664487|NCT02247804|7556217|FG002|Treatment Period 1|Adverse Event|0
4664488|NCT02247804|7556215|FG000|Treatment Period 1|Lack of Efficacy|0
4664489|NCT02247804|7556216|FG001|Treatment Period 1|Lack of Efficacy|0
4664490|NCT02247804|7556217|FG002|Treatment Period 1|Lack of Efficacy|2
4664491|NCT02247804|7556215|FG000|Treatment Period 1|Lost to Follow-up|1
4664492|NCT02247804|7556216|FG001|Treatment Period 1|Lost to Follow-up|0
4664493|NCT02247804|7556217|FG002|Treatment Period 1|Lost to Follow-up|2
4664494|NCT02247804|7556215|FG000|Treatment Period 1|Personal Reasons|7
4664495|NCT02247804|7556216|FG001|Treatment Period 1|Personal Reasons|1
4664496|NCT02247804|7556217|FG002|Treatment Period 1|Personal Reasons|2
4664497|NCT02247804|7556215|FG000|Treatment Period 1|Protocol Deviation|0
4664498|NCT02247804|7556216|FG001|Treatment Period 1|Protocol Deviation|0
4664499|NCT02247804|7556217|FG002|Treatment Period 1|Protocol Deviation|1
4664500|NCT02247804|7556215|FG000|Treatment Period 1|Randomized but not Treated|5
4664501|NCT02247804|7556216|FG001|Treatment Period 1|Randomized but not Treated|1
4664502|NCT02247804|7556217|FG002|Treatment Period 1|Randomized but not Treated|1
4664503|NCT02247804|7556215|FG000|Treatment Period 2|Adverse Event|6
4664504|NCT02247804|7556216|FG001|Treatment Period 2|Adverse Event|3
4664505|NCT02247804|7556217|FG002|Treatment Period 2|Adverse Event|3
4664506|NCT02247804|7556215|FG000|Treatment Period 2|Lack of Efficacy|0
4664507|NCT02247804|7556216|FG001|Treatment Period 2|Lack of Efficacy|0
4664508|NCT02247804|7556217|FG002|Treatment Period 2|Lack of Efficacy|1
4664509|NCT02247804|7556215|FG000|Treatment Period 2|Lost to Follow-up|0
4664510|NCT02247804|7556216|FG001|Treatment Period 2|Lost to Follow-up|1
4664511|NCT02247804|7556217|FG002|Treatment Period 2|Lost to Follow-up|1
4664512|NCT02247804|7556215|FG000|Treatment Period 2|Personal Reasons|2
4664513|NCT02247804|7556216|FG001|Treatment Period 2|Personal Reasons|1
4664514|NCT02247804|7556217|FG002|Treatment Period 2|Personal Reasons|1
4664515|NCT02247804|7556215|FG000|Treatment Period 2|Reason not Specified|0
4664516|NCT02247804|7556216|FG001|Treatment Period 2|Reason not Specified|0
4752086|NCT02564523|7726272|FG000|Overall Study|Adverse Event|0
4752087|NCT02564523|7726273|FG001|Overall Study|Adverse Event|0
4752088|NCT02564523|7726274|FG002|Overall Study|Adverse Event|0
4752089|NCT02564523|7726275|FG003|Overall Study|Adverse Event|0
4752090|NCT02564523|7726276|FG004|Overall Study|Adverse Event|0
4752091|NCT02564523|7726277|FG005|Overall Study|Adverse Event|0
4752092|NCT02564523|7726278|FG006|Overall Study|Adverse Event|0
4752093|NCT02564523|7726279|FG007|Overall Study|Adverse Event|0
4752094|NCT02564523|7726280|FG008|Overall Study|Adverse Event|0
4752095|NCT02564523|7726281|FG009|Overall Study|Adverse Event|0
4752096|NCT02564523|7726282|FG010|Overall Study|Adverse Event|0
4752097|NCT02564523|7726283|FG011|Overall Study|Adverse Event|0
4752098|NCT02564523|7726284|FG012|Overall Study|Adverse Event|0
4752099|NCT02564523|7726285|FG013|Overall Study|Adverse Event|0
4752100|NCT02564523|7726286|FG014|Overall Study|Adverse Event|0
4752101|NCT02564523|7726287|FG015|Overall Study|Adverse Event|0
4752102|NCT02564523|7726288|FG016|Overall Study|Adverse Event|0
4752103|NCT02564523|7726289|FG017|Overall Study|Adverse Event|1
4752104|NCT02564523|7726272|FG000|Overall Study|Death|0
4752105|NCT02564523|7726273|FG001|Overall Study|Death|0
4752106|NCT02564523|7726274|FG002|Overall Study|Death|0
4752107|NCT02564523|7726275|FG003|Overall Study|Death|0
4752108|NCT02564523|7726276|FG004|Overall Study|Death|0
4752109|NCT02564523|7726277|FG005|Overall Study|Death|0
4752110|NCT02564523|7726278|FG006|Overall Study|Death|1
4752111|NCT02564523|7726279|FG007|Overall Study|Death|0
4752112|NCT02564523|7726280|FG008|Overall Study|Death|0
4752113|NCT02564523|7726281|FG009|Overall Study|Death|0
4752114|NCT02564523|7726282|FG010|Overall Study|Death|1
4752115|NCT02564523|7726283|FG011|Overall Study|Death|0
4752116|NCT02564523|7726284|FG012|Overall Study|Death|0
4752117|NCT02564523|7726285|FG013|Overall Study|Death|0
4752118|NCT02564523|7726286|FG014|Overall Study|Death|0
4752119|NCT02564523|7726287|FG015|Overall Study|Death|0
4752120|NCT02564523|7726288|FG016|Overall Study|Death|0
4752121|NCT02564523|7726289|FG017|Overall Study|Death|0
4752122|NCT02564523|7726272|FG000|Overall Study|Lost to Follow-up|2
4752123|NCT02564523|7726273|FG001|Overall Study|Lost to Follow-up|1
4752124|NCT02564523|7726274|FG002|Overall Study|Lost to Follow-up|4
4664517|NCT02247804|7556217|FG002|Treatment Period 2|Reason not Specified|2
4664518|NCT02247804|7556215|FG000|Treatment Period 3|Adverse Event|4
4664519|NCT02247804|7556216|FG001|Treatment Period 3|Adverse Event|3
4664520|NCT02247804|7556217|FG002|Treatment Period 3|Adverse Event|3
4664521|NCT02247804|7556215|FG000|Treatment Period 3|Lack of Efficacy|0
4664522|NCT02247804|7556216|FG001|Treatment Period 3|Lack of Efficacy|1
4664523|NCT02247804|7556217|FG002|Treatment Period 3|Lack of Efficacy|0
4752125|NCT02564523|7726275|FG003|Overall Study|Lost to Follow-up|0
4752126|NCT02564523|7726276|FG004|Overall Study|Lost to Follow-up|1
4752127|NCT02564523|7726277|FG005|Overall Study|Lost to Follow-up|0
4752128|NCT02564523|7726278|FG006|Overall Study|Lost to Follow-up|1
4752129|NCT02564523|7726279|FG007|Overall Study|Lost to Follow-up|0
4752130|NCT02564523|7726280|FG008|Overall Study|Lost to Follow-up|0
4752131|NCT02564523|7726281|FG009|Overall Study|Lost to Follow-up|0
4752132|NCT02564523|7726282|FG010|Overall Study|Lost to Follow-up|0
4664524|NCT02247804|7556215|FG000|Treatment Period 3|Lost to Follow-up|1
4752133|NCT02564523|7726283|FG011|Overall Study|Lost to Follow-up|1
4752134|NCT02564523|7726284|FG012|Overall Study|Lost to Follow-up|1
4752135|NCT02564523|7726285|FG013|Overall Study|Lost to Follow-up|0
4752136|NCT02564523|7726286|FG014|Overall Study|Lost to Follow-up|0
4752137|NCT02564523|7726287|FG015|Overall Study|Lost to Follow-up|0
4664525|NCT02247804|7556216|FG001|Treatment Period 3|Lost to Follow-up|2
4664526|NCT02247804|7556217|FG002|Treatment Period 3|Lost to Follow-up|2
4664527|NCT02247804|7556215|FG000|Treatment Period 3|Personal Reasons|4
4664528|NCT02247804|7556216|FG001|Treatment Period 3|Personal Reasons|3
4664529|NCT02247804|7556217|FG002|Treatment Period 3|Personal Reasons|2
4664530|NCT02247804|7556215|FG000|Treatment Period 3|Reason not Specified|2
4664531|NCT02247804|7556216|FG001|Treatment Period 3|Reason not Specified|1
4664532|NCT02247804|7556217|FG002|Treatment Period 3|Reason not Specified|3
4664533|NCT02247960|7556227|FG000|Patient Consent and Randomization|Physician Decision|2
4664534|NCT02247960|7556228|FG001|Patient Consent and Randomization|Physician Decision|2
4664535|NCT02247960|7556227|FG000|Patient Consent and Randomization|Withdrawal by Subject|0
4664536|NCT02247960|7556228|FG001|Patient Consent and Randomization|Withdrawal by Subject|4
4664537|NCT02247960|7556227|FG000|Catheter Removed|Lost to Follow-up|7
4664538|NCT02247960|7556228|FG001|Catheter Removed|Lost to Follow-up|10
4664539|NCT02248480|7556258|FG000|Overall Study|Lack of Efficacy|4
4664540|NCT02248480|7556259|FG001|Overall Study|Lack of Efficacy|6
4664541|NCT02248480|7556258|FG000|Overall Study|Adverse Event|11
4664542|NCT02248480|7556259|FG001|Overall Study|Adverse Event|2
4664543|NCT02248480|7556258|FG000|Overall Study|Withdrawal by Subject|2
4664544|NCT02248480|7556259|FG001|Overall Study|Withdrawal by Subject|4
4664545|NCT02248480|7556258|FG000|Overall Study|Entry Criteria Not Met|0
4664546|NCT02248480|7556259|FG001|Overall Study|Entry Criteria Not Met|1
4664547|NCT02248480|7556258|FG000|Overall Study|Other:Physician Decision|0
4664548|NCT02248480|7556259|FG001|Overall Study|Other:Physician Decision|1
4664549|NCT02248649|7556288|FG000|Overall Study|Death|7
4664550|NCT02248649|7556289|FG001|Overall Study|Death|11
4664551|NCT02248649|7556288|FG000|Overall Study|Lost to Follow-up|14
4664552|NCT02248649|7556289|FG001|Overall Study|Lost to Follow-up|10
4664553|NCT02248675|7556310|FG000|Overall Study|Lost to Follow-up|3
4664554|NCT02248675|7556311|FG001|Overall Study|Lost to Follow-up|1
4664555|NCT02248818|7556349|FG000|Screening|Protocol Violation|0
4664556|NCT02248818|7556350|FG001|Screening|Protocol Violation|0
4664557|NCT02248818|7556351|FG002|Screening|Protocol Violation|0
4664558|NCT02248818|7556352|FG003|Screening|Protocol Violation|0
4664559|NCT02248818|7556353|FG004|Screening|Protocol Violation|0
4752138|NCT02564523|7726288|FG016|Overall Study|Lost to Follow-up|0
4752139|NCT02564523|7726289|FG017|Overall Study|Lost to Follow-up|0
4752140|NCT02564523|7726272|FG000|Overall Study|Physician Decision|0
4752141|NCT02564523|7726273|FG001|Overall Study|Physician Decision|0
4752142|NCT02564523|7726274|FG002|Overall Study|Physician Decision|0
4752143|NCT02564523|7726275|FG003|Overall Study|Physician Decision|0
4752144|NCT02564523|7726276|FG004|Overall Study|Physician Decision|1
4752145|NCT02564523|7726277|FG005|Overall Study|Physician Decision|0
4752146|NCT02564523|7726278|FG006|Overall Study|Physician Decision|0
4752147|NCT02564523|7726279|FG007|Overall Study|Physician Decision|0
4752148|NCT02564523|7726280|FG008|Overall Study|Physician Decision|0
4752149|NCT02564523|7726281|FG009|Overall Study|Physician Decision|0
4752150|NCT02564523|7726282|FG010|Overall Study|Physician Decision|1
4752151|NCT02564523|7726283|FG011|Overall Study|Physician Decision|0
4752152|NCT02564523|7726284|FG012|Overall Study|Physician Decision|0
4752153|NCT02564523|7726285|FG013|Overall Study|Physician Decision|0
4752154|NCT02564523|7726286|FG014|Overall Study|Physician Decision|0
4752155|NCT02564523|7726287|FG015|Overall Study|Physician Decision|0
4752156|NCT02564523|7726288|FG016|Overall Study|Physician Decision|0
4752157|NCT02564523|7726289|FG017|Overall Study|Physician Decision|0
4752158|NCT02564523|7726272|FG000|Overall Study|Protocol Violation|2
4752159|NCT02564523|7726273|FG001|Overall Study|Protocol Violation|2
4752160|NCT02564523|7726274|FG002|Overall Study|Protocol Violation|5
4752161|NCT02564523|7726275|FG003|Overall Study|Protocol Violation|0
4752162|NCT02564523|7726276|FG004|Overall Study|Protocol Violation|1
4752163|NCT02564523|7726277|FG005|Overall Study|Protocol Violation|0
4752164|NCT02564523|7726278|FG006|Overall Study|Protocol Violation|0
4752165|NCT02564523|7726279|FG007|Overall Study|Protocol Violation|0
4752166|NCT02564523|7726280|FG008|Overall Study|Protocol Violation|0
4752167|NCT02564523|7726281|FG009|Overall Study|Protocol Violation|0
4752168|NCT02564523|7726282|FG010|Overall Study|Protocol Violation|0
4752169|NCT02564523|7726283|FG011|Overall Study|Protocol Violation|0
4752170|NCT02564523|7726284|FG012|Overall Study|Protocol Violation|0
4752171|NCT02564523|7726285|FG013|Overall Study|Protocol Violation|0
4752172|NCT02564523|7726286|FG014|Overall Study|Protocol Violation|0
4752173|NCT02564523|7726287|FG015|Overall Study|Protocol Violation|0
4752174|NCT02564523|7726288|FG016|Overall Study|Protocol Violation|0
4752175|NCT02564523|7726289|FG017|Overall Study|Protocol Violation|0
4752176|NCT02564523|7726272|FG000|Overall Study|Other|3
4752177|NCT02564523|7726273|FG001|Overall Study|Other|0
4752178|NCT02564523|7726274|FG002|Overall Study|Other|0
4752179|NCT02564523|7726275|FG003|Overall Study|Other|1
4752180|NCT02564523|7726276|FG004|Overall Study|Other|0
4664560|NCT02248818|7556354|FG005|Screening|Protocol Violation|0
4664561|NCT02248818|7556355|FG006|Screening|Protocol Violation|0
4664562|NCT02248818|7556356|FG007|Screening|Protocol Violation|0
4664563|NCT02248818|7556357|FG008|Screening|Protocol Violation|7
4664564|NCT02248818|7556349|FG000|Screening|Study fully enrolled|0
4664565|NCT02248818|7556350|FG001|Screening|Study fully enrolled|0
4752181|NCT02564523|7726277|FG005|Overall Study|Other|0
4752182|NCT02564523|7726278|FG006|Overall Study|Other|0
4752183|NCT02564523|7726279|FG007|Overall Study|Other|0
4664566|NCT02248818|7556351|FG002|Screening|Study fully enrolled|0
4664567|NCT02248818|7556352|FG003|Screening|Study fully enrolled|0
4664568|NCT02248818|7556353|FG004|Screening|Study fully enrolled|0
4664569|NCT02248818|7556354|FG005|Screening|Study fully enrolled|0
4664570|NCT02248818|7556355|FG006|Screening|Study fully enrolled|0
4664571|NCT02248818|7556356|FG007|Screening|Study fully enrolled|0
4664572|NCT02248818|7556357|FG008|Screening|Study fully enrolled|14
4664573|NCT02248818|7556349|FG000|Screening|Physician Decision|0
4664574|NCT02248818|7556350|FG001|Screening|Physician Decision|0
4664575|NCT02248818|7556351|FG002|Screening|Physician Decision|0
4664576|NCT02248818|7556352|FG003|Screening|Physician Decision|0
4664577|NCT02248818|7556353|FG004|Screening|Physician Decision|0
4664578|NCT02248818|7556354|FG005|Screening|Physician Decision|0
4664579|NCT02248818|7556355|FG006|Screening|Physician Decision|0
4664580|NCT02248818|7556356|FG007|Screening|Physician Decision|0
4664581|NCT02248818|7556357|FG008|Screening|Physician Decision|73
4664582|NCT02248818|7556349|FG000|Screening|Withdrawal by Subject|0
4664583|NCT02248818|7556350|FG001|Screening|Withdrawal by Subject|0
4664584|NCT02248818|7556351|FG002|Screening|Withdrawal by Subject|0
4664585|NCT02248818|7556352|FG003|Screening|Withdrawal by Subject|0
4664586|NCT02248818|7556353|FG004|Screening|Withdrawal by Subject|0
4664587|NCT02248818|7556354|FG005|Screening|Withdrawal by Subject|0
4664588|NCT02248818|7556355|FG006|Screening|Withdrawal by Subject|0
4664589|NCT02248818|7556356|FG007|Screening|Withdrawal by Subject|0
4664590|NCT02248818|7556357|FG008|Screening|Withdrawal by Subject|6
4664591|NCT02248818|7556349|FG000|Screening|Lost to Follow-up|0
4664592|NCT02248818|7556350|FG001|Screening|Lost to Follow-up|0
4664593|NCT02248818|7556351|FG002|Screening|Lost to Follow-up|0
4664594|NCT02248818|7556352|FG003|Screening|Lost to Follow-up|0
4664595|NCT02248818|7556353|FG004|Screening|Lost to Follow-up|0
4664596|NCT02248818|7556354|FG005|Screening|Lost to Follow-up|0
4664597|NCT02248818|7556355|FG006|Screening|Lost to Follow-up|0
4664598|NCT02248818|7556356|FG007|Screening|Lost to Follow-up|0
4664599|NCT02248818|7556357|FG008|Screening|Lost to Follow-up|7
4664600|NCT02248818|7556349|FG000|Randomised Study|Administrative - randomization error|0
4664601|NCT02248818|7556350|FG001|Randomised Study|Administrative - randomization error|0
4664602|NCT02248818|7556351|FG002|Randomised Study|Administrative - randomization error|0
4664603|NCT02248818|7556352|FG003|Randomised Study|Administrative - randomization error|0
4664604|NCT02248818|7556353|FG004|Randomised Study|Administrative - randomization error|0
4664605|NCT02248818|7556354|FG005|Randomised Study|Administrative - randomization error|8
4664606|NCT02248818|7556355|FG006|Randomised Study|Administrative - randomization error|0
4664607|NCT02248818|7556356|FG007|Randomised Study|Administrative - randomization error|0
4664608|NCT02248818|7556357|FG008|Randomised Study|Administrative - randomization error|0
4664609|NCT02248857|7556378|FG000|3 Month|Withdrawal by Subject|9
4664610|NCT02248857|7556379|FG001|3 Month|Withdrawal by Subject|3
4664611|NCT02248857|7556380|FG002|3 Month|Withdrawal by Subject|4
4664612|NCT02248857|7556378|FG000|3 Month|Unable to reach for 3 month|35
4664613|NCT02248857|7556379|FG001|3 Month|Unable to reach for 3 month|29
4664614|NCT02248857|7556380|FG002|3 Month|Unable to reach for 3 month|26
4664615|NCT02248857|7556378|FG000|3 Month|Partially completed, unable to finish|2
4752184|NCT02564523|7726280|FG008|Overall Study|Other|0
4752185|NCT02564523|7726281|FG009|Overall Study|Other|0
4752186|NCT02564523|7726282|FG010|Overall Study|Other|0
4752187|NCT02564523|7726283|FG011|Overall Study|Other|0
4752188|NCT02564523|7726284|FG012|Overall Study|Other|0
4752189|NCT02564523|7726285|FG013|Overall Study|Other|0
4752190|NCT02564523|7726286|FG014|Overall Study|Other|0
4752191|NCT02564523|7726287|FG015|Overall Study|Other|0
4752192|NCT02564523|7726288|FG016|Overall Study|Other|0
4752193|NCT02564523|7726289|FG017|Overall Study|Other|0
4752194|NCT02094261|7726368|FG000|Overall Study|Death|24
4752195|NCT02094261|7726368|FG000|Overall Study|Lost to Follow-up|1
4752196|NCT02094261|7726368|FG000|Overall Study|Withdrawal by Subject|4
4752197|NCT02094261|7726368|FG000|Overall Study|Ongoing Study at Data Cut-off|181
4752198|NCT01988493|7726377|FG000|Overall Study|Randomized but not treated|0
4752199|NCT01988493|7726378|FG001|Overall Study|Randomized but not treated|0
4752200|NCT01988493|7726379|FG002|Overall Study|Randomized but not treated|0
4752201|NCT01988493|7726380|FG003|Overall Study|Randomized but not treated|0
4752202|NCT01988493|7726381|FG004|Overall Study|Randomized but not treated|1
4752203|NCT01798004|7726398|FG000|Overall Study|Death|2
4752204|NCT01798004|7726398|FG000|Overall Study|Lack of Efficacy|8
4664616|NCT02248857|7556379|FG001|3 Month|Partially completed, unable to finish|2
4664617|NCT02248857|7556380|FG002|3 Month|Partially completed, unable to finish|1
4664618|NCT02248857|7556378|FG000|6 Month|Lost to Follow-up|27
4752205|NCT01798004|7726398|FG000|Overall Study|Physician Decision|25
4752206|NCT01798004|7726398|FG000|Overall Study|Withdrawal by Subject|4
4752207|NCT01798004|7726398|FG000|Overall Study|Ineligible|4
4664619|NCT02248857|7556379|FG001|6 Month|Lost to Follow-up|26
4664620|NCT02248857|7556380|FG002|6 Month|Lost to Follow-up|15
4664621|NCT02248857|7556378|FG000|6 Month|Partially completed, unable to finish|0
4664622|NCT02248857|7556379|FG001|6 Month|Partially completed, unable to finish|1
4664623|NCT02248857|7556380|FG002|6 Month|Partially completed, unable to finish|0
4664624|NCT02248857|7556378|FG000|6 Month|Withdrawal by Subject|0
4664625|NCT02248857|7556379|FG001|6 Month|Withdrawal by Subject|2
4752208|NCT01798004|7726398|FG000|Overall Study|Patient/parent refusal|7
4664626|NCT02248857|7556380|FG002|6 Month|Withdrawal by Subject|2
4664627|NCT02248857|7556378|FG000|6 Month|Death|1
4664628|NCT02248857|7556379|FG001|6 Month|Death|0
4664629|NCT02248857|7556380|FG002|6 Month|Death|0
4664630|NCT02248961|7556398|FG000|Overall Study|Adverse Event|1
4664631|NCT02248961|7556399|FG001|Overall Study|Adverse Event|0
4664632|NCT02248961|7556398|FG000|Overall Study|Withdrawal by Subject|1
4664633|NCT02248961|7556399|FG001|Overall Study|Withdrawal by Subject|2
4664634|NCT02248961|7556398|FG000|Overall Study|Unmet inclusion/exclusion criteria|1
4664635|NCT02248961|7556399|FG001|Overall Study|Unmet inclusion/exclusion criteria|0
4664636|NCT02248974|7556407|FG000|1-Day Follow-Up|Lost to Follow-up|4
4664637|NCT02248974|7556408|FG001|1-Day Follow-Up|Lost to Follow-up|0
4664638|NCT02248974|7556407|FG000|1-Day Follow-Up|Withdrawal by Subject|5
4664639|NCT02248974|7556408|FG001|1-Day Follow-Up|Withdrawal by Subject|0
4664640|NCT02248974|7556407|FG000|1-Day Follow-Up|Enrolled in another study|1
4664641|NCT02248974|7556408|FG001|1-Day Follow-Up|Enrolled in another study|0
4664642|NCT02248974|7556407|FG000|1-Week Follow-Up|Became ineligible for LVAD|4
4664643|NCT02248974|7556408|FG001|1-Week Follow-Up|Became ineligible for LVAD|1
4664644|NCT02248974|7556407|FG000|1-Week Follow-Up|Enrolled in another study|1
4664645|NCT02248974|7556408|FG001|1-Week Follow-Up|Enrolled in another study|1
4664646|NCT02248974|7556407|FG000|1-Week Follow-Up|Transferred to another facility|1
4664647|NCT02248974|7556408|FG001|1-Week Follow-Up|Transferred to another facility|0
4664648|NCT02248974|7556407|FG000|1-Week Follow-Up|Cognitive Difficulty|1
4664649|NCT02248974|7556408|FG001|1-Week Follow-Up|Cognitive Difficulty|0
4664650|NCT02248974|7556407|FG000|1-Week Follow-Up|Death|1
4664651|NCT02248974|7556408|FG001|1-Week Follow-Up|Death|1
4664652|NCT02248974|7556407|FG000|1-Week Follow-Up|Excluded because of age|0
4664653|NCT02248974|7556408|FG001|1-Week Follow-Up|Excluded because of age|1
4664654|NCT02248974|7556407|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0
4664655|NCT02248974|7556408|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1
4664656|NCT02248974|7556407|FG000|1-Week Follow-Up|Timing: implanted before survey|0
4664657|NCT02248974|7556408|FG001|1-Week Follow-Up|Timing: implanted before survey|2
4664658|NCT02248974|7556407|FG000|1-Week Follow-Up|Withdrawal by Subject|0
4664659|NCT02248974|7556408|FG001|1-Week Follow-Up|Withdrawal by Subject|2
4664660|NCT02248974|7556407|FG000|1-Week Follow-Up|Lost to Follow-up|0
4664661|NCT02248974|7556408|FG001|1-Week Follow-Up|Lost to Follow-up|8
4664662|NCT02248974|7556407|FG000|1-Month Follow-Up|Lost to Follow-up|2
4664663|NCT02248974|7556408|FG001|1-Month Follow-Up|Lost to Follow-up|3
4664664|NCT02249091|7556428|FG000|Overall Study|Lack of Efficacy|8
4664665|NCT02249091|7556429|FG001|Overall Study|Lack of Efficacy|3
4664666|NCT02249091|7556428|FG000|Overall Study|Physician Decision|4
4664667|NCT02249091|7556429|FG001|Overall Study|Physician Decision|1
4664668|NCT02249091|7556428|FG000|Overall Study|Withdrawal by Subject|2
4664669|NCT02249091|7556429|FG001|Overall Study|Withdrawal by Subject|2
4664670|NCT02249091|7556428|FG000|Overall Study|Death|3
4664671|NCT02249091|7556429|FG001|Overall Study|Death|4
4664672|NCT02249091|7556428|FG000|Overall Study|Adverse Event|1
4664673|NCT02249091|7556429|FG001|Overall Study|Adverse Event|0
4664674|NCT02249091|7556428|FG000|Overall Study|Stable disease with following SCT|0
4664675|NCT02249091|7556429|FG001|Overall Study|Stable disease with following SCT|1
4664676|NCT02249091|7556428|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0
4664677|NCT02249091|7556429|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1
4664678|NCT02249091|7556428|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1
4664679|NCT02249091|7556429|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0
4664680|NCT02249091|7556428|FG000|Overall Study|Refractory AML|1
4664681|NCT02249091|7556429|FG001|Overall Study|Refractory AML|1
4752209|NCT01798004|7726398|FG000|Overall Study|Initiation of other non-protocol therapy|5
4752210|NCT01798004|7726398|FG000|Overall Study|Enrollment another COG therapeutic trial|32
4752211|NCT01751906|7726404|FG000|Overall Study|Lost to Follow-up|151
4752212|NCT01751906|7726405|FG001|Overall Study|Lost to Follow-up|68
4752213|NCT01751906|7726404|FG000|Overall Study|Withdrawal by Subject|22
4752214|NCT01751906|7726405|FG001|Overall Study|Withdrawal by Subject|18
4752215|NCT01751906|7726404|FG000|Overall Study|Physician Decision|5
4752216|NCT01751906|7726405|FG001|Overall Study|Physician Decision|2
4752217|NCT01751906|7726404|FG000|Overall Study|Death|84
4752218|NCT01751906|7726405|FG001|Overall Study|Death|43
4752219|NCT01751906|7726404|FG000|Overall Study|Denied on premises for follow-up by law|1
4752220|NCT01751906|7726405|FG001|Overall Study|Denied on premises for follow-up by law|0
4752221|NCT01447628|7726434|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0
4752222|NCT01447628|7726435|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0
4752223|NCT01447628|7726436|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0
4752224|NCT01447628|7726437|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1
4752225|NCT01175356|7726457|FG000|Overall Study|Death|1
4752226|NCT01175356|7726457|FG000|Overall Study|Lack of Efficacy|12
4752227|NCT01175356|7726457|FG000|Overall Study|Lost to Follow-up|1
4752228|NCT01175356|7726457|FG000|Overall Study|Physician Decision|23
4752229|NCT01175356|7726457|FG000|Overall Study|Ineligible|1
4752230|NCT01175356|7726457|FG000|Overall Study|Treatment Slot Not Available|18
4752231|NCT01175356|7726457|FG000|Overall Study|Refusal by patient/parent/guardian|6
4752232|NCT01175356|7726457|FG000|Overall Study|Pts MIBG non-avid after enrollment|2
4752233|NCT01175356|7726457|FG000|Overall Study|On other COG study w/tumor tx intent|7
4664682|NCT02249182|7556453|FG000|Treatment Phase|Lost to Follow-up|4
4664683|NCT02249182|7556454|FG001|Treatment Phase|Lost to Follow-up|0
4664684|NCT02249182|7556455|FG002|Treatment Phase|Lost to Follow-up|0
4664685|NCT02249182|7556456|FG003|Treatment Phase|Lost to Follow-up|0
4664686|NCT02249182|7556457|FG004|Treatment Phase|Lost to Follow-up|0
4664687|NCT02249767|7556505|FG000|Overall Study|Did not use medication|8
4664688|NCT02249767|7556506|FG001|Overall Study|Did not use medication|9
4664689|NCT02249767|7556507|FG002|Overall Study|Did not use medication|8
4664690|NCT02249832|7556527|FG000|Overall Study|Withdrawal by Subject|3
4664691|NCT02249832|7556527|FG000|Overall Study|Lost to Follow-up|10
4664692|NCT02249949|7556536|FG000|Overall Study|Cancelled prior to treatment|2
4664693|NCT02250183|7556549|FG000|Overall Study|Withdrawal by Subject|2
4664694|NCT02250183|7556549|FG000|Overall Study|Adverse Event|5
4664695|NCT02250183|7556549|FG000|Overall Study|Lost to Follow-up|1
4664696|NCT02250274|7556558|FG000|Overall Study|Insufficient blood draw amount|7
4664697|NCT02250274|7556559|FG001|Overall Study|Insufficient blood draw amount|6
4664698|NCT02250443|7556581|FG000|Overall Study|Administrative problems|7
4664699|NCT02250443|7556581|FG000|Overall Study|Adverse Event|3
4752234|NCT01175356|7726457|FG000|Overall Study|Inadequate stem cell for transplant|1
4752235|NCT01175356|7726457|FG000|Overall Study|Initiation other tx prior to completion|9
4752236|NCT00515853|7726463|FG000|Overall Study|Lost to Follow-up|9
4752237|NCT00515853|7726464|FG001|Overall Study|Lost to Follow-up|13
4752238|NCT00515853|7726463|FG000|Overall Study|Withdrawal by Subject|6
4752239|NCT00515853|7726464|FG001|Overall Study|Withdrawal by Subject|4
4752240|NCT00003458|7726470|FG000|Overall Study|Not evaluable|4
4664700|NCT02250651|7556620|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0
4664701|NCT02250651|7556621|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2
4664702|NCT02250651|7556622|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2
4664703|NCT02250651|7556620|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1
4664704|NCT02250651|7556621|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0
4664705|NCT02250651|7556622|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0
4664706|NCT02250651|7556620|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2
4664707|NCT02250651|7556621|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3
4664708|NCT02250651|7556622|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5
4664709|NCT02250651|7556620|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1
4664710|NCT02250651|7556621|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0
4664711|NCT02250651|7556622|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0
4664712|NCT02250651|7556620|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0
4664713|NCT02250651|7556621|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0
4664714|NCT02250651|7556622|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1
4664715|NCT02250651|7556620|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0
4664716|NCT02250651|7556621|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1
4664717|NCT02250651|7556622|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3
4664718|NCT02250651|7556620|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4
4664719|NCT02250651|7556621|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1
4664720|NCT02250651|7556622|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0
4664721|NCT02250651|7556620|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0
4664722|NCT02250651|7556621|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0
4664723|NCT02250651|7556622|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3
4664724|NCT02250651|7556620|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2
4664725|NCT02250651|7556621|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3
4664726|NCT02250651|7556622|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2
4664727|NCT02250651|7556620|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0
4664728|NCT02250651|7556621|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1
4664729|NCT02250651|7556622|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0
4664730|NCT02250651|7556620|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0
4664731|NCT02250651|7556621|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1
4664732|NCT02250651|7556622|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0
4664733|NCT02250651|7556620|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4
4664734|NCT02250651|7556621|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1
4664735|NCT02250651|7556622|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1
4664736|NCT02250651|7556620|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1
4664737|NCT02250651|7556621|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2
4664738|NCT02250651|7556622|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1
4664739|NCT02250651|7556620|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2
4664740|NCT02250651|7556621|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0
4664741|NCT02250651|7556622|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2
4664742|NCT02250651|7556620|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2
4664743|NCT02250651|7556621|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1
4664744|NCT02250651|7556622|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1
4664745|NCT02251275|7556661|FG000|Overall Study|Adverse Event|23
4664746|NCT02251275|7556662|FG001|Overall Study|Adverse Event|60
4664747|NCT02251275|7556663|FG002|Overall Study|Adverse Event|28
4664748|NCT02251275|7556664|FG003|Overall Study|Adverse Event|0
4664749|NCT02251275|7556665|FG004|Overall Study|Adverse Event|0
4664750|NCT02251275|7556661|FG000|Overall Study|Lost to Follow-up|5
4664751|NCT02251275|7556662|FG001|Overall Study|Lost to Follow-up|6
4664752|NCT02251275|7556663|FG002|Overall Study|Lost to Follow-up|4
4664753|NCT02251275|7556664|FG003|Overall Study|Lost to Follow-up|0
4664754|NCT02251275|7556665|FG004|Overall Study|Lost to Follow-up|0
4664755|NCT02251275|7556661|FG000|Overall Study|Physician Decision|19
4664756|NCT02251275|7556662|FG001|Overall Study|Physician Decision|30
4664757|NCT02251275|7556663|FG002|Overall Study|Physician Decision|26
4664758|NCT02251275|7556664|FG003|Overall Study|Physician Decision|0
4664759|NCT02251275|7556665|FG004|Overall Study|Physician Decision|1
4664760|NCT02251275|7556661|FG000|Overall Study|Protocol Deviation|0
4664761|NCT02251275|7556662|FG001|Overall Study|Protocol Deviation|0
4664762|NCT02251275|7556663|FG002|Overall Study|Protocol Deviation|1
4664763|NCT02251275|7556664|FG003|Overall Study|Protocol Deviation|0
4664764|NCT02251275|7556665|FG004|Overall Study|Protocol Deviation|0
4664765|NCT02251275|7556661|FG000|Overall Study|Withdrawal by Subject|25
4664766|NCT02251275|7556662|FG001|Overall Study|Withdrawal by Subject|51
4664767|NCT02251275|7556663|FG002|Overall Study|Withdrawal by Subject|35
4664768|NCT02251275|7556664|FG003|Overall Study|Withdrawal by Subject|1
4664769|NCT02251275|7556665|FG004|Overall Study|Withdrawal by Subject|0
4664770|NCT02251652|7556707|FG000|Overall Study|Withdrawal by Subject|1
4664771|NCT02251717|7556715|FG000|Overall Study|Adverse Event|0
4664772|NCT02251717|7556716|FG001|Overall Study|Adverse Event|1
4664773|NCT02251717|7556715|FG000|Overall Study|Withdrew Consent|1
4664774|NCT02251717|7556716|FG001|Overall Study|Withdrew Consent|0
4664775|NCT02251743|7556724|FG000|Overall Study|Withdrawal by Subject|1
4664776|NCT02251743|7556725|FG001|Overall Study|Withdrawal by Subject|1
4664777|NCT02251912|7556750|FG000|Overall Study|Withdrawal by Subject|2
4664778|NCT02251912|7556751|FG001|Overall Study|Withdrawal by Subject|3
4664779|NCT02251912|7556750|FG000|Overall Study|Adverse Event|0
4664780|NCT02251912|7556751|FG001|Overall Study|Adverse Event|2
4664781|NCT02251990|7556763|FG000|Period 1 (Double-blind [DB])|Adverse Event|1
4664782|NCT02251990|7556764|FG001|Period 1 (Double-blind [DB])|Adverse Event|1
4664783|NCT02251990|7556763|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5
4664784|NCT02251990|7556764|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0
4664785|NCT02251990|7556763|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1
4664786|NCT02251990|7556764|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0
4664787|NCT02251990|7556763|FG000|Period 1 (Double-blind [DB])|Not Treated|1
4664788|NCT02251990|7556764|FG001|Period 1 (Double-blind [DB])|Not Treated|0
4664789|NCT02251990|7556763|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0
4664790|NCT02251990|7556764|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1
4664791|NCT02251990|7556763|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0
4664792|NCT02251990|7556764|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2
4664793|NCT02252016|7556773|FG000|Overall Study|Lost to Follow-up|2
4664794|NCT02252016|7556774|FG001|Overall Study|Lost to Follow-up|1
4664795|NCT02252016|7556773|FG000|Overall Study|Physician Decision|1
4664796|NCT02252016|7556774|FG001|Overall Study|Physician Decision|0
4664797|NCT02252016|7556773|FG000|Overall Study|Withdrawal by Subject|0
4664798|NCT02252016|7556774|FG001|Overall Study|Withdrawal by Subject|2
4664799|NCT02252042|7556782|FG000|Overall Study|Death|170
4664800|NCT02252042|7556783|FG001|Overall Study|Death|192
4664801|NCT02252042|7556782|FG000|Overall Study|Physician Decision|0
4664802|NCT02252042|7556783|FG001|Overall Study|Physician Decision|1
4664803|NCT02252042|7556782|FG000|Overall Study|Withdrawal by Subject|13
4664804|NCT02252042|7556783|FG001|Overall Study|Withdrawal by Subject|20
4664805|NCT02252042|7556782|FG000|Overall Study|Ongoing in study|64
4664806|NCT02252042|7556783|FG001|Overall Study|Ongoing in study|35
4664807|NCT02252081|7556804|FG000|Overall Study|Withdrawal by Subject|2
4664808|NCT02252081|7556805|FG001|Overall Study|Withdrawal by Subject|1
4664809|NCT02252081|7556804|FG000|Overall Study|Adverse Event|4
4664810|NCT02252081|7556805|FG001|Overall Study|Adverse Event|1
4664811|NCT02252081|7556804|FG000|Overall Study|non compliance & others|0
4664812|NCT02252081|7556805|FG001|Overall Study|non compliance & others|2
4664813|NCT02252146|7556823|FG000|Overall Study|Lack of Efficacy|4
4664814|NCT02252146|7556823|FG000|Overall Study|Entered hospice care|1
4664815|NCT02252146|7556823|FG000|Overall Study|Inability to travel to study site|1
4664816|NCT02252211|7556829|FG000|Overall Study|Adverse Event|0
4664817|NCT02252211|7556830|FG001|Overall Study|Adverse Event|1
4664818|NCT02252211|7556831|FG002|Overall Study|Adverse Event|0
4664819|NCT02252211|7556829|FG000|Overall Study|Progressive disease|3
4664820|NCT02252211|7556830|FG001|Overall Study|Progressive disease|2
4664821|NCT02252211|7556831|FG002|Overall Study|Progressive disease|0
4664822|NCT02252211|7556829|FG000|Overall Study|Withdrawal by Subject|1
4664823|NCT02252211|7556830|FG001|Overall Study|Withdrawal by Subject|0
4664824|NCT02252211|7556831|FG002|Overall Study|Withdrawal by Subject|0
4664825|NCT02252211|7556829|FG000|Overall Study|Serious Adverse Event During Screening|1
4664826|NCT02252211|7556830|FG001|Overall Study|Serious Adverse Event During Screening|0
4664827|NCT02252211|7556831|FG002|Overall Study|Serious Adverse Event During Screening|1
4664828|NCT02252406|7556849|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2
4664829|NCT02252406|7556850|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3
4664830|NCT02252406|7556849|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1
4664831|NCT02252406|7556850|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0
4664832|NCT02252406|7556849|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1
4752241|NCT04613739|7726495|FG000|Overall Study|Lost to Follow-up|6
4752242|NCT04613739|7726496|FG001|Overall Study|Lost to Follow-up|9
4752243|NCT04613739|7726495|FG000|Overall Study|potentially duplicative/fraudulent|1
4752244|NCT04613739|7726496|FG001|Overall Study|potentially duplicative/fraudulent|3
4752245|NCT04573972|7726504|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32
4752246|NCT04573972|7726505|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14
4752247|NCT04407806|7726523|FG000|Overall Study|Withdrawal by Subject|1
4752248|NCT04407806|7726524|FG001|Overall Study|Withdrawal by Subject|2
4752249|NCT04324021|7726533|FG000|Overall Study|Adverse Event|1
4752250|NCT04324021|7726534|FG001|Overall Study|Adverse Event|0
4752251|NCT04324021|7726535|FG002|Overall Study|Adverse Event|0
4752252|NCT04324021|7726533|FG000|Overall Study|Lack of Efficacy|0
4752253|NCT04324021|7726534|FG001|Overall Study|Lack of Efficacy|0
4752254|NCT04324021|7726535|FG002|Overall Study|Lack of Efficacy|1
4752255|NCT04324021|7726533|FG000|Overall Study|Death|1
4752256|NCT04324021|7726534|FG001|Overall Study|Death|1
4752257|NCT04324021|7726535|FG002|Overall Study|Death|0
4752258|NCT04209621|7726546|FG000|Overall Study|Death|1
4752259|NCT04209621|7726546|FG000|Overall Study|Study Terminated Early|2
4752260|NCT04186663|7726551|FG000|Overall Study|Lost to Follow-up|1
4752261|NCT04186663|7726551|FG000|Overall Study|Unable to complete blood draw|3
4752262|NCT04158219|7726555|FG000|Overall Study|Lost to Follow-up|1
4752263|NCT04056299|7726575|FG000|Overall Study|Sponsor discontinued study|3
4752264|NCT04056299|7726576|FG001|Overall Study|Sponsor discontinued study|3
4752265|NCT03954743|7726624|FG000|Overall Study|Adverse Event|1
4752266|NCT03954743|7726625|FG001|Overall Study|Adverse Event|0
4752267|NCT03954743|7726624|FG000|Overall Study|Lost to Follow-up|6
4752268|NCT03954743|7726625|FG001|Overall Study|Lost to Follow-up|4
4752269|NCT03954743|7726624|FG000|Overall Study|Protocol Violation|1
4752270|NCT03954743|7726625|FG001|Overall Study|Protocol Violation|0
4752271|NCT03954743|7726624|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13
4752272|NCT03954743|7726625|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12
4752273|NCT03954743|7726624|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3
4752274|NCT03954743|7726625|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1
4752275|NCT03880565|7726633|FG000|Overall Study|Withdrawal by Subject|1
4752276|NCT03880565|7726634|FG001|Overall Study|Withdrawal by Subject|0
4752277|NCT03833661|7726640|FG000|Overall Study|Treatment ongoing|9
4752278|NCT03809663|7726648|FG000|Overall Study|Decision by sponsor|24
4752279|NCT03809663|7726649|FG001|Overall Study|Decision by sponsor|18
4752280|NCT03809663|7726650|FG002|Overall Study|Decision by sponsor|20
4752281|NCT03809663|7726651|FG003|Overall Study|Decision by sponsor|20
4752282|NCT03809663|7726652|FG004|Overall Study|Decision by sponsor|0
4752283|NCT03809663|7726653|FG005|Overall Study|Decision by sponsor|0
4752284|NCT03809663|7726648|FG000|Overall Study|Withdrawal by Subject|26
4752285|NCT03809663|7726649|FG001|Overall Study|Withdrawal by Subject|22
4752286|NCT03809663|7726650|FG002|Overall Study|Withdrawal by Subject|27
4752287|NCT03809663|7726651|FG003|Overall Study|Withdrawal by Subject|26
4752288|NCT03809663|7726652|FG004|Overall Study|Withdrawal by Subject|0
4752289|NCT03809663|7726653|FG005|Overall Study|Withdrawal by Subject|0
4752290|NCT03809663|7726648|FG000|Overall Study|Lost to Follow-up|1
4752291|NCT03809663|7726649|FG001|Overall Study|Lost to Follow-up|4
4752292|NCT03809663|7726650|FG002|Overall Study|Lost to Follow-up|1
4752293|NCT03809663|7726651|FG003|Overall Study|Lost to Follow-up|1
4752294|NCT03809663|7726652|FG004|Overall Study|Lost to Follow-up|0
4752295|NCT03809663|7726653|FG005|Overall Study|Lost to Follow-up|0
4752296|NCT03782792|7726680|FG000|Overall Study|Patient left the country|0
4752297|NCT03782792|7726681|FG001|Overall Study|Patient left the country|1
4752298|NCT03782792|7726680|FG000|Overall Study|Withdrawal by Subject|1
4752299|NCT03782792|7726681|FG001|Overall Study|Withdrawal by Subject|2
4752300|NCT03733119|7726700|FG000|Overall Study|Physician Decision|2
4752301|NCT03733119|7726701|FG001|Overall Study|Physician Decision|1
4752302|NCT03733119|7726700|FG000|Overall Study|ineligible to treat per protocol|0
4752303|NCT03733119|7726701|FG001|Overall Study|ineligible to treat per protocol|1
4752304|NCT03661996|7726712|FG000|Overall Study|Adverse Event|0
4752305|NCT03661996|7726713|FG001|Overall Study|Adverse Event|0
4752306|NCT03661996|7726714|FG002|Overall Study|Adverse Event|1
4752307|NCT03661996|7726715|FG003|Overall Study|Adverse Event|1
4752308|NCT03661996|7726716|FG004|Overall Study|Adverse Event|0
4752309|NCT03661996|7726712|FG000|Overall Study|Lost to Follow-up|5
4752310|NCT03661996|7726713|FG001|Overall Study|Lost to Follow-up|1
4752311|NCT03661996|7726714|FG002|Overall Study|Lost to Follow-up|2
4752312|NCT03661996|7726715|FG003|Overall Study|Lost to Follow-up|2
4664833|NCT02252406|7556850|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0
4664834|NCT02252406|7556849|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1
4664835|NCT02252406|7556850|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1
4664836|NCT02252406|7556849|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2
4664837|NCT02252406|7556850|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0
4664838|NCT02252536|7556867|FG000|Overall Study|Lost to Follow-up|5
4664839|NCT02252536|7556868|FG001|Overall Study|Lost to Follow-up|3
4664840|NCT02252588|7556886|FG000|Overall Study|Withdrawal by Subject|4
4664841|NCT02252588|7556887|FG001|Overall Study|Withdrawal by Subject|0
4664842|NCT02252939|7556905|FG000|Overall Study|Lost to Follow-up|3
4664843|NCT02252965|7556916|FG000|Overall Study|Adverse Event|9
4664844|NCT02252965|7556917|FG001|Overall Study|Adverse Event|14
4664845|NCT02252965|7556916|FG000|Overall Study|Lost to Follow-up|16
4664846|NCT02252965|7556917|FG001|Overall Study|Lost to Follow-up|8
4664847|NCT02252965|7556916|FG000|Overall Study|Protocol Violation|4
4664848|NCT02252965|7556917|FG001|Overall Study|Protocol Violation|5
4664849|NCT02252965|7556916|FG000|Overall Study|Lack of Efficacy|0
4664850|NCT02252965|7556917|FG001|Overall Study|Lack of Efficacy|2
4664851|NCT02252965|7556916|FG000|Overall Study|Withdrawal by Subject|7
4664852|NCT02252965|7556917|FG001|Overall Study|Withdrawal by Subject|9
4664853|NCT02252965|7556916|FG000|Overall Study|Other|4
4664854|NCT02252965|7556917|FG001|Overall Study|Other|5
4664855|NCT02253147|7556925|FG000|Overall Study|Protocol Violation|30
4664856|NCT02253147|7556925|FG000|Overall Study|Did not consent to study extension|9
4664857|NCT02253147|7556925|FG000|Overall Study|Conditional re-treatment at W52|5
4664858|NCT02253147|7556925|FG000|Overall Study|Lost to Follow-up|2
4664859|NCT02253147|7556925|FG000|Overall Study|Withdrawal by Subject|1
4664860|NCT02253433|7556969|FG000|Overall Study|Unable to Contact|9
4664861|NCT02253433|7556970|FG001|Overall Study|Unable to Contact|16
4664862|NCT02253433|7556969|FG000|Overall Study|Death|1
4664863|NCT02253433|7556970|FG001|Overall Study|Death|1
4664864|NCT02253433|7556969|FG000|Overall Study|No Longer Interested|3
4664865|NCT02253433|7556970|FG001|Overall Study|No Longer Interested|15
4664866|NCT02253433|7556969|FG000|Overall Study|Out of Study Area|2
4664867|NCT02253433|7556970|FG001|Overall Study|Out of Study Area|7
4664868|NCT02253433|7556969|FG000|Overall Study|Uncomfortable with home visitors|0
4664869|NCT02253433|7556970|FG001|Overall Study|Uncomfortable with home visitors|3
4664870|NCT02253433|7556969|FG000|Overall Study|Unstable Housing/Homeless|0
4664871|NCT02253433|7556970|FG001|Overall Study|Unstable Housing/Homeless|7
4664872|NCT02253433|7556969|FG000|Overall Study|Too Busy|0
4664873|NCT02253433|7556970|FG001|Overall Study|Too Busy|4
4664874|NCT02253433|7556969|FG000|Overall Study|Medical or Other Concerns|1
4664875|NCT02253433|7556970|FG001|Overall Study|Medical or Other Concerns|2
4752313|NCT03661996|7726716|FG004|Overall Study|Lost to Follow-up|6
4752314|NCT03661996|7726712|FG000|Overall Study|Physician Decision|1
4752315|NCT03661996|7726713|FG001|Overall Study|Physician Decision|1
4752316|NCT03661996|7726714|FG002|Overall Study|Physician Decision|1
4752317|NCT03661996|7726715|FG003|Overall Study|Physician Decision|2
4752318|NCT03661996|7726716|FG004|Overall Study|Physician Decision|0
4752319|NCT03661996|7726712|FG000|Overall Study|Protocol Violation|0
4752320|NCT03661996|7726713|FG001|Overall Study|Protocol Violation|0
4752321|NCT03661996|7726714|FG002|Overall Study|Protocol Violation|0
4752322|NCT03661996|7726715|FG003|Overall Study|Protocol Violation|0
4752323|NCT03661996|7726716|FG004|Overall Study|Protocol Violation|1
4752324|NCT03661996|7726712|FG000|Overall Study|Withdrawal by Subject|3
4752325|NCT03661996|7726713|FG001|Overall Study|Withdrawal by Subject|5
4752326|NCT03661996|7726714|FG002|Overall Study|Withdrawal by Subject|1
4752327|NCT03661996|7726715|FG003|Overall Study|Withdrawal by Subject|7
4752328|NCT03661996|7726716|FG004|Overall Study|Withdrawal by Subject|7
4752329|NCT03661996|7726712|FG000|Overall Study|Sponsors Decision|2
4752330|NCT03661996|7726713|FG001|Overall Study|Sponsors Decision|0
4752331|NCT03661996|7726714|FG002|Overall Study|Sponsors Decision|0
4752332|NCT03661996|7726715|FG003|Overall Study|Sponsors Decision|0
4752333|NCT03661996|7726716|FG004|Overall Study|Sponsors Decision|0
4752334|NCT03661996|7726712|FG000|Overall Study|Other|1
4752335|NCT03661996|7726713|FG001|Overall Study|Other|1
4752336|NCT03661996|7726714|FG002|Overall Study|Other|1
4752337|NCT03661996|7726715|FG003|Overall Study|Other|1
4752338|NCT03661996|7726716|FG004|Overall Study|Other|0
4752339|NCT03633461|7726733|FG000|Overall Study|Lost to Follow-up|0
4752340|NCT03633461|7726734|FG001|Overall Study|Lost to Follow-up|1
4752341|NCT03517722|7726762|FG000|Double Blind Period: Week 0-52|Adverse Event|9
4752342|NCT03517722|7726763|FG001|Double Blind Period: Week 0-52|Adverse Event|11
4664876|NCT02253654|7556983|FG000|Overall Study|Withdrawal by Subject|12
4664877|NCT02253654|7556984|FG001|Overall Study|Withdrawal by Subject|4
4664878|NCT02253654|7556983|FG000|Overall Study|Decision by Sponsor|1
4752343|NCT03517722|7726762|FG000|Double Blind Period: Week 0-52|Death|0
4752344|NCT03517722|7726763|FG001|Double Blind Period: Week 0-52|Death|4
4752345|NCT03517722|7726762|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2
4752346|NCT03517722|7726763|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3
4664879|NCT02253654|7556984|FG001|Overall Study|Decision by Sponsor|1
4664880|NCT02253654|7556983|FG000|Overall Study|Lost to Follow-up|2
4664881|NCT02253654|7556984|FG001|Overall Study|Lost to Follow-up|5
4752347|NCT03517722|7726762|FG000|Double Blind Period: Week 0-52|Pregnancy|0
4752348|NCT03517722|7726763|FG001|Double Blind Period: Week 0-52|Pregnancy|1
4664882|NCT02253654|7556983|FG000|Overall Study|Death|4
4664883|NCT02253654|7556984|FG001|Overall Study|Death|7
4664884|NCT02253654|7556983|FG000|Overall Study|Did Not Receive Study Treatment|4
4664885|NCT02253654|7556984|FG001|Overall Study|Did Not Receive Study Treatment|1
4664886|NCT02253992|7556993|FG000|Overall Study|Study drug toxicity|1
4664887|NCT02253992|7556994|FG001|Overall Study|Study drug toxicity|0
4664888|NCT02253992|7556995|FG002|Overall Study|Study drug toxicity|10
4664889|NCT02253992|7556993|FG000|Overall Study|Disease progression|4
4664890|NCT02253992|7556994|FG001|Overall Study|Disease progression|3
4664891|NCT02253992|7556995|FG002|Overall Study|Disease progression|98
4664892|NCT02253992|7556993|FG000|Overall Study|Withdrawal by Subject|0
4664893|NCT02253992|7556994|FG001|Overall Study|Withdrawal by Subject|0
4664894|NCT02253992|7556995|FG002|Overall Study|Withdrawal by Subject|3
4664895|NCT02253992|7556993|FG000|Overall Study|Adverse Event|0
4664896|NCT02253992|7556994|FG001|Overall Study|Adverse Event|0
4664897|NCT02253992|7556995|FG002|Overall Study|Adverse Event|8
4664898|NCT02253992|7556993|FG000|Overall Study|Death|0
4664899|NCT02253992|7556994|FG001|Overall Study|Death|0
4664900|NCT02253992|7556995|FG002|Overall Study|Death|1
4664901|NCT02253992|7556993|FG000|Overall Study|Subject discontinued study drug|1
4664902|NCT02253992|7556994|FG001|Overall Study|Subject discontinued study drug|0
4664903|NCT02253992|7556995|FG002|Overall Study|Subject discontinued study drug|1
4664904|NCT02253992|7556993|FG000|Overall Study|Completed treatment as per protocol|0
4664905|NCT02253992|7556994|FG001|Overall Study|Completed treatment as per protocol|1
4664906|NCT02253992|7556995|FG002|Overall Study|Completed treatment as per protocol|22
4664907|NCT02253992|7556993|FG000|Overall Study|Other|0
4664908|NCT02253992|7556994|FG001|Overall Study|Other|0
4664909|NCT02253992|7556995|FG002|Overall Study|Other|1
4664910|NCT02254291|7557042|FG000|Overall Study|Withdrawal by Subject|0
4664911|NCT02254291|7557043|FG001|Overall Study|Withdrawal by Subject|3
4664912|NCT02254291|7557044|FG002|Overall Study|Withdrawal by Subject|1
4664913|NCT02254291|7557042|FG000|Overall Study|Missing follow-up information|0
4664914|NCT02254291|7557043|FG001|Overall Study|Missing follow-up information|0
4664915|NCT02254291|7557044|FG002|Overall Study|Missing follow-up information|1
4664916|NCT02254304|7557054|FG000|Overall Study|Adverse Event|2
4664917|NCT02254304|7557055|FG001|Overall Study|Adverse Event|1
4664918|NCT02254304|7557054|FG000|Overall Study|Lost to Follow-up|2
4664919|NCT02254304|7557055|FG001|Overall Study|Lost to Follow-up|2
4664920|NCT02254304|7557054|FG000|Overall Study|Protocol Violation|1
4664921|NCT02254304|7557055|FG001|Overall Study|Protocol Violation|0
4664922|NCT02254304|7557054|FG000|Overall Study|Withdrawal by Subject|3
4664923|NCT02254304|7557055|FG001|Overall Study|Withdrawal by Subject|0
4664924|NCT02254304|7557054|FG000|Overall Study|Injection site pain and Injection fear|1
4664925|NCT02254304|7557055|FG001|Overall Study|Injection site pain and Injection fear|0
4664926|NCT02254304|7557054|FG000|Overall Study|Personal causes|4
4664927|NCT02254304|7557055|FG001|Overall Study|Personal causes|1
4664928|NCT02254304|7557054|FG000|Overall Study|Personal decision|1
4664929|NCT02254304|7557055|FG001|Overall Study|Personal decision|0
4664930|NCT02254408|7557065|FG000|Overall Study|Randomized But Not Treated|1
4664931|NCT02254408|7557066|FG001|Overall Study|Randomized But Not Treated|3
4664932|NCT02254408|7557065|FG000|Overall Study|Adverse Event|1
4664933|NCT02254408|7557066|FG001|Overall Study|Adverse Event|0
4664934|NCT02254408|7557065|FG000|Overall Study|Death|2
4664935|NCT02254408|7557066|FG001|Overall Study|Death|3
4664936|NCT02254408|7557065|FG000|Overall Study|Investigator's Discretion|0
4664937|NCT02254408|7557066|FG001|Overall Study|Investigator's Discretion|1
4664938|NCT02254408|7557065|FG000|Overall Study|Withdrawal by Subject|3
4664939|NCT02254408|7557066|FG001|Overall Study|Withdrawal by Subject|3
4664940|NCT02254408|7557065|FG000|Overall Study|Lost to Follow-up|1
4664941|NCT02254408|7557066|FG001|Overall Study|Lost to Follow-up|0
4664942|NCT02254421|7557074|FG000|Overall Study|Randomized but Not Treated|1
4664943|NCT02254421|7557075|FG001|Overall Study|Randomized but Not Treated|0
4664944|NCT02254421|7557074|FG000|Overall Study|Death|0
4664945|NCT02254421|7557075|FG001|Overall Study|Death|2
4664946|NCT02254421|7557074|FG000|Overall Study|Withdrew Consent|1
4664947|NCT02254421|7557075|FG001|Overall Study|Withdrew Consent|1
4664948|NCT02254460|7557081|FG000|Overall Study|Adverse Event|1
4664949|NCT02254460|7557082|FG001|Overall Study|Adverse Event|0
4664950|NCT02254486|7557099|FG000|Overall Study|Adverse Event|1
4664951|NCT02254486|7557100|FG001|Overall Study|Adverse Event|1
4664952|NCT02254486|7557099|FG000|Overall Study|Lack of Efficacy|1
4664953|NCT02254486|7557100|FG001|Overall Study|Lack of Efficacy|0
4664954|NCT02254486|7557099|FG000|Overall Study|Lost to Follow-up|2
4664955|NCT02254486|7557100|FG001|Overall Study|Lost to Follow-up|4
4664956|NCT02254486|7557099|FG000|Overall Study|Protocol Violation|1
4664957|NCT02254486|7557100|FG001|Overall Study|Protocol Violation|2
4664958|NCT02254486|7557099|FG000|Overall Study|Withdrawal by Subject|17
4664959|NCT02254486|7557100|FG001|Overall Study|Withdrawal by Subject|15
4664960|NCT02254486|7557099|FG000|Overall Study|GFR<60mL/min|16
4664961|NCT02254486|7557100|FG001|Overall Study|GFR<60mL/min|21
4664962|NCT02254486|7557099|FG000|Overall Study|Various|12
4664963|NCT02254486|7557100|FG001|Overall Study|Various|12
4664964|NCT02254551|7557106|FG000|Dose Escalation|Physician Decision|1
4664965|NCT02254551|7557106|FG000|Dose Escalation|Dose-limiting toxicity|2
4664966|NCT02254681|7557113|FG000|Overall Study|Lack of Efficacy|6
4664967|NCT02254772|7557118|FG000|Overall Study|Ineligible|1
4664968|NCT02254772|7557118|FG000|Overall Study|Withdrawal by Subject|1
4664969|NCT02255097|7557131|FG000|Overall Study|Adverse Event|24
4664970|NCT02255097|7557131|FG000|Overall Study|Clinical Progression|23
4664971|NCT02255097|7557131|FG000|Overall Study|Complete Response|1
4664972|NCT02255097|7557131|FG000|Overall Study|Excluded Medication|1
4664973|NCT02255097|7557131|FG000|Overall Study|Death|2
4664974|NCT02255097|7557131|FG000|Overall Study|Lost to Follow-up|1
4664975|NCT02255097|7557131|FG000|Overall Study|Physician Decision|1
4664976|NCT02255097|7557131|FG000|Overall Study|Progressive Disease|80
4664977|NCT02255097|7557131|FG000|Overall Study|Withdrawal by Subject|2
4664978|NCT02255097|7557131|FG000|Overall Study|Allocated but not treated|1
4664979|NCT02255097|7557131|FG000|Overall Study|Treatment Ongoing|36
4664980|NCT02255149|7557139|FG000|Overall Study|Lost to Follow-up|2
4664981|NCT02255149|7557139|FG000|Overall Study|Withdrawal by Subject|1
4664982|NCT02255149|7557139|FG000|Overall Study|Withdrawal by PI|1
4664983|NCT02255149|7557139|FG000|Overall Study|Implant Failure|1
4664984|NCT02255279|7557158|FG000|Overall Study|Lost to Follow-up|2
4664985|NCT02255279|7557159|FG001|Overall Study|Lost to Follow-up|2
4664986|NCT02255279|7557158|FG000|Overall Study|Protocol Violation|0
4664987|NCT02255279|7557159|FG001|Overall Study|Protocol Violation|1
4664988|NCT02255279|7557158|FG000|Overall Study|Withdrawal by Subject|3
4664989|NCT02255279|7557159|FG001|Overall Study|Withdrawal by Subject|6
4664990|NCT02255422|7557195|FG000|Overall Study|Withdrawal by Subject|0
4664991|NCT02255422|7557196|FG001|Overall Study|Withdrawal by Subject|0
4664992|NCT02255422|7557197|FG002|Overall Study|Withdrawal by Subject|0
4664993|NCT02255422|7557198|FG003|Overall Study|Withdrawal by Subject|0
4664994|NCT02255422|7557199|FG004|Overall Study|Withdrawal by Subject|0
4664995|NCT02255422|7557200|FG005|Overall Study|Withdrawal by Subject|0
4664996|NCT02255422|7557201|FG006|Overall Study|Withdrawal by Subject|2
4664997|NCT02255422|7557195|FG000|Overall Study|Lost to Follow-up|0
4664998|NCT02255422|7557196|FG001|Overall Study|Lost to Follow-up|0
4664999|NCT02255422|7557197|FG002|Overall Study|Lost to Follow-up|1
4665000|NCT02255422|7557198|FG003|Overall Study|Lost to Follow-up|0
4665001|NCT02255422|7557199|FG004|Overall Study|Lost to Follow-up|0
4665002|NCT02255422|7557200|FG005|Overall Study|Lost to Follow-up|0
4665003|NCT02255422|7557201|FG006|Overall Study|Lost to Follow-up|0
4665004|NCT02255461|7557222|FG000|Overall Study|Adverse Event|0
4665005|NCT02255461|7557223|FG001|Overall Study|Adverse Event|1
4665006|NCT02255461|7557224|FG002|Overall Study|Adverse Event|0
4665007|NCT02255461|7557225|FG003|Overall Study|Adverse Event|0
4665008|NCT02255461|7557226|FG004|Overall Study|Adverse Event|1
4665009|NCT02255461|7557222|FG000|Overall Study|Withdrawal by Subject|0
4665010|NCT02255461|7557223|FG001|Overall Study|Withdrawal by Subject|0
4665011|NCT02255461|7557224|FG002|Overall Study|Withdrawal by Subject|1
4665012|NCT02255461|7557225|FG003|Overall Study|Withdrawal by Subject|0
4665013|NCT02255461|7557226|FG004|Overall Study|Withdrawal by Subject|1
4665014|NCT02255461|7557222|FG000|Overall Study|Not meet dose reduction BSA requirement|0
4665015|NCT02255461|7557223|FG001|Overall Study|Not meet dose reduction BSA requirement|1
4665016|NCT02255461|7557224|FG002|Overall Study|Not meet dose reduction BSA requirement|0
4665017|NCT02255461|7557225|FG003|Overall Study|Not meet dose reduction BSA requirement|0
4665018|NCT02255461|7557226|FG004|Overall Study|Not meet dose reduction BSA requirement|0
4665019|NCT02255474|7557246|FG000|Overall Study|Lost to Follow-up|1
4665020|NCT02255474|7557247|FG001|Overall Study|Lost to Follow-up|1
4665021|NCT02255474|7557248|FG002|Overall Study|Lost to Follow-up|3
4665022|NCT02255474|7557246|FG000|Overall Study|Withdrawal by Subject|1
4665023|NCT02255474|7557247|FG001|Overall Study|Withdrawal by Subject|1
4665024|NCT02255474|7557248|FG002|Overall Study|Withdrawal by Subject|0
4665025|NCT02255500|7557259|FG000|Overall Study|Withdrawal by Subject|1
4665026|NCT02255500|7557260|FG001|Overall Study|Withdrawal by Subject|0
4665027|NCT02255552|7557277|FG000|Overall Study|Participants enrolled into another study|0
4665028|NCT02255552|7557278|FG001|Overall Study|Participants enrolled into another study|11
4665029|NCT02255552|7557277|FG000|Overall Study|Withdrawal by Subject|1
4665030|NCT02255552|7557278|FG001|Overall Study|Withdrawal by Subject|4
4665031|NCT02255565|7557287|FG000|Overall Study|Withdrawal by Subject|0
4665032|NCT02255565|7557288|FG001|Overall Study|Withdrawal by Subject|1
4665033|NCT02255565|7557289|FG002|Overall Study|Withdrawal by Subject|0
4665034|NCT02255760|7557348|FG000|Overall Study|Lost to Follow-up|0
4665035|NCT02255760|7557349|FG001|Overall Study|Lost to Follow-up|1
4665036|NCT02255760|7557350|FG002|Overall Study|Lost to Follow-up|0
4665037|NCT02255760|7557351|FG003|Overall Study|Lost to Follow-up|0
4665038|NCT02255760|7557352|FG004|Overall Study|Lost to Follow-up|0
4665039|NCT02255981|7557368|FG000|Overall Study|Lost to Follow-up|3
4665040|NCT02255981|7557368|FG000|Overall Study|Withdrawal by Subject|1
4665041|NCT02256267|7557409|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1
4665042|NCT02256267|7557409|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1
4665043|NCT02256384|7557434|FG000|Overall Study|Withdrawal by Subject|12
4665044|NCT02256384|7557434|FG000|Overall Study|Equipment not capturing data|2
4665045|NCT02256436|7557444|FG000|Overall Study|Adverse Event|9
4665046|NCT02256436|7557445|FG001|Overall Study|Adverse Event|14
4665047|NCT02256436|7557444|FG000|Overall Study|Death|216
4665048|NCT02256436|7557445|FG001|Overall Study|Death|208
4665049|NCT02256436|7557444|FG000|Overall Study|Lost to Follow-up|1
4665050|NCT02256436|7557445|FG001|Overall Study|Lost to Follow-up|2
4665051|NCT02256436|7557444|FG000|Overall Study|Physician Decision|1
4665052|NCT02256436|7557445|FG001|Overall Study|Physician Decision|0
4665053|NCT02256436|7557444|FG000|Overall Study|Protocol Violation|0
4665054|NCT02256436|7557445|FG001|Overall Study|Protocol Violation|1
4665055|NCT02256436|7557444|FG000|Overall Study|Withdrawal by Subject|26
4665056|NCT02256436|7557445|FG001|Overall Study|Withdrawal by Subject|10
4665057|NCT02256436|7557444|FG000|Overall Study|Transferred to Extension Study|11
4665058|NCT02256436|7557445|FG001|Overall Study|Transferred to Extension Study|23
4665059|NCT02256436|7557444|FG000|Overall Study|Did Not Continue on Extension Study|8
4665060|NCT02256436|7557445|FG001|Overall Study|Did Not Continue on Extension Study|12
4665061|NCT02256488|7557456|FG000|Overall Study|Lost to Follow-up|6
4665062|NCT02256488|7557457|FG001|Overall Study|Lost to Follow-up|6
4665063|NCT02256488|7557458|FG002|Overall Study|Lost to Follow-up|9
4665064|NCT02256488|7557459|FG003|Overall Study|Lost to Follow-up|3
4665065|NCT02256488|7557456|FG000|Overall Study|OTHER|1
4665066|NCT02256488|7557457|FG001|Overall Study|OTHER|0
4665067|NCT02256488|7557458|FG002|Overall Study|OTHER|1
4665068|NCT02256488|7557459|FG003|Overall Study|OTHER|1
4665069|NCT02256488|7557456|FG000|Overall Study|Withdrawal by Subject|1
4665070|NCT02256488|7557457|FG001|Overall Study|Withdrawal by Subject|0
4665071|NCT02256488|7557458|FG002|Overall Study|Withdrawal by Subject|0
4752349|NCT03517722|7726762|FG000|Double Blind Period: Week 0-52|Protocol Violation|1
4665072|NCT02256488|7557459|FG003|Overall Study|Withdrawal by Subject|2
4665073|NCT02256540|7557470|FG000|Overall Study|Withdrawal by Subject|0
4665074|NCT02256540|7557471|FG001|Overall Study|Withdrawal by Subject|1
4665075|NCT02256540|7557472|FG002|Overall Study|Withdrawal by Subject|1
4752350|NCT03517722|7726763|FG001|Double Blind Period: Week 0-52|Protocol Violation|0
4752351|NCT03517722|7726762|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11
4752352|NCT03517722|7726763|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11
4752353|NCT03517722|7726762|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76
4752354|NCT03517722|7726763|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120
4752355|NCT03517722|7726762|FG000|Double Blind Period: Week 0-52|Other|4
4752356|NCT03517722|7726763|FG001|Double Blind Period: Week 0-52|Other|3
4752357|NCT03517722|7726762|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0
4752358|NCT03517722|7726763|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2
4752359|NCT03517722|7726762|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0
4752360|NCT03517722|7726763|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1
4752361|NCT03517722|7726762|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0
4752362|NCT03517722|7726763|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1
4752363|NCT03517722|7726762|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1
4752364|NCT03517722|7726763|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1
4752365|NCT03517722|7726762|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87
4752366|NCT03517722|7726763|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134
4665076|NCT02256540|7557470|FG000|Overall Study|Back pain preventing exercise|0
4665077|NCT02256540|7557471|FG001|Overall Study|Back pain preventing exercise|0
4665078|NCT02256540|7557472|FG002|Overall Study|Back pain preventing exercise|1
4665079|NCT02256553|7557480|FG000|Period I|Adverse Event|5
4665080|NCT02256553|7557480|FG000|Period I|Protocol Violation|1
4665081|NCT02256553|7557480|FG000|Period II|Adverse Event|1
4665082|NCT02256553|7557480|FG000|Period II|Subject Moved|1
4665083|NCT02256553|7557480|FG000|Period III|Adverse Event|3
4665084|NCT02256839|7557488|FG000|Overall Study|Did not meet Eligibility Criteria|2
4665085|NCT02256839|7557489|FG001|Overall Study|Did not meet Eligibility Criteria|3
4665086|NCT02256891|7557497|FG000|Overall Study|Death|0
4665087|NCT02256891|7557498|FG001|Overall Study|Death|2
4665088|NCT02256891|7557497|FG000|Overall Study|Lost to Follow-up|0
4665089|NCT02256891|7557498|FG001|Overall Study|Lost to Follow-up|3
4665090|NCT02256891|7557497|FG000|Overall Study|Physician Decision|7
4665091|NCT02256891|7557498|FG001|Overall Study|Physician Decision|3
4665092|NCT02256891|7557497|FG000|Overall Study|Screen Fail|5
4665093|NCT02256891|7557498|FG001|Overall Study|Screen Fail|4
4665094|NCT02256891|7557497|FG000|Overall Study|Equipment Malfunction|0
4665095|NCT02256891|7557498|FG001|Overall Study|Equipment Malfunction|1
4665096|NCT02256917|7557506|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1
4665097|NCT02256917|7557506|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1
4665098|NCT02256917|7557506|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1
4665099|NCT02256917|7557506|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1
4665100|NCT02256917|7557506|FG000|Prophylactic Treatment Phase II|Discontinued medication|1
4665101|NCT02256969|7557520|FG000|Overall Study|Screenfailed or withdrew|2
4665102|NCT02256969|7557521|FG001|Overall Study|Screenfailed or withdrew|1
4665103|NCT02256969|7557522|FG002|Overall Study|Screenfailed or withdrew|1
4752367|NCT03499314|7726772|FG000|Overall Study|Time Commitment|1
4752368|NCT03499314|7726773|FG001|Overall Study|Time Commitment|2
4752369|NCT03499314|7726772|FG000|Overall Study|Medical issue unrelated to research study|1
4752370|NCT03499314|7726773|FG001|Overall Study|Medical issue unrelated to research study|1
4752371|NCT03439124|7726781|FG000|Overall Study|Adverse Event|2
4752372|NCT03439124|7726782|FG001|Overall Study|Adverse Event|0
4752373|NCT03439124|7726781|FG000|Overall Study|Lost to Follow-up|1
4752374|NCT03439124|7726782|FG001|Overall Study|Lost to Follow-up|0
4752375|NCT03439124|7726781|FG000|Overall Study|Other reasons|1
4752376|NCT03439124|7726782|FG001|Overall Study|Other reasons|0
4752377|NCT03369431|7726790|FG000|Overall Study|Lost to Follow-up|1
4752378|NCT03369431|7726791|FG001|Overall Study|Lost to Follow-up|3
4752379|NCT03369431|7726790|FG000|Overall Study|Withdrawal by Subject|2
4752380|NCT03369431|7726791|FG001|Overall Study|Withdrawal by Subject|3
4752381|NCT03369431|7726790|FG000|Overall Study|Protocol Violation|1
4752382|NCT03369431|7726791|FG001|Overall Study|Protocol Violation|1
4752383|NCT03343054|7726800|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2
4752384|NCT03343054|7726801|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6
4752385|NCT03343054|7726802|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0
4752386|NCT03343054|7726800|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1
4752387|NCT03343054|7726801|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0
4752388|NCT03343054|7726802|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0
4752389|NCT03343054|7726800|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0
4752390|NCT03343054|7726801|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0
4752391|NCT03343054|7726802|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11
4752392|NCT03343054|7726800|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0
4752393|NCT03343054|7726801|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0
4752394|NCT03343054|7726802|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8
4752395|NCT03336866|7726814|FG000|Overall Study|Lost to Follow-up|2
4752396|NCT03336866|7726815|FG001|Overall Study|Lost to Follow-up|0
4752397|NCT03336866|7726816|FG002|Overall Study|Lost to Follow-up|3
4752398|NCT03336866|7726814|FG000|Overall Study|Withdrawal by Subject|1
4752399|NCT03336866|7726815|FG001|Overall Study|Withdrawal by Subject|1
4752400|NCT03336866|7726816|FG002|Overall Study|Withdrawal by Subject|0
4752401|NCT03336866|7726814|FG000|Overall Study|Noncompliance with clinic house rules|0
4752402|NCT03336866|7726815|FG001|Overall Study|Noncompliance with clinic house rules|0
4752403|NCT03336866|7726816|FG002|Overall Study|Noncompliance with clinic house rules|1
4752404|NCT03332173|7726829|FG000|Overall Study|Death|7
4752405|NCT03332173|7726829|FG000|Overall Study|Withdrawal by Subject|6
4752406|NCT03332173|7726829|FG000|Overall Study|Lost to Follow-up|2
4752407|NCT03332173|7726829|FG000|Overall Study|Transferred to long-term extension study|29
4752408|NCT03322293|7726836|FG000|Overall Study|Lost to Follow-up|0
4752409|NCT03322293|7726837|FG001|Overall Study|Lost to Follow-up|0
4752410|NCT03322293|7726838|FG002|Overall Study|Lost to Follow-up|1
4665104|NCT02256982|7557532|FG000|Overall Study|Disease Progression|0
4665105|NCT02256982|7557533|FG001|Overall Study|Disease Progression|1
4665106|NCT02257372|7557592|FG000|Overall Study|Adverse Event|3
4665107|NCT02257372|7557593|FG001|Overall Study|Adverse Event|7
4665108|NCT02257372|7557592|FG000|Overall Study|Lack of Efficacy|2
4665109|NCT02257372|7557593|FG001|Overall Study|Lack of Efficacy|1
4665110|NCT02257372|7557592|FG000|Overall Study|Protocol Violation|1
4665111|NCT02257372|7557593|FG001|Overall Study|Protocol Violation|1
4665112|NCT02257372|7557592|FG000|Overall Study|Lost to Follow-up|0
4665113|NCT02257372|7557593|FG001|Overall Study|Lost to Follow-up|1
4665114|NCT02257372|7557592|FG000|Overall Study|Withdrew consent|1
4665115|NCT02257372|7557593|FG001|Overall Study|Withdrew consent|0
4665116|NCT02257385|7557601|FG000|Overall Study|Adverse Event|12
4665117|NCT02257385|7557602|FG001|Overall Study|Adverse Event|8
4665118|NCT02257385|7557601|FG000|Overall Study|Lack of Efficacy|1
4665119|NCT02257385|7557602|FG001|Overall Study|Lack of Efficacy|2
4665120|NCT02257385|7557601|FG000|Overall Study|Protocol Violation|5
4665121|NCT02257385|7557602|FG001|Overall Study|Protocol Violation|7
4665122|NCT02257385|7557601|FG000|Overall Study|Lost to Follow-up|0
4665123|NCT02257385|7557602|FG001|Overall Study|Lost to Follow-up|1
4665124|NCT02257385|7557601|FG000|Overall Study|Withdrawal by Subject|4
4665125|NCT02257385|7557602|FG001|Overall Study|Withdrawal by Subject|4
4665126|NCT02257489|7557617|FG000|Overall Study|Withdrawal by Subject|0
4665127|NCT02257489|7557618|FG001|Overall Study|Withdrawal by Subject|0
4665128|NCT02257489|7557619|FG002|Overall Study|Withdrawal by Subject|0
4665129|NCT02257489|7557620|FG003|Overall Study|Withdrawal by Subject|1
4665130|NCT02257489|7557621|FG004|Overall Study|Withdrawal by Subject|0
4665131|NCT02257489|7557622|FG005|Overall Study|Withdrawal by Subject|0
4665132|NCT02257489|7557623|FG006|Overall Study|Withdrawal by Subject|0
4665133|NCT02257489|7557624|FG007|Overall Study|Withdrawal by Subject|0
4752411|NCT03254394|7726860|FG000|Overall Study|Withdrawal by Subject|0
4752412|NCT03254394|7726861|FG001|Overall Study|Withdrawal by Subject|2
4752413|NCT03253809|7726867|FG000|Overall Study|Unable to obtain study related data|14
4752414|NCT03151408|7726887|FG000|Overall Study|Adverse Event|24
4752415|NCT03151408|7726888|FG001|Overall Study|Adverse Event|23
4752416|NCT03151408|7726887|FG000|Overall Study|Death|46
4752417|NCT03151408|7726888|FG001|Overall Study|Death|26
4752418|NCT03151408|7726887|FG000|Overall Study|Physician Decision|13
4752419|NCT03151408|7726888|FG001|Overall Study|Physician Decision|19
4752420|NCT03151408|7726887|FG000|Overall Study|Withdrawal by Subject|16
4752421|NCT03151408|7726888|FG001|Overall Study|Withdrawal by Subject|20
4752422|NCT03151408|7726887|FG000|Overall Study|Progressive disease|45
4752423|NCT03151408|7726888|FG001|Overall Study|Progressive disease|61
4752424|NCT03151408|7726887|FG000|Overall Study|non-compliance by patient|1
4752425|NCT03151408|7726888|FG001|Overall Study|non-compliance by patient|0
4752426|NCT03151408|7726887|FG000|Overall Study|other reasons|56
4752427|NCT03151408|7726888|FG001|Overall Study|other reasons|52
4752428|NCT03151408|7726887|FG000|Overall Study|randomized and not treated|2
4752429|NCT03151408|7726888|FG001|Overall Study|randomized and not treated|2
4752430|NCT03137173|7726896|FG000|Overall Study|Withdrawal by Subject|8
4752431|NCT03137173|7726897|FG001|Overall Study|Withdrawal by Subject|13
4752432|NCT03137173|7726896|FG000|Overall Study|Death|1
4752433|NCT03137173|7726897|FG001|Overall Study|Death|3
4752434|NCT03137173|7726896|FG000|Overall Study|Physician Decision|1
4752435|NCT03137173|7726897|FG001|Overall Study|Physician Decision|0
4752436|NCT03137173|7726896|FG000|Overall Study|Lost to Follow-up|13
4752437|NCT03137173|7726897|FG001|Overall Study|Lost to Follow-up|18
4752438|NCT03137173|7726896|FG000|Overall Study|Other reasons|3
4752439|NCT03137173|7726897|FG001|Overall Study|Other reasons|2
4752440|NCT03100149|7726916|FG000|Overall Study|Adverse Event|0
4752441|NCT03100149|7726917|FG001|Overall Study|Adverse Event|1
4752442|NCT03100149|7726918|FG002|Overall Study|Adverse Event|0
4752443|NCT03100149|7726916|FG000|Overall Study|Participant Moved out of Country|0
4752444|NCT03100149|7726917|FG001|Overall Study|Participant Moved out of Country|0
4752445|NCT03100149|7726918|FG002|Overall Study|Participant Moved out of Country|1
4752446|NCT03100149|7726916|FG000|Overall Study|Withdrawal by Subject|0
4752447|NCT03100149|7726917|FG001|Overall Study|Withdrawal by Subject|3
4752448|NCT03100149|7726918|FG002|Overall Study|Withdrawal by Subject|1
4752449|NCT03028740|7726949|FG000|Overall Study|Did not Receive Study Drug|4
4752450|NCT03028740|7726950|FG001|Overall Study|Did not Receive Study Drug|5
4752451|NCT03028740|7726949|FG000|Overall Study|Adverse Event|8
4752452|NCT03028740|7726950|FG001|Overall Study|Adverse Event|26
4752453|NCT03028740|7726949|FG000|Overall Study|Lack of Efficacy|0
4752454|NCT03028740|7726950|FG001|Overall Study|Lack of Efficacy|1
4752455|NCT03028740|7726949|FG000|Overall Study|Withdrawal by Subject|48
4665134|NCT02257489|7557625|FG008|Overall Study|Withdrawal by Subject|0
4752456|NCT03028740|7726950|FG001|Overall Study|Withdrawal by Subject|101
4752457|NCT03028740|7726949|FG000|Overall Study|Lost to Follow-up|30
4752458|NCT03028740|7726950|FG001|Overall Study|Lost to Follow-up|54
4752459|NCT03028740|7726949|FG000|Overall Study|Physician Decision|4
4752460|NCT03028740|7726950|FG001|Overall Study|Physician Decision|11
4752461|NCT03028740|7726949|FG000|Overall Study|Protocol Violation|4
4752462|NCT03028740|7726950|FG001|Overall Study|Protocol Violation|8
4752463|NCT03028740|7726949|FG000|Overall Study|Non-compliance with Study Drug|0
4752464|NCT03028740|7726950|FG001|Overall Study|Non-compliance with Study Drug|2
4665135|NCT02257632|7557667|FG000|Overall Study|Withdrawal by Subject|0
4665136|NCT02257632|7557668|FG001|Overall Study|Withdrawal by Subject|1
4665137|NCT02257632|7557667|FG000|Overall Study|Adverse Event|1
4665138|NCT02257632|7557668|FG001|Overall Study|Adverse Event|2
4665139|NCT02257684|7557676|FG000|Overall Study|Adverse Event|2
4665140|NCT02257684|7557676|FG000|Overall Study|Lack of Efficacy|1
4665141|NCT02257684|7557676|FG000|Overall Study|Sponsor's Decision|1
4665142|NCT02258074|7557719|FG000|Overall Study|Withdrawal by Subject|1
4665143|NCT02258074|7557720|FG001|Overall Study|Withdrawal by Subject|0
4665144|NCT02258074|7557721|FG002|Overall Study|Withdrawal by Subject|0
4665145|NCT02258074|7557722|FG003|Overall Study|Withdrawal by Subject|0
4665146|NCT02258334|7557759|FG000|Overall Study|Adverse Event|1
4665147|NCT02258334|7557760|FG001|Overall Study|Adverse Event|0
4665148|NCT02258334|7557761|FG002|Overall Study|Adverse Event|0
4665149|NCT02258334|7557762|FG003|Overall Study|Adverse Event|0
4665150|NCT02258464|7557797|FG000|Overall Study|Progressive disease (PD)|9
4665151|NCT02258464|7557798|FG001|Overall Study|Progressive disease (PD)|17
4665152|NCT02258464|7557797|FG000|Overall Study|Study drug never administered|1
4665153|NCT02258464|7557798|FG001|Overall Study|Study drug never administered|1
4665154|NCT02258464|7557797|FG000|Overall Study|AE not related to clinical PD|1
4665155|NCT02258464|7557798|FG001|Overall Study|AE not related to clinical PD|3
4665156|NCT02258464|7557797|FG000|Overall Study|Withdrawal by Subject|5
4665157|NCT02258464|7557798|FG001|Overall Study|Withdrawal by Subject|4
4665158|NCT02258464|7557797|FG000|Overall Study|AE related to clinical PD|1
4665159|NCT02258464|7557798|FG001|Overall Study|AE related to clinical PD|0
4665160|NCT02258529|7557816|FG000|Overall Study|Study Terminated by Sponsor|9
4665161|NCT02258529|7557816|FG000|Overall Study|Adverse Event|1
4665162|NCT02259010|7557820|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5
4665163|NCT02259088|7557828|FG000|Overall Study|Adverse Event|6
4665164|NCT02259088|7557829|FG001|Overall Study|Adverse Event|4
4665165|NCT02259088|7557828|FG000|Overall Study|Lost to Follow-up|2
4665166|NCT02259088|7557829|FG001|Overall Study|Lost to Follow-up|0
4665167|NCT02259088|7557828|FG000|Overall Study|Death|2
4665168|NCT02259088|7557829|FG001|Overall Study|Death|0
4665169|NCT02259088|7557828|FG000|Overall Study|Physician Decision|5
4665170|NCT02259088|7557829|FG001|Overall Study|Physician Decision|2
4665171|NCT02259088|7557828|FG000|Overall Study|Protocol deviation|5
4665172|NCT02259088|7557829|FG001|Overall Study|Protocol deviation|0
4665173|NCT02259088|7557828|FG000|Overall Study|Subject/guardian decision|8
4665174|NCT02259088|7557829|FG001|Overall Study|Subject/guardian decision|8
4665175|NCT02259114|7557840|FG000|Overall Study|Progressive Disease|14
4665176|NCT02259114|7557841|FG001|Overall Study|Progressive Disease|2
4665177|NCT02259114|7557842|FG002|Overall Study|Progressive Disease|10
4665178|NCT02259114|7557843|FG003|Overall Study|Progressive Disease|2
4665179|NCT02259114|7557844|FG004|Overall Study|Progressive Disease|5
4665180|NCT02259114|7557840|FG000|Overall Study|Adverse Event|2
4665181|NCT02259114|7557841|FG001|Overall Study|Adverse Event|1
4665182|NCT02259114|7557842|FG002|Overall Study|Adverse Event|0
4665183|NCT02259114|7557843|FG003|Overall Study|Adverse Event|0
4665184|NCT02259114|7557844|FG004|Overall Study|Adverse Event|1
4665185|NCT02259114|7557840|FG000|Overall Study|Death|3
4665186|NCT02259114|7557841|FG001|Overall Study|Death|0
4665187|NCT02259114|7557842|FG002|Overall Study|Death|1
4665188|NCT02259114|7557843|FG003|Overall Study|Death|0
4665189|NCT02259114|7557844|FG004|Overall Study|Death|0
4665190|NCT02259114|7557840|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0
4665191|NCT02259114|7557841|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0
4665192|NCT02259114|7557842|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1
4665193|NCT02259114|7557843|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0
4665194|NCT02259114|7557844|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0
4665195|NCT02259114|7557840|FG000|Overall Study|Withdrawal by Subject|0
4665196|NCT02259114|7557841|FG001|Overall Study|Withdrawal by Subject|0
4665197|NCT02259114|7557842|FG002|Overall Study|Withdrawal by Subject|1
4665198|NCT02259114|7557843|FG003|Overall Study|Withdrawal by Subject|1
4665199|NCT02259114|7557844|FG004|Overall Study|Withdrawal by Subject|0
4665200|NCT02259114|7557840|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1
4665201|NCT02259114|7557841|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1
4665202|NCT02259114|7557842|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0
4665203|NCT02259114|7557843|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0
4665204|NCT02259114|7557844|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0
4665205|NCT02259114|7557840|FG000|Overall Study|Not Treated|1
4665206|NCT02259114|7557841|FG001|Overall Study|Not Treated|0
4665207|NCT02259114|7557842|FG002|Overall Study|Not Treated|0
4665208|NCT02259114|7557843|FG003|Overall Study|Not Treated|0
4665209|NCT02259114|7557844|FG004|Overall Study|Not Treated|0
4665210|NCT02259231|7557863|FG000|Overall Study|Adverse Event|1
4665211|NCT02259231|7557864|FG001|Overall Study|Adverse Event|1
4665212|NCT02259231|7557865|FG002|Overall Study|Adverse Event|2
4665213|NCT02259231|7557866|FG003|Overall Study|Adverse Event|0
4665214|NCT02259231|7557867|FG004|Overall Study|Adverse Event|0
4665215|NCT02259231|7557868|FG005|Overall Study|Adverse Event|0
4665216|NCT02259231|7557869|FG006|Overall Study|Adverse Event|0
4665217|NCT02259231|7557863|FG000|Overall Study|Progressive Disease|4
4665218|NCT02259231|7557864|FG001|Overall Study|Progressive Disease|5
4665219|NCT02259231|7557865|FG002|Overall Study|Progressive Disease|4
4665220|NCT02259231|7557866|FG003|Overall Study|Progressive Disease|5
4665221|NCT02259231|7557867|FG004|Overall Study|Progressive Disease|4
4665222|NCT02259231|7557868|FG005|Overall Study|Progressive Disease|5
4665223|NCT02259231|7557869|FG006|Overall Study|Progressive Disease|4
4665224|NCT02259231|7557863|FG000|Overall Study|Sponsor termination of study|1
4665225|NCT02259231|7557864|FG001|Overall Study|Sponsor termination of study|0
4665226|NCT02259231|7557865|FG002|Overall Study|Sponsor termination of study|0
4665227|NCT02259231|7557866|FG003|Overall Study|Sponsor termination of study|1
4665228|NCT02259231|7557867|FG004|Overall Study|Sponsor termination of study|2
4665229|NCT02259231|7557868|FG005|Overall Study|Sponsor termination of study|1
4665230|NCT02259231|7557869|FG006|Overall Study|Sponsor termination of study|1
4665231|NCT02259348|7557885|FG000|Overall Study|Donors|6
4665232|NCT02259348|7557885|FG000|Overall Study|Death|4
4665233|NCT02259400|7557891|FG000|Overall Study|Death|0
4665234|NCT02259400|7557892|FG001|Overall Study|Death|2
4665235|NCT02259582|7557901|FG000|Overall Study|Physician Decision|0
4665236|NCT02259582|7557902|FG001|Overall Study|Physician Decision|1
4665237|NCT02259582|7557903|FG002|Overall Study|Physician Decision|0
4665238|NCT02259582|7557901|FG000|Overall Study|Death|0
4665239|NCT02259582|7557902|FG001|Overall Study|Death|0
4665240|NCT02259582|7557903|FG002|Overall Study|Death|1
4665241|NCT02259582|7557901|FG000|Overall Study|Adverse Event|1
4665242|NCT02259582|7557902|FG001|Overall Study|Adverse Event|0
4752465|NCT03028740|7726949|FG000|Overall Study|Study Terminated by Sponsor|467
4752466|NCT03028740|7726950|FG001|Overall Study|Study Terminated by Sponsor|917
4752467|NCT03028740|7726949|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27
4752468|NCT03028740|7726950|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55
4752469|NCT03028740|7726949|FG000|Overall Study|Reason not Specified|1
4752470|NCT03028740|7726950|FG001|Overall Study|Reason not Specified|5
4752471|NCT02998476|7727002|FG000|Overall Study|Lost to Follow-up|1
4752472|NCT02998476|7727003|FG001|Overall Study|Lost to Follow-up|0
4752473|NCT02998476|7727002|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2
4752474|NCT02998476|7727003|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0
4752475|NCT02998476|7727002|FG000|Overall Study|Withdrawal by Subject|1
4752476|NCT02998476|7727003|FG001|Overall Study|Withdrawal by Subject|2
4752477|NCT02998476|7727002|FG000|Overall Study|Death|45
4752478|NCT02998476|7727003|FG001|Overall Study|Death|2
4752479|NCT02998476|7727002|FG000|Overall Study|Other|6
4752480|NCT02998476|7727003|FG001|Overall Study|Other|1
4665243|NCT02259582|7557903|FG002|Overall Study|Adverse Event|1
4665244|NCT02259582|7557901|FG000|Overall Study|Withdrawal by Subject|0
4665245|NCT02259582|7557902|FG001|Overall Study|Withdrawal by Subject|0
4665246|NCT02259582|7557903|FG002|Overall Study|Withdrawal by Subject|1
4665247|NCT02259582|7557901|FG000|Overall Study|Disease progression|14
4665248|NCT02259582|7557902|FG001|Overall Study|Disease progression|15
4665249|NCT02259582|7557903|FG002|Overall Study|Disease progression|17
4665250|NCT02259582|7557901|FG000|Overall Study|Lack of Subject Adherence to Protocol|1
4665251|NCT02259582|7557902|FG001|Overall Study|Lack of Subject Adherence to Protocol|1
4665252|NCT02259582|7557903|FG002|Overall Study|Lack of Subject Adherence to Protocol|1
4665253|NCT02260154|7557924|FG000|Overall Study|Screening failure|2
4665254|NCT02260180|7557932|FG000|Overall Study|Adverse Event|2
4665255|NCT02260180|7557933|FG001|Overall Study|Adverse Event|0
4665256|NCT02260180|7557934|FG002|Overall Study|Adverse Event|1
4665257|NCT02260258|7557944|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2
4665258|NCT02260258|7557945|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1
4665259|NCT02260388|7557956|FG000|Overall Study|Lost to Follow-up|2
4752481|NCT02949128|7727019|FG000|Initial Evaluation Period|Failed to Meet Eligibility Criteria|2
4752482|NCT02949128|7727019|FG000|Initial Evaluation Period|Adverse Event|3
4752483|NCT02949128|7727019|FG000|Initial Evaluation Period|Death|2
4752484|NCT02949128|7727019|FG000|Initial Evaluation Period|Physician Decision|1
4752485|NCT02949128|7727019|FG000|Initial Evaluation Period|Protocol Violation|1
4752486|NCT02949128|7727019|FG000|Extension Period|Physician Decision|1
4752487|NCT02949128|7727019|FG000|Extension Period|Withdrawal by Subject|1
4752488|NCT02924064|7727029|FG000|Overall Study|Adverse Event|2
4752489|NCT02924064|7727030|FG001|Overall Study|Adverse Event|2
4752490|NCT02924064|7727029|FG000|Overall Study|Lost to Follow-up|0
4752491|NCT02924064|7727030|FG001|Overall Study|Lost to Follow-up|2
4752492|NCT02924064|7727029|FG000|Overall Study|Physician Decision|0
4752493|NCT02924064|7727030|FG001|Overall Study|Physician Decision|2
4752494|NCT02924064|7727029|FG000|Overall Study|Protocol Violation|1
4752495|NCT02924064|7727030|FG001|Overall Study|Protocol Violation|3
4752496|NCT02924064|7727029|FG000|Overall Study|Withdrawal by Subject|4
4752497|NCT02924064|7727030|FG001|Overall Study|Withdrawal by Subject|5
4752498|NCT02924064|7727029|FG000|Overall Study|Other|17
4752499|NCT02924064|7727030|FG001|Overall Study|Other|29
4752500|NCT02916706|7727038|FG000|Overall Study|Adverse Event|0
4665260|NCT02260388|7557957|FG001|Overall Study|Lost to Follow-up|8
4665261|NCT02260388|7557958|FG002|Overall Study|Lost to Follow-up|3
4665262|NCT02260388|7557959|FG003|Overall Study|Lost to Follow-up|4
4665263|NCT02260492|7557985|FG000|Overall Study|Adverse Event|6
4665264|NCT02260492|7557986|FG001|Overall Study|Adverse Event|1
4752501|NCT02916706|7727039|FG001|Overall Study|Adverse Event|1
4752502|NCT02916706|7727038|FG000|Overall Study|Lost to Follow-up|0
4752503|NCT02916706|7727039|FG001|Overall Study|Lost to Follow-up|1
4752504|NCT02916706|7727038|FG000|Overall Study|Physician Decision|1
4752505|NCT02916706|7727039|FG001|Overall Study|Physician Decision|0
4752506|NCT02916706|7727038|FG000|Overall Study|Protocol Violation|3
4752507|NCT02916706|7727039|FG001|Overall Study|Protocol Violation|1
4752508|NCT02916706|7727038|FG000|Overall Study|Withdrawal by Subject|6
4752509|NCT02916706|7727039|FG001|Overall Study|Withdrawal by Subject|9
4752510|NCT02916706|7727038|FG000|Overall Study|Other|5
4752511|NCT02916706|7727039|FG001|Overall Study|Other|19
4752512|NCT02889900|7727045|FG000|Overall Study|Adverse Event|11
4752513|NCT02889900|7727045|FG000|Overall Study|Condition under investigation worsened|32
4752514|NCT02889900|7727045|FG000|Overall Study|Other|5
4752515|NCT02889900|7727045|FG000|Overall Study|Withdrawal by Subject|7
4752516|NCT02889900|7727045|FG000|Overall Study|Not treated|2
4752517|NCT02866695|7727049|FG000|Overall Study|Adverse Event|1
4752518|NCT02866695|7727049|FG000|Overall Study|Lost to Follow-up|1
4665265|NCT02260492|7557987|FG002|Overall Study|Adverse Event|2
4665266|NCT02260492|7557985|FG000|Overall Study|Death|0
4665267|NCT02260492|7557986|FG001|Overall Study|Death|1
4665268|NCT02260492|7557987|FG002|Overall Study|Death|0
4665269|NCT02260492|7557985|FG000|Overall Study|Lost to Follow-up|12
4665270|NCT02260492|7557986|FG001|Overall Study|Lost to Follow-up|9
4665271|NCT02260492|7557987|FG002|Overall Study|Lost to Follow-up|0
4665272|NCT02260492|7557985|FG000|Overall Study|Physician Decision|2
4665273|NCT02260492|7557986|FG001|Overall Study|Physician Decision|0
4665274|NCT02260492|7557987|FG002|Overall Study|Physician Decision|1
4665275|NCT02260492|7557985|FG000|Overall Study|Withdrawal by Subject|3
4665276|NCT02260492|7557986|FG001|Overall Study|Withdrawal by Subject|2
4665277|NCT02260492|7557987|FG002|Overall Study|Withdrawal by Subject|2
4665278|NCT02260635|7558026|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1
4665279|NCT02260635|7558027|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2
4665280|NCT02260635|7558026|FG000|Open-Label Extension|Study Termination|25
4665281|NCT02260635|7558027|FG001|Open-Label Extension|Study Termination|25
4665282|NCT02260635|7558026|FG000|Open-Label Extension|Withdrawal by Subject|1
4665283|NCT02260635|7558027|FG001|Open-Label Extension|Withdrawal by Subject|0
4665284|NCT02260648|7558038|FG000|Overall Study|Adverse Event|3
4665285|NCT02260648|7558039|FG001|Overall Study|Adverse Event|0
4665286|NCT02260648|7558040|FG002|Overall Study|Adverse Event|1
4665287|NCT02260648|7558038|FG000|Overall Study|Withdrawal by Subject|1
4665288|NCT02260648|7558039|FG001|Overall Study|Withdrawal by Subject|1
4665289|NCT02260648|7558040|FG002|Overall Study|Withdrawal by Subject|0
4665290|NCT02260648|7558038|FG000|Overall Study|Protocol Violation|1
4665291|NCT02260648|7558039|FG001|Overall Study|Protocol Violation|0
4752519|NCT02854436|7727053|FG000|Overall Study|Adverse Event|1
4752520|NCT02854436|7727053|FG000|Overall Study|Death|208
4752521|NCT02854436|7727053|FG000|Overall Study|Lost to Follow-up|5
4752522|NCT02854436|7727053|FG000|Overall Study|Withdrawal by Subject|12
4665292|NCT02260648|7558040|FG002|Overall Study|Protocol Violation|0
4665293|NCT02260648|7558038|FG000|Overall Study|Discontinue Due to Study Termination|13
4665294|NCT02260648|7558039|FG001|Overall Study|Discontinue Due to Study Termination|12
4665295|NCT02260648|7558040|FG002|Overall Study|Discontinue Due to Study Termination|7
4665296|NCT02260791|7558050|FG000|Overall Study|Lost to Follow-up|4
4665297|NCT02260791|7558051|FG001|Overall Study|Lost to Follow-up|4
4665298|NCT02260791|7558050|FG000|Overall Study|Lack of Efficacy|2
4665299|NCT02260791|7558051|FG001|Overall Study|Lack of Efficacy|1
4665300|NCT02260791|7558050|FG000|Overall Study|Adverse Event|13
4665301|NCT02260791|7558051|FG001|Overall Study|Adverse Event|9
4665302|NCT02260791|7558050|FG000|Overall Study|Death|1
4665303|NCT02260791|7558051|FG001|Overall Study|Death|0
4665304|NCT02260791|7558050|FG000|Overall Study|Withdrawal by Subject|11
4665305|NCT02260791|7558051|FG001|Overall Study|Withdrawal by Subject|16
4665306|NCT02260791|7558050|FG000|Overall Study|Screen failure|0
4665307|NCT02260791|7558051|FG001|Overall Study|Screen failure|1
4665308|NCT02260791|7558050|FG000|Overall Study|Protocol deviation|2
4665309|NCT02260791|7558051|FG001|Overall Study|Protocol deviation|3
4665310|NCT02260804|7558059|FG000|Induction Study Period|Protocol Violation|2
4665311|NCT02260804|7558060|FG001|Induction Study Period|Protocol Violation|0
4665312|NCT02260804|7558059|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6
4665313|NCT02260804|7558060|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9
4665314|NCT02260804|7558059|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3
4665315|NCT02260804|7558060|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1
4665316|NCT02260804|7558059|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1
4665317|NCT02260804|7558060|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3
4665318|NCT02260804|7558059|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1
4665319|NCT02260804|7558060|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0
4665320|NCT02260804|7558059|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1
4665321|NCT02260804|7558060|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0
4665322|NCT02260804|7558059|FG000|1st Year of the Maintenance Period (MP1)|Death|0
4665323|NCT02260804|7558060|FG001|1st Year of the Maintenance Period (MP1)|Death|1
4665324|NCT02260804|7558059|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0
4665325|NCT02260804|7558060|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1
4665326|NCT02260804|7558059|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6
4665327|NCT02260804|7558060|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5
4665328|NCT02260804|7558059|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3
4665329|NCT02260804|7558060|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0
4665330|NCT02260804|7558059|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0
4665331|NCT02260804|7558060|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1
4665332|NCT02260817|7558068|FG000|Overall Study|Lost to Follow-up|0
4665333|NCT02260817|7558069|FG001|Overall Study|Lost to Follow-up|14
4665334|NCT02260817|7558068|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0
4665335|NCT02260817|7558069|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7
4665336|NCT02260817|7558068|FG000|Overall Study|Observation, no biopsy|0
4665337|NCT02260817|7558069|FG001|Overall Study|Observation, no biopsy|1
4665338|NCT02260817|7558068|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0
4665339|NCT02260817|7558069|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1
4665340|NCT02260817|7558068|FG000|Overall Study|Protocol Violation|0
4665341|NCT02260817|7558069|FG001|Overall Study|Protocol Violation|14
4665342|NCT02260882|7558077|FG000|Overall Study|Protocol Violation|0
4665343|NCT02260882|7558078|FG001|Overall Study|Protocol Violation|1
4665344|NCT02260921|7558087|FG000|Overall Study|Adverse Event|1
4665345|NCT02260921|7558088|FG001|Overall Study|Adverse Event|0
4665346|NCT02260921|7558087|FG000|Overall Study|Lost to Follow-up|4
4665347|NCT02260921|7558088|FG001|Overall Study|Lost to Follow-up|3
4665348|NCT02260921|7558087|FG000|Overall Study|Withdraw Consent|4
4665349|NCT02260921|7558088|FG001|Overall Study|Withdraw Consent|1
4665350|NCT02260921|7558087|FG000|Overall Study|Death|1
4665351|NCT02260921|7558088|FG001|Overall Study|Death|0
4665352|NCT02260921|7558087|FG000|Overall Study|Prohibited Treatment for Knee Pain|4
4665353|NCT02260921|7558088|FG001|Overall Study|Prohibited Treatment for Knee Pain|0
4665354|NCT02260934|7558096|FG000|Overall Study|Lost to Follow-up|2
4665355|NCT02260934|7558097|FG001|Overall Study|Lost to Follow-up|1
4665356|NCT02260934|7558096|FG000|Overall Study|Withdrawal by Subject|0
4665357|NCT02260934|7558097|FG001|Overall Study|Withdrawal by Subject|2
4665358|NCT02260934|7558096|FG000|Overall Study|Participant Relocated|1
4665359|NCT02260934|7558097|FG001|Overall Study|Participant Relocated|0
4665360|NCT02260934|7558096|FG000|Overall Study|Site error|0
4665361|NCT02260934|7558097|FG001|Overall Study|Site error|1
4665362|NCT02260986|7558113|FG000|Overall Study|Adverse Event|24
4665363|NCT02260986|7558114|FG001|Overall Study|Adverse Event|0
4665364|NCT02260986|7558115|FG002|Overall Study|Adverse Event|11
4665365|NCT02260986|7558113|FG000|Overall Study|Lack of Efficacy|27
4665366|NCT02260986|7558114|FG001|Overall Study|Lack of Efficacy|3
4665367|NCT02260986|7558115|FG002|Overall Study|Lack of Efficacy|0
4665368|NCT02260986|7558113|FG000|Overall Study|Protocol Violation|14
4665369|NCT02260986|7558114|FG001|Overall Study|Protocol Violation|5
4665370|NCT02260986|7558115|FG002|Overall Study|Protocol Violation|16
4665371|NCT02260986|7558113|FG000|Overall Study|Car accident|0
4752523|NCT02854436|7727053|FG000|Overall Study|Other|45
4752524|NCT02854436|7727053|FG000|Overall Study|Ongoing|18
4752525|NCT02834793|7727059|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2
4752526|NCT02834793|7727060|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1
4752527|NCT02834793|7727061|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0
4752528|NCT02834793|7727062|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0
4752529|NCT02834793|7727059|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1
4752530|NCT02834793|7727060|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0
4752531|NCT02834793|7727061|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0
4752532|NCT02834793|7727062|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0
4752533|NCT02834793|7727059|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1
4752534|NCT02834793|7727060|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0
4752535|NCT02834793|7727061|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0
4752536|NCT02834793|7727062|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0
4752537|NCT02834793|7727059|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0
4752538|NCT02834793|7727060|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3
4752539|NCT02834793|7727061|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0
4752540|NCT02834793|7727062|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0
4752541|NCT02834793|7727059|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0
4752542|NCT02834793|7727060|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1
4752543|NCT02834793|7727061|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0
4752544|NCT02834793|7727062|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0
4752545|NCT02834793|7727059|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0
4752546|NCT02834793|7727060|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0
4752547|NCT02834793|7727061|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7
4752548|NCT02834793|7727062|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0
4752549|NCT02834793|7727059|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0
4752550|NCT02834793|7727060|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0
4752551|NCT02834793|7727061|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4
4752552|NCT02834793|7727062|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0
4752553|NCT02834793|7727059|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0
4752554|NCT02834793|7727060|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0
4752555|NCT02834793|7727061|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5
4752556|NCT02834793|7727062|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0
4752557|NCT02834793|7727059|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0
4752558|NCT02834793|7727060|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0
4752559|NCT02834793|7727061|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9
4752560|NCT02834793|7727062|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0
4752561|NCT02834793|7727059|FG000|Extension Phase A (up to 52 Weeks)|Other|0
4752562|NCT02834793|7727060|FG001|Extension Phase A (up to 52 Weeks)|Other|0
4752563|NCT02834793|7727061|FG002|Extension Phase A (up to 52 Weeks)|Other|1
4752564|NCT02834793|7727062|FG003|Extension Phase A (up to 52 Weeks)|Other|0
4752565|NCT02834793|7727059|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0
4752566|NCT02834793|7727060|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0
4752567|NCT02834793|7727061|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0
4752568|NCT02834793|7727062|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1
4752569|NCT02834793|7727059|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0
4752570|NCT02834793|7727060|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0
4752571|NCT02834793|7727061|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0
4665372|NCT02260986|7558114|FG001|Overall Study|Car accident|0
4665373|NCT02260986|7558115|FG002|Overall Study|Car accident|1
4665374|NCT02260986|7558113|FG000|Overall Study|Withdrawal by Subject|17
4665375|NCT02260986|7558114|FG001|Overall Study|Withdrawal by Subject|4
4665376|NCT02260986|7558115|FG002|Overall Study|Withdrawal by Subject|9
4665377|NCT02260986|7558113|FG000|Overall Study|Incorrect randomization|0
4665378|NCT02260986|7558114|FG001|Overall Study|Incorrect randomization|1
4665379|NCT02260986|7558115|FG002|Overall Study|Incorrect randomization|0
4665380|NCT02260986|7558113|FG000|Overall Study|Lack of investigation product supply|2
4665381|NCT02260986|7558114|FG001|Overall Study|Lack of investigation product supply|0
4665382|NCT02260986|7558115|FG002|Overall Study|Lack of investigation product supply|1
4665383|NCT02260986|7558113|FG000|Overall Study|Lost to Follow-up|4
4665384|NCT02260986|7558114|FG001|Overall Study|Lost to Follow-up|0
4665385|NCT02260986|7558115|FG002|Overall Study|Lost to Follow-up|3
4665386|NCT02260986|7558113|FG000|Overall Study|Pregnancy|2
4665387|NCT02260986|7558114|FG001|Overall Study|Pregnancy|0
4665388|NCT02260986|7558115|FG002|Overall Study|Pregnancy|0
4665389|NCT02261467|7558151|FG000|Overall Study|Enrolled in Error|1
4665390|NCT02261467|7558152|FG001|Overall Study|Enrolled in Error|0
4665391|NCT02261467|7558151|FG000|Overall Study|Protocol Violation|0
4665392|NCT02261467|7558152|FG001|Overall Study|Protocol Violation|1
4665393|NCT02261467|7558151|FG000|Overall Study|Personal Reasons|17
4665394|NCT02261467|7558152|FG001|Overall Study|Personal Reasons|22
4665395|NCT02261467|7558151|FG000|Overall Study|Lost to Follow-up|2
4665396|NCT02261467|7558152|FG001|Overall Study|Lost to Follow-up|13
4665397|NCT02261467|7558151|FG000|Overall Study|Adverse Event|1
4665398|NCT02261467|7558152|FG001|Overall Study|Adverse Event|1
4665399|NCT02261493|7558161|FG000|Overall Study|Noncompliance|0
4665400|NCT02261493|7558162|FG001|Overall Study|Noncompliance|0
4665401|NCT02261493|7558163|FG002|Overall Study|Noncompliance|2
4665402|NCT02261493|7558161|FG000|Overall Study|Physician Decision|0
4665403|NCT02261493|7558162|FG001|Overall Study|Physician Decision|1
4665404|NCT02261493|7558163|FG002|Overall Study|Physician Decision|0
4665405|NCT02261493|7558161|FG000|Overall Study|Undisclosed alcohol abuse|0
4665406|NCT02261493|7558162|FG001|Overall Study|Undisclosed alcohol abuse|1
4665407|NCT02261493|7558163|FG002|Overall Study|Undisclosed alcohol abuse|0
4665408|NCT02261493|7558161|FG000|Overall Study|Protocol Violation|1
4665409|NCT02261493|7558162|FG001|Overall Study|Protocol Violation|0
4665410|NCT02261493|7558163|FG002|Overall Study|Protocol Violation|0
4665411|NCT02261493|7558161|FG000|Overall Study|Personal Reasons|14
4665412|NCT02261493|7558162|FG001|Overall Study|Personal Reasons|14
4665413|NCT02261493|7558163|FG002|Overall Study|Personal Reasons|16
4665414|NCT02261493|7558161|FG000|Overall Study|Lost to Follow-up|14
4665415|NCT02261493|7558162|FG001|Overall Study|Lost to Follow-up|27
4665416|NCT02261493|7558163|FG002|Overall Study|Lost to Follow-up|8
4665417|NCT02261493|7558161|FG000|Overall Study|Pregnancy|1
4665418|NCT02261493|7558162|FG001|Overall Study|Pregnancy|2
4665419|NCT02261493|7558163|FG002|Overall Study|Pregnancy|0
4752572|NCT02834793|7727062|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1
4752573|NCT02834793|7727059|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0
4752574|NCT02834793|7727060|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0
4752575|NCT02834793|7727061|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0
4752576|NCT02834793|7727062|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8
4752577|NCT02834793|7727059|FG000|Extension Phase B (up to 188 Weeks)|Other|0
4752578|NCT02834793|7727060|FG001|Extension Phase B (up to 188 Weeks)|Other|0
4752579|NCT02834793|7727061|FG002|Extension Phase B (up to 188 Weeks)|Other|0
4752580|NCT02834793|7727062|FG003|Extension Phase B (up to 188 Weeks)|Other|1
4752581|NCT02834793|7727059|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0
4752582|NCT02834793|7727060|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0
4752583|NCT02834793|7727061|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0
4752584|NCT02834793|7727062|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1
4752585|NCT02810457|7727072|FG000|Overall Study|Randomised but no treatment received|2
4752586|NCT02810457|7727073|FG001|Overall Study|Randomised but no treatment received|1
4752587|NCT02810457|7727072|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191
4752588|NCT02810457|7727073|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199
4752589|NCT02810457|7727072|FG000|Overall Study|Adverse Event|37
4752590|NCT02810457|7727073|FG001|Overall Study|Adverse Event|43
4752591|NCT02810457|7727072|FG000|Overall Study|Patient decision|31
4752592|NCT02810457|7727073|FG001|Overall Study|Patient decision|35
4752593|NCT02810457|7727072|FG000|Overall Study|Patient lost to follow-up|2
4752594|NCT02810457|7727073|FG001|Overall Study|Patient lost to follow-up|2
4752595|NCT02810457|7727072|FG000|Overall Study|Death|39
4752596|NCT02810457|7727073|FG001|Overall Study|Death|28
4752597|NCT02810457|7727072|FG000|Overall Study|Ongoing at data cutoff and discontinued|3
4752598|NCT02810457|7727073|FG001|Overall Study|Ongoing at data cutoff and discontinued|2
4665420|NCT02261493|7558161|FG000|Overall Study|Lack of Efficacy|0
4665421|NCT02261493|7558162|FG001|Overall Study|Lack of Efficacy|1
4665422|NCT02261493|7558163|FG002|Overall Study|Lack of Efficacy|0
4665423|NCT02261493|7558161|FG000|Overall Study|Adverse Event|0
4665424|NCT02261493|7558162|FG001|Overall Study|Adverse Event|1
4665425|NCT02261493|7558163|FG002|Overall Study|Adverse Event|0
4665426|NCT02261974|7558241|FG000|Overall Study|Withdrawal by Subject|3
4665427|NCT02261974|7558242|FG001|Overall Study|Withdrawal by Subject|2
4665428|NCT02261974|7558241|FG000|Overall Study|Pregnancy|0
4665429|NCT02261974|7558242|FG001|Overall Study|Pregnancy|1
4665430|NCT02261974|7558241|FG000|Overall Study|Missed treatment cut-off date|6
4665431|NCT02261974|7558242|FG001|Overall Study|Missed treatment cut-off date|3
4665432|NCT02261974|7558241|FG000|Overall Study|Received partial treatment; FU to 1 mo|3
4665433|NCT02261974|7558242|FG001|Overall Study|Received partial treatment; FU to 1 mo|1
4665434|NCT02261974|7558241|FG000|Overall Study|Lost to Follow-up|2
4665435|NCT02261974|7558242|FG001|Overall Study|Lost to Follow-up|0
4665436|NCT02261974|7558241|FG000|Overall Study|Adverse Event|1
4665437|NCT02261974|7558242|FG001|Overall Study|Adverse Event|0
4665438|NCT02262260|7558272|FG000|Overall Study|Adverse Event|4
4665439|NCT02262260|7558273|FG001|Overall Study|Adverse Event|1
4665440|NCT02262260|7558272|FG000|Overall Study|Withdrawal of consent|4
4665441|NCT02262260|7558273|FG001|Overall Study|Withdrawal of consent|2
4665442|NCT02262260|7558272|FG000|Overall Study|Lost to Follow-up|1
4665443|NCT02262260|7558273|FG001|Overall Study|Lost to Follow-up|2
4665444|NCT02262260|7558272|FG000|Overall Study|Protocol deviation|2
4665445|NCT02262260|7558273|FG001|Overall Study|Protocol deviation|5
4665446|NCT02262364|7558279|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1
4665447|NCT02262377|7558285|FG000|Overall Study|Lost to Follow-up|5
4665448|NCT02262377|7558286|FG001|Overall Study|Lost to Follow-up|6
4665449|NCT02262377|7558285|FG000|Overall Study|Found ineligible after enrollment|3
4665450|NCT02262377|7558286|FG001|Overall Study|Found ineligible after enrollment|0
4665451|NCT02262377|7558285|FG000|Overall Study|Withdrawal by Subject|4
4665452|NCT02262377|7558286|FG001|Overall Study|Withdrawal by Subject|0
4665453|NCT02262728|7558300|FG000|Follow-up Phase (3 Years)|Death|0
4665454|NCT02262728|7558301|FG001|Follow-up Phase (3 Years)|Death|1
4665455|NCT02262728|7558300|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4
4665456|NCT02262728|7558301|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1
4665457|NCT02262728|7558300|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0
4665458|NCT02262728|7558301|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1
4665459|NCT02262754|7558310|FG000|Overall Study|Adverse Event|3
4665460|NCT02262754|7558311|FG001|Overall Study|Adverse Event|4
4665461|NCT02262754|7558312|FG002|Overall Study|Adverse Event|0
4665462|NCT02262754|7558310|FG000|Overall Study|Lack of Efficacy|2
4665463|NCT02262754|7558311|FG001|Overall Study|Lack of Efficacy|0
4665464|NCT02262754|7558312|FG002|Overall Study|Lack of Efficacy|1
4665465|NCT02262754|7558310|FG000|Overall Study|Lost to Follow-up|0
4665466|NCT02262754|7558311|FG001|Overall Study|Lost to Follow-up|0
4665467|NCT02262754|7558312|FG002|Overall Study|Lost to Follow-up|1
4665468|NCT02262754|7558310|FG000|Overall Study|No longer meets eligibility criteria|0
4665469|NCT02262754|7558311|FG001|Overall Study|No longer meets eligibility criteria|1
4665470|NCT02262754|7558312|FG002|Overall Study|No longer meets eligibility criteria|0
4665471|NCT02262754|7558310|FG000|Overall Study|Study terminated by sponsor|5
4665472|NCT02262754|7558311|FG001|Overall Study|Study terminated by sponsor|4
4665473|NCT02262754|7558312|FG002|Overall Study|Study terminated by sponsor|4
4665474|NCT02262754|7558310|FG000|Overall Study|Protocol Violation|1
4665475|NCT02262754|7558311|FG001|Overall Study|Protocol Violation|0
4665476|NCT02262754|7558312|FG002|Overall Study|Protocol Violation|0
4665477|NCT02262754|7558310|FG000|Overall Study|Withdrawal by Subject|1
4665478|NCT02262754|7558311|FG001|Overall Study|Withdrawal by Subject|0
4665479|NCT02262754|7558312|FG002|Overall Study|Withdrawal by Subject|1
4665480|NCT02262754|7558310|FG000|Overall Study|Other|4
4665481|NCT02262754|7558311|FG001|Overall Study|Other|0
4665482|NCT02262754|7558312|FG002|Overall Study|Other|2
4665483|NCT02263079|7558349|FG000|Overall Study|Physician Decision|1
4665484|NCT02263079|7558350|FG001|Overall Study|Physician Decision|0
4665485|NCT02263079|7558351|FG002|Overall Study|Physician Decision|0
4665486|NCT02263079|7558349|FG000|Overall Study|Withdrawal by Subject|2
4665487|NCT02263079|7558350|FG001|Overall Study|Withdrawal by Subject|8
4665488|NCT02263079|7558351|FG002|Overall Study|Withdrawal by Subject|0
4665489|NCT02263326|7558389|FG000|Overall Study|Lost to Follow-up|1
4665490|NCT02263326|7558390|FG001|Overall Study|Lost to Follow-up|1
4665491|NCT02263547|7558396|FG000|Overall Study|Adverse Event|1
4665492|NCT02263547|7558396|FG000|Overall Study|Lost to Follow-up|2
4665493|NCT02264574|7558443|FG000|Overall Study|Death|21
4752599|NCT02810457|7727072|FG000|Overall Study|Clinical progression|15
4752600|NCT02810457|7727073|FG001|Overall Study|Clinical progression|16
4752601|NCT02810457|7727072|FG000|Overall Study|Investigator decision|3
4752602|NCT02810457|7727073|FG001|Overall Study|Investigator decision|2
4752603|NCT02810457|7727072|FG000|Overall Study|Patient ineligibility|3
4665494|NCT02264574|7558444|FG001|Overall Study|Death|21
4665495|NCT02264574|7558443|FG000|Overall Study|Withdrawal by Subject|8
4665496|NCT02264574|7558444|FG001|Overall Study|Withdrawal by Subject|6
4665497|NCT02264574|7558443|FG000|Overall Study|Other, Not Specified|0
4665498|NCT02264574|7558444|FG001|Overall Study|Other, Not Specified|3
4665499|NCT02264639|7558455|FG000|Overall Study|Death (after completing single-dose phase)|1
4665500|NCT02264639|7558456|FG001|Overall Study|Death (after completing single-dose phase)|0
4665501|NCT02264639|7558457|FG002|Overall Study|Death (after completing single-dose phase)|0
4665502|NCT02264639|7558458|FG003|Overall Study|Death (after completing single-dose phase)|0
4665503|NCT02264639|7558459|FG004|Overall Study|Death (after completing single-dose phase)|0
4665504|NCT02264639|7558455|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1
4665505|NCT02264639|7558456|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0
4665506|NCT02264639|7558457|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0
4665507|NCT02264639|7558458|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0
4665508|NCT02264639|7558459|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0
4665509|NCT02264639|7558455|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0
4665510|NCT02264639|7558456|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0
4665511|NCT02264639|7558457|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1
4665512|NCT02264639|7558458|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0
4665513|NCT02264639|7558459|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0
4665514|NCT02264639|7558455|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0
4665515|NCT02264639|7558456|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0
4665516|NCT02264639|7558457|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0
4665517|NCT02264639|7558458|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0
4665518|NCT02264639|7558459|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1
4665519|NCT02264821|7558477|FG000|Overall Study|Protocol Violation|1
4665520|NCT02264821|7558478|FG001|Overall Study|Protocol Violation|3
4665521|NCT02264821|7558479|FG002|Overall Study|Protocol Violation|6
4665522|NCT02264990|7558489|FG000|Overall Study|Death|255
4665523|NCT02264990|7558490|FG001|Overall Study|Death|250
4665524|NCT02264990|7558489|FG000|Overall Study|Withdrawal by Subject|4
4665525|NCT02264990|7558490|FG001|Overall Study|Withdrawal by Subject|5
4665526|NCT02264990|7558489|FG000|Overall Study|Lost to Follow-up|1
4665527|NCT02264990|7558490|FG001|Overall Study|Lost to Follow-up|3
4665528|NCT02264990|7558489|FG000|Overall Study|Other|0
4665529|NCT02264990|7558490|FG001|Overall Study|Other|1
4665530|NCT02265237|7558508|FG000|As Treated (Overall Study)|Adverse Event|1
4665531|NCT02265237|7558509|FG001|As Treated (Overall Study)|Adverse Event|1
4665532|NCT02265237|7558510|FG002|As Treated (Overall Study)|Adverse Event|0
4665533|NCT02265237|7558511|FG003|As Treated (Overall Study)|Adverse Event|0
4665534|NCT02265237|7558508|FG000|As Treated (Overall Study)|Withdrawal by Subject|1
4665535|NCT02265237|7558509|FG001|As Treated (Overall Study)|Withdrawal by Subject|0
4665536|NCT02265237|7558510|FG002|As Treated (Overall Study)|Withdrawal by Subject|1
4665537|NCT02265237|7558511|FG003|As Treated (Overall Study)|Withdrawal by Subject|0
4665538|NCT02265237|7558508|FG000|As Treated (Overall Study)|Lost to Follow-up|1
4665539|NCT02265237|7558509|FG001|As Treated (Overall Study)|Lost to Follow-up|2
4665540|NCT02265237|7558510|FG002|As Treated (Overall Study)|Lost to Follow-up|6
4665541|NCT02265237|7558511|FG003|As Treated (Overall Study)|Lost to Follow-up|0
4665542|NCT02265237|7558508|FG000|As Treated (Overall Study)|Other|2
4665543|NCT02265237|7558509|FG001|As Treated (Overall Study)|Other|0
4665544|NCT02265237|7558510|FG002|As Treated (Overall Study)|Other|3
4665545|NCT02265237|7558511|FG003|As Treated (Overall Study)|Other|1
4665546|NCT02265510|7558540|FG000|Overall Study|Withdrawal by Subject|1
4665547|NCT02265510|7558541|FG001|Overall Study|Withdrawal by Subject|1
4665548|NCT02265510|7558542|FG002|Overall Study|Withdrawal by Subject|2
4665549|NCT02265510|7558543|FG003|Overall Study|Withdrawal by Subject|1
4665550|NCT02265510|7558544|FG004|Overall Study|Withdrawal by Subject|0
4665551|NCT02265510|7558545|FG005|Overall Study|Withdrawal by Subject|2
4665552|NCT02265510|7558546|FG006|Overall Study|Withdrawal by Subject|0
4665553|NCT02265510|7558547|FG007|Overall Study|Withdrawal by Subject|2
4665554|NCT02265510|7558548|FG008|Overall Study|Withdrawal by Subject|0
4665555|NCT02265510|7558549|FG009|Overall Study|Withdrawal by Subject|0
4665556|NCT02265510|7558550|FG010|Overall Study|Withdrawal by Subject|0
4665557|NCT02265510|7558551|FG011|Overall Study|Withdrawal by Subject|0
4665558|NCT02265510|7558552|FG012|Overall Study|Withdrawal by Subject|1
4665559|NCT02265510|7558553|FG013|Overall Study|Withdrawal by Subject|0
4752604|NCT02810457|7727073|FG001|Overall Study|Patient ineligibility|0
4752605|NCT02810457|7727072|FG000|Overall Study|Miscalculated PD|1
4752606|NCT02810457|7727073|FG001|Overall Study|Miscalculated PD|0
4752607|NCT02810457|7727072|FG000|Overall Study|Physician Decision|0
4752608|NCT02810457|7727073|FG001|Overall Study|Physician Decision|1
4752609|NCT02745535|7727109|FG000|Overall Study|Death|1
4752610|NCT02745535|7727109|FG000|Overall Study|Adverse Event|3
4752611|NCT02745535|7727109|FG000|Overall Study|Lost to Follow-up|2
4665560|NCT02265510|7558540|FG000|Overall Study|Disease Progression|0
4665561|NCT02265510|7558541|FG001|Overall Study|Disease Progression|1
4665562|NCT02265510|7558542|FG002|Overall Study|Disease Progression|2
4665563|NCT02265510|7558543|FG003|Overall Study|Disease Progression|1
4665564|NCT02265510|7558544|FG004|Overall Study|Disease Progression|1
4665565|NCT02265510|7558545|FG005|Overall Study|Disease Progression|0
4665566|NCT02265510|7558546|FG006|Overall Study|Disease Progression|0
4665567|NCT02265510|7558547|FG007|Overall Study|Disease Progression|0
4665568|NCT02265510|7558548|FG008|Overall Study|Disease Progression|0
4665569|NCT02265510|7558549|FG009|Overall Study|Disease Progression|0
4665570|NCT02265510|7558550|FG010|Overall Study|Disease Progression|0
4665571|NCT02265510|7558551|FG011|Overall Study|Disease Progression|0
4665572|NCT02265510|7558552|FG012|Overall Study|Disease Progression|0
4665573|NCT02265510|7558553|FG013|Overall Study|Disease Progression|0
4665574|NCT02265510|7558540|FG000|Overall Study|Death|2
4752612|NCT02625090|7727147|FG000|Overall Study|Participant wants to be pregnant|2
4665575|NCT02265510|7558541|FG001|Overall Study|Death|0
4665576|NCT02265510|7558542|FG002|Overall Study|Death|2
4665577|NCT02265510|7558543|FG003|Overall Study|Death|2
4665578|NCT02265510|7558544|FG004|Overall Study|Death|1
4665579|NCT02265510|7558545|FG005|Overall Study|Death|3
4665580|NCT02265510|7558546|FG006|Overall Study|Death|2
4665581|NCT02265510|7558547|FG007|Overall Study|Death|1
4665582|NCT02265510|7558548|FG008|Overall Study|Death|3
4665583|NCT02265510|7558549|FG009|Overall Study|Death|3
4665584|NCT02265510|7558550|FG010|Overall Study|Death|4
4665585|NCT02265510|7558551|FG011|Overall Study|Death|12
4665586|NCT02265510|7558552|FG012|Overall Study|Death|7
4665587|NCT02265510|7558553|FG013|Overall Study|Death|6
4665588|NCT02265510|7558540|FG000|Overall Study|Lost to Follow-up|0
4665589|NCT02265510|7558541|FG001|Overall Study|Lost to Follow-up|0
4665590|NCT02265510|7558542|FG002|Overall Study|Lost to Follow-up|0
4665591|NCT02265510|7558543|FG003|Overall Study|Lost to Follow-up|0
4665592|NCT02265510|7558544|FG004|Overall Study|Lost to Follow-up|1
4665593|NCT02265510|7558545|FG005|Overall Study|Lost to Follow-up|0
4665594|NCT02265510|7558546|FG006|Overall Study|Lost to Follow-up|0
4665595|NCT02265510|7558547|FG007|Overall Study|Lost to Follow-up|0
4665596|NCT02265510|7558548|FG008|Overall Study|Lost to Follow-up|0
4665597|NCT02265510|7558549|FG009|Overall Study|Lost to Follow-up|2
4665598|NCT02265510|7558550|FG010|Overall Study|Lost to Follow-up|0
4665599|NCT02265510|7558551|FG011|Overall Study|Lost to Follow-up|0
4665600|NCT02265510|7558552|FG012|Overall Study|Lost to Follow-up|0
4665601|NCT02265510|7558553|FG013|Overall Study|Lost to Follow-up|2
4752613|NCT02625090|7727147|FG000|Overall Study|For the Promoter|1
4752614|NCT02625090|7727147|FG000|Overall Study|Sponsor's Decision|9
4752615|NCT02625090|7727147|FG000|Overall Study|Somnolence|1
4752616|NCT02625090|7727147|FG000|Overall Study|Study terminated by Sponsor|7
4752617|NCT02625090|7727147|FG000|Overall Study|Negative Benefit/Risk|1
4752618|NCT02625090|7727147|FG000|Overall Study|Protocol Deviation|2
4752619|NCT02625090|7727147|FG000|Overall Study|Lack of Efficacy|16
4752620|NCT02625090|7727147|FG000|Overall Study|Adverse Event|3
4665602|NCT02265510|7558540|FG000|Overall Study|Other|0
4665603|NCT02265510|7558541|FG001|Overall Study|Other|1
4665604|NCT02265510|7558542|FG002|Overall Study|Other|0
4665605|NCT02265510|7558543|FG003|Overall Study|Other|0
4665606|NCT02265510|7558544|FG004|Overall Study|Other|0
4665607|NCT02265510|7558545|FG005|Overall Study|Other|0
4665608|NCT02265510|7558546|FG006|Overall Study|Other|0
4665609|NCT02265510|7558547|FG007|Overall Study|Other|0
4665610|NCT02265510|7558548|FG008|Overall Study|Other|0
4665611|NCT02265510|7558549|FG009|Overall Study|Other|0
4665612|NCT02265510|7558550|FG010|Overall Study|Other|0
4665613|NCT02265510|7558551|FG011|Overall Study|Other|0
4665614|NCT02265510|7558552|FG012|Overall Study|Other|0
4665615|NCT02265510|7558553|FG013|Overall Study|Other|0
4665616|NCT02265510|7558540|FG000|Overall Study|Study Terminated by Sponsor|0
4665617|NCT02265510|7558541|FG001|Overall Study|Study Terminated by Sponsor|0
4665618|NCT02265510|7558542|FG002|Overall Study|Study Terminated by Sponsor|0
4665619|NCT02265510|7558543|FG003|Overall Study|Study Terminated by Sponsor|0
4665620|NCT02265510|7558544|FG004|Overall Study|Study Terminated by Sponsor|0
4665621|NCT02265510|7558545|FG005|Overall Study|Study Terminated by Sponsor|1
4665622|NCT02265510|7558546|FG006|Overall Study|Study Terminated by Sponsor|1
4665623|NCT02265510|7558547|FG007|Overall Study|Study Terminated by Sponsor|1
4665624|NCT02265510|7558548|FG008|Overall Study|Study Terminated by Sponsor|1
4665625|NCT02265510|7558549|FG009|Overall Study|Study Terminated by Sponsor|2
4665626|NCT02265510|7558550|FG010|Overall Study|Study Terminated by Sponsor|1
4665627|NCT02265510|7558551|FG011|Overall Study|Study Terminated by Sponsor|4
4665628|NCT02265510|7558552|FG012|Overall Study|Study Terminated by Sponsor|1
4665629|NCT02265510|7558553|FG013|Overall Study|Study Terminated by Sponsor|2
4665630|NCT02265705|7558611|FG000|Treatment Period Week 0-24|Adverse Event|3
4665631|NCT02265705|7558612|FG001|Treatment Period Week 0-24|Adverse Event|2
4665632|NCT02265705|7558613|FG002|Treatment Period Week 0-24|Adverse Event|0
4665633|NCT02265705|7558614|FG003|Treatment Period Week 0-24|Adverse Event|0
4665634|NCT02265705|7558615|FG004|Treatment Period Week 0-24|Adverse Event|0
4665635|NCT02265705|7558616|FG005|Treatment Period Week 0-24|Adverse Event|0
4665636|NCT02265705|7558617|FG006|Treatment Period Week 0-24|Adverse Event|0
4665637|NCT02265705|7558611|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1
4752621|NCT02539225|7727154|FG000|Part A|Adverse Event|13
4752622|NCT02539225|7727155|FG001|Part A|Adverse Event|4
4752623|NCT02539225|7727154|FG000|Part A|Withdrawal by Subject|2
4752624|NCT02539225|7727155|FG001|Part A|Withdrawal by Subject|4
4752625|NCT02539225|7727154|FG000|Part A|Physician Decision|4
4752626|NCT02539225|7727155|FG001|Part A|Physician Decision|7
4752627|NCT02539225|7727154|FG000|Part A|Did Not Receive study Drug|1
4752628|NCT02539225|7727155|FG001|Part A|Did Not Receive study Drug|1
4752629|NCT02539225|7727154|FG000|Pre Treatment for Part B|Progressive disease|1
4752630|NCT02539225|7727155|FG001|Pre Treatment for Part B|Progressive disease|1
4752631|NCT02539225|7727154|FG000|Pre Treatment for Part B|Adverse Event|1
4752632|NCT02539225|7727155|FG001|Pre Treatment for Part B|Adverse Event|1
4752633|NCT02539225|7727154|FG000|Pre Treatment for Part B|Withdrawal by Subject|1
4752634|NCT02539225|7727155|FG001|Pre Treatment for Part B|Withdrawal by Subject|0
4752635|NCT02539225|7727154|FG000|Pre Treatment for Part B|Physician Decision|2
4752636|NCT02539225|7727155|FG001|Pre Treatment for Part B|Physician Decision|0
4752637|NCT02539225|7727154|FG000|Part B|Adverse Event|4
4752638|NCT02539225|7727155|FG001|Part B|Adverse Event|4
4752639|NCT02539225|7727154|FG000|Part B|Withdrawal by Subject|0
4752640|NCT02539225|7727155|FG001|Part B|Withdrawal by Subject|3
4752641|NCT02539225|7727154|FG000|Part B|Physician Decision|0
4752642|NCT02539225|7727155|FG001|Part B|Physician Decision|9
4752643|NCT02526017|7727183|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0
4752644|NCT02526017|7727184|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0
4752645|NCT02526017|7727185|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0
4752646|NCT02526017|7727186|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0
4752647|NCT02526017|7727187|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1
4752648|NCT02526017|7727188|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0
4752649|NCT02526017|7727189|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0
4752650|NCT02526017|7727190|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0
4752651|NCT02526017|7727191|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0
4752652|NCT02482233|7727253|FG000|Overall Study|Lost to Follow-up|1
4752653|NCT02482233|7727254|FG001|Overall Study|Lost to Follow-up|1
4752654|NCT02476916|7727264|FG000|Core Period|Adverse Event|2
4752655|NCT02476916|7727265|FG001|Core Period|Adverse Event|2
4752656|NCT02476916|7727264|FG000|Core Period|Investigator decision|1
4752657|NCT02476916|7727265|FG001|Core Period|Investigator decision|1
4752658|NCT02476916|7727264|FG000|Core Period|Withdrawal by Subject|3
4752659|NCT02476916|7727265|FG001|Core Period|Withdrawal by Subject|0
4752660|NCT02476916|7727264|FG000|Extension Period|Prematurely Discontinued Treatment|6
4752661|NCT02476916|7727265|FG001|Extension Period|Prematurely Discontinued Treatment|1
4752662|NCT02476916|7727264|FG000|Extension Period|On Treatment|12
4752663|NCT02476916|7727265|FG001|Extension Period|On Treatment|17
4752664|NCT02450331|7727274|FG000|Overall Study|Death|120
4752665|NCT02450331|7727275|FG001|Overall Study|Death|114
4752666|NCT02450331|7727274|FG000|Overall Study|Lost to Follow-up|9
4665638|NCT02265705|7558612|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1
4665639|NCT02265705|7558613|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0
4665640|NCT02265705|7558614|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0
4665641|NCT02265705|7558615|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0
4665642|NCT02265705|7558616|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0
4665643|NCT02265705|7558617|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0
4665644|NCT02265705|7558611|FG000|Treatment Period Week 0-24|Physician Decision|1
4665645|NCT02265705|7558612|FG001|Treatment Period Week 0-24|Physician Decision|0
4665646|NCT02265705|7558613|FG002|Treatment Period Week 0-24|Physician Decision|0
4665647|NCT02265705|7558614|FG003|Treatment Period Week 0-24|Physician Decision|0
4665648|NCT02265705|7558615|FG004|Treatment Period Week 0-24|Physician Decision|0
4665649|NCT02265705|7558616|FG005|Treatment Period Week 0-24|Physician Decision|0
4665650|NCT02265705|7558617|FG006|Treatment Period Week 0-24|Physician Decision|0
4665651|NCT02265705|7558611|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7
4665652|NCT02265705|7558612|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5
4665653|NCT02265705|7558613|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0
4665654|NCT02265705|7558614|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0
4665655|NCT02265705|7558615|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0
4665656|NCT02265705|7558616|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0
4665657|NCT02265705|7558617|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0
4665658|NCT02265705|7558611|FG000|Treatment Period Week 0-24|Lack of Efficacy|0
4665659|NCT02265705|7558612|FG001|Treatment Period Week 0-24|Lack of Efficacy|1
4665660|NCT02265705|7558613|FG002|Treatment Period Week 0-24|Lack of Efficacy|0
4665661|NCT02265705|7558614|FG003|Treatment Period Week 0-24|Lack of Efficacy|0
4665662|NCT02265705|7558615|FG004|Treatment Period Week 0-24|Lack of Efficacy|0
4665663|NCT02265705|7558616|FG005|Treatment Period Week 0-24|Lack of Efficacy|0
4665664|NCT02265705|7558617|FG006|Treatment Period Week 0-24|Lack of Efficacy|0
4665665|NCT02265705|7558611|FG000|Rescue Period|Withdrawal by Subject|0
4665666|NCT02265705|7558612|FG001|Rescue Period|Withdrawal by Subject|0
4665667|NCT02265705|7558613|FG002|Rescue Period|Withdrawal by Subject|1
4665668|NCT02265705|7558614|FG003|Rescue Period|Withdrawal by Subject|0
4665669|NCT02265705|7558615|FG004|Rescue Period|Withdrawal by Subject|0
4665670|NCT02265705|7558616|FG005|Rescue Period|Withdrawal by Subject|0
4665671|NCT02265705|7558617|FG006|Rescue Period|Withdrawal by Subject|0
4665672|NCT02265705|7558611|FG000|Rescue Period|Death|0
4665673|NCT02265705|7558612|FG001|Rescue Period|Death|0
4665674|NCT02265705|7558613|FG002|Rescue Period|Death|1
4752667|NCT02450331|7727275|FG001|Overall Study|Lost to Follow-up|7
4752668|NCT02450331|7727274|FG000|Overall Study|Withdrawal by Subject|50
4752669|NCT02450331|7727275|FG001|Overall Study|Withdrawal by Subject|39
4752670|NCT02450331|7727274|FG000|Overall Study|On-Study Status: In Disease recurrence follow-up|179
4752671|NCT02450331|7727275|FG001|Overall Study|On-Study Status: In Disease recurrence follow-up|208
4752672|NCT02450331|7727274|FG000|Overall Study|On-Study Status: In Survival follow-up|45
4752673|NCT02450331|7727275|FG001|Overall Study|On-Study Status: In Survival follow-up|38
4752674|NCT02400736|7727291|FG000|Overall Study|Lost to Follow-up|6
4752675|NCT02400736|7727292|FG001|Overall Study|Lost to Follow-up|6
4752676|NCT02400736|7727291|FG000|Overall Study|Withdrawal by Subject|2
4752677|NCT02400736|7727292|FG001|Overall Study|Withdrawal by Subject|1
4752678|NCT02400736|7727291|FG000|Overall Study|Moved from the area|3
4752679|NCT02400736|7727292|FG001|Overall Study|Moved from the area|1
4752680|NCT02369653|7727304|FG000|Overall Study|Lost to Follow-up|0
4752681|NCT02369653|7727305|FG001|Overall Study|Lost to Follow-up|1
4752682|NCT02369653|7727304|FG000|Overall Study|Administrative reason by sponsor|0
4752683|NCT02369653|7727305|FG001|Overall Study|Administrative reason by sponsor|1
4752684|NCT02369653|7727304|FG000|Overall Study|Death|1
4752685|NCT02369653|7727305|FG001|Overall Study|Death|2
4752686|NCT02369653|7727304|FG000|Overall Study|Participant withdrew consent|13
4752687|NCT02369653|7727305|FG001|Overall Study|Participant withdrew consent|3
4752688|NCT02335424|7727315|FG000|Overall Study|Withdrawal by Subject|12
4752689|NCT02335424|7727315|FG000|Overall Study|Ongoing In Study|89
4752690|NCT02335424|7727315|FG000|Overall Study|Adverse Event|25
4752691|NCT02335424|7727315|FG000|Overall Study|Death|239
4752692|NCT02335424|7727315|FG000|Overall Study|Lost to Follow-up|2
4752693|NCT02335424|7727315|FG000|Overall Study|Physician Decision|3
4752694|NCT02335424|7727315|FG000|Overall Study|Not treated|4
4665675|NCT02265705|7558614|FG003|Rescue Period|Death|0
4665676|NCT02265705|7558615|FG004|Rescue Period|Death|0
4665677|NCT02265705|7558616|FG005|Rescue Period|Death|0
4665678|NCT02265705|7558617|FG006|Rescue Period|Death|0
4665679|NCT02265705|7558611|FG000|Rescue Period|Lack of Efficacy|0
4665680|NCT02265705|7558612|FG001|Rescue Period|Lack of Efficacy|0
4665681|NCT02265705|7558613|FG002|Rescue Period|Lack of Efficacy|1
4665682|NCT02265705|7558614|FG003|Rescue Period|Lack of Efficacy|0
4665683|NCT02265705|7558615|FG004|Rescue Period|Lack of Efficacy|0
4665684|NCT02265705|7558616|FG005|Rescue Period|Lack of Efficacy|0
4665685|NCT02265705|7558617|FG006|Rescue Period|Lack of Efficacy|0
4665686|NCT02265705|7558611|FG000|Open Label Period|Adverse Event|0
4665687|NCT02265705|7558612|FG001|Open Label Period|Adverse Event|0
4665688|NCT02265705|7558613|FG002|Open Label Period|Adverse Event|0
4665689|NCT02265705|7558614|FG003|Open Label Period|Adverse Event|2
4665690|NCT02265705|7558615|FG004|Open Label Period|Adverse Event|2
4665691|NCT02265705|7558616|FG005|Open Label Period|Adverse Event|0
4665692|NCT02265705|7558617|FG006|Open Label Period|Adverse Event|0
4665693|NCT02265705|7558611|FG000|Open Label Period|Physician Decision|0
4665694|NCT02265705|7558612|FG001|Open Label Period|Physician Decision|0
4665695|NCT02265705|7558613|FG002|Open Label Period|Physician Decision|0
4665696|NCT02265705|7558614|FG003|Open Label Period|Physician Decision|0
4665697|NCT02265705|7558615|FG004|Open Label Period|Physician Decision|1
4665698|NCT02265705|7558616|FG005|Open Label Period|Physician Decision|0
4665699|NCT02265705|7558617|FG006|Open Label Period|Physician Decision|0
4665700|NCT02265705|7558611|FG000|Open Label Period|Withdrawal by Subject|0
4665701|NCT02265705|7558612|FG001|Open Label Period|Withdrawal by Subject|0
4665702|NCT02265705|7558613|FG002|Open Label Period|Withdrawal by Subject|0
4665703|NCT02265705|7558614|FG003|Open Label Period|Withdrawal by Subject|0
4665704|NCT02265705|7558615|FG004|Open Label Period|Withdrawal by Subject|2
4665705|NCT02265705|7558616|FG005|Open Label Period|Withdrawal by Subject|0
4665706|NCT02265705|7558617|FG006|Open Label Period|Withdrawal by Subject|0
4665707|NCT02265705|7558611|FG000|Follow-up Period|Sponsor Decision|0
4665708|NCT02265705|7558612|FG001|Follow-up Period|Sponsor Decision|0
4665709|NCT02265705|7558613|FG002|Follow-up Period|Sponsor Decision|0
4665710|NCT02265705|7558614|FG003|Follow-up Period|Sponsor Decision|0
4665711|NCT02265705|7558615|FG004|Follow-up Period|Sponsor Decision|0
4665712|NCT02265705|7558616|FG005|Follow-up Period|Sponsor Decision|1
4665713|NCT02265705|7558617|FG006|Follow-up Period|Sponsor Decision|6
4665714|NCT02265705|7558611|FG000|Follow-up Period|Adverse Event|0
4665715|NCT02265705|7558612|FG001|Follow-up Period|Adverse Event|0
4665716|NCT02265705|7558613|FG002|Follow-up Period|Adverse Event|0
4665717|NCT02265705|7558614|FG003|Follow-up Period|Adverse Event|0
4665718|NCT02265705|7558615|FG004|Follow-up Period|Adverse Event|0
4665719|NCT02265705|7558616|FG005|Follow-up Period|Adverse Event|0
4665720|NCT02265705|7558617|FG006|Follow-up Period|Adverse Event|3
4665721|NCT02265705|7558611|FG000|Follow-up Period|Physician Decision|0
4665722|NCT02265705|7558612|FG001|Follow-up Period|Physician Decision|0
4665723|NCT02265705|7558613|FG002|Follow-up Period|Physician Decision|0
4665724|NCT02265705|7558614|FG003|Follow-up Period|Physician Decision|0
4665725|NCT02265705|7558615|FG004|Follow-up Period|Physician Decision|0
4665726|NCT02265705|7558616|FG005|Follow-up Period|Physician Decision|0
4665727|NCT02265705|7558617|FG006|Follow-up Period|Physician Decision|1
4665728|NCT02265705|7558611|FG000|Follow-up Period|Withdrawal by Subject|0
4665729|NCT02265705|7558612|FG001|Follow-up Period|Withdrawal by Subject|0
4665730|NCT02265705|7558613|FG002|Follow-up Period|Withdrawal by Subject|0
4665731|NCT02265705|7558614|FG003|Follow-up Period|Withdrawal by Subject|0
4665732|NCT02265705|7558615|FG004|Follow-up Period|Withdrawal by Subject|0
4665733|NCT02265705|7558616|FG005|Follow-up Period|Withdrawal by Subject|0
4665734|NCT02265705|7558617|FG006|Follow-up Period|Withdrawal by Subject|1
4665735|NCT02265744|7558633|FG000|Overall Study|Poor/Non-compliance|1
4665736|NCT02265744|7558634|FG001|Overall Study|Poor/Non-compliance|1
4665737|NCT02265744|7558635|FG002|Overall Study|Poor/Non-compliance|0
4665738|NCT02265744|7558636|FG003|Overall Study|Poor/Non-compliance|0
4665739|NCT02265744|7558637|FG004|Overall Study|Poor/Non-compliance|2
4665740|NCT02265744|7558633|FG000|Overall Study|Lost to Follow-up|0
4665741|NCT02265744|7558634|FG001|Overall Study|Lost to Follow-up|0
4665742|NCT02265744|7558635|FG002|Overall Study|Lost to Follow-up|0
4665743|NCT02265744|7558636|FG003|Overall Study|Lost to Follow-up|1
4665744|NCT02265744|7558637|FG004|Overall Study|Lost to Follow-up|0
4665745|NCT02265744|7558633|FG000|Overall Study|Death|0
4665746|NCT02265744|7558634|FG001|Overall Study|Death|0
4665747|NCT02265744|7558635|FG002|Overall Study|Death|0
4665748|NCT02265744|7558636|FG003|Overall Study|Death|2
4665749|NCT02265744|7558637|FG004|Overall Study|Death|0
4665750|NCT02265744|7558633|FG000|Overall Study|Withdrawal by Subject|2
4665751|NCT02265744|7558634|FG001|Overall Study|Withdrawal by Subject|0
4665752|NCT02265744|7558635|FG002|Overall Study|Withdrawal by Subject|0
4665753|NCT02265744|7558636|FG003|Overall Study|Withdrawal by Subject|2
4665754|NCT02265744|7558637|FG004|Overall Study|Withdrawal by Subject|0
4665755|NCT02265744|7558633|FG000|Overall Study|Participant request to discontinue|2
4665756|NCT02265744|7558634|FG001|Overall Study|Participant request to discontinue|2
4665757|NCT02265744|7558635|FG002|Overall Study|Participant request to discontinue|2
4665758|NCT02265744|7558636|FG003|Overall Study|Participant request to discontinue|0
4665759|NCT02265744|7558637|FG004|Overall Study|Participant request to discontinue|0
4665760|NCT02265744|7558633|FG000|Overall Study|Adverse Event|8
4665761|NCT02265744|7558634|FG001|Overall Study|Adverse Event|4
4665762|NCT02265744|7558635|FG002|Overall Study|Adverse Event|9
4665763|NCT02265744|7558636|FG003|Overall Study|Adverse Event|8
4665764|NCT02265744|7558637|FG004|Overall Study|Adverse Event|2
4665765|NCT02265744|7558633|FG000|Overall Study|Lack of Efficacy|2
4665766|NCT02265744|7558634|FG001|Overall Study|Lack of Efficacy|4
4665767|NCT02265744|7558635|FG002|Overall Study|Lack of Efficacy|3
4665768|NCT02265744|7558636|FG003|Overall Study|Lack of Efficacy|4
4665769|NCT02265744|7558637|FG004|Overall Study|Lack of Efficacy|5
4665770|NCT02265744|7558633|FG000|Overall Study|Reason not provided by Investigator|1
4665771|NCT02265744|7558634|FG001|Overall Study|Reason not provided by Investigator|0
4665772|NCT02265744|7558635|FG002|Overall Study|Reason not provided by Investigator|0
4665773|NCT02265744|7558636|FG003|Overall Study|Reason not provided by Investigator|2
4665774|NCT02265744|7558637|FG004|Overall Study|Reason not provided by Investigator|0
4665775|NCT02265744|7558633|FG000|Overall Study|Administrative reason by sponsor|3
4665776|NCT02265744|7558634|FG001|Overall Study|Administrative reason by sponsor|2
4665777|NCT02265744|7558635|FG002|Overall Study|Administrative reason by sponsor|2
4665778|NCT02265744|7558636|FG003|Overall Study|Administrative reason by sponsor|3
4665779|NCT02265744|7558637|FG004|Overall Study|Administrative reason by sponsor|3
4665780|NCT02265744|7558633|FG000|Overall Study|Subject no longer meets study criteria|0
4665781|NCT02265744|7558634|FG001|Overall Study|Subject no longer meets study criteria|0
4665782|NCT02265744|7558635|FG002|Overall Study|Subject no longer meets study criteria|0
4665783|NCT02265744|7558636|FG003|Overall Study|Subject no longer meets study criteria|0
4665784|NCT02265744|7558637|FG004|Overall Study|Subject no longer meets study criteria|1
4665785|NCT02265744|7558633|FG000|Overall Study|Pregnancy|1
4665786|NCT02265744|7558634|FG001|Overall Study|Pregnancy|2
4665787|NCT02265744|7558635|FG002|Overall Study|Pregnancy|1
4665788|NCT02265744|7558636|FG003|Overall Study|Pregnancy|1
4665789|NCT02265744|7558637|FG004|Overall Study|Pregnancy|0
4665790|NCT02265796|7558655|FG000|Overall Study|Death|1
4665791|NCT02265796|7558656|FG001|Overall Study|Death|0
4665792|NCT02265796|7558655|FG000|Overall Study|started on excluded medication|1
4665793|NCT02265796|7558656|FG001|Overall Study|started on excluded medication|0
4665794|NCT02265796|7558655|FG000|Overall Study|Withdrawal by Subject|1
4665795|NCT02265796|7558656|FG001|Overall Study|Withdrawal by Subject|1
4665796|NCT02265952|7558684|FG000|Open Label Extension (OLE) Period|Physician Decision|0
4665797|NCT02265952|7558685|FG001|Open Label Extension (OLE) Period|Physician Decision|7
4665798|NCT02265952|7558684|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0
4665799|NCT02265952|7558685|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1
4665800|NCT02266004|7558700|FG000|Overall Study|unrelated adverse event|1
4665801|NCT02266004|7558700|FG000|Overall Study|Physician Decision|1
4665802|NCT02266147|7558717|FG000|PART 1: Dose Escalation|Physician Decision|0
4665803|NCT02266147|7558718|FG001|PART 1: Dose Escalation|Physician Decision|0
4665804|NCT02266147|7558719|FG002|PART 1: Dose Escalation|Physician Decision|1
4665805|NCT02266147|7558720|FG003|PART 1: Dose Escalation|Physician Decision|0
4665806|NCT02266147|7558717|FG000|PART 1: Dose Escalation|Lack of Efficacy|0
4665807|NCT02266147|7558718|FG001|PART 1: Dose Escalation|Lack of Efficacy|2
4665808|NCT02266147|7558719|FG002|PART 1: Dose Escalation|Lack of Efficacy|1
4665809|NCT02266147|7558720|FG003|PART 1: Dose Escalation|Lack of Efficacy|1
4665810|NCT02266147|7558717|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0
4665811|NCT02266147|7558718|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0
4665812|NCT02266147|7558719|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1
4665813|NCT02266147|7558720|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3
4665814|NCT02266147|7558717|FG000|PART 1: Dose Escalation|Other|1
4665815|NCT02266147|7558718|FG001|PART 1: Dose Escalation|Other|1
4665816|NCT02266147|7558719|FG002|PART 1: Dose Escalation|Other|0
4665817|NCT02266147|7558720|FG003|PART 1: Dose Escalation|Other|0
4665818|NCT02266147|7558717|FG000|PART 2: Dose Expansion|Lack of Efficacy|1
4665819|NCT02266147|7558718|FG001|PART 2: Dose Expansion|Lack of Efficacy|0
4665820|NCT02266147|7558719|FG002|PART 2: Dose Expansion|Lack of Efficacy|0
4665821|NCT02266147|7558720|FG003|PART 2: Dose Expansion|Lack of Efficacy|1
4665822|NCT02266147|7558717|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6
4665823|NCT02266147|7558718|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0
4665824|NCT02266147|7558719|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0
4665825|NCT02266147|7558720|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8
4665826|NCT02266225|7558732|FG000|Overall Study|Lost to Follow-up|2
4665827|NCT02266225|7558732|FG000|Overall Study|Death|1
4665828|NCT02266225|7558732|FG000|Overall Study|Withdrawal by Subject|13
4752695|NCT02326974|7727319|FG000|Overall Study|Withdrawal by Subject|2
4752696|NCT02326974|7727319|FG000|Overall Study|failed heterogenity evaluation|5
4752697|NCT02284568|7727330|FG000|Overall Study|Adverse Event|2
4752698|NCT02284568|7727331|FG001|Overall Study|Adverse Event|9
4752699|NCT02284568|7727332|FG002|Overall Study|Adverse Event|4
4752700|NCT02284568|7727330|FG000|Overall Study|Withdrawal by Subject|22
4752701|NCT02284568|7727331|FG001|Overall Study|Withdrawal by Subject|21
4752702|NCT02284568|7727332|FG002|Overall Study|Withdrawal by Subject|1
4752703|NCT02284568|7727330|FG000|Overall Study|Noncompliance with study drug admin|1
4752704|NCT02284568|7727331|FG001|Overall Study|Noncompliance with study drug admin|2
4752705|NCT02284568|7727332|FG002|Overall Study|Noncompliance with study drug admin|0
4752706|NCT02284568|7727330|FG000|Overall Study|Noncompliance|1
4752707|NCT02284568|7727331|FG001|Overall Study|Noncompliance|0
4752708|NCT02284568|7727332|FG002|Overall Study|Noncompliance|0
4752709|NCT02284568|7727330|FG000|Overall Study|Protocol Violation|0
4752710|NCT02284568|7727331|FG001|Overall Study|Protocol Violation|1
4752711|NCT02284568|7727332|FG002|Overall Study|Protocol Violation|0
4752712|NCT02284568|7727330|FG000|Overall Study|Sponsor requested patient stop treatment|0
4752713|NCT02284568|7727331|FG001|Overall Study|Sponsor requested patient stop treatment|0
4752714|NCT02284568|7727332|FG002|Overall Study|Sponsor requested patient stop treatment|90
4752715|NCT02284568|7727330|FG000|Overall Study|Lost to Follow-up|0
4752716|NCT02284568|7727331|FG001|Overall Study|Lost to Follow-up|3
4752717|NCT02284568|7727332|FG002|Overall Study|Lost to Follow-up|0
4752718|NCT02284568|7727330|FG000|Overall Study|Lack of Efficacy|4
4752719|NCT02284568|7727331|FG001|Overall Study|Lack of Efficacy|7
4752720|NCT02284568|7727332|FG002|Overall Study|Lack of Efficacy|0
4752721|NCT02284568|7727330|FG000|Overall Study|Other|1
4752722|NCT02284568|7727331|FG001|Overall Study|Other|2
4752723|NCT02284568|7727332|FG002|Overall Study|Other|0
4752724|NCT02284568|7727330|FG000|Overall Study|Withdrew before taking study drug|0
4752725|NCT02284568|7727331|FG001|Overall Study|Withdrew before taking study drug|1
4665829|NCT02266381|7558767|FG000|Overall Study|Physician Decision|3
4665830|NCT02266381|7558768|FG001|Overall Study|Physician Decision|5
4665831|NCT02266381|7558769|FG002|Overall Study|Physician Decision|4
4665832|NCT02266433|7558781|FG000|Overall Study|Lost to Follow-up|54
4665833|NCT02266433|7558782|FG001|Overall Study|Lost to Follow-up|46
4665834|NCT02266433|7558781|FG000|Overall Study|Withdrawal by Subject|5
4665835|NCT02266433|7558782|FG001|Overall Study|Withdrawal by Subject|7
4665836|NCT02266706|7558816|FG000|Overall Study|Withdrawal by Subject|0
4665837|NCT02266706|7558817|FG001|Overall Study|Withdrawal by Subject|1
4665838|NCT02266706|7558818|FG002|Overall Study|Withdrawal by Subject|1
4665839|NCT02266706|7558819|FG003|Overall Study|Withdrawal by Subject|0
4665840|NCT02266706|7558820|FG004|Overall Study|Withdrawal by Subject|0
4665841|NCT02266706|7558821|FG005|Overall Study|Withdrawal by Subject|1
4665842|NCT02266706|7558822|FG006|Overall Study|Withdrawal by Subject|0
4665843|NCT02266706|7558823|FG007|Overall Study|Withdrawal by Subject|0
4665844|NCT02266706|7558824|FG008|Overall Study|Withdrawal by Subject|0
4665845|NCT02266706|7558816|FG000|Overall Study|Screen failure|0
4665846|NCT02266706|7558817|FG001|Overall Study|Screen failure|0
4665847|NCT02266706|7558818|FG002|Overall Study|Screen failure|0
4665848|NCT02266706|7558819|FG003|Overall Study|Screen failure|0
4665849|NCT02266706|7558820|FG004|Overall Study|Screen failure|0
4665850|NCT02266706|7558821|FG005|Overall Study|Screen failure|1
4665851|NCT02266706|7558822|FG006|Overall Study|Screen failure|1
4665852|NCT02266706|7558823|FG007|Overall Study|Screen failure|0
4665853|NCT02266706|7558824|FG008|Overall Study|Screen failure|0
4665854|NCT02266706|7558816|FG000|Overall Study|Enrollment in another study|0
4665855|NCT02266706|7558817|FG001|Overall Study|Enrollment in another study|0
4665856|NCT02266706|7558818|FG002|Overall Study|Enrollment in another study|0
4665857|NCT02266706|7558819|FG003|Overall Study|Enrollment in another study|1
4665858|NCT02266706|7558820|FG004|Overall Study|Enrollment in another study|0
4665859|NCT02266706|7558821|FG005|Overall Study|Enrollment in another study|0
4665860|NCT02266706|7558822|FG006|Overall Study|Enrollment in another study|0
4665861|NCT02266706|7558823|FG007|Overall Study|Enrollment in another study|0
4665862|NCT02266706|7558824|FG008|Overall Study|Enrollment in another study|0
4665863|NCT02266875|7558864|FG000|Overall Study|Withdrawal by Subject|9
4665864|NCT02266875|7558865|FG001|Overall Study|Withdrawal by Subject|0
4665865|NCT02266875|7558864|FG000|Overall Study|Lost to Follow-up|2
4665866|NCT02266875|7558865|FG001|Overall Study|Lost to Follow-up|0
4665867|NCT02266888|7558873|FG000|Overall Study|Death|2
4665868|NCT02266888|7558874|FG001|Overall Study|Death|2
4665869|NCT02266888|7558875|FG002|Overall Study|Death|4
4665870|NCT02266888|7558876|FG003|Overall Study|Death|2
4665871|NCT02266888|7558873|FG000|Overall Study|Physician Decision|0
4665872|NCT02266888|7558874|FG001|Overall Study|Physician Decision|1
4665873|NCT02266888|7558875|FG002|Overall Study|Physician Decision|2
4665874|NCT02266888|7558876|FG003|Overall Study|Physician Decision|2
4665875|NCT02266888|7558873|FG000|Overall Study|Study Terminated|5
4665876|NCT02266888|7558874|FG001|Overall Study|Study Terminated|1
4665877|NCT02266888|7558875|FG002|Overall Study|Study Terminated|0
4665878|NCT02266888|7558876|FG003|Overall Study|Study Terminated|0
4665879|NCT02266888|7558873|FG000|Overall Study|No Longer Eligible|0
4665880|NCT02266888|7558874|FG001|Overall Study|No Longer Eligible|0
4665881|NCT02266888|7558875|FG002|Overall Study|No Longer Eligible|0
4665882|NCT02266888|7558876|FG003|Overall Study|No Longer Eligible|2
4665883|NCT02266888|7558873|FG000|Overall Study|Randomization Closed|0
4665884|NCT02266888|7558874|FG001|Overall Study|Randomization Closed|0
4665885|NCT02266888|7558875|FG002|Overall Study|Randomization Closed|4
4665886|NCT02266888|7558876|FG003|Overall Study|Randomization Closed|0
4665887|NCT02266888|7558873|FG000|Overall Study|Personnel unavailable at transplant|0
4665888|NCT02266888|7558874|FG001|Overall Study|Personnel unavailable at transplant|0
4665889|NCT02266888|7558875|FG002|Overall Study|Personnel unavailable at transplant|0
4665890|NCT02266888|7558876|FG003|Overall Study|Personnel unavailable at transplant|1
4665891|NCT02266888|7558873|FG000|Overall Study|Transfer of care|0
4665892|NCT02266888|7558874|FG001|Overall Study|Transfer of care|0
4665893|NCT02266888|7558875|FG002|Overall Study|Transfer of care|1
4665894|NCT02266888|7558876|FG003|Overall Study|Transfer of care|0
4665895|NCT02267135|7558890|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1
4665896|NCT02267135|7558891|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3
4665897|NCT02267135|7558890|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0
4665898|NCT02267135|7558891|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1
4665899|NCT02267135|7558890|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1
4665900|NCT02267135|7558891|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1
4665901|NCT02267135|7558890|FG000|Period 2 (Randomized Set)|Adverse Event|2
4665902|NCT02267135|7558891|FG001|Period 2 (Randomized Set)|Adverse Event|0
4665903|NCT02267135|7558890|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1
4665904|NCT02267135|7558891|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0
4665905|NCT02267187|7558900|FG000|Overall Study|Physician Decision|2
4665906|NCT02267187|7558900|FG000|Overall Study|Screen fail|3
4665907|NCT02267278|7558923|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1
4665908|NCT02267278|7558923|FG000|Overall Study|transformation to acute leukemia (AML)|1
4665909|NCT02267278|7558923|FG000|Overall Study|Developed new cancer diagnoses|2
4665910|NCT02267278|7558923|FG000|Overall Study|prescribed prohibited medication|1
4665911|NCT02267317|7558930|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1
4665912|NCT02267317|7558931|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
4665913|NCT02267317|7558932|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
4665914|NCT02267317|7558933|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
4665915|NCT02267317|7558934|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
4665916|NCT02267317|7558935|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
4665917|NCT02267317|7558930|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1
4665918|NCT02267317|7558931|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
4665919|NCT02267317|7558932|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
4665920|NCT02267317|7558933|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
4665921|NCT02267317|7558934|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
4665922|NCT02267317|7558935|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
4665923|NCT02267746|7559022|FG000|Overall Study|Adverse Event|0
4665924|NCT02267746|7559023|FG001|Overall Study|Adverse Event|2
4665925|NCT02267746|7559024|FG002|Overall Study|Adverse Event|1
4665926|NCT02267746|7559022|FG000|Overall Study|Protocol Violation|8
4752726|NCT02284568|7727332|FG002|Overall Study|Withdrew before taking study drug|0
4752727|NCT02227238|7727346|FG000|Overall Study|Other: Reached stopping criteria|0
4752728|NCT02227238|7727347|FG001|Overall Study|Other: Reached stopping criteria|1
4752729|NCT02227238|7727346|FG000|Overall Study|Adverse Event|8
4752730|NCT02227238|7727347|FG001|Overall Study|Adverse Event|18
4665927|NCT02267746|7559023|FG001|Overall Study|Protocol Violation|7
4665928|NCT02267746|7559024|FG002|Overall Study|Protocol Violation|3
4665929|NCT02267746|7559022|FG000|Overall Study|Lack of Efficacy|11
4665930|NCT02267746|7559023|FG001|Overall Study|Lack of Efficacy|11
4665931|NCT02267746|7559024|FG002|Overall Study|Lack of Efficacy|15
4665932|NCT02267746|7559022|FG000|Overall Study|Protocol Violation|1
4665933|NCT02267746|7559023|FG001|Overall Study|Protocol Violation|2
4665934|NCT02267746|7559024|FG002|Overall Study|Protocol Violation|1
4665935|NCT02267746|7559022|FG000|Overall Study|Miscellaneous|1
4665936|NCT02267746|7559023|FG001|Overall Study|Miscellaneous|0
4665937|NCT02267746|7559024|FG002|Overall Study|Miscellaneous|1
4665938|NCT02267824|7559056|FG000|Overall Study|Pregnancy|1
4665939|NCT02267824|7559057|FG001|Overall Study|Pregnancy|1
4665940|NCT02267824|7559056|FG000|Overall Study|Lost to Follow-up|4
4665941|NCT02267824|7559057|FG001|Overall Study|Lost to Follow-up|0
4665942|NCT02267824|7559056|FG000|Overall Study|Protocol Violation|3
4665943|NCT02267824|7559057|FG001|Overall Study|Protocol Violation|0
4752731|NCT02227238|7727346|FG000|Overall Study|Lack of Efficacy|10
4752732|NCT02227238|7727347|FG001|Overall Study|Lack of Efficacy|22
4752733|NCT02227238|7727346|FG000|Overall Study|Protocol Violation|7
4752734|NCT02227238|7727347|FG001|Overall Study|Protocol Violation|8
4752735|NCT02227238|7727346|FG000|Overall Study|Withdrawal by Subject|5
4752736|NCT02227238|7727347|FG001|Overall Study|Withdrawal by Subject|4
4752737|NCT02227238|7727346|FG000|Overall Study|Physician Decision|0
4752738|NCT02227238|7727347|FG001|Overall Study|Physician Decision|9
4752739|NCT02227238|7727346|FG000|Overall Study|Lost to Follow-up|7
4665944|NCT02267824|7559056|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2
4665945|NCT02267824|7559057|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0
4665946|NCT02268045|7559083|FG000|Overall Study|Death|4
4665947|NCT02268045|7559084|FG001|Overall Study|Death|4
4665948|NCT02268045|7559083|FG000|Overall Study|Disease Progression|2
4665949|NCT02268045|7559084|FG001|Overall Study|Disease Progression|1
4665950|NCT02268045|7559083|FG000|Overall Study|Adverse Event|7
4665951|NCT02268045|7559084|FG001|Overall Study|Adverse Event|7
4665952|NCT02268045|7559083|FG000|Overall Study|Withdrawal by Subject|2
4665953|NCT02268045|7559084|FG001|Overall Study|Withdrawal by Subject|6
4665954|NCT02268045|7559083|FG000|Overall Study|Physician Decision|0
4665955|NCT02268045|7559084|FG001|Overall Study|Physician Decision|1
4665956|NCT02268045|7559083|FG000|Overall Study|Protocol Violation|1
4665957|NCT02268045|7559084|FG001|Overall Study|Protocol Violation|1
4665958|NCT02268058|7559096|FG000|Overall Study|Protocol Violation|1
4665959|NCT02268058|7559097|FG001|Overall Study|Protocol Violation|0
4665960|NCT02268058|7559098|FG002|Overall Study|Protocol Violation|0
4752740|NCT02227238|7727347|FG001|Overall Study|Lost to Follow-up|5
4752741|NCT02195986|7727356|FG000|Overall Study|Adverse Event|3
4665961|NCT02268058|7559099|FG003|Overall Study|Protocol Violation|0
4665962|NCT02268084|7559111|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0
4665963|NCT02268084|7559112|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3
4665964|NCT02268084|7559111|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9
4665965|NCT02268084|7559112|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4
4665966|NCT02268214|7559127|FG000|Overall Study|Subject no longer meets study criteria|0
4665967|NCT02268214|7559128|FG001|Overall Study|Subject no longer meets study criteria|2
4665968|NCT02268214|7559129|FG002|Overall Study|Subject no longer meets study criteria|0
4665969|NCT02268214|7559127|FG000|Overall Study|Pregnancy|2
4665970|NCT02268214|7559128|FG001|Overall Study|Pregnancy|2
4665971|NCT02268214|7559129|FG002|Overall Study|Pregnancy|1
4665972|NCT02268214|7559127|FG000|Overall Study|Lost to Follow-up|3
4665973|NCT02268214|7559128|FG001|Overall Study|Lost to Follow-up|3
4665974|NCT02268214|7559129|FG002|Overall Study|Lost to Follow-up|4
4665975|NCT02268214|7559127|FG000|Overall Study|Lack of Efficacy|1
4665976|NCT02268214|7559128|FG001|Overall Study|Lack of Efficacy|0
4665977|NCT02268214|7559129|FG002|Overall Study|Lack of Efficacy|2
4665978|NCT02268214|7559127|FG000|Overall Study|Adverse Event|11
4752742|NCT02195986|7727357|FG001|Overall Study|Adverse Event|0
4752743|NCT02195986|7727358|FG002|Overall Study|Adverse Event|0
4752744|NCT02195986|7727356|FG000|Overall Study|Withdrawal by Subject|0
4752745|NCT02195986|7727357|FG001|Overall Study|Withdrawal by Subject|3
4752746|NCT02195986|7727358|FG002|Overall Study|Withdrawal by Subject|0
4752747|NCT02195986|7727356|FG000|Overall Study|Family Emergency|0
4752748|NCT02195986|7727357|FG001|Overall Study|Family Emergency|0
4752749|NCT02195986|7727358|FG002|Overall Study|Family Emergency|1
4752750|NCT02195986|7727356|FG000|Overall Study|Protocol Violation|0
4752751|NCT02195986|7727357|FG001|Overall Study|Protocol Violation|1
4752752|NCT02195986|7727358|FG002|Overall Study|Protocol Violation|1
4752753|NCT02195986|7727356|FG000|Overall Study|Non-compliance|0
4752754|NCT02195986|7727357|FG001|Overall Study|Non-compliance|1
4752755|NCT02195986|7727358|FG002|Overall Study|Non-compliance|0
4752756|NCT02087423|7727378|FG000|Overall Study|Withdrawal by Subject|20
4752757|NCT02087423|7727379|FG001|Overall Study|Withdrawal by Subject|20
4752758|NCT02087423|7727380|FG002|Overall Study|Withdrawal by Subject|3
4752759|NCT02087423|7727378|FG000|Overall Study|Death|68
4752760|NCT02087423|7727379|FG001|Overall Study|Death|207
4752761|NCT02087423|7727380|FG002|Overall Study|Death|40
4752762|NCT02087423|7727378|FG000|Overall Study|Lost to Follow-up|0
4752763|NCT02087423|7727379|FG001|Overall Study|Lost to Follow-up|2
4752764|NCT02087423|7727380|FG002|Overall Study|Lost to Follow-up|0
4752765|NCT02087423|7727378|FG000|Overall Study|Terminated from study at final DCO|23
4752766|NCT02087423|7727379|FG001|Overall Study|Terminated from study at final DCO|36
4752767|NCT02087423|7727380|FG002|Overall Study|Terminated from study at final DCO|25
4752768|NCT02086448|7727394|FG000|Overall Study|Withdrawal by Subject|1
4752769|NCT02086448|7727395|FG001|Overall Study|Withdrawal by Subject|0
4752770|NCT02086448|7727396|FG002|Overall Study|Withdrawal by Subject|0
4752771|NCT02086448|7727397|FG003|Overall Study|Withdrawal by Subject|2
4752772|NCT01982630|7727415|FG000|Overall Study|Adverse Event|2
4752773|NCT01982630|7727416|FG001|Overall Study|Adverse Event|0
4752774|NCT01982630|7727417|FG002|Overall Study|Adverse Event|1
4752775|NCT01982630|7727418|FG003|Overall Study|Adverse Event|0
4752776|NCT01982630|7727419|FG004|Overall Study|Adverse Event|1
4752777|NCT01982630|7727420|FG005|Overall Study|Adverse Event|2
4752778|NCT01982630|7727421|FG006|Overall Study|Adverse Event|1
4752779|NCT01982630|7727422|FG007|Overall Study|Adverse Event|0
4752780|NCT01982630|7727415|FG000|Overall Study|Physician Decision|1
4752781|NCT01982630|7727416|FG001|Overall Study|Physician Decision|0
4752782|NCT01982630|7727417|FG002|Overall Study|Physician Decision|2
4752783|NCT01982630|7727418|FG003|Overall Study|Physician Decision|1
4752784|NCT01982630|7727419|FG004|Overall Study|Physician Decision|2
4665979|NCT02268214|7559128|FG001|Overall Study|Adverse Event|14
4665980|NCT02268214|7559129|FG002|Overall Study|Adverse Event|9
4665981|NCT02268214|7559127|FG000|Overall Study|Withdrawal by Subject|4
4665982|NCT02268214|7559128|FG001|Overall Study|Withdrawal by Subject|5
4665983|NCT02268214|7559129|FG002|Overall Study|Withdrawal by Subject|10
4665984|NCT02268214|7559127|FG000|Overall Study|Subject request to discontinue treatment|10
4665985|NCT02268214|7559128|FG001|Overall Study|Subject request to discontinue treatment|8
4665986|NCT02268214|7559129|FG002|Overall Study|Subject request to discontinue treatment|6
4665987|NCT02268214|7559127|FG000|Overall Study|Poor/non-compliance|2
4665988|NCT02268214|7559128|FG001|Overall Study|Poor/non-compliance|1
4665989|NCT02268214|7559129|FG002|Overall Study|Poor/non-compliance|2
4665990|NCT02268214|7559127|FG000|Overall Study|Other reasons|7
4752785|NCT01982630|7727420|FG005|Overall Study|Physician Decision|0
4752786|NCT01982630|7727421|FG006|Overall Study|Physician Decision|0
4752787|NCT01982630|7727422|FG007|Overall Study|Physician Decision|0
4752788|NCT01982630|7727415|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0
4752789|NCT01982630|7727416|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0
4752790|NCT01982630|7727417|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2
4752791|NCT01982630|7727418|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0
4665991|NCT02268214|7559128|FG001|Overall Study|Other reasons|3
4665992|NCT02268214|7559129|FG002|Overall Study|Other reasons|3
4665993|NCT02268214|7559127|FG000|Overall Study|Not entering long-term period|2
4665994|NCT02268214|7559128|FG001|Overall Study|Not entering long-term period|3
4665995|NCT02268214|7559129|FG002|Overall Study|Not entering long-term period|5
4665996|NCT02268396|7559137|FG000|Overall Study|Adverse Event|3
4665997|NCT02268396|7559137|FG000|Overall Study|Administrative|2
4665998|NCT02268396|7559137|FG000|Overall Study|Withdrawal by Subject|1
4665999|NCT02268396|7559137|FG000|Overall Study|Lost to Follow-up|2
4666000|NCT02268396|7559137|FG000|Overall Study|Protocol-Specified Criteria|2
4666001|NCT02268396|7559137|FG000|Overall Study|2 Subjects no Day 29 Assessment|2
4666002|NCT02268526|7559153|FG000|Overall Study|Adverse Event|0
4666003|NCT02268526|7559154|FG001|Overall Study|Adverse Event|2
4666004|NCT02268526|7559155|FG002|Overall Study|Adverse Event|1
4666005|NCT02268526|7559153|FG000|Overall Study|Death|1
4666006|NCT02268526|7559154|FG001|Overall Study|Death|11
4666007|NCT02268526|7559155|FG002|Overall Study|Death|0
4666008|NCT02268526|7559153|FG000|Overall Study|protocol deviation|0
4666009|NCT02268526|7559154|FG001|Overall Study|protocol deviation|1
4666010|NCT02268526|7559155|FG002|Overall Study|protocol deviation|0
4666011|NCT02268526|7559153|FG000|Overall Study|Physician Decision|0
4666012|NCT02268526|7559154|FG001|Overall Study|Physician Decision|0
4666013|NCT02268526|7559155|FG002|Overall Study|Physician Decision|1
4666014|NCT02268526|7559153|FG000|Overall Study|Subject/guardian decision|0
4666015|NCT02268526|7559154|FG001|Overall Study|Subject/guardian decision|7
4666016|NCT02268526|7559155|FG002|Overall Study|Subject/guardian decision|3
4666017|NCT02268786|7559167|FG000|Overall Study|No Euploid Embryos available|42
4666018|NCT02268786|7559168|FG001|Overall Study|No Euploid Embryos available|0
4666019|NCT02268786|7559167|FG000|Overall Study|Withdrawal by Subject|7
4666020|NCT02268786|7559168|FG001|Overall Study|Withdrawal by Subject|14
4666021|NCT02268786|7559167|FG000|Overall Study|Thaw Failure|6
4666022|NCT02268786|7559168|FG001|Overall Study|Thaw Failure|4
4666023|NCT02268786|7559167|FG000|Overall Study|Protocol Violation|1
4666024|NCT02268786|7559168|FG001|Overall Study|Protocol Violation|0
4666025|NCT02268812|7559178|FG000|Overall Study|Adverse Event|8
4666026|NCT02268812|7559179|FG001|Overall Study|Adverse Event|26
4666027|NCT02268812|7559180|FG002|Overall Study|Adverse Event|7
4666028|NCT02268812|7559181|FG003|Overall Study|Adverse Event|10
4666029|NCT02268812|7559178|FG000|Overall Study|Protocol deviation|0
4666030|NCT02268812|7559179|FG001|Overall Study|Protocol deviation|0
4666031|NCT02268812|7559180|FG002|Overall Study|Protocol deviation|1
4666032|NCT02268812|7559181|FG003|Overall Study|Protocol deviation|0
4666033|NCT02268812|7559178|FG000|Overall Study|Withdrawal by Subject|0
4666034|NCT02268812|7559179|FG001|Overall Study|Withdrawal by Subject|1
4666035|NCT02268812|7559180|FG002|Overall Study|Withdrawal by Subject|0
4666036|NCT02268812|7559181|FG003|Overall Study|Withdrawal by Subject|0
4666037|NCT02268812|7559178|FG000|Overall Study|Physician Decision|3
4666038|NCT02268812|7559179|FG001|Overall Study|Physician Decision|1
4666039|NCT02268812|7559180|FG002|Overall Study|Physician Decision|0
4666040|NCT02268812|7559181|FG003|Overall Study|Physician Decision|1
4666041|NCT02268812|7559178|FG000|Overall Study|Other|5
4666042|NCT02268812|7559179|FG001|Overall Study|Other|4
4666043|NCT02268812|7559180|FG002|Overall Study|Other|1
4666044|NCT02268812|7559181|FG003|Overall Study|Other|3
4666045|NCT02268851|7559197|FG000|Overall Study|Death|0
4666046|NCT02268851|7559198|FG001|Overall Study|Death|0
4666047|NCT02268851|7559199|FG002|Overall Study|Death|0
4666048|NCT02268851|7559200|FG003|Overall Study|Death|1
4666049|NCT02268851|7559201|FG004|Overall Study|Death|2
4666050|NCT02268851|7559202|FG005|Overall Study|Death|1
4666051|NCT02268851|7559197|FG000|Overall Study|Adverse Event|0
4666052|NCT02268851|7559198|FG001|Overall Study|Adverse Event|0
4666053|NCT02268851|7559199|FG002|Overall Study|Adverse Event|0
4666054|NCT02268851|7559200|FG003|Overall Study|Adverse Event|0
4666055|NCT02268851|7559201|FG004|Overall Study|Adverse Event|2
4666056|NCT02268851|7559202|FG005|Overall Study|Adverse Event|2
4666057|NCT02268851|7559197|FG000|Overall Study|Withdrawal by Subject|0
4666058|NCT02268851|7559198|FG001|Overall Study|Withdrawal by Subject|0
4666059|NCT02268851|7559199|FG002|Overall Study|Withdrawal by Subject|0
4666060|NCT02268851|7559200|FG003|Overall Study|Withdrawal by Subject|2
4666061|NCT02268851|7559201|FG004|Overall Study|Withdrawal by Subject|0
4666062|NCT02268851|7559202|FG005|Overall Study|Withdrawal by Subject|1
4752792|NCT01982630|7727419|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0
4752793|NCT01982630|7727420|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0
4752794|NCT01982630|7727421|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0
4752795|NCT01982630|7727422|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0
4666063|NCT02268851|7559197|FG000|Overall Study|Progressive Disease|1
4666064|NCT02268851|7559198|FG001|Overall Study|Progressive Disease|3
4666065|NCT02268851|7559199|FG002|Overall Study|Progressive Disease|0
4666066|NCT02268851|7559200|FG003|Overall Study|Progressive Disease|0
4666067|NCT02268851|7559201|FG004|Overall Study|Progressive Disease|1
4666068|NCT02268851|7559202|FG005|Overall Study|Progressive Disease|4
4666069|NCT02268851|7559197|FG000|Overall Study|Physician Decision|0
4752796|NCT01982630|7727415|FG000|Overall Study|Withdrawal by Subject|0
4666070|NCT02268851|7559198|FG001|Overall Study|Physician Decision|0
4666071|NCT02268851|7559199|FG002|Overall Study|Physician Decision|1
4666072|NCT02268851|7559200|FG003|Overall Study|Physician Decision|0
4752797|NCT01982630|7727416|FG001|Overall Study|Withdrawal by Subject|0
4752798|NCT01982630|7727417|FG002|Overall Study|Withdrawal by Subject|0
4752799|NCT01982630|7727418|FG003|Overall Study|Withdrawal by Subject|0
4752800|NCT01982630|7727419|FG004|Overall Study|Withdrawal by Subject|0
4752801|NCT01982630|7727420|FG005|Overall Study|Withdrawal by Subject|1
4752802|NCT01982630|7727421|FG006|Overall Study|Withdrawal by Subject|0
4752803|NCT01982630|7727422|FG007|Overall Study|Withdrawal by Subject|0
4752804|NCT01982448|7727477|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2
4752805|NCT01982448|7727478|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2
4752806|NCT01982448|7727477|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1
4752807|NCT01982448|7727478|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0
4752808|NCT01982448|7727477|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0
4752809|NCT01982448|7727478|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2
4752810|NCT01982448|7727477|FG000|Preoperative Chemotherapy|Lost to Follow-up|0
4752811|NCT01982448|7727478|FG001|Preoperative Chemotherapy|Lost to Follow-up|1
4666073|NCT02268851|7559201|FG004|Overall Study|Physician Decision|0
4666074|NCT02268851|7559202|FG005|Overall Study|Physician Decision|1
4666075|NCT02268851|7559197|FG000|Overall Study|Patient Compliance|0
4666076|NCT02268851|7559198|FG001|Overall Study|Patient Compliance|0
4666077|NCT02268851|7559199|FG002|Overall Study|Patient Compliance|0
4666078|NCT02268851|7559200|FG003|Overall Study|Patient Compliance|0
4666079|NCT02268851|7559201|FG004|Overall Study|Patient Compliance|1
4666080|NCT02268851|7559202|FG005|Overall Study|Patient Compliance|1
4666081|NCT02268851|7559197|FG000|Overall Study|Co-Morbid Condition|0
4666082|NCT02268851|7559198|FG001|Overall Study|Co-Morbid Condition|0
4666083|NCT02268851|7559199|FG002|Overall Study|Co-Morbid Condition|0
4666084|NCT02268851|7559200|FG003|Overall Study|Co-Morbid Condition|0
4666085|NCT02268851|7559201|FG004|Overall Study|Co-Morbid Condition|1
4666086|NCT02268851|7559202|FG005|Overall Study|Co-Morbid Condition|1
4666087|NCT02268864|7559219|FG000|Overall Study|Withdrawal by Subject|2
4666088|NCT02268864|7559220|FG001|Overall Study|Withdrawal by Subject|0
4666089|NCT02268864|7559221|FG002|Overall Study|Withdrawal by Subject|0
4666090|NCT02268864|7559219|FG000|Overall Study|Death|0
4666091|NCT02268864|7559220|FG001|Overall Study|Death|1
4666092|NCT02268864|7559221|FG002|Overall Study|Death|0
4666093|NCT02269098|7559267|FG000|Overall Study|Lost to Follow-up|14
4666094|NCT02269098|7559268|FG001|Overall Study|Lost to Follow-up|9
4666095|NCT02269124|7559277|FG000|Overall Study|Lost to Follow-up|1
4666096|NCT02269124|7559278|FG001|Overall Study|Lost to Follow-up|0
4666097|NCT02269124|7559277|FG000|Overall Study|Withdrawal by Subject|0
4666098|NCT02269124|7559278|FG001|Overall Study|Withdrawal by Subject|2
4666099|NCT02269163|7559287|FG000|Overall Study|Lost to Follow-up|1
4666100|NCT02269163|7559288|FG001|Overall Study|Lost to Follow-up|0
4666101|NCT02269163|7559287|FG000|Overall Study|Major protocol violation|0
4666102|NCT02269163|7559288|FG001|Overall Study|Major protocol violation|1
4666103|NCT02269163|7559287|FG000|Overall Study|Other|2
4666104|NCT02269163|7559288|FG001|Overall Study|Other|2
4666105|NCT02269163|7559287|FG000|Overall Study|Withdrawal by Subject|0
4666106|NCT02269163|7559288|FG001|Overall Study|Withdrawal by Subject|3
4666107|NCT02269163|7559287|FG000|Overall Study|Physician Decision|0
4666108|NCT02269163|7559288|FG001|Overall Study|Physician Decision|1
4666109|NCT02269241|7559296|FG000|Overall Study|Lost to Follow-up|269
4666110|NCT02269241|7559296|FG000|Overall Study|Withdrawal by Subject|155
4666111|NCT02269241|7559296|FG000|Overall Study|Protocol Violation|1
4666112|NCT02269241|7559296|FG000|Overall Study|Physician Decision|7
4666113|NCT02269241|7559296|FG000|Overall Study|Pregnancy|15
4666114|NCT02269241|7559296|FG000|Overall Study|Wish for pregnancy|5
4666115|NCT02269241|7559296|FG000|Overall Study|Development of an exclusion criteria|16
4666116|NCT02269241|7559296|FG000|Overall Study|Adverse Event|113
4666117|NCT02269241|7559296|FG000|Overall Study|At the specific request of the sponsor|20
4666118|NCT02269241|7559296|FG000|Overall Study|Several reasons not classified|53
4666119|NCT02269241|7559296|FG000|Overall Study|Screening failures|546
4666120|NCT02269423|7559305|FG000|Overall Study|Discontinued due to change in residence|0
4666121|NCT02269423|7559306|FG001|Overall Study|Discontinued due to change in residence|1
4666122|NCT02269423|7559307|FG002|Overall Study|Discontinued due to change in residence|0
4666123|NCT02269423|7559308|FG003|Overall Study|Discontinued due to change in residence|1
4666124|NCT02269475|7559320|FG000|Overall Study|Meet Exclusion Criteria No. 17|3
4666125|NCT02269475|7559321|FG001|Overall Study|Meet Exclusion Criteria No. 17|0
4666126|NCT02269475|7559320|FG000|Overall Study|Withdrawal by Subject|0
4666127|NCT02269475|7559321|FG001|Overall Study|Withdrawal by Subject|1
4666128|NCT02269657|7559341|FG000|Overall Study|Protocol Violation|3
4666129|NCT02269709|7559347|FG000|Time of Enrollment|Withdrawal by Subject|3
4666130|NCT02269709|7559347|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1
4666131|NCT02269709|7559347|FG000|Six Month Follow-up|Lost to Follow-up|12
4666132|NCT02269787|7559354|FG000|Overall Study|Lost to Follow-up|20
4666133|NCT02269787|7559355|FG001|Overall Study|Lost to Follow-up|6
4666134|NCT02269787|7559354|FG000|Overall Study|Death|2
4666135|NCT02269787|7559355|FG001|Overall Study|Death|3
4666136|NCT02269787|7559354|FG000|Overall Study|Incapacitated|0
4666137|NCT02269787|7559355|FG001|Overall Study|Incapacitated|1
4666138|NCT02269943|7559363|FG000|Treatment Period|Death|0
4666139|NCT02269943|7559364|FG001|Treatment Period|Death|1
4666140|NCT02269943|7559363|FG000|Treatment Period|Adverse Event|1
4666141|NCT02269943|7559364|FG001|Treatment Period|Adverse Event|10
4666142|NCT02269943|7559363|FG000|Treatment Period|Progressive Disease|5
4666143|NCT02269943|7559364|FG001|Treatment Period|Progressive Disease|17
4666144|NCT02269943|7559363|FG000|Treatment Period|Symptomatic Deterioration|0
4666145|NCT02269943|7559364|FG001|Treatment Period|Symptomatic Deterioration|2
4666146|NCT02269943|7559363|FG000|Follow-Up Survival Period|Death|3
4666147|NCT02269943|7559364|FG001|Follow-Up Survival Period|Death|16
4666148|NCT02269943|7559363|FG000|Follow-Up Survival Period|Lost to Follow-up|0
4666149|NCT02269943|7559364|FG001|Follow-Up Survival Period|Lost to Follow-up|2
4666150|NCT02269943|7559363|FG000|Follow-Up Survival Period|Alive|2
4666151|NCT02269943|7559364|FG001|Follow-Up Survival Period|Alive|8
4666152|NCT02270242|7559385|FG000|Overall Study|Withdrawal by Subject|18
4666153|NCT02270242|7559386|FG001|Overall Study|Withdrawal by Subject|25
4666154|NCT02270242|7559385|FG000|Overall Study|Lost to Follow-up|41
4666155|NCT02270242|7559386|FG001|Overall Study|Lost to Follow-up|27
4666156|NCT02270242|7559385|FG000|Overall Study|Physician Decision|0
4666157|NCT02270242|7559386|FG001|Overall Study|Physician Decision|1
4666158|NCT02270515|7559401|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1
4666159|NCT02270515|7559401|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5
4666160|NCT02270515|7559401|FG000|Intervention Period 1: 0-6 Months|Received transplant|3
4666161|NCT02270515|7559401|FG000|Intervention Period 1: 0-6 Months|Death|7
4666162|NCT02270515|7559401|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2
4666163|NCT02270515|7559401|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7
4666164|NCT02270515|7559401|FG000|Intervention Period 2: 6-12 Months|Received transplant|1
4666165|NCT02270515|7559401|FG000|Intervention Period 2: 6-12 Months|Death|5
4666166|NCT02270515|7559401|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17
4666167|NCT02270515|7559401|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1
4666168|NCT02270515|7559401|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2
4666169|NCT02270515|7559401|FG000|Intervention Period 3: 12-18 Months|Received transplant|2
4666170|NCT02270515|7559401|FG000|Intervention Period 3: 12-18 Months|Death|3
4752812|NCT01752920|7727510|FG000|Overall Study|Adverse Event|1
4752813|NCT01752920|7727511|FG001|Overall Study|Adverse Event|0
4752814|NCT01752920|7727512|FG002|Overall Study|Adverse Event|5
4752815|NCT01752920|7727513|FG003|Overall Study|Adverse Event|10
4752816|NCT01752920|7727510|FG000|Overall Study|Clinical Disease Progression|6
4752817|NCT01752920|7727511|FG001|Overall Study|Clinical Disease Progression|4
4752818|NCT01752920|7727512|FG002|Overall Study|Clinical Disease Progression|1
4752819|NCT01752920|7727513|FG003|Overall Study|Clinical Disease Progression|13
4752820|NCT01752920|7727510|FG000|Overall Study|Physician Decision|1
4752821|NCT01752920|7727511|FG001|Overall Study|Physician Decision|0
4752822|NCT01752920|7727512|FG002|Overall Study|Physician Decision|0
4752823|NCT01752920|7727513|FG003|Overall Study|Physician Decision|3
4752824|NCT01752920|7727510|FG000|Overall Study|Radiographic Disease Progression|20
4752825|NCT01752920|7727511|FG001|Overall Study|Radiographic Disease Progression|7
4752826|NCT01752920|7727512|FG002|Overall Study|Radiographic Disease Progression|12
4752827|NCT01752920|7727513|FG003|Overall Study|Radiographic Disease Progression|29
4752828|NCT01752920|7727510|FG000|Overall Study|Study Terminated by Sponsor|0
4752829|NCT01752920|7727511|FG001|Overall Study|Study Terminated by Sponsor|0
4752830|NCT01752920|7727512|FG002|Overall Study|Study Terminated by Sponsor|0
4752831|NCT01752920|7727513|FG003|Overall Study|Study Terminated by Sponsor|1
4752832|NCT01752920|7727510|FG000|Overall Study|Withdrawal by Subject|0
4752833|NCT01752920|7727511|FG001|Overall Study|Withdrawal by Subject|1
4752834|NCT01752920|7727512|FG002|Overall Study|Withdrawal by Subject|0
4752835|NCT01752920|7727513|FG003|Overall Study|Withdrawal by Subject|1
4752836|NCT01752920|7727510|FG000|Overall Study|Lack of clinical benefit|1
4752837|NCT01752920|7727511|FG001|Overall Study|Lack of clinical benefit|1
4752838|NCT01752920|7727512|FG002|Overall Study|Lack of clinical benefit|1
4752839|NCT01752920|7727513|FG003|Overall Study|Lack of clinical benefit|1
4752840|NCT01744093|7727527|FG000|Overall Study|Withdrawal by Subject|6
4752841|NCT01744093|7727528|FG001|Overall Study|Withdrawal by Subject|1
4752842|NCT01740297|7727545|FG000|Overall Study|Withdrawal by Subject|4
4752843|NCT01740297|7727546|FG001|Overall Study|Withdrawal by Subject|16
4752844|NCT01740297|7727547|FG002|Overall Study|Withdrawal by Subject|17
4666171|NCT02270515|7559401|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16
4666172|NCT02270671|7559423|FG000|Overall Study|Withdrawal by Subject|1
4666173|NCT02270671|7559424|FG001|Overall Study|Withdrawal by Subject|1
4666174|NCT02270671|7559423|FG000|Overall Study|Protocol Violation|0
4666175|NCT02270671|7559424|FG001|Overall Study|Protocol Violation|1
4666176|NCT02270671|7559423|FG000|Overall Study|Missed Post-intervention Data Collection|2
4666177|NCT02270671|7559424|FG001|Overall Study|Missed Post-intervention Data Collection|2
4666178|NCT02270671|7559423|FG000|Overall Study|Lost to Follow-up|2
4666179|NCT02270671|7559424|FG001|Overall Study|Lost to Follow-up|1
4666180|NCT02270736|7559433|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0
4666181|NCT02270736|7559434|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1
4666182|NCT02270736|7559435|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0
4666183|NCT02270736|7559436|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0
4666184|NCT02270736|7559437|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0
4666185|NCT02270736|7559433|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2
4666186|NCT02270736|7559434|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0
4666187|NCT02270736|7559435|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1
4666188|NCT02270736|7559436|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0
4666189|NCT02270736|7559437|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0
4666190|NCT02270736|7559433|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0
4666191|NCT02270736|7559434|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1
4666192|NCT02270736|7559435|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0
4666193|NCT02270736|7559436|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0
4666194|NCT02270736|7559437|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0
4666195|NCT02270736|7559433|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0
4666196|NCT02270736|7559434|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0
4666197|NCT02270736|7559435|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1
4666198|NCT02270736|7559436|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0
4666199|NCT02270736|7559437|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0
4666200|NCT02270736|7559433|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0
4666201|NCT02270736|7559434|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0
4666202|NCT02270736|7559435|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0
4666203|NCT02270736|7559436|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1
4666204|NCT02270736|7559437|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0
4666205|NCT02270736|7559433|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0
4666206|NCT02270736|7559434|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0
4666207|NCT02270736|7559435|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0
4666208|NCT02270736|7559436|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2
4666209|NCT02270736|7559437|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0
4752845|NCT01740297|7727545|FG000|Overall Study|Death|8
4752846|NCT01740297|7727546|FG001|Overall Study|Death|46
4666210|NCT02270736|7559433|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0
4666211|NCT02270736|7559434|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0
4666212|NCT02270736|7559435|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0
4666213|NCT02270736|7559436|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4
4666214|NCT02270736|7559437|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0
4666215|NCT02270736|7559433|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0
4666216|NCT02270736|7559434|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0
4666217|NCT02270736|7559435|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0
4666218|NCT02270736|7559436|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16
4666219|NCT02270736|7559437|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0
4666220|NCT02270736|7559433|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0
4666221|NCT02270736|7559434|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0
4666222|NCT02270736|7559435|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0
4666223|NCT02270736|7559436|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2
4666224|NCT02270736|7559437|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0
4666225|NCT02270944|7559452|FG000|Overall Study|Lost to Follow-up|9
4666226|NCT02270944|7559453|FG001|Overall Study|Lost to Follow-up|4
4666227|NCT02270944|7559452|FG000|Overall Study|Withdrawal by Subject|2
4666228|NCT02270944|7559453|FG001|Overall Study|Withdrawal by Subject|1
4666229|NCT02270983|7559463|FG000|Overall Study|Adverse Event|3
4666230|NCT02270983|7559464|FG001|Overall Study|Adverse Event|2
4666231|NCT02270983|7559465|FG002|Overall Study|Adverse Event|6
4666232|NCT02270983|7559463|FG000|Overall Study|Lack of Efficacy|2
4666233|NCT02270983|7559464|FG001|Overall Study|Lack of Efficacy|1
4666234|NCT02270983|7559465|FG002|Overall Study|Lack of Efficacy|1
4666235|NCT02270983|7559463|FG000|Overall Study|Withdrawal by Subject|1
4666236|NCT02270983|7559464|FG001|Overall Study|Withdrawal by Subject|0
4666237|NCT02270983|7559465|FG002|Overall Study|Withdrawal by Subject|2
4666238|NCT02270983|7559463|FG000|Overall Study|Lost to Follow-up|1
4666239|NCT02270983|7559464|FG001|Overall Study|Lost to Follow-up|1
4666240|NCT02270983|7559465|FG002|Overall Study|Lost to Follow-up|2
4666241|NCT02270983|7559463|FG000|Overall Study|Protocol Violation|1
4666242|NCT02270983|7559464|FG001|Overall Study|Protocol Violation|1
4666243|NCT02270983|7559465|FG002|Overall Study|Protocol Violation|1
4666244|NCT02270983|7559463|FG000|Overall Study|family emergency|0
4666245|NCT02270983|7559464|FG001|Overall Study|family emergency|1
4666246|NCT02270983|7559465|FG002|Overall Study|family emergency|0
4666247|NCT02270983|7559463|FG000|Overall Study|study procedure non-compliance|1
4666248|NCT02270983|7559464|FG001|Overall Study|study procedure non-compliance|0
4666249|NCT02270983|7559465|FG002|Overall Study|study procedure non-compliance|0
4666250|NCT02270983|7559463|FG000|Overall Study|moved away from study site|0
4666251|NCT02270983|7559464|FG001|Overall Study|moved away from study site|1
4666252|NCT02270983|7559465|FG002|Overall Study|moved away from study site|0
4666253|NCT02271529|7559531|FG000|Overall Study|Withdrawal by Subject|1
4666254|NCT02271854|7559552|FG000|Overall Study|Withdrawal by Subject|2
4666255|NCT02271854|7559552|FG000|Overall Study|Unable or unwilling to cooperate with st|1
4666256|NCT02271854|7559552|FG000|Overall Study|Lost to Follow-up|1
4666257|NCT02271880|7559559|FG000|Overall Study|Premature discontinuation of study|3
4666258|NCT02271880|7559560|FG001|Overall Study|Premature discontinuation of study|4
4666259|NCT02271945|7559574|FG000|Overall Study|Death|3
4666260|NCT02271945|7559575|FG001|Overall Study|Death|3
4752847|NCT01740297|7727547|FG002|Overall Study|Death|40
4752848|NCT01740297|7727545|FG000|Overall Study|Lost to Follow-up|1
4752849|NCT01740297|7727546|FG001|Overall Study|Lost to Follow-up|2
4752850|NCT01740297|7727547|FG002|Overall Study|Lost to Follow-up|4
4752851|NCT01729754|7727561|FG000|Part 1|Adverse Event|2
4752852|NCT01729754|7727562|FG001|Part 1|Adverse Event|0
4752853|NCT01729754|7727563|FG002|Part 1|Adverse Event|0
4752854|NCT01729754|7727564|FG003|Part 1|Adverse Event|1
4752855|NCT01729754|7727565|FG004|Part 1|Adverse Event|0
4752856|NCT01729754|7727566|FG005|Part 1|Adverse Event|0
4752857|NCT01729754|7727567|FG006|Part 1|Adverse Event|2
4752858|NCT01729754|7727568|FG007|Part 1|Adverse Event|0
4752859|NCT01729754|7727569|FG008|Part 1|Adverse Event|0
4752860|NCT01729754|7727570|FG009|Part 1|Adverse Event|5
4752861|NCT01729754|7727561|FG000|Part 1|Lack of Efficacy|1
4752862|NCT01729754|7727562|FG001|Part 1|Lack of Efficacy|0
4752863|NCT01729754|7727563|FG002|Part 1|Lack of Efficacy|0
4752864|NCT01729754|7727564|FG003|Part 1|Lack of Efficacy|0
4752865|NCT01729754|7727565|FG004|Part 1|Lack of Efficacy|0
4666261|NCT02271945|7559574|FG000|Overall Study|Withdrawal by Subject|1
4666262|NCT02271945|7559575|FG001|Overall Study|Withdrawal by Subject|1
4666263|NCT02271945|7559574|FG000|Overall Study|Other|1
4666264|NCT02271945|7559575|FG001|Overall Study|Other|1
4666265|NCT02271984|7559581|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0
4666266|NCT02271984|7559582|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0
4666267|NCT02271984|7559583|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0
4666268|NCT02271984|7559584|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0
4666269|NCT02271984|7559585|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0
4666270|NCT02271984|7559586|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1
4752866|NCT01729754|7727566|FG005|Part 1|Lack of Efficacy|0
4752867|NCT01729754|7727567|FG006|Part 1|Lack of Efficacy|2
4752868|NCT01729754|7727568|FG007|Part 1|Lack of Efficacy|0
4752869|NCT01729754|7727569|FG008|Part 1|Lack of Efficacy|0
4666271|NCT02271984|7559587|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0
4666272|NCT02271984|7559588|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1
4666273|NCT02271984|7559589|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0
4666274|NCT02271984|7559590|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0
4666275|NCT02271984|7559591|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0
4666276|NCT02271984|7559592|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0
4666277|NCT02272413|7559618|FG000|Randomized Through Treatment Start|Not treated|3
4666278|NCT02272413|7559619|FG001|Randomized Through Treatment Start|Not treated|5
4666279|NCT02272413|7559618|FG000|Pre-switch Period|Adverse Event|38
4666280|NCT02272413|7559619|FG001|Pre-switch Period|Adverse Event|37
4666281|NCT02272413|7559618|FG000|Pre-switch Period|Death|26
4666282|NCT02272413|7559619|FG001|Pre-switch Period|Death|26
4666283|NCT02272413|7559618|FG000|Pre-switch Period|Withdrawal by Subject|27
4666284|NCT02272413|7559619|FG001|Pre-switch Period|Withdrawal by Subject|15
4666285|NCT02272413|7559618|FG000|Pre-switch Period|Physician Decision|6
4666286|NCT02272413|7559619|FG001|Pre-switch Period|Physician Decision|18
4666287|NCT02272413|7559618|FG000|Pre-switch Period|Progressive disease|185
4666288|NCT02272413|7559619|FG001|Pre-switch Period|Progressive disease|173
4666289|NCT02272413|7559618|FG000|Pre-switch Period|Lost to Follow-up|0
4666290|NCT02272413|7559619|FG001|Pre-switch Period|Lost to Follow-up|2
4666291|NCT02272413|7559618|FG000|Pre-switch Period|Protocol Violation|1
4666292|NCT02272413|7559619|FG001|Pre-switch Period|Protocol Violation|0
4752870|NCT01729754|7727570|FG009|Part 1|Lack of Efficacy|0
4752871|NCT01729754|7727561|FG000|Part 1|Lost to Follow-up|1
4752872|NCT01729754|7727562|FG001|Part 1|Lost to Follow-up|0
4752873|NCT01729754|7727563|FG002|Part 1|Lost to Follow-up|0
4752874|NCT01729754|7727564|FG003|Part 1|Lost to Follow-up|2
4752875|NCT01729754|7727565|FG004|Part 1|Lost to Follow-up|0
4752876|NCT01729754|7727566|FG005|Part 1|Lost to Follow-up|0
4752877|NCT01729754|7727567|FG006|Part 1|Lost to Follow-up|3
4752878|NCT01729754|7727568|FG007|Part 1|Lost to Follow-up|0
4752879|NCT01729754|7727569|FG008|Part 1|Lost to Follow-up|0
4752880|NCT01729754|7727570|FG009|Part 1|Lost to Follow-up|3
4752881|NCT01729754|7727561|FG000|Part 1|Non-compliance with Study Drug|1
4752882|NCT01729754|7727562|FG001|Part 1|Non-compliance with Study Drug|0
4752883|NCT01729754|7727563|FG002|Part 1|Non-compliance with Study Drug|0
4752884|NCT01729754|7727564|FG003|Part 1|Non-compliance with Study Drug|0
4752885|NCT01729754|7727565|FG004|Part 1|Non-compliance with Study Drug|0
4752886|NCT01729754|7727566|FG005|Part 1|Non-compliance with Study Drug|0
4752887|NCT01729754|7727567|FG006|Part 1|Non-compliance with Study Drug|0
4752888|NCT01729754|7727568|FG007|Part 1|Non-compliance with Study Drug|0
4752889|NCT01729754|7727569|FG008|Part 1|Non-compliance with Study Drug|0
4752890|NCT01729754|7727570|FG009|Part 1|Non-compliance with Study Drug|0
4752891|NCT01729754|7727561|FG000|Part 1|Physician Decision|0
4752892|NCT01729754|7727562|FG001|Part 1|Physician Decision|0
4752893|NCT01729754|7727563|FG002|Part 1|Physician Decision|0
4752894|NCT01729754|7727564|FG003|Part 1|Physician Decision|0
4752895|NCT01729754|7727565|FG004|Part 1|Physician Decision|0
4752896|NCT01729754|7727566|FG005|Part 1|Physician Decision|0
4752897|NCT01729754|7727567|FG006|Part 1|Physician Decision|0
4752898|NCT01729754|7727568|FG007|Part 1|Physician Decision|0
4752899|NCT01729754|7727569|FG008|Part 1|Physician Decision|0
4752900|NCT01729754|7727570|FG009|Part 1|Physician Decision|4
4752901|NCT01729754|7727561|FG000|Part 1|Pregnancy|0
4752902|NCT01729754|7727562|FG001|Part 1|Pregnancy|0
4752903|NCT01729754|7727563|FG002|Part 1|Pregnancy|0
4752904|NCT01729754|7727564|FG003|Part 1|Pregnancy|1
4752905|NCT01729754|7727565|FG004|Part 1|Pregnancy|0
4752906|NCT01729754|7727566|FG005|Part 1|Pregnancy|0
4752907|NCT01729754|7727567|FG006|Part 1|Pregnancy|0
4752908|NCT01729754|7727568|FG007|Part 1|Pregnancy|0
4752909|NCT01729754|7727569|FG008|Part 1|Pregnancy|0
4752910|NCT01729754|7727570|FG009|Part 1|Pregnancy|1
4752911|NCT01729754|7727561|FG000|Part 1|Progressive Disease|0
4752912|NCT01729754|7727562|FG001|Part 1|Progressive Disease|0
4752913|NCT01729754|7727563|FG002|Part 1|Progressive Disease|0
4752914|NCT01729754|7727564|FG003|Part 1|Progressive Disease|0
4752915|NCT01729754|7727565|FG004|Part 1|Progressive Disease|0
4752916|NCT01729754|7727566|FG005|Part 1|Progressive Disease|0
4666293|NCT02272413|7559618|FG000|Pre-switch Period|Other than listed|10
4666294|NCT02272413|7559619|FG001|Pre-switch Period|Other than listed|11
4666295|NCT02272413|7559618|FG000|Post-switch Period|Adverse Event|4
4666296|NCT02272413|7559619|FG001|Post-switch Period|Adverse Event|4
4752917|NCT01729754|7727567|FG006|Part 1|Progressive Disease|0
4752918|NCT01729754|7727568|FG007|Part 1|Progressive Disease|0
4752919|NCT01729754|7727569|FG008|Part 1|Progressive Disease|0
4752920|NCT01729754|7727570|FG009|Part 1|Progressive Disease|1
4752921|NCT01729754|7727561|FG000|Part 1|Protocol Violation|2
4752922|NCT01729754|7727562|FG001|Part 1|Protocol Violation|0
4752923|NCT01729754|7727563|FG002|Part 1|Protocol Violation|0
4752924|NCT01729754|7727564|FG003|Part 1|Protocol Violation|1
4752925|NCT01729754|7727565|FG004|Part 1|Protocol Violation|0
4752926|NCT01729754|7727566|FG005|Part 1|Protocol Violation|0
4752927|NCT01729754|7727567|FG006|Part 1|Protocol Violation|1
4752928|NCT01729754|7727568|FG007|Part 1|Protocol Violation|0
4752929|NCT01729754|7727569|FG008|Part 1|Protocol Violation|0
4752930|NCT01729754|7727570|FG009|Part 1|Protocol Violation|0
4752931|NCT01729754|7727561|FG000|Part 1|Withdrawal by Subject|5
4752932|NCT01729754|7727562|FG001|Part 1|Withdrawal by Subject|0
4752933|NCT01729754|7727563|FG002|Part 1|Withdrawal by Subject|0
4666297|NCT02272413|7559618|FG000|Post-switch Period|Death|3
4666298|NCT02272413|7559619|FG001|Post-switch Period|Death|2
4666299|NCT02272413|7559618|FG000|Post-switch Period|Withdrawal by Subject|1
4666300|NCT02272413|7559619|FG001|Post-switch Period|Withdrawal by Subject|2
4666301|NCT02272413|7559618|FG000|Post-switch Period|Physician Decision|1
4666302|NCT02272413|7559619|FG001|Post-switch Period|Physician Decision|1
4666303|NCT02272413|7559618|FG000|Post-switch Period|Progressive disease|21
4666304|NCT02272413|7559619|FG001|Post-switch Period|Progressive disease|21
4666305|NCT02272413|7559618|FG000|Post-switch Period|Study terminated by sponsor|8
4666306|NCT02272413|7559619|FG001|Post-switch Period|Study terminated by sponsor|11
4666307|NCT02272413|7559618|FG000|Post-switch Period|Other than listed|4
4666308|NCT02272413|7559619|FG001|Post-switch Period|Other than listed|5
4666309|NCT02272634|7559630|FG000|Overall Study|Adverse Event|1
4666310|NCT02272634|7559631|FG001|Overall Study|Adverse Event|0
4666311|NCT02272634|7559632|FG002|Overall Study|Adverse Event|0
4666312|NCT02272634|7559630|FG000|Overall Study|Protocol Violation|0
4666313|NCT02272634|7559631|FG001|Overall Study|Protocol Violation|0
4666314|NCT02272634|7559632|FG002|Overall Study|Protocol Violation|1
4666315|NCT02272634|7559630|FG000|Overall Study|Withdrawal by Subject|0
4666316|NCT02272634|7559631|FG001|Overall Study|Withdrawal by Subject|1
4666317|NCT02272634|7559632|FG002|Overall Study|Withdrawal by Subject|0
4666318|NCT02272725|7559649|FG000|Overall Study|equipment malfunction|2
4666319|NCT02272725|7559650|FG001|Overall Study|equipment malfunction|0
4666320|NCT02272777|7559658|FG000|Overall Study|Adverse Event|0
4666321|NCT02272777|7559659|FG001|Overall Study|Adverse Event|1
4666322|NCT02272777|7559658|FG000|Overall Study|Withdrawal by Subject|0
4752934|NCT01729754|7727564|FG003|Part 1|Withdrawal by Subject|7
4752935|NCT01729754|7727565|FG004|Part 1|Withdrawal by Subject|0
4752936|NCT01729754|7727566|FG005|Part 1|Withdrawal by Subject|0
4752937|NCT01729754|7727567|FG006|Part 1|Withdrawal by Subject|5
4752938|NCT01729754|7727568|FG007|Part 1|Withdrawal by Subject|0
4752939|NCT01729754|7727569|FG008|Part 1|Withdrawal by Subject|0
4752940|NCT01729754|7727570|FG009|Part 1|Withdrawal by Subject|6
4752941|NCT01729754|7727561|FG000|Part 1|Other Protocol Specified Criteria|2
4752942|NCT01729754|7727562|FG001|Part 1|Other Protocol Specified Criteria|0
4752943|NCT01729754|7727563|FG002|Part 1|Other Protocol Specified Criteria|0
4752944|NCT01729754|7727564|FG003|Part 1|Other Protocol Specified Criteria|0
4752945|NCT01729754|7727565|FG004|Part 1|Other Protocol Specified Criteria|0
4752946|NCT01729754|7727566|FG005|Part 1|Other Protocol Specified Criteria|0
4752947|NCT01729754|7727567|FG006|Part 1|Other Protocol Specified Criteria|1
4752948|NCT01729754|7727568|FG007|Part 1|Other Protocol Specified Criteria|0
4752949|NCT01729754|7727569|FG008|Part 1|Other Protocol Specified Criteria|0
4752950|NCT01729754|7727570|FG009|Part 1|Other Protocol Specified Criteria|4
4752951|NCT01729754|7727561|FG000|Part 2|Adverse Event|2
4752952|NCT01729754|7727562|FG001|Part 2|Adverse Event|0
4752953|NCT01729754|7727563|FG002|Part 2|Adverse Event|0
4752954|NCT01729754|7727564|FG003|Part 2|Adverse Event|0
4752955|NCT01729754|7727565|FG004|Part 2|Adverse Event|0
4752956|NCT01729754|7727566|FG005|Part 2|Adverse Event|0
4752957|NCT01729754|7727567|FG006|Part 2|Adverse Event|0
4752958|NCT01729754|7727568|FG007|Part 2|Adverse Event|0
4752959|NCT01729754|7727569|FG008|Part 2|Adverse Event|1
4752960|NCT01729754|7727570|FG009|Part 2|Adverse Event|2
4752961|NCT01729754|7727561|FG000|Part 2|Lack of Efficacy|0
4752962|NCT01729754|7727562|FG001|Part 2|Lack of Efficacy|0
4752963|NCT01729754|7727563|FG002|Part 2|Lack of Efficacy|0
4752964|NCT01729754|7727564|FG003|Part 2|Lack of Efficacy|0
4752965|NCT01729754|7727565|FG004|Part 2|Lack of Efficacy|0
4752966|NCT01729754|7727566|FG005|Part 2|Lack of Efficacy|0
4752967|NCT01729754|7727567|FG006|Part 2|Lack of Efficacy|0
4752968|NCT01729754|7727568|FG007|Part 2|Lack of Efficacy|0
4752969|NCT01729754|7727569|FG008|Part 2|Lack of Efficacy|2
4752970|NCT01729754|7727570|FG009|Part 2|Lack of Efficacy|2
4752971|NCT01729754|7727561|FG000|Part 2|Lost to Follow-up|0
4752972|NCT01729754|7727562|FG001|Part 2|Lost to Follow-up|0
4752973|NCT01729754|7727563|FG002|Part 2|Lost to Follow-up|0
4752974|NCT01729754|7727564|FG003|Part 2|Lost to Follow-up|2
4752975|NCT01729754|7727565|FG004|Part 2|Lost to Follow-up|0
4752976|NCT01729754|7727566|FG005|Part 2|Lost to Follow-up|0
4752977|NCT01729754|7727567|FG006|Part 2|Lost to Follow-up|0
4752978|NCT01729754|7727568|FG007|Part 2|Lost to Follow-up|1
4752979|NCT01729754|7727569|FG008|Part 2|Lost to Follow-up|0
4752980|NCT01729754|7727570|FG009|Part 2|Lost to Follow-up|2
4752981|NCT01729754|7727561|FG000|Part 2|Non-Compliance with Study Drug|0
4752982|NCT01729754|7727562|FG001|Part 2|Non-Compliance with Study Drug|0
4752983|NCT01729754|7727563|FG002|Part 2|Non-Compliance with Study Drug|0
4666323|NCT02272777|7559659|FG001|Overall Study|Withdrawal by Subject|3
4666324|NCT02272777|7559658|FG000|Overall Study|Lost to Follow-up|2
4666325|NCT02272777|7559659|FG001|Overall Study|Lost to Follow-up|0
4752984|NCT01729754|7727564|FG003|Part 2|Non-Compliance with Study Drug|0
4752985|NCT01729754|7727565|FG004|Part 2|Non-Compliance with Study Drug|0
4752986|NCT01729754|7727566|FG005|Part 2|Non-Compliance with Study Drug|0
4752987|NCT01729754|7727567|FG006|Part 2|Non-Compliance with Study Drug|0
4752988|NCT01729754|7727568|FG007|Part 2|Non-Compliance with Study Drug|0
4752989|NCT01729754|7727569|FG008|Part 2|Non-Compliance with Study Drug|0
4752990|NCT01729754|7727570|FG009|Part 2|Non-Compliance with Study Drug|1
4752991|NCT01729754|7727561|FG000|Part 2|Pregnancy|0
4752992|NCT01729754|7727562|FG001|Part 2|Pregnancy|0
4666326|NCT02272777|7559658|FG000|Overall Study|Other|2
4666327|NCT02272777|7559659|FG001|Overall Study|Other|0
4666328|NCT02272816|7559665|FG000|Overall Study|Adverse Event|1
4666329|NCT02272842|7559671|FG000|Overall Study|Lost to Follow-up|8
4666330|NCT02272842|7559672|FG001|Overall Study|Lost to Follow-up|8
4666331|NCT02272842|7559671|FG000|Overall Study|Withdrawal by Subject|8
4666332|NCT02272842|7559672|FG001|Overall Study|Withdrawal by Subject|2
4666333|NCT02272985|7559679|FG000|Overall Study|Withdrawal by Subject|1
4666334|NCT02272985|7559679|FG000|Overall Study|hip fracture|1
4666335|NCT02272985|7559679|FG000|Overall Study|kidney transplantation|1
4666336|NCT02273037|7559686|FG000|Overall Study|Lost to Follow-up|1
4666337|NCT02273037|7559687|FG001|Overall Study|Lost to Follow-up|0
4666338|NCT02273037|7559686|FG000|Overall Study|Delivered before monitoring initiated|1
4666339|NCT02273037|7559687|FG001|Overall Study|Delivered before monitoring initiated|3
4666340|NCT02273037|7559686|FG000|Overall Study|Breech delivery|2
4666341|NCT02273037|7559687|FG001|Overall Study|Breech delivery|3
4666342|NCT02273037|7559686|FG000|Overall Study|Multiple delivery|2
4666343|NCT02273037|7559687|FG001|Overall Study|Multiple delivery|2
4666344|NCT02273037|7559686|FG000|Overall Study|Other complication|2
4666345|NCT02273037|7559687|FG001|Overall Study|Other complication|0
4666346|NCT02273050|7559698|FG000|Overall Study|Adverse Event|4
4666347|NCT02273050|7559699|FG001|Overall Study|Adverse Event|3
4666348|NCT02273050|7559700|FG002|Overall Study|Adverse Event|3
4666349|NCT02273050|7559698|FG000|Overall Study|Death|0
4666350|NCT02273050|7559699|FG001|Overall Study|Death|0
4666351|NCT02273050|7559700|FG002|Overall Study|Death|1
4666352|NCT02273050|7559698|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0
4666353|NCT02273050|7559699|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1
4666354|NCT02273050|7559700|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1
4666355|NCT02273050|7559698|FG000|Overall Study|Lack of Efficacy|0
4666356|NCT02273050|7559699|FG001|Overall Study|Lack of Efficacy|1
4666357|NCT02273050|7559700|FG002|Overall Study|Lack of Efficacy|1
4666358|NCT02273050|7559698|FG000|Overall Study|Withdrawal by Subject|17
4666359|NCT02273050|7559699|FG001|Overall Study|Withdrawal by Subject|14
4666360|NCT02273050|7559700|FG002|Overall Study|Withdrawal by Subject|16
4666361|NCT02273050|7559698|FG000|Overall Study|Lost to Follow-up|0
4666362|NCT02273050|7559699|FG001|Overall Study|Lost to Follow-up|2
4666363|NCT02273050|7559700|FG002|Overall Study|Lost to Follow-up|3
4666364|NCT02273050|7559698|FG000|Overall Study|Protocol Violation|3
4666365|NCT02273050|7559699|FG001|Overall Study|Protocol Violation|1
4666366|NCT02273050|7559700|FG002|Overall Study|Protocol Violation|4
4666367|NCT02273141|7559732|FG000|Overall Study|Adverse Event|0
4666368|NCT02273141|7559733|FG001|Overall Study|Adverse Event|1
4666369|NCT02273141|7559732|FG000|Overall Study|Lost to Follow-up|1
4666370|NCT02273141|7559733|FG001|Overall Study|Lost to Follow-up|3
4666371|NCT02273141|7559732|FG000|Overall Study|Withdrawal by Subject|10
4666372|NCT02273141|7559733|FG001|Overall Study|Withdrawal by Subject|15
4666373|NCT02273141|7559732|FG000|Overall Study|Various|6
4666374|NCT02273141|7559733|FG001|Overall Study|Various|6
4666375|NCT02273167|7559742|FG000|Overall Study|Adverse Event|1
4666376|NCT02273167|7559743|FG001|Overall Study|Adverse Event|0
4666377|NCT02273167|7559744|FG002|Overall Study|Adverse Event|0
4666378|NCT02273167|7559742|FG000|Overall Study|Protocol Violation|3
4666379|NCT02273167|7559743|FG001|Overall Study|Protocol Violation|1
4666380|NCT02273167|7559744|FG002|Overall Study|Protocol Violation|1
4666381|NCT02273167|7559742|FG000|Overall Study|Lost to Follow-up|0
4666382|NCT02273167|7559743|FG001|Overall Study|Lost to Follow-up|1
4666383|NCT02273167|7559744|FG002|Overall Study|Lost to Follow-up|1
4666384|NCT02273167|7559742|FG000|Overall Study|Withdrawal by Subject|10
4752993|NCT01729754|7727563|FG002|Part 2|Pregnancy|0
4752994|NCT01729754|7727564|FG003|Part 2|Pregnancy|1
4752995|NCT01729754|7727565|FG004|Part 2|Pregnancy|0
4752996|NCT01729754|7727566|FG005|Part 2|Pregnancy|0
4752997|NCT01729754|7727567|FG006|Part 2|Pregnancy|0
4752998|NCT01729754|7727568|FG007|Part 2|Pregnancy|0
4752999|NCT01729754|7727569|FG008|Part 2|Pregnancy|0
4753000|NCT01729754|7727570|FG009|Part 2|Pregnancy|1
4753001|NCT01729754|7727561|FG000|Part 2|Withdrawal by Subject|3
4753002|NCT01729754|7727562|FG001|Part 2|Withdrawal by Subject|0
4753003|NCT01729754|7727563|FG002|Part 2|Withdrawal by Subject|0
4753004|NCT01729754|7727564|FG003|Part 2|Withdrawal by Subject|2
4753005|NCT01729754|7727565|FG004|Part 2|Withdrawal by Subject|0
4753006|NCT01729754|7727566|FG005|Part 2|Withdrawal by Subject|0
4666385|NCT02273167|7559743|FG001|Overall Study|Withdrawal by Subject|12
4666386|NCT02273167|7559744|FG002|Overall Study|Withdrawal by Subject|11
4666387|NCT02273167|7559742|FG000|Overall Study|Various|10
4666388|NCT02273167|7559743|FG001|Overall Study|Various|9
4666389|NCT02273167|7559744|FG002|Overall Study|Various|8
4666390|NCT02273180|7559755|FG000|Overall Study|Adverse Event|2
4666391|NCT02273180|7559756|FG001|Overall Study|Adverse Event|2
4666392|NCT02273180|7559755|FG000|Overall Study|Lack of Efficacy|1
4666393|NCT02273180|7559756|FG001|Overall Study|Lack of Efficacy|0
4666394|NCT02273180|7559755|FG000|Overall Study|Protocol Violation|1
4753007|NCT01729754|7727567|FG006|Part 2|Withdrawal by Subject|0
4753008|NCT01729754|7727568|FG007|Part 2|Withdrawal by Subject|1
4753009|NCT01729754|7727569|FG008|Part 2|Withdrawal by Subject|1
4753010|NCT01729754|7727570|FG009|Part 2|Withdrawal by Subject|4
4753011|NCT01729754|7727561|FG000|Part 2|Other Protocol Specified Criteria|1
4666395|NCT02273180|7559756|FG001|Overall Study|Protocol Violation|7
4666396|NCT02273180|7559755|FG000|Overall Study|Randomized but not treated|1
4666397|NCT02273180|7559756|FG001|Overall Study|Randomized but not treated|0
4666398|NCT02273180|7559755|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1
4666399|NCT02273180|7559756|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0
4666400|NCT02273180|7559755|FG000|Overall Study|Other than specified above|21
4666401|NCT02273180|7559756|FG001|Overall Study|Other than specified above|10
4666402|NCT02273596|7559788|FG000|24-Week Treatment Period|Adverse Event|3
4666403|NCT02273596|7559788|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1
4666404|NCT02273596|7559788|FG000|24-Week Treatment Period|Participant was unable to Come|1
4666405|NCT02273596|7559788|FG000|24-Week Treatment Period|Physician Decision|1
4666406|NCT02273596|7559788|FG000|24-Week Treatment Period|Protocol Deviation|1
4666407|NCT02273596|7559788|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19
4666408|NCT02273596|7559788|FG000|Extension Period|Participant Withdrew for Personal Reasons|1
4666409|NCT02273596|7559788|FG000|Extension Period|Lost to Follow-up|1
4666410|NCT02273596|7559788|FG000|Extension Period|Protocol Deviation|1
4666411|NCT02273726|7559800|FG000|Overall Study|Death|70
4666412|NCT02273726|7559801|FG001|Overall Study|Death|62
4666413|NCT02273726|7559800|FG000|Overall Study|Withdrawal by Subject|41
4666414|NCT02273726|7559801|FG001|Overall Study|Withdrawal by Subject|29
4666415|NCT02273726|7559800|FG000|Overall Study|Kidney transplant|31
4666416|NCT02273726|7559801|FG001|Overall Study|Kidney transplant|39
4666417|NCT02273726|7559800|FG000|Overall Study|Physician Decision|30
4666418|NCT02273726|7559801|FG001|Overall Study|Physician Decision|15
4666419|NCT02273726|7559800|FG000|Overall Study|Adverse Event|27
4666420|NCT02273726|7559801|FG001|Overall Study|Adverse Event|9
4666421|NCT02273726|7559800|FG000|Overall Study|Lost to Follow-up|6
4666422|NCT02273726|7559801|FG001|Overall Study|Lost to Follow-up|3
4666423|NCT02273726|7559800|FG000|Overall Study|Lack of Efficacy|6
4666424|NCT02273726|7559801|FG001|Overall Study|Lack of Efficacy|1
4666425|NCT02273726|7559800|FG000|Overall Study|Protocol Violation|4
4666426|NCT02273726|7559801|FG001|Overall Study|Protocol Violation|0
4666427|NCT02273726|7559800|FG000|Overall Study|Other than specified|28
4666428|NCT02273726|7559801|FG001|Overall Study|Other than specified|30
4666429|NCT02273739|7559811|FG000|Overall Study|Progression of Disease|3
4666430|NCT02273739|7559812|FG001|Overall Study|Progression of Disease|4
4666431|NCT02273739|7559813|FG002|Overall Study|Progression of Disease|5
4666432|NCT02273739|7559814|FG003|Overall Study|Progression of Disease|2
4666433|NCT02273739|7559811|FG000|Overall Study|Death|0
4666434|NCT02273739|7559812|FG001|Overall Study|Death|0
4666435|NCT02273739|7559813|FG002|Overall Study|Death|0
4666436|NCT02273739|7559814|FG003|Overall Study|Death|2
4666437|NCT02273739|7559811|FG000|Overall Study|Adverse Event|0
4666438|NCT02273739|7559812|FG001|Overall Study|Adverse Event|0
4666439|NCT02273739|7559813|FG002|Overall Study|Adverse Event|0
4666440|NCT02273739|7559814|FG003|Overall Study|Adverse Event|1
4666441|NCT02273739|7559811|FG000|Overall Study|Withdrawal by Subject|0
4666442|NCT02273739|7559812|FG001|Overall Study|Withdrawal by Subject|0
4666443|NCT02273739|7559813|FG002|Overall Study|Withdrawal by Subject|2
4666444|NCT02273739|7559814|FG003|Overall Study|Withdrawal by Subject|1
4666445|NCT02273739|7559811|FG000|Overall Study|Physician Decision|0
4666446|NCT02273739|7559812|FG001|Overall Study|Physician Decision|0
4666447|NCT02273739|7559813|FG002|Overall Study|Physician Decision|0
4666448|NCT02273739|7559814|FG003|Overall Study|Physician Decision|1
4666449|NCT02273908|7559831|FG000|Overall Study|Adverse Event|16
4666450|NCT02273908|7559832|FG001|Overall Study|Adverse Event|0
4666451|NCT02273908|7559831|FG000|Overall Study|Lost to Follow-up|10
4666452|NCT02273908|7559832|FG001|Overall Study|Lost to Follow-up|1
4666453|NCT02273908|7559831|FG000|Overall Study|Did not meet entrance criteria|3
4666454|NCT02273908|7559832|FG001|Overall Study|Did not meet entrance criteria|2
4666455|NCT02273908|7559831|FG000|Overall Study|Withdrawal by Subject|4
4666456|NCT02273908|7559832|FG001|Overall Study|Withdrawal by Subject|2
4666457|NCT02273960|7559846|FG000|Short Term Period|Lost to Follow-up|1
4666458|NCT02273960|7559847|FG001|Short Term Period|Lost to Follow-up|0
4666459|NCT02273960|7559848|FG002|Short Term Period|Lost to Follow-up|0
4666460|NCT02273960|7559849|FG003|Short Term Period|Lost to Follow-up|0
4753012|NCT01729754|7727562|FG001|Part 2|Other Protocol Specified Criteria|0
4753013|NCT01729754|7727563|FG002|Part 2|Other Protocol Specified Criteria|0
4753014|NCT01729754|7727564|FG003|Part 2|Other Protocol Specified Criteria|0
4753015|NCT01729754|7727565|FG004|Part 2|Other Protocol Specified Criteria|0
4753016|NCT01729754|7727566|FG005|Part 2|Other Protocol Specified Criteria|0
4753017|NCT01729754|7727567|FG006|Part 2|Other Protocol Specified Criteria|0
4753018|NCT01729754|7727568|FG007|Part 2|Other Protocol Specified Criteria|1
4753019|NCT01729754|7727569|FG008|Part 2|Other Protocol Specified Criteria|0
4666461|NCT02273960|7559846|FG000|Short Term Period|Lack of Efficacy|0
4666462|NCT02273960|7559847|FG001|Short Term Period|Lack of Efficacy|0
4666463|NCT02273960|7559848|FG002|Short Term Period|Lack of Efficacy|0
4666464|NCT02273960|7559849|FG003|Short Term Period|Lack of Efficacy|1
4666465|NCT02273960|7559846|FG000|Short Term Period|ST complete, not entering LTE|4
4666466|NCT02273960|7559847|FG001|Short Term Period|ST complete, not entering LTE|6
4753020|NCT01729754|7727570|FG009|Part 2|Other Protocol Specified Criteria|0
4753021|NCT01729754|7727561|FG000|Part 3|Adverse Event|0
4666467|NCT02273960|7559848|FG002|Short Term Period|ST complete, not entering LTE|4
4666468|NCT02273960|7559849|FG003|Short Term Period|ST complete, not entering LTE|5
4666469|NCT02273960|7559846|FG000|Long Term Extension|Death|0
4666470|NCT02273960|7559847|FG001|Long Term Extension|Death|0
4666471|NCT02273960|7559848|FG002|Long Term Extension|Death|0
4666472|NCT02273960|7559849|FG003|Long Term Extension|Death|1
4666473|NCT02273973|7559861|FG000|Overall Study|Adverse Event|4
4666474|NCT02273973|7559862|FG001|Overall Study|Adverse Event|0
4666475|NCT02273973|7559861|FG000|Overall Study|Withdrawal by Subject|2
4666476|NCT02273973|7559862|FG001|Overall Study|Withdrawal by Subject|3
4666477|NCT02273973|7559861|FG000|Overall Study|Death|1
4666478|NCT02273973|7559862|FG001|Overall Study|Death|0
4666479|NCT02273973|7559861|FG000|Overall Study|Non-compliance|1
4666480|NCT02273973|7559862|FG001|Overall Study|Non-compliance|0
4666481|NCT02273973|7559861|FG000|Overall Study|Protocol Violation|1
4666482|NCT02273973|7559862|FG001|Overall Study|Protocol Violation|0
4666483|NCT02273973|7559861|FG000|Overall Study|Progression of disease|0
4666484|NCT02273973|7559862|FG001|Overall Study|Progression of disease|2
4666485|NCT02273973|7559861|FG000|Overall Study|Lost to Follow-up|0
4666486|NCT02273973|7559862|FG001|Overall Study|Lost to Follow-up|1
4666487|NCT02273973|7559861|FG000|Overall Study|Physician Decision|0
4666488|NCT02273973|7559862|FG001|Overall Study|Physician Decision|1
4666489|NCT02273973|7559861|FG000|Overall Study|Reason not specified|0
4666490|NCT02273973|7559862|FG001|Overall Study|Reason not specified|1
4753022|NCT01729754|7727562|FG001|Part 3|Adverse Event|0
4753023|NCT01729754|7727563|FG002|Part 3|Adverse Event|1
4753024|NCT01729754|7727564|FG003|Part 3|Adverse Event|0
4753025|NCT01729754|7727565|FG004|Part 3|Adverse Event|0
4753026|NCT01729754|7727566|FG005|Part 3|Adverse Event|5
4753027|NCT01729754|7727567|FG006|Part 3|Adverse Event|0
4753028|NCT01729754|7727568|FG007|Part 3|Adverse Event|0
4753029|NCT01729754|7727569|FG008|Part 3|Adverse Event|0
4753030|NCT01729754|7727570|FG009|Part 3|Adverse Event|3
4753031|NCT01729754|7727561|FG000|Part 3|Death|0
4753032|NCT01729754|7727562|FG001|Part 3|Death|0
4753033|NCT01729754|7727563|FG002|Part 3|Death|0
4753034|NCT01729754|7727564|FG003|Part 3|Death|0
4753035|NCT01729754|7727565|FG004|Part 3|Death|0
4753036|NCT01729754|7727566|FG005|Part 3|Death|2
4753037|NCT01729754|7727567|FG006|Part 3|Death|0
4753038|NCT01729754|7727568|FG007|Part 3|Death|0
4753039|NCT01729754|7727569|FG008|Part 3|Death|0
4753040|NCT01729754|7727570|FG009|Part 3|Death|0
4753041|NCT01729754|7727561|FG000|Part 3|Lack of Efficacy|0
4753042|NCT01729754|7727562|FG001|Part 3|Lack of Efficacy|0
4753043|NCT01729754|7727563|FG002|Part 3|Lack of Efficacy|0
4753044|NCT01729754|7727564|FG003|Part 3|Lack of Efficacy|0
4753045|NCT01729754|7727565|FG004|Part 3|Lack of Efficacy|2
4753046|NCT01729754|7727566|FG005|Part 3|Lack of Efficacy|0
4753047|NCT01729754|7727567|FG006|Part 3|Lack of Efficacy|0
4753048|NCT01729754|7727568|FG007|Part 3|Lack of Efficacy|0
4753049|NCT01729754|7727569|FG008|Part 3|Lack of Efficacy|0
4753050|NCT01729754|7727570|FG009|Part 3|Lack of Efficacy|4
4753051|NCT01729754|7727561|FG000|Part 3|Lost to Follow-up|0
4753052|NCT01729754|7727562|FG001|Part 3|Lost to Follow-up|1
4753053|NCT01729754|7727563|FG002|Part 3|Lost to Follow-up|2
4753054|NCT01729754|7727564|FG003|Part 3|Lost to Follow-up|0
4753055|NCT01729754|7727565|FG004|Part 3|Lost to Follow-up|0
4753056|NCT01729754|7727566|FG005|Part 3|Lost to Follow-up|3
4753057|NCT01729754|7727567|FG006|Part 3|Lost to Follow-up|0
4753058|NCT01729754|7727568|FG007|Part 3|Lost to Follow-up|0
4753059|NCT01729754|7727569|FG008|Part 3|Lost to Follow-up|1
4753060|NCT01729754|7727570|FG009|Part 3|Lost to Follow-up|0
4753061|NCT01729754|7727561|FG000|Part 3|Physician Decision|0
4753062|NCT01729754|7727562|FG001|Part 3|Physician Decision|0
4753063|NCT01729754|7727563|FG002|Part 3|Physician Decision|1
4753064|NCT01729754|7727564|FG003|Part 3|Physician Decision|0
4753065|NCT01729754|7727565|FG004|Part 3|Physician Decision|0
4753066|NCT01729754|7727566|FG005|Part 3|Physician Decision|0
4753067|NCT01729754|7727567|FG006|Part 3|Physician Decision|0
4753068|NCT01729754|7727568|FG007|Part 3|Physician Decision|0
4753069|NCT01729754|7727569|FG008|Part 3|Physician Decision|0
4753070|NCT01729754|7727570|FG009|Part 3|Physician Decision|0
4753071|NCT01729754|7727561|FG000|Part 3|Withdrawal by Subject|0
4753072|NCT01729754|7727562|FG001|Part 3|Withdrawal by Subject|4
4753073|NCT01729754|7727563|FG002|Part 3|Withdrawal by Subject|1
4753074|NCT01729754|7727564|FG003|Part 3|Withdrawal by Subject|0
4753075|NCT01729754|7727565|FG004|Part 3|Withdrawal by Subject|2
4753076|NCT01729754|7727566|FG005|Part 3|Withdrawal by Subject|1
4753077|NCT01729754|7727567|FG006|Part 3|Withdrawal by Subject|0
4753078|NCT01729754|7727568|FG007|Part 3|Withdrawal by Subject|2
4753079|NCT01729754|7727569|FG008|Part 3|Withdrawal by Subject|0
4753080|NCT01729754|7727570|FG009|Part 3|Withdrawal by Subject|0
4753081|NCT01729754|7727561|FG000|Part 3|Other Protocol Specified Criteria|0
4753082|NCT01729754|7727562|FG001|Part 3|Other Protocol Specified Criteria|0
4753083|NCT01729754|7727563|FG002|Part 3|Other Protocol Specified Criteria|0
4753084|NCT01729754|7727564|FG003|Part 3|Other Protocol Specified Criteria|0
4753085|NCT01729754|7727565|FG004|Part 3|Other Protocol Specified Criteria|0
4753086|NCT01729754|7727566|FG005|Part 3|Other Protocol Specified Criteria|2
4753087|NCT01729754|7727567|FG006|Part 3|Other Protocol Specified Criteria|0
4753088|NCT01729754|7727568|FG007|Part 3|Other Protocol Specified Criteria|1
4753089|NCT01729754|7727569|FG008|Part 3|Other Protocol Specified Criteria|0
4666491|NCT02274038|7559868|FG000|Overall Study|Death|1
4666492|NCT02274311|7559874|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1
4666493|NCT02274493|7559880|FG000|Overall Study|Withdrawal by Subject|1
4666494|NCT02274558|7559887|FG000|Overall Study|Adverse Event|2
4666495|NCT02274558|7559888|FG001|Overall Study|Adverse Event|4
4666496|NCT02274558|7559889|FG002|Overall Study|Adverse Event|2
4666497|NCT02274558|7559887|FG000|Overall Study|Non-compliance|2
4666498|NCT02274558|7559888|FG001|Overall Study|Non-compliance|1
4666499|NCT02274558|7559889|FG002|Overall Study|Non-compliance|0
4666500|NCT02274558|7559887|FG000|Overall Study|Withdrawal by Subject|1
4666501|NCT02274558|7559888|FG001|Overall Study|Withdrawal by Subject|5
4666502|NCT02274558|7559889|FG002|Overall Study|Withdrawal by Subject|4
4666503|NCT02274558|7559887|FG000|Overall Study|Death|0
4666504|NCT02274558|7559888|FG001|Overall Study|Death|0
4666505|NCT02274558|7559889|FG002|Overall Study|Death|1
4753090|NCT01729754|7727570|FG009|Part 3|Other Protocol Specified Criteria|0
4753091|NCT01668784|7727613|FG000|Randomized (Pre-treatment)|Disease Progression|0
4753092|NCT01668784|7727614|FG001|Randomized (Pre-treatment)|Disease Progression|1
4753093|NCT01668784|7727613|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0
4753094|NCT01668784|7727614|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3
4753095|NCT01668784|7727613|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1
4753096|NCT01668784|7727614|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8
4753097|NCT01668784|7727613|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1
4753098|NCT01668784|7727614|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0
4753099|NCT01668784|7727613|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2
4753100|NCT01668784|7727614|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1
4753101|NCT01668784|7727613|FG000|Randomized (Pre-treatment)|Other|0
4753102|NCT01668784|7727614|FG001|Randomized (Pre-treatment)|Other|1
4753103|NCT01668784|7727613|FG000|Treated (Overall)|Disease Progression|285
4753104|NCT01668784|7727614|FG001|Treated (Overall)|Disease Progression|273
4753105|NCT01668784|7727613|FG000|Treated (Overall)|Study Drug Toxicity|35
4753106|NCT01668784|7727614|FG001|Treated (Overall)|Study Drug Toxicity|53
4753107|NCT01668784|7727613|FG000|Treated (Overall)|Death|1
4753108|NCT01668784|7727614|FG001|Treated (Overall)|Death|1
4753109|NCT01668784|7727613|FG000|Treated (Overall)|Adverse Event Unrelated to Study Drug|9
4753110|NCT01668784|7727614|FG001|Treated (Overall)|Adverse Event Unrelated to Study Drug|14
4753111|NCT01668784|7727613|FG000|Treated (Overall)|Request to Discontinue Study Treatment|5
4753112|NCT01668784|7727614|FG001|Treated (Overall)|Request to Discontinue Study Treatment|18
4753113|NCT01668784|7727613|FG000|Treated (Overall)|Withdrawal by Subject|2
4753114|NCT01668784|7727614|FG001|Treated (Overall)|Withdrawal by Subject|3
4753115|NCT01668784|7727613|FG000|Treated (Overall)|Maximal Clinical Benefit|2
4753116|NCT01668784|7727614|FG001|Treated (Overall)|Maximal Clinical Benefit|3
4753117|NCT01668784|7727613|FG000|Treated (Overall)|Other|0
4753118|NCT01668784|7727614|FG001|Treated (Overall)|Other|4
4753119|NCT01564537|7727635|FG000|Overall Study|Withdrawal by Participant|4
4753120|NCT01564537|7727636|FG001|Overall Study|Withdrawal by Participant|4
4753121|NCT01564537|7727635|FG000|Overall Study|Lost to Follow-up|1
4753122|NCT01564537|7727636|FG001|Overall Study|Lost to Follow-up|0
4753123|NCT01564537|7727635|FG000|Overall Study|Other Miscellaneous Reasons|1
4753124|NCT01564537|7727636|FG001|Overall Study|Other Miscellaneous Reasons|2
4753125|NCT01515306|7727645|FG000|Overall Study|Adverse Event|3
4753126|NCT01515306|7727646|FG001|Overall Study|Adverse Event|2
4753127|NCT01515306|7727645|FG000|Overall Study|Progressive Disease|19
4753128|NCT01515306|7727646|FG001|Overall Study|Progressive Disease|9
4753129|NCT01515306|7727645|FG000|Overall Study|Withdrawal by Subject|1
4753130|NCT01515306|7727646|FG001|Overall Study|Withdrawal by Subject|2
4753131|NCT01515306|7727645|FG000|Overall Study|Physician Decision|1
4753132|NCT01515306|7727646|FG001|Overall Study|Physician Decision|1
4753133|NCT01423851|7727667|FG000|Whole Study|Disease progression|2
4753134|NCT01423851|7727668|FG001|Whole Study|Disease progression|1
4753135|NCT01423851|7727669|FG002|Whole Study|Disease progression|1
4753136|NCT01423851|7727670|FG003|Whole Study|Disease progression|4
4753137|NCT01423851|7727671|FG004|Whole Study|Disease progression|1
4753138|NCT01423851|7727672|FG005|Whole Study|Disease progression|3
4753139|NCT01423851|7727673|FG006|Whole Study|Disease progression|1
4753140|NCT01423851|7727674|FG007|Whole Study|Disease progression|4
4753141|NCT01423851|7727675|FG008|Whole Study|Disease progression|0
4753142|NCT01423851|7727676|FG009|Whole Study|Disease progression|2
4666506|NCT02274558|7559887|FG000|Overall Study|Lost to Follow-up|2
4666507|NCT02274558|7559888|FG001|Overall Study|Lost to Follow-up|1
4666508|NCT02274558|7559889|FG002|Overall Study|Lost to Follow-up|1
4666509|NCT02274558|7559887|FG000|Overall Study|Physician Decision|0
4666510|NCT02274558|7559888|FG001|Overall Study|Physician Decision|2
4666511|NCT02274558|7559889|FG002|Overall Study|Physician Decision|1
4666512|NCT02274766|7559924|FG000|Overall Study|Withdrawal by Subject|3
4666513|NCT02274766|7559925|FG001|Overall Study|Withdrawal by Subject|6
4666514|NCT02274766|7559924|FG000|Overall Study|Did Not Receive Study Drug|1
4666515|NCT02274766|7559925|FG001|Overall Study|Did Not Receive Study Drug|1
4753143|NCT01423851|7727677|FG010|Whole Study|Disease progression|10
4753144|NCT01423851|7727667|FG000|Whole Study|Physician Decision|0
4666516|NCT02274766|7559924|FG000|Overall Study|Subject Unwilling to Proceed|0
4753145|NCT01423851|7727668|FG001|Whole Study|Physician Decision|1
4666517|NCT02274766|7559925|FG001|Overall Study|Subject Unwilling to Proceed|1
4666518|NCT02274766|7559924|FG000|Overall Study|Adverse Event|0
4666519|NCT02274766|7559925|FG001|Overall Study|Adverse Event|1
4666520|NCT02274792|7559931|FG000|Overall Study|Withdrawal by Subject|13
4666521|NCT02274792|7559931|FG000|Overall Study|Lost to Follow-up|8
4666522|NCT02274792|7559931|FG000|Overall Study|Protocol Specified Criteria|2
4666523|NCT02274792|7559931|FG000|Overall Study|Sponsor Decision|2
4666524|NCT02274857|7559946|FG000|Overall Study|Adverse Event|1
4666525|NCT02274857|7559947|FG001|Overall Study|Adverse Event|0
4666526|NCT02274857|7559946|FG000|Overall Study|Death|1
4666527|NCT02274857|7559947|FG001|Overall Study|Death|2
4666528|NCT02274857|7559946|FG000|Overall Study|Lost to Follow-up|3
4666529|NCT02274857|7559947|FG001|Overall Study|Lost to Follow-up|0
4666530|NCT02274857|7559946|FG000|Overall Study|Physician Decision|2
4666531|NCT02274857|7559947|FG001|Overall Study|Physician Decision|0
4666532|NCT02274857|7559946|FG000|Overall Study|Trial screen failure|0
4666533|NCT02274857|7559947|FG001|Overall Study|Trial screen failure|2
4666534|NCT02274857|7559946|FG000|Overall Study|Withdrawal by Subject|11
4666535|NCT02274857|7559947|FG001|Overall Study|Withdrawal by Subject|2
4666536|NCT02274857|7559946|FG000|Overall Study|Other|2
4666537|NCT02274857|7559947|FG001|Overall Study|Other|0
4666538|NCT02274948|7559968|FG000|Overall Study|Lost to Follow-up|28
4666539|NCT02274948|7559969|FG001|Overall Study|Lost to Follow-up|25
4666540|NCT02274948|7559968|FG000|Overall Study|Withdrawal by Subject|64
4666541|NCT02274948|7559969|FG001|Overall Study|Withdrawal by Subject|58
4666542|NCT02274948|7559968|FG000|Overall Study|Stopped on family Practitioner advice|2
4666543|NCT02274948|7559969|FG001|Overall Study|Stopped on family Practitioner advice|5
4666544|NCT02274948|7559968|FG000|Overall Study|Left the area|4
4666545|NCT02274948|7559969|FG001|Overall Study|Left the area|3
4666546|NCT02275026|7559976|FG000|Overall Study|Ineligible after cognitive baseline testing|11
4666547|NCT02275026|7559976|FG000|Overall Study|Withdrawal by Subject|4
4666548|NCT02275026|7559976|FG000|Overall Study|Ineligible due to medical history|13
4666549|NCT02275026|7559976|FG000|Overall Study|MRI malfunction precluded testing|1
4666550|NCT02275026|7559976|FG000|Overall Study|Ineligible after MRI findings|1
4666551|NCT02275026|7559976|FG000|Overall Study|Lost to Follow-up|2
4666552|NCT02275026|7559976|FG000|Overall Study|Scanner failure|1
4666553|NCT02275052|7559983|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
4666554|NCT02275052|7559984|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
4666555|NCT02275052|7559985|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
4666556|NCT02275052|7559986|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
4666557|NCT02275052|7559983|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
4666558|NCT02275052|7559984|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1
4666559|NCT02275052|7559985|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
4666560|NCT02275052|7559986|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
4666561|NCT02275052|7559983|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6
4666562|NCT02275052|7559984|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4
4666563|NCT02275052|7559985|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
4666564|NCT02275052|7559986|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
4666565|NCT02275052|7559983|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1
4666566|NCT02275052|7559984|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
4666567|NCT02275052|7559985|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
4666568|NCT02275052|7559986|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
4666569|NCT02275052|7559983|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2
4666570|NCT02275052|7559984|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
4666571|NCT02275052|7559985|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
4666572|NCT02275052|7559986|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
4666573|NCT02275052|7559983|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3
4666574|NCT02275052|7559984|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0
4666575|NCT02275052|7559985|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0
4666576|NCT02275052|7559986|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0
4666577|NCT02275052|7559983|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1
4666578|NCT02275052|7559984|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0
4666579|NCT02275052|7559985|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0
4666580|NCT02275052|7559986|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0
4666581|NCT02275052|7559983|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0
4666582|NCT02275052|7559984|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0
4666583|NCT02275052|7559985|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3
4666584|NCT02275052|7559986|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2
4666585|NCT02275052|7559983|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
4666586|NCT02275052|7559984|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
4666587|NCT02275052|7559985|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
4666588|NCT02275052|7559986|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4
4666589|NCT02275052|7559983|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
4666590|NCT02275052|7559984|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
4666591|NCT02275052|7559985|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
4666592|NCT02275052|7559986|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6
4666593|NCT02275052|7559983|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
4666594|NCT02275052|7559984|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
4666595|NCT02275052|7559985|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
4753146|NCT01423851|7727669|FG002|Whole Study|Physician Decision|2
4753147|NCT01423851|7727670|FG003|Whole Study|Physician Decision|0
4753148|NCT01423851|7727671|FG004|Whole Study|Physician Decision|2
4753149|NCT01423851|7727672|FG005|Whole Study|Physician Decision|0
4753150|NCT01423851|7727673|FG006|Whole Study|Physician Decision|2
4753151|NCT01423851|7727674|FG007|Whole Study|Physician Decision|1
4753152|NCT01423851|7727675|FG008|Whole Study|Physician Decision|3
4753153|NCT01423851|7727676|FG009|Whole Study|Physician Decision|4
4753154|NCT01423851|7727677|FG010|Whole Study|Physician Decision|12
4753155|NCT01423851|7727667|FG000|Whole Study|Withdrawal by Subject|1
4753156|NCT01423851|7727668|FG001|Whole Study|Withdrawal by Subject|1
4753157|NCT01423851|7727669|FG002|Whole Study|Withdrawal by Subject|0
4753158|NCT01423851|7727670|FG003|Whole Study|Withdrawal by Subject|0
4753159|NCT01423851|7727671|FG004|Whole Study|Withdrawal by Subject|0
4753160|NCT01423851|7727672|FG005|Whole Study|Withdrawal by Subject|0
4753161|NCT01423851|7727673|FG006|Whole Study|Withdrawal by Subject|0
4666596|NCT02275052|7559986|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2
4666597|NCT02275065|7559997|FG000|Overall Study|Randomized but not treated|1
4666598|NCT02275065|7559998|FG001|Overall Study|Randomized but not treated|0
4666599|NCT02275065|7559999|FG002|Overall Study|Randomized but not treated|1
4666600|NCT02275065|7560000|FG003|Overall Study|Randomized but not treated|1
4666601|NCT02275065|7560001|FG004|Overall Study|Randomized but not treated|0
4666602|NCT02275117|7560018|FG000|Overall Study|Adverse Event|0
4666603|NCT02275117|7560019|FG001|Overall Study|Adverse Event|0
4666604|NCT02275117|7560020|FG002|Overall Study|Adverse Event|0
4666605|NCT02275117|7560021|FG003|Overall Study|Adverse Event|0
4666606|NCT02275117|7560022|FG004|Overall Study|Adverse Event|1
4666607|NCT02275117|7560018|FG000|Overall Study|Lack of Efficacy|6
4666608|NCT02275117|7560019|FG001|Overall Study|Lack of Efficacy|7
4753162|NCT01423851|7727674|FG007|Whole Study|Withdrawal by Subject|0
4753163|NCT01423851|7727675|FG008|Whole Study|Withdrawal by Subject|2
4753164|NCT01423851|7727676|FG009|Whole Study|Withdrawal by Subject|0
4753165|NCT01423851|7727677|FG010|Whole Study|Withdrawal by Subject|4
4753166|NCT01423851|7727667|FG000|Whole Study|Adverse Event|0
4753167|NCT01423851|7727668|FG001|Whole Study|Adverse Event|0
4753168|NCT01423851|7727669|FG002|Whole Study|Adverse Event|0
4753169|NCT01423851|7727670|FG003|Whole Study|Adverse Event|2
4753170|NCT01423851|7727671|FG004|Whole Study|Adverse Event|0
4753171|NCT01423851|7727672|FG005|Whole Study|Adverse Event|0
4753172|NCT01423851|7727673|FG006|Whole Study|Adverse Event|0
4753173|NCT01423851|7727674|FG007|Whole Study|Adverse Event|3
4753174|NCT01423851|7727675|FG008|Whole Study|Adverse Event|3
4753175|NCT01423851|7727676|FG009|Whole Study|Adverse Event|2
4753176|NCT01423851|7727677|FG010|Whole Study|Adverse Event|3
4753177|NCT01385176|7727708|FG000|Randomization Phase|Death|1
4753178|NCT01385176|7727709|FG001|Randomization Phase|Death|2
4753179|NCT01385176|7727708|FG000|6-18 Month All VNS Active|Death|1
4753180|NCT01385176|7727709|FG001|6-18 Month All VNS Active|Death|2
4753181|NCT01385176|7727708|FG000|6-18 Month All VNS Active|Physician Decision|0
4753182|NCT01385176|7727709|FG001|6-18 Month All VNS Active|Physician Decision|1
4753183|NCT01385176|7727708|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2
4753184|NCT01385176|7727709|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0
4753185|NCT01385176|7727708|FG000|6-18 Month All VNS Active|Heart Transplant|1
4753186|NCT01385176|7727709|FG001|6-18 Month All VNS Active|Heart Transplant|0
4753187|NCT01354431|7727736|FG000|Randomized to Enter Treatment Period|No longer met criteria|1
4753188|NCT01354431|7727737|FG001|Randomized to Enter Treatment Period|No longer met criteria|0
4753189|NCT01354431|7727738|FG002|Randomized to Enter Treatment Period|No longer met criteria|0
4753190|NCT01354431|7727736|FG000|Participants Treated|Continuing Treatment|6
4753191|NCT01354431|7727737|FG001|Participants Treated|Continuing Treatment|2
4753192|NCT01354431|7727738|FG002|Participants Treated|Continuing Treatment|4
4753193|NCT01354431|7727736|FG000|Participants Treated|Disease Progression|49
4753194|NCT01354431|7727737|FG001|Participants Treated|Disease Progression|40
4753195|NCT01354431|7727738|FG002|Participants Treated|Disease Progression|41
4753196|NCT01354431|7727736|FG000|Participants Treated|Study Drug Toxicity|2
4753197|NCT01354431|7727737|FG001|Participants Treated|Study Drug Toxicity|7
4753198|NCT01354431|7727738|FG002|Participants Treated|Study Drug Toxicity|4
4753199|NCT01354431|7727736|FG000|Participants Treated|Death|0
4753200|NCT01354431|7727737|FG001|Participants Treated|Death|1
4753201|NCT01354431|7727738|FG002|Participants Treated|Death|0
4753202|NCT01354431|7727736|FG000|Participants Treated|Adverse Event|1
4666609|NCT02275117|7560020|FG002|Overall Study|Lack of Efficacy|5
4666610|NCT02275117|7560021|FG003|Overall Study|Lack of Efficacy|2
4666611|NCT02275117|7560022|FG004|Overall Study|Lack of Efficacy|10
4753203|NCT01354431|7727737|FG001|Participants Treated|Adverse Event|2
4753204|NCT01354431|7727738|FG002|Participants Treated|Adverse Event|4
4753205|NCT01354431|7727736|FG000|Participants Treated|Withdrawal by Subject|1
4753206|NCT01354431|7727737|FG001|Participants Treated|Withdrawal by Subject|2
4666612|NCT02275117|7560018|FG000|Overall Study|Lost to Follow-up|11
4666613|NCT02275117|7560019|FG001|Overall Study|Lost to Follow-up|16
4666614|NCT02275117|7560020|FG002|Overall Study|Lost to Follow-up|15
4666615|NCT02275117|7560021|FG003|Overall Study|Lost to Follow-up|16
4666616|NCT02275117|7560022|FG004|Overall Study|Lost to Follow-up|8
4666617|NCT02275117|7560018|FG000|Overall Study|Physician Decision|0
4666618|NCT02275117|7560019|FG001|Overall Study|Physician Decision|1
4666619|NCT02275117|7560020|FG002|Overall Study|Physician Decision|1
4666620|NCT02275117|7560021|FG003|Overall Study|Physician Decision|0
4666621|NCT02275117|7560022|FG004|Overall Study|Physician Decision|1
4666622|NCT02275117|7560018|FG000|Overall Study|Protocol Violation|1
4666623|NCT02275117|7560019|FG001|Overall Study|Protocol Violation|0
4666624|NCT02275117|7560020|FG002|Overall Study|Protocol Violation|1
4666625|NCT02275117|7560021|FG003|Overall Study|Protocol Violation|1
4666626|NCT02275117|7560022|FG004|Overall Study|Protocol Violation|0
4666627|NCT02275117|7560018|FG000|Overall Study|Withdrawal by Subject|6
4666628|NCT02275117|7560019|FG001|Overall Study|Withdrawal by Subject|4
4666629|NCT02275117|7560020|FG002|Overall Study|Withdrawal by Subject|7
4666630|NCT02275117|7560021|FG003|Overall Study|Withdrawal by Subject|3
4666631|NCT02275117|7560022|FG004|Overall Study|Withdrawal by Subject|3
4666632|NCT02275117|7560018|FG000|Overall Study|Terminated by Sponsor|4
4666633|NCT02275117|7560019|FG001|Overall Study|Terminated by Sponsor|4
4666634|NCT02275117|7560020|FG002|Overall Study|Terminated by Sponsor|4
4666635|NCT02275117|7560021|FG003|Overall Study|Terminated by Sponsor|6
4666636|NCT02275117|7560022|FG004|Overall Study|Terminated by Sponsor|4
4666637|NCT02275117|7560018|FG000|Overall Study|Worsening of Study Indication|0
4666638|NCT02275117|7560019|FG001|Overall Study|Worsening of Study Indication|1
4666639|NCT02275117|7560020|FG002|Overall Study|Worsening of Study Indication|2
4666640|NCT02275117|7560021|FG003|Overall Study|Worsening of Study Indication|0
4666641|NCT02275117|7560022|FG004|Overall Study|Worsening of Study Indication|0
4666642|NCT02275117|7560018|FG000|Overall Study|Study Burden|5
4666643|NCT02275117|7560019|FG001|Overall Study|Study Burden|4
4666644|NCT02275117|7560020|FG002|Overall Study|Study Burden|7
4666645|NCT02275117|7560021|FG003|Overall Study|Study Burden|5
4666646|NCT02275117|7560022|FG004|Overall Study|Study Burden|7
4666647|NCT02275117|7560018|FG000|Overall Study|Other|1
4666648|NCT02275117|7560019|FG001|Overall Study|Other|0
4666649|NCT02275117|7560020|FG002|Overall Study|Other|0
4666650|NCT02275117|7560021|FG003|Overall Study|Other|0
4666651|NCT02275117|7560022|FG004|Overall Study|Other|2
4666652|NCT02275338|7560048|FG000|Overall Study|Adverse Event|15
4666653|NCT02275338|7560048|FG000|Overall Study|Lack of Efficacy|3
4666654|NCT02275338|7560048|FG000|Overall Study|Withdrawal by Subject|4
4666655|NCT02275338|7560048|FG000|Overall Study|Disease progression (death)|1
4666656|NCT02275338|7560048|FG000|Overall Study|Ineligible to start Phase 2|4
4666657|NCT02275338|7560048|FG000|Overall Study|Reason not specified|5
4666658|NCT02275338|7560048|FG000|Overall Study|Does not meet entry criteria|1
4666659|NCT02275364|7560053|FG000|Period 1|Withdrawal by Subject|1
4666660|NCT02275364|7560054|FG001|Period 1|Withdrawal by Subject|0
4666661|NCT02275364|7560053|FG000|Period 1|Other reason|1
4666662|NCT02275364|7560054|FG001|Period 1|Other reason|0
4666663|NCT02275611|7560075|FG000|Inpatient Withdrawal|Withdrawal by Subject|1
4666664|NCT02275611|7560076|FG001|Inpatient Withdrawal|Withdrawal by Subject|0
4666665|NCT02275611|7560077|FG002|Inpatient Withdrawal|Withdrawal by Subject|0
4666666|NCT02275611|7560078|FG003|Inpatient Withdrawal|Withdrawal by Subject|0
4666667|NCT02275780|7560105|FG000|Base Study: 96 Weeks|Adverse Event|6
4753207|NCT01354431|7727738|FG002|Participants Treated|Withdrawal by Subject|1
4753208|NCT01334606|7727750|FG000|Overall Study|Study Terminated due to slow enrolment|18
4753209|NCT01317875|7727766|FG000|Overall Study|Other|0
4753210|NCT01317875|7727767|FG001|Overall Study|Other|0
4753211|NCT01317875|7727768|FG002|Overall Study|Other|1
4753212|NCT01317875|7727769|FG003|Overall Study|Other|0
4753213|NCT01317875|7727770|FG004|Overall Study|Other|0
4753214|NCT01317875|7727771|FG005|Overall Study|Other|0
4753215|NCT01317875|7727772|FG006|Overall Study|Other|0
4753216|NCT01317875|7727773|FG007|Overall Study|Other|0
4753217|NCT01317875|7727774|FG008|Overall Study|Other|0
4753218|NCT01317875|7727775|FG009|Overall Study|Other|0
4753219|NCT01317875|7727766|FG000|Overall Study|Noncompliance with study drug|0
4753220|NCT01317875|7727767|FG001|Overall Study|Noncompliance with study drug|0
4753221|NCT01317875|7727768|FG002|Overall Study|Noncompliance with study drug|1
4753222|NCT01317875|7727769|FG003|Overall Study|Noncompliance with study drug|0
4753223|NCT01317875|7727770|FG004|Overall Study|Noncompliance with study drug|0
4666668|NCT02275780|7560106|FG001|Base Study: 96 Weeks|Adverse Event|14
4666669|NCT02275780|7560105|FG000|Base Study: 96 Weeks|Death|3
4666670|NCT02275780|7560106|FG001|Base Study: 96 Weeks|Death|1
4666671|NCT02275780|7560105|FG000|Base Study: 96 Weeks|Lack of Efficacy|21
4666672|NCT02275780|7560106|FG001|Base Study: 96 Weeks|Lack of Efficacy|32
4666673|NCT02275780|7560105|FG000|Base Study: 96 Weeks|Lost to Follow-up|28
4666674|NCT02275780|7560106|FG001|Base Study: 96 Weeks|Lost to Follow-up|24
4666675|NCT02275780|7560105|FG000|Base Study: 96 Weeks|Protocol Violation|1
4666676|NCT02275780|7560106|FG001|Base Study: 96 Weeks|Protocol Violation|6
4666677|NCT02275780|7560105|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19
4666678|NCT02275780|7560106|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22
4666679|NCT02275780|7560105|FG000|Base Study: 96 Weeks|Noncompliance with drug|9
4666680|NCT02275780|7560106|FG001|Base Study: 96 Weeks|Noncompliance with drug|6
4666681|NCT02275780|7560105|FG000|Base Study: 96 Weeks|Physician Decision|2
4666682|NCT02275780|7560106|FG001|Base Study: 96 Weeks|Physician Decision|4
4666683|NCT02275780|7560105|FG000|Base Study: 96 Weeks|Pregnancy|2
4666684|NCT02275780|7560106|FG001|Base Study: 96 Weeks|Pregnancy|1
4666685|NCT02275780|7560105|FG000|Base Study: 96 Weeks|Randomized not treated|2
4666686|NCT02275780|7560106|FG001|Base Study: 96 Weeks|Randomized not treated|1
4666687|NCT02275780|7560105|FG000|Extension Study: up to 192 Weeks|Ongoing|260
4666688|NCT02275780|7560106|FG001|Extension Study: up to 192 Weeks|Ongoing|233
4666689|NCT02275819|7560114|FG000|Overall Study|Adverse Event|0
4666690|NCT02275819|7560115|FG001|Overall Study|Adverse Event|1
4666691|NCT02276027|7560129|FG000|Overall Study|Death|1
4666692|NCT02276027|7560130|FG001|Overall Study|Death|0
4666693|NCT02276027|7560131|FG002|Overall Study|Death|0
4666694|NCT02276027|7560132|FG003|Overall Study|Death|2
4666695|NCT02276027|7560129|FG000|Overall Study|Physician Decision|0
4666696|NCT02276027|7560130|FG001|Overall Study|Physician Decision|0
4666697|NCT02276027|7560131|FG002|Overall Study|Physician Decision|0
4666698|NCT02276027|7560132|FG003|Overall Study|Physician Decision|1
4666699|NCT02276027|7560129|FG000|Overall Study|Progressive disease|1
4666700|NCT02276027|7560130|FG001|Overall Study|Progressive disease|13
4666701|NCT02276027|7560131|FG002|Overall Study|Progressive disease|12
4666702|NCT02276027|7560132|FG003|Overall Study|Progressive disease|14
4666703|NCT02276027|7560129|FG000|Overall Study|Subject/guardian decision|0
4666704|NCT02276027|7560130|FG001|Overall Study|Subject/guardian decision|1
4666705|NCT02276027|7560131|FG002|Overall Study|Subject/guardian decision|0
4666706|NCT02276027|7560132|FG003|Overall Study|Subject/guardian decision|3
4666707|NCT02276027|7560129|FG000|Overall Study|Adverse Event|0
4666708|NCT02276027|7560130|FG001|Overall Study|Adverse Event|2
4666709|NCT02276027|7560131|FG002|Overall Study|Adverse Event|8
4666710|NCT02276027|7560132|FG003|Overall Study|Adverse Event|2
4666711|NCT02276040|7560142|FG000|Overall Study|Physician Decision|15
4666712|NCT02276053|7560146|FG000|Overall Study|Death|2
4666713|NCT02276053|7560146|FG000|Overall Study|Adverse Event|5
4666714|NCT02276053|7560146|FG000|Overall Study|Lack of Efficacy|2
4666715|NCT02276053|7560146|FG000|Overall Study|Withdrawal by Subject|1
4666716|NCT02276053|7560146|FG000|Overall Study|Patient does not meet selection criteria|3
4666717|NCT02276053|7560146|FG000|Overall Study|Patient needs to increase baseline AED|1
4666718|NCT02276222|7560153|FG000|Overall Study|Adverse Event|62
4666719|NCT02276222|7560154|FG001|Overall Study|Adverse Event|11
4666720|NCT02276222|7560153|FG000|Overall Study|Death|3
4666721|NCT02276222|7560154|FG001|Overall Study|Death|4
4666722|NCT02276222|7560153|FG000|Overall Study|Lack of Efficacy|13
4666723|NCT02276222|7560154|FG001|Overall Study|Lack of Efficacy|3
4666724|NCT02276222|7560153|FG000|Overall Study|Protocol Violation|3
4753224|NCT01317875|7727771|FG005|Overall Study|Noncompliance with study drug|0
4753225|NCT01317875|7727772|FG006|Overall Study|Noncompliance with study drug|0
4753226|NCT01317875|7727773|FG007|Overall Study|Noncompliance with study drug|0
4753227|NCT01317875|7727774|FG008|Overall Study|Noncompliance with study drug|0
4753228|NCT01317875|7727775|FG009|Overall Study|Noncompliance with study drug|0
4753229|NCT01317875|7727766|FG000|Overall Study|Progressive Disease|1
4753230|NCT01317875|7727767|FG001|Overall Study|Progressive Disease|0
4753231|NCT01317875|7727768|FG002|Overall Study|Progressive Disease|2
4753232|NCT01317875|7727769|FG003|Overall Study|Progressive Disease|0
4753233|NCT01317875|7727770|FG004|Overall Study|Progressive Disease|1
4753234|NCT01317875|7727771|FG005|Overall Study|Progressive Disease|0
4753235|NCT01317875|7727772|FG006|Overall Study|Progressive Disease|0
4753236|NCT01317875|7727773|FG007|Overall Study|Progressive Disease|1
4753237|NCT01317875|7727774|FG008|Overall Study|Progressive Disease|0
4753238|NCT01317875|7727775|FG009|Overall Study|Progressive Disease|0
4753239|NCT01317875|7727766|FG000|Overall Study|Withdrawal by Subject|0
4753240|NCT01317875|7727767|FG001|Overall Study|Withdrawal by Subject|0
4753241|NCT01317875|7727768|FG002|Overall Study|Withdrawal by Subject|0
4753242|NCT01317875|7727769|FG003|Overall Study|Withdrawal by Subject|0
4753243|NCT01317875|7727770|FG004|Overall Study|Withdrawal by Subject|1
4753244|NCT01317875|7727771|FG005|Overall Study|Withdrawal by Subject|0
4753245|NCT01317875|7727772|FG006|Overall Study|Withdrawal by Subject|0
4666725|NCT02276222|7560154|FG001|Overall Study|Protocol Violation|2
4666726|NCT02276222|7560153|FG000|Overall Study|Withdrawal by Subject|79
4753246|NCT01317875|7727773|FG007|Overall Study|Withdrawal by Subject|3
4753247|NCT01317875|7727774|FG008|Overall Study|Withdrawal by Subject|0
4753248|NCT01317875|7727775|FG009|Overall Study|Withdrawal by Subject|0
4666727|NCT02276222|7560154|FG001|Overall Study|Withdrawal by Subject|33
4666728|NCT02276222|7560153|FG000|Overall Study|non compliance with study medication|6
4666729|NCT02276222|7560154|FG001|Overall Study|non compliance with study medication|2
4666730|NCT02276222|7560153|FG000|Overall Study|sponsor decision|0
4666731|NCT02276222|7560154|FG001|Overall Study|sponsor decision|3
4666732|NCT02276222|7560153|FG000|Overall Study|Lost to Follow-up|15
4666733|NCT02276222|7560154|FG001|Overall Study|Lost to Follow-up|5
4666734|NCT02276222|7560153|FG000|Overall Study|Physician Decision|2
4753249|NCT01317875|7727766|FG000|Overall Study|Physician Decision|0
4753250|NCT01317875|7727767|FG001|Overall Study|Physician Decision|1
4753251|NCT01317875|7727768|FG002|Overall Study|Physician Decision|1
4753252|NCT01317875|7727769|FG003|Overall Study|Physician Decision|0
4753253|NCT01317875|7727770|FG004|Overall Study|Physician Decision|2
4753254|NCT01317875|7727771|FG005|Overall Study|Physician Decision|0
4753255|NCT01317875|7727772|FG006|Overall Study|Physician Decision|0
4753256|NCT01317875|7727773|FG007|Overall Study|Physician Decision|2
4753257|NCT01317875|7727774|FG008|Overall Study|Physician Decision|0
4753258|NCT01317875|7727775|FG009|Overall Study|Physician Decision|0
4753259|NCT01317875|7727766|FG000|Overall Study|Death|0
4753260|NCT01317875|7727767|FG001|Overall Study|Death|0
4753261|NCT01317875|7727768|FG002|Overall Study|Death|2
4753262|NCT01317875|7727769|FG003|Overall Study|Death|1
4753263|NCT01317875|7727770|FG004|Overall Study|Death|0
4753264|NCT01317875|7727771|FG005|Overall Study|Death|1
4753265|NCT01317875|7727772|FG006|Overall Study|Death|0
4753266|NCT01317875|7727773|FG007|Overall Study|Death|4
4753267|NCT01317875|7727774|FG008|Overall Study|Death|0
4753268|NCT01317875|7727775|FG009|Overall Study|Death|0
4753269|NCT01317875|7727766|FG000|Overall Study|Adverse Event|2
4753270|NCT01317875|7727767|FG001|Overall Study|Adverse Event|1
4753271|NCT01317875|7727768|FG002|Overall Study|Adverse Event|2
4753272|NCT01317875|7727769|FG003|Overall Study|Adverse Event|1
4753273|NCT01317875|7727770|FG004|Overall Study|Adverse Event|5
4753274|NCT01317875|7727771|FG005|Overall Study|Adverse Event|1
4753275|NCT01317875|7727772|FG006|Overall Study|Adverse Event|2
4753276|NCT01317875|7727773|FG007|Overall Study|Adverse Event|5
4753277|NCT01317875|7727774|FG008|Overall Study|Adverse Event|0
4753278|NCT01317875|7727775|FG009|Overall Study|Adverse Event|0
4753279|NCT01216683|7727840|FG000|Induction|Never started treatment|0
4753280|NCT01216683|7727841|FG001|Induction|Never started treatment|6
4753281|NCT01216683|7727842|FG002|Induction|Never started treatment|3
4753282|NCT01216683|7727840|FG000|Induction|Lack of Efficacy|4
4753283|NCT01216683|7727841|FG001|Induction|Lack of Efficacy|3
4753284|NCT01216683|7727842|FG002|Induction|Lack of Efficacy|7
4753285|NCT01216683|7727840|FG000|Induction|Adverse Event|0
4753286|NCT01216683|7727841|FG001|Induction|Adverse Event|5
4753287|NCT01216683|7727842|FG002|Induction|Adverse Event|5
4753288|NCT01216683|7727840|FG000|Induction|Death|0
4753289|NCT01216683|7727841|FG001|Induction|Death|0
4753290|NCT01216683|7727842|FG002|Induction|Death|2
4753291|NCT01216683|7727840|FG000|Induction|Withdrawal by Subject|0
4753292|NCT01216683|7727841|FG001|Induction|Withdrawal by Subject|4
4753293|NCT01216683|7727842|FG002|Induction|Withdrawal by Subject|2
4753294|NCT01216683|7727840|FG000|Induction|Other disease|0
4753295|NCT01216683|7727841|FG001|Induction|Other disease|1
4753296|NCT01216683|7727842|FG002|Induction|Other disease|2
4666735|NCT02276222|7560154|FG001|Overall Study|Physician Decision|1
4666736|NCT02276222|7560153|FG000|Overall Study|sheduling conflict|1
4666737|NCT02276222|7560154|FG001|Overall Study|sheduling conflict|0
4666738|NCT02276222|7560153|FG000|Overall Study|subject withdrew after randomization|1
4666739|NCT02276222|7560154|FG001|Overall Study|subject withdrew after randomization|0
4666740|NCT02276482|7560171|FG000|Overall Study|Adverse Event|1
4666741|NCT02276482|7560172|FG001|Overall Study|Adverse Event|0
4666742|NCT02276482|7560171|FG000|Overall Study|Withdrawal by Subject|1
4666743|NCT02276482|7560172|FG001|Overall Study|Withdrawal by Subject|0
4666744|NCT02276482|7560171|FG000|Overall Study|Gram-negative infection|1
4666745|NCT02276482|7560172|FG001|Overall Study|Gram-negative infection|0
4666746|NCT02276482|7560171|FG000|Overall Study|Reason not specified|0
4666747|NCT02276482|7560172|FG001|Overall Study|Reason not specified|1
4666748|NCT02276612|7560180|FG000|Overall Study|Death|1
4666749|NCT02276612|7560181|FG001|Overall Study|Death|0
4666750|NCT02276612|7560180|FG000|Overall Study|Pregnancy|1
4666751|NCT02276612|7560181|FG001|Overall Study|Pregnancy|0
4666752|NCT02276612|7560180|FG000|Overall Study|Withdrew Consent|1
4666753|NCT02276612|7560181|FG001|Overall Study|Withdrew Consent|0
4666754|NCT02276612|7560180|FG000|Overall Study|Lost to Follow-up|1
4666755|NCT02276612|7560181|FG001|Overall Study|Lost to Follow-up|0
4666756|NCT02276807|7560202|FG000|Overall Study|Withdrawal by Subject|8
4666757|NCT02276807|7560203|FG001|Overall Study|Withdrawal by Subject|7
4666758|NCT02276807|7560202|FG000|Overall Study|Lost to Follow-up|10
4666759|NCT02276807|7560203|FG001|Overall Study|Lost to Follow-up|10
4666760|NCT02276872|7560212|FG000|Overall Study|Adverse Event|1
4666761|NCT02276872|7560213|FG001|Overall Study|Adverse Event|0
4666762|NCT02276872|7560214|FG002|Overall Study|Adverse Event|0
4666763|NCT02277691|7560290|FG000|Overall Study|Pretreatment Event/Adverse Event|33
4666764|NCT02277691|7560290|FG000|Overall Study|Voluntary Withdrawal|7
4666765|NCT02277691|7560290|FG000|Overall Study|Lack of Efficacy|5
4666766|NCT02277691|7560290|FG000|Overall Study|Used Other Antihypertensive Drug|1
4666767|NCT02277743|7560297|FG000|Overall Study|Protocol Violation|1
4666768|NCT02277743|7560298|FG001|Overall Study|Protocol Violation|1
4666769|NCT02277743|7560299|FG002|Overall Study|Protocol Violation|1
4666770|NCT02277743|7560297|FG000|Overall Study|Adverse Event|10
4666771|NCT02277743|7560298|FG001|Overall Study|Adverse Event|6
4666772|NCT02277743|7560299|FG002|Overall Study|Adverse Event|6
4666773|NCT02277743|7560297|FG000|Overall Study|Lack of Efficacy|11
4666774|NCT02277743|7560298|FG001|Overall Study|Lack of Efficacy|4
4666775|NCT02277743|7560299|FG002|Overall Study|Lack of Efficacy|3
4666776|NCT02277743|7560297|FG000|Overall Study|Other than specified above|18
4666777|NCT02277743|7560298|FG001|Overall Study|Other than specified above|5
4666778|NCT02277743|7560299|FG002|Overall Study|Other than specified above|16
4666779|NCT02277769|7560310|FG000|Overall Study|Protocol Violation|3
4753297|NCT01216683|7727840|FG000|Continuation|Lack of Efficacy|3
4753298|NCT01216683|7727841|FG001|Continuation|Lack of Efficacy|2
4753299|NCT01216683|7727842|FG002|Continuation|Lack of Efficacy|7
4753300|NCT01216683|7727840|FG000|Continuation|Adverse Event|5
4753301|NCT01216683|7727841|FG001|Continuation|Adverse Event|3
4753302|NCT01216683|7727842|FG002|Continuation|Adverse Event|16
4753303|NCT01216683|7727840|FG000|Continuation|Death|1
4753304|NCT01216683|7727841|FG001|Continuation|Death|0
4753305|NCT01216683|7727842|FG002|Continuation|Death|2
4753306|NCT01216683|7727840|FG000|Continuation|Withdrawal by Subject|4
4753307|NCT01216683|7727841|FG001|Continuation|Withdrawal by Subject|5
4753308|NCT01216683|7727842|FG002|Continuation|Withdrawal by Subject|9
4753309|NCT01216683|7727840|FG000|Continuation|Other diseases|0
4753310|NCT01216683|7727841|FG001|Continuation|Other diseases|2
4753311|NCT01216683|7727842|FG002|Continuation|Other diseases|1
4753312|NCT01216683|7727840|FG000|Continuation|Physician Decision|1
4753313|NCT01216683|7727841|FG001|Continuation|Physician Decision|0
4753314|NCT01216683|7727842|FG002|Continuation|Physician Decision|1
4753315|NCT01216683|7727840|FG000|Continuation|Non-compliance|1
4753316|NCT01216683|7727841|FG001|Continuation|Non-compliance|0
4753317|NCT01216683|7727842|FG002|Continuation|Non-compliance|1
4753318|NCT01216683|7727840|FG000|Continuation|Insurance change|0
4753319|NCT01216683|7727841|FG001|Continuation|Insurance change|1
4753320|NCT01216683|7727842|FG002|Continuation|Insurance change|0
4753321|NCT01216683|7727840|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0
4753322|NCT01216683|7727841|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1
4753323|NCT01216683|7727842|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0
4753324|NCT01216683|7727840|FG000|Continuation|Not reported|0
4753325|NCT01216683|7727841|FG001|Continuation|Not reported|0
4753326|NCT01216683|7727842|FG002|Continuation|Not reported|1
4753327|NCT01216683|7727840|FG000|Continuation|Never started treatment|0
4666780|NCT02277769|7560311|FG001|Overall Study|Protocol Violation|3
4666781|NCT02277769|7560312|FG002|Overall Study|Protocol Violation|5
4666782|NCT02277769|7560310|FG000|Overall Study|Lack of Efficacy|17
4666783|NCT02277769|7560311|FG001|Overall Study|Lack of Efficacy|0
4666784|NCT02277769|7560312|FG002|Overall Study|Lack of Efficacy|4
4666785|NCT02277769|7560310|FG000|Overall Study|Adverse Event|14
4666786|NCT02277769|7560311|FG001|Overall Study|Adverse Event|2
4666787|NCT02277769|7560312|FG002|Overall Study|Adverse Event|4
4666788|NCT02277769|7560310|FG000|Overall Study|Other than specified above|12
4666789|NCT02277769|7560311|FG001|Overall Study|Other than specified above|8
4666790|NCT02277769|7560312|FG002|Overall Study|Other than specified above|5
4666791|NCT02277990|7560333|FG000|Overall Study|Death|170
4666792|NCT02277990|7560334|FG001|Overall Study|Death|188
4666793|NCT02277990|7560333|FG000|Overall Study|Withdrawal by Subject|64
4666794|NCT02277990|7560334|FG001|Overall Study|Withdrawal by Subject|53
4666795|NCT02277990|7560333|FG000|Overall Study|Physician Decision|40
4666796|NCT02277990|7560334|FG001|Overall Study|Physician Decision|34
4666797|NCT02277990|7560333|FG000|Overall Study|Lost to Follow-up|66
4666798|NCT02277990|7560334|FG001|Overall Study|Lost to Follow-up|69
4666799|NCT02277990|7560333|FG000|Overall Study|Had other reason|26
4666800|NCT02277990|7560334|FG001|Overall Study|Had other reason|32
4753328|NCT01216683|7727841|FG001|Continuation|Never started treatment|1
4666801|NCT02278003|7560342|FG000|Overall Study|Withdrawal by Subject|11
4753329|NCT01216683|7727842|FG002|Continuation|Never started treatment|5
4753330|NCT01085097|7727866|FG000|Overall Study|Adverse Event|0
4753331|NCT01085097|7727867|FG001|Overall Study|Adverse Event|0
4666802|NCT02278003|7560343|FG001|Overall Study|Withdrawal by Subject|0
4666803|NCT02278003|7560342|FG000|Overall Study|Not Treated|1
4666804|NCT02278003|7560343|FG001|Overall Study|Not Treated|0
4666805|NCT02278003|7560342|FG000|Overall Study|Recognition task improperly completed|7
4666806|NCT02278003|7560343|FG001|Overall Study|Recognition task improperly completed|0
4666807|NCT02278263|7560365|FG000|Overall Study|Protocol Violation|7
4666808|NCT02278263|7560366|FG001|Overall Study|Protocol Violation|0
4666809|NCT02278263|7560367|FG002|Overall Study|Protocol Violation|9
4666810|NCT02278328|7560387|FG000|Neuropsych Screening|found ineligible on neuropsych|1
4666811|NCT02278328|7560388|FG001|Neuropsych Screening|found ineligible on neuropsych|0
4666812|NCT02278328|7560389|FG002|Neuropsych Screening|found ineligible on neuropsych|0
4666813|NCT02278328|7560387|FG000|Neuropsych Screening|Withdrawal by Subject|0
4666814|NCT02278328|7560388|FG001|Neuropsych Screening|Withdrawal by Subject|1
4666815|NCT02278328|7560389|FG002|Neuropsych Screening|Withdrawal by Subject|0
4666816|NCT02278328|7560387|FG000|Neuropsych Screening|incomplete consent|0
4666817|NCT02278328|7560388|FG001|Neuropsych Screening|incomplete consent|0
4666818|NCT02278328|7560389|FG002|Neuropsych Screening|incomplete consent|2
4666819|NCT02278341|7560397|FG000|Overall Study|Randomized but never received study drug|1
4666820|NCT02278341|7560398|FG001|Overall Study|Randomized but never received study drug|1
4666821|NCT02278341|7560397|FG000|Overall Study|Adverse Event|3
4666822|NCT02278341|7560398|FG001|Overall Study|Adverse Event|0
4666823|NCT02278341|7560397|FG000|Overall Study|Death|68
4666824|NCT02278341|7560398|FG001|Overall Study|Death|56
4666825|NCT02278341|7560397|FG000|Overall Study|Withdrawal by Subject|30
4666826|NCT02278341|7560398|FG001|Overall Study|Withdrawal by Subject|19
4666827|NCT02278341|7560397|FG000|Overall Study|Lost to Follow-up|0
4666828|NCT02278341|7560398|FG001|Overall Study|Lost to Follow-up|1
4666829|NCT02278341|7560397|FG000|Overall Study|Physician Decision|1
4666830|NCT02278341|7560398|FG001|Overall Study|Physician Decision|1
4666831|NCT02278341|7560397|FG000|Overall Study|Miscellaneous|15
4666832|NCT02278341|7560398|FG001|Overall Study|Miscellaneous|14
4666833|NCT02278354|7560407|FG000|Overall Study|Lost to Follow-up|2
4666834|NCT02278354|7560408|FG001|Overall Study|Lost to Follow-up|2
4666835|NCT02278354|7560407|FG000|Overall Study|Withdrawal by Subject|0
4666836|NCT02278354|7560408|FG001|Overall Study|Withdrawal by Subject|1
4666837|NCT02278354|7560407|FG000|Overall Study|<10 professional fights|2
4666838|NCT02278354|7560408|FG001|Overall Study|<10 professional fights|0
4666839|NCT02278367|7560418|FG000|Overall Study|Physician Decision|5
4666840|NCT02278367|7560419|FG001|Overall Study|Physician Decision|0
4666841|NCT02278367|7560418|FG000|Overall Study|Withdrawal by Subject|5
4666842|NCT02278367|7560419|FG001|Overall Study|Withdrawal by Subject|0
4666843|NCT02278471|7560427|FG000|Overall Study|Lost to Follow-up|6
4666844|NCT02278471|7560428|FG001|Overall Study|Lost to Follow-up|15
4666845|NCT02278471|7560427|FG000|Overall Study|Death|2
4666846|NCT02278471|7560428|FG001|Overall Study|Death|2
4666847|NCT02278471|7560427|FG000|Overall Study|Withdrawal by Subject|0
4666848|NCT02278471|7560428|FG001|Overall Study|Withdrawal by Subject|3
4666849|NCT02278614|7560455|FG000|Overall Study|Withdrawal by Subject|3
4666850|NCT02278614|7560456|FG001|Overall Study|Withdrawal by Subject|5
4666851|NCT02278614|7560455|FG000|Overall Study|Adverse Event|1
4666852|NCT02278614|7560456|FG001|Overall Study|Adverse Event|0
4666853|NCT02278614|7560455|FG000|Overall Study|left eye was not eligible|1
4666854|NCT02278614|7560456|FG001|Overall Study|left eye was not eligible|0
4666855|NCT02278939|7560472|FG000|Overall Study|lack of time|1
4666856|NCT02278939|7560473|FG001|Overall Study|lack of time|0
4666857|NCT02278939|7560472|FG000|Overall Study|Lost to Follow-up|1
4666858|NCT02278939|7560473|FG001|Overall Study|Lost to Follow-up|1
4666859|NCT02278939|7560472|FG000|Overall Study|death in family|1
4666860|NCT02278939|7560473|FG001|Overall Study|death in family|0
4666861|NCT02278939|7560472|FG000|Overall Study|family emergency unable to commit|2
4666862|NCT02278939|7560473|FG001|Overall Study|family emergency unable to commit|0
4666863|NCT02278952|7560479|FG000|Overall Study|Insufficient Sample|6
4666864|NCT02279043|7560492|FG000|Overall Study|Post-rand. exclusion - not eligible|1
4666865|NCT02279043|7560493|FG001|Overall Study|Post-rand. exclusion - not eligible|1
4666866|NCT02279043|7560494|FG002|Overall Study|Post-rand. exclusion - not eligible|0
4666867|NCT02279043|7560492|FG000|Overall Study|Lost to Follow-up|46
4666868|NCT02279043|7560493|FG001|Overall Study|Lost to Follow-up|88
4666869|NCT02279043|7560494|FG002|Overall Study|Lost to Follow-up|0
4666870|NCT02279173|7560522|FG000|Overall Study|Protocol-specified Criteria|67
4666871|NCT02279173|7560522|FG000|Overall Study|Withdrawal by Subject|20
4666872|NCT02279173|7560522|FG000|Overall Study|Decision by Sponsor|4
4666873|NCT02279173|7560522|FG000|Overall Study|Lost to Follow-up|3
4666874|NCT02279407|7560532|FG000|Overall Study|Couldn't swallow IP; noncompliance|0
4666875|NCT02279407|7560533|FG001|Overall Study|Couldn't swallow IP; noncompliance|0
4753332|NCT01085097|7727868|FG002|Overall Study|Adverse Event|2
4753333|NCT01085097|7727866|FG000|Overall Study|Treatment failure|2
4666876|NCT02279407|7560534|FG002|Overall Study|Couldn't swallow IP; noncompliance|2
4666877|NCT02279407|7560535|FG003|Overall Study|Couldn't swallow IP; noncompliance|0
4666878|NCT02279407|7560532|FG000|Overall Study|Withdrawal by Subject|1
4666879|NCT02279407|7560533|FG001|Overall Study|Withdrawal by Subject|0
4666880|NCT02279407|7560534|FG002|Overall Study|Withdrawal by Subject|1
4666881|NCT02279407|7560535|FG003|Overall Study|Withdrawal by Subject|1
4753334|NCT01085097|7727867|FG001|Overall Study|Treatment failure|0
4666882|NCT02279407|7560532|FG000|Overall Study|Adverse Event|1
4666883|NCT02279407|7560533|FG001|Overall Study|Adverse Event|1
4666884|NCT02279407|7560534|FG002|Overall Study|Adverse Event|2
4666885|NCT02279407|7560535|FG003|Overall Study|Adverse Event|0
4666886|NCT02279420|7560545|FG000|Overall Study|Lost to Follow-up|23
4666887|NCT02279498|7560551|FG000|Overall Study|Adverse Event|3
4666888|NCT02279498|7560552|FG001|Overall Study|Adverse Event|0
4666889|NCT02279498|7560551|FG000|Overall Study|Lack of Efficacy|4
4666890|NCT02279498|7560552|FG001|Overall Study|Lack of Efficacy|0
4666891|NCT02279498|7560551|FG000|Overall Study|Lost to Follow-up|0
4666892|NCT02279498|7560552|FG001|Overall Study|Lost to Follow-up|1
4666893|NCT02279498|7560551|FG000|Overall Study|Withdrawal by Subject|9
4666894|NCT02279498|7560552|FG001|Overall Study|Withdrawal by Subject|2
4666895|NCT02279498|7560551|FG000|Overall Study|Undefined|2
4666896|NCT02279498|7560552|FG001|Overall Study|Undefined|1
4666897|NCT02279524|7560562|FG000|Overall Study|Withdrawal by Subject|3
4666898|NCT02279524|7560563|FG001|Overall Study|Withdrawal by Subject|6
4666899|NCT02279524|7560564|FG002|Overall Study|Withdrawal by Subject|3
4666900|NCT02279524|7560562|FG000|Overall Study|Adverse Event|4
4666901|NCT02279524|7560563|FG001|Overall Study|Adverse Event|3
4666902|NCT02279524|7560564|FG002|Overall Study|Adverse Event|2
4666903|NCT02279524|7560562|FG000|Overall Study|Lost to Follow-up|1
4666904|NCT02279524|7560563|FG001|Overall Study|Lost to Follow-up|1
4666905|NCT02279524|7560564|FG002|Overall Study|Lost to Follow-up|0
4666906|NCT02279524|7560562|FG000|Overall Study|Disallowed medication|1
4666907|NCT02279524|7560563|FG001|Overall Study|Disallowed medication|1
4666908|NCT02279524|7560564|FG002|Overall Study|Disallowed medication|2
4666909|NCT02279524|7560562|FG000|Overall Study|Bariatric surgery|1
4666910|NCT02279524|7560563|FG001|Overall Study|Bariatric surgery|0
4666911|NCT02279524|7560564|FG002|Overall Study|Bariatric surgery|0
4666912|NCT02279732|7560607|FG000|Overall Study|Death|23
4666913|NCT02279732|7560608|FG001|Overall Study|Death|20
4666914|NCT02279732|7560607|FG000|Overall Study|Disease Progression|13
4666915|NCT02279732|7560608|FG001|Overall Study|Disease Progression|3
4666916|NCT02279732|7560607|FG000|Overall Study|Withdrawal by Subject|2
4666917|NCT02279732|7560608|FG001|Overall Study|Withdrawal by Subject|7
4666918|NCT02279732|7560607|FG000|Overall Study|Adverse Event|1
4666919|NCT02279732|7560608|FG001|Overall Study|Adverse Event|2
4666920|NCT02279732|7560607|FG000|Overall Study|Administrative Reason By Sponsor|0
4666921|NCT02279732|7560608|FG001|Overall Study|Administrative Reason By Sponsor|2
4666922|NCT02279732|7560607|FG000|Overall Study|Study Drug Toxicity|2
4666923|NCT02279732|7560608|FG001|Overall Study|Study Drug Toxicity|0
4666924|NCT02279732|7560607|FG000|Overall Study|Lost to Follow-up|0
4666925|NCT02279732|7560608|FG001|Overall Study|Lost to Follow-up|1
4666926|NCT02279732|7560607|FG000|Overall Study|Maximum Clinical Benefit|1
4666927|NCT02279732|7560608|FG001|Overall Study|Maximum Clinical Benefit|0
4666928|NCT02279732|7560607|FG000|Overall Study|Subject Requested to Discontinue|0
4666929|NCT02279732|7560608|FG001|Overall Study|Subject Requested to Discontinue|1
4666930|NCT02279732|7560607|FG000|Overall Study|Other|53
4666931|NCT02279732|7560608|FG001|Overall Study|Other|67
4666932|NCT02279732|7560607|FG000|Overall Study|Other|3
4666933|NCT02279732|7560608|FG001|Overall Study|Other|3
4666934|NCT02279862|7560616|FG000|Overall Study|Study drug toxicity|3
4666935|NCT02279862|7560617|FG001|Overall Study|Study drug toxicity|6
4666936|NCT02279862|7560616|FG000|Overall Study|No longer meets criteria|0
4666937|NCT02279862|7560617|FG001|Overall Study|No longer meets criteria|1
4666938|NCT02279862|7560616|FG000|Overall Study|Administrative reason by sponsor|0
4666939|NCT02279862|7560617|FG001|Overall Study|Administrative reason by sponsor|1
4666940|NCT02279862|7560616|FG000|Overall Study|Disease progression|5
4666941|NCT02279862|7560617|FG001|Overall Study|Disease progression|2
4666942|NCT02279862|7560616|FG000|Overall Study|Study closed by sponsor|16
4666943|NCT02279862|7560617|FG001|Overall Study|Study closed by sponsor|13
4666944|NCT02279862|7560616|FG000|Overall Study|Other|1
4666945|NCT02279862|7560617|FG001|Overall Study|Other|2
4666946|NCT02279862|7560616|FG000|Overall Study|Withdrawal by Subject|1
4666947|NCT02279862|7560617|FG001|Overall Study|Withdrawal by Subject|0
4666948|NCT02280044|7560625|FG000|Overall Study|Planned alternate|0
4666949|NCT02280044|7560626|FG001|Overall Study|Planned alternate|2
4666950|NCT02280096|7560634|FG000|Overall Study|Pregnancy|1
4666951|NCT02280096|7560635|FG001|Overall Study|Pregnancy|0
4666952|NCT02280096|7560634|FG000|Overall Study|Functional neurological disorder|1
4666953|NCT02280096|7560635|FG001|Overall Study|Functional neurological disorder|0
4666954|NCT02280096|7560634|FG000|Overall Study|Lack of attachment|0
4666955|NCT02280096|7560635|FG001|Overall Study|Lack of attachment|1
4666956|NCT02280187|7560660|FG000|Overall Study|Lost to Follow-up|218
4666957|NCT02280291|7560681|FG000|Overall Study|Lost to Follow-up|2
4666958|NCT02280291|7560682|FG001|Overall Study|Lost to Follow-up|1
4666959|NCT02280291|7560683|FG002|Overall Study|Lost to Follow-up|3
4666960|NCT02280291|7560684|FG003|Overall Study|Lost to Follow-up|8
4666961|NCT02280291|7560681|FG000|Overall Study|Protocol Violation|1
4666962|NCT02280291|7560682|FG001|Overall Study|Protocol Violation|0
4666963|NCT02280291|7560683|FG002|Overall Study|Protocol Violation|0
4666964|NCT02280291|7560684|FG003|Overall Study|Protocol Violation|0
4666965|NCT02280291|7560681|FG000|Overall Study|Other|1
4666966|NCT02280291|7560682|FG001|Overall Study|Other|1
4666967|NCT02280291|7560683|FG002|Overall Study|Other|0
4666968|NCT02280291|7560684|FG003|Overall Study|Other|0
4666969|NCT02280304|7560698|FG000|Overall Study|Lost to Follow-up|7
4666970|NCT02280304|7560699|FG001|Overall Study|Lost to Follow-up|8
4666971|NCT02280408|7560748|FG000|Overall Study|Lost to Follow-up|0
4666972|NCT02280408|7560749|FG001|Overall Study|Lost to Follow-up|2
4666973|NCT02280408|7560750|FG002|Overall Study|Lost to Follow-up|0
4666974|NCT02280408|7560751|FG003|Overall Study|Lost to Follow-up|0
4666975|NCT02280421|7560763|FG000|Washout (2 Weeks)|Adverse Event|0
4666976|NCT02280421|7560764|FG001|Washout (2 Weeks)|Adverse Event|1
4666977|NCT02280421|7560763|FG000|Washout (2 Weeks)|Withdrawal by Subject|1
4666978|NCT02280421|7560764|FG001|Washout (2 Weeks)|Withdrawal by Subject|0
4666979|NCT02280473|7560784|FG000|Overall Study|Adverse Event|1
4666980|NCT02280473|7560785|FG001|Overall Study|Adverse Event|1
4666981|NCT02280473|7560784|FG000|Overall Study|Lack of Efficacy|0
4666982|NCT02280473|7560785|FG001|Overall Study|Lack of Efficacy|1
4666983|NCT02280473|7560784|FG000|Overall Study|Lost to Follow-up|0
4666984|NCT02280473|7560785|FG001|Overall Study|Lost to Follow-up|1
4666985|NCT02280499|7560791|FG000|Overall Study|Death|14
4666986|NCT02280499|7560791|FG000|Overall Study|Lost to Follow-up|42
4666987|NCT02280499|7560791|FG000|Overall Study|Adverse Event|5
4666988|NCT02280863|7560829|FG000|Integrated Platform|Met stopping criteria|0
4666989|NCT02280863|7560830|FG001|Integrated Platform|Met stopping criteria|1
4666990|NCT02281318|7560846|FG000|Overall Study|Adverse Event|2
4666991|NCT02281318|7560847|FG001|Overall Study|Adverse Event|2
4666992|NCT02281318|7560846|FG000|Overall Study|Lack of Efficacy|2
4666993|NCT02281318|7560847|FG001|Overall Study|Lack of Efficacy|0
4666994|NCT02281318|7560846|FG000|Overall Study|Lost to Follow-up|2
4666995|NCT02281318|7560847|FG001|Overall Study|Lost to Follow-up|1
4666996|NCT02281318|7560846|FG000|Overall Study|Physician Decision|2
4666997|NCT02281318|7560847|FG001|Overall Study|Physician Decision|0
4666998|NCT02281318|7560846|FG000|Overall Study|Withdrawal by Subject|6
4666999|NCT02281318|7560847|FG001|Overall Study|Withdrawal by Subject|2
4667000|NCT02281357|7560859|FG000|Overall Study|Adverse Event|2
4667001|NCT02281357|7560860|FG001|Overall Study|Adverse Event|1
4667002|NCT02281357|7560859|FG000|Overall Study|Lost to Follow-up|1
4667003|NCT02281357|7560860|FG001|Overall Study|Lost to Follow-up|0
4667004|NCT02281357|7560859|FG000|Overall Study|Withdrawal by Subject|4
4667005|NCT02281357|7560860|FG001|Overall Study|Withdrawal by Subject|3
4753335|NCT01085097|7727868|FG002|Overall Study|Treatment failure|0
4753336|NCT00920621|7727880|FG000|Overall Study|Lost to Follow-up|16
4753337|NCT00920621|7727881|FG001|Overall Study|Lost to Follow-up|17
4753338|NCT00920621|7727882|FG002|Overall Study|Lost to Follow-up|19
4753339|NCT00920621|7727883|FG003|Overall Study|Lost to Follow-up|21
4753340|NCT00920621|7727880|FG000|Overall Study|Fetal/neonatal deaths|16
4753341|NCT00920621|7727881|FG001|Overall Study|Fetal/neonatal deaths|14
4753342|NCT00920621|7727882|FG002|Overall Study|Fetal/neonatal deaths|16
4753343|NCT00920621|7727883|FG003|Overall Study|Fetal/neonatal deaths|14
4753344|NCT00920621|7727880|FG000|Overall Study|Blood sample not collected|22
4753345|NCT00920621|7727881|FG001|Overall Study|Blood sample not collected|14
4753346|NCT00920621|7727882|FG002|Overall Study|Blood sample not collected|0
4753347|NCT00920621|7727883|FG003|Overall Study|Blood sample not collected|0
4753348|NCT00680901|7727900|FG000|Overall Study|Lost to Follow-up|8
4753349|NCT00680901|7727901|FG001|Overall Study|Lost to Follow-up|8
4753350|NCT00680901|7727900|FG000|Overall Study|Withdrawal by Subject|4
4753351|NCT00680901|7727901|FG001|Overall Study|Withdrawal by Subject|13
4753352|NCT00680901|7727900|FG000|Overall Study|Physician Decision|0
4753353|NCT00680901|7727901|FG001|Overall Study|Physician Decision|1
4753354|NCT00680901|7727900|FG000|Overall Study|Ongoing: On Study Treatment|16
4753355|NCT00680901|7727901|FG001|Overall Study|Ongoing: On Study Treatment|13
4753356|NCT00680901|7727900|FG000|Overall Study|Ongoing: In Follow Up|45
4753357|NCT00680901|7727901|FG001|Overall Study|Ongoing: In Follow Up|41
4753358|NCT00667251|7727909|FG000|Overall Study|Adverse Event|13
4753359|NCT00667251|7727910|FG001|Overall Study|Adverse Event|4
4753360|NCT00667251|7727909|FG000|Overall Study|Withdrawal by Subject|6
4753361|NCT00667251|7727910|FG001|Overall Study|Withdrawal by Subject|2
4753362|NCT00667251|7727909|FG000|Overall Study|Other/missing|46
4753363|NCT00667251|7727910|FG001|Overall Study|Other/missing|84
4753364|NCT00667251|7727909|FG000|Overall Study|Intercurrent Illness|4
4753365|NCT00667251|7727910|FG001|Overall Study|Intercurrent Illness|3
4753366|NCT00667251|7727909|FG000|Overall Study|Symptomatic progression|1
4753367|NCT00667251|7727910|FG001|Overall Study|Symptomatic progression|2
4753368|NCT00500071|7727949|FG000|Screening and Washout Phase|Protocol Violation|1
4753369|NCT00500071|7727949|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13
4753370|NCT00500071|7727949|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2
4753371|NCT00500071|7727949|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2
4753372|NCT00500071|7727949|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1
4753373|NCT00500071|7727949|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4
4753374|NCT00500071|7727949|FG000|30-day Safety Follow-up|Lost to Follow-up|17
4753375|NCT00447122|7727957|FG000|Overall Study|worsening medical condition -came off|0
4753376|NCT00447122|7727958|FG001|Overall Study|worsening medical condition -came off|1
4753377|NCT00447122|7727959|FG002|Overall Study|worsening medical condition -came off|0
4753378|NCT00447122|7727960|FG003|Overall Study|worsening medical condition -came off|0
4753379|NCT00382252|7727970|FG000|Overall Study|Death|4
4753380|NCT00382252|7727970|FG000|Overall Study|Protocol Violation|8
4667006|NCT02281552|7560925|FG000|Overall Study|Medication error|1
4667007|NCT02281552|7560926|FG001|Overall Study|Medication error|0
4667008|NCT02281552|7560925|FG000|Overall Study|Insufficient clinical response|0
4667009|NCT02281552|7560926|FG001|Overall Study|Insufficient clinical response|1
4667010|NCT02281552|7560925|FG000|Overall Study|Adverse Event|3
4667011|NCT02281552|7560926|FG001|Overall Study|Adverse Event|9
4667012|NCT02281760|7560949|FG000|Overall Study|Withdrawal by Subject|1
4667013|NCT02281773|7560958|FG000|Overall Study|Adverse Event|6
4667014|NCT02281773|7560959|FG001|Overall Study|Adverse Event|1
4667015|NCT02281773|7560960|FG002|Overall Study|Adverse Event|4
4667016|NCT02281773|7560961|FG003|Overall Study|Adverse Event|8
4667017|NCT02281773|7560962|FG004|Overall Study|Adverse Event|9
4667018|NCT02281773|7560958|FG000|Overall Study|Protocol Violation|1
4667019|NCT02281773|7560959|FG001|Overall Study|Protocol Violation|0
4667020|NCT02281773|7560960|FG002|Overall Study|Protocol Violation|0
4667021|NCT02281773|7560961|FG003|Overall Study|Protocol Violation|2
4667022|NCT02281773|7560962|FG004|Overall Study|Protocol Violation|2
4667023|NCT02281773|7560958|FG000|Overall Study|Lost to Follow-up|2
4667024|NCT02281773|7560959|FG001|Overall Study|Lost to Follow-up|2
4667025|NCT02281773|7560960|FG002|Overall Study|Lost to Follow-up|6
4667026|NCT02281773|7560961|FG003|Overall Study|Lost to Follow-up|2
4667027|NCT02281773|7560962|FG004|Overall Study|Lost to Follow-up|10
4667028|NCT02281773|7560958|FG000|Overall Study|Withdrawal by Subject|2
4667029|NCT02281773|7560959|FG001|Overall Study|Withdrawal by Subject|8
4667030|NCT02281773|7560960|FG002|Overall Study|Withdrawal by Subject|6
4667031|NCT02281773|7560961|FG003|Overall Study|Withdrawal by Subject|6
4667032|NCT02281773|7560962|FG004|Overall Study|Withdrawal by Subject|8
4667033|NCT02281773|7560958|FG000|Overall Study|Other Reason|0
4667034|NCT02281773|7560959|FG001|Overall Study|Other Reason|4
4667035|NCT02281773|7560960|FG002|Overall Study|Other Reason|2
4667036|NCT02281773|7560961|FG003|Overall Study|Other Reason|3
4667037|NCT02281773|7560962|FG004|Overall Study|Other Reason|1
4667038|NCT02282163|7560992|FG000|Overall Study|Protocol Violation|1
4667039|NCT02282293|7561007|FG000|Overall Study|Lost to Follow-up|2
4667040|NCT02282293|7561008|FG001|Overall Study|Lost to Follow-up|2
4667041|NCT02282293|7561007|FG000|Overall Study|Unable to comply with study procedures|1
4667042|NCT02282293|7561008|FG001|Overall Study|Unable to comply with study procedures|0
4667043|NCT02282293|7561007|FG000|Overall Study|Moved out of study area|0
4667044|NCT02282293|7561008|FG001|Overall Study|Moved out of study area|1
4667045|NCT02282527|7561020|FG000|Overall Study|Lost to Follow-up|0
4667046|NCT02282527|7561021|FG001|Overall Study|Lost to Follow-up|1
4667047|NCT02282527|7561020|FG000|Overall Study|Lack of home health aid|1
4667048|NCT02282527|7561021|FG001|Overall Study|Lack of home health aid|0
4667049|NCT02282605|7561033|FG000|Overall Study|negative SA result on Day -1|3
4667050|NCT02282605|7561034|FG001|Overall Study|negative SA result on Day -1|0
4667051|NCT02282605|7561035|FG002|Overall Study|negative SA result on Day -1|0
4667052|NCT02282631|7561045|FG000|Overall Study|Lost to Follow-up|2
4667053|NCT02282631|7561046|FG001|Overall Study|Lost to Follow-up|0
4667054|NCT02282813|7561070|FG000|Overall Study|Withdrawal by Subject|4
4667055|NCT02282813|7561071|FG001|Overall Study|Withdrawal by Subject|5
4667056|NCT02282813|7561072|FG002|Overall Study|Withdrawal by Subject|0
4667057|NCT02282813|7561070|FG000|Overall Study|Adverse Event|3
4667058|NCT02282813|7561071|FG001|Overall Study|Adverse Event|10
4667059|NCT02282813|7561072|FG002|Overall Study|Adverse Event|1
4667060|NCT02282813|7561070|FG000|Overall Study|Subject non-compliance|1
4667061|NCT02282813|7561071|FG001|Overall Study|Subject non-compliance|4
4667062|NCT02282813|7561072|FG002|Overall Study|Subject non-compliance|0
4667063|NCT02282813|7561070|FG000|Overall Study|Physician Decision|0
4667064|NCT02282813|7561071|FG001|Overall Study|Physician Decision|3
4667065|NCT02282813|7561072|FG002|Overall Study|Physician Decision|1
4667066|NCT02282813|7561070|FG000|Overall Study|Lost to Follow-up|2
4667067|NCT02282813|7561071|FG001|Overall Study|Lost to Follow-up|0
4667068|NCT02282813|7561072|FG002|Overall Study|Lost to Follow-up|1
4667069|NCT02282813|7561070|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1
4667070|NCT02282813|7561071|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0
4667071|NCT02282813|7561072|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0
4667072|NCT02282813|7561070|FG000|Overall Study|Lack of Efficacy|1
4667073|NCT02282813|7561071|FG001|Overall Study|Lack of Efficacy|0
4667074|NCT02282813|7561072|FG002|Overall Study|Lack of Efficacy|0
4667075|NCT02282813|7561070|FG000|Overall Study|Administrative reasons|0
4667076|NCT02282813|7561071|FG001|Overall Study|Administrative reasons|1
4667077|NCT02282813|7561072|FG002|Overall Study|Administrative reasons|0
4667078|NCT02282982|7561090|FG000|Overall Study|Lost to Follow-up|15
4667079|NCT02282982|7561090|FG000|Overall Study|Withdrew consent|2
4667080|NCT02282982|7561090|FG000|Overall Study|Death|4
4667081|NCT02282982|7561090|FG000|Overall Study|Lack of product|156
4667082|NCT02282982|7561090|FG000|Overall Study|Palivizumab is ended|11
4667083|NCT02282982|7561090|FG000|Overall Study|Other, not specified|18
4667084|NCT02283268|7561094|FG000|Overall Study|Withdrawal by Subject|1
4667085|NCT02283294|7561108|FG000|Overall Study|Lost to Follow-up|1
4667086|NCT02283294|7561109|FG001|Overall Study|Lost to Follow-up|1
4667087|NCT02283294|7561108|FG000|Overall Study|Withdrawal by Subject|1
4667088|NCT02283294|7561109|FG001|Overall Study|Withdrawal by Subject|6
4667089|NCT02283294|7561108|FG000|Overall Study|Protocol Violation|1
4667090|NCT02283294|7561109|FG001|Overall Study|Protocol Violation|0
4667091|NCT02283294|7561108|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0
4667092|NCT02283294|7561109|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1
4667093|NCT02283411|7561125|FG000|Overall Study|Withdrawal by Subject|3
4667094|NCT02283411|7561125|FG000|Overall Study|Screen Failed|28
4667095|NCT02283658|7561138|FG000|Overall Study|Withdrawal by Subject|1
4667096|NCT02283762|7561148|FG000|Main Treatment Phase (MT)|Adverse Event|9
4667097|NCT02283762|7561149|FG001|Main Treatment Phase (MT)|Adverse Event|9
4667098|NCT02283762|7561148|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1
4667099|NCT02283762|7561149|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0
4667100|NCT02283762|7561148|FG000|Main Treatment Phase (MT)|Physician Decision|1
4667101|NCT02283762|7561149|FG001|Main Treatment Phase (MT)|Physician Decision|1
4667102|NCT02283762|7561148|FG000|Main Treatment Phase (MT)|Pregnancy|0
4667103|NCT02283762|7561149|FG001|Main Treatment Phase (MT)|Pregnancy|1
4667104|NCT02283762|7561148|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7
4667105|NCT02283762|7561149|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4
4667106|NCT02283762|7561148|FG000|Long-term Extension Phase (LTE)|Adverse Event|2
4667107|NCT02283762|7561149|FG001|Long-term Extension Phase (LTE)|Adverse Event|6
4667108|NCT02283762|7561148|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1
4667109|NCT02283762|7561149|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1
4667110|NCT02283762|7561148|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1
4667111|NCT02283762|7561149|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0
4667112|NCT02283762|7561148|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4
4667113|NCT02283762|7561149|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3
4667114|NCT02283762|7561148|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1
4667115|NCT02283762|7561149|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1
4667116|NCT02283762|7561148|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0
4667117|NCT02283762|7561149|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1
4667118|NCT02283762|7561148|FG000|Long-term Extension Phase (LTE)|Physician Decision|1
4667119|NCT02283762|7561149|FG001|Long-term Extension Phase (LTE)|Physician Decision|2
4753381|NCT00382252|7727970|FG000|Overall Study|Not treated by RFA|1
4753382|NCT00324805|7727976|FG000|Overall Study|Adverse Event|62
4753383|NCT00324805|7727977|FG001|Overall Study|Adverse Event|203
4753384|NCT00324805|7727976|FG000|Overall Study|Progression|7
4753385|NCT00324805|7727977|FG001|Overall Study|Progression|35
4753386|NCT00324805|7727976|FG000|Overall Study|Withdrawal by Subject|51
4753387|NCT00324805|7727977|FG001|Overall Study|Withdrawal by Subject|174
4753388|NCT00324805|7727976|FG000|Overall Study|Death|6
4753389|NCT00324805|7727977|FG001|Overall Study|Death|9
4753390|NCT00324805|7727976|FG000|Overall Study|Alternative therapy|4
4753391|NCT00324805|7727977|FG001|Overall Study|Alternative therapy|8
4753392|NCT00324805|7727976|FG000|Overall Study|Other complicating disease|1
4753393|NCT00324805|7727977|FG001|Overall Study|Other complicating disease|9
4753394|NCT00324805|7727976|FG000|Overall Study|Other reasons|7
4753395|NCT00324805|7727977|FG001|Overall Study|Other reasons|26
4753396|NCT00324805|7727976|FG000|Overall Study|Other|0
4753397|NCT00324805|7727977|FG001|Overall Study|Other|2
4753398|NCT00324805|7727976|FG000|Overall Study|Did not start therapy|12
4753399|NCT00324805|7727977|FG001|Overall Study|Did not start therapy|17
4753400|NCT00309985|7728002|FG000|Overall Study|Disease progression|12
4753401|NCT00309985|7728003|FG001|Overall Study|Disease progression|0
4753402|NCT00309985|7728002|FG000|Overall Study|Adverse Event|30
4667120|NCT02283788|7561161|FG000|Overall Study|Adverse Event|1
4667121|NCT02283788|7561162|FG001|Overall Study|Adverse Event|3
4667122|NCT02283788|7561163|FG002|Overall Study|Adverse Event|5
4667123|NCT02283788|7561164|FG003|Overall Study|Adverse Event|1
4667124|NCT02283788|7561161|FG000|Overall Study|Withdrawal by Subject|0
4667125|NCT02283788|7561162|FG001|Overall Study|Withdrawal by Subject|1
4667126|NCT02283788|7561163|FG002|Overall Study|Withdrawal by Subject|0
4667127|NCT02283788|7561164|FG003|Overall Study|Withdrawal by Subject|1
4667128|NCT02284009|7561216|FG000|Overall Study|Adverse Event|3
4667129|NCT02284009|7561217|FG001|Overall Study|Adverse Event|0
4667130|NCT02284009|7561216|FG000|Overall Study|Lost to Follow-up|1
4667131|NCT02284009|7561217|FG001|Overall Study|Lost to Follow-up|3
4667132|NCT02284009|7561216|FG000|Overall Study|Physician Decision|0
4667133|NCT02284009|7561217|FG001|Overall Study|Physician Decision|2
4667134|NCT02284009|7561216|FG000|Overall Study|Withdrawal by Subject|2
4667135|NCT02284009|7561217|FG001|Overall Study|Withdrawal by Subject|5
4667136|NCT02284178|7561247|FG000|Overall Study|Met exclusion criteria|49
4667137|NCT02284178|7561248|FG001|Overall Study|Met exclusion criteria|54
4667138|NCT02284243|7561256|FG000|Overall Study|Lack of Efficacy|3
4667139|NCT02284243|7561257|FG001|Overall Study|Lack of Efficacy|3
4667140|NCT02284243|7561256|FG000|Overall Study|Adverse Event|1
4667141|NCT02284243|7561257|FG001|Overall Study|Adverse Event|0
4667142|NCT02284347|7561263|FG000|Overall Study|Lost to Follow-up|2
4667143|NCT02284347|7561263|FG000|Overall Study|Withdrawn prior to treatment|1
4667144|NCT02284893|7561353|FG000|26 Week (Short Term)|Adverse Event|1
4667145|NCT02284893|7561354|FG001|26 Week (Short Term)|Adverse Event|9
4667146|NCT02284893|7561353|FG000|26 Week (Short Term)|Discontinuation by the subject|2
4667147|NCT02284893|7561354|FG001|26 Week (Short Term)|Discontinuation by the subject|2
4753403|NCT00309985|7728003|FG001|Overall Study|Adverse Event|0
4753404|NCT00309985|7728002|FG000|Overall Study|Death|2
4667148|NCT02284893|7561353|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7
4667149|NCT02284893|7561354|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10
4667150|NCT02284893|7561353|FG000|26 Week (Short Term)|Lost to Follow-up|3
4667151|NCT02284893|7561354|FG001|26 Week (Short Term)|Lost to Follow-up|1
4667152|NCT02284893|7561353|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5
4667153|NCT02284893|7561354|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8
4667154|NCT02284893|7561353|FG000|26 Week (Short Term)|Other|1
4667155|NCT02284893|7561354|FG001|26 Week (Short Term)|Other|1
4667156|NCT02284893|7561353|FG000|52 Week (Long Term)|Adverse Event|3
4667157|NCT02284893|7561354|FG001|52 Week (Long Term)|Adverse Event|1
4667158|NCT02284893|7561353|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0
4667159|NCT02284893|7561354|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1
4667160|NCT02284893|7561353|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4
4667161|NCT02284893|7561354|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6
4667162|NCT02284893|7561353|FG000|52 Week (Long Term)|Lost to Follow-up|2
4667163|NCT02284893|7561354|FG001|52 Week (Long Term)|Lost to Follow-up|2
4667164|NCT02284893|7561353|FG000|52 Week (Long Term)|Non-Compliance|2
4667165|NCT02284893|7561354|FG001|52 Week (Long Term)|Non-Compliance|3
4667166|NCT02285010|7561362|FG000|Overall Study|not abdominal hysterectomy|2
4667167|NCT02285010|7561363|FG001|Overall Study|not abdominal hysterectomy|0
4667168|NCT02285010|7561362|FG000|Overall Study|Not spinal anesthesia|3
4667169|NCT02285010|7561363|FG001|Overall Study|Not spinal anesthesia|1
4667170|NCT02285114|7561382|FG000|Overall Study|Investigator's Discretion|0
4667171|NCT02285114|7561383|FG001|Overall Study|Investigator's Discretion|2
4667172|NCT02285114|7561384|FG002|Overall Study|Investigator's Discretion|0
4667173|NCT02285114|7561382|FG000|Overall Study|Withdrew Consent|0
4667174|NCT02285114|7561383|FG001|Overall Study|Withdrew Consent|0
4667175|NCT02285114|7561384|FG002|Overall Study|Withdrew Consent|1
4667176|NCT02285114|7561382|FG000|Overall Study|Enrolled but not treated|1
4667177|NCT02285114|7561383|FG001|Overall Study|Enrolled but not treated|0
4667178|NCT02285114|7561384|FG002|Overall Study|Enrolled but not treated|0
4667179|NCT02285114|7561382|FG000|Overall Study|Still on study|21
4667180|NCT02285114|7561383|FG001|Overall Study|Still on study|5
4753405|NCT00309985|7728003|FG001|Overall Study|Death|0
4753406|NCT00309985|7728002|FG000|Overall Study|Withdrawal by Subject|5
4753407|NCT00309985|7728003|FG001|Overall Study|Withdrawal by Subject|1
4753408|NCT00309985|7728002|FG000|Overall Study|Physician Decision|3
4753409|NCT00309985|7728003|FG001|Overall Study|Physician Decision|0
4753410|NCT00309985|7728002|FG000|Overall Study|Never started treatment|7
4753411|NCT00309985|7728003|FG001|Overall Study|Never started treatment|0
4753412|NCT00309985|7728002|FG000|Overall Study|Complicating disease|1
4753413|NCT00309985|7728003|FG001|Overall Study|Complicating disease|0
4753414|NCT00309985|7728002|FG000|Overall Study|Non-compliance|1
4753415|NCT00309985|7728003|FG001|Overall Study|Non-compliance|0
4753416|NCT00309985|7728002|FG000|Overall Study|Chemotherapy discontinued only|1
4753417|NCT00309985|7728003|FG001|Overall Study|Chemotherapy discontinued only|0
4753418|NCT00290251|7728012|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0
4753419|NCT00290251|7728013|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0
4753420|NCT00290251|7728014|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0
4753421|NCT00290251|7728015|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0
4753422|NCT00290251|7728016|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0
4753423|NCT00290251|7728017|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2
4753424|NCT00290251|7728012|FG000|Treatment 1 (Months 2-4)|headache|0
4753425|NCT00290251|7728013|FG001|Treatment 1 (Months 2-4)|headache|0
4753426|NCT00290251|7728014|FG002|Treatment 1 (Months 2-4)|headache|0
4753427|NCT00290251|7728015|FG003|Treatment 1 (Months 2-4)|headache|0
4753428|NCT00290251|7728016|FG004|Treatment 1 (Months 2-4)|headache|1
4753429|NCT00290251|7728017|FG005|Treatment 1 (Months 2-4)|headache|0
4753430|NCT00290251|7728012|FG000|Treatment 1 (Months 2-4)|Out of body experience|0
4753431|NCT00290251|7728013|FG001|Treatment 1 (Months 2-4)|Out of body experience|0
4753432|NCT00290251|7728014|FG002|Treatment 1 (Months 2-4)|Out of body experience|0
4753433|NCT00290251|7728015|FG003|Treatment 1 (Months 2-4)|Out of body experience|1
4753434|NCT00290251|7728016|FG004|Treatment 1 (Months 2-4)|Out of body experience|0
4753435|NCT00290251|7728017|FG005|Treatment 1 (Months 2-4)|Out of body experience|0
4667181|NCT02285114|7561384|FG002|Overall Study|Still on study|2
4667182|NCT02285153|7561400|FG000|Overall Study|Adverse Event|1
4667183|NCT02285153|7561401|FG001|Overall Study|Adverse Event|0
4667184|NCT02285361|7561416|FG000|Overall Study|Protocol Violation|43
4667185|NCT02285361|7561416|FG000|Overall Study|Lost to Follow-up|5
4667186|NCT02285361|7561416|FG000|Overall Study|Not taken GIOTRIF|2
4667187|NCT02285361|7561416|FG000|Overall Study|Consented prior to the contract date|1
4667188|NCT02285777|7561440|FG000|Overall Study|Withdrawal by Subject|1
4667189|NCT02285777|7561441|FG001|Overall Study|Withdrawal by Subject|1
4667190|NCT02285777|7561440|FG000|Overall Study|Lost to Follow-up|4
4667191|NCT02285777|7561441|FG001|Overall Study|Lost to Follow-up|2
4667192|NCT02285855|7561449|FG000|Overall Study|Withdrawal by Subject|2
4667193|NCT02285855|7561450|FG001|Overall Study|Withdrawal by Subject|1
4667194|NCT02285920|7561473|FG000|Overall Study|Kidney transplantation|2
4667195|NCT02285920|7561474|FG001|Overall Study|Kidney transplantation|2
4667196|NCT02285920|7561475|FG002|Overall Study|Kidney transplantation|2
4667197|NCT02285920|7561476|FG003|Overall Study|Kidney transplantation|0
4667198|NCT02285920|7561473|FG000|Overall Study|Change to peritoneal dialysis|0
4667199|NCT02285920|7561474|FG001|Overall Study|Change to peritoneal dialysis|0
4667200|NCT02285920|7561475|FG002|Overall Study|Change to peritoneal dialysis|1
4667201|NCT02285920|7561476|FG003|Overall Study|Change to peritoneal dialysis|0
4667202|NCT02285920|7561473|FG000|Overall Study|Transfer to non-participating unit|0
4667203|NCT02285920|7561474|FG001|Overall Study|Transfer to non-participating unit|1
4667204|NCT02285920|7561475|FG002|Overall Study|Transfer to non-participating unit|0
4667205|NCT02285920|7561476|FG003|Overall Study|Transfer to non-participating unit|0
4667206|NCT02285920|7561473|FG000|Overall Study|Dialysis discontinuation|0
4667207|NCT02285920|7561474|FG001|Overall Study|Dialysis discontinuation|1
4667208|NCT02285920|7561475|FG002|Overall Study|Dialysis discontinuation|0
4667209|NCT02285920|7561476|FG003|Overall Study|Dialysis discontinuation|0
4667210|NCT02285920|7561473|FG000|Overall Study|Death|2
4667211|NCT02285920|7561474|FG001|Overall Study|Death|0
4667212|NCT02285920|7561475|FG002|Overall Study|Death|2
4667213|NCT02285920|7561476|FG003|Overall Study|Death|1
4667214|NCT02285998|7561488|FG000|Overall Study|Adverse Event|9
4667215|NCT02285998|7561489|FG001|Overall Study|Adverse Event|8
4667216|NCT02285998|7561488|FG000|Overall Study|Physician Decision|1
4667217|NCT02285998|7561489|FG001|Overall Study|Physician Decision|2
4667218|NCT02285998|7561488|FG000|Overall Study|Lost to Follow-up|176
4667219|NCT02285998|7561489|FG001|Overall Study|Lost to Follow-up|172
4667220|NCT02285998|7561488|FG000|Overall Study|Withdrawal by Subject|53
4667221|NCT02285998|7561489|FG001|Overall Study|Withdrawal by Subject|61
4667222|NCT02285998|7561488|FG000|Overall Study|Other Reasons|7
4667223|NCT02285998|7561489|FG001|Overall Study|Other Reasons|10
4667224|NCT02286102|7561497|FG000|Overall Study|Screen Failure|1
4667225|NCT02286102|7561498|FG001|Overall Study|Screen Failure|1
4667226|NCT02286193|7561504|FG000|Overall Study|Referred: CRS unable to make contact|62
4667227|NCT02286193|7561504|FG000|Overall Study|Referred: unable to reach/resource sent|104
4667228|NCT02286193|7561504|FG000|Overall Study|Referred: Declined service|38
4667229|NCT02286466|7561511|FG000|Overall Study|Death|1
4667230|NCT02286466|7561512|FG001|Overall Study|Death|3
4753436|NCT01403948|7728053|FG000|Overall Study|Progressive disease|0
4753437|NCT01403948|7728054|FG001|Overall Study|Progressive disease|2
4753438|NCT01403948|7728055|FG002|Overall Study|Progressive disease|2
4753439|NCT01403948|7728056|FG003|Overall Study|Progressive disease|4
4753440|NCT01403948|7728057|FG004|Overall Study|Progressive disease|2
4753441|NCT01403948|7728058|FG005|Overall Study|Progressive disease|6
4753442|NCT01403948|7728059|FG006|Overall Study|Progressive disease|2
4753443|NCT01403948|7728060|FG007|Overall Study|Progressive disease|4
4753444|NCT01403948|7728061|FG008|Overall Study|Progressive disease|5
4753445|NCT01403948|7728062|FG009|Overall Study|Progressive disease|5
4753446|NCT01403948|7728053|FG000|Overall Study|Other Adverse Event (Other than DLT)|0
4753447|NCT01403948|7728054|FG001|Overall Study|Other Adverse Event (Other than DLT)|0
4753448|NCT01403948|7728055|FG002|Overall Study|Other Adverse Event (Other than DLT)|0
4753449|NCT01403948|7728056|FG003|Overall Study|Other Adverse Event (Other than DLT)|0
4753450|NCT01403948|7728057|FG004|Overall Study|Other Adverse Event (Other than DLT)|2
4753451|NCT01403948|7728058|FG005|Overall Study|Other Adverse Event (Other than DLT)|0
4753452|NCT01403948|7728059|FG006|Overall Study|Other Adverse Event (Other than DLT)|2
4753453|NCT01403948|7728060|FG007|Overall Study|Other Adverse Event (Other than DLT)|0
4753454|NCT01403948|7728061|FG008|Overall Study|Other Adverse Event (Other than DLT)|1
4753455|NCT01403948|7728062|FG009|Overall Study|Other Adverse Event (Other than DLT)|0
4753456|NCT01403948|7728053|FG000|Overall Study|Lost to Follow-up|0
4753457|NCT01403948|7728054|FG001|Overall Study|Lost to Follow-up|0
4753458|NCT01403948|7728055|FG002|Overall Study|Lost to Follow-up|0
4753459|NCT01403948|7728056|FG003|Overall Study|Lost to Follow-up|0
4753460|NCT01403948|7728057|FG004|Overall Study|Lost to Follow-up|0
4753461|NCT01403948|7728058|FG005|Overall Study|Lost to Follow-up|0
4753462|NCT01403948|7728059|FG006|Overall Study|Lost to Follow-up|0
4753463|NCT01403948|7728060|FG007|Overall Study|Lost to Follow-up|0
4753464|NCT01403948|7728061|FG008|Overall Study|Lost to Follow-up|0
4753465|NCT01403948|7728062|FG009|Overall Study|Lost to Follow-up|1
4753466|NCT01403948|7728053|FG000|Overall Study|Refused cont. medication|0
4753467|NCT01403948|7728054|FG001|Overall Study|Refused cont. medication|0
4753468|NCT01403948|7728055|FG002|Overall Study|Refused cont. medication|0
4753469|NCT01403948|7728056|FG003|Overall Study|Refused cont. medication|0
4753470|NCT01403948|7728057|FG004|Overall Study|Refused cont. medication|1
4667231|NCT02286466|7561511|FG000|Overall Study|Withdrawal by Subject|5
4667232|NCT02286466|7561512|FG001|Overall Study|Withdrawal by Subject|2
4753471|NCT01403948|7728058|FG005|Overall Study|Refused cont. medication|0
4667233|NCT02286466|7561511|FG000|Overall Study|Lost to Follow-up|1
4667234|NCT02286466|7561512|FG001|Overall Study|Lost to Follow-up|4
4667235|NCT02286466|7561511|FG000|Overall Study|Declined Clinician Assessment|0
4667236|NCT02286466|7561512|FG001|Overall Study|Declined Clinician Assessment|1
4667237|NCT02286713|7561593|FG000|One Week Follow-Up|Death|1
4667238|NCT02286713|7561594|FG001|One Week Follow-Up|Death|0
4667239|NCT02286713|7561593|FG000|One Week Follow-Up|Lost to Follow-up|17
4667240|NCT02286713|7561594|FG001|One Week Follow-Up|Lost to Follow-up|21
4667241|NCT02286713|7561593|FG000|One Week Follow-Up|Withdrawal by Subject|6
4667242|NCT02286713|7561594|FG001|One Week Follow-Up|Withdrawal by Subject|3
4667243|NCT02286713|7561593|FG000|Three Month Follow-Up|Death|1
4667244|NCT02286713|7561594|FG001|Three Month Follow-Up|Death|1
4667245|NCT02286713|7561593|FG000|Three Month Follow-Up|Lost to Follow-up|26
4667246|NCT02286713|7561594|FG001|Three Month Follow-Up|Lost to Follow-up|24
4667247|NCT02286713|7561593|FG000|Three Month Follow-Up|Withdrawal by Subject|1
4667248|NCT02286713|7561594|FG001|Three Month Follow-Up|Withdrawal by Subject|1
4667249|NCT02286713|7561593|FG000|Six Month Follow-Up|Death|2
4667250|NCT02286713|7561594|FG001|Six Month Follow-Up|Death|0
4667251|NCT02286713|7561593|FG000|Six Month Follow-Up|Lost to Follow-up|30
4667252|NCT02286713|7561594|FG001|Six Month Follow-Up|Lost to Follow-up|27
4667253|NCT02286843|7561613|FG000|Overall Study|Not Treated|4
4667254|NCT02286843|7561613|FG000|Overall Study|Protocol Violation|1
4667255|NCT02286843|7561613|FG000|Overall Study|Withdrawal by Subject|1
4667256|NCT02286895|7561619|FG000|Assessed for Measles Seroconversion|Protocol Violation|1
4667257|NCT02286895|7561620|FG001|Assessed for Measles Seroconversion|Protocol Violation|4
4667258|NCT02286895|7561619|FG000|Assessed for Measles Seroconversion|Missing measurement|6
4667259|NCT02286895|7561620|FG001|Assessed for Measles Seroconversion|Missing measurement|3
4667260|NCT02286895|7561619|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41
4667261|NCT02286895|7561620|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32
4667262|NCT02286947|7561635|FG000|Overall Study|Withdrawal by Subject|2
4667263|NCT02286960|7561643|FG000|Overall Study|Lost to Follow-up|3
4667264|NCT02286960|7561644|FG001|Overall Study|Lost to Follow-up|3
4667265|NCT02287038|7561652|FG000|Overall Study|Stopped attending appointments|3
4667266|NCT02287038|7561653|FG001|Overall Study|Stopped attending appointments|2
4667267|NCT02287038|7561652|FG000|Overall Study|Anxiety after starting medication|0
4667268|NCT02287038|7561653|FG001|Overall Study|Anxiety after starting medication|1
4667269|NCT02287038|7561652|FG000|Overall Study|Nausea after starting medication|1
4667270|NCT02287038|7561653|FG001|Overall Study|Nausea after starting medication|0
4667271|NCT02287038|7561652|FG000|Overall Study|Abnormal ECG after starting medication|1
4667272|NCT02287038|7561653|FG001|Overall Study|Abnormal ECG after starting medication|0
4753472|NCT01403948|7728059|FG006|Overall Study|Refused cont. medication|0
4753473|NCT01403948|7728060|FG007|Overall Study|Refused cont. medication|0
4753474|NCT01403948|7728061|FG008|Overall Study|Refused cont. medication|0
4753475|NCT01403948|7728062|FG009|Overall Study|Refused cont. medication|1
4753476|NCT01403948|7728053|FG000|Overall Study|other than above|1
4753477|NCT01403948|7728054|FG001|Overall Study|other than above|2
4753478|NCT01403948|7728055|FG002|Overall Study|other than above|1
4753479|NCT01403948|7728056|FG003|Overall Study|other than above|0
4753480|NCT01403948|7728057|FG004|Overall Study|other than above|1
4753481|NCT01403948|7728058|FG005|Overall Study|other than above|1
4753482|NCT01403948|7728059|FG006|Overall Study|other than above|2
4753483|NCT01403948|7728060|FG007|Overall Study|other than above|0
4753484|NCT01403948|7728061|FG008|Overall Study|other than above|0
4753485|NCT01403948|7728062|FG009|Overall Study|other than above|0
4753486|NCT01404312|7728090|FG000|Overall Study|Death|21
4753487|NCT01404312|7728091|FG001|Overall Study|Death|27
4753488|NCT01404312|7728090|FG000|Overall Study|Withdrawal by Subject|15
4753489|NCT01404312|7728091|FG001|Overall Study|Withdrawal by Subject|18
4753490|NCT01404312|7728090|FG000|Overall Study|Participant Unable to get to clinic|93
4753491|NCT01404312|7728091|FG001|Overall Study|Participant Unable to get to clinic|103
4753492|NCT01404312|7728090|FG000|Overall Study|Lost to Follow-up|115
4753493|NCT01404312|7728091|FG001|Overall Study|Lost to Follow-up|111
4753494|NCT01404312|7728090|FG000|Overall Study|Site closed|22
4753495|NCT01404312|7728091|FG001|Overall Study|Site closed|21
4753496|NCT01404312|7728090|FG000|Overall Study|Participant not willing to adhere to req|31
4753497|NCT01404312|7728091|FG001|Overall Study|Participant not willing to adhere to req|29
4753498|NCT01404312|7728090|FG000|Overall Study|Severe debilitation, unable to continue|1
4753499|NCT01404312|7728091|FG001|Overall Study|Severe debilitation, unable to continue|2
4667273|NCT02287402|7561669|FG000|Treatment Period|Adverse Event|17
4667274|NCT02287402|7561669|FG000|Treatment Period|Voluntary Withdrawal|10
4667275|NCT02287402|7561669|FG000|Follow-up|Lost to Follow-up|1
4667276|NCT02287402|7561669|FG000|Follow-up|Voluntary Withdrawal|2
4667277|NCT02287467|7561679|FG000|Overall Study|Protocol Violation|12
4667278|NCT02287467|7561680|FG001|Overall Study|Protocol Violation|9
4667279|NCT02287610|7561689|FG000|Overall Study|Lost to Follow-up|3
4667280|NCT02287610|7561689|FG000|Overall Study|Withdrawal by Subject|8
4667281|NCT02287610|7561689|FG000|Overall Study|Excluded-investigator non-responsiveness|5
4667282|NCT02287623|7561695|FG000|Overall Study|Protocol Violation|0
4667283|NCT02287623|7561696|FG001|Overall Study|Protocol Violation|1
4667284|NCT02287883|7561763|FG000|Overall Study|Death|8
4667285|NCT02287883|7561764|FG001|Overall Study|Death|7
4667286|NCT02287883|7561763|FG000|Overall Study|No longer eligible|222
4753500|NCT01425008|7728117|FG000|Dose Escalation Phase|Progressive Disease|2
4753501|NCT01425008|7728118|FG001|Dose Escalation Phase|Progressive Disease|3
4753502|NCT01425008|7728119|FG002|Dose Escalation Phase|Progressive Disease|2
4753503|NCT01425008|7728120|FG003|Dose Escalation Phase|Progressive Disease|3
4753504|NCT01425008|7728121|FG004|Dose Escalation Phase|Progressive Disease|5
4753505|NCT01425008|7728122|FG005|Dose Escalation Phase|Progressive Disease|4
4753506|NCT01425008|7728123|FG006|Dose Escalation Phase|Progressive Disease|0
4753507|NCT01425008|7728124|FG007|Dose Escalation Phase|Progressive Disease|2
4753508|NCT01425008|7728125|FG008|Dose Escalation Phase|Progressive Disease|6
4753509|NCT01425008|7728126|FG009|Dose Escalation Phase|Progressive Disease|2
4753510|NCT01425008|7728127|FG010|Dose Escalation Phase|Progressive Disease|0
4753511|NCT01425008|7728128|FG011|Dose Escalation Phase|Progressive Disease|0
4753512|NCT01425008|7728129|FG012|Dose Escalation Phase|Progressive Disease|0
4753513|NCT01425008|7728130|FG013|Dose Escalation Phase|Progressive Disease|0
4667287|NCT02287883|7561764|FG001|Overall Study|No longer eligible|182
4667288|NCT02287883|7561763|FG000|Overall Study|Non-response to survey|229
4667289|NCT02287883|7561764|FG001|Overall Study|Non-response to survey|237
4667290|NCT02287896|7561772|FG000|Second Injection Visit|Withdrawal by Subject|0
4667291|NCT02287896|7561773|FG001|Second Injection Visit|Withdrawal by Subject|1
4667292|NCT02287922|7561806|FG000|Overall Study|Adverse Event|1
4667293|NCT02287922|7561807|FG001|Overall Study|Adverse Event|1
4667294|NCT02287922|7561808|FG002|Overall Study|Adverse Event|3
4667295|NCT02287922|7561809|FG003|Overall Study|Adverse Event|4
4667296|NCT02287922|7561806|FG000|Overall Study|Withdrawal by Subject|1
4667297|NCT02287922|7561807|FG001|Overall Study|Withdrawal by Subject|1
4667298|NCT02287922|7561808|FG002|Overall Study|Withdrawal by Subject|1
4667299|NCT02287922|7561809|FG003|Overall Study|Withdrawal by Subject|2
4667300|NCT02287922|7561806|FG000|Overall Study|Lost to Follow-up|0
4667301|NCT02287922|7561807|FG001|Overall Study|Lost to Follow-up|0
4667302|NCT02287922|7561808|FG002|Overall Study|Lost to Follow-up|1
4667303|NCT02287922|7561809|FG003|Overall Study|Lost to Follow-up|0
4667304|NCT02287922|7561806|FG000|Overall Study|Sponsor's decision|0
4667305|NCT02287922|7561807|FG001|Overall Study|Sponsor's decision|0
4667306|NCT02287922|7561808|FG002|Overall Study|Sponsor's decision|0
4667307|NCT02287922|7561809|FG003|Overall Study|Sponsor's decision|1
4667308|NCT02287922|7561806|FG000|Overall Study|Other|1
4667309|NCT02287922|7561807|FG001|Overall Study|Other|0
4667310|NCT02287922|7561808|FG002|Overall Study|Other|2
4667311|NCT02287922|7561809|FG003|Overall Study|Other|0
4667312|NCT02288091|7561820|FG000|Overall Study|Lost to Follow-up|1
4667313|NCT02288091|7561820|FG000|Overall Study|Screen fail|7
4667314|NCT02288182|7561845|FG000|Overall Study|Adverse Event|0
4667315|NCT02288182|7561846|FG001|Overall Study|Adverse Event|1
4667316|NCT02288182|7561845|FG000|Overall Study|Lost to Follow-up|0
4667317|NCT02288182|7561846|FG001|Overall Study|Lost to Follow-up|1
4667318|NCT02288312|7561866|FG000|Overall Study|Pregnancy|1
4667319|NCT02288312|7561867|FG001|Overall Study|Pregnancy|0
4667320|NCT02288312|7561868|FG002|Overall Study|Pregnancy|0
4667321|NCT02288325|7561876|FG000|Run-in Period|Adverse Event|48
4667322|NCT02288325|7561877|FG001|Run-in Period|Adverse Event|0
4667323|NCT02288325|7561878|FG002|Run-in Period|Adverse Event|0
4667324|NCT02288325|7561876|FG000|Run-in Period|Lack of Efficacy|16
4667325|NCT02288325|7561877|FG001|Run-in Period|Lack of Efficacy|0
4667326|NCT02288325|7561878|FG002|Run-in Period|Lack of Efficacy|0
4667327|NCT02288325|7561876|FG000|Run-in Period|Withdrawal of Consent|28
4667328|NCT02288325|7561877|FG001|Run-in Period|Withdrawal of Consent|0
4667329|NCT02288325|7561878|FG002|Run-in Period|Withdrawal of Consent|0
4667330|NCT02288325|7561876|FG000|Run-in Period|Lost to Follow-up|25
4667331|NCT02288325|7561877|FG001|Run-in Period|Lost to Follow-up|0
4667332|NCT02288325|7561878|FG002|Run-in Period|Lost to Follow-up|0
4667333|NCT02288325|7561876|FG000|Run-in Period|Protocol Violation|17
4667334|NCT02288325|7561877|FG001|Run-in Period|Protocol Violation|0
4667335|NCT02288325|7561878|FG002|Run-in Period|Protocol Violation|0
4667336|NCT02288325|7561876|FG000|Run-in Period|Non-Compliance With Study Drug|3
4667337|NCT02288325|7561877|FG001|Run-in Period|Non-Compliance With Study Drug|0
4667338|NCT02288325|7561878|FG002|Run-in Period|Non-Compliance With Study Drug|0
4667339|NCT02288325|7561876|FG000|Run-in Period|Reason not Specified|8
4667340|NCT02288325|7561877|FG001|Run-in Period|Reason not Specified|0
4667341|NCT02288325|7561878|FG002|Run-in Period|Reason not Specified|0
4667342|NCT02288325|7561876|FG000|Stabilization Period|Adverse Event|13
4667343|NCT02288325|7561877|FG001|Stabilization Period|Adverse Event|0
4667344|NCT02288325|7561878|FG002|Stabilization Period|Adverse Event|0
4667345|NCT02288325|7561876|FG000|Stabilization Period|Lack of Efficacy|22
4667346|NCT02288325|7561877|FG001|Stabilization Period|Lack of Efficacy|0
4667347|NCT02288325|7561878|FG002|Stabilization Period|Lack of Efficacy|0
4667348|NCT02288325|7561876|FG000|Stabilization Period|Withdrawal of Consent|23
4667349|NCT02288325|7561877|FG001|Stabilization Period|Withdrawal of Consent|0
4667350|NCT02288325|7561878|FG002|Stabilization Period|Withdrawal of Consent|0
4667351|NCT02288325|7561876|FG000|Stabilization Period|Lost to Follow-up|12
4667352|NCT02288325|7561877|FG001|Stabilization Period|Lost to Follow-up|0
4667353|NCT02288325|7561878|FG002|Stabilization Period|Lost to Follow-up|0
4667354|NCT02288325|7561876|FG000|Stabilization Period|Protocol Violation|8
4667355|NCT02288325|7561877|FG001|Stabilization Period|Protocol Violation|0
4667356|NCT02288325|7561878|FG002|Stabilization Period|Protocol Violation|0
4667357|NCT02288325|7561876|FG000|Stabilization Period|Non-Compliance With Study Drug|5
4667358|NCT02288325|7561877|FG001|Stabilization Period|Non-Compliance With Study Drug|0
4667359|NCT02288325|7561878|FG002|Stabilization Period|Non-Compliance With Study Drug|0
4667360|NCT02288325|7561876|FG000|Stabilization Period|Reason not Specified|15
4667361|NCT02288325|7561877|FG001|Stabilization Period|Reason not Specified|0
4667362|NCT02288325|7561878|FG002|Stabilization Period|Reason not Specified|0
4667363|NCT02288325|7561876|FG000|Double-blind Treatment Period|Adverse Event|0
4667364|NCT02288325|7561877|FG001|Double-blind Treatment Period|Adverse Event|2
4667365|NCT02288325|7561878|FG002|Double-blind Treatment Period|Adverse Event|5
4667366|NCT02288325|7561876|FG000|Double-blind Treatment Period|Withdrawal of Consent|0
4667367|NCT02288325|7561877|FG001|Double-blind Treatment Period|Withdrawal of Consent|8
4667368|NCT02288325|7561878|FG002|Double-blind Treatment Period|Withdrawal of Consent|8
4667369|NCT02288325|7561876|FG000|Double-blind Treatment Period|Lost to Follow-up|0
4667370|NCT02288325|7561877|FG001|Double-blind Treatment Period|Lost to Follow-up|4
4667371|NCT02288325|7561878|FG002|Double-blind Treatment Period|Lost to Follow-up|5
4667372|NCT02288325|7561876|FG000|Double-blind Treatment Period|Protocol Violation|0
4667373|NCT02288325|7561877|FG001|Double-blind Treatment Period|Protocol Violation|1
4667374|NCT02288325|7561878|FG002|Double-blind Treatment Period|Protocol Violation|2
4667375|NCT02288325|7561876|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0
4667376|NCT02288325|7561877|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1
4667377|NCT02288325|7561878|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4
4667378|NCT02288325|7561876|FG000|Double-blind Treatment Period|Multiple Reasons|0
4667379|NCT02288325|7561877|FG001|Double-blind Treatment Period|Multiple Reasons|8
4667380|NCT02288325|7561878|FG002|Double-blind Treatment Period|Multiple Reasons|2
4667381|NCT02288559|7561907|FG000|Overall Study|Adverse Event|1
4667382|NCT02288559|7561908|FG001|Overall Study|Adverse Event|1
4667383|NCT02288559|7561909|FG002|Overall Study|Adverse Event|5
4667384|NCT02288559|7561910|FG003|Overall Study|Adverse Event|0
4667385|NCT02288559|7561907|FG000|Overall Study|Death|0
4667386|NCT02288559|7561908|FG001|Overall Study|Death|0
4667387|NCT02288559|7561909|FG002|Overall Study|Death|1
4667388|NCT02288559|7561910|FG003|Overall Study|Death|0
4753514|NCT01425008|7728131|FG014|Dose Escalation Phase|Progressive Disease|0
4753515|NCT01425008|7728132|FG015|Dose Escalation Phase|Progressive Disease|0
4753516|NCT01425008|7728133|FG016|Dose Escalation Phase|Progressive Disease|0
4753517|NCT01425008|7728134|FG017|Dose Escalation Phase|Progressive Disease|0
4753518|NCT01425008|7728135|FG018|Dose Escalation Phase|Progressive Disease|0
4753519|NCT01425008|7728117|FG000|Dose Escalation Phase|Adverse Event|2
4753520|NCT01425008|7728118|FG001|Dose Escalation Phase|Adverse Event|0
4753521|NCT01425008|7728119|FG002|Dose Escalation Phase|Adverse Event|0
4753522|NCT01425008|7728120|FG003|Dose Escalation Phase|Adverse Event|0
4753523|NCT01425008|7728121|FG004|Dose Escalation Phase|Adverse Event|0
4753524|NCT01425008|7728122|FG005|Dose Escalation Phase|Adverse Event|2
4753525|NCT01425008|7728123|FG006|Dose Escalation Phase|Adverse Event|0
4753526|NCT01425008|7728124|FG007|Dose Escalation Phase|Adverse Event|0
4753527|NCT01425008|7728125|FG008|Dose Escalation Phase|Adverse Event|2
4753528|NCT01425008|7728126|FG009|Dose Escalation Phase|Adverse Event|0
4753529|NCT01425008|7728127|FG010|Dose Escalation Phase|Adverse Event|0
4753530|NCT01425008|7728128|FG011|Dose Escalation Phase|Adverse Event|0
4753531|NCT01425008|7728129|FG012|Dose Escalation Phase|Adverse Event|0
4753532|NCT01425008|7728130|FG013|Dose Escalation Phase|Adverse Event|0
4753533|NCT01425008|7728131|FG014|Dose Escalation Phase|Adverse Event|0
4753534|NCT01425008|7728132|FG015|Dose Escalation Phase|Adverse Event|0
4753535|NCT01425008|7728133|FG016|Dose Escalation Phase|Adverse Event|0
4753536|NCT01425008|7728134|FG017|Dose Escalation Phase|Adverse Event|0
4753537|NCT01425008|7728135|FG018|Dose Escalation Phase|Adverse Event|0
4753538|NCT01425008|7728117|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
4753539|NCT01425008|7728118|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
4753540|NCT01425008|7728119|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
4753541|NCT01425008|7728120|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
4753542|NCT01425008|7728121|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1
4753543|NCT01425008|7728122|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
4753544|NCT01425008|7728123|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2
4753545|NCT01425008|7728124|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1
4753546|NCT01425008|7728125|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1
4753547|NCT01425008|7728126|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
4753548|NCT01425008|7728127|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
4753549|NCT01425008|7728128|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
4667389|NCT02288559|7561907|FG000|Overall Study|Lost to Follow-up|0
4667390|NCT02288559|7561908|FG001|Overall Study|Lost to Follow-up|0
4667391|NCT02288559|7561909|FG002|Overall Study|Lost to Follow-up|0
4667392|NCT02288559|7561910|FG003|Overall Study|Lost to Follow-up|1
4667393|NCT02288559|7561907|FG000|Overall Study|Withdrawal by Subject|0
4667394|NCT02288559|7561908|FG001|Overall Study|Withdrawal by Subject|0
4667395|NCT02288559|7561909|FG002|Overall Study|Withdrawal by Subject|2
4667396|NCT02288559|7561910|FG003|Overall Study|Withdrawal by Subject|1
4667397|NCT02288559|7561907|FG000|Overall Study|Reason Not Specified|0
4667398|NCT02288559|7561908|FG001|Overall Study|Reason Not Specified|0
4667399|NCT02288559|7561909|FG002|Overall Study|Reason Not Specified|3
4667400|NCT02288559|7561910|FG003|Overall Study|Reason Not Specified|0
4667401|NCT02289079|7561928|FG000|Overall Study|Physician Decision|2
4667402|NCT02289079|7561929|FG001|Overall Study|Physician Decision|0
4753550|NCT01425008|7728129|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
4753551|NCT01425008|7728130|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
4753552|NCT01425008|7728131|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
4753553|NCT01425008|7728132|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
4753554|NCT01425008|7728133|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
4753555|NCT01425008|7728134|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
4753556|NCT01425008|7728135|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
4753557|NCT01425008|7728117|FG000|Dose Escalation Phase|Withdrawal by Subject|0
4753558|NCT01425008|7728118|FG001|Dose Escalation Phase|Withdrawal by Subject|0
4753559|NCT01425008|7728119|FG002|Dose Escalation Phase|Withdrawal by Subject|0
4753560|NCT01425008|7728120|FG003|Dose Escalation Phase|Withdrawal by Subject|0
4753561|NCT01425008|7728121|FG004|Dose Escalation Phase|Withdrawal by Subject|1
4753562|NCT01425008|7728122|FG005|Dose Escalation Phase|Withdrawal by Subject|1
4753563|NCT01425008|7728123|FG006|Dose Escalation Phase|Withdrawal by Subject|1
4753564|NCT01425008|7728124|FG007|Dose Escalation Phase|Withdrawal by Subject|0
4753565|NCT01425008|7728125|FG008|Dose Escalation Phase|Withdrawal by Subject|1
4753566|NCT01425008|7728126|FG009|Dose Escalation Phase|Withdrawal by Subject|0
4753567|NCT01425008|7728127|FG010|Dose Escalation Phase|Withdrawal by Subject|0
4753568|NCT01425008|7728128|FG011|Dose Escalation Phase|Withdrawal by Subject|0
4753569|NCT01425008|7728129|FG012|Dose Escalation Phase|Withdrawal by Subject|0
4753570|NCT01425008|7728130|FG013|Dose Escalation Phase|Withdrawal by Subject|0
4753571|NCT01425008|7728131|FG014|Dose Escalation Phase|Withdrawal by Subject|0
4753572|NCT01425008|7728132|FG015|Dose Escalation Phase|Withdrawal by Subject|0
4753573|NCT01425008|7728133|FG016|Dose Escalation Phase|Withdrawal by Subject|0
4753574|NCT01425008|7728134|FG017|Dose Escalation Phase|Withdrawal by Subject|0
4753575|NCT01425008|7728135|FG018|Dose Escalation Phase|Withdrawal by Subject|0
4753576|NCT01425008|7728117|FG000|Dose Escalation Phase|Symptomatic Deterioration|0
4753577|NCT01425008|7728118|FG001|Dose Escalation Phase|Symptomatic Deterioration|0
4753578|NCT01425008|7728119|FG002|Dose Escalation Phase|Symptomatic Deterioration|1
4753579|NCT01425008|7728120|FG003|Dose Escalation Phase|Symptomatic Deterioration|0
4753580|NCT01425008|7728121|FG004|Dose Escalation Phase|Symptomatic Deterioration|0
4667403|NCT02289079|7561928|FG000|Overall Study|Lost to Follow-up|0
4667404|NCT02289079|7561929|FG001|Overall Study|Lost to Follow-up|1
4753581|NCT01425008|7728122|FG005|Dose Escalation Phase|Symptomatic Deterioration|0
4753582|NCT01425008|7728123|FG006|Dose Escalation Phase|Symptomatic Deterioration|0
4753583|NCT01425008|7728124|FG007|Dose Escalation Phase|Symptomatic Deterioration|0
4753584|NCT01425008|7728125|FG008|Dose Escalation Phase|Symptomatic Deterioration|2
4753585|NCT01425008|7728126|FG009|Dose Escalation Phase|Symptomatic Deterioration|2
4753586|NCT01425008|7728127|FG010|Dose Escalation Phase|Symptomatic Deterioration|0
4753587|NCT01425008|7728128|FG011|Dose Escalation Phase|Symptomatic Deterioration|0
4753588|NCT01425008|7728129|FG012|Dose Escalation Phase|Symptomatic Deterioration|0
4753589|NCT01425008|7728130|FG013|Dose Escalation Phase|Symptomatic Deterioration|0
4753590|NCT01425008|7728131|FG014|Dose Escalation Phase|Symptomatic Deterioration|0
4753591|NCT01425008|7728132|FG015|Dose Escalation Phase|Symptomatic Deterioration|0
4753592|NCT01425008|7728133|FG016|Dose Escalation Phase|Symptomatic Deterioration|0
4753593|NCT01425008|7728134|FG017|Dose Escalation Phase|Symptomatic Deterioration|0
4753594|NCT01425008|7728135|FG018|Dose Escalation Phase|Symptomatic Deterioration|0
4753595|NCT01425008|7728117|FG000|Dose Escalation Phase|Other|0
4753596|NCT01425008|7728118|FG001|Dose Escalation Phase|Other|0
4753597|NCT01425008|7728119|FG002|Dose Escalation Phase|Other|0
4753598|NCT01425008|7728120|FG003|Dose Escalation Phase|Other|0
4753599|NCT01425008|7728121|FG004|Dose Escalation Phase|Other|0
4753600|NCT01425008|7728122|FG005|Dose Escalation Phase|Other|0
4753601|NCT01425008|7728123|FG006|Dose Escalation Phase|Other|0
4753602|NCT01425008|7728124|FG007|Dose Escalation Phase|Other|0
4753603|NCT01425008|7728125|FG008|Dose Escalation Phase|Other|1
4753604|NCT01425008|7728126|FG009|Dose Escalation Phase|Other|0
4753605|NCT01425008|7728127|FG010|Dose Escalation Phase|Other|0
4753606|NCT01425008|7728128|FG011|Dose Escalation Phase|Other|0
4753607|NCT01425008|7728129|FG012|Dose Escalation Phase|Other|0
4753608|NCT01425008|7728130|FG013|Dose Escalation Phase|Other|0
4753609|NCT01425008|7728131|FG014|Dose Escalation Phase|Other|0
4753610|NCT01425008|7728132|FG015|Dose Escalation Phase|Other|0
4753611|NCT01425008|7728133|FG016|Dose Escalation Phase|Other|0
4667405|NCT02289352|7561960|FG000|Overall Study|Withdrawal by Subject|1
4667406|NCT02289352|7561961|FG001|Overall Study|Withdrawal by Subject|1
4667407|NCT02289352|7561962|FG002|Overall Study|Withdrawal by Subject|0
4667408|NCT02289417|7561974|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3
4667409|NCT02289417|7561975|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
4667410|NCT02289417|7561976|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1
4667411|NCT02289417|7561977|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
4667412|NCT02289417|7561978|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
4667413|NCT02289417|7561979|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
4667414|NCT02289417|7561980|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
4667415|NCT02289417|7561981|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
4667416|NCT02289417|7561982|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
4667417|NCT02289417|7561974|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1
4667418|NCT02289417|7561975|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3
4667419|NCT02289417|7561976|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2
4667420|NCT02289417|7561977|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
4667421|NCT02289417|7561978|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
4667422|NCT02289417|7561979|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
4667423|NCT02289417|7561980|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
4667424|NCT02289417|7561981|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
4667425|NCT02289417|7561982|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
4667426|NCT02289417|7561974|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
4667427|NCT02289417|7561975|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1
4667428|NCT02289417|7561976|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
4667429|NCT02289417|7561977|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
4667430|NCT02289417|7561978|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
4667431|NCT02289417|7561979|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
4667432|NCT02289417|7561980|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
4667433|NCT02289417|7561981|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
4667434|NCT02289417|7561982|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
4667435|NCT02289417|7561974|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3
4667436|NCT02289417|7561975|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
4667437|NCT02289417|7561976|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
4667438|NCT02289417|7561977|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
4667439|NCT02289417|7561978|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
4667440|NCT02289417|7561979|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
4667441|NCT02289417|7561980|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
4667442|NCT02289417|7561981|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
4667443|NCT02289417|7561982|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
4667444|NCT02289417|7561974|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0
4667445|NCT02289417|7561975|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1
4667446|NCT02289417|7561976|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4
4667447|NCT02289417|7561977|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2
4667448|NCT02289417|7561978|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2
4667449|NCT02289417|7561979|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1
4667450|NCT02289417|7561980|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0
4667451|NCT02289417|7561981|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0
4667452|NCT02289417|7561982|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0
4667453|NCT02289417|7561974|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0
4667454|NCT02289417|7561975|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0
4667455|NCT02289417|7561976|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1
4667456|NCT02289417|7561977|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0
4667457|NCT02289417|7561978|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0
4667458|NCT02289417|7561979|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0
4667459|NCT02289417|7561980|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0
4667460|NCT02289417|7561981|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0
4667461|NCT02289417|7561982|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0
4667462|NCT02289417|7561974|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0
4667463|NCT02289417|7561975|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1
4667464|NCT02289417|7561976|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4
4667465|NCT02289417|7561977|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6
4667466|NCT02289417|7561978|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2
4667467|NCT02289417|7561979|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3
4667468|NCT02289417|7561980|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0
4667469|NCT02289417|7561981|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0
4667470|NCT02289417|7561982|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0
4667471|NCT02289417|7561974|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
4667472|NCT02289417|7561975|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
4667473|NCT02289417|7561976|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1
4667474|NCT02289417|7561977|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
4667475|NCT02289417|7561978|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1
4667476|NCT02289417|7561979|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1
4667477|NCT02289417|7561980|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
4667478|NCT02289417|7561981|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
4667479|NCT02289417|7561982|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
4667480|NCT02289417|7561974|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
4667481|NCT02289417|7561975|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
4667482|NCT02289417|7561976|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
4667483|NCT02289417|7561977|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
4667484|NCT02289417|7561978|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
4667485|NCT02289417|7561979|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
4667486|NCT02289417|7561980|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1
4753612|NCT01425008|7728134|FG017|Dose Escalation Phase|Other|0
4753613|NCT01425008|7728135|FG018|Dose Escalation Phase|Other|0
4753614|NCT01425008|7728117|FG000|Dose Expansion Phase|Progressive Disease|0
4753615|NCT01425008|7728118|FG001|Dose Expansion Phase|Progressive Disease|0
4753616|NCT01425008|7728119|FG002|Dose Expansion Phase|Progressive Disease|0
4753617|NCT01425008|7728120|FG003|Dose Expansion Phase|Progressive Disease|0
4753618|NCT01425008|7728121|FG004|Dose Expansion Phase|Progressive Disease|0
4753619|NCT01425008|7728122|FG005|Dose Expansion Phase|Progressive Disease|0
4753620|NCT01425008|7728123|FG006|Dose Expansion Phase|Progressive Disease|0
4753621|NCT01425008|7728124|FG007|Dose Expansion Phase|Progressive Disease|0
4753622|NCT01425008|7728125|FG008|Dose Expansion Phase|Progressive Disease|0
4753623|NCT01425008|7728126|FG009|Dose Expansion Phase|Progressive Disease|0
4753624|NCT01425008|7728127|FG010|Dose Expansion Phase|Progressive Disease|10
4753625|NCT01425008|7728128|FG011|Dose Expansion Phase|Progressive Disease|4
4753626|NCT01425008|7728129|FG012|Dose Expansion Phase|Progressive Disease|12
4753627|NCT01425008|7728130|FG013|Dose Expansion Phase|Progressive Disease|1
4753628|NCT01425008|7728131|FG014|Dose Expansion Phase|Progressive Disease|5
4753629|NCT01425008|7728132|FG015|Dose Expansion Phase|Progressive Disease|8
4753630|NCT01425008|7728133|FG016|Dose Expansion Phase|Progressive Disease|9
4753631|NCT01425008|7728134|FG017|Dose Expansion Phase|Progressive Disease|2
4753632|NCT01425008|7728135|FG018|Dose Expansion Phase|Progressive Disease|10
4753633|NCT01425008|7728117|FG000|Dose Expansion Phase|Withdrawal by Subject|0
4753634|NCT01425008|7728118|FG001|Dose Expansion Phase|Withdrawal by Subject|0
4753635|NCT01425008|7728119|FG002|Dose Expansion Phase|Withdrawal by Subject|0
4753636|NCT01425008|7728120|FG003|Dose Expansion Phase|Withdrawal by Subject|0
4753637|NCT01425008|7728121|FG004|Dose Expansion Phase|Withdrawal by Subject|0
4753638|NCT01425008|7728122|FG005|Dose Expansion Phase|Withdrawal by Subject|0
4753639|NCT01425008|7728123|FG006|Dose Expansion Phase|Withdrawal by Subject|0
4753640|NCT01425008|7728124|FG007|Dose Expansion Phase|Withdrawal by Subject|0
4753641|NCT01425008|7728125|FG008|Dose Expansion Phase|Withdrawal by Subject|0
4753642|NCT01425008|7728126|FG009|Dose Expansion Phase|Withdrawal by Subject|0
4753643|NCT01425008|7728127|FG010|Dose Expansion Phase|Withdrawal by Subject|1
4753644|NCT01425008|7728128|FG011|Dose Expansion Phase|Withdrawal by Subject|0
4753645|NCT01425008|7728129|FG012|Dose Expansion Phase|Withdrawal by Subject|0
4753646|NCT01425008|7728130|FG013|Dose Expansion Phase|Withdrawal by Subject|0
4753647|NCT01425008|7728131|FG014|Dose Expansion Phase|Withdrawal by Subject|0
4753648|NCT01425008|7728132|FG015|Dose Expansion Phase|Withdrawal by Subject|1
4753649|NCT01425008|7728133|FG016|Dose Expansion Phase|Withdrawal by Subject|1
4753650|NCT01425008|7728134|FG017|Dose Expansion Phase|Withdrawal by Subject|0
4753651|NCT01425008|7728135|FG018|Dose Expansion Phase|Withdrawal by Subject|0
4753652|NCT01425008|7728117|FG000|Dose Expansion Phase|Other|0
4753653|NCT01425008|7728118|FG001|Dose Expansion Phase|Other|0
4753654|NCT01425008|7728119|FG002|Dose Expansion Phase|Other|0
4753655|NCT01425008|7728120|FG003|Dose Expansion Phase|Other|0
4667487|NCT02289417|7561981|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
4667488|NCT02289417|7561982|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
4667489|NCT02289417|7561974|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0
4667490|NCT02289417|7561975|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0
4667491|NCT02289417|7561976|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0
4667492|NCT02289417|7561977|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1
4667493|NCT02289417|7561978|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0
4667494|NCT02289417|7561979|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0
4667495|NCT02289417|7561980|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1
4667496|NCT02289417|7561981|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0
4667497|NCT02289417|7561982|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0
4667498|NCT02289417|7561974|FG000|Extension Phase Weeks 52-104|Adverse Event|0
4667499|NCT02289417|7561975|FG001|Extension Phase Weeks 52-104|Adverse Event|0
4667500|NCT02289417|7561976|FG002|Extension Phase Weeks 52-104|Adverse Event|0
4667501|NCT02289417|7561977|FG003|Extension Phase Weeks 52-104|Adverse Event|0
4667502|NCT02289417|7561978|FG004|Extension Phase Weeks 52-104|Adverse Event|0
4667503|NCT02289417|7561979|FG005|Extension Phase Weeks 52-104|Adverse Event|0
4667504|NCT02289417|7561980|FG006|Extension Phase Weeks 52-104|Adverse Event|0
4667505|NCT02289417|7561981|FG007|Extension Phase Weeks 52-104|Adverse Event|2
4667506|NCT02289417|7561982|FG008|Extension Phase Weeks 52-104|Adverse Event|3
4667507|NCT02289417|7561974|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0
4753656|NCT01425008|7728121|FG004|Dose Expansion Phase|Other|0
4667508|NCT02289417|7561975|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0
4667509|NCT02289417|7561976|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0
4667510|NCT02289417|7561977|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0
4667511|NCT02289417|7561978|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0
4667512|NCT02289417|7561979|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0
4667513|NCT02289417|7561980|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0
4667514|NCT02289417|7561981|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2
4667515|NCT02289417|7561982|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2
4667516|NCT02289417|7561974|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0
4667517|NCT02289417|7561975|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0
4667518|NCT02289417|7561976|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0
4667519|NCT02289417|7561977|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0
4667520|NCT02289417|7561978|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0
4667521|NCT02289417|7561979|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0
4667522|NCT02289417|7561980|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0
4667523|NCT02289417|7561981|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2
4667524|NCT02289417|7561982|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1
4667525|NCT02289417|7561974|FG000|Extension Phase Weeks 52-104|Miscellaneous|0
4753657|NCT01425008|7728122|FG005|Dose Expansion Phase|Other|0
4753658|NCT01425008|7728123|FG006|Dose Expansion Phase|Other|0
4753659|NCT01425008|7728124|FG007|Dose Expansion Phase|Other|0
4753660|NCT01425008|7728125|FG008|Dose Expansion Phase|Other|0
4753661|NCT01425008|7728126|FG009|Dose Expansion Phase|Other|0
4753662|NCT01425008|7728127|FG010|Dose Expansion Phase|Other|0
4753663|NCT01425008|7728128|FG011|Dose Expansion Phase|Other|0
4753664|NCT01425008|7728129|FG012|Dose Expansion Phase|Other|1
4753665|NCT01425008|7728130|FG013|Dose Expansion Phase|Other|0
4753666|NCT01425008|7728131|FG014|Dose Expansion Phase|Other|0
4753667|NCT01425008|7728132|FG015|Dose Expansion Phase|Other|0
4753668|NCT01425008|7728133|FG016|Dose Expansion Phase|Other|2
4753669|NCT01425008|7728134|FG017|Dose Expansion Phase|Other|0
4753670|NCT01425008|7728135|FG018|Dose Expansion Phase|Other|4
4753671|NCT01425008|7728117|FG000|Dose Expansion Phase|Symptomatic Deterioration|0
4753672|NCT01425008|7728118|FG001|Dose Expansion Phase|Symptomatic Deterioration|0
4753673|NCT01425008|7728119|FG002|Dose Expansion Phase|Symptomatic Deterioration|0
4753674|NCT01425008|7728120|FG003|Dose Expansion Phase|Symptomatic Deterioration|0
4753675|NCT01425008|7728121|FG004|Dose Expansion Phase|Symptomatic Deterioration|0
4753676|NCT01425008|7728122|FG005|Dose Expansion Phase|Symptomatic Deterioration|0
4753677|NCT01425008|7728123|FG006|Dose Expansion Phase|Symptomatic Deterioration|0
4753678|NCT01425008|7728124|FG007|Dose Expansion Phase|Symptomatic Deterioration|0
4753679|NCT01425008|7728125|FG008|Dose Expansion Phase|Symptomatic Deterioration|0
4753680|NCT01425008|7728126|FG009|Dose Expansion Phase|Symptomatic Deterioration|0
4753681|NCT01425008|7728127|FG010|Dose Expansion Phase|Symptomatic Deterioration|2
4753682|NCT01425008|7728128|FG011|Dose Expansion Phase|Symptomatic Deterioration|1
4753683|NCT01425008|7728129|FG012|Dose Expansion Phase|Symptomatic Deterioration|0
4753684|NCT01425008|7728130|FG013|Dose Expansion Phase|Symptomatic Deterioration|0
4753685|NCT01425008|7728131|FG014|Dose Expansion Phase|Symptomatic Deterioration|0
4753686|NCT01425008|7728132|FG015|Dose Expansion Phase|Symptomatic Deterioration|1
4753687|NCT01425008|7728133|FG016|Dose Expansion Phase|Symptomatic Deterioration|2
4753688|NCT01425008|7728134|FG017|Dose Expansion Phase|Symptomatic Deterioration|0
4753689|NCT01425008|7728135|FG018|Dose Expansion Phase|Symptomatic Deterioration|1
4753690|NCT01425008|7728117|FG000|Dose Expansion Phase|Adverse Event|0
4753691|NCT01425008|7728118|FG001|Dose Expansion Phase|Adverse Event|0
4753692|NCT01425008|7728119|FG002|Dose Expansion Phase|Adverse Event|0
4753693|NCT01425008|7728120|FG003|Dose Expansion Phase|Adverse Event|0
4753694|NCT01425008|7728121|FG004|Dose Expansion Phase|Adverse Event|0
4753695|NCT01425008|7728122|FG005|Dose Expansion Phase|Adverse Event|0
4753696|NCT01425008|7728123|FG006|Dose Expansion Phase|Adverse Event|0
4753697|NCT01425008|7728124|FG007|Dose Expansion Phase|Adverse Event|0
4753698|NCT01425008|7728125|FG008|Dose Expansion Phase|Adverse Event|0
4753699|NCT01425008|7728126|FG009|Dose Expansion Phase|Adverse Event|0
4753700|NCT01425008|7728127|FG010|Dose Expansion Phase|Adverse Event|2
4753701|NCT01425008|7728128|FG011|Dose Expansion Phase|Adverse Event|3
4753702|NCT01425008|7728129|FG012|Dose Expansion Phase|Adverse Event|3
4753703|NCT01425008|7728130|FG013|Dose Expansion Phase|Adverse Event|0
4753704|NCT01425008|7728131|FG014|Dose Expansion Phase|Adverse Event|1
4753705|NCT01425008|7728132|FG015|Dose Expansion Phase|Adverse Event|1
4753706|NCT01425008|7728133|FG016|Dose Expansion Phase|Adverse Event|5
4753707|NCT01425008|7728134|FG017|Dose Expansion Phase|Adverse Event|0
4753708|NCT01425008|7728135|FG018|Dose Expansion Phase|Adverse Event|3
4753709|NCT01425008|7728117|FG000|Dose Expansion Phase|Lost to Follow-up|0
4753710|NCT01425008|7728118|FG001|Dose Expansion Phase|Lost to Follow-up|0
4753711|NCT01425008|7728119|FG002|Dose Expansion Phase|Lost to Follow-up|0
4753712|NCT01425008|7728120|FG003|Dose Expansion Phase|Lost to Follow-up|0
4753713|NCT01425008|7728121|FG004|Dose Expansion Phase|Lost to Follow-up|0
4753714|NCT01425008|7728122|FG005|Dose Expansion Phase|Lost to Follow-up|0
4753715|NCT01425008|7728123|FG006|Dose Expansion Phase|Lost to Follow-up|0
4753716|NCT01425008|7728124|FG007|Dose Expansion Phase|Lost to Follow-up|0
4667526|NCT02289417|7561975|FG001|Extension Phase Weeks 52-104|Miscellaneous|0
4667527|NCT02289417|7561976|FG002|Extension Phase Weeks 52-104|Miscellaneous|0
4667528|NCT02289417|7561977|FG003|Extension Phase Weeks 52-104|Miscellaneous|0
4667529|NCT02289417|7561978|FG004|Extension Phase Weeks 52-104|Miscellaneous|0
4667530|NCT02289417|7561979|FG005|Extension Phase Weeks 52-104|Miscellaneous|0
4667531|NCT02289417|7561980|FG006|Extension Phase Weeks 52-104|Miscellaneous|0
4667532|NCT02289417|7561981|FG007|Extension Phase Weeks 52-104|Miscellaneous|1
4667533|NCT02289417|7561982|FG008|Extension Phase Weeks 52-104|Miscellaneous|0
4667534|NCT02289456|7561998|FG000|Induction Period|Death|2
4667535|NCT02289456|7561998|FG000|Induction Period|Adverse Event|11
4667536|NCT02289456|7561998|FG000|Induction Period|Progressive Disease (PD)|4
4667537|NCT02289456|7561998|FG000|Induction Period|Symptomatic Deterioration|4
4667538|NCT02289456|7561998|FG000|Induction Period|Withdrawal by Subject|2
4667539|NCT02289456|7561998|FG000|Induction Period|Miscellaneous|1
4667540|NCT02289456|7561998|FG000|Monotherapy Period|Death|1
4667541|NCT02289456|7561998|FG000|Monotherapy Period|Adverse Event|1
4667542|NCT02289456|7561998|FG000|Monotherapy Period|Progressive Disease (PD)|8
4667543|NCT02289456|7561998|FG000|Monotherapy Period|Symptomatic Deterioration|1
4667544|NCT02289456|7561998|FG000|Monotherapy Period|Withdrawal by Subject|2
4667545|NCT02289456|7561998|FG000|Monotherapy Period|Study Terminated by Sponsor|2
4667546|NCT02289456|7561998|FG000|Monotherapy Period|Miscellaneous|1
4667547|NCT02289469|7562009|FG000|Overall Study|Unable to match a control|6
4667548|NCT02289469|7562010|FG001|Overall Study|Unable to match a control|0
4667549|NCT02289690|7562026|FG000|Overall Study|Adverse Event Related to Progression|0
4667550|NCT02289690|7562027|FG001|Overall Study|Adverse Event Related to Progression|1
4667551|NCT02289690|7562028|FG002|Overall Study|Adverse Event Related to Progression|1
4667552|NCT02289690|7562029|FG003|Overall Study|Adverse Event Related to Progression|0
4667553|NCT02289690|7562030|FG004|Overall Study|Adverse Event Related to Progression|1
4667554|NCT02289690|7562031|FG005|Overall Study|Adverse Event Related to Progression|0
4667555|NCT02289690|7562032|FG006|Overall Study|Adverse Event Related to Progression|1
4667556|NCT02289690|7562033|FG007|Overall Study|Adverse Event Related to Progression|0
4667557|NCT02289690|7562034|FG008|Overall Study|Adverse Event Related to Progression|0
4667558|NCT02289690|7562035|FG009|Overall Study|Adverse Event Related to Progression|0
4667559|NCT02289690|7562026|FG000|Overall Study|Withdrawal by Subject|1
4667560|NCT02289690|7562027|FG001|Overall Study|Withdrawal by Subject|0
4667561|NCT02289690|7562028|FG002|Overall Study|Withdrawal by Subject|0
4667562|NCT02289690|7562029|FG003|Overall Study|Withdrawal by Subject|0
4667563|NCT02289690|7562030|FG004|Overall Study|Withdrawal by Subject|1
4667564|NCT02289690|7562031|FG005|Overall Study|Withdrawal by Subject|1
4667565|NCT02289690|7562032|FG006|Overall Study|Withdrawal by Subject|0
4667566|NCT02289690|7562033|FG007|Overall Study|Withdrawal by Subject|0
4667567|NCT02289690|7562034|FG008|Overall Study|Withdrawal by Subject|4
4667568|NCT02289690|7562035|FG009|Overall Study|Withdrawal by Subject|2
4667569|NCT02289690|7562026|FG000|Overall Study|Progressive Disease, Per Protocol|3
4667570|NCT02289690|7562027|FG001|Overall Study|Progressive Disease, Per Protocol|2
4667571|NCT02289690|7562028|FG002|Overall Study|Progressive Disease, Per Protocol|3
4667572|NCT02289690|7562029|FG003|Overall Study|Progressive Disease, Per Protocol|2
4667573|NCT02289690|7562030|FG004|Overall Study|Progressive Disease, Per Protocol|5
4667574|NCT02289690|7562031|FG005|Overall Study|Progressive Disease, Per Protocol|13
4667575|NCT02289690|7562032|FG006|Overall Study|Progressive Disease, Per Protocol|2
4667576|NCT02289690|7562033|FG007|Overall Study|Progressive Disease, Per Protocol|0
4667577|NCT02289690|7562034|FG008|Overall Study|Progressive Disease, Per Protocol|0
4667578|NCT02289690|7562035|FG009|Overall Study|Progressive Disease, Per Protocol|0
4667579|NCT02289690|7562026|FG000|Overall Study|Lost to Follow-up|0
4667580|NCT02289690|7562027|FG001|Overall Study|Lost to Follow-up|0
4667581|NCT02289690|7562028|FG002|Overall Study|Lost to Follow-up|0
4667582|NCT02289690|7562029|FG003|Overall Study|Lost to Follow-up|0
4667583|NCT02289690|7562030|FG004|Overall Study|Lost to Follow-up|0
4667584|NCT02289690|7562031|FG005|Overall Study|Lost to Follow-up|0
4667585|NCT02289690|7562032|FG006|Overall Study|Lost to Follow-up|0
4667586|NCT02289690|7562033|FG007|Overall Study|Lost to Follow-up|1
4667587|NCT02289690|7562034|FG008|Overall Study|Lost to Follow-up|0
4667588|NCT02289690|7562035|FG009|Overall Study|Lost to Follow-up|2
4667589|NCT02289690|7562026|FG000|Overall Study|Death|0
4667590|NCT02289690|7562027|FG001|Overall Study|Death|0
4667591|NCT02289690|7562028|FG002|Overall Study|Death|0
4667592|NCT02289690|7562029|FG003|Overall Study|Death|0
4667593|NCT02289690|7562030|FG004|Overall Study|Death|0
4667594|NCT02289690|7562031|FG005|Overall Study|Death|0
4667595|NCT02289690|7562032|FG006|Overall Study|Death|0
4667596|NCT02289690|7562033|FG007|Overall Study|Death|49
4667597|NCT02289690|7562034|FG008|Overall Study|Death|45
4667598|NCT02289690|7562035|FG009|Overall Study|Death|41
4667599|NCT02289690|7562026|FG000|Overall Study|Sponsor Discontinued Study|0
4667600|NCT02289690|7562027|FG001|Overall Study|Sponsor Discontinued Study|0
4667601|NCT02289690|7562028|FG002|Overall Study|Sponsor Discontinued Study|0
4667602|NCT02289690|7562029|FG003|Overall Study|Sponsor Discontinued Study|0
4667603|NCT02289690|7562030|FG004|Overall Study|Sponsor Discontinued Study|0
4667604|NCT02289690|7562031|FG005|Overall Study|Sponsor Discontinued Study|0
4667605|NCT02289690|7562032|FG006|Overall Study|Sponsor Discontinued Study|0
4667606|NCT02289690|7562033|FG007|Overall Study|Sponsor Discontinued Study|9
4667607|NCT02289690|7562034|FG008|Overall Study|Sponsor Discontinued Study|7
4667608|NCT02289690|7562035|FG009|Overall Study|Sponsor Discontinued Study|15
4667609|NCT02289690|7562026|FG000|Overall Study|Other|0
4667610|NCT02289690|7562027|FG001|Overall Study|Other|0
4667611|NCT02289690|7562028|FG002|Overall Study|Other|0
4667612|NCT02289690|7562029|FG003|Overall Study|Other|1
4667613|NCT02289690|7562030|FG004|Overall Study|Other|1
4667614|NCT02289690|7562031|FG005|Overall Study|Other|0
4667615|NCT02289690|7562032|FG006|Overall Study|Other|1
4667616|NCT02289690|7562033|FG007|Overall Study|Other|2
4667617|NCT02289690|7562034|FG008|Overall Study|Other|3
4667618|NCT02289690|7562035|FG009|Overall Study|Other|1
4667619|NCT02289729|7562071|FG000|Overall Study|Lack of Efficacy|3
4667620|NCT02289729|7562071|FG000|Overall Study|Very Narrow Therapeutic Margin|1
4667621|NCT02289729|7562071|FG000|Overall Study|Withdrawal by Subject|1
4667622|NCT02289729|7562071|FG000|Overall Study|Death|1
4667623|NCT02289742|7562077|FG000|First Wear Period|Adverse event prior to treatment|0
4667624|NCT02289742|7562078|FG001|First Wear Period|Adverse event prior to treatment|1
4753717|NCT01425008|7728125|FG008|Dose Expansion Phase|Lost to Follow-up|0
4753718|NCT01425008|7728126|FG009|Dose Expansion Phase|Lost to Follow-up|0
4753719|NCT01425008|7728127|FG010|Dose Expansion Phase|Lost to Follow-up|0
4753720|NCT01425008|7728128|FG011|Dose Expansion Phase|Lost to Follow-up|0
4753721|NCT01425008|7728129|FG012|Dose Expansion Phase|Lost to Follow-up|0
4753722|NCT01425008|7728130|FG013|Dose Expansion Phase|Lost to Follow-up|0
4753723|NCT01425008|7728131|FG014|Dose Expansion Phase|Lost to Follow-up|0
4753724|NCT01425008|7728132|FG015|Dose Expansion Phase|Lost to Follow-up|0
4753725|NCT01425008|7728133|FG016|Dose Expansion Phase|Lost to Follow-up|1
4753726|NCT01425008|7728134|FG017|Dose Expansion Phase|Lost to Follow-up|0
4753727|NCT01425008|7728135|FG018|Dose Expansion Phase|Lost to Follow-up|0
4753728|NCT01425008|7728117|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
4753729|NCT01425008|7728118|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
4753730|NCT01425008|7728119|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
4753731|NCT01425008|7728120|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
4753732|NCT01425008|7728121|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
4753733|NCT01425008|7728122|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
4753734|NCT01425008|7728123|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
4753735|NCT01425008|7728124|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
4667625|NCT02289742|7562079|FG002|First Wear Period|Adverse event prior to treatment|0
4667626|NCT02289742|7562080|FG003|First Wear Period|Adverse event prior to treatment|0
4667627|NCT02289742|7562077|FG000|First Wear Period|Adverse Event|0
4667628|NCT02289742|7562078|FG001|First Wear Period|Adverse Event|0
4667629|NCT02289742|7562079|FG002|First Wear Period|Adverse Event|1
4667630|NCT02289742|7562080|FG003|First Wear Period|Adverse Event|0
4667631|NCT02289742|7562077|FG000|First Wear Period|Other prior to treatment|0
4667632|NCT02289742|7562078|FG001|First Wear Period|Other prior to treatment|0
4667633|NCT02289742|7562079|FG002|First Wear Period|Other prior to treatment|0
4667634|NCT02289742|7562080|FG003|First Wear Period|Other prior to treatment|1
4667635|NCT02289742|7562077|FG000|Third Wear Period|Adverse Event|0
4667636|NCT02289742|7562078|FG001|Third Wear Period|Adverse Event|1
4667637|NCT02289742|7562079|FG002|Third Wear Period|Adverse Event|0
4667638|NCT02289742|7562080|FG003|Third Wear Period|Adverse Event|0
4667639|NCT02289742|7562077|FG000|Third Wear Period|Reason not given|0
4667640|NCT02289742|7562078|FG001|Third Wear Period|Reason not given|0
4667641|NCT02289742|7562079|FG002|Third Wear Period|Reason not given|0
4667642|NCT02289742|7562080|FG003|Third Wear Period|Reason not given|1
4667643|NCT02289820|7562105|FG000|Overall Study|Withdrawal by Subject|2
4667644|NCT02289820|7562106|FG001|Overall Study|Withdrawal by Subject|1
4667645|NCT02289820|7562107|FG002|Overall Study|Withdrawal by Subject|2
4667646|NCT02289820|7562108|FG003|Overall Study|Withdrawal by Subject|1
4667647|NCT02289820|7562109|FG004|Overall Study|Withdrawal by Subject|0
4667648|NCT02289820|7562110|FG005|Overall Study|Withdrawal by Subject|0
4667649|NCT02289820|7562111|FG006|Overall Study|Withdrawal by Subject|1
4667650|NCT02289820|7562105|FG000|Overall Study|Death|0
4667651|NCT02289820|7562106|FG001|Overall Study|Death|0
4667652|NCT02289820|7562107|FG002|Overall Study|Death|1
4667653|NCT02289820|7562108|FG003|Overall Study|Death|0
4667654|NCT02289820|7562109|FG004|Overall Study|Death|0
4667655|NCT02289820|7562110|FG005|Overall Study|Death|0
4667656|NCT02289820|7562111|FG006|Overall Study|Death|0
4667657|NCT02289820|7562105|FG000|Overall Study|Lost to Follow-up|0
4667658|NCT02289820|7562106|FG001|Overall Study|Lost to Follow-up|0
4667659|NCT02289820|7562107|FG002|Overall Study|Lost to Follow-up|3
4667660|NCT02289820|7562108|FG003|Overall Study|Lost to Follow-up|1
4667661|NCT02289820|7562109|FG004|Overall Study|Lost to Follow-up|0
4667662|NCT02289820|7562110|FG005|Overall Study|Lost to Follow-up|1
4667663|NCT02289820|7562111|FG006|Overall Study|Lost to Follow-up|1
4667664|NCT02289820|7562105|FG000|Overall Study|withdrawal of consent|0
4667665|NCT02289820|7562106|FG001|Overall Study|withdrawal of consent|1
4667666|NCT02289820|7562107|FG002|Overall Study|withdrawal of consent|0
4667667|NCT02289820|7562108|FG003|Overall Study|withdrawal of consent|0
4667668|NCT02289820|7562109|FG004|Overall Study|withdrawal of consent|0
4753736|NCT01425008|7728125|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
4753737|NCT01425008|7728126|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
4667669|NCT02289820|7562110|FG005|Overall Study|withdrawal of consent|0
4667670|NCT02289820|7562111|FG006|Overall Study|withdrawal of consent|0
4667671|NCT02289833|7562133|FG000|Overall Study|Study discontinuation|0
4667672|NCT02289833|7562134|FG001|Overall Study|Study discontinuation|1
4667673|NCT02289833|7562133|FG000|Overall Study|Lost to Follow-up|4
4667674|NCT02289833|7562134|FG001|Overall Study|Lost to Follow-up|0
4667675|NCT02289833|7562133|FG000|Overall Study|Death|23
4667676|NCT02289833|7562134|FG001|Overall Study|Death|16
4667677|NCT02289898|7562145|FG000|Overall Study|Death|5
4667678|NCT02289898|7562146|FG001|Overall Study|Death|4
4667679|NCT02289898|7562147|FG002|Overall Study|Death|3
4667680|NCT02289898|7562145|FG000|Overall Study|Physician Decision|2
4667681|NCT02289898|7562146|FG001|Overall Study|Physician Decision|5
4667682|NCT02289898|7562147|FG002|Overall Study|Physician Decision|2
4667683|NCT02289898|7562145|FG000|Overall Study|Withdrawal by Subject|0
4667684|NCT02289898|7562146|FG001|Overall Study|Withdrawal by Subject|4
4667685|NCT02289898|7562147|FG002|Overall Study|Withdrawal by Subject|1
4667686|NCT02289898|7562145|FG000|Overall Study|Adverse Event|3
4667687|NCT02289898|7562146|FG001|Overall Study|Adverse Event|5
4667688|NCT02289898|7562147|FG002|Overall Study|Adverse Event|5
4667689|NCT02289898|7562145|FG000|Overall Study|Disease progression|34
4667690|NCT02289898|7562146|FG001|Overall Study|Disease progression|28
4667691|NCT02289898|7562147|FG002|Overall Study|Disease progression|34
4667692|NCT02289898|7562145|FG000|Overall Study|Use of another anticancer therapy|0
4667693|NCT02289898|7562146|FG001|Overall Study|Use of another anticancer therapy|0
4667694|NCT02289898|7562147|FG002|Overall Study|Use of another anticancer therapy|1
4667695|NCT02289898|7562145|FG000|Overall Study|Other|8
4667696|NCT02289898|7562146|FG001|Overall Study|Other|7
4667697|NCT02289898|7562147|FG002|Overall Study|Other|10
4667698|NCT02289950|7562156|FG000|Overall Study|Progressive disease by RECIST 1.1|99
4667699|NCT02289950|7562157|FG001|Overall Study|Progressive disease by RECIST 1.1|52
4667700|NCT02289950|7562156|FG000|Overall Study|Progressive disease by Clinical Assessment|4
4667701|NCT02289950|7562157|FG001|Overall Study|Progressive disease by Clinical Assessment|4
4667702|NCT02289950|7562156|FG000|Overall Study|Lost to Follow-up|1
4667703|NCT02289950|7562157|FG001|Overall Study|Lost to Follow-up|0
4667704|NCT02289950|7562156|FG000|Overall Study|Physician Decision|9
4667705|NCT02289950|7562157|FG001|Overall Study|Physician Decision|3
4667706|NCT02289950|7562156|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9
4667707|NCT02289950|7562157|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2
4667708|NCT02289950|7562156|FG000|Overall Study|Withdrawal by Subject|1
4667709|NCT02289950|7562157|FG001|Overall Study|Withdrawal by Subject|3
4667710|NCT02289950|7562156|FG000|Overall Study|Test article held for greater than 28 days|0
4667711|NCT02289950|7562157|FG001|Overall Study|Test article held for greater than 28 days|1
4667712|NCT02289950|7562156|FG000|Overall Study|Adverse Event|11
4667713|NCT02289950|7562157|FG001|Overall Study|Adverse Event|3
4667714|NCT02289950|7562156|FG000|Overall Study|Death|1
4667715|NCT02289950|7562157|FG001|Overall Study|Death|1
4667716|NCT02289950|7562156|FG000|Overall Study|Other|5
4667717|NCT02289950|7562157|FG001|Overall Study|Other|2
4667718|NCT02289950|7562156|FG000|Overall Study|Not Treated|2
4667719|NCT02289950|7562157|FG001|Overall Study|Not Treated|1
4667720|NCT02289963|7562165|FG000|Overall Study|Adverse Event|1
4667721|NCT02289963|7562166|FG001|Overall Study|Adverse Event|2
4667722|NCT02289963|7562165|FG000|Overall Study|Poor compliance to protocol|1
4667723|NCT02289963|7562166|FG001|Overall Study|Poor compliance to protocol|0
4667724|NCT02289963|7562165|FG000|Overall Study|Withdrawal by Subject|1
4667725|NCT02289963|7562166|FG001|Overall Study|Withdrawal by Subject|0
4667726|NCT02289963|7562165|FG000|Overall Study|Last injection missed|2
4667727|NCT02289963|7562166|FG001|Overall Study|Last injection missed|2
4667728|NCT02289963|7562165|FG000|Overall Study|End treatment visit outside visit window|0
4667729|NCT02289963|7562166|FG001|Overall Study|End treatment visit outside visit window|4
4667730|NCT02289963|7562165|FG000|Overall Study|Other than specified above|0
4667731|NCT02289963|7562166|FG001|Overall Study|Other than specified above|2
4667732|NCT02290028|7562181|FG000|Overall Study|Death|217
4667733|NCT02290028|7562181|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186
4667734|NCT02290028|7562181|FG000|Overall Study|No longer under care of study physician|76
4667735|NCT02290028|7562181|FG000|Overall Study|Sentus lead or required CRT-D explanted|55
4667736|NCT02290028|7562181|FG000|Overall Study|Withdrawal by Subject|52
4667737|NCT02290028|7562181|FG000|Overall Study|Study site closure|44
4667738|NCT02290028|7562181|FG000|Overall Study|Lost to Follow-up|34
4667739|NCT02290028|7562181|FG000|Overall Study|Miscellaneous|10
4667740|NCT02290028|7562181|FG000|Overall Study|Transition to EP PASSION|1295
4667741|NCT02290028|7562181|FG000|Overall Study|Planned study completion at 12 months|257
4667742|NCT02290223|7562214|FG000|6 Months|Lost to Follow-up|9
4667743|NCT02290223|7562215|FG001|6 Months|Lost to Follow-up|6
4667744|NCT02290223|7562214|FG000|6 Months|Withdrawal by Subject|5
4667745|NCT02290223|7562215|FG001|6 Months|Withdrawal by Subject|0
4667746|NCT02290223|7562214|FG000|6 Months|deceased (not related to study)|2
4667747|NCT02290223|7562215|FG001|6 Months|deceased (not related to study)|0
4667748|NCT02290223|7562214|FG000|12 Months|Lost to Follow-up|16
4667749|NCT02290223|7562215|FG001|12 Months|Lost to Follow-up|10
4667750|NCT02290223|7562214|FG000|12 Months|Refusal|0
4667751|NCT02290223|7562215|FG001|12 Months|Refusal|1
4667752|NCT02290340|7562225|FG000|Overall Study|Lost to Follow-up|0
4667753|NCT02290340|7562226|FG001|Overall Study|Lost to Follow-up|0
4667754|NCT02290340|7562227|FG002|Overall Study|Lost to Follow-up|0
4667755|NCT02290340|7562228|FG003|Overall Study|Lost to Follow-up|1
4667756|NCT02290340|7562225|FG000|Overall Study|Withdrawal by Subject|1
4667757|NCT02290340|7562226|FG001|Overall Study|Withdrawal by Subject|0
4667758|NCT02290340|7562227|FG002|Overall Study|Withdrawal by Subject|0
4667759|NCT02290340|7562228|FG003|Overall Study|Withdrawal by Subject|0
4667760|NCT02290340|7562225|FG000|Overall Study|Other|1
4667761|NCT02290340|7562226|FG001|Overall Study|Other|0
4667762|NCT02290340|7562227|FG002|Overall Study|Other|0
4667763|NCT02290340|7562228|FG003|Overall Study|Other|1
4667764|NCT02290405|7562243|FG000|Overall Study|Withdrawal by Subject|1
4667765|NCT02290405|7562244|FG001|Overall Study|Withdrawal by Subject|0
4667766|NCT02290691|7562284|FG000|Overall Study|Noncompliance|0
4667767|NCT02290691|7562285|FG001|Overall Study|Noncompliance|1
4667768|NCT02290691|7562284|FG000|Overall Study|Withdrawal by Subject|1
4667769|NCT02290691|7562285|FG001|Overall Study|Withdrawal by Subject|1
4667770|NCT02290691|7562284|FG000|Overall Study|Lost to Follow-up|7
4667771|NCT02290691|7562285|FG001|Overall Study|Lost to Follow-up|7
4667772|NCT02290821|7562293|FG000|Overall Study|Withdrawal by Subject|1
4667773|NCT02290821|7562294|FG001|Overall Study|Withdrawal by Subject|1
4667774|NCT02290821|7562293|FG000|Overall Study|Unable or unwilling to cooperate with|2
4667775|NCT02290821|7562294|FG001|Overall Study|Unable or unwilling to cooperate with|0
4667776|NCT02290821|7562293|FG000|Overall Study|Lost to Follow-up|3
4667777|NCT02290821|7562294|FG001|Overall Study|Lost to Follow-up|2
4667778|NCT02290873|7562303|FG000|Overall Study|Withdrawal by Subject|0
4667779|NCT02290873|7562304|FG001|Overall Study|Withdrawal by Subject|1
4667780|NCT02290873|7562305|FG002|Overall Study|Withdrawal by Subject|1
4667781|NCT02290873|7562303|FG000|Overall Study|Nellcor device error|1
4667782|NCT02290873|7562304|FG001|Overall Study|Nellcor device error|0
4667783|NCT02290873|7562305|FG002|Overall Study|Nellcor device error|0
4667784|NCT02290873|7562303|FG000|Overall Study|Esophagogastroduodenoscopy was added|1
4667785|NCT02290873|7562304|FG001|Overall Study|Esophagogastroduodenoscopy was added|0
4753738|NCT01425008|7728127|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
4753739|NCT01425008|7728128|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
4753740|NCT01425008|7728129|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
4753741|NCT01425008|7728130|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
4753742|NCT01425008|7728131|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
4753743|NCT01425008|7728132|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
4753744|NCT01425008|7728133|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
4753745|NCT01425008|7728134|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
4753746|NCT01425008|7728135|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1
4667786|NCT02290873|7562305|FG002|Overall Study|Esophagogastroduodenoscopy was added|0
4667787|NCT02290873|7562303|FG000|Overall Study|Protocol Violation|0
4667788|NCT02290873|7562304|FG001|Overall Study|Protocol Violation|0
4667789|NCT02290873|7562305|FG002|Overall Study|Protocol Violation|1
4667790|NCT02290925|7562316|FG000|First Period of Three Months|Lost to Follow-up|2
4667791|NCT02290925|7562317|FG001|First Period of Three Months|Lost to Follow-up|1
4667792|NCT02290925|7562316|FG000|First Period of Three Months|Death|1
4667793|NCT02290925|7562317|FG001|First Period of Three Months|Death|0
4667794|NCT02290925|7562316|FG000|First Period of Three Months|Insulin Started|1
4667795|NCT02290925|7562317|FG001|First Period of Three Months|Insulin Started|1
4667796|NCT02290925|7562316|FG000|Second Period of 3 Months|Lost to Follow-up|1
4667797|NCT02290925|7562317|FG001|Second Period of 3 Months|Lost to Follow-up|3
4667798|NCT02290925|7562316|FG000|Second Period of 3 Months|insulin started|0
4667799|NCT02290925|7562317|FG001|Second Period of 3 Months|insulin started|1
4667800|NCT02291029|7562341|FG000|Overall Study|Withdrawal by Subject|0
4667801|NCT02291029|7562342|FG001|Overall Study|Withdrawal by Subject|0
4667802|NCT02291029|7562343|FG002|Overall Study|Withdrawal by Subject|1
4667803|NCT02291029|7562344|FG003|Overall Study|Withdrawal by Subject|0
4667804|NCT02291029|7562345|FG004|Overall Study|Withdrawal by Subject|0
4667805|NCT02291029|7562346|FG005|Overall Study|Withdrawal by Subject|0
4667806|NCT02291029|7562341|FG000|Overall Study|Adverse Event|0
4667807|NCT02291029|7562342|FG001|Overall Study|Adverse Event|1
4667808|NCT02291029|7562343|FG002|Overall Study|Adverse Event|0
4667809|NCT02291029|7562344|FG003|Overall Study|Adverse Event|0
4667810|NCT02291029|7562345|FG004|Overall Study|Adverse Event|0
4667811|NCT02291029|7562346|FG005|Overall Study|Adverse Event|0
4667812|NCT02291237|7562366|FG000|Overall Study|Study Terminated by Sponsor|72
4667813|NCT02291237|7562367|FG001|Overall Study|Study Terminated by Sponsor|67
4667814|NCT02291237|7562366|FG000|Overall Study|Adverse Event|1
4667815|NCT02291237|7562367|FG001|Overall Study|Adverse Event|3
4667816|NCT02291237|7562366|FG000|Overall Study|Investigator's Discretion|0
4667817|NCT02291237|7562367|FG001|Overall Study|Investigator's Discretion|3
4667818|NCT02291237|7562366|FG000|Overall Study|Withdrew Consent|11
4667819|NCT02291237|7562367|FG001|Overall Study|Withdrew Consent|11
4667820|NCT02291237|7562366|FG000|Overall Study|Lost to Follow-up|0
4667821|NCT02291237|7562367|FG001|Overall Study|Lost to Follow-up|2
4667822|NCT02291237|7562366|FG000|Overall Study|Subject Required Prohibited Medication|2
4667823|NCT02291237|7562367|FG001|Overall Study|Subject Required Prohibited Medication|0
4667824|NCT02291289|7562377|FG000|Induction Treatment|Not Dosed|2
4667825|NCT02291289|7562378|FG001|Induction Treatment|Not Dosed|0
4667826|NCT02291289|7562379|FG002|Induction Treatment|Not Dosed|0
4667827|NCT02291289|7562380|FG003|Induction Treatment|Not Dosed|9
4667828|NCT02291289|7562381|FG004|Induction Treatment|Not Dosed|0
4667829|NCT02291289|7562382|FG005|Induction Treatment|Not Dosed|0
4667830|NCT02291289|7562383|FG006|Induction Treatment|Not Dosed|0
4667831|NCT02291289|7562384|FG007|Induction Treatment|Not Dosed|0
4667832|NCT02291289|7562385|FG008|Induction Treatment|Not Dosed|0
4667833|NCT02291289|7562386|FG009|Induction Treatment|Not Dosed|1
4667834|NCT02291289|7562387|FG010|Induction Treatment|Not Dosed|0
4667835|NCT02291289|7562388|FG011|Induction Treatment|Not Dosed|0
4667836|NCT02291289|7562377|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0
4667837|NCT02291289|7562378|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0
4667838|NCT02291289|7562379|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0
4667839|NCT02291289|7562380|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0
4667840|NCT02291289|7562381|FG004|Maintenance Treatment Phase|Withdrawal by Subject|13
4667841|NCT02291289|7562382|FG005|Maintenance Treatment Phase|Withdrawal by Subject|11
4667842|NCT02291289|7562383|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0
4667843|NCT02291289|7562384|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0
4667844|NCT02291289|7562385|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0
4667845|NCT02291289|7562386|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0
4667846|NCT02291289|7562387|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2
4667847|NCT02291289|7562388|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3
4667848|NCT02291289|7562377|FG000|Maintenance Treatment Phase|Protocol Violation|0
4667849|NCT02291289|7562378|FG001|Maintenance Treatment Phase|Protocol Violation|1
4667850|NCT02291289|7562379|FG002|Maintenance Treatment Phase|Protocol Violation|0
4667851|NCT02291289|7562380|FG003|Maintenance Treatment Phase|Protocol Violation|0
4667852|NCT02291289|7562381|FG004|Maintenance Treatment Phase|Protocol Violation|2
4667853|NCT02291289|7562382|FG005|Maintenance Treatment Phase|Protocol Violation|1
4667854|NCT02291289|7562383|FG006|Maintenance Treatment Phase|Protocol Violation|0
4667855|NCT02291289|7562384|FG007|Maintenance Treatment Phase|Protocol Violation|0
4667856|NCT02291289|7562385|FG008|Maintenance Treatment Phase|Protocol Violation|0
4667857|NCT02291289|7562386|FG009|Maintenance Treatment Phase|Protocol Violation|0
4667858|NCT02291289|7562387|FG010|Maintenance Treatment Phase|Protocol Violation|0
4667859|NCT02291289|7562388|FG011|Maintenance Treatment Phase|Protocol Violation|0
4667860|NCT02291289|7562377|FG000|Maintenance Treatment Phase|Death|0
4667861|NCT02291289|7562378|FG001|Maintenance Treatment Phase|Death|23
4667862|NCT02291289|7562379|FG002|Maintenance Treatment Phase|Death|13
4667863|NCT02291289|7562380|FG003|Maintenance Treatment Phase|Death|0
4667864|NCT02291289|7562381|FG004|Maintenance Treatment Phase|Death|185
4667865|NCT02291289|7562382|FG005|Maintenance Treatment Phase|Death|100
4667866|NCT02291289|7562383|FG006|Maintenance Treatment Phase|Death|0
4667867|NCT02291289|7562384|FG007|Maintenance Treatment Phase|Death|1
4667868|NCT02291289|7562385|FG008|Maintenance Treatment Phase|Death|1
4667869|NCT02291289|7562386|FG009|Maintenance Treatment Phase|Death|0
4667870|NCT02291289|7562387|FG010|Maintenance Treatment Phase|Death|26
4667871|NCT02291289|7562388|FG011|Maintenance Treatment Phase|Death|11
4667872|NCT02291289|7562377|FG000|Maintenance Treatment Phase|Adverse Event|0
4667873|NCT02291289|7562378|FG001|Maintenance Treatment Phase|Adverse Event|0
4667874|NCT02291289|7562379|FG002|Maintenance Treatment Phase|Adverse Event|0
4667875|NCT02291289|7562380|FG003|Maintenance Treatment Phase|Adverse Event|0
4667876|NCT02291289|7562381|FG004|Maintenance Treatment Phase|Adverse Event|1
4667877|NCT02291289|7562382|FG005|Maintenance Treatment Phase|Adverse Event|0
4753747|NCT01470326|7728188|FG000|Overall Study|Protocol Violation|32
4667878|NCT02291289|7562383|FG006|Maintenance Treatment Phase|Adverse Event|0
4667879|NCT02291289|7562384|FG007|Maintenance Treatment Phase|Adverse Event|0
4667880|NCT02291289|7562385|FG008|Maintenance Treatment Phase|Adverse Event|0
4667881|NCT02291289|7562386|FG009|Maintenance Treatment Phase|Adverse Event|0
4667882|NCT02291289|7562387|FG010|Maintenance Treatment Phase|Adverse Event|0
4667883|NCT02291289|7562388|FG011|Maintenance Treatment Phase|Adverse Event|0
4667884|NCT02291289|7562377|FG000|Maintenance Treatment Phase|Lost to Follow-up|0
4667885|NCT02291289|7562378|FG001|Maintenance Treatment Phase|Lost to Follow-up|0
4667886|NCT02291289|7562379|FG002|Maintenance Treatment Phase|Lost to Follow-up|0
4667887|NCT02291289|7562380|FG003|Maintenance Treatment Phase|Lost to Follow-up|0
4667888|NCT02291289|7562381|FG004|Maintenance Treatment Phase|Lost to Follow-up|12
4667889|NCT02291289|7562382|FG005|Maintenance Treatment Phase|Lost to Follow-up|3
4667890|NCT02291289|7562383|FG006|Maintenance Treatment Phase|Lost to Follow-up|0
4667891|NCT02291289|7562384|FG007|Maintenance Treatment Phase|Lost to Follow-up|1
4667892|NCT02291289|7562385|FG008|Maintenance Treatment Phase|Lost to Follow-up|0
4667893|NCT02291289|7562386|FG009|Maintenance Treatment Phase|Lost to Follow-up|0
4667894|NCT02291289|7562387|FG010|Maintenance Treatment Phase|Lost to Follow-up|2
4667895|NCT02291289|7562388|FG011|Maintenance Treatment Phase|Lost to Follow-up|1
4667896|NCT02291289|7562377|FG000|Maintenance Treatment Phase|Other|0
4667897|NCT02291289|7562378|FG001|Maintenance Treatment Phase|Other|0
4667898|NCT02291289|7562379|FG002|Maintenance Treatment Phase|Other|1
4667899|NCT02291289|7562380|FG003|Maintenance Treatment Phase|Other|0
4667900|NCT02291289|7562381|FG004|Maintenance Treatment Phase|Other|29
4667901|NCT02291289|7562382|FG005|Maintenance Treatment Phase|Other|8
4667902|NCT02291289|7562383|FG006|Maintenance Treatment Phase|Other|0
4667903|NCT02291289|7562384|FG007|Maintenance Treatment Phase|Other|0
4667904|NCT02291289|7562385|FG008|Maintenance Treatment Phase|Other|1
4667905|NCT02291289|7562386|FG009|Maintenance Treatment Phase|Other|0
4667906|NCT02291289|7562387|FG010|Maintenance Treatment Phase|Other|0
4667907|NCT02291289|7562388|FG011|Maintenance Treatment Phase|Other|0
4667908|NCT02291289|7562377|FG000|Maintenance Treatment Phase|Physician Decision|0
4667909|NCT02291289|7562378|FG001|Maintenance Treatment Phase|Physician Decision|0
4667910|NCT02291289|7562379|FG002|Maintenance Treatment Phase|Physician Decision|0
4667911|NCT02291289|7562380|FG003|Maintenance Treatment Phase|Physician Decision|0
4667912|NCT02291289|7562381|FG004|Maintenance Treatment Phase|Physician Decision|2
4667913|NCT02291289|7562382|FG005|Maintenance Treatment Phase|Physician Decision|0
4667914|NCT02291289|7562383|FG006|Maintenance Treatment Phase|Physician Decision|0
4667915|NCT02291289|7562384|FG007|Maintenance Treatment Phase|Physician Decision|0
4667916|NCT02291289|7562385|FG008|Maintenance Treatment Phase|Physician Decision|0
4667917|NCT02291289|7562386|FG009|Maintenance Treatment Phase|Physician Decision|0
4667918|NCT02291289|7562387|FG010|Maintenance Treatment Phase|Physician Decision|0
4667919|NCT02291289|7562388|FG011|Maintenance Treatment Phase|Physician Decision|1
4667920|NCT02291289|7562377|FG000|Maintenance Treatment Phase|Multiple Reasons|0
4667921|NCT02291289|7562378|FG001|Maintenance Treatment Phase|Multiple Reasons|0
4667922|NCT02291289|7562379|FG002|Maintenance Treatment Phase|Multiple Reasons|0
4667923|NCT02291289|7562380|FG003|Maintenance Treatment Phase|Multiple Reasons|0
4667924|NCT02291289|7562381|FG004|Maintenance Treatment Phase|Multiple Reasons|4
4667925|NCT02291289|7562382|FG005|Maintenance Treatment Phase|Multiple Reasons|1
4667926|NCT02291289|7562383|FG006|Maintenance Treatment Phase|Multiple Reasons|0
4753748|NCT01470326|7728188|FG000|Overall Study|No Drug Administration Information|2
4753749|NCT01470326|7728188|FG000|Overall Study|No Visit After 1st Day of Treatment|119
4667927|NCT02291289|7562384|FG007|Maintenance Treatment Phase|Multiple Reasons|0
4667928|NCT02291289|7562385|FG008|Maintenance Treatment Phase|Multiple Reasons|0
4667929|NCT02291289|7562386|FG009|Maintenance Treatment Phase|Multiple Reasons|0
4667930|NCT02291289|7562387|FG010|Maintenance Treatment Phase|Multiple Reasons|0
4667931|NCT02291289|7562388|FG011|Maintenance Treatment Phase|Multiple Reasons|0
4667932|NCT02291289|7562377|FG000|Maintenance Treatment Phase|No Treatment Received|0
4667933|NCT02291289|7562378|FG001|Maintenance Treatment Phase|No Treatment Received|0
4667934|NCT02291289|7562379|FG002|Maintenance Treatment Phase|No Treatment Received|2
4667935|NCT02291289|7562380|FG003|Maintenance Treatment Phase|No Treatment Received|0
4667936|NCT02291289|7562381|FG004|Maintenance Treatment Phase|No Treatment Received|4
4667937|NCT02291289|7562382|FG005|Maintenance Treatment Phase|No Treatment Received|5
4667938|NCT02291289|7562383|FG006|Maintenance Treatment Phase|No Treatment Received|0
4667939|NCT02291289|7562384|FG007|Maintenance Treatment Phase|No Treatment Received|0
4667940|NCT02291289|7562385|FG008|Maintenance Treatment Phase|No Treatment Received|0
4667941|NCT02291289|7562386|FG009|Maintenance Treatment Phase|No Treatment Received|0
4667942|NCT02291289|7562387|FG010|Maintenance Treatment Phase|No Treatment Received|1
4667943|NCT02291289|7562388|FG011|Maintenance Treatment Phase|No Treatment Received|0
4667944|NCT02291419|7562432|FG000|Overall Study|Early study termination|1
4667945|NCT02291419|7562433|FG001|Overall Study|Early study termination|5
4667946|NCT02291432|7562439|FG000|Overall Study|Withdrawal by Subject|2
4667947|NCT02291510|7562447|FG000|Overall Study|Adverse Event|0
4667948|NCT02291510|7562448|FG001|Overall Study|Adverse Event|0
4667949|NCT02291510|7562449|FG002|Overall Study|Adverse Event|0
4667950|NCT02291510|7562450|FG003|Overall Study|Adverse Event|1
4667951|NCT02291549|7562462|FG000|Overall Study|Lost to Follow-up|1
4667952|NCT02291549|7562463|FG001|Overall Study|Lost to Follow-up|0
4667953|NCT02291549|7562462|FG000|Overall Study|Withdrawal by Subject|0
4667954|NCT02291549|7562463|FG001|Overall Study|Withdrawal by Subject|1
4667955|NCT02291601|7562471|FG000|Abdomen|Did not qualify|333
4667956|NCT02291601|7562472|FG001|Abdomen|Did not qualify|54
4667957|NCT02291601|7562473|FG002|Abdomen|Did not qualify|339
4667958|NCT02291601|7562471|FG000|Groin|Did not qualify|183
4667959|NCT02291601|7562472|FG001|Groin|Did not qualify|30
4667960|NCT02291601|7562473|FG002|Groin|Did not qualify|177
4667961|NCT02291614|7562495|FG000|Overall Study|Lost to Follow-up|0
4667962|NCT02291614|7562496|FG001|Overall Study|Lost to Follow-up|0
4667963|NCT02291614|7562497|FG002|Overall Study|Lost to Follow-up|0
4667964|NCT02291614|7562498|FG003|Overall Study|Lost to Follow-up|0
4667965|NCT02291614|7562499|FG004|Overall Study|Lost to Follow-up|0
4667966|NCT02291614|7562500|FG005|Overall Study|Lost to Follow-up|0
4667967|NCT02291614|7562501|FG006|Overall Study|Lost to Follow-up|0
4667968|NCT02291614|7562502|FG007|Overall Study|Lost to Follow-up|1
4667969|NCT02291614|7562503|FG008|Overall Study|Lost to Follow-up|0
4667970|NCT02291614|7562504|FG009|Overall Study|Lost to Follow-up|0
4667971|NCT02291614|7562505|FG010|Overall Study|Lost to Follow-up|0
4667972|NCT02291614|7562495|FG000|Overall Study|Withdrawal by Subject|0
4667973|NCT02291614|7562496|FG001|Overall Study|Withdrawal by Subject|1
4667974|NCT02291614|7562497|FG002|Overall Study|Withdrawal by Subject|0
4667975|NCT02291614|7562498|FG003|Overall Study|Withdrawal by Subject|0
4667976|NCT02291614|7562499|FG004|Overall Study|Withdrawal by Subject|0
4667977|NCT02291614|7562500|FG005|Overall Study|Withdrawal by Subject|0
4667978|NCT02291614|7562501|FG006|Overall Study|Withdrawal by Subject|0
4667979|NCT02291614|7562502|FG007|Overall Study|Withdrawal by Subject|0
4667980|NCT02291614|7562503|FG008|Overall Study|Withdrawal by Subject|0
4667981|NCT02291614|7562504|FG009|Overall Study|Withdrawal by Subject|2
4667982|NCT02291614|7562505|FG010|Overall Study|Withdrawal by Subject|2
4667983|NCT02291614|7562495|FG000|Overall Study|Decision by sponsor|0
4667984|NCT02291614|7562496|FG001|Overall Study|Decision by sponsor|0
4667985|NCT02291614|7562497|FG002|Overall Study|Decision by sponsor|0
4667986|NCT02291614|7562498|FG003|Overall Study|Decision by sponsor|1
4667987|NCT02291614|7562499|FG004|Overall Study|Decision by sponsor|0
4667988|NCT02291614|7562500|FG005|Overall Study|Decision by sponsor|0
4667989|NCT02291614|7562501|FG006|Overall Study|Decision by sponsor|0
4667990|NCT02291614|7562502|FG007|Overall Study|Decision by sponsor|0
4667991|NCT02291614|7562503|FG008|Overall Study|Decision by sponsor|0
4753750|NCT01480180|7728194|FG000|Main Phase|Withdrawal criteria|12
4753751|NCT01480180|7728195|FG001|Main Phase|Withdrawal criteria|1
4753752|NCT01480180|7728196|FG002|Main Phase|Withdrawal criteria|0
4753753|NCT01480180|7728197|FG003|Main Phase|Withdrawal criteria|0
4753754|NCT01480180|7728198|FG004|Main Phase|Withdrawal criteria|0
4753755|NCT01480180|7728199|FG005|Main Phase|Withdrawal criteria|0
4753756|NCT01480180|7728194|FG000|Main Phase|Lack of Efficacy|1
4753757|NCT01480180|7728195|FG001|Main Phase|Lack of Efficacy|0
4753758|NCT01480180|7728196|FG002|Main Phase|Lack of Efficacy|0
4753759|NCT01480180|7728197|FG003|Main Phase|Lack of Efficacy|0
4753760|NCT01480180|7728198|FG004|Main Phase|Lack of Efficacy|0
4753761|NCT01480180|7728199|FG005|Main Phase|Lack of Efficacy|0
4753762|NCT01480180|7728194|FG000|Main Phase|Non-compliance|3
4753763|NCT01480180|7728195|FG001|Main Phase|Non-compliance|0
4753764|NCT01480180|7728196|FG002|Main Phase|Non-compliance|0
4753765|NCT01480180|7728197|FG003|Main Phase|Non-compliance|0
4753766|NCT01480180|7728198|FG004|Main Phase|Non-compliance|0
4753767|NCT01480180|7728199|FG005|Main Phase|Non-compliance|0
4753768|NCT01480180|7728194|FG000|Main Phase|Unclassified|3
4753769|NCT01480180|7728195|FG001|Main Phase|Unclassified|0
4753770|NCT01480180|7728196|FG002|Main Phase|Unclassified|0
4753771|NCT01480180|7728197|FG003|Main Phase|Unclassified|0
4753772|NCT01480180|7728198|FG004|Main Phase|Unclassified|0
4753773|NCT01480180|7728199|FG005|Main Phase|Unclassified|0
4753774|NCT01480180|7728194|FG000|Extension Phase, Part 1|Withdrawal criteria|0
4753775|NCT01480180|7728195|FG001|Extension Phase, Part 1|Withdrawal criteria|0
4667992|NCT02291614|7562504|FG009|Overall Study|Decision by sponsor|0
4667993|NCT02291614|7562505|FG010|Overall Study|Decision by sponsor|0
4753776|NCT01480180|7728196|FG002|Extension Phase, Part 1|Withdrawal criteria|5
4753777|NCT01480180|7728197|FG003|Extension Phase, Part 1|Withdrawal criteria|0
4753778|NCT01480180|7728198|FG004|Extension Phase, Part 1|Withdrawal criteria|0
4753779|NCT01480180|7728199|FG005|Extension Phase, Part 1|Withdrawal criteria|0
4667994|NCT02291614|7562495|FG000|Overall Study|Death|0
4667995|NCT02291614|7562496|FG001|Overall Study|Death|0
4667996|NCT02291614|7562497|FG002|Overall Study|Death|1
4667997|NCT02291614|7562498|FG003|Overall Study|Death|0
4667998|NCT02291614|7562499|FG004|Overall Study|Death|1
4667999|NCT02291614|7562500|FG005|Overall Study|Death|1
4668000|NCT02291614|7562501|FG006|Overall Study|Death|1
4668001|NCT02291614|7562502|FG007|Overall Study|Death|0
4668002|NCT02291614|7562503|FG008|Overall Study|Death|0
4668003|NCT02291614|7562504|FG009|Overall Study|Death|0
4668004|NCT02291614|7562505|FG010|Overall Study|Death|0
4668005|NCT02291679|7562538|FG000|Overall Study|Adverse Event|2
4668006|NCT02291679|7562539|FG001|Overall Study|Adverse Event|12
4668007|NCT02291679|7562540|FG002|Overall Study|Adverse Event|19
4668008|NCT02291679|7562538|FG000|Overall Study|Protocol Violation|5
4668009|NCT02291679|7562539|FG001|Overall Study|Protocol Violation|1
4668010|NCT02291679|7562540|FG002|Overall Study|Protocol Violation|7
4668011|NCT02291679|7562538|FG000|Overall Study|Withdrew Consent|18
4668012|NCT02291679|7562539|FG001|Overall Study|Withdrew Consent|10
4668013|NCT02291679|7562540|FG002|Overall Study|Withdrew Consent|15
4668014|NCT02291679|7562538|FG000|Overall Study|Lost to Follow-up|12
4668015|NCT02291679|7562539|FG001|Overall Study|Lost to Follow-up|10
4668016|NCT02291679|7562540|FG002|Overall Study|Lost to Follow-up|9
4668017|NCT02291679|7562538|FG000|Overall Study|Insufficient Therapeutic Response|5
4668018|NCT02291679|7562539|FG001|Overall Study|Insufficient Therapeutic Response|5
4668019|NCT02291679|7562540|FG002|Overall Study|Insufficient Therapeutic Response|7
4668020|NCT02291679|7562538|FG000|Overall Study|Other|2
4668021|NCT02291679|7562539|FG001|Overall Study|Other|4
4668022|NCT02291679|7562540|FG002|Overall Study|Other|2
4668023|NCT02291861|7562564|FG000|Overall Study|Adverse Event|2
4668024|NCT02291861|7562565|FG001|Overall Study|Adverse Event|4
4668025|NCT02291861|7562566|FG002|Overall Study|Adverse Event|1
4668026|NCT02291861|7562567|FG003|Overall Study|Adverse Event|2
4668027|NCT02291861|7562564|FG000|Overall Study|Death|0
4668028|NCT02291861|7562565|FG001|Overall Study|Death|0
4668029|NCT02291861|7562566|FG002|Overall Study|Death|1
4668030|NCT02291861|7562567|FG003|Overall Study|Death|1
4668031|NCT02291861|7562564|FG000|Overall Study|Protocol Violation|1
4668032|NCT02291861|7562565|FG001|Overall Study|Protocol Violation|0
4668033|NCT02291861|7562566|FG002|Overall Study|Protocol Violation|0
4668034|NCT02291861|7562567|FG003|Overall Study|Protocol Violation|1
4668035|NCT02291861|7562564|FG000|Overall Study|Withdrawal by Subject|1
4668036|NCT02291861|7562565|FG001|Overall Study|Withdrawal by Subject|2
4668037|NCT02291861|7562566|FG002|Overall Study|Withdrawal by Subject|1
4753780|NCT01480180|7728194|FG000|Extension Phase, Part 1|Unclassified|0
4753781|NCT01480180|7728195|FG001|Extension Phase, Part 1|Unclassified|0
4753782|NCT01480180|7728196|FG002|Extension Phase, Part 1|Unclassified|1
4753783|NCT01480180|7728197|FG003|Extension Phase, Part 1|Unclassified|0
4753784|NCT01480180|7728198|FG004|Extension Phase, Part 1|Unclassified|0
4753785|NCT01480180|7728199|FG005|Extension Phase, Part 1|Unclassified|0
4753786|NCT01480180|7728194|FG000|Extension Phase, Part 1|Adverse Event|0
4753787|NCT01480180|7728195|FG001|Extension Phase, Part 1|Adverse Event|0
4753788|NCT01480180|7728196|FG002|Extension Phase, Part 1|Adverse Event|4
4753789|NCT01480180|7728197|FG003|Extension Phase, Part 1|Adverse Event|1
4753790|NCT01480180|7728198|FG004|Extension Phase, Part 1|Adverse Event|0
4753791|NCT01480180|7728199|FG005|Extension Phase, Part 1|Adverse Event|0
4753792|NCT01480180|7728194|FG000|Extension Phase, Part 1|Change of treatment|0
4753793|NCT01480180|7728195|FG001|Extension Phase, Part 1|Change of treatment|0
4668038|NCT02291861|7562567|FG003|Overall Study|Withdrawal by Subject|4
4668039|NCT02291861|7562564|FG000|Overall Study|Noncompliance|1
4668040|NCT02291861|7562565|FG001|Overall Study|Noncompliance|1
4668041|NCT02291861|7562566|FG002|Overall Study|Noncompliance|2
4668042|NCT02291861|7562567|FG003|Overall Study|Noncompliance|1
4668043|NCT02291861|7562564|FG000|Overall Study|Lost to Follow-up|2
4668044|NCT02291861|7562565|FG001|Overall Study|Lost to Follow-up|1
4668045|NCT02291861|7562566|FG002|Overall Study|Lost to Follow-up|4
4668046|NCT02291861|7562567|FG003|Overall Study|Lost to Follow-up|0
4668047|NCT02291861|7562564|FG000|Overall Study|Other|0
4668048|NCT02291861|7562565|FG001|Overall Study|Other|0
4668049|NCT02291861|7562566|FG002|Overall Study|Other|0
4668050|NCT02291861|7562567|FG003|Overall Study|Other|1
4668051|NCT02291913|7562577|FG000|Overall Study|Progressive Disease|32
4668052|NCT02291913|7562577|FG000|Overall Study|Adverse Event|11
4668053|NCT02291913|7562577|FG000|Overall Study|Death|2
4668054|NCT02291913|7562577|FG000|Overall Study|Physician Decision|1
4668055|NCT02291913|7562577|FG000|Overall Study|Withdrawal by Subject|1
4668056|NCT02291913|7562577|FG000|Overall Study|Protocol Violation|1
4668057|NCT02292212|7562594|FG000|ViE Phase|Withdrawal by Subject|1
4668058|NCT02292212|7562594|FG000|ViE Phase|Protocol Violation|2
4668059|NCT02292446|7562618|FG000|Overall Study|Adverse Event|12
4668060|NCT02292446|7562618|FG000|Overall Study|Death|1
4668061|NCT02292446|7562618|FG000|Overall Study|Disease progression|2
4668062|NCT02292446|7562618|FG000|Overall Study|Subject/guardian decision|2
4668063|NCT02292446|7562618|FG000|Overall Study|Withdrawal by Subject|3
4668064|NCT02292719|7562640|FG000|Overall Study|Withdrawal by Subject|0
4668065|NCT02292719|7562641|FG001|Overall Study|Withdrawal by Subject|0
4668066|NCT02292719|7562642|FG002|Overall Study|Withdrawal by Subject|0
4668067|NCT02292719|7562643|FG003|Overall Study|Withdrawal by Subject|1
4668068|NCT02292719|7562644|FG004|Overall Study|Withdrawal by Subject|1
4668069|NCT02292719|7562645|FG005|Overall Study|Withdrawal by Subject|0
4668070|NCT02292719|7562640|FG000|Overall Study|Subject enrolled in new study.|0
4668071|NCT02292719|7562641|FG001|Overall Study|Subject enrolled in new study.|0
4668072|NCT02292719|7562642|FG002|Overall Study|Subject enrolled in new study.|1
4668073|NCT02292719|7562643|FG003|Overall Study|Subject enrolled in new study.|0
4668074|NCT02292719|7562644|FG004|Overall Study|Subject enrolled in new study.|0
4668075|NCT02292719|7562645|FG005|Overall Study|Subject enrolled in new study.|0
4668076|NCT02292771|7562661|FG000|Overall Study|Withdrawal by Subject|2
4668077|NCT02292771|7562662|FG001|Overall Study|Withdrawal by Subject|1
4668078|NCT02292771|7562661|FG000|Overall Study|Lost to Follow-up|2
4668079|NCT02292771|7562662|FG001|Overall Study|Lost to Follow-up|1
4668080|NCT02292784|7562675|FG000|Overall Study|Lost to Follow-up|1
4668081|NCT02292784|7562676|FG001|Overall Study|Lost to Follow-up|17
4668082|NCT02292784|7562677|FG002|Overall Study|Lost to Follow-up|18
4668083|NCT02292784|7562675|FG000|Overall Study|Withdrawal by Subject|0
4668084|NCT02292784|7562676|FG001|Overall Study|Withdrawal by Subject|3
4668085|NCT02292784|7562677|FG002|Overall Study|Withdrawal by Subject|3
4668086|NCT02292849|7562688|FG000|Overall Study|Lost to Follow-up|0
4668087|NCT02292849|7562689|FG001|Overall Study|Lost to Follow-up|2
4668088|NCT02292849|7562690|FG002|Overall Study|Lost to Follow-up|2
4668089|NCT02292849|7562688|FG000|Overall Study|Physician Decision|4
4668090|NCT02292849|7562689|FG001|Overall Study|Physician Decision|0
4668091|NCT02292849|7562690|FG002|Overall Study|Physician Decision|0
4668092|NCT02292927|7562700|FG000|Overall Study|Protocol Violation|13
4668093|NCT02292927|7562701|FG001|Overall Study|Protocol Violation|7
4668094|NCT02293395|7562730|FG000|Overall Study|Lost to Follow-up|1
4668095|NCT02293395|7562731|FG001|Overall Study|Lost to Follow-up|0
4668096|NCT02293395|7562730|FG000|Overall Study|Withdrawal by Subject|8
4668097|NCT02293395|7562731|FG001|Overall Study|Withdrawal by Subject|7
4668098|NCT02293460|7562737|FG000|Overall Study|Protocol Violation|1
4668099|NCT02293460|7562737|FG000|Overall Study|Lack of Efficacy|2
4668100|NCT02293460|7562737|FG000|Overall Study|Adverse Event|2
4668101|NCT02293460|7562737|FG000|Overall Study|Withdrawal by Subject|1
4668102|NCT02293499|7562744|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0
4668103|NCT02293499|7562745|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0
4668104|NCT02293499|7562746|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10
4668105|NCT02293499|7562744|FG000|Intervention - Camp|Withdrawal by Subject|3
4668106|NCT02293499|7562745|FG001|Intervention - Camp|Withdrawal by Subject|6
4668107|NCT02293499|7562746|FG002|Intervention - Camp|Withdrawal by Subject|2
4668108|NCT02293499|7562744|FG000|Intervention - Camp|these are those not showing up at camp|24
4668109|NCT02293499|7562745|FG001|Intervention - Camp|these are those not showing up at camp|28
4668110|NCT02293499|7562746|FG002|Intervention - Camp|these are those not showing up at camp|4
4668111|NCT02293499|7562744|FG000|3 Month Follow Up|Withdrawal by Subject|1
4668112|NCT02293499|7562745|FG001|3 Month Follow Up|Withdrawal by Subject|0
4668113|NCT02293499|7562746|FG002|3 Month Follow Up|Withdrawal by Subject|4
4753794|NCT01480180|7728196|FG002|Extension Phase, Part 1|Change of treatment|0
4753795|NCT01480180|7728197|FG003|Extension Phase, Part 1|Change of treatment|9
4753796|NCT01480180|7728198|FG004|Extension Phase, Part 1|Change of treatment|0
4753797|NCT01480180|7728199|FG005|Extension Phase, Part 1|Change of treatment|0
4753798|NCT01480180|7728194|FG000|Extension Phase, Part 2|Withdrawal criteria|0
4753799|NCT01480180|7728195|FG001|Extension Phase, Part 2|Withdrawal criteria|0
4753800|NCT01480180|7728196|FG002|Extension Phase, Part 2|Withdrawal criteria|10
4753801|NCT01480180|7728197|FG003|Extension Phase, Part 2|Withdrawal criteria|6
4753802|NCT01480180|7728198|FG004|Extension Phase, Part 2|Withdrawal criteria|1
4753803|NCT01480180|7728199|FG005|Extension Phase, Part 2|Withdrawal criteria|0
4753804|NCT01480180|7728194|FG000|Extension Phase, Part 2|Lack of Efficacy|0
4753805|NCT01480180|7728195|FG001|Extension Phase, Part 2|Lack of Efficacy|0
4668114|NCT02293499|7562744|FG000|3 Month Follow Up|Lost to Follow-up|14
4668115|NCT02293499|7562745|FG001|3 Month Follow Up|Lost to Follow-up|15
4668116|NCT02293499|7562746|FG002|3 Month Follow Up|Lost to Follow-up|6
4668117|NCT02293499|7562744|FG000|6 Month Follow Up|Lost to Follow-up|17
4668118|NCT02293499|7562745|FG001|6 Month Follow Up|Lost to Follow-up|27
4668119|NCT02293499|7562746|FG002|6 Month Follow Up|Lost to Follow-up|6
4668120|NCT02293499|7562744|FG000|6 Month Follow Up|Withdrawal by Subject|0
4668121|NCT02293499|7562745|FG001|6 Month Follow Up|Withdrawal by Subject|0
4668122|NCT02293499|7562746|FG002|6 Month Follow Up|Withdrawal by Subject|1
4668123|NCT02293499|7562744|FG000|9 Month Follow Up|Withdrawal by Subject|2
4668124|NCT02293499|7562745|FG001|9 Month Follow Up|Withdrawal by Subject|0
4668125|NCT02293499|7562746|FG002|9 Month Follow Up|Withdrawal by Subject|0
4668126|NCT02293499|7562744|FG000|9 Month Follow Up|Lost to Follow-up|24
4668127|NCT02293499|7562745|FG001|9 Month Follow Up|Lost to Follow-up|28
4668128|NCT02293499|7562746|FG002|9 Month Follow Up|Lost to Follow-up|4
4668129|NCT02293499|7562744|FG000|12 Month Follow Up|Lost to Follow-up|26
4668130|NCT02293499|7562745|FG001|12 Month Follow Up|Lost to Follow-up|25
4668131|NCT02293499|7562746|FG002|12 Month Follow Up|Lost to Follow-up|6
4668132|NCT02293499|7562744|FG000|12 Month Follow Up|Withdrawal by Subject|0
4668133|NCT02293499|7562745|FG001|12 Month Follow Up|Withdrawal by Subject|1
4668134|NCT02293499|7562746|FG002|12 Month Follow Up|Withdrawal by Subject|0
4668135|NCT02293499|7562744|FG000|15 Month Follow Up|Lost to Follow-up|22
4668136|NCT02293499|7562745|FG001|15 Month Follow Up|Lost to Follow-up|22
4668137|NCT02293499|7562746|FG002|15 Month Follow Up|Lost to Follow-up|7
4668138|NCT02293538|7562774|FG000|Overall Study|Adverse Event|0
4668139|NCT02293538|7562775|FG001|Overall Study|Adverse Event|1
4668140|NCT02293538|7562774|FG000|Overall Study|Lost to Follow-up|1
4668141|NCT02293538|7562775|FG001|Overall Study|Lost to Follow-up|0
4668142|NCT02293538|7562774|FG000|Overall Study|Withdrawal by Subject|0
4668143|NCT02293538|7562775|FG001|Overall Study|Withdrawal by Subject|1
4668144|NCT02293837|7562790|FG000|Overall Study|Lost to Follow-up|0
4668145|NCT02293837|7562791|FG001|Overall Study|Lost to Follow-up|2
4668146|NCT02293837|7562792|FG002|Overall Study|Lost to Follow-up|1
4753806|NCT01480180|7728196|FG002|Extension Phase, Part 2|Lack of Efficacy|4
4753807|NCT01480180|7728197|FG003|Extension Phase, Part 2|Lack of Efficacy|0
4753808|NCT01480180|7728198|FG004|Extension Phase, Part 2|Lack of Efficacy|0
4753809|NCT01480180|7728199|FG005|Extension Phase, Part 2|Lack of Efficacy|0
4753810|NCT01480180|7728194|FG000|Extension Phase, Part 2|Unclassified|0
4753811|NCT01480180|7728195|FG001|Extension Phase, Part 2|Unclassified|0
4753812|NCT01480180|7728196|FG002|Extension Phase, Part 2|Unclassified|3
4753813|NCT01480180|7728197|FG003|Extension Phase, Part 2|Unclassified|1
4753814|NCT01480180|7728198|FG004|Extension Phase, Part 2|Unclassified|1
4753815|NCT01480180|7728199|FG005|Extension Phase, Part 2|Unclassified|0
4668147|NCT02293837|7562793|FG003|Overall Study|Lost to Follow-up|0
4668148|NCT02293837|7562790|FG000|Overall Study|Withdrawal by Subject|2
4668149|NCT02293837|7562791|FG001|Overall Study|Withdrawal by Subject|1
4668150|NCT02293837|7562792|FG002|Overall Study|Withdrawal by Subject|2
4668151|NCT02293837|7562793|FG003|Overall Study|Withdrawal by Subject|1
4668152|NCT02293837|7562790|FG000|Overall Study|COVID-19 Related|1
4753816|NCT01545050|7728235|FG000|Overall Study|Lack of Efficacy|0
4753817|NCT01545050|7728236|FG001|Overall Study|Lack of Efficacy|0
4753818|NCT01545050|7728237|FG002|Overall Study|Lack of Efficacy|0
4753819|NCT01545050|7728238|FG003|Overall Study|Lack of Efficacy|3
4753820|NCT01545050|7728239|FG004|Overall Study|Lack of Efficacy|2
4753821|NCT01545050|7728235|FG000|Overall Study|Adverse Event|1
4753822|NCT01545050|7728236|FG001|Overall Study|Adverse Event|1
4753823|NCT01545050|7728237|FG002|Overall Study|Adverse Event|2
4753824|NCT01545050|7728238|FG003|Overall Study|Adverse Event|2
4753825|NCT01545050|7728239|FG004|Overall Study|Adverse Event|0
4753826|NCT01545050|7728235|FG000|Overall Study|Discontinued study treatment|1
4753827|NCT01545050|7728236|FG001|Overall Study|Discontinued study treatment|0
4753828|NCT01545050|7728237|FG002|Overall Study|Discontinued study treatment|0
4753829|NCT01545050|7728238|FG003|Overall Study|Discontinued study treatment|0
4753830|NCT01545050|7728239|FG004|Overall Study|Discontinued study treatment|0
4753831|NCT01545050|7728235|FG000|Overall Study|Withdrawal by Subject|1
4753832|NCT01545050|7728236|FG001|Overall Study|Withdrawal by Subject|0
4753833|NCT01545050|7728237|FG002|Overall Study|Withdrawal by Subject|0
4753834|NCT01545050|7728238|FG003|Overall Study|Withdrawal by Subject|2
4753835|NCT01545050|7728239|FG004|Overall Study|Withdrawal by Subject|1
4753836|NCT01545050|7728235|FG000|Overall Study|Participant no longer meets study criteria|0
4753837|NCT01545050|7728236|FG001|Overall Study|Participant no longer meets study criteria|2
4753838|NCT01545050|7728237|FG002|Overall Study|Participant no longer meets study criteria|0
4753839|NCT01545050|7728238|FG003|Overall Study|Participant no longer meets study criteria|0
4668153|NCT02293837|7562791|FG001|Overall Study|COVID-19 Related|1
4668154|NCT02293837|7562792|FG002|Overall Study|COVID-19 Related|0
4668155|NCT02293837|7562793|FG003|Overall Study|COVID-19 Related|0
4668156|NCT02293837|7562790|FG000|Overall Study|Participant ill and could not be infused|0
4668157|NCT02293837|7562791|FG001|Overall Study|Participant ill and could not be infused|0
4668158|NCT02293837|7562792|FG002|Overall Study|Participant ill and could not be infused|1
4668159|NCT02293837|7562793|FG003|Overall Study|Participant ill and could not be infused|0
4668160|NCT02293863|7562810|FG000|Overall Study|Death|4
4668161|NCT02293863|7562811|FG001|Overall Study|Death|6
4668162|NCT02293863|7562812|FG002|Overall Study|Death|4
4668163|NCT02293863|7562810|FG000|Overall Study|Lost to Follow-up|2
4668164|NCT02293863|7562811|FG001|Overall Study|Lost to Follow-up|2
4668165|NCT02293863|7562812|FG002|Overall Study|Lost to Follow-up|2
4668166|NCT02293863|7562810|FG000|Overall Study|Withdrawal by Subject|3
4668167|NCT02293863|7562811|FG001|Overall Study|Withdrawal by Subject|3
4668168|NCT02293863|7562812|FG002|Overall Study|Withdrawal by Subject|1
4668169|NCT02293863|7562810|FG000|Overall Study|Reason Not Specified|0
4668170|NCT02293863|7562811|FG001|Overall Study|Reason Not Specified|2
4753840|NCT01545050|7728239|FG004|Overall Study|Participant no longer meets study criteria|1
4753841|NCT01545050|7728235|FG000|Overall Study|Administrative reason by sponsor|4
4753842|NCT01545050|7728236|FG001|Overall Study|Administrative reason by sponsor|2
4668171|NCT02293863|7562812|FG002|Overall Study|Reason Not Specified|2
4668172|NCT02293902|7562825|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5
4668173|NCT02293902|7562826|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6
4668174|NCT02293902|7562827|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8
4668175|NCT02293902|7562828|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0
4668176|NCT02293902|7562829|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0
4668177|NCT02293902|7562825|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5
4668178|NCT02293902|7562826|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1
4668179|NCT02293902|7562827|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2
4668180|NCT02293902|7562828|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0
4668181|NCT02293902|7562829|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0
4668182|NCT02293902|7562825|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1
4668183|NCT02293902|7562826|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
4668184|NCT02293902|7562827|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
4668185|NCT02293902|7562828|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
4668186|NCT02293902|7562829|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
4668187|NCT02293902|7562825|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0
4668188|NCT02293902|7562826|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7
4668189|NCT02293902|7562827|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1
4668190|NCT02293902|7562828|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1
4668191|NCT02293902|7562829|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6
4668192|NCT02293902|7562825|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
4668193|NCT02293902|7562826|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1
4668194|NCT02293902|7562827|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1
4668195|NCT02293902|7562828|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
4668196|NCT02293902|7562829|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
4668197|NCT02293993|7562851|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1
4668198|NCT02293993|7562852|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0
4668199|NCT02293993|7562853|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0
4668200|NCT02293993|7562854|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1
4668201|NCT02293993|7562851|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0
4668202|NCT02293993|7562852|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2
4668203|NCT02293993|7562853|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1
4668204|NCT02293993|7562854|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0
4668205|NCT02293993|7562851|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0
4668206|NCT02293993|7562852|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0
4668207|NCT02293993|7562853|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1
4753843|NCT01545050|7728237|FG002|Overall Study|Administrative reason by sponsor|3
4753844|NCT01545050|7728238|FG003|Overall Study|Administrative reason by sponsor|5
4753845|NCT01545050|7728239|FG004|Overall Study|Administrative reason by sponsor|5
4668208|NCT02293993|7562854|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0
4668209|NCT02293993|7562851|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2
4668210|NCT02293993|7562852|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2
4668211|NCT02293993|7562853|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3
4668212|NCT02293993|7562854|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1
4668213|NCT02293993|7562851|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0
4668214|NCT02293993|7562852|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1
4668215|NCT02293993|7562853|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0
4668216|NCT02293993|7562854|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0
4668217|NCT02294019|7562872|FG000|Overall Study|Adverse Event|2
4668218|NCT02294019|7562872|FG000|Overall Study|Protocol Violation|68
4668219|NCT02294019|7562872|FG000|Overall Study|Lost to Follow-up|31
4668220|NCT02294019|7562872|FG000|Overall Study|Other|1
4668221|NCT02294019|7562872|FG000|Overall Study|Withdrawal by Subject|1
4668222|NCT02294058|7562879|FG000|Overall Study|Adverse Event|16
4668223|NCT02294058|7562880|FG001|Overall Study|Adverse Event|7
4668224|NCT02294058|7562881|FG002|Overall Study|Adverse Event|13
4668225|NCT02294058|7562879|FG000|Overall Study|Lack of Efficacy|3
4668226|NCT02294058|7562880|FG001|Overall Study|Lack of Efficacy|3
4668227|NCT02294058|7562881|FG002|Overall Study|Lack of Efficacy|0
4668228|NCT02294058|7562879|FG000|Overall Study|Lost to Follow-up|1
4668229|NCT02294058|7562880|FG001|Overall Study|Lost to Follow-up|0
4668230|NCT02294058|7562881|FG002|Overall Study|Lost to Follow-up|2
4668231|NCT02294058|7562879|FG000|Overall Study|Withdrawal by Subject|10
4668232|NCT02294058|7562880|FG001|Overall Study|Withdrawal by Subject|14
4668233|NCT02294058|7562881|FG002|Overall Study|Withdrawal by Subject|13
4668234|NCT02294058|7562879|FG000|Overall Study|Physician Decision|2
4668235|NCT02294058|7562880|FG001|Overall Study|Physician Decision|1
4668236|NCT02294058|7562881|FG002|Overall Study|Physician Decision|0
4668237|NCT02294058|7562879|FG000|Overall Study|Miscellaneous|4
4668238|NCT02294058|7562880|FG001|Overall Study|Miscellaneous|1
4668239|NCT02294058|7562881|FG002|Overall Study|Miscellaneous|1
4668240|NCT02294175|7562892|FG000|Overall Study|Withdrawal by Subject|1
4668241|NCT02294175|7562893|FG001|Overall Study|Withdrawal by Subject|2
4668242|NCT02294175|7562892|FG000|Overall Study|pt taking excluded medication|3
4668243|NCT02294175|7562893|FG001|Overall Study|pt taking excluded medication|1
4668244|NCT02294175|7562892|FG000|Overall Study|Protocol Violation|1
4668245|NCT02294175|7562893|FG001|Overall Study|Protocol Violation|0
4668246|NCT02294175|7562892|FG000|Overall Study|Lost to Follow-up|0
4668247|NCT02294175|7562893|FG001|Overall Study|Lost to Follow-up|1
4753846|NCT01555021|7728266|FG000|Overall Study|Lost to Follow-up|1
4753847|NCT01555021|7728267|FG001|Overall Study|Lost to Follow-up|2
4753848|NCT01561430|7728283|FG000|Overall Study|Adverse Event|0
4753849|NCT01561430|7728284|FG001|Overall Study|Adverse Event|0
4753850|NCT01561430|7728285|FG002|Overall Study|Adverse Event|3
4753851|NCT01561430|7728286|FG003|Overall Study|Adverse Event|1
4753852|NCT01561430|7728283|FG000|Overall Study|Withdrawal by Subject|0
4753853|NCT01561430|7728284|FG001|Overall Study|Withdrawal by Subject|0
4753854|NCT01561430|7728285|FG002|Overall Study|Withdrawal by Subject|1
4753855|NCT01561430|7728286|FG003|Overall Study|Withdrawal by Subject|0
4753856|NCT01561430|7728283|FG000|Overall Study|Physician Decision|0
4753857|NCT01561430|7728284|FG001|Overall Study|Physician Decision|1
4753858|NCT01561430|7728285|FG002|Overall Study|Physician Decision|0
4753859|NCT01561430|7728286|FG003|Overall Study|Physician Decision|0
4753860|NCT01561430|7728283|FG000|Overall Study|Sponsor Decision|1
4753861|NCT01561430|7728284|FG001|Overall Study|Sponsor Decision|14
4753862|NCT01561430|7728285|FG002|Overall Study|Sponsor Decision|13
4753863|NCT01561430|7728286|FG003|Overall Study|Sponsor Decision|12
4753864|NCT01595009|7728306|FG000|Core|Patients completed per protocol|85
4753865|NCT01595009|7728307|FG001|Core|Patients completed per protocol|44
4753866|NCT01595009|7728308|FG002|Core|Patients completed per protocol|0
4753867|NCT01595009|7728309|FG003|Core|Patients completed per protocol|0
4753868|NCT01595009|7728306|FG000|Core|Adverse Event|19
4753869|NCT01595009|7728307|FG001|Core|Adverse Event|23
4753870|NCT01595009|7728308|FG002|Core|Adverse Event|0
4753871|NCT01595009|7728309|FG003|Core|Adverse Event|0
4753872|NCT01595009|7728306|FG000|Core|Disease progression|14
4753873|NCT01595009|7728307|FG001|Core|Disease progression|26
4753874|NCT01595009|7728308|FG002|Core|Disease progression|0
4753875|NCT01595009|7728309|FG003|Core|Disease progression|0
4753876|NCT01595009|7728306|FG000|Core|Withdrawal by Subject|4
4753877|NCT01595009|7728307|FG001|Core|Withdrawal by Subject|17
4753878|NCT01595009|7728308|FG002|Core|Withdrawal by Subject|0
4753879|NCT01595009|7728309|FG003|Core|Withdrawal by Subject|0
4753880|NCT01595009|7728306|FG000|Core|Death|3
4753881|NCT01595009|7728307|FG001|Core|Death|6
4753882|NCT01595009|7728308|FG002|Core|Death|0
4753883|NCT01595009|7728309|FG003|Core|Death|0
4753884|NCT01595009|7728306|FG000|Core|Lost to Follow-up|1
4753885|NCT01595009|7728307|FG001|Core|Lost to Follow-up|2
4753886|NCT01595009|7728308|FG002|Core|Lost to Follow-up|0
4668248|NCT02294175|7562892|FG000|Overall Study|wound healed|0
4668249|NCT02294175|7562893|FG001|Overall Study|wound healed|2
4668250|NCT02294227|7562902|FG000|Overall Study|Death|0
4668251|NCT02294227|7562903|FG001|Overall Study|Death|0
4668252|NCT02294227|7562904|FG002|Overall Study|Death|1
4668253|NCT02294227|7562902|FG000|Overall Study|Subject/Guardian Decision|6
4668254|NCT02294227|7562903|FG001|Overall Study|Subject/Guardian Decision|3
4668255|NCT02294227|7562904|FG002|Overall Study|Subject/Guardian Decision|7
4668256|NCT02294227|7562902|FG000|Overall Study|Physician Decision|1
4668257|NCT02294227|7562903|FG001|Overall Study|Physician Decision|2
4668258|NCT02294227|7562904|FG002|Overall Study|Physician Decision|1
4668259|NCT02294227|7562902|FG000|Overall Study|Lost to Follow-up|1
4668260|NCT02294227|7562903|FG001|Overall Study|Lost to Follow-up|0
4668261|NCT02294227|7562904|FG002|Overall Study|Lost to Follow-up|0
4668262|NCT02294227|7562902|FG000|Overall Study|Lack of Efficacy|11
4668263|NCT02294227|7562903|FG001|Overall Study|Lack of Efficacy|12
4668264|NCT02294227|7562904|FG002|Overall Study|Lack of Efficacy|8
4668265|NCT02294227|7562902|FG000|Overall Study|Adverse Event|6
4668266|NCT02294227|7562903|FG001|Overall Study|Adverse Event|8
4668267|NCT02294227|7562904|FG002|Overall Study|Adverse Event|2
4668268|NCT02294318|7562920|FG000|Overall Study|Worsening of drinking|3
4668269|NCT02294318|7562921|FG001|Overall Study|Worsening of drinking|0
4668270|NCT02294318|7562920|FG000|Overall Study|Not exposed to intervention|0
4668271|NCT02294318|7562921|FG001|Overall Study|Not exposed to intervention|2
4668272|NCT02294396|7562931|FG000|Overall Study|Adverse Event|26
4668273|NCT02294396|7562932|FG001|Overall Study|Adverse Event|25
4668274|NCT02294396|7562933|FG002|Overall Study|Adverse Event|21
4668275|NCT02294396|7562934|FG003|Overall Study|Adverse Event|24
4668276|NCT02294396|7562931|FG000|Overall Study|Electrocardiogram adviser's judgment|1
4668277|NCT02294396|7562932|FG001|Overall Study|Electrocardiogram adviser's judgment|0
4668278|NCT02294396|7562933|FG002|Overall Study|Electrocardiogram adviser's judgment|0
4668279|NCT02294396|7562934|FG003|Overall Study|Electrocardiogram adviser's judgment|1
4668280|NCT02294396|7562931|FG000|Overall Study|Withdrawal by Subject|8
4668281|NCT02294396|7562932|FG001|Overall Study|Withdrawal by Subject|6
4668282|NCT02294396|7562933|FG002|Overall Study|Withdrawal by Subject|6
4668283|NCT02294396|7562934|FG003|Overall Study|Withdrawal by Subject|8
4668284|NCT02294396|7562931|FG000|Overall Study|Lost to Follow-up|0
4668285|NCT02294396|7562932|FG001|Overall Study|Lost to Follow-up|0
4668286|NCT02294396|7562933|FG002|Overall Study|Lost to Follow-up|1
4668287|NCT02294396|7562934|FG003|Overall Study|Lost to Follow-up|1
4668288|NCT02294396|7562931|FG000|Overall Study|Protocol Deviation|3
4668289|NCT02294396|7562932|FG001|Overall Study|Protocol Deviation|2
4668290|NCT02294396|7562933|FG002|Overall Study|Protocol Deviation|2
4668291|NCT02294396|7562934|FG003|Overall Study|Protocol Deviation|1
4668292|NCT02294396|7562931|FG000|Overall Study|Miscellaneous|2
4668293|NCT02294396|7562932|FG001|Overall Study|Miscellaneous|0
4668294|NCT02294396|7562933|FG002|Overall Study|Miscellaneous|5
4668295|NCT02294396|7562934|FG003|Overall Study|Miscellaneous|2
4668296|NCT02294474|7562946|FG000|Overall Study|Adverse Event|7
4668297|NCT02294474|7562947|FG001|Overall Study|Adverse Event|7
4668298|NCT02294474|7562946|FG000|Overall Study|Lack of Efficacy|2
4668299|NCT02294474|7562947|FG001|Overall Study|Lack of Efficacy|1
4668300|NCT02294474|7562946|FG000|Overall Study|Protocol Violation|4
4668301|NCT02294474|7562947|FG001|Overall Study|Protocol Violation|2
4668302|NCT02294474|7562946|FG000|Overall Study|Other than specified above|12
4668303|NCT02294474|7562947|FG001|Overall Study|Other than specified above|12
4668304|NCT02294604|7562957|FG000|Overall Study|Did not provide samples for culture|0
4668305|NCT02294604|7562958|FG001|Overall Study|Did not provide samples for culture|1
4668306|NCT02294604|7562959|FG002|Overall Study|Did not provide samples for culture|0
4668307|NCT02294604|7562957|FG000|Overall Study|Culture contamination|1
4668308|NCT02294604|7562958|FG001|Overall Study|Culture contamination|2
4668309|NCT02294604|7562959|FG002|Overall Study|Culture contamination|0
4668310|NCT02294682|7562986|FG000|Overall Study|Could not swallow pills|1
4668311|NCT02294682|7562987|FG001|Overall Study|Could not swallow pills|0
4668312|NCT02294734|7562995|FG000|Overall Study|Adverse Event|5
4668313|NCT02294734|7562996|FG001|Overall Study|Adverse Event|5
4668314|NCT02294734|7562995|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1
4668315|NCT02294734|7562996|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0
4668316|NCT02294734|7562995|FG000|Overall Study|Lost to Follow-up|2
4668317|NCT02294734|7562996|FG001|Overall Study|Lost to Follow-up|0
4668318|NCT02294734|7562995|FG000|Overall Study|Physician Decision|2
4668319|NCT02294734|7562996|FG001|Overall Study|Physician Decision|1
4668320|NCT02294734|7562995|FG000|Overall Study|Withdrawal by Subject|4
4753887|NCT01595009|7728309|FG003|Core|Lost to Follow-up|0
4668321|NCT02294734|7562996|FG001|Overall Study|Withdrawal by Subject|2
4668322|NCT02294773|7563006|FG000|Overall Study|Withdrawal by Subject|0
4668323|NCT02294773|7563007|FG001|Overall Study|Withdrawal by Subject|2
4668324|NCT02294786|7563015|FG000|Overall Study|Withdrawal by Subject|0
4668325|NCT02294786|7563016|FG001|Overall Study|Withdrawal by Subject|1
4668326|NCT02294786|7563015|FG000|Overall Study|Physician Decision|6
4668327|NCT02294786|7563016|FG001|Overall Study|Physician Decision|7
4668328|NCT02294786|7563015|FG000|Overall Study|Lost to Follow-up|1
4668329|NCT02294786|7563016|FG001|Overall Study|Lost to Follow-up|2
4668330|NCT02294786|7563015|FG000|Overall Study|Protocol Violation|1
4668331|NCT02294786|7563016|FG001|Overall Study|Protocol Violation|0
4668332|NCT02294786|7563015|FG000|Overall Study|Adverse Event|1
4668333|NCT02294786|7563016|FG001|Overall Study|Adverse Event|1
4668334|NCT02294786|7563015|FG000|Overall Study|Death|2
4668335|NCT02294786|7563016|FG001|Overall Study|Death|3
4668336|NCT02295020|7563025|FG000|Overall Study|Adverse Event|0
4668337|NCT02295020|7563026|FG001|Overall Study|Adverse Event|1
4668338|NCT02295020|7563025|FG000|Overall Study|Withdrawal by Subject|3
4668339|NCT02295020|7563026|FG001|Overall Study|Withdrawal by Subject|2
4668340|NCT02295280|7563040|FG000|Overall Study|Adverse Event|0
4668341|NCT02295280|7563041|FG001|Overall Study|Adverse Event|1
4668342|NCT02295644|7563068|FG000|Overall Study|Did not meet inclusion criterion|0
4668343|NCT02295644|7563069|FG001|Overall Study|Did not meet inclusion criterion|0
4668344|NCT02295644|7563070|FG002|Overall Study|Did not meet inclusion criterion|1
4668345|NCT02295644|7563071|FG003|Overall Study|Did not meet inclusion criterion|2
4668346|NCT02295774|7563090|FG000|Overall Study|Physician Decision|1
4668347|NCT02295774|7563090|FG000|Overall Study|Withdrawal by Subject|2
4668348|NCT02295995|7563097|FG000|Overall Study|Lost to Follow-up|5
4668349|NCT02295995|7563098|FG001|Overall Study|Lost to Follow-up|1
4668350|NCT02296112|7563114|FG000|Overall Study|Disease progression|7
4668351|NCT02296112|7563114|FG000|Overall Study|Toxicity|1
4668352|NCT02296112|7563114|FG000|Overall Study|Began an alternate therapy|1
4668353|NCT02296138|7563125|FG000|Overall Study|Adverse Event|348
4668354|NCT02296138|7563126|FG001|Overall Study|Adverse Event|259
4668355|NCT02296138|7563125|FG000|Overall Study|Lack of Efficacy|59
4668356|NCT02296138|7563126|FG001|Overall Study|Lack of Efficacy|37
4668357|NCT02296138|7563125|FG000|Overall Study|Protocol Violation|35
4668358|NCT02296138|7563126|FG001|Overall Study|Protocol Violation|36
4668359|NCT02296138|7563125|FG000|Overall Study|Lost to Follow-up|9
4668360|NCT02296138|7563126|FG001|Overall Study|Lost to Follow-up|12
4668361|NCT02296138|7563125|FG000|Overall Study|Withdrawal by Subject|184
4668362|NCT02296138|7563126|FG001|Overall Study|Withdrawal by Subject|131
4668363|NCT02296138|7563125|FG000|Overall Study|Not Treated|1
4668364|NCT02296138|7563126|FG001|Overall Study|Not Treated|1
4668365|NCT02296138|7563125|FG000|Overall Study|Patients with data irregularities|10
4668366|NCT02296138|7563126|FG001|Overall Study|Patients with data irregularities|11
4668367|NCT02296138|7563125|FG000|Overall Study|Other than specified|15
4668368|NCT02296138|7563126|FG001|Overall Study|Other than specified|13
4668369|NCT02296190|7563142|FG000|Overall Study|Lost to Follow-up|0
4668370|NCT02296190|7563143|FG001|Overall Study|Lost to Follow-up|0
4668371|NCT02296190|7563144|FG002|Overall Study|Lost to Follow-up|0
4668372|NCT02296190|7563145|FG003|Overall Study|Lost to Follow-up|0
4668373|NCT02296190|7563146|FG004|Overall Study|Lost to Follow-up|1
4668374|NCT02296190|7563147|FG005|Overall Study|Lost to Follow-up|0
4668375|NCT02296190|7563142|FG000|Overall Study|Failure to induce PSVT|6
4668376|NCT02296190|7563143|FG001|Overall Study|Failure to induce PSVT|10
4668377|NCT02296190|7563144|FG002|Overall Study|Failure to induce PSVT|5
4668378|NCT02296190|7563145|FG003|Overall Study|Failure to induce PSVT|13
4668379|NCT02296190|7563146|FG004|Overall Study|Failure to induce PSVT|8
4668380|NCT02296190|7563147|FG005|Overall Study|Failure to induce PSVT|0
4668381|NCT02296190|7563142|FG000|Overall Study|Physician Decision|1
4668382|NCT02296190|7563143|FG001|Overall Study|Physician Decision|1
4668383|NCT02296190|7563144|FG002|Overall Study|Physician Decision|0
4668384|NCT02296190|7563145|FG003|Overall Study|Physician Decision|1
4668385|NCT02296190|7563146|FG004|Overall Study|Physician Decision|2
4668386|NCT02296190|7563147|FG005|Overall Study|Physician Decision|0
4668387|NCT02296190|7563142|FG000|Overall Study|Withdrawal by Subject|0
4668388|NCT02296190|7563143|FG001|Overall Study|Withdrawal by Subject|1
4668389|NCT02296190|7563144|FG002|Overall Study|Withdrawal by Subject|0
4668390|NCT02296190|7563145|FG003|Overall Study|Withdrawal by Subject|0
4668391|NCT02296190|7563146|FG004|Overall Study|Withdrawal by Subject|0
4668392|NCT02296190|7563147|FG005|Overall Study|Withdrawal by Subject|0
4668393|NCT02296190|7563142|FG000|Overall Study|PSVT < 5 minutes|5
4668394|NCT02296190|7563143|FG001|Overall Study|PSVT < 5 minutes|6
4668395|NCT02296190|7563144|FG002|Overall Study|PSVT < 5 minutes|6
4668396|NCT02296190|7563145|FG003|Overall Study|PSVT < 5 minutes|6
4668397|NCT02296190|7563146|FG004|Overall Study|PSVT < 5 minutes|5
4668398|NCT02296190|7563147|FG005|Overall Study|PSVT < 5 minutes|0
4668399|NCT02296190|7563142|FG000|Overall Study|Patient was given Propofol|0
4668400|NCT02296190|7563143|FG001|Overall Study|Patient was given Propofol|1
4668401|NCT02296190|7563144|FG002|Overall Study|Patient was given Propofol|0
4668402|NCT02296190|7563145|FG003|Overall Study|Patient was given Propofol|1
4668403|NCT02296190|7563146|FG004|Overall Study|Patient was given Propofol|0
4668404|NCT02296190|7563147|FG005|Overall Study|Patient was given Propofol|0
4668405|NCT02296190|7563142|FG000|Overall Study|Patient with Atrial Tachycardia|0
4668406|NCT02296190|7563143|FG001|Overall Study|Patient with Atrial Tachycardia|0
4668407|NCT02296190|7563144|FG002|Overall Study|Patient with Atrial Tachycardia|0
4668408|NCT02296190|7563145|FG003|Overall Study|Patient with Atrial Tachycardia|1
4668409|NCT02296190|7563146|FG004|Overall Study|Patient with Atrial Tachycardia|0
4668410|NCT02296190|7563147|FG005|Overall Study|Patient with Atrial Tachycardia|0
4668411|NCT02296190|7563142|FG000|Overall Study|Blood pressure <100 after sedation|0
4668412|NCT02296190|7563143|FG001|Overall Study|Blood pressure <100 after sedation|0
4668413|NCT02296190|7563144|FG002|Overall Study|Blood pressure <100 after sedation|0
4753888|NCT01595009|7728306|FG000|Core|Protocol deviation|0
4668414|NCT02296190|7563145|FG003|Overall Study|Blood pressure <100 after sedation|1
4668415|NCT02296190|7563146|FG004|Overall Study|Blood pressure <100 after sedation|0
4668416|NCT02296190|7563147|FG005|Overall Study|Blood pressure <100 after sedation|0
4668417|NCT02296190|7563142|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0
4668418|NCT02296190|7563143|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1
4668419|NCT02296190|7563144|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1
4668420|NCT02296190|7563145|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0
4668421|NCT02296190|7563146|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0
4668422|NCT02296190|7563147|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0
4668423|NCT02296190|7563142|FG000|Overall Study|Patient on antiarrhythmic medication|1
4668424|NCT02296190|7563143|FG001|Overall Study|Patient on antiarrhythmic medication|0
4668425|NCT02296190|7563144|FG002|Overall Study|Patient on antiarrhythmic medication|0
4668426|NCT02296190|7563145|FG003|Overall Study|Patient on antiarrhythmic medication|0
4668427|NCT02296190|7563146|FG004|Overall Study|Patient on antiarrhythmic medication|0
4668428|NCT02296190|7563147|FG005|Overall Study|Patient on antiarrhythmic medication|0
4668429|NCT02296190|7563142|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0
4668430|NCT02296190|7563143|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1
4668431|NCT02296190|7563144|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0
4668432|NCT02296190|7563145|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0
4668433|NCT02296190|7563146|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0
4668434|NCT02296190|7563147|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0
4668435|NCT02296190|7563142|FG000|Overall Study|Lab result not available in time|1
4668436|NCT02296190|7563143|FG001|Overall Study|Lab result not available in time|0
4668437|NCT02296190|7563144|FG002|Overall Study|Lab result not available in time|0
4668438|NCT02296190|7563145|FG003|Overall Study|Lab result not available in time|0
4668439|NCT02296190|7563146|FG004|Overall Study|Lab result not available in time|0
4668440|NCT02296190|7563147|FG005|Overall Study|Lab result not available in time|0
4668441|NCT02296242|7563165|FG000|Overall Study|Death|1
4668442|NCT02296242|7563166|FG001|Overall Study|Death|1
4668443|NCT02296242|7563167|FG002|Overall Study|Death|1
4668444|NCT02296242|7563168|FG003|Overall Study|Death|1
4668445|NCT02296242|7563169|FG004|Overall Study|Death|1
4668446|NCT02296242|7563165|FG000|Overall Study|Withdrawal by Subject|0
4668447|NCT02296242|7563166|FG001|Overall Study|Withdrawal by Subject|0
4668448|NCT02296242|7563167|FG002|Overall Study|Withdrawal by Subject|1
4668449|NCT02296242|7563168|FG003|Overall Study|Withdrawal by Subject|1
4668450|NCT02296242|7563169|FG004|Overall Study|Withdrawal by Subject|3
4668451|NCT02296242|7563165|FG000|Overall Study|Disease Progression|1
4668452|NCT02296242|7563166|FG001|Overall Study|Disease Progression|3
4668453|NCT02296242|7563167|FG002|Overall Study|Disease Progression|2
4668454|NCT02296242|7563168|FG003|Overall Study|Disease Progression|8
4668455|NCT02296242|7563169|FG004|Overall Study|Disease Progression|11
4753889|NCT01595009|7728307|FG001|Core|Protocol deviation|1
4753890|NCT01595009|7728308|FG002|Core|Protocol deviation|0
4753891|NCT01595009|7728309|FG003|Core|Protocol deviation|0
4753892|NCT01595009|7728306|FG000|Core|Administrative problems|0
4753893|NCT01595009|7728307|FG001|Core|Administrative problems|1
4753894|NCT01595009|7728308|FG002|Core|Administrative problems|0
4753895|NCT01595009|7728309|FG003|Core|Administrative problems|0
4753896|NCT01595009|7728306|FG000|Extension|Administrative problems|0
4753897|NCT01595009|7728307|FG001|Extension|Administrative problems|0
4753898|NCT01595009|7728308|FG002|Extension|Administrative problems|0
4753899|NCT01595009|7728309|FG003|Extension|Administrative problems|1
4753900|NCT01595009|7728306|FG000|Extension|Patients completed per protocol|0
4753901|NCT01595009|7728307|FG001|Extension|Patients completed per protocol|0
4753902|NCT01595009|7728308|FG002|Extension|Patients completed per protocol|0
4753903|NCT01595009|7728309|FG003|Extension|Patients completed per protocol|2
4753904|NCT01595009|7728306|FG000|Extension|Disease progression|0
4753905|NCT01595009|7728307|FG001|Extension|Disease progression|0
4668456|NCT02296242|7563165|FG000|Overall Study|Unacceptable Toxicity|0
4668457|NCT02296242|7563166|FG001|Overall Study|Unacceptable Toxicity|0
4668458|NCT02296242|7563167|FG002|Overall Study|Unacceptable Toxicity|0
4668459|NCT02296242|7563168|FG003|Overall Study|Unacceptable Toxicity|0
4668460|NCT02296242|7563169|FG004|Overall Study|Unacceptable Toxicity|1
4668461|NCT02296242|7563165|FG000|Overall Study|Patient Condition Changed|0
4668462|NCT02296242|7563166|FG001|Overall Study|Patient Condition Changed|0
4668463|NCT02296242|7563167|FG002|Overall Study|Patient Condition Changed|2
4668464|NCT02296242|7563168|FG003|Overall Study|Patient Condition Changed|0
4668465|NCT02296242|7563169|FG004|Overall Study|Patient Condition Changed|1
4668466|NCT02296242|7563165|FG000|Overall Study|At Least 3 Drug Interruptions|0
4668467|NCT02296242|7563166|FG001|Overall Study|At Least 3 Drug Interruptions|0
4668468|NCT02296242|7563167|FG002|Overall Study|At Least 3 Drug Interruptions|1
4668469|NCT02296242|7563168|FG003|Overall Study|At Least 3 Drug Interruptions|1
4668470|NCT02296242|7563169|FG004|Overall Study|At Least 3 Drug Interruptions|1
4668471|NCT02296242|7563165|FG000|Overall Study|Lost to Follow-up|1
4668472|NCT02296242|7563166|FG001|Overall Study|Lost to Follow-up|0
4668473|NCT02296242|7563167|FG002|Overall Study|Lost to Follow-up|0
4668474|NCT02296242|7563168|FG003|Overall Study|Lost to Follow-up|0
4668475|NCT02296242|7563169|FG004|Overall Study|Lost to Follow-up|0
4668476|NCT02296242|7563165|FG000|Overall Study|Need for Hydroxyurea|2
4753906|NCT01595009|7728308|FG002|Extension|Disease progression|4
4668477|NCT02296242|7563166|FG001|Overall Study|Need for Hydroxyurea|0
4668478|NCT02296242|7563167|FG002|Overall Study|Need for Hydroxyurea|0
4668479|NCT02296242|7563168|FG003|Overall Study|Need for Hydroxyurea|0
4668480|NCT02296242|7563169|FG004|Overall Study|Need for Hydroxyurea|0
4668481|NCT02296242|7563165|FG000|Overall Study|Screened for Other Protocol|0
4668482|NCT02296242|7563166|FG001|Overall Study|Screened for Other Protocol|1
4668483|NCT02296242|7563167|FG002|Overall Study|Screened for Other Protocol|0
4668484|NCT02296242|7563168|FG003|Overall Study|Screened for Other Protocol|0
4668485|NCT02296242|7563169|FG004|Overall Study|Screened for Other Protocol|0
4668486|NCT02296242|7563165|FG000|Overall Study|Physician Decision|0
4668487|NCT02296242|7563166|FG001|Overall Study|Physician Decision|1
4668488|NCT02296242|7563167|FG002|Overall Study|Physician Decision|0
4668489|NCT02296242|7563168|FG003|Overall Study|Physician Decision|1
4668490|NCT02296242|7563169|FG004|Overall Study|Physician Decision|0
4668491|NCT02296242|7563165|FG000|Overall Study|Alternative Treatment|0
4668492|NCT02296242|7563166|FG001|Overall Study|Alternative Treatment|0
4668493|NCT02296242|7563167|FG002|Overall Study|Alternative Treatment|0
4668494|NCT02296242|7563168|FG003|Overall Study|Alternative Treatment|1
4668495|NCT02296242|7563169|FG004|Overall Study|Alternative Treatment|0
4668496|NCT02296242|7563165|FG000|Overall Study|Adverse Event|0
4668497|NCT02296242|7563166|FG001|Overall Study|Adverse Event|0
4668498|NCT02296242|7563167|FG002|Overall Study|Adverse Event|0
4668499|NCT02296242|7563168|FG003|Overall Study|Adverse Event|1
4668500|NCT02296242|7563169|FG004|Overall Study|Adverse Event|0
4668501|NCT02296242|7563165|FG000|Overall Study|Lack of Efficacy|0
4668502|NCT02296242|7563166|FG001|Overall Study|Lack of Efficacy|0
4668503|NCT02296242|7563167|FG002|Overall Study|Lack of Efficacy|0
4668504|NCT02296242|7563168|FG003|Overall Study|Lack of Efficacy|0
4668505|NCT02296242|7563169|FG004|Overall Study|Lack of Efficacy|3
4668506|NCT02296320|7563192|FG000|Overall Study|Withdrawal by Subject|4
4668507|NCT02296320|7563193|FG001|Overall Study|Withdrawal by Subject|0
4668508|NCT02296320|7563194|FG002|Overall Study|Withdrawal by Subject|2
4668509|NCT02296320|7563192|FG000|Overall Study|Death|24
4668510|NCT02296320|7563193|FG001|Overall Study|Death|3
4668511|NCT02296320|7563194|FG002|Overall Study|Death|27
4668512|NCT02296320|7563192|FG000|Overall Study|Lost to Follow-up|5
4668513|NCT02296320|7563193|FG001|Overall Study|Lost to Follow-up|2
4668514|NCT02296320|7563194|FG002|Overall Study|Lost to Follow-up|7
4668515|NCT02296320|7563192|FG000|Overall Study|Not treated|2
4668516|NCT02296320|7563193|FG001|Overall Study|Not treated|0
4668517|NCT02296320|7563194|FG002|Overall Study|Not treated|0
4668518|NCT02296320|7563192|FG000|Overall Study|Not - specified|0
4668519|NCT02296320|7563193|FG001|Overall Study|Not - specified|0
4668520|NCT02296320|7563194|FG002|Overall Study|Not - specified|1
4668521|NCT02296424|7563217|FG000|Part 1|New therapy for study indication|0
4668522|NCT02296424|7563218|FG001|Part 1|New therapy for study indication|1
4668523|NCT02296424|7563219|FG002|Part 1|New therapy for study indication|0
4668524|NCT02296424|7563220|FG003|Part 1|New therapy for study indication|0
4668525|NCT02296424|7563217|FG000|Part 1|Protocol Violation|0
4668526|NCT02296424|7563218|FG001|Part 1|Protocol Violation|1
4668527|NCT02296424|7563219|FG002|Part 1|Protocol Violation|0
4668528|NCT02296424|7563220|FG003|Part 1|Protocol Violation|0
4668529|NCT02296424|7563217|FG000|Part 1|Withdrawal by Subject|0
4668530|NCT02296424|7563218|FG001|Part 1|Withdrawal by Subject|2
4668531|NCT02296424|7563219|FG002|Part 1|Withdrawal by Subject|0
4668532|NCT02296424|7563220|FG003|Part 1|Withdrawal by Subject|0
4668533|NCT02296424|7563217|FG000|Part 1|Study terminated by sponsor|0
4668534|NCT02296424|7563218|FG001|Part 1|Study terminated by sponsor|1
4668535|NCT02296424|7563219|FG002|Part 1|Study terminated by sponsor|0
4668536|NCT02296424|7563220|FG003|Part 1|Study terminated by sponsor|0
4668537|NCT02296424|7563217|FG000|Part 1|Adverse Event|2
4668538|NCT02296424|7563218|FG001|Part 1|Adverse Event|11
4668539|NCT02296424|7563219|FG002|Part 1|Adverse Event|0
4668540|NCT02296424|7563220|FG003|Part 1|Adverse Event|0
4668541|NCT02296424|7563217|FG000|Part 1|Lack of Efficacy|5
4668542|NCT02296424|7563218|FG001|Part 1|Lack of Efficacy|17
4668543|NCT02296424|7563219|FG002|Part 1|Lack of Efficacy|0
4668544|NCT02296424|7563220|FG003|Part 1|Lack of Efficacy|0
4668545|NCT02296424|7563217|FG000|Part 1|16 directly started part II|16
4668546|NCT02296424|7563218|FG001|Part 1|16 directly started part II|0
4668547|NCT02296424|7563219|FG002|Part 1|16 directly started part II|0
4668548|NCT02296424|7563220|FG003|Part 1|16 directly started part II|0
4668549|NCT02296424|7563217|FG000|Part 2|Lack of Efficacy|0
4668550|NCT02296424|7563218|FG001|Part 2|Lack of Efficacy|0
4668551|NCT02296424|7563219|FG002|Part 2|Lack of Efficacy|1
4668552|NCT02296424|7563220|FG003|Part 2|Lack of Efficacy|0
4668553|NCT02296424|7563217|FG000|Part 2|Adverse Event|0
4668554|NCT02296424|7563218|FG001|Part 2|Adverse Event|0
4668555|NCT02296424|7563219|FG002|Part 2|Adverse Event|1
4668556|NCT02296424|7563220|FG003|Part 2|Adverse Event|0
4668557|NCT02296424|7563217|FG000|Part 2|Lost to Follow-up|0
4668558|NCT02296424|7563218|FG001|Part 2|Lost to Follow-up|0
4668559|NCT02296424|7563219|FG002|Part 2|Lost to Follow-up|1
4668560|NCT02296424|7563220|FG003|Part 2|Lost to Follow-up|0
4668561|NCT02296476|7563231|FG000|Overall Study|Disease Progression|6
4668562|NCT02296476|7563232|FG001|Overall Study|Disease Progression|4
4668563|NCT02296476|7563233|FG002|Overall Study|Disease Progression|2
4753907|NCT01595009|7728309|FG003|Extension|Disease progression|7
4753908|NCT01595009|7728306|FG000|Extension|Adverse Event|0
4753909|NCT01595009|7728307|FG001|Extension|Adverse Event|0
4753910|NCT01595009|7728308|FG002|Extension|Adverse Event|0
4753911|NCT01595009|7728309|FG003|Extension|Adverse Event|1
4668564|NCT02296840|7563280|FG000|Overall Study|Adverse Event|1
4668565|NCT02296840|7563281|FG001|Overall Study|Adverse Event|1
4668566|NCT02296840|7563280|FG000|Overall Study|Protocol Violation|2
4668567|NCT02296840|7563281|FG001|Overall Study|Protocol Violation|1
4668568|NCT02296840|7563280|FG000|Overall Study|Lost to Follow-up|6
4668569|NCT02296840|7563281|FG001|Overall Study|Lost to Follow-up|17
4668570|NCT02296892|7563299|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7
4668571|NCT02296892|7563300|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4
4668572|NCT02296892|7563301|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4
4668573|NCT02296892|7563299|FG000|Overall Study|Lost to Follow-up|5
4668574|NCT02296892|7563300|FG001|Overall Study|Lost to Follow-up|0
4668575|NCT02296892|7563301|FG002|Overall Study|Lost to Follow-up|1
4668576|NCT02296931|7563311|FG000|Overall Study|Protocol Violation|0
4668577|NCT02296931|7563312|FG001|Overall Study|Protocol Violation|2
4668578|NCT02297503|7563334|FG000|Overall Study|Withdrawal by Subject|1
4668579|NCT02297503|7563335|FG001|Overall Study|Withdrawal by Subject|1
4668580|NCT02297503|7563334|FG000|Overall Study|Protocol Violation|1
4668581|NCT02297503|7563335|FG001|Overall Study|Protocol Violation|0
4668582|NCT02297503|7563334|FG000|Overall Study|Pregnancy|0
4668583|NCT02297503|7563335|FG001|Overall Study|Pregnancy|1
4668584|NCT02297503|7563334|FG000|Overall Study|Lost to Follow-up|0
4668585|NCT02297503|7563335|FG001|Overall Study|Lost to Follow-up|1
4668586|NCT02297503|7563334|FG000|Overall Study|Medical reason|0
4668587|NCT02297503|7563335|FG001|Overall Study|Medical reason|1
4668588|NCT02297516|7563352|FG000|Single Treatment Phase (6 Months)|Medical reason|1
4668589|NCT02297516|7563353|FG001|Single Treatment Phase (6 Months)|Medical reason|0
4668590|NCT02297516|7563352|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0
4668591|NCT02297516|7563353|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2
4668592|NCT02297516|7563352|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0
4668593|NCT02297516|7563353|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1
4668594|NCT02297815|7563368|FG000|Overall Study|Lost to Follow-up|236
4668595|NCT02297815|7563369|FG001|Overall Study|Lost to Follow-up|140
4668596|NCT02297841|7563377|FG000|Overall Study|Withdrawal by Subject|1
4668597|NCT02297841|7563377|FG000|Overall Study|Protocol Violation|7
4668598|NCT02298023|7563384|FG000|Overall Study|Withdrawal by Subject|1
4668599|NCT02298023|7563385|FG001|Overall Study|Withdrawal by Subject|0
4668600|NCT02298023|7563386|FG002|Overall Study|Withdrawal by Subject|0
4668601|NCT02298179|7563409|FG000|Overall Study|Lost to Follow-up|0
4668602|NCT02298179|7563410|FG001|Overall Study|Lost to Follow-up|0
4668603|NCT02298179|7563411|FG002|Overall Study|Lost to Follow-up|1
4668604|NCT02298179|7563412|FG003|Overall Study|Lost to Follow-up|0
4668605|NCT02298179|7563413|FG004|Overall Study|Lost to Follow-up|0
4668606|NCT02298179|7563414|FG005|Overall Study|Lost to Follow-up|0
4668607|NCT02298179|7563415|FG006|Overall Study|Lost to Follow-up|0
4668608|NCT02298179|7563416|FG007|Overall Study|Lost to Follow-up|1
4668609|NCT02298179|7563417|FG008|Overall Study|Lost to Follow-up|0
4668610|NCT02298179|7563418|FG009|Overall Study|Lost to Follow-up|0
4668611|NCT02298179|7563419|FG010|Overall Study|Lost to Follow-up|0
4668612|NCT02298179|7563420|FG011|Overall Study|Lost to Follow-up|0
4668613|NCT02298192|7563448|FG000|Overall Study|Unclassified|3
4668614|NCT02298192|7563449|FG001|Overall Study|Unclassified|2
4668615|NCT02298192|7563448|FG000|Overall Study|Withdrawal criteria|2
4668616|NCT02298192|7563449|FG001|Overall Study|Withdrawal criteria|0
4668617|NCT02298192|7563448|FG000|Overall Study|Withdrawal by Subject|6
4668618|NCT02298192|7563449|FG001|Overall Study|Withdrawal by Subject|1
4668619|NCT02298192|7563448|FG000|Overall Study|Lost to Follow-up|2
4668620|NCT02298192|7563449|FG001|Overall Study|Lost to Follow-up|1
4668621|NCT02298192|7563448|FG000|Overall Study|Adverse Event|6
4668622|NCT02298192|7563449|FG001|Overall Study|Adverse Event|2
4668623|NCT02298868|7563501|FG000|Overall Study|Adverse Event|1
4668624|NCT02298868|7563501|FG000|Overall Study|Death|1
4668625|NCT02298868|7563501|FG000|Overall Study|Patient underwent transplant|1
4668626|NCT02298946|7563511|FG000|Overall Study|Did not receive treatment|2
4668627|NCT02298946|7563512|FG001|Overall Study|Did not receive treatment|0
4668628|NCT02298946|7563511|FG000|Overall Study|Unevaluable|2
4668629|NCT02298946|7563512|FG001|Overall Study|Unevaluable|1
4668630|NCT02299076|7563525|FG000|Overall Study|Fraudulent Entries|20
4668631|NCT02299076|7563526|FG001|Overall Study|Fraudulent Entries|14
4668632|NCT02299167|7563570|FG000|Overall Study|patients were excluded from the study|11
4668633|NCT02299336|7563587|FG000|Overall Study|Withdrawal by Subject|11
4668634|NCT02299336|7563587|FG000|Overall Study|Adverse Event|1
4668635|NCT02299336|7563587|FG000|Overall Study|Death|1
4668636|NCT02299336|7563587|FG000|Overall Study|Lost to Follow-up|1
4668637|NCT02299375|7563602|FG000|Overall Study|Adverse Event, serious fatal|1
4668638|NCT02299375|7563603|FG001|Overall Study|Adverse Event, serious fatal|3
4668639|NCT02299375|7563602|FG000|Overall Study|Adverse Event, non-fatal|8
4668640|NCT02299375|7563603|FG001|Overall Study|Adverse Event, non-fatal|9
4668641|NCT02299375|7563602|FG000|Overall Study|Lack of Efficacy|1
4668642|NCT02299375|7563603|FG001|Overall Study|Lack of Efficacy|3
4668643|NCT02299375|7563602|FG000|Overall Study|Protocol Violation|1
4668644|NCT02299375|7563603|FG001|Overall Study|Protocol Violation|3
4668645|NCT02299375|7563602|FG000|Overall Study|Other: Met stopping criteria|1
4668646|NCT02299375|7563603|FG001|Overall Study|Other: Met stopping criteria|0
4668647|NCT02299375|7563602|FG000|Overall Study|Other: Study closed/terminated|66
4668648|NCT02299375|7563603|FG001|Overall Study|Other: Study closed/terminated|55
4668649|NCT02299375|7563602|FG000|Overall Study|Lost to Follow-up|0
4668650|NCT02299375|7563603|FG001|Overall Study|Lost to Follow-up|2
4668651|NCT02299375|7563602|FG000|Overall Study|Physician Decision|1
4668652|NCT02299375|7563603|FG001|Overall Study|Physician Decision|1
4668653|NCT02299375|7563602|FG000|Overall Study|Withdrawal by Subject|1
4668654|NCT02299375|7563603|FG001|Overall Study|Withdrawal by Subject|4
4668655|NCT02299388|7563612|FG000|Overall Study|Withdrawal by Subject|0
4668656|NCT02299388|7563613|FG001|Overall Study|Withdrawal by Subject|1
4668657|NCT02299427|7563621|FG000|Overall Study|Withdrawal by Subject|1
4668658|NCT02299427|7563622|FG001|Overall Study|Withdrawal by Subject|0
4668659|NCT02299427|7563621|FG000|Overall Study|Lost to Follow-up|1
4668660|NCT02299427|7563622|FG001|Overall Study|Lost to Follow-up|3
4668661|NCT02299427|7563621|FG000|Overall Study|not adherent to dog website use|21
4668662|NCT02299427|7563622|FG001|Overall Study|not adherent to dog website use|0
4668663|NCT02299635|7563650|FG000|Overall Study|Adverse Event|2
4668664|NCT02299635|7563650|FG000|Overall Study|Death|1
4668665|NCT02299635|7563650|FG000|Overall Study|Global deterioration of health status|1
4668666|NCT02299635|7563650|FG000|Overall Study|Objective progression or relapse|10
4668667|NCT02299635|7563650|FG000|Overall Study|Withdrawal by Subject|2
4668668|NCT02299635|7563650|FG000|Overall Study|Other|3
4668669|NCT02300103|7563708|FG000|Overall Study|Lack of Efficacy|3
4753912|NCT01620944|7728326|FG000|Overall Study|Early termination of Study|2
4753913|NCT01620944|7728327|FG001|Overall Study|Early termination of Study|1
4753914|NCT01627561|7728335|FG000|Overall Study|Lost to Follow-up|1
4753915|NCT01627561|7728336|FG001|Overall Study|Lost to Follow-up|0
4753916|NCT01627561|7728335|FG000|Overall Study|Withdrawal by Subject|0
4753917|NCT01627561|7728336|FG001|Overall Study|Withdrawal by Subject|1
4753918|NCT01627561|7728335|FG000|Overall Study|Migrated/moved from study area|0
4753919|NCT01627561|7728336|FG001|Overall Study|Migrated/moved from study area|2
4753920|NCT01652534|7728361|FG000|Overall Study|Lack of Efficacy|1
4753921|NCT01652534|7728362|FG001|Overall Study|Lack of Efficacy|0
4753922|NCT04799405|7728377|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2
4753923|NCT04537949|7728393|FG000|Overall Study|personal reasons not related to the IMP|1
4753924|NCT04537949|7728394|FG001|Overall Study|personal reasons not related to the IMP|0
4753925|NCT04537949|7728395|FG002|Overall Study|personal reasons not related to the IMP|0
4753926|NCT04537949|7728396|FG003|Overall Study|personal reasons not related to the IMP|0
4753927|NCT04537949|7728397|FG004|Overall Study|personal reasons not related to the IMP|0
4753928|NCT04537949|7728398|FG005|Overall Study|personal reasons not related to the IMP|0
4753929|NCT04537949|7728399|FG006|Overall Study|personal reasons not related to the IMP|0
4753930|NCT04537949|7728400|FG007|Overall Study|personal reasons not related to the IMP|0
4668670|NCT02300103|7563708|FG000|Overall Study|Protocol Violation|1
4668671|NCT02300103|7563708|FG000|Overall Study|Withdrew Consent|2
4668672|NCT02300129|7563712|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
4668673|NCT02300129|7563713|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1
4668674|NCT02300129|7563714|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
4668675|NCT02300129|7563715|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
4668676|NCT02300129|7563712|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
4668677|NCT02300129|7563713|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
4668678|NCT02300129|7563714|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
4668679|NCT02300129|7563715|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1
4668680|NCT02300129|7563712|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1
4668681|NCT02300129|7563713|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
4668682|NCT02300129|7563714|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
4668683|NCT02300129|7563715|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
4668684|NCT02300220|7563727|FG000|Overall Study|Lost to Follow-up|1
4668685|NCT02300220|7563728|FG001|Overall Study|Lost to Follow-up|2
4668686|NCT02300220|7563727|FG000|Overall Study|Death|1
4753945|NCT04421027|7728438|FG000|Overall Study|Adverse Event|5
4753946|NCT04421027|7728439|FG001|Overall Study|Adverse Event|3
4753947|NCT04421027|7728438|FG000|Overall Study|Death|98
4753948|NCT04421027|7728439|FG001|Overall Study|Death|61
4753949|NCT04421027|7728438|FG000|Overall Study|Lost to Follow-up|22
4668687|NCT02300220|7563728|FG001|Overall Study|Death|1
4668688|NCT02300220|7563727|FG000|Overall Study|Adverse Event|1
4668689|NCT02300220|7563728|FG001|Overall Study|Adverse Event|1
4668690|NCT02300220|7563727|FG000|Overall Study|Protocol Violation|1
4668691|NCT02300220|7563728|FG001|Overall Study|Protocol Violation|0
4668692|NCT02300220|7563727|FG000|Overall Study|Withdrawal by Subject|0
4668693|NCT02300220|7563728|FG001|Overall Study|Withdrawal by Subject|2
4668694|NCT02300220|7563727|FG000|Overall Study|Did not tolerate IMP|0
4668695|NCT02300220|7563728|FG001|Overall Study|Did not tolerate IMP|1
4668696|NCT02300259|7563737|FG000|Period 1|Adverse Event|0
4668697|NCT02300259|7563738|FG001|Period 1|Adverse Event|0
4753950|NCT04421027|7728439|FG001|Overall Study|Lost to Follow-up|20
4753951|NCT04421027|7728438|FG000|Overall Study|Other-Unknown|15
4668698|NCT02300259|7563739|FG002|Period 1|Adverse Event|1
4668699|NCT02300259|7563737|FG000|Period 1|Withdrawal by Subject|0
4668700|NCT02300259|7563738|FG001|Period 1|Withdrawal by Subject|0
4668701|NCT02300259|7563739|FG002|Period 1|Withdrawal by Subject|1
4668702|NCT02300259|7563737|FG000|Period 2|Adverse Event|1
4668703|NCT02300259|7563738|FG001|Period 2|Adverse Event|0
4668704|NCT02300259|7563739|FG002|Period 2|Adverse Event|0
4668705|NCT02300259|7563737|FG000|Period 2|Withdrawal by Subject|0
4668706|NCT02300259|7563738|FG001|Period 2|Withdrawal by Subject|0
4668707|NCT02300259|7563739|FG002|Period 2|Withdrawal by Subject|1
4668708|NCT02300298|7563767|FG000|Disposition for Nintedanib|Progressive disease|10
4668709|NCT02300298|7563768|FG001|Disposition for Nintedanib|Progressive disease|0
4668710|NCT02300298|7563767|FG000|Disposition for Docetaxel|Progressive disease|0
4668711|NCT02300298|7563768|FG001|Disposition for Docetaxel|Progressive disease|6
4668712|NCT02300298|7563767|FG000|Disposition for Docetaxel|other adverse event|0
4668713|NCT02300298|7563768|FG001|Disposition for Docetaxel|other adverse event|4
4668714|NCT02300311|7563774|FG000|Overall Study|Other than the reason specified|1
4668715|NCT02300311|7563775|FG001|Overall Study|Other than the reason specified|0
4668716|NCT02300311|7563774|FG000|Overall Study|Refused to continue taking medication|18
4668717|NCT02300311|7563775|FG001|Overall Study|Refused to continue taking medication|0
4668718|NCT02300558|7563785|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6
4668719|NCT02300558|7563785|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2
4668720|NCT02300558|7563785|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1
4668721|NCT02300558|7563785|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29
4668722|NCT02300610|7563796|FG000|Overall Study|Withdrawal by Subject|1
4668723|NCT02300610|7563797|FG001|Overall Study|Withdrawal by Subject|0
4668724|NCT02300610|7563798|FG002|Overall Study|Withdrawal by Subject|1
4668725|NCT02300987|7563835|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1
4668726|NCT02300987|7563836|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0
4668727|NCT02300987|7563835|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2
4668728|NCT02300987|7563836|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0
4668729|NCT02300987|7563835|FG000|Primary Phase : Prior to Cross-over|progressive disease|3
4668730|NCT02300987|7563836|FG001|Primary Phase : Prior to Cross-over|progressive disease|2
4668731|NCT02300987|7563835|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1
4668732|NCT02300987|7563836|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0
4668733|NCT02300987|7563835|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0
4668734|NCT02300987|7563836|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1
4668735|NCT02301143|7563856|FG000|Induction Period|Enrolled But Not Treated|1
4668736|NCT02301143|7563857|FG001|Induction Period|Enrolled But Not Treated|0
4668737|NCT02301143|7563856|FG000|Induction Period|Death|1
4668738|NCT02301143|7563857|FG001|Induction Period|Death|0
4668739|NCT02301143|7563856|FG000|Induction Period|Adverse Event|22
4668740|NCT02301143|7563857|FG001|Induction Period|Adverse Event|0
4668741|NCT02301143|7563856|FG000|Induction Period|Progressive Disease|8
4668742|NCT02301143|7563857|FG001|Induction Period|Progressive Disease|0
4668743|NCT02301143|7563856|FG000|Induction Period|Withdrawal by Subject|3
4668744|NCT02301143|7563857|FG001|Induction Period|Withdrawal by Subject|0
4668745|NCT02301143|7563856|FG000|Induction Period|Noncompliance with Study Drug|1
4668746|NCT02301143|7563857|FG001|Induction Period|Noncompliance with Study Drug|0
4753931|NCT04529499|7728420|FG000|Overall Study|Withdrawal by Subject|9
4753932|NCT04529499|7728421|FG001|Overall Study|Withdrawal by Subject|11
4753933|NCT04529499|7728420|FG000|Overall Study|Physician Decision|1
4753934|NCT04529499|7728421|FG001|Overall Study|Physician Decision|2
4753935|NCT04529499|7728420|FG000|Overall Study|Adverse Event|4
4753936|NCT04529499|7728421|FG001|Overall Study|Adverse Event|4
4753937|NCT04529499|7728420|FG000|Overall Study|Death|14
4753938|NCT04529499|7728421|FG001|Overall Study|Death|11
4753939|NCT04529499|7728420|FG000|Overall Study|Lost to Follow-up|1
4753940|NCT04529499|7728421|FG001|Overall Study|Lost to Follow-up|1
4753941|NCT04529499|7728420|FG000|Overall Study|Others|7
4753942|NCT04529499|7728421|FG001|Overall Study|Others|11
4753943|NCT04501094|7728429|FG000|Overall Study|Death (unrelated to research)|1
4753944|NCT04501094|7728430|FG001|Overall Study|Death (unrelated to research)|0
4753952|NCT04421027|7728439|FG001|Overall Study|Other-Unknown|9
4753953|NCT04421027|7728438|FG000|Overall Study|Physician Decision|1
4753954|NCT04421027|7728439|FG001|Overall Study|Physician Decision|1
4753955|NCT04421027|7728438|FG000|Overall Study|Withdrawal by Subject|7
4753956|NCT04421027|7728439|FG001|Overall Study|Withdrawal by Subject|12
4753957|NCT04421027|7728438|FG000|Overall Study|Randomized Not Dosed|9
4753958|NCT04421027|7728439|FG001|Overall Study|Randomized Not Dosed|14
4753959|NCT04414618|7728449|FG000|Overall Study|Death|3
4753960|NCT04414618|7728450|FG001|Overall Study|Death|3
4753961|NCT04414618|7728449|FG000|Overall Study|Withdrawal by Subject|2
4753962|NCT04414618|7728450|FG001|Overall Study|Withdrawal by Subject|1
4753963|NCT04414618|7728449|FG000|Overall Study|Lost to Follow-up|2
4753964|NCT04414618|7728450|FG001|Overall Study|Lost to Follow-up|3
4753965|NCT04414618|7728449|FG000|Overall Study|Physician Decision|1
4753966|NCT04414618|7728450|FG001|Overall Study|Physician Decision|0
4753967|NCT04412057|7728459|FG000|Overall Study|Death|3
4668747|NCT02301143|7563856|FG000|Induction Period|Physician Decision|4
4753968|NCT04412057|7728460|FG001|Overall Study|Death|7
4668748|NCT02301143|7563857|FG001|Induction Period|Physician Decision|0
4668749|NCT02301143|7563856|FG000|Induction Period|Symptomatic Deterioration|2
4753969|NCT04412057|7728459|FG000|Overall Study|Discharged prior to receiving study treatment|1
4753970|NCT04412057|7728460|FG001|Overall Study|Discharged prior to receiving study treatment|0
4668750|NCT02301143|7563857|FG001|Induction Period|Symptomatic Deterioration|0
4668751|NCT02301143|7563856|FG000|Induction Period|Protocol Violation|2
4668752|NCT02301143|7563857|FG001|Induction Period|Protocol Violation|0
4668753|NCT02301143|7563856|FG000|Induction Period|Other|1
4668754|NCT02301143|7563857|FG001|Induction Period|Other|0
4668755|NCT02301143|7563856|FG000|Investigator's Choice|Adverse Event|0
4668756|NCT02301143|7563857|FG001|Investigator's Choice|Adverse Event|3
4668757|NCT02301143|7563856|FG000|Investigator's Choice|Progressive Disease|0
4668758|NCT02301143|7563857|FG001|Investigator's Choice|Progressive Disease|3
4668759|NCT02301143|7563856|FG000|Investigator's Choice|Noncompliance With Study Drug|0
4668760|NCT02301143|7563857|FG001|Investigator's Choice|Noncompliance With Study Drug|1
4668761|NCT02301143|7563856|FG000|Investigator's Choice|Symptomatic Deterioration|0
4668762|NCT02301143|7563857|FG001|Investigator's Choice|Symptomatic Deterioration|1
4668763|NCT02301143|7563856|FG000|Investigator's Choice|Other|0
4668764|NCT02301143|7563857|FG001|Investigator's Choice|Other|1
4668765|NCT02301143|7563856|FG000|Investigator's Choice|Unresectable Surgery|0
4753971|NCT04402060|7728469|FG000|Overall Study|Death|1
4753972|NCT04402060|7728470|FG001|Overall Study|Death|12
4753973|NCT04402060|7728471|FG002|Overall Study|Death|7
4753974|NCT04402060|7728469|FG000|Overall Study|Adverse Event|0
4753975|NCT04402060|7728470|FG001|Overall Study|Adverse Event|0
4753976|NCT04402060|7728471|FG002|Overall Study|Adverse Event|1
4753977|NCT04402060|7728469|FG000|Overall Study|Withdrawal by Subject|0
4753978|NCT04402060|7728470|FG001|Overall Study|Withdrawal by Subject|1
4753979|NCT04402060|7728471|FG002|Overall Study|Withdrawal by Subject|2
4753980|NCT04402060|7728469|FG000|Overall Study|Sponsor Request|0
4753981|NCT04402060|7728470|FG001|Overall Study|Sponsor Request|2
4753982|NCT04402060|7728471|FG002|Overall Study|Sponsor Request|0
4753983|NCT04402060|7728469|FG000|Overall Study|Physician Decision|0
4753984|NCT04402060|7728470|FG001|Overall Study|Physician Decision|0
4753985|NCT04402060|7728471|FG002|Overall Study|Physician Decision|1
4753986|NCT04402060|7728469|FG000|Overall Study|Other|0
4753987|NCT04402060|7728470|FG001|Overall Study|Other|1
4753988|NCT04402060|7728471|FG002|Overall Study|Other|0
4753989|NCT04396626|7728484|FG000|Overall Study|Premature termination of study|975
4753990|NCT04376684|7728510|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7
4753991|NCT04376684|7728511|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8
4753992|NCT04376684|7728512|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0
4753993|NCT04376684|7728513|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0
4753994|NCT04376684|7728510|FG000|Part 1 (Up to Day 60)|Protocol Violation|2
4753995|NCT04376684|7728511|FG001|Part 1 (Up to Day 60)|Protocol Violation|3
4753996|NCT04376684|7728512|FG002|Part 1 (Up to Day 60)|Protocol Violation|0
4753997|NCT04376684|7728513|FG003|Part 1 (Up to Day 60)|Protocol Violation|0
4753998|NCT04376684|7728510|FG000|Part 1 (Up to Day 60)|Physician Decision|2
4753999|NCT04376684|7728511|FG001|Part 1 (Up to Day 60)|Physician Decision|5
4754000|NCT04376684|7728512|FG002|Part 1 (Up to Day 60)|Physician Decision|0
4754001|NCT04376684|7728513|FG003|Part 1 (Up to Day 60)|Physician Decision|0
4754002|NCT04376684|7728510|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4
4754003|NCT04376684|7728511|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8
4754004|NCT04376684|7728512|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0
4754005|NCT04376684|7728513|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0
4754006|NCT04376684|7728510|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0
4754007|NCT04376684|7728511|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0
4754008|NCT04376684|7728512|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1
4754009|NCT04376684|7728513|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1
4754010|NCT04376684|7728510|FG000|Part 2 (Up to Day 60)|Physician Decision|0
4754011|NCT04376684|7728511|FG001|Part 2 (Up to Day 60)|Physician Decision|0
4754012|NCT04376684|7728512|FG002|Part 2 (Up to Day 60)|Physician Decision|1
4754013|NCT04376684|7728513|FG003|Part 2 (Up to Day 60)|Physician Decision|1
4754014|NCT04376684|7728510|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0
4754015|NCT04376684|7728511|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0
4754016|NCT04376684|7728512|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3
4754017|NCT04376684|7728513|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2
4754018|NCT04353284|7728525|FG000|Overall Study|Adverse Event|1
4754019|NCT04353284|7728526|FG001|Overall Study|Adverse Event|1
4754020|NCT04353284|7728525|FG000|Overall Study|Lost to Follow-up|1
4754021|NCT04353284|7728526|FG001|Overall Study|Lost to Follow-up|0
4668766|NCT02301143|7563857|FG001|Investigator's Choice|Unresectable Surgery|1
4668767|NCT02301169|7563870|FG000|Overall Study|Adverse Event|1
4668768|NCT02301169|7563871|FG001|Overall Study|Adverse Event|0
4668769|NCT02301390|7563899|FG000|Overall Study|Withdrawal by Subject|3
4668770|NCT02301390|7563900|FG001|Overall Study|Withdrawal by Subject|5
4668771|NCT02301390|7563899|FG000|Overall Study|Protocol Violation|1
4668772|NCT02301390|7563900|FG001|Overall Study|Protocol Violation|0
4668773|NCT02301390|7563899|FG000|Overall Study|Physician Decision|1
4668774|NCT02301390|7563900|FG001|Overall Study|Physician Decision|0
4668775|NCT02301390|7563899|FG000|Overall Study|Lost to Follow-up|0
4668776|NCT02301390|7563900|FG001|Overall Study|Lost to Follow-up|1
4668777|NCT02301390|7563899|FG000|Overall Study|Death|2
4668778|NCT02301390|7563900|FG001|Overall Study|Death|2
4668779|NCT02301390|7563899|FG000|Overall Study|Procedure not completed|0
4668780|NCT02301390|7563900|FG001|Overall Study|Procedure not completed|4
4668781|NCT02301390|7563899|FG000|Overall Study|Missed multiple visits|1
4668782|NCT02301390|7563900|FG001|Overall Study|Missed multiple visits|1
4668783|NCT02301390|7563899|FG000|Overall Study|study terminated|2
4668784|NCT02301390|7563900|FG001|Overall Study|study terminated|0
4668785|NCT02301403|7563908|FG000|Overall Study|Withdrawal by Subject|28
4668786|NCT02301403|7563909|FG001|Overall Study|Withdrawal by Subject|41
4668787|NCT02301429|7563924|FG000|Overall Study|not acceptable vascular anatomy|3
4668788|NCT02301546|7563930|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7
4668789|NCT02301546|7563931|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8
4668790|NCT02301546|7563930|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10
4668791|NCT02301546|7563931|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7
4668792|NCT02301546|7563930|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1
4754022|NCT04294147|7728534|FG000|Overall Study|Protocol Violation|2
4754023|NCT04294147|7728535|FG001|Overall Study|Protocol Violation|0
4754024|NCT04231825|7728547|FG000|Overall Study|Protocol Violation|3
4754025|NCT04231825|7728548|FG001|Overall Study|Protocol Violation|3
4754026|NCT04231825|7728547|FG000|Overall Study|Lost to Follow-up|0
4754027|NCT04231825|7728548|FG001|Overall Study|Lost to Follow-up|1
4754028|NCT04196686|7728554|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0
4754029|NCT04196686|7728555|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3
4754030|NCT04178772|7728561|FG000|Overall Study|Unsatisfacotry VIsual Response|1
4754031|NCT04178772|7728561|FG000|Overall Study|study terminated early due to COVID-19|7
4754032|NCT04148651|7728565|FG000|Overall Study|Lost to Follow-up|2
4754033|NCT03893448|7728580|FG000|Overall Study|Withdrawal by Parent/Guardian|59
4754034|NCT03893448|7728581|FG001|Overall Study|Withdrawal by Parent/Guardian|85
4754035|NCT03893448|7728580|FG000|Overall Study|Physician Decision|8
4754036|NCT03893448|7728581|FG001|Overall Study|Physician Decision|14
4754037|NCT03893448|7728580|FG000|Overall Study|Lost to Follow-up|34
4754038|NCT03893448|7728581|FG001|Overall Study|Lost to Follow-up|27
4754039|NCT03893448|7728580|FG000|Overall Study|Death|1
4754040|NCT03893448|7728581|FG001|Overall Study|Death|0
4754041|NCT03850444|7728620|FG000|Overall Study|Adverse Event|12
4754042|NCT03850444|7728621|FG001|Overall Study|Adverse Event|9
4754043|NCT03850444|7728620|FG000|Overall Study|Death|38
4754044|NCT03850444|7728621|FG001|Overall Study|Death|64
4754045|NCT03850444|7728620|FG000|Overall Study|Lost to Follow-up|0
4754046|NCT03850444|7728621|FG001|Overall Study|Lost to Follow-up|1
4754047|NCT03850444|7728620|FG000|Overall Study|Withdrawal by Subject|0
4754048|NCT03850444|7728621|FG001|Overall Study|Withdrawal by Subject|1
4754049|NCT03850444|7728620|FG000|Overall Study|Ongoing in Study|78
4754050|NCT03850444|7728621|FG001|Overall Study|Ongoing in Study|59
4754051|NCT03814590|7728645|FG000|Overall Study|Adverse Event|0
4754052|NCT03814590|7728646|FG001|Overall Study|Adverse Event|0
4754053|NCT03814590|7728647|FG002|Overall Study|Adverse Event|0
4754054|NCT03814590|7728648|FG003|Overall Study|Adverse Event|0
4754055|NCT03814590|7728649|FG004|Overall Study|Adverse Event|0
4754056|NCT03814590|7728650|FG005|Overall Study|Adverse Event|1
4754057|NCT03814590|7728651|FG006|Overall Study|Adverse Event|1
4754058|NCT03814590|7728652|FG007|Overall Study|Adverse Event|1
4754059|NCT03814590|7728653|FG008|Overall Study|Adverse Event|0
4754060|NCT03814590|7728654|FG009|Overall Study|Adverse Event|0
4754061|NCT03814590|7728655|FG010|Overall Study|Adverse Event|1
4754062|NCT03814590|7728656|FG011|Overall Study|Adverse Event|0
4754063|NCT03814590|7728657|FG012|Overall Study|Adverse Event|3
4754064|NCT03814590|7728658|FG013|Overall Study|Adverse Event|0
4754065|NCT03814590|7728645|FG000|Overall Study|Lost to Follow-up|0
4754066|NCT03814590|7728646|FG001|Overall Study|Lost to Follow-up|2
4754067|NCT03814590|7728647|FG002|Overall Study|Lost to Follow-up|1
4668793|NCT02301546|7563931|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0
4668794|NCT02301546|7563930|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3
4668795|NCT02301546|7563931|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3
4754068|NCT03814590|7728648|FG003|Overall Study|Lost to Follow-up|0
4668796|NCT02301546|7563930|FG000|Long Term Effectiveness (~1 Year)|Death|2
4754069|NCT03814590|7728649|FG004|Overall Study|Lost to Follow-up|1
4754070|NCT03814590|7728650|FG005|Overall Study|Lost to Follow-up|1
4754071|NCT03814590|7728651|FG006|Overall Study|Lost to Follow-up|1
4754072|NCT03814590|7728652|FG007|Overall Study|Lost to Follow-up|1
4754073|NCT03814590|7728653|FG008|Overall Study|Lost to Follow-up|0
4754074|NCT03814590|7728654|FG009|Overall Study|Lost to Follow-up|0
4754075|NCT03814590|7728655|FG010|Overall Study|Lost to Follow-up|1
4668797|NCT02301546|7563931|FG001|Long Term Effectiveness (~1 Year)|Death|0
4668798|NCT02301546|7563930|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6
4668799|NCT02301546|7563931|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2
4668800|NCT02301546|7563930|FG000|Long Term Effectiveness (~1 Year)|moved away|1
4668801|NCT02301546|7563931|FG001|Long Term Effectiveness (~1 Year)|moved away|2
4668802|NCT02301624|7563939|FG000|Blind Induction Phase|Withdrawal by Subject|1
4668803|NCT02301624|7563940|FG001|Blind Induction Phase|Withdrawal by Subject|0
4668804|NCT02301624|7563939|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4
4668805|NCT02301624|7563940|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8
4668806|NCT02301624|7563939|FG000|Open-label Maintenance Phase|Adverse Event|2
4668807|NCT02301624|7563940|FG001|Open-label Maintenance Phase|Adverse Event|5
4668808|NCT02301624|7563939|FG000|Open-label Maintenance Phase|Physician Decision|3
4668809|NCT02301624|7563940|FG001|Open-label Maintenance Phase|Physician Decision|3
4668810|NCT02301624|7563939|FG000|Open-label Maintenance Phase|Death|2
4668811|NCT02301624|7563940|FG001|Open-label Maintenance Phase|Death|1
4668812|NCT02301624|7563939|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1
4668813|NCT02301624|7563940|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0
4668814|NCT02301897|7563959|FG000|Treatment Course 1|Non-Compliance|0
4668815|NCT02301897|7563960|FG001|Treatment Course 1|Non-Compliance|0
4668816|NCT02301897|7563961|FG002|Treatment Course 1|Non-Compliance|1
4668817|NCT02301897|7563959|FG000|Treatment Course 1|Adverse Event|1
4754076|NCT03814590|7728656|FG011|Overall Study|Lost to Follow-up|0
4754077|NCT03814590|7728657|FG012|Overall Study|Lost to Follow-up|0
4754078|NCT03814590|7728658|FG013|Overall Study|Lost to Follow-up|1
4754079|NCT03814590|7728645|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0
4754080|NCT03814590|7728646|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0
4754081|NCT03814590|7728647|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0
4754082|NCT03814590|7728648|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0
4754083|NCT03814590|7728649|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0
4754084|NCT03814590|7728650|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0
4754085|NCT03814590|7728651|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0
4754086|NCT03814590|7728652|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0
4754087|NCT03814590|7728653|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0
4754088|NCT03814590|7728654|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1
4754089|NCT03814590|7728655|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0
4754090|NCT03814590|7728656|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0
4754091|NCT03814590|7728657|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0
4754092|NCT03814590|7728658|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0
4754093|NCT03814590|7728645|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0
4754094|NCT03814590|7728646|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0
4754095|NCT03814590|7728647|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0
4754096|NCT03814590|7728648|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0
4754097|NCT03814590|7728649|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0
4754098|NCT03814590|7728650|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3
4754099|NCT03814590|7728651|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1
4754100|NCT03814590|7728652|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2
4754101|NCT03814590|7728653|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0
4754102|NCT03814590|7728654|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3
4754103|NCT03814590|7728655|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1
4754104|NCT03814590|7728656|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0
4754105|NCT03814590|7728657|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1
4754106|NCT03814590|7728658|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2
4754107|NCT03814590|7728645|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
4754108|NCT03814590|7728646|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
4754109|NCT03814590|7728647|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
4754110|NCT03814590|7728648|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
4754111|NCT03814590|7728649|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
4754112|NCT03814590|7728650|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
4754113|NCT03814590|7728651|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
4754114|NCT03814590|7728652|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1
4754115|NCT03814590|7728653|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
4754116|NCT03814590|7728654|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1
4754117|NCT03814590|7728655|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
4754118|NCT03814590|7728656|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
4668818|NCT02301897|7563960|FG001|Treatment Course 1|Adverse Event|1
4668819|NCT02301897|7563961|FG002|Treatment Course 1|Adverse Event|0
4668820|NCT02301897|7563959|FG000|Treatment Course 1|Lost to Follow-up|1
4668821|NCT02301897|7563960|FG001|Treatment Course 1|Lost to Follow-up|2
4668822|NCT02301897|7563961|FG002|Treatment Course 1|Lost to Follow-up|1
4668823|NCT02301897|7563959|FG000|Treatment Course 1|Withdrawal by Sponsor|0
4668824|NCT02301897|7563960|FG001|Treatment Course 1|Withdrawal by Sponsor|0
4668825|NCT02301897|7563961|FG002|Treatment Course 1|Withdrawal by Sponsor|2
4668826|NCT02301897|7563959|FG000|Treatment Course 1|Withdrawal by Subject|0
4668827|NCT02301897|7563960|FG001|Treatment Course 1|Withdrawal by Subject|0
4668828|NCT02301897|7563961|FG002|Treatment Course 1|Withdrawal by Subject|2
4668829|NCT02301897|7563959|FG000|Treatment Course 1|Other Miscellaneous Reasons|1
4668830|NCT02301897|7563960|FG001|Treatment Course 1|Other Miscellaneous Reasons|0
4668831|NCT02301897|7563961|FG002|Treatment Course 1|Other Miscellaneous Reasons|0
4668832|NCT02301897|7563959|FG000|Treatment Course 2|Lost to Follow-up|0
4668833|NCT02301897|7563960|FG001|Treatment Course 2|Lost to Follow-up|2
4668834|NCT02301897|7563961|FG002|Treatment Course 2|Lost to Follow-up|0
4668835|NCT02301897|7563959|FG000|Treatment Course 2|Pregnancy|0
4668836|NCT02301897|7563960|FG001|Treatment Course 2|Pregnancy|1
4668837|NCT02301897|7563961|FG002|Treatment Course 2|Pregnancy|1
4668838|NCT02301897|7563959|FG000|Treatment Course 2|Withdrawal by Subject|0
4668839|NCT02301897|7563960|FG001|Treatment Course 2|Withdrawal by Subject|2
4668840|NCT02301897|7563961|FG002|Treatment Course 2|Withdrawal by Subject|0
4668841|NCT02301897|7563959|FG000|Treatment Course 2|Other Miscellaneous Reasons|1
4668842|NCT02301897|7563960|FG001|Treatment Course 2|Other Miscellaneous Reasons|0
4668843|NCT02301897|7563961|FG002|Treatment Course 2|Other Miscellaneous Reasons|0
4668844|NCT02301936|7563971|FG000|Overall Study|Lost to Follow-up|1
4668845|NCT02301936|7563972|FG001|Overall Study|Lost to Follow-up|0
4668846|NCT02301975|7563981|FG000|Overall Study|Adverse Event|8
4668847|NCT02301975|7563982|FG001|Overall Study|Adverse Event|3
4668848|NCT02301975|7563983|FG002|Overall Study|Adverse Event|2
4754119|NCT03814590|7728657|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
4754120|NCT03814590|7728658|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
4754121|NCT03814590|7728645|FG000|Overall Study|UNKNOWN REASON|0
4754122|NCT03814590|7728646|FG001|Overall Study|UNKNOWN REASON|0
4754123|NCT03814590|7728647|FG002|Overall Study|UNKNOWN REASON|0
4754124|NCT03814590|7728648|FG003|Overall Study|UNKNOWN REASON|0
4754125|NCT03814590|7728649|FG004|Overall Study|UNKNOWN REASON|0
4754126|NCT03814590|7728650|FG005|Overall Study|UNKNOWN REASON|0
4754127|NCT03814590|7728651|FG006|Overall Study|UNKNOWN REASON|0
4754128|NCT03814590|7728652|FG007|Overall Study|UNKNOWN REASON|1
4754129|NCT03814590|7728653|FG008|Overall Study|UNKNOWN REASON|0
4754130|NCT03814590|7728654|FG009|Overall Study|UNKNOWN REASON|0
4754131|NCT03814590|7728655|FG010|Overall Study|UNKNOWN REASON|0
4754132|NCT03814590|7728656|FG011|Overall Study|UNKNOWN REASON|0
4754133|NCT03814590|7728657|FG012|Overall Study|UNKNOWN REASON|0
4754134|NCT03814590|7728658|FG013|Overall Study|UNKNOWN REASON|0
4754135|NCT03811574|7728701|FG000|Overall Study|Withdrawal by Subject|2
4754136|NCT03811574|7728702|FG001|Overall Study|Withdrawal by Subject|4
4754137|NCT03811574|7728703|FG002|Overall Study|Withdrawal by Subject|0
4668849|NCT02301975|7563981|FG000|Overall Study|Lack of Efficacy|1
4668850|NCT02301975|7563982|FG001|Overall Study|Lack of Efficacy|1
4668851|NCT02301975|7563983|FG002|Overall Study|Lack of Efficacy|1
4668852|NCT02301975|7563981|FG000|Overall Study|Protocol Violation|3
4668853|NCT02301975|7563982|FG001|Overall Study|Protocol Violation|5
4668854|NCT02301975|7563983|FG002|Overall Study|Protocol Violation|3
4668855|NCT02301975|7563981|FG000|Overall Study|Lost to Follow-up|0
4668856|NCT02301975|7563982|FG001|Overall Study|Lost to Follow-up|2
4668857|NCT02301975|7563983|FG002|Overall Study|Lost to Follow-up|2
4668858|NCT02301975|7563981|FG000|Overall Study|Physician Decision|4
4668859|NCT02301975|7563982|FG001|Overall Study|Physician Decision|2
4668860|NCT02301975|7563983|FG002|Overall Study|Physician Decision|3
4668861|NCT02301975|7563981|FG000|Overall Study|Withdrawal by Subject|15
4668862|NCT02301975|7563982|FG001|Overall Study|Withdrawal by Subject|12
4668863|NCT02301975|7563983|FG002|Overall Study|Withdrawal by Subject|11
4668864|NCT02301988|7563993|FG000|Overall Study|Withdrawal by Subject|2
4668865|NCT02301988|7563994|FG001|Overall Study|Withdrawal by Subject|1
4668866|NCT02301988|7563993|FG000|Overall Study|Physician Decision|2
4668867|NCT02301988|7563994|FG001|Overall Study|Physician Decision|2
4668868|NCT02301988|7563993|FG000|Overall Study|Unknown Reason|1
4668869|NCT02301988|7563994|FG001|Overall Study|Unknown Reason|3
4668870|NCT02301988|7563993|FG000|Overall Study|Lack of Efficacy|3
4668871|NCT02301988|7563994|FG001|Overall Study|Lack of Efficacy|2
4668872|NCT02301988|7563993|FG000|Overall Study|Death|1
4668873|NCT02301988|7563994|FG001|Overall Study|Death|0
4668874|NCT02301988|7563993|FG000|Overall Study|Adverse Event|1
4668875|NCT02301988|7563994|FG001|Overall Study|Adverse Event|1
4668876|NCT02302066|7564004|FG000|Overall Study|Adverse Event|1
4668877|NCT02302066|7564005|FG001|Overall Study|Adverse Event|1
4668878|NCT02302066|7564006|FG002|Overall Study|Adverse Event|3
4668879|NCT02302066|7564007|FG003|Overall Study|Adverse Event|0
4668880|NCT02302066|7564004|FG000|Overall Study|Lost to Follow-up|4
4668881|NCT02302066|7564005|FG001|Overall Study|Lost to Follow-up|5
4668882|NCT02302066|7564006|FG002|Overall Study|Lost to Follow-up|24
4668883|NCT02302066|7564007|FG003|Overall Study|Lost to Follow-up|7
4668884|NCT02302066|7564004|FG000|Overall Study|Withdrawal by Subject|25
4668885|NCT02302066|7564005|FG001|Overall Study|Withdrawal by Subject|58
4668886|NCT02302066|7564006|FG002|Overall Study|Withdrawal by Subject|124
4668887|NCT02302066|7564007|FG003|Overall Study|Withdrawal by Subject|33
4668888|NCT02302066|7564004|FG000|Overall Study|Pregnancy|2
4668889|NCT02302066|7564005|FG001|Overall Study|Pregnancy|10
4668890|NCT02302066|7564006|FG002|Overall Study|Pregnancy|12
4668891|NCT02302066|7564007|FG003|Overall Study|Pregnancy|0
4668892|NCT02302066|7564004|FG000|Overall Study|Reason Not Specified|1
4668893|NCT02302066|7564005|FG001|Overall Study|Reason Not Specified|1
4668894|NCT02302066|7564006|FG002|Overall Study|Reason Not Specified|9
4668895|NCT02302066|7564007|FG003|Overall Study|Reason Not Specified|1
4668896|NCT02302222|7564064|FG000|Overall Study|Physician Decision|0
4668897|NCT02302222|7564065|FG001|Overall Study|Physician Decision|4
4668898|NCT02302222|7564064|FG000|Overall Study|Lost to Follow-up|1
4668899|NCT02302222|7564065|FG001|Overall Study|Lost to Follow-up|0
4668900|NCT02302222|7564064|FG000|Overall Study|Treatment discontinued before day 5|0
4668901|NCT02302222|7564065|FG001|Overall Study|Treatment discontinued before day 5|1
4668902|NCT02302222|7564064|FG000|Overall Study|Withdrawn prior to any treatment|0
4668903|NCT02302222|7564065|FG001|Overall Study|Withdrawn prior to any treatment|1
4668904|NCT02302339|7564075|FG000|Overall Study|Lost to Follow-up|1
4668905|NCT02302339|7564076|FG001|Overall Study|Lost to Follow-up|0
4668906|NCT02302339|7564077|FG002|Overall Study|Lost to Follow-up|0
4668907|NCT02302339|7564078|FG003|Overall Study|Lost to Follow-up|0
4668908|NCT02302339|7564075|FG000|Overall Study|Withdrawal by Subject|0
4668909|NCT02302339|7564076|FG001|Overall Study|Withdrawal by Subject|2
4668910|NCT02302339|7564077|FG002|Overall Study|Withdrawal by Subject|1
4668911|NCT02302339|7564078|FG003|Overall Study|Withdrawal by Subject|0
4668912|NCT02302716|7564099|FG000|Overall Study|Adverse Event|1
4668913|NCT02302716|7564100|FG001|Overall Study|Adverse Event|1
4668914|NCT02302716|7564099|FG000|Overall Study|Death|0
4668915|NCT02302716|7564100|FG001|Overall Study|Death|1
4668916|NCT02302716|7564099|FG000|Overall Study|Lack of Efficacy|0
4668917|NCT02302716|7564100|FG001|Overall Study|Lack of Efficacy|1
4668918|NCT02302716|7564099|FG000|Overall Study|Lost to Follow-up|2
4668919|NCT02302716|7564100|FG001|Overall Study|Lost to Follow-up|4
4668920|NCT02302716|7564099|FG000|Overall Study|Physician Decision|3
4668921|NCT02302716|7564100|FG001|Overall Study|Physician Decision|4
4668922|NCT02302716|7564099|FG000|Overall Study|Withdrawal by Subject|13
4668923|NCT02302716|7564100|FG001|Overall Study|Withdrawal by Subject|7
4668924|NCT02302716|7564099|FG000|Overall Study|Protocol Violation|0
4668925|NCT02302716|7564100|FG001|Overall Study|Protocol Violation|1
4668926|NCT02302807|7564108|FG000|Overall Study|Withdrawal by Subject|28
4668927|NCT02302807|7564109|FG001|Overall Study|Withdrawal by Subject|11
4668928|NCT02302807|7564108|FG000|Overall Study|Lost to Follow-up|4
4668929|NCT02302807|7564109|FG001|Overall Study|Lost to Follow-up|6
4668930|NCT02302807|7564108|FG000|Overall Study|Death|397
4668931|NCT02302807|7564109|FG001|Overall Study|Death|385
4668932|NCT02302807|7564108|FG000|Overall Study|Study Terminated By Sponsor|35
4668933|NCT02302807|7564109|FG001|Overall Study|Study Terminated By Sponsor|64
4668934|NCT02302807|7564108|FG000|Overall Study|Physician Decision|0
4668935|NCT02302807|7564109|FG001|Overall Study|Physician Decision|1
4668936|NCT02302846|7564128|FG000|Overall Study|Withdrawal by Subject|1
4668937|NCT02303041|7564134|FG000|Overall Study|Adverse Event|1
4668938|NCT02303041|7564135|FG001|Overall Study|Adverse Event|2
4668939|NCT02303262|7564166|FG000|Overall Study|Withdrawal by Subject|2
4668940|NCT02303574|7564182|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
4668941|NCT02303574|7564183|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
4668942|NCT02303574|7564184|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1
4668943|NCT02303574|7564185|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
4668944|NCT02303574|7564186|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
4668945|NCT02303574|7564187|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
4668946|NCT02303574|7564188|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
4668947|NCT02303574|7564189|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
4668948|NCT02303574|7564190|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
4668949|NCT02303574|7564191|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
4668950|NCT02303574|7564182|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
4668951|NCT02303574|7564183|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
4668952|NCT02303574|7564184|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
4668953|NCT02303574|7564185|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
4668954|NCT02303574|7564186|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
4668955|NCT02303574|7564187|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
4668956|NCT02303574|7564188|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
4668957|NCT02303574|7564189|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1
4668958|NCT02303574|7564190|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
4754138|NCT03727750|7728739|FG000|Overall Study|Death|45
4754139|NCT03727750|7728739|FG000|Overall Study|Withdrawal by Subject|2
4754140|NCT03727750|7728739|FG000|Overall Study|Lost to Follow-up|1
4754141|NCT03727750|7728739|FG000|Overall Study|Other|1
4754142|NCT03726879|7728745|FG000|Overall Study|Death|6
4754143|NCT03726879|7728746|FG001|Overall Study|Death|4
4754144|NCT03726879|7728745|FG000|Overall Study|Physician Decision|0
4754145|NCT03726879|7728746|FG001|Overall Study|Physician Decision|2
4754146|NCT03726879|7728745|FG000|Overall Study|Protocol Violation|0
4754147|NCT03726879|7728746|FG001|Overall Study|Protocol Violation|1
4754148|NCT03726879|7728745|FG000|Overall Study|Withdrawal by Subject|5
4754149|NCT03726879|7728746|FG001|Overall Study|Withdrawal by Subject|5
4754150|NCT03726879|7728745|FG000|Overall Study|TSH result is unstable|0
4754151|NCT03726879|7728746|FG001|Overall Study|TSH result is unstable|1
4754152|NCT03726879|7728745|FG000|Overall Study|Continuing on Study|215
4754153|NCT03726879|7728746|FG001|Overall Study|Continuing on Study|215
4754154|NCT03715829|7728758|FG000|Dose Ranging Period|Adverse Event|2
4754155|NCT03715829|7728759|FG001|Dose Ranging Period|Adverse Event|4
4668959|NCT02303574|7564191|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
4668960|NCT02303704|7564226|FG000|Overall Study|Protocol Violation|5
4668961|NCT02303704|7564227|FG001|Overall Study|Protocol Violation|9
4668962|NCT02304380|7564266|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0
4668963|NCT02304380|7564267|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0
4668964|NCT02304380|7564268|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0
4668965|NCT02304380|7564269|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34
4668966|NCT02304380|7564270|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0
4668967|NCT02304380|7564271|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0
4668968|NCT02304484|7564307|FG000|Overall Study|Death|9
4668969|NCT02304484|7564307|FG000|Overall Study|Withdrawal by Subject|14
4668970|NCT02304484|7564307|FG000|Overall Study|Lost to Follow-up|2
4668971|NCT02304705|7564313|FG000|Overall Study|Withdrawal by Subject|2
4668972|NCT02304705|7564314|FG001|Overall Study|Withdrawal by Subject|0
4668973|NCT02304705|7564313|FG000|Overall Study|Physician Decision|2
4668974|NCT02304705|7564314|FG001|Overall Study|Physician Decision|4
4668975|NCT02304705|7564313|FG000|Overall Study|Death|0
4668976|NCT02304705|7564314|FG001|Overall Study|Death|1
4668977|NCT02304705|7564313|FG000|Overall Study|Lost to Follow-up|0
4668978|NCT02304705|7564314|FG001|Overall Study|Lost to Follow-up|2
4668979|NCT02304926|7564331|FG000|Overall Study|Lost to Follow-up|2
4668980|NCT02304926|7564332|FG001|Overall Study|Lost to Follow-up|1
4668981|NCT02305238|7564356|FG000|Overall Study|Death|2
4668982|NCT02305238|7564357|FG001|Overall Study|Death|1
4668983|NCT02305238|7564358|FG002|Overall Study|Death|0
4668984|NCT02305238|7564356|FG000|Overall Study|Progressive disease|4
4668985|NCT02305238|7564357|FG001|Overall Study|Progressive disease|4
4668986|NCT02305238|7564358|FG002|Overall Study|Progressive disease|0
4754156|NCT03715829|7728760|FG002|Dose Ranging Period|Adverse Event|5
4754157|NCT03715829|7728761|FG003|Dose Ranging Period|Adverse Event|2
4754158|NCT03715829|7728762|FG004|Dose Ranging Period|Adverse Event|3
4754159|NCT03715829|7728763|FG005|Dose Ranging Period|Adverse Event|3
4754160|NCT03715829|7728764|FG006|Dose Ranging Period|Adverse Event|0
4754161|NCT03715829|7728765|FG007|Dose Ranging Period|Adverse Event|0
4754162|NCT03715829|7728766|FG008|Dose Ranging Period|Adverse Event|0
4668987|NCT02305238|7564356|FG000|Overall Study|Logistical difficulties|1
4668988|NCT02305238|7564357|FG001|Overall Study|Logistical difficulties|3
4668989|NCT02305238|7564358|FG002|Overall Study|Logistical difficulties|0
4668990|NCT02305238|7564356|FG000|Overall Study|Protocol Violation|0
4668991|NCT02305238|7564357|FG001|Overall Study|Protocol Violation|3
4668992|NCT02305238|7564358|FG002|Overall Study|Protocol Violation|0
4668993|NCT02305238|7564356|FG000|Overall Study|Physician Decision|2
4668994|NCT02305238|7564357|FG001|Overall Study|Physician Decision|1
4668995|NCT02305238|7564358|FG002|Overall Study|Physician Decision|0
4668996|NCT02305238|7564356|FG000|Overall Study|Adverse Event|4
4668997|NCT02305238|7564357|FG001|Overall Study|Adverse Event|2
4668998|NCT02305238|7564358|FG002|Overall Study|Adverse Event|0
4668999|NCT02305238|7564356|FG000|Overall Study|Withdrawal by Subject|3
4669000|NCT02305238|7564357|FG001|Overall Study|Withdrawal by Subject|4
4669001|NCT02305238|7564358|FG002|Overall Study|Withdrawal by Subject|0
4669002|NCT02305238|7564356|FG000|Overall Study|Randomized failure|0
4669003|NCT02305238|7564357|FG001|Overall Study|Randomized failure|0
4669004|NCT02305238|7564358|FG002|Overall Study|Randomized failure|8
4669005|NCT02305238|7564356|FG000|Overall Study|Required procedure failed|0
4669006|NCT02305238|7564357|FG001|Overall Study|Required procedure failed|1
4669007|NCT02305238|7564358|FG002|Overall Study|Required procedure failed|0
4754163|NCT03715829|7728767|FG009|Dose Ranging Period|Adverse Event|0
4754164|NCT03715829|7728768|FG010|Dose Ranging Period|Adverse Event|0
4754165|NCT03715829|7728758|FG000|Dose Ranging Period|Lack of Efficacy|0
4754166|NCT03715829|7728759|FG001|Dose Ranging Period|Lack of Efficacy|1
4754167|NCT03715829|7728760|FG002|Dose Ranging Period|Lack of Efficacy|0
4754168|NCT03715829|7728761|FG003|Dose Ranging Period|Lack of Efficacy|1
4754169|NCT03715829|7728762|FG004|Dose Ranging Period|Lack of Efficacy|0
4754170|NCT03715829|7728763|FG005|Dose Ranging Period|Lack of Efficacy|0
4754171|NCT03715829|7728764|FG006|Dose Ranging Period|Lack of Efficacy|0
4754172|NCT03715829|7728765|FG007|Dose Ranging Period|Lack of Efficacy|0
4754173|NCT03715829|7728766|FG008|Dose Ranging Period|Lack of Efficacy|0
4754174|NCT03715829|7728767|FG009|Dose Ranging Period|Lack of Efficacy|0
4754175|NCT03715829|7728768|FG010|Dose Ranging Period|Lack of Efficacy|0
4754176|NCT03715829|7728758|FG000|Dose Ranging Period|Lost to Follow-up|2
4754177|NCT03715829|7728759|FG001|Dose Ranging Period|Lost to Follow-up|0
4754178|NCT03715829|7728760|FG002|Dose Ranging Period|Lost to Follow-up|1
4754179|NCT03715829|7728761|FG003|Dose Ranging Period|Lost to Follow-up|1
4754180|NCT03715829|7728762|FG004|Dose Ranging Period|Lost to Follow-up|1
4754181|NCT03715829|7728763|FG005|Dose Ranging Period|Lost to Follow-up|2
4754182|NCT03715829|7728764|FG006|Dose Ranging Period|Lost to Follow-up|0
4754183|NCT03715829|7728765|FG007|Dose Ranging Period|Lost to Follow-up|0
4754184|NCT03715829|7728766|FG008|Dose Ranging Period|Lost to Follow-up|0
4754185|NCT03715829|7728767|FG009|Dose Ranging Period|Lost to Follow-up|0
4754186|NCT03715829|7728768|FG010|Dose Ranging Period|Lost to Follow-up|0
4754187|NCT03715829|7728758|FG000|Dose Ranging Period|Protocol Violation|0
4754188|NCT03715829|7728759|FG001|Dose Ranging Period|Protocol Violation|0
4754189|NCT03715829|7728760|FG002|Dose Ranging Period|Protocol Violation|0
4754190|NCT03715829|7728761|FG003|Dose Ranging Period|Protocol Violation|1
4754191|NCT03715829|7728762|FG004|Dose Ranging Period|Protocol Violation|0
4754192|NCT03715829|7728763|FG005|Dose Ranging Period|Protocol Violation|0
4754193|NCT03715829|7728764|FG006|Dose Ranging Period|Protocol Violation|0
4754194|NCT03715829|7728765|FG007|Dose Ranging Period|Protocol Violation|0
4754195|NCT03715829|7728766|FG008|Dose Ranging Period|Protocol Violation|0
4754196|NCT03715829|7728767|FG009|Dose Ranging Period|Protocol Violation|0
4754197|NCT03715829|7728768|FG010|Dose Ranging Period|Protocol Violation|0
4754198|NCT03715829|7728758|FG000|Dose Ranging Period|Withdrawal by Subject|8
4754199|NCT03715829|7728759|FG001|Dose Ranging Period|Withdrawal by Subject|4
4754200|NCT03715829|7728760|FG002|Dose Ranging Period|Withdrawal by Subject|3
4754201|NCT03715829|7728761|FG003|Dose Ranging Period|Withdrawal by Subject|9
4754202|NCT03715829|7728762|FG004|Dose Ranging Period|Withdrawal by Subject|2
4754203|NCT03715829|7728763|FG005|Dose Ranging Period|Withdrawal by Subject|3
4754204|NCT03715829|7728764|FG006|Dose Ranging Period|Withdrawal by Subject|0
4754205|NCT03715829|7728765|FG007|Dose Ranging Period|Withdrawal by Subject|0
4754206|NCT03715829|7728766|FG008|Dose Ranging Period|Withdrawal by Subject|0
4754207|NCT03715829|7728767|FG009|Dose Ranging Period|Withdrawal by Subject|0
4754208|NCT03715829|7728768|FG010|Dose Ranging Period|Withdrawal by Subject|0
4754209|NCT03715829|7728758|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0
4754210|NCT03715829|7728759|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0
4754211|NCT03715829|7728760|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1
4754212|NCT03715829|7728761|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0
4754213|NCT03715829|7728762|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0
4754214|NCT03715829|7728763|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0
4754215|NCT03715829|7728764|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0
4754216|NCT03715829|7728765|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0
4754217|NCT03715829|7728766|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0
4754218|NCT03715829|7728767|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0
4754219|NCT03715829|7728768|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0
4669008|NCT02305381|7564419|FG000|Overall Study|Unclassified|5
4669009|NCT02305381|7564420|FG001|Overall Study|Unclassified|5
4669010|NCT02305381|7564421|FG002|Overall Study|Unclassified|7
4669011|NCT02305446|7564429|FG000|Overall Study|Adverse Event|1
4669012|NCT02305563|7564438|FG000|Treatment Period|Disease progression|0
4669013|NCT02305563|7564439|FG001|Treatment Period|Disease progression|0
4669014|NCT02305563|7564440|FG002|Treatment Period|Disease progression|15
4669015|NCT02305563|7564441|FG003|Treatment Period|Disease progression|6
4669016|NCT02305563|7564442|FG004|Treatment Period|Disease progression|6
4669017|NCT02305563|7564438|FG000|Treatment Period|Study drug toxicity|0
4669018|NCT02305563|7564439|FG001|Treatment Period|Study drug toxicity|0
4669019|NCT02305563|7564440|FG002|Treatment Period|Study drug toxicity|0
4669020|NCT02305563|7564441|FG003|Treatment Period|Study drug toxicity|1
4669021|NCT02305563|7564442|FG004|Treatment Period|Study drug toxicity|2
4669022|NCT02305563|7564438|FG000|Treatment Period|Death|0
4669023|NCT02305563|7564439|FG001|Treatment Period|Death|0
4669024|NCT02305563|7564440|FG002|Treatment Period|Death|1
4669025|NCT02305563|7564441|FG003|Treatment Period|Death|2
4669026|NCT02305563|7564442|FG004|Treatment Period|Death|1
4669027|NCT02305563|7564438|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0
4669028|NCT02305563|7564439|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0
4669029|NCT02305563|7564440|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7
4669030|NCT02305563|7564441|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1
4669031|NCT02305563|7564442|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2
4669032|NCT02305563|7564438|FG000|Treatment Period|Participant request to stop therapy|0
4669033|NCT02305563|7564439|FG001|Treatment Period|Participant request to stop therapy|2
4669034|NCT02305563|7564440|FG002|Treatment Period|Participant request to stop therapy|0
4669035|NCT02305563|7564441|FG003|Treatment Period|Participant request to stop therapy|1
4669036|NCT02305563|7564442|FG004|Treatment Period|Participant request to stop therapy|0
4669037|NCT02305563|7564438|FG000|Treatment Period|Participant withdrew consent|0
4669038|NCT02305563|7564439|FG001|Treatment Period|Participant withdrew consent|0
4669039|NCT02305563|7564440|FG002|Treatment Period|Participant withdrew consent|1
4669040|NCT02305563|7564441|FG003|Treatment Period|Participant withdrew consent|1
4669041|NCT02305563|7564442|FG004|Treatment Period|Participant withdrew consent|1
4669042|NCT02305563|7564438|FG000|Treatment Period|Maximum clinical benefit|0
4669043|NCT02305563|7564439|FG001|Treatment Period|Maximum clinical benefit|0
4669044|NCT02305563|7564440|FG002|Treatment Period|Maximum clinical benefit|0
4669045|NCT02305563|7564441|FG003|Treatment Period|Maximum clinical benefit|0
4669046|NCT02305563|7564442|FG004|Treatment Period|Maximum clinical benefit|1
4669047|NCT02305563|7564438|FG000|Treatment Period|Poor/non-compliance|0
4669048|NCT02305563|7564439|FG001|Treatment Period|Poor/non-compliance|0
4669049|NCT02305563|7564440|FG002|Treatment Period|Poor/non-compliance|0
4669050|NCT02305563|7564441|FG003|Treatment Period|Poor/non-compliance|0
4669051|NCT02305563|7564442|FG004|Treatment Period|Poor/non-compliance|1
4669052|NCT02305563|7564438|FG000|Treatment Period|Administrative reason by Sponsor|0
4669053|NCT02305563|7564439|FG001|Treatment Period|Administrative reason by Sponsor|0
4669054|NCT02305563|7564440|FG002|Treatment Period|Administrative reason by Sponsor|0
4669055|NCT02305563|7564441|FG003|Treatment Period|Administrative reason by Sponsor|0
4669056|NCT02305563|7564442|FG004|Treatment Period|Administrative reason by Sponsor|1
4669057|NCT02305563|7564438|FG000|Treatment Period|other reason|2
4669058|NCT02305563|7564439|FG001|Treatment Period|other reason|0
4669059|NCT02305563|7564440|FG002|Treatment Period|other reason|2
4669060|NCT02305563|7564441|FG003|Treatment Period|other reason|2
4669061|NCT02305563|7564442|FG004|Treatment Period|other reason|1
4669062|NCT02305563|7564438|FG000|Treatment Period|Randomized but not treated|0
4669063|NCT02305563|7564439|FG001|Treatment Period|Randomized but not treated|0
4669064|NCT02305563|7564440|FG002|Treatment Period|Randomized but not treated|0
4669065|NCT02305563|7564441|FG003|Treatment Period|Randomized but not treated|0
4669066|NCT02305563|7564442|FG004|Treatment Period|Randomized but not treated|2
4669067|NCT02305563|7564438|FG000|Treatment Period|added ULO, then disease progression|0
4669068|NCT02305563|7564439|FG001|Treatment Period|added ULO, then disease progression|0
4669069|NCT02305563|7564440|FG002|Treatment Period|added ULO, then disease progression|0
4669070|NCT02305563|7564441|FG003|Treatment Period|added ULO, then disease progression|0
4669071|NCT02305563|7564442|FG004|Treatment Period|added ULO, then disease progression|4
4669072|NCT02305563|7564438|FG000|Treatment Period|added ULO; then other reason|0
4669073|NCT02305563|7564439|FG001|Treatment Period|added ULO; then other reason|0
4669074|NCT02305563|7564440|FG002|Treatment Period|added ULO; then other reason|0
4669075|NCT02305563|7564441|FG003|Treatment Period|added ULO; then other reason|0
4669076|NCT02305563|7564442|FG004|Treatment Period|added ULO; then other reason|1
4669077|NCT02305563|7564438|FG000|Treatment Period|added ULO, then request to stop|0
4669078|NCT02305563|7564439|FG001|Treatment Period|added ULO, then request to stop|0
4669079|NCT02305563|7564440|FG002|Treatment Period|added ULO, then request to stop|0
4669080|NCT02305563|7564441|FG003|Treatment Period|added ULO, then request to stop|0
4669081|NCT02305563|7564442|FG004|Treatment Period|added ULO, then request to stop|1
4669082|NCT02305563|7564438|FG000|Follow-up Period|Death|0
4669083|NCT02305563|7564439|FG001|Follow-up Period|Death|0
4669084|NCT02305563|7564440|FG002|Follow-up Period|Death|5
4669085|NCT02305563|7564441|FG003|Follow-up Period|Death|4
4669086|NCT02305563|7564442|FG004|Follow-up Period|Death|7
4669087|NCT02305563|7564438|FG000|Follow-up Period|Participant withdrew consent|0
4669088|NCT02305563|7564439|FG001|Follow-up Period|Participant withdrew consent|0
4669089|NCT02305563|7564440|FG002|Follow-up Period|Participant withdrew consent|2
4669090|NCT02305563|7564441|FG003|Follow-up Period|Participant withdrew consent|1
4669091|NCT02305563|7564442|FG004|Follow-up Period|Participant withdrew consent|0
4669092|NCT02305563|7564438|FG000|Follow-up Period|other reason|0
4669093|NCT02305563|7564439|FG001|Follow-up Period|other reason|0
4669094|NCT02305563|7564440|FG002|Follow-up Period|other reason|0
4754220|NCT03715829|7728758|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0
4754221|NCT03715829|7728759|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0
4754222|NCT03715829|7728760|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1
4754223|NCT03715829|7728761|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0
4754224|NCT03715829|7728762|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1
4754225|NCT03715829|7728763|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0
4754226|NCT03715829|7728764|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0
4754227|NCT03715829|7728765|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0
4754228|NCT03715829|7728766|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0
4754229|NCT03715829|7728767|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0
4754230|NCT03715829|7728768|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0
4754231|NCT03715829|7728758|FG000|Dose Ranging Period|Other|0
4669095|NCT02305563|7564441|FG003|Follow-up Period|other reason|0
4669096|NCT02305563|7564442|FG004|Follow-up Period|other reason|1
4669097|NCT02305563|7564438|FG000|Follow-up Period|Followup no longer required per protocol|3
4669098|NCT02305563|7564439|FG001|Follow-up Period|Followup no longer required per protocol|3
4669099|NCT02305563|7564440|FG002|Follow-up Period|Followup no longer required per protocol|4
4669100|NCT02305563|7564441|FG003|Follow-up Period|Followup no longer required per protocol|1
4669101|NCT02305563|7564442|FG004|Follow-up Period|Followup no longer required per protocol|4
4669102|NCT02305758|7564465|FG000|Overall Study|Death|27
4669103|NCT02305758|7564466|FG001|Overall Study|Death|27
4669104|NCT02305758|7564465|FG000|Overall Study|Withdrew consent|9
4669105|NCT02305758|7564466|FG001|Overall Study|Withdrew consent|2
4669106|NCT02305758|7564465|FG000|Overall Study|Lost to Follow-up|6
4669107|NCT02305758|7564466|FG001|Overall Study|Lost to Follow-up|1
4669108|NCT02305758|7564465|FG000|Overall Study|Study Terminated by Sponsor|21
4669109|NCT02305758|7564466|FG001|Overall Study|Study Terminated by Sponsor|34
4669110|NCT02305758|7564465|FG000|Overall Study|Other, not specified|2
4669111|NCT02305758|7564466|FG001|Overall Study|Other, not specified|1
4669112|NCT02305797|7564474|FG000|Overall Study|Adverse Event|11
4669113|NCT02305797|7564475|FG001|Overall Study|Adverse Event|2
4669114|NCT02305797|7564474|FG000|Overall Study|Withdrawal by Subject|9
4669115|NCT02305797|7564475|FG001|Overall Study|Withdrawal by Subject|10
4669116|NCT02305797|7564474|FG000|Overall Study|Lack of Efficacy|6
4669117|NCT02305797|7564475|FG001|Overall Study|Lack of Efficacy|0
4669118|NCT02305797|7564474|FG000|Overall Study|Lost to Follow-up|5
4669119|NCT02305797|7564475|FG001|Overall Study|Lost to Follow-up|11
4669120|NCT02305797|7564474|FG000|Overall Study|Pregnancy|0
4669121|NCT02305797|7564475|FG001|Overall Study|Pregnancy|2
4669122|NCT02305797|7564474|FG000|Overall Study|Noncompliance|14
4669123|NCT02305797|7564475|FG001|Overall Study|Noncompliance|12
4669124|NCT02305797|7564474|FG000|Overall Study|Reason not collected|0
4669125|NCT02305797|7564475|FG001|Overall Study|Reason not collected|1
4669126|NCT02305849|7564484|FG000|Overall Study|Adverse Event|10
4669127|NCT02305849|7564485|FG001|Overall Study|Adverse Event|12
4669128|NCT02305849|7564486|FG002|Overall Study|Adverse Event|7
4669129|NCT02305849|7564487|FG003|Overall Study|Adverse Event|3
4669130|NCT02305849|7564484|FG000|Overall Study|Lack of Efficacy|10
4669131|NCT02305849|7564485|FG001|Overall Study|Lack of Efficacy|6
4669132|NCT02305849|7564486|FG002|Overall Study|Lack of Efficacy|3
4669133|NCT02305849|7564487|FG003|Overall Study|Lack of Efficacy|9
4669134|NCT02305849|7564484|FG000|Overall Study|Withdrawal by Subject|2
4669135|NCT02305849|7564485|FG001|Overall Study|Withdrawal by Subject|2
4669136|NCT02305849|7564486|FG002|Overall Study|Withdrawal by Subject|1
4669137|NCT02305849|7564487|FG003|Overall Study|Withdrawal by Subject|4
4669138|NCT02305849|7564484|FG000|Overall Study|Lost to Follow-up|0
4669139|NCT02305849|7564485|FG001|Overall Study|Lost to Follow-up|2
4669140|NCT02305849|7564486|FG002|Overall Study|Lost to Follow-up|0
4669141|NCT02305849|7564487|FG003|Overall Study|Lost to Follow-up|0
4669142|NCT02305849|7564484|FG000|Overall Study|Protocol Violation|3
4669143|NCT02305849|7564485|FG001|Overall Study|Protocol Violation|2
4669144|NCT02305849|7564486|FG002|Overall Study|Protocol Violation|1
4669145|NCT02305849|7564487|FG003|Overall Study|Protocol Violation|1
4669146|NCT02305849|7564484|FG000|Overall Study|Lab data met discontinuation criteria|0
4669147|NCT02305849|7564485|FG001|Overall Study|Lab data met discontinuation criteria|1
4669148|NCT02305849|7564486|FG002|Overall Study|Lab data met discontinuation criteria|2
4669149|NCT02305849|7564487|FG003|Overall Study|Lab data met discontinuation criteria|1
4669150|NCT02305849|7564484|FG000|Overall Study|Miscellaneous|1
4669151|NCT02305849|7564485|FG001|Overall Study|Miscellaneous|2
4669152|NCT02305849|7564486|FG002|Overall Study|Miscellaneous|4
4669153|NCT02305849|7564487|FG003|Overall Study|Miscellaneous|1
4669154|NCT02305849|7564484|FG000|Overall Study|Not fulfill eligibility criteria|1
4669155|NCT02305849|7564485|FG001|Overall Study|Not fulfill eligibility criteria|1
4669156|NCT02305849|7564486|FG002|Overall Study|Not fulfill eligibility criteria|0
4669157|NCT02305849|7564487|FG003|Overall Study|Not fulfill eligibility criteria|0
4669158|NCT02305888|7564521|FG000|Overall Study|Lost to Follow-up|0
4669159|NCT02305888|7564522|FG001|Overall Study|Lost to Follow-up|0
4669160|NCT02305888|7564523|FG002|Overall Study|Lost to Follow-up|1
4669161|NCT02305888|7564521|FG000|Overall Study|Adverse Event|0
4669162|NCT02305888|7564522|FG001|Overall Study|Adverse Event|1
4669163|NCT02305888|7564523|FG002|Overall Study|Adverse Event|0
4669164|NCT02306265|7564531|FG000|Overall Study|Withdrawal by Subject|1
4669165|NCT02306694|7564536|FG000|Overall Study|Withdrawal by Subject|3
4669166|NCT02306694|7564536|FG000|Overall Study|Lost to Follow-up|1
4669167|NCT02306850|7564551|FG000|Overall Study|Lack of Efficacy|2
4669168|NCT02307266|7564567|FG000|Overall Study|Adverse Event|3
4669169|NCT02307266|7564568|FG001|Overall Study|Adverse Event|1
4669170|NCT02307266|7564569|FG002|Overall Study|Adverse Event|5
4669171|NCT02307266|7564567|FG000|Overall Study|Withdrawal by Subject|2
4669172|NCT02307266|7564568|FG001|Overall Study|Withdrawal by Subject|0
4669173|NCT02307266|7564569|FG002|Overall Study|Withdrawal by Subject|1
4669174|NCT02307266|7564567|FG000|Overall Study|Lost to Follow-up|3
4669175|NCT02307266|7564568|FG001|Overall Study|Lost to Follow-up|0
4669176|NCT02307266|7564569|FG002|Overall Study|Lost to Follow-up|0
4669177|NCT02307370|7564581|FG000|Overall Study|Death|5
4669178|NCT02307370|7564581|FG000|Overall Study|Lost to Follow-up|1
4669179|NCT02307370|7564581|FG000|Overall Study|Withdrawal by Subject|1
4669180|NCT02307370|7564581|FG000|Overall Study|Declined Addendum ICF|6
4669181|NCT02307370|7564581|FG000|Overall Study|No response during telephone contact|5
4669182|NCT02307370|7564581|FG000|Overall Study|Protocol Violation|1
4669183|NCT02307513|7564589|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4
4669184|NCT02307513|7564590|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3
4669185|NCT02307513|7564589|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8
4669186|NCT02307513|7564590|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0
4669187|NCT02307513|7564589|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1
4669188|NCT02307513|7564590|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0
4669189|NCT02307513|7564589|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5
4669190|NCT02307513|7564590|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4
4669191|NCT02307513|7564589|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1
4669192|NCT02307513|7564590|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0
4669193|NCT02307513|7564589|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1
4669194|NCT02307513|7564590|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1
4669195|NCT02307513|7564589|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0
4669196|NCT02307513|7564590|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1
4669197|NCT02307513|7564589|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4
4669198|NCT02307513|7564590|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9
4669199|NCT02307513|7564589|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2
4669200|NCT02307513|7564590|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2
4669201|NCT02307513|7564589|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7
4669202|NCT02307513|7564590|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7
4669203|NCT02307513|7564589|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1
4669204|NCT02307513|7564590|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1
4669205|NCT02307513|7564589|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1
4669206|NCT02307513|7564590|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0
4669207|NCT02307513|7564589|FG000|Long-term Extension|Physician Decision|1
4669208|NCT02307513|7564590|FG001|Long-term Extension|Physician Decision|0
4669209|NCT02307682|7564613|FG000|Overall Study|Adverse Event|9
4669210|NCT02307682|7564614|FG001|Overall Study|Adverse Event|8
4669211|NCT02307682|7564615|FG002|Overall Study|Adverse Event|12
4669212|NCT02307682|7564613|FG000|Overall Study|Lack of Efficacy|1
4669213|NCT02307682|7564614|FG001|Overall Study|Lack of Efficacy|0
4669214|NCT02307682|7564615|FG002|Overall Study|Lack of Efficacy|1
4669215|NCT02307682|7564613|FG000|Overall Study|Physician Decision|2
4669216|NCT02307682|7564614|FG001|Overall Study|Physician Decision|2
4669217|NCT02307682|7564615|FG002|Overall Study|Physician Decision|8
4669218|NCT02307682|7564613|FG000|Overall Study|Progressive Disease|1
4669219|NCT02307682|7564614|FG001|Overall Study|Progressive Disease|0
4669220|NCT02307682|7564615|FG002|Overall Study|Progressive Disease|0
4669221|NCT02307682|7564613|FG000|Overall Study|Withdrawal by Subject|26
4669222|NCT02307682|7564614|FG001|Overall Study|Withdrawal by Subject|34
4669223|NCT02307682|7564615|FG002|Overall Study|Withdrawal by Subject|23
4669224|NCT02307682|7564613|FG000|Overall Study|Death|9
4669225|NCT02307682|7564614|FG001|Overall Study|Death|7
4669226|NCT02307682|7564615|FG002|Overall Study|Death|12
4669227|NCT02307682|7564613|FG000|Overall Study|Lost to Follow-up|1
4669228|NCT02307682|7564614|FG001|Overall Study|Lost to Follow-up|5
4669229|NCT02307682|7564615|FG002|Overall Study|Lost to Follow-up|6
4669230|NCT02307682|7564613|FG000|Overall Study|Protocol Deviation|0
4669231|NCT02307682|7564614|FG001|Overall Study|Protocol Deviation|0
4669232|NCT02307682|7564615|FG002|Overall Study|Protocol Deviation|2
4669233|NCT02307682|7564613|FG000|Overall Study|Other|1
4669234|NCT02307682|7564614|FG001|Overall Study|Other|1
4669235|NCT02307682|7564615|FG002|Overall Study|Other|0
4669236|NCT02308007|7564649|FG000|Overall Study|Normal Gram stain or neg yeast culture|66
4669237|NCT02308007|7564650|FG001|Overall Study|Normal Gram stain or neg yeast culture|64
4669238|NCT02308007|7564651|FG002|Overall Study|Normal Gram stain or neg yeast culture|67
4669239|NCT02308007|7564649|FG000|Overall Study|Positive for STD at Baseline|7
4669240|NCT02308007|7564650|FG001|Overall Study|Positive for STD at Baseline|11
4669241|NCT02308007|7564651|FG002|Overall Study|Positive for STD at Baseline|7
4669242|NCT02308007|7564649|FG000|Overall Study|Lost to Follow-up|3
4669243|NCT02308007|7564650|FG001|Overall Study|Lost to Follow-up|0
4669244|NCT02308007|7564651|FG002|Overall Study|Lost to Follow-up|1
4669245|NCT02308020|7564665|FG000|Overall Study|Lost to Follow-up|1
4669246|NCT02308020|7564666|FG001|Overall Study|Lost to Follow-up|7
4669247|NCT02308020|7564667|FG002|Overall Study|Lost to Follow-up|0
4669248|NCT02308020|7564668|FG003|Overall Study|Lost to Follow-up|0
4669249|NCT02308020|7564669|FG004|Overall Study|Lost to Follow-up|1
4669250|NCT02308020|7564670|FG005|Overall Study|Lost to Follow-up|2
4669251|NCT02308020|7564665|FG000|Overall Study|Sponsor Decision|0
4669252|NCT02308020|7564666|FG001|Overall Study|Sponsor Decision|8
4669253|NCT02308020|7564667|FG002|Overall Study|Sponsor Decision|0
4669254|NCT02308020|7564668|FG003|Overall Study|Sponsor Decision|2
4669255|NCT02308020|7564669|FG004|Overall Study|Sponsor Decision|2
4669256|NCT02308020|7564670|FG005|Overall Study|Sponsor Decision|1
4669257|NCT02308020|7564665|FG000|Overall Study|Withdrawal by Subject|3
4669258|NCT02308020|7564666|FG001|Overall Study|Withdrawal by Subject|5
4669259|NCT02308020|7564667|FG002|Overall Study|Withdrawal by Subject|3
4669260|NCT02308020|7564668|FG003|Overall Study|Withdrawal by Subject|2
4669261|NCT02308020|7564669|FG004|Overall Study|Withdrawal by Subject|1
4669262|NCT02308020|7564670|FG005|Overall Study|Withdrawal by Subject|2
4669263|NCT02308033|7564692|FG000|Overall Study|Normal Gram stain at Baseline|13
4669264|NCT02308033|7564693|FG001|Overall Study|Normal Gram stain at Baseline|10
4669265|NCT02308033|7564692|FG000|Overall Study|Positive for STD at Baseline|7
4669266|NCT02308033|7564693|FG001|Overall Study|Positive for STD at Baseline|4
4669267|NCT02308033|7564692|FG000|Overall Study|Lost to Follow-up|6
4669268|NCT02308033|7564693|FG001|Overall Study|Lost to Follow-up|5
4669269|NCT02308046|7564701|FG000|Overall Study|Negative yeast culture at Baseline|32
4669270|NCT02308046|7564702|FG001|Overall Study|Negative yeast culture at Baseline|33
4669271|NCT02308046|7564701|FG000|Overall Study|Positive for STD at Baseline|1
4669272|NCT02308046|7564702|FG001|Overall Study|Positive for STD at Baseline|2
4669273|NCT02308046|7564701|FG000|Overall Study|Lost to Follow-up|1
4669274|NCT02308046|7564702|FG001|Overall Study|Lost to Follow-up|3
4669275|NCT02308124|7564711|FG000|Overall Study|Lost to Follow-up|6
4669276|NCT02308124|7564712|FG001|Overall Study|Lost to Follow-up|6
4669277|NCT02308124|7564713|FG002|Overall Study|Lost to Follow-up|6
4669278|NCT02308124|7564711|FG000|Overall Study|Adverse Event|0
4669279|NCT02308124|7564712|FG001|Overall Study|Adverse Event|2
4669280|NCT02308124|7564713|FG002|Overall Study|Adverse Event|2
4669281|NCT02308163|7564725|FG000|Overall Study|Not fulfill eligible criteria|1
4669282|NCT02308163|7564726|FG001|Overall Study|Not fulfill eligible criteria|2
4669283|NCT02308163|7564727|FG002|Overall Study|Not fulfill eligible criteria|0
4669284|NCT02308163|7564728|FG003|Overall Study|Not fulfill eligible criteria|1
4669285|NCT02308163|7564729|FG004|Overall Study|Not fulfill eligible criteria|1
4669286|NCT02308163|7564725|FG000|Overall Study|Adverse Event|9
4669287|NCT02308163|7564726|FG001|Overall Study|Adverse Event|5
4669288|NCT02308163|7564727|FG002|Overall Study|Adverse Event|2
4669289|NCT02308163|7564728|FG003|Overall Study|Adverse Event|2
4669290|NCT02308163|7564729|FG004|Overall Study|Adverse Event|11
4669291|NCT02308163|7564725|FG000|Overall Study|Lack of Efficacy|11
4669292|NCT02308163|7564726|FG001|Overall Study|Lack of Efficacy|3
4669293|NCT02308163|7564727|FG002|Overall Study|Lack of Efficacy|8
4669294|NCT02308163|7564728|FG003|Overall Study|Lack of Efficacy|4
4669295|NCT02308163|7564729|FG004|Overall Study|Lack of Efficacy|6
4669296|NCT02308163|7564725|FG000|Overall Study|Withdrawal of consent|2
4669297|NCT02308163|7564726|FG001|Overall Study|Withdrawal of consent|3
4669298|NCT02308163|7564727|FG002|Overall Study|Withdrawal of consent|0
4669299|NCT02308163|7564728|FG003|Overall Study|Withdrawal of consent|2
4669300|NCT02308163|7564729|FG004|Overall Study|Withdrawal of consent|6
4669301|NCT02308163|7564725|FG000|Overall Study|Protocol Violation|3
4669302|NCT02308163|7564726|FG001|Overall Study|Protocol Violation|3
4669303|NCT02308163|7564727|FG002|Overall Study|Protocol Violation|3
4669304|NCT02308163|7564728|FG003|Overall Study|Protocol Violation|2
4669305|NCT02308163|7564729|FG004|Overall Study|Protocol Violation|5
4669306|NCT02308163|7564725|FG000|Overall Study|Lab data met discontinuation criteria|3
4669307|NCT02308163|7564726|FG001|Overall Study|Lab data met discontinuation criteria|0
4669308|NCT02308163|7564727|FG002|Overall Study|Lab data met discontinuation criteria|0
4669309|NCT02308163|7564728|FG003|Overall Study|Lab data met discontinuation criteria|2
4669310|NCT02308163|7564729|FG004|Overall Study|Lab data met discontinuation criteria|0
4669311|NCT02308163|7564725|FG000|Overall Study|Miscellaneous|2
4669312|NCT02308163|7564726|FG001|Overall Study|Miscellaneous|2
4669313|NCT02308163|7564727|FG002|Overall Study|Miscellaneous|1
4669314|NCT02308163|7564728|FG003|Overall Study|Miscellaneous|0
4669315|NCT02308163|7564729|FG004|Overall Study|Miscellaneous|5
4669316|NCT02308228|7564767|FG000|Overall Study|Adverse Event|3
4669317|NCT02308228|7564768|FG001|Overall Study|Adverse Event|4
4669318|NCT02308228|7564767|FG000|Overall Study|Withdrawal by Subject|5
4669319|NCT02308228|7564768|FG001|Overall Study|Withdrawal by Subject|3
4669320|NCT02308540|7564806|FG000|Overall Study|Lost to Follow-up|0
4669321|NCT02308540|7564807|FG001|Overall Study|Lost to Follow-up|0
4669322|NCT02308540|7564808|FG002|Overall Study|Lost to Follow-up|0
4669323|NCT02308540|7564809|FG003|Overall Study|Lost to Follow-up|0
4669324|NCT02308540|7564810|FG004|Overall Study|Lost to Follow-up|0
4669325|NCT02308540|7564811|FG005|Overall Study|Lost to Follow-up|1
4669326|NCT02308696|7564862|FG000|Overall Study|Lost to Follow-up|28
4669327|NCT02308696|7564863|FG001|Overall Study|Lost to Follow-up|21
4669328|NCT02308696|7564862|FG000|Overall Study|Death|8
4669329|NCT02308696|7564863|FG001|Overall Study|Death|4
4669330|NCT02308696|7564862|FG000|Overall Study|Moved to a Higher Level of Care|17
4669331|NCT02308696|7564863|FG001|Overall Study|Moved to a Higher Level of Care|6
4669332|NCT02308748|7564869|FG000|Period 1|Withdrawal by Subject|0
4669333|NCT02308748|7564870|FG001|Period 1|Withdrawal by Subject|0
4669334|NCT02308748|7564871|FG002|Period 1|Withdrawal by Subject|1
4754232|NCT03715829|7728759|FG001|Dose Ranging Period|Other|0
4754233|NCT03715829|7728760|FG002|Dose Ranging Period|Other|2
4754234|NCT03715829|7728761|FG003|Dose Ranging Period|Other|0
4754235|NCT03715829|7728762|FG004|Dose Ranging Period|Other|0
4754236|NCT03715829|7728763|FG005|Dose Ranging Period|Other|3
4754237|NCT03715829|7728764|FG006|Dose Ranging Period|Other|0
4754238|NCT03715829|7728765|FG007|Dose Ranging Period|Other|0
4754239|NCT03715829|7728766|FG008|Dose Ranging Period|Other|0
4754240|NCT03715829|7728767|FG009|Dose Ranging Period|Other|0
4754241|NCT03715829|7728768|FG010|Dose Ranging Period|Other|0
4754242|NCT03715829|7728758|FG000|Extension Period|Adverse Event|0
4754243|NCT03715829|7728759|FG001|Extension Period|Adverse Event|0
4754244|NCT03715829|7728760|FG002|Extension Period|Adverse Event|0
4754245|NCT03715829|7728761|FG003|Extension Period|Adverse Event|0
4754246|NCT03715829|7728762|FG004|Extension Period|Adverse Event|0
4754247|NCT03715829|7728763|FG005|Extension Period|Adverse Event|0
4754248|NCT03715829|7728764|FG006|Extension Period|Adverse Event|3
4754249|NCT03715829|7728765|FG007|Extension Period|Adverse Event|1
4754250|NCT03715829|7728766|FG008|Extension Period|Adverse Event|6
4754251|NCT03715829|7728767|FG009|Extension Period|Adverse Event|0
4754252|NCT03715829|7728768|FG010|Extension Period|Adverse Event|0
4754253|NCT03715829|7728758|FG000|Extension Period|Lack of Efficacy|0
4754254|NCT03715829|7728759|FG001|Extension Period|Lack of Efficacy|0
4754255|NCT03715829|7728760|FG002|Extension Period|Lack of Efficacy|0
4754256|NCT03715829|7728761|FG003|Extension Period|Lack of Efficacy|0
4754257|NCT03715829|7728762|FG004|Extension Period|Lack of Efficacy|0
4754258|NCT03715829|7728763|FG005|Extension Period|Lack of Efficacy|0
4754259|NCT03715829|7728764|FG006|Extension Period|Lack of Efficacy|1
4754260|NCT03715829|7728765|FG007|Extension Period|Lack of Efficacy|9
4754261|NCT03715829|7728766|FG008|Extension Period|Lack of Efficacy|2
4754262|NCT03715829|7728767|FG009|Extension Period|Lack of Efficacy|0
4754263|NCT03715829|7728768|FG010|Extension Period|Lack of Efficacy|0
4754264|NCT03715829|7728758|FG000|Extension Period|Lost to Follow-up|0
4754265|NCT03715829|7728759|FG001|Extension Period|Lost to Follow-up|0
4754266|NCT03715829|7728760|FG002|Extension Period|Lost to Follow-up|0
4754267|NCT03715829|7728761|FG003|Extension Period|Lost to Follow-up|0
4754268|NCT03715829|7728762|FG004|Extension Period|Lost to Follow-up|0
4754269|NCT03715829|7728763|FG005|Extension Period|Lost to Follow-up|0
4754270|NCT03715829|7728764|FG006|Extension Period|Lost to Follow-up|0
4754271|NCT03715829|7728765|FG007|Extension Period|Lost to Follow-up|0
4754272|NCT03715829|7728766|FG008|Extension Period|Lost to Follow-up|2
4754273|NCT03715829|7728767|FG009|Extension Period|Lost to Follow-up|0
4754274|NCT03715829|7728768|FG010|Extension Period|Lost to Follow-up|0
4669335|NCT02308748|7564872|FG003|Period 1|Withdrawal by Subject|0
4669336|NCT02308748|7564873|FG004|Period 1|Withdrawal by Subject|0
4669337|NCT02308748|7564874|FG005|Period 1|Withdrawal by Subject|0
4669338|NCT02308748|7564875|FG006|Period 1|Withdrawal by Subject|0
4669339|NCT02308748|7564876|FG007|Period 1|Withdrawal by Subject|0
4669340|NCT02308748|7564877|FG008|Period 1|Withdrawal by Subject|0
4669341|NCT02308748|7564878|FG009|Period 1|Withdrawal by Subject|0
4669342|NCT02308748|7564869|FG000|Period 2|Adverse Event|0
4669343|NCT02308748|7564870|FG001|Period 2|Adverse Event|0
4669344|NCT02308748|7564871|FG002|Period 2|Adverse Event|0
4669345|NCT02308748|7564872|FG003|Period 2|Adverse Event|0
4754275|NCT03715829|7728758|FG000|Extension Period|Protocol Violation|0
4754276|NCT03715829|7728759|FG001|Extension Period|Protocol Violation|0
4754277|NCT03715829|7728760|FG002|Extension Period|Protocol Violation|0
4669346|NCT02308748|7564873|FG004|Period 2|Adverse Event|0
4669347|NCT02308748|7564874|FG005|Period 2|Adverse Event|0
4669348|NCT02308748|7564875|FG006|Period 2|Adverse Event|0
4669349|NCT02308748|7564876|FG007|Period 2|Adverse Event|1
4669350|NCT02308748|7564877|FG008|Period 2|Adverse Event|0
4669351|NCT02308748|7564878|FG009|Period 2|Adverse Event|0
4669352|NCT02308748|7564869|FG000|Period 3|Protocol Violation|0
4669353|NCT02308748|7564870|FG001|Period 3|Protocol Violation|0
4669354|NCT02308748|7564871|FG002|Period 3|Protocol Violation|0
4669355|NCT02308748|7564872|FG003|Period 3|Protocol Violation|0
4669356|NCT02308748|7564873|FG004|Period 3|Protocol Violation|0
4669357|NCT02308748|7564874|FG005|Period 3|Protocol Violation|0
4669358|NCT02308748|7564875|FG006|Period 3|Protocol Violation|0
4669359|NCT02308748|7564876|FG007|Period 3|Protocol Violation|0
4669360|NCT02308748|7564877|FG008|Period 3|Protocol Violation|0
4669361|NCT02308748|7564878|FG009|Period 3|Protocol Violation|1
4669362|NCT02308748|7564869|FG000|Period 5|Adverse Event|1
4669363|NCT02308748|7564870|FG001|Period 5|Adverse Event|0
4669364|NCT02308748|7564871|FG002|Period 5|Adverse Event|0
4669365|NCT02308748|7564872|FG003|Period 5|Adverse Event|0
4669366|NCT02308748|7564873|FG004|Period 5|Adverse Event|0
4669367|NCT02308748|7564874|FG005|Period 5|Adverse Event|0
4669368|NCT02308748|7564875|FG006|Period 5|Adverse Event|0
4669369|NCT02308748|7564876|FG007|Period 5|Adverse Event|0
4669370|NCT02308748|7564877|FG008|Period 5|Adverse Event|1
4669371|NCT02308748|7564878|FG009|Period 5|Adverse Event|0
4669372|NCT02309099|7564900|FG000|Overall Study|Adverse Event|2
4669373|NCT02309099|7564901|FG001|Overall Study|Adverse Event|0
4669374|NCT02309112|7564910|FG000|Overall Study|Withdrawal by Subject|1
4669375|NCT02309112|7564911|FG001|Overall Study|Withdrawal by Subject|0
4669376|NCT02309112|7564912|FG002|Overall Study|Withdrawal by Subject|1
4669377|NCT02309112|7564910|FG000|Overall Study|Lost to Follow-up|0
4669378|NCT02309112|7564911|FG001|Overall Study|Lost to Follow-up|1
4669379|NCT02309112|7564912|FG002|Overall Study|Lost to Follow-up|0
4669380|NCT02309138|7564924|FG000|Overall Study|Withdrawal by Subject|44
4669381|NCT02309138|7564925|FG001|Overall Study|Withdrawal by Subject|15
4669382|NCT02309138|7564924|FG000|Overall Study|Protocol Violation|4
4669383|NCT02309138|7564925|FG001|Overall Study|Protocol Violation|2
4669384|NCT02309138|7564924|FG000|Overall Study|delivered before visit 2|0
4669385|NCT02309138|7564925|FG001|Overall Study|delivered before visit 2|1
4669386|NCT02309294|7564941|FG000|Overall Study|Withdrawal by Subject|2
4669387|NCT02309359|7564950|FG000|Overall Study|Adverse Event|4
4669388|NCT02309359|7564951|FG001|Overall Study|Adverse Event|5
4669389|NCT02309359|7564952|FG002|Overall Study|Adverse Event|5
4669390|NCT02309359|7564953|FG003|Overall Study|Adverse Event|4
4669391|NCT02309359|7564954|FG004|Overall Study|Adverse Event|4
4669392|NCT02309359|7564950|FG000|Overall Study|Death|1
4669393|NCT02309359|7564951|FG001|Overall Study|Death|0
4669394|NCT02309359|7564952|FG002|Overall Study|Death|0
4669395|NCT02309359|7564953|FG003|Overall Study|Death|0
4669396|NCT02309359|7564954|FG004|Overall Study|Death|0
4669397|NCT02309359|7564950|FG000|Overall Study|Withdrawal by Subject|2
4669398|NCT02309359|7564951|FG001|Overall Study|Withdrawal by Subject|2
4669399|NCT02309359|7564952|FG002|Overall Study|Withdrawal by Subject|4
4669400|NCT02309359|7564953|FG003|Overall Study|Withdrawal by Subject|4
4669401|NCT02309359|7564954|FG004|Overall Study|Withdrawal by Subject|0
4669402|NCT02309359|7564950|FG000|Overall Study|Lack of Efficacy|3
4669403|NCT02309359|7564951|FG001|Overall Study|Lack of Efficacy|1
4669404|NCT02309359|7564952|FG002|Overall Study|Lack of Efficacy|0
4669405|NCT02309359|7564953|FG003|Overall Study|Lack of Efficacy|0
4669406|NCT02309359|7564954|FG004|Overall Study|Lack of Efficacy|3
4669407|NCT02309359|7564950|FG000|Overall Study|Lost to Follow-up|0
4669408|NCT02309359|7564951|FG001|Overall Study|Lost to Follow-up|0
4669409|NCT02309359|7564952|FG002|Overall Study|Lost to Follow-up|0
4669410|NCT02309359|7564953|FG003|Overall Study|Lost to Follow-up|1
4669411|NCT02309359|7564954|FG004|Overall Study|Lost to Follow-up|0
4669412|NCT02309359|7564950|FG000|Overall Study|Other|2
4669413|NCT02309359|7564951|FG001|Overall Study|Other|0
4669414|NCT02309359|7564952|FG002|Overall Study|Other|2
4669415|NCT02309359|7564953|FG003|Overall Study|Other|3
4669416|NCT02309359|7564954|FG004|Overall Study|Other|2
4669417|NCT02309372|7564969|FG000|Overall Study|Lost to Follow-up|3
4669418|NCT02309372|7564970|FG001|Overall Study|Lost to Follow-up|2
4669419|NCT02309411|7564979|FG000|Overall Study|Physician Decision|1
4669420|NCT02309411|7564980|FG001|Overall Study|Physician Decision|0
4669421|NCT02309411|7564981|FG002|Overall Study|Physician Decision|0
4669422|NCT02309411|7564979|FG000|Overall Study|Withdrawal by Subject|1
4669423|NCT02309411|7564980|FG001|Overall Study|Withdrawal by Subject|1
4669424|NCT02309411|7564981|FG002|Overall Study|Withdrawal by Subject|0
4669425|NCT02309515|7564999|FG000|Overall Study|Withdrawal by Subject|0
4669426|NCT02309515|7565000|FG001|Overall Study|Withdrawal by Subject|1
4669427|NCT02309723|7565009|FG000|Overall Study|Withdrawal by Subject|24
4669428|NCT02309723|7565010|FG001|Overall Study|Withdrawal by Subject|23
4669429|NCT02309723|7565011|FG002|Overall Study|Withdrawal by Subject|24
4669430|NCT02310100|7565028|FG000|Overall Study|Physician Decision|3
4669431|NCT02310100|7565028|FG000|Overall Study|Withdrawal by Subject|10
4669432|NCT02310100|7565028|FG000|Overall Study|Enrollment closure|1
4669433|NCT02310100|7565028|FG000|Overall Study|Unapproved ablation operator|1
4669434|NCT02310100|7565028|FG000|Overall Study|Visit compliance|1
4669435|NCT02310100|7565028|FG000|Overall Study|Lost to Follow-up|2
4669436|NCT02310126|7565035|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0
4669437|NCT02310126|7565036|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1
4669438|NCT02310126|7565035|FG000|Period 1 (15 Minutes)|Protocol Violation|0
4669439|NCT02310126|7565036|FG001|Period 1 (15 Minutes)|Protocol Violation|1
4669440|NCT02310568|7565047|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
4754278|NCT03715829|7728761|FG003|Extension Period|Protocol Violation|0
4754279|NCT03715829|7728762|FG004|Extension Period|Protocol Violation|0
4754280|NCT03715829|7728763|FG005|Extension Period|Protocol Violation|0
4754281|NCT03715829|7728764|FG006|Extension Period|Protocol Violation|0
4754282|NCT03715829|7728765|FG007|Extension Period|Protocol Violation|0
4754283|NCT03715829|7728766|FG008|Extension Period|Protocol Violation|1
4754284|NCT03715829|7728767|FG009|Extension Period|Protocol Violation|0
4754285|NCT03715829|7728768|FG010|Extension Period|Protocol Violation|0
4754286|NCT03715829|7728758|FG000|Extension Period|Withdrawal by Subject|0
4754287|NCT03715829|7728759|FG001|Extension Period|Withdrawal by Subject|0
4754288|NCT03715829|7728760|FG002|Extension Period|Withdrawal by Subject|0
4754289|NCT03715829|7728761|FG003|Extension Period|Withdrawal by Subject|0
4754290|NCT03715829|7728762|FG004|Extension Period|Withdrawal by Subject|0
4754291|NCT03715829|7728763|FG005|Extension Period|Withdrawal by Subject|0
4754292|NCT03715829|7728764|FG006|Extension Period|Withdrawal by Subject|3
4754293|NCT03715829|7728765|FG007|Extension Period|Withdrawal by Subject|3
4754294|NCT03715829|7728766|FG008|Extension Period|Withdrawal by Subject|12
4754295|NCT03715829|7728767|FG009|Extension Period|Withdrawal by Subject|3
4754296|NCT03715829|7728768|FG010|Extension Period|Withdrawal by Subject|0
4754297|NCT03715829|7728758|FG000|Extension Period|Medication Error Without Associated Adverse Event|0
4754298|NCT03715829|7728759|FG001|Extension Period|Medication Error Without Associated Adverse Event|0
4754299|NCT03715829|7728760|FG002|Extension Period|Medication Error Without Associated Adverse Event|0
4754300|NCT03715829|7728761|FG003|Extension Period|Medication Error Without Associated Adverse Event|0
4754301|NCT03715829|7728762|FG004|Extension Period|Medication Error Without Associated Adverse Event|0
4754302|NCT03715829|7728763|FG005|Extension Period|Medication Error Without Associated Adverse Event|0
4754303|NCT03715829|7728764|FG006|Extension Period|Medication Error Without Associated Adverse Event|0
4754304|NCT03715829|7728765|FG007|Extension Period|Medication Error Without Associated Adverse Event|1
4754305|NCT03715829|7728766|FG008|Extension Period|Medication Error Without Associated Adverse Event|1
4754306|NCT03715829|7728767|FG009|Extension Period|Medication Error Without Associated Adverse Event|0
4754307|NCT03715829|7728768|FG010|Extension Period|Medication Error Without Associated Adverse Event|0
4754308|NCT03715829|7728758|FG000|Extension Period|No Longer Meets Eligibility Criteria|0
4754309|NCT03715829|7728759|FG001|Extension Period|No Longer Meets Eligibility Criteria|0
4754310|NCT03715829|7728760|FG002|Extension Period|No Longer Meets Eligibility Criteria|0
4754311|NCT03715829|7728761|FG003|Extension Period|No Longer Meets Eligibility Criteria|0
4754312|NCT03715829|7728762|FG004|Extension Period|No Longer Meets Eligibility Criteria|0
4754313|NCT03715829|7728763|FG005|Extension Period|No Longer Meets Eligibility Criteria|0
4754314|NCT03715829|7728764|FG006|Extension Period|No Longer Meets Eligibility Criteria|0
4754315|NCT03715829|7728765|FG007|Extension Period|No Longer Meets Eligibility Criteria|0
4754316|NCT03715829|7728766|FG008|Extension Period|No Longer Meets Eligibility Criteria|1
4754317|NCT03715829|7728767|FG009|Extension Period|No Longer Meets Eligibility Criteria|0
4754318|NCT03715829|7728768|FG010|Extension Period|No Longer Meets Eligibility Criteria|0
4754319|NCT03715829|7728758|FG000|Extension Period|Other|0
4754320|NCT03715829|7728759|FG001|Extension Period|Other|0
4754321|NCT03715829|7728760|FG002|Extension Period|Other|0
4754322|NCT03715829|7728761|FG003|Extension Period|Other|0
4754323|NCT03715829|7728762|FG004|Extension Period|Other|0
4754324|NCT03715829|7728763|FG005|Extension Period|Other|0
4754325|NCT03715829|7728764|FG006|Extension Period|Other|1
4754326|NCT03715829|7728765|FG007|Extension Period|Other|2
4754327|NCT03715829|7728766|FG008|Extension Period|Other|4
4754328|NCT03715829|7728767|FG009|Extension Period|Other|0
4754329|NCT03715829|7728768|FG010|Extension Period|Other|0
4754330|NCT03693430|7728796|FG000|Overall Study|Lost to Follow-up|3
4754331|NCT03693430|7728797|FG001|Overall Study|Lost to Follow-up|14
4754332|NCT03693430|7728796|FG000|Overall Study|Death|1
4754333|NCT03693430|7728797|FG001|Overall Study|Death|0
4754334|NCT03693430|7728796|FG000|Overall Study|Withdrawal by Subject|0
4754335|NCT03693430|7728797|FG001|Overall Study|Withdrawal by Subject|4
4754336|NCT03677934|7728805|FG000|Overall Study|Study is ongoing|240
4754337|NCT03677934|7728806|FG001|Overall Study|Study is ongoing|161
4754338|NCT03677934|7728805|FG000|Overall Study|Adverse Event|5
4754339|NCT03677934|7728806|FG001|Overall Study|Adverse Event|0
4669441|NCT02310568|7565048|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
4669442|NCT02310568|7565049|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
4669443|NCT02310568|7565050|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
4669444|NCT02310568|7565051|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1
4669445|NCT02310568|7565047|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1
4669446|NCT02310568|7565048|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
4754340|NCT03677934|7728805|FG000|Overall Study|Death|2
4754341|NCT03677934|7728806|FG001|Overall Study|Death|0
4754342|NCT03677934|7728805|FG000|Overall Study|Withdrawal by Subject|0
4669447|NCT02310568|7565049|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
4669448|NCT02310568|7565050|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
4669449|NCT02310568|7565051|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
4669450|NCT02310568|7565047|FG000|Stage 1 ( 4 Weeks)|Other|1
4669451|NCT02310568|7565048|FG001|Stage 1 ( 4 Weeks)|Other|1
4669452|NCT02310568|7565049|FG002|Stage 1 ( 4 Weeks)|Other|0
4669453|NCT02310568|7565050|FG003|Stage 1 ( 4 Weeks)|Other|0
4669454|NCT02310568|7565051|FG004|Stage 1 ( 4 Weeks)|Other|0
4669455|NCT02310568|7565047|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1
4669456|NCT02310568|7565048|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1
4669457|NCT02310568|7565049|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1
4669458|NCT02310568|7565050|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0
4669459|NCT02310568|7565051|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0
4669460|NCT02310568|7565047|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
4669461|NCT02310568|7565048|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
4669462|NCT02310568|7565049|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
4669463|NCT02310568|7565050|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1
4669464|NCT02310568|7565051|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
4669465|NCT02310568|7565047|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
4669466|NCT02310568|7565048|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
4669467|NCT02310568|7565049|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
4669468|NCT02310568|7565050|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1
4669469|NCT02310568|7565051|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
4669470|NCT02310568|7565047|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1
4669471|NCT02310568|7565048|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0
4669472|NCT02310568|7565049|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0
4669473|NCT02310568|7565050|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1
4669474|NCT02310568|7565051|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0
4669475|NCT02310568|7565047|FG000|Stage 2 (4 Weeks)|Other|0
4669476|NCT02310568|7565048|FG001|Stage 2 (4 Weeks)|Other|1
4669477|NCT02310568|7565049|FG002|Stage 2 (4 Weeks)|Other|1
4669478|NCT02310568|7565050|FG003|Stage 2 (4 Weeks)|Other|0
4669479|NCT02310568|7565051|FG004|Stage 2 (4 Weeks)|Other|0
4669480|NCT02310568|7565047|FG000|Stage 2 (4 Weeks)|Adverse Event|0
4669481|NCT02310568|7565048|FG001|Stage 2 (4 Weeks)|Adverse Event|0
4669482|NCT02310568|7565049|FG002|Stage 2 (4 Weeks)|Adverse Event|0
4669483|NCT02310568|7565050|FG003|Stage 2 (4 Weeks)|Adverse Event|1
4669484|NCT02310568|7565051|FG004|Stage 2 (4 Weeks)|Adverse Event|1
4669485|NCT02310568|7565047|FG000|Stage 2 (4 Weeks)|Protocol Violation|0
4669486|NCT02310568|7565048|FG001|Stage 2 (4 Weeks)|Protocol Violation|0
4669487|NCT02310568|7565049|FG002|Stage 2 (4 Weeks)|Protocol Violation|0
4669488|NCT02310568|7565050|FG003|Stage 2 (4 Weeks)|Protocol Violation|1
4669489|NCT02310568|7565051|FG004|Stage 2 (4 Weeks)|Protocol Violation|0
4669490|NCT02310568|7565047|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0
4669491|NCT02310568|7565048|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0
4669492|NCT02310568|7565049|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0
4754343|NCT03677934|7728806|FG001|Overall Study|Withdrawal by Subject|5
4754344|NCT03677934|7728805|FG000|Overall Study|Physician Decision|0
4754345|NCT03677934|7728806|FG001|Overall Study|Physician Decision|1
4754346|NCT03677934|7728805|FG000|Overall Study|Damaged implant (no associated AE reported)|1
4754347|NCT03677934|7728806|FG001|Overall Study|Damaged implant (no associated AE reported)|0
4669493|NCT02310568|7565050|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2
4669494|NCT02310568|7565051|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0
4669495|NCT02310581|7565073|FG000|Overall Study|Adverse Event|1
4669496|NCT02310581|7565074|FG001|Overall Study|Adverse Event|1
4669497|NCT02310581|7565075|FG002|Overall Study|Adverse Event|1
4669498|NCT02310581|7565076|FG003|Overall Study|Adverse Event|0
4669499|NCT02310581|7565073|FG000|Overall Study|Withdrawal by Subject|2
4669500|NCT02310581|7565074|FG001|Overall Study|Withdrawal by Subject|1
4669501|NCT02310581|7565075|FG002|Overall Study|Withdrawal by Subject|0
4669502|NCT02310581|7565076|FG003|Overall Study|Withdrawal by Subject|1
4669503|NCT02310646|7565088|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1
4669504|NCT02310646|7565089|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0
4669505|NCT02310646|7565088|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1
4669506|NCT02310646|7565089|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0
4669507|NCT02310672|7565111|FG000|Overall Study|Death|1
4669508|NCT02310672|7565111|FG000|Overall Study|Lost to Follow-up|1
4669509|NCT02310672|7565111|FG000|Overall Study|Withdrawal by Subject|1
4669510|NCT02310672|7565111|FG000|Overall Study|Sponsor's decision|12
4669511|NCT02310750|7565126|FG000|HP Period 1|Lost to Follow-up|0
4669512|NCT02310750|7565127|FG001|HP Period 1|Lost to Follow-up|0
4669513|NCT02310750|7565128|FG002|HP Period 1|Lost to Follow-up|0
4669514|NCT02310750|7565129|FG003|HP Period 1|Lost to Follow-up|0
4669515|NCT02310750|7565130|FG004|HP Period 1|Lost to Follow-up|0
4669516|NCT02310750|7565131|FG005|HP Period 1|Lost to Follow-up|0
4669517|NCT02310750|7565132|FG006|HP Period 1|Lost to Follow-up|1
4669518|NCT02310750|7565133|FG007|HP Period 1|Lost to Follow-up|0
4669519|NCT02310750|7565134|FG008|HP Period 1|Lost to Follow-up|0
4669520|NCT02310750|7565135|FG009|HP Period 1|Lost to Follow-up|0
4669521|NCT02310750|7565136|FG010|HP Period 1|Lost to Follow-up|0
4669522|NCT02310750|7565137|FG011|HP Period 1|Lost to Follow-up|0
4669523|NCT02310750|7565138|FG012|HP Period 1|Lost to Follow-up|0
4669524|NCT02310750|7565139|FG013|HP Period 1|Lost to Follow-up|0
4669525|NCT02310750|7565140|FG014|HP Period 1|Lost to Follow-up|0
4669526|NCT02310750|7565141|FG015|HP Period 1|Lost to Follow-up|0
4669527|NCT02310750|7565126|FG000|HP Period 1|Withdrawal by Subject|1
4669528|NCT02310750|7565127|FG001|HP Period 1|Withdrawal by Subject|0
4669529|NCT02310750|7565128|FG002|HP Period 1|Withdrawal by Subject|0
4669530|NCT02310750|7565129|FG003|HP Period 1|Withdrawal by Subject|1
4669531|NCT02310750|7565130|FG004|HP Period 1|Withdrawal by Subject|0
4669532|NCT02310750|7565131|FG005|HP Period 1|Withdrawal by Subject|0
4669533|NCT02310750|7565132|FG006|HP Period 1|Withdrawal by Subject|0
4669534|NCT02310750|7565133|FG007|HP Period 1|Withdrawal by Subject|0
4669535|NCT02310750|7565134|FG008|HP Period 1|Withdrawal by Subject|0
4669536|NCT02310750|7565135|FG009|HP Period 1|Withdrawal by Subject|0
4669537|NCT02310750|7565136|FG010|HP Period 1|Withdrawal by Subject|0
4669538|NCT02310750|7565137|FG011|HP Period 1|Withdrawal by Subject|0
4669539|NCT02310750|7565138|FG012|HP Period 1|Withdrawal by Subject|0
4669540|NCT02310750|7565139|FG013|HP Period 1|Withdrawal by Subject|0
4669541|NCT02310750|7565140|FG014|HP Period 1|Withdrawal by Subject|0
4669542|NCT02310750|7565141|FG015|HP Period 1|Withdrawal by Subject|0
4669543|NCT02310750|7565126|FG000|HP Washout 1|Lost to Follow-up|0
4669544|NCT02310750|7565127|FG001|HP Washout 1|Lost to Follow-up|0
4669545|NCT02310750|7565128|FG002|HP Washout 1|Lost to Follow-up|1
4669546|NCT02310750|7565129|FG003|HP Washout 1|Lost to Follow-up|1
4669547|NCT02310750|7565130|FG004|HP Washout 1|Lost to Follow-up|2
4669548|NCT02310750|7565131|FG005|HP Washout 1|Lost to Follow-up|2
4669549|NCT02310750|7565132|FG006|HP Washout 1|Lost to Follow-up|3
4669550|NCT02310750|7565133|FG007|HP Washout 1|Lost to Follow-up|0
4669551|NCT02310750|7565134|FG008|HP Washout 1|Lost to Follow-up|0
4669552|NCT02310750|7565135|FG009|HP Washout 1|Lost to Follow-up|0
4669553|NCT02310750|7565136|FG010|HP Washout 1|Lost to Follow-up|0
4669554|NCT02310750|7565137|FG011|HP Washout 1|Lost to Follow-up|0
4669555|NCT02310750|7565138|FG012|HP Washout 1|Lost to Follow-up|0
4669556|NCT02310750|7565139|FG013|HP Washout 1|Lost to Follow-up|0
4669557|NCT02310750|7565140|FG014|HP Washout 1|Lost to Follow-up|0
4669558|NCT02310750|7565141|FG015|HP Washout 1|Lost to Follow-up|0
4669559|NCT02310750|7565126|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
4669560|NCT02310750|7565127|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
4669561|NCT02310750|7565128|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
4669562|NCT02310750|7565129|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1
4669563|NCT02310750|7565130|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
4669564|NCT02310750|7565131|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2
4669565|NCT02310750|7565132|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
4669566|NCT02310750|7565133|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
4669567|NCT02310750|7565134|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6
4669568|NCT02310750|7565135|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1
4669569|NCT02310750|7565136|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
4669570|NCT02310750|7565137|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
4669571|NCT02310750|7565138|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
4669572|NCT02310750|7565139|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
4669573|NCT02310750|7565140|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
4669574|NCT02310750|7565141|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
4669575|NCT02310750|7565126|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
4669576|NCT02310750|7565127|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
4669577|NCT02310750|7565128|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
4669578|NCT02310750|7565129|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
4669579|NCT02310750|7565130|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
4669580|NCT02310750|7565131|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
4669581|NCT02310750|7565132|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
4669582|NCT02310750|7565133|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
4669583|NCT02310750|7565134|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
4669584|NCT02310750|7565135|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1
4669585|NCT02310750|7565136|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
4669586|NCT02310750|7565137|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
4669587|NCT02310750|7565138|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
4669588|NCT02310750|7565139|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
4669589|NCT02310750|7565140|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
4669590|NCT02310750|7565141|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
4669591|NCT02310750|7565126|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
4669592|NCT02310750|7565127|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
4669593|NCT02310750|7565128|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
4669594|NCT02310750|7565129|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
4669595|NCT02310750|7565130|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
4669596|NCT02310750|7565131|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
4754348|NCT03575104|7728848|FG000|Overall Study|Adverse Event|4
4754349|NCT03575104|7728849|FG001|Overall Study|Adverse Event|3
4754350|NCT03575104|7728850|FG002|Overall Study|Adverse Event|4
4754351|NCT03575104|7728848|FG000|Overall Study|Withdrawal by Subject|13
4754352|NCT03575104|7728849|FG001|Overall Study|Withdrawal by Subject|16
4754353|NCT03575104|7728850|FG002|Overall Study|Withdrawal by Subject|11
4754354|NCT03575104|7728848|FG000|Overall Study|Other reasons|6
4754355|NCT03575104|7728849|FG001|Overall Study|Other reasons|8
4754356|NCT03575104|7728850|FG002|Overall Study|Other reasons|6
4754357|NCT03575104|7728848|FG000|Overall Study|Lost to Follow-up|1
4754358|NCT03575104|7728849|FG001|Overall Study|Lost to Follow-up|2
4754359|NCT03575104|7728850|FG002|Overall Study|Lost to Follow-up|1
4754360|NCT03569475|7728861|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1
4754361|NCT03569475|7728862|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2
4754362|NCT03569475|7728863|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5
4754363|NCT03569475|7728861|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0
4754364|NCT03569475|7728862|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1
4754365|NCT03569475|7728863|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0
4754366|NCT03569475|7728861|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7
4754367|NCT03569475|7728862|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10
4754368|NCT03569475|7728863|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9
4754369|NCT03569475|7728861|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7
4754370|NCT03569475|7728862|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7
4754371|NCT03569475|7728863|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6
4754372|NCT03569475|7728861|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1
4754373|NCT03569475|7728862|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1
4754374|NCT03569475|7728863|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1
4754375|NCT03569475|7728861|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1
4754376|NCT03569475|7728862|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1
4754377|NCT03569475|7728863|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1
4754378|NCT03569475|7728861|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1
4754379|NCT03569475|7728862|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1
4754380|NCT03569475|7728863|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2
4754381|NCT03569475|7728861|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0
4754382|NCT03569475|7728862|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1
4754383|NCT03569475|7728863|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1
4754384|NCT03569475|7728861|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0
4669597|NCT02310750|7565132|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
4669598|NCT02310750|7565133|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
4669599|NCT02310750|7565134|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
4669600|NCT02310750|7565135|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
4669601|NCT02310750|7565136|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
4669602|NCT02310750|7565137|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
4669603|NCT02310750|7565138|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
4669604|NCT02310750|7565139|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
4669605|NCT02310750|7565140|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
4669606|NCT02310750|7565141|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
4669607|NCT02310750|7565126|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
4669608|NCT02310750|7565127|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
4669609|NCT02310750|7565128|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
4669610|NCT02310750|7565129|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
4669611|NCT02310750|7565130|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
4669612|NCT02310750|7565131|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
4669613|NCT02310750|7565132|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
4669614|NCT02310750|7565133|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1
4669615|NCT02310750|7565134|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1
4669616|NCT02310750|7565135|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
4669617|NCT02310750|7565136|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
4669618|NCT02310750|7565137|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
4669619|NCT02310750|7565138|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
4669620|NCT02310750|7565139|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
4669621|NCT02310750|7565140|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
4669622|NCT02310750|7565141|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
4669623|NCT02310750|7565126|FG000|HP Washout 2|Lost to Follow-up|0
4669624|NCT02310750|7565127|FG001|HP Washout 2|Lost to Follow-up|0
4669625|NCT02310750|7565128|FG002|HP Washout 2|Lost to Follow-up|0
4669626|NCT02310750|7565129|FG003|HP Washout 2|Lost to Follow-up|0
4669627|NCT02310750|7565130|FG004|HP Washout 2|Lost to Follow-up|1
4669628|NCT02310750|7565131|FG005|HP Washout 2|Lost to Follow-up|0
4669629|NCT02310750|7565132|FG006|HP Washout 2|Lost to Follow-up|7
4669630|NCT02310750|7565133|FG007|HP Washout 2|Lost to Follow-up|0
4669631|NCT02310750|7565134|FG008|HP Washout 2|Lost to Follow-up|0
4669632|NCT02310750|7565135|FG009|HP Washout 2|Lost to Follow-up|0
4669633|NCT02310750|7565136|FG010|HP Washout 2|Lost to Follow-up|0
4669634|NCT02310750|7565137|FG011|HP Washout 2|Lost to Follow-up|0
4669635|NCT02310750|7565138|FG012|HP Washout 2|Lost to Follow-up|0
4669636|NCT02310750|7565139|FG013|HP Washout 2|Lost to Follow-up|0
4669637|NCT02310750|7565140|FG014|HP Washout 2|Lost to Follow-up|0
4669638|NCT02310750|7565141|FG015|HP Washout 2|Lost to Follow-up|0
4669639|NCT02310763|7565225|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1
4669640|NCT02310763|7565226|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1
4669641|NCT02310763|7565227|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1
4669642|NCT02310763|7565225|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0
4669643|NCT02310763|7565226|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1
4754385|NCT03569475|7728862|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1
4754386|NCT03569475|7728863|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1
4754387|NCT03545191|7728917|FG000|Overall Study|Death|1
4754388|NCT03545191|7728918|FG001|Overall Study|Death|0
4754389|NCT03545191|7728919|FG002|Overall Study|Death|0
4754390|NCT03545191|7728917|FG000|Overall Study|Adverse Event|4
4754391|NCT03545191|7728918|FG001|Overall Study|Adverse Event|2
4754392|NCT03545191|7728919|FG002|Overall Study|Adverse Event|7
4754393|NCT03545191|7728917|FG000|Overall Study|Other reasons|3
4754394|NCT03545191|7728918|FG001|Overall Study|Other reasons|11
4754395|NCT03545191|7728919|FG002|Overall Study|Other reasons|8
4754396|NCT03545191|7728917|FG000|Overall Study|Withdrawal by Subject|13
4754397|NCT03545191|7728918|FG001|Overall Study|Withdrawal by Subject|10
4754398|NCT03545191|7728919|FG002|Overall Study|Withdrawal by Subject|12
4754399|NCT03545191|7728917|FG000|Overall Study|Lost to Follow-up|1
4754400|NCT03545191|7728918|FG001|Overall Study|Lost to Follow-up|2
4754401|NCT03545191|7728919|FG002|Overall Study|Lost to Follow-up|3
4754402|NCT03500549|7728929|FG000|RCP (Day 1 - Week 16)|Adverse Event|3
4754403|NCT03500549|7728930|FG001|RCP (Day 1 - Week 16)|Adverse Event|0
4754404|NCT03500549|7728929|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3
4754405|NCT03500549|7728930|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7
4669644|NCT02310763|7565227|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1
4669645|NCT02310763|7565225|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1
4669646|NCT02310763|7565226|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0
4669647|NCT02310763|7565227|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0
4669648|NCT02310763|7565225|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1
4669649|NCT02310763|7565226|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0
4669650|NCT02310763|7565227|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0
4669651|NCT02310763|7565225|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16
4669652|NCT02310763|7565226|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16
4669653|NCT02310763|7565227|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16
4754406|NCT03456700|7728941|FG000|Overall Study|Withdrawal by Subject|1
4754407|NCT03427411|7728956|FG000|Overall Study|Screen failure - platelets too low|0
4754408|NCT03427411|7728957|FG001|Overall Study|Screen failure - platelets too low|1
4754409|NCT03387150|7728970|FG000|Overall Study|Withdrawal by Subject|3
4754410|NCT03387150|7728971|FG001|Overall Study|Withdrawal by Subject|0
4754411|NCT03387150|7728972|FG002|Overall Study|Withdrawal by Subject|3
4754412|NCT03387150|7728973|FG003|Overall Study|Withdrawal by Subject|4
4754413|NCT03387150|7728974|FG004|Overall Study|Withdrawal by Subject|1
4754414|NCT03387150|7728975|FG005|Overall Study|Withdrawal by Subject|2
4754415|NCT03387150|7728976|FG006|Overall Study|Withdrawal by Subject|0
4754416|NCT03387150|7728970|FG000|Overall Study|Lost to Follow-up|3
4754417|NCT03387150|7728971|FG001|Overall Study|Lost to Follow-up|2
4754418|NCT03387150|7728972|FG002|Overall Study|Lost to Follow-up|2
4754419|NCT03387150|7728973|FG003|Overall Study|Lost to Follow-up|3
4754420|NCT03387150|7728974|FG004|Overall Study|Lost to Follow-up|3
4754421|NCT03387150|7728975|FG005|Overall Study|Lost to Follow-up|3
4754422|NCT03387150|7728976|FG006|Overall Study|Lost to Follow-up|0
4754423|NCT03387150|7728970|FG000|Overall Study|Participant unable to adhere to visit|0
4754424|NCT03387150|7728971|FG001|Overall Study|Participant unable to adhere to visit|1
4754425|NCT03387150|7728972|FG002|Overall Study|Participant unable to adhere to visit|0
4754426|NCT03387150|7728973|FG003|Overall Study|Participant unable to adhere to visit|0
4754427|NCT03387150|7728974|FG004|Overall Study|Participant unable to adhere to visit|2
4754428|NCT03387150|7728975|FG005|Overall Study|Participant unable to adhere to visit|2
4754429|NCT03387150|7728976|FG006|Overall Study|Participant unable to adhere to visit|0
4754430|NCT03370133|7728995|FG000|Initial Treatment Period (WK 16)|Adverse Event|5
4754431|NCT03370133|7728996|FG001|Initial Treatment Period (WK 16)|Adverse Event|5
4754432|NCT03370133|7728997|FG002|Initial Treatment Period (WK 16)|Adverse Event|2
4754433|NCT03370133|7728998|FG003|Initial Treatment Period (WK 16)|Adverse Event|0
4754434|NCT03370133|7728999|FG004|Initial Treatment Period (WK 16)|Adverse Event|0
4754435|NCT03370133|7729000|FG005|Initial Treatment Period (WK 16)|Adverse Event|0
4754436|NCT03370133|7728995|FG000|Initial Treatment Period (WK 16)|Death|1
4754437|NCT03370133|7728996|FG001|Initial Treatment Period (WK 16)|Death|1
4754438|NCT03370133|7728997|FG002|Initial Treatment Period (WK 16)|Death|1
4754439|NCT03370133|7728998|FG003|Initial Treatment Period (WK 16)|Death|0
4754440|NCT03370133|7728999|FG004|Initial Treatment Period (WK 16)|Death|0
4754441|NCT03370133|7729000|FG005|Initial Treatment Period (WK 16)|Death|0
4754442|NCT03370133|7728995|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2
4754443|NCT03370133|7728996|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1
4754444|NCT03370133|7728997|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0
4754445|NCT03370133|7728998|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0
4754446|NCT03370133|7728999|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0
4754447|NCT03370133|7729000|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0
4754448|NCT03370133|7728995|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0
4754449|NCT03370133|7728996|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0
4754450|NCT03370133|7728997|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2
4754451|NCT03370133|7728998|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0
4754452|NCT03370133|7728999|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0
4754453|NCT03370133|7729000|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0
4669654|NCT02310789|7565257|FG000|Overall Study|Adverse Event|1
4669655|NCT02310906|7565265|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0
4669656|NCT02310906|7565266|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0
4669657|NCT02310906|7565267|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0
4669658|NCT02310906|7565268|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2
4669659|NCT02310906|7565265|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0
4669660|NCT02310906|7565266|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0
4669661|NCT02310906|7565267|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2
4669662|NCT02310906|7565268|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4
4669663|NCT02310906|7565265|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0
4669664|NCT02310906|7565266|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0
4669665|NCT02310906|7565267|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0
4669666|NCT02310906|7565268|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1
4669667|NCT02310906|7565265|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0
4669668|NCT02310906|7565266|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0
4669669|NCT02310906|7565267|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0
4754454|NCT03370133|7728995|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0
4669670|NCT02310906|7565268|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1
4669671|NCT02311153|7565291|FG000|Overall Study|Lost to Follow-up|5
4669672|NCT02311153|7565292|FG001|Overall Study|Lost to Follow-up|7
4669673|NCT02311361|7565315|FG000|Overall Study|Did not receive treatment|0
4669674|NCT02311361|7565316|FG001|Overall Study|Did not receive treatment|1
4669675|NCT02311361|7565317|FG002|Overall Study|Did not receive treatment|0
4669676|NCT02311361|7565318|FG003|Overall Study|Did not receive treatment|1
4669677|NCT02311478|7565332|FG000|Overall Study|Withdrawal by Subject|1
4669678|NCT02311478|7565332|FG000|Overall Study|Lost to Follow-up|5
4669679|NCT02311478|7565332|FG000|Overall Study|Failed IUD Insertion|1
4669680|NCT02311881|7565339|FG000|Overall Study|Did not meet the study criteria|2
4669681|NCT02311881|7565340|FG001|Overall Study|Did not meet the study criteria|2
4669682|NCT02311881|7565341|FG002|Overall Study|Did not meet the study criteria|0
4669683|NCT02311881|7565339|FG000|Overall Study|Adverse Event|7
4669684|NCT02311881|7565340|FG001|Overall Study|Adverse Event|15
4754455|NCT03370133|7728996|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3
4754456|NCT03370133|7728997|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0
4754457|NCT03370133|7728998|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0
4754458|NCT03370133|7728999|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0
4754459|NCT03370133|7729000|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0
4754460|NCT03370133|7728995|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1
4754461|NCT03370133|7728996|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2
4754462|NCT03370133|7728997|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1
4754463|NCT03370133|7728998|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0
4754464|NCT03370133|7728999|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0
4754465|NCT03370133|7729000|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0
4754466|NCT03370133|7728995|FG000|Initial Treatment Period (WK 16)|Non-compliance|0
4754467|NCT03370133|7728996|FG001|Initial Treatment Period (WK 16)|Non-compliance|1
4754468|NCT03370133|7728997|FG002|Initial Treatment Period (WK 16)|Non-compliance|0
4754469|NCT03370133|7728998|FG003|Initial Treatment Period (WK 16)|Non-compliance|0
4754470|NCT03370133|7728999|FG004|Initial Treatment Period (WK 16)|Non-compliance|0
4754471|NCT03370133|7729000|FG005|Initial Treatment Period (WK 16)|Non-compliance|0
4754472|NCT03370133|7728995|FG000|Initial Treatment Period (WK 16)|Site closed|0
4754473|NCT03370133|7728996|FG001|Initial Treatment Period (WK 16)|Site closed|2
4754474|NCT03370133|7728997|FG002|Initial Treatment Period (WK 16)|Site closed|0
4754475|NCT03370133|7728998|FG003|Initial Treatment Period (WK 16)|Site closed|0
4754476|NCT03370133|7728999|FG004|Initial Treatment Period (WK 16)|Site closed|0
4754477|NCT03370133|7729000|FG005|Initial Treatment Period (WK 16)|Site closed|0
4754478|NCT03370133|7728995|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0
4754479|NCT03370133|7728996|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0
4754480|NCT03370133|7728997|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0
4754481|NCT03370133|7728998|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3
4754482|NCT03370133|7728999|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12
4754483|NCT03370133|7729000|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4
4754484|NCT03370133|7728995|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0
4754485|NCT03370133|7728996|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0
4754486|NCT03370133|7728997|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0
4754487|NCT03370133|7728998|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0
4754488|NCT03370133|7728999|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1
4754489|NCT03370133|7729000|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4
4754490|NCT03370133|7728995|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0
4754491|NCT03370133|7728996|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0
4754492|NCT03370133|7728997|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0
4754493|NCT03370133|7728998|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1
4754494|NCT03370133|7728999|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1
4754495|NCT03370133|7729000|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0
4754496|NCT03370133|7728995|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0
4754497|NCT03370133|7728996|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0
4754498|NCT03370133|7728997|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0
4754499|NCT03370133|7728998|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0
4754500|NCT03370133|7728999|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4
4754501|NCT03370133|7729000|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3
4754502|NCT03370133|7728995|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0
4754503|NCT03370133|7728996|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0
4754504|NCT03370133|7728997|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0
4754505|NCT03370133|7728998|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1
4754506|NCT03370133|7728999|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4
4754507|NCT03370133|7729000|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4
4754508|NCT03370133|7728995|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0
4754509|NCT03370133|7728996|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0
4669685|NCT02311881|7565341|FG002|Overall Study|Adverse Event|8
4669686|NCT02311881|7565339|FG000|Overall Study|Lost to Follow-up|3
4669687|NCT02311881|7565340|FG001|Overall Study|Lost to Follow-up|3
4669688|NCT02311881|7565341|FG002|Overall Study|Lost to Follow-up|2
4669689|NCT02311881|7565339|FG000|Overall Study|Protocol Violation|1
4669690|NCT02311881|7565340|FG001|Overall Study|Protocol Violation|2
4669691|NCT02311881|7565341|FG002|Overall Study|Protocol Violation|3
4669692|NCT02311881|7565339|FG000|Overall Study|Withdrawal of consent|14
4669693|NCT02311881|7565340|FG001|Overall Study|Withdrawal of consent|16
4669694|NCT02311881|7565341|FG002|Overall Study|Withdrawal of consent|17
4669695|NCT02311881|7565339|FG000|Overall Study|Other|0
4669696|NCT02311881|7565340|FG001|Overall Study|Other|0
4669697|NCT02311881|7565341|FG002|Overall Study|Other|1
4669698|NCT02311881|7565339|FG000|Overall Study|Lack of Efficacy|1
4669699|NCT02311881|7565340|FG001|Overall Study|Lack of Efficacy|2
4669700|NCT02311881|7565341|FG002|Overall Study|Lack of Efficacy|0
4669701|NCT02311881|7565339|FG000|Overall Study|Subject has border line pregnancy test|1
4669702|NCT02311881|7565340|FG001|Overall Study|Subject has border line pregnancy test|0
4669703|NCT02311881|7565341|FG002|Overall Study|Subject has border line pregnancy test|0
4669704|NCT02311881|7565339|FG000|Overall Study|Withdrawal by Subject|3
4669705|NCT02311881|7565340|FG001|Overall Study|Withdrawal by Subject|1
4669706|NCT02311881|7565341|FG002|Overall Study|Withdrawal by Subject|4
4669707|NCT02311881|7565339|FG000|Overall Study|Sponsor Decision|1
4669708|NCT02311881|7565340|FG001|Overall Study|Sponsor Decision|1
4669709|NCT02311881|7565341|FG002|Overall Study|Sponsor Decision|1
4669710|NCT02311881|7565339|FG000|Overall Study|Protocol Deviation|1
4669711|NCT02311881|7565340|FG001|Overall Study|Protocol Deviation|0
4669712|NCT02311881|7565341|FG002|Overall Study|Protocol Deviation|0
4669713|NCT02311881|7565339|FG000|Overall Study|Non-Compliance|1
4669714|NCT02311881|7565340|FG001|Overall Study|Non-Compliance|0
4669715|NCT02311881|7565341|FG002|Overall Study|Non-Compliance|2
4669716|NCT02311881|7565339|FG000|Overall Study|Physician Decision|0
4669717|NCT02311881|7565340|FG001|Overall Study|Physician Decision|0
4669718|NCT02311881|7565341|FG002|Overall Study|Physician Decision|1
4669719|NCT02311881|7565339|FG000|Overall Study|Medical Monitor Discretion|0
4669720|NCT02311881|7565340|FG001|Overall Study|Medical Monitor Discretion|0
4669721|NCT02311881|7565341|FG002|Overall Study|Medical Monitor Discretion|1
4669722|NCT02311881|7565339|FG000|Overall Study|Participant taking another medication|0
4669723|NCT02311881|7565340|FG001|Overall Study|Participant taking another medication|0
4669724|NCT02311881|7565341|FG002|Overall Study|Participant taking another medication|1
4669725|NCT02311881|7565339|FG000|Overall Study|Serious Adverse Event|0
4669726|NCT02311881|7565340|FG001|Overall Study|Serious Adverse Event|1
4669727|NCT02311881|7565341|FG002|Overall Study|Serious Adverse Event|0
4669728|NCT02311894|7565352|FG000|Overall Study|Discontinued in error|1
4669729|NCT02311894|7565352|FG000|Overall Study|Lost to Follow-up|1
4669730|NCT02311894|7565352|FG000|Overall Study|Adverse Event|1
4669731|NCT02311894|7565352|FG000|Overall Study|Withdrawal by Subject|1
4669732|NCT02312063|7565386|FG000|Overall Study|Withdrawal by Subject|0
4669733|NCT02312063|7565387|FG001|Overall Study|Withdrawal by Subject|1
4669734|NCT02312206|7565401|FG000|Overall Study|Adverse Event|3
4669735|NCT02312206|7565402|FG001|Overall Study|Adverse Event|6
4669736|NCT02312206|7565401|FG000|Overall Study|Withdrawal by Subject|7
4669737|NCT02312206|7565402|FG001|Overall Study|Withdrawal by Subject|6
4669738|NCT02312206|7565401|FG000|Overall Study|Physician Decision|7
4669739|NCT02312206|7565402|FG001|Overall Study|Physician Decision|6
4669740|NCT02312206|7565401|FG000|Overall Study|Death|30
4669741|NCT02312206|7565402|FG001|Overall Study|Death|36
4669742|NCT02312206|7565401|FG000|Overall Study|Study Terminated by Sponsor|81
4669743|NCT02312206|7565402|FG001|Overall Study|Study Terminated by Sponsor|74
4669744|NCT02312206|7565401|FG000|Overall Study|Disease Progression|1
4669745|NCT02312206|7565402|FG001|Overall Study|Disease Progression|0
4669746|NCT02312206|7565401|FG000|Overall Study|Patient progression and new therapy|1
4669747|NCT02312206|7565402|FG001|Overall Study|Patient progression and new therapy|0
4669748|NCT02312206|7565401|FG000|Overall Study|Patient transferred to hospice|0
4669749|NCT02312206|7565402|FG001|Overall Study|Patient transferred to hospice|1
4669750|NCT02312206|7565401|FG000|Overall Study|Subject missed 3 consecutive tx visits|0
4669751|NCT02312206|7565402|FG001|Overall Study|Subject missed 3 consecutive tx visits|1
4669752|NCT02312219|7565410|FG000|Overall Study|Withdrawal by Subject|1
4669753|NCT02312219|7565411|FG001|Overall Study|Withdrawal by Subject|2
4669754|NCT02312219|7565410|FG000|Overall Study|could not schedule imaging in time|0
4669755|NCT02312219|7565411|FG001|Overall Study|could not schedule imaging in time|2
4669756|NCT02312219|7565410|FG000|Overall Study|Other|0
4669757|NCT02312219|7565411|FG001|Overall Study|Other|1
4669758|NCT02312219|7565410|FG000|Overall Study|Not randomized. Ineligible|0
4669759|NCT02312219|7565411|FG001|Overall Study|Not randomized. Ineligible|1
4669760|NCT02312687|7565454|FG000|Overall Study|Other, Not Specified|1
4669761|NCT02312856|7565498|FG000|Overall Study|Death|1
4669762|NCT02312856|7565498|FG000|Overall Study|Lost to Follow-up|3
4669763|NCT02312934|7565508|FG000|Overall Study|Lost to Follow-up|1
4669764|NCT02312934|7565509|FG001|Overall Study|Lost to Follow-up|0
4669765|NCT02312934|7565508|FG000|Overall Study|Physician Decision|1
4669766|NCT02312934|7565509|FG001|Overall Study|Physician Decision|0
4669767|NCT02313155|7565522|FG000|Overall Study|Lost to Follow-up|0
4669768|NCT02313155|7565523|FG001|Overall Study|Lost to Follow-up|1
4669769|NCT02313233|7565531|FG000|Overall Study|Withdrawal by Subject|1
4669770|NCT02313233|7565532|FG001|Overall Study|Withdrawal by Subject|2
4669771|NCT02313233|7565531|FG000|Overall Study|Administrative reason|1
4669772|NCT02313233|7565532|FG001|Overall Study|Administrative reason|1
4669773|NCT02313558|7565559|FG000|Overall Study|Withdrawal by Subject|2
4669774|NCT02313558|7565560|FG001|Overall Study|Withdrawal by Subject|0
4669775|NCT02313558|7565559|FG000|Overall Study|Lost to Follow-up|4
4669776|NCT02313558|7565560|FG001|Overall Study|Lost to Follow-up|4
4669777|NCT02313766|7565595|FG000|Overall Study|surgery cancelled|1
4669778|NCT02313766|7565596|FG001|Overall Study|surgery cancelled|0
4669779|NCT02313766|7565597|FG002|Overall Study|surgery cancelled|0
4669780|NCT02313766|7565595|FG000|Overall Study|Lost to Follow-up|0
4669781|NCT02313766|7565596|FG001|Overall Study|Lost to Follow-up|2
4669782|NCT02313766|7565597|FG002|Overall Study|Lost to Follow-up|0
4669783|NCT02313766|7565595|FG000|Overall Study|Adverse Event|0
4669784|NCT02313766|7565596|FG001|Overall Study|Adverse Event|1
4669785|NCT02313766|7565597|FG002|Overall Study|Adverse Event|0
4669786|NCT02313909|7565607|FG000|Overall Study|Consent withdrawn by participant|33
4669787|NCT02313909|7565608|FG001|Overall Study|Consent withdrawn by participant|33
4669788|NCT02313909|7565607|FG000|Overall Study|Lost to Follow-up|24
4669789|NCT02313909|7565608|FG001|Overall Study|Lost to Follow-up|17
4669790|NCT02314026|7565624|FG000|Overall Study|Protocol Violation|28
4669791|NCT02314052|7565628|FG000|Cycle One|Adverse Event|0
4754510|NCT03370133|7728997|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0
4754511|NCT03370133|7728998|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0
4754512|NCT03370133|7728999|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1
4754513|NCT03370133|7729000|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0
4754514|NCT03370133|7728995|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0
4754515|NCT03370133|7728996|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0
4754516|NCT03370133|7728997|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0
4669792|NCT02314052|7565629|FG001|Cycle One|Adverse Event|0
4669793|NCT02314052|7565630|FG002|Cycle One|Adverse Event|0
4669794|NCT02314052|7565631|FG003|Cycle One|Adverse Event|1
4669795|NCT02314052|7565632|FG004|Cycle One|Adverse Event|0
4669796|NCT02314052|7565633|FG005|Cycle One|Adverse Event|0
4669797|NCT02314117|7565662|FG000|Overall Study|Lost to Follow-up|9
4669798|NCT02314117|7565663|FG001|Overall Study|Lost to Follow-up|14
4669799|NCT02314117|7565662|FG000|Overall Study|Withdrawal by Subject|3
4669800|NCT02314117|7565663|FG001|Overall Study|Withdrawal by Subject|2
4754517|NCT03370133|7728998|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0
4754518|NCT03370133|7728999|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0
4754519|NCT03370133|7729000|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1
4754520|NCT03366792|7729018|FG000|Overall Study|Withdrawal by Subject|7
4754521|NCT03366792|7729018|FG000|Overall Study|Lost to Follow-up|2
4754522|NCT03366792|7729018|FG000|Overall Study|Ineligible (could not reach perinium)|2
4754523|NCT03366792|7729018|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4
4754524|NCT03366337|7729026|FG000|Overall Study|Lost to Follow-up|1
4754525|NCT03366337|7729027|FG001|Overall Study|Lost to Follow-up|0
4754526|NCT03366337|7729028|FG002|Overall Study|Lost to Follow-up|1
4754527|NCT03366337|7729029|FG003|Overall Study|Lost to Follow-up|0
4754528|NCT03366337|7729026|FG000|Overall Study|Withdrawal by Subject|2
4754529|NCT03366337|7729027|FG001|Overall Study|Withdrawal by Subject|0
4754530|NCT03366337|7729028|FG002|Overall Study|Withdrawal by Subject|1
4754531|NCT03366337|7729029|FG003|Overall Study|Withdrawal by Subject|1
4754532|NCT03342053|7729041|FG000|Overall Study|Adverse Event|2
4754533|NCT03342053|7729042|FG001|Overall Study|Adverse Event|0
4754534|NCT03342053|7729041|FG000|Overall Study|Withdrawal by Subject|0
4754535|NCT03342053|7729042|FG001|Overall Study|Withdrawal by Subject|1
4754536|NCT03330847|7729051|FG000|Overall Study|Patients ongoing study|62
4754537|NCT03330847|7729052|FG001|Overall Study|Patients ongoing study|65
4754538|NCT03330847|7729053|FG002|Overall Study|Patients ongoing study|15
4669801|NCT02314143|7565673|FG000|Overall Study|Adverse Event|0
4669802|NCT02314143|7565674|FG001|Overall Study|Adverse Event|6
4669803|NCT02314143|7565675|FG002|Overall Study|Adverse Event|4
4669804|NCT02314143|7565673|FG000|Overall Study|Other (Study Closed/Terminated)|5
4669805|NCT02314143|7565674|FG001|Overall Study|Other (Study Closed/Terminated)|3
4669806|NCT02314143|7565675|FG002|Overall Study|Other (Study Closed/Terminated)|4
4669807|NCT02314143|7565673|FG000|Overall Study|Physician Decision|2
4669808|NCT02314143|7565674|FG001|Overall Study|Physician Decision|1
4669809|NCT02314143|7565675|FG002|Overall Study|Physician Decision|0
4669810|NCT02314143|7565673|FG000|Overall Study|Withdrawal by Subject|1
4669811|NCT02314143|7565674|FG001|Overall Study|Withdrawal by Subject|0
4669812|NCT02314143|7565675|FG002|Overall Study|Withdrawal by Subject|1
4669813|NCT02314247|7565686|FG000|Overall Study|Adverse Event|2
4669814|NCT02314247|7565687|FG001|Overall Study|Adverse Event|1
4669815|NCT02314247|7565688|FG002|Overall Study|Adverse Event|0
4669816|NCT02314247|7565686|FG000|Overall Study|Withdrawal by Subject|1
4669817|NCT02314247|7565687|FG001|Overall Study|Withdrawal by Subject|3
4669818|NCT02314247|7565688|FG002|Overall Study|Withdrawal by Subject|1
4669819|NCT02314247|7565686|FG000|Overall Study|Progression of Disease|6
4669820|NCT02314247|7565687|FG001|Overall Study|Progression of Disease|2
4669821|NCT02314247|7565688|FG002|Overall Study|Progression of Disease|0
4669822|NCT02314637|7565735|FG000|Overall Study|Adverse Event|4
4669823|NCT02314637|7565736|FG001|Overall Study|Adverse Event|8
4669824|NCT02314637|7565735|FG000|Overall Study|Lack of Efficacy|1
4669825|NCT02314637|7565736|FG001|Overall Study|Lack of Efficacy|0
4669826|NCT02314637|7565735|FG000|Overall Study|Physician Decision|5
4669827|NCT02314637|7565736|FG001|Overall Study|Physician Decision|2
4669828|NCT02314637|7565735|FG000|Overall Study|Withdrawal by Subject|5
4669829|NCT02314637|7565736|FG001|Overall Study|Withdrawal by Subject|4
4669830|NCT02314637|7565735|FG000|Overall Study|Other Reason|1
4669831|NCT02314637|7565736|FG001|Overall Study|Other Reason|0
4669832|NCT02314728|7565748|FG000|Overall Study|Protocol Violation|1
4669833|NCT02314728|7565749|FG001|Overall Study|Protocol Violation|0
4669834|NCT02314728|7565748|FG000|Overall Study|Lost to Follow-up|0
4669835|NCT02314728|7565749|FG001|Overall Study|Lost to Follow-up|1
4669836|NCT02314780|7565760|FG000|Overall Study|organizational reasons|0
4669837|NCT02314780|7565761|FG001|Overall Study|organizational reasons|2
4669838|NCT02314780|7565762|FG002|Overall Study|organizational reasons|0
4669839|NCT02314780|7565760|FG000|Overall Study|Adverse Event|0
4669840|NCT02314780|7565761|FG001|Overall Study|Adverse Event|1
4669841|NCT02314780|7565762|FG002|Overall Study|Adverse Event|0
4669842|NCT02315560|7565823|FG000|Overall Study|noncompliance by subjects|3
4669843|NCT02315625|7565829|FG000|First Intervention|Disease Progression|1
4669844|NCT02315625|7565830|FG001|First Intervention|Disease Progression|0
4669845|NCT02315625|7565829|FG000|Second Intervention|Physician Decision|2
4669846|NCT02315625|7565830|FG001|Second Intervention|Physician Decision|1
4669847|NCT02315625|7565829|FG000|Second Intervention|Study closure|1
4669848|NCT02315625|7565830|FG001|Second Intervention|Study closure|0
4669849|NCT02315625|7565829|FG000|Second Intervention|Disease Progression|1
4669850|NCT02315625|7565830|FG001|Second Intervention|Disease Progression|0
4669851|NCT02315664|7565840|FG000|Overall Study|Lost to Follow-up|1
4669852|NCT02315664|7565841|FG001|Overall Study|Lost to Follow-up|1
4669853|NCT02315664|7565840|FG000|Overall Study|Withdrawal by Subject|0
4669854|NCT02315664|7565841|FG001|Overall Study|Withdrawal by Subject|3
4669855|NCT02316171|7565870|FG000|Overall Study|difficulties with urinary catheter|1
4669856|NCT02316171|7565871|FG001|Overall Study|difficulties with urinary catheter|0
4669857|NCT02316171|7565872|FG002|Overall Study|difficulties with urinary catheter|0
4669858|NCT02316171|7565873|FG003|Overall Study|difficulties with urinary catheter|0
4669859|NCT02316223|7565882|FG000|Overall Study|Lack of Efficacy|0
4669860|NCT02316223|7565883|FG001|Overall Study|Lack of Efficacy|1
4669861|NCT02316223|7565884|FG002|Overall Study|Lack of Efficacy|1
4669862|NCT02316223|7565882|FG000|Overall Study|Lost to Follow-up|27
4669863|NCT02316223|7565883|FG001|Overall Study|Lost to Follow-up|34
4669864|NCT02316223|7565884|FG002|Overall Study|Lost to Follow-up|36
4669865|NCT02316223|7565882|FG000|Overall Study|COPD Diagnosis|3
4669866|NCT02316223|7565883|FG001|Overall Study|COPD Diagnosis|2
4669867|NCT02316223|7565884|FG002|Overall Study|COPD Diagnosis|3
4669868|NCT02316223|7565882|FG000|Overall Study|Reside outside study area|1
4669869|NCT02316223|7565883|FG001|Overall Study|Reside outside study area|1
4669870|NCT02316223|7565884|FG002|Overall Study|Reside outside study area|1
4669871|NCT02316223|7565882|FG000|Overall Study|No asthma|2
4669872|NCT02316223|7565883|FG001|Overall Study|No asthma|0
4669873|NCT02316223|7565884|FG002|Overall Study|No asthma|0
4669874|NCT02316223|7565882|FG000|Overall Study|Discontinued by PI|11
4669875|NCT02316223|7565883|FG001|Overall Study|Discontinued by PI|19
4669876|NCT02316223|7565884|FG002|Overall Study|Discontinued by PI|3
4669877|NCT02316353|7565894|FG000|Overall Study|Pregnancy|1
4669878|NCT02316353|7565895|FG001|Overall Study|Pregnancy|3
4669879|NCT02316353|7565894|FG000|Overall Study|Adverse Event|1
4669880|NCT02316353|7565895|FG001|Overall Study|Adverse Event|3
4669881|NCT02316353|7565894|FG000|Overall Study|Withdrawal by Subject|6
4669882|NCT02316353|7565895|FG001|Overall Study|Withdrawal by Subject|2
4669883|NCT02316548|7565932|FG000|Overall Study|Protocol Violation|0
4669884|NCT02316548|7565933|FG001|Overall Study|Protocol Violation|1
4669885|NCT02316613|7565939|FG000|Overall Study|Death|63
4669886|NCT02316613|7565939|FG000|Overall Study|Lost to Follow-up|9
4669887|NCT02316613|7565939|FG000|Overall Study|Lymphoma transformation|2
4669888|NCT02316613|7565939|FG000|Overall Study|Participant moved/changed medical team|11
4669889|NCT02316613|7565939|FG000|Overall Study|No data and duplicate cases|5
4669890|NCT02316613|7565939|FG000|Overall Study|Did not met selection criteria|14
4669891|NCT02316717|7565966|FG000|Overall Study|Adverse Event|2
4669892|NCT02316717|7565967|FG001|Overall Study|Adverse Event|2
4669893|NCT02316717|7565968|FG002|Overall Study|Adverse Event|0
4669894|NCT02316717|7565966|FG000|Overall Study|Lost to Follow-up|1
4669895|NCT02316717|7565967|FG001|Overall Study|Lost to Follow-up|2
4669896|NCT02316717|7565968|FG002|Overall Study|Lost to Follow-up|1
4669897|NCT02316717|7565966|FG000|Overall Study|Non compliance|3
4669898|NCT02316717|7565967|FG001|Overall Study|Non compliance|1
4669899|NCT02316717|7565968|FG002|Overall Study|Non compliance|0
4669900|NCT02316717|7565966|FG000|Overall Study|Protocol Violation|2
4669901|NCT02316717|7565967|FG001|Overall Study|Protocol Violation|0
4669902|NCT02316717|7565968|FG002|Overall Study|Protocol Violation|0
4669903|NCT02316717|7565966|FG000|Overall Study|Withdrawal by Subject|2
4669904|NCT02316717|7565967|FG001|Overall Study|Withdrawal by Subject|1
4669905|NCT02316717|7565968|FG002|Overall Study|Withdrawal by Subject|1
4669906|NCT02316717|7565966|FG000|Overall Study|Death|0
4669907|NCT02316717|7565967|FG001|Overall Study|Death|0
4669908|NCT02316717|7565968|FG002|Overall Study|Death|1
4669909|NCT02316717|7565966|FG000|Overall Study|Physician Decision|0
4669910|NCT02316717|7565967|FG001|Overall Study|Physician Decision|1
4669911|NCT02316717|7565968|FG002|Overall Study|Physician Decision|0
4669912|NCT02316717|7565966|FG000|Overall Study|TBC|1
4669913|NCT02316717|7565967|FG001|Overall Study|TBC|0
4669914|NCT02316717|7565968|FG002|Overall Study|TBC|0
4669915|NCT02316769|7565981|FG000|Overall Study|Physician Decision|1
4669916|NCT02316769|7565982|FG001|Overall Study|Physician Decision|0
4669917|NCT02316769|7565981|FG000|Overall Study|Withdrawal by Subject|1
4669918|NCT02316769|7565982|FG001|Overall Study|Withdrawal by Subject|0
4669919|NCT02316847|7565990|FG000|Overall Study|Adverse Event|0
4669920|NCT02316847|7565991|FG001|Overall Study|Adverse Event|3
4669921|NCT02316847|7565990|FG000|Overall Study|Lost to Follow-up|0
4669922|NCT02316847|7565991|FG001|Overall Study|Lost to Follow-up|2
4669923|NCT02316847|7565990|FG000|Overall Study|Physician Decision|0
4669924|NCT02316847|7565991|FG001|Overall Study|Physician Decision|1
4669925|NCT02316847|7565990|FG000|Overall Study|Pregnancy|0
4669926|NCT02316847|7565991|FG001|Overall Study|Pregnancy|1
4669927|NCT02316847|7565990|FG000|Overall Study|Withdrawal by Subject|2
4669928|NCT02316847|7565991|FG001|Overall Study|Withdrawal by Subject|9
4669929|NCT02316847|7565990|FG000|Overall Study|Noncompliance with study drug|0
4669930|NCT02316847|7565991|FG001|Overall Study|Noncompliance with study drug|3
4754539|NCT03283241|7729065|FG000|Overall Study|Adverse Event|4
4754540|NCT03283241|7729066|FG001|Overall Study|Adverse Event|1
4754541|NCT03283241|7729065|FG000|Overall Study|Withdrawal by Subject|0
4754542|NCT03283241|7729066|FG001|Overall Study|Withdrawal by Subject|1
4754543|NCT03283241|7729065|FG000|Overall Study|Subject relocated to Finland|0
4754544|NCT03283241|7729066|FG001|Overall Study|Subject relocated to Finland|1
4754545|NCT03242772|7729074|FG000|Overall Study|Lost to Follow-up|2
4754546|NCT03242772|7729075|FG001|Overall Study|Lost to Follow-up|0
4754547|NCT03242772|7729074|FG000|Overall Study|Physician Decision|0
4754548|NCT03242772|7729075|FG001|Overall Study|Physician Decision|1
4669931|NCT02316847|7565990|FG000|Overall Study|Withdrawn due to termination by Sponsor|7
4669932|NCT02316847|7565991|FG001|Overall Study|Withdrawn due to termination by Sponsor|67
4669933|NCT02317016|7565999|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1
4669934|NCT02317016|7565999|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1
4669935|NCT02317016|7565999|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1
4669936|NCT02317016|7565999|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23
4669937|NCT02317016|7565999|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1
4669938|NCT02317016|7565999|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2
4669939|NCT02317016|7565999|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5
4669940|NCT02317432|7566018|FG000|Overall Study|Death|4
4669941|NCT02317432|7566019|FG001|Overall Study|Death|1
4669942|NCT02317432|7566018|FG000|Overall Study|Lost to Follow-up|0
4669943|NCT02317432|7566019|FG001|Overall Study|Lost to Follow-up|5
4669944|NCT02317432|7566018|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27
4669945|NCT02317432|7566019|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0
4754549|NCT03242772|7729074|FG000|Overall Study|Withdrawal by Subject|1
4754550|NCT03242772|7729075|FG001|Overall Study|Withdrawal by Subject|0
4754551|NCT03236311|7729083|FG000|Overall Study|Study terminated by sponsor|0
4754552|NCT03236311|7729084|FG001|Overall Study|Study terminated by sponsor|2
4754553|NCT03236311|7729083|FG000|Overall Study|Adverse Event|0
4754554|NCT03236311|7729084|FG001|Overall Study|Adverse Event|1
4669946|NCT02317510|7566027|FG000|Overall Study|Adverse Event|0
4754555|NCT03192046|7729101|FG000|Overall Study|Withdrawal by Subject|1
4754556|NCT03192046|7729102|FG001|Overall Study|Withdrawal by Subject|1
4754557|NCT03190369|7729110|FG000|Overall Study|Poor compliance to protocol|0
4754558|NCT03190369|7729111|FG001|Overall Study|Poor compliance to protocol|1
4754559|NCT03190369|7729110|FG000|Overall Study|Withdraw before treatment|1
4669947|NCT02317510|7566028|FG001|Overall Study|Adverse Event|1
4669948|NCT02317562|7566046|FG000|Overall Study|Physician Decision|1
4669949|NCT02317562|7566046|FG000|Overall Study|early termination of the study|8
4669950|NCT02317562|7566046|FG000|Overall Study|Lack of Efficacy|4
4669951|NCT02317562|7566046|FG000|Overall Study|Withdrawal by Subject|1
4669952|NCT02317575|7566050|FG000|Period 1|Difficulty with venous cannulation|0
4669953|NCT02317575|7566051|FG001|Period 1|Difficulty with venous cannulation|1
4669954|NCT02317575|7566052|FG002|Period 1|Difficulty with venous cannulation|0
4669955|NCT02317575|7566053|FG003|Period 1|Difficulty with venous cannulation|0
4669956|NCT02317575|7566054|FG004|Period 1|Difficulty with venous cannulation|0
4669957|NCT02317575|7566050|FG000|Period 1|Withdrawal by Subject|1
4669958|NCT02317575|7566051|FG001|Period 1|Withdrawal by Subject|0
4669959|NCT02317575|7566052|FG002|Period 1|Withdrawal by Subject|0
4669960|NCT02317575|7566053|FG003|Period 1|Withdrawal by Subject|0
4669961|NCT02317575|7566054|FG004|Period 1|Withdrawal by Subject|0
4669962|NCT02317614|7566074|FG000|Overall Study|Lost to Follow-up|1
4669963|NCT02317614|7566075|FG001|Overall Study|Lost to Follow-up|1
4669964|NCT02317614|7566074|FG000|Overall Study|Withdrawal by Subject|1
4669965|NCT02317614|7566075|FG001|Overall Study|Withdrawal by Subject|0
4669966|NCT02317614|7566074|FG000|Overall Study|Death|1
4669967|NCT02317614|7566075|FG001|Overall Study|Death|1
4669968|NCT02317627|7566084|FG000|Overall Study|Withdrawal by Subject|0
4669969|NCT02317627|7566085|FG001|Overall Study|Withdrawal by Subject|1
4669970|NCT02317627|7566086|FG002|Overall Study|Withdrawal by Subject|1
4669971|NCT02317627|7566084|FG000|Overall Study|Lost to Follow-up|2
4669972|NCT02317627|7566085|FG001|Overall Study|Lost to Follow-up|0
4669973|NCT02317627|7566086|FG002|Overall Study|Lost to Follow-up|0
4669974|NCT02317627|7566084|FG000|Overall Study|Stopped by Investigator|0
4669975|NCT02317627|7566085|FG001|Overall Study|Stopped by Investigator|1
4669976|NCT02317627|7566086|FG002|Overall Study|Stopped by Investigator|0
4669977|NCT02317627|7566084|FG000|Overall Study|Adverse Event|0
4669978|NCT02317627|7566085|FG001|Overall Study|Adverse Event|2
4669979|NCT02317627|7566086|FG002|Overall Study|Adverse Event|3
4669980|NCT02317627|7566084|FG000|Overall Study|Non-compliance with study drug|0
4669981|NCT02317627|7566085|FG001|Overall Study|Non-compliance with study drug|1
4669982|NCT02317627|7566086|FG002|Overall Study|Non-compliance with study drug|0
4669983|NCT02317809|7566118|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2
4669984|NCT02317809|7566119|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0
4669985|NCT02317809|7566118|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1
4669986|NCT02317809|7566119|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0
4669987|NCT02318095|7566128|FG000|Overall Study|Adverse Event|1
4669988|NCT02318134|7566135|FG000|Overall Study|Withdrawal by Subject|2
4669989|NCT02318134|7566136|FG001|Overall Study|Withdrawal by Subject|1
4669990|NCT02318368|7566175|FG000|Overall Study|Withdrawal by Subject|2
4669991|NCT02318368|7566176|FG001|Overall Study|Withdrawal by Subject|0
4669992|NCT02318368|7566175|FG000|Overall Study|Study terminated by the sponsor|5
4669993|NCT02318368|7566176|FG001|Overall Study|Study terminated by the sponsor|2
4669994|NCT02318368|7566175|FG000|Overall Study|Death|0
4669995|NCT02318368|7566176|FG001|Overall Study|Death|1
4669996|NCT02318602|7566189|FG000|Overall Study|Adverse Event|0
4669997|NCT02318602|7566190|FG001|Overall Study|Adverse Event|1
4669998|NCT02318602|7566191|FG002|Overall Study|Adverse Event|1
4669999|NCT02318602|7566189|FG000|Overall Study|Withdrawal by Subject|0
4670000|NCT02318602|7566190|FG001|Overall Study|Withdrawal by Subject|3
4670001|NCT02318602|7566191|FG002|Overall Study|Withdrawal by Subject|0
4670002|NCT02318602|7566189|FG000|Overall Study|Death|1
4670003|NCT02318602|7566190|FG001|Overall Study|Death|0
4670004|NCT02318602|7566191|FG002|Overall Study|Death|0
4670005|NCT02318602|7566189|FG000|Overall Study|Guardian decision to withdraw|0
4670006|NCT02318602|7566190|FG001|Overall Study|Guardian decision to withdraw|0
4670007|NCT02318602|7566191|FG002|Overall Study|Guardian decision to withdraw|1
4670008|NCT02318667|7566205|FG000|Overall Study|Adverse Event|1
4670009|NCT02318667|7566205|FG000|Overall Study|Lack of Efficacy|6
4670010|NCT02318667|7566205|FG000|Overall Study|Protocol Violation|2
4670011|NCT02318693|7566215|FG000|Overall Study|Protocol Violation|0
4670012|NCT02318693|7566216|FG001|Overall Study|Protocol Violation|1
4670013|NCT02318706|7566226|FG000|Double-blind Phase|Adverse Event|7
4670014|NCT02318706|7566227|FG001|Double-blind Phase|Adverse Event|4
4670015|NCT02318706|7566228|FG002|Double-blind Phase|Adverse Event|3
4754560|NCT03190369|7729111|FG001|Overall Study|Withdraw before treatment|5
4754561|NCT03190369|7729110|FG000|Overall Study|Randomized but not treated|0
4754562|NCT03190369|7729111|FG001|Overall Study|Randomized but not treated|2
4754563|NCT03178487|7729119|FG000|Overall Study|Adverse Event|1
4754564|NCT03178487|7729120|FG001|Overall Study|Adverse Event|1
4670016|NCT02318706|7566229|FG003|Double-blind Phase|Adverse Event|10
4670017|NCT02318706|7566230|FG004|Double-blind Phase|Adverse Event|0
4670018|NCT02318706|7566226|FG000|Double-blind Phase|Lost to Follow-up|1
4670019|NCT02318706|7566227|FG001|Double-blind Phase|Lost to Follow-up|0
4670020|NCT02318706|7566228|FG002|Double-blind Phase|Lost to Follow-up|0
4670021|NCT02318706|7566229|FG003|Double-blind Phase|Lost to Follow-up|0
4670022|NCT02318706|7566230|FG004|Double-blind Phase|Lost to Follow-up|0
4670023|NCT02318706|7566226|FG000|Double-blind Phase|Protocol Violation|4
4754565|NCT03178487|7729119|FG000|Overall Study|Withdrawal by Subject|2
4670024|NCT02318706|7566227|FG001|Double-blind Phase|Protocol Violation|2
4670025|NCT02318706|7566228|FG002|Double-blind Phase|Protocol Violation|4
4670026|NCT02318706|7566229|FG003|Double-blind Phase|Protocol Violation|3
4670027|NCT02318706|7566230|FG004|Double-blind Phase|Protocol Violation|0
4670028|NCT02318706|7566226|FG000|Double-blind Phase|Withdrawal by Subject|9
4670029|NCT02318706|7566227|FG001|Double-blind Phase|Withdrawal by Subject|5
4670030|NCT02318706|7566228|FG002|Double-blind Phase|Withdrawal by Subject|7
4670031|NCT02318706|7566229|FG003|Double-blind Phase|Withdrawal by Subject|10
4670032|NCT02318706|7566230|FG004|Double-blind Phase|Withdrawal by Subject|0
4670033|NCT02318706|7566226|FG000|Double-blind Phase|Other|4
4670034|NCT02318706|7566227|FG001|Double-blind Phase|Other|1
4670035|NCT02318706|7566228|FG002|Double-blind Phase|Other|2
4670036|NCT02318706|7566229|FG003|Double-blind Phase|Other|1
4670037|NCT02318706|7566230|FG004|Double-blind Phase|Other|0
4670038|NCT02318706|7566226|FG000|Double-blind Phase|Death|0
4670039|NCT02318706|7566227|FG001|Double-blind Phase|Death|0
4670040|NCT02318706|7566228|FG002|Double-blind Phase|Death|2
4670041|NCT02318706|7566229|FG003|Double-blind Phase|Death|0
4670042|NCT02318706|7566230|FG004|Double-blind Phase|Death|0
4670043|NCT02318706|7566226|FG000|Open-label Extension Phase|Adverse Event|0
4670044|NCT02318706|7566227|FG001|Open-label Extension Phase|Adverse Event|0
4754566|NCT03178487|7729120|FG001|Overall Study|Withdrawal by Subject|1
4754567|NCT03178487|7729119|FG000|Overall Study|Lost to Follow-up|1
4754568|NCT03178487|7729120|FG001|Overall Study|Lost to Follow-up|0
4754569|NCT03178487|7729119|FG000|Overall Study|Other|0
4754570|NCT03178487|7729120|FG001|Overall Study|Other|2
4754571|NCT03106779|7729133|FG000|Overall Study|Lack of Efficacy|33
4754572|NCT03106779|7729134|FG001|Overall Study|Lack of Efficacy|24
4754573|NCT03106779|7729133|FG000|Overall Study|Adverse Event|8
4754574|NCT03106779|7729134|FG001|Overall Study|Adverse Event|16
4754575|NCT03106779|7729133|FG000|Overall Study|Physician Decision|10
4754576|NCT03106779|7729134|FG001|Overall Study|Physician Decision|6
4754577|NCT03106779|7729133|FG000|Overall Study|Patient/guardian decision|4
4754578|NCT03106779|7729134|FG001|Overall Study|Patient/guardian decision|3
4754579|NCT03106779|7729133|FG000|Overall Study|Progressive disease|1
4754580|NCT03106779|7729134|FG001|Overall Study|Progressive disease|3
4754581|NCT03106779|7729133|FG000|Overall Study|Lost to Follow-up|1
4754582|NCT03106779|7729134|FG001|Overall Study|Lost to Follow-up|2
4754583|NCT03106779|7729133|FG000|Overall Study|Death|1
4754584|NCT03106779|7729134|FG001|Overall Study|Death|0
4754585|NCT03106779|7729133|FG000|Overall Study|Protocol Violation|1
4754586|NCT03106779|7729134|FG001|Overall Study|Protocol Violation|0
4754587|NCT03106779|7729133|FG000|Overall Study|Not treated|1
4754588|NCT03106779|7729134|FG001|Overall Study|Not treated|0
4754589|NCT03096834|7729142|FG000|Double-Blind Treatment Epoch|Protocol deviation|2
4754590|NCT03096834|7729143|FG001|Double-Blind Treatment Epoch|Protocol deviation|1
4754591|NCT03096834|7729144|FG002|Double-Blind Treatment Epoch|Protocol deviation|0
4754592|NCT03096834|7729145|FG003|Double-Blind Treatment Epoch|Protocol deviation|0
4754593|NCT03096834|7729142|FG000|Double-Blind Treatment Epoch|Pregnancy|0
4754594|NCT03096834|7729143|FG001|Double-Blind Treatment Epoch|Pregnancy|1
4754595|NCT03096834|7729144|FG002|Double-Blind Treatment Epoch|Pregnancy|0
4754596|NCT03096834|7729145|FG003|Double-Blind Treatment Epoch|Pregnancy|0
4754597|NCT03096834|7729142|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1
4754598|NCT03096834|7729143|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1
4754599|NCT03096834|7729144|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0
4754600|NCT03096834|7729145|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0
4754601|NCT03096834|7729142|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0
4754602|NCT03096834|7729143|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0
4754603|NCT03096834|7729144|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15
4754604|NCT03096834|7729145|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15
4754605|NCT03096834|7729142|FG000|Open-Label Treatment Epoch|Adverse Event|0
4754606|NCT03096834|7729143|FG001|Open-Label Treatment Epoch|Adverse Event|0
4754607|NCT03096834|7729144|FG002|Open-Label Treatment Epoch|Adverse Event|5
4754608|NCT03096834|7729145|FG003|Open-Label Treatment Epoch|Adverse Event|6
4754609|NCT03096834|7729142|FG000|Open-Label Treatment Epoch|New therapy for study indication|0
4754610|NCT03096834|7729143|FG001|Open-Label Treatment Epoch|New therapy for study indication|0
4754611|NCT03096834|7729144|FG002|Open-Label Treatment Epoch|New therapy for study indication|1
4754612|NCT03096834|7729145|FG003|Open-Label Treatment Epoch|New therapy for study indication|1
4754613|NCT03096834|7729142|FG000|Open-Label Treatment Epoch|Physician Decision|0
4754614|NCT03096834|7729143|FG001|Open-Label Treatment Epoch|Physician Decision|0
4754615|NCT03096834|7729144|FG002|Open-Label Treatment Epoch|Physician Decision|1
4754616|NCT03096834|7729145|FG003|Open-Label Treatment Epoch|Physician Decision|0
4670045|NCT02318706|7566228|FG002|Open-label Extension Phase|Adverse Event|0
4670046|NCT02318706|7566229|FG003|Open-label Extension Phase|Adverse Event|0
4670047|NCT02318706|7566230|FG004|Open-label Extension Phase|Adverse Event|21
4670048|NCT02318706|7566226|FG000|Open-label Extension Phase|Lack of Efficacy|0
4754617|NCT03096834|7729142|FG000|Open-Label Treatment Epoch|Pregnancy|0
4754618|NCT03096834|7729143|FG001|Open-Label Treatment Epoch|Pregnancy|0
4754619|NCT03096834|7729144|FG002|Open-Label Treatment Epoch|Pregnancy|1
4754620|NCT03096834|7729145|FG003|Open-Label Treatment Epoch|Pregnancy|0
4754621|NCT03096834|7729142|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0
4754622|NCT03096834|7729143|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0
4670049|NCT02318706|7566227|FG001|Open-label Extension Phase|Lack of Efficacy|0
4670050|NCT02318706|7566228|FG002|Open-label Extension Phase|Lack of Efficacy|0
4670051|NCT02318706|7566229|FG003|Open-label Extension Phase|Lack of Efficacy|0
4670052|NCT02318706|7566230|FG004|Open-label Extension Phase|Lack of Efficacy|1
4670053|NCT02318706|7566226|FG000|Open-label Extension Phase|Death|0
4670054|NCT02318706|7566227|FG001|Open-label Extension Phase|Death|0
4670055|NCT02318706|7566228|FG002|Open-label Extension Phase|Death|0
4670056|NCT02318706|7566229|FG003|Open-label Extension Phase|Death|0
4670057|NCT02318706|7566230|FG004|Open-label Extension Phase|Death|1
4670058|NCT02318706|7566226|FG000|Open-label Extension Phase|Withdrawal by Subject|0
4670059|NCT02318706|7566227|FG001|Open-label Extension Phase|Withdrawal by Subject|0
4670060|NCT02318706|7566228|FG002|Open-label Extension Phase|Withdrawal by Subject|0
4670061|NCT02318706|7566229|FG003|Open-label Extension Phase|Withdrawal by Subject|0
4670062|NCT02318706|7566230|FG004|Open-label Extension Phase|Withdrawal by Subject|19
4670063|NCT02318719|7566246|FG000|Double-blind Phase|Adverse Event|7
4670064|NCT02318719|7566247|FG001|Double-blind Phase|Adverse Event|6
4670065|NCT02318719|7566248|FG002|Double-blind Phase|Adverse Event|12
4670066|NCT02318719|7566249|FG003|Double-blind Phase|Adverse Event|4
4670067|NCT02318719|7566250|FG004|Double-blind Phase|Adverse Event|0
4670068|NCT02318719|7566246|FG000|Double-blind Phase|Lack of Efficacy|5
4670069|NCT02318719|7566247|FG001|Double-blind Phase|Lack of Efficacy|0
4670070|NCT02318719|7566248|FG002|Double-blind Phase|Lack of Efficacy|1
4670071|NCT02318719|7566249|FG003|Double-blind Phase|Lack of Efficacy|1
4670072|NCT02318719|7566250|FG004|Double-blind Phase|Lack of Efficacy|0
4670073|NCT02318719|7566246|FG000|Double-blind Phase|Protocol Violation|0
4670074|NCT02318719|7566247|FG001|Double-blind Phase|Protocol Violation|1
4670075|NCT02318719|7566248|FG002|Double-blind Phase|Protocol Violation|3
4670076|NCT02318719|7566249|FG003|Double-blind Phase|Protocol Violation|0
4670077|NCT02318719|7566250|FG004|Double-blind Phase|Protocol Violation|0
4670078|NCT02318719|7566246|FG000|Double-blind Phase|Withdrawal by Subject|25
4670079|NCT02318719|7566247|FG001|Double-blind Phase|Withdrawal by Subject|7
4670080|NCT02318719|7566248|FG002|Double-blind Phase|Withdrawal by Subject|9
4670081|NCT02318719|7566249|FG003|Double-blind Phase|Withdrawal by Subject|10
4670082|NCT02318719|7566250|FG004|Double-blind Phase|Withdrawal by Subject|0
4670083|NCT02318719|7566246|FG000|Double-blind Phase|Other|1
4670084|NCT02318719|7566247|FG001|Double-blind Phase|Other|2
4670085|NCT02318719|7566248|FG002|Double-blind Phase|Other|0
4670086|NCT02318719|7566249|FG003|Double-blind Phase|Other|0
4670087|NCT02318719|7566250|FG004|Double-blind Phase|Other|0
4670088|NCT02318719|7566246|FG000|Open-label Extension Phase|Adverse Event|0
4670089|NCT02318719|7566247|FG001|Open-label Extension Phase|Adverse Event|0
4670090|NCT02318719|7566248|FG002|Open-label Extension Phase|Adverse Event|0
4670091|NCT02318719|7566249|FG003|Open-label Extension Phase|Adverse Event|0
4670092|NCT02318719|7566250|FG004|Open-label Extension Phase|Adverse Event|15
4670093|NCT02318719|7566246|FG000|Open-label Extension Phase|Death|0
4670094|NCT02318719|7566247|FG001|Open-label Extension Phase|Death|0
4670095|NCT02318719|7566248|FG002|Open-label Extension Phase|Death|0
4670096|NCT02318719|7566249|FG003|Open-label Extension Phase|Death|0
4670097|NCT02318719|7566250|FG004|Open-label Extension Phase|Death|1
4670098|NCT02318719|7566246|FG000|Open-label Extension Phase|Lack of Efficacy|0
4670099|NCT02318719|7566247|FG001|Open-label Extension Phase|Lack of Efficacy|0
4670100|NCT02318719|7566248|FG002|Open-label Extension Phase|Lack of Efficacy|0
4670101|NCT02318719|7566249|FG003|Open-label Extension Phase|Lack of Efficacy|0
4670102|NCT02318719|7566250|FG004|Open-label Extension Phase|Lack of Efficacy|1
4670103|NCT02318719|7566246|FG000|Open-label Extension Phase|Withdrawal by Subject|0
4670104|NCT02318719|7566247|FG001|Open-label Extension Phase|Withdrawal by Subject|0
4670105|NCT02318719|7566248|FG002|Open-label Extension Phase|Withdrawal by Subject|0
4670106|NCT02318719|7566249|FG003|Open-label Extension Phase|Withdrawal by Subject|0
4670107|NCT02318719|7566250|FG004|Open-label Extension Phase|Withdrawal by Subject|31
4670108|NCT02318719|7566246|FG000|Open-label Extension Phase|Other|0
4670109|NCT02318719|7566247|FG001|Open-label Extension Phase|Other|0
4670110|NCT02318719|7566248|FG002|Open-label Extension Phase|Other|0
4670111|NCT02318719|7566249|FG003|Open-label Extension Phase|Other|0
4670112|NCT02318719|7566250|FG004|Open-label Extension Phase|Other|7
4670113|NCT02318797|7566264|FG000|Overall Study|Death|3
4670114|NCT02318797|7566265|FG001|Overall Study|Death|6
4670115|NCT02318797|7566264|FG000|Overall Study|Lost to Follow-up|85
4670116|NCT02318797|7566265|FG001|Overall Study|Lost to Follow-up|96
4754623|NCT03096834|7729144|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9
4754624|NCT03096834|7729145|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17
4754625|NCT03096834|7729142|FG000|Safety Follow-Up Epoch|New therapy for study indication|0
4754626|NCT03096834|7729143|FG001|Safety Follow-Up Epoch|New therapy for study indication|0
4754627|NCT03096834|7729144|FG002|Safety Follow-Up Epoch|New therapy for study indication|0
4754628|NCT03096834|7729145|FG003|Safety Follow-Up Epoch|New therapy for study indication|1
4754629|NCT03096834|7729142|FG000|Safety Follow-Up Epoch|Protocol deviation|0
4754630|NCT03096834|7729143|FG001|Safety Follow-Up Epoch|Protocol deviation|0
4754631|NCT03096834|7729144|FG002|Safety Follow-Up Epoch|Protocol deviation|0
4670117|NCT02318940|7566273|FG000|Overall Study|lost the record|1
4670118|NCT02318940|7566274|FG001|Overall Study|lost the record|0
4670119|NCT02319031|7566308|FG000|Treatment Period|Death|1
4670120|NCT02319031|7566309|FG001|Treatment Period|Death|0
4670121|NCT02319044|7566318|FG000|Overall Study|Death, PI/sponsor decision, med history|0
4670122|NCT02319044|7566319|FG001|Overall Study|Death, PI/sponsor decision, med history|1
4670123|NCT02319044|7566320|FG002|Overall Study|Death, PI/sponsor decision, med history|4
4670124|NCT02319044|7566318|FG000|Overall Study|Withdrawal by Subject|3
4670125|NCT02319044|7566319|FG001|Overall Study|Withdrawal by Subject|3
4670126|NCT02319044|7566320|FG002|Overall Study|Withdrawal by Subject|6
4670127|NCT02319044|7566318|FG000|Overall Study|Condition under investigation worsened|100
4670128|NCT02319044|7566319|FG001|Overall Study|Condition under investigation worsened|50
4670129|NCT02319044|7566320|FG002|Overall Study|Condition under investigation worsened|46
4670130|NCT02319044|7566318|FG000|Overall Study|Adverse Event|17
4670131|NCT02319044|7566319|FG001|Overall Study|Adverse Event|2
4670132|NCT02319044|7566320|FG002|Overall Study|Adverse Event|8
4670133|NCT02319044|7566318|FG000|Overall Study|Study specific discontinuation criteria|2
4670134|NCT02319044|7566319|FG001|Overall Study|Study specific discontinuation criteria|2
4670135|NCT02319044|7566320|FG002|Overall Study|Study specific discontinuation criteria|1
4670136|NCT02319044|7566318|FG000|Overall Study|Not treated|0
4670137|NCT02319044|7566319|FG001|Overall Study|Not treated|2
4670138|NCT02319044|7566320|FG002|Overall Study|Not treated|2
4670139|NCT02319148|7566332|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0
4670140|NCT02319148|7566333|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0
4670141|NCT02319148|7566334|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1
4670142|NCT02319148|7566335|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1
4670143|NCT02319148|7566332|FG000|Second Intervention Period|No longer willing to participate|0
4670144|NCT02319148|7566333|FG001|Second Intervention Period|No longer willing to participate|1
4670145|NCT02319148|7566334|FG002|Second Intervention Period|No longer willing to participate|0
4670146|NCT02319148|7566335|FG003|Second Intervention Period|No longer willing to participate|0
4670147|NCT02319148|7566332|FG000|Second Intervention Period|Other|0
4670148|NCT02319148|7566333|FG001|Second Intervention Period|Other|0
4670149|NCT02319148|7566334|FG002|Second Intervention Period|Other|0
4670150|NCT02319148|7566335|FG003|Second Intervention Period|Other|1
4670151|NCT02319525|7566443|FG000|Overall Study|Withdrawal by Subject|2
4670152|NCT02319525|7566444|FG001|Overall Study|Withdrawal by Subject|1
4670153|NCT02319642|7566452|FG000|Overall Study|Adverse Event|2
4670154|NCT02319642|7566453|FG001|Overall Study|Adverse Event|4
4670155|NCT02319642|7566452|FG000|Overall Study|Lack of Efficacy|1
4670156|NCT02319642|7566453|FG001|Overall Study|Lack of Efficacy|1
4670157|NCT02319642|7566452|FG000|Overall Study|Withdrawal by Subject|1
4670158|NCT02319642|7566453|FG001|Overall Study|Withdrawal by Subject|1
4670159|NCT02319668|7566463|FG000|Overall Study|Other (Not specified)|0
4670160|NCT02319668|7566464|FG001|Overall Study|Other (Not specified)|2
4670161|NCT02319759|7566475|FG000|Week 0 - 16|Lack of Efficacy|1
4670162|NCT02319759|7566476|FG001|Week 0 - 16|Lack of Efficacy|0
4670163|NCT02319759|7566477|FG002|Week 0 - 16|Lack of Efficacy|0
4670164|NCT02319759|7566478|FG003|Week 0 - 16|Lack of Efficacy|0
4670165|NCT02319759|7566479|FG004|Week 0 - 16|Lack of Efficacy|0
4670166|NCT02319759|7566475|FG000|Week 0 - 16|Not met all Inclusion Criteria|0
4670167|NCT02319759|7566476|FG001|Week 0 - 16|Not met all Inclusion Criteria|0
4670168|NCT02319759|7566477|FG002|Week 0 - 16|Not met all Inclusion Criteria|1
4670169|NCT02319759|7566478|FG003|Week 0 - 16|Not met all Inclusion Criteria|0
4670170|NCT02319759|7566479|FG004|Week 0 - 16|Not met all Inclusion Criteria|0
4670171|NCT02319759|7566475|FG000|Week 16 - 24|Lack of Efficacy|1
4670172|NCT02319759|7566476|FG001|Week 16 - 24|Lack of Efficacy|0
4670173|NCT02319759|7566477|FG002|Week 16 - 24|Lack of Efficacy|1
4670174|NCT02319759|7566478|FG003|Week 16 - 24|Lack of Efficacy|0
4670175|NCT02319759|7566479|FG004|Week 16 - 24|Lack of Efficacy|0
4670176|NCT02319759|7566475|FG000|Week 16 - 24|Lost to Follow-up|1
4670177|NCT02319759|7566476|FG001|Week 16 - 24|Lost to Follow-up|0
4670178|NCT02319759|7566477|FG002|Week 16 - 24|Lost to Follow-up|0
4670179|NCT02319759|7566478|FG003|Week 16 - 24|Lost to Follow-up|0
4670180|NCT02319759|7566479|FG004|Week 16 - 24|Lost to Follow-up|0
4670181|NCT02319759|7566475|FG000|Week 16 - 24|Withdrawal by Subject|0
4670182|NCT02319759|7566476|FG001|Week 16 - 24|Withdrawal by Subject|0
4670183|NCT02319759|7566477|FG002|Week 16 - 24|Withdrawal by Subject|2
4670184|NCT02319759|7566478|FG003|Week 16 - 24|Withdrawal by Subject|0
4670185|NCT02319759|7566479|FG004|Week 16 - 24|Withdrawal by Subject|0
4670186|NCT02319759|7566475|FG000|Week 24 - 56|Adverse Event|0
4670187|NCT02319759|7566476|FG001|Week 24 - 56|Adverse Event|0
4670188|NCT02319759|7566477|FG002|Week 24 - 56|Adverse Event|2
4670189|NCT02319759|7566478|FG003|Week 24 - 56|Adverse Event|0
4670190|NCT02319759|7566479|FG004|Week 24 - 56|Adverse Event|0
4670191|NCT02319759|7566475|FG000|Week 24 - 56|Lack of Efficacy|0
4670192|NCT02319759|7566476|FG001|Week 24 - 56|Lack of Efficacy|0
4670193|NCT02319759|7566477|FG002|Week 24 - 56|Lack of Efficacy|0
4670194|NCT02319759|7566478|FG003|Week 24 - 56|Lack of Efficacy|2
4670195|NCT02319759|7566479|FG004|Week 24 - 56|Lack of Efficacy|1
4670196|NCT02319759|7566475|FG000|Week 24 - 56|Withdrawal by Subject|0
4670197|NCT02319759|7566476|FG001|Week 24 - 56|Withdrawal by Subject|1
4670198|NCT02319759|7566477|FG002|Week 24 - 56|Withdrawal by Subject|0
4670199|NCT02319759|7566478|FG003|Week 24 - 56|Withdrawal by Subject|0
4670200|NCT02319759|7566479|FG004|Week 24 - 56|Withdrawal by Subject|0
4670201|NCT02319759|7566475|FG000|Week 24 - 56|Lost to Follow-up|0
4670202|NCT02319759|7566476|FG001|Week 24 - 56|Lost to Follow-up|0
4670203|NCT02319759|7566477|FG002|Week 24 - 56|Lost to Follow-up|0
4670204|NCT02319759|7566478|FG003|Week 24 - 56|Lost to Follow-up|0
4670205|NCT02319759|7566479|FG004|Week 24 - 56|Lost to Follow-up|1
4670206|NCT02320058|7566512|FG000|Overall Study|Death|25
4670207|NCT02320058|7566513|FG001|Overall Study|Death|10
4670208|NCT02320058|7566512|FG000|Overall Study|Lost to Follow-up|4
4670209|NCT02320058|7566513|FG001|Overall Study|Lost to Follow-up|0
4754632|NCT03096834|7729145|FG003|Safety Follow-Up Epoch|Protocol deviation|1
4754633|NCT03096834|7729142|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0
4754634|NCT03096834|7729143|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0
4754635|NCT03096834|7729144|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1
4754636|NCT03096834|7729145|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0
4754637|NCT03089853|7729156|FG000|Overall Study|Lost to Follow-up|2
4754638|NCT03089853|7729157|FG001|Overall Study|Lost to Follow-up|1
4754639|NCT03070392|7729165|FG000|Overall Study|Not Treated|7
4754640|NCT03070392|7729166|FG001|Overall Study|Not Treated|0
4754641|NCT03070392|7729167|FG002|Overall Study|Not Treated|3
4754642|NCT03070392|7729168|FG003|Overall Study|Not Treated|12
4754643|NCT03070392|7729165|FG000|Overall Study|Death|3
4754644|NCT03070392|7729166|FG001|Overall Study|Death|0
4754645|NCT03070392|7729167|FG002|Overall Study|Death|0
4754646|NCT03070392|7729168|FG003|Overall Study|Death|1
4754647|NCT03070392|7729165|FG000|Overall Study|Withdrawal by Subject|7
4754648|NCT03070392|7729166|FG001|Overall Study|Withdrawal by Subject|0
4754649|NCT03070392|7729167|FG002|Overall Study|Withdrawal by Subject|0
4754650|NCT03070392|7729168|FG003|Overall Study|Withdrawal by Subject|3
4754651|NCT03070392|7729165|FG000|Overall Study|Physician Decision|1
4754652|NCT03070392|7729166|FG001|Overall Study|Physician Decision|0
4754653|NCT03070392|7729167|FG002|Overall Study|Physician Decision|0
4754654|NCT03070392|7729168|FG003|Overall Study|Physician Decision|2
4754655|NCT03070392|7729165|FG000|Overall Study|Progressive Disease|154
4754656|NCT03070392|7729166|FG001|Overall Study|Progressive Disease|6
4754657|NCT03070392|7729167|FG002|Overall Study|Progressive Disease|2
4754658|NCT03070392|7729168|FG003|Overall Study|Progressive Disease|70
4754659|NCT03070392|7729165|FG000|Overall Study|Adverse Event|6
4754660|NCT03070392|7729166|FG001|Overall Study|Adverse Event|1
4754661|NCT03070392|7729167|FG002|Overall Study|Adverse Event|1
4670210|NCT02320058|7566512|FG000|Overall Study|Other reasons|4
4670211|NCT02320058|7566513|FG001|Overall Study|Other reasons|1
4670212|NCT02320058|7566512|FG000|Overall Study|Withdrawal by Subject|8
4670213|NCT02320058|7566513|FG001|Overall Study|Withdrawal by Subject|2
4670214|NCT02320058|7566512|FG000|Overall Study|Not reported|1
4670215|NCT02320058|7566513|FG001|Overall Study|Not reported|0
4670216|NCT02320123|7566521|FG000|Overall Study|Lost to Follow-up|4
4670217|NCT02320123|7566522|FG001|Overall Study|Lost to Follow-up|6
4670218|NCT02320123|7566521|FG000|Overall Study|Death|6
4670219|NCT02320123|7566522|FG001|Overall Study|Death|5
4670220|NCT02320149|7566534|FG000|Overall Study|Adverse Event|3
4670221|NCT02320149|7566535|FG001|Overall Study|Adverse Event|7
4670222|NCT02320149|7566534|FG000|Overall Study|Withdrawal of Consent|28
4670223|NCT02320149|7566535|FG001|Overall Study|Withdrawal of Consent|32
4670224|NCT02320149|7566534|FG000|Overall Study|Lost to Follow-up|21
4754662|NCT03070392|7729168|FG003|Overall Study|Adverse Event|3
4754663|NCT03070392|7729165|FG000|Overall Study|Alternate anticancer treatment|1
4754664|NCT03070392|7729166|FG001|Overall Study|Alternate anticancer treatment|0
4754665|NCT03070392|7729167|FG002|Overall Study|Alternate anticancer treatment|0
4754666|NCT03070392|7729168|FG003|Overall Study|Alternate anticancer treatment|1
4754667|NCT03070392|7729165|FG000|Overall Study|Ongoing|73
4754668|NCT03070392|7729166|FG001|Overall Study|Ongoing|0
4754669|NCT03070392|7729167|FG002|Overall Study|Ongoing|0
4754670|NCT03070392|7729168|FG003|Overall Study|Ongoing|11
4670225|NCT02320149|7566535|FG001|Overall Study|Lost to Follow-up|34
4670226|NCT02320149|7566534|FG000|Overall Study|Protocol Violation|2
4670227|NCT02320149|7566535|FG001|Overall Study|Protocol Violation|1
4670228|NCT02320149|7566534|FG000|Overall Study|Noncompliance with Study Treatment|7
4670229|NCT02320149|7566535|FG001|Overall Study|Noncompliance with Study Treatment|2
4670230|NCT02320149|7566534|FG000|Overall Study|Lack of Efficacy|0
4670231|NCT02320149|7566535|FG001|Overall Study|Lack of Efficacy|1
4670232|NCT02320149|7566534|FG000|Overall Study|Other Miscellaneous Reasons|2
4670233|NCT02320149|7566535|FG001|Overall Study|Other Miscellaneous Reasons|3
4670234|NCT02320253|7566565|FG000|Overall Study|Withdrawal by Subject|3
4670235|NCT02320253|7566566|FG001|Overall Study|Withdrawal by Subject|0
4670236|NCT02320253|7566567|FG002|Overall Study|Withdrawal by Subject|0
4670237|NCT02320253|7566565|FG000|Overall Study|Lost to Follow-up|2
4670238|NCT02320253|7566566|FG001|Overall Study|Lost to Follow-up|2
4670239|NCT02320253|7566567|FG002|Overall Study|Lost to Follow-up|1
4670240|NCT02320253|7566565|FG000|Overall Study|Death|1
4670241|NCT02320253|7566566|FG001|Overall Study|Death|0
4670242|NCT02320253|7566567|FG002|Overall Study|Death|1
4670243|NCT02320487|7566575|FG000|Overall Study|Reason not Specified|1
4670244|NCT02320487|7566575|FG000|Overall Study|Physician Decision|5
4670245|NCT02320487|7566575|FG000|Overall Study|Withdrawal by Subject|1
4670246|NCT02320487|7566575|FG000|Overall Study|Death|3
4670247|NCT02320487|7566575|FG000|Overall Study|Adverse Event|11
4670248|NCT02320721|7566590|FG000|Overall Study|Adverse Event|6
4670249|NCT02320721|7566591|FG001|Overall Study|Adverse Event|6
4670250|NCT02320721|7566590|FG000|Overall Study|Lack of Efficacy|2
4670251|NCT02320721|7566591|FG001|Overall Study|Lack of Efficacy|0
4670252|NCT02320721|7566590|FG000|Overall Study|Poor compliance to protocol|3
4754671|NCT03048578|7729176|FG000|Overall Study|Withdrawal by Subject|5
4754672|NCT03048578|7729177|FG001|Overall Study|Withdrawal by Subject|6
4754673|NCT03048578|7729176|FG000|Overall Study|Lost to Follow-up|22
4754674|NCT03048578|7729177|FG001|Overall Study|Lost to Follow-up|10
4754675|NCT03048578|7729176|FG000|Overall Study|Adverse Event|1
4754676|NCT03048578|7729177|FG001|Overall Study|Adverse Event|2
4754677|NCT03048578|7729176|FG000|Overall Study|Terminated|3
4754678|NCT03048578|7729177|FG001|Overall Study|Terminated|2
4754679|NCT03015194|7729183|FG000|Overall Study|Death|10
4754680|NCT03015194|7729183|FG000|Overall Study|Withdrawal by Subject|2
4754681|NCT03012815|7729190|FG000|Overall Study|Lost to Follow-up|1
4754682|NCT03012815|7729191|FG001|Overall Study|Lost to Follow-up|0
4754683|NCT03012815|7729190|FG000|Overall Study|Physician Decision|3
4754684|NCT03012815|7729191|FG001|Overall Study|Physician Decision|2
4754685|NCT03012815|7729190|FG000|Overall Study|Adverse Event|1
4754686|NCT03012815|7729191|FG001|Overall Study|Adverse Event|0
4754687|NCT03001011|7729200|FG000|Overall Study|Adverse Event|9
4754688|NCT03001011|7729201|FG001|Overall Study|Adverse Event|3
4754689|NCT03001011|7729200|FG000|Overall Study|Chronic kidney disease lead to dialysis|15
4754690|NCT03001011|7729201|FG001|Overall Study|Chronic kidney disease lead to dialysis|10
4754691|NCT03001011|7729200|FG000|Overall Study|Other than specified above|3
4754692|NCT03001011|7729201|FG001|Overall Study|Other than specified above|8
4754693|NCT02999633|7729208|FG000|Overall Study|Adverse Event|2
4754694|NCT02999633|7729208|FG000|Overall Study|Progressive disease|12
4754695|NCT02993757|7729214|FG000|Overall Study|Non compliance with the protocol|155
4754696|NCT02993757|7729215|FG001|Overall Study|Non compliance with the protocol|170
4754697|NCT02993757|7729214|FG000|Overall Study|Lost to Follow-up|1
4754698|NCT02993757|7729215|FG001|Overall Study|Lost to Follow-up|0
4754699|NCT02993757|7729214|FG000|Overall Study|Voluntary withdraw not due adverse event|8
4754700|NCT02993757|7729215|FG001|Overall Study|Voluntary withdraw not due adverse event|8
4754701|NCT02992418|7729223|FG000|Overall Study|Withdrawal by Subject|11
4754702|NCT02992418|7729224|FG001|Overall Study|Withdrawal by Subject|12
4754703|NCT02992418|7729223|FG000|Overall Study|Non-compliance with the protocol|308
4754704|NCT02992418|7729224|FG001|Overall Study|Non-compliance with the protocol|308
4754705|NCT02992418|7729223|FG000|Overall Study|Lost to Follow-up|27
4754706|NCT02992418|7729224|FG001|Overall Study|Lost to Follow-up|22
4754707|NCT02979535|7729232|FG000|Overall Study|Non compliance with the protocol|78
4754708|NCT02979535|7729233|FG001|Overall Study|Non compliance with the protocol|82
4754709|NCT02979535|7729232|FG000|Overall Study|Consent withdrawn by participant|11
4754710|NCT02979535|7729233|FG001|Overall Study|Consent withdrawn by participant|18
4754711|NCT02979535|7729232|FG000|Overall Study|Lost to Follow-up|6
4754712|NCT02979535|7729233|FG001|Overall Study|Lost to Follow-up|1
4754713|NCT02978716|7729242|FG000|Overall Study|Death|25
4754714|NCT02978716|7729243|FG001|Overall Study|Death|13
4754715|NCT02978716|7729244|FG002|Overall Study|Death|20
4754716|NCT02978716|7729242|FG000|Overall Study|Lost to Follow-up|0
4754717|NCT02978716|7729243|FG001|Overall Study|Lost to Follow-up|0
4754718|NCT02978716|7729244|FG002|Overall Study|Lost to Follow-up|1
4754719|NCT02978716|7729242|FG000|Overall Study|Withdrawal by Subject|6
4754720|NCT02978716|7729243|FG001|Overall Study|Withdrawal by Subject|4
4754721|NCT02978716|7729244|FG002|Overall Study|Withdrawal by Subject|5
4754722|NCT02978716|7729242|FG000|Overall Study|Sponsor terminated|2
4754723|NCT02978716|7729243|FG001|Overall Study|Sponsor terminated|13
4670253|NCT02320721|7566591|FG001|Overall Study|Poor compliance to protocol|7
4670254|NCT02320721|7566590|FG000|Overall Study|Randomized but not treated|0
4670255|NCT02320721|7566591|FG001|Overall Study|Randomized but not treated|1
4754724|NCT02978716|7729244|FG002|Overall Study|Sponsor terminated|9
4754725|NCT02978716|7729242|FG000|Overall Study|Other|1
4754726|NCT02978716|7729243|FG001|Overall Study|Other|3
4670256|NCT02320721|7566590|FG000|Overall Study|Hypoglycemia|1
4670257|NCT02320721|7566591|FG001|Overall Study|Hypoglycemia|0
4670258|NCT02320721|7566590|FG000|Overall Study|Other than specified above|15
4670259|NCT02320721|7566591|FG001|Overall Study|Other than specified above|20
4670260|NCT02320903|7566620|FG000|Overall Study|Withdrawal by Subject|0
4670261|NCT02320903|7566621|FG001|Overall Study|Withdrawal by Subject|9
4670262|NCT02320903|7566622|FG002|Overall Study|Withdrawal by Subject|9
4670263|NCT02320903|7566620|FG000|Overall Study|Exited therapy; no longer eligible|8
4670264|NCT02320903|7566621|FG001|Overall Study|Exited therapy; no longer eligible|2
4670265|NCT02320903|7566622|FG002|Overall Study|Exited therapy; no longer eligible|2
4670266|NCT02320903|7566620|FG000|Overall Study|Lost to Follow-up|0
4670267|NCT02320903|7566621|FG001|Overall Study|Lost to Follow-up|5
4670268|NCT02320903|7566622|FG002|Overall Study|Lost to Follow-up|5
4670269|NCT02321098|7566634|FG000|12 Weeks Treament|Lost to Follow-up|1
4670270|NCT02321098|7566635|FG001|12 Weeks Treament|Lost to Follow-up|1
4670271|NCT02321098|7566636|FG002|12 Weeks Treament|Lost to Follow-up|0
4670272|NCT02321098|7566634|FG000|Additional 15 Months Treatment|Lack of Efficacy|0
4670273|NCT02321098|7566635|FG001|Additional 15 Months Treatment|Lack of Efficacy|0
4670274|NCT02321098|7566636|FG002|Additional 15 Months Treatment|Lack of Efficacy|6
4670275|NCT02321098|7566634|FG000|Additional 15 Months Treatment|Lost to Follow-up|0
4670276|NCT02321098|7566635|FG001|Additional 15 Months Treatment|Lost to Follow-up|0
4670277|NCT02321098|7566636|FG002|Additional 15 Months Treatment|Lost to Follow-up|1
4670278|NCT02321098|7566634|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0
4670279|NCT02321098|7566635|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0
4670280|NCT02321098|7566636|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1
4670281|NCT02321319|7566658|FG000|Overall Study|Product discontinued|5
4670282|NCT02321436|7566664|FG000|Overall Study|Withdrawal by Subject|1
4670283|NCT02321436|7566665|FG001|Overall Study|Withdrawal by Subject|0
4670284|NCT02321436|7566664|FG000|Overall Study|Lost to Follow-up|0
4670285|NCT02321436|7566665|FG001|Overall Study|Lost to Follow-up|1
4670286|NCT02321462|7566674|FG000|Overall Study|Withdrawal by Subject|5
4670287|NCT02321462|7566675|FG001|Overall Study|Withdrawal by Subject|2
4670288|NCT02321462|7566674|FG000|Overall Study|Subject withdrawn before any treatment|1
4670289|NCT02321462|7566675|FG001|Overall Study|Subject withdrawn before any treatment|1
4670290|NCT02321800|7566700|FG000|Overall Study|Withdrawal by Subject|3
4670291|NCT02321800|7566701|FG001|Overall Study|Withdrawal by Subject|3
4670292|NCT02321800|7566700|FG000|Overall Study|Death|1
4670293|NCT02321800|7566701|FG001|Overall Study|Death|0
4670294|NCT02321800|7566700|FG000|Overall Study|Protocol Violation|1
4670295|NCT02321800|7566701|FG001|Overall Study|Protocol Violation|0
4670296|NCT02321800|7566700|FG000|Overall Study|Lost to Follow-up|10
4670297|NCT02321800|7566701|FG001|Overall Study|Lost to Follow-up|4
4670298|NCT02321800|7566700|FG000|Overall Study|Adverse Event|2
4670299|NCT02321800|7566701|FG001|Overall Study|Adverse Event|3
4670300|NCT02321800|7566700|FG000|Overall Study|Other, Miscellaneous|3
4670301|NCT02321800|7566701|FG001|Overall Study|Other, Miscellaneous|1
4670302|NCT02321930|7566707|FG000|Overall Study|Lost to Follow-up|1
4670303|NCT02322021|7566715|FG000|Core Phase|Adverse Event|1
4670304|NCT02322021|7566716|FG001|Core Phase|Adverse Event|3
4670305|NCT02322021|7566717|FG002|Core Phase|Adverse Event|4
4670306|NCT02322021|7566718|FG003|Core Phase|Adverse Event|2
4670307|NCT02322021|7566719|FG004|Core Phase|Adverse Event|0
4670308|NCT02322021|7566715|FG000|Core Phase|Participant Choice|4
4670309|NCT02322021|7566716|FG001|Core Phase|Participant Choice|5
4670310|NCT02322021|7566717|FG002|Core Phase|Participant Choice|4
4754727|NCT02978716|7729244|FG002|Overall Study|Other|0
4754728|NCT02973321|7729259|FG000|Overall Study|Other than specified|0
4754729|NCT02973321|7729260|FG001|Overall Study|Other than specified|5
4754730|NCT02973321|7729261|FG002|Overall Study|Other than specified|3
4754731|NCT02973321|7729262|FG003|Overall Study|Other than specified|3
4754732|NCT02973321|7729263|FG004|Overall Study|Other than specified|1
4754733|NCT02973321|7729259|FG000|Overall Study|Lack of Efficacy|0
4754734|NCT02973321|7729260|FG001|Overall Study|Lack of Efficacy|0
4754735|NCT02973321|7729261|FG002|Overall Study|Lack of Efficacy|0
4754736|NCT02973321|7729262|FG003|Overall Study|Lack of Efficacy|0
4754737|NCT02973321|7729263|FG004|Overall Study|Lack of Efficacy|1
4754738|NCT02973321|7729259|FG000|Overall Study|Adverse Event|1
4754739|NCT02973321|7729260|FG001|Overall Study|Adverse Event|10
4754740|NCT02973321|7729261|FG002|Overall Study|Adverse Event|11
4754741|NCT02973321|7729262|FG003|Overall Study|Adverse Event|13
4754742|NCT02973321|7729263|FG004|Overall Study|Adverse Event|3
4754743|NCT02943785|7729278|FG000|Overall Study|Adverse Event|112
4670311|NCT02322021|7566718|FG003|Core Phase|Participant Choice|2
4670312|NCT02322021|7566719|FG004|Core Phase|Participant Choice|0
4670313|NCT02322021|7566715|FG000|Core Phase|Lost to Follow-up|0
4670314|NCT02322021|7566716|FG001|Core Phase|Lost to Follow-up|0
4670315|NCT02322021|7566717|FG002|Core Phase|Lost to Follow-up|0
4670316|NCT02322021|7566718|FG003|Core Phase|Lost to Follow-up|1
4670317|NCT02322021|7566719|FG004|Core Phase|Lost to Follow-up|0
4670318|NCT02322021|7566715|FG000|Core Phase|Other|0
4670319|NCT02322021|7566716|FG001|Core Phase|Other|0
4754744|NCT02943785|7729279|FG001|Overall Study|Adverse Event|97
4670320|NCT02322021|7566717|FG002|Core Phase|Other|1
4670321|NCT02322021|7566718|FG003|Core Phase|Other|0
4670322|NCT02322021|7566719|FG004|Core Phase|Other|0
4670323|NCT02322021|7566715|FG000|Extension Phase|Adverse Event|0
4670324|NCT02322021|7566716|FG001|Extension Phase|Adverse Event|0
4670325|NCT02322021|7566717|FG002|Extension Phase|Adverse Event|0
4670326|NCT02322021|7566718|FG003|Extension Phase|Adverse Event|0
4670327|NCT02322021|7566719|FG004|Extension Phase|Adverse Event|3
4670328|NCT02322021|7566715|FG000|Extension Phase|Participant Choice|0
4670329|NCT02322021|7566716|FG001|Extension Phase|Participant Choice|0
4670330|NCT02322021|7566717|FG002|Extension Phase|Participant Choice|0
4670331|NCT02322021|7566718|FG003|Extension Phase|Participant Choice|0
4670332|NCT02322021|7566719|FG004|Extension Phase|Participant Choice|6
4670333|NCT02322021|7566715|FG000|Extension Phase|Other|0
4670334|NCT02322021|7566716|FG001|Extension Phase|Other|0
4670335|NCT02322021|7566717|FG002|Extension Phase|Other|0
4670336|NCT02322021|7566718|FG003|Extension Phase|Other|0
4670337|NCT02322021|7566719|FG004|Extension Phase|Other|3
4670338|NCT02322021|7566715|FG000|Extension Phase|Lost to Follow-up|0
4670339|NCT02322021|7566716|FG001|Extension Phase|Lost to Follow-up|0
4670340|NCT02322021|7566717|FG002|Extension Phase|Lost to Follow-up|0
4670341|NCT02322021|7566718|FG003|Extension Phase|Lost to Follow-up|0
4670342|NCT02322021|7566719|FG004|Extension Phase|Lost to Follow-up|1
4670343|NCT02322021|7566715|FG000|Extension Phase|Study terminated by sponsor|0
4670344|NCT02322021|7566716|FG001|Extension Phase|Study terminated by sponsor|0
4670345|NCT02322021|7566717|FG002|Extension Phase|Study terminated by sponsor|0
4670346|NCT02322021|7566718|FG003|Extension Phase|Study terminated by sponsor|0
4670347|NCT02322021|7566719|FG004|Extension Phase|Study terminated by sponsor|28
4670348|NCT02322047|7566738|FG000|Overall Study|Physician Decision|1
4754745|NCT02943785|7729278|FG000|Overall Study|Withdrawal by Subject|63
4754746|NCT02943785|7729279|FG001|Overall Study|Withdrawal by Subject|126
4754747|NCT02943785|7729278|FG000|Overall Study|Physician Decision|23
4754748|NCT02943785|7729279|FG001|Overall Study|Physician Decision|47
4754749|NCT02943785|7729278|FG000|Overall Study|Death|46
4754750|NCT02943785|7729279|FG001|Overall Study|Death|46
4754751|NCT02943785|7729278|FG000|Overall Study|Lost to Follow-up|1
4754752|NCT02943785|7729279|FG001|Overall Study|Lost to Follow-up|0
4754753|NCT02943785|7729278|FG000|Overall Study|Other|16
4754754|NCT02943785|7729279|FG001|Overall Study|Other|19
4754755|NCT02943785|7729278|FG000|Overall Study|Did not receive any study medication|21
4754756|NCT02943785|7729279|FG001|Overall Study|Did not receive any study medication|28
4754757|NCT02937818|7729289|FG000|Overall Study|Participants decision|1
4754758|NCT02937818|7729290|FG001|Overall Study|Participants decision|0
4754759|NCT02937818|7729291|FG002|Overall Study|Participants decision|1
4754760|NCT02937818|7729292|FG003|Overall Study|Participants decision|1
4754761|NCT02937818|7729289|FG000|Overall Study|Adverse Event|2
4754762|NCT02937818|7729290|FG001|Overall Study|Adverse Event|4
4754763|NCT02937818|7729291|FG002|Overall Study|Adverse Event|1
4754764|NCT02937818|7729292|FG003|Overall Study|Adverse Event|1
4754765|NCT02937818|7729289|FG000|Overall Study|Disease progression|17
4754766|NCT02937818|7729290|FG001|Overall Study|Disease progression|14
4754767|NCT02937818|7729291|FG002|Overall Study|Disease progression|7
4754768|NCT02937818|7729292|FG003|Overall Study|Disease progression|18
4754769|NCT02937818|7729289|FG000|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|1
4754770|NCT02937818|7729290|FG001|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|2
4754771|NCT02937818|7729291|FG002|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|0
4754772|NCT02937818|7729292|FG003|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|0
4754773|NCT02937818|7729289|FG000|Overall Study|Condition under investigation worsened|0
4754774|NCT02937818|7729290|FG001|Overall Study|Condition under investigation worsened|0
4754775|NCT02937818|7729291|FG002|Overall Study|Condition under investigation worsened|1
4754776|NCT02937818|7729292|FG003|Overall Study|Condition under investigation worsened|0
4754777|NCT02937818|7729289|FG000|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|0
4754778|NCT02937818|7729290|FG001|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|0
4754779|NCT02937818|7729291|FG002|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|0
4754780|NCT02937818|7729292|FG003|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|1
4754781|NCT02923674|7729308|FG000|Overall Study|Clinic Closed Due to COVID-19|14
4754782|NCT02923674|7729309|FG001|Overall Study|Clinic Closed Due to COVID-19|11
4754783|NCT02923674|7729310|FG002|Overall Study|Clinic Closed Due to COVID-19|14
4754784|NCT02923674|7729308|FG000|Overall Study|Lost to Follow-up|7
4754785|NCT02923674|7729309|FG001|Overall Study|Lost to Follow-up|12
4754786|NCT02923674|7729310|FG002|Overall Study|Lost to Follow-up|7
4754787|NCT02923674|7729308|FG000|Overall Study|Problem with intervention|2
4754788|NCT02923674|7729309|FG001|Overall Study|Problem with intervention|2
4754789|NCT02923674|7729310|FG002|Overall Study|Problem with intervention|1
4754790|NCT02923674|7729308|FG000|Overall Study|Adverse Event|3
4754791|NCT02923674|7729309|FG001|Overall Study|Adverse Event|1
4754792|NCT02923674|7729310|FG002|Overall Study|Adverse Event|1
4754793|NCT02923674|7729308|FG000|Overall Study|Withdrawal by Subject|2
4754794|NCT02923674|7729309|FG001|Overall Study|Withdrawal by Subject|2
4754795|NCT02923674|7729310|FG002|Overall Study|Withdrawal by Subject|2
4754796|NCT02921971|7729320|FG000|Overall Study|Adverse Event|1
4754797|NCT02921971|7729321|FG001|Overall Study|Adverse Event|2
4754798|NCT02921971|7729320|FG000|Overall Study|Lack of Efficacy|3
4754799|NCT02921971|7729321|FG001|Overall Study|Lack of Efficacy|1
4670349|NCT02322047|7566739|FG001|Overall Study|Physician Decision|0
4670350|NCT02322047|7566740|FG002|Overall Study|Physician Decision|0
4670351|NCT02322047|7566741|FG003|Overall Study|Physician Decision|0
4670352|NCT02322047|7566738|FG000|Overall Study|Withdrawal by Subject|1
4670353|NCT02322047|7566739|FG001|Overall Study|Withdrawal by Subject|0
4670354|NCT02322047|7566740|FG002|Overall Study|Withdrawal by Subject|0
4670355|NCT02322047|7566741|FG003|Overall Study|Withdrawal by Subject|1
4670356|NCT02322047|7566738|FG000|Overall Study|Adverse Event|0
4670357|NCT02322047|7566739|FG001|Overall Study|Adverse Event|1
4670358|NCT02322047|7566740|FG002|Overall Study|Adverse Event|0
4670359|NCT02322047|7566741|FG003|Overall Study|Adverse Event|0
4670360|NCT02322047|7566738|FG000|Overall Study|Lost to Follow-up|0
4670361|NCT02322047|7566739|FG001|Overall Study|Lost to Follow-up|0
4670362|NCT02322047|7566740|FG002|Overall Study|Lost to Follow-up|1
4670363|NCT02322047|7566741|FG003|Overall Study|Lost to Follow-up|1
4670364|NCT02322125|7566751|FG000|Overall Study|Withdrawal by Subject|2
4670365|NCT02322190|7566755|FG000|Overall Study|Death on study|1
4670366|NCT02322190|7566756|FG001|Overall Study|Death on study|0
4670367|NCT02322216|7566763|FG000|Overall Study|Adverse Event|1
4670368|NCT02322216|7566764|FG001|Overall Study|Adverse Event|0
4670369|NCT02322216|7566763|FG000|Overall Study|Withdrawal by Subject|1
4754800|NCT02921971|7729320|FG000|Overall Study|Other than specified above|2
4754801|NCT02921971|7729321|FG001|Overall Study|Other than specified above|1
4754802|NCT02908685|7729339|FG000|Part 1 Exploratory|Withdrawal by Subject|0
4754803|NCT02908685|7729340|FG001|Part 1 Exploratory|Withdrawal by Subject|1
4754804|NCT02908685|7729341|FG002|Part 1 Exploratory|Withdrawal by Subject|0
4754805|NCT02908685|7729342|FG003|Part 1 Exploratory|Withdrawal by Subject|0
4754806|NCT02908685|7729343|FG004|Part 1 Exploratory|Withdrawal by Subject|0
4754807|NCT02908685|7729344|FG005|Part 1 Exploratory|Withdrawal by Subject|0
4754808|NCT02908685|7729345|FG006|Part 1 Exploratory|Withdrawal by Subject|0
4670370|NCT02322216|7566764|FG001|Overall Study|Withdrawal by Subject|4
4754809|NCT02908685|7729346|FG007|Part 1 Exploratory|Withdrawal by Subject|0
4754810|NCT02908685|7729347|FG008|Part 1 Exploratory|Withdrawal by Subject|0
4754811|NCT02908685|7729348|FG009|Part 1 Exploratory|Withdrawal by Subject|0
4754812|NCT02908685|7729349|FG010|Part 1 Exploratory|Withdrawal by Subject|0
4754813|NCT02908685|7729350|FG011|Part 1 Exploratory|Withdrawal by Subject|0
4754814|NCT02908685|7729339|FG000|Part 2 Confirmatory|Changed to Spinraza|0
4754815|NCT02908685|7729340|FG001|Part 2 Confirmatory|Changed to Spinraza|0
4754816|NCT02908685|7729341|FG002|Part 2 Confirmatory|Changed to Spinraza|0
4754817|NCT02908685|7729342|FG003|Part 2 Confirmatory|Changed to Spinraza|0
4754818|NCT02908685|7729343|FG004|Part 2 Confirmatory|Changed to Spinraza|0
4754819|NCT02908685|7729344|FG005|Part 2 Confirmatory|Changed to Spinraza|0
4754820|NCT02908685|7729345|FG006|Part 2 Confirmatory|Changed to Spinraza|0
4754821|NCT02908685|7729346|FG007|Part 2 Confirmatory|Changed to Spinraza|0
4754822|NCT02908685|7729347|FG008|Part 2 Confirmatory|Changed to Spinraza|0
4754823|NCT02908685|7729348|FG009|Part 2 Confirmatory|Changed to Spinraza|0
4754824|NCT02908685|7729349|FG010|Part 2 Confirmatory|Changed to Spinraza|2
4754825|NCT02908685|7729350|FG011|Part 2 Confirmatory|Changed to Spinraza|1
4754826|NCT02908685|7729339|FG000|Part 2 Confirmatory|Changed to other treatment|0
4754827|NCT02908685|7729340|FG001|Part 2 Confirmatory|Changed to other treatment|0
4754828|NCT02908685|7729341|FG002|Part 2 Confirmatory|Changed to other treatment|0
4754829|NCT02908685|7729342|FG003|Part 2 Confirmatory|Changed to other treatment|0
4754830|NCT02908685|7729343|FG004|Part 2 Confirmatory|Changed to other treatment|0
4754831|NCT02908685|7729344|FG005|Part 2 Confirmatory|Changed to other treatment|0
4754832|NCT02908685|7729345|FG006|Part 2 Confirmatory|Changed to other treatment|0
4754833|NCT02908685|7729346|FG007|Part 2 Confirmatory|Changed to other treatment|0
4754834|NCT02908685|7729347|FG008|Part 2 Confirmatory|Changed to other treatment|0
4754835|NCT02908685|7729348|FG009|Part 2 Confirmatory|Changed to other treatment|0
4754836|NCT02908685|7729349|FG010|Part 2 Confirmatory|Changed to other treatment|1
4754837|NCT02908685|7729350|FG011|Part 2 Confirmatory|Changed to other treatment|0
4754838|NCT02903914|7729375|FG000|Overall Study|Adverse Event|0
4754839|NCT02903914|7729376|FG001|Overall Study|Adverse Event|0
4754840|NCT02903914|7729377|FG002|Overall Study|Adverse Event|1
4754841|NCT02903914|7729378|FG003|Overall Study|Adverse Event|0
4754842|NCT02903914|7729379|FG004|Overall Study|Adverse Event|0
4754843|NCT02903914|7729380|FG005|Overall Study|Adverse Event|1
4754844|NCT02903914|7729381|FG006|Overall Study|Adverse Event|2
4754845|NCT02903914|7729382|FG007|Overall Study|Adverse Event|1
4754846|NCT02903914|7729375|FG000|Overall Study|Withdrawal by Subject|3
4754847|NCT02903914|7729376|FG001|Overall Study|Withdrawal by Subject|1
4754848|NCT02903914|7729377|FG002|Overall Study|Withdrawal by Subject|28
4754849|NCT02903914|7729378|FG003|Overall Study|Withdrawal by Subject|0
4754850|NCT02903914|7729379|FG004|Overall Study|Withdrawal by Subject|1
4754851|NCT02903914|7729380|FG005|Overall Study|Withdrawal by Subject|1
4754852|NCT02903914|7729381|FG006|Overall Study|Withdrawal by Subject|12
4754853|NCT02903914|7729382|FG007|Overall Study|Withdrawal by Subject|0
4754854|NCT02903914|7729375|FG000|Overall Study|Progressive Disease|1
4754855|NCT02903914|7729376|FG001|Overall Study|Progressive Disease|0
4754856|NCT02903914|7729377|FG002|Overall Study|Progressive Disease|4
4754857|NCT02903914|7729378|FG003|Overall Study|Progressive Disease|0
4754858|NCT02903914|7729379|FG004|Overall Study|Progressive Disease|0
4754859|NCT02903914|7729380|FG005|Overall Study|Progressive Disease|0
4754860|NCT02903914|7729381|FG006|Overall Study|Progressive Disease|2
4670371|NCT02322229|7566771|FG000|Overall Study|Physician Decision|2
4670372|NCT02322281|7566788|FG000|Overall Study|Progressive Disease|42
4670373|NCT02322281|7566789|FG001|Overall Study|Progressive Disease|14
4670374|NCT02322281|7566790|FG002|Overall Study|Progressive Disease|49
4670375|NCT02322281|7566788|FG000|Overall Study|Adverse Event|3
4670376|NCT02322281|7566789|FG001|Overall Study|Adverse Event|4
4670377|NCT02322281|7566790|FG002|Overall Study|Adverse Event|6
4670378|NCT02322281|7566788|FG000|Overall Study|Death|3
4670379|NCT02322281|7566789|FG001|Overall Study|Death|3
4670380|NCT02322281|7566790|FG002|Overall Study|Death|3
4670381|NCT02322281|7566788|FG000|Overall Study|Withdrawal by Subject|1
4670382|NCT02322281|7566789|FG001|Overall Study|Withdrawal by Subject|1
4670383|NCT02322281|7566790|FG002|Overall Study|Withdrawal by Subject|6
4670384|NCT02322281|7566788|FG000|Overall Study|Physician Decision|2
4670385|NCT02322281|7566789|FG001|Overall Study|Physician Decision|0
4670386|NCT02322281|7566790|FG002|Overall Study|Physician Decision|5
4670387|NCT02322281|7566788|FG000|Overall Study|Study Terminated by Sponsor|2
4670388|NCT02322281|7566789|FG001|Overall Study|Study Terminated by Sponsor|0
4670389|NCT02322281|7566790|FG002|Overall Study|Study Terminated by Sponsor|0
4670390|NCT02322281|7566788|FG000|Overall Study|Missing|0
4670391|NCT02322281|7566789|FG001|Overall Study|Missing|0
4670392|NCT02322281|7566790|FG002|Overall Study|Missing|1
4754861|NCT02903914|7729382|FG007|Overall Study|Progressive Disease|4
4754862|NCT02903914|7729375|FG000|Overall Study|Death|0
4754863|NCT02903914|7729376|FG001|Overall Study|Death|0
4754864|NCT02903914|7729377|FG002|Overall Study|Death|9
4754865|NCT02903914|7729378|FG003|Overall Study|Death|0
4754866|NCT02903914|7729379|FG004|Overall Study|Death|1
4754867|NCT02903914|7729380|FG005|Overall Study|Death|3
4754868|NCT02903914|7729381|FG006|Overall Study|Death|24
4754869|NCT02903914|7729382|FG007|Overall Study|Death|0
4754870|NCT02903914|7729375|FG000|Overall Study|Lost to Follow-up|0
4754871|NCT02903914|7729376|FG001|Overall Study|Lost to Follow-up|1
4754872|NCT02903914|7729377|FG002|Overall Study|Lost to Follow-up|0
4754873|NCT02903914|7729378|FG003|Overall Study|Lost to Follow-up|0
4754874|NCT02903914|7729379|FG004|Overall Study|Lost to Follow-up|2
4754875|NCT02903914|7729380|FG005|Overall Study|Lost to Follow-up|0
4754876|NCT02903914|7729381|FG006|Overall Study|Lost to Follow-up|1
4754877|NCT02903914|7729382|FG007|Overall Study|Lost to Follow-up|0
4754878|NCT02903914|7729375|FG000|Overall Study|Physician Decision|0
4754879|NCT02903914|7729376|FG001|Overall Study|Physician Decision|0
4754880|NCT02903914|7729377|FG002|Overall Study|Physician Decision|1
4754881|NCT02903914|7729378|FG003|Overall Study|Physician Decision|0
4754882|NCT02903914|7729379|FG004|Overall Study|Physician Decision|0
4754883|NCT02903914|7729380|FG005|Overall Study|Physician Decision|0
4754884|NCT02903914|7729381|FG006|Overall Study|Physician Decision|1
4754885|NCT02903914|7729382|FG007|Overall Study|Physician Decision|0
4754886|NCT02903914|7729375|FG000|Overall Study|Symptomatic Deterioration|0
4754887|NCT02903914|7729376|FG001|Overall Study|Symptomatic Deterioration|0
4754888|NCT02903914|7729377|FG002|Overall Study|Symptomatic Deterioration|1
4670393|NCT02322281|7566788|FG000|Overall Study|Miscellaneous|0
4670394|NCT02322281|7566789|FG001|Overall Study|Miscellaneous|0
4670395|NCT02322281|7566790|FG002|Overall Study|Miscellaneous|4
4670396|NCT02322411|7566824|FG000|Overall Study|Lost to Follow-up|4
4670397|NCT02322411|7566825|FG001|Overall Study|Lost to Follow-up|7
4670398|NCT02322411|7566824|FG000|Overall Study|Withdrawal by Subject|1
4670399|NCT02322411|7566825|FG001|Overall Study|Withdrawal by Subject|0
4670400|NCT02322749|7566835|FG000|Period 2|Adverse Event|0
4670401|NCT02322749|7566836|FG001|Period 2|Adverse Event|0
4670402|NCT02322749|7566837|FG002|Period 2|Adverse Event|0
4670403|NCT02322749|7566838|FG003|Period 2|Adverse Event|1
4670404|NCT02322749|7566839|FG004|Period 2|Adverse Event|0
4670405|NCT02322749|7566840|FG005|Period 2|Adverse Event|0
4670406|NCT02322749|7566835|FG000|Period 2|Withdrawal by Subject|0
4670407|NCT02322749|7566836|FG001|Period 2|Withdrawal by Subject|0
4670408|NCT02322749|7566837|FG002|Period 2|Withdrawal by Subject|0
4670409|NCT02322749|7566838|FG003|Period 2|Withdrawal by Subject|1
4670410|NCT02322749|7566839|FG004|Period 2|Withdrawal by Subject|0
4670411|NCT02322749|7566840|FG005|Period 2|Withdrawal by Subject|0
4670412|NCT02322749|7566835|FG000|Period 3|Withdrawal by Subject|0
4670413|NCT02322749|7566836|FG001|Period 3|Withdrawal by Subject|0
4670414|NCT02322749|7566837|FG002|Period 3|Withdrawal by Subject|1
4670415|NCT02322749|7566838|FG003|Period 3|Withdrawal by Subject|0
4670416|NCT02322749|7566839|FG004|Period 3|Withdrawal by Subject|0
4670417|NCT02322749|7566840|FG005|Period 3|Withdrawal by Subject|0
4670418|NCT02322775|7566851|FG000|Overall Study|Adverse Event|1
4754889|NCT02903914|7729378|FG003|Overall Study|Symptomatic Deterioration|0
4754890|NCT02903914|7729379|FG004|Overall Study|Symptomatic Deterioration|0
4754891|NCT02903914|7729380|FG005|Overall Study|Symptomatic Deterioration|0
4754892|NCT02903914|7729381|FG006|Overall Study|Symptomatic Deterioration|0
4754893|NCT02903914|7729382|FG007|Overall Study|Symptomatic Deterioration|0
4754894|NCT02903914|7729375|FG000|Overall Study|New Cancer Therapy|2
4670419|NCT02322775|7566852|FG001|Overall Study|Adverse Event|0
4670420|NCT02322775|7566851|FG000|Overall Study|Lost to Follow-up|0
4670421|NCT02322775|7566852|FG001|Overall Study|Lost to Follow-up|1
4670422|NCT02322775|7566851|FG000|Overall Study|Protocol Violation|1
4670423|NCT02322775|7566852|FG001|Overall Study|Protocol Violation|0
4670424|NCT02322775|7566851|FG000|Overall Study|Withdrawal by Subject|3
4670425|NCT02322775|7566852|FG001|Overall Study|Withdrawal by Subject|4
4670426|NCT02322775|7566851|FG000|Overall Study|Not willing to perform all FU visits|0
4670427|NCT02322775|7566852|FG001|Overall Study|Not willing to perform all FU visits|1
4670428|NCT02322814|7566876|FG000|Overall Study|Ongoing Study|0
4670429|NCT02322814|7566877|FG001|Overall Study|Ongoing Study|13
4670430|NCT02322814|7566878|FG002|Overall Study|Ongoing Study|14
4670431|NCT02322814|7566879|FG003|Overall Study|Ongoing Study|20
4670432|NCT02322814|7566880|FG004|Overall Study|Ongoing Study|22
4670433|NCT02322814|7566876|FG000|Overall Study|Progressive Disease|0
4670434|NCT02322814|7566877|FG001|Overall Study|Progressive Disease|2
4670435|NCT02322814|7566878|FG002|Overall Study|Progressive Disease|0
4670436|NCT02322814|7566879|FG003|Overall Study|Progressive Disease|1
4670437|NCT02322814|7566880|FG004|Overall Study|Progressive Disease|0
4670438|NCT02322814|7566876|FG000|Overall Study|Lost to Follow-up|1
4670439|NCT02322814|7566877|FG001|Overall Study|Lost to Follow-up|2
4670440|NCT02322814|7566878|FG002|Overall Study|Lost to Follow-up|1
4670441|NCT02322814|7566879|FG003|Overall Study|Lost to Follow-up|0
4670442|NCT02322814|7566880|FG004|Overall Study|Lost to Follow-up|0
4670443|NCT02322814|7566876|FG000|Overall Study|Other|2
4670444|NCT02322814|7566877|FG001|Overall Study|Other|0
4670445|NCT02322814|7566878|FG002|Overall Study|Other|0
4670446|NCT02322814|7566879|FG003|Overall Study|Other|0
4670447|NCT02322814|7566880|FG004|Overall Study|Other|0
4670448|NCT02322814|7566876|FG000|Overall Study|Protocol Violation|1
4670449|NCT02322814|7566877|FG001|Overall Study|Protocol Violation|0
4670450|NCT02322814|7566878|FG002|Overall Study|Protocol Violation|0
4670451|NCT02322814|7566879|FG003|Overall Study|Protocol Violation|0
4670452|NCT02322814|7566880|FG004|Overall Study|Protocol Violation|0
4670453|NCT02322814|7566876|FG000|Overall Study|Death|7
4670454|NCT02322814|7566877|FG001|Overall Study|Death|22
4670455|NCT02322814|7566878|FG002|Overall Study|Death|30
4670456|NCT02322814|7566879|FG003|Overall Study|Death|10
4670457|NCT02322814|7566880|FG004|Overall Study|Death|6
4670458|NCT02322814|7566876|FG000|Overall Study|Withdrawal by Subject|5
4670459|NCT02322814|7566877|FG001|Overall Study|Withdrawal by Subject|4
4670460|NCT02322814|7566878|FG002|Overall Study|Withdrawal by Subject|2
4670461|NCT02322814|7566879|FG003|Overall Study|Withdrawal by Subject|1
4670462|NCT02322814|7566880|FG004|Overall Study|Withdrawal by Subject|3
4670463|NCT02322866|7566893|FG000|Overall Study|Adverse Event|6
4670464|NCT02322866|7566894|FG001|Overall Study|Adverse Event|11
4670465|NCT02322866|7566893|FG000|Overall Study|Withdrawal of Consent|16
4670466|NCT02322866|7566894|FG001|Overall Study|Withdrawal of Consent|25
4670467|NCT02322866|7566893|FG000|Overall Study|Lost to Follow-up|36
4670468|NCT02322866|7566894|FG001|Overall Study|Lost to Follow-up|39
4670469|NCT02322866|7566893|FG000|Overall Study|Protocol Violation|1
4670470|NCT02322866|7566894|FG001|Overall Study|Protocol Violation|0
4670471|NCT02322866|7566893|FG000|Overall Study|Noncompliance with Treatment|3
4670472|NCT02322866|7566894|FG001|Overall Study|Noncompliance with Treatment|4
4670473|NCT02322866|7566893|FG000|Overall Study|Lack of Efficacy|3
4670474|NCT02322866|7566894|FG001|Overall Study|Lack of Efficacy|1
4670475|NCT02322866|7566893|FG000|Overall Study|Other Miscellaneous Reasons|6
4670476|NCT02322866|7566894|FG001|Overall Study|Other Miscellaneous Reasons|6
4670477|NCT02322879|7566902|FG000|First Intervention|Physician Decision|1
4670478|NCT02322879|7566903|FG001|First Intervention|Physician Decision|0
4670479|NCT02322892|7566911|FG000|Overall Study|Surgery cancelled|1
4670480|NCT02322892|7566912|FG001|Overall Study|Surgery cancelled|2
4670481|NCT02322892|7566911|FG000|Overall Study|Met exclusion criteria|0
4670482|NCT02322892|7566912|FG001|Overall Study|Met exclusion criteria|1
4670483|NCT02322892|7566911|FG000|Overall Study|Protocol Violation|1
4670484|NCT02322892|7566912|FG001|Overall Study|Protocol Violation|0
4670485|NCT02323113|7566946|FG000|Overall Study|Adverse Event|3
4670486|NCT02323113|7566947|FG001|Overall Study|Adverse Event|3
4670487|NCT02323113|7566948|FG002|Overall Study|Adverse Event|2
4670488|NCT02323113|7566949|FG003|Overall Study|Adverse Event|5
4670489|NCT02323113|7566950|FG004|Overall Study|Adverse Event|8
4670490|NCT02323113|7566951|FG005|Overall Study|Adverse Event|3
4670491|NCT02323113|7566952|FG006|Overall Study|Adverse Event|6
4670492|NCT02323113|7566953|FG007|Overall Study|Adverse Event|0
4670493|NCT02323113|7566946|FG000|Overall Study|Progressive Disease|0
4670494|NCT02323113|7566947|FG001|Overall Study|Progressive Disease|1
4670495|NCT02323113|7566948|FG002|Overall Study|Progressive Disease|1
4670496|NCT02323113|7566949|FG003|Overall Study|Progressive Disease|0
4670497|NCT02323113|7566950|FG004|Overall Study|Progressive Disease|0
4670498|NCT02323113|7566951|FG005|Overall Study|Progressive Disease|3
4670499|NCT02323113|7566952|FG006|Overall Study|Progressive Disease|0
4670500|NCT02323113|7566953|FG007|Overall Study|Progressive Disease|0
4670501|NCT02323113|7566946|FG000|Overall Study|Symptomatic Deterioration|0
4670502|NCT02323113|7566947|FG001|Overall Study|Symptomatic Deterioration|0
4670503|NCT02323113|7566948|FG002|Overall Study|Symptomatic Deterioration|1
4670504|NCT02323113|7566949|FG003|Overall Study|Symptomatic Deterioration|0
4670505|NCT02323113|7566950|FG004|Overall Study|Symptomatic Deterioration|1
4670506|NCT02323113|7566951|FG005|Overall Study|Symptomatic Deterioration|0
4670507|NCT02323113|7566952|FG006|Overall Study|Symptomatic Deterioration|0
4670508|NCT02323113|7566953|FG007|Overall Study|Symptomatic Deterioration|0
4670509|NCT02323113|7566946|FG000|Overall Study|Unsatisfactory Therapeutic Response|1
4670510|NCT02323113|7566947|FG001|Overall Study|Unsatisfactory Therapeutic Response|2
4670511|NCT02323113|7566948|FG002|Overall Study|Unsatisfactory Therapeutic Response|0
4670512|NCT02323113|7566949|FG003|Overall Study|Unsatisfactory Therapeutic Response|0
4670513|NCT02323113|7566950|FG004|Overall Study|Unsatisfactory Therapeutic Response|0
4670514|NCT02323113|7566951|FG005|Overall Study|Unsatisfactory Therapeutic Response|2
4670515|NCT02323113|7566952|FG006|Overall Study|Unsatisfactory Therapeutic Response|0
4670516|NCT02323113|7566953|FG007|Overall Study|Unsatisfactory Therapeutic Response|0
4670517|NCT02323113|7566946|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0
4670518|NCT02323113|7566947|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1
4670519|NCT02323113|7566948|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0
4670520|NCT02323113|7566949|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0
4670521|NCT02323113|7566950|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0
4670522|NCT02323113|7566951|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0
4670523|NCT02323113|7566952|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0
4670524|NCT02323113|7566953|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0
4670525|NCT02323204|7566976|FG000|Baseline Survey Completion|Withdrawal by Subject|10
4670526|NCT02323204|7566977|FG001|Baseline Survey Completion|Withdrawal by Subject|9
4670527|NCT02323204|7566978|FG002|Baseline Survey Completion|Withdrawal by Subject|5
4670528|NCT02323204|7566979|FG003|Baseline Survey Completion|Withdrawal by Subject|3
4670529|NCT02323204|7566976|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29
4670530|NCT02323204|7566977|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28
4670531|NCT02323204|7566978|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39
4670532|NCT02323204|7566979|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35
4670533|NCT02323204|7566976|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12
4670534|NCT02323204|7566977|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8
4670535|NCT02323204|7566978|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3
4670536|NCT02323204|7566979|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2
4670537|NCT02323204|7566976|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0
4670538|NCT02323204|7566977|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35
4670539|NCT02323204|7566978|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0
4670540|NCT02323204|7566979|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34
4670541|NCT02323204|7566976|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0
4670542|NCT02323204|7566977|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8
4670543|NCT02323204|7566978|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0
4670544|NCT02323204|7566979|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2
4670545|NCT02323204|7566976|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54
4670546|NCT02323204|7566977|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45
4670547|NCT02323204|7566978|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41
4670548|NCT02323204|7566979|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42
4670549|NCT02323204|7566976|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0
4670550|NCT02323204|7566977|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2
4670551|NCT02323204|7566978|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0
4670552|NCT02323204|7566979|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2
4670553|NCT02323204|7566976|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49
4670554|NCT02323204|7566977|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50
4670555|NCT02323204|7566978|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38
4670556|NCT02323204|7566979|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43
4670557|NCT02323204|7566976|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0
4754895|NCT02903914|7729376|FG001|Overall Study|New Cancer Therapy|2
4754896|NCT02903914|7729377|FG002|Overall Study|New Cancer Therapy|21
4754897|NCT02903914|7729378|FG003|Overall Study|New Cancer Therapy|4
4754898|NCT02903914|7729379|FG004|Overall Study|New Cancer Therapy|3
4754899|NCT02903914|7729380|FG005|Overall Study|New Cancer Therapy|6
4754900|NCT02903914|7729381|FG006|Overall Study|New Cancer Therapy|55
4754901|NCT02903914|7729382|FG007|Overall Study|New Cancer Therapy|0
4754902|NCT02903914|7729375|FG000|Overall Study|Reasoning not specified|2
4754903|NCT02903914|7729376|FG001|Overall Study|Reasoning not specified|3
4754904|NCT02903914|7729377|FG002|Overall Study|Reasoning not specified|20
4754905|NCT02903914|7729378|FG003|Overall Study|Reasoning not specified|3
4754906|NCT02903914|7729379|FG004|Overall Study|Reasoning not specified|3
4754907|NCT02903914|7729380|FG005|Overall Study|Reasoning not specified|3
4754908|NCT02903914|7729381|FG006|Overall Study|Reasoning not specified|20
4754909|NCT02903914|7729382|FG007|Overall Study|Reasoning not specified|0
4754910|NCT02890355|7729404|FG000|Overall Study|Adverse Event|5
4754911|NCT02890355|7729405|FG001|Overall Study|Adverse Event|5
4670558|NCT02323204|7566977|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0
4670559|NCT02323204|7566978|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3
4670560|NCT02323204|7566979|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1
4670561|NCT02323334|7567003|FG000|Period 3|Lost to Follow-up|0
4670562|NCT02323334|7567004|FG001|Period 3|Lost to Follow-up|0
4670563|NCT02323334|7567005|FG002|Period 3|Lost to Follow-up|1
4670564|NCT02323334|7567006|FG003|Period 3|Lost to Follow-up|0
4670565|NCT02323334|7567007|FG004|Period 3|Lost to Follow-up|0
4670566|NCT02323334|7567008|FG005|Period 3|Lost to Follow-up|0
4670567|NCT02323334|7567009|FG006|Period 3|Lost to Follow-up|0
4670568|NCT02323334|7567010|FG007|Period 3|Lost to Follow-up|0
4670569|NCT02323334|7567011|FG008|Period 3|Lost to Follow-up|0
4670570|NCT02323334|7567012|FG009|Period 3|Lost to Follow-up|0
4670571|NCT02323334|7567013|FG010|Period 3|Lost to Follow-up|0
4670572|NCT02323334|7567014|FG011|Period 3|Lost to Follow-up|0
4670573|NCT02323334|7567015|FG012|Period 3|Lost to Follow-up|0
4670574|NCT02323334|7567016|FG013|Period 3|Lost to Follow-up|0
4670575|NCT02323334|7567017|FG014|Period 3|Lost to Follow-up|0
4670576|NCT02323334|7567018|FG015|Period 3|Lost to Follow-up|0
4670577|NCT02323334|7567019|FG016|Period 3|Lost to Follow-up|0
4670578|NCT02323334|7567003|FG000|Period 3|Withdrawal by Subject|1
4670579|NCT02323334|7567004|FG001|Period 3|Withdrawal by Subject|0
4670580|NCT02323334|7567005|FG002|Period 3|Withdrawal by Subject|0
4670581|NCT02323334|7567006|FG003|Period 3|Withdrawal by Subject|0
4670582|NCT02323334|7567007|FG004|Period 3|Withdrawal by Subject|0
4670583|NCT02323334|7567008|FG005|Period 3|Withdrawal by Subject|0
4670584|NCT02323334|7567009|FG006|Period 3|Withdrawal by Subject|0
4670585|NCT02323334|7567010|FG007|Period 3|Withdrawal by Subject|0
4670586|NCT02323334|7567011|FG008|Period 3|Withdrawal by Subject|0
4670587|NCT02323334|7567012|FG009|Period 3|Withdrawal by Subject|0
4670588|NCT02323334|7567013|FG010|Period 3|Withdrawal by Subject|0
4670589|NCT02323334|7567014|FG011|Period 3|Withdrawal by Subject|0
4670590|NCT02323334|7567015|FG012|Period 3|Withdrawal by Subject|0
4670591|NCT02323334|7567016|FG013|Period 3|Withdrawal by Subject|0
4670592|NCT02323334|7567017|FG014|Period 3|Withdrawal by Subject|0
4670593|NCT02323334|7567018|FG015|Period 3|Withdrawal by Subject|0
4670594|NCT02323334|7567019|FG016|Period 3|Withdrawal by Subject|0
4670595|NCT02323646|7567084|FG000|Treatment Course 1|Adverse Event|1
4670596|NCT02323646|7567085|FG001|Treatment Course 1|Adverse Event|0
4670597|NCT02323646|7567086|FG002|Treatment Course 1|Adverse Event|1
4670598|NCT02323646|7567084|FG000|Treatment Course 1|Heavy Bleeding|1
4670599|NCT02323646|7567085|FG001|Treatment Course 1|Heavy Bleeding|1
4670600|NCT02323646|7567086|FG002|Treatment Course 1|Heavy Bleeding|0
4670601|NCT02323646|7567084|FG000|Treatment Course 1|Lost to Follow-up|1
4670602|NCT02323646|7567085|FG001|Treatment Course 1|Lost to Follow-up|0
4670603|NCT02323646|7567086|FG002|Treatment Course 1|Lost to Follow-up|2
4670604|NCT02323646|7567084|FG000|Treatment Course 1|Withdrawal by Subject|0
4670605|NCT02323646|7567085|FG001|Treatment Course 1|Withdrawal by Subject|2
4670606|NCT02323646|7567086|FG002|Treatment Course 1|Withdrawal by Subject|0
4670607|NCT02323646|7567084|FG000|Treatment Course 2|Adverse Event|1
4670608|NCT02323646|7567085|FG001|Treatment Course 2|Adverse Event|0
4670609|NCT02323646|7567086|FG002|Treatment Course 2|Adverse Event|1
4670610|NCT02323646|7567084|FG000|Treatment Course 2|Lost to Follow-up|0
4670611|NCT02323646|7567085|FG001|Treatment Course 2|Lost to Follow-up|0
4670612|NCT02323646|7567086|FG002|Treatment Course 2|Lost to Follow-up|1
4670613|NCT02323646|7567084|FG000|Treatment Course 2|Non-compliance|0
4670614|NCT02323646|7567085|FG001|Treatment Course 2|Non-compliance|1
4670615|NCT02323646|7567086|FG002|Treatment Course 2|Non-compliance|1
4670616|NCT02324049|7567098|FG000|Part C|Study terminated|11
4670617|NCT02324153|7567114|FG000|Overall Study|Withdrawal by Subject|4
4670618|NCT02324153|7567115|FG001|Overall Study|Withdrawal by Subject|1
4670619|NCT02324153|7567114|FG000|Overall Study|Surgery postponed after randomization|3
4670620|NCT02324153|7567115|FG001|Overall Study|Surgery postponed after randomization|0
4670621|NCT02324153|7567114|FG000|Overall Study|Developed delirium preoperatively|1
4670622|NCT02324153|7567115|FG001|Overall Study|Developed delirium preoperatively|0
4670623|NCT02324205|7567121|FG000|Overall Study|Withdrawal by Subject|37
4670624|NCT02324270|7567128|FG000|Overall Study|Withdrawal by Subject|0
4670625|NCT02324270|7567129|FG001|Overall Study|Withdrawal by Subject|1
4670626|NCT02324270|7567130|FG002|Overall Study|Withdrawal by Subject|0
4670627|NCT02324270|7567128|FG000|Overall Study|Lost to Follow-up|4
4670628|NCT02324270|7567129|FG001|Overall Study|Lost to Follow-up|3
4670629|NCT02324270|7567130|FG002|Overall Study|Lost to Follow-up|4
4670630|NCT02324270|7567128|FG000|Overall Study|Protocol Violation|0
4670631|NCT02324270|7567129|FG001|Overall Study|Protocol Violation|1
4670632|NCT02324270|7567130|FG002|Overall Study|Protocol Violation|1
4670633|NCT02324270|7567128|FG000|Overall Study|Non Compliance with Study Drug|1
4670634|NCT02324270|7567129|FG001|Overall Study|Non Compliance with Study Drug|2
4754912|NCT02890355|7729404|FG000|Overall Study|Refusal unrelated to adverse event|5
4754913|NCT02890355|7729405|FG001|Overall Study|Refusal unrelated to adverse event|10
4754914|NCT02890355|7729404|FG000|Overall Study|Progression/relapse|46
4754915|NCT02890355|7729405|FG001|Overall Study|Progression/relapse|39
4670635|NCT02324270|7567130|FG002|Overall Study|Non Compliance with Study Drug|0
4670636|NCT02324361|7567149|FG000|Overall Study|Lost to Follow-up|5
4670637|NCT02324361|7567150|FG001|Overall Study|Lost to Follow-up|2
4670638|NCT02324465|7567158|FG000|Overall Study|device failure|0
4670639|NCT02324465|7567159|FG001|Overall Study|device failure|1
4670640|NCT02324569|7567195|FG000|Overall Study|Pretreatment Event/Adverse Event|9
4670641|NCT02324569|7567196|FG001|Overall Study|Pretreatment Event/Adverse Event|10
4670642|NCT02324569|7567195|FG000|Overall Study|Voluntary Withdrawal|3
4670643|NCT02324569|7567196|FG001|Overall Study|Voluntary Withdrawal|6
4670644|NCT02324569|7567195|FG000|Overall Study|Lack of Efficacy|2
4670645|NCT02324569|7567196|FG001|Overall Study|Lack of Efficacy|3
4670646|NCT02324569|7567195|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0
4670647|NCT02324569|7567196|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2
4670648|NCT02324569|7567195|FG000|Overall Study|Inconvenient Schedule|2
4670649|NCT02324569|7567196|FG001|Overall Study|Inconvenient Schedule|0
4670650|NCT02324699|7567220|FG000|Overall Study|study terminated|1
4670651|NCT02324842|7567227|FG000|Overall Study|Lost to Follow-up|1
4670652|NCT02324842|7567228|FG001|Overall Study|Lost to Follow-up|1
4670653|NCT02324842|7567229|FG002|Overall Study|Lost to Follow-up|2
4670654|NCT02325219|7567258|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6
4670655|NCT02325219|7567259|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1
4670656|NCT02325219|7567260|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0
4670657|NCT02325219|7567261|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0
4670658|NCT02325219|7567262|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0
4670659|NCT02325219|7567258|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6
4670660|NCT02325219|7567259|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1
4670661|NCT02325219|7567260|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
4670662|NCT02325219|7567261|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
4670663|NCT02325219|7567262|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
4670664|NCT02325219|7567258|FG000|Controlled Period (Week 0 - 16)|Other|0
4670665|NCT02325219|7567259|FG001|Controlled Period (Week 0 - 16)|Other|0
4670666|NCT02325219|7567260|FG002|Controlled Period (Week 0 - 16)|Other|1
4670667|NCT02325219|7567261|FG003|Controlled Period (Week 0 - 16)|Other|0
4670668|NCT02325219|7567262|FG004|Controlled Period (Week 0 - 16)|Other|0
4670669|NCT02325219|7567258|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0
4670670|NCT02325219|7567259|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0
4670671|NCT02325219|7567260|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0
4670672|NCT02325219|7567261|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0
4670673|NCT02325219|7567262|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1
4670674|NCT02325219|7567258|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0
4670675|NCT02325219|7567259|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2
4670676|NCT02325219|7567260|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0
4670677|NCT02325219|7567261|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0
4670678|NCT02325219|7567262|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0
4670679|NCT02325219|7567258|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0
4670680|NCT02325219|7567259|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1
4670681|NCT02325219|7567260|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0
4670682|NCT02325219|7567261|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0
4670683|NCT02325219|7567262|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0
4670684|NCT02325401|7567278|FG000|Overall Study|Withdrawal by Subject|0
4670685|NCT02325401|7567279|FG001|Overall Study|Withdrawal by Subject|1
4670686|NCT02325401|7567280|FG002|Overall Study|Withdrawal by Subject|1
4670687|NCT02325414|7567296|FG000|Overall Study|Withdrawal by Subject|3
4670688|NCT02325414|7567297|FG001|Overall Study|Withdrawal by Subject|1
4670689|NCT02325414|7567296|FG000|Overall Study|Lost to Follow-up|5
4670690|NCT02325414|7567297|FG001|Overall Study|Lost to Follow-up|5
4670691|NCT02325518|7567307|FG000|Overall Study|Adverse Event|4
4670692|NCT02325518|7567308|FG001|Overall Study|Adverse Event|1
4670693|NCT02325518|7567307|FG000|Overall Study|Physician Decision|0
4670694|NCT02325518|7567308|FG001|Overall Study|Physician Decision|1
4670695|NCT02325518|7567307|FG000|Overall Study|Withdrawal by Subject|0
4670696|NCT02325518|7567308|FG001|Overall Study|Withdrawal by Subject|1
4670697|NCT02325713|7567344|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
4670698|NCT02325713|7567345|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
4754916|NCT02890355|7729404|FG000|Overall Study|Not protocol specified|3
4754917|NCT02890355|7729405|FG001|Overall Study|Not protocol specified|4
4754918|NCT02886286|7729415|FG000|Overall Study|pump motor stall|0
4754919|NCT02886286|7729416|FG001|Overall Study|pump motor stall|1
4754920|NCT02874742|7729425|FG000|Overall Study|Death|3
4754921|NCT02874742|7729426|FG001|Overall Study|Death|1
4754922|NCT02874742|7729427|FG002|Overall Study|Death|1
4754923|NCT02874742|7729425|FG000|Overall Study|Lost to Follow-up|2
4754924|NCT02874742|7729426|FG001|Overall Study|Lost to Follow-up|0
4754925|NCT02874742|7729427|FG002|Overall Study|Lost to Follow-up|0
4754926|NCT02874742|7729425|FG000|Overall Study|Withdrawal by Subject|8
4754927|NCT02874742|7729426|FG001|Overall Study|Withdrawal by Subject|4
4754928|NCT02874742|7729427|FG002|Overall Study|Withdrawal by Subject|0
4754929|NCT02874742|7729425|FG000|Overall Study|Other|3
4754930|NCT02874742|7729426|FG001|Overall Study|Other|1
4754931|NCT02874742|7729427|FG002|Overall Study|Other|0
4754932|NCT02874742|7729425|FG000|Overall Study|Ongoing|87
4754933|NCT02874742|7729426|FG001|Overall Study|Ongoing|98
4670699|NCT02325713|7567346|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
4670700|NCT02325713|7567347|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
4670701|NCT02325713|7567348|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
4670702|NCT02325713|7567349|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
4670703|NCT02325713|7567350|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
4670704|NCT02325713|7567351|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
4670705|NCT02325713|7567352|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
4670706|NCT02325713|7567353|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
4670707|NCT02325713|7567354|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1
4670708|NCT02325713|7567355|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
4670709|NCT02325713|7567356|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
4670710|NCT02325713|7567357|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
4670711|NCT02325713|7567358|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
4670712|NCT02325713|7567359|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
4670713|NCT02325713|7567344|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1
4670714|NCT02325713|7567345|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
4670715|NCT02325713|7567346|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
4670716|NCT02325713|7567347|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
4670717|NCT02325713|7567348|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
4670718|NCT02325713|7567349|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
4670719|NCT02325713|7567350|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
4670720|NCT02325713|7567351|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
4670721|NCT02325713|7567352|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
4670722|NCT02325713|7567353|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
4670723|NCT02325713|7567354|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
4670724|NCT02325713|7567355|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
4670725|NCT02325713|7567356|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
4670726|NCT02325713|7567357|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
4670727|NCT02325713|7567358|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
4670728|NCT02325713|7567359|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
4670729|NCT02325713|7567344|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
4670730|NCT02325713|7567345|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
4670731|NCT02325713|7567346|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
4670732|NCT02325713|7567347|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
4670733|NCT02325713|7567348|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
4754934|NCT02874742|7729427|FG002|Overall Study|Ongoing|15
4754935|NCT02865187|7729437|FG000|Overall Study|Lost to Follow-up|12
4754936|NCT02865187|7729438|FG001|Overall Study|Lost to Follow-up|7
4754937|NCT02865187|7729437|FG000|Overall Study|Adverse Event|1
4754938|NCT02865187|7729438|FG001|Overall Study|Adverse Event|0
4754939|NCT02836249|7729446|FG000|Overall Study|Randomized but Never Treated|0
4754940|NCT02836249|7729447|FG001|Overall Study|Randomized but Never Treated|1
4754941|NCT02836249|7729446|FG000|Overall Study|Pregnancy|2
4754942|NCT02836249|7729447|FG001|Overall Study|Pregnancy|0
4754943|NCT02836249|7729446|FG000|Overall Study|Withdrew Consent|0
4754944|NCT02836249|7729447|FG001|Overall Study|Withdrew Consent|1
4754945|NCT02836249|7729446|FG000|Overall Study|Lost to Follow-up|0
4754946|NCT02836249|7729447|FG001|Overall Study|Lost to Follow-up|1
4754947|NCT02836249|7729446|FG000|Overall Study|Still on Study|121
4754948|NCT02836249|7729447|FG001|Overall Study|Still on Study|55
4754949|NCT02832167|7729453|FG000|Treatment Period 1|Disease progression|92
4754950|NCT02832167|7729453|FG000|Treatment Period 1|Adverse event unrelated to study drug|11
4754951|NCT02832167|7729453|FG000|Treatment Period 1|Death|1
4754952|NCT02832167|7729453|FG000|Treatment Period 1|Study Drug Toxicity|6
4754953|NCT02832167|7729453|FG000|Treatment Period 1|Participant request to discontinue|9
4754954|NCT02832167|7729453|FG000|Treatment Period 1|No longer meet study criteria|1
4754955|NCT02832167|7729453|FG000|Treatment Period 1|Participant withdrew consent|3
4754956|NCT02832167|7729453|FG000|Treatment Period 1|Other reasons|6
4754957|NCT02832167|7729453|FG000|Transition From Period 1 to Period 2|Other reasons|1
4754958|NCT02832167|7729453|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1
4754959|NCT02832167|7729453|FG000|Transition From Period 1 to Period 2|Death|2
4754960|NCT02832167|7729453|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3
4754961|NCT02832167|7729453|FG000|Treatment Period 2|Disease progression|68
4754962|NCT02832167|7729453|FG000|Treatment Period 2|Adverse event unrelated to study drug|1
4754963|NCT02832167|7729453|FG000|Treatment Period 2|Maximum clinical benefit|1
4754964|NCT02832167|7729453|FG000|Treatment Period 2|Study Drug Toxicity|5
4670734|NCT02325713|7567349|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
4670735|NCT02325713|7567350|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
4670736|NCT02325713|7567351|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
4670737|NCT02325713|7567352|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
4670738|NCT02325713|7567353|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1
4670739|NCT02325713|7567354|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
4670740|NCT02325713|7567355|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
4670741|NCT02325713|7567356|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
4670742|NCT02325713|7567357|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
4670743|NCT02325713|7567358|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
4670744|NCT02325713|7567359|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
4670745|NCT02325739|7567385|FG000|Phase I Part|Adverse Event|1
4670746|NCT02325739|7567386|FG001|Phase I Part|Adverse Event|0
4670747|NCT02325739|7567387|FG002|Phase I Part|Adverse Event|1
4670748|NCT02325739|7567388|FG003|Phase I Part|Adverse Event|2
4670749|NCT02325739|7567389|FG004|Phase I Part|Adverse Event|3
4670750|NCT02325739|7567390|FG005|Phase I Part|Adverse Event|1
4670751|NCT02325739|7567391|FG006|Phase I Part|Adverse Event|0
4670752|NCT02325739|7567392|FG007|Phase I Part|Adverse Event|2
4670753|NCT02325739|7567393|FG008|Phase I Part|Adverse Event|0
4670754|NCT02325739|7567394|FG009|Phase I Part|Adverse Event|0
4670755|NCT02325739|7567395|FG010|Phase I Part|Adverse Event|0
4670756|NCT02325739|7567385|FG000|Phase I Part|Progressive disease|9
4670757|NCT02325739|7567386|FG001|Phase I Part|Progressive disease|6
4670758|NCT02325739|7567387|FG002|Phase I Part|Progressive disease|3
4670759|NCT02325739|7567388|FG003|Phase I Part|Progressive disease|23
4670760|NCT02325739|7567389|FG004|Phase I Part|Progressive disease|14
4670761|NCT02325739|7567390|FG005|Phase I Part|Progressive disease|6
4670762|NCT02325739|7567391|FG006|Phase I Part|Progressive disease|6
4670763|NCT02325739|7567392|FG007|Phase I Part|Progressive disease|3
4670764|NCT02325739|7567393|FG008|Phase I Part|Progressive disease|0
4670765|NCT02325739|7567394|FG009|Phase I Part|Progressive disease|0
4670766|NCT02325739|7567395|FG010|Phase I Part|Progressive disease|0
4670767|NCT02325739|7567385|FG000|Phase I Part|Subject/guardian decision|1
4670768|NCT02325739|7567386|FG001|Phase I Part|Subject/guardian decision|0
4670769|NCT02325739|7567387|FG002|Phase I Part|Subject/guardian decision|1
4670770|NCT02325739|7567388|FG003|Phase I Part|Subject/guardian decision|1
4670771|NCT02325739|7567389|FG004|Phase I Part|Subject/guardian decision|0
4670772|NCT02325739|7567390|FG005|Phase I Part|Subject/guardian decision|0
4670773|NCT02325739|7567391|FG006|Phase I Part|Subject/guardian decision|0
4670774|NCT02325739|7567392|FG007|Phase I Part|Subject/guardian decision|1
4670775|NCT02325739|7567393|FG008|Phase I Part|Subject/guardian decision|0
4670776|NCT02325739|7567394|FG009|Phase I Part|Subject/guardian decision|0
4670777|NCT02325739|7567395|FG010|Phase I Part|Subject/guardian decision|0
4670778|NCT02325739|7567385|FG000|Phase I Part|Death|0
4670779|NCT02325739|7567386|FG001|Phase I Part|Death|0
4670780|NCT02325739|7567387|FG002|Phase I Part|Death|0
4670781|NCT02325739|7567388|FG003|Phase I Part|Death|0
4670782|NCT02325739|7567389|FG004|Phase I Part|Death|2
4670783|NCT02325739|7567390|FG005|Phase I Part|Death|0
4670784|NCT02325739|7567391|FG006|Phase I Part|Death|0
4670785|NCT02325739|7567392|FG007|Phase I Part|Death|0
4670786|NCT02325739|7567393|FG008|Phase I Part|Death|0
4670787|NCT02325739|7567394|FG009|Phase I Part|Death|0
4670788|NCT02325739|7567395|FG010|Phase I Part|Death|0
4670789|NCT02325739|7567385|FG000|Phase II Part|Adverse Event|0
4670790|NCT02325739|7567386|FG001|Phase II Part|Adverse Event|0
4670791|NCT02325739|7567387|FG002|Phase II Part|Adverse Event|0
4670792|NCT02325739|7567388|FG003|Phase II Part|Adverse Event|0
4670793|NCT02325739|7567389|FG004|Phase II Part|Adverse Event|0
4670794|NCT02325739|7567390|FG005|Phase II Part|Adverse Event|0
4670795|NCT02325739|7567391|FG006|Phase II Part|Adverse Event|0
4670796|NCT02325739|7567392|FG007|Phase II Part|Adverse Event|0
4754965|NCT02832167|7729453|FG000|Treatment Period 2|Participant request to discontinue|2
4754966|NCT02832167|7729453|FG000|Treatment Period 2|Participant withdrew consent|3
4754967|NCT02832167|7729453|FG000|Treatment Period 2|Other reasons|3
4670797|NCT02325739|7567393|FG008|Phase II Part|Adverse Event|4
4670798|NCT02325739|7567394|FG009|Phase II Part|Adverse Event|5
4670799|NCT02325739|7567395|FG010|Phase II Part|Adverse Event|1
4670800|NCT02325739|7567385|FG000|Phase II Part|Physician Decision|0
4670801|NCT02325739|7567386|FG001|Phase II Part|Physician Decision|0
4670802|NCT02325739|7567387|FG002|Phase II Part|Physician Decision|0
4670803|NCT02325739|7567388|FG003|Phase II Part|Physician Decision|0
4670804|NCT02325739|7567389|FG004|Phase II Part|Physician Decision|0
4670805|NCT02325739|7567390|FG005|Phase II Part|Physician Decision|0
4670806|NCT02325739|7567391|FG006|Phase II Part|Physician Decision|0
4670807|NCT02325739|7567392|FG007|Phase II Part|Physician Decision|0
4670808|NCT02325739|7567393|FG008|Phase II Part|Physician Decision|0
4670809|NCT02325739|7567394|FG009|Phase II Part|Physician Decision|1
4670810|NCT02325739|7567395|FG010|Phase II Part|Physician Decision|0
4670811|NCT02325739|7567385|FG000|Phase II Part|Progressive disease|0
4670812|NCT02325739|7567386|FG001|Phase II Part|Progressive disease|0
4670813|NCT02325739|7567387|FG002|Phase II Part|Progressive disease|0
4670814|NCT02325739|7567388|FG003|Phase II Part|Progressive disease|0
4670815|NCT02325739|7567389|FG004|Phase II Part|Progressive disease|0
4670816|NCT02325739|7567390|FG005|Phase II Part|Progressive disease|0
4670817|NCT02325739|7567391|FG006|Phase II Part|Progressive disease|0
4670818|NCT02325739|7567392|FG007|Phase II Part|Progressive disease|0
4670819|NCT02325739|7567393|FG008|Phase II Part|Progressive disease|22
4670820|NCT02325739|7567394|FG009|Phase II Part|Progressive disease|29
4670821|NCT02325739|7567395|FG010|Phase II Part|Progressive disease|18
4670822|NCT02325739|7567385|FG000|Phase II Part|Subject/guardian decision|0
4670823|NCT02325739|7567386|FG001|Phase II Part|Subject/guardian decision|0
4670824|NCT02325739|7567387|FG002|Phase II Part|Subject/guardian decision|0
4670825|NCT02325739|7567388|FG003|Phase II Part|Subject/guardian decision|0
4670826|NCT02325739|7567389|FG004|Phase II Part|Subject/guardian decision|0
4670827|NCT02325739|7567390|FG005|Phase II Part|Subject/guardian decision|0
4670828|NCT02325739|7567391|FG006|Phase II Part|Subject/guardian decision|0
4670829|NCT02325739|7567392|FG007|Phase II Part|Subject/guardian decision|0
4670830|NCT02325739|7567393|FG008|Phase II Part|Subject/guardian decision|4
4670831|NCT02325739|7567394|FG009|Phase II Part|Subject/guardian decision|1
4670832|NCT02325739|7567395|FG010|Phase II Part|Subject/guardian decision|1
4670833|NCT02325791|7567444|FG000|Overall Study|Adverse Event|0
4670834|NCT02325791|7567445|FG001|Overall Study|Adverse Event|1
4670835|NCT02325791|7567446|FG002|Overall Study|Adverse Event|1
4670836|NCT02325791|7567447|FG003|Overall Study|Adverse Event|0
4670837|NCT02325791|7567444|FG000|Overall Study|Death|0
4670838|NCT02325791|7567445|FG001|Overall Study|Death|3
4670839|NCT02325791|7567446|FG002|Overall Study|Death|0
4754968|NCT02829918|7729457|FG000|Overall Study|Death|2
4754969|NCT02829918|7729457|FG000|Overall Study|Withdrawal by Subject|4
4754970|NCT02829918|7729457|FG000|Overall Study|Adverse Event|1
4754971|NCT02829918|7729457|FG000|Overall Study|Progression|1
4754972|NCT02824198|7729463|FG000|Overall Study|Non-compliance with the protocol|5
4754973|NCT02824198|7729464|FG001|Overall Study|Non-compliance with the protocol|1
4754974|NCT02824198|7729463|FG000|Overall Study|Lost to Follow-up|5
4754975|NCT02824198|7729464|FG001|Overall Study|Lost to Follow-up|2
4754976|NCT02824198|7729463|FG000|Overall Study|Withdrawal by Subject|5
4754977|NCT02824198|7729464|FG001|Overall Study|Withdrawal by Subject|0
4754978|NCT02821754|7729475|FG000|Overall Study|Procedure not required prior to amendment change|13
4754979|NCT02821754|7729476|FG001|Overall Study|Procedure not required prior to amendment change|11
4754980|NCT02821754|7729477|FG002|Overall Study|Procedure not required prior to amendment change|0
4754981|NCT02821754|7729475|FG000|Overall Study|Participant's Clinical status|2
4754982|NCT02821754|7729476|FG001|Overall Study|Participant's Clinical status|0
4754983|NCT02821754|7729477|FG002|Overall Study|Participant's Clinical status|0
4754984|NCT02821754|7729475|FG000|Overall Study|Participant removed for noncompliance|1
4754985|NCT02821754|7729476|FG001|Overall Study|Participant removed for noncompliance|0
4754986|NCT02821754|7729477|FG002|Overall Study|Participant removed for noncompliance|0
4754987|NCT02821754|7729475|FG000|Overall Study|Drug not available.|0
4754988|NCT02821754|7729476|FG001|Overall Study|Drug not available.|0
4754989|NCT02821754|7729477|FG002|Overall Study|Drug not available.|1
4754990|NCT02821754|7729475|FG000|Overall Study|Participant declined to participate (before treatment started.)|0
4754991|NCT02821754|7729476|FG001|Overall Study|Participant declined to participate (before treatment started.)|1
4754992|NCT02821754|7729477|FG002|Overall Study|Participant declined to participate (before treatment started.)|1
4754993|NCT02787551|7729485|FG000|Core Period: 26 Weeks|Adverse Event|10
4754994|NCT02787551|7729486|FG001|Core Period: 26 Weeks|Adverse Event|0
4754995|NCT02787551|7729485|FG000|Core Period: 26 Weeks|Lack of Efficacy|1
4754996|NCT02787551|7729486|FG001|Core Period: 26 Weeks|Lack of Efficacy|0
4754997|NCT02787551|7729485|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2
4754998|NCT02787551|7729486|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0
4754999|NCT02787551|7729485|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9
4755000|NCT02787551|7729486|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9
4755001|NCT02787551|7729485|FG000|Core Period: 26 Weeks|Randomized but not treated|2
4755002|NCT02787551|7729486|FG001|Core Period: 26 Weeks|Randomized but not treated|1
4670840|NCT02325791|7567447|FG003|Overall Study|Death|1
4670841|NCT02325791|7567444|FG000|Overall Study|Lost to Follow-up|0
4670842|NCT02325791|7567445|FG001|Overall Study|Lost to Follow-up|15
4670843|NCT02325791|7567446|FG002|Overall Study|Lost to Follow-up|14
4670844|NCT02325791|7567447|FG003|Overall Study|Lost to Follow-up|9
4670845|NCT02325791|7567444|FG000|Overall Study|Physician Decision|0
4670846|NCT02325791|7567445|FG001|Overall Study|Physician Decision|1
4670847|NCT02325791|7567446|FG002|Overall Study|Physician Decision|1
4670848|NCT02325791|7567447|FG003|Overall Study|Physician Decision|0
4670849|NCT02325791|7567444|FG000|Overall Study|Protocol Violation|0
4670850|NCT02325791|7567445|FG001|Overall Study|Protocol Violation|0
4670851|NCT02325791|7567446|FG002|Overall Study|Protocol Violation|1
4670852|NCT02325791|7567447|FG003|Overall Study|Protocol Violation|0
4670853|NCT02325791|7567444|FG000|Overall Study|Withdrawal by Subject|0
4670854|NCT02325791|7567445|FG001|Overall Study|Withdrawal by Subject|5
4670855|NCT02325791|7567446|FG002|Overall Study|Withdrawal by Subject|8
4670856|NCT02325791|7567447|FG003|Overall Study|Withdrawal by Subject|16
4670857|NCT02326025|7567471|FG000|Overall Study|Adverse Event|3
4670858|NCT02326025|7567472|FG001|Overall Study|Adverse Event|0
4670859|NCT02326025|7567471|FG000|Overall Study|Physician Decision|1
4670860|NCT02326025|7567472|FG001|Overall Study|Physician Decision|2
4670861|NCT02326025|7567471|FG000|Overall Study|Physician and Participant Decision|1
4670862|NCT02326025|7567472|FG001|Overall Study|Physician and Participant Decision|0
4670863|NCT02326025|7567471|FG000|Overall Study|Withdrawal by Subject|0
4670864|NCT02326025|7567472|FG001|Overall Study|Withdrawal by Subject|2
4670865|NCT02326025|7567471|FG000|Overall Study|Protocol Violation|0
4670866|NCT02326025|7567472|FG001|Overall Study|Protocol Violation|1
4670867|NCT02326220|7567493|FG000|Double-blind Treatment Period|Adverse Event|1
4670868|NCT02326220|7567494|FG001|Double-blind Treatment Period|Adverse Event|2
4670869|NCT02326220|7567495|FG002|Double-blind Treatment Period|Adverse Event|0
4670870|NCT02326220|7567493|FG000|Double-blind Treatment Period|Protocol Violation|0
4670871|NCT02326220|7567494|FG001|Double-blind Treatment Period|Protocol Violation|1
4670872|NCT02326220|7567495|FG002|Double-blind Treatment Period|Protocol Violation|0
4670873|NCT02326220|7567493|FG000|Double-blind Treatment Period|Withdrawal by Subject|0
4670874|NCT02326220|7567494|FG001|Double-blind Treatment Period|Withdrawal by Subject|1
4670875|NCT02326220|7567495|FG002|Double-blind Treatment Period|Withdrawal by Subject|0
4670876|NCT02326220|7567493|FG000|Open-label Treatment Period|Withdrawal by Subject|0
4670877|NCT02326220|7567494|FG001|Open-label Treatment Period|Withdrawal by Subject|0
4670878|NCT02326220|7567495|FG002|Open-label Treatment Period|Withdrawal by Subject|1
4670879|NCT02326220|7567493|FG000|Open-label Treatment Period|Lost to Follow-up|0
4670880|NCT02326220|7567494|FG001|Open-label Treatment Period|Lost to Follow-up|0
4670881|NCT02326220|7567495|FG002|Open-label Treatment Period|Lost to Follow-up|1
4670882|NCT02326272|7567517|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0
4670883|NCT02326272|7567518|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3
4670884|NCT02326272|7567519|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1
4670885|NCT02326272|7567520|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0
4670886|NCT02326272|7567521|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0
4670887|NCT02326272|7567522|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0
4670888|NCT02326272|7567523|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0
4670889|NCT02326272|7567524|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0
4670890|NCT02326272|7567525|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0
4670891|NCT02326272|7567526|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0
4670892|NCT02326272|7567527|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0
4670893|NCT02326272|7567528|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0
4670894|NCT02326272|7567529|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0
4670895|NCT02326272|7567530|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0
4670896|NCT02326272|7567531|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0
4670897|NCT02326272|7567517|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1
4670898|NCT02326272|7567518|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2
4670899|NCT02326272|7567519|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
4670900|NCT02326272|7567520|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
4670901|NCT02326272|7567521|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
4670902|NCT02326272|7567522|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
4670903|NCT02326272|7567523|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
4670904|NCT02326272|7567524|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
4670905|NCT02326272|7567525|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
4670906|NCT02326272|7567526|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
4670907|NCT02326272|7567527|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
4670908|NCT02326272|7567528|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
4670909|NCT02326272|7567529|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
4670910|NCT02326272|7567530|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
4670911|NCT02326272|7567531|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
4670912|NCT02326272|7567517|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3
4670913|NCT02326272|7567518|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2
4670914|NCT02326272|7567519|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
4670915|NCT02326272|7567520|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
4670916|NCT02326272|7567521|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
4670917|NCT02326272|7567522|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
4670918|NCT02326272|7567523|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
4670919|NCT02326272|7567524|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
4670920|NCT02326272|7567525|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
4670921|NCT02326272|7567526|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
4670922|NCT02326272|7567527|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
4670923|NCT02326272|7567528|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
4670924|NCT02326272|7567529|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
4670925|NCT02326272|7567530|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
4670926|NCT02326272|7567531|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
4670927|NCT02326272|7567517|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0
4670928|NCT02326272|7567518|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0
4670929|NCT02326272|7567519|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1
4670930|NCT02326272|7567520|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0
4670931|NCT02326272|7567521|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0
4670932|NCT02326272|7567522|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0
4670933|NCT02326272|7567523|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0
4670934|NCT02326272|7567524|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0
4670935|NCT02326272|7567525|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0
4670936|NCT02326272|7567526|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0
4670937|NCT02326272|7567527|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0
4670938|NCT02326272|7567528|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0
4670939|NCT02326272|7567529|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0
4670940|NCT02326272|7567530|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0
4670941|NCT02326272|7567531|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0
4670942|NCT02326272|7567517|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0
4670943|NCT02326272|7567518|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0
4670944|NCT02326272|7567519|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1
4670945|NCT02326272|7567520|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0
4670946|NCT02326272|7567521|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0
4670947|NCT02326272|7567522|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0
4670948|NCT02326272|7567523|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0
4670949|NCT02326272|7567524|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0
4670950|NCT02326272|7567525|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0
4670951|NCT02326272|7567526|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0
4670952|NCT02326272|7567527|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0
4670953|NCT02326272|7567528|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0
4670954|NCT02326272|7567529|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0
4670955|NCT02326272|7567530|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0
4670956|NCT02326272|7567531|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0
4670957|NCT02326272|7567517|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
4670958|NCT02326272|7567518|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
4670959|NCT02326272|7567519|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1
4670960|NCT02326272|7567520|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
4670961|NCT02326272|7567521|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
4670962|NCT02326272|7567522|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
4670963|NCT02326272|7567523|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
4670964|NCT02326272|7567524|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
4670965|NCT02326272|7567525|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
4670966|NCT02326272|7567526|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
4670967|NCT02326272|7567527|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
4670968|NCT02326272|7567528|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
4670969|NCT02326272|7567529|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
4670970|NCT02326272|7567530|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
4670971|NCT02326272|7567531|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
4670972|NCT02326272|7567517|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
4755003|NCT02787551|7729485|FG000|Core Period: 26 Weeks|Other than specified|3
4755004|NCT02787551|7729486|FG001|Core Period: 26 Weeks|Other than specified|1
4755005|NCT02787551|7729485|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1
4755006|NCT02787551|7729486|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0
4755007|NCT02787551|7729485|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3
4755008|NCT02787551|7729486|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0
4755009|NCT02787551|7729485|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5
4755010|NCT02787551|7729486|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0
4755011|NCT02735044|7729506|FG000|Overall Study|Adverse Event|3
4755012|NCT02735044|7729507|FG001|Overall Study|Adverse Event|3
4755013|NCT02735044|7729506|FG000|Overall Study|Lack of Efficacy|1
4755014|NCT02735044|7729507|FG001|Overall Study|Lack of Efficacy|0
4755015|NCT02735044|7729506|FG000|Overall Study|Poor compliance to protocol|7
4670973|NCT02326272|7567518|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
4670974|NCT02326272|7567519|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1
4670975|NCT02326272|7567520|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
4670976|NCT02326272|7567521|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
4670977|NCT02326272|7567522|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
4670978|NCT02326272|7567523|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
4670979|NCT02326272|7567524|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
4670980|NCT02326272|7567525|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
4755016|NCT02735044|7729507|FG001|Overall Study|Poor compliance to protocol|7
4670981|NCT02326272|7567526|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
4670982|NCT02326272|7567527|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
4670983|NCT02326272|7567528|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
4670984|NCT02326272|7567529|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
4670985|NCT02326272|7567530|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
4670986|NCT02326272|7567531|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
4670987|NCT02326272|7567517|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4670988|NCT02326272|7567518|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4670989|NCT02326272|7567519|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4670990|NCT02326272|7567520|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4670991|NCT02326272|7567521|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
4670992|NCT02326272|7567522|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3
4670993|NCT02326272|7567523|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4
4670994|NCT02326272|7567524|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
4670995|NCT02326272|7567525|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
4670996|NCT02326272|7567526|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4670997|NCT02326272|7567527|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4670998|NCT02326272|7567528|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4670999|NCT02326272|7567529|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4671000|NCT02326272|7567530|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4671001|NCT02326272|7567531|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4671002|NCT02326272|7567517|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4671003|NCT02326272|7567518|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4671004|NCT02326272|7567519|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4671005|NCT02326272|7567520|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4671006|NCT02326272|7567521|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4671007|NCT02326272|7567522|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2
4671008|NCT02326272|7567523|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
4671009|NCT02326272|7567524|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4671010|NCT02326272|7567525|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
4671011|NCT02326272|7567526|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
4671012|NCT02326272|7567527|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4671013|NCT02326272|7567528|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4671014|NCT02326272|7567529|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4671015|NCT02326272|7567530|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4671016|NCT02326272|7567531|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4671017|NCT02326272|7567517|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4671018|NCT02326272|7567518|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4671019|NCT02326272|7567519|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4671020|NCT02326272|7567520|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4671021|NCT02326272|7567521|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4671022|NCT02326272|7567522|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2
4671023|NCT02326272|7567523|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4671024|NCT02326272|7567524|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2
4671025|NCT02326272|7567525|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4671026|NCT02326272|7567526|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4671027|NCT02326272|7567527|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4671028|NCT02326272|7567528|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4671029|NCT02326272|7567529|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4671030|NCT02326272|7567530|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4671031|NCT02326272|7567531|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4671032|NCT02326272|7567517|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4671033|NCT02326272|7567518|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4671034|NCT02326272|7567519|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4671035|NCT02326272|7567520|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
4671036|NCT02326272|7567521|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4671037|NCT02326272|7567522|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3
4671038|NCT02326272|7567523|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
4671039|NCT02326272|7567524|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
4671040|NCT02326272|7567525|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4671041|NCT02326272|7567526|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
4671042|NCT02326272|7567527|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4671043|NCT02326272|7567528|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4671044|NCT02326272|7567529|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4671045|NCT02326272|7567530|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4671046|NCT02326272|7567531|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4671047|NCT02326272|7567517|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
4671048|NCT02326272|7567518|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
4671049|NCT02326272|7567519|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
4671050|NCT02326272|7567520|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
4671051|NCT02326272|7567521|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
4671052|NCT02326272|7567522|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
4671053|NCT02326272|7567523|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
4671054|NCT02326272|7567524|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1
4671055|NCT02326272|7567525|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
4671056|NCT02326272|7567526|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
4671057|NCT02326272|7567527|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
4671058|NCT02326272|7567528|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
4671059|NCT02326272|7567529|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
4671060|NCT02326272|7567530|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
4671061|NCT02326272|7567531|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
4671062|NCT02326272|7567517|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
4671063|NCT02326272|7567518|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
4755017|NCT02735044|7729506|FG000|Overall Study|Randomized and not treated|0
4755018|NCT02735044|7729507|FG001|Overall Study|Randomized and not treated|2
4755019|NCT02735044|7729506|FG000|Overall Study|Other, not specified above|5
4755020|NCT02735044|7729507|FG001|Overall Study|Other, not specified above|11
4755021|NCT02720744|7729524|FG000|Overall Study|Protocol Violation|0
4755022|NCT02720744|7729525|FG001|Overall Study|Protocol Violation|2
4755023|NCT02720744|7729524|FG000|Overall Study|Pregnancy|2
4755024|NCT02720744|7729525|FG001|Overall Study|Pregnancy|0
4755025|NCT02720744|7729524|FG000|Overall Study|Lack of Efficacy|2
4755026|NCT02720744|7729525|FG001|Overall Study|Lack of Efficacy|8
4755027|NCT02720744|7729524|FG000|Overall Study|Adverse Event|21
4755028|NCT02720744|7729525|FG001|Overall Study|Adverse Event|3
4755029|NCT02720744|7729524|FG000|Overall Study|Withdrawal by Subject|11
4755030|NCT02720744|7729525|FG001|Overall Study|Withdrawal by Subject|11
4755031|NCT02720744|7729524|FG000|Overall Study|Lost to follow up|2
4755032|NCT02720744|7729525|FG001|Overall Study|Lost to follow up|0
4755033|NCT02720744|7729524|FG000|Overall Study|Non Compliance with Investigational Product|0
4755034|NCT02720744|7729525|FG001|Overall Study|Non Compliance with Investigational Product|1
4755035|NCT02720744|7729524|FG000|Overall Study|Excluded Concomitant Medication|0
4755036|NCT02720744|7729525|FG001|Overall Study|Excluded Concomitant Medication|1
4755037|NCT02713867|7729533|FG000|Randomization|Other Reason|2
4755038|NCT02713867|7729534|FG001|Randomization|Other Reason|1
4755039|NCT02713867|7729533|FG000|Randomization|Participant Withdrew consent|0
4755040|NCT02713867|7729534|FG001|Randomization|Participant Withdrew consent|2
4755041|NCT02713867|7729533|FG000|Treatment Period|Not Reported|1
4755042|NCT02713867|7729534|FG001|Treatment Period|Not Reported|0
4755043|NCT02713867|7729533|FG000|Treatment Period|Other Reasons|12
4755044|NCT02713867|7729534|FG001|Treatment Period|Other Reasons|18
4755045|NCT02713867|7729533|FG000|Treatment Period|Administrative reason by sponsor|9
4755046|NCT02713867|7729534|FG001|Treatment Period|Administrative reason by sponsor|4
4755047|NCT02713867|7729533|FG000|Treatment Period|No longer meets study criteria|2
4755048|NCT02713867|7729534|FG001|Treatment Period|No longer meets study criteria|1
4755049|NCT02713867|7729533|FG000|Treatment Period|Poor/Non Compliance|1
4755050|NCT02713867|7729534|FG001|Treatment Period|Poor/Non Compliance|0
4755051|NCT02713867|7729533|FG000|Treatment Period|Maximum Clinical Benefit|3
4755052|NCT02713867|7729534|FG001|Treatment Period|Maximum Clinical Benefit|4
4755053|NCT02713867|7729533|FG000|Treatment Period|Withdrew consent|1
4755054|NCT02713867|7729534|FG001|Treatment Period|Withdrew consent|6
4755055|NCT02713867|7729533|FG000|Treatment Period|Requested to Discontinue|8
4755056|NCT02713867|7729534|FG001|Treatment Period|Requested to Discontinue|7
4755057|NCT02713867|7729533|FG000|Treatment Period|AE unrelated to Study Drug|8
4755058|NCT02713867|7729534|FG001|Treatment Period|AE unrelated to Study Drug|9
4755059|NCT02713867|7729533|FG000|Treatment Period|Death|7
4755060|NCT02713867|7729534|FG001|Treatment Period|Death|3
4671064|NCT02326272|7567519|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
4671065|NCT02326272|7567520|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
4671066|NCT02326272|7567521|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
4671067|NCT02326272|7567522|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
4671068|NCT02326272|7567523|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1
4671069|NCT02326272|7567524|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
4671070|NCT02326272|7567525|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
4671071|NCT02326272|7567526|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
4671072|NCT02326272|7567527|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
4671073|NCT02326272|7567528|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
4671074|NCT02326272|7567529|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
4671075|NCT02326272|7567530|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
4671076|NCT02326272|7567531|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
4671077|NCT02326272|7567517|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
4671078|NCT02326272|7567518|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
4671079|NCT02326272|7567519|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
4671080|NCT02326272|7567520|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
4671081|NCT02326272|7567521|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
4671082|NCT02326272|7567522|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
4671083|NCT02326272|7567523|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
4671084|NCT02326272|7567524|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
4671085|NCT02326272|7567525|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1
4671086|NCT02326272|7567526|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
4671087|NCT02326272|7567527|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
4671088|NCT02326272|7567528|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
4671089|NCT02326272|7567529|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
4671090|NCT02326272|7567530|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
4671091|NCT02326272|7567531|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
4671092|NCT02326272|7567517|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4671093|NCT02326272|7567518|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4671094|NCT02326272|7567519|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4671095|NCT02326272|7567520|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4671096|NCT02326272|7567521|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4671097|NCT02326272|7567522|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2
4671098|NCT02326272|7567523|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1
4671099|NCT02326272|7567524|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1
4671100|NCT02326272|7567525|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2
4671101|NCT02326272|7567526|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4671102|NCT02326272|7567527|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4671103|NCT02326272|7567528|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4671104|NCT02326272|7567529|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4671105|NCT02326272|7567530|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4671106|NCT02326272|7567531|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4671107|NCT02326272|7567517|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
4671108|NCT02326272|7567518|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
4671109|NCT02326272|7567519|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
4671110|NCT02326272|7567520|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
4671111|NCT02326272|7567521|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
4671112|NCT02326272|7567522|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1
4671113|NCT02326272|7567523|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
4671114|NCT02326272|7567524|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
4671115|NCT02326272|7567525|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
4671116|NCT02326272|7567526|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
4671117|NCT02326272|7567527|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
4671118|NCT02326272|7567528|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
4671119|NCT02326272|7567529|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
4671120|NCT02326272|7567530|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
4671121|NCT02326272|7567531|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
4671122|NCT02326272|7567517|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
4671123|NCT02326272|7567518|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
4671124|NCT02326272|7567519|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
4671125|NCT02326272|7567520|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
4671126|NCT02326272|7567521|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
4671127|NCT02326272|7567522|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
4755061|NCT02713867|7729533|FG000|Treatment Period|Study Drug Toxicity|16
4671128|NCT02326272|7567523|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1
4671129|NCT02326272|7567524|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
4671130|NCT02326272|7567525|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
4671131|NCT02326272|7567526|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
4671132|NCT02326272|7567527|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
4671133|NCT02326272|7567528|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
4671134|NCT02326272|7567529|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
4671135|NCT02326272|7567530|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
4671136|NCT02326272|7567531|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
4671137|NCT02326272|7567517|FG000|Open-label Period (Week 48 to Week 144)|Death|0
4671138|NCT02326272|7567518|FG001|Open-label Period (Week 48 to Week 144)|Death|0
4671139|NCT02326272|7567519|FG002|Open-label Period (Week 48 to Week 144)|Death|0
4671140|NCT02326272|7567520|FG003|Open-label Period (Week 48 to Week 144)|Death|0
4671141|NCT02326272|7567521|FG004|Open-label Period (Week 48 to Week 144)|Death|0
4671142|NCT02326272|7567522|FG005|Open-label Period (Week 48 to Week 144)|Death|0
4671143|NCT02326272|7567523|FG006|Open-label Period (Week 48 to Week 144)|Death|0
4671144|NCT02326272|7567524|FG007|Open-label Period (Week 48 to Week 144)|Death|0
4671145|NCT02326272|7567525|FG008|Open-label Period (Week 48 to Week 144)|Death|0
4671146|NCT02326272|7567526|FG009|Open-label Period (Week 48 to Week 144)|Death|0
4671147|NCT02326272|7567527|FG010|Open-label Period (Week 48 to Week 144)|Death|0
4671148|NCT02326272|7567528|FG011|Open-label Period (Week 48 to Week 144)|Death|0
4671149|NCT02326272|7567529|FG012|Open-label Period (Week 48 to Week 144)|Death|1
4671150|NCT02326272|7567530|FG013|Open-label Period (Week 48 to Week 144)|Death|0
4671151|NCT02326272|7567531|FG014|Open-label Period (Week 48 to Week 144)|Death|0
4671152|NCT02326272|7567517|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0
4671153|NCT02326272|7567518|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0
4671154|NCT02326272|7567519|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0
4671155|NCT02326272|7567520|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0
4671156|NCT02326272|7567521|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0
4671157|NCT02326272|7567522|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0
4671158|NCT02326272|7567523|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0
4671159|NCT02326272|7567524|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0
4671160|NCT02326272|7567525|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0
4671161|NCT02326272|7567526|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0
4671162|NCT02326272|7567527|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1
4671163|NCT02326272|7567528|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8
4671164|NCT02326272|7567529|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3
4671165|NCT02326272|7567530|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0
4671166|NCT02326272|7567531|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1
4671167|NCT02326272|7567517|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
4671168|NCT02326272|7567518|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
4671169|NCT02326272|7567519|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
4671170|NCT02326272|7567520|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
4671171|NCT02326272|7567521|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
4671172|NCT02326272|7567522|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
4671173|NCT02326272|7567523|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
4671174|NCT02326272|7567524|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
4671175|NCT02326272|7567525|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
4671176|NCT02326272|7567526|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
4671177|NCT02326272|7567527|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
4671178|NCT02326272|7567528|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
4671179|NCT02326272|7567529|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
4671180|NCT02326272|7567530|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
4671181|NCT02326272|7567531|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
4671182|NCT02326272|7567517|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
4671183|NCT02326272|7567518|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
4671184|NCT02326272|7567519|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
4671185|NCT02326272|7567520|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
4671186|NCT02326272|7567521|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
4671187|NCT02326272|7567522|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
4671188|NCT02326272|7567523|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
4755062|NCT02713867|7729534|FG001|Treatment Period|Study Drug Toxicity|20
4755063|NCT02713867|7729533|FG000|Treatment Period|Disease Progression|79
4755064|NCT02713867|7729534|FG001|Treatment Period|Disease Progression|78
4755065|NCT02704403|7729542|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4
4755066|NCT02704403|7729543|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3
4755067|NCT02704403|7729542|FG000|Overall Study|Administrative reasons by sponsor|1251
4755068|NCT02704403|7729543|FG001|Overall Study|Administrative reasons by sponsor|616
4755069|NCT02704403|7729542|FG000|Overall Study|Death|4
4671189|NCT02326272|7567524|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
4671190|NCT02326272|7567525|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
4671191|NCT02326272|7567526|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
4671192|NCT02326272|7567527|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
4671193|NCT02326272|7567528|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1
4671194|NCT02326272|7567529|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
4671195|NCT02326272|7567530|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
4671196|NCT02326272|7567531|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
4671197|NCT02326272|7567517|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
4671198|NCT02326272|7567518|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
4671199|NCT02326272|7567519|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
4671200|NCT02326272|7567520|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
4671201|NCT02326272|7567521|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
4671202|NCT02326272|7567522|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
4671203|NCT02326272|7567523|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
4671204|NCT02326272|7567524|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
4671205|NCT02326272|7567525|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
4671206|NCT02326272|7567526|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
4671207|NCT02326272|7567527|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1
4671208|NCT02326272|7567528|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
4671209|NCT02326272|7567529|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2
4671210|NCT02326272|7567530|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
4671211|NCT02326272|7567531|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3
4671212|NCT02326272|7567517|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4671213|NCT02326272|7567518|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4671214|NCT02326272|7567519|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4671215|NCT02326272|7567520|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4671216|NCT02326272|7567521|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4671217|NCT02326272|7567522|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4671218|NCT02326272|7567523|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4671219|NCT02326272|7567524|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4671220|NCT02326272|7567525|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4671221|NCT02326272|7567526|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4755070|NCT02704403|7729543|FG001|Overall Study|Death|3
4755071|NCT02704403|7729542|FG000|Overall Study|Endpoint event|52
4755072|NCT02704403|7729543|FG001|Overall Study|Endpoint event|24
4755073|NCT02704403|7729542|FG000|Overall Study|Lost to Follow-up|22
4755074|NCT02704403|7729543|FG001|Overall Study|Lost to Follow-up|11
4755075|NCT02704403|7729542|FG000|Overall Study|Protocol Violation|15
4755076|NCT02704403|7729543|FG001|Overall Study|Protocol Violation|15
4755077|NCT02704403|7729542|FG000|Overall Study|Adverse Event|2
4755078|NCT02704403|7729543|FG001|Overall Study|Adverse Event|0
4755079|NCT02704403|7729542|FG000|Overall Study|Withdrawal by Subject|85
4755080|NCT02704403|7729543|FG001|Overall Study|Withdrawal by Subject|45
4755081|NCT02704403|7729542|FG000|Overall Study|Investigator decision|1
4755082|NCT02704403|7729543|FG001|Overall Study|Investigator decision|1
4671222|NCT02326272|7567527|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4671223|NCT02326272|7567528|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4
4671224|NCT02326272|7567529|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4671225|NCT02326272|7567530|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4671226|NCT02326272|7567531|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2
4671227|NCT02326272|7567517|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
4671228|NCT02326272|7567518|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
4671229|NCT02326272|7567519|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
4671230|NCT02326272|7567520|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
4671231|NCT02326272|7567521|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
4671232|NCT02326272|7567522|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
4671233|NCT02326272|7567523|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
4671234|NCT02326272|7567524|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
4671235|NCT02326272|7567525|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
4671236|NCT02326272|7567526|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
4671237|NCT02326272|7567527|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
4671238|NCT02326272|7567528|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1
4671239|NCT02326272|7567529|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3
4671240|NCT02326272|7567530|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
4671241|NCT02326272|7567531|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3
4671242|NCT02326272|7567517|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
4671243|NCT02326272|7567518|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
4755083|NCT02704403|7729542|FG000|Overall Study|Follow-up not possible|1
4671244|NCT02326272|7567519|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
4671245|NCT02326272|7567520|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
4671246|NCT02326272|7567521|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
4671247|NCT02326272|7567522|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
4671248|NCT02326272|7567523|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
4671249|NCT02326272|7567524|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
4671250|NCT02326272|7567525|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
4671251|NCT02326272|7567526|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
4671252|NCT02326272|7567527|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
4671253|NCT02326272|7567528|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1
4671254|NCT02326272|7567529|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
4671255|NCT02326272|7567530|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
4671256|NCT02326272|7567531|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
4671257|NCT02326272|7567517|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0
4671258|NCT02326272|7567518|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0
4671259|NCT02326272|7567519|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0
4671260|NCT02326272|7567520|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0
4671261|NCT02326272|7567521|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0
4671262|NCT02326272|7567522|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0
4671263|NCT02326272|7567523|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0
4671264|NCT02326272|7567524|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0
4671265|NCT02326272|7567525|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0
4671266|NCT02326272|7567526|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0
4671267|NCT02326272|7567527|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0
4671268|NCT02326272|7567528|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0
4671269|NCT02326272|7567529|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1
4671270|NCT02326272|7567530|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0
4671271|NCT02326272|7567531|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0
4671272|NCT02326298|7567543|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0
4671273|NCT02326298|7567544|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0
4671274|NCT02326298|7567545|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1
4671275|NCT02326298|7567546|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0
4671276|NCT02326298|7567547|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0
4671277|NCT02326298|7567548|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0
4671278|NCT02326298|7567549|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0
4671279|NCT02326298|7567550|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0
4671280|NCT02326298|7567551|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0
4671281|NCT02326298|7567552|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0
4671282|NCT02326298|7567553|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0
4671283|NCT02326298|7567554|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0
4671284|NCT02326298|7567555|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0
4671285|NCT02326298|7567556|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0
4671286|NCT02326298|7567543|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1
4671287|NCT02326298|7567544|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
4671288|NCT02326298|7567545|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
4671289|NCT02326298|7567546|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
4671290|NCT02326298|7567547|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
4671291|NCT02326298|7567548|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
4671292|NCT02326298|7567549|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
4671293|NCT02326298|7567550|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
4671294|NCT02326298|7567551|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
4671295|NCT02326298|7567552|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
4671296|NCT02326298|7567553|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
4671297|NCT02326298|7567554|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
4671298|NCT02326298|7567555|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
4671299|NCT02326298|7567556|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
4671300|NCT02326298|7567543|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1
4671301|NCT02326298|7567544|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1
4671302|NCT02326298|7567545|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
4671303|NCT02326298|7567546|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
4671304|NCT02326298|7567547|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
4671305|NCT02326298|7567548|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
4671306|NCT02326298|7567549|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
4671307|NCT02326298|7567550|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
4671308|NCT02326298|7567551|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
4671309|NCT02326298|7567552|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
4671310|NCT02326298|7567553|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
4671311|NCT02326298|7567554|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
4671312|NCT02326298|7567555|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
4671313|NCT02326298|7567556|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
4671314|NCT02326298|7567543|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3
4755084|NCT02704403|7729543|FG001|Overall Study|Follow-up not possible|2
4671315|NCT02326298|7567544|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2
4671316|NCT02326298|7567545|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
4671317|NCT02326298|7567546|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
4671318|NCT02326298|7567547|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
4671319|NCT02326298|7567548|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
4671320|NCT02326298|7567549|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
4671321|NCT02326298|7567550|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
4671322|NCT02326298|7567551|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
4671323|NCT02326298|7567552|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
4671324|NCT02326298|7567553|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
4671325|NCT02326298|7567554|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
4671326|NCT02326298|7567555|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
4671327|NCT02326298|7567556|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
4671328|NCT02326298|7567543|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
4671329|NCT02326298|7567544|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
4671330|NCT02326298|7567545|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2
4671331|NCT02326298|7567546|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
4671332|NCT02326298|7567547|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
4671333|NCT02326298|7567548|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
4671334|NCT02326298|7567549|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
4755085|NCT02694185|7729551|FG000|Overall Study|Withdrawal by Subject|45
4755086|NCT02694185|7729552|FG001|Overall Study|Withdrawal by Subject|0
4755087|NCT02692651|7729560|FG000|Study Treatment|Death|7
4755088|NCT02692651|7729561|FG001|Study Treatment|Death|3
4755089|NCT02692651|7729560|FG000|Study Treatment|comfort care|1
4755090|NCT02692651|7729561|FG001|Study Treatment|comfort care|1
4755091|NCT02692651|7729560|FG000|Study Treatment|Protocol violation per treating team preference|8
4755092|NCT02692651|7729561|FG001|Study Treatment|Protocol violation per treating team preference|6
4755093|NCT02692651|7729560|FG000|Post Study Treatment Follow-up|Death|4
4755094|NCT02692651|7729561|FG001|Post Study Treatment Follow-up|Death|4
4755095|NCT02674061|7729569|FG000|Overall Study|Death|229
4755096|NCT02674061|7729570|FG001|Overall Study|Death|77
4755097|NCT02674061|7729569|FG000|Overall Study|Lost to Follow-up|3
4755098|NCT02674061|7729570|FG001|Overall Study|Lost to Follow-up|3
4755099|NCT02674061|7729569|FG000|Overall Study|Withdrawal by Subject|9
4755100|NCT02674061|7729570|FG001|Overall Study|Withdrawal by Subject|1
4755101|NCT02674061|7729569|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44
4755102|NCT02674061|7729570|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10
4755103|NCT02656706|7729578|FG000|Overall Study|Insurance Denial|1
4755104|NCT02642042|7729591|FG000|Overall Study|Adverse Event|22
4755105|NCT02642042|7729591|FG000|Overall Study|Refusal Unrelated to Adverse Event|1
4755106|NCT02642042|7729591|FG000|Overall Study|Progression/Relapse|28
4755107|NCT02642042|7729591|FG000|Overall Study|Death|1
4755108|NCT02642042|7729591|FG000|Overall Study|Not Protocol Specified|2
4755109|NCT02628444|7729598|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1
4755110|NCT02628444|7729599|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
4671335|NCT02326298|7567550|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
4671336|NCT02326298|7567551|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
4671337|NCT02326298|7567552|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
4671338|NCT02326298|7567553|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
4671339|NCT02326298|7567554|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
4671340|NCT02326298|7567555|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
4671341|NCT02326298|7567556|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
4671342|NCT02326298|7567543|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4671343|NCT02326298|7567544|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4671344|NCT02326298|7567545|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4671345|NCT02326298|7567546|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4671346|NCT02326298|7567547|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4671347|NCT02326298|7567548|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
4671348|NCT02326298|7567549|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3
4671349|NCT02326298|7567550|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
4671350|NCT02326298|7567551|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
4671351|NCT02326298|7567552|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
4671352|NCT02326298|7567553|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4671353|NCT02326298|7567554|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4671354|NCT02326298|7567555|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4671355|NCT02326298|7567556|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4671356|NCT02326298|7567543|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
4671357|NCT02326298|7567544|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
4671358|NCT02326298|7567545|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
4671359|NCT02326298|7567546|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
4671360|NCT02326298|7567547|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
4671361|NCT02326298|7567548|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1
4671362|NCT02326298|7567549|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2
4671363|NCT02326298|7567550|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
4671364|NCT02326298|7567551|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4
4671365|NCT02326298|7567552|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
4671366|NCT02326298|7567553|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
4671367|NCT02326298|7567554|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
4671368|NCT02326298|7567555|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
4671369|NCT02326298|7567556|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
4671370|NCT02326298|7567543|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
4671371|NCT02326298|7567544|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
4671372|NCT02326298|7567545|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
4671373|NCT02326298|7567546|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
4671374|NCT02326298|7567547|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
4671375|NCT02326298|7567548|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1
4671376|NCT02326298|7567549|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
4671377|NCT02326298|7567550|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
4671378|NCT02326298|7567551|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
4671379|NCT02326298|7567552|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
4671380|NCT02326298|7567553|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
4671381|NCT02326298|7567554|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
4671382|NCT02326298|7567555|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
4671383|NCT02326298|7567556|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
4671384|NCT02326298|7567543|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
4671385|NCT02326298|7567544|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
4671386|NCT02326298|7567545|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
4671387|NCT02326298|7567546|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
4671388|NCT02326298|7567547|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
4671389|NCT02326298|7567548|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
4671390|NCT02326298|7567549|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1
4671391|NCT02326298|7567550|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
4671392|NCT02326298|7567551|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
4671393|NCT02326298|7567552|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
4671394|NCT02326298|7567553|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
4671395|NCT02326298|7567554|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
4671396|NCT02326298|7567555|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
4671397|NCT02326298|7567556|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
4671398|NCT02326298|7567543|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
4671399|NCT02326298|7567544|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
4671400|NCT02326298|7567545|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
4671401|NCT02326298|7567546|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
4671402|NCT02326298|7567547|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
4671403|NCT02326298|7567548|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
4671404|NCT02326298|7567549|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
4671405|NCT02326298|7567550|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1
4671406|NCT02326298|7567551|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
4671407|NCT02326298|7567552|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
4671408|NCT02326298|7567553|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
4671409|NCT02326298|7567554|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
4671410|NCT02326298|7567555|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
4671411|NCT02326298|7567556|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
4671412|NCT02326298|7567543|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4671413|NCT02326298|7567544|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4671414|NCT02326298|7567545|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4671415|NCT02326298|7567546|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4671416|NCT02326298|7567547|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4671417|NCT02326298|7567548|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4671418|NCT02326298|7567549|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1
4671419|NCT02326298|7567550|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2
4671420|NCT02326298|7567551|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4671421|NCT02326298|7567552|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4671422|NCT02326298|7567553|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4671423|NCT02326298|7567554|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4671424|NCT02326298|7567555|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4671425|NCT02326298|7567556|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4671426|NCT02326298|7567543|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4671427|NCT02326298|7567544|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4671428|NCT02326298|7567545|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4671429|NCT02326298|7567546|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4671430|NCT02326298|7567547|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4671431|NCT02326298|7567548|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4671432|NCT02326298|7567549|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4671433|NCT02326298|7567550|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
4671434|NCT02326298|7567551|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4671435|NCT02326298|7567552|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4671436|NCT02326298|7567553|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4671437|NCT02326298|7567554|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4671438|NCT02326298|7567555|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4671439|NCT02326298|7567556|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4671440|NCT02326298|7567543|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
4671441|NCT02326298|7567544|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
4671442|NCT02326298|7567545|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
4671443|NCT02326298|7567546|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
4671444|NCT02326298|7567547|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
4671445|NCT02326298|7567548|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2
4671446|NCT02326298|7567549|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
4671447|NCT02326298|7567550|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
4671448|NCT02326298|7567551|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
4671449|NCT02326298|7567552|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
4671450|NCT02326298|7567553|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
4671451|NCT02326298|7567554|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
4671452|NCT02326298|7567555|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
4671453|NCT02326298|7567556|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
4671454|NCT02326298|7567543|FG000|Open-label Period (Week 48 to Week 144)|Death|0
4671455|NCT02326298|7567544|FG001|Open-label Period (Week 48 to Week 144)|Death|0
4671456|NCT02326298|7567545|FG002|Open-label Period (Week 48 to Week 144)|Death|0
4671457|NCT02326298|7567546|FG003|Open-label Period (Week 48 to Week 144)|Death|0
4671458|NCT02326298|7567547|FG004|Open-label Period (Week 48 to Week 144)|Death|0
4671459|NCT02326298|7567548|FG005|Open-label Period (Week 48 to Week 144)|Death|0
4671460|NCT02326298|7567549|FG006|Open-label Period (Week 48 to Week 144)|Death|0
4671461|NCT02326298|7567550|FG007|Open-label Period (Week 48 to Week 144)|Death|0
4671462|NCT02326298|7567551|FG008|Open-label Period (Week 48 to Week 144)|Death|0
4671463|NCT02326298|7567552|FG009|Open-label Period (Week 48 to Week 144)|Death|0
4671464|NCT02326298|7567553|FG010|Open-label Period (Week 48 to Week 144)|Death|0
4671465|NCT02326298|7567554|FG011|Open-label Period (Week 48 to Week 144)|Death|1
4671466|NCT02326298|7567555|FG012|Open-label Period (Week 48 to Week 144)|Death|0
4671467|NCT02326298|7567556|FG013|Open-label Period (Week 48 to Week 144)|Death|0
4671468|NCT02326298|7567543|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0
4671469|NCT02326298|7567544|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0
4671470|NCT02326298|7567545|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0
4671471|NCT02326298|7567546|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0
4671472|NCT02326298|7567547|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0
4671473|NCT02326298|7567548|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0
4671474|NCT02326298|7567549|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0
4671475|NCT02326298|7567550|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0
4671476|NCT02326298|7567551|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0
4671477|NCT02326298|7567552|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0
4671478|NCT02326298|7567553|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0
4671479|NCT02326298|7567554|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3
4671480|NCT02326298|7567555|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3
4755111|NCT02628444|7729600|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
4755112|NCT02628444|7729601|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
4755113|NCT02628444|7729602|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
4755114|NCT02628444|7729603|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
4755115|NCT02628444|7729604|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
4671481|NCT02326298|7567556|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0
4671482|NCT02326298|7567543|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
4671483|NCT02326298|7567544|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
4671484|NCT02326298|7567545|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
4671485|NCT02326298|7567546|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
4671486|NCT02326298|7567547|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
4755116|NCT02628444|7729605|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
4755117|NCT02628444|7729606|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0
4755118|NCT02628444|7729598|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0
4755119|NCT02628444|7729599|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4
4755120|NCT02628444|7729600|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3
4755121|NCT02628444|7729601|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0
4755122|NCT02628444|7729602|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0
4755123|NCT02628444|7729603|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0
4755124|NCT02628444|7729604|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0
4755125|NCT02628444|7729605|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0
4755126|NCT02628444|7729606|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0
4755127|NCT02628444|7729598|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21
4755128|NCT02628444|7729599|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16
4755129|NCT02628444|7729600|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25
4755130|NCT02628444|7729601|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0
4755131|NCT02628444|7729602|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0
4671487|NCT02326298|7567548|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
4671488|NCT02326298|7567549|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
4671489|NCT02326298|7567550|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
4671490|NCT02326298|7567551|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
4671491|NCT02326298|7567552|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
4671492|NCT02326298|7567553|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
4671493|NCT02326298|7567554|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
4671494|NCT02326298|7567555|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
4671495|NCT02326298|7567556|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
4671496|NCT02326298|7567543|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
4671497|NCT02326298|7567544|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
4671498|NCT02326298|7567545|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
4671499|NCT02326298|7567546|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
4671500|NCT02326298|7567547|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
4671501|NCT02326298|7567548|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
4671502|NCT02326298|7567549|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
4671503|NCT02326298|7567550|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
4671504|NCT02326298|7567551|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
4671505|NCT02326298|7567552|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
4671506|NCT02326298|7567553|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
4671507|NCT02326298|7567554|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
4671508|NCT02326298|7567555|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
4671509|NCT02326298|7567556|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2
4671510|NCT02326298|7567543|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4671511|NCT02326298|7567544|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4671512|NCT02326298|7567545|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4671513|NCT02326298|7567546|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4671514|NCT02326298|7567547|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4671515|NCT02326298|7567548|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4671516|NCT02326298|7567549|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4671517|NCT02326298|7567550|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4671518|NCT02326298|7567551|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4671519|NCT02326298|7567552|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4671520|NCT02326298|7567553|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4671521|NCT02326298|7567554|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7
4671522|NCT02326298|7567555|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2
4671523|NCT02326298|7567556|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1
4671524|NCT02326298|7567543|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
4671525|NCT02326298|7567544|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
4671526|NCT02326298|7567545|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
4671527|NCT02326298|7567546|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
4671528|NCT02326298|7567547|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
4671529|NCT02326298|7567548|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
4671530|NCT02326298|7567549|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
4671531|NCT02326298|7567550|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
4671532|NCT02326298|7567551|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
4671533|NCT02326298|7567552|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
4671534|NCT02326298|7567553|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
4671535|NCT02326298|7567554|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2
4671536|NCT02326298|7567555|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7
4671537|NCT02326298|7567556|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3
4671538|NCT02326298|7567543|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
4671539|NCT02326298|7567544|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
4671540|NCT02326298|7567545|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
4671541|NCT02326298|7567546|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
4671542|NCT02326298|7567547|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
4671543|NCT02326298|7567548|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
4671544|NCT02326298|7567549|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
4671545|NCT02326298|7567550|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
4671546|NCT02326298|7567551|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
4671547|NCT02326298|7567552|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
4755132|NCT02628444|7729603|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0
4755133|NCT02628444|7729604|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0
4755134|NCT02628444|7729605|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0
4755135|NCT02628444|7729606|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0
4755136|NCT02628444|7729598|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9
4755137|NCT02628444|7729599|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16
4755138|NCT02628444|7729600|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9
4755139|NCT02628444|7729601|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0
4755140|NCT02628444|7729602|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0
4755141|NCT02628444|7729603|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0
4671548|NCT02326298|7567553|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
4671549|NCT02326298|7567554|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6
4671550|NCT02326298|7567555|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6
4671551|NCT02326298|7567556|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3
4755142|NCT02628444|7729604|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0
4755143|NCT02628444|7729605|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0
4755144|NCT02628444|7729606|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0
4755145|NCT02628444|7729598|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5
4755146|NCT02628444|7729599|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3
4755147|NCT02628444|7729600|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5
4755148|NCT02628444|7729601|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0
4671552|NCT02326467|7567576|FG000|Overall Study|Withdrawal by Subject|1
4671553|NCT02326597|7567583|FG000|Overall Study|Lost to Follow-up|42
4671554|NCT02326597|7567584|FG001|Overall Study|Lost to Follow-up|32
4671555|NCT02326883|7567612|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84
4671556|NCT02326883|7567613|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85
4671557|NCT02326883|7567614|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69
4671558|NCT02327013|7567625|FG000|Overall Study|Adverse Event|4
4671559|NCT02327013|7567626|FG001|Overall Study|Adverse Event|4
4671560|NCT02327013|7567627|FG002|Overall Study|Adverse Event|3
4671561|NCT02327013|7567628|FG003|Overall Study|Adverse Event|0
4671562|NCT02327013|7567629|FG004|Overall Study|Adverse Event|1
4671563|NCT02327013|7567625|FG000|Overall Study|Lack of Efficacy|2
4671564|NCT02327013|7567626|FG001|Overall Study|Lack of Efficacy|0
4671565|NCT02327013|7567627|FG002|Overall Study|Lack of Efficacy|5
4671566|NCT02327013|7567628|FG003|Overall Study|Lack of Efficacy|0
4671567|NCT02327013|7567629|FG004|Overall Study|Lack of Efficacy|1
4671568|NCT02327013|7567625|FG000|Overall Study|Non-compliance with IMP|1
4671569|NCT02327013|7567626|FG001|Overall Study|Non-compliance with IMP|2
4671570|NCT02327013|7567627|FG002|Overall Study|Non-compliance with IMP|7
4671571|NCT02327013|7567628|FG003|Overall Study|Non-compliance with IMP|0
4671572|NCT02327013|7567629|FG004|Overall Study|Non-compliance with IMP|0
4671573|NCT02327013|7567625|FG000|Overall Study|Withdrawal of Consent|1
4671574|NCT02327013|7567626|FG001|Overall Study|Withdrawal of Consent|0
4671575|NCT02327013|7567627|FG002|Overall Study|Withdrawal of Consent|3
4671576|NCT02327013|7567628|FG003|Overall Study|Withdrawal of Consent|0
4671577|NCT02327013|7567629|FG004|Overall Study|Withdrawal of Consent|0
4671578|NCT02327013|7567625|FG000|Overall Study|Lost to Follow-up|2
4671579|NCT02327013|7567626|FG001|Overall Study|Lost to Follow-up|4
4671580|NCT02327013|7567627|FG002|Overall Study|Lost to Follow-up|5
4671581|NCT02327013|7567628|FG003|Overall Study|Lost to Follow-up|0
4671582|NCT02327013|7567629|FG004|Overall Study|Lost to Follow-up|0
4671583|NCT02327013|7567625|FG000|Overall Study|Administrative or other reason(s)|1
4671584|NCT02327013|7567626|FG001|Overall Study|Administrative or other reason(s)|5
4671585|NCT02327013|7567627|FG002|Overall Study|Administrative or other reason(s)|11
4671586|NCT02327013|7567628|FG003|Overall Study|Administrative or other reason(s)|1
4671587|NCT02327013|7567629|FG004|Overall Study|Administrative or other reason(s)|1
4671588|NCT02327013|7567625|FG000|Overall Study|Protocol Violation|0
4671589|NCT02327013|7567626|FG001|Overall Study|Protocol Violation|0
4671590|NCT02327013|7567627|FG002|Overall Study|Protocol Violation|3
4671591|NCT02327013|7567628|FG003|Overall Study|Protocol Violation|0
4671592|NCT02327013|7567629|FG004|Overall Study|Protocol Violation|1
4671593|NCT02327013|7567625|FG000|Overall Study|Withdrawal before treatment|2
4671594|NCT02327013|7567626|FG001|Overall Study|Withdrawal before treatment|1
4671595|NCT02327013|7567627|FG002|Overall Study|Withdrawal before treatment|5
4671596|NCT02327013|7567628|FG003|Overall Study|Withdrawal before treatment|0
4671597|NCT02327013|7567629|FG004|Overall Study|Withdrawal before treatment|0
4671598|NCT02327130|7567662|FG000|Overall Study|Discharged in less than 5 days|5
4671599|NCT02327130|7567662|FG000|Overall Study|Physician Decision|2
4671600|NCT02327130|7567662|FG000|Overall Study|Unable to provide breath sample|1
4671601|NCT02327130|7567662|FG000|Overall Study|Incorrectly place ventilator adaptor|1
4755149|NCT02628444|7729602|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0
4755150|NCT02628444|7729603|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0
4755151|NCT02628444|7729604|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0
4755152|NCT02628444|7729605|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0
4755153|NCT02628444|7729606|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0
4755154|NCT02628444|7729598|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
4755155|NCT02628444|7729599|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
4755156|NCT02628444|7729600|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
4755157|NCT02628444|7729601|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1
4755158|NCT02628444|7729602|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
4755159|NCT02628444|7729603|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
4755160|NCT02628444|7729604|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
4755161|NCT02628444|7729605|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
4755162|NCT02628444|7729606|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0
4755163|NCT02628444|7729598|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0
4755164|NCT02628444|7729599|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0
4755165|NCT02628444|7729600|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0
4755166|NCT02628444|7729601|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83
4755167|NCT02628444|7729602|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83
4755168|NCT02628444|7729603|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83
4755169|NCT02628444|7729604|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81
4755170|NCT02628444|7729605|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84
4671602|NCT02327130|7567662|FG000|Overall Study|Met exclusion criteria|3
4671603|NCT02327169|7567691|FG000|Overall Study|Progressive Disease|1
4671604|NCT02327169|7567692|FG001|Overall Study|Progressive Disease|3
4671605|NCT02327169|7567693|FG002|Overall Study|Progressive Disease|4
4671606|NCT02327169|7567694|FG003|Overall Study|Progressive Disease|3
4671607|NCT02327169|7567695|FG004|Overall Study|Progressive Disease|4
4671608|NCT02327169|7567696|FG005|Overall Study|Progressive Disease|3
4671609|NCT02327169|7567697|FG006|Overall Study|Progressive Disease|3
4671610|NCT02327169|7567698|FG007|Overall Study|Progressive Disease|3
4671611|NCT02327169|7567699|FG008|Overall Study|Progressive Disease|4
4671612|NCT02327169|7567700|FG009|Overall Study|Progressive Disease|4
4671613|NCT02327169|7567701|FG010|Overall Study|Progressive Disease|4
4671614|NCT02327169|7567702|FG011|Overall Study|Progressive Disease|3
4671615|NCT02327169|7567703|FG012|Overall Study|Progressive Disease|1
4671616|NCT02327169|7567704|FG013|Overall Study|Progressive Disease|3
4671617|NCT02327169|7567705|FG014|Overall Study|Progressive Disease|3
4671618|NCT02327169|7567691|FG000|Overall Study|Adverse Event|2
4671619|NCT02327169|7567692|FG001|Overall Study|Adverse Event|0
4671620|NCT02327169|7567693|FG002|Overall Study|Adverse Event|1
4671621|NCT02327169|7567694|FG003|Overall Study|Adverse Event|0
4671622|NCT02327169|7567695|FG004|Overall Study|Adverse Event|1
4671623|NCT02327169|7567696|FG005|Overall Study|Adverse Event|0
4671624|NCT02327169|7567697|FG006|Overall Study|Adverse Event|0
4671625|NCT02327169|7567698|FG007|Overall Study|Adverse Event|0
4671626|NCT02327169|7567699|FG008|Overall Study|Adverse Event|0
4671627|NCT02327169|7567700|FG009|Overall Study|Adverse Event|2
4671628|NCT02327169|7567701|FG010|Overall Study|Adverse Event|0
4671629|NCT02327169|7567702|FG011|Overall Study|Adverse Event|3
4671630|NCT02327169|7567703|FG012|Overall Study|Adverse Event|0
4671631|NCT02327169|7567704|FG013|Overall Study|Adverse Event|2
4671632|NCT02327169|7567705|FG014|Overall Study|Adverse Event|1
4671633|NCT02327169|7567691|FG000|Overall Study|Symptomatic Deterioration|0
4671634|NCT02327169|7567692|FG001|Overall Study|Symptomatic Deterioration|0
4671635|NCT02327169|7567693|FG002|Overall Study|Symptomatic Deterioration|1
4671636|NCT02327169|7567694|FG003|Overall Study|Symptomatic Deterioration|0
4671637|NCT02327169|7567695|FG004|Overall Study|Symptomatic Deterioration|1
4671638|NCT02327169|7567696|FG005|Overall Study|Symptomatic Deterioration|1
4671639|NCT02327169|7567697|FG006|Overall Study|Symptomatic Deterioration|0
4671640|NCT02327169|7567698|FG007|Overall Study|Symptomatic Deterioration|0
4671641|NCT02327169|7567699|FG008|Overall Study|Symptomatic Deterioration|2
4671642|NCT02327169|7567700|FG009|Overall Study|Symptomatic Deterioration|1
4671643|NCT02327169|7567701|FG010|Overall Study|Symptomatic Deterioration|0
4671644|NCT02327169|7567702|FG011|Overall Study|Symptomatic Deterioration|0
4671645|NCT02327169|7567703|FG012|Overall Study|Symptomatic Deterioration|0
4671646|NCT02327169|7567704|FG013|Overall Study|Symptomatic Deterioration|2
4671647|NCT02327169|7567705|FG014|Overall Study|Symptomatic Deterioration|1
4671648|NCT02327169|7567691|FG000|Overall Study|Reason Not Specified|0
4671649|NCT02327169|7567692|FG001|Overall Study|Reason Not Specified|0
4671650|NCT02327169|7567693|FG002|Overall Study|Reason Not Specified|1
4671651|NCT02327169|7567694|FG003|Overall Study|Reason Not Specified|0
4671652|NCT02327169|7567695|FG004|Overall Study|Reason Not Specified|0
4671653|NCT02327169|7567696|FG005|Overall Study|Reason Not Specified|0
4671654|NCT02327169|7567697|FG006|Overall Study|Reason Not Specified|0
4671655|NCT02327169|7567698|FG007|Overall Study|Reason Not Specified|0
4671656|NCT02327169|7567699|FG008|Overall Study|Reason Not Specified|0
4671657|NCT02327169|7567700|FG009|Overall Study|Reason Not Specified|1
4671658|NCT02327169|7567701|FG010|Overall Study|Reason Not Specified|2
4671659|NCT02327169|7567702|FG011|Overall Study|Reason Not Specified|1
4671660|NCT02327169|7567703|FG012|Overall Study|Reason Not Specified|0
4671661|NCT02327169|7567704|FG013|Overall Study|Reason Not Specified|0
4671662|NCT02327169|7567705|FG014|Overall Study|Reason Not Specified|2
4671663|NCT02327169|7567691|FG000|Overall Study|Withdrawal by Subject|1
4755171|NCT02628444|7729606|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85
4755172|NCT02628444|7729598|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0
4755173|NCT02628444|7729599|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0
4755174|NCT02628444|7729600|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0
4755175|NCT02628444|7729601|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5
4755176|NCT02628444|7729602|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6
4755177|NCT02628444|7729603|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10
4755178|NCT02628444|7729604|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12
4755179|NCT02628444|7729605|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11
4671664|NCT02327169|7567692|FG001|Overall Study|Withdrawal by Subject|0
4671665|NCT02327169|7567693|FG002|Overall Study|Withdrawal by Subject|0
4671666|NCT02327169|7567694|FG003|Overall Study|Withdrawal by Subject|0
4671667|NCT02327169|7567695|FG004|Overall Study|Withdrawal by Subject|1
4671668|NCT02327169|7567696|FG005|Overall Study|Withdrawal by Subject|0
4671669|NCT02327169|7567697|FG006|Overall Study|Withdrawal by Subject|0
4671670|NCT02327169|7567698|FG007|Overall Study|Withdrawal by Subject|1
4671671|NCT02327169|7567699|FG008|Overall Study|Withdrawal by Subject|0
4671672|NCT02327169|7567700|FG009|Overall Study|Withdrawal by Subject|0
4671673|NCT02327169|7567701|FG010|Overall Study|Withdrawal by Subject|0
4671674|NCT02327169|7567702|FG011|Overall Study|Withdrawal by Subject|0
4671675|NCT02327169|7567703|FG012|Overall Study|Withdrawal by Subject|0
4671676|NCT02327169|7567704|FG013|Overall Study|Withdrawal by Subject|0
4671677|NCT02327169|7567705|FG014|Overall Study|Withdrawal by Subject|3
4671678|NCT02327169|7567691|FG000|Overall Study|Lost to Follow-up|0
4671679|NCT02327169|7567692|FG001|Overall Study|Lost to Follow-up|0
4671680|NCT02327169|7567693|FG002|Overall Study|Lost to Follow-up|0
4671681|NCT02327169|7567694|FG003|Overall Study|Lost to Follow-up|0
4671682|NCT02327169|7567695|FG004|Overall Study|Lost to Follow-up|1
4671683|NCT02327169|7567696|FG005|Overall Study|Lost to Follow-up|0
4671684|NCT02327169|7567697|FG006|Overall Study|Lost to Follow-up|0
4671685|NCT02327169|7567698|FG007|Overall Study|Lost to Follow-up|0
4671686|NCT02327169|7567699|FG008|Overall Study|Lost to Follow-up|0
4671687|NCT02327169|7567700|FG009|Overall Study|Lost to Follow-up|0
4671688|NCT02327169|7567701|FG010|Overall Study|Lost to Follow-up|0
4671689|NCT02327169|7567702|FG011|Overall Study|Lost to Follow-up|0
4671690|NCT02327169|7567703|FG012|Overall Study|Lost to Follow-up|0
4671691|NCT02327169|7567704|FG013|Overall Study|Lost to Follow-up|0
4671692|NCT02327169|7567705|FG014|Overall Study|Lost to Follow-up|0
4671693|NCT02327260|7567750|FG000|Overall Study|Lost to Follow-up|2
4671694|NCT02327260|7567751|FG001|Overall Study|Lost to Follow-up|3
4671695|NCT02327260|7567752|FG002|Overall Study|Lost to Follow-up|2
4671696|NCT02327260|7567750|FG000|Overall Study|invalid phone number|1
4671697|NCT02327260|7567751|FG001|Overall Study|invalid phone number|1
4671698|NCT02327260|7567752|FG002|Overall Study|invalid phone number|0
4671699|NCT02327260|7567750|FG000|Overall Study|non-adherence to protocol|2
4671700|NCT02327260|7567751|FG001|Overall Study|non-adherence to protocol|0
4671701|NCT02327260|7567752|FG002|Overall Study|non-adherence to protocol|0
4671702|NCT02327260|7567750|FG000|Overall Study|cognitive concerns|1
4671703|NCT02327260|7567751|FG001|Overall Study|cognitive concerns|0
4671704|NCT02327260|7567752|FG002|Overall Study|cognitive concerns|0
4671705|NCT02327325|7567764|FG000|Overall Study|Withdrawal by Subject|1
4671706|NCT02327325|7567765|FG001|Overall Study|Withdrawal by Subject|4
4671707|NCT02327325|7567766|FG002|Overall Study|Withdrawal by Subject|4
4671708|NCT02327325|7567764|FG000|Overall Study|Excluded by Study Team|0
4671709|NCT02327325|7567765|FG001|Overall Study|Excluded by Study Team|0
4671710|NCT02327325|7567766|FG002|Overall Study|Excluded by Study Team|1
4671711|NCT02328027|7567797|FG000|Overall Study|Withdrawal by Subject|0
4671712|NCT02328027|7567798|FG001|Overall Study|Withdrawal by Subject|1
4671713|NCT02328040|7567805|FG000|First Intervention (2 Days)|Withdrawal by Subject|1
4671714|NCT02328040|7567806|FG001|First Intervention (2 Days)|Withdrawal by Subject|1
4671715|NCT02328326|7567814|FG000|Overall Study|Withdrawal by Subject|10
4671716|NCT02328326|7567815|FG001|Overall Study|Withdrawal by Subject|3
4671717|NCT02328326|7567814|FG000|Overall Study|Death|2
4671718|NCT02328326|7567815|FG001|Overall Study|Death|1
4755180|NCT02628444|7729606|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9
4755181|NCT02628444|7729598|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0
4755182|NCT02628444|7729599|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0
4755183|NCT02628444|7729600|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0
4755184|NCT02628444|7729601|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0
4755185|NCT02628444|7729602|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3
4755186|NCT02628444|7729603|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0
4755187|NCT02628444|7729604|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0
4755188|NCT02628444|7729605|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2
4755189|NCT02628444|7729606|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3
4755190|NCT02628444|7729598|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0
4755191|NCT02628444|7729599|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0
4755192|NCT02628444|7729600|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0
4755193|NCT02628444|7729601|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1
4671719|NCT02328326|7567814|FG000|Overall Study|Lost to Follow-up|10
4671720|NCT02328326|7567815|FG001|Overall Study|Lost to Follow-up|4
4755194|NCT02628444|7729602|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1
4755195|NCT02628444|7729603|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2
4755196|NCT02628444|7729604|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3
4755197|NCT02628444|7729605|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1
4755198|NCT02628444|7729606|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2
4755199|NCT02623725|7729642|FG000|Overall Study|Non compliance with protocol|9
4755200|NCT02623725|7729643|FG001|Overall Study|Non compliance with protocol|3
4755201|NCT02623725|7729642|FG000|Overall Study|Serious adverse event|0
4755202|NCT02623725|7729643|FG001|Overall Study|Serious adverse event|2
4755203|NCT02623725|7729642|FG000|Overall Study|Withdrawal by Subject|7
4755204|NCT02623725|7729643|FG001|Overall Study|Withdrawal by Subject|1
4755205|NCT02608684|7729651|FG000|Overall Study|Physician Decision|2
4755206|NCT02608684|7729651|FG000|Overall Study|Withdrawal by Subject|1
4755207|NCT02603887|7729655|FG000|Stage 1|Adverse Event|4
4755208|NCT02603887|7729655|FG000|Stage 1|Disease progression|1
4755209|NCT02603887|7729655|FG000|Stage 2|FDA guidance|1
4755210|NCT02601209|7729666|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1
4755211|NCT02601209|7729667|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1
4755212|NCT02601209|7729668|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1
4671721|NCT02328547|7567838|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1
4671722|NCT02328547|7567839|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0
4671723|NCT02328547|7567838|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2
4671724|NCT02328547|7567839|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0
4671725|NCT02328937|7567872|FG000|Period 1|Lost to Follow-up|0
4671726|NCT02328937|7567873|FG001|Period 1|Lost to Follow-up|0
4671727|NCT02328937|7567874|FG002|Period 1|Lost to Follow-up|0
4671728|NCT02328937|7567875|FG003|Period 1|Lost to Follow-up|1
4671729|NCT02328937|7567876|FG004|Period 1|Lost to Follow-up|0
4671730|NCT02328937|7567877|FG005|Period 1|Lost to Follow-up|0
4671731|NCT02328937|7567872|FG000|Period 2|Adverse Event|0
4671732|NCT02328937|7567873|FG001|Period 2|Adverse Event|0
4671733|NCT02328937|7567874|FG002|Period 2|Adverse Event|1
4671734|NCT02328937|7567875|FG003|Period 2|Adverse Event|0
4671735|NCT02328937|7567876|FG004|Period 2|Adverse Event|0
4671736|NCT02328937|7567877|FG005|Period 2|Adverse Event|0
4671737|NCT02329223|7567897|FG000|Overall Study|Withdrawal by Subject|1
4755213|NCT02601209|7729669|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
4755214|NCT02601209|7729670|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
4755215|NCT02601209|7729671|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
4755216|NCT02601209|7729672|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
4755217|NCT02601209|7729673|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
4671738|NCT02329223|7567898|FG001|Overall Study|Withdrawal by Subject|2
4671739|NCT02329223|7567899|FG002|Overall Study|Withdrawal by Subject|5
4671740|NCT02329223|7567897|FG000|Overall Study|Physician Decision|0
4671741|NCT02329223|7567898|FG001|Overall Study|Physician Decision|0
4671742|NCT02329223|7567899|FG002|Overall Study|Physician Decision|1
4671743|NCT02329223|7567897|FG000|Overall Study|Adverse Event|0
4671744|NCT02329223|7567898|FG001|Overall Study|Adverse Event|1
4671745|NCT02329223|7567899|FG002|Overall Study|Adverse Event|0
4671746|NCT02329431|7567909|FG000|Overall Study|Lost to Follow-up|20
4671747|NCT02329431|7567910|FG001|Overall Study|Lost to Follow-up|13
4671748|NCT02329730|7567942|FG000|Overall Study|Protocol Violation|0
4671749|NCT02329730|7567943|FG001|Overall Study|Protocol Violation|0
4671750|NCT02329730|7567944|FG002|Overall Study|Protocol Violation|0
4671751|NCT02329730|7567945|FG003|Overall Study|Protocol Violation|0
4671752|NCT02329730|7567946|FG004|Overall Study|Protocol Violation|2
4671753|NCT02329730|7567947|FG005|Overall Study|Protocol Violation|2
4671754|NCT02329730|7567948|FG006|Overall Study|Protocol Violation|0
4671755|NCT02329730|7567949|FG007|Overall Study|Protocol Violation|0
4671756|NCT02329730|7567950|FG008|Overall Study|Protocol Violation|0
4671757|NCT02329730|7567951|FG009|Overall Study|Protocol Violation|0
4671758|NCT02329730|7567952|FG010|Overall Study|Protocol Violation|0
4671759|NCT02329730|7567953|FG011|Overall Study|Protocol Violation|0
4671760|NCT02329730|7567942|FG000|Overall Study|Withdrawal by Subject|0
4671761|NCT02329730|7567943|FG001|Overall Study|Withdrawal by Subject|0
4671762|NCT02329730|7567944|FG002|Overall Study|Withdrawal by Subject|0
4671763|NCT02329730|7567945|FG003|Overall Study|Withdrawal by Subject|0
4671764|NCT02329730|7567946|FG004|Overall Study|Withdrawal by Subject|1
4671765|NCT02329730|7567947|FG005|Overall Study|Withdrawal by Subject|0
4671766|NCT02329730|7567948|FG006|Overall Study|Withdrawal by Subject|1
4671767|NCT02329730|7567949|FG007|Overall Study|Withdrawal by Subject|1
4671768|NCT02329730|7567950|FG008|Overall Study|Withdrawal by Subject|1
4671769|NCT02329730|7567951|FG009|Overall Study|Withdrawal by Subject|1
4671770|NCT02329730|7567952|FG010|Overall Study|Withdrawal by Subject|0
4671771|NCT02329730|7567953|FG011|Overall Study|Withdrawal by Subject|0
4671772|NCT02329743|7567974|FG000|Overall Study|Adverse Event|1
4671773|NCT02329743|7567975|FG001|Overall Study|Adverse Event|1
4671774|NCT02329743|7567976|FG002|Overall Study|Adverse Event|3
4671775|NCT02329743|7567974|FG000|Overall Study|Lost to Follow-up|1
4671776|NCT02329743|7567975|FG001|Overall Study|Lost to Follow-up|0
4671777|NCT02329743|7567976|FG002|Overall Study|Lost to Follow-up|1
4671778|NCT02329743|7567974|FG000|Overall Study|Withdrawal by Subject|4
4671779|NCT02329743|7567975|FG001|Overall Study|Withdrawal by Subject|4
4671780|NCT02329743|7567976|FG002|Overall Study|Withdrawal by Subject|1
4671781|NCT02329743|7567974|FG000|Overall Study|Other|0
4671782|NCT02329743|7567975|FG001|Overall Study|Other|2
4671783|NCT02329743|7567976|FG002|Overall Study|Other|3
4671784|NCT02330055|7567995|FG000|Overall Study|technical issues|2
4671785|NCT02330055|7567996|FG001|Overall Study|technical issues|0
4671786|NCT02330055|7567995|FG000|Overall Study|participant forgot to wear device|5
4671787|NCT02330055|7567996|FG001|Overall Study|participant forgot to wear device|5
4671788|NCT02330055|7567995|FG000|Overall Study|data for less than 60 minutes|3
4671789|NCT02330055|7567996|FG001|Overall Study|data for less than 60 minutes|3
4671790|NCT02330055|7567995|FG000|Overall Study|participant did not sleep|0
4671791|NCT02330055|7567996|FG001|Overall Study|participant did not sleep|1
4671792|NCT02330081|7568002|FG000|Overall Study|Adverse Event|1
4671793|NCT02330081|7568002|FG000|Overall Study|Donation did not meet criteria|1
4671794|NCT02330081|7568002|FG000|Overall Study|Protocol Violation|6
4671795|NCT02330549|7568060|FG000|Overall Study|Adverse Event|1
4671796|NCT02330549|7568061|FG001|Overall Study|Adverse Event|0
4671797|NCT02330549|7568060|FG000|Overall Study|Subject withdrew consent|2
4671798|NCT02330549|7568061|FG001|Overall Study|Subject withdrew consent|1
4671799|NCT02330549|7568060|FG000|Overall Study|Failure to meet randomization criteria|1
4671800|NCT02330549|7568061|FG001|Overall Study|Failure to meet randomization criteria|0
4671801|NCT02331368|7568149|FG000|Overall Study|Withdrawal by Subject|3
4755218|NCT02601209|7729674|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
4755219|NCT02601209|7729666|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
4755220|NCT02601209|7729667|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
4755221|NCT02601209|7729668|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
4755222|NCT02601209|7729669|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
4755223|NCT02601209|7729670|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1
4755224|NCT02601209|7729671|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2
4755225|NCT02601209|7729672|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1
4755226|NCT02601209|7729673|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
4755227|NCT02601209|7729674|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
4755228|NCT02587520|7729706|FG000|Overall Study|Protocol Violation|2
4755229|NCT02587520|7729707|FG001|Overall Study|Protocol Violation|0
4755230|NCT02587520|7729708|FG002|Overall Study|Protocol Violation|0
4755231|NCT02587520|7729709|FG003|Overall Study|Protocol Violation|2
4755232|NCT02587520|7729710|FG004|Overall Study|Protocol Violation|0
4755233|NCT02587520|7729711|FG005|Overall Study|Protocol Violation|1
4755234|NCT02587520|7729712|FG006|Overall Study|Protocol Violation|1
4755235|NCT02587520|7729713|FG007|Overall Study|Protocol Violation|1
4755236|NCT02587520|7729714|FG008|Overall Study|Protocol Violation|3
4755237|NCT02587520|7729715|FG009|Overall Study|Protocol Violation|3
4755238|NCT02587520|7729716|FG010|Overall Study|Protocol Violation|1
4755239|NCT02587520|7729717|FG011|Overall Study|Protocol Violation|2
4755240|NCT02587520|7729718|FG012|Overall Study|Protocol Violation|0
4755241|NCT02587520|7729719|FG013|Overall Study|Protocol Violation|0
4755242|NCT02587520|7729720|FG014|Overall Study|Protocol Violation|0
4755243|NCT02587520|7729721|FG015|Overall Study|Protocol Violation|0
4755244|NCT02587520|7729722|FG016|Overall Study|Protocol Violation|0
4755245|NCT02587520|7729723|FG017|Overall Study|Protocol Violation|0
4755246|NCT02587520|7729706|FG000|Overall Study|Adverse Event|0
4755247|NCT02587520|7729707|FG001|Overall Study|Adverse Event|0
4755248|NCT02587520|7729708|FG002|Overall Study|Adverse Event|0
4755249|NCT02587520|7729709|FG003|Overall Study|Adverse Event|0
4755250|NCT02587520|7729710|FG004|Overall Study|Adverse Event|0
4755251|NCT02587520|7729711|FG005|Overall Study|Adverse Event|0
4755252|NCT02587520|7729712|FG006|Overall Study|Adverse Event|0
4755253|NCT02587520|7729713|FG007|Overall Study|Adverse Event|0
4755254|NCT02587520|7729714|FG008|Overall Study|Adverse Event|0
4755255|NCT02587520|7729715|FG009|Overall Study|Adverse Event|0
4755256|NCT02587520|7729716|FG010|Overall Study|Adverse Event|0
4755257|NCT02587520|7729717|FG011|Overall Study|Adverse Event|1
4755258|NCT02587520|7729718|FG012|Overall Study|Adverse Event|0
4755259|NCT02587520|7729719|FG013|Overall Study|Adverse Event|0
4755260|NCT02587520|7729720|FG014|Overall Study|Adverse Event|0
4755261|NCT02587520|7729721|FG015|Overall Study|Adverse Event|0
4755262|NCT02587520|7729722|FG016|Overall Study|Adverse Event|0
4755263|NCT02587520|7729723|FG017|Overall Study|Adverse Event|0
4755264|NCT02587520|7729706|FG000|Overall Study|Withdrawal by Subject|0
4755265|NCT02587520|7729707|FG001|Overall Study|Withdrawal by Subject|0
4755266|NCT02587520|7729708|FG002|Overall Study|Withdrawal by Subject|1
4755267|NCT02587520|7729709|FG003|Overall Study|Withdrawal by Subject|1
4755268|NCT02587520|7729710|FG004|Overall Study|Withdrawal by Subject|0
4755269|NCT02587520|7729711|FG005|Overall Study|Withdrawal by Subject|1
4755270|NCT02587520|7729712|FG006|Overall Study|Withdrawal by Subject|1
4755271|NCT02587520|7729713|FG007|Overall Study|Withdrawal by Subject|0
4755272|NCT02587520|7729714|FG008|Overall Study|Withdrawal by Subject|0
4755273|NCT02587520|7729715|FG009|Overall Study|Withdrawal by Subject|0
4755274|NCT02587520|7729716|FG010|Overall Study|Withdrawal by Subject|0
4755275|NCT02587520|7729717|FG011|Overall Study|Withdrawal by Subject|0
4755276|NCT02587520|7729718|FG012|Overall Study|Withdrawal by Subject|0
4755277|NCT02587520|7729719|FG013|Overall Study|Withdrawal by Subject|1
4755278|NCT02587520|7729720|FG014|Overall Study|Withdrawal by Subject|0
4755279|NCT02587520|7729721|FG015|Overall Study|Withdrawal by Subject|0
4755280|NCT02587520|7729722|FG016|Overall Study|Withdrawal by Subject|0
4755281|NCT02587520|7729723|FG017|Overall Study|Withdrawal by Subject|0
4755282|NCT02587520|7729706|FG000|Overall Study|Lost to Follow-up|0
4755283|NCT02587520|7729707|FG001|Overall Study|Lost to Follow-up|2
4755284|NCT02587520|7729708|FG002|Overall Study|Lost to Follow-up|0
4755285|NCT02587520|7729709|FG003|Overall Study|Lost to Follow-up|2
4755286|NCT02587520|7729710|FG004|Overall Study|Lost to Follow-up|0
4755287|NCT02587520|7729711|FG005|Overall Study|Lost to Follow-up|1
4755288|NCT02587520|7729712|FG006|Overall Study|Lost to Follow-up|1
4755289|NCT02587520|7729713|FG007|Overall Study|Lost to Follow-up|1
4755290|NCT02587520|7729714|FG008|Overall Study|Lost to Follow-up|0
4755291|NCT02587520|7729715|FG009|Overall Study|Lost to Follow-up|2
4755292|NCT02587520|7729716|FG010|Overall Study|Lost to Follow-up|2
4755293|NCT02587520|7729717|FG011|Overall Study|Lost to Follow-up|1
4755294|NCT02587520|7729718|FG012|Overall Study|Lost to Follow-up|0
4755295|NCT02587520|7729719|FG013|Overall Study|Lost to Follow-up|0
4755296|NCT02587520|7729720|FG014|Overall Study|Lost to Follow-up|0
4671802|NCT02331394|7568153|FG000|Overall Study|Disease progression|1
4671803|NCT02331446|7568172|FG000|Overall Study|Lost to Follow-up|2
4671804|NCT02331446|7568173|FG001|Overall Study|Lost to Follow-up|1
4671805|NCT02331446|7568174|FG002|Overall Study|Lost to Follow-up|0
4671806|NCT02331446|7568175|FG003|Overall Study|Lost to Follow-up|1
4671807|NCT02331446|7568172|FG000|Overall Study|Personal Problem|2
4671808|NCT02331446|7568173|FG001|Overall Study|Personal Problem|0
4671809|NCT02331446|7568174|FG002|Overall Study|Personal Problem|0
4671810|NCT02331446|7568175|FG003|Overall Study|Personal Problem|0
4671811|NCT02331446|7568172|FG000|Overall Study|Disease|0
4671812|NCT02331446|7568173|FG001|Overall Study|Disease|2
4671813|NCT02331446|7568174|FG002|Overall Study|Disease|2
4671814|NCT02331446|7568175|FG003|Overall Study|Disease|1
4671815|NCT02331446|7568172|FG000|Overall Study|Physician Decision|0
4671816|NCT02331446|7568173|FG001|Overall Study|Physician Decision|1
4671817|NCT02331446|7568174|FG002|Overall Study|Physician Decision|0
4671818|NCT02331446|7568175|FG003|Overall Study|Physician Decision|1
4671819|NCT02331446|7568172|FG000|Overall Study|Lost before baseline analysis|0
4671820|NCT02331446|7568173|FG001|Overall Study|Lost before baseline analysis|1
4671821|NCT02331446|7568174|FG002|Overall Study|Lost before baseline analysis|1
4671822|NCT02331446|7568175|FG003|Overall Study|Lost before baseline analysis|0
4671823|NCT02331680|7568197|FG000|Overall Study|Adverse Event|3
4671824|NCT02331680|7568198|FG001|Overall Study|Adverse Event|0
4671825|NCT02331680|7568199|FG002|Overall Study|Adverse Event|2
4671826|NCT02331680|7568197|FG000|Overall Study|Physician Decision|1
4671827|NCT02331680|7568198|FG001|Overall Study|Physician Decision|1
4671828|NCT02331680|7568199|FG002|Overall Study|Physician Decision|2
4671829|NCT02331680|7568197|FG000|Overall Study|Withdrawal by Subject|0
4671830|NCT02331680|7568198|FG001|Overall Study|Withdrawal by Subject|1
4671831|NCT02331680|7568199|FG002|Overall Study|Withdrawal by Subject|2
4671832|NCT02331680|7568197|FG000|Overall Study|Met withdrawal criteria|2
4671833|NCT02331680|7568198|FG001|Overall Study|Met withdrawal criteria|2
4671834|NCT02331680|7568199|FG002|Overall Study|Met withdrawal criteria|5
4755297|NCT02587520|7729721|FG015|Overall Study|Lost to Follow-up|0
4755298|NCT02587520|7729722|FG016|Overall Study|Lost to Follow-up|0
4755299|NCT02587520|7729723|FG017|Overall Study|Lost to Follow-up|0
4755300|NCT02584829|7729763|FG000|Overall Study|Physician Decision|1
4755301|NCT02584829|7729764|FG001|Overall Study|Physician Decision|0
4755302|NCT02584829|7729763|FG000|Overall Study|Withdrawal by Subject|0
4755303|NCT02584829|7729764|FG001|Overall Study|Withdrawal by Subject|1
4755304|NCT02584829|7729763|FG000|Overall Study|Progressive Disease|0
4755305|NCT02584829|7729764|FG001|Overall Study|Progressive Disease|3
4755306|NCT02570308|7729777|FG000|Overall Study|Death|1
4755307|NCT02570308|7729778|FG001|Overall Study|Death|5
4755308|NCT02570308|7729779|FG002|Overall Study|Death|4
4755309|NCT02570308|7729780|FG003|Overall Study|Death|4
4755310|NCT02570308|7729781|FG004|Overall Study|Death|69
4755311|NCT02570308|7729777|FG000|Overall Study|Lost to Follow-up|0
4755312|NCT02570308|7729778|FG001|Overall Study|Lost to Follow-up|0
4755313|NCT02570308|7729779|FG002|Overall Study|Lost to Follow-up|0
4755314|NCT02570308|7729780|FG003|Overall Study|Lost to Follow-up|0
4755315|NCT02570308|7729781|FG004|Overall Study|Lost to Follow-up|2
4755316|NCT02570308|7729777|FG000|Overall Study|Withdrawal by Subject|0
4755317|NCT02570308|7729778|FG001|Overall Study|Withdrawal by Subject|0
4755318|NCT02570308|7729779|FG002|Overall Study|Withdrawal by Subject|0
4755319|NCT02570308|7729780|FG003|Overall Study|Withdrawal by Subject|0
4755320|NCT02570308|7729781|FG004|Overall Study|Withdrawal by Subject|1
4755321|NCT02570308|7729777|FG000|Overall Study|Other|0
4755322|NCT02570308|7729778|FG001|Overall Study|Other|0
4755323|NCT02570308|7729779|FG002|Overall Study|Other|0
4755324|NCT02570308|7729780|FG003|Overall Study|Other|0
4755325|NCT02570308|7729781|FG004|Overall Study|Other|2
4671835|NCT02331680|7568197|FG000|Overall Study|Non-compliance with study drug|0
4671836|NCT02331680|7568198|FG001|Overall Study|Non-compliance with study drug|0
4671837|NCT02331680|7568199|FG002|Overall Study|Non-compliance with study drug|1
4671838|NCT02331680|7568197|FG000|Overall Study|Protocol Violation|0
4671839|NCT02331680|7568198|FG001|Overall Study|Protocol Violation|0
4671840|NCT02331680|7568199|FG002|Overall Study|Protocol Violation|3
4671841|NCT02332239|7568222|FG000|Overall Study|Lost to Follow-up|4
4671842|NCT02332239|7568223|FG001|Overall Study|Lost to Follow-up|6
4671843|NCT02332291|7568233|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3
4671844|NCT02332291|7568234|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5
4671845|NCT02332291|7568233|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0
4671846|NCT02332291|7568234|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4
4671847|NCT02332291|7568233|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1
4671848|NCT02332291|7568234|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0
4671849|NCT02332291|7568233|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2
4671850|NCT02332291|7568234|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7
4671851|NCT02332291|7568233|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0
4671852|NCT02332291|7568234|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1
4671853|NCT02332291|7568233|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1
4671854|NCT02332291|7568234|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0
4671855|NCT02332707|7568262|FG000|Overall Study|Adverse Event|0
4671856|NCT02332707|7568263|FG001|Overall Study|Adverse Event|0
4671857|NCT02332707|7568264|FG002|Overall Study|Adverse Event|0
4671858|NCT02332707|7568265|FG003|Overall Study|Adverse Event|0
4671859|NCT02332707|7568266|FG004|Overall Study|Adverse Event|0
4671860|NCT02332707|7568267|FG005|Overall Study|Adverse Event|0
4671861|NCT02332707|7568268|FG006|Overall Study|Adverse Event|0
4671862|NCT02332707|7568269|FG007|Overall Study|Adverse Event|0
4671863|NCT02332707|7568270|FG008|Overall Study|Adverse Event|0
4671864|NCT02332707|7568271|FG009|Overall Study|Adverse Event|0
4671865|NCT02332707|7568272|FG010|Overall Study|Adverse Event|0
4671866|NCT02332707|7568273|FG011|Overall Study|Adverse Event|0
4671867|NCT02332707|7568274|FG012|Overall Study|Adverse Event|1
4671868|NCT02332707|7568275|FG013|Overall Study|Adverse Event|0
4671869|NCT02332707|7568276|FG014|Overall Study|Adverse Event|0
4671870|NCT02332707|7568277|FG015|Overall Study|Adverse Event|0
4671871|NCT02332707|7568278|FG016|Overall Study|Adverse Event|0
4671872|NCT02332707|7568279|FG017|Overall Study|Adverse Event|0
4671873|NCT02332707|7568262|FG000|Overall Study|Lost to Follow-up|0
4671874|NCT02332707|7568263|FG001|Overall Study|Lost to Follow-up|0
4671875|NCT02332707|7568264|FG002|Overall Study|Lost to Follow-up|0
4671876|NCT02332707|7568265|FG003|Overall Study|Lost to Follow-up|0
4671877|NCT02332707|7568266|FG004|Overall Study|Lost to Follow-up|0
4671878|NCT02332707|7568267|FG005|Overall Study|Lost to Follow-up|1
4671879|NCT02332707|7568268|FG006|Overall Study|Lost to Follow-up|0
4671880|NCT02332707|7568269|FG007|Overall Study|Lost to Follow-up|0
4671881|NCT02332707|7568270|FG008|Overall Study|Lost to Follow-up|0
4671882|NCT02332707|7568271|FG009|Overall Study|Lost to Follow-up|0
4671883|NCT02332707|7568272|FG010|Overall Study|Lost to Follow-up|2
4671884|NCT02332707|7568273|FG011|Overall Study|Lost to Follow-up|0
4671885|NCT02332707|7568274|FG012|Overall Study|Lost to Follow-up|3
4671886|NCT02332707|7568275|FG013|Overall Study|Lost to Follow-up|0
4671887|NCT02332707|7568276|FG014|Overall Study|Lost to Follow-up|0
4671888|NCT02332707|7568277|FG015|Overall Study|Lost to Follow-up|0
4671889|NCT02332707|7568278|FG016|Overall Study|Lost to Follow-up|0
4671890|NCT02332707|7568279|FG017|Overall Study|Lost to Follow-up|0
4671891|NCT02332707|7568262|FG000|Overall Study|Physician Decision|0
4671892|NCT02332707|7568263|FG001|Overall Study|Physician Decision|0
4671893|NCT02332707|7568264|FG002|Overall Study|Physician Decision|0
4671894|NCT02332707|7568265|FG003|Overall Study|Physician Decision|1
4671895|NCT02332707|7568266|FG004|Overall Study|Physician Decision|0
4671896|NCT02332707|7568267|FG005|Overall Study|Physician Decision|0
4671897|NCT02332707|7568268|FG006|Overall Study|Physician Decision|0
4671898|NCT02332707|7568269|FG007|Overall Study|Physician Decision|0
4671899|NCT02332707|7568270|FG008|Overall Study|Physician Decision|0
4671900|NCT02332707|7568271|FG009|Overall Study|Physician Decision|0
4671901|NCT02332707|7568272|FG010|Overall Study|Physician Decision|0
4671902|NCT02332707|7568273|FG011|Overall Study|Physician Decision|0
4671903|NCT02332707|7568274|FG012|Overall Study|Physician Decision|1
4671904|NCT02332707|7568275|FG013|Overall Study|Physician Decision|0
4671905|NCT02332707|7568276|FG014|Overall Study|Physician Decision|0
4671906|NCT02332707|7568277|FG015|Overall Study|Physician Decision|0
4671907|NCT02332707|7568278|FG016|Overall Study|Physician Decision|0
4671908|NCT02332707|7568279|FG017|Overall Study|Physician Decision|0
4671909|NCT02332707|7568262|FG000|Overall Study|Withdrawal by Subject|0
4671910|NCT02332707|7568263|FG001|Overall Study|Withdrawal by Subject|0
4671911|NCT02332707|7568264|FG002|Overall Study|Withdrawal by Subject|1
4671912|NCT02332707|7568265|FG003|Overall Study|Withdrawal by Subject|0
4671913|NCT02332707|7568266|FG004|Overall Study|Withdrawal by Subject|0
4671914|NCT02332707|7568267|FG005|Overall Study|Withdrawal by Subject|0
4671915|NCT02332707|7568268|FG006|Overall Study|Withdrawal by Subject|0
4671916|NCT02332707|7568269|FG007|Overall Study|Withdrawal by Subject|0
4671917|NCT02332707|7568270|FG008|Overall Study|Withdrawal by Subject|0
4671918|NCT02332707|7568271|FG009|Overall Study|Withdrawal by Subject|3
4671919|NCT02332707|7568272|FG010|Overall Study|Withdrawal by Subject|0
4671920|NCT02332707|7568273|FG011|Overall Study|Withdrawal by Subject|0
4671921|NCT02332707|7568274|FG012|Overall Study|Withdrawal by Subject|0
4671922|NCT02332707|7568275|FG013|Overall Study|Withdrawal by Subject|0
4671923|NCT02332707|7568276|FG014|Overall Study|Withdrawal by Subject|0
4671924|NCT02332707|7568277|FG015|Overall Study|Withdrawal by Subject|0
4671925|NCT02332707|7568278|FG016|Overall Study|Withdrawal by Subject|0
4671926|NCT02332707|7568279|FG017|Overall Study|Withdrawal by Subject|0
4671927|NCT02332720|7568340|FG000|Part A and Part B|Lost to Follow-up|1
4671928|NCT02332720|7568341|FG001|Part A and Part B|Lost to Follow-up|0
4671929|NCT02332720|7568342|FG002|Part A and Part B|Lost to Follow-up|0
4671930|NCT02332720|7568343|FG003|Part A and Part B|Lost to Follow-up|0
4671931|NCT02332720|7568344|FG004|Part A and Part B|Lost to Follow-up|0
4671932|NCT02332720|7568345|FG005|Part A and Part B|Lost to Follow-up|2
4671933|NCT02332720|7568346|FG006|Part A and Part B|Lost to Follow-up|1
4671934|NCT02332720|7568347|FG007|Part A and Part B|Lost to Follow-up|1
4671935|NCT02332720|7568348|FG008|Part A and Part B|Lost to Follow-up|0
4671936|NCT02332720|7568349|FG009|Part A and Part B|Lost to Follow-up|0
4671937|NCT02332720|7568350|FG010|Part A and Part B|Lost to Follow-up|0
4671938|NCT02332720|7568351|FG011|Part A and Part B|Lost to Follow-up|0
4671939|NCT02332720|7568352|FG012|Part A and Part B|Lost to Follow-up|0
4671940|NCT02332720|7568353|FG013|Part A and Part B|Lost to Follow-up|0
4671941|NCT02332720|7568354|FG014|Part A and Part B|Lost to Follow-up|0
4671942|NCT02332720|7568355|FG015|Part A and Part B|Lost to Follow-up|1
4671943|NCT02332720|7568356|FG016|Part A and Part B|Lost to Follow-up|0
4671944|NCT02332720|7568357|FG017|Part A and Part B|Lost to Follow-up|0
4671945|NCT02332720|7568358|FG018|Part A and Part B|Lost to Follow-up|0
4671946|NCT02332720|7568359|FG019|Part A and Part B|Lost to Follow-up|0
4671947|NCT02332720|7568360|FG020|Part A and Part B|Lost to Follow-up|0
4671948|NCT02332720|7568361|FG021|Part A and Part B|Lost to Follow-up|0
4671949|NCT02332720|7568362|FG022|Part A and Part B|Lost to Follow-up|0
4671950|NCT02332720|7568340|FG000|Part A and Part B|Adverse Event|0
4755326|NCT02516241|7729802|FG000|Overall Study|Death|255
4755327|NCT02516241|7729803|FG001|Overall Study|Death|262
4755328|NCT02516241|7729804|FG002|Overall Study|Death|270
4755329|NCT02516241|7729802|FG000|Overall Study|Lost to Follow-up|1
4755330|NCT02516241|7729803|FG001|Overall Study|Lost to Follow-up|1
4755331|NCT02516241|7729804|FG002|Overall Study|Lost to Follow-up|3
4755332|NCT02516241|7729802|FG000|Overall Study|Withdrawal by Subject|2
4755333|NCT02516241|7729803|FG001|Overall Study|Withdrawal by Subject|7
4755334|NCT02516241|7729804|FG002|Overall Study|Withdrawal by Subject|12
4755335|NCT02516241|7729802|FG000|Overall Study|participants ongoing at data cut-off|84
4755336|NCT02516241|7729803|FG001|Overall Study|participants ongoing at data cut-off|76
4755337|NCT02516241|7729804|FG002|Overall Study|participants ongoing at data cut-off|59
4755338|NCT02514083|7729817|FG000|Overall Study|Adverse Event|1
4755339|NCT02500797|7729829|FG000|Overall Study|Cancel (rapid disease progression)|0
4755340|NCT02500797|7729830|FG001|Overall Study|Cancel (rapid disease progression)|0
4755341|NCT02500797|7729831|FG002|Overall Study|Cancel (rapid disease progression)|0
4755342|NCT02500797|7729832|FG003|Overall Study|Cancel (rapid disease progression)|0
4755343|NCT02500797|7729833|FG004|Overall Study|Cancel (rapid disease progression)|1
4755344|NCT02500797|7729834|FG005|Overall Study|Cancel (rapid disease progression)|1
4755345|NCT02500797|7729835|FG006|Overall Study|Cancel (rapid disease progression)|0
4755346|NCT02500797|7729836|FG007|Overall Study|Cancel (rapid disease progression)|0
4755347|NCT02500797|7729829|FG000|Overall Study|Withdrawal by Subject|1
4755348|NCT02500797|7729830|FG001|Overall Study|Withdrawal by Subject|0
4755349|NCT02500797|7729831|FG002|Overall Study|Withdrawal by Subject|0
4755350|NCT02500797|7729832|FG003|Overall Study|Withdrawal by Subject|0
4671951|NCT02332720|7568341|FG001|Part A and Part B|Adverse Event|0
4671952|NCT02332720|7568342|FG002|Part A and Part B|Adverse Event|0
4671953|NCT02332720|7568343|FG003|Part A and Part B|Adverse Event|0
4671954|NCT02332720|7568344|FG004|Part A and Part B|Adverse Event|0
4671955|NCT02332720|7568345|FG005|Part A and Part B|Adverse Event|0
4671956|NCT02332720|7568346|FG006|Part A and Part B|Adverse Event|0
4671957|NCT02332720|7568347|FG007|Part A and Part B|Adverse Event|0
4671958|NCT02332720|7568348|FG008|Part A and Part B|Adverse Event|0
4671959|NCT02332720|7568349|FG009|Part A and Part B|Adverse Event|0
4671960|NCT02332720|7568350|FG010|Part A and Part B|Adverse Event|0
4671961|NCT02332720|7568351|FG011|Part A and Part B|Adverse Event|0
4671962|NCT02332720|7568352|FG012|Part A and Part B|Adverse Event|0
4671963|NCT02332720|7568353|FG013|Part A and Part B|Adverse Event|0
4671964|NCT02332720|7568354|FG014|Part A and Part B|Adverse Event|0
4671965|NCT02332720|7568355|FG015|Part A and Part B|Adverse Event|0
4671966|NCT02332720|7568356|FG016|Part A and Part B|Adverse Event|0
4671967|NCT02332720|7568357|FG017|Part A and Part B|Adverse Event|1
4671968|NCT02332720|7568358|FG018|Part A and Part B|Adverse Event|0
4671969|NCT02332720|7568359|FG019|Part A and Part B|Adverse Event|0
4671970|NCT02332720|7568360|FG020|Part A and Part B|Adverse Event|0
4671971|NCT02332720|7568361|FG021|Part A and Part B|Adverse Event|0
4671972|NCT02332720|7568362|FG022|Part A and Part B|Adverse Event|0
4671973|NCT02332720|7568340|FG000|Part A and Part B|Physician Decision|0
4671974|NCT02332720|7568341|FG001|Part A and Part B|Physician Decision|0
4671975|NCT02332720|7568342|FG002|Part A and Part B|Physician Decision|0
4671976|NCT02332720|7568343|FG003|Part A and Part B|Physician Decision|0
4671977|NCT02332720|7568344|FG004|Part A and Part B|Physician Decision|0
4671978|NCT02332720|7568345|FG005|Part A and Part B|Physician Decision|0
4671979|NCT02332720|7568346|FG006|Part A and Part B|Physician Decision|0
4671980|NCT02332720|7568347|FG007|Part A and Part B|Physician Decision|0
4671981|NCT02332720|7568348|FG008|Part A and Part B|Physician Decision|0
4671982|NCT02332720|7568349|FG009|Part A and Part B|Physician Decision|0
4671983|NCT02332720|7568350|FG010|Part A and Part B|Physician Decision|0
4671984|NCT02332720|7568351|FG011|Part A and Part B|Physician Decision|0
4671985|NCT02332720|7568352|FG012|Part A and Part B|Physician Decision|0
4671986|NCT02332720|7568353|FG013|Part A and Part B|Physician Decision|0
4671987|NCT02332720|7568354|FG014|Part A and Part B|Physician Decision|0
4755351|NCT02500797|7729833|FG004|Overall Study|Withdrawal by Subject|0
4755352|NCT02500797|7729834|FG005|Overall Study|Withdrawal by Subject|0
4755353|NCT02500797|7729835|FG006|Overall Study|Withdrawal by Subject|0
4755354|NCT02500797|7729836|FG007|Overall Study|Withdrawal by Subject|0
4671988|NCT02332720|7568355|FG015|Part A and Part B|Physician Decision|0
4671989|NCT02332720|7568356|FG016|Part A and Part B|Physician Decision|0
4671990|NCT02332720|7568357|FG017|Part A and Part B|Physician Decision|0
4671991|NCT02332720|7568358|FG018|Part A and Part B|Physician Decision|1
4671992|NCT02332720|7568359|FG019|Part A and Part B|Physician Decision|0
4671993|NCT02332720|7568360|FG020|Part A and Part B|Physician Decision|0
4671994|NCT02332720|7568361|FG021|Part A and Part B|Physician Decision|0
4671995|NCT02332720|7568362|FG022|Part A and Part B|Physician Decision|0
4671996|NCT02332720|7568340|FG000|Part A and Part B|Withdrawal by Subject|0
4671997|NCT02332720|7568341|FG001|Part A and Part B|Withdrawal by Subject|0
4671998|NCT02332720|7568342|FG002|Part A and Part B|Withdrawal by Subject|0
4671999|NCT02332720|7568343|FG003|Part A and Part B|Withdrawal by Subject|0
4672000|NCT02332720|7568344|FG004|Part A and Part B|Withdrawal by Subject|0
4672001|NCT02332720|7568345|FG005|Part A and Part B|Withdrawal by Subject|1
4672002|NCT02332720|7568346|FG006|Part A and Part B|Withdrawal by Subject|0
4672003|NCT02332720|7568347|FG007|Part A and Part B|Withdrawal by Subject|0
4672004|NCT02332720|7568348|FG008|Part A and Part B|Withdrawal by Subject|0
4672005|NCT02332720|7568349|FG009|Part A and Part B|Withdrawal by Subject|0
4672006|NCT02332720|7568350|FG010|Part A and Part B|Withdrawal by Subject|0
4672007|NCT02332720|7568351|FG011|Part A and Part B|Withdrawal by Subject|0
4672008|NCT02332720|7568352|FG012|Part A and Part B|Withdrawal by Subject|0
4672009|NCT02332720|7568353|FG013|Part A and Part B|Withdrawal by Subject|0
4672010|NCT02332720|7568354|FG014|Part A and Part B|Withdrawal by Subject|0
4672011|NCT02332720|7568355|FG015|Part A and Part B|Withdrawal by Subject|0
4672012|NCT02332720|7568356|FG016|Part A and Part B|Withdrawal by Subject|0
4672013|NCT02332720|7568357|FG017|Part A and Part B|Withdrawal by Subject|0
4672014|NCT02332720|7568358|FG018|Part A and Part B|Withdrawal by Subject|0
4672015|NCT02332720|7568359|FG019|Part A and Part B|Withdrawal by Subject|1
4672016|NCT02332720|7568360|FG020|Part A and Part B|Withdrawal by Subject|0
4672017|NCT02332720|7568361|FG021|Part A and Part B|Withdrawal by Subject|0
4672018|NCT02332720|7568362|FG022|Part A and Part B|Withdrawal by Subject|0
4672019|NCT02332798|7568427|FG000|Overall Study|Unwilling to Participate in Study|0
4672020|NCT02332798|7568428|FG001|Overall Study|Unwilling to Participate in Study|1
4672021|NCT02332798|7568429|FG002|Overall Study|Unwilling to Participate in Study|1
4672022|NCT02332798|7568427|FG000|Overall Study|Positive Urine Drug Test|0
4672023|NCT02332798|7568428|FG001|Overall Study|Positive Urine Drug Test|1
4755355|NCT02497612|7729865|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57
4755356|NCT02497612|7729866|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51
4755357|NCT02497612|7729867|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39
4755358|NCT02497612|7729868|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41
4755359|NCT02497612|7729865|FG000|Overall Study|Participant's request|2
4755360|NCT02497612|7729866|FG001|Overall Study|Participant's request|3
4755361|NCT02497612|7729867|FG002|Overall Study|Participant's request|4
4755362|NCT02497612|7729868|FG003|Overall Study|Participant's request|1
4755363|NCT02497612|7729865|FG000|Overall Study|Investigator's judgement|1
4755364|NCT02497612|7729866|FG001|Overall Study|Investigator's judgement|0
4755365|NCT02497612|7729867|FG002|Overall Study|Investigator's judgement|0
4672024|NCT02332798|7568429|FG002|Overall Study|Positive Urine Drug Test|0
4672025|NCT02332798|7568427|FG000|Overall Study|Abnormal Laboratory Findings|1
4672026|NCT02332798|7568428|FG001|Overall Study|Abnormal Laboratory Findings|0
4672027|NCT02332798|7568429|FG002|Overall Study|Abnormal Laboratory Findings|0
4672028|NCT02332824|7568443|FG000|Overall Study|Pretreatment Event/Adverse Event|4
4672029|NCT02332824|7568444|FG001|Overall Study|Pretreatment Event/Adverse Event|0
4672030|NCT02332824|7568445|FG002|Overall Study|Pretreatment Event/Adverse Event|1
4672031|NCT02332824|7568446|FG003|Overall Study|Pretreatment Event/Adverse Event|1
4672032|NCT02332824|7568447|FG004|Overall Study|Pretreatment Event/Adverse Event|4
4672033|NCT02332824|7568448|FG005|Overall Study|Pretreatment Event/Adverse Event|1
4672034|NCT02332824|7568443|FG000|Overall Study|Voluntary Withdrawal|1
4672035|NCT02332824|7568444|FG001|Overall Study|Voluntary Withdrawal|0
4672036|NCT02332824|7568445|FG002|Overall Study|Voluntary Withdrawal|0
4672037|NCT02332824|7568446|FG003|Overall Study|Voluntary Withdrawal|0
4672038|NCT02332824|7568447|FG004|Overall Study|Voluntary Withdrawal|0
4672039|NCT02332824|7568448|FG005|Overall Study|Voluntary Withdrawal|0
4672040|NCT02332824|7568443|FG000|Overall Study|Inconvenient schedule|1
4672041|NCT02332824|7568444|FG001|Overall Study|Inconvenient schedule|1
4672042|NCT02332824|7568445|FG002|Overall Study|Inconvenient schedule|0
4672043|NCT02332824|7568446|FG003|Overall Study|Inconvenient schedule|0
4672044|NCT02332824|7568447|FG004|Overall Study|Inconvenient schedule|0
4672045|NCT02332824|7568448|FG005|Overall Study|Inconvenient schedule|0
4672046|NCT02332824|7568443|FG000|Overall Study|Transfer|0
4672047|NCT02332824|7568444|FG001|Overall Study|Transfer|0
4672048|NCT02332824|7568445|FG002|Overall Study|Transfer|1
4672049|NCT02332824|7568446|FG003|Overall Study|Transfer|1
4672050|NCT02332824|7568447|FG004|Overall Study|Transfer|0
4672051|NCT02332824|7568448|FG005|Overall Study|Transfer|0
4672052|NCT02332876|7568473|FG000|Overall Study|Lost to Follow-up|1
4672053|NCT02332876|7568474|FG001|Overall Study|Lost to Follow-up|1
4672054|NCT02332889|7568480|FG000|Overall Study|Physician Decision|1
4672055|NCT02332915|7568490|FG000|Overall Study|Moved out of region|3
4672056|NCT02332915|7568491|FG001|Overall Study|Moved out of region|0
4672057|NCT02332915|7568490|FG000|Overall Study|Unrelated illness|1
4672058|NCT02332915|7568491|FG001|Overall Study|Unrelated illness|1
4672059|NCT02332915|7568490|FG000|Overall Study|Travel distance prohibitive|0
4672060|NCT02332915|7568491|FG001|Overall Study|Travel distance prohibitive|1
4672061|NCT02332915|7568490|FG000|Overall Study|did not meet inclusion criteria|2
4672062|NCT02332915|7568491|FG001|Overall Study|did not meet inclusion criteria|4
4672063|NCT02333331|7568526|FG000|Overall Study|Adverse Event|1
4672064|NCT02333331|7568527|FG001|Overall Study|Adverse Event|0
4672065|NCT02333331|7568528|FG002|Overall Study|Adverse Event|4
4672066|NCT02333331|7568529|FG003|Overall Study|Adverse Event|1
4672067|NCT02333331|7568526|FG000|Overall Study|Death|0
4672068|NCT02333331|7568527|FG001|Overall Study|Death|0
4672069|NCT02333331|7568528|FG002|Overall Study|Death|2
4672070|NCT02333331|7568529|FG003|Overall Study|Death|0
4672071|NCT02333331|7568526|FG000|Overall Study|Lost to Follow-up|0
4672072|NCT02333331|7568527|FG001|Overall Study|Lost to Follow-up|0
4672073|NCT02333331|7568528|FG002|Overall Study|Lost to Follow-up|1
4672074|NCT02333331|7568529|FG003|Overall Study|Lost to Follow-up|0
4672075|NCT02333331|7568526|FG000|Overall Study|Physician Decision|0
4672076|NCT02333331|7568527|FG001|Overall Study|Physician Decision|1
4672077|NCT02333331|7568528|FG002|Overall Study|Physician Decision|0
4672078|NCT02333331|7568529|FG003|Overall Study|Physician Decision|0
4672079|NCT02333331|7568526|FG000|Overall Study|Protocol Deviation|0
4672080|NCT02333331|7568527|FG001|Overall Study|Protocol Deviation|3
4672081|NCT02333331|7568528|FG002|Overall Study|Protocol Deviation|2
4672082|NCT02333331|7568529|FG003|Overall Study|Protocol Deviation|1
4672083|NCT02333331|7568526|FG000|Overall Study|Patient/Guardian Decision|1
4672084|NCT02333331|7568527|FG001|Overall Study|Patient/Guardian Decision|2
4672085|NCT02333331|7568528|FG002|Overall Study|Patient/Guardian Decision|9
4672086|NCT02333331|7568529|FG003|Overall Study|Patient/Guardian Decision|1
4672087|NCT02333383|7568539|FG000|Overall Study|Adalimumab discontinuation|21
4672088|NCT02333383|7568539|FG000|Overall Study|Lost to Follow-up|15
4672089|NCT02333383|7568539|FG000|Overall Study|Withdrawal by Subject|3
4672090|NCT02333383|7568539|FG000|Overall Study|Transfer to another hospital|2
4672091|NCT02333487|7568546|FG000|Overall Study|Adverse Event|0
4672092|NCT02333487|7568547|FG001|Overall Study|Adverse Event|2
4672093|NCT02333487|7568548|FG002|Overall Study|Adverse Event|0
4672094|NCT02333630|7568559|FG000|Overall Study|Lost to Follow-up|5
4672095|NCT02333630|7568560|FG001|Overall Study|Lost to Follow-up|2
4672096|NCT02334215|7568586|FG000|Overall Study|Death|1
4672097|NCT02334215|7568587|FG001|Overall Study|Death|1
4672098|NCT02334215|7568588|FG002|Overall Study|Death|0
4672099|NCT02334215|7568586|FG000|Overall Study|Lost to Follow-up|1
4672100|NCT02334215|7568587|FG001|Overall Study|Lost to Follow-up|0
4672101|NCT02334215|7568588|FG002|Overall Study|Lost to Follow-up|4
4672102|NCT02334215|7568586|FG000|Overall Study|Withdrawal by Subject|2
4672103|NCT02334215|7568587|FG001|Overall Study|Withdrawal by Subject|2
4672104|NCT02334215|7568588|FG002|Overall Study|Withdrawal by Subject|1
4672105|NCT02334215|7568586|FG000|Overall Study|Not released from incarceration on time|3
4672106|NCT02334215|7568587|FG001|Overall Study|Not released from incarceration on time|3
4672107|NCT02334215|7568588|FG002|Overall Study|Not released from incarceration on time|3
4672108|NCT02334215|7568586|FG000|Overall Study|Incarcerated|0
4672109|NCT02334215|7568587|FG001|Overall Study|Incarcerated|0
4672110|NCT02334215|7568588|FG002|Overall Study|Incarcerated|7
4672111|NCT02334306|7568613|FG000|Double-blind Period|Adverse Event|0
4672112|NCT02334306|7568614|FG001|Double-blind Period|Adverse Event|1
4672113|NCT02334306|7568613|FG000|Double-blind Period|Withdrawal by Subject|1
4672114|NCT02334306|7568614|FG001|Double-blind Period|Withdrawal by Subject|1
4672115|NCT02334384|7568627|FG000|Overall Study|Lost to Follow-up|1
4672116|NCT02334384|7568628|FG001|Overall Study|Lost to Follow-up|1
4672117|NCT02334423|7568636|FG000|Overall Study|Protocol Violation|10
4672118|NCT02334423|7568637|FG001|Overall Study|Protocol Violation|3
4672119|NCT02334683|7568662|FG000|First 12 Week Period|Lost to Follow-up|1
4672120|NCT02334683|7568663|FG001|First 12 Week Period|Lost to Follow-up|0
4672121|NCT02334683|7568662|FG000|Second 12 Week Period|Adverse Event|0
4672122|NCT02334683|7568663|FG001|Second 12 Week Period|Adverse Event|1
4672123|NCT02334748|7568669|FG000|Overall Study|Adverse Event|1
4672124|NCT02334748|7568669|FG000|Overall Study|Inclusion in the CACZ8852306 study|1
4672125|NCT02334748|7568669|FG000|Overall Study|Patient no longer required study drug|2
4672126|NCT02334748|7568669|FG000|Overall Study|Lack of Efficacy|4
4672127|NCT02335346|7568804|FG000|Overall Study|Adverse Event|11
4672128|NCT02335346|7568804|FG000|Overall Study|Withdrawal by Subject|1
4672129|NCT02335450|7568808|FG000|Overall Study|Pregnancy|1
4672130|NCT02335489|7568818|FG000|Overall Study|Sponsor terminated study|4
4672131|NCT02335489|7568818|FG000|Overall Study|Lost to Follow-up|1
4672132|NCT02335489|7568818|FG000|Overall Study|Withdrawal by Subject|2
4672133|NCT02335489|7568818|FG000|Overall Study|Physician Decision|2
4672134|NCT02335489|7568818|FG000|Overall Study|Lack of Efficacy|1
4672135|NCT02335983|7568845|FG000|Overall Study|Sponsor Decision|0
4672136|NCT02335983|7568846|FG001|Overall Study|Sponsor Decision|0
4672137|NCT02335983|7568847|FG002|Overall Study|Sponsor Decision|1
4672138|NCT02335983|7568848|FG003|Overall Study|Sponsor Decision|1
4672139|NCT02335983|7568849|FG004|Overall Study|Sponsor Decision|0
4672140|NCT02335983|7568850|FG005|Overall Study|Sponsor Decision|1
4672141|NCT02335983|7568845|FG000|Overall Study|Withdrawal by Subject|3
4672142|NCT02335983|7568846|FG001|Overall Study|Withdrawal by Subject|2
4672143|NCT02335983|7568847|FG002|Overall Study|Withdrawal by Subject|2
4672144|NCT02335983|7568848|FG003|Overall Study|Withdrawal by Subject|1
4672145|NCT02335983|7568849|FG004|Overall Study|Withdrawal by Subject|3
4672146|NCT02335983|7568850|FG005|Overall Study|Withdrawal by Subject|9
4672147|NCT02335983|7568845|FG000|Overall Study|Death|0
4672148|NCT02335983|7568846|FG001|Overall Study|Death|0
4672149|NCT02335983|7568847|FG002|Overall Study|Death|2
4672150|NCT02335983|7568848|FG003|Overall Study|Death|0
4672151|NCT02335983|7568849|FG004|Overall Study|Death|0
4672152|NCT02335983|7568850|FG005|Overall Study|Death|0
4672153|NCT02335983|7568845|FG000|Overall Study|Lost to Follow-up|0
4672154|NCT02335983|7568846|FG001|Overall Study|Lost to Follow-up|0
4672155|NCT02335983|7568847|FG002|Overall Study|Lost to Follow-up|0
4672156|NCT02335983|7568848|FG003|Overall Study|Lost to Follow-up|0
4672157|NCT02335983|7568849|FG004|Overall Study|Lost to Follow-up|0
4672158|NCT02335983|7568850|FG005|Overall Study|Lost to Follow-up|1
4672159|NCT02335983|7568845|FG000|Overall Study|Protocol Specified Criteria|5
4672160|NCT02335983|7568846|FG001|Overall Study|Protocol Specified Criteria|7
4672161|NCT02335983|7568847|FG002|Overall Study|Protocol Specified Criteria|27
4672162|NCT02335983|7568848|FG003|Overall Study|Protocol Specified Criteria|7
4672163|NCT02335983|7568849|FG004|Overall Study|Protocol Specified Criteria|5
4672164|NCT02335983|7568850|FG005|Overall Study|Protocol Specified Criteria|21
4672165|NCT02336074|7568875|FG000|Overall Study|Adverse Event|0
4672166|NCT02336074|7568876|FG001|Overall Study|Adverse Event|2
4672167|NCT02336165|7568892|FG000|Overall Study|Death|3
4672168|NCT02336165|7568893|FG001|Overall Study|Death|0
4672169|NCT02336165|7568894|FG002|Overall Study|Death|0
4672170|NCT02336165|7568895|FG003|Overall Study|Death|0
4672171|NCT02336165|7568896|FG004|Overall Study|Death|1
4672172|NCT02336165|7568892|FG000|Overall Study|Physician Decision|2
4672173|NCT02336165|7568893|FG001|Overall Study|Physician Decision|2
4672174|NCT02336165|7568894|FG002|Overall Study|Physician Decision|1
4672175|NCT02336165|7568895|FG003|Overall Study|Physician Decision|1
4672176|NCT02336165|7568896|FG004|Overall Study|Physician Decision|0
4672177|NCT02336165|7568892|FG000|Overall Study|Withdrawal by Subject|0
4672178|NCT02336165|7568893|FG001|Overall Study|Withdrawal by Subject|0
4672179|NCT02336165|7568894|FG002|Overall Study|Withdrawal by Subject|1
4672180|NCT02336165|7568895|FG003|Overall Study|Withdrawal by Subject|0
4672181|NCT02336165|7568896|FG004|Overall Study|Withdrawal by Subject|1
4672182|NCT02336165|7568892|FG000|Overall Study|Adverse Event|4
4672183|NCT02336165|7568893|FG001|Overall Study|Adverse Event|1
4672184|NCT02336165|7568894|FG002|Overall Study|Adverse Event|2
4672185|NCT02336165|7568895|FG003|Overall Study|Adverse Event|4
4672186|NCT02336165|7568896|FG004|Overall Study|Adverse Event|1
4672187|NCT02336165|7568892|FG000|Overall Study|Progressive disease|23
4672188|NCT02336165|7568893|FG001|Overall Study|Progressive disease|22
4672189|NCT02336165|7568894|FG002|Overall Study|Progressive disease|27
4672190|NCT02336165|7568895|FG003|Overall Study|Progressive disease|24
4672191|NCT02336165|7568896|FG004|Overall Study|Progressive disease|19
4672192|NCT02336165|7568892|FG000|Overall Study|Non-compliance|1
4672193|NCT02336165|7568893|FG001|Overall Study|Non-compliance|0
4672194|NCT02336165|7568894|FG002|Overall Study|Non-compliance|0
4672195|NCT02336165|7568895|FG003|Overall Study|Non-compliance|1
4672196|NCT02336165|7568896|FG004|Overall Study|Non-compliance|0
4672197|NCT02336165|7568892|FG000|Overall Study|Other|1
4672198|NCT02336165|7568893|FG001|Overall Study|Other|0
4672199|NCT02336165|7568894|FG002|Overall Study|Other|0
4672200|NCT02336165|7568895|FG003|Overall Study|Other|1
4672201|NCT02336165|7568896|FG004|Overall Study|Other|0
4672202|NCT02336178|7568912|FG000|Overall Study|Lost to Follow-up|1
4672203|NCT02336178|7568912|FG000|Overall Study|Protocol Violation|1
4672204|NCT02336178|7568912|FG000|Overall Study|Withdrawal by Subject|1
4672205|NCT02336178|7568912|FG000|Overall Study|Other|1
4672206|NCT02336282|7568924|FG000|Overall Study|Unrelated illness|1
4672207|NCT02336282|7568924|FG000|Overall Study|Uncomfortable with technology|1
4672208|NCT02336282|7568924|FG000|Overall Study|Lost to Follow-up|1
4672209|NCT02336282|7568924|FG000|Overall Study|Not enough time to complete sessions|2
4672210|NCT02336373|7568940|FG000|Overall Study|Protocol closed early|4
4672211|NCT02336373|7568940|FG000|Overall Study|Physician Decision|14
4672212|NCT02336451|7568955|FG000|Overall Study|Adverse Event|1
4672213|NCT02336451|7568956|FG001|Overall Study|Adverse Event|2
4672214|NCT02336451|7568957|FG002|Overall Study|Adverse Event|0
4672215|NCT02336451|7568958|FG003|Overall Study|Adverse Event|6
4672216|NCT02336451|7568959|FG004|Overall Study|Adverse Event|4
4672217|NCT02336451|7568955|FG000|Overall Study|Death|6
4672218|NCT02336451|7568956|FG001|Overall Study|Death|2
4672219|NCT02336451|7568957|FG002|Overall Study|Death|3
4672220|NCT02336451|7568958|FG003|Overall Study|Death|6
4672221|NCT02336451|7568959|FG004|Overall Study|Death|6
4672222|NCT02336451|7568955|FG000|Overall Study|Physician Decision|9
4672223|NCT02336451|7568956|FG001|Overall Study|Physician Decision|6
4672224|NCT02336451|7568957|FG002|Overall Study|Physician Decision|7
4672225|NCT02336451|7568958|FG003|Overall Study|Physician Decision|16
4672226|NCT02336451|7568959|FG004|Overall Study|Physician Decision|3
4672227|NCT02336451|7568955|FG000|Overall Study|Progressive disease|23
4672228|NCT02336451|7568956|FG001|Overall Study|Progressive disease|26
4672229|NCT02336451|7568957|FG002|Overall Study|Progressive disease|2
4672230|NCT02336451|7568958|FG003|Overall Study|Progressive disease|14
4672231|NCT02336451|7568959|FG004|Overall Study|Progressive disease|4
4672232|NCT02336451|7568955|FG000|Overall Study|Protocol Violation|1
4672233|NCT02336451|7568956|FG001|Overall Study|Protocol Violation|0
4672234|NCT02336451|7568957|FG002|Overall Study|Protocol Violation|0
4672235|NCT02336451|7568958|FG003|Overall Study|Protocol Violation|0
4672236|NCT02336451|7568959|FG004|Overall Study|Protocol Violation|0
4672237|NCT02336451|7568955|FG000|Overall Study|Patient/guardian decision|2
4672238|NCT02336451|7568956|FG001|Overall Study|Patient/guardian decision|4
4672239|NCT02336451|7568957|FG002|Overall Study|Patient/guardian decision|0
4672240|NCT02336451|7568958|FG003|Overall Study|Patient/guardian decision|2
4672241|NCT02336451|7568959|FG004|Overall Study|Patient/guardian decision|1
4672242|NCT02336555|7568975|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4672243|NCT02336555|7568976|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
4672244|NCT02336555|7568975|FG000|Treatment Period 1 (28 Days)|Physician Decision|2
4672245|NCT02336555|7568976|FG001|Treatment Period 1 (28 Days)|Physician Decision|0
4672246|NCT02336555|7568975|FG000|Treatment Period 2 (28 Days)|Adverse Event|0
4672247|NCT02336555|7568976|FG001|Treatment Period 2 (28 Days)|Adverse Event|1
4672248|NCT02336607|7569006|FG000|Overall Study|Physician Decision|1
4672249|NCT02336607|7569007|FG001|Overall Study|Physician Decision|4
4672250|NCT02336607|7569008|FG002|Overall Study|Physician Decision|3
4672251|NCT02336607|7569009|FG003|Overall Study|Physician Decision|15
4672252|NCT02336607|7569006|FG000|Overall Study|Lack of Efficacy|1
4672253|NCT02336607|7569007|FG001|Overall Study|Lack of Efficacy|0
4672254|NCT02336607|7569008|FG002|Overall Study|Lack of Efficacy|0
4755366|NCT02497612|7729868|FG003|Overall Study|Investigator's judgement|2
4755367|NCT02497612|7729865|FG000|Overall Study|Adverse Event|3
4755368|NCT02497612|7729866|FG001|Overall Study|Adverse Event|1
4755369|NCT02497612|7729867|FG002|Overall Study|Adverse Event|4
4755370|NCT02497612|7729868|FG003|Overall Study|Adverse Event|1
4755371|NCT02497612|7729865|FG000|Overall Study|Lost to Follow-up|1
4755372|NCT02497612|7729866|FG001|Overall Study|Lost to Follow-up|1
4755373|NCT02497612|7729867|FG002|Overall Study|Lost to Follow-up|0
4755374|NCT02497612|7729868|FG003|Overall Study|Lost to Follow-up|1
4755375|NCT02497612|7729865|FG000|Overall Study|Other unspecified|1
4755376|NCT02497612|7729866|FG001|Overall Study|Other unspecified|1
4755377|NCT02497612|7729867|FG002|Overall Study|Other unspecified|2
4755378|NCT02497612|7729868|FG003|Overall Study|Other unspecified|0
4755379|NCT02497612|7729865|FG000|Overall Study|Not eligible|1
4755380|NCT02497612|7729866|FG001|Overall Study|Not eligible|0
4755381|NCT02497612|7729867|FG002|Overall Study|Not eligible|0
4755382|NCT02497612|7729868|FG003|Overall Study|Not eligible|1
4755383|NCT02460458|7729878|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analyses|47
4755384|NCT02460458|7729878|FG000|Confirmatory Phase|Patients excluded due to lack of samples for central analyses|27
4755385|NCT02460458|7729878|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|14
4755386|NCT02460458|7729878|FG000|First Prospective Phase|Lost to Follow-up|16
4755387|NCT02460458|7729878|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|9
4755388|NCT02457559|7729893|FG000|Overall Study|Progressive Disease|1
4755389|NCT02457559|7729894|FG001|Overall Study|Progressive Disease|2
4755390|NCT02457559|7729895|FG002|Overall Study|Progressive Disease|3
4755391|NCT02457559|7729896|FG003|Overall Study|Progressive Disease|0
4755392|NCT02457559|7729897|FG004|Overall Study|Progressive Disease|0
4755393|NCT02457559|7729898|FG005|Overall Study|Progressive Disease|2
4755394|NCT02457559|7729899|FG006|Overall Study|Progressive Disease|1
4755395|NCT02457559|7729900|FG007|Overall Study|Progressive Disease|0
4755396|NCT02457559|7729901|FG008|Overall Study|Progressive Disease|1
4755397|NCT02457559|7729902|FG009|Overall Study|Progressive Disease|1
4755398|NCT02457559|7729903|FG010|Overall Study|Progressive Disease|1
4755399|NCT02457559|7729893|FG000|Overall Study|Investigator's Discretion|0
4755400|NCT02457559|7729894|FG001|Overall Study|Investigator's Discretion|0
4755401|NCT02457559|7729895|FG002|Overall Study|Investigator's Discretion|2
4755402|NCT02457559|7729896|FG003|Overall Study|Investigator's Discretion|0
4755403|NCT02457559|7729897|FG004|Overall Study|Investigator's Discretion|1
4755404|NCT02457559|7729898|FG005|Overall Study|Investigator's Discretion|0
4755405|NCT02457559|7729899|FG006|Overall Study|Investigator's Discretion|1
4755406|NCT02457559|7729900|FG007|Overall Study|Investigator's Discretion|0
4672255|NCT02336607|7569009|FG003|Overall Study|Lack of Efficacy|2
4672256|NCT02336607|7569006|FG000|Overall Study|Lost to Follow-up|2
4672257|NCT02336607|7569007|FG001|Overall Study|Lost to Follow-up|1
4672258|NCT02336607|7569008|FG002|Overall Study|Lost to Follow-up|0
4672259|NCT02336607|7569009|FG003|Overall Study|Lost to Follow-up|21
4672260|NCT02336607|7569006|FG000|Overall Study|Protocol Violation|0
4672261|NCT02336607|7569007|FG001|Overall Study|Protocol Violation|1
4672262|NCT02336607|7569008|FG002|Overall Study|Protocol Violation|1
4672263|NCT02336607|7569009|FG003|Overall Study|Protocol Violation|3
4672264|NCT02336607|7569006|FG000|Overall Study|Adverse Event|0
4672265|NCT02336607|7569007|FG001|Overall Study|Adverse Event|2
4672266|NCT02336607|7569008|FG002|Overall Study|Adverse Event|2
4672267|NCT02336607|7569009|FG003|Overall Study|Adverse Event|26
4672268|NCT02336607|7569006|FG000|Overall Study|Withdrawal by Subject|0
4672269|NCT02336607|7569007|FG001|Overall Study|Withdrawal by Subject|2
4672270|NCT02336607|7569008|FG002|Overall Study|Withdrawal by Subject|0
4672271|NCT02336607|7569009|FG003|Overall Study|Withdrawal by Subject|20
4672272|NCT02336737|7569019|FG000|Overall Study|Withdrawal by Subject|5
4672273|NCT02336737|7569019|FG000|Overall Study|Physician Decision|8
4672274|NCT02336815|7569026|FG000|Overall Study|Disease Progression|45
4672275|NCT02336815|7569027|FG001|Overall Study|Disease Progression|70
4672276|NCT02336815|7569026|FG000|Overall Study|Adverse Event|18
4672277|NCT02336815|7569027|FG001|Overall Study|Adverse Event|39
4672278|NCT02336815|7569026|FG000|Overall Study|Physician Decision|11
4672279|NCT02336815|7569027|FG001|Overall Study|Physician Decision|4
4672280|NCT02336815|7569026|FG000|Overall Study|Withdrawal by Subject|3
4672281|NCT02336815|7569027|FG001|Overall Study|Withdrawal by Subject|2
4672282|NCT02336815|7569026|FG000|Overall Study|Lost to Follow-up|1
4672283|NCT02336815|7569027|FG001|Overall Study|Lost to Follow-up|3
4672284|NCT02336815|7569026|FG000|Overall Study|Other|1
4672285|NCT02336815|7569027|FG001|Overall Study|Other|5
4672286|NCT02337361|7569066|FG000|3-month Follow-up|Lost to Follow-up|19
4755407|NCT02457559|7729901|FG008|Overall Study|Investigator's Discretion|1
4755408|NCT02457559|7729902|FG009|Overall Study|Investigator's Discretion|0
4755409|NCT02457559|7729903|FG010|Overall Study|Investigator's Discretion|1
4755410|NCT02457559|7729893|FG000|Overall Study|Adverse Event|0
4755411|NCT02457559|7729894|FG001|Overall Study|Adverse Event|1
4755412|NCT02457559|7729895|FG002|Overall Study|Adverse Event|2
4755413|NCT02457559|7729896|FG003|Overall Study|Adverse Event|0
4755414|NCT02457559|7729897|FG004|Overall Study|Adverse Event|0
4755415|NCT02457559|7729898|FG005|Overall Study|Adverse Event|0
4755416|NCT02457559|7729899|FG006|Overall Study|Adverse Event|0
4755417|NCT02457559|7729900|FG007|Overall Study|Adverse Event|0
4755418|NCT02457559|7729901|FG008|Overall Study|Adverse Event|0
4755419|NCT02457559|7729902|FG009|Overall Study|Adverse Event|0
4755420|NCT02457559|7729903|FG010|Overall Study|Adverse Event|0
4755421|NCT02457559|7729893|FG000|Overall Study|Reason not Specified|1
4755422|NCT02457559|7729894|FG001|Overall Study|Reason not Specified|0
4755423|NCT02457559|7729895|FG002|Overall Study|Reason not Specified|0
4755424|NCT02457559|7729896|FG003|Overall Study|Reason not Specified|0
4755425|NCT02457559|7729897|FG004|Overall Study|Reason not Specified|0
4755426|NCT02457559|7729898|FG005|Overall Study|Reason not Specified|0
4755427|NCT02457559|7729899|FG006|Overall Study|Reason not Specified|0
4755428|NCT02457559|7729900|FG007|Overall Study|Reason not Specified|0
4755429|NCT02457559|7729901|FG008|Overall Study|Reason not Specified|0
4755430|NCT02457559|7729902|FG009|Overall Study|Reason not Specified|2
4755431|NCT02457559|7729903|FG010|Overall Study|Reason not Specified|0
4755432|NCT02457559|7729893|FG000|Overall Study|Death|0
4755433|NCT02457559|7729894|FG001|Overall Study|Death|0
4755434|NCT02457559|7729895|FG002|Overall Study|Death|0
4672287|NCT02337361|7569067|FG001|3-month Follow-up|Lost to Follow-up|14
4672288|NCT02337361|7569066|FG000|6-month Follow-up|Lost to Follow-up|2
4672289|NCT02337361|7569067|FG001|6-month Follow-up|Lost to Follow-up|4
4672290|NCT02337387|7569078|FG000|Overall Study|Adverse Event|0
4672291|NCT02337387|7569079|FG001|Overall Study|Adverse Event|1
4672292|NCT02337387|7569080|FG002|Overall Study|Adverse Event|0
4672293|NCT02337387|7569081|FG003|Overall Study|Adverse Event|0
4672294|NCT02337387|7569078|FG000|Overall Study|Sponsor Decision to Terminate Study|14
4672295|NCT02337387|7569079|FG001|Overall Study|Sponsor Decision to Terminate Study|7
4672296|NCT02337387|7569080|FG002|Overall Study|Sponsor Decision to Terminate Study|3
4672297|NCT02337387|7569081|FG003|Overall Study|Sponsor Decision to Terminate Study|3
4672298|NCT02337478|7569095|FG000|Overall Study|Lack of Efficacy|5
4672299|NCT02337491|7569101|FG000|Overall Study|Death|1
4672300|NCT02337491|7569102|FG001|Overall Study|Death|1
4672301|NCT02337491|7569101|FG000|Overall Study|Adverse Event|0
4672302|NCT02337491|7569102|FG001|Overall Study|Adverse Event|1
4672303|NCT02337491|7569101|FG000|Overall Study|Withdrawal by Subject|3
4672304|NCT02337491|7569102|FG001|Overall Study|Withdrawal by Subject|0
4672305|NCT02337491|7569101|FG000|Overall Study|Progressive Disease|44
4672306|NCT02337491|7569102|FG001|Overall Study|Progressive Disease|28
4672307|NCT02337491|7569101|FG000|Overall Study|On Treatment|2
4672308|NCT02337491|7569102|FG001|Overall Study|On Treatment|0
4672309|NCT02337907|7569132|FG000|Overall Study|Other than listed|1
4755435|NCT02457559|7729896|FG003|Overall Study|Death|0
4755436|NCT02457559|7729897|FG004|Overall Study|Death|0
4672310|NCT02337907|7569133|FG001|Overall Study|Other than listed|0
4672311|NCT02337907|7569134|FG002|Overall Study|Other than listed|0
4672312|NCT02337907|7569135|FG003|Overall Study|Other than listed|1
4755437|NCT02457559|7729898|FG005|Overall Study|Death|0
4755438|NCT02457559|7729899|FG006|Overall Study|Death|0
4672313|NCT02337907|7569136|FG004|Overall Study|Other than listed|1
4672314|NCT02337907|7569137|FG005|Overall Study|Other than listed|0
4672315|NCT02337907|7569132|FG000|Overall Study|Withdrawal by Subject|2
4672316|NCT02337907|7569133|FG001|Overall Study|Withdrawal by Subject|3
4672317|NCT02337907|7569134|FG002|Overall Study|Withdrawal by Subject|0
4672318|NCT02337907|7569135|FG003|Overall Study|Withdrawal by Subject|2
4672319|NCT02337907|7569136|FG004|Overall Study|Withdrawal by Subject|5
4672320|NCT02337907|7569137|FG005|Overall Study|Withdrawal by Subject|0
4672321|NCT02337907|7569132|FG000|Overall Study|Lost to Follow-up|0
4672322|NCT02337907|7569133|FG001|Overall Study|Lost to Follow-up|0
4672323|NCT02337907|7569134|FG002|Overall Study|Lost to Follow-up|0
4672324|NCT02337907|7569135|FG003|Overall Study|Lost to Follow-up|0
4672325|NCT02337907|7569136|FG004|Overall Study|Lost to Follow-up|0
4672326|NCT02337907|7569137|FG005|Overall Study|Lost to Follow-up|1
4672327|NCT02337907|7569132|FG000|Overall Study|Adverse Event|1
4672328|NCT02337907|7569133|FG001|Overall Study|Adverse Event|1
4672329|NCT02337907|7569134|FG002|Overall Study|Adverse Event|1
4672330|NCT02337907|7569135|FG003|Overall Study|Adverse Event|1
4672331|NCT02337907|7569136|FG004|Overall Study|Adverse Event|4
4672332|NCT02337907|7569137|FG005|Overall Study|Adverse Event|0
4672333|NCT02337946|7569161|FG000|Protocol Treatment 1 Period|Adverse Event|7
4672334|NCT02337946|7569162|FG001|Protocol Treatment 1 Period|Adverse Event|0
4672335|NCT02337946|7569163|FG002|Protocol Treatment 1 Period|Adverse Event|0
4672336|NCT02337946|7569161|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1
4672337|NCT02337946|7569162|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0
4672338|NCT02337946|7569163|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0
4672339|NCT02337946|7569161|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6
4672340|NCT02337946|7569162|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0
4672341|NCT02337946|7569163|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0
4672342|NCT02337946|7569161|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15
4672343|NCT02337946|7569162|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0
4672344|NCT02337946|7569163|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0
4672345|NCT02337946|7569161|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3
4672346|NCT02337946|7569162|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0
4672347|NCT02337946|7569163|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0
4672348|NCT02337946|7569161|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9
4755439|NCT02457559|7729900|FG007|Overall Study|Death|0
4755440|NCT02457559|7729901|FG008|Overall Study|Death|1
4755441|NCT02457559|7729902|FG009|Overall Study|Death|1
4755442|NCT02457559|7729903|FG010|Overall Study|Death|0
4755443|NCT02442349|7729941|FG000|Overall Study|Death|14
4755444|NCT02442349|7729941|FG000|Overall Study|Withdrawal by Subject|8
4755445|NCT02442349|7729941|FG000|Overall Study|On-going Study at Data Cut-off|149
4755446|NCT02434354|7729945|FG000|Overall Study|screen fail|3
4755447|NCT02381652|7729961|FG000|Overall Study|Withdrawal by Subject|0
4755448|NCT02381652|7729962|FG001|Overall Study|Withdrawal by Subject|0
4755449|NCT02381652|7729963|FG002|Overall Study|Withdrawal by Subject|1
4755450|NCT02367794|7729972|FG000|Overall Study|Death|252
4755451|NCT02367794|7729973|FG001|Overall Study|Death|245
4755452|NCT02367794|7729974|FG002|Overall Study|Death|243
4755453|NCT02367794|7729972|FG000|Overall Study|Lost to Follow-up|1
4755454|NCT02367794|7729973|FG001|Overall Study|Lost to Follow-up|2
4755455|NCT02367794|7729974|FG002|Overall Study|Lost to Follow-up|2
4755456|NCT02367794|7729972|FG000|Overall Study|Physician Decision|0
4755457|NCT02367794|7729973|FG001|Overall Study|Physician Decision|5
4755458|NCT02367794|7729974|FG002|Overall Study|Physician Decision|3
4755459|NCT02367794|7729972|FG000|Overall Study|Protocol Violation|1
4755460|NCT02367794|7729973|FG001|Overall Study|Protocol Violation|0
4755461|NCT02367794|7729974|FG002|Overall Study|Protocol Violation|1
4755462|NCT02367794|7729972|FG000|Overall Study|Withdrawal by Subject|25
4755463|NCT02367794|7729973|FG001|Overall Study|Withdrawal by Subject|12
4755464|NCT02367794|7729974|FG002|Overall Study|Withdrawal by Subject|20
4755465|NCT02367794|7729972|FG000|Overall Study|Brain metastasis|1
4755466|NCT02367794|7729973|FG001|Overall Study|Brain metastasis|0
4755467|NCT02367794|7729974|FG002|Overall Study|Brain metastasis|0
4755468|NCT02367794|7729972|FG000|Overall Study|Randomized in error|0
4755469|NCT02367794|7729973|FG001|Overall Study|Randomized in error|0
4755470|NCT02367794|7729974|FG002|Overall Study|Randomized in error|1
4672349|NCT02337946|7569162|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0
4672350|NCT02337946|7569163|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0
4672351|NCT02337946|7569161|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1
4672352|NCT02337946|7569162|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0
4672353|NCT02337946|7569163|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0
4672354|NCT02337946|7569161|FG000|Protocol Treatment 1 Period|Reason not specified|8
4755471|NCT02367794|7729972|FG000|Overall Study|Patient unable to receive carboplatin|0
4755472|NCT02367794|7729973|FG001|Overall Study|Patient unable to receive carboplatin|0
4755473|NCT02367794|7729974|FG002|Overall Study|Patient unable to receive carboplatin|1
4755474|NCT02367794|7729972|FG000|Overall Study|Hypercalcemia prior to C1D1|0
4755475|NCT02367794|7729973|FG001|Overall Study|Hypercalcemia prior to C1D1|0
4755476|NCT02367794|7729974|FG002|Overall Study|Hypercalcemia prior to C1D1|1
4755477|NCT02367794|7729972|FG000|Overall Study|Adverse Event|0
4672355|NCT02337946|7569162|FG001|Protocol Treatment 1 Period|Reason not specified|0
4672356|NCT02337946|7569163|FG002|Protocol Treatment 1 Period|Reason not specified|0
4672357|NCT02337946|7569161|FG000|In-between Period|Without Informed Consent|1
4672358|NCT02337946|7569162|FG001|In-between Period|Without Informed Consent|0
4672359|NCT02337946|7569163|FG002|In-between Period|Without Informed Consent|0
4672360|NCT02337946|7569161|FG000|Protocol Treatment 2 Period|Adverse Event|0
4672361|NCT02337946|7569162|FG001|Protocol Treatment 2 Period|Adverse Event|9
4672362|NCT02337946|7569163|FG002|Protocol Treatment 2 Period|Adverse Event|9
4672363|NCT02337946|7569161|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0
4672364|NCT02337946|7569162|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3
4672365|NCT02337946|7569163|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1
4672366|NCT02337946|7569161|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0
4672367|NCT02337946|7569162|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29
4672368|NCT02337946|7569163|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29
4672369|NCT02337946|7569161|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0
4672370|NCT02337946|7569162|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1
4672371|NCT02337946|7569163|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0
4672372|NCT02337946|7569161|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0
4672373|NCT02337946|7569162|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5
4672374|NCT02337946|7569163|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7
4672375|NCT02337946|7569161|FG000|Protocol Treatment 2 Period|Reason not specified|0
4672376|NCT02337946|7569162|FG001|Protocol Treatment 2 Period|Reason not specified|4
4672377|NCT02337946|7569163|FG002|Protocol Treatment 2 Period|Reason not specified|4
4672378|NCT02338154|7569188|FG000|Overall Study|Death|46
4672379|NCT02338154|7569188|FG000|Overall Study|Valve Implant Failure|17
4672380|NCT02338154|7569188|FG000|Overall Study|Valve Explant|11
4672381|NCT02338154|7569188|FG000|Overall Study|Withdrawal by Subject or by Investigator|10
4672382|NCT02338154|7569188|FG000|Overall Study|Lost to Follow-up|8
4672383|NCT02338154|7569188|FG000|Overall Study|Other Reason|3
4672384|NCT02338154|7569188|FG000|Overall Study|Patients Without Exit Form|47
4672385|NCT02338154|7569188|FG000|Overall Study|Missing Exit Reason on Exit Form|1
4672386|NCT02338193|7569203|FG000|Overall Study|Withdrawal by Subject|0
4672387|NCT02338193|7569204|FG001|Overall Study|Withdrawal by Subject|0
4672388|NCT02338193|7569205|FG002|Overall Study|Withdrawal by Subject|2
4672389|NCT02338193|7569203|FG000|Overall Study|Pregnancy|0
4672390|NCT02338193|7569204|FG001|Overall Study|Pregnancy|1
4672391|NCT02338193|7569205|FG002|Overall Study|Pregnancy|1
4672392|NCT02338193|7569203|FG000|Overall Study|Noncompliant with visits|2
4672393|NCT02338193|7569204|FG001|Overall Study|Noncompliant with visits|2
4672394|NCT02338193|7569205|FG002|Overall Study|Noncompliant with visits|7
4672395|NCT02338193|7569203|FG000|Overall Study|moved out of state|0
4672396|NCT02338193|7569204|FG001|Overall Study|moved out of state|1
4672397|NCT02338193|7569205|FG002|Overall Study|moved out of state|0
4672398|NCT02338193|7569203|FG000|Overall Study|intolerant of side effects|1
4672399|NCT02338193|7569204|FG001|Overall Study|intolerant of side effects|0
4672400|NCT02338193|7569205|FG002|Overall Study|intolerant of side effects|0
4672401|NCT02338362|7569226|FG000|Overall Study|Withdrawal by Subject|1
4672402|NCT02338362|7569227|FG001|Overall Study|Withdrawal by Subject|1
4672403|NCT02338492|7569233|FG000|Overall Study|Death|32
4672404|NCT02338492|7569233|FG000|Overall Study|Adverse Event|3
4672405|NCT02338492|7569233|FG000|Overall Study|Lost to Follow-up|4
4672406|NCT02338492|7569233|FG000|Overall Study|Reason not captured above|6
4672407|NCT02338843|7569245|FG000|Overall Study|Adverse Event|2
4672408|NCT02338843|7569246|FG001|Overall Study|Adverse Event|1
4672409|NCT02338843|7569245|FG000|Overall Study|Death|40
4672410|NCT02338843|7569246|FG001|Overall Study|Death|53
4672411|NCT02338843|7569245|FG000|Overall Study|Physician Decision|1
4672412|NCT02338843|7569246|FG001|Overall Study|Physician Decision|0
4672413|NCT02338843|7569245|FG000|Overall Study|Withdrawal by Subject|0
4672414|NCT02338843|7569246|FG001|Overall Study|Withdrawal by Subject|2
4672415|NCT02338843|7569245|FG000|Overall Study|Subject Recovered|0
4672416|NCT02338843|7569246|FG001|Overall Study|Subject Recovered|2
4672417|NCT02338843|7569245|FG000|Overall Study|Discontinued prior to randomizat|1
4672418|NCT02338843|7569246|FG001|Overall Study|Discontinued prior to randomizat|0
4672419|NCT02338882|7569254|FG000|Overall Study|Death|1
4672420|NCT02338882|7569255|FG001|Overall Study|Death|0
4672421|NCT02338882|7569254|FG000|Overall Study|Lost to Follow-up|6
4672422|NCT02338882|7569255|FG001|Overall Study|Lost to Follow-up|3
4672423|NCT02338999|7569361|FG000|First Intervention|Withdrawal by Subject|3
4672424|NCT02338999|7569362|FG001|First Intervention|Withdrawal by Subject|1
4672425|NCT02338999|7569361|FG000|Washout Period|Withdrawal by Subject|0
4672426|NCT02338999|7569362|FG001|Washout Period|Withdrawal by Subject|2
4672427|NCT02338999|7569361|FG000|Second Intervention|Withdrawal by Subject|0
4672428|NCT02338999|7569362|FG001|Second Intervention|Withdrawal by Subject|2
4672429|NCT02339155|7569374|FG000|Overall Study|Adverse Event|0
4672430|NCT02339155|7569375|FG001|Overall Study|Adverse Event|6
4672431|NCT02339155|7569374|FG000|Overall Study|Death|1
4672432|NCT02339155|7569375|FG001|Overall Study|Death|1
4672433|NCT02339155|7569374|FG000|Overall Study|Lost to Follow-up|8
4672434|NCT02339155|7569375|FG001|Overall Study|Lost to Follow-up|9
4672435|NCT02339155|7569374|FG000|Overall Study|Physician Decision|2
4672436|NCT02339155|7569375|FG001|Overall Study|Physician Decision|1
4672437|NCT02339155|7569374|FG000|Overall Study|Withdrawal by Subject|4
4755478|NCT02367794|7729973|FG001|Overall Study|Adverse Event|0
4755479|NCT02367794|7729974|FG002|Overall Study|Adverse Event|2
4755480|NCT02367794|7729972|FG000|Overall Study|Study Terminated By Sponsor|0
4755481|NCT02367794|7729973|FG001|Overall Study|Study Terminated By Sponsor|1
4755482|NCT02367794|7729974|FG002|Overall Study|Study Terminated By Sponsor|1
4755483|NCT02367794|7729972|FG000|Overall Study|Moved to Roll-Over Study|0
4755484|NCT02367794|7729973|FG001|Overall Study|Moved to Roll-Over Study|15
4755485|NCT02367794|7729974|FG002|Overall Study|Moved to Roll-Over Study|13
4755486|NCT02367794|7729972|FG000|Overall Study|Sponsor Request|60
4755487|NCT02367794|7729973|FG001|Overall Study|Sponsor Request|57
4755488|NCT02367794|7729974|FG002|Overall Study|Sponsor Request|45
4755489|NCT02367794|7729972|FG000|Overall Study|Moved into PTAP Study|0
4755490|NCT02367794|7729973|FG001|Overall Study|Moved into PTAP Study|2
4755491|NCT02367794|7729974|FG002|Overall Study|Moved into PTAP Study|3
4755492|NCT02367794|7729972|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0
4755493|NCT02367794|7729973|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2
4755494|NCT02367794|7729974|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1
4755495|NCT02367794|7729972|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0
4755496|NCT02367794|7729973|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1
4755497|NCT02367794|7729974|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0
4755498|NCT02367794|7729972|FG000|Overall Study|Participant Enrolled in Extended Protocol|0
4755499|NCT02367794|7729973|FG001|Overall Study|Participant Enrolled in Extended Protocol|1
4755500|NCT02367794|7729974|FG002|Overall Study|Participant Enrolled in Extended Protocol|0
4755501|NCT02367794|7729972|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0
4755502|NCT02367794|7729973|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0
4755503|NCT02367794|7729974|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1
4755504|NCT02367456|7729990|FG000|Overall Study|Death|8
4755505|NCT02367456|7729991|FG001|Overall Study|Death|21
4755506|NCT02367456|7729992|FG002|Overall Study|Death|14
4755507|NCT02367456|7729990|FG000|Overall Study|Lost to Follow-up|1
4755508|NCT02367456|7729991|FG001|Overall Study|Lost to Follow-up|3
4755509|NCT02367456|7729992|FG002|Overall Study|Lost to Follow-up|1
4755510|NCT02367456|7729990|FG000|Overall Study|Ongoing|0
4755511|NCT02367456|7729991|FG001|Overall Study|Ongoing|6
4755512|NCT02367456|7729992|FG002|Overall Study|Ongoing|15
4755513|NCT02367456|7729990|FG000|Overall Study|Other reason|3
4755514|NCT02367456|7729991|FG001|Overall Study|Other reason|0
4755515|NCT02367456|7729992|FG002|Overall Study|Other reason|0
4755516|NCT02358031|7730028|FG000|Overall Study|Death|226
4755517|NCT02358031|7730029|FG001|Overall Study|Death|204
4755518|NCT02358031|7730030|FG002|Overall Study|Death|249
4755519|NCT02358031|7730028|FG000|Overall Study|Lost to Follow-up|0
4755520|NCT02358031|7730029|FG001|Overall Study|Lost to Follow-up|1
4755521|NCT02358031|7730030|FG002|Overall Study|Lost to Follow-up|1
4755522|NCT02358031|7730028|FG000|Overall Study|Withdrawal by Subject|14
4755523|NCT02358031|7730029|FG001|Overall Study|Withdrawal by Subject|12
4755524|NCT02358031|7730030|FG002|Overall Study|Withdrawal by Subject|17
4755525|NCT02358031|7730028|FG000|Overall Study|Ongoing in Study|61
4755526|NCT02358031|7730029|FG001|Overall Study|Ongoing in Study|64
4755527|NCT02358031|7730030|FG002|Overall Study|Ongoing in Study|33
4755528|NCT02353832|7730038|FG000|Overall Study|Ineligible after enrollment|1
4755529|NCT02353832|7730038|FG000|Overall Study|Lost to Follow-up|1
4755530|NCT02353728|7730042|FG000|Overall Study|Subject non-compliance|1
4755531|NCT02345070|7730049|FG000|Overall Study|Adverse Event|12
4755532|NCT02345070|7730050|FG001|Overall Study|Adverse Event|8
4755533|NCT02345070|7730051|FG002|Overall Study|Adverse Event|16
4755534|NCT02345070|7730049|FG000|Overall Study|Poor compliance to protocol|2
4672438|NCT02339155|7569375|FG001|Overall Study|Withdrawal by Subject|4
4672439|NCT02339285|7569398|FG000|Overall Study|Withdrawal by Subject|0
4672440|NCT02339285|7569399|FG001|Overall Study|Withdrawal by Subject|1
4672441|NCT02339285|7569400|FG002|Overall Study|Withdrawal by Subject|1
4672442|NCT02339285|7569398|FG000|Overall Study|Lost to Follow-up|1
4672443|NCT02339285|7569399|FG001|Overall Study|Lost to Follow-up|1
4672444|NCT02339285|7569400|FG002|Overall Study|Lost to Follow-up|1
4672445|NCT02339285|7569398|FG000|Overall Study|Protocol Deviation|0
4672446|NCT02339285|7569399|FG001|Overall Study|Protocol Deviation|1
4672447|NCT02339285|7569400|FG002|Overall Study|Protocol Deviation|0
4672448|NCT02339506|7569424|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0
4672449|NCT02339506|7569425|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1
4672450|NCT02339506|7569424|FG000|Washout (Period 2)|Withdrawal by Subject|2
4672451|NCT02339506|7569425|FG001|Washout (Period 2)|Withdrawal by Subject|0
4672452|NCT02339584|7569442|FG000|Overall Study|Adverse Event|11
4755535|NCT02345070|7730050|FG001|Overall Study|Poor compliance to protocol|0
4672453|NCT02339584|7569443|FG001|Overall Study|Adverse Event|7
4672454|NCT02339584|7569442|FG000|Overall Study|Lack of Efficacy|0
4672455|NCT02339584|7569443|FG001|Overall Study|Lack of Efficacy|1
4672456|NCT02339584|7569442|FG000|Overall Study|Physician Decision|1
4672457|NCT02339584|7569443|FG001|Overall Study|Physician Decision|2
4672458|NCT02339584|7569442|FG000|Overall Study|Protocol Violation|1
4672459|NCT02339584|7569443|FG001|Overall Study|Protocol Violation|1
4672460|NCT02339584|7569442|FG000|Overall Study|Withdrawal by Subject|2
4672461|NCT02339584|7569443|FG001|Overall Study|Withdrawal by Subject|4
4755536|NCT02345070|7730051|FG002|Overall Study|Poor compliance to protocol|0
4755537|NCT02345070|7730049|FG000|Overall Study|Other than specified above|6
4755538|NCT02345070|7730050|FG001|Overall Study|Other than specified above|3
4755539|NCT02345070|7730051|FG002|Overall Study|Other than specified above|7
4755540|NCT02325466|7730059|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0
4755541|NCT02325466|7730060|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0
4755542|NCT02325466|7730061|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1
4755543|NCT02325466|7730059|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0
4755544|NCT02325466|7730060|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2
4755545|NCT02325466|7730061|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0
4755546|NCT02325466|7730059|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1
4755547|NCT02325466|7730060|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0
4755548|NCT02325466|7730061|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2
4755549|NCT02325466|7730059|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1
4755550|NCT02325466|7730060|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0
4755551|NCT02325466|7730061|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0
4755552|NCT02325466|7730059|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1
4755553|NCT02325466|7730060|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1
4755554|NCT02325466|7730061|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0
4755555|NCT02325466|7730059|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1
4755556|NCT02325466|7730060|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0
4755557|NCT02325466|7730061|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0
4755558|NCT02325466|7730059|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1
4755559|NCT02325466|7730060|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0
4755560|NCT02325466|7730061|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0
4755561|NCT02325466|7730059|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0
4755562|NCT02325466|7730060|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1
4755563|NCT02325466|7730061|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0
4755564|NCT02325466|7730059|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0
4755565|NCT02325466|7730060|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1
4755566|NCT02325466|7730061|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0
4755567|NCT02322710|7730072|FG000|Overall Study|No efficacy assessment post-baseline|0
4755568|NCT02322710|7730073|FG001|Overall Study|No efficacy assessment post-baseline|1
4755569|NCT02322710|7730072|FG000|Overall Study|Protocol Violation|20
4755570|NCT02322710|7730073|FG001|Overall Study|Protocol Violation|25
4755571|NCT02234310|7730121|FG000|Overall Study|Physician Decision|1
4755572|NCT02234310|7730121|FG000|Overall Study|Adverse Event|1
4755573|NCT02234310|7730121|FG000|Overall Study|Eligibility Criteria not fulfilled|2
4755574|NCT02234310|7730121|FG000|Overall Study|Withdrawal by Subject|2
4755575|NCT02158091|7730135|FG000|Overall Study|DLT|2
4755576|NCT02158091|7730136|FG001|Overall Study|DLT|1
4755577|NCT02158091|7730137|FG002|Overall Study|DLT|0
4672462|NCT02339909|7569461|FG000|Overall Study|Became ineligible after randomisation|89
4672463|NCT02339909|7569462|FG001|Overall Study|Became ineligible after randomisation|63
4672464|NCT02339909|7569463|FG002|Overall Study|Became ineligible after randomisation|71
4672465|NCT02340000|7569473|FG000|Time Period 1|Withdrawal by Subject|6
4672466|NCT02340000|7569474|FG001|Time Period 1|Withdrawal by Subject|8
4672467|NCT02340000|7569473|FG000|Time Period 1|Lost to Follow-up|6
4672468|NCT02340000|7569474|FG001|Time Period 1|Lost to Follow-up|7
4672469|NCT02340000|7569473|FG000|Time Period 2|Withdrawal by Subject|9
4672470|NCT02340000|7569474|FG001|Time Period 2|Withdrawal by Subject|7
4672471|NCT02340000|7569473|FG000|Time Period 2|Lost to Follow-up|10
4672472|NCT02340000|7569474|FG001|Time Period 2|Lost to Follow-up|8
4755578|NCT02106195|7730183|FG000|Overall Study|Adverse Event|2
4755579|NCT02106195|7730183|FG000|Overall Study|Protocol Violation|1
4755580|NCT02104180|7730195|FG000|Overall Study|Protocol Violation|1
4755581|NCT02104180|7730196|FG001|Overall Study|Protocol Violation|0
4755582|NCT02075840|7730204|FG000|Overall Study|Withdrawal by Subject|13
4755583|NCT02075840|7730205|FG001|Overall Study|Withdrawal by Subject|22
4755584|NCT02075840|7730204|FG000|Overall Study|Reason not specified|1
4755585|NCT02075840|7730205|FG001|Overall Study|Reason not specified|0
4755586|NCT02075840|7730204|FG000|Overall Study|Adverse Event|0
4755587|NCT02075840|7730205|FG001|Overall Study|Adverse Event|2
4755588|NCT02075840|7730204|FG000|Overall Study|Death|35
4755589|NCT02075840|7730205|FG001|Overall Study|Death|40
4755590|NCT02075840|7730204|FG000|Overall Study|Lost to Follow-up|3
4755591|NCT02075840|7730205|FG001|Overall Study|Lost to Follow-up|2
4755592|NCT02075840|7730204|FG000|Overall Study|Physician Decision|1
4755593|NCT02075840|7730205|FG001|Overall Study|Physician Decision|3
4755594|NCT02075840|7730204|FG000|Overall Study|Ongoing at CCOD|99
4755595|NCT02075840|7730205|FG001|Overall Study|Ongoing at CCOD|82
4755596|NCT02066181|7730213|FG000|Overall Study|Withdrawal by Subject|1
4755597|NCT02066181|7730214|FG001|Overall Study|Withdrawal by Subject|1
4755598|NCT02040857|7730227|FG000|Overall Study|Adverse Event|14
4755599|NCT02040857|7730227|FG000|Overall Study|Physician Decision|5
4755600|NCT02040857|7730227|FG000|Overall Study|Withdrawal by Subject|31
4755601|NCT02040857|7730227|FG000|Overall Study|patient non-compliance|3
4755602|NCT02040857|7730227|FG000|Overall Study|Lost to Follow-up|2
4755603|NCT02040857|7730227|FG000|Overall Study|recurrence|4
4755604|NCT02040857|7730227|FG000|Overall Study|ineligible|1
4755605|NCT01943825|7730247|FG000|Overall Study|Lost to Follow-up|9
4755606|NCT01943825|7730248|FG001|Overall Study|Lost to Follow-up|3
4755607|NCT01943825|7730249|FG002|Overall Study|Lost to Follow-up|12
4755608|NCT01943825|7730250|FG003|Overall Study|Lost to Follow-up|8
4755609|NCT01943825|7730247|FG000|Overall Study|Withdrawal by Subject|1
4755610|NCT01943825|7730248|FG001|Overall Study|Withdrawal by Subject|0
4755611|NCT01943825|7730249|FG002|Overall Study|Withdrawal by Subject|3
4755612|NCT01943825|7730250|FG003|Overall Study|Withdrawal by Subject|2
4755613|NCT01943825|7730247|FG000|Overall Study|Other than specified above|0
4755614|NCT01943825|7730248|FG001|Overall Study|Other than specified above|1
4755615|NCT01943825|7730249|FG002|Overall Study|Other than specified above|0
4755616|NCT01943825|7730250|FG003|Overall Study|Other than specified above|1
4755617|NCT01940471|7730266|FG000|Double-Blind Phase|Randomized but Never Treated|1
4755618|NCT01940471|7730267|FG001|Double-Blind Phase|Randomized but Never Treated|1
4755619|NCT01940471|7730266|FG000|Double-Blind Phase|Withdrew Consent|13
4755620|NCT01940471|7730267|FG001|Double-Blind Phase|Withdrew Consent|7
4755621|NCT01940471|7730266|FG000|Double-Blind Phase|Adverse Event|1
4755622|NCT01940471|7730267|FG001|Double-Blind Phase|Adverse Event|2
4755623|NCT01940471|7730266|FG000|Double-Blind Phase|Lost to Follow-up|3
4755624|NCT01940471|7730267|FG001|Double-Blind Phase|Lost to Follow-up|2
4755625|NCT01940471|7730266|FG000|Double-Blind Phase|Pregnancy|2
4755626|NCT01940471|7730267|FG001|Double-Blind Phase|Pregnancy|1
4755627|NCT01940471|7730266|FG000|Double-Blind Phase|Investigator's Discretion|5
4755628|NCT01940471|7730267|FG001|Double-Blind Phase|Investigator's Discretion|0
4755629|NCT01940471|7730266|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1
4755630|NCT01940471|7730267|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1
4755631|NCT01940471|7730266|FG000|Double-Blind Phase|Protocol-Specified Criteria|1
4755632|NCT01940471|7730267|FG001|Double-Blind Phase|Protocol-Specified Criteria|0
4755633|NCT01940471|7730266|FG000|Double-Blind Phase|Death|1
4755634|NCT01940471|7730267|FG001|Double-Blind Phase|Death|0
4755635|NCT01940471|7730266|FG000|Double-Blind Phase|Lack of Efficacy|1
4755636|NCT01940471|7730267|FG001|Double-Blind Phase|Lack of Efficacy|0
4755637|NCT01940471|7730266|FG000|Double-Blind Phase|Protocol Violation|0
4755638|NCT01940471|7730267|FG001|Double-Blind Phase|Protocol Violation|1
4755639|NCT01940471|7730266|FG000|Double-Blind Phase|Still in Double-Blind Phase|539
4755640|NCT01940471|7730267|FG001|Double-Blind Phase|Still in Double-Blind Phase|270
4755641|NCT01940471|7730266|FG000|Open-Label Extension|Still in Open-Label Extension Phase|14
4755642|NCT01940471|7730267|FG001|Open-Label Extension|Still in Open-Label Extension Phase|8
4755643|NCT01909453|7730279|FG000|Overall Study|Ongoing|118
4755644|NCT01909453|7730280|FG001|Overall Study|Ongoing|103
4755645|NCT01909453|7730281|FG002|Overall Study|Ongoing|83
4755646|NCT01909453|7730282|FG003|Overall Study|Ongoing|164
4755647|NCT01909453|7730283|FG004|Overall Study|Ongoing|50
4755648|NCT01909453|7730279|FG000|Overall Study|Death|69
4672473|NCT02340078|7569487|FG000|Overall Study|Protocol Violation|1
4672474|NCT02340520|7569544|FG000|Overall Study|Lost to Follow-up|1
4672475|NCT02340520|7569544|FG000|Overall Study|Patient did not take drug as specified|1
4672476|NCT02340520|7569544|FG000|Overall Study|Withdrawal by Subject|1
4672477|NCT02340663|7569550|FG000|Overall Study|Lost to Follow-up|1
4672478|NCT02340663|7569551|FG001|Overall Study|Lost to Follow-up|0
4672479|NCT02340663|7569550|FG000|Overall Study|Protocol Violation|1
4672480|NCT02340663|7569551|FG001|Overall Study|Protocol Violation|0
4755649|NCT01909453|7730280|FG001|Overall Study|Death|74
4755650|NCT01909453|7730281|FG002|Overall Study|Death|88
4755651|NCT01909453|7730282|FG003|Overall Study|Death|86
4755652|NCT01909453|7730283|FG004|Overall Study|Death|29
4755653|NCT01909453|7730279|FG000|Overall Study|Lost to Follow-up|3
4755654|NCT01909453|7730280|FG001|Overall Study|Lost to Follow-up|4
4755655|NCT01909453|7730281|FG002|Overall Study|Lost to Follow-up|4
4755656|NCT01909453|7730282|FG003|Overall Study|Lost to Follow-up|3
4755657|NCT01909453|7730283|FG004|Overall Study|Lost to Follow-up|3
4755658|NCT01909453|7730279|FG000|Overall Study|Withdrawal by Subject|2
4755659|NCT01909453|7730280|FG001|Overall Study|Withdrawal by Subject|13
4755660|NCT01909453|7730281|FG002|Overall Study|Withdrawal by Subject|16
4755661|NCT01909453|7730282|FG003|Overall Study|Withdrawal by Subject|5
4755662|NCT01909453|7730283|FG004|Overall Study|Withdrawal by Subject|4
4755663|NCT01874353|7730303|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2
4755664|NCT01874353|7730304|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0
4755665|NCT01874353|7730305|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0
4755666|NCT01874353|7730306|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0
4755667|NCT01874353|7730303|FG000|Overall Study|Lost to Follow-up|2
4755668|NCT01874353|7730304|FG001|Overall Study|Lost to Follow-up|2
4755669|NCT01874353|7730305|FG002|Overall Study|Lost to Follow-up|2
4755670|NCT01874353|7730306|FG003|Overall Study|Lost to Follow-up|0
4755671|NCT01874353|7730303|FG000|Overall Study|Death|110
4755672|NCT01874353|7730304|FG001|Overall Study|Death|60
4755673|NCT01874353|7730305|FG002|Overall Study|Death|13
4755674|NCT01874353|7730306|FG003|Overall Study|Death|7
4755675|NCT01874353|7730303|FG000|Overall Study|Withdrawal by Subject|13
4755676|NCT01874353|7730304|FG001|Overall Study|Withdrawal by Subject|11
4755677|NCT01874353|7730305|FG002|Overall Study|Withdrawal by Subject|0
4755678|NCT01874353|7730306|FG003|Overall Study|Withdrawal by Subject|0
4755679|NCT01856192|7730335|FG000|Overall Study|Adverse Event|12
4755680|NCT01856192|7730336|FG001|Overall Study|Adverse Event|4
4755681|NCT01856192|7730335|FG000|Overall Study|Alternative therapy|0
4755682|NCT01856192|7730336|FG001|Overall Study|Alternative therapy|3
4755683|NCT01856192|7730335|FG000|Overall Study|Death|3
4755684|NCT01856192|7730336|FG001|Overall Study|Death|5
4755685|NCT01856192|7730335|FG000|Overall Study|Lack of Efficacy|0
4755686|NCT01856192|7730336|FG001|Overall Study|Lack of Efficacy|5
4755687|NCT01856192|7730335|FG000|Overall Study|Withdrawal by Subject|1
4755688|NCT01856192|7730336|FG001|Overall Study|Withdrawal by Subject|1
4755689|NCT01856192|7730335|FG000|Overall Study|Other diseases|1
4755690|NCT01856192|7730336|FG001|Overall Study|Other diseases|0
4755691|NCT01856192|7730335|FG000|Overall Study|Never started treatment|7
4755692|NCT01856192|7730336|FG001|Overall Study|Never started treatment|5
4755693|NCT01856192|7730335|FG000|Overall Study|Path ineligible|20
4755694|NCT01856192|7730336|FG001|Overall Study|Path ineligible|34
4755695|NCT01856192|7730335|FG000|Overall Study|Non-path ineligible|2
4755696|NCT01856192|7730336|FG001|Overall Study|Non-path ineligible|2
4755697|NCT01856192|7730335|FG000|Overall Study|Physician Decision|1
4755698|NCT01856192|7730336|FG001|Overall Study|Physician Decision|1
4755699|NCT01856192|7730335|FG000|Overall Study|Suspicion of progressive disease|1
4755700|NCT01856192|7730336|FG001|Overall Study|Suspicion of progressive disease|0
4755701|NCT01856192|7730335|FG000|Overall Study|Non-compliance|1
4755702|NCT01856192|7730336|FG001|Overall Study|Non-compliance|0
4755703|NCT01853748|7730344|FG000|Allocation|Withdrawal by Subject|1
4755704|NCT01853748|7730345|FG001|Allocation|Withdrawal by Subject|13
4755705|NCT01853748|7730344|FG000|Allocation|not sufficient to receive intervention|0
4755706|NCT01853748|7730345|FG001|Allocation|not sufficient to receive intervention|1
4755707|NCT01853748|7730344|FG000|Follow-Up|Withdrawal by Subject|7
4755708|NCT01853748|7730345|FG001|Follow-Up|Withdrawal by Subject|6
4755709|NCT01853748|7730344|FG000|Follow-Up|Adverse Event|67
4755710|NCT01853748|7730345|FG001|Follow-Up|Adverse Event|7
4755711|NCT01853748|7730344|FG000|Follow-Up|not available for data collection|16
4755712|NCT01853748|7730345|FG001|Follow-Up|not available for data collection|4
4755713|NCT01843374|7730362|FG000|Overall Study|Death|155
4755714|NCT01843374|7730363|FG001|Overall Study|Death|313
4755715|NCT01843374|7730362|FG000|Overall Study|Withdrawal by Subject|14
4755716|NCT01843374|7730363|FG001|Overall Study|Withdrawal by Subject|20
4755717|NCT01843374|7730362|FG000|Overall Study|Withdrawing due to Other reason|20
4755718|NCT01843374|7730363|FG001|Overall Study|Withdrawing due to Other reason|46
4755719|NCT01817751|7730382|FG000|Overall Study|Physician Decision|1
4755720|NCT01722331|7730389|FG000|Part 1|Adverse Event|5
4755721|NCT01722331|7730390|FG001|Part 1|Adverse Event|0
4672481|NCT02340663|7569550|FG000|Overall Study|Withdrawal by Subject|3
4755722|NCT01722331|7730391|FG002|Part 1|Adverse Event|0
4672482|NCT02340663|7569551|FG001|Overall Study|Withdrawal by Subject|1
4672483|NCT02340780|7569593|FG000|Overall Study|Ineligible|1
4672484|NCT02340806|7569599|FG000|Overall Study|Protocol Violation|2
4672485|NCT02340806|7569600|FG001|Overall Study|Protocol Violation|0
4672486|NCT02340806|7569599|FG000|Overall Study|epidural catheter replaced|2
4672487|NCT02340806|7569600|FG001|Overall Study|epidural catheter replaced|1
4672488|NCT02340806|7569599|FG000|Overall Study|history of chronic pain medication|1
4672489|NCT02340806|7569600|FG001|Overall Study|history of chronic pain medication|0
4672490|NCT02340806|7569599|FG000|Overall Study|re-dose < 90 min of CSE|1
4672491|NCT02340806|7569600|FG001|Overall Study|re-dose < 90 min of CSE|3
4672492|NCT02340819|7569606|FG000|Overall Study|Adverse Event|1
4672493|NCT02340819|7569606|FG000|Overall Study|Withdrawal by Subject|2
4672494|NCT02340819|7569606|FG000|Overall Study|Discontinued with other reason|1
4672495|NCT02340949|7569612|FG000|Overall Study|Adverse Event|4
4672496|NCT02340949|7569613|FG001|Overall Study|Adverse Event|2
4672497|NCT02340949|7569612|FG000|Overall Study|Withdrawal by Subject|2
4672498|NCT02340949|7569613|FG001|Overall Study|Withdrawal by Subject|0
4672499|NCT02340949|7569612|FG000|Overall Study|Progression disease|6
4672500|NCT02340949|7569613|FG001|Overall Study|Progression disease|2
4672501|NCT02340949|7569612|FG000|Overall Study|Death|3
4672502|NCT02340949|7569613|FG001|Overall Study|Death|0
4672503|NCT02340949|7569612|FG000|Overall Study|Physician Decision|1
4672504|NCT02340949|7569613|FG001|Overall Study|Physician Decision|0
4672505|NCT02340962|7569621|FG000|Overall Study|Lost to Follow-up|1
4672506|NCT02340962|7569622|FG001|Overall Study|Lost to Follow-up|0
4672507|NCT02340975|7569634|FG000|Overall Study|Death|6
4672508|NCT02340975|7569635|FG001|Overall Study|Death|23
4672509|NCT02340975|7569636|FG002|Overall Study|Death|21
4672510|NCT02340975|7569637|FG003|Overall Study|Death|7
4672511|NCT02340975|7569638|FG004|Overall Study|Death|21
4672512|NCT02340975|7569639|FG005|Overall Study|Death|13
4672513|NCT02340975|7569634|FG000|Overall Study|Lost to Follow-up|0
4672514|NCT02340975|7569635|FG001|Overall Study|Lost to Follow-up|0
4672515|NCT02340975|7569636|FG002|Overall Study|Lost to Follow-up|0
4672516|NCT02340975|7569637|FG003|Overall Study|Lost to Follow-up|0
4672517|NCT02340975|7569638|FG004|Overall Study|Lost to Follow-up|2
4672518|NCT02340975|7569639|FG005|Overall Study|Lost to Follow-up|0
4672519|NCT02340975|7569634|FG000|Overall Study|Withdrawal by Subject|0
4672520|NCT02340975|7569635|FG001|Overall Study|Withdrawal by Subject|0
4672521|NCT02340975|7569636|FG002|Overall Study|Withdrawal by Subject|3
4672522|NCT02340975|7569637|FG003|Overall Study|Withdrawal by Subject|3
4672523|NCT02340975|7569638|FG004|Overall Study|Withdrawal by Subject|2
4672524|NCT02340975|7569639|FG005|Overall Study|Withdrawal by Subject|0
4672525|NCT02340975|7569634|FG000|Overall Study|Other|0
4672526|NCT02340975|7569635|FG001|Overall Study|Other|4
4672527|NCT02340975|7569636|FG002|Overall Study|Other|0
4672528|NCT02340975|7569637|FG003|Overall Study|Other|2
4672529|NCT02340975|7569638|FG004|Overall Study|Other|0
4672530|NCT02340975|7569639|FG005|Overall Study|Other|6
4672531|NCT02341417|7569666|FG000|Overall Study|Withdrawal by Subject|0
4672532|NCT02341417|7569667|FG001|Overall Study|Withdrawal by Subject|2
4672533|NCT02341417|7569668|FG002|Overall Study|Withdrawal by Subject|0
4672534|NCT02341417|7569666|FG000|Overall Study|Decision by sponsor|2
4672535|NCT02341417|7569667|FG001|Overall Study|Decision by sponsor|0
4672536|NCT02341417|7569668|FG002|Overall Study|Decision by sponsor|0
4672537|NCT02341417|7569666|FG000|Overall Study|Death|0
4672538|NCT02341417|7569667|FG001|Overall Study|Death|0
4672539|NCT02341417|7569668|FG002|Overall Study|Death|1
4672540|NCT02341456|7569680|FG000|Overall Study|Disease progression|2
4672541|NCT02341456|7569681|FG001|Overall Study|Disease progression|3
4672542|NCT02341456|7569682|FG002|Overall Study|Disease progression|1
4672543|NCT02341456|7569680|FG000|Overall Study|Death|1
4672544|NCT02341456|7569681|FG001|Overall Study|Death|1
4672545|NCT02341456|7569682|FG002|Overall Study|Death|1
4672546|NCT02341456|7569680|FG000|Overall Study|Withdrawal by Subject|0
4672547|NCT02341456|7569681|FG001|Overall Study|Withdrawal by Subject|1
4672548|NCT02341456|7569682|FG002|Overall Study|Withdrawal by Subject|1
4672549|NCT02341456|7569680|FG000|Overall Study|Moved to local access programme.|0
4672550|NCT02341456|7569681|FG001|Overall Study|Moved to local access programme.|1
4672551|NCT02341456|7569682|FG002|Overall Study|Moved to local access programme.|1
4672552|NCT02341456|7569680|FG000|Overall Study|Physician Decision|1
4672553|NCT02341456|7569681|FG001|Overall Study|Physician Decision|0
4672554|NCT02341456|7569682|FG002|Overall Study|Physician Decision|0
4672555|NCT02341482|7569690|FG000|Overall Study|Adverse Event|1
4672556|NCT02342171|7569743|FG000|Overall Study|Death|4
4672557|NCT02342171|7569744|FG001|Overall Study|Death|87
4672558|NCT02342171|7569743|FG000|Overall Study|Received favipiravir|10
4672559|NCT02342171|7569744|FG001|Overall Study|Received favipiravir|0
4672560|NCT02342171|7569743|FG000|Overall Study|Missing cycle treshold value|1
4672561|NCT02342171|7569744|FG001|Overall Study|Missing cycle treshold value|0
4672562|NCT02342171|7569743|FG000|Overall Study|Unknown outcome|0
4672563|NCT02342171|7569744|FG001|Overall Study|Unknown outcome|1
4672564|NCT02342171|7569743|FG000|Overall Study|Missing age data|0
4672565|NCT02342171|7569744|FG001|Overall Study|Missing age data|1
4672566|NCT02342223|7569758|FG000|Overall Study|Lost to Follow-up|1
4672567|NCT02342288|7569764|FG000|Overall Study|no protocol anesthesiologist available|3
4755723|NCT01722331|7730392|FG003|Part 1|Adverse Event|0
4672568|NCT02342288|7569765|FG001|Overall Study|no protocol anesthesiologist available|2
4672569|NCT02342288|7569764|FG000|Overall Study|anesthesia leak in system|1
4672570|NCT02342288|7569765|FG001|Overall Study|anesthesia leak in system|0
4672571|NCT02342288|7569764|FG000|Overall Study|Withdrawal by Subject|1
4672572|NCT02342288|7569765|FG001|Overall Study|Withdrawal by Subject|0
4672573|NCT02342288|7569764|FG000|Overall Study|coordinator contaminated with blood|0
4672574|NCT02342288|7569765|FG001|Overall Study|coordinator contaminated with blood|1
4672575|NCT02342288|7569764|FG000|Overall Study|subject cannot tolerate numbing drops|0
4672576|NCT02342288|7569765|FG001|Overall Study|subject cannot tolerate numbing drops|1
4755724|NCT01722331|7730393|FG004|Part 1|Adverse Event|0
4755725|NCT01722331|7730394|FG005|Part 1|Adverse Event|0
4755726|NCT01722331|7730395|FG006|Part 1|Adverse Event|0
4755727|NCT01722331|7730389|FG000|Part 1|Lack of Efficacy|0
4755728|NCT01722331|7730390|FG001|Part 1|Lack of Efficacy|0
4755729|NCT01722331|7730391|FG002|Part 1|Lack of Efficacy|1
4755730|NCT01722331|7730392|FG003|Part 1|Lack of Efficacy|0
4755731|NCT01722331|7730393|FG004|Part 1|Lack of Efficacy|2
4755732|NCT01722331|7730394|FG005|Part 1|Lack of Efficacy|0
4755733|NCT01722331|7730395|FG006|Part 1|Lack of Efficacy|0
4755734|NCT01722331|7730389|FG000|Part 1|Lost to Follow-up|1
4755735|NCT01722331|7730390|FG001|Part 1|Lost to Follow-up|0
4755736|NCT01722331|7730391|FG002|Part 1|Lost to Follow-up|2
4755737|NCT01722331|7730392|FG003|Part 1|Lost to Follow-up|0
4755738|NCT01722331|7730393|FG004|Part 1|Lost to Follow-up|1
4755739|NCT01722331|7730394|FG005|Part 1|Lost to Follow-up|0
4755740|NCT01722331|7730395|FG006|Part 1|Lost to Follow-up|0
4755741|NCT01722331|7730389|FG000|Part 1|Physician Decision|0
4755742|NCT01722331|7730390|FG001|Part 1|Physician Decision|0
4755743|NCT01722331|7730391|FG002|Part 1|Physician Decision|3
4755744|NCT01722331|7730392|FG003|Part 1|Physician Decision|0
4755745|NCT01722331|7730393|FG004|Part 1|Physician Decision|1
4755746|NCT01722331|7730394|FG005|Part 1|Physician Decision|0
4755747|NCT01722331|7730395|FG006|Part 1|Physician Decision|0
4755748|NCT01722331|7730389|FG000|Part 1|Pregnancy|1
4755749|NCT01722331|7730390|FG001|Part 1|Pregnancy|0
4755750|NCT01722331|7730391|FG002|Part 1|Pregnancy|0
4755751|NCT01722331|7730392|FG003|Part 1|Pregnancy|0
4755752|NCT01722331|7730393|FG004|Part 1|Pregnancy|0
4755753|NCT01722331|7730394|FG005|Part 1|Pregnancy|0
4755754|NCT01722331|7730395|FG006|Part 1|Pregnancy|0
4755755|NCT01722331|7730389|FG000|Part 1|Progressive Disease|0
4755756|NCT01722331|7730390|FG001|Part 1|Progressive Disease|0
4755757|NCT01722331|7730391|FG002|Part 1|Progressive Disease|0
4755758|NCT01722331|7730392|FG003|Part 1|Progressive Disease|0
4755759|NCT01722331|7730393|FG004|Part 1|Progressive Disease|1
4755760|NCT01722331|7730394|FG005|Part 1|Progressive Disease|0
4755761|NCT01722331|7730395|FG006|Part 1|Progressive Disease|0
4755762|NCT01722331|7730389|FG000|Part 1|Protocol Violation|1
4755763|NCT01722331|7730390|FG001|Part 1|Protocol Violation|0
4755764|NCT01722331|7730391|FG002|Part 1|Protocol Violation|0
4755765|NCT01722331|7730392|FG003|Part 1|Protocol Violation|0
4755766|NCT01722331|7730393|FG004|Part 1|Protocol Violation|1
4755767|NCT01722331|7730394|FG005|Part 1|Protocol Violation|0
4755768|NCT01722331|7730395|FG006|Part 1|Protocol Violation|0
4755769|NCT01722331|7730389|FG000|Part 1|Withdrawal by Subject|2
4755770|NCT01722331|7730390|FG001|Part 1|Withdrawal by Subject|0
4755771|NCT01722331|7730391|FG002|Part 1|Withdrawal by Subject|3
4755772|NCT01722331|7730392|FG003|Part 1|Withdrawal by Subject|0
4755773|NCT01722331|7730393|FG004|Part 1|Withdrawal by Subject|3
4755774|NCT01722331|7730394|FG005|Part 1|Withdrawal by Subject|0
4755775|NCT01722331|7730395|FG006|Part 1|Withdrawal by Subject|0
4755776|NCT01722331|7730389|FG000|Part 2|Adverse Event|3
4755777|NCT01722331|7730390|FG001|Part 2|Adverse Event|0
4755778|NCT01722331|7730391|FG002|Part 2|Adverse Event|0
4755779|NCT01722331|7730392|FG003|Part 2|Adverse Event|0
4672577|NCT02342288|7569764|FG000|Overall Study|coordinator not available|0
4672578|NCT02342288|7569765|FG001|Overall Study|coordinator not available|2
4672579|NCT02342418|7569875|FG000|Overall Study|Adverse Event|0
4672580|NCT02342418|7569876|FG001|Overall Study|Adverse Event|1
4672581|NCT02342548|7569889|FG000|Overall Study|Adverse Event|12
4672582|NCT02342548|7569890|FG001|Overall Study|Adverse Event|17
4755780|NCT01722331|7730393|FG004|Part 2|Adverse Event|0
4755781|NCT01722331|7730394|FG005|Part 2|Adverse Event|1
4755782|NCT01722331|7730395|FG006|Part 2|Adverse Event|0
4755783|NCT01722331|7730389|FG000|Part 2|Lack of Efficacy|3
4755784|NCT01722331|7730390|FG001|Part 2|Lack of Efficacy|0
4755785|NCT01722331|7730391|FG002|Part 2|Lack of Efficacy|11
4672583|NCT02342548|7569891|FG002|Overall Study|Adverse Event|13
4672584|NCT02342548|7569889|FG000|Overall Study|Lost to Follow-up|0
4672585|NCT02342548|7569890|FG001|Overall Study|Lost to Follow-up|1
4755786|NCT01722331|7730392|FG003|Part 2|Lack of Efficacy|0
4755787|NCT01722331|7730393|FG004|Part 2|Lack of Efficacy|0
4755788|NCT01722331|7730394|FG005|Part 2|Lack of Efficacy|3
4755789|NCT01722331|7730395|FG006|Part 2|Lack of Efficacy|3
4755790|NCT01722331|7730389|FG000|Part 2|Lost to Follow-up|0
4755791|NCT01722331|7730390|FG001|Part 2|Lost to Follow-up|0
4755792|NCT01722331|7730391|FG002|Part 2|Lost to Follow-up|3
4755793|NCT01722331|7730392|FG003|Part 2|Lost to Follow-up|0
4755794|NCT01722331|7730393|FG004|Part 2|Lost to Follow-up|0
4755795|NCT01722331|7730394|FG005|Part 2|Lost to Follow-up|1
4755796|NCT01722331|7730395|FG006|Part 2|Lost to Follow-up|1
4672586|NCT02342548|7569891|FG002|Overall Study|Lost to Follow-up|0
4672587|NCT02342548|7569889|FG000|Overall Study|Study terminated by sponsor|20
4672588|NCT02342548|7569890|FG001|Overall Study|Study terminated by sponsor|39
4672589|NCT02342548|7569891|FG002|Overall Study|Study terminated by sponsor|25
4672590|NCT02342548|7569889|FG000|Overall Study|Protocol Violation|0
4672591|NCT02342548|7569890|FG001|Overall Study|Protocol Violation|1
4672592|NCT02342548|7569891|FG002|Overall Study|Protocol Violation|0
4672593|NCT02342548|7569889|FG000|Overall Study|Withdrawal by Subject|1
4672594|NCT02342548|7569890|FG001|Overall Study|Withdrawal by Subject|3
4672595|NCT02342548|7569891|FG002|Overall Study|Withdrawal by Subject|4
4672596|NCT02342548|7569889|FG000|Overall Study|Other|1
4672597|NCT02342548|7569890|FG001|Overall Study|Other|1
4672598|NCT02342548|7569891|FG002|Overall Study|Other|1
4672599|NCT02342639|7569909|FG000|Overall Study|Acute illness, unrelated to study drug|2
4672600|NCT02342639|7569910|FG001|Overall Study|Acute illness, unrelated to study drug|3
4672601|NCT02342639|7569909|FG000|Overall Study|Protocol Violation|0
4672602|NCT02342639|7569910|FG001|Overall Study|Protocol Violation|2
4672603|NCT02342678|7569920|FG000|Overall Study|Lost to Follow-up|0
4672604|NCT02342678|7569921|FG001|Overall Study|Lost to Follow-up|1
4672605|NCT02342678|7569920|FG000|Overall Study|Too busy to complete study|0
4672606|NCT02342678|7569921|FG001|Overall Study|Too busy to complete study|2
4672607|NCT02342678|7569920|FG000|Overall Study|Family illness/emergency|0
4672608|NCT02342678|7569921|FG001|Overall Study|Family illness/emergency|1
4672609|NCT02342678|7569920|FG000|Overall Study|Illness/medical reason|1
4672610|NCT02342678|7569921|FG001|Overall Study|Illness/medical reason|1
4672611|NCT02342704|7569929|FG000|Overall Study|Physician Decision|0
4672612|NCT02342704|7569930|FG001|Overall Study|Physician Decision|3
4672613|NCT02342704|7569929|FG000|Overall Study|Sponsor Termination|49
4672614|NCT02342704|7569930|FG001|Overall Study|Sponsor Termination|43
4672615|NCT02342704|7569929|FG000|Overall Study|Other|0
4672616|NCT02342704|7569930|FG001|Overall Study|Other|1
4672617|NCT02342704|7569929|FG000|Overall Study|Withdrawal by Subject|1
4672618|NCT02342704|7569930|FG001|Overall Study|Withdrawal by Subject|0
4672619|NCT02342704|7569929|FG000|Overall Study|Lost to Follow-up|2
4672620|NCT02342704|7569930|FG001|Overall Study|Lost to Follow-up|1
4672621|NCT02342704|7569929|FG000|Overall Study|Adverse Event|1
4672622|NCT02342704|7569930|FG001|Overall Study|Adverse Event|3
4672623|NCT02342743|7569936|FG000|Baseline Period|Withdrawal by Subject|3
4672624|NCT02342743|7569936|FG000|Baseline Period|Lost to Follow-up|2
4672625|NCT02342743|7569936|FG000|Baseline Period|Change in prophylactic medication|3
4672626|NCT02342743|7569936|FG000|Baseline Period|Screening failure regarding baseline|7
4672627|NCT02342743|7569936|FG000|Treatment Period|Withdrawal by Subject|2
4672628|NCT02342743|7569936|FG000|Treatment Period|Lost to Follow-up|8
4672629|NCT02342743|7569936|FG000|Treatment Period|Change in prophylactic medication|1
4672630|NCT02342886|7569945|FG000|Overall Study|Treatment non-compliance|1
4672631|NCT02342886|7569946|FG001|Overall Study|Treatment non-compliance|0
4672632|NCT02342886|7569947|FG002|Overall Study|Treatment non-compliance|0
4672633|NCT02342886|7569948|FG003|Overall Study|Treatment non-compliance|1
4672634|NCT02342886|7569949|FG004|Overall Study|Treatment non-compliance|0
4755797|NCT01722331|7730389|FG000|Part 2|Non-Compliance with Study Drug|1
4755798|NCT01722331|7730390|FG001|Part 2|Non-Compliance with Study Drug|0
4755799|NCT01722331|7730391|FG002|Part 2|Non-Compliance with Study Drug|1
4755800|NCT01722331|7730392|FG003|Part 2|Non-Compliance with Study Drug|0
4755801|NCT01722331|7730393|FG004|Part 2|Non-Compliance with Study Drug|0
4755802|NCT01722331|7730394|FG005|Part 2|Non-Compliance with Study Drug|0
4755803|NCT01722331|7730395|FG006|Part 2|Non-Compliance with Study Drug|0
4755804|NCT01722331|7730389|FG000|Part 2|Physician Decision|0
4755805|NCT01722331|7730390|FG001|Part 2|Physician Decision|0
4755806|NCT01722331|7730391|FG002|Part 2|Physician Decision|2
4755807|NCT01722331|7730392|FG003|Part 2|Physician Decision|0
4755808|NCT01722331|7730393|FG004|Part 2|Physician Decision|0
4755809|NCT01722331|7730394|FG005|Part 2|Physician Decision|0
4755810|NCT01722331|7730395|FG006|Part 2|Physician Decision|0
4755811|NCT01722331|7730389|FG000|Part 2|Pregnancy|0
4755812|NCT01722331|7730390|FG001|Part 2|Pregnancy|0
4755813|NCT01722331|7730391|FG002|Part 2|Pregnancy|0
4755814|NCT01722331|7730392|FG003|Part 2|Pregnancy|0
4755815|NCT01722331|7730393|FG004|Part 2|Pregnancy|0
4755816|NCT01722331|7730394|FG005|Part 2|Pregnancy|1
4755817|NCT01722331|7730395|FG006|Part 2|Pregnancy|0
4755818|NCT01722331|7730389|FG000|Part 2|Progressive Disease|0
4755819|NCT01722331|7730390|FG001|Part 2|Progressive Disease|0
4672635|NCT02342886|7569945|FG000|Overall Study|Late exclusion: rifampicin resistance|1
4672636|NCT02342886|7569946|FG001|Overall Study|Late exclusion: rifampicin resistance|0
4755820|NCT01722331|7730391|FG002|Part 2|Progressive Disease|1
4755821|NCT01722331|7730392|FG003|Part 2|Progressive Disease|0
4755822|NCT01722331|7730393|FG004|Part 2|Progressive Disease|0
4672637|NCT02342886|7569947|FG002|Overall Study|Late exclusion: rifampicin resistance|0
4672638|NCT02342886|7569948|FG003|Overall Study|Late exclusion: rifampicin resistance|0
4672639|NCT02342886|7569949|FG004|Overall Study|Late exclusion: rifampicin resistance|0
4672640|NCT02342886|7569945|FG000|Overall Study|Adverse event/specific toxicity|4
4755823|NCT01722331|7730394|FG005|Part 2|Progressive Disease|0
4755824|NCT01722331|7730395|FG006|Part 2|Progressive Disease|0
4755825|NCT01722331|7730389|FG000|Part 2|Protocol Violation|1
4755826|NCT01722331|7730390|FG001|Part 2|Protocol Violation|0
4755827|NCT01722331|7730391|FG002|Part 2|Protocol Violation|0
4672641|NCT02342886|7569946|FG001|Overall Study|Adverse event/specific toxicity|3
4672642|NCT02342886|7569947|FG002|Overall Study|Adverse event/specific toxicity|11
4672643|NCT02342886|7569948|FG003|Overall Study|Adverse event/specific toxicity|2
4672644|NCT02342886|7569949|FG004|Overall Study|Adverse event/specific toxicity|1
4672645|NCT02342886|7569945|FG000|Overall Study|Lost to Follow-up|1
4672646|NCT02342886|7569946|FG001|Overall Study|Lost to Follow-up|0
4672647|NCT02342886|7569947|FG002|Overall Study|Lost to Follow-up|0
4672648|NCT02342886|7569948|FG003|Overall Study|Lost to Follow-up|0
4672649|NCT02342886|7569949|FG004|Overall Study|Lost to Follow-up|0
4672650|NCT02342886|7569945|FG000|Overall Study|Death|1
4672651|NCT02342886|7569946|FG001|Overall Study|Death|2
4672652|NCT02342886|7569947|FG002|Overall Study|Death|1
4672653|NCT02342886|7569948|FG003|Overall Study|Death|0
4672654|NCT02342886|7569949|FG004|Overall Study|Death|1
4672655|NCT02342886|7569945|FG000|Overall Study|Withdrawal by Subject|0
4672656|NCT02342886|7569946|FG001|Overall Study|Withdrawal by Subject|1
4672657|NCT02342886|7569947|FG002|Overall Study|Withdrawal by Subject|0
4672658|NCT02342886|7569948|FG003|Overall Study|Withdrawal by Subject|1
4672659|NCT02342886|7569949|FG004|Overall Study|Withdrawal by Subject|0
4672660|NCT02342886|7569945|FG000|Overall Study|Investigator/sponsor decision|0
4672661|NCT02342886|7569946|FG001|Overall Study|Investigator/sponsor decision|2
4672662|NCT02342886|7569947|FG002|Overall Study|Investigator/sponsor decision|0
4672663|NCT02342886|7569948|FG003|Overall Study|Investigator/sponsor decision|3
4672664|NCT02342886|7569949|FG004|Overall Study|Investigator/sponsor decision|1
4672665|NCT02342886|7569945|FG000|Overall Study|Pregnancy|0
4672666|NCT02342886|7569946|FG001|Overall Study|Pregnancy|0
4672667|NCT02342886|7569947|FG002|Overall Study|Pregnancy|2
4672668|NCT02342886|7569948|FG003|Overall Study|Pregnancy|0
4672669|NCT02342886|7569949|FG004|Overall Study|Pregnancy|0
4672670|NCT02342886|7569945|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0
4672671|NCT02342886|7569946|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0
4672672|NCT02342886|7569947|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1
4672673|NCT02342886|7569948|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0
4672674|NCT02342886|7569949|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0
4672675|NCT02342886|7569945|FG000|Overall Study|Protocol Violation|0
4672676|NCT02342886|7569946|FG001|Overall Study|Protocol Violation|0
4672677|NCT02342886|7569947|FG002|Overall Study|Protocol Violation|0
4672678|NCT02342886|7569948|FG003|Overall Study|Protocol Violation|2
4755828|NCT01722331|7730392|FG003|Part 2|Protocol Violation|0
4755829|NCT01722331|7730393|FG004|Part 2|Protocol Violation|0
4755830|NCT01722331|7730394|FG005|Part 2|Protocol Violation|0
4755831|NCT01722331|7730395|FG006|Part 2|Protocol Violation|0
4755832|NCT01722331|7730389|FG000|Part 2|Withdrawal by Subject|5
4755833|NCT01722331|7730390|FG001|Part 2|Withdrawal by Subject|0
4755834|NCT01722331|7730391|FG002|Part 2|Withdrawal by Subject|3
4755835|NCT01722331|7730392|FG003|Part 2|Withdrawal by Subject|0
4755836|NCT01722331|7730393|FG004|Part 2|Withdrawal by Subject|0
4755837|NCT01722331|7730394|FG005|Part 2|Withdrawal by Subject|2
4755838|NCT01722331|7730395|FG006|Part 2|Withdrawal by Subject|2
4755839|NCT01722331|7730389|FG000|Part 2|Other Protocol Specified Criteria|6
4755840|NCT01722331|7730390|FG001|Part 2|Other Protocol Specified Criteria|0
4755841|NCT01722331|7730391|FG002|Part 2|Other Protocol Specified Criteria|10
4755842|NCT01722331|7730392|FG003|Part 2|Other Protocol Specified Criteria|0
4755843|NCT01722331|7730393|FG004|Part 2|Other Protocol Specified Criteria|0
4755844|NCT01722331|7730394|FG005|Part 2|Other Protocol Specified Criteria|2
4755845|NCT01722331|7730395|FG006|Part 2|Other Protocol Specified Criteria|1
4755846|NCT01722331|7730389|FG000|Part 3|Adverse Event|2
4755847|NCT01722331|7730390|FG001|Part 3|Adverse Event|2
4755848|NCT01722331|7730391|FG002|Part 3|Adverse Event|0
4755849|NCT01722331|7730392|FG003|Part 3|Adverse Event|1
4755850|NCT01722331|7730393|FG004|Part 3|Adverse Event|0
4755851|NCT01722331|7730394|FG005|Part 3|Adverse Event|0
4755852|NCT01722331|7730395|FG006|Part 3|Adverse Event|0
4755853|NCT01722331|7730389|FG000|Part 3|Death|1
4755854|NCT01722331|7730390|FG001|Part 3|Death|0
4672679|NCT02342886|7569949|FG004|Overall Study|Protocol Violation|0
4672680|NCT02343003|7569963|FG000|Overall Study|Withdrawal by Subject|9
4672681|NCT02343003|7569964|FG001|Overall Study|Withdrawal by Subject|4
4672682|NCT02343003|7569963|FG000|Overall Study|Lost to Follow-up|5
4672683|NCT02343003|7569964|FG001|Overall Study|Lost to Follow-up|1
4672684|NCT02343003|7569963|FG000|Overall Study|Protocol Violation|1
4672685|NCT02343003|7569964|FG001|Overall Study|Protocol Violation|0
4672686|NCT02343003|7569963|FG000|Overall Study|Death|0
4672687|NCT02343003|7569964|FG001|Overall Study|Death|1
4755855|NCT01722331|7730391|FG002|Part 3|Death|0
4672688|NCT02343003|7569963|FG000|Overall Study|exclusion criteria met|1
4672689|NCT02343003|7569964|FG001|Overall Study|exclusion criteria met|1
4672690|NCT02343003|7569963|FG000|Overall Study|terminated by sponsor|2
4672691|NCT02343003|7569964|FG001|Overall Study|terminated by sponsor|0
4672692|NCT02343406|7570012|FG000|Overall Study|Progressive disease|72
4672693|NCT02343406|7570013|FG001|Overall Study|Progressive disease|70
4755856|NCT01722331|7730392|FG003|Part 3|Death|0
4755857|NCT01722331|7730393|FG004|Part 3|Death|0
4755858|NCT01722331|7730394|FG005|Part 3|Death|0
4755859|NCT01722331|7730395|FG006|Part 3|Death|0
4755860|NCT01722331|7730389|FG000|Part 3|Lack of Efficacy|1
4755861|NCT01722331|7730390|FG001|Part 3|Lack of Efficacy|0
4672694|NCT02343406|7570014|FG002|Overall Study|Progressive disease|43
4672695|NCT02343406|7570015|FG003|Overall Study|Progressive disease|15
4672696|NCT02343406|7570016|FG004|Overall Study|Progressive disease|5
4672697|NCT02343406|7570012|FG000|Overall Study|Adverse Event|6
4672698|NCT02343406|7570013|FG001|Overall Study|Adverse Event|8
4672699|NCT02343406|7570014|FG002|Overall Study|Adverse Event|6
4672700|NCT02343406|7570015|FG003|Overall Study|Adverse Event|3
4672701|NCT02343406|7570016|FG004|Overall Study|Adverse Event|0
4672702|NCT02343406|7570012|FG000|Overall Study|Withdrawal by Subject|6
4672703|NCT02343406|7570013|FG001|Overall Study|Withdrawal by Subject|4
4672704|NCT02343406|7570014|FG002|Overall Study|Withdrawal by Subject|8
4672705|NCT02343406|7570015|FG003|Overall Study|Withdrawal by Subject|3
4672706|NCT02343406|7570016|FG004|Overall Study|Withdrawal by Subject|0
4672707|NCT02343406|7570012|FG000|Overall Study|Death|2
4672708|NCT02343406|7570013|FG001|Overall Study|Death|1
4672709|NCT02343406|7570014|FG002|Overall Study|Death|0
4672710|NCT02343406|7570015|FG003|Overall Study|Death|0
4672711|NCT02343406|7570016|FG004|Overall Study|Death|0
4672712|NCT02343406|7570012|FG000|Overall Study|Start of a new anti-cancer treatment|0
4672713|NCT02343406|7570013|FG001|Overall Study|Start of a new anti-cancer treatment|1
4672714|NCT02343406|7570014|FG002|Overall Study|Start of a new anti-cancer treatment|0
4672715|NCT02343406|7570015|FG003|Overall Study|Start of a new anti-cancer treatment|1
4672716|NCT02343406|7570016|FG004|Overall Study|Start of a new anti-cancer treatment|0
4672717|NCT02343406|7570012|FG000|Overall Study|Other primary malignancy|0
4672718|NCT02343406|7570013|FG001|Overall Study|Other primary malignancy|1
4672719|NCT02343406|7570014|FG002|Overall Study|Other primary malignancy|0
4672720|NCT02343406|7570015|FG003|Overall Study|Other primary malignancy|0
4672721|NCT02343406|7570016|FG004|Overall Study|Other primary malignancy|0
4672722|NCT02343406|7570012|FG000|Overall Study|Other, not specified|2
4672723|NCT02343406|7570013|FG001|Overall Study|Other, not specified|1
4672724|NCT02343406|7570014|FG002|Overall Study|Other, not specified|1
4672725|NCT02343406|7570015|FG003|Overall Study|Other, not specified|4
4672726|NCT02343406|7570016|FG004|Overall Study|Other, not specified|0
4672727|NCT02343458|7570031|FG000|Overall Study|Adverse Event|15
4672728|NCT02343458|7570032|FG001|Overall Study|Adverse Event|14
4755862|NCT01722331|7730391|FG002|Part 3|Lack of Efficacy|0
4755863|NCT01722331|7730392|FG003|Part 3|Lack of Efficacy|0
4755864|NCT01722331|7730393|FG004|Part 3|Lack of Efficacy|0
4755865|NCT01722331|7730394|FG005|Part 3|Lack of Efficacy|0
4755866|NCT01722331|7730395|FG006|Part 3|Lack of Efficacy|0
4755867|NCT01722331|7730389|FG000|Part 3|Lost to Follow-up|3
4755868|NCT01722331|7730390|FG001|Part 3|Lost to Follow-up|4
4755869|NCT01722331|7730391|FG002|Part 3|Lost to Follow-up|0
4755870|NCT01722331|7730392|FG003|Part 3|Lost to Follow-up|0
4755871|NCT01722331|7730393|FG004|Part 3|Lost to Follow-up|0
4755872|NCT01722331|7730394|FG005|Part 3|Lost to Follow-up|1
4755873|NCT01722331|7730395|FG006|Part 3|Lost to Follow-up|0
4755874|NCT01722331|7730389|FG000|Part 3|Non-Compliance with Study Drug|0
4755875|NCT01722331|7730390|FG001|Part 3|Non-Compliance with Study Drug|1
4755876|NCT01722331|7730391|FG002|Part 3|Non-Compliance with Study Drug|0
4755877|NCT01722331|7730392|FG003|Part 3|Non-Compliance with Study Drug|0
4755878|NCT01722331|7730393|FG004|Part 3|Non-Compliance with Study Drug|0
4755879|NCT01722331|7730394|FG005|Part 3|Non-Compliance with Study Drug|0
4755880|NCT01722331|7730395|FG006|Part 3|Non-Compliance with Study Drug|0
4755881|NCT01722331|7730389|FG000|Part 3|Physician Decision|1
4755882|NCT01722331|7730390|FG001|Part 3|Physician Decision|1
4755883|NCT01722331|7730391|FG002|Part 3|Physician Decision|0
4755884|NCT01722331|7730392|FG003|Part 3|Physician Decision|0
4755885|NCT01722331|7730393|FG004|Part 3|Physician Decision|0
4755886|NCT01722331|7730394|FG005|Part 3|Physician Decision|0
4755887|NCT01722331|7730395|FG006|Part 3|Physician Decision|1
4755888|NCT01722331|7730389|FG000|Part 3|Protocol Violation|2
4755889|NCT01722331|7730390|FG001|Part 3|Protocol Violation|1
4672729|NCT02343458|7570033|FG002|Overall Study|Adverse Event|15
4672730|NCT02343458|7570034|FG003|Overall Study|Adverse Event|3
4672731|NCT02343458|7570031|FG000|Overall Study|Lack of Efficacy|3
4672732|NCT02343458|7570032|FG001|Overall Study|Lack of Efficacy|8
4672733|NCT02343458|7570033|FG002|Overall Study|Lack of Efficacy|4
4755890|NCT01722331|7730391|FG002|Part 3|Protocol Violation|0
4755891|NCT01722331|7730392|FG003|Part 3|Protocol Violation|0
4672734|NCT02343458|7570034|FG003|Overall Study|Lack of Efficacy|8
4672735|NCT02343458|7570031|FG000|Overall Study|Withdrawal by Subject|18
4755892|NCT01722331|7730393|FG004|Part 3|Protocol Violation|0
4755893|NCT01722331|7730394|FG005|Part 3|Protocol Violation|0
4672736|NCT02343458|7570032|FG001|Overall Study|Withdrawal by Subject|17
4672737|NCT02343458|7570033|FG002|Overall Study|Withdrawal by Subject|23
4672738|NCT02343458|7570034|FG003|Overall Study|Withdrawal by Subject|14
4672739|NCT02343458|7570031|FG000|Overall Study|Physician Decision|1
4672740|NCT02343458|7570032|FG001|Overall Study|Physician Decision|4
4672741|NCT02343458|7570033|FG002|Overall Study|Physician Decision|2
4672742|NCT02343458|7570034|FG003|Overall Study|Physician Decision|2
4672743|NCT02343458|7570031|FG000|Overall Study|Lost to Follow-up|5
4672744|NCT02343458|7570032|FG001|Overall Study|Lost to Follow-up|5
4672745|NCT02343458|7570033|FG002|Overall Study|Lost to Follow-up|3
4672746|NCT02343458|7570034|FG003|Overall Study|Lost to Follow-up|1
4672747|NCT02343458|7570031|FG000|Overall Study|Protocol Violation|2
4672748|NCT02343458|7570032|FG001|Overall Study|Protocol Violation|5
4672749|NCT02343458|7570033|FG002|Overall Study|Protocol Violation|2
4672750|NCT02343458|7570034|FG003|Overall Study|Protocol Violation|2
4672751|NCT02343458|7570031|FG000|Overall Study|Protocol Specified Criteria|17
4672752|NCT02343458|7570032|FG001|Overall Study|Protocol Specified Criteria|13
4672753|NCT02343458|7570033|FG002|Overall Study|Protocol Specified Criteria|14
4672754|NCT02343458|7570034|FG003|Overall Study|Protocol Specified Criteria|8
4672755|NCT02343939|7570071|FG000|Overall Study|Death|0
4672756|NCT02343939|7570072|FG001|Overall Study|Death|15
4672757|NCT02343939|7570073|FG002|Overall Study|Death|4
4672758|NCT02343939|7570074|FG003|Overall Study|Death|2
4672759|NCT02343939|7570075|FG004|Overall Study|Death|5
4672760|NCT02343939|7570076|FG005|Overall Study|Death|11
4672761|NCT02343939|7570077|FG006|Overall Study|Death|8
4672762|NCT02343939|7570078|FG007|Overall Study|Death|22
4672763|NCT02343939|7570079|FG008|Overall Study|Death|1
4672764|NCT02343939|7570071|FG000|Overall Study|Study terminated by sponsor|0
4672765|NCT02343939|7570072|FG001|Overall Study|Study terminated by sponsor|27
4672766|NCT02343939|7570073|FG002|Overall Study|Study terminated by sponsor|0
4672767|NCT02343939|7570074|FG003|Overall Study|Study terminated by sponsor|1
4672768|NCT02343939|7570075|FG004|Overall Study|Study terminated by sponsor|1
4672769|NCT02343939|7570076|FG005|Overall Study|Study terminated by sponsor|5
4672770|NCT02343939|7570077|FG006|Overall Study|Study terminated by sponsor|3
4672771|NCT02343939|7570078|FG007|Overall Study|Study terminated by sponsor|4
4672772|NCT02343939|7570079|FG008|Overall Study|Study terminated by sponsor|0
4672773|NCT02343939|7570071|FG000|Overall Study|Withdrew consent|3
4672774|NCT02343939|7570072|FG001|Overall Study|Withdrew consent|6
4672775|NCT02343939|7570073|FG002|Overall Study|Withdrew consent|1
4672776|NCT02343939|7570074|FG003|Overall Study|Withdrew consent|2
4672777|NCT02343939|7570075|FG004|Overall Study|Withdrew consent|2
4672778|NCT02343939|7570076|FG005|Overall Study|Withdrew consent|0
4672779|NCT02343939|7570077|FG006|Overall Study|Withdrew consent|0
4672780|NCT02343939|7570078|FG007|Overall Study|Withdrew consent|8
4672781|NCT02343939|7570079|FG008|Overall Study|Withdrew consent|6
4672782|NCT02343939|7570071|FG000|Overall Study|Treatment failure|0
4672783|NCT02343939|7570072|FG001|Overall Study|Treatment failure|0
4672784|NCT02343939|7570073|FG002|Overall Study|Treatment failure|0
4672785|NCT02343939|7570074|FG003|Overall Study|Treatment failure|0
4672786|NCT02343939|7570075|FG004|Overall Study|Treatment failure|0
4672787|NCT02343939|7570076|FG005|Overall Study|Treatment failure|0
4672788|NCT02343939|7570077|FG006|Overall Study|Treatment failure|2
4672789|NCT02343939|7570078|FG007|Overall Study|Treatment failure|1
4672790|NCT02343939|7570079|FG008|Overall Study|Treatment failure|0
4672791|NCT02343939|7570071|FG000|Overall Study|Investigator's discretion|0
4672792|NCT02343939|7570072|FG001|Overall Study|Investigator's discretion|0
4672793|NCT02343939|7570073|FG002|Overall Study|Investigator's discretion|0
4672794|NCT02343939|7570074|FG003|Overall Study|Investigator's discretion|1
4672795|NCT02343939|7570075|FG004|Overall Study|Investigator's discretion|0
4672796|NCT02343939|7570076|FG005|Overall Study|Investigator's discretion|0
4672797|NCT02343939|7570077|FG006|Overall Study|Investigator's discretion|1
4672798|NCT02343939|7570078|FG007|Overall Study|Investigator's discretion|0
4672799|NCT02343939|7570079|FG008|Overall Study|Investigator's discretion|0
4672800|NCT02343939|7570071|FG000|Overall Study|Adverse Event|0
4672801|NCT02343939|7570072|FG001|Overall Study|Adverse Event|0
4672802|NCT02343939|7570073|FG002|Overall Study|Adverse Event|0
4672803|NCT02343939|7570074|FG003|Overall Study|Adverse Event|0
4672804|NCT02343939|7570075|FG004|Overall Study|Adverse Event|0
4672805|NCT02343939|7570076|FG005|Overall Study|Adverse Event|1
4672806|NCT02343939|7570077|FG006|Overall Study|Adverse Event|0
4672807|NCT02343939|7570078|FG007|Overall Study|Adverse Event|0
4672808|NCT02343939|7570079|FG008|Overall Study|Adverse Event|0
4672809|NCT02343939|7570071|FG000|Overall Study|Never Treated With ENTO|0
4672810|NCT02343939|7570072|FG001|Overall Study|Never Treated With ENTO|0
4672811|NCT02343939|7570073|FG002|Overall Study|Never Treated With ENTO|0
4672812|NCT02343939|7570074|FG003|Overall Study|Never Treated With ENTO|0
4672813|NCT02343939|7570075|FG004|Overall Study|Never Treated With ENTO|0
4672814|NCT02343939|7570076|FG005|Overall Study|Never Treated With ENTO|0
4672815|NCT02343939|7570077|FG006|Overall Study|Never Treated With ENTO|1
4672816|NCT02343939|7570078|FG007|Overall Study|Never Treated With ENTO|2
4672817|NCT02343939|7570079|FG008|Overall Study|Never Treated With ENTO|0
4672818|NCT02344004|7570115|FG000|Overall Study|Adverse Event|11
4672819|NCT02344004|7570116|FG001|Overall Study|Adverse Event|1
4672820|NCT02344004|7570115|FG000|Overall Study|Death|9
4672821|NCT02344004|7570116|FG001|Overall Study|Death|7
4672822|NCT02344004|7570115|FG000|Overall Study|Physician Decision|4
4672823|NCT02344004|7570116|FG001|Overall Study|Physician Decision|1
4672824|NCT02344004|7570115|FG000|Overall Study|Withdrawal by Subject|22
4672825|NCT02344004|7570116|FG001|Overall Study|Withdrawal by Subject|5
4672826|NCT02344004|7570115|FG000|Overall Study|Rescue Medication|2
4672827|NCT02344004|7570116|FG001|Overall Study|Rescue Medication|0
4672828|NCT02344004|7570115|FG000|Overall Study|Other Not Specified|12
4672829|NCT02344004|7570116|FG001|Overall Study|Other Not Specified|0
4672830|NCT02344004|7570115|FG000|Overall Study|Protocol Violation|1
4672831|NCT02344004|7570116|FG001|Overall Study|Protocol Violation|0
4672832|NCT02344173|7570123|FG000|Procedure|Ablation Procedure Not Performed|7
4672833|NCT02344173|7570123|FG000|12-month Visit|Death|8
4672834|NCT02344173|7570123|FG000|12-month Visit|Withdrawal by Subject|30
4755894|NCT01722331|7730395|FG006|Part 3|Protocol Violation|0
4755895|NCT01722331|7730389|FG000|Part 3|Withdrawal by Subject|4
4755896|NCT01722331|7730390|FG001|Part 3|Withdrawal by Subject|7
4755897|NCT01722331|7730391|FG002|Part 3|Withdrawal by Subject|0
4755898|NCT01722331|7730392|FG003|Part 3|Withdrawal by Subject|0
4755899|NCT01722331|7730393|FG004|Part 3|Withdrawal by Subject|0
4755900|NCT01722331|7730394|FG005|Part 3|Withdrawal by Subject|2
4755901|NCT01722331|7730395|FG006|Part 3|Withdrawal by Subject|1
4755902|NCT01722331|7730389|FG000|Part 3|Other Protocol Specified Criteria|1
4755903|NCT01722331|7730390|FG001|Part 3|Other Protocol Specified Criteria|1
4755904|NCT01722331|7730391|FG002|Part 3|Other Protocol Specified Criteria|0
4755905|NCT01722331|7730392|FG003|Part 3|Other Protocol Specified Criteria|0
4755906|NCT01722331|7730393|FG004|Part 3|Other Protocol Specified Criteria|0
4755907|NCT01722331|7730394|FG005|Part 3|Other Protocol Specified Criteria|0
4755908|NCT01722331|7730395|FG006|Part 3|Other Protocol Specified Criteria|0
4755909|NCT01716117|7730409|FG000|Overall Study|Death|5
4755910|NCT01716117|7730410|FG001|Overall Study|Death|2
4755911|NCT01716117|7730409|FG000|Overall Study|Withdrawal by Subject|2
4755912|NCT01716117|7730410|FG001|Overall Study|Withdrawal by Subject|0
4755913|NCT01698905|7730424|FG000|Overall Study|Adverse Event|4
4755914|NCT01698905|7730424|FG000|Overall Study|Physician Decision|2
4755915|NCT01698905|7730424|FG000|Overall Study|Pregnancy|1
4755916|NCT01698905|7730424|FG000|Overall Study|Protocol Violation|1
4672835|NCT02344173|7570123|FG000|12-month Visit|Lost to Follow-up|58
4672836|NCT02344342|7570183|FG000|Overall Study|Industry partner dropped out|11
4672837|NCT02344342|7570184|FG001|Overall Study|Industry partner dropped out|9
4672838|NCT02344342|7570185|FG002|Overall Study|Industry partner dropped out|14
4672839|NCT02344342|7570186|FG003|Overall Study|Industry partner dropped out|10
4672840|NCT02344576|7570217|FG000|Enrollment|Agreed to Medical Record Review Only|7
4672841|NCT02344576|7570218|FG001|Enrollment|Agreed to Medical Record Review Only|8
4672842|NCT02344576|7570219|FG002|Enrollment|Agreed to Medical Record Review Only|0
4672843|NCT02344576|7570220|FG003|Enrollment|Agreed to Medical Record Review Only|0
4672844|NCT02344576|7570217|FG000|1-Month Follow-Up|Death|13
4672845|NCT02344576|7570218|FG001|1-Month Follow-Up|Death|8
4672846|NCT02344576|7570219|FG002|1-Month Follow-Up|Death|0
4672847|NCT02344576|7570220|FG003|1-Month Follow-Up|Death|0
4672848|NCT02344576|7570217|FG000|1-Month Follow-Up|Withdrawal by Subject|3
4672849|NCT02344576|7570218|FG001|1-Month Follow-Up|Withdrawal by Subject|14
4672850|NCT02344576|7570219|FG002|1-Month Follow-Up|Withdrawal by Subject|8
4672851|NCT02344576|7570220|FG003|1-Month Follow-Up|Withdrawal by Subject|10
4672852|NCT02344576|7570217|FG000|1-Month Follow-Up|Lost to Follow-up|2
4672853|NCT02344576|7570218|FG001|1-Month Follow-Up|Lost to Follow-up|5
4672854|NCT02344576|7570219|FG002|1-Month Follow-Up|Lost to Follow-up|11
4672855|NCT02344576|7570220|FG003|1-Month Follow-Up|Lost to Follow-up|3
4672856|NCT02344576|7570217|FG000|6-Month Follow-Up|Death|14
4672857|NCT02344576|7570218|FG001|6-Month Follow-Up|Death|14
4672858|NCT02344576|7570219|FG002|6-Month Follow-Up|Death|0
4672859|NCT02344576|7570220|FG003|6-Month Follow-Up|Death|0
4672860|NCT02344576|7570217|FG000|6-Month Follow-Up|Withdrawal by Subject|1
4672861|NCT02344576|7570218|FG001|6-Month Follow-Up|Withdrawal by Subject|0
4672862|NCT02344576|7570219|FG002|6-Month Follow-Up|Withdrawal by Subject|1
4672863|NCT02344576|7570220|FG003|6-Month Follow-Up|Withdrawal by Subject|2
4672864|NCT02344576|7570217|FG000|6-Month Follow-Up|Lost to Follow-up|4
4672865|NCT02344576|7570218|FG001|6-Month Follow-Up|Lost to Follow-up|5
4672866|NCT02344576|7570219|FG002|6-Month Follow-Up|Lost to Follow-up|13
4672867|NCT02344576|7570220|FG003|6-Month Follow-Up|Lost to Follow-up|6
4672868|NCT02344745|7570243|FG000|Overall Study|Data collection sheets were lost|2
4672869|NCT02344745|7570244|FG001|Overall Study|Data collection sheets were lost|0
4672870|NCT02345161|7570263|FG000|Overall Study|Withdrawal by Subject|25
4672871|NCT02345161|7570264|FG001|Overall Study|Withdrawal by Subject|33
4672872|NCT02345161|7570263|FG000|Overall Study|Adverse Event|16
4672873|NCT02345161|7570264|FG001|Overall Study|Adverse Event|19
4672874|NCT02345161|7570263|FG000|Overall Study|Physician Decision|4
4672875|NCT02345161|7570264|FG001|Overall Study|Physician Decision|4
4672876|NCT02345161|7570263|FG000|Overall Study|Lost to Follow-up|0
4672877|NCT02345161|7570264|FG001|Overall Study|Lost to Follow-up|1
4755917|NCT01698905|7730424|FG000|Overall Study|Subject/guardian decision|2
4672878|NCT02345226|7570277|FG000|Double-Blind Phase|Adverse Event|5
4672879|NCT02345226|7570278|FG001|Double-Blind Phase|Adverse Event|6
4672880|NCT02345226|7570277|FG000|Double-Blind Phase|Death|3
4672881|NCT02345226|7570278|FG001|Double-Blind Phase|Death|0
4755918|NCT01698905|7730424|FG000|Overall Study|Death|1
4672882|NCT02345226|7570277|FG000|Double-Blind Phase|Pregnancy|0
4672883|NCT02345226|7570278|FG001|Double-Blind Phase|Pregnancy|1
4672884|NCT02345226|7570277|FG000|Double-Blind Phase|Lack of Efficacy|1
4672885|NCT02345226|7570278|FG001|Double-Blind Phase|Lack of Efficacy|0
4672886|NCT02345226|7570277|FG000|Double-Blind Phase|Investigator's Discretion|4
4672887|NCT02345226|7570278|FG001|Double-Blind Phase|Investigator's Discretion|3
4672888|NCT02345226|7570277|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1
4672889|NCT02345226|7570278|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2
4672890|NCT02345226|7570277|FG000|Double-Blind Phase|Withdrew Consent|41
4672891|NCT02345226|7570278|FG001|Double-Blind Phase|Withdrew Consent|39
4672892|NCT02345226|7570277|FG000|Double-Blind Phase|Lost to Follow-up|12
4672893|NCT02345226|7570278|FG001|Double-Blind Phase|Lost to Follow-up|16
4672894|NCT02345226|7570277|FG000|Double-Blind Phase|Randomized but Never Treated|2
4672895|NCT02345226|7570278|FG001|Double-Blind Phase|Randomized but Never Treated|4
4672896|NCT02345226|7570277|FG000|Open-Label Extension Phase|Lost to Follow-up|0
4672897|NCT02345226|7570278|FG001|Open-Label Extension Phase|Lost to Follow-up|1
4672898|NCT02345252|7570288|FG000|Double-Blind Phase|Adverse Event|2
4672899|NCT02345252|7570289|FG001|Double-Blind Phase|Adverse Event|3
4672900|NCT02345252|7570288|FG000|Double-Blind Phase|Death|1
4672901|NCT02345252|7570289|FG001|Double-Blind Phase|Death|2
4672902|NCT02345252|7570288|FG000|Double-Blind Phase|Lack of Efficacy|1
4672903|NCT02345252|7570289|FG001|Double-Blind Phase|Lack of Efficacy|0
4672904|NCT02345252|7570288|FG000|Double-Blind Phase|Investigator's Discretion|4
4672905|NCT02345252|7570289|FG001|Double-Blind Phase|Investigator's Discretion|6
4672906|NCT02345252|7570288|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1
4672907|NCT02345252|7570289|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2
4672908|NCT02345252|7570288|FG000|Double-Blind Phase|Protocol Violation|2
4672909|NCT02345252|7570289|FG001|Double-Blind Phase|Protocol Violation|1
4672910|NCT02345252|7570288|FG000|Double-Blind Phase|Withdrew Consent|21
4672911|NCT02345252|7570289|FG001|Double-Blind Phase|Withdrew Consent|23
4672912|NCT02345252|7570288|FG000|Double-Blind Phase|Lost to Follow-up|8
4672913|NCT02345252|7570289|FG001|Double-Blind Phase|Lost to Follow-up|10
4672914|NCT02345252|7570288|FG000|Double-Blind Phase|Randomized but Never Treated|0
4672915|NCT02345252|7570289|FG001|Double-Blind Phase|Randomized but Never Treated|2
4672916|NCT02345330|7570297|FG000|Overall Study|Death|1
4672917|NCT02345330|7570297|FG000|Overall Study|Progressive Disease|2
4672918|NCT02345434|7570303|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5
4672919|NCT02345434|7570304|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2
4672920|NCT02345512|7570319|FG000|Overall Study|Adverse Event|1
4755919|NCT01670500|7730447|FG000|Overall Study|Withdrawal by Subject|1
4755920|NCT01670500|7730448|FG001|Overall Study|Withdrawal by Subject|0
4755921|NCT01630590|7730454|FG000|Overall Study|Adverse Event|9
4755922|NCT01630590|7730454|FG000|Overall Study|Lack of Efficacy|37
4755923|NCT01630590|7730454|FG000|Overall Study|Withdrawal by Subject|4
4755924|NCT01630590|7730454|FG000|Overall Study|2nd primary tumor|2
4755925|NCT01630590|7730454|FG000|Overall Study|Automobile accident|1
4755926|NCT01630590|7730454|FG000|Overall Study|Maximum benefit|4
4755927|NCT01619085|7730458|FG000|Overall Study|Adverse Event|231
4755928|NCT01619085|7730458|FG000|Overall Study|Protocol Violation|4
4755929|NCT01619085|7730458|FG000|Overall Study|Lost to Follow-up|3
4755930|NCT01619085|7730458|FG000|Overall Study|Withdrawal by Subject|45
4755931|NCT01619085|7730458|FG000|Overall Study|Other than specified|96
4755932|NCT01619085|7730458|FG000|Overall Study|Not treated|1
4755933|NCT01619085|7730458|FG000|Overall Study|Death|145
4755934|NCT01499095|7730471|FG000|Overall Study|Randomized But Not Treated|1
4755935|NCT01499095|7730472|FG001|Overall Study|Randomized But Not Treated|1
4755936|NCT01499095|7730471|FG000|Overall Study|Adverse Event|12
4755937|NCT01499095|7730472|FG001|Overall Study|Adverse Event|7
4755938|NCT01499095|7730471|FG000|Overall Study|Lack of Efficacy|2
4755939|NCT01499095|7730472|FG001|Overall Study|Lack of Efficacy|1
4755940|NCT01499095|7730471|FG000|Overall Study|Protocol Violation|6
4755941|NCT01499095|7730472|FG001|Overall Study|Protocol Violation|7
4755942|NCT01499095|7730471|FG000|Overall Study|Received Rescue Therapy|32
4755943|NCT01499095|7730472|FG001|Overall Study|Received Rescue Therapy|40
4755944|NCT01499095|7730471|FG000|Overall Study|Diverse Reasons|22
4755945|NCT01499095|7730472|FG001|Overall Study|Diverse Reasons|25
4755946|NCT01499095|7730471|FG000|Overall Study|Lost to Follow-up|6
4755947|NCT01499095|7730472|FG001|Overall Study|Lost to Follow-up|4
4755948|NCT01499095|7730471|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0
4755949|NCT01499095|7730472|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5
4755950|NCT01499095|7730471|FG000|Overall Study|Hypoglycemia|3
4755951|NCT01499095|7730472|FG001|Overall Study|Hypoglycemia|1
4755952|NCT01499095|7730471|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2
4755953|NCT01499095|7730472|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1
4755954|NCT01499095|7730471|FG000|Overall Study|Change in Injection Schedule|2
4755955|NCT01499095|7730472|FG001|Overall Study|Change in Injection Schedule|0
4755956|NCT01499095|7730471|FG000|Overall Study|Perceived Lack of Efficacy|1
4672921|NCT02345512|7570319|FG000|Overall Study|Withdrawal by Subject|1
4672922|NCT02345811|7570341|FG000|First Intervention|Withdrawal by Subject|1
4755957|NCT01499095|7730472|FG001|Overall Study|Perceived Lack of Efficacy|1
4755958|NCT01499082|7730483|FG000|Overall Study|Randomized but not Treated|0
4672923|NCT02345811|7570342|FG001|First Intervention|Withdrawal by Subject|1
4672924|NCT02345889|7570354|FG000|Overall Study|Inadequate Bowel Prep|17
4672925|NCT02345889|7570355|FG001|Overall Study|Inadequate Bowel Prep|16
4672926|NCT02345889|7570356|FG002|Overall Study|Inadequate Bowel Prep|18
4672927|NCT02345889|7570357|FG003|Overall Study|Inadequate Bowel Prep|14
4672928|NCT02345889|7570354|FG000|Overall Study|Polyposis identified during procedure|1
4672929|NCT02345889|7570355|FG001|Overall Study|Polyposis identified during procedure|1
4672930|NCT02345889|7570356|FG002|Overall Study|Polyposis identified during procedure|0
4672931|NCT02345889|7570357|FG003|Overall Study|Polyposis identified during procedure|1
4672932|NCT02345889|7570354|FG000|Overall Study|Recognized ineligible post-randomization|1
4672933|NCT02345889|7570355|FG001|Overall Study|Recognized ineligible post-randomization|0
4672934|NCT02345889|7570356|FG002|Overall Study|Recognized ineligible post-randomization|2
4672935|NCT02345889|7570357|FG003|Overall Study|Recognized ineligible post-randomization|1
4672936|NCT02345889|7570354|FG000|Overall Study|Ulcerative Colitis identified|1
4672937|NCT02345889|7570355|FG001|Overall Study|Ulcerative Colitis identified|0
4672938|NCT02345889|7570356|FG002|Overall Study|Ulcerative Colitis identified|0
4672939|NCT02345889|7570357|FG003|Overall Study|Ulcerative Colitis identified|0
4672940|NCT02345889|7570354|FG000|Overall Study|Cecum not intubated|1
4672941|NCT02345889|7570355|FG001|Overall Study|Cecum not intubated|0
4672942|NCT02345889|7570356|FG002|Overall Study|Cecum not intubated|0
4672943|NCT02345889|7570357|FG003|Overall Study|Cecum not intubated|0
4672944|NCT02346136|7570369|FG000|Overall Study|Withdrawal by Subject|7
4672945|NCT02346136|7570370|FG001|Overall Study|Withdrawal by Subject|5
4672946|NCT02346136|7570369|FG000|Overall Study|Death|1
4672947|NCT02346136|7570370|FG001|Overall Study|Death|0
4672948|NCT02346136|7570369|FG000|Overall Study|Study termination|14
4672949|NCT02346136|7570370|FG001|Overall Study|Study termination|18
4672950|NCT02346240|7570380|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0
4672951|NCT02346240|7570381|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4
4672952|NCT02346240|7570382|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1
4755959|NCT01499082|7730484|FG001|Overall Study|Randomized but not Treated|1
4755960|NCT01499082|7730483|FG000|Overall Study|Adverse Event|12
4755961|NCT01499082|7730484|FG001|Overall Study|Adverse Event|16
4755962|NCT01499082|7730483|FG000|Overall Study|Lack of Efficacy|1
4755963|NCT01499082|7730484|FG001|Overall Study|Lack of Efficacy|1
4755964|NCT01499082|7730483|FG000|Overall Study|Protocol Violation|6
4755965|NCT01499082|7730484|FG001|Overall Study|Protocol Violation|8
4755966|NCT01499082|7730483|FG000|Overall Study|Diverse Reasons|18
4755967|NCT01499082|7730484|FG001|Overall Study|Diverse Reasons|14
4755968|NCT01499082|7730483|FG000|Overall Study|Site Closure for Noncompliance|5
4755969|NCT01499082|7730484|FG001|Overall Study|Site Closure for Noncompliance|2
4755970|NCT01499082|7730483|FG000|Overall Study|Hypoglycemia|2
4755971|NCT01499082|7730484|FG001|Overall Study|Hypoglycemia|3
4755972|NCT01499082|7730483|FG000|Overall Study|Lost to Follow-up|1
4755973|NCT01499082|7730484|FG001|Overall Study|Lost to Follow-up|3
4755974|NCT01496976|7730492|FG000|Overall Study|Withdrew - received stem cell transplant|1
4755975|NCT01488890|7730500|FG000|Overall Study|Serious adverse event|2
4755976|NCT01488890|7730501|FG001|Overall Study|Serious adverse event|0
4755977|NCT01488890|7730502|FG002|Overall Study|Serious adverse event|0
4755978|NCT01488890|7730503|FG003|Overall Study|Serious adverse event|0
4672953|NCT02346240|7570383|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1
4672954|NCT02346240|7570384|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0
4672955|NCT02346240|7570385|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0
4672956|NCT02346240|7570386|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0
4672957|NCT02346240|7570387|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0
4672958|NCT02346240|7570388|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0
4672959|NCT02346240|7570389|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0
4672960|NCT02346240|7570390|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0
4672961|NCT02346240|7570391|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0
4672962|NCT02346240|7570392|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0
4672963|NCT02346240|7570393|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0
4672964|NCT02346240|7570394|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0
4672965|NCT02346240|7570395|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0
4672966|NCT02346240|7570396|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0
4672967|NCT02346240|7570397|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0
4672968|NCT02346240|7570398|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0
4672969|NCT02346240|7570399|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0
4672970|NCT02346240|7570400|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0
4672971|NCT02346240|7570401|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0
4672972|NCT02346240|7570402|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0
4672973|NCT02346240|7570403|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0
4755979|NCT01488890|7730500|FG000|Overall Study|Protocol Violation|3
4755980|NCT01488890|7730501|FG001|Overall Study|Protocol Violation|0
4755981|NCT01488890|7730502|FG002|Overall Study|Protocol Violation|4
4755982|NCT01488890|7730503|FG003|Overall Study|Protocol Violation|0
4755983|NCT01488890|7730500|FG000|Overall Study|Lost to Follow-up|13
4755984|NCT01488890|7730501|FG001|Overall Study|Lost to Follow-up|10
4672974|NCT02346240|7570380|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
4672975|NCT02346240|7570381|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1
4672976|NCT02346240|7570382|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
4672977|NCT02346240|7570383|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
4672978|NCT02346240|7570384|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
4672979|NCT02346240|7570385|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
4672980|NCT02346240|7570386|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
4672981|NCT02346240|7570387|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
4672982|NCT02346240|7570388|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
4672983|NCT02346240|7570389|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
4672984|NCT02346240|7570390|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
4672985|NCT02346240|7570391|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
4672986|NCT02346240|7570392|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
4672987|NCT02346240|7570393|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
4672988|NCT02346240|7570394|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
4672989|NCT02346240|7570395|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
4672990|NCT02346240|7570396|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
4672991|NCT02346240|7570397|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
4672992|NCT02346240|7570398|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
4672993|NCT02346240|7570399|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
4672994|NCT02346240|7570400|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
4672995|NCT02346240|7570401|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
4672996|NCT02346240|7570402|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
4672997|NCT02346240|7570403|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
4672998|NCT02346240|7570380|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0
4672999|NCT02346240|7570381|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1
4673000|NCT02346240|7570382|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0
4673001|NCT02346240|7570383|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0
4673002|NCT02346240|7570384|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0
4673003|NCT02346240|7570385|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0
4673004|NCT02346240|7570386|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0
4673005|NCT02346240|7570387|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0
4673006|NCT02346240|7570388|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0
4673007|NCT02346240|7570389|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0
4673008|NCT02346240|7570390|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0
4673009|NCT02346240|7570391|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0
4673010|NCT02346240|7570392|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0
4673011|NCT02346240|7570393|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0
4673012|NCT02346240|7570394|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0
4673013|NCT02346240|7570395|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0
4673014|NCT02346240|7570396|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0
4673015|NCT02346240|7570397|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0
4673016|NCT02346240|7570398|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0
4673017|NCT02346240|7570399|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0
4755985|NCT01488890|7730502|FG002|Overall Study|Lost to Follow-up|20
4755986|NCT01488890|7730503|FG003|Overall Study|Lost to Follow-up|3
4755987|NCT01488890|7730500|FG000|Overall Study|Withdrawal by Subject|14
4755988|NCT01488890|7730501|FG001|Overall Study|Withdrawal by Subject|10
4755989|NCT01488890|7730502|FG002|Overall Study|Withdrawal by Subject|11
4755990|NCT01488890|7730503|FG003|Overall Study|Withdrawal by Subject|2
4755991|NCT01436396|7730519|FG000|Overall Study|Protocol Violation|7
4755992|NCT01436396|7730520|FG001|Overall Study|Protocol Violation|5
4755993|NCT01436396|7730519|FG000|Overall Study|Adverse Event|1
4755994|NCT01436396|7730520|FG001|Overall Study|Adverse Event|2
4755995|NCT01436396|7730519|FG000|Overall Study|Withdrawal by Subject|19
4755996|NCT01436396|7730520|FG001|Overall Study|Withdrawal by Subject|29
4755997|NCT01436396|7730519|FG000|Overall Study|Serious adverse event|2
4755998|NCT01436396|7730520|FG001|Overall Study|Serious adverse event|3
4755999|NCT01436396|7730519|FG000|Overall Study|Lost to Follow-up|3
4756000|NCT01436396|7730520|FG001|Overall Study|Lost to Follow-up|3
4756001|NCT01411241|7730528|FG000|Overall Study|Protocol Violation|0
4756002|NCT01411241|7730529|FG001|Overall Study|Protocol Violation|5
4756003|NCT01411241|7730528|FG000|Overall Study|Withdrawal by Subject|9
4756004|NCT01411241|7730529|FG001|Overall Study|Withdrawal by Subject|10
4756005|NCT01411241|7730528|FG000|Overall Study|Serious Adverse Event|0
4756006|NCT01411241|7730529|FG001|Overall Study|Serious Adverse Event|3
4756007|NCT01411241|7730528|FG000|Overall Study|Lost to Follow-up|2
4756008|NCT01411241|7730529|FG001|Overall Study|Lost to Follow-up|4
4756009|NCT01374516|7730537|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43
4756010|NCT01374516|7730538|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14
4756011|NCT01374516|7730537|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3
4756012|NCT01374516|7730538|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0
4756013|NCT01374516|7730537|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480
4756014|NCT01374516|7730538|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240
4673018|NCT02346240|7570400|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0
4673019|NCT02346240|7570401|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0
4673020|NCT02346240|7570402|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0
4673021|NCT02346240|7570403|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0
4673022|NCT02346240|7570380|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1
4673023|NCT02346240|7570381|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2
4673024|NCT02346240|7570382|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1
4673025|NCT02346240|7570383|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3
4673026|NCT02346240|7570384|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
4673027|NCT02346240|7570385|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
4673028|NCT02346240|7570386|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
4673029|NCT02346240|7570387|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
4673030|NCT02346240|7570388|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
4673031|NCT02346240|7570389|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
4673032|NCT02346240|7570390|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
4673033|NCT02346240|7570391|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
4673034|NCT02346240|7570392|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
4673035|NCT02346240|7570393|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
4673036|NCT02346240|7570394|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
4673037|NCT02346240|7570395|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
4673038|NCT02346240|7570396|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
4673039|NCT02346240|7570397|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
4673040|NCT02346240|7570398|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
4673041|NCT02346240|7570399|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
4673042|NCT02346240|7570400|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
4673043|NCT02346240|7570401|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
4673044|NCT02346240|7570402|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
4673045|NCT02346240|7570403|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
4673046|NCT02346240|7570380|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1
4673047|NCT02346240|7570381|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2
4673048|NCT02346240|7570382|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3
4673049|NCT02346240|7570383|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2
4673050|NCT02346240|7570384|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
4673051|NCT02346240|7570385|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
4756015|NCT01374516|7730537|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106
4756016|NCT01374516|7730538|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46
4756017|NCT01374516|7730537|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7
4756018|NCT01374516|7730538|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9
4756019|NCT01374516|7730537|FG000|Surveillance Expansion Period|Protocol Violation|386
4756020|NCT01374516|7730538|FG001|Surveillance Expansion Period|Protocol Violation|217
4756021|NCT01374516|7730537|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870
4756022|NCT01374516|7730538|FG001|Surveillance Expansion Period|Withdrawal by Subject|986
4756023|NCT01374516|7730537|FG000|Surveillance Expansion Period|Lost to Follow-up|73
4756024|NCT01374516|7730538|FG001|Surveillance Expansion Period|Lost to Follow-up|45
4756025|NCT01374516|7730537|FG000|Surveillance Expansion Period|Serious adverse event|20
4756026|NCT01374516|7730538|FG001|Surveillance Expansion Period|Serious adverse event|5
4756027|NCT01373281|7730553|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40
4673052|NCT02346240|7570386|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
4673053|NCT02346240|7570387|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
4673054|NCT02346240|7570388|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
4673055|NCT02346240|7570389|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
4673056|NCT02346240|7570390|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
4673057|NCT02346240|7570391|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
4673058|NCT02346240|7570392|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
4673059|NCT02346240|7570393|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
4673060|NCT02346240|7570394|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
4673061|NCT02346240|7570395|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
4673062|NCT02346240|7570396|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
4673063|NCT02346240|7570397|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
4673064|NCT02346240|7570398|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
4673065|NCT02346240|7570399|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
4673066|NCT02346240|7570400|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
4673067|NCT02346240|7570401|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
4673068|NCT02346240|7570402|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
4673069|NCT02346240|7570403|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
4673070|NCT02346240|7570380|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0
4673071|NCT02346240|7570381|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1
4673072|NCT02346240|7570382|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0
4673073|NCT02346240|7570383|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1
4673074|NCT02346240|7570384|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0
4673075|NCT02346240|7570385|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0
4673076|NCT02346240|7570386|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0
4673077|NCT02346240|7570387|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0
4673078|NCT02346240|7570388|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0
4673079|NCT02346240|7570389|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0
4673080|NCT02346240|7570390|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0
4673081|NCT02346240|7570391|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0
4673082|NCT02346240|7570392|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0
4673083|NCT02346240|7570393|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0
4673084|NCT02346240|7570394|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0
4673085|NCT02346240|7570395|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0
4673086|NCT02346240|7570396|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0
4673087|NCT02346240|7570397|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0
4673088|NCT02346240|7570398|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0
4673089|NCT02346240|7570399|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0
4673090|NCT02346240|7570400|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0
4673091|NCT02346240|7570401|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0
4673092|NCT02346240|7570402|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0
4673093|NCT02346240|7570403|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0
4673094|NCT02346240|7570380|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
4673095|NCT02346240|7570381|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
4673096|NCT02346240|7570382|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1
4673097|NCT02346240|7570383|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
4673098|NCT02346240|7570384|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
4673099|NCT02346240|7570385|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
4673100|NCT02346240|7570386|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
4673101|NCT02346240|7570387|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
4673102|NCT02346240|7570388|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
4673103|NCT02346240|7570389|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
4673104|NCT02346240|7570390|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
4673105|NCT02346240|7570391|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
4673106|NCT02346240|7570392|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
4673107|NCT02346240|7570393|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
4673108|NCT02346240|7570394|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
4673109|NCT02346240|7570395|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
4673110|NCT02346240|7570396|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
4673111|NCT02346240|7570397|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
4673112|NCT02346240|7570398|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
4673113|NCT02346240|7570399|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
4673114|NCT02346240|7570400|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
4673115|NCT02346240|7570401|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
4673116|NCT02346240|7570402|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
4673117|NCT02346240|7570403|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
4673118|NCT02346240|7570380|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4673119|NCT02346240|7570381|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4673120|NCT02346240|7570382|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4673121|NCT02346240|7570383|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4673122|NCT02346240|7570384|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4673123|NCT02346240|7570385|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4673124|NCT02346240|7570386|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4673125|NCT02346240|7570387|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
4673126|NCT02346240|7570388|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
4673127|NCT02346240|7570389|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4673128|NCT02346240|7570390|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4673129|NCT02346240|7570391|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4673130|NCT02346240|7570392|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4673131|NCT02346240|7570393|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
4673132|NCT02346240|7570394|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4
4673133|NCT02346240|7570395|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
4673134|NCT02346240|7570396|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
4673135|NCT02346240|7570397|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4673136|NCT02346240|7570398|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4673137|NCT02346240|7570399|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4673138|NCT02346240|7570400|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4673139|NCT02346240|7570401|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4673140|NCT02346240|7570402|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4673141|NCT02346240|7570403|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4673142|NCT02346240|7570380|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4673143|NCT02346240|7570381|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4673144|NCT02346240|7570382|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4673145|NCT02346240|7570383|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4673146|NCT02346240|7570384|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4673147|NCT02346240|7570385|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4673148|NCT02346240|7570386|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4673149|NCT02346240|7570387|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4673150|NCT02346240|7570388|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4673151|NCT02346240|7570389|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4673152|NCT02346240|7570390|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4673153|NCT02346240|7570391|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4673154|NCT02346240|7570392|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4673155|NCT02346240|7570393|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
4673156|NCT02346240|7570394|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4673157|NCT02346240|7570395|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3
4673158|NCT02346240|7570396|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4673159|NCT02346240|7570397|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4673160|NCT02346240|7570398|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4673161|NCT02346240|7570399|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4673162|NCT02346240|7570400|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4673163|NCT02346240|7570401|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4673164|NCT02346240|7570402|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4673165|NCT02346240|7570403|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4673166|NCT02346240|7570380|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4673167|NCT02346240|7570381|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4673168|NCT02346240|7570382|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4673169|NCT02346240|7570383|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4673170|NCT02346240|7570384|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4756028|NCT01373281|7730554|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23
4756029|NCT01373281|7730553|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5
4756030|NCT01373281|7730554|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2
4756031|NCT01373281|7730553|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5
4756032|NCT01373281|7730554|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1
4756033|NCT01373281|7730553|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4
4756034|NCT01373281|7730554|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1
4756035|NCT01373281|7730553|FG000|Surveillance Expansion Period|Withdrawal by Subject|180
4756036|NCT01373281|7730554|FG001|Surveillance Expansion Period|Withdrawal by Subject|105
4756037|NCT01373281|7730553|FG000|Surveillance Expansion Period|Protocol Violation|9
4756038|NCT01373281|7730554|FG001|Surveillance Expansion Period|Protocol Violation|1
4756039|NCT01373281|7730553|FG000|Surveillance Expansion Period|Lost to Follow-up|10
4756040|NCT01373281|7730554|FG001|Surveillance Expansion Period|Lost to Follow-up|8
4756041|NCT01373281|7730553|FG000|Surveillance Expansion Period|Serious adverse event|3
4756042|NCT01373281|7730554|FG001|Surveillance Expansion Period|Serious adverse event|4
4756043|NCT01302847|7730575|FG000|Overall Study|Ongoing|0
4756044|NCT01302847|7730576|FG001|Overall Study|Ongoing|0
4756045|NCT01302847|7730577|FG002|Overall Study|Ongoing|0
4756046|NCT01302847|7730578|FG003|Overall Study|Ongoing|0
4756047|NCT01302847|7730579|FG004|Overall Study|Ongoing|0
4756048|NCT01302847|7730580|FG005|Overall Study|Ongoing|27
4756049|NCT01302847|7730581|FG006|Overall Study|Ongoing|22
4756050|NCT01302847|7730582|FG007|Overall Study|Ongoing|17
4756051|NCT01302847|7730575|FG000|Overall Study|Death|0
4756052|NCT01302847|7730576|FG001|Overall Study|Death|1
4756053|NCT01302847|7730577|FG002|Overall Study|Death|0
4756054|NCT01302847|7730578|FG003|Overall Study|Death|0
4756055|NCT01302847|7730579|FG004|Overall Study|Death|0
4756056|NCT01302847|7730580|FG005|Overall Study|Death|1
4756057|NCT01302847|7730581|FG006|Overall Study|Death|1
4756058|NCT01302847|7730582|FG007|Overall Study|Death|0
4756059|NCT01302847|7730575|FG000|Overall Study|Pregnancy|2
4756060|NCT01302847|7730576|FG001|Overall Study|Pregnancy|0
4756061|NCT01302847|7730577|FG002|Overall Study|Pregnancy|0
4756062|NCT01302847|7730578|FG003|Overall Study|Pregnancy|0
4756063|NCT01302847|7730579|FG004|Overall Study|Pregnancy|0
4756064|NCT01302847|7730580|FG005|Overall Study|Pregnancy|0
4756065|NCT01302847|7730581|FG006|Overall Study|Pregnancy|0
4756066|NCT01302847|7730582|FG007|Overall Study|Pregnancy|0
4756067|NCT01302847|7730575|FG000|Overall Study|Virologic failure|0
4756068|NCT01302847|7730576|FG001|Overall Study|Virologic failure|2
4756069|NCT01302847|7730577|FG002|Overall Study|Virologic failure|2
4756070|NCT01302847|7730578|FG003|Overall Study|Virologic failure|0
4673171|NCT02346240|7570385|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4673172|NCT02346240|7570386|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4673173|NCT02346240|7570387|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4673174|NCT02346240|7570388|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4756071|NCT01302847|7730579|FG004|Overall Study|Virologic failure|1
4673175|NCT02346240|7570389|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4673176|NCT02346240|7570390|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4673177|NCT02346240|7570391|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4673178|NCT02346240|7570392|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4673179|NCT02346240|7570393|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4673180|NCT02346240|7570394|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1
4673181|NCT02346240|7570395|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4673182|NCT02346240|7570396|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4673183|NCT02346240|7570397|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4673184|NCT02346240|7570398|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4673185|NCT02346240|7570399|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4673186|NCT02346240|7570400|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4673187|NCT02346240|7570401|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4673188|NCT02346240|7570402|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4673189|NCT02346240|7570403|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4673190|NCT02346240|7570380|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4673191|NCT02346240|7570381|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4673192|NCT02346240|7570382|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4673193|NCT02346240|7570383|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4673194|NCT02346240|7570384|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4673195|NCT02346240|7570385|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
4673196|NCT02346240|7570386|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
4673197|NCT02346240|7570387|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
4673198|NCT02346240|7570388|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
4673199|NCT02346240|7570389|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4673200|NCT02346240|7570390|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
4673201|NCT02346240|7570391|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2
4673202|NCT02346240|7570392|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4673203|NCT02346240|7570393|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2
4756072|NCT01302847|7730580|FG005|Overall Study|Virologic failure|1
4756073|NCT01302847|7730581|FG006|Overall Study|Virologic failure|0
4756074|NCT01302847|7730582|FG007|Overall Study|Virologic failure|2
4756075|NCT01302847|7730575|FG000|Overall Study|Severe debilitation, unable to continue|0
4756076|NCT01302847|7730576|FG001|Overall Study|Severe debilitation, unable to continue|0
4756077|NCT01302847|7730577|FG002|Overall Study|Severe debilitation, unable to continue|0
4756078|NCT01302847|7730578|FG003|Overall Study|Severe debilitation, unable to continue|0
4756079|NCT01302847|7730579|FG004|Overall Study|Severe debilitation, unable to continue|0
4756080|NCT01302847|7730580|FG005|Overall Study|Severe debilitation, unable to continue|1
4756081|NCT01302847|7730581|FG006|Overall Study|Severe debilitation, unable to continue|1
4756082|NCT01302847|7730582|FG007|Overall Study|Severe debilitation, unable to continue|0
4756083|NCT01302847|7730575|FG000|Overall Study|Not able to get to clinic|1
4756084|NCT01302847|7730576|FG001|Overall Study|Not able to get to clinic|1
4756085|NCT01302847|7730577|FG002|Overall Study|Not able to get to clinic|0
4756086|NCT01302847|7730578|FG003|Overall Study|Not able to get to clinic|0
4756087|NCT01302847|7730579|FG004|Overall Study|Not able to get to clinic|0
4756088|NCT01302847|7730580|FG005|Overall Study|Not able to get to clinic|0
4756089|NCT01302847|7730581|FG006|Overall Study|Not able to get to clinic|0
4756090|NCT01302847|7730582|FG007|Overall Study|Not able to get to clinic|0
4756091|NCT01302847|7730575|FG000|Overall Study|Site closing|2
4756092|NCT01302847|7730576|FG001|Overall Study|Site closing|2
4756093|NCT01302847|7730577|FG002|Overall Study|Site closing|0
4756094|NCT01302847|7730578|FG003|Overall Study|Site closing|0
4756095|NCT01302847|7730579|FG004|Overall Study|Site closing|0
4756096|NCT01302847|7730580|FG005|Overall Study|Site closing|0
4756097|NCT01302847|7730581|FG006|Overall Study|Site closing|0
4756098|NCT01302847|7730582|FG007|Overall Study|Site closing|0
4756099|NCT01302847|7730575|FG000|Overall Study|Withdrawal by Subject|1
4756100|NCT01302847|7730576|FG001|Overall Study|Withdrawal by Subject|0
4756101|NCT01302847|7730577|FG002|Overall Study|Withdrawal by Subject|0
4756102|NCT01302847|7730578|FG003|Overall Study|Withdrawal by Subject|0
4756103|NCT01302847|7730579|FG004|Overall Study|Withdrawal by Subject|1
4756104|NCT01302847|7730580|FG005|Overall Study|Withdrawal by Subject|0
4756105|NCT01302847|7730581|FG006|Overall Study|Withdrawal by Subject|0
4756106|NCT01302847|7730582|FG007|Overall Study|Withdrawal by Subject|1
4756107|NCT01302847|7730575|FG000|Overall Study|Not willing to adhere to requirements|5
4756108|NCT01302847|7730576|FG001|Overall Study|Not willing to adhere to requirements|0
4756109|NCT01302847|7730577|FG002|Overall Study|Not willing to adhere to requirements|0
4756110|NCT01302847|7730578|FG003|Overall Study|Not willing to adhere to requirements|1
4756111|NCT01302847|7730579|FG004|Overall Study|Not willing to adhere to requirements|0
4756112|NCT01302847|7730580|FG005|Overall Study|Not willing to adhere to requirements|0
4756113|NCT01302847|7730581|FG006|Overall Study|Not willing to adhere to requirements|0
4756114|NCT01302847|7730582|FG007|Overall Study|Not willing to adhere to requirements|2
4756115|NCT01302847|7730575|FG000|Overall Study|Site unable to contact participant|2
4673204|NCT02346240|7570394|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5
4673205|NCT02346240|7570395|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2
4673206|NCT02346240|7570396|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
4673207|NCT02346240|7570397|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4673208|NCT02346240|7570398|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4673209|NCT02346240|7570399|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4673210|NCT02346240|7570400|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4673211|NCT02346240|7570401|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4673212|NCT02346240|7570402|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4673213|NCT02346240|7570403|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4673214|NCT02346240|7570380|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4673215|NCT02346240|7570381|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4673216|NCT02346240|7570382|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4673217|NCT02346240|7570383|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4673218|NCT02346240|7570384|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4673219|NCT02346240|7570385|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4673220|NCT02346240|7570386|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4673221|NCT02346240|7570387|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4673222|NCT02346240|7570388|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4673223|NCT02346240|7570389|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4673224|NCT02346240|7570390|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4673225|NCT02346240|7570391|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4673226|NCT02346240|7570392|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4673227|NCT02346240|7570393|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3
4673228|NCT02346240|7570394|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3
4673229|NCT02346240|7570395|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8
4673230|NCT02346240|7570396|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4
4673231|NCT02346240|7570397|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4673232|NCT02346240|7570398|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4673233|NCT02346240|7570399|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4673234|NCT02346240|7570400|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4673235|NCT02346240|7570401|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4673236|NCT02346240|7570402|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4673237|NCT02346240|7570403|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4673238|NCT02346240|7570380|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
4673239|NCT02346240|7570381|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
4673240|NCT02346240|7570382|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
4673241|NCT02346240|7570383|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
4673242|NCT02346240|7570384|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
4673243|NCT02346240|7570385|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
4673244|NCT02346240|7570386|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1
4673245|NCT02346240|7570387|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
4673246|NCT02346240|7570388|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
4673247|NCT02346240|7570389|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
4673248|NCT02346240|7570390|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
4673249|NCT02346240|7570391|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
4673250|NCT02346240|7570392|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
4673251|NCT02346240|7570393|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
4673252|NCT02346240|7570394|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
4673253|NCT02346240|7570395|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
4673254|NCT02346240|7570396|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
4673255|NCT02346240|7570397|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
4673256|NCT02346240|7570398|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
4673257|NCT02346240|7570399|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
4673258|NCT02346240|7570400|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
4673259|NCT02346240|7570401|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
4673260|NCT02346240|7570402|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
4673261|NCT02346240|7570403|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
4673262|NCT02346240|7570380|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
4673263|NCT02346240|7570381|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
4673264|NCT02346240|7570382|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
4673265|NCT02346240|7570383|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
4673266|NCT02346240|7570384|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
4756116|NCT01302847|7730576|FG001|Overall Study|Site unable to contact participant|1
4673267|NCT02346240|7570385|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
4673268|NCT02346240|7570386|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
4673269|NCT02346240|7570387|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
4673270|NCT02346240|7570388|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1
4673271|NCT02346240|7570389|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
4673272|NCT02346240|7570390|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
4673273|NCT02346240|7570391|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1
4673274|NCT02346240|7570392|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
4673275|NCT02346240|7570393|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1
4673276|NCT02346240|7570394|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1
4673277|NCT02346240|7570395|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
4673278|NCT02346240|7570396|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
4673279|NCT02346240|7570397|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
4673280|NCT02346240|7570398|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
4673281|NCT02346240|7570399|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
4673282|NCT02346240|7570400|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
4673283|NCT02346240|7570401|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
4673284|NCT02346240|7570402|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
4673285|NCT02346240|7570403|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
4673286|NCT02346240|7570380|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
4673287|NCT02346240|7570381|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
4673288|NCT02346240|7570382|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
4673289|NCT02346240|7570383|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
4673290|NCT02346240|7570384|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
4673291|NCT02346240|7570385|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
4673292|NCT02346240|7570386|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
4673293|NCT02346240|7570387|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
4673294|NCT02346240|7570388|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
4673295|NCT02346240|7570389|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1
4673296|NCT02346240|7570390|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
4673297|NCT02346240|7570391|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
4673298|NCT02346240|7570392|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
4673299|NCT02346240|7570393|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
4673300|NCT02346240|7570394|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
4673301|NCT02346240|7570395|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
4673302|NCT02346240|7570396|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
4673303|NCT02346240|7570397|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
4673304|NCT02346240|7570398|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
4673305|NCT02346240|7570399|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
4673306|NCT02346240|7570400|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
4673307|NCT02346240|7570401|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
4673308|NCT02346240|7570402|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
4673309|NCT02346240|7570403|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
4673310|NCT02346240|7570380|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
4673311|NCT02346240|7570381|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
4673312|NCT02346240|7570382|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
4673313|NCT02346240|7570383|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
4673314|NCT02346240|7570384|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
4673315|NCT02346240|7570385|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
4673316|NCT02346240|7570386|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
4673317|NCT02346240|7570387|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
4673318|NCT02346240|7570388|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
4673319|NCT02346240|7570389|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
4673320|NCT02346240|7570390|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1
4673321|NCT02346240|7570391|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
4673322|NCT02346240|7570392|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
4673323|NCT02346240|7570393|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
4673324|NCT02346240|7570394|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
4673325|NCT02346240|7570395|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
4673326|NCT02346240|7570396|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
4673327|NCT02346240|7570397|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
4673328|NCT02346240|7570398|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
4673329|NCT02346240|7570399|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
4673330|NCT02346240|7570400|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
4673331|NCT02346240|7570401|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
4673332|NCT02346240|7570402|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
4673333|NCT02346240|7570403|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
4673334|NCT02346240|7570380|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
4673335|NCT02346240|7570381|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
4673336|NCT02346240|7570382|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
4673337|NCT02346240|7570383|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
4673338|NCT02346240|7570384|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
4673339|NCT02346240|7570385|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
4673340|NCT02346240|7570386|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
4673341|NCT02346240|7570387|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
4673342|NCT02346240|7570388|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
4673343|NCT02346240|7570389|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
4673344|NCT02346240|7570390|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
4673345|NCT02346240|7570391|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
4673346|NCT02346240|7570392|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
4673347|NCT02346240|7570393|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
4673348|NCT02346240|7570394|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1
4673349|NCT02346240|7570395|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
4673350|NCT02346240|7570396|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
4673351|NCT02346240|7570397|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
4673352|NCT02346240|7570398|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
4673353|NCT02346240|7570399|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
4673354|NCT02346240|7570400|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
4673355|NCT02346240|7570401|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
4673356|NCT02346240|7570402|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
4673357|NCT02346240|7570403|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
4673358|NCT02346240|7570380|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
4673359|NCT02346240|7570381|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
4673360|NCT02346240|7570382|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
4673361|NCT02346240|7570383|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
4673362|NCT02346240|7570384|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
4673363|NCT02346240|7570385|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
4673364|NCT02346240|7570386|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
4673365|NCT02346240|7570387|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
4756117|NCT01302847|7730577|FG002|Overall Study|Site unable to contact participant|0
4756118|NCT01302847|7730578|FG003|Overall Study|Site unable to contact participant|0
4756119|NCT01302847|7730579|FG004|Overall Study|Site unable to contact participant|0
4756120|NCT01302847|7730580|FG005|Overall Study|Site unable to contact participant|0
4756121|NCT01302847|7730581|FG006|Overall Study|Site unable to contact participant|2
4756122|NCT01302847|7730582|FG007|Overall Study|Site unable to contact participant|0
4756123|NCT01287611|7730611|FG000|Overall Study|Lost to Follow-up|29
4756124|NCT01287611|7730612|FG001|Overall Study|Lost to Follow-up|16
4756125|NCT01287611|7730611|FG000|Overall Study|Exclusion due to expanded Kerr incision|4
4756126|NCT01287611|7730612|FG001|Overall Study|Exclusion due to expanded Kerr incision|3
4756127|NCT01275677|7730622|FG000|Overall Study|Not at risk for recurrence.|1
4756128|NCT01275677|7730623|FG001|Overall Study|Not at risk for recurrence.|1
4756129|NCT01275677|7730622|FG000|Overall Study|No follow-up|26
4756130|NCT01275677|7730623|FG001|Overall Study|No follow-up|37
4756131|NCT01275677|7730622|FG000|Overall Study|No clinical follow up.|1
4756132|NCT01275677|7730623|FG001|Overall Study|No clinical follow up.|4
4756133|NCT01254422|7730631|FG000|Overall Study|Protocol Violation|1
4756134|NCT01254422|7730632|FG001|Overall Study|Protocol Violation|0
4756135|NCT01254422|7730631|FG000|Overall Study|Adverse Event|1
4756136|NCT01254422|7730632|FG001|Overall Study|Adverse Event|0
4756137|NCT01254422|7730631|FG000|Overall Study|Serious adverse event|0
4756138|NCT01254422|7730632|FG001|Overall Study|Serious adverse event|1
4756139|NCT01254422|7730631|FG000|Overall Study|Lost to Follow-up|1
4756140|NCT01254422|7730632|FG001|Overall Study|Lost to Follow-up|0
4673366|NCT02346240|7570388|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
4673367|NCT02346240|7570389|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
4673368|NCT02346240|7570390|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
4673369|NCT02346240|7570391|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
4673370|NCT02346240|7570392|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
4673371|NCT02346240|7570393|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
4673372|NCT02346240|7570394|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1
4673373|NCT02346240|7570395|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
4673374|NCT02346240|7570396|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
4673375|NCT02346240|7570397|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
4673376|NCT02346240|7570398|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
4673377|NCT02346240|7570399|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
4673378|NCT02346240|7570400|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
4673379|NCT02346240|7570401|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
4673380|NCT02346240|7570402|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
4673381|NCT02346240|7570403|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
4673382|NCT02346240|7570380|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
4673383|NCT02346240|7570381|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
4673384|NCT02346240|7570382|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
4673385|NCT02346240|7570383|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
4673386|NCT02346240|7570384|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
4673387|NCT02346240|7570385|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
4756141|NCT01196390|7730640|FG000|Overall Study|Protocol Violation|4
4756142|NCT01196390|7730641|FG001|Overall Study|Protocol Violation|5
4756143|NCT01194570|7730651|FG000|Overall Study|Death|1
4756144|NCT01194570|7730652|FG001|Overall Study|Death|3
4673388|NCT02346240|7570386|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
4673389|NCT02346240|7570387|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
4673390|NCT02346240|7570388|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
4673391|NCT02346240|7570389|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
4673392|NCT02346240|7570390|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
4673393|NCT02346240|7570391|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
4673394|NCT02346240|7570392|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
4673395|NCT02346240|7570393|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
4673396|NCT02346240|7570394|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1
4756145|NCT01194570|7730651|FG000|Overall Study|Ongoing at CCOD|162
4756146|NCT01194570|7730652|FG001|Overall Study|Ongoing at CCOD|387
4756147|NCT01194570|7730651|FG000|Overall Study|Physician Decision|2
4756148|NCT01194570|7730652|FG001|Overall Study|Physician Decision|6
4756149|NCT01194570|7730651|FG000|Overall Study|Reason not specified|13
4756150|NCT01194570|7730652|FG001|Overall Study|Reason not specified|20
4756151|NCT01194570|7730651|FG000|Overall Study|Protocol Violation|0
4756152|NCT01194570|7730652|FG001|Overall Study|Protocol Violation|2
4756153|NCT01194570|7730651|FG000|Overall Study|Non-compliance with study drug|2
4756154|NCT01194570|7730652|FG001|Overall Study|Non-compliance with study drug|2
4673397|NCT02346240|7570395|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
4673398|NCT02346240|7570396|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
4673399|NCT02346240|7570397|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
4673400|NCT02346240|7570398|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
4673401|NCT02346240|7570399|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
4673402|NCT02346240|7570400|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
4673403|NCT02346240|7570401|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
4673404|NCT02346240|7570402|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
4673405|NCT02346240|7570403|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
4673406|NCT02346240|7570380|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
4673407|NCT02346240|7570381|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
4673408|NCT02346240|7570382|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
4673409|NCT02346240|7570383|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
4673410|NCT02346240|7570384|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
4673411|NCT02346240|7570385|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
4673412|NCT02346240|7570386|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
4673413|NCT02346240|7570387|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
4673414|NCT02346240|7570388|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
4673415|NCT02346240|7570389|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
4673416|NCT02346240|7570390|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
4673417|NCT02346240|7570391|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
4673418|NCT02346240|7570392|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
4673419|NCT02346240|7570393|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
4673420|NCT02346240|7570394|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
4673421|NCT02346240|7570395|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
4673422|NCT02346240|7570396|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
4673423|NCT02346240|7570397|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1
4673424|NCT02346240|7570398|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6
4673425|NCT02346240|7570399|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2
4673426|NCT02346240|7570400|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3
4673427|NCT02346240|7570401|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13
4673428|NCT02346240|7570402|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3
4673429|NCT02346240|7570403|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3
4673430|NCT02346240|7570380|FG000|Open-Label Period (Week 48 to Week 144)|Death|0
4673431|NCT02346240|7570381|FG001|Open-Label Period (Week 48 to Week 144)|Death|0
4673432|NCT02346240|7570382|FG002|Open-Label Period (Week 48 to Week 144)|Death|0
4673433|NCT02346240|7570383|FG003|Open-Label Period (Week 48 to Week 144)|Death|0
4673434|NCT02346240|7570384|FG004|Open-Label Period (Week 48 to Week 144)|Death|0
4673435|NCT02346240|7570385|FG005|Open-Label Period (Week 48 to Week 144)|Death|0
4673436|NCT02346240|7570386|FG006|Open-Label Period (Week 48 to Week 144)|Death|0
4673437|NCT02346240|7570387|FG007|Open-Label Period (Week 48 to Week 144)|Death|0
4673438|NCT02346240|7570388|FG008|Open-Label Period (Week 48 to Week 144)|Death|0
4673439|NCT02346240|7570389|FG009|Open-Label Period (Week 48 to Week 144)|Death|0
4673440|NCT02346240|7570390|FG010|Open-Label Period (Week 48 to Week 144)|Death|0
4673441|NCT02346240|7570391|FG011|Open-Label Period (Week 48 to Week 144)|Death|0
4673442|NCT02346240|7570392|FG012|Open-Label Period (Week 48 to Week 144)|Death|0
4673443|NCT02346240|7570393|FG013|Open-Label Period (Week 48 to Week 144)|Death|0
4673444|NCT02346240|7570394|FG014|Open-Label Period (Week 48 to Week 144)|Death|0
4673445|NCT02346240|7570395|FG015|Open-Label Period (Week 48 to Week 144)|Death|0
4673446|NCT02346240|7570396|FG016|Open-Label Period (Week 48 to Week 144)|Death|0
4673447|NCT02346240|7570397|FG017|Open-Label Period (Week 48 to Week 144)|Death|0
4673448|NCT02346240|7570398|FG018|Open-Label Period (Week 48 to Week 144)|Death|1
4673449|NCT02346240|7570399|FG019|Open-Label Period (Week 48 to Week 144)|Death|1
4673450|NCT02346240|7570400|FG020|Open-Label Period (Week 48 to Week 144)|Death|0
4673451|NCT02346240|7570401|FG021|Open-Label Period (Week 48 to Week 144)|Death|1
4673452|NCT02346240|7570402|FG022|Open-Label Period (Week 48 to Week 144)|Death|0
4673453|NCT02346240|7570403|FG023|Open-Label Period (Week 48 to Week 144)|Death|0
4673454|NCT02346240|7570380|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
4673455|NCT02346240|7570381|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
4673456|NCT02346240|7570382|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
4673457|NCT02346240|7570383|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
4673458|NCT02346240|7570384|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
4673459|NCT02346240|7570385|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
4673460|NCT02346240|7570386|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
4673461|NCT02346240|7570387|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
4673462|NCT02346240|7570388|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
4673463|NCT02346240|7570389|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
4673464|NCT02346240|7570390|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
4673465|NCT02346240|7570391|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
4673466|NCT02346240|7570392|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
4756155|NCT01194570|7730651|FG000|Overall Study|Adverse Event|12
4756156|NCT01194570|7730652|FG001|Overall Study|Adverse Event|18
4756157|NCT01194570|7730651|FG000|Overall Study|Non-compliance|2
4756158|NCT01194570|7730652|FG001|Overall Study|Non-compliance|2
4756159|NCT01194570|7730651|FG000|Overall Study|Lack of Efficacy|27
4756160|NCT01194570|7730652|FG001|Overall Study|Lack of Efficacy|21
4756161|NCT01194570|7730651|FG000|Overall Study|Withdrawal by Subject|21
4756162|NCT01194570|7730652|FG001|Overall Study|Withdrawal by Subject|22
4756163|NCT01194570|7730651|FG000|Overall Study|Pregnancy|1
4756164|NCT01194570|7730652|FG001|Overall Study|Pregnancy|1
4756165|NCT01194570|7730651|FG000|Overall Study|Lost to Follow-up|1
4756166|NCT01194570|7730652|FG001|Overall Study|Lost to Follow-up|4
4756167|NCT01187433|7730660|FG000|Overall Study|Protocol Violation|6
4756168|NCT01187433|7730661|FG001|Overall Study|Protocol Violation|2
4756169|NCT01187433|7730660|FG000|Overall Study|Withdrawal by Subject|5
4756170|NCT01187433|7730661|FG001|Overall Study|Withdrawal by Subject|2
4756171|NCT01150045|7730671|FG000|Overall Study|Protocol Violation|0
4756172|NCT01150045|7730672|FG001|Overall Study|Protocol Violation|1
4756173|NCT01150045|7730673|FG002|Overall Study|Protocol Violation|0
4756174|NCT01150045|7730674|FG003|Overall Study|Protocol Violation|1
4756175|NCT01098032|7730684|FG000|Overall Study|Withdrawal by Subject|1
4756176|NCT01098032|7730685|FG001|Overall Study|Withdrawal by Subject|1
4756177|NCT01034306|7730693|FG000|Overall Study|Adverse Event|1
4756178|NCT01034306|7730694|FG001|Overall Study|Adverse Event|0
4756179|NCT01034306|7730693|FG000|Overall Study|Lost to Follow-up|0
4756180|NCT01034306|7730694|FG001|Overall Study|Lost to Follow-up|1
4756181|NCT01034306|7730693|FG000|Overall Study|Withdrawal by Subject|2
4756182|NCT01034306|7730694|FG001|Overall Study|Withdrawal by Subject|2
4756183|NCT01034306|7730693|FG000|Overall Study|hospitalized and decided to stop|1
4756184|NCT01034306|7730694|FG001|Overall Study|hospitalized and decided to stop|0
4756185|NCT01034306|7730693|FG000|Overall Study|Noncomplience|1
4756186|NCT01034306|7730694|FG001|Overall Study|Noncomplience|0
4756187|NCT01015833|7730702|FG000|Overall Study|Death|1
4756188|NCT01015833|7730703|FG001|Overall Study|Death|0
4756189|NCT01015833|7730702|FG000|Overall Study|Withdrawal by Subject|3
4756190|NCT01015833|7730703|FG001|Overall Study|Withdrawal by Subject|2
4756191|NCT01015833|7730702|FG000|Overall Study|Adverse Event|0
4756192|NCT01015833|7730703|FG001|Overall Study|Adverse Event|1
4756193|NCT01015833|7730702|FG000|Overall Study|Physician Decision|2
4756194|NCT01015833|7730703|FG001|Overall Study|Physician Decision|0
4756195|NCT01015833|7730702|FG000|Overall Study|Symptomatic deterioration|0
4756196|NCT01015833|7730703|FG001|Overall Study|Symptomatic deterioration|1
4756197|NCT01015833|7730702|FG000|Overall Study|Other|5
4756198|NCT01015833|7730703|FG001|Overall Study|Other|1
4756199|NCT01015833|7730702|FG000|Overall Study|Motor Vehicle Accidents|1
4756200|NCT01015833|7730703|FG001|Overall Study|Motor Vehicle Accidents|0
4756201|NCT01015833|7730702|FG000|Overall Study|Did not start treatment|1
4756202|NCT01015833|7730703|FG001|Overall Study|Did not start treatment|0
4756203|NCT01005745|7730709|FG000|Overall Study|No TIL growth|1
4756204|NCT01005745|7730709|FG000|Overall Study|Disease progressed during TIL growth|3
4756205|NCT01005745|7730709|FG000|Overall Study|Death prior to treatment|1
4756206|NCT01005745|7730709|FG000|Overall Study|Inappropriate antidiuretic hormone|1
4756207|NCT00993447|7730715|FG000|Overall Study|Withdrawal by Subject|23
4756208|NCT00993447|7730716|FG001|Overall Study|Withdrawal by Subject|8
4756209|NCT00993447|7730715|FG000|Overall Study|Protocol Violation|12
4756210|NCT00993447|7730716|FG001|Overall Study|Protocol Violation|8
4756211|NCT00993447|7730715|FG000|Overall Study|Lost to Follow-up|1
4756212|NCT00993447|7730716|FG001|Overall Study|Lost to Follow-up|3
4756213|NCT00993447|7730715|FG000|Overall Study|Adverse Event|1
4756214|NCT00993447|7730716|FG001|Overall Study|Adverse Event|0
4756215|NCT00945009|7730725|FG000|Overall Study|Lack of Efficacy|10
4756216|NCT00945009|7730726|FG001|Overall Study|Lack of Efficacy|0
4756217|NCT00945009|7730727|FG002|Overall Study|Lack of Efficacy|0
4756218|NCT00945009|7730725|FG000|Overall Study|Physician Decision|21
4756219|NCT00945009|7730726|FG001|Overall Study|Physician Decision|4
4756220|NCT00945009|7730727|FG002|Overall Study|Physician Decision|3
4756221|NCT00945009|7730725|FG000|Overall Study|Protocol Violation|6
4756222|NCT00945009|7730726|FG001|Overall Study|Protocol Violation|1
4756223|NCT00945009|7730727|FG002|Overall Study|Protocol Violation|0
4756224|NCT00945009|7730725|FG000|Overall Study|Withdrawal by Subject|1
4673467|NCT02346240|7570393|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
4673468|NCT02346240|7570394|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
4673469|NCT02346240|7570395|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
4673470|NCT02346240|7570396|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
4673471|NCT02346240|7570397|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
4673472|NCT02346240|7570398|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1
4756225|NCT00945009|7730726|FG001|Overall Study|Withdrawal by Subject|0
4756226|NCT00945009|7730727|FG002|Overall Study|Withdrawal by Subject|0
4756227|NCT00945009|7730725|FG000|Overall Study|Ineligible|6
4756228|NCT00945009|7730726|FG001|Overall Study|Ineligible|1
4756229|NCT00945009|7730727|FG002|Overall Study|Ineligible|0
4756230|NCT00945009|7730725|FG000|Overall Study|Inevaluable|0
4756231|NCT00945009|7730726|FG001|Overall Study|Inevaluable|1
4756232|NCT00945009|7730727|FG002|Overall Study|Inevaluable|0
4673473|NCT02346240|7570399|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
4673474|NCT02346240|7570400|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
4673475|NCT02346240|7570401|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1
4673476|NCT02346240|7570402|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
4673477|NCT02346240|7570403|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
4673478|NCT02346240|7570380|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
4673479|NCT02346240|7570381|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
4673480|NCT02346240|7570382|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
4673481|NCT02346240|7570383|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
4673482|NCT02346240|7570384|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
4673483|NCT02346240|7570385|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
4673484|NCT02346240|7570386|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
4673485|NCT02346240|7570387|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
4673486|NCT02346240|7570388|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
4673487|NCT02346240|7570389|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
4673488|NCT02346240|7570390|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
4673489|NCT02346240|7570391|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
4673490|NCT02346240|7570392|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
4673491|NCT02346240|7570393|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
4673492|NCT02346240|7570394|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
4673493|NCT02346240|7570395|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
4673494|NCT02346240|7570396|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
4673495|NCT02346240|7570397|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
4673496|NCT02346240|7570398|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
4673497|NCT02346240|7570399|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
4673498|NCT02346240|7570400|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
4756233|NCT00945009|7730725|FG000|Overall Study|Refusal of further protocol|1
4756234|NCT00945009|7730726|FG001|Overall Study|Refusal of further protocol|0
4756235|NCT00945009|7730727|FG002|Overall Study|Refusal of further protocol|0
4756236|NCT00942877|7730737|FG000|Overall Study|Refused further treatment|1
4756237|NCT00942877|7730738|FG001|Overall Study|Refused further treatment|1
4756238|NCT00942877|7730737|FG000|Overall Study|Patient was not treated|1
4756239|NCT00942877|7730738|FG001|Overall Study|Patient was not treated|0
4756240|NCT00942877|7730737|FG000|Overall Study|Adverse Event|1
4756241|NCT00942877|7730738|FG001|Overall Study|Adverse Event|0
4756242|NCT00942877|7730737|FG000|Overall Study|Progressive disease|42
4756243|NCT00942877|7730738|FG001|Overall Study|Progressive disease|3
4756244|NCT00942331|7730747|FG000|Overall Study|Did not start treatment|15
4756245|NCT00942331|7730748|FG001|Overall Study|Did not start treatment|22
4756246|NCT00880893|7730762|FG000|Overall Study|Protocol Violation|13
4756247|NCT00880893|7730763|FG001|Overall Study|Protocol Violation|1
4756248|NCT00880893|7730762|FG000|Overall Study|Withdrawal by Subject|15
4756249|NCT00880893|7730763|FG001|Overall Study|Withdrawal by Subject|11
4756250|NCT00880893|7730762|FG000|Overall Study|Lost to Follow-up|76
4756251|NCT00880893|7730763|FG001|Overall Study|Lost to Follow-up|33
4756252|NCT00880893|7730762|FG000|Overall Study|Serious adverse event|3
4756253|NCT00880893|7730763|FG001|Overall Study|Serious adverse event|0
4756254|NCT00866918|7730771|FG000|Overall Study|Death|1
4756255|NCT00866918|7730772|FG001|Overall Study|Death|5
4756256|NCT00866918|7730771|FG000|Overall Study|Lack of Efficacy|1
4756257|NCT00866918|7730772|FG001|Overall Study|Lack of Efficacy|1
4756258|NCT00866918|7730771|FG000|Overall Study|Physician Decision|10
4756259|NCT00866918|7730772|FG001|Overall Study|Physician Decision|2
4756260|NCT00866918|7730771|FG000|Overall Study|Ineligible|2
4756261|NCT00866918|7730772|FG001|Overall Study|Ineligible|4
4756262|NCT00866918|7730771|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1
4756263|NCT00866918|7730772|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0
4756264|NCT00866918|7730771|FG000|Overall Study|Secondary malignancy|1
4756265|NCT00866918|7730772|FG001|Overall Study|Secondary malignancy|0
4756266|NCT00769379|7730780|FG000|Overall Study|No follow up data mapped to Other.|3
4756267|NCT00769379|7730781|FG001|Overall Study|No follow up data mapped to Other.|13
4756268|NCT00753545|7730789|FG000|Overall Study|Death|98
4756269|NCT00753545|7730790|FG001|Overall Study|Death|112
4756270|NCT00753545|7730789|FG000|Overall Study|Lost to Follow-up|2
4756271|NCT00753545|7730790|FG001|Overall Study|Lost to Follow-up|3
4756272|NCT00753545|7730789|FG000|Overall Study|Protocol Violation|1
4756273|NCT00753545|7730790|FG001|Overall Study|Protocol Violation|0
4756274|NCT00753545|7730789|FG000|Overall Study|Voluntary Discontinuation of Patient|7
4756275|NCT00753545|7730790|FG001|Overall Study|Voluntary Discontinuation of Patient|3
4756276|NCT00588770|7730798|FG000|Overall Study|Disease progression|85
4756277|NCT00588770|7730799|FG001|Overall Study|Disease progression|68
4756278|NCT00588770|7730798|FG000|Overall Study|Adverse Event|29
4756279|NCT00588770|7730799|FG001|Overall Study|Adverse Event|58
4756280|NCT00588770|7730798|FG000|Overall Study|Death|13
4756281|NCT00588770|7730799|FG001|Overall Study|Death|22
4756282|NCT00588770|7730798|FG000|Overall Study|Withdrawal by Subject|15
4756283|NCT00588770|7730799|FG001|Overall Study|Withdrawal by Subject|25
4673499|NCT02346240|7570401|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1
4673500|NCT02346240|7570402|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
4673501|NCT02346240|7570403|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
4673502|NCT02346240|7570380|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
4673503|NCT02346240|7570381|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
4673504|NCT02346240|7570382|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
4673505|NCT02346240|7570383|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
4673506|NCT02346240|7570384|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
4673507|NCT02346240|7570385|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
4673508|NCT02346240|7570386|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
4673509|NCT02346240|7570387|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
4673510|NCT02346240|7570388|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
4673511|NCT02346240|7570389|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
4673512|NCT02346240|7570390|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
4673513|NCT02346240|7570391|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
4673514|NCT02346240|7570392|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
4673515|NCT02346240|7570393|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
4673516|NCT02346240|7570394|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
4673517|NCT02346240|7570395|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
4673518|NCT02346240|7570396|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
4673519|NCT02346240|7570397|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2
4673520|NCT02346240|7570398|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2
4673521|NCT02346240|7570399|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3
4673522|NCT02346240|7570400|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
4673523|NCT02346240|7570401|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1
4673524|NCT02346240|7570402|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1
4673525|NCT02346240|7570403|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1
4673526|NCT02346240|7570380|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4673527|NCT02346240|7570381|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4673528|NCT02346240|7570382|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4673529|NCT02346240|7570383|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4673530|NCT02346240|7570384|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4673531|NCT02346240|7570385|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4673532|NCT02346240|7570386|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4673533|NCT02346240|7570387|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4673534|NCT02346240|7570388|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4673535|NCT02346240|7570389|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4673536|NCT02346240|7570390|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4673537|NCT02346240|7570391|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4673538|NCT02346240|7570392|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4756284|NCT00588770|7730798|FG000|Overall Study|Alternative therapy|2
4756285|NCT00588770|7730799|FG001|Overall Study|Alternative therapy|4
4756286|NCT00588770|7730798|FG000|Overall Study|Other complicating disease|3
4756287|NCT00588770|7730799|FG001|Overall Study|Other complicating disease|2
4756288|NCT00588770|7730798|FG000|Overall Study|Not start protocol therapy|0
4756289|NCT00588770|7730799|FG001|Overall Study|Not start protocol therapy|9
4756290|NCT00588770|7730798|FG000|Overall Study|Lack of Efficacy|8
4756291|NCT00588770|7730799|FG001|Overall Study|Lack of Efficacy|10
4756292|NCT00588770|7730798|FG000|Overall Study|Physician discretion|2
4756293|NCT00588770|7730799|FG001|Overall Study|Physician discretion|0
4756294|NCT00588770|7730798|FG000|Overall Study|Patient non-compliance|2
4756295|NCT00588770|7730799|FG001|Overall Study|Patient non-compliance|2
4756296|NCT00587301|7730805|FG000|Overall Study|Screen Failure|9
4756297|NCT00587301|7730805|FG000|Overall Study|Lost to Follow-up|22
4756298|NCT00587301|7730805|FG000|Overall Study|Withdrawal by Subject|7
4756299|NCT00587301|7730805|FG000|Overall Study|Protocol Violation|7
4756300|NCT00579527|7730809|FG000|Overall Study|Death|4
4756301|NCT00576836|7730814|FG000|Overall Study|Death|0
4756302|NCT00576836|7730815|FG001|Overall Study|Death|1
4756303|NCT00576836|7730814|FG000|Overall Study|Physician Decision|0
4673539|NCT02346240|7570393|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4673540|NCT02346240|7570394|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4673541|NCT02346240|7570395|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4673542|NCT02346240|7570396|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4673543|NCT02346240|7570397|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4673544|NCT02346240|7570398|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4
4673545|NCT02346240|7570399|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1
4673546|NCT02346240|7570400|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4673547|NCT02346240|7570401|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10
4756304|NCT00576836|7730815|FG001|Overall Study|Physician Decision|1
4756305|NCT00576407|7730819|FG000|Overall Study|Death|7
4756306|NCT00576407|7730819|FG000|Overall Study|Physician Decision|1
4673548|NCT02346240|7570402|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1
4673549|NCT02346240|7570403|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1
4673550|NCT02346240|7570380|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
4673551|NCT02346240|7570381|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
4673552|NCT02346240|7570382|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
4673553|NCT02346240|7570383|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
4673554|NCT02346240|7570384|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
4673555|NCT02346240|7570385|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
4673556|NCT02346240|7570386|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
4673557|NCT02346240|7570387|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
4673558|NCT02346240|7570388|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
4673559|NCT02346240|7570389|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
4673560|NCT02346240|7570390|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
4673561|NCT02346240|7570391|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
4673562|NCT02346240|7570392|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
4673563|NCT02346240|7570393|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
4673564|NCT02346240|7570394|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
4673565|NCT02346240|7570395|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
4673566|NCT02346240|7570396|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
4673567|NCT02346240|7570397|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
4673568|NCT02346240|7570398|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2
4673569|NCT02346240|7570399|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
4673570|NCT02346240|7570400|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
4673571|NCT02346240|7570401|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4
4673572|NCT02346240|7570402|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2
4673573|NCT02346240|7570403|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3
4673574|NCT02346240|7570380|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
4673575|NCT02346240|7570381|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
4673576|NCT02346240|7570382|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
4673577|NCT02346240|7570383|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
4673578|NCT02346240|7570384|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
4673579|NCT02346240|7570385|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
4673580|NCT02346240|7570386|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
4673581|NCT02346240|7570387|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
4673582|NCT02346240|7570388|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
4673583|NCT02346240|7570389|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
4673584|NCT02346240|7570390|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
4673585|NCT02346240|7570391|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
4756307|NCT00557193|7730824|FG000|Induction|Adverse Event|2
4756308|NCT00557193|7730825|FG001|Induction|Adverse Event|0
4756309|NCT00557193|7730826|FG002|Induction|Adverse Event|0
4756310|NCT00557193|7730827|FG003|Induction|Adverse Event|0
4756311|NCT00557193|7730828|FG004|Induction|Adverse Event|0
4756312|NCT00557193|7730829|FG005|Induction|Adverse Event|0
4756313|NCT00557193|7730824|FG000|Induction|Death|6
4756314|NCT00557193|7730825|FG001|Induction|Death|0
4756315|NCT00557193|7730826|FG002|Induction|Death|0
4756316|NCT00557193|7730827|FG003|Induction|Death|0
4756317|NCT00557193|7730828|FG004|Induction|Death|0
4756318|NCT00557193|7730829|FG005|Induction|Death|0
4756319|NCT00557193|7730824|FG000|Induction|Physician Decision|3
4756320|NCT00557193|7730825|FG001|Induction|Physician Decision|0
4756321|NCT00557193|7730826|FG002|Induction|Physician Decision|0
4756322|NCT00557193|7730827|FG003|Induction|Physician Decision|0
4756323|NCT00557193|7730828|FG004|Induction|Physician Decision|0
4756324|NCT00557193|7730829|FG005|Induction|Physician Decision|0
4756325|NCT00557193|7730824|FG000|Induction|Withdrawal by Subject|1
4756326|NCT00557193|7730825|FG001|Induction|Withdrawal by Subject|0
4756327|NCT00557193|7730826|FG002|Induction|Withdrawal by Subject|0
4756328|NCT00557193|7730827|FG003|Induction|Withdrawal by Subject|0
4756329|NCT00557193|7730828|FG004|Induction|Withdrawal by Subject|0
4756330|NCT00557193|7730829|FG005|Induction|Withdrawal by Subject|0
4756331|NCT00557193|7730824|FG000|Induction|Refusal of Further Protocol Therapy|2
4756332|NCT00557193|7730825|FG001|Induction|Refusal of Further Protocol Therapy|0
4756333|NCT00557193|7730826|FG002|Induction|Refusal of Further Protocol Therapy|0
4756334|NCT00557193|7730827|FG003|Induction|Refusal of Further Protocol Therapy|0
4756335|NCT00557193|7730828|FG004|Induction|Refusal of Further Protocol Therapy|0
4756336|NCT00557193|7730829|FG005|Induction|Refusal of Further Protocol Therapy|0
4756337|NCT00557193|7730824|FG000|Induction|Ineligible|8
4756338|NCT00557193|7730825|FG001|Induction|Ineligible|0
4756339|NCT00557193|7730826|FG002|Induction|Ineligible|0
4756340|NCT00557193|7730827|FG003|Induction|Ineligible|0
4756341|NCT00557193|7730828|FG004|Induction|Ineligible|0
4756342|NCT00557193|7730829|FG005|Induction|Ineligible|0
4756343|NCT00557193|7730824|FG000|Induction|Inevaluable for post Induction|2
4673586|NCT02346240|7570392|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
4673587|NCT02346240|7570393|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
4673588|NCT02346240|7570394|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
4673589|NCT02346240|7570395|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
4673590|NCT02346240|7570396|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
4673591|NCT02346240|7570397|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
4673592|NCT02346240|7570398|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1
4673593|NCT02346240|7570399|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
4673594|NCT02346240|7570400|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
4673595|NCT02346240|7570401|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
4673596|NCT02346240|7570402|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
4673597|NCT02346240|7570403|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
4673598|NCT02346370|7570428|FG000|Overall Study|Not treated|1
4673599|NCT02346370|7570429|FG001|Overall Study|Not treated|0
4673600|NCT02346370|7570430|FG002|Overall Study|Not treated|0
4673601|NCT02346370|7570428|FG000|Overall Study|Withdrawal of consent|1
4673602|NCT02346370|7570429|FG001|Overall Study|Withdrawal of consent|0
4673603|NCT02346370|7570430|FG002|Overall Study|Withdrawal of consent|0
4673604|NCT02346370|7570428|FG000|Overall Study|Death|1
4673605|NCT02346370|7570429|FG001|Overall Study|Death|3
4673606|NCT02346370|7570430|FG002|Overall Study|Death|1
4673607|NCT02346370|7570428|FG000|Overall Study|Sponsor discontinued study|5
4673608|NCT02346370|7570429|FG001|Overall Study|Sponsor discontinued study|0
4673609|NCT02346370|7570430|FG002|Overall Study|Sponsor discontinued study|2
4673610|NCT02346370|7570428|FG000|Overall Study|Radiologic progression|0
4673611|NCT02346370|7570429|FG001|Overall Study|Radiologic progression|0
4673612|NCT02346370|7570430|FG002|Overall Study|Radiologic progression|1
4673613|NCT02346370|7570428|FG000|Overall Study|Physician Decision|0
4673614|NCT02346370|7570429|FG001|Overall Study|Physician Decision|1
4673615|NCT02346370|7570430|FG002|Overall Study|Physician Decision|0
4673616|NCT02346708|7570464|FG000|Overall Study|Adverse Event|2
4673617|NCT02346708|7570465|FG001|Overall Study|Adverse Event|0
4673618|NCT02346708|7570464|FG000|Overall Study|Protocol Violation|0
4673619|NCT02346708|7570465|FG001|Overall Study|Protocol Violation|1
4673620|NCT02346721|7570472|FG000|Overall Study|Withdrew Consent|3
4673621|NCT02346721|7570472|FG000|Overall Study|Lack of Efficacy|1
4673622|NCT02347072|7570486|FG000|Overall Study|Adverse Event|2
4673623|NCT02347072|7570486|FG000|Overall Study|Withdrawal by Subject|6
4673624|NCT02347072|7570486|FG000|Overall Study|Physician Decision|1
4673625|NCT02347072|7570486|FG000|Overall Study|Lost to Follow-up|2
4673626|NCT02347072|7570486|FG000|Overall Study|Protocol Violation|1
4673627|NCT02347072|7570486|FG000|Overall Study|Disc due to Protocol-specified Criteria|6
4673628|NCT02347085|7570494|FG000|Overall Study|Adverse Event|2
4673629|NCT02347085|7570494|FG000|Overall Study|Lack of Efficacy|1
4673630|NCT02347085|7570494|FG000|Overall Study|Withdrawal by Subject|4
4673631|NCT02347085|7570494|FG000|Overall Study|Lost to Follow-up|1
4673632|NCT02347085|7570494|FG000|Overall Study|Protocol Criteria|2
4673633|NCT02347098|7570502|FG000|Overall Study|Death|1
4673634|NCT02347098|7570503|FG001|Overall Study|Death|0
4673635|NCT02347098|7570502|FG000|Overall Study|Withdrawal by Subject|1
4673636|NCT02347098|7570503|FG001|Overall Study|Withdrawal by Subject|0
4673637|NCT02347098|7570502|FG000|Overall Study|Lost to Follow-up|2
4673638|NCT02347098|7570503|FG001|Overall Study|Lost to Follow-up|2
4673639|NCT02347098|7570502|FG000|Overall Study|Refuse Follow-up Visit|1
4673640|NCT02347098|7570503|FG001|Overall Study|Refuse Follow-up Visit|5
4673641|NCT02347098|7570502|FG000|Overall Study|no visit due to illness|2
4673642|NCT02347098|7570503|FG001|Overall Study|no visit due to illness|1
4673643|NCT02347176|7570522|FG000|Overall Study|Lost to Follow-up|2
4673644|NCT02347176|7570523|FG001|Overall Study|Lost to Follow-up|3
4673645|NCT02347176|7570524|FG002|Overall Study|Lost to Follow-up|1
4673646|NCT02347176|7570525|FG003|Overall Study|Lost to Follow-up|1
4673647|NCT02347176|7570522|FG000|Overall Study|Withdrawal by Subject|9
4673648|NCT02347176|7570523|FG001|Overall Study|Withdrawal by Subject|5
4673649|NCT02347176|7570524|FG002|Overall Study|Withdrawal by Subject|5
4673650|NCT02347176|7570525|FG003|Overall Study|Withdrawal by Subject|3
4673651|NCT02347176|7570522|FG000|Overall Study|Other|1
4756344|NCT00557193|7730825|FG001|Induction|Inevaluable for post Induction|0
4756345|NCT00557193|7730826|FG002|Induction|Inevaluable for post Induction|0
4756346|NCT00557193|7730827|FG003|Induction|Inevaluable for post Induction|0
4756347|NCT00557193|7730828|FG004|Induction|Inevaluable for post Induction|0
4756348|NCT00557193|7730829|FG005|Induction|Inevaluable for post Induction|0
4756349|NCT00557193|7730824|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2
4756350|NCT00557193|7730825|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0
4673652|NCT02347176|7570523|FG001|Overall Study|Other|2
4673653|NCT02347176|7570524|FG002|Overall Study|Other|2
4673654|NCT02347176|7570525|FG003|Overall Study|Other|0
4673655|NCT02347189|7570535|FG000|Overall Study|No implant attempted of study device|9
4673656|NCT02347189|7570535|FG000|Overall Study|No primary outcome data available|2
4673657|NCT02347332|7570552|FG000|Overall Study|Not treated|5
4673658|NCT02347332|7570553|FG001|Overall Study|Not treated|2
4673659|NCT02347332|7570552|FG000|Overall Study|Progressive disease|141
4673660|NCT02347332|7570553|FG001|Overall Study|Progressive disease|159
4673661|NCT02347332|7570552|FG000|Overall Study|Adverse Event|50
4673662|NCT02347332|7570553|FG001|Overall Study|Adverse Event|41
4673663|NCT02347332|7570552|FG000|Overall Study|Death (Unknown, Various reasons)|6
4673664|NCT02347332|7570553|FG001|Overall Study|Death (Unknown, Various reasons)|6
4673665|NCT02347332|7570552|FG000|Overall Study|Protocol Violation|1
4673666|NCT02347332|7570553|FG001|Overall Study|Protocol Violation|1
4673667|NCT02347332|7570552|FG000|Overall Study|Lost to Follow-up|2
4673668|NCT02347332|7570553|FG001|Overall Study|Lost to Follow-up|1
4673669|NCT02347332|7570552|FG000|Overall Study|Physician Decision|4
4673670|NCT02347332|7570553|FG001|Overall Study|Physician Decision|3
4673671|NCT02347332|7570552|FG000|Overall Study|Withdrawal by Subject|20
4673672|NCT02347332|7570553|FG001|Overall Study|Withdrawal by Subject|14
4673673|NCT02347332|7570552|FG000|Overall Study|Protocol requirement|1
4673674|NCT02347332|7570553|FG001|Overall Study|Protocol requirement|1
4673675|NCT02347332|7570552|FG000|Overall Study|Switch Post-Trial program|0
4673676|NCT02347332|7570553|FG001|Overall Study|Switch Post-Trial program|1
4673677|NCT02347631|7570612|FG000|First Intervention (2 Months)|Adverse Event|1
4673678|NCT02347631|7570613|FG001|First Intervention (2 Months)|Adverse Event|1
4673679|NCT02347631|7570612|FG000|First Intervention (2 Months)|Pregnancy|1
4673680|NCT02347631|7570613|FG001|First Intervention (2 Months)|Pregnancy|0
4673681|NCT02347631|7570612|FG000|First Intervention (2 Months)|Moved out of area|0
4673682|NCT02347631|7570613|FG001|First Intervention (2 Months)|Moved out of area|2
4673683|NCT02347631|7570612|FG000|First Intervention (2 Months)|Lost to Follow-up|5
4673684|NCT02347631|7570613|FG001|First Intervention (2 Months)|Lost to Follow-up|3
4673685|NCT02347631|7570612|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2
4673686|NCT02347631|7570613|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2
4673687|NCT02347631|7570612|FG000|Washout 2 (1 Month)|Lost to Follow-up|0
4673688|NCT02347631|7570613|FG001|Washout 2 (1 Month)|Lost to Follow-up|1
4673689|NCT02347631|7570612|FG000|Second Intervention (2 Months)|Lost to Follow-up|7
4673690|NCT02347631|7570613|FG001|Second Intervention (2 Months)|Lost to Follow-up|4
4673691|NCT02347631|7570612|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6
4673692|NCT02347631|7570613|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0
4673693|NCT02347657|7570623|FG000|Overall Study|Physician Decision|0
4673694|NCT02347657|7570624|FG001|Overall Study|Physician Decision|1
4673695|NCT02347657|7570623|FG000|Overall Study|Adverse Event|8
4673696|NCT02347657|7570624|FG001|Overall Study|Adverse Event|4
4673697|NCT02347657|7570623|FG000|Overall Study|Withdrawal by Subject|6
4673698|NCT02347657|7570624|FG001|Overall Study|Withdrawal by Subject|7
4673699|NCT02347657|7570623|FG000|Overall Study|Randomized but not treated|1
4673700|NCT02347657|7570624|FG001|Overall Study|Randomized but not treated|0
4673701|NCT02347657|7570623|FG000|Overall Study|Other|3
4673702|NCT02347657|7570624|FG001|Overall Study|Other|3
4673703|NCT02347761|7570634|FG000|All Collected|Death|1
4673704|NCT02347761|7570635|FG001|All Collected|Death|0
4673705|NCT02347761|7570636|FG002|All Collected|Death|0
4673706|NCT02347761|7570634|FG000|All Collected|Lost to Follow-up|3
4673707|NCT02347761|7570635|FG001|All Collected|Lost to Follow-up|2
4673708|NCT02347761|7570636|FG002|All Collected|Lost to Follow-up|3
4673709|NCT02347761|7570634|FG000|All Collected|Withdrawal by Subject|11
4673710|NCT02347761|7570635|FG001|All Collected|Withdrawal by Subject|11
4673711|NCT02347761|7570636|FG002|All Collected|Withdrawal by Subject|22
4673712|NCT02347761|7570634|FG000|All Collected|invetigator disretion|2
4673713|NCT02347761|7570635|FG001|All Collected|invetigator disretion|0
4673714|NCT02347761|7570636|FG002|All Collected|invetigator disretion|0
4673715|NCT02347761|7570634|FG000|All Collected|instillation site pain|0
4673716|NCT02347761|7570635|FG001|All Collected|instillation site pain|0
4673717|NCT02347761|7570636|FG002|All Collected|instillation site pain|1
4673718|NCT02347761|7570634|FG000|All Collected|exacerbation of COPD|0
4673719|NCT02347761|7570635|FG001|All Collected|exacerbation of COPD|0
4673720|NCT02347761|7570636|FG002|All Collected|exacerbation of COPD|1
4673721|NCT02347761|7570634|FG000|All Collected|moved/travel|0
4673722|NCT02347761|7570635|FG001|All Collected|moved/travel|1
4673723|NCT02347761|7570636|FG002|All Collected|moved/travel|0
4673724|NCT02347761|7570634|FG000|On Study Treatment|Lack of Efficacy|2
4673725|NCT02347761|7570635|FG001|On Study Treatment|Lack of Efficacy|3
4673726|NCT02347761|7570636|FG002|On Study Treatment|Lack of Efficacy|4
4756351|NCT00557193|7730826|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0
4756352|NCT00557193|7730827|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0
4756353|NCT00557193|7730828|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0
4756354|NCT00557193|7730829|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0
4756355|NCT00557193|7730824|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0
4756356|NCT00557193|7730825|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1
4756357|NCT00557193|7730826|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2
4673727|NCT02347761|7570634|FG000|On Study Treatment|non-compliance with study medication|0
4673728|NCT02347761|7570635|FG001|On Study Treatment|non-compliance with study medication|0
4673729|NCT02347761|7570636|FG002|On Study Treatment|non-compliance with study medication|2
4673730|NCT02347761|7570634|FG000|On Study Treatment|Withdrawal by Subject|7
4673731|NCT02347761|7570635|FG001|On Study Treatment|Withdrawal by Subject|3
4673732|NCT02347761|7570636|FG002|On Study Treatment|Withdrawal by Subject|5
4673733|NCT02347761|7570634|FG000|On Study Treatment|move/travel|2
4673734|NCT02347761|7570635|FG001|On Study Treatment|move/travel|6
4673735|NCT02347761|7570636|FG002|On Study Treatment|move/travel|5
4673736|NCT02347761|7570634|FG000|On Study Treatment|dissastisfaction with device|2
4673737|NCT02347761|7570635|FG001|On Study Treatment|dissastisfaction with device|1
4673738|NCT02347761|7570636|FG002|On Study Treatment|dissastisfaction with device|4
4673739|NCT02347761|7570634|FG000|On Study Treatment|Lost to Follow-up|2
4673740|NCT02347761|7570635|FG001|On Study Treatment|Lost to Follow-up|1
4673741|NCT02347761|7570636|FG002|On Study Treatment|Lost to Follow-up|1
4673742|NCT02347761|7570634|FG000|On Study Treatment|investigator discretion|2
4673743|NCT02347761|7570635|FG001|On Study Treatment|investigator discretion|0
4673744|NCT02347761|7570636|FG002|On Study Treatment|investigator discretion|0
4673745|NCT02347761|7570634|FG000|On Study Treatment|durg not working|0
4673746|NCT02347761|7570635|FG001|On Study Treatment|durg not working|1
4673747|NCT02347761|7570636|FG002|On Study Treatment|durg not working|1
4673748|NCT02347761|7570634|FG000|On Study Treatment|Adverse Event|10
4673749|NCT02347761|7570635|FG001|On Study Treatment|Adverse Event|8
4673750|NCT02347761|7570636|FG002|On Study Treatment|Adverse Event|20
4673751|NCT02347774|7570647|FG000|Study Participation|Lost to Follow-up|3
4673752|NCT02347774|7570648|FG001|Study Participation|Lost to Follow-up|6
4673753|NCT02347774|7570649|FG002|Study Participation|Lost to Follow-up|2
4673754|NCT02347774|7570647|FG000|Study Participation|Withdrawal by Subject|8
4673755|NCT02347774|7570648|FG001|Study Participation|Withdrawal by Subject|9
4673756|NCT02347774|7570649|FG002|Study Participation|Withdrawal by Subject|15
4673757|NCT02347774|7570647|FG000|Study Participation|Adverse Event|1
4673758|NCT02347774|7570648|FG001|Study Participation|Adverse Event|4
4673759|NCT02347774|7570649|FG002|Study Participation|Adverse Event|6
4673760|NCT02347774|7570647|FG000|Study Participation|withdrew consent|1
4673761|NCT02347774|7570648|FG001|Study Participation|withdrew consent|1
4673762|NCT02347774|7570649|FG002|Study Participation|withdrew consent|1
4673763|NCT02347774|7570647|FG000|Study Participation|Met Prolonged QT criteria|1
4673764|NCT02347774|7570648|FG001|Study Participation|Met Prolonged QT criteria|0
4673765|NCT02347774|7570649|FG002|Study Participation|Met Prolonged QT criteria|0
4673766|NCT02347774|7570647|FG000|Study Participation|non-compliance with study drug|0
4673767|NCT02347774|7570648|FG001|Study Participation|non-compliance with study drug|1
4673768|NCT02347774|7570649|FG002|Study Participation|non-compliance with study drug|0
4673769|NCT02347774|7570647|FG000|Study Participation|incarceration|1
4673770|NCT02347774|7570648|FG001|Study Participation|incarceration|0
4673771|NCT02347774|7570649|FG002|Study Participation|incarceration|0
4673772|NCT02347774|7570647|FG000|Study Participation|randomized in error|0
4673773|NCT02347774|7570648|FG001|Study Participation|randomized in error|0
4673774|NCT02347774|7570649|FG002|Study Participation|randomized in error|1
4673775|NCT02347774|7570647|FG000|On Study Treatment|Adverse Event|9
4673776|NCT02347774|7570648|FG001|On Study Treatment|Adverse Event|15
4673777|NCT02347774|7570649|FG002|On Study Treatment|Adverse Event|19
4673778|NCT02347774|7570647|FG000|On Study Treatment|Lack of Efficacy|3
4673779|NCT02347774|7570648|FG001|On Study Treatment|Lack of Efficacy|0
4673780|NCT02347774|7570649|FG002|On Study Treatment|Lack of Efficacy|2
4673781|NCT02347774|7570647|FG000|On Study Treatment|non-complicance with study medication|0
4673782|NCT02347774|7570648|FG001|On Study Treatment|non-complicance with study medication|2
4673783|NCT02347774|7570649|FG002|On Study Treatment|non-complicance with study medication|0
4673784|NCT02347774|7570647|FG000|On Study Treatment|Protocol Violation|0
4673785|NCT02347774|7570648|FG001|On Study Treatment|Protocol Violation|0
4673786|NCT02347774|7570649|FG002|On Study Treatment|Protocol Violation|1
4673787|NCT02347774|7570647|FG000|On Study Treatment|withdrew consent|9
4673788|NCT02347774|7570648|FG001|On Study Treatment|withdrew consent|8
4673789|NCT02347774|7570649|FG002|On Study Treatment|withdrew consent|12
4673790|NCT02347774|7570647|FG000|On Study Treatment|Lost to Follow-up|2
4673791|NCT02347774|7570648|FG001|On Study Treatment|Lost to Follow-up|6
4673792|NCT02347774|7570649|FG002|On Study Treatment|Lost to Follow-up|1
4673793|NCT02347774|7570647|FG000|On Study Treatment|Met Prolonged QT criteria|1
4673794|NCT02347774|7570648|FG001|On Study Treatment|Met Prolonged QT criteria|0
4673795|NCT02347774|7570649|FG002|On Study Treatment|Met Prolonged QT criteria|0
4673796|NCT02347774|7570647|FG000|On Study Treatment|ranomized in error|0
4673797|NCT02347774|7570648|FG001|On Study Treatment|ranomized in error|0
4673798|NCT02347774|7570649|FG002|On Study Treatment|ranomized in error|1
4673799|NCT02347787|7570659|FG000|6 Month Follow-Up|Lost to Follow-up|63
4673800|NCT02347787|7570660|FG001|6 Month Follow-Up|Lost to Follow-up|47
4673801|NCT02347787|7570659|FG000|6 Month Follow-Up|Withdrawal by Subject|3
4673802|NCT02347787|7570660|FG001|6 Month Follow-Up|Withdrawal by Subject|9
4673803|NCT02347787|7570659|FG000|9 Month Follow-Up|Lost to Follow-up|52
4673804|NCT02347787|7570660|FG001|9 Month Follow-Up|Lost to Follow-up|59
4673805|NCT02347787|7570659|FG000|9 Month Follow-Up|Withdrawal by Subject|9
4673806|NCT02347787|7570660|FG001|9 Month Follow-Up|Withdrawal by Subject|12
4673807|NCT02347813|7570673|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1
4673808|NCT02347813|7570674|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1
4673809|NCT02347813|7570673|FG000|First Intervention, 24 Weeks|Adverse Event|1
4673810|NCT02347813|7570674|FG001|First Intervention, 24 Weeks|Adverse Event|1
4673811|NCT02348008|7570682|FG000|Overall Study|Adverse Event|2
4673812|NCT02348008|7570683|FG001|Overall Study|Adverse Event|3
4673813|NCT02348008|7570684|FG002|Overall Study|Adverse Event|3
4673814|NCT02348008|7570682|FG000|Overall Study|Disease Progression|1
4673815|NCT02348008|7570683|FG001|Overall Study|Disease Progression|5
4673816|NCT02348008|7570684|FG002|Overall Study|Disease Progression|16
4673817|NCT02348008|7570682|FG000|Overall Study|Withdrawal by Subject|0
4673818|NCT02348008|7570683|FG001|Overall Study|Withdrawal by Subject|1
4673819|NCT02348008|7570684|FG002|Overall Study|Withdrawal by Subject|0
4673820|NCT02348008|7570682|FG000|Overall Study|Symptomatic Deterioration|0
4673821|NCT02348008|7570683|FG001|Overall Study|Symptomatic Deterioration|1
4673822|NCT02348008|7570684|FG002|Overall Study|Symptomatic Deterioration|0
4673823|NCT02348216|7570706|FG000|Overall Study|Death|4
4673824|NCT02348216|7570707|FG001|Overall Study|Death|27
4673825|NCT02348216|7570708|FG002|Overall Study|Death|3
4673826|NCT02348216|7570709|FG003|Overall Study|Death|18
4673827|NCT02348216|7570710|FG004|Overall Study|Death|9
4673828|NCT02348216|7570711|FG005|Overall Study|Death|23
4673829|NCT02348216|7570712|FG006|Overall Study|Death|6
4673830|NCT02348216|7570706|FG000|Overall Study|Full consent withdrawal|0
4673831|NCT02348216|7570707|FG001|Overall Study|Full consent withdrawal|0
4673832|NCT02348216|7570708|FG002|Overall Study|Full consent withdrawal|0
4673833|NCT02348216|7570709|FG003|Overall Study|Full consent withdrawal|1
4673834|NCT02348216|7570710|FG004|Overall Study|Full consent withdrawal|0
4673835|NCT02348216|7570711|FG005|Overall Study|Full consent withdrawal|0
4673836|NCT02348216|7570712|FG006|Overall Study|Full consent withdrawal|1
4673837|NCT02348216|7570706|FG000|Overall Study|Lost to Follow-up|0
4673838|NCT02348216|7570707|FG001|Overall Study|Lost to Follow-up|0
4673839|NCT02348216|7570708|FG002|Overall Study|Lost to Follow-up|0
4673840|NCT02348216|7570709|FG003|Overall Study|Lost to Follow-up|0
4673841|NCT02348216|7570710|FG004|Overall Study|Lost to Follow-up|0
4673842|NCT02348216|7570711|FG005|Overall Study|Lost to Follow-up|0
4673843|NCT02348216|7570712|FG006|Overall Study|Lost to Follow-up|1
4673844|NCT02348216|7570706|FG000|Overall Study|Still on study|3
4673845|NCT02348216|7570707|FG001|Overall Study|Still on study|50
4673846|NCT02348216|7570708|FG002|Overall Study|Still on study|21
4673847|NCT02348216|7570709|FG003|Overall Study|Still on study|19
4673848|NCT02348216|7570710|FG004|Overall Study|Still on study|32
4673849|NCT02348216|7570711|FG005|Overall Study|Still on study|27
4673850|NCT02348216|7570712|FG006|Overall Study|Still on study|32
4673851|NCT02348216|7570706|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1
4673852|NCT02348216|7570707|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4
4673853|NCT02348216|7570708|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6
4673854|NCT02348216|7570709|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4
4673855|NCT02348216|7570710|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5
4673856|NCT02348216|7570711|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8
4673857|NCT02348216|7570712|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2
4673858|NCT02348489|7570763|FG000|Overall Study|Death|336
4673859|NCT02348489|7570764|FG001|Overall Study|Death|335
4673860|NCT02348489|7570763|FG000|Overall Study|Withdrawal by Subject|14
4673861|NCT02348489|7570764|FG001|Overall Study|Withdrawal by Subject|27
4673862|NCT02348489|7570763|FG000|Overall Study|Lost to Follow-up|3
4673863|NCT02348489|7570764|FG001|Overall Study|Lost to Follow-up|5
4673864|NCT02348723|7570837|FG000|Overall Study|No ablation|21
4673865|NCT02348723|7570838|FG001|Overall Study|No ablation|20
4673866|NCT02348723|7570837|FG000|Overall Study|Non-compliant with Protocol|1
4673867|NCT02348723|7570838|FG001|Overall Study|Non-compliant with Protocol|0
4673868|NCT02348723|7570837|FG000|Overall Study|Lost to Follow-up|1
4673869|NCT02348723|7570838|FG001|Overall Study|Lost to Follow-up|1
4673870|NCT02348723|7570837|FG000|Overall Study|Consent withdrawn|1
4673871|NCT02348723|7570838|FG001|Overall Study|Consent withdrawn|3
4673872|NCT02348723|7570837|FG000|Overall Study|Reason other than specified|1
4673873|NCT02348723|7570838|FG001|Overall Study|Reason other than specified|1
4673874|NCT02348723|7570837|FG000|Overall Study|Adverse Event|3
4673875|NCT02348723|7570838|FG001|Overall Study|Adverse Event|1
4673876|NCT02348840|7570857|FG000|Overall Study|Withdrawal by Subject|2
4673877|NCT02348840|7570858|FG001|Overall Study|Withdrawal by Subject|1
4673878|NCT02348840|7570859|FG002|Overall Study|Withdrawal by Subject|0
4673879|NCT02348840|7570860|FG003|Overall Study|Withdrawal by Subject|0
4673880|NCT02349048|7570909|FG000|Overall Study|Withdrawal by Subject|4
4673881|NCT02349048|7570910|FG001|Overall Study|Withdrawal by Subject|0
4673882|NCT02349048|7570909|FG000|Overall Study|Lost to Follow-up|1
4673883|NCT02349048|7570910|FG001|Overall Study|Lost to Follow-up|0
4673884|NCT02349061|7570918|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4
4756358|NCT00557193|7730827|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1
4673885|NCT02349061|7570919|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3
4673886|NCT02349061|7570920|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0
4673887|NCT02349061|7570918|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1
4673888|NCT02349061|7570919|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0
4673889|NCT02349061|7570920|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0
4673890|NCT02349061|7570918|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1
4673891|NCT02349061|7570919|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0
4673892|NCT02349061|7570920|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0
4673893|NCT02349061|7570918|FG000|Main Study: PCP (Up to Week 24)|Other|1
4673894|NCT02349061|7570919|FG001|Main Study: PCP (Up to Week 24)|Other|1
4673895|NCT02349061|7570920|FG002|Main Study: PCP (Up to Week 24)|Other|0
4673896|NCT02349061|7570918|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2
4673897|NCT02349061|7570919|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0
4673898|NCT02349061|7570920|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0
4673899|NCT02349061|7570918|FG000|Main Study: Week 24 to 56|Adverse Event|0
4673900|NCT02349061|7570919|FG001|Main Study: Week 24 to 56|Adverse Event|2
4673901|NCT02349061|7570920|FG002|Main Study: Week 24 to 56|Adverse Event|1
4673902|NCT02349061|7570918|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0
4673903|NCT02349061|7570919|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1
4673904|NCT02349061|7570920|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0
4673905|NCT02349061|7570918|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0
4673906|NCT02349061|7570919|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0
4673907|NCT02349061|7570920|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1
4673908|NCT02349061|7570918|FG000|Main Study: Week 24 to 56|Physician Decision|0
4673909|NCT02349061|7570919|FG001|Main Study: Week 24 to 56|Physician Decision|0
4673910|NCT02349061|7570920|FG002|Main Study: Week 24 to 56|Physician Decision|1
4673911|NCT02349061|7570918|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0
4673912|NCT02349061|7570919|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3
4673913|NCT02349061|7570920|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0
4673914|NCT02349061|7570918|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0
4673915|NCT02349061|7570919|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0
4673916|NCT02349061|7570920|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1
4673917|NCT02349061|7570918|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0
4673918|NCT02349061|7570919|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2
4673919|NCT02349061|7570920|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1
4673920|NCT02349061|7570918|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0
4756359|NCT00557193|7730828|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0
4673921|NCT02349061|7570919|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0
4673922|NCT02349061|7570920|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1
4673923|NCT02349295|7570946|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7
4673924|NCT02349295|7570947|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5
4673925|NCT02349295|7570948|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5
4673926|NCT02349295|7570949|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0
4673927|NCT02349295|7570950|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0
4673928|NCT02349295|7570951|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0
4673929|NCT02349295|7570952|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0
4673930|NCT02349295|7570953|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0
4673931|NCT02349295|7570954|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0
4673932|NCT02349295|7570955|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0
4673933|NCT02349295|7570956|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0
4673934|NCT02349295|7570957|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0
4673935|NCT02349295|7570958|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0
4673936|NCT02349295|7570959|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0
4673937|NCT02349295|7570946|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4
4673938|NCT02349295|7570947|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2
4673939|NCT02349295|7570948|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9
4673940|NCT02349295|7570949|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
4673941|NCT02349295|7570950|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
4673942|NCT02349295|7570951|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
4673943|NCT02349295|7570952|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
4673944|NCT02349295|7570953|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
4673945|NCT02349295|7570954|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
4673946|NCT02349295|7570955|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
4673947|NCT02349295|7570956|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
4673948|NCT02349295|7570957|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
4673949|NCT02349295|7570958|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
4673950|NCT02349295|7570959|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
4673951|NCT02349295|7570946|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2
4673952|NCT02349295|7570947|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2
4673953|NCT02349295|7570948|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7
4673954|NCT02349295|7570949|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
4673955|NCT02349295|7570950|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
4673956|NCT02349295|7570951|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
4673957|NCT02349295|7570952|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
4756360|NCT00557193|7730829|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3
4756361|NCT00557193|7730824|FG000|Post Induction Therapy by Tx Assignment|Death|0
4756362|NCT00557193|7730825|FG001|Post Induction Therapy by Tx Assignment|Death|0
4756363|NCT00557193|7730826|FG002|Post Induction Therapy by Tx Assignment|Death|2
4673958|NCT02349295|7570953|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
4673959|NCT02349295|7570954|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
4673960|NCT02349295|7570955|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
4673961|NCT02349295|7570956|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
4673962|NCT02349295|7570957|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
4673963|NCT02349295|7570958|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
4673964|NCT02349295|7570959|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
4673965|NCT02349295|7570946|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1
4673966|NCT02349295|7570947|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1
4673967|NCT02349295|7570948|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2
4673968|NCT02349295|7570949|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
4673969|NCT02349295|7570950|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
4673970|NCT02349295|7570951|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
4673971|NCT02349295|7570952|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
4673972|NCT02349295|7570953|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
4673973|NCT02349295|7570954|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
4673974|NCT02349295|7570955|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
4673975|NCT02349295|7570956|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
4673976|NCT02349295|7570957|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
4673977|NCT02349295|7570958|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
4673978|NCT02349295|7570959|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
4673979|NCT02349295|7570946|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
4673980|NCT02349295|7570947|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1
4673981|NCT02349295|7570948|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1
4673982|NCT02349295|7570949|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
4673983|NCT02349295|7570950|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
4673984|NCT02349295|7570951|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
4673985|NCT02349295|7570952|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
4673986|NCT02349295|7570953|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
4673987|NCT02349295|7570954|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
4756364|NCT00557193|7730827|FG003|Post Induction Therapy by Tx Assignment|Death|0
4756365|NCT00557193|7730828|FG004|Post Induction Therapy by Tx Assignment|Death|2
4756366|NCT00557193|7730829|FG005|Post Induction Therapy by Tx Assignment|Death|2
4756367|NCT00557193|7730824|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0
4756368|NCT00557193|7730825|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3
4756369|NCT00557193|7730826|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5
4756370|NCT00557193|7730827|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1
4756371|NCT00557193|7730828|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2
4756372|NCT00557193|7730829|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2
4756373|NCT00557193|7730824|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0
4756374|NCT00557193|7730825|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1
4756375|NCT00557193|7730826|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0
4756376|NCT00557193|7730827|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2
4756377|NCT00557193|7730828|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2
4756378|NCT00557193|7730829|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5
4756379|NCT00557193|7730824|FG000|Post Induction Therapy by Tx Assignment|Relapse|0
4756380|NCT00557193|7730825|FG001|Post Induction Therapy by Tx Assignment|Relapse|5
4756381|NCT00557193|7730826|FG002|Post Induction Therapy by Tx Assignment|Relapse|16
4756382|NCT00557193|7730827|FG003|Post Induction Therapy by Tx Assignment|Relapse|3
4756383|NCT00557193|7730828|FG004|Post Induction Therapy by Tx Assignment|Relapse|1
4756384|NCT00557193|7730829|FG005|Post Induction Therapy by Tx Assignment|Relapse|20
4756385|NCT00557193|7730824|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
4756386|NCT00557193|7730825|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
4756387|NCT00557193|7730826|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1
4756388|NCT00557193|7730827|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
4756389|NCT00557193|7730828|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
4756390|NCT00557193|7730829|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
4756391|NCT00557193|7730824|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
4756392|NCT00557193|7730825|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
4756393|NCT00557193|7730826|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2
4756394|NCT00557193|7730827|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
4756395|NCT00557193|7730828|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
4756396|NCT00557193|7730829|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
4756397|NCT00557193|7730824|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0
4756398|NCT00557193|7730825|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0
4756399|NCT00557193|7730826|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4
4673988|NCT02349295|7570955|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
4673989|NCT02349295|7570956|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
4673990|NCT02349295|7570957|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
4673991|NCT02349295|7570958|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
4673992|NCT02349295|7570959|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
4673993|NCT02349295|7570946|FG000|IR (Week 16-24)|Lack of Efficacy|0
4673994|NCT02349295|7570947|FG001|IR (Week 16-24)|Lack of Efficacy|0
4673995|NCT02349295|7570948|FG002|IR (Week 16-24)|Lack of Efficacy|0
4673996|NCT02349295|7570949|FG003|IR (Week 16-24)|Lack of Efficacy|1
4673997|NCT02349295|7570950|FG004|IR (Week 16-24)|Lack of Efficacy|0
4673998|NCT02349295|7570951|FG005|IR (Week 16-24)|Lack of Efficacy|0
4673999|NCT02349295|7570952|FG006|IR (Week 16-24)|Lack of Efficacy|0
4674000|NCT02349295|7570953|FG007|IR (Week 16-24)|Lack of Efficacy|0
4674001|NCT02349295|7570954|FG008|IR (Week 16-24)|Lack of Efficacy|0
4674002|NCT02349295|7570955|FG009|IR (Week 16-24)|Lack of Efficacy|0
4674003|NCT02349295|7570956|FG010|IR (Week 16-24)|Lack of Efficacy|0
4674004|NCT02349295|7570957|FG011|IR (Week 16-24)|Lack of Efficacy|0
4674005|NCT02349295|7570958|FG012|IR (Week 16-24)|Lack of Efficacy|0
4674006|NCT02349295|7570959|FG013|IR (Week 16-24)|Lack of Efficacy|0
4674007|NCT02349295|7570946|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
4674008|NCT02349295|7570947|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
4674009|NCT02349295|7570948|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
4674010|NCT02349295|7570949|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
4674011|NCT02349295|7570950|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
4674012|NCT02349295|7570951|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
4674013|NCT02349295|7570952|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
4674014|NCT02349295|7570953|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32
4674015|NCT02349295|7570954|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25
4674016|NCT02349295|7570955|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19
4674017|NCT02349295|7570956|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18
4674018|NCT02349295|7570957|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
4674019|NCT02349295|7570958|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
4674020|NCT02349295|7570959|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
4674021|NCT02349295|7570946|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0
4674022|NCT02349295|7570947|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0
4674023|NCT02349295|7570948|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0
4674024|NCT02349295|7570949|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0
4674025|NCT02349295|7570950|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0
4674026|NCT02349295|7570951|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0
4674027|NCT02349295|7570952|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0
4674028|NCT02349295|7570953|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9
4674029|NCT02349295|7570954|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9
4674030|NCT02349295|7570955|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2
4674031|NCT02349295|7570956|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2
4674032|NCT02349295|7570957|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0
4674033|NCT02349295|7570958|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0
4674034|NCT02349295|7570959|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0
4674035|NCT02349295|7570946|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
4674036|NCT02349295|7570947|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
4674037|NCT02349295|7570948|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
4674038|NCT02349295|7570949|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
4674039|NCT02349295|7570950|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
4674040|NCT02349295|7570951|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
4674041|NCT02349295|7570952|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
4674042|NCT02349295|7570953|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2
4674043|NCT02349295|7570954|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
4674044|NCT02349295|7570955|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3
4674045|NCT02349295|7570956|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
4674046|NCT02349295|7570957|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
4674047|NCT02349295|7570958|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
4674048|NCT02349295|7570959|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
4674049|NCT02349295|7570946|FG000|Long-Term Extension Period (Week 24-156)|Death|0
4674050|NCT02349295|7570947|FG001|Long-Term Extension Period (Week 24-156)|Death|0
4756400|NCT00557193|7730827|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0
4756401|NCT00557193|7730828|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0
4674051|NCT02349295|7570948|FG002|Long-Term Extension Period (Week 24-156)|Death|0
4674052|NCT02349295|7570949|FG003|Long-Term Extension Period (Week 24-156)|Death|0
4674053|NCT02349295|7570950|FG004|Long-Term Extension Period (Week 24-156)|Death|0
4674054|NCT02349295|7570951|FG005|Long-Term Extension Period (Week 24-156)|Death|0
4674055|NCT02349295|7570952|FG006|Long-Term Extension Period (Week 24-156)|Death|0
4674056|NCT02349295|7570953|FG007|Long-Term Extension Period (Week 24-156)|Death|1
4674057|NCT02349295|7570954|FG008|Long-Term Extension Period (Week 24-156)|Death|1
4756402|NCT00557193|7730829|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5
4674058|NCT02349295|7570955|FG009|Long-Term Extension Period (Week 24-156)|Death|1
4674059|NCT02349295|7570956|FG010|Long-Term Extension Period (Week 24-156)|Death|0
4674060|NCT02349295|7570957|FG011|Long-Term Extension Period (Week 24-156)|Death|0
4674061|NCT02349295|7570958|FG012|Long-Term Extension Period (Week 24-156)|Death|0
4674062|NCT02349295|7570959|FG013|Long-Term Extension Period (Week 24-156)|Death|0
4674063|NCT02349295|7570946|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
4674064|NCT02349295|7570947|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
4674065|NCT02349295|7570948|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
4674066|NCT02349295|7570949|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
4674067|NCT02349295|7570950|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
4674068|NCT02349295|7570951|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
4674069|NCT02349295|7570952|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
4674070|NCT02349295|7570953|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4
4674071|NCT02349295|7570954|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2
4674072|NCT02349295|7570955|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1
4674073|NCT02349295|7570956|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3
4674074|NCT02349295|7570957|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
4674075|NCT02349295|7570958|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
4674076|NCT02349295|7570959|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
4674077|NCT02349295|7570946|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
4674078|NCT02349295|7570947|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
4674079|NCT02349295|7570948|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
4674080|NCT02349295|7570949|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
4674081|NCT02349295|7570950|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
4674082|NCT02349295|7570951|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
4674083|NCT02349295|7570952|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
4674084|NCT02349295|7570953|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2
4674085|NCT02349295|7570954|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2
4674086|NCT02349295|7570955|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
4674087|NCT02349295|7570956|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
4674088|NCT02349295|7570957|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
4756403|NCT00547339|7730858|FG000|Overall Study|Physician Decision|0
4756404|NCT00547339|7730859|FG001|Overall Study|Physician Decision|0
4756405|NCT00547339|7730860|FG002|Overall Study|Physician Decision|1
4756406|NCT00547339|7730861|FG003|Overall Study|Physician Decision|0
4756407|NCT00531232|7730883|FG000|Overall Study|Investigator decision|0
4756408|NCT00531232|7730884|FG001|Overall Study|Investigator decision|0
4756409|NCT00531232|7730885|FG002|Overall Study|Investigator decision|4
4756410|NCT00531232|7730883|FG000|Overall Study|Participants refused further treatment|0
4756411|NCT00531232|7730884|FG001|Overall Study|Participants refused further treatment|1
4756412|NCT00531232|7730885|FG002|Overall Study|Participants refused further treatment|2
4756413|NCT00531232|7730883|FG000|Overall Study|Adverse events (AEs)|1
4756414|NCT00531232|7730884|FG001|Overall Study|Adverse events (AEs)|2
4756415|NCT00531232|7730885|FG002|Overall Study|Adverse events (AEs)|2
4756416|NCT00531232|7730883|FG000|Overall Study|Treatment failure|1
4756417|NCT00531232|7730884|FG001|Overall Study|Treatment failure|3
4756418|NCT00531232|7730885|FG002|Overall Study|Treatment failure|7
4756419|NCT00531232|7730883|FG000|Overall Study|Disease recurrence|0
4756420|NCT00531232|7730884|FG001|Overall Study|Disease recurrence|0
4756421|NCT00531232|7730885|FG002|Overall Study|Disease recurrence|1
4756422|NCT00531232|7730883|FG000|Overall Study|Deceased|2
4756423|NCT00531232|7730884|FG001|Overall Study|Deceased|2
4756424|NCT00531232|7730885|FG002|Overall Study|Deceased|2
4756425|NCT00531232|7730883|FG000|Overall Study|Withdrawal by Subject|0
4756426|NCT00531232|7730884|FG001|Overall Study|Withdrawal by Subject|1
4756427|NCT00531232|7730885|FG002|Overall Study|Withdrawal by Subject|2
4756428|NCT00531232|7730883|FG000|Overall Study|Other|0
4756429|NCT00531232|7730884|FG001|Overall Study|Other|0
4756430|NCT00531232|7730885|FG002|Overall Study|Other|5
4756431|NCT00379340|7730901|FG000|Overall Study|Death|0
4756432|NCT00379340|7730902|FG001|Overall Study|Death|0
4756433|NCT00379340|7730903|FG002|Overall Study|Death|0
4756434|NCT00379340|7730904|FG003|Overall Study|Death|2
4756435|NCT00379340|7730905|FG004|Overall Study|Death|0
4756436|NCT00379340|7730901|FG000|Overall Study|Lack of Efficacy|6
4756437|NCT00379340|7730902|FG001|Overall Study|Lack of Efficacy|1
4756438|NCT00379340|7730903|FG002|Overall Study|Lack of Efficacy|0
4756439|NCT00379340|7730904|FG003|Overall Study|Lack of Efficacy|4
4756440|NCT00379340|7730905|FG004|Overall Study|Lack of Efficacy|3
4756441|NCT00379340|7730901|FG000|Overall Study|Physician Decision|6
4756442|NCT00379340|7730902|FG001|Overall Study|Physician Decision|2
4756443|NCT00379340|7730903|FG002|Overall Study|Physician Decision|1
4756444|NCT00379340|7730904|FG003|Overall Study|Physician Decision|2
4756445|NCT00379340|7730905|FG004|Overall Study|Physician Decision|3
4756446|NCT00379340|7730901|FG000|Overall Study|Withdrawal by Subject|0
4756447|NCT00379340|7730902|FG001|Overall Study|Withdrawal by Subject|0
4756448|NCT00379340|7730903|FG002|Overall Study|Withdrawal by Subject|0
4674089|NCT02349295|7570958|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
4674090|NCT02349295|7570959|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
4674091|NCT02349295|7570946|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0
4674092|NCT02349295|7570947|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0
4674093|NCT02349295|7570948|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0
4674094|NCT02349295|7570949|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0
4674095|NCT02349295|7570950|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0
4674096|NCT02349295|7570951|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0
4674097|NCT02349295|7570952|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0
4674098|NCT02349295|7570953|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2
4674099|NCT02349295|7570954|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2
4674100|NCT02349295|7570955|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0
4674101|NCT02349295|7570956|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0
4674102|NCT02349295|7570957|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0
4674103|NCT02349295|7570958|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0
4674104|NCT02349295|7570959|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0
4674105|NCT02349295|7570946|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
4674106|NCT02349295|7570947|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
4674107|NCT02349295|7570948|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
4674108|NCT02349295|7570949|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
4674109|NCT02349295|7570950|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
4674110|NCT02349295|7570951|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
4674111|NCT02349295|7570952|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
4674112|NCT02349295|7570953|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
4674113|NCT02349295|7570954|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
4674114|NCT02349295|7570955|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
4674115|NCT02349295|7570956|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
4674116|NCT02349295|7570957|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1
4756449|NCT00379340|7730904|FG003|Overall Study|Withdrawal by Subject|1
4674117|NCT02349295|7570958|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5
4674118|NCT02349295|7570959|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1
4674119|NCT02349295|7570946|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
4674120|NCT02349295|7570947|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
4674121|NCT02349295|7570948|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
4674122|NCT02349295|7570949|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
4674123|NCT02349295|7570950|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
4674124|NCT02349295|7570951|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
4674125|NCT02349295|7570952|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
4674126|NCT02349295|7570953|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
4756450|NCT00379340|7730905|FG004|Overall Study|Withdrawal by Subject|0
4756451|NCT00379340|7730901|FG000|Overall Study|Refusal of further protocol therapy|1
4756452|NCT00379340|7730902|FG001|Overall Study|Refusal of further protocol therapy|0
4756453|NCT00379340|7730903|FG002|Overall Study|Refusal of further protocol therapy|1
4756454|NCT00379340|7730904|FG003|Overall Study|Refusal of further protocol therapy|1
4756455|NCT00379340|7730905|FG004|Overall Study|Refusal of further protocol therapy|7
4756456|NCT00379340|7730901|FG000|Overall Study|On more than 1 tumor therapeutic study|0
4674127|NCT02349295|7570954|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
4674128|NCT02349295|7570955|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
4674129|NCT02349295|7570956|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
4674130|NCT02349295|7570957|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1
4674131|NCT02349295|7570958|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2
4674132|NCT02349295|7570959|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
4674133|NCT02349295|7570946|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
4674134|NCT02349295|7570947|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
4674135|NCT02349295|7570948|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
4674136|NCT02349295|7570949|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
4674137|NCT02349295|7570950|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
4674138|NCT02349295|7570951|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
4674139|NCT02349295|7570952|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
4674140|NCT02349295|7570953|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
4674141|NCT02349295|7570954|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
4674142|NCT02349295|7570955|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
4674143|NCT02349295|7570956|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
4674144|NCT02349295|7570957|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1
4674145|NCT02349295|7570958|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1
4674146|NCT02349295|7570959|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
4674147|NCT02349295|7570946|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
4674148|NCT02349295|7570947|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
4674149|NCT02349295|7570948|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
4674150|NCT02349295|7570949|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
4674151|NCT02349295|7570950|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
4674152|NCT02349295|7570951|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
4674153|NCT02349295|7570952|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
4674154|NCT02349295|7570953|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
4674155|NCT02349295|7570954|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
4674156|NCT02349295|7570955|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
4674157|NCT02349295|7570956|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
4674158|NCT02349295|7570957|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2
4674159|NCT02349295|7570958|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
4674160|NCT02349295|7570959|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
4674161|NCT02349295|7570946|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
4674162|NCT02349295|7570947|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
4674163|NCT02349295|7570948|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
4674164|NCT02349295|7570949|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
4674165|NCT02349295|7570950|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
4674166|NCT02349295|7570951|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
4674167|NCT02349295|7570952|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
4674168|NCT02349295|7570953|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
4674169|NCT02349295|7570954|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
4674170|NCT02349295|7570955|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
4674171|NCT02349295|7570956|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
4674172|NCT02349295|7570957|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4
4674173|NCT02349295|7570958|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
4674174|NCT02349295|7570959|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
4756457|NCT00379340|7730902|FG001|Overall Study|On more than 1 tumor therapeutic study|0
4756458|NCT00379340|7730903|FG002|Overall Study|On more than 1 tumor therapeutic study|0
4756459|NCT00379340|7730904|FG003|Overall Study|On more than 1 tumor therapeutic study|2
4756460|NCT00379340|7730905|FG004|Overall Study|On more than 1 tumor therapeutic study|0
4756461|NCT00379340|7730901|FG000|Overall Study|Delayed nephrectomy and anaplasia|0
4756462|NCT00379340|7730902|FG001|Overall Study|Delayed nephrectomy and anaplasia|0
4756463|NCT00379340|7730903|FG002|Overall Study|Delayed nephrectomy and anaplasia|0
4756464|NCT00379340|7730904|FG003|Overall Study|Delayed nephrectomy and anaplasia|1
4756465|NCT00379340|7730905|FG004|Overall Study|Delayed nephrectomy and anaplasia|1
4756466|NCT00304070|7730921|FG000|Overall Study|Death|0
4756467|NCT00304070|7730922|FG001|Overall Study|Death|0
4756468|NCT00304070|7730923|FG002|Overall Study|Death|3
4756469|NCT00304070|7730921|FG000|Overall Study|Lost to Follow-up|0
4756470|NCT00304070|7730922|FG001|Overall Study|Lost to Follow-up|0
4756471|NCT00304070|7730923|FG002|Overall Study|Lost to Follow-up|1
4756472|NCT00304070|7730921|FG000|Overall Study|Physician Decision|0
4756473|NCT00304070|7730922|FG001|Overall Study|Physician Decision|0
4756474|NCT00304070|7730923|FG002|Overall Study|Physician Decision|3
4756475|NCT00304070|7730921|FG000|Overall Study|Withdrawal by Subject|0
4756476|NCT00304070|7730922|FG001|Overall Study|Withdrawal by Subject|0
4756477|NCT00304070|7730923|FG002|Overall Study|Withdrawal by Subject|1
4756478|NCT00304070|7730921|FG000|Overall Study|Progressive Disease|3
4756479|NCT00304070|7730922|FG001|Overall Study|Progressive Disease|7
4756480|NCT00304070|7730923|FG002|Overall Study|Progressive Disease|4
4674175|NCT02349360|7570986|FG000|Overall Study|Withdrawal by Subject|0
4674176|NCT02349360|7570987|FG001|Overall Study|Withdrawal by Subject|1
4674177|NCT02349412|7570995|FG000|Overall Study|Withdrawal by Subject|7
4674178|NCT02349412|7570996|FG001|Overall Study|Withdrawal by Subject|7
4674179|NCT02349425|7571006|FG000|Period 1|Adverse Event|1
4674180|NCT02349425|7571007|FG001|Period 1|Adverse Event|1
4674181|NCT02349425|7571008|FG002|Period 1|Adverse Event|0
4674182|NCT02349425|7571009|FG003|Period 1|Adverse Event|0
4674183|NCT02349425|7571006|FG000|Period 2|Adverse Event|0
4674184|NCT02349425|7571007|FG001|Period 2|Adverse Event|1
4674185|NCT02349425|7571008|FG002|Period 2|Adverse Event|1
4674186|NCT02349425|7571009|FG003|Period 2|Adverse Event|0
4674187|NCT02349451|7571058|FG000|Overall Study|Withdrawal by Subject|0
4674188|NCT02349451|7571059|FG001|Overall Study|Withdrawal by Subject|1
4674189|NCT02349451|7571060|FG002|Overall Study|Withdrawal by Subject|2
4674190|NCT02349451|7571061|FG003|Overall Study|Withdrawal by Subject|1
4674191|NCT02349542|7571087|FG000|Overall Study|Withdrawal by Subject|5
4674192|NCT02349633|7571105|FG000|Overall Study|Death|0
4674193|NCT02349633|7571106|FG001|Overall Study|Death|1
4674194|NCT02349633|7571107|FG002|Overall Study|Death|0
4674195|NCT02349633|7571108|FG003|Overall Study|Death|0
4674196|NCT02349633|7571109|FG004|Overall Study|Death|0
4674197|NCT02349633|7571110|FG005|Overall Study|Death|1
4674198|NCT02349633|7571111|FG006|Overall Study|Death|1
4674199|NCT02349633|7571112|FG007|Overall Study|Death|1
4674200|NCT02349633|7571113|FG008|Overall Study|Death|0
4674201|NCT02349633|7571114|FG009|Overall Study|Death|1
4674202|NCT02349633|7571115|FG010|Overall Study|Death|0
4674203|NCT02349633|7571116|FG011|Overall Study|Death|0
4674204|NCT02349633|7571117|FG012|Overall Study|Death|0
4674205|NCT02349633|7571118|FG013|Overall Study|Death|0
4674206|NCT02349633|7571105|FG000|Overall Study|Withdrawal by Subject|0
4674207|NCT02349633|7571106|FG001|Overall Study|Withdrawal by Subject|0
4674208|NCT02349633|7571107|FG002|Overall Study|Withdrawal by Subject|0
4674209|NCT02349633|7571108|FG003|Overall Study|Withdrawal by Subject|1
4674210|NCT02349633|7571109|FG004|Overall Study|Withdrawal by Subject|0
4674211|NCT02349633|7571110|FG005|Overall Study|Withdrawal by Subject|0
4674212|NCT02349633|7571111|FG006|Overall Study|Withdrawal by Subject|0
4674213|NCT02349633|7571112|FG007|Overall Study|Withdrawal by Subject|2
4674214|NCT02349633|7571113|FG008|Overall Study|Withdrawal by Subject|2
4674215|NCT02349633|7571114|FG009|Overall Study|Withdrawal by Subject|1
4674216|NCT02349633|7571115|FG010|Overall Study|Withdrawal by Subject|0
4674217|NCT02349633|7571116|FG011|Overall Study|Withdrawal by Subject|0
4674218|NCT02349633|7571117|FG012|Overall Study|Withdrawal by Subject|0
4674219|NCT02349633|7571118|FG013|Overall Study|Withdrawal by Subject|0
4674220|NCT02349633|7571105|FG000|Overall Study|Withdrawal of informed consent|0
4756481|NCT01701583|7730947|FG000|Overall Study|Withdrawal by Subject|2
4756482|NCT01701583|7730948|FG001|Overall Study|Withdrawal by Subject|0
4756483|NCT01714817|7730957|FG000|Year 1 Period|Lack of Efficacy|11
4756484|NCT01714817|7730958|FG001|Year 1 Period|Lack of Efficacy|9
4756485|NCT01714817|7730957|FG000|Year 1 Period|Adverse Event|20
4756486|NCT01714817|7730958|FG001|Year 1 Period|Adverse Event|17
4756487|NCT01714817|7730957|FG000|Year 1 Period|Withdrawal by Subject|6
4756488|NCT01714817|7730958|FG001|Year 1 Period|Withdrawal by Subject|7
4756489|NCT01714817|7730957|FG000|Year 1 Period|Death|1
4756490|NCT01714817|7730958|FG001|Year 1 Period|Death|1
4756491|NCT01714817|7730957|FG000|Year 1 Period|Lost to Follow-up|0
4756492|NCT01714817|7730958|FG001|Year 1 Period|Lost to Follow-up|2
4756493|NCT01714817|7730957|FG000|Year 1 Period|Poor / non-compliance|0
4756494|NCT01714817|7730958|FG001|Year 1 Period|Poor / non-compliance|1
4756495|NCT01714817|7730957|FG000|Year 1 Period|Pregnancy|2
4756496|NCT01714817|7730958|FG001|Year 1 Period|Pregnancy|0
4674221|NCT02349633|7571106|FG001|Overall Study|Withdrawal of informed consent|0
4674222|NCT02349633|7571107|FG002|Overall Study|Withdrawal of informed consent|0
4674223|NCT02349633|7571108|FG003|Overall Study|Withdrawal of informed consent|1
4674224|NCT02349633|7571109|FG004|Overall Study|Withdrawal of informed consent|1
4674225|NCT02349633|7571110|FG005|Overall Study|Withdrawal of informed consent|0
4674226|NCT02349633|7571111|FG006|Overall Study|Withdrawal of informed consent|0
4674227|NCT02349633|7571112|FG007|Overall Study|Withdrawal of informed consent|3
4674228|NCT02349633|7571113|FG008|Overall Study|Withdrawal of informed consent|0
4674229|NCT02349633|7571114|FG009|Overall Study|Withdrawal of informed consent|0
4674230|NCT02349633|7571115|FG010|Overall Study|Withdrawal of informed consent|0
4674231|NCT02349633|7571116|FG011|Overall Study|Withdrawal of informed consent|0
4674232|NCT02349633|7571117|FG012|Overall Study|Withdrawal of informed consent|0
4674233|NCT02349633|7571118|FG013|Overall Study|Withdrawal of informed consent|0
4674234|NCT02349633|7571105|FG000|Overall Study|Transition to compassionate use|0
4674235|NCT02349633|7571106|FG001|Overall Study|Transition to compassionate use|0
4674236|NCT02349633|7571107|FG002|Overall Study|Transition to compassionate use|0
4674237|NCT02349633|7571108|FG003|Overall Study|Transition to compassionate use|0
4674238|NCT02349633|7571109|FG004|Overall Study|Transition to compassionate use|1
4674239|NCT02349633|7571110|FG005|Overall Study|Transition to compassionate use|0
4674240|NCT02349633|7571111|FG006|Overall Study|Transition to compassionate use|0
4674241|NCT02349633|7571112|FG007|Overall Study|Transition to compassionate use|3
4674242|NCT02349633|7571113|FG008|Overall Study|Transition to compassionate use|0
4756497|NCT01714817|7730957|FG000|Year 1 Period|Participant no longer meets criteria|6
4756498|NCT01714817|7730958|FG001|Year 1 Period|Participant no longer meets criteria|2
4756499|NCT01714817|7730957|FG000|Year 1 Period|Not treated- received ACE inhibition|1
4756500|NCT01714817|7730958|FG001|Year 1 Period|Not treated- received ACE inhibition|0
4756501|NCT01714817|7730957|FG000|Year 1 Period|Change in Concomitant Medication|0
4756502|NCT01714817|7730958|FG001|Year 1 Period|Change in Concomitant Medication|1
4674243|NCT02349633|7571114|FG009|Overall Study|Transition to compassionate use|1
4674244|NCT02349633|7571115|FG010|Overall Study|Transition to compassionate use|0
4674245|NCT02349633|7571116|FG011|Overall Study|Transition to compassionate use|0
4674246|NCT02349633|7571117|FG012|Overall Study|Transition to compassionate use|0
4674247|NCT02349633|7571118|FG013|Overall Study|Transition to compassionate use|0
4674248|NCT02349633|7571105|FG000|Overall Study|Early termination of survival follow-up|0
4674249|NCT02349633|7571106|FG001|Overall Study|Early termination of survival follow-up|0
4674250|NCT02349633|7571107|FG002|Overall Study|Early termination of survival follow-up|0
4674251|NCT02349633|7571108|FG003|Overall Study|Early termination of survival follow-up|0
4674252|NCT02349633|7571109|FG004|Overall Study|Early termination of survival follow-up|0
4674253|NCT02349633|7571110|FG005|Overall Study|Early termination of survival follow-up|0
4674254|NCT02349633|7571111|FG006|Overall Study|Early termination of survival follow-up|0
4674255|NCT02349633|7571112|FG007|Overall Study|Early termination of survival follow-up|4
4674256|NCT02349633|7571113|FG008|Overall Study|Early termination of survival follow-up|0
4674257|NCT02349633|7571114|FG009|Overall Study|Early termination of survival follow-up|0
4674258|NCT02349633|7571115|FG010|Overall Study|Early termination of survival follow-up|0
4674259|NCT02349633|7571116|FG011|Overall Study|Early termination of survival follow-up|0
4674260|NCT02349633|7571117|FG012|Overall Study|Early termination of survival follow-up|0
4674261|NCT02349633|7571118|FG013|Overall Study|Early termination of survival follow-up|0
4674262|NCT02349633|7571105|FG000|Overall Study|Termination by sponsor|0
4674263|NCT02349633|7571106|FG001|Overall Study|Termination by sponsor|0
4674264|NCT02349633|7571107|FG002|Overall Study|Termination by sponsor|0
4674265|NCT02349633|7571108|FG003|Overall Study|Termination by sponsor|0
4674266|NCT02349633|7571109|FG004|Overall Study|Termination by sponsor|0
4674267|NCT02349633|7571110|FG005|Overall Study|Termination by sponsor|0
4674268|NCT02349633|7571111|FG006|Overall Study|Termination by sponsor|0
4674269|NCT02349633|7571112|FG007|Overall Study|Termination by sponsor|1
4674270|NCT02349633|7571113|FG008|Overall Study|Termination by sponsor|0
4674271|NCT02349633|7571114|FG009|Overall Study|Termination by sponsor|2
4674272|NCT02349633|7571115|FG010|Overall Study|Termination by sponsor|0
4674273|NCT02349633|7571116|FG011|Overall Study|Termination by sponsor|0
4674274|NCT02349633|7571117|FG012|Overall Study|Termination by sponsor|0
4674275|NCT02349633|7571118|FG013|Overall Study|Termination by sponsor|0
4674276|NCT02349633|7571105|FG000|Overall Study|Other|0
4674277|NCT02349633|7571106|FG001|Overall Study|Other|0
4674278|NCT02349633|7571107|FG002|Overall Study|Other|0
4674279|NCT02349633|7571108|FG003|Overall Study|Other|0
4674280|NCT02349633|7571109|FG004|Overall Study|Other|0
4674281|NCT02349633|7571110|FG005|Overall Study|Other|0
4674282|NCT02349633|7571111|FG006|Overall Study|Other|0
4674283|NCT02349633|7571112|FG007|Overall Study|Other|2
4674284|NCT02349633|7571113|FG008|Overall Study|Other|0
4674285|NCT02349633|7571114|FG009|Overall Study|Other|0
4674286|NCT02349633|7571115|FG010|Overall Study|Other|0
4674287|NCT02349633|7571116|FG011|Overall Study|Other|0
4674288|NCT02349633|7571117|FG012|Overall Study|Other|0
4674289|NCT02349633|7571118|FG013|Overall Study|Other|0
4674290|NCT02349711|7571198|FG000|Overall Study|Withdrawal by Subject|2
4674291|NCT02349711|7571199|FG001|Overall Study|Withdrawal by Subject|1
4674292|NCT02349711|7571198|FG000|Overall Study|Lost to Follow-up|1
4674293|NCT02349711|7571199|FG001|Overall Study|Lost to Follow-up|1
4674294|NCT02349789|7571205|FG000|Overall Study|Withdrawal by Subject|2
4674295|NCT02350127|7571211|FG000|4-Month Assessment|Withdrawal by Subject|10
4674296|NCT02350127|7571212|FG001|4-Month Assessment|Withdrawal by Subject|9
4674297|NCT02350127|7571211|FG000|4-Month Assessment|Death|1
4674298|NCT02350127|7571212|FG001|4-Month Assessment|Death|0
4674299|NCT02350127|7571211|FG000|8-Month Assessment|Death|1
4674300|NCT02350127|7571212|FG001|8-Month Assessment|Death|1
4674301|NCT02350127|7571211|FG000|8-Month Assessment|Withdrawal by Subject|5
4674302|NCT02350127|7571212|FG001|8-Month Assessment|Withdrawal by Subject|8
4674303|NCT02350309|7571225|FG000|Treatment Period 1 (2 Days)|Physician Decision|0
4674304|NCT02350309|7571226|FG001|Treatment Period 1 (2 Days)|Physician Decision|0
4674305|NCT02350309|7571227|FG002|Treatment Period 1 (2 Days)|Physician Decision|1
4674306|NCT02350309|7571228|FG003|Treatment Period 1 (2 Days)|Physician Decision|0
4674307|NCT02350309|7571229|FG004|Treatment Period 1 (2 Days)|Physician Decision|0
4674308|NCT02350309|7571230|FG005|Treatment Period 1 (2 Days)|Physician Decision|0
4674309|NCT02350309|7571225|FG000|Treatment Period 4 (2 Days)|Death in the Family|0
4674310|NCT02350309|7571226|FG001|Treatment Period 4 (2 Days)|Death in the Family|0
4674311|NCT02350309|7571227|FG002|Treatment Period 4 (2 Days)|Death in the Family|0
4674312|NCT02350309|7571228|FG003|Treatment Period 4 (2 Days)|Death in the Family|0
4674313|NCT02350309|7571229|FG004|Treatment Period 4 (2 Days)|Death in the Family|0
4674314|NCT02350309|7571230|FG005|Treatment Period 4 (2 Days)|Death in the Family|1
4674315|NCT02350478|7571247|FG000|Overall Study|Lost to Follow-up|5
4674316|NCT02350478|7571248|FG001|Overall Study|Lost to Follow-up|1
4674317|NCT02351167|7571364|FG000|Overall Study|Withdrawal by Subject|19
4674318|NCT02351167|7571365|FG001|Overall Study|Withdrawal by Subject|18
4674319|NCT02351167|7571366|FG002|Overall Study|Withdrawal by Subject|21
4674320|NCT02351349|7571394|FG000|Overall Study|Withdrawal by Subject|2
4674321|NCT02351349|7571395|FG001|Overall Study|Withdrawal by Subject|3
4674322|NCT02351817|7571431|FG000|Period 1|Adverse Event|1
4674323|NCT02351817|7571432|FG001|Period 1|Adverse Event|2
4674324|NCT02351817|7571431|FG000|Period 1|Lack of Efficacy|0
4674325|NCT02351817|7571432|FG001|Period 1|Lack of Efficacy|1
4674326|NCT02351817|7571431|FG000|Period 2|Adverse Event|0
4674327|NCT02351817|7571432|FG001|Period 2|Adverse Event|2
4674328|NCT02351817|7571431|FG000|Period 2|Protocol Violation|1
4674329|NCT02351817|7571432|FG001|Period 2|Protocol Violation|0
4674330|NCT02351934|7571441|FG000|Allocation|POD weight<pre-op weight|3
4674331|NCT02351934|7571442|FG001|Allocation|POD weight<pre-op weight|0
4674332|NCT02351934|7571441|FG000|Allocation|Hypotension preventing administration|2
4674333|NCT02351934|7571442|FG001|Allocation|Hypotension preventing administration|0
4674334|NCT02351934|7571441|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1
4674335|NCT02351934|7571442|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0
4674336|NCT02351934|7571441|FG000|Follow-Up|POD weight<pre-op weight|3
4674337|NCT02351934|7571442|FG001|Follow-Up|POD weight<pre-op weight|0
4674338|NCT02351934|7571441|FG000|Follow-Up|Acute Kidney Injury|1
4674339|NCT02351934|7571442|FG001|Follow-Up|Acute Kidney Injury|0
4674340|NCT02351934|7571441|FG000|Follow-Up|Early dismissal|3
4674341|NCT02351934|7571442|FG001|Follow-Up|Early dismissal|0
4674342|NCT02351934|7571441|FG000|Follow-Up|Hypotension|3
4674343|NCT02351934|7571442|FG001|Follow-Up|Hypotension|0
4674344|NCT02351934|7571441|FG000|Follow-Up|No documentation|2
4674345|NCT02351934|7571442|FG001|Follow-Up|No documentation|0
4674346|NCT02351934|7571441|FG000|Follow-Up|1 ERAS Component Noncompliant|0
4674347|NCT02351934|7571442|FG001|Follow-Up|1 ERAS Component Noncompliant|6
4674348|NCT02351934|7571441|FG000|Follow-Up|2 ERAS Components Noncompliant|0
4674349|NCT02351934|7571442|FG001|Follow-Up|2 ERAS Components Noncompliant|4
4674350|NCT02351960|7571450|FG000|Overall Study|Pretreatment Event/Adverse Event|6
4674351|NCT02351960|7571451|FG001|Overall Study|Pretreatment Event/Adverse Event|3
4674352|NCT02351960|7571450|FG000|Overall Study|Voluntary Withdrawal|5
4674353|NCT02351960|7571451|FG001|Overall Study|Voluntary Withdrawal|4
4674354|NCT02351960|7571450|FG000|Overall Study|Significant Protocol Deviation|0
4674355|NCT02351960|7571451|FG001|Overall Study|Significant Protocol Deviation|5
4674356|NCT02352493|7571494|FG000|Overall Study|Pregnancy|0
4674357|NCT02352493|7571495|FG001|Overall Study|Pregnancy|0
4674358|NCT02352493|7571496|FG002|Overall Study|Pregnancy|0
4674359|NCT02352493|7571497|FG003|Overall Study|Pregnancy|0
4674360|NCT02352493|7571498|FG004|Overall Study|Pregnancy|0
4674361|NCT02352493|7571499|FG005|Overall Study|Pregnancy|0
4674362|NCT02352493|7571500|FG006|Overall Study|Pregnancy|1
4674363|NCT02352493|7571501|FG007|Overall Study|Pregnancy|0
4674364|NCT02352493|7571502|FG008|Overall Study|Pregnancy|1
4674365|NCT02352493|7571503|FG009|Overall Study|Pregnancy|0
4674366|NCT02352493|7571504|FG010|Overall Study|Pregnancy|0
4674367|NCT02352493|7571505|FG011|Overall Study|Pregnancy|0
4674368|NCT02352493|7571506|FG012|Overall Study|Pregnancy|0
4674369|NCT02352493|7571507|FG013|Overall Study|Pregnancy|0
4674370|NCT02352493|7571508|FG014|Overall Study|Pregnancy|0
4674371|NCT02352493|7571509|FG015|Overall Study|Pregnancy|0
4674372|NCT02352493|7571510|FG016|Overall Study|Pregnancy|0
4674373|NCT02352493|7571511|FG017|Overall Study|Pregnancy|0
4674374|NCT02352493|7571494|FG000|Overall Study|Withdrawal by Subject|0
4674375|NCT02352493|7571495|FG001|Overall Study|Withdrawal by Subject|0
4674376|NCT02352493|7571496|FG002|Overall Study|Withdrawal by Subject|0
4756503|NCT01714817|7730957|FG000|Year 1 Period|Need of use of Prohibited Medications|1
4756504|NCT01714817|7730958|FG001|Year 1 Period|Need of use of Prohibited Medications|0
4756505|NCT01714817|7730957|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0
4756506|NCT01714817|7730958|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1
4756507|NCT01714817|7730957|FG000|Year 1 Period|Hypersensitivity to the medication|0
4756508|NCT01714817|7730958|FG001|Year 1 Period|Hypersensitivity to the medication|1
4756509|NCT01714817|7730957|FG000|Year 2 Period|Lack of Efficacy|4
4756510|NCT01714817|7730958|FG001|Year 2 Period|Lack of Efficacy|12
4756511|NCT01714817|7730957|FG000|Year 2 Period|Adverse Event|7
4756512|NCT01714817|7730958|FG001|Year 2 Period|Adverse Event|6
4756513|NCT01714817|7730957|FG000|Year 2 Period|Participant request to stop treatment|4
4756514|NCT01714817|7730958|FG001|Year 2 Period|Participant request to stop treatment|4
4674377|NCT02352493|7571497|FG003|Overall Study|Withdrawal by Subject|0
4674378|NCT02352493|7571498|FG004|Overall Study|Withdrawal by Subject|0
4674379|NCT02352493|7571499|FG005|Overall Study|Withdrawal by Subject|0
4674380|NCT02352493|7571500|FG006|Overall Study|Withdrawal by Subject|0
4674381|NCT02352493|7571501|FG007|Overall Study|Withdrawal by Subject|0
4674382|NCT02352493|7571502|FG008|Overall Study|Withdrawal by Subject|1
4674383|NCT02352493|7571503|FG009|Overall Study|Withdrawal by Subject|0
4674384|NCT02352493|7571504|FG010|Overall Study|Withdrawal by Subject|0
4674385|NCT02352493|7571505|FG011|Overall Study|Withdrawal by Subject|0
4674386|NCT02352493|7571506|FG012|Overall Study|Withdrawal by Subject|0
4674387|NCT02352493|7571507|FG013|Overall Study|Withdrawal by Subject|0
4674388|NCT02352493|7571508|FG014|Overall Study|Withdrawal by Subject|1
4674389|NCT02352493|7571509|FG015|Overall Study|Withdrawal by Subject|0
4674390|NCT02352493|7571510|FG016|Overall Study|Withdrawal by Subject|0
4674391|NCT02352493|7571511|FG017|Overall Study|Withdrawal by Subject|0
4674392|NCT02352493|7571494|FG000|Overall Study|Lost to Follow-up|0
4674393|NCT02352493|7571495|FG001|Overall Study|Lost to Follow-up|0
4674394|NCT02352493|7571496|FG002|Overall Study|Lost to Follow-up|0
4674395|NCT02352493|7571497|FG003|Overall Study|Lost to Follow-up|0
4674396|NCT02352493|7571498|FG004|Overall Study|Lost to Follow-up|0
4674397|NCT02352493|7571499|FG005|Overall Study|Lost to Follow-up|0
4674398|NCT02352493|7571500|FG006|Overall Study|Lost to Follow-up|0
4674399|NCT02352493|7571501|FG007|Overall Study|Lost to Follow-up|0
4674400|NCT02352493|7571502|FG008|Overall Study|Lost to Follow-up|0
4674401|NCT02352493|7571503|FG009|Overall Study|Lost to Follow-up|1
4674402|NCT02352493|7571504|FG010|Overall Study|Lost to Follow-up|0
4674403|NCT02352493|7571505|FG011|Overall Study|Lost to Follow-up|0
4674404|NCT02352493|7571506|FG012|Overall Study|Lost to Follow-up|1
4674405|NCT02352493|7571507|FG013|Overall Study|Lost to Follow-up|2
4674406|NCT02352493|7571508|FG014|Overall Study|Lost to Follow-up|0
4674407|NCT02352493|7571509|FG015|Overall Study|Lost to Follow-up|0
4674408|NCT02352493|7571510|FG016|Overall Study|Lost to Follow-up|0
4674409|NCT02352493|7571511|FG017|Overall Study|Lost to Follow-up|0
4674410|NCT02352779|7571569|FG000|Overall Study|Personal Issues|1
4674411|NCT02352779|7571570|FG001|Overall Study|Personal Issues|1
4674412|NCT02352779|7571571|FG002|Overall Study|Personal Issues|0
4674413|NCT02352779|7571569|FG000|Overall Study|Too Many Forms|2
4674414|NCT02352779|7571570|FG001|Overall Study|Too Many Forms|0
4674415|NCT02352779|7571571|FG002|Overall Study|Too Many Forms|0
4674416|NCT02352779|7571569|FG000|Overall Study|Feeling Overwhelmed|1
4674417|NCT02352779|7571570|FG001|Overall Study|Feeling Overwhelmed|0
4674418|NCT02352779|7571571|FG002|Overall Study|Feeling Overwhelmed|0
4674419|NCT02352779|7571569|FG000|Overall Study|Disliked Intervention|1
4674420|NCT02352779|7571570|FG001|Overall Study|Disliked Intervention|0
4674421|NCT02352779|7571571|FG002|Overall Study|Disliked Intervention|0
4674422|NCT02352779|7571569|FG000|Overall Study|Changed Mind|1
4674423|NCT02352779|7571570|FG001|Overall Study|Changed Mind|0
4674424|NCT02352779|7571571|FG002|Overall Study|Changed Mind|0
4674425|NCT02352779|7571569|FG000|Overall Study|Study Related Symptoms|1
4674426|NCT02352779|7571570|FG001|Overall Study|Study Related Symptoms|0
4674427|NCT02352779|7571571|FG002|Overall Study|Study Related Symptoms|0
4674428|NCT02352779|7571569|FG000|Overall Study|Absence of Symptoms|1
4674429|NCT02352779|7571570|FG001|Overall Study|Absence of Symptoms|0
4674430|NCT02352779|7571571|FG002|Overall Study|Absence of Symptoms|0
4674431|NCT02352779|7571569|FG000|Overall Study|Other Medical Reason|0
4674432|NCT02352779|7571570|FG001|Overall Study|Other Medical Reason|0
4674433|NCT02352779|7571571|FG002|Overall Study|Other Medical Reason|1
4674434|NCT02352779|7571569|FG000|Overall Study|No Reason|0
4674435|NCT02352779|7571570|FG001|Overall Study|No Reason|0
4674436|NCT02352779|7571571|FG002|Overall Study|No Reason|1
4674437|NCT02353169|7571629|FG000|Overall Study|QTc > 450 msec|1
4674438|NCT02353169|7571630|FG001|Overall Study|QTc > 450 msec|1
4674439|NCT02353169|7571631|FG002|Overall Study|QTc > 450 msec|1
4674440|NCT02353169|7571632|FG003|Overall Study|QTc > 450 msec|1
4674441|NCT02353169|7571629|FG000|Overall Study|OR team declined|2
4674442|NCT02353169|7571630|FG001|Overall Study|OR team declined|0
4674443|NCT02353169|7571631|FG002|Overall Study|OR team declined|0
4674444|NCT02353169|7571632|FG003|Overall Study|OR team declined|0
4674445|NCT02353169|7571629|FG000|Overall Study|Inhalational induction|0
4674446|NCT02353169|7571630|FG001|Overall Study|Inhalational induction|2
4674447|NCT02353169|7571631|FG002|Overall Study|Inhalational induction|0
4674448|NCT02353169|7571632|FG003|Overall Study|Inhalational induction|0
4674449|NCT02353169|7571629|FG000|Overall Study|ECG data error|0
4674450|NCT02353169|7571630|FG001|Overall Study|ECG data error|3
4674451|NCT02353169|7571631|FG002|Overall Study|ECG data error|2
4674452|NCT02353169|7571632|FG003|Overall Study|ECG data error|2
4674453|NCT02353169|7571629|FG000|Overall Study|Pre-op medication|0
4674454|NCT02353169|7571630|FG001|Overall Study|Pre-op medication|0
4674455|NCT02353169|7571631|FG002|Overall Study|Pre-op medication|1
4674456|NCT02353169|7571632|FG003|Overall Study|Pre-op medication|0
4674457|NCT02353442|7571665|FG000|Overall Study|Withdrawal by Subject|3
4674458|NCT02353442|7571666|FG001|Overall Study|Withdrawal by Subject|4
4674459|NCT02353871|7571702|FG000|Overall Study|Protocol deviation|0
4674460|NCT02353871|7571703|FG001|Overall Study|Protocol deviation|1
4674461|NCT02353871|7571702|FG000|Overall Study|Consent withdrawn|1
4674462|NCT02353871|7571703|FG001|Overall Study|Consent withdrawn|8
4674463|NCT02353871|7571702|FG000|Overall Study|Lost to Follow-up|2
4674464|NCT02353871|7571703|FG001|Overall Study|Lost to Follow-up|0
4674465|NCT02354222|7571729|FG000|Overall Study|Adverse Event|0
4674466|NCT02354222|7571730|FG001|Overall Study|Adverse Event|3
4674467|NCT02354222|7571729|FG000|Overall Study|Physician Decision|1
4674468|NCT02354222|7571730|FG001|Overall Study|Physician Decision|1
4674469|NCT02354222|7571729|FG000|Overall Study|Pregnancy|1
4674470|NCT02354222|7571730|FG001|Overall Study|Pregnancy|0
4674471|NCT02354222|7571729|FG000|Overall Study|Withdrawal by Subject|2
4674472|NCT02354222|7571730|FG001|Overall Study|Withdrawal by Subject|3
4674473|NCT02354222|7571729|FG000|Overall Study|Conflict with the stopping criteria|0
4674474|NCT02354222|7571730|FG001|Overall Study|Conflict with the stopping criteria|4
4674475|NCT02354235|7571738|FG000|Overall Study|Adverse Event|2
4756515|NCT01714817|7730957|FG000|Year 2 Period|Administrative reason by Sponsor|4
4756516|NCT01714817|7730958|FG001|Year 2 Period|Administrative reason by Sponsor|3
4756517|NCT01714817|7730957|FG000|Year 2 Period|Participant withdrew consent|1
4674476|NCT02354235|7571739|FG001|Overall Study|Adverse Event|2
4674477|NCT02354235|7571738|FG000|Overall Study|Physician Decision|0
4674478|NCT02354235|7571739|FG001|Overall Study|Physician Decision|1
4674479|NCT02354235|7571738|FG000|Overall Study|Withdrawal by Subject|1
4674480|NCT02354235|7571739|FG001|Overall Study|Withdrawal by Subject|3
4674481|NCT02354235|7571738|FG000|Overall Study|Conflict with the stopping criteria|0
4674482|NCT02354235|7571739|FG001|Overall Study|Conflict with the stopping criteria|1
4674483|NCT02354417|7571772|FG000|Overall Study|Physician Decision|1
4674484|NCT02354508|7571797|FG000|Period 1: Core Phase|Adverse Event|1
4674485|NCT02354508|7571798|FG001|Period 1: Core Phase|Adverse Event|1
4674486|NCT02354508|7571799|FG002|Period 1: Core Phase|Adverse Event|2
4674487|NCT02354508|7571797|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1
4674488|NCT02354508|7571798|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0
4674489|NCT02354508|7571799|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2
4674490|NCT02354508|7571797|FG000|Period 1: Core Phase|Withdrawal by Subject|0
4674491|NCT02354508|7571798|FG001|Period 1: Core Phase|Withdrawal by Subject|1
4674492|NCT02354508|7571799|FG002|Period 1: Core Phase|Withdrawal by Subject|2
4674493|NCT02354508|7571797|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1
4674494|NCT02354508|7571798|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3
4674495|NCT02354508|7571799|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2
4674496|NCT02354508|7571797|FG000|Period 2: Extension Phase|Withdrawal by Subject|0
4674497|NCT02354508|7571798|FG001|Period 2: Extension Phase|Withdrawal by Subject|1
4674498|NCT02354508|7571799|FG002|Period 2: Extension Phase|Withdrawal by Subject|0
4674499|NCT02354508|7571797|FG000|Period 2: Extension Phase|Physician Decision|5
4674500|NCT02354508|7571798|FG001|Period 2: Extension Phase|Physician Decision|0
4674501|NCT02354508|7571799|FG002|Period 2: Extension Phase|Physician Decision|1
4674502|NCT02354508|7571797|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1
4674503|NCT02354508|7571798|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2
4674504|NCT02354508|7571799|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2
4674505|NCT02354508|7571797|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0
4674506|NCT02354508|7571798|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1
4674507|NCT02354508|7571799|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0
4674508|NCT02354508|7571797|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3
4674509|NCT02354508|7571798|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0
4674510|NCT02354508|7571799|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1
4674511|NCT02354586|7571865|FG000|Overall Study|Death|168
4674512|NCT02354586|7571865|FG000|Overall Study|Withdrawal by Subject|51
4674513|NCT02354586|7571865|FG000|Overall Study|Lost to Follow-up|6
4674514|NCT02354586|7571865|FG000|Overall Study|Disease progression|116
4756518|NCT01714817|7730958|FG001|Year 2 Period|Participant withdrew consent|5
4756519|NCT01714817|7730957|FG000|Year 2 Period|Participant no longer meets criteria|1
4756520|NCT01714817|7730958|FG001|Year 2 Period|Participant no longer meets criteria|4
4756521|NCT01714817|7730957|FG000|Year 2 Period|Lost to Follow-up|2
4756522|NCT01714817|7730958|FG001|Year 2 Period|Lost to Follow-up|0
4756523|NCT01714817|7730957|FG000|Year 2 Period|Participant went to US stopped treatment|0
4756524|NCT01714817|7730958|FG001|Year 2 Period|Participant went to US stopped treatment|1
4756525|NCT01714817|7730957|FG000|Year 2 Period|Pregnancy|1
4756526|NCT01714817|7730958|FG001|Year 2 Period|Pregnancy|1
4756527|NCT01714817|7730957|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2
4756528|NCT01714817|7730958|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1
4756529|NCT01714817|7730957|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0
4756530|NCT01714817|7730958|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1
4756531|NCT01714817|7730957|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27
4674515|NCT02354599|7571875|FG000|Overall Study|Pretreatment Event/Adverse Event|0
4674516|NCT02354599|7571876|FG001|Overall Study|Pretreatment Event/Adverse Event|0
4674517|NCT02354599|7571877|FG002|Overall Study|Pretreatment Event/Adverse Event|0
4674518|NCT02354599|7571878|FG003|Overall Study|Pretreatment Event/Adverse Event|0
4674519|NCT02354599|7571879|FG004|Overall Study|Pretreatment Event/Adverse Event|0
4674520|NCT02354599|7571880|FG005|Overall Study|Pretreatment Event/Adverse Event|1
4674521|NCT02354599|7571875|FG000|Overall Study|Withdrawal by Subject|1
4674522|NCT02354599|7571876|FG001|Overall Study|Withdrawal by Subject|1
4674523|NCT02354599|7571877|FG002|Overall Study|Withdrawal by Subject|0
4674524|NCT02354599|7571878|FG003|Overall Study|Withdrawal by Subject|0
4674525|NCT02354599|7571879|FG004|Overall Study|Withdrawal by Subject|0
4674526|NCT02354599|7571880|FG005|Overall Study|Withdrawal by Subject|0
4674527|NCT02354690|7571900|FG000|Overall Study|Physician Decision|1
4674528|NCT02354976|7571943|FG000|Overall Study|Other - reason not specified|1
4674529|NCT02354976|7571944|FG001|Overall Study|Other - reason not specified|0
4674530|NCT02354976|7571945|FG002|Overall Study|Other - reason not specified|1
4674531|NCT02354976|7571943|FG000|Overall Study|Study-specifc withdrawal criteria|0
4674532|NCT02354976|7571944|FG001|Overall Study|Study-specifc withdrawal criteria|1
4674533|NCT02354976|7571945|FG002|Overall Study|Study-specifc withdrawal criteria|0
4674534|NCT02354976|7571943|FG000|Overall Study|Adverse Event|1
4674535|NCT02354976|7571944|FG001|Overall Study|Adverse Event|0
4674536|NCT02354976|7571945|FG002|Overall Study|Adverse Event|2
4674537|NCT02355028|7571955|FG000|Overall Study|Adverse Event|2
4674538|NCT02355028|7571956|FG001|Overall Study|Adverse Event|0
4674539|NCT02355028|7571955|FG000|Overall Study|Withdrawal by Subject|1
4674540|NCT02355028|7571956|FG001|Overall Study|Withdrawal by Subject|1
4674541|NCT02355028|7571955|FG000|Overall Study|Deemed ineligible after randomization|8
4674542|NCT02355028|7571956|FG001|Overall Study|Deemed ineligible after randomization|4
4674543|NCT02355665|7572011|FG000|Overall Study|Adverse Event|16
4674544|NCT02355665|7572012|FG001|Overall Study|Adverse Event|24
4674545|NCT02355665|7572011|FG000|Overall Study|Protocol Violation|2
4674546|NCT02355665|7572012|FG001|Overall Study|Protocol Violation|0
4674547|NCT02355665|7572011|FG000|Overall Study|Withdrawal by Subject|90
4674548|NCT02355665|7572012|FG001|Overall Study|Withdrawal by Subject|100
4674549|NCT02355665|7572011|FG000|Overall Study|Lost to Follow-up|131
4674550|NCT02355665|7572012|FG001|Overall Study|Lost to Follow-up|103
4674551|NCT02355665|7572011|FG000|Overall Study|Death|4
4674552|NCT02355665|7572012|FG001|Overall Study|Death|2
4674553|NCT02355665|7572011|FG000|Overall Study|Compliance, PI decision, move, eligible|6
4674554|NCT02355665|7572012|FG001|Overall Study|Compliance, PI decision, move, eligible|3
4674555|NCT02355691|7572020|FG000|Overall Study|Loss of Research Personnel|7
4674556|NCT02355691|7572021|FG001|Overall Study|Loss of Research Personnel|9
4674557|NCT02355743|7572027|FG000|Overall Study|Withdrawal by Subject|1
4674558|NCT02355743|7572027|FG000|Overall Study|Lost to Follow-up|1
4756532|NCT01714817|7730958|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21
4756533|NCT01714817|7730957|FG000|Long-Term Extension (LTE) Period|Disease progression|1
4756534|NCT01714817|7730958|FG001|Long-Term Extension (LTE) Period|Disease progression|4
4756535|NCT01714817|7730957|FG000|Long-Term Extension (LTE) Period|Not effective|0
4756536|NCT01714817|7730958|FG001|Long-Term Extension (LTE) Period|Not effective|1
4756537|NCT01714817|7730957|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1
4756538|NCT01714817|7730958|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1
4756539|NCT01714817|7730957|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1
4756540|NCT01714817|7730958|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1
4756541|NCT01714817|7730957|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1
4756542|NCT01714817|7730958|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0
4756543|NCT01714817|7730957|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0
4756544|NCT01714817|7730958|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1
4756545|NCT01714817|7730957|FG000|Long-Term Extension (LTE) Period|Pregnancy|1
4756546|NCT01714817|7730958|FG001|Long-Term Extension (LTE) Period|Pregnancy|0
4756547|NCT01714817|7730957|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1
4756548|NCT01714817|7730958|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0
4756549|NCT01714817|7730957|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1
4756550|NCT01714817|7730958|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0
4756551|NCT01714817|7730957|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33
4756552|NCT01714817|7730958|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38
4756553|NCT01714817|7730957|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0
4756554|NCT01714817|7730958|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1
4756555|NCT01714817|7730957|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0
4756556|NCT01714817|7730958|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1
4756557|NCT01714817|7730957|FG000|Long-Term Extension (LTE) Period|Study was terminated|0
4756558|NCT01714817|7730958|FG001|Long-Term Extension (LTE) Period|Study was terminated|1
4674559|NCT02356211|7572082|FG000|Overall Study|Withdrawal by Subject|2
4674560|NCT02356211|7572083|FG001|Overall Study|Withdrawal by Subject|2
4674561|NCT02356211|7572082|FG000|Overall Study|ineligible|1
4674562|NCT02356211|7572083|FG001|Overall Study|ineligible|8
4674563|NCT02356562|7572099|FG000|Overall Study|Withdrawal by Subject|0
4674564|NCT02356562|7572100|FG001|Overall Study|Withdrawal by Subject|1
4674565|NCT02356562|7572099|FG000|Overall Study|Re-entered treatment in a previous study|1
4674566|NCT02356562|7572100|FG001|Overall Study|Re-entered treatment in a previous study|0
4674567|NCT02356562|7572099|FG000|Overall Study|site closure|1
4674568|NCT02356562|7572100|FG001|Overall Study|site closure|0
4674569|NCT02356588|7572118|FG000|Overall Study|Lack of Efficacy|4
4674570|NCT02356588|7572119|FG001|Overall Study|Lack of Efficacy|10
4674571|NCT02356588|7572118|FG000|Overall Study|Adverse Event|0
4674572|NCT02356588|7572119|FG001|Overall Study|Adverse Event|2
4674573|NCT02356588|7572118|FG000|Overall Study|Withdrawal by Subject|1
4674574|NCT02356588|7572119|FG001|Overall Study|Withdrawal by Subject|0
4674575|NCT02356588|7572118|FG000|Overall Study|Protocol Violation|0
4674576|NCT02356588|7572119|FG001|Overall Study|Protocol Violation|1
4674577|NCT02356783|7572136|FG000|Overall Study|Lost to Follow-up|1
4674578|NCT02356783|7572137|FG001|Overall Study|Lost to Follow-up|3
4674579|NCT02356887|7572143|FG000|Overall Study|poor compliance|2
4674580|NCT02357134|7572170|FG000|Overall Study|Lost to Follow-up|1
4674581|NCT02357134|7572171|FG001|Overall Study|Lost to Follow-up|0
4674582|NCT02357134|7572172|FG002|Overall Study|Lost to Follow-up|0
4674583|NCT02357134|7572173|FG003|Overall Study|Lost to Follow-up|0
4674584|NCT02357147|7572185|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3
4674585|NCT02357147|7572186|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3
4674586|NCT02357147|7572185|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0
4674587|NCT02357147|7572186|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1
4674588|NCT02357147|7572185|FG000|Combination Treatment Phase|Investigator Discretion|1
4674589|NCT02357147|7572186|FG001|Combination Treatment Phase|Investigator Discretion|1
4674590|NCT02357147|7572185|FG000|Combination Treatment Phase|Withdrawal by Subject|4
4674591|NCT02357147|7572186|FG001|Combination Treatment Phase|Withdrawal by Subject|2
4674592|NCT02357147|7572185|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4
4674593|NCT02357147|7572186|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1
4674594|NCT02357147|7572185|FG000|Combination Treatment Phase|Adverse Event|12
4674595|NCT02357147|7572186|FG001|Combination Treatment Phase|Adverse Event|4
4674596|NCT02357147|7572185|FG000|Combination Treatment Phase|Death|1
4674597|NCT02357147|7572186|FG001|Combination Treatment Phase|Death|1
4674598|NCT02357147|7572185|FG000|Combination Treatment Phase|Sponsor Decision|0
4674599|NCT02357147|7572186|FG001|Combination Treatment Phase|Sponsor Decision|12
4674600|NCT02357147|7572185|FG000|Combination Treatment Phase|Other|1
4674601|NCT02357147|7572186|FG001|Combination Treatment Phase|Other|0
4674602|NCT02357147|7572185|FG000|Combination Treatment Phase|Not treated|0
4674603|NCT02357147|7572186|FG001|Combination Treatment Phase|Not treated|2
4674604|NCT02357147|7572185|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15
4674605|NCT02357147|7572186|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10
4674606|NCT02357147|7572185|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0
4674607|NCT02357147|7572186|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1
4674608|NCT02357147|7572185|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10
4674609|NCT02357147|7572186|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0
4674610|NCT02357147|7572185|FG000|Maintenance Treatment Phase|Adverse Event|0
4674611|NCT02357147|7572186|FG001|Maintenance Treatment Phase|Adverse Event|3
4674612|NCT02357147|7572185|FG000|Maintenance Treatment Phase|Sponsor Decision|0
4674613|NCT02357147|7572186|FG001|Maintenance Treatment Phase|Sponsor Decision|15
4674614|NCT02357147|7572185|FG000|Maintenance Treatment Phase|Not Treated|1
4674615|NCT02357147|7572186|FG001|Maintenance Treatment Phase|Not Treated|0
4674616|NCT02357342|7572224|FG000|First 6 Months|Death|2
4674617|NCT02357342|7572225|FG001|First 6 Months|Death|0
4674618|NCT02357368|7572235|FG000|Overall Study|Lost to Follow-up|0
4674619|NCT02357368|7572236|FG001|Overall Study|Lost to Follow-up|0
4674620|NCT02357368|7572237|FG002|Overall Study|Lost to Follow-up|0
4674621|NCT02357368|7572238|FG003|Overall Study|Lost to Follow-up|1
4674622|NCT02357368|7572235|FG000|Overall Study|Pregnancy|3
4674623|NCT02357368|7572236|FG001|Overall Study|Pregnancy|2
4674624|NCT02357368|7572237|FG002|Overall Study|Pregnancy|0
4674625|NCT02357368|7572238|FG003|Overall Study|Pregnancy|0
4674626|NCT02357368|7572235|FG000|Overall Study|Withdrawal by Subject|3
4674627|NCT02357368|7572236|FG001|Overall Study|Withdrawal by Subject|1
4674628|NCT02357368|7572237|FG002|Overall Study|Withdrawal by Subject|1
4674629|NCT02357368|7572238|FG003|Overall Study|Withdrawal by Subject|2
4674630|NCT02357420|7572261|FG000|Overall Study|Adverse Event|3
4756559|NCT01755689|7730971|FG000|Overall Study|Withdrawal by Subject|1
4756560|NCT01755689|7730972|FG001|Overall Study|Withdrawal by Subject|3
4756561|NCT01755689|7730973|FG002|Overall Study|Withdrawal by Subject|2
4674631|NCT02357420|7572262|FG001|Overall Study|Adverse Event|3
4674632|NCT02357420|7572263|FG002|Overall Study|Adverse Event|8
4674633|NCT02357420|7572264|FG003|Overall Study|Adverse Event|9
4756562|NCT01755689|7730974|FG003|Overall Study|Withdrawal by Subject|1
4756563|NCT01755689|7730975|FG004|Overall Study|Withdrawal by Subject|1
4674634|NCT02357420|7572261|FG000|Overall Study|Investigator Decision|1
4674635|NCT02357420|7572262|FG001|Overall Study|Investigator Decision|0
4674636|NCT02357420|7572263|FG002|Overall Study|Investigator Decision|0
4674637|NCT02357420|7572264|FG003|Overall Study|Investigator Decision|0
4674638|NCT02357420|7572261|FG000|Overall Study|Prohibited Medication|1
4756564|NCT01755689|7730971|FG000|Overall Study|Migrated/moved from study area|0
4756565|NCT01755689|7730972|FG001|Overall Study|Migrated/moved from study area|1
4756566|NCT01755689|7730973|FG002|Overall Study|Migrated/moved from study area|1
4756567|NCT01755689|7730974|FG003|Overall Study|Migrated/moved from study area|1
4756568|NCT01755689|7730975|FG004|Overall Study|Migrated/moved from study area|1
4756569|NCT01755689|7730971|FG000|Overall Study|Lost to Follow-up|1
4756570|NCT01755689|7730972|FG001|Overall Study|Lost to Follow-up|0
4756571|NCT01755689|7730973|FG002|Overall Study|Lost to Follow-up|1
4756572|NCT01755689|7730974|FG003|Overall Study|Lost to Follow-up|0
4756573|NCT01755689|7730975|FG004|Overall Study|Lost to Follow-up|2
4756574|NCT01755689|7730971|FG000|Overall Study|Pregnancy|1
4756575|NCT01755689|7730972|FG001|Overall Study|Pregnancy|1
4756576|NCT01755689|7730973|FG002|Overall Study|Pregnancy|2
4756577|NCT01755689|7730974|FG003|Overall Study|Pregnancy|4
4756578|NCT01755689|7730975|FG004|Overall Study|Pregnancy|2
4674639|NCT02357420|7572262|FG001|Overall Study|Prohibited Medication|1
4674640|NCT02357420|7572263|FG002|Overall Study|Prohibited Medication|0
4674641|NCT02357420|7572264|FG003|Overall Study|Prohibited Medication|0
4674642|NCT02357420|7572261|FG000|Overall Study|Protocol Non-compliance|0
4674643|NCT02357420|7572262|FG001|Overall Study|Protocol Non-compliance|0
4674644|NCT02357420|7572263|FG002|Overall Study|Protocol Non-compliance|0
4674645|NCT02357420|7572264|FG003|Overall Study|Protocol Non-compliance|1
4674646|NCT02357420|7572261|FG000|Overall Study|Withdrawn Consent|4
4674647|NCT02357420|7572262|FG001|Overall Study|Withdrawn Consent|8
4674648|NCT02357420|7572263|FG002|Overall Study|Withdrawn Consent|6
4674649|NCT02357420|7572264|FG003|Overall Study|Withdrawn Consent|6
4674650|NCT02357420|7572261|FG000|Overall Study|Lost to Follow-up|3
4674651|NCT02357420|7572262|FG001|Overall Study|Lost to Follow-up|0
4674652|NCT02357420|7572263|FG002|Overall Study|Lost to Follow-up|2
4674653|NCT02357420|7572264|FG003|Overall Study|Lost to Follow-up|3
4674654|NCT02357459|7572277|FG000|Overall Study|Adverse Event|0
4674655|NCT02357459|7572278|FG001|Overall Study|Adverse Event|1
4674656|NCT02357459|7572279|FG002|Overall Study|Adverse Event|1
4674657|NCT02357459|7572277|FG000|Overall Study|Withdrawal by Subject|5
4674658|NCT02357459|7572278|FG001|Overall Study|Withdrawal by Subject|3
4674659|NCT02357459|7572279|FG002|Overall Study|Withdrawal by Subject|3
4674660|NCT02357459|7572277|FG000|Overall Study|Physician Decision|0
4674661|NCT02357459|7572278|FG001|Overall Study|Physician Decision|2
4674662|NCT02357459|7572279|FG002|Overall Study|Physician Decision|0
4674663|NCT02357459|7572277|FG000|Overall Study|Protocol Violation|1
4674664|NCT02357459|7572278|FG001|Overall Study|Protocol Violation|1
4674665|NCT02357459|7572279|FG002|Overall Study|Protocol Violation|0
4674666|NCT02357459|7572277|FG000|Overall Study|Lost to Follow-up|1
4674667|NCT02357459|7572278|FG001|Overall Study|Lost to Follow-up|3
4674668|NCT02357459|7572279|FG002|Overall Study|Lost to Follow-up|0
4674669|NCT02357459|7572277|FG000|Overall Study|Lack of Efficacy|7
4674670|NCT02357459|7572278|FG001|Overall Study|Lack of Efficacy|4
4674671|NCT02357459|7572279|FG002|Overall Study|Lack of Efficacy|4
4674672|NCT02357459|7572277|FG000|Overall Study|Patient Relocated|2
4674673|NCT02357459|7572278|FG001|Overall Study|Patient Relocated|0
4674674|NCT02357459|7572279|FG002|Overall Study|Patient Relocated|0
4674675|NCT02357459|7572277|FG000|Overall Study|Instruction from PCP|1
4674676|NCT02357459|7572278|FG001|Overall Study|Instruction from PCP|0
4674677|NCT02357459|7572279|FG002|Overall Study|Instruction from PCP|0
4674678|NCT02357459|7572277|FG000|Overall Study|Incarceration|0
4674679|NCT02357459|7572278|FG001|Overall Study|Incarceration|0
4674680|NCT02357459|7572279|FG002|Overall Study|Incarceration|1
4674681|NCT02357459|7572277|FG000|Overall Study|Pre-planned Knee surgery|0
4674682|NCT02357459|7572278|FG001|Overall Study|Pre-planned Knee surgery|0
4674683|NCT02357459|7572279|FG002|Overall Study|Pre-planned Knee surgery|2
4674684|NCT02357459|7572277|FG000|Overall Study|Job Commitments|0
4674685|NCT02357459|7572278|FG001|Overall Study|Job Commitments|0
4674686|NCT02357459|7572279|FG002|Overall Study|Job Commitments|1
4674687|NCT02357576|7572297|FG000|Treatment Period|Withdrawal by Subject|0
4674688|NCT02357576|7572298|FG001|Treatment Period|Withdrawal by Subject|1
4674689|NCT02357576|7572297|FG000|Treatment Period|Physician Decision|0
4674690|NCT02357576|7572298|FG001|Treatment Period|Physician Decision|1
4674691|NCT02357576|7572297|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1
4674692|NCT02357576|7572298|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1
4674693|NCT02357576|7572297|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1
4674694|NCT02357576|7572298|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0
4674695|NCT02357576|7572297|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1
4674696|NCT02357576|7572298|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4
4674697|NCT02357576|7572297|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2
4674698|NCT02357576|7572298|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0
4674699|NCT02357901|7572335|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161
4674700|NCT02357901|7572336|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0
4674701|NCT02357901|7572337|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0
4674702|NCT02357901|7572338|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0
4674703|NCT02357901|7572335|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0
4674704|NCT02357901|7572336|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26
4674705|NCT02357901|7572337|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23
4674706|NCT02357901|7572338|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12
4674707|NCT02357901|7572335|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0
4674708|NCT02357901|7572336|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20
4674709|NCT02357901|7572337|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21
4674710|NCT02357901|7572338|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18
4674711|NCT02357901|7572335|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0
4674712|NCT02357901|7572336|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3
4756579|NCT01762761|7730997|FG000|Overall Study|Adverse Event|15
4756580|NCT01762761|7730998|FG001|Overall Study|Adverse Event|17
4756581|NCT01762761|7730997|FG000|Overall Study|Lack of Efficacy|9
4756582|NCT01762761|7730998|FG001|Overall Study|Lack of Efficacy|25
4756583|NCT01762761|7730997|FG000|Overall Study|Protocol Violation|1
4756584|NCT01762761|7730998|FG001|Overall Study|Protocol Violation|1
4756585|NCT01762761|7730997|FG000|Overall Study|Study closed/terminated|0
4674713|NCT02357901|7572337|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5
4674714|NCT02357901|7572338|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18
4674715|NCT02357901|7572335|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0
4674716|NCT02357901|7572336|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6
4674717|NCT02357901|7572337|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10
4674718|NCT02357901|7572338|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2
4674719|NCT02357901|7572335|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0
4674720|NCT02357901|7572336|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2
4674721|NCT02357901|7572337|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5
4674722|NCT02357901|7572338|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0
4674723|NCT02357901|7572335|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0
4674724|NCT02357901|7572336|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1
4674725|NCT02357901|7572337|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1
4756586|NCT01762761|7730998|FG001|Overall Study|Study closed/terminated|2
4674726|NCT02357901|7572338|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3
4674727|NCT02357901|7572335|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0
4674728|NCT02357901|7572336|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2
4674729|NCT02357901|7572337|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0
4674730|NCT02357901|7572338|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2
4674731|NCT02357901|7572335|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0
4674732|NCT02357901|7572336|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1
4674733|NCT02357901|7572337|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0
4674734|NCT02357901|7572338|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3
4674735|NCT02357901|7572335|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0
4674736|NCT02357901|7572336|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0
4674737|NCT02357901|7572337|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1
4674738|NCT02357901|7572338|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1
4674739|NCT02357901|7572335|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0
4674740|NCT02357901|7572336|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17
4674741|NCT02357901|7572337|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6
4674742|NCT02357901|7572338|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7
4674743|NCT02357940|7572348|FG000|Overall Study|Adverse Event|0
4674744|NCT02357940|7572349|FG001|Overall Study|Adverse Event|1
4674745|NCT02357940|7572348|FG000|Overall Study|Investigator's judgement|0
4674746|NCT02357940|7572349|FG001|Overall Study|Investigator's judgement|1
4674747|NCT02357979|7572357|FG000|Overall Study|Lost to Follow-up|5
4674748|NCT02357979|7572358|FG001|Overall Study|Lost to Follow-up|5
4674749|NCT02358044|7572366|FG000|Overall Study|Adverse Event|0
4674750|NCT02358044|7572367|FG001|Overall Study|Adverse Event|1
4674751|NCT02358044|7572366|FG000|Overall Study|Lost to Follow-up|2
4674752|NCT02358044|7572367|FG001|Overall Study|Lost to Follow-up|1
4674753|NCT02358044|7572366|FG000|Overall Study|Physician Decision|0
4674754|NCT02358044|7572367|FG001|Overall Study|Physician Decision|1
4674755|NCT02358044|7572366|FG000|Overall Study|Withdrawal by Subject|0
4674756|NCT02358044|7572367|FG001|Overall Study|Withdrawal by Subject|4
4674757|NCT02358343|7572387|FG000|Screening Intervention|Death|0
4674758|NCT02358343|7572388|FG001|Screening Intervention|Death|2
4674759|NCT02358343|7572389|FG002|Screening Intervention|Death|0
4674760|NCT02358343|7572390|FG003|Screening Intervention|Death|0
4674761|NCT02358343|7572391|FG004|Screening Intervention|Death|0
4674762|NCT02358343|7572387|FG000|Screening Intervention|Withdrawal by Subject|1
4674763|NCT02358343|7572388|FG001|Screening Intervention|Withdrawal by Subject|0
4674764|NCT02358343|7572389|FG002|Screening Intervention|Withdrawal by Subject|0
4674765|NCT02358343|7572390|FG003|Screening Intervention|Withdrawal by Subject|0
4756587|NCT01762761|7730997|FG000|Overall Study|Lost to Follow-up|3
4756588|NCT01762761|7730998|FG001|Overall Study|Lost to Follow-up|6
4756589|NCT01762761|7730997|FG000|Overall Study|Physician Decision|4
4756590|NCT01762761|7730998|FG001|Overall Study|Physician Decision|6
4756591|NCT01762761|7730997|FG000|Overall Study|Withdrawal by Subject|7
4756592|NCT01762761|7730998|FG001|Overall Study|Withdrawal by Subject|8
4674766|NCT02358343|7572391|FG004|Screening Intervention|Withdrawal by Subject|0
4674767|NCT02358343|7572387|FG000|Screening Intervention|Determined Ineligible|5
4674768|NCT02358343|7572388|FG001|Screening Intervention|Determined Ineligible|6
4674769|NCT02358343|7572389|FG002|Screening Intervention|Determined Ineligible|0
4674770|NCT02358343|7572390|FG003|Screening Intervention|Determined Ineligible|0
4674771|NCT02358343|7572391|FG004|Screening Intervention|Determined Ineligible|0
4674772|NCT02358343|7572387|FG000|Comparative Efficacy Trial / Observation|Death|0
4674773|NCT02358343|7572388|FG001|Comparative Efficacy Trial / Observation|Death|0
4674774|NCT02358343|7572389|FG002|Comparative Efficacy Trial / Observation|Death|2
4674775|NCT02358343|7572390|FG003|Comparative Efficacy Trial / Observation|Death|0
4674776|NCT02358343|7572391|FG004|Comparative Efficacy Trial / Observation|Death|0
4674777|NCT02358343|7572387|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0
4674778|NCT02358343|7572388|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0
4674779|NCT02358343|7572389|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2
4674780|NCT02358343|7572390|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2
4674781|NCT02358343|7572391|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2
4674782|NCT02358343|7572387|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
4674783|NCT02358343|7572388|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
4674784|NCT02358343|7572389|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1
4674785|NCT02358343|7572390|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
4674786|NCT02358343|7572391|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
4674787|NCT02358369|7572405|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35
4674788|NCT02358369|7572406|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0
4674789|NCT02358369|7572407|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0
4674790|NCT02358369|7572408|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0
4674791|NCT02358369|7572409|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0
4674792|NCT02358369|7572405|FG000|Treatment Period A/B|Adverse Event|0
4674793|NCT02358369|7572406|FG001|Treatment Period A/B|Adverse Event|0
4674794|NCT02358369|7572407|FG002|Treatment Period A/B|Adverse Event|1
4674795|NCT02358369|7572408|FG003|Treatment Period A/B|Adverse Event|2
4674796|NCT02358369|7572409|FG004|Treatment Period A/B|Adverse Event|0
4674797|NCT02358369|7572405|FG000|Treatment Period A/B|Death|0
4674798|NCT02358369|7572406|FG001|Treatment Period A/B|Death|0
4674799|NCT02358369|7572407|FG002|Treatment Period A/B|Death|1
4674800|NCT02358369|7572408|FG003|Treatment Period A/B|Death|0
4674801|NCT02358369|7572409|FG004|Treatment Period A/B|Death|0
4674802|NCT02358369|7572405|FG000|Treatment Period A/B|Withdrawal by Subject|0
4674803|NCT02358369|7572406|FG001|Treatment Period A/B|Withdrawal by Subject|2
4674804|NCT02358369|7572407|FG002|Treatment Period A/B|Withdrawal by Subject|0
4674805|NCT02358369|7572408|FG003|Treatment Period A/B|Withdrawal by Subject|2
4674806|NCT02358369|7572409|FG004|Treatment Period A/B|Withdrawal by Subject|0
4674807|NCT02358369|7572405|FG000|Treatment Period C|Adverse Event|0
4674808|NCT02358369|7572406|FG001|Treatment Period C|Adverse Event|0
4674809|NCT02358369|7572407|FG002|Treatment Period C|Adverse Event|0
4674810|NCT02358369|7572408|FG003|Treatment Period C|Adverse Event|0
4674811|NCT02358369|7572409|FG004|Treatment Period C|Adverse Event|7
4674812|NCT02358473|7572419|FG000|Overall Study|Disease Progession|6
4674813|NCT02358473|7572419|FG000|Overall Study|Adverse Event|3
4674814|NCT02358473|7572419|FG000|Overall Study|Withdrawal by Subject|2
4674815|NCT02358473|7572419|FG000|Overall Study|Physician Decision|2
4674816|NCT02358668|7572435|FG000|Overall Study|Adverse Event|2
4674817|NCT02358668|7572436|FG001|Overall Study|Adverse Event|0
4674818|NCT02358668|7572437|FG002|Overall Study|Adverse Event|0
4674819|NCT02358668|7572435|FG000|Overall Study|Withdrawal by Subject|0
4674820|NCT02358668|7572436|FG001|Overall Study|Withdrawal by Subject|1
4674821|NCT02358668|7572437|FG002|Overall Study|Withdrawal by Subject|0
4674822|NCT02358863|7572445|FG000|Overall Study|Physician Decision|3
4674823|NCT02359045|7572483|FG000|Overall Study|Eligibility criteria not fulfilled|3
4674824|NCT02359045|7572484|FG001|Overall Study|Eligibility criteria not fulfilled|1
4674825|NCT02359045|7572483|FG000|Overall Study|Lost to Follow-up|1
4674826|NCT02359045|7572484|FG001|Overall Study|Lost to Follow-up|1
4674827|NCT02359045|7572483|FG000|Overall Study|Adverse Event|0
4674828|NCT02359045|7572484|FG001|Overall Study|Adverse Event|1
4674829|NCT02359435|7572534|FG000|Overall Study|Lost to Follow-up|4
4674830|NCT02359435|7572535|FG001|Overall Study|Lost to Follow-up|4
4674831|NCT02359552|7572543|FG000|Overall Study|Lost to Follow-up|3
4674832|NCT02359552|7572544|FG001|Overall Study|Lost to Follow-up|4
4674833|NCT02359851|7572550|FG000|Overall Study|Death|1
4674834|NCT02359851|7572550|FG000|Overall Study|Disease progression|1
4674835|NCT02359877|7572558|FG000|Overall Study|Withdrawal by Subject|1
4674836|NCT02359877|7572559|FG001|Overall Study|Withdrawal by Subject|0
4674837|NCT02359877|7572560|FG002|Overall Study|Withdrawal by Subject|0
4674838|NCT02359877|7572561|FG003|Overall Study|Withdrawal by Subject|2
4674839|NCT02359877|7572558|FG000|Overall Study|Adverse Event|0
4674840|NCT02359877|7572559|FG001|Overall Study|Adverse Event|0
4674841|NCT02359877|7572560|FG002|Overall Study|Adverse Event|0
4756593|NCT01763788|7731009|FG000|Overall Study|Lost to Follow-up|0
4756594|NCT01763788|7731010|FG001|Overall Study|Lost to Follow-up|0
4756595|NCT01763788|7731011|FG002|Overall Study|Lost to Follow-up|1
4756596|NCT01763788|7731012|FG003|Overall Study|Lost to Follow-up|0
4674842|NCT02359877|7572561|FG003|Overall Study|Adverse Event|1
4674843|NCT02359890|7572589|FG000|Overall Study|Not meeting eligibility|4
4674844|NCT02359890|7572589|FG000|Overall Study|Never treated with study catheter|6
4674845|NCT02359903|7572595|FG000|Overall Study|Adverse Event|0
4674846|NCT02359903|7572596|FG001|Overall Study|Adverse Event|2
4674847|NCT02360098|7572662|FG000|Overall Study|Physician Decision|7
4674848|NCT02360228|7572695|FG000|Overall Study|Withdrawal by Subject|1
4674849|NCT02360228|7572696|FG001|Overall Study|Withdrawal by Subject|0
4674850|NCT02360228|7572697|FG002|Overall Study|Withdrawal by Subject|0
4674851|NCT02360228|7572695|FG000|Overall Study|Self-discontinued medication|0
4674852|NCT02360228|7572696|FG001|Overall Study|Self-discontinued medication|1
4674853|NCT02360228|7572697|FG002|Overall Study|Self-discontinued medication|0
4674854|NCT02360228|7572695|FG000|Overall Study|Unstable symptoms during screening|0
4674855|NCT02360228|7572696|FG001|Overall Study|Unstable symptoms during screening|0
4674856|NCT02360228|7572697|FG002|Overall Study|Unstable symptoms during screening|1
4674857|NCT02360280|7572707|FG000|Overall Study|Withdrawal by Subject|2
4674858|NCT02360280|7572708|FG001|Overall Study|Withdrawal by Subject|0
4674859|NCT02360280|7572707|FG000|Overall Study|Adverse Event|0
4674860|NCT02360280|7572708|FG001|Overall Study|Adverse Event|1
4674861|NCT02360280|7572707|FG000|Overall Study|Lost to Follow-up|1
4674862|NCT02360280|7572708|FG001|Overall Study|Lost to Follow-up|0
4674863|NCT02360293|7572716|FG000|Overall Study|Lost to Follow-up|73
4674864|NCT02360293|7572717|FG001|Overall Study|Lost to Follow-up|95
4674865|NCT02360293|7572716|FG000|Overall Study|Withdrawal by Subject|2
4674866|NCT02360293|7572717|FG001|Overall Study|Withdrawal by Subject|1
4674867|NCT02360293|7572716|FG000|Overall Study|Excluded|1
4674868|NCT02360293|7572717|FG001|Overall Study|Excluded|0
4674869|NCT02360397|7572745|FG000|Overall Study|Incomplete screening|3
4674870|NCT02360397|7572745|FG000|Overall Study|Adverse Event|1
4674871|NCT02360475|7572754|FG000|Overall Study|Lost to Follow-up|4
4674872|NCT02360475|7572755|FG001|Overall Study|Lost to Follow-up|12
4674873|NCT02360475|7572756|FG002|Overall Study|Lost to Follow-up|6
4674874|NCT02360475|7572757|FG003|Overall Study|Lost to Follow-up|4
4674875|NCT02360475|7572754|FG000|Overall Study|Withdrawal by Subject|0
4674876|NCT02360475|7572755|FG001|Overall Study|Withdrawal by Subject|1
4674877|NCT02360475|7572756|FG002|Overall Study|Withdrawal by Subject|2
4674878|NCT02360475|7572757|FG003|Overall Study|Withdrawal by Subject|0
4674879|NCT02360475|7572754|FG000|Overall Study|Migrated/moved from study area|0
4674880|NCT02360475|7572755|FG001|Overall Study|Migrated/moved from study area|0
4674881|NCT02360475|7572756|FG002|Overall Study|Migrated/moved from study area|0
4674882|NCT02360475|7572757|FG003|Overall Study|Migrated/moved from study area|1
4674883|NCT02360605|7572778|FG000|Overall Study|Withdrawal by Subject|4
4674884|NCT02360605|7572779|FG001|Overall Study|Withdrawal by Subject|9
4674885|NCT02360605|7572778|FG000|Overall Study|Lost to Follow-up|7
4674886|NCT02360605|7572779|FG001|Overall Study|Lost to Follow-up|8
4674887|NCT02360605|7572778|FG000|Overall Study|Death|0
4674888|NCT02360605|7572779|FG001|Overall Study|Death|1
4674889|NCT02360995|7572810|FG000|Overall Study|Lost to Follow-up|2
4674890|NCT02360995|7572811|FG001|Overall Study|Lost to Follow-up|0
4674891|NCT02360995|7572812|FG002|Overall Study|Lost to Follow-up|2
4756597|NCT01774370|7731022|FG000|Overall Study|Never taken the PRADAXA during the study|4
4756598|NCT01774370|7731022|FG000|Overall Study|Administered prior to the contract date|4
4756599|NCT01774370|7731022|FG000|Overall Study|Subjects of contraindications|34
4756600|NCT01774370|7731022|FG000|Overall Study|Violated inclusion/exclusion criteria|53
4756601|NCT01774370|7731022|FG000|Overall Study|Follow-up failure|34
4756610|NCT01787552|7731049|FG000|Overall Study|Withdrawal by Subject|2
4756611|NCT01787552|7731050|FG001|Overall Study|Withdrawal by Subject|0
4756612|NCT01787552|7731051|FG002|Overall Study|Withdrawal by Subject|0
4756613|NCT01787552|7731052|FG003|Overall Study|Withdrawal by Subject|4
4756614|NCT01787552|7731049|FG000|Overall Study|Physician Decision|2
4756615|NCT01787552|7731050|FG001|Overall Study|Physician Decision|2
4756616|NCT01787552|7731051|FG002|Overall Study|Physician Decision|1
4756617|NCT01787552|7731052|FG003|Overall Study|Physician Decision|2
4756618|NCT01787552|7731049|FG000|Overall Study|Death|0
4756619|NCT01787552|7731050|FG001|Overall Study|Death|0
4756620|NCT01787552|7731051|FG002|Overall Study|Death|0
4756621|NCT01787552|7731052|FG003|Overall Study|Death|1
4756622|NCT01787552|7731049|FG000|Overall Study|Adverse Event|2
4756623|NCT01787552|7731050|FG001|Overall Study|Adverse Event|5
4756624|NCT01787552|7731051|FG002|Overall Study|Adverse Event|2
4756625|NCT01787552|7731052|FG003|Overall Study|Adverse Event|16
4756626|NCT01787552|7731049|FG000|Overall Study|Study terminated by Sponsor|0
4674892|NCT02360995|7572810|FG000|Overall Study|Withdrawal by Subject|0
4674893|NCT02360995|7572811|FG001|Overall Study|Withdrawal by Subject|1
4674894|NCT02360995|7572812|FG002|Overall Study|Withdrawal by Subject|0
4674895|NCT02361216|7572822|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0
4674896|NCT02361216|7572823|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1
4674897|NCT02361216|7572822|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1
4674898|NCT02361216|7572823|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2
4674899|NCT02361216|7572822|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1
4674900|NCT02361216|7572823|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0
4674901|NCT02361216|7572822|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6
4674902|NCT02361216|7572823|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11
4674903|NCT02361216|7572822|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3
4674904|NCT02361216|7572823|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3
4674905|NCT02361216|7572822|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0
4756627|NCT01787552|7731050|FG001|Overall Study|Study terminated by Sponsor|0
4756628|NCT01787552|7731051|FG002|Overall Study|Study terminated by Sponsor|1
4756629|NCT01787552|7731052|FG003|Overall Study|Study terminated by Sponsor|3
4756630|NCT01787552|7731049|FG000|Overall Study|Progressive Disease|2
4756631|NCT01787552|7731050|FG001|Overall Study|Progressive Disease|2
4674906|NCT02361216|7572823|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2
4674907|NCT02361307|7572834|FG000|Overall Study|Unstable medical condition.|0
4674908|NCT02361307|7572835|FG001|Overall Study|Unstable medical condition.|1
4674909|NCT02361762|7572861|FG000|Overall Study|Withdrawal by Subject|0
4674910|NCT02361762|7572862|FG001|Overall Study|Withdrawal by Subject|1
4674911|NCT02361762|7572861|FG000|Overall Study|Lost to Follow-up|0
4674912|NCT02361762|7572862|FG001|Overall Study|Lost to Follow-up|1
4674913|NCT02362269|7572883|FG000|Overall Study|Moved|1
4674914|NCT02362269|7572884|FG001|Overall Study|Moved|0
4674915|NCT02362269|7572883|FG000|Overall Study|Lost to Follow-up|0
4674916|NCT02362269|7572884|FG001|Overall Study|Lost to Follow-up|6
4674917|NCT02362282|7572892|FG000|Overall Study|Withdrawal by Subject|1
4674918|NCT02362282|7572893|FG001|Overall Study|Withdrawal by Subject|0
4674919|NCT02362360|7572908|FG000|Period 1|Lack of Efficacy|1
4674920|NCT02362360|7572909|FG001|Period 1|Lack of Efficacy|0
4674921|NCT02362360|7572908|FG000|Period 1|Withdrawal by Subject|2
4674922|NCT02362360|7572909|FG001|Period 1|Withdrawal by Subject|1
4674923|NCT02362412|7572919|FG000|Treatment Period III|Lost to Follow-up|0
4674924|NCT02362412|7572920|FG001|Treatment Period III|Lost to Follow-up|1
4674925|NCT02362425|7572936|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2
4674926|NCT02362425|7572937|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0
4674927|NCT02362425|7572938|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0
4674928|NCT02362425|7572939|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0
4674929|NCT02362425|7572936|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1
4674930|NCT02362425|7572937|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0
4674931|NCT02362425|7572938|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0
4674932|NCT02362425|7572939|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0
4674933|NCT02362425|7572936|FG000|Phase 1 (up to 6 Months)|Screening failure|1
4674934|NCT02362425|7572937|FG001|Phase 1 (up to 6 Months)|Screening failure|0
4674935|NCT02362425|7572938|FG002|Phase 1 (up to 6 Months)|Screening failure|0
4674936|NCT02362425|7572939|FG003|Phase 1 (up to 6 Months)|Screening failure|0
4674937|NCT02362425|7572936|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3
4674938|NCT02362425|7572937|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0
4674939|NCT02362425|7572938|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0
4674940|NCT02362425|7572939|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0
4674941|NCT02362425|7572936|FG000|Phase 1 (up to 6 Months)|Study closure|9
4674942|NCT02362425|7572937|FG001|Phase 1 (up to 6 Months)|Study closure|0
4674943|NCT02362425|7572938|FG002|Phase 1 (up to 6 Months)|Study closure|0
4756602|NCT01777295|7731028|FG000|Overall Study|Withdrawal by Subject|2
4756603|NCT01777295|7731029|FG001|Overall Study|Withdrawal by Subject|2
4756604|NCT01777295|7731028|FG000|Overall Study|Pregnancy|0
4756605|NCT01777295|7731029|FG001|Overall Study|Pregnancy|1
4756606|NCT01777295|7731028|FG000|Overall Study|Personal problem|1
4756607|NCT01777295|7731029|FG001|Overall Study|Personal problem|0
4756608|NCT01777295|7731028|FG000|Overall Study|Investigator call for AEs check|1
4756609|NCT01777295|7731029|FG001|Overall Study|Investigator call for AEs check|0
4756632|NCT01787552|7731051|FG002|Overall Study|Progressive Disease|1
4756633|NCT01787552|7731052|FG003|Overall Study|Progressive Disease|1
4674944|NCT02362425|7572939|FG003|Phase 1 (up to 6 Months)|Study closure|0
4674945|NCT02362425|7572936|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0
4674946|NCT02362425|7572937|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0
4674947|NCT02362425|7572938|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0
4674948|NCT02362425|7572939|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2
4674949|NCT02362425|7572936|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0
4674950|NCT02362425|7572937|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0
4674951|NCT02362425|7572938|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0
4674952|NCT02362425|7572939|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1
4674953|NCT02362425|7572936|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0
4674954|NCT02362425|7572937|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0
4674955|NCT02362425|7572938|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1
4674956|NCT02362425|7572939|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0
4674957|NCT02362646|7572961|FG000|Overall Study|Death|15
4674958|NCT02362646|7572962|FG001|Overall Study|Death|8
4674959|NCT02362646|7572961|FG000|Overall Study|Withdrawal by Subject|2
4674960|NCT02362646|7572962|FG001|Overall Study|Withdrawal by Subject|2
4674961|NCT02362646|7572961|FG000|Overall Study|received transplant|21
4674962|NCT02362646|7572962|FG001|Overall Study|received transplant|14
4674963|NCT02362724|7572985|FG000|Overall Study|Withdrawal by Subject|3
4674964|NCT02362724|7572986|FG001|Overall Study|Withdrawal by Subject|1
4674965|NCT02362724|7572985|FG000|Overall Study|Adverse Event|3
4674966|NCT02362724|7572986|FG001|Overall Study|Adverse Event|0
4674967|NCT02362789|7572994|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1
4674968|NCT02362789|7572995|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0
4674969|NCT02362789|7572996|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0
4674970|NCT02362789|7572994|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1
4674971|NCT02362789|7572995|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0
4674972|NCT02362789|7572996|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0
4674973|NCT02362789|7572994|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0
4674974|NCT02362789|7572995|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2
4756634|NCT01807117|7731067|FG000|Overall Study|Physician Decision|2
4756635|NCT01807117|7731067|FG000|Overall Study|Disease diagnosis not a study disease|1
4756646|NCT01814826|7731095|FG000|Overall Study|Other|3
4756647|NCT01814826|7731096|FG001|Overall Study|Other|5
4756648|NCT01814826|7731097|FG002|Overall Study|Other|0
4756649|NCT01814826|7731095|FG000|Overall Study|Death|29
4756650|NCT01814826|7731096|FG001|Overall Study|Death|24
4756651|NCT01814826|7731097|FG002|Overall Study|Death|3
4756652|NCT01829711|7731106|FG000|Overall Study|Lost to Follow-up|2
4756653|NCT01829711|7731106|FG000|Overall Study|Withdrawal by Subject|3
4756654|NCT01829711|7731106|FG000|Overall Study|Death|4
4756655|NCT01829711|7731106|FG000|Overall Study|Started new therapies|17
4756656|NCT01829711|7731106|FG000|Overall Study|Adverse Event|3
4756657|NCT01829711|7731106|FG000|Overall Study|Due to progression of disease|13
4756658|NCT01829711|7731106|FG000|Overall Study|Due to lack of response|1
4756659|NCT01846273|7731113|FG000|Overall Study|Adverse Event|9
4756660|NCT01846273|7731114|FG001|Overall Study|Adverse Event|7
4756661|NCT01846273|7731115|FG002|Overall Study|Adverse Event|0
4756662|NCT01846273|7731113|FG000|Overall Study|Subject withdrew consent|5
4756663|NCT01846273|7731114|FG001|Overall Study|Subject withdrew consent|8
4756664|NCT01846273|7731115|FG002|Overall Study|Subject withdrew consent|0
4756665|NCT01846273|7731113|FG000|Overall Study|Lost to Follow-up|2
4756666|NCT01846273|7731114|FG001|Overall Study|Lost to Follow-up|1
4756667|NCT01846273|7731115|FG002|Overall Study|Lost to Follow-up|0
4756668|NCT01846273|7731113|FG000|Overall Study|Administrative problems|1
4756669|NCT01846273|7731114|FG001|Overall Study|Administrative problems|0
4756670|NCT01846273|7731115|FG002|Overall Study|Administrative problems|0
4756671|NCT01846273|7731113|FG000|Overall Study|Death|2
4756672|NCT01846273|7731114|FG001|Overall Study|Death|1
4756673|NCT01846273|7731115|FG002|Overall Study|Death|0
4756674|NCT01846273|7731113|FG000|Overall Study|Disease Progression|0
4756675|NCT01846273|7731114|FG001|Overall Study|Disease Progression|4
4756676|NCT01846273|7731115|FG002|Overall Study|Disease Progression|0
4756677|NCT01846273|7731113|FG000|Overall Study|Protocol Deviation|2
4756678|NCT01846273|7731114|FG001|Overall Study|Protocol Deviation|3
4756679|NCT01846273|7731115|FG002|Overall Study|Protocol Deviation|0
4756680|NCT01846273|7731113|FG000|Overall Study|Physician Decision|1
4756681|NCT01846273|7731114|FG001|Overall Study|Physician Decision|2
4756682|NCT01846273|7731115|FG002|Overall Study|Physician Decision|0
4756683|NCT01875185|7731125|FG000|Overall Study|study was terminated|52
4756684|NCT01875185|7731126|FG001|Overall Study|study was terminated|48
4756685|NCT01891643|7731152|FG000|Overall Study|Adverse event unrelated to study drug|2
4756686|NCT01891643|7731153|FG001|Overall Study|Adverse event unrelated to study drug|5
4756687|NCT01891643|7731152|FG000|Overall Study|Disease Progression|4
4756688|NCT01891643|7731153|FG001|Overall Study|Disease Progression|3
4756689|NCT01891643|7731152|FG000|Overall Study|Study Drug Toxicity|3
4756690|NCT01891643|7731153|FG001|Overall Study|Study Drug Toxicity|0
4756691|NCT01891643|7731152|FG000|Overall Study|Maximum Clinical Benefit|0
4756692|NCT01891643|7731153|FG001|Overall Study|Maximum Clinical Benefit|1
4756693|NCT01891643|7731152|FG000|Overall Study|Poor/Non-compliance|0
4756694|NCT01891643|7731153|FG001|Overall Study|Poor/Non-compliance|1
4756695|NCT01891643|7731152|FG000|Overall Study|Participant request to discontinue|1
4756696|NCT01891643|7731153|FG001|Overall Study|Participant request to discontinue|0
4756697|NCT01900691|7731159|FG000|Overall Study|Death|7
4756698|NCT01900691|7731159|FG000|Overall Study|Lost to Follow-up|4
4756699|NCT01900691|7731159|FG000|Overall Study|Study Device Not Placed|3
4756700|NCT01900691|7731159|FG000|Overall Study|Non Study stent inside study stent|1
4756701|NCT01900691|7731159|FG000|Overall Study|Six month Follow up completed, stent not removed|2
4756702|NCT01900691|7731159|FG000|Overall Study|Miscellaneous|2
4674975|NCT02362789|7572996|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6
4674976|NCT02362789|7572994|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0
4674977|NCT02362789|7572995|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1
4674978|NCT02362789|7572996|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4
4674979|NCT02362789|7572994|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0
4674980|NCT02362789|7572995|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1
4674981|NCT02362789|7572996|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2
4674982|NCT02363283|7573012|FG000|Overall Study|Withdrawal by Subject|1
4674983|NCT02363283|7573012|FG000|Overall Study|Not eligible due to transaminitis|1
4674984|NCT02363322|7573018|FG000|Overall Study|Lost to Follow-up|1
4674985|NCT02363322|7573019|FG001|Overall Study|Lost to Follow-up|0
4674986|NCT02363439|7573025|FG000|Overall Study|Lack of Efficacy|4
4674987|NCT02363478|7573029|FG000|Overall Study|Lost to Follow-up|4
4674988|NCT02363478|7573029|FG000|Overall Study|Adverse Event|4
4674989|NCT02363686|7573043|FG000|Overall Study|Withdrawal by Subject|22
4674990|NCT02363686|7573043|FG000|Overall Study|incomplete FEES examinations|13
4674991|NCT02363738|7573049|FG000|Overall Study|Adverse Event|5
4674992|NCT02363738|7573050|FG001|Overall Study|Adverse Event|2
4674993|NCT02363738|7573049|FG000|Overall Study|Lack of Efficacy|1
4674994|NCT02363738|7573050|FG001|Overall Study|Lack of Efficacy|2
4674995|NCT02363738|7573049|FG000|Overall Study|Lost to Follow-up|2
4674996|NCT02363738|7573050|FG001|Overall Study|Lost to Follow-up|1
4756636|NCT01808261|7731075|FG000|Overall Study|Physician Decision|0
4756637|NCT01808261|7731076|FG001|Overall Study|Physician Decision|2
4756638|NCT01808261|7731075|FG000|Overall Study|Study Closed/Terminated|25
4756639|NCT01808261|7731076|FG001|Overall Study|Study Closed/Terminated|23
4756640|NCT01808261|7731075|FG000|Overall Study|Adverse event, non-fatal|2
4756641|NCT01808261|7731076|FG001|Overall Study|Adverse event, non-fatal|0
4756642|NCT01808261|7731075|FG000|Overall Study|Consent withdrawn by subject|6
4756643|NCT01808261|7731076|FG001|Overall Study|Consent withdrawn by subject|7
4756644|NCT01808261|7731075|FG000|Overall Study|Lost to Follow-up|3
4756645|NCT01808261|7731076|FG001|Overall Study|Lost to Follow-up|1
4756703|NCT01901432|7731169|FG000|Overall Study|Adverse Event|0
4756704|NCT01901432|7731170|FG001|Overall Study|Adverse Event|1
4756705|NCT01901432|7731171|FG002|Overall Study|Adverse Event|1
4756706|NCT01901432|7731172|FG003|Overall Study|Adverse Event|0
4756707|NCT01901432|7731173|FG004|Overall Study|Adverse Event|1
4756708|NCT01901432|7731169|FG000|Overall Study|Withdrawal by Subject|0
4756709|NCT01901432|7731170|FG001|Overall Study|Withdrawal by Subject|0
4756710|NCT01901432|7731171|FG002|Overall Study|Withdrawal by Subject|1
4756711|NCT01901432|7731172|FG003|Overall Study|Withdrawal by Subject|0
4756712|NCT01901432|7731173|FG004|Overall Study|Withdrawal by Subject|5
4756713|NCT01901432|7731169|FG000|Overall Study|Physician Decision|0
4756714|NCT01901432|7731170|FG001|Overall Study|Physician Decision|0
4756715|NCT01901432|7731171|FG002|Overall Study|Physician Decision|0
4756716|NCT01901432|7731172|FG003|Overall Study|Physician Decision|0
4756717|NCT01901432|7731173|FG004|Overall Study|Physician Decision|2
4756718|NCT01901432|7731169|FG000|Overall Study|Patient decision to stop study drug|0
4756719|NCT01901432|7731170|FG001|Overall Study|Patient decision to stop study drug|0
4756720|NCT01901432|7731171|FG002|Overall Study|Patient decision to stop study drug|0
4756721|NCT01901432|7731172|FG003|Overall Study|Patient decision to stop study drug|0
4756722|NCT01901432|7731173|FG004|Overall Study|Patient decision to stop study drug|1
4756727|NCT01915498|7731220|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
4756728|NCT01915498|7731221|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
4756729|NCT01915498|7731222|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
4756730|NCT01915498|7731223|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1
4756731|NCT01915498|7731224|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1
4756732|NCT01915498|7731225|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
4756733|NCT01915498|7731226|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
4756734|NCT01915498|7731227|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
4756735|NCT01915498|7731228|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
4756736|NCT01915498|7731229|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1
4756737|NCT01915498|7731230|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
4756738|NCT01915498|7731231|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
4756739|NCT01915498|7731232|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1
4756740|NCT01915498|7731233|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5
4756741|NCT01915498|7731234|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1
4756742|NCT01915498|7731235|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2
4756743|NCT01915498|7731236|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2
4756744|NCT01915498|7731237|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5
4756745|NCT01915498|7731238|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
4756746|NCT01915498|7731220|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2
4756747|NCT01915498|7731221|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0
4756748|NCT01915498|7731222|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
4756749|NCT01915498|7731223|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
4674997|NCT02363946|7573092|FG000|Overall Study|Lost to Follow-up|0
4674998|NCT02363946|7573093|FG001|Overall Study|Lost to Follow-up|0
4674999|NCT02363946|7573094|FG002|Overall Study|Lost to Follow-up|0
4675000|NCT02363946|7573095|FG003|Overall Study|Lost to Follow-up|0
4675001|NCT02363946|7573096|FG004|Overall Study|Lost to Follow-up|0
4675002|NCT02363946|7573097|FG005|Overall Study|Lost to Follow-up|0
4675003|NCT02363946|7573098|FG006|Overall Study|Lost to Follow-up|0
4675004|NCT02363946|7573099|FG007|Overall Study|Lost to Follow-up|1
4675005|NCT02363946|7573100|FG008|Overall Study|Lost to Follow-up|0
4675006|NCT02363946|7573101|FG009|Overall Study|Lost to Follow-up|0
4675007|NCT02363946|7573102|FG010|Overall Study|Lost to Follow-up|0
4675008|NCT02363946|7573103|FG011|Overall Study|Lost to Follow-up|0
4675009|NCT02363946|7573104|FG012|Overall Study|Lost to Follow-up|0
4675010|NCT02363959|7573134|FG000|Overall Study|Medical instability|1
4675011|NCT02363959|7573135|FG001|Overall Study|Medical instability|0
4675012|NCT02364037|7573147|FG000|Overall Study|Withdrawal by Subject|7
4675013|NCT02364037|7573148|FG001|Overall Study|Withdrawal by Subject|4
4675014|NCT02364037|7573147|FG000|Overall Study|Lost to Follow-up|37
4675015|NCT02364037|7573148|FG001|Overall Study|Lost to Follow-up|49
4675016|NCT02364180|7573158|FG000|Overall Study|Screen Fail|1
4675017|NCT02364336|7573174|FG000|Overall Study|Adverse Event|0
4675018|NCT02364336|7573175|FG001|Overall Study|Adverse Event|1
4675019|NCT02364388|7573182|FG000|Overall Study|Protocol Violation|1
4675020|NCT02364388|7573182|FG000|Overall Study|Technical Failure|3
4675021|NCT02364388|7573182|FG000|Overall Study|No OA/US data|2
4675022|NCT02364388|7573182|FG000|Overall Study|No Biopsy|2
4675023|NCT02364947|7573226|FG000|Overall Study|Withdrawal by Subject|10
4675024|NCT02364947|7573227|FG001|Overall Study|Withdrawal by Subject|8
4675025|NCT02364947|7573228|FG002|Overall Study|Withdrawal by Subject|9
4675026|NCT02364947|7573226|FG000|Overall Study|Adverse Event|45
4675027|NCT02364947|7573227|FG001|Overall Study|Adverse Event|33
4675028|NCT02364947|7573228|FG002|Overall Study|Adverse Event|11
4756723|NCT01904279|7731194|FG000|Overall Study|Lack of Efficacy|2
4756724|NCT01904279|7731195|FG001|Overall Study|Lack of Efficacy|3
4756725|NCT01904279|7731194|FG000|Overall Study|Withdrawal by Subject|1
4756726|NCT01904279|7731195|FG001|Overall Study|Withdrawal by Subject|0
4756750|NCT01915498|7731224|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0
4756751|NCT01915498|7731225|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0
4756752|NCT01915498|7731226|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
4756753|NCT01915498|7731227|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4
4756754|NCT01915498|7731228|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
4756755|NCT01915498|7731229|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2
4675029|NCT02364947|7573226|FG000|Overall Study|Protocol Violation|1
4675030|NCT02364947|7573227|FG001|Overall Study|Protocol Violation|1
4675031|NCT02364947|7573228|FG002|Overall Study|Protocol Violation|1
4675032|NCT02364947|7573226|FG000|Overall Study|Physician Decision|3
4675033|NCT02364947|7573227|FG001|Overall Study|Physician Decision|2
4675034|NCT02364947|7573228|FG002|Overall Study|Physician Decision|5
4675035|NCT02364947|7573226|FG000|Overall Study|Death|0
4675036|NCT02364947|7573227|FG001|Overall Study|Death|1
4675037|NCT02364947|7573228|FG002|Overall Study|Death|0
4675038|NCT02364999|7573238|FG000|Overall Study|Death|136
4675039|NCT02364999|7573239|FG001|Overall Study|Death|138
4675040|NCT02364999|7573238|FG000|Overall Study|Lost to Follow-up|10
4675041|NCT02364999|7573239|FG001|Overall Study|Lost to Follow-up|15
4675042|NCT02364999|7573238|FG000|Overall Study|Protocol Violation|3
4675043|NCT02364999|7573239|FG001|Overall Study|Protocol Violation|2
4675044|NCT02364999|7573238|FG000|Overall Study|Withdrawal by Subject|14
4675045|NCT02364999|7573239|FG001|Overall Study|Withdrawal by Subject|14
4675046|NCT02364999|7573238|FG000|Overall Study|Other|0
4675047|NCT02364999|7573239|FG001|Overall Study|Other|1
4675048|NCT02364999|7573238|FG000|Overall Study|Randomized but did not receive treatment|2
4675049|NCT02364999|7573239|FG001|Overall Study|Randomized but did not receive treatment|3
4675050|NCT02365064|7573248|FG000|Overall Study|Patients met baseline exclusion requirem|2
4675051|NCT02365064|7573249|FG001|Overall Study|Patients met baseline exclusion requirem|15
4675052|NCT02365064|7573248|FG000|Overall Study|Withdrawal by Subject|6
4675053|NCT02365064|7573249|FG001|Overall Study|Withdrawal by Subject|9
4675054|NCT02365064|7573248|FG000|Overall Study|Treatment intolerance|2
4675055|NCT02365064|7573249|FG001|Overall Study|Treatment intolerance|4
4675056|NCT02365285|7573259|FG000|Overall Study|Physician Decision|0
4675057|NCT02365285|7573260|FG001|Overall Study|Physician Decision|1
4675058|NCT02365285|7573261|FG002|Overall Study|Physician Decision|1
4675059|NCT02365285|7573262|FG003|Overall Study|Physician Decision|0
4675060|NCT02365285|7573259|FG000|Overall Study|Adverse Event|0
4675061|NCT02365285|7573260|FG001|Overall Study|Adverse Event|0
4675062|NCT02365285|7573261|FG002|Overall Study|Adverse Event|0
4675063|NCT02365285|7573262|FG003|Overall Study|Adverse Event|2
4675064|NCT02365298|7573274|FG000|Period 2|incorrect Rx dispensed|1
4675065|NCT02365298|7573275|FG001|Period 2|incorrect Rx dispensed|0
4675066|NCT02365298|7573274|FG000|Period 2|Discontinued at request of Sponsor|1
4675067|NCT02365298|7573275|FG001|Period 2|Discontinued at request of Sponsor|0
4675068|NCT02365298|7573274|FG000|Period 2|Test Article longer available|0
4675069|NCT02365298|7573275|FG001|Period 2|Test Article longer available|1
4675070|NCT02365298|7573274|FG000|Period 2|Protocol Violation|0
4675071|NCT02365298|7573275|FG001|Period 2|Protocol Violation|1
4675072|NCT02365480|7573283|FG000|Overall Study|Withdrawal by Subject|2
4675073|NCT02365480|7573284|FG001|Overall Study|Withdrawal by Subject|0
4675074|NCT02365506|7573293|FG000|Overall Study|Investigator's Discretion|0
4675075|NCT02365506|7573294|FG001|Overall Study|Investigator's Discretion|0
4675076|NCT02365506|7573295|FG002|Overall Study|Investigator's Discretion|1
4675077|NCT02365519|7573305|FG000|Randomized and Treated|Adverse Event|0
4675078|NCT02365519|7573306|FG001|Randomized and Treated|Adverse Event|1
4675079|NCT02365519|7573307|FG002|Randomized and Treated|Adverse Event|0
4675080|NCT02365519|7573305|FG000|Randomized and Treated|Withdrawal by Subject|0
4675081|NCT02365519|7573306|FG001|Randomized and Treated|Withdrawal by Subject|1
4675082|NCT02365519|7573307|FG002|Randomized and Treated|Withdrawal by Subject|1
4675083|NCT02365558|7573316|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1
4675084|NCT02365558|7573317|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0
4675085|NCT02365558|7573316|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0
4675086|NCT02365558|7573317|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1
4756756|NCT01915498|7731230|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
4756757|NCT01915498|7731231|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
4756758|NCT01915498|7731232|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2
4756759|NCT01915498|7731233|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4
4756760|NCT01915498|7731234|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
4756761|NCT01915498|7731235|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4
4756762|NCT01915498|7731236|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2
4756763|NCT01915498|7731237|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16
4756764|NCT01915498|7731238|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0
4756765|NCT01915498|7731220|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1
4756766|NCT01915498|7731221|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3
4756767|NCT01915498|7731222|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3
4756768|NCT01915498|7731223|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4
4756769|NCT01915498|7731224|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2
4756770|NCT01915498|7731225|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5
4756771|NCT01915498|7731226|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5
4756772|NCT01915498|7731227|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15
4756773|NCT01915498|7731228|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4
4756774|NCT01915498|7731229|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7
4756775|NCT01915498|7731230|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3
4756776|NCT01915498|7731231|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2
4756777|NCT01915498|7731232|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3
4756778|NCT01915498|7731233|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24
4756779|NCT01915498|7731234|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14
4756780|NCT01915498|7731235|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9
4756781|NCT01915498|7731236|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8
4756782|NCT01915498|7731237|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41
4756783|NCT01915498|7731238|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0
4756784|NCT01915498|7731220|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
4756785|NCT01915498|7731221|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
4756786|NCT01915498|7731222|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
4756787|NCT01915498|7731223|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
4756788|NCT01915498|7731224|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
4675087|NCT02365584|7573328|FG000|Overall Study|Adverse Event|2
4675088|NCT02365584|7573329|FG001|Overall Study|Adverse Event|2
4675089|NCT02365584|7573328|FG000|Overall Study|Withdrawal by Subject|1
4675090|NCT02365584|7573329|FG001|Overall Study|Withdrawal by Subject|0
4675091|NCT02365584|7573328|FG000|Overall Study|Disease Progression|9
4675092|NCT02365584|7573329|FG001|Overall Study|Disease Progression|12
4675093|NCT02365636|7573338|FG000|Overall Study|Adverse Event|3
4675094|NCT02365636|7573339|FG001|Overall Study|Adverse Event|3
4675095|NCT02365636|7573340|FG002|Overall Study|Adverse Event|2
4675096|NCT02365636|7573338|FG000|Overall Study|Protocol Violation|1
4675097|NCT02365636|7573339|FG001|Overall Study|Protocol Violation|4
4675098|NCT02365636|7573340|FG002|Overall Study|Protocol Violation|0
4675099|NCT02365636|7573338|FG000|Overall Study|Lost to Follow-up|0
4675100|NCT02365636|7573339|FG001|Overall Study|Lost to Follow-up|0
4675101|NCT02365636|7573340|FG002|Overall Study|Lost to Follow-up|1
4675102|NCT02365636|7573338|FG000|Overall Study|Other|2
4675103|NCT02365636|7573339|FG001|Overall Study|Other|0
4675104|NCT02365636|7573340|FG002|Overall Study|Other|0
4675105|NCT02366091|7573374|FG000|Overall Study|Withdrawal by Subject|3
4675106|NCT02366091|7573375|FG001|Overall Study|Withdrawal by Subject|7
4675107|NCT02366091|7573376|FG002|Overall Study|Withdrawal by Subject|3
4675108|NCT02366091|7573377|FG003|Overall Study|Withdrawal by Subject|1
4675109|NCT02366130|7573387|FG000|Overall Study|Withdrawal by Subject|3
4675110|NCT02366130|7573387|FG000|Overall Study|Ineligible|6
4675111|NCT02366143|7573394|FG000|Overall Study|Death|307
4675112|NCT02366143|7573395|FG001|Overall Study|Death|278
4675113|NCT02366143|7573396|FG002|Overall Study|Death|280
4675114|NCT02366143|7573394|FG000|Overall Study|Lost to Follow-up|2
4756789|NCT01915498|7731225|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
4756790|NCT01915498|7731226|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
4756791|NCT01915498|7731227|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
4756792|NCT01915498|7731228|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
4756793|NCT01915498|7731229|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
4756794|NCT01915498|7731230|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1
4756795|NCT01915498|7731231|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
4756796|NCT01915498|7731232|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
4675115|NCT02366143|7573395|FG001|Overall Study|Lost to Follow-up|4
4675116|NCT02366143|7573396|FG002|Overall Study|Lost to Follow-up|2
4675117|NCT02366143|7573394|FG000|Overall Study|Physician Decision|1
4675118|NCT02366143|7573395|FG001|Overall Study|Physician Decision|2
4675119|NCT02366143|7573396|FG002|Overall Study|Physician Decision|1
4675120|NCT02366143|7573394|FG000|Overall Study|Protocol Violation|0
4675121|NCT02366143|7573395|FG001|Overall Study|Protocol Violation|0
4675122|NCT02366143|7573396|FG002|Overall Study|Protocol Violation|2
4675123|NCT02366143|7573394|FG000|Overall Study|Withdrawal by Subject|16
4675124|NCT02366143|7573395|FG001|Overall Study|Withdrawal by Subject|17
4675125|NCT02366143|7573396|FG002|Overall Study|Withdrawal by Subject|22
4675126|NCT02366143|7573394|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0
4675127|NCT02366143|7573395|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6
4675128|NCT02366143|7573396|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0
4675129|NCT02366143|7573394|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0
4675130|NCT02366143|7573395|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1
4675131|NCT02366143|7573396|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0
4675132|NCT02366143|7573394|FG000|Overall Study|Randomization Error|1
4675133|NCT02366143|7573395|FG001|Overall Study|Randomization Error|0
4675134|NCT02366143|7573396|FG002|Overall Study|Randomization Error|0
4675135|NCT02366143|7573394|FG000|Overall Study|PI Move and Site Closure|1
4675136|NCT02366143|7573395|FG001|Overall Study|PI Move and Site Closure|0
4675137|NCT02366143|7573396|FG002|Overall Study|PI Move and Site Closure|1
4675138|NCT02366143|7573394|FG000|Overall Study|Study Terminated By Sponsor|0
4675139|NCT02366143|7573395|FG001|Overall Study|Study Terminated By Sponsor|0
4675140|NCT02366143|7573396|FG002|Overall Study|Study Terminated By Sponsor|2
4675141|NCT02366143|7573394|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70
4675142|NCT02366143|7573395|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57
4675143|NCT02366143|7573396|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52
4675144|NCT02366143|7573394|FG000|Overall Study|Patient moved to roll-over study|1
4675145|NCT02366143|7573395|FG001|Overall Study|Patient moved to roll-over study|19
4675146|NCT02366143|7573396|FG002|Overall Study|Patient moved to roll-over study|28
4675147|NCT02366143|7573394|FG000|Overall Study|Patient moved to commercial stock|0
4675148|NCT02366143|7573395|FG001|Overall Study|Patient moved to commercial stock|0
4675149|NCT02366143|7573396|FG002|Overall Study|Patient moved to commercial stock|1
4675150|NCT02366143|7573394|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0
4675151|NCT02366143|7573395|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0
4675152|NCT02366143|7573396|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1
4675153|NCT02366143|7573394|FG000|Overall Study|Patient rolling over to patient assistance program|0
4675154|NCT02366143|7573395|FG001|Overall Study|Patient rolling over to patient assistance program|0
4675155|NCT02366143|7573396|FG002|Overall Study|Patient rolling over to patient assistance program|1
4675156|NCT02366143|7573394|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0
4675157|NCT02366143|7573395|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0
4675158|NCT02366143|7573396|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1
4675159|NCT02366143|7573394|FG000|Overall Study|Requester's instructions|1
4675160|NCT02366143|7573395|FG001|Overall Study|Requester's instructions|1
4675161|NCT02366143|7573396|FG002|Overall Study|Requester's instructions|1
4675162|NCT02366143|7573394|FG000|Overall Study|Uneligible|0
4675163|NCT02366143|7573395|FG001|Overall Study|Uneligible|1
4675164|NCT02366143|7573396|FG002|Overall Study|Uneligible|0
4675165|NCT02366143|7573394|FG000|Overall Study|Post Trial Migration|0
4675166|NCT02366143|7573395|FG001|Overall Study|Post Trial Migration|1
4675167|NCT02366143|7573396|FG002|Overall Study|Post Trial Migration|0
4675168|NCT02366143|7573394|FG000|Overall Study|Patient moving onto PTAP commercial stock|0
4675169|NCT02366143|7573395|FG001|Overall Study|Patient moving onto PTAP commercial stock|1
4675170|NCT02366143|7573396|FG002|Overall Study|Patient moving onto PTAP commercial stock|0
4675171|NCT02366143|7573394|FG000|Overall Study|Patient switched to PTAP|0
4675172|NCT02366143|7573395|FG001|Overall Study|Patient switched to PTAP|1
4675173|NCT02366143|7573396|FG002|Overall Study|Patient switched to PTAP|0
4675174|NCT02366143|7573394|FG000|Overall Study|Patient moved to commercial atezolizumab use|0
4675175|NCT02366143|7573395|FG001|Overall Study|Patient moved to commercial atezolizumab use|11
4675176|NCT02366143|7573396|FG002|Overall Study|Patient moved to commercial atezolizumab use|7
4675177|NCT02366195|7573408|FG000|Overall Study|Protocol-specified criteria|3
4675178|NCT02366195|7573408|FG000|Overall Study|Withdrawal by Subject|9
4675179|NCT02366195|7573408|FG000|Overall Study|Lost to Follow-up|1
4675180|NCT02366195|7573408|FG000|Overall Study|Death|41
4675181|NCT02366312|7573414|FG000|Overall Study|Lost to Follow-up|0
4675182|NCT02366312|7573415|FG001|Overall Study|Lost to Follow-up|1
4675183|NCT02366468|7573445|FG000|Overall Study|Adverse Event|2
4675184|NCT02366468|7573446|FG001|Overall Study|Adverse Event|0
4675185|NCT02366468|7573445|FG000|Overall Study|Withdrawal by Subject|1
4675186|NCT02366468|7573446|FG001|Overall Study|Withdrawal by Subject|5
4675187|NCT02366468|7573445|FG000|Overall Study|Lost to Follow-up|2
4675188|NCT02366468|7573446|FG001|Overall Study|Lost to Follow-up|0
4675189|NCT02366468|7573445|FG000|Overall Study|Death|1
4675190|NCT02366468|7573446|FG001|Overall Study|Death|2
4675191|NCT02366468|7573445|FG000|Overall Study|Other|0
4675192|NCT02366468|7573446|FG001|Overall Study|Other|2
4675193|NCT02366637|7573462|FG000|First Intervention Period|Adverse Event|0
4675194|NCT02366637|7573463|FG001|First Intervention Period|Adverse Event|1
4675195|NCT02366637|7573462|FG000|First Intervention Period|Study Terminated by Sponsor|6
4675196|NCT02366637|7573463|FG001|First Intervention Period|Study Terminated by Sponsor|4
4675197|NCT02366637|7573462|FG000|Second Intervention Period|Study Terminated by Sponsor|1
4675198|NCT02366637|7573463|FG001|Second Intervention Period|Study Terminated by Sponsor|1
4675199|NCT02366689|7573481|FG000|Overall Study|Withdrawal by Subject|1
4675200|NCT02366689|7573482|FG001|Overall Study|Withdrawal by Subject|0
4675201|NCT02366689|7573483|FG002|Overall Study|Withdrawal by Subject|1
4675202|NCT02366689|7573481|FG000|Overall Study|Lost to Follow-up|3
4675203|NCT02366689|7573482|FG001|Overall Study|Lost to Follow-up|2
4675204|NCT02366689|7573483|FG002|Overall Study|Lost to Follow-up|0
4675205|NCT02366689|7573481|FG000|Overall Study|Pregnancy|0
4675206|NCT02366689|7573482|FG001|Overall Study|Pregnancy|1
4675207|NCT02366689|7573483|FG002|Overall Study|Pregnancy|1
4675208|NCT02366767|7573493|FG000|Overall Study|left for home after 1 day at camp|1
4675209|NCT02366767|7573494|FG001|Overall Study|left for home after 1 day at camp|0
4675210|NCT02366910|7573518|FG000|Overall Study|Withdrawal by Subject|2
4675211|NCT02366910|7573518|FG000|Overall Study|Screen Failure|3
4675212|NCT02366923|7573524|FG000|Overall Study|Withdrawal by Subject|1
4675213|NCT02366923|7573524|FG000|Overall Study|Positive Slit Lamp Findings|2
4675214|NCT02366923|7573524|FG000|Overall Study|High Astigmatism|3
4675215|NCT02366936|7573529|FG000|Overall Study|Withdrawal by Subject|2
4675216|NCT02366936|7573529|FG000|Overall Study|Lost to Follow-up|4
4675217|NCT02366936|7573529|FG000|Overall Study|Physician Decision|2
4675218|NCT02367131|7573566|FG000|Overall Study|Adverse Event|64
4675219|NCT02367131|7573566|FG000|Overall Study|No visit since the first visit|4
4675220|NCT02367131|7573566|FG000|Overall Study|Request by patient|54
4675221|NCT02367131|7573566|FG000|Overall Study|Improvement/remission|2
4675222|NCT02367131|7573566|FG000|Overall Study|No change/progressive disease|78
4675223|NCT02367131|7573566|FG000|Overall Study|Other than stated above|20
4675224|NCT02367352|7573570|FG000|Overall Study|Progressive disease|7
4675225|NCT02367352|7573571|FG001|Overall Study|Progressive disease|0
4675226|NCT02367352|7573572|FG002|Overall Study|Progressive disease|0
4675227|NCT02367352|7573570|FG000|Overall Study|Participant Received Alternative Therapy|1
4675228|NCT02367352|7573571|FG001|Overall Study|Participant Received Alternative Therapy|0
4675229|NCT02367352|7573572|FG002|Overall Study|Participant Received Alternative Therapy|0
4675230|NCT02367352|7573570|FG000|Overall Study|Adverse Event|1
4675231|NCT02367352|7573571|FG001|Overall Study|Adverse Event|0
4675232|NCT02367352|7573572|FG002|Overall Study|Adverse Event|0
4675233|NCT02367521|7573593|FG000|Overall Study|severe headache after intervention|2
4675234|NCT02367521|7573594|FG001|Overall Study|severe headache after intervention|0
4675235|NCT02367521|7573593|FG000|Overall Study|unable to find transportation|2
4675236|NCT02367521|7573594|FG001|Overall Study|unable to find transportation|0
4675237|NCT02367716|7573609|FG000|Overall Study|Patient did not meet inclusion criteria|1
4675238|NCT02367729|7573616|FG000|Overall Study|Organic disorder diagnosed|2
4675239|NCT02367729|7573617|FG001|Overall Study|Organic disorder diagnosed|1
4675240|NCT02367729|7573616|FG000|Overall Study|Adverse Event|1
4675241|NCT02367729|7573617|FG001|Overall Study|Adverse Event|2
4675242|NCT02367729|7573616|FG000|Overall Study|Withdrawal by Subject|0
4675243|NCT02367729|7573617|FG001|Overall Study|Withdrawal by Subject|5
4675244|NCT02367781|7573626|FG000|Overall Study|Withdrawal by Subject|20
4675245|NCT02367781|7573627|FG001|Overall Study|Withdrawal by Subject|13
4675246|NCT02367781|7573626|FG000|Overall Study|Protocol Violation|0
4675247|NCT02367781|7573627|FG001|Overall Study|Protocol Violation|1
4675248|NCT02367781|7573626|FG000|Overall Study|Physician Decision|7
4675249|NCT02367781|7573627|FG001|Overall Study|Physician Decision|0
4675250|NCT02367781|7573626|FG000|Overall Study|Randomized in Error|5
4756797|NCT01915498|7731233|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
4756798|NCT01915498|7731234|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
4756799|NCT01915498|7731235|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
4756800|NCT01915498|7731236|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
4756801|NCT01915498|7731237|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
4756802|NCT01915498|7731238|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
4756803|NCT01915498|7731220|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2
4756804|NCT01915498|7731221|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1
4756805|NCT01915498|7731222|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1
4756806|NCT01915498|7731223|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1
4756807|NCT01915498|7731224|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1
4756808|NCT01915498|7731225|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2
4756809|NCT01915498|7731226|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0
4756810|NCT01915498|7731227|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1
4756811|NCT01915498|7731228|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0
4756812|NCT01915498|7731229|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0
4756813|NCT01915498|7731230|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2
4756814|NCT01915498|7731231|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0
4756815|NCT01915498|7731232|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0
4756816|NCT01915498|7731233|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4
4756817|NCT01915498|7731234|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1
4756818|NCT01915498|7731235|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4
4756819|NCT01915498|7731236|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3
4756820|NCT01915498|7731237|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16
4756821|NCT01915498|7731238|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0
4756822|NCT01915498|7731220|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
4756823|NCT01915498|7731221|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
4756824|NCT01915498|7731222|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
4756825|NCT01915498|7731223|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
4756826|NCT01915498|7731224|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1
4756827|NCT01915498|7731225|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
4756828|NCT01915498|7731226|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
4756829|NCT01915498|7731227|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
4756830|NCT01915498|7731228|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
4756831|NCT01915498|7731229|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1
4756832|NCT01915498|7731230|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
4756833|NCT01915498|7731231|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
4756834|NCT01915498|7731232|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
4756835|NCT01915498|7731233|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
4756836|NCT01915498|7731234|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
4756837|NCT01915498|7731235|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
4756838|NCT01915498|7731236|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
4756839|NCT01915498|7731237|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
4756840|NCT01915498|7731238|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
4756841|NCT01915498|7731220|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
4756842|NCT01915498|7731221|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
4756843|NCT01915498|7731222|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2
4756844|NCT01915498|7731223|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
4756845|NCT01915498|7731224|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
4756846|NCT01915498|7731225|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
4756847|NCT01915498|7731226|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
4756848|NCT01915498|7731227|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
4756849|NCT01915498|7731228|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
4756850|NCT01915498|7731229|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
4756851|NCT01915498|7731230|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
4675251|NCT02367781|7573627|FG001|Overall Study|Randomized in Error|4
4675252|NCT02367781|7573626|FG000|Overall Study|Non-Compliance|1
4675253|NCT02367781|7573627|FG001|Overall Study|Non-Compliance|0
4675254|NCT02367781|7573626|FG000|Overall Study|Lost to Follow-up|1
4675255|NCT02367781|7573627|FG001|Overall Study|Lost to Follow-up|2
4675256|NCT02367781|7573626|FG000|Overall Study|Death|330
4675257|NCT02367781|7573627|FG001|Overall Study|Death|176
4675258|NCT02367781|7573626|FG000|Overall Study|Patient Moving to Roll-Over Study|17
4675259|NCT02367781|7573627|FG001|Overall Study|Patient Moving to Roll-Over Study|5
4675260|NCT02367781|7573626|FG000|Overall Study|Prolonged Hospitalization|1
4675261|NCT02367781|7573627|FG001|Overall Study|Prolonged Hospitalization|0
4675262|NCT02367781|7573626|FG000|Overall Study|Death Prior First Dose|1
4675263|NCT02367781|7573627|FG001|Overall Study|Death Prior First Dose|0
4675264|NCT02367781|7573626|FG000|Overall Study|Administrative-Change Facility|1
4675265|NCT02367781|7573627|FG001|Overall Study|Administrative-Change Facility|0
4675266|NCT02367781|7573626|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78
4675267|NCT02367781|7573627|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29
4675268|NCT02367781|7573626|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14
4675269|NCT02367781|7573627|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9
4675270|NCT02367781|7573626|FG000|Overall Study|Study Terminated by Sponsor|3
4675271|NCT02367781|7573627|FG001|Overall Study|Study Terminated by Sponsor|1
4675272|NCT02367781|7573626|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1
4675273|NCT02367781|7573627|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0
4675274|NCT02367781|7573626|FG000|Overall Study|Sponsor Decision|2
4675275|NCT02367781|7573627|FG001|Overall Study|Sponsor Decision|0
4675276|NCT02367781|7573626|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1
4675277|NCT02367781|7573627|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0
4675278|NCT02367833|7573652|FG000|Overall Study|Withdrawal by Subject|1
4675279|NCT02367833|7573653|FG001|Overall Study|Withdrawal by Subject|1
4675280|NCT02367833|7573654|FG002|Overall Study|Withdrawal by Subject|0
4675281|NCT02367885|7573711|FG000|Overall Study|Lost to Follow-up|1
4675282|NCT02367885|7573712|FG001|Overall Study|Lost to Follow-up|0
4675283|NCT02367885|7573713|FG002|Overall Study|Lost to Follow-up|0
4675284|NCT02367885|7573711|FG000|Overall Study|Withdrawal by Subject|1
4675285|NCT02367885|7573712|FG001|Overall Study|Withdrawal by Subject|0
4675286|NCT02367885|7573713|FG002|Overall Study|Withdrawal by Subject|0
4675287|NCT02367911|7573726|FG000|Overall Study|Withdrawal by Subject|3
4675288|NCT02367911|7573727|FG001|Overall Study|Withdrawal by Subject|2
4675289|NCT02367911|7573726|FG000|Overall Study|Lost to Follow-up|2
4675290|NCT02367911|7573727|FG001|Overall Study|Lost to Follow-up|2
4675291|NCT02368210|7573744|FG000|Overall Study|Withdrawal by Subject|1
4675292|NCT02368210|7573745|FG001|Overall Study|Withdrawal by Subject|0
4675293|NCT02368210|7573744|FG000|Overall Study|Adverse Event|0
4675294|NCT02368210|7573745|FG001|Overall Study|Adverse Event|1
4675295|NCT02368314|7573753|FG000|Overall Study|Withdrawal by Subject|2
4675296|NCT02368314|7573754|FG001|Overall Study|Withdrawal by Subject|1
4675297|NCT02368314|7573753|FG000|Overall Study|Adverse Event|1
4675298|NCT02368314|7573754|FG001|Overall Study|Adverse Event|2
4675299|NCT02368691|7573779|FG000|Overall Study|Death|13
4675300|NCT02368691|7573779|FG000|Overall Study|Lack of Efficacy|15
4675301|NCT02368691|7573779|FG000|Overall Study|Physician Decision|4
4675302|NCT02369159|7573794|FG000|Overall Study|Adverse Event|0
4675303|NCT02369159|7573795|FG001|Overall Study|Adverse Event|1
4675304|NCT02369159|7573794|FG000|Overall Study|Lost to Follow-up|1
4675305|NCT02369159|7573795|FG001|Overall Study|Lost to Follow-up|1
4675306|NCT02369159|7573794|FG000|Overall Study|Withdrawal by Subject|7
4675307|NCT02369159|7573795|FG001|Overall Study|Withdrawal by Subject|0
4675308|NCT02369341|7573845|FG000|Overall Study|Migrated/moved from study area|1
4675309|NCT02369341|7573846|FG001|Overall Study|Migrated/moved from study area|0
4675310|NCT02369510|7573863|FG000|Overall Study|Spilled Medication|1
4675311|NCT02369510|7573864|FG001|Overall Study|Spilled Medication|2
4675312|NCT02369510|7573865|FG002|Overall Study|Spilled Medication|1
4756852|NCT01915498|7731231|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
4756853|NCT01915498|7731232|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
4756854|NCT01915498|7731233|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
4756855|NCT01915498|7731234|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
4756856|NCT01915498|7731235|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
4756857|NCT01915498|7731236|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4
4756858|NCT01915498|7731237|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8
4756859|NCT01915498|7731238|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
4675313|NCT02369510|7573863|FG000|Overall Study|Epidural Activation|1
4675314|NCT02369510|7573864|FG001|Overall Study|Epidural Activation|1
4675315|NCT02369510|7573865|FG002|Overall Study|Epidural Activation|5
4675316|NCT02369848|7573903|FG000|Overall Study|Death|1
4675317|NCT02369848|7573903|FG000|Overall Study|Withdrawal by Subject|2
4675318|NCT02369848|7573903|FG000|Overall Study|Lost to Follow-up|1
4675319|NCT02369874|7573910|FG000|Overall Study|Lost to Follow-up|2
4675320|NCT02369874|7573911|FG001|Overall Study|Lost to Follow-up|2
4675321|NCT02369874|7573912|FG002|Overall Study|Lost to Follow-up|2
4675322|NCT02369874|7573910|FG000|Overall Study|Withdrawal by Subject|7
4675323|NCT02369874|7573911|FG001|Overall Study|Withdrawal by Subject|9
4675324|NCT02369874|7573912|FG002|Overall Study|Withdrawal by Subject|27
4675325|NCT02369874|7573910|FG000|Overall Study|Miscellaneous|1
4675326|NCT02369874|7573911|FG001|Overall Study|Miscellaneous|1
4675327|NCT02369874|7573912|FG002|Overall Study|Miscellaneous|0
4675328|NCT02369874|7573910|FG000|Overall Study|On Treatment/Off Study|34
4675329|NCT02369874|7573911|FG001|Overall Study|On Treatment/Off Study|45
4675330|NCT02369874|7573912|FG002|Overall Study|On Treatment/Off Study|32
4675331|NCT02370043|7573938|FG000|Overall Study|Withdrawal by Subject|0
4675332|NCT02370043|7573939|FG001|Overall Study|Withdrawal by Subject|0
4675333|NCT02370043|7573940|FG002|Overall Study|Withdrawal by Subject|0
4675334|NCT02370043|7573941|FG003|Overall Study|Withdrawal by Subject|0
4675335|NCT02370043|7573942|FG004|Overall Study|Withdrawal by Subject|1
4675336|NCT02370043|7573943|FG005|Overall Study|Withdrawal by Subject|1
4675337|NCT02370095|7573982|FG000|Overall Study|Withdrawal by Subject|0
4675338|NCT02370095|7573983|FG001|Overall Study|Withdrawal by Subject|1
4675339|NCT02370121|7573991|FG000|Overall Study|Lost to Follow-up|1
4675340|NCT02370121|7573992|FG001|Overall Study|Lost to Follow-up|1
4675341|NCT02370160|7573998|FG000|Overall Study|Death|3
4675342|NCT02370160|7573999|FG001|Overall Study|Death|4
4675343|NCT02370160|7574000|FG002|Overall Study|Death|1
4675344|NCT02370238|7574015|FG000|Overall Study|Death|42
4675345|NCT02370238|7574016|FG001|Overall Study|Death|35
4675346|NCT02370238|7574015|FG000|Overall Study|Lost to Follow-up|1
4675347|NCT02370238|7574016|FG001|Overall Study|Lost to Follow-up|3
4675348|NCT02370238|7574015|FG000|Overall Study|Withdrawal by Subject|2
4675349|NCT02370238|7574016|FG001|Overall Study|Withdrawal by Subject|6
4675350|NCT02370238|7574015|FG000|Overall Study|Other|2
4675351|NCT02370238|7574016|FG001|Overall Study|Other|1
4675352|NCT02370251|7574026|FG000|Overall Study|Received less than 8 days of Omegaven|7
4675353|NCT02370251|7574026|FG000|Overall Study|Death|4
4675354|NCT02370368|7574032|FG000|Overall Study|Adverse Event|1
4675355|NCT02370368|7574033|FG001|Overall Study|Adverse Event|2
4675356|NCT02370368|7574032|FG000|Overall Study|Withdrawal by Subject|5
4675357|NCT02370368|7574033|FG001|Overall Study|Withdrawal by Subject|4
4675358|NCT02370394|7574041|FG000|Overall Study|Lost to Follow-up|2
4675359|NCT02370394|7574042|FG001|Overall Study|Lost to Follow-up|1
4675360|NCT02370394|7574041|FG000|Overall Study|Withdrawal by Subject|0
4675361|NCT02370394|7574042|FG001|Overall Study|Withdrawal by Subject|1
4675362|NCT02370420|7574064|FG000|Overall Study|Physician Decision|3
4675363|NCT02370420|7574065|FG001|Overall Study|Physician Decision|3
4675364|NCT02370420|7574064|FG000|Overall Study|Lost to Follow-up|11
4675365|NCT02370420|7574065|FG001|Overall Study|Lost to Follow-up|9
4675366|NCT02370498|7574073|FG000|Overall Study|Adverse Event|10
4675367|NCT02370498|7574074|FG001|Overall Study|Adverse Event|8
4675368|NCT02370498|7574073|FG000|Overall Study|Death|222
4675369|NCT02370498|7574074|FG001|Overall Study|Death|242
4675370|NCT02370498|7574073|FG000|Overall Study|Lost to Follow-up|1
4675371|NCT02370498|7574074|FG001|Overall Study|Lost to Follow-up|0
4675372|NCT02370498|7574073|FG000|Overall Study|Protocol Violation|1
4675373|NCT02370498|7574074|FG001|Overall Study|Protocol Violation|2
4675374|NCT02370498|7574073|FG000|Overall Study|Withdrawal by Subject|6
4675375|NCT02370498|7574074|FG001|Overall Study|Withdrawal by Subject|11
4675376|NCT02370498|7574073|FG000|Overall Study|Ongoing In Trial|56
4675377|NCT02370498|7574074|FG001|Overall Study|Ongoing In Trial|33
4675378|NCT02370511|7574083|FG000|Overall Study|Death|10
4675379|NCT02370511|7574084|FG001|Overall Study|Death|7
4675380|NCT02370511|7574085|FG002|Overall Study|Death|1
4675381|NCT02370511|7574083|FG000|Overall Study|Withdrawal by Subject|2
4675382|NCT02370511|7574084|FG001|Overall Study|Withdrawal by Subject|0
4675383|NCT02370511|7574085|FG002|Overall Study|Withdrawal by Subject|0
4675384|NCT02370511|7574083|FG000|Overall Study|Lost to Follow-up|0
4675385|NCT02370511|7574084|FG001|Overall Study|Lost to Follow-up|4
4675386|NCT02370511|7574085|FG002|Overall Study|Lost to Follow-up|0
4675387|NCT02370537|7574096|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0
4675388|NCT02370537|7574097|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1
4675389|NCT02370537|7574098|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0
4675390|NCT02370537|7574096|FG000|Part A (Open-label Recruitment)|Adverse Event|0
4675391|NCT02370537|7574097|FG001|Part A (Open-label Recruitment)|Adverse Event|0
4675392|NCT02370537|7574098|FG002|Part A (Open-label Recruitment)|Adverse Event|1
4675393|NCT02370537|7574096|FG000|Part B|Not randomised to receive treatment|1
4675394|NCT02370537|7574097|FG001|Part B|Not randomised to receive treatment|2
4675395|NCT02370537|7574098|FG002|Part B|Not randomised to receive treatment|259
4675396|NCT02370537|7574096|FG000|Part B|Withdrawal by Subject|0
4675397|NCT02370537|7574097|FG001|Part B|Withdrawal by Subject|1
4675398|NCT02370537|7574098|FG002|Part B|Withdrawal by Subject|0
4675399|NCT02370602|7574121|FG000|Overall Study|Pretreatment Event/Adverse Event|1
4675400|NCT02370602|7574122|FG001|Overall Study|Pretreatment Event/Adverse Event|0
4675401|NCT02370602|7574123|FG002|Overall Study|Pretreatment Event/Adverse Event|0
4675402|NCT02370602|7574124|FG003|Overall Study|Pretreatment Event/Adverse Event|0
4675403|NCT02370602|7574125|FG004|Overall Study|Pretreatment Event/Adverse Event|0
4675404|NCT02370602|7574126|FG005|Overall Study|Pretreatment Event/Adverse Event|0
4675405|NCT02370615|7574145|FG000|Overall Study|Adverse Event|1
4675406|NCT02370615|7574146|FG001|Overall Study|Adverse Event|0
4675407|NCT02370641|7574161|FG000|Overall Study|dropped study|4
4675408|NCT02370641|7574162|FG001|Overall Study|dropped study|2
4756860|NCT01915498|7731220|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1
4756861|NCT01915498|7731221|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2
4756862|NCT01915498|7731222|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
4756863|NCT01915498|7731223|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1
4756864|NCT01915498|7731224|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
4756865|NCT01915498|7731225|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
4756866|NCT01915498|7731226|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1
4756867|NCT01915498|7731227|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
4756868|NCT01915498|7731228|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
4756869|NCT01915498|7731229|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
4756870|NCT01915498|7731230|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1
4756871|NCT01915498|7731231|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
4756872|NCT01915498|7731232|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1
4756873|NCT01915498|7731233|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6
4756874|NCT01915498|7731234|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5
4756875|NCT01915498|7731235|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2
4756876|NCT01915498|7731236|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2
4756877|NCT01915498|7731237|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9
4756878|NCT01915498|7731238|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
4756879|NCT01915498|7731220|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
4756880|NCT01915498|7731221|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
4756881|NCT01915498|7731222|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
4756882|NCT01915498|7731223|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
4756883|NCT01915498|7731224|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
4756884|NCT01915498|7731225|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
4756885|NCT01915498|7731226|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
4756886|NCT01915498|7731227|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
4756887|NCT01915498|7731228|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
4756888|NCT01915498|7731229|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
4756889|NCT01915498|7731230|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1
4756890|NCT01915498|7731231|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
4756891|NCT01915498|7731232|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
4756892|NCT01915498|7731233|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1
4756893|NCT01915498|7731234|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
4756894|NCT01915498|7731235|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
4756895|NCT01915498|7731236|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1
4756896|NCT01915498|7731237|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1
4756897|NCT01915498|7731238|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
4756898|NCT01915498|7731220|FG000|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1
4756899|NCT01915498|7731221|FG001|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
4756900|NCT01915498|7731222|FG002|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
4756901|NCT01915498|7731223|FG003|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
4756902|NCT01915498|7731224|FG004|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
4756903|NCT01915498|7731225|FG005|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1
4756904|NCT01915498|7731226|FG006|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
4756905|NCT01915498|7731227|FG007|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
4756906|NCT01915498|7731228|FG008|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
4756907|NCT01915498|7731229|FG009|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
4756908|NCT01915498|7731230|FG010|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
4756909|NCT01915498|7731231|FG011|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
4756910|NCT01915498|7731232|FG012|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
4756911|NCT01915498|7731233|FG013|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
4756912|NCT01915498|7731234|FG014|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1
4756913|NCT01915498|7731235|FG015|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
4756914|NCT01915498|7731236|FG016|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
4756915|NCT01915498|7731237|FG017|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|2
4756916|NCT01915498|7731238|FG018|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
4756917|NCT01915498|7731220|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
4756918|NCT01915498|7731221|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
4756919|NCT01915498|7731222|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
4675409|NCT02370667|7574171|FG000|Overall Study|Lost to Follow-up|0
4756920|NCT01915498|7731223|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
4756921|NCT01915498|7731224|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
4756922|NCT01915498|7731225|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1
4756923|NCT01915498|7731226|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
4756924|NCT01915498|7731227|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
4756925|NCT01915498|7731228|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
4756926|NCT01915498|7731229|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2
4756927|NCT01915498|7731230|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
4756928|NCT01915498|7731231|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
4756929|NCT01915498|7731232|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
4756930|NCT01915498|7731233|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1
4756931|NCT01915498|7731234|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2
4756932|NCT01915498|7731235|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1
4756933|NCT01915498|7731236|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2
4756934|NCT01915498|7731237|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2
4756935|NCT01915498|7731238|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
4756936|NCT01915498|7731220|FG000|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
4756937|NCT01915498|7731221|FG001|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
4756938|NCT01915498|7731222|FG002|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
4756939|NCT01915498|7731223|FG003|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
4756940|NCT01915498|7731224|FG004|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
4756941|NCT01915498|7731225|FG005|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
4756942|NCT01915498|7731226|FG006|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
4756943|NCT01915498|7731227|FG007|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
4756944|NCT01915498|7731228|FG008|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
4756945|NCT01915498|7731229|FG009|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
4756946|NCT01915498|7731230|FG010|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
4756947|NCT01915498|7731231|FG011|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
4756948|NCT01915498|7731232|FG012|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
4756949|NCT01915498|7731233|FG013|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
4756950|NCT01915498|7731234|FG014|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
4756951|NCT01915498|7731235|FG015|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
4756952|NCT01915498|7731236|FG016|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
4756953|NCT01915498|7731237|FG017|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
4756954|NCT01915498|7731238|FG018|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|2
4675410|NCT02370667|7574172|FG001|Overall Study|Lost to Follow-up|1
4675411|NCT02370667|7574173|FG002|Overall Study|Lost to Follow-up|0
4675412|NCT02370784|7574193|FG000|Overall Study|Patient started prohibited medication|0
4675413|NCT02370784|7574194|FG001|Overall Study|Patient started prohibited medication|1
4675414|NCT02370914|7574213|FG000|Overall Study|Protocol Violation|2
4675415|NCT02371369|7574258|FG000|Part 1|Physician Decision|0
4675416|NCT02371369|7574259|FG001|Part 1|Physician Decision|3
4675417|NCT02371369|7574258|FG000|Part 1|Adverse Event|8
4675418|NCT02371369|7574259|FG001|Part 1|Adverse Event|0
4675419|NCT02371369|7574258|FG000|Part 1|Withdrawal by Subject|1
4675420|NCT02371369|7574259|FG001|Part 1|Withdrawal by Subject|6
4675421|NCT02371369|7574258|FG000|Part 1|Disease progression|0
4675422|NCT02371369|7574259|FG001|Part 1|Disease progression|1
4675423|NCT02371369|7574258|FG000|Part 1|Protocol Violation|0
4675424|NCT02371369|7574259|FG001|Part 1|Protocol Violation|1
4675425|NCT02371369|7574258|FG000|Part 2|Adverse Event|3
4675426|NCT02371369|7574259|FG001|Part 2|Adverse Event|2
4675427|NCT02371369|7574258|FG000|Part 2|Withdrawal by Subject|5
4675428|NCT02371369|7574259|FG001|Part 2|Withdrawal by Subject|1
4675429|NCT02371369|7574258|FG000|Part 2|Physician Decision|1
4675430|NCT02371369|7574259|FG001|Part 2|Physician Decision|0
4675431|NCT02371369|7574258|FG000|Part 2|Death|0
4675432|NCT02371369|7574259|FG001|Part 2|Death|1
4675433|NCT02371616|7574286|FG000|Overall Study|Protocol Violation|2
4675434|NCT02371616|7574287|FG001|Overall Study|Protocol Violation|1
4675435|NCT02371616|7574286|FG000|Overall Study|Adverse Event|0
4675436|NCT02371616|7574287|FG001|Overall Study|Adverse Event|1
4675437|NCT02371616|7574286|FG000|Overall Study|Withdrawal of Consent|1
4675438|NCT02371616|7574287|FG001|Overall Study|Withdrawal of Consent|0
4675439|NCT02371616|7574286|FG000|Overall Study|Other (Not specified)|1
4675440|NCT02371616|7574287|FG001|Overall Study|Other (Not specified)|5
4675441|NCT02371629|7574295|FG000|Overall Study|Patient decision|14
4675442|NCT02371629|7574296|FG001|Overall Study|Patient decision|10
4675443|NCT02371629|7574295|FG000|Overall Study|Adverse Event|8
4675444|NCT02371629|7574296|FG001|Overall Study|Adverse Event|8
4675445|NCT02371629|7574295|FG000|Overall Study|Physician Decision|2
4675446|NCT02371629|7574296|FG001|Overall Study|Physician Decision|3
4675447|NCT02371629|7574295|FG000|Overall Study|Death|1
4756955|NCT01917318|7731328|FG000|First Treatment|Withdrawal by Subject|0
4756956|NCT01917318|7731329|FG001|First Treatment|Withdrawal by Subject|1
4756989|NCT01945021|7731388|FG000|Overall Study|Adverse Event|1
4756990|NCT01945021|7731388|FG000|Overall Study|Withdrawal of consent|12
4675448|NCT02371629|7574296|FG001|Overall Study|Death|1
4675449|NCT02371629|7574295|FG000|Overall Study|Noncompliance with study treatment|1
4675450|NCT02371629|7574296|FG001|Overall Study|Noncompliance with study treatment|0
4675451|NCT02371629|7574295|FG000|Overall Study|Lack of Efficacy|0
4675452|NCT02371629|7574296|FG001|Overall Study|Lack of Efficacy|2
4675453|NCT02371629|7574295|FG000|Overall Study|Protocol deviation|0
4675454|NCT02371629|7574296|FG001|Overall Study|Protocol deviation|1
4675455|NCT02371746|7574318|FG000|Overall Study|Consent withdrawn|0
4675456|NCT02371746|7574319|FG001|Overall Study|Consent withdrawn|0
4675457|NCT02371746|7574320|FG002|Overall Study|Consent withdrawn|0
4675458|NCT02371746|7574321|FG003|Overall Study|Consent withdrawn|0
4675459|NCT02371746|7574322|FG004|Overall Study|Consent withdrawn|0
4675460|NCT02371746|7574323|FG005|Overall Study|Consent withdrawn|0
4675461|NCT02371746|7574324|FG006|Overall Study|Consent withdrawn|1
4675462|NCT02371759|7574348|FG000|Overall Study|Protocol Violation|3
4675463|NCT02371759|7574349|FG001|Overall Study|Protocol Violation|1
4675464|NCT02371759|7574350|FG002|Overall Study|Protocol Violation|1
4675465|NCT02371759|7574351|FG003|Overall Study|Protocol Violation|0
4675466|NCT02371759|7574352|FG004|Overall Study|Protocol Violation|3
4675467|NCT02371759|7574353|FG005|Overall Study|Protocol Violation|1
4675468|NCT02371759|7574354|FG006|Overall Study|Protocol Violation|0
4675469|NCT02371759|7574355|FG007|Overall Study|Protocol Violation|3
4675470|NCT02371759|7574348|FG000|Overall Study|Withdrawal by Subject|0
4675471|NCT02371759|7574349|FG001|Overall Study|Withdrawal by Subject|0
4675472|NCT02371759|7574350|FG002|Overall Study|Withdrawal by Subject|0
4675473|NCT02371759|7574351|FG003|Overall Study|Withdrawal by Subject|0
4675474|NCT02371759|7574352|FG004|Overall Study|Withdrawal by Subject|0
4675475|NCT02371759|7574353|FG005|Overall Study|Withdrawal by Subject|0
4675476|NCT02371759|7574354|FG006|Overall Study|Withdrawal by Subject|0
4675477|NCT02371759|7574355|FG007|Overall Study|Withdrawal by Subject|1
4675478|NCT02371980|7574402|FG000|Open-label Period|Pretreatment Event/Adverse Event|63
4675479|NCT02371980|7574403|FG001|Open-label Period|Pretreatment Event/Adverse Event|0
4675480|NCT02371980|7574404|FG002|Open-label Period|Pretreatment Event/Adverse Event|0
4675481|NCT02371980|7574405|FG003|Open-label Period|Pretreatment Event/Adverse Event|0
4675482|NCT02371980|7574406|FG004|Open-label Period|Pretreatment Event/Adverse Event|0
4675483|NCT02371980|7574402|FG000|Open-label Period|Significant Protocol Deviation|19
4675484|NCT02371980|7574403|FG001|Open-label Period|Significant Protocol Deviation|0
4675485|NCT02371980|7574404|FG002|Open-label Period|Significant Protocol Deviation|0
4675486|NCT02371980|7574405|FG003|Open-label Period|Significant Protocol Deviation|0
4675487|NCT02371980|7574406|FG004|Open-label Period|Significant Protocol Deviation|0
4675488|NCT02371980|7574402|FG000|Open-label Period|Noncompliance with Study Drug|10
4675489|NCT02371980|7574403|FG001|Open-label Period|Noncompliance with Study Drug|0
4675490|NCT02371980|7574404|FG002|Open-label Period|Noncompliance with Study Drug|0
4675491|NCT02371980|7574405|FG003|Open-label Period|Noncompliance with Study Drug|0
4675492|NCT02371980|7574406|FG004|Open-label Period|Noncompliance with Study Drug|0
4675493|NCT02371980|7574402|FG000|Open-label Period|Lost to Follow-up|55
4675494|NCT02371980|7574403|FG001|Open-label Period|Lost to Follow-up|0
4675495|NCT02371980|7574404|FG002|Open-label Period|Lost to Follow-up|0
4675496|NCT02371980|7574405|FG003|Open-label Period|Lost to Follow-up|0
4675497|NCT02371980|7574406|FG004|Open-label Period|Lost to Follow-up|0
4675498|NCT02371980|7574402|FG000|Open-label Period|Voluntary Withdrawal|91
4675499|NCT02371980|7574403|FG001|Open-label Period|Voluntary Withdrawal|0
4675500|NCT02371980|7574404|FG002|Open-label Period|Voluntary Withdrawal|0
4675501|NCT02371980|7574405|FG003|Open-label Period|Voluntary Withdrawal|0
4675502|NCT02371980|7574406|FG004|Open-label Period|Voluntary Withdrawal|0
4675503|NCT02371980|7574402|FG000|Open-label Period|Pregnancy|1
4675504|NCT02371980|7574403|FG001|Open-label Period|Pregnancy|0
4675505|NCT02371980|7574404|FG002|Open-label Period|Pregnancy|0
4675506|NCT02371980|7574405|FG003|Open-label Period|Pregnancy|0
4675507|NCT02371980|7574406|FG004|Open-label Period|Pregnancy|0
4675508|NCT02371980|7574402|FG000|Open-label Period|Lack of Efficacy|116
4675509|NCT02371980|7574403|FG001|Open-label Period|Lack of Efficacy|0
4675510|NCT02371980|7574404|FG002|Open-label Period|Lack of Efficacy|0
4675511|NCT02371980|7574405|FG003|Open-label Period|Lack of Efficacy|0
4675512|NCT02371980|7574406|FG004|Open-label Period|Lack of Efficacy|0
4675513|NCT02371980|7574402|FG000|Open-label Period|Did not Meet Randomization Criteria|162
4675514|NCT02371980|7574403|FG001|Open-label Period|Did not Meet Randomization Criteria|0
4675515|NCT02371980|7574404|FG002|Open-label Period|Did not Meet Randomization Criteria|0
4675516|NCT02371980|7574405|FG003|Open-label Period|Did not Meet Randomization Criteria|0
4675517|NCT02371980|7574406|FG004|Open-label Period|Did not Meet Randomization Criteria|0
4675518|NCT02371980|7574402|FG000|Open-label Period|Reason not Specified|9
4675519|NCT02371980|7574403|FG001|Open-label Period|Reason not Specified|0
4675520|NCT02371980|7574404|FG002|Open-label Period|Reason not Specified|0
4675521|NCT02371980|7574405|FG003|Open-label Period|Reason not Specified|0
4675522|NCT02371980|7574406|FG004|Open-label Period|Reason not Specified|0
4675523|NCT02371980|7574402|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0
4675524|NCT02371980|7574403|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4
4675525|NCT02371980|7574404|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3
4675526|NCT02371980|7574405|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2
4675527|NCT02371980|7574406|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9
4675528|NCT02371980|7574402|FG000|Double-blind Period|Significant Protocol Deviation|0
4675529|NCT02371980|7574403|FG001|Double-blind Period|Significant Protocol Deviation|2
4675530|NCT02371980|7574404|FG002|Double-blind Period|Significant Protocol Deviation|7
4675531|NCT02371980|7574405|FG003|Double-blind Period|Significant Protocol Deviation|3
4675532|NCT02371980|7574406|FG004|Double-blind Period|Significant Protocol Deviation|3
4675533|NCT02371980|7574402|FG000|Double-blind Period|Noncompliance with Study Drug|0
4675534|NCT02371980|7574403|FG001|Double-blind Period|Noncompliance with Study Drug|1
4675535|NCT02371980|7574404|FG002|Double-blind Period|Noncompliance with Study Drug|2
4675536|NCT02371980|7574405|FG003|Double-blind Period|Noncompliance with Study Drug|2
4675537|NCT02371980|7574406|FG004|Double-blind Period|Noncompliance with Study Drug|3
4675538|NCT02371980|7574402|FG000|Double-blind Period|Lost to Follow-up|0
4675539|NCT02371980|7574403|FG001|Double-blind Period|Lost to Follow-up|8
4675540|NCT02371980|7574404|FG002|Double-blind Period|Lost to Follow-up|8
4675541|NCT02371980|7574405|FG003|Double-blind Period|Lost to Follow-up|6
4675542|NCT02371980|7574406|FG004|Double-blind Period|Lost to Follow-up|5
4675543|NCT02371980|7574402|FG000|Double-blind Period|Voluntary Withdrawal|0
4675544|NCT02371980|7574403|FG001|Double-blind Period|Voluntary Withdrawal|12
4675545|NCT02371980|7574404|FG002|Double-blind Period|Voluntary Withdrawal|8
4675546|NCT02371980|7574405|FG003|Double-blind Period|Voluntary Withdrawal|9
4675547|NCT02371980|7574406|FG004|Double-blind Period|Voluntary Withdrawal|11
4675548|NCT02371980|7574402|FG000|Double-blind Period|Relapse|0
4675549|NCT02371980|7574403|FG001|Double-blind Period|Relapse|50
4675550|NCT02371980|7574404|FG002|Double-blind Period|Relapse|25
4675551|NCT02371980|7574405|FG003|Double-blind Period|Relapse|25
4675552|NCT02371980|7574406|FG004|Double-blind Period|Relapse|26
4675553|NCT02371980|7574402|FG000|Double-blind Period|Reason not Specified|0
4675554|NCT02371980|7574403|FG001|Double-blind Period|Reason not Specified|3
4675555|NCT02371980|7574404|FG002|Double-blind Period|Reason not Specified|3
4675556|NCT02371980|7574405|FG003|Double-blind Period|Reason not Specified|2
4675557|NCT02371980|7574406|FG004|Double-blind Period|Reason not Specified|1
4675558|NCT02371980|7574402|FG000|Double-blind Period|Missing|0
4675559|NCT02371980|7574403|FG001|Double-blind Period|Missing|1
4675560|NCT02371980|7574404|FG002|Double-blind Period|Missing|0
4675561|NCT02371980|7574405|FG003|Double-blind Period|Missing|0
4675562|NCT02371980|7574406|FG004|Double-blind Period|Missing|0
4675563|NCT02372006|7574420|FG000|Overall Study|Progressive disease|8
4675564|NCT02372006|7574421|FG001|Overall Study|Progressive disease|7
4675565|NCT02372006|7574422|FG002|Overall Study|Progressive disease|34
4675566|NCT02372006|7574420|FG000|Overall Study|Dose limiting toxicity|0
4675567|NCT02372006|7574421|FG001|Overall Study|Dose limiting toxicity|1
4675568|NCT02372006|7574422|FG002|Overall Study|Dose limiting toxicity|0
4675569|NCT02372006|7574420|FG000|Overall Study|Adverse Event|0
4675570|NCT02372006|7574421|FG001|Overall Study|Adverse Event|0
4675571|NCT02372006|7574422|FG002|Overall Study|Adverse Event|3
4675572|NCT02372006|7574420|FG000|Overall Study|Withdrawal by Subject|0
4675573|NCT02372006|7574421|FG001|Overall Study|Withdrawal by Subject|1
4675574|NCT02372006|7574422|FG002|Overall Study|Withdrawal by Subject|1
4675575|NCT02372006|7574420|FG000|Overall Study|Other reason for not completing|0
4675576|NCT02372006|7574421|FG001|Overall Study|Other reason for not completing|0
4675577|NCT02372006|7574422|FG002|Overall Study|Other reason for not completing|1
4675578|NCT02372058|7574431|FG000|Overall Study|Withdrawal by Subject|3
4675579|NCT02372071|7574437|FG000|Overall Study|Protocol Violation|18
4675580|NCT02372136|7574453|FG000|Overall Study|Death|3
4675581|NCT02372136|7574454|FG001|Overall Study|Death|1
4675582|NCT02372253|7574464|FG000|Overall Study|Non Compliance|2
4675583|NCT02372253|7574465|FG001|Overall Study|Non Compliance|0
4675584|NCT02372383|7574485|FG000|First Intervention (1 Day)|Unable to collect blood|0
4675585|NCT02372383|7574486|FG001|First Intervention (1 Day)|Unable to collect blood|1
4675586|NCT02372383|7574487|FG002|First Intervention (1 Day)|Unable to collect blood|0
4675587|NCT02372396|7574499|FG000|Overall Study|Lost to Follow-up|7
4675588|NCT02372396|7574500|FG001|Overall Study|Lost to Follow-up|9
4675589|NCT02372799|7574525|FG000|Treatment Period|Adverse Event|3
4675590|NCT02372799|7574526|FG001|Treatment Period|Adverse Event|10
4675591|NCT02372799|7574527|FG002|Treatment Period|Adverse Event|6
4675592|NCT02372799|7574525|FG000|Treatment Period|Insufficient therapeutic response|2
4675593|NCT02372799|7574526|FG001|Treatment Period|Insufficient therapeutic response|2
4675594|NCT02372799|7574527|FG002|Treatment Period|Insufficient therapeutic response|0
4675595|NCT02372799|7574525|FG000|Treatment Period|Withdrawal by Subject|10
4675596|NCT02372799|7574526|FG001|Treatment Period|Withdrawal by Subject|10
4675597|NCT02372799|7574527|FG002|Treatment Period|Withdrawal by Subject|2
4675598|NCT02372799|7574525|FG000|Treatment Period|Lost to Follow-up|11
4675599|NCT02372799|7574526|FG001|Treatment Period|Lost to Follow-up|5
4675600|NCT02372799|7574527|FG002|Treatment Period|Lost to Follow-up|3
4675601|NCT02372799|7574525|FG000|Treatment Period|Protocol Violation|3
4675602|NCT02372799|7574526|FG001|Treatment Period|Protocol Violation|0
4675603|NCT02372799|7574527|FG002|Treatment Period|Protocol Violation|0
4675604|NCT02372799|7574525|FG000|Treatment Period|Non-compliance with study drug|4
4675605|NCT02372799|7574526|FG001|Treatment Period|Non-compliance with study drug|4
4675606|NCT02372799|7574527|FG002|Treatment Period|Non-compliance with study drug|4
4675607|NCT02372799|7574525|FG000|Treatment Period|Miscellaneous Reasons|1
4675608|NCT02372799|7574526|FG001|Treatment Period|Miscellaneous Reasons|1
4675609|NCT02372799|7574527|FG002|Treatment Period|Miscellaneous Reasons|0
4675610|NCT02372799|7574525|FG000|Down-taper Period|Lost to Follow-up|1
4675611|NCT02372799|7574526|FG001|Down-taper Period|Lost to Follow-up|2
4675612|NCT02372799|7574527|FG002|Down-taper Period|Lost to Follow-up|2
4675613|NCT02373098|7574537|FG000|Overall Study|Lost to Follow-up|1
4675614|NCT02373098|7574538|FG001|Overall Study|Lost to Follow-up|0
4675615|NCT02373098|7574537|FG000|Overall Study|Protocol Violation|3
4675616|NCT02373098|7574538|FG001|Overall Study|Protocol Violation|0
4675617|NCT02373098|7574537|FG000|Overall Study|Withdrawal by Subject|5
4675618|NCT02373098|7574538|FG001|Overall Study|Withdrawal by Subject|0
4675619|NCT02373098|7574537|FG000|Overall Study|Adverse Event|3
4675620|NCT02373098|7574538|FG001|Overall Study|Adverse Event|0
4675621|NCT02373202|7574568|FG000|Overall Study|Adverse Event|2
4756957|NCT01921218|7731337|FG000|Overall Study|Death|2
4756958|NCT01921218|7731338|FG001|Overall Study|Death|1
4756959|NCT01921218|7731337|FG000|Overall Study|Withdrawal by Subject|0
4756960|NCT01921218|7731338|FG001|Overall Study|Withdrawal by Subject|2
4756961|NCT01921218|7731337|FG000|Overall Study|Kidney transplant|1
4756962|NCT01921218|7731338|FG001|Overall Study|Kidney transplant|1
4756991|NCT01945021|7731388|FG000|Overall Study|Lost to Follow-up|5
4756992|NCT01945021|7731388|FG000|Overall Study|Death|65
4675622|NCT02373202|7574569|FG001|Overall Study|Adverse Event|5
4675623|NCT02373202|7574570|FG002|Overall Study|Adverse Event|2
4675624|NCT02373202|7574571|FG003|Overall Study|Adverse Event|1
4675625|NCT02373202|7574568|FG000|Overall Study|Lack of Efficacy|0
4675626|NCT02373202|7574569|FG001|Overall Study|Lack of Efficacy|0
4675627|NCT02373202|7574570|FG002|Overall Study|Lack of Efficacy|1
4675628|NCT02373202|7574571|FG003|Overall Study|Lack of Efficacy|0
4675629|NCT02373202|7574568|FG000|Overall Study|Other|0
4675630|NCT02373202|7574569|FG001|Overall Study|Other|1
4675631|NCT02373202|7574570|FG002|Overall Study|Other|0
4675632|NCT02373202|7574571|FG003|Overall Study|Other|0
4675633|NCT02373813|7574593|FG000|Run-In Period|Other, Not Specified|5
4675634|NCT02373813|7574594|FG001|Run-In Period|Other, Not Specified|0
4675635|NCT02373813|7574595|FG002|Run-In Period|Other, Not Specified|0
4675636|NCT02373813|7574596|FG003|Run-In Period|Other, Not Specified|0
4675637|NCT02373813|7574593|FG000|Run-In Period|Withdrawal by Subject|16
4675638|NCT02373813|7574594|FG001|Run-In Period|Withdrawal by Subject|0
4675639|NCT02373813|7574595|FG002|Run-In Period|Withdrawal by Subject|0
4675640|NCT02373813|7574596|FG003|Run-In Period|Withdrawal by Subject|0
4675641|NCT02373813|7574593|FG000|Run-In Period|Decision by Sponsor|11
4675642|NCT02373813|7574594|FG001|Run-In Period|Decision by Sponsor|0
4675643|NCT02373813|7574595|FG002|Run-In Period|Decision by Sponsor|0
4675644|NCT02373813|7574596|FG003|Run-In Period|Decision by Sponsor|0
4675645|NCT02373813|7574593|FG000|Run-In Period|Protocol Violation|75
4675646|NCT02373813|7574594|FG001|Run-In Period|Protocol Violation|0
4675647|NCT02373813|7574595|FG002|Run-In Period|Protocol Violation|0
4675648|NCT02373813|7574596|FG003|Run-In Period|Protocol Violation|0
4675649|NCT02373813|7574593|FG000|Run-In Period|Lost to Follow-up|2
4675650|NCT02373813|7574594|FG001|Run-In Period|Lost to Follow-up|0
4675651|NCT02373813|7574595|FG002|Run-In Period|Lost to Follow-up|0
4675652|NCT02373813|7574596|FG003|Run-In Period|Lost to Follow-up|0
4675653|NCT02373813|7574593|FG000|Run-In Period|Adverse Event|3
4675654|NCT02373813|7574594|FG001|Run-In Period|Adverse Event|0
4675655|NCT02373813|7574595|FG002|Run-In Period|Adverse Event|0
4675656|NCT02373813|7574596|FG003|Run-In Period|Adverse Event|0
4675657|NCT02373813|7574593|FG000|Run-In Period|Noncompliance|1
4675658|NCT02373813|7574594|FG001|Run-In Period|Noncompliance|0
4675659|NCT02373813|7574595|FG002|Run-In Period|Noncompliance|0
4756963|NCT01923168|7731347|FG000|Overall Study|Protocol Violation|1
4756964|NCT01923168|7731348|FG001|Overall Study|Protocol Violation|1
4756965|NCT01923168|7731349|FG002|Overall Study|Protocol Violation|0
4756966|NCT01923168|7731347|FG000|Overall Study|Subject/guardian decision|14
4756967|NCT01923168|7731348|FG001|Overall Study|Subject/guardian decision|14
4756968|NCT01923168|7731349|FG002|Overall Study|Subject/guardian decision|4
4756969|NCT01923168|7731347|FG000|Overall Study|Adverse Event|12
4756970|NCT01923168|7731348|FG001|Overall Study|Adverse Event|12
4756971|NCT01923168|7731349|FG002|Overall Study|Adverse Event|0
4756972|NCT01923168|7731347|FG000|Overall Study|Physician Decision|6
4756973|NCT01923168|7731348|FG001|Overall Study|Physician Decision|9
4756974|NCT01923168|7731349|FG002|Overall Study|Physician Decision|5
4756975|NCT01923168|7731347|FG000|Overall Study|Progressive disease|4
4756976|NCT01923168|7731348|FG001|Overall Study|Progressive disease|3
4756977|NCT01923168|7731349|FG002|Overall Study|Progressive disease|7
4756978|NCT01923168|7731347|FG000|Overall Study|Death|0
4756979|NCT01923168|7731348|FG001|Overall Study|Death|0
4756980|NCT01923168|7731349|FG002|Overall Study|Death|1
4756993|NCT01956669|7731399|FG000|Overall Study|Disease Progression|12
4756994|NCT01956669|7731400|FG001|Overall Study|Disease Progression|7
4756995|NCT01956669|7731401|FG002|Overall Study|Disease Progression|7
4756996|NCT01956669|7731402|FG003|Overall Study|Disease Progression|8
4756997|NCT01956669|7731403|FG004|Overall Study|Disease Progression|4
4756998|NCT01956669|7731404|FG005|Overall Study|Disease Progression|3
4756999|NCT01956669|7731405|FG006|Overall Study|Disease Progression|5
4675660|NCT02373813|7574596|FG003|Run-In Period|Noncompliance|0
4675661|NCT02373813|7574593|FG000|Run-In Period|Ineligibility Determined|3
4675662|NCT02373813|7574594|FG001|Run-In Period|Ineligibility Determined|0
4675663|NCT02373813|7574595|FG002|Run-In Period|Ineligibility Determined|0
4675664|NCT02373813|7574596|FG003|Run-In Period|Ineligibility Determined|0
4675665|NCT02373813|7574593|FG000|Double-Blind Treatment Period|Decision by Sponsor|0
4675666|NCT02373813|7574594|FG001|Double-Blind Treatment Period|Decision by Sponsor|1
4675667|NCT02373813|7574595|FG002|Double-Blind Treatment Period|Decision by Sponsor|2
4675668|NCT02373813|7574596|FG003|Double-Blind Treatment Period|Decision by Sponsor|0
4675669|NCT02373813|7574593|FG000|Double-Blind Treatment Period|Protocol Violation|0
4675670|NCT02373813|7574594|FG001|Double-Blind Treatment Period|Protocol Violation|2
4675671|NCT02373813|7574595|FG002|Double-Blind Treatment Period|Protocol Violation|0
4675672|NCT02373813|7574596|FG003|Double-Blind Treatment Period|Protocol Violation|0
4675673|NCT02373813|7574593|FG000|Double-Blind Treatment Period|Lost to Follow-up|0
4675674|NCT02373813|7574594|FG001|Double-Blind Treatment Period|Lost to Follow-up|0
4675675|NCT02373813|7574595|FG002|Double-Blind Treatment Period|Lost to Follow-up|1
4675676|NCT02373813|7574596|FG003|Double-Blind Treatment Period|Lost to Follow-up|1
4675677|NCT02373813|7574593|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0
4675678|NCT02373813|7574594|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10
4675679|NCT02373813|7574595|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6
4675680|NCT02373813|7574596|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3
4757000|NCT01956669|7731399|FG000|Overall Study|Adverse Event|0
4675681|NCT02374099|7574626|FG000|Overall Study|Adverse Event|1
4757001|NCT01956669|7731400|FG001|Overall Study|Adverse Event|2
4757002|NCT01956669|7731401|FG002|Overall Study|Adverse Event|2
4757003|NCT01956669|7731402|FG003|Overall Study|Adverse Event|1
4675682|NCT02374099|7574627|FG001|Overall Study|Adverse Event|0
4675683|NCT02374099|7574626|FG000|Overall Study|Progressive Disease|35
4675684|NCT02374099|7574627|FG001|Overall Study|Progressive Disease|40
4675685|NCT02374099|7574626|FG000|Overall Study|Withdrawal by Subject|5
4675686|NCT02374099|7574627|FG001|Overall Study|Withdrawal by Subject|1
4675687|NCT02374099|7574626|FG000|Overall Study|Miscellaneous|2
4675688|NCT02374099|7574627|FG001|Overall Study|Miscellaneous|3
4675689|NCT02374099|7574626|FG000|Overall Study|Randomized, but not treated|2
4675690|NCT02374099|7574627|FG001|Overall Study|Randomized, but not treated|1
4675691|NCT02374099|7574626|FG000|Overall Study|Study Terminated by Sponsor|3
4675692|NCT02374099|7574627|FG001|Overall Study|Study Terminated by Sponsor|4
4675693|NCT02374255|7574660|FG000|Overall Study|Withdrawal by Subject|2
4675694|NCT02374255|7574661|FG001|Overall Study|Withdrawal by Subject|0
4675695|NCT02374255|7574662|FG002|Overall Study|Withdrawal by Subject|0
4675696|NCT02374255|7574663|FG003|Overall Study|Withdrawal by Subject|0
4675697|NCT02374307|7574681|FG000|3-months Follow-up|Lost to Follow-up|1
4675698|NCT02374307|7574682|FG001|3-months Follow-up|Lost to Follow-up|2
4675699|NCT02374307|7574681|FG000|3-months Follow-up|Withdrawal by Subject|1
4675700|NCT02374307|7574682|FG001|3-months Follow-up|Withdrawal by Subject|4
4675701|NCT02374307|7574681|FG000|3-months Follow-up|Death|1
4675702|NCT02374307|7574682|FG001|3-months Follow-up|Death|2
4675703|NCT02374307|7574681|FG000|3-months Follow-up|Missed first follow-up|5
4675704|NCT02374307|7574682|FG001|3-months Follow-up|Missed first follow-up|1
4675705|NCT02374307|7574681|FG000|6-months Follow-up|Lost to Follow-up|1
4675706|NCT02374307|7574682|FG001|6-months Follow-up|Lost to Follow-up|2
4675707|NCT02374307|7574681|FG000|6-months Follow-up|Death|2
4675708|NCT02374307|7574682|FG001|6-months Follow-up|Death|1
4675709|NCT02374307|7574681|FG000|6-months Follow-up|Withdrawal by Subject|0
4675710|NCT02374307|7574682|FG001|6-months Follow-up|Withdrawal by Subject|3
4675711|NCT02374346|7574688|FG000|Overall Study|operated or discharged during weekend|48
4675712|NCT02374463|7574714|FG000|Overall Study|Withdrawal by Subject|3
4675713|NCT02374463|7574715|FG001|Overall Study|Withdrawal by Subject|3
4675714|NCT02374593|7574724|FG000|Overall Study|non-compliant|2
4675715|NCT02374593|7574725|FG001|Overall Study|non-compliant|0
4675716|NCT02374671|7574738|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0
4675717|NCT02374671|7574739|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0
4675718|NCT02374671|7574740|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4
4675719|NCT02374671|7574738|FG000|Observation (Deferred Implantation)|Adverse Event|0
4675720|NCT02374671|7574739|FG001|Observation (Deferred Implantation)|Adverse Event|0
4675721|NCT02374671|7574740|FG002|Observation (Deferred Implantation)|Adverse Event|1
4675722|NCT02374671|7574738|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17
4756981|NCT01931098|7731379|FG000|Overall Study|Withdrawal by Subject|0
4756982|NCT01931098|7731380|FG001|Overall Study|Withdrawal by Subject|1
4756983|NCT01931098|7731379|FG000|Overall Study|Enrolled in different protocol|0
4756984|NCT01931098|7731380|FG001|Overall Study|Enrolled in different protocol|1
4756985|NCT01931098|7731379|FG000|Overall Study|Unable to begin trmt:active infection|0
4756986|NCT01931098|7731380|FG001|Overall Study|Unable to begin trmt:active infection|1
4756987|NCT01931098|7731379|FG000|Overall Study|Refused further treatment|0
4756988|NCT01931098|7731380|FG001|Overall Study|Refused further treatment|1
4757004|NCT01956669|7731403|FG004|Overall Study|Adverse Event|0
4757005|NCT01956669|7731404|FG005|Overall Study|Adverse Event|0
4757006|NCT01956669|7731405|FG006|Overall Study|Adverse Event|0
4757007|NCT01956669|7731399|FG000|Overall Study|Physician Decision|0
4757008|NCT01956669|7731400|FG001|Overall Study|Physician Decision|2
4757009|NCT01956669|7731401|FG002|Overall Study|Physician Decision|0
4757010|NCT01956669|7731402|FG003|Overall Study|Physician Decision|0
4757011|NCT01956669|7731403|FG004|Overall Study|Physician Decision|0
4757012|NCT01956669|7731404|FG005|Overall Study|Physician Decision|1
4757013|NCT01956669|7731405|FG006|Overall Study|Physician Decision|0
4757014|NCT01956669|7731399|FG000|Overall Study|Withdrawal by Subject|0
4757015|NCT01956669|7731400|FG001|Overall Study|Withdrawal by Subject|0
4757016|NCT01956669|7731401|FG002|Overall Study|Withdrawal by Subject|1
4757017|NCT01956669|7731402|FG003|Overall Study|Withdrawal by Subject|1
4757018|NCT01956669|7731403|FG004|Overall Study|Withdrawal by Subject|0
4757019|NCT01956669|7731404|FG005|Overall Study|Withdrawal by Subject|0
4757020|NCT01956669|7731405|FG006|Overall Study|Withdrawal by Subject|1
4675723|NCT02374671|7574739|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1
4675724|NCT02374671|7574740|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2
4675725|NCT02374671|7574738|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7
4675726|NCT02374671|7574739|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0
4675727|NCT02374671|7574740|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1
4675728|NCT02374671|7574738|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1
4675729|NCT02374671|7574739|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0
4675730|NCT02374671|7574740|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0
4675731|NCT02374918|7574750|FG000|Overall Study|Protocol Violation|2
4675732|NCT02374918|7574751|FG001|Overall Study|Protocol Violation|0
4675733|NCT02374918|7574752|FG002|Overall Study|Protocol Violation|2
4675734|NCT02374918|7574753|FG003|Overall Study|Protocol Violation|1
4675735|NCT02374918|7574750|FG000|Overall Study|Withdrawal by Subject|1
4675736|NCT02374918|7574751|FG001|Overall Study|Withdrawal by Subject|1
4675737|NCT02374918|7574752|FG002|Overall Study|Withdrawal by Subject|1
4675738|NCT02374918|7574753|FG003|Overall Study|Withdrawal by Subject|0
4675739|NCT02374918|7574750|FG000|Overall Study|Lack of Efficacy|0
4675740|NCT02374918|7574751|FG001|Overall Study|Lack of Efficacy|0
4675741|NCT02374918|7574752|FG002|Overall Study|Lack of Efficacy|1
4675742|NCT02374918|7574753|FG003|Overall Study|Lack of Efficacy|1
4675743|NCT02374957|7574763|FG000|Overall Study|Patient did not complete forms correctly|1
4757021|NCT01967823|7731430|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1
4757022|NCT01989676|7731440|FG000|Overall Study|Death|52
4757023|NCT01989676|7731441|FG001|Overall Study|Death|60
4757024|NCT01989676|7731440|FG000|Overall Study|Protocol Violation|2
4757025|NCT01989676|7731441|FG001|Overall Study|Protocol Violation|1
4757026|NCT01989676|7731440|FG000|Overall Study|Lost to Follow-up|8
4757027|NCT01989676|7731441|FG001|Overall Study|Lost to Follow-up|18
4757028|NCT01989676|7731440|FG000|Overall Study|No longer willing to participate in study|26
4757029|NCT01989676|7731441|FG001|Overall Study|No longer willing to participate in study|26
4757030|NCT01989676|7731440|FG000|Overall Study|Participants terminated from study by Sponsor|26
4757031|NCT01989676|7731441|FG001|Overall Study|Participants terminated from study by Sponsor|30
4757032|NCT01989676|7731440|FG000|Overall Study|Other|4
4757033|NCT01989676|7731441|FG001|Overall Study|Other|3
4757034|NCT01992653|7731456|FG000|Overall Study|Death|0
4757035|NCT01992653|7731457|FG001|Overall Study|Death|0
4757036|NCT01992653|7731458|FG002|Overall Study|Death|1
4757037|NCT01992653|7731459|FG003|Overall Study|Death|0
4757038|NCT01992653|7731460|FG004|Overall Study|Death|1
4757039|NCT01992653|7731461|FG005|Overall Study|Death|0
4757040|NCT01992653|7731462|FG006|Overall Study|Death|4
4757041|NCT01992653|7731463|FG007|Overall Study|Death|2
4757042|NCT01992653|7731456|FG000|Overall Study|Lost to Follow-up|0
4757043|NCT01992653|7731457|FG001|Overall Study|Lost to Follow-up|0
4757044|NCT01992653|7731458|FG002|Overall Study|Lost to Follow-up|0
4757045|NCT01992653|7731459|FG003|Overall Study|Lost to Follow-up|0
4757046|NCT01992653|7731460|FG004|Overall Study|Lost to Follow-up|0
4757047|NCT01992653|7731461|FG005|Overall Study|Lost to Follow-up|0
4757048|NCT01992653|7731462|FG006|Overall Study|Lost to Follow-up|0
4757049|NCT01992653|7731463|FG007|Overall Study|Lost to Follow-up|1
4757050|NCT01992653|7731456|FG000|Overall Study|Study Completed|0
4757051|NCT01992653|7731457|FG001|Overall Study|Study Completed|0
4757052|NCT01992653|7731458|FG002|Overall Study|Study Completed|0
4757053|NCT01992653|7731459|FG003|Overall Study|Study Completed|0
4757054|NCT01992653|7731460|FG004|Overall Study|Study Completed|0
4757055|NCT01992653|7731461|FG005|Overall Study|Study Completed|0
4757056|NCT01992653|7731462|FG006|Overall Study|Study Completed|0
4757057|NCT01992653|7731463|FG007|Overall Study|Study Completed|1
4757058|NCT01992653|7731456|FG000|Overall Study|Disease Progression|0
4757059|NCT01992653|7731457|FG001|Overall Study|Disease Progression|0
4757060|NCT01992653|7731458|FG002|Overall Study|Disease Progression|0
4757061|NCT01992653|7731459|FG003|Overall Study|Disease Progression|0
4757062|NCT01992653|7731460|FG004|Overall Study|Disease Progression|0
4675744|NCT02374957|7574764|FG001|Overall Study|Patient did not complete forms correctly|0
4675745|NCT02375347|7574770|FG000|Overall Study|Protocol Violation|1
4675746|NCT02375373|7574774|FG000|Overall Study|Withdrawal by Subject|11
4675747|NCT02375698|7574780|FG000|Overall Study|Withdrawal by Subject|0
4675748|NCT02375698|7574781|FG001|Overall Study|Withdrawal by Subject|2
4675749|NCT02375698|7574780|FG000|Overall Study|Physician Decision|2
4675750|NCT02375698|7574781|FG001|Overall Study|Physician Decision|0
4675751|NCT02375724|7574789|FG000|Overall Study|Lack of Efficacy|1
4675752|NCT02375724|7574790|FG001|Overall Study|Lack of Efficacy|1
4675753|NCT02375724|7574789|FG000|Overall Study|Withdrawal by Subject|1
4675754|NCT02375724|7574790|FG001|Overall Study|Withdrawal by Subject|1
4675755|NCT02375724|7574789|FG000|Overall Study|Lost to Follow-up|1
4675756|NCT02375724|7574790|FG001|Overall Study|Lost to Follow-up|0
4675757|NCT02375724|7574789|FG000|Overall Study|Protocol Violation|1
4675758|NCT02375724|7574790|FG001|Overall Study|Protocol Violation|0
4757063|NCT01992653|7731461|FG005|Overall Study|Disease Progression|0
4757064|NCT01992653|7731462|FG006|Overall Study|Disease Progression|4
4757065|NCT01992653|7731463|FG007|Overall Study|Disease Progression|0
4757066|NCT02001974|7731484|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2
4757067|NCT02001974|7731485|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3
4757068|NCT02001974|7731486|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14
4757069|NCT02001974|7731484|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1
4675759|NCT02375724|7574789|FG000|Overall Study|Adverse Event|2
4675760|NCT02375724|7574790|FG001|Overall Study|Adverse Event|4
4675761|NCT02375971|7574799|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0
4675762|NCT02375971|7574800|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0
4675763|NCT02375971|7574801|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2
4675764|NCT02375971|7574799|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1
4675765|NCT02375971|7574800|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1
4675766|NCT02375971|7574801|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1
4675767|NCT02375971|7574799|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0
4675768|NCT02375971|7574800|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0
4675769|NCT02375971|7574801|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1
4675770|NCT02375971|7574799|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0
4675771|NCT02375971|7574800|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0
4675772|NCT02375971|7574801|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1
4675773|NCT02375971|7574799|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1
4675774|NCT02375971|7574800|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0
4675775|NCT02375971|7574801|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0
4675776|NCT02375971|7574799|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1
4675777|NCT02375971|7574800|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0
4675778|NCT02375971|7574801|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1
4675779|NCT02375971|7574799|FG000|Follow-Up Phase (up to Day 169)|Death|4
4675780|NCT02375971|7574800|FG001|Follow-Up Phase (up to Day 169)|Death|4
4675781|NCT02375971|7574801|FG002|Follow-Up Phase (up to Day 169)|Death|4
4675782|NCT02375971|7574799|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1
4675783|NCT02375971|7574800|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1
4675784|NCT02375971|7574801|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0
4675785|NCT02376166|7574822|FG000|Overall Study|Adverse Event|1
4675786|NCT02376166|7574822|FG000|Overall Study|Discontinued metformin early|2
4675787|NCT02376790|7574886|FG000|Overall Study|Withdrawal by Subject|43
4675788|NCT02376790|7574887|FG001|Overall Study|Withdrawal by Subject|36
4675789|NCT02376790|7574888|FG002|Overall Study|Withdrawal by Subject|37
4675790|NCT02376790|7574886|FG000|Overall Study|Decision by Sponsor|2
4675791|NCT02376790|7574887|FG001|Overall Study|Decision by Sponsor|1
4675792|NCT02376790|7574888|FG002|Overall Study|Decision by Sponsor|4
4675793|NCT02376790|7574886|FG000|Overall Study|Lost to Follow-up|15
4675794|NCT02376790|7574887|FG001|Overall Study|Lost to Follow-up|10
4675795|NCT02376790|7574888|FG002|Overall Study|Lost to Follow-up|12
4675796|NCT02377063|7574900|FG000|Overall Study|Non-compliance|5
4675797|NCT02377349|7574906|FG000|Overall Study|Serious Adverse Event|1
4675798|NCT02377349|7574907|FG001|Overall Study|Serious Adverse Event|0
4675799|NCT02377349|7574906|FG000|Overall Study|Protocol Violation|3
4675800|NCT02377349|7574907|FG001|Overall Study|Protocol Violation|2
4675801|NCT02377349|7574906|FG000|Overall Study|Withdrawal by Subject|5
4675802|NCT02377349|7574907|FG001|Overall Study|Withdrawal by Subject|3
4675803|NCT02377349|7574906|FG000|Overall Study|Lost to follow-up (partial vaccination)|1
4675804|NCT02377349|7574907|FG001|Overall Study|Lost to follow-up (partial vaccination)|0
4675805|NCT02377349|7574906|FG000|Overall Study|Lost to follow-up (complete vaccination)|6
4675806|NCT02377349|7574907|FG001|Overall Study|Lost to follow-up (complete vaccination)|5
4675807|NCT02377349|7574906|FG000|Overall Study|Other|0
4675808|NCT02377349|7574907|FG001|Overall Study|Other|1
4675809|NCT02377362|7574935|FG000|Part A Second Treatment|Protocol Violation|0
4675810|NCT02377362|7574936|FG001|Part A Second Treatment|Protocol Violation|0
4675811|NCT02377362|7574937|FG002|Part A Second Treatment|Protocol Violation|0
4675812|NCT02377362|7574938|FG003|Part A Second Treatment|Protocol Violation|0
4675813|NCT02377362|7574939|FG004|Part A Second Treatment|Protocol Violation|1
4675814|NCT02377362|7574940|FG005|Part A Second Treatment|Protocol Violation|0
4675815|NCT02377362|7574941|FG006|Part A Second Treatment|Protocol Violation|0
4675816|NCT02377362|7574942|FG007|Part A Second Treatment|Protocol Violation|0
4675817|NCT02377362|7574943|FG008|Part A Second Treatment|Protocol Violation|0
4675818|NCT02377362|7574944|FG009|Part A Second Treatment|Protocol Violation|0
4675819|NCT02377362|7574945|FG010|Part A Second Treatment|Protocol Violation|0
4675820|NCT02377362|7574946|FG011|Part A Second Treatment|Protocol Violation|0
4675821|NCT02377362|7574947|FG012|Part A Second Treatment|Protocol Violation|0
4675822|NCT02377362|7574935|FG000|Part A Third Treatment|Highest dose level 1200 not used|0
4675823|NCT02377362|7574936|FG001|Part A Third Treatment|Highest dose level 1200 not used|0
4675824|NCT02377362|7574937|FG002|Part A Third Treatment|Highest dose level 1200 not used|0
4675825|NCT02377362|7574938|FG003|Part A Third Treatment|Highest dose level 1200 not used|4
4675826|NCT02377362|7574939|FG004|Part A Third Treatment|Highest dose level 1200 not used|3
4675827|NCT02377362|7574940|FG005|Part A Third Treatment|Highest dose level 1200 not used|4
4675828|NCT02377362|7574941|FG006|Part A Third Treatment|Highest dose level 1200 not used|0
4675829|NCT02377362|7574942|FG007|Part A Third Treatment|Highest dose level 1200 not used|0
4675830|NCT02377362|7574943|FG008|Part A Third Treatment|Highest dose level 1200 not used|0
4675831|NCT02377362|7574944|FG009|Part A Third Treatment|Highest dose level 1200 not used|0
4675832|NCT02377362|7574945|FG010|Part A Third Treatment|Highest dose level 1200 not used|0
4675833|NCT02377362|7574946|FG011|Part A Third Treatment|Highest dose level 1200 not used|0
4757070|NCT02001974|7731485|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0
4675834|NCT02377362|7574947|FG012|Part A Third Treatment|Highest dose level 1200 not used|0
4675835|NCT02377362|7574935|FG000|Part B Overall|Protocol Violation|0
4675836|NCT02377362|7574936|FG001|Part B Overall|Protocol Violation|0
4675837|NCT02377362|7574937|FG002|Part B Overall|Protocol Violation|0
4675838|NCT02377362|7574938|FG003|Part B Overall|Protocol Violation|0
4675839|NCT02377362|7574939|FG004|Part B Overall|Protocol Violation|0
4675840|NCT02377362|7574940|FG005|Part B Overall|Protocol Violation|0
4675841|NCT02377362|7574941|FG006|Part B Overall|Protocol Violation|0
4675842|NCT02377362|7574942|FG007|Part B Overall|Protocol Violation|0
4675843|NCT02377362|7574943|FG008|Part B Overall|Protocol Violation|0
4675844|NCT02377362|7574944|FG009|Part B Overall|Protocol Violation|1
4675845|NCT02377362|7574945|FG010|Part B Overall|Protocol Violation|0
4675846|NCT02377362|7574946|FG011|Part B Overall|Protocol Violation|0
4675847|NCT02377362|7574947|FG012|Part B Overall|Protocol Violation|0
4757071|NCT02001974|7731486|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4
4757072|NCT02001974|7731484|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1
4757073|NCT02001974|7731485|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0
4757074|NCT02001974|7731486|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6
4757075|NCT02001974|7731484|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0
4757076|NCT02001974|7731485|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0
4757077|NCT02001974|7731486|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2
4675848|NCT02377362|7574935|FG000|Part B Overall|Adverse Event|0
4675849|NCT02377362|7574936|FG001|Part B Overall|Adverse Event|0
4675850|NCT02377362|7574937|FG002|Part B Overall|Adverse Event|0
4675851|NCT02377362|7574938|FG003|Part B Overall|Adverse Event|0
4675852|NCT02377362|7574939|FG004|Part B Overall|Adverse Event|0
4675853|NCT02377362|7574940|FG005|Part B Overall|Adverse Event|0
4675854|NCT02377362|7574941|FG006|Part B Overall|Adverse Event|1
4675855|NCT02377362|7574942|FG007|Part B Overall|Adverse Event|1
4675856|NCT02377362|7574943|FG008|Part B Overall|Adverse Event|0
4675857|NCT02377362|7574944|FG009|Part B Overall|Adverse Event|0
4675858|NCT02377362|7574945|FG010|Part B Overall|Adverse Event|0
4675859|NCT02377362|7574946|FG011|Part B Overall|Adverse Event|0
4675860|NCT02377362|7574947|FG012|Part B Overall|Adverse Event|0
4675861|NCT02377362|7574935|FG000|Part B Overall|Withdrawal by Subject|0
4675862|NCT02377362|7574936|FG001|Part B Overall|Withdrawal by Subject|0
4675863|NCT02377362|7574937|FG002|Part B Overall|Withdrawal by Subject|0
4675864|NCT02377362|7574938|FG003|Part B Overall|Withdrawal by Subject|0
4675865|NCT02377362|7574939|FG004|Part B Overall|Withdrawal by Subject|0
4675866|NCT02377362|7574940|FG005|Part B Overall|Withdrawal by Subject|0
4675867|NCT02377362|7574941|FG006|Part B Overall|Withdrawal by Subject|1
4675868|NCT02377362|7574942|FG007|Part B Overall|Withdrawal by Subject|0
4675869|NCT02377362|7574943|FG008|Part B Overall|Withdrawal by Subject|0
4675870|NCT02377362|7574944|FG009|Part B Overall|Withdrawal by Subject|0
4675871|NCT02377362|7574945|FG010|Part B Overall|Withdrawal by Subject|0
4675872|NCT02377362|7574946|FG011|Part B Overall|Withdrawal by Subject|1
4675873|NCT02377362|7574947|FG012|Part B Overall|Withdrawal by Subject|0
4675874|NCT02377427|7574987|FG000|Part A (Up to Week 20)|Physician Decision|1
4675875|NCT02377427|7574988|FG001|Part A (Up to Week 20)|Physician Decision|0
4675876|NCT02377427|7574989|FG002|Part A (Up to Week 20)|Physician Decision|0
4675877|NCT02377427|7574990|FG003|Part A (Up to Week 20)|Physician Decision|0
4675878|NCT02377427|7574991|FG004|Part A (Up to Week 20)|Physician Decision|0
4675879|NCT02377427|7574987|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1
4675880|NCT02377427|7574988|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
4675881|NCT02377427|7574989|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
4675882|NCT02377427|7574990|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
4675883|NCT02377427|7574991|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
4675884|NCT02377427|7574987|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2
4675885|NCT02377427|7574988|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0
4675886|NCT02377427|7574989|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0
4675887|NCT02377427|7574990|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0
4675888|NCT02377427|7574991|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0
4675889|NCT02377427|7574987|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
4675890|NCT02377427|7574988|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
4675891|NCT02377427|7574989|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1
4675892|NCT02377427|7574990|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
4675893|NCT02377427|7574991|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
4675894|NCT02377466|7575006|FG000|Overall Study|Other: Randomized and not treated|0
4675895|NCT02377466|7575007|FG001|Overall Study|Other: Randomized and not treated|2
4675896|NCT02377817|7575050|FG000|Overall Study|Transportation/childcare barriers.|2
4675897|NCT02377817|7575051|FG001|Overall Study|Transportation/childcare barriers.|0
4675898|NCT02377817|7575050|FG000|Overall Study|Unrelated injury prevented lateral sleep|1
4675899|NCT02377817|7575051|FG001|Overall Study|Unrelated injury prevented lateral sleep|0
4675900|NCT02377921|7575061|FG000|Overall Study|Subject non-compliance|1
4675901|NCT02377921|7575062|FG001|Overall Study|Subject non-compliance|1
4675902|NCT02378220|7575108|FG000|Overall Study|Death|6
4675903|NCT02378220|7575109|FG001|Overall Study|Death|1
4675904|NCT02378480|7575131|FG000|Overall Study|Physician Decision|1
4675905|NCT02378480|7575132|FG001|Overall Study|Physician Decision|1
4675906|NCT02378480|7575131|FG000|Overall Study|Death|1
4675907|NCT02378480|7575132|FG001|Overall Study|Death|2
4675908|NCT02378480|7575131|FG000|Overall Study|Randomized, but Not Treated|6
4675909|NCT02378480|7575132|FG001|Overall Study|Randomized, but Not Treated|4
4675910|NCT02378480|7575131|FG000|Overall Study|Adverse Event|0
4675911|NCT02378480|7575132|FG001|Overall Study|Adverse Event|1
4675912|NCT02378480|7575131|FG000|Overall Study|Missed EOT/PTE Visit|1
4675913|NCT02378480|7575132|FG001|Overall Study|Missed EOT/PTE Visit|2
4675914|NCT02378480|7575131|FG000|Overall Study|Withdrawal by Subject|9
4675915|NCT02378480|7575132|FG001|Overall Study|Withdrawal by Subject|4
4675916|NCT02378480|7575131|FG000|Overall Study|Lost to Follow-up|10
4675917|NCT02378480|7575132|FG001|Overall Study|Lost to Follow-up|18
4675918|NCT02378506|7575138|FG000|Overall Study|Lack of Efficacy|3
4675919|NCT02378506|7575138|FG000|Overall Study|Withdrawal by Subject|4
4675920|NCT02378506|7575138|FG000|Overall Study|Protocol Violation|2
4675921|NCT02378506|7575138|FG000|Overall Study|Death|1
4675922|NCT02378506|7575138|FG000|Overall Study|Adverse Event|14
4675923|NCT02378506|7575138|FG000|Overall Study|Randomized But Not Treated|1
4675924|NCT02378662|7575144|FG000|Overall Study|Early Discontinuation|2
4675925|NCT02378662|7575145|FG001|Overall Study|Early Discontinuation|0
4675926|NCT02378883|7575213|FG000|Enrollment|Subject did not meet Inclusion criteria|6
4675927|NCT02378883|7575213|FG000|Enrollment|Attempt to use Apollo was not performed|3
4757078|NCT02014558|7731507|FG000|Overall Study|Never Received Study Drug|0
4675928|NCT02378883|7575213|FG000|30 Day Follow-Up|Withdrawal by Subject|1
4675929|NCT02378883|7575213|FG000|30 Day Follow-Up|Physician Decision|2
4675930|NCT02378883|7575213|FG000|30 Day Follow-Up|Missed Visit|2
4757079|NCT02014558|7731508|FG001|Overall Study|Never Received Study Drug|0
4675931|NCT02378883|7575213|FG000|30 Day Follow-Up|Death|1
4675932|NCT02378883|7575213|FG000|12 Months Follow-Up|Lost to Follow-up|3
4675933|NCT02378883|7575213|FG000|12 Months Follow-Up|Death|2
4675934|NCT02378935|7575225|FG000|Overall Study|Lack of Efficacy|10
4675935|NCT02378935|7575226|FG001|Overall Study|Lack of Efficacy|0
4675936|NCT02378935|7575227|FG002|Overall Study|Lack of Efficacy|2
4675937|NCT02378935|7575228|FG003|Overall Study|Lack of Efficacy|6
4675938|NCT02378935|7575229|FG004|Overall Study|Lack of Efficacy|0
4675939|NCT02378935|7575230|FG005|Overall Study|Lack of Efficacy|0
4675940|NCT02378935|7575231|FG006|Overall Study|Lack of Efficacy|0
4675941|NCT02378935|7575225|FG000|Overall Study|Death|0
4675942|NCT02378935|7575226|FG001|Overall Study|Death|0
4675943|NCT02378935|7575227|FG002|Overall Study|Death|1
4675944|NCT02378935|7575228|FG003|Overall Study|Death|0
4675945|NCT02378935|7575229|FG004|Overall Study|Death|0
4675946|NCT02378935|7575230|FG005|Overall Study|Death|0
4675947|NCT02378935|7575231|FG006|Overall Study|Death|0
4675948|NCT02378961|7575251|FG000|Overall Study|Lack of Efficacy|4
4675949|NCT02378961|7575252|FG001|Overall Study|Lack of Efficacy|2
4675950|NCT02378961|7575253|FG002|Overall Study|Lack of Efficacy|0
4675951|NCT02378961|7575254|FG003|Overall Study|Lack of Efficacy|1
4675952|NCT02378961|7575251|FG000|Overall Study|Death|0
4675953|NCT02378961|7575252|FG001|Overall Study|Death|0
4675954|NCT02378961|7575253|FG002|Overall Study|Death|1
4675955|NCT02378961|7575254|FG003|Overall Study|Death|0
4675956|NCT02379052|7575266|FG000|Overall Study|Protocol Violation|0
4675957|NCT02379052|7575267|FG001|Overall Study|Protocol Violation|1
4675958|NCT02379052|7575266|FG000|Overall Study|Adverse Event|0
4675959|NCT02379052|7575267|FG001|Overall Study|Adverse Event|1
4675960|NCT02379052|7575266|FG000|Overall Study|Physician Decision|1
4675961|NCT02379052|7575267|FG001|Overall Study|Physician Decision|1
4675962|NCT02379052|7575266|FG000|Overall Study|Withdrawal by Subject|2
4675963|NCT02379052|7575267|FG001|Overall Study|Withdrawal by Subject|0
4675964|NCT02379052|7575266|FG000|Overall Study|Lost to Follow-up|2
4675965|NCT02379052|7575267|FG001|Overall Study|Lost to Follow-up|1
4675966|NCT02379052|7575266|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1
4675967|NCT02379052|7575267|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0
4675968|NCT02379052|7575266|FG000|Overall Study|Subject was Incarcerated|0
4675969|NCT02379052|7575267|FG001|Overall Study|Subject was Incarcerated|1
4757080|NCT02014558|7731509|FG002|Overall Study|Never Received Study Drug|0
4757081|NCT02014558|7731510|FG003|Overall Study|Never Received Study Drug|0
4757082|NCT02014558|7731511|FG004|Overall Study|Never Received Study Drug|1
4757083|NCT02014558|7731512|FG005|Overall Study|Never Received Study Drug|0
4757084|NCT02014558|7731513|FG006|Overall Study|Never Received Study Drug|1
4757085|NCT02014558|7731514|FG007|Overall Study|Never Received Study Drug|0
4757086|NCT02014558|7731515|FG008|Overall Study|Never Received Study Drug|2
4757087|NCT02014558|7731516|FG009|Overall Study|Never Received Study Drug|0
4757088|NCT02014558|7731517|FG010|Overall Study|Never Received Study Drug|2
4757089|NCT02014558|7731518|FG011|Overall Study|Never Received Study Drug|2
4757090|NCT02014558|7731519|FG012|Overall Study|Never Received Study Drug|0
4757091|NCT02014558|7731507|FG000|Overall Study|Adverse Event|0
4757092|NCT02014558|7731508|FG001|Overall Study|Adverse Event|0
4757093|NCT02014558|7731509|FG002|Overall Study|Adverse Event|0
4757094|NCT02014558|7731510|FG003|Overall Study|Adverse Event|0
4757095|NCT02014558|7731511|FG004|Overall Study|Adverse Event|1
4757096|NCT02014558|7731512|FG005|Overall Study|Adverse Event|0
4757097|NCT02014558|7731513|FG006|Overall Study|Adverse Event|0
4757098|NCT02014558|7731514|FG007|Overall Study|Adverse Event|0
4757099|NCT02014558|7731515|FG008|Overall Study|Adverse Event|2
4757100|NCT02014558|7731516|FG009|Overall Study|Adverse Event|2
4757101|NCT02014558|7731517|FG010|Overall Study|Adverse Event|5
4757102|NCT02014558|7731518|FG011|Overall Study|Adverse Event|21
4757103|NCT02014558|7731519|FG012|Overall Study|Adverse Event|3
4757104|NCT02014558|7731507|FG000|Overall Study|Death|1
4757105|NCT02014558|7731508|FG001|Overall Study|Death|0
4757106|NCT02014558|7731509|FG002|Overall Study|Death|0
4757107|NCT02014558|7731510|FG003|Overall Study|Death|0
4757108|NCT02014558|7731511|FG004|Overall Study|Death|0
4757109|NCT02014558|7731512|FG005|Overall Study|Death|0
4675970|NCT02379078|7575275|FG000|Overall Study|Lost to Follow-up|33
4675971|NCT02379078|7575276|FG001|Overall Study|Lost to Follow-up|30
4675972|NCT02379078|7575275|FG000|Overall Study|Withdrawal by Subject|6
4675973|NCT02379078|7575276|FG001|Overall Study|Withdrawal by Subject|5
4675974|NCT02379091|7575286|FG000|Overall Study|Pretreatment Event/Adverse Event|0
4675975|NCT02379091|7575287|FG001|Overall Study|Pretreatment Event/Adverse Event|2
4757110|NCT02014558|7731513|FG006|Overall Study|Death|1
4757111|NCT02014558|7731514|FG007|Overall Study|Death|1
4757112|NCT02014558|7731515|FG008|Overall Study|Death|2
4675976|NCT02379091|7575288|FG002|Overall Study|Pretreatment Event/Adverse Event|0
4675977|NCT02379091|7575289|FG003|Overall Study|Pretreatment Event/Adverse Event|1
4675978|NCT02379091|7575286|FG000|Overall Study|Principal Investigator Discretion|0
4675979|NCT02379091|7575287|FG001|Overall Study|Principal Investigator Discretion|1
4675980|NCT02379091|7575288|FG002|Overall Study|Principal Investigator Discretion|0
4675981|NCT02379091|7575289|FG003|Overall Study|Principal Investigator Discretion|0
4675982|NCT02379091|7575286|FG000|Overall Study|Lost to Follow-up|0
4675983|NCT02379091|7575287|FG001|Overall Study|Lost to Follow-up|0
4675984|NCT02379091|7575288|FG002|Overall Study|Lost to Follow-up|0
4675985|NCT02379091|7575289|FG003|Overall Study|Lost to Follow-up|1
4675986|NCT02379091|7575286|FG000|Overall Study|Voluntary Withdrawal|2
4675987|NCT02379091|7575287|FG001|Overall Study|Voluntary Withdrawal|5
4675988|NCT02379091|7575288|FG002|Overall Study|Voluntary Withdrawal|2
4675989|NCT02379091|7575289|FG003|Overall Study|Voluntary Withdrawal|4
4675990|NCT02379091|7575286|FG000|Overall Study|Study Termination|7
4675991|NCT02379091|7575287|FG001|Overall Study|Study Termination|2
4675992|NCT02379091|7575288|FG002|Overall Study|Study Termination|5
4675993|NCT02379091|7575289|FG003|Overall Study|Study Termination|8
4675994|NCT02379091|7575286|FG000|Overall Study|Lack of Efficacy|3
4675995|NCT02379091|7575287|FG001|Overall Study|Lack of Efficacy|0
4675996|NCT02379091|7575288|FG002|Overall Study|Lack of Efficacy|0
4675997|NCT02379091|7575289|FG003|Overall Study|Lack of Efficacy|0
4675998|NCT02379221|7575314|FG000|Overall Study|Lost to Follow-up|1
4757113|NCT02014558|7731516|FG009|Overall Study|Death|5
4757114|NCT02014558|7731517|FG010|Overall Study|Death|5
4757115|NCT02014558|7731518|FG011|Overall Study|Death|19
4757116|NCT02014558|7731519|FG012|Overall Study|Death|2
4757117|NCT02014558|7731507|FG000|Overall Study|Lack of Efficacy|1
4757118|NCT02014558|7731508|FG001|Overall Study|Lack of Efficacy|2
4757119|NCT02014558|7731509|FG002|Overall Study|Lack of Efficacy|1
4757120|NCT02014558|7731510|FG003|Overall Study|Lack of Efficacy|1
4757121|NCT02014558|7731511|FG004|Overall Study|Lack of Efficacy|0
4757122|NCT02014558|7731512|FG005|Overall Study|Lack of Efficacy|0
4757123|NCT02014558|7731513|FG006|Overall Study|Lack of Efficacy|1
4757124|NCT02014558|7731514|FG007|Overall Study|Lack of Efficacy|3
4757125|NCT02014558|7731515|FG008|Overall Study|Lack of Efficacy|3
4757126|NCT02014558|7731516|FG009|Overall Study|Lack of Efficacy|3
4757127|NCT02014558|7731517|FG010|Overall Study|Lack of Efficacy|16
4757128|NCT02014558|7731518|FG011|Overall Study|Lack of Efficacy|8
4757129|NCT02014558|7731519|FG012|Overall Study|Lack of Efficacy|5
4757130|NCT02014558|7731507|FG000|Overall Study|Lost to Follow-up|0
4757131|NCT02014558|7731508|FG001|Overall Study|Lost to Follow-up|0
4757132|NCT02014558|7731509|FG002|Overall Study|Lost to Follow-up|0
4757133|NCT02014558|7731510|FG003|Overall Study|Lost to Follow-up|0
4757134|NCT02014558|7731511|FG004|Overall Study|Lost to Follow-up|0
4757135|NCT02014558|7731512|FG005|Overall Study|Lost to Follow-up|0
4757136|NCT02014558|7731513|FG006|Overall Study|Lost to Follow-up|0
4757137|NCT02014558|7731514|FG007|Overall Study|Lost to Follow-up|0
4757138|NCT02014558|7731515|FG008|Overall Study|Lost to Follow-up|0
4757139|NCT02014558|7731516|FG009|Overall Study|Lost to Follow-up|0
4757140|NCT02014558|7731517|FG010|Overall Study|Lost to Follow-up|1
4757141|NCT02014558|7731518|FG011|Overall Study|Lost to Follow-up|0
4757142|NCT02014558|7731519|FG012|Overall Study|Lost to Follow-up|0
4757143|NCT02014558|7731507|FG000|Overall Study|Progressive Disease|1
4757144|NCT02014558|7731508|FG001|Overall Study|Progressive Disease|0
4757145|NCT02014558|7731509|FG002|Overall Study|Progressive Disease|1
4757146|NCT02014558|7731510|FG003|Overall Study|Progressive Disease|1
4757147|NCT02014558|7731511|FG004|Overall Study|Progressive Disease|1
4757148|NCT02014558|7731512|FG005|Overall Study|Progressive Disease|2
4757149|NCT02014558|7731513|FG006|Overall Study|Progressive Disease|1
4757150|NCT02014558|7731514|FG007|Overall Study|Progressive Disease|6
4757151|NCT02014558|7731515|FG008|Overall Study|Progressive Disease|5
4757152|NCT02014558|7731516|FG009|Overall Study|Progressive Disease|6
4757153|NCT02014558|7731517|FG010|Overall Study|Progressive Disease|22
4757154|NCT02014558|7731518|FG011|Overall Study|Progressive Disease|31
4757155|NCT02014558|7731519|FG012|Overall Study|Progressive Disease|6
4757156|NCT02014558|7731507|FG000|Overall Study|Withdrawal by Subject|0
4757157|NCT02014558|7731508|FG001|Overall Study|Withdrawal by Subject|0
4757158|NCT02014558|7731509|FG002|Overall Study|Withdrawal by Subject|0
4757159|NCT02014558|7731510|FG003|Overall Study|Withdrawal by Subject|0
4757160|NCT02014558|7731511|FG004|Overall Study|Withdrawal by Subject|1
4757161|NCT02014558|7731512|FG005|Overall Study|Withdrawal by Subject|0
4757162|NCT02014558|7731513|FG006|Overall Study|Withdrawal by Subject|0
4757163|NCT02014558|7731514|FG007|Overall Study|Withdrawal by Subject|0
4757164|NCT02014558|7731515|FG008|Overall Study|Withdrawal by Subject|0
4757165|NCT02014558|7731516|FG009|Overall Study|Withdrawal by Subject|2
4757166|NCT02014558|7731517|FG010|Overall Study|Withdrawal by Subject|6
4757167|NCT02014558|7731518|FG011|Overall Study|Withdrawal by Subject|10
4757168|NCT02014558|7731519|FG012|Overall Study|Withdrawal by Subject|0
4757169|NCT02014558|7731507|FG000|Overall Study|Miscellaneous|2
4757170|NCT02014558|7731508|FG001|Overall Study|Miscellaneous|1
4757171|NCT02014558|7731509|FG002|Overall Study|Miscellaneous|1
4757172|NCT02014558|7731510|FG003|Overall Study|Miscellaneous|1
4757173|NCT02014558|7731511|FG004|Overall Study|Miscellaneous|0
4757174|NCT02014558|7731512|FG005|Overall Study|Miscellaneous|1
4757175|NCT02014558|7731513|FG006|Overall Study|Miscellaneous|0
4675999|NCT02379637|7575353|FG000|Overall Study|Protocol Violation|0
4676000|NCT02379637|7575354|FG001|Overall Study|Protocol Violation|1
4676001|NCT02379637|7575353|FG000|Overall Study|Adverse Event|1
4676002|NCT02379637|7575354|FG001|Overall Study|Adverse Event|0
4676003|NCT02379637|7575353|FG000|Overall Study|Withdrawal by Subject|1
4676004|NCT02379637|7575354|FG001|Overall Study|Withdrawal by Subject|0
4676005|NCT02379728|7575362|FG000|Overall Study|Lost to Follow-up|1
4676006|NCT02379728|7575363|FG001|Overall Study|Lost to Follow-up|0
4676007|NCT02379728|7575364|FG002|Overall Study|Lost to Follow-up|3
4676008|NCT02379728|7575365|FG003|Overall Study|Lost to Follow-up|0
4676009|NCT02379728|7575362|FG000|Overall Study|Withdrawal by Subject|5
4676010|NCT02379728|7575363|FG001|Overall Study|Withdrawal by Subject|0
4676011|NCT02379728|7575364|FG002|Overall Study|Withdrawal by Subject|5
4676012|NCT02379728|7575365|FG003|Overall Study|Withdrawal by Subject|3
4676013|NCT02379728|7575362|FG000|Overall Study|Protocol Violation|0
4676014|NCT02379728|7575363|FG001|Overall Study|Protocol Violation|0
4676015|NCT02379728|7575364|FG002|Overall Study|Protocol Violation|2
4676016|NCT02379728|7575365|FG003|Overall Study|Protocol Violation|0
4676017|NCT02379923|7575383|FG000|Overall Study|Death|5
4676018|NCT02380248|7575399|FG000|Overall Study|Lost to Follow-up|11
4676019|NCT02380248|7575399|FG000|Overall Study|Withdrawal by Subject|3
4676020|NCT02380287|7575416|FG000|Overall Study|Adverse Event|0
4676021|NCT02380287|7575417|FG001|Overall Study|Adverse Event|0
4676022|NCT02380287|7575418|FG002|Overall Study|Adverse Event|1
4676023|NCT02380287|7575419|FG003|Overall Study|Adverse Event|0
4676024|NCT02380287|7575420|FG004|Overall Study|Adverse Event|0
4676025|NCT02380287|7575421|FG005|Overall Study|Adverse Event|0
4676026|NCT02380287|7575422|FG006|Overall Study|Adverse Event|0
4676027|NCT02380287|7575423|FG007|Overall Study|Adverse Event|0
4676028|NCT02380677|7575467|FG000|Overall Study|Adverse Event|0
4676029|NCT02380677|7575468|FG001|Overall Study|Adverse Event|0
4676030|NCT02380677|7575469|FG002|Overall Study|Adverse Event|0
4676031|NCT02380677|7575470|FG003|Overall Study|Adverse Event|1
4676032|NCT02380677|7575471|FG004|Overall Study|Adverse Event|1
4676033|NCT02380677|7575472|FG005|Overall Study|Adverse Event|4
4676034|NCT02380677|7575473|FG006|Overall Study|Adverse Event|2
4676035|NCT02380677|7575474|FG007|Overall Study|Adverse Event|2
4676036|NCT02380677|7575475|FG008|Overall Study|Adverse Event|2
4676037|NCT02380677|7575476|FG009|Overall Study|Adverse Event|1
4676038|NCT02380677|7575477|FG010|Overall Study|Adverse Event|2
4676039|NCT02380677|7575478|FG011|Overall Study|Adverse Event|1
4676040|NCT02380677|7575467|FG000|Overall Study|Physician Decision|1
4676041|NCT02380677|7575468|FG001|Overall Study|Physician Decision|0
4676042|NCT02380677|7575469|FG002|Overall Study|Physician Decision|1
4676043|NCT02380677|7575470|FG003|Overall Study|Physician Decision|1
4676044|NCT02380677|7575471|FG004|Overall Study|Physician Decision|0
4676045|NCT02380677|7575472|FG005|Overall Study|Physician Decision|0
4676046|NCT02380677|7575473|FG006|Overall Study|Physician Decision|0
4676047|NCT02380677|7575474|FG007|Overall Study|Physician Decision|0
4676048|NCT02380677|7575475|FG008|Overall Study|Physician Decision|0
4676049|NCT02380677|7575476|FG009|Overall Study|Physician Decision|0
4676050|NCT02380677|7575477|FG010|Overall Study|Physician Decision|0
4676051|NCT02380677|7575478|FG011|Overall Study|Physician Decision|0
4676052|NCT02380677|7575467|FG000|Overall Study|Lack of Efficacy|0
4676053|NCT02380677|7575468|FG001|Overall Study|Lack of Efficacy|1
4676054|NCT02380677|7575469|FG002|Overall Study|Lack of Efficacy|2
4676055|NCT02380677|7575470|FG003|Overall Study|Lack of Efficacy|0
4676056|NCT02380677|7575471|FG004|Overall Study|Lack of Efficacy|4
4676057|NCT02380677|7575472|FG005|Overall Study|Lack of Efficacy|1
4676058|NCT02380677|7575473|FG006|Overall Study|Lack of Efficacy|1
4676059|NCT02380677|7575474|FG007|Overall Study|Lack of Efficacy|2
4676060|NCT02380677|7575475|FG008|Overall Study|Lack of Efficacy|2
4676061|NCT02380677|7575476|FG009|Overall Study|Lack of Efficacy|0
4676062|NCT02380677|7575477|FG010|Overall Study|Lack of Efficacy|2
4676063|NCT02380677|7575478|FG011|Overall Study|Lack of Efficacy|1
4676064|NCT02380677|7575467|FG000|Overall Study|Withdrawal by Subject|0
4676065|NCT02380677|7575468|FG001|Overall Study|Withdrawal by Subject|0
4676066|NCT02380677|7575469|FG002|Overall Study|Withdrawal by Subject|0
4676067|NCT02380677|7575470|FG003|Overall Study|Withdrawal by Subject|0
4676068|NCT02380677|7575471|FG004|Overall Study|Withdrawal by Subject|0
4676069|NCT02380677|7575472|FG005|Overall Study|Withdrawal by Subject|0
4676070|NCT02380677|7575473|FG006|Overall Study|Withdrawal by Subject|0
4676071|NCT02380677|7575474|FG007|Overall Study|Withdrawal by Subject|0
4676072|NCT02380677|7575475|FG008|Overall Study|Withdrawal by Subject|0
4676073|NCT02380677|7575476|FG009|Overall Study|Withdrawal by Subject|1
4676074|NCT02380677|7575477|FG010|Overall Study|Withdrawal by Subject|0
4676075|NCT02380677|7575478|FG011|Overall Study|Withdrawal by Subject|3
4676076|NCT02380677|7575467|FG000|Overall Study|Other|0
4676077|NCT02380677|7575468|FG001|Overall Study|Other|0
4676078|NCT02380677|7575469|FG002|Overall Study|Other|0
4676079|NCT02380677|7575470|FG003|Overall Study|Other|1
4676080|NCT02380677|7575471|FG004|Overall Study|Other|1
4676081|NCT02380677|7575472|FG005|Overall Study|Other|1
4676082|NCT02380677|7575473|FG006|Overall Study|Other|0
4676083|NCT02380677|7575474|FG007|Overall Study|Other|0
4676084|NCT02380677|7575475|FG008|Overall Study|Other|0
4676085|NCT02380677|7575476|FG009|Overall Study|Other|0
4676086|NCT02380677|7575477|FG010|Overall Study|Other|0
4676087|NCT02380677|7575478|FG011|Overall Study|Other|0
4676088|NCT02380690|7575508|FG000|Overall Study|Lost to Follow-up|14
4676089|NCT02380690|7575509|FG001|Overall Study|Lost to Follow-up|4
4676090|NCT02380690|7575508|FG000|Overall Study|Withdrawal by Subject|20
4676091|NCT02380690|7575509|FG001|Overall Study|Withdrawal by Subject|8
4676092|NCT02380703|7575517|FG000|Overall Study|Withdrawal by Subject|12
4676093|NCT02380703|7575518|FG001|Overall Study|Withdrawal by Subject|9
4676094|NCT02380703|7575517|FG000|Overall Study|Lost to Follow-up|12
4676095|NCT02380703|7575518|FG001|Overall Study|Lost to Follow-up|12
4676096|NCT02380703|7575517|FG000|Overall Study|Caregiver death|1
4676097|NCT02380703|7575518|FG001|Overall Study|Caregiver death|0
4676098|NCT02380703|7575517|FG000|Overall Study|Person with dementia (PWD) death|7
4676099|NCT02380703|7575518|FG001|Overall Study|Person with dementia (PWD) death|8
4676100|NCT02380703|7575517|FG000|Overall Study|Entered Long-term Care|4
4676101|NCT02380703|7575518|FG001|Overall Study|Entered Long-term Care|7
4676102|NCT02380742|7575526|FG000|Overall Study|Withdrawal by Subject|1
4676103|NCT02380742|7575527|FG001|Overall Study|Withdrawal by Subject|0
4676104|NCT02380859|7575535|FG000|Overall Study|Withdrawal by Subject|2
4676105|NCT02380859|7575536|FG001|Overall Study|Withdrawal by Subject|0
4676106|NCT02381795|7575606|FG000|Overall Study|Withdrawal by Subject|1
4676107|NCT02381795|7575606|FG000|Overall Study|Study Terminated|2
4676108|NCT02382016|7575612|FG000|Double-blind (DB) Treatment Period|Physician Decision|3
4676109|NCT02382016|7575613|FG001|Double-blind (DB) Treatment Period|Physician Decision|0
4676110|NCT02382016|7575612|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1
4676111|NCT02382016|7575613|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0
4757176|NCT02014558|7731514|FG007|Overall Study|Miscellaneous|1
4757177|NCT02014558|7731515|FG008|Overall Study|Miscellaneous|1
4757178|NCT02014558|7731516|FG009|Overall Study|Miscellaneous|3
4757179|NCT02014558|7731517|FG010|Overall Study|Miscellaneous|12
4757180|NCT02014558|7731518|FG011|Overall Study|Miscellaneous|11
4757181|NCT02014558|7731519|FG012|Overall Study|Miscellaneous|1
4676112|NCT02382016|7575612|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0
4676113|NCT02382016|7575613|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1
4676114|NCT02382016|7575612|FG000|Open-label (OL) Treatment Period|Physician Decision|3
4676115|NCT02382016|7575613|FG001|Open-label (OL) Treatment Period|Physician Decision|0
4676116|NCT02382016|7575612|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2
4676117|NCT02382016|7575613|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0
4676118|NCT02382016|7575612|FG000|Open-label (OL) Treatment Period|Death|4
4676119|NCT02382016|7575613|FG001|Open-label (OL) Treatment Period|Death|0
4676120|NCT02382016|7575612|FG000|OL Extension Period|Physician Decision|3
4676121|NCT02382016|7575613|FG001|OL Extension Period|Physician Decision|0
4676122|NCT02382016|7575612|FG000|OL Extension Period|Death|2
4676123|NCT02382016|7575613|FG001|OL Extension Period|Death|0
4676124|NCT02382016|7575612|FG000|OL Extension Period|Withdrawal by Subject|1
4676125|NCT02382016|7575613|FG001|OL Extension Period|Withdrawal by Subject|0
4676126|NCT02382133|7575621|FG000|Overall Study|Death|22
4676127|NCT02382133|7575621|FG000|Overall Study|transfer out of ICU|4
4676128|NCT02382133|7575621|FG000|Overall Study|Physician Decision|2
4676129|NCT02382133|7575621|FG000|Overall Study|arterial catheter loss|4
4676130|NCT02382133|7575621|FG000|Overall Study|pressure injury both sites|1
4676131|NCT02382276|7575628|FG000|Overall Study|Withdrawal by Subject|4
4676132|NCT02382276|7575629|FG001|Overall Study|Withdrawal by Subject|8
4676133|NCT02382276|7575630|FG002|Overall Study|Withdrawal by Subject|5
4676134|NCT02382276|7575628|FG000|Overall Study|Adverse Event|7
4676135|NCT02382276|7575629|FG001|Overall Study|Adverse Event|2
4676136|NCT02382276|7575630|FG002|Overall Study|Adverse Event|32
4676137|NCT02382276|7575628|FG000|Overall Study|Physician Decision|0
4676138|NCT02382276|7575629|FG001|Overall Study|Physician Decision|0
4676139|NCT02382276|7575630|FG002|Overall Study|Physician Decision|2
4676140|NCT02382640|7575640|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1
4676141|NCT02382640|7575641|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
4676142|NCT02382640|7575642|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
4676143|NCT02382640|7575643|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
4676144|NCT02382796|7575670|FG000|Overall Study|Global deterioration of health status|1
4676145|NCT02382796|7575670|FG000|Overall Study|Objective progression or relapse|3
4676146|NCT02382796|7575670|FG000|Overall Study|Commercial dacomitinib became available|3
4676147|NCT02382939|7575724|FG000|Overall Study|Adverse Event|1
4676148|NCT02382939|7575725|FG001|Overall Study|Adverse Event|1
4676149|NCT02382939|7575724|FG000|Overall Study|Withdrawal by Subject|2
4757182|NCT02024555|7731574|FG000|Overall Study|Lost to Follow-up|1
4757183|NCT02024555|7731575|FG001|Overall Study|Lost to Follow-up|1
4757184|NCT02024555|7731574|FG000|Overall Study|Withdrawal by Subject|5
4676150|NCT02382939|7575725|FG001|Overall Study|Withdrawal by Subject|2
4676151|NCT02382991|7575734|FG000|Overall Study|Adverse Event|1
4676152|NCT02382991|7575735|FG001|Overall Study|Adverse Event|2
4676153|NCT02382991|7575734|FG000|Overall Study|Lost to Follow-up|1
4676154|NCT02382991|7575735|FG001|Overall Study|Lost to Follow-up|0
4676155|NCT02382991|7575734|FG000|Overall Study|Withdrawal by Subject|0
4676156|NCT02382991|7575735|FG001|Overall Study|Withdrawal by Subject|1
4676157|NCT02383017|7575742|FG000|Overall Study|Injury Sustained Outside Study|1
4676158|NCT02383017|7575743|FG001|Overall Study|Injury Sustained Outside Study|0
4676159|NCT02383017|7575742|FG000|Overall Study|Compliance|3
4676160|NCT02383017|7575743|FG001|Overall Study|Compliance|2
4676161|NCT02383017|7575742|FG000|Overall Study|Found to be Hypogonadal|1
4676162|NCT02383017|7575743|FG001|Overall Study|Found to be Hypogonadal|0
4676163|NCT02383056|7575765|FG000|Overall Study|Adverse Event|1
4676164|NCT02383056|7575766|FG001|Overall Study|Adverse Event|0
4676165|NCT02383056|7575765|FG000|Overall Study|Lost to Follow-up|0
4676166|NCT02383056|7575766|FG001|Overall Study|Lost to Follow-up|2
4676167|NCT02383173|7575774|FG000|Overall Study|Palliative Care Team withdrew|0
4676168|NCT02383173|7575775|FG001|Overall Study|Palliative Care Team withdrew|2
4676169|NCT02383355|7575783|FG000|Overall Study|Adverse Event|2
4676170|NCT02383355|7575784|FG001|Overall Study|Adverse Event|0
4676171|NCT02383472|7575805|FG000|Overall Study|Withdrawal by Subject|1
4676172|NCT02383472|7575806|FG001|Overall Study|Withdrawal by Subject|1
4676173|NCT02383576|7575816|FG000|Overall Study|Death|53
4676174|NCT02383576|7575817|FG001|Overall Study|Death|33
4757185|NCT02024555|7731575|FG001|Overall Study|Withdrawal by Subject|1
4757186|NCT02034123|7731599|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
4757187|NCT02034123|7731600|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
4757188|NCT02034123|7731601|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
4757189|NCT02034123|7731602|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
4757190|NCT02034123|7731603|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1
4757191|NCT02034123|7731604|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
4676175|NCT02383576|7575816|FG000|Overall Study|Lost to Follow-up|7
4676176|NCT02383576|7575817|FG001|Overall Study|Lost to Follow-up|1
4676177|NCT02383576|7575816|FG000|Overall Study|Withdrew Consent|1
4676178|NCT02383576|7575817|FG001|Overall Study|Withdrew Consent|6
4676179|NCT02383576|7575816|FG000|Overall Study|Investigator's Decision|0
4676180|NCT02383576|7575817|FG001|Overall Study|Investigator's Decision|1
4676181|NCT02383576|7575816|FG000|Overall Study|Administrative/Other|2
4676182|NCT02383576|7575817|FG001|Overall Study|Administrative/Other|4
4676183|NCT02383589|7575825|FG000|Treatment Period|Adverse Event|1
4676184|NCT02383589|7575826|FG001|Treatment Period|Adverse Event|3
4676185|NCT02383589|7575825|FG000|Treatment Period|Lost to Follow-up|0
4676186|NCT02383589|7575826|FG001|Treatment Period|Lost to Follow-up|1
4676187|NCT02383589|7575825|FG000|Treatment Period|Withdrawal by Subject|0
4676188|NCT02383589|7575826|FG001|Treatment Period|Withdrawal by Subject|5
4676189|NCT02383589|7575825|FG000|Treatment Period|Non-compliance with study drug|0
4676190|NCT02383589|7575826|FG001|Treatment Period|Non-compliance with study drug|1
4676191|NCT02383589|7575825|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2
4676192|NCT02383589|7575826|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4
4676193|NCT02383589|7575825|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5
4676194|NCT02383589|7575826|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0
4676195|NCT02383589|7575825|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0
4676196|NCT02383589|7575826|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1
4676197|NCT02383758|7575849|FG000|Overall Study|Withdrawal by Subject|0
4676198|NCT02383758|7575850|FG001|Overall Study|Withdrawal by Subject|2
4676199|NCT02383862|7575858|FG000|3 Month Follow up|Lost to Follow-up|23
4676200|NCT02383862|7575859|FG001|3 Month Follow up|Lost to Follow-up|21
4676201|NCT02383940|7575874|FG000|Overall Study|Adverse Event|1
4676202|NCT02383940|7575875|FG001|Overall Study|Adverse Event|0
4676203|NCT02383940|7575874|FG000|Overall Study|Lost to Follow-up|2
4676204|NCT02383940|7575875|FG001|Overall Study|Lost to Follow-up|2
4676205|NCT02383940|7575874|FG000|Overall Study|Physician Decision|2
4676206|NCT02383940|7575875|FG001|Overall Study|Physician Decision|0
4676207|NCT02383940|7575874|FG000|Overall Study|Withdrawal by Subject|1
4676208|NCT02383940|7575875|FG001|Overall Study|Withdrawal by Subject|1
4676209|NCT02383940|7575874|FG000|Overall Study|Randomized but not treated|2
4676210|NCT02383940|7575875|FG001|Overall Study|Randomized but not treated|0
4676211|NCT02383940|7575874|FG000|Overall Study|Other than specified above|1
4676212|NCT02383940|7575875|FG001|Overall Study|Other than specified above|0
4676213|NCT02383966|7575883|FG000|Overall Study|Ongoing at clinical cut-off date|25
4676214|NCT02383966|7575884|FG001|Overall Study|Ongoing at clinical cut-off date|4
4676215|NCT02383966|7575883|FG000|Overall Study|Randomized, but not treated|1
4676216|NCT02383966|7575884|FG001|Overall Study|Randomized, but not treated|3
4676217|NCT02384382|7575929|FG000|Overall Study|Transitioned to study-NCT02960022|5
4676218|NCT02384382|7575929|FG000|Overall Study|Death|1
4676219|NCT02384382|7575929|FG000|Overall Study|Adverse Event|1
4676220|NCT02384382|7575929|FG000|Overall Study|Disease progression|16
4676221|NCT02384395|7575933|FG000|Overall Study|Physician Decision|4
4676222|NCT02384395|7575933|FG000|Overall Study|Withdrawal by Subject|3
4676223|NCT02384395|7575933|FG000|Overall Study|Lost to Follow-up|3
4676224|NCT02384460|7575939|FG000|Overall Study|Protocol Violation|0
4676225|NCT02384460|7575940|FG001|Overall Study|Protocol Violation|1
4676226|NCT02384460|7575939|FG000|Overall Study|Returned to previous therapeutic regimen|0
4676227|NCT02384460|7575940|FG001|Overall Study|Returned to previous therapeutic regimen|1
4676228|NCT02384460|7575939|FG000|Overall Study|Adverse Event|5
4676229|NCT02384460|7575940|FG001|Overall Study|Adverse Event|2
4676230|NCT02384460|7575939|FG000|Overall Study|Withdrawal by Subject|0
4676231|NCT02384460|7575940|FG001|Overall Study|Withdrawal by Subject|3
4676232|NCT02384460|7575939|FG000|Overall Study|Elective medical treatment|1
4676233|NCT02384460|7575940|FG001|Overall Study|Elective medical treatment|0
4676234|NCT02384460|7575939|FG000|Overall Study|Non-compliance|1
4676235|NCT02384460|7575940|FG001|Overall Study|Non-compliance|0
4676236|NCT02384538|7575948|FG000|Overall Study|Adverse Event|1
4676237|NCT02384538|7575949|FG001|Overall Study|Adverse Event|4
4676238|NCT02384538|7575948|FG000|Overall Study|Lack of Efficacy|4
4676239|NCT02384538|7575949|FG001|Overall Study|Lack of Efficacy|4
4676240|NCT02384538|7575948|FG000|Overall Study|Withdrew Consent|0
4676241|NCT02384538|7575949|FG001|Overall Study|Withdrew Consent|4
4676242|NCT02384538|7575948|FG000|Overall Study|Other|1
4676243|NCT02384538|7575949|FG001|Overall Study|Other|3
4676244|NCT02384941|7575958|FG000|Overall Study|Adverse Event|11
4676245|NCT02384941|7575959|FG001|Overall Study|Adverse Event|13
4676246|NCT02384941|7575960|FG002|Overall Study|Adverse Event|17
4676247|NCT02384941|7575958|FG000|Overall Study|Lost to Follow-up|3
4676248|NCT02384941|7575959|FG001|Overall Study|Lost to Follow-up|2
4676249|NCT02384941|7575960|FG002|Overall Study|Lost to Follow-up|1
4676250|NCT02384941|7575958|FG000|Overall Study|Non-Compliance With Study Drug|2
4676251|NCT02384941|7575959|FG001|Overall Study|Non-Compliance With Study Drug|0
4676252|NCT02384941|7575960|FG002|Overall Study|Non-Compliance With Study Drug|1
4676253|NCT02384941|7575958|FG000|Overall Study|Physician Decision|1
4676254|NCT02384941|7575959|FG001|Overall Study|Physician Decision|1
4676255|NCT02384941|7575960|FG002|Overall Study|Physician Decision|0
4676256|NCT02384941|7575958|FG000|Overall Study|Protocol Violation|3
4676257|NCT02384941|7575959|FG001|Overall Study|Protocol Violation|0
4676258|NCT02384941|7575960|FG002|Overall Study|Protocol Violation|0
4676259|NCT02384941|7575958|FG000|Overall Study|Withdrawal by Subject|26
4676260|NCT02384941|7575959|FG001|Overall Study|Withdrawal by Subject|19
4676261|NCT02384941|7575960|FG002|Overall Study|Withdrawal by Subject|20
4676262|NCT02384941|7575958|FG000|Overall Study|Pregnancy|0
4676263|NCT02384941|7575959|FG001|Overall Study|Pregnancy|0
4676264|NCT02384941|7575960|FG002|Overall Study|Pregnancy|1
4676265|NCT02384941|7575958|FG000|Overall Study|Other than specified above|4
4676266|NCT02384941|7575959|FG001|Overall Study|Other than specified above|0
4676267|NCT02384941|7575960|FG002|Overall Study|Other than specified above|1
4676268|NCT02385084|7575969|FG000|Period 2|Protocol Violation|0
4676269|NCT02385084|7575970|FG001|Period 2|Protocol Violation|0
4676270|NCT02385084|7575971|FG002|Period 2|Protocol Violation|1
4676271|NCT02385084|7575972|FG003|Period 2|Protocol Violation|0
4676272|NCT02385084|7575973|FG004|Period 2|Protocol Violation|0
4676273|NCT02385084|7575974|FG005|Period 2|Protocol Violation|0
4676274|NCT02385526|7576021|FG000|Overall Study|Withdrawal by Subject|0
4676275|NCT02385526|7576022|FG001|Overall Study|Withdrawal by Subject|2
4676276|NCT02385526|7576023|FG002|Overall Study|Withdrawal by Subject|0
4676277|NCT02385526|7576021|FG000|Overall Study|Lost to Follow-up|0
4676278|NCT02385526|7576022|FG001|Overall Study|Lost to Follow-up|1
4757192|NCT02034123|7731605|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
4757193|NCT02034123|7731606|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1
4757194|NCT02034123|7731607|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1
4757195|NCT02034123|7731608|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
4757196|NCT02034123|7731609|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
4757197|NCT02034123|7731610|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
4757198|NCT02034123|7731611|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
4676279|NCT02385526|7576023|FG002|Overall Study|Lost to Follow-up|0
4676280|NCT02385526|7576021|FG000|Overall Study|Physician Decision|1
4676281|NCT02385526|7576022|FG001|Overall Study|Physician Decision|0
4676282|NCT02385526|7576023|FG002|Overall Study|Physician Decision|0
4676283|NCT02385526|7576021|FG000|Overall Study|Protocol Violation|1
4676284|NCT02385526|7576022|FG001|Overall Study|Protocol Violation|0
4676285|NCT02385526|7576023|FG002|Overall Study|Protocol Violation|0
4676286|NCT02385669|7576031|FG000|Overall Study|Adverse Event|2
4676287|NCT02385708|7576037|FG000|Overall Study|Withdrawal by Subject|0
4676288|NCT02385708|7576038|FG001|Overall Study|Withdrawal by Subject|2
4676289|NCT02385708|7576037|FG000|Overall Study|Withdrawn - surgery canceled|2
4676290|NCT02385708|7576038|FG001|Overall Study|Withdrawn - surgery canceled|5
4676291|NCT02385708|7576037|FG000|Overall Study|Investigator decision|5
4676292|NCT02385708|7576038|FG001|Overall Study|Investigator decision|7
4676293|NCT02385708|7576037|FG000|Overall Study|Protocol Violation|1
4676294|NCT02385708|7576038|FG001|Overall Study|Protocol Violation|1
4676295|NCT02385799|7576050|FG000|Overall Study|Lost to Follow-up|1
4676296|NCT02385799|7576051|FG001|Overall Study|Lost to Follow-up|2
4676297|NCT02385799|7576050|FG000|Overall Study|Adverse Event|4
4676298|NCT02385799|7576051|FG001|Overall Study|Adverse Event|2
4676299|NCT02385799|7576050|FG000|Overall Study|Withdrawal by Subject|0
4676300|NCT02385799|7576051|FG001|Overall Study|Withdrawal by Subject|4
4676301|NCT02386098|7576062|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30
4676302|NCT02386098|7576063|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29
4676303|NCT02386098|7576064|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0
4676304|NCT02386098|7576065|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0
4676305|NCT02386098|7576066|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0
4676306|NCT02386098|7576062|FG000|Stage 1 (96 Weeks)|Adverse Event|2
4676307|NCT02386098|7576063|FG001|Stage 1 (96 Weeks)|Adverse Event|1
4676308|NCT02386098|7576064|FG002|Stage 1 (96 Weeks)|Adverse Event|0
4676309|NCT02386098|7576065|FG003|Stage 1 (96 Weeks)|Adverse Event|0
4676310|NCT02386098|7576066|FG004|Stage 1 (96 Weeks)|Adverse Event|0
4676311|NCT02386098|7576062|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2
4676312|NCT02386098|7576063|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2
4676313|NCT02386098|7576064|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0
4676314|NCT02386098|7576065|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0
4676315|NCT02386098|7576066|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0
4676316|NCT02386098|7576062|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
4676317|NCT02386098|7576063|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2
4676318|NCT02386098|7576064|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
4676319|NCT02386098|7576065|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
4676320|NCT02386098|7576066|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
4676321|NCT02386098|7576062|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3
4676322|NCT02386098|7576063|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1
4676323|NCT02386098|7576064|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0
4676324|NCT02386098|7576065|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0
4676325|NCT02386098|7576066|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0
4676326|NCT02386098|7576062|FG000|Stage 1 (96 Weeks)|Other|1
4676327|NCT02386098|7576063|FG001|Stage 1 (96 Weeks)|Other|0
4676328|NCT02386098|7576064|FG002|Stage 1 (96 Weeks)|Other|0
4676329|NCT02386098|7576065|FG003|Stage 1 (96 Weeks)|Other|0
4676330|NCT02386098|7576066|FG004|Stage 1 (96 Weeks)|Other|0
4676331|NCT02386098|7576062|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5
4676332|NCT02386098|7576063|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8
4676333|NCT02386098|7576064|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0
4676334|NCT02386098|7576065|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0
4676335|NCT02386098|7576066|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0
4676336|NCT02386189|7576080|FG000|Overall Study|Lost to Follow-up|2
4676337|NCT02386189|7576081|FG001|Overall Study|Lost to Follow-up|3
4676338|NCT02386189|7576080|FG000|Overall Study|Withdrawal by Subject|1
4676339|NCT02386189|7576081|FG001|Overall Study|Withdrawal by Subject|0
4676340|NCT02386189|7576080|FG000|Overall Study|Death|1
4676341|NCT02386189|7576081|FG001|Overall Study|Death|0
4676342|NCT02386345|7576096|FG000|Overall Study|Not treated|14
4676343|NCT02386345|7576096|FG000|Overall Study|Lost to Follow-up|1
4676344|NCT02386345|7576096|FG000|Overall Study|Adverse Event|5
4676345|NCT02386345|7576096|FG000|Overall Study|Repeat Procedure|10
4676346|NCT02386345|7576096|FG000|Overall Study|Did not complete 12-month follow-up|72
4676347|NCT02387164|7576129|FG000|Overall Study|Lost to Follow-up|2
4676348|NCT02387164|7576130|FG001|Overall Study|Lost to Follow-up|0
4676349|NCT02387164|7576129|FG000|Overall Study|Diagnosed|1
4676350|NCT02387164|7576130|FG001|Overall Study|Diagnosed|2
4676351|NCT02387216|7576138|FG000|Overall Study|Progressive disease|2
4676352|NCT02387216|7576139|FG001|Overall Study|Progressive disease|0
4676353|NCT02387216|7576138|FG000|Overall Study|Withdrawal by Subject|3
4676354|NCT02387216|7576139|FG001|Overall Study|Withdrawal by Subject|5
4676355|NCT02387216|7576138|FG000|Overall Study|Physician Decision|2
4676356|NCT02387216|7576139|FG001|Overall Study|Physician Decision|0
4676357|NCT02387216|7576138|FG000|Overall Study|Sponsor Decision|28
4676358|NCT02387216|7576139|FG001|Overall Study|Sponsor Decision|12
4676359|NCT02387216|7576138|FG000|Overall Study|Death|60
4676360|NCT02387216|7576139|FG001|Overall Study|Death|23
4676361|NCT02387216|7576138|FG000|Overall Study|Other|5
4676362|NCT02387216|7576139|FG001|Overall Study|Other|4
4676363|NCT02387216|7576138|FG000|Overall Study|Lost to Follow-up|0
4676364|NCT02387216|7576139|FG001|Overall Study|Lost to Follow-up|3
4676365|NCT02387372|7576174|FG000|Overall Study|Not Treated|1
4676366|NCT02387372|7576175|FG001|Overall Study|Not Treated|0
4676367|NCT02387580|7576236|FG000|Overall Study|Withdrawal by Subject|0
4676368|NCT02387580|7576237|FG001|Overall Study|Withdrawal by Subject|0
4676369|NCT02387580|7576238|FG002|Overall Study|Withdrawal by Subject|0
4676370|NCT02387580|7576239|FG003|Overall Study|Withdrawal by Subject|1
4676371|NCT02387580|7576240|FG004|Overall Study|Withdrawal by Subject|0
4676372|NCT02387580|7576241|FG005|Overall Study|Withdrawal by Subject|0
4676373|NCT02387762|7576277|FG000|Overall Study|Withdrawal by Subject|1
4676374|NCT02387762|7576278|FG001|Overall Study|Withdrawal by Subject|0
4676375|NCT02387840|7576318|FG000|Overall Study|Death|0
4676376|NCT02387840|7576319|FG001|Overall Study|Death|0
4676377|NCT02387840|7576320|FG002|Overall Study|Death|0
4676378|NCT02387840|7576321|FG003|Overall Study|Death|0
4757199|NCT02034123|7731612|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
4757200|NCT02034123|7731613|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
4757201|NCT02034123|7731614|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
4757202|NCT02034123|7731615|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
4757203|NCT02034123|7731616|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
4757204|NCT02034123|7731599|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
4757205|NCT02034123|7731600|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
4757206|NCT02034123|7731601|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
4757207|NCT02034123|7731602|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1
4757208|NCT02034123|7731603|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
4757209|NCT02034123|7731604|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
4757210|NCT02034123|7731605|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
4757211|NCT02034123|7731606|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
4757212|NCT02034123|7731607|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
4757213|NCT02034123|7731608|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
4757214|NCT02034123|7731609|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
4757215|NCT02034123|7731610|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
4757216|NCT02034123|7731611|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
4757217|NCT02034123|7731612|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
4757218|NCT02034123|7731613|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
4757219|NCT02034123|7731614|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
4757220|NCT02034123|7731615|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
4757221|NCT02034123|7731616|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
4757222|NCT02034123|7731599|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
4757223|NCT02034123|7731600|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
4676379|NCT02387840|7576322|FG004|Overall Study|Death|0
4676380|NCT02387840|7576323|FG005|Overall Study|Death|1
4676381|NCT02387957|7576350|FG000|Overall Study|The study was discontinued|21
4676382|NCT02387957|7576351|FG001|Overall Study|The study was discontinued|21
4757224|NCT02034123|7731601|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
4676383|NCT02387957|7576352|FG002|Overall Study|The study was discontinued|20
4676384|NCT02387970|7576362|FG000|Overall Study|Did not complete 1-year follow up|1
4676385|NCT02387970|7576363|FG001|Overall Study|Did not complete 1-year follow up|2
4676386|NCT02387983|7576369|FG000|Overall Study|Adverse Event|4
4676387|NCT02387983|7576369|FG000|Overall Study|Protocol Violation|1
4676388|NCT02387983|7576369|FG000|Overall Study|Withdrawal by Subject|2
4676389|NCT02388074|7576373|FG000|Overall Study|Lost in Transit|2
4676390|NCT02388074|7576373|FG000|Overall Study|Sample Not Returned|1
4676391|NCT02388165|7576379|FG000|Overall Study|Study terminated by sponsor|5
4676392|NCT02388165|7576380|FG001|Overall Study|Study terminated by sponsor|5
4676393|NCT02388165|7576379|FG000|Overall Study|Other|11
4676394|NCT02388165|7576380|FG001|Overall Study|Other|13
4676395|NCT02388165|7576379|FG000|Overall Study|No longer meet eligibility criteria|40
4676396|NCT02388165|7576380|FG001|Overall Study|No longer meet eligibility criteria|43
4676397|NCT02388165|7576379|FG000|Overall Study|Withdrawal of consent|31
4676398|NCT02388165|7576380|FG001|Overall Study|Withdrawal of consent|32
4676399|NCT02388165|7576379|FG000|Overall Study|Lost to Follow-up|19
4676400|NCT02388165|7576380|FG001|Overall Study|Lost to Follow-up|20
4676401|NCT02388165|7576379|FG000|Overall Study|Death|13
4676402|NCT02388165|7576380|FG001|Overall Study|Death|10
4676403|NCT02388165|7576379|FG000|Overall Study|Adverse Event|3
4676404|NCT02388165|7576380|FG001|Overall Study|Adverse Event|5
4676405|NCT02388165|7576379|FG000|Overall Study|Did not meet entrance criteria|5
4676406|NCT02388165|7576380|FG001|Overall Study|Did not meet entrance criteria|2
4676407|NCT02388191|7576388|FG000|Overall Study|Patient did not receive IUD|1
4676408|NCT02388191|7576389|FG001|Overall Study|Patient did not receive IUD|0
4676409|NCT02388269|7576399|FG000|Overall Study|Adverse Event|2
4676410|NCT02388269|7576400|FG001|Overall Study|Adverse Event|0
4757225|NCT02034123|7731602|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
4757226|NCT02034123|7731603|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
4757227|NCT02034123|7731604|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
4757228|NCT02034123|7731605|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
4676411|NCT02388269|7576401|FG002|Overall Study|Adverse Event|0
4676412|NCT02388269|7576399|FG000|Overall Study|Withdrawal by Subject|1
4676413|NCT02388269|7576400|FG001|Overall Study|Withdrawal by Subject|2
4676414|NCT02388269|7576401|FG002|Overall Study|Withdrawal by Subject|0
4676415|NCT02388269|7576399|FG000|Overall Study|less than 50% stimulations|1
4676416|NCT02388269|7576400|FG001|Overall Study|less than 50% stimulations|0
4676417|NCT02388269|7576401|FG002|Overall Study|less than 50% stimulations|0
4676418|NCT02388269|7576399|FG000|Overall Study|no diary data|3
4676419|NCT02388269|7576400|FG001|Overall Study|no diary data|0
4676420|NCT02388269|7576401|FG002|Overall Study|no diary data|0
4676421|NCT02388269|7576399|FG000|Overall Study|Protocol Violation|2
4676422|NCT02388269|7576400|FG001|Overall Study|Protocol Violation|0
4676423|NCT02388269|7576401|FG002|Overall Study|Protocol Violation|0
4676424|NCT02388269|7576399|FG000|Overall Study|Screen Failure|0
4676425|NCT02388269|7576400|FG001|Overall Study|Screen Failure|0
4676426|NCT02388269|7576401|FG002|Overall Study|Screen Failure|10
4676427|NCT02388295|7576428|FG000|Dose Escalation Week 1|Adverse Event|1
4676428|NCT02388295|7576429|FG001|Dose Escalation Week 1|Adverse Event|2
4676429|NCT02388295|7576430|FG002|Dose Escalation Week 1|Adverse Event|1
4676430|NCT02388295|7576428|FG000|Dose Escalation Week 1|Determined not eligible|1
4676431|NCT02388295|7576429|FG001|Dose Escalation Week 1|Determined not eligible|1
4676432|NCT02388295|7576430|FG002|Dose Escalation Week 1|Determined not eligible|1
4676433|NCT02388295|7576428|FG000|Dose Escalation Week 2|Protocol Violation|0
4676434|NCT02388295|7576429|FG001|Dose Escalation Week 2|Protocol Violation|1
4676435|NCT02388295|7576430|FG002|Dose Escalation Week 2|Protocol Violation|0
4676436|NCT02388295|7576428|FG000|Dose Escalation Week 2|Determined not eligible|1
4676437|NCT02388295|7576429|FG001|Dose Escalation Week 2|Determined not eligible|1
4676438|NCT02388295|7576430|FG002|Dose Escalation Week 2|Determined not eligible|1
4676439|NCT02388295|7576428|FG000|Treatment Weeks 3 to 12|Adverse Event|1
4676440|NCT02388295|7576429|FG001|Treatment Weeks 3 to 12|Adverse Event|1
4676441|NCT02388295|7576430|FG002|Treatment Weeks 3 to 12|Adverse Event|0
4676442|NCT02388347|7576452|FG000|Overall Study|Withdrawal by Subject|0
4676443|NCT02388347|7576453|FG001|Overall Study|Withdrawal by Subject|0
4676444|NCT02388347|7576454|FG002|Overall Study|Withdrawal by Subject|1
4676445|NCT02388347|7576455|FG003|Overall Study|Withdrawal by Subject|0
4676446|NCT02388347|7576456|FG004|Overall Study|Withdrawal by Subject|0
4757229|NCT02034123|7731606|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
4757230|NCT02034123|7731607|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1
4757231|NCT02034123|7731608|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
4757232|NCT02034123|7731609|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
4757233|NCT02034123|7731610|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
4757234|NCT02034123|7731611|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
4757235|NCT02034123|7731612|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
4757236|NCT02034123|7731613|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
4676447|NCT02388724|7576508|FG000|Overall Study|Reason not Specified|0
4676448|NCT02388724|7576509|FG001|Overall Study|Reason not Specified|1
4676449|NCT02388724|7576508|FG000|Overall Study|Major Protocol Deviation|3
4676450|NCT02388724|7576509|FG001|Overall Study|Major Protocol Deviation|3
4676451|NCT02388724|7576508|FG000|Overall Study|Pretreatment Event/Adverse Event|3
4676452|NCT02388724|7576509|FG001|Overall Study|Pretreatment Event/Adverse Event|2
4676453|NCT02388724|7576508|FG000|Overall Study|Voluntary Withdrawal|6
4676454|NCT02388724|7576509|FG001|Overall Study|Voluntary Withdrawal|5
4676455|NCT02388724|7576508|FG000|Overall Study|Randomized but not Treated|0
4676456|NCT02388724|7576509|FG001|Overall Study|Randomized but not Treated|2
4676457|NCT02388737|7576518|FG000|Overall Study|Pretreatment Event/Adverse Event|13
4676458|NCT02388737|7576519|FG001|Overall Study|Pretreatment Event/Adverse Event|11
4676459|NCT02388737|7576520|FG002|Overall Study|Pretreatment Event/Adverse Event|12
4676460|NCT02388737|7576518|FG000|Overall Study|Major Protocol Deviation|18
4676461|NCT02388737|7576519|FG001|Overall Study|Major Protocol Deviation|25
4676462|NCT02388737|7576520|FG002|Overall Study|Major Protocol Deviation|22
4676463|NCT02388737|7576518|FG000|Overall Study|Lost to Follow-up|5
4676464|NCT02388737|7576519|FG001|Overall Study|Lost to Follow-up|1
4676465|NCT02388737|7576520|FG002|Overall Study|Lost to Follow-up|4
4676466|NCT02388737|7576518|FG000|Overall Study|Voluntary Withdrawal|10
4676467|NCT02388737|7576519|FG001|Overall Study|Voluntary Withdrawal|18
4676468|NCT02388737|7576520|FG002|Overall Study|Voluntary Withdrawal|17
4676469|NCT02388737|7576518|FG000|Overall Study|Lack of Efficacy|3
4676470|NCT02388737|7576519|FG001|Overall Study|Lack of Efficacy|0
4676471|NCT02388737|7576520|FG002|Overall Study|Lack of Efficacy|3
4676472|NCT02388737|7576518|FG000|Overall Study|Reason Not Specified|5
4676473|NCT02388737|7576519|FG001|Overall Study|Reason Not Specified|5
4676474|NCT02388737|7576520|FG002|Overall Study|Reason Not Specified|4
4676475|NCT02388763|7576528|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1
4757237|NCT02034123|7731614|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
4757238|NCT02034123|7731615|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
4757239|NCT02034123|7731616|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
4676476|NCT02388763|7576529|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1
4676477|NCT02388763|7576528|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1
4676478|NCT02388763|7576529|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1
4676479|NCT02388932|7576546|FG000|Overall Study|Death|1
4676480|NCT02388997|7576553|FG000|Overall Study|Adverse Event|1
4676481|NCT02388997|7576554|FG001|Overall Study|Adverse Event|2
4676482|NCT02388997|7576553|FG000|Overall Study|Withdrawal by Subject|2
4676483|NCT02388997|7576554|FG001|Overall Study|Withdrawal by Subject|1
4676484|NCT02388997|7576553|FG000|Overall Study|Lung function exclusion criteria|0
4676485|NCT02388997|7576554|FG001|Overall Study|Lung function exclusion criteria|2
4676486|NCT02388997|7576553|FG000|Overall Study|Tested positive for virus during run-in|0
4676487|NCT02388997|7576554|FG001|Overall Study|Tested positive for virus during run-in|1
4676488|NCT02389452|7576601|FG000|Overall Study|Lost to Follow-up|13
4676489|NCT02389452|7576601|FG000|Overall Study|Adverse Event|1
4676490|NCT02389452|7576601|FG000|Overall Study|Withdrawal by Subject|5
4676491|NCT02389452|7576601|FG000|Overall Study|Enrolled but Not Eligible for Study|6
4676492|NCT02389621|7576608|FG000|Treatment Period|Withdrawal by Subject|1
4676493|NCT02389621|7576609|FG001|Treatment Period|Withdrawal by Subject|1
4676494|NCT02389621|7576608|FG000|Posttreatment Period|Adverse Event|3
4676495|NCT02389621|7576609|FG001|Posttreatment Period|Adverse Event|1
4676496|NCT02389621|7576608|FG000|Posttreatment Period|Withdrawal by Subject|3
4676497|NCT02389621|7576609|FG001|Posttreatment Period|Withdrawal by Subject|2
4676498|NCT02389621|7576608|FG000|Posttreatment Period|Lost to Follow-up|1
4676499|NCT02389621|7576609|FG001|Posttreatment Period|Lost to Follow-up|1
4676500|NCT02389621|7576608|FG000|Posttreatment Period|Other - Miscellaneous|2
4676501|NCT02389621|7576609|FG001|Posttreatment Period|Other - Miscellaneous|0
4676502|NCT02389764|7576634|FG000|Overall Study|Lack of Efficacy|9
4676503|NCT02389816|7576641|FG000|Overall Study|Randomized but Not Treated|1
4676504|NCT02389816|7576642|FG001|Overall Study|Randomized but Not Treated|0
4676505|NCT02389816|7576643|FG002|Overall Study|Randomized but Not Treated|0
4676506|NCT02389816|7576641|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4
4676507|NCT02389816|7576642|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6
4676508|NCT02389816|7576643|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7
4676509|NCT02389816|7576641|FG000|Overall Study|Major Protocol Deviation|1
4676510|NCT02389816|7576642|FG001|Overall Study|Major Protocol Deviation|0
4676511|NCT02389816|7576643|FG002|Overall Study|Major Protocol Deviation|0
4676512|NCT02389816|7576641|FG000|Overall Study|Lost to Follow-up|1
4676513|NCT02389816|7576642|FG001|Overall Study|Lost to Follow-up|0
4676514|NCT02389816|7576643|FG002|Overall Study|Lost to Follow-up|0
4676515|NCT02389816|7576641|FG000|Overall Study|Withdrawal of Consent|6
4676516|NCT02389816|7576642|FG001|Overall Study|Withdrawal of Consent|4
4676517|NCT02389816|7576643|FG002|Overall Study|Withdrawal of Consent|4
4676518|NCT02389816|7576641|FG000|Overall Study|Lack of Efficacy|1
4676519|NCT02389816|7576642|FG001|Overall Study|Lack of Efficacy|0
4676520|NCT02389816|7576643|FG002|Overall Study|Lack of Efficacy|0
4676521|NCT02389816|7576641|FG000|Overall Study|Non Compliance with Study Drug|1
4676522|NCT02389816|7576642|FG001|Overall Study|Non Compliance with Study Drug|1
4676523|NCT02389816|7576643|FG002|Overall Study|Non Compliance with Study Drug|1
4676524|NCT02389816|7576641|FG000|Overall Study|Reason not Specified|0
4676525|NCT02389816|7576642|FG001|Overall Study|Reason not Specified|2
4676526|NCT02389816|7576643|FG002|Overall Study|Reason not Specified|0
4676527|NCT02389829|7576653|FG000|Overall Study|Lost to Follow-up|0
4676528|NCT02389829|7576654|FG001|Overall Study|Lost to Follow-up|1
4676529|NCT02389894|7576692|FG000|Overall Study|Death|4
4676530|NCT02389894|7576693|FG001|Overall Study|Death|5
4676531|NCT02389894|7576694|FG002|Overall Study|Death|3
4676532|NCT02389894|7576692|FG000|Overall Study|Withdrawal by Subject|2
4676533|NCT02389894|7576693|FG001|Overall Study|Withdrawal by Subject|4
4676534|NCT02389894|7576694|FG002|Overall Study|Withdrawal by Subject|5
4676535|NCT02389894|7576692|FG000|Overall Study|Lost to Follow-up|2
4676536|NCT02389894|7576693|FG001|Overall Study|Lost to Follow-up|1
4676537|NCT02389894|7576694|FG002|Overall Study|Lost to Follow-up|1
4676538|NCT02389998|7576722|FG000|Overall Study|car accident|1
4676539|NCT02389998|7576723|FG001|Overall Study|car accident|0
4676540|NCT02390076|7576751|FG000|Overall Study|Lost to Follow-up|2
4676541|NCT02390076|7576752|FG001|Overall Study|Lost to Follow-up|1
4676542|NCT02390076|7576753|FG002|Overall Study|Lost to Follow-up|4
4676543|NCT02390167|7576761|FG000|Overall Study|Lost to Follow-up|1
4676544|NCT02390219|7576769|FG000|Overall Study|Death|1
4676545|NCT02390219|7576769|FG000|Overall Study|Physician Decision|1
4676546|NCT02390219|7576769|FG000|Overall Study|Adverse Event|6
4676547|NCT02390219|7576769|FG000|Overall Study|Withdrawal by Subject|1
4676548|NCT02390219|7576769|FG000|Overall Study|Lost to Follow-up|2
4676549|NCT02390219|7576769|FG000|Overall Study|Other|2
4676550|NCT02390557|7576776|FG000|Wave 2|Survey non-respondent|72
4676551|NCT02390557|7576777|FG001|Wave 2|Survey non-respondent|41
4676552|NCT02390557|7576778|FG002|Wave 2|Survey non-respondent|23
4676553|NCT02391038|7576821|FG000|Overall Study|Progressive disease|3
4676554|NCT02391038|7576822|FG001|Overall Study|Progressive disease|3
4676555|NCT02391038|7576823|FG002|Overall Study|Progressive disease|6
4676556|NCT02391116|7576832|FG000|Treatment|Withdrawal by Subject|1
4676557|NCT02391116|7576832|FG000|Treatment|Protocol Violation|1
4676558|NCT02391116|7576832|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9
4676559|NCT02391116|7576832|FG000|Treatment|AE with Clinical PD|3
4676560|NCT02391116|7576832|FG000|Safety Follow-up|Adverse Event|1
4676561|NCT02391116|7576832|FG000|Safety Follow-up|Withdrawal by Subject|4
4676562|NCT02391116|7576832|FG000|Safety Follow-up|Switching to Other Therapy|4
4757240|NCT02034123|7731599|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
4757241|NCT02034123|7731600|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
4757242|NCT02034123|7731601|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
4757243|NCT02034123|7731602|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1
4757244|NCT02034123|7731603|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1
4757245|NCT02034123|7731604|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
4757246|NCT02034123|7731605|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
4757247|NCT02034123|7731606|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
4757248|NCT02034123|7731607|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
4757249|NCT02034123|7731608|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
4757250|NCT02034123|7731609|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
4757251|NCT02034123|7731610|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
4757252|NCT02034123|7731611|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
4757253|NCT02034123|7731612|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
4757254|NCT02034123|7731613|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
4757255|NCT02034123|7731614|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
4757256|NCT02034123|7731615|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
4757257|NCT02034123|7731616|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
4676563|NCT02391116|7576832|FG000|Safety Follow-up|No Follow Up|1
4676564|NCT02391116|7576832|FG000|Safety Follow-up|Deterioration of General Conditions|3
4676565|NCT02391116|7576832|FG000|Active Follow-up|Withdrawal by Subject|1
4676566|NCT02391116|7576832|FG000|Active Follow-up|Switching to Other Therapy|2
4676567|NCT02391116|7576832|FG000|Survival Follow-up|Withdrawal by Subject|3
4676568|NCT02391116|7576832|FG000|Survival Follow-up|Switching to Other Therapy|1
4676569|NCT02391311|7576845|FG000|Overall Study|Lost to Follow-up|2
4676570|NCT02391311|7576846|FG001|Overall Study|Lost to Follow-up|1
4676571|NCT02391311|7576845|FG000|Overall Study|deemed ineligible after baseline|1
4676572|NCT02391311|7576846|FG001|Overall Study|deemed ineligible after baseline|1
4676573|NCT02391337|7576854|FG000|6 Months Follow-up|Death|5
4676574|NCT02391337|7576855|FG001|6 Months Follow-up|Death|4
4676575|NCT02391337|7576854|FG000|6 Months Follow-up|Withdrawal by Subject|1
4676576|NCT02391337|7576855|FG001|6 Months Follow-up|Withdrawal by Subject|1
4676577|NCT02391337|7576854|FG000|12 Months Follow-up|Death|2
4676578|NCT02391337|7576855|FG001|12 Months Follow-up|Death|0
4676579|NCT02391337|7576854|FG000|12 Months Follow-up|Withdrawal by Subject|0
4676580|NCT02391337|7576855|FG001|12 Months Follow-up|Withdrawal by Subject|1
4676581|NCT02391337|7576854|FG000|12 Months Follow-up|Lost to Follow-up|0
4676582|NCT02391337|7576855|FG001|12 Months Follow-up|Lost to Follow-up|2
4676583|NCT02391363|7576872|FG000|Overall Study|Lost to Follow-up|5
4676584|NCT02391363|7576873|FG001|Overall Study|Lost to Follow-up|5
4676585|NCT02391363|7576872|FG000|Overall Study|Withdrawal by Subject|6
4676586|NCT02391363|7576873|FG001|Overall Study|Withdrawal by Subject|3
4676587|NCT02391545|7576881|FG000|Overall Study|Death|0
4676588|NCT02391545|7576882|FG001|Overall Study|Death|2
4676589|NCT02391545|7576881|FG000|Overall Study|Lost to Follow-up|0
4676590|NCT02391545|7576882|FG001|Overall Study|Lost to Follow-up|1
4676591|NCT02391545|7576881|FG000|Overall Study|Termination of study by sponsor|20
4676592|NCT02391545|7576882|FG001|Overall Study|Termination of study by sponsor|20
4676593|NCT02391545|7576881|FG000|Overall Study|Withdrawal by Subject|0
4676594|NCT02391545|7576882|FG001|Overall Study|Withdrawal by Subject|1
4676595|NCT02391545|7576881|FG000|Overall Study|Other Reasons|6
4676596|NCT02391545|7576882|FG001|Overall Study|Other Reasons|4
4676597|NCT02391584|7576891|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1
4676598|NCT02391584|7576892|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2
4676599|NCT02391584|7576891|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1
4676600|NCT02391584|7576892|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0
4676601|NCT02391584|7576891|FG000|3 Month|Lost to Follow-up|1
4676602|NCT02391584|7576892|FG001|3 Month|Lost to Follow-up|0
4676603|NCT02391584|7576891|FG000|6 Month|Withdrawal by Subject|1
4676604|NCT02391584|7576892|FG001|6 Month|Withdrawal by Subject|0
4676605|NCT02391584|7576891|FG000|12 Month (End of Study)|Lost to Follow-up|2
4676606|NCT02391584|7576892|FG001|12 Month (End of Study)|Lost to Follow-up|0
4676607|NCT02391948|7576926|FG000|6-month Assessment|Death|0
4676608|NCT02391948|7576927|FG001|6-month Assessment|Death|0
4676609|NCT02391948|7576928|FG002|6-month Assessment|Death|0
4676610|NCT02391948|7576929|FG003|6-month Assessment|Death|0
4676611|NCT02391948|7576930|FG004|6-month Assessment|Death|1
4676612|NCT02391948|7576926|FG000|6-month Assessment|Withdrawal by Subject|0
4676613|NCT02391948|7576927|FG001|6-month Assessment|Withdrawal by Subject|0
4676614|NCT02391948|7576928|FG002|6-month Assessment|Withdrawal by Subject|1
4676615|NCT02391948|7576929|FG003|6-month Assessment|Withdrawal by Subject|2
4676616|NCT02391948|7576930|FG004|6-month Assessment|Withdrawal by Subject|0
4676617|NCT02391948|7576926|FG000|6-month Assessment|Lost to Follow-up|4
4676618|NCT02391948|7576927|FG001|6-month Assessment|Lost to Follow-up|5
4676619|NCT02391948|7576928|FG002|6-month Assessment|Lost to Follow-up|2
4676620|NCT02391948|7576929|FG003|6-month Assessment|Lost to Follow-up|3
4676621|NCT02391948|7576930|FG004|6-month Assessment|Lost to Follow-up|1
4676622|NCT02391948|7576926|FG000|6-month Assessment|Medical issue/illness|1
4676623|NCT02391948|7576927|FG001|6-month Assessment|Medical issue/illness|1
4676624|NCT02391948|7576928|FG002|6-month Assessment|Medical issue/illness|0
4676625|NCT02391948|7576929|FG003|6-month Assessment|Medical issue/illness|0
4676626|NCT02391948|7576930|FG004|6-month Assessment|Medical issue/illness|0
4676627|NCT02391948|7576926|FG000|6-month Assessment|Not able to schedule visit in timeframe|6
4676628|NCT02391948|7576927|FG001|6-month Assessment|Not able to schedule visit in timeframe|8
4676629|NCT02391948|7576928|FG002|6-month Assessment|Not able to schedule visit in timeframe|4
4676630|NCT02391948|7576929|FG003|6-month Assessment|Not able to schedule visit in timeframe|5
4676631|NCT02391948|7576930|FG004|6-month Assessment|Not able to schedule visit in timeframe|0
4676632|NCT02391948|7576926|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68
4676633|NCT02391948|7576927|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42
4676634|NCT02391948|7576928|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24
4676635|NCT02391948|7576929|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35
4676636|NCT02391948|7576930|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24
4676637|NCT02391948|7576926|FG000|12-month Assessment|Death|0
4676638|NCT02391948|7576927|FG001|12-month Assessment|Death|0
4676639|NCT02391948|7576928|FG002|12-month Assessment|Death|0
4676640|NCT02391948|7576929|FG003|12-month Assessment|Death|1
4676641|NCT02391948|7576930|FG004|12-month Assessment|Death|0
4676642|NCT02391948|7576926|FG000|12-month Assessment|Withdrawal by Subject|1
4676643|NCT02391948|7576927|FG001|12-month Assessment|Withdrawal by Subject|0
4676644|NCT02391948|7576928|FG002|12-month Assessment|Withdrawal by Subject|0
4676645|NCT02391948|7576929|FG003|12-month Assessment|Withdrawal by Subject|1
4676646|NCT02391948|7576930|FG004|12-month Assessment|Withdrawal by Subject|0
4676647|NCT02391948|7576926|FG000|12-month Assessment|Lost to Follow-up|5
4676648|NCT02391948|7576927|FG001|12-month Assessment|Lost to Follow-up|4
4676649|NCT02391948|7576928|FG002|12-month Assessment|Lost to Follow-up|4
4676650|NCT02391948|7576929|FG003|12-month Assessment|Lost to Follow-up|4
4676651|NCT02391948|7576930|FG004|12-month Assessment|Lost to Follow-up|5
4676652|NCT02391948|7576926|FG000|12-month Assessment|Medical issue/illness|0
4676653|NCT02391948|7576927|FG001|12-month Assessment|Medical issue/illness|1
4676654|NCT02391948|7576928|FG002|12-month Assessment|Medical issue/illness|0
4676655|NCT02391948|7576929|FG003|12-month Assessment|Medical issue/illness|1
4676656|NCT02391948|7576930|FG004|12-month Assessment|Medical issue/illness|0
4676657|NCT02391948|7576926|FG000|12-month Assessment|Not able to schedule visit in timeframe|2
4676658|NCT02391948|7576927|FG001|12-month Assessment|Not able to schedule visit in timeframe|4
4757258|NCT02040584|7731661|FG000|Overall Study|Adverse Event|13
4757259|NCT02040584|7731662|FG001|Overall Study|Adverse Event|6
4757260|NCT02040584|7731661|FG000|Overall Study|Protocol Violation|9
4757261|NCT02040584|7731662|FG001|Overall Study|Protocol Violation|11
4757262|NCT02040584|7731661|FG000|Overall Study|Unsatisfactory therapeutic effect|0
4757263|NCT02040584|7731662|FG001|Overall Study|Unsatisfactory therapeutic effect|1
4757264|NCT02040584|7731661|FG000|Overall Study|Death|6
4757265|NCT02040584|7731662|FG001|Overall Study|Death|3
4757266|NCT02040584|7731661|FG000|Overall Study|Transplant rejection/retransplant|0
4757267|NCT02040584|7731662|FG001|Overall Study|Transplant rejection/retransplant|1
4676659|NCT02391948|7576928|FG002|12-month Assessment|Not able to schedule visit in timeframe|0
4676660|NCT02391948|7576929|FG003|12-month Assessment|Not able to schedule visit in timeframe|2
4676661|NCT02391948|7576930|FG004|12-month Assessment|Not able to schedule visit in timeframe|1
4676662|NCT02391948|7576926|FG000|18-month Assessment|Death|0
4676663|NCT02391948|7576927|FG001|18-month Assessment|Death|0
4676664|NCT02391948|7576928|FG002|18-month Assessment|Death|0
4676665|NCT02391948|7576929|FG003|18-month Assessment|Death|1
4676666|NCT02391948|7576930|FG004|18-month Assessment|Death|1
4676667|NCT02391948|7576926|FG000|18-month Assessment|Withdrawal by Subject|1
4676668|NCT02391948|7576927|FG001|18-month Assessment|Withdrawal by Subject|0
4676669|NCT02391948|7576928|FG002|18-month Assessment|Withdrawal by Subject|0
4676670|NCT02391948|7576929|FG003|18-month Assessment|Withdrawal by Subject|1
4676671|NCT02391948|7576930|FG004|18-month Assessment|Withdrawal by Subject|0
4676672|NCT02391948|7576926|FG000|18-month Assessment|Lost to Follow-up|2
4676673|NCT02391948|7576927|FG001|18-month Assessment|Lost to Follow-up|6
4676674|NCT02391948|7576928|FG002|18-month Assessment|Lost to Follow-up|2
4676675|NCT02391948|7576929|FG003|18-month Assessment|Lost to Follow-up|2
4676676|NCT02391948|7576930|FG004|18-month Assessment|Lost to Follow-up|3
4676677|NCT02391948|7576926|FG000|18-month Assessment|Not able to schedule visit in timeframe|3
4676678|NCT02391948|7576927|FG001|18-month Assessment|Not able to schedule visit in timeframe|3
4676679|NCT02391948|7576928|FG002|18-month Assessment|Not able to schedule visit in timeframe|2
4676680|NCT02391948|7576929|FG003|18-month Assessment|Not able to schedule visit in timeframe|1
4676681|NCT02391948|7576930|FG004|18-month Assessment|Not able to schedule visit in timeframe|4
4676682|NCT02391948|7576926|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66
4676683|NCT02391948|7576927|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41
4676684|NCT02391948|7576928|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22
4676685|NCT02391948|7576929|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31
4676686|NCT02391948|7576930|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22
4676687|NCT02391948|7576926|FG000|24-month Assessment|Death|0
4676688|NCT02391948|7576927|FG001|24-month Assessment|Death|0
4676689|NCT02391948|7576928|FG002|24-month Assessment|Death|0
4676690|NCT02391948|7576929|FG003|24-month Assessment|Death|0
4676691|NCT02391948|7576930|FG004|24-month Assessment|Death|1
4676692|NCT02391948|7576926|FG000|24-month Assessment|Withdrawal by Subject|1
4676693|NCT02391948|7576927|FG001|24-month Assessment|Withdrawal by Subject|1
4676694|NCT02391948|7576928|FG002|24-month Assessment|Withdrawal by Subject|0
4676695|NCT02391948|7576929|FG003|24-month Assessment|Withdrawal by Subject|0
4676696|NCT02391948|7576930|FG004|24-month Assessment|Withdrawal by Subject|1
4676697|NCT02391948|7576926|FG000|24-month Assessment|Lost to Follow-up|5
4676698|NCT02391948|7576927|FG001|24-month Assessment|Lost to Follow-up|4
4676699|NCT02391948|7576928|FG002|24-month Assessment|Lost to Follow-up|0
4676700|NCT02391948|7576929|FG003|24-month Assessment|Lost to Follow-up|0
4676701|NCT02391948|7576930|FG004|24-month Assessment|Lost to Follow-up|0
4676702|NCT02391948|7576926|FG000|24-month Assessment|Medical issue/illness|0
4676703|NCT02391948|7576927|FG001|24-month Assessment|Medical issue/illness|0
4676704|NCT02391948|7576928|FG002|24-month Assessment|Medical issue/illness|1
4676705|NCT02391948|7576929|FG003|24-month Assessment|Medical issue/illness|0
4676706|NCT02391948|7576930|FG004|24-month Assessment|Medical issue/illness|0
4676707|NCT02391948|7576926|FG000|24-month Assessment|Not able to schedule visit in timeframe|8
4676708|NCT02391948|7576927|FG001|24-month Assessment|Not able to schedule visit in timeframe|5
4676709|NCT02391948|7576928|FG002|24-month Assessment|Not able to schedule visit in timeframe|2
4676710|NCT02391948|7576929|FG003|24-month Assessment|Not able to schedule visit in timeframe|9
4676711|NCT02391948|7576930|FG004|24-month Assessment|Not able to schedule visit in timeframe|8
4676712|NCT02391961|7576947|FG000|First Intervention (4 Weeks)|Adverse Event|2
4676713|NCT02391961|7576948|FG001|First Intervention (4 Weeks)|Adverse Event|0
4676714|NCT02391961|7576947|FG000|Washout (2 Weeks)|Withdrawal by Subject|1
4676715|NCT02391961|7576948|FG001|Washout (2 Weeks)|Withdrawal by Subject|1
4757268|NCT02040584|7731661|FG000|Overall Study|Immunosuppressant/prohibited med use|7
4676716|NCT02391961|7576947|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1
4757269|NCT02040584|7731662|FG001|Overall Study|Immunosuppressant/prohibited med use|10
4676717|NCT02391961|7576948|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1
4676718|NCT02392000|7576963|FG000|Overall Study|Greater than mild sleep apnea exclusion|18
4676719|NCT02392000|7576963|FG000|Overall Study|Withdrawal by Subject|1
4676720|NCT02392000|7576963|FG000|Overall Study|Lost to Follow-up|8
4676721|NCT02392104|7576968|FG000|Overall Study|discontinuation of warfarin|3
4676722|NCT02392104|7576968|FG000|Overall Study|bleeding event|1
4676723|NCT02392104|7576968|FG000|Overall Study|transferred care to another doctor|2
4676724|NCT02392104|7576968|FG000|Overall Study|INR goal range changed|1
4676725|NCT02392104|7576968|FG000|Overall Study|admitted to skilled nursing facility|3
4676726|NCT02392104|7576968|FG000|Overall Study|INRs drawn by visiting nurse services|1
4676727|NCT02392195|7576972|FG000|Overall Study|Lost to Follow-up|4
4676728|NCT02392195|7576972|FG000|Overall Study|Withdrawal by Subject|4
4676729|NCT02392234|7576987|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1
4676730|NCT02392234|7576988|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0
4676731|NCT02392234|7576989|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1
4676732|NCT02392234|7576990|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0
4676733|NCT02392234|7576991|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1
4676734|NCT02392234|7576992|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1
4676735|NCT02392234|7576987|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
4676736|NCT02392234|7576988|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
4676737|NCT02392234|7576989|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
4676738|NCT02392234|7576990|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
4676739|NCT02392234|7576991|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2
4676740|NCT02392234|7576992|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
4676741|NCT02392234|7576987|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
4676742|NCT02392234|7576988|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
4676743|NCT02392234|7576989|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
4676744|NCT02392234|7576990|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
4676745|NCT02392234|7576991|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
4676746|NCT02392234|7576992|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1
4676747|NCT02392234|7576987|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1
4676748|NCT02392234|7576988|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0
4676749|NCT02392234|7576989|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0
4676750|NCT02392234|7576990|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1
4676751|NCT02392234|7576991|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0
4676752|NCT02392234|7576992|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0
4676753|NCT02392234|7576987|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0
4676754|NCT02392234|7576988|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0
4676755|NCT02392234|7576989|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0
4676756|NCT02392234|7576990|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0
4676757|NCT02392234|7576991|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0
4676758|NCT02392234|7576992|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1
4676759|NCT02392234|7576987|FG000|Treatment Period 1 (8 Weeks)|Other|1
4676760|NCT02392234|7576988|FG001|Treatment Period 1 (8 Weeks)|Other|0
4676761|NCT02392234|7576989|FG002|Treatment Period 1 (8 Weeks)|Other|0
4676762|NCT02392234|7576990|FG003|Treatment Period 1 (8 Weeks)|Other|0
4676763|NCT02392234|7576991|FG004|Treatment Period 1 (8 Weeks)|Other|0
4676764|NCT02392234|7576992|FG005|Treatment Period 1 (8 Weeks)|Other|0
4676765|NCT02392234|7576987|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
4676766|NCT02392234|7576988|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
4676767|NCT02392234|7576989|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1
4676768|NCT02392234|7576990|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
4676769|NCT02392234|7576991|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1
4676770|NCT02392234|7576992|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
4676771|NCT02392234|7576987|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1
4676772|NCT02392234|7576988|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0
4676773|NCT02392234|7576989|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0
4676774|NCT02392234|7576990|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0
4757270|NCT02045797|7731681|FG000|Overall Study|Adverse Event|3
4757271|NCT02045797|7731682|FG001|Overall Study|Adverse Event|1
4757272|NCT02045797|7731683|FG002|Overall Study|Adverse Event|0
4757273|NCT02045797|7731681|FG000|Overall Study|Lack of Efficacy|1
4757274|NCT02045797|7731682|FG001|Overall Study|Lack of Efficacy|0
4757275|NCT02045797|7731683|FG002|Overall Study|Lack of Efficacy|0
4757276|NCT02045797|7731681|FG000|Overall Study|Lost to Follow-up|2
4757277|NCT02045797|7731682|FG001|Overall Study|Lost to Follow-up|3
4757278|NCT02045797|7731683|FG002|Overall Study|Lost to Follow-up|1
4757279|NCT02045797|7731681|FG000|Overall Study|Physician Decision|0
4757280|NCT02045797|7731682|FG001|Overall Study|Physician Decision|1
4757281|NCT02045797|7731683|FG002|Overall Study|Physician Decision|0
4757282|NCT02045797|7731681|FG000|Overall Study|Withdrawal by Subject|1
4757283|NCT02045797|7731682|FG001|Overall Study|Withdrawal by Subject|2
4757284|NCT02045797|7731683|FG002|Overall Study|Withdrawal by Subject|0
4757285|NCT02049710|7731693|FG000|Overall Study|Lost to Follow-up|319
4757286|NCT02049710|7731694|FG001|Overall Study|Lost to Follow-up|324
4757287|NCT02055547|7731700|FG000|Overall Study|Protocol Violation|0
4757288|NCT02055547|7731701|FG001|Overall Study|Protocol Violation|0
4757289|NCT02055547|7731702|FG002|Overall Study|Protocol Violation|1
4757290|NCT02055547|7731703|FG003|Overall Study|Protocol Violation|0
4757291|NCT02055547|7731704|FG004|Overall Study|Protocol Violation|0
4757292|NCT02055547|7731705|FG005|Overall Study|Protocol Violation|0
4757293|NCT02055547|7731706|FG006|Overall Study|Protocol Violation|1
4757294|NCT02055547|7731707|FG007|Overall Study|Protocol Violation|0
4757295|NCT02055547|7731708|FG008|Overall Study|Protocol Violation|0
4757296|NCT02055547|7731709|FG009|Overall Study|Protocol Violation|0
4757297|NCT02055547|7731710|FG010|Overall Study|Protocol Violation|0
4757298|NCT02055547|7731711|FG011|Overall Study|Protocol Violation|0
4757299|NCT02055547|7731712|FG012|Overall Study|Protocol Violation|0
4757300|NCT02055547|7731713|FG013|Overall Study|Protocol Violation|0
4757301|NCT02055547|7731714|FG014|Overall Study|Protocol Violation|0
4757302|NCT02055547|7731715|FG015|Overall Study|Protocol Violation|0
4676775|NCT02392234|7576991|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0
4676776|NCT02392234|7576992|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0
4676777|NCT02392247|7577003|FG000|Overall Study|Withdrawal by Subject|1
4676778|NCT02392247|7577003|FG000|Overall Study|Surgery cancelled; no data|1
4676779|NCT02392403|7577025|FG000|Overall Study|Adverse Event|1
4757303|NCT02055547|7731716|FG016|Overall Study|Protocol Violation|0
4757304|NCT02055547|7731717|FG017|Overall Study|Protocol Violation|0
4757305|NCT02055547|7731718|FG018|Overall Study|Protocol Violation|0
4757306|NCT02055547|7731700|FG000|Overall Study|Physician Decision|0
4757307|NCT02055547|7731701|FG001|Overall Study|Physician Decision|1
4676780|NCT02392403|7577025|FG000|Overall Study|Death|1
4676781|NCT02392403|7577025|FG000|Overall Study|Withdrawal by Subject|1
4676782|NCT02392481|7577033|FG000|Overall Study|Adverse Event|0
4676783|NCT02392481|7577034|FG001|Overall Study|Adverse Event|0
4676784|NCT02392481|7577035|FG002|Overall Study|Adverse Event|1
4676785|NCT02392481|7577036|FG003|Overall Study|Adverse Event|2
4676786|NCT02392481|7577033|FG000|Overall Study|Withdrawal by Subject|0
4676787|NCT02392481|7577034|FG001|Overall Study|Withdrawal by Subject|0
4676788|NCT02392481|7577035|FG002|Overall Study|Withdrawal by Subject|1
4676789|NCT02392481|7577036|FG003|Overall Study|Withdrawal by Subject|0
4676790|NCT02392507|7577060|FG000|Induction Regimen|Death|3
4676791|NCT02392507|7577060|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1
4676792|NCT02392507|7577060|FG000|Induction Regimen|Physician Decision|1
4676793|NCT02392507|7577060|FG000|Induction Regimen|Withdrawal by Subject|2
4676794|NCT02392507|7577060|FG000|Maintenance Regimen|Death|1
4676795|NCT02392507|7577060|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1
4676796|NCT02392559|7577071|FG000|Overall Study|Withdrawal by Subject|0
4676797|NCT02392559|7577072|FG001|Overall Study|Withdrawal by Subject|1
4676798|NCT02392611|7577088|FG000|Overall Study|Adverse Event|0
4676799|NCT02392611|7577089|FG001|Overall Study|Adverse Event|0
4676800|NCT02392611|7577090|FG002|Overall Study|Adverse Event|0
4676801|NCT02392611|7577091|FG003|Overall Study|Adverse Event|1
4676802|NCT02392611|7577092|FG004|Overall Study|Adverse Event|0
4676803|NCT02392611|7577093|FG005|Overall Study|Adverse Event|0
4676804|NCT02392611|7577094|FG006|Overall Study|Adverse Event|0
4676805|NCT02392611|7577095|FG007|Overall Study|Adverse Event|0
4676806|NCT02392611|7577096|FG008|Overall Study|Adverse Event|0
4676807|NCT02392611|7577088|FG000|Overall Study|Progressive disease|0
4676808|NCT02392611|7577089|FG001|Overall Study|Progressive disease|0
4676809|NCT02392611|7577090|FG002|Overall Study|Progressive disease|0
4676810|NCT02392611|7577091|FG003|Overall Study|Progressive disease|2
4676811|NCT02392611|7577092|FG004|Overall Study|Progressive disease|1
4676812|NCT02392611|7577093|FG005|Overall Study|Progressive disease|0
4676813|NCT02392611|7577094|FG006|Overall Study|Progressive disease|0
4676814|NCT02392611|7577095|FG007|Overall Study|Progressive disease|0
4676815|NCT02392611|7577096|FG008|Overall Study|Progressive disease|0
4676816|NCT02392611|7577088|FG000|Overall Study|Death|1
4676817|NCT02392611|7577089|FG001|Overall Study|Death|0
4676818|NCT02392611|7577090|FG002|Overall Study|Death|0
4676819|NCT02392611|7577091|FG003|Overall Study|Death|0
4676820|NCT02392611|7577092|FG004|Overall Study|Death|0
4676821|NCT02392611|7577093|FG005|Overall Study|Death|1
4676822|NCT02392611|7577094|FG006|Overall Study|Death|0
4676823|NCT02392611|7577095|FG007|Overall Study|Death|0
4676824|NCT02392611|7577096|FG008|Overall Study|Death|0
4676825|NCT02392611|7577088|FG000|Overall Study|Withdrawal by Subject|0
4676826|NCT02392611|7577089|FG001|Overall Study|Withdrawal by Subject|0
4676827|NCT02392611|7577090|FG002|Overall Study|Withdrawal by Subject|0
4676828|NCT02392611|7577091|FG003|Overall Study|Withdrawal by Subject|1
4676829|NCT02392611|7577092|FG004|Overall Study|Withdrawal by Subject|0
4676830|NCT02392611|7577093|FG005|Overall Study|Withdrawal by Subject|0
4676831|NCT02392611|7577094|FG006|Overall Study|Withdrawal by Subject|0
4676832|NCT02392611|7577095|FG007|Overall Study|Withdrawal by Subject|0
4676833|NCT02392611|7577096|FG008|Overall Study|Withdrawal by Subject|0
4676834|NCT02392611|7577088|FG000|Overall Study|Lost to Follow-up|0
4676835|NCT02392611|7577089|FG001|Overall Study|Lost to Follow-up|0
4676836|NCT02392611|7577090|FG002|Overall Study|Lost to Follow-up|0
4676837|NCT02392611|7577091|FG003|Overall Study|Lost to Follow-up|0
4676838|NCT02392611|7577092|FG004|Overall Study|Lost to Follow-up|0
4676839|NCT02392611|7577093|FG005|Overall Study|Lost to Follow-up|0
4676840|NCT02392611|7577094|FG006|Overall Study|Lost to Follow-up|1
4676841|NCT02392611|7577095|FG007|Overall Study|Lost to Follow-up|0
4676842|NCT02392611|7577096|FG008|Overall Study|Lost to Follow-up|0
4676843|NCT02392611|7577088|FG000|Overall Study|Enrolled, not treated|0
4676844|NCT02392611|7577089|FG001|Overall Study|Enrolled, not treated|0
4676845|NCT02392611|7577090|FG002|Overall Study|Enrolled, not treated|0
4676846|NCT02392611|7577091|FG003|Overall Study|Enrolled, not treated|2
4676847|NCT02392611|7577092|FG004|Overall Study|Enrolled, not treated|0
4676848|NCT02392611|7577093|FG005|Overall Study|Enrolled, not treated|0
4676849|NCT02392611|7577094|FG006|Overall Study|Enrolled, not treated|0
4676850|NCT02392611|7577095|FG007|Overall Study|Enrolled, not treated|0
4676851|NCT02392611|7577096|FG008|Overall Study|Enrolled, not treated|0
4676852|NCT02392624|7577119|FG000|Overall Study|Withdrawal by Subject|15
4676853|NCT02392624|7577120|FG001|Overall Study|Withdrawal by Subject|12
4676854|NCT02392624|7577121|FG002|Overall Study|Withdrawal by Subject|9
4676855|NCT02392624|7577119|FG000|Overall Study|Adverse Event|4
4676856|NCT02392624|7577120|FG001|Overall Study|Adverse Event|1
4676857|NCT02392624|7577121|FG002|Overall Study|Adverse Event|2
4676858|NCT02392624|7577119|FG000|Overall Study|Pregnancy|1
4676859|NCT02392624|7577120|FG001|Overall Study|Pregnancy|0
4676860|NCT02392624|7577121|FG002|Overall Study|Pregnancy|0
4676861|NCT02392624|7577119|FG000|Overall Study|Protocol Violation|0
4676862|NCT02392624|7577120|FG001|Overall Study|Protocol Violation|0
4676863|NCT02392624|7577121|FG002|Overall Study|Protocol Violation|1
4676864|NCT02392624|7577119|FG000|Overall Study|Sponsor/Investigator Decision|2
4676865|NCT02392624|7577120|FG001|Overall Study|Sponsor/Investigator Decision|1
4676866|NCT02392624|7577121|FG002|Overall Study|Sponsor/Investigator Decision|0
4676867|NCT02392624|7577119|FG000|Overall Study|Other|49
4676868|NCT02392624|7577120|FG001|Overall Study|Other|1
4676869|NCT02392624|7577121|FG002|Overall Study|Other|1
4676870|NCT02393209|7577151|FG000|Overall Study|Study Terminated by Sponsor|1
4676871|NCT02393209|7577152|FG001|Overall Study|Study Terminated by Sponsor|1
4676872|NCT02393209|7577153|FG002|Overall Study|Study Terminated by Sponsor|0
4676873|NCT02393209|7577154|FG003|Overall Study|Study Terminated by Sponsor|0
4676874|NCT02393209|7577151|FG000|Overall Study|Withdrawal by Patient|1
4676875|NCT02393209|7577152|FG001|Overall Study|Withdrawal by Patient|0
4676876|NCT02393209|7577153|FG002|Overall Study|Withdrawal by Patient|0
4676877|NCT02393209|7577154|FG003|Overall Study|Withdrawal by Patient|0
4676878|NCT02393209|7577151|FG000|Overall Study|Death|2
4676879|NCT02393209|7577152|FG001|Overall Study|Death|2
4676880|NCT02393209|7577153|FG002|Overall Study|Death|0
4676881|NCT02393209|7577154|FG003|Overall Study|Death|0
4676882|NCT02393209|7577151|FG000|Overall Study|Death due to Disease Progression|2
4676883|NCT02393209|7577152|FG001|Overall Study|Death due to Disease Progression|2
4676884|NCT02393209|7577153|FG002|Overall Study|Death due to Disease Progression|0
4676885|NCT02393209|7577154|FG003|Overall Study|Death due to Disease Progression|0
4757308|NCT02055547|7731702|FG002|Overall Study|Physician Decision|1
4757309|NCT02055547|7731703|FG003|Overall Study|Physician Decision|0
4757310|NCT02055547|7731704|FG004|Overall Study|Physician Decision|1
4757311|NCT02055547|7731705|FG005|Overall Study|Physician Decision|0
4757312|NCT02055547|7731706|FG006|Overall Study|Physician Decision|0
4757313|NCT02055547|7731707|FG007|Overall Study|Physician Decision|0
4757314|NCT02055547|7731708|FG008|Overall Study|Physician Decision|0
4757315|NCT02055547|7731709|FG009|Overall Study|Physician Decision|1
4757316|NCT02055547|7731710|FG010|Overall Study|Physician Decision|1
4757317|NCT02055547|7731711|FG011|Overall Study|Physician Decision|0
4757318|NCT02055547|7731712|FG012|Overall Study|Physician Decision|0
4757319|NCT02055547|7731713|FG013|Overall Study|Physician Decision|0
4757320|NCT02055547|7731714|FG014|Overall Study|Physician Decision|0
4757321|NCT02055547|7731715|FG015|Overall Study|Physician Decision|0
4757322|NCT02055547|7731716|FG016|Overall Study|Physician Decision|0
4757323|NCT02055547|7731717|FG017|Overall Study|Physician Decision|0
4676886|NCT02393209|7577151|FG000|Overall Study|Death from Legionella Infection|0
4676887|NCT02393209|7577152|FG001|Overall Study|Death from Legionella Infection|1
4676888|NCT02393209|7577153|FG002|Overall Study|Death from Legionella Infection|0
4676889|NCT02393209|7577154|FG003|Overall Study|Death from Legionella Infection|0
4676890|NCT02393209|7577151|FG000|Overall Study|Patient Seen by Another Oncologist|0
4676891|NCT02393209|7577152|FG001|Overall Study|Patient Seen by Another Oncologist|1
4676892|NCT02393209|7577153|FG002|Overall Study|Patient Seen by Another Oncologist|0
4676893|NCT02393209|7577154|FG003|Overall Study|Patient Seen by Another Oncologist|0
4676894|NCT02393209|7577151|FG000|Overall Study|Lost to Follow-up|0
4676895|NCT02393209|7577152|FG001|Overall Study|Lost to Follow-up|1
4676896|NCT02393209|7577153|FG002|Overall Study|Lost to Follow-up|0
4676897|NCT02393209|7577154|FG003|Overall Study|Lost to Follow-up|0
4676898|NCT02393547|7577199|FG000|Overall Study|Adverse Event|2
4676899|NCT02393547|7577199|FG000|Overall Study|Withdrawal by Subject|3
4676900|NCT02393547|7577199|FG000|Overall Study|Lost to Follow-up|1
4676901|NCT02393755|7577214|FG000|Overall Study|Withdrawal by Subject|0
4676902|NCT02393755|7577215|FG001|Overall Study|Withdrawal by Subject|3
4676903|NCT02393755|7577214|FG000|Overall Study|Adverse Event|0
4676904|NCT02393755|7577215|FG001|Overall Study|Adverse Event|2
4676905|NCT02393755|7577214|FG000|Overall Study|Physician Decision|0
4676906|NCT02393755|7577215|FG001|Overall Study|Physician Decision|2
4676907|NCT02393950|7577222|FG000|Overall Study|Adverse Event|1
4676908|NCT02393950|7577223|FG001|Overall Study|Adverse Event|0
4676909|NCT02393950|7577222|FG000|Overall Study|Withdrawal by Subject|0
4676910|NCT02393950|7577223|FG001|Overall Study|Withdrawal by Subject|1
4676911|NCT02394275|7577258|FG000|Overall Study|Adverse Event|22
4676912|NCT02394275|7577258|FG000|Overall Study|Lost to Follow-up|7
4676913|NCT02394340|7577263|FG000|Overall Study|Failed drug screen test|1
4676914|NCT02394340|7577263|FG000|Overall Study|Adverse Event|1
4676915|NCT02394561|7577278|FG000|CORE Phase|Adverse Event|7
4676916|NCT02394561|7577279|FG001|CORE Phase|Adverse Event|9
4676917|NCT02394561|7577278|FG000|CORE Phase|Death|0
4676918|NCT02394561|7577279|FG001|CORE Phase|Death|1
4676919|NCT02394561|7577278|FG000|CORE Phase|Pregnancy|1
4676920|NCT02394561|7577279|FG001|CORE Phase|Pregnancy|0
4676921|NCT02394561|7577278|FG000|CORE Phase|Lost to Follow-up|1
4676922|NCT02394561|7577279|FG001|CORE Phase|Lost to Follow-up|0
4676923|NCT02394561|7577278|FG000|CORE Phase|Physician Decision|1
4676924|NCT02394561|7577279|FG001|CORE Phase|Physician Decision|1
4676925|NCT02394561|7577278|FG000|CORE Phase|Withdrawal by Subject|2
4676926|NCT02394561|7577279|FG001|CORE Phase|Withdrawal by Subject|2
4676927|NCT02394561|7577278|FG000|CORE Phase|Lack of Efficacy|1
4676928|NCT02394561|7577279|FG001|CORE Phase|Lack of Efficacy|6
4757324|NCT02055547|7731718|FG018|Overall Study|Physician Decision|0
4757325|NCT02055547|7731700|FG000|Overall Study|Adverse Event|0
4757326|NCT02055547|7731701|FG001|Overall Study|Adverse Event|0
4757327|NCT02055547|7731702|FG002|Overall Study|Adverse Event|0
4676929|NCT02394561|7577278|FG000|Extension Phase|Adverse Event|6
4757328|NCT02055547|7731703|FG003|Overall Study|Adverse Event|0
4757329|NCT02055547|7731704|FG004|Overall Study|Adverse Event|0
4676930|NCT02394561|7577279|FG001|Extension Phase|Adverse Event|1
4676931|NCT02394561|7577278|FG000|Extension Phase|Death|0
4676932|NCT02394561|7577279|FG001|Extension Phase|Death|1
4676933|NCT02394561|7577278|FG000|Extension Phase|Protocol Violation|1
4676934|NCT02394561|7577279|FG001|Extension Phase|Protocol Violation|0
4676935|NCT02394561|7577278|FG000|Extension Phase|Lost to Follow-up|1
4676936|NCT02394561|7577279|FG001|Extension Phase|Lost to Follow-up|0
4676937|NCT02394561|7577278|FG000|Extension Phase|Physician Decision|0
4676938|NCT02394561|7577279|FG001|Extension Phase|Physician Decision|2
4676939|NCT02394561|7577278|FG000|Extension Phase|Withdrawal by Subject|0
4676940|NCT02394561|7577279|FG001|Extension Phase|Withdrawal by Subject|5
4676941|NCT02394561|7577278|FG000|Extension Phase|Lack of Efficacy|3
4676942|NCT02394561|7577279|FG001|Extension Phase|Lack of Efficacy|3
4676943|NCT02394600|7577290|FG000|Overall Study|Adverse Event|3
4676944|NCT02394600|7577291|FG001|Overall Study|Adverse Event|0
4676945|NCT02394600|7577290|FG000|Overall Study|Lost to Follow-up|0
4676946|NCT02394600|7577291|FG001|Overall Study|Lost to Follow-up|1
4676947|NCT02394600|7577290|FG000|Overall Study|Withdrawal by Subject|0
4676948|NCT02394600|7577291|FG001|Overall Study|Withdrawal by Subject|1
4676949|NCT02394600|7577290|FG000|Overall Study|Protocol Violation|1
4676950|NCT02394600|7577291|FG001|Overall Study|Protocol Violation|0
4676951|NCT02394730|7577299|FG000|Overall Study|Lost to Follow-up|1
4676952|NCT02394730|7577300|FG001|Overall Study|Lost to Follow-up|0
4676953|NCT02394730|7577299|FG000|Overall Study|Withdrawal by Subject|0
4676954|NCT02394730|7577300|FG001|Overall Study|Withdrawal by Subject|1
4676955|NCT02394756|7577306|FG000|Period 1|Lens Discomfort|0
4676956|NCT02394756|7577307|FG001|Period 1|Lens Discomfort|0
4676957|NCT02394756|7577308|FG002|Period 1|Lens Discomfort|0
4676958|NCT02394756|7577309|FG003|Period 1|Lens Discomfort|0
4676959|NCT02394756|7577310|FG004|Period 1|Lens Discomfort|0
4676960|NCT02394756|7577311|FG005|Period 1|Lens Discomfort|1
4676961|NCT02394756|7577306|FG000|Period 1|Withdrawal by Subject|0
4676962|NCT02394756|7577307|FG001|Period 1|Withdrawal by Subject|1
4676963|NCT02394756|7577308|FG002|Period 1|Withdrawal by Subject|1
4676964|NCT02394756|7577309|FG003|Period 1|Withdrawal by Subject|1
4676965|NCT02394756|7577310|FG004|Period 1|Withdrawal by Subject|0
4676966|NCT02394756|7577311|FG005|Period 1|Withdrawal by Subject|0
4676967|NCT02394756|7577306|FG000|Period 2|Unsatisfactory Visual Response|0
4676968|NCT02394756|7577307|FG001|Period 2|Unsatisfactory Visual Response|0
4676969|NCT02394756|7577308|FG002|Period 2|Unsatisfactory Visual Response|0
4676970|NCT02394756|7577309|FG003|Period 2|Unsatisfactory Visual Response|0
4676971|NCT02394756|7577310|FG004|Period 2|Unsatisfactory Visual Response|1
4757330|NCT02055547|7731705|FG005|Overall Study|Adverse Event|0
4757331|NCT02055547|7731706|FG006|Overall Study|Adverse Event|1
4757332|NCT02055547|7731707|FG007|Overall Study|Adverse Event|0
4757333|NCT02055547|7731708|FG008|Overall Study|Adverse Event|1
4757334|NCT02055547|7731709|FG009|Overall Study|Adverse Event|0
4757335|NCT02055547|7731710|FG010|Overall Study|Adverse Event|0
4757336|NCT02055547|7731711|FG011|Overall Study|Adverse Event|0
4757337|NCT02055547|7731712|FG012|Overall Study|Adverse Event|0
4757338|NCT02055547|7731713|FG013|Overall Study|Adverse Event|0
4757339|NCT02055547|7731714|FG014|Overall Study|Adverse Event|0
4757340|NCT02055547|7731715|FG015|Overall Study|Adverse Event|0
4757341|NCT02055547|7731716|FG016|Overall Study|Adverse Event|0
4757342|NCT02055547|7731717|FG017|Overall Study|Adverse Event|0
4757343|NCT02055547|7731718|FG018|Overall Study|Adverse Event|0
4757344|NCT02055547|7731700|FG000|Overall Study|Withdrawal by Subject|0
4757345|NCT02055547|7731701|FG001|Overall Study|Withdrawal by Subject|0
4757346|NCT02055547|7731702|FG002|Overall Study|Withdrawal by Subject|0
4757347|NCT02055547|7731703|FG003|Overall Study|Withdrawal by Subject|0
4757348|NCT02055547|7731704|FG004|Overall Study|Withdrawal by Subject|0
4757349|NCT02055547|7731705|FG005|Overall Study|Withdrawal by Subject|1
4757350|NCT02055547|7731706|FG006|Overall Study|Withdrawal by Subject|0
4757351|NCT02055547|7731707|FG007|Overall Study|Withdrawal by Subject|0
4757352|NCT02055547|7731708|FG008|Overall Study|Withdrawal by Subject|1
4757353|NCT02055547|7731709|FG009|Overall Study|Withdrawal by Subject|0
4757354|NCT02055547|7731710|FG010|Overall Study|Withdrawal by Subject|0
4757355|NCT02055547|7731711|FG011|Overall Study|Withdrawal by Subject|0
4757356|NCT02055547|7731712|FG012|Overall Study|Withdrawal by Subject|0
4757357|NCT02055547|7731713|FG013|Overall Study|Withdrawal by Subject|1
4757358|NCT02055547|7731714|FG014|Overall Study|Withdrawal by Subject|0
4757359|NCT02055547|7731715|FG015|Overall Study|Withdrawal by Subject|1
4757360|NCT02055547|7731716|FG016|Overall Study|Withdrawal by Subject|0
4676972|NCT02394756|7577311|FG005|Period 2|Unsatisfactory Visual Response|0
4676973|NCT02394808|7577332|FG000|Period 1|Unsatisfactory lens fitting|0
4676974|NCT02394808|7577333|FG001|Period 1|Unsatisfactory lens fitting|1
4676975|NCT02394808|7577332|FG000|Period 2|Lost to Follow-up|1
4676976|NCT02394808|7577333|FG001|Period 2|Lost to Follow-up|0
4676977|NCT02394925|7577345|FG000|Overall Study|Adverse Event|1
4676978|NCT02394925|7577345|FG000|Overall Study|Lens Discomfort|3
4676979|NCT02394925|7577345|FG000|Overall Study|Lens handling difficulities|5
4676980|NCT02394925|7577345|FG000|Overall Study|Lost to Follow-up|9
4676981|NCT02394925|7577345|FG000|Overall Study|Protocol Violation|5
4676982|NCT02394925|7577345|FG000|Overall Study|No longer meet eligibility criteria|1
4676983|NCT02394925|7577345|FG000|Overall Study|Unsatisfactory Visual Response|5
4676984|NCT02395042|7577361|FG000|Treatment 1 Period|Adverse Event|1
4676985|NCT02395042|7577362|FG001|Treatment 1 Period|Adverse Event|3
4676986|NCT02395042|7577363|FG002|Treatment 1 Period|Adverse Event|1
4676987|NCT02395042|7577361|FG000|Treatment 1 Period|Lack of Efficacy|1
4676988|NCT02395042|7577362|FG001|Treatment 1 Period|Lack of Efficacy|1
4676989|NCT02395042|7577363|FG002|Treatment 1 Period|Lack of Efficacy|0
4676990|NCT02395042|7577361|FG000|Treatment 1 Period|Lost to Follow-up|1
4676991|NCT02395042|7577362|FG001|Treatment 1 Period|Lost to Follow-up|0
4676992|NCT02395042|7577363|FG002|Treatment 1 Period|Lost to Follow-up|0
4676993|NCT02395042|7577361|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0
4676994|NCT02395042|7577362|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2
4676995|NCT02395042|7577363|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1
4676996|NCT02395042|7577361|FG000|Treatment 2 Period|Lack of Efficacy|1
4676997|NCT02395042|7577362|FG001|Treatment 2 Period|Lack of Efficacy|1
4676998|NCT02395042|7577363|FG002|Treatment 2 Period|Lack of Efficacy|0
4676999|NCT02395055|7577376|FG000|Overall Study|Withdrawal by Subject|7
4677000|NCT02395055|7577377|FG001|Overall Study|Withdrawal by Subject|3
4677001|NCT02395081|7577386|FG000|Overall Study|Withdrawal by Subject|1
4677002|NCT02395081|7577387|FG001|Overall Study|Withdrawal by Subject|1
4677003|NCT02395081|7577388|FG002|Overall Study|Withdrawal by Subject|0
4677004|NCT02395081|7577386|FG000|Overall Study|Moved where blood couldn't be collected|4
4677005|NCT02395081|7577387|FG001|Overall Study|Moved where blood couldn't be collected|1
4677006|NCT02395081|7577388|FG002|Overall Study|Moved where blood couldn't be collected|3
4677007|NCT02395081|7577386|FG000|Overall Study|Fetal Loss|2
4677008|NCT02395081|7577387|FG001|Overall Study|Fetal Loss|3
4677009|NCT02395081|7577388|FG002|Overall Study|Fetal Loss|1
4677010|NCT02395133|7577403|FG000|Overall Study|Adverse Event|4
4677011|NCT02395133|7577404|FG001|Overall Study|Adverse Event|1
4677012|NCT02395133|7577405|FG002|Overall Study|Adverse Event|3
4677013|NCT02395133|7577406|FG003|Overall Study|Adverse Event|0
4677014|NCT02395133|7577403|FG000|Overall Study|Lack of Efficacy|1
4677015|NCT02395133|7577404|FG001|Overall Study|Lack of Efficacy|0
4677016|NCT02395133|7577405|FG002|Overall Study|Lack of Efficacy|1
4677017|NCT02395133|7577406|FG003|Overall Study|Lack of Efficacy|1
4677018|NCT02395133|7577403|FG000|Overall Study|Protocol Violation|1
4677019|NCT02395133|7577404|FG001|Overall Study|Protocol Violation|1
4677020|NCT02395133|7577405|FG002|Overall Study|Protocol Violation|0
4677021|NCT02395133|7577406|FG003|Overall Study|Protocol Violation|3
4677022|NCT02395133|7577403|FG000|Overall Study|Lost to Follow-up|0
4677023|NCT02395133|7577404|FG001|Overall Study|Lost to Follow-up|1
4677024|NCT02395133|7577405|FG002|Overall Study|Lost to Follow-up|1
4677025|NCT02395133|7577406|FG003|Overall Study|Lost to Follow-up|0
4677026|NCT02395133|7577403|FG000|Overall Study|Pregnancy|0
4677027|NCT02395133|7577404|FG001|Overall Study|Pregnancy|0
4677028|NCT02395133|7577405|FG002|Overall Study|Pregnancy|3
4677029|NCT02395133|7577406|FG003|Overall Study|Pregnancy|0
4677030|NCT02395133|7577403|FG000|Overall Study|Consent withdrawn with no reason given|1
4677031|NCT02395133|7577404|FG001|Overall Study|Consent withdrawn with no reason given|3
4677032|NCT02395133|7577405|FG002|Overall Study|Consent withdrawn with no reason given|0
4677033|NCT02395133|7577406|FG003|Overall Study|Consent withdrawn with no reason given|2
4677034|NCT02395133|7577403|FG000|Overall Study|Consent withdrawn with personal reason|0
4677035|NCT02395133|7577404|FG001|Overall Study|Consent withdrawn with personal reason|1
4677036|NCT02395133|7577405|FG002|Overall Study|Consent withdrawn with personal reason|0
4677037|NCT02395133|7577406|FG003|Overall Study|Consent withdrawn with personal reason|3
4677038|NCT02395133|7577403|FG000|Overall Study|Sponsor decision|2
4677039|NCT02395133|7577404|FG001|Overall Study|Sponsor decision|0
4677040|NCT02395133|7577405|FG002|Overall Study|Sponsor decision|0
4677041|NCT02395133|7577406|FG003|Overall Study|Sponsor decision|1
4677042|NCT02395133|7577403|FG000|Overall Study|Other than specified above|5
4677043|NCT02395133|7577404|FG001|Overall Study|Other than specified above|2
4677044|NCT02395133|7577405|FG002|Overall Study|Other than specified above|2
4677045|NCT02395133|7577406|FG003|Overall Study|Other than specified above|4
4677046|NCT02395172|7577418|FG000|Overall Study|Participants randomized but not treated|3
4757361|NCT02055547|7731717|FG017|Overall Study|Withdrawal by Subject|0
4757362|NCT02055547|7731718|FG018|Overall Study|Withdrawal by Subject|0
4757363|NCT02055547|7731700|FG000|Overall Study|Lost to Follow-up|0
4757364|NCT02055547|7731701|FG001|Overall Study|Lost to Follow-up|0
4757365|NCT02055547|7731702|FG002|Overall Study|Lost to Follow-up|1
4757366|NCT02055547|7731703|FG003|Overall Study|Lost to Follow-up|0
4757367|NCT02055547|7731704|FG004|Overall Study|Lost to Follow-up|0
4757368|NCT02055547|7731705|FG005|Overall Study|Lost to Follow-up|0
4757369|NCT02055547|7731706|FG006|Overall Study|Lost to Follow-up|0
4757370|NCT02055547|7731707|FG007|Overall Study|Lost to Follow-up|0
4757371|NCT02055547|7731708|FG008|Overall Study|Lost to Follow-up|0
4757372|NCT02055547|7731709|FG009|Overall Study|Lost to Follow-up|0
4757373|NCT02055547|7731710|FG010|Overall Study|Lost to Follow-up|0
4677047|NCT02395172|7577419|FG001|Overall Study|Participants randomized but not treated|31
4677048|NCT02395302|7577433|FG000|Overall Study|Screen Failure|3
4677049|NCT02395302|7577433|FG000|Overall Study|Run In Failure|7
4677050|NCT02395302|7577433|FG000|Overall Study|Withdrawal by Subject|2
4757374|NCT02055547|7731711|FG011|Overall Study|Lost to Follow-up|0
4757375|NCT02055547|7731712|FG012|Overall Study|Lost to Follow-up|0
4757376|NCT02055547|7731713|FG013|Overall Study|Lost to Follow-up|0
4677051|NCT02395302|7577433|FG000|Overall Study|Physician Decision|2
4677052|NCT02395471|7577439|FG000|Overall Study|Lost to Follow-up|2
4677053|NCT02395471|7577440|FG001|Overall Study|Lost to Follow-up|0
4677054|NCT02395471|7577439|FG000|Overall Study|Withdrawal by Subject|2
4677055|NCT02395471|7577440|FG001|Overall Study|Withdrawal by Subject|1
4677056|NCT02395471|7577439|FG000|Overall Study|Physician Decision|1
4677057|NCT02395471|7577440|FG001|Overall Study|Physician Decision|0
4677058|NCT02395471|7577439|FG000|Overall Study|Protocol Violation|0
4677059|NCT02395471|7577440|FG001|Overall Study|Protocol Violation|1
4677060|NCT02395471|7577439|FG000|Overall Study|Failure to swollow sponge twice|1
4677061|NCT02395471|7577440|FG001|Overall Study|Failure to swollow sponge twice|0
4677062|NCT02395471|7577439|FG000|Overall Study|Patient did not return for procedure|0
4677063|NCT02395471|7577440|FG001|Overall Study|Patient did not return for procedure|1
4677064|NCT02395471|7577439|FG000|Overall Study|Subject not eligible|1
4677065|NCT02395471|7577440|FG001|Overall Study|Subject not eligible|0
4677066|NCT02395536|7577457|FG000|Overall Study|Lost to Follow-up|4
4677067|NCT02395536|7577458|FG001|Overall Study|Lost to Follow-up|4
4677068|NCT02395536|7577457|FG000|Overall Study|Death|2
4677069|NCT02395536|7577458|FG001|Overall Study|Death|0
4677070|NCT02395536|7577457|FG000|Overall Study|Physician Decision|4
4677071|NCT02395536|7577458|FG001|Overall Study|Physician Decision|6
4677072|NCT02395536|7577457|FG000|Overall Study|Withdrawal by Subject|9
4677073|NCT02395536|7577458|FG001|Overall Study|Withdrawal by Subject|17
4677074|NCT02395536|7577457|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1
4677075|NCT02395536|7577458|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2
4677076|NCT02395536|7577457|FG000|Overall Study|Insurance issue|0
4677077|NCT02395536|7577458|FG001|Overall Study|Insurance issue|1
4677078|NCT02395627|7577467|FG000|Overall Study|Withdrawal by Subject|0
4677079|NCT02395627|7577468|FG001|Overall Study|Withdrawal by Subject|2
4677080|NCT02395627|7577469|FG002|Overall Study|Withdrawal by Subject|0
4677081|NCT02395627|7577467|FG000|Overall Study|Did not receive pembrolizumab|3
4677082|NCT02395627|7577468|FG001|Overall Study|Did not receive pembrolizumab|1
4677083|NCT02395627|7577469|FG002|Overall Study|Did not receive pembrolizumab|0
4677084|NCT02395653|7577479|FG000|Overall Study|Exclusion Criteria Met at Screening|4
4677085|NCT02395653|7577479|FG000|Overall Study|Consent Withdrawn at Screening|1
4677086|NCT02395653|7577479|FG000|Overall Study|SSEC Application But With 0 Dose|1
4677087|NCT02395653|7577479|FG000|Overall Study|Investigator Decision at Screening|1
4677088|NCT02395653|7577479|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3
4677089|NCT02395653|7577479|FG000|Overall Study|Withdrawal by Subject|1
4677090|NCT02395653|7577479|FG000|Overall Study|Lost to Follow-up|1
4677091|NCT02395822|7577491|FG000|Overall Study|Withdrawal by Subject|1
4677092|NCT02395822|7577491|FG000|Overall Study|Death|1
4757377|NCT02055547|7731714|FG014|Overall Study|Lost to Follow-up|0
4757378|NCT02055547|7731715|FG015|Overall Study|Lost to Follow-up|0
4757379|NCT02055547|7731716|FG016|Overall Study|Lost to Follow-up|0
4757380|NCT02055547|7731717|FG017|Overall Study|Lost to Follow-up|0
4757381|NCT02055547|7731718|FG018|Overall Study|Lost to Follow-up|0
4677093|NCT02396212|7577548|FG000|Overall Study|Adverse Event|1
4677094|NCT02396212|7577548|FG000|Overall Study|Lack of Efficacy|2
4677095|NCT02396316|7577562|FG000|Overall Study|Physician Decision|1
4677096|NCT02396316|7577563|FG001|Overall Study|Physician Decision|0
4677097|NCT02396316|7577562|FG000|Overall Study|Progressive disease|6
4677098|NCT02396316|7577563|FG001|Overall Study|Progressive disease|3
4677099|NCT02396316|7577562|FG000|Overall Study|Protocol Violation|0
4677100|NCT02396316|7577563|FG001|Overall Study|Protocol Violation|1
4677101|NCT02396316|7577562|FG000|Overall Study|Treatment unblinded|0
4677102|NCT02396316|7577563|FG001|Overall Study|Treatment unblinded|1
4677103|NCT02396381|7577575|FG000|Overall Study|Adverse Event|3
4677104|NCT02396381|7577576|FG001|Overall Study|Adverse Event|2
4677105|NCT02396381|7577575|FG000|Overall Study|Withdrawal by Subject|33
4677106|NCT02396381|7577576|FG001|Overall Study|Withdrawal by Subject|24
4677107|NCT02396381|7577575|FG000|Overall Study|Lost to Follow-up|49
4677108|NCT02396381|7577576|FG001|Overall Study|Lost to Follow-up|31
4677109|NCT02396381|7577575|FG000|Overall Study|Protocol Violation|1
4677110|NCT02396381|7577576|FG001|Overall Study|Protocol Violation|0
4677111|NCT02396381|7577575|FG000|Overall Study|Site terminated by sponsor|7
4677112|NCT02396381|7577576|FG001|Overall Study|Site terminated by sponsor|8
4677113|NCT02396381|7577575|FG000|Overall Study|Physician Decision|5
4677114|NCT02396381|7577576|FG001|Overall Study|Physician Decision|5
4677115|NCT02396381|7577575|FG000|Overall Study|Pregnancy|2
4677116|NCT02396381|7577576|FG001|Overall Study|Pregnancy|0
4677117|NCT02396381|7577575|FG000|Overall Study|Non-compliance with study procedures|1
4677118|NCT02396381|7577576|FG001|Overall Study|Non-compliance with study procedures|0
4677119|NCT02396381|7577575|FG000|Overall Study|Moved out of town/state|1
4677120|NCT02396381|7577576|FG001|Overall Study|Moved out of town/state|3
4677121|NCT02396381|7577575|FG000|Overall Study|Could not complete visit|1
4677122|NCT02396381|7577576|FG001|Overall Study|Could not complete visit|0
4677123|NCT02396381|7577575|FG000|Overall Study|Possible conflict of interest|1
4677124|NCT02396381|7577576|FG001|Overall Study|Possible conflict of interest|0
4677125|NCT02396381|7577575|FG000|Overall Study|Randomization/Screening Error|3
4677126|NCT02396381|7577576|FG001|Overall Study|Randomization/Screening Error|1
4677127|NCT02396420|7577585|FG000|Overall Study|Death|1
4677128|NCT02396537|7577596|FG000|Overall Study|Protocol Violation|0
4677129|NCT02396537|7577597|FG001|Overall Study|Protocol Violation|1
4677130|NCT02396758|7577620|FG000|Overall Study|Withdrawal by Subject|2
4677131|NCT02396758|7577621|FG001|Overall Study|Withdrawal by Subject|0
4677132|NCT02396758|7577622|FG002|Overall Study|Withdrawal by Subject|0
4677133|NCT02396758|7577623|FG003|Overall Study|Withdrawal by Subject|1
4677134|NCT02396758|7577620|FG000|Overall Study|Lost to Follow-up|8
4677135|NCT02396758|7577621|FG001|Overall Study|Lost to Follow-up|5
4677136|NCT02396758|7577622|FG002|Overall Study|Lost to Follow-up|3
4677137|NCT02396758|7577623|FG003|Overall Study|Lost to Follow-up|3
4677138|NCT02396758|7577620|FG000|Overall Study|Death|1
4677139|NCT02396758|7577621|FG001|Overall Study|Death|1
4677140|NCT02396758|7577622|FG002|Overall Study|Death|0
4677141|NCT02396758|7577623|FG003|Overall Study|Death|1
4677142|NCT02396758|7577620|FG000|Overall Study|Randomized but not treated|1
4677143|NCT02396758|7577621|FG001|Overall Study|Randomized but not treated|0
4677144|NCT02396758|7577622|FG002|Overall Study|Randomized but not treated|1
4677145|NCT02396758|7577623|FG003|Overall Study|Randomized but not treated|0
4677146|NCT02396849|7577635|FG000|Overall Study|Lost to Follow-up|1
4677147|NCT02396849|7577636|FG001|Overall Study|Lost to Follow-up|1
4677148|NCT02396849|7577635|FG000|Overall Study|Did not tolerate intervention|1
4677149|NCT02396849|7577636|FG001|Overall Study|Did not tolerate intervention|1
4677150|NCT02396953|7577647|FG000|Overall Study|Withdrawal by Subject|0
4677151|NCT02396953|7577648|FG001|Overall Study|Withdrawal by Subject|0
4677152|NCT02396953|7577649|FG002|Overall Study|Withdrawal by Subject|1
4677153|NCT02396953|7577647|FG000|Overall Study|Insulin like Growth Factor-1 increased|3
4677154|NCT02396953|7577648|FG001|Overall Study|Insulin like Growth Factor-1 increased|2
4677155|NCT02396953|7577649|FG002|Overall Study|Insulin like Growth Factor-1 increased|2
4677156|NCT02396953|7577647|FG000|Overall Study|Personal Reasons|1
4677157|NCT02396953|7577648|FG001|Overall Study|Personal Reasons|1
4677158|NCT02396953|7577649|FG002|Overall Study|Personal Reasons|0
4677159|NCT02397057|7577666|FG000|Overall Study|Withdrawal by Subject|6
4677160|NCT02397057|7577667|FG001|Overall Study|Withdrawal by Subject|7
4677161|NCT02397057|7577666|FG000|Overall Study|Lost to Follow-up|4
4677162|NCT02397057|7577667|FG001|Overall Study|Lost to Follow-up|3
4677163|NCT02397057|7577666|FG000|Overall Study|Death|1
4677164|NCT02397057|7577667|FG001|Overall Study|Death|0
4677165|NCT02397057|7577666|FG000|Overall Study|Adverse Event|0
4677166|NCT02397057|7577667|FG001|Overall Study|Adverse Event|1
4677167|NCT02397057|7577666|FG000|Overall Study|Physician Decision|0
4677168|NCT02397057|7577667|FG001|Overall Study|Physician Decision|1
4677169|NCT02397057|7577666|FG000|Overall Study|Subject did not receive study drug|0
4677170|NCT02397057|7577667|FG001|Overall Study|Subject did not receive study drug|1
4677171|NCT02397096|7577675|FG000|Day 1 to Week 24|Adverse Event|7
4677172|NCT02397096|7577676|FG001|Day 1 to Week 24|Adverse Event|1
4677173|NCT02397096|7577675|FG000|Day 1 to Week 24|Death|1
4677174|NCT02397096|7577676|FG001|Day 1 to Week 24|Death|0
4677175|NCT02397096|7577675|FG000|Day 1 to Week 24|Lack of Efficacy|0
4677176|NCT02397096|7577676|FG001|Day 1 to Week 24|Lack of Efficacy|1
4677177|NCT02397096|7577675|FG000|Day 1 to Week 24|Lost to Follow-up|3
4677178|NCT02397096|7577676|FG001|Day 1 to Week 24|Lost to Follow-up|4
4677179|NCT02397096|7577675|FG000|Day 1 to Week 24|Physician Decision|2
4677180|NCT02397096|7577676|FG001|Day 1 to Week 24|Physician Decision|3
4677181|NCT02397096|7577675|FG000|Day 1 to Week 24|Protocol Violation|1
4677182|NCT02397096|7577676|FG001|Day 1 to Week 24|Protocol Violation|4
4757382|NCT02064387|7731764|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0
4757383|NCT02064387|7731765|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0
4757384|NCT02064387|7731766|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0
4757385|NCT02064387|7731767|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0
4757386|NCT02064387|7731768|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0
4757387|NCT02064387|7731769|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0
4757388|NCT02064387|7731770|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0
4757389|NCT02064387|7731771|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1
4757390|NCT02064387|7731772|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0
4757391|NCT02064387|7731773|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1
4757392|NCT02064387|7731774|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0
4757393|NCT02064387|7731775|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0
4757394|NCT02064387|7731764|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
4757395|NCT02064387|7731765|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
4757396|NCT02064387|7731766|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
4757397|NCT02064387|7731767|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
4757398|NCT02064387|7731768|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
4757399|NCT02064387|7731769|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
4757400|NCT02064387|7731770|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
4757401|NCT02064387|7731771|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1
4757402|NCT02064387|7731772|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
4757403|NCT02064387|7731773|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
4757404|NCT02064387|7731774|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
4757405|NCT02064387|7731775|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
4757406|NCT02064387|7731764|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
4757407|NCT02064387|7731765|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
4757408|NCT02064387|7731766|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
4757409|NCT02064387|7731767|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
4757410|NCT02064387|7731768|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
4757411|NCT02064387|7731769|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
4757412|NCT02064387|7731770|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
4757413|NCT02064387|7731771|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
4757414|NCT02064387|7731772|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1
4757415|NCT02064387|7731773|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
4757416|NCT02064387|7731774|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
4757417|NCT02064387|7731775|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
4757418|NCT02064387|7731764|FG000|Part 2 Max 35 Months Followup Duration|Death|0
4757419|NCT02064387|7731765|FG001|Part 2 Max 35 Months Followup Duration|Death|0
4757420|NCT02064387|7731766|FG002|Part 2 Max 35 Months Followup Duration|Death|0
4757421|NCT02064387|7731767|FG003|Part 2 Max 35 Months Followup Duration|Death|0
4757422|NCT02064387|7731768|FG004|Part 2 Max 35 Months Followup Duration|Death|0
4757423|NCT02064387|7731769|FG005|Part 2 Max 35 Months Followup Duration|Death|0
4757424|NCT02064387|7731770|FG006|Part 2 Max 35 Months Followup Duration|Death|0
4757425|NCT02064387|7731771|FG007|Part 2 Max 35 Months Followup Duration|Death|0
4757426|NCT02064387|7731772|FG008|Part 2 Max 35 Months Followup Duration|Death|0
4757427|NCT02064387|7731773|FG009|Part 2 Max 35 Months Followup Duration|Death|0
4757428|NCT02064387|7731774|FG010|Part 2 Max 35 Months Followup Duration|Death|5
4757429|NCT02064387|7731775|FG011|Part 2 Max 35 Months Followup Duration|Death|3
4757430|NCT02064387|7731764|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
4757431|NCT02064387|7731765|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
4757432|NCT02064387|7731766|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
4757433|NCT02064387|7731767|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
4757434|NCT02064387|7731768|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
4757435|NCT02064387|7731769|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
4757436|NCT02064387|7731770|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
4757437|NCT02064387|7731771|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
4757438|NCT02064387|7731772|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
4757439|NCT02064387|7731773|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
4757440|NCT02064387|7731774|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1
4757441|NCT02064387|7731775|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
4757442|NCT02076178|7731816|FG000|Oral Phase|Adverse Event|0
4757443|NCT02076178|7731817|FG001|Oral Phase|Adverse Event|7
4757444|NCT02076178|7731816|FG000|Oral Phase|Withdrawal by Subject|0
4677183|NCT02397096|7577675|FG000|Day 1 to Week 24|Withdrawal by Subject|6
4677184|NCT02397096|7577676|FG001|Day 1 to Week 24|Withdrawal by Subject|1
4677185|NCT02397096|7577675|FG000|Week 24 to Week 48|Adverse Event|6
4677186|NCT02397096|7577676|FG001|Week 24 to Week 48|Adverse Event|2
4677187|NCT02397096|7577675|FG000|Week 24 to Week 48|Lack of Efficacy|5
4677188|NCT02397096|7577676|FG001|Week 24 to Week 48|Lack of Efficacy|1
4677189|NCT02397096|7577675|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0
4677190|NCT02397096|7577676|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1
4677191|NCT02397096|7577675|FG000|Week 24 to Week 48|Physician Decision|2
4677192|NCT02397096|7577676|FG001|Week 24 to Week 48|Physician Decision|1
4677193|NCT02397096|7577675|FG000|Week 24 to Week 48|Withdrawal by Subject|5
4677194|NCT02397096|7577676|FG001|Week 24 to Week 48|Withdrawal by Subject|2
4677195|NCT02397096|7577675|FG000|Week 24 to Week 48|Lost to Follow-up|2
4677196|NCT02397096|7577676|FG001|Week 24 to Week 48|Lost to Follow-up|0
4677197|NCT02397096|7577675|FG000|Study Extensions|Ongoing|399
4677198|NCT02397096|7577676|FG001|Study Extensions|Ongoing|202
4677199|NCT02397278|7577711|FG000|Overall Study|Withdrawal by Subject|0
4677200|NCT02397278|7577712|FG001|Overall Study|Withdrawal by Subject|2
4677201|NCT02397278|7577711|FG000|Overall Study|Deemed ineligible following surgery|1
4677202|NCT02397278|7577712|FG001|Overall Study|Deemed ineligible following surgery|1
4677203|NCT02397408|7577727|FG000|Overall Study|Physician Decision|4
4677204|NCT02397408|7577727|FG000|Overall Study|Surgery not completed within protocol timeframe|2
4677205|NCT02397447|7577733|FG000|Overall Study|Lost to Follow-up|2
4677206|NCT02397447|7577734|FG001|Overall Study|Lost to Follow-up|2
4677207|NCT02397460|7577748|FG000|Treatment Period 2|Adverse Event|0
4677208|NCT02397460|7577749|FG001|Treatment Period 2|Adverse Event|0
4677209|NCT02397460|7577750|FG002|Treatment Period 2|Adverse Event|0
4677210|NCT02397460|7577751|FG003|Treatment Period 2|Adverse Event|0
4677211|NCT02397460|7577752|FG004|Treatment Period 2|Adverse Event|0
4677212|NCT02397460|7577753|FG005|Treatment Period 2|Adverse Event|0
4677213|NCT02397460|7577754|FG006|Treatment Period 2|Adverse Event|0
4677214|NCT02397460|7577755|FG007|Treatment Period 2|Adverse Event|1
4677215|NCT02397460|7577748|FG000|Treatment Period 4|Adverse Event|0
4677216|NCT02397460|7577749|FG001|Treatment Period 4|Adverse Event|1
4677217|NCT02397460|7577750|FG002|Treatment Period 4|Adverse Event|0
4677218|NCT02397460|7577751|FG003|Treatment Period 4|Adverse Event|0
4677219|NCT02397460|7577752|FG004|Treatment Period 4|Adverse Event|0
4677220|NCT02397460|7577753|FG005|Treatment Period 4|Adverse Event|0
4677221|NCT02397460|7577754|FG006|Treatment Period 4|Adverse Event|0
4677222|NCT02397460|7577755|FG007|Treatment Period 4|Adverse Event|0
4677223|NCT02397460|7577748|FG000|Treatment Period 4|Physician Decision|0
4757445|NCT02076178|7731817|FG001|Oral Phase|Withdrawal by Subject|4
4757446|NCT02076178|7731816|FG000|Oral Phase|Physician Decision|0
4757447|NCT02076178|7731817|FG001|Oral Phase|Physician Decision|1
4757448|NCT02076178|7731816|FG000|Injection Phase|Protocol defined stopping criteria|1
4757449|NCT02076178|7731817|FG001|Injection Phase|Protocol defined stopping criteria|0
4757450|NCT02076178|7731816|FG000|Injection Phase|Withdrawal by Subject|0
4757451|NCT02076178|7731817|FG001|Injection Phase|Withdrawal by Subject|3
4757452|NCT02076178|7731816|FG000|Injection Phase|Physician Decision|0
4757453|NCT02076178|7731817|FG001|Injection Phase|Physician Decision|3
4757454|NCT02076178|7731816|FG000|Injection Phase|Lost to Follow-up|0
4757455|NCT02076178|7731817|FG001|Injection Phase|Lost to Follow-up|1
4677224|NCT02397460|7577749|FG001|Treatment Period 4|Physician Decision|0
4677225|NCT02397460|7577750|FG002|Treatment Period 4|Physician Decision|0
4677226|NCT02397460|7577751|FG003|Treatment Period 4|Physician Decision|0
4677227|NCT02397460|7577752|FG004|Treatment Period 4|Physician Decision|1
4677228|NCT02397460|7577753|FG005|Treatment Period 4|Physician Decision|0
4677229|NCT02397460|7577754|FG006|Treatment Period 4|Physician Decision|0
4677230|NCT02397460|7577755|FG007|Treatment Period 4|Physician Decision|0
4677231|NCT02397473|7577831|FG000|Treatment Phase|Adverse Event|1
4677232|NCT02397473|7577832|FG001|Treatment Phase|Adverse Event|2
4677233|NCT02397473|7577831|FG000|Treatment Phase|Lack of Efficacy|8
4677234|NCT02397473|7577832|FG001|Treatment Phase|Lack of Efficacy|1
4677235|NCT02397473|7577831|FG000|Treatment Phase|Lost to Follow-up|1
4677236|NCT02397473|7577832|FG001|Treatment Phase|Lost to Follow-up|0
4677237|NCT02397473|7577831|FG000|Treatment Phase|Withdrawal by Subject|2
4677238|NCT02397473|7577832|FG001|Treatment Phase|Withdrawal by Subject|1
4677239|NCT02397473|7577831|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0
4677240|NCT02397473|7577832|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3
4677241|NCT02397473|7577831|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1
4677242|NCT02397473|7577832|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1
4677243|NCT02397473|7577831|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1
4677244|NCT02397473|7577832|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0
4677245|NCT02397473|7577831|FG000|Post Treatment Follow-up Phase|Protocol Violation|1
4677246|NCT02397473|7577832|FG001|Post Treatment Follow-up Phase|Protocol Violation|0
4677247|NCT02397473|7577831|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0
4677248|NCT02397473|7577832|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1
4677249|NCT02397655|7577846|FG000|Overall Study|data not completed|1301
4677250|NCT02397694|7577852|FG000|Double-Blinded Phase|Adverse Event|1
4677251|NCT02397694|7577853|FG001|Double-Blinded Phase|Adverse Event|0
4677252|NCT02397694|7577852|FG000|Double-Blinded Phase|Non-compliance with study drug|0
4677253|NCT02397694|7577853|FG001|Double-Blinded Phase|Non-compliance with study drug|2
4677254|NCT02397694|7577852|FG000|Double-Blinded Phase|Withdrawal by Subject|1
4677255|NCT02397694|7577853|FG001|Double-Blinded Phase|Withdrawal by Subject|0
4677256|NCT02397694|7577852|FG000|Double-Blinded Phase|Lost to Follow-up|1
4677257|NCT02397694|7577853|FG001|Double-Blinded Phase|Lost to Follow-up|1
4677258|NCT02397694|7577852|FG000|Open Label Extension Phase|Protocol Violation|1
4677259|NCT02397694|7577853|FG001|Open Label Extension Phase|Protocol Violation|0
4677260|NCT02397694|7577852|FG000|Open Label Extension Phase|Withdrew Consent|3
4677261|NCT02397694|7577853|FG001|Open Label Extension Phase|Withdrew Consent|1
4677262|NCT02397694|7577852|FG000|Open Label Extension Phase|Lost to Follow-up|4
4677263|NCT02397694|7577853|FG001|Open Label Extension Phase|Lost to Follow-up|0
4677264|NCT02397837|7577888|FG000|Overall Study|Withdrawal by Subject|6
4677265|NCT02397837|7577889|FG001|Overall Study|Withdrawal by Subject|5
4677266|NCT02397837|7577888|FG000|Overall Study|Physician Decision|1
4677267|NCT02397837|7577889|FG001|Overall Study|Physician Decision|1
4677268|NCT02397889|7577897|FG000|Overall Study|Physician Decision|1
4757456|NCT02079766|7731827|FG000|Overall Study|Physician Decision|1
4757457|NCT02079766|7731828|FG001|Overall Study|Physician Decision|0
4757458|NCT02079766|7731827|FG000|Overall Study|Withdrawal by Subject|1
4757459|NCT02079766|7731828|FG001|Overall Study|Withdrawal by Subject|0
4757460|NCT02081391|7731838|FG000|12-hour Treatment|Withdrawal by Subject|3
4757461|NCT02081391|7731839|FG001|12-hour Treatment|Withdrawal by Subject|2
4757462|NCT02081391|7731840|FG002|12-hour Treatment|Withdrawal by Subject|0
4757463|NCT02081391|7731841|FG003|12-hour Treatment|Withdrawal by Subject|0
4757464|NCT02081391|7731838|FG000|12-hour Treatment|Physician Decision|4
4757465|NCT02081391|7731839|FG001|12-hour Treatment|Physician Decision|1
4757466|NCT02081391|7731840|FG002|12-hour Treatment|Physician Decision|0
4757467|NCT02081391|7731841|FG003|12-hour Treatment|Physician Decision|0
4757468|NCT02081391|7731838|FG000|12-hour Treatment|Lack of Efficacy|3
4757469|NCT02081391|7731839|FG001|12-hour Treatment|Lack of Efficacy|0
4757470|NCT02081391|7731840|FG002|12-hour Treatment|Lack of Efficacy|0
4757471|NCT02081391|7731841|FG003|12-hour Treatment|Lack of Efficacy|0
4757472|NCT02081391|7731838|FG000|12-hour Treatment|Adverse Event|4
4757473|NCT02081391|7731839|FG001|12-hour Treatment|Adverse Event|2
4757474|NCT02081391|7731840|FG002|12-hour Treatment|Adverse Event|0
4757475|NCT02081391|7731841|FG003|12-hour Treatment|Adverse Event|0
4757476|NCT02081391|7731838|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2
4757477|NCT02081391|7731839|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0
4757478|NCT02081391|7731840|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1
4757479|NCT02081391|7731841|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0
4757480|NCT02081391|7731838|FG000|12-hour Treatment|Further reasons|2
4757481|NCT02081391|7731839|FG001|12-hour Treatment|Further reasons|1
4757482|NCT02081391|7731840|FG002|12-hour Treatment|Further reasons|0
4757483|NCT02081391|7731841|FG003|12-hour Treatment|Further reasons|0
4757484|NCT02081391|7731838|FG000|24-hour Treatment and Trial Completion|Physician Decision|10
4757485|NCT02081391|7731839|FG001|24-hour Treatment and Trial Completion|Physician Decision|5
4757486|NCT02081391|7731840|FG002|24-hour Treatment and Trial Completion|Physician Decision|0
4757487|NCT02081391|7731841|FG003|24-hour Treatment and Trial Completion|Physician Decision|0
4757488|NCT02081391|7731838|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1
4757489|NCT02081391|7731839|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3
4757490|NCT02081391|7731840|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0
4757491|NCT02081391|7731841|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0
4757492|NCT02081391|7731838|FG000|24-hour Treatment and Trial Completion|Adverse Event|1
4757493|NCT02081391|7731839|FG001|24-hour Treatment and Trial Completion|Adverse Event|0
4757494|NCT02081391|7731840|FG002|24-hour Treatment and Trial Completion|Adverse Event|0
4677269|NCT02397889|7577898|FG001|Overall Study|Physician Decision|0
4757495|NCT02081391|7731841|FG003|24-hour Treatment and Trial Completion|Adverse Event|0
4757496|NCT02081391|7731838|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11
4757497|NCT02081391|7731839|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5
4677270|NCT02397915|7577904|FG000|Period 1|Protocol Violation|0
4677271|NCT02397915|7577905|FG001|Period 1|Protocol Violation|1
4677272|NCT02397915|7577906|FG002|Period 1|Protocol Violation|0
4677273|NCT02397915|7577907|FG003|Period 1|Protocol Violation|0
4677274|NCT02397915|7577904|FG000|Period 1|Physician Decision|1
4757498|NCT02081391|7731840|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1
4757499|NCT02081391|7731841|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0
4757500|NCT02081391|7731838|FG000|24-hour Treatment and Trial Completion|Technical Problems|1
4757501|NCT02081391|7731839|FG001|24-hour Treatment and Trial Completion|Technical Problems|1
4757502|NCT02081391|7731840|FG002|24-hour Treatment and Trial Completion|Technical Problems|0
4757503|NCT02081391|7731841|FG003|24-hour Treatment and Trial Completion|Technical Problems|0
4757504|NCT02081391|7731838|FG000|24-hour Treatment and Trial Completion|Further reasons|3
4757505|NCT02081391|7731839|FG001|24-hour Treatment and Trial Completion|Further reasons|4
4757506|NCT02081391|7731840|FG002|24-hour Treatment and Trial Completion|Further reasons|0
4757507|NCT02081391|7731841|FG003|24-hour Treatment and Trial Completion|Further reasons|0
4677275|NCT02397915|7577905|FG001|Period 1|Physician Decision|0
4677276|NCT02397915|7577906|FG002|Period 1|Physician Decision|0
4677277|NCT02397915|7577907|FG003|Period 1|Physician Decision|0
4677278|NCT02398188|7577921|FG000|Overall Study|Adverse Event|2
4677279|NCT02398188|7577922|FG001|Overall Study|Adverse Event|3
4677280|NCT02398188|7577921|FG000|Overall Study|Lost to Follow-up|5
4677281|NCT02398188|7577922|FG001|Overall Study|Lost to Follow-up|0
4677282|NCT02398188|7577921|FG000|Overall Study|Non-compliance|4
4677283|NCT02398188|7577922|FG001|Overall Study|Non-compliance|4
4677284|NCT02398188|7577921|FG000|Overall Study|Protocol Violation|6
4677285|NCT02398188|7577922|FG001|Overall Study|Protocol Violation|10
4677286|NCT02398188|7577921|FG000|Overall Study|Sponsor Decision|2
4677287|NCT02398188|7577922|FG001|Overall Study|Sponsor Decision|1
4677288|NCT02398188|7577921|FG000|Overall Study|Pregnancy|1
4677289|NCT02398188|7577922|FG001|Overall Study|Pregnancy|0
4677290|NCT02398188|7577921|FG000|Overall Study|Withdrawal by Subject|7
4677291|NCT02398188|7577922|FG001|Overall Study|Withdrawal by Subject|16
4677292|NCT02398227|7577930|FG000|Overall Study|Lost to Follow-up|21
4677293|NCT02398227|7577931|FG001|Overall Study|Lost to Follow-up|12
4677294|NCT02398227|7577930|FG000|Overall Study|Withdrawal by Subject|5
4677295|NCT02398227|7577931|FG001|Overall Study|Withdrawal by Subject|6
4677296|NCT02398227|7577930|FG000|Overall Study|Removed from treatment and dropped out|1
4677297|NCT02398227|7577931|FG001|Overall Study|Removed from treatment and dropped out|0
4677298|NCT02399163|7577950|FG000|Overall Study|Adverse Event|2
4677299|NCT02399163|7577950|FG000|Overall Study|Protocol Deviation|2
4677300|NCT02399163|7577950|FG000|Overall Study|Withdrawal by Participant|5
4677301|NCT02399254|7577966|FG000|Overall Study|Physician Decision|2
4677302|NCT02399475|7577977|FG000|Overall Study|Physician Decision|1
4677303|NCT02399475|7577978|FG001|Overall Study|Physician Decision|0
4677304|NCT02400307|7578004|FG000|Overall Study|Enrolled and Never Dosed|1
4677305|NCT02400307|7578005|FG001|Overall Study|Enrolled and Never Dosed|0
4677306|NCT02400333|7578015|FG000|Overall Study|Withdrawal by Subject|0
4677307|NCT02400333|7578016|FG001|Overall Study|Withdrawal by Subject|1
4677308|NCT02400333|7578017|FG002|Overall Study|Withdrawal by Subject|0
4677309|NCT02400333|7578018|FG003|Overall Study|Withdrawal by Subject|1
4677310|NCT02400333|7578015|FG000|Overall Study|Protocol Violation|1
4677311|NCT02400333|7578016|FG001|Overall Study|Protocol Violation|0
4677312|NCT02400333|7578017|FG002|Overall Study|Protocol Violation|2
4677313|NCT02400333|7578018|FG003|Overall Study|Protocol Violation|1
4677314|NCT02400346|7578029|FG000|Overall Study|Adverse Event|24
4677315|NCT02400346|7578029|FG000|Overall Study|Lack of Efficacy|9
4677316|NCT02400346|7578029|FG000|Overall Study|Non-compliance with IMP|1
4677317|NCT02400346|7578029|FG000|Overall Study|Withdrawal by Subject|7
4677318|NCT02400346|7578029|FG000|Overall Study|Administrative or other reason(s)|2
4677319|NCT02400346|7578029|FG000|Overall Study|Lost to Follow-up|1
4677320|NCT02400580|7578045|FG000|Overall Study|Withdrawal by Subject|1
4677321|NCT02400580|7578046|FG001|Overall Study|Withdrawal by Subject|1
4677322|NCT02400580|7578045|FG000|Overall Study|Adverse Event|1
4677323|NCT02400580|7578046|FG001|Overall Study|Adverse Event|0
4677324|NCT02400749|7578063|FG000|Week 0 -16|Withdrawal by Subject|5
4677325|NCT02400749|7578064|FG001|Week 0 -16|Withdrawal by Subject|5
4677326|NCT02400749|7578063|FG000|Week 0 -16|Adverse Event|3
4677327|NCT02400749|7578064|FG001|Week 0 -16|Adverse Event|1
4677328|NCT02400749|7578063|FG000|Week 0 -16|Lost to Follow-up|2
4677329|NCT02400749|7578064|FG001|Week 0 -16|Lost to Follow-up|0
4677330|NCT02400749|7578063|FG000|Week 0 -16|Protocol Violation|1
4677331|NCT02400749|7578064|FG001|Week 0 -16|Protocol Violation|0
4677332|NCT02400749|7578063|FG000|Week 17 - 32|Withdrawal by Subject|3
4677333|NCT02400749|7578064|FG001|Week 17 - 32|Withdrawal by Subject|2
4677334|NCT02400749|7578063|FG000|Week 17 - 32|Adverse Event|2
4677335|NCT02400749|7578064|FG001|Week 17 - 32|Adverse Event|1
4677336|NCT02400905|7578070|FG000|Overall Study|Death|24
4677337|NCT02400905|7578070|FG000|Overall Study|Lost to Follow-up|18
4677338|NCT02400905|7578070|FG000|Overall Study|Withdrawal by Subject|16
4677339|NCT02400905|7578070|FG000|Overall Study|Physician Decision|4
4677340|NCT02400905|7578070|FG000|Overall Study|Other|1
4677341|NCT02401230|7578105|FG000|Overall Study|Adverse Event|3
4677342|NCT02401230|7578106|FG001|Overall Study|Adverse Event|2
4677343|NCT02401230|7578107|FG002|Overall Study|Adverse Event|0
4677344|NCT02401230|7578105|FG000|Overall Study|Withdrawal by Subject|2
4677345|NCT02401230|7578106|FG001|Overall Study|Withdrawal by Subject|1
4677346|NCT02401230|7578107|FG002|Overall Study|Withdrawal by Subject|1
4677347|NCT02401230|7578105|FG000|Overall Study|Lost to Follow-up|1
4677348|NCT02401230|7578106|FG001|Overall Study|Lost to Follow-up|3
4677349|NCT02401230|7578107|FG002|Overall Study|Lost to Follow-up|3
4677350|NCT02401256|7578119|FG000|Overall Study|Adverse Event|5
4677351|NCT02401256|7578119|FG000|Overall Study|Withdrawal by Subject|12
4677352|NCT02401412|7578127|FG000|Overall Study|Lost to Follow-up|1
4677353|NCT02401412|7578128|FG001|Overall Study|Lost to Follow-up|0
4677354|NCT02401412|7578127|FG000|Overall Study|Discontinued Intervention|15
4677355|NCT02401412|7578128|FG001|Overall Study|Discontinued Intervention|21
4677356|NCT02401412|7578127|FG000|Overall Study|Withdrawal by Subject|4
4677357|NCT02401412|7578128|FG001|Overall Study|Withdrawal by Subject|4
4677358|NCT02401412|7578127|FG000|Overall Study|Subject withdrawal prior to intervention|0
4757508|NCT02087189|7731861|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2
4757509|NCT02112916|7731869|FG000|Overall Study|Adverse Event|6
4757510|NCT02112916|7731870|FG001|Overall Study|Adverse Event|9
4757511|NCT02112916|7731871|FG002|Overall Study|Adverse Event|3
4757512|NCT02112916|7731872|FG003|Overall Study|Adverse Event|2
4757513|NCT02112916|7731869|FG000|Overall Study|Death|9
4757514|NCT02112916|7731870|FG001|Overall Study|Death|9
4757515|NCT02112916|7731871|FG002|Overall Study|Death|3
4757516|NCT02112916|7731872|FG003|Overall Study|Death|4
4757517|NCT02112916|7731869|FG000|Overall Study|Lost to Follow-up|1
4757518|NCT02112916|7731870|FG001|Overall Study|Lost to Follow-up|0
4757519|NCT02112916|7731871|FG002|Overall Study|Lost to Follow-up|0
4757520|NCT02112916|7731872|FG003|Overall Study|Lost to Follow-up|0
4757521|NCT02112916|7731869|FG000|Overall Study|Physician Decision|94
4757522|NCT02112916|7731870|FG001|Overall Study|Physician Decision|72
4757523|NCT02112916|7731871|FG002|Overall Study|Physician Decision|24
4757524|NCT02112916|7731872|FG003|Overall Study|Physician Decision|15
4757525|NCT02112916|7731869|FG000|Overall Study|Withdrawal by Subject|5
4757526|NCT02112916|7731870|FG001|Overall Study|Withdrawal by Subject|3
4757527|NCT02112916|7731871|FG002|Overall Study|Withdrawal by Subject|1
4757528|NCT02112916|7731872|FG003|Overall Study|Withdrawal by Subject|1
4757529|NCT02112916|7731869|FG000|Overall Study|Ineligible|4
4757530|NCT02112916|7731870|FG001|Overall Study|Ineligible|8
4757531|NCT02112916|7731871|FG002|Overall Study|Ineligible|3
4757532|NCT02112916|7731872|FG003|Overall Study|Ineligible|8
4757533|NCT02112916|7731869|FG000|Overall Study|Inevaluable|6
4757534|NCT02112916|7731870|FG001|Overall Study|Inevaluable|4
4757535|NCT02112916|7731871|FG002|Overall Study|Inevaluable|5
4757536|NCT02112916|7731872|FG003|Overall Study|Inevaluable|5
4757537|NCT02112916|7731869|FG000|Overall Study|Refusal of further protocol therapy|19
4757538|NCT02112916|7731870|FG001|Overall Study|Refusal of further protocol therapy|16
4757539|NCT02112916|7731871|FG002|Overall Study|Refusal of further protocol therapy|1
4757540|NCT02112916|7731872|FG003|Overall Study|Refusal of further protocol therapy|7
4757541|NCT02112916|7731869|FG000|Overall Study|Development of SMN|1
4757542|NCT02112916|7731870|FG001|Overall Study|Development of SMN|0
4757543|NCT02112916|7731871|FG002|Overall Study|Development of SMN|0
4757544|NCT02112916|7731872|FG003|Overall Study|Development of SMN|1
4757545|NCT02112916|7731869|FG000|Overall Study|Relapse/Progression|10
4757546|NCT02112916|7731870|FG001|Overall Study|Relapse/Progression|18
4757547|NCT02112916|7731871|FG002|Overall Study|Relapse/Progression|15
4757548|NCT02112916|7731872|FG003|Overall Study|Relapse/Progression|2
4757549|NCT02112916|7731869|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5
4757550|NCT02112916|7731870|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5
4757551|NCT02112916|7731871|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0
4757552|NCT02112916|7731872|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0
4757553|NCT02112916|7731869|FG000|Overall Study|Still on Therapy|44
4757554|NCT02112916|7731870|FG001|Overall Study|Still on Therapy|47
4757555|NCT02112916|7731871|FG002|Overall Study|Still on Therapy|3
4757556|NCT02112916|7731872|FG003|Overall Study|Still on Therapy|2
4757557|NCT02112916|7731869|FG000|Overall Study|Identified to have Ph+ T-ALL|0
4757558|NCT02112916|7731870|FG001|Overall Study|Identified to have Ph+ T-ALL|1
4757559|NCT02112916|7731871|FG002|Overall Study|Identified to have Ph+ T-ALL|0
4757560|NCT02112916|7731872|FG003|Overall Study|Identified to have Ph+ T-ALL|0
4757561|NCT02112916|7731869|FG000|Overall Study|Identified to have Ph+ T-Lly|0
4757562|NCT02112916|7731870|FG001|Overall Study|Identified to have Ph+ T-Lly|0
4757563|NCT02112916|7731871|FG002|Overall Study|Identified to have Ph+ T-Lly|1
4757564|NCT02112916|7731872|FG003|Overall Study|Identified to have Ph+ T-Lly|0
4757567|NCT02135029|7731903|FG000|Overall Study|Adverse Event|2
4677359|NCT02401412|7578128|FG001|Overall Study|Subject withdrawal prior to intervention|1
4677360|NCT02401412|7578127|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10
4677361|NCT02401412|7578128|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6
4677362|NCT02401529|7578155|FG000|Overall Study|Lost to Follow-up|2
4677363|NCT02401529|7578156|FG001|Overall Study|Lost to Follow-up|1
4677364|NCT02401529|7578155|FG000|Overall Study|Physician Decision|2
4677365|NCT02401529|7578156|FG001|Overall Study|Physician Decision|6
4677366|NCT02401529|7578155|FG000|Overall Study|Protocol Violation|5
4677367|NCT02401529|7578156|FG001|Overall Study|Protocol Violation|0
4677368|NCT02401672|7578193|FG000|Overall Study|Withdrawal by Subject|1
4677369|NCT02401672|7578194|FG001|Overall Study|Withdrawal by Subject|3
4677370|NCT02401867|7578200|FG000|Specimen Collection|Didn't receive 1 or more tests|10
4677371|NCT02401867|7578200|FG000|Analysis|Cervical assay could not be conducted|9
4677372|NCT02402166|7578235|FG000|Overall Study|Adverse Event|2
4677373|NCT02402166|7578235|FG000|Overall Study|Withdrawal by Subject|2
4677374|NCT02402166|7578235|FG000|Overall Study|Lost to Follow-up|1
4677375|NCT02402218|7578256|FG000|Overall Study|Did not pickup study medication|12
4677376|NCT02402218|7578257|FG001|Overall Study|Did not pickup study medication|9
4677377|NCT02402218|7578258|FG002|Overall Study|Did not pickup study medication|13
4677378|NCT02402218|7578256|FG000|Overall Study|Lack of Efficacy|0
4677379|NCT02402218|7578257|FG001|Overall Study|Lack of Efficacy|1
4677380|NCT02402218|7578258|FG002|Overall Study|Lack of Efficacy|1
4677381|NCT02402218|7578256|FG000|Overall Study|Death|1
4677382|NCT02402218|7578257|FG001|Overall Study|Death|0
4677383|NCT02402218|7578258|FG002|Overall Study|Death|0
4677384|NCT02402218|7578256|FG000|Overall Study|Reinfection|0
4677385|NCT02402218|7578257|FG001|Overall Study|Reinfection|0
4677386|NCT02402218|7578258|FG002|Overall Study|Reinfection|1
4677387|NCT02402218|7578256|FG000|Overall Study|Adverse Event|0
4677388|NCT02402218|7578257|FG001|Overall Study|Adverse Event|2
4677389|NCT02402218|7578258|FG002|Overall Study|Adverse Event|1
4677390|NCT02402218|7578256|FG000|Overall Study|Withdrawal by Subject|1
4677391|NCT02402218|7578257|FG001|Overall Study|Withdrawal by Subject|1
4677392|NCT02402218|7578258|FG002|Overall Study|Withdrawal by Subject|1
4677393|NCT02402322|7578278|FG000|Pretreatment|Withdrawal by Subject|3
4677394|NCT02402322|7578279|FG001|Pretreatment|Withdrawal by Subject|1
4677395|NCT02402322|7578280|FG002|Pretreatment|Withdrawal by Subject|1
4677396|NCT02402322|7578278|FG000|Follow-up|Withdrawal by Subject|6
4677397|NCT02402322|7578279|FG001|Follow-up|Withdrawal by Subject|3
4677398|NCT02402322|7578280|FG002|Follow-up|Withdrawal by Subject|24
4677399|NCT02402907|7578312|FG000|Overall Study|Delivered vaginally|9
4677400|NCT02402907|7578313|FG001|Overall Study|Delivered vaginally|3
4677401|NCT02402907|7578312|FG000|Overall Study|Delivered outside of Sinai|1
4677402|NCT02402907|7578313|FG001|Overall Study|Delivered outside of Sinai|1
4677403|NCT02402907|7578312|FG000|Overall Study|Lost to follow up after C-Section|10
4677404|NCT02402907|7578313|FG001|Overall Study|Lost to follow up after C-Section|23
4677405|NCT02402933|7578319|FG000|Overall Study|Withdrawal by Subject|4
4677406|NCT02402933|7578319|FG000|Overall Study|Discontinued; Site Termination|10
4677407|NCT02403180|7578325|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0
4677408|NCT02403180|7578326|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1
4677409|NCT02403180|7578325|FG000|Period 2 (5 Days)|Withdrawal by Subject|0
4677410|NCT02403180|7578326|FG001|Period 2 (5 Days)|Withdrawal by Subject|1
4677411|NCT02403206|7578334|FG000|Overall Study|Lost to Follow-up|4
4757565|NCT02114697|7731889|FG000|Overall Study|Study terminated|5
4757566|NCT02114697|7731890|FG001|Overall Study|Study terminated|4
4757568|NCT02135029|7731904|FG001|Overall Study|Adverse Event|2
4757569|NCT02135029|7731905|FG002|Overall Study|Adverse Event|2
4757570|NCT02135029|7731903|FG000|Overall Study|Lost to Follow-up|0
4757571|NCT02135029|7731904|FG001|Overall Study|Lost to Follow-up|1
4757572|NCT02135029|7731905|FG002|Overall Study|Lost to Follow-up|0
4757573|NCT02135029|7731903|FG000|Overall Study|Withdrawal by Subject|2
4757574|NCT02135029|7731904|FG001|Overall Study|Withdrawal by Subject|0
4757575|NCT02135029|7731905|FG002|Overall Study|Withdrawal by Subject|1
4757576|NCT02135029|7731903|FG000|Overall Study|Other|0
4757577|NCT02135029|7731904|FG001|Overall Study|Other|1
4757578|NCT02135029|7731905|FG002|Overall Study|Other|0
4757579|NCT02135029|7731903|FG000|Overall Study|Death|0
4757580|NCT02135029|7731904|FG001|Overall Study|Death|1
4757581|NCT02135029|7731905|FG002|Overall Study|Death|0
4677412|NCT02403206|7578335|FG001|Overall Study|Lost to Follow-up|3
4677413|NCT02403206|7578334|FG000|Overall Study|Physician Decision|2
4677414|NCT02403206|7578335|FG001|Overall Study|Physician Decision|0
4677415|NCT02403206|7578334|FG000|Overall Study|Withdrawal by Subject|3
4677416|NCT02403206|7578335|FG001|Overall Study|Withdrawal by Subject|3
4677417|NCT02403206|7578334|FG000|Overall Study|Reason not given|2
4677418|NCT02403206|7578335|FG001|Overall Study|Reason not given|4
4677419|NCT02403271|7578342|FG000|Period 1|Other varied reasons|1
4677420|NCT02403271|7578343|FG001|Period 1|Other varied reasons|0
4677421|NCT02403271|7578342|FG000|Period 2|Withdrawal by Subject|0
4677422|NCT02403271|7578343|FG001|Period 2|Withdrawal by Subject|14
4677423|NCT02403271|7578342|FG000|Period 2|Death|0
4677424|NCT02403271|7578343|FG001|Period 2|Death|84
4677425|NCT02403271|7578342|FG000|Period 2|Lost to Follow-up|0
4677426|NCT02403271|7578343|FG001|Period 2|Lost to Follow-up|2
4677427|NCT02403271|7578342|FG000|Period 2|Study Terminated by Sponsor|0
4677428|NCT02403271|7578343|FG001|Period 2|Study Terminated by Sponsor|14
4677429|NCT02403271|7578342|FG000|Period 2|Other varied reasons|0
4677430|NCT02403271|7578343|FG001|Period 2|Other varied reasons|10
4677431|NCT02403635|7578364|FG000|Overall Study|Not eligible|9
4677432|NCT02403674|7578386|FG000|Overall Study|Adverse Event|10
4677433|NCT02403674|7578387|FG001|Overall Study|Adverse Event|23
4677434|NCT02403674|7578386|FG000|Overall Study|Death|1
4677435|NCT02403674|7578387|FG001|Overall Study|Death|3
4677436|NCT02403674|7578386|FG000|Overall Study|Lack of Efficacy|18
4677437|NCT02403674|7578387|FG001|Overall Study|Lack of Efficacy|10
4677438|NCT02403674|7578386|FG000|Overall Study|Lost to Follow-up|6
4677439|NCT02403674|7578387|FG001|Overall Study|Lost to Follow-up|7
4677440|NCT02403674|7578386|FG000|Overall Study|Noncompliance with study drug|1
4677441|NCT02403674|7578387|FG001|Overall Study|Noncompliance with study drug|2
4677442|NCT02403674|7578386|FG000|Overall Study|Withdrawal by Subject|8
4677443|NCT02403674|7578387|FG001|Overall Study|Withdrawal by Subject|11
4677444|NCT02403674|7578386|FG000|Overall Study|Physician Decision|2
4677445|NCT02403674|7578387|FG001|Overall Study|Physician Decision|2
4677446|NCT02403674|7578386|FG000|Overall Study|Not treated with study drug|4
4677447|NCT02403674|7578387|FG001|Overall Study|Not treated with study drug|2
4677448|NCT02403674|7578386|FG000|Overall Study|Pregnancy|1
4677449|NCT02403674|7578387|FG001|Overall Study|Pregnancy|1
4677450|NCT02403674|7578386|FG000|Overall Study|Protocol Violation|4
4677451|NCT02403674|7578387|FG001|Overall Study|Protocol Violation|2
4677452|NCT02403817|7578404|FG000|Overall Study|Withdrawal by Subject|5
4677453|NCT02403817|7578405|FG001|Overall Study|Withdrawal by Subject|0
4677454|NCT02404025|7578444|FG000|Overall Study|Adverse Event|1
4677455|NCT02404025|7578444|FG000|Overall Study|Lack of Efficacy|3
4677456|NCT02404103|7578450|FG000|Overall Study|Adverse Event|1
4677457|NCT02404103|7578451|FG001|Overall Study|Adverse Event|0
4677458|NCT02404103|7578450|FG000|Overall Study|Lost to Follow-up|3
4677459|NCT02404103|7578451|FG001|Overall Study|Lost to Follow-up|3
4677460|NCT02404220|7578477|FG000|Overall Study|Adverse Event|0
4677461|NCT02404220|7578478|FG001|Overall Study|Adverse Event|0
4677462|NCT02404220|7578479|FG002|Overall Study|Adverse Event|1
4677463|NCT02404220|7578480|FG003|Overall Study|Adverse Event|0
4677464|NCT02404220|7578477|FG000|Overall Study|Death|5
4677465|NCT02404220|7578478|FG001|Overall Study|Death|5
4677466|NCT02404220|7578479|FG002|Overall Study|Death|3
4677467|NCT02404220|7578480|FG003|Overall Study|Death|8
4677468|NCT02404220|7578477|FG000|Overall Study|Progressive Disease|0
4677469|NCT02404220|7578478|FG001|Overall Study|Progressive Disease|0
4677470|NCT02404220|7578479|FG002|Overall Study|Progressive Disease|1
4677471|NCT02404220|7578480|FG003|Overall Study|Progressive Disease|1
4677472|NCT02404220|7578477|FG000|Overall Study|Study Terminated by Sponsor|0
4677473|NCT02404220|7578478|FG001|Overall Study|Study Terminated by Sponsor|0
4757582|NCT02137239|7731916|FG000|Overall Study|Discontinued Study Treatment|0
4757583|NCT02137239|7731917|FG001|Overall Study|Discontinued Study Treatment|3
4757584|NCT02137239|7731916|FG000|Overall Study|Withdrew Consent|1
4757585|NCT02137239|7731917|FG001|Overall Study|Withdrew Consent|1
4757586|NCT02137239|7731916|FG000|Overall Study|Adverse Event|2
4757587|NCT02137239|7731917|FG001|Overall Study|Adverse Event|2
4677474|NCT02404220|7578479|FG002|Overall Study|Study Terminated by Sponsor|2
4677475|NCT02404220|7578480|FG003|Overall Study|Study Terminated by Sponsor|1
4677476|NCT02404220|7578477|FG000|Overall Study|Withdrawal by Subject|0
4677477|NCT02404220|7578478|FG001|Overall Study|Withdrawal by Subject|1
4677478|NCT02404220|7578479|FG002|Overall Study|Withdrawal by Subject|0
4677479|NCT02404220|7578480|FG003|Overall Study|Withdrawal by Subject|0
4677480|NCT02404220|7578477|FG000|Overall Study|Enrolled but Never Treated|0
4677481|NCT02404220|7578478|FG001|Overall Study|Enrolled but Never Treated|2
4677482|NCT02404220|7578479|FG002|Overall Study|Enrolled but Never Treated|0
4677483|NCT02404220|7578480|FG003|Overall Study|Enrolled but Never Treated|0
4677484|NCT02404311|7578510|FG000|Part A: Month 0-18|Death|2
4677485|NCT02404311|7578511|FG001|Part A: Month 0-18|Death|0
4677486|NCT02404311|7578512|FG002|Part A: Month 0-18|Death|0
4677487|NCT02404311|7578513|FG003|Part A: Month 0-18|Death|0
4757588|NCT02148133|7731923|FG000|Overall Study|Investigator discretion|1
4757589|NCT02148133|7731923|FG000|Overall Study|Lack of Efficacy|1
4757590|NCT02148133|7731923|FG000|Overall Study|Protocol deviation|1
4677488|NCT02404311|7578514|FG004|Part A: Month 0-18|Death|0
4677489|NCT02404311|7578510|FG000|Part A: Month 0-18|Physician Decision|1
4677490|NCT02404311|7578511|FG001|Part A: Month 0-18|Physician Decision|0
4677491|NCT02404311|7578512|FG002|Part A: Month 0-18|Physician Decision|0
4677492|NCT02404311|7578513|FG003|Part A: Month 0-18|Physician Decision|0
4677493|NCT02404311|7578514|FG004|Part A: Month 0-18|Physician Decision|0
4677494|NCT02404311|7578510|FG000|Part A: Month 0-18|Lost to Follow-up|4
4677495|NCT02404311|7578511|FG001|Part A: Month 0-18|Lost to Follow-up|2
4677496|NCT02404311|7578512|FG002|Part A: Month 0-18|Lost to Follow-up|0
4677497|NCT02404311|7578513|FG003|Part A: Month 0-18|Lost to Follow-up|0
4677498|NCT02404311|7578514|FG004|Part A: Month 0-18|Lost to Follow-up|0
4677499|NCT02404311|7578510|FG000|Part A: Month 0-18|Withdrawal by Subject|6
4677500|NCT02404311|7578511|FG001|Part A: Month 0-18|Withdrawal by Subject|2
4677501|NCT02404311|7578512|FG002|Part A: Month 0-18|Withdrawal by Subject|0
4677502|NCT02404311|7578513|FG003|Part A: Month 0-18|Withdrawal by Subject|0
4677503|NCT02404311|7578514|FG004|Part A: Month 0-18|Withdrawal by Subject|0
4677504|NCT02404311|7578510|FG000|Part A: Month 0-18|HIV Infection|6
4677505|NCT02404311|7578511|FG001|Part A: Month 0-18|HIV Infection|2
4677506|NCT02404311|7578512|FG002|Part A: Month 0-18|HIV Infection|0
4677507|NCT02404311|7578513|FG003|Part A: Month 0-18|HIV Infection|0
4677508|NCT02404311|7578514|FG004|Part A: Month 0-18|HIV Infection|0
4677509|NCT02404311|7578510|FG000|Part A: Month 0-18|Participant unable to adhere|7
4677510|NCT02404311|7578511|FG001|Part A: Month 0-18|Participant unable to adhere|0
4677511|NCT02404311|7578512|FG002|Part A: Month 0-18|Participant unable to adhere|0
4677512|NCT02404311|7578513|FG003|Part A: Month 0-18|Participant unable to adhere|0
4677513|NCT02404311|7578514|FG004|Part A: Month 0-18|Participant unable to adhere|0
4677514|NCT02404350|7578530|FG000|Overall Study|Adverse Event|2
4677515|NCT02404350|7578531|FG001|Overall Study|Adverse Event|2
4677516|NCT02404350|7578532|FG002|Overall Study|Adverse Event|3
4677517|NCT02404350|7578533|FG003|Overall Study|Adverse Event|9
4677518|NCT02404350|7578530|FG000|Overall Study|Lack of Efficacy|3
4677519|NCT02404350|7578531|FG001|Overall Study|Lack of Efficacy|1
4677520|NCT02404350|7578532|FG002|Overall Study|Lack of Efficacy|0
4677521|NCT02404350|7578533|FG003|Overall Study|Lack of Efficacy|3
4677522|NCT02404350|7578530|FG000|Overall Study|Lost to Follow-up|2
4677523|NCT02404350|7578531|FG001|Overall Study|Lost to Follow-up|0
4677524|NCT02404350|7578532|FG002|Overall Study|Lost to Follow-up|0
4677525|NCT02404350|7578533|FG003|Overall Study|Lost to Follow-up|1
4677526|NCT02404350|7578530|FG000|Overall Study|Physician Decision|1
4677527|NCT02404350|7578531|FG001|Overall Study|Physician Decision|0
4677528|NCT02404350|7578532|FG002|Overall Study|Physician Decision|0
4677529|NCT02404350|7578533|FG003|Overall Study|Physician Decision|2
4677530|NCT02404350|7578530|FG000|Overall Study|Pregnancy|0
4677531|NCT02404350|7578531|FG001|Overall Study|Pregnancy|0
4677532|NCT02404350|7578532|FG002|Overall Study|Pregnancy|0
4677533|NCT02404350|7578533|FG003|Overall Study|Pregnancy|1
4677534|NCT02404350|7578530|FG000|Overall Study|Withdrawal by Subject|7
4677535|NCT02404350|7578531|FG001|Overall Study|Withdrawal by Subject|3
4677536|NCT02404350|7578532|FG002|Overall Study|Withdrawal by Subject|3
4677537|NCT02404350|7578533|FG003|Overall Study|Withdrawal by Subject|19
4677538|NCT02404350|7578530|FG000|Overall Study|Due to Non-compliance with treatment|0
4677539|NCT02404350|7578531|FG001|Overall Study|Due to Non-compliance with treatment|0
4677540|NCT02404350|7578532|FG002|Overall Study|Due to Non-compliance with treatment|0
4677541|NCT02404350|7578533|FG003|Overall Study|Due to Non-compliance with treatment|1
4677542|NCT02404350|7578530|FG000|Overall Study|Due to Technical problems|0
4677543|NCT02404350|7578531|FG001|Overall Study|Due to Technical problems|0
4677544|NCT02404350|7578532|FG002|Overall Study|Due to Technical problems|0
4757591|NCT02148133|7731923|FG000|Overall Study|Protocol-defined stopping criteria|2
4677545|NCT02404350|7578533|FG003|Overall Study|Due to Technical problems|1
4677546|NCT02404389|7578549|FG000|Overall Study|Adverse Event|1
4677547|NCT02404389|7578550|FG001|Overall Study|Adverse Event|0
4677548|NCT02404389|7578551|FG002|Overall Study|Adverse Event|1
4677549|NCT02404389|7578552|FG003|Overall Study|Adverse Event|0
4677550|NCT02404389|7578553|FG004|Overall Study|Adverse Event|2
4677551|NCT02404389|7578549|FG000|Overall Study|Subject/guardian decision|1
4677552|NCT02404389|7578550|FG001|Overall Study|Subject/guardian decision|0
4677553|NCT02404389|7578551|FG002|Overall Study|Subject/guardian decision|0
4677554|NCT02404389|7578552|FG003|Overall Study|Subject/guardian decision|1
4677555|NCT02404389|7578553|FG004|Overall Study|Subject/guardian decision|1
4677556|NCT02404441|7578577|FG000|Phase 1 Part|Adverse Event|1
4677557|NCT02404441|7578578|FG001|Phase 1 Part|Adverse Event|0
4677558|NCT02404441|7578579|FG002|Phase 1 Part|Adverse Event|0
4677559|NCT02404441|7578580|FG003|Phase 1 Part|Adverse Event|0
4677560|NCT02404441|7578581|FG004|Phase 1 Part|Adverse Event|0
4677561|NCT02404441|7578582|FG005|Phase 1 Part|Adverse Event|0
4677562|NCT02404441|7578583|FG006|Phase 1 Part|Adverse Event|0
4677563|NCT02404441|7578584|FG007|Phase 1 Part|Adverse Event|0
4677564|NCT02404441|7578585|FG008|Phase 1 Part|Adverse Event|0
4677565|NCT02404441|7578586|FG009|Phase 1 Part|Adverse Event|0
4677566|NCT02404441|7578577|FG000|Phase 1 Part|Physician Decision|0
4677567|NCT02404441|7578578|FG001|Phase 1 Part|Physician Decision|1
4677568|NCT02404441|7578579|FG002|Phase 1 Part|Physician Decision|0
4677569|NCT02404441|7578580|FG003|Phase 1 Part|Physician Decision|0
4677570|NCT02404441|7578581|FG004|Phase 1 Part|Physician Decision|0
4677571|NCT02404441|7578582|FG005|Phase 1 Part|Physician Decision|0
4677572|NCT02404441|7578583|FG006|Phase 1 Part|Physician Decision|0
4677573|NCT02404441|7578584|FG007|Phase 1 Part|Physician Decision|0
4677574|NCT02404441|7578585|FG008|Phase 1 Part|Physician Decision|0
4677575|NCT02404441|7578586|FG009|Phase 1 Part|Physician Decision|0
4677576|NCT02404441|7578577|FG000|Phase 1 Part|Progressive Disease|14
4677577|NCT02404441|7578578|FG001|Phase 1 Part|Progressive Disease|11
4677578|NCT02404441|7578579|FG002|Phase 1 Part|Progressive Disease|7
4677579|NCT02404441|7578580|FG003|Phase 1 Part|Progressive Disease|6
4677580|NCT02404441|7578581|FG004|Phase 1 Part|Progressive Disease|9
4677581|NCT02404441|7578582|FG005|Phase 1 Part|Progressive Disease|0
4677582|NCT02404441|7578583|FG006|Phase 1 Part|Progressive Disease|0
4677583|NCT02404441|7578584|FG007|Phase 1 Part|Progressive Disease|0
4677584|NCT02404441|7578585|FG008|Phase 1 Part|Progressive Disease|0
4677585|NCT02404441|7578586|FG009|Phase 1 Part|Progressive Disease|0
4677586|NCT02404441|7578577|FG000|Phase 1 Part|Subject/Guardian Decision|0
4677587|NCT02404441|7578578|FG001|Phase 1 Part|Subject/Guardian Decision|2
4677588|NCT02404441|7578579|FG002|Phase 1 Part|Subject/Guardian Decision|3
4677589|NCT02404441|7578580|FG003|Phase 1 Part|Subject/Guardian Decision|0
4677590|NCT02404441|7578581|FG004|Phase 1 Part|Subject/Guardian Decision|0
4677591|NCT02404441|7578582|FG005|Phase 1 Part|Subject/Guardian Decision|0
4677592|NCT02404441|7578583|FG006|Phase 1 Part|Subject/Guardian Decision|0
4677593|NCT02404441|7578584|FG007|Phase 1 Part|Subject/Guardian Decision|0
4677594|NCT02404441|7578585|FG008|Phase 1 Part|Subject/Guardian Decision|0
4677595|NCT02404441|7578586|FG009|Phase 1 Part|Subject/Guardian Decision|0
4677596|NCT02404441|7578577|FG000|Phase 1 Part|Death|1
4677597|NCT02404441|7578578|FG001|Phase 1 Part|Death|1
4677598|NCT02404441|7578579|FG002|Phase 1 Part|Death|1
4677599|NCT02404441|7578580|FG003|Phase 1 Part|Death|0
4677600|NCT02404441|7578581|FG004|Phase 1 Part|Death|1
4677601|NCT02404441|7578582|FG005|Phase 1 Part|Death|0
4677602|NCT02404441|7578583|FG006|Phase 1 Part|Death|0
4677603|NCT02404441|7578584|FG007|Phase 1 Part|Death|0
4677604|NCT02404441|7578585|FG008|Phase 1 Part|Death|0
4677605|NCT02404441|7578586|FG009|Phase 1 Part|Death|0
4677606|NCT02404441|7578577|FG000|Phase 2 Part|Adverse Event|0
4677607|NCT02404441|7578578|FG001|Phase 2 Part|Adverse Event|0
4677608|NCT02404441|7578579|FG002|Phase 2 Part|Adverse Event|0
4677609|NCT02404441|7578580|FG003|Phase 2 Part|Adverse Event|0
4677610|NCT02404441|7578581|FG004|Phase 2 Part|Adverse Event|0
4677611|NCT02404441|7578582|FG005|Phase 2 Part|Adverse Event|2
4677612|NCT02404441|7578583|FG006|Phase 2 Part|Adverse Event|3
4677613|NCT02404441|7578584|FG007|Phase 2 Part|Adverse Event|3
4677614|NCT02404441|7578585|FG008|Phase 2 Part|Adverse Event|6
4677615|NCT02404441|7578586|FG009|Phase 2 Part|Adverse Event|1
4677616|NCT02404441|7578577|FG000|Phase 2 Part|Physician Decision|0
4677617|NCT02404441|7578578|FG001|Phase 2 Part|Physician Decision|0
4677618|NCT02404441|7578579|FG002|Phase 2 Part|Physician Decision|0
4677619|NCT02404441|7578580|FG003|Phase 2 Part|Physician Decision|0
4677620|NCT02404441|7578581|FG004|Phase 2 Part|Physician Decision|0
4677621|NCT02404441|7578582|FG005|Phase 2 Part|Physician Decision|7
4677622|NCT02404441|7578583|FG006|Phase 2 Part|Physician Decision|9
4677623|NCT02404441|7578584|FG007|Phase 2 Part|Physician Decision|2
4677624|NCT02404441|7578585|FG008|Phase 2 Part|Physician Decision|1
4677625|NCT02404441|7578586|FG009|Phase 2 Part|Physician Decision|3
4677626|NCT02404441|7578577|FG000|Phase 2 Part|Progressive disease|0
4677627|NCT02404441|7578578|FG001|Phase 2 Part|Progressive disease|0
4677628|NCT02404441|7578579|FG002|Phase 2 Part|Progressive disease|0
4677629|NCT02404441|7578580|FG003|Phase 2 Part|Progressive disease|0
4677630|NCT02404441|7578581|FG004|Phase 2 Part|Progressive disease|0
4677631|NCT02404441|7578582|FG005|Phase 2 Part|Progressive disease|43
4677632|NCT02404441|7578583|FG006|Phase 2 Part|Progressive disease|32
4677633|NCT02404441|7578584|FG007|Phase 2 Part|Progressive disease|31
4677634|NCT02404441|7578585|FG008|Phase 2 Part|Progressive disease|39
4677635|NCT02404441|7578586|FG009|Phase 2 Part|Progressive disease|27
4677636|NCT02404441|7578577|FG000|Phase 2 Part|Subject/guardian decision|0
4677637|NCT02404441|7578578|FG001|Phase 2 Part|Subject/guardian decision|0
4677638|NCT02404441|7578579|FG002|Phase 2 Part|Subject/guardian decision|0
4677639|NCT02404441|7578580|FG003|Phase 2 Part|Subject/guardian decision|0
4677640|NCT02404441|7578581|FG004|Phase 2 Part|Subject/guardian decision|0
4677641|NCT02404441|7578582|FG005|Phase 2 Part|Subject/guardian decision|3
4677642|NCT02404441|7578583|FG006|Phase 2 Part|Subject/guardian decision|9
4677643|NCT02404441|7578584|FG007|Phase 2 Part|Subject/guardian decision|0
4677644|NCT02404441|7578585|FG008|Phase 2 Part|Subject/guardian decision|3
4677645|NCT02404441|7578586|FG009|Phase 2 Part|Subject/guardian decision|2
4677646|NCT02404441|7578577|FG000|Phase 2 Part|Death|0
4677647|NCT02404441|7578578|FG001|Phase 2 Part|Death|0
4677648|NCT02404441|7578579|FG002|Phase 2 Part|Death|0
4677649|NCT02404441|7578580|FG003|Phase 2 Part|Death|0
4677650|NCT02404441|7578581|FG004|Phase 2 Part|Death|0
4677651|NCT02404441|7578582|FG005|Phase 2 Part|Death|4
4677652|NCT02404441|7578583|FG006|Phase 2 Part|Death|8
4677653|NCT02404441|7578584|FG007|Phase 2 Part|Death|4
4677654|NCT02404441|7578585|FG008|Phase 2 Part|Death|10
4677655|NCT02404441|7578586|FG009|Phase 2 Part|Death|9
4677656|NCT02404493|7578632|FG000|Overall Study|Adverse Event|1
4677657|NCT02404493|7578633|FG001|Overall Study|Adverse Event|1
4757592|NCT02165215|7731943|FG000|Induction Phase|Adverse Event|1
4757593|NCT02165215|7731944|FG001|Induction Phase|Adverse Event|0
4757594|NCT02165215|7731945|FG002|Induction Phase|Adverse Event|0
4757595|NCT02165215|7731943|FG000|Induction Phase|Withdrawal by Subject|10
4757596|NCT02165215|7731944|FG001|Induction Phase|Withdrawal by Subject|0
4757597|NCT02165215|7731945|FG002|Induction Phase|Withdrawal by Subject|0
4757598|NCT02165215|7731943|FG000|Induction Phase|Protocol Violation|1
4757599|NCT02165215|7731944|FG001|Induction Phase|Protocol Violation|0
4757600|NCT02165215|7731945|FG002|Induction Phase|Protocol Violation|0
4757601|NCT02165215|7731943|FG000|Induction Phase|Physician Decision|1
4757602|NCT02165215|7731944|FG001|Induction Phase|Physician Decision|0
4757603|NCT02165215|7731945|FG002|Induction Phase|Physician Decision|0
4757604|NCT02165215|7731943|FG000|Induction Phase|Lack of Efficacy|2
4757605|NCT02165215|7731944|FG001|Induction Phase|Lack of Efficacy|0
4757606|NCT02165215|7731945|FG002|Induction Phase|Lack of Efficacy|0
4757607|NCT02165215|7731943|FG000|Induction Phase|Non-Compliance|2
4757608|NCT02165215|7731944|FG001|Induction Phase|Non-Compliance|0
4757609|NCT02165215|7731945|FG002|Induction Phase|Non-Compliance|0
4757610|NCT02165215|7731943|FG000|Induction Phase|Lost to Follow-up|6
4757611|NCT02165215|7731944|FG001|Induction Phase|Lost to Follow-up|0
4757612|NCT02165215|7731945|FG002|Induction Phase|Lost to Follow-up|0
4757613|NCT02165215|7731943|FG000|Maintenance Phase|Withdrawal by Subject|0
4757614|NCT02165215|7731944|FG001|Maintenance Phase|Withdrawal by Subject|7
4757615|NCT02165215|7731945|FG002|Maintenance Phase|Withdrawal by Subject|3
4757616|NCT02165215|7731943|FG000|Maintenance Phase|Multiple reasons|0
4757617|NCT02165215|7731944|FG001|Maintenance Phase|Multiple reasons|2
4757618|NCT02165215|7731945|FG002|Maintenance Phase|Multiple reasons|1
4757619|NCT02165215|7731943|FG000|Maintenance Phase|Lost to Follow-up|0
4757620|NCT02165215|7731944|FG001|Maintenance Phase|Lost to Follow-up|2
4757621|NCT02165215|7731945|FG002|Maintenance Phase|Lost to Follow-up|0
4757622|NCT02165215|7731943|FG000|Maintenance Phase|Adverse Event|0
4757623|NCT02165215|7731944|FG001|Maintenance Phase|Adverse Event|1
4757624|NCT02165215|7731945|FG002|Maintenance Phase|Adverse Event|1
4677658|NCT02404649|7578659|FG000|Overall Study|Adverse Event|1
4677659|NCT02404649|7578660|FG001|Overall Study|Adverse Event|2
4677660|NCT02404805|7578683|FG000|Overall Study|Withdrawal by Subject|1
4677661|NCT02404805|7578684|FG001|Overall Study|Withdrawal by Subject|0
4677662|NCT02404805|7578685|FG002|Overall Study|Withdrawal by Subject|0
4677663|NCT02404805|7578686|FG003|Overall Study|Withdrawal by Subject|0
4677664|NCT02404805|7578687|FG004|Overall Study|Withdrawal by Subject|0
4677665|NCT02404805|7578688|FG005|Overall Study|Withdrawal by Subject|0
4677666|NCT02405091|7578700|FG000|Overall Study|Adverse Event|16
4677667|NCT02405091|7578701|FG001|Overall Study|Adverse Event|10
4677668|NCT02405091|7578702|FG002|Overall Study|Adverse Event|0
4677669|NCT02405091|7578700|FG000|Overall Study|Protocol Violation|1
4677670|NCT02405091|7578701|FG001|Overall Study|Protocol Violation|0
4677671|NCT02405091|7578702|FG002|Overall Study|Protocol Violation|0
4677672|NCT02405091|7578700|FG000|Overall Study|Noncompliance|1
4677673|NCT02405091|7578701|FG001|Overall Study|Noncompliance|6
4677674|NCT02405091|7578702|FG002|Overall Study|Noncompliance|2
4677675|NCT02405091|7578700|FG000|Overall Study|Withdrawal by Subject|4
4677676|NCT02405091|7578701|FG001|Overall Study|Withdrawal by Subject|8
4677677|NCT02405091|7578702|FG002|Overall Study|Withdrawal by Subject|0
4677678|NCT02405091|7578700|FG000|Overall Study|Death|0
4677679|NCT02405091|7578701|FG001|Overall Study|Death|1
4677680|NCT02405091|7578702|FG002|Overall Study|Death|0
4677681|NCT02405091|7578700|FG000|Overall Study|Lost to Follow-up|5
4677682|NCT02405091|7578701|FG001|Overall Study|Lost to Follow-up|6
4677683|NCT02405091|7578702|FG002|Overall Study|Lost to Follow-up|0
4677684|NCT02405091|7578700|FG000|Overall Study|Physician Decision|2
4677685|NCT02405091|7578701|FG001|Overall Study|Physician Decision|2
4677686|NCT02405091|7578702|FG002|Overall Study|Physician Decision|0
4677687|NCT02405442|7578743|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0
4677688|NCT02405442|7578744|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2
4677689|NCT02405442|7578745|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4
4677690|NCT02405442|7578746|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1
4677691|NCT02405442|7578743|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0
4677692|NCT02405442|7578744|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1
4677693|NCT02405442|7578745|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2
4677694|NCT02405442|7578746|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0
4677695|NCT02405442|7578743|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1
4677696|NCT02405442|7578744|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1
4677697|NCT02405442|7578745|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0
4677698|NCT02405442|7578746|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0
4677699|NCT02405442|7578743|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0
4677700|NCT02405442|7578744|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1
4677701|NCT02405442|7578745|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0
4677702|NCT02405442|7578746|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0
4677703|NCT02405442|7578743|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27
4677704|NCT02405442|7578744|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28
4677705|NCT02405442|7578745|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28
4677706|NCT02405442|7578746|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13
4677707|NCT02405442|7578743|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14
4677708|NCT02405442|7578744|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11
4677709|NCT02405442|7578745|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11
4677710|NCT02405442|7578746|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2
4677711|NCT02405442|7578743|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6
4677712|NCT02405442|7578744|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1
4677713|NCT02405442|7578745|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2
4677714|NCT02405442|7578746|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6
4677715|NCT02405442|7578743|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0
4677716|NCT02405442|7578744|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1
4677717|NCT02405442|7578745|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3
4677718|NCT02405442|7578746|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2
4677719|NCT02405442|7578743|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1
4677720|NCT02405442|7578744|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2
4677721|NCT02405442|7578745|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1
4677722|NCT02405442|7578746|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1
4677723|NCT02405442|7578743|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0
4677724|NCT02405442|7578744|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1
4677725|NCT02405442|7578745|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0
4677726|NCT02405442|7578746|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0
4677727|NCT02405442|7578743|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0
4677728|NCT02405442|7578744|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1
4677729|NCT02405442|7578745|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0
4677730|NCT02405442|7578746|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0
4677731|NCT02405442|7578743|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2
4757625|NCT02180217|7731959|FG000|Overall Study|Adverse Event|3
4677732|NCT02405442|7578744|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1
4677733|NCT02405442|7578745|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2
4677734|NCT02405442|7578746|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2
4677735|NCT02405442|7578743|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0
4677736|NCT02405442|7578744|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1
4677737|NCT02405442|7578745|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0
4677738|NCT02405442|7578746|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0
4677739|NCT02405442|7578743|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1
4677740|NCT02405442|7578744|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0
4677741|NCT02405442|7578745|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0
4677742|NCT02405442|7578746|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0
4677743|NCT02405780|7578764|FG000|Period I|Adverse Event|8
4677744|NCT02405780|7578765|FG001|Period I|Adverse Event|0
4677745|NCT02405780|7578766|FG002|Period I|Adverse Event|3
4677746|NCT02405780|7578767|FG003|Period I|Adverse Event|7
4677747|NCT02405780|7578764|FG000|Period I|Medical reasons|1
4677748|NCT02405780|7578765|FG001|Period I|Medical reasons|1
4677749|NCT02405780|7578766|FG002|Period I|Medical reasons|0
4677750|NCT02405780|7578767|FG003|Period I|Medical reasons|1
4677751|NCT02405780|7578764|FG000|Period I|Screening Failure|1
4677752|NCT02405780|7578765|FG001|Period I|Screening Failure|0
4677753|NCT02405780|7578766|FG002|Period I|Screening Failure|1
4677754|NCT02405780|7578767|FG003|Period I|Screening Failure|0
4677755|NCT02405780|7578764|FG000|Period I|Withdrawal by Subject|9
4677756|NCT02405780|7578765|FG001|Period I|Withdrawal by Subject|1
4677757|NCT02405780|7578766|FG002|Period I|Withdrawal by Subject|3
4677758|NCT02405780|7578767|FG003|Period I|Withdrawal by Subject|4
4677759|NCT02405780|7578764|FG000|Period I|Non-compliance with study procedures|8
4677760|NCT02405780|7578765|FG001|Period I|Non-compliance with study procedures|6
4677761|NCT02405780|7578766|FG002|Period I|Non-compliance with study procedures|8
4677762|NCT02405780|7578767|FG003|Period I|Non-compliance with study procedures|11
4677763|NCT02405780|7578764|FG000|Period II|Adverse Event|3
4677764|NCT02405780|7578765|FG001|Period II|Adverse Event|5
4677765|NCT02405780|7578766|FG002|Period II|Adverse Event|4
4677766|NCT02405780|7578767|FG003|Period II|Adverse Event|11
4677767|NCT02405780|7578764|FG000|Period II|Medical reason|0
4677768|NCT02405780|7578765|FG001|Period II|Medical reason|1
4757626|NCT02180217|7731960|FG001|Overall Study|Adverse Event|2
4757627|NCT02180217|7731961|FG002|Overall Study|Adverse Event|22
4757628|NCT02180217|7731959|FG000|Overall Study|Death|1
4757629|NCT02180217|7731960|FG001|Overall Study|Death|1
4757630|NCT02180217|7731961|FG002|Overall Study|Death|0
4757631|NCT02180217|7731959|FG000|Overall Study|Withdrawal by Subject|1
4757632|NCT02180217|7731960|FG001|Overall Study|Withdrawal by Subject|1
4757633|NCT02180217|7731961|FG002|Overall Study|Withdrawal by Subject|4
4757634|NCT02180217|7731959|FG000|Overall Study|Subject/Guardian decision|5
4757635|NCT02180217|7731960|FG001|Overall Study|Subject/Guardian decision|3
4757636|NCT02180217|7731961|FG002|Overall Study|Subject/Guardian decision|6
4757637|NCT02180217|7731959|FG000|Overall Study|Physician Decision|1
4757638|NCT02180217|7731960|FG001|Overall Study|Physician Decision|1
4757639|NCT02180217|7731961|FG002|Overall Study|Physician Decision|6
4677769|NCT02405780|7578766|FG002|Period II|Medical reason|0
4677770|NCT02405780|7578767|FG003|Period II|Medical reason|0
4757640|NCT02180217|7731959|FG000|Overall Study|Unsatisfactory therapeutic effect|1
4757641|NCT02180217|7731960|FG001|Overall Study|Unsatisfactory therapeutic effect|0
4677771|NCT02405780|7578764|FG000|Period II|Pregnancy|0
4677772|NCT02405780|7578765|FG001|Period II|Pregnancy|0
4677773|NCT02405780|7578766|FG002|Period II|Pregnancy|1
4677774|NCT02405780|7578767|FG003|Period II|Pregnancy|0
4677775|NCT02405780|7578764|FG000|Period II|Withdrawal by Subject|7
4677776|NCT02405780|7578765|FG001|Period II|Withdrawal by Subject|4
4677777|NCT02405780|7578766|FG002|Period II|Withdrawal by Subject|0
4677778|NCT02405780|7578767|FG003|Period II|Withdrawal by Subject|3
4677779|NCT02405780|7578764|FG000|Period II|Non-compliance with study procedures|5
4677780|NCT02405780|7578765|FG001|Period II|Non-compliance with study procedures|2
4677781|NCT02405780|7578766|FG002|Period II|Non-compliance with study procedures|7
4677782|NCT02405780|7578767|FG003|Period II|Non-compliance with study procedures|4
4677783|NCT02405962|7578794|FG000|Overall Study|Lost to Follow-up|1
4677784|NCT02405962|7578795|FG001|Overall Study|Lost to Follow-up|4
4677785|NCT02405962|7578794|FG000|Overall Study|A participant has moved to another place|0
4677786|NCT02405962|7578795|FG001|Overall Study|A participant has moved to another place|1
4677787|NCT02406027|7578804|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0
4677788|NCT02406027|7578805|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2
4677789|NCT02406027|7578806|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1
4677790|NCT02406027|7578807|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0
4677791|NCT02406027|7578808|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0
4677792|NCT02406027|7578809|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0
4677793|NCT02406027|7578810|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0
4677794|NCT02406027|7578804|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3
4677795|NCT02406027|7578805|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0
4677796|NCT02406027|7578806|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1
4677797|NCT02406027|7578807|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0
4677798|NCT02406027|7578808|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0
4677799|NCT02406027|7578809|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0
4677800|NCT02406027|7578810|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0
4677801|NCT02406027|7578804|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2
4677802|NCT02406027|7578805|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1
4677803|NCT02406027|7578806|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1
4677804|NCT02406027|7578807|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0
4677805|NCT02406027|7578808|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0
4677806|NCT02406027|7578809|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0
4677807|NCT02406027|7578810|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0
4677808|NCT02406027|7578804|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1
4677809|NCT02406027|7578805|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
4677810|NCT02406027|7578806|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1
4677811|NCT02406027|7578807|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
4677812|NCT02406027|7578808|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
4677813|NCT02406027|7578809|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
4677814|NCT02406027|7578810|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
4677815|NCT02406027|7578804|FG000|Open-label Phase (Period 2)|Adverse Event|0
4677816|NCT02406027|7578805|FG001|Open-label Phase (Period 2)|Adverse Event|0
4677817|NCT02406027|7578806|FG002|Open-label Phase (Period 2)|Adverse Event|0
4677818|NCT02406027|7578807|FG003|Open-label Phase (Period 2)|Adverse Event|2
4677819|NCT02406027|7578808|FG004|Open-label Phase (Period 2)|Adverse Event|2
4677820|NCT02406027|7578809|FG005|Open-label Phase (Period 2)|Adverse Event|0
4677821|NCT02406027|7578810|FG006|Open-label Phase (Period 2)|Adverse Event|0
4677822|NCT02406027|7578804|FG000|Open-label Phase (Period 2)|Physician Decision|0
4677823|NCT02406027|7578805|FG001|Open-label Phase (Period 2)|Physician Decision|0
4677824|NCT02406027|7578806|FG002|Open-label Phase (Period 2)|Physician Decision|0
4677825|NCT02406027|7578807|FG003|Open-label Phase (Period 2)|Physician Decision|0
4677826|NCT02406027|7578808|FG004|Open-label Phase (Period 2)|Physician Decision|0
4677827|NCT02406027|7578809|FG005|Open-label Phase (Period 2)|Physician Decision|1
4677828|NCT02406027|7578810|FG006|Open-label Phase (Period 2)|Physician Decision|1
4677829|NCT02406027|7578804|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0
4677830|NCT02406027|7578805|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0
4677831|NCT02406027|7578806|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0
4677832|NCT02406027|7578807|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2
4677833|NCT02406027|7578808|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4
4677834|NCT02406027|7578809|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0
4677835|NCT02406027|7578810|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2
4677836|NCT02406027|7578804|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0
4677837|NCT02406027|7578805|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0
4677838|NCT02406027|7578806|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0
4677839|NCT02406027|7578807|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11
4677840|NCT02406027|7578808|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7
4677841|NCT02406027|7578809|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24
4757642|NCT02180217|7731961|FG002|Overall Study|Unsatisfactory therapeutic effect|0
4677842|NCT02406027|7578810|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19
4677843|NCT02406027|7578804|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
4677844|NCT02406027|7578805|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
4677845|NCT02406027|7578806|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
4677846|NCT02406027|7578807|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
4677847|NCT02406027|7578808|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
4677848|NCT02406027|7578809|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1
4677849|NCT02406027|7578810|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
4677850|NCT02406027|7578804|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
4677851|NCT02406027|7578805|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
4677852|NCT02406027|7578806|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
4677853|NCT02406027|7578807|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
4677854|NCT02406027|7578808|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1
4677855|NCT02406027|7578809|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
4677856|NCT02406027|7578810|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
4677857|NCT02406248|7578826|FG000|Overall Study|Death|7
4677858|NCT02406248|7578826|FG000|Overall Study|Withdrawal by Subject|2
4677859|NCT02406261|7578832|FG000|Period 1|Lost to Follow-up|2
4677860|NCT02406261|7578833|FG001|Period 1|Lost to Follow-up|0
4677861|NCT02406261|7578832|FG000|Period 1|Adverse Event|1
4677862|NCT02406261|7578833|FG001|Period 1|Adverse Event|0
4677863|NCT02406261|7578832|FG000|Period 2|Physician Decision|0
4677864|NCT02406261|7578833|FG001|Period 2|Physician Decision|1
4677865|NCT02406261|7578832|FG000|Period 2|Protocol Violation|0
4677866|NCT02406261|7578833|FG001|Period 2|Protocol Violation|1
4677867|NCT02406261|7578832|FG000|Period 2|Withdrawal by Subject|0
4677868|NCT02406261|7578833|FG001|Period 2|Withdrawal by Subject|1
4677869|NCT02406586|7578869|FG000|Overall Study|Lost to Follow-up|0
4677870|NCT02406586|7578870|FG001|Overall Study|Lost to Follow-up|4
4677871|NCT02406586|7578871|FG002|Overall Study|Lost to Follow-up|2
4677872|NCT02406586|7578869|FG000|Overall Study|Withdrawal by Subject|1
4677873|NCT02406586|7578870|FG001|Overall Study|Withdrawal by Subject|0
4677874|NCT02406586|7578871|FG002|Overall Study|Withdrawal by Subject|0
4677875|NCT02406612|7578884|FG000|Overall Study|Screening Failure|3
4677876|NCT02406612|7578885|FG001|Overall Study|Screening Failure|0
4677877|NCT02406612|7578884|FG000|Overall Study|Intra-procedural Exclusion|1
4677878|NCT02406612|7578885|FG001|Overall Study|Intra-procedural Exclusion|3
4677879|NCT02406612|7578884|FG000|Overall Study|Guidewire Failure|0
4677880|NCT02406612|7578885|FG001|Overall Study|Guidewire Failure|1
4677881|NCT02406651|7578891|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3
4677882|NCT02406677|7578898|FG000|Overall Study|Death|16
4677883|NCT02406677|7578899|FG001|Overall Study|Death|8
4677884|NCT02406677|7578898|FG000|Overall Study|Discharged without P2Y12|1
4677885|NCT02406677|7578899|FG001|Overall Study|Discharged without P2Y12|3
4677886|NCT02406677|7578898|FG000|Overall Study|Discharged on prasugrel|283
4677887|NCT02406677|7578899|FG001|Overall Study|Discharged on prasugrel|587
4677888|NCT02406677|7578898|FG000|Overall Study|Withdrawal by Subject|1
4677889|NCT02406677|7578899|FG001|Overall Study|Withdrawal by Subject|0
4677890|NCT02406742|7578912|FG000|Overall Study|Progression of Disease|5
4677891|NCT02406742|7578913|FG001|Overall Study|Progression of Disease|1
4677892|NCT02406742|7578914|FG002|Overall Study|Progression of Disease|6
4677893|NCT02406742|7578912|FG000|Overall Study|Adverse Event|3
4677894|NCT02406742|7578913|FG001|Overall Study|Adverse Event|0
4677895|NCT02406742|7578914|FG002|Overall Study|Adverse Event|2
4677896|NCT02406742|7578912|FG000|Overall Study|Death|1
4677897|NCT02406742|7578913|FG001|Overall Study|Death|0
4677898|NCT02406742|7578914|FG002|Overall Study|Death|0
4677899|NCT02406742|7578912|FG000|Overall Study|Lack of Efficacy|0
4677900|NCT02406742|7578913|FG001|Overall Study|Lack of Efficacy|0
4677901|NCT02406742|7578914|FG002|Overall Study|Lack of Efficacy|1
4677902|NCT02406742|7578912|FG000|Overall Study|Withdrawal by Participant|1
4677903|NCT02406742|7578913|FG001|Overall Study|Withdrawal by Participant|2
4677904|NCT02406742|7578914|FG002|Overall Study|Withdrawal by Participant|0
4677905|NCT02406742|7578912|FG000|Overall Study|Physician Decision|1
4677906|NCT02406742|7578913|FG001|Overall Study|Physician Decision|2
4677907|NCT02406742|7578914|FG002|Overall Study|Physician Decision|1
4677908|NCT02406742|7578912|FG000|Overall Study|Transition to other treatment|2
4677909|NCT02406742|7578913|FG001|Overall Study|Transition to other treatment|0
4677910|NCT02406742|7578914|FG002|Overall Study|Transition to other treatment|1
4677911|NCT02406742|7578912|FG000|Overall Study|Other Reasons|1
4677912|NCT02406742|7578913|FG001|Overall Study|Other Reasons|11
4677913|NCT02406742|7578914|FG002|Overall Study|Other Reasons|5
4677914|NCT02407054|7578976|FG000|Overall Study|Adverse Event|1
4677915|NCT02407054|7578977|FG001|Overall Study|Adverse Event|4
4677916|NCT02407054|7578978|FG002|Overall Study|Adverse Event|1
4677917|NCT02407054|7578976|FG000|Overall Study|Non-compliance with Study|0
4677918|NCT02407054|7578977|FG001|Overall Study|Non-compliance with Study|2
4677919|NCT02407054|7578978|FG002|Overall Study|Non-compliance with Study|1
4677920|NCT02407054|7578976|FG000|Overall Study|Physician Decision|1
4677921|NCT02407054|7578977|FG001|Overall Study|Physician Decision|3
4677922|NCT02407054|7578978|FG002|Overall Study|Physician Decision|3
4677923|NCT02407054|7578976|FG000|Overall Study|Withdrawal by Subject|5
4677924|NCT02407054|7578977|FG001|Overall Study|Withdrawal by Subject|9
4677925|NCT02407054|7578978|FG002|Overall Study|Withdrawal by Subject|2
4677926|NCT02407223|7578999|FG000|Overall Study|Adverse Event|1
4677927|NCT02407223|7579000|FG001|Overall Study|Adverse Event|0
4677928|NCT02407223|7579001|FG002|Overall Study|Adverse Event|1
4677929|NCT02407223|7578999|FG000|Overall Study|Lack of Efficacy|6
4677930|NCT02407223|7579000|FG001|Overall Study|Lack of Efficacy|6
4677931|NCT02407223|7579001|FG002|Overall Study|Lack of Efficacy|4
4677932|NCT02407223|7578999|FG000|Overall Study|Lost to Follow-up|1
4677933|NCT02407223|7579000|FG001|Overall Study|Lost to Follow-up|0
4677934|NCT02407223|7579001|FG002|Overall Study|Lost to Follow-up|2
4677935|NCT02407223|7578999|FG000|Overall Study|Withdrawal by Subject|2
4677936|NCT02407223|7579000|FG001|Overall Study|Withdrawal by Subject|4
4677937|NCT02407223|7579001|FG002|Overall Study|Withdrawal by Subject|4
4677938|NCT02407223|7578999|FG000|Overall Study|Study Terminated by Sponsor|77
4677939|NCT02407223|7579000|FG001|Overall Study|Study Terminated by Sponsor|80
4677940|NCT02407223|7579001|FG002|Overall Study|Study Terminated by Sponsor|86
4677941|NCT02407223|7578999|FG000|Overall Study|Subject Refused Further Study Treatment|0
4677942|NCT02407223|7579000|FG001|Overall Study|Subject Refused Further Study Treatment|1
4677943|NCT02407223|7579001|FG002|Overall Study|Subject Refused Further Study Treatment|0
4677944|NCT02407223|7578999|FG000|Overall Study|Other|29
4677945|NCT02407223|7579000|FG001|Overall Study|Other|27
4677946|NCT02407223|7579001|FG002|Overall Study|Other|25
4677947|NCT02407249|7579011|FG000|Overall Study|Did not complete 12-month follow-up|13
4677948|NCT02407249|7579011|FG000|Overall Study|Not treated|13
4677949|NCT02407457|7579017|FG000|1 Month|Death|3
4677950|NCT02407457|7579018|FG001|1 Month|Death|0
4677951|NCT02407457|7579017|FG000|1 Month|Lost to Follow-up|1
4677952|NCT02407457|7579018|FG001|1 Month|Lost to Follow-up|1
4677953|NCT02407457|7579017|FG000|1 Month|missed visit|2
4677954|NCT02407457|7579018|FG001|1 Month|missed visit|6
4677955|NCT02407457|7579017|FG000|6-Month|Death|2
4677956|NCT02407457|7579018|FG001|6-Month|Death|8
4677957|NCT02407457|7579017|FG000|6-Month|Lost to Follow-up|2
4677958|NCT02407457|7579018|FG001|6-Month|Lost to Follow-up|2
4677959|NCT02407457|7579017|FG000|6-Month|missed visit|15
4677960|NCT02407457|7579018|FG001|6-Month|missed visit|12
4677961|NCT02407457|7579017|FG000|6-Month|Over Due|1
4677962|NCT02407457|7579018|FG001|6-Month|Over Due|2
4677963|NCT02407457|7579017|FG000|6-Month|Open Repair|0
4677964|NCT02407457|7579018|FG001|6-Month|Open Repair|1
4677965|NCT02407457|7579017|FG000|1 Year|Death|6
4677966|NCT02407457|7579018|FG001|1 Year|Death|11
4677967|NCT02407457|7579017|FG000|1 Year|Lost to Follow-up|3
4677968|NCT02407457|7579018|FG001|1 Year|Lost to Follow-up|2
4677969|NCT02407457|7579017|FG000|1 Year|Missed Visit|18
4677970|NCT02407457|7579018|FG001|1 Year|Missed Visit|10
4677971|NCT02407457|7579017|FG000|1 Year|Over Due|6
4677972|NCT02407457|7579018|FG001|1 Year|Over Due|4
4677973|NCT02407457|7579017|FG000|1 Year|Open Repair|0
4677974|NCT02407457|7579018|FG001|1 Year|Open Repair|1
4677975|NCT02407457|7579017|FG000|2-year|Death|14
4677976|NCT02407457|7579018|FG001|2-year|Death|8
4677977|NCT02407457|7579017|FG000|2-year|Lost to Follow-up|6
4677978|NCT02407457|7579018|FG001|2-year|Lost to Follow-up|9
4677979|NCT02407457|7579017|FG000|2-year|Missed Visit|13
4677980|NCT02407457|7579018|FG001|2-year|Missed Visit|11
4677981|NCT02407457|7579017|FG000|2-year|Over Due|1
4677982|NCT02407457|7579018|FG001|2-year|Over Due|5
4677983|NCT02407457|7579017|FG000|2-year|Open Repair|0
4677984|NCT02407457|7579018|FG001|2-year|Open Repair|2
4677985|NCT02407457|7579017|FG000|3-year|Death|11
4677986|NCT02407457|7579018|FG001|3-year|Death|10
4677987|NCT02407457|7579017|FG000|3-year|Lost to Follow-up|6
4677988|NCT02407457|7579018|FG001|3-year|Lost to Follow-up|9
4677989|NCT02407457|7579017|FG000|3-year|Missed Visit|21
4677990|NCT02407457|7579018|FG001|3-year|Missed Visit|16
4677991|NCT02407457|7579017|FG000|3-year|Over Due|4
4677992|NCT02407457|7579018|FG001|3-year|Over Due|3
4677993|NCT02407457|7579017|FG000|4-year|Death|14
4677994|NCT02407457|7579018|FG001|4-year|Death|7
4677995|NCT02407457|7579017|FG000|4-year|Lost to Follow-up|9
4677996|NCT02407457|7579018|FG001|4-year|Lost to Follow-up|12
4677997|NCT02407457|7579017|FG000|4-year|Over Due|10
4677998|NCT02407457|7579018|FG001|4-year|Over Due|5
4677999|NCT02407457|7579017|FG000|4-year|Missed Visit|13
4678000|NCT02407457|7579018|FG001|4-year|Missed Visit|13
4678001|NCT02407457|7579017|FG000|4-year|Pending visit|19
4678002|NCT02407457|7579018|FG001|4-year|Pending visit|14
4678003|NCT02407457|7579017|FG000|4-year|Not Due|16
4678004|NCT02407457|7579018|FG001|4-year|Not Due|10
4678005|NCT02407457|7579017|FG000|5-year|Death|6
4678006|NCT02407457|7579018|FG001|5-year|Death|1
4678007|NCT02407457|7579017|FG000|5-year|Lost to Follow-up|4
4678008|NCT02407457|7579018|FG001|5-year|Lost to Follow-up|4
4678009|NCT02407457|7579017|FG000|5-year|Missed Visit|10
4678010|NCT02407457|7579018|FG001|5-year|Missed Visit|9
4678011|NCT02407457|7579017|FG000|5-year|Pending Visit|18
4678012|NCT02407457|7579018|FG001|5-year|Pending Visit|17
4678013|NCT02407457|7579017|FG000|5-year|Not Due|54
4678014|NCT02407457|7579018|FG001|5-year|Not Due|46
4678015|NCT02407704|7579028|FG000|Overall Study|Lost to Follow-up|0
4678016|NCT02407704|7579029|FG001|Overall Study|Lost to Follow-up|0
4678017|NCT02407704|7579030|FG002|Overall Study|Lost to Follow-up|0
4678018|NCT02407704|7579031|FG003|Overall Study|Lost to Follow-up|2
4678019|NCT02407704|7579028|FG000|Overall Study|Protocol Violation|0
4678020|NCT02407704|7579029|FG001|Overall Study|Protocol Violation|0
4678021|NCT02407704|7579030|FG002|Overall Study|Protocol Violation|0
4678022|NCT02407704|7579031|FG003|Overall Study|Protocol Violation|1
4678023|NCT02407704|7579028|FG000|Overall Study|Withdrawal by Subject|0
4678024|NCT02407704|7579029|FG001|Overall Study|Withdrawal by Subject|0
4678025|NCT02407704|7579030|FG002|Overall Study|Withdrawal by Subject|1
4678026|NCT02407704|7579031|FG003|Overall Study|Withdrawal by Subject|0
4678027|NCT02407990|7579070|FG000|Overall Study|Death|2
4678028|NCT02407990|7579071|FG001|Overall Study|Death|22
4678029|NCT02407990|7579072|FG002|Overall Study|Death|23
4678030|NCT02407990|7579073|FG003|Overall Study|Death|7
4678031|NCT02407990|7579074|FG004|Overall Study|Death|17
4678032|NCT02407990|7579075|FG005|Overall Study|Death|16
4757643|NCT02193867|7731985|FG000|Overall Study|Death|2
4757644|NCT02193867|7731985|FG000|Overall Study|Sponsor Study Termination|2
4757645|NCT02215096|7731992|FG000|Run-In Period (Up to Week 2)|Adverse Event|1
4757646|NCT02215096|7731993|FG001|Run-In Period (Up to Week 2)|Adverse Event|0
4757647|NCT02215096|7731994|FG002|Run-In Period (Up to Week 2)|Adverse Event|0
4757648|NCT02215096|7731995|FG003|Run-In Period (Up to Week 2)|Adverse Event|0
4757649|NCT02215096|7731996|FG004|Run-In Period (Up to Week 2)|Adverse Event|0
4757650|NCT02215096|7731992|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0
4757651|NCT02215096|7731993|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0
4757652|NCT02215096|7731994|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0
4757653|NCT02215096|7731995|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0
4757654|NCT02215096|7731996|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1
4757655|NCT02215096|7731992|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0
4757656|NCT02215096|7731993|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0
4757657|NCT02215096|7731994|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0
4757658|NCT02215096|7731995|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1
4757659|NCT02215096|7731996|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0
4757660|NCT02215096|7731992|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0
4757661|NCT02215096|7731993|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2
4757662|NCT02215096|7731994|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1
4757663|NCT02215096|7731995|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1
4757664|NCT02215096|7731996|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0
4757665|NCT02218697|7732014|FG000|Overall Study|Adverse Event|0
4757666|NCT02218697|7732015|FG001|Overall Study|Adverse Event|2
4757667|NCT02218697|7732014|FG000|Overall Study|Unwilling to be vaccinated in left arm|0
4757668|NCT02218697|7732015|FG001|Overall Study|Unwilling to be vaccinated in left arm|1
4757669|NCT02218697|7732014|FG000|Overall Study|Withdrawal by Subject|2
4757670|NCT02218697|7732015|FG001|Overall Study|Withdrawal by Subject|3
4757675|NCT02224456|7732042|FG000|Overall Study|Lack of Efficacy|1
4757676|NCT02224456|7732042|FG000|Overall Study|Lost to Follow-up|15
4757677|NCT02224456|7732042|FG000|Overall Study|Withdrawal by Subject|9
4757678|NCT02224456|7732042|FG000|Overall Study|Physician Decision|3
4757679|NCT02224456|7732042|FG000|Overall Study|Death|2
4757680|NCT02224456|7732042|FG000|Overall Study|Pregnancy|4
4757681|NCT02224456|7732042|FG000|Overall Study|Protocol Violation|1
4757682|NCT02224456|7732042|FG000|Overall Study|Treatment Interruptions of ≥28 days|1
4757683|NCT02231762|7732046|FG000|Combination Phase|Adverse Event|10
4757684|NCT02231762|7732047|FG001|Combination Phase|Adverse Event|0
4757685|NCT02231762|7732048|FG002|Combination Phase|Adverse Event|0
4757686|NCT02231762|7732049|FG003|Combination Phase|Adverse Event|0
4757687|NCT02231762|7732046|FG000|Combination Phase|Withdrawal by Subject|2
4678033|NCT02407990|7579076|FG006|Overall Study|Death|10
4678034|NCT02407990|7579077|FG007|Overall Study|Death|248
4678035|NCT02407990|7579070|FG000|Overall Study|Lost to Follow-up|0
4678036|NCT02407990|7579071|FG001|Overall Study|Lost to Follow-up|1
4678037|NCT02407990|7579072|FG002|Overall Study|Lost to Follow-up|0
4678038|NCT02407990|7579073|FG003|Overall Study|Lost to Follow-up|0
4678039|NCT02407990|7579074|FG004|Overall Study|Lost to Follow-up|0
4678040|NCT02407990|7579075|FG005|Overall Study|Lost to Follow-up|0
4757688|NCT02231762|7732047|FG001|Combination Phase|Withdrawal by Subject|0
4757689|NCT02231762|7732048|FG002|Combination Phase|Withdrawal by Subject|0
4757690|NCT02231762|7732049|FG003|Combination Phase|Withdrawal by Subject|0
4757691|NCT02231762|7732046|FG000|Combination Phase|Disease Progression|6
4678041|NCT02407990|7579076|FG006|Overall Study|Lost to Follow-up|0
4678042|NCT02407990|7579077|FG007|Overall Study|Lost to Follow-up|17
4678043|NCT02407990|7579070|FG000|Overall Study|Progressive Disease|0
4678044|NCT02407990|7579071|FG001|Overall Study|Progressive Disease|0
4678045|NCT02407990|7579072|FG002|Overall Study|Progressive Disease|0
4678046|NCT02407990|7579073|FG003|Overall Study|Progressive Disease|0
4678047|NCT02407990|7579074|FG004|Overall Study|Progressive Disease|0
4678048|NCT02407990|7579075|FG005|Overall Study|Progressive Disease|0
4678049|NCT02407990|7579076|FG006|Overall Study|Progressive Disease|0
4678050|NCT02407990|7579077|FG007|Overall Study|Progressive Disease|1
4678051|NCT02407990|7579070|FG000|Overall Study|Withdrawal by Subject|0
4678052|NCT02407990|7579071|FG001|Overall Study|Withdrawal by Subject|0
4678053|NCT02407990|7579072|FG002|Overall Study|Withdrawal by Subject|0
4678054|NCT02407990|7579073|FG003|Overall Study|Withdrawal by Subject|0
4678055|NCT02407990|7579074|FG004|Overall Study|Withdrawal by Subject|1
4678056|NCT02407990|7579075|FG005|Overall Study|Withdrawal by Subject|0
4678057|NCT02407990|7579076|FG006|Overall Study|Withdrawal by Subject|0
4678058|NCT02407990|7579077|FG007|Overall Study|Withdrawal by Subject|30
4678059|NCT02407990|7579070|FG000|Overall Study|Study Terminated by Sponsor|1
4678060|NCT02407990|7579071|FG001|Overall Study|Study Terminated by Sponsor|3
4678061|NCT02407990|7579072|FG002|Overall Study|Study Terminated by Sponsor|3
4678062|NCT02407990|7579073|FG003|Overall Study|Study Terminated by Sponsor|0
4678063|NCT02407990|7579074|FG004|Overall Study|Study Terminated by Sponsor|3
4678064|NCT02407990|7579075|FG005|Overall Study|Study Terminated by Sponsor|4
4678065|NCT02407990|7579076|FG006|Overall Study|Study Terminated by Sponsor|3
4678066|NCT02407990|7579077|FG007|Overall Study|Study Terminated by Sponsor|37
4678067|NCT02407990|7579070|FG000|Overall Study|Logistics|0
4678068|NCT02407990|7579071|FG001|Overall Study|Logistics|0
4678069|NCT02407990|7579072|FG002|Overall Study|Logistics|0
4678070|NCT02407990|7579073|FG003|Overall Study|Logistics|0
4678071|NCT02407990|7579074|FG004|Overall Study|Logistics|0
4678072|NCT02407990|7579075|FG005|Overall Study|Logistics|0
4678073|NCT02407990|7579076|FG006|Overall Study|Logistics|0
4678074|NCT02407990|7579077|FG007|Overall Study|Logistics|1
4678075|NCT02407990|7579070|FG000|Overall Study|Rolled into long-term extension study|0
4678076|NCT02407990|7579071|FG001|Overall Study|Rolled into long-term extension study|0
4678077|NCT02407990|7579072|FG002|Overall Study|Rolled into long-term extension study|0
4678078|NCT02407990|7579073|FG003|Overall Study|Rolled into long-term extension study|0
4678079|NCT02407990|7579074|FG004|Overall Study|Rolled into long-term extension study|0
4678080|NCT02407990|7579075|FG005|Overall Study|Rolled into long-term extension study|0
4678081|NCT02407990|7579076|FG006|Overall Study|Rolled into long-term extension study|0
4678082|NCT02407990|7579077|FG007|Overall Study|Rolled into long-term extension study|1
4678083|NCT02408016|7579104|FG000|Overall Study|Death|6
4678084|NCT02408016|7579105|FG001|Overall Study|Death|1
4678085|NCT02408016|7579106|FG002|Overall Study|Death|0
4678086|NCT02408016|7579104|FG000|Overall Study|Physician Decision|0
4757671|NCT02221037|7732025|FG000|Overall Study|Physician Decision|0
4757672|NCT02221037|7732026|FG001|Overall Study|Physician Decision|0
4757673|NCT02221037|7732027|FG002|Overall Study|Physician Decision|1
4757674|NCT02221037|7732028|FG003|Overall Study|Physician Decision|0
4757692|NCT02231762|7732047|FG001|Combination Phase|Disease Progression|0
4757693|NCT02231762|7732048|FG002|Combination Phase|Disease Progression|0
4757694|NCT02231762|7732049|FG003|Combination Phase|Disease Progression|0
4757695|NCT02231762|7732046|FG000|Combination Phase|Did not meet inclusion criteria|1
4757696|NCT02231762|7732047|FG001|Combination Phase|Did not meet inclusion criteria|0
4757697|NCT02231762|7732048|FG002|Combination Phase|Did not meet inclusion criteria|0
4757698|NCT02231762|7732049|FG003|Combination Phase|Did not meet inclusion criteria|0
4757699|NCT02231762|7732046|FG000|Combination Phase|Protocol Violation|1
4757700|NCT02231762|7732047|FG001|Combination Phase|Protocol Violation|0
4757701|NCT02231762|7732048|FG002|Combination Phase|Protocol Violation|0
4757702|NCT02231762|7732049|FG003|Combination Phase|Protocol Violation|0
4757703|NCT02231762|7732046|FG000|Maintenance Phase|Disease progression|0
4757704|NCT02231762|7732047|FG001|Maintenance Phase|Disease progression|3
4757705|NCT02231762|7732048|FG002|Maintenance Phase|Disease progression|4
4757706|NCT02231762|7732049|FG003|Maintenance Phase|Disease progression|3
4757707|NCT02231762|7732046|FG000|Maintenance Phase|Adverse Event|0
4757708|NCT02231762|7732047|FG001|Maintenance Phase|Adverse Event|0
4757709|NCT02231762|7732048|FG002|Maintenance Phase|Adverse Event|1
4757710|NCT02231762|7732049|FG003|Maintenance Phase|Adverse Event|2
4678087|NCT02408016|7579105|FG001|Overall Study|Physician Decision|2
4678088|NCT02408016|7579106|FG002|Overall Study|Physician Decision|0
4678089|NCT02408068|7579114|FG000|Treatment 3 (1.5 Days)|Adverse Event|0
4678090|NCT02408068|7579115|FG001|Treatment 3 (1.5 Days)|Adverse Event|0
4678091|NCT02408068|7579116|FG002|Treatment 3 (1.5 Days)|Adverse Event|1
4678092|NCT02408068|7579117|FG003|Treatment 3 (1.5 Days)|Adverse Event|0
4678093|NCT02408068|7579118|FG004|Treatment 3 (1.5 Days)|Adverse Event|0
4678094|NCT02408068|7579119|FG005|Treatment 3 (1.5 Days)|Adverse Event|0
4678095|NCT02408120|7579132|FG000|Overall Study|Withdrawal by Subject|0
4678096|NCT02408120|7579133|FG001|Overall Study|Withdrawal by Subject|1
4678097|NCT02408120|7579132|FG000|Overall Study|Treatment Refusal|1
4678098|NCT02408120|7579133|FG001|Overall Study|Treatment Refusal|0
4678099|NCT02408120|7579132|FG000|Overall Study|Received Steroids|1
4678100|NCT02408120|7579133|FG001|Overall Study|Received Steroids|1
4678101|NCT02408120|7579132|FG000|Overall Study|Discharged same day|1
4678102|NCT02408120|7579133|FG001|Overall Study|Discharged same day|1
4678103|NCT02408120|7579132|FG000|Overall Study|Did not receive insulin|1
4678104|NCT02408120|7579133|FG001|Overall Study|Did not receive insulin|2
4678105|NCT02408484|7579162|FG000|Overall Study|Withdrawal by Subject|3
4678106|NCT02408484|7579162|FG000|Overall Study|Not treated during study period|1
4678107|NCT02408523|7579184|FG000|Overall Study|Adverse Event|4
4678108|NCT02408523|7579185|FG001|Overall Study|Adverse Event|10
4678109|NCT02408523|7579184|FG000|Overall Study|Lack of Efficacy|0
4678110|NCT02408523|7579185|FG001|Overall Study|Lack of Efficacy|1
4678111|NCT02408523|7579184|FG000|Overall Study|Protocol Violation|1
4678112|NCT02408523|7579185|FG001|Overall Study|Protocol Violation|2
4678113|NCT02408523|7579184|FG000|Overall Study|Lost to Follow-up|2
4678114|NCT02408523|7579185|FG001|Overall Study|Lost to Follow-up|3
4678115|NCT02408523|7579184|FG000|Overall Study|Withdrawal by Subject|3
4678116|NCT02408523|7579185|FG001|Overall Study|Withdrawal by Subject|1
4678117|NCT02408523|7579184|FG000|Overall Study|Sponsor request|1
4678118|NCT02408523|7579185|FG001|Overall Study|Sponsor request|0
4678119|NCT02408523|7579184|FG000|Overall Study|Did not satisfy extension conditions|0
4678120|NCT02408523|7579185|FG001|Overall Study|Did not satisfy extension conditions|1
4678121|NCT02409667|7579278|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6
4678122|NCT02409667|7579279|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
4678123|NCT02409667|7579280|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
4678124|NCT02409667|7579281|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
4678125|NCT02409667|7579282|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
4678126|NCT02409667|7579278|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6
4678127|NCT02409667|7579279|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
4678128|NCT02409667|7579280|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
4678129|NCT02409667|7579281|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
4678130|NCT02409667|7579282|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
4678131|NCT02409667|7579278|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20
4678132|NCT02409667|7579279|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
4678133|NCT02409667|7579280|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
4678134|NCT02409667|7579281|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
4678135|NCT02409667|7579282|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
4678136|NCT02409667|7579278|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1
4678137|NCT02409667|7579279|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0
4678138|NCT02409667|7579280|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0
4678139|NCT02409667|7579281|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0
4678140|NCT02409667|7579282|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0
4678141|NCT02409667|7579278|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4
4678142|NCT02409667|7579279|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0
4678143|NCT02409667|7579280|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0
4678144|NCT02409667|7579281|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0
4678145|NCT02409667|7579282|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0
4678146|NCT02409667|7579278|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5
4757711|NCT02234843|7732073|FG000|Overall Study|Death|1
4757712|NCT02234843|7732074|FG001|Overall Study|Death|0
4757713|NCT02234843|7732075|FG002|Overall Study|Death|0
4757714|NCT02234843|7732076|FG003|Overall Study|Death|0
4757715|NCT02234843|7732077|FG004|Overall Study|Death|0
4757716|NCT02234843|7732078|FG005|Overall Study|Death|0
4757717|NCT02234843|7732079|FG006|Overall Study|Death|0
4757718|NCT02234843|7732080|FG007|Overall Study|Death|0
4757719|NCT02234843|7732081|FG008|Overall Study|Death|0
4757720|NCT02234843|7732082|FG009|Overall Study|Death|0
4757721|NCT02234843|7732073|FG000|Overall Study|Protocol Violation|1
4757722|NCT02234843|7732074|FG001|Overall Study|Protocol Violation|0
4757723|NCT02234843|7732075|FG002|Overall Study|Protocol Violation|1
4757724|NCT02234843|7732076|FG003|Overall Study|Protocol Violation|0
4757725|NCT02234843|7732077|FG004|Overall Study|Protocol Violation|0
4757726|NCT02234843|7732078|FG005|Overall Study|Protocol Violation|0
4757727|NCT02234843|7732079|FG006|Overall Study|Protocol Violation|0
4678147|NCT02409667|7579279|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
4757728|NCT02234843|7732080|FG007|Overall Study|Protocol Violation|0
4757729|NCT02234843|7732081|FG008|Overall Study|Protocol Violation|0
4757730|NCT02234843|7732082|FG009|Overall Study|Protocol Violation|0
4757731|NCT02234843|7732073|FG000|Overall Study|Efficacy outcome reached|2
4757732|NCT02234843|7732074|FG001|Overall Study|Efficacy outcome reached|0
4757733|NCT02234843|7732075|FG002|Overall Study|Efficacy outcome reached|0
4678148|NCT02409667|7579280|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
4678149|NCT02409667|7579281|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
4678150|NCT02409667|7579282|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
4678151|NCT02409667|7579278|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6
4678152|NCT02409667|7579279|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
4678153|NCT02409667|7579280|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
4678154|NCT02409667|7579281|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
4678155|NCT02409667|7579282|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
4678156|NCT02409667|7579278|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48
4678157|NCT02409667|7579279|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
4678158|NCT02409667|7579280|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
4678159|NCT02409667|7579281|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
4678160|NCT02409667|7579282|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
4678161|NCT02409667|7579278|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25
4678162|NCT02409667|7579279|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0
4678163|NCT02409667|7579280|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0
4678164|NCT02409667|7579281|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0
4678165|NCT02409667|7579282|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0
4678166|NCT02409667|7579278|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0
4678167|NCT02409667|7579279|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7
4678168|NCT02409667|7579280|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4
4678169|NCT02409667|7579281|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3
4678170|NCT02409667|7579282|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0
4678171|NCT02409667|7579278|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
4678172|NCT02409667|7579279|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
4678173|NCT02409667|7579280|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
4678174|NCT02409667|7579281|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2
4678175|NCT02409667|7579282|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
4678176|NCT02409667|7579278|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0
4678177|NCT02409667|7579279|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7
4678178|NCT02409667|7579280|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4
4678179|NCT02409667|7579281|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1
4678180|NCT02409667|7579282|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2
4678181|NCT02409667|7579278|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0
4678182|NCT02409667|7579279|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5
4678183|NCT02409667|7579280|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4
4678184|NCT02409667|7579281|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0
4678185|NCT02409667|7579282|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0
4678186|NCT02409667|7579278|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0
4678187|NCT02409667|7579279|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4
4678188|NCT02409667|7579280|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5
4678189|NCT02409667|7579281|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2
4678190|NCT02409667|7579282|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0
4678191|NCT02409667|7579278|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0
4678192|NCT02409667|7579279|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0
4678193|NCT02409667|7579280|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1
4678194|NCT02409667|7579281|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0
4757734|NCT02234843|7732076|FG003|Overall Study|Efficacy outcome reached|0
4757735|NCT02234843|7732077|FG004|Overall Study|Efficacy outcome reached|0
4757736|NCT02234843|7732078|FG005|Overall Study|Efficacy outcome reached|2
4757737|NCT02234843|7732079|FG006|Overall Study|Efficacy outcome reached|0
4757738|NCT02234843|7732080|FG007|Overall Study|Efficacy outcome reached|0
4757739|NCT02234843|7732081|FG008|Overall Study|Efficacy outcome reached|0
4757740|NCT02234843|7732082|FG009|Overall Study|Efficacy outcome reached|0
4757741|NCT02234843|7732073|FG000|Overall Study|Patient convenience|2
4757742|NCT02234843|7732074|FG001|Overall Study|Patient convenience|0
4757743|NCT02234843|7732075|FG002|Overall Study|Patient convenience|0
4757744|NCT02234843|7732076|FG003|Overall Study|Patient convenience|0
4757745|NCT02234843|7732077|FG004|Overall Study|Patient convenience|0
4757746|NCT02234843|7732078|FG005|Overall Study|Patient convenience|1
4757747|NCT02234843|7732079|FG006|Overall Study|Patient convenience|0
4757748|NCT02234843|7732080|FG007|Overall Study|Patient convenience|0
4757749|NCT02234843|7732081|FG008|Overall Study|Patient convenience|0
4757750|NCT02234843|7732082|FG009|Overall Study|Patient convenience|0
4757751|NCT02234843|7732073|FG000|Overall Study|Withdrawal by Subject|5
4757752|NCT02234843|7732074|FG001|Overall Study|Withdrawal by Subject|1
4757753|NCT02234843|7732075|FG002|Overall Study|Withdrawal by Subject|1
4757754|NCT02234843|7732076|FG003|Overall Study|Withdrawal by Subject|0
4757755|NCT02234843|7732077|FG004|Overall Study|Withdrawal by Subject|0
4757756|NCT02234843|7732078|FG005|Overall Study|Withdrawal by Subject|7
4757757|NCT02234843|7732079|FG006|Overall Study|Withdrawal by Subject|0
4757758|NCT02234843|7732080|FG007|Overall Study|Withdrawal by Subject|0
4678195|NCT02409667|7579282|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1
4678196|NCT02409667|7579278|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
4678197|NCT02409667|7579279|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
4678198|NCT02409667|7579280|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3
4678199|NCT02409667|7579281|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
4678200|NCT02409667|7579282|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
4678201|NCT02409680|7579295|FG000|Overall Study|Lost to Follow-up|15
4678202|NCT02409680|7579296|FG001|Overall Study|Lost to Follow-up|30
4678203|NCT02409719|7579304|FG000|Overall Study|Lost to Follow-up|3
4678204|NCT02409719|7579305|FG001|Overall Study|Lost to Follow-up|3
4678205|NCT02409732|7579311|FG000|Overall Study|Withdrawal by Subject|4
4678206|NCT02409732|7579311|FG000|Overall Study|Lost to Follow-up|2
4678207|NCT02410200|7579347|FG000|Overall Study|Adverse Event|2
4678208|NCT02410252|7579358|FG000|Overall Study|Withdrawal by Subject|4
4678209|NCT02410252|7579358|FG000|Overall Study|Physician Decision|2
4678210|NCT02410278|7579366|FG000|Run-in Period|Adverse Event|5
4678211|NCT02410278|7579367|FG001|Run-in Period|Adverse Event|0
4678212|NCT02410278|7579368|FG002|Run-in Period|Adverse Event|0
4678213|NCT02410278|7579366|FG000|Run-in Period|GSRS Threshold Not Met|30
4678214|NCT02410278|7579367|FG001|Run-in Period|GSRS Threshold Not Met|0
4678215|NCT02410278|7579368|FG002|Run-in Period|GSRS Threshold Not Met|0
4678216|NCT02410278|7579366|FG000|Run-in Period|Lost to Follow-up|1
4678217|NCT02410278|7579367|FG001|Run-in Period|Lost to Follow-up|0
4678218|NCT02410278|7579368|FG002|Run-in Period|Lost to Follow-up|0
4678219|NCT02410278|7579366|FG000|Run-in Period|Withdrawal by Subject|1
4678220|NCT02410278|7579367|FG001|Run-in Period|Withdrawal by Subject|0
4757759|NCT02234843|7732081|FG008|Overall Study|Withdrawal by Subject|0
4757760|NCT02234843|7732082|FG009|Overall Study|Withdrawal by Subject|0
4757761|NCT02234843|7732073|FG000|Overall Study|Recovery|1
4757762|NCT02234843|7732074|FG001|Overall Study|Recovery|0
4757763|NCT02234843|7732075|FG002|Overall Study|Recovery|0
4757764|NCT02234843|7732076|FG003|Overall Study|Recovery|0
4757765|NCT02234843|7732077|FG004|Overall Study|Recovery|0
4757766|NCT02234843|7732078|FG005|Overall Study|Recovery|0
4757767|NCT02234843|7732079|FG006|Overall Study|Recovery|0
4757768|NCT02234843|7732080|FG007|Overall Study|Recovery|0
4757769|NCT02234843|7732081|FG008|Overall Study|Recovery|0
4757770|NCT02234843|7732082|FG009|Overall Study|Recovery|0
4757771|NCT02234843|7732073|FG000|Overall Study|Other|0
4757772|NCT02234843|7732074|FG001|Overall Study|Other|2
4757773|NCT02234843|7732075|FG002|Overall Study|Other|0
4757774|NCT02234843|7732076|FG003|Overall Study|Other|1
4757775|NCT02234843|7732077|FG004|Overall Study|Other|0
4757776|NCT02234843|7732078|FG005|Overall Study|Other|1
4757777|NCT02234843|7732079|FG006|Overall Study|Other|0
4757778|NCT02234843|7732080|FG007|Overall Study|Other|1
4757779|NCT02234843|7732081|FG008|Overall Study|Other|0
4757780|NCT02234843|7732082|FG009|Overall Study|Other|0
4757781|NCT02234843|7732073|FG000|Overall Study|Physician Decision|4
4757782|NCT02234843|7732074|FG001|Overall Study|Physician Decision|1
4757783|NCT02234843|7732075|FG002|Overall Study|Physician Decision|0
4757784|NCT02234843|7732076|FG003|Overall Study|Physician Decision|1
4757785|NCT02234843|7732077|FG004|Overall Study|Physician Decision|0
4757786|NCT02234843|7732078|FG005|Overall Study|Physician Decision|0
4678221|NCT02410278|7579368|FG002|Run-in Period|Withdrawal by Subject|0
4678222|NCT02410278|7579366|FG000|Run-in Period|Pregnancy|1
4678223|NCT02410278|7579367|FG001|Run-in Period|Pregnancy|0
4678224|NCT02410278|7579368|FG002|Run-in Period|Pregnancy|0
4678225|NCT02410278|7579366|FG000|Study Treatment Period|Adverse Event|0
4678226|NCT02410278|7579367|FG001|Study Treatment Period|Adverse Event|6
4678227|NCT02410278|7579368|FG002|Study Treatment Period|Adverse Event|3
4678228|NCT02410278|7579366|FG000|Study Treatment Period|Physician Decision|0
4678229|NCT02410278|7579367|FG001|Study Treatment Period|Physician Decision|0
4678230|NCT02410278|7579368|FG002|Study Treatment Period|Physician Decision|1
4678231|NCT02410278|7579366|FG000|Study Treatment Period|Withdrawal by Subject|0
4678232|NCT02410278|7579367|FG001|Study Treatment Period|Withdrawal by Subject|1
4678233|NCT02410278|7579368|FG002|Study Treatment Period|Withdrawal by Subject|0
4678234|NCT02410278|7579366|FG000|Study Treatment Period|Other|0
4678235|NCT02410278|7579367|FG001|Study Treatment Period|Other|3
4678236|NCT02410278|7579368|FG002|Study Treatment Period|Other|0
4678237|NCT02410278|7579366|FG000|Study Treatment Period|GSRS Threshold Not Met|0
4678238|NCT02410278|7579367|FG001|Study Treatment Period|GSRS Threshold Not Met|1
4678239|NCT02410278|7579368|FG002|Study Treatment Period|GSRS Threshold Not Met|0
4678240|NCT02410629|7579395|FG000|Overall Study|Family cannot commit to the study|2
4757787|NCT02234843|7732079|FG006|Overall Study|Physician Decision|0
4757788|NCT02234843|7732080|FG007|Overall Study|Physician Decision|1
4757789|NCT02234843|7732081|FG008|Overall Study|Physician Decision|0
4757790|NCT02234843|7732082|FG009|Overall Study|Physician Decision|0
4757791|NCT02234843|7732073|FG000|Overall Study|Adverse Event|5
4757792|NCT02234843|7732074|FG001|Overall Study|Adverse Event|1
4757793|NCT02234843|7732075|FG002|Overall Study|Adverse Event|1
4757794|NCT02234843|7732076|FG003|Overall Study|Adverse Event|3
4757795|NCT02234843|7732077|FG004|Overall Study|Adverse Event|2
4757796|NCT02234843|7732078|FG005|Overall Study|Adverse Event|1
4757797|NCT02234843|7732079|FG006|Overall Study|Adverse Event|0
4678241|NCT02410629|7579396|FG001|Overall Study|Family cannot commit to the study|1
4678242|NCT02410629|7579395|FG000|Overall Study|Subject returned to work|1
4678243|NCT02410629|7579396|FG001|Overall Study|Subject returned to work|0
4678244|NCT02410629|7579395|FG000|Overall Study|Subject moved back to home country|0
4678245|NCT02410629|7579396|FG001|Overall Study|Subject moved back to home country|1
4678246|NCT02410629|7579395|FG000|Overall Study|Subject underwent heart surgery|0
4678247|NCT02410629|7579396|FG001|Overall Study|Subject underwent heart surgery|1
4678248|NCT02410772|7579411|FG000|Overall Study|Death|3
4678249|NCT02410772|7579412|FG001|Overall Study|Death|4
4678250|NCT02410772|7579413|FG002|Overall Study|Death|8
4678251|NCT02410772|7579411|FG000|Overall Study|Lost to Follow-up|31
4678252|NCT02410772|7579412|FG001|Overall Study|Lost to Follow-up|23
4678253|NCT02410772|7579413|FG002|Overall Study|Lost to Follow-up|22
4678254|NCT02410772|7579411|FG000|Overall Study|Pregnancy|8
4678255|NCT02410772|7579412|FG001|Overall Study|Pregnancy|4
4678256|NCT02410772|7579413|FG002|Overall Study|Pregnancy|5
4678257|NCT02410772|7579411|FG000|Overall Study|Protocol Violation|8
4678258|NCT02410772|7579412|FG001|Overall Study|Protocol Violation|8
4678259|NCT02410772|7579413|FG002|Overall Study|Protocol Violation|4
4678260|NCT02410772|7579411|FG000|Overall Study|Baseline Drug Resistance|49
4678261|NCT02410772|7579412|FG001|Overall Study|Baseline Drug Resistance|40
4678262|NCT02410772|7579413|FG002|Overall Study|Baseline Drug Resistance|51
4678263|NCT02410772|7579411|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4
4678264|NCT02410772|7579412|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6
4678265|NCT02410772|7579413|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3
4678266|NCT02410772|7579411|FG000|Overall Study|Reinfection with a new strain of MTB|0
4678267|NCT02410772|7579412|FG001|Overall Study|Reinfection with a new strain of MTB|1
4678268|NCT02410772|7579413|FG002|Overall Study|Reinfection with a new strain of MTB|0
4678269|NCT02410811|7579430|FG000|Overall Study|Withdrawal by Subject|0
4678270|NCT02410811|7579431|FG001|Overall Study|Withdrawal by Subject|0
4678271|NCT02410811|7579432|FG002|Overall Study|Withdrawal by Subject|1
4678272|NCT02410811|7579433|FG003|Overall Study|Withdrawal by Subject|0
4678273|NCT02410824|7579443|FG000|First Intervention (One Week)|Headache|0
4678274|NCT02410824|7579444|FG001|First Intervention (One Week)|Headache|1
4678275|NCT02410837|7579451|FG000|Overall Study|Death|387
4678276|NCT02410837|7579451|FG000|Overall Study|Lost to Follow-up|50
4678277|NCT02410837|7579451|FG000|Overall Study|Withdrawal by Subject|44
4678278|NCT02410837|7579451|FG000|Overall Study|Physician Decision|6
4678279|NCT02410837|7579451|FG000|Overall Study|Moved to nursing home, cannot communicat|1
4678280|NCT02411084|7579466|FG000|Overall Study|Lack of Efficacy|6
4678281|NCT02411084|7579467|FG001|Overall Study|Lack of Efficacy|3
4678282|NCT02411084|7579466|FG000|Overall Study|Death|5
4678283|NCT02411084|7579467|FG001|Overall Study|Death|4
4678284|NCT02411084|7579466|FG000|Overall Study|Adverse Event|2
4678285|NCT02411084|7579467|FG001|Overall Study|Adverse Event|1
4678286|NCT02411084|7579466|FG000|Overall Study|Other reasons|0
4678287|NCT02411084|7579467|FG001|Overall Study|Other reasons|5
4678288|NCT02411110|7579475|FG000|Treatment Period 1|Adverse Event|4
4678289|NCT02411110|7579476|FG001|Treatment Period 1|Adverse Event|2
4757798|NCT02234843|7732080|FG007|Overall Study|Adverse Event|0
4757799|NCT02234843|7732081|FG008|Overall Study|Adverse Event|1
4757800|NCT02234843|7732082|FG009|Overall Study|Adverse Event|0
4757801|NCT02234843|7732073|FG000|Overall Study|Non-compliance with study drug|1
4757802|NCT02234843|7732074|FG001|Overall Study|Non-compliance with study drug|0
4757803|NCT02234843|7732075|FG002|Overall Study|Non-compliance with study drug|0
4757804|NCT02234843|7732076|FG003|Overall Study|Non-compliance with study drug|0
4757805|NCT02234843|7732077|FG004|Overall Study|Non-compliance with study drug|0
4757806|NCT02234843|7732078|FG005|Overall Study|Non-compliance with study drug|1
4757807|NCT02234843|7732079|FG006|Overall Study|Non-compliance with study drug|1
4757808|NCT02234843|7732080|FG007|Overall Study|Non-compliance with study drug|0
4757809|NCT02234843|7732081|FG008|Overall Study|Non-compliance with study drug|0
4757810|NCT02234843|7732082|FG009|Overall Study|Non-compliance with study drug|0
4757811|NCT02234843|7732073|FG000|Overall Study|Lost to Follow-up|0
4757812|NCT02234843|7732074|FG001|Overall Study|Lost to Follow-up|1
4757813|NCT02234843|7732075|FG002|Overall Study|Lost to Follow-up|0
4757814|NCT02234843|7732076|FG003|Overall Study|Lost to Follow-up|0
4757815|NCT02234843|7732077|FG004|Overall Study|Lost to Follow-up|0
4757816|NCT02234843|7732078|FG005|Overall Study|Lost to Follow-up|0
4757817|NCT02234843|7732079|FG006|Overall Study|Lost to Follow-up|1
4757818|NCT02234843|7732080|FG007|Overall Study|Lost to Follow-up|0
4757819|NCT02234843|7732081|FG008|Overall Study|Lost to Follow-up|0
4757820|NCT02234843|7732082|FG009|Overall Study|Lost to Follow-up|0
4678290|NCT02411110|7579475|FG000|Treatment Period 1|Lost to Follow-up|1
4678291|NCT02411110|7579476|FG001|Treatment Period 1|Lost to Follow-up|0
4678292|NCT02411110|7579475|FG000|Treatment Period 1|Personal Reasons|2
4678293|NCT02411110|7579476|FG001|Treatment Period 1|Personal Reasons|5
4678294|NCT02411110|7579475|FG000|Treatment Period 1|Other Miscellaneous Reasons|2
4678295|NCT02411110|7579476|FG001|Treatment Period 1|Other Miscellaneous Reasons|0
4678296|NCT02411110|7579475|FG000|Treatment Period 2|Adverse Event|1
4678297|NCT02411110|7579476|FG001|Treatment Period 2|Adverse Event|0
4678298|NCT02411110|7579475|FG000|Treatment Period 2|Lost to Follow-up|0
4678299|NCT02411110|7579476|FG001|Treatment Period 2|Lost to Follow-up|2
4678300|NCT02411110|7579475|FG000|Treatment Period 2|Personal Reasons|0
4678301|NCT02411110|7579476|FG001|Treatment Period 2|Personal Reasons|2
4678302|NCT02411201|7579484|FG000|Overall Study|Adverse Event|2
4678303|NCT02411201|7579484|FG000|Overall Study|Withdrawal by Subject|2
4678304|NCT02411201|7579484|FG000|Overall Study|Age group completed|2
4678305|NCT02411292|7579490|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16
4678306|NCT02411292|7579490|FG000|Overall Study|Death|2
4678307|NCT02411292|7579490|FG000|Overall Study|Lost to Follow-up|3
4678308|NCT02411396|7579496|FG000|Overall Study|Lost to Follow-up|31
4678309|NCT02411396|7579496|FG000|Overall Study|Death|10
4678310|NCT02411448|7579508|FG000|Overall Study|Withdrawal by Subject|1
4678311|NCT02411448|7579509|FG001|Overall Study|Withdrawal by Subject|14
4678312|NCT02411448|7579510|FG002|Overall Study|Withdrawal by Subject|9
4678313|NCT02411448|7579508|FG000|Overall Study|Other|0
4678314|NCT02411448|7579509|FG001|Overall Study|Other|2
4678315|NCT02411448|7579510|FG002|Overall Study|Other|0
4678316|NCT02411448|7579508|FG000|Overall Study|Did not receive study treatment|0
4678317|NCT02411448|7579509|FG001|Overall Study|Did not receive study treatment|3
4678318|NCT02411448|7579510|FG002|Overall Study|Did not receive study treatment|0
4678319|NCT02411448|7579508|FG000|Overall Study|Alive on study treatment|3
4678320|NCT02411448|7579509|FG001|Overall Study|Alive on study treatment|64
4678321|NCT02411448|7579510|FG002|Overall Study|Alive on study treatment|43
4678322|NCT02411539|7579537|FG000|Overall Study|Lost to Follow-up|2
4678323|NCT02411539|7579538|FG001|Overall Study|Lost to Follow-up|0
4678324|NCT02411539|7579537|FG000|Overall Study|Confounding medical condition|0
4678325|NCT02411539|7579538|FG001|Overall Study|Confounding medical condition|1
4678326|NCT02411578|7579558|FG000|Crossover Trial Phase|Pregnancy|0
4678327|NCT02411578|7579559|FG001|Crossover Trial Phase|Pregnancy|1
4678328|NCT02411591|7579570|FG000|Overall Study|Adverse Event|0
4678329|NCT02411591|7579571|FG001|Overall Study|Adverse Event|4
4678330|NCT02411591|7579572|FG002|Overall Study|Adverse Event|2
4678331|NCT02411591|7579570|FG000|Overall Study|Withdrawal by Subject|0
4678332|NCT02411591|7579571|FG001|Overall Study|Withdrawal by Subject|3
4678333|NCT02411591|7579572|FG002|Overall Study|Withdrawal by Subject|0
4678334|NCT02411591|7579570|FG000|Overall Study|Physician Decision|0
4678335|NCT02411591|7579571|FG001|Overall Study|Physician Decision|3
4678336|NCT02411591|7579572|FG002|Overall Study|Physician Decision|1
4678337|NCT02411747|7579590|FG000|Overall Study|Withdrawal by Subject|1
4678338|NCT02411747|7579591|FG001|Overall Study|Withdrawal by Subject|0
4678339|NCT02411747|7579590|FG000|Overall Study|Protocol Violation|2
4678340|NCT02411747|7579591|FG001|Overall Study|Protocol Violation|4
4678341|NCT02412111|7579634|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1
4678342|NCT02412111|7579635|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0
4678343|NCT02412111|7579636|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0
4678344|NCT02412111|7579634|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2
4678345|NCT02412111|7579635|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0
4678346|NCT02412111|7579636|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0
4678347|NCT02412111|7579634|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0
4678348|NCT02412111|7579635|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0
4678349|NCT02412111|7579636|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2
4678350|NCT02412111|7579634|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0
4678351|NCT02412111|7579635|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0
4678352|NCT02412111|7579636|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1
4678353|NCT02412111|7579634|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0
4678354|NCT02412111|7579635|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0
4678355|NCT02412111|7579636|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1
4678356|NCT02412111|7579634|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0
4678357|NCT02412111|7579635|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1
4678358|NCT02412111|7579636|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0
4678359|NCT02412111|7579634|FG000|Active Comparator Period (8 Weeks)|Other|0
4678360|NCT02412111|7579635|FG001|Active Comparator Period (8 Weeks)|Other|0
4678361|NCT02412111|7579636|FG002|Active Comparator Period (8 Weeks)|Other|2
4678362|NCT02412306|7579655|FG000|Overall Study|Lost to Follow-up|0
4678363|NCT02412306|7579656|FG001|Overall Study|Lost to Follow-up|1
4678364|NCT02412306|7579657|FG002|Overall Study|Lost to Follow-up|0
4678365|NCT02412306|7579658|FG003|Overall Study|Lost to Follow-up|0
4678366|NCT02412306|7579659|FG004|Overall Study|Lost to Follow-up|0
4678367|NCT02412306|7579655|FG000|Overall Study|Withdrawal by Subject|0
4757821|NCT02243306|7732117|FG000|Overall Study|Adverse Event|0
4757822|NCT02243306|7732118|FG001|Overall Study|Adverse Event|1
4757823|NCT02243306|7732117|FG000|Overall Study|Other: Reached stopping criteria|0
4678368|NCT02412306|7579656|FG001|Overall Study|Withdrawal by Subject|0
4678369|NCT02412306|7579657|FG002|Overall Study|Withdrawal by Subject|1
4678370|NCT02412306|7579658|FG003|Overall Study|Withdrawal by Subject|0
4678371|NCT02412306|7579659|FG004|Overall Study|Withdrawal by Subject|0
4678372|NCT02412306|7579655|FG000|Overall Study|Death|5
4678373|NCT02412306|7579656|FG001|Overall Study|Death|7
4678374|NCT02412306|7579657|FG002|Overall Study|Death|15
4678375|NCT02412306|7579658|FG003|Overall Study|Death|0
4678376|NCT02412306|7579659|FG004|Overall Study|Death|2
4678377|NCT02412371|7579686|FG000|Overall Study|Withdrawal by Subject|0
4678378|NCT02412371|7579687|FG001|Overall Study|Withdrawal by Subject|2
4678379|NCT02412371|7579688|FG002|Overall Study|Withdrawal by Subject|0
4678380|NCT02412371|7579689|FG003|Overall Study|Withdrawal by Subject|1
4678381|NCT02412371|7579690|FG004|Overall Study|Withdrawal by Subject|1
4678382|NCT02412371|7579691|FG005|Overall Study|Withdrawal by Subject|0
4678383|NCT02412371|7579686|FG000|Overall Study|Sponsor Discontinued Study|1
4678384|NCT02412371|7579687|FG001|Overall Study|Sponsor Discontinued Study|4
4678385|NCT02412371|7579688|FG002|Overall Study|Sponsor Discontinued Study|6
4678386|NCT02412371|7579689|FG003|Overall Study|Sponsor Discontinued Study|4
4678387|NCT02412371|7579690|FG004|Overall Study|Sponsor Discontinued Study|5
4678388|NCT02412371|7579691|FG005|Overall Study|Sponsor Discontinued Study|0
4678389|NCT02412371|7579686|FG000|Overall Study|Death|4
4678390|NCT02412371|7579687|FG001|Overall Study|Death|2
4678391|NCT02412371|7579688|FG002|Overall Study|Death|1
4678392|NCT02412371|7579689|FG003|Overall Study|Death|3
4678393|NCT02412371|7579690|FG004|Overall Study|Death|5
4678394|NCT02412371|7579691|FG005|Overall Study|Death|2
4757824|NCT02243306|7732118|FG001|Overall Study|Other: Reached stopping criteria|1
4757825|NCT02243306|7732117|FG000|Overall Study|Physician Decision|0
4757826|NCT02243306|7732118|FG001|Overall Study|Physician Decision|1
4678395|NCT02412371|7579686|FG000|Overall Study|Other|2
4678396|NCT02412371|7579687|FG001|Overall Study|Other|1
4678397|NCT02412371|7579688|FG002|Overall Study|Other|0
4678398|NCT02412371|7579689|FG003|Overall Study|Other|0
4678399|NCT02412371|7579690|FG004|Overall Study|Other|1
4678400|NCT02412371|7579691|FG005|Overall Study|Other|3
4678401|NCT02412436|7579706|FG000|Overall Study|Protocol-mandated Discontinuation|7
4678402|NCT02412436|7579706|FG000|Overall Study|Lost to Follow-up|6
4678403|NCT02412436|7579706|FG000|Overall Study|Unable to get to clinic|3
4678404|NCT02412436|7579706|FG000|Overall Study|Death|1
4678405|NCT02412436|7579706|FG000|Overall Study|Not Willing to Adhere to Requirements|1
4678406|NCT02412488|7579710|FG000|Overall Study|Lost to Follow-up|10
4678407|NCT02412488|7579710|FG000|Overall Study|Withdrawal by Subject|5
4678408|NCT02412488|7579710|FG000|Overall Study|Physician Decision|1
4678409|NCT02412488|7579710|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1
4678410|NCT02412488|7579710|FG000|Overall Study|Reveal LINQ explant|1
4678411|NCT02412631|7579721|FG000|Overall Study|Adverse Event|1
4678412|NCT02412631|7579722|FG001|Overall Study|Adverse Event|2
4678413|NCT02412631|7579721|FG000|Overall Study|Lost to Follow-up|5
4678414|NCT02412631|7579722|FG001|Overall Study|Lost to Follow-up|9
4678415|NCT02412631|7579721|FG000|Overall Study|Withdrawal by Subject|9
4678416|NCT02412631|7579722|FG001|Overall Study|Withdrawal by Subject|3
4678417|NCT02412631|7579721|FG000|Overall Study|Early stop by FDA|5
4678418|NCT02412631|7579722|FG001|Overall Study|Early stop by FDA|2
4678419|NCT02412631|7579721|FG000|Overall Study|Unspecified reason|6
4678420|NCT02412631|7579722|FG001|Overall Study|Unspecified reason|8
4678421|NCT02412657|7579744|FG000|Overall Study|Lost to Follow-up|1
4678422|NCT02412657|7579745|FG001|Overall Study|Lost to Follow-up|0
4678423|NCT02412657|7579746|FG002|Overall Study|Lost to Follow-up|0
4678424|NCT02412657|7579744|FG000|Overall Study|Protocol Violation|0
4678425|NCT02412657|7579745|FG001|Overall Study|Protocol Violation|2
4678426|NCT02412657|7579746|FG002|Overall Study|Protocol Violation|3
4678427|NCT02412722|7579760|FG000|Overall Study|Adverse Event|0
4678428|NCT02412722|7579761|FG001|Overall Study|Adverse Event|2
4678429|NCT02412722|7579762|FG002|Overall Study|Adverse Event|0
4678430|NCT02412722|7579763|FG003|Overall Study|Adverse Event|3
4678431|NCT02412722|7579764|FG004|Overall Study|Adverse Event|0
4678432|NCT02412722|7579765|FG005|Overall Study|Adverse Event|3
4678433|NCT02412722|7579760|FG000|Overall Study|Progressive Disease|6
4678434|NCT02412722|7579761|FG001|Overall Study|Progressive Disease|4
4678435|NCT02412722|7579762|FG002|Overall Study|Progressive Disease|4
4678436|NCT02412722|7579763|FG003|Overall Study|Progressive Disease|9
4678437|NCT02412722|7579764|FG004|Overall Study|Progressive Disease|3
4678438|NCT02412722|7579765|FG005|Overall Study|Progressive Disease|3
4678439|NCT02412722|7579760|FG000|Overall Study|Withdrawal by Subject|2
4678440|NCT02412722|7579761|FG001|Overall Study|Withdrawal by Subject|0
4678441|NCT02412722|7579762|FG002|Overall Study|Withdrawal by Subject|1
4678442|NCT02412722|7579763|FG003|Overall Study|Withdrawal by Subject|2
4678443|NCT02412722|7579764|FG004|Overall Study|Withdrawal by Subject|1
4678444|NCT02412722|7579765|FG005|Overall Study|Withdrawal by Subject|1
4678445|NCT02412722|7579760|FG000|Overall Study|Lost to Follow-up|0
4678446|NCT02412722|7579761|FG001|Overall Study|Lost to Follow-up|0
4678447|NCT02412722|7579762|FG002|Overall Study|Lost to Follow-up|0
4678448|NCT02412722|7579763|FG003|Overall Study|Lost to Follow-up|0
4678449|NCT02412722|7579764|FG004|Overall Study|Lost to Follow-up|1
4678450|NCT02412722|7579765|FG005|Overall Study|Lost to Follow-up|0
4678451|NCT02412722|7579760|FG000|Overall Study|Received drug in run-in and discontinued|0
4678452|NCT02412722|7579761|FG001|Overall Study|Received drug in run-in and discontinued|2
4678453|NCT02412722|7579762|FG002|Overall Study|Received drug in run-in and discontinued|0
4678454|NCT02412722|7579763|FG003|Overall Study|Received drug in run-in and discontinued|0
4678455|NCT02412722|7579764|FG004|Overall Study|Received drug in run-in and discontinued|0
4678456|NCT02412722|7579765|FG005|Overall Study|Received drug in run-in and discontinued|0
4678457|NCT02412722|7579760|FG000|Overall Study|Reason not Specified|3
4678458|NCT02412722|7579761|FG001|Overall Study|Reason not Specified|0
4678459|NCT02412722|7579762|FG002|Overall Study|Reason not Specified|2
4678460|NCT02412722|7579763|FG003|Overall Study|Reason not Specified|1
4678461|NCT02412722|7579764|FG004|Overall Study|Reason not Specified|2
4678462|NCT02412722|7579765|FG005|Overall Study|Reason not Specified|6
4678463|NCT02412761|7579799|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0
4678464|NCT02412761|7579800|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1
4678465|NCT02412761|7579801|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1
4678466|NCT02412761|7579802|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0
4678467|NCT02412761|7579803|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0
4678468|NCT02412761|7579804|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1
4678469|NCT02412852|7579816|FG000|Overall Study|Withdrawal by Subject|0
4678470|NCT02412852|7579817|FG001|Overall Study|Withdrawal by Subject|1
4678471|NCT02412852|7579818|FG002|Overall Study|Withdrawal by Subject|0
4678472|NCT02412852|7579819|FG003|Overall Study|Withdrawal by Subject|0
4678473|NCT02412852|7579816|FG000|Overall Study|Physician Decision|0
4678474|NCT02412852|7579817|FG001|Overall Study|Physician Decision|0
4678475|NCT02412852|7579818|FG002|Overall Study|Physician Decision|0
4678476|NCT02412852|7579819|FG003|Overall Study|Physician Decision|1
4678477|NCT02412878|7579829|FG000|Overall Study|Withdrawal by Subject|19
4678478|NCT02412878|7579830|FG001|Overall Study|Withdrawal by Subject|10
4678479|NCT02412878|7579829|FG000|Overall Study|Lost to Follow-up|2
4678480|NCT02412878|7579830|FG001|Overall Study|Lost to Follow-up|3
4757827|NCT02246621|7732127|FG000|Overall Study|Withdrawal by Subject|28
4757828|NCT02246621|7732128|FG001|Overall Study|Withdrawal by Subject|16
4757829|NCT02246621|7732127|FG000|Overall Study|Lost to Follow-up|1
4757830|NCT02246621|7732128|FG001|Overall Study|Lost to Follow-up|0
4757831|NCT02246621|7732127|FG000|Overall Study|On Study Treatment/ Follow Up|236
4757832|NCT02246621|7732128|FG001|Overall Study|On Study Treatment/ Follow Up|119
4757833|NCT03926611|7732154|FG000|Overall Study|Adverse Event|0
4757834|NCT03926611|7732155|FG001|Overall Study|Adverse Event|0
4757835|NCT03926611|7732156|FG002|Overall Study|Adverse Event|0
4757836|NCT03926611|7732157|FG003|Overall Study|Adverse Event|3
4757837|NCT03926611|7732158|FG004|Overall Study|Adverse Event|1
4757838|NCT03926611|7732159|FG005|Overall Study|Adverse Event|3
4757839|NCT03926611|7732160|FG006|Overall Study|Adverse Event|0
4757840|NCT03926611|7732154|FG000|Overall Study|Lack of Efficacy|1
4757841|NCT03926611|7732155|FG001|Overall Study|Lack of Efficacy|2
4757842|NCT03926611|7732156|FG002|Overall Study|Lack of Efficacy|0
4757843|NCT03926611|7732157|FG003|Overall Study|Lack of Efficacy|0
4757844|NCT03926611|7732158|FG004|Overall Study|Lack of Efficacy|1
4678481|NCT02413229|7579907|FG000|Overall Study|Adverse Event|0
4678482|NCT02413229|7579908|FG001|Overall Study|Adverse Event|0
4678483|NCT02413229|7579909|FG002|Overall Study|Adverse Event|0
4678484|NCT02413229|7579910|FG003|Overall Study|Adverse Event|1
4678485|NCT02413229|7579911|FG004|Overall Study|Adverse Event|0
4678486|NCT02413229|7579912|FG005|Overall Study|Adverse Event|0
4678487|NCT02413229|7579913|FG006|Overall Study|Adverse Event|0
4678488|NCT02413229|7579914|FG007|Overall Study|Adverse Event|1
4678489|NCT02413229|7579907|FG000|Overall Study|Lost to Follow-up|0
4678490|NCT02413229|7579908|FG001|Overall Study|Lost to Follow-up|0
4678491|NCT02413229|7579909|FG002|Overall Study|Lost to Follow-up|1
4678492|NCT02413229|7579910|FG003|Overall Study|Lost to Follow-up|0
4678493|NCT02413229|7579911|FG004|Overall Study|Lost to Follow-up|2
4678494|NCT02413229|7579912|FG005|Overall Study|Lost to Follow-up|0
4678495|NCT02413229|7579913|FG006|Overall Study|Lost to Follow-up|0
4678496|NCT02413229|7579914|FG007|Overall Study|Lost to Follow-up|0
4678497|NCT02413229|7579907|FG000|Overall Study|Withdrawal by Subject|1
4678498|NCT02413229|7579908|FG001|Overall Study|Withdrawal by Subject|1
4678499|NCT02413229|7579909|FG002|Overall Study|Withdrawal by Subject|0
4678500|NCT02413229|7579910|FG003|Overall Study|Withdrawal by Subject|0
4678501|NCT02413229|7579911|FG004|Overall Study|Withdrawal by Subject|1
4678502|NCT02413229|7579912|FG005|Overall Study|Withdrawal by Subject|0
4678503|NCT02413229|7579913|FG006|Overall Study|Withdrawal by Subject|0
4678504|NCT02413229|7579914|FG007|Overall Study|Withdrawal by Subject|2
4678505|NCT02413229|7579907|FG000|Overall Study|Progressive Disease|0
4678506|NCT02413229|7579908|FG001|Overall Study|Progressive Disease|0
4678507|NCT02413229|7579909|FG002|Overall Study|Progressive Disease|0
4678508|NCT02413229|7579910|FG003|Overall Study|Progressive Disease|0
4678509|NCT02413229|7579911|FG004|Overall Study|Progressive Disease|0
4678510|NCT02413229|7579912|FG005|Overall Study|Progressive Disease|0
4678511|NCT02413229|7579913|FG006|Overall Study|Progressive Disease|0
4678512|NCT02413229|7579914|FG007|Overall Study|Progressive Disease|1
4678513|NCT02413255|7579949|FG000|Overall Study|Voluntary Withdrawal|0
4678514|NCT02413255|7579950|FG001|Overall Study|Voluntary Withdrawal|0
4678515|NCT02413255|7579951|FG002|Overall Study|Voluntary Withdrawal|0
4678516|NCT02413255|7579952|FG003|Overall Study|Voluntary Withdrawal|0
4678517|NCT02413255|7579953|FG004|Overall Study|Voluntary Withdrawal|0
4678518|NCT02413255|7579954|FG005|Overall Study|Voluntary Withdrawal|0
4678519|NCT02413255|7579955|FG006|Overall Study|Voluntary Withdrawal|0
4678520|NCT02413255|7579956|FG007|Overall Study|Voluntary Withdrawal|0
4678521|NCT02413255|7579957|FG008|Overall Study|Voluntary Withdrawal|0
4678522|NCT02413255|7579958|FG009|Overall Study|Voluntary Withdrawal|0
4678523|NCT02413255|7579959|FG010|Overall Study|Voluntary Withdrawal|0
4678524|NCT02413255|7579960|FG011|Overall Study|Voluntary Withdrawal|0
4678525|NCT02413255|7579961|FG012|Overall Study|Voluntary Withdrawal|0
4678526|NCT02413255|7579962|FG013|Overall Study|Voluntary Withdrawal|0
4678527|NCT02413255|7579963|FG014|Overall Study|Voluntary Withdrawal|1
4678528|NCT02413255|7579964|FG015|Overall Study|Voluntary Withdrawal|0
4678529|NCT02413255|7579965|FG016|Overall Study|Voluntary Withdrawal|0
4678530|NCT02413294|7580016|FG000|Overall Study|Withdrawal by Subject|1
4678531|NCT02413333|7580033|FG000|Period 1|Adverse Event|1
4678532|NCT02413333|7580034|FG001|Period 1|Adverse Event|0
4678533|NCT02413333|7580033|FG000|Period 1|Reason Not Specified|0
4678534|NCT02413333|7580034|FG001|Period 1|Reason Not Specified|1
4678535|NCT02413333|7580033|FG000|Period 2|Protocol Deviation|1
4678536|NCT02413333|7580034|FG001|Period 2|Protocol Deviation|0
4678537|NCT02413346|7580042|FG000|Overall Study|Adverse Event|6
4678538|NCT02413346|7580043|FG001|Overall Study|Adverse Event|6
4678539|NCT02413346|7580042|FG000|Overall Study|Withdrawal by Subject|30
4678540|NCT02413346|7580043|FG001|Overall Study|Withdrawal by Subject|40
4678541|NCT02413346|7580042|FG000|Overall Study|Lost to Follow-up|17
4678542|NCT02413346|7580043|FG001|Overall Study|Lost to Follow-up|21
4678543|NCT02413346|7580042|FG000|Overall Study|Protocol Violation|2
4678544|NCT02413346|7580043|FG001|Overall Study|Protocol Violation|0
4678545|NCT02413346|7580042|FG000|Overall Study|Other Miscellaneous Reasons|4
4678546|NCT02413346|7580043|FG001|Overall Study|Other Miscellaneous Reasons|3
4678547|NCT02413372|7580052|FG000|Treatment|Lost to Follow-up|0
4678548|NCT02413372|7580053|FG001|Treatment|Lost to Follow-up|2
4678549|NCT02413372|7580054|FG002|Treatment|Lost to Follow-up|1
4678550|NCT02413372|7580052|FG000|Treatment|Withdrawal by Subject|1
4678551|NCT02413372|7580053|FG001|Treatment|Withdrawal by Subject|0
4678552|NCT02413372|7580054|FG002|Treatment|Withdrawal by Subject|0
4678553|NCT02413372|7580052|FG000|Follow-up|Lost to Follow-up|1
4678554|NCT02413372|7580053|FG001|Follow-up|Lost to Follow-up|1
4678555|NCT02413372|7580054|FG002|Follow-up|Lost to Follow-up|0
4678556|NCT02413372|7580052|FG000|Follow-up|Subject Withdrew Consent|1
4678557|NCT02413372|7580053|FG001|Follow-up|Subject Withdrew Consent|0
4678558|NCT02413372|7580054|FG002|Follow-up|Subject Withdrew Consent|1
4678559|NCT02413372|7580052|FG000|Follow-up|Subject unable to return for visit|0
4678560|NCT02413372|7580053|FG001|Follow-up|Subject unable to return for visit|0
4678561|NCT02413372|7580054|FG002|Follow-up|Subject unable to return for visit|1
4678562|NCT02413398|7580064|FG000|Overall Study|Lost to Follow-up|2
4678563|NCT02413398|7580065|FG001|Overall Study|Lost to Follow-up|4
4678564|NCT02413398|7580064|FG000|Overall Study|Withdrawal by Subject|1
4678565|NCT02413398|7580065|FG001|Overall Study|Withdrawal by Subject|1
4678566|NCT02413398|7580064|FG000|Overall Study|Other Eligibility criteria|1
4678567|NCT02413398|7580065|FG001|Overall Study|Other Eligibility criteria|2
4678568|NCT02413489|7580083|FG000|Overall Study|Death|11
4678569|NCT02413489|7580084|FG001|Overall Study|Death|3
4678570|NCT02413489|7580085|FG002|Overall Study|Death|4
4678571|NCT02413489|7580083|FG000|Overall Study|Withdrawal by Subject|2
4678572|NCT02413489|7580084|FG001|Overall Study|Withdrawal by Subject|0
4678573|NCT02413489|7580085|FG002|Overall Study|Withdrawal by Subject|0
4678574|NCT02413489|7580083|FG000|Overall Study|Study Terminated By Sponsor|2
4678575|NCT02413489|7580084|FG001|Overall Study|Study Terminated By Sponsor|13
4678576|NCT02413489|7580085|FG002|Overall Study|Study Terminated By Sponsor|1
4678577|NCT02413593|7580097|FG000|Overall Study|Lost to Follow-up|3
4678578|NCT02413593|7580097|FG000|Overall Study|Adverse Event|1
4678579|NCT02413996|7580118|FG000|Overall Study|not comfortable with the intervention|9
4678580|NCT02413996|7580119|FG001|Overall Study|not comfortable with the intervention|2
4678581|NCT02414828|7580152|FG000|Overall Study|Lost to Follow-up|0
4678582|NCT02414828|7580153|FG001|Overall Study|Lost to Follow-up|1
4678583|NCT02414828|7580154|FG002|Overall Study|Lost to Follow-up|1
4678584|NCT02414828|7580155|FG003|Overall Study|Lost to Follow-up|2
4678585|NCT02414841|7580168|FG000|Overall Study|Withdrawal by Subject|7
4678586|NCT02414841|7580169|FG001|Overall Study|Withdrawal by Subject|5
4678587|NCT02414841|7580168|FG000|Overall Study|Lost to Follow-up|13
4678588|NCT02414841|7580169|FG001|Overall Study|Lost to Follow-up|6
4678589|NCT02414841|7580168|FG000|Overall Study|Death|17
4678590|NCT02414841|7580169|FG001|Overall Study|Death|14
4678591|NCT02414841|7580168|FG000|Overall Study|Received a Kidney Transplant|13
4678592|NCT02414841|7580169|FG001|Overall Study|Received a Kidney Transplant|4
4678593|NCT02414841|7580168|FG000|Overall Study|Randomized But Not Treated|6
4678594|NCT02414841|7580169|FG001|Overall Study|Randomized But Not Treated|4
4678595|NCT02414854|7580181|FG000|Overall Study|Adverse Event|9
4678596|NCT02414854|7580182|FG001|Overall Study|Adverse Event|7
4678597|NCT02414854|7580183|FG002|Overall Study|Adverse Event|1
4678598|NCT02414854|7580184|FG003|Overall Study|Adverse Event|12
4678599|NCT02414854|7580181|FG000|Overall Study|Poor compliance to protocol|1
4678600|NCT02414854|7580182|FG001|Overall Study|Poor compliance to protocol|1
4678601|NCT02414854|7580183|FG002|Overall Study|Poor compliance to protocol|2
4678602|NCT02414854|7580184|FG003|Overall Study|Poor compliance to protocol|2
4678603|NCT02414854|7580181|FG000|Overall Study|Other than specified above|12
4678604|NCT02414854|7580182|FG001|Overall Study|Other than specified above|37
4678605|NCT02414854|7580183|FG002|Overall Study|Other than specified above|17
4757845|NCT03926611|7732159|FG005|Overall Study|Lack of Efficacy|0
4757846|NCT03926611|7732160|FG006|Overall Study|Lack of Efficacy|1
4757847|NCT03926611|7732154|FG000|Overall Study|Physician Decision|0
4757848|NCT03926611|7732155|FG001|Overall Study|Physician Decision|0
4757849|NCT03926611|7732156|FG002|Overall Study|Physician Decision|0
4757850|NCT03926611|7732157|FG003|Overall Study|Physician Decision|0
4757851|NCT03926611|7732158|FG004|Overall Study|Physician Decision|0
4757852|NCT03926611|7732159|FG005|Overall Study|Physician Decision|1
4757853|NCT03926611|7732160|FG006|Overall Study|Physician Decision|0
4757854|NCT03926611|7732154|FG000|Overall Study|Protocol Violation|1
4757855|NCT03926611|7732155|FG001|Overall Study|Protocol Violation|0
4757856|NCT03926611|7732156|FG002|Overall Study|Protocol Violation|0
4757857|NCT03926611|7732157|FG003|Overall Study|Protocol Violation|1
4757858|NCT03926611|7732158|FG004|Overall Study|Protocol Violation|1
4757859|NCT03926611|7732159|FG005|Overall Study|Protocol Violation|1
4757860|NCT03926611|7732160|FG006|Overall Study|Protocol Violation|1
4757861|NCT03926611|7732154|FG000|Overall Study|Technical problems|0
4757862|NCT03926611|7732155|FG001|Overall Study|Technical problems|0
4757863|NCT03926611|7732156|FG002|Overall Study|Technical problems|0
4757864|NCT03926611|7732157|FG003|Overall Study|Technical problems|0
4757865|NCT03926611|7732158|FG004|Overall Study|Technical problems|0
4757866|NCT03926611|7732159|FG005|Overall Study|Technical problems|1
4757867|NCT03926611|7732160|FG006|Overall Study|Technical problems|0
4757868|NCT03926611|7732154|FG000|Overall Study|Withdrawal by Subject|1
4757869|NCT03926611|7732155|FG001|Overall Study|Withdrawal by Subject|1
4757870|NCT03926611|7732156|FG002|Overall Study|Withdrawal by Subject|1
4757871|NCT03926611|7732157|FG003|Overall Study|Withdrawal by Subject|0
4757872|NCT03926611|7732158|FG004|Overall Study|Withdrawal by Subject|0
4757873|NCT03926611|7732159|FG005|Overall Study|Withdrawal by Subject|1
4757874|NCT03926611|7732160|FG006|Overall Study|Withdrawal by Subject|3
4757875|NCT03926611|7732154|FG000|Overall Study|Covid-19 pandemic|0
4757876|NCT03926611|7732155|FG001|Overall Study|Covid-19 pandemic|0
4757877|NCT03926611|7732156|FG002|Overall Study|Covid-19 pandemic|1
4757878|NCT03926611|7732157|FG003|Overall Study|Covid-19 pandemic|0
4757879|NCT03926611|7732158|FG004|Overall Study|Covid-19 pandemic|1
4757880|NCT03926611|7732159|FG005|Overall Study|Covid-19 pandemic|2
4757881|NCT03926611|7732160|FG006|Overall Study|Covid-19 pandemic|0
4757882|NCT03838484|7732184|FG000|Overall Study|Lost to Follow-up|0
4757883|NCT03838484|7732185|FG001|Overall Study|Lost to Follow-up|1
4757884|NCT03838484|7732186|FG002|Overall Study|Lost to Follow-up|0
4757885|NCT03838484|7732187|FG003|Overall Study|Lost to Follow-up|0
4757886|NCT03814720|7732208|FG000|Overall Study|Lost to Follow-up|0
4757887|NCT03814720|7732209|FG001|Overall Study|Lost to Follow-up|1
4757888|NCT03814720|7732210|FG002|Overall Study|Lost to Follow-up|0
4757889|NCT03814720|7732211|FG003|Overall Study|Lost to Follow-up|0
4757890|NCT03814720|7732212|FG004|Overall Study|Lost to Follow-up|0
4678606|NCT02414854|7580184|FG003|Overall Study|Other than specified above|37
4678607|NCT02414932|7580196|FG000|Overall Study|Withdrawal by Subject|2
4678608|NCT02414932|7580197|FG001|Overall Study|Withdrawal by Subject|3
4678609|NCT02414932|7580196|FG000|Overall Study|Adverse Event|1
4678610|NCT02414932|7580197|FG001|Overall Study|Adverse Event|0
4678611|NCT02414958|7580206|FG000|Overall Study|Adverse Event|6
4678612|NCT02414958|7580207|FG001|Overall Study|Adverse Event|6
4678613|NCT02414958|7580208|FG002|Overall Study|Adverse Event|3
4678614|NCT02414958|7580206|FG000|Overall Study|Protocol Violation|10
4678615|NCT02414958|7580207|FG001|Overall Study|Protocol Violation|3
4678616|NCT02414958|7580208|FG002|Overall Study|Protocol Violation|1
4678617|NCT02414958|7580206|FG000|Overall Study|Lost to Follow-up|7
4678618|NCT02414958|7580207|FG001|Overall Study|Lost to Follow-up|4
4678619|NCT02414958|7580208|FG002|Overall Study|Lost to Follow-up|0
4678620|NCT02414958|7580206|FG000|Overall Study|Withdrawal by Subject|5
4678621|NCT02414958|7580207|FG001|Overall Study|Withdrawal by Subject|3
4678622|NCT02414958|7580208|FG002|Overall Study|Withdrawal by Subject|5
4678623|NCT02414958|7580206|FG000|Overall Study|Other than specified|4
4678624|NCT02414958|7580207|FG001|Overall Study|Other than specified|4
4678625|NCT02414958|7580208|FG002|Overall Study|Other than specified|5
4678626|NCT02415127|7580218|FG000|Overall Study|Adverse Event|1
4678627|NCT02415127|7580219|FG001|Overall Study|Adverse Event|0
4678628|NCT02415400|7580238|FG000|Overall Study|Adverse Event|0
4678629|NCT02415400|7580239|FG001|Overall Study|Adverse Event|1
4678630|NCT02415400|7580240|FG002|Overall Study|Adverse Event|1
4678631|NCT02415400|7580241|FG003|Overall Study|Adverse Event|2
4678632|NCT02415400|7580238|FG000|Overall Study|Participant request to stop therapy|4
4678633|NCT02415400|7580239|FG001|Overall Study|Participant request to stop therapy|3
4678634|NCT02415400|7580240|FG002|Overall Study|Participant request to stop therapy|8
4678635|NCT02415400|7580241|FG003|Overall Study|Participant request to stop therapy|6
4678636|NCT02415400|7580238|FG000|Overall Study|Participant withdrew consent|14
4678637|NCT02415400|7580239|FG001|Overall Study|Participant withdrew consent|12
4678638|NCT02415400|7580240|FG002|Overall Study|Participant withdrew consent|30
4678639|NCT02415400|7580241|FG003|Overall Study|Participant withdrew consent|21
4678640|NCT02415400|7580238|FG000|Overall Study|Death|39
4678641|NCT02415400|7580239|FG001|Overall Study|Death|41
4678642|NCT02415400|7580240|FG002|Overall Study|Death|35
4678643|NCT02415400|7580241|FG003|Overall Study|Death|42
4678644|NCT02415400|7580238|FG000|Overall Study|Lost to Follow-up|3
4678645|NCT02415400|7580239|FG001|Overall Study|Lost to Follow-up|3
4678646|NCT02415400|7580240|FG002|Overall Study|Lost to Follow-up|2
4678647|NCT02415400|7580241|FG003|Overall Study|Lost to Follow-up|5
4678648|NCT02415400|7580238|FG000|Overall Study|Poor/Non-Compliance|0
4678649|NCT02415400|7580239|FG001|Overall Study|Poor/Non-Compliance|1
4678650|NCT02415400|7580240|FG002|Overall Study|Poor/Non-Compliance|3
4678651|NCT02415400|7580241|FG003|Overall Study|Poor/Non-Compliance|4
4678652|NCT02415400|7580238|FG000|Overall Study|Participant no longer meets criteria|2
4678653|NCT02415400|7580239|FG001|Overall Study|Participant no longer meets criteria|0
4678654|NCT02415400|7580240|FG002|Overall Study|Participant no longer meets criteria|0
4678655|NCT02415400|7580241|FG003|Overall Study|Participant no longer meets criteria|1
4678656|NCT02415400|7580238|FG000|Overall Study|Participant doesn't answer phone|1
4678657|NCT02415400|7580239|FG001|Overall Study|Participant doesn't answer phone|0
4678658|NCT02415400|7580240|FG002|Overall Study|Participant doesn't answer phone|0
4678659|NCT02415400|7580241|FG003|Overall Study|Participant doesn't answer phone|0
4678660|NCT02415400|7580238|FG000|Overall Study|Participant wanted home visits|1
4678661|NCT02415400|7580239|FG001|Overall Study|Participant wanted home visits|0
4678662|NCT02415400|7580240|FG002|Overall Study|Participant wanted home visits|0
4678663|NCT02415400|7580241|FG003|Overall Study|Participant wanted home visits|0
4678664|NCT02415400|7580238|FG000|Overall Study|Randomized in error|2
4678665|NCT02415400|7580239|FG001|Overall Study|Randomized in error|0
4678666|NCT02415400|7580240|FG002|Overall Study|Randomized in error|0
4678667|NCT02415400|7580241|FG003|Overall Study|Randomized in error|0
4678668|NCT02415400|7580238|FG000|Overall Study|No study drug on site|0
4678669|NCT02415400|7580239|FG001|Overall Study|No study drug on site|1
4678670|NCT02415400|7580240|FG002|Overall Study|No study drug on site|0
4678671|NCT02415400|7580241|FG003|Overall Study|No study drug on site|0
4678672|NCT02415400|7580238|FG000|Overall Study|Stroke and stroke rehabilitation|0
4678673|NCT02415400|7580239|FG001|Overall Study|Stroke and stroke rehabilitation|0
4678674|NCT02415400|7580240|FG002|Overall Study|Stroke and stroke rehabilitation|1
4678675|NCT02415400|7580241|FG003|Overall Study|Stroke and stroke rehabilitation|0
4678676|NCT02415400|7580238|FG000|Overall Study|Coagulation values cannot be set|0
4678677|NCT02415400|7580239|FG001|Overall Study|Coagulation values cannot be set|0
4678678|NCT02415400|7580240|FG002|Overall Study|Coagulation values cannot be set|1
4678679|NCT02415400|7580241|FG003|Overall Study|Coagulation values cannot be set|0
4678680|NCT02415400|7580238|FG000|Overall Study|State regulations prevent participation|0
4678681|NCT02415400|7580239|FG001|Overall Study|State regulations prevent participation|0
4678682|NCT02415400|7580240|FG002|Overall Study|State regulations prevent participation|1
4678683|NCT02415400|7580241|FG003|Overall Study|State regulations prevent participation|0
4678684|NCT02415400|7580238|FG000|Overall Study|Poor treatment monitoring|0
4678685|NCT02415400|7580239|FG001|Overall Study|Poor treatment monitoring|0
4678686|NCT02415400|7580240|FG002|Overall Study|Poor treatment monitoring|1
4678687|NCT02415400|7580241|FG003|Overall Study|Poor treatment monitoring|0
4678688|NCT02415400|7580238|FG000|Overall Study|Participant in jail|0
4678689|NCT02415400|7580239|FG001|Overall Study|Participant in jail|0
4678690|NCT02415400|7580240|FG002|Overall Study|Participant in jail|1
4678691|NCT02415400|7580241|FG003|Overall Study|Participant in jail|0
4757891|NCT03635424|7732226|FG000|Overall Study|Adverse Event|1
4757892|NCT03635424|7732226|FG000|Overall Study|Death|1
4757893|NCT03635424|7732226|FG000|Overall Study|Device not implanted|1
4757894|NCT03529110|7732232|FG000|Overall Study|Progressive Disease|66
4757895|NCT03529110|7732233|FG001|Overall Study|Progressive Disease|158
4757896|NCT03529110|7732232|FG000|Overall Study|Clinical Progression|4
4757897|NCT03529110|7732233|FG001|Overall Study|Clinical Progression|12
4757898|NCT03529110|7732232|FG000|Overall Study|Adverse Event|35
4757899|NCT03529110|7732233|FG001|Overall Study|Adverse Event|17
4757900|NCT03529110|7732232|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13
4757901|NCT03529110|7732233|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11
4757902|NCT03529110|7732232|FG000|Overall Study|Lack of Efficacy|3
4757903|NCT03529110|7732233|FG001|Overall Study|Lack of Efficacy|3
4757904|NCT03529110|7732232|FG000|Overall Study|Physician Decision|2
4678692|NCT02415400|7580238|FG000|Overall Study|Investigator decision|0
4678693|NCT02415400|7580239|FG001|Overall Study|Investigator decision|0
4678694|NCT02415400|7580240|FG002|Overall Study|Investigator decision|1
4678695|NCT02415400|7580241|FG003|Overall Study|Investigator decision|1
4678696|NCT02415400|7580238|FG000|Overall Study|Site closure; participant won't transfer|0
4678697|NCT02415400|7580239|FG001|Overall Study|Site closure; participant won't transfer|0
4757905|NCT03529110|7732233|FG001|Overall Study|Physician Decision|8
4757906|NCT03529110|7732232|FG000|Overall Study|Miscellaneous|2
4757907|NCT03529110|7732233|FG001|Overall Study|Miscellaneous|5
4757908|NCT03517540|7732243|FG000|Overall Study|Protocol Violation|2
4757909|NCT03517540|7732244|FG001|Overall Study|Protocol Violation|0
4757910|NCT03517540|7732245|FG002|Overall Study|Protocol Violation|0
4757911|NCT03517540|7732246|FG003|Overall Study|Protocol Violation|1
4757912|NCT03517540|7732243|FG000|Overall Study|Adverse Event|9
4757913|NCT03517540|7732244|FG001|Overall Study|Adverse Event|3
4757914|NCT03517540|7732245|FG002|Overall Study|Adverse Event|8
4757915|NCT03517540|7732246|FG003|Overall Study|Adverse Event|1
4757916|NCT03517540|7732243|FG000|Overall Study|Withdrawal by Subject|3
4757917|NCT03517540|7732244|FG001|Overall Study|Withdrawal by Subject|4
4757918|NCT03517540|7732245|FG002|Overall Study|Withdrawal by Subject|1
4757919|NCT03517540|7732246|FG003|Overall Study|Withdrawal by Subject|3
4757920|NCT03437278|7732268|FG000|Overall Study|Adverse Event|0
4757921|NCT03437278|7732269|FG001|Overall Study|Adverse Event|0
4678698|NCT02415400|7580240|FG002|Overall Study|Site closure; participant won't transfer|0
4678699|NCT02415400|7580241|FG003|Overall Study|Site closure; participant won't transfer|1
4678700|NCT02415556|7580314|FG000|Overall Study|Adverse Event|3
4678701|NCT02415556|7580315|FG001|Overall Study|Adverse Event|4
4678702|NCT02415556|7580316|FG002|Overall Study|Adverse Event|2
4678703|NCT02415556|7580317|FG003|Overall Study|Adverse Event|4
4678704|NCT02415556|7580314|FG000|Overall Study|Lost to Follow-up|4
4678705|NCT02415556|7580315|FG001|Overall Study|Lost to Follow-up|5
4678706|NCT02415556|7580316|FG002|Overall Study|Lost to Follow-up|4
4678707|NCT02415556|7580317|FG003|Overall Study|Lost to Follow-up|1
4678708|NCT02415556|7580314|FG000|Overall Study|Withdrawal by Subject|13
4678709|NCT02415556|7580315|FG001|Overall Study|Withdrawal by Subject|4
4678710|NCT02415556|7580316|FG002|Overall Study|Withdrawal by Subject|14
4678711|NCT02415556|7580317|FG003|Overall Study|Withdrawal by Subject|12
4678712|NCT02415556|7580314|FG000|Overall Study|Physician Decision|1
4678713|NCT02415556|7580315|FG001|Overall Study|Physician Decision|3
4678714|NCT02415556|7580316|FG002|Overall Study|Physician Decision|1
4678715|NCT02415556|7580317|FG003|Overall Study|Physician Decision|2
4678716|NCT02415556|7580314|FG000|Overall Study|Censored - study completion|4
4678717|NCT02415556|7580315|FG001|Overall Study|Censored - study completion|5
4678718|NCT02415556|7580316|FG002|Overall Study|Censored - study completion|1
4678719|NCT02415556|7580317|FG003|Overall Study|Censored - study completion|0
4678720|NCT02415556|7580314|FG000|Overall Study|Family-related issues|0
4678721|NCT02415556|7580315|FG001|Overall Study|Family-related issues|0
4678722|NCT02415556|7580316|FG002|Overall Study|Family-related issues|0
4678723|NCT02415556|7580317|FG003|Overall Study|Family-related issues|1
4678724|NCT02415595|7580331|FG000|Overall Study|Administrative reason by sponsor|39
4678725|NCT02415595|7580332|FG001|Overall Study|Administrative reason by sponsor|40
4678726|NCT02415595|7580333|FG002|Overall Study|Administrative reason by sponsor|41
4678727|NCT02415595|7580334|FG003|Overall Study|Administrative reason by sponsor|39
4678728|NCT02415595|7580331|FG000|Overall Study|Adverse Event|1
4678729|NCT02415595|7580332|FG001|Overall Study|Adverse Event|3
4678730|NCT02415595|7580333|FG002|Overall Study|Adverse Event|5
4678731|NCT02415595|7580334|FG003|Overall Study|Adverse Event|10
4678732|NCT02415595|7580331|FG000|Overall Study|Lack of Efficacy|4
4757922|NCT03437278|7732270|FG002|Overall Study|Adverse Event|1
4757923|NCT03437278|7732268|FG000|Overall Study|Progressive disease|1
4757924|NCT03437278|7732269|FG001|Overall Study|Progressive disease|0
4757925|NCT03437278|7732270|FG002|Overall Study|Progressive disease|0
4757926|NCT03437278|7732268|FG000|Overall Study|Physician Decision|1
4757927|NCT03437278|7732269|FG001|Overall Study|Physician Decision|0
4757928|NCT03437278|7732270|FG002|Overall Study|Physician Decision|1
4678733|NCT02415595|7580332|FG001|Overall Study|Lack of Efficacy|4
4678734|NCT02415595|7580333|FG002|Overall Study|Lack of Efficacy|0
4678735|NCT02415595|7580334|FG003|Overall Study|Lack of Efficacy|0
4678736|NCT02415595|7580331|FG000|Overall Study|Lost to Follow-up|1
4678737|NCT02415595|7580332|FG001|Overall Study|Lost to Follow-up|3
4678738|NCT02415595|7580333|FG002|Overall Study|Lost to Follow-up|1
4678739|NCT02415595|7580334|FG003|Overall Study|Lost to Follow-up|1
4678740|NCT02415595|7580331|FG000|Overall Study|Poor/Non-compliance|1
4678741|NCT02415595|7580332|FG001|Overall Study|Poor/Non-compliance|0
4678742|NCT02415595|7580333|FG002|Overall Study|Poor/Non-compliance|1
4678743|NCT02415595|7580334|FG003|Overall Study|Poor/Non-compliance|0
4678744|NCT02415595|7580331|FG000|Overall Study|Reached stopping criteria|0
4678745|NCT02415595|7580332|FG001|Overall Study|Reached stopping criteria|1
4757929|NCT03350815|7732280|FG000|Period 1|Adverse Event|10
4757930|NCT03350815|7732281|FG001|Period 1|Adverse Event|0
4757931|NCT03350815|7732282|FG002|Period 1|Adverse Event|0
4757932|NCT03350815|7732283|FG003|Period 1|Adverse Event|0
4757933|NCT03350815|7732280|FG000|Period 1|Technical problems|1
4757934|NCT03350815|7732281|FG001|Period 1|Technical problems|0
4757935|NCT03350815|7732282|FG002|Period 1|Technical problems|0
4757936|NCT03350815|7732283|FG003|Period 1|Technical problems|0
4757937|NCT03350815|7732280|FG000|Period 1|Lost to Follow-up|3
4757938|NCT03350815|7732281|FG001|Period 1|Lost to Follow-up|0
4757939|NCT03350815|7732282|FG002|Period 1|Lost to Follow-up|0
4757940|NCT03350815|7732283|FG003|Period 1|Lost to Follow-up|0
4757941|NCT03350815|7732280|FG000|Period 1|Physician Decision|1
4757942|NCT03350815|7732281|FG001|Period 1|Physician Decision|0
4757943|NCT03350815|7732282|FG002|Period 1|Physician Decision|0
4757944|NCT03350815|7732283|FG003|Period 1|Physician Decision|0
4757945|NCT03350815|7732280|FG000|Period 1|Withdrawal by Subject|8
4757946|NCT03350815|7732281|FG001|Period 1|Withdrawal by Subject|0
4757947|NCT03350815|7732282|FG002|Period 1|Withdrawal by Subject|0
4757948|NCT03350815|7732283|FG003|Period 1|Withdrawal by Subject|0
4757949|NCT03350815|7732280|FG000|Period 1|Lack of Efficacy|15
4757950|NCT03350815|7732281|FG001|Period 1|Lack of Efficacy|0
4757951|NCT03350815|7732282|FG002|Period 1|Lack of Efficacy|0
4757952|NCT03350815|7732283|FG003|Period 1|Lack of Efficacy|0
4757953|NCT03350815|7732280|FG000|Period 1|Non-compliance with study treatment|2
4757954|NCT03350815|7732281|FG001|Period 1|Non-compliance with study treatment|0
4757955|NCT03350815|7732282|FG002|Period 1|Non-compliance with study treatment|0
4757956|NCT03350815|7732283|FG003|Period 1|Non-compliance with study treatment|0
4757957|NCT03350815|7732280|FG000|Period 1|Protocol Violation|3
4757958|NCT03350815|7732281|FG001|Period 1|Protocol Violation|0
4757959|NCT03350815|7732282|FG002|Period 1|Protocol Violation|0
4757960|NCT03350815|7732283|FG003|Period 1|Protocol Violation|0
4757961|NCT03350815|7732280|FG000|Period 2|Adverse Event|0
4757962|NCT03350815|7732281|FG001|Period 2|Adverse Event|3
4757963|NCT03350815|7732282|FG002|Period 2|Adverse Event|5
4757964|NCT03350815|7732283|FG003|Period 2|Adverse Event|0
4757965|NCT03350815|7732280|FG000|Period 2|Technical problem|0
4757966|NCT03350815|7732281|FG001|Period 2|Technical problem|1
4678746|NCT02415595|7580333|FG002|Overall Study|Reached stopping criteria|1
4678747|NCT02415595|7580334|FG003|Overall Study|Reached stopping criteria|0
4678748|NCT02415595|7580331|FG000|Overall Study|Withdrawal by Subject|4
4678749|NCT02415595|7580332|FG001|Overall Study|Withdrawal by Subject|0
4678750|NCT02415595|7580333|FG002|Overall Study|Withdrawal by Subject|1
4678751|NCT02415595|7580334|FG003|Overall Study|Withdrawal by Subject|3
4678752|NCT02415595|7580331|FG000|Overall Study|Other|0
4678753|NCT02415595|7580332|FG001|Overall Study|Other|1
4678754|NCT02415595|7580333|FG002|Overall Study|Other|1
4678755|NCT02415595|7580334|FG003|Overall Study|Other|0
4678756|NCT02415959|7580438|FG000|Overall Study|Adverse Event|0
4678757|NCT02415959|7580439|FG001|Overall Study|Adverse Event|1
4678758|NCT02415959|7580440|FG002|Overall Study|Adverse Event|0
4678759|NCT02415959|7580441|FG003|Overall Study|Adverse Event|0
4678760|NCT02415959|7580442|FG004|Overall Study|Adverse Event|0
4678761|NCT02415959|7580438|FG000|Overall Study|Protocol Violation|0
4678762|NCT02415959|7580439|FG001|Overall Study|Protocol Violation|0
4678763|NCT02415959|7580440|FG002|Overall Study|Protocol Violation|0
4678764|NCT02415959|7580441|FG003|Overall Study|Protocol Violation|1
4678765|NCT02415959|7580442|FG004|Overall Study|Protocol Violation|0
4678766|NCT02416180|7580471|FG000|Overall Study|Withdrawal by Subject|1
4678767|NCT02416453|7580495|FG000|Overall Study|Adverse Event|0
4678768|NCT02416453|7580496|FG001|Overall Study|Adverse Event|0
4678769|NCT02416453|7580497|FG002|Overall Study|Adverse Event|0
4757967|NCT03350815|7732282|FG002|Period 2|Technical problem|0
4757968|NCT03350815|7732283|FG003|Period 2|Technical problem|0
4757969|NCT03350815|7732280|FG000|Period 2|Lost to Follow-up|0
4757970|NCT03350815|7732281|FG001|Period 2|Lost to Follow-up|3
4757971|NCT03350815|7732282|FG002|Period 2|Lost to Follow-up|3
4757972|NCT03350815|7732283|FG003|Period 2|Lost to Follow-up|0
4757973|NCT03350815|7732280|FG000|Period 2|Physician Decision|0
4757974|NCT03350815|7732281|FG001|Period 2|Physician Decision|0
4757975|NCT03350815|7732282|FG002|Period 2|Physician Decision|1
4757976|NCT03350815|7732283|FG003|Period 2|Physician Decision|0
4757977|NCT03350815|7732280|FG000|Period 2|Withdrawal by Subject|0
4757978|NCT03350815|7732281|FG001|Period 2|Withdrawal by Subject|3
4678770|NCT02416453|7580498|FG003|Overall Study|Adverse Event|2
4678771|NCT02416453|7580499|FG004|Overall Study|Adverse Event|0
4678772|NCT02416453|7580500|FG005|Overall Study|Adverse Event|1
4678773|NCT02416453|7580501|FG006|Overall Study|Adverse Event|0
4678774|NCT02416453|7580502|FG007|Overall Study|Adverse Event|0
4678775|NCT02416453|7580503|FG008|Overall Study|Adverse Event|0
4678776|NCT02416453|7580504|FG009|Overall Study|Adverse Event|0
4678777|NCT02416453|7580505|FG010|Overall Study|Adverse Event|0
4678778|NCT02416453|7580495|FG000|Overall Study|Lost to Follow-up|1
4678779|NCT02416453|7580496|FG001|Overall Study|Lost to Follow-up|3
4678780|NCT02416453|7580497|FG002|Overall Study|Lost to Follow-up|0
4678781|NCT02416453|7580498|FG003|Overall Study|Lost to Follow-up|8
4678782|NCT02416453|7580499|FG004|Overall Study|Lost to Follow-up|0
4678783|NCT02416453|7580500|FG005|Overall Study|Lost to Follow-up|5
4678784|NCT02416453|7580501|FG006|Overall Study|Lost to Follow-up|1
4678785|NCT02416453|7580502|FG007|Overall Study|Lost to Follow-up|3
4678786|NCT02416453|7580503|FG008|Overall Study|Lost to Follow-up|1
4678787|NCT02416453|7580504|FG009|Overall Study|Lost to Follow-up|0
4678788|NCT02416453|7580505|FG010|Overall Study|Lost to Follow-up|0
4678789|NCT02416453|7580495|FG000|Overall Study|Physician Decision|0
4678790|NCT02416453|7580496|FG001|Overall Study|Physician Decision|0
4678791|NCT02416453|7580497|FG002|Overall Study|Physician Decision|0
4678792|NCT02416453|7580498|FG003|Overall Study|Physician Decision|0
4678793|NCT02416453|7580499|FG004|Overall Study|Physician Decision|0
4678794|NCT02416453|7580500|FG005|Overall Study|Physician Decision|1
4678795|NCT02416453|7580501|FG006|Overall Study|Physician Decision|1
4678796|NCT02416453|7580502|FG007|Overall Study|Physician Decision|1
4678797|NCT02416453|7580503|FG008|Overall Study|Physician Decision|0
4678798|NCT02416453|7580504|FG009|Overall Study|Physician Decision|0
4678799|NCT02416453|7580505|FG010|Overall Study|Physician Decision|0
4678800|NCT02416453|7580495|FG000|Overall Study|Withdrawal by Subject|2
4678801|NCT02416453|7580496|FG001|Overall Study|Withdrawal by Subject|0
4678802|NCT02416453|7580497|FG002|Overall Study|Withdrawal by Subject|0
4678803|NCT02416453|7580498|FG003|Overall Study|Withdrawal by Subject|5
4678804|NCT02416453|7580499|FG004|Overall Study|Withdrawal by Subject|1
4678805|NCT02416453|7580500|FG005|Overall Study|Withdrawal by Subject|8
4678806|NCT02416453|7580501|FG006|Overall Study|Withdrawal by Subject|0
4678807|NCT02416453|7580502|FG007|Overall Study|Withdrawal by Subject|8
4678808|NCT02416453|7580503|FG008|Overall Study|Withdrawal by Subject|4
4678809|NCT02416453|7580504|FG009|Overall Study|Withdrawal by Subject|0
4678810|NCT02416453|7580505|FG010|Overall Study|Withdrawal by Subject|0
4678811|NCT02416453|7580495|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
4678812|NCT02416453|7580496|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
4678813|NCT02416453|7580497|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1
4678814|NCT02416453|7580498|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
4678815|NCT02416453|7580499|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
4678816|NCT02416453|7580500|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
4678817|NCT02416453|7580501|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
4678818|NCT02416453|7580502|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
4678819|NCT02416453|7580503|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
4678820|NCT02416453|7580504|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
4678821|NCT02416453|7580505|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0
4757979|NCT03350815|7732282|FG002|Period 2|Withdrawal by Subject|4
4757980|NCT03350815|7732283|FG003|Period 2|Withdrawal by Subject|0
4757981|NCT03350815|7732280|FG000|Period 2|Lack of Efficacy|0
4757982|NCT03350815|7732281|FG001|Period 2|Lack of Efficacy|6
4757983|NCT03350815|7732282|FG002|Period 2|Lack of Efficacy|2
4757984|NCT03350815|7732283|FG003|Period 2|Lack of Efficacy|0
4757985|NCT03350815|7732280|FG000|Period 2|Protocol Violation|0
4678822|NCT02416453|7580495|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
4678823|NCT02416453|7580496|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
4678824|NCT02416453|7580497|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
4678825|NCT02416453|7580498|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
4678826|NCT02416453|7580499|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
4678827|NCT02416453|7580500|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1
4678828|NCT02416453|7580501|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
4678829|NCT02416453|7580502|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
4678830|NCT02416453|7580503|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
4757986|NCT03350815|7732281|FG001|Period 2|Protocol Violation|0
4757987|NCT03350815|7732282|FG002|Period 2|Protocol Violation|1
4757988|NCT03350815|7732283|FG003|Period 2|Protocol Violation|0
4757989|NCT03350815|7732280|FG000|Period 2|New therapy for study indication|0
4757990|NCT03350815|7732281|FG001|Period 2|New therapy for study indication|0
4757991|NCT03350815|7732282|FG002|Period 2|New therapy for study indication|1
4678831|NCT02416453|7580504|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
4678832|NCT02416453|7580505|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0
4678833|NCT02416791|7580568|FG000|6 Months|Lost to Follow-up|0
4678834|NCT02416791|7580569|FG001|6 Months|Lost to Follow-up|0
4678835|NCT02416791|7580570|FG002|6 Months|Lost to Follow-up|1
4678836|NCT02416908|7580581|FG000|Dose Escalation Phase|Adverse Event|0
4757992|NCT03350815|7732283|FG003|Period 2|New therapy for study indication|0
4757993|NCT03249714|7732296|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1
4678837|NCT02416908|7580582|FG001|Dose Escalation Phase|Adverse Event|0
4678838|NCT02416908|7580583|FG002|Dose Escalation Phase|Adverse Event|3
4678839|NCT02416908|7580584|FG003|Dose Escalation Phase|Adverse Event|0
4678840|NCT02416908|7580581|FG000|Dose Escalation Phase|Withdrawal by Subject|0
4678841|NCT02416908|7580582|FG001|Dose Escalation Phase|Withdrawal by Subject|0
4678842|NCT02416908|7580583|FG002|Dose Escalation Phase|Withdrawal by Subject|1
4678843|NCT02416908|7580584|FG003|Dose Escalation Phase|Withdrawal by Subject|0
4678844|NCT02416934|7580593|FG000|Overall Study|given steroids|1
4678845|NCT02416934|7580594|FG001|Overall Study|given steroids|2
4678846|NCT02416934|7580593|FG000|Overall Study|Lost to Follow-up|0
4678847|NCT02416934|7580594|FG001|Overall Study|Lost to Follow-up|2
4678848|NCT02416934|7580593|FG000|Overall Study|Withdrawal by Subject|1
4678849|NCT02416934|7580594|FG001|Overall Study|Withdrawal by Subject|0
4678850|NCT02416934|7580593|FG000|Overall Study|recruited during continuing renewal proc|0
4678851|NCT02416934|7580594|FG001|Overall Study|recruited during continuing renewal proc|1
4678852|NCT02416934|7580593|FG000|Overall Study|Protocol Violation|0
4678853|NCT02416934|7580594|FG001|Overall Study|Protocol Violation|1
4678854|NCT02416934|7580593|FG000|Overall Study|surgery started late|0
4678855|NCT02416934|7580594|FG001|Overall Study|surgery started late|1
4678856|NCT02416934|7580593|FG000|Overall Study|re-operation|1
4678857|NCT02416934|7580594|FG001|Overall Study|re-operation|0
4678858|NCT02417064|7580622|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1
4678859|NCT02417064|7580623|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7
4678860|NCT02417064|7580624|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2
4678861|NCT02417064|7580622|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1
4678862|NCT02417064|7580623|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1
4678863|NCT02417064|7580624|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0
4678864|NCT02417064|7580622|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0
4678865|NCT02417064|7580623|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1
4678866|NCT02417064|7580624|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0
4678867|NCT02417064|7580622|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2
4678868|NCT02417064|7580623|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1
4678869|NCT02417064|7580624|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1
4678870|NCT02417064|7580622|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1
4678871|NCT02417064|7580623|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5
4678872|NCT02417064|7580624|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1
4678873|NCT02417064|7580622|FG000|Double-blind Induction Phase (4 Weeks)|Other|1
4678874|NCT02417064|7580623|FG001|Double-blind Induction Phase (4 Weeks)|Other|4
4678875|NCT02417064|7580624|FG002|Double-blind Induction Phase (4 Weeks)|Other|2
4678876|NCT02417064|7580622|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0
4678877|NCT02417064|7580623|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2
4678878|NCT02417064|7580624|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1
4678879|NCT02417064|7580622|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0
4678880|NCT02417064|7580623|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0
4678881|NCT02417064|7580624|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1
4678882|NCT02417064|7580622|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3
4678883|NCT02417064|7580623|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9
4678884|NCT02417064|7580624|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2
4678885|NCT02417064|7580622|FG000|Follow-up Phase (24 Weeks)|PI Decision|34
4678886|NCT02417064|7580623|FG001|Follow-up Phase (24 Weeks)|PI Decision|29
4678887|NCT02417064|7580624|FG002|Follow-up Phase (24 Weeks)|PI Decision|44
4678888|NCT02417064|7580622|FG000|Follow-up Phase (24 Weeks)|Other|2
4678889|NCT02417064|7580623|FG001|Follow-up Phase (24 Weeks)|Other|2
4678890|NCT02417064|7580624|FG002|Follow-up Phase (24 Weeks)|Other|3
4678891|NCT02417233|7580645|FG000|Overall Study|Death|4
4678892|NCT02417233|7580646|FG001|Overall Study|Death|10
4678893|NCT02417233|7580647|FG002|Overall Study|Death|14
4678894|NCT02417233|7580645|FG000|Overall Study|Lost to Follow-up|27
4678895|NCT02417233|7580646|FG001|Overall Study|Lost to Follow-up|39
4678896|NCT02417233|7580647|FG002|Overall Study|Lost to Follow-up|34
4678897|NCT02417233|7580645|FG000|Overall Study|Protocol Violation|2
4678898|NCT02417233|7580646|FG001|Overall Study|Protocol Violation|0
4678899|NCT02417233|7580647|FG002|Overall Study|Protocol Violation|2
4678900|NCT02417233|7580645|FG000|Overall Study|Withdrawal by Subject|2
4678901|NCT02417233|7580646|FG001|Overall Study|Withdrawal by Subject|1
4678902|NCT02417233|7580647|FG002|Overall Study|Withdrawal by Subject|8
4678903|NCT02417233|7580645|FG000|Overall Study|Relocation out of study area|1
4678904|NCT02417233|7580646|FG001|Overall Study|Relocation out of study area|0
4678905|NCT02417233|7580647|FG002|Overall Study|Relocation out of study area|1
4678906|NCT02417233|7580645|FG000|Overall Study|Mentally unstable|0
4678907|NCT02417233|7580646|FG001|Overall Study|Mentally unstable|1
4678908|NCT02417233|7580647|FG002|Overall Study|Mentally unstable|0
4678909|NCT02417246|7580658|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1
4678910|NCT02417246|7580659|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1
4678911|NCT02417246|7580658|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1
4678912|NCT02417246|7580659|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0
4678913|NCT02417246|7580658|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2
4678914|NCT02417246|7580659|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3
4678915|NCT02417246|7580658|FG000|Phase 2 1st Generic Administered|Physician Decision|1
4678916|NCT02417246|7580659|FG001|Phase 2 1st Generic Administered|Physician Decision|0
4678917|NCT02417441|7580678|FG000|Overall Study|Inconclusive due to missing data|52
4678918|NCT02417441|7580679|FG001|Overall Study|Inconclusive due to missing data|19
4678919|NCT02417753|7580692|FG000|Overall Study|Death|1
4678920|NCT02417935|7580712|FG000|Treatment Period|Adverse Event|12
4678921|NCT02417935|7580713|FG001|Treatment Period|Adverse Event|10
4678922|NCT02417935|7580712|FG000|Treatment Period|Lost to Follow-up|1
4678923|NCT02417935|7580713|FG001|Treatment Period|Lost to Follow-up|0
4678924|NCT02417935|7580712|FG000|Treatment Period|Entry Criteria not met|0
4678925|NCT02417935|7580713|FG001|Treatment Period|Entry Criteria not met|1
4678926|NCT02417935|7580712|FG000|Treatment Period|Protocol Violation|2
4678927|NCT02417935|7580713|FG001|Treatment Period|Protocol Violation|1
4678928|NCT02417935|7580712|FG000|Treatment Period|Withdrawal by Subject|3
4678929|NCT02417935|7580713|FG001|Treatment Period|Withdrawal by Subject|3
4678930|NCT02417935|7580712|FG000|Treatment Period|Physician Decision|3
4678931|NCT02417935|7580713|FG001|Treatment Period|Physician Decision|1
4678932|NCT02417961|7580719|FG000|Overall Study|Adverse Event|1
4678933|NCT02417961|7580719|FG000|Overall Study|Lost to Follow-up|1
4678934|NCT02417961|7580719|FG000|Overall Study|Withdrawal by Subject|2
4678935|NCT02418000|7580728|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2
4678936|NCT02418000|7580729|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
4678937|NCT02418000|7580730|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
4678938|NCT02418000|7580731|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
4678939|NCT02418000|7580732|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
4678940|NCT02418000|7580728|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4
4678941|NCT02418000|7580729|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
4678942|NCT02418000|7580730|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
4678943|NCT02418000|7580731|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
4678944|NCT02418000|7580732|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
4678945|NCT02418000|7580728|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1
4678946|NCT02418000|7580729|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
4678947|NCT02418000|7580730|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
4678948|NCT02418000|7580731|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
4678949|NCT02418000|7580732|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
4678950|NCT02418000|7580728|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
4678951|NCT02418000|7580729|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1
4678952|NCT02418000|7580730|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
4678953|NCT02418000|7580731|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
4678954|NCT02418000|7580732|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
4678955|NCT02418000|7580728|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
4678956|NCT02418000|7580729|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9
4678957|NCT02418000|7580730|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
4678958|NCT02418000|7580731|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
4678959|NCT02418000|7580732|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
4757994|NCT03249714|7732297|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1
4757995|NCT03249714|7732296|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1
4757996|NCT03249714|7732297|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1
4757997|NCT03249714|7732296|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1
4757998|NCT03249714|7732297|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0
4757999|NCT03249714|7732296|FG000|Open-label Treatment (Extension Part)|Adverse Event|2
4758000|NCT03249714|7732297|FG001|Open-label Treatment (Extension Part)|Adverse Event|0
4758001|NCT03219333|7732321|FG000|Overall Study|Withdrawal by Subject|8
4758002|NCT03219333|7732322|FG001|Overall Study|Withdrawal by Subject|3
4758003|NCT03219333|7732321|FG000|Overall Study|Lost to Follow-up|1
4758004|NCT03219333|7732322|FG001|Overall Study|Lost to Follow-up|0
4758005|NCT03219333|7732321|FG000|Overall Study|Death|94
4758006|NCT03219333|7732322|FG001|Overall Study|Death|44
4758007|NCT03219333|7732321|FG000|Overall Study|Includes 4 participants who were enrolled and never received study treatment.|2
4758008|NCT03219333|7732322|FG001|Overall Study|Includes 4 participants who were enrolled and never received study treatment.|2
4758009|NCT03170882|7732330|FG000|Overall Study|Ongoing|10
4758010|NCT03170882|7732331|FG001|Overall Study|Ongoing|14
4758011|NCT03170882|7732330|FG000|Overall Study|Death|15
4758012|NCT03170882|7732331|FG001|Overall Study|Death|29
4758013|NCT03170882|7732330|FG000|Overall Study|Lost to Follow-up|0
4758014|NCT03170882|7732331|FG001|Overall Study|Lost to Follow-up|1
4758015|NCT03170882|7732330|FG000|Overall Study|Withdrawal by Subject|4
4758016|NCT03170882|7732331|FG001|Overall Study|Withdrawal by Subject|6
4758017|NCT03170882|7732330|FG000|Overall Study|Reason not Specified|0
4758018|NCT03170882|7732331|FG001|Overall Study|Reason not Specified|1
4758019|NCT03074318|7732341|FG000|Overall Study|Adverse Event|0
4758020|NCT03074318|7732342|FG001|Overall Study|Adverse Event|1
4758021|NCT03074318|7732343|FG002|Overall Study|Adverse Event|1
4758022|NCT03074318|7732344|FG003|Overall Study|Adverse Event|1
4758023|NCT03074318|7732341|FG000|Overall Study|Death|1
4678960|NCT02418000|7580728|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
4678961|NCT02418000|7580729|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
4678962|NCT02418000|7580730|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3
4678963|NCT02418000|7580731|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
4678964|NCT02418000|7580732|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
4678965|NCT02418000|7580728|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
4678966|NCT02418000|7580729|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
4678967|NCT02418000|7580730|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
4678968|NCT02418000|7580731|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3
4678969|NCT02418000|7580732|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
4678970|NCT02418000|7580728|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
4678971|NCT02418000|7580729|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
4678972|NCT02418000|7580730|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
4758024|NCT03074318|7732342|FG001|Overall Study|Death|0
4758025|NCT03074318|7732343|FG002|Overall Study|Death|0
4758026|NCT03074318|7732344|FG003|Overall Study|Death|0
4758027|NCT03074318|7732341|FG000|Overall Study|Withdrawal by Subject|1
4758028|NCT03074318|7732342|FG001|Overall Study|Withdrawal by Subject|2
4758029|NCT03074318|7732343|FG002|Overall Study|Withdrawal by Subject|2
4758030|NCT03074318|7732344|FG003|Overall Study|Withdrawal by Subject|4
4758031|NCT03074318|7732341|FG000|Overall Study|Trial Closure|2
4758032|NCT03074318|7732342|FG001|Overall Study|Trial Closure|2
4758033|NCT03074318|7732343|FG002|Overall Study|Trial Closure|3
4758034|NCT03074318|7732344|FG003|Overall Study|Trial Closure|11
4758035|NCT03052608|7732365|FG000|Treatment Phase|Adverse Event|10
4758036|NCT03052608|7732366|FG001|Treatment Phase|Adverse Event|12
4758037|NCT03052608|7732365|FG000|Treatment Phase|Death|6
4758038|NCT03052608|7732366|FG001|Treatment Phase|Death|4
4758039|NCT03052608|7732365|FG000|Treatment Phase|Withdrawal by Subject|4
4758040|NCT03052608|7732366|FG001|Treatment Phase|Withdrawal by Subject|12
4758041|NCT03052608|7732365|FG000|Treatment Phase|Global Deterioration of Health Status|0
4758042|NCT03052608|7732366|FG001|Treatment Phase|Global Deterioration of Health Status|3
4758043|NCT03052608|7732365|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0
4758044|NCT03052608|7732366|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1
4758045|NCT03052608|7732365|FG000|Treatment Phase|Subject didn't receive study treatment.|0
4758046|NCT03052608|7732366|FG001|Treatment Phase|Subject didn't receive study treatment.|1
4758047|NCT03052608|7732365|FG000|Treatment Phase|Ongoing|103
4758048|NCT03052608|7732366|FG001|Treatment Phase|Ongoing|31
4758049|NCT03052608|7732365|FG000|Long-Term Follow-up Phase|Death|23
4758050|NCT03052608|7732366|FG001|Long-Term Follow-up Phase|Death|28
4758051|NCT03052608|7732365|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0
4758052|NCT03052608|7732366|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2
4758053|NCT03052608|7732365|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4
4758054|NCT03052608|7732366|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18
4758055|NCT03052608|7732365|FG000|Long-Term Follow-up Phase|Ongoing|122
4758056|NCT03052608|7732366|FG001|Long-Term Follow-up Phase|Ongoing|99
4758057|NCT03010319|7732374|FG000|Overall Study|Adverse Event|15
4758058|NCT03010319|7732375|FG001|Overall Study|Adverse Event|9
4758059|NCT03010319|7732374|FG000|Overall Study|Withdrawal by Subject|1
4758060|NCT03010319|7732375|FG001|Overall Study|Withdrawal by Subject|6
4758061|NCT03010319|7732374|FG000|Overall Study|Physician Decision|2
4758062|NCT03010319|7732375|FG001|Overall Study|Physician Decision|4
4758063|NCT03010319|7732374|FG000|Overall Study|Sponsor requested withdrawal|2
4758064|NCT03010319|7732375|FG001|Overall Study|Sponsor requested withdrawal|2
4758065|NCT03010319|7732374|FG000|Overall Study|Death|1
4758066|NCT03010319|7732375|FG001|Overall Study|Death|0
4758067|NCT03010319|7732374|FG000|Overall Study|Lost to Follow-up|0
4758068|NCT03010319|7732375|FG001|Overall Study|Lost to Follow-up|1
4758069|NCT03010319|7732374|FG000|Overall Study|Other Reason|5
4758070|NCT03010319|7732375|FG001|Overall Study|Other Reason|7
4758071|NCT02915016|7732389|FG000|Overall Study|Lost to Follow-up|4
4758072|NCT02915016|7732390|FG001|Overall Study|Lost to Follow-up|2
4758073|NCT02915016|7732391|FG002|Overall Study|Lost to Follow-up|5
4758074|NCT02915016|7732392|FG003|Overall Study|Lost to Follow-up|3
4678973|NCT02418000|7580731|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
4678974|NCT02418000|7580732|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1
4678975|NCT02418000|7580728|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
4678976|NCT02418000|7580729|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
4678977|NCT02418000|7580730|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
4678978|NCT02418000|7580731|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
4678979|NCT02418000|7580732|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3
4678980|NCT02418156|7580765|FG000|Overall Study|Lost to Follow-up|12
4678981|NCT02418156|7580765|FG000|Overall Study|Death|2
4758075|NCT02915016|7732393|FG004|Overall Study|Lost to Follow-up|5
4758076|NCT02915016|7732394|FG005|Overall Study|Lost to Follow-up|2
4758077|NCT02915016|7732395|FG006|Overall Study|Lost to Follow-up|8
4758078|NCT02915016|7732396|FG007|Overall Study|Lost to Follow-up|2
4758079|NCT02915016|7732389|FG000|Overall Study|Physician Decision|0
4758080|NCT02915016|7732390|FG001|Overall Study|Physician Decision|0
4678982|NCT02418156|7580765|FG000|Overall Study|Physician Decision|1
4678983|NCT02418156|7580765|FG000|Overall Study|Withdrawal by Subject|1
4678984|NCT02418156|7580765|FG000|Overall Study|Subject refused to return|1
4678985|NCT02418182|7580771|FG000|Overall Study|Unable to re-consent|18
4678986|NCT02418182|7580772|FG001|Overall Study|Unable to re-consent|15
4678987|NCT02418182|7580771|FG000|Overall Study|Lost to Follow-up|0
4678988|NCT02418182|7580772|FG001|Overall Study|Lost to Follow-up|2
4678989|NCT02418455|7580795|FG000|48-Week Treatment Period|Other- Not Specified|1
4678990|NCT02418455|7580795|FG000|Continuation Period|Sponsor Decision|7
4678991|NCT02418468|7580803|FG000|Overall Study|Adverse Event|1
4678992|NCT02418468|7580804|FG001|Overall Study|Adverse Event|0
4678993|NCT02418468|7580803|FG000|Overall Study|Withdrawal of informed consent|1
4678994|NCT02418468|7580804|FG001|Overall Study|Withdrawal of informed consent|1
4678995|NCT02418585|7580825|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1
4678996|NCT02418585|7580826|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1
4678997|NCT02418585|7580825|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2
4678998|NCT02418585|7580826|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2
4678999|NCT02418585|7580825|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4
4679000|NCT02418585|7580826|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7
4679001|NCT02418585|7580825|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2
4679002|NCT02418585|7580826|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0
4679003|NCT02418585|7580825|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9
4679004|NCT02418585|7580826|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1
4679005|NCT02418585|7580825|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0
4679006|NCT02418585|7580826|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1
4679007|NCT02418585|7580825|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3
4679008|NCT02418585|7580826|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3
4679009|NCT02418585|7580825|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6
4758081|NCT02915016|7732391|FG002|Overall Study|Physician Decision|1
4758082|NCT02915016|7732392|FG003|Overall Study|Physician Decision|0
4758083|NCT02915016|7732393|FG004|Overall Study|Physician Decision|0
4758084|NCT02915016|7732394|FG005|Overall Study|Physician Decision|1
4758085|NCT02915016|7732395|FG006|Overall Study|Physician Decision|2
4758086|NCT02915016|7732396|FG007|Overall Study|Physician Decision|0
4758087|NCT02915016|7732389|FG000|Overall Study|Withdrawal by Subject|2
4758088|NCT02915016|7732390|FG001|Overall Study|Withdrawal by Subject|0
4758089|NCT02915016|7732391|FG002|Overall Study|Withdrawal by Subject|1
4758090|NCT02915016|7732392|FG003|Overall Study|Withdrawal by Subject|0
4758091|NCT02915016|7732393|FG004|Overall Study|Withdrawal by Subject|1
4758092|NCT02915016|7732394|FG005|Overall Study|Withdrawal by Subject|3
4758093|NCT02915016|7732395|FG006|Overall Study|Withdrawal by Subject|1
4758094|NCT02915016|7732396|FG007|Overall Study|Withdrawal by Subject|1
4758095|NCT02915016|7732389|FG000|Overall Study|Elected not to continue|0
4758096|NCT02915016|7732390|FG001|Overall Study|Elected not to continue|0
4758097|NCT02915016|7732391|FG002|Overall Study|Elected not to continue|0
4758098|NCT02915016|7732392|FG003|Overall Study|Elected not to continue|1
4758099|NCT02915016|7732393|FG004|Overall Study|Elected not to continue|0
4758100|NCT02915016|7732394|FG005|Overall Study|Elected not to continue|0
4758101|NCT02915016|7732395|FG006|Overall Study|Elected not to continue|1
4758102|NCT02915016|7732396|FG007|Overall Study|Elected not to continue|0
4758103|NCT02915016|7732389|FG000|Overall Study|HIV infection|1
4758104|NCT02915016|7732390|FG001|Overall Study|HIV infection|1
4758105|NCT02915016|7732391|FG002|Overall Study|HIV infection|1
4758106|NCT02915016|7732392|FG003|Overall Study|HIV infection|0
4758107|NCT02915016|7732393|FG004|Overall Study|HIV infection|1
4758108|NCT02915016|7732394|FG005|Overall Study|HIV infection|0
4758109|NCT02915016|7732395|FG006|Overall Study|HIV infection|0
4758110|NCT02915016|7732396|FG007|Overall Study|HIV infection|0
4758111|NCT02915016|7732389|FG000|Overall Study|Participant unable to adhere|0
4758112|NCT02915016|7732390|FG001|Overall Study|Participant unable to adhere|0
4758113|NCT02915016|7732391|FG002|Overall Study|Participant unable to adhere|0
4758114|NCT02915016|7732392|FG003|Overall Study|Participant unable to adhere|0
4758115|NCT02915016|7732393|FG004|Overall Study|Participant unable to adhere|0
4758116|NCT02915016|7732394|FG005|Overall Study|Participant unable to adhere|0
4758117|NCT02915016|7732395|FG006|Overall Study|Participant unable to adhere|0
4758118|NCT02915016|7732396|FG007|Overall Study|Participant unable to adhere|1
4758119|NCT02871401|7732416|FG000|Overall Study|Adverse Event|1
4758120|NCT02871401|7732417|FG001|Overall Study|Adverse Event|0
4758121|NCT02701283|7732435|FG000|Overall Study|Death|25
4758122|NCT02701283|7732436|FG001|Overall Study|Death|29
4679010|NCT02418585|7580826|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3
4679011|NCT02418585|7580825|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6
4679012|NCT02418585|7580826|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17
4679013|NCT02418585|7580825|FG000|Follow-up Phase (24 Weeks)|Other|3
4679014|NCT02418585|7580826|FG001|Follow-up Phase (24 Weeks)|Other|2
4679015|NCT02418754|7580850|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0
4679016|NCT02418754|7580851|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2
4758123|NCT02701283|7732437|FG002|Overall Study|Death|19
4679017|NCT02418754|7580852|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0
4758124|NCT02701283|7732435|FG000|Overall Study|Lost to Follow-up|3
4758125|NCT02701283|7732436|FG001|Overall Study|Lost to Follow-up|8
4679018|NCT02418754|7580853|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0
4679019|NCT02418754|7580854|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0
4679020|NCT02418754|7580850|FG000|Period 1 (Day 1 to Week 12)|Death|1
4679021|NCT02418754|7580851|FG001|Period 1 (Day 1 to Week 12)|Death|0
4679022|NCT02418754|7580852|FG002|Period 1 (Day 1 to Week 12)|Death|0
4679023|NCT02418754|7580853|FG003|Period 1 (Day 1 to Week 12)|Death|0
4679024|NCT02418754|7580854|FG004|Period 1 (Day 1 to Week 12)|Death|0
4679025|NCT02418754|7580850|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1
4679026|NCT02418754|7580851|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0
4679027|NCT02418754|7580852|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0
4679028|NCT02418754|7580853|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0
4679029|NCT02418754|7580854|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0
4679030|NCT02418754|7580850|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0
4679031|NCT02418754|7580851|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2
4679032|NCT02418754|7580852|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1
4679033|NCT02418754|7580853|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0
4679034|NCT02418754|7580854|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0
4679035|NCT02418754|7580850|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0
4679036|NCT02418754|7580851|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0
4679037|NCT02418754|7580852|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1
4679038|NCT02418754|7580853|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0
4679039|NCT02418754|7580854|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0
4679040|NCT02418754|7580850|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3
4679041|NCT02418754|7580851|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7
4679042|NCT02418754|7580852|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6
4679043|NCT02418754|7580853|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2
4679044|NCT02418754|7580854|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2
4679045|NCT02418754|7580850|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1
4679046|NCT02418754|7580851|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0
4679047|NCT02418754|7580852|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0
4679048|NCT02418754|7580853|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0
4679049|NCT02418754|7580854|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0
4679050|NCT02418754|7580850|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26
4679051|NCT02418754|7580851|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28
4679052|NCT02418754|7580852|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26
4679053|NCT02418754|7580853|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21
4679054|NCT02418754|7580854|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24
4679055|NCT02418754|7580850|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3
4679056|NCT02418754|7580851|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4
4679057|NCT02418754|7580852|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4
4679058|NCT02418754|7580853|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1
4679059|NCT02418754|7580854|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0
4679060|NCT02418754|7580850|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0
4679061|NCT02418754|7580851|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2
4679062|NCT02418754|7580852|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1
4679063|NCT02418754|7580853|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2
4679064|NCT02418754|7580854|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1
4679065|NCT02418754|7580850|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0
4679066|NCT02418754|7580851|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1
4679067|NCT02418754|7580852|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0
4679068|NCT02418754|7580853|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1
4679069|NCT02418754|7580854|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0
4679070|NCT02418819|7580868|FG000|Overall Study|Adverse Event|0
4679071|NCT02418819|7580869|FG001|Overall Study|Adverse Event|0
4679072|NCT02418819|7580870|FG002|Overall Study|Adverse Event|1
4679073|NCT02418819|7580871|FG003|Overall Study|Adverse Event|0
4679074|NCT02418819|7580868|FG000|Overall Study|Lost to Follow-up|1
4679075|NCT02418819|7580869|FG001|Overall Study|Lost to Follow-up|0
4679076|NCT02418819|7580870|FG002|Overall Study|Lost to Follow-up|0
4679077|NCT02418819|7580871|FG003|Overall Study|Lost to Follow-up|0
4679078|NCT02418819|7580868|FG000|Overall Study|No longer meets eligibility criteria|0
4679079|NCT02418819|7580869|FG001|Overall Study|No longer meets eligibility criteria|0
4679080|NCT02418819|7580870|FG002|Overall Study|No longer meets eligibility criteria|1
4679081|NCT02418819|7580871|FG003|Overall Study|No longer meets eligibility criteria|0
4679082|NCT02418819|7580868|FG000|Overall Study|No longer willing to participate|0
4679083|NCT02418819|7580869|FG001|Overall Study|No longer willing to participate|0
4679084|NCT02418819|7580870|FG002|Overall Study|No longer willing to participate|2
4679085|NCT02418819|7580871|FG003|Overall Study|No longer willing to participate|1
4679086|NCT02418845|7580883|FG000|Overall Study|Lost to Follow-up|7
4679087|NCT02418845|7580884|FG001|Overall Study|Lost to Follow-up|2
4679088|NCT02418845|7580883|FG000|Overall Study|Lack of Efficacy|0
4679089|NCT02418845|7580884|FG001|Overall Study|Lack of Efficacy|3
4679090|NCT02418845|7580883|FG000|Overall Study|Physician Decision|5
4679091|NCT02418845|7580884|FG001|Overall Study|Physician Decision|5
4679092|NCT02418845|7580883|FG000|Overall Study|Protocol Violation|1
4679093|NCT02418845|7580884|FG001|Overall Study|Protocol Violation|0
4679094|NCT02418845|7580883|FG000|Overall Study|Withdrawal by Subject|3
4679095|NCT02418845|7580884|FG001|Overall Study|Withdrawal by Subject|2
4679096|NCT02418910|7580890|FG000|Overall Study|Lost to Follow-up|3
4679097|NCT02418910|7580890|FG000|Overall Study|Withdrawal by Subject|4
4679098|NCT02418949|7580898|FG000|Overall Study|Withdrawal by Subject|1
4679099|NCT02418949|7580899|FG001|Overall Study|Withdrawal by Subject|0
4679100|NCT02418949|7580900|FG002|Overall Study|Withdrawal by Subject|1
4679101|NCT02418949|7580901|FG003|Overall Study|Withdrawal by Subject|1
4758126|NCT02701283|7732437|FG002|Overall Study|Lost to Follow-up|1
4758127|NCT02701283|7732435|FG000|Overall Study|Withdrawal by Subject|12
4758128|NCT02701283|7732436|FG001|Overall Study|Withdrawal by Subject|41
4758129|NCT02701283|7732437|FG002|Overall Study|Withdrawal by Subject|1
4758130|NCT02701283|7732435|FG000|Overall Study|Missed 2-year visit|22
4758131|NCT02701283|7732436|FG001|Overall Study|Missed 2-year visit|27
4758132|NCT02701283|7732437|FG002|Overall Study|Missed 2-year visit|0
4758133|NCT02701283|7732435|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7
4758134|NCT02701283|7732436|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57
4758135|NCT02701283|7732437|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0
4758136|NCT02696031|7732451|FG000|Up to Week 24|Adverse Event|2
4758137|NCT02696031|7732452|FG001|Up to Week 24|Adverse Event|4
4758138|NCT02696031|7732453|FG002|Up to Week 24|Adverse Event|2
4758139|NCT02696031|7732454|FG003|Up to Week 24|Adverse Event|0
4758140|NCT02696031|7732455|FG004|Up to Week 24|Adverse Event|0
4758141|NCT02696031|7732456|FG005|Up to Week 24|Adverse Event|0
4758142|NCT02696031|7732451|FG000|Up to Week 24|Lack of Efficacy|2
4758143|NCT02696031|7732452|FG001|Up to Week 24|Lack of Efficacy|1
4758144|NCT02696031|7732453|FG002|Up to Week 24|Lack of Efficacy|2
4758145|NCT02696031|7732454|FG003|Up to Week 24|Lack of Efficacy|0
4758146|NCT02696031|7732455|FG004|Up to Week 24|Lack of Efficacy|0
4758147|NCT02696031|7732456|FG005|Up to Week 24|Lack of Efficacy|0
4758148|NCT02696031|7732451|FG000|Up to Week 24|Lost to Follow-up|0
4758149|NCT02696031|7732452|FG001|Up to Week 24|Lost to Follow-up|1
4758150|NCT02696031|7732453|FG002|Up to Week 24|Lost to Follow-up|1
4758151|NCT02696031|7732454|FG003|Up to Week 24|Lost to Follow-up|0
4758152|NCT02696031|7732455|FG004|Up to Week 24|Lost to Follow-up|0
4758153|NCT02696031|7732456|FG005|Up to Week 24|Lost to Follow-up|0
4758154|NCT02696031|7732451|FG000|Up to Week 24|Physician Decision|1
4758155|NCT02696031|7732452|FG001|Up to Week 24|Physician Decision|0
4758156|NCT02696031|7732453|FG002|Up to Week 24|Physician Decision|1
4758157|NCT02696031|7732454|FG003|Up to Week 24|Physician Decision|0
4758158|NCT02696031|7732455|FG004|Up to Week 24|Physician Decision|0
4758159|NCT02696031|7732456|FG005|Up to Week 24|Physician Decision|0
4758160|NCT02696031|7732451|FG000|Up to Week 24|Protocol Violation|1
4758161|NCT02696031|7732452|FG001|Up to Week 24|Protocol Violation|0
4758162|NCT02696031|7732453|FG002|Up to Week 24|Protocol Violation|0
4679102|NCT02418949|7580898|FG000|Overall Study|Lost to Follow-up|1
4679103|NCT02418949|7580899|FG001|Overall Study|Lost to Follow-up|0
4679104|NCT02418949|7580900|FG002|Overall Study|Lost to Follow-up|1
4679105|NCT02418949|7580901|FG003|Overall Study|Lost to Follow-up|0
4679106|NCT02418949|7580898|FG000|Overall Study|Physician Decision|1
4679107|NCT02418949|7580899|FG001|Overall Study|Physician Decision|1
4679108|NCT02418949|7580900|FG002|Overall Study|Physician Decision|1
4679109|NCT02418949|7580901|FG003|Overall Study|Physician Decision|0
4679110|NCT02419001|7580913|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1
4679111|NCT02419001|7580914|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0
4679112|NCT02419313|7580920|FG000|First Intervention|Lost to Follow-up|2
4679113|NCT02419313|7580921|FG001|First Intervention|Lost to Follow-up|0
4679114|NCT02419313|7580920|FG000|Second Intervention|Lost to Follow-up|1
4679115|NCT02419313|7580921|FG001|Second Intervention|Lost to Follow-up|0
4679116|NCT02419469|7580927|FG000|Overall Study|Withdrawal by Subject|1
4679117|NCT02419508|7580933|FG000|Overall Study|Adverse Event|9
4679118|NCT02419508|7580934|FG001|Overall Study|Adverse Event|3
4679119|NCT02419508|7580933|FG000|Overall Study|Withdrawal by Subject|1
4679120|NCT02419508|7580934|FG001|Overall Study|Withdrawal by Subject|0
4679121|NCT02419508|7580933|FG000|Overall Study|Other - Reason not specified|0
4679122|NCT02419508|7580934|FG001|Overall Study|Other - Reason not specified|1
4679123|NCT02419573|7580950|FG000|Overall Study|Lost to Follow-up|3
4679124|NCT02419573|7580951|FG001|Overall Study|Lost to Follow-up|0
4679125|NCT02419573|7580950|FG000|Overall Study|Withdrawal by Subject|1
4679126|NCT02419573|7580951|FG001|Overall Study|Withdrawal by Subject|0
4679127|NCT02419612|7580959|FG000|Short-term Treatment Period|Adverse Event|1
4679128|NCT02419612|7580960|FG001|Short-term Treatment Period|Adverse Event|1
4679129|NCT02419612|7580959|FG000|Short-term Treatment Period|Death|0
4679130|NCT02419612|7580960|FG001|Short-term Treatment Period|Death|2
4679131|NCT02419612|7580959|FG000|Short-term Treatment Period|Lost to Follow-up|6
4679132|NCT02419612|7580960|FG001|Short-term Treatment Period|Lost to Follow-up|6
4758163|NCT02696031|7732454|FG003|Up to Week 24|Protocol Violation|0
4758164|NCT02696031|7732455|FG004|Up to Week 24|Protocol Violation|0
4758165|NCT02696031|7732456|FG005|Up to Week 24|Protocol Violation|0
4758166|NCT02696031|7732451|FG000|Up to Week 24|Withdrawal by Subject|4
4679133|NCT02419612|7580959|FG000|Short-term Treatment Period|Withdrawal by Subject|9
4679134|NCT02419612|7580960|FG001|Short-term Treatment Period|Withdrawal by Subject|9
4679135|NCT02419612|7580959|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1
4679136|NCT02419612|7580960|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1
4679137|NCT02419612|7580959|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0
4679138|NCT02419612|7580960|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2
4679139|NCT02419612|7580959|FG000|Short-term Treatment Period|Worsening of liver function|0
4679140|NCT02419612|7580960|FG001|Short-term Treatment Period|Worsening of liver function|1
4679141|NCT02419612|7580959|FG000|Short-term Treatment Period|Subject moved out of state|0
4679142|NCT02419612|7580960|FG001|Short-term Treatment Period|Subject moved out of state|1
4679143|NCT02419612|7580959|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1
4679144|NCT02419612|7580960|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1
4679145|NCT02419612|7580959|FG000|Long-term Treatment Period|Lost to Follow-up|6
4679146|NCT02419612|7580960|FG001|Long-term Treatment Period|Lost to Follow-up|4
4679147|NCT02419612|7580959|FG000|Long-term Treatment Period|Lack of Efficacy|1
4679148|NCT02419612|7580960|FG001|Long-term Treatment Period|Lack of Efficacy|1
4679149|NCT02419612|7580959|FG000|Long-term Treatment Period|Death|0
4679150|NCT02419612|7580960|FG001|Long-term Treatment Period|Death|1
4679151|NCT02419612|7580959|FG000|Long-term Treatment Period|Adverse Event|0
4679152|NCT02419612|7580960|FG001|Long-term Treatment Period|Adverse Event|5
4679153|NCT02419612|7580959|FG000|Long-term Treatment Period|Other|4
4679154|NCT02419612|7580960|FG001|Long-term Treatment Period|Other|4
4679155|NCT02419612|7580959|FG000|Long-term Treatment Period|Subject Decision|2
4679156|NCT02419612|7580960|FG001|Long-term Treatment Period|Subject Decision|4
4679157|NCT02419612|7580959|FG000|Long-term Treatment Period|Withdrawal by Subject|8
4679158|NCT02419612|7580960|FG001|Long-term Treatment Period|Withdrawal by Subject|2
4679159|NCT02419755|7580977|FG000|Overall Study|Death|1
4679160|NCT02419755|7580978|FG001|Overall Study|Death|3
4679161|NCT02419755|7580977|FG000|Overall Study|Relapse|0
4679162|NCT02419755|7580978|FG001|Overall Study|Relapse|1
4679163|NCT02419755|7580977|FG000|Overall Study|Ineligible|1
4679164|NCT02419755|7580978|FG001|Overall Study|Ineligible|0
4679165|NCT02419755|7580977|FG000|Overall Study|Withdrawal by Subject|1
4679166|NCT02419755|7580978|FG001|Overall Study|Withdrawal by Subject|0
4679167|NCT02419807|7580984|FG000|Overall Study|Withdrawal by Subject|4
4679168|NCT02419807|7580984|FG000|Overall Study|Physician Decision|1
4679169|NCT02419807|7580984|FG000|Overall Study|Protocol Violation|5
4679170|NCT02419937|7580994|FG000|Overall Study|Lost to Follow-up|1
4679171|NCT02419937|7580995|FG001|Overall Study|Lost to Follow-up|0
4679172|NCT02420093|7581021|FG000|Overall Study|Withdrawal by Subject|1
4679173|NCT02420093|7581022|FG001|Overall Study|Withdrawal by Subject|1
4679174|NCT02420223|7581034|FG000|Overall Study|Adverse Event|1
4679175|NCT02420223|7581035|FG001|Overall Study|Adverse Event|0
4679176|NCT02420223|7581034|FG000|Overall Study|Physician Decision|0
4679177|NCT02420223|7581035|FG001|Overall Study|Physician Decision|2
4679178|NCT02420262|7581043|FG000|Overall Study|Adverse Event|1
4679179|NCT02420262|7581044|FG001|Overall Study|Adverse Event|0
4679180|NCT02420262|7581043|FG000|Overall Study|Withdrawal by Subject|1
4679181|NCT02420262|7581044|FG001|Overall Study|Withdrawal by Subject|4
4679182|NCT02420262|7581043|FG000|Overall Study|Unclassified|0
4679183|NCT02420262|7581044|FG001|Overall Study|Unclassified|1
4679184|NCT02420327|7581050|FG000|Overall Study|Adverse Event|7
4679185|NCT02420327|7581050|FG000|Overall Study|Pregnancy|1
4679186|NCT02420327|7581050|FG000|Overall Study|Withdrawal by Subject|6
4679187|NCT02420327|7581050|FG000|Overall Study|Lost to Follow-up|1
4679188|NCT02420327|7581050|FG000|Overall Study|Protocol Violation|1
4758167|NCT02696031|7732452|FG001|Up to Week 24|Withdrawal by Subject|1
4758168|NCT02696031|7732453|FG002|Up to Week 24|Withdrawal by Subject|5
4758169|NCT02696031|7732454|FG003|Up to Week 24|Withdrawal by Subject|0
4758170|NCT02696031|7732455|FG004|Up to Week 24|Withdrawal by Subject|0
4758171|NCT02696031|7732456|FG005|Up to Week 24|Withdrawal by Subject|0
4758172|NCT02696031|7732451|FG000|Up to Week 52|Adverse Event|4
4758173|NCT02696031|7732452|FG001|Up to Week 52|Adverse Event|5
4758174|NCT02696031|7732453|FG002|Up to Week 52|Adverse Event|3
4758175|NCT02696031|7732454|FG003|Up to Week 52|Adverse Event|0
4758176|NCT02696031|7732455|FG004|Up to Week 52|Adverse Event|0
4758177|NCT02696031|7732456|FG005|Up to Week 52|Adverse Event|0
4758178|NCT02696031|7732451|FG000|Up to Week 52|Lack of Efficacy|10
4758179|NCT02696031|7732452|FG001|Up to Week 52|Lack of Efficacy|7
4758180|NCT02696031|7732453|FG002|Up to Week 52|Lack of Efficacy|11
4758181|NCT02696031|7732454|FG003|Up to Week 52|Lack of Efficacy|0
4758182|NCT02696031|7732455|FG004|Up to Week 52|Lack of Efficacy|0
4758183|NCT02696031|7732456|FG005|Up to Week 52|Lack of Efficacy|0
4758184|NCT02696031|7732451|FG000|Up to Week 52|Lost to Follow-up|1
4758185|NCT02696031|7732452|FG001|Up to Week 52|Lost to Follow-up|1
4758186|NCT02696031|7732453|FG002|Up to Week 52|Lost to Follow-up|1
4758187|NCT02696031|7732454|FG003|Up to Week 52|Lost to Follow-up|0
4758188|NCT02696031|7732455|FG004|Up to Week 52|Lost to Follow-up|0
4758189|NCT02696031|7732456|FG005|Up to Week 52|Lost to Follow-up|0
4758190|NCT02696031|7732451|FG000|Up to Week 52|Physician Decision|1
4758191|NCT02696031|7732452|FG001|Up to Week 52|Physician Decision|1
4758192|NCT02696031|7732453|FG002|Up to Week 52|Physician Decision|2
4758193|NCT02696031|7732454|FG003|Up to Week 52|Physician Decision|0
4758194|NCT02696031|7732455|FG004|Up to Week 52|Physician Decision|0
4679189|NCT02420353|7581062|FG000|Overall Study|Withdrawal by Subject|0
4679190|NCT02420353|7581063|FG001|Overall Study|Withdrawal by Subject|1
4679191|NCT02420379|7581071|FG000|Overall Study|Withdrawal by Subject|0
4679192|NCT02420379|7581072|FG001|Overall Study|Withdrawal by Subject|3
4679193|NCT02420379|7581071|FG000|Overall Study|Unable to complete due to schooling|0
4679194|NCT02420379|7581072|FG001|Overall Study|Unable to complete due to schooling|1
4679195|NCT02420379|7581071|FG000|Overall Study|Transitioned to commercial drug|1
4679196|NCT02420379|7581072|FG001|Overall Study|Transitioned to commercial drug|0
4679197|NCT02420691|7581082|FG000|Overall Study|Adverse Event|3
4679198|NCT02420691|7581082|FG000|Overall Study|Withdrawal by Subject|3
4679199|NCT02421120|7581130|FG000|Overall Study|Adverse Event|1
4679200|NCT02421172|7581153|FG000|Period 1|Adverse Event|1
4679201|NCT02421172|7581154|FG001|Period 1|Adverse Event|0
4679202|NCT02421172|7581155|FG002|Period 1|Adverse Event|0
4679203|NCT02421172|7581156|FG003|Period 1|Adverse Event|0
4679204|NCT02421172|7581157|FG004|Period 1|Adverse Event|0
4679205|NCT02421172|7581153|FG000|Period 1|Lost to Follow-up|3
4679206|NCT02421172|7581154|FG001|Period 1|Lost to Follow-up|1
4679207|NCT02421172|7581155|FG002|Period 1|Lost to Follow-up|0
4679208|NCT02421172|7581156|FG003|Period 1|Lost to Follow-up|0
4679209|NCT02421172|7581157|FG004|Period 1|Lost to Follow-up|0
4679210|NCT02421172|7581153|FG000|Period 1|Patient/guardian decision|0
4679211|NCT02421172|7581154|FG001|Period 1|Patient/guardian decision|1
4679212|NCT02421172|7581155|FG002|Period 1|Patient/guardian decision|0
4679213|NCT02421172|7581156|FG003|Period 1|Patient/guardian decision|0
4758195|NCT02696031|7732456|FG005|Up to Week 52|Physician Decision|0
4758196|NCT02696031|7732451|FG000|Up to Week 52|Pregnancy|0
4758197|NCT02696031|7732452|FG001|Up to Week 52|Pregnancy|2
4758198|NCT02696031|7732453|FG002|Up to Week 52|Pregnancy|0
4758199|NCT02696031|7732454|FG003|Up to Week 52|Pregnancy|0
4758200|NCT02696031|7732455|FG004|Up to Week 52|Pregnancy|0
4758201|NCT02696031|7732456|FG005|Up to Week 52|Pregnancy|0
4758202|NCT02696031|7732451|FG000|Up to Week 52|Protocol Violation|1
4758203|NCT02696031|7732452|FG001|Up to Week 52|Protocol Violation|0
4758204|NCT02696031|7732453|FG002|Up to Week 52|Protocol Violation|0
4758205|NCT02696031|7732454|FG003|Up to Week 52|Protocol Violation|0
4758206|NCT02696031|7732455|FG004|Up to Week 52|Protocol Violation|0
4758207|NCT02696031|7732456|FG005|Up to Week 52|Protocol Violation|0
4758208|NCT02696031|7732451|FG000|Up to Week 52|Withdrawal by Subject|12
4758209|NCT02696031|7732452|FG001|Up to Week 52|Withdrawal by Subject|3
4758210|NCT02696031|7732453|FG002|Up to Week 52|Withdrawal by Subject|9
4758211|NCT02696031|7732454|FG003|Up to Week 52|Withdrawal by Subject|0
4758212|NCT02696031|7732455|FG004|Up to Week 52|Withdrawal by Subject|0
4758213|NCT02696031|7732456|FG005|Up to Week 52|Withdrawal by Subject|0
4758214|NCT02696031|7732451|FG000|Up to Week 104|Pregnancy|0
4758215|NCT02696031|7732452|FG001|Up to Week 104|Pregnancy|2
4758216|NCT02696031|7732453|FG002|Up to Week 104|Pregnancy|1
4758217|NCT02696031|7732454|FG003|Up to Week 104|Pregnancy|0
4758218|NCT02696031|7732455|FG004|Up to Week 104|Pregnancy|0
4758219|NCT02696031|7732456|FG005|Up to Week 104|Pregnancy|0
4758220|NCT02696031|7732451|FG000|Up to Week 104|Withdrawal by Subject|15
4758221|NCT02696031|7732452|FG001|Up to Week 104|Withdrawal by Subject|10
4758222|NCT02696031|7732453|FG002|Up to Week 104|Withdrawal by Subject|16
4758223|NCT02696031|7732454|FG003|Up to Week 104|Withdrawal by Subject|0
4758224|NCT02696031|7732455|FG004|Up to Week 104|Withdrawal by Subject|0
4758225|NCT02696031|7732456|FG005|Up to Week 104|Withdrawal by Subject|0
4758226|NCT02696031|7732451|FG000|Up to Week 104|Protocol Violation|1
4758227|NCT02696031|7732452|FG001|Up to Week 104|Protocol Violation|0
4758228|NCT02696031|7732453|FG002|Up to Week 104|Protocol Violation|0
4758229|NCT02696031|7732454|FG003|Up to Week 104|Protocol Violation|0
4758230|NCT02696031|7732455|FG004|Up to Week 104|Protocol Violation|0
4758231|NCT02696031|7732456|FG005|Up to Week 104|Protocol Violation|0
4758232|NCT02696031|7732451|FG000|Up to Week 104|Physician Decision|1
4758233|NCT02696031|7732452|FG001|Up to Week 104|Physician Decision|2
4758234|NCT02696031|7732453|FG002|Up to Week 104|Physician Decision|3
4758235|NCT02696031|7732454|FG003|Up to Week 104|Physician Decision|0
4758236|NCT02696031|7732455|FG004|Up to Week 104|Physician Decision|0
4758237|NCT02696031|7732456|FG005|Up to Week 104|Physician Decision|0
4758238|NCT02696031|7732451|FG000|Up to Week 104|Lost to Follow-up|2
4758239|NCT02696031|7732452|FG001|Up to Week 104|Lost to Follow-up|3
4758240|NCT02696031|7732453|FG002|Up to Week 104|Lost to Follow-up|1
4758241|NCT02696031|7732454|FG003|Up to Week 104|Lost to Follow-up|0
4679214|NCT02421172|7581157|FG004|Period 1|Patient/guardian decision|0
4679215|NCT02421172|7581153|FG000|Period 2|Adverse Event|0
4758242|NCT02696031|7732455|FG004|Up to Week 104|Lost to Follow-up|0
4758243|NCT02696031|7732456|FG005|Up to Week 104|Lost to Follow-up|0
4758244|NCT02696031|7732451|FG000|Up to Week 104|Lack of Efficacy|13
4679216|NCT02421172|7581154|FG001|Period 2|Adverse Event|0
4679217|NCT02421172|7581155|FG002|Period 2|Adverse Event|4
4758245|NCT02696031|7732452|FG001|Up to Week 104|Lack of Efficacy|12
4758246|NCT02696031|7732453|FG002|Up to Week 104|Lack of Efficacy|11
4758247|NCT02696031|7732454|FG003|Up to Week 104|Lack of Efficacy|0
4679218|NCT02421172|7581156|FG003|Period 2|Adverse Event|0
4679219|NCT02421172|7581157|FG004|Period 2|Adverse Event|0
4679220|NCT02421172|7581153|FG000|Period 2|Lost to Follow-up|0
4679221|NCT02421172|7581154|FG001|Period 2|Lost to Follow-up|0
4679222|NCT02421172|7581155|FG002|Period 2|Lost to Follow-up|0
4679223|NCT02421172|7581156|FG003|Period 2|Lost to Follow-up|1
4679224|NCT02421172|7581157|FG004|Period 2|Lost to Follow-up|0
4679225|NCT02421172|7581153|FG000|Period 2|Patient/guardian decision|0
4679226|NCT02421172|7581154|FG001|Period 2|Patient/guardian decision|0
4679227|NCT02421172|7581155|FG002|Period 2|Patient/guardian decision|3
4679228|NCT02421172|7581156|FG003|Period 2|Patient/guardian decision|2
4679229|NCT02421172|7581157|FG004|Period 2|Patient/guardian decision|1
4679230|NCT02421419|7581225|FG000|Overall Study|Physician Decision|0
4679231|NCT02421419|7581226|FG001|Overall Study|Physician Decision|0
4679232|NCT02421419|7581227|FG002|Overall Study|Physician Decision|1
4679233|NCT02421510|7581238|FG000|Overall Study|Other|4
4679234|NCT02421510|7581239|FG001|Overall Study|Other|2
4679235|NCT02421510|7581240|FG002|Overall Study|Other|3
4679236|NCT02421510|7581238|FG000|Overall Study|Protocol Violation|1
4679237|NCT02421510|7581239|FG001|Overall Study|Protocol Violation|2
4679238|NCT02421510|7581240|FG002|Overall Study|Protocol Violation|0
4679239|NCT02421510|7581238|FG000|Overall Study|Death|1
4679240|NCT02421510|7581239|FG001|Overall Study|Death|0
4679241|NCT02421510|7581240|FG002|Overall Study|Death|0
4679242|NCT02421510|7581238|FG000|Overall Study|Noncompliance with study drug|1
4679243|NCT02421510|7581239|FG001|Overall Study|Noncompliance with study drug|0
4679244|NCT02421510|7581240|FG002|Overall Study|Noncompliance with study drug|0
4679245|NCT02421510|7581238|FG000|Overall Study|Physician Decision|1
4679246|NCT02421510|7581239|FG001|Overall Study|Physician Decision|1
4679247|NCT02421510|7581240|FG002|Overall Study|Physician Decision|3
4679248|NCT02421510|7581238|FG000|Overall Study|Adverse Event|9
4679249|NCT02421510|7581239|FG001|Overall Study|Adverse Event|10
4679250|NCT02421510|7581240|FG002|Overall Study|Adverse Event|18
4679251|NCT02421510|7581238|FG000|Overall Study|Pregnancy|1
4679252|NCT02421510|7581239|FG001|Overall Study|Pregnancy|1
4679253|NCT02421510|7581240|FG002|Overall Study|Pregnancy|0
4679254|NCT02421510|7581238|FG000|Overall Study|Withdrawal by Subject|14
4679255|NCT02421510|7581239|FG001|Overall Study|Withdrawal by Subject|18
4679256|NCT02421510|7581240|FG002|Overall Study|Withdrawal by Subject|12
4679257|NCT02421510|7581238|FG000|Overall Study|Lost to Follow-up|1
4679258|NCT02421510|7581239|FG001|Overall Study|Lost to Follow-up|1
4679259|NCT02421510|7581240|FG002|Overall Study|Lost to Follow-up|0
4679260|NCT02421588|7581250|FG000|Overall Study|Non-treatment-related AE|8
4679261|NCT02421588|7581251|FG001|Overall Study|Non-treatment-related AE|8
4679262|NCT02421588|7581250|FG000|Overall Study|Progressive disease|152
4679263|NCT02421588|7581251|FG001|Overall Study|Progressive disease|135
4679264|NCT02421588|7581250|FG000|Overall Study|Death|11
4679265|NCT02421588|7581251|FG001|Overall Study|Death|3
4679266|NCT02421588|7581250|FG000|Overall Study|Physician Decision|8
4679267|NCT02421588|7581251|FG001|Overall Study|Physician Decision|17
4679268|NCT02421588|7581250|FG000|Overall Study|Other reason not specified|3
4679269|NCT02421588|7581251|FG001|Overall Study|Other reason not specified|1
4679270|NCT02421588|7581250|FG000|Overall Study|Symptomatic deterioration|13
4679271|NCT02421588|7581251|FG001|Overall Study|Symptomatic deterioration|19
4679272|NCT02421588|7581250|FG000|Overall Study|Treatment-related AE|10
4758248|NCT02696031|7732455|FG004|Up to Week 104|Lack of Efficacy|0
4758249|NCT02696031|7732456|FG005|Up to Week 104|Lack of Efficacy|0
4758250|NCT02696031|7732451|FG000|Up to Week 104|Adverse Event|7
4758251|NCT02696031|7732452|FG001|Up to Week 104|Adverse Event|11
4758252|NCT02696031|7732453|FG002|Up to Week 104|Adverse Event|5
4758253|NCT02696031|7732454|FG003|Up to Week 104|Adverse Event|0
4758254|NCT02696031|7732455|FG004|Up to Week 104|Adverse Event|0
4758255|NCT02696031|7732456|FG005|Up to Week 104|Adverse Event|0
4758256|NCT02696031|7732451|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0
4758257|NCT02696031|7732452|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1
4758258|NCT02696031|7732453|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0
4758259|NCT02696031|7732454|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0
4758260|NCT02696031|7732455|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0
4758261|NCT02696031|7732456|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0
4758262|NCT02696031|7732451|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0
4758263|NCT02696031|7732452|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0
4758264|NCT02696031|7732453|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0
4679273|NCT02421588|7581251|FG001|Overall Study|Treatment-related AE|14
4679274|NCT02421588|7581250|FG000|Overall Study|Withdrawal by Subject|14
4679275|NCT02421588|7581251|FG001|Overall Study|Withdrawal by Subject|16
4679276|NCT02421588|7581250|FG000|Overall Study|Not treated|2
4679277|NCT02421588|7581251|FG001|Overall Study|Not treated|8
4679278|NCT02421601|7581257|FG000|Overall Study|Adverse Event|4
4679279|NCT02421601|7581257|FG000|Overall Study|Lack of Efficacy|5
4679280|NCT02421601|7581257|FG000|Overall Study|Physician Decision|1
4679281|NCT02421601|7581257|FG000|Overall Study|Withdrawal by Subject|31
4679282|NCT02421601|7581257|FG000|Overall Study|Others|41
4679283|NCT02421666|7581263|FG000|6-month Follow-up|Lost to Follow-up|8
4679284|NCT02421666|7581264|FG001|6-month Follow-up|Lost to Follow-up|7
4679285|NCT02421666|7581263|FG000|6-month Follow-up|Withdrawal by Subject|5
4679286|NCT02421666|7581264|FG001|6-month Follow-up|Withdrawal by Subject|6
4679287|NCT02421666|7581263|FG000|12-month Follow-up|Lost to Follow-up|5
4679288|NCT02421666|7581264|FG001|12-month Follow-up|Lost to Follow-up|5
4679289|NCT02421666|7581263|FG000|12-month Follow-up|Withdrawal by Subject|6
4679290|NCT02421666|7581264|FG001|12-month Follow-up|Withdrawal by Subject|11
4679291|NCT02421887|7581281|FG000|Overall Study|Lost to Follow-up|5
4679292|NCT02421887|7581282|FG001|Overall Study|Lost to Follow-up|0
4679293|NCT02421887|7581281|FG000|Overall Study|Withdrawal by Subject|8
4679294|NCT02421887|7581282|FG001|Overall Study|Withdrawal by Subject|5
4679295|NCT02421887|7581281|FG000|Overall Study|Physician Decision|2
4679296|NCT02421887|7581282|FG001|Overall Study|Physician Decision|4
4679297|NCT02421887|7581281|FG000|Overall Study|Adverse Event|2
4679298|NCT02421887|7581282|FG001|Overall Study|Adverse Event|0
4679299|NCT02421952|7581288|FG000|Overall Study|Diary Not Returned|93
4679300|NCT02421952|7581288|FG000|Overall Study|Failed seriation task|13
4679301|NCT02421952|7581288|FG000|Overall Study|Subject uncooperative for baseline test|2
4679302|NCT02421952|7581288|FG000|Overall Study|Surgery cancelled|1
4679303|NCT02422186|7581297|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1
4679304|NCT02422186|7581298|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0
4679305|NCT02422186|7581297|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0
4679306|NCT02422186|7581298|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1
4679307|NCT02422186|7581297|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1
4679308|NCT02422186|7581298|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2
4679309|NCT02422186|7581297|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3
4679310|NCT02422186|7581298|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1
4679311|NCT02422186|7581297|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4
4679312|NCT02422186|7581298|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2
4679313|NCT02422186|7581297|FG000|Double-blind Induction Phase (4 Weeks)|Other|1
4679314|NCT02422186|7581298|FG001|Double-blind Induction Phase (4 Weeks)|Other|0
4679315|NCT02422186|7581297|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1
4679316|NCT02422186|7581298|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0
4679317|NCT02422186|7581297|FG000|Follow-up Phase (2 Weeks)|Other|3
4679318|NCT02422186|7581298|FG001|Follow-up Phase (2 Weeks)|Other|0
4679319|NCT02422264|7581308|FG000|Overall Study|Serious Adverse Event|1
4758265|NCT02696031|7732454|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6
4758266|NCT02696031|7732455|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8
4758267|NCT02696031|7732456|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2
4758268|NCT02696031|7732451|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0
4758269|NCT02696031|7732452|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0
4758270|NCT02696031|7732453|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0
4758271|NCT02696031|7732454|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1
4758272|NCT02696031|7732455|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1
4758273|NCT02696031|7732456|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0
4758274|NCT02696031|7732451|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0
4758275|NCT02696031|7732452|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0
4758276|NCT02696031|7732453|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0
4758277|NCT02696031|7732454|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1
4758278|NCT02696031|7732455|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0
4758279|NCT02696031|7732456|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0
4758280|NCT02696031|7732451|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0
4758281|NCT02696031|7732452|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0
4758282|NCT02696031|7732453|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0
4758283|NCT02696031|7732454|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0
4758284|NCT02696031|7732455|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1
4758285|NCT02696031|7732456|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0
4758286|NCT02696031|7732451|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0
4758287|NCT02696031|7732452|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0
4679320|NCT02422264|7581309|FG001|Overall Study|Serious Adverse Event|0
4679321|NCT02422264|7581308|FG000|Overall Study|Withdrawal by Subject|1
4679322|NCT02422264|7581309|FG001|Overall Study|Withdrawal by Subject|2
4679323|NCT02422264|7581308|FG000|Overall Study|Migrated/moved from study area|3
4679324|NCT02422264|7581309|FG001|Overall Study|Migrated/moved from study area|1
4679325|NCT02422264|7581308|FG000|Overall Study|Subject vaccinated outside of the study|0
4679326|NCT02422264|7581309|FG001|Overall Study|Subject vaccinated outside of the study|1
4679327|NCT02423109|7581361|FG000|Lens 1|Adverse Event|1
4679328|NCT02423109|7581362|FG001|Lens 1|Adverse Event|0
4679329|NCT02423291|7581389|FG000|Overall Study|Lack of Efficacy|14
4679330|NCT02423291|7581389|FG000|Overall Study|Adverse Event|1
4679331|NCT02423343|7581408|FG000|Overall Study|Withdrawal by Subject|0
4679332|NCT02423343|7581409|FG001|Overall Study|Withdrawal by Subject|1
4679333|NCT02423343|7581410|FG002|Overall Study|Withdrawal by Subject|0
4679334|NCT02423343|7581411|FG003|Overall Study|Withdrawal by Subject|0
4679335|NCT02423343|7581412|FG004|Overall Study|Withdrawal by Subject|0
4679336|NCT02423343|7581413|FG005|Overall Study|Withdrawal by Subject|0
4679337|NCT02423343|7581408|FG000|Overall Study|Progressive Disease|0
4679338|NCT02423343|7581409|FG001|Overall Study|Progressive Disease|0
4679339|NCT02423343|7581410|FG002|Overall Study|Progressive Disease|0
4679340|NCT02423343|7581411|FG003|Overall Study|Progressive Disease|0
4679341|NCT02423343|7581412|FG004|Overall Study|Progressive Disease|2
4679342|NCT02423343|7581413|FG005|Overall Study|Progressive Disease|0
4679343|NCT02423343|7581408|FG000|Overall Study|Adverse Event|0
4679344|NCT02423343|7581409|FG001|Overall Study|Adverse Event|0
4679345|NCT02423343|7581410|FG002|Overall Study|Adverse Event|0
4679346|NCT02423343|7581411|FG003|Overall Study|Adverse Event|0
4679347|NCT02423343|7581412|FG004|Overall Study|Adverse Event|2
4679348|NCT02423343|7581413|FG005|Overall Study|Adverse Event|0
4679349|NCT02423343|7581408|FG000|Overall Study|Death|0
4679350|NCT02423343|7581409|FG001|Overall Study|Death|0
4679351|NCT02423343|7581410|FG002|Overall Study|Death|0
4679352|NCT02423343|7581411|FG003|Overall Study|Death|0
4679353|NCT02423343|7581412|FG004|Overall Study|Death|1
4679354|NCT02423343|7581413|FG005|Overall Study|Death|0
4679355|NCT02423798|7581469|FG000|Overall Study|Withdrawal by Subject|3
4679356|NCT02424097|7581499|FG000|Overall Study|Lost to Follow-up|1
4679357|NCT02424097|7581500|FG001|Overall Study|Lost to Follow-up|2
4679358|NCT02424149|7581508|FG000|Overall Study|surgery cancelled|2
4679359|NCT02424149|7581509|FG001|Overall Study|surgery cancelled|0
4679360|NCT02424149|7581508|FG000|Overall Study|Withdrawal by Subject|0
4679361|NCT02424149|7581509|FG001|Overall Study|Withdrawal by Subject|1
4679362|NCT02424253|7581521|FG000|Overall Study|Other, unspecified|1
4679363|NCT02424253|7581522|FG001|Overall Study|Other, unspecified|0
4679364|NCT02424253|7581521|FG000|Overall Study|Compliance problems|1
4679365|NCT02424253|7581522|FG001|Overall Study|Compliance problems|0
4679366|NCT02424253|7581521|FG000|Overall Study|Physician Decision|2
4679367|NCT02424253|7581522|FG001|Overall Study|Physician Decision|0
4679368|NCT02424253|7581521|FG000|Overall Study|Lack of Efficacy|0
4679369|NCT02424253|7581522|FG001|Overall Study|Lack of Efficacy|7
4679370|NCT02424253|7581521|FG000|Overall Study|Adverse Event|2
4679371|NCT02424253|7581522|FG001|Overall Study|Adverse Event|0
4679372|NCT02424253|7581521|FG000|Overall Study|Consent withdrawn by subject|4
4679373|NCT02424253|7581522|FG001|Overall Study|Consent withdrawn by subject|1
4679374|NCT02424253|7581521|FG000|Overall Study|Lost to Follow-up|1
4679375|NCT02424253|7581522|FG001|Overall Study|Lost to Follow-up|1
4679376|NCT02424344|7581530|FG000|Overall Study|Lack of Efficacy|0
4679377|NCT02424344|7581531|FG001|Overall Study|Lack of Efficacy|1
4679378|NCT02424344|7581530|FG000|Overall Study|Withdrawal by Subject|2
4679379|NCT02424344|7581531|FG001|Overall Study|Withdrawal by Subject|1
4679380|NCT02424344|7581530|FG000|Overall Study|Lost to Follow-up|1
4679381|NCT02424344|7581531|FG001|Overall Study|Lost to Follow-up|0
4679382|NCT02424344|7581530|FG000|Overall Study|Adverse Event|4
4679383|NCT02424344|7581531|FG001|Overall Study|Adverse Event|8
4679384|NCT02424383|7581548|FG000|Overall Study|Withdrawal by Subject|32
4679385|NCT02424383|7581548|FG000|Overall Study|Death|170
4679386|NCT02424383|7581548|FG000|Overall Study|Sponsor's decision|3
4679387|NCT02424383|7581548|FG000|Overall Study|Investigator's decision|44
4679388|NCT02424383|7581548|FG000|Overall Study|Lost to Follow-up|81
4679389|NCT02424383|7581548|FG000|Overall Study|Other|7
4679390|NCT02424383|7581548|FG000|Overall Study|Ineligible for Major Protocol Deviation|39
4679391|NCT02424539|7581566|FG000|Overall Study|Adverse Event|0
4679392|NCT02424539|7581567|FG001|Overall Study|Adverse Event|0
4679393|NCT02424539|7581568|FG002|Overall Study|Adverse Event|1
4679394|NCT02424539|7581566|FG000|Overall Study|Physician Decision|0
4679395|NCT02424539|7581567|FG001|Overall Study|Physician Decision|0
4679396|NCT02424539|7581568|FG002|Overall Study|Physician Decision|1
4679397|NCT02424539|7581566|FG000|Overall Study|Withdrawal by Subject|3
4679398|NCT02424539|7581567|FG001|Overall Study|Withdrawal by Subject|1
4679399|NCT02424539|7581568|FG002|Overall Study|Withdrawal by Subject|0
4679400|NCT02424539|7581566|FG000|Overall Study|Other: Reached stopping criteria|11
4679401|NCT02424539|7581567|FG001|Overall Study|Other: Reached stopping criteria|7
4679402|NCT02424539|7581568|FG002|Overall Study|Other: Reached stopping criteria|6
4679403|NCT02424578|7581578|FG000|Overall Study|Withdrawal by Subject|0
4679404|NCT02424578|7581579|FG001|Overall Study|Withdrawal by Subject|1
4679405|NCT02424591|7581587|FG000|Overall Study|Protocol Violation|2
4679406|NCT02424591|7581588|FG001|Overall Study|Protocol Violation|3
4679407|NCT02424630|7581596|FG000|Overall Study|No rotator cuff tear|1
4679408|NCT02424630|7581597|FG001|Overall Study|No rotator cuff tear|2
4679409|NCT02424630|7581596|FG000|Overall Study|Open procedure|0
4679410|NCT02424630|7581597|FG001|Overall Study|Open procedure|1
4679411|NCT02424734|7581606|FG000|Overall Study|Treatment stopped to be discharged home|2
4679412|NCT02424734|7581607|FG001|Overall Study|Treatment stopped to be discharged home|2
4679413|NCT02424734|7581608|FG002|Overall Study|Treatment stopped to be discharged home|0
4679414|NCT02425098|7581666|FG000|Overall Study|Lost to Follow-up|7
4679415|NCT02425098|7581667|FG001|Overall Study|Lost to Follow-up|7
4679416|NCT02425098|7581666|FG000|Overall Study|Withdrawal by Subject|4
4679417|NCT02425098|7581667|FG001|Overall Study|Withdrawal by Subject|8
4679418|NCT02425098|7581666|FG000|Overall Study|Pregnancy|2
4679419|NCT02425098|7581667|FG001|Overall Study|Pregnancy|0
4679420|NCT02425098|7581666|FG000|Overall Study|Reason not Specified|0
4758288|NCT02696031|7732453|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0
4758289|NCT02696031|7732454|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1
4758290|NCT02696031|7732455|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1
4758291|NCT02696031|7732456|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3
4758292|NCT02696031|7732451|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0
4758293|NCT02696031|7732452|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0
4758294|NCT02696031|7732453|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0
4758295|NCT02696031|7732454|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1
4758296|NCT02696031|7732455|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4
4758297|NCT02696031|7732456|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1
4758298|NCT02689453|7732468|FG000|Overall Study|Progressive disease|0
4758299|NCT02689453|7732469|FG001|Overall Study|Progressive disease|1
4758300|NCT02689453|7732470|FG002|Overall Study|Progressive disease|1
4758301|NCT02476851|7732482|FG000|Overall Study|Protocol Violation|1
4758302|NCT02476851|7732483|FG001|Overall Study|Protocol Violation|1
4758303|NCT02446600|7732493|FG000|Overall Study|Never treated|20
4758304|NCT02446600|7732494|FG001|Overall Study|Never treated|2
4758305|NCT02446600|7732495|FG002|Overall Study|Never treated|6
4758306|NCT02446600|7732496|FG003|Overall Study|Never treated|0
4758307|NCT02446600|7732493|FG000|Overall Study|Withdrawal by Subject|19
4758308|NCT02446600|7732494|FG001|Overall Study|Withdrawal by Subject|5
4758309|NCT02446600|7732495|FG002|Overall Study|Withdrawal by Subject|17
4758310|NCT02446600|7732496|FG003|Overall Study|Withdrawal by Subject|0
4758311|NCT02446600|7732493|FG000|Overall Study|Ineligible|1
4758312|NCT02446600|7732494|FG001|Overall Study|Ineligible|4
4758313|NCT02446600|7732495|FG002|Overall Study|Ineligible|4
4758314|NCT02446600|7732496|FG003|Overall Study|Ineligible|1
4758315|NCT02446600|7732493|FG000|Overall Study|Duplicate Enrollment|0
4758316|NCT02446600|7732494|FG001|Overall Study|Duplicate Enrollment|1
4758317|NCT02446600|7732495|FG002|Overall Study|Duplicate Enrollment|0
4758318|NCT02446600|7732496|FG003|Overall Study|Duplicate Enrollment|0
4758319|NCT02208024|7732525|FG000|Overall Study|Withdrawal by Subject|1
4758320|NCT02180867|7732536|FG000|Overall Study|Adverse Event|3
4758321|NCT02180867|7732537|FG001|Overall Study|Adverse Event|4
4758322|NCT02180867|7732538|FG002|Overall Study|Adverse Event|1
4758323|NCT02180867|7732539|FG003|Overall Study|Adverse Event|5
4758324|NCT02180867|7732540|FG004|Overall Study|Adverse Event|0
4758325|NCT02180867|7732541|FG005|Overall Study|Adverse Event|0
4758326|NCT02180867|7732542|FG006|Overall Study|Adverse Event|0
4758327|NCT02180867|7732536|FG000|Overall Study|Death|0
4758328|NCT02180867|7732537|FG001|Overall Study|Death|0
4758329|NCT02180867|7732538|FG002|Overall Study|Death|0
4758330|NCT02180867|7732539|FG003|Overall Study|Death|0
4758331|NCT02180867|7732540|FG004|Overall Study|Death|1
4758332|NCT02180867|7732541|FG005|Overall Study|Death|0
4758333|NCT02180867|7732542|FG006|Overall Study|Death|0
4758334|NCT02180867|7732536|FG000|Overall Study|Lack of Efficacy|0
4679421|NCT02425098|7581667|FG001|Overall Study|Reason not Specified|1
4679422|NCT02425111|7581673|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2
4679423|NCT02425111|7581673|FG000|Part A: Treatment Period|Lack of Efficacy|15
4679424|NCT02425111|7581673|FG000|Part A: Treatment Period|Voluntary Withdrawal|4
4679425|NCT02425111|7581673|FG000|Part A: Treatment Period|Lost to Follow-up|2
4679426|NCT02425111|7581673|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3
4679427|NCT02425111|7581673|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7
4679428|NCT02425891|7581718|FG000|Overall Study|Death|332
4679429|NCT02425891|7581719|FG001|Overall Study|Death|314
4679430|NCT02425891|7581718|FG000|Overall Study|Lost to Follow-up|4
4679431|NCT02425891|7581719|FG001|Overall Study|Lost to Follow-up|6
4679432|NCT02425891|7581718|FG000|Overall Study|Non-Compliance|1
4679433|NCT02425891|7581719|FG001|Overall Study|Non-Compliance|0
4679434|NCT02425891|7581718|FG000|Overall Study|Accidentally randomized screen failure participant|0
4679435|NCT02425891|7581719|FG001|Overall Study|Accidentally randomized screen failure participant|1
4679436|NCT02425891|7581718|FG000|Overall Study|Physician Decision|0
4679437|NCT02425891|7581719|FG001|Overall Study|Physician Decision|1
4679438|NCT02425891|7581718|FG000|Overall Study|Protocol Violation|1
4758335|NCT02180867|7732537|FG001|Overall Study|Lack of Efficacy|2
4758336|NCT02180867|7732538|FG002|Overall Study|Lack of Efficacy|0
4679439|NCT02425891|7581719|FG001|Overall Study|Protocol Violation|1
4679440|NCT02425891|7581718|FG000|Overall Study|Study Terminated By Sponsor|1
4679441|NCT02425891|7581719|FG001|Overall Study|Study Terminated By Sponsor|0
4679442|NCT02425891|7581718|FG000|Overall Study|Withdrawal by Subject|27
4679443|NCT02425891|7581719|FG001|Overall Study|Withdrawal by Subject|32
4679444|NCT02425891|7581718|FG000|Overall Study|On-going in Study|79
4679445|NCT02425891|7581719|FG001|Overall Study|On-going in Study|90
4679446|NCT02425891|7581718|FG000|Overall Study|Not treated|6
4679447|NCT02425891|7581719|FG001|Overall Study|Not treated|6
4679448|NCT02426086|7581732|FG000|Overall Study|Death|33
4679449|NCT02426086|7581733|FG001|Overall Study|Death|36
4679450|NCT02426086|7581732|FG000|Overall Study|Lost to Follow-up|2
4679451|NCT02426086|7581733|FG001|Overall Study|Lost to Follow-up|0
4679452|NCT02426086|7581732|FG000|Overall Study|Study Terminated by Sponsor|5
4679453|NCT02426086|7581733|FG001|Overall Study|Study Terminated by Sponsor|14
4679454|NCT02426086|7581732|FG000|Overall Study|Withdrawal by Subject|8
4679455|NCT02426086|7581733|FG001|Overall Study|Withdrawal by Subject|9
4679456|NCT02426138|7581746|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1
4679457|NCT02426138|7581747|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1
4679458|NCT02426541|7581768|FG000|Overall Study|Protocol Violation|1
4679459|NCT02426541|7581769|FG001|Overall Study|Protocol Violation|0
4679460|NCT02426580|7581777|FG000|Overall Study|Death|2
4679461|NCT02426580|7581778|FG001|Overall Study|Death|2
4679462|NCT02426580|7581777|FG000|Overall Study|Lost to Follow-up|0
4679463|NCT02426580|7581778|FG001|Overall Study|Lost to Follow-up|9
4679464|NCT02426580|7581777|FG000|Overall Study|transfer to hemodialysis|5
4679465|NCT02426580|7581778|FG001|Overall Study|transfer to hemodialysis|5
4679466|NCT02426580|7581777|FG000|Overall Study|Kidney transplant|3
4679467|NCT02426580|7581778|FG001|Overall Study|Kidney transplant|0
4679468|NCT02426580|7581777|FG000|Overall Study|Allergic to egg white|1
4679469|NCT02426580|7581778|FG001|Overall Study|Allergic to egg white|0
4679470|NCT02426658|7581784|FG000|Overall Study|Withdrawal by Subject|1
4679471|NCT02426658|7581784|FG000|Overall Study|Patient expired before treatment|2
4679472|NCT02426918|7581802|FG000|Overall Study|Adverse Event|2
4679473|NCT02426918|7581803|FG001|Overall Study|Adverse Event|2
4679474|NCT02426918|7581804|FG002|Overall Study|Adverse Event|0
4679475|NCT02426918|7581802|FG000|Overall Study|Physician Decision|1
4679476|NCT02426918|7581803|FG001|Overall Study|Physician Decision|1
4679477|NCT02426918|7581804|FG002|Overall Study|Physician Decision|1
4679478|NCT02426918|7581802|FG000|Overall Study|Withdrawal by Subject|5
4679479|NCT02426918|7581803|FG001|Overall Study|Withdrawal by Subject|5
4679480|NCT02426918|7581804|FG002|Overall Study|Withdrawal by Subject|4
4679481|NCT02426918|7581802|FG000|Overall Study|Other|9
4679482|NCT02426918|7581803|FG001|Overall Study|Other|11
4679483|NCT02426918|7581804|FG002|Overall Study|Other|9
4679484|NCT02427100|7581814|FG000|Overall Study|Lost to Follow-up|0
4679485|NCT02427100|7581815|FG001|Overall Study|Lost to Follow-up|2
4679486|NCT02427399|7581826|FG000|Overall Study|Protocol Violation|14
4679487|NCT02427399|7581827|FG001|Overall Study|Protocol Violation|16
4679488|NCT02427399|7581828|FG002|Overall Study|Protocol Violation|12
4679489|NCT02427399|7581829|FG003|Overall Study|Protocol Violation|18
4679490|NCT02427399|7581830|FG004|Overall Study|Protocol Violation|15
4679491|NCT02427477|7581844|FG000|Period 1|Adverse Event|1
4679492|NCT02427477|7581845|FG001|Period 1|Adverse Event|0
4679493|NCT02427607|7581851|FG000|Overall Study|Withdrawal by Subject|1
4679494|NCT02427646|7581857|FG000|Overall Study|Lack of Efficacy|2
4679495|NCT02427646|7581858|FG001|Overall Study|Lack of Efficacy|3
4679496|NCT02427646|7581857|FG000|Overall Study|Physician Decision|1
4679497|NCT02427646|7581858|FG001|Overall Study|Physician Decision|4
4679498|NCT02427646|7581857|FG000|Overall Study|Protocol Violation|3
4679499|NCT02427646|7581858|FG001|Overall Study|Protocol Violation|3
4679500|NCT02427646|7581857|FG000|Overall Study|Bothersome hand weakness|2
4679501|NCT02427646|7581858|FG001|Overall Study|Bothersome hand weakness|4
4679502|NCT02427802|7581905|FG000|Overall Study|Adverse Event|11
4679503|NCT02427802|7581906|FG001|Overall Study|Adverse Event|3
4679504|NCT02427802|7581907|FG002|Overall Study|Adverse Event|7
4679505|NCT02427802|7581905|FG000|Overall Study|Death|0
4679506|NCT02427802|7581906|FG001|Overall Study|Death|4
4679507|NCT02427802|7581907|FG002|Overall Study|Death|1
4679508|NCT02427802|7581905|FG000|Overall Study|Lost to Follow-up|13
4679509|NCT02427802|7581906|FG001|Overall Study|Lost to Follow-up|8
4679510|NCT02427802|7581907|FG002|Overall Study|Lost to Follow-up|8
4679511|NCT02427802|7581905|FG000|Overall Study|Physician Decision|4
4679512|NCT02427802|7581906|FG001|Overall Study|Physician Decision|2
4679513|NCT02427802|7581907|FG002|Overall Study|Physician Decision|4
4679514|NCT02427802|7581905|FG000|Overall Study|Withdrawal by Subject|10
4679515|NCT02427802|7581906|FG001|Overall Study|Withdrawal by Subject|5
4679516|NCT02427802|7581907|FG002|Overall Study|Withdrawal by Subject|11
4679517|NCT02427802|7581905|FG000|Overall Study|Protocol Violation|3
4679518|NCT02427802|7581906|FG001|Overall Study|Protocol Violation|1
4679519|NCT02427802|7581907|FG002|Overall Study|Protocol Violation|1
4679520|NCT02427802|7581905|FG000|Overall Study|protocol specific treatment unrelated|18
4679521|NCT02427802|7581906|FG001|Overall Study|protocol specific treatment unrelated|11
4679522|NCT02427802|7581907|FG002|Overall Study|protocol specific treatment unrelated|11
4679523|NCT02427841|7581915|FG000|Overall Study|Physician Decision|8
4679524|NCT02427984|7581922|FG000|Overall Study|Lost to Follow-up|13
4679525|NCT02427984|7581923|FG001|Overall Study|Lost to Follow-up|5
4679526|NCT02427984|7581924|FG002|Overall Study|Lost to Follow-up|18
4679527|NCT02428296|7581943|FG000|Overall Study|Adverse Event|7
4679528|NCT02428296|7581943|FG000|Overall Study|Withdrawal by Subject|2
4679529|NCT02428413|7581957|FG000|Overall Study|Device to measure WAG malfunctioned|3
4679530|NCT02428413|7581958|FG001|Overall Study|Device to measure WAG malfunctioned|5
4679531|NCT02428413|7581957|FG000|Overall Study|Protocol Violation|1
4679532|NCT02428413|7581958|FG001|Overall Study|Protocol Violation|2
4679533|NCT02428413|7581957|FG000|Overall Study|Case Cancelled|2
4679534|NCT02428413|7581958|FG001|Overall Study|Case Cancelled|0
4679535|NCT02428413|7581957|FG000|Overall Study|Missed Cases|1
4679536|NCT02428413|7581958|FG001|Overall Study|Missed Cases|2
4679537|NCT02428413|7581957|FG000|Overall Study|Nurse Refusal|1
4679538|NCT02428413|7581958|FG001|Overall Study|Nurse Refusal|0
4679539|NCT02428608|7581984|FG000|Overall Study|Pregnancy|2
4679540|NCT02428608|7581984|FG000|Overall Study|Lost to Follow-up|37
4679541|NCT02428608|7581984|FG000|Overall Study|Withdrawal by Subject|2
4679542|NCT02428608|7581984|FG000|Overall Study|scheduling conflicts|15
4679543|NCT02428608|7581984|FG000|Overall Study|moved away|10
4679544|NCT02428608|7581984|FG000|Overall Study|Death|1
4679545|NCT02428608|7581984|FG000|Overall Study|various|16
4679546|NCT02428699|7581989|FG000|Washout Period 1|Screen Failure|1
4679547|NCT02428699|7581990|FG001|Washout Period 1|Screen Failure|2
4679548|NCT02428855|7582001|FG000|Overall Study|Withdrawal by Subject|2
4679549|NCT02429258|7582032|FG000|Overall Study|Withdrawal by Subject|2
4679550|NCT02429258|7582033|FG001|Overall Study|Withdrawal by Subject|0
4679551|NCT02429258|7582032|FG000|Overall Study|Protocol Violation|0
4679552|NCT02429258|7582033|FG001|Overall Study|Protocol Violation|1
4679553|NCT02429310|7582041|FG000|Overall Study|Lost to Follow-up|1
4679554|NCT02429310|7582042|FG001|Overall Study|Lost to Follow-up|2
4679555|NCT02429310|7582041|FG000|Overall Study|Protocol Violation|1
4679556|NCT02429310|7582042|FG001|Overall Study|Protocol Violation|1
4679557|NCT02429427|7582050|FG000|Overall Study|Adverse Event|220
4679558|NCT02429427|7582051|FG001|Overall Study|Adverse Event|92
4679559|NCT02429427|7582050|FG000|Overall Study|Protocol Violation|10
4679560|NCT02429427|7582051|FG001|Overall Study|Protocol Violation|6
4679561|NCT02429427|7582050|FG000|Overall Study|Lost to Follow-up|15
4679562|NCT02429427|7582051|FG001|Overall Study|Lost to Follow-up|6
4679563|NCT02429427|7582050|FG000|Overall Study|Withdrawal by Subject|64
4679564|NCT02429427|7582051|FG001|Overall Study|Withdrawal by Subject|34
4679565|NCT02429427|7582050|FG000|Overall Study|Other|62
4679566|NCT02429427|7582051|FG001|Overall Study|Other|41
4679567|NCT02429778|7582059|FG000|Overall Study|Lost to Follow-up|2
4679568|NCT02429778|7582060|FG001|Overall Study|Lost to Follow-up|0
4679569|NCT02429778|7582059|FG000|Overall Study|Withdrawal by Subject|5
4679570|NCT02429778|7582060|FG001|Overall Study|Withdrawal by Subject|0
4758337|NCT02180867|7732539|FG003|Overall Study|Lack of Efficacy|1
4758338|NCT02180867|7732540|FG004|Overall Study|Lack of Efficacy|6
4758339|NCT02180867|7732541|FG005|Overall Study|Lack of Efficacy|0
4758340|NCT02180867|7732542|FG006|Overall Study|Lack of Efficacy|1
4758341|NCT02180867|7732536|FG000|Overall Study|Physician Decision|1
4758342|NCT02180867|7732537|FG001|Overall Study|Physician Decision|3
4758343|NCT02180867|7732538|FG002|Overall Study|Physician Decision|1
4758344|NCT02180867|7732539|FG003|Overall Study|Physician Decision|10
4758345|NCT02180867|7732540|FG004|Overall Study|Physician Decision|9
4758346|NCT02180867|7732541|FG005|Overall Study|Physician Decision|3
4758347|NCT02180867|7732542|FG006|Overall Study|Physician Decision|4
4758348|NCT02180867|7732536|FG000|Overall Study|Withdrawal by Subject|0
4679571|NCT02429856|7582068|FG000|Overall Study|Death|12
4679572|NCT02429856|7582069|FG001|Overall Study|Death|13
4679573|NCT02429856|7582068|FG000|Overall Study|Lost to Follow-up|6
4679574|NCT02429856|7582069|FG001|Overall Study|Lost to Follow-up|5
4679575|NCT02429856|7582068|FG000|Overall Study|Withdrawal by Subject|1
4679576|NCT02429856|7582069|FG001|Overall Study|Withdrawal by Subject|1
4679577|NCT02429934|7582083|FG000|Overall Study|Withdrawal by Subject|0
4679578|NCT02429934|7582084|FG001|Overall Study|Withdrawal by Subject|2
4679579|NCT02429934|7582083|FG000|Overall Study|Adverse Event|2
4679580|NCT02429934|7582084|FG001|Overall Study|Adverse Event|0
4679581|NCT02429934|7582083|FG000|Overall Study|Lost to Follow-up|1
4679582|NCT02429934|7582084|FG001|Overall Study|Lost to Follow-up|1
4679583|NCT02429934|7582083|FG000|Overall Study|Physician Decision|1
4679584|NCT02429934|7582084|FG001|Overall Study|Physician Decision|0
4679585|NCT02430311|7582107|FG000|Part A|Adverse Event|0
4679586|NCT02430311|7582108|FG001|Part A|Adverse Event|1
4679587|NCT02430311|7582107|FG000|Part A|Withdrawal by Subject|1
4679588|NCT02430311|7582108|FG001|Part A|Withdrawal by Subject|0
4679589|NCT02430311|7582107|FG000|Part B|Meet study-specific withdrawal criteria|6
4679590|NCT02430311|7582108|FG001|Part B|Meet study-specific withdrawal criteria|6
4679591|NCT02430311|7582107|FG000|Part B|Withdrawal by Subject|2
4679592|NCT02430311|7582108|FG001|Part B|Withdrawal by Subject|2
4758349|NCT02180867|7732537|FG001|Overall Study|Withdrawal by Subject|0
4679593|NCT02430311|7582107|FG000|Part B|Adverse Event|1
4679594|NCT02430311|7582108|FG001|Part B|Adverse Event|0
4679595|NCT02430311|7582107|FG000|Part B|Death|1
4679596|NCT02430311|7582108|FG001|Part B|Death|0
4758350|NCT02180867|7732538|FG002|Overall Study|Withdrawal by Subject|0
4758351|NCT02180867|7732539|FG003|Overall Study|Withdrawal by Subject|1
4679597|NCT02430480|7582145|FG000|Overall Study|Death|1
4679598|NCT02430480|7582145|FG000|Overall Study|Anesthesia concerns|1
4679599|NCT02430480|7582145|FG000|Overall Study|Progressed on treatment|1
4679600|NCT02430870|7582173|FG000|Part 2|Voluntary Withdrawal|0
4679601|NCT02430870|7582174|FG001|Part 2|Voluntary Withdrawal|0
4679602|NCT02430870|7582175|FG002|Part 2|Voluntary Withdrawal|0
4679603|NCT02430870|7582176|FG003|Part 2|Voluntary Withdrawal|0
4679604|NCT02430870|7582177|FG004|Part 2|Voluntary Withdrawal|0
4679605|NCT02430870|7582178|FG005|Part 2|Voluntary Withdrawal|0
4679606|NCT02430870|7582179|FG006|Part 2|Voluntary Withdrawal|1
4679607|NCT02430870|7582180|FG007|Part 2|Voluntary Withdrawal|0
4679608|NCT02430870|7582173|FG000|Part 2|Other Reason Not Specified|0
4679609|NCT02430870|7582174|FG001|Part 2|Other Reason Not Specified|0
4679610|NCT02430870|7582175|FG002|Part 2|Other Reason Not Specified|0
4679611|NCT02430870|7582176|FG003|Part 2|Other Reason Not Specified|0
4679612|NCT02430870|7582177|FG004|Part 2|Other Reason Not Specified|0
4679613|NCT02430870|7582178|FG005|Part 2|Other Reason Not Specified|0
4679614|NCT02430870|7582179|FG006|Part 2|Other Reason Not Specified|0
4679615|NCT02430870|7582180|FG007|Part 2|Other Reason Not Specified|1
4679616|NCT02431260|7582238|FG000|Overall Study|Subject Decision|0
4679617|NCT02431260|7582239|FG001|Overall Study|Subject Decision|1
4679618|NCT02431260|7582240|FG002|Overall Study|Subject Decision|1
4679619|NCT02431260|7582241|FG003|Overall Study|Subject Decision|0
4679620|NCT02431260|7582242|FG004|Overall Study|Subject Decision|0
4679621|NCT02431260|7582243|FG005|Overall Study|Subject Decision|0
4679622|NCT02431260|7582244|FG006|Overall Study|Subject Decision|0
4679623|NCT02431260|7582245|FG007|Overall Study|Subject Decision|0
4679624|NCT02431260|7582246|FG008|Overall Study|Subject Decision|1
4679625|NCT02431260|7582247|FG009|Overall Study|Subject Decision|1
4679626|NCT02431260|7582248|FG010|Overall Study|Subject Decision|0
4679627|NCT02431260|7582249|FG011|Overall Study|Subject Decision|1
4679628|NCT02431260|7582250|FG012|Overall Study|Subject Decision|0
4679629|NCT02431260|7582251|FG013|Overall Study|Subject Decision|0
4758352|NCT02180867|7732540|FG004|Overall Study|Withdrawal by Subject|1
4758353|NCT02180867|7732541|FG005|Overall Study|Withdrawal by Subject|0
4758354|NCT02180867|7732542|FG006|Overall Study|Withdrawal by Subject|0
4758355|NCT02180867|7732536|FG000|Overall Study|Ineligible|1
4758356|NCT02180867|7732537|FG001|Overall Study|Ineligible|2
4758357|NCT02180867|7732538|FG002|Overall Study|Ineligible|0
4758358|NCT02180867|7732539|FG003|Overall Study|Ineligible|3
4758359|NCT02180867|7732540|FG004|Overall Study|Ineligible|5
4758360|NCT02180867|7732541|FG005|Overall Study|Ineligible|0
4758361|NCT02180867|7732542|FG006|Overall Study|Ineligible|0
4758362|NCT02180867|7732536|FG000|Overall Study|Repeat Eligibility Studies|0
4679630|NCT02431260|7582238|FG000|Overall Study|Death|4
4679631|NCT02431260|7582239|FG001|Overall Study|Death|4
4758363|NCT02180867|7732537|FG001|Overall Study|Repeat Eligibility Studies|0
4758364|NCT02180867|7732538|FG002|Overall Study|Repeat Eligibility Studies|0
4758365|NCT02180867|7732539|FG003|Overall Study|Repeat Eligibility Studies|0
4758366|NCT02180867|7732540|FG004|Overall Study|Repeat Eligibility Studies|1
4758367|NCT02180867|7732541|FG005|Overall Study|Repeat Eligibility Studies|0
4758368|NCT02180867|7732542|FG006|Overall Study|Repeat Eligibility Studies|0
4758369|NCT02180867|7732536|FG000|Overall Study|Refusal of further protocol therapy|1
4758370|NCT02180867|7732537|FG001|Overall Study|Refusal of further protocol therapy|0
4758371|NCT02180867|7732538|FG002|Overall Study|Refusal of further protocol therapy|2
4758372|NCT02180867|7732539|FG003|Overall Study|Refusal of further protocol therapy|6
4758373|NCT02180867|7732540|FG004|Overall Study|Refusal of further protocol therapy|4
4758374|NCT02180867|7732541|FG005|Overall Study|Refusal of further protocol therapy|0
4758375|NCT02180867|7732542|FG006|Overall Study|Refusal of further protocol therapy|0
4758376|NCT01866111|7732574|FG000|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|14
4758377|NCT01866111|7732575|FG001|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|13
4758378|NCT01866111|7732576|FG002|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|20
4758379|NCT01866111|7732577|FG003|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|30
4758380|NCT01866111|7732574|FG000|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|65
4758381|NCT01866111|7732575|FG001|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|67
4758382|NCT01866111|7732576|FG002|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|63
4758383|NCT01866111|7732577|FG003|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|52
4758384|NCT01767194|7732589|FG000|Overall Study|Adverse Event|1
4758385|NCT01767194|7732590|FG001|Overall Study|Adverse Event|1
4758386|NCT01767194|7732589|FG000|Overall Study|Death|0
4758387|NCT01767194|7732590|FG001|Overall Study|Death|1
4758388|NCT01767194|7732589|FG000|Overall Study|Lack of Efficacy|12
4758389|NCT01767194|7732590|FG001|Overall Study|Lack of Efficacy|11
4758390|NCT01767194|7732589|FG000|Overall Study|Physician Decision|2
4758391|NCT01767194|7732590|FG001|Overall Study|Physician Decision|23
4758392|NCT01767194|7732589|FG000|Overall Study|Withdrawal by Subject|0
4758393|NCT01767194|7732590|FG001|Overall Study|Withdrawal by Subject|1
4679632|NCT02431260|7582240|FG002|Overall Study|Death|3
4679633|NCT02431260|7582241|FG003|Overall Study|Death|4
4679634|NCT02431260|7582242|FG004|Overall Study|Death|2
4679635|NCT02431260|7582243|FG005|Overall Study|Death|2
4679636|NCT02431260|7582244|FG006|Overall Study|Death|3
4679637|NCT02431260|7582245|FG007|Overall Study|Death|1
4679638|NCT02431260|7582246|FG008|Overall Study|Death|6
4679639|NCT02431260|7582247|FG009|Overall Study|Death|6
4679640|NCT02431260|7582248|FG010|Overall Study|Death|3
4679641|NCT02431260|7582249|FG011|Overall Study|Death|2
4679642|NCT02431260|7582250|FG012|Overall Study|Death|5
4679643|NCT02431260|7582251|FG013|Overall Study|Death|1
4679644|NCT02431260|7582238|FG000|Overall Study|Lost to Follow-up|0
4679645|NCT02431260|7582239|FG001|Overall Study|Lost to Follow-up|0
4679646|NCT02431260|7582240|FG002|Overall Study|Lost to Follow-up|0
4679647|NCT02431260|7582241|FG003|Overall Study|Lost to Follow-up|0
4679648|NCT02431260|7582242|FG004|Overall Study|Lost to Follow-up|0
4679649|NCT02431260|7582243|FG005|Overall Study|Lost to Follow-up|1
4679650|NCT02431260|7582244|FG006|Overall Study|Lost to Follow-up|0
4679651|NCT02431260|7582245|FG007|Overall Study|Lost to Follow-up|0
4679652|NCT02431260|7582246|FG008|Overall Study|Lost to Follow-up|0
4679653|NCT02431260|7582247|FG009|Overall Study|Lost to Follow-up|0
4679654|NCT02431260|7582248|FG010|Overall Study|Lost to Follow-up|0
4679655|NCT02431260|7582249|FG011|Overall Study|Lost to Follow-up|0
4679656|NCT02431260|7582250|FG012|Overall Study|Lost to Follow-up|0
4679657|NCT02431260|7582251|FG013|Overall Study|Lost to Follow-up|0
4679658|NCT02431260|7582238|FG000|Overall Study|Study Terminated by the Sponsor|0
4679659|NCT02431260|7582239|FG001|Overall Study|Study Terminated by the Sponsor|0
4679660|NCT02431260|7582240|FG002|Overall Study|Study Terminated by the Sponsor|2
4679661|NCT02431260|7582241|FG003|Overall Study|Study Terminated by the Sponsor|1
4679662|NCT02431260|7582242|FG004|Overall Study|Study Terminated by the Sponsor|1
4679663|NCT02431260|7582243|FG005|Overall Study|Study Terminated by the Sponsor|0
4679664|NCT02431260|7582244|FG006|Overall Study|Study Terminated by the Sponsor|1
4679665|NCT02431260|7582245|FG007|Overall Study|Study Terminated by the Sponsor|2
4679666|NCT02431260|7582246|FG008|Overall Study|Study Terminated by the Sponsor|1
4679667|NCT02431260|7582247|FG009|Overall Study|Study Terminated by the Sponsor|1
4679668|NCT02431260|7582248|FG010|Overall Study|Study Terminated by the Sponsor|1
4679669|NCT02431260|7582249|FG011|Overall Study|Study Terminated by the Sponsor|0
4679670|NCT02431260|7582250|FG012|Overall Study|Study Terminated by the Sponsor|4
4679671|NCT02431260|7582251|FG013|Overall Study|Study Terminated by the Sponsor|0
4679672|NCT02431260|7582238|FG000|Overall Study|Physician Decision|0
4679673|NCT02431260|7582239|FG001|Overall Study|Physician Decision|0
4679674|NCT02431260|7582240|FG002|Overall Study|Physician Decision|0
4679675|NCT02431260|7582241|FG003|Overall Study|Physician Decision|0
4679676|NCT02431260|7582242|FG004|Overall Study|Physician Decision|0
4679677|NCT02431260|7582243|FG005|Overall Study|Physician Decision|1
4679678|NCT02431260|7582244|FG006|Overall Study|Physician Decision|0
4679679|NCT02431260|7582245|FG007|Overall Study|Physician Decision|0
4679680|NCT02431260|7582246|FG008|Overall Study|Physician Decision|0
4679681|NCT02431260|7582247|FG009|Overall Study|Physician Decision|0
4679682|NCT02431260|7582248|FG010|Overall Study|Physician Decision|0
4679683|NCT02431260|7582249|FG011|Overall Study|Physician Decision|0
4679684|NCT02431260|7582250|FG012|Overall Study|Physician Decision|0
4679685|NCT02431260|7582251|FG013|Overall Study|Physician Decision|0
4679686|NCT02431260|7582238|FG000|Overall Study|Other Unspecified|0
4679687|NCT02431260|7582239|FG001|Overall Study|Other Unspecified|0
4679688|NCT02431260|7582240|FG002|Overall Study|Other Unspecified|0
4679689|NCT02431260|7582241|FG003|Overall Study|Other Unspecified|0
4679690|NCT02431260|7582242|FG004|Overall Study|Other Unspecified|0
4679691|NCT02431260|7582243|FG005|Overall Study|Other Unspecified|0
4679692|NCT02431260|7582244|FG006|Overall Study|Other Unspecified|0
4679693|NCT02431260|7582245|FG007|Overall Study|Other Unspecified|0
4679694|NCT02431260|7582246|FG008|Overall Study|Other Unspecified|0
4758394|NCT01767194|7732589|FG000|Overall Study|Ineligible|1
4758395|NCT01767194|7732590|FG001|Overall Study|Ineligible|1
4758396|NCT01767194|7732589|FG000|Overall Study|Refusal by patient/parent|2
4758397|NCT01767194|7732590|FG001|Overall Study|Refusal by patient/parent|4
4758398|NCT01767194|7732589|FG000|Overall Study|Criteria not met on time for next cycle|0
4758399|NCT01767194|7732590|FG001|Overall Study|Criteria not met on time for next cycle|1
4758400|NCT01767129|7732597|FG000|Treatment Period 1 (14 Days)|Adverse Event|1
4758401|NCT01767129|7732598|FG001|Treatment Period 1 (14 Days)|Adverse Event|0
4758402|NCT01708954|7732608|FG000|Step 1|Disease progression|26
4758403|NCT01708954|7732609|FG001|Step 1|Disease progression|17
4758404|NCT01708954|7732610|FG002|Step 1|Disease progression|14
4758405|NCT01708954|7732608|FG000|Step 1|Adverse Event|3
4758406|NCT01708954|7732609|FG001|Step 1|Adverse Event|11
4758407|NCT01708954|7732610|FG002|Step 1|Adverse Event|13
4758408|NCT01708954|7732608|FG000|Step 1|Death|3
4758409|NCT01708954|7732609|FG001|Step 1|Death|2
4758410|NCT01708954|7732610|FG002|Step 1|Death|3
4758411|NCT01708954|7732608|FG000|Step 1|Withdrawal by Subject|2
4758412|NCT01708954|7732609|FG001|Step 1|Withdrawal by Subject|5
4758413|NCT01708954|7732610|FG002|Step 1|Withdrawal by Subject|3
4758414|NCT01708954|7732608|FG000|Step 1|Other complicating disease|0
4758415|NCT01708954|7732609|FG001|Step 1|Other complicating disease|2
4679695|NCT02431260|7582247|FG009|Overall Study|Other Unspecified|0
4679696|NCT02431260|7582248|FG010|Overall Study|Other Unspecified|0
4679697|NCT02431260|7582249|FG011|Overall Study|Other Unspecified|1
4758416|NCT01708954|7732610|FG002|Step 1|Other complicating disease|0
4758417|NCT01708954|7732608|FG000|Step 1|Crossed over to Step 2|2
4679698|NCT02431260|7582250|FG012|Overall Study|Other Unspecified|1
4679699|NCT02431260|7582251|FG013|Overall Study|Other Unspecified|0
4679700|NCT02431364|7582316|FG000|Overall Study|Adverse Event|0
4679701|NCT02431364|7582317|FG001|Overall Study|Adverse Event|1
4679702|NCT02431364|7582318|FG002|Overall Study|Adverse Event|0
4679703|NCT02431364|7582319|FG003|Overall Study|Adverse Event|0
4679704|NCT02431364|7582320|FG004|Overall Study|Adverse Event|0
4679705|NCT02431364|7582316|FG000|Overall Study|Randomized but never treated|0
4679706|NCT02431364|7582317|FG001|Overall Study|Randomized but never treated|0
4679707|NCT02431364|7582318|FG002|Overall Study|Randomized but never treated|0
4679708|NCT02431364|7582319|FG003|Overall Study|Randomized but never treated|1
4679709|NCT02431364|7582320|FG004|Overall Study|Randomized but never treated|0
4679710|NCT02431468|7582348|FG000|Overall Study|Adverse Event|2
4679711|NCT02431468|7582349|FG001|Overall Study|Adverse Event|4
4679712|NCT02431468|7582350|FG002|Overall Study|Adverse Event|5
4679713|NCT02431468|7582348|FG000|Overall Study|Withdrawal by Subject|4
4679714|NCT02431468|7582349|FG001|Overall Study|Withdrawal by Subject|12
4679715|NCT02431468|7582350|FG002|Overall Study|Withdrawal by Subject|2
4679716|NCT02431468|7582348|FG000|Overall Study|noncompliance, investigator termination,|2
4679717|NCT02431468|7582349|FG001|Overall Study|noncompliance, investigator termination,|2
4679718|NCT02431468|7582350|FG002|Overall Study|noncompliance, investigator termination,|2
4679719|NCT02431533|7582366|FG000|Overall Study|Withdrawal by Subject|1
4679720|NCT02431533|7582367|FG001|Overall Study|Withdrawal by Subject|3
4679721|NCT02431533|7582366|FG000|Overall Study|Developed Exclusionary criteria|1
4679722|NCT02431533|7582367|FG001|Overall Study|Developed Exclusionary criteria|0
4679723|NCT02431559|7582377|FG000|Overall Study|Adverse Event|0
4679724|NCT02431559|7582378|FG001|Overall Study|Adverse Event|1
4679725|NCT02431559|7582379|FG002|Overall Study|Adverse Event|0
4679726|NCT02431559|7582380|FG003|Overall Study|Adverse Event|4
4679727|NCT02431559|7582377|FG000|Overall Study|Progressive disease|2
4679728|NCT02431559|7582378|FG001|Overall Study|Progressive disease|1
4679729|NCT02431559|7582379|FG002|Overall Study|Progressive disease|4
4679730|NCT02431559|7582380|FG003|Overall Study|Progressive disease|22
4679731|NCT02431559|7582377|FG000|Overall Study|Withdrawal by Subject|0
4679732|NCT02431559|7582378|FG001|Overall Study|Withdrawal by Subject|1
4679733|NCT02431559|7582379|FG002|Overall Study|Withdrawal by Subject|0
4679734|NCT02431559|7582380|FG003|Overall Study|Withdrawal by Subject|4
4679735|NCT02431559|7582377|FG000|Overall Study|Physician Decision|0
4679736|NCT02431559|7582378|FG001|Overall Study|Physician Decision|0
4679737|NCT02431559|7582379|FG002|Overall Study|Physician Decision|0
4679738|NCT02431559|7582380|FG003|Overall Study|Physician Decision|1
4679739|NCT02431676|7582441|FG000|Overall Study|no lab obtained|0
4679740|NCT02431676|7582442|FG001|Overall Study|no lab obtained|1
4679741|NCT02431676|7582443|FG002|Overall Study|no lab obtained|2
4679742|NCT02431793|7582469|FG000|Overall Study|Ineligible doe to not filling Rx|11
4679743|NCT02431793|7582470|FG001|Overall Study|Ineligible doe to not filling Rx|7
4679744|NCT02431793|7582471|FG002|Overall Study|Ineligible doe to not filling Rx|8
4679745|NCT02431793|7582469|FG000|Overall Study|Withdrawal by Subject|7
4679746|NCT02431793|7582470|FG001|Overall Study|Withdrawal by Subject|5
4679747|NCT02431793|7582471|FG002|Overall Study|Withdrawal by Subject|5
4679748|NCT02431793|7582469|FG000|Overall Study|Lost to Follow-up|101
4679749|NCT02431793|7582470|FG001|Overall Study|Lost to Follow-up|122
4679750|NCT02431793|7582471|FG002|Overall Study|Lost to Follow-up|104
4679751|NCT02431806|7582483|FG000|Double-blind Treatment Period|Did not Receive Treatment|1
4679752|NCT02431806|7582484|FG001|Double-blind Treatment Period|Did not Receive Treatment|2
4679753|NCT02431806|7582485|FG002|Double-blind Treatment Period|Did not Receive Treatment|1
4679754|NCT02431806|7582486|FG003|Double-blind Treatment Period|Did not Receive Treatment|1
4679755|NCT02431806|7582483|FG000|Double-blind Treatment Period|Adverse Event|4
4679756|NCT02431806|7582484|FG001|Double-blind Treatment Period|Adverse Event|7
4679757|NCT02431806|7582485|FG002|Double-blind Treatment Period|Adverse Event|11
4679758|NCT02431806|7582486|FG003|Double-blind Treatment Period|Adverse Event|7
4679759|NCT02431806|7582483|FG000|Double-blind Treatment Period|Lack of Efficacy|2
4679760|NCT02431806|7582484|FG001|Double-blind Treatment Period|Lack of Efficacy|0
4679761|NCT02431806|7582485|FG002|Double-blind Treatment Period|Lack of Efficacy|2
4679762|NCT02431806|7582486|FG003|Double-blind Treatment Period|Lack of Efficacy|2
4679763|NCT02431806|7582483|FG000|Double-blind Treatment Period|Withdrawal of Consent|10
4679764|NCT02431806|7582484|FG001|Double-blind Treatment Period|Withdrawal of Consent|7
4679765|NCT02431806|7582485|FG002|Double-blind Treatment Period|Withdrawal of Consent|5
4679766|NCT02431806|7582486|FG003|Double-blind Treatment Period|Withdrawal of Consent|5
4679767|NCT02431806|7582483|FG000|Double-blind Treatment Period|Lost to Follow-up|7
4679768|NCT02431806|7582484|FG001|Double-blind Treatment Period|Lost to Follow-up|4
4679769|NCT02431806|7582485|FG002|Double-blind Treatment Period|Lost to Follow-up|5
4679770|NCT02431806|7582486|FG003|Double-blind Treatment Period|Lost to Follow-up|8
4679771|NCT02431806|7582483|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1
4679772|NCT02431806|7582484|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0
4679773|NCT02431806|7582485|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3
4679774|NCT02431806|7582486|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1
4679775|NCT02431806|7582483|FG000|Double-blind Treatment Period|Reason Not Specified|0
4679776|NCT02431806|7582484|FG001|Double-blind Treatment Period|Reason Not Specified|1
4679777|NCT02431806|7582485|FG002|Double-blind Treatment Period|Reason Not Specified|5
4679778|NCT02431806|7582486|FG003|Double-blind Treatment Period|Reason Not Specified|2
4679779|NCT02432040|7582498|FG000|Overall Study|Lack of Efficacy|3
4679780|NCT02432040|7582499|FG001|Overall Study|Lack of Efficacy|0
4679781|NCT02432040|7582498|FG000|Overall Study|Lost to Follow-up|4
4679782|NCT02432040|7582499|FG001|Overall Study|Lost to Follow-up|5
4679783|NCT02432040|7582498|FG000|Overall Study|Physician Decision|1
4679784|NCT02432040|7582499|FG001|Overall Study|Physician Decision|1
4679785|NCT02432105|7582508|FG000|Overall Study|Lost to Follow-up|1
4679786|NCT02432105|7582509|FG001|Overall Study|Lost to Follow-up|1
4679787|NCT02432105|7582510|FG002|Overall Study|Lost to Follow-up|0
4679788|NCT02432105|7582508|FG000|Overall Study|Withdrawal by Subject|1
4679789|NCT02432105|7582509|FG001|Overall Study|Withdrawal by Subject|0
4679790|NCT02432105|7582510|FG002|Overall Study|Withdrawal by Subject|1
4679791|NCT02432105|7582508|FG000|Overall Study|Culture positive for yeast|0
4679792|NCT02432105|7582509|FG001|Overall Study|Culture positive for yeast|1
4679793|NCT02432105|7582510|FG002|Overall Study|Culture positive for yeast|0
4679794|NCT02432105|7582508|FG000|Overall Study|Randomized in error|0
4679795|NCT02432105|7582509|FG001|Overall Study|Randomized in error|0
4679796|NCT02432105|7582510|FG002|Overall Study|Randomized in error|2
4758418|NCT01708954|7732609|FG001|Step 1|Crossed over to Step 2|0
4758419|NCT01708954|7732610|FG002|Step 1|Crossed over to Step 2|0
4758420|NCT01708954|7732608|FG000|Step 1|Symptomatic deterioration|1
4758421|NCT01708954|7732609|FG001|Step 1|Symptomatic deterioration|0
4758422|NCT01708954|7732610|FG002|Step 1|Symptomatic deterioration|1
4758423|NCT01708954|7732608|FG000|Step 1|Off-treatment reason not submitted|1
4758424|NCT01708954|7732609|FG001|Step 1|Off-treatment reason not submitted|1
4758425|NCT01708954|7732610|FG002|Step 1|Off-treatment reason not submitted|1
4758426|NCT01708954|7732608|FG000|Step 1|Ineligible or never received treatment|4
4758427|NCT01708954|7732609|FG001|Step 1|Ineligible or never received treatment|2
4758428|NCT01708954|7732610|FG002|Step 1|Ineligible or never received treatment|8
4758429|NCT01708954|7732608|FG000|Step 2|Disease progression|9
4758430|NCT01708954|7732609|FG001|Step 2|Disease progression|4
4758431|NCT01708954|7732610|FG002|Step 2|Disease progression|0
4758432|NCT01708954|7732608|FG000|Step 2|Adverse Event|3
4758433|NCT01708954|7732609|FG001|Step 2|Adverse Event|2
4758434|NCT01708954|7732610|FG002|Step 2|Adverse Event|0
4758435|NCT01708954|7732608|FG000|Step 2|Withdrawal by Subject|1
4758436|NCT01708954|7732609|FG001|Step 2|Withdrawal by Subject|1
4758437|NCT01708954|7732610|FG002|Step 2|Withdrawal by Subject|0
4758438|NCT01708941|7732623|FG000|Overall Study|Adverse Event|4
4758439|NCT01708941|7732624|FG001|Overall Study|Adverse Event|6
4758440|NCT01708941|7732625|FG002|Overall Study|Adverse Event|1
4758441|NCT01708941|7732626|FG003|Overall Study|Adverse Event|0
4758442|NCT01708941|7732623|FG000|Overall Study|Death|1
4758443|NCT01708941|7732624|FG001|Overall Study|Death|1
4758444|NCT01708941|7732625|FG002|Overall Study|Death|2
4758445|NCT01708941|7732626|FG003|Overall Study|Death|14
4758446|NCT01708941|7732623|FG000|Overall Study|Withdrawal by Subject|1
4758447|NCT01708941|7732624|FG001|Overall Study|Withdrawal by Subject|0
4758448|NCT01708941|7732625|FG002|Overall Study|Withdrawal by Subject|3
4758449|NCT01708941|7732626|FG003|Overall Study|Withdrawal by Subject|4
4758450|NCT01708941|7732623|FG000|Overall Study|Disease progression|9
4758451|NCT01708941|7732624|FG001|Overall Study|Disease progression|10
4758452|NCT01708941|7732625|FG002|Overall Study|Disease progression|8
4758453|NCT01708941|7732626|FG003|Overall Study|Disease progression|0
4758454|NCT01708941|7732623|FG000|Overall Study|Alternative therapy|0
4758455|NCT01708941|7732624|FG001|Overall Study|Alternative therapy|0
4758456|NCT01708941|7732625|FG002|Overall Study|Alternative therapy|2
4758457|NCT01708941|7732626|FG003|Overall Study|Alternative therapy|0
4758458|NCT01708941|7732623|FG000|Overall Study|Ineligible and never started treatment|1
4758459|NCT01708941|7732624|FG001|Overall Study|Ineligible and never started treatment|0
4758460|NCT01708941|7732625|FG002|Overall Study|Ineligible and never started treatment|1
4679797|NCT02432144|7582519|FG000|Overall Study|Participant Non-Compliance|1
4679798|NCT02432235|7582552|FG000|Overall Study|Death|1
4679799|NCT02432235|7582553|FG001|Overall Study|Death|1
4679800|NCT02432235|7582554|FG002|Overall Study|Death|2
4679801|NCT02432235|7582555|FG003|Overall Study|Death|2
4679802|NCT02432235|7582556|FG004|Overall Study|Death|1
4758461|NCT01708941|7732626|FG003|Overall Study|Ineligible and never started treatment|0
4758462|NCT01708941|7732623|FG000|Overall Study|Never started treatment|2
4758463|NCT01708941|7732624|FG001|Overall Study|Never started treatment|1
4758464|NCT01708941|7732625|FG002|Overall Study|Never started treatment|0
4758465|NCT01708941|7732626|FG003|Overall Study|Never started treatment|0
4758466|NCT01708941|7732623|FG000|Overall Study|Ineligible|0
4758467|NCT01708941|7732624|FG001|Overall Study|Ineligible|0
4758468|NCT01708941|7732625|FG002|Overall Study|Ineligible|2
4758469|NCT01708941|7732626|FG003|Overall Study|Ineligible|0
4758470|NCT01622868|7732638|FG000|Overall Study|Protocol Violation|7
4758471|NCT01622868|7732639|FG001|Overall Study|Protocol Violation|0
4758472|NCT01609790|7732648|FG000|Overall Study|Protocol Violation|1
4679803|NCT02432235|7582557|FG005|Overall Study|Death|3
4758473|NCT01609790|7732649|FG001|Overall Study|Protocol Violation|7
4758474|NCT01609790|7732650|FG002|Overall Study|Protocol Violation|8
4679804|NCT02432235|7582558|FG006|Overall Study|Death|11
4679805|NCT02432235|7582559|FG007|Overall Study|Death|15
4679806|NCT02432235|7582560|FG008|Overall Study|Death|15
4679807|NCT02432235|7582561|FG009|Overall Study|Death|3
4679808|NCT02432235|7582562|FG010|Overall Study|Death|1
4679809|NCT02432235|7582563|FG011|Overall Study|Death|0
4679810|NCT02432235|7582552|FG000|Overall Study|Withdrawal by Subject|0
4679811|NCT02432235|7582553|FG001|Overall Study|Withdrawal by Subject|1
4679812|NCT02432235|7582554|FG002|Overall Study|Withdrawal by Subject|0
4679813|NCT02432235|7582555|FG003|Overall Study|Withdrawal by Subject|0
4679814|NCT02432235|7582556|FG004|Overall Study|Withdrawal by Subject|0
4679815|NCT02432235|7582557|FG005|Overall Study|Withdrawal by Subject|2
4679816|NCT02432235|7582558|FG006|Overall Study|Withdrawal by Subject|5
4679817|NCT02432235|7582559|FG007|Overall Study|Withdrawal by Subject|3
4679818|NCT02432235|7582560|FG008|Overall Study|Withdrawal by Subject|1
4679819|NCT02432235|7582561|FG009|Overall Study|Withdrawal by Subject|0
4679820|NCT02432235|7582562|FG010|Overall Study|Withdrawal by Subject|0
4679821|NCT02432235|7582563|FG011|Overall Study|Withdrawal by Subject|0
4679822|NCT02432235|7582552|FG000|Overall Study|Lost to Follow-up|0
4679823|NCT02432235|7582553|FG001|Overall Study|Lost to Follow-up|0
4679824|NCT02432235|7582554|FG002|Overall Study|Lost to Follow-up|0
4679825|NCT02432235|7582555|FG003|Overall Study|Lost to Follow-up|0
4679826|NCT02432235|7582556|FG004|Overall Study|Lost to Follow-up|0
4679827|NCT02432235|7582557|FG005|Overall Study|Lost to Follow-up|1
4679828|NCT02432235|7582558|FG006|Overall Study|Lost to Follow-up|0
4679829|NCT02432235|7582559|FG007|Overall Study|Lost to Follow-up|0
4679830|NCT02432235|7582560|FG008|Overall Study|Lost to Follow-up|1
4679831|NCT02432235|7582561|FG009|Overall Study|Lost to Follow-up|0
4679832|NCT02432235|7582562|FG010|Overall Study|Lost to Follow-up|0
4679833|NCT02432235|7582563|FG011|Overall Study|Lost to Follow-up|0
4679834|NCT02432235|7582552|FG000|Overall Study|Miscellaneous|0
4679835|NCT02432235|7582553|FG001|Overall Study|Miscellaneous|0
4679836|NCT02432235|7582554|FG002|Overall Study|Miscellaneous|0
4679837|NCT02432235|7582555|FG003|Overall Study|Miscellaneous|0
4679838|NCT02432235|7582556|FG004|Overall Study|Miscellaneous|1
4679839|NCT02432235|7582557|FG005|Overall Study|Miscellaneous|6
4679840|NCT02432235|7582558|FG006|Overall Study|Miscellaneous|2
4679841|NCT02432235|7582559|FG007|Overall Study|Miscellaneous|2
4679842|NCT02432235|7582560|FG008|Overall Study|Miscellaneous|4
4679843|NCT02432235|7582561|FG009|Overall Study|Miscellaneous|0
4679844|NCT02432235|7582562|FG010|Overall Study|Miscellaneous|0
4679845|NCT02432235|7582563|FG011|Overall Study|Miscellaneous|1
4679846|NCT02432274|7582599|FG000|Overall Study|Radiological Disease Progression|3
4679847|NCT02432274|7582600|FG001|Overall Study|Radiological Disease Progression|4
4679848|NCT02432274|7582601|FG002|Overall Study|Radiological Disease Progression|7
4679849|NCT02432274|7582602|FG003|Overall Study|Radiological Disease Progression|0
4679850|NCT02432274|7582603|FG004|Overall Study|Radiological Disease Progression|24
4679851|NCT02432274|7582604|FG005|Overall Study|Radiological Disease Progression|6
4679852|NCT02432274|7582605|FG006|Overall Study|Radiological Disease Progression|11
4679853|NCT02432274|7582606|FG007|Overall Study|Radiological Disease Progression|9
4679854|NCT02432274|7582599|FG000|Overall Study|Clinical Disease Progression|0
4679855|NCT02432274|7582600|FG001|Overall Study|Clinical Disease Progression|4
4679856|NCT02432274|7582601|FG002|Overall Study|Clinical Disease Progression|1
4679857|NCT02432274|7582602|FG003|Overall Study|Clinical Disease Progression|0
4679858|NCT02432274|7582603|FG004|Overall Study|Clinical Disease Progression|1
4679859|NCT02432274|7582604|FG005|Overall Study|Clinical Disease Progression|0
4679860|NCT02432274|7582605|FG006|Overall Study|Clinical Disease Progression|0
4679861|NCT02432274|7582606|FG007|Overall Study|Clinical Disease Progression|1
4679862|NCT02432274|7582599|FG000|Overall Study|Adverse Event|0
4679863|NCT02432274|7582600|FG001|Overall Study|Adverse Event|0
4679864|NCT02432274|7582601|FG002|Overall Study|Adverse Event|1
4679865|NCT02432274|7582602|FG003|Overall Study|Adverse Event|0
4679866|NCT02432274|7582603|FG004|Overall Study|Adverse Event|1
4679867|NCT02432274|7582604|FG005|Overall Study|Adverse Event|0
4679868|NCT02432274|7582605|FG006|Overall Study|Adverse Event|2
4679869|NCT02432274|7582606|FG007|Overall Study|Adverse Event|0
4679870|NCT02432274|7582599|FG000|Overall Study|Withdrawal by Subject|0
4679871|NCT02432274|7582600|FG001|Overall Study|Withdrawal by Subject|0
4679872|NCT02432274|7582601|FG002|Overall Study|Withdrawal by Subject|0
4679873|NCT02432274|7582602|FG003|Overall Study|Withdrawal by Subject|0
4679874|NCT02432274|7582603|FG004|Overall Study|Withdrawal by Subject|2
4679875|NCT02432274|7582604|FG005|Overall Study|Withdrawal by Subject|0
4758475|NCT01586910|7732660|FG000|Overall Study|Death|4
4679876|NCT02432274|7582605|FG006|Overall Study|Withdrawal by Subject|1
4679877|NCT02432274|7582606|FG007|Overall Study|Withdrawal by Subject|2
4679878|NCT02432274|7582599|FG000|Overall Study|Participant Choice|0
4679879|NCT02432274|7582600|FG001|Overall Study|Participant Choice|0
4679880|NCT02432274|7582601|FG002|Overall Study|Participant Choice|1
4679881|NCT02432274|7582602|FG003|Overall Study|Participant Choice|0
4679882|NCT02432274|7582603|FG004|Overall Study|Participant Choice|0
4679883|NCT02432274|7582604|FG005|Overall Study|Participant Choice|0
4679884|NCT02432274|7582605|FG006|Overall Study|Participant Choice|1
4679885|NCT02432274|7582606|FG007|Overall Study|Participant Choice|0
4679886|NCT02432274|7582599|FG000|Overall Study|Other than specified|0
4679887|NCT02432274|7582600|FG001|Overall Study|Other than specified|1
4679888|NCT02432274|7582601|FG002|Overall Study|Other than specified|0
4679889|NCT02432274|7582602|FG003|Overall Study|Other than specified|0
4679890|NCT02432274|7582603|FG004|Overall Study|Other than specified|0
4679891|NCT02432274|7582604|FG005|Overall Study|Other than specified|1
4679892|NCT02432274|7582605|FG006|Overall Study|Other than specified|0
4679893|NCT02432274|7582606|FG007|Overall Study|Other than specified|1
4679894|NCT02432274|7582599|FG000|Overall Study|Ongoing|0
4679895|NCT02432274|7582600|FG001|Overall Study|Ongoing|0
4679896|NCT02432274|7582601|FG002|Overall Study|Ongoing|1
4679897|NCT02432274|7582602|FG003|Overall Study|Ongoing|1
4679898|NCT02432274|7582603|FG004|Overall Study|Ongoing|3
4679899|NCT02432274|7582604|FG005|Overall Study|Ongoing|0
4679900|NCT02432274|7582605|FG006|Overall Study|Ongoing|0
4679901|NCT02432274|7582606|FG007|Overall Study|Ongoing|7
4679902|NCT02432703|7582662|FG000|Overall Study|Adverse Event|1
4679903|NCT02432703|7582663|FG001|Overall Study|Adverse Event|4
4679904|NCT02432703|7582662|FG000|Overall Study|Lack of Efficacy|1
4679905|NCT02432703|7582663|FG001|Overall Study|Lack of Efficacy|0
4679906|NCT02432703|7582662|FG000|Overall Study|Lost to Follow-up|5
4679907|NCT02432703|7582663|FG001|Overall Study|Lost to Follow-up|3
4679908|NCT02432703|7582662|FG000|Overall Study|Withdrawal by Subject|9
4679909|NCT02432703|7582663|FG001|Overall Study|Withdrawal by Subject|6
4679910|NCT02432703|7582662|FG000|Overall Study|Other|6
4679911|NCT02432703|7582663|FG001|Overall Study|Other|5
4679912|NCT02433080|7582690|FG000|Overall Study|Lost to Follow-up|1
4679913|NCT02433080|7582691|FG001|Overall Study|Lost to Follow-up|2
4679914|NCT02433080|7582690|FG000|Overall Study|Withdrawal by Subject|0
4679915|NCT02433080|7582691|FG001|Overall Study|Withdrawal by Subject|2
4679916|NCT02433288|7582700|FG000|Overall Study|Severe non-compliance to protocol|13
4679917|NCT02433288|7582701|FG001|Overall Study|Severe non-compliance to protocol|7
4679918|NCT02433288|7582700|FG000|Overall Study|Eligibility criteria not fullfilled|7
4679919|NCT02433288|7582701|FG001|Overall Study|Eligibility criteria not fullfilled|3
4679920|NCT02433288|7582700|FG000|Overall Study|Withdrawal by Subject|101
4758476|NCT01586910|7732661|FG001|Overall Study|Death|4
4758477|NCT01586910|7732660|FG000|Overall Study|Withdrawal by Subject|6
4758478|NCT01586910|7732661|FG001|Overall Study|Withdrawal by Subject|43
4758479|NCT01586910|7732660|FG000|Overall Study|Physician withdrew Subject|5
4758480|NCT01586910|7732661|FG001|Overall Study|Physician withdrew Subject|24
4758481|NCT01553149|7732671|FG000|Overall Study|Adverse Event|0
4758482|NCT01553149|7732672|FG001|Overall Study|Adverse Event|9
4758483|NCT01553149|7732671|FG000|Overall Study|Physician Decision|5
4758484|NCT01553149|7732672|FG001|Overall Study|Physician Decision|10
4758485|NCT01553149|7732671|FG000|Overall Study|Ineligible|0
4758486|NCT01553149|7732672|FG001|Overall Study|Ineligible|1
4758487|NCT01371981|7732699|FG000|Overall Study|Adverse Event|12
4758488|NCT01371981|7732700|FG001|Overall Study|Adverse Event|17
4758489|NCT01371981|7732701|FG002|Overall Study|Adverse Event|0
4758490|NCT01371981|7732702|FG003|Overall Study|Adverse Event|4
4758491|NCT01371981|7732703|FG004|Overall Study|Adverse Event|1
4758492|NCT01371981|7732704|FG005|Overall Study|Adverse Event|0
4758493|NCT01371981|7732699|FG000|Overall Study|Death|22
4758494|NCT01371981|7732700|FG001|Overall Study|Death|16
4758495|NCT01371981|7732701|FG002|Overall Study|Death|0
4758496|NCT01371981|7732702|FG003|Overall Study|Death|0
4758497|NCT01371981|7732703|FG004|Overall Study|Death|2
4758498|NCT01371981|7732704|FG005|Overall Study|Death|2
4758499|NCT01371981|7732699|FG000|Overall Study|Lack of Efficacy|69
4758500|NCT01371981|7732700|FG001|Overall Study|Lack of Efficacy|61
4758501|NCT01371981|7732701|FG002|Overall Study|Lack of Efficacy|4
4758502|NCT01371981|7732702|FG003|Overall Study|Lack of Efficacy|8
4758503|NCT01371981|7732703|FG004|Overall Study|Lack of Efficacy|5
4758504|NCT01371981|7732704|FG005|Overall Study|Lack of Efficacy|0
4758505|NCT01371981|7732699|FG000|Overall Study|Physician Decision|48
4758506|NCT01371981|7732700|FG001|Overall Study|Physician Decision|63
4758507|NCT01371981|7732701|FG002|Overall Study|Physician Decision|1
4758508|NCT01371981|7732702|FG003|Overall Study|Physician Decision|7
4758509|NCT01371981|7732703|FG004|Overall Study|Physician Decision|14
4758510|NCT01371981|7732704|FG005|Overall Study|Physician Decision|3
4758511|NCT01371981|7732699|FG000|Overall Study|Withdrawal by Subject|12
4758512|NCT01371981|7732700|FG001|Overall Study|Withdrawal by Subject|19
4758513|NCT01371981|7732701|FG002|Overall Study|Withdrawal by Subject|1
4758514|NCT01371981|7732702|FG003|Overall Study|Withdrawal by Subject|2
4758515|NCT01371981|7732703|FG004|Overall Study|Withdrawal by Subject|10
4758516|NCT01371981|7732704|FG005|Overall Study|Withdrawal by Subject|3
4758517|NCT01371981|7732699|FG000|Overall Study|Ineligible|19
4679921|NCT02433288|7582701|FG001|Overall Study|Withdrawal by Subject|99
4679922|NCT02433288|7582700|FG000|Overall Study|Lost to Follow-up|2
4679923|NCT02433288|7582701|FG001|Overall Study|Lost to Follow-up|14
4679924|NCT02433288|7582700|FG000|Overall Study|Death|0
4679925|NCT02433288|7582701|FG001|Overall Study|Death|3
4679926|NCT02433340|7582711|FG000|Overall Study|Adverse Event|0
4758518|NCT01371981|7732700|FG001|Overall Study|Ineligible|13
4758519|NCT01371981|7732701|FG002|Overall Study|Ineligible|0
4758520|NCT01371981|7732702|FG003|Overall Study|Ineligible|0
4758521|NCT01371981|7732703|FG004|Overall Study|Ineligible|0
4758522|NCT01371981|7732704|FG005|Overall Study|Ineligible|4
4758523|NCT01371981|7732699|FG000|Overall Study|Did not start treatment|2
4679927|NCT02433340|7582712|FG001|Overall Study|Adverse Event|0
4679928|NCT02433340|7582713|FG002|Overall Study|Adverse Event|1
4679929|NCT02433340|7582714|FG003|Overall Study|Adverse Event|0
4679930|NCT02433340|7582711|FG000|Overall Study|Withdrawal by Subject|1
4679931|NCT02433340|7582712|FG001|Overall Study|Withdrawal by Subject|0
4679932|NCT02433340|7582713|FG002|Overall Study|Withdrawal by Subject|1
4679933|NCT02433340|7582714|FG003|Overall Study|Withdrawal by Subject|2
4679934|NCT02433340|7582711|FG000|Overall Study|Lost to Follow-up|0
4679935|NCT02433340|7582712|FG001|Overall Study|Lost to Follow-up|1
4679936|NCT02433340|7582713|FG002|Overall Study|Lost to Follow-up|0
4679937|NCT02433340|7582714|FG003|Overall Study|Lost to Follow-up|0
4679938|NCT02433340|7582711|FG000|Overall Study|Required Alternative/Prohibited Therapy|1
4679939|NCT02433340|7582712|FG001|Overall Study|Required Alternative/Prohibited Therapy|0
4679940|NCT02433340|7582713|FG002|Overall Study|Required Alternative/Prohibited Therapy|0
4679941|NCT02433340|7582714|FG003|Overall Study|Required Alternative/Prohibited Therapy|0
4679942|NCT02433340|7582711|FG000|Overall Study|Other|0
4679943|NCT02433340|7582712|FG001|Overall Study|Other|1
4679944|NCT02433340|7582713|FG002|Overall Study|Other|0
4679945|NCT02433340|7582714|FG003|Overall Study|Other|0
4679946|NCT02433379|7582735|FG000|Overall Study|Screen Failures|55
4679947|NCT02433379|7582735|FG000|Overall Study|Death|57
4679948|NCT02433379|7582735|FG000|Overall Study|Total Withdrawals|209
4679949|NCT02433483|7582741|FG000|Overall Study|Unacceptable toxicity|1
4679950|NCT02433483|7582741|FG000|Overall Study|Other antineoplastic therapy/HSCT|1
4758524|NCT01371981|7732700|FG001|Overall Study|Did not start treatment|3
4758525|NCT01371981|7732701|FG002|Overall Study|Did not start treatment|0
4758526|NCT01371981|7732702|FG003|Overall Study|Did not start treatment|0
4758527|NCT01371981|7732703|FG004|Overall Study|Did not start treatment|0
4758528|NCT01371981|7732704|FG005|Overall Study|Did not start treatment|2
4758529|NCT01236560|7732746|FG000|Overall Study|Adverse Event|0
4758530|NCT01236560|7732747|FG001|Overall Study|Adverse Event|2
4758531|NCT01236560|7732748|FG002|Overall Study|Adverse Event|1
4758532|NCT01236560|7732749|FG003|Overall Study|Adverse Event|3
4758533|NCT01236560|7732750|FG004|Overall Study|Adverse Event|0
4758534|NCT01236560|7732751|FG005|Overall Study|Adverse Event|0
4758535|NCT01236560|7732746|FG000|Overall Study|Death|0
4758536|NCT01236560|7732747|FG001|Overall Study|Death|1
4758537|NCT01236560|7732748|FG002|Overall Study|Death|0
4758538|NCT01236560|7732749|FG003|Overall Study|Death|1
4758539|NCT01236560|7732750|FG004|Overall Study|Death|0
4758540|NCT01236560|7732751|FG005|Overall Study|Death|0
4758541|NCT01236560|7732746|FG000|Overall Study|Lost to Follow-up|0
4758542|NCT01236560|7732747|FG001|Overall Study|Lost to Follow-up|1
4758543|NCT01236560|7732748|FG002|Overall Study|Lost to Follow-up|1
4758544|NCT01236560|7732749|FG003|Overall Study|Lost to Follow-up|0
4758545|NCT01236560|7732750|FG004|Overall Study|Lost to Follow-up|0
4758546|NCT01236560|7732751|FG005|Overall Study|Lost to Follow-up|0
4758547|NCT01236560|7732746|FG000|Overall Study|Physician Decision|0
4758548|NCT01236560|7732747|FG001|Overall Study|Physician Decision|1
4758549|NCT01236560|7732748|FG002|Overall Study|Physician Decision|8
4758550|NCT01236560|7732749|FG003|Overall Study|Physician Decision|0
4758551|NCT01236560|7732750|FG004|Overall Study|Physician Decision|0
4758552|NCT01236560|7732751|FG005|Overall Study|Physician Decision|0
4758553|NCT01236560|7732746|FG000|Overall Study|Withdrawal by Subject|0
4758554|NCT01236560|7732747|FG001|Overall Study|Withdrawal by Subject|0
4758555|NCT01236560|7732748|FG002|Overall Study|Withdrawal by Subject|1
4758556|NCT01236560|7732749|FG003|Overall Study|Withdrawal by Subject|2
4758557|NCT01236560|7732750|FG004|Overall Study|Withdrawal by Subject|0
4758558|NCT01236560|7732751|FG005|Overall Study|Withdrawal by Subject|0
4758559|NCT01236560|7732746|FG000|Overall Study|Progressive disease|5
4758560|NCT01236560|7732747|FG001|Overall Study|Progressive disease|19
4758561|NCT01236560|7732748|FG002|Overall Study|Progressive disease|9
4758562|NCT01236560|7732749|FG003|Overall Study|Progressive disease|16
4758563|NCT01236560|7732750|FG004|Overall Study|Progressive disease|0
4758564|NCT01236560|7732751|FG005|Overall Study|Progressive disease|0
4758565|NCT01236547|7732766|FG000|Overall Study|Protocol Violation|0
4758566|NCT01236547|7732767|FG001|Overall Study|Protocol Violation|1
4758567|NCT01236547|7732768|FG002|Overall Study|Protocol Violation|1
4758568|NCT01236547|7732769|FG003|Overall Study|Protocol Violation|6
4758569|NCT01236547|7732770|FG004|Overall Study|Protocol Violation|12
4758570|NCT01142388|7732785|FG000|Overall Study|Lack of Efficacy|21
4758571|NCT01142388|7732786|FG001|Overall Study|Lack of Efficacy|31
4758572|NCT01142388|7732785|FG000|Overall Study|Adverse Event|9
4758573|NCT01142388|7732786|FG001|Overall Study|Adverse Event|5
4758574|NCT01142388|7732785|FG000|Overall Study|Death|3
4679951|NCT02433678|7582772|FG000|Overall Study|Lost to Follow-up|1
4679952|NCT02433678|7582773|FG001|Overall Study|Lost to Follow-up|2
4679953|NCT02433834|7582779|FG000|Overall Study|Protocol-specified criteria|7
4679954|NCT02433834|7582779|FG000|Overall Study|Protocol Violation|3
4679955|NCT02433834|7582779|FG000|Overall Study|Lost to Follow-up|6
4758575|NCT01142388|7732786|FG001|Overall Study|Death|2
4758576|NCT01142388|7732785|FG000|Overall Study|Withdrawal by Subject|5
4758577|NCT01142388|7732786|FG001|Overall Study|Withdrawal by Subject|3
4758578|NCT01142388|7732785|FG000|Overall Study|Alternative therapy|1
4758579|NCT01142388|7732786|FG001|Overall Study|Alternative therapy|0
4758580|NCT01142388|7732785|FG000|Overall Study|Other complications|0
4679956|NCT02433834|7582779|FG000|Overall Study|Withdrawal by Subject|14
4679957|NCT02433834|7582779|FG000|Overall Study|Adverse Event|6
4679958|NCT02433834|7582779|FG000|Overall Study|Physician Decision|1
4679959|NCT02434081|7582799|FG000|Overall Study|Death (never started treatment)|2
4679960|NCT02434081|7582799|FG000|Overall Study|Death|2
4758581|NCT01142388|7732786|FG001|Overall Study|Other complications|2
4758582|NCT01142388|7732785|FG000|Overall Study|Other|1
4758583|NCT01142388|7732786|FG001|Overall Study|Other|1
4758584|NCT01142388|7732785|FG000|Overall Study|Never started therapy|7
4758585|NCT01142388|7732786|FG001|Overall Study|Never started therapy|3
4758586|NCT01134614|7732794|FG000|Overall Study|Still on treatment as of March 2013|21
4758587|NCT01134614|7732795|FG001|Overall Study|Still on treatment as of March 2013|13
4758588|NCT01134614|7732794|FG000|Overall Study|Progressive disease|60
4758589|NCT01134614|7732795|FG001|Overall Study|Progressive disease|54
4758590|NCT01134614|7732794|FG000|Overall Study|Adverse Event|26
4758591|NCT01134614|7732795|FG001|Overall Study|Adverse Event|39
4758592|NCT01134614|7732794|FG000|Overall Study|Death|5
4679961|NCT02434081|7582799|FG000|Overall Study|Progression|20
4679962|NCT02434081|7582799|FG000|Overall Study|Adverse Event|20
4679963|NCT02434081|7582799|FG000|Overall Study|Physician Decision|2
4679964|NCT02434081|7582799|FG000|Overall Study|Withdrawal by Subject|1
4679965|NCT02434081|7582799|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1
4679966|NCT02434328|7582805|FG000|Overall Study|Adverse Event|9
4679967|NCT02434328|7582806|FG001|Overall Study|Adverse Event|4
4679968|NCT02434328|7582805|FG000|Overall Study|Lack of Efficacy|0
4679969|NCT02434328|7582806|FG001|Overall Study|Lack of Efficacy|2
4679970|NCT02434328|7582805|FG000|Overall Study|Physician Decision|0
4679971|NCT02434328|7582806|FG001|Overall Study|Physician Decision|1
4679972|NCT02434328|7582805|FG000|Overall Study|Withdrawal by Subject|12
4679973|NCT02434328|7582806|FG001|Overall Study|Withdrawal by Subject|21
4679974|NCT02434328|7582805|FG000|Overall Study|Death|4
4679975|NCT02434328|7582806|FG001|Overall Study|Death|7
4679976|NCT02434328|7582805|FG000|Overall Study|Lost to Follow-up|1
4679977|NCT02434328|7582806|FG001|Overall Study|Lost to Follow-up|6
4679978|NCT02434328|7582805|FG000|Overall Study|Other|4
4679979|NCT02434328|7582806|FG001|Overall Study|Other|1
4679980|NCT02434471|7582813|FG000|Overall Study|Physician Decision|9
4679981|NCT02434770|7582838|FG000|Week 1 to Week 18|Lost to Follow-up|0
4679982|NCT02434770|7582839|FG001|Week 1 to Week 18|Lost to Follow-up|0
4679983|NCT02434770|7582840|FG002|Week 1 to Week 18|Lost to Follow-up|2
4679984|NCT02434770|7582838|FG000|Week 1 to Week 18|Withdrawal by Subject|6
4679985|NCT02434770|7582839|FG001|Week 1 to Week 18|Withdrawal by Subject|12
4679986|NCT02434770|7582840|FG002|Week 1 to Week 18|Withdrawal by Subject|5
4679987|NCT02434770|7582838|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8
4679988|NCT02434770|7582839|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10
4679989|NCT02434770|7582840|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9
4679990|NCT02434770|7582838|FG000|Week 1 to Week 18|Relocated Out of Study Area|0
4679991|NCT02434770|7582839|FG001|Week 1 to Week 18|Relocated Out of Study Area|0
4679992|NCT02434770|7582840|FG002|Week 1 to Week 18|Relocated Out of Study Area|1
4679993|NCT02434770|7582838|FG000|Week 1 to Week 18|Death|1
4679994|NCT02434770|7582839|FG001|Week 1 to Week 18|Death|0
4679995|NCT02434770|7582840|FG002|Week 1 to Week 18|Death|0
4679996|NCT02434770|7582838|FG000|Week 18 to Week|Lost to Follow-up|2
4679997|NCT02434770|7582839|FG001|Week 18 to Week|Lost to Follow-up|2
4679998|NCT02434770|7582840|FG002|Week 18 to Week|Lost to Follow-up|1
4679999|NCT02434770|7582838|FG000|Week 18 to Week|Withdrawal by Subject|0
4680000|NCT02434770|7582839|FG001|Week 18 to Week|Withdrawal by Subject|0
4680001|NCT02434770|7582840|FG002|Week 18 to Week|Withdrawal by Subject|2
4680002|NCT02434770|7582838|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6
4680003|NCT02434770|7582839|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6
4680004|NCT02434770|7582840|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3
4680005|NCT02434939|7582852|FG000|Overall Study|Lack of Efficacy|34
4680006|NCT02434939|7582853|FG001|Overall Study|Lack of Efficacy|48
4680007|NCT02434939|7582852|FG000|Overall Study|Withdrawal by Subject|3
4680008|NCT02434939|7582853|FG001|Overall Study|Withdrawal by Subject|0
4680009|NCT02434939|7582852|FG000|Overall Study|Adverse Event|0
4680010|NCT02434939|7582853|FG001|Overall Study|Adverse Event|1
4680011|NCT02435069|7582860|FG000|Dose Response - First Intervention|Adverse Event|0
4680012|NCT02435069|7582861|FG001|Dose Response - First Intervention|Adverse Event|1
4680013|NCT02435069|7582862|FG002|Dose Response - First Intervention|Adverse Event|1
4680014|NCT02435069|7582863|FG003|Dose Response - First Intervention|Adverse Event|0
4680015|NCT02435069|7582864|FG004|Dose Response - First Intervention|Adverse Event|0
4758593|NCT01134614|7732795|FG001|Overall Study|Death|8
4758594|NCT01134614|7732794|FG000|Overall Study|Withdrawal by Subject|3
4680016|NCT02435069|7582860|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0
4680017|NCT02435069|7582861|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0
4680018|NCT02435069|7582862|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0
4680019|NCT02435069|7582863|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0
4680020|NCT02435069|7582864|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1
4680021|NCT02435147|7582884|FG000|Overall Study|non-evaluable DXA scan|11
4680022|NCT02435277|7582892|FG000|Overall Study|Adverse Event|1
4758595|NCT01134614|7732795|FG001|Overall Study|Withdrawal by Subject|2
4680023|NCT02435277|7582893|FG001|Overall Study|Adverse Event|1
4680024|NCT02435277|7582894|FG002|Overall Study|Adverse Event|0
4680025|NCT02435277|7582895|FG003|Overall Study|Adverse Event|0
4680026|NCT02435277|7582892|FG000|Overall Study|Withdrawal by Subject|1
4680027|NCT02435277|7582893|FG001|Overall Study|Withdrawal by Subject|0
4680028|NCT02435277|7582894|FG002|Overall Study|Withdrawal by Subject|0
4680029|NCT02435277|7582895|FG003|Overall Study|Withdrawal by Subject|0
4680030|NCT02435381|7582905|FG000|Overall Study|Lost to Follow-up|2
4680031|NCT02435381|7582906|FG001|Overall Study|Lost to Follow-up|1
4680032|NCT02435680|7582943|FG000|Overall Study|Physician Decision|3
4680033|NCT02435680|7582944|FG001|Overall Study|Physician Decision|0
4680034|NCT02435680|7582945|FG002|Overall Study|Physician Decision|0
4680035|NCT02435680|7582943|FG000|Overall Study|subject / guardian decision|0
4680036|NCT02435680|7582944|FG001|Overall Study|subject / guardian decision|3
4680037|NCT02435680|7582945|FG002|Overall Study|subject / guardian decision|2
4680038|NCT02435680|7582943|FG000|Overall Study|Adverse Event|8
4680039|NCT02435680|7582944|FG001|Overall Study|Adverse Event|3
4680040|NCT02435680|7582945|FG002|Overall Study|Adverse Event|2
4680041|NCT02435680|7582943|FG000|Overall Study|progressive disease|10
4680042|NCT02435680|7582944|FG001|Overall Study|progressive disease|7
4680043|NCT02435680|7582945|FG002|Overall Study|progressive disease|11
4680044|NCT02435680|7582943|FG000|Overall Study|not treated|0
4680045|NCT02435680|7582944|FG001|Overall Study|not treated|0
4680046|NCT02435680|7582945|FG002|Overall Study|not treated|1
4680047|NCT02435836|7582966|FG000|Overall Study|Lost to Follow-up|21
4680048|NCT02435836|7582966|FG000|Overall Study|Lack of Efficacy|1
4680049|NCT02435836|7582966|FG000|Overall Study|Withdrawal by Subject|236
4680050|NCT02435836|7582966|FG000|Overall Study|Insufficient Clinical Response|26
4680051|NCT02435836|7582966|FG000|Overall Study|Adverse Event|44
4680052|NCT02435836|7582966|FG000|Overall Study|Sponsor discontinued trial|167
4680053|NCT02435836|7582966|FG000|Overall Study|Noncompliance|27
4680054|NCT02435836|7582966|FG000|Overall Study|Protocol Violation|6
4680055|NCT02435836|7582966|FG000|Overall Study|Met Withdrawal Criteria|7
4680056|NCT02435836|7582966|FG000|Overall Study|AE of Worsening Schizophrenia|96
4680057|NCT02435914|7582979|FG000|Overall Study|Ocular Adverse Event|1
4680058|NCT02435914|7582980|FG001|Overall Study|Ocular Adverse Event|0
4680059|NCT02435914|7582981|FG002|Overall Study|Ocular Adverse Event|0
4680060|NCT02435914|7582982|FG003|Overall Study|Ocular Adverse Event|0
4680061|NCT02435914|7582979|FG000|Overall Study|Withdrawal by Subject|0
4680062|NCT02435914|7582980|FG001|Overall Study|Withdrawal by Subject|1
4680063|NCT02435914|7582981|FG002|Overall Study|Withdrawal by Subject|0
4680064|NCT02435914|7582982|FG003|Overall Study|Withdrawal by Subject|0
4680065|NCT02435914|7582979|FG000|Overall Study|Other Miscellaneous Reason|0
4680066|NCT02435914|7582980|FG001|Overall Study|Other Miscellaneous Reason|0
4680067|NCT02435914|7582981|FG002|Overall Study|Other Miscellaneous Reason|1
4680068|NCT02435914|7582982|FG003|Overall Study|Other Miscellaneous Reason|0
4680069|NCT02435966|7582995|FG000|Overall Study|Withdrawal by Subject|0
4680070|NCT02435966|7582996|FG001|Overall Study|Withdrawal by Subject|1
4680071|NCT02435966|7582997|FG002|Overall Study|Withdrawal by Subject|0
4680072|NCT02435992|7583010|FG000|Overall Study|non compliance with protocol|2
4680073|NCT02435992|7583011|FG001|Overall Study|non compliance with protocol|0
4680074|NCT02435992|7583012|FG002|Overall Study|non compliance with protocol|1
4680075|NCT02435992|7583013|FG003|Overall Study|non compliance with protocol|0
4680076|NCT02435992|7583014|FG004|Overall Study|non compliance with protocol|0
4680077|NCT02435992|7583010|FG000|Overall Study|Adverse Event|11
4680078|NCT02435992|7583011|FG001|Overall Study|Adverse Event|6
4680079|NCT02435992|7583012|FG002|Overall Study|Adverse Event|12
4680080|NCT02435992|7583013|FG003|Overall Study|Adverse Event|0
4680081|NCT02435992|7583014|FG004|Overall Study|Adverse Event|0
4680082|NCT02435992|7583010|FG000|Overall Study|Lack of Efficacy|4
4680083|NCT02435992|7583011|FG001|Overall Study|Lack of Efficacy|10
4680084|NCT02435992|7583012|FG002|Overall Study|Lack of Efficacy|9
4680085|NCT02435992|7583013|FG003|Overall Study|Lack of Efficacy|0
4680086|NCT02435992|7583014|FG004|Overall Study|Lack of Efficacy|0
4680087|NCT02435992|7583010|FG000|Overall Study|Withdrawal by Subject|10
4680088|NCT02435992|7583011|FG001|Overall Study|Withdrawal by Subject|8
4680089|NCT02435992|7583012|FG002|Overall Study|Withdrawal by Subject|20
4680090|NCT02435992|7583013|FG003|Overall Study|Withdrawal by Subject|0
4680091|NCT02435992|7583014|FG004|Overall Study|Withdrawal by Subject|0
4680092|NCT02435992|7583010|FG000|Overall Study|Other Reason|1
4680093|NCT02435992|7583011|FG001|Overall Study|Other Reason|0
4680094|NCT02435992|7583012|FG002|Overall Study|Other Reason|0
4680095|NCT02435992|7583013|FG003|Overall Study|Other Reason|0
4680096|NCT02435992|7583014|FG004|Overall Study|Other Reason|0
4680097|NCT02435992|7583010|FG000|Overall Study|Physician Decision|0
4758596|NCT01134614|7732794|FG000|Overall Study|Alternative therapy|2
4680098|NCT02435992|7583011|FG001|Overall Study|Physician Decision|0
4680099|NCT02435992|7583012|FG002|Overall Study|Physician Decision|1
4758597|NCT01134614|7732795|FG001|Overall Study|Alternative therapy|0
4680100|NCT02435992|7583013|FG003|Overall Study|Physician Decision|0
4680101|NCT02435992|7583014|FG004|Overall Study|Physician Decision|0
4680102|NCT02436005|7583026|FG000|Second Intervention|Adverse Event|0
4680103|NCT02436005|7583027|FG001|Second Intervention|Adverse Event|1
4680104|NCT02436135|7583042|FG000|Overall Study|Progressive Disease|3
4680105|NCT02436135|7583043|FG001|Overall Study|Progressive Disease|1
4680106|NCT02436135|7583042|FG000|Overall Study|Investigator Discretion|1
4680107|NCT02436135|7583043|FG001|Overall Study|Investigator Discretion|2
4680108|NCT02436135|7583042|FG000|Overall Study|Adverse Event|1
4680109|NCT02436135|7583043|FG001|Overall Study|Adverse Event|0
4680110|NCT02436135|7583042|FG000|Overall Study|Withdrawal by Participant|1
4680111|NCT02436135|7583043|FG001|Overall Study|Withdrawal by Participant|0
4680112|NCT02436135|7583042|FG000|Overall Study|Study Terminated By Sponsor|0
4680113|NCT02436135|7583043|FG001|Overall Study|Study Terminated By Sponsor|1
4680114|NCT02436200|7583049|FG000|Overall Study|Significant outlier|1
4680115|NCT02436239|7583057|FG000|Open-Lable Treatment Period|Adverse Event|12
4680116|NCT02436239|7583058|FG001|Open-Lable Treatment Period|Adverse Event|3
4680117|NCT02436239|7583059|FG002|Open-Lable Treatment Period|Adverse Event|4
4680118|NCT02436239|7583060|FG003|Open-Lable Treatment Period|Adverse Event|2
4680119|NCT02436239|7583057|FG000|Open-Lable Treatment Period|Lack of Efficacy|1
4680120|NCT02436239|7583058|FG001|Open-Lable Treatment Period|Lack of Efficacy|6
4680121|NCT02436239|7583059|FG002|Open-Lable Treatment Period|Lack of Efficacy|6
4680122|NCT02436239|7583060|FG003|Open-Lable Treatment Period|Lack of Efficacy|1
4680123|NCT02436239|7583057|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10
4680124|NCT02436239|7583058|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15
4680125|NCT02436239|7583059|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9
4680126|NCT02436239|7583060|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0
4680127|NCT02436239|7583057|FG000|Open-Lable Treatment Period|Lost to Follow-up|4
4680128|NCT02436239|7583058|FG001|Open-Lable Treatment Period|Lost to Follow-up|2
4680129|NCT02436239|7583059|FG002|Open-Lable Treatment Period|Lost to Follow-up|4
4758598|NCT01134614|7732794|FG000|Overall Study|Complicating disease|2
4758599|NCT01134614|7732795|FG001|Overall Study|Complicating disease|1
4758600|NCT01134614|7732794|FG000|Overall Study|Physician's decision|0
4758601|NCT01134614|7732795|FG001|Overall Study|Physician's decision|1
4758602|NCT01134614|7732794|FG000|Overall Study|Never started treatment|4
4758603|NCT01134614|7732795|FG001|Overall Study|Never started treatment|1
4758604|NCT01134614|7732794|FG000|Overall Study|Pt received tx not allowed on study|0
4758605|NCT01134614|7732795|FG001|Overall Study|Pt received tx not allowed on study|1
4758606|NCT01134614|7732794|FG000|Overall Study|Symptomatic deterioration|0
4758607|NCT01134614|7732795|FG001|Overall Study|Symptomatic deterioration|1
4758608|NCT01134614|7732794|FG000|Overall Study|Patient in hospice care|0
4758609|NCT01134614|7732795|FG001|Overall Study|Patient in hospice care|1
4758610|NCT01062425|7732803|FG000|Overall Study|Protocol Violation|3
4758611|NCT01062425|7732804|FG001|Overall Study|Protocol Violation|6
4758612|NCT00980460|7732815|FG000|Overall Study|Death|0
4758613|NCT00980460|7732816|FG001|Overall Study|Death|0
4758614|NCT00980460|7732817|FG002|Overall Study|Death|1
4758615|NCT00980460|7732818|FG003|Overall Study|Death|2
4758616|NCT00980460|7732819|FG004|Overall Study|Death|1
4758617|NCT00980460|7732815|FG000|Overall Study|Lack of Efficacy|0
4758618|NCT00980460|7732816|FG001|Overall Study|Lack of Efficacy|0
4758619|NCT00980460|7732817|FG002|Overall Study|Lack of Efficacy|10
4758620|NCT00980460|7732818|FG003|Overall Study|Lack of Efficacy|6
4758621|NCT00980460|7732819|FG004|Overall Study|Lack of Efficacy|8
4758622|NCT00980460|7732815|FG000|Overall Study|Lost to Follow-up|0
4758623|NCT00980460|7732816|FG001|Overall Study|Lost to Follow-up|0
4758624|NCT00980460|7732817|FG002|Overall Study|Lost to Follow-up|0
4758625|NCT00980460|7732818|FG003|Overall Study|Lost to Follow-up|1
4758626|NCT00980460|7732819|FG004|Overall Study|Lost to Follow-up|0
4758627|NCT00980460|7732815|FG000|Overall Study|Physician Decision|0
4758628|NCT00980460|7732816|FG001|Overall Study|Physician Decision|0
4758629|NCT00980460|7732817|FG002|Overall Study|Physician Decision|11
4758630|NCT00980460|7732818|FG003|Overall Study|Physician Decision|5
4758631|NCT00980460|7732819|FG004|Overall Study|Physician Decision|3
4758632|NCT00980460|7732815|FG000|Overall Study|Withdrawal by Subject|0
4758633|NCT00980460|7732816|FG001|Overall Study|Withdrawal by Subject|0
4758634|NCT00980460|7732817|FG002|Overall Study|Withdrawal by Subject|1
4758635|NCT00980460|7732818|FG003|Overall Study|Withdrawal by Subject|0
4758636|NCT00980460|7732819|FG004|Overall Study|Withdrawal by Subject|0
4758637|NCT00980460|7732815|FG000|Overall Study|Ineligible|0
4758638|NCT00980460|7732816|FG001|Overall Study|Ineligible|2
4758639|NCT00980460|7732817|FG002|Overall Study|Ineligible|3
4758640|NCT00980460|7732818|FG003|Overall Study|Ineligible|1
4758641|NCT00980460|7732819|FG004|Overall Study|Ineligible|4
4758642|NCT00980460|7732815|FG000|Overall Study|Refusal of further therapy|0
4758643|NCT00980460|7732816|FG001|Overall Study|Refusal of further therapy|2
4758644|NCT00980460|7732817|FG002|Overall Study|Refusal of further therapy|3
4680130|NCT02436239|7583060|FG003|Open-Lable Treatment Period|Lost to Follow-up|1
4680131|NCT02436239|7583057|FG000|Open-Lable Treatment Period|Protocol Violation|0
4680132|NCT02436239|7583058|FG001|Open-Lable Treatment Period|Protocol Violation|1
4758645|NCT00980460|7732818|FG003|Overall Study|Refusal of further therapy|2
4758646|NCT00980460|7732819|FG004|Overall Study|Refusal of further therapy|0
4758647|NCT00980460|7732815|FG000|Overall Study|No therapy within 42 days of resection|0
4758648|NCT00980460|7732816|FG001|Overall Study|No therapy within 42 days of resection|0
4758649|NCT00980460|7732817|FG002|Overall Study|No therapy within 42 days of resection|3
4758650|NCT00980460|7732818|FG003|Overall Study|No therapy within 42 days of resection|1
4758651|NCT00980460|7732819|FG004|Overall Study|No therapy within 42 days of resection|0
4758652|NCT00980460|7732815|FG000|Overall Study|No transplant by protocol timepoints|0
4680133|NCT02436239|7583059|FG002|Open-Lable Treatment Period|Protocol Violation|1
4680134|NCT02436239|7583060|FG003|Open-Lable Treatment Period|Protocol Violation|0
4680135|NCT02436239|7583057|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5
4680136|NCT02436239|7583058|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6
4680137|NCT02436239|7583059|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3
4680138|NCT02436239|7583060|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1
4680139|NCT02436239|7583057|FG000|Open-Lable Treatment Period|Other Reason|1
4680140|NCT02436239|7583058|FG001|Open-Lable Treatment Period|Other Reason|1
4680141|NCT02436239|7583059|FG002|Open-Lable Treatment Period|Other Reason|0
4680142|NCT02436239|7583060|FG003|Open-Lable Treatment Period|Other Reason|0
4680143|NCT02436239|7583057|FG000|Down-Taper Period|Withdrawal by Subject|4
4680144|NCT02436239|7583058|FG001|Down-Taper Period|Withdrawal by Subject|4
4680145|NCT02436239|7583059|FG002|Down-Taper Period|Withdrawal by Subject|1
4680146|NCT02436239|7583060|FG003|Down-Taper Period|Withdrawal by Subject|2
4680147|NCT02436304|7583073|FG000|Overall Study|Lost to Follow-up|0
4680148|NCT02436304|7583074|FG001|Overall Study|Lost to Follow-up|1
4680149|NCT02436304|7583075|FG002|Overall Study|Lost to Follow-up|0
4680150|NCT02436304|7583073|FG000|Overall Study|Withdrawal by Subject|0
4680151|NCT02436304|7583074|FG001|Overall Study|Withdrawal by Subject|1
4680152|NCT02436304|7583075|FG002|Overall Study|Withdrawal by Subject|0
4680153|NCT02436304|7583073|FG000|Overall Study|Randomized in error didn't meet I/E crit|0
4680154|NCT02436304|7583074|FG001|Overall Study|Randomized in error didn't meet I/E crit|0
4680155|NCT02436304|7583075|FG002|Overall Study|Randomized in error didn't meet I/E crit|1
4680156|NCT02436330|7583086|FG000|Cohort 1|Lost to Follow-up|5
4680157|NCT02436330|7583087|FG001|Cohort 1|Lost to Follow-up|2
4680158|NCT02436330|7583086|FG000|Cohort 1|Withdrawal by Subject|0
4680159|NCT02436330|7583087|FG001|Cohort 1|Withdrawal by Subject|1
4680160|NCT02436330|7583086|FG000|Cohort 2|Lost to Follow-up|2
4680161|NCT02436330|7583087|FG001|Cohort 2|Lost to Follow-up|0
4680162|NCT02436330|7583086|FG000|Cohort 2|Withdrawal by Subject|2
4680163|NCT02436330|7583087|FG001|Cohort 2|Withdrawal by Subject|3
4680164|NCT02436330|7583086|FG000|Cohort 3|Lost to Follow-up|1
4680165|NCT02436330|7583087|FG001|Cohort 3|Lost to Follow-up|0
4680166|NCT02436330|7583086|FG000|Cohort 3|Withdrawal by Subject|4
4680167|NCT02436330|7583087|FG001|Cohort 3|Withdrawal by Subject|0
4680168|NCT02436330|7583086|FG000|Cohort 4|Lost to Follow-up|1
4680169|NCT02436330|7583087|FG001|Cohort 4|Lost to Follow-up|0
4680170|NCT02436330|7583086|FG000|Cohort 4|Withdrawal by Subject|1
4680171|NCT02436330|7583087|FG001|Cohort 4|Withdrawal by Subject|0
4680172|NCT02436330|7583086|FG000|Cohort 5|Lost to Follow-up|3
4680173|NCT02436330|7583087|FG001|Cohort 5|Lost to Follow-up|2
4680174|NCT02436330|7583086|FG000|Cohort 5|Withdrawal by Subject|3
4680175|NCT02436330|7583087|FG001|Cohort 5|Withdrawal by Subject|2
4680176|NCT02436330|7583086|FG000|Cohort 6|Lost to Follow-up|2
4680177|NCT02436330|7583087|FG001|Cohort 6|Lost to Follow-up|0
4680178|NCT02436330|7583086|FG000|Cohort 6|Withdrawal by Subject|1
4680179|NCT02436330|7583087|FG001|Cohort 6|Withdrawal by Subject|1
4680180|NCT02436356|7583102|FG000|Overall Study|Excluded by MRI Screening|0
4680181|NCT02436356|7583103|FG001|Overall Study|Excluded by MRI Screening|0
4680182|NCT02436356|7583104|FG002|Overall Study|Excluded by MRI Screening|2
4680183|NCT02436356|7583102|FG000|Overall Study|Lost to Follow-up|0
4680184|NCT02436356|7583103|FG001|Overall Study|Lost to Follow-up|1
4680185|NCT02436356|7583104|FG002|Overall Study|Lost to Follow-up|0
4680186|NCT02436356|7583102|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1
4680187|NCT02436356|7583103|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0
4680188|NCT02436356|7583104|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0
4680189|NCT02436356|7583102|FG000|Overall Study|Excluded due to other medical conditions|3
4680190|NCT02436356|7583103|FG001|Overall Study|Excluded due to other medical conditions|0
4680191|NCT02436356|7583104|FG002|Overall Study|Excluded due to other medical conditions|0
4680192|NCT02436356|7583102|FG000|Overall Study|Withdrawal by Subject|1
4680193|NCT02436356|7583103|FG001|Overall Study|Withdrawal by Subject|0
4680194|NCT02436356|7583104|FG002|Overall Study|Withdrawal by Subject|0
4680195|NCT02436408|7583117|FG000|Overall Study|Death|1
4680196|NCT02436577|7583127|FG000|Overall Study|Protocol Deviation|0
4680197|NCT02436577|7583128|FG001|Overall Study|Protocol Deviation|1
4680198|NCT02436577|7583129|FG002|Overall Study|Protocol Deviation|0
4680199|NCT02436577|7583130|FG003|Overall Study|Protocol Deviation|0
4680200|NCT02436577|7583131|FG004|Overall Study|Protocol Deviation|0
4680201|NCT02436577|7583132|FG005|Overall Study|Protocol Deviation|0
4680202|NCT02436681|7583152|FG000|Overall Study|Lost to Follow-up|10
4680203|NCT02436681|7583152|FG000|Overall Study|Withdrawal by Subject|2
4680204|NCT02436681|7583152|FG000|Overall Study|Death|2
4680205|NCT02436759|7583158|FG000|Overall Study|Adverse Event|3
4680206|NCT02436759|7583159|FG001|Overall Study|Adverse Event|0
4680207|NCT02436759|7583158|FG000|Overall Study|Protocol Violation|1
4680208|NCT02436759|7583159|FG001|Overall Study|Protocol Violation|0
4680209|NCT02436759|7583158|FG000|Overall Study|Withdrawal by Subject|0
4680210|NCT02436759|7583159|FG001|Overall Study|Withdrawal by Subject|1
4680211|NCT02436811|7583168|FG000|Overall Study|Lost to Follow-up|2
4680212|NCT02436811|7583169|FG001|Overall Study|Lost to Follow-up|9
4680213|NCT02436811|7583170|FG002|Overall Study|Lost to Follow-up|7
4680214|NCT02436876|7583182|FG000|Overall Study|Lost to Follow-up|0
4680215|NCT02436876|7583183|FG001|Overall Study|Lost to Follow-up|1
4680216|NCT02436876|7583184|FG002|Overall Study|Lost to Follow-up|1
4680217|NCT02436876|7583185|FG003|Overall Study|Lost to Follow-up|1
4680218|NCT02436876|7583182|FG000|Overall Study|Withdrawal by Subject|1
4680219|NCT02436876|7583183|FG001|Overall Study|Withdrawal by Subject|0
4680220|NCT02436876|7583184|FG002|Overall Study|Withdrawal by Subject|0
4680221|NCT02436876|7583185|FG003|Overall Study|Withdrawal by Subject|1
4680222|NCT02436876|7583182|FG000|Overall Study|Physician Decision|0
4680223|NCT02436876|7583183|FG001|Overall Study|Physician Decision|2
4680224|NCT02436876|7583184|FG002|Overall Study|Physician Decision|1
4758653|NCT00980460|7732816|FG001|Overall Study|No transplant by protocol timepoints|0
4758654|NCT00980460|7732817|FG002|Overall Study|No transplant by protocol timepoints|3
4758655|NCT00980460|7732818|FG003|Overall Study|No transplant by protocol timepoints|0
4758656|NCT00980460|7732819|FG004|Overall Study|No transplant by protocol timepoints|0
4758657|NCT00977574|7732841|FG000|Overall Study|Never Treated|4
4758658|NCT00977574|7732842|FG001|Overall Study|Never Treated|2
4758659|NCT00977574|7732843|FG002|Overall Study|Never Treated|4
4758660|NCT00843882|7732854|FG000|Step 1|Lack of Efficacy|14
4758661|NCT00843882|7732855|FG001|Step 1|Lack of Efficacy|10
4758662|NCT00843882|7732856|FG002|Step 1|Lack of Efficacy|21
4758663|NCT00843882|7732854|FG000|Step 1|Adverse Event|8
4758664|NCT00843882|7732855|FG001|Step 1|Adverse Event|17
4758665|NCT00843882|7732856|FG002|Step 1|Adverse Event|20
4758666|NCT00843882|7732854|FG000|Step 1|Death|1
4758667|NCT00843882|7732855|FG001|Step 1|Death|2
4758668|NCT00843882|7732856|FG002|Step 1|Death|4
4758669|NCT00843882|7732854|FG000|Step 1|Withdrawal by Subject|6
4758670|NCT00843882|7732855|FG001|Step 1|Withdrawal by Subject|12
4758671|NCT00843882|7732856|FG002|Step 1|Withdrawal by Subject|9
4758672|NCT00843882|7732854|FG000|Step 1|Physician Decision|0
4758673|NCT00843882|7732855|FG001|Step 1|Physician Decision|5
4758674|NCT00843882|7732856|FG002|Step 1|Physician Decision|1
4758675|NCT00843882|7732854|FG000|Step 1|Patient and physician's decision|0
4758676|NCT00843882|7732855|FG001|Step 1|Patient and physician's decision|0
4758677|NCT00843882|7732856|FG002|Step 1|Patient and physician's decision|1
4758678|NCT00843882|7732854|FG000|Step 1|Other complicating disease|1
4758679|NCT00843882|7732855|FG001|Step 1|Other complicating disease|3
4758680|NCT00843882|7732856|FG002|Step 1|Other complicating disease|4
4758681|NCT00843882|7732854|FG000|Step 1|Alternative therapy|0
4758682|NCT00843882|7732855|FG001|Step 1|Alternative therapy|1
4758683|NCT00843882|7732856|FG002|Step 1|Alternative therapy|1
4758684|NCT00843882|7732854|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0
4758685|NCT00843882|7732855|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4
4758686|NCT00843882|7732856|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0
4758687|NCT00843882|7732854|FG000|Step 1|Off treatment reason unknown|0
4758688|NCT00843882|7732855|FG001|Step 1|Off treatment reason unknown|1
4758689|NCT00843882|7732856|FG002|Step 1|Off treatment reason unknown|4
4758690|NCT00843882|7732854|FG000|Step 1|Never started treatment|2
4680225|NCT02436876|7583185|FG003|Overall Study|Physician Decision|0
4680226|NCT02436876|7583182|FG000|Overall Study|Inadequate amount of study drug available for randomization|0
4680227|NCT02436876|7583183|FG001|Overall Study|Inadequate amount of study drug available for randomization|1
4680228|NCT02436876|7583184|FG002|Overall Study|Inadequate amount of study drug available for randomization|0
4680229|NCT02436876|7583185|FG003|Overall Study|Inadequate amount of study drug available for randomization|0
4680230|NCT02436889|7583202|FG000|Overall Study|No improvement in symptoms|1
4680231|NCT02436889|7583203|FG001|Overall Study|No improvement in symptoms|0
4680232|NCT02436889|7583202|FG000|Overall Study|Does not like/could not tolerate medicat|0
4680233|NCT02436889|7583203|FG001|Overall Study|Does not like/could not tolerate medicat|1
4680234|NCT02436915|7583211|FG000|Overall Study|Withdrawal by Subject|0
4680235|NCT02436915|7583212|FG001|Overall Study|Withdrawal by Subject|1
4680236|NCT02437084|7583220|FG000|Overall Study|Withdrawal by Subject|2
4680237|NCT02437084|7583220|FG000|Overall Study|Physician Decision|1
4680238|NCT02437162|7583227|FG000|Overall Study|Protocol Violation|0
4680239|NCT02437162|7583228|FG001|Overall Study|Protocol Violation|1
4680240|NCT02437162|7583229|FG002|Overall Study|Protocol Violation|0
4680241|NCT02437162|7583227|FG000|Overall Study|Randomized but not treated|0
4680242|NCT02437162|7583228|FG001|Overall Study|Randomized but not treated|0
4680243|NCT02437162|7583229|FG002|Overall Study|Randomized but not treated|1
4680244|NCT02437162|7583227|FG000|Overall Study|Study discontinued by Sponsor|93
4680245|NCT02437162|7583228|FG001|Overall Study|Study discontinued by Sponsor|98
4680246|NCT02437162|7583229|FG002|Overall Study|Study discontinued by Sponsor|97
4680247|NCT02437162|7583227|FG000|Overall Study|Withdrawal by Subject|13
4680248|NCT02437162|7583228|FG001|Overall Study|Withdrawal by Subject|7
4680249|NCT02437162|7583229|FG002|Overall Study|Withdrawal by Subject|9
4680250|NCT02437162|7583227|FG000|Overall Study|Adverse Event|0
4680251|NCT02437162|7583228|FG001|Overall Study|Adverse Event|1
4680252|NCT02437162|7583229|FG002|Overall Study|Adverse Event|0
4680253|NCT02437162|7583227|FG000|Overall Study|Lost to Follow-up|1
4758691|NCT00843882|7732855|FG001|Step 1|Never started treatment|0
4758692|NCT00843882|7732856|FG002|Step 1|Never started treatment|0
4758693|NCT00843882|7732854|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1
4758694|NCT00843882|7732855|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9
4758695|NCT00843882|7732856|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0
4680254|NCT02437162|7583228|FG001|Overall Study|Lost to Follow-up|0
4680255|NCT02437162|7583229|FG002|Overall Study|Lost to Follow-up|1
4680256|NCT02437162|7583227|FG000|Overall Study|Death|0
4680257|NCT02437162|7583228|FG001|Overall Study|Death|1
4680258|NCT02437162|7583229|FG002|Overall Study|Death|0
4680259|NCT02437162|7583227|FG000|Overall Study|Other|0
4680260|NCT02437162|7583228|FG001|Overall Study|Other|0
4680261|NCT02437162|7583229|FG002|Overall Study|Other|1
4680262|NCT02437188|7583244|FG000|Overall Study|Randomized but did not receive surgery|4
4680263|NCT02437188|7583245|FG001|Overall Study|Randomized but did not receive surgery|8
4680264|NCT02437188|7583244|FG000|Overall Study|Adverse Event|0
4680265|NCT02437188|7583245|FG001|Overall Study|Adverse Event|1
4680266|NCT02437305|7583267|FG000|Overall Study|Lost to Follow-up|18
4680267|NCT02437305|7583268|FG001|Overall Study|Lost to Follow-up|12
4680268|NCT02437409|7583287|FG000|Overall Study|Withdrawal by Subject|3
4680269|NCT02437409|7583287|FG000|Overall Study|Screening failure|12
4680270|NCT02437513|7583301|FG000|Overall Study|Withdrawal by Subject|2
4680271|NCT02437864|7583312|FG000|Overall Study|Protocol Violation|4
4680272|NCT02437864|7583313|FG001|Overall Study|Protocol Violation|0
4680273|NCT02437890|7583324|FG000|Overall Study|Non-compliance to study drug|0
4680274|NCT02437890|7583325|FG001|Overall Study|Non-compliance to study drug|1
4680275|NCT02437890|7583326|FG002|Overall Study|Non-compliance to study drug|0
4680276|NCT02437890|7583327|FG003|Overall Study|Non-compliance to study drug|0
4758696|NCT00843882|7732854|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0
4758697|NCT00843882|7732855|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6
4758698|NCT00843882|7732856|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0
4758699|NCT00843882|7732854|FG000|Step 2 (Cross-over to Arm B)|Death|0
4758700|NCT00843882|7732855|FG001|Step 2 (Cross-over to Arm B)|Death|3
4758701|NCT00843882|7732856|FG002|Step 2 (Cross-over to Arm B)|Death|0
4758702|NCT00843882|7732854|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2
4758703|NCT00843882|7732855|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5
4680277|NCT02437890|7583328|FG004|Overall Study|Non-compliance to study drug|1
4680278|NCT02437890|7583324|FG000|Overall Study|Sponsor's decision|1
4680279|NCT02437890|7583325|FG001|Overall Study|Sponsor's decision|1
4680280|NCT02437890|7583326|FG002|Overall Study|Sponsor's decision|4
4680281|NCT02437890|7583327|FG003|Overall Study|Sponsor's decision|0
4680282|NCT02437890|7583328|FG004|Overall Study|Sponsor's decision|2
4680283|NCT02437890|7583324|FG000|Overall Study|Physician Decision|0
4680284|NCT02437890|7583325|FG001|Overall Study|Physician Decision|0
4680285|NCT02437890|7583326|FG002|Overall Study|Physician Decision|0
4680286|NCT02437890|7583327|FG003|Overall Study|Physician Decision|1
4680287|NCT02437890|7583328|FG004|Overall Study|Physician Decision|0
4680288|NCT02437890|7583324|FG000|Overall Study|Unable to attend visit(s)|1
4680289|NCT02437890|7583325|FG001|Overall Study|Unable to attend visit(s)|0
4680290|NCT02437890|7583326|FG002|Overall Study|Unable to attend visit(s)|0
4680291|NCT02437890|7583327|FG003|Overall Study|Unable to attend visit(s)|0
4680292|NCT02437890|7583328|FG004|Overall Study|Unable to attend visit(s)|0
4680293|NCT02437890|7583324|FG000|Overall Study|Lack of Efficacy|1
4680294|NCT02437890|7583325|FG001|Overall Study|Lack of Efficacy|3
4680295|NCT02437890|7583326|FG002|Overall Study|Lack of Efficacy|0
4680296|NCT02437890|7583327|FG003|Overall Study|Lack of Efficacy|3
4680297|NCT02437890|7583328|FG004|Overall Study|Lack of Efficacy|1
4680298|NCT02437890|7583324|FG000|Overall Study|Adverse Event|4
4680299|NCT02437890|7583325|FG001|Overall Study|Adverse Event|9
4680300|NCT02437890|7583326|FG002|Overall Study|Adverse Event|5
4680301|NCT02437890|7583327|FG003|Overall Study|Adverse Event|11
4680302|NCT02437890|7583328|FG004|Overall Study|Adverse Event|7
4680303|NCT02437890|7583324|FG000|Overall Study|Withdrawal by Subject|1
4680304|NCT02437890|7583325|FG001|Overall Study|Withdrawal by Subject|2
4680305|NCT02437890|7583326|FG002|Overall Study|Withdrawal by Subject|6
4680306|NCT02437890|7583327|FG003|Overall Study|Withdrawal by Subject|5
4680307|NCT02437890|7583328|FG004|Overall Study|Withdrawal by Subject|5
4680308|NCT02437890|7583324|FG000|Overall Study|Death|0
4680309|NCT02437890|7583325|FG001|Overall Study|Death|0
4680310|NCT02437890|7583326|FG002|Overall Study|Death|0
4680311|NCT02437890|7583327|FG003|Overall Study|Death|2
4680312|NCT02437890|7583328|FG004|Overall Study|Death|0
4680313|NCT02437903|7583344|FG000|Overall Study|Adverse Event|1
4680314|NCT02437903|7583344|FG000|Overall Study|Withdrawal by Subject|1
4680315|NCT02437903|7583344|FG000|Overall Study|Lost to Follow-up|3
4680316|NCT02438137|7583351|FG000|Overall Study|Lost to Follow-up|3
4680317|NCT02438137|7583352|FG001|Overall Study|Lost to Follow-up|2
4680318|NCT02438137|7583351|FG000|Overall Study|Adverse Event|1
4680319|NCT02438137|7583352|FG001|Overall Study|Adverse Event|0
4680320|NCT02438137|7583351|FG000|Overall Study|Withdrawal by Subject|4
4680321|NCT02438137|7583352|FG001|Overall Study|Withdrawal by Subject|3
4680322|NCT02438137|7583351|FG000|Overall Study|Physician Decision|0
4680323|NCT02438137|7583352|FG001|Overall Study|Physician Decision|1
4680324|NCT02438280|7583362|FG000|Overall Study|Physician Decision|1
4680325|NCT02438280|7583363|FG001|Overall Study|Physician Decision|0
4680326|NCT02438371|7583372|FG000|Overall Study|Lost to Follow-up|3
4680327|NCT02438371|7583373|FG001|Overall Study|Lost to Follow-up|2
4758704|NCT00843882|7732856|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0
4680328|NCT02438371|7583372|FG000|Overall Study|Withdrawal by Subject|1
4680329|NCT02438371|7583373|FG001|Overall Study|Withdrawal by Subject|1
4680330|NCT02438384|7583382|FG000|Overall Study|Lost to Follow-up|8
4680331|NCT02438384|7583383|FG001|Overall Study|Lost to Follow-up|6
4680332|NCT02438384|7583384|FG002|Overall Study|Lost to Follow-up|4
4680333|NCT02438722|7583432|FG000|Overall Study|Adverse Event|12
4680334|NCT02438722|7583433|FG001|Overall Study|Adverse Event|9
4680335|NCT02438722|7583432|FG000|Overall Study|Refusal unrelated to AE|2
4680336|NCT02438722|7583433|FG001|Overall Study|Refusal unrelated to AE|5
4680337|NCT02438722|7583432|FG000|Overall Study|Disease progression/relapse|46
4680338|NCT02438722|7583433|FG001|Overall Study|Disease progression/relapse|51
4680339|NCT02438722|7583432|FG000|Overall Study|Death|0
4680340|NCT02438722|7583433|FG001|Overall Study|Death|3
4680341|NCT02438722|7583432|FG000|Overall Study|Physician Decision|2
4680342|NCT02438722|7583433|FG001|Overall Study|Physician Decision|2
4680343|NCT02438722|7583432|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1
4680344|NCT02438722|7583433|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0
4680345|NCT02438722|7583432|FG000|Overall Study|Withdrawal by Subject|0
4680346|NCT02438722|7583433|FG001|Overall Study|Withdrawal by Subject|1
4680347|NCT02438722|7583432|FG000|Overall Study|On protocol treatment|15
4680348|NCT02438722|7583433|FG001|Overall Study|On protocol treatment|14
4680349|NCT02438722|7583432|FG000|Overall Study|Did not receive protocol treatment|5
4680350|NCT02438722|7583433|FG001|Overall Study|Did not receive protocol treatment|0
4680351|NCT02438787|7583442|FG000|Overall Study|Adverse Event|1
4680352|NCT02438787|7583443|FG001|Overall Study|Adverse Event|0
4680353|NCT02438787|7583444|FG002|Overall Study|Adverse Event|2
4680354|NCT02438787|7583442|FG000|Overall Study|Lack of Efficacy|1
4680355|NCT02438787|7583443|FG001|Overall Study|Lack of Efficacy|2
4680356|NCT02438787|7583444|FG002|Overall Study|Lack of Efficacy|0
4680357|NCT02438787|7583442|FG000|Overall Study|Lost to Follow-up|0
4680358|NCT02438787|7583443|FG001|Overall Study|Lost to Follow-up|1
4680359|NCT02438787|7583444|FG002|Overall Study|Lost to Follow-up|0
4680360|NCT02438787|7583442|FG000|Overall Study|Protocol Violation|0
4680361|NCT02438787|7583443|FG001|Overall Study|Protocol Violation|0
4680362|NCT02438787|7583444|FG002|Overall Study|Protocol Violation|1
4680363|NCT02438787|7583442|FG000|Overall Study|Withdrawal by Subject|15
4680364|NCT02438787|7583443|FG001|Overall Study|Withdrawal by Subject|7
4680365|NCT02438787|7583444|FG002|Overall Study|Withdrawal by Subject|10
4680366|NCT02438787|7583442|FG000|Overall Study|Study discontinued by sponsor|64
4680367|NCT02438787|7583443|FG001|Overall Study|Study discontinued by sponsor|72
4680368|NCT02438787|7583444|FG002|Overall Study|Study discontinued by sponsor|69
4680369|NCT02438787|7583442|FG000|Overall Study|Other|0
4680370|NCT02438787|7583443|FG001|Overall Study|Other|1
4680371|NCT02438787|7583444|FG002|Overall Study|Other|0
4680372|NCT02438787|7583442|FG000|Overall Study|Site terminated by sponsor|0
4680373|NCT02438787|7583443|FG001|Overall Study|Site terminated by sponsor|0
4680374|NCT02438787|7583444|FG002|Overall Study|Site terminated by sponsor|1
4680375|NCT02438813|7583457|FG000|Overall Study|Patient Decision|59
4680376|NCT02438813|7583457|FG000|Overall Study|Patient Lost to Follow-Up|137
4680377|NCT02438813|7583457|FG000|Overall Study|Study Ended by Sponsor|80
4680378|NCT02438813|7583457|FG000|Overall Study|Patients Not Treated/No EOT Visit|249
4680379|NCT02438826|7583473|FG000|Double-Blind Treatment Phase|Adverse Event|1
4680380|NCT02438826|7583474|FG001|Double-Blind Treatment Phase|Adverse Event|1
4680381|NCT02438826|7583475|FG002|Double-Blind Treatment Phase|Adverse Event|0
4680382|NCT02438826|7583476|FG003|Double-Blind Treatment Phase|Adverse Event|0
4680383|NCT02438826|7583473|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1
4680384|NCT02438826|7583474|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0
4680385|NCT02438826|7583475|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0
4680386|NCT02438826|7583476|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0
4680387|NCT02438826|7583473|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1
4680388|NCT02438826|7583474|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1
4680389|NCT02438826|7583475|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0
4680390|NCT02438826|7583476|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0
4680391|NCT02438826|7583473|FG000|Double-Blind Treatment Phase|Protocol Violation|1
4680392|NCT02438826|7583474|FG001|Double-Blind Treatment Phase|Protocol Violation|2
4680393|NCT02438826|7583475|FG002|Double-Blind Treatment Phase|Protocol Violation|0
4680394|NCT02438826|7583476|FG003|Double-Blind Treatment Phase|Protocol Violation|0
4680395|NCT02438826|7583473|FG000|Double-Blind Treatment Phase|Screen Failure|2
4680396|NCT02438826|7583474|FG001|Double-Blind Treatment Phase|Screen Failure|0
4680397|NCT02438826|7583475|FG002|Double-Blind Treatment Phase|Screen Failure|0
4680398|NCT02438826|7583476|FG003|Double-Blind Treatment Phase|Screen Failure|0
4680399|NCT02438826|7583473|FG000|Open-Label Treatment Phase|Adverse Event|11
4680400|NCT02438826|7583474|FG001|Open-Label Treatment Phase|Adverse Event|6
4680401|NCT02438826|7583475|FG002|Open-Label Treatment Phase|Adverse Event|0
4680402|NCT02438826|7583476|FG003|Open-Label Treatment Phase|Adverse Event|0
4680403|NCT02438826|7583473|FG000|Open-Label Treatment Phase|Lack of Efficacy|27
4680404|NCT02438826|7583474|FG001|Open-Label Treatment Phase|Lack of Efficacy|18
4680405|NCT02438826|7583475|FG002|Open-Label Treatment Phase|Lack of Efficacy|0
4680406|NCT02438826|7583476|FG003|Open-Label Treatment Phase|Lack of Efficacy|0
4680407|NCT02438826|7583473|FG000|Open-Label Treatment Phase|Lost to Follow-up|0
4680408|NCT02438826|7583474|FG001|Open-Label Treatment Phase|Lost to Follow-up|2
4680409|NCT02438826|7583475|FG002|Open-Label Treatment Phase|Lost to Follow-up|0
4680410|NCT02438826|7583476|FG003|Open-Label Treatment Phase|Lost to Follow-up|0
4680411|NCT02438826|7583473|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6
4680412|NCT02438826|7583474|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7
4680413|NCT02438826|7583475|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0
4680414|NCT02438826|7583476|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0
4680415|NCT02438826|7583473|FG000|Post-Treatment Phase|Adverse Event|3
4680416|NCT02438826|7583474|FG001|Post-Treatment Phase|Adverse Event|0
4680417|NCT02438826|7583475|FG002|Post-Treatment Phase|Adverse Event|0
4680418|NCT02438826|7583476|FG003|Post-Treatment Phase|Adverse Event|0
4680419|NCT02438826|7583473|FG000|Post-Treatment Phase|Lack of Efficacy|4
4680420|NCT02438826|7583474|FG001|Post-Treatment Phase|Lack of Efficacy|0
4680421|NCT02438826|7583475|FG002|Post-Treatment Phase|Lack of Efficacy|0
4680422|NCT02438826|7583476|FG003|Post-Treatment Phase|Lack of Efficacy|0
4680423|NCT02438826|7583473|FG000|Post-Treatment Phase|Physician Decision|1
4680424|NCT02438826|7583474|FG001|Post-Treatment Phase|Physician Decision|0
4680425|NCT02438826|7583475|FG002|Post-Treatment Phase|Physician Decision|0
4680426|NCT02438826|7583476|FG003|Post-Treatment Phase|Physician Decision|0
4680427|NCT02438826|7583473|FG000|Post-Treatment Phase|Withdrawal by Subject|1
4680428|NCT02438826|7583474|FG001|Post-Treatment Phase|Withdrawal by Subject|1
4680429|NCT02438826|7583475|FG002|Post-Treatment Phase|Withdrawal by Subject|0
4680430|NCT02438826|7583476|FG003|Post-Treatment Phase|Withdrawal by Subject|0
4680431|NCT02439138|7583491|FG000|Overall Study|Adverse Event|1
4680432|NCT02439138|7583491|FG000|Overall Study|PI decision to terminate the study|2
4680433|NCT02439320|7583519|FG000|Overall Study|Adverse Event|0
4680434|NCT02439320|7583520|FG001|Overall Study|Adverse Event|2
4680435|NCT02439320|7583521|FG002|Overall Study|Adverse Event|0
4680436|NCT02439320|7583519|FG000|Overall Study|Lost to Follow-up|37
4680437|NCT02439320|7583520|FG001|Overall Study|Lost to Follow-up|34
4680438|NCT02439320|7583521|FG002|Overall Study|Lost to Follow-up|42
4680439|NCT02439320|7583519|FG000|Overall Study|Death|0
4680440|NCT02439320|7583520|FG001|Overall Study|Death|1
4680441|NCT02439320|7583521|FG002|Overall Study|Death|0
4680442|NCT02439320|7583519|FG000|Overall Study|Noncompliance with Protocol|10
4680443|NCT02439320|7583520|FG001|Overall Study|Noncompliance with Protocol|11
4680444|NCT02439320|7583521|FG002|Overall Study|Noncompliance with Protocol|7
4680445|NCT02439320|7583519|FG000|Overall Study|Pregnancy|0
4680446|NCT02439320|7583520|FG001|Overall Study|Pregnancy|1
4680447|NCT02439320|7583521|FG002|Overall Study|Pregnancy|1
4680448|NCT02439320|7583519|FG000|Overall Study|Withdrawal by Subject|12
4758705|NCT00843882|7732854|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1
4758706|NCT00843882|7732855|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1
4758707|NCT00843882|7732856|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0
4758708|NCT00843882|7732854|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0
4758709|NCT00843882|7732855|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1
4758710|NCT00843882|7732856|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0
4758711|NCT00843882|7732854|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0
4758712|NCT00843882|7732855|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1
4758713|NCT00843882|7732856|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0
4758714|NCT00644228|7732871|FG000|Randomization & Eligibility|Ineligible|31
4758715|NCT00644228|7732872|FG001|Randomization & Eligibility|Ineligible|21
4758716|NCT00644228|7732871|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1
4758717|NCT00644228|7732872|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0
4758718|NCT00644228|7732871|FG000|Randomization & Eligibility|Invalid Consent|0
4758719|NCT00644228|7732872|FG001|Randomization & Eligibility|Invalid Consent|1
4758720|NCT00644228|7732871|FG000|Induction Therapy|Adverse Event|22
4758721|NCT00644228|7732872|FG001|Induction Therapy|Adverse Event|55
4758722|NCT00644228|7732871|FG000|Induction Therapy|Withdrawal by Subject|10
4758723|NCT00644228|7732872|FG001|Induction Therapy|Withdrawal by Subject|3
4758724|NCT00644228|7732871|FG000|Induction Therapy|Progression/Relapse|24
4758725|NCT00644228|7732872|FG001|Induction Therapy|Progression/Relapse|12
4758726|NCT00644228|7732871|FG000|Induction Therapy|Death|3
4758727|NCT00644228|7732872|FG001|Induction Therapy|Death|7
4758728|NCT00644228|7732871|FG000|Induction Therapy|Not Protocol-Specified|24
4758729|NCT00644228|7732872|FG001|Induction Therapy|Not Protocol-Specified|28
4758730|NCT00644228|7732871|FG000|Maintenance|Adverse Event|27
4758731|NCT00644228|7732872|FG001|Maintenance|Adverse Event|31
4758732|NCT00644228|7732871|FG000|Maintenance|Withdrawal by Subject|6
4758733|NCT00644228|7732872|FG001|Maintenance|Withdrawal by Subject|4
4758734|NCT00644228|7732871|FG000|Maintenance|Progression/Relapse|67
4758735|NCT00644228|7732872|FG001|Maintenance|Progression/Relapse|42
4758736|NCT00644228|7732871|FG000|Maintenance|Death|3
4758737|NCT00644228|7732872|FG001|Maintenance|Death|3
4758738|NCT00644228|7732871|FG000|Maintenance|Not Protocol-Specified|14
4758739|NCT00644228|7732872|FG001|Maintenance|Not Protocol-Specified|15
4758740|NCT00644228|7732871|FG000|Maintenance|On Treatment|26
4758741|NCT00644228|7732872|FG001|Maintenance|On Treatment|40
4758742|NCT00602641|7732880|FG000|Overall Study|Never started protocol therapy|6
4758743|NCT00602641|7732881|FG001|Overall Study|Never started protocol therapy|2
4680449|NCT02439320|7583520|FG001|Overall Study|Withdrawal by Subject|16
4758744|NCT00602641|7732880|FG000|Overall Study|Still on treatment at time of analysis|8
4758745|NCT00602641|7732881|FG001|Overall Study|Still on treatment at time of analysis|15
4680450|NCT02439320|7583521|FG002|Overall Study|Withdrawal by Subject|14
4680451|NCT02439320|7583519|FG000|Overall Study|Physician Decision|2
4680452|NCT02439320|7583520|FG001|Overall Study|Physician Decision|1
4680453|NCT02439320|7583521|FG002|Overall Study|Physician Decision|0
4680454|NCT02439320|7583519|FG000|Overall Study|Sponsor Request|0
4680455|NCT02439320|7583520|FG001|Overall Study|Sponsor Request|2
4680456|NCT02439320|7583521|FG002|Overall Study|Sponsor Request|1
4680457|NCT02439320|7583519|FG000|Overall Study|Randomization Failure|35
4680458|NCT02439320|7583520|FG001|Overall Study|Randomization Failure|46
4680459|NCT02439320|7583521|FG002|Overall Study|Randomization Failure|34
4680460|NCT02440568|7583618|FG000|Overall Study|Death|1
4680461|NCT02440568|7583619|FG001|Overall Study|Death|3
4680462|NCT02440568|7583620|FG002|Overall Study|Death|4
4680463|NCT02440568|7583621|FG003|Overall Study|Death|2
4680464|NCT02440568|7583618|FG000|Overall Study|Lack of Efficacy|2
4680465|NCT02440568|7583619|FG001|Overall Study|Lack of Efficacy|0
4680466|NCT02440568|7583620|FG002|Overall Study|Lack of Efficacy|1
4680467|NCT02440568|7583621|FG003|Overall Study|Lack of Efficacy|0
4680468|NCT02440568|7583618|FG000|Overall Study|Lost to Follow-up|1
4680469|NCT02440568|7583619|FG001|Overall Study|Lost to Follow-up|0
4680470|NCT02440568|7583620|FG002|Overall Study|Lost to Follow-up|0
4680471|NCT02440568|7583621|FG003|Overall Study|Lost to Follow-up|0
4680472|NCT02440594|7583640|FG000|Overall Study|Lost to Follow-up|34
4680473|NCT02440594|7583641|FG001|Overall Study|Lost to Follow-up|33
4680474|NCT02440594|7583642|FG002|Overall Study|Lost to Follow-up|54
4680475|NCT02440594|7583643|FG003|Overall Study|Lost to Follow-up|47
4680476|NCT02440594|7583644|FG004|Overall Study|Lost to Follow-up|5
4680477|NCT02440594|7583645|FG005|Overall Study|Lost to Follow-up|4
4680478|NCT02440594|7583646|FG006|Overall Study|Lost to Follow-up|28
4680479|NCT02440594|7583647|FG007|Overall Study|Lost to Follow-up|48
4680480|NCT02440594|7583640|FG000|Overall Study|Cognitive Impairment/Communication Issue|14
4680481|NCT02440594|7583641|FG001|Overall Study|Cognitive Impairment/Communication Issue|6
4680482|NCT02440594|7583642|FG002|Overall Study|Cognitive Impairment/Communication Issue|4
4680483|NCT02440594|7583643|FG003|Overall Study|Cognitive Impairment/Communication Issue|4
4680484|NCT02440594|7583644|FG004|Overall Study|Cognitive Impairment/Communication Issue|2
4680485|NCT02440594|7583645|FG005|Overall Study|Cognitive Impairment/Communication Issue|1
4680486|NCT02440594|7583646|FG006|Overall Study|Cognitive Impairment/Communication Issue|0
4680487|NCT02440594|7583647|FG007|Overall Study|Cognitive Impairment/Communication Issue|0
4680488|NCT02440594|7583640|FG000|Overall Study|Withdrawal by Subject|81
4680489|NCT02440594|7583641|FG001|Overall Study|Withdrawal by Subject|67
4680490|NCT02440594|7583642|FG002|Overall Study|Withdrawal by Subject|59
4680491|NCT02440594|7583643|FG003|Overall Study|Withdrawal by Subject|38
4680492|NCT02440594|7583644|FG004|Overall Study|Withdrawal by Subject|2
4680493|NCT02440594|7583645|FG005|Overall Study|Withdrawal by Subject|2
4680494|NCT02440594|7583646|FG006|Overall Study|Withdrawal by Subject|7
4680495|NCT02440594|7583647|FG007|Overall Study|Withdrawal by Subject|7
4680496|NCT02440594|7583640|FG000|Overall Study|Administratively w/drawn|3
4680497|NCT02440594|7583641|FG001|Overall Study|Administratively w/drawn|2
4680498|NCT02440594|7583642|FG002|Overall Study|Administratively w/drawn|0
4680499|NCT02440594|7583643|FG003|Overall Study|Administratively w/drawn|0
4680500|NCT02440594|7583644|FG004|Overall Study|Administratively w/drawn|0
4680501|NCT02440594|7583645|FG005|Overall Study|Administratively w/drawn|0
4680502|NCT02440594|7583646|FG006|Overall Study|Administratively w/drawn|2
4680503|NCT02440594|7583647|FG007|Overall Study|Administratively w/drawn|1
4680504|NCT02440789|7583689|FG000|Overall Study|Withdrawal by Subject|3
4680505|NCT02440789|7583689|FG000|Overall Study|Not willing to adhere to reqs|1
4680506|NCT02441114|7583697|FG000|Washout2|Withdrawal by Subject|4
4680507|NCT02441179|7583703|FG000|Overall Study|Withdrawal by Subject|1
4680508|NCT02441179|7583704|FG001|Overall Study|Withdrawal by Subject|1
4758746|NCT00602641|7732880|FG000|Overall Study|Adverse Event|62
4758747|NCT00602641|7732881|FG001|Overall Study|Adverse Event|53
4758748|NCT00602641|7732880|FG000|Overall Study|Disease progression|38
4758749|NCT00602641|7732881|FG001|Overall Study|Disease progression|55
4758750|NCT00602641|7732880|FG000|Overall Study|Death|6
4758751|NCT00602641|7732881|FG001|Overall Study|Death|5
4758752|NCT00602641|7732880|FG000|Overall Study|Withdrawal by Subject|15
4758753|NCT00602641|7732881|FG001|Overall Study|Withdrawal by Subject|12
4758754|NCT00602641|7732880|FG000|Overall Study|Alternative therapy|5
4758755|NCT00602641|7732881|FG001|Overall Study|Alternative therapy|2
4758756|NCT00602641|7732880|FG000|Overall Study|Other Complicating Disease|5
4758757|NCT00602641|7732881|FG001|Overall Study|Other Complicating Disease|2
4758758|NCT00602641|7732880|FG000|Overall Study|Physician Decision|5
4758759|NCT00602641|7732881|FG001|Overall Study|Physician Decision|4
4758760|NCT00602641|7732880|FG000|Overall Study|Administrative Closure|1
4758761|NCT00602641|7732881|FG001|Overall Study|Administrative Closure|1
4758762|NCT00602641|7732880|FG000|Overall Study|Other|3
4758763|NCT00602641|7732881|FG001|Overall Study|Other|1
4758764|NCT00504582|7732894|FG000|Overall Study|Lost to Follow-up|1
4758765|NCT00504582|7732895|FG001|Overall Study|Lost to Follow-up|0
4758766|NCT00504582|7732896|FG002|Overall Study|Lost to Follow-up|0
4758767|NCT00433511|7732907|FG000|Step 1|Adverse Event|50
4680509|NCT02441218|7583713|FG000|Overall Study|Death|503
4680510|NCT02441218|7583714|FG001|Overall Study|Death|553
4758768|NCT00433511|7732908|FG001|Step 1|Adverse Event|157
4680511|NCT02441218|7583713|FG000|Overall Study|Withdrawal by Subject|73
4680512|NCT02441218|7583714|FG001|Overall Study|Withdrawal by Subject|58
4680513|NCT02441218|7583713|FG000|Overall Study|Lost to Follow-up|2
4680514|NCT02441218|7583714|FG001|Overall Study|Lost to Follow-up|1
4680515|NCT02441283|7583720|FG000|Overall Study|Withdrew consent|15
4680516|NCT02441283|7583720|FG000|Overall Study|Lost to Follow-up|42
4680517|NCT02441283|7583720|FG000|Overall Study|Death|1
4680518|NCT02441283|7583720|FG000|Overall Study|Other, not specified|32
4680519|NCT02441309|7583727|FG000|Overall Study|Disease progression|2
4680520|NCT02441309|7583728|FG001|Overall Study|Disease progression|1
4680521|NCT02441309|7583729|FG002|Overall Study|Disease progression|2
4680522|NCT02441309|7583727|FG000|Overall Study|Adverse Event|0
4680523|NCT02441309|7583728|FG001|Overall Study|Adverse Event|1
4680524|NCT02441309|7583729|FG002|Overall Study|Adverse Event|0
4680525|NCT02441309|7583727|FG000|Overall Study|Withdrawal by Subject|1
4680526|NCT02441309|7583728|FG001|Overall Study|Withdrawal by Subject|0
4680527|NCT02441309|7583729|FG002|Overall Study|Withdrawal by Subject|1
4680528|NCT02441517|7583740|FG000|Overall Study|Lost to Follow-up|1
4680529|NCT02441517|7583740|FG000|Overall Study|Withdrawal by Subject|2
4680530|NCT02441517|7583740|FG000|Overall Study|Study Terminated by Sponsor|1
4680531|NCT02441946|7583747|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1
4680532|NCT02441946|7583748|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1
4680533|NCT02441946|7583749|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0
4680534|NCT02441946|7583747|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1
4680535|NCT02441946|7583748|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0
4680536|NCT02441946|7583749|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0
4680537|NCT02441946|7583747|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0
4680538|NCT02441946|7583748|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3
4680539|NCT02441946|7583749|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0
4680540|NCT02441946|7583747|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0
4680541|NCT02441946|7583748|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1
4680542|NCT02441946|7583749|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0
4680543|NCT02441946|7583747|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15
4680544|NCT02441946|7583748|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0
4680545|NCT02441946|7583749|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0
4680546|NCT02441946|7583747|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1
4680547|NCT02441946|7583748|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0
4680548|NCT02441946|7583749|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0
4680549|NCT02441946|7583747|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1
4680550|NCT02441946|7583748|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0
4680551|NCT02441946|7583749|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0
4680552|NCT02441946|7583747|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1
4680553|NCT02441946|7583748|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0
4680554|NCT02441946|7583749|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0
4680555|NCT02441946|7583747|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9
4680556|NCT02441946|7583748|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0
4680557|NCT02441946|7583749|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0
4680558|NCT02441946|7583747|FG000|Extension Period (8 Weeks)|Adverse Event|1
4680559|NCT02441946|7583748|FG001|Extension Period (8 Weeks)|Adverse Event|0
4680560|NCT02441946|7583749|FG002|Extension Period (8 Weeks)|Adverse Event|0
4680561|NCT02441946|7583747|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1
4680562|NCT02441946|7583748|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0
4680563|NCT02441946|7583749|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0
4680564|NCT02442206|7583762|FG000|Period 1|Adverse Event|1
4680565|NCT02442206|7583763|FG001|Period 1|Adverse Event|1
4680566|NCT02442206|7583762|FG000|Period 1|withdrew consent|0
4680567|NCT02442206|7583763|FG001|Period 1|withdrew consent|1
4680568|NCT02442206|7583762|FG000|Period 1|COPD exacerbation|0
4680569|NCT02442206|7583763|FG001|Period 1|COPD exacerbation|1
4680570|NCT02442206|7583762|FG000|Period 2|Adverse Event|1
4680571|NCT02442206|7583763|FG001|Period 2|Adverse Event|0
4680572|NCT02442271|7583770|FG000|Overall Study|Adverse Event|1
4680573|NCT02442271|7583770|FG000|Overall Study|Withdrew Consent|1
4680574|NCT02442271|7583770|FG000|Overall Study|Lost to Follow-up|1
4680575|NCT02442271|7583770|FG000|Overall Study|Other|1
4680576|NCT02442284|7583788|FG000|Overall Study|Adverse Event|1
4680577|NCT02442284|7583788|FG000|Overall Study|Withdrew Consent|2
4680578|NCT02442284|7583788|FG000|Overall Study|Lost to Follow-up|3
4680579|NCT02442284|7583788|FG000|Overall Study|Other|1
4680580|NCT02442310|7583792|FG000|Overall Study|Adverse Event|2
4680581|NCT02442310|7583792|FG000|Overall Study|Withdrawal by Subject|1
4680582|NCT02442336|7583802|FG000|Overall Study|6 patients assisted with the intervention development only.|6
4680583|NCT02442336|7583802|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19
4680584|NCT02442336|7583802|FG000|Overall Study|Lost to Follow-up|11
4680585|NCT02442622|7583808|FG000|Overall Study|Withdrawal by Subject|3
4680586|NCT02442622|7583809|FG001|Overall Study|Withdrawal by Subject|1
4680587|NCT02442804|7583840|FG000|Overall Study|Withdrawal by Subject|0
4680588|NCT02442804|7583841|FG001|Overall Study|Withdrawal by Subject|1
4680589|NCT02442804|7583840|FG000|Overall Study|Adverse Event|1
4680590|NCT02442804|7583841|FG001|Overall Study|Adverse Event|0
4680591|NCT02442830|7583849|FG000|Overall Study|Technical Failure|0
4680592|NCT02442830|7583850|FG001|Overall Study|Technical Failure|1
4680593|NCT02443103|7583896|FG000|Overall Study|Adverse Event|2
4680594|NCT02443103|7583896|FG000|Overall Study|Noncompliance|1
4680595|NCT02443155|7583904|FG000|Overall Study|Adverse Event|3
4680596|NCT02443155|7583905|FG001|Overall Study|Adverse Event|4
4680597|NCT02443155|7583906|FG002|Overall Study|Adverse Event|1
4680598|NCT02443155|7583907|FG003|Overall Study|Adverse Event|2
4680599|NCT02443155|7583904|FG000|Overall Study|Unclassified|0
4680600|NCT02443155|7583905|FG001|Overall Study|Unclassified|0
4680601|NCT02443155|7583906|FG002|Overall Study|Unclassified|2
4680602|NCT02443155|7583907|FG003|Overall Study|Unclassified|1
4680603|NCT02443155|7583904|FG000|Overall Study|Withdrawal by Subject|4
4680604|NCT02443155|7583905|FG001|Overall Study|Withdrawal by Subject|7
4680605|NCT02443155|7583906|FG002|Overall Study|Withdrawal by Subject|3
4758769|NCT00433511|7732909|FG002|Step 1|Adverse Event|153
4758770|NCT00433511|7732907|FG000|Step 1|Withdrawal by Subject|45
4758771|NCT00433511|7732908|FG001|Step 1|Withdrawal by Subject|143
4758772|NCT00433511|7732909|FG002|Step 1|Withdrawal by Subject|154
4758773|NCT00433511|7732907|FG000|Step 1|Death|3
4758774|NCT00433511|7732908|FG001|Step 1|Death|1
4758775|NCT00433511|7732909|FG002|Step 1|Death|1
4758776|NCT00433511|7732907|FG000|Step 1|Physician Decision|1
4758777|NCT00433511|7732908|FG001|Step 1|Physician Decision|4
4758778|NCT00433511|7732909|FG002|Step 1|Physician Decision|3
4758779|NCT00433511|7732907|FG000|Step 1|Never started protocol therapy|28
4758780|NCT00433511|7732908|FG001|Step 1|Never started protocol therapy|64
4758781|NCT00433511|7732909|FG002|Step 1|Never started protocol therapy|66
4758782|NCT00433511|7732907|FG000|Step 1|Alternative therapy|2
4758783|NCT00433511|7732908|FG001|Step 1|Alternative therapy|1
4758784|NCT00433511|7732909|FG002|Step 1|Alternative therapy|3
4758785|NCT00433511|7732907|FG000|Step 1|Disease progression, relapse|5
4758786|NCT00433511|7732908|FG001|Step 1|Disease progression, relapse|3
4758787|NCT00433511|7732909|FG002|Step 1|Disease progression, relapse|3
4758788|NCT00433511|7732907|FG000|Step 1|Other complicating disease|2
4758789|NCT00433511|7732908|FG001|Step 1|Other complicating disease|6
4758790|NCT00433511|7732909|FG002|Step 1|Other complicating disease|3
4758791|NCT00433511|7732907|FG000|Step 1|Non-breast cancer surgery/wound issues|0
4758792|NCT00433511|7732908|FG001|Step 1|Non-breast cancer surgery/wound issues|4
4758793|NCT00433511|7732909|FG002|Step 1|Non-breast cancer surgery/wound issues|1
4758794|NCT00433511|7732907|FG000|Step 1|Suspected recurrence|0
4758795|NCT00433511|7732908|FG001|Step 1|Suspected recurrence|1
4758796|NCT00433511|7732909|FG002|Step 1|Suspected recurrence|0
4758797|NCT00433511|7732907|FG000|Step 1|Insurance/drug distribution issues|0
4758798|NCT00433511|7732908|FG001|Step 1|Insurance/drug distribution issues|1
4758799|NCT00433511|7732909|FG002|Step 1|Insurance/drug distribution issues|2
4758800|NCT00433511|7732907|FG000|Step 1|Patient moved|0
4758801|NCT00433511|7732908|FG001|Step 1|Patient moved|0
4758802|NCT00433511|7732909|FG002|Step 1|Patient moved|1
4758803|NCT00433511|7732907|FG000|Step 2 (Arm D)|Adverse Event|0
4758804|NCT00433511|7732908|FG001|Step 2 (Arm D)|Adverse Event|0
4758805|NCT00433511|7732909|FG002|Step 2 (Arm D)|Adverse Event|135
4758806|NCT00433511|7732907|FG000|Step 2 (Arm D)|Withdrawal by Subject|0
4758807|NCT00433511|7732908|FG001|Step 2 (Arm D)|Withdrawal by Subject|0
4758808|NCT00433511|7732909|FG002|Step 2 (Arm D)|Withdrawal by Subject|181
4758809|NCT00433511|7732907|FG000|Step 2 (Arm D)|Never started protocol therapy|0
4758810|NCT00433511|7732908|FG001|Step 2 (Arm D)|Never started protocol therapy|0
4758811|NCT00433511|7732909|FG002|Step 2 (Arm D)|Never started protocol therapy|148
4680606|NCT02443155|7583907|FG003|Overall Study|Withdrawal by Subject|9
4758812|NCT00433511|7732907|FG000|Step 2 (Arm D)|Physician Decision|0
4758813|NCT00433511|7732908|FG001|Step 2 (Arm D)|Physician Decision|0
4758814|NCT00433511|7732909|FG002|Step 2 (Arm D)|Physician Decision|9
4758815|NCT00433511|7732907|FG000|Step 2 (Arm D)|Disease progression, relapse|0
4758816|NCT00433511|7732908|FG001|Step 2 (Arm D)|Disease progression, relapse|0
4758817|NCT00433511|7732909|FG002|Step 2 (Arm D)|Disease progression, relapse|7
4680607|NCT02443155|7583904|FG000|Overall Study|Pregnancy|3
4680608|NCT02443155|7583905|FG001|Overall Study|Pregnancy|1
4680609|NCT02443155|7583906|FG002|Overall Study|Pregnancy|1
4680610|NCT02443155|7583907|FG003|Overall Study|Pregnancy|2
4680611|NCT02443155|7583904|FG000|Overall Study|Lost to Follow-up|1
4680612|NCT02443155|7583905|FG001|Overall Study|Lost to Follow-up|2
4680613|NCT02443155|7583906|FG002|Overall Study|Lost to Follow-up|0
4680614|NCT02443155|7583907|FG003|Overall Study|Lost to Follow-up|1
4680615|NCT02443155|7583904|FG000|Overall Study|Protocol Violation|1
4680616|NCT02443155|7583905|FG001|Overall Study|Protocol Violation|0
4680617|NCT02443155|7583906|FG002|Overall Study|Protocol Violation|1
4680618|NCT02443155|7583907|FG003|Overall Study|Protocol Violation|1
4680619|NCT02443155|7583904|FG000|Overall Study|Death|0
4680620|NCT02443155|7583905|FG001|Overall Study|Death|0
4680621|NCT02443155|7583906|FG002|Overall Study|Death|1
4680622|NCT02443155|7583907|FG003|Overall Study|Death|0
4680623|NCT02443298|7583920|FG000|Overall Study|Adverse Event|3
4680624|NCT02443298|7583921|FG001|Overall Study|Adverse Event|3
4680625|NCT02443298|7583920|FG000|Overall Study|Withdrawal by Subject|1
4680626|NCT02443298|7583921|FG001|Overall Study|Withdrawal by Subject|2
4680627|NCT02443337|7583929|FG000|Overall Study|Adverse Event|0
4680628|NCT02443337|7583930|FG001|Overall Study|Adverse Event|1
4680629|NCT02443337|7583929|FG000|Overall Study|Clinical Progressive Disease|3
4680630|NCT02443337|7583930|FG001|Overall Study|Clinical Progressive Disease|0
4680631|NCT02443337|7583929|FG000|Overall Study|Withdrawal by Subject|2
4680632|NCT02443337|7583930|FG001|Overall Study|Withdrawal by Subject|1
4680633|NCT02443402|7583943|FG000|Overall Study|Withdrawal by Subject|3
4680634|NCT02443402|7583944|FG001|Overall Study|Withdrawal by Subject|1
4680635|NCT02443402|7583943|FG000|Overall Study|Screen Failure|1
4680636|NCT02443402|7583944|FG001|Overall Study|Screen Failure|2
4680637|NCT02443688|7583975|FG000|Overall Study|Adverse Event|2
4680638|NCT02443688|7583976|FG001|Overall Study|Adverse Event|3
4680639|NCT02443688|7583977|FG002|Overall Study|Adverse Event|2
4680640|NCT02443688|7583975|FG000|Overall Study|Lost to Follow-up|1
4680641|NCT02443688|7583976|FG001|Overall Study|Lost to Follow-up|0
4680642|NCT02443688|7583977|FG002|Overall Study|Lost to Follow-up|0
4680643|NCT02443688|7583975|FG000|Overall Study|Physician Decision|3
4758818|NCT00433511|7732907|FG000|Step 2 (Arm D)|Other complicating disease|0
4758819|NCT00433511|7732908|FG001|Step 2 (Arm D)|Other complicating disease|0
4758820|NCT00433511|7732909|FG002|Step 2 (Arm D)|Other complicating disease|3
4758821|NCT00433511|7732907|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0
4758822|NCT00433511|7732908|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0
4758823|NCT00433511|7732909|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2
4758824|NCT00433511|7732907|FG000|Step 2 (Arm D)|Suspected recurrence|0
4758825|NCT00433511|7732908|FG001|Step 2 (Arm D)|Suspected recurrence|0
4758826|NCT00433511|7732909|FG002|Step 2 (Arm D)|Suspected recurrence|1
4758827|NCT00433511|7732907|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0
4758828|NCT00433511|7732908|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0
4758829|NCT00433511|7732909|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4
4758830|NCT00433511|7732907|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0
4758831|NCT00433511|7732908|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0
4758832|NCT00433511|7732909|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1
4758833|NCT00408005|7732922|FG000|Induction|Adverse Event|19
4758834|NCT00408005|7732923|FG001|Induction|Adverse Event|3
4758835|NCT00408005|7732924|FG002|Induction|Adverse Event|0
4758836|NCT00408005|7732925|FG003|Induction|Adverse Event|0
4758837|NCT00408005|7732926|FG004|Induction|Adverse Event|0
4758838|NCT00408005|7732927|FG005|Induction|Adverse Event|0
4758839|NCT00408005|7732928|FG006|Induction|Adverse Event|0
4758840|NCT00408005|7732929|FG007|Induction|Adverse Event|0
4758841|NCT00408005|7732922|FG000|Induction|Death|6
4758842|NCT00408005|7732923|FG001|Induction|Death|0
4758843|NCT00408005|7732924|FG002|Induction|Death|0
4758844|NCT00408005|7732925|FG003|Induction|Death|0
4758845|NCT00408005|7732926|FG004|Induction|Death|0
4758846|NCT00408005|7732927|FG005|Induction|Death|0
4758847|NCT00408005|7732928|FG006|Induction|Death|0
4758848|NCT00408005|7732929|FG007|Induction|Death|0
4758849|NCT00408005|7732922|FG000|Induction|Physician Decision|83
4758850|NCT00408005|7732923|FG001|Induction|Physician Decision|9
4758851|NCT00408005|7732924|FG002|Induction|Physician Decision|0
4758852|NCT00408005|7732925|FG003|Induction|Physician Decision|0
4758853|NCT00408005|7732926|FG004|Induction|Physician Decision|0
4758854|NCT00408005|7732927|FG005|Induction|Physician Decision|0
4680644|NCT02443688|7583976|FG001|Overall Study|Physician Decision|0
4680645|NCT02443688|7583977|FG002|Overall Study|Physician Decision|1
4758855|NCT00408005|7732928|FG006|Induction|Physician Decision|0
4680646|NCT02443688|7583975|FG000|Overall Study|Pregnancy|0
4680647|NCT02443688|7583976|FG001|Overall Study|Pregnancy|0
4680648|NCT02443688|7583977|FG002|Overall Study|Pregnancy|1
4680649|NCT02443688|7583975|FG000|Overall Study|Withdrawal by Subject|3
4680650|NCT02443688|7583976|FG001|Overall Study|Withdrawal by Subject|3
4680651|NCT02443688|7583977|FG002|Overall Study|Withdrawal by Subject|4
4680652|NCT02443688|7583975|FG000|Overall Study|Non-compliance with study drug|1
4680653|NCT02443688|7583976|FG001|Overall Study|Non-compliance with study drug|2
4758856|NCT00408005|7732929|FG007|Induction|Physician Decision|0
4758857|NCT00408005|7732922|FG000|Induction|Withdrawal by Subject|2
4680654|NCT02443688|7583977|FG002|Overall Study|Non-compliance with study drug|4
4680655|NCT02443688|7583975|FG000|Overall Study|Sponsor Request|2
4680656|NCT02443688|7583976|FG001|Overall Study|Sponsor Request|1
4680657|NCT02443688|7583977|FG002|Overall Study|Sponsor Request|0
4680658|NCT02443740|7583993|FG000|Intervention Period 1 (3 Days)|Adverse Event|0
4680659|NCT02443740|7583994|FG001|Intervention Period 1 (3 Days)|Adverse Event|0
4680660|NCT02443740|7583995|FG002|Intervention Period 1 (3 Days)|Adverse Event|0
4680661|NCT02443740|7583996|FG003|Intervention Period 1 (3 Days)|Adverse Event|0
4758858|NCT00408005|7732923|FG001|Induction|Withdrawal by Subject|4
4758859|NCT00408005|7732924|FG002|Induction|Withdrawal by Subject|0
4758860|NCT00408005|7732925|FG003|Induction|Withdrawal by Subject|0
4758861|NCT00408005|7732926|FG004|Induction|Withdrawal by Subject|0
4758862|NCT00408005|7732927|FG005|Induction|Withdrawal by Subject|0
4758863|NCT00408005|7732928|FG006|Induction|Withdrawal by Subject|0
4758864|NCT00408005|7732929|FG007|Induction|Withdrawal by Subject|0
4758865|NCT00408005|7732922|FG000|Induction|Ineligible|33
4758866|NCT00408005|7732923|FG001|Induction|Ineligible|14
4758867|NCT00408005|7732924|FG002|Induction|Ineligible|0
4758868|NCT00408005|7732925|FG003|Induction|Ineligible|0
4758869|NCT00408005|7732926|FG004|Induction|Ineligible|0
4758870|NCT00408005|7732927|FG005|Induction|Ineligible|0
4758871|NCT00408005|7732928|FG006|Induction|Ineligible|0
4758872|NCT00408005|7732929|FG007|Induction|Ineligible|0
4758873|NCT00408005|7732922|FG000|Induction|Refusal of Further Protocol Therapy|225
4758874|NCT00408005|7732923|FG001|Induction|Refusal of Further Protocol Therapy|44
4758875|NCT00408005|7732924|FG002|Induction|Refusal of Further Protocol Therapy|0
4758876|NCT00408005|7732925|FG003|Induction|Refusal of Further Protocol Therapy|0
4758877|NCT00408005|7732926|FG004|Induction|Refusal of Further Protocol Therapy|0
4758878|NCT00408005|7732927|FG005|Induction|Refusal of Further Protocol Therapy|0
4758879|NCT00408005|7732928|FG006|Induction|Refusal of Further Protocol Therapy|0
4758880|NCT00408005|7732929|FG007|Induction|Refusal of Further Protocol Therapy|0
4758881|NCT00408005|7732922|FG000|Induction|Entered another COG therapeutic protocol|4
4758882|NCT00408005|7732923|FG001|Induction|Entered another COG therapeutic protocol|0
4758883|NCT00408005|7732924|FG002|Induction|Entered another COG therapeutic protocol|0
4758884|NCT00408005|7732925|FG003|Induction|Entered another COG therapeutic protocol|0
4758885|NCT00408005|7732926|FG004|Induction|Entered another COG therapeutic protocol|0
4758886|NCT00408005|7732927|FG005|Induction|Entered another COG therapeutic protocol|0
4758887|NCT00408005|7732928|FG006|Induction|Entered another COG therapeutic protocol|0
4758888|NCT00408005|7732929|FG007|Induction|Entered another COG therapeutic protocol|0
4758889|NCT00408005|7732922|FG000|Induction|Patient transferred Tx to Non-COG Site|3
4758890|NCT00408005|7732923|FG001|Induction|Patient transferred Tx to Non-COG Site|2
4680662|NCT02443740|7583997|FG004|Intervention Period 1 (3 Days)|Adverse Event|0
4680663|NCT02443740|7583998|FG005|Intervention Period 1 (3 Days)|Adverse Event|1
4680664|NCT02443740|7583999|FG006|Intervention Period 1 (3 Days)|Adverse Event|0
4680665|NCT02443740|7584000|FG007|Intervention Period 1 (3 Days)|Adverse Event|0
4680666|NCT02443740|7584001|FG008|Intervention Period 1 (3 Days)|Adverse Event|0
4680667|NCT02443740|7584002|FG009|Intervention Period 1 (3 Days)|Adverse Event|0
4680668|NCT02443740|7584003|FG010|Intervention Period 1 (3 Days)|Adverse Event|0
4680669|NCT02443740|7583993|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1
4680670|NCT02443740|7583994|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0
4680671|NCT02443740|7583995|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0
4680672|NCT02443740|7583996|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0
4680673|NCT02443740|7583997|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0
4680674|NCT02443740|7583998|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0
4680675|NCT02443740|7583999|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1
4680676|NCT02443740|7584000|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0
4680677|NCT02443740|7584001|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0
4680678|NCT02443740|7584002|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0
4680679|NCT02443740|7584003|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0
4758891|NCT00408005|7732924|FG002|Induction|Patient transferred Tx to Non-COG Site|0
4758892|NCT00408005|7732925|FG003|Induction|Patient transferred Tx to Non-COG Site|0
4680680|NCT02443740|7583993|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
4680681|NCT02443740|7583994|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
4680682|NCT02443740|7583995|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
4680683|NCT02443740|7583996|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
4680684|NCT02443740|7583997|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
4680685|NCT02443740|7583998|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1
4680686|NCT02443740|7583999|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
4680687|NCT02443740|7584000|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
4680688|NCT02443740|7584001|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
4680689|NCT02443740|7584002|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
4680690|NCT02443740|7584003|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
4680691|NCT02443805|7584044|FG000|Overall Study|Adverse Event|100
4680692|NCT02443805|7584045|FG001|Overall Study|Adverse Event|18
4680693|NCT02443805|7584044|FG000|Overall Study|Withdrawal by Subject|73
4680694|NCT02443805|7584045|FG001|Overall Study|Withdrawal by Subject|74
4680695|NCT02443805|7584044|FG000|Overall Study|Lost to Follow-up|19
4680696|NCT02443805|7584045|FG001|Overall Study|Lost to Follow-up|14
4680697|NCT02443805|7584044|FG000|Overall Study|Pregnancy|6
4680698|NCT02443805|7584045|FG001|Overall Study|Pregnancy|5
4680699|NCT02443805|7584044|FG000|Overall Study|Protocol Violation|2
4680700|NCT02443805|7584045|FG001|Overall Study|Protocol Violation|4
4680701|NCT02443805|7584044|FG000|Overall Study|Lack of Efficacy|1
4680702|NCT02443805|7584045|FG001|Overall Study|Lack of Efficacy|1
4680703|NCT02443805|7584044|FG000|Overall Study|Non-compliance with study drug|6
4680704|NCT02443805|7584045|FG001|Overall Study|Non-compliance with study drug|4
4680705|NCT02443805|7584044|FG000|Overall Study|Withdrawal by parent/guardian|3
4680706|NCT02443805|7584045|FG001|Overall Study|Withdrawal by parent/guardian|5
4680707|NCT02443805|7584044|FG000|Overall Study|Any other reason not above-mentioned|3
4680708|NCT02443805|7584045|FG001|Overall Study|Any other reason not above-mentioned|2
4680709|NCT02443883|7584055|FG000|Overall Study|Adverse Event|0
4680710|NCT02443883|7584056|FG001|Overall Study|Adverse Event|1
4680711|NCT02443883|7584057|FG002|Overall Study|Adverse Event|0
4680712|NCT02443883|7584058|FG003|Overall Study|Adverse Event|0
4680713|NCT02443883|7584055|FG000|Overall Study|Lost to Follow-up|3
4680714|NCT02443883|7584056|FG001|Overall Study|Lost to Follow-up|2
4680715|NCT02443883|7584057|FG002|Overall Study|Lost to Follow-up|1
4680716|NCT02443883|7584058|FG003|Overall Study|Lost to Follow-up|0
4680717|NCT02443883|7584055|FG000|Overall Study|Physician Decision|1
4680718|NCT02443883|7584056|FG001|Overall Study|Physician Decision|1
4680719|NCT02443883|7584057|FG002|Overall Study|Physician Decision|0
4680720|NCT02443883|7584058|FG003|Overall Study|Physician Decision|3
4680721|NCT02443883|7584055|FG000|Overall Study|Withdrawal by Subject|1
4680722|NCT02443883|7584056|FG001|Overall Study|Withdrawal by Subject|0
4680723|NCT02443883|7584057|FG002|Overall Study|Withdrawal by Subject|0
4680724|NCT02443883|7584058|FG003|Overall Study|Withdrawal by Subject|2
4680725|NCT02443883|7584055|FG000|Overall Study|Randomized, but never treated|1
4680726|NCT02443883|7584056|FG001|Overall Study|Randomized, but never treated|0
4680727|NCT02443883|7584057|FG002|Overall Study|Randomized, but never treated|0
4680728|NCT02443883|7584058|FG003|Overall Study|Randomized, but never treated|0
4680729|NCT02444182|7584081|FG000|Overall Study|non-compliance|2
4680730|NCT02444182|7584082|FG001|Overall Study|non-compliance|1
4680731|NCT02444182|7584081|FG000|Overall Study|Lost to Follow-up|0
4680732|NCT02444182|7584082|FG001|Overall Study|Lost to Follow-up|4
4680733|NCT02444533|7584099|FG000|Overall Study|Not able to complete forms|0
4680734|NCT02444533|7584100|FG001|Overall Study|Not able to complete forms|2
4680735|NCT02444533|7584099|FG000|Overall Study|Only gave post-procedure complications|2
4680736|NCT02444533|7584100|FG001|Overall Study|Only gave post-procedure complications|2
4680737|NCT02444793|7584142|FG000|Overall Study|Lost to Follow-up|2
4680738|NCT02444793|7584143|FG001|Overall Study|Lost to Follow-up|2
4680739|NCT02444793|7584144|FG002|Overall Study|Lost to Follow-up|0
4680740|NCT02444793|7584145|FG003|Overall Study|Lost to Follow-up|0
4680741|NCT02444793|7584142|FG000|Overall Study|Death|0
4680742|NCT02444793|7584143|FG001|Overall Study|Death|3
4680743|NCT02444793|7584144|FG002|Overall Study|Death|0
4680744|NCT02444793|7584145|FG003|Overall Study|Death|0
4680745|NCT02444793|7584142|FG000|Overall Study|Other|0
4680746|NCT02444793|7584143|FG001|Overall Study|Other|0
4680747|NCT02444793|7584144|FG002|Overall Study|Other|2
4680748|NCT02444793|7584145|FG003|Overall Study|Other|0
4680749|NCT02444793|7584142|FG000|Overall Study|Objective progression or relapse|9
4680750|NCT02444793|7584143|FG001|Overall Study|Objective progression or relapse|1
4680751|NCT02444793|7584144|FG002|Overall Study|Objective progression or relapse|2
4680752|NCT02444793|7584145|FG003|Overall Study|Objective progression or relapse|3
4680753|NCT02445573|7584216|FG000|Overall Study|Withdrawal by Subject|1
4680754|NCT02445573|7584217|FG001|Overall Study|Withdrawal by Subject|1
4680755|NCT02445573|7584216|FG000|Overall Study|Lost to Follow-up|0
4680756|NCT02445573|7584217|FG001|Overall Study|Lost to Follow-up|1
4680757|NCT02445586|7584223|FG000|Overall Study|Death|14
4680758|NCT02445586|7584223|FG000|Overall Study|Withdrawal by Subject|13
4680759|NCT02445586|7584223|FG000|Overall Study|Disease Progression|10
4680760|NCT02445586|7584223|FG000|Overall Study|Protocol Violation|1
4680761|NCT02445586|7584223|FG000|Overall Study|Medical Condition|1
4680762|NCT02445755|7584232|FG000|Overall Study|Withdrawal by Subject|2
4680763|NCT02445755|7584232|FG000|Overall Study|Protocol Violation|6
4680764|NCT02445755|7584232|FG000|Overall Study|Screen Failure|5
4680765|NCT02445794|7584243|FG000|Overall Study|Adverse Event|0
4680766|NCT02445794|7584244|FG001|Overall Study|Adverse Event|0
4680767|NCT02445794|7584245|FG002|Overall Study|Adverse Event|2
4680768|NCT02445794|7584246|FG003|Overall Study|Adverse Event|0
4680769|NCT02445963|7584300|FG000|Overall Study|Lost to Follow-up|1
4680770|NCT02445963|7584301|FG001|Overall Study|Lost to Follow-up|0
4680771|NCT02445963|7584302|FG002|Overall Study|Lost to Follow-up|0
4680772|NCT02445963|7584303|FG003|Overall Study|Lost to Follow-up|0
4680773|NCT02445963|7584300|FG000|Overall Study|Change in employment|1
4680774|NCT02445963|7584301|FG001|Overall Study|Change in employment|0
4680775|NCT02445963|7584302|FG002|Overall Study|Change in employment|0
4680776|NCT02445963|7584303|FG003|Overall Study|Change in employment|0
4680777|NCT02445963|7584300|FG000|Overall Study|Symptoms post-vaccination|0
4680778|NCT02445963|7584301|FG001|Overall Study|Symptoms post-vaccination|0
4680779|NCT02445963|7584302|FG002|Overall Study|Symptoms post-vaccination|1
4680780|NCT02445963|7584303|FG003|Overall Study|Symptoms post-vaccination|0
4680781|NCT02446015|7584317|FG000|Overall Study|Adverse Event|0
4758893|NCT00408005|7732926|FG004|Induction|Patient transferred Tx to Non-COG Site|0
4758894|NCT00408005|7732927|FG005|Induction|Patient transferred Tx to Non-COG Site|0
4758895|NCT00408005|7732928|FG006|Induction|Patient transferred Tx to Non-COG Site|0
4758896|NCT00408005|7732929|FG007|Induction|Patient transferred Tx to Non-COG Site|0
4758897|NCT00408005|7732922|FG000|Induction|Identified as Philadelphia Chr. Positive|6
4758898|NCT00408005|7732923|FG001|Induction|Identified as Philadelphia Chr. Positive|0
4758899|NCT00408005|7732924|FG002|Induction|Identified as Philadelphia Chr. Positive|0
4758900|NCT00408005|7732925|FG003|Induction|Identified as Philadelphia Chr. Positive|0
4758901|NCT00408005|7732926|FG004|Induction|Identified as Philadelphia Chr. Positive|0
4758902|NCT00408005|7732927|FG005|Induction|Identified as Philadelphia Chr. Positive|0
4758903|NCT00408005|7732928|FG006|Induction|Identified as Philadelphia Chr. Positive|0
4758904|NCT00408005|7732929|FG007|Induction|Identified as Philadelphia Chr. Positive|0
4758905|NCT00408005|7732922|FG000|Induction|Progressive Disease|0
4758906|NCT00408005|7732923|FG001|Induction|Progressive Disease|1
4758907|NCT00408005|7732924|FG002|Induction|Progressive Disease|0
4758908|NCT00408005|7732925|FG003|Induction|Progressive Disease|0
4758909|NCT00408005|7732926|FG004|Induction|Progressive Disease|0
4758910|NCT00408005|7732927|FG005|Induction|Progressive Disease|0
4758911|NCT00408005|7732928|FG006|Induction|Progressive Disease|0
4758912|NCT00408005|7732929|FG007|Induction|Progressive Disease|0
4680782|NCT02446015|7584318|FG001|Overall Study|Adverse Event|1
4680783|NCT02446015|7584317|FG000|Overall Study|Withdrawal by Subject|1
4680784|NCT02446015|7584318|FG001|Overall Study|Withdrawal by Subject|0
4680785|NCT02446171|7584329|FG000|Overall Study|Withdrawal by Subject|0
4680786|NCT02446171|7584330|FG001|Overall Study|Withdrawal by Subject|0
4680787|NCT02446171|7584331|FG002|Overall Study|Withdrawal by Subject|2
4680788|NCT02446171|7584332|FG003|Overall Study|Withdrawal by Subject|0
4680789|NCT02446418|7584371|FG000|Overall Study|Adverse Event|4
4680790|NCT02446418|7584372|FG001|Overall Study|Adverse Event|8
4680791|NCT02446418|7584371|FG000|Overall Study|Physician Decision|5
4680792|NCT02446418|7584372|FG001|Overall Study|Physician Decision|1
4680793|NCT02446418|7584371|FG000|Overall Study|Withdrawal by Subject|3
4680794|NCT02446418|7584372|FG001|Overall Study|Withdrawal by Subject|3
4680795|NCT02446418|7584371|FG000|Overall Study|Lost to Follow-up|2
4680796|NCT02446418|7584372|FG001|Overall Study|Lost to Follow-up|2
4680797|NCT02446418|7584371|FG000|Overall Study|Protocol Violation|1
4680798|NCT02446418|7584372|FG001|Overall Study|Protocol Violation|2
4680799|NCT02446418|7584371|FG000|Overall Study|Lack of Efficacy|2
4680800|NCT02446418|7584372|FG001|Overall Study|Lack of Efficacy|0
4680801|NCT02446418|7584371|FG000|Overall Study|Protocol defined stopping criteria reach|1
4680802|NCT02446418|7584372|FG001|Overall Study|Protocol defined stopping criteria reach|0
4680803|NCT02446691|7584404|FG000|Overall Study|Withdrawal by Subject|2
4680804|NCT02446691|7584404|FG000|Overall Study|Lost to Follow-up|8
4680805|NCT02446691|7584404|FG000|Overall Study|Protocol Violation|1
4680806|NCT02446717|7584413|FG000|Overall Study|Adverse Event|0
4680807|NCT02446717|7584414|FG001|Overall Study|Adverse Event|0
4680808|NCT02446717|7584415|FG002|Overall Study|Adverse Event|1
4680809|NCT02446717|7584416|FG003|Overall Study|Adverse Event|0
4680810|NCT02446717|7584417|FG004|Overall Study|Adverse Event|0
4680811|NCT02446717|7584413|FG000|Overall Study|Lost to Follow-up|0
4680812|NCT02446717|7584414|FG001|Overall Study|Lost to Follow-up|1
4680813|NCT02446717|7584415|FG002|Overall Study|Lost to Follow-up|1
4680814|NCT02446717|7584416|FG003|Overall Study|Lost to Follow-up|0
4680815|NCT02446717|7584417|FG004|Overall Study|Lost to Follow-up|1
4680816|NCT02446717|7584413|FG000|Overall Study|Withdrew consent|0
4680817|NCT02446717|7584414|FG001|Overall Study|Withdrew consent|0
4680818|NCT02446717|7584415|FG002|Overall Study|Withdrew consent|0
4680819|NCT02446717|7584416|FG003|Overall Study|Withdrew consent|1
4680820|NCT02446717|7584417|FG004|Overall Study|Withdrew consent|0
4680821|NCT02446743|7584431|FG000|Overall Study|Withdrawal by Subject|1
4680822|NCT02446743|7584432|FG001|Overall Study|Withdrawal by Subject|1
4680823|NCT02446743|7584431|FG000|Overall Study|Lost to Follow-up|1
4680824|NCT02446743|7584432|FG001|Overall Study|Lost to Follow-up|0
4680825|NCT02446743|7584431|FG000|Overall Study|Adverse Event|1
4680826|NCT02446743|7584432|FG001|Overall Study|Adverse Event|1
4680827|NCT02446743|7584431|FG000|Overall Study|Other|2
4680828|NCT02446743|7584432|FG001|Overall Study|Other|3
4680829|NCT02446769|7584447|FG000|Screening Period|Screen Failure|11
4680830|NCT02446769|7584448|FG001|Screening Period|Screen Failure|0
4680831|NCT02446769|7584449|FG002|Screening Period|Screen Failure|0
4680832|NCT02446769|7584447|FG000|Study Period|Randomized in Error|0
4680833|NCT02446769|7584448|FG001|Study Period|Randomized in Error|2
4680834|NCT02446769|7584449|FG002|Study Period|Randomized in Error|0
4680835|NCT02446886|7584467|FG000|Overall Study|Adverse Event|1
4680836|NCT02446886|7584468|FG001|Overall Study|Adverse Event|3
4680837|NCT02446886|7584467|FG000|Overall Study|Withdrawal by Subject|1
4680838|NCT02446886|7584468|FG001|Overall Study|Withdrawal by Subject|1
4680839|NCT02446899|7584477|FG000|Overall Study|Adverse Event|4
4680840|NCT02446899|7584478|FG001|Overall Study|Adverse Event|7
4680841|NCT02446899|7584477|FG000|Overall Study|Condition Under Investigation Worsened|1
4680842|NCT02446899|7584478|FG001|Overall Study|Condition Under Investigation Worsened|4
4680843|NCT02446899|7584477|FG000|Overall Study|Study Specific Withdrawal Criteria|1
4680844|NCT02446899|7584478|FG001|Overall Study|Study Specific Withdrawal Criteria|0
4680845|NCT02446899|7584477|FG000|Overall Study|Lack of Efficacy|2
4680846|NCT02446899|7584478|FG001|Overall Study|Lack of Efficacy|8
4680847|NCT02446899|7584477|FG000|Overall Study|Lost to Follow-up|1
4680848|NCT02446899|7584478|FG001|Overall Study|Lost to Follow-up|3
4680849|NCT02446899|7584477|FG000|Overall Study|Severe Non-Compliance to Protocol|0
4680850|NCT02446899|7584478|FG001|Overall Study|Severe Non-Compliance to Protocol|1
4680851|NCT02446899|7584477|FG000|Overall Study|Withdrawal by Subject|11
4680852|NCT02446899|7584478|FG001|Overall Study|Withdrawal by Subject|19
4680853|NCT02446899|7584477|FG000|Overall Study|Miscellaneous|5
4680854|NCT02446899|7584478|FG001|Overall Study|Miscellaneous|4
4680855|NCT02446899|7584477|FG000|Overall Study|Failure to Meet Randomization Criteria|0
4680856|NCT02446899|7584478|FG001|Overall Study|Failure to Meet Randomization Criteria|2
4680857|NCT02446912|7584487|FG000|Overall Study|Adverse Event|3
4680858|NCT02446912|7584488|FG001|Overall Study|Adverse Event|13
4680859|NCT02446912|7584489|FG002|Overall Study|Adverse Event|5
4680860|NCT02446912|7584487|FG000|Overall Study|Condition under investigation worsened|0
4680861|NCT02446912|7584488|FG001|Overall Study|Condition under investigation worsened|1
4680862|NCT02446912|7584489|FG002|Overall Study|Condition under investigation worsened|1
4680863|NCT02446912|7584487|FG000|Overall Study|Study-specific withdrawal criteria|1
4680864|NCT02446912|7584488|FG001|Overall Study|Study-specific withdrawal criteria|0
4680865|NCT02446912|7584489|FG002|Overall Study|Study-specific withdrawal criteria|0
4680866|NCT02446912|7584487|FG000|Overall Study|Lack of Efficacy|1
4680867|NCT02446912|7584488|FG001|Overall Study|Lack of Efficacy|4
4680868|NCT02446912|7584489|FG002|Overall Study|Lack of Efficacy|7
4680869|NCT02446912|7584487|FG000|Overall Study|Lost to Follow-up|0
4680870|NCT02446912|7584488|FG001|Overall Study|Lost to Follow-up|0
4680871|NCT02446912|7584489|FG002|Overall Study|Lost to Follow-up|2
4680872|NCT02446912|7584487|FG000|Overall Study|Severe non-compliance to protocol|1
4680873|NCT02446912|7584488|FG001|Overall Study|Severe non-compliance to protocol|0
4680874|NCT02446912|7584489|FG002|Overall Study|Severe non-compliance to protocol|1
4680875|NCT02446912|7584487|FG000|Overall Study|Withdrawal by Subject|10
4680876|NCT02446912|7584488|FG001|Overall Study|Withdrawal by Subject|15
4680877|NCT02446912|7584489|FG002|Overall Study|Withdrawal by Subject|15
4680878|NCT02446912|7584487|FG000|Overall Study|Miscellaneous|2
4680879|NCT02446912|7584488|FG001|Overall Study|Miscellaneous|2
4680880|NCT02446912|7584489|FG002|Overall Study|Miscellaneous|4
4680881|NCT02446990|7584499|FG000|Overall Study|Death|485
4680882|NCT02446990|7584500|FG001|Overall Study|Death|458
4680883|NCT02446990|7584499|FG000|Overall Study|Lost to Follow-up|3
4680884|NCT02446990|7584500|FG001|Overall Study|Lost to Follow-up|1
4680885|NCT02446990|7584499|FG000|Overall Study|Physician Decision|1
4680886|NCT02446990|7584500|FG001|Overall Study|Physician Decision|0
4680887|NCT02446990|7584499|FG000|Overall Study|Withdrawal by Subject|231
4680888|NCT02446990|7584500|FG001|Overall Study|Withdrawal by Subject|199
4758913|NCT00408005|7732922|FG000|Induction|Inevaluable|18
4758914|NCT00408005|7732923|FG001|Induction|Inevaluable|14
4758915|NCT00408005|7732924|FG002|Induction|Inevaluable|0
4758916|NCT00408005|7732925|FG003|Induction|Inevaluable|0
4758917|NCT00408005|7732926|FG004|Induction|Inevaluable|0
4758918|NCT00408005|7732927|FG005|Induction|Inevaluable|0
4758919|NCT00408005|7732928|FG006|Induction|Inevaluable|0
4758920|NCT00408005|7732929|FG007|Induction|Inevaluable|0
4758921|NCT00408005|7732922|FG000|Induction|Failed to Complete Randomization|3
4758922|NCT00408005|7732923|FG001|Induction|Failed to Complete Randomization|2
4758923|NCT00408005|7732924|FG002|Induction|Failed to Complete Randomization|0
4758924|NCT00408005|7732925|FG003|Induction|Failed to Complete Randomization|0
4758925|NCT00408005|7732926|FG004|Induction|Failed to Complete Randomization|0
4758926|NCT00408005|7732927|FG005|Induction|Failed to Complete Randomization|0
4758927|NCT00408005|7732928|FG006|Induction|Failed to Complete Randomization|0
4758928|NCT00408005|7732929|FG007|Induction|Failed to Complete Randomization|0
4758929|NCT00408005|7732922|FG000|Induction|Protocol Deviation|3
4758930|NCT00408005|7732923|FG001|Induction|Protocol Deviation|1
4758931|NCT00408005|7732924|FG002|Induction|Protocol Deviation|0
4758932|NCT00408005|7732925|FG003|Induction|Protocol Deviation|0
4758933|NCT00408005|7732926|FG004|Induction|Protocol Deviation|0
4758934|NCT00408005|7732927|FG005|Induction|Protocol Deviation|0
4758935|NCT00408005|7732928|FG006|Induction|Protocol Deviation|0
4758936|NCT00408005|7732929|FG007|Induction|Protocol Deviation|0
4758937|NCT00408005|7732922|FG000|Induction|Hematopoietic Stem Cell Transplantation|1
4758938|NCT00408005|7732923|FG001|Induction|Hematopoietic Stem Cell Transplantation|0
4758939|NCT00408005|7732924|FG002|Induction|Hematopoietic Stem Cell Transplantation|0
4758940|NCT00408005|7732925|FG003|Induction|Hematopoietic Stem Cell Transplantation|0
4758941|NCT00408005|7732926|FG004|Induction|Hematopoietic Stem Cell Transplantation|0
4758942|NCT00408005|7732927|FG005|Induction|Hematopoietic Stem Cell Transplantation|0
4758943|NCT00408005|7732928|FG006|Induction|Hematopoietic Stem Cell Transplantation|0
4758944|NCT00408005|7732929|FG007|Induction|Hematopoietic Stem Cell Transplantation|0
4758945|NCT00408005|7732922|FG000|Induction|Recurrent leukemia|1
4758946|NCT00408005|7732923|FG001|Induction|Recurrent leukemia|0
4758947|NCT00408005|7732924|FG002|Induction|Recurrent leukemia|0
4758948|NCT00408005|7732925|FG003|Induction|Recurrent leukemia|0
4758949|NCT00408005|7732926|FG004|Induction|Recurrent leukemia|0
4758950|NCT00408005|7732927|FG005|Induction|Recurrent leukemia|0
4758951|NCT00408005|7732928|FG006|Induction|Recurrent leukemia|0
4758952|NCT00408005|7732929|FG007|Induction|Recurrent leukemia|0
4758953|NCT00408005|7732922|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0
4758954|NCT00408005|7732923|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0
4758955|NCT00408005|7732924|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7
4758956|NCT00408005|7732925|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4
4758957|NCT00408005|7732926|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8
4758958|NCT00408005|7732927|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12
4758959|NCT00408005|7732928|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2
4758960|NCT00408005|7732929|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0
4758961|NCT00408005|7732922|FG000|Post Induction Therapy by Tx Assignment|Death|0
4758962|NCT00408005|7732923|FG001|Post Induction Therapy by Tx Assignment|Death|0
4758963|NCT00408005|7732924|FG002|Post Induction Therapy by Tx Assignment|Death|3
4758964|NCT00408005|7732925|FG003|Post Induction Therapy by Tx Assignment|Death|0
4758965|NCT00408005|7732926|FG004|Post Induction Therapy by Tx Assignment|Death|5
4758966|NCT00408005|7732927|FG005|Post Induction Therapy by Tx Assignment|Death|5
4758967|NCT00408005|7732928|FG006|Post Induction Therapy by Tx Assignment|Death|3
4758968|NCT00408005|7732929|FG007|Post Induction Therapy by Tx Assignment|Death|1
4758969|NCT00408005|7732922|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
4758970|NCT00408005|7732923|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
4758971|NCT00408005|7732924|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2
4758972|NCT00408005|7732925|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
4758973|NCT00408005|7732926|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1
4758974|NCT00408005|7732927|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
4758975|NCT00408005|7732928|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
4758976|NCT00408005|7732929|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
4758977|NCT00408005|7732922|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0
4758978|NCT00408005|7732923|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0
4758979|NCT00408005|7732924|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24
4758980|NCT00408005|7732925|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19
4758981|NCT00408005|7732926|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27
4758982|NCT00408005|7732927|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45
4680889|NCT02447003|7584508|FG000|Overall Study|Other|0
4680890|NCT02447003|7584509|FG001|Overall Study|Other|4
4680891|NCT02447003|7584508|FG000|Overall Study|Site discontinued|0
4680892|NCT02447003|7584509|FG001|Overall Study|Site discontinued|2
4680893|NCT02447003|7584508|FG000|Overall Study|Physician Decision|0
4680894|NCT02447003|7584509|FG001|Overall Study|Physician Decision|1
4680895|NCT02447003|7584508|FG000|Overall Study|Withdrawal by Subject|4
4680896|NCT02447003|7584509|FG001|Overall Study|Withdrawal by Subject|3
4680897|NCT02447003|7584508|FG000|Overall Study|Sponsor Decision|6
4680898|NCT02447003|7584509|FG001|Overall Study|Sponsor Decision|11
4680899|NCT02447003|7584508|FG000|Overall Study|Progressive Disease|1
4680900|NCT02447003|7584509|FG001|Overall Study|Progressive Disease|0
4680901|NCT02447003|7584508|FG000|Overall Study|Lost to Follow-up|5
4680902|NCT02447003|7584509|FG001|Overall Study|Lost to Follow-up|0
4680903|NCT02447003|7584508|FG000|Overall Study|Death|154
4680904|NCT02447003|7584509|FG001|Overall Study|Death|63
4680905|NCT02447029|7584519|FG000|Overall Study|Withdrawal by Subject|3
4680906|NCT02447029|7584520|FG001|Overall Study|Withdrawal by Subject|2
4680907|NCT02447081|7584526|FG000|Overall Study|Death|161
4680908|NCT02447081|7584526|FG000|Overall Study|Lost to Follow-up|36
4680909|NCT02447081|7584526|FG000|Overall Study|Visit not completed|17
4680910|NCT02447081|7584526|FG000|Overall Study|unsuccessful implant procedure|10
4680911|NCT02447172|7584533|FG000|Overall Study|Adverse Event|11
4680912|NCT02447172|7584534|FG001|Overall Study|Adverse Event|8
4680913|NCT02447172|7584535|FG002|Overall Study|Adverse Event|7
4680914|NCT02447172|7584533|FG000|Overall Study|Death|3
4680915|NCT02447172|7584534|FG001|Overall Study|Death|1
4680916|NCT02447172|7584535|FG002|Overall Study|Death|0
4680917|NCT02447172|7584533|FG000|Overall Study|Protocol Violation|2
4680918|NCT02447172|7584534|FG001|Overall Study|Protocol Violation|1
4680919|NCT02447172|7584535|FG002|Overall Study|Protocol Violation|2
4680920|NCT02447172|7584533|FG000|Overall Study|Lost to Follow-up|7
4680921|NCT02447172|7584534|FG001|Overall Study|Lost to Follow-up|4
4680922|NCT02447172|7584535|FG002|Overall Study|Lost to Follow-up|4
4680923|NCT02447172|7584533|FG000|Overall Study|Withdrawal by Subject|5
4680924|NCT02447172|7584534|FG001|Overall Study|Withdrawal by Subject|1
4680925|NCT02447172|7584535|FG002|Overall Study|Withdrawal by Subject|3
4680926|NCT02447172|7584533|FG000|Overall Study|protocol specific treatment unrelated|3
4680927|NCT02447172|7584534|FG001|Overall Study|protocol specific treatment unrelated|0
4680928|NCT02447172|7584535|FG002|Overall Study|protocol specific treatment unrelated|2
4680929|NCT02447250|7584543|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1
4680930|NCT02447250|7584543|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1
4680931|NCT02447250|7584543|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4
4680932|NCT02447302|7584551|FG000|Overall Study|Physician Decision|1
4680933|NCT02447302|7584552|FG001|Overall Study|Physician Decision|0
4680934|NCT02447302|7584553|FG002|Overall Study|Physician Decision|0
4680935|NCT02447302|7584551|FG000|Overall Study|Adverse Event|4
4680936|NCT02447302|7584552|FG001|Overall Study|Adverse Event|3
4680937|NCT02447302|7584553|FG002|Overall Study|Adverse Event|0
4680938|NCT02447302|7584551|FG000|Overall Study|Withdrawal by Subject|0
4680939|NCT02447302|7584552|FG001|Overall Study|Withdrawal by Subject|1
4680940|NCT02447302|7584553|FG002|Overall Study|Withdrawal by Subject|5
4680941|NCT02447302|7584551|FG000|Overall Study|Sponsor Decision|0
4680942|NCT02447302|7584552|FG001|Overall Study|Sponsor Decision|0
4680943|NCT02447302|7584553|FG002|Overall Study|Sponsor Decision|1
4680944|NCT02447328|7584561|FG000|Overall Study|Withdrawal by Subject|1
4680945|NCT02447432|7584567|FG000|Epoch 001|Adverse Event|1
4680946|NCT02447432|7584568|FG001|Epoch 001|Adverse Event|1
4680947|NCT02447432|7584567|FG000|Epoch 001|Withdrawal by Subject|0
4680948|NCT02447432|7584568|FG001|Epoch 001|Withdrawal by Subject|4
4680949|NCT02447432|7584567|FG000|Epoch 001|Migrated/moved from study area|3
4680950|NCT02447432|7584568|FG001|Epoch 001|Migrated/moved from study area|5
4680951|NCT02447432|7584567|FG000|Epoch 001|Lost to Follow-up|1
4680952|NCT02447432|7584568|FG001|Epoch 001|Lost to Follow-up|3
4680953|NCT02447458|7584580|FG000|Overall Study|Other|0
4680954|NCT02447458|7584581|FG001|Overall Study|Other|0
4680955|NCT02447458|7584582|FG002|Overall Study|Other|1
4680956|NCT02447458|7584583|FG003|Overall Study|Other|0
4680957|NCT02447458|7584584|FG004|Overall Study|Other|0
4680958|NCT02447458|7584585|FG005|Overall Study|Other|0
4680959|NCT02447497|7584608|FG000|Overall Study|Did not meet treatment day baseline.|6
4680960|NCT02447497|7584609|FG001|Overall Study|Did not meet treatment day baseline.|5
4680961|NCT02447497|7584610|FG002|Overall Study|Did not meet treatment day baseline.|2
4680962|NCT02447497|7584611|FG003|Overall Study|Did not meet treatment day baseline.|2
4680963|NCT02447497|7584608|FG000|Overall Study|Dressing was compromised|0
4680964|NCT02447497|7584609|FG001|Overall Study|Dressing was compromised|1
4680965|NCT02447497|7584610|FG002|Overall Study|Dressing was compromised|0
4680966|NCT02447497|7584611|FG003|Overall Study|Dressing was compromised|0
4680967|NCT02447718|7584635|FG000|Overall Study|Lost to Follow-up|8
4680968|NCT02447718|7584636|FG001|Overall Study|Lost to Follow-up|0
4680969|NCT02447718|7584635|FG000|Overall Study|Withdrawal by Subject|3
4680970|NCT02447718|7584636|FG001|Overall Study|Withdrawal by Subject|0
4680971|NCT02447718|7584635|FG000|Overall Study|Screen Failure|1
4680972|NCT02447718|7584636|FG001|Overall Study|Screen Failure|0
4680973|NCT02447744|7584645|FG000|Overall Study|Withdrawal by Subject|3
4680974|NCT02447744|7584646|FG001|Overall Study|Withdrawal by Subject|1
4680975|NCT02447744|7584645|FG000|Overall Study|Data not collected b/c logistic reasons|3
4680976|NCT02447744|7584646|FG001|Overall Study|Data not collected b/c logistic reasons|0
4758983|NCT00408005|7732928|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10
4758984|NCT00408005|7732929|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4
4758985|NCT00408005|7732922|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
4758986|NCT00408005|7732923|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
4758987|NCT00408005|7732924|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1
4758988|NCT00408005|7732925|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1
4758989|NCT00408005|7732926|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
4758990|NCT00408005|7732927|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2
4758991|NCT00408005|7732928|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
4758992|NCT00408005|7732929|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
4758993|NCT00408005|7732922|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0
4758994|NCT00408005|7732923|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0
4758995|NCT00408005|7732924|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27
4758996|NCT00408005|7732925|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10
4758997|NCT00408005|7732926|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36
4758998|NCT00408005|7732927|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16
4758999|NCT00408005|7732928|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4
4759000|NCT00408005|7732929|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2
4759001|NCT00408005|7732922|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
4759002|NCT00408005|7732923|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
4759003|NCT00408005|7732924|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
4759004|NCT00408005|7732925|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
4759005|NCT00408005|7732926|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1
4759006|NCT00408005|7732927|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
4759007|NCT00408005|7732928|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
4759008|NCT00408005|7732929|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
4759009|NCT00408005|7732922|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
4759010|NCT00408005|7732923|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
4759011|NCT00408005|7732924|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3
4759012|NCT00408005|7732925|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1
4759013|NCT00408005|7732926|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1
4759014|NCT00408005|7732927|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
4680977|NCT02447848|7584652|FG000|Overall Study|Patient discharged|3
4680978|NCT02447848|7584652|FG000|Overall Study|Lack of Efficacy|4
4680979|NCT02447848|7584652|FG000|Overall Study|Withdrawal by Subject|4
4680980|NCT02447952|7584660|FG000|Overall Study|Adverse Event|2
4680981|NCT02447952|7584660|FG000|Overall Study|Physician Decision|1
4680982|NCT02447952|7584660|FG000|Overall Study|Withdrawal by Subject|4
4680983|NCT02447991|7584666|FG000|Overall Study|Withdrawn by subject - no data|0
4680984|NCT02447991|7584667|FG001|Overall Study|Withdrawn by subject - no data|2
4680985|NCT02447991|7584666|FG000|Overall Study|Withdrawn by Subject - with data|4
4680986|NCT02447991|7584667|FG001|Overall Study|Withdrawn by Subject - with data|4
4680987|NCT02447991|7584666|FG000|Overall Study|Lost to Follow-up - no data|3
4680988|NCT02447991|7584667|FG001|Overall Study|Lost to Follow-up - no data|6
4680989|NCT02447991|7584666|FG000|Overall Study|Lost to follow-up - with data|0
4680990|NCT02447991|7584667|FG001|Overall Study|Lost to follow-up - with data|3
4680991|NCT02447991|7584666|FG000|Overall Study|End of study - no treatment results|3
4680992|NCT02447991|7584667|FG001|Overall Study|End of study - no treatment results|6
4680993|NCT02447991|7584666|FG000|Overall Study|End of study - partial treatment results|0
4680994|NCT02447991|7584667|FG001|Overall Study|End of study - partial treatment results|9
4680995|NCT02448043|7584679|FG000|Overall Study|Withdrawal by Subject|2
4680996|NCT02448043|7584680|FG001|Overall Study|Withdrawal by Subject|2
4680997|NCT02448043|7584679|FG000|Overall Study|Protocol Violation|1
4680998|NCT02448043|7584680|FG001|Overall Study|Protocol Violation|2
4680999|NCT02448446|7584739|FG000|Overall Study|Withdrawal by Subject|1
4681000|NCT02448446|7584740|FG001|Overall Study|Withdrawal by Subject|0
4681001|NCT02448537|7584749|FG000|Overall Study|Withdrawal by Subject|1
4681002|NCT02448537|7584750|FG001|Overall Study|Withdrawal by Subject|1
4681003|NCT02448537|7584751|FG002|Overall Study|Withdrawal by Subject|1
4681004|NCT02448563|7584763|FG000|Overall Study|Lost to Follow-up|16
4681005|NCT02448563|7584764|FG001|Overall Study|Lost to Follow-up|10
4681006|NCT02448563|7584763|FG000|Overall Study|Withdrawal by Subject|0
4681007|NCT02448563|7584764|FG001|Overall Study|Withdrawal by Subject|1
4681008|NCT02448706|7584803|FG000|Overall Study|Withdrawal by Subject|4
4681009|NCT02448706|7584804|FG001|Overall Study|Withdrawal by Subject|3
4681010|NCT02448706|7584803|FG000|Overall Study|Protocol Violation|1
4681011|NCT02448706|7584804|FG001|Overall Study|Protocol Violation|1
4681012|NCT02448719|7584823|FG000|Overall Study|Withdrawal by Subject|0
4681013|NCT02448719|7584824|FG001|Overall Study|Withdrawal by Subject|0
4681014|NCT02448719|7584825|FG002|Overall Study|Withdrawal by Subject|0
4681015|NCT02448719|7584826|FG003|Overall Study|Withdrawal by Subject|0
4681016|NCT02448719|7584827|FG004|Overall Study|Withdrawal by Subject|1
4681017|NCT02448719|7584828|FG005|Overall Study|Withdrawal by Subject|0
4681018|NCT02448719|7584829|FG006|Overall Study|Withdrawal by Subject|0
4681019|NCT02448719|7584830|FG007|Overall Study|Withdrawal by Subject|0
4681020|NCT02448719|7584831|FG008|Overall Study|Withdrawal by Subject|0
4681021|NCT02448719|7584832|FG009|Overall Study|Withdrawal by Subject|0
4681022|NCT02448719|7584833|FG010|Overall Study|Withdrawal by Subject|0
4681023|NCT02448771|7584894|FG000|Overall Study|Disease Progression|30
4681024|NCT02448771|7584894|FG000|Overall Study|Unacceptable Toxicity|1
4681025|NCT02448771|7584894|FG000|Overall Study|Physician Decision|3
4681026|NCT02448771|7584894|FG000|Overall Study|Started new therapy|2
4681027|NCT02448810|7584907|FG000|Overall Study|Adverse Event|0
4681028|NCT02448810|7584908|FG001|Overall Study|Adverse Event|0
4681029|NCT02448810|7584909|FG002|Overall Study|Adverse Event|1
4681030|NCT02448810|7584910|FG003|Overall Study|Adverse Event|0
4681031|NCT02448810|7584911|FG004|Overall Study|Adverse Event|0
4681032|NCT02448810|7584912|FG005|Overall Study|Adverse Event|0
4681033|NCT02448810|7584913|FG006|Overall Study|Adverse Event|0
4681034|NCT02448810|7584914|FG007|Overall Study|Adverse Event|0
4681035|NCT02448810|7584907|FG000|Overall Study|Withdrawal by Subject|0
4681036|NCT02448810|7584908|FG001|Overall Study|Withdrawal by Subject|0
4681037|NCT02448810|7584909|FG002|Overall Study|Withdrawal by Subject|1
4681038|NCT02448810|7584910|FG003|Overall Study|Withdrawal by Subject|0
4681039|NCT02448810|7584911|FG004|Overall Study|Withdrawal by Subject|3
4681040|NCT02448810|7584912|FG005|Overall Study|Withdrawal by Subject|5
4681041|NCT02448810|7584913|FG006|Overall Study|Withdrawal by Subject|0
4681042|NCT02448810|7584914|FG007|Overall Study|Withdrawal by Subject|2
4681043|NCT02448810|7584907|FG000|Overall Study|Other (study terminated by sponsor)|0
4681044|NCT02448810|7584908|FG001|Overall Study|Other (study terminated by sponsor)|0
4681045|NCT02448810|7584909|FG002|Overall Study|Other (study terminated by sponsor)|0
4681046|NCT02448810|7584910|FG003|Overall Study|Other (study terminated by sponsor)|0
4681047|NCT02448810|7584911|FG004|Overall Study|Other (study terminated by sponsor)|4
4681048|NCT02448810|7584912|FG005|Overall Study|Other (study terminated by sponsor)|2
4681049|NCT02448810|7584913|FG006|Overall Study|Other (study terminated by sponsor)|2
4681050|NCT02448810|7584914|FG007|Overall Study|Other (study terminated by sponsor)|1
4681051|NCT02448810|7584907|FG000|Overall Study|Death|1
4681052|NCT02448810|7584908|FG001|Overall Study|Death|0
4681053|NCT02448810|7584909|FG002|Overall Study|Death|1
4681054|NCT02448810|7584910|FG003|Overall Study|Death|0
4681055|NCT02448810|7584911|FG004|Overall Study|Death|1
4681056|NCT02448810|7584912|FG005|Overall Study|Death|0
4681057|NCT02448810|7584913|FG006|Overall Study|Death|0
4681058|NCT02448810|7584914|FG007|Overall Study|Death|0
4681059|NCT02448810|7584907|FG000|Overall Study|Other (Progressive disease)|2
4681060|NCT02448810|7584908|FG001|Overall Study|Other (Progressive disease)|2
4681061|NCT02448810|7584909|FG002|Overall Study|Other (Progressive disease)|0
4681062|NCT02448810|7584910|FG003|Overall Study|Other (Progressive disease)|3
4681063|NCT02448810|7584911|FG004|Overall Study|Other (Progressive disease)|23
4681064|NCT02448810|7584912|FG005|Overall Study|Other (Progressive disease)|9
4681065|NCT02448810|7584913|FG006|Overall Study|Other (Progressive disease)|14
4681066|NCT02448810|7584914|FG007|Overall Study|Other (Progressive disease)|5
4681067|NCT02448810|7584907|FG000|Overall Study|Lost to Follow-up|0
4681068|NCT02448810|7584908|FG001|Overall Study|Lost to Follow-up|1
4681069|NCT02448810|7584909|FG002|Overall Study|Lost to Follow-up|0
4681070|NCT02448810|7584910|FG003|Overall Study|Lost to Follow-up|0
4681071|NCT02448810|7584911|FG004|Overall Study|Lost to Follow-up|0
4681072|NCT02448810|7584912|FG005|Overall Study|Lost to Follow-up|0
4681073|NCT02448810|7584913|FG006|Overall Study|Lost to Follow-up|0
4681074|NCT02448810|7584914|FG007|Overall Study|Lost to Follow-up|0
4681075|NCT02448810|7584907|FG000|Overall Study|Other (unspecified)|0
4681076|NCT02448810|7584908|FG001|Overall Study|Other (unspecified)|0
4681077|NCT02448810|7584909|FG002|Overall Study|Other (unspecified)|0
4681078|NCT02448810|7584910|FG003|Overall Study|Other (unspecified)|0
4681079|NCT02448810|7584911|FG004|Overall Study|Other (unspecified)|0
4681080|NCT02448810|7584912|FG005|Overall Study|Other (unspecified)|0
4681081|NCT02448810|7584913|FG006|Overall Study|Other (unspecified)|2
4681082|NCT02448810|7584914|FG007|Overall Study|Other (unspecified)|0
4681083|NCT02448875|7584948|FG000|Overall Study|Adverse Event|2
4681084|NCT02448875|7584949|FG001|Overall Study|Adverse Event|1
4681085|NCT02448875|7584950|FG002|Overall Study|Adverse Event|0
4681086|NCT02448875|7584948|FG000|Overall Study|Lost to Follow-up|1
4681087|NCT02448875|7584949|FG001|Overall Study|Lost to Follow-up|0
4681088|NCT02448875|7584950|FG002|Overall Study|Lost to Follow-up|0
4681089|NCT02448875|7584948|FG000|Overall Study|Investigator Decision|3
4681090|NCT02448875|7584949|FG001|Overall Study|Investigator Decision|0
4681091|NCT02448875|7584950|FG002|Overall Study|Investigator Decision|1
4681092|NCT02448875|7584948|FG000|Overall Study|Withdrawal by Subject|1
4681093|NCT02448875|7584949|FG001|Overall Study|Withdrawal by Subject|0
4681094|NCT02448875|7584950|FG002|Overall Study|Withdrawal by Subject|0
4681095|NCT02449018|7584971|FG000|Overall Study|Abnormal laboratory value|0
4681096|NCT02449018|7584972|FG001|Overall Study|Abnormal laboratory value|1
4681097|NCT02449018|7584971|FG000|Overall Study|Administrative problems|1
4681098|NCT02449018|7584972|FG001|Overall Study|Administrative problems|0
4681099|NCT02449018|7584971|FG000|Overall Study|Adverse Event|5
4681100|NCT02449018|7584972|FG001|Overall Study|Adverse Event|1
4681101|NCT02449018|7584971|FG000|Overall Study|Protocol deviation|4
4681102|NCT02449018|7584972|FG001|Overall Study|Protocol deviation|0
4681103|NCT02449018|7584971|FG000|Overall Study|Patient decision|2
4681104|NCT02449018|7584972|FG001|Overall Study|Patient decision|0
4681105|NCT02449044|7584978|FG000|Overall Study|Lost to Follow-up|2
4681106|NCT02449044|7584978|FG000|Overall Study|Withdrawal by Subject|13
4681107|NCT02449044|7584978|FG000|Overall Study|Adverse Event|30
4681108|NCT02449044|7584978|FG000|Overall Study|Met Withdrawal Criteria|7
4681109|NCT02449044|7584978|FG000|Overall Study|Physician Decision|9
4681110|NCT02449044|7584978|FG000|Overall Study|Sponsor Discontinued Trial|3
4681111|NCT02449889|7585043|FG000|Overall Study|Adverse Event|1
4681112|NCT02449889|7585044|FG001|Overall Study|Adverse Event|2
4681113|NCT02449889|7585045|FG002|Overall Study|Adverse Event|0
4681114|NCT02449889|7585043|FG000|Overall Study|Protocol Violation|0
4681115|NCT02449889|7585044|FG001|Overall Study|Protocol Violation|4
4681116|NCT02449889|7585045|FG002|Overall Study|Protocol Violation|1
4681117|NCT02449902|7585055|FG000|Overall Study|Adverse Event|0
4681118|NCT02449902|7585056|FG001|Overall Study|Adverse Event|1
4681119|NCT02449902|7585055|FG000|Overall Study|Withdrawal by Subject|0
4681120|NCT02449902|7585056|FG001|Overall Study|Withdrawal by Subject|1
4681121|NCT02449915|7585066|FG000|Overall Study|Exclusion criteria - drug use|1
4681122|NCT02449915|7585067|FG001|Overall Study|Exclusion criteria - drug use|0
4681123|NCT02449915|7585066|FG000|Overall Study|Withdrawal by Subject|0
4681124|NCT02449915|7585067|FG001|Overall Study|Withdrawal by Subject|2
4681125|NCT02449915|7585066|FG000|Overall Study|Intraoperative surgical findings|1
4681126|NCT02449915|7585067|FG001|Overall Study|Intraoperative surgical findings|1
4681127|NCT02449915|7585066|FG000|Overall Study|Abnormal preop lab|0
4681128|NCT02449915|7585067|FG001|Overall Study|Abnormal preop lab|1
4681129|NCT02450487|7585082|FG000|Overall Study|Lost to Follow-up|3
4681130|NCT02450526|7585091|FG000|DB Period (Cycle 1)|Adverse Event|0
4681131|NCT02450526|7585092|FG001|DB Period (Cycle 1)|Adverse Event|0
4681132|NCT02450526|7585093|FG002|DB Period (Cycle 1)|Adverse Event|2
4681133|NCT02450526|7585094|FG003|DB Period (Cycle 1)|Adverse Event|0
4681134|NCT02450526|7585095|FG004|DB Period (Cycle 1)|Adverse Event|0
4681135|NCT02450526|7585091|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28
4681136|NCT02450526|7585092|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3
4681137|NCT02450526|7585093|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8
4681138|NCT02450526|7585094|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1
4681139|NCT02450526|7585095|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0
4681140|NCT02450526|7585091|FG000|DB Period (Cycle 1)|Lost to Follow-up|1
4681141|NCT02450526|7585092|FG001|DB Period (Cycle 1)|Lost to Follow-up|0
4681142|NCT02450526|7585093|FG002|DB Period (Cycle 1)|Lost to Follow-up|0
4681143|NCT02450526|7585094|FG003|DB Period (Cycle 1)|Lost to Follow-up|0
4681144|NCT02450526|7585095|FG004|DB Period (Cycle 1)|Lost to Follow-up|0
4681145|NCT02450526|7585091|FG000|DB Period (Cycle 1)|Protocol Violation|2
4681146|NCT02450526|7585092|FG001|DB Period (Cycle 1)|Protocol Violation|0
4681147|NCT02450526|7585093|FG002|DB Period (Cycle 1)|Protocol Violation|0
4681148|NCT02450526|7585094|FG003|DB Period (Cycle 1)|Protocol Violation|1
4681149|NCT02450526|7585095|FG004|DB Period (Cycle 1)|Protocol Violation|0
4681150|NCT02450526|7585091|FG000|OL Period (Cycles 2-5)|Adverse Event|0
4681151|NCT02450526|7585092|FG001|OL Period (Cycles 2-5)|Adverse Event|0
4681152|NCT02450526|7585093|FG002|OL Period (Cycles 2-5)|Adverse Event|0
4681153|NCT02450526|7585094|FG003|OL Period (Cycles 2-5)|Adverse Event|0
4681154|NCT02450526|7585095|FG004|OL Period (Cycles 2-5)|Adverse Event|2
4681155|NCT02450526|7585091|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0
4681156|NCT02450526|7585092|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0
4681157|NCT02450526|7585093|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0
4681158|NCT02450526|7585094|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0
4681159|NCT02450526|7585095|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31
4681160|NCT02450526|7585091|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0
4681161|NCT02450526|7585092|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0
4759015|NCT00408005|7732928|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1
4759016|NCT00408005|7732929|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
4759017|NCT00408005|7732922|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0
4759018|NCT00408005|7732923|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0
4759019|NCT00408005|7732924|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0
4759020|NCT00408005|7732925|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0
4759021|NCT00408005|7732926|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1
4759022|NCT00408005|7732927|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0
4759023|NCT00408005|7732928|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7
4681162|NCT02450526|7585093|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0
4681163|NCT02450526|7585094|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0
4681164|NCT02450526|7585095|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1
4681165|NCT02450526|7585091|FG000|OL Period (Cycles 2-5)|Protocol Violation|0
4681166|NCT02450526|7585092|FG001|OL Period (Cycles 2-5)|Protocol Violation|0
4681167|NCT02450526|7585093|FG002|OL Period (Cycles 2-5)|Protocol Violation|0
4681168|NCT02450526|7585094|FG003|OL Period (Cycles 2-5)|Protocol Violation|0
4681169|NCT02450526|7585095|FG004|OL Period (Cycles 2-5)|Protocol Violation|7
4681170|NCT02450539|7585117|FG000|Overall Study|Withdrawal by Subject|12
4681171|NCT02450539|7585118|FG001|Overall Study|Withdrawal by Subject|6
4681172|NCT02450539|7585117|FG000|Overall Study|Lost to Follow-up|4
4681173|NCT02450539|7585118|FG001|Overall Study|Lost to Follow-up|1
4681174|NCT02450552|7585130|FG000|Overall Study|Withdrawal by Subject|4
4681175|NCT02450552|7585131|FG001|Overall Study|Withdrawal by Subject|0
4681176|NCT02450552|7585132|FG002|Overall Study|Withdrawal by Subject|4
4681177|NCT02450552|7585130|FG000|Overall Study|Physician Decision|1
4681178|NCT02450552|7585131|FG001|Overall Study|Physician Decision|0
4681179|NCT02450552|7585132|FG002|Overall Study|Physician Decision|1
4681180|NCT02450578|7585144|FG000|Overall Study|ECG abnormality so not treated|1
4681181|NCT02450578|7585145|FG001|Overall Study|ECG abnormality so not treated|0
4681182|NCT02450578|7585146|FG002|Overall Study|ECG abnormality so not treated|0
4681183|NCT02450578|7585147|FG003|Overall Study|ECG abnormality so not treated|0
4681184|NCT02450903|7585185|FG000|Overall Study|Adverse Event|3
4681185|NCT02450903|7585185|FG000|Overall Study|Progressive disease|15
4681186|NCT02450903|7585185|FG000|Overall Study|Switched to commercial drug|1
4681187|NCT02450903|7585185|FG000|Overall Study|Subject/guardian decision|1
4681188|NCT02451007|7585189|FG000|Overall Study|Withdrawal by Subject|4
4681189|NCT02451007|7585189|FG000|Overall Study|Adverse Event|1
4681190|NCT02451007|7585189|FG000|Overall Study|Disease Progression|2
4681191|NCT02451124|7585193|FG000|Overall Study|Withdrawal by Subject|1
4681192|NCT02451137|7585203|FG000|Overall Study|Randomized but not treated|19
4681193|NCT02451137|7585204|FG001|Overall Study|Randomized but not treated|27
4681194|NCT02451137|7585203|FG000|Overall Study|Adverse Event|43
4681195|NCT02451137|7585204|FG001|Overall Study|Adverse Event|42
4681196|NCT02451137|7585203|FG000|Overall Study|Lack of Efficacy|4
4681197|NCT02451137|7585204|FG001|Overall Study|Lack of Efficacy|9
4681198|NCT02451137|7585203|FG000|Overall Study|Participant decision:discontinue insulin|41
4681199|NCT02451137|7585204|FG001|Overall Study|Participant decision:discontinue insulin|43
4681200|NCT02451137|7585203|FG000|Overall Study|Hypoglycemia|2
4681201|NCT02451137|7585204|FG001|Overall Study|Hypoglycemia|1
4681202|NCT02451137|7585203|FG000|Overall Study|Investigator's decision|23
4681203|NCT02451137|7585204|FG001|Overall Study|Investigator's decision|19
4681204|NCT02451137|7585203|FG000|Overall Study|Lost to Follow-up|53
4681205|NCT02451137|7585204|FG001|Overall Study|Lost to Follow-up|61
4681206|NCT02451137|7585203|FG000|Overall Study|Physician Decision|6
4681207|NCT02451137|7585204|FG001|Overall Study|Physician Decision|5
4681208|NCT02451137|7585203|FG000|Overall Study|Sponsor decision|13
4681209|NCT02451137|7585204|FG001|Overall Study|Sponsor decision|25
4681210|NCT02451137|7585203|FG000|Overall Study|Withdrawal by Subject|40
4681211|NCT02451137|7585204|FG001|Overall Study|Withdrawal by Subject|63
4681212|NCT02451137|7585203|FG000|Overall Study|Other than specified above|2
4681213|NCT02451137|7585204|FG001|Overall Study|Other than specified above|3
4681214|NCT02451670|7585262|FG000|Overall Study|Did not have qualifying follow-up visit.|714
4681215|NCT02451670|7585263|FG001|Overall Study|Did not have qualifying follow-up visit.|696
4681216|NCT02451696|7585271|FG000|Overall Study|Surgery postponed|1
4681217|NCT02451696|7585272|FG001|Overall Study|Surgery postponed|0
4681218|NCT02451917|7585292|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2
4681219|NCT02451917|7585293|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0
4681220|NCT02451917|7585292|FG000|First Intervention (24 Weeks)|Death|0
4681221|NCT02451917|7585293|FG001|First Intervention (24 Weeks)|Death|1
4681222|NCT02451917|7585292|FG000|First Intervention (24 Weeks)|Adverse Event|0
4681223|NCT02451917|7585293|FG001|First Intervention (24 Weeks)|Adverse Event|2
4681224|NCT02451930|7585305|FG000|Overall Study|Death|0
4681225|NCT02451930|7585306|FG001|Overall Study|Death|15
4681226|NCT02451930|7585305|FG000|Overall Study|Lost to Follow-up|0
4681227|NCT02451930|7585306|FG001|Overall Study|Lost to Follow-up|3
4681228|NCT02451930|7585305|FG000|Overall Study|Sponsor Decision|2
4681229|NCT02451930|7585306|FG001|Overall Study|Sponsor Decision|10
4681230|NCT02451930|7585305|FG000|Overall Study|Withdrawal by Subject|0
4681231|NCT02451930|7585306|FG001|Overall Study|Withdrawal by Subject|1
4681232|NCT02451930|7585305|FG000|Overall Study|Other|0
4681233|NCT02451930|7585306|FG001|Overall Study|Other|1
4681234|NCT02452034|7585337|FG000|Overall Study|Adverse Event|0
4681235|NCT02452034|7585338|FG001|Overall Study|Adverse Event|0
4681236|NCT02452034|7585339|FG002|Overall Study|Adverse Event|0
4681237|NCT02452034|7585340|FG003|Overall Study|Adverse Event|0
4681238|NCT02452034|7585341|FG004|Overall Study|Adverse Event|0
4681239|NCT02452034|7585342|FG005|Overall Study|Adverse Event|1
4681240|NCT02452034|7585337|FG000|Overall Study|Death|0
4681241|NCT02452034|7585338|FG001|Overall Study|Death|0
4681242|NCT02452034|7585339|FG002|Overall Study|Death|0
4681243|NCT02452034|7585340|FG003|Overall Study|Death|0
4681244|NCT02452034|7585341|FG004|Overall Study|Death|1
4681245|NCT02452034|7585342|FG005|Overall Study|Death|1
4681246|NCT02452034|7585337|FG000|Overall Study|Physician Decision|0
4681247|NCT02452034|7585338|FG001|Overall Study|Physician Decision|1
4681248|NCT02452034|7585339|FG002|Overall Study|Physician Decision|1
4681249|NCT02452034|7585340|FG003|Overall Study|Physician Decision|0
4681250|NCT02452034|7585341|FG004|Overall Study|Physician Decision|0
4681251|NCT02452034|7585342|FG005|Overall Study|Physician Decision|0
4681252|NCT02452034|7585337|FG000|Overall Study|Protocol Violation|0
4681253|NCT02452034|7585338|FG001|Overall Study|Protocol Violation|0
4681254|NCT02452034|7585339|FG002|Overall Study|Protocol Violation|0
4681255|NCT02452034|7585340|FG003|Overall Study|Protocol Violation|0
4681256|NCT02452034|7585341|FG004|Overall Study|Protocol Violation|0
4681257|NCT02452034|7585342|FG005|Overall Study|Protocol Violation|1
4681258|NCT02452034|7585337|FG000|Overall Study|Screen Failure|1
4681259|NCT02452034|7585338|FG001|Overall Study|Screen Failure|0
4681260|NCT02452034|7585339|FG002|Overall Study|Screen Failure|0
4681261|NCT02452034|7585340|FG003|Overall Study|Screen Failure|1
4681262|NCT02452034|7585341|FG004|Overall Study|Screen Failure|0
4681263|NCT02452034|7585342|FG005|Overall Study|Screen Failure|0
4681264|NCT02452034|7585337|FG000|Overall Study|Withdrawn by Parent/Guardian|1
4681265|NCT02452034|7585338|FG001|Overall Study|Withdrawn by Parent/Guardian|0
4681266|NCT02452034|7585339|FG002|Overall Study|Withdrawn by Parent/Guardian|0
4681267|NCT02452034|7585340|FG003|Overall Study|Withdrawn by Parent/Guardian|0
4681268|NCT02452034|7585341|FG004|Overall Study|Withdrawn by Parent/Guardian|0
4681269|NCT02452034|7585342|FG005|Overall Study|Withdrawn by Parent/Guardian|0
4681270|NCT02452047|7585359|FG000|Overall Study|Adverse Event|0
4681271|NCT02452047|7585360|FG001|Overall Study|Adverse Event|1
4681272|NCT02452047|7585361|FG002|Overall Study|Adverse Event|1
4681273|NCT02452047|7585359|FG000|Overall Study|Death|1
4681274|NCT02452047|7585360|FG001|Overall Study|Death|3
4681275|NCT02452047|7585361|FG002|Overall Study|Death|1
4681276|NCT02452047|7585359|FG000|Overall Study|Physician Decision|1
4681277|NCT02452047|7585360|FG001|Overall Study|Physician Decision|0
4681278|NCT02452047|7585361|FG002|Overall Study|Physician Decision|0
4681279|NCT02452047|7585359|FG000|Overall Study|Lost to Follow-up|1
4681280|NCT02452047|7585360|FG001|Overall Study|Lost to Follow-up|1
4681281|NCT02452047|7585361|FG002|Overall Study|Lost to Follow-up|0
4681282|NCT02452047|7585359|FG000|Overall Study|Withdrawal by Subject|1
4681283|NCT02452047|7585360|FG001|Overall Study|Withdrawal by Subject|0
4681284|NCT02452047|7585361|FG002|Overall Study|Withdrawal by Subject|0
4681285|NCT02452190|7585380|FG000|Overall Study|Withdrawal by Sponsor|1
4681286|NCT02452190|7585381|FG001|Overall Study|Withdrawal by Sponsor|3
4681287|NCT02452190|7585380|FG000|Overall Study|Pregnancy|1
4681288|NCT02452190|7585381|FG001|Overall Study|Pregnancy|0
4681289|NCT02452190|7585380|FG000|Overall Study|Investigator's Decision|2
4681290|NCT02452190|7585381|FG001|Overall Study|Investigator's Decision|0
4681291|NCT02452190|7585380|FG000|Overall Study|Lack of Efficacy|3
4681292|NCT02452190|7585381|FG001|Overall Study|Lack of Efficacy|1
4681293|NCT02452190|7585380|FG000|Overall Study|Lost to Follow-up|4
4681294|NCT02452190|7585381|FG001|Overall Study|Lost to Follow-up|3
4681295|NCT02452190|7585380|FG000|Overall Study|Adverse Event|2
4681296|NCT02452190|7585381|FG001|Overall Study|Adverse Event|5
4681297|NCT02452190|7585380|FG000|Overall Study|Withdrawal by Subject|20
4681298|NCT02452190|7585381|FG001|Overall Study|Withdrawal by Subject|11
4681299|NCT02452190|7585380|FG000|Overall Study|Noncompliance with study drug|1
4759024|NCT00408005|7732929|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7
4759025|NCT00408005|7732922|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0
4759026|NCT00408005|7732923|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0
4759027|NCT00408005|7732924|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0
4759028|NCT00408005|7732925|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0
4759029|NCT00408005|7732926|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0
4759030|NCT00408005|7732927|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1
4759031|NCT00408005|7732928|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0
4759032|NCT00408005|7732929|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0
4759033|NCT00408005|7732922|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
4759034|NCT00408005|7732923|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
4759035|NCT00408005|7732924|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2
4759036|NCT00408005|7732925|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1
4759037|NCT00408005|7732926|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1
4759038|NCT00408005|7732927|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2
4759039|NCT00408005|7732928|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
4759040|NCT00408005|7732929|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
4759041|NCT00408005|7732922|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
4759042|NCT00408005|7732923|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
4759043|NCT00408005|7732924|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
4759044|NCT00408005|7732925|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
4759045|NCT00408005|7732926|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1
4759046|NCT00408005|7732927|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2
4759047|NCT00408005|7732928|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
4759048|NCT00408005|7732929|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
4759049|NCT00408005|7732922|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0
4759050|NCT00408005|7732923|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0
4759051|NCT00408005|7732924|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13
4759052|NCT00408005|7732925|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7
4759053|NCT00408005|7732926|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49
4759054|NCT00408005|7732927|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15
4759055|NCT00408005|7732928|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1
4759056|NCT00408005|7732929|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0
4681300|NCT02452190|7585381|FG001|Overall Study|Noncompliance with study drug|0
4681301|NCT02452190|7585380|FG000|Overall Study|Participant traveled abroad|1
4681302|NCT02452190|7585381|FG001|Overall Study|Participant traveled abroad|0
4681303|NCT02452190|7585380|FG000|Overall Study|Death|0
4681304|NCT02452190|7585381|FG001|Overall Study|Death|1
4681305|NCT02452320|7585389|FG000|Overall Study|Adverse Event|0
4681306|NCT02452320|7585390|FG001|Overall Study|Adverse Event|1
4681307|NCT02452424|7585411|FG000|Overall Study|Death|2
4681308|NCT02452424|7585412|FG001|Overall Study|Death|2
4681309|NCT02452424|7585413|FG002|Overall Study|Death|2
4681310|NCT02452424|7585414|FG003|Overall Study|Death|6
4681311|NCT02452424|7585415|FG004|Overall Study|Death|2
4681312|NCT02452424|7585416|FG005|Overall Study|Death|0
4681313|NCT02452424|7585417|FG006|Overall Study|Death|5
4681314|NCT02452424|7585418|FG007|Overall Study|Death|1
4681315|NCT02452424|7585419|FG008|Overall Study|Death|3
4681316|NCT02452424|7585420|FG009|Overall Study|Death|1
4681317|NCT02452424|7585421|FG010|Overall Study|Death|0
4681318|NCT02452424|7585411|FG000|Overall Study|Lost to Follow-up|0
4681319|NCT02452424|7585412|FG001|Overall Study|Lost to Follow-up|1
4681320|NCT02452424|7585413|FG002|Overall Study|Lost to Follow-up|1
4681321|NCT02452424|7585414|FG003|Overall Study|Lost to Follow-up|0
4681322|NCT02452424|7585415|FG004|Overall Study|Lost to Follow-up|0
4681323|NCT02452424|7585416|FG005|Overall Study|Lost to Follow-up|0
4681324|NCT02452424|7585417|FG006|Overall Study|Lost to Follow-up|0
4681325|NCT02452424|7585418|FG007|Overall Study|Lost to Follow-up|0
4681326|NCT02452424|7585419|FG008|Overall Study|Lost to Follow-up|0
4681327|NCT02452424|7585420|FG009|Overall Study|Lost to Follow-up|0
4681328|NCT02452424|7585421|FG010|Overall Study|Lost to Follow-up|0
4681329|NCT02452424|7585411|FG000|Overall Study|Withdrawal by Subject|0
4681330|NCT02452424|7585412|FG001|Overall Study|Withdrawal by Subject|0
4681331|NCT02452424|7585413|FG002|Overall Study|Withdrawal by Subject|3
4681332|NCT02452424|7585414|FG003|Overall Study|Withdrawal by Subject|2
4681333|NCT02452424|7585415|FG004|Overall Study|Withdrawal by Subject|0
4681334|NCT02452424|7585416|FG005|Overall Study|Withdrawal by Subject|0
4681335|NCT02452424|7585417|FG006|Overall Study|Withdrawal by Subject|1
4681336|NCT02452424|7585418|FG007|Overall Study|Withdrawal by Subject|0
4681337|NCT02452424|7585419|FG008|Overall Study|Withdrawal by Subject|1
4681338|NCT02452424|7585420|FG009|Overall Study|Withdrawal by Subject|1
4681339|NCT02452424|7585421|FG010|Overall Study|Withdrawal by Subject|0
4681340|NCT02452424|7585411|FG000|Overall Study|Other|0
4681341|NCT02452424|7585412|FG001|Overall Study|Other|0
4681342|NCT02452424|7585413|FG002|Overall Study|Other|1
4681343|NCT02452424|7585414|FG003|Overall Study|Other|0
4681344|NCT02452424|7585415|FG004|Overall Study|Other|0
4681345|NCT02452424|7585416|FG005|Overall Study|Other|1
4681346|NCT02452424|7585417|FG006|Overall Study|Other|4
4681347|NCT02452424|7585418|FG007|Overall Study|Other|3
4681348|NCT02452424|7585419|FG008|Overall Study|Other|0
4681349|NCT02452424|7585420|FG009|Overall Study|Other|0
4681350|NCT02452424|7585421|FG010|Overall Study|Other|1
4681351|NCT02452424|7585411|FG000|Overall Study|Progressive disease (per RECIST)|0
4681352|NCT02452424|7585412|FG001|Overall Study|Progressive disease (per RECIST)|0
4681353|NCT02452424|7585413|FG002|Overall Study|Progressive disease (per RECIST)|0
4681354|NCT02452424|7585414|FG003|Overall Study|Progressive disease (per RECIST)|0
4681355|NCT02452424|7585415|FG004|Overall Study|Progressive disease (per RECIST)|0
4681356|NCT02452424|7585416|FG005|Overall Study|Progressive disease (per RECIST)|0
4681357|NCT02452424|7585417|FG006|Overall Study|Progressive disease (per RECIST)|0
4681358|NCT02452424|7585418|FG007|Overall Study|Progressive disease (per RECIST)|0
4681359|NCT02452424|7585419|FG008|Overall Study|Progressive disease (per RECIST)|2
4681360|NCT02452424|7585420|FG009|Overall Study|Progressive disease (per RECIST)|0
4681361|NCT02452424|7585421|FG010|Overall Study|Progressive disease (per RECIST)|0
4681362|NCT02452424|7585411|FG000|Overall Study|Adverse Event|0
4681363|NCT02452424|7585412|FG001|Overall Study|Adverse Event|0
4681364|NCT02452424|7585413|FG002|Overall Study|Adverse Event|0
4681365|NCT02452424|7585414|FG003|Overall Study|Adverse Event|0
4681366|NCT02452424|7585415|FG004|Overall Study|Adverse Event|0
4681367|NCT02452424|7585416|FG005|Overall Study|Adverse Event|0
4681368|NCT02452424|7585417|FG006|Overall Study|Adverse Event|0
4681369|NCT02452424|7585418|FG007|Overall Study|Adverse Event|0
4681370|NCT02452424|7585419|FG008|Overall Study|Adverse Event|0
4681371|NCT02452424|7585420|FG009|Overall Study|Adverse Event|0
4681372|NCT02452424|7585421|FG010|Overall Study|Adverse Event|1
4681373|NCT02452463|7585450|FG000|Overall Study|Death|1
4681374|NCT02452463|7585451|FG001|Overall Study|Death|0
4681375|NCT02452463|7585452|FG002|Overall Study|Death|0
4681376|NCT02452463|7585450|FG000|Overall Study|Study Suspended|1
4681377|NCT02452463|7585451|FG001|Overall Study|Study Suspended|0
4681378|NCT02452463|7585452|FG002|Overall Study|Study Suspended|0
4681379|NCT02452463|7585450|FG000|Overall Study|Recommended by DSMB|0
4681380|NCT02452463|7585451|FG001|Overall Study|Recommended by DSMB|1
4681381|NCT02452463|7585452|FG002|Overall Study|Recommended by DSMB|0
4681382|NCT02452463|7585450|FG000|Overall Study|Withdrawal by Subject|0
4681383|NCT02452463|7585451|FG001|Overall Study|Withdrawal by Subject|1
4681384|NCT02452463|7585452|FG002|Overall Study|Withdrawal by Subject|0
4681385|NCT02452476|7585462|FG000|Overall Study|Death|4
4681386|NCT02452476|7585463|FG001|Overall Study|Death|7
4681387|NCT02452476|7585462|FG000|Overall Study|Lost to Follow-up|1
4681388|NCT02452476|7585463|FG001|Overall Study|Lost to Follow-up|1
4681389|NCT02452476|7585462|FG000|Overall Study|Physician Decision|1
4681390|NCT02452476|7585463|FG001|Overall Study|Physician Decision|1
4681391|NCT02452476|7585462|FG000|Overall Study|Not treated|5
4681392|NCT02452476|7585463|FG001|Overall Study|Not treated|1
4681393|NCT02452762|7585480|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4
4681394|NCT02452762|7585481|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3
4681395|NCT02452762|7585480|FG000|Overall Study|Withdrawal by Subject|1
4681396|NCT02452762|7585481|FG001|Overall Study|Withdrawal by Subject|0
4681397|NCT02452892|7585496|FG000|Week 1 Initial Randommization|Adverse Event|1
4681398|NCT02452892|7585497|FG001|Week 1 Initial Randommization|Adverse Event|0
4681399|NCT02452892|7585498|FG002|Week 1 Initial Randommization|Adverse Event|0
4681400|NCT02452892|7585499|FG003|Week 1 Initial Randommization|Adverse Event|0
4681401|NCT02452892|7585496|FG000|Week 1 Initial Randommization|Lost to Follow-up|0
4681402|NCT02452892|7585497|FG001|Week 1 Initial Randommization|Lost to Follow-up|0
4681403|NCT02452892|7585498|FG002|Week 1 Initial Randommization|Lost to Follow-up|1
4681404|NCT02452892|7585499|FG003|Week 1 Initial Randommization|Lost to Follow-up|0
4681405|NCT02452892|7585496|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
4681406|NCT02452892|7585497|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
4681407|NCT02452892|7585498|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
4681408|NCT02452892|7585499|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2
4681409|NCT02452892|7585496|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2
4681410|NCT02452892|7585497|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
4681411|NCT02452892|7585498|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
4681412|NCT02452892|7585499|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
4681413|NCT02452892|7585496|FG000|Follow-up|Withdrawal by Subject|0
4681414|NCT02452892|7585497|FG001|Follow-up|Withdrawal by Subject|0
4681415|NCT02452892|7585498|FG002|Follow-up|Withdrawal by Subject|0
4681416|NCT02452892|7585499|FG003|Follow-up|Withdrawal by Subject|1
4681417|NCT02452892|7585496|FG000|Follow-up|Subject left town on Day 42|1
4681418|NCT02452892|7585497|FG001|Follow-up|Subject left town on Day 42|0
4681419|NCT02452892|7585498|FG002|Follow-up|Subject left town on Day 42|0
4681420|NCT02452892|7585499|FG003|Follow-up|Subject left town on Day 42|0
4681421|NCT02453048|7585532|FG000|Overall Study|Only part of initial 6 mo. study|0
4681422|NCT02453048|7585533|FG001|Overall Study|Only part of initial 6 mo. study|0
4681423|NCT02453048|7585534|FG002|Overall Study|Only part of initial 6 mo. study|0
4681424|NCT02453048|7585535|FG003|Overall Study|Only part of initial 6 mo. study|0
4681425|NCT02453048|7585536|FG004|Overall Study|Only part of initial 6 mo. study|6
4681426|NCT02453048|7585532|FG000|Overall Study|Lost to Follow-up|0
4681427|NCT02453048|7585533|FG001|Overall Study|Lost to Follow-up|1
4681428|NCT02453048|7585534|FG002|Overall Study|Lost to Follow-up|2
4681429|NCT02453048|7585535|FG003|Overall Study|Lost to Follow-up|0
4681430|NCT02453048|7585536|FG004|Overall Study|Lost to Follow-up|0
4681431|NCT02453191|7585552|FG000|Overall Study|Withdrawal by Subject|1
4681432|NCT02453256|7585558|FG000|Double Blind Period|Death|1
4681433|NCT02453256|7585559|FG001|Double Blind Period|Death|1
4681434|NCT02453256|7585558|FG000|Double Blind Period|Adverse Event|3
4681435|NCT02453256|7585559|FG001|Double Blind Period|Adverse Event|2
4681436|NCT02453256|7585558|FG000|Double Blind Period|Withdrawal by Subject|9
4681437|NCT02453256|7585559|FG001|Double Blind Period|Withdrawal by Subject|5
4681438|NCT02453256|7585558|FG000|Double Blind Period|Other|0
4681439|NCT02453256|7585559|FG001|Double Blind Period|Other|1
4681440|NCT02453256|7585558|FG000|Open Label Period|Adverse Event|1
4681441|NCT02453256|7585559|FG001|Open Label Period|Adverse Event|3
4681442|NCT02453256|7585558|FG000|Open Label Period|Death|0
4681443|NCT02453256|7585559|FG001|Open Label Period|Death|1
4681444|NCT02453256|7585558|FG000|Open Label Period|Lost to Follow-up|1
4681445|NCT02453256|7585559|FG001|Open Label Period|Lost to Follow-up|0
4681446|NCT02453256|7585558|FG000|Open Label Period|Other|0
4681447|NCT02453256|7585559|FG001|Open Label Period|Other|2
4681448|NCT02453256|7585558|FG000|Open Label Period|Withdrawal by Subject|5
4681449|NCT02453256|7585559|FG001|Open Label Period|Withdrawal by Subject|1
4681450|NCT02453282|7585575|FG000|Overall Study|Death|275
4681451|NCT02453282|7585576|FG001|Overall Study|Death|277
4681452|NCT02453282|7585577|FG002|Overall Study|Death|296
4681453|NCT02453282|7585575|FG000|Overall Study|Lost to Follow-up|1
4681454|NCT02453282|7585576|FG001|Overall Study|Lost to Follow-up|0
4681455|NCT02453282|7585577|FG002|Overall Study|Lost to Follow-up|2
4681456|NCT02453282|7585575|FG000|Overall Study|Withdrawal by Subject|12
4681457|NCT02453282|7585576|FG001|Overall Study|Withdrawal by Subject|10
4681458|NCT02453282|7585577|FG002|Overall Study|Withdrawal by Subject|11
4681459|NCT02453282|7585575|FG000|Overall Study|Participants ongoing at data cut-off|85
4681460|NCT02453282|7585576|FG001|Overall Study|Participants ongoing at data cut-off|84
4681461|NCT02453282|7585577|FG002|Overall Study|Participants ongoing at data cut-off|62
4681462|NCT02453282|7585575|FG000|Overall Study|Other|1
4681463|NCT02453282|7585576|FG001|Overall Study|Other|1
4681464|NCT02453282|7585577|FG002|Overall Study|Other|1
4681465|NCT02453321|7585590|FG000|Overall Study|Weakness|1
4681466|NCT02453321|7585591|FG001|Overall Study|Weakness|1
4681467|NCT02453321|7585592|FG002|Overall Study|Weakness|2
4681468|NCT02453321|7585590|FG000|Overall Study|Deep Venous Thrombosis|0
4681469|NCT02453321|7585591|FG001|Overall Study|Deep Venous Thrombosis|1
4681470|NCT02453321|7585592|FG002|Overall Study|Deep Venous Thrombosis|0
4681471|NCT02453334|7585605|FG000|Overall Study|Death|15
4681472|NCT02453334|7585606|FG001|Overall Study|Death|13
4681473|NCT02453334|7585605|FG000|Overall Study|Adverse Event|2
4681474|NCT02453334|7585606|FG001|Overall Study|Adverse Event|1
4681475|NCT02453334|7585605|FG000|Overall Study|Lost to Follow-up|5
4681476|NCT02453334|7585606|FG001|Overall Study|Lost to Follow-up|9
4681477|NCT02453334|7585605|FG000|Overall Study|Physician Decision|1
4681478|NCT02453334|7585606|FG001|Overall Study|Physician Decision|0
4681479|NCT02453334|7585605|FG000|Overall Study|Withdrawal by Subject|17
4681480|NCT02453334|7585606|FG001|Overall Study|Withdrawal by Subject|13
4681481|NCT02453334|7585605|FG000|Overall Study|Other reason|1
4681482|NCT02453334|7585606|FG001|Overall Study|Other reason|4
4681483|NCT02453386|7585632|FG000|Overall Study|Adverse Event|22
4681484|NCT02453386|7585633|FG001|Overall Study|Adverse Event|30
4681485|NCT02453386|7585634|FG002|Overall Study|Adverse Event|15
4681486|NCT02453386|7585632|FG000|Overall Study|Protocol Violation|1
4681487|NCT02453386|7585633|FG001|Overall Study|Protocol Violation|0
4681488|NCT02453386|7585634|FG002|Overall Study|Protocol Violation|1
4681489|NCT02453386|7585632|FG000|Overall Study|Withdrawal by Subject|10
4681490|NCT02453386|7585633|FG001|Overall Study|Withdrawal by Subject|9
4681491|NCT02453386|7585634|FG002|Overall Study|Withdrawal by Subject|9
4681492|NCT02453386|7585632|FG000|Overall Study|Sponsor Terminated Study|14
4681493|NCT02453386|7585633|FG001|Overall Study|Sponsor Terminated Study|8
4681494|NCT02453386|7585634|FG002|Overall Study|Sponsor Terminated Study|11
4681495|NCT02453386|7585632|FG000|Overall Study|Subject Terminated by Sponsor|1
4681496|NCT02453386|7585633|FG001|Overall Study|Subject Terminated by Sponsor|1
4681497|NCT02453386|7585634|FG002|Overall Study|Subject Terminated by Sponsor|1
4681498|NCT02453386|7585632|FG000|Overall Study|Sponsor Terminated by Investigator|0
4681499|NCT02453386|7585633|FG001|Overall Study|Sponsor Terminated by Investigator|1
4681500|NCT02453386|7585634|FG002|Overall Study|Sponsor Terminated by Investigator|2
4681501|NCT02453386|7585632|FG000|Overall Study|Lost to Follow-up|0
4681502|NCT02453386|7585633|FG001|Overall Study|Lost to Follow-up|0
4681503|NCT02453386|7585634|FG002|Overall Study|Lost to Follow-up|1
4681504|NCT02453386|7585632|FG000|Overall Study|Other|1
4681505|NCT02453386|7585633|FG001|Overall Study|Other|0
4681506|NCT02453386|7585634|FG002|Overall Study|Other|1
4681507|NCT02453555|7585651|FG000|24-week Double-blind Treatment Period|Adverse Event|2
4681508|NCT02453555|7585652|FG001|24-week Double-blind Treatment Period|Adverse Event|0
4681509|NCT02453555|7585653|FG002|24-week Double-blind Treatment Period|Adverse Event|0
4681510|NCT02453555|7585654|FG003|24-week Double-blind Treatment Period|Adverse Event|0
4681511|NCT02453555|7585655|FG004|24-week Double-blind Treatment Period|Adverse Event|0
4681512|NCT02453555|7585656|FG005|24-week Double-blind Treatment Period|Adverse Event|0
4681513|NCT02453555|7585651|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1
4681514|NCT02453555|7585652|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0
4681515|NCT02453555|7585653|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0
4681516|NCT02453555|7585654|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0
4681517|NCT02453555|7585655|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0
4681518|NCT02453555|7585656|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0
4681519|NCT02453555|7585651|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2
4681520|NCT02453555|7585652|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4
4681521|NCT02453555|7585653|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0
4681522|NCT02453555|7585654|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0
4681523|NCT02453555|7585655|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0
4681524|NCT02453555|7585656|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0
4681525|NCT02453555|7585651|FG000|24-week Double-blind Treatment Period|Other than specified above|0
4681526|NCT02453555|7585652|FG001|24-week Double-blind Treatment Period|Other than specified above|3
4681527|NCT02453555|7585653|FG002|24-week Double-blind Treatment Period|Other than specified above|0
4681528|NCT02453555|7585654|FG003|24-week Double-blind Treatment Period|Other than specified above|0
4681529|NCT02453555|7585655|FG004|24-week Double-blind Treatment Period|Other than specified above|0
4681530|NCT02453555|7585656|FG005|24-week Double-blind Treatment Period|Other than specified above|0
4681531|NCT02453555|7585651|FG000|Extension Period|Adverse Event|0
4681532|NCT02453555|7585652|FG001|Extension Period|Adverse Event|0
4681533|NCT02453555|7585653|FG002|Extension Period|Adverse Event|1
4681534|NCT02453555|7585654|FG003|Extension Period|Adverse Event|2
4681535|NCT02453555|7585655|FG004|Extension Period|Adverse Event|1
4681536|NCT02453555|7585656|FG005|Extension Period|Adverse Event|1
4681537|NCT02453555|7585651|FG000|Extension Period|Protocol Violation|0
4681538|NCT02453555|7585652|FG001|Extension Period|Protocol Violation|0
4681539|NCT02453555|7585653|FG002|Extension Period|Protocol Violation|1
4681540|NCT02453555|7585654|FG003|Extension Period|Protocol Violation|0
4681541|NCT02453555|7585655|FG004|Extension Period|Protocol Violation|0
4681542|NCT02453555|7585656|FG005|Extension Period|Protocol Violation|0
4681543|NCT02453555|7585651|FG000|Extension Period|Withdrawal by Subject|0
4681544|NCT02453555|7585652|FG001|Extension Period|Withdrawal by Subject|0
4681545|NCT02453555|7585653|FG002|Extension Period|Withdrawal by Subject|1
4681546|NCT02453555|7585654|FG003|Extension Period|Withdrawal by Subject|0
4681547|NCT02453555|7585655|FG004|Extension Period|Withdrawal by Subject|0
4681548|NCT02453555|7585656|FG005|Extension Period|Withdrawal by Subject|0
4681549|NCT02453685|7585700|FG000|Overall Study|Adverse Event|0
4681550|NCT02453685|7585701|FG001|Overall Study|Adverse Event|1
4681551|NCT02453685|7585700|FG000|Overall Study|Protocol Violation|7
4681552|NCT02453685|7585701|FG001|Overall Study|Protocol Violation|4
4681553|NCT02453685|7585700|FG000|Overall Study|Lost to Follow-up|0
4681554|NCT02453685|7585701|FG001|Overall Study|Lost to Follow-up|1
4681555|NCT02453685|7585700|FG000|Overall Study|Withdrawal by Subject|8
4681556|NCT02453685|7585701|FG001|Overall Study|Withdrawal by Subject|4
4681557|NCT02453685|7585700|FG000|Overall Study|Unclassified|4
4681558|NCT02453685|7585701|FG001|Overall Study|Unclassified|2
4681559|NCT02453711|7585716|FG000|Overall Study|Withdrawal by Subject|5
4681560|NCT02453711|7585717|FG001|Overall Study|Withdrawal by Subject|4
4681561|NCT02453711|7585718|FG002|Overall Study|Withdrawal by Subject|6
4681562|NCT02453711|7585719|FG003|Overall Study|Withdrawal by Subject|4
4681563|NCT02453711|7585720|FG004|Overall Study|Withdrawal by Subject|1
4681564|NCT02453711|7585721|FG005|Overall Study|Withdrawal by Subject|1
4681565|NCT02453711|7585722|FG006|Overall Study|Withdrawal by Subject|0
4681566|NCT02453711|7585723|FG007|Overall Study|Withdrawal by Subject|1
4681567|NCT02453711|7585724|FG008|Overall Study|Withdrawal by Subject|7
4681568|NCT02453711|7585716|FG000|Overall Study|Lost to Follow-up|5
4681569|NCT02453711|7585717|FG001|Overall Study|Lost to Follow-up|3
4681570|NCT02453711|7585718|FG002|Overall Study|Lost to Follow-up|2
4681571|NCT02453711|7585719|FG003|Overall Study|Lost to Follow-up|3
4681572|NCT02453711|7585720|FG004|Overall Study|Lost to Follow-up|1
4681573|NCT02453711|7585721|FG005|Overall Study|Lost to Follow-up|5
4681574|NCT02453711|7585722|FG006|Overall Study|Lost to Follow-up|2
4681575|NCT02453711|7585723|FG007|Overall Study|Lost to Follow-up|6
4681576|NCT02453711|7585724|FG008|Overall Study|Lost to Follow-up|6
4681577|NCT02453711|7585716|FG000|Overall Study|Death|0
4681578|NCT02453711|7585717|FG001|Overall Study|Death|0
4681579|NCT02453711|7585718|FG002|Overall Study|Death|0
4681580|NCT02453711|7585719|FG003|Overall Study|Death|0
4681581|NCT02453711|7585720|FG004|Overall Study|Death|0
4681582|NCT02453711|7585721|FG005|Overall Study|Death|0
4681583|NCT02453711|7585722|FG006|Overall Study|Death|1
4681584|NCT02453711|7585723|FG007|Overall Study|Death|0
4681585|NCT02453711|7585724|FG008|Overall Study|Death|0
4681586|NCT02453711|7585716|FG000|Overall Study|Unclassified|1
4681587|NCT02453711|7585717|FG001|Overall Study|Unclassified|0
4681588|NCT02453711|7585718|FG002|Overall Study|Unclassified|1
4681589|NCT02453711|7585719|FG003|Overall Study|Unclassified|0
4681590|NCT02453711|7585720|FG004|Overall Study|Unclassified|0
4681591|NCT02453711|7585721|FG005|Overall Study|Unclassified|0
4681592|NCT02453711|7585722|FG006|Overall Study|Unclassified|0
4681593|NCT02453711|7585723|FG007|Overall Study|Unclassified|0
4681594|NCT02453711|7585724|FG008|Overall Study|Unclassified|0
4681595|NCT02453841|7585751|FG000|Overall Study|Protocol Violation|1
4681596|NCT02453841|7585751|FG000|Overall Study|Unable to obtain blood samples|2
4681597|NCT02454101|7585763|FG000|Overall Study|Adverse Event|2
4681598|NCT02454101|7585764|FG001|Overall Study|Adverse Event|3
4681599|NCT02454101|7585763|FG000|Overall Study|Lost to Follow-up|3
4681600|NCT02454101|7585764|FG001|Overall Study|Lost to Follow-up|4
4759057|NCT00408005|7732922|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0
4759058|NCT00408005|7732923|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0
4759059|NCT00408005|7732924|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3
4759060|NCT00408005|7732925|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1
4759061|NCT00408005|7732926|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1
4759062|NCT00408005|7732927|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1
4759063|NCT00408005|7732928|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0
4759064|NCT00408005|7732929|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0
4759065|NCT00098475|7732951|FG000|Step 1|Progressive disease|33
4759066|NCT00098475|7732952|FG001|Step 1|Progressive disease|35
4759067|NCT00098475|7732953|FG002|Step 1|Progressive disease|2
4759068|NCT00098475|7732954|FG003|Step 1|Progressive disease|1
4759069|NCT00098475|7732951|FG000|Step 1|Adverse Event|56
4759070|NCT00098475|7732952|FG001|Step 1|Adverse Event|37
4759071|NCT00098475|7732953|FG002|Step 1|Adverse Event|0
4759072|NCT00098475|7732954|FG003|Step 1|Adverse Event|1
4759073|NCT00098475|7732951|FG000|Step 1|Death|8
4759074|NCT00098475|7732952|FG001|Step 1|Death|5
4759075|NCT00098475|7732953|FG002|Step 1|Death|0
4759076|NCT00098475|7732954|FG003|Step 1|Death|1
4759077|NCT00098475|7732951|FG000|Step 1|Withdrawal by Subject|14
4759078|NCT00098475|7732952|FG001|Step 1|Withdrawal by Subject|11
4759079|NCT00098475|7732953|FG002|Step 1|Withdrawal by Subject|0
4759080|NCT00098475|7732954|FG003|Step 1|Withdrawal by Subject|0
4759081|NCT00098475|7732951|FG000|Step 1|Physician Decision|5
4759082|NCT00098475|7732952|FG001|Step 1|Physician Decision|2
4759083|NCT00098475|7732953|FG002|Step 1|Physician Decision|0
4759084|NCT00098475|7732954|FG003|Step 1|Physician Decision|0
4759085|NCT00098475|7732951|FG000|Step 1|Alternative therapy|31
4759086|NCT00098475|7732952|FG001|Step 1|Alternative therapy|43
4759087|NCT00098475|7732953|FG002|Step 1|Alternative therapy|1
4759088|NCT00098475|7732954|FG003|Step 1|Alternative therapy|0
4759089|NCT00098475|7732951|FG000|Step 1|Other disease|2
4759090|NCT00098475|7732952|FG001|Step 1|Other disease|1
4759091|NCT00098475|7732953|FG002|Step 1|Other disease|1
4759092|NCT00098475|7732954|FG003|Step 1|Other disease|0
4759093|NCT00098475|7732951|FG000|Step 1|Never started treatment|0
4759094|NCT00098475|7732952|FG001|Step 1|Never started treatment|2
4759095|NCT00098475|7732953|FG002|Step 1|Never started treatment|0
4759096|NCT00098475|7732954|FG003|Step 1|Never started treatment|0
4759097|NCT00098475|7732951|FG000|Step 1|Still on treatment as of this analysis|14
4759098|NCT00098475|7732952|FG001|Step 1|Still on treatment as of this analysis|27
4759099|NCT00098475|7732953|FG002|Step 1|Still on treatment as of this analysis|0
4759100|NCT00098475|7732954|FG003|Step 1|Still on treatment as of this analysis|0
4759101|NCT00098475|7732951|FG000|Step 1|Knee surgery|1
4759102|NCT00098475|7732952|FG001|Step 1|Knee surgery|0
4759103|NCT00098475|7732953|FG002|Step 1|Knee surgery|0
4759104|NCT00098475|7732954|FG003|Step 1|Knee surgery|0
4759105|NCT00098475|7732951|FG000|Step 1|Complications|1
4759106|NCT00098475|7732952|FG001|Step 1|Complications|0
4759107|NCT00098475|7732953|FG002|Step 1|Complications|0
4759108|NCT00098475|7732954|FG003|Step 1|Complications|0
4759109|NCT00098475|7732951|FG000|Step 1|Cannot comply due to other tx|0
4759110|NCT00098475|7732952|FG001|Step 1|Cannot comply due to other tx|1
4759111|NCT00098475|7732953|FG002|Step 1|Cannot comply due to other tx|0
4759112|NCT00098475|7732954|FG003|Step 1|Cannot comply due to other tx|0
4759113|NCT00098475|7732951|FG000|Step 1|Both patient and physician's decision|2
4759114|NCT00098475|7732952|FG001|Step 1|Both patient and physician's decision|1
4759115|NCT00098475|7732953|FG002|Step 1|Both patient and physician's decision|0
4759116|NCT00098475|7732954|FG003|Step 1|Both patient and physician's decision|0
4759117|NCT00098475|7732951|FG000|Step 1|Incorrect disease assessment|2
4759118|NCT00098475|7732952|FG001|Step 1|Incorrect disease assessment|0
4759119|NCT00098475|7732953|FG002|Step 1|Incorrect disease assessment|0
4759120|NCT00098475|7732954|FG003|Step 1|Incorrect disease assessment|0
4759121|NCT00098475|7732951|FG000|Step 1|Off treatment for > specified timeframe|1
4759122|NCT00098475|7732952|FG001|Step 1|Off treatment for > specified timeframe|1
4759123|NCT00098475|7732953|FG002|Step 1|Off treatment for > specified timeframe|0
4759124|NCT00098475|7732954|FG003|Step 1|Off treatment for > specified timeframe|0
4759125|NCT00098475|7732951|FG000|Step 1|Declining performance status|0
4759126|NCT00098475|7732952|FG001|Step 1|Declining performance status|1
4681601|NCT02454478|7585826|FG000|Overall Study|Incomplete DLT Evaluation|1
4681602|NCT02454530|7585832|FG000|Overall Study|Other|8
4681603|NCT02454530|7585833|FG001|Overall Study|Other|13
4681604|NCT02454530|7585832|FG000|Overall Study|Missing information|56
4681605|NCT02454530|7585833|FG001|Overall Study|Missing information|69
4681606|NCT02454530|7585832|FG000|Overall Study|Death|2
4681607|NCT02454530|7585833|FG001|Overall Study|Death|41
4681608|NCT02454530|7585832|FG000|Overall Study|Lost to Follow-up|4
4681609|NCT02454530|7585833|FG001|Overall Study|Lost to Follow-up|4
4681610|NCT02454608|7585843|FG000|Double-Blind Period|Lack of Efficacy|0
4681611|NCT02454608|7585844|FG001|Double-Blind Period|Lack of Efficacy|2
4681612|NCT02454608|7585845|FG002|Double-Blind Period|Lack of Efficacy|0
4681613|NCT02454608|7585843|FG000|Open Label Period|Lost to Follow-up|0
4681614|NCT02454608|7585844|FG001|Open Label Period|Lost to Follow-up|0
4681615|NCT02454608|7585845|FG002|Open Label Period|Lost to Follow-up|11
4681616|NCT02454608|7585843|FG000|Open Label Period|Withdrawal by Subject|0
4681617|NCT02454608|7585844|FG001|Open Label Period|Withdrawal by Subject|0
4681618|NCT02454608|7585845|FG002|Open Label Period|Withdrawal by Subject|8
4681619|NCT02454959|7585853|FG000|Overall Study|Protocol-Specified Criteria|3
4681620|NCT02454959|7585853|FG000|Overall Study|Physician Decision|1
4681621|NCT02454959|7585853|FG000|Overall Study|Withdrawal by Subject|3
4681622|NCT02454959|7585853|FG000|Overall Study|Adverse Event|2
4681623|NCT02454972|7585868|FG000|Overall Study|Progressive disease|17
4681624|NCT02454972|7585869|FG001|Overall Study|Progressive disease|16
4681625|NCT02454972|7585870|FG002|Overall Study|Progressive disease|59
4681626|NCT02454972|7585871|FG003|Overall Study|Progressive disease|23
4681627|NCT02454972|7585872|FG004|Overall Study|Progressive disease|16
4681628|NCT02454972|7585873|FG005|Overall Study|Progressive disease|12
4681629|NCT02454972|7585874|FG006|Overall Study|Progressive disease|19
4681630|NCT02454972|7585875|FG007|Overall Study|Progressive disease|27
4681631|NCT02454972|7585876|FG008|Overall Study|Progressive disease|84
4681632|NCT02454972|7585868|FG000|Overall Study|Death|0
4681633|NCT02454972|7585869|FG001|Overall Study|Death|0
4681634|NCT02454972|7585870|FG002|Overall Study|Death|5
4681635|NCT02454972|7585871|FG003|Overall Study|Death|1
4681636|NCT02454972|7585872|FG004|Overall Study|Death|0
4681637|NCT02454972|7585873|FG005|Overall Study|Death|0
4681638|NCT02454972|7585874|FG006|Overall Study|Death|0
4681639|NCT02454972|7585875|FG007|Overall Study|Death|0
4681640|NCT02454972|7585876|FG008|Overall Study|Death|2
4681641|NCT02454972|7585868|FG000|Overall Study|Physician Decision|0
4681642|NCT02454972|7585869|FG001|Overall Study|Physician Decision|1
4681643|NCT02454972|7585870|FG002|Overall Study|Physician Decision|2
4681644|NCT02454972|7585871|FG003|Overall Study|Physician Decision|1
4681645|NCT02454972|7585872|FG004|Overall Study|Physician Decision|2
4681646|NCT02454972|7585873|FG005|Overall Study|Physician Decision|0
4681647|NCT02454972|7585874|FG006|Overall Study|Physician Decision|0
4681648|NCT02454972|7585875|FG007|Overall Study|Physician Decision|1
4681649|NCT02454972|7585876|FG008|Overall Study|Physician Decision|4
4681650|NCT02454972|7585868|FG000|Overall Study|Non treatment-related adverse event|2
4681651|NCT02454972|7585869|FG001|Overall Study|Non treatment-related adverse event|0
4681652|NCT02454972|7585870|FG002|Overall Study|Non treatment-related adverse event|1
4681653|NCT02454972|7585871|FG003|Overall Study|Non treatment-related adverse event|0
4681654|NCT02454972|7585872|FG004|Overall Study|Non treatment-related adverse event|0
4681655|NCT02454972|7585873|FG005|Overall Study|Non treatment-related adverse event|1
4681656|NCT02454972|7585874|FG006|Overall Study|Non treatment-related adverse event|0
4681657|NCT02454972|7585875|FG007|Overall Study|Non treatment-related adverse event|1
4681658|NCT02454972|7585876|FG008|Overall Study|Non treatment-related adverse event|0
4681659|NCT02454972|7585868|FG000|Overall Study|Treatment-related adverse events|0
4681660|NCT02454972|7585869|FG001|Overall Study|Treatment-related adverse events|1
4681661|NCT02454972|7585870|FG002|Overall Study|Treatment-related adverse events|1
4681662|NCT02454972|7585871|FG003|Overall Study|Treatment-related adverse events|0
4681663|NCT02454972|7585872|FG004|Overall Study|Treatment-related adverse events|2
4681664|NCT02454972|7585873|FG005|Overall Study|Treatment-related adverse events|0
4681665|NCT02454972|7585874|FG006|Overall Study|Treatment-related adverse events|0
4681666|NCT02454972|7585875|FG007|Overall Study|Treatment-related adverse events|2
4681667|NCT02454972|7585876|FG008|Overall Study|Treatment-related adverse events|2
4681668|NCT02454972|7585868|FG000|Overall Study|Patient moves to compassionate use|0
4681669|NCT02454972|7585869|FG001|Overall Study|Patient moves to compassionate use|0
4681670|NCT02454972|7585870|FG002|Overall Study|Patient moves to compassionate use|0
4681671|NCT02454972|7585871|FG003|Overall Study|Patient moves to compassionate use|0
4681672|NCT02454972|7585872|FG004|Overall Study|Patient moves to compassionate use|0
4681673|NCT02454972|7585873|FG005|Overall Study|Patient moves to compassionate use|0
4681674|NCT02454972|7585874|FG006|Overall Study|Patient moves to compassionate use|2
4681675|NCT02454972|7585875|FG007|Overall Study|Patient moves to compassionate use|0
4681676|NCT02454972|7585876|FG008|Overall Study|Patient moves to compassionate use|11
4681677|NCT02454972|7585868|FG000|Overall Study|Withdrawal by Subject|0
4681678|NCT02454972|7585869|FG001|Overall Study|Withdrawal by Subject|1
4681679|NCT02454972|7585870|FG002|Overall Study|Withdrawal by Subject|5
4681680|NCT02454972|7585871|FG003|Overall Study|Withdrawal by Subject|2
4681681|NCT02454972|7585872|FG004|Overall Study|Withdrawal by Subject|3
4681682|NCT02454972|7585873|FG005|Overall Study|Withdrawal by Subject|2
4681683|NCT02454972|7585874|FG006|Overall Study|Withdrawal by Subject|0
4681684|NCT02454972|7585875|FG007|Overall Study|Withdrawal by Subject|1
4681685|NCT02454972|7585876|FG008|Overall Study|Withdrawal by Subject|2
4681686|NCT02454972|7585868|FG000|Overall Study|Multiple delay/holds on treatment|0
4681687|NCT02454972|7585869|FG001|Overall Study|Multiple delay/holds on treatment|0
4681688|NCT02454972|7585870|FG002|Overall Study|Multiple delay/holds on treatment|0
4681689|NCT02454972|7585871|FG003|Overall Study|Multiple delay/holds on treatment|1
4681690|NCT02454972|7585872|FG004|Overall Study|Multiple delay/holds on treatment|0
4681691|NCT02454972|7585873|FG005|Overall Study|Multiple delay/holds on treatment|0
4681692|NCT02454972|7585874|FG006|Overall Study|Multiple delay/holds on treatment|0
4681693|NCT02454972|7585875|FG007|Overall Study|Multiple delay/holds on treatment|0
4681694|NCT02454972|7585876|FG008|Overall Study|Multiple delay/holds on treatment|0
4681695|NCT02454972|7585868|FG000|Overall Study|Never treated|0
4681696|NCT02454972|7585869|FG001|Overall Study|Never treated|0
4681697|NCT02454972|7585870|FG002|Overall Study|Never treated|3
4681698|NCT02454972|7585871|FG003|Overall Study|Never treated|1
4681699|NCT02454972|7585872|FG004|Overall Study|Never treated|1
4681700|NCT02454972|7585873|FG005|Overall Study|Never treated|0
4681701|NCT02454972|7585874|FG006|Overall Study|Never treated|0
4681702|NCT02454972|7585875|FG007|Overall Study|Never treated|0
4681703|NCT02454972|7585876|FG008|Overall Study|Never treated|5
4681704|NCT02455050|7585892|FG000|Treatment Period 1|Lost to Follow-up|1
4681705|NCT02455050|7585893|FG001|Treatment Period 1|Lost to Follow-up|1
4681706|NCT02455050|7585894|FG002|Treatment Period 1|Lost to Follow-up|1
4681707|NCT02455050|7585895|FG003|Treatment Period 1|Lost to Follow-up|2
4681708|NCT02455050|7585892|FG000|Treatment Period 2|Lost to Follow-up|1
4681709|NCT02455050|7585893|FG001|Treatment Period 2|Lost to Follow-up|0
4681710|NCT02455050|7585894|FG002|Treatment Period 2|Lost to Follow-up|2
4681711|NCT02455050|7585895|FG003|Treatment Period 2|Lost to Follow-up|1
4681712|NCT02455076|7585920|FG000|Inpatient|Withdrawal by Subject|1
4681713|NCT02455076|7585921|FG001|Inpatient|Withdrawal by Subject|0
4681714|NCT02455076|7585922|FG002|Inpatient|Withdrawal by Subject|0
4681715|NCT02455076|7585923|FG003|Inpatient|Withdrawal by Subject|0
4681716|NCT02455076|7585924|FG004|Inpatient|Withdrawal by Subject|0
4681717|NCT02455076|7585920|FG000|Inpatient|Discharged <24 h after admission|0
4681718|NCT02455076|7585921|FG001|Inpatient|Discharged <24 h after admission|1
4681719|NCT02455076|7585922|FG002|Inpatient|Discharged <24 h after admission|0
4681720|NCT02455076|7585923|FG003|Inpatient|Discharged <24 h after admission|0
4681721|NCT02455076|7585924|FG004|Inpatient|Discharged <24 h after admission|0
4681722|NCT02455076|7585920|FG000|Inpatient|Adverse Event|3
4681723|NCT02455076|7585921|FG001|Inpatient|Adverse Event|0
4681724|NCT02455076|7585922|FG002|Inpatient|Adverse Event|0
4681725|NCT02455076|7585923|FG003|Inpatient|Adverse Event|0
4681726|NCT02455076|7585924|FG004|Inpatient|Adverse Event|0
4681727|NCT02455076|7585920|FG000|Outpatient|Adverse Event|0
4681728|NCT02455076|7585921|FG001|Outpatient|Adverse Event|0
4681729|NCT02455076|7585922|FG002|Outpatient|Adverse Event|0
4681730|NCT02455076|7585923|FG003|Outpatient|Adverse Event|5
4681731|NCT02455076|7585924|FG004|Outpatient|Adverse Event|0
4681732|NCT02455076|7585920|FG000|Outpatient|Lost to Follow-up|0
4681733|NCT02455076|7585921|FG001|Outpatient|Lost to Follow-up|0
4681734|NCT02455076|7585922|FG002|Outpatient|Lost to Follow-up|0
4681735|NCT02455076|7585923|FG003|Outpatient|Lost to Follow-up|1
4681736|NCT02455076|7585924|FG004|Outpatient|Lost to Follow-up|12
4681737|NCT02455336|7585942|FG000|Overall Study|Withdrawal by Subject|0
4681738|NCT02455336|7585943|FG001|Overall Study|Withdrawal by Subject|2
4681739|NCT02455336|7585942|FG000|Overall Study|Adverse Event|3
4681740|NCT02455336|7585943|FG001|Overall Study|Adverse Event|0
4681741|NCT02455336|7585942|FG000|Overall Study|Non-responder to treatment|2
4681742|NCT02455336|7585943|FG001|Overall Study|Non-responder to treatment|0
4681743|NCT02455388|7585951|FG000|Overall Study|Protocol Violation|1
4681744|NCT02455388|7585952|FG001|Overall Study|Protocol Violation|0
4681745|NCT02455388|7585953|FG002|Overall Study|Protocol Violation|4
4681746|NCT02455388|7585951|FG000|Overall Study|Withdrawal by Subject|0
4759127|NCT00098475|7732953|FG002|Step 1|Declining performance status|0
4759128|NCT00098475|7732954|FG003|Step 1|Declining performance status|0
4759129|NCT00098475|7732951|FG000|Step 1|Insurance issue|0
4759130|NCT00098475|7732952|FG001|Step 1|Insurance issue|1
4759131|NCT00098475|7732953|FG002|Step 1|Insurance issue|0
4759132|NCT00098475|7732954|FG003|Step 1|Insurance issue|0
4759133|NCT00098475|7732951|FG000|Step 1|Rising paraprotein|0
4759134|NCT00098475|7732952|FG001|Step 1|Rising paraprotein|1
4759135|NCT00098475|7732953|FG002|Step 1|Rising paraprotein|0
4759136|NCT00098475|7732954|FG003|Step 1|Rising paraprotein|0
4759137|NCT00098475|7732951|FG000|Step 1|Referred to other physicians|0
4759138|NCT00098475|7732952|FG001|Step 1|Referred to other physicians|1
4759139|NCT00098475|7732953|FG002|Step 1|Referred to other physicians|0
4759140|NCT00098475|7732954|FG003|Step 1|Referred to other physicians|0
4759141|NCT00098475|7732951|FG000|Step 1|Criteria to continue treatment not met|0
4759142|NCT00098475|7732952|FG001|Step 1|Criteria to continue treatment not met|1
4759143|NCT00098475|7732953|FG002|Step 1|Criteria to continue treatment not met|0
4759144|NCT00098475|7732954|FG003|Step 1|Criteria to continue treatment not met|0
4759145|NCT00098475|7732951|FG000|Step 1|Misinterpretation of lab data|0
4759146|NCT00098475|7732952|FG001|Step 1|Misinterpretation of lab data|1
4681747|NCT02455388|7585952|FG001|Overall Study|Withdrawal by Subject|0
4681748|NCT02455388|7585953|FG002|Overall Study|Withdrawal by Subject|7
4681749|NCT02455518|7585969|FG000|Overall Study|Protocol Violation|0
4681750|NCT02455518|7585970|FG001|Overall Study|Protocol Violation|1
4681751|NCT02455518|7585971|FG002|Overall Study|Protocol Violation|1
4681752|NCT02455518|7585972|FG003|Overall Study|Protocol Violation|3
4681753|NCT02456103|7585982|FG000|Overall Study|Study Closure|207
4681754|NCT02456103|7585982|FG000|Overall Study|Physician Decision|1
4681755|NCT02456103|7585982|FG000|Overall Study|Required prohibited medications|5
4681756|NCT02456103|7585982|FG000|Overall Study|Protocol Violation|1
4681757|NCT02456103|7585982|FG000|Overall Study|Adverse Event|5
4681758|NCT02456103|7585982|FG000|Overall Study|Abnormal Laboratory Value|2
4681759|NCT02456103|7585982|FG000|Overall Study|Lost to Follow-up|1
4681760|NCT02456103|7585982|FG000|Overall Study|Withdrawal by Subject|24
4681761|NCT02456636|7585989|FG000|Overall Study|Death|0
4681762|NCT02456636|7585990|FG001|Overall Study|Death|3
4681763|NCT02456636|7585991|FG002|Overall Study|Death|0
4681764|NCT02456636|7585989|FG000|Overall Study|Pregnancy|1
4681765|NCT02456636|7585990|FG001|Overall Study|Pregnancy|3
4681766|NCT02456636|7585991|FG002|Overall Study|Pregnancy|5
4681767|NCT02456636|7585989|FG000|Overall Study|Physician Decision|4
4681768|NCT02456636|7585990|FG001|Overall Study|Physician Decision|5
4681769|NCT02456636|7585991|FG002|Overall Study|Physician Decision|4
4681770|NCT02456636|7585989|FG000|Overall Study|Withdrawal by Subject|13
4681771|NCT02456636|7585990|FG001|Overall Study|Withdrawal by Subject|14
4681772|NCT02456636|7585991|FG002|Overall Study|Withdrawal by Subject|16
4681773|NCT02456636|7585989|FG000|Overall Study|Lost to Follow-up|50
4681774|NCT02456636|7585990|FG001|Overall Study|Lost to Follow-up|44
4681775|NCT02456636|7585991|FG002|Overall Study|Lost to Follow-up|50
4681776|NCT02456662|7586001|FG000|Overall Study|Lost to Follow-up|2
4681777|NCT02456662|7586002|FG001|Overall Study|Lost to Follow-up|1
4681778|NCT02456727|7586010|FG000|Overall Study|Lost to Follow-up|63
4681779|NCT02456727|7586011|FG001|Overall Study|Lost to Follow-up|65
4681780|NCT02456727|7586010|FG000|Overall Study|Death|2
4681781|NCT02456727|7586011|FG001|Overall Study|Death|1
4681782|NCT02456727|7586010|FG000|Overall Study|Withdrawal by Subject|1
4681783|NCT02456727|7586011|FG001|Overall Study|Withdrawal by Subject|10
4681784|NCT02456727|7586010|FG000|Overall Study|Never Initiated Treatment|43
4681785|NCT02456727|7586011|FG001|Overall Study|Never Initiated Treatment|30
4681786|NCT02456740|7586036|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1
4681787|NCT02456740|7586037|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1
4681788|NCT02456740|7586038|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1
4681789|NCT02456740|7586039|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
4681790|NCT02456740|7586040|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
4681791|NCT02456740|7586041|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
4681792|NCT02456740|7586042|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
4681793|NCT02456740|7586043|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
4681794|NCT02456740|7586044|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
4681795|NCT02456740|7586036|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27
4681796|NCT02456740|7586037|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28
4681797|NCT02456740|7586038|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21
4681798|NCT02456740|7586039|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
4681799|NCT02456740|7586040|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
4681800|NCT02456740|7586041|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
4681801|NCT02456740|7586042|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
4681802|NCT02456740|7586043|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
4681803|NCT02456740|7586044|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
4681804|NCT02456740|7586036|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9
4681805|NCT02456740|7586037|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4
4681806|NCT02456740|7586038|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5
4681807|NCT02456740|7586039|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
4681808|NCT02456740|7586040|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
4681809|NCT02456740|7586041|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
4681810|NCT02456740|7586042|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
4681811|NCT02456740|7586043|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
4681812|NCT02456740|7586044|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
4681813|NCT02456740|7586036|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
4681814|NCT02456740|7586037|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
4759147|NCT00098475|7732953|FG002|Step 1|Misinterpretation of lab data|0
4759148|NCT00098475|7732954|FG003|Step 1|Misinterpretation of lab data|0
4759149|NCT00098475|7732951|FG000|Step 1|Patient fell with fracture|1
4759150|NCT00098475|7732952|FG001|Step 1|Patient fell with fracture|0
4759151|NCT00098475|7732953|FG002|Step 1|Patient fell with fracture|0
4759152|NCT00098475|7732954|FG003|Step 1|Patient fell with fracture|0
4759153|NCT00098475|7732951|FG000|Step 1|Not documented|0
4759154|NCT00098475|7732952|FG001|Step 1|Not documented|1
4759155|NCT00098475|7732953|FG002|Step 1|Not documented|0
4681815|NCT02456740|7586038|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
4681816|NCT02456740|7586039|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1
4681817|NCT02456740|7586040|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4
4681818|NCT02456740|7586041|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
4681819|NCT02456740|7586042|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
4681820|NCT02456740|7586043|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
4681821|NCT02456740|7586044|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5
4681822|NCT02456740|7586036|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
4681823|NCT02456740|7586037|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
4681824|NCT02456740|7586038|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
4681825|NCT02456740|7586039|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10
4681826|NCT02456740|7586040|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11
4681827|NCT02456740|7586041|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9
4681828|NCT02456740|7586042|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8
4681829|NCT02456740|7586043|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8
4681830|NCT02456740|7586044|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9
4681831|NCT02456740|7586036|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0
4681832|NCT02456740|7586037|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0
4681833|NCT02456740|7586038|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0
4681834|NCT02456740|7586039|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0
4681835|NCT02456740|7586040|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0
4681836|NCT02456740|7586041|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0
4681837|NCT02456740|7586042|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0
4681838|NCT02456740|7586043|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1
4681839|NCT02456740|7586044|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0
4681840|NCT02456740|7586036|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
4681841|NCT02456740|7586037|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
4681842|NCT02456740|7586038|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
4681843|NCT02456740|7586039|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3
4681844|NCT02456740|7586040|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2
4681845|NCT02456740|7586041|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4
4681846|NCT02456740|7586042|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1
4681847|NCT02456740|7586043|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3
4681848|NCT02456740|7586044|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4
4681849|NCT02456909|7586065|FG000|Overall Study|Did not receive allocated intervention|24
4681850|NCT02456909|7586066|FG001|Overall Study|Did not receive allocated intervention|26
4681851|NCT02456909|7586065|FG000|Overall Study|Did not complete the primary outcome|0
4681852|NCT02456909|7586066|FG001|Overall Study|Did not complete the primary outcome|1
4681853|NCT02457065|7586074|FG000|Overall Study|Lost to Follow-up|9
4681854|NCT02457065|7586075|FG001|Overall Study|Lost to Follow-up|11
4681855|NCT02457182|7586083|FG000|Overall Study|Lost to Follow-up|1
4681856|NCT02457182|7586084|FG001|Overall Study|Lost to Follow-up|0
4681857|NCT02457195|7586090|FG000|Overall Study|Adverse Event|3
4681858|NCT02457195|7586090|FG000|Overall Study|Protocol Violation|2
4681859|NCT02457195|7586090|FG000|Overall Study|Withdrawal by Subject|4
4681860|NCT02457247|7586098|FG000|Period 1|Pretreatment Event/Adverse Event|0
4681861|NCT02457247|7586099|FG001|Period 1|Pretreatment Event/Adverse Event|1
4681862|NCT02457247|7586100|FG002|Period 1|Pretreatment Event/Adverse Event|0
4681863|NCT02457247|7586101|FG003|Period 1|Pretreatment Event/Adverse Event|0
4681864|NCT02457247|7586098|FG000|Period 1|Significant Protocol Deviation|1
4681865|NCT02457247|7586099|FG001|Period 1|Significant Protocol Deviation|1
4681866|NCT02457247|7586100|FG002|Period 1|Significant Protocol Deviation|0
4681867|NCT02457247|7586101|FG003|Period 1|Significant Protocol Deviation|0
4681868|NCT02457247|7586098|FG000|Period 1|Voluntary Withdrawal|1
4681869|NCT02457247|7586099|FG001|Period 1|Voluntary Withdrawal|0
4681870|NCT02457247|7586100|FG002|Period 1|Voluntary Withdrawal|0
4681871|NCT02457247|7586101|FG003|Period 1|Voluntary Withdrawal|0
4681872|NCT02457247|7586098|FG000|Period 2|Pretreatment Event/Adverse Event|0
4681873|NCT02457247|7586099|FG001|Period 2|Pretreatment Event/Adverse Event|1
4681874|NCT02457247|7586100|FG002|Period 2|Pretreatment Event/Adverse Event|0
4681875|NCT02457247|7586101|FG003|Period 2|Pretreatment Event/Adverse Event|0
4681876|NCT02457247|7586098|FG000|Period 2|Significant Protocol Deviation|1
4681877|NCT02457247|7586099|FG001|Period 2|Significant Protocol Deviation|0
4681878|NCT02457247|7586100|FG002|Period 2|Significant Protocol Deviation|0
4681879|NCT02457247|7586101|FG003|Period 2|Significant Protocol Deviation|0
4681880|NCT02457247|7586098|FG000|Period 2|Lost to Follow-up|0
4681881|NCT02457247|7586099|FG001|Period 2|Lost to Follow-up|1
4681882|NCT02457247|7586100|FG002|Period 2|Lost to Follow-up|0
4681883|NCT02457247|7586101|FG003|Period 2|Lost to Follow-up|0
4681884|NCT02457247|7586098|FG000|Period 2|Voluntary Withdrawal|1
4681885|NCT02457247|7586099|FG001|Period 2|Voluntary Withdrawal|1
4681886|NCT02457247|7586100|FG002|Period 2|Voluntary Withdrawal|0
4681887|NCT02457247|7586101|FG003|Period 2|Voluntary Withdrawal|0
4681888|NCT02457325|7586133|FG000|First Intervention (1 Day)|Lost to Follow-up|2
4681889|NCT02457325|7586134|FG001|First Intervention (1 Day)|Lost to Follow-up|2
4681890|NCT02457520|7586151|FG000|Active Treatment Phase|Adverse Event|10
4681891|NCT02457520|7586151|FG000|Active Treatment Phase|Lost to Follow-up|8
4681892|NCT02457520|7586151|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3
4681893|NCT02457520|7586151|FG000|Active Treatment Phase|other|4
4681894|NCT02457520|7586151|FG000|Active Treatment Phase|Physician Decision|1
4681895|NCT02457520|7586151|FG000|Active Treatment Phase|Protocol Violation|1
4681896|NCT02457520|7586151|FG000|Active Treatment Phase|Withdrawal by Subject|7
4681897|NCT02457520|7586151|FG000|Post-treatment Period|Other: Retreatment Required|7
4681898|NCT02457520|7586151|FG000|Post-treatment Period|Lost to Follow-up|23
4681899|NCT02457520|7586151|FG000|Post-treatment Period|Other|3
4681900|NCT02457520|7586151|FG000|Post-treatment Period|Physician Decision|1
4681901|NCT02457520|7586151|FG000|Post-treatment Period|Withdrawal by Subject|14
4681902|NCT02457546|7586183|FG000|Overall Study|Other reasons|4
4681903|NCT02457546|7586184|FG001|Overall Study|Other reasons|1
4681904|NCT02457546|7586183|FG000|Overall Study|Refused to complete study/procedures|1
4681905|NCT02457546|7586184|FG001|Overall Study|Refused to complete study/procedures|1
4681906|NCT02457546|7586183|FG000|Overall Study|Lost to Follow-up|4
4681907|NCT02457546|7586184|FG001|Overall Study|Lost to Follow-up|1
4681908|NCT02457546|7586183|FG000|Overall Study|Adverse Event|0
4681909|NCT02457546|7586184|FG001|Overall Study|Adverse Event|1
4681910|NCT02457611|7586190|FG000|Overall Study|Lost to Follow-up|3
4681911|NCT02457637|7586194|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71
4681912|NCT02457793|7586209|FG000|Overall Study|Reason not specified|0
4681913|NCT02457793|7586210|FG001|Overall Study|Reason not specified|0
4681914|NCT02457793|7586211|FG002|Overall Study|Reason not specified|0
4681915|NCT02457793|7586212|FG003|Overall Study|Reason not specified|1
4681916|NCT02457793|7586213|FG004|Overall Study|Reason not specified|1
4681917|NCT02457793|7586214|FG005|Overall Study|Reason not specified|1
4681918|NCT02457793|7586209|FG000|Overall Study|Withdrawal by Subject|0
4681919|NCT02457793|7586210|FG001|Overall Study|Withdrawal by Subject|4
4681920|NCT02457793|7586211|FG002|Overall Study|Withdrawal by Subject|2
4681921|NCT02457793|7586212|FG003|Overall Study|Withdrawal by Subject|2
4681922|NCT02457793|7586213|FG004|Overall Study|Withdrawal by Subject|2
4681923|NCT02457793|7586214|FG005|Overall Study|Withdrawal by Subject|2
4681924|NCT02457793|7586209|FG000|Overall Study|Adverse Event|0
4681925|NCT02457793|7586210|FG001|Overall Study|Adverse Event|0
4681926|NCT02457793|7586211|FG002|Overall Study|Adverse Event|0
4681927|NCT02457793|7586212|FG003|Overall Study|Adverse Event|1
4681928|NCT02457793|7586213|FG004|Overall Study|Adverse Event|0
4681929|NCT02457793|7586214|FG005|Overall Study|Adverse Event|0
4681930|NCT02457793|7586209|FG000|Overall Study|Physician Decision|1
4681931|NCT02457793|7586210|FG001|Overall Study|Physician Decision|0
4681932|NCT02457793|7586211|FG002|Overall Study|Physician Decision|1
4681933|NCT02457793|7586212|FG003|Overall Study|Physician Decision|1
4681934|NCT02457793|7586213|FG004|Overall Study|Physician Decision|1
4681935|NCT02457793|7586214|FG005|Overall Study|Physician Decision|3
4681936|NCT02457819|7586229|FG000|Overall Study|reason not given|8
4681937|NCT02457819|7586229|FG000|Overall Study|Withdrawal by Subject|24
4681938|NCT02457819|7586229|FG000|Overall Study|Protocol Violation|1
4681939|NCT02457819|7586229|FG000|Overall Study|non compliance with study drug|4
4681940|NCT02457819|7586229|FG000|Overall Study|Lost to Follow-up|10
4681941|NCT02457819|7586229|FG000|Overall Study|Lack of Efficacy|19
4681942|NCT02457819|7586229|FG000|Overall Study|Adverse Event|33
4681943|NCT02458092|7586239|FG000|Overall Study|Withdrawal by Subject|1
4681944|NCT02458092|7586240|FG001|Overall Study|Withdrawal by Subject|0
4681945|NCT02458287|7586255|FG000|Overall Study|Adverse Event|0
4681946|NCT02458287|7586256|FG001|Overall Study|Adverse Event|0
4681947|NCT02458287|7586257|FG002|Overall Study|Adverse Event|0
4681948|NCT02458287|7586258|FG003|Overall Study|Adverse Event|1
4681949|NCT02458287|7586255|FG000|Overall Study|Lost to Follow-up|0
4681950|NCT02458287|7586256|FG001|Overall Study|Lost to Follow-up|1
4681951|NCT02458287|7586257|FG002|Overall Study|Lost to Follow-up|1
4681952|NCT02458287|7586258|FG003|Overall Study|Lost to Follow-up|0
4681953|NCT02458287|7586255|FG000|Overall Study|Protocol Violation|0
4681954|NCT02458287|7586256|FG001|Overall Study|Protocol Violation|1
4681955|NCT02458287|7586257|FG002|Overall Study|Protocol Violation|0
4681956|NCT02458287|7586258|FG003|Overall Study|Protocol Violation|0
4681957|NCT02458287|7586255|FG000|Overall Study|Withdrawal by Subject|0
4681958|NCT02458287|7586256|FG001|Overall Study|Withdrawal by Subject|2
4681959|NCT02458287|7586257|FG002|Overall Study|Withdrawal by Subject|2
4681960|NCT02458287|7586258|FG003|Overall Study|Withdrawal by Subject|1
4681961|NCT02458287|7586255|FG000|Overall Study|Relocated Out of State|0
4681962|NCT02458287|7586256|FG001|Overall Study|Relocated Out of State|0
4681963|NCT02458287|7586257|FG002|Overall Study|Relocated Out of State|0
4681964|NCT02458287|7586258|FG003|Overall Study|Relocated Out of State|1
4681965|NCT02458469|7586290|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0
4681966|NCT02458469|7586291|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0
4681967|NCT02458469|7586292|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1
4681968|NCT02458469|7586293|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0
4681969|NCT02458469|7586294|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0
4681970|NCT02458469|7586295|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0
4681971|NCT02458469|7586290|FG000|First Intervention (2 Weeks)|Physician Decision|1
4759156|NCT00098475|7732954|FG003|Step 1|Not documented|0
4681972|NCT02458469|7586291|FG001|First Intervention (2 Weeks)|Physician Decision|0
4681973|NCT02458469|7586292|FG002|First Intervention (2 Weeks)|Physician Decision|0
4681974|NCT02458469|7586293|FG003|First Intervention (2 Weeks)|Physician Decision|0
4681975|NCT02458469|7586294|FG004|First Intervention (2 Weeks)|Physician Decision|0
4681976|NCT02458469|7586295|FG005|First Intervention (2 Weeks)|Physician Decision|0
4681977|NCT02458469|7586290|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0
4681978|NCT02458469|7586291|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0
4681979|NCT02458469|7586292|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0
4681980|NCT02458469|7586293|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0
4681981|NCT02458469|7586294|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0
4681982|NCT02458469|7586295|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1
4681983|NCT02458638|7586303|FG000|Overall Study|Death|309
4681984|NCT02458638|7586303|FG000|Overall Study|End of Cohort/End of Study|67
4681985|NCT02458638|7586303|FG000|Overall Study|Lost to Follow-up|31
4681986|NCT02458638|7586303|FG000|Overall Study|Other Reasons|4
4681987|NCT02458638|7586303|FG000|Overall Study|Physician Decision|1
4681988|NCT02458638|7586303|FG000|Overall Study|Withdrawal by Subject|47
4681989|NCT02459093|7586327|FG000|Overall Study|Protocol Violation|6
4681990|NCT02459093|7586328|FG001|Overall Study|Protocol Violation|11
4681991|NCT02459093|7586327|FG000|Overall Study|Lost to Follow-up|6
4681992|NCT02459093|7586328|FG001|Overall Study|Lost to Follow-up|7
4681993|NCT02459262|7586358|FG000|Overall Study|Withdrawal by Subject|0
4681994|NCT02459262|7586359|FG001|Overall Study|Withdrawal by Subject|0
4681995|NCT02459262|7586360|FG002|Overall Study|Withdrawal by Subject|0
4681996|NCT02459262|7586361|FG003|Overall Study|Withdrawal by Subject|0
4681997|NCT02459262|7586362|FG004|Overall Study|Withdrawal by Subject|0
4681998|NCT02459262|7586363|FG005|Overall Study|Withdrawal by Subject|0
4681999|NCT02459262|7586364|FG006|Overall Study|Withdrawal by Subject|0
4682000|NCT02459262|7586365|FG007|Overall Study|Withdrawal by Subject|0
4682001|NCT02459262|7586366|FG008|Overall Study|Withdrawal by Subject|0
4682002|NCT02459262|7586367|FG009|Overall Study|Withdrawal by Subject|1
4682003|NCT02459262|7586368|FG010|Overall Study|Withdrawal by Subject|0
4682004|NCT02459418|7586403|FG000|Overall Study|Exclusion Criteria|4
4682005|NCT02459418|7586404|FG001|Overall Study|Exclusion Criteria|0
4682006|NCT02459418|7586403|FG000|Overall Study|Protocol Violation|0
4682007|NCT02459418|7586404|FG001|Overall Study|Protocol Violation|2
4682008|NCT02459418|7586403|FG000|Overall Study|Physician Decision|0
4682009|NCT02459418|7586404|FG001|Overall Study|Physician Decision|2
4682010|NCT02459418|7586403|FG000|Overall Study|Endometrial thickness of >5 mm|1
4682011|NCT02459418|7586404|FG001|Overall Study|Endometrial thickness of >5 mm|0
4682012|NCT02459418|7586403|FG000|Overall Study|Adverse Event|0
4682013|NCT02459418|7586404|FG001|Overall Study|Adverse Event|1
4682014|NCT02459418|7586403|FG000|Overall Study|Withdrawal by Subject|1
4682015|NCT02459418|7586404|FG001|Overall Study|Withdrawal by Subject|1
4682016|NCT02459418|7586403|FG000|Overall Study|Elevated Creatine Kinase|1
4682017|NCT02459418|7586404|FG001|Overall Study|Elevated Creatine Kinase|0
4682018|NCT02459418|7586403|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1
4682019|NCT02459418|7586404|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0
4682020|NCT02459587|7586415|FG000|3-Month Follow-up Assessment|Death|0
4682021|NCT02459587|7586416|FG001|3-Month Follow-up Assessment|Death|2
4682022|NCT02459587|7586415|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3
4682023|NCT02459587|7586416|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3
4682024|NCT02459587|7586415|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27
4682025|NCT02459587|7586416|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22
4682026|NCT02459587|7586415|FG000|3-Month Follow-up Assessment|Researcher withdrew|2
4682027|NCT02459587|7586416|FG001|3-Month Follow-up Assessment|Researcher withdrew|4
4682028|NCT02459587|7586415|FG000|6-month Follow-up Assessment|Death|2
4682029|NCT02459587|7586416|FG001|6-month Follow-up Assessment|Death|1
4682030|NCT02459587|7586415|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1
4682031|NCT02459587|7586416|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2
4682032|NCT02459587|7586415|FG000|6-month Follow-up Assessment|Lost to Follow-up|21
4682033|NCT02459587|7586416|FG001|6-month Follow-up Assessment|Lost to Follow-up|22
4682034|NCT02459587|7586415|FG000|12-month Follow-up Assessment|Death|2
4682035|NCT02459587|7586416|FG001|12-month Follow-up Assessment|Death|0
4682036|NCT02459587|7586415|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2
4682037|NCT02459587|7586416|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4
4682038|NCT02459587|7586415|FG000|12-month Follow-up Assessment|Lost to Follow-up|18
4682039|NCT02459587|7586416|FG001|12-month Follow-up Assessment|Lost to Follow-up|22
4682040|NCT02459587|7586415|FG000|12-month Follow-up Assessment|Researcher withdrew|0
4682041|NCT02459587|7586416|FG001|12-month Follow-up Assessment|Researcher withdrew|1
4682042|NCT02459665|7586427|FG000|Overall Study|Withdrawal by Subject|0
4682043|NCT02459665|7586428|FG001|Overall Study|Withdrawal by Subject|1
4682044|NCT02459665|7586429|FG002|Overall Study|Withdrawal by Subject|1
4682045|NCT02459665|7586430|FG003|Overall Study|Withdrawal by Subject|2
4682046|NCT02459899|7586464|FG000|Overall Study|Adverse Event|1
4682047|NCT02459899|7586465|FG001|Overall Study|Adverse Event|1
4682048|NCT02459899|7586466|FG002|Overall Study|Adverse Event|0
4682049|NCT02459899|7586467|FG003|Overall Study|Adverse Event|0
4682050|NCT02459899|7586464|FG000|Overall Study|Lost to Follow-up|1
4682051|NCT02459899|7586465|FG001|Overall Study|Lost to Follow-up|2
4682052|NCT02459899|7586466|FG002|Overall Study|Lost to Follow-up|0
4682053|NCT02459899|7586467|FG003|Overall Study|Lost to Follow-up|1
4682054|NCT02459899|7586464|FG000|Overall Study|Non-compliance with the treatment|0
4682055|NCT02459899|7586465|FG001|Overall Study|Non-compliance with the treatment|0
4682056|NCT02459899|7586466|FG002|Overall Study|Non-compliance with the treatment|0
4682057|NCT02459899|7586467|FG003|Overall Study|Non-compliance with the treatment|1
4682058|NCT02459899|7586464|FG000|Overall Study|Withdrawal by Subject|1
4682059|NCT02459899|7586465|FG001|Overall Study|Withdrawal by Subject|3
4682060|NCT02459899|7586466|FG002|Overall Study|Withdrawal by Subject|0
4682061|NCT02459899|7586467|FG003|Overall Study|Withdrawal by Subject|0
4682062|NCT02459951|7586477|FG000|Overall Study|Unable to meet holding requirement|1
4682063|NCT02459964|7586485|FG000|Overall Study|Withdrawal by Subject|0
4682064|NCT02459964|7586486|FG001|Overall Study|Withdrawal by Subject|0
4682065|NCT02459964|7586487|FG002|Overall Study|Withdrawal by Subject|1
4682066|NCT02459964|7586485|FG000|Overall Study|Abnormal EKG changes|0
4682067|NCT02459964|7586486|FG001|Overall Study|Abnormal EKG changes|0
4682068|NCT02459964|7586487|FG002|Overall Study|Abnormal EKG changes|1
4682069|NCT02460263|7586500|FG000|Transition Period|Withdrawal by Subject|1
4682070|NCT02460263|7586500|FG000|Transition Period|Death|1
4682071|NCT02460380|7586510|FG000|Overall Study|Withdrawal by Subject|10
4682072|NCT02460380|7586511|FG001|Overall Study|Withdrawal by Subject|5
4682073|NCT02460562|7586520|FG000|Overall Study|Lost to Follow-up|15
4682074|NCT02460562|7586521|FG001|Overall Study|Lost to Follow-up|16
4682075|NCT02460575|7586529|FG000|Overall Study|Lost to Follow-up|1
4682076|NCT02460575|7586530|FG001|Overall Study|Lost to Follow-up|0
4682077|NCT02460679|7586545|FG000|Overall Study|Investigator Decision|1
4682078|NCT02460679|7586545|FG000|Overall Study|Withdrawal by Subject|4
4682079|NCT02460822|7586549|FG000|Overall Study|Withdrawal by Subject|1
4682080|NCT02460978|7586556|FG000|Overall Study|Adverse Event|17
4682081|NCT02460978|7586557|FG001|Overall Study|Adverse Event|11
4682082|NCT02460978|7586558|FG002|Overall Study|Adverse Event|11
4682083|NCT02460978|7586556|FG000|Overall Study|Withdrawal by Subject|5
4682084|NCT02460978|7586557|FG001|Overall Study|Withdrawal by Subject|5
4682085|NCT02460978|7586558|FG002|Overall Study|Withdrawal by Subject|14
4682086|NCT02460978|7586556|FG000|Overall Study|Lost to Follow-up|2
4682087|NCT02460978|7586557|FG001|Overall Study|Lost to Follow-up|3
4682088|NCT02460978|7586558|FG002|Overall Study|Lost to Follow-up|1
4682089|NCT02460978|7586556|FG000|Overall Study|Protocol Violation|1
4682090|NCT02460978|7586557|FG001|Overall Study|Protocol Violation|1
4682091|NCT02460978|7586558|FG002|Overall Study|Protocol Violation|1
4682092|NCT02460978|7586556|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2
4682093|NCT02460978|7586557|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5
4682094|NCT02460978|7586558|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4
4682095|NCT02460978|7586556|FG000|Overall Study|Pregnancy|0
4682096|NCT02460978|7586557|FG001|Overall Study|Pregnancy|0
4682097|NCT02460978|7586558|FG002|Overall Study|Pregnancy|2
4682098|NCT02460991|7586568|FG000|Overall Study|Withdrawal by Subject|0
4682099|NCT02460991|7586569|FG001|Overall Study|Withdrawal by Subject|2
4682100|NCT02461134|7586580|FG000|Overall Study|Adverse Event|1
4682101|NCT02461160|7586597|FG000|Overall Study|Lost to Follow-up|0
4682102|NCT02461160|7586598|FG001|Overall Study|Lost to Follow-up|0
4682103|NCT02461160|7586599|FG002|Overall Study|Lost to Follow-up|0
4682104|NCT02461160|7586600|FG003|Overall Study|Lost to Follow-up|0
4682105|NCT02461160|7586601|FG004|Overall Study|Lost to Follow-up|0
4682106|NCT02461160|7586602|FG005|Overall Study|Lost to Follow-up|0
4682107|NCT02461160|7586603|FG006|Overall Study|Lost to Follow-up|0
4682108|NCT02461160|7586604|FG007|Overall Study|Lost to Follow-up|1
4682109|NCT02461160|7586605|FG008|Overall Study|Lost to Follow-up|0
4682110|NCT02461160|7586606|FG009|Overall Study|Lost to Follow-up|0
4682111|NCT02461160|7586607|FG010|Overall Study|Lost to Follow-up|0
4682112|NCT02461160|7586608|FG011|Overall Study|Lost to Follow-up|0
4682113|NCT02461160|7586609|FG012|Overall Study|Lost to Follow-up|0
4682114|NCT02461290|7586658|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7
4682115|NCT02461290|7586658|FG000|Overall Study|Lost to Follow-up|3
4682116|NCT02461589|7586704|FG000|Overall Study|Withdrawal by Subject|5
4682117|NCT02461589|7586705|FG001|Overall Study|Withdrawal by Subject|1
4682118|NCT02461589|7586706|FG002|Overall Study|Withdrawal by Subject|3
4682119|NCT02461589|7586707|FG003|Overall Study|Withdrawal by Subject|2
4682120|NCT02461589|7586708|FG004|Overall Study|Withdrawal by Subject|1
4682121|NCT02461589|7586709|FG005|Overall Study|Withdrawal by Subject|2
4682122|NCT02461589|7586710|FG006|Overall Study|Withdrawal by Subject|1
4682123|NCT02461589|7586711|FG007|Overall Study|Withdrawal by Subject|3
4682124|NCT02461589|7586712|FG008|Overall Study|Withdrawal by Subject|3
4682125|NCT02461589|7586713|FG009|Overall Study|Withdrawal by Subject|1
4682126|NCT02461589|7586704|FG000|Overall Study|Lost to Follow-up|0
4682127|NCT02461589|7586705|FG001|Overall Study|Lost to Follow-up|0
4682128|NCT02461589|7586706|FG002|Overall Study|Lost to Follow-up|2
4682129|NCT02461589|7586707|FG003|Overall Study|Lost to Follow-up|3
4682130|NCT02461589|7586708|FG004|Overall Study|Lost to Follow-up|1
4682131|NCT02461589|7586709|FG005|Overall Study|Lost to Follow-up|1
4682132|NCT02461589|7586710|FG006|Overall Study|Lost to Follow-up|3
4682133|NCT02461589|7586711|FG007|Overall Study|Lost to Follow-up|1
4682134|NCT02461589|7586712|FG008|Overall Study|Lost to Follow-up|3
4682135|NCT02461589|7586713|FG009|Overall Study|Lost to Follow-up|1
4682136|NCT02461589|7586704|FG000|Overall Study|Death|0
4682137|NCT02461589|7586705|FG001|Overall Study|Death|0
4682138|NCT02461589|7586706|FG002|Overall Study|Death|0
4682139|NCT02461589|7586707|FG003|Overall Study|Death|0
4682140|NCT02461589|7586708|FG004|Overall Study|Death|0
4682141|NCT02461589|7586709|FG005|Overall Study|Death|0
4682142|NCT02461589|7586710|FG006|Overall Study|Death|0
4682143|NCT02461589|7586711|FG007|Overall Study|Death|1
4682144|NCT02461589|7586712|FG008|Overall Study|Death|0
4682145|NCT02461589|7586713|FG009|Overall Study|Death|0
4682146|NCT02461589|7586704|FG000|Overall Study|Unclassified|0
4682147|NCT02461589|7586705|FG001|Overall Study|Unclassified|0
4682148|NCT02461589|7586706|FG002|Overall Study|Unclassified|0
4682149|NCT02461589|7586707|FG003|Overall Study|Unclassified|0
4682150|NCT02461589|7586708|FG004|Overall Study|Unclassified|0
4682151|NCT02461589|7586709|FG005|Overall Study|Unclassified|0
4682152|NCT02461589|7586710|FG006|Overall Study|Unclassified|1
4682153|NCT02461589|7586711|FG007|Overall Study|Unclassified|0
4682154|NCT02461589|7586712|FG008|Overall Study|Unclassified|0
4682155|NCT02461589|7586713|FG009|Overall Study|Unclassified|2
4682156|NCT02461589|7586704|FG000|Overall Study|Missing follow-up information|1
4682157|NCT02461589|7586705|FG001|Overall Study|Missing follow-up information|1
4682158|NCT02461589|7586706|FG002|Overall Study|Missing follow-up information|0
4682159|NCT02461589|7586707|FG003|Overall Study|Missing follow-up information|0
4682160|NCT02461589|7586708|FG004|Overall Study|Missing follow-up information|0
4682161|NCT02461589|7586709|FG005|Overall Study|Missing follow-up information|0
4682162|NCT02461589|7586710|FG006|Overall Study|Missing follow-up information|1
4682163|NCT02461589|7586711|FG007|Overall Study|Missing follow-up information|0
4682164|NCT02461589|7586712|FG008|Overall Study|Missing follow-up information|0
4682165|NCT02461589|7586713|FG009|Overall Study|Missing follow-up information|0
4682166|NCT02461589|7586704|FG000|Overall Study|Withdrawal from trial before exposure|0
4682167|NCT02461589|7586705|FG001|Overall Study|Withdrawal from trial before exposure|0
4682168|NCT02461589|7586706|FG002|Overall Study|Withdrawal from trial before exposure|0
4682169|NCT02461589|7586707|FG003|Overall Study|Withdrawal from trial before exposure|0
4682170|NCT02461589|7586708|FG004|Overall Study|Withdrawal from trial before exposure|0
4682171|NCT02461589|7586709|FG005|Overall Study|Withdrawal from trial before exposure|0
4682172|NCT02461589|7586710|FG006|Overall Study|Withdrawal from trial before exposure|0
4682173|NCT02461589|7586711|FG007|Overall Study|Withdrawal from trial before exposure|0
4682174|NCT02461589|7586712|FG008|Overall Study|Withdrawal from trial before exposure|0
4682175|NCT02461589|7586713|FG009|Overall Study|Withdrawal from trial before exposure|1
4682176|NCT02461628|7586737|FG000|Overall Study|Refused to complete survey|4
4682177|NCT02461628|7586738|FG001|Overall Study|Refused to complete survey|7
4682178|NCT02461745|7586755|FG000|Overall Study|Lack of Efficacy|9
4682179|NCT02461745|7586756|FG001|Overall Study|Lack of Efficacy|1
4682180|NCT02461745|7586755|FG000|Overall Study|Lost to Follow-up|2
4682181|NCT02461745|7586756|FG001|Overall Study|Lost to Follow-up|2
4682182|NCT02461745|7586755|FG000|Overall Study|Withdrawal by Subject|3
4682183|NCT02461745|7586756|FG001|Overall Study|Withdrawal by Subject|1
4682184|NCT02461758|7586768|FG000|Overall Study|Lost to Follow-up|0
4682185|NCT02461758|7586769|FG001|Overall Study|Lost to Follow-up|1
4682186|NCT02461758|7586770|FG002|Overall Study|Lost to Follow-up|1
4682187|NCT02461758|7586771|FG003|Overall Study|Lost to Follow-up|0
4682188|NCT02462057|7586819|FG000|Overall Study|Left Vitality|32
4682189|NCT02462057|7586820|FG001|Overall Study|Left Vitality|27
4682190|NCT02462057|7586821|FG002|Overall Study|Left Vitality|23
4682191|NCT02462057|7586822|FG003|Overall Study|Left Vitality|35
4682192|NCT02462057|7586823|FG004|Overall Study|Left Vitality|33
4682193|NCT02462057|7586819|FG000|Overall Study|Joined HealthyFood Before Intervention|22
4682194|NCT02462057|7586820|FG001|Overall Study|Joined HealthyFood Before Intervention|13
4682195|NCT02462057|7586821|FG002|Overall Study|Joined HealthyFood Before Intervention|23
4682196|NCT02462057|7586822|FG003|Overall Study|Joined HealthyFood Before Intervention|16
4682197|NCT02462057|7586823|FG004|Overall Study|Joined HealthyFood Before Intervention|17
4682198|NCT02462083|7586844|FG000|Overall Study|Sponsor request|39
4682199|NCT02462083|7586844|FG000|Overall Study|Withdrawal by Subject|87
4682200|NCT02462083|7586844|FG000|Overall Study|Lost to Follow-up|41
4682201|NCT02462083|7586844|FG000|Overall Study|Lack of Efficacy|151
4682202|NCT02462083|7586844|FG000|Overall Study|Pregnancy|1
4682203|NCT02462083|7586844|FG000|Overall Study|Protocol Violation|6
4682204|NCT02462083|7586844|FG000|Overall Study|Adverse Event|33
4682205|NCT02462083|7586844|FG000|Overall Study|Worsening condition|16
4682206|NCT02462083|7586844|FG000|Overall Study|Other than specified|45
4682207|NCT02462473|7586893|FG000|Overall Study|Death|1
4682208|NCT02462473|7586893|FG000|Overall Study|Other|3
4682209|NCT02462486|7586900|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1
4682210|NCT02462486|7586901|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1
4682211|NCT02462486|7586902|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3
4682212|NCT02462486|7586900|FG000|Overall Study|Adverse Event|53
4682213|NCT02462486|7586901|FG001|Overall Study|Adverse Event|48
4682214|NCT02462486|7586902|FG002|Overall Study|Adverse Event|21
4682215|NCT02462486|7586900|FG000|Overall Study|Lack of Efficacy|6
4682216|NCT02462486|7586901|FG001|Overall Study|Lack of Efficacy|12
4682217|NCT02462486|7586902|FG002|Overall Study|Lack of Efficacy|3
4682218|NCT02462486|7586900|FG000|Overall Study|Lost to Follow-up|3
4682219|NCT02462486|7586901|FG001|Overall Study|Lost to Follow-up|4
4682220|NCT02462486|7586902|FG002|Overall Study|Lost to Follow-up|2
4682221|NCT02462486|7586900|FG000|Overall Study|Withdrawal by Subject|25
4682222|NCT02462486|7586901|FG001|Overall Study|Withdrawal by Subject|22
4682223|NCT02462486|7586902|FG002|Overall Study|Withdrawal by Subject|19
4682224|NCT02462486|7586900|FG000|Overall Study|Protocol Violation|3
4682225|NCT02462486|7586901|FG001|Overall Study|Protocol Violation|1
4682226|NCT02462486|7586902|FG002|Overall Study|Protocol Violation|1
4682227|NCT02462486|7586900|FG000|Overall Study|Reason not Specified|3
4682228|NCT02462486|7586901|FG001|Overall Study|Reason not Specified|4
4682229|NCT02462486|7586902|FG002|Overall Study|Reason not Specified|3
4682230|NCT02462720|7586910|FG000|Part 2|Withdrawal by Subject|1
4682231|NCT02462720|7586911|FG001|Part 2|Withdrawal by Subject|0
4682232|NCT02462720|7586910|FG000|Part 2|Protocol Violation|0
4682233|NCT02462720|7586911|FG001|Part 2|Protocol Violation|1
4682234|NCT02462759|7586921|FG000|Part 1: Double Blind|Death|1
4682235|NCT02462759|7586922|FG001|Part 1: Double Blind|Death|0
4682236|NCT02462759|7586923|FG002|Part 1: Double Blind|Death|0
4682237|NCT02462928|7586937|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1
4682238|NCT02462928|7586938|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1
4682239|NCT02462928|7586939|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2
4682240|NCT02462928|7586937|FG000|Overall Study|Adverse Event|47
4682241|NCT02462928|7586938|FG001|Overall Study|Adverse Event|51
4682242|NCT02462928|7586939|FG002|Overall Study|Adverse Event|25
4682243|NCT02462928|7586937|FG000|Overall Study|Lack of Efficacy|3
4682244|NCT02462928|7586938|FG001|Overall Study|Lack of Efficacy|8
4682245|NCT02462928|7586939|FG002|Overall Study|Lack of Efficacy|3
4682246|NCT02462928|7586937|FG000|Overall Study|Lost to Follow-up|4
4682247|NCT02462928|7586938|FG001|Overall Study|Lost to Follow-up|4
4682248|NCT02462928|7586939|FG002|Overall Study|Lost to Follow-up|1
4682249|NCT02462928|7586937|FG000|Overall Study|Withdrawal by Patient|31
4682250|NCT02462928|7586938|FG001|Overall Study|Withdrawal by Patient|21
4682251|NCT02462928|7586939|FG002|Overall Study|Withdrawal by Patient|21
4682252|NCT02462928|7586937|FG000|Overall Study|Protocol Violation|0
4682253|NCT02462928|7586938|FG001|Overall Study|Protocol Violation|1
4682254|NCT02462928|7586939|FG002|Overall Study|Protocol Violation|0
4682255|NCT02462928|7586937|FG000|Overall Study|Reason not Specified|4
4682256|NCT02462928|7586938|FG001|Overall Study|Reason not Specified|6
4682257|NCT02462928|7586939|FG002|Overall Study|Reason not Specified|5
4682258|NCT02463032|7586962|FG000|Overall Study|Lack of Efficacy|61
4682259|NCT02463032|7586963|FG001|Overall Study|Lack of Efficacy|50
4682260|NCT02463032|7586962|FG000|Overall Study|Death|8
4682261|NCT02463032|7586963|FG001|Overall Study|Death|8
4682262|NCT02463032|7586962|FG000|Overall Study|Adverse Event|2
4682263|NCT02463032|7586963|FG001|Overall Study|Adverse Event|6
4682264|NCT02463071|7586972|FG000|Overall Study|Adverse Event|3
4682265|NCT02463071|7586973|FG001|Overall Study|Adverse Event|5
4682266|NCT02463071|7586974|FG002|Overall Study|Adverse Event|1
4682267|NCT02463071|7586972|FG000|Overall Study|Death|1
4682268|NCT02463071|7586973|FG001|Overall Study|Death|0
4682269|NCT02463071|7586974|FG002|Overall Study|Death|0
4682270|NCT02463071|7586972|FG000|Overall Study|Eligibility criteria not fulfilled|1
4682271|NCT02463071|7586973|FG001|Overall Study|Eligibility criteria not fulfilled|0
4682272|NCT02463071|7586974|FG002|Overall Study|Eligibility criteria not fulfilled|0
4682273|NCT02463071|7586972|FG000|Overall Study|Reason not specified|7
4682274|NCT02463071|7586973|FG001|Overall Study|Reason not specified|9
4682275|NCT02463071|7586974|FG002|Overall Study|Reason not specified|4
4682276|NCT02463071|7586972|FG000|Overall Study|Protocol Violation|0
4682277|NCT02463071|7586973|FG001|Overall Study|Protocol Violation|2
4682278|NCT02463071|7586974|FG002|Overall Study|Protocol Violation|0
4682279|NCT02463071|7586972|FG000|Overall Study|Lost to Follow-up|0
4682280|NCT02463071|7586973|FG001|Overall Study|Lost to Follow-up|0
4682281|NCT02463071|7586974|FG002|Overall Study|Lost to Follow-up|1
4682282|NCT02463097|7586982|FG000|Overall Study|Withdrawal by Subject|1
4682283|NCT02463331|7586992|FG000|Overall Study|Adverse Event|4
4682284|NCT02463331|7586993|FG001|Overall Study|Adverse Event|2
4682285|NCT02463331|7586992|FG000|Overall Study|Lost to Follow-up|1
4682286|NCT02463331|7586993|FG001|Overall Study|Lost to Follow-up|1
4682287|NCT02463331|7586992|FG000|Overall Study|Pregnancy|2
4682288|NCT02463331|7586993|FG001|Overall Study|Pregnancy|3
4682289|NCT02463331|7586992|FG000|Overall Study|Lack of Efficacy|6
4682290|NCT02463331|7586993|FG001|Overall Study|Lack of Efficacy|0
4682291|NCT02463331|7586992|FG000|Overall Study|Physician Decision|3
4682292|NCT02463331|7586993|FG001|Overall Study|Physician Decision|0
4759157|NCT00098475|7732951|FG000|Step 2|Disease progression|1
4759158|NCT00098475|7732952|FG001|Step 2|Disease progression|4
4759159|NCT00098475|7732953|FG002|Step 2|Disease progression|0
4759160|NCT00098475|7732954|FG003|Step 2|Disease progression|0
4759161|NCT00098475|7732951|FG000|Step 2|Adverse Event|2
4759162|NCT00098475|7732952|FG001|Step 2|Adverse Event|0
4759163|NCT00098475|7732953|FG002|Step 2|Adverse Event|0
4759164|NCT00098475|7732954|FG003|Step 2|Adverse Event|0
4682293|NCT02463357|7587004|FG000|Overall Study|Withdrawal by Subject|1
4682294|NCT02463357|7587005|FG001|Overall Study|Withdrawal by Subject|0
4682295|NCT02463357|7587006|FG002|Overall Study|Withdrawal by Subject|0
4682296|NCT02463357|7587007|FG003|Overall Study|Withdrawal by Subject|0
4682297|NCT02463357|7587008|FG004|Overall Study|Withdrawal by Subject|0
4682298|NCT02463357|7587004|FG000|Overall Study|Withdrawal by Subject|0
4682299|NCT02463357|7587005|FG001|Overall Study|Withdrawal by Subject|0
4682300|NCT02463357|7587006|FG002|Overall Study|Withdrawal by Subject|0
4682301|NCT02463357|7587007|FG003|Overall Study|Withdrawal by Subject|0
4682302|NCT02463357|7587008|FG004|Overall Study|Withdrawal by Subject|1
4682303|NCT02463409|7587020|FG000|Overall Study|Withdrawal by Subject|1
4682304|NCT02463409|7587020|FG000|Overall Study|Screen failure|1
4682305|NCT02464059|7587047|FG000|Overall Study|Lost to Follow-up|6
4682306|NCT02465034|7587122|FG000|Overall Study|Withdrawal by Subject|1
4682307|NCT02465034|7587123|FG001|Overall Study|Withdrawal by Subject|1
4682308|NCT02465034|7587122|FG000|Overall Study|Screen fail|2
4682309|NCT02465034|7587123|FG001|Overall Study|Screen fail|0
4682310|NCT02465034|7587122|FG000|Overall Study|Could not be scheduled for study visit|0
4682311|NCT02465034|7587123|FG001|Overall Study|Could not be scheduled for study visit|5
4682312|NCT02465203|7587162|FG000|Overall Study|Protocol Violation|1
4682313|NCT02465203|7587163|FG001|Overall Study|Protocol Violation|1
4682314|NCT02465203|7587164|FG002|Overall Study|Protocol Violation|1
4682315|NCT02465203|7587162|FG000|Overall Study|Study terminated by sponsor|50
4682316|NCT02465203|7587163|FG001|Overall Study|Study terminated by sponsor|34
4682317|NCT02465203|7587164|FG002|Overall Study|Study terminated by sponsor|11
4682318|NCT02465203|7587162|FG000|Overall Study|New therapy for study indication|4
4682319|NCT02465203|7587163|FG001|Overall Study|New therapy for study indication|0
4682320|NCT02465203|7587164|FG002|Overall Study|New therapy for study indication|0
4682321|NCT02465203|7587162|FG000|Overall Study|Patient/guardian decision|1
4682322|NCT02465203|7587163|FG001|Overall Study|Patient/guardian decision|1
4682323|NCT02465203|7587164|FG002|Overall Study|Patient/guardian decision|1
4759165|NCT00098475|7732951|FG000|Step 2|Withdrawal by Subject|0
4759166|NCT00098475|7732952|FG001|Step 2|Withdrawal by Subject|2
4682324|NCT02465437|7587205|FG000|Overall Study|Physician Decision|0
4682325|NCT02465437|7587206|FG001|Overall Study|Physician Decision|0
4682326|NCT02465437|7587207|FG002|Overall Study|Physician Decision|1
4682327|NCT02465437|7587208|FG003|Overall Study|Physician Decision|0
4682328|NCT02465437|7587205|FG000|Overall Study|Withdrawal by Subject|1
4682329|NCT02465437|7587206|FG001|Overall Study|Withdrawal by Subject|0
4682330|NCT02465437|7587207|FG002|Overall Study|Withdrawal by Subject|0
4682331|NCT02465437|7587208|FG003|Overall Study|Withdrawal by Subject|1
4682332|NCT02465437|7587205|FG000|Overall Study|Adverse Event|0
4682333|NCT02465437|7587206|FG001|Overall Study|Adverse Event|1
4759167|NCT00098475|7732953|FG002|Step 2|Withdrawal by Subject|0
4759168|NCT00098475|7732954|FG003|Step 2|Withdrawal by Subject|0
4759169|NCT00098475|7732951|FG000|Step 2|Physician Decision|0
4759170|NCT00098475|7732952|FG001|Step 2|Physician Decision|1
4759171|NCT00098475|7732953|FG002|Step 2|Physician Decision|0
4759172|NCT00098475|7732954|FG003|Step 2|Physician Decision|0
4759173|NCT00098475|7732951|FG000|Step 2|Alternative therapy|1
4759174|NCT00098475|7732952|FG001|Step 2|Alternative therapy|2
4759175|NCT00098475|7732953|FG002|Step 2|Alternative therapy|0
4759176|NCT00098475|7732954|FG003|Step 2|Alternative therapy|0
4759177|NCT00098475|7732951|FG000|Step 2|Never started treatment|1
4759178|NCT00098475|7732952|FG001|Step 2|Never started treatment|1
4759179|NCT00098475|7732953|FG002|Step 2|Never started treatment|0
4759180|NCT00098475|7732954|FG003|Step 2|Never started treatment|0
4759181|NCT00026312|7732966|FG000|Overall Study|Adverse Event|0
4759182|NCT00026312|7732967|FG001|Overall Study|Adverse Event|32
4759183|NCT00026312|7732966|FG000|Overall Study|Death|1
4759184|NCT00026312|7732967|FG001|Overall Study|Death|7
4759185|NCT00026312|7732966|FG000|Overall Study|Lack of Efficacy|19
4759186|NCT00026312|7732967|FG001|Overall Study|Lack of Efficacy|114
4759187|NCT00026312|7732966|FG000|Overall Study|Lost to Follow-up|0
4759188|NCT00026312|7732967|FG001|Overall Study|Lost to Follow-up|5
4759189|NCT00026312|7732966|FG000|Overall Study|Physician Decision|1
4759190|NCT00026312|7732967|FG001|Overall Study|Physician Decision|37
4759191|NCT00026312|7732966|FG000|Overall Study|Protocol Violation|0
4759192|NCT00026312|7732967|FG001|Overall Study|Protocol Violation|3
4759193|NCT00026312|7732966|FG000|Overall Study|Withdrawal by Subject|1
4759194|NCT00026312|7732967|FG001|Overall Study|Withdrawal by Subject|6
4759195|NCT00026312|7732966|FG000|Overall Study|Ineligible|4
4759196|NCT00026312|7732967|FG001|Overall Study|Ineligible|5
4759197|NCT00026312|7732966|FG000|Overall Study|Entry onto another COG study|0
4759198|NCT00026312|7732967|FG001|Overall Study|Entry onto another COG study|1
4759199|NCT00026312|7732966|FG000|Overall Study|Refusal by patient/parent/guardian|8
4682334|NCT02465437|7587207|FG002|Overall Study|Adverse Event|0
4682335|NCT02465437|7587208|FG003|Overall Study|Adverse Event|0
4759200|NCT00026312|7732967|FG001|Overall Study|Refusal by patient/parent/guardian|59
4682336|NCT02465463|7587244|FG000|Overall Study|Lost to Follow-up|2
4682337|NCT02465463|7587245|FG001|Overall Study|Lost to Follow-up|1
4682338|NCT02465463|7587244|FG000|Overall Study|Death|1
4682339|NCT02465463|7587245|FG001|Overall Study|Death|0
4682340|NCT02465463|7587244|FG000|Overall Study|Protocol Violation|1
4682341|NCT02465463|7587245|FG001|Overall Study|Protocol Violation|0
4682342|NCT02465489|7587252|FG000|Overall Study|Adverse Event|5
4682343|NCT02465515|7587266|FG000|Overall Study|Investigator site closed|4
4682344|NCT02465515|7587267|FG001|Overall Study|Investigator site closed|5
4682345|NCT02465515|7587266|FG000|Overall Study|Withdrawal by Subject|74
4682346|NCT02465515|7587267|FG001|Overall Study|Withdrawal by Subject|43
4682347|NCT02465515|7587266|FG000|Overall Study|Physician Decision|8
4682348|NCT02465515|7587267|FG001|Overall Study|Physician Decision|12
4682349|NCT02465515|7587266|FG000|Overall Study|Lost to Follow-up|68
4682350|NCT02465515|7587267|FG001|Overall Study|Lost to Follow-up|51
4682351|NCT02465528|7587277|FG000|Overall Study|Progressive disease|0
4682352|NCT02465528|7587278|FG001|Overall Study|Progressive disease|2
4682353|NCT02465528|7587279|FG002|Overall Study|Progressive disease|9
4682354|NCT02465528|7587280|FG003|Overall Study|Progressive disease|4
4682355|NCT02465528|7587277|FG000|Overall Study|Study terminated by sponsor|1
4682356|NCT02465528|7587278|FG001|Overall Study|Study terminated by sponsor|2
4682357|NCT02465528|7587279|FG002|Overall Study|Study terminated by sponsor|0
4682358|NCT02465528|7587280|FG003|Overall Study|Study terminated by sponsor|0
4682359|NCT02465528|7587277|FG000|Overall Study|Withdrawal by Subject|0
4682360|NCT02465528|7587278|FG001|Overall Study|Withdrawal by Subject|0
4682361|NCT02465528|7587279|FG002|Overall Study|Withdrawal by Subject|2
4682362|NCT02465528|7587280|FG003|Overall Study|Withdrawal by Subject|0
4682363|NCT02465528|7587277|FG000|Overall Study|Adverse Event|0
4682364|NCT02465528|7587278|FG001|Overall Study|Adverse Event|0
4682365|NCT02465528|7587279|FG002|Overall Study|Adverse Event|0
4682366|NCT02465528|7587280|FG003|Overall Study|Adverse Event|1
4682367|NCT02465528|7587277|FG000|Overall Study|Physician Decision|0
4682368|NCT02465528|7587278|FG001|Overall Study|Physician Decision|0
4682369|NCT02465528|7587279|FG002|Overall Study|Physician Decision|1
4682370|NCT02465528|7587280|FG003|Overall Study|Physician Decision|0
4682371|NCT02465567|7587296|FG000|Overall Study|Adverse Event|118
4682372|NCT02465567|7587297|FG001|Overall Study|Adverse Event|113
4682373|NCT02465567|7587298|FG002|Overall Study|Adverse Event|147
4682374|NCT02465567|7587299|FG003|Overall Study|Adverse Event|138
4682375|NCT02465567|7587296|FG000|Overall Study|Lack of Efficacy|103
4682376|NCT02465567|7587297|FG001|Overall Study|Lack of Efficacy|102
4682377|NCT02465567|7587298|FG002|Overall Study|Lack of Efficacy|171
4682378|NCT02465567|7587299|FG003|Overall Study|Lack of Efficacy|135
4682379|NCT02465567|7587296|FG000|Overall Study|Withdrawal by Subject|104
4682380|NCT02465567|7587297|FG001|Overall Study|Withdrawal by Subject|94
4682381|NCT02465567|7587298|FG002|Overall Study|Withdrawal by Subject|123
4682382|NCT02465567|7587299|FG003|Overall Study|Withdrawal by Subject|130
4682383|NCT02465567|7587296|FG000|Overall Study|Physician Decision|23
4759201|NCT02257918|7732980|FG000|Overall Study|Lost to Follow-up|4
4759202|NCT02257918|7732981|FG001|Overall Study|Lost to Follow-up|1
4759203|NCT02257918|7732982|FG002|Overall Study|Lost to Follow-up|0
4759204|NCT02257918|7732980|FG000|Overall Study|Withdrawal by Subject|0
4759205|NCT02257918|7732981|FG001|Overall Study|Withdrawal by Subject|0
4759206|NCT02257918|7732982|FG002|Overall Study|Withdrawal by Subject|1
4759207|NCT02257918|7732980|FG000|Overall Study|Pregnancy|0
4682384|NCT02465567|7587297|FG001|Overall Study|Physician Decision|33
4682385|NCT02465567|7587298|FG002|Overall Study|Physician Decision|38
4682386|NCT02465567|7587299|FG003|Overall Study|Physician Decision|28
4682387|NCT02465567|7587296|FG000|Overall Study|Major Protocol Deviation|24
4682388|NCT02465567|7587297|FG001|Overall Study|Major Protocol Deviation|26
4682389|NCT02465567|7587298|FG002|Overall Study|Major Protocol Deviation|22
4682390|NCT02465567|7587299|FG003|Overall Study|Major Protocol Deviation|25
4682391|NCT02465567|7587296|FG000|Overall Study|Lost to Follow-up|25
4682392|NCT02465567|7587297|FG001|Overall Study|Lost to Follow-up|21
4682393|NCT02465567|7587298|FG002|Overall Study|Lost to Follow-up|19
4682394|NCT02465567|7587299|FG003|Overall Study|Lost to Follow-up|15
4682395|NCT02465567|7587296|FG000|Overall Study|Protocol Specified Criteria|20
4682396|NCT02465567|7587297|FG001|Overall Study|Protocol Specified Criteria|10
4759208|NCT02257918|7732981|FG001|Overall Study|Pregnancy|0
4759209|NCT02257918|7732982|FG002|Overall Study|Pregnancy|1
4759210|NCT02258542|7732994|FG000|Overall Study|eg. not made to the visit|7
4759211|NCT02258542|7732995|FG001|Overall Study|eg. not made to the visit|4
4759212|NCT02258542|7732996|FG002|Overall Study|eg. not made to the visit|0
4759213|NCT02258542|7732997|FG003|Overall Study|eg. not made to the visit|1
4759214|NCT02258542|7732994|FG000|Overall Study|study specific discount. criteria|1
4759215|NCT02258542|7732995|FG001|Overall Study|study specific discount. criteria|1
4759216|NCT02258542|7732996|FG002|Overall Study|study specific discount. criteria|0
4759217|NCT02258542|7732997|FG003|Overall Study|study specific discount. criteria|0
4759218|NCT02258542|7732994|FG000|Overall Study|Withdrawal by Subject|20
4759219|NCT02258542|7732995|FG001|Overall Study|Withdrawal by Subject|20
4682397|NCT02465567|7587298|FG002|Overall Study|Protocol Specified Criteria|9
4682398|NCT02465567|7587299|FG003|Overall Study|Protocol Specified Criteria|12
4682399|NCT02465567|7587296|FG000|Overall Study|Administrative Reasons|12
4682400|NCT02465567|7587297|FG001|Overall Study|Administrative Reasons|9
4682401|NCT02465567|7587298|FG002|Overall Study|Administrative Reasons|11
4682402|NCT02465567|7587299|FG003|Overall Study|Administrative Reasons|5
4682403|NCT02465567|7587296|FG000|Overall Study|Randomized but not treated|1
4682404|NCT02465567|7587297|FG001|Overall Study|Randomized but not treated|5
4682405|NCT02465567|7587298|FG002|Overall Study|Randomized but not treated|4
4682406|NCT02465567|7587299|FG003|Overall Study|Randomized but not treated|5
4682407|NCT02465567|7587296|FG000|Overall Study|enrolled in >1 studies|18
4682408|NCT02465567|7587297|FG001|Overall Study|enrolled in >1 studies|11
4682409|NCT02465567|7587298|FG002|Overall Study|enrolled in >1 studies|19
4682410|NCT02465567|7587299|FG003|Overall Study|enrolled in >1 studies|15
4682411|NCT02465567|7587296|FG000|Overall Study|missing PI Signature|1
4682412|NCT02465567|7587297|FG001|Overall Study|missing PI Signature|0
4682413|NCT02465567|7587298|FG002|Overall Study|missing PI Signature|0
4682414|NCT02465567|7587299|FG003|Overall Study|missing PI Signature|0
4682415|NCT02465866|7587323|FG000|Period 3|Withdrawal by Subject|0
4682416|NCT02465866|7587324|FG001|Period 3|Withdrawal by Subject|1
4682417|NCT02465866|7587325|FG002|Period 3|Withdrawal by Subject|0
4682418|NCT02465866|7587326|FG003|Period 3|Withdrawal by Subject|0
4682419|NCT02465931|7587338|FG000|Overall Study|Lost to Follow-up|9
4682420|NCT02465931|7587339|FG001|Overall Study|Lost to Follow-up|11
4682421|NCT02465931|7587338|FG000|Overall Study|Protocol Violation|1
4682422|NCT02465931|7587339|FG001|Overall Study|Protocol Violation|0
4682423|NCT02465931|7587338|FG000|Overall Study|Withdrawal by Subject|1
4682424|NCT02465931|7587339|FG001|Overall Study|Withdrawal by Subject|0
4682425|NCT02466386|7587370|FG000|Overall Study|Adverse Event|5
4682426|NCT02466386|7587370|FG000|Overall Study|Protocol Violation|2
4682427|NCT02466386|7587370|FG000|Overall Study|Withdrawal by Subject|14
4682428|NCT02466386|7587370|FG000|Overall Study|Lost to Follow-up|5
4682429|NCT02466386|7587370|FG000|Overall Study|Lack of Efficacy|8
4682430|NCT02466386|7587370|FG000|Overall Study|Other|10
4682431|NCT02466399|7587376|FG000|Overall Study|Adverse Event|1
4682432|NCT02466399|7587377|FG001|Overall Study|Adverse Event|0
4682433|NCT02466399|7587376|FG000|Overall Study|Early exit due to family emergency|1
4682434|NCT02466399|7587377|FG001|Overall Study|Early exit due to family emergency|0
4682435|NCT02466425|7587395|FG000|Overall Study|Adverse Event|3
4682436|NCT02466425|7587396|FG001|Overall Study|Adverse Event|11
4682437|NCT02466425|7587395|FG000|Overall Study|Lack of Efficacy|4
4682438|NCT02466425|7587396|FG001|Overall Study|Lack of Efficacy|1
4682439|NCT02466425|7587395|FG000|Overall Study|Lost to Follow-up|3
4682440|NCT02466425|7587396|FG001|Overall Study|Lost to Follow-up|0
4682441|NCT02466425|7587395|FG000|Overall Study|Protocol Violation|1
4682442|NCT02466425|7587396|FG001|Overall Study|Protocol Violation|0
4682443|NCT02466425|7587395|FG000|Overall Study|Withdrawal by Subject|0
4682444|NCT02466425|7587396|FG001|Overall Study|Withdrawal by Subject|1
4682445|NCT02466425|7587395|FG000|Overall Study|Other|1
4682446|NCT02466425|7587396|FG001|Overall Study|Other|3
4682447|NCT02466425|7587395|FG000|Overall Study|Withdrawal by Parent/Guardian|2
4682448|NCT02466425|7587396|FG001|Overall Study|Withdrawal by Parent/Guardian|0
4682449|NCT02466516|7587407|FG000|Overall Study|Adverse Event|1
4682450|NCT02466516|7587408|FG001|Overall Study|Adverse Event|1
4682451|NCT02466516|7587409|FG002|Overall Study|Adverse Event|0
4682452|NCT02466516|7587410|FG003|Overall Study|Adverse Event|0
4682453|NCT02466516|7587411|FG004|Overall Study|Adverse Event|0
4682454|NCT02466516|7587407|FG000|Overall Study|Withdrew Consent|1
4682455|NCT02466516|7587408|FG001|Overall Study|Withdrew Consent|0
4682456|NCT02466516|7587409|FG002|Overall Study|Withdrew Consent|0
4682457|NCT02466516|7587410|FG003|Overall Study|Withdrew Consent|0
4682458|NCT02466516|7587411|FG004|Overall Study|Withdrew Consent|0
4682459|NCT02466516|7587407|FG000|Overall Study|Lost to Follow-up|2
4682460|NCT02466516|7587408|FG001|Overall Study|Lost to Follow-up|0
4682461|NCT02466516|7587409|FG002|Overall Study|Lost to Follow-up|1
4682462|NCT02466516|7587410|FG003|Overall Study|Lost to Follow-up|0
4682463|NCT02466516|7587411|FG004|Overall Study|Lost to Follow-up|0
4682464|NCT02466555|7587423|FG000|Overall Study|Lost to Follow-up|2
4682465|NCT02466659|7587446|FG000|Overall Study|Lost to Follow-up|5
4682466|NCT02466659|7587447|FG001|Overall Study|Lost to Follow-up|2
4682467|NCT02467192|7587486|FG000|Overall Study|Death|1
4682468|NCT02467192|7587486|FG000|Overall Study|revealed to have pneumonia before|2
4759220|NCT02258542|7732996|FG002|Overall Study|Withdrawal by Subject|7
4759221|NCT02258542|7732997|FG003|Overall Study|Withdrawal by Subject|1
4759222|NCT02258542|7732994|FG000|Overall Study|Lost to Follow-up|5
4759223|NCT02258542|7732995|FG001|Overall Study|Lost to Follow-up|12
4759224|NCT02258542|7732996|FG002|Overall Study|Lost to Follow-up|1
4759225|NCT02258542|7732997|FG003|Overall Study|Lost to Follow-up|2
4759226|NCT02258542|7732994|FG000|Overall Study|Death|5
4759227|NCT02258542|7732995|FG001|Overall Study|Death|4
4759228|NCT02258542|7732996|FG002|Overall Study|Death|0
4759229|NCT02258542|7732997|FG003|Overall Study|Death|1
4759230|NCT02258542|7732994|FG000|Overall Study|Adverse Event|3
4759231|NCT02258542|7732995|FG001|Overall Study|Adverse Event|4
4759232|NCT02258542|7732996|FG002|Overall Study|Adverse Event|0
4759233|NCT02258542|7732997|FG003|Overall Study|Adverse Event|0
4759234|NCT02258542|7732994|FG000|Overall Study|Protocol Violation|1
4759235|NCT02258542|7732995|FG001|Overall Study|Protocol Violation|2
4759236|NCT02258542|7732996|FG002|Overall Study|Protocol Violation|0
4682469|NCT02468193|7587569|FG000|Overall Study|Adverse Event|4
4682470|NCT02468193|7587569|FG000|Overall Study|Subject/ Guardian decision|2
4682471|NCT02468557|7587589|FG000|Overall Study|Adverse Event|1
4682472|NCT02468557|7587589|FG000|Overall Study|Death|1
4682473|NCT02468557|7587589|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10
4682474|NCT02468557|7587589|FG000|Overall Study|All Enrolled but Never Dosed|4
4682475|NCT02468648|7587606|FG000|Overall Study|Death|1
4682476|NCT02468674|7587619|FG000|Overall Study|Adverse Event|0
4682477|NCT02468674|7587620|FG001|Overall Study|Adverse Event|0
4682478|NCT02468674|7587621|FG002|Overall Study|Adverse Event|0
4682479|NCT02468674|7587622|FG003|Overall Study|Adverse Event|1
4682480|NCT02468674|7587623|FG004|Overall Study|Adverse Event|0
4682481|NCT02468674|7587624|FG005|Overall Study|Adverse Event|1
4682482|NCT02468674|7587625|FG006|Overall Study|Adverse Event|0
4682483|NCT02468674|7587626|FG007|Overall Study|Adverse Event|0
4682484|NCT02468674|7587627|FG008|Overall Study|Adverse Event|0
4682485|NCT02468674|7587619|FG000|Overall Study|Lost to Follow-up|1
4682486|NCT02468674|7587620|FG001|Overall Study|Lost to Follow-up|0
4682487|NCT02468674|7587621|FG002|Overall Study|Lost to Follow-up|0
4682488|NCT02468674|7587622|FG003|Overall Study|Lost to Follow-up|0
4682489|NCT02468674|7587623|FG004|Overall Study|Lost to Follow-up|0
4682490|NCT02468674|7587624|FG005|Overall Study|Lost to Follow-up|0
4682491|NCT02468674|7587625|FG006|Overall Study|Lost to Follow-up|0
4682492|NCT02468674|7587626|FG007|Overall Study|Lost to Follow-up|1
4682493|NCT02468674|7587627|FG008|Overall Study|Lost to Follow-up|1
4682494|NCT02468674|7587619|FG000|Overall Study|Physician Decision|0
4682495|NCT02468674|7587620|FG001|Overall Study|Physician Decision|0
4682496|NCT02468674|7587621|FG002|Overall Study|Physician Decision|0
4682497|NCT02468674|7587622|FG003|Overall Study|Physician Decision|0
4682498|NCT02468674|7587623|FG004|Overall Study|Physician Decision|0
4682499|NCT02468674|7587624|FG005|Overall Study|Physician Decision|0
4682500|NCT02468674|7587625|FG006|Overall Study|Physician Decision|1
4682501|NCT02468674|7587626|FG007|Overall Study|Physician Decision|0
4682502|NCT02468674|7587627|FG008|Overall Study|Physician Decision|0
4682503|NCT02468674|7587619|FG000|Overall Study|Patient/Guardian Decision|0
4682504|NCT02468674|7587620|FG001|Overall Study|Patient/Guardian Decision|0
4682505|NCT02468674|7587621|FG002|Overall Study|Patient/Guardian Decision|0
4682506|NCT02468674|7587622|FG003|Overall Study|Patient/Guardian Decision|0
4682507|NCT02468674|7587623|FG004|Overall Study|Patient/Guardian Decision|1
4682508|NCT02468674|7587624|FG005|Overall Study|Patient/Guardian Decision|0
4682509|NCT02468674|7587625|FG006|Overall Study|Patient/Guardian Decision|0
4682510|NCT02468674|7587626|FG007|Overall Study|Patient/Guardian Decision|2
4682511|NCT02468674|7587627|FG008|Overall Study|Patient/Guardian Decision|1
4682512|NCT02468674|7587619|FG000|Overall Study|Protocol Deviation|0
4682513|NCT02468674|7587620|FG001|Overall Study|Protocol Deviation|0
4682514|NCT02468674|7587621|FG002|Overall Study|Protocol Deviation|0
4682515|NCT02468674|7587622|FG003|Overall Study|Protocol Deviation|0
4682516|NCT02468674|7587623|FG004|Overall Study|Protocol Deviation|0
4682517|NCT02468674|7587624|FG005|Overall Study|Protocol Deviation|0
4682518|NCT02468674|7587625|FG006|Overall Study|Protocol Deviation|0
4682519|NCT02468674|7587626|FG007|Overall Study|Protocol Deviation|1
4682520|NCT02468674|7587627|FG008|Overall Study|Protocol Deviation|1
4682521|NCT02468934|7587669|FG000|Overall Study|Withdrawal by Subject|4
4682522|NCT02468934|7587669|FG000|Overall Study|Screen Failure|3
4682523|NCT02469038|7587677|FG000|Overall Study|Physician Decision|4
4682524|NCT02469038|7587678|FG001|Overall Study|Physician Decision|5
4682525|NCT02469064|7587686|FG000|Overall Study|Request not to receive intervention.|1
4682526|NCT02469064|7587687|FG001|Overall Study|Request not to receive intervention.|3
4682527|NCT02469077|7587695|FG000|Post Randomization/Intervention Period|Scheduling issues|3
4682528|NCT02469077|7587696|FG001|Post Randomization/Intervention Period|Scheduling issues|2
4682529|NCT02469077|7587695|FG000|Post Randomization/Intervention Period|Relocated|1
4682530|NCT02469077|7587696|FG001|Post Randomization/Intervention Period|Relocated|1
4682531|NCT02469077|7587695|FG000|Post Randomization/Intervention Period|Conflicting health issues|0
4682532|NCT02469077|7587696|FG001|Post Randomization/Intervention Period|Conflicting health issues|1
4682533|NCT02469077|7587695|FG000|Post Intervention /Followup|Withdrawal by Subject|2
4682534|NCT02469077|7587696|FG001|Post Intervention /Followup|Withdrawal by Subject|1
4682535|NCT02469090|7587708|FG000|Period 1: Dose Titration Phase|Adverse Event|12
4682536|NCT02469090|7587709|FG001|Period 1: Dose Titration Phase|Adverse Event|0
4682537|NCT02469090|7587710|FG002|Period 1: Dose Titration Phase|Adverse Event|0
4682538|NCT02469090|7587708|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8
4682539|NCT02469090|7587709|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0
4682540|NCT02469090|7587710|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0
4682541|NCT02469090|7587708|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1
4682542|NCT02469090|7587709|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0
4682543|NCT02469090|7587710|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0
4682544|NCT02469090|7587708|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11
4682545|NCT02469090|7587709|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0
4682546|NCT02469090|7587710|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0
4682547|NCT02469090|7587708|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0
4682548|NCT02469090|7587709|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5
4682549|NCT02469090|7587710|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15
4759237|NCT02258542|7732997|FG003|Overall Study|Protocol Violation|0
4682550|NCT02469090|7587708|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0
4682551|NCT02469090|7587709|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3
4682552|NCT02469090|7587710|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4
4682553|NCT02469090|7587708|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0
4682554|NCT02469090|7587709|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1
4682555|NCT02469090|7587710|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0
4682556|NCT02469090|7587708|FG000|Period 2: Maintenance Treatment Phase|Death|0
4682557|NCT02469090|7587709|FG001|Period 2: Maintenance Treatment Phase|Death|0
4682558|NCT02469090|7587710|FG002|Period 2: Maintenance Treatment Phase|Death|1
4682559|NCT02469168|7587723|FG000|Overall Study|Trial closed|1
4682560|NCT02469168|7587724|FG001|Overall Study|Trial closed|0
4682561|NCT02469246|7587732|FG000|Double-Blind Phase|Randomized and Never Treated|5
4682562|NCT02469246|7587733|FG001|Double-Blind Phase|Randomized and Never Treated|6
4682563|NCT02469246|7587732|FG000|Double-Blind Phase|Adverse Event|12
4682564|NCT02469246|7587733|FG001|Double-Blind Phase|Adverse Event|9
4682565|NCT02469246|7587732|FG000|Double-Blind Phase|Death|2
4682566|NCT02469246|7587733|FG001|Double-Blind Phase|Death|0
4759238|NCT02258542|7732994|FG000|Overall Study|Eligibility criteria not fulfilled|0
4759239|NCT02258542|7732995|FG001|Overall Study|Eligibility criteria not fulfilled|2
4759240|NCT02258542|7732996|FG002|Overall Study|Eligibility criteria not fulfilled|0
4759241|NCT02258542|7732997|FG003|Overall Study|Eligibility criteria not fulfilled|0
4682567|NCT02469246|7587732|FG000|Double-Blind Phase|Lack of Efficacy|2
4682568|NCT02469246|7587733|FG001|Double-Blind Phase|Lack of Efficacy|1
4682569|NCT02469246|7587732|FG000|Double-Blind Phase|Investigator's Discretion|8
4682570|NCT02469246|7587733|FG001|Double-Blind Phase|Investigator's Discretion|8
4682571|NCT02469246|7587732|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3
4682572|NCT02469246|7587733|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1
4682573|NCT02469246|7587732|FG000|Double-Blind Phase|Protocol Violation|1
4682574|NCT02469246|7587733|FG001|Double-Blind Phase|Protocol Violation|1
4682575|NCT02469246|7587732|FG000|Double-Blind Phase|Withdrew Consent|25
4682576|NCT02469246|7587733|FG001|Double-Blind Phase|Withdrew Consent|25
4682577|NCT02469246|7587732|FG000|Double-Blind Phase|Lost to Follow-up|9
4682578|NCT02469246|7587733|FG001|Double-Blind Phase|Lost to Follow-up|5
4682579|NCT02469298|7587745|FG000|Overall Study|Protocol Violation|0
4682580|NCT02469298|7587746|FG001|Overall Study|Protocol Violation|1
4682581|NCT02469298|7587747|FG002|Overall Study|Protocol Violation|1
4682582|NCT02469298|7587748|FG003|Overall Study|Protocol Violation|0
4682583|NCT02469298|7587745|FG000|Overall Study|Lost to Follow-up|1
4682584|NCT02469298|7587746|FG001|Overall Study|Lost to Follow-up|0
4682585|NCT02469298|7587747|FG002|Overall Study|Lost to Follow-up|1
4682586|NCT02469298|7587748|FG003|Overall Study|Lost to Follow-up|0
4682587|NCT02469298|7587745|FG000|Overall Study|Physician Decision|0
4682588|NCT02469298|7587746|FG001|Overall Study|Physician Decision|0
4682589|NCT02469298|7587747|FG002|Overall Study|Physician Decision|0
4682590|NCT02469298|7587748|FG003|Overall Study|Physician Decision|1
4682591|NCT02469298|7587745|FG000|Overall Study|Withdrawal by Subject|0
4682592|NCT02469298|7587746|FG001|Overall Study|Withdrawal by Subject|0
4682593|NCT02469298|7587747|FG002|Overall Study|Withdrawal by Subject|0
4682594|NCT02469298|7587748|FG003|Overall Study|Withdrawal by Subject|1
4682595|NCT02469610|7587785|FG000|Overall Study|Death|1
4682596|NCT02469610|7587786|FG001|Overall Study|Death|0
4682597|NCT02469610|7587785|FG000|Overall Study|Lost to Follow-up|1
4682598|NCT02469610|7587786|FG001|Overall Study|Lost to Follow-up|0
4682599|NCT02469610|7587785|FG000|Overall Study|exclusion criteria|2
4682600|NCT02469610|7587786|FG001|Overall Study|exclusion criteria|1
4682601|NCT02469623|7587792|FG000|Overall Study|Not consented for long-term follow-up|4
4682602|NCT02469623|7587792|FG000|Overall Study|Lost to Follow-up|4
4682603|NCT02469623|7587792|FG000|Overall Study|Withdrawal by Subject|2
4682604|NCT02469623|7587792|FG000|Overall Study|Death|3
4682605|NCT02469857|7587812|FG000|Overall Study|Death|24
4682606|NCT02469857|7587813|FG001|Overall Study|Death|29
4682607|NCT02469857|7587812|FG000|Overall Study|Discontinuation|1
4682608|NCT02469857|7587813|FG001|Overall Study|Discontinuation|3
4682609|NCT02469896|7587835|FG000|Overall Study|Withdrawal by Subject|2
4682610|NCT02469896|7587836|FG001|Overall Study|Withdrawal by Subject|0
4682611|NCT02469961|7587848|FG000|Overall Study|Physician Decision|4
4682612|NCT02469961|7587849|FG001|Overall Study|Physician Decision|1
4682617|NCT02470403|7587914|FG000|Overall Study|Adverse Event|1
4682618|NCT02470403|7587915|FG001|Overall Study|Adverse Event|0
4682619|NCT02470403|7587916|FG002|Overall Study|Adverse Event|0
4682620|NCT02470403|7587917|FG003|Overall Study|Adverse Event|0
4682621|NCT02470403|7587918|FG004|Overall Study|Adverse Event|0
4682622|NCT02470403|7587914|FG000|Overall Study|Lost to Follow-up|0
4759242|NCT02290431|7733025|FG000|Overall Study|Adverse Event|20
4759243|NCT02290431|7733025|FG000|Overall Study|Progressive disease|4
4759244|NCT02290431|7733025|FG000|Overall Study|Study terminated by Sponsor|1
4759245|NCT02290431|7733025|FG000|Overall Study|Physician Decision|2
4759246|NCT02314923|7733039|FG000|Overall Study|Death|0
4759247|NCT02314923|7733040|FG001|Overall Study|Death|0
4759248|NCT02314923|7733041|FG002|Overall Study|Death|0
4759249|NCT02314923|7733042|FG003|Overall Study|Death|1
4759250|NCT02314923|7733043|FG004|Overall Study|Death|0
4759251|NCT02314923|7733044|FG005|Overall Study|Death|0
4759252|NCT02314923|7733045|FG006|Overall Study|Death|0
4759253|NCT02314923|7733046|FG007|Overall Study|Death|0
4759254|NCT02314923|7733047|FG008|Overall Study|Death|0
4759255|NCT02314923|7733048|FG009|Overall Study|Death|0
4759256|NCT02314923|7733039|FG000|Overall Study|Lost to Follow-up|2
4759257|NCT02314923|7733040|FG001|Overall Study|Lost to Follow-up|3
4759258|NCT02314923|7733041|FG002|Overall Study|Lost to Follow-up|1
4759259|NCT02314923|7733042|FG003|Overall Study|Lost to Follow-up|0
4759260|NCT02314923|7733043|FG004|Overall Study|Lost to Follow-up|0
4759261|NCT02314923|7733044|FG005|Overall Study|Lost to Follow-up|0
4759262|NCT02314923|7733045|FG006|Overall Study|Lost to Follow-up|3
4682623|NCT02470403|7587915|FG001|Overall Study|Lost to Follow-up|1
4759263|NCT02314923|7733046|FG007|Overall Study|Lost to Follow-up|4
4759264|NCT02314923|7733047|FG008|Overall Study|Lost to Follow-up|2
4759265|NCT02314923|7733048|FG009|Overall Study|Lost to Follow-up|0
4759266|NCT02314923|7733039|FG000|Overall Study|Withdrawal by Subject|0
4759267|NCT02314923|7733040|FG001|Overall Study|Withdrawal by Subject|0
4682624|NCT02470403|7587916|FG002|Overall Study|Lost to Follow-up|0
4682625|NCT02470403|7587917|FG003|Overall Study|Lost to Follow-up|0
4682626|NCT02470403|7587918|FG004|Overall Study|Lost to Follow-up|0
4682627|NCT02470403|7587914|FG000|Overall Study|Subject/guardian decision|1
4682628|NCT02470403|7587915|FG001|Overall Study|Subject/guardian decision|0
4682629|NCT02470403|7587916|FG002|Overall Study|Subject/guardian decision|0
4682630|NCT02470403|7587917|FG003|Overall Study|Subject/guardian decision|4
4682631|NCT02470403|7587918|FG004|Overall Study|Subject/guardian decision|0
4759268|NCT02314923|7733041|FG002|Overall Study|Withdrawal by Subject|1
4682632|NCT02470429|7587935|FG000|Overall Study|Adverse Event|1
4682633|NCT02470429|7587936|FG001|Overall Study|Adverse Event|0
4682634|NCT02470429|7587935|FG000|Overall Study|Withdrawal by Subject|1
4682635|NCT02470429|7587936|FG001|Overall Study|Withdrawal by Subject|0
4682636|NCT02470585|7587950|FG000|Overall Study|Death|82
4682637|NCT02470585|7587951|FG001|Overall Study|Death|87
4682638|NCT02470585|7587952|FG002|Overall Study|Death|86
4682639|NCT02470585|7587950|FG000|Overall Study|Withdrawal by Subject|19
4682640|NCT02470585|7587951|FG001|Overall Study|Withdrawal by Subject|21
4682641|NCT02470585|7587952|FG002|Overall Study|Withdrawal by Subject|29
4682642|NCT02470585|7587950|FG000|Overall Study|Lost to Follow-up|2
4682643|NCT02470585|7587951|FG001|Overall Study|Lost to Follow-up|5
4682644|NCT02470585|7587952|FG002|Overall Study|Lost to Follow-up|4
4682645|NCT02470585|7587950|FG000|Overall Study|Other|4
4682646|NCT02470585|7587951|FG001|Overall Study|Other|4
4682647|NCT02470585|7587952|FG002|Overall Study|Other|6
4682648|NCT02470806|7587978|FG000|Overall Study|Lost to Follow-up|1
4682649|NCT02470806|7587979|FG001|Overall Study|Lost to Follow-up|1
4682650|NCT02470806|7587978|FG000|Overall Study|Adverse Event|5
4682651|NCT02470806|7587979|FG001|Overall Study|Adverse Event|2
4682652|NCT02470806|7587978|FG000|Overall Study|Protocol Violation|4
4682653|NCT02470806|7587979|FG001|Overall Study|Protocol Violation|11
4682654|NCT02470806|7587978|FG000|Overall Study|Physician Decision|0
4682655|NCT02470806|7587979|FG001|Overall Study|Physician Decision|3
4682656|NCT02470806|7587978|FG000|Overall Study|Withdrawal by Subject|3
4682657|NCT02470806|7587979|FG001|Overall Study|Withdrawal by Subject|10
4682658|NCT02470806|7587978|FG000|Overall Study|Lack of Efficacy|5
4682659|NCT02470806|7587979|FG001|Overall Study|Lack of Efficacy|15
4682660|NCT02471014|7588003|FG000|Overall Study|Lost to Follow-up|2
4682661|NCT02471014|7588004|FG001|Overall Study|Lost to Follow-up|2
4682662|NCT02471183|7588010|FG000|Main Treatment Period|Adverse Event|1
4682663|NCT02471183|7588010|FG000|Main Treatment Period|Withdrawal by Subject|1
4682664|NCT02471183|7588010|FG000|Extended Treatment Period|Lack of Efficacy|1
4682665|NCT02471404|7588025|FG000|Overall Study|Adverse Event|7
4682666|NCT02471404|7588026|FG001|Overall Study|Adverse Event|1
4682667|NCT02471404|7588027|FG002|Overall Study|Adverse Event|2
4682668|NCT02471404|7588025|FG000|Overall Study|Developed Study Withdrawal Criteria|4
4682669|NCT02471404|7588026|FG001|Overall Study|Developed Study Withdrawal Criteria|1
4682670|NCT02471404|7588027|FG002|Overall Study|Developed Study Withdrawal Criteria|2
4682671|NCT02471404|7588025|FG000|Overall Study|Failure to Meet Randomization Criteria|2
4682672|NCT02471404|7588026|FG001|Overall Study|Failure to Meet Randomization Criteria|0
4682673|NCT02471404|7588027|FG002|Overall Study|Failure to Meet Randomization Criteria|1
4682674|NCT02471404|7588025|FG000|Overall Study|Lost to Follow-up|1
4682675|NCT02471404|7588026|FG001|Overall Study|Lost to Follow-up|1
4682676|NCT02471404|7588027|FG002|Overall Study|Lost to Follow-up|3
4682677|NCT02471404|7588025|FG000|Overall Study|Protocol Violation|1
4682678|NCT02471404|7588026|FG001|Overall Study|Protocol Violation|0
4682679|NCT02471404|7588027|FG002|Overall Study|Protocol Violation|0
4682680|NCT02471404|7588025|FG000|Overall Study|Withdrawal by Subject|8
4682681|NCT02471404|7588026|FG001|Overall Study|Withdrawal by Subject|4
4682682|NCT02471404|7588027|FG002|Overall Study|Withdrawal by Subject|5
4682683|NCT02471404|7588025|FG000|Overall Study|Other reasons not specified|10
4682684|NCT02471404|7588026|FG001|Overall Study|Other reasons not specified|7
4682685|NCT02471404|7588027|FG002|Overall Study|Other reasons not specified|12
4682686|NCT02471586|7588047|FG000|Overall Study|Lost to Follow-up|3
4682687|NCT02471586|7588048|FG001|Overall Study|Lost to Follow-up|8
4682688|NCT02471586|7588049|FG002|Overall Study|Lost to Follow-up|4
4682689|NCT02471586|7588047|FG000|Overall Study|Death|2
4682690|NCT02471586|7588048|FG001|Overall Study|Death|2
4682691|NCT02471586|7588049|FG002|Overall Study|Death|0
4759269|NCT02314923|7733042|FG003|Overall Study|Withdrawal by Subject|0
4759270|NCT02314923|7733043|FG004|Overall Study|Withdrawal by Subject|1
4759271|NCT02314923|7733044|FG005|Overall Study|Withdrawal by Subject|0
4759272|NCT02314923|7733045|FG006|Overall Study|Withdrawal by Subject|1
4759273|NCT02314923|7733046|FG007|Overall Study|Withdrawal by Subject|0
4759274|NCT02314923|7733047|FG008|Overall Study|Withdrawal by Subject|0
4759275|NCT02314923|7733048|FG009|Overall Study|Withdrawal by Subject|0
4759276|NCT02314923|7733039|FG000|Overall Study|Physician Decision|0
4759277|NCT02314923|7733040|FG001|Overall Study|Physician Decision|1
4759278|NCT02314923|7733041|FG002|Overall Study|Physician Decision|0
4759279|NCT02314923|7733042|FG003|Overall Study|Physician Decision|0
4759280|NCT02314923|7733043|FG004|Overall Study|Physician Decision|0
4759281|NCT02314923|7733044|FG005|Overall Study|Physician Decision|0
4759282|NCT02314923|7733045|FG006|Overall Study|Physician Decision|0
4759283|NCT02314923|7733046|FG007|Overall Study|Physician Decision|0
4759284|NCT02314923|7733047|FG008|Overall Study|Physician Decision|0
4759285|NCT02314923|7733048|FG009|Overall Study|Physician Decision|0
4759286|NCT02314923|7733039|FG000|Overall Study|Participant unavailable|0
4759287|NCT02314923|7733040|FG001|Overall Study|Participant unavailable|0
4759288|NCT02314923|7733041|FG002|Overall Study|Participant unavailable|0
4759289|NCT02314923|7733042|FG003|Overall Study|Participant unavailable|0
4759290|NCT02314923|7733043|FG004|Overall Study|Participant unavailable|0
4759291|NCT02314923|7733044|FG005|Overall Study|Participant unavailable|1
4759292|NCT02314923|7733045|FG006|Overall Study|Participant unavailable|0
4759293|NCT02314923|7733046|FG007|Overall Study|Participant unavailable|0
4682692|NCT02471612|7588059|FG000|Overall Study|Lost to Follow-up|2
4682693|NCT02471716|7588090|FG000|Overall Study|Withdrawal by Subject|0
4682694|NCT02471716|7588091|FG001|Overall Study|Withdrawal by Subject|1
4682695|NCT02471716|7588092|FG002|Overall Study|Withdrawal by Subject|0
4682696|NCT02471716|7588093|FG003|Overall Study|Withdrawal by Subject|2
4682697|NCT02471716|7588094|FG004|Overall Study|Withdrawal by Subject|5
4682698|NCT02471716|7588090|FG000|Overall Study|Study Terminiated by sponsor|0
4682699|NCT02471716|7588091|FG001|Overall Study|Study Terminiated by sponsor|0
4682700|NCT02471716|7588092|FG002|Overall Study|Study Terminiated by sponsor|0
4682701|NCT02471716|7588093|FG003|Overall Study|Study Terminiated by sponsor|1
4682702|NCT02471716|7588094|FG004|Overall Study|Study Terminiated by sponsor|0
4682703|NCT02471716|7588090|FG000|Overall Study|Lost to Follow-up|0
4682704|NCT02471716|7588091|FG001|Overall Study|Lost to Follow-up|0
4682705|NCT02471716|7588092|FG002|Overall Study|Lost to Follow-up|0
4682706|NCT02471716|7588093|FG003|Overall Study|Lost to Follow-up|3
4682707|NCT02471716|7588094|FG004|Overall Study|Lost to Follow-up|2
4682708|NCT02471716|7588090|FG000|Overall Study|Death|0
4682709|NCT02471716|7588091|FG001|Overall Study|Death|0
4682710|NCT02471716|7588092|FG002|Overall Study|Death|0
4682711|NCT02471716|7588093|FG003|Overall Study|Death|1
4682712|NCT02471716|7588094|FG004|Overall Study|Death|0
4682713|NCT02471716|7588090|FG000|Overall Study|Other|0
4682714|NCT02471716|7588091|FG001|Overall Study|Other|0
4682715|NCT02471716|7588092|FG002|Overall Study|Other|0
4682716|NCT02471716|7588093|FG003|Overall Study|Other|8
4682717|NCT02471716|7588094|FG004|Overall Study|Other|9
4682718|NCT02471755|7588110|FG000|Overall Study|Withdrawal by Subject|1
4682719|NCT02471755|7588111|FG001|Overall Study|Withdrawal by Subject|0
4682720|NCT02471755|7588110|FG000|Overall Study|Lost to Follow-up|0
4682721|NCT02471755|7588111|FG001|Overall Study|Lost to Follow-up|1
4682722|NCT02472145|7588120|FG000|Overall Study|Death|10
4682723|NCT02472145|7588121|FG001|Overall Study|Death|101
4682724|NCT02472145|7588122|FG002|Overall Study|Death|99
4682725|NCT02472145|7588120|FG000|Overall Study|Lost to Follow-up|0
4682726|NCT02472145|7588121|FG001|Overall Study|Lost to Follow-up|1
4682727|NCT02472145|7588122|FG002|Overall Study|Lost to Follow-up|0
4682728|NCT02472145|7588120|FG000|Overall Study|Withdrawal by Subject|0
4682729|NCT02472145|7588121|FG001|Overall Study|Withdrawal by Subject|9
4682730|NCT02472145|7588122|FG002|Overall Study|Withdrawal by Subject|13
4682731|NCT02472145|7588120|FG000|Overall Study|Sponsor decision|0
4682732|NCT02472145|7588121|FG001|Overall Study|Sponsor decision|3
4682733|NCT02472145|7588122|FG002|Overall Study|Sponsor decision|2
4682734|NCT02472145|7588120|FG000|Overall Study|Other|0
4682735|NCT02472145|7588121|FG001|Overall Study|Other|45
4682736|NCT02472145|7588122|FG002|Overall Study|Other|43
4682737|NCT02472353|7588162|FG000|Overall Study|Lost to Follow-up|1
4682738|NCT02472353|7588163|FG001|Overall Study|Lost to Follow-up|1
4682739|NCT02472353|7588162|FG000|Overall Study|Withdrawal by Subject|2
4682740|NCT02472353|7588163|FG001|Overall Study|Withdrawal by Subject|1
4682741|NCT02472353|7588162|FG000|Overall Study|Study Termination|1
4682742|NCT02472353|7588163|FG001|Overall Study|Study Termination|4
4682743|NCT02472366|7588171|FG000|Overall Study|Lost to Follow-up|1
4682744|NCT02472366|7588172|FG001|Overall Study|Lost to Follow-up|0
4682745|NCT02472405|7588178|FG000|Overall Study|Lost to Follow-up|9
4682746|NCT02472405|7588178|FG000|Overall Study|Adverse Event|1
4682747|NCT02472652|7588204|FG000|Overall Study|Lost to Follow-up|1
4682748|NCT02472756|7588217|FG000|Induction (Approximately 6 Months)|Adverse Event|1
4682749|NCT02472756|7588217|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1
4682750|NCT02472756|7588217|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7
4682751|NCT02472756|7588217|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2
4682752|NCT02472756|7588217|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1
4682753|NCT02472795|7588226|FG000|Overall Study|Adverse Event|0
4682754|NCT02472795|7588227|FG001|Overall Study|Adverse Event|1
4682755|NCT02472795|7588228|FG002|Overall Study|Adverse Event|0
4682756|NCT02472795|7588229|FG003|Overall Study|Adverse Event|0
4682757|NCT02472795|7588230|FG004|Overall Study|Adverse Event|2
4682758|NCT02472795|7588226|FG000|Overall Study|Withdrawal by Subject|0
4682759|NCT02472795|7588227|FG001|Overall Study|Withdrawal by Subject|0
4682760|NCT02472795|7588228|FG002|Overall Study|Withdrawal by Subject|0
4682761|NCT02472795|7588229|FG003|Overall Study|Withdrawal by Subject|0
4682762|NCT02472795|7588230|FG004|Overall Study|Withdrawal by Subject|1
4682763|NCT02472847|7588244|FG000|Overall Study|Withdrawal by Subject|1
4682764|NCT02472847|7588245|FG001|Overall Study|Withdrawal by Subject|5
4682765|NCT02472886|7588254|FG000|Overall Study|Lack of Efficacy|0
4682766|NCT02472886|7588255|FG001|Overall Study|Lack of Efficacy|2
4682767|NCT02472886|7588256|FG002|Overall Study|Lack of Efficacy|1
4682768|NCT02472977|7588272|FG000|Overall Study|Disease progression|4
4682769|NCT02472977|7588273|FG001|Overall Study|Disease progression|25
4682770|NCT02472977|7588274|FG002|Overall Study|Disease progression|6
4682771|NCT02472977|7588272|FG000|Overall Study|Withdrawal by Subject|0
4682772|NCT02472977|7588273|FG001|Overall Study|Withdrawal by Subject|1
4682773|NCT02472977|7588274|FG002|Overall Study|Withdrawal by Subject|0
4682774|NCT02472977|7588272|FG000|Overall Study|Study drug toxicity|2
4682775|NCT02472977|7588273|FG001|Overall Study|Study drug toxicity|0
4682776|NCT02472977|7588274|FG002|Overall Study|Study drug toxicity|2
4759294|NCT02314923|7733047|FG008|Overall Study|Participant unavailable|0
4682777|NCT02472977|7588272|FG000|Overall Study|Subject request to discontinue treatment|0
4682778|NCT02472977|7588273|FG001|Overall Study|Subject request to discontinue treatment|1
4682779|NCT02472977|7588274|FG002|Overall Study|Subject request to discontinue treatment|0
4682780|NCT02473250|7588282|FG000|Overall Study|Lost to Follow-up|10
4682781|NCT02473250|7588282|FG000|Overall Study|Physician Decision|5
4682782|NCT02473250|7588282|FG000|Overall Study|Did not tolerate medication washout|3
4682783|NCT02473250|7588282|FG000|Overall Study|Antidepressant effect of divalproex|2
4682784|NCT02473289|7588289|FG000|Overall Study|Adverse Event|2
4682785|NCT02473289|7588290|FG001|Overall Study|Adverse Event|3
4682786|NCT02473289|7588289|FG000|Overall Study|Lost to Follow-up|1
4682787|NCT02473289|7588290|FG001|Overall Study|Lost to Follow-up|1
4682788|NCT02473289|7588289|FG000|Overall Study|Protocol Violation|0
4682789|NCT02473289|7588290|FG001|Overall Study|Protocol Violation|1
4682790|NCT02473289|7588289|FG000|Overall Study|Withdrawal of consent|6
4682791|NCT02473289|7588290|FG001|Overall Study|Withdrawal of consent|7
4682792|NCT02473289|7588289|FG000|Overall Study|Treatment Unblinded + Adverse event|0
4682793|NCT02473289|7588290|FG001|Overall Study|Treatment Unblinded + Adverse event|1
4682794|NCT02473289|7588289|FG000|Overall Study|Other|2
4682795|NCT02473289|7588290|FG001|Overall Study|Other|0
4682796|NCT02473367|7588296|FG000|Wait 1|Withdrawal by Subject|1
4682797|NCT02473367|7588296|FG000|Period 4|Lost to Follow-up|1
4682798|NCT02473393|7588310|FG000|Overall Study|Adverse Event|0
4682799|NCT02473393|7588311|FG001|Overall Study|Adverse Event|0
4682800|NCT02473393|7588312|FG002|Overall Study|Adverse Event|1
4682801|NCT02473393|7588313|FG003|Overall Study|Adverse Event|0
4682802|NCT02473393|7588310|FG000|Overall Study|Withdrawal by Subject|0
4682803|NCT02473393|7588311|FG001|Overall Study|Withdrawal by Subject|0
4682804|NCT02473393|7588312|FG002|Overall Study|Withdrawal by Subject|1
4682805|NCT02473393|7588313|FG003|Overall Study|Withdrawal by Subject|1
4682806|NCT02473471|7588323|FG000|Overall Study|poor oral hygiene|2
4682807|NCT02473471|7588323|FG000|Overall Study|Lost to Follow-up|1
4682808|NCT02473510|7588335|FG000|Overall Study|Lost to Follow-up|1
4682809|NCT02473510|7588336|FG001|Overall Study|Lost to Follow-up|2
4682810|NCT02473614|7588342|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1
4682811|NCT02473614|7588343|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0
4682812|NCT02473640|7588350|FG000|Treatment Period 1|Adverse Event|1
4682813|NCT02473913|7588378|FG000|Overall Study|Lost to Follow-up|3
4682814|NCT02473913|7588379|FG001|Overall Study|Lost to Follow-up|3
4682815|NCT02473952|7588387|FG000|Overall Study|Adverse Event|2
4682816|NCT02473952|7588388|FG001|Overall Study|Adverse Event|2
4682817|NCT02473952|7588387|FG000|Overall Study|Withdrawal by Subject|0
4682818|NCT02473952|7588388|FG001|Overall Study|Withdrawal by Subject|6
4682819|NCT02473965|7588396|FG000|Overall Study|Adverse Event|6
4682820|NCT02473965|7588397|FG001|Overall Study|Adverse Event|4
4682821|NCT02473965|7588396|FG000|Overall Study|MG worsening|4
4682822|NCT02473965|7588397|FG001|Overall Study|MG worsening|1
4682823|NCT02473965|7588396|FG000|Overall Study|Withdrawal by Subject|2
4682824|NCT02473965|7588397|FG001|Overall Study|Withdrawal by Subject|3
4682825|NCT02473965|7588396|FG000|Overall Study|Physician Decision|0
4682826|NCT02473965|7588397|FG001|Overall Study|Physician Decision|2
4682827|NCT02474069|7588407|FG000|Selection Phase (SP)|Adverse Event|8
4682828|NCT02474069|7588408|FG001|Selection Phase (SP)|Adverse Event|0
4682829|NCT02474069|7588409|FG002|Selection Phase (SP)|Adverse Event|0
4682830|NCT02474069|7588407|FG000|Selection Phase (SP)|Lack of Efficacy|1
4682831|NCT02474069|7588408|FG001|Selection Phase (SP)|Lack of Efficacy|0
4682832|NCT02474069|7588409|FG002|Selection Phase (SP)|Lack of Efficacy|0
4682833|NCT02474069|7588407|FG000|Selection Phase (SP)|Lost to Follow-up|4
4682834|NCT02474069|7588408|FG001|Selection Phase (SP)|Lost to Follow-up|0
4682835|NCT02474069|7588409|FG002|Selection Phase (SP)|Lost to Follow-up|0
4682836|NCT02474069|7588407|FG000|Selection Phase (SP)|Physician Decision|1
4682837|NCT02474069|7588408|FG001|Selection Phase (SP)|Physician Decision|0
4682838|NCT02474069|7588409|FG002|Selection Phase (SP)|Physician Decision|0
4682839|NCT02474069|7588407|FG000|Selection Phase (SP)|Protocol Violation|1
4682840|NCT02474069|7588408|FG001|Selection Phase (SP)|Protocol Violation|0
4682841|NCT02474069|7588409|FG002|Selection Phase (SP)|Protocol Violation|0
4759295|NCT02314923|7733048|FG009|Overall Study|Participant unavailable|0
4759296|NCT02314923|7733039|FG000|Overall Study|Screen failure|0
4759297|NCT02314923|7733040|FG001|Overall Study|Screen failure|0
4759298|NCT02314923|7733041|FG002|Overall Study|Screen failure|0
4759299|NCT02314923|7733042|FG003|Overall Study|Screen failure|0
4759300|NCT02314923|7733043|FG004|Overall Study|Screen failure|0
4759301|NCT02314923|7733044|FG005|Overall Study|Screen failure|0
4759302|NCT02314923|7733045|FG006|Overall Study|Screen failure|1
4759303|NCT02314923|7733046|FG007|Overall Study|Screen failure|0
4759304|NCT02314923|7733047|FG008|Overall Study|Screen failure|0
4759305|NCT02314923|7733048|FG009|Overall Study|Screen failure|0
4759306|NCT02314923|7733039|FG000|Overall Study|Participant relocation|1
4759307|NCT02314923|7733040|FG001|Overall Study|Participant relocation|0
4759308|NCT02314923|7733041|FG002|Overall Study|Participant relocation|0
4759309|NCT02314923|7733042|FG003|Overall Study|Participant relocation|0
4682842|NCT02474069|7588407|FG000|Selection Phase (SP)|No longer requires treatment|1
4759310|NCT02314923|7733043|FG004|Overall Study|Participant relocation|0
4759311|NCT02314923|7733044|FG005|Overall Study|Participant relocation|0
4682843|NCT02474069|7588408|FG001|Selection Phase (SP)|No longer requires treatment|0
4682844|NCT02474069|7588409|FG002|Selection Phase (SP)|No longer requires treatment|0
4682845|NCT02474069|7588407|FG000|Selection Phase (SP)|Technical Problem|1
4682846|NCT02474069|7588408|FG001|Selection Phase (SP)|Technical Problem|0
4682847|NCT02474069|7588409|FG002|Selection Phase (SP)|Technical Problem|0
4682848|NCT02474069|7588407|FG000|Selection Phase (SP)|Withdrawal by Subject|3
4682849|NCT02474069|7588408|FG001|Selection Phase (SP)|Withdrawal by Subject|0
4682850|NCT02474069|7588409|FG002|Selection Phase (SP)|Withdrawal by Subject|0
4682851|NCT02474069|7588407|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3
4682852|NCT02474069|7588408|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0
4682853|NCT02474069|7588409|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0
4682854|NCT02474069|7588407|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0
4682855|NCT02474069|7588408|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3
4682856|NCT02474069|7588409|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2
4682857|NCT02474069|7588407|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0
4682858|NCT02474069|7588408|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4
4682859|NCT02474069|7588409|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1
4682860|NCT02474069|7588407|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0
4682861|NCT02474069|7588408|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0
4682862|NCT02474069|7588409|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1
4682863|NCT02474069|7588407|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0
4682864|NCT02474069|7588408|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2
4682865|NCT02474069|7588409|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2
4682866|NCT02474082|7588421|FG000|Overall Study|Adverse Event|2
4759312|NCT02314923|7733045|FG006|Overall Study|Participant relocation|0
4759313|NCT02314923|7733046|FG007|Overall Study|Participant relocation|1
4759314|NCT02314923|7733047|FG008|Overall Study|Participant relocation|0
4759315|NCT02314923|7733048|FG009|Overall Study|Participant relocation|0
4682867|NCT02474082|7588422|FG001|Overall Study|Adverse Event|32
4682868|NCT02474082|7588421|FG000|Overall Study|Withdrawal of informed consent|1
4682869|NCT02474082|7588422|FG001|Overall Study|Withdrawal of informed consent|11
4682870|NCT02474082|7588421|FG000|Overall Study|Lost to Follow-up|2
4682871|NCT02474082|7588422|FG001|Overall Study|Lost to Follow-up|2
4682872|NCT02474082|7588421|FG000|Overall Study|Dose tapering not achieved|0
4682873|NCT02474082|7588422|FG001|Overall Study|Dose tapering not achieved|4
4682874|NCT02474082|7588421|FG000|Overall Study|Participant/guardian decision|1
4682875|NCT02474082|7588422|FG001|Overall Study|Participant/guardian decision|2
4682876|NCT02474082|7588421|FG000|Overall Study|Non-compliance with study treatment|0
4682877|NCT02474082|7588422|FG001|Overall Study|Non-compliance with study treatment|2
4682878|NCT02474082|7588421|FG000|Overall Study|Protocol deviation|0
4682879|NCT02474082|7588422|FG001|Overall Study|Protocol deviation|1
4682880|NCT02474199|7588430|FG000|Overall Study|Lost to Follow-up|1
4682881|NCT02474199|7588431|FG001|Overall Study|Lost to Follow-up|0
4682882|NCT02474199|7588432|FG002|Overall Study|Lost to Follow-up|0
4682883|NCT02474199|7588433|FG003|Overall Study|Lost to Follow-up|0
4682884|NCT02474199|7588430|FG000|Overall Study|Withdrawal by Subject|1
4682885|NCT02474199|7588431|FG001|Overall Study|Withdrawal by Subject|2
4682886|NCT02474199|7588432|FG002|Overall Study|Withdrawal by Subject|0
4682887|NCT02474199|7588433|FG003|Overall Study|Withdrawal by Subject|1
4682888|NCT02474199|7588430|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0
4682889|NCT02474199|7588431|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1
4682890|NCT02474199|7588432|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0
4682891|NCT02474199|7588433|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0
4682892|NCT02474199|7588430|FG000|Overall Study|Did not meet eligibility criteria|0
4682893|NCT02474199|7588431|FG001|Overall Study|Did not meet eligibility criteria|0
4682894|NCT02474199|7588432|FG002|Overall Study|Did not meet eligibility criteria|2
4682895|NCT02474199|7588433|FG003|Overall Study|Did not meet eligibility criteria|2
4682896|NCT02474355|7588440|FG000|Overall Study|Other|43
4682897|NCT02474355|7588440|FG000|Overall Study|Eligibility Criteria not Fulfilled|2
4682898|NCT02474355|7588440|FG000|Overall Study|Lost to Follow-up|98
4682899|NCT02474355|7588440|FG000|Overall Study|Withdrawal by Subject|124
4682900|NCT02474355|7588440|FG000|Overall Study|Death|1361
4682901|NCT02474589|7588490|FG000|Overall Study|Adverse Event|6
4682902|NCT02474589|7588491|FG001|Overall Study|Adverse Event|2
4682903|NCT02474589|7588490|FG000|Overall Study|Lost to Follow-up|6
4682904|NCT02474589|7588491|FG001|Overall Study|Lost to Follow-up|1
4682905|NCT02474589|7588490|FG000|Overall Study|Protocol Violation|4
4682906|NCT02474589|7588491|FG001|Overall Study|Protocol Violation|1
4682907|NCT02474589|7588490|FG000|Overall Study|Withdrawal by Subject|4
4682908|NCT02474589|7588491|FG001|Overall Study|Withdrawal by Subject|0
4682909|NCT02474589|7588490|FG000|Overall Study|Inability to complete study procedures|5
4682910|NCT02474589|7588491|FG001|Overall Study|Inability to complete study procedures|1
4682911|NCT02475265|7588527|FG000|Overall Study|Physician Decision|1
4682912|NCT02475265|7588527|FG000|Overall Study|Withdrawal by Subject|2
4682913|NCT02475278|7588531|FG000|Overall Study|Lost to Follow-up|1
4682914|NCT02475278|7588531|FG000|Overall Study|Reason Not Specified|1
4682915|NCT02475369|7588535|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7
4682916|NCT02475369|7588536|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2
4682917|NCT02475395|7588549|FG000|Overall Study|Protocol Violation|30
4682918|NCT02475395|7588550|FG001|Overall Study|Protocol Violation|3
4682919|NCT02475564|7588558|FG000|Overall Study|Withdrawal by Subject|1
4682920|NCT02475564|7588559|FG001|Overall Study|Withdrawal by Subject|0
4682921|NCT02475564|7588558|FG000|Overall Study|Lost to Follow-up|2
4682922|NCT02475564|7588559|FG001|Overall Study|Lost to Follow-up|1
4682923|NCT02475564|7588558|FG000|Overall Study|Intense Menstrual bleeding|1
4682924|NCT02475564|7588559|FG001|Overall Study|Intense Menstrual bleeding|0
4682925|NCT02475629|7588565|FG000|Overall Study|Adverse Event|1
4682926|NCT02475629|7588565|FG000|Overall Study|Death|4
4682927|NCT02475629|7588565|FG000|Overall Study|Physician Decision|1
4682928|NCT02475629|7588565|FG000|Overall Study|Withdrawal by Subject|1
4682929|NCT02475629|7588565|FG000|Overall Study|Lost to Follow-up|1
4682930|NCT02475629|7588565|FG000|Overall Study|Subject non-compliance|1
4682931|NCT02475655|7588571|FG000|Overall Study|Lost to Follow-up|0
4682932|NCT02475655|7588572|FG001|Overall Study|Lost to Follow-up|1
4682933|NCT02475733|7588580|FG000|Overall Study|Withdrawal by Subject|1
4682934|NCT02475733|7588581|FG001|Overall Study|Withdrawal by Subject|0
4682935|NCT02475733|7588580|FG000|Overall Study|Physician Decision|1
4682936|NCT02475733|7588581|FG001|Overall Study|Physician Decision|0
4682937|NCT02475850|7588598|FG000|Overall Study|Death|155
4682938|NCT02475850|7588599|FG001|Overall Study|Death|141
4682939|NCT02475850|7588598|FG000|Overall Study|Lost to Follow-up|217
4682940|NCT02475850|7588599|FG001|Overall Study|Lost to Follow-up|188
4682941|NCT02475850|7588598|FG000|Overall Study|Withdrawal by Subject|221
4682942|NCT02475850|7588599|FG001|Overall Study|Withdrawal by Subject|155
4682943|NCT02475954|7588608|FG000|Overall Study|Withdrawal by Subject|2
4682944|NCT02475954|7588609|FG001|Overall Study|Withdrawal by Subject|2
4682945|NCT02475954|7588608|FG000|Overall Study|Lost to Follow-up|11
4682946|NCT02475954|7588609|FG001|Overall Study|Lost to Follow-up|9
4759316|NCT04524507|7733089|FG000|Overall Study|Lost to Follow-up|2
4759317|NCT04524507|7733090|FG001|Overall Study|Lost to Follow-up|4
4759318|NCT04524507|7733089|FG000|Overall Study|Withdrawal by Subject|2
4759319|NCT04524507|7733090|FG001|Overall Study|Withdrawal by Subject|9
4759320|NCT04524507|7733089|FG000|Overall Study|Death|2
4682947|NCT02475954|7588608|FG000|Overall Study|Death|1
4682948|NCT02475954|7588609|FG001|Overall Study|Death|1
4759321|NCT04524507|7733090|FG001|Overall Study|Death|10
4759322|NCT04382924|7733099|FG000|Overall Study|Death|2
4759323|NCT04382924|7733100|FG001|Overall Study|Death|5
4759324|NCT04382924|7733101|FG002|Overall Study|Death|4
4759325|NCT04382924|7733099|FG000|Overall Study|Protocol Violation|0
4759326|NCT04382924|7733100|FG001|Overall Study|Protocol Violation|1
4759327|NCT04382924|7733101|FG002|Overall Study|Protocol Violation|1
4759328|NCT04382924|7733099|FG000|Overall Study|Transferred to other hospital/declined in person visits|0
4759329|NCT04382924|7733100|FG001|Overall Study|Transferred to other hospital/declined in person visits|1
4759330|NCT04382924|7733101|FG002|Overall Study|Transferred to other hospital/declined in person visits|1
4759331|NCT04382924|7733099|FG000|Overall Study|Withdrawal by Subject|6
4759332|NCT04382924|7733100|FG001|Overall Study|Withdrawal by Subject|3
4759333|NCT04382924|7733101|FG002|Overall Study|Withdrawal by Subject|6
4759334|NCT03842436|7733132|FG000|Overall Study|Lost to Follow-up|1
4682949|NCT02475980|7588616|FG000|Overall Study|Lost to Follow-up|4
4682950|NCT02475980|7588616|FG000|Overall Study|Withdrawal by Subject|1
4682951|NCT02476175|7588636|FG000|Overall Study|Adverse Event|2
4682952|NCT02476422|7588653|FG000|Overall Study|Subject/guardian decision|0
4682953|NCT02476422|7588654|FG001|Overall Study|Subject/guardian decision|1
4682954|NCT02476578|7588688|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35
4682955|NCT02476578|7588689|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43
4682956|NCT02476578|7588688|FG000|Overall Study|Lost to Follow-up|6
4682957|NCT02476578|7588689|FG001|Overall Study|Lost to Follow-up|13
4682958|NCT02476617|7588695|FG000|Overall Study|Adverse Event|1
4682959|NCT02476617|7588695|FG000|Overall Study|Lost to Follow-up|1
4682960|NCT02477020|7588720|FG000|Overall Study|Pretreatment Event/Adverse Event|6
4682961|NCT02477020|7588721|FG001|Overall Study|Pretreatment Event/Adverse Event|6
4682962|NCT02477020|7588720|FG000|Overall Study|Voluntary Withdrawal|7
4682963|NCT02477020|7588721|FG001|Overall Study|Voluntary Withdrawal|16
4682964|NCT02477020|7588720|FG000|Overall Study|Reason not Specified|3
4682965|NCT02477020|7588721|FG001|Overall Study|Reason not Specified|1
4682966|NCT02477020|7588720|FG000|Overall Study|Lack of Efficacy|14
4682967|NCT02477020|7588721|FG001|Overall Study|Lack of Efficacy|5
4682968|NCT02477111|7588727|FG000|Overall Study|Death|5
4682969|NCT02477111|7588727|FG000|Overall Study|Withdrawal by Subject|2
4682970|NCT02477111|7588727|FG000|Overall Study|missed visit|4
4682971|NCT02477215|7588737|FG000|Dose Escalation Phase|Physician Decision|1
4682972|NCT02477215|7588738|FG001|Dose Escalation Phase|Physician Decision|2
4682973|NCT02477215|7588739|FG002|Dose Escalation Phase|Physician Decision|0
4682974|NCT02477215|7588737|FG000|Fixed Dose Phase|Physician Decision|0
4682975|NCT02477215|7588738|FG001|Fixed Dose Phase|Physician Decision|7
4682976|NCT02477215|7588739|FG002|Fixed Dose Phase|Physician Decision|0
4682977|NCT02477332|7588770|FG000|Overall Study|Adverse Event|0
4682978|NCT02477332|7588771|FG001|Overall Study|Adverse Event|1
4682979|NCT02477332|7588772|FG002|Overall Study|Adverse Event|1
4682980|NCT02477332|7588773|FG003|Overall Study|Adverse Event|2
4682981|NCT02477332|7588774|FG004|Overall Study|Adverse Event|1
4682982|NCT02477332|7588775|FG005|Overall Study|Adverse Event|2
4682983|NCT02477332|7588770|FG000|Overall Study|Lack of Efficacy|1
4682984|NCT02477332|7588771|FG001|Overall Study|Lack of Efficacy|2
4682985|NCT02477332|7588772|FG002|Overall Study|Lack of Efficacy|1
4682986|NCT02477332|7588773|FG003|Overall Study|Lack of Efficacy|2
4682987|NCT02477332|7588774|FG004|Overall Study|Lack of Efficacy|1
4682988|NCT02477332|7588775|FG005|Overall Study|Lack of Efficacy|1
4682989|NCT02477332|7588770|FG000|Overall Study|Non-compliance with study treatment|0
4682990|NCT02477332|7588771|FG001|Overall Study|Non-compliance with study treatment|1
4682991|NCT02477332|7588772|FG002|Overall Study|Non-compliance with study treatment|2
4682992|NCT02477332|7588773|FG003|Overall Study|Non-compliance with study treatment|0
4682993|NCT02477332|7588774|FG004|Overall Study|Non-compliance with study treatment|0
4682994|NCT02477332|7588775|FG005|Overall Study|Non-compliance with study treatment|0
4682995|NCT02477332|7588770|FG000|Overall Study|Pregnancy|0
4682996|NCT02477332|7588771|FG001|Overall Study|Pregnancy|0
4682997|NCT02477332|7588772|FG002|Overall Study|Pregnancy|0
4682998|NCT02477332|7588773|FG003|Overall Study|Pregnancy|1
4682999|NCT02477332|7588774|FG004|Overall Study|Pregnancy|0
4683000|NCT02477332|7588775|FG005|Overall Study|Pregnancy|0
4683001|NCT02477332|7588770|FG000|Overall Study|Protocol Violation|2
4683002|NCT02477332|7588771|FG001|Overall Study|Protocol Violation|0
4683003|NCT02477332|7588772|FG002|Overall Study|Protocol Violation|3
4683004|NCT02477332|7588773|FG003|Overall Study|Protocol Violation|3
4683005|NCT02477332|7588774|FG004|Overall Study|Protocol Violation|1
4683006|NCT02477332|7588775|FG005|Overall Study|Protocol Violation|1
4683007|NCT02477332|7588770|FG000|Overall Study|Technical problems|0
4683008|NCT02477332|7588771|FG001|Overall Study|Technical problems|0
4683009|NCT02477332|7588772|FG002|Overall Study|Technical problems|1
4683010|NCT02477332|7588773|FG003|Overall Study|Technical problems|0
4683011|NCT02477332|7588774|FG004|Overall Study|Technical problems|0
4683012|NCT02477332|7588775|FG005|Overall Study|Technical problems|0
4683013|NCT02477332|7588770|FG000|Overall Study|Lost to Follow-up|0
4683014|NCT02477332|7588771|FG001|Overall Study|Lost to Follow-up|0
4683015|NCT02477332|7588772|FG002|Overall Study|Lost to Follow-up|2
4683016|NCT02477332|7588773|FG003|Overall Study|Lost to Follow-up|0
4683017|NCT02477332|7588774|FG004|Overall Study|Lost to Follow-up|0
4683018|NCT02477332|7588775|FG005|Overall Study|Lost to Follow-up|0
4683019|NCT02477332|7588770|FG000|Overall Study|Physician Decision|0
4683020|NCT02477332|7588771|FG001|Overall Study|Physician Decision|0
4683021|NCT02477332|7588772|FG002|Overall Study|Physician Decision|1
4683022|NCT02477332|7588773|FG003|Overall Study|Physician Decision|3
4683023|NCT02477332|7588774|FG004|Overall Study|Physician Decision|0
4683024|NCT02477332|7588775|FG005|Overall Study|Physician Decision|1
4683025|NCT02477332|7588770|FG000|Overall Study|Withdrawal by Subject|0
4683026|NCT02477332|7588771|FG001|Overall Study|Withdrawal by Subject|3
4683027|NCT02477332|7588772|FG002|Overall Study|Withdrawal by Subject|1
4683028|NCT02477332|7588773|FG003|Overall Study|Withdrawal by Subject|2
4683029|NCT02477332|7588774|FG004|Overall Study|Withdrawal by Subject|1
4683030|NCT02477332|7588775|FG005|Overall Study|Withdrawal by Subject|0
4683031|NCT02477527|7588800|FG000|Overall Study|Lost to Follow-up|2
4683032|NCT02477527|7588800|FG000|Overall Study|Withdrawal by Subject|1
4683033|NCT02477527|7588800|FG000|Overall Study|Screen Failure|3
4683034|NCT02477553|7588806|FG000|Overall Study|Screening up-to-date|12
4683035|NCT02477553|7588807|FG001|Overall Study|Screening up-to-date|13
4683036|NCT02477553|7588806|FG000|Overall Study|No MD visit|1
4759335|NCT03462030|7733153|FG000|Overall Study|Withdrawal by Subject|1
4759336|NCT03462030|7733154|FG001|Overall Study|Withdrawal by Subject|1
4759337|NCT03446768|7733162|FG000|Overall Study|Withdrawal by Subject|0
4759338|NCT03446768|7733163|FG001|Overall Study|Withdrawal by Subject|1
4759339|NCT03253393|7733231|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6
4759340|NCT03253393|7733232|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7
4759341|NCT03253393|7733233|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0
4759342|NCT03188822|7733247|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6
4759343|NCT03188822|7733247|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1
4759344|NCT03128671|7733253|FG000|Allocation|ICU discharge prior to intervention initiation|4
4759345|NCT03128671|7733254|FG001|Allocation|ICU discharge prior to intervention initiation|0
4759346|NCT03128671|7733253|FG000|Allocation|Death|1
4759347|NCT03128671|7733254|FG001|Allocation|Death|0
4759348|NCT03128671|7733253|FG000|Allocation|Withdrawal by Subject|4
4683037|NCT02477553|7588807|FG001|Overall Study|No MD visit|1
4683038|NCT02477553|7588806|FG000|Overall Study|Workup consistent w/CRC|1
4683039|NCT02477553|7588807|FG001|Overall Study|Workup consistent w/CRC|1
4683040|NCT02477553|7588806|FG000|Overall Study|Technical issues with intervention|2
4683041|NCT02477553|7588807|FG001|Overall Study|Technical issues with intervention|0
4683042|NCT02477553|7588806|FG000|Overall Study|Elevated risk for CRC|2
4683043|NCT02477553|7588807|FG001|Overall Study|Elevated risk for CRC|2
4683044|NCT02477553|7588806|FG000|Overall Study|MD advised against screening|1
4683045|NCT02477553|7588807|FG001|Overall Study|MD advised against screening|3
4683046|NCT02477553|7588806|FG000|Overall Study|patient deceased|1
4683047|NCT02477553|7588807|FG001|Overall Study|patient deceased|0
4683048|NCT02477605|7588815|FG000|Overall Study|Discontinued prior to treatment|1
4683049|NCT02477605|7588816|FG001|Overall Study|Discontinued prior to treatment|0
4683050|NCT02477605|7588815|FG000|Overall Study|Lost to Follow-up|0
4683051|NCT02477605|7588816|FG001|Overall Study|Lost to Follow-up|2
4683052|NCT02477605|7588815|FG000|Overall Study|Withdrawal by Subject|0
4683053|NCT02477605|7588816|FG001|Overall Study|Withdrawal by Subject|1
4683054|NCT02477605|7588815|FG000|Overall Study|Administered gas during surgery|0
4683055|NCT02477605|7588816|FG001|Overall Study|Administered gas during surgery|1
4683056|NCT02477670|7588828|FG000|Stage 1|Adverse Event|2
4683057|NCT02477670|7588829|FG001|Stage 1|Adverse Event|7
4683058|NCT02477670|7588830|FG002|Stage 1|Adverse Event|0
4683059|NCT02477670|7588831|FG003|Stage 1|Adverse Event|0
4683060|NCT02477670|7588832|FG004|Stage 1|Adverse Event|0
4683061|NCT02477670|7588833|FG005|Stage 1|Adverse Event|0
4683062|NCT02477670|7588834|FG006|Stage 1|Adverse Event|0
4683063|NCT02477670|7588828|FG000|Stage 1|Lost to Follow-up|0
4683064|NCT02477670|7588829|FG001|Stage 1|Lost to Follow-up|2
4683065|NCT02477670|7588830|FG002|Stage 1|Lost to Follow-up|0
4683066|NCT02477670|7588831|FG003|Stage 1|Lost to Follow-up|0
4683067|NCT02477670|7588832|FG004|Stage 1|Lost to Follow-up|0
4683068|NCT02477670|7588833|FG005|Stage 1|Lost to Follow-up|0
4683069|NCT02477670|7588834|FG006|Stage 1|Lost to Follow-up|0
4683070|NCT02477670|7588828|FG000|Stage 1|Withdrawal by Subject|1
4683071|NCT02477670|7588829|FG001|Stage 1|Withdrawal by Subject|2
4683072|NCT02477670|7588830|FG002|Stage 1|Withdrawal by Subject|0
4683073|NCT02477670|7588831|FG003|Stage 1|Withdrawal by Subject|0
4683074|NCT02477670|7588832|FG004|Stage 1|Withdrawal by Subject|0
4683075|NCT02477670|7588833|FG005|Stage 1|Withdrawal by Subject|0
4683076|NCT02477670|7588834|FG006|Stage 1|Withdrawal by Subject|0
4683077|NCT02477670|7588828|FG000|Stage 1|Non-compliance with Study Drug|1
4683078|NCT02477670|7588829|FG001|Stage 1|Non-compliance with Study Drug|2
4683079|NCT02477670|7588830|FG002|Stage 1|Non-compliance with Study Drug|0
4683080|NCT02477670|7588831|FG003|Stage 1|Non-compliance with Study Drug|0
4683081|NCT02477670|7588832|FG004|Stage 1|Non-compliance with Study Drug|0
4683082|NCT02477670|7588833|FG005|Stage 1|Non-compliance with Study Drug|0
4683083|NCT02477670|7588834|FG006|Stage 1|Non-compliance with Study Drug|0
4683084|NCT02477670|7588828|FG000|Stage 2|Adverse Event|0
4683085|NCT02477670|7588829|FG001|Stage 2|Adverse Event|0
4683086|NCT02477670|7588830|FG002|Stage 2|Adverse Event|1
4683087|NCT02477670|7588831|FG003|Stage 2|Adverse Event|0
4683088|NCT02477670|7588832|FG004|Stage 2|Adverse Event|0
4683089|NCT02477670|7588833|FG005|Stage 2|Adverse Event|0
4683090|NCT02477670|7588834|FG006|Stage 2|Adverse Event|0
4683091|NCT02477670|7588828|FG000|Stage 2|Antipsychotic Medication Changed|0
4683092|NCT02477670|7588829|FG001|Stage 2|Antipsychotic Medication Changed|0
4683093|NCT02477670|7588830|FG002|Stage 2|Antipsychotic Medication Changed|1
4683094|NCT02477670|7588831|FG003|Stage 2|Antipsychotic Medication Changed|0
4683095|NCT02477670|7588832|FG004|Stage 2|Antipsychotic Medication Changed|0
4683096|NCT02477670|7588833|FG005|Stage 2|Antipsychotic Medication Changed|0
4683097|NCT02477670|7588834|FG006|Stage 2|Antipsychotic Medication Changed|0
4683098|NCT02477670|7588828|FG000|Stage 2|Withdrawal by Subject|0
4683099|NCT02477670|7588829|FG001|Stage 2|Withdrawal by Subject|0
4683100|NCT02477670|7588830|FG002|Stage 2|Withdrawal by Subject|0
4683101|NCT02477670|7588831|FG003|Stage 2|Withdrawal by Subject|1
4683102|NCT02477670|7588832|FG004|Stage 2|Withdrawal by Subject|0
4683103|NCT02477670|7588833|FG005|Stage 2|Withdrawal by Subject|0
4683104|NCT02477670|7588834|FG006|Stage 2|Withdrawal by Subject|0
4683105|NCT02477800|7588852|FG000|Placebo-Controlled Period|Adverse Event|16
4683106|NCT02477800|7588853|FG001|Placebo-Controlled Period|Adverse Event|25
4683107|NCT02477800|7588854|FG002|Placebo-Controlled Period|Adverse Event|28
4683108|NCT02477800|7588855|FG003|Placebo-Controlled Period|Adverse Event|0
4683109|NCT02477800|7588856|FG004|Placebo-Controlled Period|Adverse Event|0
4683110|NCT02477800|7588857|FG005|Placebo-Controlled Period|Adverse Event|0
4683111|NCT02477800|7588858|FG006|Placebo-Controlled Period|Adverse Event|0
4683112|NCT02477800|7588852|FG000|Placebo-Controlled Period|Change of Treatment|1
4683113|NCT02477800|7588853|FG001|Placebo-Controlled Period|Change of Treatment|2
4683114|NCT02477800|7588854|FG002|Placebo-Controlled Period|Change of Treatment|1
4683115|NCT02477800|7588855|FG003|Placebo-Controlled Period|Change of Treatment|0
4683116|NCT02477800|7588856|FG004|Placebo-Controlled Period|Change of Treatment|0
4683117|NCT02477800|7588857|FG005|Placebo-Controlled Period|Change of Treatment|0
4683118|NCT02477800|7588858|FG006|Placebo-Controlled Period|Change of Treatment|0
4683119|NCT02477800|7588852|FG000|Placebo-Controlled Period|Consent Withdrawn|26
4683120|NCT02477800|7588853|FG001|Placebo-Controlled Period|Consent Withdrawn|16
4683121|NCT02477800|7588854|FG002|Placebo-Controlled Period|Consent Withdrawn|27
4683122|NCT02477800|7588855|FG003|Placebo-Controlled Period|Consent Withdrawn|0
4683123|NCT02477800|7588856|FG004|Placebo-Controlled Period|Consent Withdrawn|0
4683124|NCT02477800|7588857|FG005|Placebo-Controlled Period|Consent Withdrawn|0
4683125|NCT02477800|7588858|FG006|Placebo-Controlled Period|Consent Withdrawn|0
4683126|NCT02477800|7588852|FG000|Placebo-Controlled Period|Death|0
4683127|NCT02477800|7588853|FG001|Placebo-Controlled Period|Death|3
4683128|NCT02477800|7588854|FG002|Placebo-Controlled Period|Death|2
4759349|NCT03128671|7733254|FG001|Allocation|Withdrawal by Subject|0
4759350|NCT03128671|7733253|FG000|Intervention|Withdrawal by Subject|11
4759351|NCT03128671|7733254|FG001|Intervention|Withdrawal by Subject|10
4759352|NCT03128671|7733253|FG000|Intervention|Palliative/hospice care initiated|9
4759353|NCT03128671|7733254|FG001|Intervention|Palliative/hospice care initiated|10
4759354|NCT03128671|7733253|FG000|Intervention|Death|13
4759355|NCT03128671|7733254|FG001|Intervention|Death|11
4759356|NCT03128671|7733253|FG000|Intervention|Interrupted by hurricane|1
4759357|NCT03128671|7733254|FG001|Intervention|Interrupted by hurricane|0
4759358|NCT03128671|7733253|FG000|Intervention|Physician Decision|2
4759359|NCT03128671|7733254|FG001|Intervention|Physician Decision|3
4759360|NCT03111732|7733260|FG000|Overall Study|Enrolled in different study|1
4759361|NCT03111732|7733260|FG000|Overall Study|Progressive disease|3
4759362|NCT03111732|7733260|FG000|Overall Study|Withdrawal by Subject|1
4759363|NCT03065244|7733271|FG000|Overall Study|Lost to Follow-up|1
4759364|NCT03065244|7733272|FG001|Overall Study|Lost to Follow-up|1
4759365|NCT03065244|7733271|FG000|Overall Study|Diagnosed with a different disease|1
4683129|NCT02477800|7588855|FG003|Placebo-Controlled Period|Death|0
4683130|NCT02477800|7588856|FG004|Placebo-Controlled Period|Death|0
4683131|NCT02477800|7588857|FG005|Placebo-Controlled Period|Death|0
4683132|NCT02477800|7588858|FG006|Placebo-Controlled Period|Death|0
4683133|NCT02477800|7588852|FG000|Placebo-Controlled Period|Disease Progression|1
4683134|NCT02477800|7588853|FG001|Placebo-Controlled Period|Disease Progression|0
4683135|NCT02477800|7588854|FG002|Placebo-Controlled Period|Disease Progression|1
4759366|NCT03065244|7733272|FG001|Overall Study|Diagnosed with a different disease|1
4759367|NCT03065244|7733271|FG000|Overall Study|Protocol Violation|0
4683136|NCT02477800|7588855|FG003|Placebo-Controlled Period|Disease Progression|0
4683137|NCT02477800|7588856|FG004|Placebo-Controlled Period|Disease Progression|0
4683138|NCT02477800|7588857|FG005|Placebo-Controlled Period|Disease Progression|0
4683139|NCT02477800|7588858|FG006|Placebo-Controlled Period|Disease Progression|0
4683140|NCT02477800|7588852|FG000|Placebo-Controlled Period|Investigator Decision|3
4683141|NCT02477800|7588853|FG001|Placebo-Controlled Period|Investigator Decision|2
4683142|NCT02477800|7588854|FG002|Placebo-Controlled Period|Investigator Decision|1
4683143|NCT02477800|7588855|FG003|Placebo-Controlled Period|Investigator Decision|0
4683144|NCT02477800|7588856|FG004|Placebo-Controlled Period|Investigator Decision|0
4683145|NCT02477800|7588857|FG005|Placebo-Controlled Period|Investigator Decision|0
4683146|NCT02477800|7588858|FG006|Placebo-Controlled Period|Investigator Decision|0
4683147|NCT02477800|7588852|FG000|Placebo-Controlled Period|Lost to Follow-up|1
4683148|NCT02477800|7588853|FG001|Placebo-Controlled Period|Lost to Follow-up|3
4683149|NCT02477800|7588854|FG002|Placebo-Controlled Period|Lost to Follow-up|3
4683150|NCT02477800|7588855|FG003|Placebo-Controlled Period|Lost to Follow-up|0
4683151|NCT02477800|7588856|FG004|Placebo-Controlled Period|Lost to Follow-up|0
4683152|NCT02477800|7588857|FG005|Placebo-Controlled Period|Lost to Follow-up|0
4683153|NCT02477800|7588858|FG006|Placebo-Controlled Period|Lost to Follow-up|0
4683154|NCT02477800|7588852|FG000|Placebo-Controlled Period|Relocation|2
4683155|NCT02477800|7588853|FG001|Placebo-Controlled Period|Relocation|0
4683156|NCT02477800|7588854|FG002|Placebo-Controlled Period|Relocation|0
4683157|NCT02477800|7588855|FG003|Placebo-Controlled Period|Relocation|0
4683158|NCT02477800|7588856|FG004|Placebo-Controlled Period|Relocation|0
4683159|NCT02477800|7588857|FG005|Placebo-Controlled Period|Relocation|0
4683160|NCT02477800|7588858|FG006|Placebo-Controlled Period|Relocation|0
4683161|NCT02477800|7588852|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1
4683162|NCT02477800|7588853|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1
4683163|NCT02477800|7588854|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1
4683164|NCT02477800|7588855|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0
4683165|NCT02477800|7588856|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0
4683166|NCT02477800|7588857|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0
4683167|NCT02477800|7588858|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0
4683168|NCT02477800|7588852|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2
4683169|NCT02477800|7588853|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1
4683170|NCT02477800|7588854|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0
4683171|NCT02477800|7588855|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0
4683172|NCT02477800|7588856|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0
4683173|NCT02477800|7588857|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0
4683174|NCT02477800|7588858|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0
4683175|NCT02477800|7588852|FG000|Placebo-Controlled Period|Study Visit Burden|5
4683176|NCT02477800|7588853|FG001|Placebo-Controlled Period|Study Visit Burden|3
4683177|NCT02477800|7588854|FG002|Placebo-Controlled Period|Study Visit Burden|11
4683178|NCT02477800|7588855|FG003|Placebo-Controlled Period|Study Visit Burden|0
4683179|NCT02477800|7588856|FG004|Placebo-Controlled Period|Study Visit Burden|0
4683180|NCT02477800|7588857|FG005|Placebo-Controlled Period|Study Visit Burden|0
4683181|NCT02477800|7588858|FG006|Placebo-Controlled Period|Study Visit Burden|0
4683182|NCT02477800|7588852|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1
4683183|NCT02477800|7588853|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5
4683184|NCT02477800|7588854|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3
4683185|NCT02477800|7588855|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
4683186|NCT02477800|7588856|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
4683187|NCT02477800|7588857|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
4683188|NCT02477800|7588858|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
4683189|NCT02477800|7588852|FG000|Placebo-Controlled Period|Reason not Specified|161
4683190|NCT02477800|7588853|FG001|Placebo-Controlled Period|Reason not Specified|161
4683191|NCT02477800|7588854|FG002|Placebo-Controlled Period|Reason not Specified|189
4683192|NCT02477800|7588855|FG003|Placebo-Controlled Period|Reason not Specified|0
4683193|NCT02477800|7588856|FG004|Placebo-Controlled Period|Reason not Specified|0
4683194|NCT02477800|7588857|FG005|Placebo-Controlled Period|Reason not Specified|0
4683195|NCT02477800|7588858|FG006|Placebo-Controlled Period|Reason not Specified|0
4683196|NCT02477800|7588852|FG000|Long Term Extension Period|Adverse Event|0
4683197|NCT02477800|7588853|FG001|Long Term Extension Period|Adverse Event|0
4683198|NCT02477800|7588854|FG002|Long Term Extension Period|Adverse Event|0
4683199|NCT02477800|7588855|FG003|Long Term Extension Period|Adverse Event|6
4683200|NCT02477800|7588856|FG004|Long Term Extension Period|Adverse Event|2
4683201|NCT02477800|7588857|FG005|Long Term Extension Period|Adverse Event|4
4683202|NCT02477800|7588858|FG006|Long Term Extension Period|Adverse Event|3
4683203|NCT02477800|7588852|FG000|Long Term Extension Period|Death|0
4683204|NCT02477800|7588853|FG001|Long Term Extension Period|Death|0
4683205|NCT02477800|7588854|FG002|Long Term Extension Period|Death|0
4683206|NCT02477800|7588855|FG003|Long Term Extension Period|Death|1
4683207|NCT02477800|7588856|FG004|Long Term Extension Period|Death|1
4683208|NCT02477800|7588857|FG005|Long Term Extension Period|Death|1
4683209|NCT02477800|7588858|FG006|Long Term Extension Period|Death|2
4683210|NCT02477800|7588852|FG000|Long Term Extension Period|Consent Withdrawn|0
4759368|NCT03065244|7733272|FG001|Overall Study|Protocol Violation|1
4759369|NCT03065244|7733271|FG000|Overall Study|Withdrawal by Subject|1
4759370|NCT03065244|7733272|FG001|Overall Study|Withdrawal by Subject|1
4759371|NCT02879305|7733280|FG000|Overall Study|Investigator Site Closed|55
4759372|NCT02879305|7733281|FG001|Overall Study|Investigator Site Closed|57
4759373|NCT02879305|7733280|FG000|Overall Study|Withdrawal by Subject|44
4759374|NCT02879305|7733281|FG001|Overall Study|Withdrawal by Subject|42
4759375|NCT02879305|7733280|FG000|Overall Study|Lost to Follow-up|17
4759376|NCT02879305|7733281|FG001|Overall Study|Lost to Follow-up|12
4759377|NCT02879305|7733280|FG000|Overall Study|Other|1
4759378|NCT02879305|7733281|FG001|Overall Study|Other|0
4759379|NCT02787850|7733298|FG000|Overall Study|Withdrawal by Subject|0
4759380|NCT02787850|7733299|FG001|Overall Study|Withdrawal by Subject|1
4759381|NCT02676284|7733318|FG000|Overall Study|Withdrawal by Subject|1
4759382|NCT02431702|7733322|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7
4759383|NCT02431702|7733323|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0
4759384|NCT02431702|7733324|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0
4759385|NCT02431702|7733325|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0
4759386|NCT02431702|7733326|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0
4759387|NCT02431702|7733327|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0
4759388|NCT02431702|7733328|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0
4759389|NCT02431702|7733322|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11
4759390|NCT02431702|7733323|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0
4759391|NCT02431702|7733324|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0
4759392|NCT02431702|7733325|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0
4759393|NCT02431702|7733326|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0
4759394|NCT02431702|7733327|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0
4759395|NCT02431702|7733328|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23
4759396|NCT02431702|7733322|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9
4759397|NCT02431702|7733323|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0
4759398|NCT02431702|7733324|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0
4759399|NCT02431702|7733325|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0
4759400|NCT02431702|7733326|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0
4759401|NCT02431702|7733327|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0
4759402|NCT02431702|7733328|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6
4759403|NCT02431702|7733322|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5
4759404|NCT02431702|7733323|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0
4759405|NCT02431702|7733324|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0
4759406|NCT02431702|7733325|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0
4759407|NCT02431702|7733326|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0
4759408|NCT02431702|7733327|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0
4759409|NCT02431702|7733328|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3
4759410|NCT02431702|7733322|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2
4759411|NCT02431702|7733323|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0
4759412|NCT02431702|7733324|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0
4759413|NCT02431702|7733325|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0
4759414|NCT02431702|7733326|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0
4759415|NCT02431702|7733327|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0
4759416|NCT02431702|7733328|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0
4759417|NCT02431702|7733322|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0
4759418|NCT02431702|7733323|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5
4759419|NCT02431702|7733324|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1
4759420|NCT02431702|7733325|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0
4759421|NCT02431702|7733326|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0
4759422|NCT02431702|7733327|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0
4759423|NCT02431702|7733328|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0
4759424|NCT02431702|7733322|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0
4759425|NCT02431702|7733323|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6
4759426|NCT02431702|7733324|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13
4759427|NCT02431702|7733325|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0
4759428|NCT02431702|7733326|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0
4759429|NCT02431702|7733327|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0
4759430|NCT02431702|7733328|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0
4759431|NCT02431702|7733322|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0
4759432|NCT02431702|7733323|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11
4759433|NCT02431702|7733324|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8
4759434|NCT02431702|7733325|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0
4759435|NCT02431702|7733326|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0
4759436|NCT02431702|7733327|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0
4759437|NCT02431702|7733328|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0
4683211|NCT02477800|7588853|FG001|Long Term Extension Period|Consent Withdrawn|0
4683212|NCT02477800|7588854|FG002|Long Term Extension Period|Consent Withdrawn|0
4683213|NCT02477800|7588855|FG003|Long Term Extension Period|Consent Withdrawn|10
4683214|NCT02477800|7588856|FG004|Long Term Extension Period|Consent Withdrawn|4
4683215|NCT02477800|7588857|FG005|Long Term Extension Period|Consent Withdrawn|13
4683216|NCT02477800|7588858|FG006|Long Term Extension Period|Consent Withdrawn|16
4683217|NCT02477800|7588852|FG000|Long Term Extension Period|Disease Progression|0
4683218|NCT02477800|7588853|FG001|Long Term Extension Period|Disease Progression|0
4683219|NCT02477800|7588854|FG002|Long Term Extension Period|Disease Progression|0
4683220|NCT02477800|7588855|FG003|Long Term Extension Period|Disease Progression|3
4683221|NCT02477800|7588856|FG004|Long Term Extension Period|Disease Progression|1
4683222|NCT02477800|7588857|FG005|Long Term Extension Period|Disease Progression|1
4683223|NCT02477800|7588858|FG006|Long Term Extension Period|Disease Progression|0
4683224|NCT02477800|7588852|FG000|Long Term Extension Period|Investigator Decision|0
4683225|NCT02477800|7588853|FG001|Long Term Extension Period|Investigator Decision|0
4683226|NCT02477800|7588854|FG002|Long Term Extension Period|Investigator Decision|0
4683227|NCT02477800|7588855|FG003|Long Term Extension Period|Investigator Decision|0
4683228|NCT02477800|7588856|FG004|Long Term Extension Period|Investigator Decision|0
4683229|NCT02477800|7588857|FG005|Long Term Extension Period|Investigator Decision|0
4683230|NCT02477800|7588858|FG006|Long Term Extension Period|Investigator Decision|2
4683231|NCT02477800|7588852|FG000|Long Term Extension Period|Lost to Follow-up|0
4683232|NCT02477800|7588853|FG001|Long Term Extension Period|Lost to Follow-up|0
4683233|NCT02477800|7588854|FG002|Long Term Extension Period|Lost to Follow-up|0
4683234|NCT02477800|7588855|FG003|Long Term Extension Period|Lost to Follow-up|0
4683235|NCT02477800|7588856|FG004|Long Term Extension Period|Lost to Follow-up|1
4683236|NCT02477800|7588857|FG005|Long Term Extension Period|Lost to Follow-up|3
4683237|NCT02477800|7588858|FG006|Long Term Extension Period|Lost to Follow-up|0
4683238|NCT02477800|7588852|FG000|Long Term Extension Period|Site Terminated By Sponsor|0
4683239|NCT02477800|7588853|FG001|Long Term Extension Period|Site Terminated By Sponsor|0
4683240|NCT02477800|7588854|FG002|Long Term Extension Period|Site Terminated By Sponsor|0
4683241|NCT02477800|7588855|FG003|Long Term Extension Period|Site Terminated By Sponsor|0
4683242|NCT02477800|7588856|FG004|Long Term Extension Period|Site Terminated By Sponsor|0
4683243|NCT02477800|7588857|FG005|Long Term Extension Period|Site Terminated By Sponsor|2
4683244|NCT02477800|7588858|FG006|Long Term Extension Period|Site Terminated By Sponsor|1
4683245|NCT02477800|7588852|FG000|Long Term Extension Period|Study Visit Burden|0
4683246|NCT02477800|7588853|FG001|Long Term Extension Period|Study Visit Burden|0
4683247|NCT02477800|7588854|FG002|Long Term Extension Period|Study Visit Burden|0
4683248|NCT02477800|7588855|FG003|Long Term Extension Period|Study Visit Burden|3
4683249|NCT02477800|7588856|FG004|Long Term Extension Period|Study Visit Burden|0
4683250|NCT02477800|7588857|FG005|Long Term Extension Period|Study Visit Burden|2
4683251|NCT02477800|7588858|FG006|Long Term Extension Period|Study Visit Burden|2
4683252|NCT02477800|7588852|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0
4683253|NCT02477800|7588853|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0
4683254|NCT02477800|7588854|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0
4759438|NCT02431702|7733322|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0
4759439|NCT02431702|7733323|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2
4759440|NCT02431702|7733324|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0
4759441|NCT02431702|7733325|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0
4759442|NCT02431702|7733326|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0
4759443|NCT02431702|7733327|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0
4759444|NCT02431702|7733328|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0
4759445|NCT02431702|7733322|FG000|Part 2: 9Month Disease Progression Phase|Other|0
4759446|NCT02431702|7733323|FG001|Part 2: 9Month Disease Progression Phase|Other|2
4759447|NCT02431702|7733324|FG002|Part 2: 9Month Disease Progression Phase|Other|2
4759448|NCT02431702|7733325|FG003|Part 2: 9Month Disease Progression Phase|Other|0
4759449|NCT02431702|7733326|FG004|Part 2: 9Month Disease Progression Phase|Other|0
4759450|NCT02431702|7733327|FG005|Part 2: 9Month Disease Progression Phase|Other|0
4759451|NCT02431702|7733328|FG006|Part 2: 9Month Disease Progression Phase|Other|0
4759452|NCT02431702|7733322|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0
4759453|NCT02431702|7733323|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0
4759454|NCT02431702|7733324|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5
4759455|NCT02431702|7733325|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0
4759456|NCT02431702|7733326|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0
4759457|NCT02431702|7733327|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0
4759458|NCT02431702|7733328|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0
4759459|NCT02431702|7733322|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0
4759460|NCT02431702|7733323|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0
4759461|NCT02431702|7733324|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0
4759462|NCT02431702|7733325|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2
4759463|NCT02431702|7733326|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3
4683255|NCT02477800|7588855|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1
4683256|NCT02477800|7588856|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3
4683257|NCT02477800|7588857|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3
4683258|NCT02477800|7588858|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1
4683259|NCT02477800|7588852|FG000|Long Term Extension Period|Reason not Specified|0
4683260|NCT02477800|7588853|FG001|Long Term Extension Period|Reason not Specified|0
4683261|NCT02477800|7588854|FG002|Long Term Extension Period|Reason not Specified|0
4683262|NCT02477800|7588855|FG003|Long Term Extension Period|Reason not Specified|126
4683263|NCT02477800|7588856|FG004|Long Term Extension Period|Reason not Specified|140
4683264|NCT02477800|7588857|FG005|Long Term Extension Period|Reason not Specified|270
4683265|NCT02477800|7588858|FG006|Long Term Extension Period|Reason not Specified|224
4683266|NCT02477839|7588872|FG000|Overall Study|Adverse Event|0
4683267|NCT02477839|7588873|FG001|Overall Study|Adverse Event|1
4683268|NCT02477839|7588872|FG000|Overall Study|Protocol Violation|0
4683269|NCT02477839|7588873|FG001|Overall Study|Protocol Violation|2
4683270|NCT02477839|7588872|FG000|Overall Study|Withdrawal by Subject|3
4683271|NCT02477839|7588873|FG001|Overall Study|Withdrawal by Subject|3
4683272|NCT02477839|7588872|FG000|Overall Study|Participant had PGS during V6|0
4683273|NCT02477839|7588873|FG001|Overall Study|Participant had PGS during V6|1
4683274|NCT02477839|7588872|FG000|Overall Study|Parents decided to stop medication|0
4683275|NCT02477839|7588873|FG001|Overall Study|Parents decided to stop medication|1
4683276|NCT02477839|7588872|FG000|Overall Study|Lack of tolerability|0
4683277|NCT02477839|7588873|FG001|Overall Study|Lack of tolerability|1
4683278|NCT02477839|7588872|FG000|Overall Study|Exclusion criterion|0
4683279|NCT02477839|7588873|FG001|Overall Study|Exclusion criterion|1
4683280|NCT02478164|7588881|FG000|Overall Study|Lack of Efficacy|13
4683281|NCT02478164|7588881|FG000|Overall Study|Adverse Event|1
4683282|NCT02478164|7588881|FG000|Overall Study|Withdrawal by Subject|1
4683283|NCT02478359|7588887|FG000|Overall Study|Disenrolled from health plan|106
4683284|NCT02478359|7588888|FG001|Overall Study|Disenrolled from health plan|65
4683285|NCT02478372|7588898|FG000|Overall Study|Protocol Violation|12
4683286|NCT02478372|7588899|FG001|Overall Study|Protocol Violation|8
4683287|NCT02478372|7588898|FG000|Overall Study|Lost to Follow-up|1
4683288|NCT02478372|7588899|FG001|Overall Study|Lost to Follow-up|4
4683289|NCT02478372|7588898|FG000|Overall Study|Death|0
4683290|NCT02478372|7588899|FG001|Overall Study|Death|2
4683291|NCT02478398|7588907|FG000|Overall Study|Adverse Event|20
4683292|NCT02478398|7588908|FG001|Overall Study|Adverse Event|5
4683293|NCT02478398|7588907|FG000|Overall Study|Lost to Follow-up|5
4683294|NCT02478398|7588908|FG001|Overall Study|Lost to Follow-up|4
4683295|NCT02478398|7588907|FG000|Overall Study|Non-Compliance With Study Drug|5
4683296|NCT02478398|7588908|FG001|Overall Study|Non-Compliance With Study Drug|1
4683297|NCT02478398|7588907|FG000|Overall Study|Protocol Violation|3
4683298|NCT02478398|7588908|FG001|Overall Study|Protocol Violation|1
4683299|NCT02478398|7588907|FG000|Overall Study|Withdrawal By Parent/Guardian|9
4683300|NCT02478398|7588908|FG001|Overall Study|Withdrawal By Parent/Guardian|6
4683301|NCT02478398|7588907|FG000|Overall Study|Withdrawal By Participant|10
4683302|NCT02478398|7588908|FG001|Overall Study|Withdrawal By Participant|4
4683303|NCT02478463|7588915|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1
4683304|NCT02478463|7588915|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1
4683305|NCT02478463|7588915|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1
4683306|NCT02478632|7588943|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4
4683307|NCT02478632|7588944|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5
4683308|NCT02478632|7588943|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2
4683309|NCT02478632|7588944|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3
4683310|NCT02478632|7588943|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5
4683311|NCT02478632|7588944|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1
4683312|NCT02479139|7588964|FG000|Overall Study|Lost to Follow-up|2
4683313|NCT02479139|7588965|FG001|Overall Study|Lost to Follow-up|4
4683314|NCT02479139|7588966|FG002|Overall Study|Lost to Follow-up|4
4683315|NCT02479139|7588967|FG003|Overall Study|Lost to Follow-up|2
4683316|NCT02479139|7588968|FG004|Overall Study|Lost to Follow-up|3
4683317|NCT02479139|7588969|FG005|Overall Study|Lost to Follow-up|5
4683318|NCT02479139|7588964|FG000|Overall Study|Withdrew Consent|5
4683319|NCT02479139|7588965|FG001|Overall Study|Withdrew Consent|6
4683320|NCT02479139|7588966|FG002|Overall Study|Withdrew Consent|1
4683321|NCT02479139|7588967|FG003|Overall Study|Withdrew Consent|4
4683322|NCT02479139|7588968|FG004|Overall Study|Withdrew Consent|1
4683323|NCT02479139|7588969|FG005|Overall Study|Withdrew Consent|1
4683324|NCT02479139|7588964|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0
4683325|NCT02479139|7588965|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0
4683326|NCT02479139|7588966|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1
4683327|NCT02479139|7588967|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0
4683328|NCT02479139|7588968|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0
4683329|NCT02479139|7588969|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0
4683330|NCT02479139|7588964|FG000|Overall Study|Other Miscellaneous Reasons|1
4683331|NCT02479139|7588965|FG001|Overall Study|Other Miscellaneous Reasons|0
4683332|NCT02479139|7588966|FG002|Overall Study|Other Miscellaneous Reasons|1
4683333|NCT02479139|7588967|FG003|Overall Study|Other Miscellaneous Reasons|1
4683334|NCT02479139|7588968|FG004|Overall Study|Other Miscellaneous Reasons|1
4683335|NCT02479139|7588969|FG005|Overall Study|Other Miscellaneous Reasons|0
4683336|NCT02479412|7588992|FG000|Overall Study|Adverse Event|0
4683337|NCT02479412|7588993|FG001|Overall Study|Adverse Event|0
4683338|NCT02479412|7588994|FG002|Overall Study|Adverse Event|1
4683339|NCT02479412|7588995|FG003|Overall Study|Adverse Event|0
4683340|NCT02479412|7588996|FG004|Overall Study|Adverse Event|0
4683341|NCT02479412|7588997|FG005|Overall Study|Adverse Event|0
4683342|NCT02479412|7588998|FG006|Overall Study|Adverse Event|0
4683343|NCT02479412|7588999|FG007|Overall Study|Adverse Event|0
4683344|NCT02479412|7589000|FG008|Overall Study|Adverse Event|0
4683345|NCT02479412|7588992|FG000|Overall Study|Study-specific withdrawal criteria|0
4683346|NCT02479412|7588993|FG001|Overall Study|Study-specific withdrawal criteria|0
4683347|NCT02479412|7588994|FG002|Overall Study|Study-specific withdrawal criteria|1
4683348|NCT02479412|7588995|FG003|Overall Study|Study-specific withdrawal criteria|1
4683349|NCT02479412|7588996|FG004|Overall Study|Study-specific withdrawal criteria|0
4683350|NCT02479412|7588997|FG005|Overall Study|Study-specific withdrawal criteria|0
4683351|NCT02479412|7588998|FG006|Overall Study|Study-specific withdrawal criteria|0
4683352|NCT02479412|7588999|FG007|Overall Study|Study-specific withdrawal criteria|1
4683353|NCT02479412|7589000|FG008|Overall Study|Study-specific withdrawal criteria|1
4683354|NCT02479412|7588992|FG000|Overall Study|Randomization to wrong PK sampling group|0
4683355|NCT02479412|7588993|FG001|Overall Study|Randomization to wrong PK sampling group|0
4683356|NCT02479412|7588994|FG002|Overall Study|Randomization to wrong PK sampling group|0
4683357|NCT02479412|7588995|FG003|Overall Study|Randomization to wrong PK sampling group|0
4683358|NCT02479412|7588996|FG004|Overall Study|Randomization to wrong PK sampling group|1
4683359|NCT02479412|7588997|FG005|Overall Study|Randomization to wrong PK sampling group|0
4683360|NCT02479412|7588998|FG006|Overall Study|Randomization to wrong PK sampling group|0
4683361|NCT02479412|7588999|FG007|Overall Study|Randomization to wrong PK sampling group|0
4683362|NCT02479412|7589000|FG008|Overall Study|Randomization to wrong PK sampling group|0
4759464|NCT02431702|7733327|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0
4759465|NCT02431702|7733328|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0
4759466|NCT02431702|7733322|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0
4759467|NCT02431702|7733323|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0
4759468|NCT02431702|7733324|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0
4759469|NCT02431702|7733325|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1
4759470|NCT02431702|7733326|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0
4759471|NCT02431702|7733327|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5
4759472|NCT02431702|7733328|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0
4759473|NCT02431702|7733322|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0
4759474|NCT02431702|7733323|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0
4759475|NCT02431702|7733324|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0
4759476|NCT02431702|7733325|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5
4759477|NCT02431702|7733326|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6
4759478|NCT02431702|7733327|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6
4759479|NCT02431702|7733328|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0
4759480|NCT02431702|7733322|FG000|Part 3: 9 Month of Additional Treatment|Other|0
4759481|NCT02431702|7733323|FG001|Part 3: 9 Month of Additional Treatment|Other|0
4759482|NCT02431702|7733324|FG002|Part 3: 9 Month of Additional Treatment|Other|0
4759483|NCT02431702|7733325|FG003|Part 3: 9 Month of Additional Treatment|Other|1
4759484|NCT02431702|7733326|FG004|Part 3: 9 Month of Additional Treatment|Other|1
4759485|NCT02431702|7733327|FG005|Part 3: 9 Month of Additional Treatment|Other|6
4759486|NCT02431702|7733328|FG006|Part 3: 9 Month of Additional Treatment|Other|0
4759487|NCT02200770|7733365|FG000|Randomized-controlled Period (RCP)|Adverse Event|0
4759488|NCT02200770|7733366|FG001|Randomized-controlled Period (RCP)|Adverse Event|2
4759489|NCT02200770|7733365|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1
4759490|NCT02200770|7733366|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1
4759491|NCT02200770|7733365|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0
4759492|NCT02200770|7733366|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1
4759493|NCT02200770|7733365|FG000|Randomized-controlled Period (RCP)|Other|1
4759494|NCT02200770|7733366|FG001|Randomized-controlled Period (RCP)|Other|2
4759495|NCT02200770|7733365|FG000|Open-label Period (OLP)|Adverse Event|1
4759496|NCT02200770|7733366|FG001|Open-label Period (OLP)|Adverse Event|2
4759497|NCT02200770|7733365|FG000|Open-label Period (OLP)|Death|1
4759498|NCT02200770|7733366|FG001|Open-label Period (OLP)|Death|2
4759499|NCT02200770|7733365|FG000|Open-label Period (OLP)|Lost to Follow-up|0
4759500|NCT02200770|7733366|FG001|Open-label Period (OLP)|Lost to Follow-up|1
4759501|NCT02200770|7733365|FG000|Open-label Period (OLP)|Withdrawal by Subject|0
4759502|NCT02200770|7733366|FG001|Open-label Period (OLP)|Withdrawal by Subject|14
4759503|NCT02200770|7733365|FG000|Open-label Period (OLP)|Other|6
4683363|NCT02479802|7589025|FG000|Overall Study|Lost to Follow-up|1
4683364|NCT02479802|7589025|FG000|Overall Study|Adverse Event|1
4683365|NCT02479880|7589031|FG000|Overall Study|Study Terminated by Sponsor|13
4683366|NCT02479880|7589032|FG001|Overall Study|Study Terminated by Sponsor|12
4683367|NCT02479880|7589031|FG000|Overall Study|Pregnancy|0
4683368|NCT02479880|7589032|FG001|Overall Study|Pregnancy|1
4683369|NCT02480010|7589040|FG000|Overall Study|Adverse Event|3
4683370|NCT02480010|7589041|FG001|Overall Study|Adverse Event|1
4683371|NCT02480010|7589040|FG000|Overall Study|Death|1
4683372|NCT02480010|7589041|FG001|Overall Study|Death|0
4683373|NCT02480010|7589040|FG000|Overall Study|Insufficient therapeutic response|31
4683374|NCT02480010|7589041|FG001|Overall Study|Insufficient therapeutic response|29
4683375|NCT02480010|7589040|FG000|Overall Study|Refused Treatment|0
4683376|NCT02480010|7589041|FG001|Overall Study|Refused Treatment|3
4683377|NCT02480114|7589049|FG000|Overall Study|Not completing surveys|3
4683378|NCT02480114|7589050|FG001|Overall Study|Not completing surveys|2
4683379|NCT02480114|7589049|FG000|Overall Study|Withdrawal by Subject|2
4683380|NCT02480114|7589050|FG001|Overall Study|Withdrawal by Subject|4
4683381|NCT02480114|7589049|FG000|Overall Study|Disease progression|3
4683382|NCT02480114|7589050|FG001|Overall Study|Disease progression|0
4683383|NCT02480114|7589049|FG000|Overall Study|Improper completion of survey|1
4683384|NCT02480114|7589050|FG001|Overall Study|Improper completion of survey|1
4683385|NCT02480114|7589049|FG000|Overall Study|Not eligible|0
4683386|NCT02480114|7589050|FG001|Overall Study|Not eligible|1
4683387|NCT02480153|7589058|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0
4683388|NCT02480153|7589059|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1
4683389|NCT02480153|7589060|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0
4683390|NCT02480153|7589058|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0
4683391|NCT02480153|7589059|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1
4683392|NCT02480153|7589060|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0
4683393|NCT02480153|7589058|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1
4683394|NCT02480153|7589059|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2
4683395|NCT02480153|7589060|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0
4683396|NCT02480153|7589058|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3
4683397|NCT02480153|7589059|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8
4683398|NCT02480153|7589060|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0
4683399|NCT02480153|7589058|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0
4683400|NCT02480153|7589059|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1
4683401|NCT02480153|7589060|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0
4683402|NCT02480153|7589058|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0
4683403|NCT02480153|7589059|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1
4683404|NCT02480153|7589060|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0
4683405|NCT02480153|7589058|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0
4683406|NCT02480153|7589059|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2
4683407|NCT02480153|7589060|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0
4759504|NCT02200770|7733366|FG001|Open-label Period (OLP)|Other|15
4759505|NCT02136069|7733376|FG000|Overall Study|UC flare-up|1
4759506|NCT02136069|7733377|FG001|Overall Study|UC flare-up|0
4759507|NCT02136069|7733376|FG000|Overall Study|Adverse Event|6
4759508|NCT02136069|7733377|FG001|Overall Study|Adverse Event|8
4759509|NCT02136069|7733376|FG000|Overall Study|Death|0
4759510|NCT02136069|7733377|FG001|Overall Study|Death|1
4759511|NCT02136069|7733376|FG000|Overall Study|Lack of Efficacy|10
4759512|NCT02136069|7733377|FG001|Overall Study|Lack of Efficacy|4
4759513|NCT02136069|7733376|FG000|Overall Study|Lost to Follow-up|1
4759514|NCT02136069|7733377|FG001|Overall Study|Lost to Follow-up|0
4759515|NCT02136069|7733376|FG000|Overall Study|Non-Compliance|1
4759516|NCT02136069|7733377|FG001|Overall Study|Non-Compliance|0
4759517|NCT02136069|7733376|FG000|Overall Study|Physician Decision|5
4759518|NCT02136069|7733377|FG001|Overall Study|Physician Decision|4
4759519|NCT02136069|7733376|FG000|Overall Study|Withdrawal by Subject|10
4759520|NCT02136069|7733377|FG001|Overall Study|Withdrawal by Subject|11
4759521|NCT02086552|7733383|FG000|Overall Study|Withdrawal by Subject|1
4759522|NCT01209767|7733392|FG000|Overall Study|Withdrawal by Subject|1
4759523|NCT01209767|7733392|FG000|Overall Study|Lost to Follow-up|3
4759524|NCT01186848|7733400|FG000|Overall Study|Lost to Follow-up|4
4759525|NCT01186848|7733400|FG000|Overall Study|Withdrawal by Subject|2
4759526|NCT01186848|7733400|FG000|Overall Study|Adverse Event|2
4759527|NCT01024608|7733417|FG000|Overall Study|Adverse Event|1
4759528|NCT01024608|7733418|FG001|Overall Study|Adverse Event|0
4759529|NCT01024608|7733417|FG000|Overall Study|Withdrawal by Subject|1
4759530|NCT01024608|7733418|FG001|Overall Study|Withdrawal by Subject|0
4759531|NCT01024608|7733417|FG000|Overall Study|Lost to Follow-up|0
4759532|NCT01024608|7733418|FG001|Overall Study|Lost to Follow-up|1
4759533|NCT01024608|7733417|FG000|Overall Study|Protocol Violation|0
4759534|NCT01024608|7733418|FG001|Overall Study|Protocol Violation|3
4759535|NCT01024608|7733417|FG000|Overall Study|Never received study treatment|2
4759536|NCT01024608|7733418|FG001|Overall Study|Never received study treatment|0
4759537|NCT00988247|7733426|FG000|Overall Study|Adverse Event|17
4759538|NCT00988247|7733427|FG001|Overall Study|Adverse Event|3
4683408|NCT02480153|7589058|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4
4683409|NCT02480153|7589059|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1
4683410|NCT02480153|7589060|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3
4683411|NCT02480153|7589058|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0
4683412|NCT02480153|7589059|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1
4683413|NCT02480153|7589060|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0
4683414|NCT02480153|7589058|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8
4683415|NCT02480153|7589059|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3
4683416|NCT02480153|7589060|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1
4683417|NCT02480153|7589058|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6
4683418|NCT02480153|7589059|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7
4759539|NCT00988247|7733426|FG000|Overall Study|Withdrawal by Subject|44
4759540|NCT00988247|7733427|FG001|Overall Study|Withdrawal by Subject|13
4759541|NCT00988247|7733426|FG000|Overall Study|Pregnancy|1
4759542|NCT00988247|7733427|FG001|Overall Study|Pregnancy|2
4759543|NCT00988247|7733426|FG000|Overall Study|Lost to Follow-up|11
4759544|NCT00988247|7733427|FG001|Overall Study|Lost to Follow-up|2
4759545|NCT00988247|7733426|FG000|Overall Study|Protocol Violation|4
4759546|NCT00988247|7733427|FG001|Overall Study|Protocol Violation|5
4759547|NCT00988247|7733426|FG000|Overall Study|Sponsor requested withdrawal|3
4759548|NCT00988247|7733427|FG001|Overall Study|Sponsor requested withdrawal|1
4759549|NCT00988247|7733426|FG000|Overall Study|Other|3
4759550|NCT00988247|7733427|FG001|Overall Study|Other|0
4759551|NCT00730639|7733459|FG000|Overall Study|Adverse Event|3
4759552|NCT00730639|7733460|FG001|Overall Study|Adverse Event|0
4759553|NCT00730639|7733461|FG002|Overall Study|Adverse Event|9
4759554|NCT00730639|7733462|FG003|Overall Study|Adverse Event|8
4759555|NCT00730639|7733463|FG004|Overall Study|Adverse Event|23
4759556|NCT00730639|7733459|FG000|Overall Study|Complete Response|0
4759557|NCT00730639|7733460|FG001|Overall Study|Complete Response|0
4759558|NCT00730639|7733461|FG002|Overall Study|Complete Response|2
4759559|NCT00730639|7733462|FG003|Overall Study|Complete Response|2
4759560|NCT00730639|7733463|FG004|Overall Study|Complete Response|1
4759561|NCT00730639|7733459|FG000|Overall Study|Completed Maximum Cycles|0
4759562|NCT00730639|7733460|FG001|Overall Study|Completed Maximum Cycles|0
4759563|NCT00730639|7733461|FG002|Overall Study|Completed Maximum Cycles|11
4759564|NCT00730639|7733462|FG003|Overall Study|Completed Maximum Cycles|3
4759565|NCT00730639|7733463|FG004|Overall Study|Completed Maximum Cycles|6
4759566|NCT00730639|7733459|FG000|Overall Study|Death|0
4759567|NCT00730639|7733460|FG001|Overall Study|Death|0
4759568|NCT00730639|7733461|FG002|Overall Study|Death|0
4759569|NCT00730639|7733462|FG003|Overall Study|Death|0
4759570|NCT00730639|7733463|FG004|Overall Study|Death|2
4759571|NCT00730639|7733459|FG000|Overall Study|Disease Progression|12
4759572|NCT00730639|7733460|FG001|Overall Study|Disease Progression|13
4759573|NCT00730639|7733461|FG002|Overall Study|Disease Progression|48
4759574|NCT00730639|7733462|FG003|Overall Study|Disease Progression|32
4759575|NCT00730639|7733463|FG004|Overall Study|Disease Progression|88
4759576|NCT00730639|7733459|FG000|Overall Study|non-specified|0
4759577|NCT00730639|7733460|FG001|Overall Study|non-specified|0
4759578|NCT00730639|7733461|FG002|Overall Study|non-specified|4
4759579|NCT00730639|7733462|FG003|Overall Study|non-specified|2
4759580|NCT00730639|7733463|FG004|Overall Study|non-specified|3
4759581|NCT00730639|7733459|FG000|Overall Study|Protocol Violation|0
4759582|NCT00730639|7733460|FG001|Overall Study|Protocol Violation|0
4759583|NCT00730639|7733461|FG002|Overall Study|Protocol Violation|1
4759584|NCT00730639|7733462|FG003|Overall Study|Protocol Violation|0
4759585|NCT00730639|7733463|FG004|Overall Study|Protocol Violation|0
4759586|NCT00730639|7733459|FG000|Overall Study|Withdrawal by Subject|0
4759587|NCT00730639|7733460|FG001|Overall Study|Withdrawal by Subject|0
4759588|NCT00730639|7733461|FG002|Overall Study|Withdrawal by Subject|6
4759589|NCT00730639|7733462|FG003|Overall Study|Withdrawal by Subject|3
4759590|NCT00730639|7733463|FG004|Overall Study|Withdrawal by Subject|4
4759591|NCT00730639|7733459|FG000|Overall Study|Treatment on-going|2
4759592|NCT00730639|7733460|FG001|Overall Study|Treatment on-going|5
4759593|NCT00730639|7733461|FG002|Overall Study|Treatment on-going|5
4759594|NCT00730639|7733462|FG003|Overall Study|Treatment on-going|4
4759595|NCT00730639|7733463|FG004|Overall Study|Treatment on-going|4
4683419|NCT02480153|7589060|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3
4683420|NCT02480153|7589058|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2
4683421|NCT02480153|7589059|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0
4683422|NCT02480153|7589060|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0
4683423|NCT02480153|7589058|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0
4683424|NCT02480153|7589059|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1
4683425|NCT02480153|7589060|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0
4683426|NCT02480153|7589058|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3
4683427|NCT02480153|7589059|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2
4683428|NCT02480153|7589060|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1
4683429|NCT02480153|7589058|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4
4683430|NCT02480153|7589059|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0
4683431|NCT02480153|7589060|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1
4683432|NCT02480153|7589058|FG000|Period 3: Week 52 Dosing to Week 78|Other|0
4759596|NCT04834362|7733501|FG000|Overall Study|Death|1
4759597|NCT04834362|7733502|FG001|Overall Study|Death|2
4683433|NCT02480153|7589059|FG001|Period 3: Week 52 Dosing to Week 78|Other|0
4683434|NCT02480153|7589060|FG002|Period 3: Week 52 Dosing to Week 78|Other|1
4683435|NCT02480153|7589058|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0
4683436|NCT02480153|7589059|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0
4683437|NCT02480153|7589060|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1
4683438|NCT02480153|7589058|FG000|Period 3: Week 52 Dosing to Week 78|Death|0
4683439|NCT02480153|7589059|FG001|Period 3: Week 52 Dosing to Week 78|Death|1
4683440|NCT02480153|7589060|FG002|Period 3: Week 52 Dosing to Week 78|Death|0
4683441|NCT02480621|7589130|FG000|Randomization|Withdrawal by Subject|1
4683442|NCT02480621|7589131|FG001|Randomization|Withdrawal by Subject|0
4683443|NCT02480621|7589130|FG000|Randomization|Surgeon did not give intervention|0
4683444|NCT02480621|7589131|FG001|Randomization|Surgeon did not give intervention|1
4683445|NCT02480621|7589130|FG000|Follow Up|Lost to Follow-up|4
4683446|NCT02480621|7589131|FG001|Follow Up|Lost to Follow-up|2
4683447|NCT02480712|7589137|FG000|Overall Study|Enrolled but Never Treated|1
4683448|NCT02480712|7589137|FG000|Overall Study|Lost to Follow-up|5
4683449|NCT02480712|7589137|FG000|Overall Study|Withdrew Consent|3
4683450|NCT02480712|7589137|FG000|Overall Study|Death|1
4683451|NCT02480712|7589137|FG000|Overall Study|Lack of Efficacy|1
4683452|NCT02480764|7589150|FG000|Overall Study|Pretreatment Event/Adverse Event|3
4683453|NCT02480764|7589151|FG001|Overall Study|Pretreatment Event/Adverse Event|6
4683454|NCT02480764|7589152|FG002|Overall Study|Pretreatment Event/Adverse Event|3
4683455|NCT02480764|7589150|FG000|Overall Study|Major Protocol Deviation|1
4683456|NCT02480764|7589151|FG001|Overall Study|Major Protocol Deviation|4
4683457|NCT02480764|7589152|FG002|Overall Study|Major Protocol Deviation|3
4683458|NCT02480764|7589150|FG000|Overall Study|Lost to Follow-up|0
4683459|NCT02480764|7589151|FG001|Overall Study|Lost to Follow-up|1
4683460|NCT02480764|7589152|FG002|Overall Study|Lost to Follow-up|2
4683461|NCT02480764|7589150|FG000|Overall Study|Voluntary Withdrawal|6
4683462|NCT02480764|7589151|FG001|Overall Study|Voluntary Withdrawal|5
4683463|NCT02480764|7589152|FG002|Overall Study|Voluntary Withdrawal|10
4683464|NCT02480764|7589150|FG000|Overall Study|Lack of Efficacy|0
4683465|NCT02480764|7589151|FG001|Overall Study|Lack of Efficacy|3
4683466|NCT02480764|7589152|FG002|Overall Study|Lack of Efficacy|3
4683467|NCT02480764|7589150|FG000|Overall Study|Reason not Specified|0
4683468|NCT02480764|7589151|FG001|Overall Study|Reason not Specified|1
4683469|NCT02480764|7589152|FG002|Overall Study|Reason not Specified|0
4683470|NCT02481050|7589175|FG000|Overall Study|Adverse Event|1
4683471|NCT02481050|7589175|FG000|Overall Study|Disease Progression|47
4683472|NCT02481050|7589175|FG000|Overall Study|Withdrawal by Subject|7
4683473|NCT02481050|7589175|FG000|Overall Study|Other|3
4683474|NCT02481869|7589320|FG000|Overall Study|Lost to Follow-up|3
4683475|NCT02481869|7589321|FG001|Overall Study|Lost to Follow-up|4
4683476|NCT02481869|7589320|FG000|Overall Study|Withdrawal by Subject|2
4683477|NCT02481869|7589321|FG001|Overall Study|Withdrawal by Subject|0
4683478|NCT02481934|7589328|FG000|Overall Study|Death|2
4683479|NCT02481947|7589334|FG000|Overall Study|Withdrawal by Subject|24
4683480|NCT02481947|7589335|FG001|Overall Study|Withdrawal by Subject|10
4683481|NCT02481947|7589334|FG000|Overall Study|Lost to Follow-up|11
4683482|NCT02481947|7589335|FG001|Overall Study|Lost to Follow-up|5
4683483|NCT02481947|7589334|FG000|Overall Study|Adverse Event|6
4683484|NCT02481947|7589335|FG001|Overall Study|Adverse Event|11
4683485|NCT02481947|7589334|FG000|Overall Study|Physician Decision|4
4683486|NCT02481947|7589335|FG001|Overall Study|Physician Decision|5
4683487|NCT02481947|7589334|FG000|Overall Study|Protocol Violation|1
4683488|NCT02481947|7589335|FG001|Overall Study|Protocol Violation|5
4683489|NCT02482129|7589352|FG000|Overall Study|Adverse Event-prior to treatment|0
4683490|NCT02482129|7589353|FG001|Overall Study|Adverse Event-prior to treatment|1
4683491|NCT02482129|7589352|FG000|Overall Study|Withdrawal by subject-prior to treatment|0
4683492|NCT02482129|7589353|FG001|Overall Study|Withdrawal by subject-prior to treatment|1
4683493|NCT02482129|7589352|FG000|Overall Study|Unable to draw blood-prior to treatment|1
4683494|NCT02482129|7589353|FG001|Overall Study|Unable to draw blood-prior to treatment|0
4683495|NCT02482129|7589352|FG000|Overall Study|Criteria not met-prior to treatment|1
4683496|NCT02482129|7589353|FG001|Overall Study|Criteria not met-prior to treatment|0
4683497|NCT02482129|7589352|FG000|Overall Study|Adverse Event|1
4683498|NCT02482129|7589353|FG001|Overall Study|Adverse Event|0
4683499|NCT02482129|7589352|FG000|Overall Study|Withdrawal by Subject|2
4683500|NCT02482129|7589353|FG001|Overall Study|Withdrawal by Subject|0
4683501|NCT02482129|7589352|FG000|Overall Study|Criteria not met|1
4683502|NCT02482129|7589353|FG001|Overall Study|Criteria not met|0
4683503|NCT02482298|7589364|FG000|Overall Study|Withdrawal by Subject|2
4683504|NCT02482298|7589365|FG001|Overall Study|Withdrawal by Subject|1
4683505|NCT02482298|7589366|FG002|Overall Study|Withdrawal by Subject|2
4683506|NCT02482298|7589364|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0
4683507|NCT02482298|7589365|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1
4683508|NCT02482298|7589366|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0
4683509|NCT02482298|7589364|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0
4683510|NCT02482298|7589365|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0
4683511|NCT02482298|7589366|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1
4683512|NCT02482298|7589364|FG000|Overall Study|Lost to Follow-up|0
4683513|NCT02482298|7589365|FG001|Overall Study|Lost to Follow-up|1
4683514|NCT02482298|7589366|FG002|Overall Study|Lost to Follow-up|0
4683515|NCT02482428|7589379|FG000|Overall Study|Lost to Follow-up|4
4683516|NCT02482428|7589380|FG001|Overall Study|Lost to Follow-up|9
4683517|NCT02482428|7589381|FG002|Overall Study|Lost to Follow-up|1
4683518|NCT02482428|7589382|FG003|Overall Study|Lost to Follow-up|2
4683519|NCT02482428|7589383|FG004|Overall Study|Lost to Follow-up|4
4683520|NCT02482428|7589379|FG000|Overall Study|Physician Decision|0
4759598|NCT04611789|7733528|FG000|Overall Study|Lost to Follow-up|1
4759599|NCT04611789|7733529|FG001|Overall Study|Lost to Follow-up|0
4759600|NCT04611789|7733530|FG002|Overall Study|Lost to Follow-up|0
4759601|NCT04254809|7733593|FG000|Overall Study|Lost to Follow-up|5
4759602|NCT04254809|7733594|FG001|Overall Study|Lost to Follow-up|10
4759603|NCT04230122|7733602|FG000|Overall Study|Lost to Follow-up|1
4759604|NCT04230122|7733603|FG001|Overall Study|Lost to Follow-up|0
4759605|NCT04033068|7733632|FG000|Overall Study|Withdrawal by Subject|0
4759606|NCT04033068|7733633|FG001|Overall Study|Withdrawal by Subject|0
4683521|NCT02482428|7589380|FG001|Overall Study|Physician Decision|0
4683522|NCT02482428|7589381|FG002|Overall Study|Physician Decision|0
4683523|NCT02482428|7589382|FG003|Overall Study|Physician Decision|0
4759607|NCT04033068|7733634|FG002|Overall Study|Withdrawal by Subject|1
4683524|NCT02482428|7589383|FG004|Overall Study|Physician Decision|1
4683525|NCT02482428|7589379|FG000|Overall Study|protocol deviation|1
4683526|NCT02482428|7589380|FG001|Overall Study|protocol deviation|1
4683527|NCT02482428|7589381|FG002|Overall Study|protocol deviation|0
4683528|NCT02482428|7589382|FG003|Overall Study|protocol deviation|0
4683529|NCT02482428|7589383|FG004|Overall Study|protocol deviation|0
4683530|NCT02482428|7589379|FG000|Overall Study|subject/guardian decision|4
4683531|NCT02482428|7589380|FG001|Overall Study|subject/guardian decision|2
4683532|NCT02482428|7589381|FG002|Overall Study|subject/guardian decision|0
4683533|NCT02482428|7589382|FG003|Overall Study|subject/guardian decision|0
4683534|NCT02482428|7589383|FG004|Overall Study|subject/guardian decision|2
4683535|NCT02482571|7589397|FG000|Overall Study|Adverse Event|1
4683536|NCT02482571|7589397|FG000|Overall Study|Scanner or Respiract failure|3
4683537|NCT02482571|7589397|FG000|Overall Study|Withdrawal by Subject|4
4683538|NCT02482805|7589453|FG000|Overall Study|Lost to Follow-up|4
4683539|NCT02482805|7589454|FG001|Overall Study|Lost to Follow-up|4
4683540|NCT02482805|7589455|FG002|Overall Study|Lost to Follow-up|0
4759608|NCT04033068|7733635|FG003|Overall Study|Withdrawal by Subject|0
4759609|NCT04033068|7733632|FG000|Overall Study|Lost to Follow-up|0
4759610|NCT04033068|7733633|FG001|Overall Study|Lost to Follow-up|1
4759611|NCT04033068|7733634|FG002|Overall Study|Lost to Follow-up|0
4759612|NCT04033068|7733635|FG003|Overall Study|Lost to Follow-up|0
4759613|NCT04033068|7733632|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0
4759614|NCT04033068|7733633|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0
4759615|NCT04033068|7733634|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0
4759616|NCT04033068|7733635|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1
4683541|NCT02482935|7589478|FG000|Period 1|Withdrawal by Subject|1
4759617|NCT03561597|7733645|FG000|Overall Study|Lost to Follow-up|20
4759618|NCT03350984|7733660|FG000|Overall Study|Death|1
4759619|NCT03350984|7733661|FG001|Overall Study|Death|0
4759620|NCT03350984|7733660|FG000|Overall Study|Lost to Follow-up|5
4759621|NCT03350984|7733661|FG001|Overall Study|Lost to Follow-up|6
4759622|NCT03350984|7733660|FG000|Overall Study|Protocol Violation|1
4759623|NCT03350984|7733661|FG001|Overall Study|Protocol Violation|2
4759624|NCT03350984|7733660|FG000|Overall Study|Physician Decision|1
4759625|NCT03350984|7733661|FG001|Overall Study|Physician Decision|0
4759626|NCT03277261|7733669|FG000|Overall Study|Adverse Event|17
4759627|NCT03277261|7733670|FG001|Overall Study|Adverse Event|1
4759628|NCT03277261|7733669|FG000|Overall Study|Participant Withdrawal of Consent|6
4759629|NCT03277261|7733670|FG001|Overall Study|Participant Withdrawal of Consent|15
4759630|NCT03277261|7733669|FG000|Overall Study|Investigator / Sponsor Decision|4
4759631|NCT03277261|7733670|FG001|Overall Study|Investigator / Sponsor Decision|2
4759632|NCT03277261|7733669|FG000|Overall Study|Pregnancy|2
4759633|NCT03277261|7733670|FG001|Overall Study|Pregnancy|0
4759634|NCT03277261|7733669|FG000|Overall Study|Lost to Follow-up|2
4759635|NCT03277261|7733670|FG001|Overall Study|Lost to Follow-up|2
4759636|NCT03277261|7733669|FG000|Overall Study|Lack of Efficacy|2
4759637|NCT03277261|7733670|FG001|Overall Study|Lack of Efficacy|2
4759638|NCT03277261|7733669|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1
4759639|NCT03277261|7733670|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1
4759640|NCT03277248|7733679|FG000|Overall Study|Adverse Event|3
4759641|NCT03277248|7733680|FG001|Overall Study|Adverse Event|1
4759642|NCT03277248|7733679|FG000|Overall Study|Subject Withdrawal of Consent|6
4759643|NCT03277248|7733680|FG001|Overall Study|Subject Withdrawal of Consent|23
4759644|NCT03277248|7733679|FG000|Overall Study|Investigator/Sponsor Decision|2
4759645|NCT03277248|7733680|FG001|Overall Study|Investigator/Sponsor Decision|2
4759646|NCT03277248|7733679|FG000|Overall Study|Pregnancy|4
4759647|NCT03277248|7733680|FG001|Overall Study|Pregnancy|1
4759648|NCT03277248|7733679|FG000|Overall Study|Lost to Follow-up|0
4759649|NCT03277248|7733680|FG001|Overall Study|Lost to Follow-up|2
4759650|NCT03277248|7733679|FG000|Overall Study|Lack of Efficacy|0
4759651|NCT03277248|7733680|FG001|Overall Study|Lack of Efficacy|2
4759652|NCT03277248|7733679|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3
4759653|NCT03277248|7733680|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3
4759654|NCT03179462|7733689|FG000|Overall Study|screening failure|1
4759655|NCT03179462|7733690|FG001|Overall Study|screening failure|2
4759656|NCT03179462|7733691|FG002|Overall Study|screening failure|0
4759657|NCT03099707|7733701|FG000|Overall Study|Withdrawal by Subject|0
4759658|NCT03099707|7733702|FG001|Overall Study|Withdrawal by Subject|3
4759659|NCT03099707|7733701|FG000|Overall Study|Lost to Follow-up|0
4759660|NCT03099707|7733702|FG001|Overall Study|Lost to Follow-up|1
4759661|NCT03064763|7733708|FG000|Overall Study|Ongoing in study|10
4759662|NCT03064763|7733708|FG000|Overall Study|Death|8
4759663|NCT02906033|7733733|FG000|Baseline|Protocol Violation|37
4759664|NCT02906033|7733734|FG001|Baseline|Protocol Violation|33
4759665|NCT02906033|7733733|FG000|Follow-up|Lost to Follow-up|46
4759666|NCT02906033|7733734|FG001|Follow-up|Lost to Follow-up|62
4759667|NCT02837783|7733742|FG000|Overall Study|Adverse Event|1
4759668|NCT02837783|7733743|FG001|Overall Study|Adverse Event|0
4759669|NCT02837783|7733742|FG000|Overall Study|Other, Not Specified|1
4759670|NCT02837783|7733743|FG001|Overall Study|Other, Not Specified|2
4759671|NCT02786537|7733755|FG000|As Randomized|Adverse Event|0
4759672|NCT02786537|7733756|FG001|As Randomized|Adverse Event|11
4683542|NCT02482935|7589479|FG001|Period 1|Withdrawal by Subject|0
4683543|NCT02483416|7589494|FG000|Overall Study|Other reason|0
4683544|NCT02483416|7589495|FG001|Overall Study|Other reason|1
4683545|NCT02483416|7589494|FG000|Overall Study|Treatment stop|3
4683546|NCT02483416|7589495|FG001|Overall Study|Treatment stop|0
4683547|NCT02483520|7589504|FG000|Overall Study|Lost to Follow-up|3
4683548|NCT02483520|7589505|FG001|Overall Study|Lost to Follow-up|4
4683549|NCT02483520|7589504|FG000|Overall Study|Withdrawal by Subject|4
4759673|NCT02786537|7733757|FG002|As Randomized|Adverse Event|0
4683550|NCT02483520|7589505|FG001|Overall Study|Withdrawal by Subject|14
4683551|NCT02483520|7589504|FG000|Overall Study|Hospitalized|2
4683552|NCT02483520|7589505|FG001|Overall Study|Hospitalized|3
4683553|NCT02483520|7589504|FG000|Overall Study|Moved to LTC|2
4683554|NCT02483520|7589505|FG001|Overall Study|Moved to LTC|3
4683555|NCT02483572|7589513|FG000|Overall Study|Withdrawal by Subject|1
4683556|NCT02483572|7589514|FG001|Overall Study|Withdrawal by Subject|0
4683557|NCT02483572|7589513|FG000|Overall Study|Lost to Follow-up|1
4683558|NCT02483572|7589514|FG001|Overall Study|Lost to Follow-up|0
4683559|NCT02483572|7589513|FG000|Overall Study|Physician Decision|0
4683560|NCT02483572|7589514|FG001|Overall Study|Physician Decision|1
4683561|NCT02483585|7589522|FG000|Double-blind Treatment Phase|Decision by Sponsor|1
4683562|NCT02483585|7589523|FG001|Double-blind Treatment Phase|Decision by Sponsor|1
4683563|NCT02483585|7589522|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12
4683564|NCT02483585|7589523|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12
4683565|NCT02483585|7589522|FG000|Double-blind Treatment Phase|Lost to Follow-up|3
4683566|NCT02483585|7589523|FG001|Double-blind Treatment Phase|Lost to Follow-up|2
4683567|NCT02483585|7589522|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6
4683568|NCT02483585|7589523|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5
4683569|NCT02483585|7589522|FG000|Open-label Treatment Phase|Decision by Sponsor|0
4683570|NCT02483585|7589523|FG001|Open-label Treatment Phase|Decision by Sponsor|1
4683571|NCT02483585|7589522|FG000|Open-label Treatment Phase|Withdrawal by Subject|18
4683572|NCT02483585|7589523|FG001|Open-label Treatment Phase|Withdrawal by Subject|14
4683573|NCT02483585|7589522|FG000|Open-label Treatment Phase|Lost to Follow-up|3
4683574|NCT02483585|7589523|FG001|Open-label Treatment Phase|Lost to Follow-up|5
4683575|NCT02483611|7589536|FG000|Overall Study|Protocol Violation|0
4683576|NCT02483611|7589537|FG001|Overall Study|Protocol Violation|0
4683577|NCT02483611|7589538|FG002|Overall Study|Protocol Violation|1
4683578|NCT02483975|7589557|FG000|Overall Study|Adverse Event|0
4683579|NCT02483975|7589558|FG001|Overall Study|Adverse Event|1
4683580|NCT02483975|7589557|FG000|Overall Study|Lost to Follow-up|0
4683581|NCT02483975|7589558|FG001|Overall Study|Lost to Follow-up|1
4683582|NCT02483975|7589557|FG000|Overall Study|Physician Decision|2
4683583|NCT02483975|7589558|FG001|Overall Study|Physician Decision|0
4683584|NCT02484547|7589580|FG000|Placebo-Controlled Period|Adverse Event|10
4683585|NCT02484547|7589581|FG001|Placebo-Controlled Period|Adverse Event|13
4683586|NCT02484547|7589582|FG002|Placebo-Controlled Period|Adverse Event|20
4683587|NCT02484547|7589583|FG003|Placebo-Controlled Period|Adverse Event|0
4759674|NCT02786537|7733758|FG003|As Randomized|Adverse Event|4
4759675|NCT02786537|7733759|FG004|As Randomized|Adverse Event|6
4759676|NCT02786537|7733760|FG005|As Randomized|Adverse Event|2
4759677|NCT02786537|7733755|FG000|As Randomized|Lack of Efficacy|0
4759678|NCT02786537|7733756|FG001|As Randomized|Lack of Efficacy|0
4759679|NCT02786537|7733757|FG002|As Randomized|Lack of Efficacy|0
4759680|NCT02786537|7733758|FG003|As Randomized|Lack of Efficacy|1
4759681|NCT02786537|7733759|FG004|As Randomized|Lack of Efficacy|0
4759682|NCT02786537|7733760|FG005|As Randomized|Lack of Efficacy|0
4759683|NCT02786537|7733755|FG000|As Randomized|Withdrawal by Subject|1
4759684|NCT02786537|7733756|FG001|As Randomized|Withdrawal by Subject|2
4759685|NCT02786537|7733757|FG002|As Randomized|Withdrawal by Subject|0
4759686|NCT02786537|7733758|FG003|As Randomized|Withdrawal by Subject|1
4759687|NCT02786537|7733759|FG004|As Randomized|Withdrawal by Subject|1
4759688|NCT02786537|7733760|FG005|As Randomized|Withdrawal by Subject|0
4759689|NCT02786537|7733755|FG000|As Randomized|Death|0
4759690|NCT02786537|7733756|FG001|As Randomized|Death|2
4759691|NCT02786537|7733757|FG002|As Randomized|Death|0
4759692|NCT02786537|7733758|FG003|As Randomized|Death|3
4759693|NCT02786537|7733759|FG004|As Randomized|Death|1
4759694|NCT02786537|7733760|FG005|As Randomized|Death|0
4759695|NCT02786537|7733755|FG000|As Randomized|Non-compliance with study drug|1
4759696|NCT02786537|7733756|FG001|As Randomized|Non-compliance with study drug|11
4759697|NCT02786537|7733757|FG002|As Randomized|Non-compliance with study drug|0
4759698|NCT02786537|7733758|FG003|As Randomized|Non-compliance with study drug|1
4759699|NCT02786537|7733759|FG004|As Randomized|Non-compliance with study drug|0
4759700|NCT02786537|7733760|FG005|As Randomized|Non-compliance with study drug|1
4759701|NCT02786537|7733755|FG000|As Randomized|Lost to treatment follow-up|4
4759702|NCT02786537|7733756|FG001|As Randomized|Lost to treatment follow-up|32
4759703|NCT02786537|7733757|FG002|As Randomized|Lost to treatment follow-up|0
4759704|NCT02786537|7733758|FG003|As Randomized|Lost to treatment follow-up|24
4759705|NCT02786537|7733759|FG004|As Randomized|Lost to treatment follow-up|4
4759706|NCT02786537|7733760|FG005|As Randomized|Lost to treatment follow-up|4
4759707|NCT02786537|7733755|FG000|As Randomized|Incarceration|0
4759708|NCT02786537|7733756|FG001|As Randomized|Incarceration|1
4759709|NCT02786537|7733757|FG002|As Randomized|Incarceration|0
4759710|NCT02786537|7733758|FG003|As Randomized|Incarceration|0
4759711|NCT02786537|7733759|FG004|As Randomized|Incarceration|0
4759712|NCT02786537|7733760|FG005|As Randomized|Incarceration|0
4759713|NCT02786537|7733755|FG000|As Randomized|Opiate Dependency Relapse|0
4759714|NCT02786537|7733756|FG001|As Randomized|Opiate Dependency Relapse|1
4759715|NCT02786537|7733757|FG002|As Randomized|Opiate Dependency Relapse|0
4759716|NCT02786537|7733758|FG003|As Randomized|Opiate Dependency Relapse|0
4759717|NCT02786537|7733759|FG004|As Randomized|Opiate Dependency Relapse|0
4683588|NCT02484547|7589584|FG004|Placebo-Controlled Period|Adverse Event|0
4683589|NCT02484547|7589585|FG005|Placebo-Controlled Period|Adverse Event|0
4759718|NCT02786537|7733760|FG005|As Randomized|Opiate Dependency Relapse|0
4759719|NCT02786537|7733755|FG000|As Randomized|HCV drugs stolen from pt|0
4683590|NCT02484547|7589586|FG006|Placebo-Controlled Period|Adverse Event|0
4683591|NCT02484547|7589580|FG000|Placebo-Controlled Period|Change of Treatment|0
4683592|NCT02484547|7589581|FG001|Placebo-Controlled Period|Change of Treatment|0
4683593|NCT02484547|7589582|FG002|Placebo-Controlled Period|Change of Treatment|1
4683594|NCT02484547|7589583|FG003|Placebo-Controlled Period|Change of Treatment|0
4759720|NCT02786537|7733756|FG001|As Randomized|HCV drugs stolen from pt|1
4759721|NCT02786537|7733757|FG002|As Randomized|HCV drugs stolen from pt|0
4759722|NCT02786537|7733758|FG003|As Randomized|HCV drugs stolen from pt|0
4759723|NCT02786537|7733759|FG004|As Randomized|HCV drugs stolen from pt|0
4759724|NCT02786537|7733760|FG005|As Randomized|HCV drugs stolen from pt|0
4759725|NCT02786537|7733755|FG000|As Randomized|Advised to stop after lapse in dosing|0
4759726|NCT02786537|7733756|FG001|As Randomized|Advised to stop after lapse in dosing|1
4759727|NCT02786537|7733757|FG002|As Randomized|Advised to stop after lapse in dosing|0
4759728|NCT02786537|7733758|FG003|As Randomized|Advised to stop after lapse in dosing|0
4759729|NCT02786537|7733759|FG004|As Randomized|Advised to stop after lapse in dosing|0
4759730|NCT02786537|7733760|FG005|As Randomized|Advised to stop after lapse in dosing|0
4759731|NCT02786537|7733755|FG000|As Randomized|Subject lost insurance|0
4759732|NCT02786537|7733756|FG001|As Randomized|Subject lost insurance|0
4759733|NCT02786537|7733757|FG002|As Randomized|Subject lost insurance|0
4759734|NCT02786537|7733758|FG003|As Randomized|Subject lost insurance|1
4759735|NCT02786537|7733759|FG004|As Randomized|Subject lost insurance|0
4759736|NCT02786537|7733760|FG005|As Randomized|Subject lost insurance|0
4759737|NCT02786537|7733755|FG000|As Treated|Adverse Event|0
4759738|NCT02786537|7733756|FG001|As Treated|Adverse Event|11
4759739|NCT02786537|7733757|FG002|As Treated|Adverse Event|0
4759740|NCT02786537|7733758|FG003|As Treated|Adverse Event|4
4759741|NCT02786537|7733759|FG004|As Treated|Adverse Event|6
4759742|NCT02786537|7733760|FG005|As Treated|Adverse Event|2
4759743|NCT02786537|7733755|FG000|As Treated|Death|0
4759744|NCT02786537|7733756|FG001|As Treated|Death|2
4759745|NCT02786537|7733757|FG002|As Treated|Death|0
4759746|NCT02786537|7733758|FG003|As Treated|Death|3
4759747|NCT02786537|7733759|FG004|As Treated|Death|1
4759748|NCT02786537|7733760|FG005|As Treated|Death|0
4759749|NCT02786537|7733755|FG000|As Treated|Lack of Efficacy|0
4759750|NCT02786537|7733756|FG001|As Treated|Lack of Efficacy|0
4759751|NCT02786537|7733757|FG002|As Treated|Lack of Efficacy|0
4759752|NCT02786537|7733758|FG003|As Treated|Lack of Efficacy|1
4759753|NCT02786537|7733759|FG004|As Treated|Lack of Efficacy|0
4759754|NCT02786537|7733760|FG005|As Treated|Lack of Efficacy|0
4759755|NCT02786537|7733755|FG000|As Treated|Lost to Follow-up|4
4759756|NCT02786537|7733756|FG001|As Treated|Lost to Follow-up|32
4759757|NCT02786537|7733757|FG002|As Treated|Lost to Follow-up|0
4759758|NCT02786537|7733758|FG003|As Treated|Lost to Follow-up|25
4759759|NCT02786537|7733759|FG004|As Treated|Lost to Follow-up|4
4759760|NCT02786537|7733760|FG005|As Treated|Lost to Follow-up|4
4759761|NCT02786537|7733755|FG000|As Treated|Non-compliance with study drug|1
4759762|NCT02786537|7733756|FG001|As Treated|Non-compliance with study drug|11
4759763|NCT02786537|7733757|FG002|As Treated|Non-compliance with study drug|0
4759764|NCT02786537|7733758|FG003|As Treated|Non-compliance with study drug|1
4759765|NCT02786537|7733759|FG004|As Treated|Non-compliance with study drug|0
4759766|NCT02786537|7733760|FG005|As Treated|Non-compliance with study drug|1
4683595|NCT02484547|7589584|FG004|Placebo-Controlled Period|Change of Treatment|0
4683596|NCT02484547|7589585|FG005|Placebo-Controlled Period|Change of Treatment|0
4683597|NCT02484547|7589586|FG006|Placebo-Controlled Period|Change of Treatment|0
4683598|NCT02484547|7589580|FG000|Placebo-Controlled Period|Consent Withdrawn|15
4683599|NCT02484547|7589581|FG001|Placebo-Controlled Period|Consent Withdrawn|32
4683600|NCT02484547|7589582|FG002|Placebo-Controlled Period|Consent Withdrawn|26
4683601|NCT02484547|7589583|FG003|Placebo-Controlled Period|Consent Withdrawn|0
4683602|NCT02484547|7589584|FG004|Placebo-Controlled Period|Consent Withdrawn|0
4759767|NCT02786537|7733755|FG000|As Treated|Lost insurance|0
4759768|NCT02786537|7733756|FG001|As Treated|Lost insurance|0
4759769|NCT02786537|7733757|FG002|As Treated|Lost insurance|0
4759770|NCT02786537|7733758|FG003|As Treated|Lost insurance|1
4759771|NCT02786537|7733759|FG004|As Treated|Lost insurance|0
4759772|NCT02786537|7733760|FG005|As Treated|Lost insurance|0
4759773|NCT02786537|7733755|FG000|As Treated|Withdrawal by Subject|1
4759774|NCT02786537|7733756|FG001|As Treated|Withdrawal by Subject|2
4759775|NCT02786537|7733757|FG002|As Treated|Withdrawal by Subject|0
4759776|NCT02786537|7733758|FG003|As Treated|Withdrawal by Subject|0
4759777|NCT02786537|7733759|FG004|As Treated|Withdrawal by Subject|1
4759778|NCT02786537|7733760|FG005|As Treated|Withdrawal by Subject|0
4759779|NCT02786537|7733755|FG000|As Treated|Incarceration|0
4759780|NCT02786537|7733756|FG001|As Treated|Incarceration|1
4759781|NCT02786537|7733757|FG002|As Treated|Incarceration|0
4759782|NCT02786537|7733758|FG003|As Treated|Incarceration|0
4759783|NCT02786537|7733759|FG004|As Treated|Incarceration|0
4759784|NCT02786537|7733760|FG005|As Treated|Incarceration|0
4759785|NCT02786537|7733755|FG000|As Treated|Opiate dependency relapse|0
4759786|NCT02786537|7733756|FG001|As Treated|Opiate dependency relapse|1
4759787|NCT02786537|7733757|FG002|As Treated|Opiate dependency relapse|0
4759788|NCT02786537|7733758|FG003|As Treated|Opiate dependency relapse|0
4759789|NCT02786537|7733759|FG004|As Treated|Opiate dependency relapse|0
4759790|NCT02786537|7733760|FG005|As Treated|Opiate dependency relapse|0
4759791|NCT02786537|7733755|FG000|As Treated|Drugs stolen from patient|0
4759792|NCT02786537|7733756|FG001|As Treated|Drugs stolen from patient|1
4759793|NCT02786537|7733757|FG002|As Treated|Drugs stolen from patient|0
4759794|NCT02786537|7733758|FG003|As Treated|Drugs stolen from patient|0
4759795|NCT02786537|7733759|FG004|As Treated|Drugs stolen from patient|0
4759796|NCT02786537|7733760|FG005|As Treated|Drugs stolen from patient|0
4759797|NCT02786537|7733755|FG000|As Treated|Advised to stop tx after loss of meds|0
4759798|NCT02786537|7733756|FG001|As Treated|Advised to stop tx after loss of meds|1
4759799|NCT02786537|7733757|FG002|As Treated|Advised to stop tx after loss of meds|0
4759800|NCT02786537|7733758|FG003|As Treated|Advised to stop tx after loss of meds|0
4759801|NCT02786537|7733759|FG004|As Treated|Advised to stop tx after loss of meds|0
4759802|NCT02786537|7733760|FG005|As Treated|Advised to stop tx after loss of meds|0
4759803|NCT02740231|7733870|FG000|Overall Study|Withdrawal by Subject|1
4759804|NCT02740231|7733871|FG001|Overall Study|Withdrawal by Subject|1
4759805|NCT02740231|7733872|FG002|Overall Study|Withdrawal by Subject|1
4759806|NCT02740231|7733873|FG003|Overall Study|Withdrawal by Subject|0
4759807|NCT02740231|7733870|FG000|Overall Study|Lack of Efficacy|0
4759808|NCT02740231|7733871|FG001|Overall Study|Lack of Efficacy|1
4759809|NCT02740231|7733872|FG002|Overall Study|Lack of Efficacy|0
4759810|NCT02740231|7733873|FG003|Overall Study|Lack of Efficacy|4
4759811|NCT02740231|7733870|FG000|Overall Study|Lost to Follow-up|1
4759812|NCT02740231|7733871|FG001|Overall Study|Lost to Follow-up|3
4759813|NCT02740231|7733872|FG002|Overall Study|Lost to Follow-up|0
4759814|NCT02740231|7733873|FG003|Overall Study|Lost to Follow-up|3
4759815|NCT02740231|7733870|FG000|Overall Study|Adverse Event|0
4759816|NCT02740231|7733871|FG001|Overall Study|Adverse Event|1
4759817|NCT02740231|7733872|FG002|Overall Study|Adverse Event|0
4759818|NCT02740231|7733873|FG003|Overall Study|Adverse Event|1
4759819|NCT02710084|7733885|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3
4759820|NCT02710084|7733886|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1
4759821|NCT02660034|7733907|FG000|Overall Study|Progressive Disease (Radiographic)|3
4759822|NCT02660034|7733908|FG001|Overall Study|Progressive Disease (Radiographic)|1
4759823|NCT02660034|7733909|FG002|Overall Study|Progressive Disease (Radiographic)|0
4759824|NCT02660034|7733910|FG003|Overall Study|Progressive Disease (Radiographic)|1
4759825|NCT02660034|7733911|FG004|Overall Study|Progressive Disease (Radiographic)|0
4759826|NCT02660034|7733912|FG005|Overall Study|Progressive Disease (Radiographic)|0
4759827|NCT02660034|7733913|FG006|Overall Study|Progressive Disease (Radiographic)|0
4759828|NCT02660034|7733914|FG007|Overall Study|Progressive Disease (Radiographic)|0
4759829|NCT02660034|7733915|FG008|Overall Study|Progressive Disease (Radiographic)|0
4759830|NCT02660034|7733916|FG009|Overall Study|Progressive Disease (Radiographic)|0
4759831|NCT02660034|7733917|FG010|Overall Study|Progressive Disease (Radiographic)|0
4759832|NCT02660034|7733918|FG011|Overall Study|Progressive Disease (Radiographic)|0
4759833|NCT02660034|7733919|FG012|Overall Study|Progressive Disease (Radiographic)|0
4759834|NCT02660034|7733920|FG013|Overall Study|Progressive Disease (Radiographic)|0
4759835|NCT02660034|7733907|FG000|Overall Study|Progressive Disease (Clinical)|7
4759836|NCT02660034|7733908|FG001|Overall Study|Progressive Disease (Clinical)|8
4759837|NCT02660034|7733909|FG002|Overall Study|Progressive Disease (Clinical)|3
4683603|NCT02484547|7589585|FG005|Placebo-Controlled Period|Consent Withdrawn|0
4683604|NCT02484547|7589586|FG006|Placebo-Controlled Period|Consent Withdrawn|0
4683605|NCT02484547|7589580|FG000|Placebo-Controlled Period|Death|5
4683606|NCT02484547|7589581|FG001|Placebo-Controlled Period|Death|0
4683607|NCT02484547|7589582|FG002|Placebo-Controlled Period|Death|6
4683608|NCT02484547|7589583|FG003|Placebo-Controlled Period|Death|0
4683609|NCT02484547|7589584|FG004|Placebo-Controlled Period|Death|0
4683610|NCT02484547|7589585|FG005|Placebo-Controlled Period|Death|0
4683611|NCT02484547|7589586|FG006|Placebo-Controlled Period|Death|0
4683612|NCT02484547|7589580|FG000|Placebo-Controlled Period|Disease Progression|2
4683613|NCT02484547|7589581|FG001|Placebo-Controlled Period|Disease Progression|0
4683614|NCT02484547|7589582|FG002|Placebo-Controlled Period|Disease Progression|1
4683615|NCT02484547|7589583|FG003|Placebo-Controlled Period|Disease Progression|0
4683616|NCT02484547|7589584|FG004|Placebo-Controlled Period|Disease Progression|0
4683617|NCT02484547|7589585|FG005|Placebo-Controlled Period|Disease Progression|0
4683618|NCT02484547|7589586|FG006|Placebo-Controlled Period|Disease Progression|0
4683619|NCT02484547|7589580|FG000|Placebo-Controlled Period|Investigator Decision|2
4683620|NCT02484547|7589581|FG001|Placebo-Controlled Period|Investigator Decision|2
4683621|NCT02484547|7589582|FG002|Placebo-Controlled Period|Investigator Decision|5
4683622|NCT02484547|7589583|FG003|Placebo-Controlled Period|Investigator Decision|0
4683623|NCT02484547|7589584|FG004|Placebo-Controlled Period|Investigator Decision|0
4683624|NCT02484547|7589585|FG005|Placebo-Controlled Period|Investigator Decision|0
4683625|NCT02484547|7589586|FG006|Placebo-Controlled Period|Investigator Decision|0
4683626|NCT02484547|7589580|FG000|Placebo-Controlled Period|Lost to Follow-up|3
4683627|NCT02484547|7589581|FG001|Placebo-Controlled Period|Lost to Follow-up|1
4683628|NCT02484547|7589582|FG002|Placebo-Controlled Period|Lost to Follow-up|3
4683629|NCT02484547|7589583|FG003|Placebo-Controlled Period|Lost to Follow-up|0
4683630|NCT02484547|7589584|FG004|Placebo-Controlled Period|Lost to Follow-up|0
4683631|NCT02484547|7589585|FG005|Placebo-Controlled Period|Lost to Follow-up|0
4683632|NCT02484547|7589586|FG006|Placebo-Controlled Period|Lost to Follow-up|0
4683633|NCT02484547|7589580|FG000|Placebo-Controlled Period|Relocation|1
4683634|NCT02484547|7589581|FG001|Placebo-Controlled Period|Relocation|1
4683635|NCT02484547|7589582|FG002|Placebo-Controlled Period|Relocation|1
4683636|NCT02484547|7589583|FG003|Placebo-Controlled Period|Relocation|0
4683637|NCT02484547|7589584|FG004|Placebo-Controlled Period|Relocation|0
4683638|NCT02484547|7589585|FG005|Placebo-Controlled Period|Relocation|0
4683639|NCT02484547|7589586|FG006|Placebo-Controlled Period|Relocation|0
4683640|NCT02484547|7589580|FG000|Placebo-Controlled Period|Study Visit Burden|2
4683641|NCT02484547|7589581|FG001|Placebo-Controlled Period|Study Visit Burden|8
4683642|NCT02484547|7589582|FG002|Placebo-Controlled Period|Study Visit Burden|5
4683643|NCT02484547|7589583|FG003|Placebo-Controlled Period|Study Visit Burden|0
4683644|NCT02484547|7589584|FG004|Placebo-Controlled Period|Study Visit Burden|0
4683645|NCT02484547|7589585|FG005|Placebo-Controlled Period|Study Visit Burden|0
4683646|NCT02484547|7589586|FG006|Placebo-Controlled Period|Study Visit Burden|0
4683647|NCT02484547|7589580|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4
4759838|NCT02660034|7733910|FG003|Overall Study|Progressive Disease (Clinical)|9
4759839|NCT02660034|7733911|FG004|Overall Study|Progressive Disease (Clinical)|3
4759840|NCT02660034|7733912|FG005|Overall Study|Progressive Disease (Clinical)|0
4759841|NCT02660034|7733913|FG006|Overall Study|Progressive Disease (Clinical)|0
4759842|NCT02660034|7733914|FG007|Overall Study|Progressive Disease (Clinical)|0
4759843|NCT02660034|7733915|FG008|Overall Study|Progressive Disease (Clinical)|0
4759844|NCT02660034|7733916|FG009|Overall Study|Progressive Disease (Clinical)|0
4759845|NCT02660034|7733917|FG010|Overall Study|Progressive Disease (Clinical)|0
4759846|NCT02660034|7733918|FG011|Overall Study|Progressive Disease (Clinical)|0
4759847|NCT02660034|7733919|FG012|Overall Study|Progressive Disease (Clinical)|0
4759848|NCT02660034|7733920|FG013|Overall Study|Progressive Disease (Clinical)|0
4759849|NCT02660034|7733907|FG000|Overall Study|Lost to Follow-up|0
4759850|NCT02660034|7733908|FG001|Overall Study|Lost to Follow-up|0
4759851|NCT02660034|7733909|FG002|Overall Study|Lost to Follow-up|1
4759852|NCT02660034|7733910|FG003|Overall Study|Lost to Follow-up|1
4759853|NCT02660034|7733911|FG004|Overall Study|Lost to Follow-up|0
4759854|NCT02660034|7733912|FG005|Overall Study|Lost to Follow-up|0
4759855|NCT02660034|7733913|FG006|Overall Study|Lost to Follow-up|0
4759856|NCT02660034|7733914|FG007|Overall Study|Lost to Follow-up|0
4759857|NCT02660034|7733915|FG008|Overall Study|Lost to Follow-up|0
4759858|NCT02660034|7733916|FG009|Overall Study|Lost to Follow-up|1
4759859|NCT02660034|7733917|FG010|Overall Study|Lost to Follow-up|1
4759860|NCT02660034|7733918|FG011|Overall Study|Lost to Follow-up|1
4759861|NCT02660034|7733919|FG012|Overall Study|Lost to Follow-up|0
4759862|NCT02660034|7733920|FG013|Overall Study|Lost to Follow-up|0
4759863|NCT02660034|7733907|FG000|Overall Study|Participant moved into special access scheme|1
4759864|NCT02660034|7733908|FG001|Overall Study|Participant moved into special access scheme|2
4759865|NCT02660034|7733909|FG002|Overall Study|Participant moved into special access scheme|0
4759866|NCT02660034|7733910|FG003|Overall Study|Participant moved into special access scheme|0
4759867|NCT02660034|7733911|FG004|Overall Study|Participant moved into special access scheme|0
4759868|NCT02660034|7733912|FG005|Overall Study|Participant moved into special access scheme|0
4759869|NCT02660034|7733913|FG006|Overall Study|Participant moved into special access scheme|0
4759870|NCT02660034|7733914|FG007|Overall Study|Participant moved into special access scheme|0
4759871|NCT02660034|7733915|FG008|Overall Study|Participant moved into special access scheme|0
4759872|NCT02660034|7733916|FG009|Overall Study|Participant moved into special access scheme|0
4683648|NCT02484547|7589581|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1
4683649|NCT02484547|7589582|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1
4683650|NCT02484547|7589583|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
4683651|NCT02484547|7589584|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
4683652|NCT02484547|7589585|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
4683653|NCT02484547|7589586|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0
4683654|NCT02484547|7589580|FG000|Placebo-Controlled Period|Reason not Specified|216
4683655|NCT02484547|7589581|FG001|Placebo-Controlled Period|Reason not Specified|194
4683656|NCT02484547|7589582|FG002|Placebo-Controlled Period|Reason not Specified|183
4683657|NCT02484547|7589583|FG003|Placebo-Controlled Period|Reason not Specified|0
4683658|NCT02484547|7589584|FG004|Placebo-Controlled Period|Reason not Specified|0
4683659|NCT02484547|7589585|FG005|Placebo-Controlled Period|Reason not Specified|0
4683660|NCT02484547|7589586|FG006|Placebo-Controlled Period|Reason not Specified|0
4683661|NCT02484547|7589580|FG000|Long-Term Extension Period|Adverse Event|0
4683662|NCT02484547|7589581|FG001|Long-Term Extension Period|Adverse Event|0
4683663|NCT02484547|7589582|FG002|Long-Term Extension Period|Adverse Event|0
4683664|NCT02484547|7589583|FG003|Long-Term Extension Period|Adverse Event|0
4683665|NCT02484547|7589584|FG004|Long-Term Extension Period|Adverse Event|1
4683666|NCT02484547|7589585|FG005|Long-Term Extension Period|Adverse Event|3
4683667|NCT02484547|7589586|FG006|Long-Term Extension Period|Adverse Event|2
4683668|NCT02484547|7589580|FG000|Long-Term Extension Period|Death|0
4683669|NCT02484547|7589581|FG001|Long-Term Extension Period|Death|0
4683670|NCT02484547|7589582|FG002|Long-Term Extension Period|Death|0
4759873|NCT02660034|7733917|FG010|Overall Study|Participant moved into special access scheme|0
4759874|NCT02660034|7733918|FG011|Overall Study|Participant moved into special access scheme|0
4759875|NCT02660034|7733919|FG012|Overall Study|Participant moved into special access scheme|0
4759876|NCT02660034|7733920|FG013|Overall Study|Participant moved into special access scheme|0
4759877|NCT02660034|7733907|FG000|Overall Study|Adverse Event|1
4759878|NCT02660034|7733908|FG001|Overall Study|Adverse Event|0
4759879|NCT02660034|7733909|FG002|Overall Study|Adverse Event|0
4759880|NCT02660034|7733910|FG003|Overall Study|Adverse Event|0
4759881|NCT02660034|7733911|FG004|Overall Study|Adverse Event|0
4759882|NCT02660034|7733912|FG005|Overall Study|Adverse Event|0
4759883|NCT02660034|7733913|FG006|Overall Study|Adverse Event|0
4759884|NCT02660034|7733914|FG007|Overall Study|Adverse Event|0
4759885|NCT02660034|7733915|FG008|Overall Study|Adverse Event|0
4759886|NCT02660034|7733916|FG009|Overall Study|Adverse Event|0
4759887|NCT02660034|7733917|FG010|Overall Study|Adverse Event|0
4759888|NCT02660034|7733918|FG011|Overall Study|Adverse Event|0
4759889|NCT02660034|7733919|FG012|Overall Study|Adverse Event|0
4759890|NCT02660034|7733920|FG013|Overall Study|Adverse Event|0
4759891|NCT02660034|7733907|FG000|Overall Study|Sponsor Decision|0
4759892|NCT02660034|7733908|FG001|Overall Study|Sponsor Decision|1
4759893|NCT02660034|7733909|FG002|Overall Study|Sponsor Decision|2
4683671|NCT02484547|7589583|FG003|Long-Term Extension Period|Death|0
4683672|NCT02484547|7589584|FG004|Long-Term Extension Period|Death|0
4683673|NCT02484547|7589585|FG005|Long-Term Extension Period|Death|3
4683674|NCT02484547|7589586|FG006|Long-Term Extension Period|Death|0
4683675|NCT02484547|7589580|FG000|Long-Term Extension Period|Disease Progression|0
4683676|NCT02484547|7589581|FG001|Long-Term Extension Period|Disease Progression|0
4683677|NCT02484547|7589582|FG002|Long-Term Extension Period|Disease Progression|0
4683678|NCT02484547|7589583|FG003|Long-Term Extension Period|Disease Progression|0
4683679|NCT02484547|7589584|FG004|Long-Term Extension Period|Disease Progression|2
4683680|NCT02484547|7589585|FG005|Long-Term Extension Period|Disease Progression|4
4683681|NCT02484547|7589586|FG006|Long-Term Extension Period|Disease Progression|0
4683682|NCT02484547|7589580|FG000|Long-Term Extension Period|Lost to Follow-up|0
4683683|NCT02484547|7589581|FG001|Long-Term Extension Period|Lost to Follow-up|0
4683684|NCT02484547|7589582|FG002|Long-Term Extension Period|Lost to Follow-up|0
4683685|NCT02484547|7589583|FG003|Long-Term Extension Period|Lost to Follow-up|1
4683686|NCT02484547|7589584|FG004|Long-Term Extension Period|Lost to Follow-up|1
4683687|NCT02484547|7589585|FG005|Long-Term Extension Period|Lost to Follow-up|2
4683688|NCT02484547|7589586|FG006|Long-Term Extension Period|Lost to Follow-up|0
4683689|NCT02484547|7589580|FG000|Long-Term Extension Period|Loss of Capacity|0
4683690|NCT02484547|7589581|FG001|Long-Term Extension Period|Loss of Capacity|0
4683691|NCT02484547|7589582|FG002|Long-Term Extension Period|Loss of Capacity|0
4683692|NCT02484547|7589583|FG003|Long-Term Extension Period|Loss of Capacity|0
4683693|NCT02484547|7589584|FG004|Long-Term Extension Period|Loss of Capacity|1
4683694|NCT02484547|7589585|FG005|Long-Term Extension Period|Loss of Capacity|0
4683695|NCT02484547|7589586|FG006|Long-Term Extension Period|Loss of Capacity|0
4683696|NCT02484547|7589580|FG000|Long-Term Extension Period|Change of Treatment|0
4683697|NCT02484547|7589581|FG001|Long-Term Extension Period|Change of Treatment|0
4683698|NCT02484547|7589582|FG002|Long-Term Extension Period|Change of Treatment|0
4683699|NCT02484547|7589583|FG003|Long-Term Extension Period|Change of Treatment|0
4683700|NCT02484547|7589584|FG004|Long-Term Extension Period|Change of Treatment|0
4683701|NCT02484547|7589585|FG005|Long-Term Extension Period|Change of Treatment|0
4683702|NCT02484547|7589586|FG006|Long-Term Extension Period|Change of Treatment|1
4759894|NCT02660034|7733910|FG003|Overall Study|Sponsor Decision|2
4759895|NCT02660034|7733911|FG004|Overall Study|Sponsor Decision|3
4683703|NCT02484547|7589580|FG000|Long-Term Extension Period|Consent Withdrawn|0
4683704|NCT02484547|7589581|FG001|Long-Term Extension Period|Consent Withdrawn|0
4683705|NCT02484547|7589582|FG002|Long-Term Extension Period|Consent Withdrawn|0
4683706|NCT02484547|7589583|FG003|Long-Term Extension Period|Consent Withdrawn|6
4683707|NCT02484547|7589584|FG004|Long-Term Extension Period|Consent Withdrawn|7
4683708|NCT02484547|7589585|FG005|Long-Term Extension Period|Consent Withdrawn|13
4683709|NCT02484547|7589586|FG006|Long-Term Extension Period|Consent Withdrawn|17
4683710|NCT02484547|7589580|FG000|Long-Term Extension Period|Investigator Decision|0
4683711|NCT02484547|7589581|FG001|Long-Term Extension Period|Investigator Decision|0
4683712|NCT02484547|7589582|FG002|Long-Term Extension Period|Investigator Decision|0
4683713|NCT02484547|7589583|FG003|Long-Term Extension Period|Investigator Decision|2
4683714|NCT02484547|7589584|FG004|Long-Term Extension Period|Investigator Decision|1
4683715|NCT02484547|7589585|FG005|Long-Term Extension Period|Investigator Decision|0
4683716|NCT02484547|7589586|FG006|Long-Term Extension Period|Investigator Decision|1
4683717|NCT02484547|7589580|FG000|Long-Term Extension Period|Relocation|0
4683718|NCT02484547|7589581|FG001|Long-Term Extension Period|Relocation|0
4683719|NCT02484547|7589582|FG002|Long-Term Extension Period|Relocation|0
4683720|NCT02484547|7589583|FG003|Long-Term Extension Period|Relocation|1
4683721|NCT02484547|7589584|FG004|Long-Term Extension Period|Relocation|1
4683722|NCT02484547|7589585|FG005|Long-Term Extension Period|Relocation|0
4683723|NCT02484547|7589586|FG006|Long-Term Extension Period|Relocation|0
4683724|NCT02484547|7589580|FG000|Long-Term Extension Period|Study Visit Burden|0
4683725|NCT02484547|7589581|FG001|Long-Term Extension Period|Study Visit Burden|0
4683726|NCT02484547|7589582|FG002|Long-Term Extension Period|Study Visit Burden|0
4683727|NCT02484547|7589583|FG003|Long-Term Extension Period|Study Visit Burden|2
4683728|NCT02484547|7589584|FG004|Long-Term Extension Period|Study Visit Burden|0
4683729|NCT02484547|7589585|FG005|Long-Term Extension Period|Study Visit Burden|0
4683730|NCT02484547|7589586|FG006|Long-Term Extension Period|Study Visit Burden|3
4683731|NCT02484547|7589580|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0
4683732|NCT02484547|7589581|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0
4683733|NCT02484547|7589582|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0
4683734|NCT02484547|7589583|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0
4683735|NCT02484547|7589584|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1
4683736|NCT02484547|7589585|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3
4683737|NCT02484547|7589586|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2
4683738|NCT02484547|7589580|FG000|Long-Term Extension Period|Reason not Specified|0
4683739|NCT02484547|7589581|FG001|Long-Term Extension Period|Reason not Specified|0
4683740|NCT02484547|7589582|FG002|Long-Term Extension Period|Reason not Specified|0
4683741|NCT02484547|7589583|FG003|Long-Term Extension Period|Reason not Specified|119
4683742|NCT02484547|7589584|FG004|Long-Term Extension Period|Reason not Specified|117
4683743|NCT02484547|7589585|FG005|Long-Term Extension Period|Reason not Specified|223
4683744|NCT02484547|7589586|FG006|Long-Term Extension Period|Reason not Specified|231
4683745|NCT02484651|7589600|FG000|Overall Study|Patients' data files were corrupted.|1
4683746|NCT02484651|7589601|FG001|Overall Study|Patients' data files were corrupted.|1
4683747|NCT02484651|7589600|FG000|Overall Study|BIS monitoring failed.|1
4683748|NCT02484651|7589601|FG001|Overall Study|BIS monitoring failed.|1
4683749|NCT02484651|7589600|FG000|Overall Study|Time of the procedure less than 90 min.|1
4759896|NCT02660034|7733912|FG005|Overall Study|Sponsor Decision|0
4759897|NCT02660034|7733913|FG006|Overall Study|Sponsor Decision|0
4759898|NCT02660034|7733914|FG007|Overall Study|Sponsor Decision|0
4759899|NCT02660034|7733915|FG008|Overall Study|Sponsor Decision|0
4759900|NCT02660034|7733916|FG009|Overall Study|Sponsor Decision|0
4759901|NCT02660034|7733917|FG010|Overall Study|Sponsor Decision|0
4759902|NCT02660034|7733918|FG011|Overall Study|Sponsor Decision|0
4759903|NCT02660034|7733919|FG012|Overall Study|Sponsor Decision|0
4759904|NCT02660034|7733920|FG013|Overall Study|Sponsor Decision|1
4759905|NCT02660034|7733907|FG000|Overall Study|Withdrawal by Subject|0
4759906|NCT02660034|7733908|FG001|Overall Study|Withdrawal by Subject|0
4759907|NCT02660034|7733909|FG002|Overall Study|Withdrawal by Subject|0
4759908|NCT02660034|7733910|FG003|Overall Study|Withdrawal by Subject|0
4759909|NCT02660034|7733911|FG004|Overall Study|Withdrawal by Subject|0
4759910|NCT02660034|7733912|FG005|Overall Study|Withdrawal by Subject|0
4683750|NCT02484651|7589601|FG001|Overall Study|Time of the procedure less than 90 min.|2
4683751|NCT02484690|7589613|FG000|Overall Study|Adverse Event|1
4683752|NCT02484690|7589614|FG001|Overall Study|Adverse Event|3
4683753|NCT02484690|7589615|FG002|Overall Study|Adverse Event|0
4683754|NCT02484690|7589616|FG003|Overall Study|Adverse Event|0
4683755|NCT02484690|7589617|FG004|Overall Study|Adverse Event|5
4683756|NCT02484690|7589613|FG000|Overall Study|Death|0
4683757|NCT02484690|7589614|FG001|Overall Study|Death|0
4683758|NCT02484690|7589615|FG002|Overall Study|Death|0
4683759|NCT02484690|7589616|FG003|Overall Study|Death|0
4683760|NCT02484690|7589617|FG004|Overall Study|Death|1
4683761|NCT02484690|7589613|FG000|Overall Study|Withdrawal by Subject|1
4683762|NCT02484690|7589614|FG001|Overall Study|Withdrawal by Subject|3
4683763|NCT02484690|7589615|FG002|Overall Study|Withdrawal by Subject|1
4683764|NCT02484690|7589616|FG003|Overall Study|Withdrawal by Subject|2
4683765|NCT02484690|7589617|FG004|Overall Study|Withdrawal by Subject|0
4759911|NCT02660034|7733913|FG006|Overall Study|Withdrawal by Subject|1
4759912|NCT02660034|7733914|FG007|Overall Study|Withdrawal by Subject|1
4759913|NCT02660034|7733915|FG008|Overall Study|Withdrawal by Subject|1
4759914|NCT02660034|7733916|FG009|Overall Study|Withdrawal by Subject|0
4759915|NCT02660034|7733917|FG010|Overall Study|Withdrawal by Subject|0
4759916|NCT02660034|7733918|FG011|Overall Study|Withdrawal by Subject|1
4759917|NCT02660034|7733919|FG012|Overall Study|Withdrawal by Subject|2
4759918|NCT02660034|7733920|FG013|Overall Study|Withdrawal by Subject|0
4759919|NCT02660034|7733907|FG000|Overall Study|Death|0
4759920|NCT02660034|7733908|FG001|Overall Study|Death|0
4759921|NCT02660034|7733909|FG002|Overall Study|Death|0
4759922|NCT02660034|7733910|FG003|Overall Study|Death|0
4759923|NCT02660034|7733911|FG004|Overall Study|Death|0
4759924|NCT02660034|7733912|FG005|Overall Study|Death|13
4759925|NCT02660034|7733913|FG006|Overall Study|Death|14
4759926|NCT02660034|7733914|FG007|Overall Study|Death|10
4759927|NCT02660034|7733915|FG008|Overall Study|Death|9
4759928|NCT02660034|7733916|FG009|Overall Study|Death|21
4759929|NCT02660034|7733917|FG010|Overall Study|Death|17
4759930|NCT02660034|7733918|FG011|Overall Study|Death|15
4759931|NCT02660034|7733919|FG012|Overall Study|Death|18
4759932|NCT02660034|7733920|FG013|Overall Study|Death|7
4759933|NCT02660034|7733907|FG000|Overall Study|Physician Decision|0
4759934|NCT02660034|7733908|FG001|Overall Study|Physician Decision|0
4759935|NCT02660034|7733909|FG002|Overall Study|Physician Decision|0
4759936|NCT02660034|7733910|FG003|Overall Study|Physician Decision|0
4759937|NCT02660034|7733911|FG004|Overall Study|Physician Decision|0
4759938|NCT02660034|7733912|FG005|Overall Study|Physician Decision|0
4759939|NCT02660034|7733913|FG006|Overall Study|Physician Decision|0
4759940|NCT02660034|7733914|FG007|Overall Study|Physician Decision|0
4759941|NCT02660034|7733915|FG008|Overall Study|Physician Decision|0
4759942|NCT02660034|7733916|FG009|Overall Study|Physician Decision|0
4759943|NCT02660034|7733917|FG010|Overall Study|Physician Decision|0
4759944|NCT02660034|7733918|FG011|Overall Study|Physician Decision|0
4759945|NCT02660034|7733919|FG012|Overall Study|Physician Decision|0
4759946|NCT02660034|7733920|FG013|Overall Study|Physician Decision|1
4759947|NCT02660034|7733907|FG000|Overall Study|Participants transferred to LTE|0
4759948|NCT02660034|7733908|FG001|Overall Study|Participants transferred to LTE|0
4759949|NCT02660034|7733909|FG002|Overall Study|Participants transferred to LTE|0
4759950|NCT02660034|7733910|FG003|Overall Study|Participants transferred to LTE|0
4759951|NCT02660034|7733911|FG004|Overall Study|Participants transferred to LTE|0
4759952|NCT02660034|7733912|FG005|Overall Study|Participants transferred to LTE|10
4759953|NCT02660034|7733913|FG006|Overall Study|Participants transferred to LTE|8
4759954|NCT02660034|7733914|FG007|Overall Study|Participants transferred to LTE|8
4759955|NCT02660034|7733915|FG008|Overall Study|Participants transferred to LTE|10
4759956|NCT02660034|7733916|FG009|Overall Study|Participants transferred to LTE|1
4759957|NCT02660034|7733917|FG010|Overall Study|Participants transferred to LTE|2
4759958|NCT02660034|7733918|FG011|Overall Study|Participants transferred to LTE|4
4759959|NCT02660034|7733919|FG012|Overall Study|Participants transferred to LTE|1
4759960|NCT02660034|7733920|FG013|Overall Study|Participants transferred to LTE|1
4759961|NCT02640625|7733954|FG000|Overall Study|Adverse Event|1
4759962|NCT02561962|7733968|FG000|Overall Study|Ongoing in study|1
4683766|NCT02484690|7589613|FG000|Overall Study|Physician Decision|2
4683767|NCT02484690|7589614|FG001|Overall Study|Physician Decision|0
4683768|NCT02484690|7589615|FG002|Overall Study|Physician Decision|1
4683769|NCT02484690|7589616|FG003|Overall Study|Physician Decision|0
4683770|NCT02484690|7589617|FG004|Overall Study|Physician Decision|0
4683771|NCT02484690|7589613|FG000|Overall Study|Lost to Follow-up|0
4683772|NCT02484690|7589614|FG001|Overall Study|Lost to Follow-up|0
4683773|NCT02484690|7589615|FG002|Overall Study|Lost to Follow-up|1
4759963|NCT02561962|7733969|FG001|Overall Study|Ongoing in study|0
4759964|NCT02561962|7733970|FG002|Overall Study|Ongoing in study|0
4759965|NCT02561962|7733971|FG003|Overall Study|Ongoing in study|1
4759966|NCT02561962|7733972|FG004|Overall Study|Ongoing in study|0
4759967|NCT02561962|7733973|FG005|Overall Study|Ongoing in study|1
4759968|NCT02561962|7733974|FG006|Overall Study|Ongoing in study|0
4759969|NCT02561962|7733975|FG007|Overall Study|Ongoing in study|4
4759970|NCT02561962|7733976|FG008|Overall Study|Ongoing in study|1
4759971|NCT02561962|7733968|FG000|Overall Study|Withdrawal by Subject|1
4683774|NCT02484690|7589616|FG003|Overall Study|Lost to Follow-up|0
4683775|NCT02484690|7589617|FG004|Overall Study|Lost to Follow-up|0
4683776|NCT02484729|7589640|FG000|Overall Study|Failure of IntelliCap Error|0
4683777|NCT02484729|7589641|FG001|Overall Study|Failure of IntelliCap Error|0
4683778|NCT02484729|7589642|FG002|Overall Study|Failure of IntelliCap Error|0
4683779|NCT02484729|7589643|FG003|Overall Study|Failure of IntelliCap Error|0
4683780|NCT02484729|7589644|FG004|Overall Study|Failure of IntelliCap Error|0
4683781|NCT02484729|7589645|FG005|Overall Study|Failure of IntelliCap Error|0
4683782|NCT02484729|7589646|FG006|Overall Study|Failure of IntelliCap Error|0
4683783|NCT02484729|7589647|FG007|Overall Study|Failure of IntelliCap Error|0
4683784|NCT02484729|7589648|FG008|Overall Study|Failure of IntelliCap Error|0
4683785|NCT02484729|7589649|FG009|Overall Study|Failure of IntelliCap Error|1
4683786|NCT02484911|7589726|FG000|Overall Study|Withdrawal by Subject|2
4683787|NCT02484911|7589727|FG001|Overall Study|Withdrawal by Subject|1
4683788|NCT02484911|7589726|FG000|Overall Study|Protocol Violation|2
4683789|NCT02484911|7589727|FG001|Overall Study|Protocol Violation|1
4683790|NCT02485158|7589734|FG000|Overall Study|Withdrawal by Subject|3
4759972|NCT02561962|7733969|FG001|Overall Study|Withdrawal by Subject|0
4759973|NCT02561962|7733970|FG002|Overall Study|Withdrawal by Subject|0
4759974|NCT02561962|7733971|FG003|Overall Study|Withdrawal by Subject|0
4759975|NCT02561962|7733972|FG004|Overall Study|Withdrawal by Subject|1
4759976|NCT02561962|7733973|FG005|Overall Study|Withdrawal by Subject|1
4759977|NCT02561962|7733974|FG006|Overall Study|Withdrawal by Subject|2
4759978|NCT02561962|7733975|FG007|Overall Study|Withdrawal by Subject|1
4759979|NCT02561962|7733976|FG008|Overall Study|Withdrawal by Subject|0
4759980|NCT02561962|7733968|FG000|Overall Study|Decision by sponsor|0
4759981|NCT02561962|7733969|FG001|Overall Study|Decision by sponsor|0
4759982|NCT02561962|7733970|FG002|Overall Study|Decision by sponsor|0
4759983|NCT02561962|7733971|FG003|Overall Study|Decision by sponsor|0
4683791|NCT02485158|7589734|FG000|Overall Study|expected drug side effect|1
4683792|NCT02485301|7589745|FG000|Overall Study|Serious Adverse Events|2
4683793|NCT02485301|7589746|FG001|Overall Study|Serious Adverse Events|1
4683794|NCT02485301|7589745|FG000|Overall Study|Protocol Violation|0
4683795|NCT02485301|7589746|FG001|Overall Study|Protocol Violation|1
4683796|NCT02485301|7589745|FG000|Overall Study|Withdrawal by Subject|6
4683797|NCT02485301|7589746|FG001|Overall Study|Withdrawal by Subject|7
4683798|NCT02485301|7589745|FG000|Overall Study|Migrated/moved from study area|10
4683799|NCT02485301|7589746|FG001|Overall Study|Migrated/moved from study area|19
4683800|NCT02485301|7589745|FG000|Overall Study|Lost to Follow-up|17
4683801|NCT02485301|7589746|FG001|Overall Study|Lost to Follow-up|17
4683802|NCT02485301|7589745|FG000|Overall Study|Other|3
4683803|NCT02485301|7589746|FG001|Overall Study|Other|4
4683804|NCT02485353|7589752|FG000|Overall Study|Death|1
4683805|NCT02485353|7589752|FG000|Overall Study|Disease Progression|1
4683806|NCT02485483|7589758|FG000|Overall Study|Depression at baseline|15
4683807|NCT02485483|7589759|FG001|Overall Study|Depression at baseline|0
4683808|NCT02485483|7589758|FG000|Overall Study|Discontinued after baseline|39
4683809|NCT02485483|7589759|FG001|Overall Study|Discontinued after baseline|0
4683810|NCT02485704|7589780|FG000|Overall Study|Lost to Follow-up|4
4683811|NCT02485704|7589781|FG001|Overall Study|Lost to Follow-up|5
4683812|NCT02485704|7589780|FG000|Overall Study|Withdrawal by Subject|0
4683813|NCT02485704|7589781|FG001|Overall Study|Withdrawal by Subject|3
4683814|NCT02485704|7589780|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1
4683815|NCT02485704|7589781|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0
4683816|NCT02485717|7589790|FG000|Overall Study|Lost to Follow-up|6
4683817|NCT02485717|7589791|FG001|Overall Study|Lost to Follow-up|0
4683818|NCT02485717|7589792|FG002|Overall Study|Lost to Follow-up|0
4683819|NCT02485717|7589790|FG000|Overall Study|Withdrawal by Subject|0
4683820|NCT02485717|7589791|FG001|Overall Study|Withdrawal by Subject|0
4683821|NCT02485717|7589792|FG002|Overall Study|Withdrawal by Subject|1
4683822|NCT02485717|7589790|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0
4683823|NCT02485717|7589791|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1
4683824|NCT02485717|7589792|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0
4683825|NCT02485717|7589790|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0
4683826|NCT02485717|7589791|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1
4683827|NCT02485717|7589792|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0
4683828|NCT02485925|7589815|FG000|Overall Study|Withdrawal by Subject|3
4683829|NCT02485925|7589815|FG000|Overall Study|Death|1
4683830|NCT02485925|7589815|FG000|Overall Study|Lost to Follow-up|11
4683831|NCT02486302|7589852|FG000|Overall Study|Discontinued prematurely|410
4683832|NCT02486302|7589852|FG000|Overall Study|Documentation not completed|255
4683833|NCT02486302|7589852|FG000|Overall Study|Excluded due to legal reasons|8
4683834|NCT02486302|7589852|FG000|Overall Study|Not treated|3
4683835|NCT02486406|7589878|FG000|Overall Study|Withdrew consent|1
4683836|NCT02486406|7589879|FG001|Overall Study|Withdrew consent|0
4683837|NCT02486406|7589880|FG002|Overall Study|Withdrew consent|0
4683838|NCT02486406|7589881|FG003|Overall Study|Withdrew consent|1
4683839|NCT02486406|7589878|FG000|Overall Study|Lost to Follow-up|1
4683840|NCT02486406|7589879|FG001|Overall Study|Lost to Follow-up|3
4683841|NCT02486406|7589880|FG002|Overall Study|Lost to Follow-up|1
4759984|NCT02561962|7733972|FG004|Overall Study|Decision by sponsor|1
4759985|NCT02561962|7733973|FG005|Overall Study|Decision by sponsor|1
4759986|NCT02561962|7733974|FG006|Overall Study|Decision by sponsor|0
4759987|NCT02561962|7733975|FG007|Overall Study|Decision by sponsor|3
4759988|NCT02561962|7733976|FG008|Overall Study|Decision by sponsor|0
4759989|NCT02561962|7733968|FG000|Overall Study|Lost to Follow-up|0
4759990|NCT02561962|7733969|FG001|Overall Study|Lost to Follow-up|0
4683842|NCT02486406|7589881|FG003|Overall Study|Lost to Follow-up|3
4683843|NCT02486406|7589878|FG000|Overall Study|Other, not specified|0
4683844|NCT02486406|7589879|FG001|Overall Study|Other, not specified|0
4683845|NCT02486406|7589880|FG002|Overall Study|Other, not specified|1
4683846|NCT02486406|7589881|FG003|Overall Study|Other, not specified|0
4683847|NCT02486588|7589919|FG000|Overall Study|Randomized in error- ineligible|738
4683848|NCT02486588|7589920|FG001|Overall Study|Randomized in error- ineligible|750
4683849|NCT02486588|7589921|FG002|Overall Study|Randomized in error- ineligible|755
4683850|NCT02486588|7589922|FG003|Overall Study|Randomized in error- ineligible|738
4759991|NCT02561962|7733970|FG002|Overall Study|Lost to Follow-up|0
4759992|NCT02561962|7733971|FG003|Overall Study|Lost to Follow-up|0
4759993|NCT02561962|7733972|FG004|Overall Study|Lost to Follow-up|0
4759994|NCT02561962|7733973|FG005|Overall Study|Lost to Follow-up|1
4759995|NCT02561962|7733974|FG006|Overall Study|Lost to Follow-up|0
4759996|NCT02561962|7733975|FG007|Overall Study|Lost to Follow-up|0
4759997|NCT02561962|7733976|FG008|Overall Study|Lost to Follow-up|0
4759998|NCT02500589|7733998|FG000|Overall Study|Withdrawal by Subject|11
4759999|NCT02500589|7733999|FG001|Overall Study|Withdrawal by Subject|14
4760000|NCT02500589|7733998|FG000|Overall Study|Lost to Follow-up|10
4760001|NCT02500589|7733999|FG001|Overall Study|Lost to Follow-up|12
4760002|NCT02500589|7733998|FG000|Overall Study|Excluded post rand: cognitive impairment|0
4760003|NCT02500589|7733999|FG001|Overall Study|Excluded post rand: cognitive impairment|1
4760004|NCT02500589|7733998|FG000|Overall Study|Death|7
4760005|NCT02500589|7733999|FG001|Overall Study|Death|5
4760006|NCT02474329|7734009|FG000|Overall Study|Withdraw or did not contribute data.|13
4760007|NCT02471339|7734016|FG000|Overall Study|Did not provide follow-up data|2
4760008|NCT02471339|7734017|FG001|Overall Study|Did not provide follow-up data|0
4760009|NCT01388491|7734048|FG000|Overall Study|Adverse Event|10
4760010|NCT01388491|7734049|FG001|Overall Study|Adverse Event|9
4760011|NCT01388491|7734048|FG000|Overall Study|Sponsor Request|9
4760012|NCT01388491|7734049|FG001|Overall Study|Sponsor Request|7
4760013|NCT01388491|7734048|FG000|Overall Study|Withdrawal by Subject|6
4760014|NCT01388491|7734049|FG001|Overall Study|Withdrawal by Subject|10
4760015|NCT01388491|7734048|FG000|Overall Study|Lost to Follow-up|4
4760016|NCT01388491|7734049|FG001|Overall Study|Lost to Follow-up|3
4760017|NCT01388491|7734048|FG000|Overall Study|Protocol Violation|2
4760018|NCT01388491|7734049|FG001|Overall Study|Protocol Violation|0
4760019|NCT01388491|7734048|FG000|Overall Study|Noncompliance|2
4760020|NCT01388491|7734049|FG001|Overall Study|Noncompliance|0
4760021|NCT01388491|7734048|FG000|Overall Study|Pregnancy|1
4760022|NCT01388491|7734049|FG001|Overall Study|Pregnancy|0
4683851|NCT02486588|7589923|FG004|Overall Study|Randomized in error- ineligible|746
4683852|NCT02486588|7589924|FG005|Overall Study|Randomized in error- ineligible|746
4683853|NCT02486627|7589945|FG000|Overall Study|Death|1
4683854|NCT02486627|7589946|FG001|Overall Study|Death|0
4683855|NCT02486627|7589945|FG000|Overall Study|Other Unspecified|0
4683856|NCT02486627|7589946|FG001|Overall Study|Other Unspecified|2
4683857|NCT02486627|7589945|FG000|Overall Study|Consent Withdrawn by Participant|4
4683858|NCT02486627|7589946|FG001|Overall Study|Consent Withdrawn by Participant|3
4683859|NCT02486627|7589945|FG000|Overall Study|Significant Participant Noncompliance|1
4683860|NCT02486627|7589946|FG001|Overall Study|Significant Participant Noncompliance|1
4683861|NCT02486627|7589945|FG000|Overall Study|Lost to Follow-up|1
4683862|NCT02486627|7589946|FG001|Overall Study|Lost to Follow-up|3
4683863|NCT02486653|7589954|FG000|Overall Study|Withdrawal by Subject|1
4683864|NCT02486653|7589955|FG001|Overall Study|Withdrawal by Subject|3
4683865|NCT02486653|7589954|FG000|Overall Study|Protocol Violation|1
4683866|NCT02486653|7589955|FG001|Overall Study|Protocol Violation|0
4683867|NCT02486653|7589954|FG000|Overall Study|surgery cancelled|4
4683868|NCT02486653|7589955|FG001|Overall Study|surgery cancelled|1
4683869|NCT02486692|7589963|FG000|Overall Study|did not login for randomization|4
4683870|NCT02486692|7589964|FG001|Overall Study|did not login for randomization|7
4683871|NCT02486757|7589970|FG000|Overall Study|Lost to Follow-up|1
4683872|NCT02486796|7589976|FG000|Overall Study|Withdrawal by Subject|1
4683873|NCT02486796|7589977|FG001|Overall Study|Withdrawal by Subject|1
4683874|NCT02486796|7589976|FG000|Overall Study|Physician Decision|1
4683875|NCT02486796|7589977|FG001|Overall Study|Physician Decision|0
4683876|NCT02486952|7589992|FG000|Overall Study|Not Started Induction Therapy|3
4683877|NCT02486952|7589992|FG000|Overall Study|Adverse Event|1
4683878|NCT02486952|7589992|FG000|Overall Study|Death|15
4683879|NCT02486952|7589992|FG000|Overall Study|Lack of Efficacy|3
4683880|NCT02486952|7589992|FG000|Overall Study|Lost to Follow-up|26
4683881|NCT02486952|7589992|FG000|Overall Study|Other|2
4683882|NCT02487030|7590003|FG000|Overall Study|Lack of Efficacy|2
4683883|NCT02487030|7590004|FG001|Overall Study|Lack of Efficacy|4
4683884|NCT02487030|7590005|FG002|Overall Study|Lack of Efficacy|1
4683885|NCT02487030|7590006|FG003|Overall Study|Lack of Efficacy|0
4683886|NCT02487030|7590007|FG004|Overall Study|Lack of Efficacy|1
4683887|NCT02487030|7590008|FG005|Overall Study|Lack of Efficacy|0
4683888|NCT02487030|7590009|FG006|Overall Study|Lack of Efficacy|0
4683889|NCT02487030|7590003|FG000|Overall Study|Lost to Follow-up|0
4760023|NCT01373151|7734062|FG000|Period 1|Lack of Efficacy|3
4760024|NCT01373151|7734063|FG001|Period 1|Lack of Efficacy|0
4760025|NCT01373151|7734064|FG002|Period 1|Lack of Efficacy|0
4760026|NCT01373151|7734065|FG003|Period 1|Lack of Efficacy|0
4760027|NCT01373151|7734066|FG004|Period 1|Lack of Efficacy|1
4760028|NCT01373151|7734067|FG005|Period 1|Lack of Efficacy|0
4760029|NCT01373151|7734068|FG006|Period 1|Lack of Efficacy|0
4760030|NCT01373151|7734062|FG000|Period 1|Adverse Event|0
4760031|NCT01373151|7734063|FG001|Period 1|Adverse Event|0
4760032|NCT01373151|7734064|FG002|Period 1|Adverse Event|1
4760033|NCT01373151|7734065|FG003|Period 1|Adverse Event|0
4760034|NCT01373151|7734066|FG004|Period 1|Adverse Event|4
4760035|NCT01373151|7734067|FG005|Period 1|Adverse Event|3
4760036|NCT01373151|7734068|FG006|Period 1|Adverse Event|0
4760037|NCT01373151|7734062|FG000|Period 1|Withdrawal by Subject|2
4760038|NCT01373151|7734063|FG001|Period 1|Withdrawal by Subject|0
4760039|NCT01373151|7734064|FG002|Period 1|Withdrawal by Subject|3
4760040|NCT01373151|7734065|FG003|Period 1|Withdrawal by Subject|1
4760041|NCT01373151|7734066|FG004|Period 1|Withdrawal by Subject|0
4760042|NCT01373151|7734067|FG005|Period 1|Withdrawal by Subject|1
4760043|NCT01373151|7734068|FG006|Period 1|Withdrawal by Subject|0
4760044|NCT01373151|7734062|FG000|Period 2|Lack of Efficacy|9
4760045|NCT01373151|7734063|FG001|Period 2|Lack of Efficacy|0
4760046|NCT01373151|7734064|FG002|Period 2|Lack of Efficacy|0
4760047|NCT01373151|7734065|FG003|Period 2|Lack of Efficacy|1
4760048|NCT01373151|7734066|FG004|Period 2|Lack of Efficacy|2
4760049|NCT01373151|7734067|FG005|Period 2|Lack of Efficacy|0
4760050|NCT01373151|7734068|FG006|Period 2|Lack of Efficacy|3
4760051|NCT01373151|7734062|FG000|Period 2|Adverse Event|0
4760052|NCT01373151|7734063|FG001|Period 2|Adverse Event|0
4760053|NCT01373151|7734064|FG002|Period 2|Adverse Event|3
4760054|NCT01373151|7734065|FG003|Period 2|Adverse Event|3
4760055|NCT01373151|7734066|FG004|Period 2|Adverse Event|0
4760056|NCT01373151|7734067|FG005|Period 2|Adverse Event|0
4760057|NCT01373151|7734068|FG006|Period 2|Adverse Event|1
4760058|NCT01373151|7734062|FG000|Period 2|subject request to discontinue|0
4760059|NCT01373151|7734063|FG001|Period 2|subject request to discontinue|1
4760060|NCT01373151|7734064|FG002|Period 2|subject request to discontinue|0
4760061|NCT01373151|7734065|FG003|Period 2|subject request to discontinue|0
4760062|NCT01373151|7734066|FG004|Period 2|subject request to discontinue|0
4760063|NCT01373151|7734067|FG005|Period 2|subject request to discontinue|0
4760064|NCT01373151|7734068|FG006|Period 2|subject request to discontinue|0
4760065|NCT01373151|7734062|FG000|Period 2|Withdrawal by Subject|0
4760066|NCT01373151|7734063|FG001|Period 2|Withdrawal by Subject|0
4760067|NCT01373151|7734064|FG002|Period 2|Withdrawal by Subject|0
4760068|NCT01373151|7734065|FG003|Period 2|Withdrawal by Subject|1
4760069|NCT01373151|7734066|FG004|Period 2|Withdrawal by Subject|0
4760070|NCT01373151|7734067|FG005|Period 2|Withdrawal by Subject|0
4683890|NCT02487030|7590004|FG001|Overall Study|Lost to Follow-up|0
4683891|NCT02487030|7590005|FG002|Overall Study|Lost to Follow-up|1
4683892|NCT02487030|7590006|FG003|Overall Study|Lost to Follow-up|1
4683893|NCT02487030|7590007|FG004|Overall Study|Lost to Follow-up|0
4683894|NCT02487030|7590008|FG005|Overall Study|Lost to Follow-up|1
4760071|NCT01373151|7734068|FG006|Period 2|Withdrawal by Subject|0
4760072|NCT01373151|7734062|FG000|Period 2|Other|0
4760073|NCT01373151|7734063|FG001|Period 2|Other|0
4683895|NCT02487030|7590009|FG006|Overall Study|Lost to Follow-up|0
4683896|NCT02487030|7590003|FG000|Overall Study|Adverse Event|0
4683897|NCT02487030|7590004|FG001|Overall Study|Adverse Event|0
4683898|NCT02487030|7590005|FG002|Overall Study|Adverse Event|0
4683899|NCT02487030|7590006|FG003|Overall Study|Adverse Event|1
4683900|NCT02487030|7590007|FG004|Overall Study|Adverse Event|0
4683901|NCT02487030|7590008|FG005|Overall Study|Adverse Event|0
4683902|NCT02487030|7590009|FG006|Overall Study|Adverse Event|0
4683903|NCT02487030|7590003|FG000|Overall Study|Death|0
4683904|NCT02487030|7590004|FG001|Overall Study|Death|0
4683905|NCT02487030|7590005|FG002|Overall Study|Death|0
4683906|NCT02487030|7590006|FG003|Overall Study|Death|0
4683907|NCT02487030|7590007|FG004|Overall Study|Death|1
4683908|NCT02487030|7590008|FG005|Overall Study|Death|0
4683909|NCT02487030|7590009|FG006|Overall Study|Death|0
4683910|NCT02487199|7590033|FG000|Overall Study|Withdrew Consent|0
4683911|NCT02487199|7590034|FG001|Overall Study|Withdrew Consent|1
4683912|NCT02487446|7590065|FG000|Period 1|Physician Decision|0
4683913|NCT02487446|7590066|FG001|Period 1|Physician Decision|1
4683914|NCT02487446|7590065|FG000|Period 1|Lack of Efficacy|1
4683915|NCT02487446|7590066|FG001|Period 1|Lack of Efficacy|0
4683916|NCT02487446|7590065|FG000|Period 1|Protocol deviation|3
4683917|NCT02487446|7590066|FG001|Period 1|Protocol deviation|2
4683918|NCT02487446|7590065|FG000|Period 1|Lost to Follow-up|2
4683919|NCT02487446|7590066|FG001|Period 1|Lost to Follow-up|0
4683920|NCT02487446|7590065|FG000|Period 1|Withdrawal by Subject|2
4683921|NCT02487446|7590066|FG001|Period 1|Withdrawal by Subject|0
4760074|NCT01373151|7734064|FG002|Period 2|Other|1
4760075|NCT01373151|7734065|FG003|Period 2|Other|0
4760076|NCT01373151|7734066|FG004|Period 2|Other|0
4760077|NCT01373151|7734067|FG005|Period 2|Other|0
4760078|NCT01373151|7734068|FG006|Period 2|Other|1
4760079|NCT01281644|7734097|FG000|Overall Study|Lost to Follow-up|3
4760080|NCT01281644|7734097|FG000|Overall Study|Withdrawal by Subject|2
4760081|NCT00960297|7734109|FG000|Overall Study|Physician Decision|1
4760082|NCT00960297|7734109|FG000|Overall Study|Venous port infection|1
4760083|NCT00960297|7734109|FG000|Overall Study|Disease progression|1
4760084|NCT00910650|7734113|FG000|Overall Study|Death|2
4760085|NCT00703326|7734123|FG000|Overall Study|Lost to Follow-up|47
4760086|NCT00703326|7734124|FG001|Overall Study|Lost to Follow-up|18
4683922|NCT02487446|7590065|FG000|Period 1|Adverse Event|5
4683923|NCT02487446|7590066|FG001|Period 1|Adverse Event|5
4683924|NCT02487446|7590065|FG000|Washout|Lost to Follow-up|0
4683925|NCT02487446|7590066|FG001|Washout|Lost to Follow-up|2
4683926|NCT02487446|7590065|FG000|Washout|Withdrawal by Subject|1
4683927|NCT02487446|7590066|FG001|Washout|Withdrawal by Subject|4
4683928|NCT02487446|7590065|FG000|Washout|Adverse Event|2
4683929|NCT02487446|7590066|FG001|Washout|Adverse Event|2
4683930|NCT02487446|7590065|FG000|Period 2|Protocol deviation|0
4683931|NCT02487446|7590066|FG001|Period 2|Protocol deviation|1
4683932|NCT02487446|7590065|FG000|Period 2|Lost to Follow-up|1
4683933|NCT02487446|7590066|FG001|Period 2|Lost to Follow-up|1
4683934|NCT02487446|7590065|FG000|Period 2|Withdrawal by Subject|1
4683935|NCT02487446|7590066|FG001|Period 2|Withdrawal by Subject|1
4683936|NCT02487446|7590065|FG000|Period 2|Adverse Event|6
4683937|NCT02487446|7590066|FG001|Period 2|Adverse Event|2
4683938|NCT02487472|7590073|FG000|Overall Study|Did not complete telephonic interviews|9
4683939|NCT02487472|7590073|FG000|Overall Study|Other|2
4683940|NCT02487498|7590088|FG000|Period: Period 1|Adverse Event|2
4683941|NCT02487498|7590089|FG001|Period: Period 1|Adverse Event|4
4683942|NCT02487498|7590088|FG000|Period: Period 1|Subject/guardian decision|2
4683943|NCT02487498|7590089|FG001|Period: Period 1|Subject/guardian decision|4
4683944|NCT02487498|7590088|FG000|Period: Period 1|Lost to Follow-up|0
4683945|NCT02487498|7590089|FG001|Period: Period 1|Lost to Follow-up|2
4683946|NCT02487498|7590088|FG000|Period: Period 1|Lack of Efficacy|1
4683947|NCT02487498|7590089|FG001|Period: Period 1|Lack of Efficacy|0
4683948|NCT02487498|7590088|FG000|Period: Period 1|Physician Decision|0
4683949|NCT02487498|7590089|FG001|Period: Period 1|Physician Decision|1
4683950|NCT02487498|7590088|FG000|Period: Period 1|Protocol deviation|1
4683951|NCT02487498|7590089|FG001|Period: Period 1|Protocol deviation|0
4683952|NCT02487498|7590088|FG000|Period: Washout|Subject/guardian decision|0
4683953|NCT02487498|7590089|FG001|Period: Washout|Subject/guardian decision|5
4683954|NCT02487498|7590088|FG000|Period: Washout|Lack of Efficacy|1
4683955|NCT02487498|7590089|FG001|Period: Washout|Lack of Efficacy|1
4683956|NCT02487498|7590088|FG000|Period: Washout|Physician Decision|1
4683957|NCT02487498|7590089|FG001|Period: Washout|Physician Decision|0
4683958|NCT02487498|7590088|FG000|Period: Washout|Non-compliance with study treatment|0
4683959|NCT02487498|7590089|FG001|Period: Washout|Non-compliance with study treatment|1
4683960|NCT02487498|7590088|FG000|Period: Period 2|Adverse Event|2
4760087|NCT00703326|7734123|FG000|Overall Study|Withdrawal by Subject|54
4683961|NCT02487498|7590089|FG001|Period: Period 2|Adverse Event|2
4760088|NCT00703326|7734124|FG001|Overall Study|Withdrawal by Subject|20
4683962|NCT02487498|7590088|FG000|Period: Period 2|Subject/guardian decision|2
4683963|NCT02487498|7590089|FG001|Period: Period 2|Subject/guardian decision|1
4760089|NCT00703326|7734123|FG000|Overall Study|Adverse Event|1
4760090|NCT00703326|7734124|FG001|Overall Study|Adverse Event|0
4683964|NCT02487498|7590088|FG000|Period: Period 2|Lost to Follow-up|1
4683965|NCT02487498|7590089|FG001|Period: Period 2|Lost to Follow-up|1
4683966|NCT02487498|7590088|FG000|Period: Period 2|Death|0
4683967|NCT02487498|7590089|FG001|Period: Period 2|Death|1
4683968|NCT02487498|7590088|FG000|Period: Period 2|Physician Decision|1
4683969|NCT02487498|7590089|FG001|Period: Period 2|Physician Decision|0
4683970|NCT02487771|7590114|FG000|Overall Study|Lost to Follow-up|2
4683971|NCT02487771|7590115|FG001|Overall Study|Lost to Follow-up|3
4683972|NCT02487771|7590114|FG000|Overall Study|Moved out of area|5
4683973|NCT02487771|7590115|FG001|Overall Study|Moved out of area|6
4683974|NCT02487771|7590114|FG000|Overall Study|Withdrawal by Subject|3
4683975|NCT02487771|7590115|FG001|Overall Study|Withdrawal by Subject|5
4683976|NCT02487810|7590123|FG000|Overall Study|Withdrawal by Subject|1
4683977|NCT02487810|7590124|FG001|Overall Study|Withdrawal by Subject|0
4683978|NCT02488005|7590147|FG000|Overall Study|Lost to Follow-up|2
4683979|NCT02488109|7590162|FG000|Treatment in Hospital|Withdrawal by Subject|0
4683980|NCT02488109|7590163|FG001|Treatment in Hospital|Withdrawal by Subject|5
4683981|NCT02488109|7590162|FG000|12-month Follow-Up|Lost to Follow-up|4
4683982|NCT02488109|7590163|FG001|12-month Follow-Up|Lost to Follow-up|7
4683983|NCT02488239|7590171|FG000|Overall Study|Death|3
4683984|NCT02488239|7590171|FG000|Overall Study|Withdrawal by Subject|3
4683985|NCT02488239|7590171|FG000|Overall Study|Physician Decision|2
4683986|NCT02488239|7590171|FG000|Overall Study|Consent ineligible|1
4683987|NCT02488239|7590171|FG000|Overall Study|Did not undergo implant procedure|1
4683988|NCT02488330|7590189|FG000|Overall Study|Adverse Event|1
4683989|NCT02488330|7590189|FG000|Overall Study|Physician Decision|2
4683990|NCT02488330|7590189|FG000|Overall Study|Death|2
4683991|NCT02488330|7590189|FG000|Overall Study|Disease Progression|3
4683992|NCT02488330|7590189|FG000|Overall Study|Study Termination by Sponsor|4
4683993|NCT02488681|7590193|FG000|Overall Study|Implant unsuccessful|7
4683994|NCT02488824|7590199|FG000|Overall Study|Adverse Event|1
4683995|NCT02488824|7590200|FG001|Overall Study|Adverse Event|1
4683996|NCT02488915|7590206|FG000|Overall Study|Death|21
4683997|NCT02488915|7590206|FG000|Overall Study|Lost to Follow-up|4
4683998|NCT02488915|7590206|FG000|Overall Study|Withdrawal by Subject|1
4683999|NCT02488980|7590213|FG000|Overall Study|Protocol Violation|2
4684000|NCT02488980|7590214|FG001|Overall Study|Protocol Violation|2
4684001|NCT02488980|7590215|FG002|Overall Study|Protocol Violation|2
4684002|NCT02489045|7590223|FG000|Overall Study|unable to collect usable data|53
4684003|NCT02489045|7590223|FG000|Follow-up|Lost to Follow-up|10
4684004|NCT02489279|7590257|FG000|Overall Study|Lost to Follow-up|12
4684005|NCT02489279|7590258|FG001|Overall Study|Lost to Follow-up|10
4760091|NCT00602667|7734134|FG000|Overall Study|Still on Therapy|0
4760092|NCT00602667|7734135|FG001|Overall Study|Still on Therapy|2
4760093|NCT00602667|7734136|FG002|Overall Study|Still on Therapy|2
4760094|NCT00602667|7734134|FG000|Overall Study|Death|0
4760095|NCT00602667|7734135|FG001|Overall Study|Death|1
4760096|NCT00602667|7734136|FG002|Overall Study|Death|1
4760097|NCT00602667|7734134|FG000|Overall Study|Family request|3
4760098|NCT00602667|7734135|FG001|Overall Study|Family request|25
4760099|NCT00602667|7734136|FG002|Overall Study|Family request|6
4760100|NCT00602667|7734134|FG000|Overall Study|Excessive toxicity|1
4760101|NCT00602667|7734135|FG001|Overall Study|Excessive toxicity|1
4760102|NCT00602667|7734136|FG002|Overall Study|Excessive toxicity|0
4760103|NCT00602667|7734134|FG000|Overall Study|Second malignancy|0
4760104|NCT00602667|7734135|FG001|Overall Study|Second malignancy|1
4760105|NCT00602667|7734136|FG002|Overall Study|Second malignancy|0
4760106|NCT00602667|7734134|FG000|Overall Study|Physician Decision|2
4760107|NCT00602667|7734135|FG001|Overall Study|Physician Decision|3
4760108|NCT00602667|7734136|FG002|Overall Study|Physician Decision|8
4760109|NCT00602667|7734134|FG000|Overall Study|Progressive disease|13
4760110|NCT00602667|7734135|FG001|Overall Study|Progressive disease|48
4760111|NCT00602667|7734136|FG002|Overall Study|Progressive disease|45
4760112|NCT00602667|7734134|FG000|Overall Study|Progressive disease prior to therapy|0
4760113|NCT00602667|7734135|FG001|Overall Study|Progressive disease prior to therapy|0
4760114|NCT00602667|7734136|FG002|Overall Study|Progressive disease prior to therapy|1
4760115|NCT00472186|7734177|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1
4760116|NCT00472186|7734178|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0
4684006|NCT02489344|7590264|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1
4684007|NCT02489344|7590264|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1
4684008|NCT02489344|7590264|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1
4684009|NCT02489344|7590264|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2
4684010|NCT02489500|7590274|FG000|Overall Study|Death|1
4684011|NCT02489500|7590275|FG001|Overall Study|Death|1
4684012|NCT02489630|7590283|FG000|Overall Study|Oversedation|1
4684013|NCT02489630|7590284|FG001|Overall Study|Oversedation|1
4760117|NCT03996876|7734188|FG000|Overall Study|Incomplete Data|2
4760118|NCT03996876|7734189|FG001|Overall Study|Incomplete Data|4
4760119|NCT03589976|7734198|FG000|Overall Study|Death|5
4760120|NCT03589976|7734199|FG001|Overall Study|Death|1
4760121|NCT03589976|7734198|FG000|Overall Study|Adverse Event|5
4760122|NCT03589976|7734199|FG001|Overall Study|Adverse Event|1
4760123|NCT03589976|7734198|FG000|Overall Study|Withdrawal by Subject|4
4760124|NCT03589976|7734199|FG001|Overall Study|Withdrawal by Subject|1
4760125|NCT03589976|7734198|FG000|Overall Study|Lost to Follow-up|1
4760126|NCT03589976|7734199|FG001|Overall Study|Lost to Follow-up|0
4760127|NCT03589976|7734198|FG000|Overall Study|Other|4
4760128|NCT03589976|7734199|FG001|Overall Study|Other|3
4760129|NCT03135262|7734246|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1
4760130|NCT03135262|7734247|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0
4760131|NCT03135262|7734248|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0
4760132|NCT03135262|7734249|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0
4760133|NCT03135262|7734250|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0
4760134|NCT03135262|7734246|FG000|Overall Study|Progression of disease|0
4760135|NCT03135262|7734247|FG001|Overall Study|Progression of disease|0
4760136|NCT03135262|7734248|FG002|Overall Study|Progression of disease|0
4760137|NCT03135262|7734249|FG003|Overall Study|Progression of disease|1
4760138|NCT03135262|7734250|FG004|Overall Study|Progression of disease|0
4760139|NCT03135262|7734246|FG000|Overall Study|Death|6
4760140|NCT03135262|7734247|FG001|Overall Study|Death|2
4760141|NCT03135262|7734248|FG002|Overall Study|Death|2
4760142|NCT03135262|7734249|FG003|Overall Study|Death|2
4760143|NCT03135262|7734250|FG004|Overall Study|Death|0
4760144|NCT03135262|7734246|FG000|Overall Study|Withdrawal by Subject|0
4760145|NCT03135262|7734247|FG001|Overall Study|Withdrawal by Subject|0
4760146|NCT03135262|7734248|FG002|Overall Study|Withdrawal by Subject|1
4760147|NCT03135262|7734249|FG003|Overall Study|Withdrawal by Subject|0
4760148|NCT03135262|7734250|FG004|Overall Study|Withdrawal by Subject|1
4684014|NCT02489630|7590283|FG000|Overall Study|Time to med. admin. > protocol limit|1
4684015|NCT02489630|7590284|FG001|Overall Study|Time to med. admin. > protocol limit|1
4684016|NCT02489773|7590301|FG000|Overall Study|Lost to Follow-up|4
4684017|NCT02489773|7590302|FG001|Overall Study|Lost to Follow-up|1
4684018|NCT02489773|7590301|FG000|Overall Study|Physician Decision|1
4684019|NCT02489773|7590302|FG001|Overall Study|Physician Decision|0
4684020|NCT02489773|7590301|FG000|Overall Study|Withdrawal by Subject|1
4684021|NCT02489773|7590302|FG001|Overall Study|Withdrawal by Subject|0
4684022|NCT02489773|7590301|FG000|Overall Study|Leave the country or the state|1
4684023|NCT02489773|7590302|FG001|Overall Study|Leave the country or the state|1
4684024|NCT02489799|7590310|FG000|Overall Study|Lost to Follow-up|4
4684025|NCT02489799|7590311|FG001|Overall Study|Lost to Follow-up|1
4684026|NCT02489799|7590310|FG000|Overall Study|Failure to Maintain Eligibility|4
4684027|NCT02489799|7590311|FG001|Overall Study|Failure to Maintain Eligibility|6
4684028|NCT02489799|7590310|FG000|Overall Study|Withdrawal by Subject|1
4684029|NCT02489799|7590311|FG001|Overall Study|Withdrawal by Subject|1
4684030|NCT02489799|7590310|FG000|Overall Study|Death|0
4684031|NCT02489799|7590311|FG001|Overall Study|Death|1
4684032|NCT02489968|7590319|FG000|Open-label Treatment Period|Adverse Event|14
4684033|NCT02489968|7590320|FG001|Open-label Treatment Period|Adverse Event|7
4684034|NCT02489968|7590321|FG002|Open-label Treatment Period|Adverse Event|0
4684035|NCT02489968|7590322|FG003|Open-label Treatment Period|Adverse Event|0
4684036|NCT02489968|7590323|FG004|Open-label Treatment Period|Adverse Event|0
4684037|NCT02489968|7590324|FG005|Open-label Treatment Period|Adverse Event|0
4684038|NCT02489968|7590319|FG000|Open-label Treatment Period|Protocol Violation|2
4684039|NCT02489968|7590320|FG001|Open-label Treatment Period|Protocol Violation|2
4684040|NCT02489968|7590321|FG002|Open-label Treatment Period|Protocol Violation|0
4684041|NCT02489968|7590322|FG003|Open-label Treatment Period|Protocol Violation|0
4684042|NCT02489968|7590323|FG004|Open-label Treatment Period|Protocol Violation|0
4684043|NCT02489968|7590324|FG005|Open-label Treatment Period|Protocol Violation|0
4684044|NCT02489968|7590319|FG000|Open-label Treatment Period|Lost to Follow-up|0
4684045|NCT02489968|7590320|FG001|Open-label Treatment Period|Lost to Follow-up|3
4684046|NCT02489968|7590321|FG002|Open-label Treatment Period|Lost to Follow-up|0
4684047|NCT02489968|7590322|FG003|Open-label Treatment Period|Lost to Follow-up|0
4760149|NCT03135262|7734246|FG000|Overall Study|Study terminated by sponsor|2
4760150|NCT03135262|7734247|FG001|Overall Study|Study terminated by sponsor|4
4760151|NCT03135262|7734248|FG002|Overall Study|Study terminated by sponsor|4
4760152|NCT03135262|7734249|FG003|Overall Study|Study terminated by sponsor|3
4760153|NCT03135262|7734250|FG004|Overall Study|Study terminated by sponsor|0
4684048|NCT02489968|7590323|FG004|Open-label Treatment Period|Lost to Follow-up|0
4684049|NCT02489968|7590324|FG005|Open-label Treatment Period|Lost to Follow-up|0
4684050|NCT02489968|7590319|FG000|Open-label Treatment Period|Withdrawal by Subject|4
4684051|NCT02489968|7590320|FG001|Open-label Treatment Period|Withdrawal by Subject|7
4684052|NCT02489968|7590321|FG002|Open-label Treatment Period|Withdrawal by Subject|0
4684053|NCT02489968|7590322|FG003|Open-label Treatment Period|Withdrawal by Subject|0
4684054|NCT02489968|7590323|FG004|Open-label Treatment Period|Withdrawal by Subject|0
4684055|NCT02489968|7590324|FG005|Open-label Treatment Period|Withdrawal by Subject|0
4684056|NCT02489968|7590319|FG000|Open-label Treatment Period|Other than specified above|204
4684057|NCT02489968|7590320|FG001|Open-label Treatment Period|Other than specified above|189
4684058|NCT02489968|7590321|FG002|Open-label Treatment Period|Other than specified above|0
4684059|NCT02489968|7590322|FG003|Open-label Treatment Period|Other than specified above|0
4684060|NCT02489968|7590323|FG004|Open-label Treatment Period|Other than specified above|0
4684061|NCT02489968|7590324|FG005|Open-label Treatment Period|Other than specified above|0
4684062|NCT02489968|7590319|FG000|Double-blind Treatment Period|Adverse Event|0
4684063|NCT02489968|7590320|FG001|Double-blind Treatment Period|Adverse Event|0
4684064|NCT02489968|7590321|FG002|Double-blind Treatment Period|Adverse Event|2
4684065|NCT02489968|7590322|FG003|Double-blind Treatment Period|Adverse Event|6
4684066|NCT02489968|7590323|FG004|Double-blind Treatment Period|Adverse Event|4
4684067|NCT02489968|7590324|FG005|Double-blind Treatment Period|Adverse Event|5
4684068|NCT02489968|7590319|FG000|Double-blind Treatment Period|Protocol Violation|0
4760154|NCT03104075|7734282|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1
4760155|NCT03104075|7734283|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0
4760156|NCT03038087|7734290|FG000|Overall Study|lost data|1
4684069|NCT02489968|7590320|FG001|Double-blind Treatment Period|Protocol Violation|0
4684070|NCT02489968|7590321|FG002|Double-blind Treatment Period|Protocol Violation|0
4684071|NCT02489968|7590322|FG003|Double-blind Treatment Period|Protocol Violation|0
4684072|NCT02489968|7590323|FG004|Double-blind Treatment Period|Protocol Violation|1
4684073|NCT02489968|7590324|FG005|Double-blind Treatment Period|Protocol Violation|1
4684074|NCT02489968|7590319|FG000|Double-blind Treatment Period|Withdrawal by Subject|0
4684075|NCT02489968|7590320|FG001|Double-blind Treatment Period|Withdrawal by Subject|0
4684076|NCT02489968|7590321|FG002|Double-blind Treatment Period|Withdrawal by Subject|0
4684077|NCT02489968|7590322|FG003|Double-blind Treatment Period|Withdrawal by Subject|2
4684078|NCT02489968|7590323|FG004|Double-blind Treatment Period|Withdrawal by Subject|0
4684079|NCT02489968|7590324|FG005|Double-blind Treatment Period|Withdrawal by Subject|2
4684080|NCT02489968|7590319|FG000|Double-blind Treatment Period|Other than specified above|0
4684081|NCT02489968|7590320|FG001|Double-blind Treatment Period|Other than specified above|0
4684082|NCT02489968|7590321|FG002|Double-blind Treatment Period|Other than specified above|0
4684083|NCT02489968|7590322|FG003|Double-blind Treatment Period|Other than specified above|0
4684084|NCT02489968|7590323|FG004|Double-blind Treatment Period|Other than specified above|1
4684085|NCT02489968|7590324|FG005|Double-blind Treatment Period|Other than specified above|0
4684086|NCT02489981|7590336|FG000|Overall Study|Adverse Event|21
4684087|NCT02489981|7590336|FG000|Overall Study|Insufficient effectiveness|16
4684088|NCT02489981|7590336|FG000|Overall Study|Improved|31
4684089|NCT02489981|7590336|FG000|Overall Study|Lost to Follow-up|31
4684090|NCT02489981|7590336|FG000|Overall Study|Other than listed|28
4684091|NCT02490371|7590351|FG000|Overall Study|Lost to Follow-up|1
4684092|NCT02490371|7590352|FG001|Overall Study|Lost to Follow-up|1
4684093|NCT02490475|7590362|FG000|Period 1: First 6 Cycles|Adverse Event|2
4684094|NCT02490475|7590363|FG001|Period 1: First 6 Cycles|Adverse Event|1
4684095|NCT02490475|7590364|FG002|Period 1: First 6 Cycles|Adverse Event|0
4684096|NCT02490475|7590365|FG003|Period 1: First 6 Cycles|Adverse Event|1
4684097|NCT02490475|7590362|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
4684098|NCT02490475|7590363|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0
4684099|NCT02490475|7590364|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
4684100|NCT02490475|7590365|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
4684101|NCT02490475|7590362|FG000|Period 1: First 6 Cycles|Refused Treatment|1
4684102|NCT02490475|7590363|FG001|Period 1: First 6 Cycles|Refused Treatment|0
4684103|NCT02490475|7590364|FG002|Period 1: First 6 Cycles|Refused Treatment|0
4684104|NCT02490475|7590365|FG003|Period 1: First 6 Cycles|Refused Treatment|0
4684105|NCT02490475|7590362|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1
4684106|NCT02490475|7590363|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1
4684107|NCT02490475|7590364|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4
4684108|NCT02490475|7590365|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2
4684109|NCT02490475|7590362|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1
4684110|NCT02490475|7590363|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0
4684111|NCT02490475|7590364|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2
4684112|NCT02490475|7590365|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0
4684113|NCT02490475|7590362|FG000|Period 2: Extension Phase|Refused Treatment|0
4684114|NCT02490475|7590363|FG001|Period 2: Extension Phase|Refused Treatment|0
4684115|NCT02490475|7590364|FG002|Period 2: Extension Phase|Refused Treatment|0
4684116|NCT02490475|7590365|FG003|Period 2: Extension Phase|Refused Treatment|1
4684117|NCT02490475|7590362|FG000|Period 2: Extension Phase|Adverse Event|0
4684118|NCT02490475|7590363|FG001|Period 2: Extension Phase|Adverse Event|0
4684119|NCT02490475|7590364|FG002|Period 2: Extension Phase|Adverse Event|1
4684120|NCT02490475|7590365|FG003|Period 2: Extension Phase|Adverse Event|0
4684121|NCT02490878|7590406|FG000|Overall Study|deemed ineligible|0
4684122|NCT02490878|7590407|FG001|Overall Study|deemed ineligible|1
4684123|NCT02490878|7590406|FG000|Overall Study|progression prior to treatment|0
4684124|NCT02490878|7590407|FG001|Overall Study|progression prior to treatment|1
4684125|NCT02490878|7590406|FG000|Overall Study|only submitted baseline QOL|0
4684126|NCT02490878|7590407|FG001|Overall Study|only submitted baseline QOL|1
4684127|NCT02491073|7590415|FG000|Overall Study|screen failure|1
4684128|NCT02491073|7590416|FG001|Overall Study|screen failure|0
4684129|NCT02491463|7590459|FG000|Overall Study|Withdrawal by Subject|1
4684130|NCT02491463|7590460|FG001|Overall Study|Withdrawal by Subject|2
4684131|NCT02491463|7590461|FG002|Overall Study|Withdrawal by Subject|0
4684132|NCT02491463|7590462|FG003|Overall Study|Withdrawal by Subject|0
4684133|NCT02491463|7590459|FG000|Overall Study|Migrated/moved from study area|1
4684134|NCT02491463|7590460|FG001|Overall Study|Migrated/moved from study area|5
4684135|NCT02491463|7590461|FG002|Overall Study|Migrated/moved from study area|1
4684136|NCT02491463|7590462|FG003|Overall Study|Migrated/moved from study area|1
4684137|NCT02491463|7590459|FG000|Overall Study|Lost to Follow-up|0
4684138|NCT02491463|7590460|FG001|Overall Study|Lost to Follow-up|3
4684139|NCT02491463|7590461|FG002|Overall Study|Lost to Follow-up|3
4684140|NCT02491463|7590462|FG003|Overall Study|Lost to Follow-up|0
4684141|NCT02491671|7590474|FG000|Overall Study|Adverse Event|6
4684142|NCT02491671|7590475|FG001|Overall Study|Adverse Event|8
4684143|NCT02491671|7590474|FG000|Overall Study|Death|0
4684144|NCT02491671|7590475|FG001|Overall Study|Death|2
4684145|NCT02491671|7590474|FG000|Overall Study|Use of sealants other than Hemopatch|5
4684146|NCT02491671|7590475|FG001|Overall Study|Use of sealants other than Hemopatch|3
4684147|NCT02491684|7590483|FG000|Treatment Phase|Adverse Event|2
4684148|NCT02491684|7590484|FG001|Treatment Phase|Adverse Event|2
4684149|NCT02491684|7590483|FG000|Treatment Phase|Incorrect randomisation|1
4684150|NCT02491684|7590484|FG001|Treatment Phase|Incorrect randomisation|0
4684151|NCT02491684|7590483|FG000|Treatment Phase|Investigator and Sponsor decision|0
4684152|NCT02491684|7590484|FG001|Treatment Phase|Investigator and Sponsor decision|1
4684153|NCT02491892|7590501|FG000|Overall Study|Adverse Event|1
4684154|NCT02491892|7590502|FG001|Overall Study|Adverse Event|1
4684155|NCT02491892|7590501|FG000|Overall Study|Death|1
4684156|NCT02491892|7590502|FG001|Overall Study|Death|1
4684157|NCT02491892|7590501|FG000|Overall Study|Lack of Efficacy|37
4684158|NCT02491892|7590502|FG001|Overall Study|Lack of Efficacy|36
4684159|NCT02491892|7590501|FG000|Overall Study|Refused Treatment|1
4684160|NCT02491892|7590502|FG001|Overall Study|Refused Treatment|0
4684161|NCT02491892|7590501|FG000|Overall Study|Lost to Follow-up|1
4684162|NCT02491892|7590502|FG001|Overall Study|Lost to Follow-up|0
4684163|NCT02492100|7590512|FG000|Overall Study|Death|1
4684164|NCT02492763|7590547|FG000|Overall Study|Withdrawal by Subject|0
4684165|NCT02492763|7590548|FG001|Overall Study|Withdrawal by Subject|2
4684166|NCT02492763|7590549|FG002|Overall Study|Withdrawal by Subject|1
4684167|NCT02492763|7590550|FG003|Overall Study|Withdrawal by Subject|0
4684168|NCT02492763|7590547|FG000|Overall Study|Adverse Event|3
4684169|NCT02492763|7590548|FG001|Overall Study|Adverse Event|1
4684170|NCT02492763|7590549|FG002|Overall Study|Adverse Event|1
4684171|NCT02492763|7590550|FG003|Overall Study|Adverse Event|2
4684172|NCT02492763|7590547|FG000|Overall Study|Death|0
4684173|NCT02492763|7590548|FG001|Overall Study|Death|0
4684174|NCT02492763|7590549|FG002|Overall Study|Death|1
4684175|NCT02492763|7590550|FG003|Overall Study|Death|0
4684176|NCT02492763|7590547|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0
4684177|NCT02492763|7590548|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1
4684178|NCT02492763|7590549|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0
4684179|NCT02492763|7590550|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0
4684180|NCT02492763|7590547|FG000|Overall Study|Lost to Follow-up|0
4684181|NCT02492763|7590548|FG001|Overall Study|Lost to Follow-up|0
4684182|NCT02492763|7590549|FG002|Overall Study|Lost to Follow-up|1
4684183|NCT02492763|7590550|FG003|Overall Study|Lost to Follow-up|0
4684184|NCT02492763|7590547|FG000|Overall Study|Non-Compliance With Study Drug|0
4684185|NCT02492763|7590548|FG001|Overall Study|Non-Compliance With Study Drug|1
4684186|NCT02492763|7590549|FG002|Overall Study|Non-Compliance With Study Drug|0
4684187|NCT02492763|7590550|FG003|Overall Study|Non-Compliance With Study Drug|0
4684188|NCT02492763|7590547|FG000|Overall Study|Screen Failure|0
4684189|NCT02492763|7590548|FG001|Overall Study|Screen Failure|0
4684190|NCT02492763|7590549|FG002|Overall Study|Screen Failure|0
4684191|NCT02492763|7590550|FG003|Overall Study|Screen Failure|1
4684192|NCT02492763|7590547|FG000|Overall Study|Study Terminated by Sponsor|13
4684193|NCT02492763|7590548|FG001|Overall Study|Study Terminated by Sponsor|10
4684194|NCT02492763|7590549|FG002|Overall Study|Study Terminated by Sponsor|6
4684195|NCT02492763|7590550|FG003|Overall Study|Study Terminated by Sponsor|10
4684196|NCT02492841|7590567|FG000|Overall Study|Lost to Follow-up|34
4684197|NCT02492841|7590568|FG001|Overall Study|Lost to Follow-up|31
4684198|NCT02492841|7590569|FG002|Overall Study|Lost to Follow-up|35
4684199|NCT02492880|7590589|FG000|Overall Study|Lost to Follow-up|1
4684200|NCT02492880|7590589|FG000|Overall Study|Protocol Violation|1
4684201|NCT02492958|7590597|FG000|Overall Study|Withdrawal by Subject|0
4684202|NCT02492958|7590598|FG001|Overall Study|Withdrawal by Subject|0
4684203|NCT02492958|7590599|FG002|Overall Study|Withdrawal by Subject|1
4684204|NCT02492958|7590600|FG003|Overall Study|Withdrawal by Subject|0
4684205|NCT02492958|7590597|FG000|Overall Study|Adverse Event|1
4684206|NCT02492958|7590598|FG001|Overall Study|Adverse Event|0
4684207|NCT02492958|7590599|FG002|Overall Study|Adverse Event|1
4684208|NCT02492958|7590600|FG003|Overall Study|Adverse Event|0
4684209|NCT02492984|7590612|FG000|Overall Study|Adverse Event|1
4684210|NCT02492984|7590613|FG001|Overall Study|Adverse Event|0
4684211|NCT02492984|7590612|FG000|Overall Study|Protocol Violation|1
4684212|NCT02492984|7590613|FG001|Overall Study|Protocol Violation|0
4684213|NCT02492984|7590612|FG000|Overall Study|Withdrawal by Subject|1
4684214|NCT02492984|7590613|FG001|Overall Study|Withdrawal by Subject|0
4684215|NCT02492997|7590624|FG000|Overall Study|Withdrawal by Subject|1
4684216|NCT02492997|7590625|FG001|Overall Study|Withdrawal by Subject|0
4684217|NCT02492997|7590624|FG000|Overall Study|Gained Weight|1
4684218|NCT02492997|7590625|FG001|Overall Study|Gained Weight|0
4684219|NCT02492997|7590624|FG000|Overall Study|Lost to Follow-up|0
4760157|NCT02662985|7734330|FG000|Treatment Period 1|Adverse Event|0
4760158|NCT02662985|7734331|FG001|Treatment Period 1|Adverse Event|2
4760159|NCT02662985|7734330|FG000|Treatment Period 1|Protocol Violation|0
4760160|NCT02662985|7734331|FG001|Treatment Period 1|Protocol Violation|1
4760161|NCT02662985|7734330|FG000|Treatment Period 1|Physician Decision|1
4760162|NCT02662985|7734331|FG001|Treatment Period 1|Physician Decision|0
4760163|NCT02662985|7734330|FG000|Treatment Period 1|Withdrawal by Subject|0
4760164|NCT02662985|7734331|FG001|Treatment Period 1|Withdrawal by Subject|1
4760165|NCT02662985|7734330|FG000|Treatment Period 2|Lack of Efficacy|0
4760166|NCT02662985|7734331|FG001|Treatment Period 2|Lack of Efficacy|1
4760167|NCT02662985|7734330|FG000|Treatment Period 2|Lost to Follow-up|1
4760168|NCT02662985|7734331|FG001|Treatment Period 2|Lost to Follow-up|0
4760169|NCT02662985|7734330|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4
4760170|NCT02662985|7734331|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4
4760171|NCT02662985|7734330|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1
4760172|NCT02662985|7734331|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1
4760173|NCT02662985|7734330|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0
4760174|NCT02662985|7734331|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1
4760175|NCT02662985|7734330|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1
4760176|NCT02662985|7734331|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2
4760177|NCT02662985|7734330|FG000|Treatment Period 3 (Extension Period)|Death|0
4760178|NCT02662985|7734331|FG001|Treatment Period 3 (Extension Period)|Death|1
4760179|NCT02606461|7734341|FG000|Overall Study|Withdrawal by Subject|3
4760180|NCT02606461|7734342|FG001|Overall Study|Withdrawal by Subject|2
4760181|NCT02606461|7734343|FG002|Overall Study|Withdrawal by Subject|14
4760182|NCT02606461|7734344|FG003|Overall Study|Withdrawal by Subject|11
4760183|NCT02606461|7734341|FG000|Overall Study|Death|16
4760184|NCT02606461|7734342|FG001|Overall Study|Death|25
4760185|NCT02606461|7734343|FG002|Overall Study|Death|105
4760186|NCT02606461|7734344|FG003|Overall Study|Death|58
4760187|NCT02606461|7734341|FG000|Overall Study|Lost to Follow-up|2
4760188|NCT02606461|7734342|FG001|Overall Study|Lost to Follow-up|2
4760189|NCT02606461|7734343|FG002|Overall Study|Lost to Follow-up|4
4760190|NCT02606461|7734344|FG003|Overall Study|Lost to Follow-up|1
4760191|NCT02606461|7734341|FG000|Overall Study|Physician Decision|0
4760192|NCT02606461|7734342|FG001|Overall Study|Physician Decision|0
4760193|NCT02606461|7734343|FG002|Overall Study|Physician Decision|1
4760194|NCT02606461|7734344|FG003|Overall Study|Physician Decision|1
4760195|NCT02606461|7734341|FG000|Overall Study|Disease Progression|1
4760196|NCT02606461|7734342|FG001|Overall Study|Disease Progression|0
4760197|NCT02606461|7734343|FG002|Overall Study|Disease Progression|0
4760198|NCT02606461|7734344|FG003|Overall Study|Disease Progression|0
4760199|NCT02606461|7734341|FG000|Overall Study|No treatment|0
4684220|NCT02492997|7590625|FG001|Overall Study|Lost to Follow-up|1
4684221|NCT02493062|7590644|FG000|Overall Study|Physician Decision|12
4760200|NCT02606461|7734342|FG001|Overall Study|No treatment|0
4760201|NCT02606461|7734343|FG002|Overall Study|No treatment|1
4760202|NCT02606461|7734344|FG003|Overall Study|No treatment|0
4760203|NCT02606461|7734341|FG000|Overall Study|Ongoing|5
4684222|NCT02493127|7590654|FG000|Overall Study|Lost to Follow-up|1
4684223|NCT02493127|7590655|FG001|Overall Study|Lost to Follow-up|1
4684224|NCT02493361|7590672|FG000|Overall Study|Withdrawal by Subject|3
4760204|NCT02606461|7734342|FG001|Overall Study|Ongoing|1
4684225|NCT02493517|7590691|FG000|Overall Study|Protocol Violation|1
4684226|NCT02493517|7590692|FG001|Overall Study|Protocol Violation|2
4684227|NCT02493517|7590691|FG000|Overall Study|Withdrawal by Subject|1
4684228|NCT02493517|7590692|FG001|Overall Study|Withdrawal by Subject|2
4684229|NCT02493517|7590691|FG000|Overall Study|Adverse Event|0
4684230|NCT02493517|7590692|FG001|Overall Study|Adverse Event|2
4684231|NCT02493517|7590691|FG000|Overall Study|Missed study visit|0
4684232|NCT02493517|7590692|FG001|Overall Study|Missed study visit|1
4684233|NCT02493660|7590720|FG000|Overall Study|Physician Decision|0
4684234|NCT02493660|7590721|FG001|Overall Study|Physician Decision|1
4684235|NCT02493712|7590730|FG000|Overall Study|Withdrawal by Subject|1
4684236|NCT02493712|7590731|FG001|Overall Study|Withdrawal by Subject|0
4684237|NCT02493712|7590732|FG002|Overall Study|Withdrawal by Subject|2
4684238|NCT02493712|7590730|FG000|Overall Study|Protocol Violation|0
4684239|NCT02493712|7590731|FG001|Overall Study|Protocol Violation|0
4684240|NCT02493712|7590732|FG002|Overall Study|Protocol Violation|1
4684241|NCT02493712|7590730|FG000|Overall Study|Lost to Follow-up|1
4684242|NCT02493712|7590731|FG001|Overall Study|Lost to Follow-up|0
4684243|NCT02493712|7590732|FG002|Overall Study|Lost to Follow-up|0
4684244|NCT02493712|7590730|FG000|Overall Study|Physician Decision|0
4684245|NCT02493712|7590731|FG001|Overall Study|Physician Decision|1
4684246|NCT02493712|7590732|FG002|Overall Study|Physician Decision|0
4684247|NCT02493712|7590730|FG000|Overall Study|Lack of Efficacy|0
4684248|NCT02493712|7590731|FG001|Overall Study|Lack of Efficacy|5
4684249|NCT02493712|7590732|FG002|Overall Study|Lack of Efficacy|3
4684250|NCT02493764|7590742|FG000|Overall Study|Adverse Event|2
4684251|NCT02493764|7590743|FG001|Overall Study|Adverse Event|2
4684252|NCT02493764|7590742|FG000|Overall Study|Death|44
4684253|NCT02493764|7590743|FG001|Overall Study|Death|58
4684254|NCT02493764|7590742|FG000|Overall Study|Lost to Follow-up|2
4684255|NCT02493764|7590743|FG001|Overall Study|Lost to Follow-up|1
4684256|NCT02493764|7590742|FG000|Overall Study|Protocol Violation|6
4684257|NCT02493764|7590743|FG001|Overall Study|Protocol Violation|7
4684258|NCT02493764|7590742|FG000|Overall Study|Physician Decision|1
4684259|NCT02493764|7590743|FG001|Overall Study|Physician Decision|1
4684260|NCT02493764|7590742|FG000|Overall Study|Participant moved|17
4684261|NCT02493764|7590743|FG001|Overall Study|Participant moved|5
4684262|NCT02493764|7590742|FG000|Overall Study|Withdrawal parent/guardian|0
4684263|NCT02493764|7590743|FG001|Overall Study|Withdrawal parent/guardian|1
4684264|NCT02493764|7590742|FG000|Overall Study|Withdrawal by Subject|11
4684265|NCT02493764|7590743|FG001|Overall Study|Withdrawal by Subject|7
4684266|NCT02493777|7590751|FG000|Overall Study|Lost to Follow-up|0
4684267|NCT02493777|7590752|FG001|Overall Study|Lost to Follow-up|1
4684268|NCT02493855|7590761|FG000|Overall Study|Non-compliance|1
4684269|NCT02493855|7590762|FG001|Overall Study|Non-compliance|0
4684270|NCT02493855|7590763|FG002|Overall Study|Non-compliance|0
4684271|NCT02493855|7590761|FG000|Overall Study|Adverse Event|0
4684272|NCT02493855|7590762|FG001|Overall Study|Adverse Event|1
4684273|NCT02493855|7590763|FG002|Overall Study|Adverse Event|0
4684274|NCT02493855|7590761|FG000|Overall Study|Withdrawal by Subject|1
4684275|NCT02493855|7590762|FG001|Overall Study|Withdrawal by Subject|0
4684276|NCT02493855|7590763|FG002|Overall Study|Withdrawal by Subject|0
4684277|NCT02493868|7590771|FG000|Induction Phase: DE Participants|Adverse Event|22
4684278|NCT02493868|7590772|FG001|Induction Phase: DE Participants|Adverse Event|0
4684279|NCT02493868|7590771|FG000|Induction Phase: DE Participants|Lost to Follow-up|1
4684280|NCT02493868|7590772|FG001|Induction Phase: DE Participants|Lost to Follow-up|0
4684281|NCT02493868|7590771|FG000|Induction Phase: DE Participants|Lack of Efficacy|2
4684282|NCT02493868|7590772|FG001|Induction Phase: DE Participants|Lack of Efficacy|0
4684283|NCT02493868|7590771|FG000|Induction Phase: DE Participants|Protocol Violation|2
4684284|NCT02493868|7590772|FG001|Induction Phase: DE Participants|Protocol Violation|0
4684285|NCT02493868|7590771|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15
4684286|NCT02493868|7590772|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0
4684287|NCT02493868|7590771|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114
4684288|NCT02493868|7590772|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0
4684289|NCT02493868|7590771|FG000|Induction Phase: DE Participants|Other|8
4760205|NCT02606461|7734343|FG002|Overall Study|Ongoing|63
4760206|NCT02606461|7734344|FG003|Overall Study|Ongoing|26
4760207|NCT02536339|7734357|FG000|Overall Study|Death|20
4760208|NCT02536339|7734357|FG000|Overall Study|Withdrawal by Subject|3
4760209|NCT02536339|7734357|FG000|Overall Study|Lost to Follow-up|2
4760210|NCT02536339|7734357|FG000|Overall Study|Treatment discontinued|2
4760211|NCT02536339|7734357|FG000|Overall Study|Physician Decision|1
4760212|NCT02323295|7734363|FG000|Overall Study|Adverse Event|0
4760213|NCT02323295|7734364|FG001|Overall Study|Adverse Event|1
4760214|NCT02323295|7734363|FG000|Overall Study|Withdrawal by Subject|0
4760215|NCT02323295|7734364|FG001|Overall Study|Withdrawal by Subject|1
4760216|NCT02323295|7734363|FG000|Overall Study|Patient did not have surgery as planned.|0
4760217|NCT02323295|7734364|FG001|Overall Study|Patient did not have surgery as planned.|1
4760218|NCT02036970|7734394|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0
4760219|NCT02036970|7734395|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0
4760220|NCT02036970|7734396|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3
4684290|NCT02493868|7590772|FG001|Induction Phase: DE Participants|Other|0
4684291|NCT02493868|7590771|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5
4684292|NCT02493868|7590772|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0
4684293|NCT02493868|7590771|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2
4684294|NCT02493868|7590772|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1
4684295|NCT02493868|7590771|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8
4684296|NCT02493868|7590772|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0
4684297|NCT02493868|7590771|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4
4684298|NCT02493868|7590772|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1
4684299|NCT02493868|7590771|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8
4684300|NCT02493868|7590772|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3
4684301|NCT02493868|7590771|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14
4684302|NCT02493868|7590772|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5
4684303|NCT02493868|7590771|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107
4684304|NCT02493868|7590772|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20
4684305|NCT02493868|7590771|FG000|Optimization Phase: DE+TE Participants|Other|10
4684306|NCT02493868|7590772|FG001|Optimization Phase: DE+TE Participants|Other|2
4684307|NCT02493868|7590771|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1
4684308|NCT02493868|7590772|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4
4684309|NCT02493868|7590771|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1
4684310|NCT02493868|7590772|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0
4684311|NCT02493868|7590771|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1
4684312|NCT02493868|7590772|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1
4684313|NCT02493868|7590771|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5
4684314|NCT02493868|7590772|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7
4684315|NCT02493868|7590771|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1
4684316|NCT02493868|7590772|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0
4684317|NCT02493868|7590771|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0
4684318|NCT02493868|7590772|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1
4760221|NCT02036970|7734397|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2
4760222|NCT02036970|7734398|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0
4760223|NCT02036970|7734399|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1
4760224|NCT02036970|7734400|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0
4760225|NCT02036970|7734401|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1
4760226|NCT02036970|7734402|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3
4760227|NCT02036970|7734403|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1
4760228|NCT02036970|7734394|FG000|Part 1: Day 1 Through Week 16|Death|0
4760229|NCT02036970|7734395|FG001|Part 1: Day 1 Through Week 16|Death|0
4760230|NCT02036970|7734396|FG002|Part 1: Day 1 Through Week 16|Death|0
4760231|NCT02036970|7734397|FG003|Part 1: Day 1 Through Week 16|Death|0
4760232|NCT02036970|7734398|FG004|Part 1: Day 1 Through Week 16|Death|0
4760233|NCT02036970|7734399|FG005|Part 1: Day 1 Through Week 16|Death|0
4760234|NCT02036970|7734400|FG006|Part 1: Day 1 Through Week 16|Death|0
4760235|NCT02036970|7734401|FG007|Part 1: Day 1 Through Week 16|Death|0
4760236|NCT02036970|7734402|FG008|Part 1: Day 1 Through Week 16|Death|1
4760237|NCT02036970|7734403|FG009|Part 1: Day 1 Through Week 16|Death|0
4760238|NCT02036970|7734394|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1
4760239|NCT02036970|7734395|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0
4760240|NCT02036970|7734396|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1
4760241|NCT02036970|7734397|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0
4760242|NCT02036970|7734398|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0
4760243|NCT02036970|7734399|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0
4760244|NCT02036970|7734400|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0
4760245|NCT02036970|7734401|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0
4760246|NCT02036970|7734402|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2
4760247|NCT02036970|7734403|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0
4760248|NCT02036970|7734394|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0
4760249|NCT02036970|7734395|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0
4760250|NCT02036970|7734396|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0
4760251|NCT02036970|7734397|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0
4760252|NCT02036970|7734398|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1
4760253|NCT02036970|7734399|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0
4760254|NCT02036970|7734400|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0
4760255|NCT02036970|7734401|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0
4760256|NCT02036970|7734402|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2
4760257|NCT02036970|7734403|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4
4760258|NCT02036970|7734394|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0
4760259|NCT02036970|7734395|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0
4760260|NCT02036970|7734396|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0
4760261|NCT02036970|7734397|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1
4760262|NCT02036970|7734398|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0
4760263|NCT02036970|7734399|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0
4760264|NCT02036970|7734400|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0
4684319|NCT02493868|7590771|FG000|Maintenance Phase: DE+TE Participants|Other|4
4684320|NCT02493868|7590772|FG001|Maintenance Phase: DE+TE Participants|Other|9
4684321|NCT02493868|7590771|FG000|Follow-up Phase|Lost to Follow-up|1
4684322|NCT02493868|7590772|FG001|Follow-up Phase|Lost to Follow-up|0
4684323|NCT02493868|7590771|FG000|Follow-up Phase|Withdrawal by Subject|3
4684324|NCT02493868|7590772|FG001|Follow-up Phase|Withdrawal by Subject|0
4684325|NCT02493868|7590771|FG000|Follow-up Phase|Investigator Decision|5
4684326|NCT02493868|7590772|FG001|Follow-up Phase|Investigator Decision|1
4684327|NCT02493868|7590771|FG000|Follow-up Phase|Other|2
4684328|NCT02493868|7590772|FG001|Follow-up Phase|Other|1
4684329|NCT02493946|7590787|FG000|DB Period|Withdrawal by Subject|8
4760265|NCT02036970|7734401|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0
4760266|NCT02036970|7734402|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0
4760267|NCT02036970|7734403|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0
4760268|NCT02036970|7734394|FG000|Part 2: Week 16 Onwards|Adverse Event|0
4760269|NCT02036970|7734395|FG001|Part 2: Week 16 Onwards|Adverse Event|2
4760270|NCT02036970|7734396|FG002|Part 2: Week 16 Onwards|Adverse Event|1
4760271|NCT02036970|7734397|FG003|Part 2: Week 16 Onwards|Adverse Event|1
4760272|NCT02036970|7734398|FG004|Part 2: Week 16 Onwards|Adverse Event|1
4760273|NCT02036970|7734399|FG005|Part 2: Week 16 Onwards|Adverse Event|0
4760274|NCT02036970|7734400|FG006|Part 2: Week 16 Onwards|Adverse Event|1
4760275|NCT02036970|7734401|FG007|Part 2: Week 16 Onwards|Adverse Event|0
4760276|NCT02036970|7734402|FG008|Part 2: Week 16 Onwards|Adverse Event|6
4760277|NCT02036970|7734403|FG009|Part 2: Week 16 Onwards|Adverse Event|3
4760278|NCT02036970|7734394|FG000|Part 2: Week 16 Onwards|Protocol Violation|0
4760279|NCT02036970|7734395|FG001|Part 2: Week 16 Onwards|Protocol Violation|0
4760280|NCT02036970|7734396|FG002|Part 2: Week 16 Onwards|Protocol Violation|0
4760281|NCT02036970|7734397|FG003|Part 2: Week 16 Onwards|Protocol Violation|0
4760282|NCT02036970|7734398|FG004|Part 2: Week 16 Onwards|Protocol Violation|0
4760283|NCT02036970|7734399|FG005|Part 2: Week 16 Onwards|Protocol Violation|0
4760284|NCT02036970|7734400|FG006|Part 2: Week 16 Onwards|Protocol Violation|0
4760285|NCT02036970|7734401|FG007|Part 2: Week 16 Onwards|Protocol Violation|1
4760286|NCT02036970|7734402|FG008|Part 2: Week 16 Onwards|Protocol Violation|0
4760287|NCT02036970|7734403|FG009|Part 2: Week 16 Onwards|Protocol Violation|0
4760288|NCT02036970|7734394|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0
4760289|NCT02036970|7734395|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1
4760290|NCT02036970|7734396|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1
4760291|NCT02036970|7734397|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0
4760292|NCT02036970|7734398|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0
4760293|NCT02036970|7734399|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0
4760294|NCT02036970|7734400|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0
4760295|NCT02036970|7734401|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0
4760296|NCT02036970|7734402|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3
4760297|NCT02036970|7734403|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0
4760298|NCT02036970|7734394|FG000|Part 2: Week 16 Onwards|Progressive Disease|0
4760299|NCT02036970|7734395|FG001|Part 2: Week 16 Onwards|Progressive Disease|2
4760300|NCT02036970|7734396|FG002|Part 2: Week 16 Onwards|Progressive Disease|1
4760301|NCT02036970|7734397|FG003|Part 2: Week 16 Onwards|Progressive Disease|1
4760302|NCT02036970|7734398|FG004|Part 2: Week 16 Onwards|Progressive Disease|0
4760303|NCT02036970|7734399|FG005|Part 2: Week 16 Onwards|Progressive Disease|0
4760304|NCT02036970|7734400|FG006|Part 2: Week 16 Onwards|Progressive Disease|0
4760305|NCT02036970|7734401|FG007|Part 2: Week 16 Onwards|Progressive Disease|0
4760306|NCT02036970|7734402|FG008|Part 2: Week 16 Onwards|Progressive Disease|0
4760307|NCT02036970|7734403|FG009|Part 2: Week 16 Onwards|Progressive Disease|2
4760308|NCT01958021|7734437|FG000|Overall Study|Progressive disease|87
4760309|NCT01958021|7734438|FG001|Overall Study|Progressive disease|146
4760310|NCT01958021|7734437|FG000|Overall Study|Adverse Event|25
4760311|NCT01958021|7734438|FG001|Overall Study|Adverse Event|7
4760312|NCT01958021|7734437|FG000|Overall Study|Subject/guardian decision|12
4760313|NCT01958021|7734438|FG001|Overall Study|Subject/guardian decision|13
4760314|NCT01958021|7734437|FG000|Overall Study|Physician Decision|10
4760315|NCT01958021|7734438|FG001|Overall Study|Physician Decision|13
4760316|NCT01958021|7734437|FG000|Overall Study|Protocol Violation|3
4760317|NCT01958021|7734438|FG001|Overall Study|Protocol Violation|1
4760318|NCT01958021|7734437|FG000|Overall Study|Death|2
4760319|NCT01958021|7734438|FG001|Overall Study|Death|0
4760320|NCT01941719|7734446|FG000|Overall Study|Lost to Follow-up|20
4760321|NCT01941719|7734447|FG001|Overall Study|Lost to Follow-up|19
4760322|NCT01828099|7734456|FG000|Overall Study|Adverse Event|15
4760323|NCT01828099|7734457|FG001|Overall Study|Adverse Event|18
4760324|NCT01828099|7734456|FG000|Overall Study|Death|9
4760325|NCT01828099|7734457|FG001|Overall Study|Death|11
4760326|NCT01828099|7734456|FG000|Overall Study|Lost to Follow-up|2
4760327|NCT01828099|7734457|FG001|Overall Study|Lost to Follow-up|0
4684330|NCT02493946|7590788|FG001|DB Period|Withdrawal by Subject|5
4760328|NCT01828099|7734456|FG000|Overall Study|Non-compliance with study treatment|2
4760329|NCT01828099|7734457|FG001|Overall Study|Non-compliance with study treatment|0
4760330|NCT01828099|7734456|FG000|Overall Study|Physician Decision|7
4760331|NCT01828099|7734457|FG001|Overall Study|Physician Decision|11
4760332|NCT01828099|7734456|FG000|Overall Study|Progressive disease|51
4684331|NCT02493946|7590789|FG002|DB Period|Withdrawal by Subject|0
4684332|NCT02493946|7590787|FG000|Open Label Period|Withdrawal by Subject|0
4684333|NCT02493946|7590788|FG001|Open Label Period|Withdrawal by Subject|0
4684334|NCT02493946|7590789|FG002|Open Label Period|Withdrawal by Subject|74
4684335|NCT02493946|7590787|FG000|Open Label Period|Adverse Event|0
4684336|NCT02493946|7590788|FG001|Open Label Period|Adverse Event|0
4684337|NCT02493946|7590789|FG002|Open Label Period|Adverse Event|4
4684338|NCT02493946|7590787|FG000|Open Label Period|Lost to Follow-up|0
4684339|NCT02493946|7590788|FG001|Open Label Period|Lost to Follow-up|0
4684340|NCT02493946|7590789|FG002|Open Label Period|Lost to Follow-up|1
4684341|NCT02493946|7590787|FG000|Open Label Period|Investigator decision, non-compliance|0
4684342|NCT02493946|7590788|FG001|Open Label Period|Investigator decision, non-compliance|0
4684343|NCT02493946|7590789|FG002|Open Label Period|Investigator decision, non-compliance|2
4684344|NCT02493946|7590787|FG000|Open Label Period|Investigator decision, non-availability|0
4684345|NCT02493946|7590788|FG001|Open Label Period|Investigator decision, non-availability|0
4684346|NCT02493946|7590789|FG002|Open Label Period|Investigator decision, non-availability|1
4684347|NCT02493946|7590787|FG000|Open Label Period|Pregnancy|0
4684348|NCT02493946|7590788|FG001|Open Label Period|Pregnancy|0
4684349|NCT02493946|7590789|FG002|Open Label Period|Pregnancy|3
4684350|NCT02493946|7590787|FG000|Open Label Period|Site error|0
4684351|NCT02493946|7590788|FG001|Open Label Period|Site error|0
4684352|NCT02493946|7590789|FG002|Open Label Period|Site error|1
4684353|NCT02494401|7590843|FG000|Overall Study|Lost to Follow-up|22
4684354|NCT02494401|7590844|FG001|Overall Study|Lost to Follow-up|25
4684355|NCT02494401|7590843|FG000|Overall Study|Withdrawal by Subject|3
4684356|NCT02494401|7590844|FG001|Overall Study|Withdrawal by Subject|2
4684357|NCT02494583|7590870|FG000|Overall Study|Death|195
4684358|NCT02494583|7590871|FG001|Overall Study|Death|189
4684359|NCT02494583|7590872|FG002|Overall Study|Death|201
4684360|NCT02494583|7590870|FG000|Overall Study|Lost to Follow-up|1
4684361|NCT02494583|7590871|FG001|Overall Study|Lost to Follow-up|0
4684362|NCT02494583|7590872|FG002|Overall Study|Lost to Follow-up|0
4684363|NCT02494583|7590870|FG000|Overall Study|Protocol Violation|1
4684364|NCT02494583|7590871|FG001|Overall Study|Protocol Violation|2
4684365|NCT02494583|7590872|FG002|Overall Study|Protocol Violation|0
4684366|NCT02494583|7590870|FG000|Overall Study|Withdrawal by Subject|3
4684367|NCT02494583|7590871|FG001|Overall Study|Withdrawal by Subject|15
4684368|NCT02494583|7590872|FG002|Overall Study|Withdrawal by Subject|15
4684369|NCT02494583|7590870|FG000|Overall Study|Ongoing in Study|56
4684370|NCT02494583|7590871|FG001|Overall Study|Ongoing in Study|51
4684371|NCT02494583|7590872|FG002|Overall Study|Ongoing in Study|34
4684372|NCT02494596|7590880|FG000|Overall Study|Insufficient Therapeutic Response|3
4684373|NCT02494596|7590881|FG001|Overall Study|Insufficient Therapeutic Response|3
4684374|NCT02494596|7590882|FG002|Overall Study|Insufficient Therapeutic Response|1
4684375|NCT02494596|7590880|FG000|Overall Study|Adverse Event|0
4684376|NCT02494596|7590881|FG001|Overall Study|Adverse Event|1
4684377|NCT02494596|7590882|FG002|Overall Study|Adverse Event|0
4684378|NCT02494596|7590880|FG000|Overall Study|Refused Treatment|0
4684379|NCT02494596|7590881|FG001|Overall Study|Refused Treatment|1
4684380|NCT02494596|7590882|FG002|Overall Study|Refused Treatment|0
4684381|NCT02494778|7590897|FG000|Overall Study|Death|3
4684382|NCT02494778|7590897|FG000|Overall Study|Other|173
4684383|NCT02494778|7590897|FG000|Overall Study|Lack of Efficacy|4
4684384|NCT02494778|7590897|FG000|Overall Study|Adverse Event|18
4684385|NCT02494778|7590897|FG000|Overall Study|Withdrawal by Subject|20
4684386|NCT02494778|7590897|FG000|Overall Study|Lost to Follow-up|2
4684387|NCT02494778|7590897|FG000|Overall Study|Noncompliant with study drug admin.|1
4684388|NCT02495025|7590912|FG000|Overall Study|Lost to Follow-up|21
4684389|NCT02495025|7590913|FG001|Overall Study|Lost to Follow-up|14
4684390|NCT02495025|7590912|FG000|Overall Study|Withdrawal by Subject|5
4684391|NCT02495025|7590913|FG001|Overall Study|Withdrawal by Subject|0
4684392|NCT02495168|7590946|FG000|Overall Study|Other than Specified|18
4684393|NCT02495168|7590947|FG001|Overall Study|Other than Specified|22
4684394|NCT02495168|7590948|FG002|Overall Study|Other than Specified|5
4684395|NCT02495168|7590946|FG000|Overall Study|Did not Complete Final Visit On Time|4
4684396|NCT02495168|7590947|FG001|Overall Study|Did not Complete Final Visit On Time|3
4684397|NCT02495168|7590948|FG002|Overall Study|Did not Complete Final Visit On Time|2
4684398|NCT02495168|7590946|FG000|Overall Study|Physician Decision|1
4684399|NCT02495168|7590947|FG001|Overall Study|Physician Decision|1
4684400|NCT02495168|7590948|FG002|Overall Study|Physician Decision|0
4684401|NCT02495168|7590946|FG000|Overall Study|Lost to Follow-up|10
4684402|NCT02495168|7590947|FG001|Overall Study|Lost to Follow-up|6
4684403|NCT02495168|7590948|FG002|Overall Study|Lost to Follow-up|1
4684404|NCT02495168|7590946|FG000|Overall Study|Withdrawal by Subject|1
4684405|NCT02495168|7590947|FG001|Overall Study|Withdrawal by Subject|4
4684406|NCT02495168|7590948|FG002|Overall Study|Withdrawal by Subject|2
4684407|NCT02495168|7590946|FG000|Overall Study|Protocol Violation|0
4684408|NCT02495168|7590947|FG001|Overall Study|Protocol Violation|10
4684409|NCT02495168|7590948|FG002|Overall Study|Protocol Violation|1
4684410|NCT02495168|7590946|FG000|Overall Study|Adverse Event|4
4684411|NCT02495168|7590947|FG001|Overall Study|Adverse Event|8
4684412|NCT02495168|7590948|FG002|Overall Study|Adverse Event|3
4684413|NCT02495168|7590946|FG000|Overall Study|Lack of Efficacy|0
4684414|NCT02495168|7590947|FG001|Overall Study|Lack of Efficacy|0
4684415|NCT02495168|7590948|FG002|Overall Study|Lack of Efficacy|3
4684416|NCT02495233|7590958|FG000|Overall Study|Miscellaneous|0
4684417|NCT02495233|7590959|FG001|Overall Study|Miscellaneous|1
4684418|NCT02495389|7590978|FG000|Overall Study|Withdrawal by Subject|40
4684419|NCT02495844|7591022|FG000|Overall Study|Lack of Efficacy|1
4760333|NCT01828099|7734457|FG001|Overall Study|Progressive disease|94
4760334|NCT01828099|7734456|FG000|Overall Study|Protocol Violation|1
4760335|NCT01828099|7734457|FG001|Overall Study|Protocol Violation|0
4760336|NCT01828099|7734456|FG000|Overall Study|Subject/guardian decision|7
4760337|NCT01828099|7734457|FG001|Overall Study|Subject/guardian decision|23
4760338|NCT01593254|7734465|FG000|Treatment Period|Treatment Failure|1
4760339|NCT01593254|7734466|FG001|Treatment Period|Treatment Failure|2
4760340|NCT01593254|7734465|FG000|Treatment Period|Pregnancy|0
4760341|NCT01593254|7734466|FG001|Treatment Period|Pregnancy|1
4760342|NCT01593254|7734465|FG000|Treatment Period|Poor/Non-Compliance|2
4760343|NCT01593254|7734466|FG001|Treatment Period|Poor/Non-Compliance|1
4760344|NCT01593254|7734465|FG000|Treatment Period|Maximum clinical benefit|1
4760345|NCT01593254|7734466|FG001|Treatment Period|Maximum clinical benefit|0
4760346|NCT01593254|7734465|FG000|Treatment Period|Subject withdrew consent|0
4760347|NCT01593254|7734466|FG001|Treatment Period|Subject withdrew consent|5
4760348|NCT01593254|7734465|FG000|Treatment Period|Subject Request to Discontinue|1
4760349|NCT01593254|7734466|FG001|Treatment Period|Subject Request to Discontinue|1
4760350|NCT01593254|7734465|FG000|Treatment Period|AE unrelated to Study Drug|0
4760351|NCT01593254|7734466|FG001|Treatment Period|AE unrelated to Study Drug|1
4760352|NCT01593254|7734465|FG000|Treatment Period|Death|2
4760353|NCT01593254|7734466|FG001|Treatment Period|Death|1
4760354|NCT01593254|7734465|FG000|Treatment Period|Study Drug Toxicity|3
4760355|NCT01593254|7734466|FG001|Treatment Period|Study Drug Toxicity|9
4760356|NCT01593254|7734465|FG000|Treatment Period|Disease Progression|1
4760357|NCT01593254|7734466|FG001|Treatment Period|Disease Progression|6
4760358|NCT01593254|7734465|FG000|Treatment Period|Did Not Achieve RCC|0
4760359|NCT01593254|7734466|FG001|Treatment Period|Did Not Achieve RCC|1
4760360|NCT01593254|7734465|FG000|Treatment Period|Patient Refused to Return|0
4760361|NCT01593254|7734466|FG001|Treatment Period|Patient Refused to Return|1
4760362|NCT01593254|7734465|FG000|Treatment Period|No Response|1
4760363|NCT01593254|7734466|FG001|Treatment Period|No Response|0
4760364|NCT01593254|7734465|FG000|Treatment Period|T315I MUTATION|0
4760365|NCT01593254|7734466|FG001|Treatment Period|T315I MUTATION|1
4760366|NCT01593254|7734465|FG000|Treatment Period|Investigator Decision|2
4760367|NCT01593254|7734466|FG001|Treatment Period|Investigator Decision|1
4760368|NCT01593254|7734465|FG000|Follow-Up Period|Withdrawal by Subject|0
4760369|NCT01593254|7734466|FG001|Follow-Up Period|Withdrawal by Subject|2
4760370|NCT01593254|7734465|FG000|Follow-Up Period|Non-Compliance|1
4760371|NCT01593254|7734466|FG001|Follow-Up Period|Non-Compliance|0
4760372|NCT01593254|7734465|FG000|Follow-Up Period|Death|2
4760373|NCT01593254|7734466|FG001|Follow-Up Period|Death|2
4760374|NCT01593254|7734465|FG000|Follow-Up Period|Subject request to Discontinue|0
4760375|NCT01593254|7734466|FG001|Follow-Up Period|Subject request to Discontinue|1
4760376|NCT01593254|7734465|FG000|Follow-Up Period|Pregnancy|0
4760377|NCT01593254|7734466|FG001|Follow-Up Period|Pregnancy|1
4760378|NCT01593254|7734465|FG000|Follow-Up Period|Study Drug Toxicity|0
4760379|NCT01593254|7734466|FG001|Follow-Up Period|Study Drug Toxicity|1
4760380|NCT01593254|7734465|FG000|Follow-Up Period|Patient refused to return|0
4760381|NCT01593254|7734466|FG001|Follow-Up Period|Patient refused to return|1
4760382|NCT01593254|7734465|FG000|Follow-Up Period|Fundus Hemorrhage|0
4760383|NCT01593254|7734466|FG001|Follow-Up Period|Fundus Hemorrhage|1
4760384|NCT01593254|7734465|FG000|Follow-Up Period|Disease Progression|0
4760385|NCT01593254|7734466|FG001|Follow-Up Period|Disease Progression|1
4760386|NCT01593254|7734465|FG000|Follow-Up Period|Study Drug Side Effects|0
4760387|NCT01593254|7734466|FG001|Follow-Up Period|Study Drug Side Effects|1
4760388|NCT00943618|7734492|FG000|Overall Study|Lost to Follow-up|38
4760389|NCT00943618|7734493|FG001|Overall Study|Lost to Follow-up|48
4760390|NCT00943618|7734494|FG002|Overall Study|Lost to Follow-up|20
4760391|NCT00943618|7734492|FG000|Overall Study|Discontinued Medication|17
4760392|NCT00943618|7734493|FG001|Overall Study|Discontinued Medication|29
4684420|NCT02495844|7591023|FG001|Overall Study|Lack of Efficacy|2
4760393|NCT00943618|7734494|FG002|Overall Study|Discontinued Medication|11
4760394|NCT00529763|7734505|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1
4760395|NCT00529763|7734506|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3
4684421|NCT02495844|7591022|FG000|Overall Study|AE, non-fatal|0
4684422|NCT02495844|7591023|FG001|Overall Study|AE, non-fatal|1
4684423|NCT02495844|7591022|FG000|Overall Study|Hepatitis Positivity|0
4684424|NCT02495844|7591023|FG001|Overall Study|Hepatitis Positivity|1
4684425|NCT02495857|7591034|FG000|Overall Study|Adverse Event|5
4684426|NCT02495857|7591035|FG001|Overall Study|Adverse Event|0
4684427|NCT02495857|7591036|FG002|Overall Study|Adverse Event|1
4684428|NCT02495857|7591034|FG000|Overall Study|Withdrawal by Subject|9
4684429|NCT02495857|7591035|FG001|Overall Study|Withdrawal by Subject|6
4684430|NCT02495857|7591036|FG002|Overall Study|Withdrawal by Subject|10
4684431|NCT02495857|7591034|FG000|Overall Study|Physician Decision|0
4684432|NCT02495857|7591035|FG001|Overall Study|Physician Decision|1
4684433|NCT02495857|7591036|FG002|Overall Study|Physician Decision|0
4684434|NCT02495857|7591034|FG000|Overall Study|Protocol Violation|1
4684435|NCT02495857|7591035|FG001|Overall Study|Protocol Violation|1
4684436|NCT02495857|7591036|FG002|Overall Study|Protocol Violation|2
4684437|NCT02495857|7591034|FG000|Overall Study|Lost to Follow-up|4
4684438|NCT02495857|7591035|FG001|Overall Study|Lost to Follow-up|5
4684439|NCT02495857|7591036|FG002|Overall Study|Lost to Follow-up|3
4684440|NCT02495857|7591034|FG000|Overall Study|Other|3
4684441|NCT02495857|7591035|FG001|Overall Study|Other|3
4684442|NCT02495857|7591036|FG002|Overall Study|Other|2
4684443|NCT02495883|7591046|FG000|Overall Study|Excessive head motion|1
4684444|NCT02495883|7591047|FG001|Overall Study|Excessive head motion|0
4684445|NCT02495948|7591052|FG000|Period 1, First 30 Days of Wear|Adverse Event|0
4684446|NCT02495948|7591053|FG001|Period 1, First 30 Days of Wear|Adverse Event|1
4684447|NCT02495948|7591052|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1
4684448|NCT02495948|7591053|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1
4684449|NCT02496000|7591063|FG000|Overall Study|Withdrawal by Subject|1
4684450|NCT02496000|7591064|FG001|Overall Study|Withdrawal by Subject|2
4684451|NCT02496000|7591065|FG002|Overall Study|Withdrawal by Subject|0
4684452|NCT02496000|7591063|FG000|Overall Study|Lost to Follow-up|1
4684453|NCT02496000|7591064|FG001|Overall Study|Lost to Follow-up|0
4684454|NCT02496000|7591065|FG002|Overall Study|Lost to Follow-up|1
4684455|NCT02496000|7591063|FG000|Overall Study|Protocol Violation|0
4684456|NCT02496000|7591064|FG001|Overall Study|Protocol Violation|0
4684457|NCT02496000|7591065|FG002|Overall Study|Protocol Violation|1
4684458|NCT02496000|7591063|FG000|Overall Study|Non-compliance or lack of cooperation|0
4684459|NCT02496000|7591064|FG001|Overall Study|Non-compliance or lack of cooperation|2
4684460|NCT02496000|7591065|FG002|Overall Study|Non-compliance or lack of cooperation|0
4684461|NCT02496000|7591063|FG000|Overall Study|undetermined|0
4684462|NCT02496000|7591064|FG001|Overall Study|undetermined|1
4684463|NCT02496000|7591065|FG002|Overall Study|undetermined|0
4684464|NCT02496091|7591074|FG000|Overall Study|Eligibility criteria not fulfilled|2
4684465|NCT02496221|7591079|FG000|Treatment Period 2 - 4 Days|Adverse Event|0
4684466|NCT02496221|7591080|FG001|Treatment Period 2 - 4 Days|Adverse Event|1
4684467|NCT02496221|7591079|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1
4684468|NCT02496221|7591080|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0
4684469|NCT02496221|7591079|FG000|Treatment Period 2 - 4 Days|Physician Decision|1
4684470|NCT02496221|7591080|FG001|Treatment Period 2 - 4 Days|Physician Decision|0
4684471|NCT02496533|7591090|FG000|Overall Study|Lack of data on outcome|3
4684472|NCT02496533|7591091|FG001|Overall Study|Lack of data on outcome|0
4684473|NCT02496533|7591090|FG000|Overall Study|Patient did not complete all measures|0
4684474|NCT02496533|7591091|FG001|Overall Study|Patient did not complete all measures|4
4684475|NCT02496533|7591090|FG000|Overall Study|Late for radiologic testing|0
4684476|NCT02496533|7591091|FG001|Overall Study|Late for radiologic testing|2
4684477|NCT02496702|7591099|FG000|Overall Study|Lost to Follow-up|8
4684478|NCT02496702|7591100|FG001|Overall Study|Lost to Follow-up|6
4684479|NCT02496702|7591099|FG000|Overall Study|Only partially tested|0
4684480|NCT02496702|7591100|FG001|Overall Study|Only partially tested|2
4684481|NCT02496767|7591110|FG000|Open-label Lead-in Phase|Adverse Event|176
4684482|NCT02496767|7591111|FG001|Open-label Lead-in Phase|Adverse Event|0
4684483|NCT02496767|7591112|FG002|Open-label Lead-in Phase|Adverse Event|0
4684484|NCT02496767|7591113|FG003|Open-label Lead-in Phase|Adverse Event|0
4684485|NCT02496767|7591114|FG004|Open-label Lead-in Phase|Adverse Event|0
4684486|NCT02496767|7591115|FG005|Open-label Lead-in Phase|Adverse Event|0
4684487|NCT02496767|7591116|FG006|Open-label Lead-in Phase|Adverse Event|0
4684488|NCT02496767|7591117|FG007|Open-label Lead-in Phase|Adverse Event|0
4684489|NCT02496767|7591110|FG000|Open-label Lead-in Phase|Protocol Violation|2
4684490|NCT02496767|7591111|FG001|Open-label Lead-in Phase|Protocol Violation|0
4684491|NCT02496767|7591112|FG002|Open-label Lead-in Phase|Protocol Violation|0
4684492|NCT02496767|7591113|FG003|Open-label Lead-in Phase|Protocol Violation|0
4684493|NCT02496767|7591114|FG004|Open-label Lead-in Phase|Protocol Violation|0
4684494|NCT02496767|7591115|FG005|Open-label Lead-in Phase|Protocol Violation|0
4684495|NCT02496767|7591116|FG006|Open-label Lead-in Phase|Protocol Violation|0
4684496|NCT02496767|7591117|FG007|Open-label Lead-in Phase|Protocol Violation|0
4684497|NCT02496767|7591110|FG000|Open-label Lead-in Phase|Lost to Follow-up|1
4684498|NCT02496767|7591111|FG001|Open-label Lead-in Phase|Lost to Follow-up|0
4684499|NCT02496767|7591112|FG002|Open-label Lead-in Phase|Lost to Follow-up|0
4684500|NCT02496767|7591113|FG003|Open-label Lead-in Phase|Lost to Follow-up|0
4684501|NCT02496767|7591114|FG004|Open-label Lead-in Phase|Lost to Follow-up|0
4684502|NCT02496767|7591115|FG005|Open-label Lead-in Phase|Lost to Follow-up|0
4760396|NCT00529763|7734507|FG002|Overall Study|Adverse Event Unrelated to Study Drug|1
4760397|NCT00529763|7734505|FG000|Overall Study|Death|0
4760398|NCT00529763|7734506|FG001|Overall Study|Death|1
4760399|NCT00529763|7734507|FG002|Overall Study|Death|1
4760400|NCT00529763|7734505|FG000|Overall Study|Disease Progression|6
4760401|NCT00529763|7734506|FG001|Overall Study|Disease Progression|16
4684503|NCT02496767|7591116|FG006|Open-label Lead-in Phase|Lost to Follow-up|0
4760402|NCT00529763|7734507|FG002|Overall Study|Disease Progression|1
4760403|NCT00529763|7734505|FG000|Overall Study|Lost to Follow-up|0
4760404|NCT00529763|7734506|FG001|Overall Study|Lost to Follow-up|1
4684504|NCT02496767|7591117|FG007|Open-label Lead-in Phase|Lost to Follow-up|0
4684505|NCT02496767|7591110|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0
4684506|NCT02496767|7591111|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13
4684507|NCT02496767|7591112|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23
4684508|NCT02496767|7591113|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43
4684509|NCT02496767|7591114|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43
4684510|NCT02496767|7591115|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0
4684511|NCT02496767|7591116|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0
4684512|NCT02496767|7591117|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0
4684513|NCT02496767|7591110|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0
4684514|NCT02496767|7591111|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13
4684515|NCT02496767|7591112|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9
4684516|NCT02496767|7591113|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8
4684517|NCT02496767|7591114|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14
4684518|NCT02496767|7591115|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0
4684519|NCT02496767|7591116|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0
4684520|NCT02496767|7591117|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0
4684521|NCT02496767|7591110|FG000|Double-blind, Placebo-controlled Phase|Death|0
4684522|NCT02496767|7591111|FG001|Double-blind, Placebo-controlled Phase|Death|10
4684523|NCT02496767|7591112|FG002|Double-blind, Placebo-controlled Phase|Death|6
4684524|NCT02496767|7591113|FG003|Double-blind, Placebo-controlled Phase|Death|2
4684525|NCT02496767|7591114|FG004|Double-blind, Placebo-controlled Phase|Death|4
4684526|NCT02496767|7591115|FG005|Double-blind, Placebo-controlled Phase|Death|0
4684527|NCT02496767|7591116|FG006|Double-blind, Placebo-controlled Phase|Death|0
4684528|NCT02496767|7591117|FG007|Double-blind, Placebo-controlled Phase|Death|0
4684529|NCT02496767|7591110|FG000|Double-blind, Placebo-controlled Phase|Various|0
4684530|NCT02496767|7591111|FG001|Double-blind, Placebo-controlled Phase|Various|9
4684531|NCT02496767|7591112|FG002|Double-blind, Placebo-controlled Phase|Various|4
4684532|NCT02496767|7591113|FG003|Double-blind, Placebo-controlled Phase|Various|5
4684533|NCT02496767|7591114|FG004|Double-blind, Placebo-controlled Phase|Various|2
4684534|NCT02496767|7591115|FG005|Double-blind, Placebo-controlled Phase|Various|0
4684535|NCT02496767|7591116|FG006|Double-blind, Placebo-controlled Phase|Various|0
4684536|NCT02496767|7591117|FG007|Double-blind, Placebo-controlled Phase|Various|0
4684537|NCT02496767|7591110|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
4684538|NCT02496767|7591111|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4
4684539|NCT02496767|7591112|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3
4684540|NCT02496767|7591113|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1
4684541|NCT02496767|7591114|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2
4684542|NCT02496767|7591115|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
4684543|NCT02496767|7591116|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
4684544|NCT02496767|7591117|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
4684545|NCT02496767|7591110|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0
4684546|NCT02496767|7591111|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4
4684547|NCT02496767|7591112|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1
4684548|NCT02496767|7591113|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0
4684549|NCT02496767|7591114|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0
4684550|NCT02496767|7591115|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0
4684551|NCT02496767|7591116|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0
4684552|NCT02496767|7591117|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0
4684553|NCT02496767|7591110|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
4684554|NCT02496767|7591111|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2
4684555|NCT02496767|7591112|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
4684556|NCT02496767|7591113|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2
4684557|NCT02496767|7591114|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1
4684558|NCT02496767|7591115|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
4684559|NCT02496767|7591116|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
4684560|NCT02496767|7591117|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
4684561|NCT02496767|7591110|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0
4684562|NCT02496767|7591111|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1
4684563|NCT02496767|7591112|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0
4684564|NCT02496767|7591113|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0
4684565|NCT02496767|7591114|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0
4684566|NCT02496767|7591115|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0
4684567|NCT02496767|7591116|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0
4684568|NCT02496767|7591117|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0
4684569|NCT02496767|7591110|FG000|Double-blind, Withdrawal Phase|Progressive disease|0
4684570|NCT02496767|7591111|FG001|Double-blind, Withdrawal Phase|Progressive disease|0
4684571|NCT02496767|7591112|FG002|Double-blind, Withdrawal Phase|Progressive disease|0
4684572|NCT02496767|7591113|FG003|Double-blind, Withdrawal Phase|Progressive disease|0
4760405|NCT00529763|7734507|FG002|Overall Study|Lost to Follow-up|1
4684573|NCT02496767|7591114|FG004|Double-blind, Withdrawal Phase|Progressive disease|0
4684574|NCT02496767|7591115|FG005|Double-blind, Withdrawal Phase|Progressive disease|4
4684575|NCT02496767|7591116|FG006|Double-blind, Withdrawal Phase|Progressive disease|0
4684576|NCT02496767|7591117|FG007|Double-blind, Withdrawal Phase|Progressive disease|1
4684577|NCT02496767|7591110|FG000|Double-blind, Withdrawal Phase|Adverse Event|0
4684578|NCT02496767|7591111|FG001|Double-blind, Withdrawal Phase|Adverse Event|0
4684579|NCT02496767|7591112|FG002|Double-blind, Withdrawal Phase|Adverse Event|0
4684580|NCT02496767|7591113|FG003|Double-blind, Withdrawal Phase|Adverse Event|0
4684581|NCT02496767|7591114|FG004|Double-blind, Withdrawal Phase|Adverse Event|0
4684582|NCT02496767|7591115|FG005|Double-blind, Withdrawal Phase|Adverse Event|1
4684583|NCT02496767|7591116|FG006|Double-blind, Withdrawal Phase|Adverse Event|2
4684584|NCT02496767|7591117|FG007|Double-blind, Withdrawal Phase|Adverse Event|1
4684585|NCT02496767|7591110|FG000|Double-blind, Withdrawal Phase|Death|0
4684586|NCT02496767|7591111|FG001|Double-blind, Withdrawal Phase|Death|0
4684587|NCT02496767|7591112|FG002|Double-blind, Withdrawal Phase|Death|0
4684588|NCT02496767|7591113|FG003|Double-blind, Withdrawal Phase|Death|0
4684589|NCT02496767|7591114|FG004|Double-blind, Withdrawal Phase|Death|0
4684590|NCT02496767|7591115|FG005|Double-blind, Withdrawal Phase|Death|0
4684591|NCT02496767|7591116|FG006|Double-blind, Withdrawal Phase|Death|1
4684592|NCT02496767|7591117|FG007|Double-blind, Withdrawal Phase|Death|2
4684593|NCT02496767|7591110|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0
4684594|NCT02496767|7591111|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0
4684595|NCT02496767|7591112|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0
4684596|NCT02496767|7591113|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0
4684597|NCT02496767|7591114|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0
4684598|NCT02496767|7591115|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1
4684599|NCT02496767|7591116|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1
4684600|NCT02496767|7591117|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1
4684601|NCT02496884|7591135|FG000|Overall Study|Counted twice as enrolled|2
4684602|NCT02496884|7591136|FG001|Overall Study|Counted twice as enrolled|0
4760406|NCT00529763|7734505|FG000|Overall Study|Stem Cell Transplant|0
4760407|NCT00529763|7734506|FG001|Overall Study|Stem Cell Transplant|3
4760408|NCT00529763|7734507|FG002|Overall Study|Stem Cell Transplant|0
4760409|NCT00529763|7734505|FG000|Overall Study|Study Drug Toxicity|1
4760410|NCT00529763|7734506|FG001|Overall Study|Study Drug Toxicity|6
4760411|NCT00529763|7734507|FG002|Overall Study|Study Drug Toxicity|1
4760412|NCT00529763|7734505|FG000|Overall Study|Patient Withdrew Consent|2
4760413|NCT00529763|7734506|FG001|Overall Study|Patient Withdrew Consent|3
4760414|NCT00529763|7734507|FG002|Overall Study|Patient Withdrew Consent|2
4684603|NCT02496884|7591137|FG002|Overall Study|Counted twice as enrolled|0
4684604|NCT02496884|7591138|FG003|Overall Study|Counted twice as enrolled|0
4684605|NCT02496884|7591135|FG000|Overall Study|Withdrawal by Subject|0
4684606|NCT02496884|7591136|FG001|Overall Study|Withdrawal by Subject|3
4684607|NCT02496884|7591137|FG002|Overall Study|Withdrawal by Subject|0
4684608|NCT02496884|7591138|FG003|Overall Study|Withdrawal by Subject|0
4684609|NCT02497001|7591152|FG000|Overall Study|Lost to Follow-up|10
4684610|NCT02497001|7591153|FG001|Overall Study|Lost to Follow-up|2
4684611|NCT02497001|7591154|FG002|Overall Study|Lost to Follow-up|0
4684612|NCT02497001|7591155|FG003|Overall Study|Lost to Follow-up|2
4684613|NCT02497001|7591152|FG000|Overall Study|Adverse Event|28
4684614|NCT02497001|7591153|FG001|Overall Study|Adverse Event|30
4684615|NCT02497001|7591154|FG002|Overall Study|Adverse Event|11
4684616|NCT02497001|7591155|FG003|Overall Study|Adverse Event|11
4684617|NCT02497001|7591152|FG000|Overall Study|Withdrawal by Subject|14
4684618|NCT02497001|7591153|FG001|Overall Study|Withdrawal by Subject|37
4684619|NCT02497001|7591154|FG002|Overall Study|Withdrawal by Subject|19
4684620|NCT02497001|7591155|FG003|Overall Study|Withdrawal by Subject|15
4684621|NCT02497001|7591152|FG000|Overall Study|Physician Decision|5
4684622|NCT02497001|7591153|FG001|Overall Study|Physician Decision|11
4684623|NCT02497001|7591154|FG002|Overall Study|Physician Decision|5
4684624|NCT02497001|7591155|FG003|Overall Study|Physician Decision|1
4684625|NCT02497001|7591152|FG000|Overall Study|subjects that were not treated|1
4684626|NCT02497001|7591153|FG001|Overall Study|subjects that were not treated|2
4684627|NCT02497001|7591154|FG002|Overall Study|subjects that were not treated|2
4684628|NCT02497001|7591155|FG003|Overall Study|subjects that were not treated|1
4684629|NCT02497001|7591152|FG000|Overall Study|Major Protocol Deviation|3
4684630|NCT02497001|7591153|FG001|Overall Study|Major Protocol Deviation|4
4684631|NCT02497001|7591154|FG002|Overall Study|Major Protocol Deviation|4
4684632|NCT02497001|7591155|FG003|Overall Study|Major Protocol Deviation|4
4684633|NCT02497001|7591152|FG000|Overall Study|Lack of Efficacy|10
4684634|NCT02497001|7591153|FG001|Overall Study|Lack of Efficacy|16
4684635|NCT02497001|7591154|FG002|Overall Study|Lack of Efficacy|6
4684636|NCT02497001|7591155|FG003|Overall Study|Lack of Efficacy|6
4684637|NCT02497001|7591152|FG000|Overall Study|Protocol Violation|3
4684638|NCT02497001|7591153|FG001|Overall Study|Protocol Violation|1
4684639|NCT02497001|7591154|FG002|Overall Study|Protocol Violation|3
4684640|NCT02497001|7591155|FG003|Overall Study|Protocol Violation|1
4684641|NCT02497287|7591205|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84
4684642|NCT02497287|7591205|FG000|Induction Phase (4 Weeks)|Adverse Event|52
4684643|NCT02497287|7591205|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22
4684644|NCT02497287|7591205|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21
4684645|NCT02497287|7591205|FG000|Induction Phase (4 Weeks)|Other|13
4684646|NCT02497287|7591205|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5
4684647|NCT02497287|7591205|FG000|Induction Phase (4 Weeks)|Protocol Violation|1
4684648|NCT02497287|7591205|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1
4684649|NCT02497287|7591205|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331
4684650|NCT02497287|7591205|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30
4684651|NCT02497287|7591205|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25
4684652|NCT02497287|7591205|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25
4684653|NCT02497287|7591205|FG000|Optimization/Maintenance (48 Weeks)|Other|21
4684654|NCT02497287|7591205|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10
4684655|NCT02497287|7591205|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3
4684656|NCT02497287|7591205|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3
4684657|NCT02497287|7591205|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2
4684658|NCT02497287|7591205|FG000|Optimization/Maintenance (48 Weeks)|Death|2
4684659|NCT02497287|7591205|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1
4684660|NCT02497287|7591205|FG000|Follow-up Phase (4 Week)|PI Decision|12
4684661|NCT02497287|7591205|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10
4684662|NCT02497287|7591205|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5
4684663|NCT02497287|7591205|FG000|Follow-up Phase (4 Week)|Adverse Event|3
4684664|NCT02497287|7591205|FG000|Follow-up Phase (4 Week)|Other|1
4684665|NCT02497391|7591211|FG000|Period 2 (14 Days)|Withdrawal by Subject|1
4684666|NCT02497391|7591212|FG001|Period 2 (14 Days)|Withdrawal by Subject|0
4684667|NCT02497391|7591213|FG002|Period 2 (14 Days)|Withdrawal by Subject|1
4684668|NCT02497391|7591214|FG003|Period 2 (14 Days)|Withdrawal by Subject|0
4684669|NCT02497391|7591215|FG004|Period 2 (14 Days)|Withdrawal by Subject|0
4684670|NCT02497391|7591216|FG005|Period 2 (14 Days)|Withdrawal by Subject|0
4684671|NCT02497391|7591211|FG000|Period 2 (14 Days)|Sponsor Decision|3
4684672|NCT02497391|7591212|FG001|Period 2 (14 Days)|Sponsor Decision|1
4684673|NCT02497391|7591213|FG002|Period 2 (14 Days)|Sponsor Decision|2
4684674|NCT02497391|7591214|FG003|Period 2 (14 Days)|Sponsor Decision|3
4684675|NCT02497391|7591215|FG004|Period 2 (14 Days)|Sponsor Decision|2
4684676|NCT02497391|7591216|FG005|Period 2 (14 Days)|Sponsor Decision|3
4684677|NCT02497391|7591211|FG000|Period 3 (14 Days)|Adverse Event|0
4684678|NCT02497391|7591212|FG001|Period 3 (14 Days)|Adverse Event|1
4684679|NCT02497391|7591213|FG002|Period 3 (14 Days)|Adverse Event|0
4684680|NCT02497391|7591214|FG003|Period 3 (14 Days)|Adverse Event|0
4684681|NCT02497391|7591215|FG004|Period 3 (14 Days)|Adverse Event|0
4684682|NCT02497391|7591216|FG005|Period 3 (14 Days)|Adverse Event|0
4684683|NCT02497391|7591211|FG000|Period 3 (14 Days)|Sponsor Decision|0
4684684|NCT02497391|7591212|FG001|Period 3 (14 Days)|Sponsor Decision|0
4684685|NCT02497391|7591213|FG002|Period 3 (14 Days)|Sponsor Decision|0
4684686|NCT02497391|7591214|FG003|Period 3 (14 Days)|Sponsor Decision|0
4684687|NCT02497391|7591215|FG004|Period 3 (14 Days)|Sponsor Decision|1
4684688|NCT02497391|7591216|FG005|Period 3 (14 Days)|Sponsor Decision|0
4684689|NCT02497391|7591211|FG000|Period 3 (14 Days)|Withdrawal by Subject|0
4684690|NCT02497391|7591212|FG001|Period 3 (14 Days)|Withdrawal by Subject|0
4684691|NCT02497391|7591213|FG002|Period 3 (14 Days)|Withdrawal by Subject|1
4684692|NCT02497391|7591214|FG003|Period 3 (14 Days)|Withdrawal by Subject|0
4684693|NCT02497391|7591215|FG004|Period 3 (14 Days)|Withdrawal by Subject|0
4760415|NCT03938272|7734524|FG000|Overall Study|Withdrawal by Subject|1
4760416|NCT03938272|7734525|FG001|Overall Study|Withdrawal by Subject|0
4760417|NCT03938272|7734524|FG000|Overall Study|Physician Decision|0
4760418|NCT03938272|7734525|FG001|Overall Study|Physician Decision|2
4760419|NCT03938272|7734524|FG000|Overall Study|Study termination by sponsor|10
4760420|NCT03938272|7734525|FG001|Overall Study|Study termination by sponsor|8
4760421|NCT03641339|7734537|FG000|Overall Study|Physician Decision|1
4760422|NCT03641339|7734538|FG001|Overall Study|Physician Decision|0
4760423|NCT03641339|7734539|FG002|Overall Study|Physician Decision|0
4760424|NCT03641339|7734540|FG003|Overall Study|Physician Decision|0
4760425|NCT03641339|7734541|FG004|Overall Study|Physician Decision|0
4760426|NCT03641339|7734542|FG005|Overall Study|Physician Decision|0
4760427|NCT03641339|7734537|FG000|Overall Study|Withdrawal by Subject|0
4760428|NCT03641339|7734538|FG001|Overall Study|Withdrawal by Subject|2
4760429|NCT03641339|7734539|FG002|Overall Study|Withdrawal by Subject|0
4760430|NCT03641339|7734540|FG003|Overall Study|Withdrawal by Subject|2
4760431|NCT03641339|7734541|FG004|Overall Study|Withdrawal by Subject|0
4760432|NCT03641339|7734542|FG005|Overall Study|Withdrawal by Subject|1
4760433|NCT03625466|7734558|FG000|Overall Study|Adverse Event|0
4760434|NCT03625466|7734559|FG001|Overall Study|Adverse Event|1
4760435|NCT03625466|7734558|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0
4760436|NCT03625466|7734559|FG001|Overall Study|Withdrawal of Consent (not due to AE)|1
4760437|NCT03476239|7734565|FG000|Overall Study|Continuing study|43
4760438|NCT03476239|7734565|FG000|Overall Study|Withdrawal by Subject|6
4760439|NCT03476239|7734565|FG000|Overall Study|Death|39
4760440|NCT03476239|7734565|FG000|Overall Study|Lost to Follow-up|2
4760441|NCT03476239|7734565|FG000|Overall Study|Data Not Available|15
4760442|NCT03476239|7734565|FG000|Overall Study|Did not receive study drug|1
4760443|NCT03317795|7734571|FG000|Overall Study|IUD Expulsion|1
4760444|NCT03317795|7734572|FG001|Overall Study|IUD Expulsion|0
4760445|NCT03317795|7734571|FG000|Overall Study|Lost to Follow-up|1
4760446|NCT03317795|7734572|FG001|Overall Study|Lost to Follow-up|3
4760447|NCT03317795|7734571|FG000|Overall Study|Treatment change|0
4760448|NCT03317795|7734572|FG001|Overall Study|Treatment change|3
4760449|NCT03317795|7734571|FG000|Overall Study|Intolerance of medication|0
4760450|NCT03317795|7734572|FG001|Overall Study|Intolerance of medication|1
4760451|NCT03287245|7734582|FG000|Overall Study|Study terminated by sponsor|3
4760452|NCT03287245|7734583|FG001|Overall Study|Study terminated by sponsor|0
4760453|NCT03287245|7734584|FG002|Overall Study|Study terminated by sponsor|3
4760454|NCT03287245|7734585|FG003|Overall Study|Study terminated by sponsor|1
4760455|NCT03287245|7734582|FG000|Overall Study|Adverse Event|1
4760456|NCT03287245|7734583|FG001|Overall Study|Adverse Event|0
4760457|NCT03287245|7734584|FG002|Overall Study|Adverse Event|0
4760458|NCT03287245|7734585|FG003|Overall Study|Adverse Event|0
4760459|NCT03287245|7734582|FG000|Overall Study|Withdrawal by Subject|8
4760460|NCT03287245|7734583|FG001|Overall Study|Withdrawal by Subject|3
4760461|NCT03287245|7734584|FG002|Overall Study|Withdrawal by Subject|3
4760462|NCT03287245|7734585|FG003|Overall Study|Withdrawal by Subject|0
4760463|NCT03287245|7734582|FG000|Overall Study|Physician Decision|3
4760464|NCT03287245|7734583|FG001|Overall Study|Physician Decision|2
4760465|NCT03287245|7734584|FG002|Overall Study|Physician Decision|0
4760466|NCT03287245|7734585|FG003|Overall Study|Physician Decision|0
4760467|NCT03092219|7734626|FG000|Overall Study|Protocol Violation|7
4760468|NCT03092219|7734627|FG001|Overall Study|Protocol Violation|4
4760469|NCT03033069|7734640|FG000|Overall Study|Adverse Event|6
4760470|NCT03033069|7734641|FG001|Overall Study|Adverse Event|7
4760471|NCT03033069|7734642|FG002|Overall Study|Adverse Event|4
4760472|NCT03033069|7734643|FG003|Overall Study|Adverse Event|6
4760473|NCT03033069|7734640|FG000|Overall Study|Lack of Efficacy|0
4760474|NCT03033069|7734641|FG001|Overall Study|Lack of Efficacy|0
4760475|NCT03033069|7734642|FG002|Overall Study|Lack of Efficacy|1
4760476|NCT03033069|7734643|FG003|Overall Study|Lack of Efficacy|0
4760477|NCT03033069|7734640|FG000|Overall Study|Lost to Follow-up|6
4760478|NCT03033069|7734641|FG001|Overall Study|Lost to Follow-up|5
4760479|NCT03033069|7734642|FG002|Overall Study|Lost to Follow-up|5
4760480|NCT03033069|7734643|FG003|Overall Study|Lost to Follow-up|6
4760481|NCT03033069|7734640|FG000|Overall Study|Non-Compliance With Study Drug|1
4760482|NCT03033069|7734641|FG001|Overall Study|Non-Compliance With Study Drug|1
4760483|NCT03033069|7734642|FG002|Overall Study|Non-Compliance With Study Drug|1
4684694|NCT02497391|7591216|FG005|Period 3 (14 Days)|Withdrawal by Subject|0
4760484|NCT03033069|7734643|FG003|Overall Study|Non-Compliance With Study Drug|0
4760485|NCT03033069|7734640|FG000|Overall Study|Protocol Deviation|0
4760486|NCT03033069|7734641|FG001|Overall Study|Protocol Deviation|1
4684695|NCT02497404|7591224|FG000|Overall Study|Adverse Event|1
4684696|NCT02497469|7591230|FG000|Overall Study|Randomized but not Treated|0
4684697|NCT02497469|7591231|FG001|Overall Study|Randomized but not Treated|2
4684698|NCT02497469|7591230|FG000|Overall Study|Pretreatment Event/Adverse Event|18
4684699|NCT02497469|7591231|FG001|Overall Study|Pretreatment Event/Adverse Event|16
4684700|NCT02497469|7591230|FG000|Overall Study|Leukopenia or Lymphopenia|1
4684701|NCT02497469|7591231|FG001|Overall Study|Leukopenia or Lymphopenia|0
4684702|NCT02497469|7591230|FG000|Overall Study|Significant Protocol Deviation|4
4684703|NCT02497469|7591231|FG001|Overall Study|Significant Protocol Deviation|5
4684704|NCT02497469|7591230|FG000|Overall Study|Lost to Follow-up|14
4684705|NCT02497469|7591231|FG001|Overall Study|Lost to Follow-up|4
4684706|NCT02497469|7591230|FG000|Overall Study|Voluntary Withdrawal|39
4684707|NCT02497469|7591231|FG001|Overall Study|Voluntary Withdrawal|41
4684708|NCT02497469|7591230|FG000|Overall Study|Pregnancy|1
4684709|NCT02497469|7591231|FG001|Overall Study|Pregnancy|1
4684710|NCT02497469|7591230|FG000|Overall Study|Lack of Efficacy|86
4684711|NCT02497469|7591231|FG001|Overall Study|Lack of Efficacy|40
4684712|NCT02497469|7591230|FG000|Overall Study|Reason not Specified|6
4684713|NCT02497469|7591231|FG001|Overall Study|Reason not Specified|6
4684714|NCT02497755|7591239|FG000|Overall Study|Protocol Violation|1
4684715|NCT02497755|7591240|FG001|Overall Study|Protocol Violation|0
4684716|NCT02497781|7591249|FG000|Overall Study|Withdrawal by Subject|2
4684717|NCT02497781|7591250|FG001|Overall Study|Withdrawal by Subject|0
4684718|NCT02497781|7591249|FG000|Overall Study|Lack of Efficacy|0
4684719|NCT02497781|7591250|FG001|Overall Study|Lack of Efficacy|1
4684720|NCT02497781|7591249|FG000|Overall Study|Randomised but not treated|1
4684721|NCT02497781|7591250|FG001|Overall Study|Randomised but not treated|1
4684722|NCT02497781|7591249|FG000|Overall Study|Lost to Follow-up|1
4684723|NCT02497781|7591250|FG001|Overall Study|Lost to Follow-up|1
4684724|NCT02497976|7591266|FG000|Overall Study|Withdrawal by Subject|2
4684725|NCT02497976|7591267|FG001|Overall Study|Withdrawal by Subject|0
4684726|NCT02497976|7591266|FG000|Overall Study|Moved out of area|0
4684727|NCT02497976|7591267|FG001|Overall Study|Moved out of area|1
4760487|NCT03033069|7734642|FG002|Overall Study|Protocol Deviation|0
4760488|NCT03033069|7734643|FG003|Overall Study|Protocol Deviation|0
4760489|NCT03033069|7734640|FG000|Overall Study|Withdrawal by Subject|10
4760490|NCT03033069|7734641|FG001|Overall Study|Withdrawal by Subject|10
4760491|NCT03033069|7734642|FG002|Overall Study|Withdrawal by Subject|11
4760492|NCT03033069|7734643|FG003|Overall Study|Withdrawal by Subject|6
4760493|NCT03033069|7734640|FG000|Overall Study|Withdrawal By Caregiver|1
4760494|NCT03033069|7734641|FG001|Overall Study|Withdrawal By Caregiver|0
4760495|NCT03033069|7734642|FG002|Overall Study|Withdrawal By Caregiver|0
4760496|NCT03033069|7734643|FG003|Overall Study|Withdrawal By Caregiver|0
4760497|NCT03033069|7734640|FG000|Overall Study|Reason not Specified|0
4760498|NCT03033069|7734641|FG001|Overall Study|Reason not Specified|1
4760499|NCT03033069|7734642|FG002|Overall Study|Reason not Specified|0
4760500|NCT03033069|7734643|FG003|Overall Study|Reason not Specified|1
4760501|NCT02663622|7734672|FG000|Overall Study|Ongoing in study|0
4760502|NCT02663622|7734673|FG001|Overall Study|Ongoing in study|0
4760503|NCT02663622|7734674|FG002|Overall Study|Ongoing in study|0
4760504|NCT02663622|7734675|FG003|Overall Study|Ongoing in study|6
4760505|NCT02663622|7734672|FG000|Overall Study|Death|3
4760506|NCT02663622|7734673|FG001|Overall Study|Death|1
4760507|NCT02663622|7734674|FG002|Overall Study|Death|1
4760508|NCT02663622|7734675|FG003|Overall Study|Death|8
4760509|NCT02663622|7734672|FG000|Overall Study|Protocol Violation|0
4760510|NCT02663622|7734673|FG001|Overall Study|Protocol Violation|0
4760511|NCT02663622|7734674|FG002|Overall Study|Protocol Violation|0
4760512|NCT02663622|7734675|FG003|Overall Study|Protocol Violation|1
4760513|NCT02609503|7734686|FG000|Overall Study|Adverse Event|1
4760514|NCT02609503|7734686|FG000|Overall Study|Death|1
4760515|NCT02609503|7734686|FG000|Overall Study|Withdrawal by Subject|1
4760516|NCT02609503|7734686|FG000|Overall Study|Disease progression|1
4760517|NCT02587598|7734704|FG000|Overall Study|Death|4
4760518|NCT02587598|7734705|FG001|Overall Study|Death|8
4760519|NCT02587598|7734706|FG002|Overall Study|Death|4
4760520|NCT02587598|7734707|FG003|Overall Study|Death|16
4760521|NCT02587598|7734708|FG004|Overall Study|Death|9
4760522|NCT02587598|7734709|FG005|Overall Study|Death|4
4760523|NCT02587598|7734710|FG006|Overall Study|Death|6
4760524|NCT02587598|7734711|FG007|Overall Study|Death|7
4760525|NCT02587598|7734712|FG008|Overall Study|Death|9
4760526|NCT02587598|7734713|FG009|Overall Study|Death|1
4760527|NCT02587598|7734714|FG010|Overall Study|Death|3
4760528|NCT02587598|7734704|FG000|Overall Study|Study Terminated by the Sponsor|0
4760529|NCT02587598|7734705|FG001|Overall Study|Study Terminated by the Sponsor|1
4760530|NCT02587598|7734706|FG002|Overall Study|Study Terminated by the Sponsor|0
4760531|NCT02587598|7734707|FG003|Overall Study|Study Terminated by the Sponsor|3
4760532|NCT02587598|7734708|FG004|Overall Study|Study Terminated by the Sponsor|0
4760533|NCT02587598|7734709|FG005|Overall Study|Study Terminated by the Sponsor|1
4760534|NCT02587598|7734710|FG006|Overall Study|Study Terminated by the Sponsor|0
4760535|NCT02587598|7734711|FG007|Overall Study|Study Terminated by the Sponsor|0
4760536|NCT02587598|7734712|FG008|Overall Study|Study Terminated by the Sponsor|0
4760537|NCT02587598|7734713|FG009|Overall Study|Study Terminated by the Sponsor|1
4760538|NCT02587598|7734714|FG010|Overall Study|Study Terminated by the Sponsor|6
4684728|NCT02498067|7591273|FG000|Overall Study|Lost to Follow-up|22
4684729|NCT02498067|7591273|FG000|Overall Study|Did not meet inclusion criteria|11
4684730|NCT02498236|7591287|FG000|Overall Study|Did not show for testing|1
4684731|NCT02498236|7591288|FG001|Overall Study|Did not show for testing|0
4684732|NCT02498236|7591289|FG002|Overall Study|Did not show for testing|0
4684733|NCT02498236|7591290|FG003|Overall Study|Did not show for testing|0
4684734|NCT02498236|7591291|FG004|Overall Study|Did not show for testing|0
4684735|NCT02498236|7591292|FG005|Overall Study|Did not show for testing|0
4684736|NCT02498236|7591293|FG006|Overall Study|Did not show for testing|0
4684737|NCT02498236|7591294|FG007|Overall Study|Did not show for testing|1
4684738|NCT02498236|7591287|FG000|Overall Study|Equipment failure|0
4684739|NCT02498236|7591288|FG001|Overall Study|Equipment failure|0
4684740|NCT02498236|7591289|FG002|Overall Study|Equipment failure|0
4684741|NCT02498236|7591290|FG003|Overall Study|Equipment failure|0
4684742|NCT02498236|7591291|FG004|Overall Study|Equipment failure|0
4684743|NCT02498236|7591292|FG005|Overall Study|Equipment failure|0
4684744|NCT02498236|7591293|FG006|Overall Study|Equipment failure|1
4684745|NCT02498236|7591294|FG007|Overall Study|Equipment failure|0
4684746|NCT02498236|7591287|FG000|Overall Study|Withdrawal by Subject|0
4684747|NCT02498236|7591288|FG001|Overall Study|Withdrawal by Subject|0
4684748|NCT02498236|7591289|FG002|Overall Study|Withdrawal by Subject|0
4684749|NCT02498236|7591290|FG003|Overall Study|Withdrawal by Subject|0
4684750|NCT02498236|7591291|FG004|Overall Study|Withdrawal by Subject|1
4684751|NCT02498236|7591292|FG005|Overall Study|Withdrawal by Subject|0
4684752|NCT02498236|7591293|FG006|Overall Study|Withdrawal by Subject|0
4684753|NCT02498236|7591294|FG007|Overall Study|Withdrawal by Subject|0
4684754|NCT02498418|7591318|FG000|Overall Study|Lack of Efficacy|0
4684755|NCT02498418|7591319|FG001|Overall Study|Lack of Efficacy|0
4684756|NCT02498418|7591320|FG002|Overall Study|Lack of Efficacy|1
4684757|NCT02498418|7591318|FG000|Overall Study|Withdrawal by Subject|2
4684758|NCT02498418|7591319|FG001|Overall Study|Withdrawal by Subject|0
4684759|NCT02498418|7591320|FG002|Overall Study|Withdrawal by Subject|3
4684760|NCT02498418|7591318|FG000|Overall Study|Lost to Follow-up|0
4684761|NCT02498418|7591319|FG001|Overall Study|Lost to Follow-up|1
4684762|NCT02498418|7591320|FG002|Overall Study|Lost to Follow-up|1
4684763|NCT02498418|7591318|FG000|Overall Study|Participant taken prohibited medication|0
4684764|NCT02498418|7591319|FG001|Overall Study|Participant taken prohibited medication|1
4684765|NCT02498418|7591320|FG002|Overall Study|Participant taken prohibited medication|1
4684766|NCT02498652|7591348|FG000|Overall Study|Protocol Violation|0
4684767|NCT02498652|7591349|FG001|Overall Study|Protocol Violation|1
4684768|NCT02498678|7591375|FG000|Overall Study|interference from the surgical team|0
4684769|NCT02498678|7591376|FG001|Overall Study|interference from the surgical team|2
4684770|NCT02498821|7591393|FG000|Overall Study|Screen failure|3
4684771|NCT02498821|7591394|FG001|Overall Study|Screen failure|5
4684772|NCT02499029|7591411|FG000|Overall Study|Lost to Follow-up|2
4684773|NCT02499029|7591412|FG001|Overall Study|Lost to Follow-up|2
4684774|NCT02499029|7591411|FG000|Overall Study|Physician Decision|2
4684775|NCT02499029|7591412|FG001|Overall Study|Physician Decision|1
4684776|NCT02499029|7591411|FG000|Overall Study|Death|1
4684777|NCT02499029|7591412|FG001|Overall Study|Death|0
4684778|NCT02499120|7591424|FG000|Overall Study|Death|45
4684779|NCT02499120|7591425|FG001|Overall Study|Death|42
4684780|NCT02499120|7591424|FG000|Overall Study|Lost to Follow-up|1
4684781|NCT02499120|7591425|FG001|Overall Study|Lost to Follow-up|2
4684782|NCT02499120|7591424|FG000|Overall Study|Participant refused further follow-up|1
4684783|NCT02499120|7591425|FG001|Overall Study|Participant refused further follow-up|0
4684784|NCT02499120|7591424|FG000|Overall Study|Withdrawal by Subject|2
4684785|NCT02499120|7591425|FG001|Overall Study|Withdrawal by Subject|5
4684786|NCT02499120|7591424|FG000|Overall Study|Other|1
4684787|NCT02499120|7591425|FG001|Overall Study|Other|0
4684788|NCT02499120|7591424|FG000|Overall Study|Ongoing on study|15
4684789|NCT02499120|7591425|FG001|Overall Study|Ongoing on study|11
4684790|NCT02499146|7591431|FG000|Overall Study|Lost to Follow-up|1
4684791|NCT02499146|7591431|FG000|Overall Study|Withdrawal by Subject|1
4684792|NCT02499146|7591431|FG000|Overall Study|Other|2
4684793|NCT02499146|7591431|FG000|Overall Study|Ongoing at date of cut-off|9
4684794|NCT02499146|7591431|FG000|Overall Study|Began other treatment/therapy|13
4760539|NCT02587598|7734704|FG000|Overall Study|Reason for study withdrawal not specified|0
4760540|NCT02587598|7734705|FG001|Overall Study|Reason for study withdrawal not specified|1
4760541|NCT02587598|7734706|FG002|Overall Study|Reason for study withdrawal not specified|0
4760542|NCT02587598|7734707|FG003|Overall Study|Reason for study withdrawal not specified|0
4760543|NCT02587598|7734708|FG004|Overall Study|Reason for study withdrawal not specified|0
4760544|NCT02587598|7734709|FG005|Overall Study|Reason for study withdrawal not specified|0
4760545|NCT02587598|7734710|FG006|Overall Study|Reason for study withdrawal not specified|0
4760546|NCT02587598|7734711|FG007|Overall Study|Reason for study withdrawal not specified|0
4684795|NCT02499159|7591437|FG000|Randomization|Protocol Violation|1
4684796|NCT02499159|7591438|FG001|Randomization|Protocol Violation|1
4684797|NCT02499159|7591437|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1
4684798|NCT02499159|7591438|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1
4684799|NCT02499159|7591437|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3
4684800|NCT02499159|7591438|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1
4684801|NCT02499159|7591437|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2
4684802|NCT02499159|7591438|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0
4684803|NCT02499159|7591437|FG000|30-Day Follow-Up Phone Call|Other|1
4684804|NCT02499159|7591438|FG001|30-Day Follow-Up Phone Call|Other|0
4684805|NCT02499172|7591448|FG000|Overall Study|Financial reason|0
4684806|NCT02499172|7591449|FG001|Overall Study|Financial reason|0
4684807|NCT02499172|7591450|FG002|Overall Study|Financial reason|523
4684808|NCT02499172|7591451|FG003|Overall Study|Financial reason|436
4684809|NCT02499172|7591448|FG000|Overall Study|Lost to Follow-up|65
4684810|NCT02499172|7591449|FG001|Overall Study|Lost to Follow-up|64
4684811|NCT02499172|7591450|FG002|Overall Study|Lost to Follow-up|0
4684812|NCT02499172|7591451|FG003|Overall Study|Lost to Follow-up|0
4684813|NCT02499263|7591461|FG000|Overall Study|Lost to Follow-up|9
4684814|NCT02499263|7591461|FG000|Overall Study|Participant's withdrawal of consent|4
4684815|NCT02499263|7591461|FG000|Overall Study|Lack of Efficacy|22
4684816|NCT02499263|7591461|FG000|Overall Study|investigator's judgment|12
4684817|NCT02499263|7591461|FG000|Overall Study|Adverse Events/Serious Adverse Events|11
4684818|NCT02499263|7591461|FG000|Overall Study|Participant's decision|3
4684819|NCT02499263|7591461|FG000|Overall Study|Pregnancy|1
4684820|NCT02499406|7591469|FG000|Overall Study|missed 3 treatment sessions|4
4684821|NCT02499575|7591492|FG000|Overall Study|Protocol Violation|0
4684822|NCT02499575|7591493|FG001|Overall Study|Protocol Violation|1
4684823|NCT02499770|7591505|FG000|Overall Study|Death|17
4684824|NCT02499770|7591506|FG001|Overall Study|Death|56
4684825|NCT02499770|7591505|FG000|Overall Study|Study completion|1
4684826|NCT02499770|7591506|FG001|Overall Study|Study completion|10
4684827|NCT02499770|7591505|FG000|Overall Study|Withdrawal by Subject|0
4684828|NCT02499770|7591506|FG001|Overall Study|Withdrawal by Subject|7
4684829|NCT02499770|7591505|FG000|Overall Study|Lost to Follow-up|0
4684830|NCT02499770|7591506|FG001|Overall Study|Lost to Follow-up|2
4684831|NCT02499770|7591505|FG000|Overall Study|Subject declined further treatment|1
4684832|NCT02499770|7591506|FG001|Overall Study|Subject declined further treatment|0
4684833|NCT02499770|7591505|FG000|Overall Study|Withdrawn by PI for compassionate reason|0
4684834|NCT02499770|7591506|FG001|Overall Study|Withdrawn by PI for compassionate reason|1
4684835|NCT02499770|7591505|FG000|Overall Study|Randomized but not enrolled|0
4684836|NCT02499770|7591506|FG001|Overall Study|Randomized but not enrolled|1
4684837|NCT02499783|7591520|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2
4684838|NCT02499783|7591521|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4
4684839|NCT02499783|7591522|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0
4684840|NCT02499783|7591520|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1
4684841|NCT02499783|7591521|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0
4684842|NCT02499783|7591522|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0
4684843|NCT02499783|7591520|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1
4684844|NCT02499783|7591521|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1
4684845|NCT02499783|7591522|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0
4684846|NCT02499783|7591520|FG000|DB Period: Weeks 0-8|Adverse Event|8
4684847|NCT02499783|7591521|FG001|DB Period: Weeks 0-8|Adverse Event|6
4684848|NCT02499783|7591522|FG002|DB Period: Weeks 0-8|Adverse Event|0
4684849|NCT02499783|7591520|FG000|DB Period: Weeks 0-8|Withdrew Consent|1
4684850|NCT02499783|7591521|FG001|DB Period: Weeks 0-8|Withdrew Consent|0
4684851|NCT02499783|7591522|FG002|DB Period: Weeks 0-8|Withdrew Consent|0
4684852|NCT02499783|7591520|FG000|DB Period: Weeks 0-8|Other|1
4684853|NCT02499783|7591521|FG001|DB Period: Weeks 0-8|Other|1
4684854|NCT02499783|7591522|FG002|DB Period: Weeks 0-8|Other|0
4684855|NCT02499783|7591520|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0
4684856|NCT02499783|7591521|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0
4684857|NCT02499783|7591522|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16
4684858|NCT02499783|7591520|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0
4684859|NCT02499783|7591521|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0
4684860|NCT02499783|7591522|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2
4684861|NCT02499783|7591520|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0
4684862|NCT02499783|7591521|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0
4684863|NCT02499783|7591522|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9
4684864|NCT02499783|7591520|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0
4684865|NCT02499783|7591521|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0
4684866|NCT02499783|7591522|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2
4684867|NCT02499952|7591532|FG000|Overall Study|Lost to Follow-up|1
4684868|NCT02499952|7591532|FG000|Overall Study|Death|9
4684869|NCT02500043|7591538|FG000|Overall Study|Randomized, but not Treated|2
4684870|NCT02500043|7591539|FG001|Overall Study|Randomized, but not Treated|2
4684871|NCT02500043|7591538|FG000|Overall Study|Ongoing at Date of Cut-Off|19
4684872|NCT02500043|7591539|FG001|Overall Study|Ongoing at Date of Cut-Off|3
4684873|NCT02500043|7591538|FG000|Overall Study|Adverse Event|33
4684874|NCT02500043|7591539|FG001|Overall Study|Adverse Event|11
4684875|NCT02500043|7591538|FG000|Overall Study|Clinical Progression|54
4684876|NCT02500043|7591539|FG001|Overall Study|Clinical Progression|35
4684877|NCT02500043|7591538|FG000|Overall Study|Radiological Progression|192
4684878|NCT02500043|7591539|FG001|Overall Study|Radiological Progression|110
4684879|NCT02500043|7591538|FG000|Overall Study|Physician's Decision|11
4684880|NCT02500043|7591539|FG001|Overall Study|Physician's Decision|3
4684881|NCT02500043|7591538|FG000|Overall Study|Withdrawal by Subject|14
4684882|NCT02500043|7591539|FG001|Overall Study|Withdrawal by Subject|4
4684883|NCT02500043|7591538|FG000|Overall Study|Death|11
4684884|NCT02500043|7591539|FG001|Overall Study|Death|2
4684885|NCT02500043|7591538|FG000|Overall Study|Protocol Deviation|1
4684886|NCT02500043|7591539|FG001|Overall Study|Protocol Deviation|0
4684887|NCT02500056|7591547|FG000|Overall Study|Lost to Follow-up|3
4684888|NCT02500056|7591548|FG001|Overall Study|Lost to Follow-up|7
4684889|NCT02500056|7591547|FG000|Overall Study|Recurrence|1
4684890|NCT02500056|7591548|FG001|Overall Study|Recurrence|0
4684891|NCT02500056|7591547|FG000|Overall Study|Death|3
4684892|NCT02500056|7591548|FG001|Overall Study|Death|1
4684893|NCT02500537|7591563|FG000|Overall Study|Death|2
4684894|NCT02500537|7591564|FG001|Overall Study|Death|0
4684895|NCT02500537|7591563|FG000|Overall Study|Lost to Follow-up|0
4684896|NCT02500537|7591564|FG001|Overall Study|Lost to Follow-up|1
4684897|NCT02500537|7591563|FG000|Overall Study|Withdrawal by Subject|1
4684898|NCT02500537|7591564|FG001|Overall Study|Withdrawal by Subject|0
4684899|NCT02500550|7591571|FG000|Overall Study|Death|7
4684900|NCT02500641|7591599|FG000|Overall Study|Adverse Event|0
4684901|NCT02500641|7591600|FG001|Overall Study|Adverse Event|2
4684902|NCT02500641|7591599|FG000|Overall Study|Withdrawal by Subject|4
4684903|NCT02500641|7591600|FG001|Overall Study|Withdrawal by Subject|5
4684904|NCT02500641|7591599|FG000|Overall Study|Unable to follow study procedures|3
4684905|NCT02500641|7591600|FG001|Overall Study|Unable to follow study procedures|2
4684906|NCT02500641|7591599|FG000|Overall Study|Protocol Violation|1
4760547|NCT02587598|7734712|FG008|Overall Study|Reason for study withdrawal not specified|0
4760548|NCT02587598|7734713|FG009|Overall Study|Reason for study withdrawal not specified|0
4760549|NCT02587598|7734714|FG010|Overall Study|Reason for study withdrawal not specified|0
4760550|NCT02587598|7734704|FG000|Overall Study|Withdrawal by Subject|0
4760551|NCT02587598|7734705|FG001|Overall Study|Withdrawal by Subject|1
4760552|NCT02587598|7734706|FG002|Overall Study|Withdrawal by Subject|0
4760553|NCT02587598|7734707|FG003|Overall Study|Withdrawal by Subject|2
4760554|NCT02587598|7734708|FG004|Overall Study|Withdrawal by Subject|3
4760555|NCT02587598|7734709|FG005|Overall Study|Withdrawal by Subject|1
4760556|NCT02587598|7734710|FG006|Overall Study|Withdrawal by Subject|0
4760557|NCT02587598|7734711|FG007|Overall Study|Withdrawal by Subject|0
4760558|NCT02587598|7734712|FG008|Overall Study|Withdrawal by Subject|0
4684907|NCT02500641|7591600|FG001|Overall Study|Protocol Violation|2
4684908|NCT02500641|7591599|FG000|Overall Study|Lost to Follow-up|1
4684909|NCT02500641|7591600|FG001|Overall Study|Lost to Follow-up|0
4684910|NCT02500641|7591599|FG000|Overall Study|Sponsor decision|1
4684911|NCT02500641|7591600|FG001|Overall Study|Sponsor decision|0
4684912|NCT02500641|7591599|FG000|Overall Study|Non compliance to study drug|0
4684913|NCT02500641|7591600|FG001|Overall Study|Non compliance to study drug|1
4684914|NCT02500706|7591609|FG000|Overall Study|Adverse Event|0
4684915|NCT02500706|7591610|FG001|Overall Study|Adverse Event|0
4684916|NCT02500706|7591611|FG002|Overall Study|Adverse Event|1
4684917|NCT02500706|7591609|FG000|Overall Study|Lost to Follow-up|0
4684918|NCT02500706|7591610|FG001|Overall Study|Lost to Follow-up|1
4684919|NCT02500706|7591611|FG002|Overall Study|Lost to Follow-up|1
4684920|NCT02500706|7591609|FG000|Overall Study|Withdrawal by Subject|4
4684921|NCT02500706|7591610|FG001|Overall Study|Withdrawal by Subject|6
4684922|NCT02500706|7591611|FG002|Overall Study|Withdrawal by Subject|4
4684923|NCT02500706|7591609|FG000|Overall Study|Unclassified|0
4684924|NCT02500706|7591610|FG001|Overall Study|Unclassified|0
4684925|NCT02500706|7591611|FG002|Overall Study|Unclassified|1
4684926|NCT02500719|7591621|FG000|Overall Study|Lost to Follow-up|2
4684927|NCT02500719|7591622|FG001|Overall Study|Lost to Follow-up|3
4684928|NCT02500719|7591621|FG000|Overall Study|Trauma history|1
4684929|NCT02500719|7591622|FG001|Overall Study|Trauma history|0
4684930|NCT02500719|7591621|FG000|Overall Study|MRI data found to be unusable during analysis|0
4684931|NCT02500719|7591622|FG001|Overall Study|MRI data found to be unusable during analysis|1
4684932|NCT02500719|7591621|FG000|Overall Study|Did not meet criteria for PTSD|0
4684933|NCT02500719|7591622|FG001|Overall Study|Did not meet criteria for PTSD|1
4684934|NCT02500719|7591621|FG000|Overall Study|Claustrophobia|0
4684935|NCT02500719|7591622|FG001|Overall Study|Claustrophobia|1
4684936|NCT02500719|7591621|FG000|Overall Study|History of head trauma|0
4684937|NCT02500719|7591622|FG001|Overall Study|History of head trauma|1
4684938|NCT02500732|7591630|FG000|Overall Study|Physician Decision|0
4684939|NCT02500732|7591631|FG001|Overall Study|Physician Decision|1
4684940|NCT02500758|7591639|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0
4684941|NCT02500758|7591640|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1
4684942|NCT02500758|7591639|FG000|Washout (1 Week)|Lost to Follow-up|2
4684943|NCT02500758|7591640|FG001|Washout (1 Week)|Lost to Follow-up|2
4684944|NCT02500758|7591639|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2
4684945|NCT02500758|7591640|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0
4684946|NCT02500758|7591639|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0
4684947|NCT02500758|7591640|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1
4684948|NCT02500758|7591639|FG000|Second Intervention (2 Minutes)|Protocol Violation|1
4684949|NCT02500758|7591640|FG001|Second Intervention (2 Minutes)|Protocol Violation|1
4684950|NCT02500979|7591662|FG000|Period 1|Hyperglycemia|1
4760559|NCT02587598|7734713|FG009|Overall Study|Withdrawal by Subject|1
4760560|NCT02587598|7734714|FG010|Overall Study|Withdrawal by Subject|2
4760561|NCT02587598|7734704|FG000|Overall Study|Physician Decision|0
4760562|NCT02587598|7734705|FG001|Overall Study|Physician Decision|0
4760563|NCT02587598|7734706|FG002|Overall Study|Physician Decision|0
4760564|NCT02587598|7734707|FG003|Overall Study|Physician Decision|0
4760565|NCT02587598|7734708|FG004|Overall Study|Physician Decision|0
4760566|NCT02587598|7734709|FG005|Overall Study|Physician Decision|0
4760567|NCT02587598|7734710|FG006|Overall Study|Physician Decision|0
4760568|NCT02587598|7734711|FG007|Overall Study|Physician Decision|0
4760569|NCT02587598|7734712|FG008|Overall Study|Physician Decision|0
4760570|NCT02587598|7734713|FG009|Overall Study|Physician Decision|0
4760571|NCT02587598|7734714|FG010|Overall Study|Physician Decision|3
4684951|NCT02500979|7591663|FG001|Period 1|Hyperglycemia|0
4684952|NCT02500979|7591662|FG000|Period 1|Severe non-compliance to protocol|0
4684953|NCT02500979|7591663|FG001|Period 1|Severe non-compliance to protocol|1
4684954|NCT02500979|7591662|FG000|Period 1|Adverse Event|1
4684955|NCT02500979|7591663|FG001|Period 1|Adverse Event|0
4684956|NCT02500979|7591662|FG000|Period 1|Subject decision|2
4684957|NCT02500979|7591663|FG001|Period 1|Subject decision|0
4684958|NCT02500979|7591662|FG000|Period 2|Change in risk|1
4684959|NCT02500979|7591663|FG001|Period 2|Change in risk|0
4684960|NCT02501161|7591681|FG000|Overall Study|Adverse Event|2
4684961|NCT02501161|7591682|FG001|Overall Study|Adverse Event|6
4684962|NCT02501161|7591681|FG000|Overall Study|Lost to Follow-up|7
4684963|NCT02501161|7591682|FG001|Overall Study|Lost to Follow-up|4
4684964|NCT02501161|7591681|FG000|Overall Study|Withdrawal by Subject|10
4684965|NCT02501161|7591682|FG001|Overall Study|Withdrawal by Subject|15
4684966|NCT02501161|7591681|FG000|Overall Study|Other|3
4684967|NCT02501161|7591682|FG001|Overall Study|Other|0
4684968|NCT02501473|7591712|FG000|Overall Study|Study Terminated|2
4684969|NCT02501473|7591713|FG001|Overall Study|Study Terminated|3
4684970|NCT02501473|7591714|FG002|Overall Study|Study Terminated|7
4684971|NCT02501473|7591715|FG003|Overall Study|Study Terminated|9
4684972|NCT02501473|7591716|FG004|Overall Study|Study Terminated|2
4684973|NCT02501473|7591717|FG005|Overall Study|Study Terminated|10
4684974|NCT02501473|7591718|FG006|Overall Study|Study Terminated|1
4684975|NCT02501473|7591719|FG007|Overall Study|Study Terminated|0
4684976|NCT02501473|7591712|FG000|Overall Study|Withdrawal by Subject|0
4684977|NCT02501473|7591713|FG001|Overall Study|Withdrawal by Subject|0
4684978|NCT02501473|7591714|FG002|Overall Study|Withdrawal by Subject|3
4684979|NCT02501473|7591715|FG003|Overall Study|Withdrawal by Subject|3
4684980|NCT02501473|7591716|FG004|Overall Study|Withdrawal by Subject|2
4684981|NCT02501473|7591717|FG005|Overall Study|Withdrawal by Subject|2
4684982|NCT02501473|7591718|FG006|Overall Study|Withdrawal by Subject|0
4684983|NCT02501473|7591719|FG007|Overall Study|Withdrawal by Subject|0
4684984|NCT02501473|7591712|FG000|Overall Study|Death|0
4684985|NCT02501473|7591713|FG001|Overall Study|Death|0
4684986|NCT02501473|7591714|FG002|Overall Study|Death|1
4684987|NCT02501473|7591715|FG003|Overall Study|Death|1
4684988|NCT02501473|7591716|FG004|Overall Study|Death|0
4684989|NCT02501473|7591717|FG005|Overall Study|Death|1
4684990|NCT02501473|7591718|FG006|Overall Study|Death|0
4684991|NCT02501473|7591719|FG007|Overall Study|Death|0
4684992|NCT02501473|7591712|FG000|Overall Study|Lost to Follow-up|1
4684993|NCT02501473|7591713|FG001|Overall Study|Lost to Follow-up|0
4684994|NCT02501473|7591714|FG002|Overall Study|Lost to Follow-up|1
4684995|NCT02501473|7591715|FG003|Overall Study|Lost to Follow-up|0
4684996|NCT02501473|7591716|FG004|Overall Study|Lost to Follow-up|0
4684997|NCT02501473|7591717|FG005|Overall Study|Lost to Follow-up|1
4684998|NCT02501473|7591718|FG006|Overall Study|Lost to Follow-up|0
4684999|NCT02501473|7591719|FG007|Overall Study|Lost to Follow-up|0
4685000|NCT02501473|7591712|FG000|Overall Study|Reason not specified|0
4685001|NCT02501473|7591713|FG001|Overall Study|Reason not specified|0
4685002|NCT02501473|7591714|FG002|Overall Study|Reason not specified|1
4685003|NCT02501473|7591715|FG003|Overall Study|Reason not specified|1
4685004|NCT02501473|7591716|FG004|Overall Study|Reason not specified|0
4685005|NCT02501473|7591717|FG005|Overall Study|Reason not specified|0
4685006|NCT02501473|7591718|FG006|Overall Study|Reason not specified|0
4685007|NCT02501473|7591719|FG007|Overall Study|Reason not specified|0
4685008|NCT02501629|7591753|FG000|Overall Study|Death|0
4685009|NCT02501629|7591754|FG001|Overall Study|Death|1
4685010|NCT02501629|7591753|FG000|Overall Study|Withdrawn from study by sponsor|1
4685011|NCT02501629|7591754|FG001|Overall Study|Withdrawn from study by sponsor|0
4685012|NCT02501629|7591753|FG000|Overall Study|Early termination by sponsor|1
4685013|NCT02501629|7591754|FG001|Overall Study|Early termination by sponsor|0
4685014|NCT02501629|7591753|FG000|Overall Study|Withdrawal by Subject|3
4685015|NCT02501629|7591754|FG001|Overall Study|Withdrawal by Subject|5
4685016|NCT02501629|7591753|FG000|Overall Study|Subject did not return to site|0
4685017|NCT02501629|7591754|FG001|Overall Study|Subject did not return to site|1
4685018|NCT02501642|7591762|FG000|Overall Study|Lost to Follow-up|7
4685019|NCT02501642|7591763|FG001|Overall Study|Lost to Follow-up|11
4685020|NCT02501811|7591773|FG000|Overall Study|Death|1
4685021|NCT02501811|7591774|FG001|Overall Study|Death|3
4685022|NCT02501811|7591775|FG002|Overall Study|Death|2
4685023|NCT02501811|7591776|FG003|Overall Study|Death|3
4685024|NCT02501811|7591773|FG000|Overall Study|Withdrawal by Subject|3
4685025|NCT02501811|7591774|FG001|Overall Study|Withdrawal by Subject|3
4685026|NCT02501811|7591775|FG002|Overall Study|Withdrawal by Subject|2
4685027|NCT02501811|7591776|FG003|Overall Study|Withdrawal by Subject|3
4685028|NCT02501811|7591773|FG000|Overall Study|Lost to Follow-up|0
4685029|NCT02501811|7591774|FG001|Overall Study|Lost to Follow-up|0
4685030|NCT02501811|7591775|FG002|Overall Study|Lost to Follow-up|2
4685031|NCT02501811|7591776|FG003|Overall Study|Lost to Follow-up|1
4685032|NCT02501902|7591794|FG000|Overall Study|Subject Refused Further Follow-up|0
4685033|NCT02501902|7591795|FG001|Overall Study|Subject Refused Further Follow-up|0
4685034|NCT02501902|7591796|FG002|Overall Study|Subject Refused Further Follow-up|0
4685035|NCT02501902|7591797|FG003|Overall Study|Subject Refused Further Follow-up|0
4685036|NCT02501902|7591798|FG004|Overall Study|Subject Refused Further Follow-up|0
4685037|NCT02501902|7591799|FG005|Overall Study|Subject Refused Further Follow-up|0
4685038|NCT02501902|7591800|FG006|Overall Study|Subject Refused Further Follow-up|0
4685039|NCT02501902|7591801|FG007|Overall Study|Subject Refused Further Follow-up|1
4685040|NCT02501902|7591794|FG000|Overall Study|Study Terminated by Sponsor|0
4685041|NCT02501902|7591795|FG001|Overall Study|Study Terminated by Sponsor|3
4685042|NCT02501902|7591796|FG002|Overall Study|Study Terminated by Sponsor|0
4685043|NCT02501902|7591797|FG003|Overall Study|Study Terminated by Sponsor|1
4685044|NCT02501902|7591798|FG004|Overall Study|Study Terminated by Sponsor|1
4685045|NCT02501902|7591799|FG005|Overall Study|Study Terminated by Sponsor|0
4685046|NCT02501902|7591800|FG006|Overall Study|Study Terminated by Sponsor|2
4685047|NCT02501902|7591801|FG007|Overall Study|Study Terminated by Sponsor|4
4685048|NCT02501902|7591794|FG000|Overall Study|Death|3
4685049|NCT02501902|7591795|FG001|Overall Study|Death|4
4685050|NCT02501902|7591796|FG002|Overall Study|Death|4
4685051|NCT02501902|7591797|FG003|Overall Study|Death|10
4685052|NCT02501902|7591798|FG004|Overall Study|Death|10
4685053|NCT02501902|7591799|FG005|Overall Study|Death|11
4685054|NCT02501902|7591800|FG006|Overall Study|Death|7
4685055|NCT02501902|7591801|FG007|Overall Study|Death|15
4685056|NCT02501928|7591827|FG000|Overall Study|Withdrawal By Parent/Guardian|0
4685057|NCT02501928|7591828|FG001|Overall Study|Withdrawal By Parent/Guardian|0
4685058|NCT02501928|7591829|FG002|Overall Study|Withdrawal By Parent/Guardian|0
4685059|NCT02501928|7591830|FG003|Overall Study|Withdrawal By Parent/Guardian|0
4685060|NCT02501928|7591831|FG004|Overall Study|Withdrawal By Parent/Guardian|1
4685061|NCT02501928|7591832|FG005|Overall Study|Withdrawal By Parent/Guardian|0
4685062|NCT02502097|7591857|FG000|Period 1|Adverse Event|0
4685063|NCT02502097|7591858|FG001|Period 1|Adverse Event|0
4685064|NCT02502097|7591859|FG002|Period 1|Adverse Event|1
4685065|NCT02502097|7591860|FG003|Period 1|Adverse Event|0
4685066|NCT02502097|7591857|FG000|Wash Out Period|Adverse Event|0
4685067|NCT02502097|7591858|FG001|Wash Out Period|Adverse Event|1
4685068|NCT02502097|7591859|FG002|Wash Out Period|Adverse Event|1
4685069|NCT02502097|7591860|FG003|Wash Out Period|Adverse Event|1
4685070|NCT02502097|7591857|FG000|Period 2|Adverse Event|0
4760572|NCT02485574|7734750|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4
4760573|NCT02214160|7734762|FG000|Overall Study|Withdrawal by Subject|1
4760574|NCT02214160|7734763|FG001|Overall Study|Withdrawal by Subject|0
4760575|NCT02214160|7734764|FG002|Overall Study|Withdrawal by Subject|6
4760576|NCT02214160|7734762|FG000|Overall Study|Death|2
4760577|NCT02214160|7734763|FG001|Overall Study|Death|2
4760578|NCT02214160|7734764|FG002|Overall Study|Death|1
4760579|NCT02214160|7734762|FG000|Overall Study|Subject Non-Compliance|0
4760580|NCT02214160|7734763|FG001|Overall Study|Subject Non-Compliance|3
4760581|NCT02214160|7734764|FG002|Overall Study|Subject Non-Compliance|1
4760582|NCT02214160|7734762|FG000|Overall Study|Adverse Event|0
4760583|NCT02214160|7734763|FG001|Overall Study|Adverse Event|1
4760584|NCT02214160|7734764|FG002|Overall Study|Adverse Event|1
4760585|NCT02214160|7734762|FG000|Overall Study|Sponsor Decision|0
4760586|NCT02214160|7734763|FG001|Overall Study|Sponsor Decision|2
4760587|NCT02214160|7734764|FG002|Overall Study|Sponsor Decision|0
4760588|NCT02214160|7734762|FG000|Overall Study|Protocol Violation|1
4760589|NCT02214160|7734763|FG001|Overall Study|Protocol Violation|0
4760590|NCT02214160|7734764|FG002|Overall Study|Protocol Violation|0
4760591|NCT02214160|7734762|FG000|Overall Study|Physician Decision|0
4760592|NCT02214160|7734763|FG001|Overall Study|Physician Decision|0
4760593|NCT02214160|7734764|FG002|Overall Study|Physician Decision|1
4760594|NCT01460160|7734791|FG000|Treatment Phase|Lack of Efficacy|3
4760595|NCT01460160|7734791|FG000|Treatment Phase|Study Drug Toxicity|2
4760596|NCT01460160|7734791|FG000|Treatment Phase|Adverse Event|8
4760597|NCT01460160|7734791|FG000|Treatment Phase|Withdrawal by Subject|4
4760598|NCT01460160|7734791|FG000|Treatment Phase|Death|2
4760599|NCT01460160|7734791|FG000|Treatment Phase|Other reasons|9
4760600|NCT01460160|7734791|FG000|Follow-up Phase|Withdrawal by Subject|4
4760601|NCT01460160|7734791|FG000|Follow-up Phase|Death|14
4760602|NCT01460160|7734791|FG000|Follow-up Phase|Lost to Follow-up|7
4760603|NCT01460160|7734791|FG000|Follow-up Phase|Follow-up no longer required per protocol|70
4760604|NCT01460160|7734791|FG000|Follow-up Phase|Other and not reported reasons|5
4760605|NCT01170702|7734808|FG000|Overall Study|Exclusion criteria met after consent|1
4760606|NCT01170702|7734809|FG001|Overall Study|Exclusion criteria met after consent|2
4760607|NCT01170702|7734810|FG002|Overall Study|Exclusion criteria met after consent|0
4760608|NCT01170702|7734811|FG003|Overall Study|Exclusion criteria met after consent|2
4760609|NCT01018563|7734821|FG000|Overall Study|Termination of the study by Sponsor|2
4760610|NCT01018563|7734822|FG001|Overall Study|Termination of the study by Sponsor|1
4760611|NCT00805961|7734832|FG000|Modality Therapy|Withdrawal by Subject|1
4760612|NCT00805961|7734832|FG000|Modality Therapy|Adverse Event|1
4760613|NCT00805961|7734832|FG000|Modality Therapy|Disease Progression|2
4760614|NCT00805961|7734832|FG000|Treatment-Free Interval|Adverse Event|3
4760615|NCT00805961|7734832|FG000|Treatment-Free Interval|Intercurrent Illness|2
4760616|NCT00805961|7734832|FG000|Treatment-Free Interval|Physician Decision|1
4760617|NCT00805961|7734832|FG000|Treatment-Free Interval|Lack of Efficacy|1
4760618|NCT00805961|7734832|FG000|Maintenance Treatment|Lack of Efficacy|13
4685071|NCT02502097|7591858|FG001|Period 2|Adverse Event|0
4685072|NCT02502097|7591859|FG002|Period 2|Adverse Event|1
4685073|NCT02502097|7591860|FG003|Period 2|Adverse Event|0
4685074|NCT02502149|7591867|FG000|Intermediate|Discontinued prematurely|1
4685075|NCT02502149|7591868|FG001|Intermediate|Discontinued prematurely|0
4685076|NCT02502149|7591869|FG002|Intermediate|Discontinued prematurely|0
4685077|NCT02502149|7591870|FG003|Intermediate|Discontinued prematurely|0
4685078|NCT02502149|7591871|FG004|Intermediate|Discontinued prematurely|0
4685079|NCT02502526|7591913|FG000|Overall Study|Lost to Follow-up|2
4685080|NCT02502526|7591914|FG001|Overall Study|Lost to Follow-up|2
4685081|NCT02502526|7591915|FG002|Overall Study|Lost to Follow-up|3
4685082|NCT02502526|7591913|FG000|Overall Study|Withdrawal by Subject|0
4685083|NCT02502526|7591914|FG001|Overall Study|Withdrawal by Subject|1
4685084|NCT02502526|7591915|FG002|Overall Study|Withdrawal by Subject|1
4685085|NCT02502526|7591913|FG000|Overall Study|Disqualified due to cataract grading|0
4685086|NCT02502526|7591914|FG001|Overall Study|Disqualified due to cataract grading|0
4685087|NCT02502526|7591915|FG002|Overall Study|Disqualified due to cataract grading|1
4685088|NCT02502526|7591913|FG000|Overall Study|Enrollment suspension|4
4685089|NCT02502526|7591914|FG001|Overall Study|Enrollment suspension|1
4685090|NCT02502526|7591915|FG002|Overall Study|Enrollment suspension|1
4685091|NCT02502734|7591924|FG000|Double-blind Treatment Period 1|Adverse Event|1
4685092|NCT02502734|7591925|FG001|Double-blind Treatment Period 1|Adverse Event|0
4685093|NCT02502734|7591924|FG000|Washout Period|Adverse Event|1
4685094|NCT02502734|7591925|FG001|Washout Period|Adverse Event|0
4685095|NCT02502864|7591933|FG000|Overall Study|Withdrawal by Subject|1
4685096|NCT02503085|7591937|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1
4685097|NCT02503085|7591938|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0
4685098|NCT02503085|7591939|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1
4685099|NCT02503085|7591940|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0
4685100|NCT02503202|7591952|FG000|Base Study: Up to Month 6|Death|1
4685101|NCT02503202|7591953|FG001|Base Study: Up to Month 6|Death|1
4685102|NCT02503202|7591954|FG002|Base Study: Up to Month 6|Death|0
4685103|NCT02503202|7591955|FG003|Base Study: Up to Month 6|Death|0
4685104|NCT02503202|7591956|FG004|Base Study: Up to Month 6|Death|0
4685105|NCT02503202|7591952|FG000|Base Study: Up to Month 6|Lost to Follow-up|11
4685106|NCT02503202|7591953|FG001|Base Study: Up to Month 6|Lost to Follow-up|8
4685107|NCT02503202|7591954|FG002|Base Study: Up to Month 6|Lost to Follow-up|10
4685108|NCT02503202|7591955|FG003|Base Study: Up to Month 6|Lost to Follow-up|5
4685109|NCT02503202|7591956|FG004|Base Study: Up to Month 6|Lost to Follow-up|1
4685110|NCT02503202|7591952|FG000|Base Study: Up to Month 6|Physician Decision|0
4685111|NCT02503202|7591953|FG001|Base Study: Up to Month 6|Physician Decision|0
4685112|NCT02503202|7591954|FG002|Base Study: Up to Month 6|Physician Decision|0
4685113|NCT02503202|7591955|FG003|Base Study: Up to Month 6|Physician Decision|0
4685114|NCT02503202|7591956|FG004|Base Study: Up to Month 6|Physician Decision|1
4685115|NCT02503202|7591952|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6
4685116|NCT02503202|7591953|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3
4685117|NCT02503202|7591954|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4
4685118|NCT02503202|7591955|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4
4685119|NCT02503202|7591956|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1
4685120|NCT02503202|7591952|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0
4685121|NCT02503202|7591953|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0
4685122|NCT02503202|7591954|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1
4685123|NCT02503202|7591955|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2
4685124|NCT02503202|7591956|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0
4685125|NCT02503202|7591952|FG000|Extension: Month 6 to 24|Protocol Violation|0
4685126|NCT02503202|7591953|FG001|Extension: Month 6 to 24|Protocol Violation|0
4685127|NCT02503202|7591954|FG002|Extension: Month 6 to 24|Protocol Violation|0
4685128|NCT02503202|7591955|FG003|Extension: Month 6 to 24|Protocol Violation|1
4685129|NCT02503202|7591956|FG004|Extension: Month 6 to 24|Protocol Violation|0
4685130|NCT02503202|7591952|FG000|Extension: Month 6 to 24|Death|1
4685131|NCT02503202|7591953|FG001|Extension: Month 6 to 24|Death|0
4685132|NCT02503202|7591954|FG002|Extension: Month 6 to 24|Death|0
4685133|NCT02503202|7591955|FG003|Extension: Month 6 to 24|Death|0
4685134|NCT02503202|7591956|FG004|Extension: Month 6 to 24|Death|0
4685135|NCT02503202|7591952|FG000|Extension: Month 6 to 24|Lost to Follow-up|4
4685136|NCT02503202|7591953|FG001|Extension: Month 6 to 24|Lost to Follow-up|8
4685137|NCT02503202|7591954|FG002|Extension: Month 6 to 24|Lost to Follow-up|6
4685138|NCT02503202|7591955|FG003|Extension: Month 6 to 24|Lost to Follow-up|10
4685139|NCT02503202|7591956|FG004|Extension: Month 6 to 24|Lost to Follow-up|1
4685140|NCT02503202|7591952|FG000|Extension: Month 6 to 24|Physician Decision|1
4685141|NCT02503202|7591953|FG001|Extension: Month 6 to 24|Physician Decision|0
4760619|NCT00805961|7734832|FG000|Maintenance Treatment|Intercurrent Illness|7
4760620|NCT00805961|7734832|FG000|Maintenance Treatment|Adverse Event|6
4760621|NCT00805961|7734832|FG000|Maintenance Treatment|Withdrawal by Subject|5
4760622|NCT00805961|7734832|FG000|Maintenance Treatment|Symptomatic Deterioration|2
4760623|NCT00805961|7734832|FG000|Maintenance Treatment|Withdrawn Consent|1
4685142|NCT02503202|7591954|FG002|Extension: Month 6 to 24|Physician Decision|1
4685143|NCT02503202|7591955|FG003|Extension: Month 6 to 24|Physician Decision|3
4685144|NCT02503202|7591956|FG004|Extension: Month 6 to 24|Physician Decision|0
4685145|NCT02503202|7591952|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5
4685146|NCT02503202|7591953|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8
4685147|NCT02503202|7591954|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2
4685148|NCT02503202|7591955|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4
4685149|NCT02503202|7591956|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0
4685150|NCT02503215|7591968|FG000|Overall Study|Unable to wear compression stockings|1
4685151|NCT02503215|7591968|FG000|Overall Study|Unable to use positive airway pressure|2
4685152|NCT02503332|7591985|FG000|Overall Study|Adverse Event|17
4685153|NCT02503332|7591986|FG001|Overall Study|Adverse Event|5
4685154|NCT02503332|7591987|FG002|Overall Study|Adverse Event|3
4685155|NCT02503332|7591988|FG003|Overall Study|Adverse Event|1
4685156|NCT02503332|7591985|FG000|Overall Study|Investigator's Decision|5
4685157|NCT02503332|7591986|FG001|Overall Study|Investigator's Decision|1
4685158|NCT02503332|7591987|FG002|Overall Study|Investigator's Decision|0
4685159|NCT02503332|7591988|FG003|Overall Study|Investigator's Decision|0
4685160|NCT02503332|7591985|FG000|Overall Study|Sponsor's Decision|1
4685161|NCT02503332|7591986|FG001|Overall Study|Sponsor's Decision|0
4685162|NCT02503332|7591987|FG002|Overall Study|Sponsor's Decision|0
4685163|NCT02503332|7591988|FG003|Overall Study|Sponsor's Decision|1
4685164|NCT02503332|7591985|FG000|Overall Study|Subject Request|6
4685165|NCT02503332|7591986|FG001|Overall Study|Subject Request|5
4685166|NCT02503332|7591987|FG002|Overall Study|Subject Request|2
4685167|NCT02503332|7591988|FG003|Overall Study|Subject Request|1
4685168|NCT02503332|7591985|FG000|Overall Study|Death|0
4685169|NCT02503332|7591986|FG001|Overall Study|Death|2
4685170|NCT02503332|7591987|FG002|Overall Study|Death|2
4685171|NCT02503332|7591988|FG003|Overall Study|Death|0
4685172|NCT02503332|7591985|FG000|Overall Study|Other|5
4685173|NCT02503332|7591986|FG001|Overall Study|Other|6
4685174|NCT02503332|7591987|FG002|Overall Study|Other|1
4685175|NCT02503332|7591988|FG003|Overall Study|Other|1
4685176|NCT02503501|7592018|FG000|Overall Study|Physician Decision|1
4685177|NCT02503501|7592019|FG001|Overall Study|Physician Decision|0
4685178|NCT02503501|7592018|FG000|Overall Study|Protocol Violation|0
4685179|NCT02503501|7592019|FG001|Overall Study|Protocol Violation|1
4685180|NCT02503501|7592018|FG000|Overall Study|Withdrawal by Subject|0
4685181|NCT02503501|7592019|FG001|Overall Study|Withdrawal by Subject|2
4685182|NCT02503540|7592025|FG000|Overall Study|Death|2
4685183|NCT02503540|7592025|FG000|Overall Study|Withdrawal by Subject|1
4685184|NCT02503787|7592039|FG000|Enrollment|Withdrawal by Subject|6
4685185|NCT02503787|7592039|FG000|Enrollment|Inclusion/exclusion criteria not met|4
4685186|NCT02503787|7592039|FG000|Enrollment|Physician Decision|2
4685187|NCT02503787|7592039|FG000|Enrollment|Insurance issue|2
4685188|NCT02503787|7592039|FG000|Enrollment|Lost to Follow-up|1
4685189|NCT02503787|7592039|FG000|Enrollment|Study closure|1
4685190|NCT02503787|7592039|FG000|Enrollment|Adverse Event|1
4685191|NCT02503787|7592039|FG000|Enrollment|Protocol Violation|1
4685192|NCT02503787|7592039|FG000|Enrollment|Inability to implant system|1
4685193|NCT02503787|7592039|FG000|Enrollment|Unable to be programmed|1
4685194|NCT02503787|7592039|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6
4685195|NCT02503787|7592039|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1
4685196|NCT02503787|7592039|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3
4685197|NCT02503787|7592039|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2
4685198|NCT02503787|7592039|FG000|Implant to 3 Month Endpoint|Adverse Event|2
4685199|NCT02503787|7592039|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1
4685200|NCT02503865|7592063|FG000|Overall Study|Moved out of area|1
4685201|NCT02503865|7592064|FG001|Overall Study|Moved out of area|8
4685202|NCT02503865|7592065|FG002|Overall Study|Moved out of area|0
4685203|NCT02503865|7592063|FG000|Overall Study|Refused treatment|4
4685204|NCT02503865|7592064|FG001|Overall Study|Refused treatment|39
4685205|NCT02503865|7592065|FG002|Overall Study|Refused treatment|2
4685206|NCT02504216|7592085|FG000|Overall Study|Lost to Follow-up|3
4685207|NCT02504216|7592086|FG001|Overall Study|Lost to Follow-up|3
4685208|NCT02504216|7592085|FG000|Overall Study|Withdrawal by Subject|8
4685209|NCT02504216|7592086|FG001|Overall Study|Withdrawal by Subject|12
4685210|NCT02504268|7592095|FG000|Overall Study|Adverse Event|18
4685211|NCT02504268|7592096|FG001|Overall Study|Adverse Event|8
4685212|NCT02504268|7592097|FG002|Overall Study|Adverse Event|14
4685213|NCT02504268|7592098|FG003|Overall Study|Adverse Event|0
4685214|NCT02504268|7592099|FG004|Overall Study|Adverse Event|0
4685215|NCT02504268|7592100|FG005|Overall Study|Adverse Event|0
4685216|NCT02504268|7592101|FG006|Overall Study|Adverse Event|0
4685217|NCT02504268|7592102|FG007|Overall Study|Adverse Event|0
4685218|NCT02504268|7592103|FG008|Overall Study|Adverse Event|0
4685219|NCT02504268|7592095|FG000|Overall Study|Withdrawal of Consent|11
4685220|NCT02504268|7592096|FG001|Overall Study|Withdrawal of Consent|10
4685221|NCT02504268|7592097|FG002|Overall Study|Withdrawal of Consent|3
4685222|NCT02504268|7592098|FG003|Overall Study|Withdrawal of Consent|0
4685223|NCT02504268|7592099|FG004|Overall Study|Withdrawal of Consent|0
4685224|NCT02504268|7592100|FG005|Overall Study|Withdrawal of Consent|0
4685225|NCT02504268|7592101|FG006|Overall Study|Withdrawal of Consent|0
4685226|NCT02504268|7592102|FG007|Overall Study|Withdrawal of Consent|0
4685227|NCT02504268|7592103|FG008|Overall Study|Withdrawal of Consent|0
4685228|NCT02504268|7592095|FG000|Overall Study|Pregnancy|2
4685229|NCT02504268|7592096|FG001|Overall Study|Pregnancy|0
4685230|NCT02504268|7592097|FG002|Overall Study|Pregnancy|0
4685231|NCT02504268|7592098|FG003|Overall Study|Pregnancy|0
4685232|NCT02504268|7592099|FG004|Overall Study|Pregnancy|0
4685233|NCT02504268|7592100|FG005|Overall Study|Pregnancy|0
4685234|NCT02504268|7592101|FG006|Overall Study|Pregnancy|0
4685235|NCT02504268|7592102|FG007|Overall Study|Pregnancy|0
4685236|NCT02504268|7592103|FG008|Overall Study|Pregnancy|0
4685237|NCT02504268|7592095|FG000|Overall Study|Lost to Follow-up|3
4685238|NCT02504268|7592096|FG001|Overall Study|Lost to Follow-up|6
4685239|NCT02504268|7592097|FG002|Overall Study|Lost to Follow-up|4
4685240|NCT02504268|7592098|FG003|Overall Study|Lost to Follow-up|0
4685241|NCT02504268|7592099|FG004|Overall Study|Lost to Follow-up|0
4685242|NCT02504268|7592100|FG005|Overall Study|Lost to Follow-up|0
4685243|NCT02504268|7592101|FG006|Overall Study|Lost to Follow-up|0
4685244|NCT02504268|7592102|FG007|Overall Study|Lost to Follow-up|0
4685245|NCT02504268|7592103|FG008|Overall Study|Lost to Follow-up|0
4685246|NCT02504268|7592095|FG000|Overall Study|Death|1
4685247|NCT02504268|7592096|FG001|Overall Study|Death|1
4685248|NCT02504268|7592097|FG002|Overall Study|Death|0
4760624|NCT03921424|7734853|FG000|Overall Study|Lost to Follow-up|0
4760625|NCT03921424|7734854|FG001|Overall Study|Lost to Follow-up|1
4760626|NCT03921424|7734853|FG000|Overall Study|Withdrawal By Parent/Guardian|0
4760627|NCT03921424|7734854|FG001|Overall Study|Withdrawal By Parent/Guardian|2
4760628|NCT03598777|7734867|FG000|Overall Study|Study Terminated by Sponsor|3
4760629|NCT03598777|7734868|FG001|Overall Study|Study Terminated by Sponsor|0
4760630|NCT03598777|7734869|FG002|Overall Study|Study Terminated by Sponsor|0
4760631|NCT03598777|7734870|FG003|Overall Study|Study Terminated by Sponsor|0
4760632|NCT03598777|7734871|FG004|Overall Study|Study Terminated by Sponsor|15
4760633|NCT03598777|7734867|FG000|Overall Study|Withdrawal by Subject|1
4760634|NCT03598777|7734868|FG001|Overall Study|Withdrawal by Subject|1
4760635|NCT03598777|7734869|FG002|Overall Study|Withdrawal by Subject|0
4760636|NCT03598777|7734870|FG003|Overall Study|Withdrawal by Subject|0
4760637|NCT03598777|7734871|FG004|Overall Study|Withdrawal by Subject|0
4760638|NCT03598777|7734867|FG000|Overall Study|Adverse Event|1
4760639|NCT03598777|7734868|FG001|Overall Study|Adverse Event|0
4760640|NCT03598777|7734869|FG002|Overall Study|Adverse Event|0
4760641|NCT03598777|7734870|FG003|Overall Study|Adverse Event|0
4760642|NCT03598777|7734871|FG004|Overall Study|Adverse Event|0
4760643|NCT03598777|7734867|FG000|Overall Study|Lost to Follow-up|1
4760644|NCT03598777|7734868|FG001|Overall Study|Lost to Follow-up|0
4760645|NCT03598777|7734869|FG002|Overall Study|Lost to Follow-up|0
4760646|NCT03598777|7734870|FG003|Overall Study|Lost to Follow-up|0
4760647|NCT03598777|7734871|FG004|Overall Study|Lost to Follow-up|0
4760648|NCT03406078|7734888|FG000|Overall Study|Death|1
4760649|NCT03406078|7734889|FG001|Overall Study|Death|0
4760650|NCT03406078|7734888|FG000|Overall Study|Lost to Follow-up|0
4760651|NCT03406078|7734889|FG001|Overall Study|Lost to Follow-up|1
4760652|NCT03406078|7734888|FG000|Overall Study|Withdrawal by Subject|5
4760653|NCT03406078|7734889|FG001|Overall Study|Withdrawal by Subject|2
4760654|NCT03345342|7734911|FG000|Open-Label Phase|Adverse Event|30
4760655|NCT03345342|7734912|FG001|Open-Label Phase|Adverse Event|0
4760656|NCT03345342|7734913|FG002|Open-Label Phase|Adverse Event|0
4760657|NCT03345342|7734914|FG003|Open-Label Phase|Adverse Event|0
4760658|NCT03345342|7734915|FG004|Open-Label Phase|Adverse Event|0
4760659|NCT03345342|7734911|FG000|Open-Label Phase|Death|1
4760660|NCT03345342|7734912|FG001|Open-Label Phase|Death|0
4760661|NCT03345342|7734913|FG002|Open-Label Phase|Death|0
4760662|NCT03345342|7734914|FG003|Open-Label Phase|Death|0
4760663|NCT03345342|7734915|FG004|Open-Label Phase|Death|0
4760664|NCT03345342|7734911|FG000|Open-Label Phase|Initiated Prohibited Medication|2
4760665|NCT03345342|7734912|FG001|Open-Label Phase|Initiated Prohibited Medication|0
4760666|NCT03345342|7734913|FG002|Open-Label Phase|Initiated Prohibited Medication|0
4760667|NCT03345342|7734914|FG003|Open-Label Phase|Initiated Prohibited Medication|0
4760668|NCT03345342|7734915|FG004|Open-Label Phase|Initiated Prohibited Medication|0
4760669|NCT03345342|7734911|FG000|Open-Label Phase|Lack of Efficacy|6
4760670|NCT03345342|7734912|FG001|Open-Label Phase|Lack of Efficacy|0
4760671|NCT03345342|7734913|FG002|Open-Label Phase|Lack of Efficacy|0
4760672|NCT03345342|7734914|FG003|Open-Label Phase|Lack of Efficacy|0
4760673|NCT03345342|7734915|FG004|Open-Label Phase|Lack of Efficacy|0
4760674|NCT03345342|7734911|FG000|Open-Label Phase|Lost to Follow-up|9
4760675|NCT03345342|7734912|FG001|Open-Label Phase|Lost to Follow-up|0
4760676|NCT03345342|7734913|FG002|Open-Label Phase|Lost to Follow-up|0
4760677|NCT03345342|7734914|FG003|Open-Label Phase|Lost to Follow-up|0
4760678|NCT03345342|7734915|FG004|Open-Label Phase|Lost to Follow-up|0
4760679|NCT03345342|7734911|FG000|Open-Label Phase|Non-Compliance with Study Drug|4
4760680|NCT03345342|7734912|FG001|Open-Label Phase|Non-Compliance with Study Drug|0
4760681|NCT03345342|7734913|FG002|Open-Label Phase|Non-Compliance with Study Drug|0
4760682|NCT03345342|7734914|FG003|Open-Label Phase|Non-Compliance with Study Drug|0
4760683|NCT03345342|7734915|FG004|Open-Label Phase|Non-Compliance with Study Drug|0
4760684|NCT03345342|7734911|FG000|Open-Label Phase|Physician Decision|4
4760685|NCT03345342|7734912|FG001|Open-Label Phase|Physician Decision|0
4760686|NCT03345342|7734913|FG002|Open-Label Phase|Physician Decision|0
4760687|NCT03345342|7734914|FG003|Open-Label Phase|Physician Decision|0
4760688|NCT03345342|7734915|FG004|Open-Label Phase|Physician Decision|0
4760689|NCT03345342|7734911|FG000|Open-Label Phase|Protocol Violation|8
4685249|NCT02504268|7592098|FG003|Overall Study|Death|0
4685250|NCT02504268|7592099|FG004|Overall Study|Death|0
4685251|NCT02504268|7592100|FG005|Overall Study|Death|0
4685252|NCT02504268|7592101|FG006|Overall Study|Death|0
4685253|NCT02504268|7592102|FG007|Overall Study|Death|0
4685254|NCT02504268|7592103|FG008|Overall Study|Death|0
4685255|NCT02504268|7592095|FG000|Overall Study|Subject Request to Discontinue|11
4685256|NCT02504268|7592096|FG001|Overall Study|Subject Request to Discontinue|3
4685257|NCT02504268|7592097|FG002|Overall Study|Subject Request to Discontinue|6
4685258|NCT02504268|7592098|FG003|Overall Study|Subject Request to Discontinue|0
4685259|NCT02504268|7592099|FG004|Overall Study|Subject Request to Discontinue|0
4685260|NCT02504268|7592100|FG005|Overall Study|Subject Request to Discontinue|0
4685261|NCT02504268|7592101|FG006|Overall Study|Subject Request to Discontinue|0
4685262|NCT02504268|7592102|FG007|Overall Study|Subject Request to Discontinue|0
4685263|NCT02504268|7592103|FG008|Overall Study|Subject Request to Discontinue|0
4685264|NCT02504268|7592095|FG000|Overall Study|No Longer Meets Study Criteria|2
4685265|NCT02504268|7592096|FG001|Overall Study|No Longer Meets Study Criteria|3
4685266|NCT02504268|7592097|FG002|Overall Study|No Longer Meets Study Criteria|0
4685267|NCT02504268|7592098|FG003|Overall Study|No Longer Meets Study Criteria|0
4685268|NCT02504268|7592099|FG004|Overall Study|No Longer Meets Study Criteria|0
4685269|NCT02504268|7592100|FG005|Overall Study|No Longer Meets Study Criteria|0
4685270|NCT02504268|7592101|FG006|Overall Study|No Longer Meets Study Criteria|0
4685271|NCT02504268|7592102|FG007|Overall Study|No Longer Meets Study Criteria|0
4685272|NCT02504268|7592103|FG008|Overall Study|No Longer Meets Study Criteria|0
4685273|NCT02504268|7592095|FG000|Overall Study|Lack of Efficacy|11
4685274|NCT02504268|7592096|FG001|Overall Study|Lack of Efficacy|35
4685275|NCT02504268|7592097|FG002|Overall Study|Lack of Efficacy|9
4685276|NCT02504268|7592098|FG003|Overall Study|Lack of Efficacy|0
4685277|NCT02504268|7592099|FG004|Overall Study|Lack of Efficacy|0
4685278|NCT02504268|7592100|FG005|Overall Study|Lack of Efficacy|0
4685279|NCT02504268|7592101|FG006|Overall Study|Lack of Efficacy|0
4685280|NCT02504268|7592102|FG007|Overall Study|Lack of Efficacy|0
4685281|NCT02504268|7592103|FG008|Overall Study|Lack of Efficacy|0
4685282|NCT02504268|7592095|FG000|Overall Study|Poor/Non-Compliance|3
4685283|NCT02504268|7592096|FG001|Overall Study|Poor/Non-Compliance|2
4685284|NCT02504268|7592097|FG002|Overall Study|Poor/Non-Compliance|3
4685285|NCT02504268|7592098|FG003|Overall Study|Poor/Non-Compliance|0
4685286|NCT02504268|7592099|FG004|Overall Study|Poor/Non-Compliance|0
4685287|NCT02504268|7592100|FG005|Overall Study|Poor/Non-Compliance|0
4685288|NCT02504268|7592101|FG006|Overall Study|Poor/Non-Compliance|0
4685289|NCT02504268|7592102|FG007|Overall Study|Poor/Non-Compliance|0
4685290|NCT02504268|7592103|FG008|Overall Study|Poor/Non-Compliance|0
4685291|NCT02504268|7592095|FG000|Overall Study|Not Disclosed|1
4685292|NCT02504268|7592096|FG001|Overall Study|Not Disclosed|0
4685293|NCT02504268|7592097|FG002|Overall Study|Not Disclosed|2
4685294|NCT02504268|7592098|FG003|Overall Study|Not Disclosed|0
4685295|NCT02504268|7592099|FG004|Overall Study|Not Disclosed|0
4685296|NCT02504268|7592100|FG005|Overall Study|Not Disclosed|0
4685297|NCT02504268|7592101|FG006|Overall Study|Not Disclosed|0
4685298|NCT02504268|7592102|FG007|Overall Study|Not Disclosed|0
4685299|NCT02504268|7592103|FG008|Overall Study|Not Disclosed|0
4685300|NCT02504294|7592125|FG000|Overall Study|Adverse Event|15
4685301|NCT02504294|7592126|FG001|Overall Study|Adverse Event|12
4685302|NCT02504294|7592125|FG000|Overall Study|Withdrawal by Subject|7
4685303|NCT02504294|7592126|FG001|Overall Study|Withdrawal by Subject|1
4685304|NCT02504294|7592125|FG000|Overall Study|Protocol Violation|27
4685305|NCT02504294|7592126|FG001|Overall Study|Protocol Violation|26
4685306|NCT02504294|7592125|FG000|Overall Study|Physician Decision|1
4685307|NCT02504294|7592126|FG001|Overall Study|Physician Decision|2
4685308|NCT02504294|7592125|FG000|Overall Study|Lost to Follow-up|6
4685309|NCT02504294|7592126|FG001|Overall Study|Lost to Follow-up|7
4685310|NCT02504320|7592136|FG000|Treatment Period 1|Positive Drug Screen|0
4685311|NCT02504320|7592137|FG001|Treatment Period 1|Positive Drug Screen|0
4685312|NCT02504320|7592138|FG002|Treatment Period 1|Positive Drug Screen|1
4685313|NCT02504320|7592139|FG003|Treatment Period 1|Positive Drug Screen|0
4685314|NCT02504320|7592136|FG000|Treatment Period 2|Positive Drug Screen|0
4685315|NCT02504320|7592137|FG001|Treatment Period 2|Positive Drug Screen|1
4685316|NCT02504320|7592138|FG002|Treatment Period 2|Positive Drug Screen|0
4685317|NCT02504320|7592139|FG003|Treatment Period 2|Positive Drug Screen|0
4685318|NCT02504320|7592136|FG000|Treatment Period 3|Positive Drug Screen|0
4685319|NCT02504320|7592137|FG001|Treatment Period 3|Positive Drug Screen|0
4685320|NCT02504320|7592138|FG002|Treatment Period 3|Positive Drug Screen|0
4685321|NCT02504320|7592139|FG003|Treatment Period 3|Positive Drug Screen|1
4685322|NCT02504320|7592136|FG000|Treatment Period 3|Adverse Event|0
4685323|NCT02504320|7592137|FG001|Treatment Period 3|Adverse Event|0
4685324|NCT02504320|7592138|FG002|Treatment Period 3|Adverse Event|1
4685325|NCT02504320|7592139|FG003|Treatment Period 3|Adverse Event|0
4685326|NCT02504424|7592149|FG000|Overall Study|Withdrawal by Subject|2
4685327|NCT02504502|7592156|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4
4685328|NCT02504502|7592157|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7
4685329|NCT02504502|7592156|FG000|Crossover to Enhanced Report|Lost to Follow-up|5
4685330|NCT02504502|7592157|FG001|Crossover to Enhanced Report|Lost to Follow-up|0
4685331|NCT02504541|7592163|FG000|Overall Study|Adverse Event|4
4685332|NCT02504541|7592163|FG000|Overall Study|Withdrawal by Subject|4
4685333|NCT02504541|7592163|FG000|Overall Study|Lost to Follow-up|1
4685334|NCT02504541|7592163|FG000|Overall Study|Met Stopping Criteria|1
4685335|NCT02504541|7592163|FG000|Overall Study|Protocol Violation|2
4685336|NCT02504541|7592163|FG000|Overall Study|Termination by Sponsor|1
4685337|NCT02504541|7592163|FG000|Overall Study|Other|2
4685338|NCT02504541|7592163|FG000|Overall Study|Multiple|5
4685339|NCT02504671|7592196|FG000|Overall Study|Withdrawal by Subject|1
4685340|NCT02504671|7592197|FG001|Overall Study|Withdrawal by Subject|5
4685341|NCT02504671|7592198|FG002|Overall Study|Withdrawal by Subject|4
4685342|NCT02504671|7592199|FG003|Overall Study|Withdrawal by Subject|4
4685343|NCT02504671|7592200|FG004|Overall Study|Withdrawal by Subject|5
4685344|NCT02504671|7592201|FG005|Overall Study|Withdrawal by Subject|3
4685345|NCT02504671|7592196|FG000|Overall Study|Lack of Efficacy|1
4685346|NCT02504671|7592197|FG001|Overall Study|Lack of Efficacy|3
4685347|NCT02504671|7592198|FG002|Overall Study|Lack of Efficacy|1
4685348|NCT02504671|7592199|FG003|Overall Study|Lack of Efficacy|0
4685349|NCT02504671|7592200|FG004|Overall Study|Lack of Efficacy|4
4685350|NCT02504671|7592201|FG005|Overall Study|Lack of Efficacy|4
4685351|NCT02504671|7592196|FG000|Overall Study|Adverse Event|1
4685352|NCT02504671|7592197|FG001|Overall Study|Adverse Event|1
4685353|NCT02504671|7592198|FG002|Overall Study|Adverse Event|0
4685354|NCT02504671|7592199|FG003|Overall Study|Adverse Event|1
4685355|NCT02504671|7592200|FG004|Overall Study|Adverse Event|0
4685356|NCT02504671|7592201|FG005|Overall Study|Adverse Event|2
4685357|NCT02504671|7592196|FG000|Overall Study|Protocol Violation|2
4685358|NCT02504671|7592197|FG001|Overall Study|Protocol Violation|1
4685359|NCT02504671|7592198|FG002|Overall Study|Protocol Violation|0
4685360|NCT02504671|7592199|FG003|Overall Study|Protocol Violation|0
4685361|NCT02504671|7592200|FG004|Overall Study|Protocol Violation|0
4685362|NCT02504671|7592201|FG005|Overall Study|Protocol Violation|1
4685363|NCT02504671|7592196|FG000|Overall Study|Lost to Follow-up|0
4685364|NCT02504671|7592197|FG001|Overall Study|Lost to Follow-up|0
4685365|NCT02504671|7592198|FG002|Overall Study|Lost to Follow-up|2
4685366|NCT02504671|7592199|FG003|Overall Study|Lost to Follow-up|0
4685367|NCT02504671|7592200|FG004|Overall Study|Lost to Follow-up|0
4685368|NCT02504671|7592201|FG005|Overall Study|Lost to Follow-up|1
4685369|NCT02504671|7592196|FG000|Overall Study|Protocol defined stopping criteria|7
4685370|NCT02504671|7592197|FG001|Overall Study|Protocol defined stopping criteria|4
4685371|NCT02504671|7592198|FG002|Overall Study|Protocol defined stopping criteria|3
4685372|NCT02504671|7592199|FG003|Overall Study|Protocol defined stopping criteria|5
4685373|NCT02504671|7592200|FG004|Overall Study|Protocol defined stopping criteria|3
4685374|NCT02504671|7592201|FG005|Overall Study|Protocol defined stopping criteria|3
4685375|NCT02504827|7592233|FG000|Overall Study|Could not produce sputum|1
4685376|NCT02504892|7592237|FG000|Overall Study|Adverse event-pneumonitis|2
4685377|NCT02505217|7592252|FG000|Overall Study|Withdrawal by Subject|1
4685378|NCT02505217|7592253|FG001|Overall Study|Withdrawal by Subject|2
4685379|NCT02505334|7592265|FG000|Main Treatment Period|Adverse Event|3
4685380|NCT02505334|7592266|FG001|Main Treatment Period|Adverse Event|3
4685381|NCT02505334|7592265|FG000|Main Treatment Period|Lack of Efficacy|7
4685382|NCT02505334|7592266|FG001|Main Treatment Period|Lack of Efficacy|17
4685383|NCT02505334|7592265|FG000|Main Treatment Period|Protocol Violation|0
4685384|NCT02505334|7592266|FG001|Main Treatment Period|Protocol Violation|1
4685385|NCT02505334|7592265|FG000|Main Treatment Period|Withdrawal by Subject|1
4685386|NCT02505334|7592266|FG001|Main Treatment Period|Withdrawal by Subject|8
4685387|NCT02505334|7592265|FG000|Main Treatment Period|Unclassified|4
4685388|NCT02505334|7592266|FG001|Main Treatment Period|Unclassified|10
4685389|NCT02505334|7592265|FG000|Extension Treatment Period|Adverse Event|5
4760690|NCT03345342|7734912|FG001|Open-Label Phase|Protocol Violation|0
4760691|NCT03345342|7734913|FG002|Open-Label Phase|Protocol Violation|0
4760692|NCT03345342|7734914|FG003|Open-Label Phase|Protocol Violation|0
4760693|NCT03345342|7734915|FG004|Open-Label Phase|Protocol Violation|0
4760694|NCT03345342|7734911|FG000|Open-Label Phase|Withdrawal by Subject|57
4760695|NCT03345342|7734912|FG001|Open-Label Phase|Withdrawal by Subject|0
4760696|NCT03345342|7734913|FG002|Open-Label Phase|Withdrawal by Subject|0
4760697|NCT03345342|7734914|FG003|Open-Label Phase|Withdrawal by Subject|0
4760698|NCT03345342|7734915|FG004|Open-Label Phase|Withdrawal by Subject|0
4760699|NCT03345342|7734911|FG000|Open-Label Phase|Other|15
4760700|NCT03345342|7734912|FG001|Open-Label Phase|Other|0
4760701|NCT03345342|7734913|FG002|Open-Label Phase|Other|0
4760702|NCT03345342|7734914|FG003|Open-Label Phase|Other|0
4760703|NCT03345342|7734915|FG004|Open-Label Phase|Other|0
4760704|NCT03345342|7734911|FG000|Double-Blind Phase|Adverse Event|0
4760705|NCT03345342|7734912|FG001|Double-Blind Phase|Adverse Event|1
4760706|NCT03345342|7734913|FG002|Double-Blind Phase|Adverse Event|6
4760707|NCT03345342|7734914|FG003|Double-Blind Phase|Adverse Event|0
4760708|NCT03345342|7734915|FG004|Double-Blind Phase|Adverse Event|0
4685390|NCT02505334|7592266|FG001|Extension Treatment Period|Adverse Event|0
4685391|NCT02505334|7592265|FG000|Extension Treatment Period|Lack of Efficacy|4
4685392|NCT02505334|7592266|FG001|Extension Treatment Period|Lack of Efficacy|0
4685393|NCT02505334|7592265|FG000|Extension Treatment Period|Withdrawal by Subject|6
4685394|NCT02505334|7592266|FG001|Extension Treatment Period|Withdrawal by Subject|0
4685395|NCT02505334|7592265|FG000|Extension Treatment Period|Unclassified|3
4685396|NCT02505334|7592266|FG001|Extension Treatment Period|Unclassified|0
4760709|NCT03345342|7734911|FG000|Double-Blind Phase|Death|0
4760710|NCT03345342|7734912|FG001|Double-Blind Phase|Death|2
4685397|NCT02505542|7592272|FG000|Part A: Open-Label Period|Adverse Event|31
4685398|NCT02505542|7592273|FG001|Part A: Open-Label Period|Adverse Event|0
4685399|NCT02505542|7592274|FG002|Part A: Open-Label Period|Adverse Event|0
4685400|NCT02505542|7592275|FG003|Part A: Open-Label Period|Adverse Event|0
4685401|NCT02505542|7592272|FG000|Part A: Open-Label Period|Lack of Efficacy|5
4685402|NCT02505542|7592273|FG001|Part A: Open-Label Period|Lack of Efficacy|0
4685403|NCT02505542|7592274|FG002|Part A: Open-Label Period|Lack of Efficacy|0
4685404|NCT02505542|7592275|FG003|Part A: Open-Label Period|Lack of Efficacy|0
4685405|NCT02505542|7592272|FG000|Part A: Open-Label Period|Protocol Violation|1
4685406|NCT02505542|7592273|FG001|Part A: Open-Label Period|Protocol Violation|0
4685407|NCT02505542|7592274|FG002|Part A: Open-Label Period|Protocol Violation|0
4685408|NCT02505542|7592275|FG003|Part A: Open-Label Period|Protocol Violation|0
4685409|NCT02505542|7592272|FG000|Part A: Open-Label Period|Lost to Follow-up|5
4685410|NCT02505542|7592273|FG001|Part A: Open-Label Period|Lost to Follow-up|0
4685411|NCT02505542|7592274|FG002|Part A: Open-Label Period|Lost to Follow-up|0
4685412|NCT02505542|7592275|FG003|Part A: Open-Label Period|Lost to Follow-up|0
4685413|NCT02505542|7592272|FG000|Part A: Open-Label Period|Withdrawal by Subject|27
4685414|NCT02505542|7592273|FG001|Part A: Open-Label Period|Withdrawal by Subject|0
4685415|NCT02505542|7592274|FG002|Part A: Open-Label Period|Withdrawal by Subject|0
4685416|NCT02505542|7592275|FG003|Part A: Open-Label Period|Withdrawal by Subject|0
4685417|NCT02505542|7592272|FG000|Part A: Open-Label Period|New medical history available|1
4685418|NCT02505542|7592273|FG001|Part A: Open-Label Period|New medical history available|0
4685419|NCT02505542|7592274|FG002|Part A: Open-Label Period|New medical history available|0
4685420|NCT02505542|7592275|FG003|Part A: Open-Label Period|New medical history available|0
4685421|NCT02505542|7592272|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1
4685422|NCT02505542|7592273|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0
4685423|NCT02505542|7592274|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0
4685424|NCT02505542|7592275|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0
4685425|NCT02505542|7592272|FG000|Part A: Open-Label Period|Pregnancy|2
4685426|NCT02505542|7592273|FG001|Part A: Open-Label Period|Pregnancy|0
4685427|NCT02505542|7592274|FG002|Part A: Open-Label Period|Pregnancy|0
4685428|NCT02505542|7592275|FG003|Part A: Open-Label Period|Pregnancy|0
4685429|NCT02505542|7592272|FG000|Part A: Open-Label Period|Sponsor directive|1
4685430|NCT02505542|7592273|FG001|Part A: Open-Label Period|Sponsor directive|0
4685431|NCT02505542|7592274|FG002|Part A: Open-Label Period|Sponsor directive|0
4685432|NCT02505542|7592275|FG003|Part A: Open-Label Period|Sponsor directive|0
4685433|NCT02505542|7592272|FG000|Part A: Open-Label Period|Medical monitor decision|1
4685434|NCT02505542|7592273|FG001|Part A: Open-Label Period|Medical monitor decision|0
4685435|NCT02505542|7592274|FG002|Part A: Open-Label Period|Medical monitor decision|0
4760711|NCT03345342|7734913|FG002|Double-Blind Phase|Death|1
4760712|NCT03345342|7734914|FG003|Double-Blind Phase|Death|0
4760713|NCT03345342|7734915|FG004|Double-Blind Phase|Death|0
4760714|NCT03345342|7734911|FG000|Double-Blind Phase|Initiated Prohibited Medication|0
4760715|NCT03345342|7734912|FG001|Double-Blind Phase|Initiated Prohibited Medication|0
4760716|NCT03345342|7734913|FG002|Double-Blind Phase|Initiated Prohibited Medication|2
4760717|NCT03345342|7734914|FG003|Double-Blind Phase|Initiated Prohibited Medication|0
4760718|NCT03345342|7734915|FG004|Double-Blind Phase|Initiated Prohibited Medication|0
4760719|NCT03345342|7734911|FG000|Double-Blind Phase|Lost to Follow-up|0
4760720|NCT03345342|7734912|FG001|Double-Blind Phase|Lost to Follow-up|1
4760721|NCT03345342|7734913|FG002|Double-Blind Phase|Lost to Follow-up|7
4760722|NCT03345342|7734914|FG003|Double-Blind Phase|Lost to Follow-up|0
4760723|NCT03345342|7734915|FG004|Double-Blind Phase|Lost to Follow-up|0
4760724|NCT03345342|7734911|FG000|Double-Blind Phase|Physician Decision|0
4760725|NCT03345342|7734912|FG001|Double-Blind Phase|Physician Decision|1
4760726|NCT03345342|7734913|FG002|Double-Blind Phase|Physician Decision|4
4760727|NCT03345342|7734914|FG003|Double-Blind Phase|Physician Decision|0
4760728|NCT03345342|7734915|FG004|Double-Blind Phase|Physician Decision|0
4760729|NCT03345342|7734911|FG000|Double-Blind Phase|Protocol Violation|0
4760730|NCT03345342|7734912|FG001|Double-Blind Phase|Protocol Violation|0
4760731|NCT03345342|7734913|FG002|Double-Blind Phase|Protocol Violation|1
4760732|NCT03345342|7734914|FG003|Double-Blind Phase|Protocol Violation|0
4760733|NCT03345342|7734915|FG004|Double-Blind Phase|Protocol Violation|0
4760734|NCT03345342|7734911|FG000|Double-Blind Phase|Withdrawal by Subject|0
4760735|NCT03345342|7734912|FG001|Double-Blind Phase|Withdrawal by Subject|16
4760736|NCT03345342|7734913|FG002|Double-Blind Phase|Withdrawal by Subject|38
4760737|NCT03345342|7734914|FG003|Double-Blind Phase|Withdrawal by Subject|0
4760738|NCT03345342|7734915|FG004|Double-Blind Phase|Withdrawal by Subject|0
4760739|NCT03345342|7734911|FG000|Double-Blind Phase|Other|0
4760740|NCT03345342|7734912|FG001|Double-Blind Phase|Other|1
4760741|NCT03345342|7734913|FG002|Double-Blind Phase|Other|3
4760742|NCT03345342|7734914|FG003|Double-Blind Phase|Other|0
4760743|NCT03345342|7734915|FG004|Double-Blind Phase|Other|0
4760744|NCT03345342|7734911|FG000|Follow-Up Phase|Adverse Event|0
4760745|NCT03345342|7734912|FG001|Follow-Up Phase|Adverse Event|0
4760746|NCT03345342|7734913|FG002|Follow-Up Phase|Adverse Event|0
4760747|NCT03345342|7734914|FG003|Follow-Up Phase|Adverse Event|0
4760748|NCT03345342|7734915|FG004|Follow-Up Phase|Adverse Event|4
4685436|NCT02505542|7592275|FG003|Part A: Open-Label Period|Medical monitor decision|0
4685437|NCT02505542|7592272|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1
4685438|NCT02505542|7592273|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0
4685439|NCT02505542|7592274|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0
4685440|NCT02505542|7592275|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0
4685441|NCT02505542|7592272|FG000|Part A: Open-Label Period|Non-compliance|1
4685442|NCT02505542|7592273|FG001|Part A: Open-Label Period|Non-compliance|0
4685443|NCT02505542|7592274|FG002|Part A: Open-Label Period|Non-compliance|0
4685444|NCT02505542|7592275|FG003|Part A: Open-Label Period|Non-compliance|0
4685445|NCT02505542|7592272|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2
4685446|NCT02505542|7592273|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0
4685447|NCT02505542|7592274|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0
4685448|NCT02505542|7592275|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0
4685449|NCT02505542|7592272|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3
4685450|NCT02505542|7592273|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0
4685451|NCT02505542|7592274|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0
4685452|NCT02505542|7592275|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0
4685453|NCT02505542|7592272|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341
4685454|NCT02505542|7592273|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0
4685455|NCT02505542|7592274|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0
4685456|NCT02505542|7592275|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0
4685457|NCT02505542|7592272|FG000|Part B: Double-Blind Period|Adverse Event|0
4685458|NCT02505542|7592273|FG001|Part B: Double-Blind Period|Adverse Event|0
4685459|NCT02505542|7592274|FG002|Part B: Double-Blind Period|Adverse Event|1
4685460|NCT02505542|7592275|FG003|Part B: Double-Blind Period|Adverse Event|3
4685461|NCT02505542|7592272|FG000|Part B: Double-Blind Period|Lost to Follow-up|0
4685462|NCT02505542|7592273|FG001|Part B: Double-Blind Period|Lost to Follow-up|0
4685463|NCT02505542|7592274|FG002|Part B: Double-Blind Period|Lost to Follow-up|0
4685464|NCT02505542|7592275|FG003|Part B: Double-Blind Period|Lost to Follow-up|1
4685465|NCT02505542|7592272|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0
4685466|NCT02505542|7592273|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8
4685467|NCT02505542|7592274|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7
4685468|NCT02505542|7592275|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2
4685469|NCT02505542|7592272|FG000|Part B: Double-Blind Period|Planning pregnancy|0
4685470|NCT02505542|7592273|FG001|Part B: Double-Blind Period|Planning pregnancy|1
4685471|NCT02505542|7592274|FG002|Part B: Double-Blind Period|Planning pregnancy|0
4685472|NCT02505542|7592275|FG003|Part B: Double-Blind Period|Planning pregnancy|0
4685473|NCT02505542|7592272|FG000|Part B: Double-Blind Period|Week 94 missed|0
4685474|NCT02505542|7592273|FG001|Part B: Double-Blind Period|Week 94 missed|0
4685475|NCT02505542|7592274|FG002|Part B: Double-Blind Period|Week 94 missed|1
4685476|NCT02505542|7592275|FG003|Part B: Double-Blind Period|Week 94 missed|0
4685477|NCT02505542|7592272|FG000|Part B: Double-Blind Period|Patient was moved from the country|0
4685478|NCT02505542|7592273|FG001|Part B: Double-Blind Period|Patient was moved from the country|0
4685479|NCT02505542|7592274|FG002|Part B: Double-Blind Period|Patient was moved from the country|0
4685480|NCT02505542|7592275|FG003|Part B: Double-Blind Period|Patient was moved from the country|1
4760749|NCT03345342|7734911|FG000|Follow-Up Phase|Lost to Follow-up|0
4760750|NCT03345342|7734912|FG001|Follow-Up Phase|Lost to Follow-up|0
4760751|NCT03345342|7734913|FG002|Follow-Up Phase|Lost to Follow-up|0
4760752|NCT03345342|7734914|FG003|Follow-Up Phase|Lost to Follow-up|0
4760753|NCT03345342|7734915|FG004|Follow-Up Phase|Lost to Follow-up|6
4760754|NCT03345342|7734911|FG000|Follow-Up Phase|Physician Decision|0
4760755|NCT03345342|7734912|FG001|Follow-Up Phase|Physician Decision|0
4760756|NCT03345342|7734913|FG002|Follow-Up Phase|Physician Decision|0
4760757|NCT03345342|7734914|FG003|Follow-Up Phase|Physician Decision|0
4760758|NCT03345342|7734915|FG004|Follow-Up Phase|Physician Decision|5
4760759|NCT03345342|7734911|FG000|Follow-Up Phase|Withdrawal by Subject|0
4760760|NCT03345342|7734912|FG001|Follow-Up Phase|Withdrawal by Subject|0
4760761|NCT03345342|7734913|FG002|Follow-Up Phase|Withdrawal by Subject|0
4760762|NCT03345342|7734914|FG003|Follow-Up Phase|Withdrawal by Subject|5
4760763|NCT03345342|7734915|FG004|Follow-Up Phase|Withdrawal by Subject|15
4760764|NCT03345342|7734911|FG000|Follow-Up Phase|Other|0
4760765|NCT03345342|7734912|FG001|Follow-Up Phase|Other|0
4760766|NCT03345342|7734913|FG002|Follow-Up Phase|Other|0
4760767|NCT03345342|7734914|FG003|Follow-Up Phase|Other|3
4760768|NCT03345342|7734915|FG004|Follow-Up Phase|Other|1
4760769|NCT03265145|7734929|FG000|Overall Study|Protocol Violation|2
4760770|NCT03265145|7734930|FG001|Overall Study|Protocol Violation|0
4760771|NCT03265145|7734929|FG000|Overall Study|Adverse Event|1
4760772|NCT03265145|7734930|FG001|Overall Study|Adverse Event|0
4760773|NCT03265145|7734929|FG000|Overall Study|Withdrawal by Subject|23
4760774|NCT03265145|7734930|FG001|Overall Study|Withdrawal by Subject|19
4760775|NCT03265145|7734929|FG000|Overall Study|Death|12
4760776|NCT03265145|7734930|FG001|Overall Study|Death|12
4760777|NCT03265145|7734929|FG000|Overall Study|Lost to Follow-up|13
4760778|NCT03265145|7734930|FG001|Overall Study|Lost to Follow-up|9
4760779|NCT03265145|7734929|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0
4685481|NCT02505542|7592272|FG000|Part B: Double-Blind Period|Lack of Efficacy|0
4685482|NCT02505542|7592273|FG001|Part B: Double-Blind Period|Lack of Efficacy|1
4685483|NCT02505542|7592274|FG002|Part B: Double-Blind Period|Lack of Efficacy|0
4685484|NCT02505542|7592275|FG003|Part B: Double-Blind Period|Lack of Efficacy|0
4685485|NCT02505542|7592272|FG000|Part B: Double-Blind Period|Miscalculation|0
4685486|NCT02505542|7592273|FG001|Part B: Double-Blind Period|Miscalculation|1
4685487|NCT02505542|7592274|FG002|Part B: Double-Blind Period|Miscalculation|0
4685488|NCT02505542|7592275|FG003|Part B: Double-Blind Period|Miscalculation|0
4685489|NCT02505542|7592272|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0
4685490|NCT02505542|7592273|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1
4685491|NCT02505542|7592274|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0
4685492|NCT02505542|7592275|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0
4685493|NCT02505867|7592303|FG000|Overall Study|Lack of Efficacy|6
4685494|NCT02505867|7592304|FG001|Overall Study|Lack of Efficacy|6
4685495|NCT02505945|7592321|FG000|Overall Study|Withdrawal by Subject|13
4685496|NCT02505945|7592322|FG001|Overall Study|Withdrawal by Subject|2
4685497|NCT02505945|7592321|FG000|Overall Study|Adverse Event|1
4685498|NCT02505945|7592322|FG001|Overall Study|Adverse Event|0
4685499|NCT02505945|7592321|FG000|Overall Study|Physician Decision|2
4685500|NCT02505945|7592322|FG001|Overall Study|Physician Decision|1
4685501|NCT02505945|7592321|FG000|Overall Study|Lost to Follow-up|6
4685502|NCT02505945|7592322|FG001|Overall Study|Lost to Follow-up|1
4685503|NCT02506036|7592330|FG000|First Intervention (4-6 Weeks)|Death|1
4685504|NCT02506036|7592331|FG001|First Intervention (4-6 Weeks)|Death|0
4685505|NCT02506036|7592330|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0
4685506|NCT02506036|7592331|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1
4685507|NCT02506036|7592330|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0
4685508|NCT02506036|7592331|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1
4685509|NCT02506257|7592354|FG000|Overall Study|Adverse Event|0
4685510|NCT02506257|7592355|FG001|Overall Study|Adverse Event|2
4685511|NCT02506257|7592356|FG002|Overall Study|Adverse Event|3
4685512|NCT02506257|7592357|FG003|Overall Study|Adverse Event|0
4685513|NCT02506257|7592354|FG000|Overall Study|Protocol Violation|0
4685514|NCT02506257|7592355|FG001|Overall Study|Protocol Violation|0
4685515|NCT02506257|7592356|FG002|Overall Study|Protocol Violation|1
4685516|NCT02506257|7592357|FG003|Overall Study|Protocol Violation|0
4760780|NCT03265145|7734930|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1
4760781|NCT03265145|7734929|FG000|Overall Study|Switched back to previous medication|1
4760782|NCT03265145|7734930|FG001|Overall Study|Switched back to previous medication|0
4760783|NCT03265145|7734929|FG000|Overall Study|Did not want to take medication|1
4760784|NCT03265145|7734930|FG001|Overall Study|Did not want to take medication|0
4760785|NCT03265145|7734929|FG000|Overall Study|Subject could not afford medication|0
4760786|NCT03265145|7734930|FG001|Overall Study|Subject could not afford medication|1
4760787|NCT03265145|7734929|FG000|Overall Study|Site closed|2
4760788|NCT03265145|7734930|FG001|Overall Study|Site closed|3
4760789|NCT03265145|7734929|FG000|Overall Study|Incorrectly randomized|16
4760790|NCT03265145|7734930|FG001|Overall Study|Incorrectly randomized|6
4760791|NCT03265145|7734929|FG000|Overall Study|Entered into Electronic Data Capture in error|0
4760792|NCT03265145|7734930|FG001|Overall Study|Entered into Electronic Data Capture in error|1
4760793|NCT03265145|7734929|FG000|Overall Study|Physician Decision|0
4760794|NCT03265145|7734930|FG001|Overall Study|Physician Decision|3
4760795|NCT03265145|7734929|FG000|Overall Study|Subject transferred to another facility|0
4760796|NCT03265145|7734930|FG001|Overall Study|Subject transferred to another facility|1
4760797|NCT02880241|7734958|FG000|Overall Study|Lack of Efficacy|1
4760798|NCT02880241|7734959|FG001|Overall Study|Lack of Efficacy|0
4760799|NCT02880241|7734960|FG002|Overall Study|Lack of Efficacy|0
4760800|NCT02880241|7734961|FG003|Overall Study|Lack of Efficacy|0
4760801|NCT02880241|7734962|FG004|Overall Study|Lack of Efficacy|0
4760802|NCT02880241|7734963|FG005|Overall Study|Lack of Efficacy|0
4760803|NCT02832687|7734981|FG000|Overall Study|Adverse Event|0
4760804|NCT02832687|7734982|FG001|Overall Study|Adverse Event|2
4760805|NCT02499900|7734994|FG000|Core Study Period|Other|1
4760806|NCT02499900|7734995|FG001|Core Study Period|Other|4
4760807|NCT02499900|7734994|FG000|Core Study Period|Lost to Follow-up|1
4760808|NCT02499900|7734995|FG001|Core Study Period|Lost to Follow-up|2
4760809|NCT02499900|7734994|FG000|Core Study Period|Per sponsor request|0
4760810|NCT02499900|7734995|FG001|Core Study Period|Per sponsor request|1
4760811|NCT02499900|7734994|FG000|Core Study Period|Pregnancy|1
4760812|NCT02499900|7734995|FG001|Core Study Period|Pregnancy|0
4760813|NCT02499900|7734994|FG000|Core Study Period|Protocol Violation|3
4760814|NCT02499900|7734995|FG001|Core Study Period|Protocol Violation|0
4760815|NCT02499900|7734994|FG000|Core Study Period|Withdrawal by Subject|11
4760816|NCT02499900|7734995|FG001|Core Study Period|Withdrawal by Subject|10
4760817|NCT02499900|7734994|FG000|Core Study Period|Adverse Event|18
4760818|NCT02499900|7734995|FG001|Core Study Period|Adverse Event|14
4760819|NCT02499900|7734994|FG000|Core Study Period|Death|0
4760820|NCT02499900|7734995|FG001|Core Study Period|Death|1
4760821|NCT02499900|7734994|FG000|Completed Core, Continued Into Extension|Physician Decision|1
4760822|NCT02499900|7734995|FG001|Completed Core, Continued Into Extension|Physician Decision|0
4685517|NCT02506816|7592440|FG000|Overall Study|Adverse Event|3
4685518|NCT02506881|7592461|FG000|First Intervention (Day 1)|Protocol Violation|0
4685519|NCT02506881|7592462|FG001|First Intervention (Day 1)|Protocol Violation|0
4685520|NCT02506881|7592463|FG002|First Intervention (Day 1)|Protocol Violation|1
4685521|NCT02506881|7592464|FG003|First Intervention (Day 1)|Protocol Violation|0
4685522|NCT02506881|7592461|FG000|First Intervention (Day 1)|Withdrawal by Subject|1
4685523|NCT02506881|7592462|FG001|First Intervention (Day 1)|Withdrawal by Subject|0
4685524|NCT02506881|7592463|FG002|First Intervention (Day 1)|Withdrawal by Subject|0
4685525|NCT02506881|7592464|FG003|First Intervention (Day 1)|Withdrawal by Subject|0
4685526|NCT02506881|7592461|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0
4685527|NCT02506881|7592462|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0
4685528|NCT02506881|7592463|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12
4685529|NCT02506881|7592464|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12
4685530|NCT02507219|7592491|FG000|Overall Study|Physician Decision|1
4685531|NCT02507219|7592492|FG001|Overall Study|Physician Decision|0
4685532|NCT02507219|7592493|FG002|Overall Study|Physician Decision|0
4685533|NCT02507219|7592494|FG003|Overall Study|Physician Decision|0
4685534|NCT02507219|7592495|FG004|Overall Study|Physician Decision|0
4685535|NCT02507219|7592496|FG005|Overall Study|Physician Decision|0
4685536|NCT02507219|7592491|FG000|Overall Study|Withdrawal by Subject|0
4685537|NCT02507219|7592492|FG001|Overall Study|Withdrawal by Subject|0
4685538|NCT02507219|7592493|FG002|Overall Study|Withdrawal by Subject|0
4685539|NCT02507219|7592494|FG003|Overall Study|Withdrawal by Subject|0
4685540|NCT02507219|7592495|FG004|Overall Study|Withdrawal by Subject|1
4685541|NCT02507219|7592496|FG005|Overall Study|Withdrawal by Subject|0
4685542|NCT02507297|7592506|FG000|Overall Study|Withdrawal by Subject|1
4685543|NCT02507297|7592507|FG001|Overall Study|Withdrawal by Subject|0
4685544|NCT02507297|7592506|FG000|Overall Study|Lost to Follow-up|0
4685545|NCT02507297|7592507|FG001|Overall Study|Lost to Follow-up|1
4685546|NCT02507349|7592515|FG000|Overall Study|Death|12
4685547|NCT02507349|7592516|FG001|Overall Study|Death|16
4685548|NCT02507349|7592515|FG000|Overall Study|Withdrawal by Subject|1
4685549|NCT02507349|7592516|FG001|Overall Study|Withdrawal by Subject|1
4685550|NCT02507349|7592515|FG000|Overall Study|Lost to Follow-up|174
4685551|NCT02507349|7592516|FG001|Overall Study|Lost to Follow-up|144
4685552|NCT02507375|7592524|FG000|Overall Study|Progressive Disease|4
4685553|NCT02507375|7592525|FG001|Overall Study|Progressive Disease|5
4685554|NCT02507375|7592524|FG000|Overall Study|Death|0
4685555|NCT02507375|7592525|FG001|Overall Study|Death|1
4685556|NCT02507375|7592524|FG000|Overall Study|Refused treatment|0
4685557|NCT02507375|7592525|FG001|Overall Study|Refused treatment|1
4685558|NCT02507375|7592524|FG000|Overall Study|Adverse Event|0
4685559|NCT02507375|7592525|FG001|Overall Study|Adverse Event|1
4685560|NCT02507752|7592545|FG000|Overall Study|Adverse Event|1
4685561|NCT02507752|7592545|FG000|Overall Study|Protocol Violation|6
4685562|NCT02507752|7592545|FG000|Overall Study|Lost to Follow-up|7
4685563|NCT02507752|7592545|FG000|Overall Study|Infusion reaction at first infusion|1
4685564|NCT02507752|7592545|FG000|Overall Study|Participant didn't perform visit Week 12|1
4685565|NCT02507752|7592545|FG000|Overall Study|Participant didn't perform visit Week 24|1
4685566|NCT02508116|7592564|FG000|Overall Study|Lost to Follow-up|2
4685567|NCT02508116|7592565|FG001|Overall Study|Lost to Follow-up|3
4760823|NCT02499900|7734994|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0
4760824|NCT02499900|7734995|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2
4760825|NCT02499900|7734994|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1
4760826|NCT02499900|7734995|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0
4760827|NCT02499900|7734994|FG000|Completed Core, Continued Into Extension|Personal motivation|1
4760828|NCT02499900|7734995|FG001|Completed Core, Continued Into Extension|Personal motivation|0
4760829|NCT02499900|7734994|FG000|Extension Study Period|Adverse Event|2
4760830|NCT02499900|7734995|FG001|Extension Study Period|Adverse Event|4
4760831|NCT02499900|7734994|FG000|Extension Study Period|Withdrawal by Subject|5
4760832|NCT02499900|7734995|FG001|Extension Study Period|Withdrawal by Subject|2
4760833|NCT02499900|7734994|FG000|Extension Study Period|Physician Decision|2
4760834|NCT02499900|7734995|FG001|Extension Study Period|Physician Decision|5
4760835|NCT02499900|7734994|FG000|Extension Study Period|Pregnancy|1
4760836|NCT02499900|7734995|FG001|Extension Study Period|Pregnancy|2
4760837|NCT02499900|7734994|FG000|Extension Study Period|Lost to Follow-up|2
4760838|NCT02499900|7734995|FG001|Extension Study Period|Lost to Follow-up|5
4760839|NCT02499900|7734994|FG000|Extension Study Period|Other|0
4760840|NCT02499900|7734995|FG001|Extension Study Period|Other|2
4760841|NCT02269917|7735022|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25
4760842|NCT02269917|7735023|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7
4760843|NCT02269917|7735024|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0
4685568|NCT02508116|7592564|FG000|Overall Study|Withdrawal by Subject|3
4685569|NCT02508116|7592565|FG001|Overall Study|Withdrawal by Subject|2
4685570|NCT02508116|7592564|FG000|Overall Study|Protocol Violation|1
4685571|NCT02508116|7592565|FG001|Overall Study|Protocol Violation|2
4685572|NCT02508116|7592564|FG000|Overall Study|Physician Decision|2
4685573|NCT02508116|7592565|FG001|Overall Study|Physician Decision|0
4685574|NCT02508194|7592573|FG000|Overall Study|Death|5
4685575|NCT02508194|7592574|FG001|Overall Study|Death|3
4685576|NCT02508194|7592573|FG000|Overall Study|Lost to Follow-up|25
4685577|NCT02508194|7592574|FG001|Overall Study|Lost to Follow-up|18
4685578|NCT02508194|7592573|FG000|Overall Study|Withdrawal by Subject|20
4685579|NCT02508194|7592574|FG001|Overall Study|Withdrawal by Subject|18
4685580|NCT02508194|7592573|FG000|Overall Study|Error in Randomization|1
4685581|NCT02508194|7592574|FG001|Overall Study|Error in Randomization|3
4685582|NCT02508194|7592573|FG000|Overall Study|Principal Investigator Decision|1
4685583|NCT02508194|7592574|FG001|Overall Study|Principal Investigator Decision|2
4685584|NCT02508428|7592613|FG000|Overall Study|Death|32
4685585|NCT02508428|7592614|FG001|Overall Study|Death|33
4685586|NCT02508428|7592613|FG000|Overall Study|Liner revised|3
4685587|NCT02508428|7592614|FG001|Overall Study|Liner revised|19
4685588|NCT02508428|7592613|FG000|Overall Study|Incomplete follow-up|17
4685589|NCT02508428|7592614|FG001|Overall Study|Incomplete follow-up|15
4685590|NCT02508532|7592636|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0
4685591|NCT02508532|7592637|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0
4685592|NCT02508532|7592638|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0
4685593|NCT02508532|7592639|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0
4685594|NCT02508532|7592640|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0
4685595|NCT02508532|7592641|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0
4685596|NCT02508532|7592642|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1
4685597|NCT02508532|7592643|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0
4685598|NCT02508532|7592644|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0
4685599|NCT02508532|7592636|FG000|Part 1 - Dose Determining Period|Not Evaluable|0
4685600|NCT02508532|7592637|FG001|Part 1 - Dose Determining Period|Not Evaluable|0
4685601|NCT02508532|7592638|FG002|Part 1 - Dose Determining Period|Not Evaluable|0
4685602|NCT02508532|7592639|FG003|Part 1 - Dose Determining Period|Not Evaluable|0
4685603|NCT02508532|7592640|FG004|Part 1 - Dose Determining Period|Not Evaluable|0
4685604|NCT02508532|7592641|FG005|Part 1 - Dose Determining Period|Not Evaluable|0
4685605|NCT02508532|7592642|FG006|Part 1 - Dose Determining Period|Not Evaluable|0
4685606|NCT02508532|7592643|FG007|Part 1 - Dose Determining Period|Not Evaluable|1
4685607|NCT02508532|7592644|FG008|Part 1 - Dose Determining Period|Not Evaluable|0
4685608|NCT02508532|7592636|FG000|Part 2 - Treatment|Disease Progression|0
4685609|NCT02508532|7592637|FG001|Part 2 - Treatment|Disease Progression|0
4685610|NCT02508532|7592638|FG002|Part 2 - Treatment|Disease Progression|0
4685611|NCT02508532|7592639|FG003|Part 2 - Treatment|Disease Progression|0
4685612|NCT02508532|7592640|FG004|Part 2 - Treatment|Disease Progression|0
4685613|NCT02508532|7592641|FG005|Part 2 - Treatment|Disease Progression|0
4685614|NCT02508532|7592642|FG006|Part 2 - Treatment|Disease Progression|0
4685615|NCT02508532|7592643|FG007|Part 2 - Treatment|Disease Progression|0
4685616|NCT02508532|7592644|FG008|Part 2 - Treatment|Disease Progression|118
4685617|NCT02508532|7592636|FG000|Part 2 - Treatment|Adverse Event|0
4685618|NCT02508532|7592637|FG001|Part 2 - Treatment|Adverse Event|0
4685619|NCT02508532|7592638|FG002|Part 2 - Treatment|Adverse Event|0
4685620|NCT02508532|7592639|FG003|Part 2 - Treatment|Adverse Event|0
4685621|NCT02508532|7592640|FG004|Part 2 - Treatment|Adverse Event|0
4685622|NCT02508532|7592641|FG005|Part 2 - Treatment|Adverse Event|0
4685623|NCT02508532|7592642|FG006|Part 2 - Treatment|Adverse Event|0
4685624|NCT02508532|7592643|FG007|Part 2 - Treatment|Adverse Event|0
4685625|NCT02508532|7592644|FG008|Part 2 - Treatment|Adverse Event|49
4685626|NCT02508532|7592636|FG000|Part 2 - Treatment|Physician Decision|0
4685627|NCT02508532|7592637|FG001|Part 2 - Treatment|Physician Decision|0
4685628|NCT02508532|7592638|FG002|Part 2 - Treatment|Physician Decision|0
4685629|NCT02508532|7592639|FG003|Part 2 - Treatment|Physician Decision|0
4685630|NCT02508532|7592640|FG004|Part 2 - Treatment|Physician Decision|0
4685631|NCT02508532|7592641|FG005|Part 2 - Treatment|Physician Decision|0
4685632|NCT02508532|7592642|FG006|Part 2 - Treatment|Physician Decision|0
4685633|NCT02508532|7592643|FG007|Part 2 - Treatment|Physician Decision|0
4685634|NCT02508532|7592644|FG008|Part 2 - Treatment|Physician Decision|12
4685635|NCT02508532|7592636|FG000|Part 2 - Treatment|Administrative|0
4685636|NCT02508532|7592637|FG001|Part 2 - Treatment|Administrative|0
4685637|NCT02508532|7592638|FG002|Part 2 - Treatment|Administrative|0
4685638|NCT02508532|7592639|FG003|Part 2 - Treatment|Administrative|0
4685639|NCT02508532|7592640|FG004|Part 2 - Treatment|Administrative|0
4685640|NCT02508532|7592641|FG005|Part 2 - Treatment|Administrative|0
4685641|NCT02508532|7592642|FG006|Part 2 - Treatment|Administrative|0
4685642|NCT02508532|7592643|FG007|Part 2 - Treatment|Administrative|0
4685643|NCT02508532|7592644|FG008|Part 2 - Treatment|Administrative|3
4685644|NCT02508532|7592636|FG000|Part 2 - Treatment|Sponsor Decision|0
4685645|NCT02508532|7592637|FG001|Part 2 - Treatment|Sponsor Decision|0
4685646|NCT02508532|7592638|FG002|Part 2 - Treatment|Sponsor Decision|0
4685647|NCT02508532|7592639|FG003|Part 2 - Treatment|Sponsor Decision|0
4685648|NCT02508532|7592640|FG004|Part 2 - Treatment|Sponsor Decision|0
4685649|NCT02508532|7592641|FG005|Part 2 - Treatment|Sponsor Decision|0
4685650|NCT02508532|7592642|FG006|Part 2 - Treatment|Sponsor Decision|0
4685651|NCT02508532|7592643|FG007|Part 2 - Treatment|Sponsor Decision|0
4685652|NCT02508532|7592644|FG008|Part 2 - Treatment|Sponsor Decision|28
4685653|NCT02508532|7592636|FG000|Part 2 - Treatment|Death|0
4685654|NCT02508532|7592637|FG001|Part 2 - Treatment|Death|0
4685655|NCT02508532|7592638|FG002|Part 2 - Treatment|Death|0
4685656|NCT02508532|7592639|FG003|Part 2 - Treatment|Death|0
4685657|NCT02508532|7592640|FG004|Part 2 - Treatment|Death|0
4685658|NCT02508532|7592641|FG005|Part 2 - Treatment|Death|0
4685659|NCT02508532|7592642|FG006|Part 2 - Treatment|Death|0
4685660|NCT02508532|7592643|FG007|Part 2 - Treatment|Death|0
4685661|NCT02508532|7592644|FG008|Part 2 - Treatment|Death|1
4685662|NCT02508532|7592636|FG000|Part 2 - Treatment|Withdrawal by Subject|0
4685663|NCT02508532|7592637|FG001|Part 2 - Treatment|Withdrawal by Subject|0
4685664|NCT02508532|7592638|FG002|Part 2 - Treatment|Withdrawal by Subject|0
4685665|NCT02508532|7592639|FG003|Part 2 - Treatment|Withdrawal by Subject|0
4685666|NCT02508532|7592640|FG004|Part 2 - Treatment|Withdrawal by Subject|0
4685667|NCT02508532|7592641|FG005|Part 2 - Treatment|Withdrawal by Subject|0
4685668|NCT02508532|7592642|FG006|Part 2 - Treatment|Withdrawal by Subject|0
4685669|NCT02508532|7592643|FG007|Part 2 - Treatment|Withdrawal by Subject|0
4685670|NCT02508532|7592644|FG008|Part 2 - Treatment|Withdrawal by Subject|6
4685671|NCT02508532|7592636|FG000|Part 1 and Part 2 End of Study|Disease Progression|2
4685672|NCT02508532|7592637|FG001|Part 1 and Part 2 End of Study|Disease Progression|0
4685673|NCT02508532|7592638|FG002|Part 1 and Part 2 End of Study|Disease Progression|0
4685674|NCT02508532|7592639|FG003|Part 1 and Part 2 End of Study|Disease Progression|0
4685675|NCT02508532|7592640|FG004|Part 1 and Part 2 End of Study|Disease Progression|0
4685676|NCT02508532|7592641|FG005|Part 1 and Part 2 End of Study|Disease Progression|0
4760844|NCT02269917|7735022|FG000|BL to EOE-Test and BL to Switch-Control|Other|19
4760845|NCT02269917|7735023|FG001|BL to EOE-Test and BL to Switch-Control|Other|4
4760846|NCT02269917|7735024|FG002|BL to EOE-Test and BL to Switch-Control|Other|0
4760847|NCT02269917|7735022|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32
4760848|NCT02269917|7735023|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10
4760849|NCT02269917|7735024|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0
4760850|NCT02269917|7735022|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24
4760851|NCT02269917|7735023|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4
4760852|NCT02269917|7735024|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0
4760853|NCT02269917|7735022|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4
4760854|NCT02269917|7735023|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0
4760855|NCT02269917|7735024|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0
4760856|NCT02269917|7735022|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4
4760857|NCT02269917|7735023|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0
4760858|NCT02269917|7735024|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0
4760859|NCT02269917|7735022|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2
4760860|NCT02269917|7735023|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1
4760861|NCT02269917|7735024|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0
4760862|NCT02269917|7735022|FG000|BL to EOE-Test and BL to Switch-Control|Death|4
4760863|NCT02269917|7735023|FG001|BL to EOE-Test and BL to Switch-Control|Death|0
4760864|NCT02269917|7735024|FG002|BL to EOE-Test and BL to Switch-Control|Death|0
4760865|NCT02269917|7735022|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3
4760866|NCT02269917|7735023|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5
4760867|NCT02269917|7735024|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0
4760868|NCT02269917|7735022|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0
4760869|NCT02269917|7735023|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0
4760870|NCT02269917|7735024|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1
4760871|NCT02269917|7735022|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0
4760872|NCT02269917|7735023|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0
4760873|NCT02269917|7735024|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10
4760874|NCT02269917|7735022|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0
4760875|NCT02269917|7735023|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0
4760876|NCT02269917|7735024|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11
4760877|NCT02269917|7735022|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0
4760878|NCT02269917|7735023|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0
4760879|NCT02269917|7735024|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1
4760880|NCT02269917|7735022|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0
4760881|NCT02269917|7735023|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0
4760882|NCT02269917|7735024|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2
4760883|NCT02269917|7735022|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0
4760884|NCT02269917|7735023|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0
4760885|NCT02269917|7735024|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5
4760886|NCT02269917|7735022|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0
4760887|NCT02269917|7735023|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0
4760888|NCT02269917|7735024|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8
4685677|NCT02508532|7592642|FG006|Part 1 and Part 2 End of Study|Disease Progression|0
4685678|NCT02508532|7592643|FG007|Part 1 and Part 2 End of Study|Disease Progression|1
4685679|NCT02508532|7592644|FG008|Part 1 and Part 2 End of Study|Disease Progression|6
4685680|NCT02508532|7592636|FG000|Part 1 and Part 2 End of Study|Adverse Event|1
4685681|NCT02508532|7592637|FG001|Part 1 and Part 2 End of Study|Adverse Event|0
4685682|NCT02508532|7592638|FG002|Part 1 and Part 2 End of Study|Adverse Event|1
4685683|NCT02508532|7592639|FG003|Part 1 and Part 2 End of Study|Adverse Event|0
4685684|NCT02508532|7592640|FG004|Part 1 and Part 2 End of Study|Adverse Event|0
4685685|NCT02508532|7592641|FG005|Part 1 and Part 2 End of Study|Adverse Event|0
4685686|NCT02508532|7592642|FG006|Part 1 and Part 2 End of Study|Adverse Event|0
4685687|NCT02508532|7592643|FG007|Part 1 and Part 2 End of Study|Adverse Event|0
4685688|NCT02508532|7592644|FG008|Part 1 and Part 2 End of Study|Adverse Event|2
4685689|NCT02508532|7592636|FG000|Part 1 and Part 2 End of Study|Death|0
4685690|NCT02508532|7592637|FG001|Part 1 and Part 2 End of Study|Death|4
4685691|NCT02508532|7592638|FG002|Part 1 and Part 2 End of Study|Death|2
4685692|NCT02508532|7592639|FG003|Part 1 and Part 2 End of Study|Death|4
4685693|NCT02508532|7592640|FG004|Part 1 and Part 2 End of Study|Death|3
4685694|NCT02508532|7592641|FG005|Part 1 and Part 2 End of Study|Death|0
4685695|NCT02508532|7592642|FG006|Part 1 and Part 2 End of Study|Death|0
4685696|NCT02508532|7592643|FG007|Part 1 and Part 2 End of Study|Death|1
4685697|NCT02508532|7592644|FG008|Part 1 and Part 2 End of Study|Death|111
4685698|NCT02508532|7592636|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1
4685699|NCT02508532|7592637|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1
4685700|NCT02508532|7592638|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1
4685701|NCT02508532|7592639|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0
4685702|NCT02508532|7592640|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0
4685703|NCT02508532|7592641|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0
4685704|NCT02508532|7592642|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0
4685705|NCT02508532|7592643|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0
4685706|NCT02508532|7592644|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6
4685707|NCT02508532|7592636|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0
4685708|NCT02508532|7592637|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0
4685709|NCT02508532|7592638|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0
4685710|NCT02508532|7592639|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0
4685711|NCT02508532|7592640|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0
4685712|NCT02508532|7592641|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0
4685713|NCT02508532|7592642|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0
4685714|NCT02508532|7592643|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0
4685715|NCT02508532|7592644|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15
4685716|NCT02508532|7592636|FG000|Part 1 and Part 2 End of Study|Physician Decision|0
4685717|NCT02508532|7592637|FG001|Part 1 and Part 2 End of Study|Physician Decision|0
4685718|NCT02508532|7592638|FG002|Part 1 and Part 2 End of Study|Physician Decision|1
4685719|NCT02508532|7592639|FG003|Part 1 and Part 2 End of Study|Physician Decision|0
4685720|NCT02508532|7592640|FG004|Part 1 and Part 2 End of Study|Physician Decision|1
4685721|NCT02508532|7592641|FG005|Part 1 and Part 2 End of Study|Physician Decision|0
4685722|NCT02508532|7592642|FG006|Part 1 and Part 2 End of Study|Physician Decision|0
4685723|NCT02508532|7592643|FG007|Part 1 and Part 2 End of Study|Physician Decision|0
4685724|NCT02508532|7592644|FG008|Part 1 and Part 2 End of Study|Physician Decision|8
4685725|NCT02508532|7592636|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0
4685726|NCT02508532|7592637|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0
4685727|NCT02508532|7592638|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0
4685728|NCT02508532|7592639|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0
4685729|NCT02508532|7592640|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0
4685730|NCT02508532|7592641|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0
4685731|NCT02508532|7592642|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0
4685732|NCT02508532|7592643|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0
4685733|NCT02508532|7592644|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1
4685734|NCT02508532|7592636|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2
4685735|NCT02508532|7592637|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1
4685736|NCT02508532|7592638|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1
4685737|NCT02508532|7592639|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2
4685738|NCT02508532|7592640|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2
4685739|NCT02508532|7592641|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0
4685740|NCT02508532|7592642|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0
4685741|NCT02508532|7592643|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1
4685742|NCT02508532|7592644|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|67
4685743|NCT02508532|7592636|FG000|Part 1 and Part 2 End of Study|Continuing in study|0
4685744|NCT02508532|7592637|FG001|Part 1 and Part 2 End of Study|Continuing in study|0
4685745|NCT02508532|7592638|FG002|Part 1 and Part 2 End of Study|Continuing in study|0
4685746|NCT02508532|7592639|FG003|Part 1 and Part 2 End of Study|Continuing in study|0
4685747|NCT02508532|7592640|FG004|Part 1 and Part 2 End of Study|Continuing in study|0
4685748|NCT02508532|7592641|FG005|Part 1 and Part 2 End of Study|Continuing in study|0
4685749|NCT02508532|7592642|FG006|Part 1 and Part 2 End of Study|Continuing in study|0
4685750|NCT02508532|7592643|FG007|Part 1 and Part 2 End of Study|Continuing in study|0
4685751|NCT02508532|7592644|FG008|Part 1 and Part 2 End of Study|Continuing in study|1
4760889|NCT02225366|7735035|FG000|Overall Study|Lack of Efficacy|1
4760890|NCT02225366|7735036|FG001|Overall Study|Lack of Efficacy|0
4685752|NCT02508649|7592681|FG000|Overall Study|Withdrawal by Subject|4
4685753|NCT02508649|7592682|FG001|Overall Study|Withdrawal by Subject|6
4685754|NCT02508649|7592683|FG002|Overall Study|Withdrawal by Subject|5
4685755|NCT02508649|7592684|FG003|Overall Study|Withdrawal by Subject|6
4685756|NCT02508649|7592681|FG000|Overall Study|Investigator withdrew the subject|1
4685757|NCT02508649|7592682|FG001|Overall Study|Investigator withdrew the subject|2
4685758|NCT02508649|7592683|FG002|Overall Study|Investigator withdrew the subject|1
4685759|NCT02508649|7592684|FG003|Overall Study|Investigator withdrew the subject|0
4685760|NCT02508649|7592681|FG000|Overall Study|Post randomization screening failure|12
4685761|NCT02508649|7592682|FG001|Overall Study|Post randomization screening failure|4
4685762|NCT02508649|7592683|FG002|Overall Study|Post randomization screening failure|9
4685763|NCT02508649|7592684|FG003|Overall Study|Post randomization screening failure|3
4685764|NCT02508649|7592681|FG000|Overall Study|Lost to Follow-up|1
4685765|NCT02508649|7592682|FG001|Overall Study|Lost to Follow-up|1
4685766|NCT02508649|7592683|FG002|Overall Study|Lost to Follow-up|0
4685767|NCT02508649|7592684|FG003|Overall Study|Lost to Follow-up|1
4685768|NCT02508701|7592701|FG000|Overall Study|Lost to Follow-up|9
4685769|NCT02508701|7592702|FG001|Overall Study|Lost to Follow-up|5
4685770|NCT02508701|7592703|FG002|Overall Study|Lost to Follow-up|5
4685771|NCT02508701|7592704|FG003|Overall Study|Lost to Follow-up|3
4685772|NCT02508935|7592718|FG000|Overall Study|Withdrawal by Subject|1
4685773|NCT02508935|7592718|FG000|Overall Study|Withdrawal by Caregiver|8
4685774|NCT02508935|7592718|FG000|Overall Study|Pain Score <4|1
4685775|NCT02508935|7592718|FG000|Overall Study|Emesis|3
4685776|NCT02508935|7592718|FG000|Overall Study|Adverse Event|3
4685777|NCT02508935|7592718|FG000|Overall Study|Protocol Violation|1
4685778|NCT02508935|7592718|FG000|Overall Study|Physician Decision|1
4685779|NCT02508935|7592718|FG000|Overall Study|Trial terminated by sponsor|5
4685780|NCT02509026|7592724|FG000|Induction Period (24 Weeks)|Adverse Event|5
4685781|NCT02509026|7592724|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5
4685782|NCT02509026|7592724|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6
4685783|NCT02509026|7592724|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1
4685784|NCT02509026|7592724|FG000|Induction Period (24 Weeks)|Other|2
4685785|NCT02509026|7592724|FG000|Induction Period (24 Weeks)|Protocol Violation|1
4685786|NCT02509026|7592724|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1
4685787|NCT02509026|7592724|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1
4685788|NCT02509026|7592724|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2
4685789|NCT02509026|7592724|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5
4685790|NCT02509026|7592724|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1
4685791|NCT02509026|7592724|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2
4685792|NCT02509026|7592724|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1
4685793|NCT02509078|7592773|FG000|Overall Study|Protocol Violation|1
4685794|NCT02509078|7592774|FG001|Overall Study|Protocol Violation|1
4685795|NCT02509117|7592792|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
4685796|NCT02509117|7592793|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1
4685797|NCT02509117|7592794|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
4685798|NCT02509117|7592795|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
4685799|NCT02509117|7592796|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
4685800|NCT02509117|7592797|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
4685801|NCT02509117|7592798|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
4685802|NCT02509117|7592799|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
4685803|NCT02509117|7592800|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
4685804|NCT02509117|7592801|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
4685805|NCT02509117|7592792|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
4685806|NCT02509117|7592793|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
4685807|NCT02509117|7592794|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
4685808|NCT02509117|7592795|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
4685809|NCT02509117|7592796|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
4685810|NCT02509117|7592797|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
4685811|NCT02509117|7592798|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
4760891|NCT02021773|7735045|FG000|Overall Study|Adverse Event|1
4760892|NCT02021773|7735046|FG001|Overall Study|Adverse Event|4
4760893|NCT02021773|7735047|FG002|Overall Study|Adverse Event|3
4760894|NCT02021773|7735045|FG000|Overall Study|Lack of Efficacy|2
4760895|NCT02021773|7735046|FG001|Overall Study|Lack of Efficacy|2
4760896|NCT02021773|7735047|FG002|Overall Study|Lack of Efficacy|2
4760897|NCT02021773|7735045|FG000|Overall Study|Protocol Violation|2
4760898|NCT02021773|7735046|FG001|Overall Study|Protocol Violation|3
4760899|NCT02021773|7735047|FG002|Overall Study|Protocol Violation|1
4760900|NCT02021773|7735045|FG000|Overall Study|Withdrawal by Subject|3
4760901|NCT02021773|7735046|FG001|Overall Study|Withdrawal by Subject|4
4760902|NCT02021773|7735047|FG002|Overall Study|Withdrawal by Subject|5
4760903|NCT02021773|7735045|FG000|Overall Study|Lost to Follow-up|1
4685812|NCT02509117|7592799|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
4685813|NCT02509117|7592800|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
4685814|NCT02509117|7592801|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1
4685815|NCT02509117|7592792|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
4685816|NCT02509117|7592793|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
4685817|NCT02509117|7592794|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
4685818|NCT02509117|7592795|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
4685819|NCT02509117|7592796|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
4685820|NCT02509117|7592797|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
4685821|NCT02509117|7592798|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
4685822|NCT02509117|7592799|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
4685823|NCT02509117|7592800|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
4685824|NCT02509117|7592801|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1
4685825|NCT02509156|7592841|FG000|Randomized Phase|Death|1
4685826|NCT02509156|7592842|FG001|Randomized Phase|Death|0
4685827|NCT02509156|7592841|FG000|Randomized Phase|Withdrawal by Subject|1
4685828|NCT02509156|7592842|FG001|Randomized Phase|Withdrawal by Subject|1
4685829|NCT02510001|7592911|FG000|Overall Study|Early disease progression|0
4685830|NCT02510001|7592912|FG001|Overall Study|Early disease progression|0
4685831|NCT02510001|7592913|FG002|Overall Study|Early disease progression|0
4685832|NCT02510001|7592914|FG003|Overall Study|Early disease progression|1
4685833|NCT02510001|7592915|FG004|Overall Study|Early disease progression|1
4685834|NCT02510001|7592916|FG005|Overall Study|Early disease progression|1
4685835|NCT02510001|7592917|FG006|Overall Study|Early disease progression|0
4685836|NCT02510001|7592918|FG007|Overall Study|Early disease progression|0
4685837|NCT02510001|7592911|FG000|Overall Study|Adverse Event|0
4685838|NCT02510001|7592912|FG001|Overall Study|Adverse Event|0
4685839|NCT02510001|7592913|FG002|Overall Study|Adverse Event|0
4685840|NCT02510001|7592914|FG003|Overall Study|Adverse Event|1
4685841|NCT02510001|7592915|FG004|Overall Study|Adverse Event|2
4685842|NCT02510001|7592916|FG005|Overall Study|Adverse Event|1
4685843|NCT02510001|7592917|FG006|Overall Study|Adverse Event|2
4685844|NCT02510001|7592918|FG007|Overall Study|Adverse Event|5
4685845|NCT02510001|7592911|FG000|Overall Study|Physician Decision|0
4685846|NCT02510001|7592912|FG001|Overall Study|Physician Decision|0
4685847|NCT02510001|7592913|FG002|Overall Study|Physician Decision|0
4685848|NCT02510001|7592914|FG003|Overall Study|Physician Decision|0
4685849|NCT02510001|7592915|FG004|Overall Study|Physician Decision|1
4685850|NCT02510001|7592916|FG005|Overall Study|Physician Decision|0
4685851|NCT02510001|7592917|FG006|Overall Study|Physician Decision|0
4685852|NCT02510001|7592918|FG007|Overall Study|Physician Decision|0
4685853|NCT02510001|7592911|FG000|Overall Study|Withdrawal by Subject|0
4685854|NCT02510001|7592912|FG001|Overall Study|Withdrawal by Subject|0
4685855|NCT02510001|7592913|FG002|Overall Study|Withdrawal by Subject|0
4685856|NCT02510001|7592914|FG003|Overall Study|Withdrawal by Subject|0
4685857|NCT02510001|7592915|FG004|Overall Study|Withdrawal by Subject|0
4685858|NCT02510001|7592916|FG005|Overall Study|Withdrawal by Subject|0
4685859|NCT02510001|7592917|FG006|Overall Study|Withdrawal by Subject|0
4685860|NCT02510001|7592918|FG007|Overall Study|Withdrawal by Subject|2
4685861|NCT02510014|7592956|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1
4685862|NCT02510014|7592957|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1
4685863|NCT02510014|7592956|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1
4685864|NCT02510014|7592957|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0
4685865|NCT02510014|7592956|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44
4685866|NCT02510014|7592957|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3
4685867|NCT02510014|7592956|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0
4685868|NCT02510014|7592957|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1
4685869|NCT02510014|7592956|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22
4685870|NCT02510014|7592957|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3
4685871|NCT02510014|7592956|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7
4685872|NCT02510014|7592957|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1
4685873|NCT02510014|7592956|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2
4685874|NCT02510014|7592957|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0
4685875|NCT02510014|7592956|FG000|Run-In Period (Days -14 to Day -1)|Other|19
4685876|NCT02510014|7592957|FG001|Run-In Period (Days -14 to Day -1)|Other|1
4685877|NCT02510014|7592956|FG000|Treatment Period|Adverse Event|11
4685878|NCT02510014|7592957|FG001|Treatment Period|Adverse Event|4
4685879|NCT02510014|7592956|FG000|Treatment Period|Withdrawal symptoms|3
4685880|NCT02510014|7592957|FG001|Treatment Period|Withdrawal symptoms|0
4685881|NCT02510014|7592956|FG000|Treatment Period|Lost to Follow-up|80
4685882|NCT02510014|7592957|FG001|Treatment Period|Lost to Follow-up|19
4685883|NCT02510014|7592956|FG000|Treatment Period|Physician Decision|5
4685884|NCT02510014|7592957|FG001|Treatment Period|Physician Decision|0
4685885|NCT02510014|7592956|FG000|Treatment Period|Withdrawal by Subject|67
4685886|NCT02510014|7592957|FG001|Treatment Period|Withdrawal by Subject|24
4685887|NCT02510014|7592956|FG000|Treatment Period|Withdrawn by the investigator|7
4685888|NCT02510014|7592957|FG001|Treatment Period|Withdrawn by the investigator|1
4685889|NCT02510014|7592956|FG000|Treatment Period|Protocol Violation|4
4685890|NCT02510014|7592957|FG001|Treatment Period|Protocol Violation|4
4685891|NCT02510014|7592956|FG000|Treatment Period|Incarceration, pregnancy, misc|29
4685892|NCT02510014|7592957|FG001|Treatment Period|Incarceration, pregnancy, misc|5
4685893|NCT02510664|7592975|FG000|Overall Study|Transferred Care|9
4685894|NCT02510664|7592976|FG001|Overall Study|Transferred Care|9
4685895|NCT02510664|7592977|FG002|Overall Study|Transferred Care|0
4685896|NCT02510664|7592975|FG000|Overall Study|Provider Retired/No Time to Reschedule|10
4685897|NCT02510664|7592976|FG001|Overall Study|Provider Retired/No Time to Reschedule|10
4685898|NCT02510664|7592977|FG002|Overall Study|Provider Retired/No Time to Reschedule|0
4685899|NCT02510664|7592975|FG000|Overall Study|Time Constraints|1
4685900|NCT02510664|7592976|FG001|Overall Study|Time Constraints|1
4685901|NCT02510664|7592977|FG002|Overall Study|Time Constraints|0
4685902|NCT02510794|7592994|FG000|Overall Study|Adverse Event|0
4685903|NCT02510794|7592995|FG001|Overall Study|Adverse Event|1
4685904|NCT02510794|7592996|FG002|Overall Study|Adverse Event|0
4685905|NCT02510794|7592997|FG003|Overall Study|Adverse Event|0
4685906|NCT02510794|7592994|FG000|Overall Study|Death|1
4685907|NCT02510794|7592995|FG001|Overall Study|Death|2
4685908|NCT02510794|7592996|FG002|Overall Study|Death|1
4685909|NCT02510794|7592997|FG003|Overall Study|Death|1
4685910|NCT02510794|7592994|FG000|Overall Study|Lack of Efficacy|3
4760904|NCT02021773|7735046|FG001|Overall Study|Lost to Follow-up|3
4760905|NCT02021773|7735047|FG002|Overall Study|Lost to Follow-up|0
4760906|NCT02021773|7735045|FG000|Overall Study|Reason not specified|3
4760907|NCT02021773|7735046|FG001|Overall Study|Reason not specified|0
4760908|NCT02021773|7735047|FG002|Overall Study|Reason not specified|0
4760909|NCT01530997|7735055|FG000|Overall Study|Physician Decision|1
4760910|NCT01530997|7735055|FG000|Overall Study|Withdrawal by Subject|1
4760911|NCT01067521|7735081|FG000|Double-Blind Placebo-Controlled Period|Death|0
4760912|NCT01067521|7735082|FG001|Double-Blind Placebo-Controlled Period|Death|1
4760913|NCT01067521|7735081|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29
4760914|NCT01067521|7735082|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6
4760915|NCT01067521|7735081|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34
4760916|NCT01067521|7735082|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17
4760917|NCT01067521|7735081|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1
4760918|NCT01067521|7735082|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1
4760919|NCT01067521|7735081|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4
4685911|NCT02510794|7592995|FG001|Overall Study|Lack of Efficacy|1
4685912|NCT02510794|7592996|FG002|Overall Study|Lack of Efficacy|1
4685913|NCT02510794|7592997|FG003|Overall Study|Lack of Efficacy|0
4685914|NCT02510794|7592994|FG000|Overall Study|Participant moved out of the area|0
4685915|NCT02510794|7592995|FG001|Overall Study|Participant moved out of the area|0
4685916|NCT02510794|7592996|FG002|Overall Study|Participant moved out of the area|0
4685917|NCT02510794|7592997|FG003|Overall Study|Participant moved out of the area|1
4685918|NCT02510794|7592994|FG000|Overall Study|Physician Decision|3
4685919|NCT02510794|7592995|FG001|Overall Study|Physician Decision|0
4685920|NCT02510794|7592996|FG002|Overall Study|Physician Decision|0
4685921|NCT02510794|7592997|FG003|Overall Study|Physician Decision|0
4685922|NCT02510794|7592994|FG000|Overall Study|Protocol Violation|0
4685923|NCT02510794|7592995|FG001|Overall Study|Protocol Violation|0
4685924|NCT02510794|7592996|FG002|Overall Study|Protocol Violation|1
4685925|NCT02510794|7592997|FG003|Overall Study|Protocol Violation|0
4685926|NCT02510794|7592994|FG000|Overall Study|Withdrawal by Subject|1
4685927|NCT02510794|7592995|FG001|Overall Study|Withdrawal by Subject|2
4685928|NCT02510794|7592996|FG002|Overall Study|Withdrawal by Subject|4
4685929|NCT02510794|7592997|FG003|Overall Study|Withdrawal by Subject|3
4685930|NCT02510820|7593009|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0
4685931|NCT02510820|7593010|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1
4685932|NCT02510820|7593009|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1
4685933|NCT02510820|7593010|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0
4685934|NCT02511184|7593019|FG000|Overall Study|Death|1
4685935|NCT02511184|7593020|FG001|Overall Study|Death|0
4685936|NCT02511184|7593019|FG000|Overall Study|Lost to Follow-up|0
4685937|NCT02511184|7593020|FG001|Overall Study|Lost to Follow-up|1
4685938|NCT02511184|7593019|FG000|Overall Study|Study terminated by sponsor|1
4685939|NCT02511184|7593020|FG001|Overall Study|Study terminated by sponsor|5
4685940|NCT02511184|7593019|FG000|Overall Study|Withdrawal by Subject|0
4685941|NCT02511184|7593020|FG001|Overall Study|Withdrawal by Subject|1
4685942|NCT02511431|7593046|FG000|Treatment|Lost to Follow-up|0
4685943|NCT02511431|7593047|FG001|Treatment|Lost to Follow-up|0
4685944|NCT02511431|7593048|FG002|Treatment|Lost to Follow-up|1
4685945|NCT02511431|7593049|FG003|Treatment|Lost to Follow-up|0
4685946|NCT02511431|7593050|FG004|Treatment|Lost to Follow-up|0
4685947|NCT02511431|7593051|FG005|Treatment|Lost to Follow-up|1
4685948|NCT02511678|7593102|FG000|Overall Study|Withdrawal by Subject|2
4685949|NCT02511678|7593102|FG000|Overall Study|Lost to Follow-up|4
4685950|NCT02511678|7593102|FG000|Overall Study|Death|19
4685951|NCT02511678|7593102|FG000|Overall Study|Adverse Event|1
4685952|NCT02511678|7593102|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5
4685953|NCT02511678|7593102|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1
4685954|NCT02511678|7593102|FG000|Overall Study|Required Radiofrequency Ablation|1
4685955|NCT02511678|7593102|FG000|Overall Study|Biopsy was Negative|1
4685956|NCT02511678|7593102|FG000|Overall Study|Protocol Violation|1
4685957|NCT02511678|7593102|FG000|Overall Study|Received Radiation Treatment|1
4685958|NCT02511782|7593126|FG000|Overall Study|Withdrawal by Subject|1
4685959|NCT02511782|7593127|FG001|Overall Study|Withdrawal by Subject|0
4685960|NCT02511782|7593128|FG002|Overall Study|Withdrawal by Subject|0
4685961|NCT02512042|7593138|FG000|Overall Study|Adverse Event|0
4685962|NCT02512042|7593139|FG001|Overall Study|Adverse Event|4
4685963|NCT02512042|7593138|FG000|Overall Study|Withdrawal by Subject|6
4685964|NCT02512042|7593139|FG001|Overall Study|Withdrawal by Subject|6
4685965|NCT02512042|7593138|FG000|Overall Study|Non-compliance with study drug|1
4685966|NCT02512042|7593139|FG001|Overall Study|Non-compliance with study drug|2
4685967|NCT02512042|7593138|FG000|Overall Study|Lost to Follow-up|5
4685968|NCT02512042|7593139|FG001|Overall Study|Lost to Follow-up|2
4685969|NCT02512042|7593138|FG000|Overall Study|Other|11
4685970|NCT02512042|7593139|FG001|Overall Study|Other|11
4685971|NCT02512068|7593147|FG000|Overall Study|Pretreatment Event/Adverse Event|8
4685972|NCT02512068|7593148|FG001|Overall Study|Pretreatment Event/Adverse Event|6
4685973|NCT02512068|7593147|FG000|Overall Study|Major Protocol Deviation|1
4685974|NCT02512068|7593148|FG001|Overall Study|Major Protocol Deviation|0
4685975|NCT02512068|7593147|FG000|Overall Study|Voluntary Withdrawal|0
4685976|NCT02512068|7593148|FG001|Overall Study|Voluntary Withdrawal|1
4685977|NCT02512068|7593147|FG000|Overall Study|Lack of Efficacy|0
4685978|NCT02512068|7593148|FG001|Overall Study|Lack of Efficacy|1
4685979|NCT02512068|7593147|FG000|Overall Study|Reason Not Specified|3
4685980|NCT02512068|7593148|FG001|Overall Study|Reason Not Specified|5
4685981|NCT02512302|7593176|FG000|Period 1|Adverse Event|0
4685982|NCT02512302|7593177|FG001|Period 1|Adverse Event|1
4685983|NCT02512302|7593178|FG002|Period 1|Adverse Event|0
4685984|NCT02512302|7593179|FG003|Period 1|Adverse Event|0
4685985|NCT02512302|7593180|FG004|Period 1|Adverse Event|0
4685986|NCT02512302|7593181|FG005|Period 1|Adverse Event|0
4685987|NCT02512302|7593182|FG006|Period 1|Adverse Event|0
4685988|NCT02512302|7593183|FG007|Period 1|Adverse Event|0
4685989|NCT02512302|7593184|FG008|Period 1|Adverse Event|0
4685990|NCT02512302|7593185|FG009|Period 1|Adverse Event|0
4685991|NCT02512302|7593176|FG000|Period 2|Adverse Event|0
4685992|NCT02512302|7593177|FG001|Period 2|Adverse Event|0
4685993|NCT02512302|7593178|FG002|Period 2|Adverse Event|0
4685994|NCT02512302|7593179|FG003|Period 2|Adverse Event|0
4685995|NCT02512302|7593180|FG004|Period 2|Adverse Event|0
4685996|NCT02512302|7593181|FG005|Period 2|Adverse Event|0
4685997|NCT02512302|7593182|FG006|Period 2|Adverse Event|0
4685998|NCT02512302|7593183|FG007|Period 2|Adverse Event|0
4685999|NCT02512302|7593184|FG008|Period 2|Adverse Event|0
4686000|NCT02512302|7593185|FG009|Period 2|Adverse Event|1
4686001|NCT02512302|7593176|FG000|Period 3|Lost to Follow-up|0
4686002|NCT02512302|7593177|FG001|Period 3|Lost to Follow-up|0
4760920|NCT01067521|7735082|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1
4686003|NCT02512302|7593178|FG002|Period 3|Lost to Follow-up|1
4686004|NCT02512302|7593179|FG003|Period 3|Lost to Follow-up|0
4686005|NCT02512302|7593180|FG004|Period 3|Lost to Follow-up|0
4686006|NCT02512302|7593181|FG005|Period 3|Lost to Follow-up|0
4686007|NCT02512302|7593182|FG006|Period 3|Lost to Follow-up|0
4686008|NCT02512302|7593183|FG007|Period 3|Lost to Follow-up|0
4686009|NCT02512302|7593184|FG008|Period 3|Lost to Follow-up|0
4686010|NCT02512302|7593185|FG009|Period 3|Lost to Follow-up|0
4686011|NCT02512302|7593176|FG000|Period 4|Adverse Event|0
4686012|NCT02512302|7593177|FG001|Period 4|Adverse Event|0
4686013|NCT02512302|7593178|FG002|Period 4|Adverse Event|0
4686014|NCT02512302|7593179|FG003|Period 4|Adverse Event|0
4686015|NCT02512302|7593180|FG004|Period 4|Adverse Event|0
4686016|NCT02512302|7593181|FG005|Period 4|Adverse Event|0
4686017|NCT02512302|7593182|FG006|Period 4|Adverse Event|1
4686018|NCT02512302|7593183|FG007|Period 4|Adverse Event|0
4686019|NCT02512302|7593184|FG008|Period 4|Adverse Event|0
4686020|NCT02512302|7593185|FG009|Period 4|Adverse Event|0
4686021|NCT02512861|7593280|FG000|Overall Study|Protocol Violation|3
4686022|NCT02512861|7593281|FG001|Overall Study|Protocol Violation|7
4686023|NCT02512861|7593280|FG000|Overall Study|Physician Decision|3
4686024|NCT02512861|7593281|FG001|Overall Study|Physician Decision|1
4686025|NCT02512861|7593280|FG000|Overall Study|Withdrawal by Subject|0
4686026|NCT02512861|7593281|FG001|Overall Study|Withdrawal by Subject|1
4686027|NCT02512965|7593303|FG000|Overall Study|Withdrawal by Subject|0
4686028|NCT02512965|7593304|FG001|Overall Study|Withdrawal by Subject|4
4686029|NCT02513160|7593334|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33
4686030|NCT02513160|7593335|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
4686031|NCT02513160|7593336|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
4686032|NCT02513160|7593337|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
4686033|NCT02513160|7593334|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214
4686034|NCT02513160|7593335|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
4686035|NCT02513160|7593336|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
4686036|NCT02513160|7593337|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
4686037|NCT02513160|7593334|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6
4686038|NCT02513160|7593335|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
4686039|NCT02513160|7593336|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
4686040|NCT02513160|7593337|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
4686041|NCT02513160|7593334|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4
4686042|NCT02513160|7593335|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0
4686043|NCT02513160|7593336|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0
4686044|NCT02513160|7593337|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0
4686045|NCT02513160|7593334|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20
4686046|NCT02513160|7593335|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
4686047|NCT02513160|7593336|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
4686048|NCT02513160|7593337|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
4686049|NCT02513160|7593334|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1
4686050|NCT02513160|7593335|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
4686051|NCT02513160|7593336|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
4686052|NCT02513160|7593337|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
4686053|NCT02513160|7593334|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10
4760921|NCT01067521|7735081|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2
4760922|NCT01067521|7735082|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0
4760923|NCT01067521|7735081|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2
4760924|NCT01067521|7735082|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0
4760925|NCT01067521|7735081|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7
4760926|NCT01067521|7735082|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4
4760927|NCT01067521|7735081|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5
4760928|NCT01067521|7735082|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1
4760929|NCT01067521|7735081|FG000|Open-Label Period|Death|3
4760930|NCT01067521|7735082|FG001|Open-Label Period|Death|1
4760931|NCT01067521|7735081|FG000|Open-Label Period|Adverse Event|30
4760932|NCT01067521|7735082|FG001|Open-Label Period|Adverse Event|28
4760933|NCT01067521|7735081|FG000|Open-Label Period|Withdrawal by Subject|160
4760934|NCT01067521|7735082|FG001|Open-Label Period|Withdrawal by Subject|88
4760935|NCT01067521|7735081|FG000|Open-Label Period|Physician Decision|13
4760936|NCT01067521|7735082|FG001|Open-Label Period|Physician Decision|11
4760937|NCT01067521|7735081|FG000|Open-Label Period|Non-compliance with study drug|5
4760938|NCT01067521|7735082|FG001|Open-Label Period|Non-compliance with study drug|0
4760939|NCT01067521|7735081|FG000|Open-Label Period|Protocol Violation|3
4760940|NCT01067521|7735082|FG001|Open-Label Period|Protocol Violation|0
4760941|NCT01067521|7735081|FG000|Open-Label Period|Pregnancy|14
4760942|NCT01067521|7735082|FG001|Open-Label Period|Pregnancy|8
4760943|NCT01067521|7735081|FG000|Open-Label Period|Teva requested subject to be withdrawn|5
4760944|NCT01067521|7735082|FG001|Open-Label Period|Teva requested subject to be withdrawn|2
4760945|NCT01067521|7735081|FG000|Open-Label Period|Lost to Follow-up|21
4760946|NCT01067521|7735082|FG001|Open-Label Period|Lost to Follow-up|20
4760947|NCT01047319|7735096|FG000|Overall Study|Teva requested participant withdrawal|3
4760948|NCT01047319|7735097|FG001|Overall Study|Teva requested participant withdrawal|0
4760949|NCT01047319|7735098|FG002|Overall Study|Teva requested participant withdrawal|1
4760950|NCT01047319|7735096|FG000|Overall Study|Protocol Violation|3
4760951|NCT01047319|7735097|FG001|Overall Study|Protocol Violation|2
4760952|NCT01047319|7735098|FG002|Overall Study|Protocol Violation|4
4760953|NCT01047319|7735096|FG000|Overall Study|Lack of Efficacy|4
4760954|NCT01047319|7735097|FG001|Overall Study|Lack of Efficacy|3
4760955|NCT01047319|7735098|FG002|Overall Study|Lack of Efficacy|3
4760956|NCT01047319|7735096|FG000|Overall Study|Death|5
4686054|NCT02513160|7593335|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
4686055|NCT02513160|7593336|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
4686056|NCT02513160|7593337|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
4686057|NCT02513160|7593334|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2
4686058|NCT02513160|7593335|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2
4686059|NCT02513160|7593336|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0
4686060|NCT02513160|7593337|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1
4686061|NCT02513160|7593334|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1
4686062|NCT02513160|7593335|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0
4686063|NCT02513160|7593336|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0
4686064|NCT02513160|7593337|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0
4686065|NCT02513160|7593334|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2
4686066|NCT02513160|7593335|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
4686067|NCT02513160|7593336|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
4686068|NCT02513160|7593337|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
4686069|NCT02513160|7593334|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1
4760957|NCT01047319|7735097|FG001|Overall Study|Death|1
4760958|NCT01047319|7735098|FG002|Overall Study|Death|5
4760959|NCT01047319|7735096|FG000|Overall Study|Pregnancy|13
4760960|NCT01047319|7735097|FG001|Overall Study|Pregnancy|8
4760961|NCT01047319|7735098|FG002|Overall Study|Pregnancy|8
4760962|NCT01047319|7735096|FG000|Overall Study|Physician Decision|12
4760963|NCT01047319|7735097|FG001|Overall Study|Physician Decision|9
4760964|NCT01047319|7735098|FG002|Overall Study|Physician Decision|10
4760965|NCT01047319|7735096|FG000|Overall Study|Lost to Follow-up|14
4760966|NCT01047319|7735097|FG001|Overall Study|Lost to Follow-up|10
4760967|NCT01047319|7735098|FG002|Overall Study|Lost to Follow-up|10
4760968|NCT01047319|7735096|FG000|Overall Study|Adverse Event|16
4760969|NCT01047319|7735097|FG001|Overall Study|Adverse Event|27
4760970|NCT01047319|7735098|FG002|Overall Study|Adverse Event|21
4760971|NCT01047319|7735096|FG000|Overall Study|Withdrawal by Subject|77
4760972|NCT01047319|7735097|FG001|Overall Study|Withdrawal by Subject|75
4760973|NCT01047319|7735098|FG002|Overall Study|Withdrawal by Subject|87
4760974|NCT01047319|7735096|FG000|Overall Study|Study terminated by Sponsor|198
4760975|NCT01047319|7735097|FG001|Overall Study|Study terminated by Sponsor|215
4760976|NCT01047319|7735098|FG002|Overall Study|Study terminated by Sponsor|203
4760977|NCT00988052|7735108|FG000|Overall Study|Missing|1
4760978|NCT00988052|7735109|FG001|Overall Study|Missing|0
4760979|NCT00988052|7735108|FG000|Overall Study|Teva requested subject withdrawal|3
4760980|NCT00988052|7735109|FG001|Overall Study|Teva requested subject withdrawal|1
4760981|NCT00988052|7735108|FG000|Overall Study|Death|1
4760982|NCT00988052|7735109|FG001|Overall Study|Death|3
4760983|NCT00988052|7735108|FG000|Overall Study|Protocol Violation|6
4760984|NCT00988052|7735109|FG001|Overall Study|Protocol Violation|5
4760985|NCT00988052|7735108|FG000|Overall Study|Pregnancy|6
4760986|NCT00988052|7735109|FG001|Overall Study|Pregnancy|6
4760987|NCT00988052|7735108|FG000|Overall Study|Lack of Efficacy|8
4760988|NCT00988052|7735109|FG001|Overall Study|Lack of Efficacy|7
4760989|NCT00988052|7735108|FG000|Overall Study|Lost to Follow-up|6
4760990|NCT00988052|7735109|FG001|Overall Study|Lost to Follow-up|11
4760991|NCT00988052|7735108|FG000|Overall Study|Physician Decision|27
4760992|NCT00988052|7735109|FG001|Overall Study|Physician Decision|28
4760993|NCT00988052|7735108|FG000|Overall Study|Adverse Event|35
4760994|NCT00988052|7735109|FG001|Overall Study|Adverse Event|28
4760995|NCT00988052|7735108|FG000|Overall Study|Withdrawal by Subject|90
4760996|NCT00988052|7735109|FG001|Overall Study|Withdrawal by Subject|91
4760997|NCT00988052|7735108|FG000|Overall Study|Study terminated by sponsor|240
4760998|NCT00988052|7735109|FG001|Overall Study|Study terminated by sponsor|236
4686070|NCT02513160|7593335|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
4686071|NCT02513160|7593336|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
4686072|NCT02513160|7593337|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
4686073|NCT02513160|7593334|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
4686074|NCT02513160|7593335|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1
4686075|NCT02513160|7593336|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
4686076|NCT02513160|7593337|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
4686077|NCT02513459|7593367|FG000|Overall Study|Adverse Event|7
4686078|NCT02513459|7593367|FG000|Overall Study|Withdrew consent|5
4686079|NCT02513459|7593367|FG000|Overall Study|Loss of efficacy|2
4686080|NCT02513459|7593367|FG000|Overall Study|Pregnancy|2
4686081|NCT02513459|7593367|FG000|Overall Study|Subject decision|2
4686082|NCT02513459|7593367|FG000|Overall Study|Lack of response|1
4686083|NCT02513459|7593367|FG000|Overall Study|Reproductive plans|1
4686084|NCT02513459|7593367|FG000|Overall Study|Surgery planned-- not done|1
4686085|NCT02513472|7593378|FG000|Overall Study|Radiological Disease Progression|45
4686086|NCT02513472|7593379|FG001|Overall Study|Radiological Disease Progression|56
4686087|NCT02513472|7593378|FG000|Overall Study|Clinical Disease Progression|5
4686088|NCT02513472|7593379|FG001|Overall Study|Clinical Disease Progression|12
4686089|NCT02513472|7593378|FG000|Overall Study|Adverse Event|7
4686090|NCT02513472|7593379|FG001|Overall Study|Adverse Event|11
4686091|NCT02513472|7593378|FG000|Overall Study|Withdrawal by Subject|0
4686092|NCT02513472|7593379|FG001|Overall Study|Withdrawal by Subject|4
4686093|NCT02513472|7593378|FG000|Overall Study|Subject Choice|2
4686094|NCT02513472|7593379|FG001|Overall Study|Subject Choice|6
4686095|NCT02513472|7593378|FG000|Overall Study|Treatment Completed as per Protocol|3
4686096|NCT02513472|7593379|FG001|Overall Study|Treatment Completed as per Protocol|1
4760999|NCT04553406|7735131|FG000|Overall Study|Study Discontinuation|0
4761000|NCT04553406|7735132|FG001|Overall Study|Study Discontinuation|1
4761001|NCT03792750|7735138|FG000|Overall Study|Death|3
4761002|NCT03739138|7735159|FG000|Overall Study|Death|0
4761003|NCT03739138|7735160|FG001|Overall Study|Death|7
4761004|NCT03739138|7735161|FG002|Overall Study|Death|4
4761005|NCT03739138|7735162|FG003|Overall Study|Death|13
4761006|NCT03739138|7735163|FG004|Overall Study|Death|0
4761007|NCT03739138|7735159|FG000|Overall Study|Lost to Follow-up|0
4761008|NCT03739138|7735160|FG001|Overall Study|Lost to Follow-up|0
4761009|NCT03739138|7735161|FG002|Overall Study|Lost to Follow-up|1
4761010|NCT03739138|7735162|FG003|Overall Study|Lost to Follow-up|0
4761011|NCT03739138|7735163|FG004|Overall Study|Lost to Follow-up|0
4761012|NCT03739138|7735159|FG000|Overall Study|Study Terminated By Sponsor|0
4761013|NCT03739138|7735160|FG001|Overall Study|Study Terminated By Sponsor|0
4761014|NCT03739138|7735161|FG002|Overall Study|Study Terminated By Sponsor|0
4761015|NCT03739138|7735162|FG003|Overall Study|Study Terminated By Sponsor|4
4761016|NCT03739138|7735163|FG004|Overall Study|Study Terminated By Sponsor|0
4761017|NCT03739138|7735159|FG000|Overall Study|Withdrawal by Subject|0
4761018|NCT03739138|7735160|FG001|Overall Study|Withdrawal by Subject|0
4761019|NCT03739138|7735161|FG002|Overall Study|Withdrawal by Subject|0
4761020|NCT03739138|7735162|FG003|Overall Study|Withdrawal by Subject|1
4761021|NCT03739138|7735163|FG004|Overall Study|Withdrawal by Subject|0
4686097|NCT02513472|7593378|FG000|Overall Study|Other|3
4686098|NCT02513472|7593379|FG001|Overall Study|Other|3
4761022|NCT03518086|7735173|FG000|Overall Study|Adverse Event|23
4761023|NCT03518086|7735174|FG001|Overall Study|Adverse Event|15
4761024|NCT03518086|7735175|FG002|Overall Study|Adverse Event|0
4761025|NCT03518086|7735176|FG003|Overall Study|Adverse Event|0
4761026|NCT03518086|7735173|FG000|Overall Study|Withdrawal by Subject|8
4686099|NCT02513550|7593400|FG000|Double Blind Treatment Period|Withdrawal by Subject|11
4686100|NCT02513550|7593401|FG001|Double Blind Treatment Period|Withdrawal by Subject|11
4686101|NCT02513550|7593402|FG002|Double Blind Treatment Period|Withdrawal by Subject|25
4686102|NCT02513550|7593403|FG003|Double Blind Treatment Period|Withdrawal by Subject|0
4686103|NCT02513550|7593404|FG004|Double Blind Treatment Period|Withdrawal by Subject|0
4686104|NCT02513550|7593405|FG005|Double Blind Treatment Period|Withdrawal by Subject|0
4686105|NCT02513550|7593400|FG000|Double Blind Treatment Period|Adverse Event|5
4686106|NCT02513550|7593401|FG001|Double Blind Treatment Period|Adverse Event|13
4686107|NCT02513550|7593402|FG002|Double Blind Treatment Period|Adverse Event|17
4686108|NCT02513550|7593403|FG003|Double Blind Treatment Period|Adverse Event|0
4686109|NCT02513550|7593404|FG004|Double Blind Treatment Period|Adverse Event|1
4686110|NCT02513550|7593405|FG005|Double Blind Treatment Period|Adverse Event|0
4686111|NCT02513550|7593400|FG000|Double Blind Treatment Period|Lost to Follow-up|9
4686112|NCT02513550|7593401|FG001|Double Blind Treatment Period|Lost to Follow-up|7
4686113|NCT02513550|7593402|FG002|Double Blind Treatment Period|Lost to Follow-up|11
4686114|NCT02513550|7593403|FG003|Double Blind Treatment Period|Lost to Follow-up|0
4686115|NCT02513550|7593404|FG004|Double Blind Treatment Period|Lost to Follow-up|0
4686116|NCT02513550|7593405|FG005|Double Blind Treatment Period|Lost to Follow-up|1
4686117|NCT02513550|7593400|FG000|Double Blind Treatment Period|Lack of Efficacy|4
4686118|NCT02513550|7593401|FG001|Double Blind Treatment Period|Lack of Efficacy|5
4686119|NCT02513550|7593402|FG002|Double Blind Treatment Period|Lack of Efficacy|6
4686120|NCT02513550|7593403|FG003|Double Blind Treatment Period|Lack of Efficacy|0
4686121|NCT02513550|7593404|FG004|Double Blind Treatment Period|Lack of Efficacy|0
4686122|NCT02513550|7593405|FG005|Double Blind Treatment Period|Lack of Efficacy|0
4686123|NCT02513550|7593400|FG000|Double Blind Treatment Period|Protocol Violation|1
4686124|NCT02513550|7593401|FG001|Double Blind Treatment Period|Protocol Violation|1
4686125|NCT02513550|7593402|FG002|Double Blind Treatment Period|Protocol Violation|4
4686126|NCT02513550|7593403|FG003|Double Blind Treatment Period|Protocol Violation|0
4686127|NCT02513550|7593404|FG004|Double Blind Treatment Period|Protocol Violation|0
4686128|NCT02513550|7593405|FG005|Double Blind Treatment Period|Protocol Violation|0
4686129|NCT02513550|7593400|FG000|Double Blind Treatment Period|Physician Decision|2
4686130|NCT02513550|7593401|FG001|Double Blind Treatment Period|Physician Decision|0
4686131|NCT02513550|7593402|FG002|Double Blind Treatment Period|Physician Decision|4
4686132|NCT02513550|7593403|FG003|Double Blind Treatment Period|Physician Decision|0
4686133|NCT02513550|7593404|FG004|Double Blind Treatment Period|Physician Decision|0
4686134|NCT02513550|7593405|FG005|Double Blind Treatment Period|Physician Decision|0
4686135|NCT02513550|7593400|FG000|Double Blind Treatment Period|Site terminated by sponsor|1
4686136|NCT02513550|7593401|FG001|Double Blind Treatment Period|Site terminated by sponsor|1
4686137|NCT02513550|7593402|FG002|Double Blind Treatment Period|Site terminated by sponsor|3
4686138|NCT02513550|7593403|FG003|Double Blind Treatment Period|Site terminated by sponsor|0
4686139|NCT02513550|7593404|FG004|Double Blind Treatment Period|Site terminated by sponsor|0
4686140|NCT02513550|7593405|FG005|Double Blind Treatment Period|Site terminated by sponsor|0
4686141|NCT02513550|7593400|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
4686142|NCT02513550|7593401|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
4686143|NCT02513550|7593402|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1
4686144|NCT02513550|7593403|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
4686145|NCT02513550|7593404|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
4686146|NCT02513550|7593405|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
4686147|NCT02513550|7593400|FG000|Double Blind Treatment Period|Due to personal business|2
4686148|NCT02513550|7593401|FG001|Double Blind Treatment Period|Due to personal business|0
4686149|NCT02513550|7593402|FG002|Double Blind Treatment Period|Due to personal business|1
4686150|NCT02513550|7593403|FG003|Double Blind Treatment Period|Due to personal business|0
4686151|NCT02513550|7593404|FG004|Double Blind Treatment Period|Due to personal business|0
4686152|NCT02513550|7593405|FG005|Double Blind Treatment Period|Due to personal business|0
4686153|NCT02513550|7593400|FG000|Double Blind Treatment Period|Death|1
4686154|NCT02513550|7593401|FG001|Double Blind Treatment Period|Death|0
4686155|NCT02513550|7593402|FG002|Double Blind Treatment Period|Death|2
4686156|NCT02513550|7593403|FG003|Double Blind Treatment Period|Death|0
4686157|NCT02513550|7593404|FG004|Double Blind Treatment Period|Death|0
4686158|NCT02513550|7593405|FG005|Double Blind Treatment Period|Death|0
4686159|NCT02513550|7593400|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12
4686160|NCT02513550|7593401|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20
4686161|NCT02513550|7593402|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26
4686162|NCT02513550|7593403|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0
4686163|NCT02513550|7593404|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0
4686164|NCT02513550|7593405|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0
4686165|NCT02513550|7593400|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12
4686166|NCT02513550|7593401|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16
4686167|NCT02513550|7593402|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20
4686168|NCT02513550|7593403|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0
4686169|NCT02513550|7593404|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0
4686170|NCT02513550|7593405|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0
4686171|NCT02513550|7593400|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4
4686172|NCT02513550|7593401|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2
4686173|NCT02513550|7593402|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7
4686174|NCT02513550|7593403|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0
4686175|NCT02513550|7593404|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0
4761027|NCT03518086|7735174|FG001|Overall Study|Withdrawal by Subject|5
4761028|NCT03518086|7735175|FG002|Overall Study|Withdrawal by Subject|0
4761029|NCT03518086|7735176|FG003|Overall Study|Withdrawal by Subject|0
4761030|NCT03518086|7735173|FG000|Overall Study|Lack of Efficacy|5
4761031|NCT03518086|7735174|FG001|Overall Study|Lack of Efficacy|5
4761032|NCT03518086|7735175|FG002|Overall Study|Lack of Efficacy|0
4761033|NCT03518086|7735176|FG003|Overall Study|Lack of Efficacy|0
4761034|NCT03518086|7735173|FG000|Overall Study|Protocol Violation|1
4761035|NCT03518086|7735174|FG001|Overall Study|Protocol Violation|5
4761036|NCT03518086|7735175|FG002|Overall Study|Protocol Violation|0
4761037|NCT03518086|7735176|FG003|Overall Study|Protocol Violation|0
4761038|NCT03518086|7735173|FG000|Overall Study|Lost to Follow-up|0
4761039|NCT03518086|7735174|FG001|Overall Study|Lost to Follow-up|3
4761040|NCT03518086|7735175|FG002|Overall Study|Lost to Follow-up|0
4686176|NCT02513550|7593405|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0
4686177|NCT02513550|7593400|FG000|Post-Treatment Follow-up Period|Adverse Event|1
4686178|NCT02513550|7593401|FG001|Post-Treatment Follow-up Period|Adverse Event|1
4686179|NCT02513550|7593402|FG002|Post-Treatment Follow-up Period|Adverse Event|4
4686180|NCT02513550|7593403|FG003|Post-Treatment Follow-up Period|Adverse Event|0
4686181|NCT02513550|7593404|FG004|Post-Treatment Follow-up Period|Adverse Event|0
4686182|NCT02513550|7593405|FG005|Post-Treatment Follow-up Period|Adverse Event|0
4686183|NCT02513550|7593400|FG000|Post-Treatment Follow-up Period|Physician Decision|2
4686184|NCT02513550|7593401|FG001|Post-Treatment Follow-up Period|Physician Decision|0
4686185|NCT02513550|7593402|FG002|Post-Treatment Follow-up Period|Physician Decision|0
4686186|NCT02513550|7593403|FG003|Post-Treatment Follow-up Period|Physician Decision|0
4686187|NCT02513550|7593404|FG004|Post-Treatment Follow-up Period|Physician Decision|0
4686188|NCT02513550|7593405|FG005|Post-Treatment Follow-up Period|Physician Decision|0
4686189|NCT02513550|7593400|FG000|Post-Treatment Follow-up Period|Death|0
4686190|NCT02513550|7593401|FG001|Post-Treatment Follow-up Period|Death|0
4686191|NCT02513550|7593402|FG002|Post-Treatment Follow-up Period|Death|1
4761041|NCT03518086|7735176|FG003|Overall Study|Lost to Follow-up|0
4761042|NCT03518086|7735173|FG000|Overall Study|Insufficient Diary Data|0
4761043|NCT03518086|7735174|FG001|Overall Study|Insufficient Diary Data|2
4761044|NCT03518086|7735175|FG002|Overall Study|Insufficient Diary Data|0
4761045|NCT03518086|7735176|FG003|Overall Study|Insufficient Diary Data|0
4761046|NCT03518086|7735173|FG000|Overall Study|Non- compliance to Protocol|0
4761047|NCT03518086|7735174|FG001|Overall Study|Non- compliance to Protocol|1
4761048|NCT03518086|7735175|FG002|Overall Study|Non- compliance to Protocol|0
4761049|NCT03518086|7735176|FG003|Overall Study|Non- compliance to Protocol|0
4761050|NCT03518086|7735173|FG000|Overall Study|COVID-19 Related Study Disruption|0
4761051|NCT03518086|7735174|FG001|Overall Study|COVID-19 Related Study Disruption|2
4761052|NCT03518086|7735175|FG002|Overall Study|COVID-19 Related Study Disruption|0
4761053|NCT03518086|7735176|FG003|Overall Study|COVID-19 Related Study Disruption|0
4761054|NCT03518086|7735173|FG000|Overall Study|Site Terminated by Sponsor|0
4761055|NCT03518086|7735174|FG001|Overall Study|Site Terminated by Sponsor|1
4761056|NCT03518086|7735175|FG002|Overall Study|Site Terminated by Sponsor|0
4761057|NCT03518086|7735176|FG003|Overall Study|Site Terminated by Sponsor|0
4761058|NCT03468309|7735183|FG000|Overall Study|Lost to Follow-up|4
4761059|NCT03468309|7735183|FG000|Overall Study|Withdrawal by Subject|2
4761060|NCT03347123|7735189|FG000|Overall Study|Death|1
4761061|NCT03347123|7735190|FG001|Overall Study|Death|2
4761062|NCT03347123|7735191|FG002|Overall Study|Death|0
4761063|NCT03347123|7735192|FG003|Overall Study|Death|0
4761064|NCT03347123|7735193|FG004|Overall Study|Death|0
4761065|NCT03347123|7735194|FG005|Overall Study|Death|0
4761066|NCT03347123|7735195|FG006|Overall Study|Death|0
4761067|NCT03347123|7735189|FG000|Overall Study|Withdrawal by Subject|1
4761068|NCT03347123|7735190|FG001|Overall Study|Withdrawal by Subject|0
4761069|NCT03347123|7735191|FG002|Overall Study|Withdrawal by Subject|0
4761070|NCT03347123|7735192|FG003|Overall Study|Withdrawal by Subject|0
4761071|NCT03347123|7735193|FG004|Overall Study|Withdrawal by Subject|0
4761072|NCT03347123|7735194|FG005|Overall Study|Withdrawal by Subject|0
4761073|NCT03347123|7735195|FG006|Overall Study|Withdrawal by Subject|0
4761074|NCT03347123|7735189|FG000|Overall Study|Reason not Specified|3
4761075|NCT03347123|7735190|FG001|Overall Study|Reason not Specified|4
4761076|NCT03347123|7735191|FG002|Overall Study|Reason not Specified|0
4761077|NCT03347123|7735192|FG003|Overall Study|Reason not Specified|0
4761078|NCT03347123|7735193|FG004|Overall Study|Reason not Specified|0
4761079|NCT03347123|7735194|FG005|Overall Study|Reason not Specified|0
4761080|NCT03347123|7735195|FG006|Overall Study|Reason not Specified|0
4761081|NCT03318523|7735210|FG000|PC Period: Up to Year 1|Adverse Event|1
4761082|NCT03318523|7735211|FG001|PC Period: Up to Year 1|Adverse Event|0
4761083|NCT03318523|7735212|FG002|PC Period: Up to Year 1|Adverse Event|2
4761084|NCT03318523|7735213|FG003|PC Period: Up to Year 1|Adverse Event|0
4761085|NCT03318523|7735214|FG004|PC Period: Up to Year 1|Adverse Event|0
4686192|NCT02513550|7593403|FG003|Post-Treatment Follow-up Period|Death|0
4686193|NCT02513550|7593404|FG004|Post-Treatment Follow-up Period|Death|0
4686194|NCT02513550|7593405|FG005|Post-Treatment Follow-up Period|Death|0
4686195|NCT02513550|7593400|FG000|Post-Treatment Follow-up Period|Subject move out of town|0
4686196|NCT02513550|7593401|FG001|Post-Treatment Follow-up Period|Subject move out of town|0
4686197|NCT02513550|7593402|FG002|Post-Treatment Follow-up Period|Subject move out of town|1
4686198|NCT02513550|7593403|FG003|Post-Treatment Follow-up Period|Subject move out of town|0
4686199|NCT02513550|7593404|FG004|Post-Treatment Follow-up Period|Subject move out of town|0
4686200|NCT02513550|7593405|FG005|Post-Treatment Follow-up Period|Subject move out of town|0
4686201|NCT02513550|7593400|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
4686202|NCT02513550|7593401|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
4686203|NCT02513550|7593402|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3
4686204|NCT02513550|7593403|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
4686205|NCT02513550|7593404|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
4686206|NCT02513550|7593405|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
4686207|NCT02513550|7593400|FG000|Post-Treatment Follow-up Period|Labor Reasons|0
4686208|NCT02513550|7593401|FG001|Post-Treatment Follow-up Period|Labor Reasons|0
4686209|NCT02513550|7593402|FG002|Post-Treatment Follow-up Period|Labor Reasons|1
4686210|NCT02513550|7593403|FG003|Post-Treatment Follow-up Period|Labor Reasons|0
4686211|NCT02513550|7593404|FG004|Post-Treatment Follow-up Period|Labor Reasons|0
4686212|NCT02513550|7593405|FG005|Post-Treatment Follow-up Period|Labor Reasons|0
4761086|NCT03318523|7735215|FG005|PC Period: Up to Year 1|Adverse Event|0
4761087|NCT03318523|7735216|FG006|PC Period: Up to Year 1|Adverse Event|0
4761088|NCT03318523|7735217|FG007|PC Period: Up to Year 1|Adverse Event|0
4761089|NCT03318523|7735218|FG008|PC Period: Up to Year 1|Adverse Event|0
4761090|NCT03318523|7735219|FG009|PC Period: Up to Year 1|Adverse Event|0
4761091|NCT03318523|7735210|FG000|PC Period: Up to Year 1|Consent Withdrawn|3
4761092|NCT03318523|7735211|FG001|PC Period: Up to Year 1|Consent Withdrawn|2
4761093|NCT03318523|7735212|FG002|PC Period: Up to Year 1|Consent Withdrawn|0
4761094|NCT03318523|7735213|FG003|PC Period: Up to Year 1|Consent Withdrawn|4
4761095|NCT03318523|7735214|FG004|PC Period: Up to Year 1|Consent Withdrawn|0
4761096|NCT03318523|7735215|FG005|PC Period: Up to Year 1|Consent Withdrawn|0
4761097|NCT03318523|7735216|FG006|PC Period: Up to Year 1|Consent Withdrawn|0
4761098|NCT03318523|7735217|FG007|PC Period: Up to Year 1|Consent Withdrawn|0
4761099|NCT03318523|7735218|FG008|PC Period: Up to Year 1|Consent Withdrawn|0
4761100|NCT03318523|7735219|FG009|PC Period: Up to Year 1|Consent Withdrawn|0
4761101|NCT03318523|7735210|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0
4761102|NCT03318523|7735211|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0
4761103|NCT03318523|7735212|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0
4761104|NCT03318523|7735213|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0
4761105|NCT03318523|7735214|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1
4761106|NCT03318523|7735215|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0
4761107|NCT03318523|7735216|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0
4761108|NCT03318523|7735217|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1
4761109|NCT03318523|7735218|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0
4761110|NCT03318523|7735219|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2
4761111|NCT03318523|7735210|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0
4761112|NCT03318523|7735211|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0
4761113|NCT03318523|7735212|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0
4761114|NCT03318523|7735213|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0
4761115|NCT03318523|7735214|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1
4761116|NCT03318523|7735215|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0
4761117|NCT03318523|7735216|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0
4761118|NCT03318523|7735217|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1
4761119|NCT03318523|7735218|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3
4761120|NCT03318523|7735219|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2
4761121|NCT03318523|7735210|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0
4761122|NCT03318523|7735211|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0
4761123|NCT03318523|7735212|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0
4761124|NCT03318523|7735213|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0
4761125|NCT03318523|7735214|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0
4761126|NCT03318523|7735215|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1
4761127|NCT03318523|7735216|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0
4686213|NCT02513732|7593435|FG000|Overall Study|Lost to Follow-up|11
4686214|NCT02513732|7593435|FG000|Overall Study|Death|9
4686215|NCT02513732|7593435|FG000|Overall Study|Changing hospital|2
4686216|NCT02513745|7593441|FG000|Overall Study|Criteria at time of surgery not met.|3
4686217|NCT02513745|7593442|FG001|Overall Study|Criteria at time of surgery not met.|3
4686218|NCT02513771|7593450|FG000|Overall Study|Lost to Follow-up|1
4686219|NCT02513771|7593451|FG001|Overall Study|Lost to Follow-up|1
4686220|NCT02513771|7593450|FG000|Overall Study|Not being able to get to clinic|1
4686221|NCT02513771|7593451|FG001|Overall Study|Not being able to get to clinic|0
4686222|NCT02513823|7593457|FG000|Overall Study|Lost to Follow-up|4
4686223|NCT02513823|7593457|FG000|Overall Study|Physician Decision|1
4686224|NCT02514122|7593499|FG000|Overall Study|Withdrawal by Subject|2
4686225|NCT02514122|7593500|FG001|Overall Study|Withdrawal by Subject|0
4686226|NCT02514174|7593506|FG000|Overall Study|Patient refused to continue medication|1
4761128|NCT03318523|7735217|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0
4761129|NCT03318523|7735218|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0
4761130|NCT03318523|7735219|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0
4761131|NCT03318523|7735210|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0
4761132|NCT03318523|7735211|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0
4761133|NCT03318523|7735212|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0
4761134|NCT03318523|7735213|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0
4761135|NCT03318523|7735214|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0
4761136|NCT03318523|7735215|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0
4761137|NCT03318523|7735216|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0
4686227|NCT02514174|7593506|FG000|Overall Study|Adverse Event|2
4686228|NCT02514174|7593506|FG000|Overall Study|Study closed by sponsor|9
4686229|NCT02514174|7593506|FG000|Overall Study|Progressive disease|11
4686230|NCT02514174|7593506|FG000|Overall Study|Treatment change|1
4686231|NCT02514174|7593506|FG000|Overall Study|Treated off study with Afatinib.|1
4686232|NCT02514473|7593512|FG000|Overall Study|Adverse Event|0
4686233|NCT02514473|7593513|FG001|Overall Study|Adverse Event|2
4686234|NCT02514473|7593512|FG000|Overall Study|Withdrawal by Subject|2
4686235|NCT02514473|7593513|FG001|Overall Study|Withdrawal by Subject|1
4686236|NCT02514473|7593512|FG000|Overall Study|Lost to Follow-up|0
4686237|NCT02514473|7593513|FG001|Overall Study|Lost to Follow-up|1
4686238|NCT02514473|7593512|FG000|Overall Study|Other|1
4686239|NCT02514473|7593513|FG001|Overall Study|Other|1
4686240|NCT02514551|7593522|FG000|Overall Study|Lost to Follow-up|0
4686241|NCT02514551|7593523|FG001|Overall Study|Lost to Follow-up|1
4686242|NCT02514551|7593522|FG000|Overall Study|Participant Never Treated|0
4686243|NCT02514551|7593523|FG001|Overall Study|Participant Never Treated|2
4686244|NCT02514577|7593532|FG000|Overall Study|Lost to Follow-up|6
4686245|NCT02514577|7593533|FG001|Overall Study|Lost to Follow-up|6
4686246|NCT02514577|7593532|FG000|Overall Study|Protocol Violation|1
4686247|NCT02514577|7593533|FG001|Overall Study|Protocol Violation|0
4686248|NCT02514577|7593532|FG000|Overall Study|Withdrawal by Subject|6
4761138|NCT03318523|7735217|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0
4761139|NCT03318523|7735218|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0
4686249|NCT02514577|7593533|FG001|Overall Study|Withdrawal by Subject|6
4686250|NCT02514577|7593532|FG000|Overall Study|Adverse Event|1
4686251|NCT02514577|7593533|FG001|Overall Study|Adverse Event|1
4686252|NCT02514746|7593541|FG000|Overall Study|Chronically Ill|1
4686253|NCT02514746|7593542|FG001|Overall Study|Chronically Ill|2
4686254|NCT02514746|7593541|FG000|Overall Study|Physician Decision|4
4686255|NCT02514746|7593542|FG001|Overall Study|Physician Decision|2
4686256|NCT02514746|7593541|FG000|Overall Study|Withdrawal by Subject|12
4686257|NCT02514746|7593542|FG001|Overall Study|Withdrawal by Subject|10
4686258|NCT02514746|7593541|FG000|Overall Study|Other|5
4686259|NCT02514746|7593542|FG001|Overall Study|Other|1
4686260|NCT02514772|7593552|FG000|Overall Study|Adverse Event|1
4686261|NCT02514772|7593553|FG001|Overall Study|Adverse Event|0
4686262|NCT02514772|7593552|FG000|Overall Study|Death|0
4686263|NCT02514772|7593553|FG001|Overall Study|Death|1
4686264|NCT02514772|7593552|FG000|Overall Study|Withdrawal by Subject|2
4686265|NCT02514772|7593553|FG001|Overall Study|Withdrawal by Subject|1
4686266|NCT02514824|7593563|FG000|Overall Study|Withdrawal by Subject|1
4686267|NCT02514824|7593564|FG001|Overall Study|Withdrawal by Subject|0
4686268|NCT02514824|7593565|FG002|Overall Study|Withdrawal by Subject|0
4686269|NCT02514824|7593566|FG003|Overall Study|Withdrawal by Subject|0
4686270|NCT02514824|7593563|FG000|Overall Study|Dose-Limiting Toxicity|0
4686271|NCT02514824|7593564|FG001|Overall Study|Dose-Limiting Toxicity|1
4686272|NCT02514824|7593565|FG002|Overall Study|Dose-Limiting Toxicity|0
4686273|NCT02514824|7593566|FG003|Overall Study|Dose-Limiting Toxicity|0
4686274|NCT02515045|7593584|FG000|Overall Study|Adverse Event|0
4686275|NCT02515045|7593585|FG001|Overall Study|Adverse Event|3
4686276|NCT02515045|7593586|FG002|Overall Study|Adverse Event|3
4686277|NCT02515045|7593584|FG000|Overall Study|Lost to Follow-up|0
4686278|NCT02515045|7593585|FG001|Overall Study|Lost to Follow-up|1
4686279|NCT02515045|7593586|FG002|Overall Study|Lost to Follow-up|1
4686280|NCT02515097|7593605|FG000|Overall Study|Lost to Follow-up|4
4686281|NCT02515097|7593606|FG001|Overall Study|Lost to Follow-up|2
4686282|NCT02515097|7593605|FG000|Overall Study|Withdrawal by Subject|1
4686283|NCT02515097|7593606|FG001|Overall Study|Withdrawal by Subject|3
4686284|NCT02515097|7593605|FG000|Overall Study|Adverse Event|2
4686285|NCT02515097|7593606|FG001|Overall Study|Adverse Event|1
4761140|NCT03318523|7735219|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1
4761141|NCT03318523|7735210|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0
4761142|NCT03318523|7735211|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0
4761143|NCT03318523|7735212|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0
4761144|NCT03318523|7735213|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0
4761145|NCT03318523|7735214|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17
4761146|NCT03318523|7735215|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36
4761147|NCT03318523|7735216|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39
4761148|NCT03318523|7735217|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48
4761149|NCT03318523|7735218|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94
4761150|NCT03318523|7735219|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91
4761151|NCT03318523|7735210|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0
4761152|NCT03318523|7735211|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0
4761153|NCT03318523|7735212|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0
4761154|NCT03318523|7735213|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0
4761155|NCT03318523|7735214|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1
4761156|NCT03318523|7735215|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0
4761157|NCT03318523|7735216|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0
4761158|NCT03318523|7735217|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2
4761159|NCT03318523|7735218|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3
4761160|NCT03318523|7735219|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0
4761161|NCT03260894|7735245|FG000|Overall Study|Death|6
4761162|NCT03260894|7735246|FG001|Overall Study|Death|8
4761163|NCT03260894|7735245|FG000|Overall Study|Withdrawal by Subject|4
4761164|NCT03260894|7735246|FG001|Overall Study|Withdrawal by Subject|11
4761165|NCT03260894|7735245|FG000|Overall Study|On-going at clinical cut off date|36
4761166|NCT03260894|7735246|FG001|Overall Study|On-going at clinical cut off date|31
4761167|NCT03125902|7735254|FG000|Overall Study|Death|52
4761168|NCT03125902|7735255|FG001|Overall Study|Death|123
4761169|NCT03125902|7735254|FG000|Overall Study|Lost to Follow-up|1
4761170|NCT03125902|7735255|FG001|Overall Study|Lost to Follow-up|0
4761171|NCT03125902|7735254|FG000|Overall Study|Mastectomy|0
4761172|NCT03125902|7735255|FG001|Overall Study|Mastectomy|1
4761173|NCT03125902|7735254|FG000|Overall Study|Physician Decision|1
4761174|NCT03125902|7735255|FG001|Overall Study|Physician Decision|0
4761175|NCT03125902|7735254|FG000|Overall Study|Withdrawal by Subject|13
4761176|NCT03125902|7735255|FG001|Overall Study|Withdrawal by Subject|25
4761177|NCT03125902|7735254|FG000|Overall Study|Study is ongoing|153
4761178|NCT03125902|7735255|FG001|Overall Study|Study is ongoing|282
4761179|NCT02906020|7735272|FG000|Part 1: Dose Escalation Period|Adverse Event|0
4761180|NCT02906020|7735273|FG001|Part 1: Dose Escalation Period|Adverse Event|1
4761181|NCT02906020|7735274|FG002|Part 1: Dose Escalation Period|Adverse Event|0
4761182|NCT02906020|7735275|FG003|Part 1: Dose Escalation Period|Adverse Event|1
4686286|NCT02515279|7593621|FG000|Overall Study|Adverse Event|7
4686287|NCT02515279|7593621|FG000|Overall Study|Lack of Efficacy|31
4686288|NCT02515279|7593621|FG000|Overall Study|Lost to Follow-up|9
4686289|NCT02515279|7593621|FG000|Overall Study|Withdrawal by Subject|18
4686290|NCT02515279|7593621|FG000|Overall Study|End-of-treatment visit not attended|17
4686291|NCT02515279|7593621|FG000|Overall Study|Other|22
4686292|NCT02515331|7593641|FG000|Overall Study|Withdrawal by Subject|0
4686293|NCT02515331|7593642|FG001|Overall Study|Withdrawal by Subject|0
4686294|NCT02515331|7593643|FG002|Overall Study|Withdrawal by Subject|1
4686295|NCT02515331|7593641|FG000|Overall Study|Protocol deviation|0
4686296|NCT02515331|7593642|FG001|Overall Study|Protocol deviation|0
4686297|NCT02515331|7593643|FG002|Overall Study|Protocol deviation|3
4686298|NCT02515331|7593641|FG000|Overall Study|Adverse Event|2
4761183|NCT02906020|7735276|FG004|Part 1: Dose Escalation Period|Adverse Event|0
4761184|NCT02906020|7735277|FG005|Part 1: Dose Escalation Period|Adverse Event|0
4761185|NCT02906020|7735278|FG006|Part 1: Dose Escalation Period|Adverse Event|0
4761186|NCT02906020|7735279|FG007|Part 1: Dose Escalation Period|Adverse Event|0
4761187|NCT02906020|7735280|FG008|Part 1: Dose Escalation Period|Adverse Event|0
4761188|NCT02906020|7735281|FG009|Part 1: Dose Escalation Period|Adverse Event|0
4761189|NCT02906020|7735282|FG010|Part 1: Dose Escalation Period|Adverse Event|0
4761190|NCT02906020|7735283|FG011|Part 1: Dose Escalation Period|Adverse Event|0
4761191|NCT02906020|7735284|FG012|Part 1: Dose Escalation Period|Adverse Event|0
4761192|NCT02906020|7735285|FG013|Part 1: Dose Escalation Period|Adverse Event|0
4761193|NCT02906020|7735286|FG014|Part 1: Dose Escalation Period|Adverse Event|0
4761194|NCT02906020|7735287|FG015|Part 1: Dose Escalation Period|Adverse Event|0
4761195|NCT02906020|7735272|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0
4761196|NCT02906020|7735273|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0
4761197|NCT02906020|7735274|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0
4761198|NCT02906020|7735275|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0
4761199|NCT02906020|7735276|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0
4761200|NCT02906020|7735277|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0
4761201|NCT02906020|7735278|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0
4761202|NCT02906020|7735279|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0
4761203|NCT02906020|7735280|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6
4761204|NCT02906020|7735281|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15
4761205|NCT02906020|7735282|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0
4761206|NCT02906020|7735283|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0
4761207|NCT02906020|7735284|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0
4761208|NCT02906020|7735285|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0
4761209|NCT02906020|7735286|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0
4761210|NCT02906020|7735287|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0
4761211|NCT02906020|7735272|FG000|Part 2: Double-blind Treatment Period|Other|0
4761212|NCT02906020|7735273|FG001|Part 2: Double-blind Treatment Period|Other|0
4761213|NCT02906020|7735274|FG002|Part 2: Double-blind Treatment Period|Other|0
4761214|NCT02906020|7735275|FG003|Part 2: Double-blind Treatment Period|Other|0
4761215|NCT02906020|7735276|FG004|Part 2: Double-blind Treatment Period|Other|0
4761216|NCT02906020|7735277|FG005|Part 2: Double-blind Treatment Period|Other|0
4761217|NCT02906020|7735278|FG006|Part 2: Double-blind Treatment Period|Other|0
4761218|NCT02906020|7735279|FG007|Part 2: Double-blind Treatment Period|Other|0
4761219|NCT02906020|7735280|FG008|Part 2: Double-blind Treatment Period|Other|6
4761220|NCT02906020|7735281|FG009|Part 2: Double-blind Treatment Period|Other|10
4761221|NCT02906020|7735282|FG010|Part 2: Double-blind Treatment Period|Other|0
4761222|NCT02906020|7735283|FG011|Part 2: Double-blind Treatment Period|Other|0
4761223|NCT02906020|7735284|FG012|Part 2: Double-blind Treatment Period|Other|0
4761224|NCT02906020|7735285|FG013|Part 2: Double-blind Treatment Period|Other|0
4761225|NCT02906020|7735286|FG014|Part 2: Double-blind Treatment Period|Other|0
4761226|NCT02906020|7735287|FG015|Part 2: Double-blind Treatment Period|Other|0
4761227|NCT02906020|7735272|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0
4761228|NCT02906020|7735273|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0
4761229|NCT02906020|7735274|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0
4761230|NCT02906020|7735275|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0
4761231|NCT02906020|7735276|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0
4761232|NCT02906020|7735277|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0
4761233|NCT02906020|7735278|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0
4761234|NCT02906020|7735279|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0
4761235|NCT02906020|7735280|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0
4761236|NCT02906020|7735281|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0
4761237|NCT02906020|7735282|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0
4686299|NCT02515331|7593642|FG001|Overall Study|Adverse Event|0
4686300|NCT02515331|7593643|FG002|Overall Study|Adverse Event|0
4761238|NCT02906020|7735283|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0
4761239|NCT02906020|7735284|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10
4761240|NCT02906020|7735285|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4
4761241|NCT02906020|7735286|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0
4686301|NCT02515630|7593653|FG000|Overall Study|Withdrawal by Subject|5
4686302|NCT02515630|7593653|FG000|Overall Study|Adverse Event|4
4686303|NCT02515630|7593653|FG000|Overall Study|Physician Decision|4
4686304|NCT02515630|7593653|FG000|Overall Study|Death|2
4686305|NCT02515630|7593653|FG000|Overall Study|Disease Progression|1
4686306|NCT02515669|7593673|FG000|228 Week Open-Label Phase|Other|0
4686307|NCT02515669|7593674|FG001|228 Week Open-Label Phase|Other|0
4686308|NCT02515669|7593675|FG002|228 Week Open-Label Phase|Other|1
4686309|NCT02515669|7593676|FG003|228 Week Open-Label Phase|Other|4
4686310|NCT02515669|7593673|FG000|228 Week Open-Label Phase|Lack of Efficacy|0
4686311|NCT02515669|7593674|FG001|228 Week Open-Label Phase|Lack of Efficacy|0
4686312|NCT02515669|7593675|FG002|228 Week Open-Label Phase|Lack of Efficacy|1
4686313|NCT02515669|7593676|FG003|228 Week Open-Label Phase|Lack of Efficacy|0
4686314|NCT02515669|7593673|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0
4686315|NCT02515669|7593674|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0
4686316|NCT02515669|7593675|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2
4686317|NCT02515669|7593676|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3
4686318|NCT02515669|7593673|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0
4686319|NCT02515669|7593674|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7
4686320|NCT02515669|7593675|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2
4686321|NCT02515669|7593676|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17
4686322|NCT02515669|7593673|FG000|228 Week Open-Label Phase|Missing|0
4686323|NCT02515669|7593674|FG001|228 Week Open-Label Phase|Missing|2
4686324|NCT02515669|7593675|FG002|228 Week Open-Label Phase|Missing|2
4686325|NCT02515669|7593676|FG003|228 Week Open-Label Phase|Missing|2
4686326|NCT02515942|7593739|FG000|Overall Study|Adverse Event|5
4686327|NCT02515942|7593740|FG001|Overall Study|Adverse Event|0
4686328|NCT02515942|7593741|FG002|Overall Study|Adverse Event|0
4686329|NCT02515942|7593739|FG000|Overall Study|Death|0
4686330|NCT02515942|7593740|FG001|Overall Study|Death|0
4686331|NCT02515942|7593741|FG002|Overall Study|Death|1
4686332|NCT02515942|7593739|FG000|Overall Study|Lack of Efficacy|0
4686333|NCT02515942|7593740|FG001|Overall Study|Lack of Efficacy|0
4686334|NCT02515942|7593741|FG002|Overall Study|Lack of Efficacy|1
4686335|NCT02515942|7593739|FG000|Overall Study|Lost to Follow-up|2
4686336|NCT02515942|7593740|FG001|Overall Study|Lost to Follow-up|0
4686337|NCT02515942|7593741|FG002|Overall Study|Lost to Follow-up|0
4686338|NCT02515942|7593739|FG000|Overall Study|Withdrawal by Subject|0
4686339|NCT02515942|7593740|FG001|Overall Study|Withdrawal by Subject|3
4686340|NCT02515942|7593741|FG002|Overall Study|Withdrawal by Subject|2
4686341|NCT02515994|7593753|FG000|Overall Study|Protocol Violation|3
4686342|NCT02515994|7593754|FG001|Overall Study|Protocol Violation|5
4686343|NCT02515994|7593753|FG000|Overall Study|No Longer Meets Eligibility Criteria|2
4686344|NCT02515994|7593754|FG001|Overall Study|No Longer Meets Eligibility Criteria|1
4686345|NCT02515994|7593753|FG000|Overall Study|Adverse Event|3
4686346|NCT02515994|7593754|FG001|Overall Study|Adverse Event|1
4686347|NCT02515994|7593753|FG000|Overall Study|Withdrawal by Subject|2
4686348|NCT02515994|7593754|FG001|Overall Study|Withdrawal by Subject|0
4686349|NCT02516098|7593776|FG000|Period 1|Protocol Violation|1
4686350|NCT02516098|7593777|FG001|Period 1|Protocol Violation|0
4686351|NCT02516098|7593776|FG000|Washout After Period 1|Adverse Event|0
4686352|NCT02516098|7593777|FG001|Washout After Period 1|Adverse Event|1
4686353|NCT02516098|7593776|FG000|Period 2|Withdrawal by Subject|0
4686354|NCT02516098|7593777|FG001|Period 2|Withdrawal by Subject|1
4686355|NCT02516163|7593789|FG000|Overall Study|Withdrawal by Subject|1
4686356|NCT02516163|7593789|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11
4686357|NCT02516163|7593789|FG000|Overall Study|Unfit/delay in surgery|3
4686358|NCT02516163|7593789|FG000|Overall Study|Use of incorrect measurement technique|5
4686359|NCT02516163|7593789|FG000|Overall Study|Data not recorded|2
4686360|NCT02516163|7593789|FG000|Overall Study|MRI contraindication exclusion|6
4686361|NCT02516202|7593796|FG000|Overall Study|Withdrawal by Subject|1
4686362|NCT02516202|7593797|FG001|Overall Study|Withdrawal by Subject|0
4686363|NCT02516202|7593798|FG002|Overall Study|Withdrawal by Subject|1
4686364|NCT02516202|7593796|FG000|Overall Study|Lost to Follow-up|1
4686365|NCT02516202|7593797|FG001|Overall Study|Lost to Follow-up|1
4686366|NCT02516202|7593798|FG002|Overall Study|Lost to Follow-up|1
4686367|NCT02516202|7593796|FG000|Overall Study|Stopped Follow-up|0
4686368|NCT02516202|7593797|FG001|Overall Study|Stopped Follow-up|0
4686369|NCT02516202|7593798|FG002|Overall Study|Stopped Follow-up|1
4686370|NCT02516306|7593808|FG000|Period 2: Day 8 - 91|Protocol Violation|1
4686371|NCT02516306|7593809|FG001|Period 2: Day 8 - 91|Protocol Violation|2
4686372|NCT02516332|7593818|FG000|Overall Study|Withdrawal by Subject|2
4686373|NCT02516332|7593819|FG001|Overall Study|Withdrawal by Subject|1
4761242|NCT02906020|7735287|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0
4761243|NCT02906020|7735272|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0
4761244|NCT02906020|7735273|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0
4761245|NCT02906020|7735274|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0
4761246|NCT02906020|7735275|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0
4761247|NCT02906020|7735276|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0
4761248|NCT02906020|7735277|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0
4686374|NCT02516332|7593820|FG002|Overall Study|Withdrawal by Subject|2
4686375|NCT02516410|7593830|FG000|Overall Study|Adverse Event|0
4686376|NCT02516410|7593831|FG001|Overall Study|Adverse Event|1
4686377|NCT02516410|7593830|FG000|Overall Study|Withdrawal by Subject|0
4686378|NCT02516410|7593831|FG001|Overall Study|Withdrawal by Subject|1
4686379|NCT02516592|7593844|FG000|Overall Study|Patient withdrew consent|5
4686380|NCT02516592|7593845|FG001|Overall Study|Patient withdrew consent|2
4686381|NCT02516592|7593844|FG000|Overall Study|Protocol deviation|4
4686382|NCT02516592|7593845|FG001|Overall Study|Protocol deviation|4
4686383|NCT02516592|7593844|FG000|Overall Study|Lost to Follow-up|2
4686384|NCT02516592|7593845|FG001|Overall Study|Lost to Follow-up|3
4686385|NCT02516592|7593844|FG000|Overall Study|Patient/guardian decision|2
4686386|NCT02516592|7593845|FG001|Overall Study|Patient/guardian decision|1
4686387|NCT02516592|7593844|FG000|Overall Study|Adverse Event|1
4686388|NCT02516592|7593845|FG001|Overall Study|Adverse Event|2
4686389|NCT02516592|7593844|FG000|Overall Study|Abnormal test procedure result|1
4686390|NCT02516592|7593845|FG001|Overall Study|Abnormal test procedure result|0
4686391|NCT02516592|7593844|FG000|Overall Study|Death|1
4686392|NCT02516592|7593845|FG001|Overall Study|Death|1
4686393|NCT02516605|7593856|FG000|Overall Study|Protocol Violation|0
4686394|NCT02516605|7593857|FG001|Overall Study|Protocol Violation|0
4686395|NCT02516605|7593858|FG002|Overall Study|Protocol Violation|0
4686396|NCT02516605|7593859|FG003|Overall Study|Protocol Violation|0
4686397|NCT02516605|7593860|FG004|Overall Study|Protocol Violation|1
4686398|NCT02516605|7593856|FG000|Overall Study|Withdrawal by Subject|0
4686399|NCT02516605|7593857|FG001|Overall Study|Withdrawal by Subject|0
4686400|NCT02516605|7593858|FG002|Overall Study|Withdrawal by Subject|0
4686401|NCT02516605|7593859|FG003|Overall Study|Withdrawal by Subject|1
4686402|NCT02516605|7593860|FG004|Overall Study|Withdrawal by Subject|0
4686403|NCT02516982|7593880|FG000|Overall Study|Called in to antenatal appointment|32
4686404|NCT02516982|7593881|FG001|Overall Study|Called in to antenatal appointment|35
4686405|NCT02516982|7593882|FG002|Overall Study|Called in to antenatal appointment|0
4686406|NCT02516982|7593883|FG003|Overall Study|Called in to antenatal appointment|0
4686407|NCT02516982|7593880|FG000|Overall Study|Withdrawal by Subject|0
4686408|NCT02516982|7593881|FG001|Overall Study|Withdrawal by Subject|0
4686409|NCT02516982|7593882|FG002|Overall Study|Withdrawal by Subject|1
4686410|NCT02516982|7593883|FG003|Overall Study|Withdrawal by Subject|2
4686411|NCT02516982|7593880|FG000|Overall Study|Protocol Violation|0
4686412|NCT02516982|7593881|FG001|Overall Study|Protocol Violation|0
4686413|NCT02516982|7593882|FG002|Overall Study|Protocol Violation|1
4686414|NCT02516982|7593883|FG003|Overall Study|Protocol Violation|1
4686415|NCT02516982|7593880|FG000|Overall Study|Did not install the app|0
4686416|NCT02516982|7593881|FG001|Overall Study|Did not install the app|0
4686417|NCT02516982|7593882|FG002|Overall Study|Did not install the app|46
4686418|NCT02516982|7593883|FG003|Overall Study|Did not install the app|47
4686419|NCT02517268|7593909|FG000|Overall Study|Withdrawal by Subject|1
4686420|NCT02517268|7593910|FG001|Overall Study|Withdrawal by Subject|0
4686421|NCT02517463|7593918|FG000|Overall Study|Lost to Follow-up|5
4686422|NCT02517463|7593919|FG001|Overall Study|Lost to Follow-up|2
4686423|NCT02517515|7593927|FG000|Overall Study|Adverse Event|0
4686424|NCT02517515|7593928|FG001|Overall Study|Adverse Event|1
4686425|NCT02517515|7593927|FG000|Overall Study|Withdrew Consent|0
4686426|NCT02517515|7593928|FG001|Overall Study|Withdrew Consent|1
4686427|NCT02517515|7593927|FG000|Overall Study|Lost to Follow-up|1
4686428|NCT02517515|7593928|FG001|Overall Study|Lost to Follow-up|0
4686429|NCT02517515|7593927|FG000|Overall Study|Other|1
4686430|NCT02517515|7593928|FG001|Overall Study|Other|0
4686431|NCT02517528|7593935|FG000|Overall Study|Withdrawal by Subject|1
4686432|NCT02517541|7593939|FG000|Baseline Period (Own Product)|Protocol Violation|1
4686433|NCT02517541|7593939|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3
4686434|NCT02517541|7593939|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2
4686435|NCT02517541|7593939|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1
4686436|NCT02517541|7593939|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4
4686437|NCT02517541|7593939|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2
4686438|NCT02517866|7593974|FG000|Overall Study|Pretreatment Event/Adverse Event|9
4686439|NCT02517866|7593975|FG001|Overall Study|Pretreatment Event/Adverse Event|2
4686440|NCT02517866|7593976|FG002|Overall Study|Pretreatment Event/Adverse Event|0
4686441|NCT02517866|7593974|FG000|Overall Study|Significant Protocol Deviation|4
4686442|NCT02517866|7593975|FG001|Overall Study|Significant Protocol Deviation|1
4686443|NCT02517866|7593976|FG002|Overall Study|Significant Protocol Deviation|0
4686444|NCT02517866|7593974|FG000|Overall Study|Lost to Follow-up|1
4686445|NCT02517866|7593975|FG001|Overall Study|Lost to Follow-up|0
4686446|NCT02517866|7593976|FG002|Overall Study|Lost to Follow-up|0
4686447|NCT02517866|7593974|FG000|Overall Study|Voluntary Withdrawal|2
4686448|NCT02517866|7593975|FG001|Overall Study|Voluntary Withdrawal|2
4686449|NCT02517866|7593976|FG002|Overall Study|Voluntary Withdrawal|0
4686450|NCT02517866|7593974|FG000|Overall Study|Investigator Decision|2
4686451|NCT02517866|7593975|FG001|Overall Study|Investigator Decision|1
4686452|NCT02517866|7593976|FG002|Overall Study|Investigator Decision|0
4686453|NCT02517866|7593974|FG000|Overall Study|Reason not specified|2
4686454|NCT02517866|7593975|FG001|Overall Study|Reason not specified|0
4686455|NCT02517866|7593976|FG002|Overall Study|Reason not specified|0
4686456|NCT02517905|7593988|FG000|Overall Study|Lost to Follow-up|4
4686457|NCT02517905|7593989|FG001|Overall Study|Lost to Follow-up|0
4686458|NCT02517905|7593988|FG000|Overall Study|Withdrawal by Subject|4
4686459|NCT02517905|7593989|FG001|Overall Study|Withdrawal by Subject|0
4761249|NCT02906020|7735278|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0
4761250|NCT02906020|7735279|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0
4761251|NCT02906020|7735280|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0
4761252|NCT02906020|7735281|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0
4686460|NCT02517905|7593988|FG000|Overall Study|Screen failure|2
4686461|NCT02517905|7593989|FG001|Overall Study|Screen failure|2
4686462|NCT02518048|7594004|FG000|Overall Study|Withdrawal by Subject|1
4686463|NCT02518113|7594013|FG000|Overall Study|Adverse Event|1
4686464|NCT02518113|7594014|FG001|Overall Study|Adverse Event|0
4686465|NCT02518113|7594015|FG002|Overall Study|Adverse Event|1
4686466|NCT02518113|7594016|FG003|Overall Study|Adverse Event|0
4686467|NCT02518113|7594013|FG000|Overall Study|Death|1
4686468|NCT02518113|7594014|FG001|Overall Study|Death|2
4686469|NCT02518113|7594015|FG002|Overall Study|Death|0
4686470|NCT02518113|7594016|FG003|Overall Study|Death|0
4686471|NCT02518113|7594013|FG000|Overall Study|Physician Decision|0
4686472|NCT02518113|7594014|FG001|Overall Study|Physician Decision|1
4686473|NCT02518113|7594015|FG002|Overall Study|Physician Decision|0
4686474|NCT02518113|7594016|FG003|Overall Study|Physician Decision|0
4686475|NCT02518113|7594013|FG000|Overall Study|Progressive Disease|1
4686476|NCT02518113|7594014|FG001|Overall Study|Progressive Disease|2
4686477|NCT02518113|7594015|FG002|Overall Study|Progressive Disease|3
4686478|NCT02518113|7594016|FG003|Overall Study|Progressive Disease|0
4686479|NCT02518464|7594050|FG000|Overall Study|Adverse Event|2
4686480|NCT02518490|7594054|FG000|Overall Study|Withdrawal by Subject|1
4686481|NCT02518490|7594055|FG001|Overall Study|Withdrawal by Subject|1
4686482|NCT02518620|7594064|FG000|Overall Study|Adverse Event|23
4686483|NCT02518620|7594065|FG001|Overall Study|Adverse Event|11
4686484|NCT02518620|7594064|FG000|Overall Study|Lack of Efficacy|2
4686485|NCT02518620|7594065|FG001|Overall Study|Lack of Efficacy|0
4686486|NCT02518620|7594064|FG000|Overall Study|Non-Compliance with Study Drug|1
4686487|NCT02518620|7594065|FG001|Overall Study|Non-Compliance with Study Drug|0
4686488|NCT02518620|7594064|FG000|Overall Study|Physician Decision|1
4686489|NCT02518620|7594065|FG001|Overall Study|Physician Decision|1
4686490|NCT02518620|7594064|FG000|Overall Study|Sponsor's Decision|0
4686491|NCT02518620|7594065|FG001|Overall Study|Sponsor's Decision|3
4686492|NCT02518620|7594064|FG000|Overall Study|Lost to Follow-up|1
4686493|NCT02518620|7594065|FG001|Overall Study|Lost to Follow-up|1
4686494|NCT02518620|7594064|FG000|Overall Study|Withdrawal by Subject|17
4686495|NCT02518620|7594065|FG001|Overall Study|Withdrawal by Subject|9
4686496|NCT02518620|7594064|FG000|Overall Study|Death|1
4686497|NCT02518620|7594065|FG001|Overall Study|Death|0
4686498|NCT02518620|7594064|FG000|Overall Study|Pregnancy Wish|3
4686499|NCT02518620|7594065|FG001|Overall Study|Pregnancy Wish|0
4761253|NCT02906020|7735282|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0
4761254|NCT02906020|7735283|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0
4761255|NCT02906020|7735284|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7
4761256|NCT02906020|7735285|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4
4761257|NCT02906020|7735286|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0
4761258|NCT02906020|7735287|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1
4761259|NCT02906020|7735272|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
4761260|NCT02906020|7735273|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
4761261|NCT02906020|7735274|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
4761262|NCT02906020|7735275|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
4761263|NCT02906020|7735276|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
4761264|NCT02906020|7735277|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
4761265|NCT02906020|7735278|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
4761266|NCT02906020|7735279|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
4761267|NCT02906020|7735280|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
4761268|NCT02906020|7735281|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
4761269|NCT02906020|7735282|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
4761270|NCT02906020|7735283|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
4761271|NCT02906020|7735284|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1
4761272|NCT02906020|7735285|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1
4761273|NCT02906020|7735286|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
4761274|NCT02906020|7735287|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0
4761275|NCT02906020|7735272|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
4761276|NCT02906020|7735273|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
4761277|NCT02906020|7735274|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
4761278|NCT02906020|7735275|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
4761279|NCT02906020|7735276|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
4761280|NCT02906020|7735277|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
4761281|NCT02906020|7735278|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
4761282|NCT02906020|7735279|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
4686500|NCT02518620|7594064|FG000|Overall Study|Pregnancy|1
4686501|NCT02518620|7594065|FG001|Overall Study|Pregnancy|0
4686502|NCT02518620|7594064|FG000|Overall Study|Relocation|2
4686503|NCT02518620|7594065|FG001|Overall Study|Relocation|1
4686504|NCT02518685|7594075|FG000|Overall Study|Adverse Event|29
4686505|NCT02518685|7594076|FG001|Overall Study|Adverse Event|1
4686506|NCT02518685|7594075|FG000|Overall Study|Withdrawal by Subject|10
4686507|NCT02518685|7594076|FG001|Overall Study|Withdrawal by Subject|3
4686508|NCT02518685|7594075|FG000|Overall Study|relocation, study fatigue|7
4686509|NCT02518685|7594076|FG001|Overall Study|relocation, study fatigue|2
4686510|NCT02518685|7594075|FG000|Overall Study|Pregnancy|1
4686511|NCT02518685|7594076|FG001|Overall Study|Pregnancy|0
4686512|NCT02518685|7594075|FG000|Overall Study|Physician Decision|1
4686513|NCT02518685|7594076|FG001|Overall Study|Physician Decision|0
4686514|NCT02518685|7594075|FG000|Overall Study|Lost to Follow-up|1
4686515|NCT02518685|7594076|FG001|Overall Study|Lost to Follow-up|4
4686516|NCT02518919|7594086|FG000|Overall Study|Protocol Violation|1
4686517|NCT02518919|7594087|FG001|Overall Study|Protocol Violation|1
4686518|NCT02518919|7594088|FG002|Overall Study|Protocol Violation|2
4686519|NCT02518971|7594098|FG000|Overall Study|Lost to Follow-up|0
4686520|NCT02518971|7594099|FG001|Overall Study|Lost to Follow-up|1
4686521|NCT02518971|7594098|FG000|Overall Study|Physician Decision|6
4686522|NCT02518971|7594099|FG001|Overall Study|Physician Decision|6
4686523|NCT02518971|7594098|FG000|Overall Study|Protocol Violation|6
4686524|NCT02518971|7594099|FG001|Overall Study|Protocol Violation|4
4686525|NCT02518971|7594098|FG000|Overall Study|Withdrawal by Subject|4
4686526|NCT02518971|7594099|FG001|Overall Study|Withdrawal by Subject|5
4686527|NCT02518971|7594098|FG000|Overall Study|Side effects|1
4686528|NCT02518971|7594099|FG001|Overall Study|Side effects|0
4686529|NCT02518971|7594098|FG000|Overall Study|medication lost in mail|0
4686530|NCT02518971|7594099|FG001|Overall Study|medication lost in mail|1
4686531|NCT02518971|7594098|FG000|Overall Study|eligibility criteria no longer met|6
4686532|NCT02518971|7594099|FG001|Overall Study|eligibility criteria no longer met|3
4686533|NCT02519231|7594154|FG000|Overall Study|Lost to Follow-up|2
4686534|NCT02519231|7594155|FG001|Overall Study|Lost to Follow-up|5
4686535|NCT02519231|7594154|FG000|Overall Study|Withdrawal by Subject|0
4686536|NCT02519231|7594155|FG001|Overall Study|Withdrawal by Subject|1
4686537|NCT02519504|7594182|FG000|Overall Study|Protocol Violation|6
4686538|NCT02519504|7594183|FG001|Overall Study|Protocol Violation|5
4686539|NCT02519504|7594182|FG000|Overall Study|Ineligible for direct testing|12
4686540|NCT02519504|7594183|FG001|Overall Study|Ineligible for direct testing|12
4686541|NCT02519504|7594182|FG000|Overall Study|Did not participate in direct testing|95
4686542|NCT02519504|7594183|FG001|Overall Study|Did not participate in direct testing|86
4686543|NCT02519595|7594192|FG000|Overall Study|Protocol Violation|8
4686544|NCT02519595|7594193|FG001|Overall Study|Protocol Violation|22
4686545|NCT02519595|7594194|FG002|Overall Study|Protocol Violation|16
4686546|NCT02519842|7594217|FG000|Base Study: Cycle 1|Screening Failure|1
4686547|NCT02519842|7594218|FG001|Base Study: Cycle 1|Screening Failure|1
4686548|NCT02519842|7594219|FG002|Base Study: Cycle 1|Screening Failure|0
4686549|NCT02519842|7594217|FG000|Base Study: Cycle 1|Adverse Event|1
4686550|NCT02519842|7594218|FG001|Base Study: Cycle 1|Adverse Event|0
4686551|NCT02519842|7594219|FG002|Base Study: Cycle 1|Adverse Event|0
4686552|NCT02519842|7594217|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0
4686553|NCT02519842|7594218|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1
4686554|NCT02519842|7594219|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0
4686555|NCT02519842|7594217|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0
4686556|NCT02519842|7594218|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1
4686557|NCT02519842|7594219|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0
4686558|NCT02519842|7594217|FG000|Optional Extension: Cycles 2-6|Physician Decision|0
4686559|NCT02519842|7594218|FG001|Optional Extension: Cycles 2-6|Physician Decision|0
4686560|NCT02519842|7594219|FG002|Optional Extension: Cycles 2-6|Physician Decision|5
4686561|NCT02519842|7594217|FG000|Optional Extension: Cycles 2-6|Adverse Event|0
4686562|NCT02519842|7594218|FG001|Optional Extension: Cycles 2-6|Adverse Event|0
4686563|NCT02519842|7594219|FG002|Optional Extension: Cycles 2-6|Adverse Event|1
4686564|NCT02519842|7594217|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0
4686565|NCT02519842|7594218|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0
4686566|NCT02519842|7594219|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3
4686567|NCT02519842|7594217|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0
4686568|NCT02519842|7594218|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0
4686569|NCT02519842|7594219|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1
4686570|NCT02519842|7594217|FG000|Optional Extension: Cycles 2-6|Death|0
4686571|NCT02519842|7594218|FG001|Optional Extension: Cycles 2-6|Death|0
4686572|NCT02519842|7594219|FG002|Optional Extension: Cycles 2-6|Death|1
4686573|NCT02519842|7594217|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0
4686574|NCT02519842|7594218|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0
4686575|NCT02519842|7594219|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2
4686576|NCT02519842|7594217|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0
4686577|NCT02519842|7594218|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0
4686578|NCT02519842|7594219|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13
4686579|NCT02519842|7594217|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0
4686580|NCT02519842|7594218|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0
4686581|NCT02519842|7594219|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1
4686582|NCT02519842|7594217|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0
4686583|NCT02519842|7594218|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0
4686584|NCT02519842|7594219|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2
4686585|NCT02519855|7594229|FG000|Overall Study|Adverse Event|0
4686586|NCT02519855|7594230|FG001|Overall Study|Adverse Event|1
4686587|NCT02519855|7594229|FG000|Overall Study|Lost to Follow-up|3
4686588|NCT02519855|7594230|FG001|Overall Study|Lost to Follow-up|3
4686589|NCT02520089|7594238|FG000|Overall Study|Lost to Follow-up|3
4686590|NCT02520089|7594239|FG001|Overall Study|Lost to Follow-up|4
4686591|NCT02520284|7594248|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1
4686592|NCT02520284|7594249|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3
4686593|NCT02520284|7594250|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0
4686594|NCT02520284|7594248|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1
4686595|NCT02520284|7594249|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1
4686596|NCT02520284|7594250|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1
4686597|NCT02520284|7594248|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0
4686598|NCT02520284|7594249|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0
4686599|NCT02520284|7594250|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1
4686600|NCT02520284|7594248|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17
4686601|NCT02520284|7594249|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11
4686602|NCT02520284|7594250|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15
4686603|NCT02520284|7594248|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2
4686604|NCT02520284|7594249|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2
4686605|NCT02520284|7594250|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3
4686606|NCT02520284|7594248|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1
4686607|NCT02520284|7594249|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1
4686608|NCT02520284|7594250|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0
4686609|NCT02520284|7594248|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0
4686610|NCT02520284|7594249|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2
4686611|NCT02520284|7594250|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0
4686612|NCT02520284|7594248|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25
4686613|NCT02520284|7594249|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29
4686614|NCT02520284|7594250|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28
4686615|NCT02520284|7594248|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3
4686616|NCT02520284|7594249|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4
4686617|NCT02520284|7594250|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2
4686618|NCT02520284|7594248|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2
4686619|NCT02520284|7594249|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1
4686620|NCT02520284|7594250|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3
4686621|NCT02520284|7594248|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2
4686622|NCT02520284|7594249|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1
4686623|NCT02520284|7594250|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1
4686624|NCT02520310|7594264|FG000|At 6 Months Clinical Follow-up|Death|1
4686625|NCT02520310|7594264|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1
4686626|NCT02520310|7594264|FG000|AT 3 Year Clinical Follow-up|Death|2
4686627|NCT02520310|7594264|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2
4686628|NCT02520310|7594264|FG000|AT 4 Year Clinical Follow-up|Death|1
4686629|NCT02520310|7594264|FG000|AT 4 Year Clinical Follow-up|missed visit|1
4686630|NCT02520388|7594272|FG000|Overall Study|Physician Decision|1
4686631|NCT02520388|7594273|FG001|Overall Study|Physician Decision|0
4686632|NCT02520388|7594272|FG000|Overall Study|Subject or parent/guardian request|0
4686633|NCT02520388|7594273|FG001|Overall Study|Subject or parent/guardian request|6
4686634|NCT02520388|7594272|FG000|Overall Study|Adverse Event|1
4686635|NCT02520388|7594273|FG001|Overall Study|Adverse Event|4
4686636|NCT02520388|7594272|FG000|Overall Study|Lost to Follow-up|3
4686637|NCT02520388|7594273|FG001|Overall Study|Lost to Follow-up|2
4761283|NCT02906020|7735280|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
4761284|NCT02906020|7735281|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
4761285|NCT02906020|7735282|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
4761286|NCT02906020|7735283|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
4761287|NCT02906020|7735284|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1
4761288|NCT02906020|7735285|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4
4761289|NCT02906020|7735286|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
4761290|NCT02906020|7735287|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0
4761291|NCT02906020|7735272|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
4761292|NCT02906020|7735273|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
4761293|NCT02906020|7735274|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
4761294|NCT02906020|7735275|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
4686638|NCT02520388|7594272|FG000|Overall Study|Other (reason not defined)|4
4686639|NCT02520388|7594273|FG001|Overall Study|Other (reason not defined)|4
4686640|NCT02520531|7594304|FG000|Overall Study|Revision of study device components|2
4686641|NCT02520531|7594305|FG001|Overall Study|Revision of study device components|2
4686642|NCT02520531|7594304|FG000|Overall Study|Death|1
4686643|NCT02520531|7594305|FG001|Overall Study|Death|2
4686644|NCT02520531|7594304|FG000|Overall Study|Lost to Follow-up|1
4686645|NCT02520531|7594305|FG001|Overall Study|Lost to Follow-up|1
4686646|NCT02520531|7594304|FG000|Overall Study|Meet exclusion criterion|0
4686647|NCT02520531|7594305|FG001|Overall Study|Meet exclusion criterion|1
4686648|NCT02520531|7594304|FG000|Overall Study|Withdrawal by Subject|1
4686649|NCT02520531|7594305|FG001|Overall Study|Withdrawal by Subject|0
4686650|NCT02520531|7594304|FG000|Overall Study|Not study device|1
4686651|NCT02520531|7594305|FG001|Overall Study|Not study device|0
4686652|NCT02521376|7594337|FG000|Overall Study|Enrolled, But Not Treated|1
4686653|NCT02521376|7594338|FG001|Overall Study|Enrolled, But Not Treated|0
4686654|NCT02521376|7594339|FG002|Overall Study|Enrolled, But Not Treated|0
4686655|NCT02521376|7594340|FG003|Overall Study|Enrolled, But Not Treated|0
4686656|NCT02521792|7594378|FG000|Overall Study|Study Terminated|6
4686657|NCT02521870|7594390|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0
4686658|NCT02521870|7594391|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1
4686659|NCT02521870|7594392|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0
4686660|NCT02521870|7594393|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0
4686661|NCT02521870|7594394|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0
4686662|NCT02521870|7594395|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0
4686663|NCT02521870|7594396|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0
4686664|NCT02521870|7594397|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0
4686665|NCT02521870|7594398|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0
4686666|NCT02521870|7594399|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0
4686667|NCT02521870|7594400|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0
4686668|NCT02521870|7594401|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0
4686669|NCT02521870|7594390|FG000|Phase 1: Dose Escalation|Adverse Event|2
4761295|NCT02906020|7735276|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
4761296|NCT02906020|7735277|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
4761297|NCT02906020|7735278|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
4761298|NCT02906020|7735279|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
4761299|NCT02906020|7735280|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
4761300|NCT02906020|7735281|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
4761301|NCT02906020|7735282|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
4761302|NCT02906020|7735283|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0
4761303|NCT02906020|7735284|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67
4761304|NCT02906020|7735285|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64
4761305|NCT02906020|7735286|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7
4761306|NCT02906020|7735287|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8
4761307|NCT02906020|7735272|FG000|Part 2: Long-term Follow-up Period|Other|0
4761308|NCT02906020|7735273|FG001|Part 2: Long-term Follow-up Period|Other|0
4761309|NCT02906020|7735274|FG002|Part 2: Long-term Follow-up Period|Other|0
4761310|NCT02906020|7735275|FG003|Part 2: Long-term Follow-up Period|Other|0
4761311|NCT02906020|7735276|FG004|Part 2: Long-term Follow-up Period|Other|0
4686670|NCT02521870|7594391|FG001|Phase 1: Dose Escalation|Adverse Event|1
4686671|NCT02521870|7594392|FG002|Phase 1: Dose Escalation|Adverse Event|0
4686672|NCT02521870|7594393|FG003|Phase 1: Dose Escalation|Adverse Event|0
4686673|NCT02521870|7594394|FG004|Phase 1: Dose Escalation|Adverse Event|0
4686674|NCT02521870|7594395|FG005|Phase 1: Dose Escalation|Adverse Event|0
4686675|NCT02521870|7594396|FG006|Phase 1: Dose Escalation|Adverse Event|0
4686676|NCT02521870|7594397|FG007|Phase 1: Dose Escalation|Adverse Event|0
4686677|NCT02521870|7594398|FG008|Phase 1: Dose Escalation|Adverse Event|0
4686678|NCT02521870|7594399|FG009|Phase 1: Dose Escalation|Adverse Event|0
4686679|NCT02521870|7594400|FG010|Phase 1: Dose Escalation|Adverse Event|0
4686680|NCT02521870|7594401|FG011|Phase 1: Dose Escalation|Adverse Event|0
4686681|NCT02521870|7594390|FG000|Phase 1: Dose Escalation|Progressive Disease|3
4686682|NCT02521870|7594391|FG001|Phase 1: Dose Escalation|Progressive Disease|2
4686683|NCT02521870|7594392|FG002|Phase 1: Dose Escalation|Progressive Disease|4
4686684|NCT02521870|7594393|FG003|Phase 1: Dose Escalation|Progressive Disease|6
4686685|NCT02521870|7594394|FG004|Phase 1: Dose Escalation|Progressive Disease|0
4686686|NCT02521870|7594395|FG005|Phase 1: Dose Escalation|Progressive Disease|0
4686687|NCT02521870|7594396|FG006|Phase 1: Dose Escalation|Progressive Disease|0
4686688|NCT02521870|7594397|FG007|Phase 1: Dose Escalation|Progressive Disease|0
4686689|NCT02521870|7594398|FG008|Phase 1: Dose Escalation|Progressive Disease|0
4686690|NCT02521870|7594399|FG009|Phase 1: Dose Escalation|Progressive Disease|0
4686691|NCT02521870|7594400|FG010|Phase 1: Dose Escalation|Progressive Disease|0
4686692|NCT02521870|7594401|FG011|Phase 1: Dose Escalation|Progressive Disease|0
4686693|NCT02521870|7594390|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0
4686694|NCT02521870|7594391|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0
4686695|NCT02521870|7594392|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0
4686696|NCT02521870|7594393|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0
4686697|NCT02521870|7594394|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5
4686698|NCT02521870|7594395|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1
4686699|NCT02521870|7594396|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1
4686700|NCT02521870|7594397|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0
4686701|NCT02521870|7594398|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1
4686702|NCT02521870|7594399|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1
4686703|NCT02521870|7594400|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2
4686704|NCT02521870|7594401|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0
4686705|NCT02521870|7594390|FG000|Phase 2: Dose Expansion|Adverse Event|0
4686706|NCT02521870|7594391|FG001|Phase 2: Dose Expansion|Adverse Event|0
4686707|NCT02521870|7594392|FG002|Phase 2: Dose Expansion|Adverse Event|0
4686708|NCT02521870|7594393|FG003|Phase 2: Dose Expansion|Adverse Event|0
4686709|NCT02521870|7594394|FG004|Phase 2: Dose Expansion|Adverse Event|11
4686710|NCT02521870|7594395|FG005|Phase 2: Dose Expansion|Adverse Event|2
4686711|NCT02521870|7594396|FG006|Phase 2: Dose Expansion|Adverse Event|0
4686712|NCT02521870|7594397|FG007|Phase 2: Dose Expansion|Adverse Event|1
4686713|NCT02521870|7594398|FG008|Phase 2: Dose Expansion|Adverse Event|5
4686714|NCT02521870|7594399|FG009|Phase 2: Dose Expansion|Adverse Event|0
4686715|NCT02521870|7594400|FG010|Phase 2: Dose Expansion|Adverse Event|1
4686716|NCT02521870|7594401|FG011|Phase 2: Dose Expansion|Adverse Event|0
4686717|NCT02521870|7594390|FG000|Phase 2: Dose Expansion|Progressive Disease|0
4686718|NCT02521870|7594391|FG001|Phase 2: Dose Expansion|Progressive Disease|0
4686719|NCT02521870|7594392|FG002|Phase 2: Dose Expansion|Progressive Disease|0
4686720|NCT02521870|7594393|FG003|Phase 2: Dose Expansion|Progressive Disease|0
4686721|NCT02521870|7594394|FG004|Phase 2: Dose Expansion|Progressive Disease|22
4686722|NCT02521870|7594395|FG005|Phase 2: Dose Expansion|Progressive Disease|18
4761312|NCT02906020|7735277|FG005|Part 2: Long-term Follow-up Period|Other|0
4761313|NCT02906020|7735278|FG006|Part 2: Long-term Follow-up Period|Other|0
4761314|NCT02906020|7735279|FG007|Part 2: Long-term Follow-up Period|Other|0
4761315|NCT02906020|7735280|FG008|Part 2: Long-term Follow-up Period|Other|0
4761316|NCT02906020|7735281|FG009|Part 2: Long-term Follow-up Period|Other|0
4761317|NCT02906020|7735282|FG010|Part 2: Long-term Follow-up Period|Other|0
4761318|NCT02906020|7735283|FG011|Part 2: Long-term Follow-up Period|Other|0
4761319|NCT02906020|7735284|FG012|Part 2: Long-term Follow-up Period|Other|13
4761320|NCT02906020|7735285|FG013|Part 2: Long-term Follow-up Period|Other|8
4761321|NCT02906020|7735286|FG014|Part 2: Long-term Follow-up Period|Other|3
4761322|NCT02906020|7735287|FG015|Part 2: Long-term Follow-up Period|Other|2
4761323|NCT02899299|7735317|FG000|Pre-treatment|Participant request to discontinue study treatment|0
4761324|NCT02899299|7735318|FG001|Pre-treatment|Participant request to discontinue study treatment|3
4761325|NCT02899299|7735317|FG000|Pre-treatment|Participant withdrew consent|1
4761326|NCT02899299|7735318|FG001|Pre-treatment|Participant withdrew consent|11
4761327|NCT02899299|7735317|FG000|Pre-treatment|Participant no longer meets study criteria|2
4761328|NCT02899299|7735318|FG001|Pre-treatment|Participant no longer meets study criteria|3
4761329|NCT02899299|7735317|FG000|Pre-treatment|Not reported|0
4761330|NCT02899299|7735318|FG001|Pre-treatment|Not reported|1
4761331|NCT02899299|7735317|FG000|Treatment|Disease Progression|182
4761332|NCT02899299|7735318|FG001|Treatment|Disease Progression|44
4761333|NCT02899299|7735317|FG000|Treatment|Study Drug Toxicity|59
4761334|NCT02899299|7735318|FG001|Treatment|Study Drug Toxicity|24
4761335|NCT02899299|7735317|FG000|Treatment|Adverse Event unrelated to Study Drug|12
4761336|NCT02899299|7735318|FG001|Treatment|Adverse Event unrelated to Study Drug|9
4761337|NCT02899299|7735317|FG000|Treatment|Participant request to discontinue Study treatment|4
4761338|NCT02899299|7735318|FG001|Treatment|Participant request to discontinue Study treatment|10
4761339|NCT02899299|7735317|FG000|Treatment|Participant withdrew consent|6
4686723|NCT02521870|7594396|FG006|Phase 2: Dose Expansion|Progressive Disease|17
4686724|NCT02521870|7594397|FG007|Phase 2: Dose Expansion|Progressive Disease|7
4686725|NCT02521870|7594398|FG008|Phase 2: Dose Expansion|Progressive Disease|5
4686726|NCT02521870|7594399|FG009|Phase 2: Dose Expansion|Progressive Disease|17
4686727|NCT02521870|7594400|FG010|Phase 2: Dose Expansion|Progressive Disease|17
4686728|NCT02521870|7594401|FG011|Phase 2: Dose Expansion|Progressive Disease|21
4686729|NCT02521870|7594390|FG000|Phase 2: Dose Expansion|Death|0
4686730|NCT02521870|7594391|FG001|Phase 2: Dose Expansion|Death|0
4686731|NCT02521870|7594392|FG002|Phase 2: Dose Expansion|Death|0
4686732|NCT02521870|7594393|FG003|Phase 2: Dose Expansion|Death|0
4686733|NCT02521870|7594394|FG004|Phase 2: Dose Expansion|Death|1
4686734|NCT02521870|7594395|FG005|Phase 2: Dose Expansion|Death|1
4686735|NCT02521870|7594396|FG006|Phase 2: Dose Expansion|Death|3
4686736|NCT02521870|7594397|FG007|Phase 2: Dose Expansion|Death|1
4686737|NCT02521870|7594398|FG008|Phase 2: Dose Expansion|Death|1
4686738|NCT02521870|7594399|FG009|Phase 2: Dose Expansion|Death|5
4686739|NCT02521870|7594400|FG010|Phase 2: Dose Expansion|Death|2
4686740|NCT02521870|7594401|FG011|Phase 2: Dose Expansion|Death|2
4686741|NCT02521870|7594390|FG000|Phase 2: Dose Expansion|Other|0
4686742|NCT02521870|7594391|FG001|Phase 2: Dose Expansion|Other|0
4686743|NCT02521870|7594392|FG002|Phase 2: Dose Expansion|Other|0
4686744|NCT02521870|7594393|FG003|Phase 2: Dose Expansion|Other|0
4686745|NCT02521870|7594394|FG004|Phase 2: Dose Expansion|Other|10
4686746|NCT02521870|7594395|FG005|Phase 2: Dose Expansion|Other|3
4686747|NCT02521870|7594396|FG006|Phase 2: Dose Expansion|Other|2
4686748|NCT02521870|7594397|FG007|Phase 2: Dose Expansion|Other|0
4686749|NCT02521870|7594398|FG008|Phase 2: Dose Expansion|Other|10
4686750|NCT02521870|7594399|FG009|Phase 2: Dose Expansion|Other|5
4686751|NCT02521870|7594400|FG010|Phase 2: Dose Expansion|Other|1
4686752|NCT02521870|7594401|FG011|Phase 2: Dose Expansion|Other|7
4686753|NCT02521870|7594390|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0
4686754|NCT02521870|7594391|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0
4686755|NCT02521870|7594392|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0
4686756|NCT02521870|7594393|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0
4686757|NCT02521870|7594394|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1
4686758|NCT02521870|7594395|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0
4686759|NCT02521870|7594396|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0
4686760|NCT02521870|7594397|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0
4686761|NCT02521870|7594398|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0
4686762|NCT02521870|7594399|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0
4686763|NCT02521870|7594400|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0
4686764|NCT02521870|7594401|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0
4686765|NCT02521870|7594390|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
4686766|NCT02521870|7594391|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
4686767|NCT02521870|7594392|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
4686768|NCT02521870|7594393|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
4686769|NCT02521870|7594394|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2
4686770|NCT02521870|7594395|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
4686771|NCT02521870|7594396|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
4686772|NCT02521870|7594397|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
4686773|NCT02521870|7594398|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
4686774|NCT02521870|7594399|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
4686775|NCT02521870|7594400|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
4686776|NCT02521870|7594401|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0
4686777|NCT02521948|7594431|FG000|Overall Study|Adverse Event|2
4686778|NCT02521948|7594431|FG000|Overall Study|Death|4
4686779|NCT02521948|7594431|FG000|Overall Study|Lost to Follow-up|1
4686780|NCT02521948|7594431|FG000|Overall Study|Did not attend one or both follow-ups|6
4686781|NCT02522286|7594468|FG000|Overall Study|Withdrawal by Subject|3
4686782|NCT02522286|7594469|FG001|Overall Study|Withdrawal by Subject|0
4686783|NCT02522286|7594470|FG002|Overall Study|Withdrawal by Subject|0
4686784|NCT02522286|7594471|FG003|Overall Study|Withdrawal by Subject|3
4686785|NCT02522299|7594483|FG000|Overall Study|Adverse Event|2
4686786|NCT02522299|7594484|FG001|Overall Study|Adverse Event|0
4686787|NCT02522299|7594483|FG000|Overall Study|Physician Decision|0
4686788|NCT02522299|7594484|FG001|Overall Study|Physician Decision|1
4686789|NCT02522299|7594483|FG000|Overall Study|Withdrawal by Subject|2
4686790|NCT02522299|7594484|FG001|Overall Study|Withdrawal by Subject|0
4686791|NCT02522325|7594504|FG000|Overall Study|Adverse Event|0
4686792|NCT02522325|7594505|FG001|Overall Study|Adverse Event|1
4686793|NCT02522377|7594513|FG000|Overall Study|Withdrawal by Subject|1
4686794|NCT02522377|7594514|FG001|Overall Study|Withdrawal by Subject|0
4686795|NCT02522377|7594513|FG000|Overall Study|Remission Achieved|3
4686796|NCT02522377|7594514|FG001|Overall Study|Remission Achieved|0
4761340|NCT02899299|7735318|FG001|Treatment|Participant withdrew consent|3
4761341|NCT02899299|7735317|FG000|Treatment|Lost to Follow-up|0
4761342|NCT02899299|7735318|FG001|Treatment|Lost to Follow-up|1
4761343|NCT02899299|7735317|FG000|Treatment|Maximum Clinical Benefit|10
4686797|NCT02522403|7594522|FG000|Overall Study|Lost to Follow-up|2
4686798|NCT02522403|7594523|FG001|Overall Study|Lost to Follow-up|2
4686799|NCT02522403|7594522|FG000|Overall Study|Withdrawal by Subject|2
4686800|NCT02522403|7594523|FG001|Overall Study|Withdrawal by Subject|4
4686801|NCT02522481|7594538|FG000|Overall Study|discontinued|1
4686802|NCT02522481|7594538|FG000|Overall Study|Not dosed|2
4686803|NCT02522494|7594551|FG000|Overall Study|Lost to Follow-up|6
4686804|NCT02522494|7594552|FG001|Overall Study|Lost to Follow-up|2
4686805|NCT02522494|7594551|FG000|Overall Study|Withdrawal by Subject|1
4686806|NCT02522494|7594552|FG001|Overall Study|Withdrawal by Subject|0
4686807|NCT02522494|7594551|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6
4686808|NCT02522494|7594552|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2
4686809|NCT02522494|7594551|FG000|Overall Study|Participant did not watch the video|1
4686810|NCT02522494|7594552|FG001|Overall Study|Participant did not watch the video|0
4686811|NCT02522494|7594551|FG000|Overall Study|Death|0
4686812|NCT02522494|7594552|FG001|Overall Study|Death|1
4686813|NCT02522624|7594560|FG000|Overall Study|Technical failure|1
4686814|NCT02522624|7594561|FG001|Overall Study|Technical failure|0
4686815|NCT02522728|7594569|FG000|Overall Study|Withdrawal by Subject|6
4686816|NCT02522728|7594570|FG001|Overall Study|Withdrawal by Subject|6
4686817|NCT02522728|7594569|FG000|Overall Study|Death|4
4686818|NCT02522728|7594570|FG001|Overall Study|Death|3
4686819|NCT02522728|7594569|FG000|Overall Study|Adverse Event|2
4686820|NCT02522728|7594570|FG001|Overall Study|Adverse Event|1
4686821|NCT02522728|7594569|FG000|Overall Study|Did not receive randomized study device|0
4686822|NCT02522728|7594570|FG001|Overall Study|Did not receive randomized study device|1
4686823|NCT02522767|7594578|FG000|Double-blind|Withdrawal by Subject|8
4686824|NCT02522767|7594579|FG001|Double-blind|Withdrawal by Subject|11
4686825|NCT02522767|7594578|FG000|Double-blind|Lost to Follow-up|1
4686826|NCT02522767|7594579|FG001|Double-blind|Lost to Follow-up|0
4686827|NCT02522767|7594578|FG000|Double-blind|Adverse Event|1
4686828|NCT02522767|7594579|FG001|Double-blind|Adverse Event|10
4686829|NCT02522767|7594578|FG000|Double-blind|Protocol Violation|0
4686830|NCT02522767|7594579|FG001|Double-blind|Protocol Violation|1
4686831|NCT02522767|7594578|FG000|Double-blind|Lack of Efficacy|0
4686832|NCT02522767|7594579|FG001|Double-blind|Lack of Efficacy|2
4686833|NCT02522767|7594578|FG000|Double-blind|Protocol Deviation|1
4686834|NCT02522767|7594579|FG001|Double-blind|Protocol Deviation|0
4686835|NCT02522767|7594578|FG000|Open-label|Withdrawal by Subject|2
4686836|NCT02522767|7594579|FG001|Open-label|Withdrawal by Subject|3
4686837|NCT02522767|7594578|FG000|Open-label|Lost to Follow-up|0
4686838|NCT02522767|7594579|FG001|Open-label|Lost to Follow-up|1
4686839|NCT02522767|7594578|FG000|Open-label|Adverse Event|2
4686840|NCT02522767|7594579|FG001|Open-label|Adverse Event|1
4686841|NCT02522767|7594578|FG000|Open-label|Lack of Efficacy|1
4686842|NCT02522767|7594579|FG001|Open-label|Lack of Efficacy|1
4686843|NCT02522767|7594578|FG000|Open-label|Protocol Violation|0
4686844|NCT02522767|7594579|FG001|Open-label|Protocol Violation|1
4686845|NCT02522780|7594589|FG000|Overall Study|Consent withdrawn by subject|5
4686846|NCT02522780|7594590|FG001|Overall Study|Consent withdrawn by subject|7
4686847|NCT02522780|7594589|FG000|Overall Study|Protocol deviation|1
4686848|NCT02522780|7594590|FG001|Overall Study|Protocol deviation|3
4686849|NCT02522780|7594589|FG000|Overall Study|Subject refused endoscopic procedure|0
4686850|NCT02522780|7594590|FG001|Overall Study|Subject refused endoscopic procedure|1
4686851|NCT02522780|7594589|FG000|Overall Study|Adverse event, non-fatal|11
4686852|NCT02522780|7594590|FG001|Overall Study|Adverse event, non-fatal|16
4686853|NCT02522884|7594606|FG000|Overall Study|Withdrawal by Subject|6
4686854|NCT02522884|7594606|FG000|Overall Study|Death|3
4686855|NCT02522884|7594606|FG000|Overall Study|Missed 12-month Follow-up|9
4686856|NCT02523599|7594642|FG000|Overall Study|Adverse Event|1
4686857|NCT02523599|7594643|FG001|Overall Study|Adverse Event|0
4686858|NCT02523599|7594642|FG000|Overall Study|Physician Decision|1
4686859|NCT02523599|7594643|FG001|Overall Study|Physician Decision|0
4686860|NCT02523599|7594642|FG000|Overall Study|Lost to Follow-up|4
4686861|NCT02523599|7594643|FG001|Overall Study|Lost to Follow-up|1
4686862|NCT02523599|7594642|FG000|Overall Study|Did not return for Day 30 visit|2
4686863|NCT02523599|7594643|FG001|Overall Study|Did not return for Day 30 visit|0
4686864|NCT02524145|7594692|FG000|Overall Study|Withdrawal by Subject|2
4686865|NCT02524145|7594693|FG001|Overall Study|Withdrawal by Subject|2
4686866|NCT02524145|7594694|FG002|Overall Study|Withdrawal by Subject|3
4686867|NCT02524158|7594704|FG000|12-weeks Assessment|Withdrawal by Subject|1
4686868|NCT02524158|7594705|FG001|12-weeks Assessment|Withdrawal by Subject|1
4686869|NCT02524158|7594704|FG000|12-weeks Assessment|Lost to Follow-up|18
4686870|NCT02524158|7594705|FG001|12-weeks Assessment|Lost to Follow-up|12
4686871|NCT02524158|7594704|FG000|6-month Assessment|Withdrawal by Subject|1
4686872|NCT02524158|7594705|FG001|6-month Assessment|Withdrawal by Subject|1
4686873|NCT02524158|7594704|FG000|6-month Assessment|Lost to Follow-up|21
4686874|NCT02524158|7594705|FG001|6-month Assessment|Lost to Follow-up|20
4761344|NCT02899299|7735318|FG001|Treatment|Maximum Clinical Benefit|2
4761345|NCT02899299|7735317|FG000|Treatment|Poor/Non-compliance|1
4761346|NCT02899299|7735318|FG001|Treatment|Poor/Non-compliance|0
4761347|NCT02899299|7735317|FG000|Treatment|Participant no longer meets Study criteria|4
4761348|NCT02899299|7735318|FG001|Treatment|Participant no longer meets Study criteria|0
4761349|NCT02899299|7735317|FG000|Treatment|Administrative reason by Sponsor|2
4761350|NCT02899299|7735318|FG001|Treatment|Administrative reason by Sponsor|0
4761351|NCT02899299|7735317|FG000|Treatment|Other reasons|11
4761352|NCT02899299|7735318|FG001|Treatment|Other reasons|2
4686875|NCT02524665|7594734|FG000|Overall Study|Lost to Follow-up|1
4686876|NCT02524730|7594739|FG000|Overall Study|Lost to Follow-up|5
4686877|NCT02524730|7594739|FG000|Overall Study|Withdrawal by Subject|18
4686878|NCT02524730|7594739|FG000|Overall Study|Death|10
4686879|NCT02524730|7594739|FG000|Overall Study|Adverse Event|8
4686880|NCT02524730|7594739|FG000|Overall Study|Protocol Violation|1
4686881|NCT02524730|7594739|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4
4686882|NCT02524847|7594747|FG000|Overall Study|Adverse Event|4
4686883|NCT02524847|7594747|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4
4686884|NCT02524847|7594747|FG000|Overall Study|Condition no Longer Requires Treatment|4
4686885|NCT02524847|7594747|FG000|Overall Study|Death|1
4686886|NCT02524847|7594747|FG000|Overall Study|Reason not Specified|1
4686887|NCT02525094|7594790|FG000|Overall Study|Lost to Follow-up|2
4686888|NCT02525094|7594791|FG001|Overall Study|Lost to Follow-up|1
4686889|NCT02525094|7594790|FG000|Overall Study|Withdrawal by Subject|5
4686890|NCT02525094|7594791|FG001|Overall Study|Withdrawal by Subject|6
4686891|NCT02525094|7594790|FG000|Overall Study|Not Treated|1
4686892|NCT02525094|7594791|FG001|Overall Study|Not Treated|1
4686893|NCT02525133|7594800|FG000|Overall Study|Adverse Event|0
4686894|NCT02525133|7594801|FG001|Overall Study|Adverse Event|1
4686895|NCT02525133|7594800|FG000|Overall Study|Death|0
4686896|NCT02525133|7594801|FG001|Overall Study|Death|1
4686897|NCT02525133|7594800|FG000|Overall Study|did not meet randomization criteria|1
4686898|NCT02525133|7594801|FG001|Overall Study|did not meet randomization criteria|0
4686899|NCT02525133|7594800|FG000|Overall Study|Lost to Follow-up|5
4761353|NCT02899299|7735317|FG000|Treatment|Not reported: Includes participants who achieved max duration of treatment|4
4761354|NCT02899299|7735318|FG001|Treatment|Not reported: Includes participants who achieved max duration of treatment|189
4761355|NCT02891226|7735328|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4
4761356|NCT02891226|7735329|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1
4761357|NCT02891226|7735330|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3
4761358|NCT02891226|7735331|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0
4761359|NCT02891226|7735332|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0
4761360|NCT02891226|7735333|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0
4761361|NCT02891226|7735334|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0
4761362|NCT02891226|7735335|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0
4761363|NCT02891226|7735336|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0
4761364|NCT02891226|7735337|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0
4761365|NCT02891226|7735338|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0
4761366|NCT02891226|7735339|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0
4761367|NCT02891226|7735340|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0
4761368|NCT02891226|7735341|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0
4761369|NCT02891226|7735342|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0
4761370|NCT02891226|7735343|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0
4761371|NCT02891226|7735328|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1
4761372|NCT02891226|7735329|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1
4761373|NCT02891226|7735330|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
4761374|NCT02891226|7735331|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
4761375|NCT02891226|7735332|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
4761376|NCT02891226|7735333|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
4761377|NCT02891226|7735334|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
4761378|NCT02891226|7735335|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
4761379|NCT02891226|7735336|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
4761380|NCT02891226|7735337|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
4761381|NCT02891226|7735338|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
4761382|NCT02891226|7735339|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
4761383|NCT02891226|7735340|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
4761384|NCT02891226|7735341|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
4761385|NCT02891226|7735342|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
4761386|NCT02891226|7735343|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
4761387|NCT02891226|7735328|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
4761388|NCT02891226|7735329|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
4761389|NCT02891226|7735330|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
4761390|NCT02891226|7735331|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2
4761391|NCT02891226|7735332|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
4761392|NCT02891226|7735333|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
4761393|NCT02891226|7735334|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
4761394|NCT02891226|7735335|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
4761395|NCT02891226|7735336|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
4761396|NCT02891226|7735337|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
4761397|NCT02891226|7735338|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
4761398|NCT02891226|7735339|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
4686900|NCT02525133|7594801|FG001|Overall Study|Lost to Follow-up|1
4686901|NCT02525133|7594800|FG000|Overall Study|randomized not enrolled|3
4686902|NCT02525133|7594801|FG001|Overall Study|randomized not enrolled|0
4686903|NCT02525133|7594800|FG000|Overall Study|Withdrawal by Subject|1
4686904|NCT02525133|7594801|FG001|Overall Study|Withdrawal by Subject|0
4686905|NCT02525471|7594813|FG000|Overall Study|Screen Failure|6
4686906|NCT02525471|7594813|FG000|Overall Study|Withdrawal by Subject|4
4686907|NCT02525471|7594813|FG000|Overall Study|Death|1
4686908|NCT02525588|7594859|FG000|Overall Study|Death|3
4686909|NCT02525588|7594860|FG001|Overall Study|Death|1
4686910|NCT02525588|7594859|FG000|Overall Study|Lost to Follow-up|2
4686911|NCT02525588|7594860|FG001|Overall Study|Lost to Follow-up|0
4761399|NCT02891226|7735340|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
4761400|NCT02891226|7735341|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
4761401|NCT02891226|7735342|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
4761402|NCT02891226|7735343|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
4761403|NCT02891226|7735328|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
4761404|NCT02891226|7735329|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
4761405|NCT02891226|7735330|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1
4761406|NCT02891226|7735331|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
4761407|NCT02891226|7735332|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
4761408|NCT02891226|7735333|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
4761409|NCT02891226|7735334|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
4761410|NCT02891226|7735335|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
4761411|NCT02891226|7735336|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
4761412|NCT02891226|7735337|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
4761413|NCT02891226|7735338|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
4761414|NCT02891226|7735339|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
4761415|NCT02891226|7735340|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
4761416|NCT02891226|7735341|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
4761417|NCT02891226|7735342|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
4761418|NCT02891226|7735343|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0
4761419|NCT02891226|7735328|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
4761420|NCT02891226|7735329|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
4761421|NCT02891226|7735330|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
4761422|NCT02891226|7735331|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1
4761423|NCT02891226|7735332|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
4761424|NCT02891226|7735333|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
4686912|NCT02525588|7594859|FG000|Overall Study|Withdrawal by Subject|1
4686913|NCT02525588|7594860|FG001|Overall Study|Withdrawal by Subject|1
4686914|NCT02525588|7594859|FG000|Overall Study|Adverse Event|0
4686915|NCT02525588|7594860|FG001|Overall Study|Adverse Event|1
4686916|NCT02525627|7594868|FG000|Overall Study|Revision|1
4686917|NCT02525627|7594869|FG001|Overall Study|Revision|1
4761425|NCT02891226|7735334|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
4761426|NCT02891226|7735335|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
4761427|NCT02891226|7735336|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
4761428|NCT02891226|7735337|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
4761429|NCT02891226|7735338|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
4761430|NCT02891226|7735339|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
4761431|NCT02891226|7735340|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
4761432|NCT02891226|7735341|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
4761433|NCT02891226|7735342|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
4761434|NCT02891226|7735343|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0
4761435|NCT02891226|7735328|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
4761436|NCT02891226|7735329|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
4761437|NCT02891226|7735330|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
4761438|NCT02891226|7735331|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1
4761439|NCT02891226|7735332|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
4761440|NCT02891226|7735333|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
4686918|NCT02525627|7594868|FG000|Overall Study|Withdrawal by Subject|1
4686919|NCT02525627|7594869|FG001|Overall Study|Withdrawal by Subject|2
4686920|NCT02525627|7594868|FG000|Overall Study|Death|1
4686921|NCT02525627|7594869|FG001|Overall Study|Death|0
4686922|NCT02525627|7594868|FG000|Overall Study|Site terminated|11
4686923|NCT02525627|7594869|FG001|Overall Study|Site terminated|10
4686924|NCT02525744|7594888|FG000|Period 1|Physician Decision|0
4686925|NCT02525744|7594889|FG001|Period 1|Physician Decision|0
4686926|NCT02525744|7594890|FG002|Period 1|Physician Decision|1
4686927|NCT02525744|7594891|FG003|Period 1|Physician Decision|0
4686928|NCT02525744|7594888|FG000|Period 3|Adverse Event|0
4686929|NCT02525744|7594889|FG001|Period 3|Adverse Event|1
4686930|NCT02525744|7594890|FG002|Period 3|Adverse Event|0
4686931|NCT02525744|7594891|FG003|Period 3|Adverse Event|0
4686932|NCT02525744|7594888|FG000|Period 4|Withdrawal by Subject|1
4686933|NCT02525744|7594889|FG001|Period 4|Withdrawal by Subject|0
4686934|NCT02525744|7594890|FG002|Period 4|Withdrawal by Subject|0
4686935|NCT02525744|7594891|FG003|Period 4|Withdrawal by Subject|0
4686936|NCT02525744|7594888|FG000|Period 5|Physician Decision|1
4686937|NCT02525744|7594889|FG001|Period 5|Physician Decision|0
4686938|NCT02525744|7594890|FG002|Period 5|Physician Decision|0
4686939|NCT02525744|7594891|FG003|Period 5|Physician Decision|0
4761441|NCT02891226|7735334|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
4761442|NCT02891226|7735335|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
4761443|NCT02891226|7735336|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
4686940|NCT02525861|7594903|FG000|Overall Study|Adverse Event|1
4686941|NCT02525861|7594904|FG001|Overall Study|Adverse Event|0
4686942|NCT02525861|7594903|FG000|Overall Study|Withdrawal by Subject|0
4686943|NCT02525861|7594904|FG001|Overall Study|Withdrawal by Subject|1
4686944|NCT02525861|7594903|FG000|Overall Study|Physician Decision|0
4686945|NCT02525861|7594904|FG001|Overall Study|Physician Decision|1
4686946|NCT02525874|7594912|FG000|Overall Study|Other|1
4686947|NCT02525874|7594912|FG000|Overall Study|Investigator Decision|1
4686948|NCT02525874|7594912|FG000|Overall Study|Consent withdrawn|22
4686949|NCT02525874|7594912|FG000|Overall Study|Non-compliance with study drug|3
4686950|NCT02525874|7594912|FG000|Overall Study|Adverse Event|17
4686951|NCT02525874|7594912|FG000|Overall Study|Lost to Follow-up|7
4686952|NCT02525874|7594912|FG000|Overall Study|Disease progression, defined by protocol|2
4686953|NCT02525874|7594912|FG000|Overall Study|Disease relapse|4
4686954|NCT02525874|7594912|FG000|Overall Study|Alternative Treatment for MS|2
4686955|NCT02525874|7594912|FG000|Overall Study|New lesions in Brain|1
4686956|NCT02526160|7594918|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0
4686957|NCT02526160|7594919|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1
4686958|NCT02526160|7594918|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0
4686959|NCT02526160|7594919|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1
4686960|NCT02526160|7594918|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3
4686961|NCT02526160|7594919|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3
4686962|NCT02526160|7594918|FG000|Open-Label Treatment Extension Period I|Death|0
4686963|NCT02526160|7594919|FG001|Open-Label Treatment Extension Period I|Death|1
4686964|NCT02526160|7594918|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3
4686965|NCT02526160|7594919|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1
4686966|NCT02526160|7594918|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0
4686967|NCT02526160|7594919|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1
4686968|NCT02526160|7594918|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0
4686969|NCT02526160|7594919|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1
4686970|NCT02526160|7594918|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1
4686971|NCT02526160|7594919|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0
4686972|NCT02526212|7594932|FG000|Overall Study|Incarceration|1
4686973|NCT02526212|7594933|FG001|Overall Study|Incarceration|0
4686974|NCT02526212|7594932|FG000|Overall Study|Lost to Follow-up|1
4686975|NCT02526212|7594933|FG001|Overall Study|Lost to Follow-up|0
4686976|NCT02526212|7594932|FG000|Overall Study|Death|0
4761444|NCT02891226|7735337|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
4761445|NCT02891226|7735338|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
4761446|NCT02891226|7735339|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
4761447|NCT02891226|7735340|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
4761448|NCT02891226|7735341|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
4761449|NCT02891226|7735342|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
4761450|NCT02891226|7735343|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0
4761451|NCT02891226|7735328|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0
4761452|NCT02891226|7735329|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0
4761453|NCT02891226|7735330|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0
4761454|NCT02891226|7735331|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0
4761455|NCT02891226|7735332|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0
4761456|NCT02891226|7735333|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0
4761457|NCT02891226|7735334|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1
4761458|NCT02891226|7735335|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1
4761459|NCT02891226|7735336|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3
4761460|NCT02891226|7735337|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7
4761461|NCT02891226|7735338|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0
4761462|NCT02891226|7735339|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0
4761463|NCT02891226|7735340|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0
4761464|NCT02891226|7735341|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0
4761465|NCT02891226|7735342|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0
4761466|NCT02891226|7735343|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0
4761467|NCT02891226|7735328|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
4761468|NCT02891226|7735329|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
4761469|NCT02891226|7735330|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
4761470|NCT02891226|7735331|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
4761471|NCT02891226|7735332|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
4761472|NCT02891226|7735333|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1
4761473|NCT02891226|7735334|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
4761474|NCT02891226|7735335|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
4761475|NCT02891226|7735336|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
4761476|NCT02891226|7735337|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1
4761477|NCT02891226|7735338|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
4761478|NCT02891226|7735339|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
4761479|NCT02891226|7735340|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
4761480|NCT02891226|7735341|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
4761481|NCT02891226|7735342|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
4761482|NCT02891226|7735343|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0
4761483|NCT02891226|7735328|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
4761484|NCT02891226|7735329|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
4761485|NCT02891226|7735330|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
4761486|NCT02891226|7735331|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
4761487|NCT02891226|7735332|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
4686977|NCT02526212|7594933|FG001|Overall Study|Death|1
4686978|NCT02526290|7594959|FG000|Overall Study|Adverse Event|3
4686979|NCT02526290|7594959|FG000|Overall Study|Withdrawal by Subject|4
4686980|NCT02526290|7594959|FG000|Overall Study|Physician Decision|1
4686981|NCT02526524|7594969|FG000|Overall Study|Withdrawal by Subject|3
4686982|NCT02526524|7594970|FG001|Overall Study|Withdrawal by Subject|3
4686983|NCT02526524|7594971|FG002|Overall Study|Withdrawal by Subject|6
4686984|NCT02526524|7594972|FG003|Overall Study|Withdrawal by Subject|1
4686985|NCT02526524|7594973|FG004|Overall Study|Withdrawal by Subject|9
4686986|NCT02526524|7594974|FG005|Overall Study|Withdrawal by Subject|5
4686987|NCT02526524|7594969|FG000|Overall Study|Adverse Event|3
4686988|NCT02526524|7594970|FG001|Overall Study|Adverse Event|2
4686989|NCT02526524|7594971|FG002|Overall Study|Adverse Event|4
4686990|NCT02526524|7594972|FG003|Overall Study|Adverse Event|2
4686991|NCT02526524|7594973|FG004|Overall Study|Adverse Event|6
4686992|NCT02526524|7594974|FG005|Overall Study|Adverse Event|8
4686993|NCT02526524|7594969|FG000|Overall Study|Lost to Follow-up|2
4686994|NCT02526524|7594970|FG001|Overall Study|Lost to Follow-up|3
4686995|NCT02526524|7594971|FG002|Overall Study|Lost to Follow-up|8
4686996|NCT02526524|7594972|FG003|Overall Study|Lost to Follow-up|1
4686997|NCT02526524|7594973|FG004|Overall Study|Lost to Follow-up|2
4686998|NCT02526524|7594974|FG005|Overall Study|Lost to Follow-up|5
4686999|NCT02526524|7594969|FG000|Overall Study|Protocol Violation|3
4687000|NCT02526524|7594970|FG001|Overall Study|Protocol Violation|1
4687001|NCT02526524|7594971|FG002|Overall Study|Protocol Violation|5
4687002|NCT02526524|7594972|FG003|Overall Study|Protocol Violation|3
4687003|NCT02526524|7594973|FG004|Overall Study|Protocol Violation|4
4687004|NCT02526524|7594974|FG005|Overall Study|Protocol Violation|3
4687005|NCT02526524|7594969|FG000|Overall Study|Loss of Glucose Control|0
4687006|NCT02526524|7594970|FG001|Overall Study|Loss of Glucose Control|0
4687007|NCT02526524|7594971|FG002|Overall Study|Loss of Glucose Control|3
4687008|NCT02526524|7594972|FG003|Overall Study|Loss of Glucose Control|0
4687009|NCT02526524|7594973|FG004|Overall Study|Loss of Glucose Control|2
4687010|NCT02526524|7594974|FG005|Overall Study|Loss of Glucose Control|0
4687011|NCT02526524|7594969|FG000|Overall Study|Physician Decision|0
4687012|NCT02526524|7594970|FG001|Overall Study|Physician Decision|0
4687013|NCT02526524|7594971|FG002|Overall Study|Physician Decision|0
4687014|NCT02526524|7594972|FG003|Overall Study|Physician Decision|0
4687015|NCT02526524|7594973|FG004|Overall Study|Physician Decision|1
4687016|NCT02526524|7594974|FG005|Overall Study|Physician Decision|0
4687017|NCT02526524|7594969|FG000|Overall Study|Sponsor Decision|1
4687018|NCT02526524|7594970|FG001|Overall Study|Sponsor Decision|0
4687019|NCT02526524|7594971|FG002|Overall Study|Sponsor Decision|0
4687020|NCT02526524|7594972|FG003|Overall Study|Sponsor Decision|0
4687021|NCT02526524|7594973|FG004|Overall Study|Sponsor Decision|0
4687022|NCT02526524|7594974|FG005|Overall Study|Sponsor Decision|0
4687023|NCT02526550|7594988|FG000|Overall Study|Lost to Follow-up|1
4687024|NCT02526693|7595027|FG000|Overall Study|Physician Decision|3
4687025|NCT02526693|7595028|FG001|Overall Study|Physician Decision|1
4687026|NCT02527148|7595040|FG000|Overall Study|Did not receive study intervention|1
4687027|NCT02527148|7595041|FG001|Overall Study|Did not receive study intervention|0
4687028|NCT02527161|7595049|FG000|Overall Study|Failed MRI|52
4687029|NCT02527161|7595049|FG000|Overall Study|Withdrawal by Subject|19
4687030|NCT02527161|7595049|FG000|Overall Study|Delay in or unfit for surgery|16
4687031|NCT02527161|7595049|FG000|Overall Study|MRI contraindication|6
4687032|NCT02527161|7595049|FG000|Overall Study|Consent violation|4
4687033|NCT02527161|7595049|FG000|Overall Study|Only Recruited to Part A|27
4687034|NCT02527161|7595049|FG000|Overall Study|Physician Decision|1
4687035|NCT02527161|7595049|FG000|Overall Study|Adverse Event|1
4687036|NCT02527161|7595049|FG000|Overall Study|Lost to Follow-up|6
4687037|NCT02527343|7595065|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1
4687038|NCT02527343|7595066|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0
4687039|NCT02527343|7595067|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0
4687040|NCT02527343|7595068|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0
4687041|NCT02527343|7595069|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0
4687042|NCT02527343|7595070|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0
4687043|NCT02527343|7595065|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1
4687044|NCT02527343|7595066|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0
4687045|NCT02527343|7595067|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0
4687046|NCT02527343|7595068|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0
4687047|NCT02527343|7595069|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0
4687048|NCT02527343|7595070|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0
4687049|NCT02527343|7595065|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0
4687050|NCT02527343|7595066|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4
4687051|NCT02527343|7595067|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0
4687052|NCT02527343|7595068|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0
4687053|NCT02527343|7595069|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0
4687054|NCT02527343|7595070|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0
4687055|NCT02527343|7595065|FG000|RT Period: Weeks 1 to 52|Other|4
4687056|NCT02527343|7595066|FG001|RT Period: Weeks 1 to 52|Other|3
4687057|NCT02527343|7595067|FG002|RT Period: Weeks 1 to 52|Other|0
4687058|NCT02527343|7595068|FG003|RT Period: Weeks 1 to 52|Other|0
4687059|NCT02527343|7595069|FG004|RT Period: Weeks 1 to 52|Other|0
4687060|NCT02527343|7595070|FG005|RT Period: Weeks 1 to 52|Other|0
4687061|NCT02527343|7595065|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0
4687062|NCT02527343|7595066|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0
4687063|NCT02527343|7595067|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1
4687064|NCT02527343|7595068|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0
4687065|NCT02527343|7595069|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0
4687066|NCT02527343|7595070|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0
4687067|NCT02527343|7595065|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0
4687068|NCT02527343|7595066|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0
4687069|NCT02527343|7595067|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0
4687070|NCT02527343|7595068|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2
4687071|NCT02527343|7595069|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0
4687072|NCT02527343|7595070|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0
4687073|NCT02527343|7595065|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0
4687074|NCT02527343|7595066|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0
4687075|NCT02527343|7595067|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0
4687076|NCT02527343|7595068|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0
4687077|NCT02527343|7595069|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1
4687078|NCT02527343|7595070|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0
4687079|NCT02527343|7595065|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0
4687080|NCT02527343|7595066|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0
4687081|NCT02527343|7595067|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0
4687082|NCT02527343|7595068|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0
4687083|NCT02527343|7595069|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3
4687084|NCT02527343|7595070|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1
4687085|NCT02527343|7595065|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0
4687086|NCT02527343|7595066|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0
4687087|NCT02527343|7595067|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0
4687088|NCT02527343|7595068|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0
4687089|NCT02527343|7595069|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2
4687090|NCT02527343|7595070|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1
4687091|NCT02527343|7595065|FG000|OLE Period-Year 1: Week 53 to 104|Other|0
4687092|NCT02527343|7595066|FG001|OLE Period-Year 1: Week 53 to 104|Other|0
4687093|NCT02527343|7595067|FG002|OLE Period-Year 1: Week 53 to 104|Other|0
4687094|NCT02527343|7595068|FG003|OLE Period-Year 1: Week 53 to 104|Other|0
4687095|NCT02527343|7595069|FG004|OLE Period-Year 1: Week 53 to 104|Other|5
4687096|NCT02527343|7595070|FG005|OLE Period-Year 1: Week 53 to 104|Other|7
4687097|NCT02527343|7595065|FG000|OLE Period-Year 2: Week 105 to 156|Other|0
4687098|NCT02527343|7595066|FG001|OLE Period-Year 2: Week 105 to 156|Other|0
4687099|NCT02527343|7595067|FG002|OLE Period-Year 2: Week 105 to 156|Other|0
4687100|NCT02527343|7595068|FG003|OLE Period-Year 2: Week 105 to 156|Other|0
4687101|NCT02527343|7595069|FG004|OLE Period-Year 2: Week 105 to 156|Other|1
4687102|NCT02527343|7595070|FG005|OLE Period-Year 2: Week 105 to 156|Other|2
4687103|NCT02527343|7595065|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0
4687104|NCT02527343|7595066|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0
4687105|NCT02527343|7595067|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0
4687106|NCT02527343|7595068|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0
4687107|NCT02527343|7595069|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1
4687108|NCT02527343|7595070|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0
4687109|NCT02527343|7595065|FG000|PT Follow-up: Weeks 104 to 169|Other|0
4687110|NCT02527343|7595066|FG001|PT Follow-up: Weeks 104 to 169|Other|0
4687111|NCT02527343|7595067|FG002|PT Follow-up: Weeks 104 to 169|Other|0
4687112|NCT02527343|7595068|FG003|PT Follow-up: Weeks 104 to 169|Other|0
4687113|NCT02527343|7595069|FG004|PT Follow-up: Weeks 104 to 169|Other|0
4687114|NCT02527343|7595070|FG005|PT Follow-up: Weeks 104 to 169|Other|1
4687115|NCT02527421|7595087|FG000|Overall Study|Withdrawal by Subject|1
4687116|NCT02527421|7595088|FG001|Overall Study|Withdrawal by Subject|0
4687117|NCT02528188|7595121|FG000|Overall Study|Adverse Event|23
4687118|NCT02528188|7595122|FG001|Overall Study|Adverse Event|22
4687119|NCT02528188|7595123|FG002|Overall Study|Adverse Event|8
4687120|NCT02528188|7595121|FG000|Overall Study|Protocol Violation|4
4687121|NCT02528188|7595122|FG001|Overall Study|Protocol Violation|6
4687122|NCT02528188|7595123|FG002|Overall Study|Protocol Violation|4
4687123|NCT02528188|7595121|FG000|Overall Study|Lack of Efficacy|19
4687124|NCT02528188|7595122|FG001|Overall Study|Lack of Efficacy|21
4687125|NCT02528188|7595123|FG002|Overall Study|Lack of Efficacy|22
4687126|NCT02528188|7595121|FG000|Overall Study|Withdrawal by Subject|97
4687127|NCT02528188|7595122|FG001|Overall Study|Withdrawal by Subject|104
4687128|NCT02528188|7595123|FG002|Overall Study|Withdrawal by Subject|100
4687129|NCT02528188|7595121|FG000|Overall Study|Lost to Follow-up|25
4687130|NCT02528188|7595122|FG001|Overall Study|Lost to Follow-up|21
4687131|NCT02528188|7595123|FG002|Overall Study|Lost to Follow-up|31
4687132|NCT02528188|7595121|FG000|Overall Study|Death|4
4687133|NCT02528188|7595122|FG001|Overall Study|Death|4
4687134|NCT02528188|7595123|FG002|Overall Study|Death|0
4687135|NCT02528188|7595121|FG000|Overall Study|Other|89
4687136|NCT02528188|7595122|FG001|Overall Study|Other|91
4687137|NCT02528188|7595123|FG002|Overall Study|Other|74
4687138|NCT02528188|7595121|FG000|Overall Study|Randomized but not treated|6
4687139|NCT02528188|7595122|FG001|Overall Study|Randomized but not treated|7
4687140|NCT02528188|7595123|FG002|Overall Study|Randomized but not treated|12
4687141|NCT02528214|7595133|FG000|Overall Study|Protocol Violation|0
4687142|NCT02528214|7595134|FG001|Overall Study|Protocol Violation|1
4687143|NCT02528214|7595133|FG000|Overall Study|Adverse Event|0
4687144|NCT02528214|7595134|FG001|Overall Study|Adverse Event|1
4761488|NCT02891226|7735333|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
4761489|NCT02891226|7735334|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1
4761490|NCT02891226|7735335|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2
4761491|NCT02891226|7735336|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1
4761492|NCT02891226|7735337|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6
4761493|NCT02891226|7735338|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
4761494|NCT02891226|7735339|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
4761495|NCT02891226|7735340|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
4761496|NCT02891226|7735341|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
4761497|NCT02891226|7735342|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
4761498|NCT02891226|7735343|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0
4761499|NCT02891226|7735328|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
4761500|NCT02891226|7735329|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
4761501|NCT02891226|7735330|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
4761502|NCT02891226|7735331|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
4761503|NCT02891226|7735332|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1
4761504|NCT02891226|7735333|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
4761505|NCT02891226|7735334|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
4761506|NCT02891226|7735335|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
4761507|NCT02891226|7735336|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
4761508|NCT02891226|7735337|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
4761509|NCT02891226|7735338|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
4761510|NCT02891226|7735339|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
4761511|NCT02891226|7735340|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
4761512|NCT02891226|7735341|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
4761513|NCT02891226|7735342|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
4761514|NCT02891226|7735343|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0
4761515|NCT02891226|7735328|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
4761516|NCT02891226|7735329|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
4761517|NCT02891226|7735330|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
4761518|NCT02891226|7735331|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
4761519|NCT02891226|7735332|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
4761520|NCT02891226|7735333|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
4761521|NCT02891226|7735334|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1
4761522|NCT02891226|7735335|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
4761523|NCT02891226|7735336|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
4761524|NCT02891226|7735337|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
4761525|NCT02891226|7735338|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
4761526|NCT02891226|7735339|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
4761527|NCT02891226|7735340|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
4761528|NCT02891226|7735341|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
4761529|NCT02891226|7735342|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
4761530|NCT02891226|7735343|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0
4761531|NCT02891226|7735328|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
4761532|NCT02891226|7735329|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
4761533|NCT02891226|7735330|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
4761534|NCT02891226|7735331|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
4761535|NCT02891226|7735332|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
4761536|NCT02891226|7735333|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
4761537|NCT02891226|7735334|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
4761538|NCT02891226|7735335|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1
4761539|NCT02891226|7735336|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1
4761540|NCT02891226|7735337|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1
4761541|NCT02891226|7735338|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
4761542|NCT02891226|7735339|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
4761543|NCT02891226|7735340|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
4761544|NCT02891226|7735341|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
4761545|NCT02891226|7735342|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
4761546|NCT02891226|7735343|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0
4761547|NCT02891226|7735328|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
4687145|NCT02528214|7595133|FG000|Overall Study|Other than specified above|0
4687146|NCT02528214|7595134|FG001|Overall Study|Other than specified above|1
4687147|NCT02528253|7595146|FG000|Overall Study|Adverse Event|3
4687148|NCT02528253|7595147|FG001|Overall Study|Adverse Event|4
4687149|NCT02528253|7595148|FG002|Overall Study|Adverse Event|4
4687150|NCT02528253|7595149|FG003|Overall Study|Adverse Event|8
4687151|NCT02528253|7595150|FG004|Overall Study|Adverse Event|18
4687152|NCT02528253|7595146|FG000|Overall Study|Death|2
4687153|NCT02528253|7595147|FG001|Overall Study|Death|2
4687154|NCT02528253|7595148|FG002|Overall Study|Death|1
4687155|NCT02528253|7595149|FG003|Overall Study|Death|0
4687156|NCT02528253|7595150|FG004|Overall Study|Death|1
4687157|NCT02528253|7595146|FG000|Overall Study|Insufficient clinical response|7
4687158|NCT02528253|7595147|FG001|Overall Study|Insufficient clinical response|10
4687159|NCT02528253|7595148|FG002|Overall Study|Insufficient clinical response|13
4687160|NCT02528253|7595149|FG003|Overall Study|Insufficient clinical response|12
4687161|NCT02528253|7595150|FG004|Overall Study|Insufficient clinical response|16
4687162|NCT02528253|7595146|FG000|Overall Study|Lost to Follow-up|16
4687163|NCT02528253|7595147|FG001|Overall Study|Lost to Follow-up|9
4687164|NCT02528253|7595148|FG002|Overall Study|Lost to Follow-up|31
4687165|NCT02528253|7595149|FG003|Overall Study|Lost to Follow-up|16
4687166|NCT02528253|7595150|FG004|Overall Study|Lost to Follow-up|34
4687167|NCT02528253|7595146|FG000|Overall Study|Other|21
4687168|NCT02528253|7595147|FG001|Overall Study|Other|22
4687169|NCT02528253|7595148|FG002|Overall Study|Other|58
4687170|NCT02528253|7595149|FG003|Overall Study|Other|52
4687171|NCT02528253|7595150|FG004|Overall Study|Other|76
4687172|NCT02528253|7595146|FG000|Overall Study|Withdrawal by Subject|25
4687173|NCT02528253|7595147|FG001|Overall Study|Withdrawal by Subject|20
4687174|NCT02528253|7595148|FG002|Overall Study|Withdrawal by Subject|29
4687175|NCT02528253|7595149|FG003|Overall Study|Withdrawal by Subject|48
4761548|NCT02891226|7735329|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
4761549|NCT02891226|7735330|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
4761550|NCT02891226|7735331|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
4761551|NCT02891226|7735332|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
4761552|NCT02891226|7735333|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
4761553|NCT02891226|7735334|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
4761554|NCT02891226|7735335|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1
4761555|NCT02891226|7735336|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
4761556|NCT02891226|7735337|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
4761557|NCT02891226|7735338|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
4761558|NCT02891226|7735339|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
4761559|NCT02891226|7735340|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
4687176|NCT02528253|7595150|FG004|Overall Study|Withdrawal by Subject|73
4687177|NCT02528253|7595146|FG000|Overall Study|Protocol Violation|1
4687178|NCT02528253|7595147|FG001|Overall Study|Protocol Violation|2
4687179|NCT02528253|7595148|FG002|Overall Study|Protocol Violation|4
4687180|NCT02528253|7595149|FG003|Overall Study|Protocol Violation|0
4687181|NCT02528253|7595150|FG004|Overall Study|Protocol Violation|4
4687182|NCT02528253|7595146|FG000|Overall Study|Withdrawn Due to Pregnancy|0
4687183|NCT02528253|7595147|FG001|Overall Study|Withdrawn Due to Pregnancy|1
4687184|NCT02528253|7595148|FG002|Overall Study|Withdrawn Due to Pregnancy|0
4687185|NCT02528253|7595149|FG003|Overall Study|Withdrawn Due to Pregnancy|0
4687186|NCT02528253|7595150|FG004|Overall Study|Withdrawn Due to Pregnancy|1
4687187|NCT02528305|7595181|FG000|Overall Study|Withdrawal by Subject|1
4687188|NCT02528305|7595181|FG000|Overall Study|Adverse Event|1
4687189|NCT02528305|7595181|FG000|Overall Study|Physician Decision|1
4687190|NCT02528331|7595208|FG000|Overall Study|Withdrawal by Subject|2
4687191|NCT02528357|7595231|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
4687192|NCT02528357|7595232|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1
4687193|NCT02528357|7595233|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
4687194|NCT02528357|7595234|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
4687195|NCT02528357|7595235|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
4687196|NCT02528357|7595236|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
4687197|NCT02528357|7595237|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
4687198|NCT02528357|7595238|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
4687199|NCT02528357|7595239|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
4687200|NCT02528357|7595240|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
4687201|NCT02528357|7595241|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
4687202|NCT02528357|7595242|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
4687203|NCT02528357|7595243|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
4687204|NCT02528357|7595244|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
4687205|NCT02528357|7595245|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
4687206|NCT02528357|7595246|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
4687207|NCT02528357|7595247|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
4687208|NCT02528357|7595248|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
4687209|NCT02528357|7595249|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0
4687210|NCT02528357|7595231|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
4687211|NCT02528357|7595232|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
4687212|NCT02528357|7595233|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
4687213|NCT02528357|7595234|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1
4687214|NCT02528357|7595235|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
4687215|NCT02528357|7595236|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2
4687216|NCT02528357|7595237|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
4687217|NCT02528357|7595238|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1
4687218|NCT02528357|7595239|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
4687219|NCT02528357|7595240|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
4687220|NCT02528357|7595241|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
4687221|NCT02528357|7595242|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
4687222|NCT02528357|7595243|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
4687223|NCT02528357|7595244|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
4687224|NCT02528357|7595245|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
4687225|NCT02528357|7595246|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
4687226|NCT02528357|7595247|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
4687227|NCT02528357|7595248|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
4687228|NCT02528357|7595249|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0
4687229|NCT02528357|7595231|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
4687230|NCT02528357|7595232|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
4687231|NCT02528357|7595233|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2
4687232|NCT02528357|7595234|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
4761560|NCT02891226|7735341|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
4761561|NCT02891226|7735342|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
4761562|NCT02891226|7735343|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0
4761563|NCT02891226|7735328|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
4761564|NCT02891226|7735329|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
4761565|NCT02891226|7735330|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
4761566|NCT02891226|7735331|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
4761567|NCT02891226|7735332|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
4761568|NCT02891226|7735333|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
4761569|NCT02891226|7735334|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
4761570|NCT02891226|7735335|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
4761571|NCT02891226|7735336|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1
4761572|NCT02891226|7735337|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
4761573|NCT02891226|7735338|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
4761574|NCT02891226|7735339|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
4761575|NCT02891226|7735340|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
4761576|NCT02891226|7735341|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
4761577|NCT02891226|7735342|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
4761578|NCT02891226|7735343|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0
4761579|NCT02891226|7735328|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
4761580|NCT02891226|7735329|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
4761581|NCT02891226|7735330|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
4761582|NCT02891226|7735331|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
4761583|NCT02891226|7735332|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
4761584|NCT02891226|7735333|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
4761585|NCT02891226|7735334|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
4761586|NCT02891226|7735335|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
4761587|NCT02891226|7735336|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
4761588|NCT02891226|7735337|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1
4761589|NCT02891226|7735338|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
4761590|NCT02891226|7735339|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
4761591|NCT02891226|7735340|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
4761592|NCT02891226|7735341|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
4761593|NCT02891226|7735342|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
4761594|NCT02891226|7735343|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0
4761595|NCT02891226|7735328|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
4761596|NCT02891226|7735329|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
4761597|NCT02891226|7735330|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
4761598|NCT02891226|7735331|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
4761599|NCT02891226|7735332|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
4687233|NCT02528357|7595235|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3
4687234|NCT02528357|7595236|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
4687235|NCT02528357|7595237|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2
4687236|NCT02528357|7595238|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1
4687237|NCT02528357|7595239|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
4687238|NCT02528357|7595240|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
4687239|NCT02528357|7595241|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
4687240|NCT02528357|7595242|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
4687241|NCT02528357|7595243|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
4687242|NCT02528357|7595244|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
4687243|NCT02528357|7595245|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
4687244|NCT02528357|7595246|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
4687245|NCT02528357|7595247|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
4687246|NCT02528357|7595248|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
4687247|NCT02528357|7595249|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0
4687248|NCT02528357|7595231|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
4687249|NCT02528357|7595232|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
4687250|NCT02528357|7595233|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
4687251|NCT02528357|7595234|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
4687252|NCT02528357|7595235|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1
4761600|NCT02891226|7735333|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
4761601|NCT02891226|7735334|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
4761602|NCT02891226|7735335|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
4761603|NCT02891226|7735336|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
4761604|NCT02891226|7735337|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1
4761605|NCT02891226|7735338|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
4761606|NCT02891226|7735339|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
4761607|NCT02891226|7735340|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
4761608|NCT02891226|7735341|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
4761609|NCT02891226|7735342|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
4761610|NCT02891226|7735343|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0
4761611|NCT02891226|7735328|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0
4761612|NCT02891226|7735329|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0
4761613|NCT02891226|7735330|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0
4761614|NCT02891226|7735331|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0
4761615|NCT02891226|7735332|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0
4761616|NCT02891226|7735333|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0
4761617|NCT02891226|7735334|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0
4761618|NCT02891226|7735335|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0
4761619|NCT02891226|7735336|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0
4761620|NCT02891226|7735337|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0
4761621|NCT02891226|7735338|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5
4761622|NCT02891226|7735339|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0
4761623|NCT02891226|7735340|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0
4761624|NCT02891226|7735341|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0
4761625|NCT02891226|7735342|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0
4761626|NCT02891226|7735343|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0
4761627|NCT02891226|7735328|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
4761628|NCT02891226|7735329|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
4761629|NCT02891226|7735330|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
4761630|NCT02891226|7735331|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
4761631|NCT02891226|7735332|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
4761632|NCT02891226|7735333|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
4761633|NCT02891226|7735334|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
4761634|NCT02891226|7735335|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
4761635|NCT02891226|7735336|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
4761636|NCT02891226|7735337|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
4761637|NCT02891226|7735338|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1
4761638|NCT02891226|7735339|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
4761639|NCT02891226|7735340|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
4761640|NCT02891226|7735341|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
4761641|NCT02891226|7735342|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
4761642|NCT02891226|7735343|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0
4761643|NCT02891226|7735328|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
4761644|NCT02891226|7735329|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
4761645|NCT02891226|7735330|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
4761646|NCT02891226|7735331|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
4761647|NCT02891226|7735332|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
4761648|NCT02891226|7735333|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
4761649|NCT02891226|7735334|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
4761650|NCT02891226|7735335|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
4761651|NCT02891226|7735336|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
4761652|NCT02891226|7735337|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
4761653|NCT02891226|7735338|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14
4687253|NCT02528357|7595236|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
4687254|NCT02528357|7595237|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
4687255|NCT02528357|7595238|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
4687256|NCT02528357|7595239|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
4687257|NCT02528357|7595240|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
4687258|NCT02528357|7595241|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
4687259|NCT02528357|7595242|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
4687260|NCT02528357|7595243|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
4687261|NCT02528357|7595244|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
4687262|NCT02528357|7595245|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
4687263|NCT02528357|7595246|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
4687264|NCT02528357|7595247|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
4687265|NCT02528357|7595248|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
4687266|NCT02528357|7595249|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0
4687267|NCT02528357|7595231|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
4687268|NCT02528357|7595232|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
4687269|NCT02528357|7595233|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
4687270|NCT02528357|7595234|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
4761654|NCT02891226|7735339|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
4761655|NCT02891226|7735340|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
4761656|NCT02891226|7735341|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
4761657|NCT02891226|7735342|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
4761658|NCT02891226|7735343|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0
4761659|NCT02891226|7735328|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
4761660|NCT02891226|7735329|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
4761661|NCT02891226|7735330|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
4761662|NCT02891226|7735331|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
4761663|NCT02891226|7735332|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
4761664|NCT02891226|7735333|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
4761665|NCT02891226|7735334|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
4761666|NCT02891226|7735335|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
4761667|NCT02891226|7735336|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
4761668|NCT02891226|7735337|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
4761669|NCT02891226|7735338|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108
4761670|NCT02891226|7735339|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
4761671|NCT02891226|7735340|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
4761672|NCT02891226|7735341|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
4761673|NCT02891226|7735342|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
4761674|NCT02891226|7735343|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0
4761675|NCT02891226|7735328|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
4761676|NCT02891226|7735329|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
4761677|NCT02891226|7735330|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
4761678|NCT02891226|7735331|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
4761679|NCT02891226|7735332|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
4761680|NCT02891226|7735333|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
4761681|NCT02891226|7735334|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
4761682|NCT02891226|7735335|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
4761683|NCT02891226|7735336|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
4761684|NCT02891226|7735337|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
4687271|NCT02528357|7595235|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
4687272|NCT02528357|7595236|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
4687273|NCT02528357|7595237|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
4687274|NCT02528357|7595238|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
4687275|NCT02528357|7595239|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
4687276|NCT02528357|7595240|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
4687277|NCT02528357|7595241|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
4687278|NCT02528357|7595242|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
4687279|NCT02528357|7595243|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
4687280|NCT02528357|7595244|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1
4687281|NCT02528357|7595245|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5
4687282|NCT02528357|7595246|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
4687283|NCT02528357|7595247|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
4687284|NCT02528357|7595248|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
4687285|NCT02528357|7595249|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0
4687286|NCT02528357|7595231|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
4687287|NCT02528357|7595232|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
4687288|NCT02528357|7595233|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
4687289|NCT02528357|7595234|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
4687290|NCT02528357|7595235|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
4687291|NCT02528357|7595236|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
4687292|NCT02528357|7595237|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
4687293|NCT02528357|7595238|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
4687294|NCT02528357|7595239|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
4687295|NCT02528357|7595240|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
4687296|NCT02528357|7595241|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
4687297|NCT02528357|7595242|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
4687298|NCT02528357|7595243|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
4687299|NCT02528357|7595244|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1
4761685|NCT02891226|7735338|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2
4761686|NCT02891226|7735339|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
4761687|NCT02891226|7735340|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
4761688|NCT02891226|7735341|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
4761689|NCT02891226|7735342|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
4761690|NCT02891226|7735343|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0
4761691|NCT02891226|7735328|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
4761692|NCT02891226|7735329|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
4761693|NCT02891226|7735330|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
4761694|NCT02891226|7735331|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
4761695|NCT02891226|7735332|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
4761696|NCT02891226|7735333|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
4761697|NCT02891226|7735334|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
4761698|NCT02891226|7735335|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
4761699|NCT02891226|7735336|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
4761700|NCT02891226|7735337|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
4761701|NCT02891226|7735338|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3
4687300|NCT02528357|7595245|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
4687301|NCT02528357|7595246|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
4687302|NCT02528357|7595247|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
4687303|NCT02528357|7595248|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
4687304|NCT02528357|7595249|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0
4687305|NCT02528357|7595231|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
4687306|NCT02528357|7595232|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
4687307|NCT02528357|7595233|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
4687308|NCT02528357|7595234|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
4687309|NCT02528357|7595235|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
4687310|NCT02528357|7595236|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
4687311|NCT02528357|7595237|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
4687312|NCT02528357|7595238|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
4687313|NCT02528357|7595239|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
4687314|NCT02528357|7595240|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
4687315|NCT02528357|7595241|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3
4687316|NCT02528357|7595242|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
4687317|NCT02528357|7595243|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1
4687318|NCT02528357|7595244|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3
4687319|NCT02528357|7595245|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1
4687320|NCT02528357|7595246|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
4687321|NCT02528357|7595247|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
4687322|NCT02528357|7595248|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
4687323|NCT02528357|7595249|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0
4687324|NCT02528357|7595231|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
4687325|NCT02528357|7595232|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
4687326|NCT02528357|7595233|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
4687327|NCT02528357|7595234|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
4687328|NCT02528357|7595235|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
4687329|NCT02528357|7595236|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
4687330|NCT02528357|7595237|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
4687331|NCT02528357|7595238|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
4687332|NCT02528357|7595239|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1
4687333|NCT02528357|7595240|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1
4687334|NCT02528357|7595241|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
4687335|NCT02528357|7595242|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3
4687336|NCT02528357|7595243|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4
4687337|NCT02528357|7595244|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1
4687338|NCT02528357|7595245|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1
4687339|NCT02528357|7595246|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
4687340|NCT02528357|7595247|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
4687341|NCT02528357|7595248|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
4687342|NCT02528357|7595249|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0
4687343|NCT02528357|7595231|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
4687344|NCT02528357|7595232|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
4687345|NCT02528357|7595233|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
4687346|NCT02528357|7595234|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
4687347|NCT02528357|7595235|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
4687348|NCT02528357|7595236|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
4687349|NCT02528357|7595237|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
4687350|NCT02528357|7595238|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
4761702|NCT02891226|7735339|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
4761703|NCT02891226|7735340|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
4761704|NCT02891226|7735341|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
4761705|NCT02891226|7735342|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
4761706|NCT02891226|7735343|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0
4761707|NCT02891226|7735328|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
4761708|NCT02891226|7735329|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
4761709|NCT02891226|7735330|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
4761710|NCT02891226|7735331|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
4687351|NCT02528357|7595239|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
4687352|NCT02528357|7595240|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
4687353|NCT02528357|7595241|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
4687354|NCT02528357|7595242|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
4687355|NCT02528357|7595243|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
4687356|NCT02528357|7595244|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
4687357|NCT02528357|7595245|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
4687358|NCT02528357|7595246|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
4687359|NCT02528357|7595247|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2
4687360|NCT02528357|7595248|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
4687361|NCT02528357|7595249|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0
4687362|NCT02528357|7595231|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
4687363|NCT02528357|7595232|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
4687364|NCT02528357|7595233|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
4687365|NCT02528357|7595234|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
4687366|NCT02528357|7595235|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
4687367|NCT02528357|7595236|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
4687368|NCT02528357|7595237|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
4687369|NCT02528357|7595238|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
4687370|NCT02528357|7595239|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
4687371|NCT02528357|7595240|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
4687372|NCT02528357|7595241|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
4687373|NCT02528357|7595242|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
4687374|NCT02528357|7595243|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
4687375|NCT02528357|7595244|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
4687376|NCT02528357|7595245|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
4687377|NCT02528357|7595246|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0
4687378|NCT02528357|7595247|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1
4687379|NCT02528357|7595248|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4
4687380|NCT02528357|7595249|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3
4687381|NCT02528942|7595320|FG000|Overall Study|Did not meet imaging criteria|9
4687382|NCT02528942|7595320|FG000|Overall Study|Lost to Follow-up|25
4687383|NCT02529137|7595333|FG000|Overall Study|Discontinuation for different reasons|8
4687384|NCT02529488|7595338|FG000|Overall Study|Adverse Event|1
4687385|NCT02529488|7595338|FG000|Overall Study|Death|3
4687386|NCT02529553|7595355|FG000|Overall Study|Progressive Disease|1
4687387|NCT02529553|7595356|FG001|Overall Study|Progressive Disease|0
4687388|NCT02529553|7595357|FG002|Overall Study|Progressive Disease|1
4687389|NCT02529553|7595358|FG003|Overall Study|Progressive Disease|3
4687390|NCT02529553|7595359|FG004|Overall Study|Progressive Disease|2
4687391|NCT02529553|7595360|FG005|Overall Study|Progressive Disease|3
4687392|NCT02529553|7595361|FG006|Overall Study|Progressive Disease|3
4687393|NCT02529553|7595362|FG007|Overall Study|Progressive Disease|5
4687394|NCT02529553|7595363|FG008|Overall Study|Progressive Disease|3
4687395|NCT02529553|7595355|FG000|Overall Study|Physician Decision|0
4687396|NCT02529553|7595356|FG001|Overall Study|Physician Decision|1
4687397|NCT02529553|7595357|FG002|Overall Study|Physician Decision|0
4687398|NCT02529553|7595358|FG003|Overall Study|Physician Decision|0
4687399|NCT02529553|7595359|FG004|Overall Study|Physician Decision|1
4687400|NCT02529553|7595360|FG005|Overall Study|Physician Decision|0
4687401|NCT02529553|7595361|FG006|Overall Study|Physician Decision|0
4687402|NCT02529553|7595362|FG007|Overall Study|Physician Decision|0
4687403|NCT02529553|7595363|FG008|Overall Study|Physician Decision|0
4687404|NCT02529553|7595355|FG000|Overall Study|Withdrawal by Subject|0
4687405|NCT02529553|7595356|FG001|Overall Study|Withdrawal by Subject|0
4687406|NCT02529553|7595357|FG002|Overall Study|Withdrawal by Subject|0
4687407|NCT02529553|7595358|FG003|Overall Study|Withdrawal by Subject|0
4687408|NCT02529553|7595359|FG004|Overall Study|Withdrawal by Subject|0
4687409|NCT02529553|7595360|FG005|Overall Study|Withdrawal by Subject|1
4687410|NCT02529553|7595361|FG006|Overall Study|Withdrawal by Subject|0
4687411|NCT02529553|7595362|FG007|Overall Study|Withdrawal by Subject|1
4687412|NCT02529553|7595363|FG008|Overall Study|Withdrawal by Subject|0
4687413|NCT02529995|7595386|FG000|Part A|Ongoing Study at Data Cut-off|14
4687414|NCT02529995|7595387|FG001|Part A|Ongoing Study at Data Cut-off|16
4687415|NCT02529995|7595386|FG000|Part A|Discontinued Study|1
4687416|NCT02529995|7595387|FG001|Part A|Discontinued Study|0
4687417|NCT02529995|7595386|FG000|Part B|Ongoing Study at Data Cut-off|0
4687418|NCT02529995|7595387|FG001|Part B|Ongoing Study at Data Cut-off|7
4687419|NCT02529995|7595386|FG000|Part B|Discontinued Study|6
4687420|NCT02529995|7595387|FG001|Part B|Discontinued Study|5
4687421|NCT02530125|7595393|FG000|Completed Treatment|Early termination of study|1
4687422|NCT02530125|7595393|FG000|Followed for Survival for 2 Years|Early termination of study|3
4687423|NCT02530242|7595408|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0
4687424|NCT02530242|7595409|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1
4687425|NCT02530385|7595437|FG000|Overall Study|Withdrawal by Subject|0
4687426|NCT02530385|7595438|FG001|Overall Study|Withdrawal by Subject|1
4687427|NCT02530619|7595528|FG000|Registered for Study|Withdrawal by Subject|2
4687428|NCT02530619|7595528|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2
4687429|NCT02530619|7595528|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2
4687430|NCT02530619|7595528|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4
4687431|NCT02530619|7595528|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2
4687432|NCT02530619|7595528|FG000|Follow-up Period (6 Months)|Death|4
4687433|NCT02530619|7595528|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2
4687434|NCT02530619|7595528|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5
4687435|NCT02530671|7595534|FG000|Overall Study|Lost to Follow-up|2
4687436|NCT02530671|7595535|FG001|Overall Study|Lost to Follow-up|0
4687437|NCT02530671|7595534|FG000|Overall Study|Withdrawal by Subject|1
4687438|NCT02530671|7595535|FG001|Overall Study|Withdrawal by Subject|0
4687439|NCT02530905|7595543|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0
4687440|NCT02530905|7595544|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0
4687441|NCT02530905|7595545|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1
4687442|NCT02530970|7595567|FG000|Overall Study|Adverse Event|8
4687443|NCT02530970|7595567|FG000|Overall Study|Lost to Follow-up|88
4687444|NCT02530970|7595567|FG000|Overall Study|Physician Decision|5
4687445|NCT02530970|7595567|FG000|Overall Study|Withdrawal by Subject|14
4687446|NCT02530970|7595567|FG000|Overall Study|Death|6
4687447|NCT02530970|7595567|FG000|Overall Study|Hospitalization|1
4687448|NCT02530970|7595567|FG000|Overall Study|Insurance|2
4687449|NCT02530970|7595567|FG000|Overall Study|Explant|2
4687450|NCT02530970|7595567|FG000|Overall Study|Change in Provider|5
4687451|NCT02530970|7595567|FG000|Overall Study|Relocation|3
4687452|NCT02531035|7595593|FG000|Overall Study|Death|0
4687453|NCT02531035|7595594|FG001|Overall Study|Death|1
4687454|NCT02531035|7595593|FG000|Overall Study|Protocol Violation|1
4687455|NCT02531035|7595594|FG001|Overall Study|Protocol Violation|1
4761711|NCT02891226|7735332|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
4761712|NCT02891226|7735333|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
4761713|NCT02891226|7735334|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
4761714|NCT02891226|7735335|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
4761715|NCT02891226|7735336|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
4761716|NCT02891226|7735337|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
4761717|NCT02891226|7735338|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2
4761718|NCT02891226|7735339|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
4761719|NCT02891226|7735340|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
4761720|NCT02891226|7735341|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
4761721|NCT02891226|7735342|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
4761722|NCT02891226|7735343|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0
4761723|NCT02891226|7735328|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
4761724|NCT02891226|7735329|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
4761725|NCT02891226|7735330|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
4761726|NCT02891226|7735331|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
4761727|NCT02891226|7735332|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
4761728|NCT02891226|7735333|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
4761729|NCT02891226|7735334|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
4761730|NCT02891226|7735335|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
4761731|NCT02891226|7735336|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
4761732|NCT02891226|7735337|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
4761733|NCT02891226|7735338|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2
4761734|NCT02891226|7735339|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
4761735|NCT02891226|7735340|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
4687456|NCT02531035|7595593|FG000|Overall Study|Noncompliance with study drug|8
4687457|NCT02531035|7595594|FG001|Overall Study|Noncompliance with study drug|3
4687458|NCT02531035|7595593|FG000|Overall Study|Physician Decision|1
4687459|NCT02531035|7595594|FG001|Overall Study|Physician Decision|0
4687460|NCT02531035|7595593|FG000|Overall Study|Adverse Event|16
4687461|NCT02531035|7595594|FG001|Overall Study|Adverse Event|45
4687462|NCT02531035|7595593|FG000|Overall Study|Other|3
4687463|NCT02531035|7595594|FG001|Overall Study|Other|2
4687464|NCT02531035|7595593|FG000|Overall Study|Withdrawal by Subject|42
4687465|NCT02531035|7595594|FG001|Overall Study|Withdrawal by Subject|32
4687466|NCT02531035|7595593|FG000|Overall Study|Lost to Follow-up|8
4687467|NCT02531035|7595594|FG001|Overall Study|Lost to Follow-up|10
4687468|NCT02531035|7595593|FG000|Overall Study|Randomized, not treated|2
4687469|NCT02531035|7595594|FG001|Overall Study|Randomized, not treated|1
4687470|NCT02531113|7595600|FG000|Induction Period: Week 0 to 12|Adverse Event|4
4687471|NCT02531113|7595600|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4
4687472|NCT02531113|7595600|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3
4687473|NCT02531113|7595600|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2
4687474|NCT02531113|7595600|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5
4687475|NCT02531113|7595600|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19
4687476|NCT02531113|7595600|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11
4687477|NCT02531113|7595600|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1
4687478|NCT02531373|7595622|FG000|Overall Study|Lack of Efficacy|0
4687479|NCT02531373|7595623|FG001|Overall Study|Lack of Efficacy|0
4687480|NCT02531373|7595624|FG002|Overall Study|Lack of Efficacy|0
4687481|NCT02531373|7595625|FG003|Overall Study|Lack of Efficacy|0
4687482|NCT02531373|7595626|FG004|Overall Study|Lack of Efficacy|3
4687483|NCT02531373|7595627|FG005|Overall Study|Lack of Efficacy|2
4687484|NCT02531373|7595628|FG006|Overall Study|Lack of Efficacy|4
4761736|NCT02891226|7735341|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
4761737|NCT02891226|7735342|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
4761738|NCT02891226|7735343|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0
4761739|NCT02891226|7735328|FG000|Follow-up Period|Withdrawal by Subject|0
4761740|NCT02891226|7735329|FG001|Follow-up Period|Withdrawal by Subject|0
4761741|NCT02891226|7735330|FG002|Follow-up Period|Withdrawal by Subject|0
4761742|NCT02891226|7735331|FG003|Follow-up Period|Withdrawal by Subject|0
4761743|NCT02891226|7735332|FG004|Follow-up Period|Withdrawal by Subject|0
4761744|NCT02891226|7735333|FG005|Follow-up Period|Withdrawal by Subject|0
4761745|NCT02891226|7735334|FG006|Follow-up Period|Withdrawal by Subject|0
4761746|NCT02891226|7735335|FG007|Follow-up Period|Withdrawal by Subject|0
4761747|NCT02891226|7735336|FG008|Follow-up Period|Withdrawal by Subject|0
4761748|NCT02891226|7735337|FG009|Follow-up Period|Withdrawal by Subject|0
4761749|NCT02891226|7735338|FG010|Follow-up Period|Withdrawal by Subject|0
4761750|NCT02891226|7735339|FG011|Follow-up Period|Withdrawal by Subject|1
4761751|NCT02891226|7735340|FG012|Follow-up Period|Withdrawal by Subject|0
4761752|NCT02891226|7735341|FG013|Follow-up Period|Withdrawal by Subject|0
4761753|NCT02891226|7735342|FG014|Follow-up Period|Withdrawal by Subject|1
4761754|NCT02891226|7735343|FG015|Follow-up Period|Withdrawal by Subject|1
4687485|NCT02531373|7595629|FG007|Overall Study|Lack of Efficacy|8
4687486|NCT02531373|7595630|FG008|Overall Study|Lack of Efficacy|5
4687487|NCT02531373|7595622|FG000|Overall Study|Lost to Follow-up|0
4687488|NCT02531373|7595623|FG001|Overall Study|Lost to Follow-up|0
4687489|NCT02531373|7595624|FG002|Overall Study|Lost to Follow-up|0
4687490|NCT02531373|7595625|FG003|Overall Study|Lost to Follow-up|0
4687491|NCT02531373|7595626|FG004|Overall Study|Lost to Follow-up|0
4687492|NCT02531373|7595627|FG005|Overall Study|Lost to Follow-up|2
4687493|NCT02531373|7595628|FG006|Overall Study|Lost to Follow-up|2
4687494|NCT02531373|7595629|FG007|Overall Study|Lost to Follow-up|0
4687495|NCT02531373|7595630|FG008|Overall Study|Lost to Follow-up|0
4687496|NCT02531373|7595622|FG000|Overall Study|Physician Decision|0
4687497|NCT02531373|7595623|FG001|Overall Study|Physician Decision|0
4687498|NCT02531373|7595624|FG002|Overall Study|Physician Decision|0
4687499|NCT02531373|7595625|FG003|Overall Study|Physician Decision|0
4687500|NCT02531373|7595626|FG004|Overall Study|Physician Decision|2
4687501|NCT02531373|7595627|FG005|Overall Study|Physician Decision|1
4687502|NCT02531373|7595628|FG006|Overall Study|Physician Decision|0
4687503|NCT02531373|7595629|FG007|Overall Study|Physician Decision|0
4687504|NCT02531373|7595630|FG008|Overall Study|Physician Decision|0
4687505|NCT02531373|7595622|FG000|Overall Study|Protocol Violation|0
4687506|NCT02531373|7595623|FG001|Overall Study|Protocol Violation|0
4687507|NCT02531373|7595624|FG002|Overall Study|Protocol Violation|0
4687508|NCT02531373|7595625|FG003|Overall Study|Protocol Violation|0
4687509|NCT02531373|7595626|FG004|Overall Study|Protocol Violation|0
4687510|NCT02531373|7595627|FG005|Overall Study|Protocol Violation|1
4687511|NCT02531373|7595628|FG006|Overall Study|Protocol Violation|1
4687512|NCT02531373|7595629|FG007|Overall Study|Protocol Violation|0
4687513|NCT02531373|7595630|FG008|Overall Study|Protocol Violation|1
4687514|NCT02531373|7595622|FG000|Overall Study|Withdrawal by Parent/Guardian|0
4687515|NCT02531373|7595623|FG001|Overall Study|Withdrawal by Parent/Guardian|0
4687516|NCT02531373|7595624|FG002|Overall Study|Withdrawal by Parent/Guardian|0
4687517|NCT02531373|7595625|FG003|Overall Study|Withdrawal by Parent/Guardian|0
4687518|NCT02531373|7595626|FG004|Overall Study|Withdrawal by Parent/Guardian|0
4687519|NCT02531373|7595627|FG005|Overall Study|Withdrawal by Parent/Guardian|3
4687520|NCT02531373|7595628|FG006|Overall Study|Withdrawal by Parent/Guardian|4
4687521|NCT02531373|7595629|FG007|Overall Study|Withdrawal by Parent/Guardian|1
4687522|NCT02531373|7595630|FG008|Overall Study|Withdrawal by Parent/Guardian|3
4687523|NCT02531373|7595622|FG000|Overall Study|Withdrawal by Subject|0
4687524|NCT02531373|7595623|FG001|Overall Study|Withdrawal by Subject|0
4687525|NCT02531373|7595624|FG002|Overall Study|Withdrawal by Subject|0
4687526|NCT02531373|7595625|FG003|Overall Study|Withdrawal by Subject|0
4687527|NCT02531373|7595626|FG004|Overall Study|Withdrawal by Subject|3
4687528|NCT02531373|7595627|FG005|Overall Study|Withdrawal by Subject|0
4687529|NCT02531373|7595628|FG006|Overall Study|Withdrawal by Subject|0
4687530|NCT02531373|7595629|FG007|Overall Study|Withdrawal by Subject|0
4687531|NCT02531373|7595630|FG008|Overall Study|Withdrawal by Subject|0
4687532|NCT02531438|7595653|FG000|Overall Study|Adverse Event|7
4687533|NCT02531438|7595654|FG001|Overall Study|Adverse Event|9
4687534|NCT02531438|7595653|FG000|Overall Study|Lost to Follow-up|0
4687535|NCT02531438|7595654|FG001|Overall Study|Lost to Follow-up|3
4687536|NCT02531438|7595653|FG000|Overall Study|Withdrawal by Subject|7
4687537|NCT02531438|7595654|FG001|Overall Study|Withdrawal by Subject|8
4687538|NCT02531438|7595653|FG000|Overall Study|Physician Decision|0
4687539|NCT02531438|7595654|FG001|Overall Study|Physician Decision|1
4687540|NCT02531438|7595653|FG000|Overall Study|Death|6
4687541|NCT02531438|7595654|FG001|Overall Study|Death|3
4687542|NCT02531438|7595653|FG000|Overall Study|Randomized, but Not Treated|4
4687543|NCT02531438|7595654|FG001|Overall Study|Randomized, but Not Treated|0
4687544|NCT02531438|7595653|FG000|Overall Study|Missed EOT/PTE Visit|5
4687545|NCT02531438|7595654|FG001|Overall Study|Missed EOT/PTE Visit|2
4687546|NCT02531438|7595653|FG000|Overall Study|Randomized with Exclusion Criteria|1
4687547|NCT02531438|7595654|FG001|Overall Study|Randomized with Exclusion Criteria|0
4687548|NCT02531633|7595665|FG000|Part A (52 Weeks)|Sponsor request|24
4687549|NCT02531633|7595666|FG001|Part A (52 Weeks)|Sponsor request|24
4687550|NCT02531633|7595667|FG002|Part A (52 Weeks)|Sponsor request|18
4687551|NCT02531633|7595668|FG003|Part A (52 Weeks)|Sponsor request|18
4687552|NCT02531633|7595669|FG004|Part A (52 Weeks)|Sponsor request|19
4687553|NCT02531633|7595670|FG005|Part A (52 Weeks)|Sponsor request|0
4687554|NCT02531633|7595671|FG006|Part A (52 Weeks)|Sponsor request|0
4687555|NCT02531633|7595672|FG007|Part A (52 Weeks)|Sponsor request|0
4687556|NCT02531633|7595673|FG008|Part A (52 Weeks)|Sponsor request|0
4687557|NCT02531633|7595674|FG009|Part A (52 Weeks)|Sponsor request|0
4687558|NCT02531633|7595665|FG000|Part A (52 Weeks)|Protocol Violation|1
4687559|NCT02531633|7595666|FG001|Part A (52 Weeks)|Protocol Violation|0
4687560|NCT02531633|7595667|FG002|Part A (52 Weeks)|Protocol Violation|0
4761755|NCT02549092|7735376|FG000|Treatment Period|Adverse Event|2
4761756|NCT02549092|7735377|FG001|Treatment Period|Adverse Event|2
4687561|NCT02531633|7595668|FG003|Part A (52 Weeks)|Protocol Violation|0
4687562|NCT02531633|7595669|FG004|Part A (52 Weeks)|Protocol Violation|0
4687563|NCT02531633|7595670|FG005|Part A (52 Weeks)|Protocol Violation|0
4687564|NCT02531633|7595671|FG006|Part A (52 Weeks)|Protocol Violation|0
4687565|NCT02531633|7595672|FG007|Part A (52 Weeks)|Protocol Violation|0
4687566|NCT02531633|7595673|FG008|Part A (52 Weeks)|Protocol Violation|0
4687567|NCT02531633|7595674|FG009|Part A (52 Weeks)|Protocol Violation|0
4687568|NCT02531633|7595665|FG000|Part A (52 Weeks)|Lost to Follow-up|0
4687569|NCT02531633|7595666|FG001|Part A (52 Weeks)|Lost to Follow-up|0
4687570|NCT02531633|7595667|FG002|Part A (52 Weeks)|Lost to Follow-up|0
4687571|NCT02531633|7595668|FG003|Part A (52 Weeks)|Lost to Follow-up|0
4687572|NCT02531633|7595669|FG004|Part A (52 Weeks)|Lost to Follow-up|1
4687573|NCT02531633|7595670|FG005|Part A (52 Weeks)|Lost to Follow-up|0
4687574|NCT02531633|7595671|FG006|Part A (52 Weeks)|Lost to Follow-up|0
4687575|NCT02531633|7595672|FG007|Part A (52 Weeks)|Lost to Follow-up|0
4687576|NCT02531633|7595673|FG008|Part A (52 Weeks)|Lost to Follow-up|0
4687577|NCT02531633|7595674|FG009|Part A (52 Weeks)|Lost to Follow-up|0
4687578|NCT02531633|7595665|FG000|Part A (52 Weeks)|Physician Decision|1
4687579|NCT02531633|7595666|FG001|Part A (52 Weeks)|Physician Decision|4
4687580|NCT02531633|7595667|FG002|Part A (52 Weeks)|Physician Decision|3
4687581|NCT02531633|7595668|FG003|Part A (52 Weeks)|Physician Decision|1
4687582|NCT02531633|7595669|FG004|Part A (52 Weeks)|Physician Decision|0
4687583|NCT02531633|7595670|FG005|Part A (52 Weeks)|Physician Decision|0
4687584|NCT02531633|7595671|FG006|Part A (52 Weeks)|Physician Decision|0
4687585|NCT02531633|7595672|FG007|Part A (52 Weeks)|Physician Decision|0
4687586|NCT02531633|7595673|FG008|Part A (52 Weeks)|Physician Decision|0
4687587|NCT02531633|7595674|FG009|Part A (52 Weeks)|Physician Decision|0
4687588|NCT02531633|7595665|FG000|Part A (52 Weeks)|Withdrawal by Subject|6
4687589|NCT02531633|7595666|FG001|Part A (52 Weeks)|Withdrawal by Subject|6
4687590|NCT02531633|7595667|FG002|Part A (52 Weeks)|Withdrawal by Subject|1
4687591|NCT02531633|7595668|FG003|Part A (52 Weeks)|Withdrawal by Subject|3
4687592|NCT02531633|7595669|FG004|Part A (52 Weeks)|Withdrawal by Subject|3
4687593|NCT02531633|7595670|FG005|Part A (52 Weeks)|Withdrawal by Subject|0
4687594|NCT02531633|7595671|FG006|Part A (52 Weeks)|Withdrawal by Subject|0
4687595|NCT02531633|7595672|FG007|Part A (52 Weeks)|Withdrawal by Subject|0
4687596|NCT02531633|7595673|FG008|Part A (52 Weeks)|Withdrawal by Subject|0
4687597|NCT02531633|7595674|FG009|Part A (52 Weeks)|Withdrawal by Subject|0
4687598|NCT02531633|7595665|FG000|Part A (52 Weeks)|Other|2
4687599|NCT02531633|7595666|FG001|Part A (52 Weeks)|Other|0
4687600|NCT02531633|7595667|FG002|Part A (52 Weeks)|Other|0
4687601|NCT02531633|7595668|FG003|Part A (52 Weeks)|Other|0
4687602|NCT02531633|7595669|FG004|Part A (52 Weeks)|Other|0
4687603|NCT02531633|7595670|FG005|Part A (52 Weeks)|Other|0
4687604|NCT02531633|7595671|FG006|Part A (52 Weeks)|Other|0
4687605|NCT02531633|7595672|FG007|Part A (52 Weeks)|Other|0
4687606|NCT02531633|7595673|FG008|Part A (52 Weeks)|Other|0
4687607|NCT02531633|7595674|FG009|Part A (52 Weeks)|Other|0
4687608|NCT02531633|7595665|FG000|Part B (104 Weeks)|Sponsor request|0
4687609|NCT02531633|7595666|FG001|Part B (104 Weeks)|Sponsor request|0
4687610|NCT02531633|7595667|FG002|Part B (104 Weeks)|Sponsor request|0
4687611|NCT02531633|7595668|FG003|Part B (104 Weeks)|Sponsor request|0
4687612|NCT02531633|7595669|FG004|Part B (104 Weeks)|Sponsor request|0
4687613|NCT02531633|7595670|FG005|Part B (104 Weeks)|Sponsor request|8
4687614|NCT02531633|7595671|FG006|Part B (104 Weeks)|Sponsor request|5
4687615|NCT02531633|7595672|FG007|Part B (104 Weeks)|Sponsor request|3
4761757|NCT02549092|7735376|FG000|Treatment Period|Withdrawal by Subject|1
4761758|NCT02549092|7735377|FG001|Treatment Period|Withdrawal by Subject|3
4761759|NCT02549092|7735376|FG000|Treatment Period|Lack of Efficacy|0
4761760|NCT02549092|7735377|FG001|Treatment Period|Lack of Efficacy|2
4761761|NCT02549092|7735376|FG000|Extension/Transition Period|Still in Extension/Transition Period|4
4761762|NCT02549092|7735377|FG001|Extension/Transition Period|Still in Extension/Transition Period|8
4761763|NCT02549092|7735376|FG000|Extension/Transition Period|Premature Discontinuation for Unspecified Reason|1
4761764|NCT02549092|7735377|FG001|Extension/Transition Period|Premature Discontinuation for Unspecified Reason|1
4761765|NCT02323126|7735398|FG000|Overall Study|Patient / guardian decision|0
4761766|NCT02323126|7735399|FG001|Overall Study|Patient / guardian decision|1
4761767|NCT02323126|7735400|FG002|Overall Study|Patient / guardian decision|2
4761768|NCT02323126|7735398|FG000|Overall Study|Progressive disease|14
4761769|NCT02323126|7735399|FG001|Overall Study|Progressive disease|8
4761770|NCT02323126|7735400|FG002|Overall Study|Progressive disease|14
4761771|NCT02323126|7735398|FG000|Overall Study|Physician Decision|0
4761772|NCT02323126|7735399|FG001|Overall Study|Physician Decision|1
4761773|NCT02323126|7735400|FG002|Overall Study|Physician Decision|3
4761774|NCT02323126|7735398|FG000|Overall Study|Death|1
4761775|NCT02323126|7735399|FG001|Overall Study|Death|1
4761776|NCT02323126|7735400|FG002|Overall Study|Death|4
4761777|NCT02323126|7735398|FG000|Overall Study|Adverse Event|3
4761778|NCT02323126|7735399|FG001|Overall Study|Adverse Event|5
4761779|NCT02323126|7735400|FG002|Overall Study|Adverse Event|7
4761780|NCT01902290|7735413|FG000|Overall Study|Withdrawal by Subject|19
4761781|NCT01902290|7735414|FG001|Overall Study|Withdrawal by Subject|27
4761782|NCT01902290|7735413|FG000|Overall Study|Lost to Follow-up|2
4761783|NCT01902290|7735414|FG001|Overall Study|Lost to Follow-up|2
4687616|NCT02531633|7595673|FG008|Part B (104 Weeks)|Sponsor request|5
4687617|NCT02531633|7595674|FG009|Part B (104 Weeks)|Sponsor request|4
4687618|NCT02531633|7595665|FG000|Part B (104 Weeks)|Lost to Follow-up|0
4687619|NCT02531633|7595666|FG001|Part B (104 Weeks)|Lost to Follow-up|0
4761784|NCT01902290|7735413|FG000|Overall Study|Death|1
4761785|NCT01902290|7735414|FG001|Overall Study|Death|0
4687620|NCT02531633|7595667|FG002|Part B (104 Weeks)|Lost to Follow-up|0
4687621|NCT02531633|7595668|FG003|Part B (104 Weeks)|Lost to Follow-up|0
4761786|NCT01902290|7735413|FG000|Overall Study|Sponsor Decision|26
4761787|NCT01902290|7735414|FG001|Overall Study|Sponsor Decision|24
4761788|NCT01126749|7735425|FG000|Phase 1b|Other|0
4761789|NCT01126749|7735426|FG001|Phase 1b|Other|1
4761790|NCT01126749|7735427|FG002|Phase 1b|Other|0
4761791|NCT01126749|7735428|FG003|Phase 1b|Other|0
4761792|NCT01126749|7735425|FG000|Phase 1b|Withdrawal by Subject|0
4761793|NCT01126749|7735426|FG001|Phase 1b|Withdrawal by Subject|1
4761794|NCT01126749|7735427|FG002|Phase 1b|Withdrawal by Subject|0
4761795|NCT01126749|7735428|FG003|Phase 1b|Withdrawal by Subject|0
4761796|NCT01126749|7735425|FG000|Phase 1b|Death|3
4761797|NCT01126749|7735426|FG001|Phase 1b|Death|4
4761798|NCT01126749|7735427|FG002|Phase 1b|Death|0
4761799|NCT01126749|7735428|FG003|Phase 1b|Death|0
4761800|NCT01126749|7735425|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0
4761801|NCT01126749|7735426|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0
4761802|NCT01126749|7735427|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4
4761803|NCT01126749|7735428|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7
4761804|NCT01126749|7735425|FG000|Phase 2|Study Termination by Sponsor|0
4761805|NCT01126749|7735426|FG001|Phase 2|Study Termination by Sponsor|0
4761806|NCT01126749|7735427|FG002|Phase 2|Study Termination by Sponsor|12
4761807|NCT01126749|7735428|FG003|Phase 2|Study Termination by Sponsor|6
4761808|NCT01126749|7735425|FG000|Phase 2|Other|0
4761809|NCT01126749|7735426|FG001|Phase 2|Other|0
4761810|NCT01126749|7735427|FG002|Phase 2|Other|4
4761811|NCT01126749|7735428|FG003|Phase 2|Other|2
4761812|NCT01126749|7735425|FG000|Phase 2|Withdrawal by Subject|0
4761813|NCT01126749|7735426|FG001|Phase 2|Withdrawal by Subject|0
4761814|NCT01126749|7735427|FG002|Phase 2|Withdrawal by Subject|0
4761815|NCT01126749|7735428|FG003|Phase 2|Withdrawal by Subject|2
4761816|NCT01126749|7735425|FG000|Phase 2|Lost to Follow-up|0
4761817|NCT01126749|7735426|FG001|Phase 2|Lost to Follow-up|0
4761818|NCT01126749|7735427|FG002|Phase 2|Lost to Follow-up|0
4761819|NCT01126749|7735428|FG003|Phase 2|Lost to Follow-up|1
4761820|NCT01126749|7735425|FG000|Phase 2|Death|0
4761821|NCT01126749|7735426|FG001|Phase 2|Death|0
4761822|NCT01126749|7735427|FG002|Phase 2|Death|22
4761823|NCT01126749|7735428|FG003|Phase 2|Death|22
4761824|NCT01126749|7735425|FG000|Phase 2|Adverse Event|0
4761825|NCT01126749|7735426|FG001|Phase 2|Adverse Event|0
4761826|NCT01126749|7735427|FG002|Phase 2|Adverse Event|0
4761827|NCT01126749|7735428|FG003|Phase 2|Adverse Event|1
4761828|NCT01059448|7735451|FG000|Overall Study|Adverse Event|1
4761829|NCT01059448|7735452|FG001|Overall Study|Adverse Event|3
4761830|NCT01059448|7735453|FG002|Overall Study|Adverse Event|0
4761831|NCT01059448|7735454|FG003|Overall Study|Adverse Event|1
4761832|NCT01059448|7735451|FG000|Overall Study|Withdrawal by Subject|2
4761833|NCT01059448|7735452|FG001|Overall Study|Withdrawal by Subject|0
4761834|NCT01059448|7735453|FG002|Overall Study|Withdrawal by Subject|2
4761835|NCT01059448|7735454|FG003|Overall Study|Withdrawal by Subject|4
4761836|NCT01059448|7735451|FG000|Overall Study|Disease Progression|2
4761837|NCT01059448|7735452|FG001|Overall Study|Disease Progression|1
4761838|NCT01059448|7735453|FG002|Overall Study|Disease Progression|4
4761839|NCT01059448|7735454|FG003|Overall Study|Disease Progression|2
4761840|NCT01059448|7735451|FG000|Overall Study|Administrative Decision|43
4761841|NCT01059448|7735452|FG001|Overall Study|Administrative Decision|49
4761842|NCT01059448|7735453|FG002|Overall Study|Administrative Decision|45
4761843|NCT01059448|7735454|FG003|Overall Study|Administrative Decision|46
4761844|NCT01059448|7735451|FG000|Overall Study|Lost to Follow-up|0
4761845|NCT01059448|7735452|FG001|Overall Study|Lost to Follow-up|0
4761846|NCT01059448|7735453|FG002|Overall Study|Lost to Follow-up|2
4761847|NCT01059448|7735454|FG003|Overall Study|Lost to Follow-up|0
4761848|NCT01059448|7735451|FG000|Overall Study|Death|0
4761849|NCT01059448|7735452|FG001|Overall Study|Death|1
4761850|NCT01059448|7735453|FG002|Overall Study|Death|0
4761851|NCT01059448|7735454|FG003|Overall Study|Death|0
4761852|NCT01059448|7735451|FG000|Overall Study|Other|1
4761853|NCT01059448|7735452|FG001|Overall Study|Other|1
4761854|NCT01059448|7735453|FG002|Overall Study|Other|0
4761855|NCT01059448|7735454|FG003|Overall Study|Other|1
4687622|NCT02531633|7595669|FG004|Part B (104 Weeks)|Lost to Follow-up|0
4687623|NCT02531633|7595670|FG005|Part B (104 Weeks)|Lost to Follow-up|0
4687624|NCT02531633|7595671|FG006|Part B (104 Weeks)|Lost to Follow-up|0
4687625|NCT02531633|7595672|FG007|Part B (104 Weeks)|Lost to Follow-up|1
4687626|NCT02531633|7595673|FG008|Part B (104 Weeks)|Lost to Follow-up|0
4687627|NCT02531633|7595674|FG009|Part B (104 Weeks)|Lost to Follow-up|0
4761856|NCT00821587|7735475|FG000|Overall Study|Physician Decision|0
4761857|NCT00821587|7735476|FG001|Overall Study|Physician Decision|1
4761858|NCT00585195|7735503|FG000|Overall Study|Adverse Event|0
4761859|NCT00585195|7735504|FG001|Overall Study|Adverse Event|0
4761860|NCT00585195|7735505|FG002|Overall Study|Adverse Event|0
4761861|NCT00585195|7735506|FG003|Overall Study|Adverse Event|0
4761862|NCT00585195|7735507|FG004|Overall Study|Adverse Event|2
4761863|NCT00585195|7735508|FG005|Overall Study|Adverse Event|1
4761864|NCT00585195|7735509|FG006|Overall Study|Adverse Event|0
4761865|NCT00585195|7735510|FG007|Overall Study|Adverse Event|1
4761866|NCT00585195|7735511|FG008|Overall Study|Adverse Event|0
4761867|NCT00585195|7735512|FG009|Overall Study|Adverse Event|0
4687628|NCT02531646|7595717|FG000|Overall Study|equip. image processing issue|5
4687629|NCT02531646|7595718|FG001|Overall Study|equip. image processing issue|1
4687630|NCT02531646|7595719|FG002|Overall Study|equip. image processing issue|0
4687631|NCT02531698|7595729|FG000|Overall Study|Adverse Event|2
4687632|NCT02531698|7595730|FG001|Overall Study|Adverse Event|1
4687633|NCT02531698|7595729|FG000|Overall Study|Withdrawal by Subject|6
4687634|NCT02531698|7595730|FG001|Overall Study|Withdrawal by Subject|1
4687635|NCT02531698|7595729|FG000|Overall Study|Protocol Violation|2
4687636|NCT02531698|7595730|FG001|Overall Study|Protocol Violation|0
4687637|NCT02531698|7595729|FG000|Overall Study|Lost to Follow-up|1
4687638|NCT02531698|7595730|FG001|Overall Study|Lost to Follow-up|0
4687639|NCT02531802|7595766|FG000|Received Vaccination 2|Medication interfering with study taken|0
4687640|NCT02531802|7595767|FG001|Received Vaccination 2|Medication interfering with study taken|0
4687641|NCT02531802|7595768|FG002|Received Vaccination 2|Medication interfering with study taken|1
4687642|NCT02531802|7595769|FG003|Received Vaccination 2|Medication interfering with study taken|0
4687643|NCT02531802|7595770|FG004|Received Vaccination 2|Medication interfering with study taken|0
4687644|NCT02531802|7595771|FG005|Received Vaccination 2|Medication interfering with study taken|0
4687645|NCT02531802|7595772|FG006|Received Vaccination 2|Medication interfering with study taken|0
4687646|NCT02531802|7595773|FG007|Received Vaccination 2|Medication interfering with study taken|0
4687647|NCT02531802|7595774|FG008|Received Vaccination 2|Medication interfering with study taken|0
4687648|NCT02531802|7595775|FG009|Received Vaccination 2|Medication interfering with study taken|1
4687649|NCT02531802|7595776|FG010|Received Vaccination 2|Medication interfering with study taken|1
4687650|NCT02531802|7595777|FG011|Received Vaccination 2|Medication interfering with study taken|0
4687651|NCT02531802|7595778|FG012|Received Vaccination 2|Medication interfering with study taken|1
4687652|NCT02531802|7595779|FG013|Received Vaccination 2|Medication interfering with study taken|0
4687653|NCT02531802|7595780|FG014|Received Vaccination 2|Medication interfering with study taken|0
4687654|NCT02531802|7595781|FG015|Received Vaccination 2|Medication interfering with study taken|0
4687655|NCT02531802|7595782|FG016|Received Vaccination 2|Medication interfering with study taken|0
4687656|NCT02531802|7595783|FG017|Received Vaccination 2|Medication interfering with study taken|0
4687657|NCT02531802|7595784|FG018|Received Vaccination 2|Medication interfering with study taken|1
4687658|NCT02531802|7595785|FG019|Received Vaccination 2|Medication interfering with study taken|0
4687659|NCT02531802|7595786|FG020|Received Vaccination 2|Medication interfering with study taken|0
4687660|NCT02531802|7595766|FG000|Received Vaccination 2|Physician Decision|0
4687661|NCT02531802|7595767|FG001|Received Vaccination 2|Physician Decision|0
4687662|NCT02531802|7595768|FG002|Received Vaccination 2|Physician Decision|0
4687663|NCT02531802|7595769|FG003|Received Vaccination 2|Physician Decision|0
4687664|NCT02531802|7595770|FG004|Received Vaccination 2|Physician Decision|0
4687665|NCT02531802|7595771|FG005|Received Vaccination 2|Physician Decision|1
4687666|NCT02531802|7595772|FG006|Received Vaccination 2|Physician Decision|0
4687667|NCT02531802|7595773|FG007|Received Vaccination 2|Physician Decision|0
4687668|NCT02531802|7595774|FG008|Received Vaccination 2|Physician Decision|0
4687669|NCT02531802|7595775|FG009|Received Vaccination 2|Physician Decision|2
4687670|NCT02531802|7595776|FG010|Received Vaccination 2|Physician Decision|0
4687671|NCT02531802|7595777|FG011|Received Vaccination 2|Physician Decision|0
4687672|NCT02531802|7595778|FG012|Received Vaccination 2|Physician Decision|0
4687673|NCT02531802|7595779|FG013|Received Vaccination 2|Physician Decision|1
4687674|NCT02531802|7595780|FG014|Received Vaccination 2|Physician Decision|0
4687675|NCT02531802|7595781|FG015|Received Vaccination 2|Physician Decision|0
4687676|NCT02531802|7595782|FG016|Received Vaccination 2|Physician Decision|0
4687677|NCT02531802|7595783|FG017|Received Vaccination 2|Physician Decision|1
4687678|NCT02531802|7595784|FG018|Received Vaccination 2|Physician Decision|0
4761868|NCT00585195|7735513|FG010|Overall Study|Adverse Event|3
4761869|NCT00585195|7735514|FG011|Overall Study|Adverse Event|0
4761870|NCT00585195|7735515|FG012|Overall Study|Adverse Event|8
4761871|NCT00585195|7735516|FG013|Overall Study|Adverse Event|6
4761872|NCT00585195|7735517|FG014|Overall Study|Adverse Event|4
4761873|NCT00585195|7735518|FG015|Overall Study|Adverse Event|1
4761874|NCT00585195|7735519|FG016|Overall Study|Adverse Event|14
4761875|NCT00585195|7735520|FG017|Overall Study|Adverse Event|9
4761876|NCT00585195|7735521|FG018|Overall Study|Adverse Event|2
4761877|NCT00585195|7735522|FG019|Overall Study|Adverse Event|3
4761878|NCT00585195|7735523|FG020|Overall Study|Adverse Event|1
4761879|NCT00585195|7735503|FG000|Overall Study|Progressive Disease|2
4761880|NCT00585195|7735504|FG001|Overall Study|Progressive Disease|2
4761881|NCT00585195|7735505|FG002|Overall Study|Progressive Disease|5
4761882|NCT00585195|7735506|FG003|Overall Study|Progressive Disease|4
4761883|NCT00585195|7735507|FG004|Overall Study|Progressive Disease|6
4761884|NCT00585195|7735508|FG005|Overall Study|Progressive Disease|4
4761885|NCT00585195|7735509|FG006|Overall Study|Progressive Disease|6
4761886|NCT00585195|7735510|FG007|Overall Study|Progressive Disease|3
4761887|NCT00585195|7735511|FG008|Overall Study|Progressive Disease|0
4761888|NCT00585195|7735512|FG009|Overall Study|Progressive Disease|5
4761889|NCT00585195|7735513|FG010|Overall Study|Progressive Disease|2
4761890|NCT00585195|7735514|FG011|Overall Study|Progressive Disease|25
4761891|NCT00585195|7735515|FG012|Overall Study|Progressive Disease|29
4761892|NCT00585195|7735516|FG013|Overall Study|Progressive Disease|26
4761893|NCT00585195|7735517|FG014|Overall Study|Progressive Disease|21
4761894|NCT00585195|7735518|FG015|Overall Study|Progressive Disease|12
4687679|NCT02531802|7595785|FG019|Received Vaccination 2|Physician Decision|0
4687680|NCT02531802|7595786|FG020|Received Vaccination 2|Physician Decision|0
4687681|NCT02531802|7595766|FG000|Received Vaccination 2|Adverse Event|0
4687682|NCT02531802|7595767|FG001|Received Vaccination 2|Adverse Event|0
4687683|NCT02531802|7595768|FG002|Received Vaccination 2|Adverse Event|0
4687684|NCT02531802|7595769|FG003|Received Vaccination 2|Adverse Event|0
4687685|NCT02531802|7595770|FG004|Received Vaccination 2|Adverse Event|0
4687686|NCT02531802|7595771|FG005|Received Vaccination 2|Adverse Event|2
4687687|NCT02531802|7595772|FG006|Received Vaccination 2|Adverse Event|0
4687688|NCT02531802|7595773|FG007|Received Vaccination 2|Adverse Event|0
4687689|NCT02531802|7595774|FG008|Received Vaccination 2|Adverse Event|0
4687690|NCT02531802|7595775|FG009|Received Vaccination 2|Adverse Event|0
4687691|NCT02531802|7595776|FG010|Received Vaccination 2|Adverse Event|0
4687692|NCT02531802|7595777|FG011|Received Vaccination 2|Adverse Event|0
4687693|NCT02531802|7595778|FG012|Received Vaccination 2|Adverse Event|0
4687694|NCT02531802|7595779|FG013|Received Vaccination 2|Adverse Event|0
4687695|NCT02531802|7595780|FG014|Received Vaccination 2|Adverse Event|0
4687696|NCT02531802|7595781|FG015|Received Vaccination 2|Adverse Event|0
4687697|NCT02531802|7595782|FG016|Received Vaccination 2|Adverse Event|0
4687698|NCT02531802|7595783|FG017|Received Vaccination 2|Adverse Event|2
4687699|NCT02531802|7595784|FG018|Received Vaccination 2|Adverse Event|1
4687700|NCT02531802|7595785|FG019|Received Vaccination 2|Adverse Event|0
4687701|NCT02531802|7595786|FG020|Received Vaccination 2|Adverse Event|1
4687702|NCT02531802|7595766|FG000|Received Vaccination 2|Withdrawal by Subject|0
4761895|NCT00585195|7735519|FG016|Overall Study|Progressive Disease|94
4761896|NCT00585195|7735520|FG017|Overall Study|Progressive Disease|42
4761897|NCT00585195|7735521|FG018|Overall Study|Progressive Disease|4
4761898|NCT00585195|7735522|FG019|Overall Study|Progressive Disease|9
4761899|NCT00585195|7735523|FG020|Overall Study|Progressive Disease|8
4761900|NCT00585195|7735503|FG000|Overall Study|Withdrawal by Subject|1
4761901|NCT00585195|7735504|FG001|Overall Study|Withdrawal by Subject|1
4761902|NCT00585195|7735505|FG002|Overall Study|Withdrawal by Subject|2
4761903|NCT00585195|7735506|FG003|Overall Study|Withdrawal by Subject|2
4761904|NCT00585195|7735507|FG004|Overall Study|Withdrawal by Subject|0
4761905|NCT00585195|7735508|FG005|Overall Study|Withdrawal by Subject|0
4761906|NCT00585195|7735509|FG006|Overall Study|Withdrawal by Subject|0
4761907|NCT00585195|7735510|FG007|Overall Study|Withdrawal by Subject|1
4761908|NCT00585195|7735511|FG008|Overall Study|Withdrawal by Subject|0
4761909|NCT00585195|7735512|FG009|Overall Study|Withdrawal by Subject|0
4761910|NCT00585195|7735513|FG010|Overall Study|Withdrawal by Subject|3
4761911|NCT00585195|7735514|FG011|Overall Study|Withdrawal by Subject|8
4761912|NCT00585195|7735515|FG012|Overall Study|Withdrawal by Subject|15
4761913|NCT00585195|7735516|FG013|Overall Study|Withdrawal by Subject|0
4761914|NCT00585195|7735517|FG014|Overall Study|Withdrawal by Subject|3
4761915|NCT00585195|7735518|FG015|Overall Study|Withdrawal by Subject|0
4761916|NCT00585195|7735519|FG016|Overall Study|Withdrawal by Subject|7
4761917|NCT00585195|7735520|FG017|Overall Study|Withdrawal by Subject|1
4761918|NCT00585195|7735521|FG018|Overall Study|Withdrawal by Subject|2
4761919|NCT00585195|7735522|FG019|Overall Study|Withdrawal by Subject|2
4761920|NCT00585195|7735523|FG020|Overall Study|Withdrawal by Subject|0
4761921|NCT00585195|7735503|FG000|Overall Study|Other|0
4761922|NCT00585195|7735504|FG001|Overall Study|Other|1
4761923|NCT00585195|7735505|FG002|Overall Study|Other|1
4761924|NCT00585195|7735506|FG003|Overall Study|Other|1
4761925|NCT00585195|7735507|FG004|Overall Study|Other|0
4761926|NCT00585195|7735508|FG005|Overall Study|Other|1
4761927|NCT00585195|7735509|FG006|Overall Study|Other|0
4761928|NCT00585195|7735510|FG007|Overall Study|Other|0
4761929|NCT00585195|7735511|FG008|Overall Study|Other|2
4761930|NCT00585195|7735512|FG009|Overall Study|Other|1
4761931|NCT00585195|7735513|FG010|Overall Study|Other|0
4761932|NCT00585195|7735514|FG011|Overall Study|Other|19
4761933|NCT00585195|7735515|FG012|Overall Study|Other|23
4761934|NCT00585195|7735516|FG013|Overall Study|Other|7
4761935|NCT00585195|7735517|FG014|Overall Study|Other|11
4761936|NCT00585195|7735518|FG015|Overall Study|Other|3
4761937|NCT00585195|7735519|FG016|Overall Study|Other|28
4761938|NCT00585195|7735520|FG017|Overall Study|Other|12
4761939|NCT00585195|7735521|FG018|Overall Study|Other|10
4761940|NCT00585195|7735522|FG019|Overall Study|Other|4
4761941|NCT00585195|7735523|FG020|Overall Study|Other|2
4761942|NCT00585195|7735503|FG000|Overall Study|Randomized not treated|0
4761943|NCT00585195|7735504|FG001|Overall Study|Randomized not treated|0
4687703|NCT02531802|7595767|FG001|Received Vaccination 2|Withdrawal by Subject|0
4761944|NCT00585195|7735505|FG002|Overall Study|Randomized not treated|1
4761945|NCT00585195|7735506|FG003|Overall Study|Randomized not treated|0
4761946|NCT00585195|7735507|FG004|Overall Study|Randomized not treated|1
4761947|NCT00585195|7735508|FG005|Overall Study|Randomized not treated|0
4761948|NCT00585195|7735509|FG006|Overall Study|Randomized not treated|1
4761949|NCT00585195|7735510|FG007|Overall Study|Randomized not treated|0
4761950|NCT00585195|7735511|FG008|Overall Study|Randomized not treated|0
4761951|NCT00585195|7735512|FG009|Overall Study|Randomized not treated|0
4761952|NCT00585195|7735513|FG010|Overall Study|Randomized not treated|2
4761953|NCT00585195|7735514|FG011|Overall Study|Randomized not treated|0
4761954|NCT00585195|7735515|FG012|Overall Study|Randomized not treated|0
4687704|NCT02531802|7595768|FG002|Received Vaccination 2|Withdrawal by Subject|0
4687705|NCT02531802|7595769|FG003|Received Vaccination 2|Withdrawal by Subject|0
4687706|NCT02531802|7595770|FG004|Received Vaccination 2|Withdrawal by Subject|0
4687707|NCT02531802|7595771|FG005|Received Vaccination 2|Withdrawal by Subject|0
4687708|NCT02531802|7595772|FG006|Received Vaccination 2|Withdrawal by Subject|0
4687709|NCT02531802|7595773|FG007|Received Vaccination 2|Withdrawal by Subject|0
4687710|NCT02531802|7595774|FG008|Received Vaccination 2|Withdrawal by Subject|0
4687711|NCT02531802|7595775|FG009|Received Vaccination 2|Withdrawal by Subject|0
4687712|NCT02531802|7595776|FG010|Received Vaccination 2|Withdrawal by Subject|1
4687713|NCT02531802|7595777|FG011|Received Vaccination 2|Withdrawal by Subject|0
4687714|NCT02531802|7595778|FG012|Received Vaccination 2|Withdrawal by Subject|1
4687715|NCT02531802|7595779|FG013|Received Vaccination 2|Withdrawal by Subject|1
4687716|NCT02531802|7595780|FG014|Received Vaccination 2|Withdrawal by Subject|1
4687717|NCT02531802|7595781|FG015|Received Vaccination 2|Withdrawal by Subject|0
4687718|NCT02531802|7595782|FG016|Received Vaccination 2|Withdrawal by Subject|0
4687719|NCT02531802|7595783|FG017|Received Vaccination 2|Withdrawal by Subject|1
4687720|NCT02531802|7595784|FG018|Received Vaccination 2|Withdrawal by Subject|1
4687721|NCT02531802|7595785|FG019|Received Vaccination 2|Withdrawal by Subject|1
4687722|NCT02531802|7595786|FG020|Received Vaccination 2|Withdrawal by Subject|0
4687723|NCT02532179|7595887|FG000|Overall Study|Lost to Follow-up|1
4687724|NCT02532179|7595887|FG000|Overall Study|Pregnancy|1
4687725|NCT02532179|7595887|FG000|Overall Study|Subject received depot steroid injection|1
4687726|NCT02532283|7595893|FG000|Overall Study|Adverse Event|0
4687727|NCT02532283|7595894|FG001|Overall Study|Adverse Event|1
4687728|NCT02532283|7595893|FG000|Overall Study|Death|1
4687729|NCT02532283|7595894|FG001|Overall Study|Death|0
4687730|NCT02532283|7595893|FG000|Overall Study|Lost to Follow-up|0
4687731|NCT02532283|7595894|FG001|Overall Study|Lost to Follow-up|1
4687732|NCT02532283|7595893|FG000|Overall Study|Withdrawal by Subject|8
4687733|NCT02532283|7595894|FG001|Overall Study|Withdrawal by Subject|3
4687734|NCT02532374|7595902|FG000|Overall Study|Withdrawal by Subject|1
4687735|NCT02532374|7595902|FG000|Overall Study|Physician Decision|1
4687736|NCT02532465|7595916|FG000|Overall Study|Protocol Violation|1
4687737|NCT02532465|7595917|FG001|Overall Study|Protocol Violation|0
4687738|NCT02532465|7595916|FG000|Overall Study|Lack of Efficacy|0
4687739|NCT02532465|7595917|FG001|Overall Study|Lack of Efficacy|1
4687740|NCT02532517|7595923|FG000|Overall Study|Did not complete 24-Month visit|4
4687741|NCT02532517|7595923|FG000|Overall Study|Failed Angiographic eligibility|1
4687742|NCT02532517|7595923|FG000|Overall Study|Lost to Follow-up|4
4687743|NCT02532517|7595923|FG000|Overall Study|Withdrawal by Subject|4
4687744|NCT02532517|7595923|FG000|Overall Study|Death|4
4687745|NCT02532543|7595931|FG000|Overall Study|Lost to Follow-up|0
4687746|NCT02532543|7595932|FG001|Overall Study|Lost to Follow-up|0
4687747|NCT02532543|7595933|FG002|Overall Study|Lost to Follow-up|1
4687748|NCT02532543|7595934|FG003|Overall Study|Lost to Follow-up|0
4687749|NCT02532647|7595957|FG000|Overall Study|Did not receive trial medication|1
4687750|NCT02532647|7595958|FG001|Overall Study|Did not receive trial medication|0
4687751|NCT02532647|7595959|FG002|Overall Study|Did not receive trial medication|1
4687752|NCT02532764|7595977|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
4687753|NCT02532764|7595978|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
4761955|NCT00585195|7735516|FG013|Overall Study|Randomized not treated|0
4761956|NCT00585195|7735517|FG014|Overall Study|Randomized not treated|0
4761957|NCT00585195|7735518|FG015|Overall Study|Randomized not treated|1
4687754|NCT02532764|7595979|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
4687755|NCT02532764|7595980|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
4687756|NCT02532764|7595981|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
4761958|NCT00585195|7735519|FG016|Overall Study|Randomized not treated|0
4761959|NCT00585195|7735520|FG017|Overall Study|Randomized not treated|1
4761960|NCT00585195|7735521|FG018|Overall Study|Randomized not treated|3
4761961|NCT00585195|7735522|FG019|Overall Study|Randomized not treated|0
4761962|NCT00585195|7735523|FG020|Overall Study|Randomized not treated|2
4761963|NCT00585195|7735503|FG000|Overall Study|Death|0
4761964|NCT00585195|7735504|FG001|Overall Study|Death|0
4761965|NCT00585195|7735505|FG002|Overall Study|Death|0
4761966|NCT00585195|7735506|FG003|Overall Study|Death|0
4761967|NCT00585195|7735507|FG004|Overall Study|Death|0
4761968|NCT00585195|7735508|FG005|Overall Study|Death|0
4761969|NCT00585195|7735509|FG006|Overall Study|Death|0
4761970|NCT00585195|7735510|FG007|Overall Study|Death|0
4761971|NCT00585195|7735511|FG008|Overall Study|Death|1
4761972|NCT00585195|7735512|FG009|Overall Study|Death|0
4761973|NCT00585195|7735513|FG010|Overall Study|Death|1
4761974|NCT00585195|7735514|FG011|Overall Study|Death|1
4761975|NCT00585195|7735515|FG012|Overall Study|Death|7
4761976|NCT00585195|7735516|FG013|Overall Study|Death|2
4761977|NCT00585195|7735517|FG014|Overall Study|Death|8
4761978|NCT00585195|7735518|FG015|Overall Study|Death|2
4761979|NCT00585195|7735519|FG016|Overall Study|Death|11
4761980|NCT00585195|7735520|FG017|Overall Study|Death|0
4761981|NCT00585195|7735521|FG018|Overall Study|Death|0
4761982|NCT00585195|7735522|FG019|Overall Study|Death|0
4761983|NCT00585195|7735523|FG020|Overall Study|Death|1
4761984|NCT00585195|7735503|FG000|Overall Study|Lost to Follow-up|0
4687757|NCT02532764|7595982|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
4687758|NCT02532764|7595983|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
4687759|NCT02532764|7595984|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1
4687760|NCT02532764|7595985|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1
4687761|NCT02532764|7595986|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1
4687762|NCT02532855|7596015|FG000|Overall Study|Lost to Follow-up|4
4687763|NCT02532855|7596016|FG001|Overall Study|Lost to Follow-up|3
4687764|NCT02532855|7596015|FG000|Overall Study|Withdrawal by Subject|4
4687765|NCT02532855|7596016|FG001|Overall Study|Withdrawal by Subject|8
4687766|NCT02532972|7596031|FG000|Overall Study|Withdrawal by Subject|1
4761985|NCT00585195|7735504|FG001|Overall Study|Lost to Follow-up|0
4761986|NCT00585195|7735505|FG002|Overall Study|Lost to Follow-up|0
4761987|NCT00585195|7735506|FG003|Overall Study|Lost to Follow-up|0
4761988|NCT00585195|7735507|FG004|Overall Study|Lost to Follow-up|0
4761989|NCT00585195|7735508|FG005|Overall Study|Lost to Follow-up|0
4761990|NCT00585195|7735509|FG006|Overall Study|Lost to Follow-up|0
4761991|NCT00585195|7735510|FG007|Overall Study|Lost to Follow-up|0
4761992|NCT00585195|7735511|FG008|Overall Study|Lost to Follow-up|0
4761993|NCT00585195|7735512|FG009|Overall Study|Lost to Follow-up|0
4761994|NCT00585195|7735513|FG010|Overall Study|Lost to Follow-up|0
4761995|NCT00585195|7735514|FG011|Overall Study|Lost to Follow-up|0
4761996|NCT00585195|7735515|FG012|Overall Study|Lost to Follow-up|1
4761997|NCT00585195|7735516|FG013|Overall Study|Lost to Follow-up|0
4761998|NCT00585195|7735517|FG014|Overall Study|Lost to Follow-up|0
4761999|NCT00585195|7735518|FG015|Overall Study|Lost to Follow-up|0
4762000|NCT00585195|7735519|FG016|Overall Study|Lost to Follow-up|0
4762001|NCT00585195|7735520|FG017|Overall Study|Lost to Follow-up|2
4762002|NCT00585195|7735521|FG018|Overall Study|Lost to Follow-up|0
4762003|NCT00585195|7735522|FG019|Overall Study|Lost to Follow-up|0
4762004|NCT00585195|7735523|FG020|Overall Study|Lost to Follow-up|0
4762005|NCT00585195|7735503|FG000|Overall Study|Ongoing|0
4762006|NCT00585195|7735504|FG001|Overall Study|Ongoing|0
4762007|NCT00585195|7735505|FG002|Overall Study|Ongoing|0
4762008|NCT00585195|7735506|FG003|Overall Study|Ongoing|0
4762009|NCT00585195|7735507|FG004|Overall Study|Ongoing|0
4762010|NCT00585195|7735508|FG005|Overall Study|Ongoing|0
4762011|NCT00585195|7735509|FG006|Overall Study|Ongoing|0
4762012|NCT00585195|7735510|FG007|Overall Study|Ongoing|0
4762013|NCT00585195|7735511|FG008|Overall Study|Ongoing|0
4762014|NCT00585195|7735512|FG009|Overall Study|Ongoing|0
4762015|NCT00585195|7735513|FG010|Overall Study|Ongoing|0
4762016|NCT00585195|7735514|FG011|Overall Study|Ongoing|0
4762017|NCT00585195|7735515|FG012|Overall Study|Ongoing|2
4762018|NCT00585195|7735516|FG013|Overall Study|Ongoing|0
4762019|NCT00585195|7735517|FG014|Overall Study|Ongoing|0
4762020|NCT00585195|7735518|FG015|Overall Study|Ongoing|0
4762021|NCT00585195|7735519|FG016|Overall Study|Ongoing|0
4762022|NCT00585195|7735520|FG017|Overall Study|Ongoing|0
4762023|NCT00585195|7735521|FG018|Overall Study|Ongoing|0
4762024|NCT00585195|7735522|FG019|Overall Study|Ongoing|0
4762025|NCT00585195|7735523|FG020|Overall Study|Ongoing|0
4762026|NCT00585195|7735503|FG000|Overall Study|Withdrawn Due to Pregnancy|0
4762027|NCT00585195|7735504|FG001|Overall Study|Withdrawn Due to Pregnancy|0
4762028|NCT00585195|7735505|FG002|Overall Study|Withdrawn Due to Pregnancy|0
4762029|NCT00585195|7735506|FG003|Overall Study|Withdrawn Due to Pregnancy|0
4762030|NCT00585195|7735507|FG004|Overall Study|Withdrawn Due to Pregnancy|0
4762031|NCT00585195|7735508|FG005|Overall Study|Withdrawn Due to Pregnancy|0
4762032|NCT00585195|7735509|FG006|Overall Study|Withdrawn Due to Pregnancy|0
4762033|NCT00585195|7735510|FG007|Overall Study|Withdrawn Due to Pregnancy|0
4762034|NCT00585195|7735511|FG008|Overall Study|Withdrawn Due to Pregnancy|0
4762035|NCT00585195|7735512|FG009|Overall Study|Withdrawn Due to Pregnancy|0
4762036|NCT00585195|7735513|FG010|Overall Study|Withdrawn Due to Pregnancy|0
4762037|NCT00585195|7735514|FG011|Overall Study|Withdrawn Due to Pregnancy|0
4762038|NCT00585195|7735515|FG012|Overall Study|Withdrawn Due to Pregnancy|0
4762039|NCT00585195|7735516|FG013|Overall Study|Withdrawn Due to Pregnancy|0
4762040|NCT00585195|7735517|FG014|Overall Study|Withdrawn Due to Pregnancy|1
4762041|NCT00585195|7735518|FG015|Overall Study|Withdrawn Due to Pregnancy|0
4762042|NCT00585195|7735519|FG016|Overall Study|Withdrawn Due to Pregnancy|0
4762043|NCT00585195|7735520|FG017|Overall Study|Withdrawn Due to Pregnancy|0
4762044|NCT00585195|7735521|FG018|Overall Study|Withdrawn Due to Pregnancy|0
4762045|NCT00585195|7735522|FG019|Overall Study|Withdrawn Due to Pregnancy|0
4762046|NCT00585195|7735523|FG020|Overall Study|Withdrawn Due to Pregnancy|0
4762047|NCT00278915|7735606|FG000|Overall Study|Lack of Efficacy|1
4762048|NCT04446429|7735612|FG000|Overall Study|Lost to Follow-up|6
4762049|NCT04446429|7735613|FG001|Overall Study|Lost to Follow-up|0
4762050|NCT04194528|7735636|FG000|Overall Study|Adverse Event|1
4687767|NCT02533180|7596075|FG000|Overall Study|Death|0
4687768|NCT02533180|7596076|FG001|Overall Study|Death|1
4687769|NCT02533180|7596075|FG000|Overall Study|Lost to Follow-up|0
4687770|NCT02533180|7596076|FG001|Overall Study|Lost to Follow-up|1
4687771|NCT02533180|7596075|FG000|Overall Study|Physician Decision|0
4687772|NCT02533180|7596076|FG001|Overall Study|Physician Decision|1
4687773|NCT02533180|7596075|FG000|Overall Study|Withdrawal by Subject|2
4687774|NCT02533180|7596076|FG001|Overall Study|Withdrawal by Subject|4
4687775|NCT02533180|7596075|FG000|Overall Study|Screen Failure|37
4687776|NCT02533180|7596076|FG001|Overall Study|Screen Failure|0
4687777|NCT02533180|7596075|FG000|Overall Study|Protocol Deviation|0
4687778|NCT02533180|7596076|FG001|Overall Study|Protocol Deviation|1
4687779|NCT02533180|7596075|FG000|Overall Study|On Study|0
4687780|NCT02533180|7596076|FG001|Overall Study|On Study|39
4687781|NCT02533258|7596081|FG000|Overall Study|Adverse Event|1
4687782|NCT02533258|7596081|FG000|Overall Study|Death|2
4687783|NCT02533258|7596081|FG000|Overall Study|Other|1
4687784|NCT02533258|7596081|FG000|Overall Study|Economic factor|1
4687785|NCT02533258|7596081|FG000|Overall Study|Progression of pleural effusion|1
4687786|NCT02533258|7596081|FG000|Overall Study|Lack of Efficacy|2
4687787|NCT02533375|7596085|FG000|Overall Study|Lack of Efficacy|3
4687788|NCT02533375|7596085|FG000|Overall Study|Adverse Event|2
4687789|NCT02533401|7596089|FG000|Overall Study|Adverse Event/Intercurrent Disease|3
4687790|NCT02533401|7596089|FG000|Overall Study|Death|5
4687791|NCT02533401|7596089|FG000|Overall Study|Insufficient Response/Progressed Disease|1
4687792|NCT02533401|7596089|FG000|Overall Study|Lost to Follow-up|1
4687793|NCT02533401|7596089|FG000|Overall Study|Violation of Selection Criteria|1
4687794|NCT02533453|7596100|FG000|Overall Study|Adverse Event|6
4687795|NCT02533453|7596100|FG000|Overall Study|Protocol Violation|1
4687796|NCT02533453|7596100|FG000|Overall Study|Withdrawal by Subject|2
4687797|NCT02533570|7596125|FG000|Overall Study|Adverse Event|0
4687798|NCT02533570|7596126|FG001|Overall Study|Adverse Event|1
4687799|NCT02533570|7596127|FG002|Overall Study|Adverse Event|1
4762051|NCT03116685|7735681|FG000|Overall Study|Physician Decision|0
4762052|NCT03116685|7735682|FG001|Overall Study|Physician Decision|1
4762053|NCT03099304|7735693|FG000|DB Period Day 1 to Week 24|Adverse Event|1
4762054|NCT03099304|7735694|FG001|DB Period Day 1 to Week 24|Adverse Event|1
4762055|NCT03099304|7735695|FG002|DB Period Day 1 to Week 24|Adverse Event|0
4762056|NCT03099304|7735696|FG003|DB Period Day 1 to Week 24|Adverse Event|0
4762057|NCT03099304|7735697|FG004|DB Period Day 1 to Week 24|Adverse Event|1
4762058|NCT03099304|7735693|FG000|DB Period Day 1 to Week 24|Lost to Follow-up|1
4762059|NCT03099304|7735694|FG001|DB Period Day 1 to Week 24|Lost to Follow-up|1
4762060|NCT03099304|7735695|FG002|DB Period Day 1 to Week 24|Lost to Follow-up|0
4762061|NCT03099304|7735696|FG003|DB Period Day 1 to Week 24|Lost to Follow-up|0
4762062|NCT03099304|7735697|FG004|DB Period Day 1 to Week 24|Lost to Follow-up|0
4762063|NCT03099304|7735693|FG000|DB Period Day 1 to Week 24|Reason not specified|0
4762064|NCT03099304|7735694|FG001|DB Period Day 1 to Week 24|Reason not specified|0
4762065|NCT03099304|7735695|FG002|DB Period Day 1 to Week 24|Reason not specified|0
4762066|NCT03099304|7735696|FG003|DB Period Day 1 to Week 24|Reason not specified|1
4762067|NCT03099304|7735697|FG004|DB Period Day 1 to Week 24|Reason not specified|0
4762068|NCT03099304|7735693|FG000|DB Period Day 1 to Week 24|Withdrawal by Subject|3
4762069|NCT03099304|7735694|FG001|DB Period Day 1 to Week 24|Withdrawal by Subject|3
4762070|NCT03099304|7735695|FG002|DB Period Day 1 to Week 24|Withdrawal by Subject|0
4762071|NCT03099304|7735696|FG003|DB Period Day 1 to Week 24|Withdrawal by Subject|2
4762072|NCT03099304|7735697|FG004|DB Period Day 1 to Week 24|Withdrawal by Subject|2
4762073|NCT03099304|7735693|FG000|DB Period Day 1 to Week 24|Protocol Violation|0
4762074|NCT03099304|7735694|FG001|DB Period Day 1 to Week 24|Protocol Violation|0
4762075|NCT03099304|7735695|FG002|DB Period Day 1 to Week 24|Protocol Violation|1
4762076|NCT03099304|7735696|FG003|DB Period Day 1 to Week 24|Protocol Violation|1
4762077|NCT03099304|7735697|FG004|DB Period Day 1 to Week 24|Protocol Violation|0
4762078|NCT03099304|7735693|FG000|DB Period Weeks 24 to 52|Protocol Violation|0
4762079|NCT03099304|7735694|FG001|DB Period Weeks 24 to 52|Protocol Violation|0
4762080|NCT03099304|7735695|FG002|DB Period Weeks 24 to 52|Protocol Violation|1
4762081|NCT03099304|7735696|FG003|DB Period Weeks 24 to 52|Protocol Violation|0
4762082|NCT03099304|7735697|FG004|DB Period Weeks 24 to 52|Protocol Violation|0
4762083|NCT03099304|7735693|FG000|DB Period Weeks 24 to 52|Lost to Follow-up|0
4762084|NCT03099304|7735694|FG001|DB Period Weeks 24 to 52|Lost to Follow-up|1
4762085|NCT03099304|7735695|FG002|DB Period Weeks 24 to 52|Lost to Follow-up|1
4762086|NCT03099304|7735696|FG003|DB Period Weeks 24 to 52|Lost to Follow-up|1
4762087|NCT03099304|7735697|FG004|DB Period Weeks 24 to 52|Lost to Follow-up|0
4762088|NCT03099304|7735693|FG000|DB Period Weeks 24 to 52|Adverse Event|0
4687800|NCT02533674|7596143|FG000|Dose Level I|Progressive disease|1
4687801|NCT02533674|7596144|FG001|Dose Level I|Progressive disease|0
4762089|NCT03099304|7735694|FG001|DB Period Weeks 24 to 52|Adverse Event|0
4762090|NCT03099304|7735695|FG002|DB Period Weeks 24 to 52|Adverse Event|0
4762091|NCT03099304|7735696|FG003|DB Period Weeks 24 to 52|Adverse Event|1
4762092|NCT03099304|7735697|FG004|DB Period Weeks 24 to 52|Adverse Event|1
4762093|NCT03099304|7735693|FG000|DB Period Weeks 24 to 52|Withdrawal by Subject|0
4762094|NCT03099304|7735694|FG001|DB Period Weeks 24 to 52|Withdrawal by Subject|0
4687802|NCT02533674|7596145|FG002|Dose Level I|Progressive disease|0
4687803|NCT02533674|7596146|FG003|Dose Level I|Progressive disease|0
4687804|NCT02533674|7596147|FG004|Dose Level I|Progressive disease|0
4687805|NCT02533674|7596148|FG005|Dose Level I|Progressive disease|0
4687806|NCT02533674|7596149|FG006|Dose Level I|Progressive disease|0
4687807|NCT02533674|7596150|FG007|Dose Level I|Progressive disease|0
4687808|NCT02533674|7596143|FG000|Dose Level I|Withdrawal by Subject|1
4687809|NCT02533674|7596144|FG001|Dose Level I|Withdrawal by Subject|0
4687810|NCT02533674|7596145|FG002|Dose Level I|Withdrawal by Subject|0
4687811|NCT02533674|7596146|FG003|Dose Level I|Withdrawal by Subject|0
4687812|NCT02533674|7596147|FG004|Dose Level I|Withdrawal by Subject|0
4687813|NCT02533674|7596148|FG005|Dose Level I|Withdrawal by Subject|0
4687814|NCT02533674|7596149|FG006|Dose Level I|Withdrawal by Subject|0
4687815|NCT02533674|7596150|FG007|Dose Level I|Withdrawal by Subject|0
4687816|NCT02533674|7596143|FG000|Dose Level I|Physician Decision|1
4687817|NCT02533674|7596144|FG001|Dose Level I|Physician Decision|0
4687818|NCT02533674|7596145|FG002|Dose Level I|Physician Decision|0
4687819|NCT02533674|7596146|FG003|Dose Level I|Physician Decision|0
4687820|NCT02533674|7596147|FG004|Dose Level I|Physician Decision|0
4687821|NCT02533674|7596148|FG005|Dose Level I|Physician Decision|0
4687822|NCT02533674|7596149|FG006|Dose Level I|Physician Decision|0
4687823|NCT02533674|7596150|FG007|Dose Level I|Physician Decision|0
4687824|NCT02533674|7596143|FG000|Dose Level I|Death|1
4687825|NCT02533674|7596144|FG001|Dose Level I|Death|0
4687826|NCT02533674|7596145|FG002|Dose Level I|Death|0
4687827|NCT02533674|7596146|FG003|Dose Level I|Death|0
4687828|NCT02533674|7596147|FG004|Dose Level I|Death|0
4687829|NCT02533674|7596148|FG005|Dose Level I|Death|0
4687830|NCT02533674|7596149|FG006|Dose Level I|Death|0
4687831|NCT02533674|7596150|FG007|Dose Level I|Death|0
4687832|NCT02533674|7596143|FG000|Dose Level I|Never Treated|1
4687833|NCT02533674|7596144|FG001|Dose Level I|Never Treated|0
4687834|NCT02533674|7596145|FG002|Dose Level I|Never Treated|0
4687835|NCT02533674|7596146|FG003|Dose Level I|Never Treated|0
4687836|NCT02533674|7596147|FG004|Dose Level I|Never Treated|0
4687837|NCT02533674|7596148|FG005|Dose Level I|Never Treated|0
4687838|NCT02533674|7596149|FG006|Dose Level I|Never Treated|0
4687839|NCT02533674|7596150|FG007|Dose Level I|Never Treated|0
4687840|NCT02533674|7596143|FG000|Dose Level II|Progressive disease|0
4687841|NCT02533674|7596144|FG001|Dose Level II|Progressive disease|3
4687842|NCT02533674|7596145|FG002|Dose Level II|Progressive disease|0
4687843|NCT02533674|7596146|FG003|Dose Level II|Progressive disease|0
4687844|NCT02533674|7596147|FG004|Dose Level II|Progressive disease|0
4687845|NCT02533674|7596148|FG005|Dose Level II|Progressive disease|0
4687846|NCT02533674|7596149|FG006|Dose Level II|Progressive disease|0
4687847|NCT02533674|7596150|FG007|Dose Level II|Progressive disease|0
4687848|NCT02533674|7596143|FG000|Dose Level II|Withdrawal by Subject|0
4687849|NCT02533674|7596144|FG001|Dose Level II|Withdrawal by Subject|1
4687850|NCT02533674|7596145|FG002|Dose Level II|Withdrawal by Subject|0
4687851|NCT02533674|7596146|FG003|Dose Level II|Withdrawal by Subject|0
4687852|NCT02533674|7596147|FG004|Dose Level II|Withdrawal by Subject|0
4687853|NCT02533674|7596148|FG005|Dose Level II|Withdrawal by Subject|0
4687854|NCT02533674|7596149|FG006|Dose Level II|Withdrawal by Subject|0
4687855|NCT02533674|7596150|FG007|Dose Level II|Withdrawal by Subject|0
4687856|NCT02533674|7596143|FG000|Dose Level II|Treatment-related AE|0
4687857|NCT02533674|7596144|FG001|Dose Level II|Treatment-related AE|1
4687858|NCT02533674|7596145|FG002|Dose Level II|Treatment-related AE|0
4687859|NCT02533674|7596146|FG003|Dose Level II|Treatment-related AE|0
4687860|NCT02533674|7596147|FG004|Dose Level II|Treatment-related AE|0
4687861|NCT02533674|7596148|FG005|Dose Level II|Treatment-related AE|0
4687862|NCT02533674|7596149|FG006|Dose Level II|Treatment-related AE|0
4687863|NCT02533674|7596150|FG007|Dose Level II|Treatment-related AE|0
4687864|NCT02533674|7596143|FG000|Dose Level II|Physician Decision|0
4762095|NCT03099304|7735695|FG002|DB Period Weeks 24 to 52|Withdrawal by Subject|0
4762096|NCT03099304|7735696|FG003|DB Period Weeks 24 to 52|Withdrawal by Subject|4
4762097|NCT03099304|7735697|FG004|DB Period Weeks 24 to 52|Withdrawal by Subject|1
4762098|NCT03099304|7735693|FG000|DB Period Weeks 24 to 52|Reason not specified|0
4762099|NCT03099304|7735694|FG001|DB Period Weeks 24 to 52|Reason not specified|0
4762100|NCT03099304|7735695|FG002|DB Period Weeks 24 to 52|Reason not specified|0
4762101|NCT03099304|7735696|FG003|DB Period Weeks 24 to 52|Reason not specified|1
4762102|NCT03099304|7735697|FG004|DB Period Weeks 24 to 52|Reason not specified|0
4687865|NCT02533674|7596144|FG001|Dose Level II|Physician Decision|1
4687866|NCT02533674|7596145|FG002|Dose Level II|Physician Decision|0
4687867|NCT02533674|7596146|FG003|Dose Level II|Physician Decision|0
4687868|NCT02533674|7596147|FG004|Dose Level II|Physician Decision|0
4687869|NCT02533674|7596148|FG005|Dose Level II|Physician Decision|0
4687870|NCT02533674|7596149|FG006|Dose Level II|Physician Decision|0
4687871|NCT02533674|7596150|FG007|Dose Level II|Physician Decision|0
4687872|NCT02533674|7596143|FG000|Dose Level II|Non-treatment-related AE|0
4687873|NCT02533674|7596144|FG001|Dose Level II|Non-treatment-related AE|1
4687874|NCT02533674|7596145|FG002|Dose Level II|Non-treatment-related AE|0
4687875|NCT02533674|7596146|FG003|Dose Level II|Non-treatment-related AE|0
4687876|NCT02533674|7596147|FG004|Dose Level II|Non-treatment-related AE|0
4687877|NCT02533674|7596148|FG005|Dose Level II|Non-treatment-related AE|0
4687878|NCT02533674|7596149|FG006|Dose Level II|Non-treatment-related AE|0
4687879|NCT02533674|7596150|FG007|Dose Level II|Non-treatment-related AE|0
4687880|NCT02533674|7596143|FG000|Dose Level III|Progressive disease|0
4687881|NCT02533674|7596144|FG001|Dose Level III|Progressive disease|0
4687882|NCT02533674|7596145|FG002|Dose Level III|Progressive disease|2
4687883|NCT02533674|7596146|FG003|Dose Level III|Progressive disease|0
4687884|NCT02533674|7596147|FG004|Dose Level III|Progressive disease|0
4687885|NCT02533674|7596148|FG005|Dose Level III|Progressive disease|0
4687886|NCT02533674|7596149|FG006|Dose Level III|Progressive disease|0
4687887|NCT02533674|7596150|FG007|Dose Level III|Progressive disease|0
4687888|NCT02533674|7596143|FG000|Dose Level III|Withdrawal by Subject|0
4687889|NCT02533674|7596144|FG001|Dose Level III|Withdrawal by Subject|0
4687890|NCT02533674|7596145|FG002|Dose Level III|Withdrawal by Subject|1
4687891|NCT02533674|7596146|FG003|Dose Level III|Withdrawal by Subject|0
4687892|NCT02533674|7596147|FG004|Dose Level III|Withdrawal by Subject|0
4687893|NCT02533674|7596148|FG005|Dose Level III|Withdrawal by Subject|0
4687894|NCT02533674|7596149|FG006|Dose Level III|Withdrawal by Subject|0
4687895|NCT02533674|7596150|FG007|Dose Level III|Withdrawal by Subject|0
4687896|NCT02533674|7596143|FG000|Dose Level III|Treatment-related AE|0
4687897|NCT02533674|7596144|FG001|Dose Level III|Treatment-related AE|0
4687898|NCT02533674|7596145|FG002|Dose Level III|Treatment-related AE|1
4687899|NCT02533674|7596146|FG003|Dose Level III|Treatment-related AE|0
4687900|NCT02533674|7596147|FG004|Dose Level III|Treatment-related AE|0
4687901|NCT02533674|7596148|FG005|Dose Level III|Treatment-related AE|0
4687902|NCT02533674|7596149|FG006|Dose Level III|Treatment-related AE|0
4687903|NCT02533674|7596150|FG007|Dose Level III|Treatment-related AE|0
4687904|NCT02533674|7596143|FG000|Dose Level IV|Progressive disease|0
4687905|NCT02533674|7596144|FG001|Dose Level IV|Progressive disease|0
4687906|NCT02533674|7596145|FG002|Dose Level IV|Progressive disease|0
4687907|NCT02533674|7596146|FG003|Dose Level IV|Progressive disease|3
4687908|NCT02533674|7596147|FG004|Dose Level IV|Progressive disease|0
4687909|NCT02533674|7596148|FG005|Dose Level IV|Progressive disease|0
4687910|NCT02533674|7596149|FG006|Dose Level IV|Progressive disease|0
4687911|NCT02533674|7596150|FG007|Dose Level IV|Progressive disease|0
4687912|NCT02533674|7596143|FG000|Dose Level IV|Withdrawal by Subject|0
4687913|NCT02533674|7596144|FG001|Dose Level IV|Withdrawal by Subject|0
4687914|NCT02533674|7596145|FG002|Dose Level IV|Withdrawal by Subject|0
4687915|NCT02533674|7596146|FG003|Dose Level IV|Withdrawal by Subject|1
4687916|NCT02533674|7596147|FG004|Dose Level IV|Withdrawal by Subject|0
4687917|NCT02533674|7596148|FG005|Dose Level IV|Withdrawal by Subject|0
4687918|NCT02533674|7596149|FG006|Dose Level IV|Withdrawal by Subject|0
4762103|NCT02682901|7735743|FG000|Overall Study|Adverse Event|10
4762104|NCT02682901|7735744|FG001|Overall Study|Adverse Event|3
4762105|NCT02682901|7735743|FG000|Overall Study|Lack of Efficacy|0
4762106|NCT02682901|7735744|FG001|Overall Study|Lack of Efficacy|1
4762107|NCT02567825|7735752|FG000|Overall Study|No follow-up post-randomization|5
4762108|NCT02567825|7735753|FG001|Overall Study|No follow-up post-randomization|1
4762109|NCT02567825|7735752|FG000|Overall Study|Follow-up less than 23 months|16
4762110|NCT02567825|7735753|FG001|Overall Study|Follow-up less than 23 months|20
4762111|NCT02555657|7735761|FG000|Overall Study|Death|274
4762112|NCT02555657|7735762|FG001|Overall Study|Death|262
4762113|NCT02555657|7735761|FG000|Overall Study|Physician Decision|0
4762114|NCT02555657|7735762|FG001|Overall Study|Physician Decision|1
4762115|NCT02555657|7735761|FG000|Overall Study|Sponsor Decision|27
4762116|NCT02555657|7735762|FG001|Overall Study|Sponsor Decision|15
4762117|NCT02555657|7735761|FG000|Overall Study|Withdrawal by Subject|11
4687919|NCT02533674|7596150|FG007|Dose Level IV|Withdrawal by Subject|0
4687920|NCT02533674|7596143|FG000|Dose Level IV|Physician Decision|0
4687921|NCT02533674|7596144|FG001|Dose Level IV|Physician Decision|0
4687922|NCT02533674|7596145|FG002|Dose Level IV|Physician Decision|0
4687923|NCT02533674|7596146|FG003|Dose Level IV|Physician Decision|1
4687924|NCT02533674|7596147|FG004|Dose Level IV|Physician Decision|0
4687925|NCT02533674|7596148|FG005|Dose Level IV|Physician Decision|0
4687926|NCT02533674|7596149|FG006|Dose Level IV|Physician Decision|0
4687927|NCT02533674|7596150|FG007|Dose Level IV|Physician Decision|0
4687928|NCT02533674|7596143|FG000|Dose Level V|Progressive disease|0
4687929|NCT02533674|7596144|FG001|Dose Level V|Progressive disease|0
4687930|NCT02533674|7596145|FG002|Dose Level V|Progressive disease|0
4687931|NCT02533674|7596146|FG003|Dose Level V|Progressive disease|0
4687932|NCT02533674|7596147|FG004|Dose Level V|Progressive disease|3
4687933|NCT02533674|7596148|FG005|Dose Level V|Progressive disease|0
4687934|NCT02533674|7596149|FG006|Dose Level V|Progressive disease|0
4687935|NCT02533674|7596150|FG007|Dose Level V|Progressive disease|0
4687936|NCT02533674|7596143|FG000|Dose Level V|Withdrawal by Subject|0
4687937|NCT02533674|7596144|FG001|Dose Level V|Withdrawal by Subject|0
4687938|NCT02533674|7596145|FG002|Dose Level V|Withdrawal by Subject|0
4762118|NCT02555657|7735762|FG001|Overall Study|Withdrawal by Subject|32
4687939|NCT02533674|7596146|FG003|Dose Level V|Withdrawal by Subject|0
4687940|NCT02533674|7596147|FG004|Dose Level V|Withdrawal by Subject|1
4687941|NCT02533674|7596148|FG005|Dose Level V|Withdrawal by Subject|0
4687942|NCT02533674|7596149|FG006|Dose Level V|Withdrawal by Subject|0
4687943|NCT02533674|7596150|FG007|Dose Level V|Withdrawal by Subject|0
4687944|NCT02533674|7596143|FG000|Dose Level V|Physician Decision|0
4687945|NCT02533674|7596144|FG001|Dose Level V|Physician Decision|0
4687946|NCT02533674|7596145|FG002|Dose Level V|Physician Decision|0
4687947|NCT02533674|7596146|FG003|Dose Level V|Physician Decision|0
4687948|NCT02533674|7596147|FG004|Dose Level V|Physician Decision|1
4687949|NCT02533674|7596148|FG005|Dose Level V|Physician Decision|0
4687950|NCT02533674|7596149|FG006|Dose Level V|Physician Decision|0
4687951|NCT02533674|7596150|FG007|Dose Level V|Physician Decision|0
4687952|NCT02533674|7596143|FG000|Dose Level VI|Progressive disease|0
4687953|NCT02533674|7596144|FG001|Dose Level VI|Progressive disease|0
4687954|NCT02533674|7596145|FG002|Dose Level VI|Progressive disease|0
4687955|NCT02533674|7596146|FG003|Dose Level VI|Progressive disease|0
4687956|NCT02533674|7596147|FG004|Dose Level VI|Progressive disease|0
4687957|NCT02533674|7596148|FG005|Dose Level VI|Progressive disease|7
4687958|NCT02533674|7596149|FG006|Dose Level VI|Progressive disease|0
4687959|NCT02533674|7596150|FG007|Dose Level VI|Progressive disease|0
4687960|NCT02533674|7596143|FG000|Dose Level VI|Withdrawal by Subject|0
4687961|NCT02533674|7596144|FG001|Dose Level VI|Withdrawal by Subject|0
4687962|NCT02533674|7596145|FG002|Dose Level VI|Withdrawal by Subject|0
4687963|NCT02533674|7596146|FG003|Dose Level VI|Withdrawal by Subject|0
4687964|NCT02533674|7596147|FG004|Dose Level VI|Withdrawal by Subject|0
4687965|NCT02533674|7596148|FG005|Dose Level VI|Withdrawal by Subject|1
4687966|NCT02533674|7596149|FG006|Dose Level VI|Withdrawal by Subject|0
4687967|NCT02533674|7596150|FG007|Dose Level VI|Withdrawal by Subject|0
4687968|NCT02533674|7596143|FG000|Dose Level VI|Treatment-related AE|0
4687969|NCT02533674|7596144|FG001|Dose Level VI|Treatment-related AE|0
4687970|NCT02533674|7596145|FG002|Dose Level VI|Treatment-related AE|0
4687971|NCT02533674|7596146|FG003|Dose Level VI|Treatment-related AE|0
4687972|NCT02533674|7596147|FG004|Dose Level VI|Treatment-related AE|0
4687973|NCT02533674|7596148|FG005|Dose Level VI|Treatment-related AE|1
4687974|NCT02533674|7596149|FG006|Dose Level VI|Treatment-related AE|0
4687975|NCT02533674|7596150|FG007|Dose Level VI|Treatment-related AE|0
4687976|NCT02533674|7596143|FG000|Dose Level VII|Progressive disease|0
4687977|NCT02533674|7596144|FG001|Dose Level VII|Progressive disease|0
4687978|NCT02533674|7596145|FG002|Dose Level VII|Progressive disease|0
4762119|NCT02190721|7735772|FG000|Overall Study|Patient was out of the city|0
4762120|NCT02190721|7735773|FG001|Overall Study|Patient was out of the city|1
4762121|NCT02190721|7735774|FG002|Overall Study|Patient was out of the city|0
4687979|NCT02533674|7596146|FG003|Dose Level VII|Progressive disease|0
4687980|NCT02533674|7596147|FG004|Dose Level VII|Progressive disease|0
4687981|NCT02533674|7596148|FG005|Dose Level VII|Progressive disease|0
4687982|NCT02533674|7596149|FG006|Dose Level VII|Progressive disease|10
4687983|NCT02533674|7596150|FG007|Dose Level VII|Progressive disease|0
4687984|NCT02533674|7596143|FG000|Dose Level VII|Withdrawal by Subject|0
4687985|NCT02533674|7596144|FG001|Dose Level VII|Withdrawal by Subject|0
4687986|NCT02533674|7596145|FG002|Dose Level VII|Withdrawal by Subject|0
4687987|NCT02533674|7596146|FG003|Dose Level VII|Withdrawal by Subject|0
4687988|NCT02533674|7596147|FG004|Dose Level VII|Withdrawal by Subject|0
4687989|NCT02533674|7596148|FG005|Dose Level VII|Withdrawal by Subject|0
4687990|NCT02533674|7596149|FG006|Dose Level VII|Withdrawal by Subject|3
4687991|NCT02533674|7596150|FG007|Dose Level VII|Withdrawal by Subject|0
4687992|NCT02533674|7596143|FG000|Dose Level VII|Treatment-related AE|0
4687993|NCT02533674|7596144|FG001|Dose Level VII|Treatment-related AE|0
4687994|NCT02533674|7596145|FG002|Dose Level VII|Treatment-related AE|0
4762122|NCT00739401|7735807|FG000|Overall Study|patients were not due for the 2 year follow-up|34
4762123|NCT00739401|7735807|FG000|Overall Study|Death|3
4762124|NCT00739401|7735807|FG000|Overall Study|Withdrawal by Subject|4
4762125|NCT00651742|7735811|FG000|Overall Study|Objective Disease Progression|22
4762126|NCT00651742|7735811|FG000|Overall Study|Toxicity|3
4762127|NCT00651742|7735811|FG000|Overall Study|Investigator Judgment|1
4762128|NCT00651742|7735811|FG000|Overall Study|Withdrawal of Consent|1
4762129|NCT00651742|7735811|FG000|Overall Study|Enrolled but not treated|1
4687995|NCT02533674|7596146|FG003|Dose Level VII|Treatment-related AE|0
4687996|NCT02533674|7596147|FG004|Dose Level VII|Treatment-related AE|0
4687997|NCT02533674|7596148|FG005|Dose Level VII|Treatment-related AE|0
4687998|NCT02533674|7596149|FG006|Dose Level VII|Treatment-related AE|1
4687999|NCT02533674|7596150|FG007|Dose Level VII|Treatment-related AE|0
4688000|NCT02533674|7596143|FG000|Dose Level VII|Death|0
4688001|NCT02533674|7596144|FG001|Dose Level VII|Death|0
4688002|NCT02533674|7596145|FG002|Dose Level VII|Death|0
4688003|NCT02533674|7596146|FG003|Dose Level VII|Death|0
4688004|NCT02533674|7596147|FG004|Dose Level VII|Death|0
4688005|NCT02533674|7596148|FG005|Dose Level VII|Death|0
4688006|NCT02533674|7596149|FG006|Dose Level VII|Death|2
4688007|NCT02533674|7596150|FG007|Dose Level VII|Death|0
4688008|NCT02533674|7596143|FG000|Dose Level VIII|Progressive disease|0
4688009|NCT02533674|7596144|FG001|Dose Level VIII|Progressive disease|0
4688010|NCT02533674|7596145|FG002|Dose Level VIII|Progressive disease|0
4688011|NCT02533674|7596146|FG003|Dose Level VIII|Progressive disease|0
4688012|NCT02533674|7596147|FG004|Dose Level VIII|Progressive disease|0
4688013|NCT02533674|7596148|FG005|Dose Level VIII|Progressive disease|0
4688014|NCT02533674|7596149|FG006|Dose Level VIII|Progressive disease|0
4688015|NCT02533674|7596150|FG007|Dose Level VIII|Progressive disease|3
4688016|NCT02533674|7596143|FG000|Dose Level VIII|Withdrawal by Subject|0
4688017|NCT02533674|7596144|FG001|Dose Level VIII|Withdrawal by Subject|0
4688018|NCT02533674|7596145|FG002|Dose Level VIII|Withdrawal by Subject|0
4688019|NCT02533674|7596146|FG003|Dose Level VIII|Withdrawal by Subject|0
4688020|NCT02533674|7596147|FG004|Dose Level VIII|Withdrawal by Subject|0
4688021|NCT02533674|7596148|FG005|Dose Level VIII|Withdrawal by Subject|0
4688022|NCT02533674|7596149|FG006|Dose Level VIII|Withdrawal by Subject|0
4688023|NCT02533674|7596150|FG007|Dose Level VIII|Withdrawal by Subject|1
4688024|NCT02533674|7596143|FG000|Dose Level VIII|Treatment-related AE|0
4688025|NCT02533674|7596144|FG001|Dose Level VIII|Treatment-related AE|0
4688026|NCT02533674|7596145|FG002|Dose Level VIII|Treatment-related AE|0
4688027|NCT02533674|7596146|FG003|Dose Level VIII|Treatment-related AE|0
4688028|NCT02533674|7596147|FG004|Dose Level VIII|Treatment-related AE|0
4688029|NCT02533674|7596148|FG005|Dose Level VIII|Treatment-related AE|0
4688030|NCT02533674|7596149|FG006|Dose Level VIII|Treatment-related AE|0
4688031|NCT02533674|7596150|FG007|Dose Level VIII|Treatment-related AE|1
4688032|NCT02533674|7596143|FG000|Dose Level VIII|Never treated|0
4688033|NCT02533674|7596144|FG001|Dose Level VIII|Never treated|0
4688034|NCT02533674|7596145|FG002|Dose Level VIII|Never treated|0
4688035|NCT02533674|7596146|FG003|Dose Level VIII|Never treated|0
4688036|NCT02533674|7596147|FG004|Dose Level VIII|Never treated|0
4688037|NCT02533674|7596148|FG005|Dose Level VIII|Never treated|0
4688038|NCT02533674|7596149|FG006|Dose Level VIII|Never treated|0
4688039|NCT02533674|7596150|FG007|Dose Level VIII|Never treated|1
4688040|NCT02533999|7596197|FG000|Overall Study|Lost to Follow-up|3
4688041|NCT02533999|7596198|FG001|Overall Study|Lost to Follow-up|5
4688042|NCT02533999|7596197|FG000|Overall Study|Protocol Violation|3
4688043|NCT02533999|7596198|FG001|Overall Study|Protocol Violation|0
4688044|NCT02533999|7596197|FG000|Overall Study|Adverse Event|0
4688045|NCT02533999|7596198|FG001|Overall Study|Adverse Event|1
4688046|NCT02533999|7596197|FG000|Overall Study|Randomized but intervention not received|0
4688047|NCT02533999|7596198|FG001|Overall Study|Randomized but intervention not received|1
4688048|NCT02534324|7596222|FG000|Overall Study|Protocol Violation|4
4688049|NCT02534324|7596223|FG001|Overall Study|Protocol Violation|1
4688050|NCT02534324|7596222|FG000|Overall Study|Lost to Follow-up|20
4688051|NCT02534324|7596223|FG001|Overall Study|Lost to Follow-up|7
4688052|NCT02534324|7596222|FG000|Overall Study|Adverse Event|1
4688053|NCT02534324|7596223|FG001|Overall Study|Adverse Event|0
4688054|NCT02534350|7596231|FG000|Overall Study|Randomized But Not Treated|1
4688055|NCT02534350|7596232|FG001|Overall Study|Randomized But Not Treated|0
4688056|NCT02534350|7596231|FG000|Overall Study|Protocol Violation|1
4688057|NCT02534350|7596232|FG001|Overall Study|Protocol Violation|0
4688058|NCT02534350|7596231|FG000|Overall Study|Withdrew Consent|2
4688059|NCT02534350|7596232|FG001|Overall Study|Withdrew Consent|0
4688060|NCT02534493|7596238|FG000|Overall Study|Lost to Follow-up|1
4688061|NCT02534493|7596238|FG000|Overall Study|Withdrawal by Subject|1
4688062|NCT02534883|7596246|FG000|Overall Study|Early Termination|8
4688063|NCT02534883|7596247|FG001|Overall Study|Early Termination|3
4688064|NCT02534896|7596256|FG000|Overall Study|Adverse Event|2
4688065|NCT02534896|7596257|FG001|Overall Study|Adverse Event|1
4688066|NCT02534896|7596258|FG002|Overall Study|Adverse Event|1
4688067|NCT02534896|7596256|FG000|Overall Study|Insufficient therapeutic response|2
4688068|NCT02534896|7596257|FG001|Overall Study|Insufficient therapeutic response|0
4688069|NCT02534896|7596258|FG002|Overall Study|Insufficient therapeutic response|0
4688070|NCT02534935|7596269|FG000|Stage 1: 24 Months|Withdrawal by Subject|0
4688071|NCT02534935|7596270|FG001|Stage 1: 24 Months|Withdrawal by Subject|3
4688072|NCT02534935|7596271|FG002|Stage 1: 24 Months|Withdrawal by Subject|3
4688073|NCT02534935|7596269|FG000|Stage 1: 24 Months|No longer willing to participate in study|0
4688074|NCT02534935|7596270|FG001|Stage 1: 24 Months|No longer willing to participate in study|1
4688075|NCT02534935|7596271|FG002|Stage 1: 24 Months|No longer willing to participate in study|1
4688076|NCT02534935|7596269|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0
4688077|NCT02534935|7596270|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3
4688078|NCT02534935|7596271|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0
4688079|NCT02534935|7596269|FG000|Stage 1: 24 Months|Lost to Follow-up|0
4688080|NCT02534935|7596270|FG001|Stage 1: 24 Months|Lost to Follow-up|1
4688081|NCT02534935|7596271|FG002|Stage 1: 24 Months|Lost to Follow-up|1
4688082|NCT02534935|7596269|FG000|Stage 1: 24 Months|Adverse Event|0
4688083|NCT02534935|7596270|FG001|Stage 1: 24 Months|Adverse Event|2
4688084|NCT02534935|7596271|FG002|Stage 1: 24 Months|Adverse Event|0
4688085|NCT02534935|7596269|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0
4688086|NCT02534935|7596270|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4
4688087|NCT02534935|7596271|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0
4688088|NCT02534935|7596269|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0
4762130|NCT04930263|7735830|FG000|Overall Study|Withdrawal by Subject|3
4762131|NCT04930263|7735831|FG001|Overall Study|Withdrawal by Subject|5
4762132|NCT04321252|7735846|FG000|Overall Study|Withdrawal by Subject|0
4762133|NCT04321252|7735847|FG001|Overall Study|Withdrawal by Subject|0
4762134|NCT04321252|7735848|FG002|Overall Study|Withdrawal by Subject|0
4762135|NCT04321252|7735849|FG003|Overall Study|Withdrawal by Subject|0
4762136|NCT04321252|7735850|FG004|Overall Study|Withdrawal by Subject|0
4762137|NCT04321252|7735851|FG005|Overall Study|Withdrawal by Subject|1
4762138|NCT04321252|7735852|FG006|Overall Study|Withdrawal by Subject|0
4762139|NCT04321252|7735853|FG007|Overall Study|Withdrawal by Subject|0
4762140|NCT04321252|7735854|FG008|Overall Study|Withdrawal by Subject|0
4762141|NCT04176445|7735884|FG000|Overall Study|Adverse Event|0
4762142|NCT04176445|7735885|FG001|Overall Study|Adverse Event|1
4762143|NCT04176445|7735884|FG000|Overall Study|change plans weaning after first intervention|0
4762144|NCT04176445|7735885|FG001|Overall Study|change plans weaning after first intervention|1
4762145|NCT04126213|7735897|FG000|Overall Study|Lost to Follow-up|9
4762146|NCT04126213|7735898|FG001|Overall Study|Lost to Follow-up|1
4762147|NCT04126213|7735899|FG002|Overall Study|Lost to Follow-up|5
4762148|NCT04126213|7735900|FG003|Overall Study|Lost to Follow-up|10
4762149|NCT04126213|7735901|FG004|Overall Study|Lost to Follow-up|4
4762150|NCT04126213|7735902|FG005|Overall Study|Lost to Follow-up|7
4762151|NCT04126213|7735897|FG000|Overall Study|Withdrawal by Subject|3
4762152|NCT04126213|7735898|FG001|Overall Study|Withdrawal by Subject|2
4762153|NCT04126213|7735899|FG002|Overall Study|Withdrawal by Subject|1
4762154|NCT04126213|7735900|FG003|Overall Study|Withdrawal by Subject|1
4762155|NCT04126213|7735901|FG004|Overall Study|Withdrawal by Subject|1
4762156|NCT04126213|7735902|FG005|Overall Study|Withdrawal by Subject|1
4762157|NCT04126213|7735897|FG000|Overall Study|Other|0
4762158|NCT04126213|7735898|FG001|Overall Study|Other|0
4762159|NCT04126213|7735899|FG002|Overall Study|Other|2
4762160|NCT04126213|7735900|FG003|Overall Study|Other|2
4762161|NCT04126213|7735901|FG004|Overall Study|Other|0
4762162|NCT04126213|7735902|FG005|Overall Study|Other|1
4762163|NCT04126213|7735897|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
4762164|NCT04126213|7735898|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2
4762165|NCT04126213|7735899|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1
4762166|NCT04126213|7735900|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0
4688089|NCT02534935|7596270|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1
4688090|NCT02534935|7596271|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0
4688091|NCT02535000|7596299|FG000|Overall Study|Cancellation of surgery.|1
4688092|NCT02535000|7596300|FG001|Overall Study|Cancellation of surgery.|2
4688093|NCT02535364|7596320|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22
4688094|NCT02535364|7596320|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2
4688095|NCT02535364|7596320|FG000|Part A Screening Through Leukapheresis|Disease progression|1
4688096|NCT02535364|7596320|FG000|Part B Screening|Study placed on clinical hold by FDA|7
4688097|NCT02535364|7596320|FG000|Part B Screening|Unable to manufacture JCAR015|3
4688098|NCT02535364|7596320|FG000|Part B Screening|Death|2
4688099|NCT02535364|7596320|FG000|Part B Screening|Physician Decision|1
4688100|NCT02535364|7596320|FG000|Part B Screening|Withdrawal by Subject|1
4688101|NCT02535364|7596320|FG000|Part B Screening|Adverse Event|1
4688102|NCT02535364|7596320|FG000|Part B Screening|Change in diagnosis, no longer eligible|2
4688103|NCT02535364|7596320|FG000|Study Treatment|Death|1
4688104|NCT02535364|7596320|FG000|Study Treatment|Study placed on clinical hold by FDA|1
4688105|NCT02535364|7596320|FG000|12-Month Follow-up Period|Disease progression|22
4688106|NCT02535364|7596320|FG000|12-Month Follow-up Period|Death|5
4688107|NCT02535364|7596320|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5
4688108|NCT02535364|7596320|FG000|12-Month Follow-up Period|Subject received alternative therapy|2
4688109|NCT02535364|7596320|FG000|12-Month Follow-up Period|Subject transferred to hospice|1
4688110|NCT02535416|7596333|FG000|Overall Study|Family bereavement overseas|1
4762167|NCT04126213|7735901|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1
4688111|NCT02535416|7596334|FG001|Overall Study|Family bereavement overseas|0
4688112|NCT02535416|7596335|FG002|Overall Study|Family bereavement overseas|0
4688113|NCT02535416|7596336|FG003|Overall Study|Family bereavement overseas|0
4688114|NCT02535416|7596337|FG004|Overall Study|Family bereavement overseas|0
4688115|NCT02535416|7596338|FG005|Overall Study|Family bereavement overseas|0
4688116|NCT02535416|7596339|FG006|Overall Study|Family bereavement overseas|0
4688117|NCT02535416|7596340|FG007|Overall Study|Family bereavement overseas|0
4688118|NCT02535416|7596341|FG008|Overall Study|Family bereavement overseas|0
4688119|NCT02535715|7596393|FG000|Overall Study|Withdrawal by Subject|0
4688120|NCT02535715|7596394|FG001|Overall Study|Withdrawal by Subject|0
4688121|NCT02535715|7596395|FG002|Overall Study|Withdrawal by Subject|1
4688122|NCT02535741|7596406|FG000|Overall Study|Adverse Event|3
4688123|NCT02535741|7596406|FG000|Overall Study|Withdrawal by Subject|9
4688124|NCT02535741|7596406|FG000|Overall Study|Lost to Follow-up|10
4688125|NCT02535741|7596406|FG000|Overall Study|Exclusion criteria: Bilateral implant|4
4762168|NCT04126213|7735902|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2
4762169|NCT03672188|7735938|FG000|Overall Study|Withdrawal by Subject|0
4762170|NCT03672188|7735939|FG001|Overall Study|Withdrawal by Subject|0
4762171|NCT03672188|7735940|FG002|Overall Study|Withdrawal by Subject|0
4762172|NCT03672188|7735941|FG003|Overall Study|Withdrawal by Subject|3
4762173|NCT03672188|7735942|FG004|Overall Study|Withdrawal by Subject|0
4762174|NCT03672188|7735943|FG005|Overall Study|Withdrawal by Subject|0
4762175|NCT03672188|7735944|FG006|Overall Study|Withdrawal by Subject|0
4762176|NCT03672188|7735945|FG007|Overall Study|Withdrawal by Subject|0
4762177|NCT03672188|7735946|FG008|Overall Study|Withdrawal by Subject|0
4762178|NCT03672188|7735947|FG009|Overall Study|Withdrawal by Subject|0
4762179|NCT03672188|7735948|FG010|Overall Study|Withdrawal by Subject|0
4762180|NCT03672188|7735949|FG011|Overall Study|Withdrawal by Subject|0
4762181|NCT03672188|7735950|FG012|Overall Study|Withdrawal by Subject|0
4762182|NCT03672188|7735951|FG013|Overall Study|Withdrawal by Subject|0
4762183|NCT03672188|7735952|FG014|Overall Study|Withdrawal by Subject|0
4762184|NCT03672188|7735938|FG000|Overall Study|Death|0
4762185|NCT03672188|7735939|FG001|Overall Study|Death|0
4762186|NCT03672188|7735940|FG002|Overall Study|Death|0
4762187|NCT03672188|7735941|FG003|Overall Study|Death|0
4762188|NCT03672188|7735942|FG004|Overall Study|Death|0
4762189|NCT03672188|7735943|FG005|Overall Study|Death|0
4762190|NCT03672188|7735944|FG006|Overall Study|Death|0
4762191|NCT03672188|7735945|FG007|Overall Study|Death|0
4762192|NCT03672188|7735946|FG008|Overall Study|Death|0
4762193|NCT03672188|7735947|FG009|Overall Study|Death|0
4762194|NCT03672188|7735948|FG010|Overall Study|Death|0
4762195|NCT03672188|7735949|FG011|Overall Study|Death|0
4762196|NCT03672188|7735950|FG012|Overall Study|Death|1
4762197|NCT03672188|7735951|FG013|Overall Study|Death|0
4762198|NCT03672188|7735952|FG014|Overall Study|Death|0
4762199|NCT03672188|7735938|FG000|Overall Study|Lost to Follow-up|0
4762200|NCT03672188|7735939|FG001|Overall Study|Lost to Follow-up|0
4762201|NCT03672188|7735940|FG002|Overall Study|Lost to Follow-up|1
4762202|NCT03672188|7735941|FG003|Overall Study|Lost to Follow-up|0
4762203|NCT03672188|7735942|FG004|Overall Study|Lost to Follow-up|0
4762204|NCT03672188|7735943|FG005|Overall Study|Lost to Follow-up|0
4762205|NCT03672188|7735944|FG006|Overall Study|Lost to Follow-up|0
4762206|NCT03672188|7735945|FG007|Overall Study|Lost to Follow-up|0
4762207|NCT03672188|7735946|FG008|Overall Study|Lost to Follow-up|0
4762208|NCT03672188|7735947|FG009|Overall Study|Lost to Follow-up|0
4762209|NCT03672188|7735948|FG010|Overall Study|Lost to Follow-up|0
4762210|NCT03672188|7735949|FG011|Overall Study|Lost to Follow-up|0
4762211|NCT03672188|7735950|FG012|Overall Study|Lost to Follow-up|0
4762212|NCT03672188|7735951|FG013|Overall Study|Lost to Follow-up|0
4762213|NCT03672188|7735952|FG014|Overall Study|Lost to Follow-up|0
4762214|NCT03573336|7736025|FG000|Overall Study|Study terminated|2
4762215|NCT03573336|7736026|FG001|Overall Study|Study terminated|4
4762216|NCT03573336|7736027|FG002|Overall Study|Study terminated|2
4762217|NCT03230916|7736046|FG000|Overall Study|Withdrawal by Subject|0
4762218|NCT03230916|7736047|FG001|Overall Study|Withdrawal by Subject|0
4762219|NCT03230916|7736048|FG002|Overall Study|Withdrawal by Subject|0
4762220|NCT03230916|7736049|FG003|Overall Study|Withdrawal by Subject|0
4762221|NCT03230916|7736050|FG004|Overall Study|Withdrawal by Subject|0
4762222|NCT03230916|7736051|FG005|Overall Study|Withdrawal by Subject|1
4762223|NCT03230916|7736052|FG006|Overall Study|Withdrawal by Subject|0
4762224|NCT03230916|7736053|FG007|Overall Study|Withdrawal by Subject|0
4762225|NCT03230916|7736054|FG008|Overall Study|Withdrawal by Subject|0
4762226|NCT03230916|7736055|FG009|Overall Study|Withdrawal by Subject|0
4762227|NCT03230916|7736056|FG010|Overall Study|Withdrawal by Subject|0
4688126|NCT02535741|7596406|FG000|Overall Study|Missing data|6
4688127|NCT02536313|7596471|FG000|Overall Study|Lack of Efficacy|0
4688128|NCT02536313|7596472|FG001|Overall Study|Lack of Efficacy|1
4688129|NCT02536378|7596482|FG000|Overall Study|Physician Decision|0
4688130|NCT02536378|7596483|FG001|Overall Study|Physician Decision|2
4762228|NCT03195894|7736099|FG000|Overall Study|"An example is Started other treatment."|4
4762229|NCT03195894|7736100|FG001|Overall Study|"An example is Started other treatment."|5
4762230|NCT03195894|7736099|FG000|Overall Study|Withdrawal by Subject|15
4762231|NCT03195894|7736100|FG001|Overall Study|Withdrawal by Subject|4
4762232|NCT03195894|7736099|FG000|Overall Study|Lost to Follow-up|14
4688131|NCT02536378|7596482|FG000|Overall Study|Withdrawal by Subject|0
4688132|NCT02536378|7596483|FG001|Overall Study|Withdrawal by Subject|1
4688133|NCT02536378|7596482|FG000|Overall Study|Death|1
4688134|NCT02536378|7596483|FG001|Overall Study|Death|2
4688135|NCT02536378|7596482|FG000|Overall Study|Patient refused further follow up|6
4688136|NCT02536378|7596483|FG001|Overall Study|Patient refused further follow up|2
4688137|NCT02536404|7596493|FG000|Overall Study|Adverse Event|5
4688138|NCT02536404|7596494|FG001|Overall Study|Adverse Event|0
4688139|NCT02536404|7596493|FG000|Overall Study|Withdrawal by Subject|4
4688140|NCT02536404|7596494|FG001|Overall Study|Withdrawal by Subject|1
4688141|NCT02536404|7596493|FG000|Overall Study|Physician Decision|10
4688142|NCT02536404|7596494|FG001|Overall Study|Physician Decision|0
4688143|NCT02536404|7596493|FG000|Overall Study|Sponsor decision|1
4688144|NCT02536404|7596494|FG001|Overall Study|Sponsor decision|0
4688145|NCT02536508|7596503|FG000|Overall Study|Withdrawal by Subject|18
4688146|NCT02536508|7596504|FG001|Overall Study|Withdrawal by Subject|13
4688147|NCT02536508|7596505|FG002|Overall Study|Withdrawal by Subject|7
4688148|NCT02536508|7596503|FG000|Overall Study|Adverse Event|14
4688149|NCT02536508|7596504|FG001|Overall Study|Adverse Event|13
4688150|NCT02536508|7596505|FG002|Overall Study|Adverse Event|6
4688151|NCT02536508|7596503|FG000|Overall Study|Lost to Follow-up|12
4688152|NCT02536508|7596504|FG001|Overall Study|Lost to Follow-up|4
4688153|NCT02536508|7596505|FG002|Overall Study|Lost to Follow-up|0
4688154|NCT02536508|7596503|FG000|Overall Study|Lack of Efficacy|3
4688155|NCT02536508|7596504|FG001|Overall Study|Lack of Efficacy|5
4688156|NCT02536508|7596505|FG002|Overall Study|Lack of Efficacy|4
4688157|NCT02536508|7596503|FG000|Overall Study|Protocol Discontinuation Criteria|3
4688158|NCT02536508|7596504|FG001|Overall Study|Protocol Discontinuation Criteria|2
4688159|NCT02536508|7596505|FG002|Overall Study|Protocol Discontinuation Criteria|2
4688160|NCT02536508|7596503|FG000|Overall Study|Physician Decision|0
4688161|NCT02536508|7596504|FG001|Overall Study|Physician Decision|4
4688162|NCT02536508|7596505|FG002|Overall Study|Physician Decision|2
4688163|NCT02536508|7596503|FG000|Overall Study|Major Protocol Deviation|2
4688164|NCT02536508|7596504|FG001|Overall Study|Major Protocol Deviation|2
4688165|NCT02536508|7596505|FG002|Overall Study|Major Protocol Deviation|2
4688166|NCT02536508|7596503|FG000|Overall Study|Administrative Reasons|0
4688167|NCT02536508|7596504|FG001|Overall Study|Administrative Reasons|1
4688168|NCT02536508|7596505|FG002|Overall Study|Administrative Reasons|0
4688169|NCT02536664|7596515|FG000|Overall Study|Inadequate completion of documentation|2
4688170|NCT02536664|7596516|FG001|Overall Study|Inadequate completion of documentation|4
4688171|NCT02536664|7596515|FG000|Overall Study|Progression|13
4688172|NCT02536664|7596516|FG001|Overall Study|Progression|18
4688173|NCT02536664|7596515|FG000|Overall Study|Death due to lymphoma|2
4688174|NCT02536664|7596516|FG001|Overall Study|Death due to lymphoma|1
4688175|NCT02536664|7596515|FG000|Overall Study|Death due to other reason|3
4688176|NCT02536664|7596516|FG001|Overall Study|Death due to other reason|2
4688177|NCT02536664|7596515|FG000|Overall Study|Intolerability|8
4688178|NCT02536664|7596516|FG001|Overall Study|Intolerability|6
4688179|NCT02536664|7596515|FG000|Overall Study|Withdrawal by Subject|8
4688180|NCT02536664|7596516|FG001|Overall Study|Withdrawal by Subject|5
4688181|NCT02536664|7596515|FG000|Overall Study|Other|18
4688182|NCT02536664|7596516|FG001|Overall Study|Other|24
4688183|NCT02536664|7596515|FG000|Overall Study|Missing|53
4688184|NCT02536664|7596516|FG001|Overall Study|Missing|20
4688185|NCT02536781|7596524|FG000|Overall Study|Lost to Follow-up|2
4688186|NCT02536781|7596525|FG001|Overall Study|Lost to Follow-up|0
4688187|NCT02536833|7596535|FG000|Overall Study|Discontinued Before Treatment|0
4688188|NCT02536833|7596536|FG001|Overall Study|Discontinued Before Treatment|0
4688189|NCT02536833|7596537|FG002|Overall Study|Discontinued Before Treatment|1
4688190|NCT02536833|7596538|FG003|Overall Study|Discontinued Before Treatment|2
4688191|NCT02536833|7596535|FG000|Overall Study|Adverse Event|1
4688192|NCT02536833|7596536|FG001|Overall Study|Adverse Event|3
4688193|NCT02536833|7596537|FG002|Overall Study|Adverse Event|4
4688194|NCT02536833|7596538|FG003|Overall Study|Adverse Event|1
4688195|NCT02536833|7596535|FG000|Overall Study|Lost to Follow-up|2
4688196|NCT02536833|7596536|FG001|Overall Study|Lost to Follow-up|1
4688197|NCT02536833|7596537|FG002|Overall Study|Lost to Follow-up|2
4688198|NCT02536833|7596538|FG003|Overall Study|Lost to Follow-up|2
4688199|NCT02536833|7596535|FG000|Overall Study|Physician Decision|0
4762233|NCT03195894|7736100|FG001|Overall Study|Lost to Follow-up|19
4762234|NCT03032705|7736111|FG000|Overall Study|Lost to Follow-up|16
4762235|NCT03032705|7736112|FG001|Overall Study|Lost to Follow-up|17
4762236|NCT03032705|7736111|FG000|Overall Study|did not quality|6
4762237|NCT03032705|7736112|FG001|Overall Study|did not quality|6
4688200|NCT02536833|7596536|FG001|Overall Study|Physician Decision|0
4688201|NCT02536833|7596537|FG002|Overall Study|Physician Decision|0
4688202|NCT02536833|7596538|FG003|Overall Study|Physician Decision|1
4688203|NCT02536833|7596535|FG000|Overall Study|Site Terminated by Sponsor|2
4688204|NCT02536833|7596536|FG001|Overall Study|Site Terminated by Sponsor|2
4688205|NCT02536833|7596537|FG002|Overall Study|Site Terminated by Sponsor|2
4688206|NCT02536833|7596538|FG003|Overall Study|Site Terminated by Sponsor|2
4688207|NCT02536833|7596535|FG000|Overall Study|Subject Non-Compliance|0
4688208|NCT02536833|7596536|FG001|Overall Study|Subject Non-Compliance|1
4688209|NCT02536833|7596537|FG002|Overall Study|Subject Non-Compliance|1
4688210|NCT02536833|7596538|FG003|Overall Study|Subject Non-Compliance|0
4688211|NCT02536833|7596535|FG000|Overall Study|Withdrawal by Subject|4
4688212|NCT02536833|7596536|FG001|Overall Study|Withdrawal by Subject|3
4688213|NCT02536833|7596537|FG002|Overall Study|Withdrawal by Subject|5
4688214|NCT02536833|7596538|FG003|Overall Study|Withdrawal by Subject|11
4688215|NCT02536846|7596549|FG000|Overall Study|Withdrawal by Subject|1
4688216|NCT02536963|7596554|FG000|Overall Study|Withdrawal by Subject|18
4688217|NCT02536976|7596560|FG000|Overall Study|Physician Decision|0
4688218|NCT02536976|7596561|FG001|Overall Study|Physician Decision|1
4688219|NCT02537015|7596569|FG000|Overall Study|Adverse Event|3
4688220|NCT02537015|7596569|FG000|Overall Study|Withdrawal by Subject|2
4688221|NCT02537015|7596569|FG000|Overall Study|Other Miscellaneous Reasons|1
4688222|NCT02537431|7596573|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1
4688223|NCT02537522|7596586|FG000|Phase I - Contralateral|Subject no longer eligible|15
4688224|NCT02537522|7596587|FG001|Phase I - Contralateral|Subject no longer eligible|7
4688225|NCT02537522|7596588|FG002|Phase I - Contralateral|Subject no longer eligible|0
4688226|NCT02537522|7596589|FG003|Phase I - Contralateral|Subject no longer eligible|0
4688227|NCT02537522|7596586|FG000|Phase I - Contralateral|Withdrawal by Subject|0
4688228|NCT02537522|7596587|FG001|Phase I - Contralateral|Withdrawal by Subject|1
4688229|NCT02537522|7596588|FG002|Phase I - Contralateral|Withdrawal by Subject|0
4688230|NCT02537522|7596589|FG003|Phase I - Contralateral|Withdrawal by Subject|0
4688231|NCT02537522|7596586|FG000|Phase I - Contralateral|incorrect randomization|0
4688232|NCT02537522|7596587|FG001|Phase I - Contralateral|incorrect randomization|1
4688233|NCT02537522|7596588|FG002|Phase I - Contralateral|incorrect randomization|0
4688234|NCT02537522|7596589|FG003|Phase I - Contralateral|incorrect randomization|0
4688235|NCT02537522|7596586|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0
4688236|NCT02537522|7596587|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1
4688237|NCT02537522|7596588|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0
4688238|NCT02537522|7596589|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0
4688239|NCT02537522|7596586|FG000|Phase II - Period 1 Bilateral|Adverse Event|0
4688240|NCT02537522|7596587|FG001|Phase II - Period 1 Bilateral|Adverse Event|0
4688241|NCT02537522|7596588|FG002|Phase II - Period 1 Bilateral|Adverse Event|0
4688242|NCT02537522|7596589|FG003|Phase II - Period 1 Bilateral|Adverse Event|1
4688243|NCT02537574|7596598|FG000|Overall Study|Adverse Event|1
4688244|NCT02537574|7596599|FG001|Overall Study|Adverse Event|3
4688245|NCT02537574|7596600|FG002|Overall Study|Adverse Event|2
4688246|NCT02537574|7596598|FG000|Overall Study|Lost to Follow-up|40
4688247|NCT02537574|7596599|FG001|Overall Study|Lost to Follow-up|51
4688248|NCT02537574|7596600|FG002|Overall Study|Lost to Follow-up|55
4688249|NCT02537574|7596598|FG000|Overall Study|Noncompliance with study drug|0
4688250|NCT02537574|7596599|FG001|Overall Study|Noncompliance with study drug|1
4688251|NCT02537574|7596600|FG002|Overall Study|Noncompliance with study drug|1
4688252|NCT02537574|7596598|FG000|Overall Study|Physician Decision|2
4688253|NCT02537574|7596599|FG001|Overall Study|Physician Decision|0
4688254|NCT02537574|7596600|FG002|Overall Study|Physician Decision|0
4688255|NCT02537574|7596598|FG000|Overall Study|Protocol Violation|4
4688256|NCT02537574|7596599|FG001|Overall Study|Protocol Violation|2
4688257|NCT02537574|7596600|FG002|Overall Study|Protocol Violation|3
4688258|NCT02537574|7596598|FG000|Overall Study|Withdrawal by Subject|37
4688259|NCT02537574|7596599|FG001|Overall Study|Withdrawal by Subject|27
4688260|NCT02537574|7596600|FG002|Overall Study|Withdrawal by Subject|29
4688261|NCT02537574|7596598|FG000|Overall Study|Lack of Efficacy|14
4688262|NCT02537574|7596599|FG001|Overall Study|Lack of Efficacy|16
4688263|NCT02537574|7596600|FG002|Overall Study|Lack of Efficacy|15
4688264|NCT02537574|7596598|FG000|Overall Study|Duplicate Patient|1
4688265|NCT02537574|7596599|FG001|Overall Study|Duplicate Patient|0
4688266|NCT02537574|7596600|FG002|Overall Study|Duplicate Patient|0
4688267|NCT02537574|7596598|FG000|Overall Study|Patient not Stable|0
4688268|NCT02537574|7596599|FG001|Overall Study|Patient not Stable|1
4688269|NCT02537574|7596600|FG002|Overall Study|Patient not Stable|0
4688270|NCT02537574|7596598|FG000|Overall Study|Incarceration|0
4688271|NCT02537574|7596599|FG001|Overall Study|Incarceration|1
4688272|NCT02537574|7596600|FG002|Overall Study|Incarceration|0
4688273|NCT02537574|7596598|FG000|Overall Study|Failed Naloxone Challenge|0
4688274|NCT02537574|7596599|FG001|Overall Study|Failed Naloxone Challenge|1
4688275|NCT02537574|7596600|FG002|Overall Study|Failed Naloxone Challenge|0
4688276|NCT02537574|7596598|FG000|Overall Study|Transportation Issues|0
4688277|NCT02537574|7596599|FG001|Overall Study|Transportation Issues|0
4688278|NCT02537574|7596600|FG002|Overall Study|Transportation Issues|1
4688279|NCT02537574|7596598|FG000|Overall Study|Subject did not want last Vivitrol Injec|0
4688280|NCT02537574|7596599|FG001|Overall Study|Subject did not want last Vivitrol Injec|0
4688281|NCT02537574|7596600|FG002|Overall Study|Subject did not want last Vivitrol Injec|1
4688282|NCT02537574|7596598|FG000|Overall Study|Noncompliance with Protocol|0
4688283|NCT02537574|7596599|FG001|Overall Study|Noncompliance with Protocol|0
4688284|NCT02537574|7596600|FG002|Overall Study|Noncompliance with Protocol|1
4688285|NCT02538029|7596647|FG000|Overall Study|unable to complete cognitive assessments|1
4688286|NCT02538029|7596648|FG001|Overall Study|unable to complete cognitive assessments|0
4688287|NCT02538029|7596649|FG002|Overall Study|unable to complete cognitive assessments|1
4688288|NCT02538094|7596670|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0
4688289|NCT02538094|7596671|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1
4688290|NCT02538094|7596670|FG000|Washout (4 Weeks)|Withdrawal by Subject|0
4688291|NCT02538094|7596671|FG001|Washout (4 Weeks)|Withdrawal by Subject|1
4688292|NCT02538107|7596677|FG000|Overall Study|Did not receive any Mircera dose|11
4688293|NCT02538107|7596677|FG000|Overall Study|Missing|5
4688294|NCT02538107|7596677|FG000|Overall Study|Necessity of dialysis|20
4688295|NCT02538107|7596677|FG000|Overall Study|Administration of other ESA|11
4688296|NCT02538107|7596677|FG000|Overall Study|No further treatment necessary|18
4762238|NCT02573259|7736125|FG000|Overall Study|Death|1
4762239|NCT02573259|7736126|FG001|Overall Study|Death|6
4762240|NCT02573259|7736127|FG002|Overall Study|Death|5
4762241|NCT02573259|7736128|FG003|Overall Study|Death|6
4688297|NCT02538107|7596677|FG000|Overall Study|Withdrawal by Subject|17
4688298|NCT02538107|7596677|FG000|Overall Study|Death|4
4688299|NCT02538107|7596677|FG000|Overall Study|Administrative reason|5
4688300|NCT02538107|7596677|FG000|Overall Study|Adverse Event|4
4688301|NCT02538107|7596677|FG000|Overall Study|Surgery|1
4688302|NCT02538107|7596677|FG000|Overall Study|Other|7
4688303|NCT02538107|7596677|FG000|Overall Study|Not recorded|7
4688304|NCT02538341|7596693|FG000|Overall Study|Lost to Follow-up|51
4688305|NCT02538341|7596694|FG001|Overall Study|Lost to Follow-up|46
4688306|NCT02538341|7596693|FG000|Overall Study|Withdrawal by Subject|3
4688307|NCT02538341|7596694|FG001|Overall Study|Withdrawal by Subject|1
4688308|NCT02538341|7596693|FG000|Overall Study|Death|2
4688309|NCT02538341|7596694|FG001|Overall Study|Death|0
4688310|NCT02538471|7596718|FG000|Overall Study|Progression of disease|2
4688311|NCT02538614|7596731|FG000|Overall Study|Progressive Disease|2
4688312|NCT02538900|7596762|FG000|Overall Study|Death|2
4688313|NCT02538900|7596763|FG001|Overall Study|Death|2
4688314|NCT02538900|7596764|FG002|Overall Study|Death|2
4762242|NCT02573259|7736129|FG004|Overall Study|Death|9
4762243|NCT02573259|7736130|FG005|Overall Study|Death|32
4762244|NCT02573259|7736131|FG006|Overall Study|Death|21
4762245|NCT02573259|7736125|FG000|Overall Study|Lost to Follow-up|0
4762246|NCT02573259|7736126|FG001|Overall Study|Lost to Follow-up|0
4762247|NCT02573259|7736127|FG002|Overall Study|Lost to Follow-up|0
4762248|NCT02573259|7736128|FG003|Overall Study|Lost to Follow-up|0
4762249|NCT02573259|7736129|FG004|Overall Study|Lost to Follow-up|0
4688315|NCT02538900|7596762|FG000|Overall Study|Withdrawal by Subject|18
4688316|NCT02538900|7596763|FG001|Overall Study|Withdrawal by Subject|16
4688317|NCT02538900|7596764|FG002|Overall Study|Withdrawal by Subject|15
4688318|NCT02538965|7596772|FG000|Treatment Period|Other = Death due to disease progression|1
4762250|NCT02573259|7736130|FG005|Overall Study|Lost to Follow-up|2
4762251|NCT02573259|7736131|FG006|Overall Study|Lost to Follow-up|1
4762252|NCT02573259|7736125|FG000|Overall Study|Participant refused further follow-up|0
4688319|NCT02538965|7596772|FG000|Treatment Period|Adverse Event|2
4688320|NCT02538965|7596772|FG000|Treatment Period|Withdrawal by Parent/Guardian|2
4688321|NCT02538965|7596772|FG000|Treatment Period|Treatment Failure|9
4688322|NCT02538965|7596772|FG000|Treatment Period|Disease Progression|1
4688323|NCT02538965|7596772|FG000|Treatment Period|Physician Decision|2
4688324|NCT02538965|7596772|FG000|Follow-Up Period|Other = Death due to disease progression|13
4688325|NCT02538965|7596772|FG000|Follow-Up Period|Withdrawal by Parent|4
4688326|NCT02539134|7596791|FG000|Overall Study|Lost to Follow-up|1
4688327|NCT02539134|7596792|FG001|Overall Study|Lost to Follow-up|0
4688328|NCT02539134|7596793|FG002|Overall Study|Lost to Follow-up|0
4688329|NCT02539134|7596794|FG003|Overall Study|Lost to Follow-up|0
4688330|NCT02539134|7596795|FG004|Overall Study|Lost to Follow-up|0
4688331|NCT02539134|7596796|FG005|Overall Study|Lost to Follow-up|0
4688332|NCT02539368|7596829|FG000|Overall Study|Death|4
4688333|NCT02539368|7596830|FG001|Overall Study|Death|2
4688334|NCT02539368|7596831|FG002|Overall Study|Death|1
4688335|NCT02539368|7596832|FG003|Overall Study|Death|0
4688336|NCT02539368|7596833|FG004|Overall Study|Death|0
4688337|NCT02539368|7596829|FG000|Overall Study|Withdrawal by Subject|44
4688338|NCT02539368|7596830|FG001|Overall Study|Withdrawal by Subject|35
4688339|NCT02539368|7596831|FG002|Overall Study|Withdrawal by Subject|9
4688340|NCT02539368|7596832|FG003|Overall Study|Withdrawal by Subject|1
4688341|NCT02539368|7596833|FG004|Overall Study|Withdrawal by Subject|3
4688342|NCT02539368|7596829|FG000|Overall Study|Physician Decision|49
4688343|NCT02539368|7596830|FG001|Overall Study|Physician Decision|15
4688344|NCT02539368|7596831|FG002|Overall Study|Physician Decision|7
4688345|NCT02539368|7596832|FG003|Overall Study|Physician Decision|0
4688346|NCT02539368|7596833|FG004|Overall Study|Physician Decision|2
4688347|NCT02539368|7596829|FG000|Overall Study|Lost to Follow-up|96
4688348|NCT02539368|7596830|FG001|Overall Study|Lost to Follow-up|21
4688349|NCT02539368|7596831|FG002|Overall Study|Lost to Follow-up|16
4688350|NCT02539368|7596832|FG003|Overall Study|Lost to Follow-up|4
4688351|NCT02539368|7596833|FG004|Overall Study|Lost to Follow-up|3
4688352|NCT02539368|7596829|FG000|Overall Study|Adverse Event|44
4688353|NCT02539368|7596830|FG001|Overall Study|Adverse Event|5
4688354|NCT02539368|7596831|FG002|Overall Study|Adverse Event|9
4688355|NCT02539368|7596832|FG003|Overall Study|Adverse Event|0
4688356|NCT02539368|7596833|FG004|Overall Study|Adverse Event|3
4688357|NCT02539368|7596829|FG000|Overall Study|Participant Non-compliant|13
4688358|NCT02539368|7596830|FG001|Overall Study|Participant Non-compliant|2
4688359|NCT02539368|7596831|FG002|Overall Study|Participant Non-compliant|1
4688360|NCT02539368|7596832|FG003|Overall Study|Participant Non-compliant|1
4688361|NCT02539368|7596833|FG004|Overall Study|Participant Non-compliant|0
4688362|NCT02539368|7596829|FG000|Overall Study|Other|145
4688363|NCT02539368|7596830|FG001|Overall Study|Other|18
4688364|NCT02539368|7596831|FG002|Overall Study|Other|24
4688365|NCT02539368|7596832|FG003|Overall Study|Other|1
4688366|NCT02539368|7596833|FG004|Overall Study|Other|3
4688367|NCT02539368|7596829|FG000|Overall Study|Missing|10
4762253|NCT02573259|7736126|FG001|Overall Study|Participant refused further follow-up|2
4762254|NCT02573259|7736127|FG002|Overall Study|Participant refused further follow-up|1
4762255|NCT02573259|7736128|FG003|Overall Study|Participant refused further follow-up|0
4762256|NCT02573259|7736129|FG004|Overall Study|Participant refused further follow-up|3
4762257|NCT02573259|7736130|FG005|Overall Study|Participant refused further follow-up|20
4762258|NCT02573259|7736131|FG006|Overall Study|Participant refused further follow-up|7
4762259|NCT02573259|7736125|FG000|Overall Study|Other|0
4762260|NCT02573259|7736126|FG001|Overall Study|Other|0
4762261|NCT02573259|7736127|FG002|Overall Study|Other|0
4762262|NCT02573259|7736128|FG003|Overall Study|Other|0
4762263|NCT02573259|7736129|FG004|Overall Study|Other|1
4762264|NCT02573259|7736130|FG005|Overall Study|Other|4
4762265|NCT02573259|7736131|FG006|Overall Study|Other|5
4762266|NCT02318329|7736173|FG000|Overall Study|Progressive Disease|2
4762267|NCT02318329|7736174|FG001|Overall Study|Progressive Disease|3
4762268|NCT02318329|7736175|FG002|Overall Study|Progressive Disease|2
4762269|NCT02318329|7736176|FG003|Overall Study|Progressive Disease|3
4762270|NCT02318329|7736177|FG004|Overall Study|Progressive Disease|3
4762271|NCT02318329|7736178|FG005|Overall Study|Progressive Disease|3
4762272|NCT02318329|7736179|FG006|Overall Study|Progressive Disease|1
4762273|NCT02318329|7736180|FG007|Overall Study|Progressive Disease|1
4762274|NCT02318329|7736181|FG008|Overall Study|Progressive Disease|5
4762275|NCT02318329|7736182|FG009|Overall Study|Progressive Disease|39
4762276|NCT02318329|7736173|FG000|Overall Study|Death|0
4762277|NCT02318329|7736174|FG001|Overall Study|Death|0
4762278|NCT02318329|7736175|FG002|Overall Study|Death|0
4688368|NCT02539368|7596830|FG001|Overall Study|Missing|3
4762279|NCT02318329|7736176|FG003|Overall Study|Death|0
4688369|NCT02539368|7596831|FG002|Overall Study|Missing|0
4688370|NCT02539368|7596832|FG003|Overall Study|Missing|0
4688371|NCT02539368|7596833|FG004|Overall Study|Missing|0
4688372|NCT02539797|7596866|FG000|Overall Study|Lost to Follow-up|0
4688373|NCT02539797|7596867|FG001|Overall Study|Lost to Follow-up|1
4688374|NCT02539797|7596868|FG002|Overall Study|Lost to Follow-up|0
4688375|NCT02540083|7596891|FG000|Overall Study|Withdrawal by Subject|16
4688376|NCT02540213|7596912|FG000|Overall Study|Death/adverse event|18
4688377|NCT02540213|7596912|FG000|Overall Study|Administrative reasons|3
4688378|NCT02540213|7596912|FG000|Overall Study|Kidney transplant|3
4688379|NCT02540213|7596912|FG000|Overall Study|Lack of Efficacy|6
4688380|NCT02540213|7596912|FG000|Overall Study|Consent withdrawn|7
4688381|NCT02540213|7596912|FG000|Overall Study|Enrolled but not treated|2
4688382|NCT02540265|7596928|FG000|Overall Study|Lost to Follow-up|0
4688383|NCT02540265|7596929|FG001|Overall Study|Lost to Follow-up|0
4688384|NCT02540265|7596930|FG002|Overall Study|Lost to Follow-up|1
4688385|NCT02540291|7596942|FG000|Overall Study|Death|7
4688386|NCT02540291|7596943|FG001|Overall Study|Death|7
4688387|NCT02540291|7596944|FG002|Overall Study|Death|5
4688388|NCT02540291|7596945|FG003|Overall Study|Death|7
4688389|NCT02540291|7596942|FG000|Overall Study|Lost to Follow-up|0
4688390|NCT02540291|7596943|FG001|Overall Study|Lost to Follow-up|0
4688391|NCT02540291|7596944|FG002|Overall Study|Lost to Follow-up|1
4688392|NCT02540291|7596945|FG003|Overall Study|Lost to Follow-up|0
4688393|NCT02540291|7596942|FG000|Overall Study|Withdrawal Of Consent|0
4688394|NCT02540291|7596943|FG001|Overall Study|Withdrawal Of Consent|1
4688395|NCT02540291|7596944|FG002|Overall Study|Withdrawal Of Consent|0
4688396|NCT02540291|7596945|FG003|Overall Study|Withdrawal Of Consent|0
4688397|NCT02540291|7596942|FG000|Overall Study|Study Terminated By Sponsor|1
4688398|NCT02540291|7596943|FG001|Overall Study|Study Terminated By Sponsor|0
4688399|NCT02540291|7596944|FG002|Overall Study|Study Terminated By Sponsor|0
4688400|NCT02540291|7596945|FG003|Overall Study|Study Terminated By Sponsor|0
4688401|NCT02540291|7596942|FG000|Overall Study|Other|0
4688402|NCT02540291|7596943|FG001|Overall Study|Other|0
4688403|NCT02540291|7596944|FG002|Overall Study|Other|1
4688404|NCT02540291|7596945|FG003|Overall Study|Other|0
4688405|NCT02540356|7596959|FG000|Overall Study|Terminated due to disease progression|1
4688406|NCT02540356|7596960|FG001|Overall Study|Terminated due to disease progression|0
4688407|NCT02540538|7596977|FG000|Overall Study|Pregnancy|0
4688408|NCT02540538|7596978|FG001|Overall Study|Pregnancy|1
4688409|NCT02540538|7596979|FG002|Overall Study|Pregnancy|0
4688410|NCT02540668|7596997|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0
4688411|NCT02540668|7596998|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1
4688412|NCT02540850|7597017|FG000|Overall Study|Lost to Follow-up|69
4688413|NCT02540850|7597018|FG001|Overall Study|Lost to Follow-up|66
4688414|NCT02540850|7597019|FG002|Overall Study|Lost to Follow-up|34
4688415|NCT02540954|7597029|FG000|Overall Study|Physician Decision|3
4688416|NCT02540954|7597030|FG001|Overall Study|Physician Decision|1
4688417|NCT02540954|7597029|FG000|Overall Study|Withdrawal by Subject|6
4688418|NCT02540954|7597030|FG001|Overall Study|Withdrawal by Subject|5
4688419|NCT02540954|7597029|FG000|Overall Study|Lost to Follow-up|1
4688420|NCT02540954|7597030|FG001|Overall Study|Lost to Follow-up|1
4688421|NCT02540954|7597029|FG000|Overall Study|Adverse Event|4
4688422|NCT02540954|7597030|FG001|Overall Study|Adverse Event|2
4688423|NCT02540954|7597029|FG000|Overall Study|Death|0
4688424|NCT02540954|7597030|FG001|Overall Study|Death|3
4688425|NCT02540954|7597029|FG000|Overall Study|Treatment failure|1
4688426|NCT02540954|7597030|FG001|Overall Study|Treatment failure|0
4688427|NCT02540954|7597029|FG000|Overall Study|Other reason|4
4688428|NCT02540954|7597030|FG001|Overall Study|Other reason|2
4688429|NCT02540993|7597038|FG000|Overall Study|Lost to Follow-up|5
4688430|NCT02540993|7597039|FG001|Overall Study|Lost to Follow-up|3
4688431|NCT02540993|7597038|FG000|Overall Study|Withdrawal by Subject|4
4688432|NCT02540993|7597039|FG001|Overall Study|Withdrawal by Subject|6
4688433|NCT02540993|7597038|FG000|Overall Study|GCP violations|33
4688434|NCT02540993|7597039|FG001|Overall Study|GCP violations|27
4762280|NCT02318329|7736177|FG004|Overall Study|Death|0
4762281|NCT02318329|7736178|FG005|Overall Study|Death|0
4762282|NCT02318329|7736179|FG006|Overall Study|Death|0
4762283|NCT02318329|7736180|FG007|Overall Study|Death|0
4762284|NCT02318329|7736181|FG008|Overall Study|Death|0
4762285|NCT02318329|7736182|FG009|Overall Study|Death|5
4762286|NCT02318329|7736173|FG000|Overall Study|Lost to Follow-up|0
4762287|NCT02318329|7736174|FG001|Overall Study|Lost to Follow-up|0
4762288|NCT02318329|7736175|FG002|Overall Study|Lost to Follow-up|0
4762289|NCT02318329|7736176|FG003|Overall Study|Lost to Follow-up|0
4762290|NCT02318329|7736177|FG004|Overall Study|Lost to Follow-up|0
4762291|NCT02318329|7736178|FG005|Overall Study|Lost to Follow-up|0
4762292|NCT02318329|7736179|FG006|Overall Study|Lost to Follow-up|0
4762293|NCT02318329|7736180|FG007|Overall Study|Lost to Follow-up|0
4762294|NCT02318329|7736181|FG008|Overall Study|Lost to Follow-up|0
4762295|NCT02318329|7736182|FG009|Overall Study|Lost to Follow-up|1
4762296|NCT02318329|7736173|FG000|Overall Study|Withdrawal by Subject|0
4762297|NCT02318329|7736174|FG001|Overall Study|Withdrawal by Subject|0
4762298|NCT02318329|7736175|FG002|Overall Study|Withdrawal by Subject|0
4762299|NCT02318329|7736176|FG003|Overall Study|Withdrawal by Subject|0
4762300|NCT02318329|7736177|FG004|Overall Study|Withdrawal by Subject|0
4762301|NCT02318329|7736178|FG005|Overall Study|Withdrawal by Subject|0
4762302|NCT02318329|7736179|FG006|Overall Study|Withdrawal by Subject|0
4762303|NCT02318329|7736180|FG007|Overall Study|Withdrawal by Subject|0
4762304|NCT02318329|7736181|FG008|Overall Study|Withdrawal by Subject|0
4762305|NCT02318329|7736182|FG009|Overall Study|Withdrawal by Subject|6
4762306|NCT02318329|7736173|FG000|Overall Study|Other|1
4762307|NCT02318329|7736174|FG001|Overall Study|Other|1
4762308|NCT02318329|7736175|FG002|Overall Study|Other|1
4762309|NCT02318329|7736176|FG003|Overall Study|Other|0
4762310|NCT02318329|7736177|FG004|Overall Study|Other|0
4688435|NCT02541604|7597077|FG000|Overall Study|Death|6
4688436|NCT02541604|7597078|FG001|Overall Study|Death|5
4688437|NCT02541604|7597079|FG002|Overall Study|Death|7
4688438|NCT02541604|7597080|FG003|Overall Study|Death|2
4688439|NCT02541604|7597081|FG004|Overall Study|Death|9
4688440|NCT02541604|7597082|FG005|Overall Study|Death|8
4688441|NCT02541604|7597083|FG006|Overall Study|Death|9
4688442|NCT02541604|7597084|FG007|Overall Study|Death|9
4688443|NCT02541604|7597085|FG008|Overall Study|Death|3
4688444|NCT02541604|7597086|FG009|Overall Study|Death|4
4688445|NCT02541604|7597087|FG010|Overall Study|Death|2
4688446|NCT02541604|7597088|FG011|Overall Study|Death|3
4688447|NCT02541604|7597077|FG000|Overall Study|Lost to Follow-up|2
4688448|NCT02541604|7597078|FG001|Overall Study|Lost to Follow-up|0
4688449|NCT02541604|7597079|FG002|Overall Study|Lost to Follow-up|1
4688450|NCT02541604|7597080|FG003|Overall Study|Lost to Follow-up|0
4688451|NCT02541604|7597081|FG004|Overall Study|Lost to Follow-up|0
4688452|NCT02541604|7597082|FG005|Overall Study|Lost to Follow-up|1
4688453|NCT02541604|7597083|FG006|Overall Study|Lost to Follow-up|1
4688454|NCT02541604|7597084|FG007|Overall Study|Lost to Follow-up|0
4688455|NCT02541604|7597085|FG008|Overall Study|Lost to Follow-up|0
4688456|NCT02541604|7597086|FG009|Overall Study|Lost to Follow-up|0
4688457|NCT02541604|7597087|FG010|Overall Study|Lost to Follow-up|0
4688458|NCT02541604|7597088|FG011|Overall Study|Lost to Follow-up|0
4688459|NCT02541604|7597077|FG000|Overall Study|Withdrawal by Subject|2
4688460|NCT02541604|7597078|FG001|Overall Study|Withdrawal by Subject|0
4688461|NCT02541604|7597079|FG002|Overall Study|Withdrawal by Subject|1
4688462|NCT02541604|7597080|FG003|Overall Study|Withdrawal by Subject|0
4688463|NCT02541604|7597081|FG004|Overall Study|Withdrawal by Subject|1
4688464|NCT02541604|7597082|FG005|Overall Study|Withdrawal by Subject|1
4688465|NCT02541604|7597083|FG006|Overall Study|Withdrawal by Subject|0
4688466|NCT02541604|7597084|FG007|Overall Study|Withdrawal by Subject|0
4688467|NCT02541604|7597085|FG008|Overall Study|Withdrawal by Subject|1
4688468|NCT02541604|7597086|FG009|Overall Study|Withdrawal by Subject|0
4688469|NCT02541604|7597087|FG010|Overall Study|Withdrawal by Subject|0
4688470|NCT02541604|7597088|FG011|Overall Study|Withdrawal by Subject|0
4688471|NCT02541604|7597077|FG000|Overall Study|Study Terminated by Sponsor|1
4688472|NCT02541604|7597078|FG001|Overall Study|Study Terminated by Sponsor|4
4688473|NCT02541604|7597079|FG002|Overall Study|Study Terminated by Sponsor|2
4688474|NCT02541604|7597080|FG003|Overall Study|Study Terminated by Sponsor|1
4762311|NCT02318329|7736178|FG005|Overall Study|Other|0
4762312|NCT02318329|7736179|FG006|Overall Study|Other|0
4762313|NCT02318329|7736180|FG007|Overall Study|Other|0
4762314|NCT02318329|7736181|FG008|Overall Study|Other|1
4762315|NCT02318329|7736182|FG009|Overall Study|Other|1
4762316|NCT01602666|7736225|FG000|Induction Chemotherapy|Death|2
4762317|NCT01602666|7736226|FG001|Induction Chemotherapy|Death|1
4762318|NCT01602666|7736225|FG000|Induction Chemotherapy|Lack of Efficacy|16
4762319|NCT01602666|7736226|FG001|Induction Chemotherapy|Lack of Efficacy|7
4762320|NCT01602666|7736225|FG000|Induction Chemotherapy|Physician Decision|12
4762321|NCT01602666|7736226|FG001|Induction Chemotherapy|Physician Decision|5
4762322|NCT01602666|7736225|FG000|Induction Chemotherapy|Withdrawal by Subject|0
4762323|NCT01602666|7736226|FG001|Induction Chemotherapy|Withdrawal by Subject|2
4762324|NCT01602666|7736225|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5
4762325|NCT01602666|7736226|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6
4762326|NCT01602666|7736225|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2
4762327|NCT01602666|7736226|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3
4762328|NCT01602666|7736225|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4
4762329|NCT01602666|7736226|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5
4762330|NCT01602666|7736225|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2
4762331|NCT01602666|7736226|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3
4762332|NCT01602666|7736225|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4
4762333|NCT01602666|7736226|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0
4762334|NCT01602666|7736225|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0
4762335|NCT01602666|7736226|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14
4762336|NCT01602666|7736225|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0
4762337|NCT01602666|7736226|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9
4762338|NCT01375959|7736236|FG000|First Intervention (6 Weeks)|Adverse Event|2
4762339|NCT01375959|7736237|FG001|First Intervention (6 Weeks)|Adverse Event|3
4762340|NCT01375959|7736236|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0
4762341|NCT01375959|7736237|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1
4762342|NCT01375959|7736236|FG000|Second Intervention (6 Weeks)|Adverse Event|0
4762343|NCT01375959|7736237|FG001|Second Intervention (6 Weeks)|Adverse Event|2
4762344|NCT01224106|7736248|FG000|Double-Blind Treatment Phase|Death|3
4688475|NCT02541604|7597081|FG004|Overall Study|Study Terminated by Sponsor|0
4688476|NCT02541604|7597082|FG005|Overall Study|Study Terminated by Sponsor|0
4688477|NCT02541604|7597083|FG006|Overall Study|Study Terminated by Sponsor|0
4688478|NCT02541604|7597084|FG007|Overall Study|Study Terminated by Sponsor|0
4688479|NCT02541604|7597085|FG008|Overall Study|Study Terminated by Sponsor|0
4688480|NCT02541604|7597086|FG009|Overall Study|Study Terminated by Sponsor|0
4688481|NCT02541604|7597087|FG010|Overall Study|Study Terminated by Sponsor|0
4688482|NCT02541604|7597088|FG011|Overall Study|Study Terminated by Sponsor|0
4688483|NCT02541604|7597077|FG000|Overall Study|Medical condition may jeopardize safety|0
4688484|NCT02541604|7597078|FG001|Overall Study|Medical condition may jeopardize safety|0
4688485|NCT02541604|7597079|FG002|Overall Study|Medical condition may jeopardize safety|0
4688486|NCT02541604|7597080|FG003|Overall Study|Medical condition may jeopardize safety|0
4688487|NCT02541604|7597081|FG004|Overall Study|Medical condition may jeopardize safety|0
4688488|NCT02541604|7597082|FG005|Overall Study|Medical condition may jeopardize safety|0
4688489|NCT02541604|7597083|FG006|Overall Study|Medical condition may jeopardize safety|0
4688490|NCT02541604|7597084|FG007|Overall Study|Medical condition may jeopardize safety|1
4688491|NCT02541604|7597085|FG008|Overall Study|Medical condition may jeopardize safety|0
4688492|NCT02541604|7597086|FG009|Overall Study|Medical condition may jeopardize safety|0
4688493|NCT02541604|7597087|FG010|Overall Study|Medical condition may jeopardize safety|0
4688494|NCT02541604|7597088|FG011|Overall Study|Medical condition may jeopardize safety|0
4688495|NCT02541669|7597142|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0
4688496|NCT02541669|7597143|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0
4688497|NCT02541669|7597144|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1
4688498|NCT02541669|7597145|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0
4688499|NCT02541669|7597146|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1
4688500|NCT02541903|7597176|FG000|Overall Study|Death|1
4688501|NCT02542072|7597199|FG000|First Intervention (1 Month)|Adverse Event|1
4688502|NCT02542072|7597200|FG001|First Intervention (1 Month)|Adverse Event|1
4688503|NCT02542072|7597199|FG000|First Intervention (1 Month)|Lost to Follow-up|2
4688504|NCT02542072|7597200|FG001|First Intervention (1 Month)|Lost to Follow-up|0
4688505|NCT02542072|7597199|FG000|First Intervention (1 Month)|Lens discomfort|1
4688506|NCT02542072|7597200|FG001|First Intervention (1 Month)|Lens discomfort|2
4688507|NCT02542072|7597199|FG000|First Intervention (1 Month)|Protocol Violation|1
4688508|NCT02542072|7597200|FG001|First Intervention (1 Month)|Protocol Violation|0
4688509|NCT02542072|7597199|FG000|Second Intervention (1 Month)|Lost to Follow-up|1
4688510|NCT02542072|7597200|FG001|Second Intervention (1 Month)|Lost to Follow-up|0
4688511|NCT02542072|7597199|FG000|Second Intervention (1 Month)|Lens discomfort|1
4688512|NCT02542072|7597200|FG001|Second Intervention (1 Month)|Lens discomfort|0
4688513|NCT02542605|7597275|FG000|Part B: Challenge Phase|Sponsor decision|1
4688514|NCT02542605|7597276|FG001|Part B: Challenge Phase|Sponsor decision|0
4688515|NCT02542605|7597277|FG002|Part B: Challenge Phase|Sponsor decision|0
4688516|NCT02542605|7597275|FG000|Part B: Randomization Phase|Withdrawal by Subject|0
4688517|NCT02542605|7597276|FG001|Part B: Randomization Phase|Withdrawal by Subject|0
4688518|NCT02542605|7597277|FG002|Part B: Randomization Phase|Withdrawal by Subject|1
4688519|NCT02542631|7597288|FG000|Overall Study|Adverse Event|1
4688520|NCT02542631|7597289|FG001|Overall Study|Adverse Event|1
4688521|NCT02542631|7597288|FG000|Overall Study|Sponsor Termination|1
4688522|NCT02542631|7597289|FG001|Overall Study|Sponsor Termination|0
4688523|NCT02542631|7597288|FG000|Overall Study|Withdrawal by Subject|11
4688524|NCT02542631|7597289|FG001|Overall Study|Withdrawal by Subject|16
4688525|NCT02542631|7597288|FG000|Overall Study|Protocol Violation|1
4688526|NCT02542631|7597289|FG001|Overall Study|Protocol Violation|1
4688527|NCT02542631|7597288|FG000|Overall Study|Physician Decision|6
4688528|NCT02542631|7597289|FG001|Overall Study|Physician Decision|4
4688529|NCT02542631|7597288|FG000|Overall Study|Lost to Follow-up|6
4688530|NCT02542631|7597289|FG001|Overall Study|Lost to Follow-up|5
4688531|NCT02542631|7597288|FG000|Overall Study|Death|1
4688532|NCT02542631|7597289|FG001|Overall Study|Death|2
4688533|NCT02542631|7597288|FG000|Overall Study|Other|2
4688534|NCT02542631|7597289|FG001|Overall Study|Other|1
4688535|NCT02542631|7597288|FG000|Overall Study|Used Prohibited Medication|2
4688536|NCT02542631|7597289|FG001|Overall Study|Used Prohibited Medication|1
4688537|NCT02542865|7597304|FG000|Overall Study|Identified as screen failure|1
4688538|NCT02542865|7597305|FG001|Overall Study|Identified as screen failure|0
4688539|NCT02542865|7597304|FG000|Overall Study|Withdrawal by Subject|16
4688540|NCT02542865|7597305|FG001|Overall Study|Withdrawal by Subject|0
4688541|NCT02542943|7597314|FG000|Overall Study|Lost to Follow-up|1
4688542|NCT02542943|7597315|FG001|Overall Study|Lost to Follow-up|0
4688543|NCT02542943|7597316|FG002|Overall Study|Lost to Follow-up|0
4688544|NCT02542943|7597314|FG000|Overall Study|Withdrawal by Subject|0
4688545|NCT02542943|7597315|FG001|Overall Study|Withdrawal by Subject|1
4688546|NCT02542943|7597316|FG002|Overall Study|Withdrawal by Subject|0
4688547|NCT02543203|7597327|FG000|Overall Study|Unpalatable Fragrance|2
4688548|NCT02543203|7597328|FG001|Overall Study|Unpalatable Fragrance|2
4688549|NCT02543203|7597327|FG000|Overall Study|Lost to Follow-up|1
4688550|NCT02543203|7597328|FG001|Overall Study|Lost to Follow-up|0
4688551|NCT02543203|7597327|FG000|Overall Study|Increased Irritability|1
4688552|NCT02543203|7597328|FG001|Overall Study|Increased Irritability|0
4688553|NCT02543203|7597327|FG000|Overall Study|Family|1
4688554|NCT02543203|7597328|FG001|Overall Study|Family|2
4688555|NCT02543203|7597327|FG000|Overall Study|Negative Behavior|1
4688556|NCT02543203|7597328|FG001|Overall Study|Negative Behavior|0
4688557|NCT02543203|7597327|FG000|Overall Study|Withdrawal by Subject|0
4688558|NCT02543203|7597328|FG001|Overall Study|Withdrawal by Subject|1
4688559|NCT02543294|7597342|FG000|Overall Study|Lost to Follow-up|3
4688560|NCT02543294|7597342|FG000|Overall Study|Physician Decision|2
4688561|NCT02543294|7597342|FG000|Overall Study|Withdrawal by Subject|7
4688562|NCT02543346|7597347|FG000|Second Priming Visit|Withdrawal by Subject|0
4688563|NCT02543346|7597348|FG001|Second Priming Visit|Withdrawal by Subject|2
4688564|NCT02543346|7597349|FG002|Second Priming Visit|Withdrawal by Subject|2
4688565|NCT02543346|7597350|FG003|Second Priming Visit|Withdrawal by Subject|2
4688566|NCT02543346|7597347|FG000|Second Priming Visit|Adverse Event|1
4688567|NCT02543346|7597348|FG001|Second Priming Visit|Adverse Event|0
4688568|NCT02543346|7597349|FG002|Second Priming Visit|Adverse Event|0
4688569|NCT02543346|7597350|FG003|Second Priming Visit|Adverse Event|0
4688570|NCT02543528|7597373|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0
4688571|NCT02543528|7597374|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0
4688572|NCT02543528|7597375|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0
4688573|NCT02543528|7597376|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0
4688574|NCT02543528|7597377|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2
4688575|NCT02543528|7597373|FG000|Adaptation Period|Lens Handling Difficultes|0
4688576|NCT02543528|7597374|FG001|Adaptation Period|Lens Handling Difficultes|0
4688577|NCT02543528|7597375|FG002|Adaptation Period|Lens Handling Difficultes|0
4688578|NCT02543528|7597376|FG003|Adaptation Period|Lens Handling Difficultes|0
4688579|NCT02543528|7597377|FG004|Adaptation Period|Lens Handling Difficultes|8
4688580|NCT02543528|7597373|FG000|Adaptation Period|Lost to Follow-up|0
4688581|NCT02543528|7597374|FG001|Adaptation Period|Lost to Follow-up|0
4688582|NCT02543528|7597375|FG002|Adaptation Period|Lost to Follow-up|0
4688583|NCT02543528|7597376|FG003|Adaptation Period|Lost to Follow-up|0
4688584|NCT02543528|7597377|FG004|Adaptation Period|Lost to Follow-up|14
4688585|NCT02543528|7597373|FG000|Adaptation Period|Adverse Event|0
4688586|NCT02543528|7597374|FG001|Adaptation Period|Adverse Event|0
4688587|NCT02543528|7597375|FG002|Adaptation Period|Adverse Event|0
4688588|NCT02543528|7597376|FG003|Adaptation Period|Adverse Event|0
4688589|NCT02543528|7597377|FG004|Adaptation Period|Adverse Event|2
4688590|NCT02543528|7597373|FG000|Extended Wear Period|Adverse Event|17
4688591|NCT02543528|7597374|FG001|Extended Wear Period|Adverse Event|11
4688592|NCT02543528|7597375|FG002|Extended Wear Period|Adverse Event|16
4688593|NCT02543528|7597376|FG003|Extended Wear Period|Adverse Event|3
4688594|NCT02543528|7597377|FG004|Extended Wear Period|Adverse Event|0
4688595|NCT02543528|7597373|FG000|Extended Wear Period|Missed too many scheduled visits|0
4688596|NCT02543528|7597374|FG001|Extended Wear Period|Missed too many scheduled visits|0
4688597|NCT02543528|7597375|FG002|Extended Wear Period|Missed too many scheduled visits|1
4688598|NCT02543528|7597376|FG003|Extended Wear Period|Missed too many scheduled visits|3
4688599|NCT02543528|7597377|FG004|Extended Wear Period|Missed too many scheduled visits|0
4688600|NCT02543528|7597373|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1
4688601|NCT02543528|7597374|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0
4688602|NCT02543528|7597375|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0
4688603|NCT02543528|7597376|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0
4688604|NCT02543528|7597377|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0
4688605|NCT02543528|7597373|FG000|Extended Wear Period|Lost to Follow-up|0
4688606|NCT02543528|7597374|FG001|Extended Wear Period|Lost to Follow-up|1
4688607|NCT02543528|7597375|FG002|Extended Wear Period|Lost to Follow-up|2
4688608|NCT02543528|7597376|FG003|Extended Wear Period|Lost to Follow-up|1
4688609|NCT02543528|7597377|FG004|Extended Wear Period|Lost to Follow-up|0
4688610|NCT02543528|7597373|FG000|Extended Wear Period|Withdrawal by Subject|10
4688611|NCT02543528|7597374|FG001|Extended Wear Period|Withdrawal by Subject|9
4688612|NCT02543528|7597375|FG002|Extended Wear Period|Withdrawal by Subject|4
4688613|NCT02543528|7597376|FG003|Extended Wear Period|Withdrawal by Subject|5
4688614|NCT02543528|7597377|FG004|Extended Wear Period|Withdrawal by Subject|0
4688615|NCT02543658|7597402|FG000|Overall Study|Lack of Efficacy|0
4688616|NCT02543658|7597403|FG001|Overall Study|Lack of Efficacy|4
4762345|NCT01224106|7736249|FG001|Double-Blind Treatment Phase|Death|0
4762346|NCT01224106|7736250|FG002|Double-Blind Treatment Phase|Death|0
4762347|NCT01224106|7736251|FG003|Double-Blind Treatment Phase|Death|0
4762348|NCT01224106|7736252|FG004|Double-Blind Treatment Phase|Death|0
4762349|NCT01224106|7736248|FG000|Double-Blind Treatment Phase|Physician Decision|6
4762350|NCT01224106|7736249|FG001|Double-Blind Treatment Phase|Physician Decision|5
4762351|NCT01224106|7736250|FG002|Double-Blind Treatment Phase|Physician Decision|4
4762352|NCT01224106|7736251|FG003|Double-Blind Treatment Phase|Physician Decision|0
4762353|NCT01224106|7736252|FG004|Double-Blind Treatment Phase|Physician Decision|0
4762354|NCT01224106|7736248|FG000|Double-Blind Treatment Phase|Adverse Event|0
4762355|NCT01224106|7736249|FG001|Double-Blind Treatment Phase|Adverse Event|5
4762356|NCT01224106|7736250|FG002|Double-Blind Treatment Phase|Adverse Event|3
4762357|NCT01224106|7736251|FG003|Double-Blind Treatment Phase|Adverse Event|0
4762358|NCT01224106|7736252|FG004|Double-Blind Treatment Phase|Adverse Event|0
4762359|NCT01224106|7736248|FG000|Double-Blind Treatment Phase|Other|0
4762360|NCT01224106|7736249|FG001|Double-Blind Treatment Phase|Other|0
4762361|NCT01224106|7736250|FG002|Double-Blind Treatment Phase|Other|1
4762362|NCT01224106|7736251|FG003|Double-Blind Treatment Phase|Other|0
4688617|NCT02543801|7597425|FG000|Overall Study|Protocol Violation|1
4688618|NCT02543801|7597426|FG001|Overall Study|Protocol Violation|2
4688619|NCT02543801|7597427|FG002|Overall Study|Protocol Violation|0
4688620|NCT02543801|7597428|FG003|Overall Study|Protocol Violation|0
4688621|NCT02543892|7597456|FG000|Received Vaccination 2|Withdrawal by Subject|1
4688622|NCT02543892|7597457|FG001|Received Vaccination 2|Withdrawal by Subject|0
4688623|NCT02543892|7597458|FG002|Received Vaccination 2|Withdrawal by Subject|0
4688624|NCT02543892|7597459|FG003|Received Vaccination 2|Withdrawal by Subject|0
4688625|NCT02543892|7597460|FG004|Received Vaccination 2|Withdrawal by Subject|0
4688626|NCT02543892|7597461|FG005|Received Vaccination 2|Withdrawal by Subject|0
4688627|NCT02543892|7597462|FG006|Received Vaccination 2|Withdrawal by Subject|0
4688628|NCT02543892|7597463|FG007|Received Vaccination 2|Withdrawal by Subject|1
4688629|NCT02543892|7597456|FG000|Received Vaccination 2|Physician Decision|0
4688630|NCT02543892|7597457|FG001|Received Vaccination 2|Physician Decision|0
4688631|NCT02543892|7597458|FG002|Received Vaccination 2|Physician Decision|0
4688632|NCT02543892|7597459|FG003|Received Vaccination 2|Physician Decision|0
4688633|NCT02543892|7597460|FG004|Received Vaccination 2|Physician Decision|0
4688634|NCT02543892|7597461|FG005|Received Vaccination 2|Physician Decision|1
4688635|NCT02543892|7597462|FG006|Received Vaccination 2|Physician Decision|0
4688636|NCT02543892|7597463|FG007|Received Vaccination 2|Physician Decision|0
4688637|NCT02543892|7597456|FG000|Received Vaccination 2|Adverse Event|0
4688638|NCT02543892|7597457|FG001|Received Vaccination 2|Adverse Event|1
4688639|NCT02543892|7597458|FG002|Received Vaccination 2|Adverse Event|0
4688640|NCT02543892|7597459|FG003|Received Vaccination 2|Adverse Event|0
4688641|NCT02543892|7597460|FG004|Received Vaccination 2|Adverse Event|0
4688642|NCT02543892|7597461|FG005|Received Vaccination 2|Adverse Event|0
4688643|NCT02543892|7597462|FG006|Received Vaccination 2|Adverse Event|0
4688644|NCT02543892|7597463|FG007|Received Vaccination 2|Adverse Event|0
4688645|NCT02543892|7597456|FG000|Had Immunology Data|Withdrawal by Subject|0
4688646|NCT02543892|7597457|FG001|Had Immunology Data|Withdrawal by Subject|0
4688647|NCT02543892|7597458|FG002|Had Immunology Data|Withdrawal by Subject|0
4688648|NCT02543892|7597459|FG003|Had Immunology Data|Withdrawal by Subject|0
4688649|NCT02543892|7597460|FG004|Had Immunology Data|Withdrawal by Subject|0
4688650|NCT02543892|7597461|FG005|Had Immunology Data|Withdrawal by Subject|0
4688651|NCT02543892|7597462|FG006|Had Immunology Data|Withdrawal by Subject|1
4688652|NCT02543892|7597463|FG007|Had Immunology Data|Withdrawal by Subject|0
4688653|NCT02543918|7597488|FG000|Overall Study|Never treated|0
4688654|NCT02543918|7597489|FG001|Overall Study|Never treated|1
4688655|NCT02543918|7597488|FG000|Overall Study|Lost to Follow-up|1
4688656|NCT02543918|7597489|FG001|Overall Study|Lost to Follow-up|1
4688657|NCT02543918|7597488|FG000|Overall Study|Withdrawal by Subject|1
4688658|NCT02543918|7597489|FG001|Overall Study|Withdrawal by Subject|1
4688659|NCT02543918|7597488|FG000|Overall Study|Adverse Event|1
4688660|NCT02543918|7597489|FG001|Overall Study|Adverse Event|1
4688661|NCT02544074|7597516|FG000|Overall Study|Withdrawal by Subject|0
4688662|NCT02544074|7597517|FG001|Overall Study|Withdrawal by Subject|1
4688663|NCT02544074|7597518|FG002|Overall Study|Withdrawal by Subject|0
4688664|NCT02544074|7597519|FG003|Overall Study|Withdrawal by Subject|0
4688665|NCT02544074|7597520|FG004|Overall Study|Withdrawal by Subject|0
4688666|NCT02544074|7597521|FG005|Overall Study|Withdrawal by Subject|0
4688667|NCT02544074|7597522|FG006|Overall Study|Withdrawal by Subject|0
4688668|NCT02544074|7597523|FG007|Overall Study|Withdrawal by Subject|0
4762363|NCT01224106|7736252|FG004|Double-Blind Treatment Phase|Other|0
4762364|NCT01224106|7736248|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7
4762365|NCT01224106|7736249|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8
4762366|NCT01224106|7736250|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8
4762367|NCT01224106|7736251|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0
4762368|NCT01224106|7736252|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0
4762369|NCT01224106|7736248|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62
4762370|NCT01224106|7736249|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68
4762371|NCT01224106|7736250|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63
4762372|NCT01224106|7736251|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0
4762373|NCT01224106|7736252|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0
4762374|NCT01224106|7736248|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1
4762375|NCT01224106|7736249|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0
4762376|NCT01224106|7736250|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1
4762377|NCT01224106|7736251|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0
4762378|NCT01224106|7736252|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0
4762379|NCT01224106|7736248|FG000|Open-Label Extension (OLE) Phase|Death|0
4762380|NCT01224106|7736249|FG001|Open-Label Extension (OLE) Phase|Death|0
4762381|NCT01224106|7736250|FG002|Open-Label Extension (OLE) Phase|Death|0
4762382|NCT01224106|7736251|FG003|Open-Label Extension (OLE) Phase|Death|1
4762383|NCT01224106|7736252|FG004|Open-Label Extension (OLE) Phase|Death|3
4762384|NCT01224106|7736248|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0
4762385|NCT01224106|7736249|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0
4688669|NCT02544074|7597524|FG008|Overall Study|Withdrawal by Subject|0
4688670|NCT02544074|7597525|FG009|Overall Study|Withdrawal by Subject|0
4688671|NCT02544074|7597526|FG010|Overall Study|Withdrawal by Subject|0
4688672|NCT02544074|7597527|FG011|Overall Study|Withdrawal by Subject|0
4688673|NCT02544074|7597528|FG012|Overall Study|Withdrawal by Subject|0
4688674|NCT02544074|7597529|FG013|Overall Study|Withdrawal by Subject|0
4688675|NCT02544074|7597530|FG014|Overall Study|Withdrawal by Subject|0
4688676|NCT02544074|7597531|FG015|Overall Study|Withdrawal by Subject|0
4688677|NCT02544074|7597532|FG016|Overall Study|Withdrawal by Subject|0
4688678|NCT02544074|7597533|FG017|Overall Study|Withdrawal by Subject|0
4688679|NCT02544074|7597534|FG018|Overall Study|Withdrawal by Subject|0
4688680|NCT02544074|7597535|FG019|Overall Study|Withdrawal by Subject|0
4688681|NCT02544074|7597536|FG020|Overall Study|Withdrawal by Subject|0
4688682|NCT02544074|7597516|FG000|Overall Study|Tablet error|0
4688683|NCT02544074|7597517|FG001|Overall Study|Tablet error|0
4688684|NCT02544074|7597518|FG002|Overall Study|Tablet error|0
4688685|NCT02544074|7597519|FG003|Overall Study|Tablet error|0
4688686|NCT02544074|7597520|FG004|Overall Study|Tablet error|0
4688687|NCT02544074|7597521|FG005|Overall Study|Tablet error|1
4688688|NCT02544074|7597522|FG006|Overall Study|Tablet error|0
4688689|NCT02544074|7597523|FG007|Overall Study|Tablet error|0
4688690|NCT02544074|7597524|FG008|Overall Study|Tablet error|0
4688691|NCT02544074|7597525|FG009|Overall Study|Tablet error|1
4688692|NCT02544074|7597526|FG010|Overall Study|Tablet error|0
4688693|NCT02544074|7597527|FG011|Overall Study|Tablet error|0
4688694|NCT02544074|7597528|FG012|Overall Study|Tablet error|0
4688695|NCT02544074|7597529|FG013|Overall Study|Tablet error|0
4688696|NCT02544074|7597530|FG014|Overall Study|Tablet error|0
4688697|NCT02544074|7597531|FG015|Overall Study|Tablet error|0
4688698|NCT02544074|7597532|FG016|Overall Study|Tablet error|0
4688699|NCT02544074|7597533|FG017|Overall Study|Tablet error|0
4688700|NCT02544074|7597534|FG018|Overall Study|Tablet error|0
4688701|NCT02544074|7597535|FG019|Overall Study|Tablet error|0
4688702|NCT02544074|7597536|FG020|Overall Study|Tablet error|0
4688703|NCT02544113|7597572|FG000|Overall Study|Death|3
4688704|NCT02544113|7597573|FG001|Overall Study|Death|4
4688705|NCT02544152|7597581|FG000|Overall Study|Adverse Event|0
4688706|NCT02544152|7597582|FG001|Overall Study|Adverse Event|4
4688707|NCT02544152|7597581|FG000|Overall Study|Withdrawal by Subject|0
4688708|NCT02544152|7597582|FG001|Overall Study|Withdrawal by Subject|3
4688709|NCT02544152|7597581|FG000|Overall Study|Other|1
4688710|NCT02544152|7597582|FG001|Overall Study|Other|0
4688711|NCT02544217|7597594|FG000|Overall Study|Withdrawal by Subject|1
4688712|NCT02544217|7597595|FG001|Overall Study|Withdrawal by Subject|1
4688713|NCT02544217|7597596|FG002|Overall Study|Withdrawal by Subject|0
4688714|NCT02544217|7597597|FG003|Overall Study|Withdrawal by Subject|0
4688715|NCT02544217|7597598|FG004|Overall Study|Withdrawal by Subject|0
4688716|NCT02544217|7597599|FG005|Overall Study|Withdrawal by Subject|0
4688717|NCT02544321|7597668|FG000|Overall Study|Withdrawal by Subject|1
4688718|NCT02544321|7597669|FG001|Overall Study|Withdrawal by Subject|2
4688719|NCT02544321|7597668|FG000|Overall Study|Adverse Event|1
4688720|NCT02544321|7597669|FG001|Overall Study|Adverse Event|1
4688721|NCT02544321|7597668|FG000|Overall Study|Protocol Violation|0
4688722|NCT02544321|7597669|FG001|Overall Study|Protocol Violation|1
4688723|NCT02544451|7597687|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1
4688724|NCT02544451|7597688|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6
4688725|NCT02544451|7597689|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0
4688726|NCT02544451|7597690|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0
4688727|NCT02544451|7597687|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3
4688728|NCT02544451|7597688|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2
4688729|NCT02544451|7597689|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1
4688730|NCT02544451|7597690|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0
4688731|NCT02544451|7597687|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2
4688732|NCT02544451|7597688|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0
4688733|NCT02544451|7597689|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0
4688734|NCT02544451|7597690|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0
4688735|NCT02544451|7597687|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4
4688736|NCT02544451|7597688|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0
4688737|NCT02544451|7597689|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0
4688738|NCT02544451|7597690|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0
4688739|NCT02544451|7597687|FG000|Treatment Period 1 (96 Weeks)|Other|4
4688740|NCT02544451|7597688|FG001|Treatment Period 1 (96 Weeks)|Other|4
4688741|NCT02544451|7597689|FG002|Treatment Period 1 (96 Weeks)|Other|0
4762386|NCT01224106|7736250|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0
4762387|NCT01224106|7736251|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2
4762388|NCT01224106|7736252|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6
4762389|NCT01224106|7736248|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0
4762390|NCT01224106|7736249|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0
4762391|NCT01224106|7736250|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0
4762392|NCT01224106|7736251|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2
4762393|NCT01224106|7736252|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7
4762394|NCT01224106|7736248|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0
4762395|NCT01224106|7736249|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0
4762396|NCT01224106|7736250|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0
4762397|NCT01224106|7736251|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6
4762398|NCT01224106|7736252|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15
4762399|NCT01224106|7736248|FG000|Open-Label Extension (OLE) Phase|Other|0
4688742|NCT02544451|7597690|FG003|Treatment Period 1 (96 Weeks)|Other|0
4688743|NCT02544451|7597687|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0
4688744|NCT02544451|7597688|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0
4688745|NCT02544451|7597689|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0
4688746|NCT02544451|7597690|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10
4688747|NCT02544633|7597717|FG000|Treatment Period|Patient Still on Treatment/Study|0
4688748|NCT02544633|7597718|FG001|Treatment Period|Patient Still on Treatment/Study|1
4688749|NCT02544633|7597719|FG002|Treatment Period|Patient Still on Treatment/Study|1
4688750|NCT02544633|7597720|FG003|Treatment Period|Patient Still on Treatment/Study|0
4688751|NCT02544633|7597717|FG000|Treatment Period|Adverse Event|7
4688752|NCT02544633|7597718|FG001|Treatment Period|Adverse Event|4
4688753|NCT02544633|7597719|FG002|Treatment Period|Adverse Event|0
4688754|NCT02544633|7597720|FG003|Treatment Period|Adverse Event|5
4688755|NCT02544633|7597717|FG000|Treatment Period|Lack of Efficacy|17
4688756|NCT02544633|7597718|FG001|Treatment Period|Lack of Efficacy|11
4688757|NCT02544633|7597719|FG002|Treatment Period|Lack of Efficacy|5
4688758|NCT02544633|7597720|FG003|Treatment Period|Lack of Efficacy|5
4688759|NCT02544633|7597717|FG000|Treatment Period|Global Deterioration of Health|3
4688760|NCT02544633|7597718|FG001|Treatment Period|Global Deterioration of Health|3
4688761|NCT02544633|7597719|FG002|Treatment Period|Global Deterioration of Health|0
4688762|NCT02544633|7597720|FG003|Treatment Period|Global Deterioration of Health|1
4688763|NCT02544633|7597717|FG000|Treatment Period|Withdrawal by Subject|1
4688764|NCT02544633|7597718|FG001|Treatment Period|Withdrawal by Subject|0
4688765|NCT02544633|7597719|FG002|Treatment Period|Withdrawal by Subject|0
4688766|NCT02544633|7597720|FG003|Treatment Period|Withdrawal by Subject|0
4688767|NCT02544633|7597717|FG000|Treatment Period|Lost to Follow-up|0
4688768|NCT02544633|7597718|FG001|Treatment Period|Lost to Follow-up|1
4688769|NCT02544633|7597719|FG002|Treatment Period|Lost to Follow-up|0
4688770|NCT02544633|7597720|FG003|Treatment Period|Lost to Follow-up|0
4688771|NCT02544633|7597717|FG000|Treatment Period|Death|0
4688772|NCT02544633|7597718|FG001|Treatment Period|Death|0
4688773|NCT02544633|7597719|FG002|Treatment Period|Death|1
4688774|NCT02544633|7597720|FG003|Treatment Period|Death|0
4688775|NCT02544633|7597717|FG000|Treatment Period|Non-compliance|0
4688776|NCT02544633|7597718|FG001|Treatment Period|Non-compliance|0
4688777|NCT02544633|7597719|FG002|Treatment Period|Non-compliance|1
4688778|NCT02544633|7597720|FG003|Treatment Period|Non-compliance|0
4688779|NCT02544633|7597717|FG000|Treatment Period|Clinical Disease Progression|0
4688780|NCT02544633|7597718|FG001|Treatment Period|Clinical Disease Progression|0
4688781|NCT02544633|7597719|FG002|Treatment Period|Clinical Disease Progression|0
4688782|NCT02544633|7597720|FG003|Treatment Period|Clinical Disease Progression|1
4688783|NCT02544633|7597717|FG000|Survival Follow-up Period|Death|12
4688784|NCT02544633|7597718|FG001|Survival Follow-up Period|Death|14
4688785|NCT02544633|7597719|FG002|Survival Follow-up Period|Death|3
4688786|NCT02544633|7597720|FG003|Survival Follow-up Period|Death|9
4688787|NCT02544633|7597717|FG000|Survival Follow-up Period|Lost to Follow-up|0
4688788|NCT02544633|7597718|FG001|Survival Follow-up Period|Lost to Follow-up|1
4688789|NCT02544633|7597719|FG002|Survival Follow-up Period|Lost to Follow-up|1
4688790|NCT02544633|7597720|FG003|Survival Follow-up Period|Lost to Follow-up|0
4688791|NCT02544633|7597717|FG000|Survival Follow-up Period|Withdrawal by Subject|4
4688792|NCT02544633|7597718|FG001|Survival Follow-up Period|Withdrawal by Subject|0
4688793|NCT02544633|7597719|FG002|Survival Follow-up Period|Withdrawal by Subject|1
4688794|NCT02544633|7597720|FG003|Survival Follow-up Period|Withdrawal by Subject|0
4688795|NCT02544633|7597717|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12
4688796|NCT02544633|7597718|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4
4688797|NCT02544633|7597719|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2
4688798|NCT02544633|7597720|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3
4688799|NCT02544763|7597745|FG000|Overall Study|Adverse Event|8
4688800|NCT02544763|7597746|FG001|Overall Study|Adverse Event|8
4688801|NCT02544763|7597747|FG002|Overall Study|Adverse Event|0
4688802|NCT02544763|7597745|FG000|Overall Study|Withdrawn by parent/guardian|1
4688803|NCT02544763|7597746|FG001|Overall Study|Withdrawn by parent/guardian|1
4688804|NCT02544763|7597747|FG002|Overall Study|Withdrawn by parent/guardian|1
4688805|NCT02544763|7597745|FG000|Overall Study|Met withdrawal criteria|0
4688806|NCT02544763|7597746|FG001|Overall Study|Met withdrawal criteria|2
4688807|NCT02544763|7597747|FG002|Overall Study|Met withdrawal criteria|0
4688808|NCT02544763|7597745|FG000|Overall Study|Physician Decision|0
4688809|NCT02544763|7597746|FG001|Overall Study|Physician Decision|1
4688810|NCT02544763|7597747|FG002|Overall Study|Physician Decision|0
4762400|NCT01224106|7736249|FG001|Open-Label Extension (OLE) Phase|Other|0
4762401|NCT01224106|7736250|FG002|Open-Label Extension (OLE) Phase|Other|0
4762402|NCT01224106|7736251|FG003|Open-Label Extension (OLE) Phase|Other|5
4762403|NCT01224106|7736252|FG004|Open-Label Extension (OLE) Phase|Other|3
4762404|NCT00354835|7736281|FG000|Overall Study|Death|1
4762405|NCT00354835|7736282|FG001|Overall Study|Death|1
4762406|NCT00354835|7736281|FG000|Overall Study|Physician Decision|8
4762407|NCT00354835|7736282|FG001|Overall Study|Physician Decision|13
4762408|NCT00354835|7736281|FG000|Overall Study|Withdrawal by Subject|2
4762409|NCT00354835|7736282|FG001|Overall Study|Withdrawal by Subject|1
4762410|NCT00354835|7736281|FG000|Overall Study|Ineligible|17
4688811|NCT02544763|7597745|FG000|Overall Study|Difficulties taking IMP|1
4688812|NCT02544763|7597746|FG001|Overall Study|Difficulties taking IMP|0
4688813|NCT02544763|7597747|FG002|Overall Study|Difficulties taking IMP|0
4688814|NCT02545075|7597766|FG000|Randomization|Lost to Follow-up|0
4688815|NCT02545075|7597767|FG001|Randomization|Lost to Follow-up|1
4688816|NCT02545075|7597766|FG000|Randomization|Withdrawal by Subject|0
4688817|NCT02545075|7597767|FG001|Randomization|Withdrawal by Subject|6
4688818|NCT02545075|7597766|FG000|Treatment|Disease progression|71
4688819|NCT02545075|7597767|FG001|Treatment|Disease progression|32
4688820|NCT02545075|7597766|FG000|Treatment|Participant dicontinued study treatment|7
4688821|NCT02545075|7597767|FG001|Treatment|Participant dicontinued study treatment|9
4762411|NCT00354835|7736282|FG001|Overall Study|Ineligible|16
4762412|NCT00354835|7736281|FG000|Overall Study|Disease progression or relapse|15
4762413|NCT00354835|7736282|FG001|Overall Study|Disease progression or relapse|22
4762414|NCT00354835|7736281|FG000|Overall Study|Adverse Event|6
4762415|NCT00354835|7736282|FG001|Overall Study|Adverse Event|0
4762416|NCT00354835|7736281|FG000|Overall Study|Refusal of further therapy|3
4762417|NCT00354835|7736282|FG001|Overall Study|Refusal of further therapy|8
4688822|NCT02545075|7597766|FG000|Treatment|Withdrawal by Subject|1
4688823|NCT02545075|7597767|FG001|Treatment|Withdrawal by Subject|0
4688824|NCT02545075|7597766|FG000|Treatment|Adverse event not related to study drug|1
4688825|NCT02545075|7597767|FG001|Treatment|Adverse event not related to study drug|0
4688826|NCT02545075|7597766|FG000|Treatment|Death|1
4688827|NCT02545075|7597767|FG001|Treatment|Death|0
4688828|NCT02545075|7597766|FG000|Treatment|Participant drug toxicity|1
4688829|NCT02545075|7597767|FG001|Treatment|Participant drug toxicity|0
4688830|NCT02545075|7597766|FG000|Treatment|Completed treatment|40
4688831|NCT02545075|7597767|FG001|Treatment|Completed treatment|12
4688832|NCT02545270|7597780|FG000|Overall Study|technical difficulties|0
4688833|NCT02545270|7597781|FG001|Overall Study|technical difficulties|1
4688834|NCT02545270|7597782|FG002|Overall Study|technical difficulties|0
4688835|NCT02545270|7597780|FG000|Overall Study|Videos being too similar to other|0
4688836|NCT02545270|7597781|FG001|Overall Study|Videos being too similar to other|0
4688837|NCT02545270|7597782|FG002|Overall Study|Videos being too similar to other|2
4688838|NCT02545322|7597791|FG000|Overall Study|Withdrawal by Subject|3
4688839|NCT02545504|7597797|FG000|Overall Study|Death|174
4688840|NCT02545504|7597798|FG001|Overall Study|Death|168
4688841|NCT02545504|7597797|FG000|Overall Study|Unknown reason|30
4688842|NCT02545504|7597798|FG001|Overall Study|Unknown reason|32
4688843|NCT02545504|7597797|FG000|Overall Study|Withdrew consent|9
4688844|NCT02545504|7597798|FG001|Overall Study|Withdrew consent|11
4688845|NCT02545504|7597797|FG000|Overall Study|Investigator's discretion|3
4688846|NCT02545504|7597798|FG001|Overall Study|Investigator's discretion|1
4688847|NCT02545504|7597797|FG000|Overall Study|Lost to Follow-up|2
4688848|NCT02545504|7597798|FG001|Overall Study|Lost to Follow-up|2
4688849|NCT02545543|7597810|FG000|Overall Study|Lost to Follow-up|67
4688850|NCT02545543|7597811|FG001|Overall Study|Lost to Follow-up|25
4688851|NCT02545543|7597810|FG000|Overall Study|Physician Decision|3
4688852|NCT02545543|7597811|FG001|Overall Study|Physician Decision|0
4688853|NCT02545543|7597810|FG000|Overall Study|Withdrawal by Subject|9
4688854|NCT02545543|7597811|FG001|Overall Study|Withdrawal by Subject|8
4688855|NCT02545543|7597810|FG000|Overall Study|Noncomplaince|1
4688856|NCT02545543|7597811|FG001|Overall Study|Noncomplaince|0
4688857|NCT02545543|7597810|FG000|Overall Study|Enrolment of subject at >1 study site|1
4688858|NCT02545543|7597811|FG001|Overall Study|Enrolment of subject at >1 study site|1
4688859|NCT02545933|7597845|FG000|Overall Study|Adverse Event|3
4688860|NCT02545933|7597846|FG001|Overall Study|Adverse Event|0
4688861|NCT02545933|7597847|FG002|Overall Study|Adverse Event|0
4688862|NCT02545933|7597845|FG000|Overall Study|Withdrawal by Subject|2
4688863|NCT02545933|7597846|FG001|Overall Study|Withdrawal by Subject|3
4688864|NCT02545933|7597847|FG002|Overall Study|Withdrawal by Subject|3
4688865|NCT02545933|7597845|FG000|Overall Study|Protocol Violation|1
4688866|NCT02545933|7597846|FG001|Overall Study|Protocol Violation|0
4762418|NCT04531241|7736303|FG000|Period 1|Withdrawal by Subject|2
4762419|NCT04531241|7736304|FG001|Period 1|Withdrawal by Subject|0
4762420|NCT04531241|7736303|FG000|Period 1|Dispesed incorrect lens power|1
4762421|NCT04531241|7736304|FG001|Period 1|Dispesed incorrect lens power|0
4762422|NCT04531241|7736303|FG000|Period 1|Protocol Violation|1
4762423|NCT04531241|7736304|FG001|Period 1|Protocol Violation|0
4762424|NCT04531241|7736303|FG000|Period 1|No longer eligible|0
4762425|NCT04531241|7736304|FG001|Period 1|No longer eligible|1
4762426|NCT04531241|7736303|FG000|Period 1|Lens Discomfort|0
4762427|NCT04531241|7736304|FG001|Period 1|Lens Discomfort|1
4762428|NCT04531241|7736303|FG000|Period 2|Covid-19 Related|1
4762429|NCT04531241|7736304|FG001|Period 2|Covid-19 Related|1
4688867|NCT02545933|7597847|FG002|Overall Study|Protocol Violation|1
4688868|NCT02546193|7597857|FG000|Overall Study|Withdrawal by Subject|2
4688869|NCT02546193|7597858|FG001|Overall Study|Withdrawal by Subject|0
4688870|NCT02546193|7597859|FG002|Overall Study|Withdrawal by Subject|1
4688871|NCT02546193|7597860|FG003|Overall Study|Withdrawal by Subject|0
4688872|NCT02546193|7597857|FG000|Overall Study|Not eligible at time of induction|4
4688873|NCT02546193|7597858|FG001|Overall Study|Not eligible at time of induction|6
4688874|NCT02546193|7597859|FG002|Overall Study|Not eligible at time of induction|1
4688875|NCT02546193|7597860|FG003|Overall Study|Not eligible at time of induction|0
4688876|NCT02546323|7597868|FG000|Overall Study|Withdrawal by Subject|36
4688877|NCT02546323|7597869|FG001|Overall Study|Withdrawal by Subject|33
4688878|NCT02546323|7597868|FG000|Overall Study|Eligibility Criteria not Fulfilled|0
4688879|NCT02546323|7597869|FG001|Overall Study|Eligibility Criteria not Fulfilled|1
4688880|NCT02546323|7597868|FG000|Overall Study|Adverse Event|17
4688881|NCT02546323|7597869|FG001|Overall Study|Adverse Event|11
4688882|NCT02546323|7597868|FG000|Overall Study|Patient Specific Reasons|1
4688883|NCT02546323|7597869|FG001|Overall Study|Patient Specific Reasons|2
4688884|NCT02546323|7597868|FG000|Overall Study|Lost to Follow-up|2
4688885|NCT02546323|7597869|FG001|Overall Study|Lost to Follow-up|3
4688886|NCT02546323|7597868|FG000|Overall Study|Non-compliance with Study Drug|2
4688887|NCT02546323|7597869|FG001|Overall Study|Non-compliance with Study Drug|2
4688888|NCT02546323|7597868|FG000|Overall Study|Met Withdrawal Criteria|2
4688889|NCT02546323|7597869|FG001|Overall Study|Met Withdrawal Criteria|14
4688890|NCT02546362|7597875|FG000|4-week Treatment Period|Lost to Follow-up|1
4688891|NCT02546362|7597875|FG000|4-week Treatment Period|Change in medication|2
4762430|NCT04185220|7736349|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0
4762431|NCT04185220|7736350|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1
4762432|NCT04185220|7736349|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0
4762433|NCT04185220|7736350|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1
4762434|NCT03815175|7736367|FG000|Overall Study|Subject Lost to Follow-up|6
4762435|NCT03815175|7736367|FG000|Overall Study|Subject Withdrew Consent|48
4762436|NCT03815175|7736367|FG000|Overall Study|Subject Withdrawn by Physician/Site|10
4762437|NCT03815175|7736367|FG000|Overall Study|Death|86
4762438|NCT03815175|7736367|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1
4762439|NCT03815175|7736367|FG000|Overall Study|Subject Discontinued by Sponsor|2
4762440|NCT03815175|7736367|FG000|Overall Study|Other Status Change Reason|1
4762441|NCT03815175|7736367|FG000|Overall Study|Missed Visit|12
4762442|NCT03600714|7736371|FG000|Overall Study|Out of country and could not return for post-treatment visits|1
4762443|NCT03470441|7736392|FG000|Overall Study|Death|0
4762444|NCT03470441|7736393|FG001|Overall Study|Death|1
4762445|NCT03470441|7736394|FG002|Overall Study|Death|1
4762446|NCT03470441|7736395|FG003|Overall Study|Death|0
4762447|NCT03470441|7736392|FG000|Overall Study|Adverse Event|0
4762448|NCT03470441|7736393|FG001|Overall Study|Adverse Event|0
4762449|NCT03470441|7736394|FG002|Overall Study|Adverse Event|0
4688892|NCT02546362|7597875|FG000|12-week Treatment Period|Withdrawal by Subject|6
4688893|NCT02546362|7597875|FG000|12-week Treatment Period|Lost to Follow-up|2
4688894|NCT02546362|7597875|FG000|12-week Treatment Period|Change in medication|1
4688895|NCT02546544|7597893|FG000|Overall Study|Disease Progression|14
4688896|NCT02546544|7597893|FG000|Overall Study|Adverse Event|1
4688897|NCT02546544|7597893|FG000|Overall Study|Withdrawal by Subject|1
4688898|NCT02546609|7597913|FG000|Overall Study|Withdrawal by Subject|0
4688899|NCT02546609|7597914|FG001|Overall Study|Withdrawal by Subject|1
4688900|NCT02546609|7597915|FG002|Overall Study|Withdrawal by Subject|2
4688901|NCT02546609|7597913|FG000|Overall Study|Adverse Event|0
4688902|NCT02546609|7597914|FG001|Overall Study|Adverse Event|6
4688903|NCT02546609|7597915|FG002|Overall Study|Adverse Event|1
4688904|NCT02546609|7597913|FG000|Overall Study|Protocol Violation|0
4688905|NCT02546609|7597914|FG001|Overall Study|Protocol Violation|1
4688906|NCT02546609|7597915|FG002|Overall Study|Protocol Violation|1
4688907|NCT02546609|7597913|FG000|Overall Study|Lost to Follow-up|2
4688908|NCT02546609|7597914|FG001|Overall Study|Lost to Follow-up|3
4688909|NCT02546609|7597915|FG002|Overall Study|Lost to Follow-up|1
4688910|NCT02546609|7597913|FG000|Overall Study|travel or work schedule restriction|0
4688911|NCT02546609|7597914|FG001|Overall Study|travel or work schedule restriction|0
4688912|NCT02546609|7597915|FG002|Overall Study|travel or work schedule restriction|2
4762450|NCT03470441|7736395|FG003|Overall Study|Adverse Event|1
4762451|NCT03470441|7736392|FG000|Overall Study|Withdrawal by Subject|1
4762452|NCT03470441|7736393|FG001|Overall Study|Withdrawal by Subject|4
4762453|NCT03470441|7736394|FG002|Overall Study|Withdrawal by Subject|1
4762454|NCT03470441|7736395|FG003|Overall Study|Withdrawal by Subject|3
4762455|NCT03452397|7736409|FG000|Overall Study|Adverse Event|1
4762456|NCT03452397|7736410|FG001|Overall Study|Adverse Event|0
4762457|NCT03452397|7736411|FG002|Overall Study|Adverse Event|0
4762458|NCT03452397|7736412|FG003|Overall Study|Adverse Event|0
4762459|NCT03452397|7736409|FG000|Overall Study|Administrative reason|0
4762460|NCT03452397|7736410|FG001|Overall Study|Administrative reason|0
4762461|NCT03452397|7736411|FG002|Overall Study|Administrative reason|1
4762462|NCT03452397|7736412|FG003|Overall Study|Administrative reason|1
4762463|NCT03452397|7736409|FG000|Overall Study|Withdrawal by Subject|0
4762464|NCT03452397|7736410|FG001|Overall Study|Withdrawal by Subject|0
4762465|NCT03452397|7736411|FG002|Overall Study|Withdrawal by Subject|1
4762466|NCT03452397|7736412|FG003|Overall Study|Withdrawal by Subject|0
4762467|NCT03448939|7736426|FG000|Overall Study|Adverse Event|5
4762468|NCT03448939|7736427|FG001|Overall Study|Adverse Event|1
4762469|NCT03448939|7736426|FG000|Overall Study|Lost to Follow-up|6
4762470|NCT03448939|7736427|FG001|Overall Study|Lost to Follow-up|6
4762471|NCT03448939|7736426|FG000|Overall Study|Pregnancy|1
4762472|NCT03448939|7736427|FG001|Overall Study|Pregnancy|1
4762473|NCT03448939|7736426|FG000|Overall Study|Withdrawal by Subject|9
4762474|NCT03448939|7736427|FG001|Overall Study|Withdrawal by Subject|3
4762475|NCT03410108|7736433|FG000|Overall Study|Ongoing|41
4762476|NCT03410108|7736433|FG000|Overall Study|Adverse Event|4
4762477|NCT03410108|7736433|FG000|Overall Study|Progressive Disease|58
4762478|NCT03410108|7736433|FG000|Overall Study|Withdrawal by Subject|1
4688913|NCT02546765|7597927|FG000|Overall Study|Withdrawal by Subject|0
4688914|NCT02546765|7597928|FG001|Overall Study|Withdrawal by Subject|1
4688915|NCT02546765|7597929|FG002|Overall Study|Withdrawal by Subject|0
4688916|NCT02546765|7597930|FG003|Overall Study|Withdrawal by Subject|0
4688917|NCT02546856|7597953|FG000|4 Months Evaluation|Death|2
4688918|NCT02546856|7597954|FG001|4 Months Evaluation|Death|3
4688919|NCT02546856|7597953|FG000|4 Months Evaluation|Withdrawal by Subject|2
4688920|NCT02546856|7597954|FG001|4 Months Evaluation|Withdrawal by Subject|3
4688921|NCT02546856|7597953|FG000|4 Months Evaluation|Lost to Follow-up|3
4688922|NCT02546856|7597954|FG001|4 Months Evaluation|Lost to Follow-up|3
4688923|NCT02546856|7597953|FG000|4 Months Evaluation|Physician Decision|3
4688924|NCT02546856|7597954|FG001|4 Months Evaluation|Physician Decision|0
4688925|NCT02546856|7597953|FG000|4 Months Evaluation|Working or living abroad|5
4688926|NCT02546856|7597954|FG001|4 Months Evaluation|Working or living abroad|1
4688927|NCT02546856|7597953|FG000|4 Months Evaluation|reasons not due to titration|4
4688928|NCT02546856|7597954|FG001|4 Months Evaluation|reasons not due to titration|1
4688929|NCT02546856|7597953|FG000|4 Months Evaluation|HF Unit not active in summer|1
4688930|NCT02546856|7597954|FG001|4 Months Evaluation|HF Unit not active in summer|0
4688931|NCT02546856|7597953|FG000|6 Months Evaluation|Death|1
4688932|NCT02546856|7597954|FG001|6 Months Evaluation|Death|1
4688933|NCT02546856|7597953|FG000|6 Months Evaluation|Lost to Follow-up|1
4688934|NCT02546856|7597954|FG001|6 Months Evaluation|Lost to Follow-up|1
4688935|NCT02546856|7597953|FG000|6 Months Evaluation|Working or living abroad|6
4688936|NCT02546856|7597954|FG001|6 Months Evaluation|Working or living abroad|4
4688937|NCT02546856|7597953|FG000|6 Months Evaluation|reasons not due to titration|0
4688938|NCT02546856|7597954|FG001|6 Months Evaluation|reasons not due to titration|1
4688939|NCT02547038|7597983|FG000|Overall Study|Lost to Follow-up|3
4688940|NCT02547038|7597984|FG001|Overall Study|Lost to Follow-up|2
4688941|NCT02547220|7598001|FG000|Overall Study|Withdrawal by Subject|1
4688942|NCT02547220|7598002|FG001|Overall Study|Withdrawal by Subject|0
4688943|NCT02547220|7598001|FG000|Overall Study|Study terminated by sponsor|18
4688944|NCT02547220|7598002|FG001|Overall Study|Study terminated by sponsor|20
4688945|NCT02547233|7598010|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1
4688946|NCT02547233|7598011|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0
4688947|NCT02547233|7598010|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1
4688948|NCT02547233|7598011|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0
4688949|NCT02547233|7598010|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0
4688950|NCT02547233|7598011|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9
4688951|NCT02547233|7598010|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0
4688952|NCT02547233|7598011|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1
4688953|NCT02547233|7598010|FG000|12-month Follow-up|Withdrawal by Subject|10
4688954|NCT02547233|7598011|FG001|12-month Follow-up|Withdrawal by Subject|10
4688955|NCT02547233|7598010|FG000|12-month Follow-up|Lost to Follow-up|3
4688956|NCT02547233|7598011|FG001|12-month Follow-up|Lost to Follow-up|3
4688957|NCT02547233|7598010|FG000|12-month Follow-up|Lack of Efficacy|1
4688958|NCT02547233|7598011|FG001|12-month Follow-up|Lack of Efficacy|2
4688959|NCT02547233|7598010|FG000|12-month Follow-up|Protocol Violation|0
4688960|NCT02547233|7598011|FG001|12-month Follow-up|Protocol Violation|1
4688961|NCT02547233|7598010|FG000|12-month Follow-up|Other|0
4688962|NCT02547233|7598011|FG001|12-month Follow-up|Other|1
4688963|NCT02547363|7598021|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0
4688964|NCT02547363|7598022|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1
4688965|NCT02547363|7598021|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2
4688966|NCT02547363|7598022|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8
4688967|NCT02547363|7598021|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1
4688968|NCT02547363|7598022|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1
4688969|NCT02547363|7598021|FG000|3-day Treatment and 8-week Follow-up|Other|1
4688970|NCT02547363|7598022|FG001|3-day Treatment and 8-week Follow-up|Other|1
4688971|NCT02547363|7598021|FG000|12-month Follow-up|Withdrawal by Subject|4
4688972|NCT02547363|7598022|FG001|12-month Follow-up|Withdrawal by Subject|3
4688973|NCT02547363|7598021|FG000|12-month Follow-up|Lost to Follow-up|4
4688974|NCT02547363|7598022|FG001|12-month Follow-up|Lost to Follow-up|1
4688975|NCT02547363|7598021|FG000|12-month Follow-up|Lack of Efficacy|1
4688976|NCT02547363|7598022|FG001|12-month Follow-up|Lack of Efficacy|1
4688977|NCT02547363|7598021|FG000|12-month Follow-up|Other|1
4688978|NCT02547363|7598022|FG001|12-month Follow-up|Other|0
4688979|NCT02547428|7598032|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8
4688980|NCT02547428|7598033|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1
4688981|NCT02547428|7598032|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1
4688982|NCT02547428|7598033|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1
4688983|NCT02547428|7598032|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1
4688984|NCT02547428|7598033|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1
4688985|NCT02547428|7598032|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1
4688986|NCT02547428|7598033|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3
4688987|NCT02547428|7598032|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0
4688988|NCT02547428|7598033|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3
4688989|NCT02547428|7598032|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0
4688990|NCT02547428|7598033|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3
4688991|NCT02547428|7598032|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0
4688992|NCT02547428|7598033|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1
4688993|NCT02547428|7598032|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1
4688994|NCT02547428|7598033|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0
4688995|NCT02547454|7598046|FG000|Overall Study|Due to hemodialysis|53
4688996|NCT02547454|7598046|FG000|Overall Study|Due to transplantation|1
4688997|NCT02547454|7598046|FG000|Overall Study|Due to no further need to treat|4
4688998|NCT02547454|7598046|FG000|Overall Study|Death|38
4688999|NCT02547454|7598046|FG000|Overall Study|Lost to Follow-up|26
4689000|NCT02547454|7598046|FG000|Overall Study|Other|39
4689001|NCT02547454|7598046|FG000|Overall Study|No data|11
4689002|NCT02547649|7598062|FG000|Overall Study|Lost to Follow-up|3
4689003|NCT02547649|7598063|FG001|Overall Study|Lost to Follow-up|1
4689004|NCT02547649|7598064|FG002|Overall Study|Lost to Follow-up|1
4689005|NCT02547649|7598062|FG000|Overall Study|Not vaccinated|0
4689006|NCT02547649|7598063|FG001|Overall Study|Not vaccinated|0
4689007|NCT02547649|7598064|FG002|Overall Study|Not vaccinated|1
4689008|NCT02547649|7598062|FG000|Overall Study|Withdrawal by Subject|0
4689009|NCT02547649|7598063|FG001|Overall Study|Withdrawal by Subject|4
4689010|NCT02547649|7598064|FG002|Overall Study|Withdrawal by Subject|2
4689011|NCT02547766|7598077|FG000|Overall Study|Withdrawal by Subject|1
4689012|NCT02547922|7598093|FG000|Overall Study|Withdrawal by Subject|9
4689013|NCT02547922|7598094|FG001|Overall Study|Withdrawal by Subject|6
4762479|NCT03283371|7736451|FG000|Placebo-controlled|Adverse Event|1
4762480|NCT03283371|7736452|FG001|Placebo-controlled|Adverse Event|1
4762481|NCT03283371|7736453|FG002|Placebo-controlled|Adverse Event|0
4762482|NCT03283371|7736454|FG003|Placebo-controlled|Adverse Event|0
4762483|NCT03283371|7736451|FG000|Placebo-controlled|Lack of Efficacy|1
4762484|NCT03283371|7736452|FG001|Placebo-controlled|Lack of Efficacy|0
4762485|NCT03283371|7736453|FG002|Placebo-controlled|Lack of Efficacy|0
4762486|NCT03283371|7736454|FG003|Placebo-controlled|Lack of Efficacy|0
4762487|NCT03283371|7736451|FG000|Placebo-controlled|Withdrawal by Subject|1
4762488|NCT03283371|7736452|FG001|Placebo-controlled|Withdrawal by Subject|1
4762489|NCT03283371|7736453|FG002|Placebo-controlled|Withdrawal by Subject|0
4762490|NCT03283371|7736454|FG003|Placebo-controlled|Withdrawal by Subject|0
4762491|NCT03283371|7736451|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0
4762492|NCT03283371|7736452|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1
4762493|NCT03283371|7736453|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0
4762494|NCT03283371|7736454|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0
4762495|NCT03283371|7736451|FG000|Open-label Phase|Adverse Event|0
4762496|NCT03283371|7736452|FG001|Open-label Phase|Adverse Event|0
4762497|NCT03283371|7736453|FG002|Open-label Phase|Adverse Event|2
4762498|NCT03283371|7736454|FG003|Open-label Phase|Adverse Event|0
4762499|NCT03283371|7736451|FG000|Open-label Phase|Withdrawal by Subject|0
4762500|NCT03283371|7736452|FG001|Open-label Phase|Withdrawal by Subject|0
4762501|NCT03283371|7736453|FG002|Open-label Phase|Withdrawal by Subject|1
4762502|NCT03283371|7736454|FG003|Open-label Phase|Withdrawal by Subject|0
4762503|NCT03283371|7736451|FG000|Open-label Phase|Other|0
4762504|NCT03283371|7736452|FG001|Open-label Phase|Other|0
4762505|NCT03283371|7736453|FG002|Open-label Phase|Other|1
4762506|NCT03283371|7736454|FG003|Open-label Phase|Other|1
4762507|NCT03257254|7736464|FG000|Overall Study|Withdrawal by Subject|7
4762508|NCT03257254|7736464|FG000|Overall Study|Lost to Follow-up|9
4762509|NCT03257254|7736464|FG000|Overall Study|Study discontinued by sponsor|5
4762510|NCT03084718|7736473|FG000|Overall Study|Withdrawal by Subject|4
4762511|NCT03084718|7736474|FG001|Overall Study|Withdrawal by Subject|3
4762512|NCT03084718|7736475|FG002|Overall Study|Withdrawal by Subject|4
4762513|NCT03084718|7736476|FG003|Overall Study|Withdrawal by Subject|0
4762514|NCT03084718|7736477|FG004|Overall Study|Withdrawal by Subject|0
4762515|NCT03084718|7736473|FG000|Overall Study|Physician Decision|1
4762516|NCT03084718|7736474|FG001|Overall Study|Physician Decision|0
4762517|NCT03084718|7736475|FG002|Overall Study|Physician Decision|0
4762518|NCT03084718|7736476|FG003|Overall Study|Physician Decision|0
4762519|NCT03084718|7736477|FG004|Overall Study|Physician Decision|0
4762520|NCT03084718|7736473|FG000|Overall Study|Adverse Event|3
4762521|NCT03084718|7736474|FG001|Overall Study|Adverse Event|5
4762522|NCT03084718|7736475|FG002|Overall Study|Adverse Event|5
4762523|NCT03084718|7736476|FG003|Overall Study|Adverse Event|8
4762524|NCT03084718|7736477|FG004|Overall Study|Adverse Event|2
4762525|NCT03084718|7736473|FG000|Overall Study|Lack of Efficacy|2
4762526|NCT03084718|7736474|FG001|Overall Study|Lack of Efficacy|0
4762527|NCT03084718|7736475|FG002|Overall Study|Lack of Efficacy|1
4762528|NCT03084718|7736476|FG003|Overall Study|Lack of Efficacy|4
4762529|NCT03084718|7736477|FG004|Overall Study|Lack of Efficacy|0
4762530|NCT03084718|7736473|FG000|Overall Study|Lost to Follow-up|0
4762531|NCT03084718|7736474|FG001|Overall Study|Lost to Follow-up|1
4762532|NCT03084718|7736475|FG002|Overall Study|Lost to Follow-up|0
4762533|NCT03084718|7736476|FG003|Overall Study|Lost to Follow-up|0
4689014|NCT02547922|7598095|FG002|Overall Study|Withdrawal by Subject|10
4689015|NCT02547922|7598093|FG000|Overall Study|Adverse Event|3
4689016|NCT02547922|7598094|FG001|Overall Study|Adverse Event|1
4689017|NCT02547922|7598095|FG002|Overall Study|Adverse Event|2
4689018|NCT02547922|7598093|FG000|Overall Study|Lost to Follow-up|1
4689019|NCT02547922|7598094|FG001|Overall Study|Lost to Follow-up|0
4689020|NCT02547922|7598095|FG002|Overall Study|Lost to Follow-up|0
4689021|NCT02547922|7598093|FG000|Overall Study|Lack of Efficacy|5
4689022|NCT02547922|7598094|FG001|Overall Study|Lack of Efficacy|7
4689023|NCT02547922|7598095|FG002|Overall Study|Lack of Efficacy|4
4689024|NCT02547922|7598093|FG000|Overall Study|Death|1
4689025|NCT02547922|7598094|FG001|Overall Study|Death|0
4689026|NCT02547922|7598095|FG002|Overall Study|Death|0
4689027|NCT02547922|7598093|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4
4689028|NCT02547922|7598094|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8
4689029|NCT02547922|7598095|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9
4762534|NCT03084718|7736477|FG004|Overall Study|Lost to Follow-up|2
4762535|NCT03084718|7736473|FG000|Overall Study|Protocol Violation|0
4762536|NCT03084718|7736474|FG001|Overall Study|Protocol Violation|0
4762537|NCT03084718|7736475|FG002|Overall Study|Protocol Violation|1
4762538|NCT03084718|7736476|FG003|Overall Study|Protocol Violation|0
4762539|NCT03084718|7736477|FG004|Overall Study|Protocol Violation|0
4762540|NCT03084718|7736473|FG000|Overall Study|Death|0
4762541|NCT03084718|7736474|FG001|Overall Study|Death|1
4762542|NCT03084718|7736475|FG002|Overall Study|Death|0
4762543|NCT03084718|7736476|FG003|Overall Study|Death|0
4762544|NCT03084718|7736477|FG004|Overall Study|Death|0
4762545|NCT03084718|7736473|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1
4762546|NCT03084718|7736474|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0
4762547|NCT03084718|7736475|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1
4762548|NCT03084718|7736476|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2
4762549|NCT03084718|7736477|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0
4762550|NCT03069417|7736494|FG000|Overall Study|Lost to Follow-up|2
4762551|NCT03069417|7736495|FG001|Overall Study|Lost to Follow-up|0
4762552|NCT03069417|7736494|FG000|Overall Study|Reason Unknown|4
4762553|NCT03069417|7736495|FG001|Overall Study|Reason Unknown|7
4762554|NCT02936323|7736524|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0
4762555|NCT02936323|7736525|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1
4762556|NCT02936323|7736526|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0
4762557|NCT02936323|7736527|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1
4762558|NCT02936323|7736528|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1
4762559|NCT02936323|7736529|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1
4762560|NCT02936323|7736530|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0
4689030|NCT02547922|7598093|FG000|Overall Study|TECHNICAL PROBLEMS|1
4689031|NCT02547922|7598094|FG001|Overall Study|TECHNICAL PROBLEMS|0
4689032|NCT02547922|7598095|FG002|Overall Study|TECHNICAL PROBLEMS|0
4689033|NCT02547922|7598093|FG000|Overall Study|PROGRESSIVE DISEASE|1
4689034|NCT02547922|7598094|FG001|Overall Study|PROGRESSIVE DISEASE|0
4689035|NCT02547922|7598095|FG002|Overall Study|PROGRESSIVE DISEASE|2
4689036|NCT02547922|7598093|FG000|Overall Study|Physician Decision|2
4689037|NCT02547922|7598094|FG001|Overall Study|Physician Decision|1
4689038|NCT02547922|7598095|FG002|Overall Study|Physician Decision|2
4689039|NCT02547922|7598093|FG000|Overall Study|Patients did not receive IP|1
4689040|NCT02547922|7598094|FG001|Overall Study|Patients did not receive IP|1
4689041|NCT02547922|7598095|FG002|Overall Study|Patients did not receive IP|0
4689042|NCT02547935|7598112|FG000|Overall Study|Other|0
4689043|NCT02547935|7598113|FG001|Overall Study|Other|1
4689044|NCT02547935|7598114|FG002|Overall Study|Other|0
4689045|NCT02547935|7598112|FG000|Overall Study|Withdrawal by Subject|2
4762561|NCT02936323|7736531|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0
4762562|NCT02936323|7736532|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0
4762563|NCT02936323|7736533|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0
4689046|NCT02547935|7598113|FG001|Overall Study|Withdrawal by Subject|3
4689047|NCT02547935|7598114|FG002|Overall Study|Withdrawal by Subject|4
4689048|NCT02547935|7598112|FG000|Overall Study|Screen Failure|2
4689049|NCT02547935|7598113|FG001|Overall Study|Screen Failure|0
4689050|NCT02547935|7598114|FG002|Overall Study|Screen Failure|0
4689051|NCT02547935|7598112|FG000|Overall Study|Physician Decision|0
4689052|NCT02547935|7598113|FG001|Overall Study|Physician Decision|1
4689053|NCT02547935|7598114|FG002|Overall Study|Physician Decision|0
4689054|NCT02547935|7598112|FG000|Overall Study|Lost to Follow-up|0
4689055|NCT02547935|7598113|FG001|Overall Study|Lost to Follow-up|2
4689056|NCT02547935|7598114|FG002|Overall Study|Lost to Follow-up|1
4689057|NCT02547935|7598112|FG000|Overall Study|Death|1
4689058|NCT02547935|7598113|FG001|Overall Study|Death|1
4689059|NCT02547935|7598114|FG002|Overall Study|Death|0
4689060|NCT02547974|7598128|FG000|Overall Study|Withdrawal by Subject|1
4689061|NCT02547974|7598129|FG001|Overall Study|Withdrawal by Subject|0
4689062|NCT02547974|7598130|FG002|Overall Study|Withdrawal by Subject|0
4689063|NCT02547974|7598131|FG003|Overall Study|Withdrawal by Subject|0
4689064|NCT02547987|7598144|FG000|Overall Study|Withdrawal by Subject|1
4689065|NCT02547987|7598144|FG000|Overall Study|Adverse Event|2
4689066|NCT02548078|7598150|FG000|Overall Study|Serious adverse event/Adverse event|1
4689067|NCT02548078|7598151|FG001|Overall Study|Serious adverse event/Adverse event|0
4689068|NCT02548078|7598150|FG000|Overall Study|Moved from study area|3
4689069|NCT02548078|7598151|FG001|Overall Study|Moved from study area|3
4689070|NCT02548078|7598150|FG000|Overall Study|Lost to Follow-up|1
4689071|NCT02548078|7598151|FG001|Overall Study|Lost to Follow-up|3
4689072|NCT02548156|7598164|FG000|Washout Period 1|Lost to Follow-up|0
4689073|NCT02548156|7598165|FG001|Washout Period 1|Lost to Follow-up|0
4689074|NCT02548156|7598166|FG002|Washout Period 1|Lost to Follow-up|0
4689075|NCT02548156|7598167|FG003|Washout Period 1|Lost to Follow-up|0
4689076|NCT02548156|7598168|FG004|Washout Period 1|Lost to Follow-up|1
4689077|NCT02548156|7598169|FG005|Washout Period 1|Lost to Follow-up|0
4689078|NCT02548455|7598210|FG000|Overall Study|Withdrawal by Subject|27
4689079|NCT02548455|7598210|FG000|Overall Study|Death|26
4689080|NCT02548455|7598210|FG000|Overall Study|Lost to Follow-up|14
4689081|NCT02548455|7598210|FG000|Overall Study|Visit not completed|173
4689082|NCT02548585|7598221|FG000|Overall Study|Withdrawal by Subject|0
4689083|NCT02548585|7598222|FG001|Overall Study|Withdrawal by Subject|0
4689084|NCT02548585|7598223|FG002|Overall Study|Withdrawal by Subject|0
4689085|NCT02548585|7598224|FG003|Overall Study|Withdrawal by Subject|0
4689086|NCT02548585|7598225|FG004|Overall Study|Withdrawal by Subject|0
4689087|NCT02548585|7598226|FG005|Overall Study|Withdrawal by Subject|1
4689088|NCT02548585|7598227|FG006|Overall Study|Withdrawal by Subject|0
4689089|NCT02548585|7598221|FG000|Overall Study|Lost to Follow-up|1
4689090|NCT02548585|7598222|FG001|Overall Study|Lost to Follow-up|0
4689091|NCT02548585|7598223|FG002|Overall Study|Lost to Follow-up|0
4689092|NCT02548585|7598224|FG003|Overall Study|Lost to Follow-up|0
4689093|NCT02548585|7598225|FG004|Overall Study|Lost to Follow-up|0
4689094|NCT02548585|7598226|FG005|Overall Study|Lost to Follow-up|0
4689095|NCT02548585|7598227|FG006|Overall Study|Lost to Follow-up|0
4689096|NCT02548585|7598221|FG000|Overall Study|Other|1
4689097|NCT02548585|7598222|FG001|Overall Study|Other|0
4689098|NCT02548585|7598223|FG002|Overall Study|Other|0
4689099|NCT02548585|7598224|FG003|Overall Study|Other|2
4689100|NCT02548585|7598225|FG004|Overall Study|Other|3
4689101|NCT02548585|7598226|FG005|Overall Study|Other|0
4689102|NCT02548585|7598227|FG006|Overall Study|Other|1
4689103|NCT02548585|7598221|FG000|Overall Study|Randomized but not treated|0
4762564|NCT02936323|7736524|FG000|Phase 1 Dose Escalation|Death|2
4762565|NCT02936323|7736525|FG001|Phase 1 Dose Escalation|Death|1
4762566|NCT02936323|7736526|FG002|Phase 1 Dose Escalation|Death|3
4762567|NCT02936323|7736527|FG003|Phase 1 Dose Escalation|Death|1
4762568|NCT02936323|7736528|FG004|Phase 1 Dose Escalation|Death|2
4762569|NCT02936323|7736529|FG005|Phase 1 Dose Escalation|Death|3
4762570|NCT02936323|7736530|FG006|Phase 1 Dose Escalation|Death|3
4762571|NCT02936323|7736531|FG007|Phase 1 Dose Escalation|Death|0
4762572|NCT02936323|7736532|FG008|Phase 1 Dose Escalation|Death|0
4762573|NCT02936323|7736533|FG009|Phase 1 Dose Escalation|Death|0
4762574|NCT02936323|7736524|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0
4762575|NCT02936323|7736525|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0
4762576|NCT02936323|7736526|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0
4762577|NCT02936323|7736527|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0
4762578|NCT02936323|7736528|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0
4762579|NCT02936323|7736529|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1
4762580|NCT02936323|7736530|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0
4762581|NCT02936323|7736531|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0
4689104|NCT02548585|7598222|FG001|Overall Study|Randomized but not treated|0
4689105|NCT02548585|7598223|FG002|Overall Study|Randomized but not treated|0
4689106|NCT02548585|7598224|FG003|Overall Study|Randomized but not treated|0
4689107|NCT02548585|7598225|FG004|Overall Study|Randomized but not treated|0
4689108|NCT02548585|7598226|FG005|Overall Study|Randomized but not treated|1
4689109|NCT02548585|7598227|FG006|Overall Study|Randomized but not treated|0
4689110|NCT02548650|7598270|FG000|Triple Therapy|Adverse Event|1
4689111|NCT02548650|7598271|FG001|Triple Therapy|Adverse Event|0
4689112|NCT02548650|7598270|FG000|Triple Therapy|Withdrawal by Subject|0
4689113|NCT02548650|7598271|FG001|Triple Therapy|Withdrawal by Subject|4
4689114|NCT02548650|7598270|FG000|Double Therapy|Adverse Event|1
4689115|NCT02548650|7598271|FG001|Double Therapy|Adverse Event|1
4689116|NCT02548650|7598270|FG000|Double Therapy|Withdrawal by Subject|0
4689117|NCT02548650|7598271|FG001|Double Therapy|Withdrawal by Subject|1
4689118|NCT02548962|7598310|FG000|Overall Study|Withdrawal by Subject|1
4689119|NCT02548962|7598311|FG001|Overall Study|Withdrawal by Subject|0
4689120|NCT02549027|7598346|FG000|Washout After Period 4|Withdrawal by Subject|0
4689121|NCT02549027|7598347|FG001|Washout After Period 4|Withdrawal by Subject|1
4762582|NCT02936323|7736532|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0
4762583|NCT02936323|7736533|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0
4762584|NCT02936323|7736524|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0
4762585|NCT02936323|7736525|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0
4762586|NCT02936323|7736526|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0
4762587|NCT02936323|7736527|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0
4762588|NCT02936323|7736528|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0
4762589|NCT02936323|7736529|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0
4762590|NCT02936323|7736530|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0
4762591|NCT02936323|7736531|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11
4762592|NCT02936323|7736532|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4
4762593|NCT02936323|7736533|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2
4762594|NCT02936323|7736524|FG000|Phase 2a Dose Expansion|Physician Decision|0
4762595|NCT02936323|7736525|FG001|Phase 2a Dose Expansion|Physician Decision|0
4762596|NCT02936323|7736526|FG002|Phase 2a Dose Expansion|Physician Decision|0
4762597|NCT02936323|7736527|FG003|Phase 2a Dose Expansion|Physician Decision|0
4762598|NCT02936323|7736528|FG004|Phase 2a Dose Expansion|Physician Decision|0
4762599|NCT02936323|7736529|FG005|Phase 2a Dose Expansion|Physician Decision|0
4689122|NCT02549027|7598348|FG002|Washout After Period 4|Withdrawal by Subject|1
4689123|NCT02549027|7598349|FG003|Washout After Period 4|Withdrawal by Subject|1
4689124|NCT02549027|7598350|FG004|Washout After Period 4|Withdrawal by Subject|0
4689125|NCT02549027|7598351|FG005|Washout After Period 4|Withdrawal by Subject|0
4689126|NCT02549027|7598346|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0
4689127|NCT02549027|7598347|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0
4689128|NCT02549027|7598348|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0
4689129|NCT02549027|7598349|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0
4689130|NCT02549027|7598350|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2
4689131|NCT02549027|7598351|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0
4689132|NCT02549196|7598382|FG000|Overall Study|Protocol Violation|0
4689133|NCT02549196|7598383|FG001|Overall Study|Protocol Violation|0
4689134|NCT02549196|7598384|FG002|Overall Study|Protocol Violation|0
4689135|NCT02549196|7598385|FG003|Overall Study|Protocol Violation|1
4689136|NCT02549196|7598382|FG000|Overall Study|Withdrawal by Subject|1
4689137|NCT02549196|7598383|FG001|Overall Study|Withdrawal by Subject|0
4689138|NCT02549196|7598384|FG002|Overall Study|Withdrawal by Subject|1
4689139|NCT02549196|7598385|FG003|Overall Study|Withdrawal by Subject|0
4689140|NCT02549287|7598397|FG000|Overall Study|Lost to Follow-up|65
4689141|NCT02549287|7598398|FG001|Overall Study|Lost to Follow-up|26
4689142|NCT02549287|7598397|FG000|Overall Study|Withdrawal by Subject|15
4689143|NCT02549287|7598398|FG001|Overall Study|Withdrawal by Subject|6
4689144|NCT02549339|7598406|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2
4689145|NCT02549339|7598407|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0
4689146|NCT02549339|7598406|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1
4689147|NCT02549339|7598407|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3
4689148|NCT02549339|7598406|FG000|3-day Treatment and 8-week Follow-up|Other|1
4689149|NCT02549339|7598407|FG001|3-day Treatment and 8-week Follow-up|Other|0
4689150|NCT02549339|7598406|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0
4689151|NCT02549339|7598407|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2
4689152|NCT02549339|7598406|FG000|12-month Follow-up|Lack of Efficacy|0
4689153|NCT02549339|7598407|FG001|12-month Follow-up|Lack of Efficacy|2
4689154|NCT02549339|7598406|FG000|12-month Follow-up|Withdrawal by Subject|8
4689155|NCT02549339|7598407|FG001|12-month Follow-up|Withdrawal by Subject|3
4689156|NCT02549339|7598406|FG000|12-month Follow-up|Lost to Follow-up|1
4689157|NCT02549339|7598407|FG001|12-month Follow-up|Lost to Follow-up|3
4689158|NCT02549339|7598406|FG000|12-month Follow-up|Other|0
4689159|NCT02549339|7598407|FG001|12-month Follow-up|Other|3
4689160|NCT02549352|7598417|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0
4689161|NCT02549352|7598418|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1
4689162|NCT02549352|7598417|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2
4762600|NCT02936323|7736530|FG006|Phase 2a Dose Expansion|Physician Decision|0
4762601|NCT02936323|7736531|FG007|Phase 2a Dose Expansion|Physician Decision|0
4762602|NCT02936323|7736532|FG008|Phase 2a Dose Expansion|Physician Decision|0
4762603|NCT02936323|7736533|FG009|Phase 2a Dose Expansion|Physician Decision|1
4762604|NCT02936323|7736524|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0
4762605|NCT02936323|7736525|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0
4762606|NCT02936323|7736526|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0
4762607|NCT02936323|7736527|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0
4762608|NCT02936323|7736528|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0
4762609|NCT02936323|7736529|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0
4762610|NCT02936323|7736530|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0
4762611|NCT02936323|7736531|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2
4762612|NCT02936323|7736532|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1
4762613|NCT02936323|7736533|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0
4762614|NCT02936323|7736524|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0
4762615|NCT02936323|7736525|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0
4762616|NCT02936323|7736526|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0
4762617|NCT02936323|7736527|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0
4762618|NCT02936323|7736528|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0
4762619|NCT02936323|7736529|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0
4762620|NCT02936323|7736530|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0
4762621|NCT02936323|7736531|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0
4762622|NCT02936323|7736532|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0
4762623|NCT02936323|7736533|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1
4762624|NCT02936323|7736524|FG000|Phase 2a Dose Expansion|Death|0
4762625|NCT02936323|7736525|FG001|Phase 2a Dose Expansion|Death|0
4762626|NCT02936323|7736526|FG002|Phase 2a Dose Expansion|Death|0
4762627|NCT02936323|7736527|FG003|Phase 2a Dose Expansion|Death|0
4762628|NCT02936323|7736528|FG004|Phase 2a Dose Expansion|Death|0
4762629|NCT02936323|7736529|FG005|Phase 2a Dose Expansion|Death|0
4762630|NCT02936323|7736530|FG006|Phase 2a Dose Expansion|Death|0
4762631|NCT02936323|7736531|FG007|Phase 2a Dose Expansion|Death|4
4762632|NCT02936323|7736532|FG008|Phase 2a Dose Expansion|Death|8
4762633|NCT02936323|7736533|FG009|Phase 2a Dose Expansion|Death|10
4762634|NCT02437318|7736576|FG000|Overall Study|Progressive disease|173
4762635|NCT02437318|7736577|FG001|Overall Study|Progressive disease|208
4762636|NCT02437318|7736576|FG000|Overall Study|Subject/guardian decision|22
4762637|NCT02437318|7736577|FG001|Overall Study|Subject/guardian decision|10
4762638|NCT02437318|7736576|FG000|Overall Study|Physician Decision|11
4762639|NCT02437318|7736577|FG001|Overall Study|Physician Decision|10
4762640|NCT02437318|7736576|FG000|Overall Study|Adverse Event|14
4762641|NCT02437318|7736577|FG001|Overall Study|Adverse Event|3
4762642|NCT02437318|7736576|FG000|Overall Study|Death|4
4762643|NCT02437318|7736577|FG001|Overall Study|Death|4
4762644|NCT02437318|7736576|FG000|Overall Study|Protocol Violation|5
4762645|NCT02437318|7736577|FG001|Overall Study|Protocol Violation|6
4762646|NCT02437318|7736576|FG000|Overall Study|Untreated|0
4762647|NCT02437318|7736577|FG001|Overall Study|Untreated|1
4762648|NCT02429791|7736585|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6
4762649|NCT02429791|7736586|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2
4762650|NCT02429791|7736585|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0
4762651|NCT02429791|7736586|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2
4689163|NCT02549352|7598418|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3
4689164|NCT02549352|7598417|FG000|3-day Treatment and 8-week Follow-up|Other|0
4689165|NCT02549352|7598418|FG001|3-day Treatment and 8-week Follow-up|Other|2
4689166|NCT02549352|7598417|FG000|12-month Follow-up|Withdrawal by Subject|4
4689167|NCT02549352|7598418|FG001|12-month Follow-up|Withdrawal by Subject|5
4689168|NCT02549352|7598417|FG000|12-month Follow-up|Lost to Follow-up|3
4689169|NCT02549352|7598418|FG001|12-month Follow-up|Lost to Follow-up|2
4689170|NCT02549352|7598417|FG000|12-month Follow-up|Death|0
4689171|NCT02549352|7598418|FG001|12-month Follow-up|Death|1
4689172|NCT02549352|7598417|FG000|12-month Follow-up|Protocol Violation|0
4689173|NCT02549352|7598418|FG001|12-month Follow-up|Protocol Violation|1
4689174|NCT02549352|7598417|FG000|12-month Follow-up|Other|1
4689175|NCT02549352|7598418|FG001|12-month Follow-up|Other|3
4689176|NCT02549573|7598448|FG000|Overall Study|Withdrawal by Subject|0
4689177|NCT02549573|7598449|FG001|Overall Study|Withdrawal by Subject|2
4689178|NCT02549573|7598448|FG000|Overall Study|Protocol Violation|0
4689179|NCT02549573|7598449|FG001|Overall Study|Protocol Violation|1
4689180|NCT02549859|7598455|FG000|Long-term 60 Hz DBS|Study Closed|1
4689181|NCT02550106|7598463|FG000|Overall Study|Adverse Event|1
4689182|NCT02550106|7598463|FG000|Overall Study|Lack of Efficacy|3
4689183|NCT02550106|7598463|FG000|Overall Study|Protocol Violation|6
4689184|NCT02550106|7598463|FG000|Overall Study|Withdrawal by Subject|2
4762652|NCT02429791|7736585|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2
4762653|NCT02429791|7736586|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1
4762654|NCT02429791|7736585|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1
4762655|NCT02429791|7736586|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2
4762656|NCT02429791|7736585|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1
4762657|NCT02429791|7736586|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4
4762658|NCT02429791|7736585|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3
4762659|NCT02429791|7736586|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7
4762660|NCT02429791|7736585|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11
4762661|NCT02429791|7736586|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12
4762662|NCT02429791|7736585|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0
4762663|NCT02429791|7736586|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4
4762664|NCT02429791|7736585|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4
4762665|NCT02429791|7736586|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3
4762666|NCT02429791|7736585|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0
4762667|NCT02429791|7736586|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1
4762668|NCT02429791|7736585|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3
4762669|NCT02429791|7736586|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3
4762670|NCT02429791|7736585|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7
4762671|NCT02429791|7736586|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5
4762672|NCT02422797|7736601|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11
4762673|NCT02422797|7736602|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1
4762674|NCT02422797|7736601|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0
4762675|NCT02422797|7736602|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1
4762676|NCT02422797|7736601|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1
4762677|NCT02422797|7736602|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2
4762678|NCT02422797|7736601|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1
4762679|NCT02422797|7736602|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1
4762680|NCT02422797|7736601|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0
4762681|NCT02422797|7736602|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3
4762682|NCT02422797|7736601|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1
4762683|NCT02422797|7736602|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1
4762684|NCT02422797|7736601|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2
4762685|NCT02422797|7736602|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7
4762686|NCT02422797|7736601|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0
4762687|NCT02422797|7736602|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1
4762688|NCT02422797|7736601|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10
4762689|NCT02422797|7736602|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6
4762690|NCT02422797|7736601|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5
4762691|NCT02422797|7736602|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3
4762692|NCT02422797|7736601|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2
4762693|NCT02422797|7736602|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2
4762694|NCT02422797|7736601|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2
4762695|NCT02422797|7736602|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6
4762696|NCT02422797|7736601|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1
4762697|NCT02422797|7736602|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0
4762698|NCT02422797|7736601|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3
4762699|NCT02422797|7736602|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0
4762700|NCT02422615|7736620|FG000|Overall Study|Progressive disease|193
4762701|NCT02422615|7736621|FG001|Overall Study|Progressive disease|142
4762702|NCT02422615|7736620|FG000|Overall Study|Adverse Event|41
4689185|NCT02550795|7598498|FG000|Overall Study|Physician Decision|0
4689186|NCT02550795|7598499|FG001|Overall Study|Physician Decision|1
4689187|NCT02550795|7598500|FG002|Overall Study|Physician Decision|0
4689188|NCT02550873|7598510|FG000|Randomized Double Blind|Adverse Event|3
4689189|NCT02550873|7598511|FG001|Randomized Double Blind|Adverse Event|1
4689190|NCT02550873|7598512|FG002|Randomized Double Blind|Adverse Event|0
4689191|NCT02550873|7598510|FG000|Randomized Double Blind|Disease progression|1
4689192|NCT02550873|7598511|FG001|Randomized Double Blind|Disease progression|1
4689193|NCT02550873|7598512|FG002|Randomized Double Blind|Disease progression|0
4689194|NCT02550873|7598510|FG000|Open Label Extension|Study ongoing|0
4689195|NCT02550873|7598511|FG001|Open Label Extension|Study ongoing|0
4689196|NCT02550873|7598512|FG002|Open Label Extension|Study ongoing|111
4689197|NCT02550938|7598538|FG000|Overall Study|Lost to Follow-up|8
4689198|NCT02550938|7598539|FG001|Overall Study|Lost to Follow-up|7
4689199|NCT02550938|7598540|FG002|Overall Study|Lost to Follow-up|12
4689200|NCT02550938|7598541|FG003|Overall Study|Lost to Follow-up|11
4689201|NCT02551055|7598558|FG000|Overall Study|Death|2
4689202|NCT02551055|7598559|FG001|Overall Study|Death|4
4689203|NCT02551055|7598560|FG002|Overall Study|Death|2
4689204|NCT02551055|7598561|FG003|Overall Study|Death|2
4689205|NCT02551055|7598562|FG004|Overall Study|Death|2
4689206|NCT02551055|7598563|FG005|Overall Study|Death|1
4689207|NCT02551055|7598564|FG006|Overall Study|Death|2
4689208|NCT02551055|7598565|FG007|Overall Study|Death|0
4689209|NCT02551055|7598558|FG000|Overall Study|Study Terminated by Sponsor|1
4689210|NCT02551055|7598559|FG001|Overall Study|Study Terminated by Sponsor|1
4689211|NCT02551055|7598560|FG002|Overall Study|Study Terminated by Sponsor|0
4689212|NCT02551055|7598561|FG003|Overall Study|Study Terminated by Sponsor|2
4689213|NCT02551055|7598562|FG004|Overall Study|Study Terminated by Sponsor|2
4689214|NCT02551055|7598563|FG005|Overall Study|Study Terminated by Sponsor|0
4689215|NCT02551055|7598564|FG006|Overall Study|Study Terminated by Sponsor|0
4689216|NCT02551055|7598565|FG007|Overall Study|Study Terminated by Sponsor|0
4689217|NCT02551055|7598558|FG000|Overall Study|Withdrawal by Subject|1
4689218|NCT02551055|7598559|FG001|Overall Study|Withdrawal by Subject|1
4689219|NCT02551055|7598560|FG002|Overall Study|Withdrawal by Subject|0
4689220|NCT02551055|7598561|FG003|Overall Study|Withdrawal by Subject|1
4689221|NCT02551055|7598562|FG004|Overall Study|Withdrawal by Subject|2
4689222|NCT02551055|7598563|FG005|Overall Study|Withdrawal by Subject|0
4689223|NCT02551055|7598564|FG006|Overall Study|Withdrawal by Subject|0
4689224|NCT02551055|7598565|FG007|Overall Study|Withdrawal by Subject|0
4762703|NCT02422615|7736621|FG001|Overall Study|Adverse Event|10
4762704|NCT02422615|7736620|FG000|Overall Study|Physician Decision|22
4689225|NCT02551055|7598558|FG000|Overall Study|Reason not specified|0
4689226|NCT02551055|7598559|FG001|Overall Study|Reason not specified|0
4689227|NCT02551055|7598560|FG002|Overall Study|Reason not specified|0
4689228|NCT02551055|7598561|FG003|Overall Study|Reason not specified|0
4689229|NCT02551055|7598562|FG004|Overall Study|Reason not specified|1
4689230|NCT02551055|7598563|FG005|Overall Study|Reason not specified|0
4689231|NCT02551055|7598564|FG006|Overall Study|Reason not specified|1
4689232|NCT02551055|7598565|FG007|Overall Study|Reason not specified|0
4689233|NCT02551159|7598595|FG000|Overall Study|Death|352
4689234|NCT02551159|7598596|FG001|Overall Study|Death|174
4689235|NCT02551159|7598597|FG002|Overall Study|Death|161
4689236|NCT02551159|7598595|FG000|Overall Study|Withdrawal by Subject|8
4689237|NCT02551159|7598596|FG001|Overall Study|Withdrawal by Subject|5
4689238|NCT02551159|7598597|FG002|Overall Study|Withdrawal by Subject|16
4689239|NCT02551159|7598595|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53
4689240|NCT02551159|7598596|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25
4689241|NCT02551159|7598597|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29
4689242|NCT02551666|7598627|FG000|Overall Study|Withdrawal by Subject|1
4689243|NCT02551666|7598628|FG001|Overall Study|Withdrawal by Subject|3
4689244|NCT02551692|7598637|FG000|Overall Study|Lost to Follow-up|0
4689245|NCT02551692|7598638|FG001|Overall Study|Lost to Follow-up|1
4689246|NCT02551692|7598639|FG002|Overall Study|Lost to Follow-up|4
4689247|NCT02551692|7598637|FG000|Overall Study|Withdrawal by Subject|1
4689248|NCT02551692|7598638|FG001|Overall Study|Withdrawal by Subject|0
4689249|NCT02551692|7598639|FG002|Overall Study|Withdrawal by Subject|1
4689250|NCT02551731|7598647|FG000|Overall Study|Withdrawal by Subject|2
4689251|NCT02551874|7598703|FG000|Overall Study|Lost to Follow-up|0
4689252|NCT02551874|7598704|FG001|Overall Study|Lost to Follow-up|2
4689253|NCT02551874|7598703|FG000|Overall Study|Pregnancy|0
4689254|NCT02551874|7598704|FG001|Overall Study|Pregnancy|1
4689255|NCT02551874|7598703|FG000|Overall Study|Reason not reported|10
4689256|NCT02551874|7598704|FG001|Overall Study|Reason not reported|4
4689257|NCT02551874|7598703|FG000|Overall Study|Did not receive randomized treatment|0
4689258|NCT02551874|7598704|FG001|Overall Study|Did not receive randomized treatment|7
4689259|NCT02551874|7598703|FG000|Overall Study|Did not enter long-term study|18
4689260|NCT02551874|7598704|FG001|Overall Study|Did not enter long-term study|25
4689261|NCT02552121|7598731|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2
4689262|NCT02552121|7598732|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
4689263|NCT02552121|7598733|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
4689264|NCT02552121|7598734|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
4762705|NCT02422615|7736621|FG001|Overall Study|Physician Decision|7
4689265|NCT02552121|7598735|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
4689266|NCT02552121|7598736|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
4689267|NCT02552121|7598737|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
4689268|NCT02552121|7598738|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
4689269|NCT02552121|7598731|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1
4689270|NCT02552121|7598732|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
4689271|NCT02552121|7598733|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
4689272|NCT02552121|7598734|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
4689273|NCT02552121|7598735|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
4689274|NCT02552121|7598736|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
4689275|NCT02552121|7598737|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
4689276|NCT02552121|7598738|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
4689277|NCT02552121|7598731|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
4689278|NCT02552121|7598732|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1
4689279|NCT02552121|7598733|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
4689280|NCT02552121|7598734|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
4689281|NCT02552121|7598735|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
4689282|NCT02552121|7598736|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
4689283|NCT02552121|7598737|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
4689284|NCT02552121|7598738|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
4689285|NCT02552121|7598731|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
4689286|NCT02552121|7598732|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2
4689287|NCT02552121|7598733|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
4689288|NCT02552121|7598734|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
4689289|NCT02552121|7598735|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
4689290|NCT02552121|7598736|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
4689291|NCT02552121|7598737|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
4689292|NCT02552121|7598738|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
4689293|NCT02552121|7598731|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
4689294|NCT02552121|7598732|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2
4689295|NCT02552121|7598733|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
4689296|NCT02552121|7598734|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
4689297|NCT02552121|7598735|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
4689298|NCT02552121|7598736|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
4689299|NCT02552121|7598737|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
4689300|NCT02552121|7598738|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
4689301|NCT02552121|7598731|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
4689302|NCT02552121|7598732|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1
4689303|NCT02552121|7598733|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
4689304|NCT02552121|7598734|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
4689305|NCT02552121|7598735|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
4689306|NCT02552121|7598736|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
4689307|NCT02552121|7598737|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
4689308|NCT02552121|7598738|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
4689309|NCT02552121|7598731|FG000|Part 2: Cohort Expansion|Patient Choice|0
4689310|NCT02552121|7598732|FG001|Part 2: Cohort Expansion|Patient Choice|0
4689311|NCT02552121|7598733|FG002|Part 2: Cohort Expansion|Patient Choice|1
4689312|NCT02552121|7598734|FG003|Part 2: Cohort Expansion|Patient Choice|0
4689313|NCT02552121|7598735|FG004|Part 2: Cohort Expansion|Patient Choice|0
4689314|NCT02552121|7598736|FG005|Part 2: Cohort Expansion|Patient Choice|0
4689315|NCT02552121|7598737|FG006|Part 2: Cohort Expansion|Patient Choice|1
4689316|NCT02552121|7598738|FG007|Part 2: Cohort Expansion|Patient Choice|0
4689317|NCT02552121|7598731|FG000|Part 2: Cohort Expansion|Disease Progression|0
4689318|NCT02552121|7598732|FG001|Part 2: Cohort Expansion|Disease Progression|0
4689319|NCT02552121|7598733|FG002|Part 2: Cohort Expansion|Disease Progression|3
4689320|NCT02552121|7598734|FG003|Part 2: Cohort Expansion|Disease Progression|2
4689321|NCT02552121|7598735|FG004|Part 2: Cohort Expansion|Disease Progression|1
4689322|NCT02552121|7598736|FG005|Part 2: Cohort Expansion|Disease Progression|4
4689323|NCT02552121|7598737|FG006|Part 2: Cohort Expansion|Disease Progression|0
4689324|NCT02552121|7598738|FG007|Part 2: Cohort Expansion|Disease Progression|3
4689325|NCT02552121|7598731|FG000|Part 2: Cohort Expansion|Adverse Event|0
4689326|NCT02552121|7598732|FG001|Part 2: Cohort Expansion|Adverse Event|0
4689327|NCT02552121|7598733|FG002|Part 2: Cohort Expansion|Adverse Event|6
4689328|NCT02552121|7598734|FG003|Part 2: Cohort Expansion|Adverse Event|1
4689329|NCT02552121|7598735|FG004|Part 2: Cohort Expansion|Adverse Event|0
4762706|NCT02422615|7736620|FG000|Overall Study|Subject/guardian decision|21
4762707|NCT02422615|7736621|FG001|Overall Study|Subject/guardian decision|5
4762708|NCT02422615|7736620|FG000|Overall Study|Death|2
4762709|NCT02422615|7736621|FG001|Overall Study|Death|0
4762710|NCT02422615|7736620|FG000|Overall Study|Protocol Violation|1
4762711|NCT02422615|7736621|FG001|Overall Study|Protocol Violation|1
4762712|NCT02422615|7736620|FG000|Overall Study|Technical problems|0
4762713|NCT02422615|7736621|FG001|Overall Study|Technical problems|1
4762714|NCT02132611|7736640|FG000|Overall Study|Death|2
4762715|NCT01796197|7736644|FG000|Overall Study|Lost to Follow-up|1
4762716|NCT01796197|7736644|FG000|Overall Study|Lack of Efficacy|1
4689330|NCT02552121|7598736|FG005|Part 2: Cohort Expansion|Adverse Event|0
4689331|NCT02552121|7598737|FG006|Part 2: Cohort Expansion|Adverse Event|0
4689332|NCT02552121|7598738|FG007|Part 2: Cohort Expansion|Adverse Event|0
4689333|NCT02552121|7598731|FG000|Part 2: Cohort Expansion|Death|0
4689334|NCT02552121|7598732|FG001|Part 2: Cohort Expansion|Death|0
4689335|NCT02552121|7598733|FG002|Part 2: Cohort Expansion|Death|1
4689336|NCT02552121|7598734|FG003|Part 2: Cohort Expansion|Death|0
4689337|NCT02552121|7598735|FG004|Part 2: Cohort Expansion|Death|0
4689338|NCT02552121|7598736|FG005|Part 2: Cohort Expansion|Death|0
4689339|NCT02552121|7598737|FG006|Part 2: Cohort Expansion|Death|0
4689340|NCT02552121|7598738|FG007|Part 2: Cohort Expansion|Death|0
4689341|NCT02552147|7598770|FG000|First Intervention (7 Days)|Protocol Violation|1
4689342|NCT02552147|7598771|FG001|First Intervention (7 Days)|Protocol Violation|0
4689343|NCT02552147|7598770|FG000|Second Intervention (7 Days)|Protocol Violation|2
4689344|NCT02552147|7598771|FG001|Second Intervention (7 Days)|Protocol Violation|0
4689345|NCT02552212|7598779|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6
4689346|NCT02552212|7598780|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3
4689347|NCT02552212|7598781|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0
4689348|NCT02552212|7598779|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2
4689349|NCT02552212|7598780|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2
4689350|NCT02552212|7598781|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0
4689351|NCT02552212|7598779|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1
4689352|NCT02552212|7598780|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1
4689353|NCT02552212|7598781|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0
4689354|NCT02552212|7598779|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1
4689355|NCT02552212|7598780|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0
4689356|NCT02552212|7598781|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0
4689357|NCT02552212|7598779|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3
4689358|NCT02552212|7598780|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7
4689359|NCT02552212|7598781|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0
4689360|NCT02552212|7598779|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1
4689361|NCT02552212|7598780|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1
4689362|NCT02552212|7598781|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0
4689363|NCT02552212|7598779|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0
4689364|NCT02552212|7598780|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1
4689365|NCT02552212|7598781|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0
4689366|NCT02552212|7598779|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0
4689367|NCT02552212|7598780|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1
4689368|NCT02552212|7598781|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0
4689369|NCT02552212|7598779|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0
4689370|NCT02552212|7598780|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1
4689371|NCT02552212|7598781|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0
4689372|NCT02552212|7598779|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1
4689373|NCT02552212|7598780|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0
4689374|NCT02552212|7598781|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0
4689375|NCT02552212|7598779|FG000|SFE Period (Week 52 - 156)|Adverse Event|0
4689376|NCT02552212|7598780|FG001|SFE Period (Week 52 - 156)|Adverse Event|0
4689377|NCT02552212|7598781|FG002|SFE Period (Week 52 - 156)|Adverse Event|5
4689378|NCT02552212|7598779|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0
4689379|NCT02552212|7598780|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0
4689380|NCT02552212|7598781|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4
4689381|NCT02552212|7598779|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0
4689382|NCT02552212|7598780|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0
4689383|NCT02552212|7598781|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2
4689384|NCT02552212|7598779|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0
4689385|NCT02552212|7598780|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0
4689386|NCT02552212|7598781|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18
4689387|NCT02552212|7598779|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0
4689388|NCT02552212|7598780|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0
4689389|NCT02552212|7598781|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1
4689390|NCT02552212|7598779|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0
4689391|NCT02552212|7598780|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0
4689392|NCT02552212|7598781|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1
4762717|NCT01147822|7736650|FG000|Overall Study|Death|66
4762718|NCT01147822|7736651|FG001|Overall Study|Death|59
4762719|NCT01147822|7736650|FG000|Overall Study|Protocol Violation|0
4762720|NCT01147822|7736651|FG001|Overall Study|Protocol Violation|1
4762721|NCT01147822|7736650|FG000|Overall Study|Lost to Follow-up|3
4762722|NCT01147822|7736651|FG001|Overall Study|Lost to Follow-up|2
4762723|NCT01147822|7736650|FG000|Overall Study|Physician Decision|0
4762724|NCT01147822|7736651|FG001|Overall Study|Physician Decision|2
4762725|NCT01147822|7736650|FG000|Overall Study|Withdrawal by Subject|8
4762726|NCT01147822|7736651|FG001|Overall Study|Withdrawal by Subject|13
4762727|NCT01147822|7736650|FG000|Overall Study|Not Completed/Ongoing|111
4762728|NCT01147822|7736651|FG001|Overall Study|Not Completed/Ongoing|102
4689393|NCT02552212|7598779|FG000|SFE Period (Week 52 - 156)|Investigator decision|0
4689394|NCT02552212|7598780|FG001|SFE Period (Week 52 - 156)|Investigator decision|0
4689395|NCT02552212|7598781|FG002|SFE Period (Week 52 - 156)|Investigator decision|1
4689396|NCT02552212|7598779|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0
4689397|NCT02552212|7598780|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0
4689398|NCT02552212|7598781|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1
4689399|NCT02552212|7598779|FG000|SFE Period (Week 52 - 156)|Compassionate access|0
4689400|NCT02552212|7598780|FG001|SFE Period (Week 52 - 156)|Compassionate access|0
4689401|NCT02552212|7598781|FG002|SFE Period (Week 52 - 156)|Compassionate access|2
4689402|NCT02552212|7598779|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0
4689403|NCT02552212|7598780|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0
4689404|NCT02552212|7598781|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1
4689405|NCT02552212|7598779|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0
4689406|NCT02552212|7598780|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0
4689407|NCT02552212|7598781|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1
4689408|NCT02552225|7598799|FG000|Overall Study|Withdrawal by Subject|1
4689409|NCT02552225|7598800|FG001|Overall Study|Withdrawal by Subject|0
4689410|NCT02552238|7598806|FG000|Overall Study|Withdrawal by Subject|2
4689411|NCT02552238|7598806|FG000|Overall Study|Adverse Event|2
4689412|NCT02552303|7598821|FG000|Allocation|Withdrawal by Subject|2
4689413|NCT02552303|7598822|FG001|Allocation|Withdrawal by Subject|1
4689414|NCT02552303|7598823|FG002|Allocation|Withdrawal by Subject|1
4689415|NCT02552303|7598824|FG003|Allocation|Withdrawal by Subject|1
4689416|NCT02552303|7598821|FG000|Allocation|ineligible|1
4689417|NCT02552303|7598822|FG001|Allocation|ineligible|1
4689418|NCT02552303|7598823|FG002|Allocation|ineligible|0
4689419|NCT02552303|7598824|FG003|Allocation|ineligible|0
4689420|NCT02552303|7598821|FG000|Follow-Up|Lost to Follow-up|0
4689421|NCT02552303|7598822|FG001|Follow-Up|Lost to Follow-up|0
4689422|NCT02552303|7598823|FG002|Follow-Up|Lost to Follow-up|1
4689423|NCT02552303|7598824|FG003|Follow-Up|Lost to Follow-up|0
4689424|NCT02552303|7598821|FG000|Follow-Up|ineligible|0
4689425|NCT02552303|7598822|FG001|Follow-Up|ineligible|2
4689426|NCT02552303|7598823|FG002|Follow-Up|ineligible|0
4689427|NCT02552303|7598824|FG003|Follow-Up|ineligible|0
4689428|NCT02552316|7598834|FG000|Overall Study|Withdrawal by Subject|1
4689429|NCT02552316|7598834|FG000|Overall Study|Withdrawal due to non-compliance|1
4689430|NCT02552355|7598886|FG000|Overall Study|Adverse Event|0
4689431|NCT02552355|7598887|FG001|Overall Study|Adverse Event|2
4689432|NCT02552355|7598888|FG002|Overall Study|Adverse Event|2
4689433|NCT02552355|7598889|FG003|Overall Study|Adverse Event|0
4689434|NCT02552355|7598886|FG000|Overall Study|Withdrawal by Subject|0
4689435|NCT02552355|7598887|FG001|Overall Study|Withdrawal by Subject|0
4689436|NCT02552355|7598888|FG002|Overall Study|Withdrawal by Subject|0
4689437|NCT02552355|7598889|FG003|Overall Study|Withdrawal by Subject|1
4689438|NCT02552732|7598904|FG000|Overall Study|Lost to Follow-up|2
4689439|NCT02552732|7598904|FG000|Overall Study|Physician Decision|1
4689440|NCT02552732|7598904|FG000|Overall Study|Day 1 SpO2 > 96%|1
4689441|NCT02552732|7598904|FG000|Overall Study|Withdrawal by Subject|6
4762729|NCT04476251|7736672|FG000|Overall Study|Not treated|1
4762730|NCT03915860|7736680|FG000|Overall Study|Adverse Event|3
4762731|NCT03915860|7736680|FG000|Overall Study|Withdrawal by Subject|6
4762732|NCT03915860|7736680|FG000|Overall Study|Lost to Follow-up|2
4762733|NCT03915860|7736680|FG000|Overall Study|Other than specified|3
4762734|NCT03795233|7736699|FG000|Overall Study|Withdrawal by Subject|2
4762735|NCT03795233|7736700|FG001|Overall Study|Withdrawal by Subject|1
4762736|NCT03795233|7736699|FG000|Overall Study|Lost to Follow-up|1
4762737|NCT03795233|7736700|FG001|Overall Study|Lost to Follow-up|0
4762738|NCT03795233|7736699|FG000|Overall Study|Death|1
4762739|NCT03795233|7736700|FG001|Overall Study|Death|0
4762740|NCT03786380|7736711|FG000|Overall Study|Adverse Event|1
4762741|NCT03786380|7736712|FG001|Overall Study|Adverse Event|0
4762742|NCT03786380|7736713|FG002|Overall Study|Adverse Event|0
4762743|NCT03786380|7736714|FG003|Overall Study|Adverse Event|3
4762744|NCT03786380|7736715|FG004|Overall Study|Adverse Event|1
4762745|NCT03786380|7736711|FG000|Overall Study|Lack of Efficacy|0
4762746|NCT03786380|7736712|FG001|Overall Study|Lack of Efficacy|0
4762747|NCT03786380|7736713|FG002|Overall Study|Lack of Efficacy|0
4762748|NCT03786380|7736714|FG003|Overall Study|Lack of Efficacy|0
4762749|NCT03786380|7736715|FG004|Overall Study|Lack of Efficacy|1
4762750|NCT03786380|7736711|FG000|Overall Study|Withdrawal by Subject|1
4762751|NCT03786380|7736712|FG001|Overall Study|Withdrawal by Subject|2
4689442|NCT02552888|7598920|FG000|Overall Study|Lost to Follow-up|1
4689443|NCT02552888|7598921|FG001|Overall Study|Lost to Follow-up|1
4689444|NCT02552966|7598931|FG000|Overall Study|Lost to Follow-up|2
4689445|NCT02552966|7598931|FG000|Overall Study|Withdrawal by Subject|3
4689446|NCT02553317|7598941|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0
4689447|NCT02553317|7598942|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1
4762752|NCT03786380|7736713|FG002|Overall Study|Withdrawal by Subject|2
4762753|NCT03786380|7736714|FG003|Overall Study|Withdrawal by Subject|1
4762754|NCT03786380|7736715|FG004|Overall Study|Withdrawal by Subject|2
4762755|NCT03786380|7736711|FG000|Overall Study|Lost to Follow-up|3
4689448|NCT02553317|7598941|FG000|Overall Treatment Period + Follow-up|Physician Decision|2
4689449|NCT02553317|7598942|FG001|Overall Treatment Period + Follow-up|Physician Decision|4
4689450|NCT02553317|7598941|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0
4689451|NCT02553317|7598942|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1
4689452|NCT02553317|7598941|FG000|Overall Treatment Period + Follow-up|Death|1
4689453|NCT02553317|7598942|FG001|Overall Treatment Period + Follow-up|Death|3
4689454|NCT02553317|7598941|FG000|Overall Treatment Period + Follow-up|Adverse Event|6
4689455|NCT02553317|7598942|FG001|Overall Treatment Period + Follow-up|Adverse Event|5
4689456|NCT02553317|7598941|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4
4689457|NCT02553317|7598942|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5
4689458|NCT02553317|7598941|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0
4689459|NCT02553317|7598942|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1
4689460|NCT02553317|7598941|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1
4689461|NCT02553317|7598942|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1
4689462|NCT02553317|7598941|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0
4689463|NCT02553317|7598942|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1
4689464|NCT02553317|7598941|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0
4689465|NCT02553317|7598942|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1
4689466|NCT02553330|7598952|FG000|Overall Study|Study Terminated by Sponsor|2
4689467|NCT02553330|7598953|FG001|Overall Study|Study Terminated by Sponsor|13
4689468|NCT02553330|7598954|FG002|Overall Study|Study Terminated by Sponsor|12
4689469|NCT02553330|7598952|FG000|Overall Study|Withdrawal by Subject|3
4689470|NCT02553330|7598953|FG001|Overall Study|Withdrawal by Subject|19
4689471|NCT02553330|7598954|FG002|Overall Study|Withdrawal by Subject|21
4689472|NCT02553330|7598952|FG000|Overall Study|Other|0
4689473|NCT02553330|7598953|FG001|Overall Study|Other|1
4689474|NCT02553330|7598954|FG002|Overall Study|Other|0
4689475|NCT02553330|7598952|FG000|Overall Study|Non compliance to study treatment|0
4689476|NCT02553330|7598953|FG001|Overall Study|Non compliance to study treatment|1
4689477|NCT02553330|7598954|FG002|Overall Study|Non compliance to study treatment|0
4689478|NCT02553330|7598952|FG000|Overall Study|Adverse Event|0
4689479|NCT02553330|7598953|FG001|Overall Study|Adverse Event|1
4689480|NCT02553330|7598954|FG002|Overall Study|Adverse Event|0
4689481|NCT02553330|7598952|FG000|Overall Study|Lost to Follow-up|0
4689482|NCT02553330|7598953|FG001|Overall Study|Lost to Follow-up|4
4689483|NCT02553330|7598954|FG002|Overall Study|Lost to Follow-up|4
4689484|NCT02553421|7598975|FG000|Overall Study|Lost to Follow-up|21
4689485|NCT02553421|7598976|FG001|Overall Study|Lost to Follow-up|1
4689486|NCT02553421|7598975|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5
4689487|NCT02553421|7598976|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0
4689488|NCT02553421|7598975|FG000|Overall Study|Improper Device Placement|3
4689489|NCT02553421|7598976|FG001|Overall Study|Improper Device Placement|0
4762756|NCT03786380|7736712|FG001|Overall Study|Lost to Follow-up|0
4762757|NCT03786380|7736713|FG002|Overall Study|Lost to Follow-up|1
4762758|NCT03786380|7736714|FG003|Overall Study|Lost to Follow-up|2
4762759|NCT03786380|7736715|FG004|Overall Study|Lost to Follow-up|0
4762760|NCT03786380|7736711|FG000|Overall Study|Physician Decision|0
4762761|NCT03786380|7736712|FG001|Overall Study|Physician Decision|0
4762762|NCT03786380|7736713|FG002|Overall Study|Physician Decision|1
4762763|NCT03786380|7736714|FG003|Overall Study|Physician Decision|0
4762764|NCT03786380|7736715|FG004|Overall Study|Physician Decision|0
4762765|NCT03786380|7736711|FG000|Overall Study|Study Terminated by the Sponsor|30
4762766|NCT03786380|7736712|FG001|Overall Study|Study Terminated by the Sponsor|20
4762767|NCT03786380|7736713|FG002|Overall Study|Study Terminated by the Sponsor|50
4762768|NCT03786380|7736714|FG003|Overall Study|Study Terminated by the Sponsor|57
4762769|NCT03786380|7736715|FG004|Overall Study|Study Terminated by the Sponsor|23
4762770|NCT03786380|7736711|FG000|Overall Study|Reason Not Specified|0
4762771|NCT03786380|7736712|FG001|Overall Study|Reason Not Specified|0
4762772|NCT03786380|7736713|FG002|Overall Study|Reason Not Specified|0
4762773|NCT03786380|7736714|FG003|Overall Study|Reason Not Specified|0
4762774|NCT03786380|7736715|FG004|Overall Study|Reason Not Specified|1
4762775|NCT03645863|7736739|FG000|Overall Study|Withdrawal by Subject|1
4762776|NCT03645863|7736740|FG001|Overall Study|Withdrawal by Subject|0
4762777|NCT03645863|7736741|FG002|Overall Study|Withdrawal by Subject|0
4762778|NCT03564145|7736749|FG000|Overall Study|Adverse Event|4
4762779|NCT03564145|7736749|FG000|Overall Study|Lost to Follow-up|21
4762780|NCT03564145|7736749|FG000|Overall Study|Protocol Violation|2
4762781|NCT03564145|7736749|FG000|Overall Study|Withdrawal by Subject|48
4762782|NCT03564145|7736749|FG000|Overall Study|Study Terminated by Sponsor|146
4762783|NCT03564145|7736749|FG000|Overall Study|Physician Decision|1
4762784|NCT03564145|7736749|FG000|Overall Study|Other Than Specified|1
4762785|NCT03564145|7736749|FG000|Overall Study|Pregnancy|1
4762786|NCT03564119|7736755|FG000|Overall Study|Adverse Event|4
4762787|NCT03564119|7736756|FG001|Overall Study|Adverse Event|0
4762788|NCT03564119|7736755|FG000|Overall Study|Lost to Follow-up|1
4762789|NCT03564119|7736756|FG001|Overall Study|Lost to Follow-up|4
4762790|NCT03564119|7736755|FG000|Overall Study|Protocol Violation|1
4762791|NCT03564119|7736756|FG001|Overall Study|Protocol Violation|0
4762792|NCT03564119|7736755|FG000|Overall Study|Withdrawal by Subject|9
4689490|NCT02553499|7598997|FG000|Overall Study|Adverse Event|0
4689491|NCT02553499|7598998|FG001|Overall Study|Adverse Event|0
4689492|NCT02553499|7598999|FG002|Overall Study|Adverse Event|0
4689493|NCT02553499|7599000|FG003|Overall Study|Adverse Event|0
4689494|NCT02553499|7599001|FG004|Overall Study|Adverse Event|0
4689495|NCT02553499|7599002|FG005|Overall Study|Adverse Event|0
4689496|NCT02553499|7599003|FG006|Overall Study|Adverse Event|1
4689497|NCT02553499|7599004|FG007|Overall Study|Adverse Event|1
4689498|NCT02553499|7599005|FG008|Overall Study|Adverse Event|0
4689499|NCT02553499|7599006|FG009|Overall Study|Adverse Event|0
4689500|NCT02553499|7599007|FG010|Overall Study|Adverse Event|0
4689501|NCT02553499|7599008|FG011|Overall Study|Adverse Event|0
4689502|NCT02553499|7599009|FG012|Overall Study|Adverse Event|0
4689503|NCT02553499|7599010|FG013|Overall Study|Adverse Event|1
4689504|NCT02553499|7598997|FG000|Overall Study|Death|0
4689505|NCT02553499|7598998|FG001|Overall Study|Death|1
4689506|NCT02553499|7598999|FG002|Overall Study|Death|1
4689507|NCT02553499|7599000|FG003|Overall Study|Death|0
4689508|NCT02553499|7599001|FG004|Overall Study|Death|1
4689509|NCT02553499|7599002|FG005|Overall Study|Death|2
4689510|NCT02553499|7599003|FG006|Overall Study|Death|0
4689511|NCT02553499|7599004|FG007|Overall Study|Death|0
4689512|NCT02553499|7599005|FG008|Overall Study|Death|0
4689513|NCT02553499|7599006|FG009|Overall Study|Death|0
4689514|NCT02553499|7599007|FG010|Overall Study|Death|1
4689515|NCT02553499|7599008|FG011|Overall Study|Death|0
4689516|NCT02553499|7599009|FG012|Overall Study|Death|0
4689517|NCT02553499|7599010|FG013|Overall Study|Death|0
4689518|NCT02553499|7598997|FG000|Overall Study|Lost to Follow-up|0
4689519|NCT02553499|7598998|FG001|Overall Study|Lost to Follow-up|0
4689520|NCT02553499|7598999|FG002|Overall Study|Lost to Follow-up|0
4689521|NCT02553499|7599000|FG003|Overall Study|Lost to Follow-up|0
4689522|NCT02553499|7599001|FG004|Overall Study|Lost to Follow-up|0
4689523|NCT02553499|7599002|FG005|Overall Study|Lost to Follow-up|0
4689524|NCT02553499|7599003|FG006|Overall Study|Lost to Follow-up|1
4689525|NCT02553499|7599004|FG007|Overall Study|Lost to Follow-up|0
4689526|NCT02553499|7599005|FG008|Overall Study|Lost to Follow-up|0
4689527|NCT02553499|7599006|FG009|Overall Study|Lost to Follow-up|0
4689528|NCT02553499|7599007|FG010|Overall Study|Lost to Follow-up|0
4689529|NCT02553499|7599008|FG011|Overall Study|Lost to Follow-up|0
4689530|NCT02553499|7599009|FG012|Overall Study|Lost to Follow-up|0
4689531|NCT02553499|7599010|FG013|Overall Study|Lost to Follow-up|0
4689532|NCT02553499|7598997|FG000|Overall Study|Physician Decision|0
4689533|NCT02553499|7598998|FG001|Overall Study|Physician Decision|1
4689534|NCT02553499|7598999|FG002|Overall Study|Physician Decision|1
4689535|NCT02553499|7599000|FG003|Overall Study|Physician Decision|0
4689536|NCT02553499|7599001|FG004|Overall Study|Physician Decision|1
4689537|NCT02553499|7599002|FG005|Overall Study|Physician Decision|0
4689538|NCT02553499|7599003|FG006|Overall Study|Physician Decision|0
4689539|NCT02553499|7599004|FG007|Overall Study|Physician Decision|1
4689540|NCT02553499|7599005|FG008|Overall Study|Physician Decision|1
4689541|NCT02553499|7599006|FG009|Overall Study|Physician Decision|2
4689542|NCT02553499|7599007|FG010|Overall Study|Physician Decision|1
4689543|NCT02553499|7599008|FG011|Overall Study|Physician Decision|3
4689544|NCT02553499|7599009|FG012|Overall Study|Physician Decision|1
4689545|NCT02553499|7599010|FG013|Overall Study|Physician Decision|0
4689546|NCT02553499|7598997|FG000|Overall Study|Progressive Disease|0
4689547|NCT02553499|7598998|FG001|Overall Study|Progressive Disease|0
4689548|NCT02553499|7598999|FG002|Overall Study|Progressive Disease|0
4689549|NCT02553499|7599000|FG003|Overall Study|Progressive Disease|2
4689550|NCT02553499|7599001|FG004|Overall Study|Progressive Disease|1
4689551|NCT02553499|7599002|FG005|Overall Study|Progressive Disease|1
4689552|NCT02553499|7599003|FG006|Overall Study|Progressive Disease|1
4689553|NCT02553499|7599004|FG007|Overall Study|Progressive Disease|0
4689554|NCT02553499|7599005|FG008|Overall Study|Progressive Disease|0
4689555|NCT02553499|7599006|FG009|Overall Study|Progressive Disease|1
4689556|NCT02553499|7599007|FG010|Overall Study|Progressive Disease|0
4689557|NCT02553499|7599008|FG011|Overall Study|Progressive Disease|0
4689558|NCT02553499|7599009|FG012|Overall Study|Progressive Disease|2
4689559|NCT02553499|7599010|FG013|Overall Study|Progressive Disease|1
4689560|NCT02553499|7598997|FG000|Overall Study|Study Terminated by Sponsor|0
4689561|NCT02553499|7598998|FG001|Overall Study|Study Terminated by Sponsor|0
4689562|NCT02553499|7598999|FG002|Overall Study|Study Terminated by Sponsor|0
4689563|NCT02553499|7599000|FG003|Overall Study|Study Terminated by Sponsor|0
4689564|NCT02553499|7599001|FG004|Overall Study|Study Terminated by Sponsor|0
4689565|NCT02553499|7599002|FG005|Overall Study|Study Terminated by Sponsor|0
4689566|NCT02553499|7599003|FG006|Overall Study|Study Terminated by Sponsor|0
4689567|NCT02553499|7599004|FG007|Overall Study|Study Terminated by Sponsor|0
4689568|NCT02553499|7599005|FG008|Overall Study|Study Terminated by Sponsor|1
4689569|NCT02553499|7599006|FG009|Overall Study|Study Terminated by Sponsor|0
4689570|NCT02553499|7599007|FG010|Overall Study|Study Terminated by Sponsor|0
4689571|NCT02553499|7599008|FG011|Overall Study|Study Terminated by Sponsor|0
4689572|NCT02553499|7599009|FG012|Overall Study|Study Terminated by Sponsor|0
4689573|NCT02553499|7599010|FG013|Overall Study|Study Terminated by Sponsor|0
4689574|NCT02553499|7598997|FG000|Overall Study|Withdrawal by Subject|2
4689575|NCT02553499|7598998|FG001|Overall Study|Withdrawal by Subject|0
4689576|NCT02553499|7598999|FG002|Overall Study|Withdrawal by Subject|0
4689577|NCT02553499|7599000|FG003|Overall Study|Withdrawal by Subject|0
4689578|NCT02553499|7599001|FG004|Overall Study|Withdrawal by Subject|0
4689579|NCT02553499|7599002|FG005|Overall Study|Withdrawal by Subject|0
4689580|NCT02553499|7599003|FG006|Overall Study|Withdrawal by Subject|0
4689581|NCT02553499|7599004|FG007|Overall Study|Withdrawal by Subject|1
4689582|NCT02553499|7599005|FG008|Overall Study|Withdrawal by Subject|1
4689583|NCT02553499|7599006|FG009|Overall Study|Withdrawal by Subject|0
4689584|NCT02553499|7599007|FG010|Overall Study|Withdrawal by Subject|1
4689585|NCT02553499|7599008|FG011|Overall Study|Withdrawal by Subject|0
4689586|NCT02553499|7599009|FG012|Overall Study|Withdrawal by Subject|0
4689587|NCT02553499|7599010|FG013|Overall Study|Withdrawal by Subject|0
4689588|NCT02553538|7599047|FG000|Overall Study|Could Not Reach by Telephone|133
4689589|NCT02553538|7599048|FG001|Overall Study|Could Not Reach by Telephone|0
4689590|NCT02553538|7599047|FG000|Overall Study|Died or Left Network|54
4689591|NCT02553538|7599048|FG001|Overall Study|Died or Left Network|56
4689592|NCT02553629|7599056|FG000|Overall Study|Logistic reasons|3
4689593|NCT02553629|7599057|FG001|Overall Study|Logistic reasons|6
4689594|NCT02553772|7599074|FG000|Overall Study|Adverse Event|2
4689595|NCT02553772|7599075|FG001|Overall Study|Adverse Event|3
4689596|NCT02553772|7599074|FG000|Overall Study|Lost to Follow-up|2
4689597|NCT02553772|7599075|FG001|Overall Study|Lost to Follow-up|1
4689598|NCT02553772|7599074|FG000|Overall Study|Withdrawal of Consent|1
4689599|NCT02553772|7599075|FG001|Overall Study|Withdrawal of Consent|1
4689600|NCT02553772|7599074|FG000|Overall Study|Lack of Efficacy|1
4689601|NCT02553772|7599075|FG001|Overall Study|Lack of Efficacy|0
4689602|NCT02553772|7599074|FG000|Overall Study|Other Miscellaneous Reasons|0
4689603|NCT02553772|7599075|FG001|Overall Study|Other Miscellaneous Reasons|1
4689604|NCT02553928|7599104|FG000|Overall Study|Adverse Event|2
4689605|NCT02553928|7599105|FG001|Overall Study|Adverse Event|1
4689606|NCT02553928|7599104|FG000|Overall Study|Lost to Follow-up|0
4689607|NCT02553928|7599105|FG001|Overall Study|Lost to Follow-up|1
4689608|NCT02553928|7599104|FG000|Overall Study|Administrative reason(s)|0
4689609|NCT02553928|7599105|FG001|Overall Study|Administrative reason(s)|1
4689610|NCT02554019|7599115|FG000|Overall Study|Withdrawal by Subject|1
4689611|NCT02554019|7599116|FG001|Overall Study|Withdrawal by Subject|0
4689612|NCT02554019|7599117|FG002|Overall Study|Withdrawal by Subject|2
4689613|NCT02554019|7599115|FG000|Overall Study|Adverse Event|1
4689614|NCT02554019|7599116|FG001|Overall Study|Adverse Event|0
4689615|NCT02554019|7599117|FG002|Overall Study|Adverse Event|0
4689616|NCT02554279|7599127|FG000|Overall Study|Adverse Event|2
4689617|NCT02554279|7599128|FG001|Overall Study|Adverse Event|5
4689618|NCT02554279|7599127|FG000|Overall Study|Lost to Follow-up|3
4689619|NCT02554279|7599128|FG001|Overall Study|Lost to Follow-up|2
4689620|NCT02554279|7599127|FG000|Overall Study|Withdrawal by Subject|6
4689621|NCT02554279|7599128|FG001|Overall Study|Withdrawal by Subject|4
4689622|NCT02554279|7599127|FG000|Overall Study|Protocol Violation|2
4689623|NCT02554279|7599128|FG001|Overall Study|Protocol Violation|1
4689624|NCT02554279|7599127|FG000|Overall Study|Other reason|19
4689625|NCT02554279|7599128|FG001|Overall Study|Other reason|6
4689626|NCT02554474|7599153|FG000|Overall Study|Protocol Violation|1
4689627|NCT02554474|7599154|FG001|Overall Study|Protocol Violation|1
4689628|NCT02554474|7599153|FG000|Overall Study|Health issue not related to the study|1
4689629|NCT02554474|7599154|FG001|Overall Study|Health issue not related to the study|0
4689630|NCT02554474|7599153|FG000|Overall Study|Withdrawal by Subject|1
4689631|NCT02554474|7599154|FG001|Overall Study|Withdrawal by Subject|1
4689632|NCT02554513|7599160|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0
4689633|NCT02554513|7599161|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1
4689634|NCT02554656|7599173|FG000|Overall Study|Protocol Violation|3
4689635|NCT02554682|7599187|FG000|Overall Study|Lost to Follow-up|11
4689636|NCT02554682|7599188|FG001|Overall Study|Lost to Follow-up|9
4689637|NCT02554682|7599189|FG002|Overall Study|Lost to Follow-up|4
4689638|NCT02554682|7599190|FG003|Overall Study|Lost to Follow-up|3
4689639|NCT02554682|7599191|FG004|Overall Study|Lost to Follow-up|2
4689640|NCT02554682|7599192|FG005|Overall Study|Lost to Follow-up|1
4689641|NCT02554682|7599193|FG006|Overall Study|Lost to Follow-up|6
4689642|NCT02554682|7599194|FG007|Overall Study|Lost to Follow-up|6
4689643|NCT02554682|7599195|FG008|Overall Study|Lost to Follow-up|2
4689644|NCT02554682|7599196|FG009|Overall Study|Lost to Follow-up|2
4689645|NCT02554682|7599187|FG000|Overall Study|Withdrawal by Subject|2
4689646|NCT02554682|7599188|FG001|Overall Study|Withdrawal by Subject|1
4689647|NCT02554682|7599189|FG002|Overall Study|Withdrawal by Subject|0
4689648|NCT02554682|7599190|FG003|Overall Study|Withdrawal by Subject|0
4689649|NCT02554682|7599191|FG004|Overall Study|Withdrawal by Subject|0
4689650|NCT02554682|7599192|FG005|Overall Study|Withdrawal by Subject|0
4689651|NCT02554682|7599193|FG006|Overall Study|Withdrawal by Subject|0
4689652|NCT02554682|7599194|FG007|Overall Study|Withdrawal by Subject|0
4689653|NCT02554682|7599195|FG008|Overall Study|Withdrawal by Subject|0
4689654|NCT02554682|7599196|FG009|Overall Study|Withdrawal by Subject|0
4689655|NCT02554682|7599187|FG000|Overall Study|Physician Decision|2
4689656|NCT02554682|7599188|FG001|Overall Study|Physician Decision|2
4689657|NCT02554682|7599189|FG002|Overall Study|Physician Decision|0
4689658|NCT02554682|7599190|FG003|Overall Study|Physician Decision|0
4689659|NCT02554682|7599191|FG004|Overall Study|Physician Decision|0
4689660|NCT02554682|7599192|FG005|Overall Study|Physician Decision|0
4689661|NCT02554682|7599193|FG006|Overall Study|Physician Decision|0
4689662|NCT02554682|7599194|FG007|Overall Study|Physician Decision|0
4689663|NCT02554682|7599195|FG008|Overall Study|Physician Decision|0
4689664|NCT02554682|7599196|FG009|Overall Study|Physician Decision|0
4689665|NCT02554721|7599226|FG000|Overall Study|Adverse Event|1
4689666|NCT02554721|7599227|FG001|Overall Study|Adverse Event|0
4689667|NCT02554721|7599228|FG002|Overall Study|Adverse Event|0
4689668|NCT02554721|7599229|FG003|Overall Study|Adverse Event|0
4689669|NCT02554721|7599230|FG004|Overall Study|Adverse Event|1
4689670|NCT02554721|7599226|FG000|Overall Study|Noncompliance|0
4689671|NCT02554721|7599227|FG001|Overall Study|Noncompliance|0
4689672|NCT02554721|7599228|FG002|Overall Study|Noncompliance|0
4689673|NCT02554721|7599229|FG003|Overall Study|Noncompliance|0
4689674|NCT02554721|7599230|FG004|Overall Study|Noncompliance|1
4689675|NCT02554786|7599254|FG000|Overall Study|Subject/guardian decision|29
4689676|NCT02554786|7599255|FG001|Overall Study|Subject/guardian decision|17
4689677|NCT02554786|7599256|FG002|Overall Study|Subject/guardian decision|18
4689678|NCT02554786|7599257|FG003|Overall Study|Subject/guardian decision|30
4689679|NCT02554786|7599258|FG004|Overall Study|Subject/guardian decision|20
4689680|NCT02554786|7599254|FG000|Overall Study|Lost to Follow-up|4
4689681|NCT02554786|7599255|FG001|Overall Study|Lost to Follow-up|3
4689682|NCT02554786|7599256|FG002|Overall Study|Lost to Follow-up|4
4689683|NCT02554786|7599257|FG003|Overall Study|Lost to Follow-up|2
4689684|NCT02554786|7599258|FG004|Overall Study|Lost to Follow-up|2
4689685|NCT02554786|7599254|FG000|Overall Study|Protocol deviation|1
4689686|NCT02554786|7599255|FG001|Overall Study|Protocol deviation|3
4689687|NCT02554786|7599256|FG002|Overall Study|Protocol deviation|3
4689688|NCT02554786|7599257|FG003|Overall Study|Protocol deviation|4
4689689|NCT02554786|7599258|FG004|Overall Study|Protocol deviation|2
4689690|NCT02554786|7599254|FG000|Overall Study|Technical problems|1
4689691|NCT02554786|7599255|FG001|Overall Study|Technical problems|1
4689692|NCT02554786|7599256|FG002|Overall Study|Technical problems|0
4689693|NCT02554786|7599257|FG003|Overall Study|Technical problems|2
4689694|NCT02554786|7599258|FG004|Overall Study|Technical problems|1
4689695|NCT02554786|7599254|FG000|Overall Study|Adverse Event|0
4689696|NCT02554786|7599255|FG001|Overall Study|Adverse Event|0
4689697|NCT02554786|7599256|FG002|Overall Study|Adverse Event|0
4689698|NCT02554786|7599257|FG003|Overall Study|Adverse Event|0
4689699|NCT02554786|7599258|FG004|Overall Study|Adverse Event|2
4689700|NCT02554786|7599254|FG000|Overall Study|Death|0
4689701|NCT02554786|7599255|FG001|Overall Study|Death|0
4689702|NCT02554786|7599256|FG002|Overall Study|Death|0
4689703|NCT02554786|7599257|FG003|Overall Study|Death|1
4689704|NCT02554786|7599258|FG004|Overall Study|Death|0
4689705|NCT02554786|7599254|FG000|Overall Study|Non-compliance with study treatment|0
4689706|NCT02554786|7599255|FG001|Overall Study|Non-compliance with study treatment|1
4689707|NCT02554786|7599256|FG002|Overall Study|Non-compliance with study treatment|1
4689708|NCT02554786|7599257|FG003|Overall Study|Non-compliance with study treatment|0
4689709|NCT02554786|7599258|FG004|Overall Study|Non-compliance with study treatment|1
4689710|NCT02554786|7599254|FG000|Overall Study|Physician Decision|0
4689711|NCT02554786|7599255|FG001|Overall Study|Physician Decision|1
4689712|NCT02554786|7599256|FG002|Overall Study|Physician Decision|4
4689713|NCT02554786|7599257|FG003|Overall Study|Physician Decision|1
4689714|NCT02554786|7599258|FG004|Overall Study|Physician Decision|1
4689715|NCT02554786|7599254|FG000|Overall Study|Pregnancy|0
4689716|NCT02554786|7599255|FG001|Overall Study|Pregnancy|0
4689717|NCT02554786|7599256|FG002|Overall Study|Pregnancy|0
4689718|NCT02554786|7599257|FG003|Overall Study|Pregnancy|1
4689719|NCT02554786|7599258|FG004|Overall Study|Pregnancy|1
4689720|NCT02554877|7599287|FG000|Overall Study|Adverse Event|2
4689721|NCT02554877|7599288|FG001|Overall Study|Adverse Event|0
4689722|NCT02554877|7599289|FG002|Overall Study|Adverse Event|0
4689723|NCT02554877|7599290|FG003|Overall Study|Adverse Event|1
4689724|NCT02554877|7599287|FG000|Overall Study|Lost to Follow-up|1
4689725|NCT02554877|7599288|FG001|Overall Study|Lost to Follow-up|1
4689726|NCT02554877|7599289|FG002|Overall Study|Lost to Follow-up|1
4689727|NCT02554877|7599290|FG003|Overall Study|Lost to Follow-up|2
4689728|NCT02554877|7599287|FG000|Overall Study|Did not meet entrance criteria|0
4689729|NCT02554877|7599288|FG001|Overall Study|Did not meet entrance criteria|0
4689730|NCT02554877|7599289|FG002|Overall Study|Did not meet entrance criteria|1
4689731|NCT02554877|7599290|FG003|Overall Study|Did not meet entrance criteria|0
4689732|NCT02554877|7599287|FG000|Overall Study|No longer met eligibility criteria|1
4689733|NCT02554877|7599288|FG001|Overall Study|No longer met eligibility criteria|0
4689734|NCT02554877|7599289|FG002|Overall Study|No longer met eligibility criteria|1
4689735|NCT02554877|7599290|FG003|Overall Study|No longer met eligibility criteria|1
4689736|NCT02554877|7599287|FG000|Overall Study|Protocol Violation|3
4689737|NCT02554877|7599288|FG001|Overall Study|Protocol Violation|1
4689738|NCT02554877|7599289|FG002|Overall Study|Protocol Violation|1
4689739|NCT02554877|7599290|FG003|Overall Study|Protocol Violation|0
4689740|NCT02554877|7599287|FG000|Overall Study|Other|1
4689741|NCT02554877|7599288|FG001|Overall Study|Other|3
4689742|NCT02554877|7599289|FG002|Overall Study|Other|0
4689743|NCT02554877|7599290|FG003|Overall Study|Other|3
4689744|NCT02554877|7599287|FG000|Overall Study|Insufficient clinical response|4
4689745|NCT02554877|7599288|FG001|Overall Study|Insufficient clinical response|0
4689746|NCT02554877|7599289|FG002|Overall Study|Insufficient clinical response|0
4689747|NCT02554877|7599290|FG003|Overall Study|Insufficient clinical response|0
4689748|NCT02554877|7599287|FG000|Overall Study|No longer willing to participate|0
4689749|NCT02554877|7599288|FG001|Overall Study|No longer willing to participate|2
4689750|NCT02554877|7599289|FG002|Overall Study|No longer willing to participate|2
4689751|NCT02554877|7599290|FG003|Overall Study|No longer willing to participate|0
4689752|NCT02554890|7599302|FG000|Double-blind|Adverse Event|45
4689753|NCT02554890|7599303|FG001|Double-blind|Adverse Event|51
4689754|NCT02554890|7599302|FG000|Double-blind|Death|6
4689755|NCT02554890|7599303|FG001|Double-blind|Death|4
4689756|NCT02554890|7599302|FG000|Double-blind|Protocol Violation|1
4689757|NCT02554890|7599303|FG001|Double-blind|Protocol Violation|1
4689758|NCT02554890|7599302|FG000|Double-blind|Physician Decision|4
4689759|NCT02554890|7599303|FG001|Double-blind|Physician Decision|3
4689760|NCT02554890|7599302|FG000|Double-blind|Subject/Guardian decision|21
4689761|NCT02554890|7599303|FG001|Double-blind|Subject/Guardian decision|16
4689762|NCT02554890|7599302|FG000|Double-blind|Lost to Follow-up|7
4689763|NCT02554890|7599303|FG001|Double-blind|Lost to Follow-up|5
4689764|NCT02554890|7599302|FG000|Double-blind|Technical problems|1
4689765|NCT02554890|7599303|FG001|Double-blind|Technical problems|0
4689766|NCT02554890|7599302|FG000|Double-blind|Withdrawal by Subject|5
4689767|NCT02554890|7599303|FG001|Double-blind|Withdrawal by Subject|6
4689768|NCT02554890|7599302|FG000|Double-blind|Noncompliance with study treatment|6
4689769|NCT02554890|7599303|FG001|Double-blind|Noncompliance with study treatment|5
4689770|NCT02554890|7599302|FG000|Open-label|Adverse Event|0
4689771|NCT02554890|7599303|FG001|Open-label|Adverse Event|30
4689772|NCT02554890|7599302|FG000|Open-label|Death|0
4689773|NCT02554890|7599303|FG001|Open-label|Death|1
4689774|NCT02554890|7599302|FG000|Open-label|Physician Decision|0
4689775|NCT02554890|7599303|FG001|Open-label|Physician Decision|1
4689776|NCT02554890|7599302|FG000|Open-label|Subject/Guardian decision|0
4689777|NCT02554890|7599303|FG001|Open-label|Subject/Guardian decision|11
4689778|NCT02554890|7599302|FG000|Open-label|Lost to Follow-up|0
4689779|NCT02554890|7599303|FG001|Open-label|Lost to Follow-up|7
4689780|NCT02554890|7599302|FG000|Open-label|Technical problems|0
4689781|NCT02554890|7599303|FG001|Open-label|Technical problems|1
4689782|NCT02554890|7599302|FG000|Open-label|Withdrawal by Subject|0
4689783|NCT02554890|7599303|FG001|Open-label|Withdrawal by Subject|1
4689784|NCT02554903|7599313|FG000|Overall Study|Death|1
4689785|NCT02554903|7599314|FG001|Overall Study|Death|1
4689786|NCT02554903|7599313|FG000|Overall Study|Physician Decision|2
4689787|NCT02554903|7599314|FG001|Overall Study|Physician Decision|2
4689788|NCT02554903|7599313|FG000|Overall Study|Heart Transplant|1
4689789|NCT02554903|7599314|FG001|Overall Study|Heart Transplant|2
4762793|NCT03564119|7736756|FG001|Overall Study|Withdrawal by Subject|4
4762794|NCT03564119|7736755|FG000|Overall Study|Other Than Specified|0
4762795|NCT03564119|7736756|FG001|Overall Study|Other Than Specified|1
4762796|NCT03181529|7736811|FG000|Overall Study|Withdrawal by Subject|1
4762797|NCT03181529|7736812|FG001|Overall Study|Withdrawal by Subject|1
4762798|NCT03181529|7736811|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1
4762799|NCT03181529|7736812|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0
4762800|NCT02946931|7736818|FG000|Overall Study|Did not require collection of CRFs|573
4762801|NCT02946931|7736818|FG000|Overall Study|Other than listed|38
4762802|NCT02946931|7736818|FG000|Overall Study|Discharge from hospital|117
4762803|NCT02946931|7736818|FG000|Overall Study|Adverse Event|81
4762804|NCT02946931|7736818|FG000|Overall Study|CRFs not fixed|2
4762805|NCT02946931|7736818|FG000|Overall Study|CRFs not valid|1
4762806|NCT02946931|7736818|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6
4762807|NCT02779556|7736824|FG000|Baseline|Partial baseline interview completed|1
4762808|NCT02779556|7736825|FG001|Baseline|Partial baseline interview completed|0
4762809|NCT02779556|7736824|FG000|3 Months|Lost to Follow-up|40
4762810|NCT02779556|7736825|FG001|3 Months|Lost to Follow-up|29
4762811|NCT02779556|7736824|FG000|3 Months|Missed 3 month clinic visit|27
4762812|NCT02779556|7736825|FG001|3 Months|Missed 3 month clinic visit|19
4762813|NCT02779556|7736824|FG000|6 Month|Lost to Follow-up|33
4762814|NCT02779556|7736825|FG001|6 Month|Lost to Follow-up|39
4762815|NCT02779556|7736824|FG000|6 Month HbA1c|No value collected during window|69
4762816|NCT02779556|7736825|FG001|6 Month HbA1c|No value collected during window|50
4762817|NCT02779556|7736824|FG000|12 Month HbA1c|No value collected during window|138
4762818|NCT02779556|7736825|FG001|12 Month HbA1c|No value collected during window|102
4762819|NCT02675751|7736849|FG000|Overall Study|Lost to Follow-up|16
4762820|NCT02621424|7736864|FG000|Overall Study|Withdrawal by Subject|1
4762821|NCT02621424|7736865|FG001|Overall Study|Withdrawal by Subject|2
4762822|NCT02595372|7736871|FG000|Overall Study|Adverse Event|6
4762823|NCT02595372|7736871|FG000|Overall Study|Physician Decision|2
4762824|NCT02595372|7736871|FG000|Overall Study|Disease Progression|1
4762825|NCT02334722|7736883|FG000|Overall Study|Lost to Follow-up|4
4762826|NCT02334722|7736884|FG001|Overall Study|Lost to Follow-up|0
4762827|NCT02334722|7736883|FG000|Overall Study|6 week questionnaire not completed|2
4762828|NCT02334722|7736884|FG001|Overall Study|6 week questionnaire not completed|0
4762829|NCT02334722|7736883|FG000|Overall Study|Unable to obtain medication|1
4762830|NCT02334722|7736884|FG001|Overall Study|Unable to obtain medication|1
4762831|NCT02334722|7736883|FG000|Overall Study|Withdrawal by Subject|0
4762832|NCT02334722|7736884|FG001|Overall Study|Withdrawal by Subject|3
4762833|NCT02334722|7736883|FG000|Overall Study|Adverse Event|0
4762834|NCT02334722|7736884|FG001|Overall Study|Adverse Event|2
4762835|NCT02334722|7736883|FG000|Overall Study|Physician Decision|0
4762836|NCT02334722|7736884|FG001|Overall Study|Physician Decision|1
4762837|NCT01966731|7736894|FG000|Overall Study|Death|2
4762838|NCT01966731|7736894|FG000|Overall Study|Lost to Follow-up|1
4762839|NCT01966731|7736894|FG000|Overall Study|Physician Decision|2
4762840|NCT01966731|7736894|FG000|Overall Study|Follow up is not complete|600
4762841|NCT01966731|7736894|FG000|Overall Study|Screening Failure|29
4762842|NCT01966731|7736894|FG000|Overall Study|Found to be ineligible|1
4762843|NCT01844518|7736918|FG000|Overall Study|Adverse Event|7
4762844|NCT01844518|7736919|FG001|Overall Study|Adverse Event|1
4762845|NCT01844518|7736918|FG000|Overall Study|Lack of Efficacy|17
4762846|NCT01844518|7736919|FG001|Overall Study|Lack of Efficacy|5
4762847|NCT01844518|7736918|FG000|Overall Study|Participant's request to discontinue|4
4762848|NCT01844518|7736919|FG001|Overall Study|Participant's request to discontinue|1
4762849|NCT01844518|7736918|FG000|Overall Study|Poor/Non-compliance|1
4762850|NCT01844518|7736919|FG001|Overall Study|Poor/Non-compliance|0
4762851|NCT01844518|7736918|FG000|Overall Study|No Longer Met Study Criteria|2
4762852|NCT01844518|7736919|FG001|Overall Study|No Longer Met Study Criteria|0
4762853|NCT01844518|7736918|FG000|Overall Study|Withdrawal by Subject|9
4762854|NCT01844518|7736919|FG001|Overall Study|Withdrawal by Subject|0
4762855|NCT01844518|7736918|FG000|Overall Study|Pregnancy|1
4762856|NCT01844518|7736919|FG001|Overall Study|Pregnancy|0
4762857|NCT01675479|7736928|FG000|Overall Study|Lost to Follow-up|11
4762858|NCT01349959|7736941|FG000|Overall Study|Adverse Event|7
4762859|NCT01168219|7736945|FG000|Overall Study|off study before starting treatment|2
4762860|NCT01168219|7736945|FG000|Overall Study|withdrew before transplant|1
4762861|NCT01168219|7736945|FG000|Overall Study|ineligible due to CML|2
4762862|NCT00812708|7736966|FG000|Overall Study|Device could not be implanted|2
4762863|NCT00812708|7736966|FG000|Overall Study|Lack of medical insurance|1
4762864|NCT00812708|7736966|FG000|Overall Study|Switched to another study|1
4762865|NCT00812708|7736966|FG000|Overall Study|Surgery cancelled due to uveitis|1
4762866|NCT00812708|7736966|FG000|Overall Study|Signed consent but later withdrew|3
4762867|NCT00792259|7736974|FG000|Overall Study|Poor Quality Scans|1
4762868|NCT00792259|7736975|FG001|Overall Study|Poor Quality Scans|0
4762869|NCT00792259|7736976|FG002|Overall Study|Poor Quality Scans|0
4762870|NCT00741988|7736986|FG000|Overall Study|Adverse Event|2
4762871|NCT00741988|7736987|FG001|Overall Study|Adverse Event|4
4762872|NCT00741988|7736986|FG000|Overall Study|Lack of Efficacy|2
4762873|NCT00741988|7736987|FG001|Overall Study|Lack of Efficacy|0
4762874|NCT00515671|7737004|FG000|Overall Study|Lost to Follow-up|13
4762875|NCT00515671|7737005|FG001|Overall Study|Lost to Follow-up|10
4762876|NCT00515671|7737004|FG000|Overall Study|Withdrawal by Subject|3
4762877|NCT00515671|7737005|FG001|Overall Study|Withdrawal by Subject|5
4762878|NCT00515671|7737004|FG000|Overall Study|incarcerated|1
4762879|NCT00515671|7737005|FG001|Overall Study|incarcerated|2
4762880|NCT00455403|7737013|FG000|Overall Study|Lost to Follow-up|2
4762881|NCT00455403|7737014|FG001|Overall Study|Lost to Follow-up|1
4762882|NCT00455403|7737013|FG000|Overall Study|Withdrawal by Subject|1
4762883|NCT00455403|7737014|FG001|Overall Study|Withdrawal by Subject|3
4762884|NCT00455403|7737013|FG000|Overall Study|Protocol Violation|0
4762885|NCT00455403|7737014|FG001|Overall Study|Protocol Violation|2
4762886|NCT00238420|7737022|FG000|Overall Study|Protocol Violation|1
4762887|NCT00238420|7737023|FG001|Overall Study|Protocol Violation|1
4762888|NCT04128319|7737042|FG000|Overall Study|Death|3
4762889|NCT03761810|7737048|FG000|Overall Study|Adverse Event|12
4762890|NCT03761810|7737049|FG001|Overall Study|Adverse Event|0
4762891|NCT03761810|7737048|FG000|Overall Study|Lost to Follow-up|15
4762892|NCT03761810|7737049|FG001|Overall Study|Lost to Follow-up|7
4762893|NCT03761810|7737048|FG000|Overall Study|Pregnancy|1
4762894|NCT03761810|7737049|FG001|Overall Study|Pregnancy|0
4762895|NCT03761810|7737048|FG000|Overall Study|Withdrawal by Subject|14
4762896|NCT03761810|7737049|FG001|Overall Study|Withdrawal by Subject|5
4762897|NCT03761810|7737048|FG000|Overall Study|Physician Decision|1
4762898|NCT03761810|7737049|FG001|Overall Study|Physician Decision|0
4762899|NCT03761810|7737048|FG000|Overall Study|Withdrawal by Parent/Guardian|4
4762900|NCT03761810|7737049|FG001|Overall Study|Withdrawal by Parent/Guardian|0
4762901|NCT03761810|7737048|FG000|Overall Study|Other Than Specified|1
4762902|NCT03761810|7737049|FG001|Overall Study|Other Than Specified|0
4762903|NCT03761784|7737057|FG000|Overall Study|Adverse Event|4
4762904|NCT03761784|7737058|FG001|Overall Study|Adverse Event|0
4762905|NCT03761784|7737057|FG000|Overall Study|Lost to Follow-up|10
4762906|NCT03761784|7737058|FG001|Overall Study|Lost to Follow-up|7
4762907|NCT03761784|7737057|FG000|Overall Study|Pregnancy|1
4762908|NCT03761784|7737058|FG001|Overall Study|Pregnancy|0
4762909|NCT03761784|7737057|FG000|Overall Study|Protocol Violation|2
4762910|NCT03761784|7737058|FG001|Overall Study|Protocol Violation|0
4762911|NCT03761784|7737057|FG000|Overall Study|Withdrawal by Parent or Guardian|4
4762912|NCT03761784|7737058|FG001|Overall Study|Withdrawal by Parent or Guardian|1
4762913|NCT03761784|7737057|FG000|Overall Study|Withdrawal by Subject|9
4762914|NCT03761784|7737058|FG001|Overall Study|Withdrawal by Subject|4
4762915|NCT03761784|7737057|FG000|Overall Study|Physician Decision|1
4762916|NCT03761784|7737058|FG001|Overall Study|Physician Decision|0
4762917|NCT03761784|7737057|FG000|Overall Study|Other Than Specified|1
4762918|NCT03761784|7737058|FG001|Overall Study|Other Than Specified|0
4762919|NCT03541317|7737066|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1
4762920|NCT03541317|7737067|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0
4762921|NCT03541317|7737068|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0
4762922|NCT03541317|7737069|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0
4762923|NCT03541317|7737070|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0
4762924|NCT03541317|7737071|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0
4762925|NCT03361865|7737094|FG000|Overall Study|Death|17
4762926|NCT03361865|7737095|FG001|Overall Study|Death|18
4762927|NCT03361865|7737094|FG000|Overall Study|Physician Decision|1
4762928|NCT03361865|7737095|FG001|Overall Study|Physician Decision|9
4762929|NCT03361865|7737094|FG000|Overall Study|Withdrawal by Subject|1
4762930|NCT03361865|7737095|FG001|Overall Study|Withdrawal by Subject|0
4762931|NCT02929056|7737121|FG000|Overall Study|Lost to Follow-up|0
4762932|NCT02929056|7737122|FG001|Overall Study|Lost to Follow-up|1
4762933|NCT02896855|7737130|FG000|Overall Study|Death|50
4762934|NCT02896855|7737131|FG001|Overall Study|Death|40
4762935|NCT02896855|7737130|FG000|Overall Study|Lost to Follow-up|15
4762936|NCT02896855|7737131|FG001|Overall Study|Lost to Follow-up|9
4762937|NCT02896855|7737130|FG000|Overall Study|Withdrawal by Subject|7
4762938|NCT02896855|7737131|FG001|Overall Study|Withdrawal by Subject|4
4762939|NCT02871778|7737144|FG000|Part A: Treatment Period 1|Adverse Event|1
4762940|NCT02871778|7737145|FG001|Part A: Treatment Period 1|Adverse Event|1
4762941|NCT02871778|7737146|FG002|Part A: Treatment Period 1|Adverse Event|1
4762942|NCT02871778|7737147|FG003|Part A: Treatment Period 1|Adverse Event|0
4762943|NCT02871778|7737148|FG004|Part A: Treatment Period 1|Adverse Event|0
4762944|NCT02871778|7737149|FG005|Part A: Treatment Period 1|Adverse Event|0
4762945|NCT02871778|7737150|FG006|Part A: Treatment Period 1|Adverse Event|0
4762946|NCT02871778|7737151|FG007|Part A: Treatment Period 1|Adverse Event|0
4762947|NCT02871778|7737144|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2
4762948|NCT02871778|7737145|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2
4762949|NCT02871778|7737146|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0
4762950|NCT02871778|7737147|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2
4762951|NCT02871778|7737148|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0
4762952|NCT02871778|7737149|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0
4762953|NCT02871778|7737150|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0
4762954|NCT02871778|7737151|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0
4762955|NCT02871778|7737144|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0
4762956|NCT02871778|7737145|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0
4762957|NCT02871778|7737146|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1
4762958|NCT02871778|7737147|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0
4762959|NCT02871778|7737148|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0
4762960|NCT02871778|7737149|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0
4762961|NCT02871778|7737150|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0
4762962|NCT02871778|7737151|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0
4762963|NCT02871778|7737144|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0
4762964|NCT02871778|7737145|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0
4762965|NCT02871778|7737146|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1
4762966|NCT02871778|7737147|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0
4762967|NCT02871778|7737148|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0
4762968|NCT02871778|7737149|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0
4762969|NCT02871778|7737150|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0
4762970|NCT02871778|7737151|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0
4762971|NCT02871778|7737144|FG000|Part A: Treatment Period 1|Wrong drug shipment|0
4762972|NCT02871778|7737145|FG001|Part A: Treatment Period 1|Wrong drug shipment|1
4762973|NCT02871778|7737146|FG002|Part A: Treatment Period 1|Wrong drug shipment|0
4762974|NCT02871778|7737147|FG003|Part A: Treatment Period 1|Wrong drug shipment|0
4762975|NCT02871778|7737148|FG004|Part A: Treatment Period 1|Wrong drug shipment|0
4762976|NCT02871778|7737149|FG005|Part A: Treatment Period 1|Wrong drug shipment|0
4762977|NCT02871778|7737150|FG006|Part A: Treatment Period 1|Wrong drug shipment|0
4762978|NCT02871778|7737151|FG007|Part A: Treatment Period 1|Wrong drug shipment|0
4762979|NCT02871778|7737144|FG000|Part A: Treatment Period 2|Adverse Event|2
4762980|NCT02871778|7737145|FG001|Part A: Treatment Period 2|Adverse Event|2
4762981|NCT02871778|7737146|FG002|Part A: Treatment Period 2|Adverse Event|0
4762982|NCT02871778|7737147|FG003|Part A: Treatment Period 2|Adverse Event|0
4762983|NCT02871778|7737148|FG004|Part A: Treatment Period 2|Adverse Event|0
4762984|NCT02871778|7737149|FG005|Part A: Treatment Period 2|Adverse Event|0
4762985|NCT02871778|7737150|FG006|Part A: Treatment Period 2|Adverse Event|0
4762986|NCT02871778|7737151|FG007|Part A: Treatment Period 2|Adverse Event|0
4762987|NCT02871778|7737144|FG000|Part A: Treatment Period 2|Lost to Follow-up|0
4762988|NCT02871778|7737145|FG001|Part A: Treatment Period 2|Lost to Follow-up|0
4762989|NCT02871778|7737146|FG002|Part A: Treatment Period 2|Lost to Follow-up|0
4762990|NCT02871778|7737147|FG003|Part A: Treatment Period 2|Lost to Follow-up|1
4762991|NCT02871778|7737148|FG004|Part A: Treatment Period 2|Lost to Follow-up|0
4762992|NCT02871778|7737149|FG005|Part A: Treatment Period 2|Lost to Follow-up|0
4762993|NCT02871778|7737150|FG006|Part A: Treatment Period 2|Lost to Follow-up|0
4762994|NCT02871778|7737151|FG007|Part A: Treatment Period 2|Lost to Follow-up|0
4762995|NCT02871778|7737144|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1
4762996|NCT02871778|7737145|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0
4762997|NCT02871778|7737146|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1
4762998|NCT02871778|7737147|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0
4762999|NCT02871778|7737148|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0
4763000|NCT02871778|7737149|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0
4763001|NCT02871778|7737150|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0
4763002|NCT02871778|7737151|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0
4763003|NCT02871778|7737144|FG000|Part B: Treatment Period 3|Adverse Event|0
4763004|NCT02871778|7737145|FG001|Part B: Treatment Period 3|Adverse Event|0
4763005|NCT02871778|7737146|FG002|Part B: Treatment Period 3|Adverse Event|0
4763006|NCT02871778|7737147|FG003|Part B: Treatment Period 3|Adverse Event|0
4763007|NCT02871778|7737148|FG004|Part B: Treatment Period 3|Adverse Event|1
4763008|NCT02871778|7737149|FG005|Part B: Treatment Period 3|Adverse Event|1
4763009|NCT02871778|7737150|FG006|Part B: Treatment Period 3|Adverse Event|1
4763010|NCT02871778|7737151|FG007|Part B: Treatment Period 3|Adverse Event|0
4763011|NCT02756208|7737184|FG000|Overall Study|Withdrawal by Subject|1
4763012|NCT02756208|7737185|FG001|Overall Study|Withdrawal by Subject|0
4763013|NCT02756208|7737186|FG002|Overall Study|Withdrawal by Subject|1
4763014|NCT02756208|7737187|FG003|Overall Study|Withdrawal by Subject|3
4763015|NCT02756208|7737184|FG000|Overall Study|Lost to Follow-up|3
4763016|NCT02756208|7737185|FG001|Overall Study|Lost to Follow-up|1
4763017|NCT02756208|7737186|FG002|Overall Study|Lost to Follow-up|1
4763018|NCT02756208|7737187|FG003|Overall Study|Lost to Follow-up|1
4763019|NCT02756208|7737184|FG000|Overall Study|Physician Decision|1
4763020|NCT02756208|7737185|FG001|Overall Study|Physician Decision|0
4763021|NCT02756208|7737186|FG002|Overall Study|Physician Decision|0
4763022|NCT02756208|7737187|FG003|Overall Study|Physician Decision|0
4763023|NCT02756208|7737184|FG000|Overall Study|Protocol Violation|0
4763024|NCT02756208|7737185|FG001|Overall Study|Protocol Violation|1
4763025|NCT02756208|7737186|FG002|Overall Study|Protocol Violation|0
4763026|NCT02756208|7737187|FG003|Overall Study|Protocol Violation|0
4763027|NCT02714218|7737200|FG000|Overall Study|Disease Progression|56
4763028|NCT02714218|7737201|FG001|Overall Study|Disease Progression|51
4763029|NCT02714218|7737202|FG002|Overall Study|Disease Progression|14
4763030|NCT02714218|7737200|FG000|Overall Study|Adverse Event Unrelated to Study Drug|10
4763031|NCT02714218|7737201|FG001|Overall Study|Adverse Event Unrelated to Study Drug|6
4763032|NCT02714218|7737202|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0
4763033|NCT02714218|7737200|FG000|Overall Study|Study Drug Toxicity|46
4763034|NCT02714218|7737201|FG001|Overall Study|Study Drug Toxicity|69
4763035|NCT02714218|7737202|FG002|Overall Study|Study Drug Toxicity|4
4763036|NCT02714218|7737200|FG000|Overall Study|Request to Discontinue Treatment|1
4763037|NCT02714218|7737201|FG001|Overall Study|Request to Discontinue Treatment|5
4763038|NCT02714218|7737202|FG002|Overall Study|Request to Discontinue Treatment|1
4763039|NCT02714218|7737200|FG000|Overall Study|Participant Withdrew Consent|2
4763040|NCT02714218|7737201|FG001|Overall Study|Participant Withdrew Consent|3
4763041|NCT02714218|7737202|FG002|Overall Study|Participant Withdrew Consent|0
4763042|NCT02714218|7737200|FG000|Overall Study|Maximum Clinical Benefit|2
4763043|NCT02714218|7737201|FG001|Overall Study|Maximum Clinical Benefit|2
4763044|NCT02714218|7737202|FG002|Overall Study|Maximum Clinical Benefit|0
4763045|NCT02714218|7737200|FG000|Overall Study|Medical Decision|0
4763046|NCT02714218|7737201|FG001|Overall Study|Medical Decision|1
4763047|NCT02714218|7737202|FG002|Overall Study|Medical Decision|0
4763048|NCT02714218|7737200|FG000|Overall Study|Not Reported|9
4763049|NCT02714218|7737201|FG001|Overall Study|Not Reported|5
4763050|NCT02714218|7737202|FG002|Overall Study|Not Reported|0
4763051|NCT02714218|7737200|FG000|Overall Study|Completed|2
4763052|NCT02714218|7737201|FG001|Overall Study|Completed|0
4763053|NCT02714218|7737202|FG002|Overall Study|Completed|0
4763054|NCT02714218|7737200|FG000|Overall Study|Dose Delayed > 6 weeks|1
4763055|NCT02714218|7737201|FG001|Overall Study|Dose Delayed > 6 weeks|0
4763056|NCT02714218|7737202|FG002|Overall Study|Dose Delayed > 6 weeks|0
4763057|NCT02714218|7737200|FG000|Overall Study|Complete Response|1
4763058|NCT02714218|7737201|FG001|Overall Study|Complete Response|0
4763059|NCT02714218|7737202|FG002|Overall Study|Complete Response|0
4763060|NCT02714218|7737200|FG000|Overall Study|Stop treatment, but will do follow up|0
4763061|NCT02714218|7737201|FG001|Overall Study|Stop treatment, but will do follow up|1
4763062|NCT02714218|7737202|FG002|Overall Study|Stop treatment, but will do follow up|0
4763063|NCT02564263|7737211|FG000|Overall Study|Adverse Event|31
4763064|NCT02564263|7737212|FG001|Overall Study|Adverse Event|29
4763065|NCT02564263|7737211|FG000|Overall Study|Death|236
4763066|NCT02564263|7737212|FG001|Overall Study|Death|242
4763067|NCT02564263|7737211|FG000|Overall Study|Withdrawal by Subject|5
4763068|NCT02564263|7737212|FG001|Overall Study|Withdrawal by Subject|18
4763069|NCT02564263|7737211|FG000|Overall Study|Ongoing in Study|42
4763070|NCT02564263|7737212|FG001|Overall Study|Ongoing in Study|25
4763071|NCT02149121|7737225|FG000|Main Study Period|Lack of Efficacy|2
4763072|NCT02149121|7737226|FG001|Main Study Period|Lack of Efficacy|2
4763073|NCT02149121|7737227|FG002|Main Study Period|Lack of Efficacy|1
4763074|NCT02149121|7737228|FG003|Main Study Period|Lack of Efficacy|0
4763075|NCT02149121|7737229|FG004|Main Study Period|Lack of Efficacy|0
4763076|NCT02149121|7737230|FG005|Main Study Period|Lack of Efficacy|0
4763077|NCT02149121|7737231|FG006|Main Study Period|Lack of Efficacy|0
4763078|NCT02149121|7737225|FG000|Main Study Period|Withdrawal by Subject|9
4763079|NCT02149121|7737226|FG001|Main Study Period|Withdrawal by Subject|5
4763080|NCT02149121|7737227|FG002|Main Study Period|Withdrawal by Subject|1
4763081|NCT02149121|7737228|FG003|Main Study Period|Withdrawal by Subject|0
4763082|NCT02149121|7737229|FG004|Main Study Period|Withdrawal by Subject|0
4763083|NCT02149121|7737230|FG005|Main Study Period|Withdrawal by Subject|0
4763084|NCT02149121|7737231|FG006|Main Study Period|Withdrawal by Subject|0
4763085|NCT02149121|7737225|FG000|Main Study Period|Adverse Event|2
4763086|NCT02149121|7737226|FG001|Main Study Period|Adverse Event|5
4763087|NCT02149121|7737227|FG002|Main Study Period|Adverse Event|1
4763088|NCT02149121|7737228|FG003|Main Study Period|Adverse Event|0
4763089|NCT02149121|7737229|FG004|Main Study Period|Adverse Event|0
4763090|NCT02149121|7737230|FG005|Main Study Period|Adverse Event|0
4763091|NCT02149121|7737231|FG006|Main Study Period|Adverse Event|0
4763092|NCT02149121|7737225|FG000|Main Study Period|Protocol Violation|2
4763093|NCT02149121|7737226|FG001|Main Study Period|Protocol Violation|0
4763094|NCT02149121|7737227|FG002|Main Study Period|Protocol Violation|0
4763095|NCT02149121|7737228|FG003|Main Study Period|Protocol Violation|0
4763096|NCT02149121|7737229|FG004|Main Study Period|Protocol Violation|0
4763097|NCT02149121|7737230|FG005|Main Study Period|Protocol Violation|0
4763098|NCT02149121|7737231|FG006|Main Study Period|Protocol Violation|0
4763099|NCT02149121|7737225|FG000|Main Study Period|Lost to Follow-up|2
4763100|NCT02149121|7737226|FG001|Main Study Period|Lost to Follow-up|1
4763101|NCT02149121|7737227|FG002|Main Study Period|Lost to Follow-up|0
4763102|NCT02149121|7737228|FG003|Main Study Period|Lost to Follow-up|0
4763103|NCT02149121|7737229|FG004|Main Study Period|Lost to Follow-up|0
4763104|NCT02149121|7737230|FG005|Main Study Period|Lost to Follow-up|0
4763105|NCT02149121|7737231|FG006|Main Study Period|Lost to Follow-up|0
4763106|NCT02149121|7737225|FG000|Main Study Period|Death|1
4763107|NCT02149121|7737226|FG001|Main Study Period|Death|0
4763108|NCT02149121|7737227|FG002|Main Study Period|Death|0
4763109|NCT02149121|7737228|FG003|Main Study Period|Death|0
4763110|NCT02149121|7737229|FG004|Main Study Period|Death|0
4763111|NCT02149121|7737230|FG005|Main Study Period|Death|0
4763112|NCT02149121|7737231|FG006|Main Study Period|Death|0
4763113|NCT02149121|7737225|FG000|Main Study Period|Physician Decision|1
4763114|NCT02149121|7737226|FG001|Main Study Period|Physician Decision|0
4763115|NCT02149121|7737227|FG002|Main Study Period|Physician Decision|0
4763116|NCT02149121|7737228|FG003|Main Study Period|Physician Decision|0
4763117|NCT02149121|7737229|FG004|Main Study Period|Physician Decision|0
4763118|NCT02149121|7737230|FG005|Main Study Period|Physician Decision|0
4763119|NCT02149121|7737231|FG006|Main Study Period|Physician Decision|0
4763120|NCT02149121|7737225|FG000|Main Study Period|Developed any malignancy|0
4763121|NCT02149121|7737226|FG001|Main Study Period|Developed any malignancy|1
4763122|NCT02149121|7737227|FG002|Main Study Period|Developed any malignancy|1
4763123|NCT02149121|7737228|FG003|Main Study Period|Developed any malignancy|0
4763124|NCT02149121|7737229|FG004|Main Study Period|Developed any malignancy|0
4763125|NCT02149121|7737230|FG005|Main Study Period|Developed any malignancy|0
4763126|NCT02149121|7737231|FG006|Main Study Period|Developed any malignancy|0
4763127|NCT02149121|7737225|FG000|Main Study Period|Unmet predefined eligibility criteria|2
4763128|NCT02149121|7737226|FG001|Main Study Period|Unmet predefined eligibility criteria|2
4763129|NCT02149121|7737227|FG002|Main Study Period|Unmet predefined eligibility criteria|0
4763130|NCT02149121|7737228|FG003|Main Study Period|Unmet predefined eligibility criteria|0
4763131|NCT02149121|7737229|FG004|Main Study Period|Unmet predefined eligibility criteria|0
4763132|NCT02149121|7737230|FG005|Main Study Period|Unmet predefined eligibility criteria|0
4763133|NCT02149121|7737231|FG006|Main Study Period|Unmet predefined eligibility criteria|0
4763134|NCT02149121|7737225|FG000|Main Study Period|Disease progression|0
4763135|NCT02149121|7737226|FG001|Main Study Period|Disease progression|1
4763136|NCT02149121|7737227|FG002|Main Study Period|Disease progression|0
4763137|NCT02149121|7737228|FG003|Main Study Period|Disease progression|0
4763138|NCT02149121|7737229|FG004|Main Study Period|Disease progression|0
4763139|NCT02149121|7737230|FG005|Main Study Period|Disease progression|0
4763140|NCT02149121|7737231|FG006|Main Study Period|Disease progression|0
4763141|NCT02149121|7737225|FG000|Extension Study Period|Withdrawal by Subject|0
4763142|NCT02149121|7737226|FG001|Extension Study Period|Withdrawal by Subject|0
4763143|NCT02149121|7737227|FG002|Extension Study Period|Withdrawal by Subject|0
4763144|NCT02149121|7737228|FG003|Extension Study Period|Withdrawal by Subject|1
4763145|NCT02149121|7737229|FG004|Extension Study Period|Withdrawal by Subject|0
4763146|NCT02149121|7737230|FG005|Extension Study Period|Withdrawal by Subject|2
4763147|NCT02149121|7737231|FG006|Extension Study Period|Withdrawal by Subject|0
4763148|NCT01889186|7737254|FG000|Overall Study|Adverse event- not related to progression|18
4763149|NCT01889186|7737255|FG001|Overall Study|Adverse event- not related to progression|5
4763150|NCT01889186|7737254|FG000|Overall Study|Adverse event- related to progression|7
4763151|NCT01889186|7737255|FG001|Overall Study|Adverse event- related to progression|2
4763152|NCT01889186|7737254|FG000|Overall Study|COVID-19 logistical restrictions|1
4763153|NCT01889186|7737255|FG001|Overall Study|COVID-19 logistical restrictions|0
4763154|NCT01889186|7737254|FG000|Overall Study|Investigator request|1
4763155|NCT01889186|7737255|FG001|Overall Study|Investigator request|1
4763156|NCT01889186|7737254|FG000|Overall Study|Progressive disease- Richter's|12
4763157|NCT01889186|7737255|FG001|Overall Study|Progressive disease- Richter's|7
4763158|NCT01889186|7737254|FG000|Overall Study|Progressive disease per protocol|46
4763159|NCT01889186|7737255|FG001|Overall Study|Progressive disease per protocol|17
4763160|NCT01889186|7737254|FG000|Overall Study|Stem cell transplant|2
4763161|NCT01889186|7737255|FG001|Overall Study|Stem cell transplant|1
4763162|NCT01889186|7737254|FG000|Overall Study|Withdrew consent|2
4763163|NCT01889186|7737255|FG001|Overall Study|Withdrew consent|3
4763164|NCT01889186|7737254|FG000|Overall Study|Other, not specified|18
4763165|NCT01889186|7737255|FG001|Overall Study|Other, not specified|15
4763166|NCT01850004|7737263|FG000|Overall Study|Subject Moved|1
4763167|NCT01850004|7737263|FG000|Overall Study|Poor/Non-compliance|1
4763168|NCT01850004|7737263|FG000|Overall Study|Subject Withdrew Consent|4
4763169|NCT01850004|7737263|FG000|Overall Study|Subject Request to Discontinue Treatment|1
4763170|NCT01850004|7737263|FG000|Overall Study|AE Unrelated to Study Drug|1
4763171|NCT01844505|7737275|FG000|Overall Study|Disease progression|170
4763172|NCT01844505|7737276|FG001|Overall Study|Disease progression|88
4763173|NCT01844505|7737277|FG002|Overall Study|Disease progression|224
4763174|NCT01844505|7737275|FG000|Overall Study|Study drug toxicity|40
4763175|NCT01844505|7737276|FG001|Overall Study|Study drug toxicity|131
4763176|NCT01844505|7737277|FG002|Overall Study|Study drug toxicity|50
4763177|NCT01844505|7737275|FG000|Overall Study|Death|1
4763178|NCT01844505|7737276|FG001|Overall Study|Death|3
4763179|NCT01844505|7737277|FG002|Overall Study|Death|1
4763180|NCT01844505|7737275|FG000|Overall Study|Adverse event unrelated to study drug|7
4763181|NCT01844505|7737276|FG001|Overall Study|Adverse event unrelated to study drug|15
4763182|NCT01844505|7737277|FG002|Overall Study|Adverse event unrelated to study drug|6
4763183|NCT01844505|7737275|FG000|Overall Study|Subject request discontinue treatment|17
4763184|NCT01844505|7737276|FG001|Overall Study|Subject request discontinue treatment|14
4763185|NCT01844505|7737277|FG002|Overall Study|Subject request discontinue treatment|8
4763186|NCT01844505|7737275|FG000|Overall Study|Withdrawal by Subject|0
4763187|NCT01844505|7737276|FG001|Overall Study|Withdrawal by Subject|3
4763188|NCT01844505|7737277|FG002|Overall Study|Withdrawal by Subject|0
4763189|NCT01844505|7737275|FG000|Overall Study|Lost to Follow-up|1
4763190|NCT01844505|7737276|FG001|Overall Study|Lost to Follow-up|0
4763191|NCT01844505|7737277|FG002|Overall Study|Lost to Follow-up|0
4763192|NCT01844505|7737275|FG000|Overall Study|Maximum clinical benefit|8
4763193|NCT01844505|7737276|FG001|Overall Study|Maximum clinical benefit|11
4763194|NCT01844505|7737277|FG002|Overall Study|Maximum clinical benefit|2
4763195|NCT01844505|7737275|FG000|Overall Study|Poor/non-compliance|1
4763196|NCT01844505|7737276|FG001|Overall Study|Poor/non-compliance|1
4763197|NCT01844505|7737277|FG002|Overall Study|Poor/non-compliance|1
4763198|NCT01844505|7737275|FG000|Overall Study|Subject no longer meets criteria|0
4763199|NCT01844505|7737276|FG001|Overall Study|Subject no longer meets criteria|1
4763200|NCT01844505|7737277|FG002|Overall Study|Subject no longer meets criteria|0
4763201|NCT01844505|7737275|FG000|Overall Study|Other Reasons|4
4763202|NCT01844505|7737276|FG001|Overall Study|Other Reasons|2
4763203|NCT01844505|7737277|FG002|Overall Study|Other Reasons|2
4763204|NCT01844505|7737275|FG000|Overall Study|Not Reported|0
4763205|NCT01844505|7737276|FG001|Overall Study|Not Reported|0
4763206|NCT01844505|7737277|FG002|Overall Study|Not Reported|1
4763207|NCT01757535|7737287|FG000|Overall Study|Disease Relapse|143
4763208|NCT01757535|7737288|FG001|Overall Study|Disease Relapse|180
4763209|NCT01757535|7737287|FG000|Overall Study|Adverse Event|29
4763210|NCT01757535|7737288|FG001|Overall Study|Adverse Event|11
4763211|NCT01757535|7737287|FG000|Overall Study|Withdrawal by Subject|9
4763212|NCT01757535|7737288|FG001|Overall Study|Withdrawal by Subject|13
4763213|NCT01757535|7737287|FG000|Overall Study|Miscellaneous|5
4763214|NCT01757535|7737288|FG001|Overall Study|Miscellaneous|2
4763215|NCT01757535|7737287|FG000|Overall Study|Physician Decision|6
4763216|NCT01757535|7737288|FG001|Overall Study|Physician Decision|0
4763217|NCT01757535|7737287|FG000|Overall Study|Death|1
4763218|NCT01757535|7737288|FG001|Overall Study|Death|2
4763219|NCT01510184|7737296|FG000|Overall Study|Sponsor discretion|28
4763220|NCT01510184|7737297|FG001|Overall Study|Sponsor discretion|28
4763221|NCT01510184|7737296|FG000|Overall Study|Death|1
4763222|NCT01510184|7737297|FG001|Overall Study|Death|2
4763223|NCT01510184|7737296|FG000|Overall Study|Withdrawal by Subject|1
4763224|NCT01510184|7737297|FG001|Overall Study|Withdrawal by Subject|4
4763225|NCT01510184|7737296|FG000|Overall Study|Other|0
4763226|NCT01510184|7737297|FG001|Overall Study|Other|1
4763227|NCT01471444|7737305|FG000|Overall Study|Physician Decision|3
4763228|NCT01471444|7737306|FG001|Overall Study|Physician Decision|2
4763229|NCT01471444|7737305|FG000|Overall Study|Withdrawal by Subject|0
4763230|NCT01471444|7737306|FG001|Overall Study|Withdrawal by Subject|1
4763231|NCT01238211|7737313|FG000|Overall Study|Continues active treatment|31
4763232|NCT01238211|7737313|FG000|Overall Study|Adverse Event|7
4763233|NCT01238211|7737313|FG000|Overall Study|Death|4
4763234|NCT01238211|7737313|FG000|Overall Study|Relapse/Progression|2
4763235|NCT01238211|7737313|FG000|Overall Study|Withdrawal by Subject|7
4763236|NCT01238211|7737313|FG000|Overall Study|Non-protocol treatment|4
4763237|NCT01238211|7737313|FG000|Overall Study|Investigator/Patient Decision|3
4763238|NCT03745651|7737361|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1
4763239|NCT03745651|7737362|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1
4763240|NCT03745651|7737363|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0
4763241|NCT03745651|7737364|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0
4763242|NCT03745651|7737365|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0
4763243|NCT03745651|7737366|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0
4763244|NCT03745651|7737367|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0
4763245|NCT03745651|7737361|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3
4763246|NCT03745651|7737362|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13
4763247|NCT03745651|7737363|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4
4763248|NCT03745651|7737364|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0
4763249|NCT03745651|7737365|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0
4763250|NCT03745651|7737366|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0
4763251|NCT03745651|7737367|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0
4763252|NCT03745651|7737361|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3
4763253|NCT03745651|7737362|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
4763254|NCT03745651|7737363|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1
4763255|NCT03745651|7737364|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
4763256|NCT03745651|7737365|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
4763257|NCT03745651|7737366|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
4763258|NCT03745651|7737367|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
4763259|NCT03745651|7737361|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
4763260|NCT03745651|7737362|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2
4763261|NCT03745651|7737363|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
4763262|NCT03745651|7737364|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
4763263|NCT03745651|7737365|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
4763264|NCT03745651|7737366|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
4763265|NCT03745651|7737367|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
4763266|NCT03745651|7737361|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11
4763267|NCT03745651|7737362|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21
4763268|NCT03745651|7737363|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15
4763269|NCT03745651|7737364|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0
4763270|NCT03745651|7737365|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0
4763271|NCT03745651|7737366|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0
4763272|NCT03745651|7737367|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0
4763273|NCT03745651|7737361|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1
4763274|NCT03745651|7737362|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2
4763275|NCT03745651|7737363|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2
4763276|NCT03745651|7737364|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0
4763277|NCT03745651|7737365|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0
4763278|NCT03745651|7737366|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0
4763279|NCT03745651|7737367|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0
4763280|NCT03745651|7737361|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
4763281|NCT03745651|7737362|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
4763282|NCT03745651|7737363|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
4763283|NCT03745651|7737364|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
4763284|NCT03745651|7737365|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
4763285|NCT03745651|7737366|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4
4763286|NCT03745651|7737367|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
4763287|NCT03745651|7737361|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0
4763288|NCT03745651|7737362|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0
4763289|NCT03745651|7737363|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0
4763290|NCT03745651|7737364|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1
4763291|NCT03745651|7737365|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0
4763292|NCT03745651|7737366|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4
4763293|NCT03745651|7737367|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4
4763294|NCT03745651|7737361|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0
4763295|NCT03745651|7737362|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0
4763296|NCT03745651|7737363|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0
4763297|NCT03745651|7737364|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4
4763298|NCT03745651|7737365|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2
4763299|NCT03745651|7737366|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13
4763300|NCT03745651|7737367|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10
4763301|NCT03745651|7737361|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0
4763302|NCT03745651|7737362|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0
4763303|NCT03745651|7737363|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0
4763304|NCT03745651|7737364|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1
4763305|NCT03745651|7737365|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0
4763306|NCT03745651|7737366|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4
4763307|NCT03745651|7737367|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2
4763308|NCT03745651|7737361|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0
4763309|NCT03745651|7737362|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0
4763310|NCT03745651|7737363|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0
4763311|NCT03745651|7737364|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1
4763312|NCT03745651|7737365|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0
4763313|NCT03745651|7737366|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0
4763314|NCT03745651|7737367|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1
4763315|NCT03745651|7737361|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
4763316|NCT03745651|7737362|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
4763317|NCT03745651|7737363|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
4763318|NCT03745651|7737364|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
4763319|NCT03745651|7737365|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
4763320|NCT03745651|7737366|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1
4763321|NCT03745651|7737367|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
4763322|NCT03745651|7737361|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0
4763323|NCT03745651|7737362|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0
4763324|NCT03745651|7737363|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0
4763325|NCT03745651|7737364|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12
4763326|NCT03745651|7737365|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8
4763327|NCT03745651|7737366|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26
4763328|NCT03745651|7737367|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34
4763329|NCT03745651|7737361|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0
4763330|NCT03745651|7737362|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0
4763331|NCT03745651|7737363|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0
4763332|NCT03745651|7737364|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1
4763333|NCT03745651|7737365|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1
4763334|NCT03745651|7737366|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1
4763335|NCT03745651|7737367|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0
4763336|NCT03745638|7737386|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4
4763337|NCT03745638|7737387|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2
4763338|NCT03745638|7737388|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1
4763339|NCT03745638|7737389|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0
4763340|NCT03745638|7737390|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0
4763341|NCT03745638|7737391|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0
4763342|NCT03745638|7737392|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0
4763343|NCT03745638|7737386|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1
4763344|NCT03745638|7737387|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0
4763345|NCT03745638|7737388|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0
4763346|NCT03745638|7737389|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0
4763347|NCT03745638|7737390|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0
4763348|NCT03745638|7737391|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0
4763349|NCT03745638|7737392|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0
4763350|NCT03745638|7737386|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5
4763351|NCT03745638|7737387|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12
4763352|NCT03745638|7737388|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8
4763353|NCT03745638|7737389|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0
4763354|NCT03745638|7737390|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0
4763355|NCT03745638|7737391|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0
4763356|NCT03745638|7737392|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0
4763357|NCT03745638|7737386|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1
4763358|NCT03745638|7737387|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1
4763359|NCT03745638|7737388|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
4763360|NCT03745638|7737389|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
4763361|NCT03745638|7737390|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
4763362|NCT03745638|7737391|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
4763363|NCT03745638|7737392|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0
4763364|NCT03745638|7737386|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1
4763365|NCT03745638|7737387|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0
4763366|NCT03745638|7737388|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0
4763367|NCT03745638|7737389|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0
4763368|NCT03745638|7737390|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0
4763369|NCT03745638|7737391|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0
4763370|NCT03745638|7737392|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0
4763371|NCT03745638|7737386|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
4763372|NCT03745638|7737387|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3
4763373|NCT03745638|7737388|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
4763374|NCT03745638|7737389|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
4763375|NCT03745638|7737390|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
4763376|NCT03745638|7737391|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
4763377|NCT03745638|7737392|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0
4763378|NCT03745638|7737386|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17
4763379|NCT03745638|7737387|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11
4763380|NCT03745638|7737388|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19
4763381|NCT03745638|7737389|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0
4763382|NCT03745638|7737390|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0
4763383|NCT03745638|7737391|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0
4763384|NCT03745638|7737392|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0
4763385|NCT03745638|7737386|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2
4763386|NCT03745638|7737387|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1
4763387|NCT03745638|7737388|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0
4763388|NCT03745638|7737389|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0
4763389|NCT03745638|7737390|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0
4763390|NCT03745638|7737391|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0
4763391|NCT03745638|7737392|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0
4763392|NCT03745638|7737386|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
4763393|NCT03745638|7737387|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
4763394|NCT03745638|7737388|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
4763395|NCT03745638|7737389|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
4763396|NCT03745638|7737390|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0
4763397|NCT03745638|7737391|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6
4763398|NCT03745638|7737392|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1
4763399|NCT03745638|7737386|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0
4763400|NCT03745638|7737387|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0
4763401|NCT03745638|7737388|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0
4763402|NCT03745638|7737389|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1
4763403|NCT03745638|7737390|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0
4763404|NCT03745638|7737391|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2
4763405|NCT03745638|7737392|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2
4763406|NCT03745638|7737386|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0
4763407|NCT03745638|7737387|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0
4763408|NCT03745638|7737388|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0
4763409|NCT03745638|7737389|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3
4763410|NCT03745638|7737390|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5
4763411|NCT03745638|7737391|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13
4763412|NCT03745638|7737392|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24
4763413|NCT03745638|7737386|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0
4763414|NCT03745638|7737387|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0
4763415|NCT03745638|7737388|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0
4763416|NCT03745638|7737389|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0
4763417|NCT03745638|7737390|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1
4763418|NCT03745638|7737391|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3
4763419|NCT03745638|7737392|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0
4763420|NCT03745638|7737386|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
4763421|NCT03745638|7737387|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
4763422|NCT03745638|7737388|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
4763423|NCT03745638|7737389|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
4763424|NCT03745638|7737390|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
4763425|NCT03745638|7737391|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1
4763426|NCT03745638|7737392|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0
4763427|NCT03745638|7737386|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0
4763428|NCT03745638|7737387|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0
4763429|NCT03745638|7737388|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0
4763430|NCT03745638|7737389|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7
4763431|NCT03745638|7737390|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3
4763432|NCT03745638|7737391|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17
4763433|NCT03745638|7737392|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21
4763434|NCT03745638|7737386|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0
4763435|NCT03745638|7737387|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0
4763436|NCT03745638|7737388|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0
4763437|NCT03745638|7737389|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0
4763438|NCT03745638|7737390|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0
4763439|NCT03745638|7737391|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4
4763440|NCT03745638|7737392|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3
4763441|NCT03715764|7737411|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2
4763442|NCT03715764|7737412|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3
4763443|NCT03715764|7737411|FG000|3 Month Follow-up|Lost to Follow-up|2
4763444|NCT03715764|7737412|FG001|3 Month Follow-up|Lost to Follow-up|2
4763445|NCT03715764|7737411|FG000|3 Month Follow-up|Withdrawal by Subject|1
4763446|NCT03715764|7737412|FG001|3 Month Follow-up|Withdrawal by Subject|1
4763447|NCT03715764|7737411|FG000|6 Month Follow-up|Lost to Follow-up|3
4763448|NCT03715764|7737412|FG001|6 Month Follow-up|Lost to Follow-up|0
4763449|NCT03715764|7737411|FG000|12 Month Follow-up|Lost to Follow-up|2
4763450|NCT03715764|7737412|FG001|12 Month Follow-up|Lost to Follow-up|3
4763451|NCT03715764|7737411|FG000|12 Month Follow-up|Pregnancy|0
4763452|NCT03715764|7737412|FG001|12 Month Follow-up|Pregnancy|1
4763453|NCT03715764|7737411|FG000|12 Month Follow-up|Surgery|2
4763454|NCT03715764|7737412|FG001|12 Month Follow-up|Surgery|0
4763455|NCT03715764|7737411|FG000|12 Month Follow-up|Wrong address|1
4763456|NCT03715764|7737412|FG001|12 Month Follow-up|Wrong address|0
4763457|NCT03715764|7737411|FG000|12 Month Follow-up|No symptoms|1
4763458|NCT03715764|7737412|FG001|12 Month Follow-up|No symptoms|0
4763459|NCT03715764|7737411|FG000|12 Month Follow-up|Changed primary care centre|0
4763460|NCT03715764|7737412|FG001|12 Month Follow-up|Changed primary care centre|1
4763461|NCT03654729|7737425|FG000|Overall Study|Death|9
4763462|NCT03654729|7737426|FG001|Overall Study|Death|9
4763463|NCT03654729|7737427|FG002|Overall Study|Death|16
4763464|NCT03654729|7737425|FG000|Overall Study|Withdrawal by Subject|8
4763465|NCT03654729|7737426|FG001|Overall Study|Withdrawal by Subject|6
4763466|NCT03654729|7737427|FG002|Overall Study|Withdrawal by Subject|4
4763467|NCT03654729|7737425|FG000|Overall Study|Study terminated by Sponsor|3
4763468|NCT03654729|7737426|FG001|Overall Study|Study terminated by Sponsor|5
4763469|NCT03654729|7737427|FG002|Overall Study|Study terminated by Sponsor|4
4763470|NCT03654729|7737425|FG000|Overall Study|Not reported|2
4763471|NCT03654729|7737426|FG001|Overall Study|Not reported|4
4763472|NCT03654729|7737427|FG002|Overall Study|Not reported|5
4763473|NCT03654729|7737425|FG000|Overall Study|Progressive disease|3
4763474|NCT03654729|7737426|FG001|Overall Study|Progressive disease|0
4763475|NCT03654729|7737427|FG002|Overall Study|Progressive disease|0
4763476|NCT03654729|7737425|FG000|Overall Study|Lost to Follow-up|2
4763477|NCT03654729|7737426|FG001|Overall Study|Lost to Follow-up|0
4763478|NCT03654729|7737427|FG002|Overall Study|Lost to Follow-up|0
4763479|NCT03654729|7737425|FG000|Overall Study|Physician Decision|2
4763480|NCT03654729|7737426|FG001|Overall Study|Physician Decision|0
4763481|NCT03654729|7737427|FG002|Overall Study|Physician Decision|0
4763482|NCT03654729|7737425|FG000|Overall Study|Protocol Violation|1
4763483|NCT03654729|7737426|FG001|Overall Study|Protocol Violation|1
4763484|NCT03654729|7737427|FG002|Overall Study|Protocol Violation|0
4763485|NCT03654729|7737425|FG000|Overall Study|Non-compliance with study drug|0
4763486|NCT03654729|7737426|FG001|Overall Study|Non-compliance with study drug|1
4763487|NCT03654729|7737427|FG002|Overall Study|Non-compliance with study drug|0
4763488|NCT03654729|7737425|FG000|Overall Study|Site terminated by Sponsor|1
4763489|NCT03654729|7737426|FG001|Overall Study|Site terminated by Sponsor|0
4763490|NCT03654729|7737427|FG002|Overall Study|Site terminated by Sponsor|0
4763491|NCT02976038|7737479|FG000|Overall Study|Physician Decision|22
4763492|NCT02976038|7737479|FG000|Overall Study|Withdrawal by Subject|3
4763493|NCT02976038|7737479|FG000|Overall Study|Lost to Follow-up|2
4763494|NCT02976038|7737479|FG000|Overall Study|Adverse Event|1
4763495|NCT02631070|7737495|FG000|Overall Study|Withdrawal by Subject|35
4763496|NCT02631070|7737496|FG001|Overall Study|Withdrawal by Subject|13
4763497|NCT02631070|7737495|FG000|Overall Study|Death|45
4763498|NCT02631070|7737496|FG001|Overall Study|Death|24
4763499|NCT02631070|7737495|FG000|Overall Study|Lost to Follow-up|5
4763500|NCT02631070|7737496|FG001|Overall Study|Lost to Follow-up|1
4763501|NCT02631070|7737495|FG000|Overall Study|Transition to rollover protocol|52
4763502|NCT02631070|7737496|FG001|Overall Study|Transition to rollover protocol|21
4763503|NCT02631070|7737495|FG000|Overall Study|Other reasons|12
4763504|NCT02631070|7737496|FG001|Overall Study|Other reasons|5
4763505|NCT02513667|7737504|FG000|Overall Study|Withdrawal by Subject|0
4763506|NCT02513667|7737505|FG001|Overall Study|Withdrawal by Subject|1
4763507|NCT02281955|7737511|FG000|Overall Study|Death|1
4763508|NCT02202434|7737519|FG000|Overall Study|Death|70
4763509|NCT02202434|7737520|FG001|Overall Study|Death|39
4763510|NCT02202434|7737521|FG002|Overall Study|Death|13
4763511|NCT02202434|7737522|FG003|Overall Study|Death|27
4763512|NCT02202434|7737519|FG000|Overall Study|Lost to Follow-up|1
4763513|NCT02202434|7737520|FG001|Overall Study|Lost to Follow-up|1
4763514|NCT02202434|7737521|FG002|Overall Study|Lost to Follow-up|1
4763515|NCT02202434|7737522|FG003|Overall Study|Lost to Follow-up|0
4763516|NCT02202434|7737519|FG000|Overall Study|Physician Decision|2
4763517|NCT02202434|7737520|FG001|Overall Study|Physician Decision|3
4763518|NCT02202434|7737521|FG002|Overall Study|Physician Decision|0
4763519|NCT02202434|7737522|FG003|Overall Study|Physician Decision|0
4763520|NCT02202434|7737519|FG000|Overall Study|Withdrawal by Subject|13
4763521|NCT02202434|7737520|FG001|Overall Study|Withdrawal by Subject|14
4763522|NCT02202434|7737521|FG002|Overall Study|Withdrawal by Subject|1
4763523|NCT02202434|7737522|FG003|Overall Study|Withdrawal by Subject|4
4763524|NCT02202434|7737519|FG000|Overall Study|Completed Study|1
4763525|NCT02202434|7737520|FG001|Overall Study|Completed Study|0
4763526|NCT02202434|7737521|FG002|Overall Study|Completed Study|0
4763527|NCT02202434|7737522|FG003|Overall Study|Completed Study|0
4763528|NCT02202434|7737519|FG000|Overall Study|Visit Missed|21
4763529|NCT02202434|7737520|FG001|Overall Study|Visit Missed|12
4763530|NCT02202434|7737521|FG002|Overall Study|Visit Missed|0
4763531|NCT02202434|7737522|FG003|Overall Study|Visit Missed|5
4763532|NCT02202434|7737519|FG000|Overall Study|Other|1
4763533|NCT02202434|7737520|FG001|Overall Study|Other|0
4763534|NCT02202434|7737521|FG002|Overall Study|Other|0
4763535|NCT02202434|7737522|FG003|Overall Study|Other|1
4763536|NCT02097134|7737532|FG000|Overall Study|Physician Decision|4
4763537|NCT02097134|7737532|FG000|Overall Study|Non-Protocol Therapy|1
4763538|NCT02097134|7737532|FG000|Overall Study|Progressive Disease|3
4763539|NCT02097134|7737532|FG000|Overall Study|Refusal of Further Protocol Therapy|1
4763540|NCT01230242|7737541|FG000|Overall Study|Physician Decision|2
4763541|NCT01230242|7737541|FG000|Overall Study|Withdrawal by Subject|1
4763542|NCT00983437|7737545|FG000|Overall Study|Adverse Event|9
4763543|NCT00983437|7737545|FG000|Overall Study|Lack of Efficacy|1
4763544|NCT00983437|7737545|FG000|Overall Study|Withdrawal by Subject|8
4763545|NCT00983437|7737545|FG000|Overall Study|Noncompliance to Study Procedures|1
4763546|NCT00983437|7737545|FG000|Overall Study|Lost to Follow-up|2
4763547|NCT00983437|7737545|FG000|Overall Study|Other Reason|26
4763548|NCT00965757|7737551|FG000|Double-blind Phase|Progression of concomitant disease|1
4763549|NCT00965757|7737552|FG001|Double-blind Phase|Progression of concomitant disease|2
4763550|NCT00965757|7737553|FG002|Double-blind Phase|Progression of concomitant disease|0
4763551|NCT00965757|7737554|FG003|Double-blind Phase|Progression of concomitant disease|0
4763552|NCT00965757|7737551|FG000|Double-blind Phase|Adverse drug reaction|2
4763553|NCT00965757|7737552|FG001|Double-blind Phase|Adverse drug reaction|1
4763554|NCT00965757|7737553|FG002|Double-blind Phase|Adverse drug reaction|0
4763555|NCT00965757|7737554|FG003|Double-blind Phase|Adverse drug reaction|0
4763556|NCT00965757|7737551|FG000|Double-blind Phase|Abnormal Laboratory Value|2
4763557|NCT00965757|7737552|FG001|Double-blind Phase|Abnormal Laboratory Value|0
4763558|NCT00965757|7737553|FG002|Double-blind Phase|Abnormal Laboratory Value|0
4763559|NCT00965757|7737554|FG003|Double-blind Phase|Abnormal Laboratory Value|0
4763560|NCT00965757|7737551|FG000|Double-blind Phase|Lack of Efficacy|7
4763561|NCT00965757|7737552|FG001|Double-blind Phase|Lack of Efficacy|11
4763562|NCT00965757|7737553|FG002|Double-blind Phase|Lack of Efficacy|0
4763563|NCT00965757|7737554|FG003|Double-blind Phase|Lack of Efficacy|0
4763564|NCT00965757|7737551|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2
4763565|NCT00965757|7737552|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0
4763566|NCT00965757|7737553|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0
4763567|NCT00965757|7737554|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0
4763568|NCT00965757|7737551|FG000|Double-blind Phase|Lost to Follow-up|0
4763569|NCT00965757|7737552|FG001|Double-blind Phase|Lost to Follow-up|1
4763570|NCT00965757|7737553|FG002|Double-blind Phase|Lost to Follow-up|0
4763571|NCT00965757|7737554|FG003|Double-blind Phase|Lost to Follow-up|0
4763572|NCT00965757|7737551|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2
4763573|NCT00965757|7737552|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3
4763574|NCT00965757|7737553|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0
4763575|NCT00965757|7737554|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0
4763576|NCT00965757|7737551|FG000|Double-blind Phase|Other|1
4763577|NCT00965757|7737552|FG001|Double-blind Phase|Other|0
4763578|NCT00965757|7737553|FG002|Double-blind Phase|Other|0
4763579|NCT00965757|7737554|FG003|Double-blind Phase|Other|0
4763580|NCT00965757|7737551|FG000|Extension Phase|Progression of concomitant disease|0
4763581|NCT00965757|7737552|FG001|Extension Phase|Progression of concomitant disease|0
4763582|NCT00965757|7737553|FG002|Extension Phase|Progression of concomitant disease|4
4763583|NCT00965757|7737554|FG003|Extension Phase|Progression of concomitant disease|2
4763584|NCT00965757|7737551|FG000|Extension Phase|Adverse drug reaction|0
4763585|NCT00965757|7737552|FG001|Extension Phase|Adverse drug reaction|0
4763586|NCT00965757|7737553|FG002|Extension Phase|Adverse drug reaction|6
4763587|NCT00965757|7737554|FG003|Extension Phase|Adverse drug reaction|3
4763588|NCT00965757|7737551|FG000|Extension Phase|Abnormal Laboratory Value|0
4763589|NCT00965757|7737552|FG001|Extension Phase|Abnormal Laboratory Value|0
4763590|NCT00965757|7737553|FG002|Extension Phase|Abnormal Laboratory Value|6
4763591|NCT00965757|7737554|FG003|Extension Phase|Abnormal Laboratory Value|1
4763592|NCT00965757|7737551|FG000|Extension Phase|Lack of Efficacy|0
4763593|NCT00965757|7737552|FG001|Extension Phase|Lack of Efficacy|0
4763594|NCT00965757|7737553|FG002|Extension Phase|Lack of Efficacy|8
4763595|NCT00965757|7737554|FG003|Extension Phase|Lack of Efficacy|12
4763596|NCT00965757|7737551|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0
4763597|NCT00965757|7737552|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0
4763598|NCT00965757|7737553|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4
4763599|NCT00965757|7737554|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0
4763600|NCT00965757|7737551|FG000|Extension Phase|Lost to Follow-up|0
4763601|NCT00965757|7737552|FG001|Extension Phase|Lost to Follow-up|0
4763602|NCT00965757|7737553|FG002|Extension Phase|Lost to Follow-up|0
4763603|NCT00965757|7737554|FG003|Extension Phase|Lost to Follow-up|1
4763604|NCT00965757|7737551|FG000|Extension Phase|Ineligible after Taking Study Drug|0
4763605|NCT00965757|7737552|FG001|Extension Phase|Ineligible after Taking Study Drug|0
4763606|NCT00965757|7737553|FG002|Extension Phase|Ineligible after Taking Study Drug|3
4763607|NCT00965757|7737554|FG003|Extension Phase|Ineligible after Taking Study Drug|3
4763608|NCT00965757|7737551|FG000|Extension Phase|Protocol Violation|0
4763609|NCT00965757|7737552|FG001|Extension Phase|Protocol Violation|0
4763610|NCT00965757|7737553|FG002|Extension Phase|Protocol Violation|0
4763611|NCT00965757|7737554|FG003|Extension Phase|Protocol Violation|1
4763612|NCT00965757|7737551|FG000|Extension Phase|Other|0
4763613|NCT00965757|7737552|FG001|Extension Phase|Other|0
4763614|NCT00965757|7737553|FG002|Extension Phase|Other|2
4763615|NCT00965757|7737554|FG003|Extension Phase|Other|1
4763616|NCT00928447|7737562|FG000|Overall Study|Withdrawal by Subject|1
4763617|NCT00928447|7737562|FG000|Overall Study|Investigator's decision|1
4763618|NCT00893789|7737570|FG000|Overall Study|Withdrawal by Subject|3
4763619|NCT00893789|7737571|FG001|Overall Study|Withdrawal by Subject|1
4763620|NCT00893789|7737572|FG002|Overall Study|Withdrawal by Subject|3
4763621|NCT00893789|7737573|FG003|Overall Study|Withdrawal by Subject|1
4763622|NCT00893789|7737570|FG000|Overall Study|Noncompliance With Study Drug|1
4763623|NCT00893789|7737571|FG001|Overall Study|Noncompliance With Study Drug|0
4763624|NCT00893789|7737572|FG002|Overall Study|Noncompliance With Study Drug|1
4763625|NCT00893789|7737573|FG003|Overall Study|Noncompliance With Study Drug|2
4763626|NCT00893789|7737570|FG000|Overall Study|Noncompliance With Study Procedures|1
4763627|NCT00893789|7737571|FG001|Overall Study|Noncompliance With Study Procedures|0
4763628|NCT00893789|7737572|FG002|Overall Study|Noncompliance With Study Procedures|0
4763629|NCT00893789|7737573|FG003|Overall Study|Noncompliance With Study Procedures|0
4763630|NCT00893789|7737570|FG000|Overall Study|Taking Excluded Concomitant Medication|1
4763631|NCT00893789|7737571|FG001|Overall Study|Taking Excluded Concomitant Medication|0
4763632|NCT00893789|7737572|FG002|Overall Study|Taking Excluded Concomitant Medication|1
4763633|NCT00893789|7737573|FG003|Overall Study|Taking Excluded Concomitant Medication|0
4763634|NCT00893789|7737570|FG000|Overall Study|Adverse Event|0
4763635|NCT00893789|7737571|FG001|Overall Study|Adverse Event|2
4763636|NCT00893789|7737572|FG002|Overall Study|Adverse Event|1
4763637|NCT00893789|7737573|FG003|Overall Study|Adverse Event|5
4763638|NCT00893789|7737570|FG000|Overall Study|Protocol Violation|0
4763639|NCT00893789|7737571|FG001|Overall Study|Protocol Violation|1
4763640|NCT00893789|7737572|FG002|Overall Study|Protocol Violation|1
4763641|NCT00893789|7737573|FG003|Overall Study|Protocol Violation|4
4763642|NCT00893789|7737570|FG000|Overall Study|Lost to Follow-up|0
4763643|NCT00893789|7737571|FG001|Overall Study|Lost to Follow-up|0
4763644|NCT00893789|7737572|FG002|Overall Study|Lost to Follow-up|0
4763645|NCT00893789|7737573|FG003|Overall Study|Lost to Follow-up|1
4763646|NCT03901144|7737591|FG000|Overall Study|Lost to Follow-up|1
4763647|NCT03901144|7737592|FG001|Overall Study|Lost to Follow-up|1
4763648|NCT03901144|7737593|FG002|Overall Study|Lost to Follow-up|1
4763649|NCT03901144|7737594|FG003|Overall Study|Lost to Follow-up|1
4763734|NCT01721759|7737880|FG000|Overall Study|Disease progression|78
4763735|NCT01721759|7737880|FG000|Overall Study|Study drug toxicity|14
4763736|NCT01721759|7737880|FG000|Overall Study|Adverse event unrelated to study drug|9
4763737|NCT01721759|7737880|FG000|Overall Study|Withdrawal by Subject|1
4763738|NCT01285102|7737893|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4
4763650|NCT03461211|7737619|FG000|Overall Study|Adverse Event|1
4763651|NCT03461211|7737620|FG001|Overall Study|Adverse Event|1
4763652|NCT03461211|7737619|FG000|Overall Study|Lack of Efficacy|0
4763653|NCT03461211|7737620|FG001|Overall Study|Lack of Efficacy|1
4763654|NCT03282123|7737628|FG000|Overall Study|Withdrawal by Subject|5
4763655|NCT03276780|7737635|FG000|Overall Study|Withdrawal by Subject|5
4763656|NCT03276780|7737636|FG001|Overall Study|Withdrawal by Subject|3
4763657|NCT03276780|7737635|FG000|Overall Study|Lost to Follow-up|3
4763658|NCT03276780|7737636|FG001|Overall Study|Lost to Follow-up|5
4763659|NCT03276780|7737635|FG000|Overall Study|Moved out of state|1
4763660|NCT03276780|7737636|FG001|Overall Study|Moved out of state|1
4763661|NCT03276780|7737635|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1
4763662|NCT03276780|7737636|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0
4763663|NCT03276780|7737635|FG000|Overall Study|No show to appointments after baseline through Week 5|8
4763664|NCT03276780|7737636|FG001|Overall Study|No show to appointments after baseline through Week 5|1
4763665|NCT03050814|7737660|FG000|Overall Study|Screen failures|0
4763666|NCT03050814|7737661|FG001|Overall Study|Screen failures|0
4763667|NCT03050814|7737662|FG002|Overall Study|Screen failures|4
4763668|NCT02797262|7737670|FG000|Overall Study|Withdrawal by Subject|5
4763669|NCT02797262|7737671|FG001|Overall Study|Withdrawal by Subject|1
4763670|NCT02797262|7737670|FG000|Overall Study|Lost to Follow-up|10
4763671|NCT02797262|7737671|FG001|Overall Study|Lost to Follow-up|7
4763672|NCT02797262|7737670|FG000|Overall Study|Death|1
4763673|NCT02797262|7737671|FG001|Overall Study|Death|2
4763674|NCT02797262|7737670|FG000|Overall Study|Adverse Event|1
4763675|NCT02797262|7737671|FG001|Overall Study|Adverse Event|0
4763676|NCT02797262|7737670|FG000|Overall Study|COVID-19|2
4763677|NCT02797262|7737671|FG001|Overall Study|COVID-19|1
4763678|NCT02797262|7737670|FG000|Overall Study|Out-of-country|1
4763679|NCT02797262|7737671|FG001|Overall Study|Out-of-country|0
4763680|NCT02409368|7737689|FG000|Overall Study|Adverse event unrelated to study drug|16
4763681|NCT02409368|7737690|FG001|Overall Study|Adverse event unrelated to study drug|42
4763682|NCT02409368|7737691|FG002|Overall Study|Adverse event unrelated to study drug|10
4763683|NCT02409368|7737689|FG000|Overall Study|Death|5
4763684|NCT02409368|7737690|FG001|Overall Study|Death|17
4763685|NCT02409368|7737691|FG002|Overall Study|Death|5
4763686|NCT02409368|7737689|FG000|Overall Study|Disease Progression|101
4763687|NCT02409368|7737690|FG001|Overall Study|Disease Progression|346
4763688|NCT02409368|7737691|FG002|Overall Study|Disease Progression|63
4763689|NCT02409368|7737689|FG000|Overall Study|Lost to Follow-up|1
4763690|NCT02409368|7737690|FG001|Overall Study|Lost to Follow-up|5
4763691|NCT02409368|7737691|FG002|Overall Study|Lost to Follow-up|0
4763692|NCT02409368|7737689|FG000|Overall Study|maximum clinical benefit|3
4763693|NCT02409368|7737690|FG001|Overall Study|maximum clinical benefit|8
4763694|NCT02409368|7737691|FG002|Overall Study|maximum clinical benefit|1
4763695|NCT02409368|7737689|FG000|Overall Study|poor/non compliant|0
4763696|NCT02409368|7737690|FG001|Overall Study|poor/non compliant|2
4763697|NCT02409368|7737691|FG002|Overall Study|poor/non compliant|2
4763698|NCT02409368|7737689|FG000|Overall Study|study drug toxicity|12
4763699|NCT02409368|7737690|FG001|Overall Study|study drug toxicity|35
4763700|NCT02409368|7737691|FG002|Overall Study|study drug toxicity|6
4763701|NCT02409368|7737689|FG000|Overall Study|no longer meets study criteria|3
4763702|NCT02409368|7737690|FG001|Overall Study|no longer meets study criteria|9
4763703|NCT02409368|7737691|FG002|Overall Study|no longer meets study criteria|3
4763704|NCT02409368|7737689|FG000|Overall Study|Participant request to discontinue|3
4763705|NCT02409368|7737690|FG001|Overall Study|Participant request to discontinue|3
4763706|NCT02409368|7737691|FG002|Overall Study|Participant request to discontinue|3
4763707|NCT02409368|7737689|FG000|Overall Study|Participant withdrew consent|2
4763708|NCT02409368|7737690|FG001|Overall Study|Participant withdrew consent|4
4763709|NCT02409368|7737691|FG002|Overall Study|Participant withdrew consent|3
4763710|NCT02409368|7737689|FG000|Overall Study|Other Reasons|2
4763711|NCT02409368|7737690|FG001|Overall Study|Other Reasons|17
4763712|NCT02409368|7737691|FG002|Overall Study|Other Reasons|3
4763713|NCT02409368|7737689|FG000|Overall Study|Not Reported|0
4763714|NCT02409368|7737690|FG001|Overall Study|Not Reported|1
4763715|NCT02409368|7737691|FG002|Overall Study|Not Reported|0
4763716|NCT02277119|7737712|FG000|Overall Study|Lack of Efficacy|1
4763717|NCT02277119|7737713|FG001|Overall Study|Lack of Efficacy|1
4763718|NCT02277119|7737714|FG002|Overall Study|Lack of Efficacy|1
4763719|NCT02277119|7737712|FG000|Overall Study|Protocol Violation|2
4763720|NCT02277119|7737713|FG001|Overall Study|Protocol Violation|3
4763721|NCT02277119|7737714|FG002|Overall Study|Protocol Violation|7
4763722|NCT02220894|7737724|FG000|Overall Study|Adverse Event|118
4763723|NCT02220894|7737725|FG001|Overall Study|Adverse Event|70
4763724|NCT02220894|7737724|FG000|Overall Study|Death|252
4763725|NCT02220894|7737725|FG001|Overall Study|Death|368
4763726|NCT02220894|7737724|FG000|Overall Study|Lost to Follow-up|0
4763727|NCT02220894|7737725|FG001|Overall Study|Lost to Follow-up|2
4763728|NCT02220894|7737724|FG000|Overall Study|Withdrawal by Parent/Guardian|0
4763729|NCT02220894|7737725|FG001|Overall Study|Withdrawal by Parent/Guardian|1
4763730|NCT02220894|7737724|FG000|Overall Study|Withdrawal by Subject|2
4763731|NCT02220894|7737725|FG001|Overall Study|Withdrawal by Subject|13
4763732|NCT02220894|7737724|FG000|Overall Study|Ongoing in Study|265
4763733|NCT02220894|7737725|FG001|Overall Study|Ongoing in Study|183
4763739|NCT03877926|7737978|FG000|Overall Study|Adverse Event|1
4763740|NCT03877926|7737979|FG001|Overall Study|Adverse Event|0
4763741|NCT03877926|7737980|FG002|Overall Study|Adverse Event|0
4763742|NCT03877926|7737981|FG003|Overall Study|Adverse Event|0
4763743|NCT03877926|7737978|FG000|Overall Study|Death|2
4763744|NCT03877926|7737979|FG001|Overall Study|Death|2
4763745|NCT03877926|7737980|FG002|Overall Study|Death|2
4763746|NCT03877926|7737981|FG003|Overall Study|Death|0
4763747|NCT03877926|7737978|FG000|Overall Study|Lost to Follow-up|41
4763748|NCT03877926|7737979|FG001|Overall Study|Lost to Follow-up|52
4763749|NCT03877926|7737980|FG002|Overall Study|Lost to Follow-up|45
4763750|NCT03877926|7737981|FG003|Overall Study|Lost to Follow-up|17
4763751|NCT03877926|7737978|FG000|Overall Study|Physician Decision|2
4763752|NCT03877926|7737979|FG001|Overall Study|Physician Decision|0
4763753|NCT03877926|7737980|FG002|Overall Study|Physician Decision|2
4763754|NCT03877926|7737981|FG003|Overall Study|Physician Decision|0
4763755|NCT03877926|7737978|FG000|Overall Study|Withdrawal by Subject|18
4763756|NCT03877926|7737979|FG001|Overall Study|Withdrawal by Subject|21
4763757|NCT03877926|7737980|FG002|Overall Study|Withdrawal by Subject|12
4763758|NCT03877926|7737981|FG003|Overall Study|Withdrawal by Subject|4
4763759|NCT03877926|7737978|FG000|Overall Study|Other - Various|4
4763760|NCT03877926|7737979|FG001|Overall Study|Other - Various|1
4763761|NCT03877926|7737980|FG002|Overall Study|Other - Various|1
4763762|NCT03877926|7737981|FG003|Overall Study|Other - Various|0
4763763|NCT03877926|7737978|FG000|Overall Study|Not Treated|3
4763764|NCT03877926|7737979|FG001|Overall Study|Not Treated|1
4763765|NCT03877926|7737980|FG002|Overall Study|Not Treated|1
4763766|NCT03877926|7737981|FG003|Overall Study|Not Treated|0
4763767|NCT03862807|7738004|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1
4763768|NCT03857867|7738008|FG000|Overall Study|Physician Decision|1
4763769|NCT03691571|7738015|FG000|Overall Study|Withdrawal by Subject|9
4763770|NCT03691571|7738016|FG001|Overall Study|Withdrawal by Subject|2
4763771|NCT03436199|7738026|FG000|Overall Study|Adverse Event|15
4763772|NCT03436199|7738027|FG001|Overall Study|Adverse Event|40
4763773|NCT03436199|7738028|FG002|Overall Study|Adverse Event|7
4763774|NCT03436199|7738026|FG000|Overall Study|Withdrawal by Subject|4
4763775|NCT03436199|7738027|FG001|Overall Study|Withdrawal by Subject|10
4763776|NCT03436199|7738028|FG002|Overall Study|Withdrawal by Subject|3
4763777|NCT03436199|7738026|FG000|Overall Study|Lost to Follow-up|1
4763778|NCT03436199|7738027|FG001|Overall Study|Lost to Follow-up|0
4763779|NCT03436199|7738028|FG002|Overall Study|Lost to Follow-up|2
4763780|NCT03436199|7738026|FG000|Overall Study|Protocol Violation|1
4763781|NCT03436199|7738027|FG001|Overall Study|Protocol Violation|1
4763782|NCT03436199|7738028|FG002|Overall Study|Protocol Violation|0
4763783|NCT03436199|7738026|FG000|Overall Study|Physician Decision|0
4763784|NCT03436199|7738027|FG001|Overall Study|Physician Decision|1
4763785|NCT03436199|7738028|FG002|Overall Study|Physician Decision|0
4763786|NCT03436199|7738026|FG000|Overall Study|Could not return to clinic|1
4763787|NCT03436199|7738027|FG001|Overall Study|Could not return to clinic|0
4763788|NCT03436199|7738028|FG002|Overall Study|Could not return to clinic|0
4763789|NCT03436199|7738026|FG000|Overall Study|Withdrawn per physician|0
4763790|NCT03436199|7738027|FG001|Overall Study|Withdrawn per physician|1
4763791|NCT03436199|7738028|FG002|Overall Study|Withdrawn per physician|0
4763792|NCT03250273|7738047|FG000|Overall Study|Disease Progression|2
4763793|NCT03250273|7738048|FG001|Overall Study|Disease Progression|9
4763794|NCT03250273|7738047|FG000|Overall Study|Adverse Event|0
4763795|NCT03250273|7738048|FG001|Overall Study|Adverse Event|1
4763796|NCT03250273|7738047|FG000|Overall Study|Death|0
4763797|NCT03250273|7738048|FG001|Overall Study|Death|1
4763798|NCT03250273|7738047|FG000|Overall Study|Failed to Maintain Eligibility|0
4763799|NCT03250273|7738048|FG001|Overall Study|Failed to Maintain Eligibility|1
4763800|NCT03217136|7738056|FG000|Overall Study|Lost to Follow-up|2
4763801|NCT03217136|7738057|FG001|Overall Study|Lost to Follow-up|1
4763802|NCT03217136|7738056|FG000|Overall Study|Site Randomized Participant in Error|0
4763803|NCT03217136|7738057|FG001|Overall Study|Site Randomized Participant in Error|1
4763804|NCT03217136|7738056|FG000|Overall Study|Did Not Meet Criteria after Randomization|0
4763805|NCT03217136|7738057|FG001|Overall Study|Did Not Meet Criteria after Randomization|1
4763806|NCT03217136|7738056|FG000|Overall Study|Dispensing Error|1
4763807|NCT03217136|7738057|FG001|Overall Study|Dispensing Error|0
4763808|NCT03217136|7738056|FG000|Overall Study|Withdrawal by Parent/Guardian|1
4763809|NCT03217136|7738057|FG001|Overall Study|Withdrawal by Parent/Guardian|0
4763810|NCT03181542|7738065|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1
4763811|NCT03181542|7738066|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0
4763812|NCT02983617|7738074|FG000|Overall Study|Adverse Event|0
4763813|NCT02983617|7738075|FG001|Overall Study|Adverse Event|7
4763814|NCT02983617|7738074|FG000|Overall Study|Death|0
4763815|NCT02983617|7738075|FG001|Overall Study|Death|1
4763816|NCT02983617|7738074|FG000|Overall Study|Investigator's Discretion|0
4763817|NCT02983617|7738075|FG001|Overall Study|Investigator's Discretion|1
4763818|NCT02649946|7738109|FG000|Overall Study|Withdrawal by Subject|1
4763819|NCT02649946|7738110|FG001|Overall Study|Withdrawal by Subject|1
4763820|NCT02649946|7738109|FG000|Overall Study|Death|7
4763821|NCT02649946|7738110|FG001|Overall Study|Death|9
4763822|NCT02649946|7738109|FG000|Overall Study|Physician Decision|1
4763823|NCT02649946|7738110|FG001|Overall Study|Physician Decision|0
4763824|NCT02649946|7738109|FG000|Overall Study|Lost to Follow-up|2
4763825|NCT02649946|7738110|FG001|Overall Study|Lost to Follow-up|1
4763826|NCT02649946|7738109|FG000|Overall Study|Erroneously enrolled|1
4763827|NCT02649946|7738110|FG001|Overall Study|Erroneously enrolled|0
4763828|NCT02649946|7738109|FG000|Overall Study|Missed 6-month follow-up visit|0
4763829|NCT02649946|7738110|FG001|Overall Study|Missed 6-month follow-up visit|4
4763830|NCT02431247|7738118|FG000|BL to EOE-Test and BL to Switch- Control|Other|11
4763831|NCT02431247|7738119|FG001|BL to EOE-Test and BL to Switch- Control|Other|2
4763832|NCT02431247|7738120|FG002|BL to EOE-Test and BL to Switch- Control|Other|0
4763833|NCT02431247|7738118|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17
4763834|NCT02431247|7738119|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8
4763835|NCT02431247|7738120|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0
4763836|NCT02431247|7738118|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9
4763837|NCT02431247|7738119|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4
4763838|NCT02431247|7738120|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0
4763839|NCT02431247|7738118|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1
4763840|NCT02431247|7738119|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1
4763841|NCT02431247|7738120|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0
4763842|NCT02431247|7738118|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12
4763843|NCT02431247|7738119|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16
4763844|NCT02431247|7738120|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0
4763845|NCT02431247|7738118|FG000|BL to EOE-Test and BL to Switch- Control|Death|0
4763846|NCT02431247|7738119|FG001|BL to EOE-Test and BL to Switch- Control|Death|1
4763847|NCT02431247|7738120|FG002|BL to EOE-Test and BL to Switch- Control|Death|0
4763848|NCT02431247|7738118|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14
4763849|NCT02431247|7738119|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9
4763850|NCT02431247|7738120|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0
4763851|NCT02431247|7738118|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2
4763852|NCT02431247|7738119|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0
4763853|NCT02431247|7738120|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0
4763854|NCT02431247|7738118|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0
4763855|NCT02431247|7738119|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0
4763856|NCT02431247|7738120|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4
4763857|NCT02431247|7738118|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0
4763858|NCT02431247|7738119|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0
4763859|NCT02431247|7738120|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12
4763860|NCT02431247|7738118|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0
4763861|NCT02431247|7738119|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0
4763862|NCT02431247|7738120|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1
4763863|NCT02431247|7738118|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0
4763864|NCT02431247|7738119|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0
4763865|NCT02431247|7738120|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5
4763866|NCT02431247|7738118|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0
4763867|NCT02431247|7738119|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0
4763868|NCT02431247|7738120|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1
4763869|NCT02431247|7738118|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0
4763870|NCT02431247|7738119|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0
4763871|NCT02431247|7738120|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10
4763872|NCT02345850|7738135|FG000|Overall Study|Not transplanted|10
4763873|NCT02345850|7738136|FG001|Overall Study|Not transplanted|5
4763874|NCT02345850|7738137|FG002|Overall Study|Not transplanted|4
4763875|NCT02345850|7738135|FG000|Overall Study|Lost to Follow-up|2
4763876|NCT02345850|7738136|FG001|Overall Study|Lost to Follow-up|3
4763877|NCT02345850|7738137|FG002|Overall Study|Lost to Follow-up|2
4763878|NCT02345850|7738135|FG000|Overall Study|Withdrawal by Subject|1
4763879|NCT02345850|7738136|FG001|Overall Study|Withdrawal by Subject|0
4763880|NCT02345850|7738137|FG002|Overall Study|Withdrawal by Subject|0
4763881|NCT02343302|7738147|FG000|Overall Study|Physician Decision|1
4763882|NCT02343302|7738148|FG001|Overall Study|Physician Decision|1
4763883|NCT02281084|7738158|FG000|Overall Study|Adverse Event|1
4763884|NCT02281084|7738159|FG001|Overall Study|Adverse Event|0
4763885|NCT02281084|7738160|FG002|Overall Study|Adverse Event|0
4763886|NCT02281084|7738161|FG003|Overall Study|Adverse Event|0
4763887|NCT02281084|7738158|FG000|Overall Study|Withdrawal by Subject|1
4763888|NCT02281084|7738159|FG001|Overall Study|Withdrawal by Subject|2
4763889|NCT02281084|7738160|FG002|Overall Study|Withdrawal by Subject|0
4763890|NCT02281084|7738161|FG003|Overall Study|Withdrawal by Subject|0
4763891|NCT02281084|7738158|FG000|Overall Study|Death|20
4763892|NCT02281084|7738159|FG001|Overall Study|Death|16
4763893|NCT02281084|7738160|FG002|Overall Study|Death|3
4763894|NCT02281084|7738161|FG003|Overall Study|Death|5
4763895|NCT02281084|7738158|FG000|Overall Study|Physician Decision|0
4763896|NCT02281084|7738159|FG001|Overall Study|Physician Decision|0
4763897|NCT02281084|7738160|FG002|Overall Study|Physician Decision|1
4763898|NCT02281084|7738161|FG003|Overall Study|Physician Decision|0
4763899|NCT01464164|7738207|FG000|Overall Study|Screen failure|0
4763900|NCT01464164|7738208|FG001|Overall Study|Screen failure|1
4763901|NCT01464164|7738209|FG002|Overall Study|Screen failure|2
4763902|NCT01464164|7738210|FG003|Overall Study|Screen failure|0
4763903|NCT01464164|7738211|FG004|Overall Study|Screen failure|0
4763904|NCT01464164|7738212|FG005|Overall Study|Screen failure|0
4763905|NCT01464164|7738213|FG006|Overall Study|Screen failure|0
4763906|NCT01464164|7738207|FG000|Overall Study|Physician Decision|0
4763907|NCT01464164|7738208|FG001|Overall Study|Physician Decision|0
4763908|NCT01464164|7738209|FG002|Overall Study|Physician Decision|0
4763909|NCT01464164|7738210|FG003|Overall Study|Physician Decision|0
4763910|NCT01464164|7738211|FG004|Overall Study|Physician Decision|0
4763911|NCT01464164|7738212|FG005|Overall Study|Physician Decision|0
4763912|NCT01464164|7738213|FG006|Overall Study|Physician Decision|2
4763913|NCT01111565|7738243|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3
4763914|NCT01111565|7738244|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0
4763915|NCT01111565|7738245|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0
4763916|NCT01111565|7738246|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0
4763917|NCT01111565|7738247|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0
4763918|NCT01111565|7738243|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1
4763919|NCT01111565|7738244|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0
4763920|NCT01111565|7738245|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0
4763921|NCT01111565|7738246|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0
4763922|NCT01111565|7738247|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0
4763923|NCT01111565|7738243|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58
4763924|NCT01111565|7738244|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0
4763925|NCT01111565|7738245|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0
4763926|NCT01111565|7738246|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0
4763927|NCT01111565|7738247|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0
4763928|NCT01111565|7738243|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1
4763929|NCT01111565|7738244|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0
4763930|NCT01111565|7738245|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0
4763931|NCT01111565|7738246|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0
4763932|NCT01111565|7738247|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0
4763933|NCT01111565|7738243|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1
4763934|NCT01111565|7738244|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0
4763935|NCT01111565|7738245|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0
4763936|NCT01111565|7738246|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0
4763937|NCT01111565|7738247|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0
4763938|NCT01111565|7738243|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1
4763939|NCT01111565|7738244|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0
4763940|NCT01111565|7738245|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0
4763941|NCT01111565|7738246|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0
4763942|NCT01111565|7738247|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0
4763943|NCT01111565|7738243|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1
4763944|NCT01111565|7738244|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0
4763945|NCT01111565|7738245|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0
4763946|NCT01111565|7738246|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0
4763947|NCT01111565|7738247|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0
4763948|NCT01111565|7738243|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0
4763949|NCT01111565|7738244|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0
4763950|NCT01111565|7738245|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0
4763951|NCT01111565|7738246|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1
4763952|NCT01111565|7738247|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0
4763953|NCT01111565|7738243|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0
4763954|NCT01111565|7738244|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0
4763955|NCT01111565|7738245|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2
4763956|NCT01111565|7738246|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0
4763957|NCT01111565|7738247|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0
4763958|NCT01111565|7738243|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0
4763959|NCT01111565|7738244|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7
4763960|NCT01111565|7738245|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3
4763961|NCT01111565|7738246|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2
4763962|NCT01111565|7738247|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3
4763963|NCT01111565|7738243|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0
4763964|NCT01111565|7738244|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0
4763965|NCT01111565|7738245|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0
4763966|NCT01111565|7738246|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1
4763967|NCT01111565|7738247|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0
4763968|NCT01111565|7738243|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0
4763969|NCT01111565|7738244|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0
4763970|NCT01111565|7738245|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0
4763971|NCT01111565|7738246|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0
4763972|NCT01111565|7738247|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1
4763973|NCT01092117|7738257|FG000|Index Procedure to 1 Month|Death|1
4763974|NCT01092117|7738257|FG000|1 Month|Death|1
4763975|NCT01092117|7738257|FG000|1 Month|Withdrawal by Subject|1
4763976|NCT01092117|7738257|FG000|1 Month|Lost to Follow-up|1
4763977|NCT01092117|7738257|FG000|6 Months|Death|2
4763978|NCT01092117|7738257|FG000|6 Months|Withdrawal by Subject|3
4763979|NCT01092117|7738257|FG000|12 Month|Death|11
4763980|NCT01092117|7738257|FG000|12 Month|Withdrawal by Subject|2
4763981|NCT01092117|7738257|FG000|12 Month|Lost to Follow-up|1
4763982|NCT01092117|7738257|FG000|Year 2|Death|5
4763983|NCT01092117|7738257|FG000|Year 2|Withdrawal by Subject|4
4763984|NCT01092117|7738257|FG000|Year 2|Lost to Follow-up|1
4763985|NCT01092117|7738257|FG000|Year 3|Death|7
4763986|NCT01092117|7738257|FG000|Year 3|Withdrawal by Subject|9
4763987|NCT01092117|7738257|FG000|Year 3|Lost to Follow-up|3
4763988|NCT01092117|7738257|FG000|Year 4|Death|8
4763989|NCT01092117|7738257|FG000|Year 4|Withdrawal by Subject|4
4763990|NCT01092117|7738257|FG000|Year 4|Lost to Follow-up|4
4763991|NCT00950989|7738265|FG000|Overall Study|Death|0
4763992|NCT00950989|7738266|FG001|Overall Study|Death|0
4763993|NCT00950989|7738267|FG002|Overall Study|Death|1
4763994|NCT00950989|7738268|FG003|Overall Study|Death|0
4763995|NCT00950989|7738265|FG000|Overall Study|Administrative Decision|0
4763996|NCT00950989|7738266|FG001|Overall Study|Administrative Decision|1
4763997|NCT00950989|7738267|FG002|Overall Study|Administrative Decision|0
4763998|NCT00950989|7738268|FG003|Overall Study|Administrative Decision|0
4763999|NCT00950989|7738265|FG000|Overall Study|Disease Progression|0
4764000|NCT00950989|7738266|FG001|Overall Study|Disease Progression|0
4764001|NCT00950989|7738267|FG002|Overall Study|Disease Progression|1
4764002|NCT00950989|7738268|FG003|Overall Study|Disease Progression|0
4764003|NCT00950989|7738265|FG000|Overall Study|Withdrawal by Subject|2
4764004|NCT00950989|7738266|FG001|Overall Study|Withdrawal by Subject|1
4764005|NCT00950989|7738267|FG002|Overall Study|Withdrawal by Subject|0
4764006|NCT00950989|7738268|FG003|Overall Study|Withdrawal by Subject|0
4764007|NCT00950989|7738265|FG000|Overall Study|Adverse Event|2
4764008|NCT00950989|7738266|FG001|Overall Study|Adverse Event|1
4764009|NCT00950989|7738267|FG002|Overall Study|Adverse Event|1
4764010|NCT00950989|7738268|FG003|Overall Study|Adverse Event|0
4764011|NCT00489307|7738283|FG000|Overall Study|Death|1
4764012|NCT00489307|7738284|FG001|Overall Study|Death|1
4764013|NCT00489307|7738283|FG000|Overall Study|Lost to Follow-up|2
4764014|NCT00489307|7738284|FG001|Overall Study|Lost to Follow-up|2
4764015|NCT00489307|7738283|FG000|Overall Study|Physician Decision|1
4764016|NCT00489307|7738284|FG001|Overall Study|Physician Decision|0
4764017|NCT00489307|7738283|FG000|Overall Study|Withdrawal by Subject|2
4764018|NCT00489307|7738284|FG001|Overall Study|Withdrawal by Subject|4
4764019|NCT00489307|7738283|FG000|Overall Study|Hospitalization unrelated to treatment|10
4764020|NCT00489307|7738284|FG001|Overall Study|Hospitalization unrelated to treatment|7
4764021|NCT00489307|7738283|FG000|Overall Study|Surgery after assignment|1
4764022|NCT00489307|7738284|FG001|Overall Study|Surgery after assignment|0
4764023|NCT00489307|7738283|FG000|Overall Study|Did not fill up the forms|2
4764024|NCT00489307|7738284|FG001|Overall Study|Did not fill up the forms|1
4764025|NCT00489307|7738283|FG000|Overall Study|Patient or family refusal|5
4764026|NCT00489307|7738284|FG001|Overall Study|Patient or family refusal|9
4764027|NCT00072410|7738292|FG000|Overall Study|Progressive disease|0
4764028|NCT00072410|7738293|FG001|Overall Study|Progressive disease|3
4764029|NCT04498247|7738340|FG000|Overall Study|Lost to Follow-up|0
4764030|NCT04498247|7738341|FG001|Overall Study|Lost to Follow-up|0
4764031|NCT04498247|7738342|FG002|Overall Study|Lost to Follow-up|0
4764032|NCT04498247|7738343|FG003|Overall Study|Lost to Follow-up|1
4764033|NCT04498247|7738344|FG004|Overall Study|Lost to Follow-up|0
4764034|NCT04498247|7738345|FG005|Overall Study|Lost to Follow-up|0
4764035|NCT04498247|7738346|FG006|Overall Study|Lost to Follow-up|0
4764036|NCT04498247|7738347|FG007|Overall Study|Lost to Follow-up|0
4764037|NCT04498247|7738340|FG000|Overall Study|Mistakenly Randomized; Not Treated|1
4764038|NCT04498247|7738341|FG001|Overall Study|Mistakenly Randomized; Not Treated|0
4764039|NCT04498247|7738342|FG002|Overall Study|Mistakenly Randomized; Not Treated|0
4764040|NCT04498247|7738343|FG003|Overall Study|Mistakenly Randomized; Not Treated|0
4764041|NCT04498247|7738344|FG004|Overall Study|Mistakenly Randomized; Not Treated|0
4764042|NCT04498247|7738345|FG005|Overall Study|Mistakenly Randomized; Not Treated|0
4764043|NCT04498247|7738346|FG006|Overall Study|Mistakenly Randomized; Not Treated|0
4764044|NCT04498247|7738347|FG007|Overall Study|Mistakenly Randomized; Not Treated|0
4764045|NCT04498247|7738340|FG000|Overall Study|Withdrawal by Subject|0
4764046|NCT04498247|7738341|FG001|Overall Study|Withdrawal by Subject|8
4764047|NCT04498247|7738342|FG002|Overall Study|Withdrawal by Subject|0
4764048|NCT04498247|7738343|FG003|Overall Study|Withdrawal by Subject|7
4764049|NCT04498247|7738344|FG004|Overall Study|Withdrawal by Subject|0
4764050|NCT04498247|7738345|FG005|Overall Study|Withdrawal by Subject|0
4764051|NCT04498247|7738346|FG006|Overall Study|Withdrawal by Subject|1
4764052|NCT04498247|7738347|FG007|Overall Study|Withdrawal by Subject|0
4764053|NCT04498247|7738340|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0
4764054|NCT04498247|7738341|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4
4764055|NCT04498247|7738342|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0
4764056|NCT04498247|7738343|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3
4764057|NCT04498247|7738344|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0
4764058|NCT04498247|7738345|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0
4764059|NCT04498247|7738346|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7
4764060|NCT04498247|7738347|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0
4764061|NCT04472650|7738364|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1
4764062|NCT04472650|7738365|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0
4764063|NCT04151290|7738382|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286
4764064|NCT04038385|7738388|FG000|Overall Study|Completed baseline assessment only|7
4764065|NCT04038385|7738389|FG001|Overall Study|Completed baseline assessment only|4
4764066|NCT04038385|7738388|FG000|Overall Study|Moved out of area|4
4764067|NCT04038385|7738389|FG001|Overall Study|Moved out of area|2
4764068|NCT04038385|7738388|FG000|Overall Study|Discontinued study involvement|6
4764069|NCT04038385|7738389|FG001|Overall Study|Discontinued study involvement|1
4764070|NCT03978091|7738401|FG000|Overall Study|Lost to Follow-up|0
4764071|NCT03978091|7738402|FG001|Overall Study|Lost to Follow-up|0
4764072|NCT03978091|7738403|FG002|Overall Study|Lost to Follow-up|1
4764073|NCT03978091|7738404|FG003|Overall Study|Lost to Follow-up|0
4764074|NCT03978091|7738405|FG004|Overall Study|Lost to Follow-up|0
4764075|NCT03978091|7738406|FG005|Overall Study|Lost to Follow-up|0
4764076|NCT03978091|7738401|FG000|Overall Study|Withdrawal by Subject|0
4764077|NCT03978091|7738402|FG001|Overall Study|Withdrawal by Subject|0
4764078|NCT03978091|7738403|FG002|Overall Study|Withdrawal by Subject|0
4764079|NCT03978091|7738404|FG003|Overall Study|Withdrawal by Subject|1
4764080|NCT03978091|7738405|FG004|Overall Study|Withdrawal by Subject|1
4764081|NCT03978091|7738406|FG005|Overall Study|Withdrawal by Subject|0
4764082|NCT03923738|7738420|FG000|Period 1|Adverse Event|1
4764083|NCT03923738|7738420|FG000|Period 1|Withdrawal by Subject|1
4764084|NCT03887117|7738430|FG000|Overall Study|Discontinued prematurely|0
4764085|NCT03887117|7738431|FG001|Overall Study|Discontinued prematurely|1
4764086|NCT03887117|7738432|FG002|Overall Study|Discontinued prematurely|1
4764087|NCT03887117|7738433|FG003|Overall Study|Discontinued prematurely|2
4764088|NCT03858634|7738454|FG000|Overall Study|Withdrawal by Subject|1
4764089|NCT03858634|7738455|FG001|Overall Study|Withdrawal by Subject|0
4764090|NCT03858634|7738454|FG000|Overall Study|Adverse Event|1
4764091|NCT03858634|7738455|FG001|Overall Study|Adverse Event|0
4764092|NCT03858634|7738454|FG000|Overall Study|Lost to Follow-up|0
4764093|NCT03858634|7738455|FG001|Overall Study|Lost to Follow-up|1
4764094|NCT03858634|7738454|FG000|Overall Study|Other, Not Specified|1
4764095|NCT03858634|7738455|FG001|Overall Study|Other, Not Specified|1
4764096|NCT03819114|7738473|FG000|Overall Study|Protocol Violation|0
4764097|NCT03819114|7738474|FG001|Overall Study|Protocol Violation|1
4764098|NCT03819114|7738475|FG002|Overall Study|Protocol Violation|1
4764099|NCT03819114|7738476|FG003|Overall Study|Protocol Violation|0
4764100|NCT03819114|7738473|FG000|Overall Study|Lost to Follow-up|0
4764101|NCT03819114|7738474|FG001|Overall Study|Lost to Follow-up|0
4764102|NCT03819114|7738475|FG002|Overall Study|Lost to Follow-up|1
4764103|NCT03819114|7738476|FG003|Overall Study|Lost to Follow-up|0
4764104|NCT03804268|7738490|FG000|Overall Study|Adverse Event|2
4764105|NCT03804268|7738491|FG001|Overall Study|Adverse Event|2
4764106|NCT03804268|7738490|FG000|Overall Study|Withdrawal by Subject|2
4764107|NCT03804268|7738491|FG001|Overall Study|Withdrawal by Subject|0
4764108|NCT03804268|7738490|FG000|Overall Study|Lost to Follow-up|1
4764109|NCT03804268|7738491|FG001|Overall Study|Lost to Follow-up|0
4764110|NCT03804268|7738490|FG000|Overall Study|Physician Decision|2
4764111|NCT03804268|7738491|FG001|Overall Study|Physician Decision|0
4764112|NCT04435808|7738500|FG000|Overall Study|Study stopped by DSMB|0
4764113|NCT04435808|7738501|FG001|Overall Study|Study stopped by DSMB|1
4764114|NCT04409262|7738509|FG000|Overall Study|Adverse Event|0
4764115|NCT04409262|7738510|FG001|Overall Study|Adverse Event|2
4764116|NCT04409262|7738509|FG000|Overall Study|Death|55
4764117|NCT04409262|7738510|FG001|Overall Study|Death|97
4764118|NCT04409262|7738509|FG000|Overall Study|Lost to Follow-up|12
4764119|NCT04409262|7738510|FG001|Overall Study|Lost to Follow-up|23
4764120|NCT04409262|7738509|FG000|Overall Study|Lack of Staff|0
4764121|NCT04409262|7738510|FG001|Overall Study|Lack of Staff|1
4764122|NCT04409262|7738509|FG000|Overall Study|Protocol Violation|3
4764123|NCT04409262|7738510|FG001|Overall Study|Protocol Violation|1
4764124|NCT04409262|7738509|FG000|Overall Study|Withdrawal by Subject|5
4764125|NCT04409262|7738510|FG001|Overall Study|Withdrawal by Subject|10
4764126|NCT04305912|7738519|FG000|First Intervention|COVID-19 Suspension|2
4764127|NCT04305912|7738520|FG001|First Intervention|COVID-19 Suspension|0
4764128|NCT04305912|7738519|FG000|First Intervention|Withdrawal by Subject|0
4764129|NCT04305912|7738520|FG001|First Intervention|Withdrawal by Subject|1
4764130|NCT04305912|7738519|FG000|Second Intervention|Adverse Event|0
4764131|NCT04305912|7738520|FG001|Second Intervention|Adverse Event|1
4764132|NCT03987919|7738539|FG000|Overall Study|Adverse Event|1
4764133|NCT03987919|7738540|FG001|Overall Study|Adverse Event|4
4764134|NCT03987919|7738541|FG002|Overall Study|Adverse Event|1
4764135|NCT03987919|7738542|FG003|Overall Study|Adverse Event|3
4764136|NCT03987919|7738539|FG000|Overall Study|Death|4
4764137|NCT03987919|7738540|FG001|Overall Study|Death|4
4764138|NCT03987919|7738541|FG002|Overall Study|Death|4
4764139|NCT03987919|7738542|FG003|Overall Study|Death|1
4764140|NCT03987919|7738539|FG000|Overall Study|Lost to Follow-up|5
4764141|NCT03987919|7738540|FG001|Overall Study|Lost to Follow-up|6
4764142|NCT03987919|7738541|FG002|Overall Study|Lost to Follow-up|8
4764143|NCT03987919|7738542|FG003|Overall Study|Lost to Follow-up|12
4764144|NCT03987919|7738539|FG000|Overall Study|Physician Decision|0
4764145|NCT03987919|7738540|FG001|Overall Study|Physician Decision|2
4764146|NCT03987919|7738541|FG002|Overall Study|Physician Decision|0
4764147|NCT03987919|7738542|FG003|Overall Study|Physician Decision|4
4764148|NCT03987919|7738539|FG000|Overall Study|Pregnancy|1
4764149|NCT03987919|7738540|FG001|Overall Study|Pregnancy|0
4764150|NCT03987919|7738541|FG002|Overall Study|Pregnancy|1
4764151|NCT03987919|7738542|FG003|Overall Study|Pregnancy|1
4764152|NCT03987919|7738539|FG000|Overall Study|Protocol Violation|0
4764153|NCT03987919|7738540|FG001|Overall Study|Protocol Violation|1
4764154|NCT03987919|7738541|FG002|Overall Study|Protocol Violation|0
4764155|NCT03987919|7738542|FG003|Overall Study|Protocol Violation|0
4764156|NCT03987919|7738539|FG000|Overall Study|Site terminated by Sponsor|0
4764157|NCT03987919|7738540|FG001|Overall Study|Site terminated by Sponsor|0
4764158|NCT03987919|7738541|FG002|Overall Study|Site terminated by Sponsor|0
4764159|NCT03987919|7738542|FG003|Overall Study|Site terminated by Sponsor|1
4764160|NCT03987919|7738539|FG000|Overall Study|Withdrawal by Subject|7
4764161|NCT03987919|7738540|FG001|Overall Study|Withdrawal by Subject|7
4764162|NCT03987919|7738541|FG002|Overall Study|Withdrawal by Subject|8
4764163|NCT03987919|7738542|FG003|Overall Study|Withdrawal by Subject|4
4764164|NCT03987919|7738539|FG000|Overall Study|Other - as reported by the investigator|1
4764165|NCT03987919|7738540|FG001|Overall Study|Other - as reported by the investigator|3
4764166|NCT03987919|7738541|FG002|Overall Study|Other - as reported by the investigator|2
4764167|NCT03987919|7738542|FG003|Overall Study|Other - as reported by the investigator|0
4764168|NCT03861039|7738571|FG000|Overall Study|Adverse Event|2
4764169|NCT03861039|7738572|FG001|Overall Study|Adverse Event|5
4764170|NCT03861039|7738573|FG002|Overall Study|Adverse Event|11
4764171|NCT03861039|7738571|FG000|Overall Study|Withdrawal by Subject|1
4764172|NCT03861039|7738572|FG001|Overall Study|Withdrawal by Subject|3
4764173|NCT03861039|7738573|FG002|Overall Study|Withdrawal by Subject|4
4764174|NCT03759587|7738583|FG000|Overall Study|Ongoing|19
4764175|NCT03730662|7738591|FG000|Treatment Period (52 Weeks)|Adverse Event|3
4764176|NCT03730662|7738592|FG001|Treatment Period (52 Weeks)|Adverse Event|2
4764177|NCT03730662|7738593|FG002|Treatment Period (52 Weeks)|Adverse Event|0
4764178|NCT03730662|7738594|FG003|Treatment Period (52 Weeks)|Adverse Event|3
4764179|NCT03730662|7738591|FG000|Treatment Period (52 Weeks)|Screen Failure|0
4764180|NCT03730662|7738592|FG001|Treatment Period (52 Weeks)|Screen Failure|1
4764181|NCT03730662|7738593|FG002|Treatment Period (52 Weeks)|Screen Failure|0
4764182|NCT03730662|7738594|FG003|Treatment Period (52 Weeks)|Screen Failure|0
4764183|NCT03730662|7738591|FG000|Treatment Period (52 Weeks)|Death|6
4764184|NCT03730662|7738592|FG001|Treatment Period (52 Weeks)|Death|2
4764185|NCT03730662|7738593|FG002|Treatment Period (52 Weeks)|Death|2
4764186|NCT03730662|7738594|FG003|Treatment Period (52 Weeks)|Death|9
4764187|NCT03730662|7738591|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4
4764188|NCT03730662|7738592|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2
4764189|NCT03730662|7738593|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2
4764190|NCT03730662|7738594|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11
4764191|NCT03730662|7738591|FG000|Treatment Period (52 Weeks)|Physician Decision|1
4764192|NCT03730662|7738592|FG001|Treatment Period (52 Weeks)|Physician Decision|1
4764193|NCT03730662|7738593|FG002|Treatment Period (52 Weeks)|Physician Decision|0
4764194|NCT03730662|7738594|FG003|Treatment Period (52 Weeks)|Physician Decision|3
4764195|NCT03730662|7738591|FG000|Treatment Period (52 Weeks)|Protocol Violation|0
4764196|NCT03730662|7738592|FG001|Treatment Period (52 Weeks)|Protocol Violation|1
4764197|NCT03730662|7738593|FG002|Treatment Period (52 Weeks)|Protocol Violation|0
4764198|NCT03730662|7738594|FG003|Treatment Period (52 Weeks)|Protocol Violation|1
4764199|NCT03730662|7738591|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5
4764200|NCT03730662|7738592|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0
4764201|NCT03730662|7738593|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5
4764202|NCT03730662|7738594|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23
4764203|NCT03730662|7738591|FG000|Treatment Period (52 Weeks)|Personal Reason|2
4764204|NCT03730662|7738592|FG001|Treatment Period (52 Weeks)|Personal Reason|2
4764205|NCT03730662|7738593|FG002|Treatment Period (52 Weeks)|Personal Reason|0
4764206|NCT03730662|7738594|FG003|Treatment Period (52 Weeks)|Personal Reason|2
4764207|NCT03730662|7738591|FG000|Variable Treatment Period|Adverse Event|1
4764208|NCT03730662|7738592|FG001|Variable Treatment Period|Adverse Event|2
4764209|NCT03730662|7738593|FG002|Variable Treatment Period|Adverse Event|0
4764210|NCT03730662|7738594|FG003|Variable Treatment Period|Adverse Event|7
4764211|NCT03730662|7738591|FG000|Variable Treatment Period|Death|9
4764212|NCT03730662|7738592|FG001|Variable Treatment Period|Death|0
4764213|NCT03730662|7738593|FG002|Variable Treatment Period|Death|6
4764214|NCT03730662|7738594|FG003|Variable Treatment Period|Death|26
4764215|NCT03730662|7738591|FG000|Variable Treatment Period|Lost to Follow-up|2
4764216|NCT03730662|7738592|FG001|Variable Treatment Period|Lost to Follow-up|1
4764217|NCT03730662|7738593|FG002|Variable Treatment Period|Lost to Follow-up|4
4764218|NCT03730662|7738594|FG003|Variable Treatment Period|Lost to Follow-up|11
4764219|NCT03730662|7738591|FG000|Variable Treatment Period|Personal Reason|0
4764220|NCT03730662|7738592|FG001|Variable Treatment Period|Personal Reason|2
4764221|NCT03730662|7738593|FG002|Variable Treatment Period|Personal Reason|1
4764222|NCT03730662|7738594|FG003|Variable Treatment Period|Personal Reason|6
4764223|NCT03730662|7738591|FG000|Variable Treatment Period|Physician Decision|0
4764224|NCT03730662|7738592|FG001|Variable Treatment Period|Physician Decision|0
4764225|NCT03730662|7738593|FG002|Variable Treatment Period|Physician Decision|0
4764226|NCT03730662|7738594|FG003|Variable Treatment Period|Physician Decision|3
4764227|NCT03730662|7738591|FG000|Variable Treatment Period|Protocol Violation|0
4764228|NCT03730662|7738592|FG001|Variable Treatment Period|Protocol Violation|1
4764229|NCT03730662|7738593|FG002|Variable Treatment Period|Protocol Violation|1
4764230|NCT03730662|7738594|FG003|Variable Treatment Period|Protocol Violation|1
4764231|NCT03730662|7738591|FG000|Variable Treatment Period|Withdrawal by Subject|2
4764232|NCT03730662|7738592|FG001|Variable Treatment Period|Withdrawal by Subject|1
4764233|NCT03730662|7738593|FG002|Variable Treatment Period|Withdrawal by Subject|4
4764234|NCT03730662|7738594|FG003|Variable Treatment Period|Withdrawal by Subject|17
4764235|NCT03538444|7738610|FG000|Overall Study|opioid withdrawal|1
4764236|NCT03538444|7738611|FG001|Overall Study|opioid withdrawal|0
4764237|NCT03410693|7738619|FG000|Overall Study|Disc trt: Withdrawal by participant|6
4764238|NCT03410693|7738620|FG001|Overall Study|Disc trt: Withdrawal by participant|4
4764239|NCT03410693|7738619|FG000|Overall Study|Disc trt: Lost to follow up|0
4764240|NCT03410693|7738620|FG001|Overall Study|Disc trt: Lost to follow up|1
4764241|NCT03410693|7738619|FG000|Overall Study|Disc trt: radiological progression|58
4764242|NCT03410693|7738620|FG001|Overall Study|Disc trt: radiological progression|50
4764243|NCT03410693|7738619|FG000|Overall Study|Disc trt: Other|1
4764244|NCT03410693|7738620|FG001|Overall Study|Disc trt: Other|0
4764245|NCT03410693|7738619|FG000|Overall Study|Study drug never administered|1
4764246|NCT03410693|7738620|FG001|Overall Study|Study drug never administered|6
4764247|NCT03410693|7738619|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6
4764248|NCT03410693|7738620|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4
4764249|NCT03410693|7738619|FG000|Overall Study|Disc trt: Adverse Event (AE)|13
4764250|NCT03410693|7738620|FG001|Overall Study|Disc trt: Adverse Event (AE)|9
4764251|NCT03410693|7738619|FG000|Overall Study|Disc trt: Physician decision|0
4764252|NCT03410693|7738620|FG001|Overall Study|Disc trt: Physician decision|5
4764253|NCT03410693|7738619|FG000|Overall Study|Disc trt: clinical progression|1
4764254|NCT03410693|7738620|FG001|Overall Study|Disc trt: clinical progression|5
4764255|NCT03410693|7738619|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1
4764256|NCT03410693|7738620|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4
4764257|NCT03252925|7738647|FG000|Overall Study|Withdrawal by Subject|1
4764258|NCT03252925|7738648|FG001|Overall Study|Withdrawal by Subject|0
4764259|NCT03252925|7738647|FG000|Overall Study|Protocol Violation|6
4764260|NCT03252925|7738648|FG001|Overall Study|Protocol Violation|0
4764261|NCT03252925|7738647|FG000|Overall Study|Adverse Event|1
4764262|NCT03252925|7738648|FG001|Overall Study|Adverse Event|0
4764263|NCT03252925|7738647|FG000|Overall Study|Lost to Follow-up|6
4764264|NCT03252925|7738648|FG001|Overall Study|Lost to Follow-up|6
4764265|NCT03185832|7738658|FG000|Overall Study|Death|9
4764266|NCT03185832|7738659|FG001|Overall Study|Death|14
4764267|NCT03185832|7738660|FG002|Overall Study|Death|9
4764268|NCT03185832|7738661|FG003|Overall Study|Death|7
4764269|NCT03185832|7738658|FG000|Overall Study|Withdrawn - vital status available|0
4764270|NCT03185832|7738659|FG001|Overall Study|Withdrawn - vital status available|1
4764271|NCT03185832|7738660|FG002|Overall Study|Withdrawn - vital status available|1
4764272|NCT03185832|7738661|FG003|Overall Study|Withdrawn - vital status available|4
4764273|NCT02959918|7738692|FG000|Overall Study|Adverse Event|1
4764274|NCT02959918|7738693|FG001|Overall Study|Adverse Event|1
4764275|NCT02959918|7738694|FG002|Overall Study|Adverse Event|2
4764276|NCT02959918|7738695|FG003|Overall Study|Adverse Event|0
4764277|NCT02959918|7738696|FG004|Overall Study|Adverse Event|0
4764278|NCT02959918|7738697|FG005|Overall Study|Adverse Event|2
4764279|NCT02959918|7738698|FG006|Overall Study|Adverse Event|2
4764280|NCT02959918|7738699|FG007|Overall Study|Adverse Event|1
4764281|NCT02959918|7738700|FG008|Overall Study|Adverse Event|2
4764282|NCT02959918|7738701|FG009|Overall Study|Adverse Event|1
4764283|NCT02959918|7738702|FG010|Overall Study|Adverse Event|1
4764284|NCT02959918|7738703|FG011|Overall Study|Adverse Event|3
4764285|NCT02959918|7738704|FG012|Overall Study|Adverse Event|2
4764286|NCT02959918|7738705|FG013|Overall Study|Adverse Event|4
4764287|NCT02959918|7738692|FG000|Overall Study|Lost to Follow-up|0
4764288|NCT02959918|7738693|FG001|Overall Study|Lost to Follow-up|0
4764289|NCT02959918|7738694|FG002|Overall Study|Lost to Follow-up|0
4764290|NCT02959918|7738695|FG003|Overall Study|Lost to Follow-up|0
4764291|NCT02959918|7738696|FG004|Overall Study|Lost to Follow-up|0
4764292|NCT02959918|7738697|FG005|Overall Study|Lost to Follow-up|0
4764293|NCT02959918|7738698|FG006|Overall Study|Lost to Follow-up|0
4764294|NCT02959918|7738699|FG007|Overall Study|Lost to Follow-up|0
4764295|NCT02959918|7738700|FG008|Overall Study|Lost to Follow-up|0
4764296|NCT02959918|7738701|FG009|Overall Study|Lost to Follow-up|1
4764297|NCT02959918|7738702|FG010|Overall Study|Lost to Follow-up|0
4764298|NCT02959918|7738703|FG011|Overall Study|Lost to Follow-up|0
4764299|NCT02959918|7738704|FG012|Overall Study|Lost to Follow-up|1
4764300|NCT02959918|7738705|FG013|Overall Study|Lost to Follow-up|0
4764301|NCT02959918|7738692|FG000|Overall Study|Withdrawal by Subject|0
4764302|NCT02959918|7738693|FG001|Overall Study|Withdrawal by Subject|0
4764303|NCT02959918|7738694|FG002|Overall Study|Withdrawal by Subject|1
4764304|NCT02959918|7738695|FG003|Overall Study|Withdrawal by Subject|2
4764305|NCT02959918|7738696|FG004|Overall Study|Withdrawal by Subject|0
4764306|NCT02959918|7738697|FG005|Overall Study|Withdrawal by Subject|0
4764307|NCT02959918|7738698|FG006|Overall Study|Withdrawal by Subject|1
4764308|NCT02959918|7738699|FG007|Overall Study|Withdrawal by Subject|0
4764309|NCT02959918|7738700|FG008|Overall Study|Withdrawal by Subject|1
4764310|NCT02959918|7738701|FG009|Overall Study|Withdrawal by Subject|1
4764311|NCT02959918|7738702|FG010|Overall Study|Withdrawal by Subject|2
4764312|NCT02959918|7738703|FG011|Overall Study|Withdrawal by Subject|3
4764313|NCT02959918|7738704|FG012|Overall Study|Withdrawal by Subject|1
4764314|NCT02959918|7738705|FG013|Overall Study|Withdrawal by Subject|1
4764315|NCT02959918|7738692|FG000|Overall Study|Protocol Violation|0
4764316|NCT02959918|7738693|FG001|Overall Study|Protocol Violation|0
4764317|NCT02959918|7738694|FG002|Overall Study|Protocol Violation|1
4764318|NCT02959918|7738695|FG003|Overall Study|Protocol Violation|0
4764319|NCT02959918|7738696|FG004|Overall Study|Protocol Violation|0
4764320|NCT02959918|7738697|FG005|Overall Study|Protocol Violation|1
4764321|NCT02959918|7738698|FG006|Overall Study|Protocol Violation|0
4764322|NCT02959918|7738699|FG007|Overall Study|Protocol Violation|0
4764323|NCT02959918|7738700|FG008|Overall Study|Protocol Violation|2
4764324|NCT02959918|7738701|FG009|Overall Study|Protocol Violation|1
4764325|NCT02959918|7738702|FG010|Overall Study|Protocol Violation|0
4764326|NCT02959918|7738703|FG011|Overall Study|Protocol Violation|1
4764327|NCT02959918|7738704|FG012|Overall Study|Protocol Violation|1
4764328|NCT02959918|7738705|FG013|Overall Study|Protocol Violation|0
4764329|NCT02959918|7738692|FG000|Overall Study|Stopping Rule Met|1
4764330|NCT02959918|7738693|FG001|Overall Study|Stopping Rule Met|0
4764331|NCT02959918|7738694|FG002|Overall Study|Stopping Rule Met|3
4764332|NCT02959918|7738695|FG003|Overall Study|Stopping Rule Met|4
4764333|NCT02959918|7738696|FG004|Overall Study|Stopping Rule Met|5
4764334|NCT02959918|7738697|FG005|Overall Study|Stopping Rule Met|3
4764335|NCT02959918|7738698|FG006|Overall Study|Stopping Rule Met|2
4764336|NCT02959918|7738699|FG007|Overall Study|Stopping Rule Met|4
4764337|NCT02959918|7738700|FG008|Overall Study|Stopping Rule Met|1
4764338|NCT02959918|7738701|FG009|Overall Study|Stopping Rule Met|1
4764339|NCT02959918|7738702|FG010|Overall Study|Stopping Rule Met|3
4764340|NCT02959918|7738703|FG011|Overall Study|Stopping Rule Met|5
4764341|NCT02959918|7738704|FG012|Overall Study|Stopping Rule Met|2
4764342|NCT02959918|7738705|FG013|Overall Study|Stopping Rule Met|1
4764343|NCT02959918|7738692|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1
4764344|NCT02959918|7738693|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2
4764345|NCT02959918|7738694|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1
4764346|NCT02959918|7738695|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3
4764347|NCT02959918|7738696|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0
4764348|NCT02959918|7738697|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0
4764349|NCT02959918|7738698|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0
4764350|NCT02959918|7738699|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0
4764351|NCT02959918|7738700|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0
4764352|NCT02959918|7738701|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0
4764353|NCT02959918|7738702|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0
4764354|NCT02959918|7738703|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0
4764355|NCT02959918|7738704|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0
4764356|NCT02959918|7738705|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0
4764357|NCT02959918|7738692|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0
4764358|NCT02959918|7738693|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0
4764359|NCT02959918|7738694|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0
4764360|NCT02959918|7738695|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0
4764361|NCT02959918|7738696|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0
4764362|NCT02959918|7738697|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0
4764363|NCT02959918|7738698|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0
4764364|NCT02959918|7738699|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1
4764365|NCT02959918|7738700|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0
4764366|NCT02959918|7738701|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0
4764367|NCT02959918|7738702|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0
4764368|NCT02959918|7738703|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0
4764369|NCT02959918|7738704|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0
4764370|NCT02959918|7738705|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0
4764371|NCT02959918|7738692|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0
4764372|NCT02959918|7738693|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0
4764373|NCT02959918|7738694|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0
4764374|NCT02959918|7738695|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0
4764375|NCT02959918|7738696|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0
4764376|NCT02959918|7738697|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0
4764377|NCT02959918|7738698|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0
4764378|NCT02959918|7738699|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0
4764379|NCT02959918|7738700|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1
4764380|NCT02959918|7738701|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0
4764381|NCT02959918|7738702|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0
4764382|NCT02959918|7738703|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0
4764383|NCT02959918|7738704|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0
4764384|NCT02959918|7738705|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0
4764385|NCT02959918|7738692|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
4764386|NCT02959918|7738693|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
4764387|NCT02959918|7738694|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
4764388|NCT02959918|7738695|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
4764389|NCT02959918|7738696|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
4764390|NCT02959918|7738697|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
4764391|NCT02959918|7738698|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
4764392|NCT02959918|7738699|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
4764393|NCT02959918|7738700|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
4764394|NCT02959918|7738701|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1
4764395|NCT02959918|7738702|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
4764396|NCT02959918|7738703|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
4764397|NCT02959918|7738704|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
4764398|NCT02959918|7738705|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0
4764399|NCT02485691|7738740|FG000|Overall Study|Adverse Event|25
4764400|NCT02485691|7738741|FG001|Overall Study|Adverse Event|11
4764401|NCT02485691|7738740|FG000|Overall Study|Poor compliance to protocol|0
4764402|NCT02485691|7738741|FG001|Overall Study|Poor compliance to protocol|1
4764403|NCT02485691|7738740|FG000|Overall Study|Disease progression|57
4764404|NCT02485691|7738741|FG001|Overall Study|Disease progression|92
4764405|NCT02485691|7738740|FG000|Overall Study|Investigator's decision|23
4764406|NCT02485691|7738741|FG001|Overall Study|Investigator's decision|5
4764407|NCT02485691|7738740|FG000|Overall Study|Participant's request|13
4764408|NCT02485691|7738741|FG001|Overall Study|Participant's request|6
4764409|NCT02485691|7738740|FG000|Overall Study|Other reason|8
4764410|NCT02485691|7738741|FG001|Overall Study|Other reason|9
4764411|NCT02485691|7738740|FG000|Overall Study|Randomized and not treated|3
4764412|NCT02485691|7738741|FG001|Overall Study|Randomized and not treated|2
4764413|NCT02472964|7738750|FG000|Part 1 (up to Week 24)|Adverse Event|2
4764414|NCT02472964|7738751|FG001|Part 1 (up to Week 24)|Adverse Event|4
4764415|NCT02472964|7738750|FG000|Part 1 (up to Week 24)|disease progression|58
4764416|NCT02472964|7738751|FG001|Part 1 (up to Week 24)|disease progression|47
4764417|NCT02472964|7738750|FG000|Part 1 (up to Week 24)|Death|3
4764418|NCT02472964|7738751|FG001|Part 1 (up to Week 24)|Death|6
4764419|NCT02472964|7738750|FG000|Part 1 (up to Week 24)|Physician Decision|3
4764420|NCT02472964|7738751|FG001|Part 1 (up to Week 24)|Physician Decision|1
4764421|NCT02472964|7738750|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0
4764422|NCT02472964|7738751|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1
4764423|NCT02472964|7738750|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7
4764424|NCT02472964|7738751|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2
4764425|NCT02472964|7738750|FG000|Part 1 (up to Week 24)|Other|2
4764426|NCT02472964|7738751|FG001|Part 1 (up to Week 24)|Other|1
4764427|NCT02472964|7738750|FG000|Part 2 (Week 24-week 48)|Adverse Event|4
4764428|NCT02472964|7738751|FG001|Part 2 (Week 24-week 48)|Adverse Event|2
4764429|NCT02472964|7738750|FG000|Part 2 (Week 24-week 48)|Disease Progression|52
4764430|NCT02472964|7738751|FG001|Part 2 (Week 24-week 48)|Disease Progression|56
4764431|NCT02472964|7738750|FG000|Part 2 (Week 24-week 48)|Death|0
4764432|NCT02472964|7738751|FG001|Part 2 (Week 24-week 48)|Death|1
4764433|NCT02472964|7738750|FG000|Part 2 (Week 24-week 48)|Physician Decision|1
4764434|NCT02472964|7738751|FG001|Part 2 (Week 24-week 48)|Physician Decision|1
4764435|NCT02472964|7738750|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2
4764436|NCT02472964|7738751|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1
4764437|NCT02472964|7738750|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3
4764438|NCT02472964|7738751|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1
4764439|NCT02472964|7738750|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3
4764440|NCT02472964|7738751|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1
4764441|NCT02178722|7738762|FG000|Overall Study|Withdrawal by Subject|0
4764442|NCT02178722|7738763|FG001|Overall Study|Withdrawal by Subject|0
4764443|NCT02178722|7738764|FG002|Overall Study|Withdrawal by Subject|0
4764444|NCT02178722|7738765|FG003|Overall Study|Withdrawal by Subject|2
4764445|NCT02178722|7738766|FG004|Overall Study|Withdrawal by Subject|33
4764446|NCT02178722|7738762|FG000|Overall Study|Death|2
4764447|NCT02178722|7738763|FG001|Overall Study|Death|13
4764448|NCT02178722|7738764|FG002|Overall Study|Death|12
4764449|NCT02178722|7738765|FG003|Overall Study|Death|12
4764450|NCT02178722|7738766|FG004|Overall Study|Death|205
4764451|NCT02178722|7738762|FG000|Overall Study|Lost to Follow-up|0
4764452|NCT02178722|7738763|FG001|Overall Study|Lost to Follow-up|0
4764453|NCT02178722|7738764|FG002|Overall Study|Lost to Follow-up|0
4764454|NCT02178722|7738765|FG003|Overall Study|Lost to Follow-up|2
4764455|NCT02178722|7738766|FG004|Overall Study|Lost to Follow-up|11
4764456|NCT02178722|7738762|FG000|Overall Study|Study terminated by Sponsor|2
4764457|NCT02178722|7738763|FG001|Overall Study|Study terminated by Sponsor|7
4764458|NCT02178722|7738764|FG002|Overall Study|Study terminated by Sponsor|6
4764459|NCT02178722|7738765|FG003|Overall Study|Study terminated by Sponsor|4
4764460|NCT02178722|7738766|FG004|Overall Study|Study terminated by Sponsor|128
4764461|NCT02178722|7738762|FG000|Overall Study|Physician Decision|0
4764462|NCT02178722|7738763|FG001|Overall Study|Physician Decision|0
4764463|NCT02178722|7738764|FG002|Overall Study|Physician Decision|0
4764464|NCT02178722|7738765|FG003|Overall Study|Physician Decision|0
4764465|NCT02178722|7738766|FG004|Overall Study|Physician Decision|3
4764466|NCT02178722|7738762|FG000|Overall Study|Other|0
4764467|NCT02178722|7738763|FG001|Overall Study|Other|0
4764468|NCT02178722|7738764|FG002|Overall Study|Other|0
4764469|NCT02178722|7738765|FG003|Overall Study|Other|0
4764470|NCT02178722|7738766|FG004|Overall Study|Other|2
4764471|NCT01258803|7738781|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1
4764472|NCT01258803|7738782|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1
4764473|NCT01258803|7738783|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0
4764474|NCT01258803|7738784|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0
4764475|NCT01258803|7738785|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0
4764476|NCT01258803|7738786|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1
4764477|NCT01258803|7738781|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
4764478|NCT01258803|7738782|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1
4764479|NCT01258803|7738783|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
4764480|NCT01258803|7738784|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
4764481|NCT01258803|7738785|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
4764482|NCT01258803|7738786|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
4764483|NCT01258803|7738781|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0
4764484|NCT01258803|7738782|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0
4764485|NCT01258803|7738783|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1
4764486|NCT01258803|7738784|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0
4764487|NCT01258803|7738785|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0
4764488|NCT01258803|7738786|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0
4764489|NCT00862251|7738807|FG000|Overall Study|Adverse Event|8
4764490|NCT00862251|7738808|FG001|Overall Study|Adverse Event|3
4764491|NCT00862251|7738809|FG002|Overall Study|Adverse Event|1
4764492|NCT00862251|7738807|FG000|Overall Study|Lost to Follow-up|0
4764493|NCT00862251|7738808|FG001|Overall Study|Lost to Follow-up|0
4764494|NCT00862251|7738809|FG002|Overall Study|Lost to Follow-up|1
4764495|NCT00862251|7738807|FG000|Overall Study|Protocol Violation|2
4764496|NCT00862251|7738808|FG001|Overall Study|Protocol Violation|0
4764497|NCT00862251|7738809|FG002|Overall Study|Protocol Violation|1
4764498|NCT00862251|7738807|FG000|Overall Study|Withdrawal by Subject|9
4764499|NCT00862251|7738808|FG001|Overall Study|Withdrawal by Subject|2
4764500|NCT00862251|7738809|FG002|Overall Study|Withdrawal by Subject|6
4764501|NCT00783263|7738824|FG000|Overall Study|Adverse Event|3
4764502|NCT00783263|7738825|FG001|Overall Study|Adverse Event|0
4764503|NCT00783263|7738826|FG002|Overall Study|Adverse Event|2
4764504|NCT00783263|7738827|FG003|Overall Study|Adverse Event|1
4764505|NCT00783263|7738824|FG000|Overall Study|Lost to Follow-up|1
4764506|NCT00783263|7738825|FG001|Overall Study|Lost to Follow-up|1
4764507|NCT00783263|7738826|FG002|Overall Study|Lost to Follow-up|0
4764508|NCT00783263|7738827|FG003|Overall Study|Lost to Follow-up|0
4764509|NCT00783263|7738824|FG000|Overall Study|Withdrawal by Subject|0
4764510|NCT00783263|7738825|FG001|Overall Study|Withdrawal by Subject|1
4764511|NCT00783263|7738826|FG002|Overall Study|Withdrawal by Subject|1
4764512|NCT00783263|7738827|FG003|Overall Study|Withdrawal by Subject|2
4764513|NCT00782184|7738852|FG000|Overall Study|Adverse Event|1
4764514|NCT00782184|7738853|FG001|Overall Study|Adverse Event|2
4764515|NCT00782184|7738852|FG000|Overall Study|Protocol Violation|0
4764516|NCT00782184|7738853|FG001|Overall Study|Protocol Violation|1
4764517|NCT00782184|7738852|FG000|Overall Study|Withdrawal by Subject|3
4764518|NCT00782184|7738853|FG001|Overall Study|Withdrawal by Subject|2
4764519|NCT00635882|7738866|FG000|Overall Study|Protocol Violation|1
4764520|NCT00635882|7738867|FG001|Overall Study|Protocol Violation|0
4764521|NCT00635882|7738868|FG002|Overall Study|Protocol Violation|0
4764522|NCT00635882|7738869|FG003|Overall Study|Protocol Violation|0
4764523|NCT00635882|7738870|FG004|Overall Study|Protocol Violation|0
4764524|NCT00635882|7738871|FG005|Overall Study|Protocol Violation|0
4764525|NCT00535405|7738899|FG000|Overall Study|Adverse Event|6
4764526|NCT00535405|7738900|FG001|Overall Study|Adverse Event|8
4764527|NCT00535405|7738901|FG002|Overall Study|Adverse Event|3
4764528|NCT00535405|7738902|FG003|Overall Study|Adverse Event|8
4764529|NCT00535405|7738903|FG004|Overall Study|Adverse Event|6
4764530|NCT00535405|7738899|FG000|Overall Study|Lost to Follow-up|1
4764531|NCT00535405|7738900|FG001|Overall Study|Lost to Follow-up|3
4764532|NCT00535405|7738901|FG002|Overall Study|Lost to Follow-up|3
4764533|NCT00535405|7738902|FG003|Overall Study|Lost to Follow-up|2
4764534|NCT00535405|7738903|FG004|Overall Study|Lost to Follow-up|1
4764535|NCT00535405|7738899|FG000|Overall Study|Physician Decision|3
4764536|NCT00535405|7738900|FG001|Overall Study|Physician Decision|2
4764537|NCT00535405|7738901|FG002|Overall Study|Physician Decision|0
4764538|NCT00535405|7738902|FG003|Overall Study|Physician Decision|1
4764539|NCT00535405|7738903|FG004|Overall Study|Physician Decision|1
4764540|NCT00535405|7738899|FG000|Overall Study|Protocol Violation|2
4764541|NCT00535405|7738900|FG001|Overall Study|Protocol Violation|2
4764542|NCT00535405|7738901|FG002|Overall Study|Protocol Violation|2
4764543|NCT00535405|7738902|FG003|Overall Study|Protocol Violation|1
4764544|NCT00535405|7738903|FG004|Overall Study|Protocol Violation|0
4764545|NCT00535405|7738899|FG000|Overall Study|Withdrawal by Subject|5
4764546|NCT00535405|7738900|FG001|Overall Study|Withdrawal by Subject|11
4764547|NCT00535405|7738901|FG002|Overall Study|Withdrawal by Subject|10
4764548|NCT00535405|7738902|FG003|Overall Study|Withdrawal by Subject|10
4764549|NCT00535405|7738903|FG004|Overall Study|Withdrawal by Subject|8
4764550|NCT00496730|7738917|FG000|Overall Study|Lost to Follow-up|4
4764551|NCT00496730|7738918|FG001|Overall Study|Lost to Follow-up|3
4764552|NCT00496730|7738917|FG000|Overall Study|Withdrawal by Subject|2
4764553|NCT00496730|7738918|FG001|Overall Study|Withdrawal by Subject|2
4764554|NCT00462748|7738927|FG000|Overall Study|Adverse Event|7
4764555|NCT00462748|7738928|FG001|Overall Study|Adverse Event|5
4764556|NCT00462748|7738929|FG002|Overall Study|Adverse Event|9
4764557|NCT00462748|7738927|FG000|Overall Study|Protocol Violation|0
4764558|NCT00462748|7738928|FG001|Overall Study|Protocol Violation|2
4764559|NCT00462748|7738929|FG002|Overall Study|Protocol Violation|1
4764560|NCT00462748|7738927|FG000|Overall Study|Withdrew consent|3
4764561|NCT00462748|7738928|FG001|Overall Study|Withdrew consent|3
4764562|NCT00462748|7738929|FG002|Overall Study|Withdrew consent|0
4764563|NCT00462748|7738927|FG000|Overall Study|Lost to Follow-up|1
4764564|NCT00462748|7738928|FG001|Overall Study|Lost to Follow-up|1
4764565|NCT00462748|7738929|FG002|Overall Study|Lost to Follow-up|1
4764566|NCT00462748|7738927|FG000|Overall Study|Discontinued after 41 days Rx|1
4764567|NCT00462748|7738928|FG001|Overall Study|Discontinued after 41 days Rx|0
4764568|NCT00462748|7738929|FG002|Overall Study|Discontinued after 41 days Rx|0
4764569|NCT00418834|7738939|FG000|Overall Study|Adverse Event|16
4764570|NCT00418834|7738940|FG001|Overall Study|Adverse Event|9
4764571|NCT00418834|7738939|FG000|Overall Study|Lost to Follow-up|0
4764572|NCT00418834|7738940|FG001|Overall Study|Lost to Follow-up|1
4764573|NCT00418834|7738939|FG000|Overall Study|Protocol Violation|4
4764574|NCT00418834|7738940|FG001|Overall Study|Protocol Violation|3
4764575|NCT00418834|7738939|FG000|Overall Study|Withdrawal by Subject|3
4764576|NCT00418834|7738940|FG001|Overall Study|Withdrawal by Subject|7
4764577|NCT00409773|7738951|FG000|Overall Study|Adverse Event|3
4764578|NCT00409773|7738952|FG001|Overall Study|Adverse Event|4
4764579|NCT00409773|7738953|FG002|Overall Study|Adverse Event|4
4764580|NCT00409773|7738954|FG003|Overall Study|Adverse Event|2
4764581|NCT00409773|7738955|FG004|Overall Study|Adverse Event|6
4764582|NCT00409773|7738951|FG000|Overall Study|Lost to Follow-up|6
4764583|NCT00409773|7738952|FG001|Overall Study|Lost to Follow-up|1
4764584|NCT00409773|7738953|FG002|Overall Study|Lost to Follow-up|2
4764585|NCT00409773|7738954|FG003|Overall Study|Lost to Follow-up|3
4764586|NCT00409773|7738955|FG004|Overall Study|Lost to Follow-up|1
4764587|NCT00409773|7738951|FG000|Overall Study|Physician Decision|0
4764588|NCT00409773|7738952|FG001|Overall Study|Physician Decision|0
4764589|NCT00409773|7738953|FG002|Overall Study|Physician Decision|0
4764590|NCT00409773|7738954|FG003|Overall Study|Physician Decision|2
4764591|NCT00409773|7738955|FG004|Overall Study|Physician Decision|0
4764592|NCT00409773|7738951|FG000|Overall Study|Protocol Violation|0
4764593|NCT00409773|7738952|FG001|Overall Study|Protocol Violation|2
4764594|NCT00409773|7738953|FG002|Overall Study|Protocol Violation|3
4764595|NCT00409773|7738954|FG003|Overall Study|Protocol Violation|3
4764596|NCT00409773|7738955|FG004|Overall Study|Protocol Violation|1
4764597|NCT00409773|7738951|FG000|Overall Study|Withdrawal by Subject|0
4764598|NCT00409773|7738952|FG001|Overall Study|Withdrawal by Subject|0
4764599|NCT00409773|7738953|FG002|Overall Study|Withdrawal by Subject|0
4764600|NCT00409773|7738954|FG003|Overall Study|Withdrawal by Subject|2
4764601|NCT00409773|7738955|FG004|Overall Study|Withdrawal by Subject|1
4764602|NCT00409773|7738951|FG000|Overall Study|Lack of Eligibility|0
4764603|NCT00409773|7738952|FG001|Overall Study|Lack of Eligibility|0
4764604|NCT00409773|7738953|FG002|Overall Study|Lack of Eligibility|0
4764605|NCT00409773|7738954|FG003|Overall Study|Lack of Eligibility|0
4764606|NCT00409773|7738955|FG004|Overall Study|Lack of Eligibility|1
4764607|NCT00276484|7738969|FG000|Overall Study|Adverse Event|4
4764608|NCT00276484|7738970|FG001|Overall Study|Adverse Event|7
4764609|NCT00276484|7738969|FG000|Overall Study|Lost to Follow-up|1
4764610|NCT00276484|7738970|FG001|Overall Study|Lost to Follow-up|1
4764611|NCT00276484|7738969|FG000|Overall Study|Protocol Violation|0
4764612|NCT00276484|7738970|FG001|Overall Study|Protocol Violation|1
4764613|NCT00276484|7738969|FG000|Overall Study|Withdrawal by Subject|4
4764614|NCT00276484|7738970|FG001|Overall Study|Withdrawal by Subject|3
4764615|NCT00276484|7738969|FG000|Overall Study|Could not take time off work|0
4764616|NCT00276484|7738970|FG001|Overall Study|Could not take time off work|1
4764617|NCT00276458|7738978|FG000|Overall Study|Adverse Event|0
4764618|NCT00276458|7738979|FG001|Overall Study|Adverse Event|2
4764619|NCT00276458|7738978|FG000|Overall Study|Lost to Follow-up|2
4764620|NCT00276458|7738979|FG001|Overall Study|Lost to Follow-up|2
4764621|NCT00276458|7738978|FG000|Overall Study|Protocol Violation|4
4764622|NCT00276458|7738979|FG001|Overall Study|Protocol Violation|3
4764623|NCT00271817|7738988|FG000|Part 1|Adverse Event|68
4764624|NCT00271817|7738989|FG001|Part 1|Adverse Event|25
4764625|NCT00271817|7738990|FG002|Part 1|Adverse Event|156
4764626|NCT00271817|7738988|FG000|Part 1|Lost to Follow-up|6
4764627|NCT00271817|7738989|FG001|Part 1|Lost to Follow-up|8
4764628|NCT00271817|7738990|FG002|Part 1|Lost to Follow-up|24
4764629|NCT00271817|7738988|FG000|Part 1|Protocol Violation|5
4764630|NCT00271817|7738989|FG001|Part 1|Protocol Violation|4
4764631|NCT00271817|7738990|FG002|Part 1|Protocol Violation|7
4764632|NCT00271817|7738988|FG000|Part 1|Patient Moved|3
4764633|NCT00271817|7738989|FG001|Part 1|Patient Moved|1
4764634|NCT00271817|7738990|FG002|Part 1|Patient Moved|5
4764635|NCT00271817|7738988|FG000|Part 1|Withdrawal by Subject|23
4764636|NCT00271817|7738989|FG001|Part 1|Withdrawal by Subject|17
4764637|NCT00271817|7738990|FG002|Part 1|Withdrawal by Subject|45
4764638|NCT00271817|7738988|FG000|Part 1|LDL < 50 mg/dL|1
4764639|NCT00271817|7738989|FG001|Part 1|LDL < 50 mg/dL|4
4764640|NCT00271817|7738990|FG002|Part 1|LDL < 50 mg/dL|48
4764641|NCT00271817|7738988|FG000|Part 2|Adverse Event|0
4764642|NCT00271817|7738989|FG001|Part 2|Adverse Event|17
4764643|NCT00271817|7738990|FG002|Part 2|Adverse Event|33
4764644|NCT00271817|7738988|FG000|Part 2|Lack of Efficacy|0
4764645|NCT00271817|7738989|FG001|Part 2|Lack of Efficacy|1
4764646|NCT00271817|7738990|FG002|Part 2|Lack of Efficacy|6
4764647|NCT00271817|7738988|FG000|Part 2|Lost to Follow-up|0
4764648|NCT00271817|7738989|FG001|Part 2|Lost to Follow-up|6
4764649|NCT00271817|7738990|FG002|Part 2|Lost to Follow-up|18
4764650|NCT00271817|7738988|FG000|Part 2|Protocol Violation|0
4764651|NCT00271817|7738989|FG001|Part 2|Protocol Violation|3
4764652|NCT00271817|7738990|FG002|Part 2|Protocol Violation|5
4764653|NCT00271817|7738988|FG000|Part 2|Patient Moved|0
4764654|NCT00271817|7738989|FG001|Part 2|Patient Moved|0
4764655|NCT00271817|7738990|FG002|Part 2|Patient Moved|5
4764656|NCT00271817|7738988|FG000|Part 2|Withdrawal by Subject|0
4764657|NCT00271817|7738989|FG001|Part 2|Withdrawal by Subject|2
4764658|NCT00271817|7738990|FG002|Part 2|Withdrawal by Subject|13
4764659|NCT00271817|7738988|FG000|Part 2|LDL < 50 mg/dL|0
4764660|NCT00271817|7738989|FG001|Part 2|LDL < 50 mg/dL|3
4764661|NCT00271817|7738990|FG002|Part 2|LDL < 50 mg/dL|4
4764662|NCT03420781|7739022|FG000|Treatment Period (40 Weeks)|Adverse Event|1
4764663|NCT03420781|7739023|FG001|Treatment Period (40 Weeks)|Adverse Event|6
4764664|NCT03420781|7739024|FG002|Treatment Period (40 Weeks)|Adverse Event|0
4764665|NCT03420781|7739025|FG003|Treatment Period (40 Weeks)|Adverse Event|0
4764666|NCT03420781|7739026|FG004|Treatment Period (40 Weeks)|Adverse Event|0
4764667|NCT03420781|7739022|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1
4764668|NCT03420781|7739023|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1
4764669|NCT03420781|7739024|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0
4764670|NCT03420781|7739025|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0
4764671|NCT03420781|7739026|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0
4764672|NCT03420781|7739022|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22
4764673|NCT03420781|7739023|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16
4764674|NCT03420781|7739024|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0
4764675|NCT03420781|7739025|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0
4764676|NCT03420781|7739026|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0
4764677|NCT03420781|7739022|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10
4764678|NCT03420781|7739023|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6
4764679|NCT03420781|7739024|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0
4764680|NCT03420781|7739025|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0
4764681|NCT03420781|7739026|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0
4764682|NCT03420781|7739022|FG000|Treatment Period (40 Weeks)|Death|2
4764683|NCT03420781|7739023|FG001|Treatment Period (40 Weeks)|Death|2
4764684|NCT03420781|7739024|FG002|Treatment Period (40 Weeks)|Death|0
4764685|NCT03420781|7739025|FG003|Treatment Period (40 Weeks)|Death|0
4764686|NCT03420781|7739026|FG004|Treatment Period (40 Weeks)|Death|0
4764687|NCT03420781|7739022|FG000|Treatment Period (40 Weeks)|Physician Decision|3
4764688|NCT03420781|7739023|FG001|Treatment Period (40 Weeks)|Physician Decision|4
4764689|NCT03420781|7739024|FG002|Treatment Period (40 Weeks)|Physician Decision|0
4764690|NCT03420781|7739025|FG003|Treatment Period (40 Weeks)|Physician Decision|0
4764691|NCT03420781|7739026|FG004|Treatment Period (40 Weeks)|Physician Decision|0
4764692|NCT03420781|7739022|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0
4764693|NCT03420781|7739023|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2
4764694|NCT03420781|7739024|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0
4764695|NCT03420781|7739025|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0
4764696|NCT03420781|7739026|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0
4764697|NCT03420781|7739022|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101
4764698|NCT03420781|7739023|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89
4764699|NCT03420781|7739024|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0
4764700|NCT03420781|7739025|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0
4764701|NCT03420781|7739026|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0
4764702|NCT03420781|7739022|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1
4764703|NCT03420781|7739023|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0
4764704|NCT03420781|7739024|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0
4764705|NCT03420781|7739025|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0
4764706|NCT03420781|7739026|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0
4764707|NCT03420781|7739022|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3
4764708|NCT03420781|7739023|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0
4764709|NCT03420781|7739024|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0
4764710|NCT03420781|7739025|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0
4764711|NCT03420781|7739026|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0
4764712|NCT03420781|7739022|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0
4764713|NCT03420781|7739023|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0
4764714|NCT03420781|7739024|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0
4764715|NCT03420781|7739025|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2
4764716|NCT03420781|7739026|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0
4764717|NCT03420781|7739022|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0
4764718|NCT03420781|7739023|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0
4764719|NCT03420781|7739024|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0
4764720|NCT03420781|7739025|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0
4764721|NCT03420781|7739026|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2
4764722|NCT03420781|7739022|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0
4764723|NCT03420781|7739023|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0
4764724|NCT03420781|7739024|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6
4764725|NCT03420781|7739025|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3
4764726|NCT03420781|7739026|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3
4764727|NCT03316586|7739042|FG000|Overall Study|Adverse Event|2
4764728|NCT03316586|7739042|FG000|Overall Study|Physician Decision|3
4764729|NCT03316586|7739042|FG000|Overall Study|Lack of Efficacy|10
4764730|NCT03316586|7739042|FG000|Overall Study|still on treatment|1
4764731|NCT03316586|7739042|FG000|Overall Study|Patient needed radiation therapy|1
4764732|NCT03316586|7739042|FG000|Overall Study|Physician Decision to send patient for breast surgery|1
4764798|NCT02574455|7739231|FG000|Overall Study|Death|197
4764799|NCT02574455|7739232|FG001|Overall Study|Death|210
4764733|NCT03269695|7739061|FG000|Overall Study|Adverse Event|2
4764734|NCT03269695|7739062|FG001|Overall Study|Adverse Event|1
4764735|NCT03269695|7739061|FG000|Overall Study|Lack of Efficacy|0
4764736|NCT03269695|7739062|FG001|Overall Study|Lack of Efficacy|1
4764737|NCT03269695|7739061|FG000|Overall Study|Withdrawal by Subject|0
4764738|NCT03269695|7739062|FG001|Overall Study|Withdrawal by Subject|1
4764739|NCT03227757|7739069|FG000|Overall Study|Death|7
4764740|NCT03227757|7739069|FG000|Overall Study|Withdrawal|5
4764741|NCT03227757|7739069|FG000|Overall Study|Missed visits|4
4764742|NCT03142334|7739079|FG000|Overall Study|Death|18
4764743|NCT03142334|7739080|FG001|Overall Study|Death|33
4764744|NCT03142334|7739079|FG000|Overall Study|Withdrawal by Subject|15
4764745|NCT03142334|7739080|FG001|Overall Study|Withdrawal by Subject|11
4764746|NCT03142334|7739079|FG000|Overall Study|Ongoing on trial follow up|463
4764747|NCT03142334|7739080|FG001|Overall Study|Ongoing on trial follow up|454
4764748|NCT02857426|7739160|FG000|Overall Study|Disease progression|34
4764749|NCT02857426|7739161|FG001|Overall Study|Disease progression|13
4764750|NCT02857426|7739160|FG000|Overall Study|Study drug toxicity|4
4764751|NCT02857426|7739161|FG001|Overall Study|Study drug toxicity|1
4764752|NCT02857426|7739160|FG000|Overall Study|Death|1
4764753|NCT02857426|7739161|FG001|Overall Study|Death|0
4764754|NCT02857426|7739160|FG000|Overall Study|Adverse event unrelated to study drug|6
4764755|NCT02857426|7739161|FG001|Overall Study|Adverse event unrelated to study drug|2
4764756|NCT02857426|7739160|FG000|Overall Study|Participant withdrew consent|1
4764757|NCT02857426|7739161|FG001|Overall Study|Participant withdrew consent|1
4764758|NCT02857426|7739160|FG000|Overall Study|Maximum clinical benefit|1
4764759|NCT02857426|7739161|FG001|Overall Study|Maximum clinical benefit|0
4764760|NCT02857426|7739160|FG000|Overall Study|Completed treatment|0
4764761|NCT02857426|7739161|FG001|Overall Study|Completed treatment|2
4764762|NCT02855125|7739169|FG000|Overall Study|Withdrawal by Subject|2
4764763|NCT02855125|7739170|FG001|Overall Study|Withdrawal by Subject|2
4764764|NCT02855125|7739169|FG000|Overall Study|Clinical Disease Progression|5
4764765|NCT02855125|7739170|FG001|Overall Study|Clinical Disease Progression|4
4764766|NCT02855125|7739169|FG000|Overall Study|Radiologic Disease Progression|36
4764767|NCT02855125|7739170|FG001|Overall Study|Radiologic Disease Progression|39
4764768|NCT02855125|7739169|FG000|Overall Study|Adverse Event|11
4764769|NCT02855125|7739170|FG001|Overall Study|Adverse Event|7
4764770|NCT02855125|7739169|FG000|Overall Study|Physician Decision|1
4764771|NCT02855125|7739170|FG001|Overall Study|Physician Decision|0
4764772|NCT02855125|7739169|FG000|Overall Study|On Treatment|9
4764773|NCT02855125|7739170|FG001|Overall Study|On Treatment|11
4764774|NCT02855125|7739169|FG000|Overall Study|Randomized but not treated|0
4764775|NCT02855125|7739170|FG001|Overall Study|Randomized but not treated|1
4764776|NCT02836236|7739178|FG000|Overall Study|Randomized but Never Treated|1
4764777|NCT02836236|7739179|FG001|Overall Study|Randomized but Never Treated|0
4764778|NCT02836236|7739178|FG000|Overall Study|Withdrew Consent|2
4764779|NCT02836236|7739179|FG001|Overall Study|Withdrew Consent|0
4764780|NCT02836236|7739178|FG000|Overall Study|Adverse Event|0
4764781|NCT02836236|7739179|FG001|Overall Study|Adverse Event|1
4764782|NCT02836236|7739178|FG000|Overall Study|Investigator's Discretion|1
4764783|NCT02836236|7739179|FG001|Overall Study|Investigator's Discretion|0
4764784|NCT02836236|7739178|FG000|Overall Study|Still on Study|101
4764785|NCT02836236|7739179|FG001|Overall Study|Still on Study|49
4764786|NCT02680587|7739197|FG000|Overall Study|Withdrawal by Subject|1
4764787|NCT02680587|7739198|FG001|Overall Study|Withdrawal by Subject|0
4764788|NCT02652949|7739219|FG000|30-Day Follow-up for Primary Endpoint|Death|1
4764789|NCT02652949|7739219|FG000|30-Day Follow-up for Secondary Endpoint|Death|1
4764790|NCT02652949|7739219|FG000|6-Month Follow-up Secondary Endpoint|Death|5
4764791|NCT02652949|7739219|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2
4764792|NCT02652949|7739219|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1
4764793|NCT02652949|7739219|FG000|12-Month Follow-up Secondary Endpoint|Death|4
4764794|NCT02652949|7739219|FG000|24-Month Follow-up Secondary Endpoint|Death|2
4764795|NCT02652949|7739219|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3
4764796|NCT02652949|7739219|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2
4764797|NCT02652949|7739219|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28
4764800|NCT02574455|7739231|FG000|Overall Study|Withdrawal of Consent|11
4764801|NCT02574455|7739232|FG001|Overall Study|Withdrawal of Consent|28
4764802|NCT02574455|7739231|FG000|Overall Study|Lost to Follow-up|4
4764803|NCT02574455|7739232|FG001|Overall Study|Lost to Follow-up|4
4764804|NCT02574455|7739231|FG000|Overall Study|Sponsor's Decision|55
4764805|NCT02574455|7739232|FG001|Overall Study|Sponsor's Decision|20
4764806|NCT02527798|7739244|FG000|Overall Study|Physician Decision|1
4764807|NCT02527798|7739245|FG001|Overall Study|Physician Decision|0
4764808|NCT02527798|7739246|FG002|Overall Study|Physician Decision|1
4764809|NCT02527798|7739247|FG003|Overall Study|Physician Decision|1
4764810|NCT02527798|7739248|FG004|Overall Study|Physician Decision|0
4764811|NCT02527798|7739249|FG005|Overall Study|Physician Decision|0
4764812|NCT02527798|7739244|FG000|Overall Study|Death|0
4764813|NCT02527798|7739245|FG001|Overall Study|Death|0
4764814|NCT02527798|7739246|FG002|Overall Study|Death|1
4764815|NCT02527798|7739247|FG003|Overall Study|Death|0
4764816|NCT02527798|7739248|FG004|Overall Study|Death|0
4764817|NCT02527798|7739249|FG005|Overall Study|Death|0
4764818|NCT02527798|7739244|FG000|Overall Study|Withdrawal by Subject|0
4764819|NCT02527798|7739245|FG001|Overall Study|Withdrawal by Subject|1
4764820|NCT02527798|7739246|FG002|Overall Study|Withdrawal by Subject|2
4764821|NCT02527798|7739247|FG003|Overall Study|Withdrawal by Subject|0
4764822|NCT02527798|7739248|FG004|Overall Study|Withdrawal by Subject|0
4764823|NCT02527798|7739249|FG005|Overall Study|Withdrawal by Subject|0
4764824|NCT02527798|7739244|FG000|Overall Study|Reason undisclosed|1
4764825|NCT02527798|7739245|FG001|Overall Study|Reason undisclosed|0
4764826|NCT02527798|7739246|FG002|Overall Study|Reason undisclosed|1
4764827|NCT02527798|7739247|FG003|Overall Study|Reason undisclosed|0
4764828|NCT02527798|7739248|FG004|Overall Study|Reason undisclosed|0
4764829|NCT02527798|7739249|FG005|Overall Study|Reason undisclosed|0
4764830|NCT02527798|7739244|FG000|Overall Study|Did not receive intervention|1
4764831|NCT02527798|7739245|FG001|Overall Study|Did not receive intervention|1
4764832|NCT02527798|7739246|FG002|Overall Study|Did not receive intervention|0
4764833|NCT02527798|7739247|FG003|Overall Study|Did not receive intervention|0
4764834|NCT02527798|7739248|FG004|Overall Study|Did not receive intervention|0
4764835|NCT02527798|7739249|FG005|Overall Study|Did not receive intervention|0
4764836|NCT02279745|7739300|FG000|Overall Study|Adverse Event|7
4764837|NCT02279745|7739300|FG000|Overall Study|Death|6
4764838|NCT02279745|7739300|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2
4764839|NCT02279745|7739300|FG000|Overall Study|Withdrawal by Subject|2
4764840|NCT02279745|7739300|FG000|Overall Study|Pregnancy|1
4764841|NCT02279745|7739300|FG000|Overall Study|Study Non-compliance|1
4764842|NCT02279745|7739300|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1
4764843|NCT02030938|7739323|FG000|Overall Study|Lost to Follow-up|4
4764844|NCT02030938|7739323|FG000|Overall Study|Withdrawal by Subject|1
4764845|NCT02006147|7739335|FG000|Overall Study|Protocol Violation|1
4764846|NCT02006147|7739336|FG001|Overall Study|Protocol Violation|1
4764847|NCT02006147|7739337|FG002|Overall Study|Protocol Violation|0
4764848|NCT02006147|7739338|FG003|Overall Study|Protocol Violation|0
4764849|NCT02006147|7739335|FG000|Overall Study|Withdrawal by Subject|0
4764850|NCT02006147|7739336|FG001|Overall Study|Withdrawal by Subject|1
4764851|NCT02006147|7739337|FG002|Overall Study|Withdrawal by Subject|0
4764852|NCT02006147|7739338|FG003|Overall Study|Withdrawal by Subject|0
4764853|NCT02006147|7739335|FG000|Overall Study|Withdrawal by Sponsor|1
4764854|NCT02006147|7739336|FG001|Overall Study|Withdrawal by Sponsor|0
4764855|NCT02006147|7739337|FG002|Overall Study|Withdrawal by Sponsor|0
4764856|NCT02006147|7739338|FG003|Overall Study|Withdrawal by Sponsor|0
4764857|NCT01999179|7739344|FG000|Overall Study|Adverse Event|1
4764858|NCT01999179|7739344|FG000|Overall Study|Lost to Follow-up|1
4764859|NCT01999179|7739344|FG000|Overall Study|Change in Therapy|3
4764860|NCT01999179|7739344|FG000|Overall Study|New catheter|2
4764861|NCT01940341|7739350|FG000|Double-Blind Phase|Randomized but Never Treated|0
4764862|NCT01940341|7739351|FG001|Double-Blind Phase|Randomized but Never Treated|1
4764863|NCT01940341|7739350|FG000|Double-Blind Phase|Adverse Event|3
4764864|NCT01940341|7739351|FG001|Double-Blind Phase|Adverse Event|2
4764865|NCT01940341|7739350|FG000|Double-Blind Phase|Withdrew Consent|3
4764866|NCT01940341|7739351|FG001|Double-Blind Phase|Withdrew Consent|2
4764867|NCT01940341|7739350|FG000|Double-Blind Phase|Lost to Follow-up|4
4764868|NCT01940341|7739351|FG001|Double-Blind Phase|Lost to Follow-up|1
4764869|NCT01940341|7739350|FG000|Double-Blind Phase|Pregnancy|0
4764870|NCT01940341|7739351|FG001|Double-Blind Phase|Pregnancy|1
4764871|NCT01940341|7739350|FG000|Double-Blind Phase|Investigator's Discretion|1
4764872|NCT01940341|7739351|FG001|Double-Blind Phase|Investigator's Discretion|0
4764873|NCT01940341|7739350|FG000|Double-Blind Phase|Non-Compliance with Study Drug|0
4764874|NCT01940341|7739351|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1
4764875|NCT01940341|7739350|FG000|Double-Blind Phase|Protocol Specified Criteria|1
4764876|NCT01940341|7739351|FG001|Double-Blind Phase|Protocol Specified Criteria|0
4764877|NCT01940341|7739350|FG000|Double-Blind Phase|Still on Double-Blind Treatment|269
4764878|NCT01940341|7739351|FG001|Double-Blind Phase|Still on Double-Blind Treatment|132
4764879|NCT01940341|7739350|FG000|Open-label Extension Phase|Still on Study|4
4764880|NCT01940341|7739351|FG001|Open-label Extension Phase|Still on Study|1
4764881|NCT01925794|7739359|FG000|180 Days|Death|2
4764882|NCT01925794|7739359|FG000|180 Days|Withdrawal by Subject|2
4764883|NCT01925794|7739359|FG000|270 Days|Death|2
4764884|NCT01925794|7739359|FG000|270 Days|Protocol Violation|3
4764885|NCT01849250|7739382|FG000|Overall Study|Withdrawal by Subject|1
4764886|NCT01849250|7739383|FG001|Overall Study|Withdrawal by Subject|0
4764887|NCT01849250|7739382|FG000|Overall Study|Not Evaluable|5
4764888|NCT01849250|7739383|FG001|Overall Study|Not Evaluable|3
4764889|NCT01849250|7739382|FG000|Overall Study|Screen Failure|1
4764890|NCT01849250|7739383|FG001|Overall Study|Screen Failure|0
4764891|NCT01441115|7739394|FG000|Overall Study|Taken off study - Principal Investigator discretion|1
4764892|NCT01295944|7739401|FG000|Overall Study|Switched to alternative treatment|1
4764893|NCT01295944|7739401|FG000|Overall Study|Ineligible|9
4764894|NCT01295944|7739401|FG000|Overall Study|Withdrawal by Subject|4
4764895|NCT01295944|7739401|FG000|Overall Study|Participant chose to be treated in Peru|1
4764896|NCT01295944|7739401|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1
4764897|NCT01295944|7739401|FG000|Overall Study|Participant was diagnosed with stage 1 infiltrated ductal carcinoma of the right breast(10/03/2013).|1
4764898|NCT01295944|7739401|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1
4764899|NCT01199302|7739409|FG000|Overall Study|Adverse Event|1
4764900|NCT01199302|7739410|FG001|Overall Study|Adverse Event|1
4764901|NCT01199302|7739411|FG002|Overall Study|Adverse Event|2
4764902|NCT01199302|7739412|FG003|Overall Study|Adverse Event|0
4764903|NCT01199302|7739409|FG000|Overall Study|Withdrawal by Subject|2
4764904|NCT01199302|7739410|FG001|Overall Study|Withdrawal by Subject|2
4764905|NCT01199302|7739411|FG002|Overall Study|Withdrawal by Subject|3
4764906|NCT01199302|7739412|FG003|Overall Study|Withdrawal by Subject|0
4764907|NCT01199302|7739409|FG000|Overall Study|Disease Progression|3
4764908|NCT01199302|7739410|FG001|Overall Study|Disease Progression|4
4764909|NCT01199302|7739411|FG002|Overall Study|Disease Progression|4
4764910|NCT01199302|7739412|FG003|Overall Study|Disease Progression|2
4764911|NCT01199302|7739409|FG000|Overall Study|Study Termination|13
4764912|NCT01199302|7739410|FG001|Overall Study|Study Termination|8
4764913|NCT01199302|7739411|FG002|Overall Study|Study Termination|11
4764914|NCT01199302|7739412|FG003|Overall Study|Study Termination|9
4764915|NCT01199302|7739409|FG000|Overall Study|Lost to Follow-up|0
4764916|NCT01199302|7739410|FG001|Overall Study|Lost to Follow-up|1
4764917|NCT01199302|7739411|FG002|Overall Study|Lost to Follow-up|0
4764918|NCT01199302|7739412|FG003|Overall Study|Lost to Follow-up|0
4764919|NCT01199302|7739409|FG000|Overall Study|Other|1
4764920|NCT01199302|7739410|FG001|Overall Study|Other|0
4764921|NCT01199302|7739411|FG002|Overall Study|Other|0
4764922|NCT01199302|7739412|FG003|Overall Study|Other|0
4764923|NCT01123707|7739423|FG000|Overall Study|Lost to Follow-up|3
4764924|NCT01123707|7739424|FG001|Overall Study|Lost to Follow-up|1
4764925|NCT01123707|7739425|FG002|Overall Study|Lost to Follow-up|3
4764926|NCT01123707|7739426|FG003|Overall Study|Lost to Follow-up|2
4764927|NCT01123707|7739423|FG000|Overall Study|Adverse Event|5
4764928|NCT01123707|7739424|FG001|Overall Study|Adverse Event|7
4764929|NCT01123707|7739425|FG002|Overall Study|Adverse Event|5
4764930|NCT01123707|7739426|FG003|Overall Study|Adverse Event|3
4764931|NCT01123707|7739423|FG000|Overall Study|Sponsor Discontinued Study|30
4764932|NCT01123707|7739424|FG001|Overall Study|Sponsor Discontinued Study|24
4764933|NCT01123707|7739425|FG002|Overall Study|Sponsor Discontinued Study|25
4764934|NCT01123707|7739426|FG003|Overall Study|Sponsor Discontinued Study|40
4764935|NCT01123707|7739423|FG000|Overall Study|Participant Met Withdrawal Criteria|1
4764936|NCT01123707|7739424|FG001|Overall Study|Participant Met Withdrawal Criteria|1
4764937|NCT01123707|7739425|FG002|Overall Study|Participant Met Withdrawal Criteria|0
4764938|NCT01123707|7739426|FG003|Overall Study|Participant Met Withdrawal Criteria|1
4764939|NCT01123707|7739423|FG000|Overall Study|Investigator Withdrew Participant|0
4764940|NCT01123707|7739424|FG001|Overall Study|Investigator Withdrew Participant|1
4764941|NCT01123707|7739425|FG002|Overall Study|Investigator Withdrew Participant|1
4764942|NCT01123707|7739426|FG003|Overall Study|Investigator Withdrew Participant|1
4764943|NCT01123707|7739423|FG000|Overall Study|Subject Withdrew Consent|4
4764944|NCT01123707|7739424|FG001|Overall Study|Subject Withdrew Consent|5
4764945|NCT01123707|7739425|FG002|Overall Study|Subject Withdrew Consent|1
4764946|NCT01123707|7739426|FG003|Overall Study|Subject Withdrew Consent|2
4764947|NCT01123707|7739423|FG000|Overall Study|Lack of Efficacy|1
4764948|NCT01123707|7739424|FG001|Overall Study|Lack of Efficacy|2
4764949|NCT01123707|7739425|FG002|Overall Study|Lack of Efficacy|1
4764950|NCT01123707|7739426|FG003|Overall Study|Lack of Efficacy|0
4764951|NCT01123707|7739423|FG000|Overall Study|Subject Met Exclusion Criteria|0
4764952|NCT01123707|7739424|FG001|Overall Study|Subject Met Exclusion Criteria|0
4764953|NCT01123707|7739425|FG002|Overall Study|Subject Met Exclusion Criteria|2
4764954|NCT01123707|7739426|FG003|Overall Study|Subject Met Exclusion Criteria|1
4764955|NCT00462943|7739443|FG000|Overall Study|Failure to achieve a response|5
4764956|NCT00462943|7739444|FG001|Overall Study|Failure to achieve a response|5
4764957|NCT00462943|7739445|FG002|Overall Study|Failure to achieve a response|1
4764958|NCT00462943|7739443|FG000|Overall Study|Adverse Event|6
4764959|NCT00462943|7739444|FG001|Overall Study|Adverse Event|4
4764960|NCT00462943|7739445|FG002|Overall Study|Adverse Event|1
4764961|NCT00462943|7739443|FG000|Overall Study|Protocol Violation|1
4764962|NCT00462943|7739444|FG001|Overall Study|Protocol Violation|0
4764963|NCT00462943|7739445|FG002|Overall Study|Protocol Violation|0
4764964|NCT00462943|7739443|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8
4764965|NCT00462943|7739444|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2
4764966|NCT00462943|7739445|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4
4764967|NCT00462943|7739443|FG000|Overall Study|Disease Progression|15
4764968|NCT00462943|7739444|FG001|Overall Study|Disease Progression|15
4764969|NCT00462943|7739445|FG002|Overall Study|Disease Progression|9
4764970|NCT00462943|7739443|FG000|Overall Study|Death|5
4764971|NCT00462943|7739444|FG001|Overall Study|Death|2
4764972|NCT00462943|7739445|FG002|Overall Study|Death|7
4764973|NCT00462943|7739443|FG000|Overall Study|Stem Cell Transplant|1
4764974|NCT00462943|7739444|FG001|Overall Study|Stem Cell Transplant|1
4764975|NCT00462943|7739445|FG002|Overall Study|Stem Cell Transplant|0
4764976|NCT00462943|7739443|FG000|Overall Study|Bone Marrow Transplant|1
4764977|NCT00462943|7739444|FG001|Overall Study|Bone Marrow Transplant|0
4764978|NCT00462943|7739445|FG002|Overall Study|Bone Marrow Transplant|0
4764979|NCT00462943|7739443|FG000|Overall Study|Required Lymphocyte Infusion|1
4764980|NCT00462943|7739444|FG001|Overall Study|Required Lymphocyte Infusion|0
4764981|NCT00462943|7739445|FG002|Overall Study|Required Lymphocyte Infusion|0
4764982|NCT00462943|7739443|FG000|Overall Study|Transplant - not specified|1
4764983|NCT00462943|7739444|FG001|Overall Study|Transplant - not specified|0
4764984|NCT00462943|7739445|FG002|Overall Study|Transplant - not specified|1
4764985|NCT00462943|7739443|FG000|Overall Study|Physician Decision|1
4764986|NCT00462943|7739444|FG001|Overall Study|Physician Decision|0
4764987|NCT00462943|7739445|FG002|Overall Study|Physician Decision|0
4764988|NCT00462943|7739443|FG000|Overall Study|Withdrawal by Subject|0
4764989|NCT00462943|7739444|FG001|Overall Study|Withdrawal by Subject|1
4764990|NCT00462943|7739445|FG002|Overall Study|Withdrawal by Subject|0
4764991|NCT00248287|7739455|FG000|Overall Study|Adverse Event|11
4764992|NCT00248287|7739456|FG001|Overall Study|Adverse Event|10
4764993|NCT00248287|7739455|FG000|Overall Study|Death|1
4764994|NCT00248287|7739456|FG001|Overall Study|Death|0
4764995|NCT00248287|7739455|FG000|Overall Study|Lost to Follow-up|0
4764996|NCT00248287|7739456|FG001|Overall Study|Lost to Follow-up|1
4764997|NCT00248287|7739455|FG000|Overall Study|Investigator Request|4
4764998|NCT00248287|7739456|FG001|Overall Study|Investigator Request|3
4764999|NCT00248287|7739455|FG000|Overall Study|Patient Request|5
4765000|NCT00248287|7739456|FG001|Overall Study|Patient Request|3
4765001|NCT00248287|7739455|FG000|Overall Study|Other|3
4765002|NCT00248287|7739456|FG001|Overall Study|Other|2
4765003|NCT00105560|7739466|FG000|Overall Study|Lost to Follow-up|1
4765004|NCT04569786|7739500|FG000|Overall Study|Lost to Follow-up|1
4765005|NCT04569786|7739501|FG001|Overall Study|Lost to Follow-up|0
4765006|NCT04569786|7739502|FG002|Overall Study|Lost to Follow-up|4
4765007|NCT04569786|7739503|FG003|Overall Study|Lost to Follow-up|1
4765008|NCT04569786|7739504|FG004|Overall Study|Lost to Follow-up|0
4765009|NCT04569786|7739500|FG000|Overall Study|Withdrawal by Subject|0
4765010|NCT04569786|7739501|FG001|Overall Study|Withdrawal by Subject|0
4765011|NCT04569786|7739502|FG002|Overall Study|Withdrawal by Subject|0
4765012|NCT04569786|7739503|FG003|Overall Study|Withdrawal by Subject|5
4765013|NCT04569786|7739504|FG004|Overall Study|Withdrawal by Subject|1
4765014|NCT04569786|7739500|FG000|Overall Study|Physician Decision|0
4765015|NCT04569786|7739501|FG001|Overall Study|Physician Decision|0
4765016|NCT04569786|7739502|FG002|Overall Study|Physician Decision|0
4765017|NCT04569786|7739503|FG003|Overall Study|Physician Decision|1
4765018|NCT04569786|7739504|FG004|Overall Study|Physician Decision|0
4765019|NCT04129944|7739525|FG000|Overall Study|Death|0
4765020|NCT04129944|7739526|FG001|Overall Study|Death|0
4765021|NCT04129944|7739527|FG002|Overall Study|Death|0
4765022|NCT04129944|7739528|FG003|Overall Study|Death|1
4765023|NCT04129944|7739525|FG000|Overall Study|Lost to Follow-up|1
4765024|NCT04129944|7739526|FG001|Overall Study|Lost to Follow-up|0
4765025|NCT04129944|7739527|FG002|Overall Study|Lost to Follow-up|0
4765026|NCT04129944|7739528|FG003|Overall Study|Lost to Follow-up|0
4765027|NCT04129944|7739525|FG000|Overall Study|Withdrawal by Subject|1
4765028|NCT04129944|7739526|FG001|Overall Study|Withdrawal by Subject|0
4765029|NCT04129944|7739527|FG002|Overall Study|Withdrawal by Subject|1
4765030|NCT04129944|7739528|FG003|Overall Study|Withdrawal by Subject|2
4765031|NCT03857542|7739549|FG000|Overall Study|Adverse Event|1
4765032|NCT03857542|7739550|FG001|Overall Study|Adverse Event|3
4765033|NCT03857542|7739549|FG000|Overall Study|Withdrawal by Subject|2
4765034|NCT03857542|7739550|FG001|Overall Study|Withdrawal by Subject|1
4765035|NCT03857542|7739549|FG000|Overall Study|Lost to Follow-up|2
4765036|NCT03857542|7739550|FG001|Overall Study|Lost to Follow-up|1
4765037|NCT03857542|7739549|FG000|Overall Study|Reason not Specified|1
4765038|NCT03857542|7739550|FG001|Overall Study|Reason not Specified|0
4765039|NCT03848832|7739560|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0
4765040|NCT03848832|7739561|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0
4765041|NCT03848832|7739562|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1
4765042|NCT03848832|7739560|FG000|Overall Study|Withdrawal by Subject|0
4765043|NCT03848832|7739561|FG001|Overall Study|Withdrawal by Subject|0
4765044|NCT03848832|7739562|FG002|Overall Study|Withdrawal by Subject|1
4765045|NCT03848832|7739560|FG000|Overall Study|Withdrawal (Covid-19)|0
4765046|NCT03848832|7739561|FG001|Overall Study|Withdrawal (Covid-19)|2
4765047|NCT03848832|7739562|FG002|Overall Study|Withdrawal (Covid-19)|0
4765048|NCT03848832|7739560|FG000|Overall Study|Physician Decision|2
4765049|NCT03848832|7739561|FG001|Overall Study|Physician Decision|1
4765050|NCT03848832|7739562|FG002|Overall Study|Physician Decision|3
4765051|NCT03848832|7739560|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0
4765052|NCT03848832|7739561|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0
4765053|NCT03848832|7739562|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1
4765054|NCT03848832|7739560|FG000|Overall Study|Adverse Event|1
4765055|NCT03848832|7739561|FG001|Overall Study|Adverse Event|0
4765056|NCT03848832|7739562|FG002|Overall Study|Adverse Event|0
4765057|NCT03656744|7739584|FG000|Overall Study|Adverse Event|1
4765058|NCT03656744|7739585|FG001|Overall Study|Adverse Event|4
4765059|NCT03656744|7739586|FG002|Overall Study|Adverse Event|1
4765060|NCT03656744|7739584|FG000|Overall Study|Protocol Violation|1
4765061|NCT03656744|7739585|FG001|Overall Study|Protocol Violation|0
4765062|NCT03656744|7739586|FG002|Overall Study|Protocol Violation|0
4765063|NCT03656744|7739584|FG000|Overall Study|Lost to Follow-up|2
4765064|NCT03656744|7739585|FG001|Overall Study|Lost to Follow-up|2
4765065|NCT03656744|7739586|FG002|Overall Study|Lost to Follow-up|0
4765066|NCT03656744|7739584|FG000|Overall Study|Withdrawal by Subject|0
4765067|NCT03656744|7739585|FG001|Overall Study|Withdrawal by Subject|1
4765068|NCT03656744|7739586|FG002|Overall Study|Withdrawal by Subject|0
4765069|NCT03656744|7739584|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1
4765070|NCT03656744|7739585|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0
4765071|NCT03656744|7739586|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0
4765072|NCT03510598|7739594|FG000|Overall Study|Withdrawal by Subject|1
4765073|NCT03487796|7739602|FG000|Overall Study|Lost to Follow-up|18
4765074|NCT03487796|7739603|FG001|Overall Study|Lost to Follow-up|6
4765075|NCT03446612|7739617|FG000|Overall Study|Protocol defined stopping criteria|0
4765076|NCT03446612|7739618|FG001|Overall Study|Protocol defined stopping criteria|1
4765077|NCT03370120|7739639|FG000|Overall Study|Adverse event, non-fatal|24
4765078|NCT03370120|7739639|FG000|Overall Study|Withdrawal by Subject|6
4765079|NCT03370120|7739639|FG000|Overall Study|Lost to Follow-up|1
4765080|NCT03370120|7739639|FG000|Overall Study|Lack of Efficacy|37
4765081|NCT03370120|7739639|FG000|Overall Study|Per sponsor's instructions|1
4765082|NCT03370120|7739639|FG000|Overall Study|Study was terminated by parent company UCB|2
4765083|NCT03370120|7739639|FG000|Overall Study|The study was ended by the promoter|3
4765084|NCT03370120|7739639|FG000|Overall Study|Discontinuation of drug development|3
4765085|NCT03370120|7739639|FG000|Overall Study|End of project|2
4765086|NCT03370120|7739639|FG000|Overall Study|Premature study closure|2
4765087|NCT03370120|7739639|FG000|Overall Study|Premature program termination|1
4765088|NCT03370120|7739639|FG000|Overall Study|Premature study termination|7
4765089|NCT03370120|7739639|FG000|Overall Study|Trial terminated by sponsor|2
4765090|NCT03370120|7739639|FG000|Overall Study|Trial discontinued by sponsor|2
4765091|NCT03370120|7739639|FG000|Overall Study|Study ended|15
4765092|NCT03370120|7739639|FG000|Overall Study|Clinical trial has been cancelled|1
4765093|NCT03370120|7739639|FG000|Overall Study|End of study per sponsor decision|2
4765094|NCT03370120|7739639|FG000|Overall Study|Promoter's decision|2
4765095|NCT03370120|7739639|FG000|Overall Study|The trial has been suspended|3
4765096|NCT03370120|7739639|FG000|Overall Study|Sponsor stopped PSL development based on data|3
4765097|NCT03370120|7739639|FG000|Overall Study|Early termination by order of sponsor|2
4765098|NCT03370120|7739639|FG000|Overall Study|Discontinuation of the study|5
4765099|NCT03370120|7739639|FG000|Overall Study|End of clinical trial discontinuation|1
4765100|NCT03370120|7739639|FG000|Overall Study|Because the clinical trial ended halfway|4
4765101|NCT03370120|7739639|FG000|Overall Study|Development discontinued|5
4765102|NCT03370120|7739639|FG000|Overall Study|Padsenovil program closed|3
4765103|NCT03370120|7739639|FG000|Overall Study|End of project|2
4765104|NCT03370120|7739639|FG000|Overall Study|Termination of project|1
4765105|NCT03370120|7739639|FG000|Overall Study|The study was interrupted by sponsor|4
4765106|NCT03370120|7739639|FG000|Overall Study|The protocol was interrupted by sponsor|1
4765107|NCT03370120|7739639|FG000|Overall Study|End of sponsor decision|1
4765108|NCT03370120|7739639|FG000|Overall Study|The study was terminated prematurely by study lead|1
4765109|NCT03370120|7739639|FG000|Overall Study|Early termination of studies|5
4765110|NCT03370120|7739639|FG000|Overall Study|This study is ended early|1
4765111|NCT03370120|7739639|FG000|Overall Study|End of padsevonil program|2
4765112|NCT03370120|7739639|FG000|Overall Study|Decision of sponsor|6
4765113|NCT03370120|7739639|FG000|Overall Study|Asked by the sponsor|3
4765114|NCT03370120|7739639|FG000|Overall Study|Sponsor decision to stop the protocol|1
4765115|NCT03370120|7739639|FG000|Overall Study|PI decision poor compliance from participant|1
4765116|NCT03370120|7739639|FG000|Overall Study|Promoter ended the study|3
4765117|NCT03370120|7739639|FG000|Overall Study|Premature study close by sponsor's decision|4
4765118|NCT03370120|7739639|FG000|Overall Study|Study terminated by sponsor|33
4765119|NCT03370120|7739639|FG000|Overall Study|Sponsor prematurely terminated this study|2
4765120|NCT03370120|7739639|FG000|Overall Study|Sponsor decision to terminate study|63
4765121|NCT03370120|7739639|FG000|Overall Study|Program closure|3
4765122|NCT03370120|7739639|FG000|Overall Study|Study ended prematurely|1
4765123|NCT03370120|7739639|FG000|Overall Study|Study stopped by sponsor|2
4765124|NCT03370120|7739639|FG000|Overall Study|Program termination|55
4765125|NCT03370120|7739639|FG000|Overall Study|Sponsor decision|62
4765126|NCT03370120|7739639|FG000|Overall Study|Sponsor study closure|10
4765127|NCT03143829|7739662|FG000|Overall Study|Withdrawal by Subject|2
4765128|NCT03143829|7739663|FG001|Overall Study|Withdrawal by Subject|5
4765129|NCT03143829|7739662|FG000|Overall Study|Lost to Follow-up|0
4765130|NCT03143829|7739663|FG001|Overall Study|Lost to Follow-up|2
4765131|NCT03143829|7739662|FG000|Overall Study|Death|1
4765132|NCT03143829|7739663|FG001|Overall Study|Death|1
4765133|NCT03143829|7739662|FG000|Overall Study|changed treatment, no longer eligible|2
4765134|NCT03143829|7739663|FG001|Overall Study|changed treatment, no longer eligible|2
4765135|NCT02963610|7739678|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3
4765136|NCT02766335|7739685|FG000|Initial Registration|Adverse Event|6
4765137|NCT02766335|7739686|FG001|Initial Registration|Adverse Event|3
4765138|NCT02766335|7739687|FG002|Initial Registration|Adverse Event|0
4765139|NCT02766335|7739685|FG000|Initial Registration|Refusal unrelated to adverse event|1
4765140|NCT02766335|7739686|FG001|Initial Registration|Refusal unrelated to adverse event|0
4765141|NCT02766335|7739687|FG002|Initial Registration|Refusal unrelated to adverse event|0
4765142|NCT02766335|7739685|FG000|Initial Registration|Progression/relapse|49
4765143|NCT02766335|7739686|FG001|Initial Registration|Progression/relapse|15
4765144|NCT02766335|7739687|FG002|Initial Registration|Progression/relapse|0
4765145|NCT02766335|7739685|FG000|Initial Registration|Death|1
4765146|NCT02766335|7739686|FG001|Initial Registration|Death|3
4765147|NCT02766335|7739687|FG002|Initial Registration|Death|0
4765148|NCT02766335|7739685|FG000|Initial Registration|not protocol specified|1
4765149|NCT02766335|7739686|FG001|Initial Registration|not protocol specified|9
4765150|NCT02766335|7739687|FG002|Initial Registration|not protocol specified|0
4765151|NCT02766335|7739685|FG000|Re-registration of Arm I to MEDI4738|Death|0
4765152|NCT02766335|7739686|FG001|Re-registration of Arm I to MEDI4738|Death|0
4765153|NCT02766335|7739687|FG002|Re-registration of Arm I to MEDI4738|Death|1
4765154|NCT02766335|7739685|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0
4765155|NCT02766335|7739686|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0
4765156|NCT02766335|7739687|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1
4765157|NCT02606136|7739693|FG000|Overall Study|Participant/Legal Guardian Decision|5
4765158|NCT02606136|7739693|FG000|Overall Study|Withdrawal by Subject|1
4765159|NCT02228382|7739702|FG000|Overall Study|Death|5
4765160|NCT02228382|7739703|FG001|Overall Study|Death|7
4765161|NCT02228382|7739704|FG002|Overall Study|Death|5
4765162|NCT02228382|7739705|FG003|Overall Study|Death|0
4765163|NCT02228382|7739706|FG004|Overall Study|Death|2
4765164|NCT02228382|7739702|FG000|Overall Study|Participant refused further follow-up|0
4765165|NCT02228382|7739703|FG001|Overall Study|Participant refused further follow-up|0
4765166|NCT02228382|7739704|FG002|Overall Study|Participant refused further follow-up|1
4765167|NCT02228382|7739705|FG003|Overall Study|Participant refused further follow-up|0
4765168|NCT02228382|7739706|FG004|Overall Study|Participant refused further follow-up|0
4765169|NCT02228382|7739702|FG000|Overall Study|Study terminated by sponsor|3
4765170|NCT02228382|7739703|FG001|Overall Study|Study terminated by sponsor|5
4765171|NCT02228382|7739704|FG002|Overall Study|Study terminated by sponsor|7
4765172|NCT02228382|7739705|FG003|Overall Study|Study terminated by sponsor|0
4765173|NCT02228382|7739706|FG004|Overall Study|Study terminated by sponsor|0
4765174|NCT02228382|7739702|FG000|Overall Study|Lost to Follow-up|0
4765175|NCT02228382|7739703|FG001|Overall Study|Lost to Follow-up|0
4765176|NCT02228382|7739704|FG002|Overall Study|Lost to Follow-up|3
4765177|NCT02228382|7739705|FG003|Overall Study|Lost to Follow-up|1
4765178|NCT02228382|7739706|FG004|Overall Study|Lost to Follow-up|0
4765179|NCT02228382|7739702|FG000|Overall Study|Withdrawal by Subject|0
4765180|NCT02228382|7739703|FG001|Overall Study|Withdrawal by Subject|3
4765181|NCT02228382|7739704|FG002|Overall Study|Withdrawal by Subject|2
4765182|NCT02228382|7739705|FG003|Overall Study|Withdrawal by Subject|1
4765183|NCT02228382|7739706|FG004|Overall Study|Withdrawal by Subject|0
4765184|NCT02228382|7739702|FG000|Overall Study|Other|2
4765185|NCT02228382|7739703|FG001|Overall Study|Other|3
4765186|NCT02228382|7739704|FG002|Overall Study|Other|3
4765187|NCT02228382|7739705|FG003|Overall Study|Other|0
4765188|NCT02228382|7739706|FG004|Overall Study|Other|0
4765189|NCT02001623|7739756|FG000|Overall Study|Disease Progression|2
4765190|NCT02001623|7739757|FG001|Overall Study|Disease Progression|2
4765191|NCT02001623|7739758|FG002|Overall Study|Disease Progression|3
4765192|NCT02001623|7739759|FG003|Overall Study|Disease Progression|2
4765193|NCT02001623|7739760|FG004|Overall Study|Disease Progression|3
4765194|NCT02001623|7739761|FG005|Overall Study|Disease Progression|2
4765195|NCT02001623|7739762|FG006|Overall Study|Disease Progression|3
4765196|NCT02001623|7739763|FG007|Overall Study|Disease Progression|3
4765197|NCT02001623|7739764|FG008|Overall Study|Disease Progression|7
4765198|NCT02001623|7739765|FG009|Overall Study|Disease Progression|40
4765199|NCT02001623|7739766|FG010|Overall Study|Disease Progression|5
4765200|NCT02001623|7739767|FG011|Overall Study|Disease Progression|9
4765201|NCT02001623|7739768|FG012|Overall Study|Disease Progression|9
4765202|NCT02001623|7739769|FG013|Overall Study|Disease Progression|20
4765203|NCT02001623|7739770|FG014|Overall Study|Disease Progression|9
4765204|NCT02001623|7739756|FG000|Overall Study|Physician Decision|0
4765205|NCT02001623|7739757|FG001|Overall Study|Physician Decision|0
4765206|NCT02001623|7739758|FG002|Overall Study|Physician Decision|0
4765207|NCT02001623|7739759|FG003|Overall Study|Physician Decision|0
4765208|NCT02001623|7739760|FG004|Overall Study|Physician Decision|0
4765209|NCT02001623|7739761|FG005|Overall Study|Physician Decision|0
4765210|NCT02001623|7739762|FG006|Overall Study|Physician Decision|0
4765211|NCT02001623|7739763|FG007|Overall Study|Physician Decision|0
4765212|NCT02001623|7739764|FG008|Overall Study|Physician Decision|3
4765213|NCT02001623|7739765|FG009|Overall Study|Physician Decision|2
4765214|NCT02001623|7739766|FG010|Overall Study|Physician Decision|3
4765215|NCT02001623|7739767|FG011|Overall Study|Physician Decision|3
4765216|NCT02001623|7739768|FG012|Overall Study|Physician Decision|1
4765217|NCT02001623|7739769|FG013|Overall Study|Physician Decision|2
4765218|NCT02001623|7739770|FG014|Overall Study|Physician Decision|1
4765219|NCT02001623|7739756|FG000|Overall Study|Death|0
4765220|NCT02001623|7739757|FG001|Overall Study|Death|1
4765221|NCT02001623|7739758|FG002|Overall Study|Death|0
4765222|NCT02001623|7739759|FG003|Overall Study|Death|0
4765223|NCT02001623|7739760|FG004|Overall Study|Death|0
4765224|NCT02001623|7739761|FG005|Overall Study|Death|0
4765225|NCT02001623|7739762|FG006|Overall Study|Death|0
4765226|NCT02001623|7739763|FG007|Overall Study|Death|0
4765227|NCT02001623|7739764|FG008|Overall Study|Death|0
4765228|NCT02001623|7739765|FG009|Overall Study|Death|0
4765229|NCT02001623|7739766|FG010|Overall Study|Death|0
4765230|NCT02001623|7739767|FG011|Overall Study|Death|0
4765231|NCT02001623|7739768|FG012|Overall Study|Death|0
4765232|NCT02001623|7739769|FG013|Overall Study|Death|0
4765233|NCT02001623|7739770|FG014|Overall Study|Death|0
4765234|NCT02001623|7739756|FG000|Overall Study|Adverse Event|0
4765235|NCT02001623|7739757|FG001|Overall Study|Adverse Event|0
4765236|NCT02001623|7739758|FG002|Overall Study|Adverse Event|0
4765237|NCT02001623|7739759|FG003|Overall Study|Adverse Event|0
4765238|NCT02001623|7739760|FG004|Overall Study|Adverse Event|0
4765239|NCT02001623|7739761|FG005|Overall Study|Adverse Event|1
4765240|NCT02001623|7739762|FG006|Overall Study|Adverse Event|0
4765241|NCT02001623|7739763|FG007|Overall Study|Adverse Event|3
4765242|NCT02001623|7739764|FG008|Overall Study|Adverse Event|4
4765243|NCT02001623|7739765|FG009|Overall Study|Adverse Event|6
4765244|NCT02001623|7739766|FG010|Overall Study|Adverse Event|4
4765245|NCT02001623|7739767|FG011|Overall Study|Adverse Event|0
4765246|NCT02001623|7739768|FG012|Overall Study|Adverse Event|3
4765247|NCT02001623|7739769|FG013|Overall Study|Adverse Event|5
4765248|NCT02001623|7739770|FG014|Overall Study|Adverse Event|6
4765249|NCT02001623|7739756|FG000|Overall Study|Other - Miscellaneous|0
4765250|NCT02001623|7739757|FG001|Overall Study|Other - Miscellaneous|0
4765251|NCT02001623|7739758|FG002|Overall Study|Other - Miscellaneous|0
4765252|NCT02001623|7739759|FG003|Overall Study|Other - Miscellaneous|0
4765253|NCT02001623|7739760|FG004|Overall Study|Other - Miscellaneous|0
4765254|NCT02001623|7739761|FG005|Overall Study|Other - Miscellaneous|0
4765255|NCT02001623|7739762|FG006|Overall Study|Other - Miscellaneous|0
4765256|NCT02001623|7739763|FG007|Overall Study|Other - Miscellaneous|0
4765257|NCT02001623|7739764|FG008|Overall Study|Other - Miscellaneous|0
4765258|NCT02001623|7739765|FG009|Overall Study|Other - Miscellaneous|1
4765259|NCT02001623|7739766|FG010|Overall Study|Other - Miscellaneous|0
4765260|NCT02001623|7739767|FG011|Overall Study|Other - Miscellaneous|0
4765261|NCT02001623|7739768|FG012|Overall Study|Other - Miscellaneous|0
4765262|NCT02001623|7739769|FG013|Overall Study|Other - Miscellaneous|1
4765263|NCT02001623|7739770|FG014|Overall Study|Other - Miscellaneous|0
4765264|NCT02001623|7739756|FG000|Overall Study|Withdrawal by Subject|1
4765265|NCT02001623|7739757|FG001|Overall Study|Withdrawal by Subject|0
4765266|NCT02001623|7739758|FG002|Overall Study|Withdrawal by Subject|0
4765267|NCT02001623|7739759|FG003|Overall Study|Withdrawal by Subject|0
4765268|NCT02001623|7739760|FG004|Overall Study|Withdrawal by Subject|0
4765269|NCT02001623|7739761|FG005|Overall Study|Withdrawal by Subject|0
4765270|NCT02001623|7739762|FG006|Overall Study|Withdrawal by Subject|0
4765271|NCT02001623|7739763|FG007|Overall Study|Withdrawal by Subject|0
4765272|NCT02001623|7739764|FG008|Overall Study|Withdrawal by Subject|1
4765273|NCT02001623|7739765|FG009|Overall Study|Withdrawal by Subject|3
4765274|NCT02001623|7739766|FG010|Overall Study|Withdrawal by Subject|2
4765275|NCT02001623|7739767|FG011|Overall Study|Withdrawal by Subject|2
4765276|NCT02001623|7739768|FG012|Overall Study|Withdrawal by Subject|1
4765277|NCT02001623|7739769|FG013|Overall Study|Withdrawal by Subject|5
4765278|NCT02001623|7739770|FG014|Overall Study|Withdrawal by Subject|2
4765279|NCT02001623|7739756|FG000|Overall Study|Lost to Follow-up|0
4765280|NCT02001623|7739757|FG001|Overall Study|Lost to Follow-up|0
4765281|NCT02001623|7739758|FG002|Overall Study|Lost to Follow-up|0
4765282|NCT02001623|7739759|FG003|Overall Study|Lost to Follow-up|0
4765283|NCT02001623|7739760|FG004|Overall Study|Lost to Follow-up|0
4765284|NCT02001623|7739761|FG005|Overall Study|Lost to Follow-up|0
4765285|NCT02001623|7739762|FG006|Overall Study|Lost to Follow-up|0
4765286|NCT02001623|7739763|FG007|Overall Study|Lost to Follow-up|0
4765287|NCT02001623|7739764|FG008|Overall Study|Lost to Follow-up|0
4765288|NCT02001623|7739765|FG009|Overall Study|Lost to Follow-up|1
4765289|NCT02001623|7739766|FG010|Overall Study|Lost to Follow-up|0
4765290|NCT02001623|7739767|FG011|Overall Study|Lost to Follow-up|0
4765291|NCT02001623|7739768|FG012|Overall Study|Lost to Follow-up|0
4765292|NCT02001623|7739769|FG013|Overall Study|Lost to Follow-up|0
4765293|NCT02001623|7739770|FG014|Overall Study|Lost to Follow-up|0
4765294|NCT02001623|7739756|FG000|Overall Study|Start of New Anti-cancer Treatment|0
4765295|NCT02001623|7739757|FG001|Overall Study|Start of New Anti-cancer Treatment|0
4765296|NCT02001623|7739758|FG002|Overall Study|Start of New Anti-cancer Treatment|0
4765297|NCT02001623|7739759|FG003|Overall Study|Start of New Anti-cancer Treatment|0
4765298|NCT02001623|7739760|FG004|Overall Study|Start of New Anti-cancer Treatment|0
4765299|NCT02001623|7739761|FG005|Overall Study|Start of New Anti-cancer Treatment|0
4765300|NCT02001623|7739762|FG006|Overall Study|Start of New Anti-cancer Treatment|0
4765301|NCT02001623|7739763|FG007|Overall Study|Start of New Anti-cancer Treatment|0
4765302|NCT02001623|7739764|FG008|Overall Study|Start of New Anti-cancer Treatment|0
4765303|NCT02001623|7739765|FG009|Overall Study|Start of New Anti-cancer Treatment|0
4765304|NCT02001623|7739766|FG010|Overall Study|Start of New Anti-cancer Treatment|0
4765305|NCT02001623|7739767|FG011|Overall Study|Start of New Anti-cancer Treatment|1
4765306|NCT02001623|7739768|FG012|Overall Study|Start of New Anti-cancer Treatment|0
4765307|NCT02001623|7739769|FG013|Overall Study|Start of New Anti-cancer Treatment|1
4765308|NCT02001623|7739770|FG014|Overall Study|Start of New Anti-cancer Treatment|0
4765309|NCT02001623|7739756|FG000|Overall Study|Dose Delay Due to Toxicity|0
4765310|NCT02001623|7739757|FG001|Overall Study|Dose Delay Due to Toxicity|0
4765311|NCT02001623|7739758|FG002|Overall Study|Dose Delay Due to Toxicity|0
4765312|NCT02001623|7739759|FG003|Overall Study|Dose Delay Due to Toxicity|0
4765313|NCT02001623|7739760|FG004|Overall Study|Dose Delay Due to Toxicity|0
4765314|NCT02001623|7739761|FG005|Overall Study|Dose Delay Due to Toxicity|0
4765315|NCT02001623|7739762|FG006|Overall Study|Dose Delay Due to Toxicity|0
4765316|NCT02001623|7739763|FG007|Overall Study|Dose Delay Due to Toxicity|0
4765317|NCT02001623|7739764|FG008|Overall Study|Dose Delay Due to Toxicity|0
4765318|NCT02001623|7739765|FG009|Overall Study|Dose Delay Due to Toxicity|0
4765319|NCT02001623|7739766|FG010|Overall Study|Dose Delay Due to Toxicity|0
4765320|NCT02001623|7739767|FG011|Overall Study|Dose Delay Due to Toxicity|0
4765321|NCT02001623|7739768|FG012|Overall Study|Dose Delay Due to Toxicity|0
4765322|NCT02001623|7739769|FG013|Overall Study|Dose Delay Due to Toxicity|1
4765323|NCT02001623|7739770|FG014|Overall Study|Dose Delay Due to Toxicity|0
4765324|NCT01900002|7739819|FG000|Overall Study|Withdrawal by Subject|2
4765325|NCT01900002|7739819|FG000|Overall Study|ineligible for Y-90|4
4765326|NCT01595061|7739823|FG000|Overall Study|Never Treated|3
4765327|NCT01595061|7739823|FG000|Overall Study|Inadequate Pathology|1
4765328|NCT04388527|7739836|FG000|Overall Study|Death|14
4765329|NCT04388527|7739836|FG000|Overall Study|Withdrawal by Subject|2
4765330|NCT04388527|7739836|FG000|Overall Study|Lost to Follow-up|1
4765331|NCT04126083|7739849|FG000|Overall Study|Withdrawal by Subject|1
4765332|NCT03444038|7739972|FG000|Overall Study|Adverse Event|12
4765333|NCT03444038|7739972|FG000|Overall Study|Withdrawal by Subject|7
4765334|NCT03444038|7739972|FG000|Overall Study|Lost to Follow-up|1
4765335|NCT03444038|7739972|FG000|Overall Study|Physician Decision|2
4765336|NCT03444038|7739972|FG000|Overall Study|Lack of Efficacy|7
4765337|NCT03265665|7739982|FG000|24-week Data Collection|Withdrawal by Subject|2
4765338|NCT03265665|7739983|FG001|24-week Data Collection|Withdrawal by Subject|2
4765339|NCT03265665|7739982|FG000|24-week Data Collection|Lost to Follow-up|4
4765340|NCT03265665|7739983|FG001|24-week Data Collection|Lost to Follow-up|5
4765341|NCT03265665|7739982|FG000|36-week Data Collection|Lost to Follow-up|6
4765342|NCT03265665|7739983|FG001|36-week Data Collection|Lost to Follow-up|8
4765343|NCT02725593|7739997|FG000|Blinded Treatment Period|Withdrawal by Subject|4
4765344|NCT02725593|7739998|FG001|Blinded Treatment Period|Withdrawal by Subject|3
4765345|NCT02725593|7739997|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0
4765346|NCT02725593|7739998|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2
4765347|NCT02725593|7739997|FG000|Blinded Treatment Period|Lost to Follow-up|1
4765348|NCT02725593|7739998|FG001|Blinded Treatment Period|Lost to Follow-up|1
4765349|NCT02725593|7739997|FG000|Long Term Extension|Withdrawal by Subject|1
4765350|NCT02725593|7739998|FG001|Long Term Extension|Withdrawal by Subject|3
4765351|NCT02716675|7740007|FG000|Overall Study|Death|2
4765352|NCT02716675|7740008|FG001|Overall Study|Death|3
4765353|NCT02716675|7740009|FG002|Overall Study|Death|0
4765354|NCT02716675|7740007|FG000|Overall Study|Physician Decision|2
4765355|NCT02716675|7740008|FG001|Overall Study|Physician Decision|1
4765356|NCT02716675|7740009|FG002|Overall Study|Physician Decision|1
4765357|NCT02716675|7740007|FG000|Overall Study|Lost to Follow-up|100
4765358|NCT02716675|7740008|FG001|Overall Study|Lost to Follow-up|87
4765359|NCT02716675|7740009|FG002|Overall Study|Lost to Follow-up|99
4765360|NCT02716675|7740007|FG000|Overall Study|Withdrawal by Subject|22
4765361|NCT02716675|7740008|FG001|Overall Study|Withdrawal by Subject|25
4765362|NCT02716675|7740009|FG002|Overall Study|Withdrawal by Subject|20
4765363|NCT02716675|7740007|FG000|Overall Study|Protocol Violation|0
4765364|NCT02716675|7740008|FG001|Overall Study|Protocol Violation|3
4765365|NCT02716675|7740009|FG002|Overall Study|Protocol Violation|1
4765366|NCT02716675|7740007|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36
4765367|NCT02716675|7740008|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31
4765368|NCT02716675|7740009|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42
4765369|NCT02716675|7740007|FG000|Overall Study|Other|38
4765370|NCT02716675|7740008|FG001|Overall Study|Other|47
4765371|NCT02716675|7740009|FG002|Overall Study|Other|48
4765372|NCT02636946|7740024|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0
4765373|NCT02636946|7740025|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1
4765374|NCT02636946|7740024|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1
4765375|NCT02636946|7740025|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0
4765376|NCT02636946|7740024|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0
4765377|NCT02636946|7740025|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1
4765378|NCT02636946|7740024|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0
4765379|NCT02636946|7740025|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1
4765380|NCT02636946|7740024|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0
4765381|NCT02636946|7740025|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2
4765382|NCT02636946|7740024|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2
4765383|NCT02636946|7740025|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1
4765384|NCT02631941|7740041|FG000|Overall Study|Physician Decision|0
4765385|NCT02631941|7740042|FG001|Overall Study|Physician Decision|1
4765386|NCT02631941|7740043|FG002|Overall Study|Physician Decision|0
4765387|NCT02631941|7740044|FG003|Overall Study|Physician Decision|0
4765388|NCT02631941|7740045|FG004|Overall Study|Physician Decision|0
4765389|NCT02631941|7740046|FG005|Overall Study|Physician Decision|0
4765390|NCT02631941|7740047|FG006|Overall Study|Physician Decision|0
4765391|NCT02631941|7740048|FG007|Overall Study|Physician Decision|0
4765392|NCT02631941|7740049|FG008|Overall Study|Physician Decision|0
4765393|NCT02631941|7740050|FG009|Overall Study|Physician Decision|0
4765394|NCT02631941|7740041|FG000|Overall Study|Adverse Event|0
4765395|NCT02631941|7740042|FG001|Overall Study|Adverse Event|1
4765396|NCT02631941|7740043|FG002|Overall Study|Adverse Event|0
4765397|NCT02631941|7740044|FG003|Overall Study|Adverse Event|0
4765398|NCT02631941|7740045|FG004|Overall Study|Adverse Event|0
4765399|NCT02631941|7740046|FG005|Overall Study|Adverse Event|0
4765400|NCT02631941|7740047|FG006|Overall Study|Adverse Event|0
4765401|NCT02631941|7740048|FG007|Overall Study|Adverse Event|0
4765402|NCT02631941|7740049|FG008|Overall Study|Adverse Event|0
4765403|NCT02631941|7740050|FG009|Overall Study|Adverse Event|0
4765404|NCT02631941|7740041|FG000|Overall Study|Withdrawal by Subject|0
4765405|NCT02631941|7740042|FG001|Overall Study|Withdrawal by Subject|0
4765406|NCT02631941|7740043|FG002|Overall Study|Withdrawal by Subject|0
4765407|NCT02631941|7740044|FG003|Overall Study|Withdrawal by Subject|0
4765408|NCT02631941|7740045|FG004|Overall Study|Withdrawal by Subject|1
4765409|NCT02631941|7740046|FG005|Overall Study|Withdrawal by Subject|0
4765410|NCT02631941|7740047|FG006|Overall Study|Withdrawal by Subject|0
4765411|NCT02631941|7740048|FG007|Overall Study|Withdrawal by Subject|1
4765412|NCT02631941|7740049|FG008|Overall Study|Withdrawal by Subject|0
4765413|NCT02631941|7740050|FG009|Overall Study|Withdrawal by Subject|0
4765414|NCT02631941|7740041|FG000|Overall Study|Lost to Follow-up|0
4765415|NCT02631941|7740042|FG001|Overall Study|Lost to Follow-up|0
4765416|NCT02631941|7740043|FG002|Overall Study|Lost to Follow-up|0
4765417|NCT02631941|7740044|FG003|Overall Study|Lost to Follow-up|0
4765418|NCT02631941|7740045|FG004|Overall Study|Lost to Follow-up|0
4765419|NCT02631941|7740046|FG005|Overall Study|Lost to Follow-up|0
4765420|NCT02631941|7740047|FG006|Overall Study|Lost to Follow-up|0
4765421|NCT02631941|7740048|FG007|Overall Study|Lost to Follow-up|0
4765422|NCT02631941|7740049|FG008|Overall Study|Lost to Follow-up|1
4765423|NCT02631941|7740050|FG009|Overall Study|Lost to Follow-up|0
4765424|NCT02568215|7740063|FG000|Overall Study|Death|1
4765425|NCT02568215|7740064|FG001|Overall Study|Death|2
4765426|NCT02568215|7740065|FG002|Overall Study|Death|0
4765427|NCT02568215|7740063|FG000|Overall Study|Physician Decision|2
4765428|NCT02568215|7740064|FG001|Overall Study|Physician Decision|2
4765429|NCT02568215|7740065|FG002|Overall Study|Physician Decision|2
4765430|NCT02568215|7740063|FG000|Overall Study|Lost to Follow-up|29
4765431|NCT02568215|7740064|FG001|Overall Study|Lost to Follow-up|32
4765432|NCT02568215|7740065|FG002|Overall Study|Lost to Follow-up|41
4765433|NCT02568215|7740063|FG000|Overall Study|Withdrawal by Subject|21
4765434|NCT02568215|7740064|FG001|Overall Study|Withdrawal by Subject|19
4765435|NCT02568215|7740065|FG002|Overall Study|Withdrawal by Subject|22
4765436|NCT02568215|7740063|FG000|Overall Study|Protocol Violation|1
4765437|NCT02568215|7740064|FG001|Overall Study|Protocol Violation|1
4765438|NCT02568215|7740065|FG002|Overall Study|Protocol Violation|0
4765439|NCT02568215|7740063|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25
4765440|NCT02568215|7740064|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23
4765441|NCT02568215|7740065|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21
4765442|NCT02568215|7740063|FG000|Overall Study|Other|0
4765443|NCT02568215|7740064|FG001|Overall Study|Other|1
4765444|NCT02568215|7740065|FG002|Overall Study|Other|4
4765445|NCT02528643|7740093|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5
4765446|NCT02528643|7740094|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8
4765447|NCT02528643|7740093|FG000|DB (Median Duration up to 14.65 Months)|Death|1
4765448|NCT02528643|7740094|FG001|DB (Median Duration up to 14.65 Months)|Death|6
4765449|NCT02528643|7740093|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0
4765450|NCT02528643|7740094|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1
4765451|NCT02528643|7740093|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44
4765452|NCT02528643|7740094|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82
4765453|NCT02528643|7740093|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2
4765454|NCT02528643|7740094|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8
4765455|NCT02528643|7740093|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3
4765456|NCT02528643|7740094|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5
4765457|NCT02528643|7740093|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0
4765458|NCT02528643|7740094|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1
4765459|NCT02527434|7740105|FG000|Overall Study|Lost to Follow-up|2
4765460|NCT02527434|7740106|FG001|Overall Study|Lost to Follow-up|2
4765461|NCT02527434|7740107|FG002|Overall Study|Lost to Follow-up|0
4765462|NCT02527434|7740105|FG000|Overall Study|Death|19
4765463|NCT02527434|7740106|FG001|Overall Study|Death|6
4765464|NCT02527434|7740107|FG002|Overall Study|Death|17
4765465|NCT02527434|7740105|FG000|Overall Study|Withdrawal by Subject|5
4765466|NCT02527434|7740106|FG001|Overall Study|Withdrawal by Subject|3
4765467|NCT02527434|7740107|FG002|Overall Study|Withdrawal by Subject|3
4765468|NCT02527434|7740105|FG000|Overall Study|Reason Not Specified|1
4765469|NCT02527434|7740106|FG001|Overall Study|Reason Not Specified|0
4765470|NCT02527434|7740107|FG002|Overall Study|Reason Not Specified|0
4765471|NCT02527434|7740105|FG000|Overall Study|Site closure|1
4765472|NCT02527434|7740106|FG001|Overall Study|Site closure|0
4765473|NCT02527434|7740107|FG002|Overall Study|Site closure|0
4765474|NCT02237508|7740161|FG000|Overall Study|Withdrawal by Subject|0
4765475|NCT02237508|7740162|FG001|Overall Study|Withdrawal by Subject|2
4765476|NCT02237508|7740163|FG002|Overall Study|Withdrawal by Subject|0
4765477|NCT02237508|7740164|FG003|Overall Study|Withdrawal by Subject|1
4765478|NCT02237508|7740165|FG004|Overall Study|Withdrawal by Subject|0
4765479|NCT02237508|7740166|FG005|Overall Study|Withdrawal by Subject|1
4765480|NCT02237508|7740167|FG006|Overall Study|Withdrawal by Subject|1
4765481|NCT02237508|7740168|FG007|Overall Study|Withdrawal by Subject|0
4765482|NCT02237508|7740169|FG008|Overall Study|Withdrawal by Subject|1
4765483|NCT02237508|7740170|FG009|Overall Study|Withdrawal by Subject|0
4765484|NCT02237508|7740161|FG000|Overall Study|Physician Decision|0
4765485|NCT02237508|7740162|FG001|Overall Study|Physician Decision|1
4765486|NCT02237508|7740163|FG002|Overall Study|Physician Decision|0
4765487|NCT02237508|7740164|FG003|Overall Study|Physician Decision|0
4765488|NCT02237508|7740165|FG004|Overall Study|Physician Decision|0
4765489|NCT02237508|7740166|FG005|Overall Study|Physician Decision|0
4765490|NCT02237508|7740167|FG006|Overall Study|Physician Decision|0
4765491|NCT02237508|7740168|FG007|Overall Study|Physician Decision|0
4765492|NCT02237508|7740169|FG008|Overall Study|Physician Decision|0
4765493|NCT02237508|7740170|FG009|Overall Study|Physician Decision|0
4765494|NCT02237508|7740161|FG000|Overall Study|Protocol Violation|0
4765495|NCT02237508|7740162|FG001|Overall Study|Protocol Violation|0
4765496|NCT02237508|7740163|FG002|Overall Study|Protocol Violation|1
4765497|NCT02237508|7740164|FG003|Overall Study|Protocol Violation|0
4765498|NCT02237508|7740165|FG004|Overall Study|Protocol Violation|0
4765499|NCT02237508|7740166|FG005|Overall Study|Protocol Violation|0
4765500|NCT02237508|7740167|FG006|Overall Study|Protocol Violation|0
4765501|NCT02237508|7740168|FG007|Overall Study|Protocol Violation|0
4765502|NCT02237508|7740169|FG008|Overall Study|Protocol Violation|0
4765503|NCT02237508|7740170|FG009|Overall Study|Protocol Violation|0
4765504|NCT02197234|7740188|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1
4765505|NCT02197234|7740188|FG000|Part A: Day 3-30 (AZD9291 Alone)|Adverse Event|1
4765506|NCT02197234|7740188|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1
4765507|NCT02197234|7740188|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1
4765508|NCT02197234|7740188|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1
4765509|NCT02197234|7740188|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6
4765510|NCT02197234|7740188|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22
4765511|NCT02163733|7740197|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0
4765512|NCT02163733|7740198|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0
4765513|NCT02163733|7740199|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5
4765514|NCT02163733|7740197|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0
4765515|NCT02163733|7740198|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0
4765516|NCT02163733|7740199|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19
4765517|NCT02157883|7740206|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1
4765518|NCT02157883|7740206|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3
4765519|NCT02157883|7740206|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15
4765520|NCT02157883|7740206|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1
4765521|NCT02157883|7740206|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3
4765522|NCT01802632|7740219|FG000|Overall Study|Death|28
4765523|NCT01802632|7740220|FG001|Overall Study|Death|1
4765524|NCT01802632|7740221|FG002|Overall Study|Death|38
4765525|NCT01802632|7740222|FG003|Overall Study|Death|0
4765526|NCT01802632|7740223|FG004|Overall Study|Death|2
4765527|NCT01802632|7740224|FG005|Overall Study|Death|0
4765528|NCT01802632|7740219|FG000|Overall Study|Withdrawal by Subject|4
4765529|NCT01802632|7740220|FG001|Overall Study|Withdrawal by Subject|2
4765530|NCT01802632|7740221|FG002|Overall Study|Withdrawal by Subject|7
4765531|NCT01802632|7740222|FG003|Overall Study|Withdrawal by Subject|3
4765532|NCT01802632|7740223|FG004|Overall Study|Withdrawal by Subject|0
4765533|NCT01802632|7740224|FG005|Overall Study|Withdrawal by Subject|1
4765534|NCT01802632|7740219|FG000|Overall Study|Objective Disease Progression|1
4765535|NCT01802632|7740220|FG001|Overall Study|Objective Disease Progression|12
4765536|NCT01802632|7740221|FG002|Overall Study|Objective Disease Progression|104
4765537|NCT01802632|7740222|FG003|Overall Study|Objective Disease Progression|6
4765538|NCT01802632|7740223|FG004|Overall Study|Objective Disease Progression|4
4765539|NCT01802632|7740224|FG005|Overall Study|Objective Disease Progression|4
4765540|NCT01802632|7740219|FG000|Overall Study|Ongoing Study at Data Cut-off|168
4765541|NCT01802632|7740220|FG001|Overall Study|Ongoing Study at Data Cut-off|16
4765542|NCT01802632|7740221|FG002|Overall Study|Ongoing Study at Data Cut-off|115
4765543|NCT01802632|7740222|FG003|Overall Study|Ongoing Study at Data Cut-off|50
4765544|NCT01802632|7740223|FG004|Overall Study|Ongoing Study at Data Cut-off|6
4765545|NCT01802632|7740224|FG005|Overall Study|Ongoing Study at Data Cut-off|22
4765546|NCT01802632|7740219|FG000|Overall Study|Other (not specified)|0
4765547|NCT01802632|7740220|FG001|Overall Study|Other (not specified)|0
4765548|NCT01802632|7740221|FG002|Overall Study|Other (not specified)|7
4765549|NCT01802632|7740222|FG003|Overall Study|Other (not specified)|1
4765550|NCT01802632|7740223|FG004|Overall Study|Other (not specified)|0
4765551|NCT01802632|7740224|FG005|Overall Study|Other (not specified)|1
4765552|NCT01706705|7740236|FG000|Overall Study|Death|1
4765553|NCT01706705|7740236|FG000|Overall Study|Lack of Efficacy|13
4765554|NCT01706705|7740236|FG000|Overall Study|Non-clinical|6
4765555|NCT01625286|7740248|FG000|Overall Study|Adverse Event|0
4765556|NCT01625286|7740249|FG001|Overall Study|Adverse Event|0
4765557|NCT01625286|7740250|FG002|Overall Study|Adverse Event|0
4765558|NCT01625286|7740251|FG003|Overall Study|Adverse Event|0
4765559|NCT01625286|7740252|FG004|Overall Study|Adverse Event|1
4765560|NCT01625286|7740253|FG005|Overall Study|Adverse Event|2
4765561|NCT01625286|7740254|FG006|Overall Study|Adverse Event|1
4765562|NCT01625286|7740248|FG000|Overall Study|Death|0
4765563|NCT01625286|7740249|FG001|Overall Study|Death|0
4765564|NCT01625286|7740250|FG002|Overall Study|Death|1
4765565|NCT01625286|7740251|FG003|Overall Study|Death|1
4765566|NCT01625286|7740252|FG004|Overall Study|Death|0
4765567|NCT01625286|7740253|FG005|Overall Study|Death|11
4765568|NCT01625286|7740254|FG006|Overall Study|Death|16
4765569|NCT01625286|7740248|FG000|Overall Study|Withdrawal by Subject|0
4765570|NCT01625286|7740249|FG001|Overall Study|Withdrawal by Subject|1
4765571|NCT01625286|7740250|FG002|Overall Study|Withdrawal by Subject|0
4765572|NCT01625286|7740251|FG003|Overall Study|Withdrawal by Subject|1
4765573|NCT01625286|7740252|FG004|Overall Study|Withdrawal by Subject|0
4765574|NCT01625286|7740253|FG005|Overall Study|Withdrawal by Subject|0
4765575|NCT01625286|7740254|FG006|Overall Study|Withdrawal by Subject|1
4765576|NCT01625286|7740248|FG000|Overall Study|Any reason not specifically recorded|0
4765577|NCT01625286|7740249|FG001|Overall Study|Any reason not specifically recorded|0
4765578|NCT01625286|7740250|FG002|Overall Study|Any reason not specifically recorded|0
4765579|NCT01625286|7740251|FG003|Overall Study|Any reason not specifically recorded|0
4765580|NCT01625286|7740252|FG004|Overall Study|Any reason not specifically recorded|0
4765581|NCT01625286|7740253|FG005|Overall Study|Any reason not specifically recorded|1
4765582|NCT01625286|7740254|FG006|Overall Study|Any reason not specifically recorded|0
4765583|NCT01625286|7740248|FG000|Overall Study|Progressive disease|6
4765584|NCT01625286|7740249|FG001|Overall Study|Progressive disease|3
4765585|NCT01625286|7740250|FG002|Overall Study|Progressive disease|4
4765586|NCT01625286|7740251|FG003|Overall Study|Progressive disease|5
4765587|NCT01625286|7740252|FG004|Overall Study|Progressive disease|5
4765588|NCT01625286|7740253|FG005|Overall Study|Progressive disease|0
4765589|NCT01625286|7740254|FG006|Overall Study|Progressive disease|0
4765590|NCT01625286|7740248|FG000|Overall Study|Lost to Follow-up|0
4765591|NCT01625286|7740249|FG001|Overall Study|Lost to Follow-up|0
4765592|NCT01625286|7740250|FG002|Overall Study|Lost to Follow-up|0
4765593|NCT01625286|7740251|FG003|Overall Study|Lost to Follow-up|0
4765594|NCT01625286|7740252|FG004|Overall Study|Lost to Follow-up|0
4765595|NCT01625286|7740253|FG005|Overall Study|Lost to Follow-up|0
4765596|NCT01625286|7740254|FG006|Overall Study|Lost to Follow-up|1
4765597|NCT01625286|7740248|FG000|Overall Study|Ongoing off-treatment at DCO|0
4765598|NCT01625286|7740249|FG001|Overall Study|Ongoing off-treatment at DCO|0
4765599|NCT01625286|7740250|FG002|Overall Study|Ongoing off-treatment at DCO|0
4765600|NCT01625286|7740251|FG003|Overall Study|Ongoing off-treatment at DCO|0
4765601|NCT01625286|7740252|FG004|Overall Study|Ongoing off-treatment at DCO|0
4765602|NCT01625286|7740253|FG005|Overall Study|Ongoing off-treatment at DCO|32
4765603|NCT01625286|7740254|FG006|Overall Study|Ongoing off-treatment at DCO|31
4765604|NCT01625286|7740248|FG000|Overall Study|Ongoing on-treatment at DCO|6
4765605|NCT01625286|7740249|FG001|Overall Study|Ongoing on-treatment at DCO|4
4765606|NCT01625286|7740250|FG002|Overall Study|Ongoing on-treatment at DCO|0
4765607|NCT01625286|7740251|FG003|Overall Study|Ongoing on-treatment at DCO|0
4765608|NCT01625286|7740252|FG004|Overall Study|Ongoing on-treatment at DCO|0
4765609|NCT01625286|7740253|FG005|Overall Study|Ongoing on-treatment at DCO|8
4765610|NCT01625286|7740254|FG006|Overall Study|Ongoing on-treatment at DCO|6
4765611|NCT01609842|7740274|FG000|Concurrent Intervention Control|pharmacy data not available|2
4765612|NCT01609842|7740275|FG001|Concurrent Intervention Control|pharmacy data not available|0
4765613|NCT00288080|7740309|FG000|Overall Study|Withdrawal by Subject|1
4765614|NCT00288080|7740310|FG001|Overall Study|Withdrawal by Subject|3
4765615|NCT00288080|7740309|FG000|Overall Study|Protocol Violation|25
4765616|NCT00288080|7740310|FG001|Overall Study|Protocol Violation|20
4765617|NCT00099437|7740318|FG000|Overall Study|Lost to Follow-up|30
4765618|NCT00099437|7740319|FG001|Overall Study|Lost to Follow-up|33
4765619|NCT00099437|7740318|FG000|Overall Study|Death|293
4765620|NCT00099437|7740319|FG001|Overall Study|Death|261
4765621|NCT00099437|7740318|FG000|Overall Study|Withdrawal by Subject|6
4765622|NCT00099437|7740319|FG001|Overall Study|Withdrawal by Subject|10
4765623|NCT00099437|7740318|FG000|Overall Study|Ongoing in FU but not on treatment|37
4765624|NCT00099437|7740319|FG001|Overall Study|Ongoing in FU but not on treatment|45
4765625|NCT00003479|7740325|FG000|Overall Study|Not evaluable|3
4765626|NCT04160195|7740331|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1
4765627|NCT04160195|7740332|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0
4765628|NCT04159701|7740342|FG000|Period 1: Treatment Period|Pregnancy|1
4765629|NCT04159701|7740343|FG001|Period 1: Treatment Period|Pregnancy|0
4765630|NCT04159701|7740342|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4
4765631|NCT04159701|7740343|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1
4765632|NCT04159701|7740342|FG000|Period 1: Treatment Period|Withdrawal by Subject|3
4765633|NCT04159701|7740343|FG001|Period 1: Treatment Period|Withdrawal by Subject|0
4765634|NCT04159701|7740342|FG000|Washout Period|site terminated by sponsor|0
4765635|NCT04159701|7740343|FG001|Washout Period|site terminated by sponsor|1
4765636|NCT04159701|7740342|FG000|Washout Period|study terminated by sponsor|10
4765637|NCT04159701|7740343|FG001|Washout Period|study terminated by sponsor|3
4765638|NCT04159701|7740342|FG000|Washout Period|Withdrawal by Subject|1
4765639|NCT04159701|7740343|FG001|Washout Period|Withdrawal by Subject|0
4765640|NCT04159701|7740342|FG000|Washout Period|Inadvertent Enrollment|1
4765641|NCT04159701|7740343|FG001|Washout Period|Inadvertent Enrollment|0
4765642|NCT04159701|7740342|FG000|Washout Period|Miscellaneous|1
4765643|NCT04159701|7740343|FG001|Washout Period|Miscellaneous|0
4765644|NCT04159701|7740342|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0
4765645|NCT04159701|7740343|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2
4765646|NCT04159701|7740342|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0
4765647|NCT04159701|7740343|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1
4765648|NCT04159701|7740342|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6
4765649|NCT04159701|7740343|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3
4765650|NCT04159701|7740342|FG000|Post-treatment Follow-up|Withdrawal by Subject|3
4765651|NCT04159701|7740343|FG001|Post-treatment Follow-up|Withdrawal by Subject|0
4765652|NCT04159701|7740342|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1
4765653|NCT04159701|7740343|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0
4765654|NCT04152447|7740355|FG000|Overall Study|Lost to Follow-up|1
4765655|NCT04152447|7740356|FG001|Overall Study|Lost to Follow-up|0
4765656|NCT04152447|7740355|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1
4765657|NCT04152447|7740356|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1
4765658|NCT04152447|7740355|FG000|Overall Study|Withdrawal by Subject|0
4765659|NCT04152447|7740356|FG001|Overall Study|Withdrawal by Subject|1
4765660|NCT04152447|7740355|FG000|Overall Study|Found ineligible after enrolling|1
4765661|NCT04152447|7740356|FG001|Overall Study|Found ineligible after enrolling|1
4765662|NCT04152447|7740355|FG000|Overall Study|Did not receive VR headset in time.|0
4765663|NCT04152447|7740356|FG001|Overall Study|Did not receive VR headset in time.|2
4765664|NCT03965962|7740379|FG000|Overall Study|Adverse Event|1
4765665|NCT03965962|7740380|FG001|Overall Study|Adverse Event|0
4765666|NCT03965962|7740381|FG002|Overall Study|Adverse Event|0
4765667|NCT03965962|7740382|FG003|Overall Study|Adverse Event|0
4765668|NCT03965962|7740379|FG000|Overall Study|Protocol Violation|21
4765669|NCT03965962|7740380|FG001|Overall Study|Protocol Violation|4
4765670|NCT03965962|7740381|FG002|Overall Study|Protocol Violation|10
4765671|NCT03965962|7740382|FG003|Overall Study|Protocol Violation|5
4765672|NCT03965962|7740379|FG000|Overall Study|Lost to Follow-up|0
4765673|NCT03965962|7740380|FG001|Overall Study|Lost to Follow-up|1
4765674|NCT03965962|7740381|FG002|Overall Study|Lost to Follow-up|0
4765675|NCT03965962|7740382|FG003|Overall Study|Lost to Follow-up|0
4765676|NCT03965962|7740379|FG000|Overall Study|Withdrawal by Subject|3
4765677|NCT03965962|7740380|FG001|Overall Study|Withdrawal by Subject|0
4765678|NCT03965962|7740381|FG002|Overall Study|Withdrawal by Subject|0
4765679|NCT03965962|7740382|FG003|Overall Study|Withdrawal by Subject|1
4765680|NCT03861481|7740394|FG000|Overall Study|COVID-19 pandemic circumstances|0
4765681|NCT03861481|7740395|FG001|Overall Study|COVID-19 pandemic circumstances|1
4765682|NCT03861481|7740394|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1
4765683|NCT03861481|7740395|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0
4765684|NCT03861481|7740394|FG000|Overall Study|Relapse|1
4765685|NCT03861481|7740395|FG001|Overall Study|Relapse|0
4765686|NCT03861481|7740394|FG000|Overall Study|Withdrawal by Subject|0
4765687|NCT03861481|7740395|FG001|Overall Study|Withdrawal by Subject|1
4765688|NCT03861481|7740394|FG000|Overall Study|Lack of Efficacy|4
4765689|NCT03861481|7740395|FG001|Overall Study|Lack of Efficacy|5
4765690|NCT03794544|7740415|FG000|Overall Study|Withdrawal by Subject|1
4765691|NCT03794544|7740416|FG001|Overall Study|Withdrawal by Subject|1
4765692|NCT03794544|7740417|FG002|Overall Study|Withdrawal by Subject|0
4765693|NCT03794544|7740418|FG003|Overall Study|Withdrawal by Subject|0
4765694|NCT03794544|7740415|FG000|Overall Study|Death|0
4765695|NCT03794544|7740416|FG001|Overall Study|Death|0
4765696|NCT03794544|7740417|FG002|Overall Study|Death|0
4765697|NCT03794544|7740418|FG003|Overall Study|Death|1
4765698|NCT03794544|7740415|FG000|Overall Study|Lost to Follow-up|0
4765699|NCT03794544|7740416|FG001|Overall Study|Lost to Follow-up|1
4765700|NCT03794544|7740417|FG002|Overall Study|Lost to Follow-up|1
4765701|NCT03794544|7740418|FG003|Overall Study|Lost to Follow-up|0
4765702|NCT03794544|7740415|FG000|Overall Study|Other|0
4765703|NCT03794544|7740416|FG001|Overall Study|Other|1
4765704|NCT03794544|7740417|FG002|Overall Study|Other|0
4765705|NCT03794544|7740418|FG003|Overall Study|Other|0
4765706|NCT03732807|7740435|FG000|Treatment Period (up to Week 24)|Adverse Event|3
4765707|NCT03732807|7740436|FG001|Treatment Period (up to Week 24)|Adverse Event|0
4765708|NCT03732807|7740437|FG002|Treatment Period (up to Week 24)|Adverse Event|2
4765709|NCT03732807|7740438|FG003|Treatment Period (up to Week 24)|Adverse Event|4
4765710|NCT03732807|7740439|FG004|Treatment Period (up to Week 24)|Adverse Event|2
4765711|NCT03732807|7740440|FG005|Treatment Period (up to Week 24)|Adverse Event|0
4765712|NCT03732807|7740441|FG006|Treatment Period (up to Week 24)|Adverse Event|1
4765713|NCT03732807|7740435|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1
4765714|NCT03732807|7740436|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0
4765715|NCT03732807|7740437|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1
4765716|NCT03732807|7740438|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2
4765717|NCT03732807|7740439|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1
4765718|NCT03732807|7740440|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0
4765719|NCT03732807|7740441|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0
4765720|NCT03732807|7740435|FG000|Treatment Period (up to Week 24)|Physician Decision|0
4765721|NCT03732807|7740436|FG001|Treatment Period (up to Week 24)|Physician Decision|1
4765722|NCT03732807|7740437|FG002|Treatment Period (up to Week 24)|Physician Decision|2
4765723|NCT03732807|7740438|FG003|Treatment Period (up to Week 24)|Physician Decision|5
4765724|NCT03732807|7740439|FG004|Treatment Period (up to Week 24)|Physician Decision|0
4765725|NCT03732807|7740440|FG005|Treatment Period (up to Week 24)|Physician Decision|0
4765726|NCT03732807|7740441|FG006|Treatment Period (up to Week 24)|Physician Decision|1
4765727|NCT03732807|7740435|FG000|Treatment Period (up to Week 24)|Pregnancy|1
4765728|NCT03732807|7740436|FG001|Treatment Period (up to Week 24)|Pregnancy|0
4765729|NCT03732807|7740437|FG002|Treatment Period (up to Week 24)|Pregnancy|0
4765730|NCT03732807|7740438|FG003|Treatment Period (up to Week 24)|Pregnancy|0
4765731|NCT03732807|7740439|FG004|Treatment Period (up to Week 24)|Pregnancy|1
4765732|NCT03732807|7740440|FG005|Treatment Period (up to Week 24)|Pregnancy|0
4765733|NCT03732807|7740441|FG006|Treatment Period (up to Week 24)|Pregnancy|1
4765734|NCT03732807|7740435|FG000|Treatment Period (up to Week 24)|Protocol Violation|1
4765735|NCT03732807|7740436|FG001|Treatment Period (up to Week 24)|Protocol Violation|1
4765736|NCT03732807|7740437|FG002|Treatment Period (up to Week 24)|Protocol Violation|0
4765737|NCT03732807|7740438|FG003|Treatment Period (up to Week 24)|Protocol Violation|0
4765738|NCT03732807|7740439|FG004|Treatment Period (up to Week 24)|Protocol Violation|0
4765739|NCT03732807|7740440|FG005|Treatment Period (up to Week 24)|Protocol Violation|0
4765740|NCT03732807|7740441|FG006|Treatment Period (up to Week 24)|Protocol Violation|0
4765741|NCT03732807|7740435|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4
4765742|NCT03732807|7740436|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4
4765743|NCT03732807|7740437|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4
4765744|NCT03732807|7740438|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4
4765745|NCT03732807|7740439|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1
4765746|NCT03732807|7740440|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1
4765747|NCT03732807|7740441|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2
4765748|NCT03732807|7740435|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0
4765749|NCT03732807|7740436|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0
4765750|NCT03732807|7740437|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0
4765751|NCT03732807|7740438|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0
4765752|NCT03732807|7740439|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0
4765753|NCT03732807|7740440|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1
4765754|NCT03732807|7740441|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0
4765755|NCT03732807|7740435|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0
4765756|NCT03732807|7740436|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2
4765757|NCT03732807|7740437|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2
4765758|NCT03732807|7740438|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1
4765759|NCT03732807|7740439|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0
4765760|NCT03732807|7740440|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0
4765761|NCT03732807|7740441|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2
4765762|NCT03732807|7740435|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2
4765763|NCT03732807|7740436|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1
4765764|NCT03732807|7740437|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0
4765765|NCT03732807|7740438|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3
4765766|NCT03732807|7740439|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3
4765767|NCT03732807|7740440|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0
4765768|NCT03732807|7740441|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1
4765769|NCT03732807|7740435|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0
4765770|NCT03732807|7740436|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0
4765771|NCT03732807|7740437|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2
4765772|NCT03732807|7740438|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1
4765773|NCT03732807|7740439|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1
4765774|NCT03732807|7740440|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2
4765775|NCT03732807|7740441|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0
4765776|NCT03732807|7740435|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0
4765777|NCT03732807|7740436|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1
4765778|NCT03732807|7740437|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0
4765779|NCT03732807|7740438|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0
4765780|NCT03732807|7740439|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0
4765781|NCT03732807|7740440|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0
4765782|NCT03732807|7740441|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0
4765783|NCT03732807|7740435|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0
4765784|NCT03732807|7740436|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1
4765785|NCT03732807|7740437|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0
4765786|NCT03732807|7740438|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1
4765787|NCT03732807|7740439|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1
4765788|NCT03732807|7740440|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0
4765789|NCT03732807|7740441|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0
4765790|NCT03732807|7740435|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3
4765791|NCT03732807|7740436|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2
4765792|NCT03732807|7740437|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1
4765793|NCT03732807|7740438|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1
4765794|NCT03732807|7740439|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0
4765795|NCT03732807|7740440|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1
4765796|NCT03732807|7740441|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1
4765797|NCT03732807|7740435|FG000|Treatment Extension (Week 25 up to 48)|Other|1
4765798|NCT03732807|7740436|FG001|Treatment Extension (Week 25 up to 48)|Other|4
4765799|NCT03732807|7740437|FG002|Treatment Extension (Week 25 up to 48)|Other|0
4765800|NCT03732807|7740438|FG003|Treatment Extension (Week 25 up to 48)|Other|2
4765801|NCT03732807|7740439|FG004|Treatment Extension (Week 25 up to 48)|Other|0
4765802|NCT03732807|7740440|FG005|Treatment Extension (Week 25 up to 48)|Other|0
4765803|NCT03732807|7740441|FG006|Treatment Extension (Week 25 up to 48)|Other|0
4765804|NCT03731364|7740463|FG000|Overall Study|Adverse Event|0
4765805|NCT03731364|7740464|FG001|Overall Study|Adverse Event|0
4765806|NCT03731364|7740465|FG002|Overall Study|Adverse Event|1
4765807|NCT03731364|7740466|FG003|Overall Study|Adverse Event|2
4765808|NCT03731364|7740467|FG004|Overall Study|Adverse Event|1
4765809|NCT04598152|7740506|FG000|Overall Study|Lost to Follow-up|0
4765810|NCT04598152|7740507|FG001|Overall Study|Lost to Follow-up|1
4765811|NCT04570670|7740541|FG000|Overall Study|Withdrawal by Subject|1
4765812|NCT04570670|7740542|FG001|Overall Study|Withdrawal by Subject|0
4765813|NCT04546581|7740558|FG000|Overall Study|Adverse Event|9
4765814|NCT04546581|7740559|FG001|Overall Study|Adverse Event|3
4765815|NCT04546581|7740558|FG000|Overall Study|Physician Decision|0
4765816|NCT04546581|7740559|FG001|Overall Study|Physician Decision|1
4765817|NCT04546581|7740558|FG000|Overall Study|Protocol Violation|1
4765818|NCT04546581|7740559|FG001|Overall Study|Protocol Violation|2
4765819|NCT04546581|7740558|FG000|Overall Study|Withdrawal by Subject|3
4765820|NCT04546581|7740559|FG001|Overall Study|Withdrawal by Subject|7
4765821|NCT03915626|7740569|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1
4765822|NCT03698279|7740585|FG000|Overall Study|Withdrawal by parent/guardian|1
4765823|NCT03698279|7740586|FG001|Overall Study|Withdrawal by parent/guardian|1
4765824|NCT03698279|7740587|FG002|Overall Study|Withdrawal by parent/guardian|1
4765825|NCT03698279|7740588|FG003|Overall Study|Withdrawal by parent/guardian|1
4765826|NCT03698279|7740589|FG004|Overall Study|Withdrawal by parent/guardian|0
4765827|NCT03698279|7740590|FG005|Overall Study|Withdrawal by parent/guardian|0
4765828|NCT03698279|7740585|FG000|Overall Study|Protocol deviation|1
4765829|NCT03698279|7740586|FG001|Overall Study|Protocol deviation|0
4765830|NCT03698279|7740587|FG002|Overall Study|Protocol deviation|1
4765831|NCT03698279|7740588|FG003|Overall Study|Protocol deviation|0
4765832|NCT03698279|7740589|FG004|Overall Study|Protocol deviation|0
4765833|NCT03698279|7740590|FG005|Overall Study|Protocol deviation|0
4765834|NCT03698279|7740585|FG000|Overall Study|Withdrawal by Subject|0
4765835|NCT03698279|7740586|FG001|Overall Study|Withdrawal by Subject|0
4765836|NCT03698279|7740587|FG002|Overall Study|Withdrawal by Subject|1
4765837|NCT03698279|7740588|FG003|Overall Study|Withdrawal by Subject|0
4765838|NCT03698279|7740589|FG004|Overall Study|Withdrawal by Subject|0
4765839|NCT03698279|7740590|FG005|Overall Study|Withdrawal by Subject|0
4765840|NCT03698279|7740585|FG000|Overall Study|Lost to Follow-up|3
4765841|NCT03698279|7740586|FG001|Overall Study|Lost to Follow-up|1
4765842|NCT03698279|7740587|FG002|Overall Study|Lost to Follow-up|4
4765843|NCT03698279|7740588|FG003|Overall Study|Lost to Follow-up|5
4765844|NCT03698279|7740589|FG004|Overall Study|Lost to Follow-up|0
4765845|NCT03698279|7740590|FG005|Overall Study|Lost to Follow-up|0
4765846|NCT03478930|7740620|FG000|Overall Study|Adverse Event|0
4765847|NCT03478930|7740621|FG001|Overall Study|Adverse Event|1
4765848|NCT03478930|7740620|FG000|Overall Study|Lack of Efficacy|3
4765849|NCT03478930|7740621|FG001|Overall Study|Lack of Efficacy|3
4765850|NCT03478930|7740620|FG000|Overall Study|Withdrawal by Subject|6
4765851|NCT03478930|7740621|FG001|Overall Study|Withdrawal by Subject|5
4765852|NCT03434353|7740632|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10
4765853|NCT03434353|7740633|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3
4765854|NCT03434353|7740634|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11
4765855|NCT03434353|7740635|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3
4765856|NCT03434353|7740636|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17
4765857|NCT03434353|7740632|FG000|Overall Study|Withdrew consent|1
4765858|NCT03434353|7740633|FG001|Overall Study|Withdrew consent|0
4765859|NCT03434353|7740634|FG002|Overall Study|Withdrew consent|3
4765860|NCT03434353|7740635|FG003|Overall Study|Withdrew consent|0
4765861|NCT03434353|7740636|FG004|Overall Study|Withdrew consent|0
4765862|NCT03434353|7740632|FG000|Overall Study|Adverse Event|1
4765863|NCT03434353|7740633|FG001|Overall Study|Adverse Event|0
4765864|NCT03434353|7740634|FG002|Overall Study|Adverse Event|0
4765865|NCT03434353|7740635|FG003|Overall Study|Adverse Event|0
4765866|NCT03434353|7740636|FG004|Overall Study|Adverse Event|1
4765867|NCT03434353|7740632|FG000|Overall Study|Lost to Follow-up|2
4765868|NCT03434353|7740633|FG001|Overall Study|Lost to Follow-up|0
4765869|NCT03434353|7740634|FG002|Overall Study|Lost to Follow-up|0
4765870|NCT03434353|7740635|FG003|Overall Study|Lost to Follow-up|0
4765871|NCT03434353|7740636|FG004|Overall Study|Lost to Follow-up|0
4765872|NCT03415022|7740650|FG000|Overall Study|Withdrawal by Subject|1
4765873|NCT03415022|7740651|FG001|Overall Study|Withdrawal by Subject|2
4765874|NCT03415022|7740650|FG000|Overall Study|COVID-19 Suspension|2
4765875|NCT03415022|7740651|FG001|Overall Study|COVID-19 Suspension|3
4765876|NCT03415022|7740650|FG000|Overall Study|Lost to Follow-up|2
4765877|NCT03415022|7740651|FG001|Overall Study|Lost to Follow-up|0
4765878|NCT03401749|7740660|FG000|Overall Study|Lost to Follow-up|20
4765879|NCT03401749|7740661|FG001|Overall Study|Lost to Follow-up|16
4765880|NCT03401749|7740662|FG002|Overall Study|Lost to Follow-up|26
4765881|NCT03351244|7740673|FG000|Overall Study|Adverse Event|7
4765882|NCT03351244|7740674|FG001|Overall Study|Adverse Event|11
4765883|NCT03351244|7740675|FG002|Overall Study|Adverse Event|12
4765884|NCT03351244|7740673|FG000|Overall Study|Investigator's decision|0
4765885|NCT03351244|7740674|FG001|Overall Study|Investigator's decision|0
4765886|NCT03351244|7740675|FG002|Overall Study|Investigator's decision|2
4765887|NCT03351244|7740673|FG000|Overall Study|System error|0
4765888|NCT03351244|7740674|FG001|Overall Study|System error|0
4765889|NCT03351244|7740675|FG002|Overall Study|System error|2
4765890|NCT03351244|7740673|FG000|Overall Study|COVID-19 restrictions|3
4765891|NCT03351244|7740674|FG001|Overall Study|COVID-19 restrictions|0
4765892|NCT03351244|7740675|FG002|Overall Study|COVID-19 restrictions|1
4765893|NCT03351244|7740673|FG000|Overall Study|Non-compliance|2
4765894|NCT03351244|7740674|FG001|Overall Study|Non-compliance|5
4765895|NCT03351244|7740675|FG002|Overall Study|Non-compliance|0
4765896|NCT03351244|7740673|FG000|Overall Study|Withdrawal by Subject|11
4765897|NCT03351244|7740674|FG001|Overall Study|Withdrawal by Subject|16
4765898|NCT03351244|7740675|FG002|Overall Study|Withdrawal by Subject|13
4765899|NCT03351244|7740673|FG000|Overall Study|Lost to Follow-up|2
4765900|NCT03351244|7740674|FG001|Overall Study|Lost to Follow-up|6
4765901|NCT03351244|7740675|FG002|Overall Study|Lost to Follow-up|4
4765902|NCT03351244|7740673|FG000|Overall Study|Protocol Violation|2
4765903|NCT03351244|7740674|FG001|Overall Study|Protocol Violation|2
4765904|NCT03351244|7740675|FG002|Overall Study|Protocol Violation|0
4765905|NCT03283670|7740685|FG000|Placebo Gas|Withdrawal by Subject|2
4765906|NCT03283670|7740685|FG000|25% Nitrous Oxide|Withdrawal by Subject|4
4765907|NCT03283670|7740685|FG000|50% Nitrous Oxide|Withdrawal by Subject|1
4765908|NCT03219567|7740716|FG000|Overall Study|Withdrawal by Subject|0
4765909|NCT03219567|7740717|FG001|Overall Study|Withdrawal by Subject|1
4765910|NCT03194646|7740737|FG000|Overall Study|Adverse Event|24
4765911|NCT03194646|7740738|FG001|Overall Study|Adverse Event|25
4765912|NCT03194646|7740739|FG002|Overall Study|Adverse Event|14
4765913|NCT03194646|7740740|FG003|Overall Study|Adverse Event|17
4765914|NCT03194646|7740737|FG000|Overall Study|Lack of Efficacy|4
4765915|NCT03194646|7740738|FG001|Overall Study|Lack of Efficacy|2
4765916|NCT03194646|7740739|FG002|Overall Study|Lack of Efficacy|2
4765917|NCT03194646|7740740|FG003|Overall Study|Lack of Efficacy|12
4765918|NCT03194646|7740737|FG000|Overall Study|Lost to Follow-up|30
4765919|NCT03194646|7740738|FG001|Overall Study|Lost to Follow-up|22
4765920|NCT03194646|7740739|FG002|Overall Study|Lost to Follow-up|12
4765921|NCT03194646|7740740|FG003|Overall Study|Lost to Follow-up|35
4765922|NCT03194646|7740737|FG000|Overall Study|Non-compliance with study drug|4
4765923|NCT03194646|7740738|FG001|Overall Study|Non-compliance with study drug|0
4765924|NCT03194646|7740739|FG002|Overall Study|Non-compliance with study drug|1
4765925|NCT03194646|7740740|FG003|Overall Study|Non-compliance with study drug|1
4765926|NCT03194646|7740737|FG000|Overall Study|Other|87
4765927|NCT03194646|7740738|FG001|Overall Study|Other|67
4765928|NCT03194646|7740739|FG002|Overall Study|Other|34
4765929|NCT03194646|7740740|FG003|Overall Study|Other|31
4765930|NCT03194646|7740737|FG000|Overall Study|Physician Decision|7
4765931|NCT03194646|7740738|FG001|Overall Study|Physician Decision|9
4765932|NCT03194646|7740739|FG002|Overall Study|Physician Decision|5
4765933|NCT03194646|7740740|FG003|Overall Study|Physician Decision|4
4765934|NCT03194646|7740737|FG000|Overall Study|Pregnancy|4
4765935|NCT03194646|7740738|FG001|Overall Study|Pregnancy|5
4765936|NCT03194646|7740739|FG002|Overall Study|Pregnancy|1
4765937|NCT03194646|7740740|FG003|Overall Study|Pregnancy|2
4765938|NCT03194646|7740737|FG000|Overall Study|Protocol Violation|4
4765939|NCT03194646|7740738|FG001|Overall Study|Protocol Violation|2
4765940|NCT03194646|7740739|FG002|Overall Study|Protocol Violation|1
4765941|NCT03194646|7740740|FG003|Overall Study|Protocol Violation|1
4765942|NCT03194646|7740737|FG000|Overall Study|Site terminated by sponsor|0
4765943|NCT03194646|7740738|FG001|Overall Study|Site terminated by sponsor|0
4765944|NCT03194646|7740739|FG002|Overall Study|Site terminated by sponsor|2
4765945|NCT03194646|7740740|FG003|Overall Study|Site terminated by sponsor|0
4765946|NCT03194646|7740737|FG000|Overall Study|Study terminated by sponsor|60
4765947|NCT03194646|7740738|FG001|Overall Study|Study terminated by sponsor|61
4765948|NCT03194646|7740739|FG002|Overall Study|Study terminated by sponsor|30
4765949|NCT03194646|7740740|FG003|Overall Study|Study terminated by sponsor|34
4765950|NCT03194646|7740737|FG000|Overall Study|Withdrawal by Subject|74
4765951|NCT03194646|7740738|FG001|Overall Study|Withdrawal by Subject|75
4765952|NCT03194646|7740739|FG002|Overall Study|Withdrawal by Subject|36
4765953|NCT03194646|7740740|FG003|Overall Study|Withdrawal by Subject|131
4765954|NCT03194646|7740737|FG000|Overall Study|Missing|4
4765955|NCT03194646|7740738|FG001|Overall Study|Missing|0
4765956|NCT03194646|7740739|FG002|Overall Study|Missing|1
4765957|NCT03194646|7740740|FG003|Overall Study|Missing|12
4765958|NCT03153111|7740757|FG000|Overall Study|Death|2
4765959|NCT03153111|7740758|FG001|Overall Study|Death|5
4765960|NCT03153111|7740757|FG000|Overall Study|Lost to Follow-up|1
4765961|NCT03153111|7740758|FG001|Overall Study|Lost to Follow-up|0
4765962|NCT03153111|7740757|FG000|Overall Study|Physician Decision|5
4765963|NCT03153111|7740758|FG001|Overall Study|Physician Decision|1
4765964|NCT03153111|7740757|FG000|Overall Study|Withdrawal by Subject|3
4765965|NCT03153111|7740758|FG001|Overall Study|Withdrawal by Subject|3
4765966|NCT03128411|7740764|FG000|Treatment Phase|Adverse Event|21
4765967|NCT03128411|7740764|FG000|Treatment Phase|Physician Decision|1
4765968|NCT03128411|7740764|FG000|Treatment Phase|Other|2
4765969|NCT03128411|7740764|FG000|Long Term Follow-up Phase|Death|2
4765970|NCT03073733|7740771|FG000|Overall Study|Lost to Follow-up|1
4765971|NCT03073733|7740772|FG001|Overall Study|Lost to Follow-up|0
4765972|NCT03073733|7740773|FG002|Overall Study|Lost to Follow-up|0
4765973|NCT03073733|7740771|FG000|Overall Study|Physician Decision|0
4765974|NCT03073733|7740772|FG001|Overall Study|Physician Decision|1
4765975|NCT03073733|7740773|FG002|Overall Study|Physician Decision|0
4765976|NCT03073733|7740771|FG000|Overall Study|Withdrawal by Subject|0
4765977|NCT03073733|7740772|FG001|Overall Study|Withdrawal by Subject|0
4765978|NCT03073733|7740773|FG002|Overall Study|Withdrawal by Subject|1
4765979|NCT02821000|7740783|FG000|Overall Study|Death|44
4765980|NCT02821000|7740783|FG000|Overall Study|Withdrawal by Subject|1
4765981|NCT02821000|7740783|FG000|Overall Study|Ongoing in Study|58
4765982|NCT02702414|7740811|FG000|Overall Study|Death|77
4765983|NCT02702414|7740812|FG001|Overall Study|Death|34
4765984|NCT02702414|7740811|FG000|Overall Study|Lost to Follow-up|0
4765985|NCT02702414|7740812|FG001|Overall Study|Lost to Follow-up|1
4765986|NCT02702414|7740811|FG000|Overall Study|Withdrawal by Subject|0
4765987|NCT02702414|7740812|FG001|Overall Study|Withdrawal by Subject|1
4765988|NCT02702414|7740811|FG000|Overall Study|Participants Ongoing in Study|27
4765989|NCT02702414|7740812|FG001|Overall Study|Participants Ongoing in Study|15
4765990|NCT02702414|7740811|FG000|Overall Study|Not Treated|1
4765991|NCT02702414|7740812|FG001|Overall Study|Not Treated|0
4765992|NCT02425904|7740845|FG000|Overall Study|Lost to Follow-up|1
4765993|NCT02425904|7740846|FG001|Overall Study|Lost to Follow-up|0
4765994|NCT02425904|7740845|FG000|Overall Study|Withdrawal by Subject|2
4765995|NCT02425904|7740846|FG001|Overall Study|Withdrawal by Subject|0
4765996|NCT02425904|7740845|FG000|Overall Study|Death|0
4765997|NCT02425904|7740846|FG001|Overall Study|Death|3
4765998|NCT02420795|7740856|FG000|Overall Study|Withdrawal by Subject|1
4765999|NCT02420795|7740857|FG001|Overall Study|Withdrawal by Subject|0
4766000|NCT02420795|7740858|FG002|Overall Study|Withdrawal by Subject|0
4766001|NCT02420795|7740856|FG000|Overall Study|Adverse Event|1
4766002|NCT02420795|7740857|FG001|Overall Study|Adverse Event|0
4766003|NCT02420795|7740858|FG002|Overall Study|Adverse Event|0
4766004|NCT02420795|7740856|FG000|Overall Study|Progressive disease|2
4766005|NCT02420795|7740857|FG001|Overall Study|Progressive disease|2
4766006|NCT02420795|7740858|FG002|Overall Study|Progressive disease|4
4766007|NCT02420795|7740856|FG000|Overall Study|Death|0
4766008|NCT02420795|7740857|FG001|Overall Study|Death|0
4766009|NCT02420795|7740858|FG002|Overall Study|Death|1
4766010|NCT02240485|7740870|FG000|3 Months Post-admission|Lost to Follow-up|1
4766011|NCT02240485|7740871|FG001|3 Months Post-admission|Lost to Follow-up|5
4766012|NCT02240485|7740870|FG000|3 Months Post-admission|Withdrawal by Subject|2
4766013|NCT02240485|7740871|FG001|3 Months Post-admission|Withdrawal by Subject|1
4766014|NCT02240485|7740870|FG000|9 Months Post-admission|Lost to Follow-up|3
4766015|NCT02240485|7740871|FG001|9 Months Post-admission|Lost to Follow-up|1
4766016|NCT02240485|7740870|FG000|9 Months Post-admission|Withdrawal by Subject|0
4766017|NCT02240485|7740871|FG001|9 Months Post-admission|Withdrawal by Subject|3
4766018|NCT02240485|7740870|FG000|18 Months Post-admission|Lost to Follow-up|1
4766019|NCT02240485|7740871|FG001|18 Months Post-admission|Lost to Follow-up|1
4766020|NCT02240485|7740870|FG000|18 Months Post-admission|Withdrawal by Subject|2
4766021|NCT02240485|7740871|FG001|18 Months Post-admission|Withdrawal by Subject|4
4766022|NCT02227147|7740883|FG000|Controlled Treatment Period|Adverse Event|4
4766023|NCT02227147|7740884|FG001|Controlled Treatment Period|Adverse Event|3
4766024|NCT02227147|7740883|FG000|Controlled Treatment Period|Other|2
4766025|NCT02227147|7740884|FG001|Controlled Treatment Period|Other|0
4766026|NCT02227147|7740883|FG000|Follow-up Period|Other|3
4766027|NCT02227147|7740884|FG001|Follow-up Period|Other|5
4766028|NCT02199691|7740898|FG000|Overall Study|Protocol Violation|3
4766029|NCT02199691|7740899|FG001|Overall Study|Protocol Violation|3
4766030|NCT02199691|7740900|FG002|Overall Study|Protocol Violation|6
4766031|NCT02199691|7740901|FG003|Overall Study|Protocol Violation|7
4766032|NCT02199691|7740898|FG000|Overall Study|Withdrawal by Subject|5
4766033|NCT02199691|7740899|FG001|Overall Study|Withdrawal by Subject|3
4766034|NCT02199691|7740900|FG002|Overall Study|Withdrawal by Subject|12
4766035|NCT02199691|7740901|FG003|Overall Study|Withdrawal by Subject|13
4766036|NCT02199691|7740898|FG000|Overall Study|Lost to Follow-up|2
4766037|NCT02199691|7740899|FG001|Overall Study|Lost to Follow-up|1
4766038|NCT02199691|7740900|FG002|Overall Study|Lost to Follow-up|9
4766039|NCT02199691|7740901|FG003|Overall Study|Lost to Follow-up|10
4766040|NCT02163694|7740915|FG000|Overall Study|Adverse event- related to progression|3
4766041|NCT02163694|7740916|FG001|Overall Study|Adverse event- related to progression|8
4766042|NCT02163694|7740915|FG000|Overall Study|Adverse event- not related to progression|7
4766043|NCT02163694|7740916|FG001|Overall Study|Adverse event- not related to progression|17
4766044|NCT02163694|7740915|FG000|Overall Study|Withdrew consent|8
4766045|NCT02163694|7740916|FG001|Overall Study|Withdrew consent|21
4766046|NCT02163694|7740915|FG000|Overall Study|Lost to Follow-up|1
4766047|NCT02163694|7740916|FG001|Overall Study|Lost to Follow-up|2
4766048|NCT02163694|7740915|FG000|Overall Study|Progressive disease per protocol|122
4766049|NCT02163694|7740916|FG001|Overall Study|Progressive disease per protocol|197
4766050|NCT02163694|7740915|FG000|Overall Study|Other, not specified|13
4766051|NCT02163694|7740916|FG001|Overall Study|Other, not specified|22
4766052|NCT01751984|7740957|FG000|Overall Study|Adverse Event|5
4766053|NCT01751984|7740958|FG001|Overall Study|Adverse Event|3
4766054|NCT01751984|7740957|FG000|Overall Study|Withdrawal by Subject|0
4766055|NCT01751984|7740958|FG001|Overall Study|Withdrawal by Subject|1
4766056|NCT01751984|7740957|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1
4766057|NCT01751984|7740958|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0
4766058|NCT01732627|7740966|FG000|Overall Study|Withdrawal by Subject|1
4766059|NCT01732627|7740967|FG001|Overall Study|Withdrawal by Subject|0
4766060|NCT01702571|7740975|FG000|Overall Study|Death|1067
4766061|NCT01702571|7740976|FG001|Overall Study|Death|76
4766062|NCT01702571|7740975|FG000|Overall Study|Lost to Follow-up|144
4766063|NCT01702571|7740976|FG001|Overall Study|Lost to Follow-up|10
4766064|NCT01702571|7740975|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4
4766065|NCT01702571|7740976|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0
4766066|NCT01702571|7740975|FG000|Overall Study|Investigator Decision|5
4766067|NCT01702571|7740976|FG001|Overall Study|Investigator Decision|0
4766068|NCT01702571|7740975|FG000|Overall Study|Not Classifiable|1
4766069|NCT01702571|7740976|FG001|Overall Study|Not Classifiable|0
4766070|NCT01702571|7740975|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93
4766071|NCT01702571|7740976|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0
4766072|NCT01702571|7740975|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0
4766073|NCT01702571|7740976|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1
4766074|NCT01702571|7740975|FG000|Overall Study|Progressive Disease|3
4766075|NCT01702571|7740976|FG001|Overall Study|Progressive Disease|0
4766076|NCT01702571|7740975|FG000|Overall Study|Protocol Violation|2
4766077|NCT01702571|7740976|FG001|Overall Study|Protocol Violation|0
4766078|NCT01702571|7740975|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9
4766079|NCT01702571|7740976|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1
4766080|NCT01702571|7740975|FG000|Overall Study|Termination By Sponsor|4
4766081|NCT01702571|7740976|FG001|Overall Study|Termination By Sponsor|0
4766082|NCT01702571|7740975|FG000|Overall Study|Withdrawal by Subject|177
4766083|NCT01702571|7740976|FG001|Overall Study|Withdrawal by Subject|29
4766084|NCT01578239|7740984|FG000|Treatment Period|Progressive Disease|19
4766085|NCT01578239|7740985|FG001|Treatment Period|Progressive Disease|64
4766086|NCT01578239|7740984|FG000|Treatment Period|Physician Decision|17
4766087|NCT01578239|7740985|FG001|Treatment Period|Physician Decision|17
4766088|NCT01578239|7740984|FG000|Treatment Period|Adverse Event|13
4766089|NCT01578239|7740985|FG001|Treatment Period|Adverse Event|10
4766090|NCT01578239|7740984|FG000|Treatment Period|Non-compliance|2
4766091|NCT01578239|7740985|FG001|Treatment Period|Non-compliance|0
4766092|NCT01578239|7740984|FG000|Treatment Period|Withdrawal by Subject|10
4766093|NCT01578239|7740985|FG001|Treatment Period|Withdrawal by Subject|9
4766094|NCT01578239|7740984|FG000|Treatment Period|Other|6
4766095|NCT01578239|7740985|FG001|Treatment Period|Other|1
4766096|NCT01578239|7740984|FG000|Long-term Follow-Up Period|Death|69
4766097|NCT01578239|7740985|FG001|Long-term Follow-Up Period|Death|64
4766098|NCT01578239|7740984|FG000|Long-term Follow-Up Period|Consent withdrawal|4
4766099|NCT01578239|7740985|FG001|Long-term Follow-Up Period|Consent withdrawal|10
4766100|NCT01578239|7740984|FG000|Long-term Follow-Up Period|Lost to Follow-up|2
4766101|NCT01578239|7740985|FG001|Long-term Follow-Up Period|Lost to Follow-up|4
4766102|NCT01578239|7740984|FG000|Long-term Follow-Up Period|Other|2
4766103|NCT01578239|7740985|FG001|Long-term Follow-Up Period|Other|2
4766104|NCT01458340|7740994|FG000|Overall Study|Adverse Event|5
4766105|NCT01458340|7740995|FG001|Overall Study|Adverse Event|4
4766106|NCT01458340|7740996|FG002|Overall Study|Adverse Event|2
4766107|NCT01458340|7740994|FG000|Overall Study|Lost to Follow-up|3
4766108|NCT01458340|7740995|FG001|Overall Study|Lost to Follow-up|3
4766109|NCT01458340|7740996|FG002|Overall Study|Lost to Follow-up|10
4766110|NCT01458340|7740994|FG000|Overall Study|Miscellaneous|0
4766111|NCT01458340|7740995|FG001|Overall Study|Miscellaneous|1
4766112|NCT01458340|7740996|FG002|Overall Study|Miscellaneous|0
4766113|NCT01458340|7740994|FG000|Overall Study|Physician Decision|1
4766114|NCT01458340|7740995|FG001|Overall Study|Physician Decision|1
4766115|NCT01458340|7740996|FG002|Overall Study|Physician Decision|2
4766116|NCT01458340|7740994|FG000|Overall Study|Protocol Violation|6
4766117|NCT01458340|7740995|FG001|Overall Study|Protocol Violation|6
4766118|NCT01458340|7740996|FG002|Overall Study|Protocol Violation|5
4766119|NCT01458340|7740994|FG000|Overall Study|Withdrawal by Subject|12
4766120|NCT01458340|7740995|FG001|Overall Study|Withdrawal by Subject|6
4766121|NCT01458340|7740996|FG002|Overall Study|Withdrawal by Subject|4
4766122|NCT01336634|7741044|FG000|Overall Study|Study closed/terminated|5
4766123|NCT01336634|7741045|FG001|Overall Study|Study closed/terminated|6
4766124|NCT01336634|7741046|FG002|Overall Study|Study closed/terminated|6
4766125|NCT01336634|7741044|FG000|Overall Study|Lost to Follow-up|2
4766126|NCT01336634|7741045|FG001|Overall Study|Lost to Follow-up|1
4766127|NCT01336634|7741046|FG002|Overall Study|Lost to Follow-up|1
4766128|NCT01336634|7741044|FG000|Overall Study|Physician Decision|1
4766129|NCT01336634|7741045|FG001|Overall Study|Physician Decision|1
4766130|NCT01336634|7741046|FG002|Overall Study|Physician Decision|0
4766131|NCT01336634|7741044|FG000|Overall Study|Withdrawal by Subject|6
4766132|NCT01336634|7741045|FG001|Overall Study|Withdrawal by Subject|0
4766133|NCT01336634|7741046|FG002|Overall Study|Withdrawal by Subject|2
4766134|NCT01155375|7741059|FG000|Overall Study|Adverse Event|1
4766135|NCT01155375|7741060|FG001|Overall Study|Adverse Event|0
4766136|NCT00628095|7741073|FG000|Overall Study|Adverse Event|5
4766137|NCT00628095|7741074|FG001|Overall Study|Adverse Event|3
4766138|NCT00628095|7741073|FG000|Overall Study|Lack of Efficacy|0
4766139|NCT00628095|7741074|FG001|Overall Study|Lack of Efficacy|3
4766140|NCT00628095|7741073|FG000|Overall Study|Withdrawal by Subject|2
4766141|NCT00628095|7741074|FG001|Overall Study|Withdrawal by Subject|0
4766142|NCT00628095|7741073|FG000|Overall Study|Other|0
4766143|NCT00628095|7741074|FG001|Overall Study|Other|1
4766144|NCT03945825|7741106|FG000|Overall Study|Enrolled but treatment not administered|0
4766145|NCT03945825|7741107|FG001|Overall Study|Enrolled but treatment not administered|0
4766146|NCT03945825|7741108|FG002|Overall Study|Enrolled but treatment not administered|0
4766147|NCT03945825|7741109|FG003|Overall Study|Enrolled but treatment not administered|0
4766148|NCT03945825|7741110|FG004|Overall Study|Enrolled but treatment not administered|1
4766149|NCT03945825|7741111|FG005|Overall Study|Enrolled but treatment not administered|0
4766150|NCT03945825|7741106|FG000|Overall Study|Lost to Follow-up|1
4766151|NCT03945825|7741107|FG001|Overall Study|Lost to Follow-up|5
4766152|NCT03945825|7741108|FG002|Overall Study|Lost to Follow-up|0
4766153|NCT03945825|7741109|FG003|Overall Study|Lost to Follow-up|1
4766154|NCT03945825|7741110|FG004|Overall Study|Lost to Follow-up|2
4766155|NCT03945825|7741111|FG005|Overall Study|Lost to Follow-up|2
4766156|NCT03945825|7741106|FG000|Overall Study|Withdrawal by Subject|1
4766157|NCT03945825|7741107|FG001|Overall Study|Withdrawal by Subject|0
4766158|NCT03945825|7741108|FG002|Overall Study|Withdrawal by Subject|1
4766159|NCT03945825|7741109|FG003|Overall Study|Withdrawal by Subject|1
4766160|NCT03945825|7741110|FG004|Overall Study|Withdrawal by Subject|0
4766161|NCT03945825|7741111|FG005|Overall Study|Withdrawal by Subject|1
4766239|NCT03158285|7741255|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1
4766240|NCT03158285|7741256|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1
4766241|NCT03158285|7741257|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0
4766242|NCT03158285|7741255|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0
4766243|NCT03158285|7741256|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1
4766244|NCT03158285|7741257|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0
4766245|NCT03158285|7741255|FG000|Placebo-controlled Period: Week 0 - 24|Other|1
4766246|NCT03158285|7741256|FG001|Placebo-controlled Period: Week 0 - 24|Other|1
4766247|NCT03158285|7741257|FG002|Placebo-controlled Period: Week 0 - 24|Other|0
4766248|NCT03158285|7741255|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3
4766249|NCT03158285|7741256|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0
4766250|NCT03158285|7741257|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1
4766251|NCT03158285|7741255|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5
4766252|NCT03158285|7741256|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3
4766253|NCT03158285|7741257|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4
4766254|NCT03158285|7741255|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1
4766255|NCT03158285|7741256|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2
4766256|NCT03158285|7741257|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1
4766257|NCT03158285|7741255|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0
4766258|NCT03158285|7741256|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0
4766259|NCT03158285|7741257|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1
4766260|NCT03158285|7741255|FG000|Active Treatment Period: Week 24 - 52|Other|1
4766261|NCT03158285|7741256|FG001|Active Treatment Period: Week 24 - 52|Other|1
4766262|NCT03158285|7741257|FG002|Active Treatment Period: Week 24 - 52|Other|0
4766263|NCT03158285|7741255|FG000|Active Treatment Period: Week 52-100|Adverse Event|7
4766264|NCT03158285|7741256|FG001|Active Treatment Period: Week 52-100|Adverse Event|5
4766265|NCT03158285|7741257|FG002|Active Treatment Period: Week 52-100|Adverse Event|3
4766266|NCT03158285|7741255|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1
4766267|NCT03158285|7741256|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1
4766268|NCT03158285|7741257|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3
4766269|NCT03158285|7741255|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5
4766270|NCT03158285|7741256|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2
4766271|NCT03158285|7741257|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1
4766272|NCT03158285|7741255|FG000|Active Treatment Period: Week 52-100|Pregnancy|0
4766273|NCT03158285|7741256|FG001|Active Treatment Period: Week 52-100|Pregnancy|0
4766274|NCT03158285|7741257|FG002|Active Treatment Period: Week 52-100|Pregnancy|1
4766275|NCT03158285|7741255|FG000|Active Treatment Period: Week 52-100|Death|1
4766276|NCT03158285|7741256|FG001|Active Treatment Period: Week 52-100|Death|0
4766277|NCT03158285|7741257|FG002|Active Treatment Period: Week 52-100|Death|0
4766278|NCT03158285|7741255|FG000|Active Treatment Period: Week 52-100|Other|4
4766279|NCT03158285|7741256|FG001|Active Treatment Period: Week 52-100|Other|1
4766280|NCT03158285|7741257|FG002|Active Treatment Period: Week 52-100|Other|0
4766162|NCT03562767|7741158|FG000|Overall Study|Physician Decision|2
4766163|NCT03562767|7741159|FG001|Overall Study|Physician Decision|0
4766164|NCT03562767|7741160|FG002|Overall Study|Physician Decision|0
4766165|NCT03562767|7741158|FG000|Overall Study|Logistic Reason|1
4766166|NCT03562767|7741159|FG001|Overall Study|Logistic Reason|3
4766167|NCT03562767|7741160|FG002|Overall Study|Logistic Reason|0
4766168|NCT03559699|7741172|FG000|Overall Study|Withdrawal by Subject|6
4766169|NCT03559699|7741172|FG000|Overall Study|Lost to Follow-up|1
4766170|NCT03305016|7741189|FG000|Overall Study|Withdrawal by Subject|2
4766171|NCT03291067|7741206|FG000|Overall Study|Adverse Event|0
4766172|NCT03291067|7741207|FG001|Overall Study|Adverse Event|2
4766173|NCT03291067|7741208|FG002|Overall Study|Adverse Event|17
4766174|NCT03291067|7741209|FG003|Overall Study|Adverse Event|3
4766175|NCT03291067|7741206|FG000|Overall Study|Lost to Follow-up|2
4766176|NCT03291067|7741207|FG001|Overall Study|Lost to Follow-up|1
4766177|NCT03291067|7741208|FG002|Overall Study|Lost to Follow-up|0
4766178|NCT03291067|7741209|FG003|Overall Study|Lost to Follow-up|1
4766179|NCT03291067|7741206|FG000|Overall Study|Physician Decision|0
4766180|NCT03291067|7741207|FG001|Overall Study|Physician Decision|0
4766181|NCT03291067|7741208|FG002|Overall Study|Physician Decision|1
4766182|NCT03291067|7741209|FG003|Overall Study|Physician Decision|0
4766183|NCT03291067|7741206|FG000|Overall Study|Protocol Violation|5
4766184|NCT03291067|7741207|FG001|Overall Study|Protocol Violation|3
4766185|NCT03291067|7741208|FG002|Overall Study|Protocol Violation|4
4766186|NCT03291067|7741209|FG003|Overall Study|Protocol Violation|2
4766187|NCT03291067|7741206|FG000|Overall Study|Withdrawal by Subject|3
4766188|NCT03291067|7741207|FG001|Overall Study|Withdrawal by Subject|4
4766189|NCT03291067|7741208|FG002|Overall Study|Withdrawal by Subject|7
4766190|NCT03291067|7741209|FG003|Overall Study|Withdrawal by Subject|5
4766191|NCT03291067|7741206|FG000|Overall Study|Other|0
4766192|NCT03291067|7741207|FG001|Overall Study|Other|4
4766193|NCT03291067|7741208|FG002|Overall Study|Other|4
4766194|NCT03291067|7741209|FG003|Overall Study|Other|6
4766195|NCT03271047|7741223|FG000|Phase 1b: Dose Finding Period|Death|8
4766196|NCT03271047|7741224|FG001|Phase 1b: Dose Finding Period|Death|8
4766197|NCT03271047|7741225|FG002|Phase 1b: Dose Finding Period|Death|0
4766198|NCT03271047|7741226|FG003|Phase 1b: Dose Finding Period|Death|0
4766199|NCT03271047|7741223|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1
4766200|NCT03271047|7741224|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0
4766201|NCT03271047|7741225|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0
4766202|NCT03271047|7741226|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0
4766203|NCT03271047|7741223|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0
4766204|NCT03271047|7741224|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2
4766205|NCT03271047|7741225|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0
4766206|NCT03271047|7741226|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0
4766207|NCT03271047|7741223|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1
4766208|NCT03271047|7741224|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1
4766209|NCT03271047|7741225|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0
4766210|NCT03271047|7741226|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0
4766211|NCT03271047|7741223|FG000|Randomized Phase 2 Period|Other|0
4766212|NCT03271047|7741224|FG001|Randomized Phase 2 Period|Other|0
4766213|NCT03271047|7741225|FG002|Randomized Phase 2 Period|Other|0
4766214|NCT03271047|7741226|FG003|Randomized Phase 2 Period|Other|1
4766215|NCT03271047|7741223|FG000|Randomized Phase 2 Period|Death|0
4766216|NCT03271047|7741224|FG001|Randomized Phase 2 Period|Death|0
4766217|NCT03271047|7741225|FG002|Randomized Phase 2 Period|Death|20
4766218|NCT03271047|7741226|FG003|Randomized Phase 2 Period|Death|21
4766219|NCT03271047|7741223|FG000|Randomized Phase 2 Period|Lost to Follow-up|0
4766220|NCT03271047|7741224|FG001|Randomized Phase 2 Period|Lost to Follow-up|0
4766221|NCT03271047|7741225|FG002|Randomized Phase 2 Period|Lost to Follow-up|2
4766222|NCT03271047|7741226|FG003|Randomized Phase 2 Period|Lost to Follow-up|1
4766223|NCT03271047|7741223|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0
4766224|NCT03271047|7741224|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0
4766225|NCT03271047|7741225|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5
4766226|NCT03271047|7741226|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0
4766227|NCT03271047|7741223|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0
4766228|NCT03271047|7741224|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0
4766229|NCT03271047|7741225|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0
4766230|NCT03271047|7741226|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4
4766231|NCT03257436|7741238|FG000|Overall Study|Withdrawal by Subject|76
4766232|NCT03257436|7741238|FG000|Overall Study|Death|19
4766233|NCT03158285|7741255|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4
4766234|NCT03158285|7741256|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2
4766235|NCT03158285|7741257|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6
4766236|NCT03158285|7741255|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0
4766237|NCT03158285|7741256|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3
4766238|NCT03158285|7741257|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3
4766281|NCT04723173|7741270|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1
4766282|NCT03683823|7741314|FG000|Post-treatment Assessment|Withdrawal by Subject|1
4766283|NCT03683823|7741315|FG001|Post-treatment Assessment|Withdrawal by Subject|1
4766284|NCT03683823|7741314|FG000|Post-treatment Assessment|Lost to Follow-up|0
4766285|NCT03683823|7741315|FG001|Post-treatment Assessment|Lost to Follow-up|1
4766286|NCT03683823|7741314|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1
4766287|NCT03683823|7741315|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1
4766288|NCT03515551|7741341|FG000|Overall Study|Death|4
4766289|NCT03515551|7741342|FG001|Overall Study|Death|1
4766290|NCT03515551|7741343|FG002|Overall Study|Death|2
4766291|NCT03515551|7741344|FG003|Overall Study|Death|2
4766292|NCT03515551|7741345|FG004|Overall Study|Death|2
4766293|NCT03515551|7741346|FG005|Overall Study|Death|4
4766294|NCT03515551|7741347|FG006|Overall Study|Death|1
4766295|NCT03515551|7741341|FG000|Overall Study|Lost to Follow-up|0
4766296|NCT03515551|7741342|FG001|Overall Study|Lost to Follow-up|0
4766297|NCT03515551|7741343|FG002|Overall Study|Lost to Follow-up|1
4766298|NCT03515551|7741344|FG003|Overall Study|Lost to Follow-up|0
4766299|NCT03515551|7741345|FG004|Overall Study|Lost to Follow-up|0
4766300|NCT03515551|7741346|FG005|Overall Study|Lost to Follow-up|0
4766301|NCT03515551|7741347|FG006|Overall Study|Lost to Follow-up|0
4766302|NCT03515551|7741341|FG000|Overall Study|Withdrawal by Subject|0
4766303|NCT03515551|7741342|FG001|Overall Study|Withdrawal by Subject|1
4766304|NCT03515551|7741343|FG002|Overall Study|Withdrawal by Subject|0
4766305|NCT03515551|7741344|FG003|Overall Study|Withdrawal by Subject|0
4766306|NCT03515551|7741345|FG004|Overall Study|Withdrawal by Subject|0
4766307|NCT03515551|7741346|FG005|Overall Study|Withdrawal by Subject|0
4766308|NCT03515551|7741347|FG006|Overall Study|Withdrawal by Subject|1
4766309|NCT03515551|7741341|FG000|Overall Study|Study ended by sponsor|0
4766310|NCT03515551|7741342|FG001|Overall Study|Study ended by sponsor|0
4766311|NCT03515551|7741343|FG002|Overall Study|Study ended by sponsor|2
4766312|NCT03515551|7741344|FG003|Overall Study|Study ended by sponsor|1
4766313|NCT03515551|7741345|FG004|Overall Study|Study ended by sponsor|3
4766314|NCT03515551|7741346|FG005|Overall Study|Study ended by sponsor|0
4766315|NCT03515551|7741347|FG006|Overall Study|Study ended by sponsor|3
4766316|NCT03515551|7741341|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0
4766317|NCT03515551|7741342|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1
4766318|NCT03515551|7741343|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0
4766319|NCT03515551|7741344|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0
4766320|NCT03515551|7741345|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0
4766321|NCT03515551|7741346|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0
4766322|NCT03515551|7741347|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0
4766323|NCT03385265|7741372|FG000|Overall Study|Withdrawal by Subject|5
4766324|NCT03385265|7741373|FG001|Overall Study|Withdrawal by Subject|2
4766325|NCT03385265|7741374|FG002|Overall Study|Withdrawal by Subject|5
4766326|NCT03385265|7741375|FG003|Overall Study|Withdrawal by Subject|2
4766327|NCT02987543|7741430|FG000|Overall Study|Ongoing study at data cut off|49
4766328|NCT02987543|7741431|FG001|Overall Study|Ongoing study at data cut off|21
4766329|NCT02987543|7741432|FG002|Overall Study|Ongoing study at data cut off|19
4766330|NCT02987543|7741433|FG003|Overall Study|Ongoing study at data cut off|12
4766331|NCT02987543|7741430|FG000|Overall Study|Death|88
4766332|NCT02987543|7741431|FG001|Overall Study|Death|54
4766333|NCT02987543|7741432|FG002|Overall Study|Death|67
4766334|NCT02987543|7741433|FG003|Overall Study|Death|28
4766335|NCT02987543|7741430|FG000|Overall Study|Lost to Follow-up|3
4766336|NCT02987543|7741431|FG001|Overall Study|Lost to Follow-up|0
4766337|NCT02987543|7741432|FG002|Overall Study|Lost to Follow-up|1
4766338|NCT02987543|7741433|FG003|Overall Study|Lost to Follow-up|0
4766339|NCT02987543|7741430|FG000|Overall Study|Screen failure|0
4766340|NCT02987543|7741431|FG001|Overall Study|Screen failure|0
4766341|NCT02987543|7741432|FG002|Overall Study|Screen failure|0
4766342|NCT02987543|7741433|FG003|Overall Study|Screen failure|1
4766343|NCT02987543|7741430|FG000|Overall Study|Withdrawal by Subject|21
4766344|NCT02987543|7741431|FG001|Overall Study|Withdrawal by Subject|7
4766345|NCT02987543|7741432|FG002|Overall Study|Withdrawal by Subject|7
4766346|NCT02987543|7741433|FG003|Overall Study|Withdrawal by Subject|6
4766347|NCT02987543|7741430|FG000|Overall Study|Study terminated by sponsor|1
4766348|NCT02987543|7741431|FG001|Overall Study|Study terminated by sponsor|0
4766349|NCT02987543|7741432|FG002|Overall Study|Study terminated by sponsor|0
4766350|NCT02987543|7741433|FG003|Overall Study|Study terminated by sponsor|0
4766351|NCT02987543|7741430|FG000|Overall Study|Investigator decision|0
4766352|NCT02987543|7741431|FG001|Overall Study|Investigator decision|1
4766353|NCT02987543|7741432|FG002|Overall Study|Investigator decision|0
4766354|NCT02987543|7741433|FG003|Overall Study|Investigator decision|0
4766355|NCT02987543|7741430|FG000|Overall Study|Disease progression|0
4766356|NCT02987543|7741431|FG001|Overall Study|Disease progression|0
4766357|NCT02987543|7741432|FG002|Overall Study|Disease progression|0
4766358|NCT02987543|7741433|FG003|Overall Study|Disease progression|1
4766359|NCT02919306|7741441|FG000|Overall Study|Withdrawal by Subject|1
4766360|NCT02919306|7741442|FG001|Overall Study|Withdrawal by Subject|0
4766361|NCT02919306|7741441|FG000|Overall Study|Protocol Violation|1
4766362|NCT02919306|7741442|FG001|Overall Study|Protocol Violation|0
4766363|NCT02763189|7741450|FG000|Overall Study|Device failure|0
4766364|NCT02763189|7741451|FG001|Overall Study|Device failure|2
4766365|NCT02659514|7741468|FG000|Overall Study|Adverse Event|3
4766366|NCT02659514|7741469|FG001|Overall Study|Adverse Event|12
4766367|NCT02659514|7741468|FG000|Overall Study|Disease Progression|23
4766368|NCT02659514|7741469|FG001|Overall Study|Disease Progression|13
4766369|NCT02659514|7741468|FG000|Overall Study|Withdrawal by Subject|0
4766370|NCT02659514|7741469|FG001|Overall Study|Withdrawal by Subject|4
4766371|NCT02659514|7741468|FG000|Overall Study|Lost to Follow-up|0
4766372|NCT02659514|7741469|FG001|Overall Study|Lost to Follow-up|1
4766373|NCT02659514|7741468|FG000|Overall Study|Death|6
4766374|NCT02659514|7741469|FG001|Overall Study|Death|1
4766375|NCT02659514|7741468|FG000|Overall Study|Reason Unspecified|0
4766376|NCT02659514|7741469|FG001|Overall Study|Reason Unspecified|3
4766377|NCT02390245|7741494|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0
4766378|NCT02390245|7741495|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104
4766379|NCT02390245|7741496|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|105
4766380|NCT02390245|7741494|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0
4766381|NCT02390245|7741495|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|94
4766382|NCT02390245|7741496|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|105
4766383|NCT02254278|7741505|FG000|Overall Study|Protocol Violation|1
4766384|NCT02254278|7741506|FG001|Overall Study|Protocol Violation|1
4766385|NCT01850524|7741517|FG000|Overall Study|Ongoing on Treatment|57
4766386|NCT01850524|7741518|FG001|Overall Study|Ongoing on Treatment|54
4766387|NCT01850524|7741517|FG000|Overall Study|Adverse Event|96
4766388|NCT01850524|7741518|FG001|Overall Study|Adverse Event|122
4766389|NCT01850524|7741517|FG000|Overall Study|Lost to Follow-up|2
4766390|NCT01850524|7741518|FG001|Overall Study|Lost to Follow-up|0
4766391|NCT01850524|7741517|FG000|Overall Study|Progressive Disease|166
4766392|NCT01850524|7741518|FG001|Overall Study|Progressive Disease|123
4766393|NCT01850524|7741517|FG000|Overall Study|Protocol Violation|1
4766394|NCT01850524|7741518|FG001|Overall Study|Protocol Violation|2
4766395|NCT01850524|7741517|FG000|Overall Study|Withdrawal by Subject|8
4766396|NCT01850524|7741518|FG001|Overall Study|Withdrawal by Subject|19
4766397|NCT01850524|7741517|FG000|Overall Study|Participant Wished to Discontinue Treatment|15
4766398|NCT01850524|7741518|FG001|Overall Study|Participant Wished to Discontinue Treatment|22
4766399|NCT01850524|7741517|FG000|Overall Study|Investigator Decision|4
4766400|NCT01850524|7741518|FG001|Overall Study|Investigator Decision|4
4766401|NCT01850524|7741517|FG000|Overall Study|Participants Removed From Study|0
4766402|NCT01850524|7741518|FG001|Overall Study|Participants Removed From Study|1
4766403|NCT01850524|7741517|FG000|Overall Study|Medical Monitor Decision|0
4766404|NCT01850524|7741518|FG001|Overall Study|Medical Monitor Decision|1
4766405|NCT01850524|7741517|FG000|Overall Study|Participants Decision|2
4766406|NCT01850524|7741518|FG001|Overall Study|Participants Decision|2
4766407|NCT01850524|7741517|FG000|Overall Study|Progressive Disease Per Local Lab|1
4766408|NCT01850524|7741518|FG001|Overall Study|Progressive Disease Per Local Lab|0
4766409|NCT01850524|7741517|FG000|Overall Study|Lack of Improvement|0
4766410|NCT01850524|7741518|FG001|Overall Study|Lack of Improvement|1
4766411|NCT01850524|7741517|FG000|Overall Study|Minimal Response|1
4766412|NCT01850524|7741518|FG001|Overall Study|Minimal Response|0
4766413|NCT01850524|7741517|FG000|Overall Study|Comorbidities|1
4766414|NCT01850524|7741518|FG001|Overall Study|Comorbidities|0
4766415|NCT01673867|7741528|FG000|Randomization|AE unrelated to study drug|1
4766416|NCT01673867|7741529|FG001|Randomization|AE unrelated to study drug|0
4766417|NCT01673867|7741528|FG000|Randomization|Requested treatment discontinuation|0
4766418|NCT01673867|7741529|FG001|Randomization|Requested treatment discontinuation|4
4766419|NCT01673867|7741528|FG000|Randomization|Withdrawal by Subject|0
4766420|NCT01673867|7741529|FG001|Randomization|Withdrawal by Subject|12
4766421|NCT01673867|7741528|FG000|Randomization|Lost to Follow-up|0
4766422|NCT01673867|7741529|FG001|Randomization|Lost to Follow-up|1
4766423|NCT01673867|7741528|FG000|Randomization|No longer meets criteria|4
4766424|NCT01673867|7741529|FG001|Randomization|No longer meets criteria|5
4766425|NCT01673867|7741528|FG000|Treatment|Disease Progression|194
4766426|NCT01673867|7741529|FG001|Treatment|Disease Progression|179
4766427|NCT01673867|7741528|FG000|Treatment|Study Drug Toxicity|17
4766428|NCT01673867|7741529|FG001|Treatment|Study Drug Toxicity|42
4766429|NCT01673867|7741528|FG000|Treatment|Death|1
4766430|NCT01673867|7741529|FG001|Treatment|Death|1
4766431|NCT01673867|7741528|FG000|Treatment|AE unrelated to study drug|19
4766432|NCT01673867|7741529|FG001|Treatment|AE unrelated to study drug|11
4766433|NCT01673867|7741528|FG000|Treatment|Requested treatment discontinuation|5
4766434|NCT01673867|7741529|FG001|Treatment|Requested treatment discontinuation|16
4766435|NCT01673867|7741528|FG000|Treatment|Withdrawal by Subject|4
4766436|NCT01673867|7741529|FG001|Treatment|Withdrawal by Subject|6
4766437|NCT01673867|7741528|FG000|Treatment|Maximum clinical benefit|0
4766438|NCT01673867|7741529|FG001|Treatment|Maximum clinical benefit|10
4766439|NCT01673867|7741528|FG000|Treatment|No longer meets criteria|2
4766440|NCT01673867|7741529|FG001|Treatment|No longer meets criteria|0
4766441|NCT01673867|7741528|FG000|Treatment|Required steroid therapy|1
4766442|NCT01673867|7741529|FG001|Treatment|Required steroid therapy|0
4766443|NCT01673867|7741528|FG000|Treatment|Health status not improved|1
4766444|NCT01673867|7741529|FG001|Treatment|Health status not improved|0
4766445|NCT01673867|7741528|FG000|Treatment|Required prolonged hospitalization|0
4766446|NCT01673867|7741529|FG001|Treatment|Required prolonged hospitalization|1
4766447|NCT01673867|7741528|FG000|Treatment|Symptomatic deterioration|0
4766448|NCT01673867|7741529|FG001|Treatment|Symptomatic deterioration|1
4766449|NCT01673867|7741528|FG000|Treatment|Physician Decision|0
4766450|NCT01673867|7741529|FG001|Treatment|Physician Decision|1
4766451|NCT00335777|7741539|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5
4766452|NCT00335777|7741539|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6
4766453|NCT00335777|7741539|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18
4766454|NCT00335777|7741539|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1
4766455|NCT00335777|7741539|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12
4766456|NCT00159588|7741547|FG000|5 Month Follow-up|Withdrawal by Subject|2
4766457|NCT00159588|7741548|FG001|5 Month Follow-up|Withdrawal by Subject|4
4766458|NCT00159588|7741549|FG002|5 Month Follow-up|Withdrawal by Subject|2
4766459|NCT03051217|7741563|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2
4766460|NCT03051217|7741564|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0
4766461|NCT03051217|7741565|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1
4766462|NCT03051217|7741566|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0
4766463|NCT03051217|7741567|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0
4766464|NCT03051217|7741568|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0
4766465|NCT03051217|7741569|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0
4766466|NCT03051217|7741563|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0
4766467|NCT03051217|7741564|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1
4766468|NCT03051217|7741565|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0
4766469|NCT03051217|7741566|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0
4766470|NCT03051217|7741567|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0
4766471|NCT03051217|7741568|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0
4766472|NCT03051217|7741569|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0
4766473|NCT03051217|7741563|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
4766474|NCT03051217|7741564|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
4766475|NCT03051217|7741565|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
4766476|NCT03051217|7741566|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
4766477|NCT03051217|7741567|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
4766478|NCT03051217|7741568|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
4766479|NCT03051217|7741569|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
4766480|NCT03051217|7741563|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0
4766481|NCT03051217|7741564|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0
4766482|NCT03051217|7741565|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0
4766483|NCT03051217|7741566|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1
4766484|NCT03051217|7741567|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2
4766485|NCT03051217|7741568|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1
4766486|NCT03051217|7741569|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1
4766487|NCT03051217|7741563|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
4766488|NCT03051217|7741564|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
4766489|NCT03051217|7741565|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
4766490|NCT03051217|7741566|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1
4766491|NCT03051217|7741567|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
4766492|NCT03051217|7741568|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
4766493|NCT03051217|7741569|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
4766494|NCT03051217|7741563|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
4766495|NCT03051217|7741564|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
4766496|NCT03051217|7741565|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
4766497|NCT03051217|7741566|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1
4766498|NCT03051217|7741567|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
4766499|NCT03051217|7741568|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
4766500|NCT03051217|7741569|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
4766501|NCT03051217|7741563|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
4766502|NCT03051217|7741564|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
4766503|NCT03051217|7741565|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
4766504|NCT03051217|7741566|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
4766505|NCT03051217|7741567|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1
4766506|NCT03051217|7741568|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
4766507|NCT03051217|7741569|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
4766508|NCT03051217|7741563|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
4766509|NCT03051217|7741564|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
4766510|NCT03051217|7741565|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
4766511|NCT03051217|7741566|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
4766512|NCT03051217|7741567|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
4766513|NCT03051217|7741568|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1
4766514|NCT03051217|7741569|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
4766515|NCT03025542|7741585|FG000|Overall Study|Adverse Event|0
4766516|NCT03025542|7741586|FG001|Overall Study|Adverse Event|2
4766517|NCT03025542|7741585|FG000|Overall Study|Lost to Follow-up|1
4766518|NCT03025542|7741586|FG001|Overall Study|Lost to Follow-up|0
4766519|NCT03025542|7741585|FG000|Overall Study|Withdrawal by Subject|1
4766520|NCT03025542|7741586|FG001|Overall Study|Withdrawal by Subject|0
4766521|NCT02889809|7741622|FG000|Overall Study|Withdrawal by Subject|30
4766522|NCT02889809|7741623|FG001|Overall Study|Withdrawal by Subject|21
4766523|NCT02889809|7741622|FG000|Overall Study|Lost to Follow-up|1
4766524|NCT02889809|7741623|FG001|Overall Study|Lost to Follow-up|1
4766525|NCT02889809|7741622|FG000|Overall Study|Site Closed|12
4766526|NCT02889809|7741623|FG001|Overall Study|Site Closed|11
4766527|NCT02849587|7741632|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2
4766528|NCT02849587|7741633|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3
4766529|NCT02849587|7741634|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2
4766530|NCT02849587|7741632|FG000|Overall Study|Withdrawal by Subject|0
4766531|NCT02849587|7741633|FG001|Overall Study|Withdrawal by Subject|1
4766532|NCT02849587|7741634|FG002|Overall Study|Withdrawal by Subject|0
4766533|NCT02815540|7741646|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2
4766534|NCT02781727|7741681|FG000|Pre-dosing Period|Withdrawal by Subject|1
4766535|NCT02781727|7741682|FG001|Pre-dosing Period|Withdrawal by Subject|0
4766536|NCT02781727|7741681|FG000|Treatment Period|Withdrawal by Subject|1
4766537|NCT02781727|7741682|FG001|Treatment Period|Withdrawal by Subject|0
4766538|NCT02781727|7741681|FG000|Treatment Period|Lost to Follow-up|0
4766539|NCT02781727|7741682|FG001|Treatment Period|Lost to Follow-up|1
4766540|NCT02778204|7741692|FG000|Overall Study|Adverse Event|1
4766541|NCT02778204|7741693|FG001|Overall Study|Adverse Event|0
4766542|NCT02778204|7741694|FG002|Overall Study|Adverse Event|0
4766543|NCT02778204|7741695|FG003|Overall Study|Adverse Event|0
4766544|NCT02778204|7741692|FG000|Overall Study|Withdrawal by Subject|0
4766545|NCT02778204|7741693|FG001|Overall Study|Withdrawal by Subject|0
4766546|NCT02778204|7741694|FG002|Overall Study|Withdrawal by Subject|1
4766547|NCT02778204|7741695|FG003|Overall Study|Withdrawal by Subject|2
4766548|NCT02778204|7741692|FG000|Overall Study|Lost to Follow-up|1
4766549|NCT02778204|7741693|FG001|Overall Study|Lost to Follow-up|0
4766550|NCT02778204|7741694|FG002|Overall Study|Lost to Follow-up|2
4766551|NCT02778204|7741695|FG003|Overall Study|Lost to Follow-up|1
4766552|NCT02778204|7741692|FG000|Overall Study|Protocol Violation|0
4766553|NCT02778204|7741693|FG001|Overall Study|Protocol Violation|0
4766554|NCT02778204|7741694|FG002|Overall Study|Protocol Violation|1
4766555|NCT02778204|7741695|FG003|Overall Study|Protocol Violation|0
4766556|NCT02778204|7741692|FG000|Overall Study|Eligibility Violation|0
4766557|NCT02778204|7741693|FG001|Overall Study|Eligibility Violation|0
4766558|NCT02778204|7741694|FG002|Overall Study|Eligibility Violation|0
4766559|NCT02778204|7741695|FG003|Overall Study|Eligibility Violation|1
4766560|NCT02496611|7741718|FG000|Overall Study|Lost to Follow-up|2
4766561|NCT02496611|7741719|FG001|Overall Study|Lost to Follow-up|1
4766562|NCT02496611|7741718|FG000|Overall Study|Withdrawal by Subject|5
4766563|NCT02496611|7741719|FG001|Overall Study|Withdrawal by Subject|2
4766564|NCT02227199|7741738|FG000|Overall Study|Physician Decision|0
4766565|NCT02227199|7741739|FG001|Overall Study|Physician Decision|0
4766566|NCT02227199|7741740|FG002|Overall Study|Physician Decision|1
4766567|NCT02227199|7741738|FG000|Overall Study|Adverse Event|0
4766568|NCT02227199|7741739|FG001|Overall Study|Adverse Event|0
4766569|NCT02227199|7741740|FG002|Overall Study|Adverse Event|3
4766570|NCT02177695|7741754|FG000|ITT Analysis|Ineligible|5
4766571|NCT02177695|7741755|FG001|ITT Analysis|Ineligible|5
4766572|NCT02177695|7741754|FG000|Primary COXEN Analysis|inadequate tissue submitted|5
4766573|NCT02177695|7741755|FG001|Primary COXEN Analysis|inadequate tissue submitted|6
4766574|NCT02177695|7741754|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15
4766575|NCT02177695|7741755|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8
4766576|NCT02177695|7741754|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13
4766577|NCT02177695|7741755|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13
4766578|NCT02105636|7741785|FG000|Overall Study|Disease Progression|162
4766579|NCT02105636|7741786|FG001|Overall Study|Disease Progression|83
4766580|NCT02105636|7741785|FG000|Overall Study|Study Drug Toxicity|9
4766581|NCT02105636|7741786|FG001|Overall Study|Study Drug Toxicity|11
4766582|NCT02105636|7741785|FG000|Overall Study|Adverse Event Unrelated to Study Drug|12
4766583|NCT02105636|7741786|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3
4766584|NCT02105636|7741785|FG000|Overall Study|Subject Request to Discontinue Treatment|4
4766585|NCT02105636|7741786|FG001|Overall Study|Subject Request to Discontinue Treatment|6
4766586|NCT02105636|7741785|FG000|Overall Study|Subject Withdrew Consent|4
4766587|NCT02105636|7741786|FG001|Overall Study|Subject Withdrew Consent|1
4766588|NCT02105636|7741785|FG000|Overall Study|Maximum Clinical Benefit|1
4766589|NCT02105636|7741786|FG001|Overall Study|Maximum Clinical Benefit|1
4766590|NCT02105636|7741785|FG000|Overall Study|Poor/Non-compliance|0
4766591|NCT02105636|7741786|FG001|Overall Study|Poor/Non-compliance|1
4766592|NCT02105636|7741785|FG000|Overall Study|Reason Not Specified|0
4766593|NCT02105636|7741786|FG001|Overall Study|Reason Not Specified|2
4766594|NCT02105636|7741785|FG000|Overall Study|Not Reported|3
4766595|NCT02105636|7741786|FG001|Overall Study|Not Reported|0
4766596|NCT02038946|7741793|FG000|Overall Study|Death|5
4766597|NCT02038946|7741793|FG000|Overall Study|Withdrawal by Subject|3
4766598|NCT02038946|7741793|FG000|Overall Study|Lost to Follow-up|2
4766599|NCT02038946|7741793|FG000|Overall Study|Other reasons|2
4766600|NCT01988571|7741799|FG000|Overall Study|Death|3
4766601|NCT01988571|7741800|FG001|Overall Study|Death|1
4766602|NCT01988571|7741799|FG000|Overall Study|Physician Decision|2
4766603|NCT01988571|7741800|FG001|Overall Study|Physician Decision|1
4766604|NCT01988571|7741799|FG000|Overall Study|Lost to Follow-up|3
4766605|NCT01988571|7741800|FG001|Overall Study|Lost to Follow-up|0
4766606|NCT01988571|7741799|FG000|Overall Study|Withdrawal by Subject|31
4766607|NCT01988571|7741800|FG001|Overall Study|Withdrawal by Subject|33
4766608|NCT01715285|7741808|FG000|Treatment Period|Adverse Event|60
4766609|NCT01715285|7741809|FG001|Treatment Period|Adverse Event|33
4766610|NCT01715285|7741810|FG002|Treatment Period|Adverse Event|0
4766611|NCT01715285|7741808|FG000|Treatment Period|Lost to Follow-up|3
4766612|NCT01715285|7741809|FG001|Treatment Period|Lost to Follow-up|2
4766613|NCT01715285|7741810|FG002|Treatment Period|Lost to Follow-up|0
4766614|NCT01715285|7741808|FG000|Treatment Period|Death|36
4766615|NCT01715285|7741809|FG001|Treatment Period|Death|23
4766616|NCT01715285|7741810|FG002|Treatment Period|Death|0
4766617|NCT01715285|7741808|FG000|Treatment Period|Noncompliance With Study Drug|4
4766618|NCT01715285|7741809|FG001|Treatment Period|Noncompliance With Study Drug|2
4766619|NCT01715285|7741810|FG002|Treatment Period|Noncompliance With Study Drug|0
4766620|NCT01715285|7741808|FG000|Treatment Period|Progressive Disease|254
4766621|NCT01715285|7741809|FG001|Treatment Period|Progressive Disease|388
4766622|NCT01715285|7741810|FG002|Treatment Period|Progressive Disease|0
4766623|NCT01715285|7741808|FG000|Treatment Period|Withdrawal Of Consent|52
4766624|NCT01715285|7741809|FG001|Treatment Period|Withdrawal Of Consent|47
4766625|NCT01715285|7741810|FG002|Treatment Period|Withdrawal Of Consent|0
4766626|NCT01715285|7741808|FG000|Treatment Period|Physician Decision|21
4766627|NCT01715285|7741809|FG001|Treatment Period|Physician Decision|23
4766628|NCT01715285|7741810|FG002|Treatment Period|Physician Decision|0
4766629|NCT01715285|7741808|FG000|Treatment Period|Ongoing|157
4766630|NCT01715285|7741809|FG001|Treatment Period|Ongoing|0
4766631|NCT01715285|7741810|FG002|Treatment Period|Ongoing|0
4766632|NCT01715285|7741808|FG000|Treatment Period|Other|10
4766633|NCT01715285|7741809|FG001|Treatment Period|Other|12
4766634|NCT01715285|7741810|FG002|Treatment Period|Other|0
4766635|NCT01715285|7741808|FG000|Treatment Period|Placebo Cross-over|0
4766636|NCT01715285|7741809|FG001|Treatment Period|Placebo Cross-over|72
4766637|NCT01715285|7741810|FG002|Treatment Period|Placebo Cross-over|0
4766638|NCT01715285|7741808|FG000|Open-label (OL) Extension Phase|Ongoing|157
4766639|NCT01715285|7741809|FG001|Open-label (OL) Extension Phase|Ongoing|0
4766640|NCT01715285|7741810|FG002|Open-label (OL) Extension Phase|Ongoing|72
4766641|NCT01332266|7741826|FG000|Phase 1b|Death|3
4766642|NCT01332266|7741827|FG001|Phase 1b|Death|3
4766643|NCT01332266|7741828|FG002|Phase 1b|Death|2
4766644|NCT01332266|7741829|FG003|Phase 1b|Death|0
4766645|NCT01332266|7741830|FG004|Phase 1b|Death|0
4766646|NCT01332266|7741826|FG000|Phase 1b|Lost to Follow-up|0
4766647|NCT01332266|7741827|FG001|Phase 1b|Lost to Follow-up|1
4766648|NCT01332266|7741828|FG002|Phase 1b|Lost to Follow-up|0
4766649|NCT01332266|7741829|FG003|Phase 1b|Lost to Follow-up|0
4766650|NCT01332266|7741830|FG004|Phase 1b|Lost to Follow-up|0
4766651|NCT01332266|7741826|FG000|Phase 1b|Withdrawal by Subject|1
4766652|NCT01332266|7741827|FG001|Phase 1b|Withdrawal by Subject|1
4766653|NCT01332266|7741828|FG002|Phase 1b|Withdrawal by Subject|1
4766654|NCT01332266|7741829|FG003|Phase 1b|Withdrawal by Subject|0
4766655|NCT01332266|7741830|FG004|Phase 1b|Withdrawal by Subject|0
4766656|NCT01332266|7741826|FG000|Phase 2|Death|0
4766657|NCT01332266|7741827|FG001|Phase 2|Death|0
4766658|NCT01332266|7741828|FG002|Phase 2|Death|0
4766659|NCT01332266|7741829|FG003|Phase 2|Death|33
4766660|NCT01332266|7741830|FG004|Phase 2|Death|36
4766661|NCT01332266|7741826|FG000|Phase 2|Lost to Follow-up|0
4766662|NCT01332266|7741827|FG001|Phase 2|Lost to Follow-up|0
4766663|NCT01332266|7741828|FG002|Phase 2|Lost to Follow-up|0
4766664|NCT01332266|7741829|FG003|Phase 2|Lost to Follow-up|2
4766665|NCT01332266|7741830|FG004|Phase 2|Lost to Follow-up|0
4766666|NCT01332266|7741826|FG000|Phase 2|Physician Decision|0
4766667|NCT01332266|7741827|FG001|Phase 2|Physician Decision|0
4766668|NCT01332266|7741828|FG002|Phase 2|Physician Decision|0
4766669|NCT01332266|7741829|FG003|Phase 2|Physician Decision|3
4766670|NCT01332266|7741830|FG004|Phase 2|Physician Decision|1
4766671|NCT01332266|7741826|FG000|Phase 2|Symptomatic deterioration|0
4766672|NCT01332266|7741827|FG001|Phase 2|Symptomatic deterioration|0
4766673|NCT01332266|7741828|FG002|Phase 2|Symptomatic deterioration|0
4766674|NCT01332266|7741829|FG003|Phase 2|Symptomatic deterioration|0
4766675|NCT01332266|7741830|FG004|Phase 2|Symptomatic deterioration|1
4766676|NCT01332266|7741826|FG000|Phase 2|Progression Disease|0
4766677|NCT01332266|7741827|FG001|Phase 2|Progression Disease|0
4766678|NCT01332266|7741828|FG002|Phase 2|Progression Disease|0
4766679|NCT01332266|7741829|FG003|Phase 2|Progression Disease|2
4766680|NCT01332266|7741830|FG004|Phase 2|Progression Disease|1
4766681|NCT01332266|7741826|FG000|Phase 2|Withdrawal by Subject|0
4766682|NCT01332266|7741827|FG001|Phase 2|Withdrawal by Subject|0
4766683|NCT01332266|7741828|FG002|Phase 2|Withdrawal by Subject|0
4766684|NCT01332266|7741829|FG003|Phase 2|Withdrawal by Subject|2
4766685|NCT01332266|7741830|FG004|Phase 2|Withdrawal by Subject|2
4766686|NCT01150890|7741847|FG000|Overall Study|Other|0
4766687|NCT01150890|7741848|FG001|Overall Study|Other|1
4766688|NCT01150890|7741849|FG002|Overall Study|Other|0
4766689|NCT01150890|7741850|FG003|Overall Study|Other|2
4766690|NCT01150890|7741847|FG000|Overall Study|Pregnancy|0
4766691|NCT01150890|7741848|FG001|Overall Study|Pregnancy|0
4766692|NCT01150890|7741849|FG002|Overall Study|Pregnancy|0
4766693|NCT01150890|7741850|FG003|Overall Study|Pregnancy|1
4766694|NCT01150890|7741847|FG000|Overall Study|Administrative Decision|4
4766695|NCT01150890|7741848|FG001|Overall Study|Administrative Decision|4
4766696|NCT01150890|7741849|FG002|Overall Study|Administrative Decision|5
4766697|NCT01150890|7741850|FG003|Overall Study|Administrative Decision|6
4766698|NCT01150890|7741847|FG000|Overall Study|Ineligibility determined|0
4766699|NCT01150890|7741848|FG001|Overall Study|Ineligibility determined|1
4766700|NCT01150890|7741849|FG002|Overall Study|Ineligibility determined|0
4766701|NCT01150890|7741850|FG003|Overall Study|Ineligibility determined|0
4766702|NCT01150890|7741847|FG000|Overall Study|Adverse Event|0
4766703|NCT01150890|7741848|FG001|Overall Study|Adverse Event|0
4766704|NCT01150890|7741849|FG002|Overall Study|Adverse Event|2
4766705|NCT01150890|7741850|FG003|Overall Study|Adverse Event|0
4766706|NCT01150890|7741847|FG000|Overall Study|Withdrawal by Subject|0
4766707|NCT01150890|7741848|FG001|Overall Study|Withdrawal by Subject|0
4766708|NCT01150890|7741849|FG002|Overall Study|Withdrawal by Subject|2
4766709|NCT01150890|7741850|FG003|Overall Study|Withdrawal by Subject|1
4766710|NCT01150890|7741847|FG000|Overall Study|Disease progression|0
4766711|NCT01150890|7741848|FG001|Overall Study|Disease progression|7
4766712|NCT01150890|7741849|FG002|Overall Study|Disease progression|3
4766713|NCT01150890|7741850|FG003|Overall Study|Disease progression|7
4766714|NCT01140867|7741863|FG000|Overall Study|Adverse Event|22
4766715|NCT01140867|7741863|FG000|Overall Study|Lack of Efficacy|3
4766716|NCT01140867|7741863|FG000|Overall Study|Lost to Follow-up|2
4766717|NCT01140867|7741863|FG000|Overall Study|Withdrawal by Subject|1
4766718|NCT01140867|7741863|FG000|Overall Study|Protocol Violation|1
4766719|NCT01140867|7741863|FG000|Overall Study|Uncooperative patient|2
4766720|NCT01140867|7741863|FG000|Overall Study|Medication Noncompliance|2
4766721|NCT01137773|7741869|FG000|Overall Study|Death|3
4766722|NCT01137773|7741870|FG001|Overall Study|Death|3
4766723|NCT01137773|7741869|FG000|Overall Study|Lost to Follow-up|6
4766724|NCT01137773|7741870|FG001|Overall Study|Lost to Follow-up|0
4766725|NCT01127256|7741880|FG000|Overall Study|Adverse Event|13
4766726|NCT01127256|7741881|FG001|Overall Study|Adverse Event|13
4766727|NCT01127256|7741880|FG000|Overall Study|Lack of Efficacy|4
4766728|NCT01127256|7741881|FG001|Overall Study|Lack of Efficacy|0
4766729|NCT01127256|7741880|FG000|Overall Study|Lost to Follow-up|16
4766730|NCT01127256|7741881|FG001|Overall Study|Lost to Follow-up|17
4766731|NCT01127256|7741880|FG000|Overall Study|Withdrawal by Subject|5
4766732|NCT01127256|7741881|FG001|Overall Study|Withdrawal by Subject|9
4766733|NCT01127256|7741880|FG000|Overall Study|Protocol Violation|1
4766734|NCT01127256|7741881|FG001|Overall Study|Protocol Violation|0
4766735|NCT01004861|7741900|FG000|Overall Study|Disease progression|3
4766736|NCT01004861|7741901|FG001|Overall Study|Disease progression|4
4766737|NCT01004861|7741902|FG002|Overall Study|Disease progression|5
4766738|NCT01004861|7741903|FG003|Overall Study|Disease progression|4
4766739|NCT01004861|7741904|FG004|Overall Study|Disease progression|4
4766740|NCT01004861|7741905|FG005|Overall Study|Disease progression|4
4766741|NCT01004861|7741906|FG006|Overall Study|Disease progression|5
4766742|NCT01004861|7741907|FG007|Overall Study|Disease progression|1
4766743|NCT01004861|7741908|FG008|Overall Study|Disease progression|4
4766744|NCT01004861|7741909|FG009|Overall Study|Disease progression|7
4766745|NCT01004861|7741910|FG010|Overall Study|Disease progression|6
4766746|NCT01004861|7741911|FG011|Overall Study|Disease progression|3
4766747|NCT01004861|7741912|FG012|Overall Study|Disease progression|8
4766748|NCT01004861|7741900|FG000|Overall Study|Physician Decision|0
4766749|NCT01004861|7741901|FG001|Overall Study|Physician Decision|2
4766750|NCT01004861|7741902|FG002|Overall Study|Physician Decision|1
4766751|NCT01004861|7741903|FG003|Overall Study|Physician Decision|1
4766752|NCT01004861|7741904|FG004|Overall Study|Physician Decision|1
4766753|NCT01004861|7741905|FG005|Overall Study|Physician Decision|0
4766754|NCT01004861|7741906|FG006|Overall Study|Physician Decision|0
4766755|NCT01004861|7741907|FG007|Overall Study|Physician Decision|1
4766756|NCT01004861|7741908|FG008|Overall Study|Physician Decision|0
4766757|NCT01004861|7741909|FG009|Overall Study|Physician Decision|0
4766758|NCT01004861|7741910|FG010|Overall Study|Physician Decision|0
4766759|NCT01004861|7741911|FG011|Overall Study|Physician Decision|0
4766760|NCT01004861|7741912|FG012|Overall Study|Physician Decision|3
4766761|NCT01004861|7741900|FG000|Overall Study|Adverse Event|0
4766762|NCT01004861|7741901|FG001|Overall Study|Adverse Event|0
4766763|NCT01004861|7741902|FG002|Overall Study|Adverse Event|0
4766764|NCT01004861|7741903|FG003|Overall Study|Adverse Event|1
4766765|NCT01004861|7741904|FG004|Overall Study|Adverse Event|0
4766766|NCT01004861|7741905|FG005|Overall Study|Adverse Event|2
4766767|NCT01004861|7741906|FG006|Overall Study|Adverse Event|1
4766768|NCT01004861|7741907|FG007|Overall Study|Adverse Event|1
4766769|NCT01004861|7741908|FG008|Overall Study|Adverse Event|13
4766770|NCT01004861|7741909|FG009|Overall Study|Adverse Event|1
4766771|NCT01004861|7741910|FG010|Overall Study|Adverse Event|1
4766772|NCT01004861|7741911|FG011|Overall Study|Adverse Event|0
4766773|NCT01004861|7741912|FG012|Overall Study|Adverse Event|2
4766774|NCT01004861|7741900|FG000|Overall Study|Protocol Violation|0
4766775|NCT01004861|7741901|FG001|Overall Study|Protocol Violation|0
4766776|NCT01004861|7741902|FG002|Overall Study|Protocol Violation|0
4766777|NCT01004861|7741903|FG003|Overall Study|Protocol Violation|0
4766778|NCT01004861|7741904|FG004|Overall Study|Protocol Violation|1
4766779|NCT01004861|7741905|FG005|Overall Study|Protocol Violation|0
4766780|NCT01004861|7741906|FG006|Overall Study|Protocol Violation|0
4766781|NCT01004861|7741907|FG007|Overall Study|Protocol Violation|0
4766782|NCT01004861|7741908|FG008|Overall Study|Protocol Violation|0
4766783|NCT01004861|7741909|FG009|Overall Study|Protocol Violation|0
4766784|NCT01004861|7741910|FG010|Overall Study|Protocol Violation|0
4766785|NCT01004861|7741911|FG011|Overall Study|Protocol Violation|0
4766786|NCT01004861|7741912|FG012|Overall Study|Protocol Violation|0
4766787|NCT01004861|7741900|FG000|Overall Study|Lost to Follow-up|0
4766788|NCT01004861|7741901|FG001|Overall Study|Lost to Follow-up|0
4766789|NCT01004861|7741902|FG002|Overall Study|Lost to Follow-up|0
4766790|NCT01004861|7741903|FG003|Overall Study|Lost to Follow-up|0
4766791|NCT01004861|7741904|FG004|Overall Study|Lost to Follow-up|0
4766792|NCT01004861|7741905|FG005|Overall Study|Lost to Follow-up|0
4766793|NCT01004861|7741906|FG006|Overall Study|Lost to Follow-up|0
4766794|NCT01004861|7741907|FG007|Overall Study|Lost to Follow-up|1
4766795|NCT01004861|7741908|FG008|Overall Study|Lost to Follow-up|3
4766796|NCT01004861|7741909|FG009|Overall Study|Lost to Follow-up|0
4766797|NCT01004861|7741910|FG010|Overall Study|Lost to Follow-up|0
4766798|NCT01004861|7741911|FG011|Overall Study|Lost to Follow-up|1
4766799|NCT01004861|7741912|FG012|Overall Study|Lost to Follow-up|0
4766800|NCT01004861|7741900|FG000|Overall Study|Non-compliance|0
4766801|NCT01004861|7741901|FG001|Overall Study|Non-compliance|0
4766802|NCT01004861|7741902|FG002|Overall Study|Non-compliance|0
4766803|NCT01004861|7741903|FG003|Overall Study|Non-compliance|0
4766804|NCT01004861|7741904|FG004|Overall Study|Non-compliance|0
4766805|NCT01004861|7741905|FG005|Overall Study|Non-compliance|0
4766806|NCT01004861|7741906|FG006|Overall Study|Non-compliance|0
4766807|NCT01004861|7741907|FG007|Overall Study|Non-compliance|0
4766808|NCT01004861|7741908|FG008|Overall Study|Non-compliance|5
4766809|NCT01004861|7741909|FG009|Overall Study|Non-compliance|0
4766810|NCT01004861|7741910|FG010|Overall Study|Non-compliance|0
4766811|NCT01004861|7741911|FG011|Overall Study|Non-compliance|0
4766812|NCT01004861|7741912|FG012|Overall Study|Non-compliance|1
4766813|NCT01004861|7741900|FG000|Overall Study|Other|0
4766814|NCT01004861|7741901|FG001|Overall Study|Other|0
4766815|NCT01004861|7741902|FG002|Overall Study|Other|0
4766816|NCT01004861|7741903|FG003|Overall Study|Other|0
4766817|NCT01004861|7741904|FG004|Overall Study|Other|0
4766818|NCT01004861|7741905|FG005|Overall Study|Other|0
4766819|NCT01004861|7741906|FG006|Overall Study|Other|0
4766820|NCT01004861|7741907|FG007|Overall Study|Other|0
4766821|NCT01004861|7741908|FG008|Overall Study|Other|0
4766822|NCT01004861|7741909|FG009|Overall Study|Other|2
4766823|NCT01004861|7741910|FG010|Overall Study|Other|1
4766824|NCT01004861|7741911|FG011|Overall Study|Other|2
4766825|NCT01004861|7741912|FG012|Overall Study|Other|3
4766826|NCT01004861|7741900|FG000|Overall Study|Patient decision|0
4766827|NCT01004861|7741901|FG001|Overall Study|Patient decision|0
4766828|NCT01004861|7741902|FG002|Overall Study|Patient decision|0
4766829|NCT01004861|7741903|FG003|Overall Study|Patient decision|0
4766830|NCT01004861|7741904|FG004|Overall Study|Patient decision|1
4766831|NCT01004861|7741905|FG005|Overall Study|Patient decision|0
4766832|NCT01004861|7741906|FG006|Overall Study|Patient decision|1
4766833|NCT01004861|7741907|FG007|Overall Study|Patient decision|0
4766834|NCT01004861|7741908|FG008|Overall Study|Patient decision|7
4766835|NCT01004861|7741909|FG009|Overall Study|Patient decision|1
4766836|NCT01004861|7741910|FG010|Overall Study|Patient decision|1
4766837|NCT01004861|7741911|FG011|Overall Study|Patient decision|2
4766838|NCT01004861|7741912|FG012|Overall Study|Patient decision|3
4766839|NCT01004861|7741900|FG000|Overall Study|Transitioned to Phase 4 study|0
4766840|NCT01004861|7741901|FG001|Overall Study|Transitioned to Phase 4 study|0
4766841|NCT01004861|7741902|FG002|Overall Study|Transitioned to Phase 4 study|0
4766842|NCT01004861|7741903|FG003|Overall Study|Transitioned to Phase 4 study|0
4766843|NCT01004861|7741904|FG004|Overall Study|Transitioned to Phase 4 study|0
4766844|NCT01004861|7741905|FG005|Overall Study|Transitioned to Phase 4 study|0
4766845|NCT01004861|7741906|FG006|Overall Study|Transitioned to Phase 4 study|0
4766846|NCT01004861|7741907|FG007|Overall Study|Transitioned to Phase 4 study|0
4766847|NCT01004861|7741908|FG008|Overall Study|Transitioned to Phase 4 study|2
4766848|NCT01004861|7741909|FG009|Overall Study|Transitioned to Phase 4 study|0
4766849|NCT01004861|7741910|FG010|Overall Study|Transitioned to Phase 4 study|0
4766850|NCT01004861|7741911|FG011|Overall Study|Transitioned to Phase 4 study|0
4766851|NCT01004861|7741912|FG012|Overall Study|Transitioned to Phase 4 study|0
4766852|NCT01004861|7741900|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
4766853|NCT01004861|7741901|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
4766854|NCT01004861|7741902|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
4766855|NCT01004861|7741903|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
4766856|NCT01004861|7741904|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
4766857|NCT01004861|7741905|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
4766858|NCT01004861|7741906|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
4766859|NCT01004861|7741907|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
4766860|NCT01004861|7741908|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1
4766861|NCT01004861|7741909|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
4766862|NCT01004861|7741910|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
4766863|NCT01004861|7741911|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
4766864|NCT01004861|7741912|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0
4766865|NCT01004861|7741900|FG000|Overall Study|Patient withdrew|0
4766866|NCT01004861|7741901|FG001|Overall Study|Patient withdrew|0
4766867|NCT01004861|7741902|FG002|Overall Study|Patient withdrew|0
4766868|NCT01004861|7741903|FG003|Overall Study|Patient withdrew|0
4766869|NCT01004861|7741904|FG004|Overall Study|Patient withdrew|0
4766870|NCT01004861|7741905|FG005|Overall Study|Patient withdrew|0
4766871|NCT01004861|7741906|FG006|Overall Study|Patient withdrew|0
4766872|NCT01004861|7741907|FG007|Overall Study|Patient withdrew|0
4766873|NCT01004861|7741908|FG008|Overall Study|Patient withdrew|1
4766874|NCT01004861|7741909|FG009|Overall Study|Patient withdrew|0
4766875|NCT01004861|7741910|FG010|Overall Study|Patient withdrew|0
4766876|NCT01004861|7741911|FG011|Overall Study|Patient withdrew|0
4766877|NCT01004861|7741912|FG012|Overall Study|Patient withdrew|0
4766878|NCT01004861|7741900|FG000|Overall Study|Surgical resection|0
4766879|NCT01004861|7741901|FG001|Overall Study|Surgical resection|0
4766880|NCT01004861|7741902|FG002|Overall Study|Surgical resection|0
4766881|NCT01004861|7741903|FG003|Overall Study|Surgical resection|0
4766882|NCT01004861|7741904|FG004|Overall Study|Surgical resection|0
4766883|NCT01004861|7741905|FG005|Overall Study|Surgical resection|0
4766884|NCT01004861|7741906|FG006|Overall Study|Surgical resection|0
4766885|NCT01004861|7741907|FG007|Overall Study|Surgical resection|0
4766886|NCT01004861|7741908|FG008|Overall Study|Surgical resection|1
4766887|NCT01004861|7741909|FG009|Overall Study|Surgical resection|0
4766888|NCT01004861|7741910|FG010|Overall Study|Surgical resection|0
4766889|NCT01004861|7741911|FG011|Overall Study|Surgical resection|0
4766890|NCT01004861|7741912|FG012|Overall Study|Surgical resection|0
4766891|NCT01004861|7741900|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0
4766892|NCT01004861|7741901|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0
4766893|NCT01004861|7741902|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0
4766894|NCT01004861|7741903|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0
4766895|NCT01004861|7741904|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0
4766896|NCT01004861|7741905|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0
4766897|NCT01004861|7741906|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0
4766898|NCT01004861|7741907|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0
4766899|NCT01004861|7741908|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1
4766900|NCT01004861|7741909|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0
4766901|NCT01004861|7741910|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0
4766902|NCT01004861|7741911|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0
4766903|NCT01004861|7741912|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0
4766904|NCT01004861|7741900|FG000|Overall Study|Study termination by Sponsor|0
4766905|NCT01004861|7741901|FG001|Overall Study|Study termination by Sponsor|0
4766906|NCT01004861|7741902|FG002|Overall Study|Study termination by Sponsor|0
4766907|NCT01004861|7741903|FG003|Overall Study|Study termination by Sponsor|0
4766908|NCT01004861|7741904|FG004|Overall Study|Study termination by Sponsor|0
4766909|NCT01004861|7741905|FG005|Overall Study|Study termination by Sponsor|0
4766910|NCT01004861|7741906|FG006|Overall Study|Study termination by Sponsor|0
4766911|NCT01004861|7741907|FG007|Overall Study|Study termination by Sponsor|0
4766912|NCT01004861|7741908|FG008|Overall Study|Study termination by Sponsor|1
4766913|NCT01004861|7741909|FG009|Overall Study|Study termination by Sponsor|0
4766914|NCT01004861|7741910|FG010|Overall Study|Study termination by Sponsor|0
4766915|NCT01004861|7741911|FG011|Overall Study|Study termination by Sponsor|0
4766916|NCT01004861|7741912|FG012|Overall Study|Study termination by Sponsor|0
4766917|NCT00912223|7741944|FG000|Overall Study|Withdrawal by Subject|1
4766918|NCT00912223|7741944|FG000|Overall Study|Not transplanted|1
4766919|NCT00912223|7741944|FG000|Overall Study|Transformed disease|1
4766920|NCT00381381|7741948|FG000|Overall Study|Adverse Event|3
4766921|NCT00381381|7741948|FG000|Overall Study|Lost to Follow-up|52
4766922|NCT00381381|7741948|FG000|Overall Study|Withdrawal by Subject|9
4766923|NCT04706403|7741972|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0
4766924|NCT04706403|7741973|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0
4766925|NCT04706403|7741974|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1
4766926|NCT04706403|7741975|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1
4766927|NCT04706403|7741976|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2
4766928|NCT03712124|7742000|FG000|Overall Study|Protocol Violation|1
4766929|NCT03712124|7742001|FG001|Overall Study|Protocol Violation|0
4766930|NCT03535740|7742013|FG000|Overall Study|Ongoing at Data Cut-off Date: 30 September 2020|55
4766931|NCT03535740|7742013|FG000|Overall Study|Death|34
4766932|NCT03535740|7742013|FG000|Overall Study|Lost to Follow-up|1
4766933|NCT03535740|7742013|FG000|Overall Study|Withdrawal by Subject|13
4766934|NCT03503318|7742021|FG000|Overall Study|Death|1
4766935|NCT03503318|7742022|FG001|Overall Study|Death|0
4766936|NCT03503318|7742023|FG002|Overall Study|Death|4
4766937|NCT03503318|7742021|FG000|Overall Study|Adverse Event|3
4766938|NCT03503318|7742022|FG001|Overall Study|Adverse Event|4
4766939|NCT03503318|7742023|FG002|Overall Study|Adverse Event|2
4766940|NCT03503318|7742021|FG000|Overall Study|Withdrawal by Subject|12
4766941|NCT03503318|7742022|FG001|Overall Study|Withdrawal by Subject|17
4766942|NCT03503318|7742023|FG002|Overall Study|Withdrawal by Subject|16
4766943|NCT03503318|7742021|FG000|Overall Study|Protocol Violation|5
4766944|NCT03503318|7742022|FG001|Overall Study|Protocol Violation|0
4766945|NCT03503318|7742023|FG002|Overall Study|Protocol Violation|3
4766946|NCT03503318|7742021|FG000|Overall Study|Lost to Follow-up|17
4766947|NCT03503318|7742022|FG001|Overall Study|Lost to Follow-up|15
4766948|NCT03503318|7742023|FG002|Overall Study|Lost to Follow-up|12
4766949|NCT03503318|7742021|FG000|Overall Study|Other than specified|1
4766950|NCT03503318|7742022|FG001|Overall Study|Other than specified|3
4766951|NCT03503318|7742023|FG002|Overall Study|Other than specified|3
4766952|NCT02921789|7742051|FG000|Overall Study|Adverse Event|0
4766953|NCT02921789|7742052|FG001|Overall Study|Adverse Event|1
4766954|NCT02921789|7742051|FG000|Overall Study|Lost to Follow-up|1
4766955|NCT02921789|7742052|FG001|Overall Study|Lost to Follow-up|0
4766956|NCT02921789|7742051|FG000|Overall Study|Protocol Deviation|2
4766957|NCT02921789|7742052|FG001|Overall Study|Protocol Deviation|0
4766958|NCT02921789|7742051|FG000|Overall Study|Withdrawal by Subject|2
4766959|NCT02921789|7742052|FG001|Overall Study|Withdrawal by Subject|1
4766960|NCT02921789|7742051|FG000|Overall Study|Miscellaneous|3
4766961|NCT02921789|7742052|FG001|Overall Study|Miscellaneous|2
4766962|NCT02896257|7742072|FG000|Providers|Without eligible patients|21
4766963|NCT02896257|7742073|FG001|Providers|Without eligible patients|28
4766964|NCT02896257|7742072|FG000|Patients|PFT entry criteria not met|43
4766965|NCT02896257|7742073|FG001|Patients|PFT entry criteria not met|50
4766966|NCT02896257|7742072|FG000|Patients|No capacity to review|8
4766967|NCT02896257|7742073|FG001|Patients|No capacity to review|11
4766968|NCT02896257|7742072|FG000|Patients|Appointment rescheduled/cancelled|5
4766969|NCT02896257|7742073|FG001|Patients|Appointment rescheduled/cancelled|7
4766970|NCT02896257|7742072|FG000|Patients|PCP not assigned a clinic|4
4766971|NCT02896257|7742073|FG001|Patients|PCP not assigned a clinic|0
4766972|NCT02896257|7742072|FG000|Patients|No history of COPD|0
4766973|NCT02896257|7742073|FG001|Patients|No history of COPD|1
4766974|NCT02896257|7742072|FG000|Patients|Deceased between review and index date|0
4766975|NCT02896257|7742073|FG001|Patients|Deceased between review and index date|1
4766976|NCT02896257|7742072|FG000|Patients|No ICS Rx upon review|1
4766977|NCT02896257|7742073|FG001|Patients|No ICS Rx upon review|1
4766978|NCT02896257|7742072|FG000|Patients|Protocol Violation|2
4766979|NCT02896257|7742073|FG001|Patients|Protocol Violation|1
4766980|NCT02896257|7742072|FG000|Patients|Hospice care|0
4766981|NCT02896257|7742073|FG001|Patients|Hospice care|1
4766982|NCT02736617|7742089|FG000|Treatment|Adverse Event|1
4766983|NCT02736617|7742089|FG000|Treatment|Lack of Efficacy|1
4766984|NCT02736617|7742089|FG000|Treatment|Withdrawal by Subject|1
4766985|NCT02736617|7742089|FG000|Maintenance|Lack of Efficacy|4
4766986|NCT02736617|7742089|FG000|Maintenance|Physician Decision|1
4766987|NCT02579265|7742100|FG000|Overall Study|Weaned off earlier than 28 days|44
4766988|NCT02579265|7742101|FG001|Overall Study|Weaned off earlier than 28 days|43
4766989|NCT02579265|7742100|FG000|Overall Study|Adverse Event|2
4766990|NCT02579265|7742101|FG001|Overall Study|Adverse Event|0
4766991|NCT02579265|7742100|FG000|Overall Study|Any other reason not specified|0
4766992|NCT02579265|7742101|FG001|Overall Study|Any other reason not specified|2
4766993|NCT02579265|7742100|FG000|Overall Study|Withdrawal by Subject|2
4766994|NCT02579265|7742101|FG001|Overall Study|Withdrawal by Subject|0
4766995|NCT02579265|7742100|FG000|Overall Study|Physician Decision|1
4766996|NCT02579265|7742101|FG001|Overall Study|Physician Decision|0
4766997|NCT02579265|7742100|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1
4766998|NCT02579265|7742101|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0
4766999|NCT02013167|7742109|FG000|Overall Study|Withdrawal by Subject|15
4767000|NCT02013167|7742110|FG001|Overall Study|Withdrawal by Subject|14
4767001|NCT02013167|7742109|FG000|Overall Study|Sponsor Decision|1
4767002|NCT02013167|7742110|FG001|Overall Study|Sponsor Decision|3
4767003|NCT02013167|7742109|FG000|Overall Study|Lost to Follow-up|0
4767004|NCT02013167|7742110|FG001|Overall Study|Lost to Follow-up|1
4767005|NCT02013167|7742109|FG000|Overall Study|Death|85
4767006|NCT02013167|7742110|FG001|Overall Study|Death|160
4767007|NCT02004522|7742119|FG000|Overall Study|Adverse Event|55
4767008|NCT02004522|7742120|FG001|Overall Study|Adverse Event|6
4767009|NCT02004522|7742119|FG000|Overall Study|Withdrawal by Subject|13
4767010|NCT02004522|7742120|FG001|Overall Study|Withdrawal by Subject|7
4767011|NCT02004522|7742119|FG000|Overall Study|Death|12
4767012|NCT02004522|7742120|FG001|Overall Study|Death|3
4767013|NCT02004522|7742119|FG000|Overall Study|Physician Decision|3
4767014|NCT02004522|7742120|FG001|Overall Study|Physician Decision|4
4767015|NCT02004522|7742119|FG000|Overall Study|Protocol Violation|1
4767016|NCT02004522|7742120|FG001|Overall Study|Protocol Violation|0
4767017|NCT02004522|7742119|FG000|Overall Study|Other is reason listed by PI.|4
4767018|NCT02004522|7742120|FG001|Overall Study|Other is reason listed by PI.|1
4767019|NCT02004522|7742119|FG000|Overall Study|Never Dosed|2
4767020|NCT02004522|7742120|FG001|Overall Study|Never Dosed|4
4767021|NCT02004522|7742119|FG000|Overall Study|Disease Progression|35
4767022|NCT02004522|7742120|FG001|Overall Study|Disease Progression|31
4767023|NCT02004522|7742119|FG000|Overall Study|Completed Treatrment Cycles Per Protocol|1
4767024|NCT02004522|7742120|FG001|Overall Study|Completed Treatrment Cycles Per Protocol|103
4767025|NCT02000427|7742126|FG000|Overall Study|Death|22
4767026|NCT01981850|7742137|FG000|Main Phase Stage 1|Death|2
4767027|NCT01981850|7742138|FG001|Main Phase Stage 1|Death|0
4767028|NCT01981850|7742139|FG002|Main Phase Stage 1|Death|0
4767029|NCT01981850|7742140|FG003|Main Phase Stage 1|Death|0
4767030|NCT01981850|7742141|FG004|Main Phase Stage 1|Death|0
4767031|NCT01981850|7742142|FG005|Main Phase Stage 1|Death|0
4767032|NCT01981850|7742143|FG006|Main Phase Stage 1|Death|0
4767033|NCT01981850|7742144|FG007|Main Phase Stage 1|Death|0
4767034|NCT01981850|7742145|FG008|Main Phase Stage 1|Death|0
4767035|NCT01981850|7742146|FG009|Main Phase Stage 1|Death|0
4767036|NCT01981850|7742137|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1
4767037|NCT01981850|7742138|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0
4767038|NCT01981850|7742139|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0
4767039|NCT01981850|7742140|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0
4767040|NCT01981850|7742141|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0
4767041|NCT01981850|7742142|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0
4767042|NCT01981850|7742143|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0
4767043|NCT01981850|7742144|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0
4767044|NCT01981850|7742145|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0
4767045|NCT01981850|7742146|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0
4767046|NCT01981850|7742137|FG000|Main Phase Stage 1|Lack of Efficacy|0
4767047|NCT01981850|7742138|FG001|Main Phase Stage 1|Lack of Efficacy|2
4767048|NCT01981850|7742139|FG002|Main Phase Stage 1|Lack of Efficacy|0
4767049|NCT01981850|7742140|FG003|Main Phase Stage 1|Lack of Efficacy|0
4767050|NCT01981850|7742141|FG004|Main Phase Stage 1|Lack of Efficacy|0
4767051|NCT01981850|7742142|FG005|Main Phase Stage 1|Lack of Efficacy|0
4767052|NCT01981850|7742143|FG006|Main Phase Stage 1|Lack of Efficacy|0
4767053|NCT01981850|7742144|FG007|Main Phase Stage 1|Lack of Efficacy|0
4767054|NCT01981850|7742145|FG008|Main Phase Stage 1|Lack of Efficacy|0
4767055|NCT01981850|7742146|FG009|Main Phase Stage 1|Lack of Efficacy|0
4767056|NCT01981850|7742137|FG000|Main Phase Stage 1|Various reasons|0
4767057|NCT01981850|7742138|FG001|Main Phase Stage 1|Various reasons|0
4767058|NCT01981850|7742139|FG002|Main Phase Stage 1|Various reasons|2
4767059|NCT01981850|7742140|FG003|Main Phase Stage 1|Various reasons|0
4767060|NCT01981850|7742141|FG004|Main Phase Stage 1|Various reasons|0
4767061|NCT01981850|7742142|FG005|Main Phase Stage 1|Various reasons|0
4767062|NCT01981850|7742143|FG006|Main Phase Stage 1|Various reasons|0
4767063|NCT01981850|7742144|FG007|Main Phase Stage 1|Various reasons|0
4767064|NCT01981850|7742145|FG008|Main Phase Stage 1|Various reasons|0
4767065|NCT01981850|7742146|FG009|Main Phase Stage 1|Various reasons|0
4767066|NCT01981850|7742137|FG000|Main Phase Stage 2|Adverse Event|0
4767067|NCT01981850|7742138|FG001|Main Phase Stage 2|Adverse Event|0
4767068|NCT01981850|7742139|FG002|Main Phase Stage 2|Adverse Event|0
4767069|NCT01981850|7742140|FG003|Main Phase Stage 2|Adverse Event|0
4767070|NCT01981850|7742141|FG004|Main Phase Stage 2|Adverse Event|6
4767071|NCT01981850|7742142|FG005|Main Phase Stage 2|Adverse Event|5
4767072|NCT01981850|7742143|FG006|Main Phase Stage 2|Adverse Event|7
4767073|NCT01981850|7742144|FG007|Main Phase Stage 2|Adverse Event|0
4767074|NCT01981850|7742145|FG008|Main Phase Stage 2|Adverse Event|0
4767075|NCT01981850|7742146|FG009|Main Phase Stage 2|Adverse Event|0
4767076|NCT01981850|7742137|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0
4767077|NCT01981850|7742138|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0
4767078|NCT01981850|7742139|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0
4767079|NCT01981850|7742140|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0
4767080|NCT01981850|7742141|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4
4767081|NCT01981850|7742142|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3
4767082|NCT01981850|7742143|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3
4767083|NCT01981850|7742144|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0
4767084|NCT01981850|7742145|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0
4767085|NCT01981850|7742146|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0
4767086|NCT01981850|7742137|FG000|Main Phase Stage 2|Lack of Efficacy|0
4767087|NCT01981850|7742138|FG001|Main Phase Stage 2|Lack of Efficacy|0
4767088|NCT01981850|7742139|FG002|Main Phase Stage 2|Lack of Efficacy|0
4767089|NCT01981850|7742140|FG003|Main Phase Stage 2|Lack of Efficacy|0
4767090|NCT01981850|7742141|FG004|Main Phase Stage 2|Lack of Efficacy|1
4767091|NCT01981850|7742142|FG005|Main Phase Stage 2|Lack of Efficacy|2
4767092|NCT01981850|7742143|FG006|Main Phase Stage 2|Lack of Efficacy|0
4767093|NCT01981850|7742144|FG007|Main Phase Stage 2|Lack of Efficacy|0
4767094|NCT01981850|7742145|FG008|Main Phase Stage 2|Lack of Efficacy|0
4767095|NCT01981850|7742146|FG009|Main Phase Stage 2|Lack of Efficacy|0
4767096|NCT01981850|7742137|FG000|Main Phase Stage 2|Various reasons|0
4767097|NCT01981850|7742138|FG001|Main Phase Stage 2|Various reasons|0
4767098|NCT01981850|7742139|FG002|Main Phase Stage 2|Various reasons|0
4767099|NCT01981850|7742140|FG003|Main Phase Stage 2|Various reasons|0
4767100|NCT01981850|7742141|FG004|Main Phase Stage 2|Various reasons|2
4767101|NCT01981850|7742142|FG005|Main Phase Stage 2|Various reasons|0
4767102|NCT01981850|7742143|FG006|Main Phase Stage 2|Various reasons|1
4767103|NCT01981850|7742144|FG007|Main Phase Stage 2|Various reasons|0
4767104|NCT01981850|7742145|FG008|Main Phase Stage 2|Various reasons|0
4767105|NCT01981850|7742146|FG009|Main Phase Stage 2|Various reasons|0
4767106|NCT01981850|7742137|FG000|Main Phase Stage 2|Progressive Disease|0
4767107|NCT01981850|7742138|FG001|Main Phase Stage 2|Progressive Disease|0
4767108|NCT01981850|7742139|FG002|Main Phase Stage 2|Progressive Disease|0
4767109|NCT01981850|7742140|FG003|Main Phase Stage 2|Progressive Disease|0
4767110|NCT01981850|7742141|FG004|Main Phase Stage 2|Progressive Disease|0
4767111|NCT01981850|7742142|FG005|Main Phase Stage 2|Progressive Disease|6
4767112|NCT01981850|7742143|FG006|Main Phase Stage 2|Progressive Disease|6
4767113|NCT01981850|7742144|FG007|Main Phase Stage 2|Progressive Disease|0
4767114|NCT01981850|7742145|FG008|Main Phase Stage 2|Progressive Disease|0
4767115|NCT01981850|7742146|FG009|Main Phase Stage 2|Progressive Disease|0
4767116|NCT01981850|7742137|FG000|Open Label Extension (OLE)|Adverse Event|0
4767117|NCT01981850|7742138|FG001|Open Label Extension (OLE)|Adverse Event|0
4767118|NCT01981850|7742139|FG002|Open Label Extension (OLE)|Adverse Event|0
4767119|NCT01981850|7742140|FG003|Open Label Extension (OLE)|Adverse Event|0
4767120|NCT01981850|7742141|FG004|Open Label Extension (OLE)|Adverse Event|0
4767121|NCT01981850|7742142|FG005|Open Label Extension (OLE)|Adverse Event|0
4767122|NCT01981850|7742143|FG006|Open Label Extension (OLE)|Adverse Event|0
4767123|NCT01981850|7742144|FG007|Open Label Extension (OLE)|Adverse Event|2
4767124|NCT01981850|7742145|FG008|Open Label Extension (OLE)|Adverse Event|1
4767125|NCT01981850|7742146|FG009|Open Label Extension (OLE)|Adverse Event|8
4767126|NCT01981850|7742137|FG000|Open Label Extension (OLE)|Lack of Efficacy|0
4767127|NCT01981850|7742138|FG001|Open Label Extension (OLE)|Lack of Efficacy|0
4767128|NCT01981850|7742139|FG002|Open Label Extension (OLE)|Lack of Efficacy|0
4767129|NCT01981850|7742140|FG003|Open Label Extension (OLE)|Lack of Efficacy|0
4767130|NCT01981850|7742141|FG004|Open Label Extension (OLE)|Lack of Efficacy|0
4767131|NCT01981850|7742142|FG005|Open Label Extension (OLE)|Lack of Efficacy|0
4767132|NCT01981850|7742143|FG006|Open Label Extension (OLE)|Lack of Efficacy|0
4767133|NCT01981850|7742144|FG007|Open Label Extension (OLE)|Lack of Efficacy|4
4767134|NCT01981850|7742145|FG008|Open Label Extension (OLE)|Lack of Efficacy|1
4767135|NCT01981850|7742146|FG009|Open Label Extension (OLE)|Lack of Efficacy|19
4767136|NCT01981850|7742137|FG000|Open Label Extension (OLE)|Various reasons|0
4767137|NCT01981850|7742138|FG001|Open Label Extension (OLE)|Various reasons|0
4767138|NCT01981850|7742139|FG002|Open Label Extension (OLE)|Various reasons|0
4767139|NCT01981850|7742140|FG003|Open Label Extension (OLE)|Various reasons|0
4767140|NCT01981850|7742141|FG004|Open Label Extension (OLE)|Various reasons|0
4767141|NCT01981850|7742142|FG005|Open Label Extension (OLE)|Various reasons|0
4767142|NCT01981850|7742143|FG006|Open Label Extension (OLE)|Various reasons|0
4767143|NCT01981850|7742144|FG007|Open Label Extension (OLE)|Various reasons|3
4767144|NCT01981850|7742145|FG008|Open Label Extension (OLE)|Various reasons|1
4767145|NCT01981850|7742146|FG009|Open Label Extension (OLE)|Various reasons|3
4767146|NCT01981850|7742137|FG000|Open Label Extension (OLE)|Progressive Disease|0
4767147|NCT01981850|7742138|FG001|Open Label Extension (OLE)|Progressive Disease|0
4767148|NCT01981850|7742139|FG002|Open Label Extension (OLE)|Progressive Disease|0
4767149|NCT01981850|7742140|FG003|Open Label Extension (OLE)|Progressive Disease|0
4767150|NCT01981850|7742141|FG004|Open Label Extension (OLE)|Progressive Disease|0
4767151|NCT01981850|7742142|FG005|Open Label Extension (OLE)|Progressive Disease|0
4767152|NCT01981850|7742143|FG006|Open Label Extension (OLE)|Progressive Disease|0
4767153|NCT01981850|7742144|FG007|Open Label Extension (OLE)|Progressive Disease|3
4767154|NCT01981850|7742145|FG008|Open Label Extension (OLE)|Progressive Disease|2
4767155|NCT01981850|7742146|FG009|Open Label Extension (OLE)|Progressive Disease|9
4767156|NCT01981850|7742137|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0
4767157|NCT01981850|7742138|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0
4767158|NCT01981850|7742139|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0
4767159|NCT01981850|7742140|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0
4767160|NCT01981850|7742141|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0
4767161|NCT01981850|7742142|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0
4767162|NCT01981850|7742143|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0
4767163|NCT01981850|7742144|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0
4767164|NCT01981850|7742145|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0
4767165|NCT01981850|7742146|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8
4767166|NCT01981850|7742137|FG000|Open Label Extension (OLE)|Lost to Follow-up|0
4767167|NCT01981850|7742138|FG001|Open Label Extension (OLE)|Lost to Follow-up|0
4767168|NCT01981850|7742139|FG002|Open Label Extension (OLE)|Lost to Follow-up|0
4767169|NCT01981850|7742140|FG003|Open Label Extension (OLE)|Lost to Follow-up|0
4767170|NCT01981850|7742141|FG004|Open Label Extension (OLE)|Lost to Follow-up|0
4767171|NCT01981850|7742142|FG005|Open Label Extension (OLE)|Lost to Follow-up|0
4767172|NCT01981850|7742143|FG006|Open Label Extension (OLE)|Lost to Follow-up|0
4767173|NCT01981850|7742144|FG007|Open Label Extension (OLE)|Lost to Follow-up|0
4767174|NCT01981850|7742145|FG008|Open Label Extension (OLE)|Lost to Follow-up|0
4767175|NCT01981850|7742146|FG009|Open Label Extension (OLE)|Lost to Follow-up|1
4767176|NCT01804816|7742178|FG000|No Acupuncture (Initial 5 Weeks)|Withdrawal by Subject|3
4767177|NCT01804816|7742178|FG000|Acupuncture (Second 5 Weeks)|Physician Decision|1
4767178|NCT01519960|7742212|FG000|Overall Study|Ongoing in Follow-Up|101
4767179|NCT01519960|7742213|FG001|Overall Study|Ongoing in Follow-Up|11
4767180|NCT01519960|7742214|FG002|Overall Study|Ongoing in Follow-Up|10
4767181|NCT01519960|7742212|FG000|Overall Study|Ongoing/Switched to PEG-IFN|0
4767182|NCT01519960|7742213|FG001|Overall Study|Ongoing/Switched to PEG-IFN|33
4767183|NCT01519960|7742214|FG002|Overall Study|Ongoing/Switched to PEG-IFN|0
4767184|NCT01519960|7742212|FG000|Overall Study|Adverse Event|0
4767185|NCT01519960|7742213|FG001|Overall Study|Adverse Event|1
4767186|NCT01519960|7742214|FG002|Overall Study|Adverse Event|0
4767187|NCT01519960|7742212|FG000|Overall Study|Withdrawal by Subject|0
4767188|NCT01519960|7742213|FG001|Overall Study|Withdrawal by Subject|4
4767189|NCT01519960|7742214|FG002|Overall Study|Withdrawal by Subject|0
4767190|NCT01519960|7742212|FG000|Overall Study|Lost to Follow-up|0
4767191|NCT01519960|7742213|FG001|Overall Study|Lost to Follow-up|1
4767192|NCT01519960|7742214|FG002|Overall Study|Lost to Follow-up|0
4767193|NCT00688376|7742227|FG000|Double-Blind Phase|Adverse Event|4
4767194|NCT00688376|7742228|FG001|Double-Blind Phase|Adverse Event|4
4767195|NCT00688376|7742227|FG000|Double-Blind Phase|Protocol Violation|1
4767196|NCT00688376|7742228|FG001|Double-Blind Phase|Protocol Violation|2
4767197|NCT00688376|7742227|FG000|Double-Blind Phase|Withdrawal by Subject|1
4767198|NCT00688376|7742228|FG001|Double-Blind Phase|Withdrawal by Subject|0
4767199|NCT00688376|7742227|FG000|Double-Blind Phase|Not treated|0
4767200|NCT00688376|7742228|FG001|Double-Blind Phase|Not treated|1
4767201|NCT00688376|7742227|FG000|Blinded Extension Phase|Adverse Event|3
4767202|NCT00688376|7742228|FG001|Blinded Extension Phase|Adverse Event|4
4767203|NCT00688376|7742227|FG000|Blinded Extension Phase|Withdrawal by Subject|0
4767204|NCT00688376|7742228|FG001|Blinded Extension Phase|Withdrawal by Subject|1
4767205|NCT00688376|7742227|FG000|Blinded Extension Phase|Physician Decision|1
4767206|NCT00688376|7742228|FG001|Blinded Extension Phase|Physician Decision|0
4767207|NCT00688376|7742227|FG000|Blinded Extension Phase|Other|1
4767208|NCT00688376|7742228|FG001|Blinded Extension Phase|Other|0
4767209|NCT00121108|7742255|FG000|Overall Study|Lost to Follow-up|10
4767210|NCT00121108|7742256|FG001|Overall Study|Lost to Follow-up|22
4767211|NCT00121108|7742255|FG000|Overall Study|Withdrawal by Subject|106
4767212|NCT00121108|7742256|FG001|Overall Study|Withdrawal by Subject|195
4767213|NCT00121108|7742255|FG000|Overall Study|Death|5
4767214|NCT00121108|7742256|FG001|Overall Study|Death|8
4767215|NCT00003102|7742266|FG000|Overall Study|Physician Decision|1
4767216|NCT00003102|7742267|FG001|Overall Study|Physician Decision|1
4767217|NCT00003102|7742268|FG002|Overall Study|Physician Decision|0
4767218|NCT00003102|7742266|FG000|Overall Study|Progressive Disease|0
4767219|NCT00003102|7742267|FG001|Overall Study|Progressive Disease|1
4767220|NCT00003102|7742268|FG002|Overall Study|Progressive Disease|0
4767221|NCT00003102|7742266|FG000|Overall Study|Adverse Event|0
4767222|NCT00003102|7742267|FG001|Overall Study|Adverse Event|1
4767223|NCT00003102|7742268|FG002|Overall Study|Adverse Event|1
4767224|NCT00003102|7742266|FG000|Overall Study|Death|0
4767225|NCT00003102|7742267|FG001|Overall Study|Death|0
4767226|NCT00003102|7742268|FG002|Overall Study|Death|1
4767227|NCT04633837|7742278|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5
4767228|NCT04633837|7742279|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0
4767229|NCT04057937|7742287|FG000|Placebo-controlled Phase|Adverse Event|3
4767230|NCT04057937|7742288|FG001|Placebo-controlled Phase|Adverse Event|0
4767231|NCT04057937|7742287|FG000|Active-treatment Phase|Withdrawal by Subject|1
4767232|NCT04057937|7742288|FG001|Active-treatment Phase|Withdrawal by Subject|0
4767233|NCT04057937|7742287|FG000|Active-treatment Phase|Pregnancy|0
4767234|NCT04057937|7742288|FG001|Active-treatment Phase|Pregnancy|1
4767235|NCT04057937|7742287|FG000|Active-treatment Phase|Physician Decision|0
4767236|NCT04057937|7742288|FG001|Active-treatment Phase|Physician Decision|1
4767237|NCT03032510|7742301|FG000|Overall Study|Adverse Event|5
4767238|NCT03032510|7742302|FG001|Overall Study|Adverse Event|2
4767239|NCT03032510|7742301|FG000|Overall Study|Lost to Follow-up|8
4767240|NCT03032510|7742302|FG001|Overall Study|Lost to Follow-up|7
4767241|NCT03032510|7742301|FG000|Overall Study|Withdrawal by Subject|8
4767242|NCT03032510|7742302|FG001|Overall Study|Withdrawal by Subject|7
4767243|NCT03032510|7742301|FG000|Overall Study|Subject noncompliance|4
4767244|NCT03032510|7742302|FG001|Overall Study|Subject noncompliance|2
4767245|NCT03032510|7742301|FG000|Overall Study|Physician Decision|2
4767246|NCT03032510|7742302|FG001|Overall Study|Physician Decision|0
4767247|NCT02946047|7742333|FG000|Overall Study|Adverse Event|1
4767248|NCT02946047|7742334|FG001|Overall Study|Adverse Event|0
4767249|NCT02946047|7742335|FG002|Overall Study|Adverse Event|0
4767250|NCT02946047|7742336|FG003|Overall Study|Adverse Event|0
4767251|NCT02784704|7742354|FG000|Overall Study|Adverse Event|4
4767252|NCT02784704|7742355|FG001|Overall Study|Adverse Event|2
4767253|NCT02784704|7742354|FG000|Overall Study|Lost to Follow-up|6
4767254|NCT02784704|7742355|FG001|Overall Study|Lost to Follow-up|4
4767255|NCT02784704|7742354|FG000|Overall Study|Withdrawal by Subject|1
4767256|NCT02784704|7742355|FG001|Overall Study|Withdrawal by Subject|3
4767257|NCT02784704|7742354|FG000|Overall Study|Subject Non Compliance|2
4767258|NCT02784704|7742355|FG001|Overall Study|Subject Non Compliance|0
4767259|NCT04831515|7742363|FG000|First Intervention|Adverse Event|0
4767260|NCT04831515|7742364|FG001|First Intervention|Adverse Event|1
4767261|NCT03881059|7742395|FG000|Treatment Period - Part A|Adverse Event|1
4767262|NCT03881059|7742396|FG001|Treatment Period - Part A|Adverse Event|3
4767263|NCT03881059|7742397|FG002|Treatment Period - Part A|Adverse Event|4
4767264|NCT03881059|7742395|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0
4767265|NCT03881059|7742396|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1
4767266|NCT03881059|7742397|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1
4767267|NCT03881059|7742395|FG000|Treatment Period - Part A|Withdrawal by Subject|5
4767268|NCT03881059|7742396|FG001|Treatment Period - Part A|Withdrawal by Subject|2
4767269|NCT03881059|7742397|FG002|Treatment Period - Part A|Withdrawal by Subject|3
4767270|NCT03881059|7742395|FG000|Treatment Period - Part A|Other reasons|2
4767271|NCT03881059|7742396|FG001|Treatment Period - Part A|Other reasons|1
4767272|NCT03881059|7742397|FG002|Treatment Period - Part A|Other reasons|0
4767273|NCT03881059|7742395|FG000|Treatment Period - Part B|Adverse Event|0
4767274|NCT03881059|7742396|FG001|Treatment Period - Part B|Adverse Event|0
4767275|NCT03881059|7742397|FG002|Treatment Period - Part B|Adverse Event|3
4767276|NCT03881059|7742395|FG000|Treatment Period - Part B|Death|0
4767277|NCT03881059|7742396|FG001|Treatment Period - Part B|Death|1
4767278|NCT03881059|7742397|FG002|Treatment Period - Part B|Death|1
4767279|NCT03881059|7742395|FG000|Treatment Period - Part B|Lack of Efficacy|1
4767280|NCT03881059|7742396|FG001|Treatment Period - Part B|Lack of Efficacy|1
4767281|NCT03881059|7742397|FG002|Treatment Period - Part B|Lack of Efficacy|0
4767282|NCT03881059|7742395|FG000|Treatment Period - Part B|Lost to Follow-up|1
4767283|NCT03881059|7742396|FG001|Treatment Period - Part B|Lost to Follow-up|1
4767284|NCT03881059|7742397|FG002|Treatment Period - Part B|Lost to Follow-up|0
4767285|NCT03881059|7742395|FG000|Treatment Period - Part B|Site terminated by sponsor|1
4767286|NCT03881059|7742396|FG001|Treatment Period - Part B|Site terminated by sponsor|0
4767287|NCT03881059|7742397|FG002|Treatment Period - Part B|Site terminated by sponsor|3
4767288|NCT03881059|7742395|FG000|Treatment Period - Part B|Withdrawal by Subject|1
4767289|NCT03881059|7742396|FG001|Treatment Period - Part B|Withdrawal by Subject|0
4767290|NCT03881059|7742397|FG002|Treatment Period - Part B|Withdrawal by Subject|1
4767291|NCT03881059|7742395|FG000|Treatment Period - Part B|Other reasons|4
4767292|NCT03881059|7742396|FG001|Treatment Period - Part B|Other reasons|3
4767293|NCT03881059|7742397|FG002|Treatment Period - Part B|Other reasons|3
4767294|NCT03817853|7742414|FG000|Induction Phase|Adverse Event|5
4767295|NCT03817853|7742415|FG001|Induction Phase|Adverse Event|0
4767296|NCT03817853|7742416|FG002|Induction Phase|Adverse Event|0
4767297|NCT03817853|7742414|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3
4767298|NCT03817853|7742415|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0
4767299|NCT03817853|7742416|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0
4767300|NCT03817853|7742414|FG000|Induction Phase|Physician Decision|2
4767301|NCT03817853|7742415|FG001|Induction Phase|Physician Decision|0
4767302|NCT03817853|7742416|FG002|Induction Phase|Physician Decision|0
4767303|NCT03817853|7742414|FG000|Induction Phase|Progressive Disease|4
4767304|NCT03817853|7742415|FG001|Induction Phase|Progressive Disease|0
4767305|NCT03817853|7742416|FG002|Induction Phase|Progressive Disease|0
4767306|NCT03817853|7742414|FG000|Induction Phase|Withdrawal by Subject|3
4767307|NCT03817853|7742415|FG001|Induction Phase|Withdrawal by Subject|0
4767308|NCT03817853|7742416|FG002|Induction Phase|Withdrawal by Subject|0
4767309|NCT03817853|7742414|FG000|Induction Phase|Continuing on Study|34
4767310|NCT03817853|7742415|FG001|Induction Phase|Continuing on Study|0
4767311|NCT03817853|7742416|FG002|Induction Phase|Continuing on Study|0
4767312|NCT03817853|7742414|FG000|Maintenance/ Follow-up Phase|Adverse Event|0
4767313|NCT03817853|7742415|FG001|Maintenance/ Follow-up Phase|Adverse Event|1
4767314|NCT03817853|7742416|FG002|Maintenance/ Follow-up Phase|Adverse Event|0
4767315|NCT03817853|7742414|FG000|Maintenance/ Follow-up Phase|Death|0
4767316|NCT03817853|7742415|FG001|Maintenance/ Follow-up Phase|Death|1
4767317|NCT03817853|7742416|FG002|Maintenance/ Follow-up Phase|Death|1
4767318|NCT03817853|7742414|FG000|Maintenance/ Follow-up Phase|Progressive Disease|0
4767319|NCT03817853|7742415|FG001|Maintenance/ Follow-up Phase|Progressive Disease|1
4767320|NCT03817853|7742416|FG002|Maintenance/ Follow-up Phase|Progressive Disease|3
4767321|NCT03817853|7742414|FG000|Maintenance/ Follow-up Phase|Withdrawal by Subject|0
4767322|NCT03817853|7742415|FG001|Maintenance/ Follow-up Phase|Withdrawal by Subject|1
4767323|NCT03817853|7742416|FG002|Maintenance/ Follow-up Phase|Withdrawal by Subject|0
4767324|NCT03817853|7742414|FG000|Maintenance/ Follow-up Phase|Continuing on Study|0
4767325|NCT03817853|7742415|FG001|Maintenance/ Follow-up Phase|Continuing on Study|52
4767326|NCT03817853|7742416|FG002|Maintenance/ Follow-up Phase|Continuing on Study|2
4767327|NCT03450629|7742426|FG000|Overall Study|Adverse Event|15
4767328|NCT03450629|7742427|FG001|Overall Study|Adverse Event|14
4767329|NCT03450629|7742426|FG000|Overall Study|Physician Decision|2
4767330|NCT03450629|7742427|FG001|Overall Study|Physician Decision|2
4767331|NCT03450629|7742426|FG000|Overall Study|Lack of Efficacy|2
4767332|NCT03450629|7742427|FG001|Overall Study|Lack of Efficacy|0
4767333|NCT03450629|7742426|FG000|Overall Study|Lost to Follow-up|4
4767334|NCT03450629|7742427|FG001|Overall Study|Lost to Follow-up|2
4767335|NCT03450629|7742426|FG000|Overall Study|No Longer Meets Eligibility Criteria|0
4767336|NCT03450629|7742427|FG001|Overall Study|No Longer Meets Eligibility Criteria|1
4767337|NCT03450629|7742426|FG000|Overall Study|Non-Compliance With Study Drug|2
4767338|NCT03450629|7742427|FG001|Overall Study|Non-Compliance With Study Drug|1
4767339|NCT03450629|7742426|FG000|Overall Study|Protocol Violation|11
4767340|NCT03450629|7742427|FG001|Overall Study|Protocol Violation|8
4767341|NCT03450629|7742426|FG000|Overall Study|Withdrawal by Subject|12
4767342|NCT03450629|7742427|FG001|Overall Study|Withdrawal by Subject|6
4767343|NCT03367403|7742436|FG000|Overall Study|Adverse Event|20
4767344|NCT03367403|7742437|FG001|Overall Study|Adverse Event|6
4767345|NCT03367403|7742438|FG002|Overall Study|Adverse Event|2
4767346|NCT03367403|7742436|FG000|Overall Study|Withdrawal by Subject|12
4767347|NCT03367403|7742437|FG001|Overall Study|Withdrawal by Subject|12
4767348|NCT03367403|7742438|FG002|Overall Study|Withdrawal by Subject|1
4767349|NCT03367403|7742436|FG000|Overall Study|Death|1
4767350|NCT03367403|7742437|FG001|Overall Study|Death|2
4767351|NCT03367403|7742438|FG002|Overall Study|Death|0
4767352|NCT03367403|7742436|FG000|Overall Study|Physician Decision|0
4767353|NCT03367403|7742437|FG001|Overall Study|Physician Decision|1
4767354|NCT03367403|7742438|FG002|Overall Study|Physician Decision|0
4767355|NCT03367403|7742436|FG000|Overall Study|Protocol Violation|1
4767356|NCT03367403|7742437|FG001|Overall Study|Protocol Violation|1
4767357|NCT03367403|7742438|FG002|Overall Study|Protocol Violation|0
4767358|NCT03367403|7742436|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0
4767359|NCT03367403|7742437|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2
4767360|NCT03367403|7742438|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0
4767361|NCT03367403|7742436|FG000|Overall Study|COVID-19|3
4767362|NCT03367403|7742437|FG001|Overall Study|COVID-19|7
4767363|NCT03367403|7742438|FG002|Overall Study|COVID-19|0
4767364|NCT03367403|7742436|FG000|Overall Study|Abuse of Alcohol Intake|0
4767365|NCT03367403|7742437|FG001|Overall Study|Abuse of Alcohol Intake|1
4767366|NCT03367403|7742438|FG002|Overall Study|Abuse of Alcohol Intake|0
4767367|NCT03367403|7742436|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0
4767368|NCT03367403|7742437|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1
4767369|NCT03367403|7742438|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0
4767370|NCT03286426|7742446|FG000|Overall Study|Physician Decision|3
4767371|NCT02809677|7742463|FG000|Overall Study|Withdrawal by Subject|8
4767372|NCT02554253|7742474|FG000|Overall Study|ineligible after enrollment|1
4767373|NCT02554253|7742475|FG001|Overall Study|ineligible after enrollment|0
4767374|NCT02554253|7742474|FG000|Overall Study|converted to transcatheter procedure|0
4767375|NCT02554253|7742475|FG001|Overall Study|converted to transcatheter procedure|1
4767376|NCT02554253|7742474|FG000|Overall Study|received both drugs|0
4767377|NCT02554253|7742475|FG001|Overall Study|received both drugs|1
4767378|NCT01307046|7742503|FG000|Overall Study|Adverse Event|3
4767379|NCT01307046|7742504|FG001|Overall Study|Adverse Event|3
4767380|NCT01307046|7742503|FG000|Overall Study|Lack of Efficacy|0
4767381|NCT01307046|7742504|FG001|Overall Study|Lack of Efficacy|2
4767382|NCT01307046|7742503|FG000|Overall Study|Physician Decision|2
4767383|NCT01307046|7742504|FG001|Overall Study|Physician Decision|0
4767384|NCT01307046|7742503|FG000|Overall Study|Withdrawal by Subject|1
4767385|NCT01307046|7742504|FG001|Overall Study|Withdrawal by Subject|1
4767386|NCT01307046|7742503|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4
4767387|NCT01307046|7742504|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2
4767388|NCT01307046|7742503|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2
4767389|NCT01307046|7742504|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3
4767390|NCT01307033|7742512|FG000|8-week Double-blind Period|Adverse Event|2
4767391|NCT01307033|7742513|FG001|8-week Double-blind Period|Adverse Event|0
4767392|NCT01307033|7742514|FG002|8-week Double-blind Period|Adverse Event|0
4767393|NCT01307033|7742515|FG003|8-week Double-blind Period|Adverse Event|0
4767394|NCT01307033|7742512|FG000|8-week Double-blind Period|Withdrawal by Subject|4
4767395|NCT01307033|7742513|FG001|8-week Double-blind Period|Withdrawal by Subject|1
4767396|NCT01307033|7742514|FG002|8-week Double-blind Period|Withdrawal by Subject|0
4767397|NCT01307033|7742515|FG003|8-week Double-blind Period|Withdrawal by Subject|0
4767398|NCT01307033|7742512|FG000|8-week Double-blind Period|Lack of Efficacy|1
4767399|NCT01307033|7742513|FG001|8-week Double-blind Period|Lack of Efficacy|0
4767400|NCT01307033|7742514|FG002|8-week Double-blind Period|Lack of Efficacy|0
4767401|NCT01307033|7742515|FG003|8-week Double-blind Period|Lack of Efficacy|0
4767402|NCT01307033|7742512|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
4767403|NCT01307033|7742513|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3
4767404|NCT01307033|7742514|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
4767405|NCT01307033|7742515|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
4767406|NCT01307033|7742512|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6
4767407|NCT01307033|7742513|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3
4767408|NCT01307033|7742514|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0
4767409|NCT01307033|7742515|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0
4767410|NCT01307033|7742512|FG000|44-week Open-label Extension|Adverse Event|0
4767411|NCT01307033|7742513|FG001|44-week Open-label Extension|Adverse Event|0
4767412|NCT01307033|7742514|FG002|44-week Open-label Extension|Adverse Event|2
4767413|NCT01307033|7742515|FG003|44-week Open-label Extension|Adverse Event|1
4767414|NCT01307033|7742512|FG000|44-week Open-label Extension|Withdrawal by Subject|0
4767415|NCT01307033|7742513|FG001|44-week Open-label Extension|Withdrawal by Subject|0
4767416|NCT01307033|7742514|FG002|44-week Open-label Extension|Withdrawal by Subject|2
4767417|NCT01307033|7742515|FG003|44-week Open-label Extension|Withdrawal by Subject|1
4767418|NCT01307033|7742512|FG000|44-week Open-label Extension|Physician Decision|0
4767419|NCT01307033|7742513|FG001|44-week Open-label Extension|Physician Decision|0
4767420|NCT01307033|7742514|FG002|44-week Open-label Extension|Physician Decision|1
4767421|NCT01307033|7742515|FG003|44-week Open-label Extension|Physician Decision|0
4767422|NCT01307033|7742512|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
4767423|NCT01307033|7742513|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
4767424|NCT01307033|7742514|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
4767425|NCT01307033|7742515|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2
4767426|NCT01307033|7742512|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0
4767427|NCT01307033|7742513|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0
4767428|NCT01307033|7742514|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6
4767429|NCT01307033|7742515|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7
4767430|NCT01307033|7742512|FG000|44-week Open-label Extension|Death|0
4767431|NCT01307033|7742513|FG001|44-week Open-label Extension|Death|0
4767432|NCT01307033|7742514|FG002|44-week Open-label Extension|Death|0
4767433|NCT01307033|7742515|FG003|44-week Open-label Extension|Death|1
4767434|NCT00739674|7742529|FG000|Overall Study|Screening failures|19
4767435|NCT00739674|7742530|FG001|Overall Study|Screening failures|17
4767436|NCT00739674|7742529|FG000|Overall Study|Site 212 removal|19
4767437|NCT00739674|7742530|FG001|Overall Study|Site 212 removal|13
4767438|NCT00739674|7742529|FG000|Overall Study|No follow-up data|33
4767439|NCT00739674|7742530|FG001|Overall Study|No follow-up data|18
4767440|NCT00739674|7742529|FG000|Overall Study|Dietician consultation >30 days|1
4767441|NCT00739674|7742530|FG001|Overall Study|Dietician consultation >30 days|9
4767442|NCT00739674|7742529|FG000|Overall Study|Adverse Event|22
4767443|NCT00739674|7742530|FG001|Overall Study|Adverse Event|13
4767444|NCT00739674|7742529|FG000|Overall Study|Death|1
4767445|NCT00739674|7742530|FG001|Overall Study|Death|0
4767446|NCT00739674|7742529|FG000|Overall Study|Lack of Efficacy|1
4767447|NCT00739674|7742530|FG001|Overall Study|Lack of Efficacy|0
4767448|NCT00739674|7742529|FG000|Overall Study|Lost to Follow-up|52
4767449|NCT00739674|7742530|FG001|Overall Study|Lost to Follow-up|30
4767450|NCT00739674|7742529|FG000|Overall Study|Protocol Violation|5
4767451|NCT00739674|7742530|FG001|Overall Study|Protocol Violation|5
4767452|NCT00739674|7742529|FG000|Overall Study|Withdrawal by Subject|9
4767453|NCT00739674|7742530|FG001|Overall Study|Withdrawal by Subject|9
4767454|NCT00739674|7742529|FG000|Overall Study|Reason missing|2
4767455|NCT00739674|7742530|FG001|Overall Study|Reason missing|0
4767456|NCT00739674|7742529|FG000|Overall Study|Clinic closed|6
4767457|NCT00739674|7742530|FG001|Overall Study|Clinic closed|4
4767458|NCT00739674|7742529|FG000|Overall Study|Patient moved|3
4767459|NCT00739674|7742530|FG001|Overall Study|Patient moved|2
4767460|NCT00739674|7742529|FG000|Overall Study|Non compliant|4
4767461|NCT00739674|7742530|FG001|Overall Study|Non compliant|0
4767462|NCT00739674|7742529|FG000|Overall Study|Unable to attend visit|3
4767463|NCT00739674|7742530|FG001|Overall Study|Unable to attend visit|1
4767464|NCT00739674|7742529|FG000|Overall Study|Home monitoring off meds|1
4767465|NCT00739674|7742530|FG001|Overall Study|Home monitoring off meds|0
4767466|NCT00739674|7742529|FG000|Overall Study|Erectile dysfunction|0
4767467|NCT00739674|7742530|FG001|Overall Study|Erectile dysfunction|1
4767468|NCT00546754|7742538|FG000|Overall Study|Serious Adverse Event|1
4767469|NCT00546754|7742539|FG001|Overall Study|Serious Adverse Event|1
4767470|NCT00546754|7742538|FG000|Overall Study|Adverse Event|11
4767471|NCT00546754|7742539|FG001|Overall Study|Adverse Event|16
4767472|NCT00546754|7742538|FG000|Overall Study|Lack of Efficacy|1
4767473|NCT00546754|7742539|FG001|Overall Study|Lack of Efficacy|1
4767474|NCT00546754|7742538|FG000|Overall Study|Lost to Follow-up|9
4767475|NCT00546754|7742539|FG001|Overall Study|Lost to Follow-up|15
4767476|NCT00546754|7742538|FG000|Overall Study|Protocol Violation|3
4767477|NCT00546754|7742539|FG001|Overall Study|Protocol Violation|0
4767478|NCT00546754|7742538|FG000|Overall Study|Withdrawal by Subject|6
4767479|NCT00546754|7742539|FG001|Overall Study|Withdrawal by Subject|7
4767480|NCT00546754|7742538|FG000|Overall Study|Dyspnea|1
4767481|NCT00546754|7742539|FG001|Overall Study|Dyspnea|0
4767482|NCT00546754|7742538|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1
4767483|NCT00546754|7742539|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0
4767484|NCT00546754|7742538|FG000|Overall Study|Hip Replacement|1
4767485|NCT00546754|7742539|FG001|Overall Study|Hip Replacement|0
4767486|NCT00546754|7742538|FG000|Overall Study|Suicide|1
4767487|NCT00546754|7742539|FG001|Overall Study|Suicide|0
4767488|NCT00546754|7742538|FG000|Overall Study|Missing Cooperation|1
4767489|NCT00546754|7742539|FG001|Overall Study|Missing Cooperation|0
4767490|NCT00546754|7742538|FG000|Overall Study|Elevated Creatinine and Potassium levels|0
4767491|NCT00546754|7742539|FG001|Overall Study|Elevated Creatinine and Potassium levels|1
4767492|NCT00546754|7742538|FG000|Overall Study|Patient's Decision|0
4767493|NCT00546754|7742539|FG001|Overall Study|Patient's Decision|1
4767494|NCT00546754|7742538|FG000|Overall Study|Missing|14
4767495|NCT00546754|7742539|FG001|Overall Study|Missing|7
4767496|NCT00479713|7742547|FG000|Overall Study|Adverse Event|8
4767497|NCT00479713|7742548|FG001|Overall Study|Adverse Event|6
4767498|NCT00479713|7742547|FG000|Overall Study|Death|1
4767499|NCT00479713|7742548|FG001|Overall Study|Death|0
4767500|NCT00479713|7742547|FG000|Overall Study|Lost to Follow-up|0
4767501|NCT00479713|7742548|FG001|Overall Study|Lost to Follow-up|1
4767502|NCT00479713|7742547|FG000|Overall Study|Protocol Violation|0
4767503|NCT00479713|7742548|FG001|Overall Study|Protocol Violation|1
4767504|NCT00479713|7742547|FG000|Overall Study|Withdrawal by Subject|4
4767505|NCT00479713|7742548|FG001|Overall Study|Withdrawal by Subject|1
4767506|NCT00406783|7742556|FG000|Overall Study|Adverse Event|4
4767507|NCT00406783|7742557|FG001|Overall Study|Adverse Event|4
4767508|NCT00406783|7742556|FG000|Overall Study|Treatment Failure|2
4767509|NCT00406783|7742557|FG001|Overall Study|Treatment Failure|3
4767510|NCT00406783|7742556|FG000|Overall Study|Lost to Follow-up|3
4767511|NCT00406783|7742557|FG001|Overall Study|Lost to Follow-up|0
4767512|NCT00406783|7742556|FG000|Overall Study|Withdrawal by Subject|1
4767513|NCT00406783|7742557|FG001|Overall Study|Withdrawal by Subject|4
4767514|NCT00406783|7742556|FG000|Overall Study|Protocol Violation|4
4767515|NCT00406783|7742557|FG001|Overall Study|Protocol Violation|4
4767516|NCT00405964|7742565|FG000|Overall Study|Treatment Failure|17
4767517|NCT00405964|7742566|FG001|Overall Study|Treatment Failure|45
4767518|NCT00405964|7742565|FG000|Overall Study|Adverse Event|7
4767519|NCT00405964|7742566|FG001|Overall Study|Adverse Event|16
4767520|NCT00405964|7742565|FG000|Overall Study|Lost to Follow-up|5
4767521|NCT00405964|7742566|FG001|Overall Study|Lost to Follow-up|5
4767522|NCT00405964|7742565|FG000|Overall Study|Withdrawal by Subject|19
4767523|NCT00405964|7742566|FG001|Overall Study|Withdrawal by Subject|23
4767524|NCT00405964|7742565|FG000|Overall Study|Protocol Violation|11
4767525|NCT00405964|7742566|FG001|Overall Study|Protocol Violation|6
4767526|NCT00383721|7742577|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11
4767527|NCT00383721|7742578|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5
4767528|NCT00383721|7742579|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7
4767529|NCT00383721|7742580|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14
4767530|NCT00383721|7742581|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13
4767531|NCT00383721|7742577|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1
4767532|NCT00383721|7742578|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
4767533|NCT00383721|7742579|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
4767534|NCT00383721|7742580|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4
4767535|NCT00383721|7742581|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8
4767536|NCT00383721|7742577|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0
4767537|NCT00383721|7742578|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0
4767538|NCT00383721|7742579|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
4767539|NCT00383721|7742580|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1
4767540|NCT00383721|7742581|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4
4767541|NCT00383721|7742577|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4
4767542|NCT00383721|7742578|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12
4767543|NCT00383721|7742579|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15
4767544|NCT00383721|7742580|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10
4767545|NCT00383721|7742581|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11
4767546|NCT00383721|7742577|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5
4767547|NCT00383721|7742578|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
4767548|NCT00383721|7742579|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6
4767549|NCT00383721|7742580|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8
4767550|NCT00383721|7742581|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9
4767551|NCT00383721|7742577|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7
4767552|NCT00383721|7742578|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
4767553|NCT00383721|7742579|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4
4767554|NCT00383721|7742580|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6
4767555|NCT00383721|7742581|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6
4767556|NCT00383721|7742577|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5
4767557|NCT00383721|7742578|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6
4767558|NCT00383721|7742579|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11
4767559|NCT00383721|7742580|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4
4767560|NCT00383721|7742581|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13
4767561|NCT00383721|7742577|FG000|26-Week Double-Blind Treatment Period|Administrative|1
4767562|NCT00383721|7742578|FG001|26-Week Double-Blind Treatment Period|Administrative|3
4767563|NCT00383721|7742579|FG002|26-Week Double-Blind Treatment Period|Administrative|3
4767564|NCT00383721|7742580|FG003|26-Week Double-Blind Treatment Period|Administrative|3
4767565|NCT00383721|7742581|FG004|26-Week Double-Blind Treatment Period|Administrative|3
4767566|NCT00383721|7742577|FG000|26-Week Double-Blind Treatment Period|Ongoing|1
4767567|NCT00383721|7742578|FG001|26-Week Double-Blind Treatment Period|Ongoing|0
4767568|NCT00383721|7742579|FG002|26-Week Double-Blind Treatment Period|Ongoing|0
4767569|NCT00383721|7742580|FG003|26-Week Double-Blind Treatment Period|Ongoing|0
4767570|NCT00383721|7742581|FG004|26-Week Double-Blind Treatment Period|Ongoing|0
4767571|NCT00383721|7742577|FG000|26-Week Treatment Safety Extension|Adverse Event|6
4767572|NCT00383721|7742578|FG001|26-Week Treatment Safety Extension|Adverse Event|7
4767573|NCT00383721|7742579|FG002|26-Week Treatment Safety Extension|Adverse Event|10
4767574|NCT00383721|7742580|FG003|26-Week Treatment Safety Extension|Adverse Event|1
4767575|NCT00383721|7742581|FG004|26-Week Treatment Safety Extension|Adverse Event|0
4767576|NCT00383721|7742577|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0
4767577|NCT00383721|7742578|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2
4767578|NCT00383721|7742579|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4
4767579|NCT00383721|7742580|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1
4767580|NCT00383721|7742581|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0
4767581|NCT00383721|7742577|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2
4767582|NCT00383721|7742578|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0
4767583|NCT00383721|7742579|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1
4767584|NCT00383721|7742580|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1
4767585|NCT00383721|7742581|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0
4767586|NCT00383721|7742577|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
4767587|NCT00383721|7742578|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4
4767588|NCT00383721|7742579|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
4767589|NCT00383721|7742580|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7
4767590|NCT00383721|7742581|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0
4767591|NCT00383721|7742577|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1
4767592|NCT00383721|7742578|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1
4767593|NCT00383721|7742579|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1
4767594|NCT00383721|7742580|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1
4767595|NCT00383721|7742581|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0
4767596|NCT00383721|7742577|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2
4767597|NCT00383721|7742578|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1
4767598|NCT00383721|7742579|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1
4767599|NCT00383721|7742580|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4
4767600|NCT00383721|7742581|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0
4767601|NCT00383721|7742577|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
4767602|NCT00383721|7742578|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
4767603|NCT00383721|7742579|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
4767604|NCT00383721|7742580|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
4767605|NCT00383721|7742581|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
4767606|NCT00383721|7742577|FG000|26-Week Treatment Safety Extension|Administrative|1
4767607|NCT00383721|7742578|FG001|26-Week Treatment Safety Extension|Administrative|2
4767608|NCT00383721|7742579|FG002|26-Week Treatment Safety Extension|Administrative|3
4767609|NCT00383721|7742580|FG003|26-Week Treatment Safety Extension|Administrative|1
4767610|NCT00383721|7742581|FG004|26-Week Treatment Safety Extension|Administrative|0
4767611|NCT00383552|7742597|FG000|Overall Study|Adverse Event|7
4767612|NCT00383552|7742598|FG001|Overall Study|Adverse Event|6
4767613|NCT00383552|7742599|FG002|Overall Study|Adverse Event|9
4767614|NCT00383552|7742600|FG003|Overall Study|Adverse Event|6
4767615|NCT00383552|7742597|FG000|Overall Study|Lack of Efficacy|4
4767616|NCT00383552|7742598|FG001|Overall Study|Lack of Efficacy|13
4767617|NCT00383552|7742599|FG002|Overall Study|Lack of Efficacy|29
4767618|NCT00383552|7742600|FG003|Overall Study|Lack of Efficacy|42
4767619|NCT00383552|7742597|FG000|Overall Study|Lost to Follow-up|0
4767620|NCT00383552|7742598|FG001|Overall Study|Lost to Follow-up|1
4767621|NCT00383552|7742599|FG002|Overall Study|Lost to Follow-up|5
4767622|NCT00383552|7742600|FG003|Overall Study|Lost to Follow-up|1
4767623|NCT00383552|7742597|FG000|Overall Study|Did not wish to continue (unrelated)|4
4767624|NCT00383552|7742598|FG001|Overall Study|Did not wish to continue (unrelated)|9
4767625|NCT00383552|7742599|FG002|Overall Study|Did not wish to continue (unrelated)|5
4767626|NCT00383552|7742600|FG003|Overall Study|Did not wish to continue (unrelated)|6
4767627|NCT00383552|7742597|FG000|Overall Study|Did not wish to continue (related)|1
4767628|NCT00383552|7742598|FG001|Overall Study|Did not wish to continue (related)|0
4767629|NCT00383552|7742599|FG002|Overall Study|Did not wish to continue (related)|2
4767630|NCT00383552|7742600|FG003|Overall Study|Did not wish to continue (related)|3
4767631|NCT00383552|7742597|FG000|Overall Study|Noncompliance with the protocol|11
4767632|NCT00383552|7742598|FG001|Overall Study|Noncompliance with the protocol|6
4767633|NCT00383552|7742599|FG002|Overall Study|Noncompliance with the protocol|8
4767634|NCT00383552|7742600|FG003|Overall Study|Noncompliance with the protocol|10
4767635|NCT00383552|7742597|FG000|Overall Study|Did not meet protocol eligibility|8
4767636|NCT00383552|7742598|FG001|Overall Study|Did not meet protocol eligibility|6
4767637|NCT00383552|7742599|FG002|Overall Study|Did not meet protocol eligibility|2
4767638|NCT00383552|7742600|FG003|Overall Study|Did not meet protocol eligibility|3
4767639|NCT00383552|7742597|FG000|Overall Study|Administrative|1
4767640|NCT00383552|7742598|FG001|Overall Study|Administrative|0
4767641|NCT00383552|7742599|FG002|Overall Study|Administrative|1
4767642|NCT00383552|7742600|FG003|Overall Study|Administrative|1
4767643|NCT00383435|7742620|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10
4767644|NCT00383435|7742621|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2
4767645|NCT00383435|7742622|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8
4767646|NCT00383435|7742623|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6
4767647|NCT00383435|7742624|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8
4767648|NCT00383435|7742620|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
4767649|NCT00383435|7742621|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2
4767650|NCT00383435|7742622|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
4767651|NCT00383435|7742623|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5
4767652|NCT00383435|7742624|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8
4767653|NCT00383435|7742620|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3
4767654|NCT00383435|7742621|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3
4767655|NCT00383435|7742622|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1
4767656|NCT00383435|7742623|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
4767657|NCT00383435|7742624|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
4767658|NCT00383435|7742620|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7
4767659|NCT00383435|7742621|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12
4767660|NCT00383435|7742622|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14
4767661|NCT00383435|7742623|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10
4767662|NCT00383435|7742624|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17
4767663|NCT00383435|7742620|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2
4767664|NCT00383435|7742621|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
4767665|NCT00383435|7742622|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7
4767666|NCT00383435|7742623|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
4767667|NCT00383435|7742624|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7
4767668|NCT00383435|7742620|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1
4767669|NCT00383435|7742621|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
4767670|NCT00383435|7742622|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3
4767671|NCT00383435|7742623|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
4767672|NCT00383435|7742624|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4
4767673|NCT00383435|7742620|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10
4767674|NCT00383435|7742621|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8
4767675|NCT00383435|7742622|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9
4767676|NCT00383435|7742623|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5
4767677|NCT00383435|7742624|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6
4767678|NCT00383435|7742620|FG000|26-Week Double-Blind Treatment Period|Administrative|5
4767679|NCT00383435|7742621|FG001|26-Week Double-Blind Treatment Period|Administrative|3
4767680|NCT00383435|7742622|FG002|26-Week Double-Blind Treatment Period|Administrative|1
4767681|NCT00383435|7742623|FG003|26-Week Double-Blind Treatment Period|Administrative|1
4767682|NCT00383435|7742624|FG004|26-Week Double-Blind Treatment Period|Administrative|1
4767683|NCT00383435|7742620|FG000|26-Week Treatment Safety Extension|Adverse Event|4
4767684|NCT00383435|7742621|FG001|26-Week Treatment Safety Extension|Adverse Event|2
4767685|NCT00383435|7742622|FG002|26-Week Treatment Safety Extension|Adverse Event|5
4767686|NCT00383435|7742623|FG003|26-Week Treatment Safety Extension|Adverse Event|5
4767687|NCT00383435|7742624|FG004|26-Week Treatment Safety Extension|Adverse Event|1
4767688|NCT00383435|7742620|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1
4767689|NCT00383435|7742621|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1
4767690|NCT00383435|7742622|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1
4767691|NCT00383435|7742623|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1
4767692|NCT00383435|7742624|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0
4767693|NCT00383435|7742620|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0
4767694|NCT00383435|7742621|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2
4767695|NCT00383435|7742622|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1
4767696|NCT00383435|7742623|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0
4767697|NCT00383435|7742624|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1
4767698|NCT00383435|7742620|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
4767699|NCT00383435|7742621|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
4767700|NCT00383435|7742622|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
4767701|NCT00383435|7742623|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
4767702|NCT00383435|7742624|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0
4767703|NCT00383435|7742620|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1
4767704|NCT00383435|7742621|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0
4767705|NCT00383435|7742622|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2
4767706|NCT00383435|7742623|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0
4767707|NCT00383435|7742624|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1
4767708|NCT00383435|7742620|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4
4767709|NCT00383435|7742621|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1
4767710|NCT00383435|7742622|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1
4767711|NCT00383435|7742623|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1
4767712|NCT00383435|7742624|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0
4767713|NCT00383435|7742620|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
4767714|NCT00383435|7742621|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
4767715|NCT00383435|7742622|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
4767716|NCT00383435|7742623|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
4767717|NCT00383435|7742624|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
4767718|NCT00383435|7742620|FG000|26-Week Treatment Safety Extension|Administrative|1
4767719|NCT00383435|7742621|FG001|26-Week Treatment Safety Extension|Administrative|1
4767720|NCT00383435|7742622|FG002|26-Week Treatment Safety Extension|Administrative|0
4767721|NCT00383435|7742623|FG003|26-Week Treatment Safety Extension|Administrative|1
4767722|NCT00383435|7742624|FG004|26-Week Treatment Safety Extension|Administrative|0
4767723|NCT00381485|7742639|FG000|Open-Label Run-In Period|Adverse Event|9
4767724|NCT00381485|7742640|FG001|Open-Label Run-In Period|Adverse Event|0
4767725|NCT00381485|7742641|FG002|Open-Label Run-In Period|Adverse Event|0
4767726|NCT00381485|7742642|FG003|Open-Label Run-In Period|Adverse Event|0
4767727|NCT00381485|7742639|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76
4767728|NCT00381485|7742640|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0
4767729|NCT00381485|7742641|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0
4767730|NCT00381485|7742642|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0
4767731|NCT00381485|7742639|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16
4767732|NCT00381485|7742640|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
4767733|NCT00381485|7742641|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
4767734|NCT00381485|7742642|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
4767735|NCT00381485|7742639|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1
4767736|NCT00381485|7742640|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
4767737|NCT00381485|7742641|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
4767738|NCT00381485|7742642|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
4767739|NCT00381485|7742639|FG000|Open-Label Run-In Period|Lost to Follow-up|3
4767740|NCT00381485|7742640|FG001|Open-Label Run-In Period|Lost to Follow-up|0
4767741|NCT00381485|7742641|FG002|Open-Label Run-In Period|Lost to Follow-up|0
4767742|NCT00381485|7742642|FG003|Open-Label Run-In Period|Lost to Follow-up|0
4767743|NCT00381485|7742639|FG000|Open-Label Run-In Period|Treatment failure|1
4767744|NCT00381485|7742640|FG001|Open-Label Run-In Period|Treatment failure|0
4767745|NCT00381485|7742641|FG002|Open-Label Run-In Period|Treatment failure|0
4767746|NCT00381485|7742642|FG003|Open-Label Run-In Period|Treatment failure|0
4767747|NCT00381485|7742639|FG000|Double-Blind Treatment Period|Adverse Event|0
4767748|NCT00381485|7742640|FG001|Double-Blind Treatment Period|Adverse Event|2
4767749|NCT00381485|7742641|FG002|Double-Blind Treatment Period|Adverse Event|2
4767750|NCT00381485|7742642|FG003|Double-Blind Treatment Period|Adverse Event|5
4767751|NCT00381485|7742639|FG000|Double-Blind Treatment Period|Lack of Efficacy|0
4767752|NCT00381485|7742640|FG001|Double-Blind Treatment Period|Lack of Efficacy|8
4767753|NCT00381485|7742641|FG002|Double-Blind Treatment Period|Lack of Efficacy|11
4767754|NCT00381485|7742642|FG003|Double-Blind Treatment Period|Lack of Efficacy|13
4767755|NCT00381485|7742639|FG000|Double-Blind Treatment Period|Lost to Follow-up|0
4767756|NCT00381485|7742640|FG001|Double-Blind Treatment Period|Lost to Follow-up|0
4767757|NCT00381485|7742641|FG002|Double-Blind Treatment Period|Lost to Follow-up|1
4767758|NCT00381485|7742642|FG003|Double-Blind Treatment Period|Lost to Follow-up|1
4767759|NCT00381485|7742639|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0
4767760|NCT00381485|7742640|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9
4767761|NCT00381485|7742641|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3
4767762|NCT00381485|7742642|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3
4767763|NCT00381485|7742639|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0
4767764|NCT00381485|7742640|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5
4767765|NCT00381485|7742641|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7
4767766|NCT00381485|7742642|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5
4767767|NCT00381485|7742639|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0
4767768|NCT00381485|7742640|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2
4767769|NCT00381485|7742641|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1
4767770|NCT00381485|7742642|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4
4767771|NCT00381485|7742639|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
4767772|NCT00381485|7742640|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
4767773|NCT00381485|7742641|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
4767774|NCT00381485|7742642|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1
4767775|NCT00381485|7742639|FG000|Double-Blind Treatment Period|Administrative|0
4767776|NCT00381485|7742640|FG001|Double-Blind Treatment Period|Administrative|1
4767777|NCT00381485|7742641|FG002|Double-Blind Treatment Period|Administrative|0
4767778|NCT00381485|7742642|FG003|Double-Blind Treatment Period|Administrative|1
4767779|NCT00379288|7742655|FG000|Overall Study|Adverse Event|5
4767780|NCT00379288|7742656|FG001|Overall Study|Adverse Event|6
4767781|NCT00379288|7742657|FG002|Overall Study|Adverse Event|2
4767782|NCT00379288|7742658|FG003|Overall Study|Adverse Event|0
4767783|NCT00379288|7742655|FG000|Overall Study|Treatment Failure|0
4767784|NCT00379288|7742656|FG001|Overall Study|Treatment Failure|1
4767785|NCT00379288|7742657|FG002|Overall Study|Treatment Failure|0
4767786|NCT00379288|7742658|FG003|Overall Study|Treatment Failure|1
4767787|NCT00379288|7742655|FG000|Overall Study|Lost to Follow-up|3
4767788|NCT00379288|7742656|FG001|Overall Study|Lost to Follow-up|3
4767789|NCT00379288|7742657|FG002|Overall Study|Lost to Follow-up|2
4767790|NCT00379288|7742658|FG003|Overall Study|Lost to Follow-up|0
4767791|NCT00379288|7742655|FG000|Overall Study|Subject withdrew-unrelated to study drug|0
4767792|NCT00379288|7742656|FG001|Overall Study|Subject withdrew-unrelated to study drug|3
4767793|NCT00379288|7742657|FG002|Overall Study|Subject withdrew-unrelated to study drug|4
4767794|NCT00379288|7742658|FG003|Overall Study|Subject withdrew-unrelated to study drug|2
4767795|NCT00379288|7742655|FG000|Overall Study|Subject withdrew-related to study drug|1
4767796|NCT00379288|7742656|FG001|Overall Study|Subject withdrew-related to study drug|0
4767797|NCT00379288|7742657|FG002|Overall Study|Subject withdrew-related to study drug|0
4767798|NCT00379288|7742658|FG003|Overall Study|Subject withdrew-related to study drug|1
4767799|NCT00379288|7742655|FG000|Overall Study|Noncompliance with protocol|8
4767800|NCT00379288|7742656|FG001|Overall Study|Noncompliance with protocol|6
4767801|NCT00379288|7742657|FG002|Overall Study|Noncompliance with protocol|2
4767802|NCT00379288|7742658|FG003|Overall Study|Noncompliance with protocol|1
4767803|NCT00379288|7742655|FG000|Overall Study|Did not meet protocol eligibility|0
4767804|NCT00379288|7742656|FG001|Overall Study|Did not meet protocol eligibility|1
4767805|NCT00379288|7742657|FG002|Overall Study|Did not meet protocol eligibility|0
4767806|NCT00379288|7742658|FG003|Overall Study|Did not meet protocol eligibility|2
4767807|NCT00379288|7742655|FG000|Overall Study|Administrative|2
4767808|NCT00379288|7742656|FG001|Overall Study|Administrative|2
4767809|NCT00379288|7742657|FG002|Overall Study|Administrative|0
4767810|NCT00379288|7742658|FG003|Overall Study|Administrative|1
4767811|NCT00378378|7742671|FG000|Overall Study|Withdrawal by Subject|0
4767812|NCT00378378|7742672|FG001|Overall Study|Withdrawal by Subject|1
4767813|NCT00378378|7742673|FG002|Overall Study|Withdrawal by Subject|0
4767814|NCT00378378|7742671|FG000|Overall Study|Treatment Failure|0
4767815|NCT00378378|7742672|FG001|Overall Study|Treatment Failure|0
4767816|NCT00378378|7742673|FG002|Overall Study|Treatment Failure|1
4767817|NCT00378378|7742671|FG000|Overall Study|Non-compliance with protocol|0
4767818|NCT00378378|7742672|FG001|Overall Study|Non-compliance with protocol|0
4767819|NCT00378378|7742673|FG002|Overall Study|Non-compliance with protocol|1
4767820|NCT00089895|7742683|FG000|Overall Study|Consent Withdrawn|11
4767821|NCT00089895|7742684|FG001|Overall Study|Consent Withdrawn|14
4767822|NCT00089895|7742683|FG000|Overall Study|Technical reason|7
4767823|NCT00089895|7742684|FG001|Overall Study|Technical reason|2
4767824|NCT00089895|7742683|FG000|Overall Study|Surgery|0
4767825|NCT00089895|7742684|FG001|Overall Study|Surgery|1
4767826|NCT00089895|7742683|FG000|Overall Study|Bleeding|0
4767827|NCT00089895|7742684|FG001|Overall Study|Bleeding|2
4767828|NCT00089895|7742683|FG000|Overall Study|Physician Decision|3
4767829|NCT00089895|7742684|FG001|Overall Study|Physician Decision|7
4767830|NCT00089895|7742683|FG000|Overall Study|Exclusion criteria met|6
4767831|NCT00089895|7742684|FG001|Overall Study|Exclusion criteria met|6
4767832|NCT00089895|7742683|FG000|Overall Study|Not otherwise specified|4
4767833|NCT00089895|7742684|FG001|Overall Study|Not otherwise specified|8
4767834|NCT00089895|7742683|FG000|Overall Study|Missing|4
4767835|NCT00089895|7742684|FG001|Overall Study|Missing|2
4767836|NCT02577354|7742692|FG000|Overall Study|Lack of Efficacy|4
4767837|NCT02577354|7742693|FG001|Overall Study|Lack of Efficacy|4
4767838|NCT02577354|7742692|FG000|Overall Study|Lost to Follow-up|3
4767839|NCT02577354|7742693|FG001|Overall Study|Lost to Follow-up|1
4767840|NCT02577354|7742692|FG000|Overall Study|Missed Visit|4
4767841|NCT02577354|7742693|FG001|Overall Study|Missed Visit|3
4767842|NCT02577354|7742692|FG000|Overall Study|Adverse Event|4
4767843|NCT02577354|7742693|FG001|Overall Study|Adverse Event|5
4767844|NCT02471807|7742713|FG000|Overall Study|Death|14
4767845|NCT02471807|7742713|FG000|Overall Study|Withdrawal by Subject|1
4767846|NCT02471807|7742713|FG000|Overall Study|Explant|5
4767847|NCT02471807|7742713|FG000|Overall Study|Visits not yet due|2
4767848|NCT02471807|7742713|FG000|Overall Study|Missed Visit|1
4767849|NCT02321514|7742717|FG000|Overall Study|Death|15
4767850|NCT02321514|7742717|FG000|Overall Study|Missed Visit|7
4767851|NCT02321514|7742717|FG000|Overall Study|Study Exit|3
4767852|NCT01453946|7742739|FG000|Overall Study|Did not receive drug for the taper phase|1
4767853|NCT01453946|7742739|FG000|Overall Study|Protocol Violation|2
4767854|NCT01453946|7742739|FG000|Overall Study|Lack of Efficacy|3
4767855|NCT01453946|7742739|FG000|Overall Study|Adverse Event|3
4767856|NCT01444092|7742743|FG000|Overall Study|Adverse Event|8
4767857|NCT01444092|7742743|FG000|Overall Study|Protocol Violation|1
4767858|NCT01444092|7742743|FG000|Overall Study|Withdrawal by Subject|1
4767859|NCT01444092|7742743|FG000|Overall Study|Other Eligibility criteria|7
4767860|NCT01332968|7742749|FG000|Induction Period|Withdrawal by Subject|3
4767861|NCT01332968|7742750|FG001|Induction Period|Withdrawal by Subject|5
4767862|NCT01332968|7742751|FG002|Induction Period|Withdrawal by Subject|0
4767863|NCT01332968|7742752|FG003|Induction Period|Withdrawal by Subject|0
4767864|NCT01332968|7742753|FG004|Induction Period|Withdrawal by Subject|0
4767865|NCT01332968|7742754|FG005|Induction Period|Withdrawal by Subject|0
4767866|NCT01332968|7742755|FG006|Induction Period|Withdrawal by Subject|0
4767867|NCT01332968|7742756|FG007|Induction Period|Withdrawal by Subject|0
4767868|NCT01332968|7742749|FG000|Induction Period|Protocol Violation|3
4767869|NCT01332968|7742750|FG001|Induction Period|Protocol Violation|4
4767870|NCT01332968|7742751|FG002|Induction Period|Protocol Violation|0
4767871|NCT01332968|7742752|FG003|Induction Period|Protocol Violation|0
4767872|NCT01332968|7742753|FG004|Induction Period|Protocol Violation|0
4767873|NCT01332968|7742754|FG005|Induction Period|Protocol Violation|0
4767874|NCT01332968|7742755|FG006|Induction Period|Protocol Violation|0
4767875|NCT01332968|7742756|FG007|Induction Period|Protocol Violation|0
4767876|NCT01332968|7742749|FG000|Induction Period|Progressive disease|15
4767877|NCT01332968|7742750|FG001|Induction Period|Progressive disease|7
4767878|NCT01332968|7742751|FG002|Induction Period|Progressive disease|0
4767879|NCT01332968|7742752|FG003|Induction Period|Progressive disease|0
4767880|NCT01332968|7742753|FG004|Induction Period|Progressive disease|0
4767881|NCT01332968|7742754|FG005|Induction Period|Progressive disease|0
4767882|NCT01332968|7742755|FG006|Induction Period|Progressive disease|0
4767883|NCT01332968|7742756|FG007|Induction Period|Progressive disease|0
4767884|NCT01332968|7742749|FG000|Induction Period|Physician Decision|6
4767885|NCT01332968|7742750|FG001|Induction Period|Physician Decision|1
4767886|NCT01332968|7742751|FG002|Induction Period|Physician Decision|0
4767887|NCT01332968|7742752|FG003|Induction Period|Physician Decision|0
4767888|NCT01332968|7742753|FG004|Induction Period|Physician Decision|0
4767889|NCT01332968|7742754|FG005|Induction Period|Physician Decision|0
4767890|NCT01332968|7742755|FG006|Induction Period|Physician Decision|0
4767891|NCT01332968|7742756|FG007|Induction Period|Physician Decision|0
4767892|NCT01332968|7742749|FG000|Induction Period|Other|2
4767893|NCT01332968|7742750|FG001|Induction Period|Other|2
4767894|NCT01332968|7742751|FG002|Induction Period|Other|0
4767895|NCT01332968|7742752|FG003|Induction Period|Other|0
4767896|NCT01332968|7742753|FG004|Induction Period|Other|0
4767897|NCT01332968|7742754|FG005|Induction Period|Other|0
4767898|NCT01332968|7742755|FG006|Induction Period|Other|0
4767899|NCT01332968|7742756|FG007|Induction Period|Other|0
4767900|NCT01332968|7742749|FG000|Induction Period|Non-compliance|1
4767901|NCT01332968|7742750|FG001|Induction Period|Non-compliance|0
4767902|NCT01332968|7742751|FG002|Induction Period|Non-compliance|0
4767903|NCT01332968|7742752|FG003|Induction Period|Non-compliance|0
4767904|NCT01332968|7742753|FG004|Induction Period|Non-compliance|0
4767905|NCT01332968|7742754|FG005|Induction Period|Non-compliance|0
4767906|NCT01332968|7742755|FG006|Induction Period|Non-compliance|0
4767907|NCT01332968|7742756|FG007|Induction Period|Non-compliance|0
4767908|NCT01332968|7742749|FG000|Induction Period|Death|1
4767909|NCT01332968|7742750|FG001|Induction Period|Death|4
4767910|NCT01332968|7742751|FG002|Induction Period|Death|0
4767911|NCT01332968|7742752|FG003|Induction Period|Death|0
4767912|NCT01332968|7742753|FG004|Induction Period|Death|0
4767913|NCT01332968|7742754|FG005|Induction Period|Death|0
4767914|NCT01332968|7742755|FG006|Induction Period|Death|0
4767915|NCT01332968|7742756|FG007|Induction Period|Death|0
4767916|NCT01332968|7742749|FG000|Induction Period|Adverse Event|23
4767917|NCT01332968|7742750|FG001|Induction Period|Adverse Event|26
4767918|NCT01332968|7742751|FG002|Induction Period|Adverse Event|0
4767919|NCT01332968|7742752|FG003|Induction Period|Adverse Event|0
4767920|NCT01332968|7742753|FG004|Induction Period|Adverse Event|0
4767921|NCT01332968|7742754|FG005|Induction Period|Adverse Event|0
4767922|NCT01332968|7742755|FG006|Induction Period|Adverse Event|0
4767923|NCT01332968|7742756|FG007|Induction Period|Adverse Event|0
4767924|NCT01332968|7742749|FG000|Induction Period|Randomized, but not treated|4
4767925|NCT01332968|7742750|FG001|Induction Period|Randomized, but not treated|7
4767926|NCT01332968|7742751|FG002|Induction Period|Randomized, but not treated|0
4767927|NCT01332968|7742752|FG003|Induction Period|Randomized, but not treated|0
4767928|NCT01332968|7742753|FG004|Induction Period|Randomized, but not treated|0
4767929|NCT01332968|7742754|FG005|Induction Period|Randomized, but not treated|0
4767930|NCT01332968|7742755|FG006|Induction Period|Randomized, but not treated|0
4767931|NCT01332968|7742756|FG007|Induction Period|Randomized, but not treated|0
4767932|NCT01332968|7742749|FG000|Maintenance/Observation Period|Withdrawal by Subject|0
4767933|NCT01332968|7742750|FG001|Maintenance/Observation Period|Withdrawal by Subject|0
4767934|NCT01332968|7742751|FG002|Maintenance/Observation Period|Withdrawal by Subject|10
4767935|NCT01332968|7742752|FG003|Maintenance/Observation Period|Withdrawal by Subject|5
4767936|NCT01332968|7742753|FG004|Maintenance/Observation Period|Withdrawal by Subject|0
4767937|NCT01332968|7742754|FG005|Maintenance/Observation Period|Withdrawal by Subject|0
4767938|NCT01332968|7742755|FG006|Maintenance/Observation Period|Withdrawal by Subject|0
4767939|NCT01332968|7742756|FG007|Maintenance/Observation Period|Withdrawal by Subject|0
4767940|NCT01332968|7742749|FG000|Maintenance/Observation Period|Protocol Violation|0
4767941|NCT01332968|7742750|FG001|Maintenance/Observation Period|Protocol Violation|0
4767942|NCT01332968|7742751|FG002|Maintenance/Observation Period|Protocol Violation|1
4767943|NCT01332968|7742752|FG003|Maintenance/Observation Period|Protocol Violation|1
4767944|NCT01332968|7742753|FG004|Maintenance/Observation Period|Protocol Violation|0
4767945|NCT01332968|7742754|FG005|Maintenance/Observation Period|Protocol Violation|0
4767946|NCT01332968|7742755|FG006|Maintenance/Observation Period|Protocol Violation|0
4767947|NCT01332968|7742756|FG007|Maintenance/Observation Period|Protocol Violation|0
4767948|NCT01332968|7742749|FG000|Maintenance/Observation Period|Progressive disease|0
4767949|NCT01332968|7742750|FG001|Maintenance/Observation Period|Progressive disease|0
4767950|NCT01332968|7742751|FG002|Maintenance/Observation Period|Progressive disease|72
4767951|NCT01332968|7742752|FG003|Maintenance/Observation Period|Progressive disease|39
4767952|NCT01332968|7742753|FG004|Maintenance/Observation Period|Progressive disease|0
4767953|NCT01332968|7742754|FG005|Maintenance/Observation Period|Progressive disease|0
4767954|NCT01332968|7742755|FG006|Maintenance/Observation Period|Progressive disease|0
4767955|NCT01332968|7742756|FG007|Maintenance/Observation Period|Progressive disease|0
4767956|NCT01332968|7742749|FG000|Maintenance/Observation Period|Physician Decision|0
4767957|NCT01332968|7742750|FG001|Maintenance/Observation Period|Physician Decision|0
4767958|NCT01332968|7742751|FG002|Maintenance/Observation Period|Physician Decision|14
4767959|NCT01332968|7742752|FG003|Maintenance/Observation Period|Physician Decision|19
4767960|NCT01332968|7742753|FG004|Maintenance/Observation Period|Physician Decision|0
4767961|NCT01332968|7742754|FG005|Maintenance/Observation Period|Physician Decision|0
4767962|NCT01332968|7742755|FG006|Maintenance/Observation Period|Physician Decision|0
4767963|NCT01332968|7742756|FG007|Maintenance/Observation Period|Physician Decision|0
4767964|NCT01332968|7742749|FG000|Maintenance/Observation Period|Other|0
4767965|NCT01332968|7742750|FG001|Maintenance/Observation Period|Other|0
4767966|NCT01332968|7742751|FG002|Maintenance/Observation Period|Other|4
4767967|NCT01332968|7742752|FG003|Maintenance/Observation Period|Other|5
4767968|NCT01332968|7742753|FG004|Maintenance/Observation Period|Other|0
4767969|NCT01332968|7742754|FG005|Maintenance/Observation Period|Other|0
4767970|NCT01332968|7742755|FG006|Maintenance/Observation Period|Other|0
4767971|NCT01332968|7742756|FG007|Maintenance/Observation Period|Other|0
4767972|NCT01332968|7742749|FG000|Maintenance/Observation Period|Non-compliance|0
4767973|NCT01332968|7742750|FG001|Maintenance/Observation Period|Non-compliance|0
4767974|NCT01332968|7742751|FG002|Maintenance/Observation Period|Non-compliance|2
4767975|NCT01332968|7742752|FG003|Maintenance/Observation Period|Non-compliance|3
4767976|NCT01332968|7742753|FG004|Maintenance/Observation Period|Non-compliance|0
4767977|NCT01332968|7742754|FG005|Maintenance/Observation Period|Non-compliance|1
4767978|NCT01332968|7742755|FG006|Maintenance/Observation Period|Non-compliance|0
4767979|NCT01332968|7742756|FG007|Maintenance/Observation Period|Non-compliance|0
4767980|NCT01332968|7742749|FG000|Maintenance/Observation Period|Lost to Follow-up|0
4767981|NCT01332968|7742750|FG001|Maintenance/Observation Period|Lost to Follow-up|0
4767982|NCT01332968|7742751|FG002|Maintenance/Observation Period|Lost to Follow-up|1
4767983|NCT01332968|7742752|FG003|Maintenance/Observation Period|Lost to Follow-up|2
4767984|NCT01332968|7742753|FG004|Maintenance/Observation Period|Lost to Follow-up|0
4767985|NCT01332968|7742754|FG005|Maintenance/Observation Period|Lost to Follow-up|0
4767986|NCT01332968|7742755|FG006|Maintenance/Observation Period|Lost to Follow-up|0
4767987|NCT01332968|7742756|FG007|Maintenance/Observation Period|Lost to Follow-up|0
4767988|NCT01332968|7742749|FG000|Maintenance/Observation Period|Death|0
4767989|NCT01332968|7742750|FG001|Maintenance/Observation Period|Death|0
4767990|NCT01332968|7742751|FG002|Maintenance/Observation Period|Death|5
4767991|NCT01332968|7742752|FG003|Maintenance/Observation Period|Death|6
4767992|NCT01332968|7742753|FG004|Maintenance/Observation Period|Death|0
4767993|NCT01332968|7742754|FG005|Maintenance/Observation Period|Death|0
4767994|NCT01332968|7742755|FG006|Maintenance/Observation Period|Death|0
4767995|NCT01332968|7742756|FG007|Maintenance/Observation Period|Death|0
4767996|NCT01332968|7742749|FG000|Maintenance/Observation Period|Adverse Event|0
4767997|NCT01332968|7742750|FG001|Maintenance/Observation Period|Adverse Event|0
4767998|NCT01332968|7742751|FG002|Maintenance/Observation Period|Adverse Event|50
4767999|NCT01332968|7742752|FG003|Maintenance/Observation Period|Adverse Event|65
4768000|NCT01332968|7742753|FG004|Maintenance/Observation Period|Adverse Event|0
4768001|NCT01332968|7742754|FG005|Maintenance/Observation Period|Adverse Event|0
4768002|NCT01332968|7742755|FG006|Maintenance/Observation Period|Adverse Event|0
4768003|NCT01332968|7742756|FG007|Maintenance/Observation Period|Adverse Event|0
4768004|NCT01332968|7742749|FG000|Maintenance/Observation Period|Treatment ongoing|0
4768005|NCT01332968|7742750|FG001|Maintenance/Observation Period|Treatment ongoing|0
4768006|NCT01332968|7742751|FG002|Maintenance/Observation Period|Treatment ongoing|54
4768007|NCT01332968|7742752|FG003|Maintenance/Observation Period|Treatment ongoing|62
4768008|NCT01332968|7742753|FG004|Maintenance/Observation Period|Treatment ongoing|10
4768009|NCT01332968|7742754|FG005|Maintenance/Observation Period|Treatment ongoing|8
4768010|NCT01332968|7742755|FG006|Maintenance/Observation Period|Treatment ongoing|0
4768011|NCT01332968|7742756|FG007|Maintenance/Observation Period|Treatment ongoing|0
4768012|NCT01332968|7742749|FG000|Follow-Up Period|Death|0
4768013|NCT01332968|7742750|FG001|Follow-Up Period|Death|0
4768014|NCT01332968|7742751|FG002|Follow-Up Period|Death|0
4768015|NCT01332968|7742752|FG003|Follow-Up Period|Death|0
4768016|NCT01332968|7742753|FG004|Follow-Up Period|Death|0
4768017|NCT01332968|7742754|FG005|Follow-Up Period|Death|0
4768018|NCT01332968|7742755|FG006|Follow-Up Period|Death|38
4768019|NCT01332968|7742756|FG007|Follow-Up Period|Death|22
4768020|NCT01332968|7742749|FG000|Follow-Up Period|Follow-up ongoing|0
4768021|NCT01332968|7742750|FG001|Follow-Up Period|Follow-up ongoing|0
4768022|NCT01332968|7742751|FG002|Follow-Up Period|Follow-up ongoing|0
4768023|NCT01332968|7742752|FG003|Follow-Up Period|Follow-up ongoing|0
4768024|NCT01332968|7742753|FG004|Follow-Up Period|Follow-up ongoing|0
4768025|NCT01332968|7742754|FG005|Follow-Up Period|Follow-up ongoing|0
4768026|NCT01332968|7742755|FG006|Follow-Up Period|Follow-up ongoing|502
4768027|NCT01332968|7742756|FG007|Follow-Up Period|Follow-up ongoing|505
4768028|NCT01332968|7742749|FG000|Follow-Up Period|Withdrawal by Subject|0
4768029|NCT01332968|7742750|FG001|Follow-Up Period|Withdrawal by Subject|0
4768030|NCT01332968|7742751|FG002|Follow-Up Period|Withdrawal by Subject|0
4768031|NCT01332968|7742752|FG003|Follow-Up Period|Withdrawal by Subject|0
4768032|NCT01332968|7742753|FG004|Follow-Up Period|Withdrawal by Subject|0
4768033|NCT01332968|7742754|FG005|Follow-Up Period|Withdrawal by Subject|0
4768034|NCT01332968|7742755|FG006|Follow-Up Period|Withdrawal by Subject|1
4768035|NCT01332968|7742756|FG007|Follow-Up Period|Withdrawal by Subject|2
4768036|NCT01332968|7742749|FG000|Follow-Up Period|Lost to Follow-up|0
4768037|NCT01332968|7742750|FG001|Follow-Up Period|Lost to Follow-up|0
4768038|NCT01332968|7742751|FG002|Follow-Up Period|Lost to Follow-up|0
4768039|NCT01332968|7742752|FG003|Follow-Up Period|Lost to Follow-up|0
4768040|NCT01332968|7742753|FG004|Follow-Up Period|Lost to Follow-up|0
4768041|NCT01332968|7742754|FG005|Follow-Up Period|Lost to Follow-up|0
4768042|NCT01332968|7742755|FG006|Follow-Up Period|Lost to Follow-up|1
4768043|NCT01332968|7742756|FG007|Follow-Up Period|Lost to Follow-up|2
4768044|NCT01265784|7742767|FG000|Overall Study|Lost to Follow-up|5
4768045|NCT01265784|7742768|FG001|Overall Study|Lost to Follow-up|3
4768046|NCT01265784|7742769|FG002|Overall Study|Lost to Follow-up|2
4768047|NCT01265784|7742767|FG000|Overall Study|Withdrawal by Subject|0
4768048|NCT01265784|7742768|FG001|Overall Study|Withdrawal by Subject|5
4768049|NCT01265784|7742769|FG002|Overall Study|Withdrawal by Subject|0
4768050|NCT01265784|7742767|FG000|Overall Study|Physician Decision|1
4768051|NCT01265784|7742768|FG001|Overall Study|Physician Decision|0
4768052|NCT01265784|7742769|FG002|Overall Study|Physician Decision|1
4768053|NCT01265784|7742767|FG000|Overall Study|Adverse Event|1
4768054|NCT01265784|7742768|FG001|Overall Study|Adverse Event|0
4768055|NCT01265784|7742769|FG002|Overall Study|Adverse Event|0
4768056|NCT01265784|7742767|FG000|Overall Study|Death|3
4768057|NCT01265784|7742768|FG001|Overall Study|Death|0
4768058|NCT01265784|7742769|FG002|Overall Study|Death|0
4768059|NCT01265784|7742767|FG000|Overall Study|Protocol Violation|2
4768060|NCT01265784|7742768|FG001|Overall Study|Protocol Violation|0
4768061|NCT01265784|7742769|FG002|Overall Study|Protocol Violation|0
4768062|NCT01265784|7742767|FG000|Overall Study|Incorrectly Randomized|0
4768063|NCT01265784|7742768|FG001|Overall Study|Incorrectly Randomized|0
4768064|NCT01265784|7742769|FG002|Overall Study|Incorrectly Randomized|1
4768065|NCT00577577|7742779|FG000|Overall Study|Adverse Event|3
4768066|NCT00577577|7742780|FG001|Overall Study|Adverse Event|2
4768067|NCT00577577|7742779|FG000|Overall Study|Lost to Follow-up|1
4768068|NCT00577577|7742780|FG001|Overall Study|Lost to Follow-up|0
4768069|NCT00577577|7742779|FG000|Overall Study|Protocol Violation|0
4768070|NCT00577577|7742780|FG001|Overall Study|Protocol Violation|3
4768071|NCT00577577|7742779|FG000|Overall Study|Transportation|1
4768072|NCT00577577|7742780|FG001|Overall Study|Transportation|0
4768073|NCT00392327|7742794|FG000|Overall Study|Death|1
4768074|NCT00392327|7742795|FG001|Overall Study|Death|0
4768075|NCT00392327|7742796|FG002|Overall Study|Death|1
4768076|NCT00392327|7742797|FG003|Overall Study|Death|0
4768077|NCT00392327|7742798|FG004|Overall Study|Death|0
4768078|NCT00392327|7742799|FG005|Overall Study|Death|0
4768079|NCT00392327|7742800|FG006|Overall Study|Death|0
4768080|NCT00392327|7742801|FG007|Overall Study|Death|0
4768081|NCT00392327|7742794|FG000|Overall Study|Lack of Efficacy|8
4768082|NCT00392327|7742795|FG001|Overall Study|Lack of Efficacy|8
4768083|NCT00392327|7742796|FG002|Overall Study|Lack of Efficacy|9
4768084|NCT00392327|7742797|FG003|Overall Study|Lack of Efficacy|6
4768085|NCT00392327|7742798|FG004|Overall Study|Lack of Efficacy|3
4768086|NCT00392327|7742799|FG005|Overall Study|Lack of Efficacy|3
4768087|NCT00392327|7742800|FG006|Overall Study|Lack of Efficacy|3
4768088|NCT00392327|7742801|FG007|Overall Study|Lack of Efficacy|3
4768089|NCT00392327|7742794|FG000|Overall Study|Physician Decision|3
4768090|NCT00392327|7742795|FG001|Overall Study|Physician Decision|5
4768091|NCT00392327|7742796|FG002|Overall Study|Physician Decision|2
4768092|NCT00392327|7742797|FG003|Overall Study|Physician Decision|2
4768093|NCT00392327|7742798|FG004|Overall Study|Physician Decision|0
4768094|NCT00392327|7742799|FG005|Overall Study|Physician Decision|1
4768095|NCT00392327|7742800|FG006|Overall Study|Physician Decision|5
4768096|NCT00392327|7742801|FG007|Overall Study|Physician Decision|3
4768097|NCT00392327|7742794|FG000|Overall Study|Protocol Violation|0
4768098|NCT00392327|7742795|FG001|Overall Study|Protocol Violation|0
4768099|NCT00392327|7742796|FG002|Overall Study|Protocol Violation|1
4768100|NCT00392327|7742797|FG003|Overall Study|Protocol Violation|0
4768101|NCT00392327|7742798|FG004|Overall Study|Protocol Violation|0
4768102|NCT00392327|7742799|FG005|Overall Study|Protocol Violation|0
4768103|NCT00392327|7742800|FG006|Overall Study|Protocol Violation|0
4768104|NCT00392327|7742801|FG007|Overall Study|Protocol Violation|0
4768105|NCT00392327|7742794|FG000|Overall Study|Withdrawal by Subject|3
4768106|NCT00392327|7742795|FG001|Overall Study|Withdrawal by Subject|2
4768107|NCT00392327|7742796|FG002|Overall Study|Withdrawal by Subject|4
4768108|NCT00392327|7742797|FG003|Overall Study|Withdrawal by Subject|6
4768109|NCT00392327|7742798|FG004|Overall Study|Withdrawal by Subject|0
4768110|NCT00392327|7742799|FG005|Overall Study|Withdrawal by Subject|1
4768111|NCT00392327|7742800|FG006|Overall Study|Withdrawal by Subject|1
4768112|NCT00392327|7742801|FG007|Overall Study|Withdrawal by Subject|5
4768113|NCT00392327|7742794|FG000|Overall Study|Ineligible|0
4768114|NCT00392327|7742795|FG001|Overall Study|Ineligible|4
4768115|NCT00392327|7742796|FG002|Overall Study|Ineligible|3
4768116|NCT00392327|7742797|FG003|Overall Study|Ineligible|2
4768117|NCT00392327|7742798|FG004|Overall Study|Ineligible|0
4768118|NCT00392327|7742799|FG005|Overall Study|Ineligible|0
4768119|NCT00392327|7742800|FG006|Overall Study|Ineligible|0
4768120|NCT00392327|7742801|FG007|Overall Study|Ineligible|0
4768121|NCT00085202|7742821|FG000|Overall Study|Still on therapy|2
4768122|NCT00085202|7742822|FG001|Overall Study|Still on therapy|0
4768123|NCT00085202|7742821|FG000|Overall Study|Bone involvement confirmed by bone scan|0
4768124|NCT00085202|7742822|FG001|Overall Study|Bone involvement confirmed by bone scan|1
4768125|NCT00085202|7742821|FG000|Overall Study|Excessive toxicity|6
4768126|NCT00085202|7742822|FG001|Overall Study|Excessive toxicity|5
4768127|NCT00085202|7742821|FG000|Overall Study|Non-specified|3
4768128|NCT00085202|7742822|FG001|Overall Study|Non-specified|5
4768129|NCT00085202|7742821|FG000|Overall Study|Withdrawal by Subject|2
4768130|NCT00085202|7742822|FG001|Overall Study|Withdrawal by Subject|1
4768131|NCT00085202|7742821|FG000|Overall Study|Physician Decision|4
4768132|NCT00085202|7742822|FG001|Overall Study|Physician Decision|1
4768133|NCT00085202|7742821|FG000|Overall Study|Progressive disease|1
4768134|NCT00085202|7742822|FG001|Overall Study|Progressive disease|11
4768135|NCT04386616|7742923|FG000|Overall Study|Death|22
4768136|NCT04386616|7742924|FG001|Overall Study|Death|22
4768137|NCT04386616|7742925|FG002|Overall Study|Death|21
4768138|NCT04386616|7742923|FG000|Overall Study|Lost to Follow-up|5
4768139|NCT04386616|7742924|FG001|Overall Study|Lost to Follow-up|8
4768140|NCT04386616|7742925|FG002|Overall Study|Lost to Follow-up|6
4768141|NCT04386616|7742923|FG000|Overall Study|Withdrawal by Subject|2
4768142|NCT04386616|7742924|FG001|Overall Study|Withdrawal by Subject|4
4768143|NCT04386616|7742925|FG002|Overall Study|Withdrawal by Subject|1
4768144|NCT04386616|7742923|FG000|Overall Study|Adverse Event|1
4768145|NCT04386616|7742924|FG001|Overall Study|Adverse Event|1
4768146|NCT04386616|7742925|FG002|Overall Study|Adverse Event|0
4768147|NCT04296942|7742958|FG000|Overall Study|Study closure by sponsor|1
4768148|NCT04296942|7742959|FG001|Overall Study|Study closure by sponsor|0
4768149|NCT04296942|7742960|FG002|Overall Study|Study closure by sponsor|0
4768150|NCT04278872|7742972|FG000|Overall Study|Adverse Event|1
4768151|NCT04278872|7742973|FG001|Overall Study|Adverse Event|0
4768152|NCT04278872|7742972|FG000|Overall Study|Protocol Violation|0
4768153|NCT04278872|7742973|FG001|Overall Study|Protocol Violation|1
4768154|NCT04278872|7742972|FG000|Overall Study|Study Termination|2
4768155|NCT04278872|7742973|FG001|Overall Study|Study Termination|0
4768156|NCT04213807|7742982|FG000|Overall Study|Physician Decision|0
4768157|NCT04213807|7742983|FG001|Overall Study|Physician Decision|0
4768158|NCT04213807|7742984|FG002|Overall Study|Physician Decision|1
4768159|NCT03721107|7743066|FG000|Overall Study|Adverse Event|1
4768160|NCT03721107|7743067|FG001|Overall Study|Adverse Event|1
4768161|NCT03721107|7743068|FG002|Overall Study|Adverse Event|6
4768162|NCT03721107|7743069|FG003|Overall Study|Adverse Event|5
4768163|NCT03721107|7743066|FG000|Overall Study|Lost to Follow-up|2
4768164|NCT03721107|7743067|FG001|Overall Study|Lost to Follow-up|0
4768165|NCT03721107|7743068|FG002|Overall Study|Lost to Follow-up|3
4768166|NCT03721107|7743069|FG003|Overall Study|Lost to Follow-up|0
4768167|NCT03721107|7743066|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0
4768168|NCT03721107|7743067|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0
4768169|NCT03721107|7743068|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0
4768170|NCT03721107|7743069|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1
4768171|NCT03721107|7743066|FG000|Overall Study|Physician Decision|0
4768172|NCT03721107|7743067|FG001|Overall Study|Physician Decision|1
4768173|NCT03721107|7743068|FG002|Overall Study|Physician Decision|0
4768174|NCT03721107|7743069|FG003|Overall Study|Physician Decision|0
4768175|NCT03721107|7743066|FG000|Overall Study|Pregnancy|0
4768176|NCT03721107|7743067|FG001|Overall Study|Pregnancy|0
4768177|NCT03721107|7743068|FG002|Overall Study|Pregnancy|1
4768178|NCT03721107|7743069|FG003|Overall Study|Pregnancy|0
4768179|NCT03721107|7743066|FG000|Overall Study|Withdrawal by Subject|1
4768180|NCT03721107|7743067|FG001|Overall Study|Withdrawal by Subject|1
4768181|NCT03721107|7743068|FG002|Overall Study|Withdrawal by Subject|5
4768182|NCT03721107|7743069|FG003|Overall Study|Withdrawal by Subject|5
4768183|NCT03721107|7743066|FG000|Overall Study|Other|1
4768184|NCT03721107|7743067|FG001|Overall Study|Other|0
4768185|NCT03721107|7743068|FG002|Overall Study|Other|0
4768186|NCT03721107|7743069|FG003|Overall Study|Other|1
4768187|NCT03644849|7743109|FG000|Overall Study|Lost to Follow-up|1
4768188|NCT03644849|7743110|FG001|Overall Study|Lost to Follow-up|3
4768189|NCT03604159|7743118|FG000|Overall Study|Lost to Follow-up|6
4768190|NCT03604159|7743119|FG001|Overall Study|Lost to Follow-up|7
4768191|NCT03602885|7743127|FG000|Overall Study|Lost to Follow-up|3
4768192|NCT03602885|7743128|FG001|Overall Study|Lost to Follow-up|0
4768193|NCT03539601|7743138|FG000|Overall Study|Withdraw by parent/guardian|1
4768194|NCT03539601|7743139|FG001|Overall Study|Withdraw by parent/guardian|0
4768195|NCT03539601|7743140|FG002|Overall Study|Withdraw by parent/guardian|1
4768196|NCT03539601|7743141|FG003|Overall Study|Withdraw by parent/guardian|0
4768197|NCT03539601|7743138|FG000|Overall Study|Adverse Event|0
4768198|NCT03539601|7743139|FG001|Overall Study|Adverse Event|2
4768199|NCT03539601|7743140|FG002|Overall Study|Adverse Event|0
4768200|NCT03539601|7743141|FG003|Overall Study|Adverse Event|0
4768201|NCT03539601|7743138|FG000|Overall Study|Lost to Follow-up|2
4768202|NCT03539601|7743139|FG001|Overall Study|Lost to Follow-up|4
4768203|NCT03539601|7743140|FG002|Overall Study|Lost to Follow-up|5
4768204|NCT03539601|7743141|FG003|Overall Study|Lost to Follow-up|0
4768205|NCT03539601|7743138|FG000|Overall Study|Withdrawal by Subject|2
4768206|NCT03539601|7743139|FG001|Overall Study|Withdrawal by Subject|0
4768207|NCT03539601|7743140|FG002|Overall Study|Withdrawal by Subject|0
4768208|NCT03539601|7743141|FG003|Overall Study|Withdrawal by Subject|1
4768209|NCT03539601|7743138|FG000|Overall Study|Randomized but not treated|1
4768210|NCT03539601|7743139|FG001|Overall Study|Randomized but not treated|1
4768211|NCT03539601|7743140|FG002|Overall Study|Randomized but not treated|0
4768212|NCT03539601|7743141|FG003|Overall Study|Randomized but not treated|0
4768213|NCT03539458|7743159|FG000|Overall Study|Death|1
4768214|NCT03532451|7743165|FG000|Overall Study|Withdrawal by Subject|0
4768215|NCT03532451|7743166|FG001|Overall Study|Withdrawal by Subject|1
4768216|NCT03532451|7743165|FG000|Overall Study|Progression prior to the surgery|1
4768217|NCT03532451|7743166|FG001|Overall Study|Progression prior to the surgery|0
4768218|NCT03464136|7743183|FG000|Overall Study|Lost to Follow-up|5
4768219|NCT03464136|7743184|FG001|Overall Study|Lost to Follow-up|8
4768220|NCT03464136|7743183|FG000|Overall Study|Withdrawal by Subject|16
4768221|NCT03464136|7743184|FG001|Overall Study|Withdrawal by Subject|13
4768222|NCT03464136|7743183|FG000|Overall Study|Death|1
4768223|NCT03464136|7743184|FG001|Overall Study|Death|0
4768224|NCT03464136|7743183|FG000|Overall Study|Other|8
4768225|NCT03464136|7743184|FG001|Overall Study|Other|4
4768226|NCT03439657|7743192|FG000|Overall Study|Adverse Event|2
4768227|NCT03439657|7743193|FG001|Overall Study|Adverse Event|3
4768228|NCT03439657|7743192|FG000|Overall Study|Lost to Follow-up|1
4768229|NCT03439657|7743193|FG001|Overall Study|Lost to Follow-up|0
4768230|NCT03439657|7743192|FG000|Overall Study|Protocol Violation|1
4768231|NCT03439657|7743193|FG001|Overall Study|Protocol Violation|1
4768232|NCT03439657|7743192|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3
4768233|NCT03439657|7743193|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0
4768234|NCT03377790|7743203|FG000|Overall Study|Withdrawal by Subject|1
4768235|NCT03377790|7743204|FG001|Overall Study|Withdrawal by Subject|0
4768236|NCT03377790|7743203|FG000|Overall Study|Adverse Event|1
4768237|NCT03377790|7743204|FG001|Overall Study|Adverse Event|0
4768238|NCT03377790|7743203|FG000|Overall Study|Lost to Follow-up|0
4768239|NCT03377790|7743204|FG001|Overall Study|Lost to Follow-up|2
4768240|NCT03377790|7743203|FG000|Overall Study|Randomized but not treated|1
4768241|NCT03377790|7743204|FG001|Overall Study|Randomized but not treated|0
4768242|NCT03377790|7743203|FG000|Overall Study|Withdrawn by Parent/Guardian|7
4768243|NCT03377790|7743204|FG001|Overall Study|Withdrawn by Parent/Guardian|4
4768244|NCT03353675|7743210|FG000|Overall Study|Adverse Event|4
4768245|NCT03294109|7743216|FG000|Overall Study|Withdrawal by Subject|6
4768246|NCT03294109|7743217|FG001|Overall Study|Withdrawal by Subject|5
4768247|NCT03268005|7743226|FG000|Overall Study|Death|2
4768248|NCT03268005|7743227|FG001|Overall Study|Death|1
4768249|NCT03268005|7743226|FG000|Overall Study|Lost to Follow-up|2
4768250|NCT03268005|7743227|FG001|Overall Study|Lost to Follow-up|2
4768251|NCT03268005|7743226|FG000|Overall Study|Withdrawal by Subject|11
4768252|NCT03268005|7743227|FG001|Overall Study|Withdrawal by Subject|11
4768253|NCT03225170|7743236|FG000|Overall Study|Lost to Follow-up|4
4768254|NCT03225170|7743237|FG001|Overall Study|Lost to Follow-up|4
4768255|NCT03225170|7743238|FG002|Overall Study|Lost to Follow-up|0
4768256|NCT03225170|7743236|FG000|Overall Study|Did not complete intervention/control writing exercise|0
4768257|NCT03225170|7743237|FG001|Overall Study|Did not complete intervention/control writing exercise|1
4768258|NCT03225170|7743238|FG002|Overall Study|Did not complete intervention/control writing exercise|0
4768259|NCT03219034|7743262|FG000|Overall Study|Lost to Follow-up|9
4768260|NCT03219034|7743263|FG001|Overall Study|Lost to Follow-up|13
4768261|NCT03219034|7743262|FG000|Overall Study|Additional dental work needed|1
4768262|NCT03219034|7743263|FG001|Overall Study|Additional dental work needed|0
4768263|NCT03219034|7743262|FG000|Overall Study|UPPP Surgery|1
4768264|NCT03219034|7743263|FG001|Overall Study|UPPP Surgery|0
4768265|NCT03219034|7743262|FG000|Overall Study|Dental sensitivity|0
4768266|NCT03219034|7743263|FG001|Overall Study|Dental sensitivity|1
4768267|NCT03219034|7743262|FG000|Overall Study|Death in family|0
4768268|NCT03219034|7743263|FG001|Overall Study|Death in family|1
4768269|NCT03168438|7743273|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0
4768270|NCT03168438|7743274|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1
4768271|NCT03110380|7743283|FG000|Double-Blind Treatment Phase|Withdrew Consent|10
4768272|NCT03110380|7743284|FG001|Double-Blind Treatment Phase|Withdrew Consent|16
4768273|NCT03110380|7743285|FG002|Double-Blind Treatment Phase|Withdrew Consent|0
4768274|NCT03110380|7743286|FG003|Double-Blind Treatment Phase|Withdrew Consent|0
4768275|NCT03110380|7743283|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4
4768276|NCT03110380|7743284|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3
4768277|NCT03110380|7743285|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0
4768278|NCT03110380|7743286|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0
4768279|NCT03110380|7743283|FG000|Double-Blind Treatment Phase|Adverse Event|3
4768280|NCT03110380|7743284|FG001|Double-Blind Treatment Phase|Adverse Event|3
4768281|NCT03110380|7743285|FG002|Double-Blind Treatment Phase|Adverse Event|0
4768282|NCT03110380|7743286|FG003|Double-Blind Treatment Phase|Adverse Event|0
4768283|NCT03110380|7743283|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1
4768284|NCT03110380|7743284|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3
4768285|NCT03110380|7743285|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0
4768286|NCT03110380|7743286|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0
4768287|NCT03110380|7743283|FG000|Double-Blind Treatment Phase|Death|2
4768288|NCT03110380|7743284|FG001|Double-Blind Treatment Phase|Death|1
4768289|NCT03110380|7743285|FG002|Double-Blind Treatment Phase|Death|0
4768290|NCT03110380|7743286|FG003|Double-Blind Treatment Phase|Death|0
4768291|NCT03110380|7743283|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1
4768292|NCT03110380|7743284|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1
4768293|NCT03110380|7743285|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0
4768294|NCT03110380|7743286|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0
4768295|NCT03110380|7743283|FG000|Double-Blind Treatment Phase|Protocol Violation|0
4768296|NCT03110380|7743284|FG001|Double-Blind Treatment Phase|Protocol Violation|1
4768297|NCT03110380|7743285|FG002|Double-Blind Treatment Phase|Protocol Violation|0
4768298|NCT03110380|7743286|FG003|Double-Blind Treatment Phase|Protocol Violation|0
4768299|NCT03110380|7743283|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0
4768300|NCT03110380|7743284|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2
4768301|NCT03110380|7743285|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0
4768302|NCT03110380|7743286|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0
4768303|NCT03110380|7743283|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0
4768304|NCT03110380|7743284|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0
4768305|NCT03110380|7743285|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3
4768306|NCT03110380|7743286|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1
4768307|NCT03110380|7743283|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0
4768308|NCT03110380|7743284|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0
4768309|NCT03110380|7743285|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1
4768310|NCT03110380|7743286|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1
4768311|NCT03110380|7743283|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0
4768312|NCT03110380|7743284|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0
4768313|NCT03110380|7743285|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0
4768314|NCT03110380|7743286|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1
4768315|NCT03078478|7743302|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36
4768316|NCT03078478|7743303|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36
4768317|NCT03078478|7743302|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7
4768318|NCT03078478|7743303|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4
4768319|NCT03078478|7743302|FG000|Maintenance Period 1 (36 Weeks)|Death|3
4768320|NCT03078478|7743303|FG001|Maintenance Period 1 (36 Weeks)|Death|3
4768321|NCT03078478|7743302|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1
4768322|NCT03078478|7743303|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0
4768323|NCT03078478|7743302|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18
4768324|NCT03078478|7743303|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13
4768325|NCT03078478|7743302|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3
4768326|NCT03078478|7743303|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6
4768327|NCT03078478|7743302|FG000|Maintencance Period 2 (36 Weeks)|Death|4
4768328|NCT03078478|7743303|FG001|Maintencance Period 2 (36 Weeks)|Death|6
4768329|NCT03078478|7743302|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0
4768330|NCT03078478|7743303|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2
4768331|NCT02993263|7743318|FG000|Overall Study|Equipment Software failed and results were lost.|323
4768332|NCT02985684|7743322|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5
4768333|NCT02985684|7743322|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5
4768334|NCT02985684|7743322|FG000|6-Month Closure Success Evaluation|Device Removal|3
4768335|NCT02873195|7743337|FG000|Overall Study|Ineligible|5
4768336|NCT02873195|7743338|FG001|Overall Study|Ineligible|0
4768337|NCT02785952|7743346|FG000|Overall Study|Adverse Event|31
4768338|NCT02785952|7743347|FG001|Overall Study|Adverse Event|19
4768339|NCT02785952|7743346|FG000|Overall Study|Refusal unrelated to adverse events|10
4768340|NCT02785952|7743347|FG001|Overall Study|Refusal unrelated to adverse events|5
4768341|NCT02785952|7743346|FG000|Overall Study|Disease progression/relapse|61
4768342|NCT02785952|7743347|FG001|Overall Study|Disease progression/relapse|89
4768343|NCT02785952|7743346|FG000|Overall Study|Death|11
4768344|NCT02785952|7743347|FG001|Overall Study|Death|7
4768345|NCT02785952|7743346|FG000|Overall Study|Other- not protocol specified|6
4768346|NCT02785952|7743347|FG001|Overall Study|Other- not protocol specified|4
4768347|NCT02785952|7743346|FG000|Overall Study|On protocol treatment|6
4768348|NCT02785952|7743347|FG001|Overall Study|On protocol treatment|3
4768349|NCT02748616|7743359|FG000|Overall Study|Lost to Follow-up|1
4768350|NCT02748616|7743359|FG000|Overall Study|Withdrawal by Subject|2
4768351|NCT02748616|7743359|FG000|Overall Study|Physician Decision|2
4768352|NCT02748616|7743359|FG000|Overall Study|Did Not Complete Ursodial Course|2
4768353|NCT02719522|7743363|FG000|Overall Study|Implant Failure|4
4768354|NCT02719522|7743363|FG000|Overall Study|Death|2
4768355|NCT02719522|7743363|FG000|Overall Study|Lost to Follow-up|5
4768356|NCT02585232|7743384|FG000|Overall Study|Lost to Follow-up|8
4768357|NCT02585232|7743385|FG001|Overall Study|Lost to Follow-up|8
4768358|NCT02585232|7743384|FG000|Overall Study|Withdrawal by Subject|4
4768359|NCT02585232|7743385|FG001|Overall Study|Withdrawal by Subject|8
4768360|NCT02583269|7743396|FG000|Overall Study|Patient hospitalized prior to start|1
4768361|NCT02583269|7743397|FG001|Overall Study|Patient hospitalized prior to start|0
4768362|NCT02583269|7743398|FG002|Overall Study|Patient hospitalized prior to start|0
4768363|NCT02583269|7743399|FG003|Overall Study|Patient hospitalized prior to start|0
4768364|NCT02583269|7743400|FG004|Overall Study|Patient hospitalized prior to start|0
4768365|NCT02545283|7743436|FG000|Overall Study|Lost to Follow-up|2
4768366|NCT02545283|7743437|FG001|Overall Study|Lost to Follow-up|4
4768367|NCT02545283|7743436|FG000|Overall Study|Withdrawal by Subject|5
4768368|NCT02545283|7743437|FG001|Overall Study|Withdrawal by Subject|9
4768369|NCT02545283|7743436|FG000|Overall Study|Death|109
4768370|NCT02545283|7743437|FG001|Overall Study|Death|211
4768371|NCT02545283|7743436|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0
4768372|NCT02545283|7743437|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3
4768373|NCT02545283|7743436|FG000|Overall Study|Study Terminated By Sponsor|33
4768374|NCT02545283|7743437|FG001|Overall Study|Study Terminated By Sponsor|71
4768375|NCT02524171|7743447|FG000|6-month Follow-up|Lost to Follow-up|53
4768376|NCT02524171|7743448|FG001|6-month Follow-up|Lost to Follow-up|45
4768377|NCT02524171|7743447|FG000|12-month Follow-up Interview|Lost to Follow-up|45
4768378|NCT02524171|7743448|FG001|12-month Follow-up Interview|Lost to Follow-up|41
4768379|NCT02476968|7743484|FG000|Overall Study|Other|0
4768380|NCT02476968|7743485|FG001|Overall Study|Other|2
4768381|NCT02476968|7743486|FG002|Overall Study|Other|0
4768382|NCT02476968|7743484|FG000|Overall Study|Lost to Follow-up|10
4768383|NCT02476968|7743485|FG001|Overall Study|Lost to Follow-up|0
4768384|NCT02476968|7743486|FG002|Overall Study|Lost to Follow-up|1
4768385|NCT02476968|7743484|FG000|Overall Study|Death|34
4768386|NCT02476968|7743485|FG001|Overall Study|Death|6
4768387|NCT02476968|7743486|FG002|Overall Study|Death|0
4768388|NCT02476968|7743484|FG000|Overall Study|Eligibility criteria not fulfilled|0
4768389|NCT02476968|7743485|FG001|Overall Study|Eligibility criteria not fulfilled|0
4768390|NCT02476968|7743486|FG002|Overall Study|Eligibility criteria not fulfilled|1
4768391|NCT02476968|7743484|FG000|Overall Study|Patient decision|30
4768392|NCT02476968|7743485|FG001|Overall Study|Patient decision|7
4768393|NCT02476968|7743486|FG002|Overall Study|Patient decision|0
4768394|NCT02306122|7743503|FG000|Initial Physician Randomization|Physician Decision|0
4768395|NCT02306122|7743504|FG001|Initial Physician Randomization|Physician Decision|0
4768396|NCT02306122|7743505|FG002|Initial Physician Randomization|Physician Decision|0
4768397|NCT02306122|7743506|FG003|Initial Physician Randomization|Physician Decision|0
4768398|NCT02306122|7743507|FG004|Initial Physician Randomization|Physician Decision|0
4768399|NCT02306122|7743508|FG005|Initial Physician Randomization|Physician Decision|0
4768400|NCT02306122|7743509|FG006|Initial Physician Randomization|Physician Decision|0
4768401|NCT02306122|7743510|FG007|Initial Physician Randomization|Physician Decision|0
4768402|NCT02306122|7743511|FG008|Initial Physician Randomization|Physician Decision|1
4768403|NCT02306122|7743512|FG009|Initial Physician Randomization|Physician Decision|0
4768404|NCT02306122|7743513|FG010|Initial Physician Randomization|Physician Decision|0
4768405|NCT02147184|7743551|FG000|Overall Study|Lost to Follow-up|28
4768406|NCT02147184|7743552|FG001|Overall Study|Lost to Follow-up|15
4768407|NCT02147184|7743551|FG000|Overall Study|Study Burden|11
4768408|NCT02147184|7743552|FG001|Overall Study|Study Burden|7
4768409|NCT02147184|7743551|FG000|Overall Study|Pregnancy|6
4768410|NCT02147184|7743552|FG001|Overall Study|Pregnancy|0
4768411|NCT02147184|7743551|FG000|Overall Study|Moved out of state|3
4768412|NCT02147184|7743552|FG001|Overall Study|Moved out of state|3
4768413|NCT02147184|7743551|FG000|Overall Study|Physician Decision|0
4768414|NCT02147184|7743552|FG001|Overall Study|Physician Decision|2
4768415|NCT02147184|7743551|FG000|Overall Study|Other|1
4768416|NCT02147184|7743552|FG001|Overall Study|Other|0
4768417|NCT02000219|7743577|FG000|14-Week Study Period|Physician Decision|1
4768418|NCT02000219|7743577|FG000|14-Week Study Period|Adverse Event|1
4768419|NCT02000219|7743577|FG000|14-Week Study Period|Underwent transplantation|1
4768420|NCT02000219|7743577|FG000|Continuation Period|Withdrawal by Subject|1
4768421|NCT02000219|7743577|FG000|Continuation Period|Had liver transplant|2
4768422|NCT02000219|7743577|FG000|Continuation Period|Non-compliance with study drug|2
4768423|NCT01978938|7743583|FG000|Overall Study|Lost to Follow-up|12
4768424|NCT01978938|7743584|FG001|Overall Study|Lost to Follow-up|6
4768425|NCT01978938|7743583|FG000|Overall Study|Withdrawal by Subject|8
4768426|NCT01978938|7743584|FG001|Overall Study|Withdrawal by Subject|4
4768427|NCT01978938|7743583|FG000|Overall Study|Adverse Event, non-fatal|2
4768428|NCT01978938|7743584|FG001|Overall Study|Adverse Event, non-fatal|1
4768429|NCT01978938|7743583|FG000|Overall Study|Participant noncompliance|1
4768430|NCT01978938|7743584|FG001|Overall Study|Participant noncompliance|1
4768431|NCT01978938|7743583|FG000|Overall Study|Did not meet inclusion criteria|0
4768432|NCT01978938|7743584|FG001|Overall Study|Did not meet inclusion criteria|1
4768433|NCT01978938|7743583|FG000|Overall Study|Previously scheduled procedure|0
4768434|NCT01978938|7743584|FG001|Overall Study|Previously scheduled procedure|1
4768435|NCT01854385|7743590|FG000|Pre-Treatment|Withdrawal by Subject|4
4768436|NCT01854385|7743590|FG000|Pre-Treatment|Did not meet criteria based on headache number|15
4768437|NCT01854385|7743590|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3
4768438|NCT01854385|7743590|FG000|Pre-Treatment|Unable to come for study visits|1
4768439|NCT01854385|7743590|FG000|Treatment|Lost to Follow-up|1
4768440|NCT01844856|7743596|FG000|Overall Study|Lost to Follow-up|15
4768441|NCT01844856|7743597|FG001|Overall Study|Lost to Follow-up|3
4768442|NCT01844856|7743596|FG000|Overall Study|Adverse Event|3
4768443|NCT01844856|7743597|FG001|Overall Study|Adverse Event|6
4768444|NCT01844856|7743596|FG000|Overall Study|Withdrawal by Subject|3
4768445|NCT01844856|7743597|FG001|Overall Study|Withdrawal by Subject|2
4768446|NCT01844856|7743596|FG000|Overall Study|Noncompliance|2
4768447|NCT01844856|7743597|FG001|Overall Study|Noncompliance|3
4768448|NCT01844856|7743596|FG000|Overall Study|Enterococcus Resistant|0
4768449|NCT01844856|7743597|FG001|Overall Study|Enterococcus Resistant|1
4768450|NCT01844856|7743596|FG000|Overall Study|Inadvertently Not Scheduled|1
4768451|NCT01844856|7743597|FG001|Overall Study|Inadvertently Not Scheduled|0
4768452|NCT01844856|7743596|FG000|Overall Study|Randomized but was a Screen Failure|0
4768453|NCT01844856|7743597|FG001|Overall Study|Randomized but was a Screen Failure|1
4768454|NCT01712789|7743661|FG000|Overall Study|Lack of Efficacy|2
4768455|NCT01712789|7743661|FG000|Overall Study|Lost to Follow-up|1
4768456|NCT01712789|7743661|FG000|Overall Study|Progressive Disease|504
4768457|NCT01712789|7743661|FG000|Overall Study|Death|57
4768458|NCT01712789|7743661|FG000|Overall Study|Adverse Event|52
4768459|NCT01712789|7743661|FG000|Overall Study|Miscellaneous|31
4768460|NCT01712789|7743661|FG000|Overall Study|Withdrawal by Subject|21
4768461|NCT01712789|7743661|FG000|Overall Study|Transition to Commercial Treatment|8
4768462|NCT01712789|7743661|FG000|Overall Study|Participants Did Not Receive Study Drug|6
4768463|NCT01651403|7743667|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1
4768464|NCT01651403|7743668|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1
4768465|NCT01651403|7743667|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3
4768466|NCT01651403|7743668|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3
4768467|NCT01651403|7743667|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0
4768468|NCT01651403|7743668|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1
4768469|NCT01651403|7743667|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13
4768470|NCT01651403|7743668|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9
4768471|NCT01651403|7743667|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2
4768472|NCT01651403|7743668|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1
4768473|NCT01651403|7743667|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6
4768474|NCT01651403|7743668|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4
4768475|NCT01542736|7743683|FG000|Overall Study|Death|1
4768476|NCT01535807|7743689|FG000|Overall Study|Withdrawal by Subject|1
4768477|NCT01535807|7743690|FG001|Overall Study|Withdrawal by Subject|1
4768478|NCT01535807|7743689|FG000|Overall Study|Data collection error|1
4768479|NCT01535807|7743690|FG001|Overall Study|Data collection error|1
4768480|NCT01147666|7743711|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1
4768481|NCT01147666|7743712|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1
4768482|NCT01147666|7743713|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1
4768483|NCT01147666|7743714|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0
4768484|NCT01147666|7743715|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0
4768485|NCT01147666|7743716|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0
4768486|NCT01147666|7743717|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0
4768487|NCT01147666|7743718|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0
4768488|NCT01147666|7743719|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0
4768489|NCT01147666|7743720|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0
4768490|NCT01147666|7743721|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0
4768491|NCT01147666|7743722|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0
4768492|NCT01147666|7743723|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1
4768493|NCT01147666|7743724|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0
4768494|NCT01147666|7743725|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0
4768495|NCT01147666|7743711|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0
4768496|NCT01147666|7743712|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1
4768497|NCT01147666|7743713|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0
4768498|NCT01147666|7743714|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0
4768499|NCT01147666|7743715|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3
4768500|NCT01147666|7743716|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1
4768501|NCT01147666|7743717|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2
4768502|NCT01147666|7743718|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2
4768503|NCT01147666|7743719|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0
4768504|NCT01147666|7743720|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1
4768505|NCT01147666|7743721|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0
4768506|NCT01147666|7743722|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0
4768507|NCT01147666|7743723|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1
4768508|NCT01147666|7743724|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0
4768509|NCT01147666|7743725|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3
4768510|NCT01147666|7743711|FG000|Dosing Period 1: 6-Week Treatment|Death|0
4768511|NCT01147666|7743712|FG001|Dosing Period 1: 6-Week Treatment|Death|0
4768512|NCT01147666|7743713|FG002|Dosing Period 1: 6-Week Treatment|Death|0
4768513|NCT01147666|7743714|FG003|Dosing Period 1: 6-Week Treatment|Death|0
4768514|NCT01147666|7743715|FG004|Dosing Period 1: 6-Week Treatment|Death|1
4768515|NCT01147666|7743716|FG005|Dosing Period 1: 6-Week Treatment|Death|1
4768516|NCT01147666|7743717|FG006|Dosing Period 1: 6-Week Treatment|Death|1
4768517|NCT01147666|7743718|FG007|Dosing Period 1: 6-Week Treatment|Death|0
4768518|NCT01147666|7743719|FG008|Dosing Period 1: 6-Week Treatment|Death|0
4768519|NCT01147666|7743720|FG009|Dosing Period 1: 6-Week Treatment|Death|0
4768520|NCT01147666|7743721|FG010|Dosing Period 1: 6-Week Treatment|Death|0
4768521|NCT01147666|7743722|FG011|Dosing Period 1: 6-Week Treatment|Death|0
4768522|NCT01147666|7743723|FG012|Dosing Period 1: 6-Week Treatment|Death|1
4768523|NCT01147666|7743724|FG013|Dosing Period 1: 6-Week Treatment|Death|0
4768524|NCT01147666|7743725|FG014|Dosing Period 1: 6-Week Treatment|Death|0
4768525|NCT01147666|7743711|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1
4768526|NCT01147666|7743712|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
4768527|NCT01147666|7743713|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
4768528|NCT01147666|7743714|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1
4768529|NCT01147666|7743715|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
4768530|NCT01147666|7743716|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
4768531|NCT01147666|7743717|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
4768532|NCT01147666|7743718|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
4768533|NCT01147666|7743719|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
4768534|NCT01147666|7743720|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
4768535|NCT01147666|7743721|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1
4768536|NCT01147666|7743722|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
4768537|NCT01147666|7743723|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
4768538|NCT01147666|7743724|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
4768539|NCT01147666|7743725|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0
4768540|NCT01147666|7743711|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0
4768541|NCT01147666|7743712|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0
4768542|NCT01147666|7743713|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0
4768543|NCT01147666|7743714|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0
4768544|NCT01147666|7743715|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1
4768545|NCT01147666|7743716|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1
4768546|NCT01147666|7743717|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0
4768547|NCT01147666|7743718|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1
4768548|NCT01147666|7743719|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0
4768549|NCT01147666|7743720|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1
4768550|NCT01147666|7743721|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0
4768551|NCT01147666|7743722|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1
4768552|NCT01147666|7743723|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0
4768553|NCT01147666|7743724|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1
4768554|NCT01147666|7743725|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0
4768555|NCT01147666|7743711|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0
4768556|NCT01147666|7743712|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0
4768557|NCT01147666|7743713|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0
4768558|NCT01147666|7743714|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1
4768559|NCT01147666|7743715|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0
4768560|NCT01147666|7743716|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0
4768561|NCT01147666|7743717|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0
4768562|NCT01147666|7743718|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0
4768563|NCT01147666|7743719|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0
4768564|NCT01147666|7743720|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0
4768565|NCT01147666|7743721|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2
4768566|NCT01147666|7743722|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0
4768567|NCT01147666|7743723|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0
4768568|NCT01147666|7743724|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0
4768569|NCT01147666|7743725|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0
4768570|NCT01147666|7743711|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
4768571|NCT01147666|7743712|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
4768572|NCT01147666|7743713|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
4768573|NCT01147666|7743714|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
4768574|NCT01147666|7743715|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
4768575|NCT01147666|7743716|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
4768576|NCT01147666|7743717|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
4768577|NCT01147666|7743718|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
4768578|NCT01147666|7743719|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
4768579|NCT01147666|7743720|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
4768580|NCT01147666|7743721|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
4768581|NCT01147666|7743722|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1
4768582|NCT01147666|7743723|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1
4768583|NCT01147666|7743724|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0
4768584|NCT01147666|7743725|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1
4768585|NCT01147666|7743711|FG000|Dosing Period 2: 19-Week Treatment|Death|0
4768586|NCT01147666|7743712|FG001|Dosing Period 2: 19-Week Treatment|Death|0
4768587|NCT01147666|7743713|FG002|Dosing Period 2: 19-Week Treatment|Death|0
4768588|NCT01147666|7743714|FG003|Dosing Period 2: 19-Week Treatment|Death|0
4768589|NCT01147666|7743715|FG004|Dosing Period 2: 19-Week Treatment|Death|1
4768590|NCT01147666|7743716|FG005|Dosing Period 2: 19-Week Treatment|Death|1
4768591|NCT01147666|7743717|FG006|Dosing Period 2: 19-Week Treatment|Death|1
4768592|NCT01147666|7743718|FG007|Dosing Period 2: 19-Week Treatment|Death|0
4768593|NCT01147666|7743719|FG008|Dosing Period 2: 19-Week Treatment|Death|0
4768594|NCT01147666|7743720|FG009|Dosing Period 2: 19-Week Treatment|Death|0
4768595|NCT01147666|7743721|FG010|Dosing Period 2: 19-Week Treatment|Death|0
4768596|NCT01147666|7743722|FG011|Dosing Period 2: 19-Week Treatment|Death|0
4768597|NCT01147666|7743723|FG012|Dosing Period 2: 19-Week Treatment|Death|1
4768598|NCT01147666|7743724|FG013|Dosing Period 2: 19-Week Treatment|Death|0
4768599|NCT01147666|7743725|FG014|Dosing Period 2: 19-Week Treatment|Death|0
4768600|NCT01147666|7743711|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0
4768601|NCT01147666|7743712|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0
4768602|NCT01147666|7743713|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0
4768603|NCT01147666|7743714|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0
4768604|NCT01147666|7743715|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3
4768605|NCT01147666|7743716|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1
4768606|NCT01147666|7743717|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2
4768607|NCT01147666|7743718|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2
4768608|NCT01147666|7743719|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0
4768609|NCT01147666|7743720|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1
4768610|NCT01147666|7743721|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0
4768611|NCT01147666|7743722|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0
4768612|NCT01147666|7743723|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1
4768613|NCT01147666|7743724|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0
4768614|NCT01147666|7743725|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2
4768615|NCT01147666|7743711|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
4768616|NCT01147666|7743712|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
4768617|NCT01147666|7743713|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
4768618|NCT01147666|7743714|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1
4768619|NCT01147666|7743715|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
4768620|NCT01147666|7743716|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
4768621|NCT01147666|7743717|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
4768622|NCT01147666|7743718|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
4768623|NCT01147666|7743719|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
4768624|NCT01147666|7743720|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
4768625|NCT01147666|7743721|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
4768626|NCT01147666|7743722|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
4768627|NCT01147666|7743723|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
4768628|NCT01147666|7743724|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
4768629|NCT01147666|7743725|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0
4768630|NCT01147666|7743711|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
4768631|NCT01147666|7743712|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
4768632|NCT01147666|7743713|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
4768633|NCT01147666|7743714|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
4768634|NCT01147666|7743715|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1
4768635|NCT01147666|7743716|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1
4768636|NCT01147666|7743717|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
4768637|NCT01147666|7743718|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1
4768638|NCT01147666|7743719|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
4768639|NCT01147666|7743720|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1
4768640|NCT01147666|7743721|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
4768641|NCT01147666|7743722|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
4768642|NCT01147666|7743723|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
4768643|NCT01147666|7743724|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1
4768644|NCT01147666|7743725|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0
4768645|NCT01147666|7743711|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0
4768646|NCT01147666|7743712|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0
4768647|NCT01147666|7743713|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0
4768648|NCT01147666|7743714|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1
4768649|NCT01147666|7743715|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0
4768650|NCT01147666|7743716|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0
4768651|NCT01147666|7743717|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0
4768652|NCT01147666|7743718|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0
4768653|NCT01147666|7743719|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0
4768654|NCT01147666|7743720|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0
4768655|NCT01147666|7743721|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2
4768656|NCT01147666|7743722|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0
4768657|NCT01147666|7743723|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0
4768658|NCT01147666|7743724|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0
4768659|NCT01147666|7743725|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0
4768660|NCT01147666|7743711|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0
4768661|NCT01147666|7743712|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0
4768662|NCT01147666|7743713|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0
4768663|NCT01147666|7743714|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0
4768664|NCT01147666|7743715|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0
4768665|NCT01147666|7743716|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0
4768666|NCT01147666|7743717|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0
4768667|NCT01147666|7743718|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0
4768668|NCT01147666|7743719|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0
4768669|NCT01147666|7743720|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0
4768670|NCT01147666|7743721|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0
4768671|NCT01147666|7743722|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0
4768672|NCT01147666|7743723|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1
4768673|NCT01147666|7743724|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0
4768674|NCT01147666|7743725|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0
4768675|NCT01147666|7743711|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
4768676|NCT01147666|7743712|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
4768677|NCT01147666|7743713|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
4768678|NCT01147666|7743714|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
4768679|NCT01147666|7743715|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
4768680|NCT01147666|7743716|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
4768681|NCT01147666|7743717|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
4768682|NCT01147666|7743718|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
4768683|NCT01147666|7743719|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
4768684|NCT01147666|7743720|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
4768685|NCT01147666|7743721|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
4768686|NCT01147666|7743722|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
4768687|NCT01147666|7743723|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1
4768688|NCT01147666|7743724|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0
4768689|NCT01147666|7743725|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1
4768690|NCT00982111|7743789|FG000|Overall Study|Adverse Event|1
4768691|NCT00982111|7743790|FG001|Overall Study|Adverse Event|1
4768692|NCT00982111|7743789|FG000|Overall Study|Progressive Disease|46
4768693|NCT00982111|7743790|FG001|Overall Study|Progressive Disease|39
4768694|NCT00982111|7743789|FG000|Overall Study|Lost to Follow-up|9
4768695|NCT00982111|7743790|FG001|Overall Study|Lost to Follow-up|6
4768696|NCT00982111|7743789|FG000|Overall Study|New Anti-Cancer Therapy|5
4768697|NCT00982111|7743790|FG001|Overall Study|New Anti-Cancer Therapy|5
4768698|NCT00982111|7743789|FG000|Overall Study|Medical Decision|1
4768699|NCT00982111|7743790|FG001|Overall Study|Medical Decision|0
4768700|NCT00982111|7743789|FG000|Overall Study|Withdrawal by Subject|17
4768701|NCT00982111|7743790|FG001|Overall Study|Withdrawal by Subject|19
4768702|NCT00982111|7743789|FG000|Overall Study|Global Study End|0
4768703|NCT00982111|7743790|FG001|Overall Study|Global Study End|1
4768704|NCT00982111|7743789|FG000|Overall Study|Sponsor's Decision|0
4768705|NCT00982111|7743790|FG001|Overall Study|Sponsor's Decision|1
4768706|NCT00116142|7743804|FG000|Overall Study|Adverse Event|8
4768707|NCT00116142|7743805|FG001|Overall Study|Adverse Event|7
4768708|NCT00116142|7743804|FG000|Overall Study|Protocol Violation|2
4768709|NCT00116142|7743805|FG001|Overall Study|Protocol Violation|1
4768710|NCT00116142|7743804|FG000|Overall Study|Withdrawal by Subject|5
4768711|NCT00116142|7743805|FG001|Overall Study|Withdrawal by Subject|5
4768712|NCT00116142|7743804|FG000|Overall Study|Physician Decision|3
4768713|NCT00116142|7743805|FG001|Overall Study|Physician Decision|1
4768714|NCT00116142|7743804|FG000|Overall Study|Delayed Radiation Therapy|1
4768715|NCT00116142|7743805|FG001|Overall Study|Delayed Radiation Therapy|0
4768716|NCT00116142|7743804|FG000|Overall Study|Patient could not tolerate docetaxel|0
4768717|NCT00116142|7743805|FG001|Overall Study|Patient could not tolerate docetaxel|2
4768718|NCT00116142|7743804|FG000|Overall Study|Patient stopped due to depression|0
4768719|NCT00116142|7743805|FG001|Overall Study|Patient stopped due to depression|1
4768720|NCT00116142|7743804|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0
4768721|NCT00116142|7743805|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1
4768722|NCT00116142|7743804|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0
4768723|NCT00116142|7743805|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1
4768724|NCT00116142|7743804|FG000|Overall Study|Patient didn't start due to low platelet counts|0
4768725|NCT00116142|7743805|FG001|Overall Study|Patient didn't start due to low platelet counts|1
4768726|NCT00070018|7743814|FG000|Overall Study|Adverse Event|2
4768727|NCT00070018|7743814|FG000|Overall Study|Lack of Efficacy|1
4768728|NCT00070018|7743814|FG000|Overall Study|Withdrawal by Subject|1
4768729|NCT04447287|7743827|FG000|Period 1: Run-in Period|Adverse Event|3
4768730|NCT04447287|7743828|FG001|Period 1: Run-in Period|Adverse Event|0
4768731|NCT04447287|7743829|FG002|Period 1: Run-in Period|Adverse Event|0
4768732|NCT04447287|7743827|FG000|Period 1: Run-in Period|Withdrawal by Subject|1
4768733|NCT04447287|7743828|FG001|Period 1: Run-in Period|Withdrawal by Subject|0
4768734|NCT04447287|7743829|FG002|Period 1: Run-in Period|Withdrawal by Subject|0
4768735|NCT04447287|7743827|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1
4768736|NCT04447287|7743828|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0
4768737|NCT04447287|7743829|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0
4768738|NCT04039503|7743885|FG000|Overall Study|Adverse Event|3
4768739|NCT04039503|7743886|FG001|Overall Study|Adverse Event|0
4768740|NCT04039503|7743887|FG002|Overall Study|Adverse Event|2
4768741|NCT04039503|7743888|FG003|Overall Study|Adverse Event|0
4768742|NCT04039503|7743885|FG000|Overall Study|Lost to Follow-up|0
4768743|NCT04039503|7743886|FG001|Overall Study|Lost to Follow-up|0
4768744|NCT04039503|7743887|FG002|Overall Study|Lost to Follow-up|1
4768745|NCT04039503|7743888|FG003|Overall Study|Lost to Follow-up|0
4768746|NCT04039503|7743885|FG000|Overall Study|Protocol Violation|0
4768747|NCT04039503|7743886|FG001|Overall Study|Protocol Violation|1
4768748|NCT04039503|7743887|FG002|Overall Study|Protocol Violation|2
4768749|NCT04039503|7743888|FG003|Overall Study|Protocol Violation|1
4768750|NCT04039503|7743885|FG000|Overall Study|Withdrawal by Subject|4
4768751|NCT04039503|7743886|FG001|Overall Study|Withdrawal by Subject|3
4768752|NCT04039503|7743887|FG002|Overall Study|Withdrawal by Subject|5
4768753|NCT04039503|7743888|FG003|Overall Study|Withdrawal by Subject|2
4768754|NCT03695172|7743906|FG000|Overall Study|Withdrawal by Subject|1
4768755|NCT03695172|7743907|FG001|Overall Study|Withdrawal by Subject|1
4768756|NCT03695172|7743908|FG002|Overall Study|Withdrawal by Subject|0
4768757|NCT03394027|7743936|FG000|Overall Study|Ineligible|3
4768758|NCT03394027|7743937|FG001|Overall Study|Ineligible|1
4768759|NCT03394027|7743938|FG002|Overall Study|Ineligible|3
4768760|NCT03394027|7743936|FG000|Overall Study|Participant declined to participate before treatment started|0
4768761|NCT03394027|7743937|FG001|Overall Study|Participant declined to participate before treatment started|0
4768762|NCT03394027|7743938|FG002|Overall Study|Participant declined to participate before treatment started|1
4768763|NCT03357952|7743966|FG000|Overall Study|Withdrawal by Subject|0
4768764|NCT03357952|7743967|FG001|Overall Study|Withdrawal by Subject|1
4768765|NCT03357952|7743966|FG000|Overall Study|Sponsor Decision|9
4768766|NCT03357952|7743967|FG001|Overall Study|Sponsor Decision|0
4768767|NCT03170869|7743982|FG000|Overall Study|Protocol Violation|5
4768768|NCT03170869|7743982|FG000|Overall Study|Early study termination|3
4768769|NCT03066622|7743989|FG000|Overall Study|Lost to Follow-up|24
4768770|NCT03066622|7743990|FG001|Overall Study|Lost to Follow-up|25
4768771|NCT03066622|7743989|FG000|Overall Study|Withdrawal by Subject|2
4768772|NCT03066622|7743990|FG001|Overall Study|Withdrawal by Subject|1
4768773|NCT03052920|7743996|FG000|Overall Study|Withdrawal by Subject|1
4768774|NCT03016312|7744015|FG000|Overall Study|Death|194
4768775|NCT03016312|7744016|FG001|Overall Study|Death|164
4768776|NCT03016312|7744015|FG000|Overall Study|Lost to Follow-up|11
4768777|NCT03016312|7744016|FG001|Overall Study|Lost to Follow-up|12
4768778|NCT03016312|7744015|FG000|Overall Study|Started new therapy, loss of contact|2
4768779|NCT03016312|7744016|FG001|Overall Study|Started new therapy, loss of contact|1
4768780|NCT03016312|7744015|FG000|Overall Study|Physician Decision|0
4768781|NCT03016312|7744016|FG001|Overall Study|Physician Decision|2
4768782|NCT03016312|7744015|FG000|Overall Study|Withdrawal by Subject|34
4768783|NCT03016312|7744016|FG001|Overall Study|Withdrawal by Subject|39
4768784|NCT02722434|7744034|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1
4768785|NCT02722434|7744035|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0
4768786|NCT02722434|7744034|FG000|Overall Study|Withdrawal After Beginning Treatment|0
4768787|NCT02722434|7744035|FG001|Overall Study|Withdrawal After Beginning Treatment|3
4768788|NCT02604511|7744045|FG000|Overall Study|Adverse Event|3
4768789|NCT02604511|7744045|FG000|Overall Study|Disease Progression|4
4768790|NCT02604511|7744045|FG000|Overall Study|Withdrawal by Subject|3
4768791|NCT02604511|7744045|FG000|Overall Study|Participant ineligible|1
4768792|NCT02604511|7744045|FG000|Overall Study|Intercurrent illness|1
4768793|NCT01963728|7744087|FG000|Overall Study|Study terminated early|0
4768794|NCT01963728|7744088|FG001|Overall Study|Study terminated early|1
4768795|NCT01248247|7744098|FG000|Overall Study|Adverse Event|2
4768796|NCT01248247|7744099|FG001|Overall Study|Adverse Event|4
4768797|NCT01248247|7744100|FG002|Overall Study|Adverse Event|4
4768798|NCT01248247|7744101|FG003|Overall Study|Adverse Event|2
4768799|NCT01248247|7744098|FG000|Overall Study|Death|0
4768800|NCT01248247|7744099|FG001|Overall Study|Death|1
4768801|NCT01248247|7744100|FG002|Overall Study|Death|4
4768802|NCT01248247|7744101|FG003|Overall Study|Death|7
4768803|NCT01248247|7744098|FG000|Overall Study|Lost to Follow-up|0
4768804|NCT01248247|7744099|FG001|Overall Study|Lost to Follow-up|1
4768805|NCT01248247|7744100|FG002|Overall Study|Lost to Follow-up|1
4768806|NCT01248247|7744101|FG003|Overall Study|Lost to Follow-up|0
4768807|NCT01248247|7744098|FG000|Overall Study|Alternative treatment|0
4768808|NCT01248247|7744099|FG001|Overall Study|Alternative treatment|1
4768809|NCT01248247|7744100|FG002|Overall Study|Alternative treatment|0
4768810|NCT01248247|7744101|FG003|Overall Study|Alternative treatment|0
4768811|NCT01248247|7744098|FG000|Overall Study|Other|2
4768812|NCT01248247|7744099|FG001|Overall Study|Other|8
4768813|NCT01248247|7744100|FG002|Overall Study|Other|8
4768814|NCT01248247|7744101|FG003|Overall Study|Other|5
4768815|NCT01248247|7744098|FG000|Overall Study|Progression|18
4768816|NCT01248247|7744099|FG001|Overall Study|Progression|27
4768817|NCT01248247|7744100|FG002|Overall Study|Progression|56
4768818|NCT01248247|7744101|FG003|Overall Study|Progression|44
4768819|NCT01248247|7744098|FG000|Overall Study|Refuse further treatment|0
4768820|NCT01248247|7744099|FG001|Overall Study|Refuse further treatment|0
4768821|NCT01248247|7744100|FG002|Overall Study|Refuse further treatment|1
4768822|NCT01248247|7744101|FG003|Overall Study|Refuse further treatment|2
4768823|NCT01248247|7744098|FG000|Overall Study|Complicating disease|0
4768824|NCT01248247|7744099|FG001|Overall Study|Complicating disease|0
4768825|NCT01248247|7744100|FG002|Overall Study|Complicating disease|1
4768826|NCT01248247|7744101|FG003|Overall Study|Complicating disease|1
4768827|NCT01164228|7744113|FG000|Overall Study|Progression|24
4768828|NCT01164228|7744114|FG001|Overall Study|Progression|25
4768829|NCT01164228|7744113|FG000|Overall Study|Adverse Event|13
4768830|NCT01164228|7744114|FG001|Overall Study|Adverse Event|7
4768831|NCT01164228|7744113|FG000|Overall Study|Death|1
4768832|NCT01164228|7744114|FG001|Overall Study|Death|1
4768833|NCT01164228|7744113|FG000|Overall Study|Withdrawal by Subject|2
4768834|NCT01164228|7744114|FG001|Overall Study|Withdrawal by Subject|0
4768835|NCT01164228|7744113|FG000|Overall Study|Physician Decision|1
4768836|NCT01164228|7744114|FG001|Overall Study|Physician Decision|2
4768837|NCT01164228|7744113|FG000|Overall Study|Symptomatic deterioration|1
4768838|NCT01164228|7744114|FG001|Overall Study|Symptomatic deterioration|0
4768839|NCT01164228|7744113|FG000|Overall Study|Never started treatment|1
4768840|NCT01164228|7744114|FG001|Overall Study|Never started treatment|3
4768841|NCT01164228|7744113|FG000|Overall Study|Ineligible|1
4768842|NCT01164228|7744114|FG001|Overall Study|Ineligible|0
4768843|NCT00591318|7744181|FG000|Overall Study|Lack of Efficacy|2
4768844|NCT00591318|7744182|FG001|Overall Study|Lack of Efficacy|0
4768845|NCT00591318|7744181|FG000|Overall Study|Adverse Event|2
4768846|NCT00591318|7744182|FG001|Overall Study|Adverse Event|0
4768847|NCT04534517|7744203|FG000|Overall Study|Adverse Event|1
4768848|NCT04534517|7744203|FG000|Overall Study|Withdrawal by Subject|1
4768849|NCT04534517|7744203|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1
4768850|NCT04534517|7744203|FG000|Overall Study|COVID-19 Related|1
4768851|NCT04494646|7744209|FG000|Overall Study|Adverse Event|0
4768852|NCT04494646|7744210|FG001|Overall Study|Adverse Event|1
4768853|NCT04494646|7744209|FG000|Overall Study|Withdrawal by Subject|0
4768854|NCT04494646|7744210|FG001|Overall Study|Withdrawal by Subject|1
4768889|NCT03158688|7744291|FG000|Overall Study|Continuing in study|107
4768890|NCT03158688|7744292|FG001|Overall Study|Continuing in study|233
4768891|NCT03158688|7744291|FG000|Overall Study|Death|36
4768892|NCT03158688|7744292|FG001|Overall Study|Death|59
4768893|NCT03158688|7744291|FG000|Overall Study|Withdrawal by Subject|9
4768894|NCT03158688|7744292|FG001|Overall Study|Withdrawal by Subject|14
4768895|NCT03158688|7744291|FG000|Overall Study|Decision by sponsor|2
4768896|NCT03158688|7744292|FG001|Overall Study|Decision by sponsor|3
4768897|NCT03158688|7744291|FG000|Overall Study|Lost to Follow-up|0
4768898|NCT03158688|7744292|FG001|Overall Study|Lost to Follow-up|3
4768899|NCT03103321|7744302|FG000|Overall Study|Protocol Violation|1
4768900|NCT03103321|7744303|FG001|Overall Study|Protocol Violation|1
4768901|NCT03103321|7744304|FG002|Overall Study|Protocol Violation|1
4768902|NCT03103321|7744305|FG003|Overall Study|Protocol Violation|0
4768903|NCT03079869|7744317|FG000|Overall Study|Adverse Event|6
4768904|NCT03079869|7744318|FG001|Overall Study|Adverse Event|8
4768905|NCT03079869|7744317|FG000|Overall Study|Withdrawal by Subject|4
4768906|NCT03079869|7744318|FG001|Overall Study|Withdrawal by Subject|1
4768907|NCT03079869|7744317|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3
4768908|NCT03079869|7744318|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2
4768909|NCT03033875|7744327|FG000|Overall Study|Withdrawal by Subject|5
4768910|NCT03033875|7744328|FG001|Overall Study|Withdrawal by Subject|9
4768911|NCT03033875|7744329|FG002|Overall Study|Withdrawal by Subject|4
4768912|NCT03033875|7744327|FG000|Overall Study|Other|14
4768913|NCT03033875|7744328|FG001|Overall Study|Other|15
4768914|NCT03033875|7744329|FG002|Overall Study|Other|8
4768915|NCT02887248|7744341|FG000|Overall Study|Withdrawal by Subject|1
4768916|NCT02887248|7744341|FG000|Overall Study|Adverse Event|1
4768917|NCT02887248|7744341|FG000|Overall Study|Progressive Disease|1
4768918|NCT02849990|7744345|FG000|Overall Study|Adverse Event|1
4768919|NCT02849990|7744345|FG000|Overall Study|Withdrawal by Subject|1
4768920|NCT02467270|7744378|FG000|Overall Study|Participants Never Treated|0
4768921|NCT02467270|7744379|FG001|Overall Study|Participants Never Treated|1
4768922|NCT02467270|7744380|FG002|Overall Study|Participants Never Treated|0
4768923|NCT02467270|7744378|FG000|Overall Study|Ongoing|50
4768924|NCT02467270|7744379|FG001|Overall Study|Ongoing|41
4768925|NCT02467270|7744380|FG002|Overall Study|Ongoing|43
4768926|NCT02467270|7744378|FG000|Overall Study|Adverse Event|16
4768927|NCT02467270|7744379|FG001|Overall Study|Adverse Event|15
4768928|NCT02467270|7744380|FG002|Overall Study|Adverse Event|14
4768929|NCT02467270|7744378|FG000|Overall Study|Progressive Disease|7
4768930|NCT02467270|7744379|FG001|Overall Study|Progressive Disease|7
4768931|NCT02467270|7744380|FG002|Overall Study|Progressive Disease|4
4768932|NCT02467270|7744378|FG000|Overall Study|Death|2
4768933|NCT02467270|7744379|FG001|Overall Study|Death|0
4768934|NCT02467270|7744380|FG002|Overall Study|Death|2
4768935|NCT02467270|7744378|FG000|Overall Study|Lack of Efficacy|12
4768936|NCT02467270|7744379|FG001|Overall Study|Lack of Efficacy|18
4768937|NCT02467270|7744380|FG002|Overall Study|Lack of Efficacy|23
4768938|NCT02467270|7744378|FG000|Overall Study|Non-compliance With Study Drug|0
4768939|NCT02467270|7744379|FG001|Overall Study|Non-compliance With Study Drug|2
4768940|NCT02467270|7744380|FG002|Overall Study|Non-compliance With Study Drug|1
4768941|NCT02467270|7744378|FG000|Overall Study|Lost to Follow-up|2
4768942|NCT02467270|7744379|FG001|Overall Study|Lost to Follow-up|1
4768943|NCT02467270|7744380|FG002|Overall Study|Lost to Follow-up|0
4768944|NCT02467270|7744378|FG000|Overall Study|Pregnancy|0
4768945|NCT02467270|7744379|FG001|Overall Study|Pregnancy|1
4768946|NCT02467270|7744380|FG002|Overall Study|Pregnancy|0
4768947|NCT02467270|7744378|FG000|Overall Study|Physician Decision|0
4768948|NCT02467270|7744379|FG001|Overall Study|Physician Decision|4
4768949|NCT02467270|7744380|FG002|Overall Study|Physician Decision|1
4768950|NCT02467270|7744378|FG000|Overall Study|Withdrawal by Subject|4
4768951|NCT02467270|7744379|FG001|Overall Study|Withdrawal by Subject|3
4768952|NCT02467270|7744380|FG002|Overall Study|Withdrawal by Subject|5
4768953|NCT02467270|7744378|FG000|Overall Study|Reason not Specified|1
4768954|NCT02467270|7744379|FG001|Overall Study|Reason not Specified|2
4768955|NCT02467270|7744380|FG002|Overall Study|Reason not Specified|1
4768956|NCT02452554|7744394|FG000|Overall Study|Death|2
4768957|NCT02452554|7744395|FG001|Overall Study|Death|1
4768958|NCT02452554|7744396|FG002|Overall Study|Death|0
4768959|NCT02452554|7744397|FG003|Overall Study|Death|0
4768960|NCT02452554|7744398|FG004|Overall Study|Death|0
4768961|NCT02452554|7744399|FG005|Overall Study|Death|0
4768962|NCT02452554|7744394|FG000|Overall Study|Lack of Efficacy|13
4768963|NCT02452554|7744395|FG001|Overall Study|Lack of Efficacy|14
4768964|NCT02452554|7744396|FG002|Overall Study|Lack of Efficacy|9
4768965|NCT02452554|7744397|FG003|Overall Study|Lack of Efficacy|1
4768966|NCT02452554|7744398|FG004|Overall Study|Lack of Efficacy|5
4768967|NCT02452554|7744399|FG005|Overall Study|Lack of Efficacy|8
4768855|NCT04258020|7744218|FG000|Overall Study|Withdrawal by Subject|1
4768856|NCT04258020|7744219|FG001|Overall Study|Withdrawal by Subject|0
4768857|NCT04234464|7744227|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1
4768858|NCT04234464|7744228|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0
4768859|NCT03852316|7744234|FG000|Overall Study|Protocol Violation|1
4768860|NCT03852316|7744234|FG000|Overall Study|Withdrawal by Subject|2
4768861|NCT03852316|7744234|FG000|Overall Study|Enrolled but Device not Utilized|1
4768862|NCT03789318|7744243|FG000|Overall Study|Adverse Event|0
4768863|NCT03789318|7744244|FG001|Overall Study|Adverse Event|0
4768864|NCT03789318|7744245|FG002|Overall Study|Adverse Event|1
4768865|NCT03789318|7744246|FG003|Overall Study|Adverse Event|1
4768866|NCT03789318|7744247|FG004|Overall Study|Adverse Event|0
4768867|NCT03789318|7744243|FG000|Overall Study|Lost to Follow-up|0
4768868|NCT03789318|7744244|FG001|Overall Study|Lost to Follow-up|0
4768869|NCT03789318|7744245|FG002|Overall Study|Lost to Follow-up|1
4768870|NCT03789318|7744246|FG003|Overall Study|Lost to Follow-up|0
4768871|NCT03789318|7744247|FG004|Overall Study|Lost to Follow-up|0
4768872|NCT03789318|7744243|FG000|Overall Study|Withdrawal by Subject|0
4768873|NCT03789318|7744244|FG001|Overall Study|Withdrawal by Subject|0
4768874|NCT03789318|7744245|FG002|Overall Study|Withdrawal by Subject|1
4768875|NCT03789318|7744246|FG003|Overall Study|Withdrawal by Subject|0
4768876|NCT03789318|7744247|FG004|Overall Study|Withdrawal by Subject|0
4768877|NCT03774875|7744261|FG000|Overall Study|Adverse Event|8
4768878|NCT03774875|7744262|FG001|Overall Study|Adverse Event|16
4768879|NCT03774875|7744261|FG000|Overall Study|Lack of Efficacy|2
4768880|NCT03774875|7744262|FG001|Overall Study|Lack of Efficacy|4
4768881|NCT03774875|7744261|FG000|Overall Study|Withdrawal by Subject|12
4768882|NCT03774875|7744262|FG001|Overall Study|Withdrawal by Subject|10
4768883|NCT03774875|7744261|FG000|Overall Study|Lost to Follow-up|0
4768884|NCT03774875|7744262|FG001|Overall Study|Lost to Follow-up|2
4768885|NCT03774875|7744261|FG000|Overall Study|Protocol Deviation|0
4768886|NCT03774875|7744262|FG001|Overall Study|Protocol Deviation|1
4768887|NCT03774875|7744261|FG000|Overall Study|Reason Unknown|1
4768888|NCT03774875|7744262|FG001|Overall Study|Reason Unknown|0
4768968|NCT02452554|7744394|FG000|Overall Study|Physician Decision|0
4768969|NCT02452554|7744395|FG001|Overall Study|Physician Decision|1
4768970|NCT02452554|7744396|FG002|Overall Study|Physician Decision|0
4768971|NCT02452554|7744397|FG003|Overall Study|Physician Decision|0
4768972|NCT02452554|7744398|FG004|Overall Study|Physician Decision|0
4768973|NCT02452554|7744399|FG005|Overall Study|Physician Decision|0
4768974|NCT02452554|7744394|FG000|Overall Study|Withdrawal by Subject|1
4768975|NCT02452554|7744395|FG001|Overall Study|Withdrawal by Subject|0
4768976|NCT02452554|7744396|FG002|Overall Study|Withdrawal by Subject|2
4768977|NCT02452554|7744397|FG003|Overall Study|Withdrawal by Subject|0
4768978|NCT02452554|7744398|FG004|Overall Study|Withdrawal by Subject|0
4768979|NCT02452554|7744399|FG005|Overall Study|Withdrawal by Subject|1
4768980|NCT02452554|7744394|FG000|Overall Study|Ineligible|0
4768981|NCT02452554|7744395|FG001|Overall Study|Ineligible|1
4768982|NCT02452554|7744396|FG002|Overall Study|Ineligible|0
4768983|NCT02452554|7744397|FG003|Overall Study|Ineligible|0
4768984|NCT02452554|7744398|FG004|Overall Study|Ineligible|0
4768985|NCT02452554|7744399|FG005|Overall Study|Ineligible|0
4768986|NCT02452554|7744394|FG000|Overall Study|Never Received Treatment|1
4768987|NCT02452554|7744395|FG001|Overall Study|Never Received Treatment|0
4768988|NCT02452554|7744396|FG002|Overall Study|Never Received Treatment|0
4768989|NCT02452554|7744397|FG003|Overall Study|Never Received Treatment|0
4768990|NCT02452554|7744398|FG004|Overall Study|Never Received Treatment|0
4768991|NCT02452554|7744399|FG005|Overall Study|Never Received Treatment|0
4768992|NCT02318277|7744435|FG000|Overall Study|Physician Decision|0
4768993|NCT02318277|7744436|FG001|Overall Study|Physician Decision|0
4768994|NCT02318277|7744437|FG002|Overall Study|Physician Decision|0
4768995|NCT02318277|7744438|FG003|Overall Study|Physician Decision|0
4768996|NCT02318277|7744439|FG004|Overall Study|Physician Decision|0
4768997|NCT02318277|7744440|FG005|Overall Study|Physician Decision|0
4768998|NCT02318277|7744441|FG006|Overall Study|Physician Decision|0
4768999|NCT02318277|7744442|FG007|Overall Study|Physician Decision|1
4769000|NCT02318277|7744435|FG000|Overall Study|Other|0
4769001|NCT02318277|7744436|FG001|Overall Study|Other|0
4769002|NCT02318277|7744437|FG002|Overall Study|Other|0
4769003|NCT02318277|7744438|FG003|Overall Study|Other|0
4769004|NCT02318277|7744439|FG004|Overall Study|Other|0
4769005|NCT02318277|7744440|FG005|Overall Study|Other|0
4769006|NCT02318277|7744441|FG006|Overall Study|Other|1
4769007|NCT02318277|7744442|FG007|Overall Study|Other|0
4769008|NCT02318277|7744435|FG000|Overall Study|Withdrawal by Subject|0
4769009|NCT02318277|7744436|FG001|Overall Study|Withdrawal by Subject|0
4769010|NCT02318277|7744437|FG002|Overall Study|Withdrawal by Subject|1
4769011|NCT02318277|7744438|FG003|Overall Study|Withdrawal by Subject|0
4769012|NCT02318277|7744439|FG004|Overall Study|Withdrawal by Subject|1
4769013|NCT02318277|7744440|FG005|Overall Study|Withdrawal by Subject|1
4769014|NCT02318277|7744441|FG006|Overall Study|Withdrawal by Subject|6
4769015|NCT02318277|7744442|FG007|Overall Study|Withdrawal by Subject|14
4769016|NCT02318277|7744435|FG000|Overall Study|Participant trial terminated by sponsor|0
4769017|NCT02318277|7744436|FG001|Overall Study|Participant trial terminated by sponsor|0
4769018|NCT02318277|7744437|FG002|Overall Study|Participant trial terminated by sponsor|1
4769019|NCT02318277|7744438|FG003|Overall Study|Participant trial terminated by sponsor|0
4769020|NCT02318277|7744439|FG004|Overall Study|Participant trial terminated by sponsor|1
4769021|NCT02318277|7744440|FG005|Overall Study|Participant trial terminated by sponsor|2
4769022|NCT02318277|7744441|FG006|Overall Study|Participant trial terminated by sponsor|5
4769023|NCT02318277|7744442|FG007|Overall Study|Participant trial terminated by sponsor|16
4769024|NCT02318277|7744435|FG000|Overall Study|Lost to Follow-up|1
4769025|NCT02318277|7744436|FG001|Overall Study|Lost to Follow-up|0
4769026|NCT02318277|7744437|FG002|Overall Study|Lost to Follow-up|1
4769027|NCT02318277|7744438|FG003|Overall Study|Lost to Follow-up|0
4769028|NCT02318277|7744439|FG004|Overall Study|Lost to Follow-up|0
4769029|NCT02318277|7744440|FG005|Overall Study|Lost to Follow-up|0
4769030|NCT02318277|7744441|FG006|Overall Study|Lost to Follow-up|3
4769031|NCT02318277|7744442|FG007|Overall Study|Lost to Follow-up|4
4769032|NCT02318277|7744435|FG000|Overall Study|Death|5
4769033|NCT02318277|7744436|FG001|Overall Study|Death|3
4769034|NCT02318277|7744437|FG002|Overall Study|Death|1
4769035|NCT02318277|7744438|FG003|Overall Study|Death|4
4769036|NCT02318277|7744439|FG004|Overall Study|Death|6
4769037|NCT02318277|7744440|FG005|Overall Study|Death|5
4769038|NCT02318277|7744441|FG006|Overall Study|Death|34
4769039|NCT02318277|7744442|FG007|Overall Study|Death|58
4769040|NCT02318277|7744435|FG000|Overall Study|Transitioned to Hospice|0
4769041|NCT02318277|7744436|FG001|Overall Study|Transitioned to Hospice|0
4769042|NCT02318277|7744437|FG002|Overall Study|Transitioned to Hospice|0
4769043|NCT02318277|7744438|FG003|Overall Study|Transitioned to Hospice|0
4769044|NCT02318277|7744439|FG004|Overall Study|Transitioned to Hospice|0
4769045|NCT02318277|7744440|FG005|Overall Study|Transitioned to Hospice|1
4769046|NCT02318277|7744441|FG006|Overall Study|Transitioned to Hospice|0
4769047|NCT02318277|7744442|FG007|Overall Study|Transitioned to Hospice|0
4769048|NCT02143063|7744498|FG000|Overall Study|Lost to Follow-up|16
4769049|NCT02143063|7744499|FG001|Overall Study|Lost to Follow-up|28
4769050|NCT02143063|7744500|FG002|Overall Study|Lost to Follow-up|29
4769051|NCT02143063|7744498|FG000|Overall Study|Withdrawal by Subject|0
4769052|NCT02143063|7744499|FG001|Overall Study|Withdrawal by Subject|1
4769053|NCT02143063|7744500|FG002|Overall Study|Withdrawal by Subject|0
4769054|NCT02143063|7744498|FG000|Overall Study|Death|0
4769055|NCT02143063|7744499|FG001|Overall Study|Death|1
4769056|NCT02143063|7744500|FG002|Overall Study|Death|1
4769057|NCT02017964|7744508|FG000|Overall Study|Patient deemed ineligible|1
4769058|NCT01968785|7744514|FG000|Overall Study|Withdrawal by Subject|1
4769059|NCT01968785|7744515|FG001|Overall Study|Withdrawal by Subject|0
4769060|NCT01956110|7744523|FG000|Overall Study|Protocol Violation|25
4769061|NCT01956110|7744524|FG001|Overall Study|Protocol Violation|11
4769062|NCT01956110|7744523|FG000|Overall Study|Adverse Event|9
4769063|NCT01956110|7744524|FG001|Overall Study|Adverse Event|10
4769064|NCT01956110|7744523|FG000|Overall Study|Personal reasons|1
4769065|NCT01956110|7744524|FG001|Overall Study|Personal reasons|1
4769066|NCT01648023|7744533|FG000|Overall Study|Screen Fail Post Randomization|1
4769067|NCT01648023|7744534|FG001|Overall Study|Screen Fail Post Randomization|2
4769068|NCT01083433|7744557|FG000|Overall Study|Lost to Follow-up|2
4769069|NCT01083433|7744558|FG001|Overall Study|Lost to Follow-up|1
4769070|NCT01083433|7744559|FG002|Overall Study|Lost to Follow-up|1
4769071|NCT01083433|7744557|FG000|Overall Study|Withdrawal by Subject|0
4769072|NCT01083433|7744558|FG001|Overall Study|Withdrawal by Subject|5
4769073|NCT01083433|7744559|FG002|Overall Study|Withdrawal by Subject|3
4769074|NCT01083433|7744557|FG000|Overall Study|Pregnancy|0
4769075|NCT01083433|7744558|FG001|Overall Study|Pregnancy|0
4769076|NCT01083433|7744559|FG002|Overall Study|Pregnancy|1
4769077|NCT00787176|7744575|FG000|Overall Study|Low quality fetal heart rate tracing|7
4769078|NCT00787176|7744576|FG001|Overall Study|Low quality fetal heart rate tracing|3
4769079|NCT00787176|7744577|FG002|Overall Study|Low quality fetal heart rate tracing|6
4769080|NCT00787176|7744578|FG003|Overall Study|Low quality fetal heart rate tracing|5
4769081|NCT00352534|7744591|FG000|Initial Staging|Ineligible|8
4769082|NCT00352534|7744592|FG001|Initial Staging|Ineligible|9
4769083|NCT00352534|7744593|FG002|Initial Staging|Ineligible|0
4769084|NCT00352534|7744594|FG003|Initial Staging|Ineligible|0
4769085|NCT00352534|7744595|FG004|Initial Staging|Ineligible|0
4769086|NCT00352534|7744596|FG005|Initial Staging|Ineligible|0
4769087|NCT00352534|7744597|FG006|Initial Staging|Ineligible|0
4769088|NCT00352534|7744591|FG000|Final Risk Group Assignment|Lack of Efficacy|0
4769089|NCT00352534|7744592|FG001|Final Risk Group Assignment|Lack of Efficacy|0
4769090|NCT00352534|7744593|FG002|Final Risk Group Assignment|Lack of Efficacy|0
4769091|NCT00352534|7744594|FG003|Final Risk Group Assignment|Lack of Efficacy|2
4769092|NCT00352534|7744595|FG004|Final Risk Group Assignment|Lack of Efficacy|1
4769093|NCT00352534|7744596|FG005|Final Risk Group Assignment|Lack of Efficacy|19
4769094|NCT00352534|7744597|FG006|Final Risk Group Assignment|Lack of Efficacy|0
4769095|NCT00352534|7744591|FG000|Final Risk Group Assignment|Physician Decision|0
4769096|NCT00352534|7744592|FG001|Final Risk Group Assignment|Physician Decision|0
4769097|NCT00352534|7744593|FG002|Final Risk Group Assignment|Physician Decision|0
4769098|NCT00352534|7744594|FG003|Final Risk Group Assignment|Physician Decision|0
4769099|NCT00352534|7744595|FG004|Final Risk Group Assignment|Physician Decision|0
4769100|NCT00352534|7744596|FG005|Final Risk Group Assignment|Physician Decision|8
4769101|NCT00352534|7744597|FG006|Final Risk Group Assignment|Physician Decision|0
4769102|NCT00352534|7744591|FG000|Final Risk Group Assignment|Withdrawal by Subject|0
4769103|NCT00352534|7744592|FG001|Final Risk Group Assignment|Withdrawal by Subject|0
4769104|NCT00352534|7744593|FG002|Final Risk Group Assignment|Withdrawal by Subject|0
4769105|NCT00352534|7744594|FG003|Final Risk Group Assignment|Withdrawal by Subject|0
4769106|NCT00352534|7744595|FG004|Final Risk Group Assignment|Withdrawal by Subject|0
4769107|NCT00352534|7744596|FG005|Final Risk Group Assignment|Withdrawal by Subject|3
4769108|NCT00352534|7744597|FG006|Final Risk Group Assignment|Withdrawal by Subject|0
4769109|NCT00352534|7744591|FG000|Final Risk Group Assignment|Ineligible|0
4769110|NCT00352534|7744592|FG001|Final Risk Group Assignment|Ineligible|0
4769111|NCT00352534|7744593|FG002|Final Risk Group Assignment|Ineligible|3
4769112|NCT00352534|7744594|FG003|Final Risk Group Assignment|Ineligible|1
4769113|NCT00352534|7744595|FG004|Final Risk Group Assignment|Ineligible|0
4769114|NCT00352534|7744596|FG005|Final Risk Group Assignment|Ineligible|13
4769115|NCT00352534|7744597|FG006|Final Risk Group Assignment|Ineligible|0
4769116|NCT00352534|7744591|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0
4769117|NCT00352534|7744592|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0
4769118|NCT00352534|7744593|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0
4769119|NCT00352534|7744594|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0
4769120|NCT00352534|7744595|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0
4769121|NCT00352534|7744596|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0
4769122|NCT00352534|7744597|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28
4769123|NCT00352534|7744591|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
4769124|NCT00352534|7744592|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
4769125|NCT00352534|7744593|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
4769126|NCT00352534|7744594|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
4769127|NCT00352534|7744595|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
4769128|NCT00352534|7744596|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
4769129|NCT00352534|7744597|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11
4769130|NCT00352534|7744591|FG000|Final Risk Group Assignment|Death|0
4769131|NCT00352534|7744592|FG001|Final Risk Group Assignment|Death|0
4769132|NCT00352534|7744593|FG002|Final Risk Group Assignment|Death|0
4769133|NCT00352534|7744594|FG003|Final Risk Group Assignment|Death|0
4769134|NCT00352534|7744595|FG004|Final Risk Group Assignment|Death|0
4769135|NCT00352534|7744596|FG005|Final Risk Group Assignment|Death|2
4769136|NCT00352534|7744597|FG006|Final Risk Group Assignment|Death|0
4769137|NCT00033293|7744609|FG000|Overall Study|Death|0
4769138|NCT00033293|7744610|FG001|Overall Study|Death|1
4769139|NCT00033293|7744609|FG000|Overall Study|Lack of Efficacy|5
4769140|NCT00033293|7744610|FG001|Overall Study|Lack of Efficacy|8
4769141|NCT00033293|7744609|FG000|Overall Study|Lost to Follow-up|0
4769142|NCT00033293|7744610|FG001|Overall Study|Lost to Follow-up|1
4769143|NCT00033293|7744609|FG000|Overall Study|Physician Decision|3
4769144|NCT00033293|7744610|FG001|Overall Study|Physician Decision|1
4769145|NCT00033293|7744609|FG000|Overall Study|Withdrawal by Subject|1
4769146|NCT00033293|7744610|FG001|Overall Study|Withdrawal by Subject|0
4769147|NCT00033293|7744609|FG000|Overall Study|Could not be weaned from steroid therapy|1
4769148|NCT00033293|7744610|FG001|Overall Study|Could not be weaned from steroid therapy|1
4769149|NCT00033293|7744609|FG000|Overall Study|Treatment refused|0
4769150|NCT00033293|7744610|FG001|Overall Study|Treatment refused|6
4769151|NCT04497415|7744620|FG000|Overall Study|Lost to Follow-up|43
4769152|NCT04497415|7744621|FG001|Overall Study|Lost to Follow-up|27
4769153|NCT03894540|7744655|FG000|Overall Study|Adverse Event|0
4769154|NCT03894540|7744656|FG001|Overall Study|Adverse Event|0
4769155|NCT03894540|7744657|FG002|Overall Study|Adverse Event|0
4769156|NCT03894540|7744658|FG003|Overall Study|Adverse Event|0
4769157|NCT03894540|7744659|FG004|Overall Study|Adverse Event|1
4769158|NCT03894540|7744660|FG005|Overall Study|Adverse Event|0
4769159|NCT03894540|7744655|FG000|Overall Study|Withdrawal by Subject|0
4769160|NCT03894540|7744656|FG001|Overall Study|Withdrawal by Subject|0
4769161|NCT03894540|7744657|FG002|Overall Study|Withdrawal by Subject|0
4769162|NCT03894540|7744658|FG003|Overall Study|Withdrawal by Subject|0
4769163|NCT03894540|7744659|FG004|Overall Study|Withdrawal by Subject|1
4769164|NCT03894540|7744660|FG005|Overall Study|Withdrawal by Subject|0
4769165|NCT03894540|7744655|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0
4769166|NCT03894540|7744656|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0
4769167|NCT03894540|7744657|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1
4769168|NCT03894540|7744658|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3
4769169|NCT03894540|7744659|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2
4769170|NCT03894540|7744660|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3
4769171|NCT03894540|7744655|FG000|Overall Study|Progressive Disease Clinical|1
4769172|NCT03894540|7744656|FG001|Overall Study|Progressive Disease Clinical|1
4769173|NCT03894540|7744657|FG002|Overall Study|Progressive Disease Clinical|0
4769174|NCT03894540|7744658|FG003|Overall Study|Progressive Disease Clinical|1
4769175|NCT03894540|7744659|FG004|Overall Study|Progressive Disease Clinical|5
4769176|NCT03894540|7744660|FG005|Overall Study|Progressive Disease Clinical|1
4769177|NCT03894540|7744655|FG000|Overall Study|Study termination by sponsor|0
4769178|NCT03894540|7744656|FG001|Overall Study|Study termination by sponsor|0
4769179|NCT03894540|7744657|FG002|Overall Study|Study termination by sponsor|0
4769180|NCT03894540|7744658|FG003|Overall Study|Study termination by sponsor|0
4769181|NCT03894540|7744659|FG004|Overall Study|Study termination by sponsor|2
4769182|NCT03894540|7744660|FG005|Overall Study|Study termination by sponsor|0
4769183|NCT03725293|7744684|FG000|Overall Study|Physician Decision|9
4769184|NCT03725293|7744685|FG001|Overall Study|Physician Decision|6
4769185|NCT03725293|7744684|FG000|Overall Study|alternative vascular access needs|1
4769186|NCT03725293|7744685|FG001|Overall Study|alternative vascular access needs|2
4769187|NCT03725293|7744684|FG000|Overall Study|venous anatomy screen failures|2
4769188|NCT03725293|7744685|FG001|Overall Study|venous anatomy screen failures|1
4769189|NCT03702231|7744694|FG000|Overall Study|Withdrawal by Subject|1
4769190|NCT03702231|7744695|FG001|Overall Study|Withdrawal by Subject|0
4769191|NCT03702231|7744696|FG002|Overall Study|Withdrawal by Subject|0
4769192|NCT03702231|7744694|FG000|Overall Study|Protocol Violation|0
4769193|NCT03702231|7744695|FG001|Overall Study|Protocol Violation|0
4769194|NCT03702231|7744696|FG002|Overall Study|Protocol Violation|1
4769195|NCT03702231|7744694|FG000|Overall Study|COVID Pandemic|3
4769196|NCT03702231|7744695|FG001|Overall Study|COVID Pandemic|4
4769197|NCT03702231|7744696|FG002|Overall Study|COVID Pandemic|1
4769198|NCT03556358|7744727|FG000|Overall Study|Subjects Randomized that did not Treat|3
4769199|NCT03556358|7744728|FG001|Overall Study|Subjects Randomized that did not Treat|0
4769200|NCT03556358|7744727|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7
4769201|NCT03556358|7744728|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5
4769202|NCT03556358|7744727|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0
4769203|NCT03556358|7744728|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1
4769204|NCT03556358|7744727|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0
4769205|NCT03556358|7744728|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1
4769206|NCT03556358|7744727|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0
4769207|NCT03556358|7744728|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2
4769208|NCT03556358|7744727|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0
4769209|NCT03556358|7744728|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1
4769210|NCT03556358|7744727|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1
4769211|NCT03556358|7744728|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2
4769212|NCT03290781|7744741|FG000|Overall Study|Adverse Event|5
4769213|NCT03290781|7744742|FG001|Overall Study|Adverse Event|7
4769214|NCT03290781|7744743|FG002|Overall Study|Adverse Event|4
4769215|NCT03290781|7744744|FG003|Overall Study|Adverse Event|1
4769216|NCT03290781|7744745|FG004|Overall Study|Adverse Event|0
4769217|NCT03290781|7744746|FG005|Overall Study|Adverse Event|0
4769218|NCT03290781|7744747|FG006|Overall Study|Adverse Event|0
4769219|NCT03290781|7744741|FG000|Overall Study|Death|0
4769220|NCT03290781|7744742|FG001|Overall Study|Death|0
4769221|NCT03290781|7744743|FG002|Overall Study|Death|1
4769222|NCT03290781|7744744|FG003|Overall Study|Death|0
4769223|NCT03290781|7744745|FG004|Overall Study|Death|1
4769224|NCT03290781|7744746|FG005|Overall Study|Death|0
4769225|NCT03290781|7744747|FG006|Overall Study|Death|0
4769226|NCT03290781|7744741|FG000|Overall Study|Withdrawal by Subject|6
4769227|NCT03290781|7744742|FG001|Overall Study|Withdrawal by Subject|5
4769228|NCT03290781|7744743|FG002|Overall Study|Withdrawal by Subject|9
4769229|NCT03290781|7744744|FG003|Overall Study|Withdrawal by Subject|10
4769230|NCT03290781|7744745|FG004|Overall Study|Withdrawal by Subject|1
4769231|NCT03290781|7744746|FG005|Overall Study|Withdrawal by Subject|2
4769232|NCT03290781|7744747|FG006|Overall Study|Withdrawal by Subject|0
4769233|NCT03290781|7744741|FG000|Overall Study|Physician Decision|0
4769234|NCT03290781|7744742|FG001|Overall Study|Physician Decision|1
4769235|NCT03290781|7744743|FG002|Overall Study|Physician Decision|0
4769236|NCT03290781|7744744|FG003|Overall Study|Physician Decision|0
4769237|NCT03290781|7744745|FG004|Overall Study|Physician Decision|0
4769238|NCT03290781|7744746|FG005|Overall Study|Physician Decision|0
4769239|NCT03290781|7744747|FG006|Overall Study|Physician Decision|0
4769240|NCT03290781|7744741|FG000|Overall Study|Site Terminated by Sponsor|1
4769241|NCT03290781|7744742|FG001|Overall Study|Site Terminated by Sponsor|0
4769242|NCT03290781|7744743|FG002|Overall Study|Site Terminated by Sponsor|2
4769243|NCT03290781|7744744|FG003|Overall Study|Site Terminated by Sponsor|1
4769244|NCT03290781|7744745|FG004|Overall Study|Site Terminated by Sponsor|0
4769245|NCT03290781|7744746|FG005|Overall Study|Site Terminated by Sponsor|0
4769246|NCT03290781|7744747|FG006|Overall Study|Site Terminated by Sponsor|0
4769247|NCT03290781|7744741|FG000|Overall Study|Lost to Follow-up|0
4769248|NCT03290781|7744742|FG001|Overall Study|Lost to Follow-up|0
4769249|NCT03290781|7744743|FG002|Overall Study|Lost to Follow-up|0
4769250|NCT03290781|7744744|FG003|Overall Study|Lost to Follow-up|1
4769251|NCT03290781|7744745|FG004|Overall Study|Lost to Follow-up|0
4769252|NCT03290781|7744746|FG005|Overall Study|Lost to Follow-up|0
4769253|NCT03290781|7744747|FG006|Overall Study|Lost to Follow-up|0
4769254|NCT03290781|7744741|FG000|Overall Study|Protocol Deviation|2
4769255|NCT03290781|7744742|FG001|Overall Study|Protocol Deviation|0
4769256|NCT03290781|7744743|FG002|Overall Study|Protocol Deviation|0
4769257|NCT03290781|7744744|FG003|Overall Study|Protocol Deviation|1
4769258|NCT03290781|7744745|FG004|Overall Study|Protocol Deviation|0
4769259|NCT03290781|7744746|FG005|Overall Study|Protocol Deviation|0
4769260|NCT03290781|7744747|FG006|Overall Study|Protocol Deviation|0
4769261|NCT03290781|7744741|FG000|Overall Study|Disease Relapse|32
4769262|NCT03290781|7744742|FG001|Overall Study|Disease Relapse|5
4769263|NCT03290781|7744743|FG002|Overall Study|Disease Relapse|38
4769264|NCT03290781|7744744|FG003|Overall Study|Disease Relapse|7
4769265|NCT03290781|7744745|FG004|Overall Study|Disease Relapse|3
4769266|NCT03290781|7744746|FG005|Overall Study|Disease Relapse|1
4769267|NCT03290781|7744747|FG006|Overall Study|Disease Relapse|4
4769268|NCT03290781|7744741|FG000|Overall Study|Other|3
4769269|NCT03290781|7744742|FG001|Overall Study|Other|0
4769270|NCT03290781|7744743|FG002|Overall Study|Other|2
4769271|NCT03290781|7744744|FG003|Overall Study|Other|2
4769272|NCT03290781|7744745|FG004|Overall Study|Other|0
4769273|NCT03290781|7744746|FG005|Overall Study|Other|0
4769274|NCT03290781|7744747|FG006|Overall Study|Other|0
4769275|NCT03228680|7744806|FG000|Overall Study|Adverse Event|13
4769276|NCT03228680|7744807|FG001|Overall Study|Adverse Event|18
4769277|NCT03228680|7744806|FG000|Overall Study|Randomization failure|0
4769278|NCT03228680|7744807|FG001|Overall Study|Randomization failure|1
4769279|NCT03228680|7744806|FG000|Overall Study|Withdrawal by Subject|1
4769280|NCT03228680|7744807|FG001|Overall Study|Withdrawal by Subject|0
4769281|NCT03228680|7744806|FG000|Overall Study|Other|9
4769282|NCT03228680|7744807|FG001|Overall Study|Other|16
4769283|NCT02679781|7744847|FG000|Overall Study|Lost to Follow-up|1
4769284|NCT02679781|7744848|FG001|Overall Study|Lost to Follow-up|2
4769285|NCT02679781|7744847|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6
4769286|NCT02679781|7744848|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1
4769287|NCT02624869|7744857|FG000|Overall Study|Lost to Follow-up|0
4769288|NCT02624869|7744858|FG001|Overall Study|Lost to Follow-up|0
4769289|NCT02624869|7744859|FG002|Overall Study|Lost to Follow-up|1
4769290|NCT02624869|7744857|FG000|Overall Study|Withdrawal by Subject|1
4769291|NCT02624869|7744858|FG001|Overall Study|Withdrawal by Subject|3
4769292|NCT02624869|7744859|FG002|Overall Study|Withdrawal by Subject|1
4769293|NCT02569242|7744883|FG000|Overall Study|Death|1
4769294|NCT02569242|7744884|FG001|Overall Study|Death|0
4769295|NCT02569242|7744883|FG000|Overall Study|Withdrawal by Subject|0
4769296|NCT02569242|7744884|FG001|Overall Study|Withdrawal by Subject|1
4769297|NCT02435433|7744907|FG000|Overall Study|On Treatment|11
4769298|NCT02435433|7744908|FG001|Overall Study|On Treatment|0
4769299|NCT02435433|7744909|FG002|Overall Study|On Treatment|0
4769300|NCT02435433|7744910|FG003|Overall Study|On Treatment|0
4769301|NCT02435433|7744911|FG004|Overall Study|On Treatment|0
4769302|NCT02435433|7744907|FG000|Overall Study|Withdrawal by Subject|2
4769303|NCT02435433|7744908|FG001|Overall Study|Withdrawal by Subject|3
4769304|NCT02435433|7744909|FG002|Overall Study|Withdrawal by Subject|0
4769305|NCT02435433|7744910|FG003|Overall Study|Withdrawal by Subject|0
4769306|NCT02435433|7744911|FG004|Overall Study|Withdrawal by Subject|0
4769307|NCT02435433|7744907|FG000|Overall Study|Lost to Follow-up|2
4769308|NCT02435433|7744908|FG001|Overall Study|Lost to Follow-up|2
4769309|NCT02435433|7744909|FG002|Overall Study|Lost to Follow-up|0
4769310|NCT02435433|7744910|FG003|Overall Study|Lost to Follow-up|0
4769311|NCT02435433|7744911|FG004|Overall Study|Lost to Follow-up|0
4769312|NCT02426125|7744921|FG000|Overall Study|Lost to Follow-up|12
4769313|NCT02426125|7744922|FG001|Overall Study|Lost to Follow-up|10
4769314|NCT02426125|7744921|FG000|Overall Study|Protocol Violation|1
4769315|NCT02426125|7744922|FG001|Overall Study|Protocol Violation|0
4769316|NCT02426125|7744921|FG000|Overall Study|Withdrawal by Subject|16
4769317|NCT02426125|7744922|FG001|Overall Study|Withdrawal by Subject|16
4769318|NCT02368886|7744943|FG000|Overall Study|Cancel|1
4769319|NCT02368886|7744944|FG001|Overall Study|Cancel|1
4769320|NCT02368886|7744945|FG002|Overall Study|Cancel|1
4769321|NCT02368886|7744946|FG003|Overall Study|Cancel|3
4769322|NCT02368886|7744943|FG000|Overall Study|Ineligible|0
4769323|NCT02368886|7744944|FG001|Overall Study|Ineligible|0
4769324|NCT02368886|7744945|FG002|Overall Study|Ineligible|0
4769325|NCT02368886|7744946|FG003|Overall Study|Ineligible|1
4769326|NCT02354703|7744958|FG000|Overall Study|Withdrawal by Subject|1
4769327|NCT02354703|7744959|FG001|Overall Study|Withdrawal by Subject|1
4769328|NCT02354703|7744960|FG002|Overall Study|Withdrawal by Subject|1
4769329|NCT02354703|7744961|FG003|Overall Study|Withdrawal by Subject|1
4769330|NCT02354703|7744958|FG000|Overall Study|Lost to Follow-up|2
4769331|NCT02354703|7744959|FG001|Overall Study|Lost to Follow-up|7
4769332|NCT02354703|7744960|FG002|Overall Study|Lost to Follow-up|9
4769333|NCT02354703|7744961|FG003|Overall Study|Lost to Follow-up|2
4769334|NCT02354703|7744958|FG000|Overall Study|Adverse Event|0
4769335|NCT02354703|7744959|FG001|Overall Study|Adverse Event|0
4769336|NCT02354703|7744960|FG002|Overall Study|Adverse Event|1
4769337|NCT02354703|7744961|FG003|Overall Study|Adverse Event|0
4769338|NCT01981551|7744973|FG000|Overall Study|Refused further treatment|8
4769339|NCT01981551|7744973|FG000|Overall Study|Adverse Event|1
4769340|NCT00468130|7744983|FG000|Overall Study|Adverse Event|2
4769341|NCT00468130|7744984|FG001|Overall Study|Adverse Event|1
4769342|NCT00468130|7744983|FG000|Overall Study|Withdrawal by Subject|0
4769343|NCT00468130|7744984|FG001|Overall Study|Withdrawal by Subject|1
4769344|NCT00384111|7744992|FG000|Overall Study|Disease Progression|3
4769345|NCT00384111|7744992|FG000|Overall Study|Adverse Event|1
4769346|NCT00384111|7744992|FG000|Overall Study|Investigator Decision|3
4769347|NCT00384111|7744992|FG000|Overall Study|Study Terminated by the Sponsor|19
4769348|NCT04854642|7744996|FG000|Overall Study|Adverse Event|1
4769349|NCT04854642|7744997|FG001|Overall Study|Adverse Event|2
4769350|NCT04854642|7744996|FG000|Overall Study|Withdrawal by Subject|0
4769351|NCT04854642|7744997|FG001|Overall Study|Withdrawal by Subject|1
4769352|NCT04608344|7745007|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0
4769353|NCT04608344|7745008|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1
4769354|NCT04608344|7745007|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1
4769355|NCT04608344|7745008|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0
4769356|NCT04388787|7745035|FG000|Blinded Period|Patient could not follow instructions|1
4769357|NCT04388787|7745035|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9
4769358|NCT04377620|7745059|FG000|Overall Study|Death|42
4769359|NCT04377620|7745060|FG001|Overall Study|Death|48
4769360|NCT04377620|7745061|FG002|Overall Study|Death|36
4769361|NCT04377620|7745059|FG000|Overall Study|Withdrawal by Subject|0
4769362|NCT04377620|7745060|FG001|Overall Study|Withdrawal by Subject|2
4769363|NCT04377620|7745061|FG002|Overall Study|Withdrawal by Subject|0
4769364|NCT04310566|7745092|FG000|Period 1|Study Termination due to COVID-19|15
4769365|NCT04310566|7745093|FG001|Period 1|Study Termination due to COVID-19|17
4769366|NCT04310566|7745092|FG000|Period 1|Protocol Violation|0
4769367|NCT04310566|7745093|FG001|Period 1|Protocol Violation|1
4769368|NCT04310566|7745092|FG000|Period 1|Subject no longer meets eligbility criteria|0
4769369|NCT04310566|7745093|FG001|Period 1|Subject no longer meets eligbility criteria|1
4769370|NCT04310566|7745092|FG000|Period 1|Lost to Follow-up|1
4769371|NCT04310566|7745093|FG001|Period 1|Lost to Follow-up|0
4769372|NCT04310566|7745092|FG000|Period 1|Withdrawal by Subject|0
4769373|NCT04310566|7745093|FG001|Period 1|Withdrawal by Subject|1
4769374|NCT04310566|7745092|FG000|Period 2|Study Termination|7
4769375|NCT04310566|7745093|FG001|Period 2|Study Termination|5
4769417|NCT03885999|7745158|FG000|Overall Study|Adverse Event|1
4769418|NCT03882970|7745166|FG000|Overall Study|Adverse Event|5
4769419|NCT03882970|7745167|FG001|Overall Study|Adverse Event|7
4769420|NCT03882970|7745168|FG002|Overall Study|Adverse Event|3
4769421|NCT03882970|7745169|FG003|Overall Study|Adverse Event|1
4769422|NCT03882970|7745166|FG000|Overall Study|Death|1
4769423|NCT03882970|7745167|FG001|Overall Study|Death|2
4769424|NCT03882970|7745168|FG002|Overall Study|Death|1
4769425|NCT03882970|7745169|FG003|Overall Study|Death|1
4769426|NCT03882970|7745166|FG000|Overall Study|Lost to Follow-up|8
4769427|NCT03882970|7745167|FG001|Overall Study|Lost to Follow-up|9
4769428|NCT03882970|7745168|FG002|Overall Study|Lost to Follow-up|5
4769429|NCT03882970|7745169|FG003|Overall Study|Lost to Follow-up|5
4769430|NCT03882970|7745166|FG000|Overall Study|Physician Decision|0
4769431|NCT03882970|7745167|FG001|Overall Study|Physician Decision|2
4769432|NCT03882970|7745168|FG002|Overall Study|Physician Decision|2
4769433|NCT03882970|7745169|FG003|Overall Study|Physician Decision|2
4769434|NCT03882970|7745166|FG000|Overall Study|Protocol Violation|2
4769435|NCT03882970|7745167|FG001|Overall Study|Protocol Violation|0
4769436|NCT03882970|7745168|FG002|Overall Study|Protocol Violation|0
4769437|NCT03882970|7745169|FG003|Overall Study|Protocol Violation|0
4769438|NCT03882970|7745166|FG000|Overall Study|Withdrawal by Subject|8
4769439|NCT03882970|7745167|FG001|Overall Study|Withdrawal by Subject|17
4769440|NCT03882970|7745168|FG002|Overall Study|Withdrawal by Subject|7
4769441|NCT03882970|7745169|FG003|Overall Study|Withdrawal by Subject|22
4769442|NCT03882970|7745166|FG000|Overall Study|Personal Reason|2
4769443|NCT03882970|7745167|FG001|Overall Study|Personal Reason|3
4769376|NCT04206020|7745101|FG000|Overall Study|Adverse Event|1
4769377|NCT04206020|7745102|FG001|Overall Study|Adverse Event|4
4769378|NCT04206020|7745101|FG000|Overall Study|Protocol Violation|2
4769379|NCT04206020|7745102|FG001|Overall Study|Protocol Violation|0
4769380|NCT04206020|7745101|FG000|Overall Study|Withdrawal by Subject|2
4769381|NCT04206020|7745102|FG001|Overall Study|Withdrawal by Subject|0
4769382|NCT04206020|7745101|FG000|Overall Study|Lost to Follow-up|2
4769383|NCT04206020|7745102|FG001|Overall Study|Lost to Follow-up|0
4769384|NCT04206020|7745101|FG000|Overall Study|Pregnancy|0
4769385|NCT04206020|7745102|FG001|Overall Study|Pregnancy|1
4769386|NCT04206020|7745101|FG000|Overall Study|Unable to attend visits|1
4769387|NCT04206020|7745102|FG001|Overall Study|Unable to attend visits|2
4769388|NCT04097301|7745108|FG000|Overall Study|Death|1
4769389|NCT04097301|7745108|FG000|Overall Study|Withdrawal by Subject|1
4769390|NCT04097301|7745108|FG000|Overall Study|Screening Failure|5
4769391|NCT03953079|7745121|FG000|Core Study|Withdrawal by Subject|1
4769392|NCT03953079|7745122|FG001|Core Study|Withdrawal by Subject|2
4769393|NCT03953079|7745123|FG002|Core Study|Withdrawal by Subject|1
4769394|NCT03953079|7745121|FG000|Core Study|COVID-19|0
4769395|NCT03953079|7745122|FG001|Core Study|COVID-19|1
4769396|NCT03953079|7745123|FG002|Core Study|COVID-19|0
4769397|NCT03953079|7745121|FG000|Core Study|Difficulties leaving the house|0
4769398|NCT03953079|7745122|FG001|Core Study|Difficulties leaving the house|1
4769399|NCT03953079|7745123|FG002|Core Study|Difficulties leaving the house|0
4769400|NCT03953079|7745121|FG000|Extension Study|Withdrawal by Subject|1
4769401|NCT03953079|7745122|FG001|Extension Study|Withdrawal by Subject|0
4769402|NCT03953079|7745123|FG002|Extension Study|Withdrawal by Subject|0
4769403|NCT03953079|7745121|FG000|Extension Study|Received Rescue Treatment|5
4769404|NCT03953079|7745122|FG001|Extension Study|Received Rescue Treatment|6
4769405|NCT03953079|7745123|FG002|Extension Study|Received Rescue Treatment|5
4769406|NCT03922750|7745135|FG000|Overall Study|Unclassified|0
4769407|NCT03922750|7745136|FG001|Overall Study|Unclassified|0
4769408|NCT03922750|7745137|FG002|Overall Study|Unclassified|1
4769409|NCT03922750|7745135|FG000|Overall Study|Adverse Event|0
4769410|NCT03922750|7745136|FG001|Overall Study|Adverse Event|1
4769411|NCT03922750|7745137|FG002|Overall Study|Adverse Event|0
4769412|NCT03910673|7745150|FG000|Overall Study|Adverse Event|0
4769413|NCT03910673|7745151|FG001|Overall Study|Adverse Event|0
4769414|NCT03910673|7745152|FG002|Overall Study|Adverse Event|0
4769415|NCT03910673|7745153|FG003|Overall Study|Adverse Event|2
4769416|NCT03910673|7745154|FG004|Overall Study|Adverse Event|0
4769444|NCT03882970|7745168|FG002|Overall Study|Personal Reason|1
4769445|NCT03882970|7745169|FG003|Overall Study|Personal Reason|3
4769446|NCT03867734|7745193|FG000|Overall Study|Lost to Follow-up|2
4769447|NCT03781778|7745203|FG000|Overall Study|Withdrawal by Subject|2
4769448|NCT03781778|7745204|FG001|Overall Study|Withdrawal by Subject|2
4769449|NCT03730480|7745227|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1
4769450|NCT03713034|7745240|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5
4769451|NCT03713034|7745241|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4
4769452|NCT03654404|7745249|FG000|Overall Study|Death|1
4769453|NCT03654404|7745249|FG000|Overall Study|Lost to Follow-up|2
4769454|NCT03654404|7745249|FG000|Overall Study|Withdrawal by Subject|5
4769455|NCT03567057|7745256|FG000|Overall Study|Adverse Event|56
4769456|NCT03567057|7745257|FG001|Overall Study|Adverse Event|53
4769457|NCT03567057|7745258|FG002|Overall Study|Adverse Event|28
4769458|NCT03567057|7745256|FG000|Overall Study|Withdrawal by Subject|22
4769459|NCT03567057|7745257|FG001|Overall Study|Withdrawal by Subject|24
4769460|NCT03567057|7745258|FG002|Overall Study|Withdrawal by Subject|13
4769461|NCT03567057|7745256|FG000|Overall Study|Lost to Follow-up|3
4769462|NCT03567057|7745257|FG001|Overall Study|Lost to Follow-up|5
4769463|NCT03567057|7745258|FG002|Overall Study|Lost to Follow-up|2
4769464|NCT03567057|7745256|FG000|Overall Study|COVID-19 pandemic|4
4769465|NCT03567057|7745257|FG001|Overall Study|COVID-19 pandemic|3
4769466|NCT03567057|7745258|FG002|Overall Study|COVID-19 pandemic|0
4769467|NCT03567057|7745256|FG000|Overall Study|Non-compliance with study drug|4
4769468|NCT03567057|7745257|FG001|Overall Study|Non-compliance with study drug|2
4769469|NCT03567057|7745258|FG002|Overall Study|Non-compliance with study drug|0
4769470|NCT03567057|7745256|FG000|Overall Study|Lack of Efficacy|3
4769471|NCT03567057|7745257|FG001|Overall Study|Lack of Efficacy|0
4769472|NCT03567057|7745258|FG002|Overall Study|Lack of Efficacy|1
4769473|NCT03567057|7745256|FG000|Overall Study|Death|1
4769474|NCT03567057|7745257|FG001|Overall Study|Death|0
4769475|NCT03567057|7745258|FG002|Overall Study|Death|0
4769476|NCT03567057|7745256|FG000|Overall Study|Physician Decision|1
4769477|NCT03567057|7745257|FG001|Overall Study|Physician Decision|0
4769478|NCT03567057|7745258|FG002|Overall Study|Physician Decision|0
4769479|NCT03567057|7745256|FG000|Overall Study|Unstable medical condition|1
4769480|NCT03567057|7745257|FG001|Overall Study|Unstable medical condition|0
4769481|NCT03567057|7745258|FG002|Overall Study|Unstable medical condition|0
4769482|NCT03567057|7745256|FG000|Overall Study|Medical history event|0
4769483|NCT03567057|7745257|FG001|Overall Study|Medical history event|0
4769484|NCT03567057|7745258|FG002|Overall Study|Medical history event|1
4769485|NCT03567057|7745256|FG000|Overall Study|Other|0
4769486|NCT03567057|7745257|FG001|Overall Study|Other|0
4769487|NCT03567057|7745258|FG002|Overall Study|Other|1
4769488|NCT03548987|7745268|FG000|Run-in Period (Week 0 to Week 20)|Other|9
4769489|NCT03548987|7745269|FG001|Run-in Period (Week 0 to Week 20)|Other|0
4769490|NCT03548987|7745268|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8
4769491|NCT03548987|7745269|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0
4769492|NCT03548987|7745268|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11
4769493|NCT03548987|7745269|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0
4769494|NCT03548987|7745268|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2
4769495|NCT03548987|7745269|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0
4769496|NCT03548987|7745268|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19
4769497|NCT03548987|7745269|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0
4769498|NCT03548987|7745268|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1
4769499|NCT03548987|7745269|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0
4769500|NCT03548987|7745268|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1
4769501|NCT03548987|7745269|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0
4769502|NCT03548987|7745268|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48
4769503|NCT03548987|7745269|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0
4769504|NCT03548987|7745268|FG000|Maintenance Period (Week 20 to Week 68)|other|12
4769505|NCT03548987|7745269|FG001|Maintenance Period (Week 20 to Week 68)|other|23
4769506|NCT03548987|7745268|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2
4769507|NCT03548987|7745269|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1
4769508|NCT03548987|7745268|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1
4769509|NCT03548987|7745269|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1
4769510|NCT03548987|7745268|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2
4769511|NCT03548987|7745269|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0
4769512|NCT03548987|7745268|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1
4769513|NCT03548987|7745269|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0
4769514|NCT03548987|7745268|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13
4769515|NCT03548987|7745269|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6
4769516|NCT03548064|7745284|FG000|Overall Study|Withdrawal by Subject|0
4769517|NCT03548064|7745285|FG001|Overall Study|Withdrawal by Subject|0
4769518|NCT03548064|7745286|FG002|Overall Study|Withdrawal by Subject|0
4769519|NCT03548064|7745287|FG003|Overall Study|Withdrawal by Subject|1
4769520|NCT03548064|7745288|FG004|Overall Study|Withdrawal by Subject|0
4769521|NCT03548064|7745289|FG005|Overall Study|Withdrawal by Subject|0
4769522|NCT03548064|7745290|FG006|Overall Study|Withdrawal by Subject|0
4769523|NCT03548064|7745291|FG007|Overall Study|Withdrawal by Subject|0
4769524|NCT03548064|7745284|FG000|Overall Study|Lost to Follow-up|0
4769525|NCT03548064|7745285|FG001|Overall Study|Lost to Follow-up|0
4769526|NCT03548064|7745286|FG002|Overall Study|Lost to Follow-up|0
4769527|NCT03548064|7745287|FG003|Overall Study|Lost to Follow-up|0
4769528|NCT03548064|7745288|FG004|Overall Study|Lost to Follow-up|2
4769529|NCT03548064|7745289|FG005|Overall Study|Lost to Follow-up|0
4769530|NCT03548064|7745290|FG006|Overall Study|Lost to Follow-up|0
4769531|NCT03548064|7745291|FG007|Overall Study|Lost to Follow-up|0
4769532|NCT03548064|7745284|FG000|Overall Study|Covid-19 Pandemic|0
4769533|NCT03548064|7745285|FG001|Overall Study|Covid-19 Pandemic|0
4769534|NCT03548064|7745286|FG002|Overall Study|Covid-19 Pandemic|0
4769535|NCT03548064|7745287|FG003|Overall Study|Covid-19 Pandemic|0
4769536|NCT03548064|7745288|FG004|Overall Study|Covid-19 Pandemic|10
4769537|NCT03548064|7745289|FG005|Overall Study|Covid-19 Pandemic|3
4769538|NCT03548064|7745290|FG006|Overall Study|Covid-19 Pandemic|0
4769539|NCT03548064|7745291|FG007|Overall Study|Covid-19 Pandemic|0
4769540|NCT03446456|7745317|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1
4769541|NCT03446456|7745318|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1
4769542|NCT03446456|7745317|FG000|Overall Study|Lost to Follow-up|1
4769543|NCT03446456|7745318|FG001|Overall Study|Lost to Follow-up|3
4769544|NCT03446456|7745317|FG000|Overall Study|Participant failed the toxicology test|1
4769545|NCT03446456|7745318|FG001|Overall Study|Participant failed the toxicology test|0
4769546|NCT03446456|7745317|FG000|Overall Study|Break down of the experimental equipment|1
4769547|NCT03446456|7745318|FG001|Overall Study|Break down of the experimental equipment|0
4769548|NCT03382834|7745326|FG000|Overall Study|Lost to Follow-up|1
4769549|NCT03382834|7745327|FG001|Overall Study|Lost to Follow-up|0
4769550|NCT03382834|7745326|FG000|Overall Study|Withdrawal by Subject|0
4769551|NCT03382834|7745327|FG001|Overall Study|Withdrawal by Subject|1
4769552|NCT03371823|7745335|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1
4769553|NCT03371823|7745336|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0
4769554|NCT03353350|7745346|FG000|30-week Core Treatment Period|Protocol Violation|1
4769555|NCT03353350|7745347|FG001|30-week Core Treatment Period|Protocol Violation|1
4769556|NCT03353350|7745348|FG002|30-week Core Treatment Period|Protocol Violation|1
4769557|NCT03353350|7745349|FG003|30-week Core Treatment Period|Protocol Violation|0
4769558|NCT03353350|7745346|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2
4769559|NCT03353350|7745347|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2
4769560|NCT03353350|7745348|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2
4769561|NCT03353350|7745349|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0
4769562|NCT03353350|7745346|FG000|30-week Core Treatment Period|Adverse Event|0
4769563|NCT03353350|7745347|FG001|30-week Core Treatment Period|Adverse Event|4
4769564|NCT03353350|7745348|FG002|30-week Core Treatment Period|Adverse Event|2
4769565|NCT03353350|7745349|FG003|30-week Core Treatment Period|Adverse Event|3
4769566|NCT03353350|7745346|FG000|30-week Core Treatment Period|Withdrawal by Subject|19
4769567|NCT03353350|7745347|FG001|30-week Core Treatment Period|Withdrawal by Subject|12
4769568|NCT03353350|7745348|FG002|30-week Core Treatment Period|Withdrawal by Subject|19
4769569|NCT03353350|7745349|FG003|30-week Core Treatment Period|Withdrawal by Subject|19
4769570|NCT03353350|7745346|FG000|26-week Treatment Extension Period|Protocol Violation|2
4769571|NCT03353350|7745347|FG001|26-week Treatment Extension Period|Protocol Violation|0
4769572|NCT03353350|7745348|FG002|26-week Treatment Extension Period|Protocol Violation|0
4769573|NCT03353350|7745349|FG003|26-week Treatment Extension Period|Protocol Violation|0
4769574|NCT03353350|7745346|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0
4769575|NCT03353350|7745347|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0
4769576|NCT03353350|7745348|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1
4769577|NCT03353350|7745349|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1
4769578|NCT03353350|7745346|FG000|26-week Treatment Extension Period|Adverse Event|1
4769579|NCT03353350|7745347|FG001|26-week Treatment Extension Period|Adverse Event|0
4769580|NCT03353350|7745348|FG002|26-week Treatment Extension Period|Adverse Event|0
4769581|NCT03353350|7745349|FG003|26-week Treatment Extension Period|Adverse Event|1
4769582|NCT03353350|7745346|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2
4769583|NCT03353350|7745347|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3
4769584|NCT03353350|7745348|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3
4769585|NCT03353350|7745349|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12
4769586|NCT03350503|7745359|FG000|Overall Study|Adverse Event|1
4769587|NCT03350503|7745359|FG000|Overall Study|Hospital Transfer or Removal|2
4769588|NCT03350503|7745359|FG000|Overall Study|Subject Wishes|2
4769589|NCT03326193|7745363|FG000|Overall Study|Treatment ongoing at the time of analysis|26
4769590|NCT03326193|7745363|FG000|Overall Study|Death|19
4769591|NCT03326193|7745363|FG000|Overall Study|Withdrawal by Subject|8
4769592|NCT03282565|7745379|FG000|Overall Study|COVID-19 Research Shutdown|0
4769593|NCT03282565|7745380|FG001|Overall Study|COVID-19 Research Shutdown|2
4769594|NCT03282565|7745381|FG002|Overall Study|COVID-19 Research Shutdown|2
4769595|NCT03276936|7745391|FG000|Overall Study|Adverse Event|4
4769596|NCT03276936|7745392|FG001|Overall Study|Adverse Event|2
4769597|NCT03276936|7745391|FG000|Overall Study|Lost to Follow-up|16
4769598|NCT03276936|7745392|FG001|Overall Study|Lost to Follow-up|13
4769599|NCT03276936|7745391|FG000|Overall Study|Withdrawal by Subject|30
4769600|NCT03276936|7745392|FG001|Overall Study|Withdrawal by Subject|20
4769601|NCT03276936|7745391|FG000|Overall Study|Not mentioned|6
4769602|NCT03276936|7745392|FG001|Overall Study|Not mentioned|3
4769603|NCT03271021|7745400|FG000|Overall Study|Adverse Event|3
4769604|NCT03271021|7745401|FG001|Overall Study|Adverse Event|2
4769605|NCT03271021|7745400|FG000|Overall Study|Withdrawal by Subject|36
4769606|NCT03271021|7745401|FG001|Overall Study|Withdrawal by Subject|53
4769607|NCT03271021|7745400|FG000|Overall Study|Lost to Follow-up|34
4769608|NCT03271021|7745401|FG001|Overall Study|Lost to Follow-up|39
4769609|NCT03271021|7745400|FG000|Overall Study|Protocol Violation|6
4769610|NCT03271021|7745401|FG001|Overall Study|Protocol Violation|4
4769611|NCT03271021|7745400|FG000|Overall Study|Abnormal Lab Results|1
4769612|NCT03271021|7745401|FG001|Overall Study|Abnormal Lab Results|0
4769613|NCT03271021|7745400|FG000|Overall Study|Miscellaneous|9
4769614|NCT03271021|7745401|FG001|Overall Study|Miscellaneous|8
4769615|NCT03255083|7745411|FG000|Overall Study|Clinical progression|1
4769616|NCT03255083|7745412|FG001|Overall Study|Clinical progression|0
4769617|NCT03255083|7745413|FG002|Overall Study|Clinical progression|0
4769618|NCT03255083|7745414|FG003|Overall Study|Clinical progression|0
4769619|NCT03255083|7745411|FG000|Overall Study|Adverse Event|0
4769620|NCT03255083|7745412|FG001|Overall Study|Adverse Event|1
4769621|NCT03255083|7745413|FG002|Overall Study|Adverse Event|0
4769622|NCT03255083|7745414|FG003|Overall Study|Adverse Event|0
4769623|NCT03255083|7745411|FG000|Overall Study|Progressive disease by RECIST version 1.1|4
4769624|NCT03255083|7745412|FG001|Overall Study|Progressive disease by RECIST version 1.1|1
4769625|NCT03255083|7745413|FG002|Overall Study|Progressive disease by RECIST version 1.1|2
4769626|NCT03255083|7745414|FG003|Overall Study|Progressive disease by RECIST version 1.1|1
4769627|NCT03255083|7745411|FG000|Overall Study|Withdrawal by Subject|1
4769628|NCT03255083|7745412|FG001|Overall Study|Withdrawal by Subject|1
4769629|NCT03255083|7745413|FG002|Overall Study|Withdrawal by Subject|1
4769630|NCT03255083|7745414|FG003|Overall Study|Withdrawal by Subject|0
4769631|NCT03227471|7745439|FG000|Overall Study|Withdrawal by Subject|0
4769632|NCT03227471|7745440|FG001|Overall Study|Withdrawal by Subject|0
4769633|NCT03227471|7745441|FG002|Overall Study|Withdrawal by Subject|0
4769634|NCT03227471|7745442|FG003|Overall Study|Withdrawal by Subject|0
4769635|NCT03227471|7745443|FG004|Overall Study|Withdrawal by Subject|1
4769636|NCT03227471|7745444|FG005|Overall Study|Withdrawal by Subject|0
4769637|NCT03227471|7745445|FG006|Overall Study|Withdrawal by Subject|0
4769638|NCT03227471|7745446|FG007|Overall Study|Withdrawal by Subject|0
4769639|NCT03227471|7745447|FG008|Overall Study|Withdrawal by Subject|0
4769640|NCT03227471|7745448|FG009|Overall Study|Withdrawal by Subject|0
4769641|NCT03227471|7745449|FG010|Overall Study|Withdrawal by Subject|0
4769642|NCT03227471|7745450|FG011|Overall Study|Withdrawal by Subject|0
4769643|NCT03227471|7745451|FG012|Overall Study|Withdrawal by Subject|1
4769644|NCT03227471|7745452|FG013|Overall Study|Withdrawal by Subject|0
4769645|NCT03227471|7745453|FG014|Overall Study|Withdrawal by Subject|0
4769646|NCT03227471|7745439|FG000|Overall Study|Randomized, Never Dosed|0
4769647|NCT03227471|7745440|FG001|Overall Study|Randomized, Never Dosed|0
4769648|NCT03227471|7745441|FG002|Overall Study|Randomized, Never Dosed|0
4769649|NCT03227471|7745442|FG003|Overall Study|Randomized, Never Dosed|0
4769650|NCT03227471|7745443|FG004|Overall Study|Randomized, Never Dosed|0
4769651|NCT03227471|7745444|FG005|Overall Study|Randomized, Never Dosed|0
4769652|NCT03227471|7745445|FG006|Overall Study|Randomized, Never Dosed|0
4769653|NCT03227471|7745446|FG007|Overall Study|Randomized, Never Dosed|0
4769654|NCT03227471|7745447|FG008|Overall Study|Randomized, Never Dosed|0
4769655|NCT03227471|7745448|FG009|Overall Study|Randomized, Never Dosed|0
4769656|NCT03227471|7745449|FG010|Overall Study|Randomized, Never Dosed|0
4769657|NCT03227471|7745450|FG011|Overall Study|Randomized, Never Dosed|0
4769658|NCT03227471|7745451|FG012|Overall Study|Randomized, Never Dosed|0
4769659|NCT03227471|7745452|FG013|Overall Study|Randomized, Never Dosed|0
4769660|NCT03227471|7745453|FG014|Overall Study|Randomized, Never Dosed|1
4769661|NCT03221842|7745514|FG000|Period 1 (Open-label)|Adverse Event|4
4769662|NCT03221842|7745515|FG001|Period 1 (Open-label)|Adverse Event|0
4769663|NCT03221842|7745514|FG000|Period 1 (Open-label)|Physician Decision|2
4769664|NCT03221842|7745515|FG001|Period 1 (Open-label)|Physician Decision|0
4769665|NCT03221842|7745514|FG000|Period 1 (Open-label)|Lost to Follow-up|1
4769666|NCT03221842|7745515|FG001|Period 1 (Open-label)|Lost to Follow-up|0
4769667|NCT03221842|7745514|FG000|Period 1 (Open-label)|Terminated by sponsor|1
4769668|NCT03221842|7745515|FG001|Period 1 (Open-label)|Terminated by sponsor|0
4769669|NCT03221842|7745514|FG000|Period 1 (Open-label)|Other|2
4769670|NCT03221842|7745515|FG001|Period 1 (Open-label)|Other|0
4769671|NCT03221842|7745514|FG000|Period 2 (Randomized, Blinded)|Death|0
4769672|NCT03221842|7745515|FG001|Period 2 (Randomized, Blinded)|Death|1
4769673|NCT03221842|7745514|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1
4769674|NCT03221842|7745515|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0
4769675|NCT03194321|7745525|FG000|Overall Study|Withdrawal by Subject|1
4769676|NCT03194321|7745525|FG000|Overall Study|Lost to Follow-up|1
4769677|NCT03194321|7745525|FG000|Overall Study|Travel for Follow-up|1
4769678|NCT03085095|7745531|FG000|Overall Study|Adverse Event|23
4769679|NCT03085095|7745532|FG001|Overall Study|Adverse Event|8
4769680|NCT03085095|7745531|FG000|Overall Study|Protocol Violation|0
4769681|NCT03085095|7745532|FG001|Overall Study|Protocol Violation|1
4769682|NCT03085095|7745531|FG000|Overall Study|Lost to Follow-up|2
4769683|NCT03085095|7745532|FG001|Overall Study|Lost to Follow-up|1
4769684|NCT03085095|7745531|FG000|Overall Study|Withdrawal by Subject|17
4769685|NCT03085095|7745532|FG001|Overall Study|Withdrawal by Subject|6
4769686|NCT03085095|7745531|FG000|Overall Study|Physician Decision|9
4769687|NCT03085095|7745532|FG001|Overall Study|Physician Decision|3
4769688|NCT03085095|7745531|FG000|Overall Study|Testosterone Suppression Level Not Met|7
4769689|NCT03085095|7745532|FG001|Overall Study|Testosterone Suppression Level Not Met|13
4769690|NCT03085095|7745531|FG000|Overall Study|Did not Receive Study Drug|2
4769691|NCT03085095|7745532|FG001|Overall Study|Did not Receive Study Drug|2
4769692|NCT03085095|7745531|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1
4769693|NCT03085095|7745532|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0
4769694|NCT03048422|7745544|FG000|Overall Study|Death|1
4769695|NCT03048422|7745545|FG001|Overall Study|Death|0
4769696|NCT03048422|7745546|FG002|Overall Study|Death|0
4769697|NCT03048422|7745544|FG000|Overall Study|Lost to Follow-up|5
4769698|NCT03048422|7745545|FG001|Overall Study|Lost to Follow-up|0
4769699|NCT03048422|7745546|FG002|Overall Study|Lost to Follow-up|1
4769700|NCT03048422|7745544|FG000|Overall Study|Withdrawal by Subject|5
4769701|NCT03048422|7745545|FG001|Overall Study|Withdrawal by Subject|7
4769702|NCT03048422|7745546|FG002|Overall Study|Withdrawal by Subject|4
4769703|NCT03048422|7745544|FG000|Overall Study|Moved|3
4769704|NCT03048422|7745545|FG001|Overall Study|Moved|2
4769705|NCT03048422|7745546|FG002|Overall Study|Moved|2
4769706|NCT03048422|7745544|FG000|Overall Study|Noncompliant with Study Requirements|2
4769707|NCT03048422|7745545|FG001|Overall Study|Noncompliant with Study Requirements|1
4769708|NCT03048422|7745546|FG002|Overall Study|Noncompliant with Study Requirements|2
4769709|NCT03048422|7745544|FG000|Overall Study|Not Able to Get to Clinic|1
4769710|NCT03048422|7745545|FG001|Overall Study|Not Able to Get to Clinic|0
4769711|NCT03048422|7745546|FG002|Overall Study|Not Able to Get to Clinic|0
4769712|NCT03032068|7745564|FG000|Overall Study|Adverse Event|1
4769713|NCT02835690|7745584|FG000|Overall Study|Death|4
4769714|NCT02835690|7745585|FG001|Overall Study|Death|6
4769715|NCT02835690|7745586|FG002|Overall Study|Death|6
4769716|NCT02835690|7745584|FG000|Overall Study|Ongoing in Study (Follow-up)|10
4769717|NCT02835690|7745585|FG001|Overall Study|Ongoing in Study (Follow-up)|7
4769718|NCT02835690|7745586|FG002|Overall Study|Ongoing in Study (Follow-up)|9
4769719|NCT02835690|7745584|FG000|Overall Study|Not Treated|0
4769720|NCT02835690|7745585|FG001|Overall Study|Not Treated|2
4769721|NCT02835690|7745586|FG002|Overall Study|Not Treated|0
4769722|NCT02828982|7745594|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1
4769723|NCT02828982|7745595|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1
4769724|NCT02815280|7745609|FG000|Double-Blind Phase|Adverse Event|1
4769725|NCT02815280|7745610|FG001|Double-Blind Phase|Adverse Event|1
4769726|NCT02815280|7745609|FG000|Double-Blind Phase|Lost to Follow-up|10
4769727|NCT02815280|7745610|FG001|Double-Blind Phase|Lost to Follow-up|9
4769728|NCT02815280|7745609|FG000|Double-Blind Phase|Withdrawal by Subject|20
4769729|NCT02815280|7745610|FG001|Double-Blind Phase|Withdrawal by Subject|11
4769730|NCT02815280|7745609|FG000|Double-Blind Phase|Protocol Violation|2
4769731|NCT02815280|7745610|FG001|Double-Blind Phase|Protocol Violation|2
4769732|NCT02815280|7745609|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3
4769733|NCT02815280|7745610|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2
4769734|NCT02815280|7745609|FG000|Open-Label Phase|Adverse Event|2
4769735|NCT02815280|7745610|FG001|Open-Label Phase|Adverse Event|3
4769736|NCT02815280|7745609|FG000|Open-Label Phase|Lost to Follow-up|18
4769737|NCT02815280|7745610|FG001|Open-Label Phase|Lost to Follow-up|9
4769738|NCT02815280|7745609|FG000|Open-Label Phase|Withdrawal by Subject|33
4769739|NCT02815280|7745610|FG001|Open-Label Phase|Withdrawal by Subject|18
4769740|NCT02815280|7745609|FG000|Open-Label Phase|Protocol Violation|3
4769741|NCT02815280|7745610|FG001|Open-Label Phase|Protocol Violation|0
4769742|NCT02815280|7745609|FG000|Open-Label Phase|Administrative|26
4769743|NCT02815280|7745610|FG001|Open-Label Phase|Administrative|12
4769744|NCT02815280|7745609|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5
4769745|NCT02815280|7745610|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2
4769746|NCT02815267|7745622|FG000|Double-Blind Phase|Adverse Event|0
4769747|NCT02815267|7745623|FG001|Double-Blind Phase|Adverse Event|3
4769748|NCT02815267|7745622|FG000|Double-Blind Phase|Lost to Follow-up|17
4769749|NCT02815267|7745623|FG001|Double-Blind Phase|Lost to Follow-up|9
4769750|NCT02815267|7745622|FG000|Double-Blind Phase|Withdrawal by Subject|11
4769751|NCT02815267|7745623|FG001|Double-Blind Phase|Withdrawal by Subject|10
4769752|NCT02815267|7745622|FG000|Double-Blind Phase|Protocol Violation|3
4769753|NCT02815267|7745623|FG001|Double-Blind Phase|Protocol Violation|2
4769754|NCT02815267|7745622|FG000|Double-Blind Phase|Site withdrawal|1
4769755|NCT02815267|7745623|FG001|Double-Blind Phase|Site withdrawal|6
4769756|NCT02815267|7745622|FG000|Double-Blind Phase|Received a disallowed medication|1
4769757|NCT02815267|7745623|FG001|Double-Blind Phase|Received a disallowed medication|1
4769758|NCT02815267|7745622|FG000|Open-Label Phase|Adverse Event|1
4769759|NCT02815267|7745623|FG001|Open-Label Phase|Adverse Event|1
4769760|NCT02815267|7745622|FG000|Open-Label Phase|Lost to Follow-up|23
4769761|NCT02815267|7745623|FG001|Open-Label Phase|Lost to Follow-up|9
4769762|NCT02815267|7745622|FG000|Open-Label Phase|Withdrawal by Subject|24
4769763|NCT02815267|7745623|FG001|Open-Label Phase|Withdrawal by Subject|13
4769764|NCT02815267|7745622|FG000|Open-Label Phase|Protocol Violation|0
4769765|NCT02815267|7745623|FG001|Open-Label Phase|Protocol Violation|1
4769766|NCT02815267|7745622|FG000|Open-Label Phase|Administrative|21
4769767|NCT02815267|7745623|FG001|Open-Label Phase|Administrative|12
4769768|NCT02815267|7745622|FG000|Open-Label Phase|Other|2
4769769|NCT02815267|7745623|FG001|Open-Label Phase|Other|5
4769770|NCT02802228|7745635|FG000|Overall Study|Withdrawal by Subject|2
4769771|NCT02802228|7745636|FG001|Overall Study|Withdrawal by Subject|0
4769772|NCT02802228|7745635|FG000|Overall Study|Lost to Follow-up|1
4769773|NCT02802228|7745636|FG001|Overall Study|Lost to Follow-up|0
4769774|NCT02802228|7745635|FG000|Overall Study|Adverse Event|1
4769775|NCT02802228|7745636|FG001|Overall Study|Adverse Event|0
4769776|NCT02802228|7745635|FG000|Overall Study|Physician Decision|1
4769777|NCT02802228|7745636|FG001|Overall Study|Physician Decision|0
4769778|NCT02674516|7745667|FG000|Overall Study|Lost to Follow-up|3
4769779|NCT02674516|7745668|FG001|Overall Study|Lost to Follow-up|0
4769780|NCT02674516|7745667|FG000|Overall Study|Protocol Violation|0
4769781|NCT02674516|7745668|FG001|Overall Study|Protocol Violation|4
4769782|NCT02674516|7745667|FG000|Overall Study|Knowledge of study hypothesis|1
4769783|NCT02674516|7745668|FG001|Overall Study|Knowledge of study hypothesis|0
4769784|NCT02655016|7745676|FG000|Overall Study|Disease progression|6
4769785|NCT02655016|7745677|FG001|Overall Study|Disease progression|4
4769786|NCT02655016|7745676|FG000|Overall Study|Site closed|0
4769787|NCT02655016|7745677|FG001|Overall Study|Site closed|1
4769788|NCT02655016|7745676|FG000|Overall Study|Death|30
4769789|NCT02655016|7745677|FG001|Overall Study|Death|48
4769790|NCT02655016|7745676|FG000|Overall Study|Lost to Follow-up|1
4769791|NCT02655016|7745677|FG001|Overall Study|Lost to Follow-up|1
4769792|NCT02655016|7745676|FG000|Overall Study|Withdrawal by Subject|18
4769793|NCT02655016|7745677|FG001|Overall Study|Withdrawal by Subject|36
4769794|NCT02505425|7745697|FG000|Overall Study|Lost to Follow-up|41
4769795|NCT02505425|7745698|FG001|Overall Study|Lost to Follow-up|61
4769796|NCT02505425|7745699|FG002|Overall Study|Lost to Follow-up|31
4769797|NCT02505425|7745700|FG003|Overall Study|Lost to Follow-up|19
4769798|NCT02505425|7745697|FG000|Overall Study|Withdrawal by Subject|39
4769799|NCT02505425|7745698|FG001|Overall Study|Withdrawal by Subject|9
4769800|NCT02505425|7745699|FG002|Overall Study|Withdrawal by Subject|19
4769801|NCT02505425|7745700|FG003|Overall Study|Withdrawal by Subject|7
4769802|NCT02505425|7745697|FG000|Overall Study|Death|8
4769803|NCT02505425|7745698|FG001|Overall Study|Death|12
4769804|NCT02505425|7745699|FG002|Overall Study|Death|0
4769805|NCT02505425|7745700|FG003|Overall Study|Death|0
4769806|NCT02487979|7745710|FG000|Overall Study|Physician Decision|2
4769807|NCT02487979|7745710|FG000|Overall Study|Withdrawal by Subject|2
4769808|NCT02487979|7745710|FG000|Overall Study|Progressive Disease|17
4769809|NCT02463448|7745714|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3
4769810|NCT02463448|7745714|FG000|6 Months Through 12 Months|Lost to Follow-up|1
4769811|NCT02463448|7745714|FG000|6 Months Through 12 Months|Withdrawal by Subject|1
4769812|NCT02463448|7745714|FG000|12 Months Through End of Study|Lost to Follow-up|1
4769813|NCT02276547|7745727|FG000|Overall Study|Death|2
4769814|NCT02276547|7745727|FG000|Overall Study|Explant|2
4769815|NCT02263885|7745731|FG000|Overall Study|Withdrawal by Subject|7
4769816|NCT02263885|7745731|FG000|Overall Study|Alternative Treatment|3
4769817|NCT02213926|7745736|FG000|Overall Study|Death|59
4769818|NCT02213926|7745736|FG000|Overall Study|Withdrawal by Subject|10
4769819|NCT02213926|7745736|FG000|Overall Study|study terminated by sponsor|51
4769820|NCT02213926|7745736|FG000|Overall Study|Lost to Follow-up|3
4769821|NCT02213926|7745736|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1
4769822|NCT02008396|7745742|FG000|Overall Study|Protocol Violation|0
4769823|NCT02008396|7745743|FG001|Overall Study|Protocol Violation|1
4769824|NCT01995175|7745750|FG000|Overall Study|Withdrawal by Subject|35
4769825|NCT01995175|7745750|FG000|Overall Study|Lost to Follow-up|102
4769826|NCT01995175|7745750|FG000|Overall Study|Other|67
4769827|NCT01995175|7745750|FG000|Overall Study|Migrated / moved from the study area|49
4769828|NCT01804270|7745764|FG000|Overall Study|Withdrawal by Subject|1
4769829|NCT01804270|7745765|FG001|Overall Study|Withdrawal by Subject|1
4769830|NCT01781390|7745774|FG000|Overall Study|Withdrawal of Consent|0
4769831|NCT01781390|7745775|FG001|Overall Study|Withdrawal of Consent|3
4769832|NCT01781390|7745776|FG002|Overall Study|Withdrawal of Consent|1
4769833|NCT01781390|7745774|FG000|Overall Study|Lost to Follow-up|1
4769834|NCT01781390|7745775|FG001|Overall Study|Lost to Follow-up|1
4769835|NCT01781390|7745776|FG002|Overall Study|Lost to Follow-up|1
4769836|NCT01781390|7745774|FG000|Overall Study|Adverse Event|1
4769837|NCT01781390|7745775|FG001|Overall Study|Adverse Event|2
4769838|NCT01781390|7745776|FG002|Overall Study|Adverse Event|1
4769839|NCT01781390|7745774|FG000|Overall Study|Participants who were Randomized and Not Treated|1
4769840|NCT01781390|7745775|FG001|Overall Study|Participants who were Randomized and Not Treated|1
4769841|NCT01781390|7745776|FG002|Overall Study|Participants who were Randomized and Not Treated|1
4769842|NCT01566695|7745786|FG000|Overall Study|Lack of Efficacy|18
4769843|NCT01566695|7745787|FG001|Overall Study|Lack of Efficacy|45
4769844|NCT01566695|7745786|FG000|Overall Study|Adverse Event|28
4769845|NCT01566695|7745787|FG001|Overall Study|Adverse Event|27
4769846|NCT01566695|7745786|FG000|Overall Study|Death|20
4769847|NCT01566695|7745787|FG001|Overall Study|Death|8
4769848|NCT01566695|7745786|FG000|Overall Study|Withdrawal by Subject|14
4769849|NCT01566695|7745787|FG001|Overall Study|Withdrawal by Subject|7
4769850|NCT01566695|7745786|FG000|Overall Study|Progressive Disease|11
4769851|NCT01566695|7745787|FG001|Overall Study|Progressive Disease|6
4769852|NCT01566695|7745786|FG000|Overall Study|Miscellaneous|4
4769853|NCT01566695|7745787|FG001|Overall Study|Miscellaneous|6
4769854|NCT01338636|7745793|FG000|Overall Study|Withdrawn due to lack of improvement|8
4769855|NCT01208974|7745797|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1
4769856|NCT01208974|7745798|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0
4769857|NCT01208974|7745799|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0
4769858|NCT01208974|7745800|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0
4769859|NCT01208974|7745797|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1
4769860|NCT01208974|7745798|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0
4769861|NCT01208974|7745799|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0
4769862|NCT01208974|7745800|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0
4769863|NCT01208974|7745797|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1
4769864|NCT01208974|7745798|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0
4769865|NCT01208974|7745799|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0
4769866|NCT01208974|7745800|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0
4769867|NCT00938912|7745807|FG000|Overall Study|Withdrawal by Subject|28
4769868|NCT00938912|7745807|FG000|Overall Study|Lost to Follow-up|4
4769869|NCT00938912|7745807|FG000|Overall Study|Lack of Efficacy|43
4769870|NCT00938912|7745807|FG000|Overall Study|Adverse event, non-fatal|24
4769871|NCT00938912|7745807|FG000|Overall Study|Adverse event, fatal|1
4769872|NCT00938912|7745807|FG000|Overall Study|Participant self adjusted antiepileptic medication|1
4769873|NCT00938912|7745807|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1
4769874|NCT00938912|7745807|FG000|Overall Study|Participant needed prohibit medication|1
4769875|NCT00938912|7745807|FG000|Overall Study|Participant was scheduled for lobal resection|1
4769876|NCT00938912|7745807|FG000|Overall Study|Did not meet Eligibility criteria|1
4769877|NCT00938912|7745807|FG000|Overall Study|Participant relocated not related to AE|1
4769878|NCT00938912|7745807|FG000|Overall Study|Participant moved to another city|1
4769879|NCT00938912|7745807|FG000|Overall Study|Participant experienced break through seizures|1
4769880|NCT00938912|7745807|FG000|Overall Study|No longer wished to participate in the study|1
4769881|NCT00938912|7745807|FG000|Overall Study|Protocol Deviation|2
4769882|NCT00676715|7745843|FG000|Overall Study|Withdrawal by Subject|7
4769883|NCT00676715|7745844|FG001|Overall Study|Withdrawal by Subject|9
4769884|NCT00676715|7745845|FG002|Overall Study|Withdrawal by Subject|10
4769885|NCT00676715|7745846|FG003|Overall Study|Withdrawal by Subject|10
4769886|NCT00676715|7745843|FG000|Overall Study|Other|2
4769887|NCT00676715|7745844|FG001|Overall Study|Other|6
4769888|NCT00676715|7745845|FG002|Overall Study|Other|4
4769889|NCT00676715|7745846|FG003|Overall Study|Other|3
4769890|NCT00676715|7745843|FG000|Overall Study|Lost to Follow-up|1
4769891|NCT00676715|7745844|FG001|Overall Study|Lost to Follow-up|1
4769892|NCT00676715|7745845|FG002|Overall Study|Lost to Follow-up|7
4769893|NCT00676715|7745846|FG003|Overall Study|Lost to Follow-up|3
4769894|NCT00676715|7745843|FG000|Overall Study|Death|1
4769895|NCT00676715|7745844|FG001|Overall Study|Death|1
4769896|NCT00676715|7745845|FG002|Overall Study|Death|1
4769897|NCT00676715|7745846|FG003|Overall Study|Death|0
4769898|NCT00676715|7745843|FG000|Overall Study|Adverse Event|0
4769899|NCT00676715|7745844|FG001|Overall Study|Adverse Event|1
4769900|NCT00676715|7745845|FG002|Overall Study|Adverse Event|2
4769901|NCT00676715|7745846|FG003|Overall Study|Adverse Event|0
4769902|NCT00676715|7745843|FG000|Overall Study|Participants Ongoing|29
4769903|NCT00676715|7745844|FG001|Overall Study|Participants Ongoing|29
4769904|NCT00676715|7745845|FG002|Overall Study|Participants Ongoing|17
4769905|NCT00676715|7745846|FG003|Overall Study|Participants Ongoing|24
4769906|NCT00579826|7745858|FG000|Overall Study|Withdrawal by Subject|5
4769907|NCT00579826|7745859|FG001|Overall Study|Withdrawal by Subject|3
4769908|NCT00322218|7745867|FG000|Overall Study|Death|3
4769909|NCT00322218|7745868|FG001|Overall Study|Death|6
4769910|NCT00186888|7745877|FG000|Overall Study|Toxicity|0
4769911|NCT00186888|7745878|FG001|Overall Study|Toxicity|1
4769912|NCT00186888|7745879|FG002|Overall Study|Toxicity|0
4769913|NCT00186888|7745877|FG000|Overall Study|Relapse or progression of disease|4
4769914|NCT00186888|7745878|FG001|Overall Study|Relapse or progression of disease|2
4769915|NCT00186888|7745879|FG002|Overall Study|Relapse or progression of disease|0
4769916|NCT04311463|7745964|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1
4769917|NCT04311463|7745965|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0
4769918|NCT04311463|7745964|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1
4769919|NCT04311463|7745965|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1
4769920|NCT04311463|7745964|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2
4769921|NCT04311463|7745965|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1
4769922|NCT03930186|7745981|FG000|Weeks 0 to 16|Adverse Event|6
4769923|NCT03930186|7745981|FG000|Weeks 0 to 16|Withdrawal by Subject|6
4769924|NCT03930186|7745981|FG000|Weeks 16 to 32|Adverse Event|1
4769925|NCT03930186|7745981|FG000|Weeks 16 to 32|Withdrawal by Subject|3
4769926|NCT03740100|7745985|FG000|Overall Study|Adverse Event|1
4769927|NCT03740100|7745985|FG000|Overall Study|Death|1
4769928|NCT03597295|7745989|FG000|Overall Study|Death|37
4769929|NCT03597295|7745989|FG000|Overall Study|Lost to Follow-up|3
4769930|NCT03597295|7745989|FG000|Overall Study|Participants ongoing in the study|54
4769931|NCT03086369|7745999|FG000|Overall Study|Adverse Event|0
4769932|NCT03086369|7746000|FG001|Overall Study|Adverse Event|0
4769933|NCT03086369|7746001|FG002|Overall Study|Adverse Event|0
4769934|NCT03086369|7746002|FG003|Overall Study|Adverse Event|3
4769935|NCT03086369|7746003|FG004|Overall Study|Adverse Event|4
4769936|NCT03086369|7745999|FG000|Overall Study|Lost to Follow-up|1
4769937|NCT03086369|7746000|FG001|Overall Study|Lost to Follow-up|0
4769938|NCT03086369|7746001|FG002|Overall Study|Lost to Follow-up|0
4769939|NCT03086369|7746002|FG003|Overall Study|Lost to Follow-up|2
4769940|NCT03086369|7746003|FG004|Overall Study|Lost to Follow-up|1
4769941|NCT03086369|7745999|FG000|Overall Study|Physician Decision|0
4769942|NCT03086369|7746000|FG001|Overall Study|Physician Decision|0
4769943|NCT03086369|7746001|FG002|Overall Study|Physician Decision|0
4769944|NCT03086369|7746002|FG003|Overall Study|Physician Decision|2
4769945|NCT03086369|7746003|FG004|Overall Study|Physician Decision|5
4769946|NCT03086369|7745999|FG000|Overall Study|Withdrawal by Subject|0
4769947|NCT03086369|7746000|FG001|Overall Study|Withdrawal by Subject|0
4769948|NCT03086369|7746001|FG002|Overall Study|Withdrawal by Subject|0
4769949|NCT03086369|7746002|FG003|Overall Study|Withdrawal by Subject|5
4769950|NCT03086369|7746003|FG004|Overall Study|Withdrawal by Subject|5
4769951|NCT03086369|7745999|FG000|Overall Study|Progressive Disease|0
4769952|NCT03086369|7746000|FG001|Overall Study|Progressive Disease|0
4769953|NCT03086369|7746001|FG002|Overall Study|Progressive Disease|0
4769954|NCT03086369|7746002|FG003|Overall Study|Progressive Disease|14
4769955|NCT03086369|7746003|FG004|Overall Study|Progressive Disease|4
4769956|NCT03086369|7745999|FG000|Overall Study|On Treatment|0
4769957|NCT03086369|7746000|FG001|Overall Study|On Treatment|0
4769958|NCT03086369|7746001|FG002|Overall Study|On Treatment|0
4769959|NCT03086369|7746002|FG003|Overall Study|On Treatment|1
4769960|NCT03086369|7746003|FG004|Overall Study|On Treatment|2
4769961|NCT02849626|7746029|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11
4769962|NCT02849626|7746030|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3
4769963|NCT02849626|7746029|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7
4769964|NCT02849626|7746030|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2
4769965|NCT02849626|7746029|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6
4769966|NCT02849626|7746030|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2
4769967|NCT02849626|7746029|FG000|Core Phase (up to 23 Weeks)|Non-specified|3
4769968|NCT02849626|7746030|FG001|Core Phase (up to 23 Weeks)|Non-specified|0
4769969|NCT02849626|7746029|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3
4769970|NCT02849626|7746030|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2
4769971|NCT02849626|7746029|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4
4769972|NCT02849626|7746030|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0
4769973|NCT02849626|7746029|FG000|Extension Phase A (up to 29 Weeks)|Inadequate therapeutic effect|3
4769974|NCT02849626|7746030|FG001|Extension Phase A (up to 29 Weeks)|Inadequate therapeutic effect|1
4769975|NCT02849626|7746029|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1
4769976|NCT02849626|7746030|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0
4769977|NCT02779855|7746049|FG000|Overall Study|Withdrawal by patient prior to treatment|1
4769978|NCT02779855|7746050|FG001|Overall Study|Withdrawal by patient prior to treatment|0
4769979|NCT02779855|7746051|FG002|Overall Study|Withdrawal by patient prior to treatment|0
4769980|NCT02654132|7746062|FG000|Overall Study|Disease Progression|26
4769981|NCT02654132|7746063|FG001|Overall Study|Disease Progression|31
4769982|NCT02654132|7746062|FG000|Overall Study|Adverse Event Unrelated to Study Drug|5
4769983|NCT02654132|7746063|FG001|Overall Study|Adverse Event Unrelated to Study Drug|5
4769984|NCT02654132|7746062|FG000|Overall Study|Switched to another tx|0
4769985|NCT02654132|7746063|FG001|Overall Study|Switched to another tx|1
4769986|NCT02654132|7746062|FG000|Overall Study|Study Drug Toxicity|1
4769987|NCT02654132|7746063|FG001|Overall Study|Study Drug Toxicity|2
4769988|NCT02654132|7746062|FG000|Overall Study|Maximum Clinical Benefit|0
4769989|NCT02654132|7746063|FG001|Overall Study|Maximum Clinical Benefit|2
4769990|NCT02654132|7746062|FG000|Overall Study|Subj Request to Discontinue Treatment|1
4769991|NCT02654132|7746063|FG001|Overall Study|Subj Request to Discontinue Treatment|0
4769992|NCT02654132|7746062|FG000|Overall Study|Not Reported|0
4769993|NCT02654132|7746063|FG001|Overall Study|Not Reported|1
4769994|NCT02654132|7746062|FG000|Overall Study|Subject Withdrew Consent|2
4769995|NCT02654132|7746063|FG001|Overall Study|Subject Withdrew Consent|1
4769996|NCT02654132|7746062|FG000|Overall Study|Inadequate response to therapy|1
4769997|NCT02654132|7746063|FG001|Overall Study|Inadequate response to therapy|0
4769998|NCT02654132|7746062|FG000|Overall Study|Clinical Progression (not protocol)|0
4769999|NCT02654132|7746063|FG001|Overall Study|Clinical Progression (not protocol)|1
4770000|NCT02654132|7746062|FG000|Overall Study|Never treated|0
4770001|NCT02654132|7746063|FG001|Overall Study|Never treated|2
4770002|NCT02603432|7746072|FG000|Overall Study|Ongoing|184
4770003|NCT02603432|7746073|FG001|Overall Study|Ongoing|144
4770004|NCT02603432|7746072|FG000|Overall Study|Adverse Event|1
4770005|NCT02603432|7746073|FG001|Overall Study|Adverse Event|0
4770006|NCT02603432|7746072|FG000|Overall Study|Death|144
4770007|NCT02603432|7746073|FG001|Overall Study|Death|177
4770008|NCT02603432|7746072|FG000|Overall Study|Lost to Follow-up|4
4770009|NCT02603432|7746073|FG001|Overall Study|Lost to Follow-up|6
4770010|NCT02603432|7746072|FG000|Overall Study|Progressive Disease|5
4770011|NCT02603432|7746073|FG001|Overall Study|Progressive Disease|5
4770012|NCT02603432|7746072|FG000|Overall Study|Withdrawal by Subject|9
4770013|NCT02603432|7746073|FG001|Overall Study|Withdrawal by Subject|17
4770014|NCT02603432|7746072|FG000|Overall Study|No Longer Meets Eligibility Criteria|3
4770015|NCT02603432|7746073|FG001|Overall Study|No Longer Meets Eligibility Criteria|0
4770016|NCT02603432|7746072|FG000|Overall Study|Other|0
4770017|NCT02603432|7746073|FG001|Overall Study|Other|1
4770018|NCT02600923|7746079|FG000|Overall Study|Death|10
4770019|NCT02600923|7746079|FG000|Overall Study|Adverse Event|3
4770020|NCT02600923|7746079|FG000|Overall Study|Global deterioration of health status|2
4770021|NCT02600923|7746079|FG000|Overall Study|Insufficient clinical response|6
4770022|NCT02600923|7746079|FG000|Overall Study|Lost to Follow-up|1
4770023|NCT02600923|7746079|FG000|Overall Study|Withdrawal by Subject|5
4770024|NCT02600923|7746079|FG000|Overall Study|Objective progression or relapse|50
4770025|NCT02600923|7746079|FG000|Overall Study|Study terminated by Sponsor|53
4770026|NCT02600923|7746079|FG000|Overall Study|Not treated|1
4770027|NCT02412735|7746104|FG000|Overall Study|Adverse Event|0
4770028|NCT02412735|7746105|FG001|Overall Study|Adverse Event|1
4770029|NCT02412735|7746106|FG002|Overall Study|Adverse Event|2
4770030|NCT02412735|7746104|FG000|Overall Study|Withdrawal by Subject|23
4770031|NCT02412735|7746105|FG001|Overall Study|Withdrawal by Subject|27
4770032|NCT02412735|7746106|FG002|Overall Study|Withdrawal by Subject|22
4770033|NCT02412735|7746104|FG000|Overall Study|Investigator Decision|3
4770034|NCT02412735|7746105|FG001|Overall Study|Investigator Decision|3
4770035|NCT02412735|7746106|FG002|Overall Study|Investigator Decision|2
4770036|NCT02412735|7746104|FG000|Overall Study|Lost to Follow-up|17
4770037|NCT02412735|7746105|FG001|Overall Study|Lost to Follow-up|11
4770038|NCT02412735|7746106|FG002|Overall Study|Lost to Follow-up|18
4770039|NCT02412735|7746104|FG000|Overall Study|Reason not Specified|3
4770040|NCT02412735|7746105|FG001|Overall Study|Reason not Specified|2
4770041|NCT02412735|7746106|FG002|Overall Study|Reason not Specified|2
4770042|NCT02371889|7746116|FG000|Overall Study|Adverse medication effect|11
4770043|NCT02371889|7746117|FG001|Overall Study|Adverse medication effect|2
4770044|NCT02371889|7746116|FG000|Overall Study|Lost to Follow-up|6
4770045|NCT02371889|7746117|FG001|Overall Study|Lost to Follow-up|5
4770046|NCT02371889|7746116|FG000|Overall Study|Personal time constraints|2
4770047|NCT02371889|7746117|FG001|Overall Study|Personal time constraints|4
4770048|NCT02371889|7746116|FG000|Overall Study|Lack of Efficacy|0
4770049|NCT02371889|7746117|FG001|Overall Study|Lack of Efficacy|2
4770050|NCT02371889|7746116|FG000|Overall Study|Relapse|0
4770051|NCT02371889|7746117|FG001|Overall Study|Relapse|1
4770052|NCT02272803|7746129|FG000|Overall Study|Disease progression|4
4770053|NCT02272803|7746130|FG001|Overall Study|Disease progression|2
4770054|NCT02272803|7746129|FG000|Overall Study|Adverse Event unrelated to study drug|1
4770055|NCT02272803|7746130|FG001|Overall Study|Adverse Event unrelated to study drug|4
4770056|NCT02272803|7746129|FG000|Overall Study|Study drug toxicity|1
4770057|NCT02272803|7746130|FG001|Overall Study|Study drug toxicity|4
4770058|NCT02272803|7746129|FG000|Overall Study|Subj request to discontinue study trt|1
4770059|NCT02272803|7746130|FG001|Overall Study|Subj request to discontinue study trt|4
4770060|NCT02272803|7746129|FG000|Overall Study|Maximum clinical benefit|1
4770061|NCT02272803|7746130|FG001|Overall Study|Maximum clinical benefit|1
4770062|NCT02272803|7746129|FG000|Overall Study|Subject moved to care facility|0
4770063|NCT02272803|7746130|FG001|Overall Study|Subject moved to care facility|1
4770064|NCT02272803|7746129|FG000|Overall Study|Poor/non-compliance|0
4770065|NCT02272803|7746130|FG001|Overall Study|Poor/non-compliance|1
4770066|NCT02272803|7746129|FG000|Overall Study|Withdrawal by Subject|1
4770067|NCT02272803|7746130|FG001|Overall Study|Withdrawal by Subject|0
4770068|NCT02186834|7746136|FG000|Dose Escalation|Death|0
4770069|NCT02186834|7746137|FG001|Dose Escalation|Death|0
4770070|NCT02186834|7746138|FG002|Dose Escalation|Death|0
4770071|NCT02186834|7746139|FG003|Dose Escalation|Death|1
4770072|NCT02186834|7746140|FG004|Dose Escalation|Death|0
4770073|NCT02186834|7746141|FG005|Dose Escalation|Death|0
4770074|NCT02186834|7746136|FG000|Treatment at RP2D|Died prior to treatment|0
4770075|NCT02186834|7746137|FG001|Treatment at RP2D|Died prior to treatment|0
4770076|NCT02186834|7746138|FG002|Treatment at RP2D|Died prior to treatment|0
4770077|NCT02186834|7746139|FG003|Treatment at RP2D|Died prior to treatment|0
4770078|NCT02186834|7746140|FG004|Treatment at RP2D|Died prior to treatment|0
4770079|NCT02186834|7746141|FG005|Treatment at RP2D|Died prior to treatment|1
4770080|NCT02100722|7746161|FG000|Overall Study|Withdrawal pre-procedure|4
4770081|NCT02100722|7746162|FG001|Overall Study|Withdrawal pre-procedure|9
4770082|NCT02100722|7746161|FG000|Overall Study|Withdrawal post-procedure|0
4770083|NCT02100722|7746162|FG001|Overall Study|Withdrawal post-procedure|3
4770084|NCT02100722|7746161|FG000|Overall Study|Lost to Follow-up|2
4770085|NCT02100722|7746162|FG001|Overall Study|Lost to Follow-up|2
4770086|NCT02100722|7746161|FG000|Overall Study|Continuing on study|751
4770087|NCT02100722|7746162|FG001|Overall Study|Continuing on study|729
4770088|NCT02059265|7746169|FG000|Overall Study|Ineligible|4
4770089|NCT02046096|7746175|FG000|Overall Study|Death|28
4770090|NCT02046096|7746176|FG001|Overall Study|Death|45
4770091|NCT02046096|7746175|FG000|Overall Study|Lost to Follow-up|9
4770092|NCT02046096|7746176|FG001|Overall Study|Lost to Follow-up|20
4770093|NCT02046096|7746175|FG000|Overall Study|Withdrawal by Subject|5
4770094|NCT02046096|7746176|FG001|Overall Study|Withdrawal by Subject|17
4770095|NCT02046096|7746175|FG000|Overall Study|Other endpoint|2
4770096|NCT02046096|7746176|FG001|Overall Study|Other endpoint|19
4770097|NCT01945775|7746186|FG000|Overall Study|Death|214
4770098|NCT01945775|7746187|FG001|Overall Study|Death|98
4770099|NCT01945775|7746186|FG000|Overall Study|Lost to Follow-up|12
4770100|NCT01945775|7746187|FG001|Overall Study|Lost to Follow-up|7
4770101|NCT01945775|7746186|FG000|Overall Study|Withdrawal by Subject|11
4770102|NCT01945775|7746187|FG001|Overall Study|Withdrawal by Subject|21
4770103|NCT01945775|7746186|FG000|Overall Study|Other|50
4770104|NCT01945775|7746187|FG001|Overall Study|Other|18
4770105|NCT01781637|7746195|FG000|Overall Study|Adverse Event|1
4770106|NCT01781637|7746196|FG001|Overall Study|Adverse Event|0
4770107|NCT01781637|7746195|FG000|Overall Study|Lack of Efficacy|2
4770108|NCT01781637|7746196|FG001|Overall Study|Lack of Efficacy|6
4770109|NCT01781637|7746195|FG000|Overall Study|Withdrawal by Subject|1
4770110|NCT01781637|7746196|FG001|Overall Study|Withdrawal by Subject|0
4770111|NCT01711541|7746207|FG000|Overall Study|Cancel prior to treatment|0
4770112|NCT01711541|7746208|FG001|Overall Study|Cancel prior to treatment|0
4770113|NCT01711541|7746209|FG002|Overall Study|Cancel prior to treatment|0
4770114|NCT01711541|7746210|FG003|Overall Study|Cancel prior to treatment|1
4770115|NCT01711541|7746211|FG004|Overall Study|Cancel prior to treatment|0
4770116|NCT01711541|7746207|FG000|Overall Study|Ineligible|0
4770117|NCT01711541|7746208|FG001|Overall Study|Ineligible|1
4770118|NCT01711541|7746209|FG002|Overall Study|Ineligible|0
4770119|NCT01711541|7746210|FG003|Overall Study|Ineligible|0
4770120|NCT01711541|7746211|FG004|Overall Study|Ineligible|0
4770121|NCT01670539|7746228|FG000|Overall Study|Death|3
4770122|NCT01670539|7746229|FG001|Overall Study|Death|5
4770123|NCT01670539|7746228|FG000|Overall Study|Withdrawal by Subject|3
4770124|NCT01670539|7746229|FG001|Overall Study|Withdrawal by Subject|0
4770125|NCT00407602|7746236|FG000|Overall Study|Death - unrelated to device|1
4770126|NCT00407602|7746236|FG000|Overall Study|Device explanted|5
4770127|NCT00407602|7746236|FG000|Overall Study|Withdrawal by Subject|1
4770128|NCT04567186|7746260|FG000|Period 1|COVID-19 related|1
4770129|NCT04567186|7746261|FG001|Period 1|COVID-19 related|0
4770130|NCT04567186|7746260|FG000|Period 1|Protocol Violation|0
4770131|NCT04567186|7746261|FG001|Period 1|Protocol Violation|1
4770132|NCT04567186|7746260|FG000|Period 1|Adverse Event|0
4770133|NCT04567186|7746261|FG001|Period 1|Adverse Event|2
4770134|NCT04567186|7746260|FG000|Period 2|COVID-19 Related|0
4770135|NCT04567186|7746261|FG001|Period 2|COVID-19 Related|1
4770136|NCT04567186|7746260|FG000|Period 2|Protocol Violation|0
4770137|NCT04567186|7746261|FG001|Period 2|Protocol Violation|1
4770138|NCT04567186|7746260|FG000|Period 2|Lost to Follow-up|0
4770139|NCT04567186|7746261|FG001|Period 2|Lost to Follow-up|1
4770140|NCT04567186|7746260|FG000|Period 3|Subject no longer meets eligibilty criteria|1
4770141|NCT04567186|7746261|FG001|Period 3|Subject no longer meets eligibilty criteria|0
4770142|NCT04065074|7746284|FG000|Overall Study|Adverse Event|1
4770143|NCT04065074|7746284|FG000|Overall Study|Protocol Non-Compliance after injection|1
4770144|NCT03980730|7746290|FG000|Overall Study|Study Terminated by Sponsor|0
4770145|NCT03980730|7746291|FG001|Overall Study|Study Terminated by Sponsor|3
4770146|NCT03980730|7746290|FG000|Overall Study|Adverse Event|2
4770147|NCT03980730|7746291|FG001|Overall Study|Adverse Event|0
4770148|NCT03980730|7746290|FG000|Overall Study|Sponsor Request|0
4770149|NCT03980730|7746291|FG001|Overall Study|Sponsor Request|1
4770150|NCT03793010|7746299|FG000|Overall Study|Withdrawal by Subject|5
4770151|NCT03793010|7746300|FG001|Overall Study|Withdrawal by Subject|7
4770152|NCT03793010|7746299|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19
4770153|NCT03793010|7746300|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18
4770154|NCT03793010|7746299|FG000|Overall Study|Lost to Follow-up|1
4770155|NCT03793010|7746300|FG001|Overall Study|Lost to Follow-up|2
4770156|NCT03793010|7746299|FG000|Overall Study|Patient couldn't sit still for injection|1
4770157|NCT03793010|7746300|FG001|Overall Study|Patient couldn't sit still for injection|0
4770158|NCT03793010|7746299|FG000|Overall Study|Withdrew to pursue other treatment|1
4770159|NCT03793010|7746300|FG001|Overall Study|Withdrew to pursue other treatment|0
4770160|NCT03793010|7746299|FG000|Overall Study|Did not meet eligibility criteria|1
4770161|NCT03793010|7746300|FG001|Overall Study|Did not meet eligibility criteria|0
4770162|NCT03644017|7746306|FG000|Overall Study|Access Abandonment|5
4770163|NCT03644017|7746306|FG000|Overall Study|Kidney Transplant|2
4770164|NCT03592186|7746312|FG000|Overall Study|Withdrawal by Subject|1
4770165|NCT03592186|7746313|FG001|Overall Study|Withdrawal by Subject|0
4770166|NCT03592186|7746312|FG000|Overall Study|Lost to Follow-up|16
4770167|NCT03592186|7746313|FG001|Overall Study|Lost to Follow-up|11
4770168|NCT03529942|7746319|FG000|Overall Study|Withdrawal by Subject|13
4770169|NCT03529942|7746319|FG000|Overall Study|Physician Decision|1
4770170|NCT03529942|7746319|FG000|Overall Study|Lost to Follow-up|7
4770171|NCT03529942|7746319|FG000|Overall Study|Needle inserted but no drug administered|1
4770172|NCT03529942|7746319|FG000|Overall Study|Personal reasons|1
4770173|NCT03373760|7746328|FG000|Overall Study|Adverse Event|8
4770174|NCT03373760|7746328|FG000|Overall Study|Disease Progression|46
4770175|NCT03373760|7746328|FG000|Overall Study|Death|4
4770176|NCT03349775|7746337|FG000|Overall Study|Side Effects|1
4770177|NCT03349775|7746338|FG001|Overall Study|Side Effects|2
4770178|NCT03349775|7746337|FG000|Overall Study|Withdrawal by Subject|1
4770179|NCT03349775|7746338|FG001|Overall Study|Withdrawal by Subject|1
4770180|NCT03349775|7746337|FG000|Overall Study|No primary outcome measurements|0
4770181|NCT03349775|7746338|FG001|Overall Study|No primary outcome measurements|1
4770182|NCT03256344|7746355|FG000|Overall Study|Ongoing on study|3
4770183|NCT03256344|7746356|FG001|Overall Study|Ongoing on study|3
4770184|NCT03256344|7746355|FG000|Overall Study|Death|5
4770185|NCT03256344|7746356|FG001|Overall Study|Death|19
4770186|NCT03256344|7746355|FG000|Overall Study|Withdrawal by Subject|3
4770187|NCT03256344|7746356|FG001|Overall Study|Withdrawal by Subject|3
4770188|NCT03207815|7746364|FG000|Overall Study|Protocol Violation|3
4770189|NCT03207815|7746365|FG001|Overall Study|Protocol Violation|1
4770190|NCT03207815|7746364|FG000|Overall Study|Adverse Event|1
4770191|NCT03207815|7746365|FG001|Overall Study|Adverse Event|2
4770192|NCT03207815|7746364|FG000|Overall Study|Lost to Follow-up|1
4770193|NCT03207815|7746365|FG001|Overall Study|Lost to Follow-up|2
4770194|NCT03207815|7746364|FG000|Overall Study|Investigator's Discretion|1
4770195|NCT03207815|7746365|FG001|Overall Study|Investigator's Discretion|1
4770196|NCT03207815|7746364|FG000|Overall Study|Lack of Efficacy|0
4770197|NCT03207815|7746365|FG001|Overall Study|Lack of Efficacy|1
4770198|NCT03207815|7746364|FG000|Overall Study|Pregnancy/Partner Pregnancy|1
4770199|NCT03207815|7746365|FG001|Overall Study|Pregnancy/Partner Pregnancy|0
4770200|NCT03207815|7746364|FG000|Overall Study|Withdrew Consent|1
4770201|NCT03207815|7746365|FG001|Overall Study|Withdrew Consent|0
4770202|NCT02968563|7746391|FG000|Overall Study|Adverse Event|0
4770203|NCT02968563|7746392|FG001|Overall Study|Adverse Event|6
4770204|NCT02968563|7746391|FG000|Overall Study|Death|1
4770205|NCT02968563|7746392|FG001|Overall Study|Death|1
4770206|NCT02968563|7746391|FG000|Overall Study|Lost to Follow-up|0
4770207|NCT02968563|7746392|FG001|Overall Study|Lost to Follow-up|1
4770208|NCT02915783|7746398|FG000|Overall Study|Ongoing: Receiving Treatment|6
4770209|NCT02915783|7746398|FG000|Overall Study|Ongoing: In Survival Follow Up|8
4770210|NCT02913482|7746405|FG000|Overall Study|Death|0
4770211|NCT02913482|7746406|FG001|Overall Study|Death|2
4770212|NCT02913482|7746407|FG002|Overall Study|Death|2
4770213|NCT02913482|7746405|FG000|Overall Study|Progressive Disease|1
4770214|NCT02913482|7746406|FG001|Overall Study|Progressive Disease|1
4770215|NCT02913482|7746407|FG002|Overall Study|Progressive Disease|1
4770216|NCT02787044|7746419|FG000|Overall Study|Lost to Follow-up|15
4770217|NCT02787044|7746420|FG001|Overall Study|Lost to Follow-up|19
4770218|NCT02698163|7746432|FG000|Overall Study|Lost to Follow-up|0
4770219|NCT02698163|7746433|FG001|Overall Study|Lost to Follow-up|1
4770220|NCT02352948|7746464|FG000|Overall Study|Death|47
4770221|NCT02352948|7746465|FG001|Overall Study|Death|48
4770222|NCT02352948|7746466|FG002|Overall Study|Death|114
4770223|NCT02352948|7746467|FG003|Overall Study|Death|74
4770224|NCT02352948|7746468|FG004|Overall Study|Death|77
4770225|NCT02352948|7746469|FG005|Overall Study|Death|44
4770226|NCT02352948|7746464|FG000|Overall Study|Lost to Follow-up|1
4770227|NCT02352948|7746465|FG001|Overall Study|Lost to Follow-up|0
4770228|NCT02352948|7746466|FG002|Overall Study|Lost to Follow-up|2
4770229|NCT02352948|7746467|FG003|Overall Study|Lost to Follow-up|1
4770230|NCT02352948|7746468|FG004|Overall Study|Lost to Follow-up|2
4770231|NCT02352948|7746469|FG005|Overall Study|Lost to Follow-up|1
4770232|NCT02352948|7746464|FG000|Overall Study|Withdrawal by Subject|1
4770233|NCT02352948|7746465|FG001|Overall Study|Withdrawal by Subject|10
4770234|NCT02352948|7746466|FG002|Overall Study|Withdrawal by Subject|11
4770235|NCT02352948|7746467|FG003|Overall Study|Withdrawal by Subject|23
4770236|NCT02352948|7746468|FG004|Overall Study|Withdrawal by Subject|9
4770237|NCT02352948|7746469|FG005|Overall Study|Withdrawal by Subject|4
4770238|NCT02352948|7746464|FG000|Overall Study|Eligibility criteria not fulfilled|0
4770239|NCT02352948|7746465|FG001|Overall Study|Eligibility criteria not fulfilled|1
4770240|NCT02352948|7746466|FG002|Overall Study|Eligibility criteria not fulfilled|0
4770241|NCT02352948|7746467|FG003|Overall Study|Eligibility criteria not fulfilled|1
4770242|NCT02352948|7746468|FG004|Overall Study|Eligibility criteria not fulfilled|0
4770243|NCT02352948|7746469|FG005|Overall Study|Eligibility criteria not fulfilled|0
4770244|NCT02352948|7746464|FG000|Overall Study|Other|0
4770245|NCT02352948|7746465|FG001|Overall Study|Other|0
4770246|NCT02352948|7746466|FG002|Overall Study|Other|2
4770247|NCT02352948|7746467|FG003|Overall Study|Other|0
4770248|NCT02352948|7746468|FG004|Overall Study|Other|0
4770249|NCT02352948|7746469|FG005|Overall Study|Other|0
4770250|NCT01816165|7746491|FG000|Overall Study|Adverse Event|1
4770251|NCT01816165|7746492|FG001|Overall Study|Adverse Event|0
4770252|NCT01816165|7746493|FG002|Overall Study|Adverse Event|0
4770253|NCT01816165|7746494|FG003|Overall Study|Adverse Event|0
4770254|NCT01813929|7746516|FG000|Overall Study|Withdrawal by Subject|0
4770255|NCT01813929|7746517|FG001|Overall Study|Withdrawal by Subject|1
4770256|NCT00882050|7746538|FG000|Overall Study|Physician Decision|1
4770257|NCT00882050|7746539|FG001|Overall Study|Physician Decision|0
4770258|NCT00882050|7746540|FG002|Overall Study|Physician Decision|0
4770259|NCT00070564|7746554|FG000|Overall Study|Progression|2
4770260|NCT00070564|7746555|FG001|Overall Study|Progression|4
4770261|NCT00070564|7746556|FG002|Overall Study|Progression|7
4770262|NCT00070564|7746557|FG003|Overall Study|Progression|7
4770263|NCT00070564|7746558|FG004|Overall Study|Progression|1
4770264|NCT00070564|7746559|FG005|Overall Study|Progression|0
4770265|NCT00070564|7746554|FG000|Overall Study|Delinquent|1
4770266|NCT00070564|7746555|FG001|Overall Study|Delinquent|4
4770267|NCT00070564|7746556|FG002|Overall Study|Delinquent|2
4770268|NCT00070564|7746557|FG003|Overall Study|Delinquent|0
4770269|NCT00070564|7746558|FG004|Overall Study|Delinquent|0
4770270|NCT00070564|7746559|FG005|Overall Study|Delinquent|0
4770271|NCT00070564|7746554|FG000|Overall Study|Adverse Event|150
4770272|NCT00070564|7746555|FG001|Overall Study|Adverse Event|142
4770273|NCT00070564|7746556|FG002|Overall Study|Adverse Event|120
4770274|NCT00070564|7746557|FG003|Overall Study|Adverse Event|108
4770275|NCT00070564|7746558|FG004|Overall Study|Adverse Event|63
4770276|NCT00070564|7746559|FG005|Overall Study|Adverse Event|36
4770277|NCT00070564|7746554|FG000|Overall Study|Death|4
4770278|NCT00070564|7746555|FG001|Overall Study|Death|1
4770279|NCT00070564|7746556|FG002|Overall Study|Death|5
4770280|NCT00070564|7746557|FG003|Overall Study|Death|3
4770281|NCT00070564|7746558|FG004|Overall Study|Death|0
4770282|NCT00070564|7746559|FG005|Overall Study|Death|1
4770283|NCT00070564|7746554|FG000|Overall Study|Other, not protocol specified|17
4770284|NCT00070564|7746555|FG001|Overall Study|Other, not protocol specified|15
4770285|NCT00070564|7746556|FG002|Overall Study|Other, not protocol specified|14
4770286|NCT00070564|7746557|FG003|Overall Study|Other, not protocol specified|19
4770287|NCT00070564|7746558|FG004|Overall Study|Other, not protocol specified|6
4770288|NCT00070564|7746559|FG005|Overall Study|Other, not protocol specified|7
4770289|NCT00070564|7746554|FG000|Overall Study|Withdrawal by Subject|26
4770290|NCT00070564|7746555|FG001|Overall Study|Withdrawal by Subject|37
4770291|NCT00070564|7746556|FG002|Overall Study|Withdrawal by Subject|23
4770292|NCT00070564|7746557|FG003|Overall Study|Withdrawal by Subject|30
4770293|NCT00070564|7746558|FG004|Overall Study|Withdrawal by Subject|8
4770294|NCT00070564|7746559|FG005|Overall Study|Withdrawal by Subject|8
4770295|NCT00070564|7746554|FG000|Overall Study|Not reported|0
4770296|NCT00070564|7746555|FG001|Overall Study|Not reported|0
4770297|NCT00070564|7746556|FG002|Overall Study|Not reported|0
4770298|NCT00070564|7746557|FG003|Overall Study|Not reported|0
4770299|NCT00070564|7746558|FG004|Overall Study|Not reported|1
4770300|NCT00070564|7746559|FG005|Overall Study|Not reported|0
4770301|NCT04425720|7746590|FG000|Overall Study|Withdrawal by Subject|0
4770302|NCT04425720|7746591|FG001|Overall Study|Withdrawal by Subject|20
4770303|NCT04409509|7746600|FG000|Overall Study|Failure to meet randomization requirement|1
4770304|NCT04409509|7746601|FG001|Overall Study|Failure to meet randomization requirement|0
4770305|NCT04409509|7746600|FG000|Overall Study|Adverse Event|0
4770306|NCT04409509|7746601|FG001|Overall Study|Adverse Event|1
4770307|NCT04409509|7746600|FG000|Overall Study|Death|11
4770308|NCT04409509|7746601|FG001|Overall Study|Death|10
4770309|NCT04409509|7746600|FG000|Overall Study|Non-compliance with study drug|0
4770310|NCT04409509|7746601|FG001|Overall Study|Non-compliance with study drug|1
4770311|NCT04409509|7746600|FG000|Overall Study|Lost to Follow-up|0
4770312|NCT04409509|7746601|FG001|Overall Study|Lost to Follow-up|3
4770313|NCT04409509|7746600|FG000|Overall Study|Withdrawal by Subject|0
4770314|NCT04409509|7746601|FG001|Overall Study|Withdrawal by Subject|3
4770315|NCT04409509|7746600|FG000|Overall Study|Randomized by mistake|0
4770316|NCT04409509|7746601|FG001|Overall Study|Randomized by mistake|1
4770317|NCT04409509|7746600|FG000|Overall Study|Other|1
4770318|NCT04409509|7746601|FG001|Overall Study|Other|1
4770319|NCT04380519|7746611|FG000|Overall Study|Withdrawal by Subject|4
4770320|NCT04380519|7746612|FG001|Overall Study|Withdrawal by Subject|0
4770321|NCT04380519|7746613|FG002|Overall Study|Withdrawal by Subject|1
4770322|NCT04380519|7746611|FG000|Overall Study|Death|14
4770323|NCT04380519|7746612|FG001|Overall Study|Death|9
4770324|NCT04380519|7746613|FG002|Overall Study|Death|6
4770325|NCT04380519|7746611|FG000|Overall Study|Adverse Event|0
4770326|NCT04380519|7746612|FG001|Overall Study|Adverse Event|1
4770327|NCT04380519|7746613|FG002|Overall Study|Adverse Event|0
4770328|NCT04380519|7746611|FG000|Overall Study|relatives' decision|0
4770329|NCT04380519|7746612|FG001|Overall Study|relatives' decision|1
4770330|NCT04380519|7746613|FG002|Overall Study|relatives' decision|0
4770331|NCT04362813|7746623|FG000|Overall Study|Death|12
4770332|NCT04362813|7746624|FG001|Overall Study|Death|16
4770333|NCT04362813|7746623|FG000|Overall Study|Withdrawal by Subject|3
4770334|NCT04362813|7746624|FG001|Overall Study|Withdrawal by Subject|1
4770335|NCT04362813|7746623|FG000|Overall Study|Protocol Violation|0
4770336|NCT04362813|7746624|FG001|Overall Study|Protocol Violation|3
4770337|NCT04362813|7746623|FG000|Overall Study|Lost to Follow-up|1
4770338|NCT04362813|7746624|FG001|Overall Study|Lost to Follow-up|1
4770339|NCT04362813|7746623|FG000|Overall Study|Enrolled but did not receive treatment|2
4770340|NCT04362813|7746624|FG001|Overall Study|Enrolled but did not receive treatment|4
